id|nct_id|mesh_term|downcase_mesh_term|mesh_type
154749399|NCT00483366|Capecitabine|capecitabine|mesh-list
154749477|NCT02493582|Apatinib|apatinib|mesh-list
154750370|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
154750518|NCT02725866|Ritonavir|ritonavir|mesh-list
154750743|NCT04945824|Dexamethasone|dexamethasone|mesh-list
154750968|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
154751269|NCT01804036|Zolpidem|zolpidem|mesh-list
154751413|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752091|NCT04745130|Cetuximab|cetuximab|mesh-list
154752192|NCT01772147|Xhance|xhance|mesh-list
154752387|NCT01884844|Vitamin D|vitamin d|mesh-list
154752459|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
154752992|NCT01920802|Iloperidone|iloperidone|mesh-list
154753373|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753741|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154753972|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
154754118|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
154754345|NCT02611323|Rituximab|rituximab|mesh-list
154755173|NCT02715726|Simvastatin|simvastatin|mesh-list
154755482|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755636|NCT01173172|Boron|boron|mesh-list
154755702|NCT03773484|Analgesics|analgesics|mesh-ancestor
154755941|NCT03289182|Rituximab|rituximab|mesh-list
154756235|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
154757056|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
154757603|NCT05861050|Venetoclax|venetoclax|mesh-list
154757817|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
154758045|NCT04352400|Nafamostat|nafamostat|mesh-list
154758123|NCT04207723|Paroxetine|paroxetine|mesh-list
154758192|NCT03920215|Varenicline|varenicline|mesh-list
154758492|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
154758568|NCT01522768|Paclitaxel|paclitaxel|mesh-list
154758643|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
154758951|NCT00789399|PENTA|penta|mesh-list
154759448|NCT02028676|Lamivudine|lamivudine|mesh-list
154759538|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759617|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154759761|NCT00158223|Pimozide|pimozide|mesh-list
154759833|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
154760057|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
154760132|NCT02374060|Hormones|hormones|mesh-ancestor
154760283|NCT02043652|Chloroquine|chloroquine|mesh-list
154760577|NCT04733937|Caseins|caseins|mesh-list
154761027|NCT02412982|Enoxaparin|enoxaparin|mesh-list
154761098|NCT03209856|Vitamin D|vitamin d|mesh-list
154761628|NCT06074757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154761710|NCT06000709|Phenol|phenol|mesh-list
154762159|NCT04046549|Methylprednisolone|methylprednisolone|mesh-list
154762310|NCT03403205|Choline|choline|mesh-list
154762621|NCT06242886|Oxytocin|oxytocin|mesh-list
154762986|NCT06098677|Carotenoids|carotenoids|mesh-list
154763142|NCT05879835|Heparin|heparin|mesh-list
154763507|NCT04345718|Buprenorphine|buprenorphine|mesh-list
154763815|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
154764123|NCT02445066|Vitamin D|vitamin d|mesh-list
154764192|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
154764346|NCT02449278|Prednisone|prednisone|mesh-list
154764495|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
154764900|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154765202|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
154765354|NCT00226239|Docetaxel|docetaxel|mesh-list
154765434|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
154765502|NCT00703014|Progesterone|progesterone|mesh-list
154765955|NCT02126553|Lenalidomide|lenalidomide|mesh-list
154766259|NCT03178656|Sorafenib|sorafenib|mesh-list
154767079|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
154768359|NCT02696226|Analgesics|analgesics|mesh-ancestor
154768816|NCT02680054|Insulin|insulin|mesh-list
154768898|NCT04707508|Metformin|metformin|mesh-list
154768995|NCT03417388|Aspirin|aspirin|mesh-list
154769042|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
154769342|NCT01556165|Rasagiline|rasagiline|mesh-list
154769486|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
154769711|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154770094|NCT00264381|Dalteparin|dalteparin|mesh-list
154770160|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154770388|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770470|NCT02388048|Ofatumumab|ofatumumab|mesh-list
154770534|NCT00512070|Olanzapine|olanzapine|mesh-list
154770691|NCT01528969|Sorbitol|sorbitol|mesh-list
154771428|NCT02376426|Antiviral Agents|antiviral agents|mesh-ancestor
154771654|NCT06306131|Meloxicam|meloxicam|mesh-list
154772030|NCT06036511|Anesthetics|anesthetics|mesh-ancestor
154772098|NCT05838768|Irinotecan|irinotecan|mesh-list
154772401|NCT04983901|Vancomycin|vancomycin|mesh-list
154772473|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
154772776|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772862|NCT03580525|Nicotine|nicotine|mesh-list
154774210|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
154774434|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
154774881|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
154774964|NCT02352168|Budesonide|budesonide|mesh-list
154775415|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
154775565|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
154775713|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154775872|NCT03105180|Mannitol|mannitol|mesh-list
154775945|NCT02338206|Hormones|hormones|mesh-list
154777165|NCT02646839|Biotin|biotin|mesh-list
154777217|NCT02547025|Rabeprazole|rabeprazole|mesh-list
154777824|NCT04088305|Vancomycin|vancomycin|mesh-list
154778120|NCT01477853|Metformin|metformin|mesh-list
154779323|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
154779845|NCT01687478|Olanzapine|olanzapine|mesh-list
154779986|NCT01559012|Clonidine|clonidine|mesh-list
154780211|NCT01451203|Methotrexate|methotrexate|mesh-list
154780444|NCT04108676|Fluzoparib|fluzoparib|mesh-list
154780662|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
154781115|NCT01444781|Vaccines|vaccines|mesh-list
154781184|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154781703|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
154781999|NCT01530464|Protective Agents|protective agents|mesh-ancestor
154782366|NCT01439347|Vincristine|vincristine|mesh-list
154782441|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
154782818|NCT01414075|Iron|iron|mesh-list
154782967|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
154783063|NCT04797312|Sufentanil|sufentanil|mesh-list
154783113|NCT01390441|Hormones|hormones|mesh-ancestor
154783187|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
154783337|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154783501|NCT00684723|Lovastatin|lovastatin|mesh-list
154783830|NCT00691665|Xhance|xhance|mesh-list
154783867|NCT03359460|Growth Substances|growth substances|mesh-ancestor
154784492|NCT03925350|Niraparib|niraparib|mesh-list
154785061|NCT03599791|Xhance|xhance|mesh-list
154785152|NCT06123169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785227|NCT06122090|Bimatoprost|bimatoprost|mesh-list
154785303|NCT06121518|Vasodilator Agents|vasodilator agents|mesh-ancestor
154785526|NCT06115473|Autonomic Agents|autonomic agents|mesh-ancestor
154785754|NCT05747352|Insulin|insulin|mesh-list
154785818|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
154785967|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154786115|NCT04998344|Vaccines|vaccines|mesh-list
154787036|NCT03247088|Busulfan|busulfan|mesh-list
154787177|NCT03020030|Hormones|hormones|mesh-ancestor
154787683|NCT05632549|Biotin|biotin|mesh-list
154787779|NCT01272531|Valproic Acid|valproic acid|mesh-list
154788001|NCT01406795|Heparin|heparin|mesh-list
154788298|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
154788604|NCT04985266|Tamoxifen|tamoxifen|mesh-list
154788760|NCT04156087|Durvalumab|durvalumab|mesh-list
154788900|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
154789200|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154789351|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
154789655|NCT04142749|Oltipraz|oltipraz|mesh-list
154789732|NCT04094948|Clenbuterol|clenbuterol|mesh-list
154789814|NCT04148599|Analgesics|analgesics|mesh-ancestor
154789888|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
154790256|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154790487|NCT03158935|Analgesics|analgesics|mesh-ancestor
154790789|NCT01670929|Progesterone|progesterone|mesh-list
154791089|NCT02626507|Fulvestrant|fulvestrant|mesh-list
154791161|NCT01923649|Lanreotide|lanreotide|mesh-list
154791244|NCT04115748|Adalimumab|adalimumab|mesh-list
154791392|NCT03807037|Vitamin E|vitamin e|mesh-list
154791616|NCT03700099|Docetaxel|docetaxel|mesh-list
154791777|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
154791845|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792457|NCT00089479|Docetaxel|docetaxel|mesh-list
154792670|NCT04094558|Lactulose|lactulose|mesh-list
154792740|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792892|NCT00797277|Lorazepam|lorazepam|mesh-list
154792963|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
154793203|NCT00081289|Vitamins|vitamins|mesh-ancestor
154545361|NCT02035943|Insulin|insulin|mesh-list
154793659|NCT01478048|BB 1101|bb 1101|mesh-list
154793809|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154794404|NCT05686915|Cobalt|cobalt|mesh-list
154794487|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
154794629|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794729|NCT00857961|Hormones|hormones|mesh-ancestor
154795095|NCT00867789|Trimethoprim|trimethoprim|mesh-list
154796126|NCT01830777|Immunotoxins|immunotoxins|mesh-ancestor
154796430|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
154796501|NCT03024515|Analgesics|analgesics|mesh-ancestor
154796575|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
154796653|NCT05243251|Olanzapine|olanzapine|mesh-list
154796819|NCT05244109|Antibodies|antibodies|mesh-list
154796878|NCT05249725|Irsogladine|irsogladine|mesh-list
154797021|NCT05242081|Narcotics|narcotics|mesh-ancestor
154797249|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154797324|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797634|NCT01360866|Analgesics|analgesics|mesh-ancestor
154798143|NCT01040871|Doxorubicin|doxorubicin|mesh-list
154798295|NCT03406533|Narcotics|narcotics|mesh-ancestor
154798825|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798978|NCT03402087|Deucravacitinib|deucravacitinib|mesh-list
154799054|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
154800186|NCT04355637|Budesonide|budesonide|mesh-list
154800550|NCT03891173|Vinorelbine|vinorelbine|mesh-list
154800623|NCT03580733|Caspofungin|caspofungin|mesh-list
154800770|NCT03067896|Bupivacaine|bupivacaine|mesh-list
154801002|NCT01674257|Fluorides|fluorides|mesh-list
154801596|NCT00967551|Zinc|zinc|mesh-list
154801712|NCT01672710|Niacin|niacin|mesh-list
154802155|NCT00990561|Clobetasol|clobetasol|mesh-list
154802204|NCT01363661|Molsidomine|molsidomine|mesh-list
154802279|NCT00994929|Oprelvekin|oprelvekin|mesh-list
154802518|NCT01025427|Tenofovir|tenofovir|mesh-list
154802651|NCT04358133|Narcotics|narcotics|mesh-ancestor
154802730|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154802951|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154803107|NCT05852093|Narcotics|narcotics|mesh-ancestor
154803330|NCT05345691|Denosumab|denosumab|mesh-list
154803402|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803627|NCT04625907|Dactinomycin|dactinomycin|mesh-list
154803930|NCT03377543|Aspirin|aspirin|mesh-list
154804312|NCT00492999|Leucovorin|leucovorin|mesh-list
154804847|NCT03013101|Antibodies|antibodies|mesh-list
154805070|NCT01624259|Metformin|metformin|mesh-list
154805447|NCT00085709|Cytarabine|cytarabine|mesh-list
154805966|NCT03369041|Irinotecan|irinotecan|mesh-list
154806104|NCT04278599|Zinc|zinc|mesh-list
154807015|NCT04784143|Hallucinogens|hallucinogens|mesh-ancestor
154807085|NCT04639414|Semaglutide|semaglutide|mesh-list
154807306|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807384|NCT03761511|Niacin|niacin|mesh-list
154807683|NCT02925234|Crizotinib|crizotinib|mesh-list
154807770|NCT02518945|Hormones|hormones|mesh-ancestor
154808226|NCT01237041|Niacin|niacin|mesh-list
154808280|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
154808729|NCT00631111|Ibuprofen|ibuprofen|mesh-list
154809047|NCT06254690|Docetaxel|docetaxel|mesh-list
154809257|NCT06252961|Immunologic Factors|immunologic factors|mesh-ancestor
154809558|NCT05931276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154809637|NCT05686993|Nifedipine|nifedipine|mesh-list
154809787|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
154809856|NCT04844528|Vitamins|vitamins|mesh-ancestor
154810080|NCT03900949|Immunotoxins|immunotoxins|mesh-ancestor
154810152|NCT03538899|Busulfan|busulfan|mesh-list
154810378|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154810475|NCT02358031|Cetuximab|cetuximab|mesh-list
154810606|NCT01928563|Udenafil|udenafil|mesh-list
154810682|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154810831|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
154810979|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154811441|NCT03100253|Adalimumab|adalimumab|mesh-list
154811885|NCT05792410|Fulvestrant|fulvestrant|mesh-list
154811958|NCT05456932|Iron|iron|mesh-list
154812184|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812261|NCT00545077|Growth Substances|growth substances|mesh-ancestor
154812420|NCT04273321|Hormones|hormones|mesh-ancestor
154812788|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
154813087|NCT01459081|Zanamivir|zanamivir|mesh-list
154813177|NCT01892683|Propofol|propofol|mesh-list
154813539|NCT01893541|Propranolol|propranolol|mesh-list
154814367|NCT04638036|Cetuximab|cetuximab|mesh-list
154814667|NCT05909215|Dexmedetomidine|dexmedetomidine|mesh-list
154814890|NCT05903456|Lenvatinib|lenvatinib|mesh-list
154815190|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154816023|NCT00004125|Tamoxifen|tamoxifen|mesh-list
154816157|NCT01883024|Insulin|insulin|mesh-list
154816382|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816461|NCT01404429|Methotrexate|methotrexate|mesh-list
154817583|NCT01895257|Vitamins|vitamins|mesh-ancestor
154817877|NCT02921477|Bosutinib|bosutinib|mesh-list
154817961|NCT04391621|Hormones|hormones|mesh-ancestor
154818027|NCT02611752|Buprenorphine|buprenorphine|mesh-list
154818256|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
154818401|NCT01458041|Iloprost|iloprost|mesh-list
154818784|NCT04783753|Quinidine|quinidine|mesh-list
154818854|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
154819160|NCT01890005|Aspirin|aspirin|mesh-list
154819386|NCT00650143|Incretins|incretins|mesh-ancestor
154819769|NCT01436799|Alfentanil|alfentanil|mesh-list
154819991|NCT03039426|Analgesics|analgesics|mesh-ancestor
154820291|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
154820818|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
154821272|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154821728|NCT01526577|Ticagrelor|ticagrelor|mesh-list
154821809|NCT01530243|Terazosin|terazosin|mesh-list
154822480|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
154822892|NCT00080483|Hormones|hormones|mesh-ancestor
154823020|NCT05574985|Vaccines|vaccines|mesh-list
154823167|NCT00347412|Paclitaxel|paclitaxel|mesh-list
154823468|NCT00023309|Lamivudine|lamivudine|mesh-list
154823534|NCT04745988|Antidotes|antidotes|mesh-ancestor
154824211|NCT00054353|Melphalan|melphalan|mesh-list
154824284|NCT04739670|Bevacizumab|bevacizumab|mesh-list
154825113|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825199|NCT00243061|Cediranib|cediranib|mesh-list
154825262|NCT00144391|Hormones|hormones|mesh-ancestor
154825485|NCT00149227|Valsartan|valsartan|mesh-list
154826027|NCT04790175|Tolvaptan|tolvaptan|mesh-list
154826323|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
154826706|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
154826919|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154827590|NCT05532852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827666|NCT00218465|Glycine|glycine|mesh-list
154827816|NCT00281021|Digoxin|digoxin|mesh-list
154827969|NCT01794039|Ichthammol|ichthammol|mesh-list
154828113|NCT00287989|Paclitaxel|paclitaxel|mesh-list
154828188|NCT04058678|Danazol|danazol|mesh-list
154828338|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
154828414|NCT05748561|Glucocorticoids|glucocorticoids|mesh-ancestor
154828730|NCT05950204|Vitamin D|vitamin d|mesh-list
154829005|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154829298|NCT06215833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154829901|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830053|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
154830433|NCT03388190|Leucovorin|leucovorin|mesh-list
154830962|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831116|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
154831413|NCT02203604|Interleukin-2|interleukin-2|mesh-list
154583627|NCT02260492|Xhance|xhance|mesh-list
154831636|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831790|NCT00552279|Vaccines|vaccines|mesh-list
154832554|NCT00340379|Sertraline|sertraline|mesh-list
154832764|NCT00558207|Gemcitabine|gemcitabine|mesh-list
154833085|NCT00315341|Methadone|methadone|mesh-list
154833368|NCT01794767|Heparin|heparin|mesh-list
154833659|NCT00387829|Estrogens|estrogens|mesh-ancestor
154833807|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
154834129|NCT00405353|Hormones|hormones|mesh-ancestor
154834260|NCT05965154|Bevacizumab|bevacizumab|mesh-list
154834480|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154834632|NCT04641351|Hormones|hormones|mesh-ancestor
154835082|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
154835152|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835484|NCT03940807|Estradiol|estradiol|mesh-list
154835518|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
154835672|NCT00534833|Vaccines|vaccines|mesh-list
154835743|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
154835900|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154836202|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154836279|NCT03590912|Cetirizine|cetirizine|mesh-list
154836628|NCT00513799|Mupirocin|mupirocin|mesh-list
154836959|NCT05679908|Oxytocin|oxytocin|mesh-list
154837033|NCT05406726|Hormones|hormones|mesh-ancestor
154837490|NCT03569085|Isoflurane|isoflurane|mesh-list
154837561|NCT03019081|Isoproterenol|isoproterenol|mesh-list
154837712|NCT04193774|Benoxinate|benoxinate|mesh-list
154837943|NCT00475085|Aprepitant|aprepitant|mesh-list
154838010|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
154838081|NCT04027166|Analgesics|analgesics|mesh-ancestor
154838156|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
154838387|NCT00483509|Doxorubicin|doxorubicin|mesh-list
154838531|NCT00452387|Analgesics|analgesics|mesh-ancestor
154838701|NCT00568633|Hormones|hormones|mesh-ancestor
154838914|NCT00550589|Cidofovir|cidofovir|mesh-list
154839063|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
154839363|NCT02125721|Penicillamine|penicillamine|mesh-list
154839429|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154839511|NCT03623828|Emetics|emetics|mesh-ancestor
154839579|NCT03620123|Docetaxel|docetaxel|mesh-list
154839951|NCT00507767|Dasatinib|dasatinib|mesh-list
154840558|NCT00586729|Mafenide|mafenide|mesh-list
154840628|NCT05247385|Ticagrelor|ticagrelor|mesh-list
154841880|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
154842390|NCT03086720|Eusol|eusol|mesh-list
154842472|NCT00566813|Hormones|hormones|mesh-ancestor
154842540|NCT02987985|Acetaminophen|acetaminophen|mesh-list
154842615|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842766|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154842919|NCT02987751|Insulin|insulin|mesh-list
154842990|NCT01276093|Amiodarone|amiodarone|mesh-list
154843062|NCT00727597|Efavirenz|efavirenz|mesh-list
154843287|NCT05740215|Lenvatinib|lenvatinib|mesh-list
154843411|NCT00753337|Cobalt|cobalt|mesh-list
154843757|NCT00080288|Modafinil|modafinil|mesh-list
154843812|NCT03080324|Analgesics|analgesics|mesh-ancestor
154844257|NCT00670241|Hormones|hormones|mesh-ancestor
154844329|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154844631|NCT00738049|Darusentan|darusentan|mesh-list
154844779|NCT04746495|Diuretics|diuretics|mesh-ancestor
154845040|NCT03793439|Prednisone|prednisone|mesh-list
154845667|NCT03873116|Berotralstat|berotralstat|mesh-list
154845889|NCT00661895|Hydralazine|hydralazine|mesh-list
154846113|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154846262|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846341|NCT02997215|Lidocaine|lidocaine|mesh-list
154846488|NCT00759811|Methotrexate|methotrexate|mesh-list
154846576|NCT00706589|Aripiprazole|aripiprazole|mesh-list
154846635|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
154846795|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
154846876|NCT02995187|Apatinib|apatinib|mesh-list
154847311|NCT01273727|Hormones|hormones|mesh-ancestor
154847460|NCT01279499|Sevoflurane|sevoflurane|mesh-list
154848529|NCT01979445|Cangrelor|cangrelor|mesh-list
154848754|NCT03378297|Analgesics|analgesics|mesh-ancestor
154848975|NCT02008617|Bupivacaine|bupivacaine|mesh-list
154849426|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
154849581|NCT00767507|Cangrelor|cangrelor|mesh-list
154849646|NCT05718609|Rabeprazole|rabeprazole|mesh-list
154849798|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
154849873|NCT03808805|Aprepitant|aprepitant|mesh-list
154850174|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
154850262|NCT04807101|Midazolam|midazolam|mesh-list
154850399|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850481|NCT00801827|Fallypride|fallypride|mesh-list
154850697|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154850852|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
154850920|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154851379|NCT00859651|Vitamin D|vitamin d|mesh-list
154851454|NCT04344483|Lidocaine|lidocaine|mesh-list
154852128|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154852355|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852505|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
154852726|NCT00369538|Losartan|losartan|mesh-list
154852796|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154853258|NCT02311920|Nivolumab|nivolumab|mesh-list
154853408|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
154854088|NCT02748070|Fluticasone|fluticasone|mesh-list
154854313|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
154854474|NCT01040845|Colchicine|colchicine|mesh-list
154854690|NCT04382027|Vitamins|vitamins|mesh-list
154854839|NCT01831505|Hormones|hormones|mesh-ancestor
154854918|NCT00014911|Sirolimus|sirolimus|mesh-list
154855369|NCT01835639|Vitamin D|vitamin d|mesh-list
154855434|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
154855661|NCT04371601|Hormones|hormones|mesh-list
154855755|NCT04370977|Artesunate|artesunate|mesh-list
154855902|NCT03401593|Midazolam|midazolam|mesh-list
154856708|NCT01047293|Vitamins|vitamins|mesh-ancestor
154856873|NCT03035617|Bupivacaine|bupivacaine|mesh-list
154856931|NCT02822950|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154857153|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
154857523|NCT00357981|Ortho Evra|ortho evra|mesh-list
154857835|NCT02241941|Daptomycin|daptomycin|mesh-list
154858432|NCT03023527|Elotuzumab|elotuzumab|mesh-list
154858653|NCT01575925|Pomalidomide|pomalidomide|mesh-list
154858806|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154858952|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154859115|NCT00987727|Glycerol|glycerol|mesh-list
154859849|NCT03034005|Hormones|hormones|mesh-ancestor
154859918|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501188|NCT03709355|Rifampin|rifampin|mesh-list
154501561|NCT03221816|Folic Acid|folic acid|mesh-list
154501636|NCT02554786|Xhance|xhance|mesh-list
154501754|NCT00578955|BB 1101|bb 1101|mesh-list
154502154|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154226174|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
154502369|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
154502513|NCT00508989|Niacin|niacin|mesh-list
154502818|NCT00415623|Amlodipine|amlodipine|mesh-list
154503119|NCT03628079|Mebendazole|mebendazole|mesh-list
154503268|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154503342|NCT02285985|Saxagliptin|saxagliptin|mesh-list
154503419|NCT03194594|Dexamethasone|dexamethasone|mesh-list
154503566|NCT03197402|Caseins|caseins|mesh-list
154503949|NCT00189254|Imiquimod|imiquimod|mesh-list
154504097|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
154504175|NCT02443064|Vancomycin|vancomycin|mesh-list
154504321|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
154504549|NCT02436980|Midazolam|midazolam|mesh-list
154505071|NCT02427932|Gentamicins|gentamicins|mesh-list
154505233|NCT05103254|Ezetimibe|ezetimibe|mesh-list
154860217|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
154505992|NCT02405858|Hormones|hormones|mesh-ancestor
154506224|NCT02404376|Exenatide|exenatide|mesh-list
154506506|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154506652|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154506881|NCT02403284|Liraglutide|liraglutide|mesh-list
154506958|NCT02303769|Tamsulosin|tamsulosin|mesh-list
154507855|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154508086|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154508234|NCT00076973|Montelukast|montelukast|mesh-list
154508380|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
154508625|NCT02311101|Mitomycins|mitomycins|mesh-list
154508706|NCT04050761|Nivolumab|nivolumab|mesh-list
154509435|NCT05423249|Vitamins|vitamins|mesh-ancestor
154509588|NCT04005729|Cangrelor|cangrelor|mesh-list
154509973|NCT02682602|Tacrine|tacrine|mesh-list
154510341|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
154510419|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154510501|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
154510620|NCT05348824|Eusol|eusol|mesh-list
154510871|NCT04672928|Paclitaxel|paclitaxel|mesh-list
154511027|NCT05166616|Osimertinib|osimertinib|mesh-list
154511270|NCT04372017|Vitamin D|vitamin d|mesh-list
154511476|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
154511779|NCT03662035|Apatinib|apatinib|mesh-list
154511870|NCT05797714|Tenofovir|tenofovir|mesh-list
154512156|NCT04430517|Niacin|niacin|mesh-list
154512465|NCT01256398|Hematinics|hematinics|mesh-ancestor
154513883|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
154513958|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
154514110|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514198|NCT02976103|Analgesics|analgesics|mesh-list
154514256|NCT02910167|Analgesics|analgesics|mesh-ancestor
154514335|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
154514406|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
154514481|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514564|NCT04969510|Pramoxine|pramoxine|mesh-list
154514787|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
154515012|NCT03641053|Iodine|iodine|mesh-list
154515311|NCT06325605|Dexetimide|dexetimide|mesh-list
154515408|NCT06324435|Apremilast|apremilast|mesh-list
154515690|NCT05963204|Mannitol|mannitol|mesh-list
154516067|NCT05366725|Avelumab|avelumab|mesh-list
154516290|NCT04989218|Cisplatin|cisplatin|mesh-list
154516364|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516518|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
154516597|NCT04383275|Capecitabine|capecitabine|mesh-list
154516821|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517432|NCT03007147|Antidotes|antidotes|mesh-ancestor
154517812|NCT02101853|Dexamethasone|dexamethasone|mesh-list
154517892|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
154517967|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
154518196|NCT03465423|Propofol|propofol|mesh-list
154518421|NCT03655535|PAZ320|paz320|mesh-list
154518495|NCT02980133|Xhance|xhance|mesh-list
154518520|NCT02979431|Gontivimab|gontivimab|mesh-list
154519102|NCT03446547|Durvalumab|durvalumab|mesh-list
154519248|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154519323|NCT03432663|Amiodarone|amiodarone|mesh-list
154519628|NCT03650777|Warfarin|warfarin|mesh-list
154519694|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
154519768|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
154519850|NCT03421119|Insulin|insulin|mesh-list
154520073|NCT03647579|Midazolam|midazolam|mesh-list
154520453|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520524|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520602|NCT03397173|Vitamins|vitamins|mesh-ancestor
154520823|NCT02354768|Loperamide|loperamide|mesh-list
154520974|NCT05061563|Esomeprazole|esomeprazole|mesh-list
154521281|NCT02865499|Acarbose|acarbose|mesh-list
154521367|NCT03394989|Xhance|xhance|mesh-list
154521501|NCT02033551|Veliparib|veliparib|mesh-list
154521575|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154521650|NCT03390387|BB 1101|bb 1101|mesh-list
154522254|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
154522847|NCT05383313|Ketamine|ketamine|mesh-list
154523050|NCT02033941|Phenol|phenol|mesh-list
154523144|NCT04997174|Celecoxib|celecoxib|mesh-list
154523674|NCT03316274|Nivolumab|nivolumab|mesh-list
154523968|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154524568|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
154524802|NCT04233567|Infigratinib|infigratinib|mesh-list
154525047|NCT01697566|Metformin|metformin|mesh-list
154525127|NCT00006478|Sargramostim|sargramostim|mesh-list
154525272|NCT05831878|Immunoconjugates|immunoconjugates|mesh-ancestor
154525347|NCT05947669|Prednisolone|prednisolone|mesh-list
154525646|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525799|NCT03984097|Hormones|hormones|mesh-ancestor
154525866|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154525940|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526013|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
154526089|NCT05788276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526238|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
154526764|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
154527136|NCT03367143|Carboplatin|carboplatin|mesh-list
154527593|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154527670|NCT04444011|Antacids|antacids|mesh-ancestor
154528350|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
154528497|NCT01678820|Metformin|metformin|mesh-list
154528577|NCT03122769|Metformin|metformin|mesh-list
154528725|NCT05599971|Fluorouracil|fluorouracil|mesh-list
154528947|NCT02510469|Apatinib|apatinib|mesh-list
154529176|NCT04501107|Insulin|insulin|mesh-list
154529555|NCT04482686|Vitamin D|vitamin d|mesh-list
154529629|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154529703|NCT03579914|Metoprolol|metoprolol|mesh-list
154529854|NCT02495415|Retinamide|retinamide|mesh-list
154529933|NCT03566329|Analgesics|analgesics|mesh-ancestor
154530004|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530083|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
154530227|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530453|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154530605|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
154530754|NCT00706641|Dasatinib|dasatinib|mesh-list
154530829|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530913|NCT03333525|Insulin|insulin|mesh-list
154531060|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
154531219|NCT02489955|Tobramycin|tobramycin|mesh-list
154531434|NCT00584246|Pregabalin|pregabalin|mesh-list
154531675|NCT02256800|Vitamins|vitamins|mesh-ancestor
154531889|NCT03801200|Apatinib|apatinib|mesh-list
154532112|NCT05384847|Hormones|hormones|mesh-list
154532185|NCT05870501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154532260|NCT05790577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154532491|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
154532568|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532790|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532885|NCT03829579|Esketamine|esketamine|mesh-list
154533016|NCT02468180|Polidocanol|polidocanol|mesh-list
154533244|NCT05118620|Bupivacaine|bupivacaine|mesh-list
154533394|NCT03357380|Semaglutide|semaglutide|mesh-list
154533692|NCT02051569|Tryptophan|tryptophan|mesh-list
154534133|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534592|NCT03308643|Oxytocin|oxytocin|mesh-list
154534660|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534808|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534886|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
154535134|NCT03867110|Ezetimibe|ezetimibe|mesh-list
154535181|NCT03104036|Analgesics|analgesics|mesh-ancestor
154535255|NCT02086604|Immunoconjugates|immunoconjugates|mesh-ancestor
154535331|NCT02059915|Analgesics|analgesics|mesh-ancestor
154535409|NCT02063269|Rivastigmine|rivastigmine|mesh-list
154535631|NCT02462499|Diuretics|diuretics|mesh-ancestor
154535706|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154535778|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154535925|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154536074|NCT02067013|Growth Substances|growth substances|mesh-ancestor
154536224|NCT02076529|Ramosetron|ramosetron|mesh-list
154536822|NCT06126354|Glucocorticoids|glucocorticoids|mesh-ancestor
154536970|NCT06067399|Analgesics|analgesics|mesh-ancestor
154537272|NCT05667727|Albuterol|albuterol|mesh-list
154537434|NCT05463224|Lazertinib|lazertinib|mesh-list
154537495|NCT05322473|Adalimumab|adalimumab|mesh-list
154537575|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537719|NCT04961190|Paroxetine|paroxetine|mesh-list
154538166|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538241|NCT03913559|Methotrexate|methotrexate|mesh-list
154538318|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
154538691|NCT02483247|Paclitaxel|paclitaxel|mesh-list
154538995|NCT00412594|Cladribine|cladribine|mesh-list
154539072|NCT02082613|Polidocanol|polidocanol|mesh-list
154539299|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
154539447|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
154539855|NCT02103205|Iron|iron|mesh-list
154539894|NCT05050604|Choline|choline|mesh-list
154540045|NCT02101255|Protective Agents|protective agents|mesh-ancestor
154540265|NCT03554395|Antibodies|antibodies|mesh-list
154540349|NCT03282513|Ivosidenib|ivosidenib|mesh-list
154540568|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
154540640|NCT02115763|Caffeine|caffeine|mesh-list
154541175|NCT02121613|Tamsulosin|tamsulosin|mesh-list
154541311|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154541458|NCT05008250|Metoprolol|metoprolol|mesh-list
154541708|NCT03077516|Meloxicam|meloxicam|mesh-list
154541908|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
154542169|NCT02126293|Zinc|zinc|mesh-list
154542209|NCT02126527|Sirolimus|sirolimus|mesh-list
154542596|NCT03582605|Amoxicillin|amoxicillin|mesh-list
154542667|NCT02128945|Fludarabine|fludarabine|mesh-list
154542896|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
154543204|NCT02523911|Simethicone|simethicone|mesh-list
154543347|NCT02137525|Analgesics|analgesics|mesh-ancestor
154543421|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543733|NCT03566303|Vitamin K|vitamin k|mesh-list
154543873|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154544023|NCT04267614|Analgesics|analgesics|mesh-ancestor
154544173|NCT02903537|Vitamin D|vitamin d|mesh-list
154544663|NCT05728268|Paclitaxel|paclitaxel|mesh-list
154544728|NCT01651780|Heparin|heparin|mesh-list
154545151|NCT01355159|Folic Acid|folic acid|mesh-list
154545294|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154545536|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154545684|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
154545981|NCT02388724|Lansoprazole|lansoprazole|mesh-list
154546061|NCT01333865|Memantine|memantine|mesh-list
154546356|NCT02064023|Insulin|insulin|mesh-list
154547403|NCT04942652|Itraconazole|itraconazole|mesh-list
154547776|NCT03228303|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154548238|NCT03231813|Emollients|emollients|mesh-list
154548324|NCT02451033|Hormones|hormones|mesh-list
154548379|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548696|NCT02142751|Meropenem|meropenem|mesh-list
154548840|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
154548992|NCT03197961|Tenofovir|tenofovir|mesh-list
154549234|NCT03201861|Paclitaxel|paclitaxel|mesh-list
154549292|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
154549447|NCT02710071|Nebivolol|nebivolol|mesh-list
154549742|NCT02441673|Nefopam|nefopam|mesh-list
154549969|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
154550122|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
154550201|NCT02145715|Bortezomib|bortezomib|mesh-list
154550282|NCT04877210|Insulin|insulin|mesh-list
154550422|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
154550650|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
154550727|NCT02613572|Vitamins|vitamins|mesh-ancestor
154550804|NCT02089295|Oxycodone|oxycodone|mesh-list
154550874|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551098|NCT02337946|Antidotes|antidotes|mesh-ancestor
154551410|NCT02097017|Lidocaine|lidocaine|mesh-list
154551478|NCT02103023|Vaccines|vaccines|mesh-list
154551699|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154551850|NCT02611778|Growth Substances|growth substances|mesh-ancestor
154552304|NCT05371288|Expectorants|expectorants|mesh-ancestor
154552385|NCT04942067|Hormones|hormones|mesh-ancestor
154552687|NCT03063632|Interferons|interferons|mesh-list
154553178|NCT04851392|Dronabinol|dronabinol|mesh-list
154553436|NCT00702273|Ganirelix|ganirelix|mesh-list
154553588|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
154553746|NCT02706483|Plecanatide|plecanatide|mesh-list
154553817|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
154553891|NCT02426229|Dabigatran|dabigatran|mesh-list
154554040|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
154554119|NCT02114645|Progestins|progestins|mesh-ancestor
154554265|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
154554344|NCT04806230|Citalopram|citalopram|mesh-list
154554415|NCT04813874|Analgesics|analgesics|mesh-ancestor
154554638|NCT02251847|Ezetimibe|ezetimibe|mesh-list
154554942|NCT06103721|Analgesics|analgesics|mesh-ancestor
154555029|NCT05817240|Nintedanib|nintedanib|mesh-list
154555087|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
154555167|NCT05464615|Amoxicillin|amoxicillin|mesh-list
154555619|NCT02834403|Aspirin|aspirin|mesh-list
154556079|NCT03550781|Prednisone|prednisone|mesh-list
154556134|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
154860312|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
154556430|NCT04091126|Dexamethasone|dexamethasone|mesh-list
154556736|NCT03548129|Fosfomycin|fosfomycin|mesh-list
154556951|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154557024|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
154557109|NCT00103285|Vitamins|vitamins|mesh-ancestor
154557351|NCT03107169|Vancomycin|vancomycin|mesh-list
154558008|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
154612688|NCT01459484|Cisplatin|cisplatin|mesh-list
154612920|NCT03329651|Metformin|metformin|mesh-list
154612993|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154558029|NCT02408289|Protective Agents|protective agents|mesh-ancestor
154613516|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
154613590|NCT03320447|Lidocaine|lidocaine|mesh-list
154613659|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154613740|NCT03091257|Trametinib|trametinib|mesh-list
154614112|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
154614301|NCT02451865|Docetaxel|docetaxel|mesh-list
154614335|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
154614637|NCT05002725|Lidocaine|lidocaine|mesh-list
154614710|NCT02479217|Docetaxel|docetaxel|mesh-list
154614785|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
154615090|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
154615457|NCT02472275|Androgens|androgens|mesh-list
154615539|NCT03108833|Saruplase|saruplase|mesh-list
154615830|NCT04442633|Miconazole|miconazole|mesh-list
154616053|NCT03302351|Ketamine|ketamine|mesh-list
154616201|NCT02467595|Narcotics|narcotics|mesh-ancestor
154616282|NCT03299621|Rocuronium|rocuronium|mesh-list
154616575|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616723|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616797|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
154617325|NCT03289559|Testosterone|testosterone|mesh-list
154617401|NCT04979091|Hormones|hormones|mesh-list
154617768|NCT02458625|Iron|iron|mesh-list
154618137|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154618218|NCT01670019|Asenapine|asenapine|mesh-list
154618361|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
154618659|NCT04950933|Riluzole|riluzole|mesh-list
154619096|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
154619475|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
154619774|NCT04896177|Sirolimus|sirolimus|mesh-list
154621051|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
154621197|NCT04703101|Vitamins|vitamins|mesh-ancestor
154621349|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
154621801|NCT03081689|Paclitaxel|paclitaxel|mesh-list
154622026|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622106|NCT01582191|Everolimus|everolimus|mesh-list
154622250|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154623303|NCT04842825|Cetrorelix|cetrorelix|mesh-list
154623675|NCT04820439|Mitogens|mitogens|mesh-list
154623903|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624126|NCT04800081|Valsartan|valsartan|mesh-list
154624881|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
154625276|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
154625334|NCT05552391|Analgesics|analgesics|mesh-ancestor
154625628|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625922|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626000|NCT02438345|Leronlimab|leronlimab|mesh-list
154626153|NCT02576145|Daclizumab|daclizumab|mesh-list
154626226|NCT02575833|Erenumab|erenumab|mesh-list
154626296|NCT03187691|Amphotericin B|amphotericin b|mesh-list
154626669|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154626746|NCT03184493|Metformin|metformin|mesh-list
154626894|NCT03182855|Ticagrelor|ticagrelor|mesh-list
154627191|NCT02072434|Enoxaparin|enoxaparin|mesh-list
154627341|NCT02098876|Everolimus|everolimus|mesh-list
154627562|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
154628106|NCT02410031|Hormones|hormones|mesh-ancestor
154628396|NCT05506137|Miotics|miotics|mesh-ancestor
154628469|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
154629441|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154629591|NCT02394821|Metronidazole|metronidazole|mesh-list
154629821|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630113|NCT02055820|Doxorubicin|doxorubicin|mesh-list
154631338|NCT02079532|Rituximab|rituximab|mesh-list
154632212|NCT02345993|Hormones|hormones|mesh-ancestor
154632571|NCT02039531|Mitogens|mitogens|mesh-list
154632717|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
154633089|NCT02440399|Narcotics|narcotics|mesh-ancestor
154633537|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633980|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
154634124|NCT03180229|Granisetron|granisetron|mesh-list
154634706|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
154635303|NCT01987102|Antidotes|antidotes|mesh-ancestor
154635529|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
154635682|NCT00708097|Fluorides|fluorides|mesh-list
153995938|NCT02550067|Copper|copper|mesh-list
154636282|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
154636430|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
154636729|NCT06121180|Aflibercept|aflibercept|mesh-list
154636884|NCT06054529|Vitamins|vitamins|mesh-ancestor
154637043|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
154637108|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154637709|NCT01725113|Calcitriol|calcitriol|mesh-list
154638162|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638238|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
154638389|NCT05746351|Narcotics|narcotics|mesh-ancestor
154638626|NCT01999114|Narcotics|narcotics|mesh-ancestor
154638926|NCT05030545|Eplerenone|eplerenone|mesh-list
154639058|NCT04941937|Thalidomide|thalidomide|mesh-list
154639353|NCT05898984|Hormones|hormones|mesh-ancestor
154639944|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640539|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
154640694|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
154641328|NCT02364583|Primaquine|primaquine|mesh-list
154641389|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
154641463|NCT01970488|Adalimumab|adalimumab|mesh-list
154641615|NCT02373163|Diuretics|diuretics|mesh-ancestor
154641692|NCT05052515|Choline|choline|mesh-list
154641838|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
154641914|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
154642073|NCT05047991|Vitamins|vitamins|mesh-ancestor
154642362|NCT04434365|Analgesics|analgesics|mesh-ancestor
154642672|NCT05255575|Ertapenem|ertapenem|mesh-list
154642810|NCT05008367|Dexamethasone|dexamethasone|mesh-list
154642956|NCT05991466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643106|NCT05874037|Serotonin Agents|serotonin agents|mesh-ancestor
154643250|NCT05045638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643702|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154643777|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154643850|NCT05916742|Antipyretics|antipyretics|mesh-ancestor
154643998|NCT05914701|Antiviral Agents|antiviral agents|mesh-ancestor
154644077|NCT05914129|Liver Extracts|liver extracts|mesh-list
154644551|NCT05423340|Nicotine|nicotine|mesh-list
154644833|NCT04907968|Carboplatin|carboplatin|mesh-list
154645056|NCT04589208|Ketamine|ketamine|mesh-list
154645142|NCT04502433|Poractant alfa|poractant alfa|mesh-list
154645809|NCT02798523|Hormones|hormones|mesh-ancestor
154645968|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
154646408|NCT00003237|Paclitaxel|paclitaxel|mesh-list
154646487|NCT03078725|Metformin|metformin|mesh-list
154646781|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154646863|NCT02335255|Naftifine|naftifine|mesh-list
154647235|NCT06274879|Durvalumab|durvalumab|mesh-list
154647615|NCT05800366|Prednisone|prednisone|mesh-list
154647764|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
154648137|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154648212|NCT04408313|Analgesics|analgesics|mesh-ancestor
154649045|NCT05077111|Anesthetics|anesthetics|mesh-list
154649343|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
154649721|NCT03140449|Temsirolimus|temsirolimus|mesh-list
154649810|NCT04985201|Irinotecan|irinotecan|mesh-list
154649870|NCT04982861|Cefixime|cefixime|mesh-list
154402127|NCT03054870|Xenon|xenon|mesh-list
154650112|NCT01794793|Hormones|hormones|mesh-ancestor
154650539|NCT04447235|Ivermectin|ivermectin|mesh-list
154650950|NCT01618708|Hylan|hylan|mesh-list
154651001|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
154651535|NCT03060707|Bromides|bromides|mesh-list
154651829|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
154651908|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
154652056|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
154652730|NCT03843151|Itraconazole|itraconazole|mesh-list
154652883|NCT04926155|Metformin|metformin|mesh-list
154653187|NCT04901663|Omeprazole|omeprazole|mesh-list
154653711|NCT03049085|Aspirin|aspirin|mesh-list
154654386|NCT03040817|Esomeprazole|esomeprazole|mesh-list
154654541|NCT03039101|Montelukast|montelukast|mesh-list
154655444|NCT04814381|Ketamine|ketamine|mesh-list
154655517|NCT05051137|Analgesics|analgesics|mesh-ancestor
154655902|NCT03078829|Leuprolide|leuprolide|mesh-list
154656357|NCT06161870|Vancomycin|vancomycin|mesh-list
154656504|NCT05971602|Rifampin|rifampin|mesh-list
154657711|NCT03075241|Zolpidem|zolpidem|mesh-list
154658457|NCT04338659|Antibodies|antibodies|mesh-list
154658522|NCT05613491|Insulin|insulin|mesh-list
154658604|NCT01672801|Nimodipine|nimodipine|mesh-list
154659121|NCT04062695|Tofacitinib|tofacitinib|mesh-list
154659272|NCT05700617|Dobutamine|dobutamine|mesh-list
154659573|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
154659647|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
154659876|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
154659950|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
154660475|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
154660637|NCT04933279|Iodine|iodine|mesh-list
154660775|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
154660999|NCT04917757|Hormones|hormones|mesh-ancestor
154661381|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
154661526|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
154661602|NCT04888663|Paclitaxel|paclitaxel|mesh-list
154661749|NCT02419755|Cytarabine|cytarabine|mesh-list
154661899|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662127|NCT04371445|Protective Agents|protective agents|mesh-ancestor
154662296|NCT03044665|Ezetimibe|ezetimibe|mesh-list
154662506|NCT05512325|Bevacizumab|bevacizumab|mesh-list
154662664|NCT05505461|Antibodies|antibodies|mesh-list
154662730|NCT02564471|Atovaquone|atovaquone|mesh-list
154662881|NCT03041935|Ropivacaine|ropivacaine|mesh-list
154663035|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
154663257|NCT01668667|Gabapentin|gabapentin|mesh-list
154663626|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
154663858|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154664007|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
154664388|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154664461|NCT05347459|Hormones|hormones|mesh-ancestor
154664539|NCT05548465|Dsuvia|dsuvia|mesh-list
154664614|NCT05550415|Simvastatin|simvastatin|mesh-list
154665357|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
154665509|NCT03571633|Paclitaxel|paclitaxel|mesh-list
154665655|NCT05305651|Sotrovimab|sotrovimab|mesh-list
154665805|NCT04903509|Acetaminophen|acetaminophen|mesh-list
154665954|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
154666548|NCT05487391|Paclitaxel|paclitaxel|mesh-list
154666626|NCT05472259|Vitamins|vitamins|mesh-ancestor
154667154|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
154667378|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
154667456|NCT02554721|Aspirin|aspirin|mesh-list
154667823|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
154667902|NCT02294019|Ibuprofen|ibuprofen|mesh-list
154668049|NCT01660711|Antidotes|antidotes|mesh-ancestor
154668131|NCT02362269|Vitamin D|vitamin d|mesh-list
154668202|NCT02317809|Hormones|hormones|mesh-ancestor
154668342|NCT05300269|Capecitabine|capecitabine|mesh-list
154420675|NCT04017598|Iron|iron|mesh-list
154669016|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669310|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
154669986|NCT02267187|Anesthetics|anesthetics|mesh-list
154670294|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
154670506|NCT01636947|Dexamethasone|dexamethasone|mesh-list
154671029|NCT02469519|Betamethasone|betamethasone|mesh-list
154671178|NCT02198235|Narcotics|narcotics|mesh-ancestor
154671404|NCT02391337|Digoxin|digoxin|mesh-list
154671481|NCT02195583|Zinc|zinc|mesh-list
154671631|NCT01889602|Topiramate|topiramate|mesh-list
154672042|NCT01888432|Everolimus|everolimus|mesh-list
154672084|NCT02188719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154672311|NCT01912612|Analgesics|analgesics|mesh-ancestor
154673358|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
154673505|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673725|NCT02503085|Analgesics|analgesics|mesh-ancestor
154673798|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154673870|NCT01614886|Rivastigmine|rivastigmine|mesh-list
154673946|NCT01925950|Beclomethasone|beclomethasone|mesh-list
154674560|NCT01613326|Albuterol|albuterol|mesh-list
154674776|NCT01860040|Pemetrexed|pemetrexed|mesh-list
154674915|NCT02038881|Antiviral Agents|antiviral agents|mesh-ancestor
154675364|NCT02372006|Afatinib|afatinib|mesh-list
154675582|NCT02363738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154675809|NCT01644175|Protease Inhibitors|protease inhibitors|mesh-ancestor
154676485|NCT02022657|Tenofovir|tenofovir|mesh-list
154676781|NCT01838044|Analgesics|analgesics|mesh-ancestor
154676866|NCT04726618|Xenon|xenon|mesh-list
154677009|NCT01652573|Calcitonin|calcitonin|mesh-list
154677164|NCT02404493|Decanoic acid|decanoic acid|mesh-list
154677227|NCT04414852|Apatinib|apatinib|mesh-list
154677376|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
154677457|NCT02421419|Hormones|hormones|mesh-ancestor
154677526|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
154677600|NCT01624233|Ixekizumab|ixekizumab|mesh-list
154677750|NCT01807156|Tivozanib|tivozanib|mesh-list
154677972|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
154678119|NCT01648283|Methadone|methadone|mesh-list
154678194|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678420|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
154678645|NCT02006121|Apomorphine|apomorphine|mesh-list
154678798|NCT02003391|Timolol|timolol|mesh-list
154679116|NCT01729156|Metformin|metformin|mesh-list
154679769|NCT03746080|Plerixafor|plerixafor|mesh-list
154680440|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
154680965|NCT02230891|Diuretics|diuretics|mesh-ancestor
154681487|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
154681636|NCT02298179|Antacids|antacids|mesh-ancestor
154681783|NCT01954251|Vaccines|vaccines|mesh-list
154682387|NCT04835870|Prednisone|prednisone|mesh-list
154682712|NCT04836962|Hormones|hormones|mesh-ancestor
154682764|NCT04808882|Tinzaparin|tinzaparin|mesh-list
154683053|NCT02049866|Denosumab|denosumab|mesh-list
154684105|NCT02236130|Morphine|morphine|mesh-list
154684557|NCT02168816|Tazobactam|tazobactam|mesh-list
154684822|NCT02188784|Iron|iron|mesh-list
154685158|NCT01576042|Amiodarone|amiodarone|mesh-list
154685530|NCT04641195|Vitamins|vitamins|mesh-list
154685604|NCT02177942|Micronutrients|micronutrients|mesh-list
154685682|NCT02177786|Selonsertib|selonsertib|mesh-list
154685832|NCT01527682|Dorzolamide|dorzolamide|mesh-list
154685987|NCT01510756|Sorafenib|sorafenib|mesh-list
154686050|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
154686804|NCT02072096|Acarbose|acarbose|mesh-list
154686884|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
154687028|NCT01884597|Growth Substances|growth substances|mesh-ancestor
154687101|NCT01461928|Rituximab|rituximab|mesh-list
154687622|NCT06091943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687851|NCT05880056|Bisoprolol|bisoprolol|mesh-list
154687997|NCT05659251|Paclitaxel|paclitaxel|mesh-list
154688062|NCT05481112|Narcotics|narcotics|mesh-ancestor
154688166|NCT05303311|Meperidine|meperidine|mesh-list
154688751|NCT04334512|Vitamin D|vitamin d|mesh-list
154688812|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688965|NCT03955198|Durvalumab|durvalumab|mesh-list
154689347|NCT02989584|Gemcitabine|gemcitabine|mesh-list
154689492|NCT01666080|Fludarabine|fludarabine|mesh-list
154689874|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154690320|NCT02216123|Chloroquine|chloroquine|mesh-list
154691067|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
154691141|NCT01623115|Alirocumab|alirocumab|mesh-list
154691297|NCT02155985|Aspirin|aspirin|mesh-list
154691517|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691594|NCT02042443|Leucovorin|leucovorin|mesh-list
154691753|NCT02064920|Donepezil|donepezil|mesh-list
154691890|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
154692561|NCT05535738|Xhance|xhance|mesh-list
154692791|NCT03184155|Nicardipine|nicardipine|mesh-list
154692856|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
154693087|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
154693305|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
154693530|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154693611|NCT02050321|Acitretin|acitretin|mesh-list
154693753|NCT01843023|Naltrexone|naltrexone|mesh-list
154693912|NCT01967173|Hormones|hormones|mesh-ancestor
154694136|NCT01964755|Vitamins|vitamins|mesh-ancestor
154694206|NCT01989169|Midazolam|midazolam|mesh-list
154694277|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
154694430|NCT01836471|Xhance|xhance|mesh-list
154694800|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154695328|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154695409|NCT01436110|Xhance|xhance|mesh-list
154695475|NCT01965704|Ondansetron|ondansetron|mesh-list
154695628|NCT01955707|Natalizumab|natalizumab|mesh-list
154695697|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154695846|NCT05119166|Niacinamide|niacinamide|mesh-list
154695920|NCT02015819|Leucovorin|leucovorin|mesh-list
154696002|NCT02025725|Metoclopramide|metoclopramide|mesh-list
154696068|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696215|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154696285|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
154696511|NCT01435018|Bleomycin|bleomycin|mesh-list
154696587|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
154696820|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
154697421|NCT01617187|Olanzapine|olanzapine|mesh-list
154697567|NCT01912963|Pertuzumab|pertuzumab|mesh-list
154697704|NCT01405924|Dexamethasone|dexamethasone|mesh-list
154697785|NCT01754259|Ranolazine|ranolazine|mesh-list
154698076|NCT01778049|Incretins|incretins|mesh-ancestor
154698221|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698365|NCT01383928|Dexamethasone|dexamethasone|mesh-list
154698664|NCT04628026|Venetoclax|venetoclax|mesh-list
154698968|NCT01843751|Naloxone|naloxone|mesh-list
154699041|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
154699185|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699407|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
154700078|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
154700305|NCT04020094|Atezolizumab|atezolizumab|mesh-list
154700454|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
154700757|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701137|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154701213|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154701971|NCT00003820|Rituximab|rituximab|mesh-list
154702043|NCT04763434|Hormones|hormones|mesh-ancestor
154703252|NCT04746430|Dexamethasone|dexamethasone|mesh-list
154703839|NCT05929755|Antiemetics|antiemetics|mesh-ancestor
154704294|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
154704742|NCT01924234|Morphine|morphine|mesh-list
154704815|NCT01925092|Mifepristone|mifepristone|mesh-list
154704890|NCT00986986|Vitamins|vitamins|mesh-ancestor
154704969|NCT01921192|Folic Acid|folic acid|mesh-list
154705040|NCT00984568|Hormones|hormones|mesh-ancestor
154705116|NCT01928329|Exenatide|exenatide|mesh-list
154705339|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
154705417|NCT03827278|Amebicides|amebicides|mesh-ancestor
154705564|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
154705650|NCT01455922|Exenatide|exenatide|mesh-list
154705800|NCT01892176|Ubiquinone|ubiquinone|mesh-list
154705869|NCT02789878|Prednisone|prednisone|mesh-list
154706091|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
154706774|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154706886|NCT02556424|Hormones|hormones|mesh-ancestor
154707447|NCT01895764|Adalimumab|adalimumab|mesh-list
154707816|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
154708198|NCT04770688|Osimertinib|osimertinib|mesh-list
154708272|NCT00062764|Pioglitazone|pioglitazone|mesh-list
154708494|NCT00076258|Serotonin Agents|serotonin agents|mesh-ancestor
154708740|NCT00185692|Hormones|hormones|mesh-ancestor
154709694|NCT05294263|Varenicline|varenicline|mesh-list
154709918|NCT04551495|Letrozole|letrozole|mesh-list
154710886|NCT06160414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711190|NCT05951959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711264|NCT05903092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154711340|NCT05715281|Atezolizumab|atezolizumab|mesh-list
154711860|NCT05176483|Nivolumab|nivolumab|mesh-list
154712095|NCT04882241|Antidotes|antidotes|mesh-ancestor
154712397|NCT04505566|Analgesics|analgesics|mesh-ancestor
154712694|NCT03984448|Prednisone|prednisone|mesh-list
154712773|NCT03926338|Celecoxib|celecoxib|mesh-list
154712925|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
154713004|NCT03595592|Paclitaxel|paclitaxel|mesh-list
154713296|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
154713677|NCT06017037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154714351|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
154714745|NCT03691493|Tamoxifen|tamoxifen|mesh-list
154714892|NCT02903368|Hormones|hormones|mesh-ancestor
154715344|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
154715718|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
154715871|NCT00350272|Lamivudine|lamivudine|mesh-list
154716029|NCT00218062|Modafinil|modafinil|mesh-list
154716323|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
154716402|NCT01790516|Cetuximab|cetuximab|mesh-list
154716532|NCT01898728|Iodine|iodine|mesh-list
154716776|NCT01790542|Iron|iron|mesh-list
154717289|NCT00315328|Atropine|atropine|mesh-list
154717376|NCT04408911|Midazolam|midazolam|mesh-list
154717448|NCT01521117|Donepezil|donepezil|mesh-list
154717511|NCT01465191|Morphine|morphine|mesh-list
154717856|NCT01458639|Xenon|xenon|mesh-list
154718937|NCT00476788|Insulin|insulin|mesh-list
154719164|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
154719528|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719673|NCT01408563|Fludarabine|fludarabine|mesh-list
154719913|NCT01427751|Hormones|hormones|mesh-ancestor
154720124|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
154720659|NCT03024957|Analgesics|analgesics|mesh-ancestor
154720955|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
154721206|NCT03597867|Diclofenac|diclofenac|mesh-list
154721404|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154721858|NCT06016465|Autonomic Agents|autonomic agents|mesh-ancestor
154721943|NCT05880394|Copper|copper|mesh-list
154722007|NCT05781711|Metformin|metformin|mesh-list
154722156|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722459|NCT04888741|Sirolimus|sirolimus|mesh-list
154722690|NCT04216472|Paclitaxel|paclitaxel|mesh-list
154722833|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
154723132|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154723209|NCT03047135|Olaparib|olaparib|mesh-list
154723360|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
154723586|NCT01119508|Temozolomide|temozolomide|mesh-list
154724191|NCT01811953|Metformin|metformin|mesh-list
154724268|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
154724490|NCT01592110|Risperidone|risperidone|mesh-list
154724566|NCT01866319|Ipilimumab|ipilimumab|mesh-list
154724856|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724934|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
154725019|NCT00629122|Ionophores|ionophores|mesh-ancestor
154725241|NCT00687076|Niacin|niacin|mesh-list
154725402|NCT00656656|Rituximab|rituximab|mesh-list
154725460|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
154725828|NCT01275976|Complement C1s|complement c1s|mesh-list
154725909|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
154726044|NCT04144101|Aceclofenac|aceclofenac|mesh-list
154726196|NCT02991196|Nivolumab|nivolumab|mesh-list
154726942|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
154727383|NCT00246376|Niacin|niacin|mesh-list
154727495|NCT00243412|Rituximab|rituximab|mesh-list
154727689|NCT00758836|Ibuprofen|ibuprofen|mesh-list
154727989|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
154728149|NCT00790270|Ibuprofen|ibuprofen|mesh-list
154728374|NCT01709084|Tenofovir|tenofovir|mesh-list
154729033|NCT01737931|Dexamethasone|dexamethasone|mesh-list
154729188|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
154729341|NCT00838162|Ritonavir|ritonavir|mesh-list
154729853|NCT01714609|Sorafenib|sorafenib|mesh-list
154730230|NCT01910519|Vaccines|vaccines|mesh-list
154730823|NCT00895180|Ramucirumab|ramucirumab|mesh-list
154732188|NCT03403972|Vancomycin|vancomycin|mesh-list
154732264|NCT02242474|Analgesics|analgesics|mesh-ancestor
154732417|NCT04548518|Vaccines|vaccines|mesh-list
154733004|NCT03685149|Flecainide|flecainide|mesh-list
154733154|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
154733300|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154733451|NCT04355416|Curcumin|curcumin|mesh-list
154733749|NCT03032458|Meperidine|meperidine|mesh-list
154733904|NCT03031444|Leucovorin|leucovorin|mesh-list
154734283|NCT00946270|Prednisone|prednisone|mesh-list
154734654|NCT03088371|Lidocaine|lidocaine|mesh-list
154734949|NCT00974818|Mitomycins|mitomycins|mesh-list
154735628|NCT01882985|Lycopene|lycopene|mesh-list
154735996|NCT01880957|Lamotrigine|lamotrigine|mesh-list
154736291|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
154736444|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736657|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
154737801|NCT01200160|Niacin|niacin|mesh-list
154738474|NCT03437226|Simendan|simendan|mesh-list
154738542|NCT03437070|Doxorubicin|doxorubicin|mesh-list
154738690|NCT00632931|Vorinostat|vorinostat|mesh-list
154738935|NCT04450446|Heparin|heparin|mesh-list
154739139|NCT01925547|Analgesics|analgesics|mesh-ancestor
154739286|NCT01247272|Fluoxetine|fluoxetine|mesh-list
154739361|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154739522|NCT03427944|Calcium|calcium|mesh-list
154739584|NCT03423030|Macozinone|macozinone|mesh-list
154739804|NCT05872789|GABA Modulators|gaba modulators|mesh-ancestor
154739885|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154741027|NCT01352182|Pioglitazone|pioglitazone|mesh-list
154741382|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154741684|NCT01849289|Insulin|insulin|mesh-list
154741849|NCT01381120|Oxycodone|oxycodone|mesh-list
154742206|NCT03417648|Vitamin E|vitamin e|mesh-list
154742356|NCT01423162|Protective Agents|protective agents|mesh-ancestor
154742438|NCT01396486|Inositol|inositol|mesh-list
154742509|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
154742590|NCT01611857|Vitamins|vitamins|mesh-ancestor
154742818|NCT04697693|Analgesics|analgesics|mesh-ancestor
154742882|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
154742960|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
154743259|NCT03390738|Nivolumab|nivolumab|mesh-list
154743554|NCT01468012|Levodopa|levodopa|mesh-list
154743713|NCT05565976|Analgesics|analgesics|mesh-ancestor
154743937|NCT01516684|Narcotics|narcotics|mesh-ancestor
154744081|NCT03378960|Omeprazole|omeprazole|mesh-list
154744522|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154744602|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744747|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
154744983|NCT02520102|Sargramostim|sargramostim|mesh-list
154745051|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745125|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
154745275|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
154745426|NCT03356964|Hormones|hormones|mesh-list
154745733|NCT03355014|Metformin|metformin|mesh-list
154746039|NCT02253108|Everolimus|everolimus|mesh-list
154746407|NCT02506842|Leucovorin|leucovorin|mesh-list
154746483|NCT02506140|Aspirin|aspirin|mesh-list
154746719|NCT02505048|Rucaparib|rucaparib|mesh-list
154747006|NCT01622296|Lidocaine|lidocaine|mesh-list
154747234|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747460|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
154747549|NCT04461418|Hormones|hormones|mesh-ancestor
154747627|NCT03120468|Topiramate|topiramate|mesh-list
154748352|NCT05168735|Ketamine|ketamine|mesh-list
154748651|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
154748731|NCT04194554|Leuprolide|leuprolide|mesh-list
154748951|NCT03660046|Etonogestrel|etonogestrel|mesh-list
153765436|NCT02085148|Irinotecan|irinotecan|mesh-list
154138772|NCT03970824|Adalimumab|adalimumab|mesh-list
153979057|NCT00720421|Lorazepam|lorazepam|mesh-list
154139152|NCT00875030|Artesunate|artesunate|mesh-list
153979667|NCT02571517|Hormones|hormones|mesh-ancestor
153979981|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980136|NCT00734773|Cytarabine|cytarabine|mesh-list
153980441|NCT02674737|Narcotics|narcotics|mesh-ancestor
153981061|NCT02665533|Narcotics|narcotics|mesh-ancestor
154255064|NCT05617664|Coagulants|coagulants|mesh-ancestor
154255065|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153982513|NCT05930808|Bisoprolol|bisoprolol|mesh-list
153982615|NCT05238207|Psyllium|psyllium|mesh-list
153982701|NCT04683939|Paclitaxel|paclitaxel|mesh-list
153982811|NCT03767348|Nivolumab|nivolumab|mesh-list
153982958|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
153983280|NCT00742924|Leucovorin|leucovorin|mesh-list
154255067|NCT03909776|Cisplatin|cisplatin|mesh-list
154142067|NCT00528645|Saracatinib|saracatinib|mesh-list
153983550|NCT00962780|Vaccines|vaccines|mesh-list
154255069|NCT01148264|Olanzapine|olanzapine|mesh-list
153983936|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143046|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
154143125|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
154143270|NCT01669824|Analgesics|analgesics|mesh-ancestor
153985316|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
154143652|NCT02577809|Narcotics|narcotics|mesh-ancestor
154255072|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
154144176|NCT00946608|Loratadine|loratadine|mesh-list
153986472|NCT00715624|Metformin|metformin|mesh-list
154144322|NCT01021930|Sirolimus|sirolimus|mesh-list
154144469|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
154255075|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154144996|NCT00720161|Metformin|metformin|mesh-list
153987577|NCT05158153|Furosemide|furosemide|mesh-list
153774714|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
154145222|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153987975|NCT01845337|Capecitabine|capecitabine|mesh-list
154145376|NCT00894374|Artesunate|artesunate|mesh-list
153525813|NCT05187377|Hormones|hormones|mesh-list
154255077|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153988846|NCT00669955|Omeprazole|omeprazole|mesh-list
153988941|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255079|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989767|NCT00661635|Analgesics|analgesics|mesh-ancestor
153989951|NCT00663897|Lansoprazole|lansoprazole|mesh-list
153990506|NCT00783523|Doxycycline|doxycycline|mesh-list
153990648|NCT00788749|Xhance|xhance|mesh-list
154147620|NCT06134622|Tirofiban|tirofiban|mesh-list
153991097|NCT00677391|Sibutramine|sibutramine|mesh-list
154147990|NCT05925127|Vaccines|vaccines|mesh-list
153991728|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153991823|NCT00686439|Adalimumab|adalimumab|mesh-list
154148668|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
154148744|NCT05003453|Hormones|hormones|mesh-ancestor
153992547|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154148967|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
154149194|NCT04146493|Heparin|heparin|mesh-list
153992998|NCT00594165|Rotigotine|rotigotine|mesh-list
153993234|NCT04203680|Tryptophan|tryptophan|mesh-list
154149493|NCT03637062|Progesterone|progesterone|mesh-list
154149579|NCT03483038|Irinotecan|irinotecan|mesh-list
153993529|NCT04252274|Cobicistat|cobicistat|mesh-list
154149792|NCT02990338|Hormones|hormones|mesh-ancestor
153993804|NCT00863655|Exemestane|exemestane|mesh-list
154150027|NCT02231723|Irinotecan|irinotecan|mesh-list
153994708|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
154150175|NCT00713219|Docetaxel|docetaxel|mesh-list
154150176|NCT00713219|Cetuximab|cetuximab|mesh-list
154150324|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154150397|NCT01028638|Growth Substances|growth substances|mesh-ancestor
154150471|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
153996009|NCT02861261|Promethazine|promethazine|mesh-list
154150548|NCT00933998|Vitamins|vitamins|mesh-ancestor
154150703|NCT00738257|Pamidronate|pamidronate|mesh-list
154150771|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996879|NCT00830323|Analgesics|analgesics|mesh-ancestor
154150918|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154150996|NCT00940472|Metformin|metformin|mesh-list
154151067|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153997538|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997756|NCT02842580|Antidotes|antidotes|mesh-ancestor
154151750|NCT02917564|Triamcinolone|triamcinolone|mesh-list
154000726|NCT05602519|Rocuronium|rocuronium|mesh-list
154151900|NCT00954278|Sorafenib|sorafenib|mesh-list
153760443|NCT00216645|Doxorubicin|doxorubicin|mesh-list
154255085|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
154007071|NCT02752308|Atropine|atropine|mesh-list
154007385|NCT00949325|Sirolimus|sirolimus|mesh-list
154007433|NCT04221672|Terlipressin|terlipressin|mesh-list
154153476|NCT00689117|Tretinoin|tretinoin|mesh-list
154255090|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154153681|NCT00106639|Tofacitinib|tofacitinib|mesh-list
154153760|NCT00960830|Mirtazapine|mirtazapine|mesh-list
154008539|NCT00900445|Prednisone|prednisone|mesh-list
154008778|NCT04242368|Xhance|xhance|mesh-list
154008813|NCT00900913|Ropivacaine|ropivacaine|mesh-list
154154799|NCT00981786|Travoprost|travoprost|mesh-list
154009788|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
154009984|NCT02731092|Lactoferrin|lactoferrin|mesh-list
154010149|NCT00933049|Amoxicillin|amoxicillin|mesh-list
154010239|NCT05784688|Pembrolizumab|pembrolizumab|mesh-list
154155547|NCT05919121|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154010794|NCT00128297|Pamidronate|pamidronate|mesh-list
154010916|NCT00772005|Modafinil|modafinil|mesh-list
154011038|NCT00926419|Vaccines|vaccines|mesh-list
154011298|NCT00930475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154012765|NCT00929669|Pasireotide|pasireotide|mesh-list
153584891|NCT01763463|Xhance|xhance|mesh-list
154013416|NCT02794610|Tacrolimus|tacrolimus|mesh-list
154158035|NCT04990323|Vidarabine|vidarabine|mesh-list
154255095|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
154159161|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154015554|NCT02336750|Mirtazapine|mirtazapine|mesh-list
154015655|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
154015735|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
154015881|NCT05342558|Fluticasone|fluticasone|mesh-list
154159541|NCT01760226|Hormones|hormones|mesh-ancestor
154016250|NCT00745875|Pemetrexed|pemetrexed|mesh-list
154255102|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159839|NCT00098839|Methotrexate|methotrexate|mesh-list
154016856|NCT02776436|Hormones|hormones|mesh-ancestor
154160509|NCT00755963|Estradiol|estradiol|mesh-list
154160660|NCT01324180|Metformin|metformin|mesh-list
154017791|NCT03651804|Diphosphonates|diphosphonates|mesh-list
154160808|NCT00482001|Donepezil|donepezil|mesh-list
154160900|NCT00489411|Analgesics|analgesics|mesh-ancestor
153775777|NCT05001776|PENTA|penta|mesh-list
154018321|NCT00648453|Clopidogrel|clopidogrel|mesh-list
154255106|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
154023775|NCT00650819|Ezetimibe|ezetimibe|mesh-list
154027058|NCT04887285|Anesthetics|anesthetics|mesh-list
154255108|NCT03908528|Doxorubicin|doxorubicin|mesh-list
154027341|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154255109|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154255110|NCT03908528|Paclitaxel|paclitaxel|mesh-list
154162758|NCT04360070|Ketamine|ketamine|mesh-list
154255111|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154163222|NCT05361278|Eusol|eusol|mesh-list
154177888|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
154163453|NCT00762671|Ebselen|ebselen|mesh-list
154178161|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178364|NCT00869063|Diclofenac|diclofenac|mesh-list
154163739|NCT00673673|Bevacizumab|bevacizumab|mesh-list
154179166|NCT05556889|Iodine|iodine|mesh-list
154179731|NCT02670707|Hormones|hormones|mesh-ancestor
154179893|NCT05264883|Decitabine|decitabine|mesh-list
154180002|NCT04931355|Cetrorelix|cetrorelix|mesh-list
154180116|NCT04648020|Clonidine|clonidine|mesh-list
153602983|NCT01908322|Sorafenib|sorafenib|mesh-list
154165229|NCT00789971|Triamcinolone|triamcinolone|mesh-list
154180462|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
154180549|NCT02813135|Antiemetics|antiemetics|mesh-ancestor
154180661|NCT01892709|Hydromorphone|hydromorphone|mesh-list
154180959|NCT00528866|Docetaxel|docetaxel|mesh-list
154165834|NCT00073021|Mesalamine|mesalamine|mesh-list
154181642|NCT00527618|Acyclovir|acyclovir|mesh-list
154181837|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
154166733|NCT01097551|Phenylephrine|phenylephrine|mesh-list
154264117|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
154264222|NCT03904498|Tolcapone|tolcapone|mesh-list
154167110|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154167187|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
154167264|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
154264602|NCT03330847|Adavosertib|adavosertib|mesh-list
154167411|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
154167489|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
154265277|NCT00288587|Diuretics|diuretics|mesh-list
154255130|NCT03908528|Protective Agents|protective agents|mesh-ancestor
154168610|NCT06329830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255152|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
154266391|NCT03799172|Echinocandins|echinocandins|mesh-list
154169093|NCT06045754|Adalimumab|adalimumab|mesh-list
154169249|NCT05884398|Androgens|androgens|mesh-list
154169547|NCT05615012|Protective Agents|protective agents|mesh-ancestor
154267139|NCT00379288|Xhance|xhance|mesh-list
154267158|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
154267240|NCT01309412|Siltuximab|siltuximab|mesh-list
154255203|NCT03557242|Warfarin|warfarin|mesh-list
154267420|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
154267692|NCT01561742|Minocycline|minocycline|mesh-list
154170282|NCT04925531|Ampicillin|ampicillin|mesh-list
154267900|NCT01322438|Rifampin|rifampin|mesh-list
154267980|NCT01352494|Docetaxel|docetaxel|mesh-list
154268092|NCT01352650|Plerixafor|plerixafor|mesh-list
154268154|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154170810|NCT04192136|Niacinamide|niacinamide|mesh-list
154268349|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
154170961|NCT04116203|Metformin|metformin|mesh-list
154171189|NCT03847610|Penicillin V|penicillin v|mesh-list
154171363|NCT03457701|Iron|iron|mesh-list
154171467|NCT03234972|Hormones|hormones|mesh-ancestor
154255242|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171845|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
154172010|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
153923718|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
154255250|NCT02527772|Fluorouracil|fluorouracil|mesh-list
154270620|NCT01708941|Interferons|interferons|mesh-list
153924406|NCT01218308|Vaccines|vaccines|mesh-list
153924547|NCT02664493|Prednisolone|prednisolone|mesh-list
153924691|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
153924761|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
154255254|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154255255|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
154271849|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
154255257|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925279|NCT00625560|Entecavir|entecavir|mesh-list
153925433|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
154272396|NCT01118598|Niacin|niacin|mesh-list
153925580|NCT02652637|Metronidazole|metronidazole|mesh-list
154273216|NCT01221402|Niacin|niacin|mesh-list
153926625|NCT00598975|Irinotecan|irinotecan|mesh-list
154274253|NCT03917628|Adalimumab|adalimumab|mesh-list
153927002|NCT02224144|Vitamin D|vitamin d|mesh-list
153927163|NCT02856867|Leucovorin|leucovorin|mesh-list
154274943|NCT05839938|Micronutrients|micronutrients|mesh-ancestor
154275045|NCT05770180|Vaccines|vaccines|mesh-list
153616684|NCT06185985|Viloxazine|viloxazine|mesh-list
154255261|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255263|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
153928047|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153928124|NCT02153632|Amantadine|amantadine|mesh-list
153928198|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
153928277|NCT00690898|Lanreotide|lanreotide|mesh-list
154276502|NCT02312245|Topotecan|topotecan|mesh-list
154255266|NCT02527772|Protective Agents|protective agents|mesh-ancestor
154276819|NCT05795478|Pregabalin|pregabalin|mesh-list
154276883|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276884|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928788|NCT00657943|Metformin|metformin|mesh-list
154277167|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
153929017|NCT00667771|Naltrexone|naltrexone|mesh-list
154277353|NCT01141452|Xhance|xhance|mesh-list
154255268|NCT02527772|Vitamins|vitamins|mesh-ancestor
153929164|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277657|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277757|NCT01142622|Ropivacaine|ropivacaine|mesh-list
154255269|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
154278319|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154278541|NCT03902340|Analgesics|analgesics|mesh-list
154278790|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278903|NCT05941338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154278905|NCT05941338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930351|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154279093|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
154255278|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
154279396|NCT03006432|Protective Agents|protective agents|mesh-ancestor
153930651|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
154279631|NCT02527668|Vitamins|vitamins|mesh-ancestor
154255279|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
154280885|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255280|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154255282|NCT00660218|Cetuximab|cetuximab|mesh-list
154255283|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
154282915|NCT01288092|Dactolisib|dactolisib|mesh-list
154283834|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
154283835|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
153931321|NCT00679237|Metformin|metformin|mesh-list
153931399|NCT02627521|Ticagrelor|ticagrelor|mesh-list
154286317|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
154286318|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286319|NCT03942094|Nilotinib|nilotinib|mesh-list
154286682|NCT05219656|Cyclosporins|cyclosporins|mesh-list
154286683|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286685|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286941|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154286942|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153931713|NCT02809378|Thiopental|thiopental|mesh-list
154287167|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
154287350|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287526|NCT04136444|Padsevonil|padsevonil|mesh-list
154287527|NCT04136444|Anticonvulsants|anticonvulsants|mesh-ancestor
154287528|NCT03751332|Tacrolimus|tacrolimus|mesh-list
154287752|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154255285|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255286|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
154255287|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
154288458|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
154255288|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932449|NCT00695071|Itraconazole|itraconazole|mesh-list
153932519|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
154289377|NCT01350934|Vitamin D|vitamin d|mesh-list
154289458|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154289459|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289569|NCT03735368|Benoxinate|benoxinate|mesh-list
153932671|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
154290157|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861551|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154290704|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
154290706|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
154290889|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
154255291|NCT00314951|Vancomycin|vancomycin|mesh-list
154291439|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
154291617|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
154255294|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291990|NCT03686722|Metformin|metformin|mesh-list
154292247|NCT02954406|Growth Substances|growth substances|mesh-ancestor
154292248|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
153933651|NCT01095666|Metformin|metformin|mesh-list
154255295|NCT00085644|Adalimumab|adalimumab|mesh-list
154292698|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
154292699|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154293144|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933940|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293331|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154293480|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934108|NCT01078974|Rituximab|rituximab|mesh-list
154293735|NCT05974501|Antiemetics|antiemetics|mesh-ancestor
154293779|NCT05974423|Antipyretics|antipyretics|mesh-ancestor
154255296|NCT00085644|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154293960|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
154255297|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294098|NCT04332367|Paclitaxel|paclitaxel|mesh-list
154294099|NCT04332367|Carboplatin|carboplatin|mesh-list
154294328|NCT00006734|Ifosfamide|ifosfamide|mesh-list
154294329|NCT00006734|Doxorubicin|doxorubicin|mesh-list
154255298|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255299|NCT01257074|Acyclovir|acyclovir|mesh-list
153934531|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
154295062|NCT06034561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295246|NCT05786547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295248|NCT05786547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295438|NCT05628363|Androgens|androgens|mesh-list
154295554|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154295555|NCT05403476|Hormones|hormones|mesh-ancestor
154255300|NCT01257074|Penciclovir|penciclovir|mesh-list
154295832|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255301|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
154255304|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
154296616|NCT02912559|Antidotes|antidotes|mesh-ancestor
154255305|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
154296844|NCT00753545|Olaparib|olaparib|mesh-list
154296870|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
154297300|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154297301|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
154297549|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
153935506|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
154297928|NCT01105299|Anastrozole|anastrozole|mesh-list
154297929|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154298111|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154298328|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298513|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
154298514|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
154298927|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
154299098|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299099|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299211|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255308|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
154299685|NCT03609424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154299832|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153936535|NCT00941655|Leucovorin|leucovorin|mesh-list
154300303|NCT01233219|Analgesics|analgesics|mesh-ancestor
154300431|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
154255321|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
154861592|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154300945|NCT02868892|Pemetrexed|pemetrexed|mesh-list
154301128|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
154255325|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154301677|NCT02034604|Tamsulosin|tamsulosin|mesh-list
154301679|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154301942|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154302112|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
154302115|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
153937622|NCT01042392|Ramipril|ramipril|mesh-list
154302229|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302408|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
153937761|NCT01040832|Cetuximab|cetuximab|mesh-list
154302608|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302717|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255326|NCT01092858|Androgens|androgens|mesh-ancestor
154255327|NCT01092858|Hormones|hormones|mesh-ancestor
154303625|NCT01260753|Xhance|xhance|mesh-list
153938367|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
154303789|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153938434|NCT05265676|Enoxaparin|enoxaparin|mesh-list
154304054|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
153938657|NCT01123889|Lidocaine|lidocaine|mesh-list
154304395|NCT01161147|Analgesics|analgesics|mesh-ancestor
154304533|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
154304705|NCT05363384|Metformin|metformin|mesh-list
154304825|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154304826|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939023|NCT01061736|Hematinics|hematinics|mesh-ancestor
154305125|NCT02526615|Metformin|metformin|mesh-list
153939092|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154305423|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154305425|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
153939388|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153939550|NCT02584426|Cefazolin|cefazolin|mesh-list
154861606|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154305869|NCT01176669|Apatinib|apatinib|mesh-list
153939900|NCT02702674|Oxytocin|oxytocin|mesh-list
153940352|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
153940439|NCT01099709|Oxycodone|oxycodone|mesh-list
154306779|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940792|NCT01104701|Hormones|hormones|mesh-ancestor
154255343|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154255344|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
154307543|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307673|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154308066|NCT01198665|Hormones|hormones|mesh-ancestor
154308128|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
153941974|NCT04212832|Bupivacaine|bupivacaine|mesh-list
153942429|NCT01004406|Atorvastatin|atorvastatin|mesh-list
154255363|NCT01257386|Analgesics|analgesics|mesh-ancestor
154308816|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308895|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308976|NCT03813303|Narcotics|narcotics|mesh-ancestor
154255364|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
154309219|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
154309293|NCT02048644|Beclomethasone|beclomethasone|mesh-list
154309364|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
154309608|NCT03795207|Durvalumab|durvalumab|mesh-list
154309772|NCT03789123|Androgens|androgens|mesh-ancestor
154309927|NCT03787641|Protamines|protamines|mesh-list
153943996|NCT02665702|Cisplatin|cisplatin|mesh-list
154310407|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
153944453|NCT04170790|Saxagliptin|saxagliptin|mesh-list
153944523|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255369|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154311045|NCT01321671|Pregabalin|pregabalin|mesh-list
153944762|NCT01169636|Ifosfamide|ifosfamide|mesh-list
154311121|NCT03764163|Xenon|xenon|mesh-list
153944837|NCT00839527|Metformin|metformin|mesh-list
153944973|NCT02536690|Midazolam|midazolam|mesh-list
153945121|NCT02658214|Durvalumab|durvalumab|mesh-list
153945274|NCT02650102|Olanzapine|olanzapine|mesh-list
153945455|NCT03542266|Cc-486|cc-486|mesh-list
153945572|NCT00653614|Diuretics|diuretics|mesh-ancestor
153945791|NCT00986154|Warfarin|warfarin|mesh-list
154312373|NCT03934372|Ponatinib|ponatinib|mesh-list
153945944|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
154312524|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
154312725|NCT01939275|Copper|copper|mesh-list
154312837|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
153946998|NCT00597766|Hormones|hormones|mesh-ancestor
154313948|NCT03968861|Xenon|xenon|mesh-list
154255379|NCT01255046|Donepezil|donepezil|mesh-list
154314247|NCT02097160|Vitamin D|vitamin d|mesh-list
154314325|NCT02102776|Mitomycins|mitomycins|mesh-list
154314429|NCT05423392|Lidocaine|lidocaine|mesh-list
154314485|NCT04230213|Adalimumab|adalimumab|mesh-list
154314854|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314939|NCT02112292|Hormones|hormones|mesh-ancestor
153948430|NCT03685188|Sufentanil|sufentanil|mesh-list
154255386|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
154255387|NCT01149356|Exemestane|exemestane|mesh-list
154315827|NCT06148545|Iron|iron|mesh-list
154315963|NCT06116201|Hormone Antagonists|hormone antagonists|mesh-ancestor
153949640|NCT00974922|Aliskiren|aliskiren|mesh-list
153949714|NCT05780723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317031|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
154255391|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950605|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317654|NCT02138812|Paclitaxel|paclitaxel|mesh-list
154317891|NCT00133991|Antidotes|antidotes|mesh-ancestor
154318141|NCT03547024|Hormones|hormones|mesh-ancestor
154318367|NCT03396952|Analgesics|analgesics|mesh-ancestor
154318820|NCT02147548|Etifoxine|etifoxine|mesh-list
154318895|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154255914|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
154318973|NCT03818399|Buprenorphine|buprenorphine|mesh-list
154319049|NCT03818321|Methenamine|methenamine|mesh-list
154319228|NCT00121667|Metformin|metformin|mesh-list
154319855|NCT03731091|Calcitriol|calcitriol|mesh-list
154320792|NCT02173756|Analgesics|analgesics|mesh-ancestor
153953665|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
154255918|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154322282|NCT02204644|Flumatinib|flumatinib|mesh-list
154322612|NCT02258620|Isosorbide|isosorbide|mesh-list
153954554|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
154323830|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
153955008|NCT04137328|Hormones|hormones|mesh-ancestor
154325305|NCT00945802|Hormones|hormones|mesh-ancestor
153955233|NCT02621554|Resveratrol|resveratrol|mesh-list
153955332|NCT00932646|Olodaterol|olodaterol|mesh-list
153955380|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
153955455|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153956127|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956276|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328074|NCT05981079|Piperacillin|piperacillin|mesh-list
154329110|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
153729851|NCT04726631|Coagulants|coagulants|mesh-ancestor
154329345|NCT04662710|Leucovorin|leucovorin|mesh-list
154329748|NCT05874544|Rifabutin|rifabutin|mesh-list
153509238|NCT03254394|Lidocaine|lidocaine|mesh-list
154255401|NCT01148576|Vitamin E|vitamin e|mesh-list
154255413|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
154255414|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154255415|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154332759|NCT01211509|Montelukast|montelukast|mesh-list
154332909|NCT03145766|Antibodies|antibodies|mesh-list
154333084|NCT01212523|Propofol|propofol|mesh-list
154255923|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333222|NCT01116193|Lenalidomide|lenalidomide|mesh-list
154333602|NCT03936205|Analgesics|analgesics|mesh-ancestor
153959074|NCT00916123|Prednisone|prednisone|mesh-list
154333772|NCT01218607|Bosentan|bosentan|mesh-list
153959437|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
153959589|NCT02820987|Piperacillin|piperacillin|mesh-list
154335028|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
153959825|NCT06278051|Warfarin|warfarin|mesh-list
154335671|NCT02315196|Paclitaxel|paclitaxel|mesh-list
154335814|NCT01126645|Sorafenib|sorafenib|mesh-list
154335928|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960041|NCT06233695|Diuretics|diuretics|mesh-list
154336146|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154336782|NCT05562492|Insulin|insulin|mesh-list
153960351|NCT05575804|Capecitabine|capecitabine|mesh-list
154255417|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154337449|NCT02543879|Azacitidine|azacitidine|mesh-list
154339235|NCT02308930|Vitamin D|vitamin d|mesh-list
154339339|NCT01143025|Ropivacaine|ropivacaine|mesh-list
153961712|NCT00720785|Bortezomib|bortezomib|mesh-list
154339609|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
153961881|NCT02815449|Iron|iron|mesh-list
153962008|NCT04303520|Fludarabine|fludarabine|mesh-list
154340053|NCT03433040|Hormones|hormones|mesh-ancestor
154340154|NCT01145365|Anesthetics|anesthetics|mesh-list
153719880|NCT00134667|Verteporfin|verteporfin|mesh-list
154340253|NCT03498820|Remifentanil|remifentanil|mesh-list
153962299|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
153523023|NCT01990196|Trametinib|trametinib|mesh-list
154344466|NCT03879811|Nivolumab|nivolumab|mesh-list
153964623|NCT02784561|Cytarabine|cytarabine|mesh-list
153965076|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
154345766|NCT01171807|Hormones|hormones|mesh-ancestor
154345826|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
153965370|NCT02771457|Infliximab|infliximab|mesh-list
153965443|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965595|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
153965670|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
154346677|NCT01177579|Copper|copper|mesh-list
153965820|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
154346975|NCT03364686|Biotin|biotin|mesh-list
153723748|NCT05594121|Buprenorphine|buprenorphine|mesh-list
154347374|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
154347562|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153966574|NCT04217733|Mebeverine|mebeverine|mesh-list
154348653|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
154255932|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349947|NCT03845179|Incretins|incretins|mesh-ancestor
154350308|NCT01199029|Prednisone|prednisone|mesh-list
154350402|NCT01215149|Vaccines|vaccines|mesh-list
153968953|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
153969030|NCT00806260|Ethanol|ethanol|mesh-list
154352096|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154255432|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154352398|NCT01132235|Etanercept|etanercept|mesh-list
154352954|NCT03335163|Topiramate|topiramate|mesh-list
154353167|NCT01649947|Paclitaxel|paclitaxel|mesh-list
154255441|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
153970840|NCT04301336|Zinc|zinc|mesh-list
154353698|NCT03445624|Infliximab|infliximab|mesh-list
154353797|NCT03445078|Selenium|selenium|mesh-list
153971181|NCT01010204|Varenicline|varenicline|mesh-list
154255451|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354360|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
154354447|NCT03359850|Niraparib|niraparib|mesh-list
154255452|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154255453|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971934|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
154355254|NCT03463252|Progesterone|progesterone|mesh-list
154861878|NCT00633945|Lenalidomide|lenalidomide|mesh-list
154355335|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
153730832|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154356450|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
154356554|NCT02891226|Mirikizumab|mirikizumab|mesh-list
154356844|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154356933|NCT03427216|Diazepam|diazepam|mesh-list
154357038|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357040|NCT00458003|Protective Agents|protective agents|mesh-ancestor
154357177|NCT01239719|Hormones|hormones|mesh-ancestor
154357383|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154357476|NCT03764527|Artesunate|artesunate|mesh-list
154357477|NCT03764527|Lumefantrine|lumefantrine|mesh-list
154357576|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756512|NCT02072863|Prednisone|prednisone|mesh-list
154358382|NCT04623684|Tropicamide|tropicamide|mesh-list
154358563|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
154358666|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
153757865|NCT00176618|Curcumin|curcumin|mesh-list
154358962|NCT04732260|Letermovir|letermovir|mesh-list
154359045|NCT03288987|Leucovorin|leucovorin|mesh-list
154359857|NCT05083910|Carbetocin|carbetocin|mesh-list
153596897|NCT01865175|Iron|iron|mesh-list
154360098|NCT04691856|Acetaminophen|acetaminophen|mesh-list
154360185|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154360427|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360540|NCT04320745|Testosterone|testosterone|mesh-list
154361019|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361132|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
154361134|NCT03912389|Carboplatin|carboplatin|mesh-list
153359685|NCT04409834|Enoxaparin|enoxaparin|mesh-list
154361469|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
153761861|NCT00188045|Diuretics|diuretics|mesh-ancestor
154362645|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153762411|NCT00220350|Leuprolide|leuprolide|mesh-list
154255470|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154363589|NCT03736369|Fexuprazan|fexuprazan|mesh-list
154255472|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154364783|NCT05156814|Hormones|hormones|mesh-ancestor
154364842|NCT03359746|Grazoprevir|grazoprevir|mesh-list
154365754|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
153765375|NCT02408861|Nivolumab|nivolumab|mesh-list
154366204|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
154366290|NCT03198507|Amoxicillin|amoxicillin|mesh-list
154366651|NCT01194791|Dexamethasone|dexamethasone|mesh-list
153766168|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
153766265|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
154366929|NCT01584557|Tolvaptan|tolvaptan|mesh-list
154255476|NCT05570786|Hormones|hormones|mesh-ancestor
153731526|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
153766711|NCT00191828|Olanzapine|olanzapine|mesh-list
153766926|NCT00215202|Gefitinib|gefitinib|mesh-list
153619777|NCT01986608|Lacosamide|lacosamide|mesh-list
154367688|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
154114019|NCT02538003|Delpazolid|delpazolid|mesh-list
154367941|NCT05222204|Paclitaxel|paclitaxel|mesh-list
154368018|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255934|NCT01260506|Bevacizumab|bevacizumab|mesh-list
154368506|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
154369209|NCT05863845|Antimetabolites|antimetabolites|mesh-ancestor
154255486|NCT00336479|Interferons|interferons|mesh-list
154370046|NCT03510715|Niacin|niacin|mesh-list
154370250|NCT01303055|Incretins|incretins|mesh-ancestor
154255489|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
154370535|NCT02496910|Amlodipine|amlodipine|mesh-list
153770756|NCT01085812|Analgesics|analgesics|mesh-ancestor
154371099|NCT03797729|Tirofiban|tirofiban|mesh-list
154371286|NCT03794297|Dabrafenib|dabrafenib|mesh-list
153771257|NCT01084330|Docetaxel|docetaxel|mesh-list
154371550|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154255500|NCT03905564|Doxylamine|doxylamine|mesh-list
154372034|NCT03786887|Nalbuphine|nalbuphine|mesh-list
154372916|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154372917|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
154255506|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773114|NCT04667299|Amoxicillin|amoxicillin|mesh-list
154255507|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
154373925|NCT04641312|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154374670|NCT06041217|Semaglutide|semaglutide|mesh-list
154374763|NCT05954442|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154374848|NCT05858957|Analgesics|analgesics|mesh-ancestor
154375266|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154375460|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375921|NCT04706091|Suvorexant|suvorexant|mesh-list
153775621|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
153775713|NCT05129358|Furosemide|furosemide|mesh-list
154376267|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376357|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
154376684|NCT03099499|TIC10 compound|tic10 compound|mesh-list
154376834|NCT02759107|Dulaglutide|dulaglutide|mesh-list
154376972|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
154255512|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
154377154|NCT01280994|Xenon|xenon|mesh-list
154377479|NCT06064175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377481|NCT06064175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255513|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
153776858|NCT04612894|Apatinib|apatinib|mesh-list
154378064|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
154378340|NCT02909036|Melphalan|melphalan|mesh-list
154378440|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
154255516|NCT01151384|Docetaxel|docetaxel|mesh-list
154378959|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154379289|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
154379377|NCT01318590|Hormones|hormones|mesh-ancestor
154255519|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
154255520|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
154379833|NCT01319448|Amodiaquine|amodiaquine|mesh-list
154379834|NCT01319448|Mefloquine|mefloquine|mesh-list
154380212|NCT00480662|Alendronate|alendronate|mesh-list
154380215|NCT00398606|Alendronate|alendronate|mesh-list
154380301|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380388|NCT06029933|Vaccines|vaccines|mesh-list
154380582|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154381740|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
153780667|NCT00179959|Eusol|eusol|mesh-list
154381954|NCT04813107|Tislelizumab|tislelizumab|mesh-list
153359932|NCT02861573|Belzutifan|belzutifan|mesh-list
154382299|NCT02458924|Niacin|niacin|mesh-list
154382617|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
154255528|NCT00314249|Milnacipran|milnacipran|mesh-list
154383024|NCT03004131|Xhance|xhance|mesh-list
154383111|NCT01346865|Cilostazol|cilostazol|mesh-list
154558204|NCT02162797|Zinc|zinc|mesh-list
154558238|NCT02164825|Morphine|morphine|mesh-list
154558303|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
154558392|NCT06110195|Paclitaxel|paclitaxel|mesh-list
154558451|NCT06109389|Lidocaine|lidocaine|mesh-list
154558597|NCT06003829|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
154558812|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558884|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559034|NCT04709276|Nivolumab|nivolumab|mesh-list
154559105|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559180|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154559255|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
154559479|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154559481|NCT02538510|Vorinostat|vorinostat|mesh-list
154559632|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
154559780|NCT02412267|Etoposide|etoposide|mesh-list
154559931|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559933|NCT02401425|Letrozole|letrozole|mesh-list
154560006|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
154560084|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
154560161|NCT02171689|Afatinib|afatinib|mesh-list
154560230|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560451|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154560826|NCT03455504|Venetoclax|venetoclax|mesh-list
154561073|NCT06009744|Zinc|zinc|mesh-list
154561133|NCT06008925|Nivolumab|nivolumab|mesh-list
154561352|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154561657|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
154561734|NCT02182531|Ephedrine|ephedrine|mesh-list
154561797|NCT03537157|Rifaximin|rifaximin|mesh-list
154561872|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
154562021|NCT06219733|Vactosertib|vactosertib|mesh-list
154562099|NCT06218550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562191|NCT06217887|Metformin|metformin|mesh-list
154562347|NCT06090227|Metformin|metformin|mesh-list
154562397|NCT06086392|Dexamethasone|dexamethasone|mesh-list
154562465|NCT05916586|Prednisone|prednisone|mesh-list
154562539|NCT05848843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562689|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
154562908|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154563229|NCT04226690|Dronabinol|dronabinol|mesh-list
154563355|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
154563731|NCT02573870|Xhance|xhance|mesh-list
154563732|NCT02573870|Albuterol|albuterol|mesh-list
154563860|NCT02177851|Iron|iron|mesh-list
154564027|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
154564418|NCT03536065|Narcotics|narcotics|mesh-ancestor
154564624|NCT02194309|Telmisartan|telmisartan|mesh-list
154564795|NCT02198209|Hormones|hormones|mesh-ancestor
154565305|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565375|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
154565600|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565753|NCT01846390|Romidepsin|romidepsin|mesh-list
154565904|NCT00535353|Irinotecan|irinotecan|mesh-list
154565976|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566284|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154566436|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
154566507|NCT02205775|Atorvastatin|atorvastatin|mesh-list
154566659|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566882|NCT02144753|Psyllium|psyllium|mesh-list
154566957|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154567029|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154567176|NCT02228005|Sertraline|sertraline|mesh-list
154567399|NCT02149901|Ephedrine|ephedrine|mesh-list
154567468|NCT02146937|Bicalutamide|bicalutamide|mesh-list
154567621|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154567691|NCT03542357|Calcitonin|calcitonin|mesh-list
154567843|NCT01358864|Interferons|interferons|mesh-list
154567920|NCT04480359|Analgesics|analgesics|mesh-ancestor
154568067|NCT00054158|Dexamethasone|dexamethasone|mesh-list
154568141|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
154568373|NCT05489666|Vitamin D|vitamin d|mesh-list
154568668|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568753|NCT01499563|Risperidone|risperidone|mesh-list
154569183|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
154569188|NCT01338883|Efavirenz|efavirenz|mesh-list
154569474|NCT02765165|Lomustine|lomustine|mesh-list
154569550|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154569624|NCT03504644|Vincristine|vincristine|mesh-list
154569706|NCT02153879|Niacin|niacin|mesh-list
154569930|NCT03542825|Iron|iron|mesh-list
154570019|NCT04196283|Paclitaxel|paclitaxel|mesh-list
154570073|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
154570147|NCT04474327|Montelukast|montelukast|mesh-list
154570234|NCT02159027|Maraviroc|maraviroc|mesh-list
154570517|NCT02255591|Epinephrine|epinephrine|mesh-list
154570671|NCT02171585|Dabigatran|dabigatran|mesh-list
154570971|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
154571050|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
154571265|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
154571862|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572311|NCT02280265|Coagulants|coagulants|mesh-ancestor
154572754|NCT03133897|Hormones|hormones|mesh-ancestor
154572971|NCT00393991|Xhance|xhance|mesh-list
154573148|NCT00097357|Enoxaparin|enoxaparin|mesh-list
154573199|NCT02191709|Levomethorphan|levomethorphan|mesh-list
154573275|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
154573495|NCT02030717|Clonidine|clonidine|mesh-list
154573724|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
154573798|NCT02376075|Hormones|hormones|mesh-ancestor
154574022|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
154574395|NCT05791669|Listerine|listerine|mesh-list
154574472|NCT05790239|Amphetamine|amphetamine|mesh-list
154574769|NCT02959944|Hormones|hormones|mesh-ancestor
154574920|NCT00783367|Dexamethasone|dexamethasone|mesh-list
154574992|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
154575049|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
154575346|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575585|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154575736|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154575926|NCT02290717|Xhance|xhance|mesh-list
154576030|NCT02359617|Insulin|insulin|mesh-list
154576104|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
154576549|NCT04464967|Cetuximab|cetuximab|mesh-list
154576625|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154576699|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
154576925|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577006|NCT04464811|Furosemide|furosemide|mesh-list
154577151|NCT02233439|Galactogogues|galactogogues|mesh-list
154577299|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154577608|NCT02300623|Stavudine|stavudine|mesh-list
154577678|NCT02336139|Velpatasvir|velpatasvir|mesh-list
154577754|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
154577904|NCT03505489|Mannitol|mannitol|mesh-list
154578427|NCT02313727|Pamidronate|pamidronate|mesh-list
154578581|NCT02319499|Vitamin A|vitamin a|mesh-list
154578655|NCT03499171|Citalopram|citalopram|mesh-list
154578802|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579104|NCT02620553|Insulin|insulin|mesh-list
154579171|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
154579274|NCT01516073|Xhance|xhance|mesh-list
154579328|NCT01480583|Alovudine|alovudine|mesh-list
154579613|NCT01253603|Xhance|xhance|mesh-list
154579621|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
154579695|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
154580378|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
154580443|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
154580571|NCT05311436|Iron|iron|mesh-list
154580666|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
154580740|NCT00978497|Ribavirin|ribavirin|mesh-list
154580741|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
154580813|NCT02284906|Pioglitazone|pioglitazone|mesh-list
154581110|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154581259|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154581332|NCT05200052|Colchicine|colchicine|mesh-list
154581411|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
154581775|NCT04215146|Paclitaxel|paclitaxel|mesh-list
154582129|NCT04460521|Antidotes|antidotes|mesh-ancestor
154582205|NCT03484195|Fluorouracil|fluorouracil|mesh-list
154862233|NCT00952133|Dexamethasone|dexamethasone|mesh-list
154582946|NCT05668455|Povidone|povidone|mesh-list
154583536|NCT03483181|Enoxaparin|enoxaparin|mesh-list
154583606|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583906|NCT03480997|Bromides|bromides|mesh-list
154583979|NCT05944341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154584055|NCT05943223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154584131|NCT05768360|Furosemide|furosemide|mesh-list
154584579|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
154862274|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
154584802|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154584876|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
154585096|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
154862277|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154585320|NCT02480114|Hydrocodone|hydrocodone|mesh-list
154585470|NCT00231257|Sirolimus|sirolimus|mesh-list
154585636|NCT03951025|Melatonin|melatonin|mesh-list
154585769|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
154585851|NCT04859062|Lidocaine|lidocaine|mesh-list
154585921|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154586372|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154586522|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
154586598|NCT04890106|Bimatoprost|bimatoprost|mesh-list
154586826|NCT02473250|Fluoxetine|fluoxetine|mesh-list
154587043|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
154587117|NCT02465528|Ceritinib|ceritinib|mesh-list
154587419|NCT03520985|Hormones|hormones|mesh-ancestor
154587481|NCT03138447|Insulin|insulin|mesh-list
154587554|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587859|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
154588080|NCT02303951|Vemurafenib|vemurafenib|mesh-list
154588155|NCT03135795|Analgesics|analgesics|mesh-ancestor
154588456|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
154588752|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
154589123|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
154589152|NCT02874430|Metformin|metformin|mesh-list
154589415|NCT05331807|Vitamin D|vitamin d|mesh-list
154589653|NCT06229977|Hormones|hormones|mesh-ancestor
154589718|NCT06228820|Aspirin|aspirin|mesh-list
154589791|NCT06228339|Urological Agents|urological agents|mesh-ancestor
154589923|NCT05954624|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154590065|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154590154|NCT05256745|Paclitaxel|paclitaxel|mesh-list
154590214|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
154590287|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590328|NCT04518228|Ritonavir|ritonavir|mesh-list
154590436|NCT04170855|Diuretics|diuretics|mesh-ancestor
154590451|NCT04143711|Paclitaxel|paclitaxel|mesh-list
154590660|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590883|NCT00861042|Lacosamide|lacosamide|mesh-list
154591248|NCT03494387|Vitamins|vitamins|mesh-ancestor
154591406|NCT04600895|Favipiravir|favipiravir|mesh-list
154591975|NCT03131843|Ethanol|ethanol|mesh-list
154592070|NCT03104075|Vaccines|vaccines|mesh-list
154592183|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
154592622|NCT05134415|Menthol|menthol|mesh-list
154593069|NCT05170711|Anesthetics|anesthetics|mesh-list
154593141|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
154593366|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
154593509|NCT05174845|Vitamins|vitamins|mesh-ancestor
154593747|NCT00003857|Tamoxifen|tamoxifen|mesh-list
154594808|NCT03436121|Midazolam|midazolam|mesh-list
154318866|NCT02153866|Vaccines|vaccines|mesh-list
154595074|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595297|NCT03437785|Protective Agents|protective agents|mesh-ancestor
154595369|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595444|NCT03440359|Letrozole|letrozole|mesh-list
154595692|NCT03428191|Remifentanil|remifentanil|mesh-list
154595739|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
154595889|NCT03420469|Bupropion|bupropion|mesh-list
154596049|NCT01239797|Elotuzumab|elotuzumab|mesh-list
154596268|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
154596411|NCT03411109|Analgesics|analgesics|mesh-ancestor
154596484|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154596933|NCT01936857|Naloxone|naloxone|mesh-list
154597013|NCT01602224|Dexamethasone|dexamethasone|mesh-list
154597081|NCT03396497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154597158|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
154597605|NCT00540839|Xhance|xhance|mesh-list
154597606|NCT00540839|Montelukast|montelukast|mesh-list
154597694|NCT03395665|Estradiol|estradiol|mesh-list
154749099|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
154597830|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
154749100|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154597989|NCT04448717|Antibodies|antibodies|mesh-list
154598052|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154749101|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154598213|NCT03378401|Octenidine|octenidine|mesh-list
154749102|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154598318|NCT03374501|PAZ320|paz320|mesh-list
154749103|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749104|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749105|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
154598725|NCT03373825|Fentanyl|fentanyl|mesh-list
154749106|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599323|NCT03356353|Urological Agents|urological agents|mesh-ancestor
154749107|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599478|NCT03355027|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154749108|NCT02708836|Anesthetics|anesthetics|mesh-list
154599619|NCT04503967|Nivolumab|nivolumab|mesh-list
154599731|NCT05364619|Bismuth|bismuth|mesh-list
154749109|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749110|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599925|NCT04435587|Ritonavir|ritonavir|mesh-list
154749111|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154749112|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154600143|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
154600328|NCT04486911|Letrozole|letrozole|mesh-list
154600365|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154600451|NCT04502641|Docetaxel|docetaxel|mesh-list
154749113|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749114|NCT02473276|Morphine|morphine|mesh-list
154749115|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154749116|NCT02473276|Narcotics|narcotics|mesh-ancestor
154600661|NCT06151470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154749117|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749118|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749119|NCT02473276|Analgesics|analgesics|mesh-ancestor
154749120|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
154749121|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749122|NCT02451423|Atezolizumab|atezolizumab|mesh-list
154749123|NCT02451423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154749124|NCT02451423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749125|NCT02451423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749126|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749127|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154749128|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749129|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749130|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749131|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154749132|NCT02189720|Amifampridine|amifampridine|mesh-list
154749133|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154749134|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749135|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749136|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154600940|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749137|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154601014|NCT05413122|Nicotine|nicotine|mesh-list
154601120|NCT04991103|Dexamethasone|dexamethasone|mesh-list
154601122|NCT04991103|Bortezomib|bortezomib|mesh-list
154601198|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
154601347|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
154601424|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601572|NCT03819660|Amifampridine|amifampridine|mesh-list
154601573|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154749138|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749139|NCT02184195|Olaparib|olaparib|mesh-list
154749140|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154749141|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602016|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154749142|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749143|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749144|NCT02181413|Ixazomib|ixazomib|mesh-list
154749145|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749146|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749147|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
154749148|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749149|NCT02151981|Osimertinib|osimertinib|mesh-list
154749150|NCT02151981|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154749151|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749152|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602764|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
154749153|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602934|NCT02491879|Ketoprofen|ketoprofen|mesh-list
154603065|NCT02488603|Tamoxifen|tamoxifen|mesh-list
154603212|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
154749154|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749155|NCT02138617|Leucovorin|leucovorin|mesh-list
154749156|NCT02138617|Bevacizumab|bevacizumab|mesh-list
154749157|NCT02138617|Fluorouracil|fluorouracil|mesh-list
154749158|NCT02138617|Irinotecan|irinotecan|mesh-list
154603601|NCT02485873|Vitamin K|vitamin k|mesh-list
154749159|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
154603667|NCT02476981|Ephedrine|ephedrine|mesh-list
154603836|NCT02479555|BB 1101|bb 1101|mesh-list
154603887|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
154603970|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
154604045|NCT05714371|Dabrafenib|dabrafenib|mesh-list
154604118|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604192|NCT03903939|Iloprost|iloprost|mesh-list
154749160|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749161|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604495|NCT03174847|Diuretics|diuretics|mesh-ancestor
154749162|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154604568|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154604647|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
154604720|NCT03311425|Protective Agents|protective agents|mesh-ancestor
154749163|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154749164|NCT02138617|Growth Substances|growth substances|mesh-ancestor
154749165|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604943|NCT04368403|Brodalumab|brodalumab|mesh-list
154749166|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
154749167|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
154749168|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749169|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154749170|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749171|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
154749172|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154749173|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749174|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749175|NCT02138617|Antidotes|antidotes|mesh-ancestor
154749176|NCT02138617|Protective Agents|protective agents|mesh-ancestor
154605313|NCT03370835|Metoprolol|metoprolol|mesh-list
154749177|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
154749178|NCT02138617|Vitamins|vitamins|mesh-ancestor
154749179|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
154749180|NCT02118584|Etrolizumab|etrolizumab|mesh-list
154749181|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154749182|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
154749183|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749184|NCT01996605|Oxytocin|oxytocin|mesh-list
154749185|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
154749186|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154749187|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749188|NCT01974440|Prednisone|prednisone|mesh-list
154749189|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
154749190|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154749191|NCT01974440|Rituximab|rituximab|mesh-list
154749192|NCT01974440|Doxorubicin|doxorubicin|mesh-list
154749193|NCT01974440|Vincristine|vincristine|mesh-list
154749194|NCT01974440|Ibrutinib|ibrutinib|mesh-list
154605816|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
154605892|NCT03365765|Apatinib|apatinib|mesh-list
154605967|NCT03536455|Diuretics|diuretics|mesh-ancestor
154749195|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749196|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
154606042|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
154749197|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749198|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154749199|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154749200|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
154749201|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606525|NCT03265795|Ether|ether|mesh-list
154749202|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749203|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154606855|NCT02517827|Paclitaxel|paclitaxel|mesh-list
154749204|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154607155|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
154749205|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154749206|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154607376|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749207|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749208|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607527|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154749209|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154749210|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
154749211|NCT01974440|Hormones|hormones|mesh-ancestor
154331459|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
154607825|NCT03235609|Narcotics|narcotics|mesh-ancestor
154607893|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607966|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749212|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608041|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154749213|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154608118|NCT03121079|Interferons|interferons|mesh-list
154749214|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154749215|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
154749216|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
154749217|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
154749218|NCT01974440|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154749219|NCT01974440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749220|NCT01921166|Leuprolide|leuprolide|mesh-list
154749221|NCT01921166|Clomiphene|clomiphene|mesh-list
154749222|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154608631|NCT06066840|Antibodies|antibodies|mesh-list
154749223|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
154749224|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154749225|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749226|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154749227|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749228|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154749229|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
154749230|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154749231|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154749232|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154609198|NCT04226495|Dsuvia|dsuvia|mesh-list
154749233|NCT01696461|Plerixafor|plerixafor|mesh-list
154749234|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154749235|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154749236|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
154749237|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609904|NCT06118905|Zoledronic Acid|zoledronic acid|mesh-list
154609981|NCT06077487|Ketamine|ketamine|mesh-list
154749238|NCT01688492|Ipilimumab|ipilimumab|mesh-list
154610271|NCT05843643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610345|NCT05735184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610422|NCT05675410|Bleomycin|bleomycin|mesh-list
154749239|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749240|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610813|NCT05076617|Alprazolam|alprazolam|mesh-list
154749241|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611020|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154611169|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
154611243|NCT04402788|Atezolizumab|atezolizumab|mesh-list
154611315|NCT04338269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611391|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611466|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154749242|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611697|NCT03297606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154749243|NCT01606098|Bevacizumab|bevacizumab|mesh-list
154611766|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749244|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749245|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611995|NCT02379416|Paclitaxel|paclitaxel|mesh-list
154749246|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154749247|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154749248|NCT01606098|Growth Substances|growth substances|mesh-ancestor
154749249|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749250|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
154749251|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
154749252|NCT01568307|Serotonin|serotonin|mesh-list
154225080|NCT04557449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154749253|NCT01568307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154225227|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
154749254|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154749255|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154749256|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
154225457|NCT03970772|Glucagon|glucagon|mesh-list
154225528|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154749257|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225614|NCT01072604|Aspirin|aspirin|mesh-list
154749258|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749259|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225678|NCT00237458|Lacosamide|lacosamide|mesh-list
154749260|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154225767|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
154749261|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749262|NCT01508221|Vitamin E|vitamin e|mesh-list
154749263|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
154749264|NCT01508221|Vitamins|vitamins|mesh-ancestor
154749265|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
154749266|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749267|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
154749268|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226218|NCT00006604|Ritonavir|ritonavir|mesh-list
154226371|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154749269|NCT01508221|Protective Agents|protective agents|mesh-ancestor
154226597|NCT00428597|Sunitinib|sunitinib|mesh-list
154749270|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154749271|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226749|NCT00004228|Vincristine|vincristine|mesh-list
154226836|NCT00195260|Bosutinib|bosutinib|mesh-list
154749272|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154749273|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154227200|NCT00185588|Vatalanib|vatalanib|mesh-list
154749274|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
154227377|NCT00180674|Warfarin|warfarin|mesh-list
154749275|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154749276|NCT01485861|Prednisone|prednisone|mesh-list
154749277|NCT01485861|Prednisolone|prednisolone|mesh-list
154749278|NCT01485861|Ipatasertib|ipatasertib|mesh-list
154749279|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227585|NCT00168818|Enoxaparin|enoxaparin|mesh-list
154749280|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
154749281|NCT01485861|Hormones|hormones|mesh-ancestor
154227945|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154749282|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228094|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
154749283|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749284|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154749285|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749286|NCT01485861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749287|NCT01485861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749288|NCT01485861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749289|NCT01241734|Lenalidomide|lenalidomide|mesh-list
154749290|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
154228393|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154749291|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749292|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154749293|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154749294|NCT01241734|Growth Substances|growth substances|mesh-ancestor
154749295|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
154749296|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749297|NCT01101438|Metformin|metformin|mesh-list
154228686|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
154228757|NCT03935152|Hormones|hormones|mesh-ancestor
154749298|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154749299|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749300|NCT01094769|Moxonidine|moxonidine|mesh-list
154749301|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154749302|NCT01007773|Fentanyl|fentanyl|mesh-list
154749303|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
154749304|NCT01007773|Propofol|propofol|mesh-list
154229205|NCT01126450|Growth Substances|growth substances|mesh-ancestor
154229351|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
154749305|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154749306|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229493|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154229574|NCT03927118|Hormones|hormones|mesh-ancestor
154749307|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749308|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154749309|NCT01007773|Analgesics|analgesics|mesh-ancestor
154749310|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
154749311|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749312|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154749313|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154749314|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154749315|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
154749316|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229720|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154229785|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154749317|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229881|NCT01585792|Glimepiride|glimepiride|mesh-list
154749318|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154749319|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
154749320|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
154749321|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154501262|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154230127|NCT01137994|Paclitaxel|paclitaxel|mesh-list
154749322|NCT01007773|Narcotics|narcotics|mesh-ancestor
154230155|NCT03739606|Antibodies|antibodies|mesh-list
154749323|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154749324|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154749325|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154749326|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749327|NCT00936663|Incretins|incretins|mesh-ancestor
154749328|NCT00936663|Hormones|hormones|mesh-ancestor
154230378|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
154230379|NCT01329640|Trastuzumab|trastuzumab|mesh-list
154749329|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154749330|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154749331|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
154749332|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230526|NCT00113529|Gefitinib|gefitinib|mesh-list
154749333|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749334|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
154749335|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
154749336|NCT00681343|Daclizumab|daclizumab|mesh-list
154749337|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
153977571|NCT00769132|Vitamins|vitamins|mesh-ancestor
154749338|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749339|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749340|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749341|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749342|NCT00665457|Celecoxib|celecoxib|mesh-list
154749343|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
154749344|NCT00665457|Docetaxel|docetaxel|mesh-list
154749345|NCT00665457|Doxorubicin|doxorubicin|mesh-list
154749346|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154749347|NCT00665457|Capecitabine|capecitabine|mesh-list
154749348|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749349|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
154749350|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231108|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
154749351|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154231260|NCT01251172|Melphalan|melphalan|mesh-list
154749352|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154749353|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
154231582|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
154231660|NCT01150318|Iodine|iodine|mesh-list
154231729|NCT01150786|Protective Agents|protective agents|mesh-ancestor
154231877|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231952|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
154749354|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749355|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232252|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749356|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154232330|NCT03887260|Fentanyl|fentanyl|mesh-list
154749357|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
154749358|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
154749359|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
154232796|NCT01268176|Vitamin D|vitamin d|mesh-list
154232845|NCT03876574|Dexamethasone|dexamethasone|mesh-list
154232922|NCT01159210|Coagulants|coagulants|mesh-ancestor
154233078|NCT03757234|Levofloxacin|levofloxacin|mesh-list
154749360|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154749361|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154233406|NCT00163020|Hormones|hormones|mesh-ancestor
154749362|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749363|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233525|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
154233599|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154749364|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154749365|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
154233974|NCT01177852|Promethazine|promethazine|mesh-list
154234049|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234130|NCT01174888|Cytarabine|cytarabine|mesh-list
154234198|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234273|NCT03862768|Sunitinib|sunitinib|mesh-list
154234348|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234721|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234804|NCT00113490|Palivizumab|palivizumab|mesh-list
154749366|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154749367|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154749368|NCT00665457|Analgesics|analgesics|mesh-ancestor
154235171|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235251|NCT03847558|Hormones|hormones|mesh-list
154749369|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
154749370|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749371|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235638|NCT03844984|Lidocaine|lidocaine|mesh-list
154235692|NCT01198210|Dexamethasone|dexamethasone|mesh-list
154749372|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154749373|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154749374|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154749375|NCT00574730|Rituximab|rituximab|mesh-list
154749376|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154236067|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
154749377|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236134|NCT05667220|Incretins|incretins|mesh-ancestor
153983120|NCT00744328|Sertraline|sertraline|mesh-list
154749378|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
154749379|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749380|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154749381|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
154236662|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
154236738|NCT00142584|Nebivolol|nebivolol|mesh-list
154749382|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154749383|NCT00496756|Sorafenib|sorafenib|mesh-list
154237040|NCT03799822|Vitamin K|vitamin k|mesh-list
154237184|NCT00141102|Analgesics|analgesics|mesh-ancestor
154237312|NCT01306318|Diclofenac|diclofenac|mesh-list
154237406|NCT03794596|Aspirin|aspirin|mesh-list
154237481|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
154237552|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154237629|NCT03786562|Nalbuphine|nalbuphine|mesh-list
154237704|NCT00413153|Ritonavir|ritonavir|mesh-list
154749384|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238008|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
154749385|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238224|NCT01309984|Propofol|propofol|mesh-list
154749386|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749387|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238428|NCT03770026|Clomiphene|clomiphene|mesh-list
154238643|NCT03762148|Iron|iron|mesh-list
154238726|NCT00405821|Acyclovir|acyclovir|mesh-list
154749388|NCT00483561|Etoposide|etoposide|mesh-list
154749389|NCT00483561|Gefitinib|gefitinib|mesh-list
154749390|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154749391|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239029|NCT01076634|Insulin|insulin|mesh-list
154239175|NCT00140426|Risperidone|risperidone|mesh-list
154749392|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154749393|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154239403|NCT03756064|Docetaxel|docetaxel|mesh-list
154749394|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239622|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239700|NCT01083264|Gestodene|gestodene|mesh-list
154239945|NCT01079754|Morphine|morphine|mesh-list
154749395|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240231|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154240458|NCT00096044|Lenalidomide|lenalidomide|mesh-list
154749396|NCT00483561|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154240536|NCT04052620|Analgesics|analgesics|mesh-ancestor
154240607|NCT04018612|Analgesics|analgesics|mesh-ancestor
154749397|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749398|NCT00483366|Gemcitabine|gemcitabine|mesh-list
154240828|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
154749400|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
154240979|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154749401|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154749402|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
154749403|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749404|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749405|NCT00483366|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154241198|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749406|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749407|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749408|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
154749409|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154749410|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
154749411|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749412|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749413|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154749414|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
154749415|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154749416|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
154749417|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749418|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241926|NCT00384293|Niacin|niacin|mesh-list
154749419|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154749420|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
154749421|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
154749422|NCT00278083|Protective Agents|protective agents|mesh-ancestor
154749423|NCT02492412|Cyclosporine|cyclosporine|mesh-list
154749424|NCT02492412|Cyclosporins|cyclosporins|mesh-list
154749425|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749426|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749427|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749428|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
154749429|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242473|NCT01324583|Hormones|hormones|mesh-ancestor
154242533|NCT03665038|Brexanolone|brexanolone|mesh-list
154749430|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
154749431|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154749432|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
154749433|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154749434|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154749435|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154749436|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154749437|NCT03329898|Estradiol|estradiol|mesh-list
154749438|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154749439|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
154749440|NCT03329898|Estrogens|estrogens|mesh-ancestor
154749441|NCT03329898|Hormones|hormones|mesh-ancestor
154242897|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154242969|NCT03961659|Metformin|metformin|mesh-list
153989858|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
154243042|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154749442|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154749443|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749444|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154749445|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
154243191|NCT00079274|Vitamins|vitamins|mesh-ancestor
154749446|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154243334|NCT01088906|Pemetrexed|pemetrexed|mesh-list
154749447|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154749448|NCT03329898|Progestins|progestins|mesh-ancestor
154749449|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
154749450|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154243638|NCT00103857|Metformin|metformin|mesh-list
154749451|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749452|NCT02492568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154749453|NCT02492568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749454|NCT01722292|Carboplatin|carboplatin|mesh-list
154749455|NCT01722292|Etoposide|etoposide|mesh-list
154749456|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243926|NCT05768373|Fluorides|fluorides|mesh-list
154243996|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
154244072|NCT04535713|Nivolumab|nivolumab|mesh-list
154749457|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154749458|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154244296|NCT03003520|Prednisone|prednisone|mesh-list
154749459|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749460|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749461|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749462|NCT02493894|Cefazolin|cefazolin|mesh-list
154749463|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154244520|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
154749464|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154749465|NCT02493738|Itraconazole|itraconazole|mesh-list
154749466|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
154244671|NCT04991974|Naloxone|naloxone|mesh-list
154244743|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749467|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154244829|NCT05934097|Glucocorticoids|glucocorticoids|mesh-ancestor
154749468|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154749469|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154749470|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749471|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245001|NCT05932264|Apatinib|apatinib|mesh-list
154749472|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154749473|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
154749474|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159273|NCT02827877|Copper|copper|mesh-list
154749475|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749476|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154749478|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749479|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749480|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749481|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749482|NCT05560360|Efavirenz|efavirenz|mesh-list
154749483|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154749484|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154749485|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749486|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245643|NCT04897217|Megestrol|megestrol|mesh-list
154749487|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
154749488|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245695|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749489|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154245772|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749490|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154245844|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154749491|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154749492|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154749493|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154246083|NCT03485274|Vortioxetine|vortioxetine|mesh-list
154749494|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154749495|NCT03329118|Simvastatin|simvastatin|mesh-list
154246215|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749496|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154749497|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154749498|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
154749499|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749500|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154246368|NCT02527200|Liraglutide|liraglutide|mesh-list
154749501|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154246438|NCT02243878|Ranibizumab|ranibizumab|mesh-list
154749502|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749503|NCT01723384|Naltrexone|naltrexone|mesh-list
154246512|NCT00810732|Nifedipine|nifedipine|mesh-list
154749504|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154749505|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154749506|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749507|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
154749508|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749509|NCT02492490|Basiliximab|basiliximab|mesh-list
154246660|NCT00059930|Hormones|hormones|mesh-ancestor
154749510|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749511|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
154749512|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749513|NCT02493504|Heparin|heparin|mesh-list
154749514|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
154749515|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154749516|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154749517|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749518|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
154749519|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154749520|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
154749521|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749522|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749523|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154749524|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
154749525|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154749526|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154749527|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154749528|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
154749529|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749530|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749531|NCT03328728|Hylan|hylan|mesh-list
154749532|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
154247396|NCT03469258|Pancrelipase|pancrelipase|mesh-list
154749533|NCT03328728|Protective Agents|protective agents|mesh-ancestor
154749534|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749535|NCT03328494|Paclitaxel|paclitaxel|mesh-list
154749536|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154749537|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749538|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
154749539|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247984|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
154749540|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
154248148|NCT01327118|Dinoprost|dinoprost|mesh-list
154248212|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749541|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749542|NCT02491398|Rituximab|rituximab|mesh-list
154749543|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154749544|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749545|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749546|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
154248431|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
154248502|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749547|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749548|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154749549|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154749550|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
154749551|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749552|NCT03333018|Bromides|bromides|mesh-list
154749553|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
154749554|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154749555|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
154749556|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749557|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749558|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154749559|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
154749560|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154749561|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154749562|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154749563|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
154749564|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749565|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248799|NCT03389308|Diacerein|diacerein|mesh-list
154749566|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
154749567|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154749568|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154248963|NCT03387046|Hormones|hormones|mesh-ancestor
154249021|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
154249095|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154749569|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749570|NCT01723696|Vitamins|vitamins|mesh-list
154749571|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
154749572|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
154249255|NCT05583071|Rituximab|rituximab|mesh-list
154749573|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749574|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
154749575|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749576|NCT01723696|Protective Agents|protective agents|mesh-ancestor
154749577|NCT03327558|Mesalamine|mesalamine|mesh-list
154249395|NCT04574583|Antiviral Agents|antiviral agents|mesh-ancestor
154749578|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154249471|NCT03694002|Antibodies|antibodies|mesh-list
154249544|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154249620|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749579|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154749580|NCT03327558|Analgesics|analgesics|mesh-ancestor
154749581|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
154749582|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749583|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749584|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154749585|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154749586|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
154749587|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154249916|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
154749588|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154749589|NCT02242630|Prednisolone|prednisolone|mesh-list
154749590|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
154749591|NCT02242630|Triamcinolone|triamcinolone|mesh-list
154250160|NCT03950804|Eculizumab|eculizumab|mesh-list
154749592|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154749593|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154749594|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154749595|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
154749596|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154749597|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154749598|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
154749599|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
154749600|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749601|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250279|NCT01102244|Hormones|hormones|mesh-ancestor
154749602|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154749603|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
154749604|NCT02242630|Hormones|hormones|mesh-ancestor
154749605|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250420|NCT00356525|Carboplatin|carboplatin|mesh-list
154749606|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154749607|NCT02242630|Protective Agents|protective agents|mesh-ancestor
154749608|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154749609|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749610|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749611|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
154749612|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250631|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749613|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749614|NCT03109158|Cetuximab|cetuximab|mesh-list
154749615|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749616|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749617|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
154749618|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
154501559|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154749619|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
154749620|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154749621|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
154749622|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
154749623|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749624|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749625|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749626|NCT03327168|Adenosine|adenosine|mesh-list
154749627|NCT03327168|Analgesics|analgesics|mesh-ancestor
154749628|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
154749629|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749630|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749631|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154749632|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251365|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154749633|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154749634|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
154749635|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
154749636|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749637|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749638|NCT01726738|Trametinib|trametinib|mesh-list
154749639|NCT01726738|Dabrafenib|dabrafenib|mesh-list
154749640|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998821|NCT00839761|Iron|iron|mesh-list
154251963|NCT01124630|Vitamins|vitamins|mesh-ancestor
154749641|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749642|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252103|NCT01121042|Ondansetron|ondansetron|mesh-list
154749643|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749644|NCT02492178|Artesunate|artesunate|mesh-list
154749645|NCT02492178|Quinine|quinine|mesh-list
154749646|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
154749647|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154749648|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154749649|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154749650|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749651|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
154252402|NCT03931928|Tamoxifen|tamoxifen|mesh-list
154749652|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
154749653|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154749654|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
154749655|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154749656|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749657|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154749658|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749659|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154749660|NCT02492178|Analgesics|analgesics|mesh-ancestor
154749661|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
154749662|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
154749663|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154749664|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154252457|NCT01127594|Temozolomide|temozolomide|mesh-list
154252516|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154252598|NCT01218386|Estradiol|estradiol|mesh-list
154749665|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749666|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
154749667|NCT04494126|Coagulants|coagulants|mesh-ancestor
154749668|NCT01730872|Prednisolone|prednisolone|mesh-list
154252812|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154749669|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154749670|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
154252953|NCT03928262|Benralizumab|benralizumab|mesh-list
154749671|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154749672|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
154253174|NCT01129856|Hormones|hormones|mesh-ancestor
154749673|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154749674|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154749675|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154749676|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
154749677|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154749678|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
154253569|NCT03140176|Sunitinib|sunitinib|mesh-list
154749679|NCT01730872|Hormones|hormones|mesh-ancestor
154749680|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154749681|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749682|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154393058|NCT02398630|Hormones|hormones|mesh-list
154749683|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749684|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
154749685|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
154749686|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749687|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154749688|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154749689|NCT01730872|Protective Agents|protective agents|mesh-ancestor
154749690|NCT02491086|Nicotine|nicotine|mesh-list
154749691|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154749692|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
154501635|NCT02554786|Fluticasone|fluticasone|mesh-list
154393504|NCT03582215|Analgesics|analgesics|mesh-ancestor
154749693|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393570|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
154749694|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749695|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154749696|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154749697|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
154749698|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393798|NCT01568268|Palonosetron|palonosetron|mesh-list
154749699|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749700|NCT03469492|Insulin|insulin|mesh-list
154749701|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154749702|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393946|NCT05119075|Dopamine|dopamine|mesh-list
154394014|NCT05308849|beta-Lactams|beta-lactams|mesh-list
154749703|NCT03331770|Latanoprost|latanoprost|mesh-list
154749704|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154749705|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154749706|NCT03331692|Anesthetics|anesthetics|mesh-list
154749707|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749708|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749709|NCT04826692|Metformin|metformin|mesh-list
154749710|NCT04826692|Biguanides|biguanides|mesh-list
154749711|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154749712|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394610|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
154394683|NCT01380678|Bevacizumab|bevacizumab|mesh-list
154749713|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154749714|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154749715|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394904|NCT05421936|Osimertinib|osimertinib|mesh-list
154749716|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749717|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
154394975|NCT06170359|Anesthetics|anesthetics|mesh-list
154749718|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749719|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
154749720|NCT04825990|Olaparib|olaparib|mesh-list
154749721|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749722|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749723|NCT04825990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154395412|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
154395484|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749724|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749725|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154749726|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749727|NCT03331302|Xenon|xenon|mesh-list
154749728|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154749729|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
154749730|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
154749731|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749732|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749733|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
154749734|NCT01738672|Entonox|entonox|mesh-list
154749735|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154749736|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
154749737|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
154395999|NCT02879409|Insulin|insulin|mesh-list
154749738|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749739|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396091|NCT02408549|Lacosamide|lacosamide|mesh-list
154396147|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
154749740|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154749741|NCT01738672|Analgesics|analgesics|mesh-ancestor
154749742|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
154749743|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749744|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154749745|NCT02488512|Edotreotide|edotreotide|mesh-list
154749746|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154749747|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749748|NCT01808651|Fluoxetine|fluoxetine|mesh-list
154749749|NCT01808651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154749750|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154749751|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749752|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749753|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749754|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
154749755|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749756|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154396425|NCT03662516|Hormones|hormones|mesh-ancestor
154749757|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
154396499|NCT02391688|Bupropion|bupropion|mesh-list
154396581|NCT04055480|Insulin|insulin|mesh-list
154749758|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154396649|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749759|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154749760|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154749761|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749762|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
154749763|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
154749764|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749765|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749766|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154749767|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
154749768|NCT05316376|Paclitaxel|paclitaxel|mesh-list
154749769|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154749770|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154749771|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749772|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
154749773|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
154749774|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
154749775|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749776|NCT01743976|Donepezil|donepezil|mesh-list
154749777|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154749778|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397077|NCT02381548|Belinostat|belinostat|mesh-list
154749779|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749780|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
154397388|NCT02384746|Ixazomib|ixazomib|mesh-list
154749781|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749782|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749783|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
154749784|NCT05315830|Vaccines|vaccines|mesh-list
154749785|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
154749786|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749787|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
154749788|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154749789|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154397921|NCT02359162|Etoposide|etoposide|mesh-list
154749790|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154749791|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749792|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749793|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
154749794|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749795|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749796|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154749797|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749798|NCT04639960|Risperidone|risperidone|mesh-list
154749799|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154398707|NCT04796922|Rituximab|rituximab|mesh-list
154749800|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
154749801|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749802|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749803|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749804|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154749805|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154749806|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749807|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154749808|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154749809|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
154749810|NCT03109314|Donepezil|donepezil|mesh-list
154749811|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154749812|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398769|NCT03504917|Natriuretic Agents|natriuretic agents|mesh-ancestor
154749813|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398899|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
154749814|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
154749815|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749816|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749817|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
154749818|NCT04566016|Anesthetics|anesthetics|mesh-list
154749819|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749820|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749821|NCT03320538|Rabeprazole|rabeprazole|mesh-list
154749822|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154749823|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154749824|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154749825|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749826|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749827|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
154749828|NCT03322878|Analgesics|analgesics|mesh-ancestor
154749829|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
154749830|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749831|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749832|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
154749833|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749834|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154749835|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
154749836|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154749837|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749838|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749839|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154749840|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
154749841|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154749842|NCT03322800|Ziresovir|ziresovir|mesh-list
154399247|NCT03726281|Nivolumab|nivolumab|mesh-list
154749843|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
154749844|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154749845|NCT03320460|Clobetasol|clobetasol|mesh-list
154749846|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399563|NCT02331862|Hormones|hormones|mesh-ancestor
153974274|NCT05681039|Carboplatin|carboplatin|mesh-list
154749847|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
154749848|NCT03320460|Hormones|hormones|mesh-ancestor
154399912|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154399984|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154400058|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154749849|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400211|NCT05080348|Ropivacaine|ropivacaine|mesh-list
154749850|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749851|NCT00706134|Aliskiren|aliskiren|mesh-list
153975014|NCT04154956|Docetaxel|docetaxel|mesh-list
154749852|NCT00706134|Renin Inhibitors|renin inhibitors|mesh-ancestor
154749853|NCT00706134|Protease Inhibitors|protease inhibitors|mesh-ancestor
154749854|NCT00706134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400639|NCT03461003|Diuretics|diuretics|mesh-ancestor
154400784|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749855|NCT00706134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749856|NCT04471714|Baclofen|baclofen|mesh-list
154400941|NCT04820205|Ketamine|ketamine|mesh-list
154749857|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154401002|NCT03634293|Alirocumab|alirocumab|mesh-list
154401071|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
154749858|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749859|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154749860|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401218|NCT05733000|Vitamins|vitamins|mesh-ancestor
154749861|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154749862|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
154401359|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
154749863|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
154401434|NCT05186454|Hormones|hormones|mesh-ancestor
154749864|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401502|NCT03447353|Alprazolam|alprazolam|mesh-list
154401574|NCT02900378|Enalapril|enalapril|mesh-list
154749865|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749866|NCT03325686|Vitamin D|vitamin d|mesh-list
154749867|NCT03325686|Vitamins|vitamins|mesh-ancestor
154749868|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
154749869|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401871|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154749870|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154749871|NCT05315128|Methotrexate|methotrexate|mesh-list
154749872|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154749873|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
154749874|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154749875|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749876|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154402391|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
154749877|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
154402538|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154402613|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402689|NCT02899988|Mirikizumab|mirikizumab|mesh-list
154749878|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749879|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749880|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
154749881|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749882|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154749883|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749884|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
154749885|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154749886|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154749887|NCT03322488|Metronidazole|metronidazole|mesh-list
154749888|NCT03322488|Doxycycline|doxycycline|mesh-list
154749889|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
154403048|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
154749890|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154749891|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154749892|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154403416|NCT03036852|Velpatasvir|velpatasvir|mesh-list
154749893|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154749894|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
154403499|NCT04906889|Analgesics|analgesics|mesh-ancestor
154749895|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154749896|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749897|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749898|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749899|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749900|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154749901|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154749902|NCT01808573|Capecitabine|capecitabine|mesh-list
154749903|NCT01808573|Lapatinib|lapatinib|mesh-list
154749904|NCT01808573|Neratinib|neratinib|mesh-list
154749905|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154749906|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
154749907|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749908|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749909|NCT01808573|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154749910|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749911|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749912|NCT01746940|Cocaine|cocaine|mesh-list
154749913|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154749914|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
154749915|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
154403933|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
154749916|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749917|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749918|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
154749919|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749920|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154749921|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154749922|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154749923|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749924|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749925|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
154749926|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749927|NCT01747330|Pancreatin|pancreatin|mesh-list
154749928|NCT01747330|Pancrelipase|pancrelipase|mesh-list
154749929|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154749930|NCT02990962|Triamcinolone|triamcinolone|mesh-list
154749931|NCT02990962|Lidocaine|lidocaine|mesh-list
154749932|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154749933|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
154749934|NCT02990962|Hormones|hormones|mesh-ancestor
154749935|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154749936|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749937|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749938|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
154749939|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
154749940|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154749941|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
154749942|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749943|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154749944|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154749945|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154749946|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749947|NCT03322098|Atropine|atropine|mesh-list
154749948|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
154749949|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154749950|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154749951|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154749952|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
154749953|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749954|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749955|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154749956|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
154749957|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
154749958|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
154749959|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154749960|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154749961|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
154749962|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749963|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749964|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
154749965|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154749966|NCT01808339|Fluticasone|fluticasone|mesh-list
154749967|NCT01808339|Xhance|xhance|mesh-list
154749968|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154749969|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154749970|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
154749971|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749972|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749973|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154749974|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
154404159|NCT03295721|Bupivacaine|bupivacaine|mesh-list
154749975|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
154404242|NCT01667133|Ponatinib|ponatinib|mesh-list
154749976|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154749977|NCT01749904|Timolol|timolol|mesh-list
154749978|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154749979|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154749980|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
154749981|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749982|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749983|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749984|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154404513|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154404664|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
154749985|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154749986|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154749987|NCT02484768|Hematinics|hematinics|mesh-ancestor
154749988|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
154749989|NCT03316326|Irinotecan|irinotecan|mesh-list
154749990|NCT03316326|Tegafur|tegafur|mesh-list
154749991|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749992|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154405108|NCT04059978|Analgesics|analgesics|mesh-ancestor
154749993|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749994|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749995|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405180|NCT03113643|Azacitidine|azacitidine|mesh-list
154749996|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154749997|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
154749998|NCT02487732|Ticagrelor|ticagrelor|mesh-list
154749999|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154750000|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154750001|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154750002|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154750003|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154750004|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
154750005|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405476|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750006|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405775|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
154750007|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750008|NCT03833362|Interferons|interferons|mesh-list
154750009|NCT03833362|Ritonavir|ritonavir|mesh-list
154750010|NCT03833362|Ribavirin|ribavirin|mesh-list
154406122|NCT05178953|Zinc|zinc|mesh-list
154406153|NCT03287219|Methylene Blue|methylene blue|mesh-list
154750011|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
154750012|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
154750013|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154750014|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154406296|NCT03617900|Analgesics|analgesics|mesh-ancestor
154750015|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750016|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
154750017|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750018|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154406604|NCT03658746|Antacids|antacids|mesh-ancestor
154750019|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154750020|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
154750021|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750022|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750023|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154750024|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154750025|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154750026|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154407111|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
154750027|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
154750028|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
154407188|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154750029|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750030|NCT05463588|Methamphetamine|methamphetamine|mesh-list
154750031|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154750032|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750033|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
154750034|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
154407710|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750035|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407787|NCT00406783|Desloratadine|desloratadine|mesh-list
154750036|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
154407863|NCT05030129|Pyridoxal|pyridoxal|mesh-list
154407941|NCT01335529|Ribavirin|ribavirin|mesh-list
154750037|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408154|NCT02591615|Carboplatin|carboplatin|mesh-list
154750038|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750039|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
154408310|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
154750040|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154408379|NCT02034890|Protective Agents|protective agents|mesh-ancestor
154750041|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154408455|NCT03652896|Liver Extracts|liver extracts|mesh-list
154750042|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154750043|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154750044|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
154408604|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154408681|NCT03163667|Everolimus|everolimus|mesh-list
154750045|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154750046|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
154750047|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154750048|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408902|NCT03600974|Citalopram|citalopram|mesh-list
154750049|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154750050|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154750051|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154750052|NCT02490540|Sufentanil|sufentanil|mesh-list
154750053|NCT02490540|Dsuvia|dsuvia|mesh-list
154750054|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154750055|NCT02490540|Narcotics|narcotics|mesh-ancestor
154409198|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
154409350|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750056|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750057|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750058|NCT02490540|Analgesics|analgesics|mesh-ancestor
154409593|NCT03576794|Hormones|hormones|mesh-ancestor
154409640|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154750059|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
154750060|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750061|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154750062|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154750063|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
154750064|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
154750065|NCT02484300|Melatonin|melatonin|mesh-list
154750066|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
154410086|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154750067|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410236|NCT02554253|Ketamine|ketamine|mesh-list
154750068|NCT02484300|Protective Agents|protective agents|mesh-ancestor
154410307|NCT01307033|Losartan|losartan|mesh-list
154410381|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
154750069|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410612|NCT03067610|Paclitaxel|paclitaxel|mesh-list
154410758|NCT04851821|Protective Agents|protective agents|mesh-ancestor
154410829|NCT05708534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750070|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750071|NCT02727660|Budesonide|budesonide|mesh-list
154750072|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
154750073|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750074|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154750075|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
154411200|NCT00871351|Ezetimibe|ezetimibe|mesh-list
154750076|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750077|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750078|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154750079|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
154411349|NCT01348321|Levamisole|levamisole|mesh-list
154750080|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
154411498|NCT01354964|Vitamin D|vitamin d|mesh-list
154411568|NCT02821910|Incretins|incretins|mesh-ancestor
154750081|NCT02727660|Hormones|hormones|mesh-ancestor
154750082|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411646|NCT02036060|Hormones|hormones|mesh-ancestor
154750083|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154411717|NCT03604159|Buprenorphine|buprenorphine|mesh-list
154750084|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154750085|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154750086|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
154750087|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411784|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154750088|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750089|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
154750090|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154750091|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750092|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750093|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154750094|NCT02490072|Analgesics|analgesics|mesh-ancestor
154412000|NCT06273462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750095|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
154750096|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750097|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154750098|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154750099|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154750100|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
154750101|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412291|NCT06178588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750102|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750103|NCT02483598|Buspirone|buspirone|mesh-list
154750104|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154750105|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154750106|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750107|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412583|NCT05727969|Analgesics|analgesics|mesh-ancestor
154750108|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154750109|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154750110|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
154750111|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750112|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750113|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
154750114|NCT03321318|Vitamin D|vitamin d|mesh-list
154750115|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
154750116|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154750117|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750118|NCT03321318|Vitamins|vitamins|mesh-ancestor
154750119|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
154750120|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154750121|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154750122|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154750123|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
154750124|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750125|NCT01784861|Everolimus|everolimus|mesh-list
154750126|NCT01784861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154750127|NCT01784861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154750128|NCT01784861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750129|NCT01784861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750130|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750131|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
154412875|NCT05358886|BPN14770|bpn14770|mesh-list
154750132|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750133|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750134|NCT03318744|Aspirin|aspirin|mesh-list
154750135|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154750136|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154750137|NCT03318744|Analgesics|analgesics|mesh-ancestor
154750138|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
154750139|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750140|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750141|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750142|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750143|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154750144|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154750145|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750146|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154750147|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154750148|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750149|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
154750150|NCT01751386|Baclofen|baclofen|mesh-list
154750151|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154750152|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413147|NCT04845035|Cytarabine|cytarabine|mesh-list
154750153|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154750154|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750155|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154750156|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
154750157|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
154750158|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750159|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750160|NCT02489760|Adalimumab|adalimumab|mesh-list
154750161|NCT02489760|Etanercept|etanercept|mesh-list
154750162|NCT02489760|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154750163|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750164|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750165|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154750166|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154750167|NCT02489760|Analgesics|analgesics|mesh-ancestor
154750168|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
154750169|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750170|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750171|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750172|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750173|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
154750174|NCT01752712|Oxytocin|oxytocin|mesh-list
154750175|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
154750176|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154413487|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750177|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750178|NCT05127928|Vitamins|vitamins|mesh-list
154750179|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
154750180|NCT05127928|Vitamin E|vitamin e|mesh-list
154750181|NCT05127928|Tocopherols|tocopherols|mesh-list
154750182|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
154750183|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750184|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
154750185|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750186|NCT05127928|Protective Agents|protective agents|mesh-ancestor
154750187|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
154750188|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154750189|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
154750190|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750191|NCT02483130|Expectorants|expectorants|mesh-ancestor
154750192|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
154750193|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154750194|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
154750195|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750196|NCT02483130|Protective Agents|protective agents|mesh-ancestor
154750197|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750198|NCT02483130|Antidotes|antidotes|mesh-ancestor
154750199|NCT03318354|Olmesartan|olmesartan|mesh-list
154750200|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154750201|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154413689|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
154750202|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154750203|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154750204|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750205|NCT05093140|Prednisone|prednisone|mesh-list
154750206|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
154750207|NCT05093140|Vincristine|vincristine|mesh-list
154750208|NCT05093140|Doxorubicin|doxorubicin|mesh-list
154750209|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154750210|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750211|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
154750212|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750213|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750214|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154414151|NCT03640650|Hormones|hormones|mesh-ancestor
154414208|NCT02053142|Acyclovir|acyclovir|mesh-list
154750215|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
154414282|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750216|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750217|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750218|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154750219|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750220|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
154750221|NCT05093140|Hormones|hormones|mesh-ancestor
154414568|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154750222|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414644|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
154750223|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750224|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154414941|NCT03614052|Tamsulosin|tamsulosin|mesh-list
154750225|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
154750226|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
154750227|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
154750228|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154750229|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154750230|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154750231|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750232|NCT00705666|Ribavirin|ribavirin|mesh-list
154750233|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154750234|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
154750235|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750236|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
154750237|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750238|NCT04955236|Fentanyl|fentanyl|mesh-list
154750239|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154750240|NCT04955236|Narcotics|narcotics|mesh-ancestor
154750241|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750242|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750243|NCT04955236|Analgesics|analgesics|mesh-ancestor
154750244|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
154750245|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750246|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154750247|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154750248|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
154750249|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
154750250|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
154750251|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154415743|NCT03628521|Pemetrexed|pemetrexed|mesh-list
154750252|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415884|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
154415957|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
154750253|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750254|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154750255|NCT03957304|Analgesics|analgesics|mesh-ancestor
154750256|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
154750257|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750258|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154750259|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154750260|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154750261|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
154750262|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416104|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
154750263|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750264|NCT03320928|Methotrexate|methotrexate|mesh-list
154750265|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154750266|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
154750267|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154750268|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750269|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154750270|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
154750271|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750272|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750273|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
154750274|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750275|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154750276|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750277|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
154750278|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154416473|NCT01358045|Calcitriol|calcitriol|mesh-list
154750279|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154750280|NCT02488902|Mefloquine|mefloquine|mesh-list
154750281|NCT02488902|Tafenoquine|tafenoquine|mesh-list
154750282|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
154416532|NCT02079194|Analgesics|analgesics|mesh-ancestor
154750283|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154750284|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154750285|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750286|NCT02253160|Lenograstim|lenograstim|mesh-list
154416674|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
154416823|NCT02033538|Paclitaxel|paclitaxel|mesh-list
154417123|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750287|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154417274|NCT02086838|Dextrans|dextrans|mesh-list
154750288|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
154417421|NCT03627897|Bupivacaine|bupivacaine|mesh-list
154417577|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750289|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750290|NCT02254252|Nicorandil|nicorandil|mesh-list
154750291|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
154750292|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
154750293|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154750294|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154750295|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
154750296|NCT02254252|Vitamins|vitamins|mesh-ancestor
154750297|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
154750298|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750299|NCT03315078|Busulfan|busulfan|mesh-list
154417895|NCT05217069|Hematinics|hematinics|mesh-ancestor
154417974|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154418052|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
154750300|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
154418276|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
154418424|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154418512|NCT05617521|Caffeine|caffeine|mesh-list
154418649|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418870|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
154418944|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154419026|NCT03119701|Interferons|interferons|mesh-list
154419164|NCT02116712|Saracatinib|saracatinib|mesh-list
154750301|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750302|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154419496|NCT02131220|Tirofiban|tirofiban|mesh-list
154750303|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
154750304|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750305|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154419913|NCT05812430|Paclitaxel|paclitaxel|mesh-list
154419990|NCT05754853|Paclitaxel|paclitaxel|mesh-list
154420060|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420203|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
154420426|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154750306|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750307|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154421107|NCT01333033|Vitamins|vitamins|mesh-ancestor
154421187|NCT03602898|Cyclosporine|cyclosporine|mesh-list
154421261|NCT02132234|Adalimumab|adalimumab|mesh-list
154750308|NCT02255110|Doxorubicin|doxorubicin|mesh-list
154421407|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
154421483|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154421559|NCT02138708|Adenosine|adenosine|mesh-list
154421641|NCT01343277|Dacarbazine|dacarbazine|mesh-list
154421784|NCT01360463|Methadone|methadone|mesh-list
154422021|NCT05736913|Vaccines|vaccines|mesh-list
154422084|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
154750309|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154422160|NCT03585894|Ketorolac|ketorolac|mesh-list
154422233|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154422384|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
154422536|NCT05575544|Analgesics|analgesics|mesh-ancestor
154422621|NCT03547778|Misoprostol|misoprostol|mesh-list
154750310|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422989|NCT00109928|Hormones|hormones|mesh-ancestor
154423066|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750311|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154423290|NCT03095521|Menthol|menthol|mesh-list
154750312|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154750313|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423394|NCT02140814|Niacin|niacin|mesh-list
154750314|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750315|NCT03320694|Insulin|insulin|mesh-list
154750316|NCT03320694|Metformin|metformin|mesh-list
154750317|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154750318|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
154750319|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154750320|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750321|NCT02482740|Tamoxifen|tamoxifen|mesh-list
154750322|NCT02482740|Letrozole|letrozole|mesh-list
154750323|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750324|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154750325|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154423516|NCT03565536|Sorafenib|sorafenib|mesh-list
154423578|NCT02039674|Paclitaxel|paclitaxel|mesh-list
154423652|NCT04455100|Itraconazole|itraconazole|mesh-list
154750326|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750327|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750328|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154750329|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
153998436|NCT00887484|Analgesics|analgesics|mesh-ancestor
154424014|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154424092|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424161|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
154424309|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154424460|NCT03097315|Hormones|hormones|mesh-ancestor
154750330|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750331|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750332|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750333|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154750334|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154750335|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154750336|NCT03315000|Fluticasone|fluticasone|mesh-list
154750337|NCT03315000|Xhance|xhance|mesh-list
154750338|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750339|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154750340|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
154750341|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750342|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750343|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154750344|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
154750345|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
154750346|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154750347|NCT02482818|Pregabalin|pregabalin|mesh-list
154750348|NCT02482818|Analgesics|analgesics|mesh-ancestor
154750349|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
154750350|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750351|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750352|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
154750353|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154424584|NCT01338870|Incretins|incretins|mesh-ancestor
154750354|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154750355|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424881|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750356|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154750357|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154750358|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154425176|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
154425325|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154425481|NCT04260659|Analgesics|analgesics|mesh-ancestor
154750359|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750360|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154750361|NCT02989870|Sorafenib|sorafenib|mesh-list
154750362|NCT02989870|Bavituximab|bavituximab|mesh-list
154425855|NCT05959863|Captopril|captopril|mesh-list
154750363|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750364|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154750365|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750366|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750367|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154750368|NCT02480088|Palonosetron|palonosetron|mesh-list
154502290|NCT00658047|Methotrexate|methotrexate|mesh-list
154750369|NCT02480088|Ramosetron|ramosetron|mesh-list
154750371|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
154425987|NCT05790252|Buprenorphine|buprenorphine|mesh-list
154750372|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750373|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750374|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750375|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154426211|NCT04424641|Antibodies|antibodies|mesh-list
154426279|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426507|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154750376|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154750377|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
154426803|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154750378|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427027|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
154750379|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750380|NCT01807624|Phenylephrine|phenylephrine|mesh-list
154750381|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
154427332|NCT04356495|Hormones|hormones|mesh-ancestor
154750382|NCT01807624|Tetracaine|tetracaine|mesh-list
154427426|NCT00911547|Hormones|hormones|mesh-ancestor
154750383|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
154750384|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
154427546|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154750385|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750386|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427840|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427923|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
154427996|NCT02805972|Naloxone|naloxone|mesh-list
154428075|NCT03540836|Cortisone|cortisone|mesh-list
154428143|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
154428219|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
154750387|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
154428519|NCT02171468|Dabigatran|dabigatran|mesh-list
154750388|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750389|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154429051|NCT02178644|Capecitabine|capecitabine|mesh-list
154750390|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154750391|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
154750392|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429418|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
154429490|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
154429564|NCT02180516|Analgesics|analgesics|mesh-ancestor
154429934|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154430154|NCT01333956|Pregabalin|pregabalin|mesh-list
154750393|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430452|NCT02194166|Paclitaxel|paclitaxel|mesh-list
154750394|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
154750395|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
154750396|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
154431050|NCT02068170|Fluconazole|fluconazole|mesh-list
154750397|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153602635|NCT01906242|Eusol|eusol|mesh-list
154431344|NCT02066610|Protective Agents|protective agents|mesh-ancestor
154431419|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431567|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154431642|NCT05461235|Nivolumab|nivolumab|mesh-list
154431714|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431787|NCT02258282|Etanercept|etanercept|mesh-list
154431866|NCT01380301|Miltefosine|miltefosine|mesh-list
154750398|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
154750399|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154750400|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
154750401|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154432019|NCT02080416|Nelfinavir|nelfinavir|mesh-list
154750402|NCT01807624|Protective Agents|protective agents|mesh-ancestor
154750403|NCT01808326|Chlorambucil|chlorambucil|mesh-list
154432091|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
154750404|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154432263|NCT02258204|Ketamine|ketamine|mesh-list
154750405|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
154432312|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750406|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432535|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432764|NCT02079558|Oxytocin|oxytocin|mesh-list
154750407|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750408|NCT03317730|Oxycodone|oxycodone|mesh-list
154750409|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154433216|NCT02232776|Losartan|losartan|mesh-list
154750410|NCT03317730|Narcotics|narcotics|mesh-ancestor
154433529|NCT02264834|Dsuvia|dsuvia|mesh-list
154433580|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154750411|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750412|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750413|NCT03317730|Analgesics|analgesics|mesh-ancestor
154433802|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
154433874|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433948|NCT05375734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434107|NCT06091891|Hemostatics|hemostatics|mesh-ancestor
154750414|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
154750415|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750416|NCT02486484|Aflibercept|aflibercept|mesh-list
154750417|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154750418|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154750419|NCT02486484|Growth Substances|growth substances|mesh-ancestor
154750420|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750421|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
154750422|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750423|NCT03317652|Nitroprusside|nitroprusside|mesh-list
154750424|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154750425|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
154434459|NCT05799729|Anesthetics|anesthetics|mesh-ancestor
154750426|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154434600|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
154434672|NCT05392075|Vaccines|vaccines|mesh-list
154434758|NCT05126784|Denosumab|denosumab|mesh-list
154434823|NCT04983615|Narcotics|narcotics|mesh-ancestor
154434896|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
154750427|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750428|NCT02479854|Montelukast|montelukast|mesh-list
154435119|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
154435191|NCT03534180|Romidepsin|romidepsin|mesh-list
154435269|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435357|NCT02446457|Rituximab|rituximab|mesh-list
154435495|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435574|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
154750429|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154750430|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
154750431|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154750432|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
154750433|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750434|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750435|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154750436|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154750437|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750438|NCT01809106|Fentanyl|fentanyl|mesh-list
154750439|NCT01809106|Morphine|morphine|mesh-list
154750440|NCT01809106|Oxycodone|oxycodone|mesh-list
154750441|NCT01809106|Buprenorphine|buprenorphine|mesh-list
154435935|NCT00153920|Bortezomib|bortezomib|mesh-list
154436005|NCT01126970|Orlistat|orlistat|mesh-list
154750442|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154750443|NCT01809106|Narcotics|narcotics|mesh-ancestor
154502366|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750444|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750445|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750446|NCT01809106|Analgesics|analgesics|mesh-ancestor
154750447|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
154750448|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750449|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154750450|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154750451|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
154750452|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
154750453|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154750454|NCT03804580|Osimertinib|osimertinib|mesh-list
154436891|NCT04724759|Lidocaine|lidocaine|mesh-list
154750455|NCT03804580|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154437045|NCT00944294|Adenosine|adenosine|mesh-list
154750456|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154750457|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437232|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437308|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
154437384|NCT05200793|Metformin|metformin|mesh-list
154437631|NCT00830102|Xhance|xhance|mesh-list
154750458|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750459|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750460|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
154750461|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154750462|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154750463|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154750464|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154750465|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750466|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
154750467|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750468|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437829|NCT05156879|Diuretics|diuretics|mesh-ancestor
154750469|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154437895|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
154750470|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750471|NCT01810666|Factor VIII|factor viii|mesh-list
154750472|NCT01810666|Coagulants|coagulants|mesh-ancestor
154750473|NCT02482272|Lamivudine|lamivudine|mesh-list
154750474|NCT02482272|Adefovir|adefovir|mesh-list
154750475|NCT02482272|Entecavir|entecavir|mesh-list
154750476|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154438351|NCT04161430|Incretins|incretins|mesh-ancestor
154438504|NCT02284412|Neostigmine|neostigmine|mesh-list
154750477|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154750478|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438706|NCT00427154|Metformin|metformin|mesh-list
154750479|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750480|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
154439006|NCT04769401|Progesterone|progesterone|mesh-list
154439085|NCT00650702|Latanoprost|latanoprost|mesh-list
154750481|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750482|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154439155|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750483|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154750484|NCT01766440|Calcitriol|calcitriol|mesh-list
154439377|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
154439452|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154439538|NCT02097966|Ribavirin|ribavirin|mesh-list
154439602|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
154439675|NCT00036608|Entecavir|entecavir|mesh-list
154439751|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154439823|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439989|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
154440137|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440216|NCT02107716|Lidocaine|lidocaine|mesh-list
154750485|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154750486|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750487|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154750488|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154440436|NCT02114502|Hormones|hormones|mesh-ancestor
154440507|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154440656|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440729|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
154440803|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750489|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440960|NCT05001802|Ropivacaine|ropivacaine|mesh-list
154441106|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154750490|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154750491|NCT01766440|Vitamins|vitamins|mesh-ancestor
154750492|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
154441636|NCT04307797|Exenatide|exenatide|mesh-list
154441703|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
154750493|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154750494|NCT02479620|Dexamethasone|dexamethasone|mesh-list
154442007|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
154750495|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
154442218|NCT00085774|Albuterol|albuterol|mesh-list
154750496|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154750497|NCT02479620|BB 1101|bb 1101|mesh-list
154750498|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750499|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
154750500|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
154442442|NCT05174455|Niraparib|niraparib|mesh-list
154750501|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442671|NCT05303272|Abatacept|abatacept|mesh-list
154442737|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154750502|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443115|NCT04727034|Propofol|propofol|mesh-list
154443195|NCT02028364|Everolimus|everolimus|mesh-list
154750503|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750504|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
154750505|NCT02479620|Hormones|hormones|mesh-ancestor
154443553|NCT02646748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443626|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154443700|NCT05885386|Temozolomide|temozolomide|mesh-list
154443775|NCT05884151|Tranexamic Acid|tranexamic acid|mesh-list
154443997|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154444070|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444146|NCT03567720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444147|NCT03519906|Metoprolol|metoprolol|mesh-list
154444438|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444514|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444588|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
154750506|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444660|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444732|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444803|NCT02300948|Hematinics|hematinics|mesh-ancestor
154444955|NCT05890768|Risperidone|risperidone|mesh-list
154445107|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
154445180|NCT04916509|Fulvestrant|fulvestrant|mesh-list
154445371|NCT03508726|Vitamins|vitamins|mesh-ancestor
154750507|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750508|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750509|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
154750510|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445856|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
154446080|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
154446154|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154446229|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154446456|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
154446528|NCT02141178|Bupivacaine|bupivacaine|mesh-list
154750511|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750512|NCT02481960|Irinotecan|irinotecan|mesh-list
154750513|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154750514|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154750515|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750516|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502447|NCT02280603|Minoxidil|minoxidil|mesh-list
154750517|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750519|NCT02725866|Ribavirin|ribavirin|mesh-list
154447120|NCT02146638|Fentanyl|fentanyl|mesh-list
154447197|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
154447351|NCT03350984|Insulin|insulin|mesh-list
154750520|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154750521|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154750522|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
154750523|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447942|NCT00354835|Vincristine|vincristine|mesh-list
154448015|NCT03744546|Tilavonemab|tilavonemab|mesh-list
154448090|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
154750524|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750525|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154448625|NCT02765490|Simeprevir|simeprevir|mesh-list
154448837|NCT00102960|Ritonavir|ritonavir|mesh-list
154449285|NCT06204185|Metformin|metformin|mesh-list
154449434|NCT06202963|Sensory System Agents|sensory system agents|mesh-ancestor
154449504|NCT06201377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154024571|NCT00633035|Famotidine|famotidine|mesh-list
154450049|NCT04864782|Paclitaxel|paclitaxel|mesh-list
154450113|NCT04760691|Tenofovir|tenofovir|mesh-list
154024914|NCT02672358|Trametinib|trametinib|mesh-list
154450422|NCT03519971|Paclitaxel|paclitaxel|mesh-list
154450496|NCT03073967|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154450571|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
154450719|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450867|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154451017|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154451171|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
154451236|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154750526|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154451468|NCT06153368|Antidotes|antidotes|mesh-ancestor
154750527|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
154451620|NCT05849090|Tobramycin|tobramycin|mesh-list
154451779|NCT05432934|Hormones|hormones|mesh-ancestor
154750528|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452065|NCT04228263|Analgesics|analgesics|mesh-ancestor
154452139|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
154452454|NCT02003222|Antibodies|antibodies|mesh-list
154452669|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
154452810|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452888|NCT02255682|Simvastatin|simvastatin|mesh-list
154453111|NCT02169570|Vitamins|vitamins|mesh-list
154453268|NCT03591549|Fulvestrant|fulvestrant|mesh-list
154453335|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154453483|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453561|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
154454218|NCT02177370|Fenoterol|fenoterol|mesh-list
154454441|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454516|NCT02182050|Nintedanib|nintedanib|mesh-list
154454592|NCT02239107|Antidotes|antidotes|mesh-ancestor
154454815|NCT03034135|Disulfiram|disulfiram|mesh-list
154454891|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
154860545|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
154455124|NCT02183142|Meloxicam|meloxicam|mesh-list
154455192|NCT02183376|Hormones|hormones|mesh-ancestor
154455480|NCT03700177|Hormones|hormones|mesh-ancestor
154455706|NCT02191332|Nevirapine|nevirapine|mesh-list
154750529|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154456075|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154750530|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154750531|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
154750532|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154456443|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
154456593|NCT02751450|Fluorides|fluorides|mesh-list
154456989|NCT02231658|Hormones|hormones|mesh-ancestor
154750533|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154457492|NCT05767398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457719|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
154458161|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458314|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
154458407|NCT03480308|Fentanyl|fentanyl|mesh-list
154458697|NCT05257148|Nebivolol|nebivolol|mesh-list
154860567|NCT03014947|Adalimumab|adalimumab|mesh-list
154459749|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
154460061|NCT04977544|Sertraline|sertraline|mesh-list
154460199|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
154460867|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154461180|NCT04878718|Vancomycin|vancomycin|mesh-list
154461395|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
154461467|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154461540|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
154461768|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154461858|NCT04874506|TEMPO|tempo|mesh-list
154462303|NCT02232516|Growth Substances|growth substances|mesh-ancestor
154462674|NCT02262858|Telmisartan|telmisartan|mesh-list
154462819|NCT02235324|Leucovorin|leucovorin|mesh-list
154462894|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154463191|NCT05728619|Temozolomide|temozolomide|mesh-list
154463415|NCT04282031|Letrozole|letrozole|mesh-list
154463487|NCT04153383|Milrinone|milrinone|mesh-list
154463568|NCT03783351|Ticagrelor|ticagrelor|mesh-list
154860589|NCT01057225|Hormones|hormones|mesh-ancestor
154464449|NCT06136351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464599|NCT05974462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464687|NCT05893771|Hormones|hormones|mesh-ancestor
154464751|NCT05848765|Lenalidomide|lenalidomide|mesh-list
154464833|NCT05776459|Prednisolone|prednisolone|mesh-list
154464898|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154465649|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
154465884|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
154466334|NCT01979536|Crizotinib|crizotinib|mesh-list
154466475|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154466772|NCT01434498|Ledipasvir|ledipasvir|mesh-list
154466994|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
154467069|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
154467449|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154467534|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
154467598|NCT03460808|Antidotes|antidotes|mesh-ancestor
154467882|NCT00805350|SR 46349B|sr 46349b|mesh-list
154468097|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
154468239|NCT04819438|Protective Agents|protective agents|mesh-ancestor
154468319|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
154468693|NCT00829530|Ramipril|ramipril|mesh-list
154468915|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860612|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469439|NCT05616442|Vitamin E|vitamin e|mesh-list
154469511|NCT02076945|Lidocaine|lidocaine|mesh-list
154469590|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
154469658|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469948|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154470025|NCT03128216|Bupivacaine|bupivacaine|mesh-list
154860629|NCT01058941|Protective Agents|protective agents|mesh-ancestor
154470377|NCT02075619|Amlodipine|amlodipine|mesh-list
154470444|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470521|NCT02084355|Analgesics|analgesics|mesh-ancestor
154470593|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
154194603|NCT00496782|Maraviroc|maraviroc|mesh-list
154471057|NCT01309191|Minoxidil|minoxidil|mesh-list
154471197|NCT03419858|Naloxone|naloxone|mesh-list
154471338|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154471484|NCT05816694|Antimitotic Agents|antimitotic agents|mesh-ancestor
154471559|NCT05659823|Fentanyl|fentanyl|mesh-list
154471636|NCT05474001|Fentanyl|fentanyl|mesh-list
154471792|NCT04704271|Dronabinol|dronabinol|mesh-list
154472305|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
154472461|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
154472920|NCT03126578|Midazolam|midazolam|mesh-list
154472974|NCT03126422|Analgesics|analgesics|mesh-ancestor
154473197|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473270|NCT02479646|Lenograstim|lenograstim|mesh-list
154473654|NCT02112981|Sirolimus|sirolimus|mesh-list
154473821|NCT02117583|Oxycodone|oxycodone|mesh-list
154473874|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
154474027|NCT06283667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154474105|NCT06282666|Anesthetics|anesthetics|mesh-list
154474323|NCT06281106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474633|NCT06181734|Ivosidenib|ivosidenib|mesh-list
154474779|NCT06119581|Pemetrexed|pemetrexed|mesh-list
154474939|NCT06048484|Folfirinox|folfirinox|mesh-list
154475378|NCT05776953|Ketorolac|ketorolac|mesh-list
154475526|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154475601|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154475674|NCT05548582|Acetaminophen|acetaminophen|mesh-list
154475820|NCT05463419|Vaccines|vaccines|mesh-list
154476116|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
154476188|NCT05132075|Docetaxel|docetaxel|mesh-list
154860672|NCT04347980|Hormones|hormones|mesh-ancestor
154476494|NCT06275204|Antacids|antacids|mesh-ancestor
154476561|NCT06215820|Tramadol|tramadol|mesh-list
154476636|NCT06124157|Dasatinib|dasatinib|mesh-list
154476714|NCT06099639|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154476787|NCT06047366|Sensory System Agents|sensory system agents|mesh-ancestor
154750534|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476935|NCT05934669|GABA Modulators|gaba modulators|mesh-ancestor
154477010|NCT05834478|Fallypride|fallypride|mesh-list
154477160|NCT05580562|TIC10 compound|tic10 compound|mesh-list
154477240|NCT05498220|Dexamethasone|dexamethasone|mesh-list
154750535|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
154750536|NCT03314298|Anastrozole|anastrozole|mesh-list
154750537|NCT03314298|Testosterone|testosterone|mesh-list
154477909|NCT04179864|Hormones|hormones|mesh-ancestor
154477981|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
154478064|NCT03929666|Leucovorin|leucovorin|mesh-list
154478285|NCT03526835|Pembrolizumab|pembrolizumab|mesh-list
154478581|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
154478662|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
154478877|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479105|NCT04878198|Melatonin|melatonin|mesh-list
154750538|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
154750539|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
154479397|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479468|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750540|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154750541|NCT03314298|Androgens|androgens|mesh-ancestor
154750542|NCT03314298|Hormones|hormones|mesh-ancestor
154480143|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480367|NCT02981628|Vitamins|vitamins|mesh-ancestor
154480444|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480533|NCT02735707|Analgesics|analgesics|mesh-ancestor
154480602|NCT02616965|Immunotoxins|immunotoxins|mesh-ancestor
154480675|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154480749|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154480824|NCT01886872|Rituximab|rituximab|mesh-list
154480903|NCT01167712|Paclitaxel|paclitaxel|mesh-list
154481051|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154481425|NCT03532620|Calcium|calcium|mesh-list
154481575|NCT05554822|Aspirin|aspirin|mesh-list
154481648|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481801|NCT02129985|Incretins|incretins|mesh-ancestor
154481869|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
154482017|NCT02137161|Tobramycin|tobramycin|mesh-list
154482167|NCT02137239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154482311|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
154482393|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
154482988|NCT04466904|Dulaglutide|dulaglutide|mesh-list
154483422|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154484019|NCT02295930|Bevacizumab|bevacizumab|mesh-list
154484093|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154484169|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
154484240|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154484473|NCT02766777|Lubiprostone|lubiprostone|mesh-list
154484543|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
154484614|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484686|NCT02300688|Maleic acid|maleic acid|mesh-list
154484760|NCT03367676|Docetaxel|docetaxel|mesh-list
154484770|NCT02158689|Letrozole|letrozole|mesh-list
154485078|NCT03366584|Zinc|zinc|mesh-list
154485126|NCT02303106|Lamotrigine|lamotrigine|mesh-list
154485199|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
154485282|NCT02303418|Oxytocin|oxytocin|mesh-list
154485347|NCT02307396|Pimozide|pimozide|mesh-list
154485423|NCT04523792|Buprenorphine|buprenorphine|mesh-list
154485574|NCT02308332|Tenofovir|tenofovir|mesh-list
154485645|NCT02312544|Timolol|timolol|mesh-list
154485720|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154485822|NCT03354494|Hormones|hormones|mesh-ancestor
154485871|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
154485948|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154486031|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
154486173|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154486326|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486471|NCT05516446|Paclitaxel|paclitaxel|mesh-list
154486622|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
154486770|NCT02437370|Docetaxel|docetaxel|mesh-list
154486864|NCT00708500|Ribavirin|ribavirin|mesh-list
154487154|NCT02161965|Warfarin|warfarin|mesh-list
154487761|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
154487983|NCT02507648|Oseltamivir|oseltamivir|mesh-list
154488135|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488208|NCT02174211|Ranibizumab|ranibizumab|mesh-list
154488360|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154488731|NCT03333278|Vitamins|vitamins|mesh-list
154489109|NCT03323372|Listerine|listerine|mesh-list
154489177|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
154489772|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
154489924|NCT04979377|Androgens|androgens|mesh-ancestor
154490072|NCT04485130|Disulfiram|disulfiram|mesh-list
154490145|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490294|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
154490369|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
154490677|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490750|NCT03325790|Ebselen|ebselen|mesh-list
154490823|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154491511|NCT05460338|Vitamins|vitamins|mesh-ancestor
154491585|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
154491657|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
154491732|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154491809|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
154491896|NCT02473328|Ritonavir|ritonavir|mesh-list
154492030|NCT02195661|Melatonin|melatonin|mesh-list
154492643|NCT02192229|Vitamin D|vitamin d|mesh-list
154492867|NCT02523846|Morphine|morphine|mesh-list
154492938|NCT03483948|Azacitidine|azacitidine|mesh-list
154493531|NCT05351346|Decitabine|decitabine|mesh-list
154493606|NCT06144814|Hormones|hormones|mesh-ancestor
154493682|NCT06143579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493840|NCT05921604|Gabapentin|gabapentin|mesh-list
154493907|NCT05838716|Vitamin D|vitamin d|mesh-list
154493985|NCT05639218|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154494065|NCT05519059|Paclitaxel|paclitaxel|mesh-list
154494444|NCT04864067|Leucovorin|leucovorin|mesh-list
154494512|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
154494666|NCT04426591|Biotin|biotin|mesh-list
154495031|NCT03403621|Pentamidine|pentamidine|mesh-list
154495265|NCT02339740|Hormones|hormones|mesh-ancestor
154495416|NCT00381641|Sunitinib|sunitinib|mesh-list
154495560|NCT04263480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495635|NCT03732664|Tislelizumab|tislelizumab|mesh-list
154496007|NCT00412022|Tamoxifen|tamoxifen|mesh-list
154496087|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
154496156|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496305|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496605|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
154496751|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
154496826|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154496974|NCT02262897|Paclitaxel|paclitaxel|mesh-list
154497055|NCT03469128|Sertraline|sertraline|mesh-list
154497196|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
154497271|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154497424|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497499|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
154497718|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154497794|NCT01116141|Folic Acid|folic acid|mesh-list
154497869|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154497945|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498021|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154498093|NCT04495478|Ramucirumab|ramucirumab|mesh-list
154498106|NCT00884715|Octreotide|octreotide|mesh-list
154498168|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
154498246|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154498540|NCT04730206|Antiviral Agents|antiviral agents|mesh-ancestor
154498617|NCT02462252|Cyclosporine|cyclosporine|mesh-list
154498766|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
154499065|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154499137|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
154499212|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499289|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
154499573|NCT02460146|CXA-10|cxa-10|mesh-list
154499594|NCT02460068|Nivolumab|nivolumab|mesh-list
154499668|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
154499740|NCT02737475|Vaccines|vaccines|mesh-list
154500041|NCT05492812|Melatonin|melatonin|mesh-list
154500564|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154500712|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154500858|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
154501000|NCT03241784|Analgesics|analgesics|mesh-ancestor
154501075|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501076|NCT04094519|Digoxin|digoxin|mesh-list
154501077|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154501078|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154501079|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501089|NCT02189798|Imidacloprid|imidacloprid|mesh-list
153583220|NCT01754870|Rituximab|rituximab|mesh-list
153583330|NCT01755403|Benzonidazole|benzonidazole|mesh-list
154255538|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
154255539|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360035|NCT01268111|Vitamins|vitamins|mesh-ancestor
154255540|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
154255541|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153584966|NCT01763749|Clopidogrel|clopidogrel|mesh-list
153585084|NCT01764867|Dexetimide|dexetimide|mesh-list
153606476|NCT05628038|Leucovorin|leucovorin|mesh-list
154255571|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255572|NCT03900026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154255573|NCT03900026|Protease Inhibitors|protease inhibitors|mesh-ancestor
154255574|NCT03900026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255575|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154255576|NCT01149668|Abexinostat|abexinostat|mesh-list
153616369|NCT06327321|Dermatologic Agents|dermatologic agents|mesh-ancestor
153616403|NCT06327113|Cefazolin|cefazolin|mesh-list
153616404|NCT06327113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153616405|NCT06327113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617114|NCT05789173|Antiviral Agents|antiviral agents|mesh-ancestor
154255645|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
154255646|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
154255648|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255649|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154255650|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
154255651|NCT01255358|Hormones|hormones|mesh-ancestor
154255652|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154255654|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255713|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255714|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255715|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
154255716|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255717|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154255718|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154255719|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
154255759|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154255760|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
154255761|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255762|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255763|NCT01149122|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153494819|NCT00656916|Xhance|xhance|mesh-list
154255799|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154255877|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154255878|NCT03890042|Progestins|progestins|mesh-ancestor
154255800|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154255801|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154255802|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255805|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
154253879|NCT01231490|Analgesics|analgesics|mesh-ancestor
153518601|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154253942|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154253985|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
154253986|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254050|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154254051|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545407|NCT06308588|Blinatumomab|blinatumomab|mesh-list
153545477|NCT06307652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254099|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154254100|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154254162|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254217|NCT01143584|Dopamine|dopamine|mesh-list
154254218|NCT01143584|Cabergoline|cabergoline|mesh-list
154254219|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
154254233|NCT01145846|Idarubicin|idarubicin|mesh-list
154254326|NCT03523000|Narcotics|narcotics|mesh-ancestor
154860803|NCT03242590|Hormones|hormones|mesh-ancestor
154066361|NCT00851552|Rituximab|rituximab|mesh-list
154098487|NCT04045301|Omalizumab|omalizumab|mesh-list
153732935|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
154255018|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
154261420|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
154392582|NCT03294460|Ethanol|ethanol|mesh-list
154132521|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
154132897|NCT00927966|Everolimus|everolimus|mesh-list
154132969|NCT04005417|Fluorides|fluorides|mesh-list
154133334|NCT00720083|Cisplatin|cisplatin|mesh-list
154175510|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154133483|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
154133784|NCT04469556|Leucovorin|leucovorin|mesh-list
153972114|NCT02700711|Analgesics|analgesics|mesh-ancestor
153972334|NCT00617253|Sunitinib|sunitinib|mesh-list
154255021|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134456|NCT00517192|Ritonavir|ritonavir|mesh-list
154255024|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153973984|NCT06029296|Analgesics|analgesics|mesh-ancestor
154255050|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
154135322|NCT00844688|Sorafenib|sorafenib|mesh-list
154255051|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
153975230|NCT02521753|Metformin|metformin|mesh-list
153975571|NCT05772871|Hormones|hormones|mesh-ancestor
153975802|NCT04492033|Irinotecan|irinotecan|mesh-list
153733474|NCT05148637|Lidocaine|lidocaine|mesh-list
153976347|NCT02705287|Vitamin D|vitamin d|mesh-list
154137125|NCT00868010|Donepezil|donepezil|mesh-list
153976870|NCT00620919|Secretin|secretin|mesh-list
153977363|NCT02873351|Levodopa|levodopa|mesh-list
154137952|NCT01019746|Propofol|propofol|mesh-list
153978045|NCT02871869|Hormones|hormones|mesh-ancestor
154089459|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089578|NCT02557945|Gabapentin|gabapentin|mesh-list
154756533|NCT02458716|Androgens|androgens|mesh-list
154756534|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
154756535|NCT02458716|Hormones|hormones|mesh-ancestor
153360836|NCT01476449|Ranibizumab|ranibizumab|mesh-list
153556221|NCT01612377|Prednisone|prednisone|mesh-list
153659107|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
154090007|NCT00783081|Protective Agents|protective agents|mesh-ancestor
154090316|NCT00709982|Estradiol|estradiol|mesh-list
153659826|NCT00070447|Hormones|hormones|mesh-ancestor
154090868|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154756536|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091162|NCT00796887|Vitamins|vitamins|mesh-ancestor
154756537|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756538|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154091580|NCT00797745|Ritonavir|ritonavir|mesh-list
154756539|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
153660685|NCT00077116|Cytarabine|cytarabine|mesh-list
154091990|NCT01034683|Antidotes|antidotes|mesh-ancestor
154756540|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154756541|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154756542|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756543|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
154756544|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
154756545|NCT03268278|Lidocaine|lidocaine|mesh-list
154756546|NCT03268278|Epinephrine|epinephrine|mesh-list
154756547|NCT03268278|Buprenorphine|buprenorphine|mesh-list
154092812|NCT04560127|Apatinib|apatinib|mesh-list
154756548|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
154756549|NCT03268278|Anesthetics|anesthetics|mesh-list
154092923|NCT04147208|Ritonavir|ritonavir|mesh-list
154756550|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154093139|NCT06062719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154093250|NCT05879367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756551|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093366|NCT05144945|Vaccines|vaccines|mesh-list
154756552|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
154756553|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093553|NCT03976258|Heroin|heroin|mesh-list
154756554|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154756555|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154256644|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154756556|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154756557|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154094110|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153360899|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153360907|NCT00859508|Estradiol|estradiol|mesh-list
154756558|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756559|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154756560|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154756561|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
154756562|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756563|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154756564|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154756565|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
154095724|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756566|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154756567|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
154096562|NCT04066088|Guanfacine|guanfacine|mesh-list
154096941|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756568|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
154756569|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
154756570|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154097631|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154756571|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154756572|NCT03268278|Narcotics|narcotics|mesh-ancestor
154756573|NCT03268278|Analgesics|analgesics|mesh-ancestor
154756574|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154756575|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
154756576|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154098125|NCT04728932|Simendan|simendan|mesh-list
153360917|NCT01377467|Denosumab|denosumab|mesh-list
154756577|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
153736432|NCT02583828|Letrozole|letrozole|mesh-list
154098929|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756578|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099467|NCT04039828|Zinc|zinc|mesh-list
154756579|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
154756580|NCT05045586|Protective Agents|protective agents|mesh-ancestor
154756581|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
153667969|NCT00030381|Esorubicin|esorubicin|mesh-list
154756582|NCT03263520|Dexamethasone|dexamethasone|mesh-list
154756583|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
154756584|NCT03263520|Nandrolone|nandrolone|mesh-list
154100665|NCT00738192|Dsuvia|dsuvia|mesh-list
154756585|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
154756586|NCT03263520|BB 1101|bb 1101|mesh-list
154100782|NCT00613366|Antacids|antacids|mesh-ancestor
154756587|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756588|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
154756589|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
154756590|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256661|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154101294|NCT01041235|Docetaxel|docetaxel|mesh-list
154101441|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101443|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756591|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101653|NCT01038661|Docetaxel|docetaxel|mesh-list
154756592|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154756593|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
154756594|NCT03263520|Hormones|hormones|mesh-ancestor
154756595|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756596|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154756597|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756598|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
154756599|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756600|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756601|NCT03263520|Androgens|androgens|mesh-ancestor
154102282|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
154756602|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
154102510|NCT00817011|Trazodone|trazodone|mesh-list
154102737|NCT00607048|Paclitaxel|paclitaxel|mesh-list
154103030|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756603|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154756604|NCT02456844|Leucovorin|leucovorin|mesh-list
154756605|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
154103584|NCT00908362|Hormones|hormones|mesh-ancestor
154103865|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
154756606|NCT02456844|Methotrexate|methotrexate|mesh-list
154104820|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
154756607|NCT02456844|Digoxin|digoxin|mesh-list
154756608|NCT02456844|Midazolam|midazolam|mesh-list
154756609|NCT02456844|Pravastatin|pravastatin|mesh-list
154756610|NCT02456844|Montelukast|montelukast|mesh-list
154256667|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
154756611|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153672422|NCT00039351|Prednisone|prednisone|mesh-list
154756612|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
154105999|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154756613|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154106485|NCT00852423|Artemether|artemether|mesh-list
154106489|NCT00852423|Artenimol|artenimol|mesh-list
154106633|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
154756614|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673958|NCT00052611|Analgesics|analgesics|mesh-ancestor
154756615|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154756616|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
153360974|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108098|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154756617|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756618|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756619|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
154756620|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756621|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154109036|NCT00879723|Vitamins|vitamins|mesh-list
154756622|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154756623|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
154756624|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154756625|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154756626|NCT02456844|Antidotes|antidotes|mesh-ancestor
154756627|NCT02456844|Protective Agents|protective agents|mesh-ancestor
154756628|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
154756629|NCT02456844|Vitamins|vitamins|mesh-ancestor
154756630|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
154756631|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154756632|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153677329|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153360989|NCT03839498|Axitinib|axitinib|mesh-list
154756633|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154111834|NCT00378703|Sorafenib|sorafenib|mesh-list
154756634|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154756635|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154756636|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154756637|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154112738|NCT00359281|Niacin|niacin|mesh-list
154756638|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
154756639|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
154756640|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
154756641|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
154756642|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756643|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154756644|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
154756645|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154756646|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
154256682|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680006|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
153736445|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154756647|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256684|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
154756648|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154115180|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154115485|NCT00567567|Carboplatin|carboplatin|mesh-list
154756649|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154116516|NCT04046016|Paclitaxel|paclitaxel|mesh-list
154116634|NCT02554734|Levodopa|levodopa|mesh-list
153682807|NCT03399838|Analgesics|analgesics|mesh-ancestor
154117230|NCT00801294|Nintedanib|nintedanib|mesh-list
153683036|NCT00046319|Ambrisentan|ambrisentan|mesh-list
154117839|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
154118020|NCT01055431|Iron|iron|mesh-list
154756650|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154118034|NCT00936195|Lopinavir|lopinavir|mesh-list
154756651|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154256686|NCT03877562|Olanzapine|olanzapine|mesh-list
154256687|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
154756652|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154256688|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
154756653|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154119329|NCT00764036|Artesunate|artesunate|mesh-list
154756654|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154756655|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154756656|NCT02456844|Analgesics|analgesics|mesh-ancestor
154756657|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
154756658|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756659|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154756660|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154756661|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756662|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154756663|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
154756664|NCT03263208|Fludarabine|fludarabine|mesh-list
154756665|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154756666|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
153361521|NCT04411446|Vitamin D|vitamin d|mesh-list
154120909|NCT00778778|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154121097|NCT01664182|Bevacizumab|bevacizumab|mesh-list
154121384|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153361619|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
154756667|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361680|NCT01395329|BQ 788|bq 788|mesh-list
154756668|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122760|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154756669|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154756670|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
153361753|NCT01512251|Vemurafenib|vemurafenib|mesh-list
154756671|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756672|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756673|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154123574|NCT00629772|Infliximab|infliximab|mesh-list
154756674|NCT03259542|Itraconazole|itraconazole|mesh-list
154123750|NCT00525148|Afatinib|afatinib|mesh-list
154756675|NCT03259542|Mifepristone|mifepristone|mesh-list
154756676|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
154756677|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756678|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154124380|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756679|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154124589|NCT02549430|Anastrozole|anastrozole|mesh-list
153361904|NCT02504892|Everolimus|everolimus|mesh-list
154756680|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361931|NCT05946486|Rituximab|rituximab|mesh-list
154756681|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756682|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154756683|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
154756684|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508598|NCT02321397|Oxycodone|oxycodone|mesh-list
153356021|NCT00603044|Xhance|xhance|mesh-list
154756685|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126709|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
154756686|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154756687|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153362003|NCT05945173|Ethanol|ethanol|mesh-list
154756688|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
154756689|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154756690|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154756691|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154756692|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154756693|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
154756694|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154756695|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154756696|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
154756697|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154256701|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
154256702|NCT01160666|Belimumab|belimumab|mesh-list
154756698|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154756699|NCT03267654|Apatinib|apatinib|mesh-list
154756700|NCT03267654|Gefitinib|gefitinib|mesh-list
154756701|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756702|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154756703|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756704|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133061|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756705|NCT03267654|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154756706|NCT03263052|Tacrolimus|tacrolimus|mesh-list
154756707|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154756708|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
154756709|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756710|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154756711|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382746|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
154756712|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756713|NCT03259152|Denosumab|denosumab|mesh-list
154756714|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154136309|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154756715|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756716|NCT02456142|Morphine|morphine|mesh-list
154756717|NCT02456142|Bupivacaine|bupivacaine|mesh-list
153362219|NCT04731844|Curcumin|curcumin|mesh-list
154756718|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
154756719|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
154256713|NCT03760250|Imiquimod|imiquimod|mesh-list
154137502|NCT00532779|Naltrexone|naltrexone|mesh-list
154137612|NCT02582177|Dexamethasone|dexamethasone|mesh-list
154137613|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
154756720|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756721|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756722|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
154756723|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138011|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
154756724|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154756725|NCT02456142|Narcotics|narcotics|mesh-ancestor
154756726|NCT02456142|Analgesics|analgesics|mesh-ancestor
154756727|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154756728|NCT03262740|Norethindrone|norethindrone|mesh-list
154756729|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
153659398|NCT00066352|Bortezomib|bortezomib|mesh-list
153659399|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659400|NCT00066391|Irinotecan|irinotecan|mesh-list
153659565|NCT00067912|Analgesics|analgesics|mesh-ancestor
153660029|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
154756730|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154756731|NCT03262740|Estradiol|estradiol|mesh-list
154756732|NCT03262740|Branebrutinib|branebrutinib|mesh-list
154756733|NCT03262740|Estrogens|estrogens|mesh-ancestor
154756734|NCT03262740|Hormones|hormones|mesh-ancestor
154756735|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153822685|NCT00479739|Xhance|xhance|mesh-list
153662089|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153362675|NCT03008057|Vitamin D|vitamin d|mesh-list
154756736|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756737|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153666705|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
153666706|NCT00022932|Antibodies|antibodies|mesh-list
153666707|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
153666708|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666709|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666710|NCT00022971|Rituximab|rituximab|mesh-list
153480771|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153480772|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667410|NCT04206488|Digoxin|digoxin|mesh-list
154756738|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
154756739|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154756740|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154756741|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154756742|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154756743|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154756744|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154756745|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154756746|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154756747|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256719|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153668582|NCT03150836|Durvalumab|durvalumab|mesh-list
153668583|NCT03150836|Tremelimumab|tremelimumab|mesh-list
153668584|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670125|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
154756748|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756749|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154756750|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153362816|NCT00895934|Azacitidine|azacitidine|mesh-list
153484738|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153484739|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484740|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484741|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153484742|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153484743|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153484744|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484745|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154756751|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756752|NCT03258684|Thiamine|thiamine|mesh-list
154756753|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
154756754|NCT03258684|Vitamins|vitamins|mesh-ancestor
154756755|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
154756756|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756757|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153676494|NCT00034385|Valganciclovir|valganciclovir|mesh-list
153676793|NCT00062478|Camptothecin|camptothecin|mesh-list
153677509|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153677511|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677512|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
153677513|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153677514|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153677515|NCT00396734|Topiramate|topiramate|mesh-list
153677516|NCT00396734|Modafinil|modafinil|mesh-list
153677517|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
153677518|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153487195|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
153677629|NCT00070239|Growth Substances|growth substances|mesh-ancestor
153677635|NCT00070278|Epirubicin|epirubicin|mesh-list
153678517|NCT00204568|Trofosfamide|trofosfamide|mesh-list
153678518|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154508673|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
154756758|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
154756759|NCT03266250|Anesthetics|anesthetics|mesh-list
154756760|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756761|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756762|NCT03258372|Rifampin|rifampin|mesh-list
154756763|NCT03258372|Mifepristone|mifepristone|mesh-list
154756764|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153681147|NCT00042887|Mitomycins|mitomycins|mesh-list
153681148|NCT00042887|Mitomycin|mitomycin|mesh-list
153681193|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681196|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256721|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
153681879|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
153681920|NCT00074178|Cytarabine|cytarabine|mesh-list
153682152|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154756765|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
153683041|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153683042|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683043|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683044|NCT00079872|Pemetrexed|pemetrexed|mesh-list
153683214|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
153683215|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153683216|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683217|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
153683218|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683219|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153683220|NCT00403663|Narcotics|narcotics|mesh-ancestor
153683221|NCT00403663|Analgesics|analgesics|mesh-ancestor
153683222|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153683223|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153814941|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153814942|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
153814943|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756766|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154756767|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756768|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
154756769|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154756770|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756771|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756772|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154756773|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154756774|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154756775|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154756776|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154756777|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154256723|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154256724|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256725|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154256726|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256727|NCT01160900|Bivalirudin|bivalirudin|mesh-list
154256728|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154256729|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154256730|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
154256731|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154256732|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
154256733|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256734|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731774|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756778|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154756779|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
154756780|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154756781|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756782|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154756783|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154756784|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154756785|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
154756786|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154756787|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154756788|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
154756789|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756790|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
154756791|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154756792|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154756793|NCT02456454|Valproic Acid|valproic acid|mesh-list
154756794|NCT02456454|Risperidone|risperidone|mesh-list
154756795|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154756796|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
154756797|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756798|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756799|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756800|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154756801|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154756802|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756803|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154756804|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154756805|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
154756806|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
154756807|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756808|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
154756809|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
154756810|NCT03258294|Melatonin|melatonin|mesh-list
154756811|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
154756812|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256735|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
154256736|NCT01160978|Simvastatin|simvastatin|mesh-list
154256738|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154756813|NCT03258294|Protective Agents|protective agents|mesh-ancestor
154756814|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756815|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756816|NCT03265782|Acetaminophen|acetaminophen|mesh-list
154756817|NCT03265782|Ibuprofen|ibuprofen|mesh-list
154756818|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154756819|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154756820|NCT03265782|Analgesics|analgesics|mesh-ancestor
154756821|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
154256770|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256771|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
153731826|NCT00406302|Docetaxel|docetaxel|mesh-list
154756822|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756823|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756824|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756825|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154756826|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154756827|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756828|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756829|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
154756830|NCT03798054|Insulin|insulin|mesh-list
154256772|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256773|NCT01161368|Vinorelbine|vinorelbine|mesh-list
154256774|NCT01161368|Lapatinib|lapatinib|mesh-list
154256775|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154508748|NCT02323191|Atezolizumab|atezolizumab|mesh-list
154756831|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154756832|NCT03798054|Metformin|metformin|mesh-list
154756833|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
154756834|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154756835|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154756836|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756837|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756838|NCT03265470|Fentanyl|fentanyl|mesh-list
154756839|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
153363523|NCT01837628|Emollients|emollients|mesh-ancestor
153814960|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154756840|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154756841|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756842|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756843|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154756844|NCT03265470|Analgesics|analgesics|mesh-ancestor
154756845|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
154756846|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756847|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154256776|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256777|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731833|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568861|NCT05316116|Siltuximab|siltuximab|mesh-list
153365519|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153814971|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154756848|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154756849|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154756850|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
154756851|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756852|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756853|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154756854|NCT03265470|Narcotics|narcotics|mesh-ancestor
153814993|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
154756855|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154756856|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154756857|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
154756858|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
154756859|NCT02019940|Riluzole|riluzole|mesh-list
154756860|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
154756861|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154756862|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154756863|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256778|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
153814995|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814997|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153814998|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
153360228|NCT00809276|Busulfan|busulfan|mesh-list
154756864|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756865|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756866|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154756867|NCT02019940|Protective Agents|protective agents|mesh-ancestor
154756868|NCT01229943|Bevacizumab|bevacizumab|mesh-list
154756869|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154756870|NCT01229943|Everolimus|everolimus|mesh-list
154756871|NCT01229943|Octreotide|octreotide|mesh-list
154756872|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
154756873|NCT01229943|Antibodies|antibodies|mesh-list
154756874|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
154756875|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154756876|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
154756877|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756878|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154756879|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154756880|NCT01229943|Growth Substances|growth substances|mesh-ancestor
154756881|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256779|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
153814101|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153363819|NCT01726088|Modafinil|modafinil|mesh-list
154756882|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
154756883|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
154756884|NCT01229943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154756885|NCT01229943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154756886|NCT01229943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756887|NCT01229943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756888|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154756889|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154756890|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154756891|NCT02020408|Raclopride|raclopride|mesh-list
154756892|NCT02020408|Amphetamine|amphetamine|mesh-list
154256780|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756893|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
154756894|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154756895|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756896|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
154756897|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
154756898|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756899|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
154756900|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256781|NCT01161368|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153782029|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782030|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153782031|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782036|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
154756901|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756902|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
154756903|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154756904|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154756905|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154756906|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154756907|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153814153|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
154756908|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154756909|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756910|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154756911|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154756912|NCT01219257|Adalimumab|adalimumab|mesh-list
154756913|NCT01219257|Infliximab|infliximab|mesh-list
154756914|NCT01219257|Golimumab|golimumab|mesh-list
154756915|NCT01219257|Etanercept|etanercept|mesh-list
154756916|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154756917|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756918|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154756919|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
153363871|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
153782064|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153782066|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154756920|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154756921|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154756922|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154756923|NCT01219257|Analgesics|analgesics|mesh-ancestor
154756924|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
154756925|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756926|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756927|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154756928|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
154756929|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153814758|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814760|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153814761|NCT00447018|Diuretics|diuretics|mesh-ancestor
153815025|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153814766|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153782083|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154756930|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154756931|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756932|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154756933|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154756934|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154756935|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756936|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
154756937|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756938|NCT04389801|Deferoxamine|deferoxamine|mesh-list
154756939|NCT04389801|Siderophores|siderophores|mesh-ancestor
154756940|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154756941|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
154756942|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
153782084|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756943|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756944|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
154756945|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154756946|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
154756947|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154756948|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
154756949|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756950|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756951|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
154756952|NCT03548220|Mitapivat|mitapivat|mesh-list
154756953|NCT03548220|Enzyme Activators|enzyme activators|mesh-ancestor
154756954|NCT03548220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756955|NCT03257670|Lidocaine|lidocaine|mesh-list
154756956|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
154756957|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
154756958|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756959|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256782|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256783|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256784|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
154256785|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154256786|NCT01280162|Piperaquine|piperaquine|mesh-list
154256787|NCT01280162|Artenimol|artenimol|mesh-list
154256788|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
154256789|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154256790|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154256791|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256792|NCT01167062|Tamsulosin|tamsulosin|mesh-list
154256793|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154256794|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154256795|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153363957|NCT01728740|Metformin|metformin|mesh-list
153814768|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782093|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
154756960|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
154756961|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756962|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154756963|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154756964|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154756965|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154756966|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756967|NCT03265002|Psyllium|psyllium|mesh-list
154756968|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
154756969|NCT03265002|Cathartics|cathartics|mesh-ancestor
154756970|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154756971|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
154756972|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
154756973|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
154756974|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756975|NCT03257514|Protective Agents|protective agents|mesh-ancestor
154756976|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256796|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154256797|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256798|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256799|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256800|NCT01167062|Urological Agents|urological agents|mesh-ancestor
154256801|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154256802|NCT01280240|Hematinics|hematinics|mesh-ancestor
154256803|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
154256804|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154256805|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256806|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154256807|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256808|NCT03874364|Lidocaine|lidocaine|mesh-list
154256809|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
154256810|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
153363999|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
154256811|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256812|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756977|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
154756978|NCT03257514|Vitamins|vitamins|mesh-ancestor
154756979|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
154756980|NCT04781751|Insulin|insulin|mesh-list
154508892|NCT03625505|Gilteritinib|gilteritinib|mesh-list
154756981|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154756982|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756983|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154756984|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756985|NCT03261024|Nickel|nickel|mesh-list
154756986|NCT03261024|Trace Elements|trace elements|mesh-ancestor
154756987|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
154756988|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756989|NCT04777383|Atropine|atropine|mesh-list
154756990|NCT04777383|Phenylephrine|phenylephrine|mesh-list
154756991|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
154756992|NCT04777383|Norepinephrine|norepinephrine|mesh-list
154756993|NCT04777383|Acetylcholine|acetylcholine|mesh-list
154756994|NCT04777383|Neostigmine|neostigmine|mesh-list
154756995|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154756996|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
154756997|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
154756998|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256813|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
154256814|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256815|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154256816|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154256817|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154256818|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256819|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256820|NCT01163396|Leucovorin|leucovorin|mesh-list
154256821|NCT01163396|Bevacizumab|bevacizumab|mesh-list
154256822|NCT01163396|Fluorouracil|fluorouracil|mesh-list
154256823|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
154256824|NCT01163396|Irinotecan|irinotecan|mesh-list
154256825|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154256826|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364034|NCT03006965|BAX 855|bax 855|mesh-list
154256827|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154256828|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154256829|NCT01163396|Growth Substances|growth substances|mesh-ancestor
154756999|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757000|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
154757001|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154757002|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
154757003|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
154757004|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154757005|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154757006|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154757007|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
154757008|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757009|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757010|NCT04777383|Protective Agents|protective agents|mesh-ancestor
154757011|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154757012|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757013|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154757014|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154757015|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
154757016|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154757017|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154256830|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256831|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
154256832|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
154256833|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256834|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154256835|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256836|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
154256837|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154256838|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154256839|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256840|NCT01163396|Antidotes|antidotes|mesh-ancestor
153364055|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814775|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782122|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783588|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154757018|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
154757019|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154757020|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757021|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154757022|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
154757023|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154757024|NCT03257124|Osimertinib|osimertinib|mesh-list
154757025|NCT03257124|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154757026|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154757027|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256841|NCT01163396|Protective Agents|protective agents|mesh-ancestor
154757028|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757029|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757030|NCT02089113|Dexamethasone|dexamethasone|mesh-list
154757031|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757032|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
154757033|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
154757034|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757035|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757036|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757037|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
154757038|NCT02089113|Hormones|hormones|mesh-ancestor
154757039|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256842|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
154256843|NCT01163396|Vitamins|vitamins|mesh-ancestor
154256844|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
154256845|NCT01269788|Fluoxetine|fluoxetine|mesh-list
154256846|NCT01269788|Omeprazole|omeprazole|mesh-list
154256847|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154256848|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154256849|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154256850|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364099|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814786|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782143|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757040|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154757041|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757042|NCT03260634|Voriconazole|voriconazole|mesh-list
154757043|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
154757044|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757045|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154757046|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154757047|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757048|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757049|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154757050|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
154757051|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757052|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757053|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154508982|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
153782145|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
153782146|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
154757054|NCT04777227|Lidocaine|lidocaine|mesh-list
154757055|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
154757057|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757058|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757059|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
154757060|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757061|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757062|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153387549|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364188|NCT01724138|Deferasirox|deferasirox|mesh-list
154757063|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154757064|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154757065|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757066|NCT03260556|Pirfenidone|pirfenidone|mesh-list
154757067|NCT03260556|Analgesics|analgesics|mesh-ancestor
154757068|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
154757069|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757070|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757071|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154757072|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757073|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757074|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154757075|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757076|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154757077|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154757078|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757079|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154757080|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154757081|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154757082|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757083|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
154757084|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367605|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387579|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153387580|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
154757085|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154757086|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
154757087|NCT03252366|Coagulants|coagulants|mesh-ancestor
154757088|NCT04346277|Antibodies|antibodies|mesh-list
154757089|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154757090|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
154757091|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757092|NCT04780347|Paclitaxel|paclitaxel|mesh-list
154757093|NCT04780347|Capecitabine|capecitabine|mesh-list
154757094|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154757095|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154757096|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757097|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
153364229|NCT03001193|Oxytocin|oxytocin|mesh-list
153368123|NCT00458835|Hormones|hormones|mesh-ancestor
153368124|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368125|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368126|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153368127|NCT01044758|Levetiracetam|levetiracetam|mesh-list
153368128|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
153368129|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
153368130|NCT03013400|Ebselen|ebselen|mesh-list
153368131|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153368132|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153368133|NCT03013400|Analgesics|analgesics|mesh-ancestor
154757098|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
154757099|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
154757100|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757101|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154757102|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
154757103|NCT02455596|Interferons|interferons|mesh-list
154757104|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757105|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
153364265|NCT01724372|Fluoxetine|fluoxetine|mesh-list
153814826|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153368134|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
153828140|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
153828143|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828144|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
153828145|NCT05644210|Hormones|hormones|mesh-ancestor
153828146|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828147|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153828148|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153368148|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368149|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368150|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368151|NCT01097642|Cetuximab|cetuximab|mesh-list
153368152|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368153|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814827|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757106|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757107|NCT02455440|Propofol|propofol|mesh-list
154757108|NCT02455440|Sevoflurane|sevoflurane|mesh-list
154757109|NCT02455440|Esmolol|esmolol|mesh-list
154757110|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154757111|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757112|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757113|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154757114|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
154757115|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
154757116|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154757117|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154757118|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153828197|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828198|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828199|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828200|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153828201|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828202|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828203|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153828204|NCT01307020|Narcotics|narcotics|mesh-ancestor
153828205|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828207|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828208|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153828209|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
153828210|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828211|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828212|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153368210|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
153783798|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153814828|NCT04715360|Favipiravir|favipiravir|mesh-list
154757119|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154757120|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154757121|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
154757122|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757123|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757124|NCT03260166|Niacinamide|niacinamide|mesh-list
154757125|NCT03260166|Niacin|niacin|mesh-list
154757126|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
154757127|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
154757128|NCT03260166|Vitamins|vitamins|mesh-ancestor
154509060|NCT05436886|Gabapentin|gabapentin|mesh-list
153814829|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
153828224|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
153828225|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828227|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153828238|NCT01306162|Dabigatran|dabigatran|mesh-list
153828239|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
153828240|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153828241|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
153368241|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368242|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153368243|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153368244|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153368245|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
153368246|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368247|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153368248|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153783817|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153783818|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783819|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
153783820|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783821|NCT00237224|Letrozole|letrozole|mesh-list
154256851|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757129|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
154757130|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757131|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154757132|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
154757133|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757134|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154757135|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
154757136|NCT03260010|Fosfomycin|fosfomycin|mesh-list
154757137|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154757138|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757139|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
154757140|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154757141|NCT03260088|Antibodies|antibodies|mesh-list
154757142|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
154256852|NCT01269788|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154256853|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256854|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256855|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256856|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
154256857|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256858|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154256859|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
154256860|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153364332|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783830|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783831|NCT00262236|Aliskiren|aliskiren|mesh-list
153783832|NCT00262236|Renin Inhibitors|renin inhibitors|mesh-ancestor
154757143|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
154757144|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757145|NCT04776135|Edaravone|edaravone|mesh-list
154757146|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154757147|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
154757148|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757149|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154757150|NCT04776135|Protective Agents|protective agents|mesh-ancestor
153814835|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814836|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828348|NCT01303627|Analgesics|analgesics|mesh-ancestor
154256861|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154757151|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757152|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154757153|NCT03474276|Azithromycin|azithromycin|mesh-list
154757154|NCT03474276|Albendazole|albendazole|mesh-list
154757155|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
154757156|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757157|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
154757158|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
154757159|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154757160|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154757161|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
154757162|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
154757163|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
154757164|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757165|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757166|NCT04779255|Acetaminophen|acetaminophen|mesh-list
154757167|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757168|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757169|NCT04779255|Analgesics|analgesics|mesh-ancestor
154757170|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
154256862|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154256863|NCT01163630|Esomeprazole|esomeprazole|mesh-list
154256864|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154256865|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154256866|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154256867|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256868|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256869|NCT03874130|Scopolamine|scopolamine|mesh-list
154256870|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154256871|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154256872|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
154256873|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
154256874|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256875|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364378|NCT01045694|Hormones|hormones|mesh-ancestor
153814837|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
153814838|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814839|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154757171|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757172|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
154757173|NCT04779567|Acetaminophen|acetaminophen|mesh-list
154757174|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757175|NCT04779567|Analgesics|analgesics|mesh-ancestor
154757176|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
154757177|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757178|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757179|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
154757180|NCT02352844|Everolimus|everolimus|mesh-list
154757181|NCT02352844|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154757182|NCT02352844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154757183|NCT02352844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814840|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783848|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783850|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153814843|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153783859|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153783860|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
154757184|NCT02352844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757185|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757186|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
154757187|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757188|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757189|NCT03255642|Clonazepam|clonazepam|mesh-list
154757190|NCT03255642|Melatonin|melatonin|mesh-list
154757191|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
154757192|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757193|NCT03255642|Protective Agents|protective agents|mesh-ancestor
154757194|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757195|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757196|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
154757197|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
154757198|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
154757199|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757200|NCT03562377|Vaccines|vaccines|mesh-list
154757201|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
154757202|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509113|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154757203|NCT02352922|Bupivacaine|bupivacaine|mesh-list
154757204|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
153814845|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153814846|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368581|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821077|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
153821078|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821079|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153821080|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
153361033|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361151|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153361152|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
153361153|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153830665|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153821328|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
153821329|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153821330|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153821331|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153361281|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153361298|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153361299|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153361300|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
153361301|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256876|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154256877|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
154757205|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
154757206|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757207|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757208|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
154757209|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757210|NCT03255330|Dipyrone|dipyrone|mesh-list
154757211|NCT03255330|Gabapentin|gabapentin|mesh-list
154757212|NCT03255330|Tramadol|tramadol|mesh-list
154757213|NCT03255330|Analgesics|analgesics|mesh-ancestor
154757214|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
154757215|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757216|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757217|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
154757218|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154256878|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154256879|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
154256880|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256881|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256882|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154256883|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
154256884|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153364477|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814848|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814849|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
153361302|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361303|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
153361304|NCT01505933|Propofol|propofol|mesh-list
153361305|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153361306|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821925|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814855|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154757219|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154757220|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757221|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154757222|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154757223|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154757224|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757225|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757226|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
154757227|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154757228|NCT03255330|Narcotics|narcotics|mesh-ancestor
154757229|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154757230|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822027|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
153361986|NCT05945771|Antioxidants|antioxidants|mesh-ancestor
153361987|NCT05945771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361988|NCT05945771|Protective Agents|protective agents|mesh-ancestor
153361989|NCT05945771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361990|NCT05945745|Immunomodulating Agents|immunomodulating agents|mesh-list
153362386|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757231|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757232|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154757233|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
154757234|NCT02353780|Etanercept|etanercept|mesh-list
154757235|NCT02353780|Infliximab|infliximab|mesh-list
154757236|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
154757237|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154757238|NCT02353780|Abatacept|abatacept|mesh-list
154757239|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154757240|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757241|NCT02353780|Analgesics|analgesics|mesh-ancestor
154757242|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
154757243|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757244|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757245|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757246|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154757247|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757248|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757249|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
154757250|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154757251|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757252|NCT02353780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154757253|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757254|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
154757255|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154757256|NCT03246360|Cloxacillin|cloxacillin|mesh-list
154757257|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757258|NCT02354092|Anesthetics|anesthetics|mesh-list
154757259|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
154757260|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757261|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757262|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
154757263|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757264|NCT00907101|Adapalene|adapalene|mesh-list
154757265|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
153814878|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
153366261|NCT03516968|Vitamin D|vitamin d|mesh-list
153366262|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153366263|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366264|NCT03516968|Vitamins|vitamins|mesh-ancestor
153366265|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
153366266|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153366267|NCT04355156|Axitinib|axitinib|mesh-list
153366268|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366269|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153366270|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366271|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757266|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154757267|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
154757268|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154757269|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757270|NCT00907101|Analgesics|analgesics|mesh-ancestor
154757271|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
154757272|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757273|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757274|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757275|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154757276|NCT03245970|Atenolol|atenolol|mesh-list
154757277|NCT03245970|Labetalol|labetalol|mesh-list
154757278|NCT03245970|Nifedipine|nifedipine|mesh-list
154757279|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814882|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814884|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153826870|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757280|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154757281|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757282|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154757283|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757284|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
154757285|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
154757286|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154757287|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757288|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154757289|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
154757290|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
154757291|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757292|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154757293|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154757294|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154757295|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
154757296|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757297|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
154757298|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154757299|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154757300|NCT02454348|Vasopressins|vasopressins|mesh-list
154757301|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
153364720|NCT02462928|Ranibizumab|ranibizumab|mesh-list
153367037|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153827036|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367254|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154757302|NCT02454348|Norepinephrine|norepinephrine|mesh-list
154757303|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154757304|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154757305|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
154757306|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757307|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757308|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757309|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
154757310|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
154757311|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757312|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154757313|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
154757314|NCT02454348|Coagulants|coagulants|mesh-ancestor
153367255|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153367320|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153367321|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153827326|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827328|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153827329|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154757315|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154757316|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
154757317|NCT02455908|Aldesleukin|aldesleukin|mesh-list
154757318|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757319|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154757320|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154757321|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
154757322|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757323|NCT06112665|Tofacitinib|tofacitinib|mesh-list
154757324|NCT06112665|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154757325|NCT06112665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153827584|NCT00482222|Calcium|calcium|mesh-list
153827585|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
153367749|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153367750|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153367752|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153367753|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
153367754|NCT03013712|Immunomodulating Agents|immunomodulating agents|mesh-list
153367755|NCT03013712|Immunologic Factors|immunologic factors|mesh-ancestor
153367756|NCT03013712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367758|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153827796|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827797|NCT00482573|Epinephrine|epinephrine|mesh-list
154757326|NCT06112665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757327|NCT06112665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757328|NCT06112548|Acetaminophen|acetaminophen|mesh-list
154757329|NCT06112548|Ketorolac|ketorolac|mesh-list
154757330|NCT06112548|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154757331|NCT06112548|Epinephrine|epinephrine|mesh-list
154757332|NCT06112548|Tramadol|tramadol|mesh-list
154757333|NCT06112548|Bupivacaine|bupivacaine|mesh-list
154757334|NCT06112548|Anesthetics, Local|anesthetics, local|mesh-ancestor
154757335|NCT06112548|Anesthetics|anesthetics|mesh-ancestor
154757336|NCT06112548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814892|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757337|NCT06112548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757338|NCT06112548|Sensory System Agents|sensory system agents|mesh-ancestor
154757339|NCT06112548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757340|NCT06112548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757341|NCT06112548|Analgesics|analgesics|mesh-ancestor
154757342|NCT06112548|Antipyretics|antipyretics|mesh-ancestor
154757343|NCT06112548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154757344|NCT06112548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154757345|NCT06112548|Adrenergic Agents|adrenergic agents|mesh-ancestor
154757346|NCT06112548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757347|NCT06112548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757348|NCT06112548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154757349|NCT06112548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154757350|NCT06112548|Autonomic Agents|autonomic agents|mesh-ancestor
154757351|NCT06112548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154757352|NCT06112548|Respiratory System Agents|respiratory system agents|mesh-ancestor
154757353|NCT06112548|Mydriatics|mydriatics|mesh-ancestor
154757354|NCT06112548|Sympathomimetics|sympathomimetics|mesh-ancestor
153814893|NCT00343850|Mesalamine|mesalamine|mesh-list
153814896|NCT00343850|Analgesics|analgesics|mesh-ancestor
154757355|NCT06112548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154757356|NCT06112548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154757357|NCT06112548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153440502|NCT00003151|Antacids|antacids|mesh-ancestor
154757358|NCT06112548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509273|NCT04703361|Niacin|niacin|mesh-list
154256894|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
154757359|NCT06112548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154757360|NCT06112548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757361|NCT06112548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154757362|NCT06112548|Narcotics|narcotics|mesh-ancestor
154757363|NCT06112223|Gabapentin|gabapentin|mesh-list
154757364|NCT06112223|Tramadol|tramadol|mesh-list
154757365|NCT06112223|Analgesics|analgesics|mesh-ancestor
154757366|NCT06112223|Sensory System Agents|sensory system agents|mesh-ancestor
154757367|NCT06112223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757368|NCT06112223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757369|NCT06112223|Anticonvulsants|anticonvulsants|mesh-ancestor
154757370|NCT06112223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154757371|NCT06112223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154757372|NCT06112223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757373|NCT06112223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154757374|NCT06112223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154757375|NCT06112223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154757376|NCT06112223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757377|NCT06112223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256895|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154256896|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
154256897|NCT05387642|Pramoxine|pramoxine|mesh-list
154256898|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
154256899|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
154256900|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256901|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256902|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
153899410|NCT06266871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899411|NCT06266871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899412|NCT06266832|Capecitabine|capecitabine|mesh-list
153364900|NCT04716335|Harmine|harmine|mesh-list
154757378|NCT06112223|Antimanic Agents|antimanic agents|mesh-ancestor
154757379|NCT06112223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154757380|NCT06112223|Narcotics|narcotics|mesh-ancestor
154757381|NCT06112041|Thymopentin|thymopentin|mesh-list
154757382|NCT06112041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154757383|NCT06112041|Immunologic Factors|immunologic factors|mesh-ancestor
154757384|NCT06112041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757385|NCT06111885|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154757386|NCT06111885|Chlorthalidone|chlorthalidone|mesh-list
154757387|NCT06111885|Indapamide|indapamide|mesh-list
154757388|NCT06111885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153441313|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441314|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153441315|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153899939|NCT05710406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899941|NCT05707468|Hormones|hormones|mesh-list
153899945|NCT05694871|Cemiplimab|cemiplimab|mesh-list
153899946|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
153899947|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
153899948|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
153373113|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814906|NCT00344006|Dapsone|dapsone|mesh-list
154757389|NCT06111885|Diuretics|diuretics|mesh-ancestor
154757390|NCT06111885|Natriuretic Agents|natriuretic agents|mesh-ancestor
154757391|NCT06111885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757392|NCT06111885|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154757393|NCT06111885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154757394|NCT06111885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757395|NCT06111768|Dapagliflozin|dapagliflozin|mesh-list
154757396|NCT06111768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154757397|NCT06111768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757398|NCT06111768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154757399|NCT06111768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757400|NCT06111625|Blinatumomab|blinatumomab|mesh-list
154757401|NCT06111625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757402|NCT06111521|Digoxin|digoxin|mesh-list
154757403|NCT06111521|Midazolam|midazolam|mesh-list
154757404|NCT06111521|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154757405|NCT06111521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154757406|NCT06111521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154757407|NCT06111521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757408|NCT06111521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757409|NCT06111521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154757410|NCT06111521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154757411|NCT06111521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153814907|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
153814908|NCT00344006|Proguanil|proguanil|mesh-list
153814909|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
153814910|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153441446|NCT00004903|Cytarabine|cytarabine|mesh-list
153900077|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
153900078|NCT05550402|Bromides|bromides|mesh-list
153900079|NCT05550402|Albuterol|albuterol|mesh-list
153900080|NCT05550402|Ipratropium|ipratropium|mesh-list
153900081|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
153900082|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153900083|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
153900084|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757412|NCT06111521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154757413|NCT06111521|Anesthetics, General|anesthetics, general|mesh-ancestor
154757414|NCT06111521|Anesthetics|anesthetics|mesh-ancestor
154757415|NCT06111521|GABA Modulators|gaba modulators|mesh-ancestor
154757416|NCT06111521|GABA Agents|gaba agents|mesh-ancestor
154757417|NCT06111521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757418|NCT06111521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757419|NCT06111521|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154757420|NCT06111521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154757421|NCT06111521|Antimetabolites|antimetabolites|mesh-ancestor
154757422|NCT06111521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154757423|NCT06111521|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154256911|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154256912|NCT00313781|Prednisone|prednisone|mesh-list
154256913|NCT00313781|Docetaxel|docetaxel|mesh-list
154256914|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256915|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
154256916|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
154256917|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
154256918|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256919|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154256920|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
153364955|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814913|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900139|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410750|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900142|NCT05303792|Prednisone|prednisone|mesh-list
153900143|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
153900144|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
153900145|NCT05303792|Rituximab|rituximab|mesh-list
153814914|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
154757424|NCT06111521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757425|NCT06111521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757426|NCT06111521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154757427|NCT06111521|Protective Agents|protective agents|mesh-ancestor
154757428|NCT06111352|Atropine|atropine|mesh-list
154757429|NCT06111352|Pralidoxime|pralidoxime|mesh-list
154757430|NCT06111352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154757431|NCT06111352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757432|NCT06111352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154757433|NCT06111352|Autonomic Agents|autonomic agents|mesh-ancestor
154757434|NCT06111352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814915|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
153441594|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441595|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441596|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441597|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441598|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441599|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153814916|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154757435|NCT06111352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757436|NCT06111352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154757437|NCT06111352|Respiratory System Agents|respiratory system agents|mesh-ancestor
154757438|NCT06111352|Mydriatics|mydriatics|mesh-ancestor
154757439|NCT06111352|Parasympatholytics|parasympatholytics|mesh-ancestor
154757440|NCT06111352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154757441|NCT06111352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154757442|NCT06111352|Cholinergic Agents|cholinergic agents|mesh-ancestor
153814917|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
153441683|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441684|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441685|NCT00005041|Tipifarnib|tipifarnib|mesh-list
153441686|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441687|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153441688|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153441689|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153441690|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441691|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
153900323|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153900335|NCT04926818|Ofatumumab|ofatumumab|mesh-list
154757443|NCT06111352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757444|NCT06111352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757445|NCT06111352|Antidotes|antidotes|mesh-ancestor
154757446|NCT06111352|Protective Agents|protective agents|mesh-ancestor
154757447|NCT06111352|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
154757448|NCT06111352|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
154757449|NCT06111326|Durvalumab|durvalumab|mesh-list
154757450|NCT06111326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154757451|NCT06111326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757452|NCT06111300|Dexmedetomidine|dexmedetomidine|mesh-list
154757453|NCT06111300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154757454|NCT06111300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900414|NCT04734535|Thrombin|thrombin|mesh-list
153900415|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
153441827|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441828|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153441829|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
153441830|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441831|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441832|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441835|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441836|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153900462|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900463|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900464|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153900465|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153900466|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
153441867|NCT00005113|Cyclosporine|cyclosporine|mesh-list
153900473|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900474|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
153900491|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900492|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153900493|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153900494|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153900495|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153900496|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814920|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757455|NCT06111300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757456|NCT06111300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757457|NCT06111300|Analgesics|analgesics|mesh-ancestor
154757458|NCT06111300|Sensory System Agents|sensory system agents|mesh-ancestor
154757459|NCT06111300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757460|NCT06111300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154757461|NCT06111300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154757462|NCT06111300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154757463|NCT06111300|Adrenergic Agents|adrenergic agents|mesh-ancestor
154757464|NCT06111300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833371|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153900500|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900501|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900502|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900504|NCT04569032|Immunoconjugates|immunoconjugates|mesh-ancestor
153900507|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
153900508|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153900509|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153814921|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
153441922|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154757465|NCT06111300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757466|NCT06111274|Gemcitabine|gemcitabine|mesh-list
154757467|NCT06111274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154757468|NCT06111274|Antimetabolites|antimetabolites|mesh-ancestor
154757469|NCT06111274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757470|NCT06111274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757471|NCT06111261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154757472|NCT06111209|Methyltestosterone|methyltestosterone|mesh-list
154757473|NCT06111209|Testosterone|testosterone|mesh-list
154757474|NCT06111209|Testosterone undecanoate|testosterone undecanoate|mesh-list
154757475|NCT06111209|Testosterone enanthate|testosterone enanthate|mesh-list
154757476|NCT06111209|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154757477|NCT06111209|Androgens|androgens|mesh-ancestor
154757478|NCT06111209|Hormones|hormones|mesh-ancestor
154757479|NCT06111209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757480|NCT06111209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757481|NCT06111209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154757482|NCT06111209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441923|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153441924|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153441925|NCT00005635|Paclitaxel|paclitaxel|mesh-list
153441926|NCT00005635|Trastuzumab|trastuzumab|mesh-list
153441927|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441928|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900612|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757483|NCT06111209|Anabolic Agents|anabolic agents|mesh-ancestor
154757484|NCT06111053|Nicotine|nicotine|mesh-list
154757485|NCT06111053|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154757486|NCT06111053|Autonomic Agents|autonomic agents|mesh-ancestor
154757487|NCT06111053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757488|NCT06111053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757489|NCT06111053|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154757490|NCT06111053|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154757491|NCT06111053|Cholinergic Agents|cholinergic agents|mesh-ancestor
154757492|NCT06111053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757493|NCT06111053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757494|NCT06110910|Hormones|hormones|mesh-list
153900613|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900615|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153900616|NCT04194203|Growth Substances|growth substances|mesh-ancestor
153900617|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900618|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
153900619|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442007|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442008|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442009|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
153442010|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153442011|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442012|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153442013|NCT00004699|Mitogens|mitogens|mesh-list
153442014|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
153442015|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442016|NCT00004705|Amiloride|amiloride|mesh-list
153442017|NCT00004705|Diuretics|diuretics|mesh-ancestor
153442018|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
153442019|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442020|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153442021|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153442022|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442026|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
154256921|NCT00313781|Hormones|hormones|mesh-ancestor
154256922|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757495|NCT06110910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757496|NCT06110910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757497|NCT06110663|Carboplatin|carboplatin|mesh-list
154757498|NCT06110663|Pemetrexed|pemetrexed|mesh-list
154757499|NCT06110663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757500|NCT06110663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757501|NCT06110663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757502|NCT06110663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154757503|NCT06110663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154757504|NCT06100289|Vedolizumab|vedolizumab|mesh-list
154757505|NCT06100289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757506|NCT06098846|Vitamin D|vitamin d|mesh-list
154757507|NCT06098846|Vitamins|vitamins|mesh-ancestor
154757508|NCT06098846|Micronutrients|micronutrients|mesh-ancestor
154757509|NCT06098846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757510|NCT06098846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154757511|NCT06069154|Anesthetics|anesthetics|mesh-list
154757512|NCT06069154|Anesthetics, Local|anesthetics, local|mesh-list
154757513|NCT06069154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757514|NCT06069154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256923|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900653|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153900655|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
154757515|NCT06069154|Sensory System Agents|sensory system agents|mesh-ancestor
154757516|NCT06069154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757517|NCT06066450|Sirolimus|sirolimus|mesh-list
154757518|NCT06066450|Temsirolimus|temsirolimus|mesh-list
154757519|NCT06066450|MTOR Inhibitors|mtor inhibitors|mesh-list
154757520|NCT06066450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154757521|NCT06066450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757522|NCT06066450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153900656|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
153900657|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900658|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153833492|NCT00514410|Vitamins|vitamins|mesh-ancestor
153900675|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
153900676|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900677|NCT03936270|Letrozole|letrozole|mesh-list
153900678|NCT03936270|Palbociclib|palbociclib|mesh-list
153900679|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900680|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153900681|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153442076|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
153814930|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154757523|NCT06066450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757524|NCT06066450|Antifungal Agents|antifungal agents|mesh-ancestor
154757525|NCT06066450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757526|NCT06066450|Immunologic Factors|immunologic factors|mesh-ancestor
154757527|NCT06066450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757528|NCT06066450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154757529|NCT06066450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757530|NCT06066450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757531|NCT06029530|Atropine|atropine|mesh-list
153814931|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
153900738|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900750|NCT03728179|Aspirin|aspirin|mesh-list
153900783|NCT03642665|Progesterone|progesterone|mesh-list
153900784|NCT03642665|Estrogens|estrogens|mesh-ancestor
153900786|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900787|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900788|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153900789|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
153900790|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153900791|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153900792|NCT03642665|Progestins|progestins|mesh-ancestor
153900793|NCT03609216|Gemcitabine|gemcitabine|mesh-list
153900794|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757532|NCT06029530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153365117|NCT05208983|Vaccines|vaccines|mesh-list
153814933|NCT00344123|Tipranavir|tipranavir|mesh-list
153814934|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153814935|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153442244|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153442245|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153442246|NCT02130024|Growth Substances|growth substances|mesh-ancestor
154757533|NCT06029530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757534|NCT06029530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154757535|NCT06029530|Autonomic Agents|autonomic agents|mesh-ancestor
154757536|NCT06029530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757537|NCT06029530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757538|NCT06029530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154757539|NCT06029530|Respiratory System Agents|respiratory system agents|mesh-ancestor
154757540|NCT06029530|Mydriatics|mydriatics|mesh-ancestor
154757541|NCT06029530|Parasympatholytics|parasympatholytics|mesh-ancestor
154757542|NCT06029530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154757543|NCT06029530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153442247|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442248|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
153442249|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442250|NCT02105688|Grazoprevir|grazoprevir|mesh-list
153442251|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
153900850|NCT03345784|Adavosertib|adavosertib|mesh-list
153900851|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900853|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900854|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
153900855|NCT03345576|Testosterone|testosterone|mesh-list
153900856|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
153900870|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442276|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
153442277|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
153442278|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442279|NCT02127372|Cisplatin|cisplatin|mesh-list
153442280|NCT02127372|Docetaxel|docetaxel|mesh-list
153442281|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
153442282|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901053|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901054|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757544|NCT06029530|Cholinergic Agents|cholinergic agents|mesh-ancestor
154757545|NCT06029530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757546|NCT06029530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757547|NCT06024707|Omalizumab|omalizumab|mesh-list
154757548|NCT06024707|Benralizumab|benralizumab|mesh-list
154757549|NCT06024707|Reslizumab|reslizumab|mesh-list
154757550|NCT06024707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154757551|NCT06024707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154256937|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256938|NCT01281566|Cisapride|cisapride|mesh-list
153901142|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
153901143|NCT01857115|Hormones|hormones|mesh-ancestor
153901144|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901145|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153901146|NCT01754402|Dexamethasone|dexamethasone|mesh-list
153901147|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153833820|NCT01248468|Aspirin|aspirin|mesh-list
153901152|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901153|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901154|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901156|NCT01754402|Hormones|hormones|mesh-ancestor
154757552|NCT06024707|Respiratory System Agents|respiratory system agents|mesh-ancestor
154757553|NCT06023212|Tranexamic Acid|tranexamic acid|mesh-list
154757554|NCT06023212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154757555|NCT06023212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153901275|NCT02697344|Gossypol|gossypol|mesh-list
153442757|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442758|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442759|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442760|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
153442761|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
153442762|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153442763|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
153442764|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442833|NCT02064894|Morphine|morphine|mesh-list
153442834|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153442835|NCT02064894|Narcotics|narcotics|mesh-ancestor
153442836|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442837|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442838|NCT02064894|Analgesics|analgesics|mesh-ancestor
153442839|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
153442842|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153442843|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442844|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901454|NCT05940441|Antimetabolites|antimetabolites|mesh-ancestor
153442919|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
153442920|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153442921|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442922|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
153442923|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
154757556|NCT06023212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757557|NCT06023212|Hemostatics|hemostatics|mesh-ancestor
154757558|NCT06023212|Coagulants|coagulants|mesh-ancestor
154757559|NCT05993039|Remifentanil|remifentanil|mesh-list
154757560|NCT05993039|Propofol|propofol|mesh-list
154757561|NCT05993039|Sevoflurane|sevoflurane|mesh-list
154757562|NCT05993039|Isoflurane|isoflurane|mesh-list
154757563|NCT05993039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153901592|NCT05937282|Analgesics|analgesics|mesh-ancestor
154757564|NCT05993039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901644|NCT05932251|Metformin|metformin|mesh-list
154757565|NCT05993039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757566|NCT05993039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154757567|NCT05993039|Anesthetics, General|anesthetics, general|mesh-ancestor
154757568|NCT05993039|Anesthetics|anesthetics|mesh-ancestor
154757569|NCT05993039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154757570|NCT05993039|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154757571|NCT05993039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154757572|NCT05993039|Narcotics|narcotics|mesh-ancestor
154757573|NCT05993039|Analgesics|analgesics|mesh-ancestor
154757574|NCT05993039|Sensory System Agents|sensory system agents|mesh-ancestor
154757575|NCT05993039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757576|NCT05988372|Paclitaxel|paclitaxel|mesh-list
154757577|NCT05988372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154757578|NCT05988372|Gemcitabine|gemcitabine|mesh-list
154757579|NCT05988372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154757580|NCT05988372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757581|NCT05988372|Tubulin Modulators|tubulin modulators|mesh-ancestor
154757582|NCT05988372|Antimitotic Agents|antimitotic agents|mesh-ancestor
154757583|NCT05988372|Mitosis Modulators|mitosis modulators|mesh-ancestor
154757584|NCT05988372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757585|NCT05988372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154757586|NCT05988372|Antimetabolites|antimetabolites|mesh-ancestor
154757587|NCT05972564|Empagliflozin|empagliflozin|mesh-list
154757588|NCT05972564|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154757589|NCT05972564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757590|NCT05972564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154757591|NCT05972564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256942|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
154256943|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365470|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153443131|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443132|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153443133|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153443134|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153443135|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
153443136|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443137|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443138|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153443139|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
153443140|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
153443141|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153443142|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154757592|NCT05920343|Rivaroxaban|rivaroxaban|mesh-list
154757593|NCT05920343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154757594|NCT05920343|Antithrombins|antithrombins|mesh-ancestor
154757595|NCT05920343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154757596|NCT05920343|Protease Inhibitors|protease inhibitors|mesh-ancestor
154757597|NCT05920343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757598|NCT05920343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901737|NCT05881083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153901738|NCT05881083|Autonomic Agents|autonomic agents|mesh-ancestor
153901739|NCT05881083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901740|NCT05881083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901752|NCT05870683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153901753|NCT05870683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901754|NCT05870683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443166|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
153443167|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443170|NCT02057250|Methotrexate|methotrexate|mesh-list
153443171|NCT02057250|Leflunomide|leflunomide|mesh-list
153443172|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153443173|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
153443174|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153443175|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443176|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153443177|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
153733465|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733466|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
153733467|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443178|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443179|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443180|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
153443181|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443182|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153443183|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443184|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
153443185|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443186|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154757599|NCT05920343|Anticoagulants|anticoagulants|mesh-ancestor
154757600|NCT05861050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154757601|NCT05861050|Obinutuzumab|obinutuzumab|mesh-list
154757602|NCT05861050|Lenalidomide|lenalidomide|mesh-list
154757604|NCT05861050|Antibodies|antibodies|mesh-list
154757605|NCT05861050|Immunoglobulins|immunoglobulins|mesh-list
154757606|NCT05861050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154757607|NCT05861050|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154757608|NCT05861050|Immunologic Factors|immunologic factors|mesh-ancestor
154757609|NCT05861050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256944|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256945|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256946|NCT00368537|Ampicillin|ampicillin|mesh-list
153901755|NCT05860400|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153901756|NCT05860400|Immunologic Factors|immunologic factors|mesh-ancestor
153901757|NCT05860400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901758|NCT05847452|Benralizumab|benralizumab|mesh-list
153901759|NCT05847452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153901760|NCT05847452|Respiratory System Agents|respiratory system agents|mesh-ancestor
153901762|NCT05833776|Bupivacaine|bupivacaine|mesh-list
153901763|NCT05833776|Anesthetics, Local|anesthetics, local|mesh-ancestor
153901764|NCT05833776|Anesthetics|anesthetics|mesh-ancestor
153901765|NCT05833776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901766|NCT05833776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901767|NCT05833776|Sensory System Agents|sensory system agents|mesh-ancestor
153901768|NCT05833776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901769|NCT05833776|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153901771|NCT05833776|Analgesics|analgesics|mesh-ancestor
153901772|NCT05833776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153901782|NCT05760261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153901783|NCT05760261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153901784|NCT05760261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901785|NCT05760261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901786|NCT05760261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153901787|NCT05760261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153901788|NCT05760261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153901789|NCT05760261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153901790|NCT05760261|Anesthetics, General|anesthetics, general|mesh-ancestor
153901791|NCT05760261|Anesthetics|anesthetics|mesh-ancestor
154757610|NCT05861050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757611|NCT05861050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154757612|NCT05861050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154757613|NCT05861050|Growth Substances|growth substances|mesh-ancestor
154757614|NCT05861050|Growth Inhibitors|growth inhibitors|mesh-ancestor
154757615|NCT05849857|Dexamethasone|dexamethasone|mesh-list
154757616|NCT05849857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757617|NCT05849857|Antiemetics|antiemetics|mesh-ancestor
154757618|NCT05849857|Autonomic Agents|autonomic agents|mesh-ancestor
154757619|NCT05849857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757620|NCT05849857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757621|NCT05849857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757622|NCT05849857|Glucocorticoids|glucocorticoids|mesh-ancestor
154757623|NCT05849857|Hormones|hormones|mesh-ancestor
154757624|NCT05849857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757625|NCT05849857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154757626|NCT05849857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757627|NCT05581589|Camptothecin|camptothecin|mesh-list
154256947|NCT00368537|Tigecycline|tigecycline|mesh-list
154256948|NCT00368537|Sulbactam|sulbactam|mesh-list
154256949|NCT00368537|Sultamicillin|sultamicillin|mesh-list
153443237|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153443238|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443239|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153901807|NCT05725798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154757628|NCT05581589|Irinotecan|irinotecan|mesh-list
154757629|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
154757630|NCT05581589|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154757631|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
154757632|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757633|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154757634|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757635|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154757636|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153901833|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901834|NCT05513924|Fluorouracil|fluorouracil|mesh-list
153901835|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153901836|NCT05513924|Latanoprost|latanoprost|mesh-list
153901837|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
153901838|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901839|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153901840|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901841|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901842|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
153901852|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901853|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901854|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153901855|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153901856|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
153901857|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
153901858|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901859|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153443274|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
153443275|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
153443281|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153443282|NCT02034006|Growth Substances|growth substances|mesh-ancestor
153443283|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443284|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
153443285|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443286|NCT02052960|Cisplatin|cisplatin|mesh-list
153443287|NCT02052960|Fluorouracil|fluorouracil|mesh-list
153443288|NCT02052960|Cetuximab|cetuximab|mesh-list
153443289|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443290|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
153443291|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443292|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154757637|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757638|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757639|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154757640|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
154757641|NCT05571046|Hormones|hormones|mesh-ancestor
154757642|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757643|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757644|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757645|NCT05546411|Leucovorin|leucovorin|mesh-list
154757646|NCT05546411|Fluorouracil|fluorouracil|mesh-list
154757647|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
154757648|NCT05546411|Irinotecan|irinotecan|mesh-list
154757649|NCT05546411|Camptothecin|camptothecin|mesh-list
154757650|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
154757651|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757652|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
154757653|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757654|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153443344|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443345|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901905|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901918|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
153901919|NCT05255666|Irinotecan|irinotecan|mesh-list
153901920|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901921|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901922|NCT05255666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153901923|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901924|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153901925|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153901926|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901927|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
153901928|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154757655|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757656|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757657|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
154757658|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154757659|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154757660|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757661|NCT05546411|Antidotes|antidotes|mesh-ancestor
154757662|NCT05546411|Protective Agents|protective agents|mesh-ancestor
154757663|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
154757664|NCT05546411|Vitamins|vitamins|mesh-ancestor
154757665|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
154757666|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154757667|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
154757668|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
154757669|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154757670|NCT05478954|Amodiaquine|amodiaquine|mesh-list
154757671|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
154757672|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154757673|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153365736|NCT02486796|Ubiquinone|ubiquinone|mesh-list
153901984|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901985|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
153901986|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
153443408|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443409|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153443410|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153443411|NCT02029638|Analgesics|analgesics|mesh-ancestor
153443412|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
153443413|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443414|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
153443415|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153443416|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153443417|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
153443418|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153443419|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443420|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443421|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
153443422|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
153443423|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153443434|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443435|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153443436|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
153443437|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
153443438|NCT02047734|Interferons|interferons|mesh-list
153443439|NCT02047734|Interferon-beta|interferon-beta|mesh-list
153443440|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
153443441|NCT02047734|Ozanimod|ozanimod|mesh-list
153443442|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443443|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
153443444|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443445|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
153443446|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757674|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757675|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154757676|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757677|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757678|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154757679|NCT05456113|Cannabidiol|cannabidiol|mesh-list
154757680|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
154757681|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
154757682|NCT05323721|Piperaquine|piperaquine|mesh-list
154757683|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
154757684|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153902046|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
153902047|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902048|NCT04609319|Dacomitinib|dacomitinib|mesh-list
153902049|NCT04609319|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153902050|NCT04609319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153902051|NCT04609319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902052|NCT04609319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902053|NCT04591353|Lidocaine|lidocaine|mesh-list
153902054|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
153902055|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
153902056|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902057|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902058|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
153902059|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443494|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443495|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153443496|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443498|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153443499|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443500|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153443501|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153443502|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153443503|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153443504|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
153443505|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443506|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443507|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154757685|NCT05323721|Amodiaquine|amodiaquine|mesh-list
154757686|NCT05323721|Artenimol|artenimol|mesh-list
154757687|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
154757688|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154757689|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154757690|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757691|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154757692|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757693|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757694|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154757695|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
154757696|NCT05306873|Cyclosporine|cyclosporine|mesh-list
154757697|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154757698|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757699|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154757700|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
154757701|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154757702|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757703|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757704|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757705|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
153733515|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153733516|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153733517|NCT00148278|Protective Agents|protective agents|mesh-ancestor
153733518|NCT05594849|Budesonide|budesonide|mesh-list
153733519|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153733520|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153733521|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
153733522|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733523|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733524|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154757706|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
153902184|NCT03750968|Carotenoids|carotenoids|mesh-list
154757707|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757708|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
154757709|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757710|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154757711|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154757712|NCT05306587|Daratumumab|daratumumab|mesh-list
154757713|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757714|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
154757715|NCT05303987|Propofol|propofol|mesh-list
154757716|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154757717|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757718|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757719|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757720|NCT05303987|Analgesics|analgesics|mesh-ancestor
154757721|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
154757722|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757723|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154757724|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154757725|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154757726|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
153443679|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
153443680|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443681|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153733745|NCT00148551|Hormones|hormones|mesh-ancestor
154757727|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757728|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757729|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154757730|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
154757731|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
154757732|NCT05302596|Semaglutide|semaglutide|mesh-list
154757733|NCT05302596|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154757734|NCT05302596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154757735|NCT05302596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757736|NCT05263284|Venetoclax|venetoclax|mesh-list
154757737|NCT05263284|Adenosine|adenosine|mesh-list
154757738|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757739|NCT05263284|Analgesics|analgesics|mesh-ancestor
154757740|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
154757741|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757742|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757743|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757744|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
154757745|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154757746|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
154757747|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
154757748|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757749|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757750|NCT05255003|Enoxaparin|enoxaparin|mesh-list
154757751|NCT05255003|Dalteparin|dalteparin|mesh-list
154757752|NCT05255003|Tinzaparin|tinzaparin|mesh-list
153366219|NCT01661621|Doxazosin|doxazosin|mesh-list
153733937|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
153733938|NCT00467116|Gemcitabine|gemcitabine|mesh-list
153733939|NCT00467116|Cetuximab|cetuximab|mesh-list
153733940|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153733941|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
153733942|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733943|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733944|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153733945|NCT00157482|Simvastatin|simvastatin|mesh-list
153733947|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153733948|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153733949|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
153733950|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733951|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153733952|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154757753|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154757754|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
154757755|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154757756|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154757757|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734011|NCT00406887|Hormones|hormones|mesh-ancestor
154757758|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154757759|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154757760|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
154757761|NCT05217589|Hormones|hormones|mesh-ancestor
153366356|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
154757762|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757763|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757764|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757765|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757766|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
154757767|NCT05170828|Sirolimus|sirolimus|mesh-list
154757768|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
154757769|NCT05170828|Busulfan|busulfan|mesh-list
154757770|NCT05170828|Fludarabine|fludarabine|mesh-list
154757771|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757772|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
154757773|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757774|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153366401|NCT02238977|Bupropion|bupropion|mesh-list
154757775|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154757776|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
154757777|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757778|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757779|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154757780|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154757781|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154757782|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
153734410|NCT06245109|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153734412|NCT06245109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153734496|NCT06217562|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153734497|NCT06217562|Natriuretic Agents|natriuretic agents|mesh-ancestor
154757783|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154757784|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757785|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757786|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
154757787|NCT05130788|Nicotine|nicotine|mesh-list
154757788|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154757789|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
154757790|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757791|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757792|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154757793|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153782032|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
153782033|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757794|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
154757795|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757796|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757797|NCT05055128|Lansoprazole|lansoprazole|mesh-list
154757798|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
154757799|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154757800|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757801|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154757802|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734624|NCT06059846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153734625|NCT06059846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734626|NCT06059846|Protease Inhibitors|protease inhibitors|mesh-ancestor
153734627|NCT06059846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734628|NCT06059846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734629|NCT06052839|Paclitaxel|paclitaxel|mesh-list
153734630|NCT06052839|Carboplatin|carboplatin|mesh-list
153734717|NCT05915169|Sensory System Agents|sensory system agents|mesh-ancestor
154757803|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757804|NCT05004987|Dexetimide|dexetimide|mesh-list
154757805|NCT05004987|Citalopram|citalopram|mesh-list
154757806|NCT05004987|Escitalopram|escitalopram|mesh-list
154757807|NCT05004987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154757808|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154757809|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154757810|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757811|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757812|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
154757813|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757814|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154757815|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154757816|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
153734718|NCT05915169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734719|NCT05915169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734720|NCT05915169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734722|NCT05913284|Morphine|morphine|mesh-list
154757818|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757819|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154757820|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154757821|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
154757822|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154757823|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
154757824|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154757825|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
154757826|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154757827|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757828|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154757829|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757830|NCT04940286|Paclitaxel|paclitaxel|mesh-list
154757831|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154757832|NCT04940286|Gemcitabine|gemcitabine|mesh-list
154757833|NCT04940286|Durvalumab|durvalumab|mesh-list
153366531|NCT03033836|Dolutegravir|dolutegravir|mesh-list
153734782|NCT05869136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153734783|NCT05869136|Immunologic Factors|immunologic factors|mesh-ancestor
153734784|NCT05869136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734785|NCT05869136|Viscosupplements|viscosupplements|mesh-ancestor
153734786|NCT05869136|Protective Agents|protective agents|mesh-ancestor
153734787|NCT05867251|Carboplatin|carboplatin|mesh-list
153734788|NCT05867251|Letrozole|letrozole|mesh-list
153734789|NCT05867251|Fulvestrant|fulvestrant|mesh-list
153734790|NCT05867251|Palbociclib|palbociclib|mesh-list
153734791|NCT05867251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734792|NCT05867251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153734793|NCT05867251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153734794|NCT05867251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734795|NCT05867251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902529|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153443947|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153443948|NCT01934556|Growth Substances|growth substances|mesh-ancestor
153443949|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443950|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
153443951|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443952|NCT04411212|Lenograstim|lenograstim|mesh-list
153443953|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153443954|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
153443955|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443956|NCT01620138|Cabergoline|cabergoline|mesh-list
153443957|NCT01620138|Pasireotide|pasireotide|mesh-list
153443958|NCT01620138|Hormones|hormones|mesh-ancestor
154757834|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
154757835|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154757836|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
154757837|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154757838|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757839|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
154757840|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
154757841|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
154757842|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757843|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154757844|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
154757845|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154757846|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
153443959|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757847|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757848|NCT04887857|Azacitidine|azacitidine|mesh-list
154757849|NCT04887857|Venetoclax|venetoclax|mesh-list
154757850|NCT04887857|Cc-486|cc-486|mesh-list
154757851|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154757852|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
154757853|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757854|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757855|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757856|NCT04841096|Metformin|metformin|mesh-list
153734952|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
153734953|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153734959|NCT05568095|Leucovorin|leucovorin|mesh-list
153734960|NCT05568095|Capecitabine|capecitabine|mesh-list
153734961|NCT05568095|Fluorouracil|fluorouracil|mesh-list
154757857|NCT04841096|Glimepiride|glimepiride|mesh-list
154757858|NCT04841096|Vildagliptin|vildagliptin|mesh-list
154757859|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154757860|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757861|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757862|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757863|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
154757864|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153734962|NCT05568095|Nivolumab|nivolumab|mesh-list
153734963|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
153734964|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153734976|NCT05568095|Vitamins|vitamins|mesh-ancestor
153902538|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902539|NCT04261933|Semaglutide|semaglutide|mesh-list
153902540|NCT04261933|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153902541|NCT04261933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153902542|NCT04261933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902543|NCT00609817|Dexamethasone|dexamethasone|mesh-list
153902544|NCT00609817|Bortezomib|bortezomib|mesh-list
153902546|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
153735069|NCT05355441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735071|NCT05345171|Prednisolone|prednisolone|mesh-list
153735072|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735073|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
153735074|NCT05345171|Hormones|hormones|mesh-ancestor
153735075|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735076|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735077|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735078|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757865|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
154757866|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757867|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757868|NCT04824612|Triamcinolone|triamcinolone|mesh-list
154757869|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154757870|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154757871|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154757872|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757873|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
154757874|NCT04824612|Hormones|hormones|mesh-ancestor
154757875|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757876|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757877|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757878|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
153902559|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153902560|NCT00929695|Prednisolone|prednisolone|mesh-list
153902561|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
153902562|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153902563|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
153902564|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902565|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
153902566|NCT00929695|Hormones|hormones|mesh-ancestor
153902567|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902568|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902569|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153902570|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902571|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
153902572|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
153444004|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153444005|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444006|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444007|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444008|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153444009|NCT01930188|Semaglutide|semaglutide|mesh-list
153444010|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153444011|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444012|NCT01930188|Incretins|incretins|mesh-ancestor
153444013|NCT01930188|Hormones|hormones|mesh-ancestor
153444014|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902596|NCT00923845|Pentostatin|pentostatin|mesh-list
153902597|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153444015|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153444016|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
153444017|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735273|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153735274|NCT05092373|Atezolizumab|atezolizumab|mesh-list
153735275|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154757879|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757880|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757881|NCT04803201|Prednisone|prednisone|mesh-list
154757882|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
154757883|NCT04803201|Doxorubicin|doxorubicin|mesh-list
154757884|NCT04803201|Etoposide|etoposide|mesh-list
154757885|NCT04803201|Vincristine|vincristine|mesh-list
154757886|NCT04803201|Azacitidine|azacitidine|mesh-list
154757887|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154757888|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
154757889|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757890|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154757891|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153444075|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
153444076|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153444077|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444078|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153444079|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
153902632|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
153902634|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154757892|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
154757893|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757894|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444096|NCT03888755|Icatibant|icatibant|mesh-list
153735425|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153735427|NCT04842071|Listerine|listerine|mesh-list
153735428|NCT04842071|Fluorides|fluorides|mesh-list
153735429|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
153735430|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
153735431|NCT04842071|Protective Agents|protective agents|mesh-ancestor
153735432|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735433|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153735446|NCT04835129|Hormones|hormones|mesh-ancestor
154757895|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154757896|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154757897|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154757898|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154757899|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757900|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757901|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
154757902|NCT04803201|Hormones|hormones|mesh-ancestor
154757903|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757904|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154757905|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154757906|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
154757907|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
154757908|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
154757909|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154757910|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
154757911|NCT04782258|Tolvaptan|tolvaptan|mesh-list
154757912|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153902723|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153902724|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902725|NCT01217814|Leucovorin|leucovorin|mesh-list
153902726|NCT01217814|Folic Acid|folic acid|mesh-list
153444151|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
153444152|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
153444153|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444154|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153444155|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
153444156|NCT02994251|Gemcitabine|gemcitabine|mesh-list
153444157|NCT02994251|Doxorubicin|doxorubicin|mesh-list
153444158|NCT02994251|Mitomycins|mitomycins|mesh-list
153444159|NCT02994251|Mitomycin|mitomycin|mesh-list
153444160|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444161|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153444162|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
153444166|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153366963|NCT02455518|Analgesics|analgesics|mesh-ancestor
153902744|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153902745|NCT01217814|Antidotes|antidotes|mesh-ancestor
153444173|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
153444174|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444175|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153444176|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153444177|NCT02826551|Bupivacaine|bupivacaine|mesh-list
153444178|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
153444179|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
153902748|NCT01217814|Vitamins|vitamins|mesh-ancestor
153902749|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
153902750|NCT01217814|Hematinics|hematinics|mesh-ancestor
154757913|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757914|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
154757915|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757916|NCT04779307|Vedolizumab|vedolizumab|mesh-list
154757917|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757918|NCT04767191|Lumefantrine|lumefantrine|mesh-list
154757919|NCT04767191|Artemether|artemether|mesh-list
154757920|NCT04767191|Piperaquine|piperaquine|mesh-list
154757921|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154757922|NCT04767191|Artenimol|artenimol|mesh-list
154757923|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
154757924|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154757925|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154757926|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154757927|NCT04711109|Denosumab|denosumab|mesh-list
153902754|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
153902755|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
153902756|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444204|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153444205|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444206|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
153444207|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444208|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
153444209|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444210|NCT01340885|Rivastigmine|rivastigmine|mesh-list
153444211|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153444212|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153444213|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153444214|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444215|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444216|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
153444217|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444218|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444219|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153444220|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444221|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
153444222|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153444223|NCT01340885|Protective Agents|protective agents|mesh-ancestor
153444224|NCT01326923|Cetuximab|cetuximab|mesh-list
153902774|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757928|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153902784|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
154757929|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757930|NCT04668300|Durvalumab|durvalumab|mesh-list
154757931|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
154757932|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154757933|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
154757934|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154757935|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757936|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
154757937|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757938|NCT04666038|Rituximab|rituximab|mesh-list
154757939|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154757940|NCT04666038|Idelalisib|idelalisib|mesh-list
154757941|NCT04666038|Pirtobrutinib|pirtobrutinib|mesh-list
153367053|NCT00975650|Hormones|hormones|mesh-ancestor
153735510|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757942|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154757943|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757944|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
154757945|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757946|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154757947|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154757948|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
154757949|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757950|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256957|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
153444284|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444285|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
153444286|NCT01222871|Hormones|hormones|mesh-ancestor
153444287|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444288|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444289|NCT01219673|Minocycline|minocycline|mesh-list
153444290|NCT01219673|Modafinil|modafinil|mesh-list
153444291|NCT01219673|Bupropion|bupropion|mesh-list
154757951|NCT04666038|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154757952|NCT04666038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154757953|NCT04662125|Acetaminophen|acetaminophen|mesh-list
154757954|NCT04662125|Prednisolone|prednisolone|mesh-list
154757955|NCT04662125|Pregabalin|pregabalin|mesh-list
154757956|NCT04662125|Caffeine|caffeine|mesh-list
154757957|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757958|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
154757959|NCT04662125|Hormones|hormones|mesh-ancestor
154757960|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154757961|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154757962|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154757963|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444319|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444320|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
153444321|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
153444322|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444323|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444324|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154757964|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757965|NCT04662125|Analgesics|analgesics|mesh-ancestor
154757966|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
154757967|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
153735590|NCT04543227|Narcotics|narcotics|mesh-ancestor
154757968|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154757969|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444430|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903034|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
153903035|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153903036|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
153903037|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153903038|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903039|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153903040|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153903041|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757970|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757971|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154757972|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154757973|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154757974|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154757975|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154757976|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757977|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
154757978|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154757979|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154757980|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903064|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
153903065|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903066|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903067|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903068|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903073|NCT04252885|Ritonavir|ritonavir|mesh-list
154757981|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154757982|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154757983|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
154757984|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154757985|NCT04654689|Curcumin|curcumin|mesh-list
154757986|NCT04654689|Resveratrol|resveratrol|mesh-list
154757987|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154757988|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154757989|NCT04654689|Analgesics|analgesics|mesh-ancestor
154757990|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
154757991|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154757992|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903091|NCT04962841|Sertraline|sertraline|mesh-list
153903092|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153903093|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903094|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153903095|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153903096|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903097|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903098|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153444571|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153444572|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153444573|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
153444574|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153444589|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757993|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154757994|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154757995|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154757996|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154757997|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154757998|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
154757999|NCT04654689|Protective Agents|protective agents|mesh-ancestor
154758000|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154758001|NCT04579848|Folic Acid|folic acid|mesh-list
154758002|NCT04579848|Methotrexate|methotrexate|mesh-list
154758003|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154758004|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
154758005|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154758006|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758007|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154758008|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
153735659|NCT04423367|Dexamethasone|dexamethasone|mesh-list
153735660|NCT04423367|Bortezomib|bortezomib|mesh-list
153735661|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735662|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
153735663|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
153735664|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735666|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153735668|NCT04423367|Hormones|hormones|mesh-ancestor
153735669|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735670|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735671|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735672|NCT04391049|Paclitaxel|paclitaxel|mesh-list
153735673|NCT04391049|Carboplatin|carboplatin|mesh-list
153735674|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153735675|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154758009|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758010|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758011|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
154758012|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758013|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154758014|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758015|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
153903270|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903271|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758016|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154758017|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154758018|NCT04579848|Hematinics|hematinics|mesh-ancestor
154758019|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
154758020|NCT04579848|Vitamins|vitamins|mesh-ancestor
154758021|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
154758022|NCT04445662|Varenicline|varenicline|mesh-list
154758023|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154758024|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154758025|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
154256960|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444763|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444764|NCT00791843|Hormones|hormones|mesh-list
153444765|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
153836001|NCT01580514|Exenatide|exenatide|mesh-list
154758026|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758027|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758028|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758029|NCT04435834|Propofol|propofol|mesh-list
154758030|NCT04435834|Sevoflurane|sevoflurane|mesh-list
154758031|NCT04435834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154758032|NCT04435834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758033|NCT04435834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758034|NCT04435834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154758035|NCT04435834|Anesthetics, General|anesthetics, general|mesh-ancestor
154758036|NCT04435834|Anesthetics|anesthetics|mesh-ancestor
154256961|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256962|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444801|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153444802|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153444803|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
153903332|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
153903333|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903335|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153903336|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
153903337|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153903338|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903340|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154758037|NCT04435834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154758038|NCT04435834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154758039|NCT04354012|Gentian Violet|gentian violet|mesh-list
154758040|NCT04354012|Methylene Blue|methylene blue|mesh-list
154758041|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758042|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509952|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
153903358|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903359|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
153903360|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903361|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153903362|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758043|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154758044|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758046|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154758047|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758048|NCT04352400|Analgesics|analgesics|mesh-ancestor
154758049|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
154758050|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758051|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758052|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758053|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154758054|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
153735739|NCT04301765|Androgens|androgens|mesh-ancestor
153735740|NCT04301765|Hormones|hormones|mesh-ancestor
153735741|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735742|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735743|NCT04289467|Fenfluramine|fenfluramine|mesh-list
153735744|NCT04289467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153735745|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153735746|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153735747|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758055|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
154758056|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758057|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758058|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154758059|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154758060|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154758061|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758062|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
154758063|NCT04351698|Montelukast|montelukast|mesh-list
154758064|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154758065|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
154758066|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154758067|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
154758068|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758069|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758070|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153903383|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
153903384|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153903385|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153903386|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153903387|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903388|NCT04203043|Pycnogenols|pycnogenols|mesh-list
153903389|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153903390|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
153903391|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758071|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154758072|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758073|NCT04300556|Dexamethasone|dexamethasone|mesh-list
154758074|NCT04300556|Prednisone|prednisone|mesh-list
154758075|NCT04300556|Prednisolone|prednisolone|mesh-list
154758076|NCT04300556|Farletuzumab|farletuzumab|mesh-list
154758077|NCT04300556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758078|NCT04300556|Antiemetics|antiemetics|mesh-ancestor
154758079|NCT04300556|Autonomic Agents|autonomic agents|mesh-ancestor
154758080|NCT04300556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758081|NCT04300556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758082|NCT04300556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758083|NCT04300556|Glucocorticoids|glucocorticoids|mesh-ancestor
154758084|NCT04300556|Hormones|hormones|mesh-ancestor
154758085|NCT04300556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758086|NCT04300556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154758087|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758088|NCT04291105|Cemiplimab|cemiplimab|mesh-list
154758089|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153367751|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903409|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903410|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903411|NCT04404049|UB-421|ub-421|mesh-list
153903412|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153903413|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
153903414|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903415|NCT04911517|Capecitabine|capecitabine|mesh-list
153903416|NCT04911517|Antibodies|antibodies|mesh-list
153903417|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153903420|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153903421|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
153903422|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903423|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903424|NCT00637897|Paclitaxel|paclitaxel|mesh-list
153903432|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903433|NCT03992443|Reteplase|reteplase|mesh-list
153903434|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153903435|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153903436|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903437|NCT04816513|Ustekinumab|ustekinumab|mesh-list
153903438|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
153903440|NCT04203511|Etoposide|etoposide|mesh-list
153903441|NCT04203511|Carboplatin|carboplatin|mesh-list
153367826|NCT02441946|Loperamide|loperamide|mesh-list
153903455|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153903456|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153903457|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903458|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
153903459|NCT03690037|Coagulants|coagulants|mesh-ancestor
153903460|NCT00910273|Etanercept|etanercept|mesh-list
153903461|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153903462|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758090|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758091|NCT04233346|Ponatinib|ponatinib|mesh-list
154758092|NCT04233346|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154758093|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758094|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758095|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758096|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758097|NCT04207931|Fluocinonide|fluocinonide|mesh-list
154758098|NCT04207931|Triamcinolone|triamcinolone|mesh-list
154758099|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154758100|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154758101|NCT04207931|Betamethasone|betamethasone|mesh-list
154758102|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
154758103|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154758104|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
154758105|NCT04207931|Clobetasol|clobetasol|mesh-list
154758106|NCT04207931|Minoxidil|minoxidil|mesh-list
153836261|NCT00513188|Hormones|hormones|mesh-ancestor
153735788|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
153735789|NCT04172246|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153735790|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153735791|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736456|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903501|NCT01286753|Vemurafenib|vemurafenib|mesh-list
153903502|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903503|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153903504|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903505|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903506|NCT01284959|Risperidone|risperidone|mesh-list
153903507|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153903508|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153903509|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
153903510|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903511|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903512|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903513|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153903514|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153903515|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153903516|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153903517|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153444966|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444967|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153444968|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153444969|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153444970|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153444980|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153444981|NCT01629329|Aspirin|aspirin|mesh-list
153444982|NCT01629329|Acetaminophen|acetaminophen|mesh-list
153444983|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
153444984|NCT01629329|Caffeine|caffeine|mesh-list
153444985|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153444986|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153444987|NCT01629329|Analgesics|analgesics|mesh-ancestor
153444988|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
153444989|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758107|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154758108|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154758109|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758110|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
154758111|NCT04207931|Hormones|hormones|mesh-ancestor
154758112|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758113|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445013|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153445014|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
153445015|NCT01606709|Leuprolide|leuprolide|mesh-list
153445016|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153445017|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
153445018|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153445019|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445020|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153445021|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445022|NCT00423059|Bevacizumab|bevacizumab|mesh-list
153445023|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153445024|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445025|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154758114|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758115|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
154758116|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445122|NCT00500045|Niacin|niacin|mesh-list
154510026|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
154758117|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758118|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154758119|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
154758120|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154758121|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
154758122|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154758124|NCT04207723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154758125|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154758126|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153782228|NCT04673812|Naloxone|naloxone|mesh-list
153735796|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153903654|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903655|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153903656|NCT01268891|Protective Agents|protective agents|mesh-ancestor
153903657|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903658|NCT04323527|Chloroquine|chloroquine|mesh-list
153903659|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153903660|NCT04323527|Amebicides|amebicides|mesh-ancestor
153903661|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153903662|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153903663|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903664|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
153903665|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903666|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153903667|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153903668|NCT04323527|Analgesics|analgesics|mesh-ancestor
153903669|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
153903670|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914664|NCT05342857|Aflibercept|aflibercept|mesh-list
153445123|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
153445124|NCT00500045|Niacinamide|niacinamide|mesh-list
153445125|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153445126|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
153445127|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445128|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153445129|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
153445142|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
153445143|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
153445144|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445145|NCT00000773|Atovaquone|atovaquone|mesh-list
153414718|NCT02207400|Fluorides|fluorides|mesh-list
153445146|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445147|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
153903671|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903673|NCT04323527|Filaricides|filaricides|mesh-ancestor
153445166|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
153445167|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445168|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153735797|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
153445169|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445170|NCT00379847|Conivaptan|conivaptan|mesh-list
153445171|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153445172|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445173|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
153903694|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153903695|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758127|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758128|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758129|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
154758130|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758131|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154758132|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
154758133|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154758134|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154758135|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153368032|NCT01094522|Analgesics|analgesics|mesh-ancestor
153735798|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735799|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735800|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445195|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
153445196|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445197|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445198|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153903719|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
153903720|NCT01265615|Vitamin D|vitamin d|mesh-list
153903721|NCT01265615|Calcitriol|calcitriol|mesh-list
153903722|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153903723|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903724|NCT01265615|Vitamins|vitamins|mesh-ancestor
153903725|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
153903726|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153903727|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153903728|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903729|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903730|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153903731|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154758136|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758137|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
154758138|NCT04207177|Tacrolimus|tacrolimus|mesh-list
154758139|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758140|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
154758141|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758142|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154758143|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758144|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758145|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154758146|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758147|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154758148|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
154758149|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154758150|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758151|NCT04173494|Danazol|danazol|mesh-list
154758152|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154758153|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154758154|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
153445211|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445212|NCT01351415|Bevacizumab|bevacizumab|mesh-list
153445213|NCT01351415|Docetaxel|docetaxel|mesh-list
153445214|NCT01351415|Pemetrexed|pemetrexed|mesh-list
153445215|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153445216|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153903743|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153903744|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903745|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903746|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903747|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153903748|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
153903749|NCT01263509|Vitamins|vitamins|mesh-ancestor
153903750|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
153903751|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
153903752|NCT01263197|Propranolol|propranolol|mesh-list
153903753|NCT01263197|Albuterol|albuterol|mesh-list
153903754|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153903755|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153445229|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445230|NCT01351415|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153445231|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153445234|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
153445235|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
153445236|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
153445237|NCT00281879|Melphalan|melphalan|mesh-list
153445238|NCT00281879|Busulfan|busulfan|mesh-list
153445239|NCT00281879|Carmustine|carmustine|mesh-list
153445240|NCT00281879|Methotrexate|methotrexate|mesh-list
153445241|NCT00281879|Fludarabine|fludarabine|mesh-list
153445242|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
153903838|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153903839|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153903840|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153903841|NCT04005287|Pirenzepine|pirenzepine|mesh-list
153903842|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153903843|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153903844|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153903845|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153903846|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
153903847|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903848|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903879|NCT00694733|Estrogens|estrogens|mesh-list
153903880|NCT00694733|Testosterone|testosterone|mesh-list
153903881|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
153903882|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
153903883|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153903884|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153903885|NCT00694733|Hormones|hormones|mesh-ancestor
153903886|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153903887|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903888|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153903898|NCT00694733|Androgens|androgens|mesh-ancestor
153903900|NCT01259297|Amlodipine|amlodipine|mesh-list
153903901|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153903902|NCT01259297|Aliskiren|aliskiren|mesh-list
153903903|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153903904|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153903905|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903906|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903907|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153903908|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903909|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
154758155|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758156|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758157|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758158|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758159|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758160|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
154758161|NCT04150640|Nivolumab|nivolumab|mesh-list
154758162|NCT04150640|Trastuzumab|trastuzumab|mesh-list
154758163|NCT04150640|Fluorouracil|fluorouracil|mesh-list
154758164|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
154758165|NCT04150640|Irinotecan|irinotecan|mesh-list
153903910|NCT01259297|Diuretics|diuretics|mesh-ancestor
153903911|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
153903912|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153903913|NCT01259297|Renin Inhibitors|renin inhibitors|mesh-ancestor
153903914|NCT01259297|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903915|NCT01259297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903916|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
153903917|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153445380|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153445381|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
153445382|NCT04941833|Desogestrel|desogestrel|mesh-list
153445383|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153445384|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153445391|NCT04941833|Progestins|progestins|mesh-ancestor
154758166|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758167|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758168|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154758169|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758170|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
154758171|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154758172|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758173|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
154758174|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758175|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154758176|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154758177|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368240|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
153445456|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
153445461|NCT00000161|Aspirin|aspirin|mesh-list
154758178|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154758179|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
154758180|NCT04038502|Carboplatin|carboplatin|mesh-list
154758181|NCT04038502|Olaparib|olaparib|mesh-list
154758182|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758183|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154758184|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758185|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758186|NCT03951142|Losartan|losartan|mesh-list
153368290|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
153904023|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904024|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
153904025|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904026|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
153904027|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904028|NCT01256567|Docetaxel|docetaxel|mesh-list
153904029|NCT01256567|Ramucirumab|ramucirumab|mesh-list
153904030|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904031|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
153904032|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
153904033|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
153904034|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904035|NCT01256567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153904036|NCT01256567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153904037|NCT01256567|Growth Substances|growth substances|mesh-ancestor
153904038|NCT01256567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368315|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
153904044|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153904045|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153904046|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904047|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904048|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153904049|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
153904050|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904051|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904052|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153904053|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153904058|NCT00996658|Incretins|incretins|mesh-ancestor
154758187|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154758188|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154758189|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154758190|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154758191|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758193|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154758194|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154758195|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
154758196|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758197|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758198|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758199|NCT03874429|Hyaluronic Acid|hyaluronic acid|mesh-list
154758200|NCT03874429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154758201|NCT03874429|Immunologic Factors|immunologic factors|mesh-ancestor
154758202|NCT03874429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758203|NCT03874429|Viscosupplements|viscosupplements|mesh-ancestor
154758204|NCT03874429|Protective Agents|protective agents|mesh-ancestor
154758205|NCT03871153|Paclitaxel|paclitaxel|mesh-list
154758206|NCT03871153|Carboplatin|carboplatin|mesh-list
154758207|NCT03871153|Durvalumab|durvalumab|mesh-list
154758208|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154758209|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758210|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
154758211|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
154256963|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256964|NCT01281800|Gemcitabine|gemcitabine|mesh-list
153904100|NCT01124175|Losartan|losartan|mesh-list
153904101|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153904102|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153904103|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153904104|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153904105|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904106|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153904107|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
153904108|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904109|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153904110|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153904111|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904112|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904113|NCT02882451|Pinaverium|pinaverium|mesh-list
153445595|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445596|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445597|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445598|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153445599|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
153445600|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
153445601|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445602|NCT00000263|Analgesics|analgesics|mesh-ancestor
153445603|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
153445604|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445605|NCT00000269|Pergolide|pergolide|mesh-list
153445607|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
153904114|NCT02882451|Bromides|bromides|mesh-list
153904115|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904116|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904117|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
153904118|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153904119|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904120|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153904121|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
153904122|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
153904123|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904124|NCT00999544|Oxycodone|oxycodone|mesh-list
153904125|NCT00999544|Aprepitant|aprepitant|mesh-list
153445644|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445645|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
153445646|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904137|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153904138|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904139|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904140|NCT02869984|Ramosetron|ramosetron|mesh-list
153904141|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
153904142|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
153904143|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904144|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904145|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153904146|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153904147|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
154758212|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
154758213|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758214|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758215|NCT03845517|PF-06700841|pf-06700841|mesh-list
154758216|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758217|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758218|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758219|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
154758220|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
154758221|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256965|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154256966|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
153904165|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
153904166|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904167|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153904168|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153904169|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904170|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904171|NCT01255787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153904181|NCT04540835|Calcium|calcium|mesh-list
154758222|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758223|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758224|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
154758225|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
154758226|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
154758227|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
154758228|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758229|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758230|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758231|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
154758232|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
154758233|NCT03734211|Evolocumab|evolocumab|mesh-list
154758234|NCT03734211|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154758235|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154758236|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154758237|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
154758238|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758239|NCT03734211|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154758240|NCT03734211|Protease Inhibitors|protease inhibitors|mesh-ancestor
153904220|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153904221|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153904222|NCT01254305|Analgesics|analgesics|mesh-ancestor
153904223|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
153904224|NCT01122927|Aripiprazole|aripiprazole|mesh-list
153904225|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
154758241|NCT03734211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758242|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154758243|NCT03673826|Dexamethasone|dexamethasone|mesh-list
154758244|NCT03673826|Lenalidomide|lenalidomide|mesh-list
154758245|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758246|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
154758247|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
154758248|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758249|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758250|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758251|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
154758252|NCT03673826|Hormones|hormones|mesh-ancestor
154758253|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758254|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154758255|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758256|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
154758257|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154758258|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153731837|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
153445803|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
153904286|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
153904287|NCT02868814|Pregabalin|pregabalin|mesh-list
153904288|NCT02868814|Analgesics|analgesics|mesh-ancestor
153904289|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
153904290|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758259|NCT03673826|Growth Substances|growth substances|mesh-ancestor
154758260|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
154758261|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154758262|NCT03476330|Quercetin|quercetin|mesh-list
154758263|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
154758264|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758265|NCT03476330|Protective Agents|protective agents|mesh-ancestor
154758266|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758267|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
154758268|NCT03458455|Nivolumab|nivolumab|mesh-list
154758269|NCT03458455|Ipilimumab|ipilimumab|mesh-list
154758270|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758271|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758272|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154758273|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758274|NCT03414034|Prednisone|prednisone|mesh-list
154758275|NCT03414034|Onvansertib|onvansertib|mesh-list
154758276|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758277|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
154758278|NCT03414034|Hormones|hormones|mesh-ancestor
154256967|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256968|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445812|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445813|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
153445814|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445815|NCT00000311|Buprenorphine|buprenorphine|mesh-list
153445816|NCT00000311|Methadone|methadone|mesh-list
153445817|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445818|NCT00000311|Narcotics|narcotics|mesh-ancestor
153445821|NCT00000311|Analgesics|analgesics|mesh-ancestor
153445832|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445833|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153445834|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153445835|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445836|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445837|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153445838|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
153445840|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
153445841|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445842|NCT00001757|Voriconazole|voriconazole|mesh-list
153904343|NCT00993616|Belinostat|belinostat|mesh-list
154758279|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758280|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758281|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154758282|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758283|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758284|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758285|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758286|NCT03340129|Nivolumab|nivolumab|mesh-list
154758287|NCT03340129|Ipilimumab|ipilimumab|mesh-list
154758288|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758289|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445857|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153445858|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
153445859|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445860|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445861|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445862|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445863|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
153445864|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445865|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153445866|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153904351|NCT01120275|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153904353|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758290|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154758291|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758292|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154758293|NCT03333408|Clindamycin|clindamycin|mesh-list
154758294|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
154758295|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
154758296|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153445878|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445879|NCT00000335|Analgesics|analgesics|mesh-ancestor
153445880|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
153445881|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445882|NCT00000341|Buprenorphine|buprenorphine|mesh-list
153445883|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445884|NCT00000341|Narcotics|narcotics|mesh-ancestor
153445885|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735829|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735830|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735831|NCT04114136|Metformin|metformin|mesh-list
153904375|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153904376|NCT01252667|Cyclosporine|cyclosporine|mesh-list
153904377|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
153904378|NCT01252667|Clofarabine|clofarabine|mesh-list
153904379|NCT01252667|Cyclosporins|cyclosporins|mesh-list
153904380|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904381|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904382|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153904383|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
153904384|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904385|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
153904386|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904387|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
153904389|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153904390|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153904391|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904392|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153445886|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445887|NCT00000341|Analgesics|analgesics|mesh-ancestor
153445888|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
153445889|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445890|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154758297|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758298|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154758299|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758300|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758301|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154758302|NCT03282396|Ibrutinib|ibrutinib|mesh-list
154758303|NCT03282396|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154758304|NCT03282396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758305|NCT03282396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758306|NCT03282396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758307|NCT03240861|Aldesleukin|aldesleukin|mesh-list
154256969|NCT03982121|Nivolumab|nivolumab|mesh-list
154256970|NCT03982121|Ipilimumab|ipilimumab|mesh-list
154256971|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154256972|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256973|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154256974|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256975|NCT01167530|Everolimus|everolimus|mesh-list
154256976|NCT01167530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154256977|NCT01167530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256978|NCT01167530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368699|NCT02384850|Antidotes|antidotes|mesh-ancestor
153445891|NCT00000347|Risperidone|risperidone|mesh-list
153445892|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153445893|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
153445894|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445895|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445896|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445897|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153445898|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153445899|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445900|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445901|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153445902|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
153445903|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
153445904|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445906|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153445907|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
153904393|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
154758308|NCT03240861|Plerixafor|plerixafor|mesh-list
154758309|NCT03240861|Fludarabine|fludarabine|mesh-list
154758310|NCT03240861|Busulfan|busulfan|mesh-list
154758311|NCT03240861|Interleukin-2|interleukin-2|mesh-list
154758312|NCT03240861|Lenograstim|lenograstim|mesh-list
154758313|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758314|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758315|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758316|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
154758317|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758318|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153904402|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153904403|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904404|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904405|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
153904406|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904407|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153904408|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153904409|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153445916|NCT00000353|Naloxone|naloxone|mesh-list
154758319|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
154758320|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154758321|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154758322|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758323|NCT03240861|Analgesics|analgesics|mesh-ancestor
154758324|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
154758325|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758326|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154758327|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154758328|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
154758329|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758330|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
154758331|NCT03164993|Doxorubicin|doxorubicin|mesh-list
153904431|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904432|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
153904433|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904434|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153904435|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153904436|NCT01252355|Analgesics|analgesics|mesh-ancestor
153904437|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
153904438|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904439|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904440|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904442|NCT01118325|Clopidogrel|clopidogrel|mesh-list
153445934|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445935|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445937|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153445938|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
153445939|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445940|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
153445941|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153445942|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153445943|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445944|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445945|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904453|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153904454|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153904455|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904456|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904457|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904458|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904459|NCT01117857|Analgesics|analgesics|mesh-ancestor
153904460|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
153445952|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153445953|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
153445954|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153445955|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153445956|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445957|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153445959|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153445960|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445961|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445962|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153445963|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153904476|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153904477|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153904478|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153904479|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904480|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904481|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
153445972|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153445974|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445975|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153445976|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153445977|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445995|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
153445996|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758332|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154758333|NCT03164993|Atezolizumab|atezolizumab|mesh-list
154758334|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758335|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
154758336|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758337|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510246|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758338|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154758339|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
154758340|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758341|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758342|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154758343|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154758344|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154758345|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154758346|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758347|NCT03164993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154758348|NCT03164993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758349|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
154758350|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153446035|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368930|NCT02383758|Bisacodyl|bisacodyl|mesh-list
153446058|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153446059|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446060|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446061|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446062|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153446063|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
153446064|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153446065|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446066|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153446067|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153446068|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153446069|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153446070|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446072|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415633|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
153904568|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
153904569|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904570|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153904571|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153904572|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
153904573|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904574|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153904575|NCT02867800|Analgesics|analgesics|mesh-ancestor
153904576|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
153904577|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904578|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
153904579|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153904580|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153904581|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
153904583|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904584|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
153904585|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
153446073|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446074|NCT00001955|Celecoxib|celecoxib|mesh-list
153368978|NCT01181258|Hormones|hormones|mesh-ancestor
153446077|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758351|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154758352|NCT03110822|Prednisolone|prednisolone|mesh-list
154758353|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
154758354|NCT03110822|Lenalidomide|lenalidomide|mesh-list
153446225|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446226|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446227|NCT00000659|Zidovudine|zidovudine|mesh-list
153446228|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
153446229|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446230|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446231|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446232|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446233|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
153446234|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446235|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446259|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446260|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446261|NCT00002027|Diclazuril|diclazuril|mesh-list
153446262|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
153446263|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153446264|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153446265|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446266|NCT00000695|Interferons|interferons|mesh-list
153446267|NCT00000695|Zidovudine|zidovudine|mesh-list
153446268|NCT00000695|Interferon-beta|interferon-beta|mesh-list
153446270|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446271|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
153904764|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904765|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153904766|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904767|NCT04654052|Clopidogrel|clopidogrel|mesh-list
153904768|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153904776|NCT05625308|Folic Acid|folic acid|mesh-list
153446282|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153446283|NCT00000701|Zidovudine|zidovudine|mesh-list
153415790|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904780|NCT05625308|Vitamins|vitamins|mesh-ancestor
153904781|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
153904782|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904783|NCT05625308|Hematinics|hematinics|mesh-ancestor
153904784|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
153904785|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153904786|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
153904787|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
153904788|NCT05625308|Protective Agents|protective agents|mesh-ancestor
153904789|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
153904790|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904791|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153904792|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153904793|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446284|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
153446285|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446298|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
153446300|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446301|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
153446302|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446303|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
153446304|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446305|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
153446306|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446329|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415846|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
153904822|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
153904823|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
153904824|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153904825|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153904826|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153904827|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153904828|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153904829|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153904830|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153904831|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153446337|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
153446338|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
153446339|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446340|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446341|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446342|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758355|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154758356|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
154758357|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
154758358|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758359|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154758360|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154758361|NCT03110822|Growth Substances|growth substances|mesh-ancestor
154758362|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
154758363|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256980|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153415867|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
153904836|NCT01116687|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153904837|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904838|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904839|NCT02867020|Prednisone|prednisone|mesh-list
153904840|NCT02867020|Goserelin|goserelin|mesh-list
153904841|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904842|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
153904843|NCT02867020|Hormones|hormones|mesh-ancestor
153904844|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904845|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904846|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153904847|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904848|NCT03817502|Cariprazine|cariprazine|mesh-list
153904849|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153904850|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153904851|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904852|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904853|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904854|NCT04319978|Dexamethasone|dexamethasone|mesh-list
153446351|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446352|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446353|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
153446354|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446355|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446356|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446357|NCT00002051|Thymopentin|thymopentin|mesh-list
153446358|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154256981|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
153904855|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
153904856|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904857|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
153904858|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
153904859|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904860|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904862|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
154758364|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758365|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
154758366|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
154758367|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758368|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758369|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
154758370|NCT03110822|Hormones|hormones|mesh-ancestor
154256982|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446395|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446396|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446397|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
153446398|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904870|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904871|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904872|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153904873|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904874|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
153904875|NCT00624182|Gemcitabine|gemcitabine|mesh-list
153904876|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153904877|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
153904878|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904879|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904880|NCT00625677|Vaccines|vaccines|mesh-list
153904881|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
153904882|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904883|NCT00979576|Pemetrexed|pemetrexed|mesh-list
153904884|NCT00979576|Nintedanib|nintedanib|mesh-list
153904885|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904886|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904887|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904888|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153904890|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153904891|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
153904899|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904900|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904901|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153904902|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153904903|NCT02867332|Analgesics|analgesics|mesh-ancestor
153904904|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
153904905|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446407|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
153446408|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
153446409|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369306|NCT01189292|Hormones|hormones|mesh-ancestor
153735837|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735838|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904906|NCT02702180|Molgramostim|molgramostim|mesh-list
153904907|NCT02702180|Sargramostim|sargramostim|mesh-list
153904908|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904909|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
153904911|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
153904913|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153904914|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904915|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
153904916|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904917|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153904918|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904919|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446421|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153446422|NCT00002075|Flucytosine|flucytosine|mesh-list
153446423|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
154758371|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758372|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154758373|NCT03110822|Protective Agents|protective agents|mesh-ancestor
154758374|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154758375|NCT03077542|Sirolimus|sirolimus|mesh-list
154758376|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
154758377|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
154758378|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
154758379|NCT03077542|Pentostatin|pentostatin|mesh-list
154758380|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758381|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
154758382|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369334|NCT03010202|Hormones|hormones|mesh-ancestor
153904920|NCT04116502|Interferons|interferons|mesh-list
153904921|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
153904922|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
153904923|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
153904924|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904925|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
153904926|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904927|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
153904928|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904929|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
153904930|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904931|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904932|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153904934|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
153904935|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
153904940|NCT02866786|Metformin|metformin|mesh-list
154758383|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154758384|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154758385|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
154758386|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758387|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758388|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154758389|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154758390|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758391|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154758392|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
154758393|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446515|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446516|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446517|NCT00002339|Fluconazole|fluconazole|mesh-list
153446518|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
153446519|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905018|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
153905019|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153905020|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
153905021|NCT01257698|Timolol|timolol|mesh-list
153905022|NCT01257698|Dorzolamide|dorzolamide|mesh-list
153905023|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153905024|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153416151|NCT03889106|Ribavirin|ribavirin|mesh-list
153905025|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153905026|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
153905027|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905028|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905029|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905030|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153905031|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153905032|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153905035|NCT01257542|Levomethorphan|levomethorphan|mesh-list
154758394|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758395|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
154758396|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154758397|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154758398|NCT03051256|Methadone|methadone|mesh-list
154758399|NCT03051256|D-methadone|d-methadone|mesh-list
154758400|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154758401|NCT03051256|Narcotics|narcotics|mesh-ancestor
154758402|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758403|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758404|NCT03051256|Analgesics|analgesics|mesh-ancestor
154758405|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
154758406|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905042|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905043|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905044|NCT01257542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153905045|NCT01257542|Narcotics|narcotics|mesh-ancestor
153905046|NCT01257542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905047|NCT01257542|Analgesics|analgesics|mesh-ancestor
153905048|NCT01257542|Sensory System Agents|sensory system agents|mesh-ancestor
153905067|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
153905068|NCT01204710|Olaratumab|olaratumab|mesh-list
153905069|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153905070|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
153905071|NCT01204710|Hormones|hormones|mesh-ancestor
153905072|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905073|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905074|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153905075|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905076|NCT01204710|Analgesics|analgesics|mesh-ancestor
153905077|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
153905078|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905079|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153905081|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905096|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153905097|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905098|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905099|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153905100|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905101|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
153905134|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905135|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153905136|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905137|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905138|NCT01256060|Oxytocin|oxytocin|mesh-list
153905139|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
153905140|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153905142|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
154758407|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
154758408|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
154758409|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758410|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
154758411|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154758412|NCT02728531|Cytarabine|cytarabine|mesh-list
154510327|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758413|NCT02728531|Rituximab|rituximab|mesh-list
154758414|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154758415|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758416|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905172|NCT01254890|Azacitidine|azacitidine|mesh-list
153905204|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905205|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
153905206|NCT01105377|Azacitidine|azacitidine|mesh-list
153905207|NCT01105377|Entinostat|entinostat|mesh-list
153905208|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153905209|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153905210|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
153905211|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735839|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153905212|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905213|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905214|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153905215|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153905216|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153905217|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153905218|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153905219|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
153905220|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905221|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905222|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446730|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446731|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446732|NCT00002399|Fluconazole|fluconazole|mesh-list
153446745|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154758417|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
154758418|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758419|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154758420|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154758421|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
154758422|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758423|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
154758424|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758425|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256983|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256984|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
153905237|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
153905238|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
153905239|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153905240|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153446747|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153446748|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153446749|NCT00002405|Amprenavir|amprenavir|mesh-list
153446750|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153446759|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153905264|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
153905265|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905266|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905267|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153446776|NCT00002423|Abacavir|abacavir|mesh-list
153446777|NCT00002423|Nelfinavir|nelfinavir|mesh-list
153446778|NCT00002423|Indinavir|indinavir|mesh-list
153446779|NCT00002423|Amprenavir|amprenavir|mesh-list
153446780|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446781|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446782|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758426|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154758427|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
154758428|NCT02710331|Ethanol|ethanol|mesh-list
154758429|NCT02710331|Dronabinol|dronabinol|mesh-list
153446811|NCT02973581|Analgesics|analgesics|mesh-ancestor
154758430|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154758431|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758432|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758433|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758434|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
154758435|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154758436|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758437|NCT02710331|Analgesics|analgesics|mesh-ancestor
153905369|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153905370|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153905371|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153905372|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905373|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153905374|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
153905375|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153905377|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
153905378|NCT01102491|Ramosetron|ramosetron|mesh-list
153905391|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153905392|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905394|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
153905395|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905396|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153446911|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153446912|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446913|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153446914|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153446915|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153446916|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
153446917|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446918|NCT00002471|Antidotes|antidotes|mesh-ancestor
153446919|NCT00002471|Protective Agents|protective agents|mesh-ancestor
153446920|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
153446921|NCT00002471|Vitamins|vitamins|mesh-ancestor
153446922|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
153446923|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
153446924|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
153446925|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
153446926|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153446927|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153446928|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
153446929|NCT00002477|Carboplatin|carboplatin|mesh-list
153446930|NCT00002477|Doxorubicin|doxorubicin|mesh-list
153446931|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153446932|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256985|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153838207|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
153905419|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153905420|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905421|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153905422|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
153905423|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905424|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
153905425|NCT01253174|Drospirenone|drospirenone|mesh-list
153905426|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153905427|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
153446944|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758438|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
154758439|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758440|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154758441|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154758442|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758443|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758444|NCT02710331|Hormones|hormones|mesh-ancestor
154758445|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758446|NCT02461927|Midazolam|midazolam|mesh-list
154256986|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154256987|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256988|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
153905428|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905430|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153905431|NCT01253174|Diuretics|diuretics|mesh-ancestor
153905432|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
153905433|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
153905434|NCT01253174|Vitamins|vitamins|mesh-ancestor
153905435|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
153905436|NCT01108731|Milnacipran|milnacipran|mesh-list
153905437|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
153905438|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153446957|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446958|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153446959|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153446960|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
153446961|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446962|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446963|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153446964|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153446965|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153446966|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153446967|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446968|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153446969|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
153446970|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153446971|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153446972|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
153446973|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
153446974|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153446975|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446976|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153446977|NCT00002489|Antidotes|antidotes|mesh-ancestor
153446978|NCT00002489|Protective Agents|protective agents|mesh-ancestor
153446979|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
153905439|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153905442|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758447|NCT02461927|Naltrexone|naltrexone|mesh-list
154758448|NCT02461927|Ketamine|ketamine|mesh-list
154758449|NCT02461927|Analgesics|analgesics|mesh-ancestor
154758450|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
154758451|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758452|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758453|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154758454|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154758455|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
154758456|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
154758457|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758458|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154758459|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154758460|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758461|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758462|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154758463|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154758464|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154758465|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153905465|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905518|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
153905519|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
153905520|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
153905521|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905523|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153447042|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447044|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447046|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447047|NCT00002171|Nelfinavir|nelfinavir|mesh-list
153447048|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447049|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447050|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447051|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447052|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369985|NCT04342572|Melphalan|melphalan|mesh-list
153905524|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153905525|NCT02879097|Growth Substances|growth substances|mesh-ancestor
153905526|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905527|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
153905528|NCT02878863|Peoniflorin|peoniflorin|mesh-list
153905529|NCT02878863|Silymarin|silymarin|mesh-list
153905530|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
153905532|NCT02878863|Protective Agents|protective agents|mesh-ancestor
153905534|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153905535|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153905536|NCT02878863|Analgesics|analgesics|mesh-ancestor
153905537|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
153905538|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905539|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153905540|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153905541|NCT02881125|Paclitaxel|paclitaxel|mesh-list
153905542|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153905543|NCT02881125|Nortriptyline|nortriptyline|mesh-list
153905557|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905558|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905559|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153905560|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153905561|NCT01097577|Pregabalin|pregabalin|mesh-list
153905562|NCT01097577|Analgesics|analgesics|mesh-ancestor
153905563|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
153905564|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905565|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905566|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
153905567|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153905568|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905569|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905580|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905581|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153905582|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153905583|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
153905584|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
153905585|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905586|NCT01251614|Adalimumab|adalimumab|mesh-list
153905587|NCT01251614|Methotrexate|methotrexate|mesh-list
153905588|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154758466|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154758467|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
154758468|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
154758469|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154758470|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154758471|NCT02403323|Etrolizumab|etrolizumab|mesh-list
154758472|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758473|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
154758474|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905597|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905598|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153905599|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153905600|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
153905601|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153905602|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153905603|NCT01251614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153905604|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153905605|NCT01106625|Metformin|metformin|mesh-list
153905606|NCT01106625|Canagliflozin|canagliflozin|mesh-list
153905607|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153905608|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905609|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153905610|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447136|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447137|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910734|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153447138|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447139|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
153447140|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447141|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153447142|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153447143|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153447144|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153447145|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153447146|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153447147|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154758475|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
154758476|NCT02394795|Leucovorin|leucovorin|mesh-list
154758477|NCT02394795|Bevacizumab|bevacizumab|mesh-list
154758478|NCT02394795|Panitumumab|panitumumab|mesh-list
154758479|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
154758480|NCT02394795|Fluorouracil|fluorouracil|mesh-list
154758481|NCT02394795|Calcium|calcium|mesh-list
154758482|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
154758483|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758484|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758485|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154758486|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154758487|NCT02394795|Growth Substances|growth substances|mesh-ancestor
154758488|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758489|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
154758490|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154758491|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154758493|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758494|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154758495|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758496|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
154758497|NCT02394795|Antidotes|antidotes|mesh-ancestor
154758498|NCT02394795|Protective Agents|protective agents|mesh-ancestor
154758499|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
154758500|NCT02394795|Vitamins|vitamins|mesh-ancestor
154758501|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
154758502|NCT02344498|Tenofovir|tenofovir|mesh-list
154758503|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
154256995|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447235|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447236|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
153905676|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153905677|NCT04828005|Naloxone|naloxone|mesh-list
153905678|NCT04828005|Nalmefene|nalmefene|mesh-list
153905679|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153905680|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905681|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
153905682|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905683|NCT02878161|Prednisone|prednisone|mesh-list
153905684|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
153905685|NCT02878161|Adalimumab|adalimumab|mesh-list
153905686|NCT02878161|Infliximab|infliximab|mesh-list
153905687|NCT02878161|Etanercept|etanercept|mesh-list
153905688|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153905689|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153905690|NCT02878161|Methotrexate|methotrexate|mesh-list
153905691|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
153905692|NCT02878161|Leflunomide|leflunomide|mesh-list
153905693|NCT02878161|Hormones|hormones|mesh-ancestor
153905712|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
153905713|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905714|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153905715|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153905716|NCT02878161|Protective Agents|protective agents|mesh-ancestor
153905717|NCT02878161|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153905718|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153905719|NCT02878161|Analgesics|analgesics|mesh-ancestor
153905722|NCT02877225|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153905723|NCT02877225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153905724|NCT02877225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905725|NCT02877225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905726|NCT01093755|Omeprazole|omeprazole|mesh-list
153905727|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
153905728|NCT01093755|Lansoprazole|lansoprazole|mesh-list
153905729|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153905730|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153905731|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153905732|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447272|NCT00002531|Cytarabine|cytarabine|mesh-list
154256996|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
153905739|NCT01092663|Hormones|hormones|mesh-ancestor
153905740|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905741|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153905742|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
153905743|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905744|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905745|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153905746|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153905747|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
153905748|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153905749|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
153905750|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153905751|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
153905752|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905753|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758504|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758505|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154758506|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154758507|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758508|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758509|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154758510|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154758511|NCT02294357|Dexamethasone|dexamethasone|mesh-list
154758512|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
154758513|NCT02294357|Prednisone|prednisone|mesh-list
154758514|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
154758515|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153370360|NCT01217970|Ibudilast|ibudilast|mesh-list
153905757|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153905758|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153905759|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
153905760|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905761|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905762|NCT01092507|Vaccines|vaccines|mesh-list
153905763|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
153905764|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905765|NCT01078545|Leuprolide|leuprolide|mesh-list
153905766|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153905767|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
153905768|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153905769|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905770|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153905771|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905772|NCT01091259|Bevacizumab|bevacizumab|mesh-list
153905773|NCT01091259|Irinotecan|irinotecan|mesh-list
153905774|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153447306|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153447308|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447309|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447310|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447311|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447313|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
154758516|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154758517|NCT02294357|Prednisolone|prednisolone|mesh-list
154758518|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
154758519|NCT02294357|Lenalidomide|lenalidomide|mesh-list
154758520|NCT02294357|Pomalidomide|pomalidomide|mesh-list
154758521|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154758522|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
154758523|NCT02294357|BB 1101|bb 1101|mesh-list
154758524|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758525|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
154758526|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
153905775|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905776|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153905777|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153905778|NCT01091259|Growth Substances|growth substances|mesh-ancestor
153905779|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905780|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
153905781|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153905782|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153905783|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905784|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905785|NCT01078389|Febuxostat|febuxostat|mesh-list
153905786|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
153905787|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153905788|NCT01090323|Deferasirox|deferasirox|mesh-list
153905789|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153905790|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
153905791|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
153905792|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905793|NCT02876991|Listerine|listerine|mesh-list
153905794|NCT02876991|Fluorides|fluorides|mesh-list
153447325|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
153447332|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
153447334|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153447335|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153905795|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
153905796|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
153905797|NCT02876991|Protective Agents|protective agents|mesh-ancestor
153905798|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905799|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153905800|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905801|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153905802|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153905803|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905804|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153905805|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
154758527|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758528|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758529|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758530|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
154758531|NCT02294357|Hormones|hormones|mesh-ancestor
154758532|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758533|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154758534|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758535|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
154758536|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758537|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758538|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
154256997|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256998|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256999|NCT00313313|Metformin|metformin|mesh-list
154257000|NCT00313313|Saxagliptin|saxagliptin|mesh-list
154257001|NCT00313313|Glyburide|glyburide|mesh-list
154257002|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154257003|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257004|NCT00313313|Incretins|incretins|mesh-ancestor
153905820|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905821|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905822|NCT01200810|Bicalutamide|bicalutamide|mesh-list
153905823|NCT01200810|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153905824|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
153905825|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
153905826|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905827|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905828|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905829|NCT01200810|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153447370|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
153447371|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
153447372|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447373|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447374|NCT00002549|Analgesics|analgesics|mesh-ancestor
153447375|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
154758539|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154758540|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154758541|NCT02294357|Growth Substances|growth substances|mesh-ancestor
154758542|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
154758543|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154758544|NCT02294357|Protective Agents|protective agents|mesh-ancestor
154758545|NCT02128113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154758546|NCT02128113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154758547|NCT02013154|Paclitaxel|paclitaxel|mesh-list
154758548|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
154758549|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154758550|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257005|NCT00313313|Hormones|hormones|mesh-ancestor
153370499|NCT02379390|Prednisone|prednisone|mesh-list
153905831|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905832|NCT01200342|Paclitaxel|paclitaxel|mesh-list
153905833|NCT01200342|Carboplatin|carboplatin|mesh-list
153905834|NCT01200342|Oblimersen|oblimersen|mesh-list
153905835|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153905836|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905837|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
153905838|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
153905839|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
153905840|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905841|NCT01198548|Vitamin D|vitamin d|mesh-list
153905842|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
153905843|NCT01198548|Leucovorin|leucovorin|mesh-list
153905848|NCT01198548|Antibodies|antibodies|mesh-list
153905849|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
153447388|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153910736|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153447389|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447390|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447391|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447392|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447393|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
153447394|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447395|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447396|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447397|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447399|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447400|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758551|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
154758552|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
154758553|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
154758554|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758555|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758556|NCT02013154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154758557|NCT01823848|Mineral Oil|mineral oil|mesh-list
154758558|NCT01823848|Emollients|emollients|mesh-ancestor
154758559|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
154758560|NCT01743950|Bevacizumab|bevacizumab|mesh-list
154758561|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758562|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758563|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154758564|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154758565|NCT01743950|Growth Substances|growth substances|mesh-ancestor
154758566|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370526|NCT01224626|Linezolid|linezolid|mesh-list
153905850|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153905851|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
153905852|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905853|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153905854|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153905855|NCT01198548|Growth Substances|growth substances|mesh-ancestor
153905868|NCT01198548|Protective Agents|protective agents|mesh-ancestor
153905869|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
153905870|NCT00977938|Aspirin|aspirin|mesh-list
153905871|NCT00977938|Clopidogrel|clopidogrel|mesh-list
153905872|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153905873|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153905874|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153905875|NCT00977938|Analgesics|analgesics|mesh-ancestor
153905876|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
153905877|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905878|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905879|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153905880|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153905881|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154758567|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
154758569|NCT01522768|Afatinib|afatinib|mesh-list
154758570|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154758571|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758572|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
154758573|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
154758574|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
154758575|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758576|NCT01522768|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154758577|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153370618|NCT01291784|Antibodies|antibodies|mesh-list
153905899|NCT04290208|Acetaminophen|acetaminophen|mesh-list
153905900|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153905901|NCT04290208|Analgesics|analgesics|mesh-ancestor
153905902|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
153905903|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905904|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905905|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
153905906|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153905907|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905908|NCT01090011|Cetuximab|cetuximab|mesh-list
153905909|NCT01090011|Afatinib|afatinib|mesh-list
153905910|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153838684|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838686|NCT00527228|Deflazacort|deflazacort|mesh-list
153905918|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
153905919|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
153905920|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153447459|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447460|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
154758578|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758579|NCT01484327|Carvedilol|carvedilol|mesh-list
154758580|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154758581|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154758582|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
154758583|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758584|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370671|NCT00003407|Cytarabine|cytarabine|mesh-list
153447523|NCT00002657|Bleomycin|bleomycin|mesh-list
153905959|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153370721|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154758585|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758586|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154758587|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
154758588|NCT01484327|Protective Agents|protective agents|mesh-ancestor
154758589|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154758590|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154758591|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154758592|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
153906032|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153906033|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906034|NCT02888327|Protective Agents|protective agents|mesh-ancestor
153906035|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
153906036|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906037|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153906038|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153906039|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153906040|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
153906041|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153906043|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
153906044|NCT01248065|Ciclesonide|ciclesonide|mesh-list
153906045|NCT01248065|Vitamins|vitamins|mesh-ancestor
153906046|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
154758593|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154758594|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154758595|NCT00836823|Alfuzosin|alfuzosin|mesh-list
154758596|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154758597|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154758598|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154758599|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
154758600|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758601|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758602|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758603|NCT00836823|Urological Agents|urological agents|mesh-ancestor
154758604|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
154758605|NCT00344058|Analgesics|analgesics|mesh-ancestor
154758606|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
154257006|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257007|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154257008|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
154758607|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758608|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758609|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
154758610|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758611|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154758612|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
154758613|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154758614|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154758615|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758616|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154758617|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
154758618|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154758619|NCT00202007|Risperidone|risperidone|mesh-list
154758620|NCT00202007|Aripiprazole|aripiprazole|mesh-list
154257018|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
154257019|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
154257020|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447658|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447659|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447660|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447661|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
153906086|NCT02866396|Analgesics|analgesics|mesh-ancestor
153906087|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
153906088|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906089|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758621|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154758622|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
154758623|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758624|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758625|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758626|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154758627|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154257021|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257022|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154257023|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154257024|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
154257025|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
153447682|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153447683|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447684|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
153447685|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153447686|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153447687|NCT00002753|Antibodies|antibodies|mesh-list
153447688|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153447689|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
153906110|NCT00626613|Galantamine|galantamine|mesh-list
153906111|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153838839|NCT00528983|Cc-486|cc-486|mesh-list
154758628|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758629|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154758630|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154758631|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
154758632|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
154758633|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
154758634|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154758635|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154758636|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154758637|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154758638|NCT03245424|Ivosidenib|ivosidenib|mesh-list
154758639|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257026|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
154257027|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257028|NCT01268930|Hemostatics|hemostatics|mesh-list
154257029|NCT01268930|Coagulants|coagulants|mesh-ancestor
154257030|NCT02526758|Budesonide|budesonide|mesh-list
154257031|NCT02526758|Beclomethasone|beclomethasone|mesh-list
154257032|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
153447702|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447703|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
153447704|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447705|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
153447706|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906137|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153906138|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153906139|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153906140|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
153906141|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153906142|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906143|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906144|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906146|NCT00909727|Ivacaftor|ivacaftor|mesh-list
153906147|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153906148|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906149|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906150|NCT00977080|Cinacalcet|cinacalcet|mesh-list
153906151|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153447707|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154758640|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758641|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758642|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154758644|NCT03251040|Coagulants|coagulants|mesh-ancestor
154758645|NCT04754763|Propolis|propolis|mesh-list
154758646|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758647|NCT02454894|Lidocaine|lidocaine|mesh-list
154758648|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
154758649|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
154257033|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257034|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154257035|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
154257036|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257037|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257038|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154257039|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
154257040|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
154257041|NCT02526758|Hormones|hormones|mesh-ancestor
153447708|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
153447709|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153447710|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153447711|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153447712|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153447713|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153447714|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
153447715|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
153447716|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153447717|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153447719|NCT00002765|Immunotoxins|immunotoxins|mesh-list
154758650|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758651|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758652|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
154758653|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758654|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154758655|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154758656|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154257042|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257043|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154257044|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154257045|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154257046|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
154257047|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731883|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
153906164|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906165|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
153906166|NCT00975286|Metformin|metformin|mesh-list
153906167|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
153906168|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153906169|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906170|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906172|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153906173|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
153906174|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906176|NCT03741517|Edotreotide|edotreotide|mesh-list
154758657|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154758658|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758659|NCT03250962|Decitabine|decitabine|mesh-list
154758660|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154758661|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
154758662|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758663|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758664|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758665|NCT04774029|Lidocaine|lidocaine|mesh-list
154758666|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
154758667|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
154758668|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758669|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758670|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
154758671|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758672|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154758673|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154257060|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
154257061|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257062|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257063|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154257064|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154257065|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
154257066|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447791|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447792|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447793|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153906205|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
154758674|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154758675|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154758676|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758677|NCT03245346|Anesthetics|anesthetics|mesh-list
154758678|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758679|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758680|NCT03244956|Trametinib|trametinib|mesh-list
154758681|NCT03244956|Dabrafenib|dabrafenib|mesh-list
154758682|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758683|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758684|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758685|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758686|NCT03244488|Mecamylamine|mecamylamine|mesh-list
154257067|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154257068|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154257069|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
154257070|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154257071|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154257072|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
154257073|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257075|NCT00312845|Rituximab|rituximab|mesh-list
154758687|NCT03244488|Scopolamine|scopolamine|mesh-list
154758688|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154758689|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154758690|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
154758691|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
154758692|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758693|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758694|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758695|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
154758696|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154257079|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
153370993|NCT01337336|Fluticasone|fluticasone|mesh-list
153906260|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153906261|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153906262|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153906263|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153906264|NCT00907153|Vitamin D|vitamin d|mesh-list
153906265|NCT00907153|Vitamins|vitamins|mesh-ancestor
153447828|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447829|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153447830|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153447831|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153447832|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153447834|NCT05749445|Nirmatrelvir|nirmatrelvir|mesh-list
153447835|NCT05749445|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153447836|NCT05749445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447837|NCT05749445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447838|NCT05749445|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447839|NCT05749445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447840|NCT05749445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447841|NCT05749445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447842|NCT05749445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153906267|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906268|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153906269|NCT00904033|Calcitriol|calcitriol|mesh-list
153906270|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153906271|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906272|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153906273|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906275|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153906277|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
153906278|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153906279|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
153906280|NCT05175625|Paraproteins|paraproteins|mesh-list
153906281|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
153447845|NCT05749445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153447846|NCT05749445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153447848|NCT05749367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153447849|NCT05749367|Anesthetics, Local|anesthetics, local|mesh-ancestor
154758697|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
154758698|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758699|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758700|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154758701|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
154758702|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154758703|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154758704|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154257080|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447883|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153447884|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
153447885|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
153447886|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447887|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447888|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153447889|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
153447890|NCT05522465|Hormones|hormones|mesh-ancestor
153447891|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153447892|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153447893|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447895|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153447896|NCT05215691|Narcotics|narcotics|mesh-ancestor
153906315|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906316|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153906317|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153906318|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153906319|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906320|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153906321|NCT02850445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153906322|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154758705|NCT03254784|Deucravacitinib|deucravacitinib|mesh-list
154758706|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
154758707|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758708|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758709|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758710|NCT03245190|Chiauranib|chiauranib|mesh-list
154758711|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758712|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758713|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758714|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758715|NCT01969708|Bevacizumab|bevacizumab|mesh-list
154758716|NCT01969708|Aflibercept|aflibercept|mesh-list
154758717|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154257081|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154257082|NCT01168544|Vitamin D|vitamin d|mesh-list
154257083|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
153447915|NCT04811339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447916|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153447917|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
153447918|NCT04331093|Apatinib|apatinib|mesh-list
153447919|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447920|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906334|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153906335|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906336|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906337|NCT02850211|Ibuprofen|ibuprofen|mesh-list
153906338|NCT02850211|Celecoxib|celecoxib|mesh-list
153906339|NCT02850211|Tramadol|tramadol|mesh-list
153906340|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153906341|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153906342|NCT02850211|Analgesics|analgesics|mesh-ancestor
153906343|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
154758718|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447980|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153447981|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
153906397|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906398|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906399|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
153906400|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153906401|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906402|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906403|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153906404|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153906405|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153906406|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906407|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153906408|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
153906409|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906410|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
153906417|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153906418|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
153906419|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
153906420|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906421|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906422|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153906423|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153906424|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153906425|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
153906426|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906427|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906428|NCT02888561|Protective Agents|protective agents|mesh-ancestor
153906429|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153906430|NCT04319549|Eusol|eusol|mesh-list
154758719|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154758720|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154758721|NCT01969708|Growth Substances|growth substances|mesh-ancestor
154758722|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758723|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
154758724|NCT03243864|Ceftazidime|ceftazidime|mesh-list
154758725|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154758726|NCT03243864|Avibactam|avibactam|mesh-list
154257085|NCT01168544|Vitamins|vitamins|mesh-list
153906434|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153906435|NCT04319549|Analgesics|analgesics|mesh-ancestor
153906436|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
153906437|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906438|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906439|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906440|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906441|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153906442|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906443|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906444|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
153906445|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906446|NCT00903409|Simvastatin|simvastatin|mesh-list
153448012|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153448013|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153448014|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153448015|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153448016|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153379368|NCT03008889|Antidotes|antidotes|mesh-ancestor
153448023|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448024|NCT04332107|Azithromycin|azithromycin|mesh-list
153448025|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153448026|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448027|NCT04328285|Ritonavir|ritonavir|mesh-list
153448028|NCT04328285|Lopinavir|lopinavir|mesh-list
153448029|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
153448030|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153448031|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153448032|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
153910737|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546033|NCT06263153|Immunologic Factors|immunologic factors|mesh-ancestor
153906447|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153906448|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153906449|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
153906450|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906451|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153906452|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153906453|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906454|NCT01237223|Amlodipine|amlodipine|mesh-list
153906455|NCT01237223|Aliskiren|aliskiren|mesh-list
153906456|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154758727|NCT03243864|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154758728|NCT03243864|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154758729|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154758730|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758731|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154758732|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758733|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758734|NCT03250494|Dexamethasone|dexamethasone|mesh-list
154758735|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
154758736|NCT03250494|BB 1101|bb 1101|mesh-list
154758737|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758738|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
154758739|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
154758740|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758741|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546113|NCT06233071|Hormones|hormones|mesh-ancestor
153906465|NCT01237223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906466|NCT01236365|Atorvastatin|atorvastatin|mesh-list
153906467|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153906468|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153906469|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
153906470|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906471|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153906472|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153906473|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906474|NCT00903331|Macitentan|macitentan|mesh-list
153906475|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153906476|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153906477|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906478|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153906479|NCT01235741|Pramlintide|pramlintide|mesh-list
153906480|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906481|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758742|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758743|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
154758744|NCT03250494|Hormones|hormones|mesh-ancestor
154758745|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758746|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154758747|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758748|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
154758749|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758750|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758751|NCT03254628|Misoprostol|misoprostol|mesh-list
154758752|NCT03254628|Oxytocin|oxytocin|mesh-list
154758753|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
154758754|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154758755|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257086|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
153371351|NCT01307930|Anidulafungin|anidulafungin|mesh-list
153906482|NCT02849353|Immunomodulating Agents|immunomodulating agents|mesh-list
153906483|NCT02849353|Immunologic Factors|immunologic factors|mesh-ancestor
153906484|NCT02849353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906485|NCT01235507|Methotrexate|methotrexate|mesh-list
153906486|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153906487|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
153906488|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153906489|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906490|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153906491|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
153906492|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906493|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906494|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
153906495|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906496|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153906497|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906498|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
153906499|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154758756|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154758757|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
154758758|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154758759|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758760|NCT01970176|Tadalafil|tadalafil|mesh-list
154758761|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
154758762|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154758763|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154758764|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371393|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153906505|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153906506|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
153906507|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906508|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906509|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906510|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
153906511|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153906512|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153906513|NCT01234649|Metformin|metformin|mesh-list
153906514|NCT01234649|Liraglutide|liraglutide|mesh-list
153906515|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906516|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906517|NCT01234649|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153906518|NCT01234649|Incretins|incretins|mesh-ancestor
153906519|NCT01234649|Hormones|hormones|mesh-ancestor
153448093|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448095|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153448096|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448098|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379530|NCT02248220|Pramipexole|pramipexole|mesh-list
153448102|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448103|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448104|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448105|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448106|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
154758765|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758766|NCT01970176|Urological Agents|urological agents|mesh-ancestor
154758767|NCT02024386|Riociguat|riociguat|mesh-list
154758768|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
154758769|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758770|NCT03250338|Cytarabine|cytarabine|mesh-list
154758771|NCT03250338|Fludarabine|fludarabine|mesh-list
154758772|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
154257087|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257088|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154257089|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154257090|NCT00368069|Levetiracetam|levetiracetam|mesh-list
154257091|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
154257092|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
154257093|NCT01165814|Naproxen|naproxen|mesh-list
153906520|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906521|NCT02876679|Cyclosporine|cyclosporine|mesh-list
153906522|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
153906523|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
153906524|NCT02876679|Cyclosporins|cyclosporins|mesh-list
153906525|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153906526|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906527|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
153906528|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906529|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906530|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153906531|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
153906532|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906533|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906534|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153906535|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906536|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
153906537|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906538|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
153906539|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153906540|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153906544|NCT01075815|Hormones|hormones|mesh-list
154758773|NCT03250338|Idarubicin|idarubicin|mesh-list
154758774|NCT03250338|Crenolanib|crenolanib|mesh-list
154758775|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758776|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154758777|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
154758778|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758779|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758780|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
154758781|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257094|NCT01165814|Tramadol|tramadol|mesh-list
153906545|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153906546|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906547|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906548|NCT01072149|Fluticasone|fluticasone|mesh-list
153906549|NCT01072149|Xhance|xhance|mesh-list
153906550|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906551|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153906552|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
153906553|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906554|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906555|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153906556|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
153906557|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
153906558|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153906559|NCT04413253|Dexamethasone|dexamethasone|mesh-list
153906560|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153448152|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448153|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
153448154|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448155|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
153448156|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448157|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153448158|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
153448159|NCT03058289|Ipilimumab|ipilimumab|mesh-list
153448160|NCT03058289|Antibodies|antibodies|mesh-list
153448161|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
153448162|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
153448163|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448165|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758782|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
154758783|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758784|NCT03250338|Analgesics|analgesics|mesh-ancestor
154758785|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
154758786|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758787|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154510698|NCT02680574|Hematinics|hematinics|mesh-ancestor
154758788|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154758789|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758790|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154257095|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153906569|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
153906570|NCT04413253|Hormones|hormones|mesh-ancestor
153906571|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906573|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906574|NCT01679119|Prednisolone|prednisolone|mesh-list
153906575|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
153906576|NCT01679119|Rituximab|rituximab|mesh-list
153906577|NCT01679119|Gemcitabine|gemcitabine|mesh-list
153906578|NCT01679119|Vincristine|vincristine|mesh-list
153906579|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153906580|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906598|NCT01679119|Hormones|hormones|mesh-ancestor
153906599|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906600|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153906601|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153906602|NCT01679119|Immunotoxins|immunotoxins|mesh-ancestor
153906603|NCT01679119|Immunoconjugates|immunoconjugates|mesh-ancestor
153906604|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
153906605|NCT04778787|Digoxin|digoxin|mesh-list
153906606|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153906607|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
153906608|NCT04778787|Diuretics|diuretics|mesh-list
153906622|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906623|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448226|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448227|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448228|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448229|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
153448230|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154758791|NCT01971580|Ambrisentan|ambrisentan|mesh-list
154758792|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154758793|NCT00354562|Docetaxel|docetaxel|mesh-list
154758794|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758795|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
154758796|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154758797|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
154758798|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758799|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154257096|NCT01165814|Narcotics|narcotics|mesh-ancestor
153448244|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448245|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
153448246|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448247|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448248|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448249|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
153448250|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448251|NCT00003005|Cordycepin|cordycepin|mesh-list
153448252|NCT00003005|Pentostatin|pentostatin|mesh-list
153735841|NCT04111315|Dipyrone|dipyrone|mesh-list
153906651|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906652|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906653|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153906654|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
153906655|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153906656|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153906657|NCT01234337|Capecitabine|capecitabine|mesh-list
153906658|NCT01234337|Sorafenib|sorafenib|mesh-list
153906659|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153906660|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
153448267|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153448268|NCT00003017|Growth Substances|growth substances|mesh-ancestor
153448269|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
153448270|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448271|NCT00003023|Vaccines|vaccines|mesh-list
153448272|NCT00003023|Antibodies|antibodies|mesh-list
153448273|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153448274|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
153448275|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
153448276|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448277|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153448278|NCT03850067|Carboplatin|carboplatin|mesh-list
153448279|NCT03850067|Nivolumab|nivolumab|mesh-list
153448280|NCT03850067|Etoposide|etoposide|mesh-list
153448281|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
153906691|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153906692|NCT01074255|Aprepitant|aprepitant|mesh-list
153906693|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
153448290|NCT00003029|Fluorouracil|fluorouracil|mesh-list
154758800|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154758801|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
154758802|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154758803|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758804|NCT02355886|Gabapentin|gabapentin|mesh-list
154758805|NCT02355886|Analgesics|analgesics|mesh-ancestor
154758806|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
154758807|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257097|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906713|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906714|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153906715|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153906716|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906717|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906718|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153906719|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906720|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906721|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906722|NCT04697485|Eplerenone|eplerenone|mesh-list
153906723|NCT04697485|Bumetanide|bumetanide|mesh-list
153906724|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153906725|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906726|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758808|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758809|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
154758810|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154758811|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154758812|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758813|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154758814|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154758815|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153371667|NCT01750931|Analgesics|analgesics|mesh-ancestor
153906739|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153906740|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906741|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906742|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153906743|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906744|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906745|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906746|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153906747|NCT00626769|Genistein|genistein|mesh-list
153906748|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153906749|NCT00626769|Protective Agents|protective agents|mesh-ancestor
153906750|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906751|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906752|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906753|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906758|NCT00626769|Hormones|hormones|mesh-ancestor
153371720|NCT01250834|Dulaglutide|dulaglutide|mesh-list
153906763|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153906764|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153906765|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153906766|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153906767|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153906768|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906769|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448372|NCT00003101|Thiotepa|thiotepa|mesh-list
154758816|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154758817|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758818|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
154758819|NCT02356198|Hydromorphone|hydromorphone|mesh-list
154758820|NCT02356198|Bupivacaine|bupivacaine|mesh-list
154758821|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
154758822|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
154758823|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758824|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758825|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
154758826|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758827|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154758828|NCT02356198|Narcotics|narcotics|mesh-ancestor
154758829|NCT02356198|Analgesics|analgesics|mesh-ancestor
154758830|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
154758831|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154758832|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758833|NCT03254004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153731922|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
153906794|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153906795|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153906796|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906797|NCT04304313|Urological Agents|urological agents|mesh-ancestor
153906798|NCT01072929|Modafinil|modafinil|mesh-list
153906799|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153906800|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906801|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153906802|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153906803|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153906804|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906805|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
153906806|NCT04305015|Narcotics|narcotics|mesh-ancestor
153448401|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
153448402|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448403|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448405|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
153906814|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153906815|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153906816|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906817|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906818|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906819|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906820|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906821|NCT01231607|Urological Agents|urological agents|mesh-ancestor
153906822|NCT01231373|Polidocanol|polidocanol|mesh-list
153906823|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153906824|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154758834|NCT03254004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758835|NCT04778865|Vitamin D|vitamin d|mesh-list
154758836|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
154758837|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
154758838|NCT04778865|Vitamins|vitamins|mesh-list
154758839|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
154758840|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758841|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154758842|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154758843|NCT02025634|Acetaminophen|acetaminophen|mesh-list
154758844|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758845|NCT02025634|Analgesics|analgesics|mesh-ancestor
153548238|NCT04931615|Thrombin|thrombin|mesh-list
153906840|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906841|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906842|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
153906843|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448438|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906846|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
154758846|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
154758847|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758848|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758849|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
154758850|NCT04773951|Antibodies|antibodies|mesh-list
153548533|NCT04733118|Trastuzumab|trastuzumab|mesh-list
154758851|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154758852|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
154758853|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758854|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
154758855|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
154758856|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758857|NCT04773717|Protective Agents|protective agents|mesh-ancestor
154257103|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153548773|NCT04602221|BI 425809|bi 425809|mesh-list
154758858|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758859|NCT04773717|Vitamins|vitamins|mesh-ancestor
154758860|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
154758861|NCT04444167|Lenvatinib|lenvatinib|mesh-list
154758862|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907325|NCT00973102|Estrogens|estrogens|mesh-list
154758863|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153372045|NCT02253173|Estradiol|estradiol|mesh-list
154758864|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758865|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758866|NCT03243006|Acetaminophen|acetaminophen|mesh-list
154758867|NCT03243006|Tramadol|tramadol|mesh-list
154758868|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154758869|NCT03243006|Analgesics|analgesics|mesh-ancestor
153549636|NCT03969901|Relebactam|relebactam|mesh-list
153907611|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154758870|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
154758871|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758872|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758873|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
154758874|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154758875|NCT03243006|Narcotics|narcotics|mesh-ancestor
154257112|NCT00367835|Guanfacine|guanfacine|mesh-list
154758876|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758877|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
154758878|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153372329|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
153449590|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758879|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154758880|NCT03249402|Estradiol|estradiol|mesh-list
154758881|NCT03249402|Estrogens|estrogens|mesh-ancestor
154758882|NCT03249402|Hormones|hormones|mesh-ancestor
154758883|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154758884|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758885|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154758886|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
154758887|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154758888|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154758889|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154758890|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154758891|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154758892|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154758893|NCT03242460|Dexamethasone|dexamethasone|mesh-list
154758894|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
154758895|NCT03242460|Pomalidomide|pomalidomide|mesh-list
154758896|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154758897|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
154758898|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758899|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154758900|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154758901|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
153372552|NCT02392871|Trametinib|trametinib|mesh-list
153551143|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551334|NCT01571050|Antacids|antacids|mesh-ancestor
153551437|NCT01571791|Ketorolac|ketorolac|mesh-list
154758902|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758903|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758904|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153450498|NCT05894889|Paclitaxel|paclitaxel|mesh-list
154758905|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154758906|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
154758907|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
153552192|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154758908|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909051|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
153552497|NCT01578473|Androgens|androgens|mesh-ancestor
154758909|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758910|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
154758911|NCT03242460|Hormones|hormones|mesh-ancestor
153731931|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154758912|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731932|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154758913|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154758914|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154758915|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154758916|NCT03242460|Growth Substances|growth substances|mesh-ancestor
154758917|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
154758918|NCT01972516|Tivozanib|tivozanib|mesh-list
154758919|NCT01972516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154758920|NCT01972516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257123|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
154758921|NCT01972516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758922|NCT03242616|Pemetrexed|pemetrexed|mesh-list
154758923|NCT03242616|Vinorelbine|vinorelbine|mesh-list
154758924|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758925|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553772|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154257127|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554035|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
154758926|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758927|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154758928|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154758929|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154758930|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
154758931|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
153748611|NCT00188955|Sirolimus|sirolimus|mesh-list
154758932|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
154758933|NCT01748825|Adavosertib|adavosertib|mesh-list
154758934|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257132|NCT01164800|Trandolapril|trandolapril|mesh-list
154758935|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758936|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
154758937|NCT03253224|Analgesics|analgesics|mesh-ancestor
153555072|NCT03462251|Paclitaxel|paclitaxel|mesh-list
153555181|NCT05701124|Ranibizumab|ranibizumab|mesh-list
154758938|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
154510857|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
154758939|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758940|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373629|NCT03349281|Methotrexate|methotrexate|mesh-list
154758941|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
154758942|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758943|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154758944|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
154758945|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153750331|NCT03456661|Analgesics|analgesics|mesh-ancestor
154758946|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153555915|NCT01608217|Hormones|hormones|mesh-ancestor
153556097|NCT01611480|Imiquimod|imiquimod|mesh-list
154758947|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758948|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154758949|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
154758950|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154758952|NCT00789399|Fondaparinux|fondaparinux|mesh-list
154758953|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154758954|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
153751711|NCT00162695|Vincristine|vincristine|mesh-list
154758955|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154758956|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
153556941|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
154758957|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557075|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154758958|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758959|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
154758960|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154758961|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154758962|NCT01720667|Levetiracetam|levetiracetam|mesh-list
154758963|NCT01720667|Phenobarbital|phenobarbital|mesh-list
154758964|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
154758965|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
153834058|NCT02949765|Iron|iron|mesh-list
154758966|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154758967|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758968|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374132|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
154758969|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154758970|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154758971|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683484|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154758972|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154758973|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
154758974|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
154263468|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
154758975|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154758976|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154758977|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154758978|NCT04773093|Lidocaine|lidocaine|mesh-list
154758979|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
154758980|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
153559290|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263473|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758981|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154758982|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758983|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
153686559|NCT00044382|Lenalidomide|lenalidomide|mesh-list
154263476|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
154758984|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154758985|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153559852|NCT01635816|Vaccines|vaccines|mesh-list
154758986|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154758987|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154758988|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154758989|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374699|NCT01547000|Guanfacine|guanfacine|mesh-list
154758990|NCT01720043|Bortezomib|bortezomib|mesh-list
154758991|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154758992|NCT02455362|Morphine|morphine|mesh-list
154758993|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154758994|NCT02455362|Narcotics|narcotics|mesh-ancestor
154758995|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153688910|NCT00055757|Tipifarnib|tipifarnib|mesh-list
154758996|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154758997|NCT02455362|Analgesics|analgesics|mesh-ancestor
153560968|NCT01650012|Eplerenone|eplerenone|mesh-list
153561175|NCT01651312|Urological Agents|urological agents|mesh-ancestor
154758998|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
154758999|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759000|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
154759001|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154759002|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
153375056|NCT01555281|Dexamethasone|dexamethasone|mesh-list
154759003|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154759004|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759005|NCT03253068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154759006|NCT03253068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759007|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154759008|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154759009|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759010|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153690549|NCT00185419|Desogestrel|desogestrel|mesh-list
154759011|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154759012|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690825|NCT00187564|Vitamins|vitamins|mesh-ancestor
154759013|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759014|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
154759015|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759016|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154759017|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153691144|NCT00189709|Micafungin|micafungin|mesh-list
153691206|NCT00190060|Hormones|hormones|mesh-ancestor
154759018|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153564663|NCT05596968|Sorafenib|sorafenib|mesh-list
154759019|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154759020|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759021|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759022|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759023|NCT03249168|Analgesics|analgesics|mesh-ancestor
154759024|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
154759025|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759026|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
154759027|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154759028|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
154759029|NCT03248856|Triamcinolone|triamcinolone|mesh-list
154759030|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154759031|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154759032|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154759033|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154759034|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
154759035|NCT03248856|Hormones|hormones|mesh-ancestor
154759036|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759037|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759038|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759039|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
154759040|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263478|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153566235|NCT05870800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759041|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759042|NCT03241602|Lidocaine|lidocaine|mesh-list
154759043|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
154759044|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
154759045|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759046|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759047|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
154759048|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759049|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153693041|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
154759050|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154759051|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153693380|NCT00223717|Losartan|losartan|mesh-list
153693481|NCT00085527|Romidepsin|romidepsin|mesh-list
154759052|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154759053|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759054|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
154759055|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154759056|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
154759057|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759058|NCT02357290|Expectorants|expectorants|mesh-ancestor
154759059|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
154759060|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154759061|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
154759062|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759063|NCT02357290|Protective Agents|protective agents|mesh-ancestor
154759064|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759065|NCT02357290|Antidotes|antidotes|mesh-ancestor
154759066|NCT00687765|Temozolomide|temozolomide|mesh-list
154759067|NCT00687765|Iniparib|iniparib|mesh-list
153332262|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
154759068|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154759069|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
153694547|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
154759070|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759071|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759072|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154759073|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759074|NCT03248544|Vitamin D|vitamin d|mesh-list
154759075|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
154759076|NCT03248544|Vitamins|vitamins|mesh-ancestor
154759077|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
154759078|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759079|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154759080|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153334376|NCT02565108|Cannabidiol|cannabidiol|mesh-list
154759081|NCT03248700|Vitamins|vitamins|mesh-list
154759082|NCT03248700|Vitamin A|vitamin a|mesh-list
154759083|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
154759084|NCT03248700|Retinol acetate|retinol acetate|mesh-list
154510999|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154759085|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
154759086|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759087|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
154759088|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759089|NCT03248700|Protective Agents|protective agents|mesh-ancestor
154759090|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153695883|NCT00098007|Everolimus|everolimus|mesh-list
154759091|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759092|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154759093|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
154759094|NCT03238482|Fluticasone|fluticasone|mesh-list
154759095|NCT03238482|Xhance|xhance|mesh-list
154759096|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153335579|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
153696642|NCT00076869|Amphotericin B|amphotericin b|mesh-list
154759097|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154759098|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154759099|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154759100|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
154759101|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759102|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759103|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154759104|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
154759105|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
154759106|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154759107|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154759108|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154759109|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154759110|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
153697707|NCT00103272|Bortezomib|bortezomib|mesh-list
154759111|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759112|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759113|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
154759114|NCT03238482|Hormones|hormones|mesh-ancestor
154759115|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759116|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
154759117|NCT02454504|Neostigmine|neostigmine|mesh-list
153698165|NCT00068861|Metformin|metformin|mesh-list
154759118|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154759119|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698361|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759120|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759121|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
154759122|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759123|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759124|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154759125|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
154759126|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759127|NCT03240822|Antibodies|antibodies|mesh-list
154759128|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154759129|NCT03240822|Tacrolimus|tacrolimus|mesh-list
154759130|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
154257186|NCT01274780|Ritonavir|ritonavir|mesh-list
153698704|NCT00255541|Glyburide|glyburide|mesh-list
154759131|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759132|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759133|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154257189|NCT01274780|Tenofovir|tenofovir|mesh-list
154759134|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340030|NCT00002458|Antibodies|antibodies|mesh-list
154759135|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759136|NCT03238560|Montelukast|montelukast|mesh-list
154759137|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154759138|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
154759139|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154759140|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
154257199|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759141|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341002|NCT05293210|Hormones|hormones|mesh-ancestor
153341149|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
154759142|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759143|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154759144|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154759145|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759146|NCT04486092|Valproic Acid|valproic acid|mesh-list
154257204|NCT01169870|Paclitaxel|paclitaxel|mesh-list
154759147|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
154759148|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700219|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154759149|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759150|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
154759151|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759152|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377342|NCT04792073|Avelumab|avelumab|mesh-list
154759153|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
154759154|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153342930|NCT00067028|Cytarabine|cytarabine|mesh-list
154759155|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426249|NCT00368654|Methotrexate|methotrexate|mesh-list
154759156|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154004154|NCT02716038|Paclitaxel|paclitaxel|mesh-list
154759157|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
154759158|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154759159|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759160|NCT03238638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153701970|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154759161|NCT03238638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759162|NCT00668655|Metronidazole|metronidazole|mesh-list
154759163|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703110|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153703269|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154759164|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153377809|NCT03754049|Hormones|hormones|mesh-ancestor
154759165|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154759166|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154759167|NCT02454426|Vortioxetine|vortioxetine|mesh-list
154759168|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
154759169|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154759170|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153378001|NCT03300427|Valsartan|valsartan|mesh-list
154759171|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154759172|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705248|NCT00120432|Phenylephrine|phenylephrine|mesh-list
153705575|NCT00087867|Bortezomib|bortezomib|mesh-list
154759173|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759174|NCT02454426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154759175|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153706221|NCT00083681|Growth Substances|growth substances|mesh-ancestor
154759176|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154759177|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347958|NCT00178178|Bupivacaine|bupivacaine|mesh-list
154759178|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759179|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
153707005|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
154759180|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154759181|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154759182|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154759183|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154759184|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154759185|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154759186|NCT03238092|Estradiol|estradiol|mesh-list
154759187|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154759188|NCT03238092|Testosterone|testosterone|mesh-list
153708292|NCT05826964|Exemestane|exemestane|mesh-list
154759189|NCT03238092|Estrogens|estrogens|mesh-ancestor
154759190|NCT03238092|Hormones|hormones|mesh-ancestor
154759191|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759192|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759193|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154759194|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
154759195|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154759196|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154759197|NCT03238092|Androgens|androgens|mesh-ancestor
154759198|NCT03247998|Remifentanil|remifentanil|mesh-list
154759199|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759200|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759201|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154759202|NCT03247998|Narcotics|narcotics|mesh-ancestor
154759203|NCT03247998|Analgesics|analgesics|mesh-ancestor
154759204|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
154759205|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759206|NCT03248076|Fentanyl|fentanyl|mesh-list
154759207|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154759208|NCT03248076|Narcotics|narcotics|mesh-ancestor
154759209|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759210|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759211|NCT03248076|Analgesics|analgesics|mesh-ancestor
154759212|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
154759213|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759214|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154257238|NCT01283048|Growth Substances|growth substances|mesh-ancestor
154759215|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154759216|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
154759217|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
154759218|NCT03240120|Tinzaparin|tinzaparin|mesh-list
154257242|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
154759219|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154759220|NCT03240120|Dalteparin|dalteparin|mesh-list
154759221|NCT03240120|Dabigatran|dabigatran|mesh-list
154759222|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
154759223|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154759224|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
154759225|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759226|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759227|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
154759228|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154759229|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153353345|NCT01489969|Melatonin|melatonin|mesh-list
153711704|NCT00084461|Romidepsin|romidepsin|mesh-list
154759230|NCT03237936|Cyclosporine|cyclosporine|mesh-list
154759231|NCT03237936|Cyclosporins|cyclosporins|mesh-list
154759232|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353979|NCT03236792|Hormones|hormones|mesh-ancestor
153712155|NCT00319306|Budesonide|budesonide|mesh-list
153354474|NCT04866602|Proguanil|proguanil|mesh-list
153379139|NCT02988089|Antacids|antacids|mesh-ancestor
153712924|NCT00087113|Pemetrexed|pemetrexed|mesh-list
154257251|NCT01172912|Carboplatin|carboplatin|mesh-list
153713260|NCT00331786|Aspirin|aspirin|mesh-list
153396454|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
154759233|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759234|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759235|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
153382584|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759236|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759237|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
154759238|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759239|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
154759240|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154759241|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154759242|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154759243|NCT03247920|Amoxicillin|amoxicillin|mesh-list
154759244|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
154759245|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
153715392|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715601|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
153473160|NCT03016650|Acetaminophen|acetaminophen|mesh-list
153473300|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
154759246|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154759247|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759248|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154759249|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759250|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759251|NCT03239964|Dexamethasone|dexamethasone|mesh-list
154759252|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154759253|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
154759254|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
154759255|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759256|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759257|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154759258|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
154759259|NCT03239964|Hormones|hormones|mesh-ancestor
153475061|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154257259|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717893|NCT00097214|Cetuximab|cetuximab|mesh-list
153380210|NCT01911065|Vaccines|vaccines|mesh-list
154257260|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257261|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
154759260|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759261|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154759262|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759263|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
154759264|NCT03239886|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153380441|NCT01935791|Incretins|incretins|mesh-ancestor
154759265|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154759266|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380585|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
153719682|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154759267|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263488|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759268|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759269|NCT03102723|Cangrelor|cangrelor|mesh-list
154263491|NCT05353257|Etoposide|etoposide|mesh-list
153720456|NCT00437671|Antibodies|antibodies|mesh-list
153720663|NCT00439543|Iloprost|iloprost|mesh-list
153487325|NCT01951950|Esmolol|esmolol|mesh-list
154759270|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154759271|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154759272|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154759273|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154759274|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
154759275|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759276|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813937|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
154759277|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759278|NCT03237312|Hormones|hormones|mesh-list
153721847|NCT03274765|Estradiol|estradiol|mesh-list
153381349|NCT02331095|Warfarin|warfarin|mesh-list
154759279|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759280|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759281|NCT03241914|Megestrol|megestrol|mesh-list
154759282|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
154759283|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
154759284|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154759285|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
154759286|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154759287|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381573|NCT05709938|Insulin|insulin|mesh-list
154759288|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153722953|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154257266|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154759289|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154759290|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154759291|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154257268|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759292|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153723825|NCT00114023|Imiquimod|imiquimod|mesh-list
154257271|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
154759293|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759294|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
154759295|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154759296|NCT00057681|Valproic Acid|valproic acid|mesh-list
154759297|NCT00057681|Risperidone|risperidone|mesh-list
154759298|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
154759299|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154759300|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
154759301|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759302|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759303|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759304|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154759305|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154759306|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759307|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154511234|NCT03670043|Metformin|metformin|mesh-list
154759308|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154759309|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
154759310|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
154759311|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759312|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
154759313|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
154759314|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
154759315|NCT03234816|Norepinephrine|norepinephrine|mesh-list
154759316|NCT03234816|Bupivacaine|bupivacaine|mesh-list
154759317|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
154759318|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
154759319|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382346|NCT03226899|Colchicine|colchicine|mesh-list
154759320|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759321|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
154759322|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726246|NCT00480571|Perphenazine|perphenazine|mesh-list
153726425|NCT00481663|Incretins|incretins|mesh-ancestor
153726542|NCT00120302|Analgesics|analgesics|mesh-ancestor
153726635|NCT00120497|Hormones|hormones|mesh-list
153726726|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759323|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153382677|NCT03309657|Tazobactam|tazobactam|mesh-list
154759324|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153726989|NCT00121316|Analgesics|analgesics|mesh-ancestor
154759325|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
154759326|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759327|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727098|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759328|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
154759329|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
154759330|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154759331|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
154759332|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
154759333|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759334|NCT03247452|Protective Agents|protective agents|mesh-ancestor
154759335|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759336|NCT03247452|Vitamins|vitamins|mesh-ancestor
154759337|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
154759338|NCT03247140|Amlodipine|amlodipine|mesh-list
154759339|NCT03247140|Telmisartan|telmisartan|mesh-list
154759340|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154759341|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154759342|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154759343|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153727901|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
154759344|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383291|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153728492|NCT00499018|Cytarabine|cytarabine|mesh-list
153729042|NCT00147654|Urological Agents|urological agents|mesh-ancestor
153729250|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
153729489|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759345|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784133|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784434|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153784435|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
153784541|NCT04534465|Diuretics|diuretics|mesh-ancestor
153784722|NCT05896930|Leprostatic Agents|leprostatic agents|mesh-ancestor
153784990|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153784995|NCT04101838|Vaccines|vaccines|mesh-list
154759346|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153859825|NCT00538811|Amantadine|amantadine|mesh-list
154759347|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785656|NCT01644799|Lenalidomide|lenalidomide|mesh-list
154759348|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
154759349|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154759350|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154759351|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
154759352|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154759353|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154759354|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759355|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153787379|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759356|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154759357|NCT03237546|Anesthetics|anesthetics|mesh-list
154759358|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759359|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759360|NCT03247296|Ribavirin|ribavirin|mesh-list
154759361|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
154759362|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
154759363|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759364|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
154759365|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759366|NCT03247218|Memantine|memantine|mesh-list
154759367|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154759368|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154759369|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
153787557|NCT00284505|Growth Substances|growth substances|mesh-ancestor
154759370|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759371|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759372|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759373|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154759374|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154759375|NCT03237624|Chitosan|chitosan|mesh-list
154759376|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154759377|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154759378|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
154759379|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759380|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154759381|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
154759382|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
154759383|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
154759384|NCT03237624|Coagulants|coagulants|mesh-ancestor
154759385|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
154759386|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154759387|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759388|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759389|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154759390|NCT03234660|Analgesics|analgesics|mesh-ancestor
154759391|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
154759392|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759393|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154759394|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154759395|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154759396|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
154759397|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759398|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759399|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
154759400|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154759401|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154759402|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154759403|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154759404|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759405|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
154759406|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759407|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788561|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759408|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154759409|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759410|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
154759411|NCT00059475|Interleukin-2|interleukin-2|mesh-list
154759412|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154759413|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759414|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154759415|NCT00059475|Analgesics|analgesics|mesh-ancestor
154759416|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
154759417|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759418|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759419|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154759420|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
154759421|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154759422|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
154759423|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759424|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
154759425|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154759426|NCT00059475|Protective Agents|protective agents|mesh-ancestor
154759427|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
154759428|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
153371749|NCT01250990|Niacin|niacin|mesh-list
154759429|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
154759430|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154759431|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154759432|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759433|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
154759434|NCT02453802|Coagulants|coagulants|mesh-ancestor
154759435|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154759436|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
154759437|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154759438|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
154759439|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759440|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
154759441|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
154759442|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154759443|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154759444|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154759445|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154759446|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759447|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759449|NCT02028676|Zidovudine|zidovudine|mesh-list
154759450|NCT02028676|Efavirenz|efavirenz|mesh-list
154759451|NCT02028676|Nevirapine|nevirapine|mesh-list
154759452|NCT02028676|Abacavir|abacavir|mesh-list
154759453|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
154759454|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154759455|NCT02028676|Trimethoprim|trimethoprim|mesh-list
153831976|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153372049|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759456|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
154759457|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154759458|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154759459|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153791672|NCT06299605|Bismuth|bismuth|mesh-list
153372357|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154759460|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759461|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759462|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
154759463|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759464|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154759465|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154759466|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
154759467|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153372358|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153372359|NCT05167643|Anastrozole|anastrozole|mesh-list
154759468|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154759469|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154759470|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154759471|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154759472|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154759473|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154759474|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
154759475|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153385086|NCT03415581|Oxycodone|oxycodone|mesh-list
154759476|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154759477|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154759478|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154759479|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154759480|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154759481|NCT03233880|Azithromycin|azithromycin|mesh-list
154759482|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154759483|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759484|NCT00061893|Celecoxib|celecoxib|mesh-list
154759485|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
153373106|NCT02023593|Leucovorin|leucovorin|mesh-list
154759486|NCT00061893|Ifosfamide|ifosfamide|mesh-list
154759487|NCT00061893|Doxorubicin|doxorubicin|mesh-list
154759488|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154759489|NCT00061893|Etoposide|etoposide|mesh-list
154759490|NCT00061893|Vincristine|vincristine|mesh-list
154759491|NCT00061893|Vinblastine|vinblastine|mesh-list
154759492|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759493|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
154759494|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385113|NCT04203225|Tetracaine|tetracaine|mesh-list
154759495|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154759496|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154759497|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
154759498|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759499|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759500|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154759501|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154759502|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154759503|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154759504|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759505|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154759506|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
154759507|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
154759508|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
154759509|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154759510|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154759511|NCT00061893|Analgesics|analgesics|mesh-ancestor
154759512|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
154759513|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759514|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154759515|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154759516|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154759517|NCT02957019|Rituximab|rituximab|mesh-list
154759518|NCT02957019|Interleukin-2|interleukin-2|mesh-list
154759519|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154759520|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759521|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
154759522|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759523|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154759524|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154759525|NCT02957019|Analgesics|analgesics|mesh-ancestor
154759526|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
154759527|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759528|NCT02028754|Levofloxacin|levofloxacin|mesh-list
154759529|NCT02028754|Prednisolone|prednisolone|mesh-list
154759530|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
154759531|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154759532|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154759533|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
154759534|NCT02028754|Hormones|hormones|mesh-ancestor
154759535|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759536|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759537|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154759539|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154759540|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154759541|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759542|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154759543|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154759544|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154759545|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759546|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759547|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154759548|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154759549|NCT02028754|Laxatives|laxatives|mesh-ancestor
154759550|NCT02453490|Fluorouracil|fluorouracil|mesh-list
154759551|NCT02453490|Raltitrexed|raltitrexed|mesh-list
154759552|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
154759553|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759554|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154759555|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759556|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759557|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
154759558|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759559|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154759560|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759561|NCT01974700|Levetiracetam|levetiracetam|mesh-list
154759562|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
154759563|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
154759564|NCT03236610|Tenofovir|tenofovir|mesh-list
154759565|NCT03236610|Entecavir|entecavir|mesh-list
154759566|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
154759567|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759568|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154759569|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154759570|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263494|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154759571|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759572|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154759573|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154759574|NCT05287893|Pyronaridine|pyronaridine|mesh-list
154759575|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
154759576|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154759577|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154759578|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759579|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154759580|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759581|NCT02357836|Itraconazole|itraconazole|mesh-list
154759582|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
154759583|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759584|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154759585|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154759586|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759587|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759588|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154759589|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
153834039|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
154759590|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759591|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759592|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154759593|NCT02359006|Minocycline|minocycline|mesh-list
154759594|NCT02359006|Tetracycline|tetracycline|mesh-list
153374145|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
153374184|NCT05442411|Analgesics|analgesics|mesh-ancestor
154759595|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154759596|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759597|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154759598|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257332|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834309|NCT00519753|Timolol|timolol|mesh-list
154759599|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759600|NCT04485702|Midazolam|midazolam|mesh-list
154759601|NCT04485702|Ketamine|ketamine|mesh-list
154759602|NCT04485702|Analgesics|analgesics|mesh-ancestor
154759603|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
154759604|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759605|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759606|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154759607|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154759608|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
154759609|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
154759610|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759611|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154759612|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154759613|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759614|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759615|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154759616|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154759618|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154759619|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154759620|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
154759621|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
154759622|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154759623|NCT00068367|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154759624|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154759625|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759626|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759627|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759628|NCT03233412|Imiquimod|imiquimod|mesh-list
154759629|NCT03233412|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154759630|NCT03233412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759631|NCT03233412|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154759632|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
154759633|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759634|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154759635|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759636|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
154759637|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
154759638|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759639|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
154759640|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759641|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759642|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154759643|NCT01976572|Candesartan|candesartan|mesh-list
154759644|NCT01976572|Candesartan cilexetil|candesartan cilexetil|mesh-list
154759645|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154759646|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154759647|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154759648|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759649|NCT01976650|Dexamethasone|dexamethasone|mesh-list
154759650|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154759651|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
154759652|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
154759653|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759654|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759655|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154759656|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
154759657|NCT01976650|Hormones|hormones|mesh-ancestor
154759658|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759659|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154759660|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759661|NCT01978600|Timolol|timolol|mesh-list
154759662|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154759663|NCT01978600|Brinzolamide|brinzolamide|mesh-list
154759664|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759665|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759666|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154759667|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154759668|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
154759669|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759670|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759671|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154759672|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154759673|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154759674|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154759675|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154759676|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154759677|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
154759678|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154759679|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
154759680|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759681|NCT03236220|Expectorants|expectorants|mesh-ancestor
154759682|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
154759683|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154759684|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
154759685|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759686|NCT03236220|Protective Agents|protective agents|mesh-ancestor
154759687|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759688|NCT03236220|Antidotes|antidotes|mesh-ancestor
154759689|NCT03232632|Flutemetamol|flutemetamol|mesh-list
154759690|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154759691|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759692|NCT01747499|Azacitidine|azacitidine|mesh-list
154759693|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154759694|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
154759695|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759696|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759697|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759698|NCT00071721|Valproic Acid|valproic acid|mesh-list
154759699|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
154759700|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759701|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732027|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
154759702|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
154759703|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759704|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759705|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
154759706|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154759707|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759708|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154759709|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
154759710|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154759711|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759712|NCT05606055|Tenofovir|tenofovir|mesh-list
154759713|NCT05606055|Emtricitabine|emtricitabine|mesh-list
154759714|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
154759715|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759716|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154759717|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154759718|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759719|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759720|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154759721|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154759722|NCT01896609|Interferons|interferons|mesh-list
154759723|NCT01896609|Ribavirin|ribavirin|mesh-list
154759724|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
154759725|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
154759726|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154759727|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
154759728|NCT01896609|Complement Factor H|complement factor h|mesh-list
154759729|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759730|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
154759731|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759732|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
154759733|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759734|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
153834618|NCT04513457|Liver Extracts|liver extracts|mesh-list
154759735|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759736|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154759737|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759738|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154759739|NCT03232554|Iron|iron|mesh-list
154759740|NCT03232554|Trace Elements|trace elements|mesh-ancestor
154759741|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
154759742|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759743|NCT03232398|Warfarin|warfarin|mesh-list
154759744|NCT03232398|Apixaban|apixaban|mesh-list
154759745|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
154759746|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154759747|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
154759748|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154759749|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
154759750|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759751|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759752|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
154759753|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
154759754|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154759755|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759756|NCT02362048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154759757|NCT02362048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759758|NCT02362048|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154759759|NCT02362048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154759760|NCT02362048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759762|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154759763|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154759764|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759765|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759766|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154759767|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154759768|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
154759769|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257352|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759770|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759771|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154759772|NCT03228576|Everolimus|everolimus|mesh-list
154759773|NCT03228576|Tacrolimus|tacrolimus|mesh-list
154759774|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759775|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
154759776|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759777|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154759778|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759779|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759780|NCT03228576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154759781|NCT03228576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154759782|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759783|NCT00158379|Paclitaxel|paclitaxel|mesh-list
154759784|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154759785|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759786|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
154759787|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
154759788|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
154759789|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759790|NCT03228498|Choline|choline|mesh-list
153803454|NCT00323583|Paclitaxel|paclitaxel|mesh-list
153803848|NCT00304200|Sunitinib|sunitinib|mesh-list
154759791|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
154759792|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154759793|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
154759794|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759795|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154759796|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154759797|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
154759798|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154759799|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154759800|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759801|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759802|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154759803|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154759804|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759805|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
154759806|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759807|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
154759808|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154759809|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759810|NCT02364076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154759811|NCT02364076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759812|NCT02453022|Omeprazole|omeprazole|mesh-list
154759813|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154759814|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154759815|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154759816|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759817|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759818|NCT00163293|Ciclesonide|ciclesonide|mesh-list
154759819|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
154759820|NCT00163293|Hormones|hormones|mesh-ancestor
154263503|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759821|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759822|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759823|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154759824|NCT02365870|Rotigotine|rotigotine|mesh-list
154759825|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
154759826|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
154759827|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759828|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759829|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759830|NCT03228108|Amoxicillin|amoxicillin|mesh-list
154759831|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
154759832|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154511754|NCT00328653|Cyclosporins|cyclosporins|mesh-list
154759834|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
154759835|NCT03228108|Fosfomycin|fosfomycin|mesh-list
154759836|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154759837|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
154759838|NCT03228108|Trimethoprim|trimethoprim|mesh-list
154759839|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
154759840|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154759841|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759842|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154759843|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154759844|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759845|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759846|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759847|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154759848|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154759849|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154759850|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
153374978|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154759851|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154759852|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154759853|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154759854|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154759855|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154759856|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154759857|NCT00078897|Selenium|selenium|mesh-list
154759858|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
154759859|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759860|NCT00078897|Protective Agents|protective agents|mesh-ancestor
154759861|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759862|NCT00078897|Trace Elements|trace elements|mesh-ancestor
154759863|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
154759864|NCT03228030|Thiamine|thiamine|mesh-list
154759865|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
154759866|NCT03228030|Vitamins|vitamins|mesh-ancestor
154759867|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
154759868|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759869|NCT01717313|Metformin|metformin|mesh-list
154759870|NCT01717313|Glimepiride|glimepiride|mesh-list
154759871|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154759872|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759873|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154759874|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759875|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
154759876|NCT00081861|Bevacizumab|bevacizumab|mesh-list
154759877|NCT00081861|Rituximab|rituximab|mesh-list
154759878|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154759879|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374998|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759880|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154759881|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154759882|NCT00081861|Growth Substances|growth substances|mesh-ancestor
154759883|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759884|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
154759885|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
154759886|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154759887|NCT03120234|Fentanyl|fentanyl|mesh-list
154759888|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
154759889|NCT03120234|Ketamine|ketamine|mesh-list
154759890|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154759891|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759892|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759893|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154759894|NCT03120234|Analgesics|analgesics|mesh-ancestor
153375019|NCT02420262|Incretins|incretins|mesh-ancestor
154759895|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
154759896|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759897|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154759898|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154759899|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154759900|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
154759901|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759902|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759903|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154759904|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154511831|NCT05797948|Growth Substances|growth substances|mesh-ancestor
154759905|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
154759906|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
154759907|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154759908|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154759909|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154759910|NCT03120234|Narcotics|narcotics|mesh-ancestor
154759911|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154759912|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
154759913|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154759914|NCT03232710|Aripiprazole|aripiprazole|mesh-list
154759915|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
154759916|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154759917|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154759918|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154759919|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759920|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759921|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
154759922|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
154759923|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154759924|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759925|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154759926|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154759927|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
154759928|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154759929|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154759930|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154759931|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154759932|NCT03227484|Empagliflozin|empagliflozin|mesh-list
154759933|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154759934|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759935|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154759936|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759937|NCT01744691|Ibrutinib|ibrutinib|mesh-list
154759938|NCT01744691|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154759939|NCT01744691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154759940|NCT01744691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759941|NCT01744691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759942|NCT02038894|Propofol|propofol|mesh-list
154759943|NCT02038894|Sevoflurane|sevoflurane|mesh-list
154759944|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154759945|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154759946|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154759947|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154759948|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
154759949|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
154759950|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154759951|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154759952|NCT01375374|Lacosamide|lacosamide|mesh-list
154759953|NCT01375374|Levetiracetam|levetiracetam|mesh-list
154759954|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
154759955|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
154759956|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154759957|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154759958|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154759959|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759960|NCT04348786|Amoxicillin|amoxicillin|mesh-list
154759961|NCT04348786|Doxycycline|doxycycline|mesh-list
154759962|NCT04348786|Levofloxacin|levofloxacin|mesh-list
154759963|NCT04348786|Esomeprazole|esomeprazole|mesh-list
154759964|NCT04348786|Bismuth|bismuth|mesh-list
154759965|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154759966|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154759967|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154759968|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154759969|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154759970|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154759971|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154759972|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759973|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
154759974|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154759975|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154759976|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154759977|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154759978|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154511904|NCT05797220|Cholinergic Agents|cholinergic agents|mesh-ancestor
154759979|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154759980|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154759981|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153835125|NCT00524199|Mesna|mesna|mesh-list
154759982|NCT04348786|Antacids|antacids|mesh-ancestor
154759983|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
154759984|NCT02369068|Triamcinolone|triamcinolone|mesh-list
154759985|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154759986|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154759987|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154759988|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154759989|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
154759990|NCT02369068|Hormones|hormones|mesh-ancestor
154759991|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154759992|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835147|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
154759993|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154759994|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
154759995|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154759996|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154759997|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154759998|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154759999|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760000|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
154760001|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760002|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
154760003|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154760004|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760005|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154760006|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760007|NCT02371252|Alendronate|alendronate|mesh-list
154760008|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154760009|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760010|NCT03221946|Diclofenac|diclofenac|mesh-list
154760011|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154760012|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154760013|NCT03221946|Analgesics|analgesics|mesh-ancestor
154760014|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
154760015|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760016|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760017|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154760018|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760019|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154760020|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760021|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760022|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
154760023|NCT03229746|Vincristine|vincristine|mesh-list
154760024|NCT03229746|Azathioprine|azathioprine|mesh-list
154760025|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154760026|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760027|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
154760028|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
154760029|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
154760030|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760031|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
154760032|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154760033|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154760034|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760035|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760036|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760037|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
154760038|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154760039|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760040|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
154760041|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760042|NCT02040298|Clemastine|clemastine|mesh-list
154760043|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
154760044|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
154760045|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153835261|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760046|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
154760047|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
154760048|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760049|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760050|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760051|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154760052|NCT03229668|Pregabalin|pregabalin|mesh-list
154760053|NCT03229668|Analgesics|analgesics|mesh-ancestor
154760054|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
154760055|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511977|NCT05622123|Incretins|incretins|mesh-ancestor
154760056|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760058|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154760059|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760060|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760061|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154760062|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154760063|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154760064|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760065|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154760066|NCT03230058|Voriconazole|voriconazole|mesh-list
154760067|NCT03230058|Natamycin|natamycin|mesh-list
154760068|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154760069|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154760070|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
154760071|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760072|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154760073|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154760074|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760075|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760076|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154760077|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
154760078|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760079|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760080|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154760081|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154760082|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154760083|NCT01985542|Immunomodulating Agents|immunomodulating agents|mesh-list
154760084|NCT01985542|Immunologic Factors|immunologic factors|mesh-ancestor
154760085|NCT01985542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835300|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153835301|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154760086|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154760087|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760088|NCT00081939|Thalidomide|thalidomide|mesh-list
154760089|NCT00081939|Bortezomib|bortezomib|mesh-list
154760090|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760091|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760092|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
154760093|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760094|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
154760095|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154760096|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760097|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154760098|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154760099|NCT00081939|Growth Substances|growth substances|mesh-ancestor
154760100|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
154760101|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
154760102|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154760103|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154760104|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760105|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760106|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760107|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
154760108|NCT03221634|Daratumumab|daratumumab|mesh-list
154760109|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760110|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760111|NCT03221634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154760112|NCT03221634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760113|NCT05003037|Carboplatin|carboplatin|mesh-list
154760114|NCT05003037|Pemetrexed|pemetrexed|mesh-list
154760115|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760116|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760117|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760118|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154760119|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154760120|NCT02374060|Dexamethasone|dexamethasone|mesh-list
154760121|NCT02374060|Triamcinolone|triamcinolone|mesh-list
154760122|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154760123|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154760124|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154760125|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154760126|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
154760127|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
154512052|NCT05215548|Afatinib|afatinib|mesh-list
154760128|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760129|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760130|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154760131|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
153835380|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835381|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153835382|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153835383|NCT05149274|Fexuprazan|fexuprazan|mesh-list
153835384|NCT05149274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835385|NCT02276690|Hepcidins|hepcidins|mesh-list
153835386|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835387|NCT02947269|Prucalopride|prucalopride|mesh-list
153835388|NCT02947269|Laxatives|laxatives|mesh-ancestor
154257413|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153808523|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154760133|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760134|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154760135|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760136|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760137|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
154760138|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835469|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835470|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
153375570|NCT02772783|Insulin|insulin|mesh-list
153810005|NCT00349791|Hormones|hormones|mesh-ancestor
154760139|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760140|NCT03221166|Thalidomide|thalidomide|mesh-list
154760141|NCT03221166|Infliximab|infliximab|mesh-list
154760142|NCT03221166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154760143|NCT03221166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154760144|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
154760145|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154760146|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760147|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760148|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
154760149|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760150|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
154760151|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154760152|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760153|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154760154|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154760155|NCT03221166|Growth Substances|growth substances|mesh-ancestor
154760156|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
154760157|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760158|NCT03220932|Bevacizumab|bevacizumab|mesh-list
154760159|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760160|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760161|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154760162|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154760163|NCT03220932|Growth Substances|growth substances|mesh-ancestor
154760164|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760165|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
153835601|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153835602|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835603|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153835604|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153835605|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153375664|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375665|NCT05450055|Lidocaine|lidocaine|mesh-list
153375666|NCT05450055|Analgesics|analgesics|mesh-list
153810416|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
153810417|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
153810418|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153810419|NCT00319163|Estradiol|estradiol|mesh-list
153810420|NCT00319163|Estrogens|estrogens|mesh-ancestor
153810421|NCT00319163|Hormones|hormones|mesh-ancestor
153810422|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153810423|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810424|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153810425|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
153810426|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153810427|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153810428|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153810429|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153810465|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153810466|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153810467|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
153810537|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357176|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153432192|NCT05118490|Isoniazid|isoniazid|mesh-list
153357208|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
153357209|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357210|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
153357211|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
153357212|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432275|NCT05087914|Analgesics|analgesics|mesh-ancestor
153864397|NCT00565500|Ibuprofen|ibuprofen|mesh-list
153810580|NCT00346749|Fluticasone|fluticasone|mesh-list
154760166|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
154760167|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154760168|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760169|NCT04484688|Bisoprolol|bisoprolol|mesh-list
154760170|NCT04484688|Perindopril|perindopril|mesh-list
154760171|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154760172|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
154760173|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
154760174|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375732|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153375733|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375734|NCT04080843|Capecitabine|capecitabine|mesh-list
153375735|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
153375736|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153375737|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
153375738|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375739|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375740|NCT04737837|Lacosamide|lacosamide|mesh-list
153736359|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736360|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153357217|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357231|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357232|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357233|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154760175|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760176|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154760177|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154760178|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154760179|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154760180|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760181|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760182|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154760183|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
154760184|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375756|NCT02973711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375757|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153375758|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153375759|NCT02369874|Durvalumab|durvalumab|mesh-list
153375760|NCT02369874|Tremelimumab|tremelimumab|mesh-list
153375761|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153375762|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153375763|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375764|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
153375765|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375766|NCT00372645|Folic Acid|folic acid|mesh-list
154760185|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
154760186|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760187|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154760188|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760189|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760190|NCT00082329|Plerixafor|plerixafor|mesh-list
154760191|NCT00082329|Lenograstim|lenograstim|mesh-list
154760192|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154760193|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
153375779|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153375780|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153375781|NCT00372801|Analgesics|analgesics|mesh-ancestor
153375782|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
153375783|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375784|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375785|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375786|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153375787|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153864567|NCT00564642|Protective Agents|protective agents|mesh-ancestor
153357238|NCT00741026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153405037|NCT00358358|Xhance|xhance|mesh-list
154257414|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
154760194|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760195|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154760196|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154760197|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
154760198|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760199|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
154760200|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154760201|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760202|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154760203|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
154760204|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154760205|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760206|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154760207|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
154760208|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154760209|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154760210|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154760211|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257415|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
154257416|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257417|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257418|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
154257419|NCT01170494|Vitamin D|vitamin d|mesh-list
154257420|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
154257421|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154257422|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257423|NCT01170494|Vitamins|vitamins|mesh-ancestor
153732031|NCT00140348|Immunologic Factors|immunologic factors|mesh-ancestor
153388017|NCT00000885|Lamivudine|lamivudine|mesh-list
153375800|NCT05455359|Laxatives|laxatives|mesh-ancestor
153375801|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153375802|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153375803|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
153375804|NCT00373503|Lofexidine|lofexidine|mesh-list
153375806|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
153810606|NCT00320567|Norgestimate|norgestimate|mesh-list
153810607|NCT00320567|Estradiol|estradiol|mesh-list
153810608|NCT00320567|Estrogens|estrogens|mesh-ancestor
154760212|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760213|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
154760214|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760215|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760216|NCT03220542|Amoxicillin|amoxicillin|mesh-list
154760217|NCT03220542|Clarithromycin|clarithromycin|mesh-list
154760218|NCT03220542|Sulforaphane|sulforaphane|mesh-list
154760219|NCT03220542|Esomeprazole|esomeprazole|mesh-list
154760220|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154760221|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760222|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154760223|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154760224|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154760225|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760226|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760227|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154760228|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154760229|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154760230|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154760231|NCT03220542|Protective Agents|protective agents|mesh-ancestor
154760232|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760233|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760234|NCT03220152|Tenofovir|tenofovir|mesh-list
154760235|NCT03220152|Emtricitabine|emtricitabine|mesh-list
154760236|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
154760237|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760238|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154760239|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154760240|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760241|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760242|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154257424|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
154257425|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154257426|NCT01587326|Escitalopram|escitalopram|mesh-list
154257427|NCT01587326|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154257428|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154257429|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154257430|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257431|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257432|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
154257433|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760243|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154760244|NCT03220464|Interferons|interferons|mesh-list
154760245|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
154760246|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760247|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
154760248|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760249|NCT03206658|Spironolactone|spironolactone|mesh-list
154760250|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154760251|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
154760252|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760253|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760254|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154760255|NCT03206658|Diuretics|diuretics|mesh-ancestor
154760256|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
154760257|NCT00170157|Ipilimumab|ipilimumab|mesh-list
154760258|NCT00170157|Leuprolide|leuprolide|mesh-list
154760259|NCT00170157|Goserelin|goserelin|mesh-list
154760260|NCT00170157|Bicalutamide|bicalutamide|mesh-list
154760261|NCT00170157|Flutamide|flutamide|mesh-list
154760262|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760263|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760264|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154760265|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760266|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154760267|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
154760268|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154760269|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760270|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154257438|NCT03294538|Estrogens|estrogens|mesh-ancestor
154257439|NCT03294538|Hormones|hormones|mesh-ancestor
154257440|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257441|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257442|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154257443|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
154257444|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154257445|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154257446|NCT03872336|Labetalol|labetalol|mesh-list
153388078|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153835786|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153835787|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153835788|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835789|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835790|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
153375851|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
153375852|NCT01516268|Sufentanil|sufentanil|mesh-list
153375853|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153375854|NCT01516268|Narcotics|narcotics|mesh-ancestor
154760271|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
154760272|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
154760273|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760274|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
154760275|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
154760276|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760277|NCT00170625|Topotecan|topotecan|mesh-list
154760278|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154760279|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154760280|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760281|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760282|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760284|NCT02043652|Primaquine|primaquine|mesh-list
154760285|NCT02043652|Amebicides|amebicides|mesh-ancestor
154760286|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154760287|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154760288|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760289|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
153388130|NCT04344041|Vitamin D|vitamin d|mesh-list
153835808|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153835809|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
153835810|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835811|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153375876|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357240|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760290|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760291|NCT01898169|Nicotine|nicotine|mesh-list
154760292|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154760293|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
154760294|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760295|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760296|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154760297|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154760298|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
154760299|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760300|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760301|NCT03227016|Topotecan|topotecan|mesh-list
154760302|NCT03227016|Veliparib|veliparib|mesh-list
154760303|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154760304|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154760305|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154760306|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760307|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760308|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835842|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153835843|NCT00528177|Morphine|morphine|mesh-list
153835844|NCT00528177|Oxycodone|oxycodone|mesh-list
153835845|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153835846|NCT00528177|Narcotics|narcotics|mesh-ancestor
153835847|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835848|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835849|NCT00528177|Analgesics|analgesics|mesh-ancestor
153375911|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153375912|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153375913|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375914|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375915|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375916|NCT02787057|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153375917|NCT02787057|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153375918|NCT01468532|Prednisone|prednisone|mesh-list
153375919|NCT01468532|Docetaxel|docetaxel|mesh-list
153375920|NCT01468532|Pasireotide|pasireotide|mesh-list
153375921|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375922|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
153375928|NCT01468532|Hormones|hormones|mesh-ancestor
153810611|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357241|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357242|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357243|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
153357244|NCT00741104|Infliximab|infliximab|mesh-list
153357245|NCT00741104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154760309|NCT04748991|Amiodarone|amiodarone|mesh-list
154760310|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154760311|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
154760312|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154760313|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760314|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760315|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154760316|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154760317|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154760318|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760319|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154760320|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154760321|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153835869|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153835870|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835871|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
153835872|NCT02953106|Fluticasone|fluticasone|mesh-list
153835873|NCT02953106|Azelastine|azelastine|mesh-list
153835874|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375937|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153375938|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153375939|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153375940|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
153375941|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
153375942|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375943|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375944|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375956|NCT06195306|Tamoxifen|tamoxifen|mesh-list
153357255|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760322|NCT03230136|Anesthetics|anesthetics|mesh-list
154760323|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760324|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760325|NCT00176865|Cyclosporine|cyclosporine|mesh-list
154760326|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
154760327|NCT00176865|Fludarabine|fludarabine|mesh-list
154760328|NCT00176865|Melphalan|melphalan|mesh-list
154760329|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
154760330|NCT00176865|Cyclosporins|cyclosporins|mesh-list
154760331|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154760332|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
153848146|NCT03540758|Niacin|niacin|mesh-list
153375963|NCT06195306|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153375965|NCT06195306|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153375966|NCT06195267|Sivelestat|sivelestat|mesh-list
153375967|NCT06195267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153375968|NCT06195267|Protease Inhibitors|protease inhibitors|mesh-ancestor
153375969|NCT06195267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375970|NCT06195267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375971|NCT06195254|Antibodies|antibodies|mesh-list
153375972|NCT06195254|Antibodies, Blocking|antibodies, blocking|mesh-list
154760333|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154760334|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
154760335|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154760336|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760337|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760338|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760339|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
154760340|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760341|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760342|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
154760343|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760344|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
154760345|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760346|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154760347|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154760348|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154760349|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
154760350|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154760351|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154760352|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
154760353|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154760354|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760355|NCT02451072|Ketanserin|ketanserin|mesh-list
154760356|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154760357|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
154760358|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257447|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154257448|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154257449|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
154257450|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257451|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257452|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257453|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154257454|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
154257455|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
153388303|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153375984|NCT06195137|Purinergic Agents|purinergic agents|mesh-ancestor
153375985|NCT06195137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375986|NCT06195137|Antioxidants|antioxidants|mesh-ancestor
153375987|NCT06195137|Protective Agents|protective agents|mesh-ancestor
153375988|NCT06195137|Vitamin B Complex|vitamin b complex|mesh-ancestor
153375989|NCT06195137|Vitamins|vitamins|mesh-ancestor
153375990|NCT06195137|Micronutrients|micronutrients|mesh-ancestor
153375991|NCT06195111|Trifluridine|trifluridine|mesh-list
153375992|NCT06195111|Antimetabolites|antimetabolites|mesh-ancestor
153375993|NCT06195111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375994|NCT06195111|Antiviral Agents|antiviral agents|mesh-ancestor
153375995|NCT06195111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760359|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154760360|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154760361|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
154760362|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760363|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760364|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154760365|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154760366|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154760367|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154760368|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760369|NCT02450994|Dexamethasone|dexamethasone|mesh-list
153357256|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154760370|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154760371|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
154760372|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
154760373|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760374|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760375|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154760376|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
154760377|NCT02450994|Hormones|hormones|mesh-ancestor
154760378|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760379|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153835997|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376065|NCT06191289|Estrogens|estrogens|mesh-ancestor
153376066|NCT06191289|Hormones|hormones|mesh-ancestor
153376067|NCT06191289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376068|NCT06191289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376069|NCT06191250|Durvalumab|durvalumab|mesh-list
153376070|NCT06191250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376071|NCT06191250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376072|NCT06191133|Fenofibrate|fenofibrate|mesh-list
153376073|NCT06191133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153810630|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154760380|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760381|NCT00177255|Docetaxel|docetaxel|mesh-list
154760382|NCT00177255|Capecitabine|capecitabine|mesh-list
154760383|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760384|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
154760385|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
154760386|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
154760387|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760388|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154760389|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
154760390|NCT02401048|Durvalumab|durvalumab|mesh-list
154760391|NCT02401048|Ibrutinib|ibrutinib|mesh-list
154760392|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760393|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760394|NCT02401048|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154760395|NCT02401048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154760396|NCT02401048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760397|NCT02401048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376096|NCT06190691|Pirtobrutinib|pirtobrutinib|mesh-list
153376097|NCT06190691|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153376098|NCT06190691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153376099|NCT06190691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376100|NCT06190691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376101|NCT06190678|Pirtobrutinib|pirtobrutinib|mesh-list
153376102|NCT06190678|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153376103|NCT06190678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153376104|NCT06190678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376105|NCT06190678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376107|NCT06190600|Cyclophosphamide|cyclophosphamide|mesh-list
153376108|NCT06190600|Doxorubicin|doxorubicin|mesh-list
153376109|NCT06190600|Trastuzumab|trastuzumab|mesh-list
153376110|NCT06190600|Pertuzumab|pertuzumab|mesh-list
153376111|NCT06190600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153376112|NCT06190600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836026|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154760398|NCT02046382|Acetaminophen|acetaminophen|mesh-list
154760399|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154760400|NCT02046382|Analgesics|analgesics|mesh-ancestor
154760401|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
154760402|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760403|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760404|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
154760405|NCT03205176|Olaparib|olaparib|mesh-list
154760406|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154760407|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760408|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760409|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760410|NCT02046772|Morphine|morphine|mesh-list
154760411|NCT02046772|Bupivacaine|bupivacaine|mesh-list
154760412|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
154760413|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
154760414|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760415|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760416|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
154760417|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760418|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154760419|NCT02046772|Narcotics|narcotics|mesh-ancestor
154760420|NCT02046772|Analgesics|analgesics|mesh-ancestor
154760421|NCT00178503|Methylphenidate|methylphenidate|mesh-list
154760422|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154760423|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257456|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257457|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154257458|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154257459|NCT02987530|Tenofovir|tenofovir|mesh-list
154257460|NCT02987530|Emtricitabine|emtricitabine|mesh-list
154257461|NCT02987530|Dolutegravir|dolutegravir|mesh-list
154257462|NCT02987530|Darunavir|darunavir|mesh-list
154257463|NCT02987530|Cobicistat|cobicistat|mesh-list
154257464|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154257465|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
154257466|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257467|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153732032|NCT00140348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732033|NCT01240759|Metformin|metformin|mesh-list
153388491|NCT00001131|Aldesleukin|aldesleukin|mesh-list
153376119|NCT06190600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376120|NCT06190600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376121|NCT06190600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153376122|NCT06190600|Alkylating Agents|alkylating agents|mesh-ancestor
153376123|NCT06190600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153376127|NCT06190600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760424|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154760425|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154760426|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760427|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760428|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
154760429|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760430|NCT02376010|Warfarin|warfarin|mesh-list
154760431|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
153376142|NCT06190483|Antiemetics|antiemetics|mesh-ancestor
153376143|NCT06190483|Autonomic Agents|autonomic agents|mesh-ancestor
153376144|NCT06190483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376145|NCT06190483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153376146|NCT06190483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153376147|NCT06190483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376148|NCT06190483|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153376149|NCT06190483|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154760432|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
154760433|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154760434|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
154760435|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154760436|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
154760437|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760438|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760439|NCT00085293|Decitabine|decitabine|mesh-list
154760440|NCT00085293|Azacitidine|azacitidine|mesh-list
154760441|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153376173|NCT06190405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376174|NCT06190314|Vitamin B 12|vitamin b 12|mesh-list
153376175|NCT06190314|Hydroxocobalamin|hydroxocobalamin|mesh-list
153376176|NCT06190314|Vitamins|vitamins|mesh-ancestor
153376177|NCT06190314|Micronutrients|micronutrients|mesh-ancestor
153376178|NCT06190314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376179|NCT06190314|Vitamin B Complex|vitamin b complex|mesh-ancestor
153376180|NCT06190314|Hematinics|hematinics|mesh-ancestor
153376181|NCT06190301|Rituximab|rituximab|mesh-list
153376182|NCT06190301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376184|NCT06190301|Immunologic Factors|immunologic factors|mesh-ancestor
153865075|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154760442|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154760443|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
154760444|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760445|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760446|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760447|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154760448|NCT02402062|Sunitinib|sunitinib|mesh-list
154760449|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760450|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154760451|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154760452|NCT02402062|Growth Substances|growth substances|mesh-ancestor
154760453|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257468|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154257469|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257470|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257471|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154257472|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154257473|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154257474|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153732034|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153376204|NCT06190158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376205|NCT06190158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153376206|NCT06190145|Teriflunomide|teriflunomide|mesh-list
153376209|NCT06190145|Analgesics|analgesics|mesh-ancestor
153865359|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865360|NCT00565383|Analgesics|analgesics|mesh-ancestor
153865361|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
153865362|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760454|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
154760455|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154760456|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760457|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760458|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154760459|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154760460|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
154760461|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760462|NCT02450838|Antacids|antacids|mesh-ancestor
153376235|NCT06189898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376236|NCT06189885|Vancomycin|vancomycin|mesh-list
153376237|NCT06189885|Cefazolin|cefazolin|mesh-list
153376238|NCT06189885|Daptomycin|daptomycin|mesh-list
153376239|NCT06189885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153376240|NCT06189885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376241|NCT06188260|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153376242|NCT06188260|Lubricant Eye Drops|lubricant eye drops|mesh-list
153376243|NCT06188260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153376244|NCT06188026|Levonorgestrel|levonorgestrel|mesh-list
153357267|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760463|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760464|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154760465|NCT03214302|Tenofovir|tenofovir|mesh-list
154760466|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
154760467|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760468|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154760469|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154760470|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760471|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760472|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154760473|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154760474|NCT00085839|Paclitaxel|paclitaxel|mesh-list
154760475|NCT00085839|Carboplatin|carboplatin|mesh-list
154760476|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153376265|NCT06187311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376266|NCT06187311|Anticoagulants|anticoagulants|mesh-ancestor
153836182|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
153836183|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836184|NCT02951897|Pemetrexed|pemetrexed|mesh-list
153836185|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836186|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836187|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836188|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153836189|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153836190|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
153836191|NCT00511823|Granisetron|granisetron|mesh-list
153836192|NCT00511823|Casopitant|casopitant|mesh-list
153836193|NCT00511823|Dolasetron|dolasetron|mesh-list
153836194|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153405961|NCT05749926|Vaccines|vaccines|mesh-list
154760477|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154760478|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760479|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
154760480|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
154760481|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154760482|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760483|NCT00085839|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154760484|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154760485|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760486|NCT03204474|Lacosamide|lacosamide|mesh-list
154760487|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
154760488|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153388703|NCT00002097|Ionophores|ionophores|mesh-ancestor
153810652|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153810653|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
153865589|NCT04590183|Tacrolimus|tacrolimus|mesh-list
153406034|NCT05601700|Paclitaxel|paclitaxel|mesh-list
153406064|NCT05460871|Pregabalin|pregabalin|mesh-list
154760489|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154760490|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760491|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760492|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154760493|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154760494|NCT03204318|Norethindrone|norethindrone|mesh-list
154760495|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
154760496|NCT03204318|Estradiol|estradiol|mesh-list
154760497|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154760498|NCT03204318|Relugolix|relugolix|mesh-list
154760499|NCT03204318|Estrogens|estrogens|mesh-ancestor
154760500|NCT03204318|Hormones|hormones|mesh-ancestor
154760501|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760502|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512443|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
154760503|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154760504|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
154760505|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154760506|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154760507|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154760508|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154760509|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154760510|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
154760511|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
154760512|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
154760513|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154760514|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760515|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760516|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154760517|NCT03204006|Analgesics|analgesics|mesh-ancestor
154760518|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
154760519|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257475|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154257476|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154257477|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
154257478|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154257479|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154257480|NCT03865550|Ketamine|ketamine|mesh-list
154760520|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154760521|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154760522|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154760523|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
154760524|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760525|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760526|NCT03226080|Rocuronium|rocuronium|mesh-list
154760527|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154760528|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154760529|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154760530|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760531|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760532|NCT03225924|Prednisone|prednisone|mesh-list
154760533|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
154760534|NCT03225924|Rituximab|rituximab|mesh-list
154760535|NCT03225924|Doxorubicin|doxorubicin|mesh-list
154760536|NCT03225924|Vincristine|vincristine|mesh-list
154760537|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760538|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
154760539|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760540|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760541|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154760542|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
154760543|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257493|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257494|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
154257495|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257496|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154257497|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154257498|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257499|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257500|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
154257501|NCT01285466|Paclitaxel|paclitaxel|mesh-list
154257502|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154257503|NCT01285466|Trastuzumab|trastuzumab|mesh-list
154257504|NCT01285466|Dactolisib|dactolisib|mesh-list
154257505|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154257506|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257507|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
153732035|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388769|NCT00001449|Protective Agents|protective agents|mesh-ancestor
153376356|NCT06061575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153376357|NCT06061575|Analgesics|analgesics|mesh-ancestor
153376358|NCT06061575|Sensory System Agents|sensory system agents|mesh-ancestor
153376359|NCT06061575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376360|NCT06061575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376361|NCT06061575|Antipyretics|antipyretics|mesh-ancestor
153376362|NCT06061575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154760544|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760545|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154760546|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760547|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154760548|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154760549|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154760550|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760551|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153388793|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
153376379|NCT06029998|Bortezomib|bortezomib|mesh-list
153376380|NCT06029998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376381|NCT06026852|Meropenem|meropenem|mesh-list
153376382|NCT06026852|Tazobactam|tazobactam|mesh-list
153376383|NCT06026852|Piperacillin|piperacillin|mesh-list
153376384|NCT06026852|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153376385|NCT06026852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153836292|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865715|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865717|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
153865718|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153865719|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153865720|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153865721|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406179|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
153406202|NCT05206110|Analgesics|analgesics|mesh-ancestor
154760552|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
154760553|NCT03225924|Hormones|hormones|mesh-ancestor
154760554|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760555|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154760556|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154760557|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
154760558|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
154760559|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
154760560|NCT03119532|Metronidazole|metronidazole|mesh-list
154760561|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376404|NCT06008860|Respiratory System Agents|respiratory system agents|mesh-ancestor
153376405|NCT06008860|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153376406|NCT06008860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376407|NCT06008860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376408|NCT06008860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153376409|NCT06008860|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153376410|NCT06008860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153376411|NCT06008860|Histamine Antagonists|histamine antagonists|mesh-ancestor
153376412|NCT06008860|Histamine Agents|histamine agents|mesh-ancestor
153865782|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
153865817|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865818|NCT04588389|Lidocaine|lidocaine|mesh-list
153865819|NCT04588389|Ropivacaine|ropivacaine|mesh-list
153865820|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
153865821|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
153865822|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865823|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865824|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
153865825|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865826|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153865827|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153865828|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153406251|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760562|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154760563|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154760564|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154760565|NCT02404168|Lamotrigine|lamotrigine|mesh-list
154760566|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
154760567|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154760568|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760569|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760570|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154760571|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760572|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154760573|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154760574|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376436|NCT06001658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376437|NCT06001658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153376438|NCT05980559|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153376439|NCT05980559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153836349|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
153836350|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836351|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153836352|NCT00513656|Oxycodone|oxycodone|mesh-list
153836353|NCT00513656|Naloxone|naloxone|mesh-list
153836354|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153836355|NCT00513656|Narcotics|narcotics|mesh-ancestor
153836356|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836357|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836359|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
153810660|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154760575|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154760576|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154760578|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
154760579|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
154760580|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760581|NCT02051452|Methylphenidate|methylphenidate|mesh-list
154760582|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154760583|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760584|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153836373|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836374|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
153836375|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153836376|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153836377|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
153836379|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836380|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
153836381|NCT00513929|Astringents|astringents|mesh-ancestor
153836382|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836383|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
153865892|NCT04619303|Hormones|hormones|mesh-ancestor
153865910|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153865911|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
153865912|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865913|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865914|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406342|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153406343|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406344|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406345|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406346|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406347|NCT04721548|Minoxidil|minoxidil|mesh-list
153406348|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154760585|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154760586|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760587|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760588|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
154760589|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760590|NCT00180687|Bupivacaine|bupivacaine|mesh-list
154760591|NCT00180687|Coal Tar|coal tar|mesh-list
154760592|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
154760593|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
154760594|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760595|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760596|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
153376483|NCT05938608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153836393|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836394|NCT00512291|Olanzapine|olanzapine|mesh-list
153836395|NCT00512291|Fluoxetine|fluoxetine|mesh-list
153836396|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
153836397|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
153836398|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836399|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406382|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
153406383|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810673|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154760597|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760598|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
154760599|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
154760600|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154760601|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
154760602|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760603|NCT02384044|Listerine|listerine|mesh-list
154760604|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
154760605|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
154760606|NCT02384044|Protective Agents|protective agents|mesh-ancestor
154760607|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760608|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154760609|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760610|NCT02384200|Vancomycin|vancomycin|mesh-list
154760611|NCT02384200|Gentamicins|gentamicins|mesh-list
154760612|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
154760613|NCT02384200|Ampicillin|ampicillin|mesh-list
154760614|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
154760615|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154760616|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760617|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154760618|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760619|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760620|NCT02384200|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154760621|NCT02384200|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154257508|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
154257509|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
154257510|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257511|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154257513|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154257514|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154257515|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
154257516|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389017|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153836417|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836418|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
153836419|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836420|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836421|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
153836422|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153836423|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836424|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153836425|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153836426|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153836427|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836428|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
153836429|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760622|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154760623|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
154760624|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154760625|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154760626|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760627|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
154760628|NCT02051686|Coagulants|coagulants|mesh-ancestor
154760629|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
154760630|NCT00182793|Melphalan|melphalan|mesh-list
154760631|NCT00182793|Thiotepa|thiotepa|mesh-list
154760632|NCT00182793|Carboplatin|carboplatin|mesh-list
154760633|NCT00182793|Trastuzumab|trastuzumab|mesh-list
154760634|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760635|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
154760636|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376535|NCT05833763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376536|NCT05833763|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153376537|NCT05833763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153836440|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153836441|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836442|NCT00531336|Bevacizumab|bevacizumab|mesh-list
153836443|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836444|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836445|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153836446|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153836447|NCT00531336|Growth Substances|growth substances|mesh-ancestor
153836448|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836449|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
154760637|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760638|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154760639|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
154760640|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760641|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760642|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154760643|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760644|NCT00183339|Fluoxetine|fluoxetine|mesh-list
154760645|NCT00183339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154760646|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154760647|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760648|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760649|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760650|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
154257517|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154257518|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154257519|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257520|NCT01174394|Fluoxetine|fluoxetine|mesh-list
154257521|NCT01174394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154257522|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154257523|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732036|NCT00140387|Immunomodulating Agents|immunomodulating agents|mesh-list
153389059|NCT00002349|Stavudine|stavudine|mesh-list
153376567|NCT05819619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836467|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836468|NCT00512486|Benralizumab|benralizumab|mesh-list
153836469|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153836470|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
153836471|NCT00530595|Losartan|losartan|mesh-list
153406556|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153406558|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
153406559|NCT04294459|Promethazine|promethazine|mesh-list
153406560|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
153406561|NCT04294459|Ranitidine|ranitidine|mesh-list
153406562|NCT04294459|Montelukast|montelukast|mesh-list
153406563|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406565|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
153406566|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406567|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406568|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
153406570|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
154760651|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760652|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154760653|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
154760654|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154760655|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154760656|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154760657|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760658|NCT01743989|Nilotinib|nilotinib|mesh-list
154760659|NCT01743989|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154760660|NCT01743989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154760661|NCT01743989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376598|NCT05766267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810677|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
153810678|NCT00347100|Glyburide|glyburide|mesh-list
154760662|NCT01743989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760663|NCT00183729|Memantine|memantine|mesh-list
154760664|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154760665|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154760666|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
154760667|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760668|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760669|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760670|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154760671|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154257524|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257525|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257526|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
154257527|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257528|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154257529|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
154257530|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154257531|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154257532|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153732037|NCT00140387|Immunologic Factors|immunologic factors|mesh-ancestor
153406628|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406629|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406630|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
153406631|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153406632|NCT04194528|Narcotics|narcotics|mesh-ancestor
154760672|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
154760673|NCT00186069|Analgesics|analgesics|mesh-ancestor
154760674|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
154760675|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760676|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760677|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
154760678|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760679|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154760680|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
154760681|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154760682|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760683|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760684|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154760685|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
154760686|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154760687|NCT01742897|Fentanyl|fentanyl|mesh-list
154760688|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154760689|NCT01742897|Narcotics|narcotics|mesh-ancestor
154760690|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760691|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760692|NCT01742897|Analgesics|analgesics|mesh-ancestor
154760693|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
154760694|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760695|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154760696|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154760697|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
154760698|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
154760699|NCT01741259|Meperidine|meperidine|mesh-list
154257533|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257534|NCT01174472|Paclitaxel|paclitaxel|mesh-list
154257535|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154257536|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257537|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
154257538|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
154257539|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
154257540|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389139|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
153836564|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
153836565|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836566|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
153836567|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153836568|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836569|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836570|NCT00531024|Bevacizumab|bevacizumab|mesh-list
153836571|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836572|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836573|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154760700|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154760701|NCT01741259|Narcotics|narcotics|mesh-ancestor
154760702|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760703|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760704|NCT01741259|Analgesics|analgesics|mesh-ancestor
154760705|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
154760706|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760707|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154760708|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154760709|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
154760710|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154760711|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
154760712|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154760713|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760714|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154760715|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154760716|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760717|NCT02387554|Losartan|losartan|mesh-list
154760718|NCT02387554|Amlodipine|amlodipine|mesh-list
154760719|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
154760720|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154760721|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154760722|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760723|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760724|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154760725|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257541|NCT00335153|Levodopa|levodopa|mesh-list
154257542|NCT00335153|Carbidopa|carbidopa|mesh-list
154257543|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154257544|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154257545|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154257546|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
154257547|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257548|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389172|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
153836592|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836593|NCT02943798|Paclitaxel|paclitaxel|mesh-list
153836594|NCT02943798|Etoposide|etoposide|mesh-list
153836595|NCT02943798|Carboplatin|carboplatin|mesh-list
153836596|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153836597|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836598|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
153836599|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
153836600|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
153836601|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836602|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153836605|NCT02943369|Ticagrelor|ticagrelor|mesh-list
154760726|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
154760727|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154760728|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154760729|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154760730|NCT02387554|Diuretics|diuretics|mesh-ancestor
154760731|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
154760732|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154760733|NCT02387710|Tiagabine|tiagabine|mesh-list
154760734|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
154760735|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
154760736|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154760737|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760738|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760739|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
154760740|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732039|NCT00504634|Bortezomib|bortezomib|mesh-list
153836620|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836621|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836622|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153836623|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153836624|NCT00515957|Antibodies|antibodies|mesh-list
153836625|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
153836626|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836627|NCT02943642|Vorinostat|vorinostat|mesh-list
153836628|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836629|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153836630|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836631|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836632|NCT04695509|Propofol|propofol|mesh-list
153836638|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
154760741|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760742|NCT01740791|Velpatasvir|velpatasvir|mesh-list
154760743|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
154760744|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760745|NCT01740323|Curcumin|curcumin|mesh-list
154760746|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154760747|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154760748|NCT01740323|Analgesics|analgesics|mesh-ancestor
154760749|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
154760750|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760751|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760752|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154760753|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760754|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760755|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760756|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760757|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
154760758|NCT00090051|Rituximab|rituximab|mesh-list
154760759|NCT00090051|Fludarabine|fludarabine|mesh-list
154760760|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
154760761|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760762|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
154760763|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760764|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760765|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154760766|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
154760767|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760768|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760769|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154760770|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154760771|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154760772|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
154760773|NCT01740089|Ribavirin|ribavirin|mesh-list
154760774|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154760775|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
154760776|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760777|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
154760778|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760779|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
154760780|NCT01739933|Propofol|propofol|mesh-list
154760781|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154760782|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760783|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760784|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154760785|NCT01739933|Analgesics|analgesics|mesh-ancestor
154760786|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
154760787|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760788|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154760789|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154760790|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154760791|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
154760792|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760793|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760794|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154760795|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
154760796|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
154760797|NCT00094497|Doxorubicin|doxorubicin|mesh-list
154760798|NCT00094497|Etoposide|etoposide|mesh-list
154760799|NCT00094497|Mitotane|mitotane|mesh-list
154760800|NCT00094497|Streptozocin|streptozocin|mesh-list
153836662|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153836663|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153836664|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153836665|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836666|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153836667|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153836671|NCT02943252|Apatinib|apatinib|mesh-list
153836672|NCT02943252|Tegafur|tegafur|mesh-list
153836673|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836674|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153836675|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376750|NCT05681299|Incretins|incretins|mesh-ancestor
153376751|NCT05675813|Azacitidine|azacitidine|mesh-list
153376752|NCT05675813|Tislelizumab|tislelizumab|mesh-list
153376753|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153376754|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
153376755|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406715|NCT03916510|Capecitabine|capecitabine|mesh-list
153406756|NCT03829371|Melphalan|melphalan|mesh-list
153406757|NCT03829371|Bortezomib|bortezomib|mesh-list
153406758|NCT03829371|Daratumumab|daratumumab|mesh-list
153406759|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866289|NCT00563147|Temsirolimus|temsirolimus|mesh-list
153866407|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760801|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760802|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154760803|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154760804|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154760805|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760806|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760807|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154760808|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154760809|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
154760810|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154760811|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
154760812|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760813|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760814|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154760815|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
154760816|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154760817|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
154760818|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760819|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760820|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154760821|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
154760822|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
154760823|NCT00094887|Protective Agents|protective agents|mesh-ancestor
154760824|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
154760825|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760826|NCT00097695|Icatibant|icatibant|mesh-list
154760827|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154760828|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154760829|NCT00097695|Analgesics|analgesics|mesh-ancestor
154760830|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
154760831|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760832|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760833|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154760834|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760835|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154760836|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154760837|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760838|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154760839|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154760840|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
154760841|NCT02096679|Osimertinib|osimertinib|mesh-list
154760842|NCT02096679|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154760843|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154760844|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760845|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760846|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760847|NCT00195039|Antibodies|antibodies|mesh-list
154760848|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154760849|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
154760850|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760851|NCT02054338|Paclitaxel|paclitaxel|mesh-list
154760852|NCT02054338|Gemcitabine|gemcitabine|mesh-list
154760853|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154760854|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760855|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
154760856|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
154760857|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
154760858|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760859|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154760860|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
154760861|NCT00198081|Celecoxib|celecoxib|mesh-list
153389303|NCT00002427|Didanosine|didanosine|mesh-list
153836700|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153836701|NCT00514982|Analgesics|analgesics|mesh-ancestor
153836703|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836705|NCT00531999|Lopinavir|lopinavir|mesh-list
153836706|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
153836707|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153836708|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153836709|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
153376784|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153376785|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376786|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376787|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153376788|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153376789|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376790|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376792|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
153376793|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153376796|NCT05592678|Donepezil|donepezil|mesh-list
154760862|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154760863|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154760864|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154760865|NCT00198081|Analgesics|analgesics|mesh-ancestor
154760866|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
154760867|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760868|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760869|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154760870|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760871|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154760872|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760873|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512811|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
153836729|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
153836730|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153836731|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
153836732|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153836733|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
153836734|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
153836735|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
153376808|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376809|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376810|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153376811|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
153376812|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376813|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376814|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154760874|NCT00100659|Interferons|interferons|mesh-list
154760875|NCT00100659|Ribavirin|ribavirin|mesh-list
154760876|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760877|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
154760878|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760879|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
154760880|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760881|NCT00101361|Oxandrolone|oxandrolone|mesh-list
154760882|NCT00101361|Androgens|androgens|mesh-ancestor
154760883|NCT00101361|Hormones|hormones|mesh-ancestor
154760884|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760885|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866489|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866491|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153866492|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153866493|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866494|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153866495|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153866496|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153406966|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406967|NCT03144804|Lamivudine|lamivudine|mesh-list
153406968|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153406969|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153406970|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866531|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866533|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
154760886|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
154760887|NCT03225690|Morphine|morphine|mesh-list
154760888|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154760889|NCT03225690|Narcotics|narcotics|mesh-ancestor
154760890|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154760891|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760892|NCT03225690|Analgesics|analgesics|mesh-ancestor
154760893|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
154760894|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760895|NCT02389738|Temozolomide|temozolomide|mesh-list
153389388|NCT00002463|Leucovorin|leucovorin|mesh-list
153836793|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153836794|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153836795|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
153376872|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376873|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153376874|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
153376875|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
153376876|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376880|NCT05562973|Psilocybin|psilocybin|mesh-list
153866733|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866734|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153866735|NCT00575796|Vinblastine|vinblastine|mesh-list
153866736|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866737|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866738|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
153866742|NCT00575835|Vitamin D|vitamin d|mesh-list
153866760|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866761|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866762|NCT03454217|Analgesics|analgesics|mesh-ancestor
153866763|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
153866764|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866850|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153866851|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866853|NCT00576225|Carboplatin|carboplatin|mesh-list
153866854|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153866855|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866856|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866857|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
153866858|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407310|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407311|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154760896|NCT02389738|Regadenoson|regadenoson|mesh-list
154760897|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154760898|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
154760899|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760900|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760901|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154760902|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154760903|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
154760904|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
154760905|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760906|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760907|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154760908|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153376892|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153376893|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153376894|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
153376895|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376896|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153376897|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153376898|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376899|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376900|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153376901|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153376902|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
153376903|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153376904|NCT05498272|Olaparib|olaparib|mesh-list
153407472|NCT00309478|Methotrexate|methotrexate|mesh-list
153407473|NCT00309478|Goserelin|goserelin|mesh-list
153407474|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153867083|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153407545|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407546|NCT00080938|Temozolomide|temozolomide|mesh-list
153407547|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407548|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
153407549|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407550|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407552|NCT00074282|Rituximab|rituximab|mesh-list
154760909|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154760910|NCT00201123|Interferons|interferons|mesh-list
154760911|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
154760912|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760913|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
154760914|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154760915|NCT01712009|Loratadine|loratadine|mesh-list
154760916|NCT01712009|Naproxen|naproxen|mesh-list
154760917|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154257577|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154257578|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257579|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867186|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153867187|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
153867188|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407678|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153407679|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
153407680|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407681|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153407682|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153407683|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153407684|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
154760918|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154760919|NCT01712009|Analgesics|analgesics|mesh-ancestor
154760920|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
154760921|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154760922|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760923|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154760924|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760925|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
154760926|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154760927|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389452|NCT00002481|Cytarabine|cytarabine|mesh-list
153376961|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836876|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836877|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
153836878|NCT02950220|Ibrutinib|ibrutinib|mesh-list
153836879|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836880|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836881|NCT02950220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153836882|NCT02950220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836883|NCT02950220|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153810761|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357362|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867359|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867360|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867361|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867367|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
153407908|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760928|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760929|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
154760930|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
154760931|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154760932|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154760933|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154760934|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
154760935|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
154760936|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760937|NCT03212352|Misoprostol|misoprostol|mesh-list
154760938|NCT03212352|Mifepristone|mifepristone|mesh-list
154760939|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154760940|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
154760941|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154760942|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760943|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154760944|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154760945|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
154760946|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154760947|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154760948|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154760949|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154760950|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
154760951|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154760952|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154760953|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
154760954|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154760955|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
154760956|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154760957|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154760958|NCT00201825|Docetaxel|docetaxel|mesh-list
154760959|NCT00201825|Capecitabine|capecitabine|mesh-list
154760960|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154760961|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154760962|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154760963|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154257580|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
154760964|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760965|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154760966|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
154760967|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
154760968|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154760969|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760970|NCT01711853|Dabigatran|dabigatran|mesh-list
154760971|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
153389487|NCT00002487|Dipyridamole|dipyridamole|mesh-list
153836904|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836905|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836906|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
153836907|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836908|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
153836909|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
153836910|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153407909|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
153407910|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153407911|NCT04926233|Bromides|bromides|mesh-list
153407912|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
153407913|NCT04926233|Olodaterol|olodaterol|mesh-list
153407914|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153867433|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153867434|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867435|NCT00581685|Celecoxib|celecoxib|mesh-list
153867535|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153867536|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
153867537|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153867538|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153867542|NCT00567983|Cyclosporine|cyclosporine|mesh-list
153408052|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867550|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867552|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867553|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153867554|NCT00582582|Vitamin D|vitamin d|mesh-list
154760972|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154760973|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
154760974|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760975|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760976|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
154760977|NCT00202449|Prazosin|prazosin|mesh-list
154760978|NCT00202449|Paroxetine|paroxetine|mesh-list
154760979|NCT00202449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154760980|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154760981|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154760982|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154760983|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154760984|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
154760985|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154760986|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154760987|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
154760988|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154257590|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154257591|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
154257592|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257593|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257594|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154257595|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
154257596|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
154257597|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
153732044|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153836925|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836926|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
153836927|NCT00516425|Doxorubicin|doxorubicin|mesh-list
153836928|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153836929|NCT00516425|Epirubicin|epirubicin|mesh-list
153836930|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153836931|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
153836932|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836933|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154760989|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154760990|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154760991|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154760992|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154760993|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154760994|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154760995|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154760996|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
154760997|NCT03203304|Nivolumab|nivolumab|mesh-list
154760998|NCT03203304|Ipilimumab|ipilimumab|mesh-list
154760999|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154761000|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761001|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154761002|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257598|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154257599|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154257600|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
154257601|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257602|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257603|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
154257604|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154761003|NCT03225456|Oxytocin|oxytocin|mesh-list
154761004|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
154761005|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154761006|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761007|NCT00203229|Lamotrigine|lamotrigine|mesh-list
154761008|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
154761009|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154761010|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761011|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836978|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153836979|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153836980|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
153836981|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153836982|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153836983|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153836984|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153836985|NCT02942550|Bromides|bromides|mesh-list
153836986|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
153408366|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153408367|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
153408368|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408421|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153408422|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153408423|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
153408424|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408425|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153408426|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153408427|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
153408428|NCT02958878|Tamsulosin|tamsulosin|mesh-list
153408429|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153408430|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153867919|NCT00569465|Expectorants|expectorants|mesh-ancestor
153408449|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
153408450|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408451|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408452|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153408453|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408455|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
153408456|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153408457|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
153408458|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761012|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154761013|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761014|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154761015|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154761016|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761017|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154761018|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154761019|NCT00203931|Pemetrexed|pemetrexed|mesh-list
154761020|NCT00203931|Cetuximab|cetuximab|mesh-list
153389609|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
153837005|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
153837006|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837007|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
153837008|NCT00516854|Clidinium|clidinium|mesh-list
153837009|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153837010|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153837011|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837012|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867952|NCT00569699|Growth Substances|growth substances|mesh-ancestor
153867953|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761021|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761022|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512959|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
154761023|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761024|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154761025|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154761026|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154761028|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
154761029|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
154761030|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154761031|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154761032|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761033|NCT03203616|Trastuzumab|trastuzumab|mesh-list
154761034|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154761035|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154761036|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761037|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
154761038|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
154761039|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
154761040|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761041|NCT03203616|Immunotoxins|immunotoxins|mesh-ancestor
154761042|NCT03203616|Immunoconjugates|immunoconjugates|mesh-ancestor
154761043|NCT03203616|Immunologic Factors|immunologic factors|mesh-ancestor
154761044|NCT03203616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761045|NCT02450214|Ketamine|ketamine|mesh-list
154761046|NCT02450214|Analgesics|analgesics|mesh-ancestor
154761047|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
154761048|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761049|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257608|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154257609|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
154257610|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257611|NCT01286246|Progesterone|progesterone|mesh-list
154761050|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154761051|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154761052|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
154761053|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
154761054|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761055|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154761056|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154761057|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257619|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154257620|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868130|NCT04573803|Phenytoin|phenytoin|mesh-list
153868131|NCT04573803|Levetiracetam|levetiracetam|mesh-list
153868132|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
153868133|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
153868134|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153408628|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
153408629|NCT00377273|Fluorouracil|fluorouracil|mesh-list
153408630|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
153408631|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408632|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153408633|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868156|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868157|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868158|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868159|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868160|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153868161|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868162|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
153868163|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868164|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153868165|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
153868172|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868173|NCT00571805|Varenicline|varenicline|mesh-list
153408669|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408670|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154761058|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761059|NCT02450682|Warfarin|warfarin|mesh-list
154761060|NCT02450682|Apixaban|apixaban|mesh-list
154761061|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
154761062|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154761063|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
154761064|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154761065|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
153837109|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
153837110|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837111|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837112|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153837113|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
153837114|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
153837115|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
153377206|NCT05100017|Oxybutynin|oxybutynin|mesh-list
153868222|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868223|NCT01142128|Esomeprazole|esomeprazole|mesh-list
153868224|NCT01142128|Pancrelipase|pancrelipase|mesh-list
153868225|NCT01142128|Pancreatin|pancreatin|mesh-list
153868226|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153868227|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868228|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153868229|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868230|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868231|NCT04572867|Diuretics|diuretics|mesh-list
153868232|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
153868233|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868234|NCT01142089|Rifamycins|rifamycins|mesh-list
153868235|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
153868236|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868237|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868238|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868239|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
153408738|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
153868240|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153868261|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153868262|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
153868263|NCT00572741|Vitamins|vitamins|mesh-ancestor
153868264|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
153868265|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868295|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154761066|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761067|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761068|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
154761069|NCT01740401|Ipilimumab|ipilimumab|mesh-list
154761070|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154761071|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
154761072|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761073|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761074|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154761075|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
154761076|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257621|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257622|NCT01063127|Insulin|insulin|mesh-list
153868317|NCT03450798|Anesthetics|anesthetics|mesh-list
153408817|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408818|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153408819|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
153408820|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
153408821|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153408822|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
153408823|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408824|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408825|NCT04031885|Paclitaxel|paclitaxel|mesh-list
153868343|NCT00573404|Sunitinib|sunitinib|mesh-list
154761077|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761078|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154761079|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154761080|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154761081|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
154761082|NCT03202836|Progesterone|progesterone|mesh-list
154761083|NCT03202836|Progestins|progestins|mesh-ancestor
154761084|NCT03202836|Hormones|hormones|mesh-ancestor
154761085|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761086|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761087|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154761088|NCT03203070|Dipyrone|dipyrone|mesh-list
154761089|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154761090|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154761091|NCT03203070|Analgesics|analgesics|mesh-ancestor
154761092|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
154761093|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761094|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761095|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761096|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761097|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
154761099|NCT03209856|Calcitriol|calcitriol|mesh-list
154257623|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154257624|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257625|NCT03865004|Acetaminophen|acetaminophen|mesh-list
154257626|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154257627|NCT03865004|Morphine|morphine|mesh-list
154257628|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154257629|NCT03865004|Narcotics|narcotics|mesh-ancestor
154257630|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257631|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257632|NCT03865004|Analgesics|analgesics|mesh-ancestor
154257633|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
154257634|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257635|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154257636|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
154257637|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154257638|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257639|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154257640|NCT00334295|Fulvestrant|fulvestrant|mesh-list
154257641|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153732049|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732050|NCT02955628|Ibrutinib|ibrutinib|mesh-list
153837184|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153377277|NCT04932434|Psilocybin|psilocybin|mesh-list
153409022|NCT03498014|Analgesics|analgesics|mesh-ancestor
154761100|NCT03209856|Vitamins|vitamins|mesh-ancestor
154761101|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
154761102|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761103|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154761104|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154761105|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154761106|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761107|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761108|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154761109|NCT02413918|Iloperidone|iloperidone|mesh-list
154761110|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154257642|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257643|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154257644|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154257645|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
154257646|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257647|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257648|NCT01285778|Panitumumab|panitumumab|mesh-list
154257649|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154257650|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732051|NCT02955628|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153837209|NCT00517985|Analgesics|analgesics|mesh-ancestor
153868541|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
153868542|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868543|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
153868545|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810821|NCT00322166|Calcium|calcium|mesh-list
153357414|NCT01271348|Etoricoxib|etoricoxib|mesh-list
153357415|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153409134|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409185|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153409187|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868658|NCT01137604|Growth Substances|growth substances|mesh-ancestor
153868659|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868660|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
153868661|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868662|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868663|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761111|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154761112|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761113|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761114|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154761115|NCT03209622|Nicotine|nicotine|mesh-list
154761116|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154761117|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
154761118|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761119|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761120|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154761121|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154761122|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
154761123|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761124|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761125|NCT00099021|Pioglitazone|pioglitazone|mesh-list
154257651|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
154257652|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154257653|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
154257654|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257655|NCT01063205|Expectorants|expectorants|mesh-ancestor
154004600|NCT02782182|Folfirinox|folfirinox|mesh-list
154257656|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
154257657|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154257658|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
154257659|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257660|NCT01063205|Protective Agents|protective agents|mesh-ancestor
153569083|NCT04708886|Alendronate|alendronate|mesh-list
153389749|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837237|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154761126|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154761127|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761128|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154761129|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154761130|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
154761131|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761132|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761133|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154761134|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
154761135|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154761136|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154761137|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154761138|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154761139|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761140|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761141|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
154761142|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154257661|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257662|NCT01063205|Antidotes|antidotes|mesh-ancestor
154257663|NCT01175096|Everolimus|everolimus|mesh-list
154257664|NCT01175096|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154257665|NCT01175096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154257666|NCT01175096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257667|NCT01175096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257668|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154257669|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
154257670|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732054|NCT02955628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732056|NCT01247701|Busulfan|busulfan|mesh-list
153389770|NCT00002547|Cytarabine|cytarabine|mesh-list
153837265|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153837266|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837267|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837268|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153810831|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409390|NCT03042468|Pluvicto|pluvicto|mesh-list
153868877|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868878|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409404|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409405|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153409406|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153409408|NCT04795752|Cyclosporine|cyclosporine|mesh-list
153409409|NCT04795752|Cyclosporins|cyclosporins|mesh-list
153409410|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761143|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154761144|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761145|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
154761146|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
154761147|NCT01710527|Metformin|metformin|mesh-list
154761148|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154761149|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761150|NCT00354952|Azithromycin|azithromycin|mesh-list
154761151|NCT00354952|Clarithromycin|clarithromycin|mesh-list
154761152|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154761153|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761154|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154761155|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761156|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761157|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154761158|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154257671|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257672|NCT01285934|Insulin|insulin|mesh-list
154761159|NCT01706939|Carboplatin|carboplatin|mesh-list
154761160|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761161|NCT03209232|Infliximab|infliximab|mesh-list
154761162|NCT03209232|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154761163|NCT03209232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761164|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
154761165|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154761166|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761167|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
154761168|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154761169|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761170|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
154761171|NCT01709903|Fluticasone|fluticasone|mesh-list
154761172|NCT01709903|Xhance|xhance|mesh-list
154761173|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
154761174|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154257676|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154257677|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154257678|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257679|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
154257680|NCT01060163|Coagulants|coagulants|mesh-ancestor
154257681|NCT01063439|Cytarabine|cytarabine|mesh-list
154257682|NCT01063439|Etoposide|etoposide|mesh-list
154257683|NCT01063439|Melphalan|melphalan|mesh-list
154257684|NCT01063439|Busulfan|busulfan|mesh-list
154257685|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154257686|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732057|NCT01247701|Fludarabine|fludarabine|mesh-list
153732058|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732059|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
153837345|NCT02940444|Heparin|heparin|mesh-list
153868985|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
153868986|NCT00193479|Analgesics|analgesics|mesh-ancestor
154761175|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154761176|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761177|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154761178|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
154761179|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761180|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761181|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154761182|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
154761183|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154761184|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154761185|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153837376|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
153837377|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
153837378|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153837379|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
153837380|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153837381|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837382|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837383|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
153837384|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153837385|NCT02940483|Azacitidine|azacitidine|mesh-list
153837386|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153837387|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
153869083|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869084|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153869085|NCT00191334|Gemcitabine|gemcitabine|mesh-list
153869090|NCT00191139|Cisplatin|cisplatin|mesh-list
153409633|NCT04500613|Dexamethasone|dexamethasone|mesh-list
153409662|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
153409663|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409664|NCT00360295|Azithromycin|azithromycin|mesh-list
153409665|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409667|NCT02976727|Vitamin D|vitamin d|mesh-list
154761186|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154761187|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154761188|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
154761189|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761190|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761191|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
154761192|NCT01709903|Hormones|hormones|mesh-ancestor
153837405|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837406|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153837407|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153837408|NCT00520091|Analgesics|analgesics|mesh-ancestor
153837409|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
153837410|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837411|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869144|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
153409842|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
153409843|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409844|NCT03822637|Expectorants|expectorants|mesh-ancestor
153409851|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
153409852|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409853|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409854|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153409855|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153409856|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
153409857|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409858|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409859|NCT02412306|Blinatumomab|blinatumomab|mesh-list
153409860|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409861|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
153409862|NCT05616468|Fludarabine|fludarabine|mesh-list
153409863|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153409865|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869376|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154761193|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761194|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
154761195|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154761196|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154761197|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154761198|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
154761199|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
154761200|NCT03202446|Chitosan|chitosan|mesh-list
154761201|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153837421|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153837422|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153837423|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
153837424|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
153837425|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837426|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153837427|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153837428|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810918|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810919|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761202|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
154761203|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761204|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761205|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154761206|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
154761207|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761208|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761209|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154761210|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154761211|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154761212|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
154257687|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154257688|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154257689|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257690|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257691|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154257692|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
154257693|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
154257694|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257695|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154257696|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
154257697|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357502|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153810944|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
153357515|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553926|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553927|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153553928|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553929|NCT01595737|Simendan|simendan|mesh-list
153553953|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
153553954|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153553955|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553956|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153553957|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553958|NCT01595828|Pitavastatin|pitavastatin|mesh-list
153553959|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153553960|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153553961|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153553962|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
153553963|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761213|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154761214|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
154761215|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
154761216|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
154761217|NCT03202446|Coagulants|coagulants|mesh-ancestor
154761218|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
154761219|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154761220|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
154761221|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761222|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761223|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154761224|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
154761225|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154761226|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
154257698|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154761227|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761228|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761229|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154761230|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
154761231|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
154761232|NCT03208764|Protective Agents|protective agents|mesh-ancestor
154761233|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154761234|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
153837496|NCT00520949|Amoxicillin|amoxicillin|mesh-list
154761235|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761236|NCT05718310|Nitroglycerin|nitroglycerin|mesh-list
154761237|NCT05718310|Vasodilator Agents|vasodilator agents|mesh-ancestor
154761238|NCT03224208|Vemurafenib|vemurafenib|mesh-list
154761239|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761240|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154761241|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761242|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761243|NCT05718232|Lenvatinib|lenvatinib|mesh-list
154761244|NCT05718232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761245|NCT05718232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154761246|NCT05718232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761247|NCT05718232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761248|NCT00355966|Misoprostol|misoprostol|mesh-list
154761249|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154761250|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
154761251|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154257706|NCT03868202|Progesterone|progesterone|mesh-list
154761252|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761253|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154761254|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154761255|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
154761256|NCT03208218|Lenalidomide|lenalidomide|mesh-list
154761257|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
154761258|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761259|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154761260|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154761261|NCT03208218|Growth Substances|growth substances|mesh-ancestor
154761262|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
154761263|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761264|NCT05372380|Atorvastatin|atorvastatin|mesh-list
154761265|NCT05372380|Ezetimibe|ezetimibe|mesh-list
154761266|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154761267|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154761268|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
154761269|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761270|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154761271|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154761272|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761273|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
154761274|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154761275|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761276|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761277|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154761278|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154761279|NCT02451774|Protective Agents|protective agents|mesh-ancestor
154761280|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761281|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
154761282|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154761283|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
154761284|NCT00355576|Minocycline|minocycline|mesh-list
154761285|NCT00355576|Celecoxib|celecoxib|mesh-list
154761286|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154761287|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154761288|NCT00355576|Analgesics|analgesics|mesh-ancestor
154761289|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
154761290|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761291|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761292|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761293|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761294|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154761295|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154761296|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761297|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761298|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154761299|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761300|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
154761301|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154761302|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154761303|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761304|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
154761305|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
154761306|NCT02448264|Berotralstat|berotralstat|mesh-list
154761307|NCT02448264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153837604|NCT02937519|Cisplatin|cisplatin|mesh-list
154761308|NCT02448264|Protease Inhibitors|protease inhibitors|mesh-ancestor
154761309|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761310|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761311|NCT02451852|Osimertinib|osimertinib|mesh-list
154761312|NCT02451852|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154761313|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154761314|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761315|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761316|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761317|NCT00421642|Adalimumab|adalimumab|mesh-list
154761318|NCT00421642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154761319|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761320|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761321|NCT03200964|Anesthetics|anesthetics|mesh-list
153837614|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
154761322|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513266|NCT03666299|Lidocaine|lidocaine|mesh-list
154761323|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761324|NCT04484844|Listerine|listerine|mesh-list
154761325|NCT04484844|Fluorides|fluorides|mesh-list
154761326|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
154761327|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
154761328|NCT04484844|Protective Agents|protective agents|mesh-ancestor
154761329|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761330|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154761331|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761332|NCT03119454|Betamethasone|betamethasone|mesh-list
154761333|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154761334|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761335|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
154761336|NCT03119454|Hormones|hormones|mesh-ancestor
154761337|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761338|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837719|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837743|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154761339|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154761340|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
154761341|NCT04485156|Rifampin|rifampin|mesh-list
154761342|NCT04485156|Isoniazid|isoniazid|mesh-list
154761343|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
154761344|NCT04485156|Ethambutol|ethambutol|mesh-list
154761345|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154761346|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
154761347|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154761348|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761349|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
154761350|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153837744|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837747|NCT04694105|Dexamethasone|dexamethasone|mesh-list
154761351|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761352|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761353|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154761354|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154761355|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154761356|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154761357|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154761358|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154761359|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154761360|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154761361|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
154761362|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154761363|NCT04637620|Sertraline|sertraline|mesh-list
154761364|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
154761365|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154761366|NCT04637620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154761367|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154761368|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761369|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761370|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761371|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
154761372|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761373|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
154761374|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154761375|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154761376|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761377|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
154761378|NCT00355108|Coagulants|coagulants|mesh-ancestor
154761379|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154761380|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154761381|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761382|NCT03200886|Triamcinolone|triamcinolone|mesh-list
154761383|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154761384|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154761385|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154761386|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761387|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
154761388|NCT03200886|Hormones|hormones|mesh-ancestor
154761389|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761390|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761391|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154761392|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
154761393|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761394|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761395|NCT05717764|Capecitabine|capecitabine|mesh-list
154761396|NCT05717764|Mitoxantrone|mitoxantrone|mesh-list
154761397|NCT05717764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154761398|NCT05717764|Antimetabolites|antimetabolites|mesh-ancestor
154761399|NCT05717764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761400|NCT05717764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761401|NCT05717764|Analgesics|analgesics|mesh-ancestor
154761402|NCT05717764|Sensory System Agents|sensory system agents|mesh-ancestor
154761403|NCT05717764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761404|NCT05717764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761405|NCT05717764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154761406|NCT05717764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154761407|NCT05717764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761408|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154761409|NCT03118830|Cetrorelix|cetrorelix|mesh-list
154761410|NCT03118830|Hormones|hormones|mesh-list
154761411|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154761412|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761413|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761414|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
154761415|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154761416|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
154761417|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154761418|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154761419|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154761420|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761421|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154761422|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
154761423|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
154761424|NCT03223506|Acetaminophen|acetaminophen|mesh-list
154761425|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154761426|NCT03223506|Analgesics|analgesics|mesh-ancestor
154761427|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
154761428|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761429|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761430|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
154761431|NCT03223896|Naloxone|naloxone|mesh-list
154761432|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154761433|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761434|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
154761435|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761436|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
154761437|NCT02447796|Propofol|propofol|mesh-list
154761438|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154761439|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761440|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761441|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154761442|NCT02447796|Analgesics|analgesics|mesh-ancestor
154761443|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
154761444|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761445|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154761446|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154257758|NCT01175486|Pioglitazone|pioglitazone|mesh-list
154761447|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153559496|NCT01633749|Vaccines|vaccines|mesh-list
154761448|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
154761449|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761450|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761451|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154761452|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
154761453|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
154761454|NCT05225116|Lenvatinib|lenvatinib|mesh-list
154761455|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761456|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154761457|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761458|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761459|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
154761460|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
154761461|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761462|NCT03222960|Propolis|propolis|mesh-list
154761463|NCT03222960|Fluorides|fluorides|mesh-list
154761464|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
154761465|NCT03222960|Protective Agents|protective agents|mesh-ancestor
154761466|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837891|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154761467|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761468|NCT05681260|Cytarabine|cytarabine|mesh-list
154761469|NCT05681260|Dexamethasone|dexamethasone|mesh-list
154761470|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
154761471|NCT05681260|Prednisone|prednisone|mesh-list
154761472|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
154761473|NCT05681260|Ifosfamide|ifosfamide|mesh-list
154761474|NCT05681260|Doxorubicin|doxorubicin|mesh-list
154761475|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154761476|NCT05681260|Methotrexate|methotrexate|mesh-list
154761477|NCT05681260|Etoposide|etoposide|mesh-list
154761478|NCT05681260|Vincristine|vincristine|mesh-list
154761479|NCT05681260|Bortezomib|bortezomib|mesh-list
154761480|NCT05681260|Daunorubicin|daunorubicin|mesh-list
154761481|NCT05681260|Asparaginase|asparaginase|mesh-list
154761482|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
154761483|NCT05681260|Vindesine|vindesine|mesh-list
154761484|NCT05681260|Pegaspargase|pegaspargase|mesh-list
154761485|NCT05681260|BB 1101|bb 1101|mesh-list
154761486|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154761487|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
154761488|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761489|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761490|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153378014|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761491|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
154761492|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761493|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761494|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154761495|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761496|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
154761497|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
154761498|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761499|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153378050|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154761500|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
154761501|NCT05681260|Hormones|hormones|mesh-ancestor
154761502|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761503|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154761504|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
154761505|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761506|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154761507|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154761508|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154761509|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154761510|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
154761511|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154761512|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154761513|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
154761514|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
154761515|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154761516|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154761517|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154761518|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
154761519|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761520|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
154761521|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
154761522|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
154761523|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
154761524|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154761525|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761526|NCT03199950|Haloperidol|haloperidol|mesh-list
153378109|NCT03110107|Nivolumab|nivolumab|mesh-list
154761527|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
154761528|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
154761529|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
154761530|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761531|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761532|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154761533|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154761534|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154761535|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761536|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154761537|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154761538|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
154761539|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761540|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761541|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154761542|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154761543|NCT05156632|Vaccines|vaccines|mesh-list
154761544|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
154761545|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761546|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154761547|NCT05156632|Antacids|antacids|mesh-ancestor
154761548|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761549|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154761550|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
154761551|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154761552|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154761553|NCT02447016|Tenofovir|tenofovir|mesh-list
154761554|NCT02447016|Emtricitabine|emtricitabine|mesh-list
154761555|NCT02447016|Efavirenz|efavirenz|mesh-list
154761556|NCT02447016|Rilpivirine|rilpivirine|mesh-list
154761557|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
154761558|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761559|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154761560|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154761561|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761562|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761563|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154761564|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154761565|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154761566|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154761567|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154761568|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154761569|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154761570|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154761571|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154761572|NCT02447094|Plasminogen|plasminogen|mesh-list
154761573|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154761574|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154761575|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761576|NCT02446860|Nivolumab|nivolumab|mesh-list
154761577|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154761578|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761579|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154761580|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761581|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
154761582|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154761583|NCT02449746|Antibodies|antibodies|mesh-list
154761584|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
154761585|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154761586|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
154761587|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761588|NCT02446782|Clindamycin|clindamycin|mesh-list
154761589|NCT02446782|Cefazolin|cefazolin|mesh-list
154761590|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154761591|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761592|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154761593|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761594|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761595|NCT06076434|Heparin|heparin|mesh-list
154761596|NCT06076434|Anticoagulants|anticoagulants|mesh-ancestor
154761597|NCT06076434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154761598|NCT06076434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154761599|NCT06076434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761600|NCT06076330|Plasma-lyte 148|plasma-lyte 148|mesh-list
154761601|NCT06076330|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154761602|NCT06076330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154761603|NCT06076200|Tazobactam|tazobactam|mesh-list
154761604|NCT06076200|Piperacillin|piperacillin|mesh-list
154761605|NCT06076200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154761606|NCT06076200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761607|NCT06076200|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153390913|NCT00002691|Leucovorin|leucovorin|mesh-list
154761608|NCT06076200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761609|NCT06076200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761610|NCT06075238|Blinatumomab|blinatumomab|mesh-list
154761611|NCT06075238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761612|NCT06075212|Blinatumomab|blinatumomab|mesh-list
154761613|NCT06075212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761614|NCT06075134|Zinc|zinc|mesh-list
154761615|NCT06075134|Botulinum Toxins|botulinum toxins|mesh-list
154761616|NCT06075134|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154761617|NCT06075134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761618|NCT06075134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838208|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761619|NCT06075134|Cholinergic Agents|cholinergic agents|mesh-ancestor
154761620|NCT06075134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761621|NCT06075134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761622|NCT06075134|Trace Elements|trace elements|mesh-ancestor
154761623|NCT06075134|Micronutrients|micronutrients|mesh-ancestor
154761624|NCT06074757|Fulvestrant|fulvestrant|mesh-list
154761625|NCT06074757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154761626|NCT06074757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761627|NCT06074757|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154761629|NCT06074757|Hormone Antagonists|hormone antagonists|mesh-ancestor
154761630|NCT06074757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761631|NCT06074757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761632|NCT06074484|Disitamab vedotin|disitamab vedotin|mesh-list
154761633|NCT06074484|Immunoconjugates|immunoconjugates|mesh-ancestor
154761634|NCT06074484|Immunologic Factors|immunologic factors|mesh-ancestor
154761635|NCT06074484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838249|NCT02946359|Crizotinib|crizotinib|mesh-list
154761636|NCT06074016|Oxazolidinones|oxazolidinones|mesh-list
154761637|NCT06074016|Zolmitriptan|zolmitriptan|mesh-list
154761638|NCT06074016|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154761639|NCT06074016|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154761640|NCT06074016|Serotonin Agents|serotonin agents|mesh-ancestor
154761641|NCT06074016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761642|NCT06074016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761643|NCT06074016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761644|NCT06074016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761645|NCT06074016|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154761646|NCT06074016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761647|NCT06071455|Vitamin D|vitamin d|mesh-list
154761648|NCT06071455|Cholecalciferol|cholecalciferol|mesh-list
154761649|NCT06071455|Vitamins|vitamins|mesh-ancestor
154761650|NCT06071455|Micronutrients|micronutrients|mesh-ancestor
154761651|NCT06071455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761652|NCT06071455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154761653|NCT06071455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154761654|NCT06071429|Sirolimus|sirolimus|mesh-list
154761655|NCT06071429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154761656|NCT06071429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761657|NCT06071429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154761658|NCT06071429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761659|NCT06071429|Antifungal Agents|antifungal agents|mesh-ancestor
154761660|NCT06071429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154761661|NCT06071429|Immunologic Factors|immunologic factors|mesh-ancestor
154761662|NCT06071429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761663|NCT06071156|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154761664|NCT06071156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761665|NCT06054191|Trametinib|trametinib|mesh-list
154761666|NCT06054191|Dabrafenib|dabrafenib|mesh-list
154761667|NCT06054191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761668|NCT06054191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154761669|NCT06054191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761670|NCT06054191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761671|NCT06053489|Anesthetics|anesthetics|mesh-list
154761672|NCT06053489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761673|NCT06053489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761674|NCT06028672|Dactinomycin|dactinomycin|mesh-list
154761675|NCT06028672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154761676|NCT06028672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761677|NCT06028672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154761678|NCT06028672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761679|NCT06028672|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154257797|NCT03860636|Estradiol|estradiol|mesh-list
154761680|NCT06028672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761681|NCT06028672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761682|NCT06028672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154761683|NCT06028321|Pindolol|pindolol|mesh-list
154761684|NCT06028321|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154761685|NCT06028321|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154761686|NCT06028321|Adrenergic Agents|adrenergic agents|mesh-ancestor
154761687|NCT06028321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761688|NCT06028321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761689|NCT06028321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761690|NCT06028321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154761691|NCT06028321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154761692|NCT06028321|Serotonin Agents|serotonin agents|mesh-ancestor
154761693|NCT06028321|Vasodilator Agents|vasodilator agents|mesh-ancestor
154761694|NCT06024733|Lidocaine|lidocaine|mesh-list
154761695|NCT06024733|Sevoflurane|sevoflurane|mesh-list
154761696|NCT06024733|Anesthetics, Local|anesthetics, local|mesh-ancestor
154761697|NCT06024733|Anesthetics|anesthetics|mesh-ancestor
154761698|NCT06024733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761699|NCT06024733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761700|NCT06024733|Sensory System Agents|sensory system agents|mesh-ancestor
154761701|NCT06024733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761702|NCT06024733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154761703|NCT06024733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154761704|NCT06024733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154761705|NCT06024733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761706|NCT06024733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761707|NCT06024733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154761708|NCT06024733|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154761709|NCT06024733|Anesthetics, General|anesthetics, general|mesh-ancestor
154257815|NCT03860012|Folic Acid|folic acid|mesh-list
154761711|NCT06000709|Methylprednisolone|methylprednisolone|mesh-list
154761712|NCT06000709|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154761713|NCT06000709|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154761714|NCT06000709|Prednisolone|prednisolone|mesh-list
154761715|NCT06000709|Prednisolone acetate|prednisolone acetate|mesh-list
154761716|NCT06000709|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154761717|NCT06000709|Prednisolone phosphate|prednisolone phosphate|mesh-list
154761718|NCT06000709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761719|NCT06000709|Antiemetics|antiemetics|mesh-ancestor
154761720|NCT06000709|Autonomic Agents|autonomic agents|mesh-ancestor
154761721|NCT06000709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761722|NCT06000709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761723|NCT06000709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154761724|NCT06000709|Glucocorticoids|glucocorticoids|mesh-ancestor
154761725|NCT06000709|Hormones|hormones|mesh-ancestor
154761726|NCT06000709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761727|NCT06000709|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154761728|NCT06000709|Protective Agents|protective agents|mesh-ancestor
154761729|NCT06000709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154761730|NCT06000709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761731|NCT06000709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154761732|NCT06000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761733|NCT06000709|Disinfectants|disinfectants|mesh-ancestor
154761734|NCT06000709|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154761735|NCT06000709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154761736|NCT05957055|Methylphenidate|methylphenidate|mesh-list
154761737|NCT05957055|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154761738|NCT05957055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154761739|NCT05957055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761740|NCT05957055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154761741|NCT05957055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154761742|NCT05957055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761743|NCT05957055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761744|NCT05957055|Dopamine Agents|dopamine agents|mesh-ancestor
154761745|NCT05957055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761746|NCT05951465|Propofol|propofol|mesh-list
154761747|NCT05951465|Esketamine|esketamine|mesh-list
154761748|NCT05951465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154761749|NCT05951465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761750|NCT05951465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761751|NCT05951465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154761752|NCT05951465|Anesthetics, General|anesthetics, general|mesh-ancestor
154761753|NCT05951465|Anesthetics|anesthetics|mesh-ancestor
154761754|NCT05951465|Antidepressive Agents|antidepressive agents|mesh-ancestor
154761755|NCT05951465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154761756|NCT05940649|Norepinephrine|norepinephrine|mesh-list
154761757|NCT05940649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154761758|NCT05940649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154761759|NCT05940649|Adrenergic Agents|adrenergic agents|mesh-ancestor
154761760|NCT05940649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154761761|NCT05940649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761762|NCT05940649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761763|NCT05940649|Sympathomimetics|sympathomimetics|mesh-ancestor
154761764|NCT05940649|Autonomic Agents|autonomic agents|mesh-ancestor
154761765|NCT05940649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761766|NCT05940649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154761767|NCT05911061|Vaccines|vaccines|mesh-list
154761768|NCT05911061|Immunologic Factors|immunologic factors|mesh-ancestor
154761769|NCT05911061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761770|NCT05911048|Vaccines|vaccines|mesh-list
154761771|NCT05911048|Immunologic Factors|immunologic factors|mesh-ancestor
154761772|NCT05911048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761773|NCT05892887|Bupivacaine|bupivacaine|mesh-list
154761774|NCT05892887|Anesthetics, Local|anesthetics, local|mesh-ancestor
154761775|NCT05892887|Anesthetics|anesthetics|mesh-ancestor
154761776|NCT05892887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761777|NCT05892887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761778|NCT05892887|Sensory System Agents|sensory system agents|mesh-ancestor
154761779|NCT05892887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761780|NCT05834348|Docetaxel|docetaxel|mesh-list
154761781|NCT05834348|Bevacizumab|bevacizumab|mesh-list
154761782|NCT05834348|Carboplatin|carboplatin|mesh-list
154761783|NCT05834348|Pembrolizumab|pembrolizumab|mesh-list
154761784|NCT05834348|Nivolumab|nivolumab|mesh-list
154761785|NCT05834348|Atezolizumab|atezolizumab|mesh-list
154761786|NCT05834348|Gefitinib|gefitinib|mesh-list
154761787|NCT05834348|Osimertinib|osimertinib|mesh-list
154761788|NCT05834348|Afatinib|afatinib|mesh-list
154761789|NCT05834348|Crizotinib|crizotinib|mesh-list
154761790|NCT05834348|Ceritinib|ceritinib|mesh-list
154761791|NCT05834348|Alectinib|alectinib|mesh-list
154761792|NCT05834348|Dacomitinib|dacomitinib|mesh-list
154761793|NCT05834348|Entrectinib|entrectinib|mesh-list
154761794|NCT05834348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761795|NCT05834348|Tubulin Modulators|tubulin modulators|mesh-ancestor
154761796|NCT05834348|Antimitotic Agents|antimitotic agents|mesh-ancestor
154761797|NCT05834348|Mitosis Modulators|mitosis modulators|mesh-ancestor
154761798|NCT05834348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761799|NCT05834348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154761800|NCT05834348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154761801|NCT05834348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154761802|NCT05834348|Growth Substances|growth substances|mesh-ancestor
154761803|NCT05834348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761804|NCT05834348|Growth Inhibitors|growth inhibitors|mesh-ancestor
154761805|NCT05834348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154761806|NCT05834348|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154761807|NCT05834348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154761808|NCT05834348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761809|NCT05777278|Docetaxel|docetaxel|mesh-list
154761810|NCT05777278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761811|NCT05777278|Tubulin Modulators|tubulin modulators|mesh-ancestor
154761812|NCT05777278|Antimitotic Agents|antimitotic agents|mesh-ancestor
154761813|NCT05777278|Mitosis Modulators|mitosis modulators|mesh-ancestor
154761814|NCT05777278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761815|NCT05761431|Octreotide|octreotide|mesh-list
154761816|NCT05761431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154761817|NCT05761431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154761818|NCT05761431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761819|NCT05748236|Lamotrigine|lamotrigine|mesh-list
154761820|NCT05748236|Carbamazepine|carbamazepine|mesh-list
154761821|NCT05748236|Anticonvulsants|anticonvulsants|mesh-ancestor
154761822|NCT05748236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154761823|NCT05748236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761824|NCT05748236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761825|NCT05748236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154761826|NCT05748236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761827|NCT05748236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154761828|NCT05748236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154761829|NCT05748236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761830|NCT05748236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154761831|NCT05748236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154761832|NCT05748236|Antimanic Agents|antimanic agents|mesh-ancestor
154761833|NCT05748236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154761834|NCT05748236|Analgesics|analgesics|mesh-ancestor
154761835|NCT05748236|Sensory System Agents|sensory system agents|mesh-ancestor
154761836|NCT05748236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761837|NCT05748236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154761838|NCT05748236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154761839|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
154761840|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154761841|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154761842|NCT05608499|Clobetasol|clobetasol|mesh-list
154761843|NCT05608499|Halobetasol|halobetasol|mesh-list
154761844|NCT05608499|Tazarotene|tazarotene|mesh-list
154761845|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
154513785|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
154761846|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
154761847|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154761848|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761849|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
154761850|NCT05608499|Hormones|hormones|mesh-ancestor
154761851|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761852|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761853|NCT05576662|Ritonavir|ritonavir|mesh-list
154761854|NCT05576662|Nirmatrelvir|nirmatrelvir|mesh-list
154761855|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154761856|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154761857|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
154761858|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761859|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761860|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154761861|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154761862|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
154761863|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761864|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154761865|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154761866|NCT05564650|Azacitidine|azacitidine|mesh-list
154761867|NCT05564650|Decitabine|decitabine|mesh-list
154761868|NCT05564650|Venetoclax|venetoclax|mesh-list
154761869|NCT05564650|Navitoclax|navitoclax|mesh-list
154761870|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154761871|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
154761872|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761873|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761874|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761875|NCT05557721|Lidocaine|lidocaine|mesh-list
154761876|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
154761877|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
154761878|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761879|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761880|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
154761881|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761882|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154761883|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154761884|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154761885|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761886|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761887|NCT05546788|Chlorhexidine|chlorhexidine|mesh-list
154761888|NCT05546788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154761889|NCT05546788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761890|NCT05546788|Disinfectants|disinfectants|mesh-ancestor
154761891|NCT05534802|Urinastatin|urinastatin|mesh-list
154761892|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154761893|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154761894|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
154761895|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761896|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761897|NCT05510089|Cytarabine|cytarabine|mesh-list
154761898|NCT05510089|Etoposide|etoposide|mesh-list
154761899|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154761900|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761901|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154761902|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154761903|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761904|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761905|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154761906|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
154761907|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
154761908|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761909|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154761910|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
154761911|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761912|NCT05497492|Lidocaine|lidocaine|mesh-list
154761913|NCT05497492|Sufentanil|sufentanil|mesh-list
154761914|NCT05497492|Propofol|propofol|mesh-list
154761915|NCT05497492|Esketamine|esketamine|mesh-list
154761916|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
154257858|NCT00074490|Hormones|hormones|mesh-ancestor
154761917|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
154761918|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154761919|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761920|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
154761921|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154761922|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154761923|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154761924|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154761925|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154761926|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513857|NCT02509312|Analgesics|analgesics|mesh-ancestor
154761927|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154761928|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154761929|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
154761930|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154761931|NCT05497492|Narcotics|narcotics|mesh-ancestor
154761932|NCT05497492|Analgesics|analgesics|mesh-ancestor
154761933|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154761934|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
154761935|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153838605|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153838606|NCT02945696|Ropivacaine|ropivacaine|mesh-list
153838612|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838614|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
153838615|NCT02924766|Niraparib|niraparib|mesh-list
153838616|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838617|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
153838618|NCT02924766|Hormones|hormones|mesh-ancestor
153378715|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761936|NCT05453500|Prednisone|prednisone|mesh-list
154761937|NCT05453500|Cortisone|cortisone|mesh-list
154761938|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
154761939|NCT05453500|Rituximab|rituximab|mesh-list
154761940|NCT05453500|Doxorubicin|doxorubicin|mesh-list
154761941|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154761942|NCT05453500|Etoposide|etoposide|mesh-list
154761943|NCT05453500|Vincristine|vincristine|mesh-list
154761944|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
154761945|NCT05453500|Daunorubicin|daunorubicin|mesh-list
154761946|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
154761947|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154761948|NCT05453500|Antibodies|antibodies|mesh-list
154761949|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
154761950|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154761951|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154761952|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
154761953|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154761954|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154761955|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154761956|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
154761957|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761958|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761959|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154761960|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154761961|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154761962|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154761963|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761964|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154761965|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
154761966|NCT05453500|Hormones|hormones|mesh-ancestor
154761967|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154761968|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154761969|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154761970|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
154761971|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
154761972|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
154761973|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
154761974|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
154761975|NCT05414136|Trastuzumab|trastuzumab|mesh-list
154761976|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154761977|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761978|NCT05410496|Tenofovir|tenofovir|mesh-list
154761979|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
154761980|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154761981|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154761982|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154761983|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761984|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761985|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154761986|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154761987|NCT05391126|Irinotecan|irinotecan|mesh-list
154761988|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154761989|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154761990|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154761991|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154761992|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154761993|NCT05384938|Benralizumab|benralizumab|mesh-list
153391587|NCT05184777|Hormones|hormones|mesh-ancestor
154761994|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154761995|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
154761996|NCT05371132|Deferoxamine|deferoxamine|mesh-list
154761997|NCT05371132|Siderophores|siderophores|mesh-ancestor
154761998|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154761999|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
154762000|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
154762001|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762002|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
154762003|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154762004|NCT05345990|Antibodies|antibodies|mesh-list
154762005|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
154762006|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762007|NCT05302011|Carboplatin|carboplatin|mesh-list
154762008|NCT05302011|Docetaxel|docetaxel|mesh-list
154762009|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
154762010|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762011|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
154762012|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
154762013|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
154762014|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762015|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762016|NCT05302011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762017|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
154762018|NCT05279872|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154762019|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154762020|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762021|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762022|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762023|NCT05245552|Vaccines|vaccines|mesh-list
154762024|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
154762025|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762026|NCT05206227|Histamine Antagonists|histamine antagonists|mesh-list
154762027|NCT05206227|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154762028|NCT05206227|Histamine Agents|histamine agents|mesh-ancestor
154762029|NCT05206227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762030|NCT05206227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257881|NCT01288664|Tacrolimus|tacrolimus|mesh-list
154762031|NCT05206227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762032|NCT05118672|Acetaminophen|acetaminophen|mesh-list
154762033|NCT05118672|Fexofenadine|fexofenadine|mesh-list
154762034|NCT05118672|Phenylephrine|phenylephrine|mesh-list
154762035|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
154762036|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154762037|NCT05118672|Analgesics|analgesics|mesh-ancestor
154762038|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
154762039|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762040|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762041|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
154762042|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154762043|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
154762044|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
154762045|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
154762046|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154762047|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
154762048|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
154762049|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154762050|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154762051|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154762052|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
154762053|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762054|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762055|NCT05118672|Protective Agents|protective agents|mesh-ancestor
154762056|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154762057|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154762058|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154762059|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
154762060|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
154762061|NCT05053633|Anesthetics|anesthetics|mesh-list
154762062|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762063|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762064|NCT05008484|Vitamin D|vitamin d|mesh-list
154762065|NCT05008484|Vitamins|vitamins|mesh-ancestor
154762066|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
154762067|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762068|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154762069|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154762070|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
154762071|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154762072|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
154762073|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762074|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
154762075|NCT04972383|Protective Agents|protective agents|mesh-ancestor
154762076|NCT04953754|Melatonin|melatonin|mesh-list
154762077|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
154762078|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762079|NCT04953754|Protective Agents|protective agents|mesh-ancestor
154762080|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762081|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762082|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154762083|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
154762084|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154762085|NCT04795869|Antibodies|antibodies|mesh-list
154762086|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
154762087|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154762088|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
154762089|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
154762090|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762091|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762092|NCT04795869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762093|NCT04795869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762094|NCT04795869|Immunotoxins|immunotoxins|mesh-ancestor
154762095|NCT04677504|Bevacizumab|bevacizumab|mesh-list
154762096|NCT04677504|Atezolizumab|atezolizumab|mesh-list
154762097|NCT04677504|Gemcitabine|gemcitabine|mesh-list
154762098|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762099|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762100|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154762101|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154762102|NCT04677504|Growth Substances|growth substances|mesh-ancestor
154762103|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762104|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
154762105|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154762106|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
154762107|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762108|NCT04677504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762109|NCT04635631|Talazoparib|talazoparib|mesh-list
154762110|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154762111|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762112|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762113|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762114|NCT04524832|Semaglutide|semaglutide|mesh-list
154762115|NCT04524832|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154762116|NCT04524832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154762117|NCT04524832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762118|NCT04483102|Liver Extracts|liver extracts|mesh-list
154762119|NCT04483102|Hematinics|hematinics|mesh-ancestor
154762120|NCT04477772|Antibodies|antibodies|mesh-list
154762121|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154762122|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
154762123|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762124|NCT04471597|Bupivacaine|bupivacaine|mesh-list
154762125|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
154762126|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
154762127|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762128|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762129|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
154762130|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762131|NCT04454411|Naltrexone|naltrexone|mesh-list
154762132|NCT04454411|Buprenorphine|buprenorphine|mesh-list
154762133|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154762134|NCT04454411|Narcotics|narcotics|mesh-ancestor
154762135|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762136|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762137|NCT04454411|Analgesics|analgesics|mesh-ancestor
154762138|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
154762139|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762140|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154762141|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154762142|NCT04387500|Axitinib|axitinib|mesh-list
154762143|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762144|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154762145|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762146|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257942|NCT01180946|Vitamin D|vitamin d|mesh-list
154762147|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154762148|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
154762149|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762150|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154762151|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154762152|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762153|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762154|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154514091|NCT02906917|Insulin|insulin|mesh-list
154762155|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154762156|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154762157|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154762158|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762160|NCT04046549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154762161|NCT04046549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154762162|NCT04046549|Prednisolone|prednisolone|mesh-list
154762163|NCT04046549|Prednisolone acetate|prednisolone acetate|mesh-list
154762164|NCT04046549|Abatacept|abatacept|mesh-list
154762165|NCT04046549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154762166|NCT04046549|Prednisolone phosphate|prednisolone phosphate|mesh-list
154762167|NCT04046549|Thymoglobulin|thymoglobulin|mesh-list
154762168|NCT04046549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154762169|NCT04046549|Antiemetics|antiemetics|mesh-ancestor
154762170|NCT04046549|Autonomic Agents|autonomic agents|mesh-ancestor
154762171|NCT04046549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257945|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
154762172|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762173|NCT04046549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154762174|NCT04046549|Glucocorticoids|glucocorticoids|mesh-ancestor
154762175|NCT04046549|Hormones|hormones|mesh-ancestor
154762176|NCT04046549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154762177|NCT04046549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154762178|NCT04046549|Protective Agents|protective agents|mesh-ancestor
154762179|NCT04046549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154762180|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762181|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
154762182|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762183|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762184|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762185|NCT04046549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762186|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154762187|NCT03975231|Trametinib|trametinib|mesh-list
154762188|NCT03975231|Dabrafenib|dabrafenib|mesh-list
154762189|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762190|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154762191|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762192|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762193|NCT03964753|Paclitaxel|paclitaxel|mesh-list
154762194|NCT03964753|Cisplatin|cisplatin|mesh-list
154257955|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762195|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154762196|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762197|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
154762198|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
154762199|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
154762200|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762201|NCT03933384|Tenofovir|tenofovir|mesh-list
154762202|NCT03933384|Entecavir|entecavir|mesh-list
154762203|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
154762204|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762205|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154762206|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154762207|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762208|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762209|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154762210|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154762211|NCT03821714|Vitamins|vitamins|mesh-list
154762212|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
154762213|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154762214|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154762215|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154762216|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
154762217|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
154762218|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762219|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154762220|NCT03821714|Hormones|hormones|mesh-ancestor
154762221|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154762222|NCT03783715|Ketoprofen|ketoprofen|mesh-list
154762223|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154762224|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154762225|NCT03783715|Analgesics|analgesics|mesh-ancestor
154762226|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
154762227|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762228|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762229|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154762230|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154762231|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154762232|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762233|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762234|NCT03725436|Paclitaxel|paclitaxel|mesh-list
154762235|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154762236|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154762237|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762238|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154762239|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154762240|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154762241|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762242|NCT03703050|Nivolumab|nivolumab|mesh-list
154762243|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762244|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762245|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762246|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762247|NCT03691350|Nicotine|nicotine|mesh-list
154762248|NCT03691350|Dimercaprol|dimercaprol|mesh-list
154762249|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154762250|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
154257969|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762251|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762252|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762253|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154762254|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154762255|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
154762256|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762257|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762258|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
154762259|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
154762260|NCT03657342|Cyclosporine|cyclosporine|mesh-list
154762261|NCT03657342|Cyclosporins|cyclosporins|mesh-list
154762262|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378927|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762263|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762264|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762265|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
154762266|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762267|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
154762268|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762269|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
154762270|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154762271|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154762272|NCT03656926|Cyclosporine|cyclosporine|mesh-list
154762273|NCT03656926|Cyclosporins|cyclosporins|mesh-list
154762274|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762275|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762276|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762277|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
154762278|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762279|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
154762280|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762281|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
154762282|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154762283|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154762284|NCT03617458|Metformin|metformin|mesh-list
154762285|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154762286|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762287|NCT03607890|Nivolumab|nivolumab|mesh-list
154762288|NCT03607890|Relatlimab|relatlimab|mesh-list
154762289|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762290|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762291|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762292|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762293|NCT03580499|Vitamins|vitamins|mesh-list
154762294|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
154762295|NCT03580499|Pyridoxal|pyridoxal|mesh-list
154762296|NCT03580499|Pyridoxine|pyridoxine|mesh-list
154762297|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
154762298|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
154762299|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762300|NCT03466151|Sirolimus|sirolimus|mesh-list
154762301|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154762302|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762303|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154762304|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257991|NCT03088826|Analgesics|analgesics|mesh-ancestor
154762305|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
154762306|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762307|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
154762308|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762309|NCT03403205|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154762311|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
154762312|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154762313|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
154762314|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762315|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153566563|NCT06234592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566564|NCT06234592|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153413177|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
153783079|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783080|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153783081|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783082|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153783102|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783103|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783104|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
153783105|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153783106|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154762316|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154762317|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
154762318|NCT03403205|Chelating Agents|chelating agents|mesh-ancestor
154762319|NCT03403205|Sequestering Agents|sequestering agents|mesh-ancestor
154762320|NCT03403205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762321|NCT03403205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154762322|NCT03403205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154762323|NCT03403205|Growth Substances|growth substances|mesh-ancestor
153392009|NCT00000429|Antacids|antacids|mesh-ancestor
153379052|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153379053|NCT01536938|Vitamins|vitamins|mesh-ancestor
153379054|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
153379055|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153379056|NCT01588418|Exenatide|exenatide|mesh-list
153379057|NCT01588418|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153379058|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153783147|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
153413311|NCT02551094|Colchicine|colchicine|mesh-list
154762324|NCT03403205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762325|NCT03403205|Growth Inhibitors|growth inhibitors|mesh-ancestor
154762326|NCT03403205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762327|NCT03375112|Bupivacaine|bupivacaine|mesh-list
154762328|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
154762329|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
154762330|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762331|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762332|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
154762333|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762334|NCT03162432|Vitamin D|vitamin d|mesh-list
154762335|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
154762336|NCT03162432|Vitamins|vitamins|mesh-ancestor
154762337|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
154762338|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762339|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154258004|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258005|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258006|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
154258007|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258008|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258009|NCT01179464|Simvastatin|simvastatin|mesh-list
154258010|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154258011|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154258012|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
154258013|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258014|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154258015|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154258016|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258017|NCT01179620|Certoparin|certoparin|mesh-list
153732071|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154762340|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154762341|NCT03133923|Vaccines|vaccines|mesh-list
154762342|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
154762343|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762344|NCT03076203|Niraparib|niraparib|mesh-list
154762345|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154762346|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154762347|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762348|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762349|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762350|NCT03075423|Nivolumab|nivolumab|mesh-list
154762351|NCT03075423|Ipilimumab|ipilimumab|mesh-list
153379111|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
153379112|NCT02840097|Coagulants|coagulants|mesh-ancestor
153379113|NCT02841033|Daratumumab|daratumumab|mesh-list
153379114|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379115|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153379116|NCT02988089|Amoxicillin|amoxicillin|mesh-list
153379117|NCT02988089|Metronidazole|metronidazole|mesh-list
153379118|NCT02988089|Clarithromycin|clarithromycin|mesh-list
153379119|NCT02988089|Levofloxacin|levofloxacin|mesh-list
153379120|NCT02988089|Ofloxacin|ofloxacin|mesh-list
153379121|NCT02988089|Tetracycline|tetracycline|mesh-list
153379122|NCT02988089|Tinidazole|tinidazole|mesh-list
153379123|NCT02988089|Furazolidone|furazolidone|mesh-list
153379124|NCT02988089|Bismuth|bismuth|mesh-list
153839019|NCT00531167|Lamivudine|lamivudine|mesh-list
154762352|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762353|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762354|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762355|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762356|NCT03033914|Doxorubicin|doxorubicin|mesh-list
154762357|NCT03033914|Bleomycin|bleomycin|mesh-list
154762358|NCT03033914|Nivolumab|nivolumab|mesh-list
154762359|NCT03033914|Dacarbazine|dacarbazine|mesh-list
154762360|NCT03033914|Vinblastine|vinblastine|mesh-list
154762361|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154762362|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762363|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154762364|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154258018|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
154258019|NCT01288820|Artesunate|artesunate|mesh-list
154258020|NCT01288820|Primaquine|primaquine|mesh-list
154258021|NCT01288820|Piperaquine|piperaquine|mesh-list
154258022|NCT01288820|Amodiaquine|amodiaquine|mesh-list
154258023|NCT01288820|Artenimol|artenimol|mesh-list
154258024|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
154258025|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153332040|NCT03633448|Guaifenesin|guaifenesin|mesh-list
154762365|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762366|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762367|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762368|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762369|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154762370|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
154762371|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154762372|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
153392132|NCT00000477|Lovastatin|lovastatin|mesh-list
154762373|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
154762374|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
154762375|NCT02957032|Cytarabine|cytarabine|mesh-list
154762376|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154762377|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
154762378|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762379|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762380|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
154762381|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762382|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762383|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
154514319|NCT03469557|Capecitabine|capecitabine|mesh-list
154762384|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762385|NCT02897375|Carboplatin|carboplatin|mesh-list
154762386|NCT02897375|Palbociclib|palbociclib|mesh-list
153334585|NCT01455896|Hormones|hormones|mesh-ancestor
154762387|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762388|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154762389|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762390|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762391|NCT02781792|Temozolomide|temozolomide|mesh-list
153392336|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
154762392|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154762393|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
154762394|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762395|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762396|NCT02753283|Vitamin D|vitamin d|mesh-list
154762397|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
154762398|NCT02753283|Denosumab|denosumab|mesh-list
154762399|NCT02753283|Calcium|calcium|mesh-list
154762400|NCT02753283|Vitamins|vitamins|mesh-ancestor
154762401|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
154762402|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762403|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154762404|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154762405|NCT02660255|Cannabidiol|cannabidiol|mesh-list
154762406|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
154762407|NCT02596685|Nicotine|nicotine|mesh-list
154762408|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154762409|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
154762410|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762411|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762412|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154762413|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154762414|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
154762415|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762416|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762417|NCT02509052|Leflunomide|leflunomide|mesh-list
154258038|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
154762418|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762419|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762420|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762421|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
154762422|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762423|NCT02365597|Metformin|metformin|mesh-list
154762424|NCT02365597|Midazolam|midazolam|mesh-list
154762425|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154762426|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762427|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154762428|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154762429|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762430|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154762431|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154762432|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154762433|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154762434|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
154762435|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
154762436|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
154762437|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
154762438|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762439|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762440|NCT02231632|Vaccines|vaccines|mesh-list
154762441|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
154762442|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762443|NCT02220894|Paclitaxel|paclitaxel|mesh-list
154762444|NCT02220894|Carboplatin|carboplatin|mesh-list
154762445|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
154762446|NCT02220894|Pemetrexed|pemetrexed|mesh-list
154762447|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154762448|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762449|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
154762450|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
154762451|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
154762452|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762453|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762454|NCT02220894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762455|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762456|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154762457|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154762458|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154762459|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154762460|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
154762461|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154762462|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762463|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
153839676|NCT06025474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153339450|NCT00995501|BB 1101|bb 1101|mesh-list
153339451|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154762464|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762465|NCT02068092|Protective Agents|protective agents|mesh-ancestor
154762466|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762467|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154762468|NCT02023463|Leuprolide|leuprolide|mesh-list
154762469|NCT02023463|Goserelin|goserelin|mesh-list
154762470|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154762471|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
154762472|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154762473|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762474|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154762475|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762476|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
154762477|NCT01959672|Leucovorin|leucovorin|mesh-list
154762478|NCT01959672|Folic Acid|folic acid|mesh-list
154762479|NCT01959672|Nelfinavir|nelfinavir|mesh-list
154762480|NCT01959672|Gemcitabine|gemcitabine|mesh-list
154762481|NCT01959672|Fluorouracil|fluorouracil|mesh-list
154762482|NCT01959672|Oregovomab|oregovomab|mesh-list
154762483|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154762484|NCT01959672|Antibodies|antibodies|mesh-list
154762485|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
154762486|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154762487|NCT01959672|Calcium|calcium|mesh-list
154762488|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
154762489|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
154762490|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762491|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154762492|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
154258071|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762493|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762494|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762495|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154762496|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154762497|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762498|NCT01959672|Antidotes|antidotes|mesh-ancestor
154762499|NCT01959672|Protective Agents|protective agents|mesh-ancestor
154762500|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
154762501|NCT01959672|Vitamins|vitamins|mesh-ancestor
154762502|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
153839827|NCT06022939|Melphalan|melphalan|mesh-list
154762503|NCT01959672|Hematinics|hematinics|mesh-ancestor
154762504|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154762505|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154762506|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
154762507|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762508|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154762509|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154762510|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
154762511|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762512|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154762513|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
153839873|NCT06020755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762514|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762515|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154762516|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
154762517|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762518|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762519|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154762520|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154762521|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154258081|NCT01089192|Metformin|metformin|mesh-list
154762522|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
154762523|NCT01949857|Vaccines|vaccines|mesh-list
154762524|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
154762525|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762526|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153346192|NCT00005764|Lamivudine|lamivudine|mesh-list
154762527|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
154762528|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762529|NCT00617799|Aldesleukin|aldesleukin|mesh-list
154762530|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762531|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154762532|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154762533|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
154762534|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514466|NCT02506816|Olaparib|olaparib|mesh-list
154762535|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
154762536|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154762537|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762538|NCT00574509|Cytarabine|cytarabine|mesh-list
154762539|NCT00574509|Etoposide|etoposide|mesh-list
154762540|NCT00574509|Melphalan|melphalan|mesh-list
154762541|NCT00574509|Carmustine|carmustine|mesh-list
154762542|NCT00574509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154258101|NCT01093092|Vitamins|vitamins|mesh-ancestor
154762543|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762544|NCT00574509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154762545|NCT00574509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154762546|NCT00574509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762547|NCT00574509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762548|NCT00574509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154762549|NCT00574509|Antimetabolites|antimetabolites|mesh-ancestor
154762550|NCT00574509|Antiviral Agents|antiviral agents|mesh-ancestor
154762551|NCT00574509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762552|NCT00574509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762553|NCT00574509|Immunologic Factors|immunologic factors|mesh-ancestor
154762554|NCT00574509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762555|NCT00574509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154762556|NCT00574509|Alkylating Agents|alkylating agents|mesh-ancestor
154762557|NCT00574509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154762558|NCT00071760|Ritonavir|ritonavir|mesh-list
154762559|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
154762560|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154762561|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154762562|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
154762563|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762564|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762565|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154762566|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154762567|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
154762568|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258110|NCT01179776|Iloprost|iloprost|mesh-list
153840146|NCT05869812|Calcium|calcium|mesh-list
154762569|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154258122|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153347965|NCT01441843|Lorazepam|lorazepam|mesh-list
153380404|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
153348234|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153348235|NCT05307341|Narcotics|narcotics|mesh-ancestor
154762570|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154762571|NCT04745260|Midazolam|midazolam|mesh-list
154762572|NCT04745260|Fentanyl|fentanyl|mesh-list
154762573|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154762574|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154762575|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762576|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762577|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154762578|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154762579|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154762580|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154762581|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
154762582|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
153349521|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154762583|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
154762584|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
154762585|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762586|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762587|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154762588|NCT04745260|Narcotics|narcotics|mesh-ancestor
154762589|NCT04745260|Analgesics|analgesics|mesh-ancestor
154762590|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
154258127|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258134|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258135|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
153352188|NCT00462722|Analgesics|analgesics|mesh-ancestor
154762591|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762592|NCT03199482|Dexamethasone|dexamethasone|mesh-list
154762593|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154762594|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
154762595|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
154762596|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762597|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762598|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154762599|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
154762600|NCT03199482|Hormones|hormones|mesh-ancestor
154762601|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154762602|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154762603|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762604|NCT02446704|Temozolomide|temozolomide|mesh-list
154762605|NCT02446704|Olaparib|olaparib|mesh-list
154762606|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154762607|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
154762608|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762609|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762610|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154762611|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392980|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514532|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154762612|NCT06242977|Anesthetics|anesthetics|mesh-list
154762613|NCT06242977|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154762614|NCT06242977|Anesthetics, Local|anesthetics, local|mesh-list
154762615|NCT06242977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762616|NCT06242977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762617|NCT06242977|Sensory System Agents|sensory system agents|mesh-ancestor
154258152|NCT01289132|Candesartan|candesartan|mesh-list
154762618|NCT06242977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840797|NCT04590937|Diuretics|diuretics|mesh-ancestor
154762619|NCT06242977|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154762620|NCT06242938|Antihypertensive Agents|antihypertensive agents|mesh-list
154762622|NCT06242886|Oxytocics|oxytocics|mesh-ancestor
154762623|NCT06242886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154762624|NCT06242886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762625|NCT06242834|Pembrolizumab|pembrolizumab|mesh-list
154762626|NCT06242834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762627|NCT06242834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762628|NCT06242834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154762629|NCT06242834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762630|NCT06242769|Fluorides|fluorides|mesh-list
154762631|NCT06242769|Tin Fluorides|tin fluorides|mesh-list
153356314|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153356315|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
153356316|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356317|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153356318|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153356319|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356320|NCT01288781|Acetazolamide|acetazolamide|mesh-list
153356321|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
154762632|NCT06242769|Cariostatic Agents|cariostatic agents|mesh-ancestor
154762633|NCT06242769|Protective Agents|protective agents|mesh-ancestor
154762634|NCT06242769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762635|NCT06242743|Pyrithione zinc|pyrithione zinc|mesh-list
154762636|NCT06242743|Keratolytic Agents|keratolytic agents|mesh-ancestor
154762637|NCT06242743|Dermatologic Agents|dermatologic agents|mesh-ancestor
154762638|NCT06242652|Adalimumab|adalimumab|mesh-list
154762639|NCT06242652|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154762640|NCT06242652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154762641|NCT06242652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153841013|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153841014|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841015|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
153841016|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841017|NCT04231448|Prednisone|prednisone|mesh-list
153841018|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
153841019|NCT04231448|Rituximab|rituximab|mesh-list
153841020|NCT04231448|Doxorubicin|doxorubicin|mesh-list
153841021|NCT04231448|Vincristine|vincristine|mesh-list
153841022|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363381|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153363382|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363383|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153438085|NCT00005036|Vitamins|vitamins|mesh-ancestor
153382567|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153382568|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762642|NCT06242236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154762643|NCT06242236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762644|NCT06242236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762645|NCT06242145|Cilostazol|cilostazol|mesh-list
154762646|NCT06242145|Clopidogrel|clopidogrel|mesh-list
154762647|NCT06242145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154762648|NCT06242145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154762649|NCT06242145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154762650|NCT06242145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154762651|NCT06242145|Purinergic Agents|purinergic agents|mesh-ancestor
154762652|NCT06242145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762653|NCT06242145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762654|NCT06242145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762655|NCT06242145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154762656|NCT06242145|Autonomic Agents|autonomic agents|mesh-ancestor
154762657|NCT06242145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258159|NCT01287260|Nifedipine|nifedipine|mesh-list
154762658|NCT06242145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154762659|NCT06242145|Respiratory System Agents|respiratory system agents|mesh-ancestor
154762660|NCT06242145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154762661|NCT06242145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154762662|NCT06242145|Vasodilator Agents|vasodilator agents|mesh-ancestor
154762663|NCT06242145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154762664|NCT06242145|Protective Agents|protective agents|mesh-ancestor
154762665|NCT06242145|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154762666|NCT06242145|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154762667|NCT06242145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762668|NCT06242132|Cilostazol|cilostazol|mesh-list
154762669|NCT06242132|Clopidogrel|clopidogrel|mesh-list
154762670|NCT06242132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154762671|NCT06242132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154762672|NCT06242132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154762673|NCT06242132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154762674|NCT06242132|Purinergic Agents|purinergic agents|mesh-ancestor
154762675|NCT06242132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762676|NCT06242132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762677|NCT06242132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762678|NCT06242132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154762679|NCT06242132|Autonomic Agents|autonomic agents|mesh-ancestor
154762680|NCT06242132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762681|NCT06242132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154762682|NCT06242132|Respiratory System Agents|respiratory system agents|mesh-ancestor
154762683|NCT06242132|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154762684|NCT06242132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154762685|NCT06242132|Vasodilator Agents|vasodilator agents|mesh-ancestor
154762686|NCT06242132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154514616|NCT04053985|Lenvatinib|lenvatinib|mesh-list
154762687|NCT06242132|Protective Agents|protective agents|mesh-ancestor
154762688|NCT06242132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154762689|NCT06242132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154762690|NCT06242132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762691|NCT06242067|Trifluridine|trifluridine|mesh-list
154762692|NCT06242067|Irinotecan|irinotecan|mesh-list
154762693|NCT06242067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762694|NCT06242067|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154762695|NCT06242067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154762696|NCT06242067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762697|NCT06242067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762698|NCT06242067|Antimetabolites|antimetabolites|mesh-ancestor
154762699|NCT06242067|Antiviral Agents|antiviral agents|mesh-ancestor
154762700|NCT06242067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762701|NCT06241638|Vitamin B 12|vitamin b 12|mesh-list
154762702|NCT06241638|Hydroxocobalamin|hydroxocobalamin|mesh-list
154762703|NCT06241638|Dapagliflozin|dapagliflozin|mesh-list
154762704|NCT06241638|Vitamins|vitamins|mesh-ancestor
154762705|NCT06241638|Micronutrients|micronutrients|mesh-ancestor
154762706|NCT06241638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762707|NCT06241638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154762708|NCT06241638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762709|NCT06241638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154762710|NCT06241638|Vitamin B Complex|vitamin b complex|mesh-ancestor
154762711|NCT06241638|Hematinics|hematinics|mesh-ancestor
154762712|NCT06241547|Dexamethasone|dexamethasone|mesh-list
154762713|NCT06241547|Ondansetron|ondansetron|mesh-list
154258168|NCT01181570|Adalimumab|adalimumab|mesh-list
154762714|NCT06241547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154762715|NCT06241547|Antiemetics|antiemetics|mesh-ancestor
154762716|NCT06241547|Autonomic Agents|autonomic agents|mesh-ancestor
154762717|NCT06241547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762718|NCT06241547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762719|NCT06241547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154762720|NCT06241547|Glucocorticoids|glucocorticoids|mesh-ancestor
154762721|NCT06241547|Hormones|hormones|mesh-ancestor
154258187|NCT05200312|Doxorubicin|doxorubicin|mesh-list
154762722|NCT06241547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154762723|NCT06241547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153487347|NCT01955382|Artesunate|artesunate|mesh-list
154762724|NCT06241547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762725|NCT06241547|Antipruritics|antipruritics|mesh-ancestor
154762726|NCT06241547|Dermatologic Agents|dermatologic agents|mesh-ancestor
154762727|NCT06241547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154762728|NCT06241547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154762729|NCT06241547|Serotonin Agents|serotonin agents|mesh-ancestor
154762730|NCT06241547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762731|NCT06241547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762732|NCT06241469|Paclitaxel|paclitaxel|mesh-list
154762733|NCT06241469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154762734|NCT06241469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762735|NCT06241469|Tubulin Modulators|tubulin modulators|mesh-ancestor
154762736|NCT06241469|Antimitotic Agents|antimitotic agents|mesh-ancestor
154762737|NCT06241469|Mitosis Modulators|mitosis modulators|mesh-ancestor
154762738|NCT06241469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762739|NCT06241235|Paclitaxel|paclitaxel|mesh-list
154762740|NCT06241235|Bevacizumab|bevacizumab|mesh-list
154762741|NCT06241235|Carboplatin|carboplatin|mesh-list
154762742|NCT06241235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154762743|NCT06241235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762744|NCT06241235|Tubulin Modulators|tubulin modulators|mesh-ancestor
154762745|NCT06241235|Antimitotic Agents|antimitotic agents|mesh-ancestor
154762746|NCT06241235|Mitosis Modulators|mitosis modulators|mesh-ancestor
154762747|NCT06241235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762748|NCT06241235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154762749|NCT06241235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154762750|NCT06241235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154762751|NCT06241235|Growth Substances|growth substances|mesh-ancestor
154762752|NCT06241235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762753|NCT06241235|Growth Inhibitors|growth inhibitors|mesh-ancestor
154762754|NCT06241183|Famotidine|famotidine|mesh-list
154762755|NCT06241183|Antacids|antacids|mesh-list
154762756|NCT06241183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154762757|NCT06241183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154762758|NCT06241183|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154762759|NCT06241183|Histamine Antagonists|histamine antagonists|mesh-ancestor
154762760|NCT06241183|Histamine Agents|histamine agents|mesh-ancestor
154762761|NCT06241183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762762|NCT06241183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381674|NCT01661270|Aflibercept|aflibercept|mesh-list
153381675|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153381676|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153381677|NCT01661270|Growth Substances|growth substances|mesh-ancestor
153381678|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381679|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
153381680|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488888|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153488889|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153488894|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
154762763|NCT06241183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762764|NCT06241131|Desflurane|desflurane|mesh-list
154762765|NCT06241131|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154762766|NCT06241131|Anesthetics, General|anesthetics, general|mesh-ancestor
154762767|NCT06241131|Anesthetics|anesthetics|mesh-ancestor
154762768|NCT06241131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762769|NCT06241131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762770|NCT06241105|Lenvatinib|lenvatinib|mesh-list
154762771|NCT06241105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762772|NCT06241105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154762773|NCT06241105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762774|NCT06241105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762775|NCT06240520|Pyrimethamine|pyrimethamine|mesh-list
154762776|NCT06240520|Lenalidomide|lenalidomide|mesh-list
154762777|NCT06240520|Panobinostat|panobinostat|mesh-list
154762778|NCT06240520|Immunologic Factors|immunologic factors|mesh-ancestor
154762779|NCT06240520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762780|NCT06240520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154762781|NCT06240520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154762782|NCT06240520|Growth Substances|growth substances|mesh-ancestor
154762783|NCT06240520|Growth Inhibitors|growth inhibitors|mesh-ancestor
154762784|NCT06240520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762785|NCT06240520|Antimalarials|antimalarials|mesh-ancestor
154762786|NCT06240520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154762787|NCT06240520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154762788|NCT06240520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762789|NCT06240520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154762790|NCT06240520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762791|NCT06240520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258213|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
154258214|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154258215|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154258216|NCT05200312|Growth Substances|growth substances|mesh-ancestor
154258217|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
154258218|NCT05200312|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154258219|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258220|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
154258221|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154258222|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258223|NCT02940730|Dalbavancin|dalbavancin|mesh-list
154258224|NCT02940730|Teicoplanin|teicoplanin|mesh-list
154258225|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154258226|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258227|NCT01587638|Metoprolol|metoprolol|mesh-list
154258228|NCT01587638|Atenolol|atenolol|mesh-list
154258229|NCT01587638|Carvedilol|carvedilol|mesh-list
153732137|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381709|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381710|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154762792|NCT06240520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154762793|NCT06240416|Methamphetamine|methamphetamine|mesh-list
154762794|NCT06240416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154762795|NCT06240416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762796|NCT06240416|Sympathomimetics|sympathomimetics|mesh-ancestor
154762797|NCT06240416|Autonomic Agents|autonomic agents|mesh-ancestor
154762798|NCT06240416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762799|NCT06240416|Dopamine Agents|dopamine agents|mesh-ancestor
154762800|NCT06240416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762801|NCT06240416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762802|NCT06240416|Adrenergic Agents|adrenergic agents|mesh-ancestor
154762803|NCT06240416|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154762804|NCT06240416|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154762805|NCT06240416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154762806|NCT06240416|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154762807|NCT06240403|Digoxin|digoxin|mesh-list
154762808|NCT06240403|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154762809|NCT06240403|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154762810|NCT06240403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762811|NCT06240403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762812|NCT06240403|Protective Agents|protective agents|mesh-ancestor
154762813|NCT06240403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762814|NCT06240390|Analgesics, Opioid|analgesics, opioid|mesh-list
154762815|NCT06240390|Narcotics|narcotics|mesh-ancestor
154762816|NCT06240390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762817|NCT06240390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762818|NCT06240390|Analgesics|analgesics|mesh-ancestor
154762819|NCT06240390|Sensory System Agents|sensory system agents|mesh-ancestor
154762820|NCT06240390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762821|NCT06238011|Dexmedetomidine|dexmedetomidine|mesh-list
154762822|NCT06238011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154762823|NCT06238011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762824|NCT06238011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762825|NCT06238011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154762826|NCT06238011|Analgesics|analgesics|mesh-ancestor
154762827|NCT06238011|Sensory System Agents|sensory system agents|mesh-ancestor
154762828|NCT06238011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762829|NCT06238011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154762830|NCT06238011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154762831|NCT06238011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154762832|NCT06238011|Adrenergic Agents|adrenergic agents|mesh-ancestor
154762833|NCT06238011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762834|NCT06238011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762835|NCT06237881|Cyclophosphamide|cyclophosphamide|mesh-list
154514771|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
154762836|NCT06237881|Fludarabine|fludarabine|mesh-list
154762837|NCT06237881|Interleukin-2|interleukin-2|mesh-list
154762838|NCT06237881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762839|NCT06237881|Immunologic Factors|immunologic factors|mesh-ancestor
154762840|NCT06237881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762841|NCT06237881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154762842|NCT06237881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154762843|NCT06237881|Alkylating Agents|alkylating agents|mesh-ancestor
154762844|NCT06237881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762845|NCT06237881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762846|NCT06237881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154762847|NCT06237881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154762848|NCT06237881|Analgesics|analgesics|mesh-ancestor
154762849|NCT06237881|Sensory System Agents|sensory system agents|mesh-ancestor
154762850|NCT06237881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762851|NCT06231355|Bupivacaine|bupivacaine|mesh-list
154762852|NCT06231355|Anesthetics, Local|anesthetics, local|mesh-ancestor
154762853|NCT06231355|Anesthetics|anesthetics|mesh-ancestor
154762854|NCT06231355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258253|NCT01287338|Analgesics|analgesics|mesh-ancestor
153368482|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368483|NCT02322320|Lenalidomide|lenalidomide|mesh-list
153368503|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
154762855|NCT06231355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762856|NCT06231355|Sensory System Agents|sensory system agents|mesh-ancestor
154762857|NCT06231355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762858|NCT06218212|Calcium Carbonate|calcium carbonate|mesh-list
154762859|NCT06218212|Calcium|calcium|mesh-list
154762860|NCT06218212|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
154762861|NCT06218212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154762862|NCT06218212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762863|NCT06218212|Antacids|antacids|mesh-ancestor
154762864|NCT06218212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732140|NCT00140894|Rofecoxib|rofecoxib|mesh-list
154762865|NCT06218212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154762866|NCT06218212|Chelating Agents|chelating agents|mesh-ancestor
154762867|NCT06218212|Sequestering Agents|sequestering agents|mesh-ancestor
154762868|NCT06194864|Itraconazole|itraconazole|mesh-list
154762869|NCT06194864|Rifampin|rifampin|mesh-list
154762870|NCT06194864|Ecopipam|ecopipam|mesh-list
154762871|NCT06194864|Antifungal Agents|antifungal agents|mesh-ancestor
154762872|NCT06194864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762873|NCT06194864|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154762874|NCT06194864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154762875|NCT06194864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762876|NCT06194864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762877|NCT06194864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154762878|NCT06194864|Hormone Antagonists|hormone antagonists|mesh-ancestor
154762879|NCT06194864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154762880|NCT06194864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762881|NCT06194864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154762882|NCT06194864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154762883|NCT06194864|Antitubercular Agents|antitubercular agents|mesh-ancestor
154762884|NCT06194864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154762885|NCT06194864|Leprostatic Agents|leprostatic agents|mesh-ancestor
154762886|NCT06194864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154762887|NCT06194864|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153841791|NCT01906814|Carboplatin|carboplatin|mesh-list
154762888|NCT06194864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154762889|NCT06194864|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154762890|NCT06194864|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154762891|NCT06194864|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154762892|NCT06194864|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154762893|NCT06194864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154762894|NCT06194864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153841823|NCT01571037|Milrinone|milrinone|mesh-list
154762895|NCT06194864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762896|NCT06194864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154762897|NCT06194864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154762898|NCT06194864|Dopamine Agents|dopamine agents|mesh-ancestor
154762899|NCT06194864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762900|NCT06190652|Immunomodulating Agents|immunomodulating agents|mesh-list
154762901|NCT06190652|Immunologic Factors|immunologic factors|mesh-ancestor
154762902|NCT06190652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762903|NCT06183229|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
154762904|NCT06183229|Interferon Inducers|interferon inducers|mesh-ancestor
154762905|NCT06183229|Immunologic Factors|immunologic factors|mesh-ancestor
154762906|NCT06183229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762907|NCT06175273|Cyproheptadine|cyproheptadine|mesh-list
154762908|NCT06175273|Dronabinol|dronabinol|mesh-list
154762909|NCT06175273|Hallucinogens|hallucinogens|mesh-ancestor
154762910|NCT06175273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762911|NCT06175273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154762912|NCT06175273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154762913|NCT06175273|Analgesics|analgesics|mesh-ancestor
154762914|NCT06175273|Sensory System Agents|sensory system agents|mesh-ancestor
153841852|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
154762915|NCT06175273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762916|NCT06175273|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154762917|NCT06175273|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154762918|NCT06175273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762919|NCT06175273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762920|NCT06175273|Hormones|hormones|mesh-ancestor
154762921|NCT06175273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154762922|NCT06175273|Antipruritics|antipruritics|mesh-ancestor
154762923|NCT06175273|Dermatologic Agents|dermatologic agents|mesh-ancestor
154762924|NCT06175273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154762925|NCT06175273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154762926|NCT06175273|Histamine Antagonists|histamine antagonists|mesh-ancestor
154762927|NCT06175273|Histamine Agents|histamine agents|mesh-ancestor
154762928|NCT06175273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154762929|NCT06175273|Serotonin Agents|serotonin agents|mesh-ancestor
154762930|NCT06175273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154258272|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258278|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
153834801|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834806|NCT00521703|Lidocaine|lidocaine|mesh-list
154762931|NCT06148792|Primaquine|primaquine|mesh-list
154762932|NCT06148792|Tafenoquine|tafenoquine|mesh-list
154762933|NCT06148792|Antimalarials|antimalarials|mesh-ancestor
154762934|NCT06148792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154762935|NCT06148792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154762936|NCT06148792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762937|NCT06147505|Temozolomide|temozolomide|mesh-list
154762938|NCT06147505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154762939|NCT06147505|Alkylating Agents|alkylating agents|mesh-ancestor
154762940|NCT06147505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762941|NCT06147505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762942|NCT06145854|Cabotegravir|cabotegravir|mesh-list
154762943|NCT06145854|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154762944|NCT06145854|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154762945|NCT06145854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154762946|NCT06145854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762947|NCT06145854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154762948|NCT06145854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154762949|NCT06145854|Antiviral Agents|antiviral agents|mesh-ancestor
153835395|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835396|NCT00526305|Cytarabine|cytarabine|mesh-list
153835397|NCT00526305|Dexamethasone|dexamethasone|mesh-list
154762950|NCT06145854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154762951|NCT06139692|Midazolam|midazolam|mesh-list
154762952|NCT06139692|Dexmedetomidine|dexmedetomidine|mesh-list
154762953|NCT06139692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154762954|NCT06139692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154762955|NCT06139692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762956|NCT06139692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154762957|NCT06139692|Analgesics|analgesics|mesh-ancestor
153375796|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
153835928|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153376187|NCT06190158|Dexamethasone|dexamethasone|mesh-list
154762958|NCT06139692|Sensory System Agents|sensory system agents|mesh-ancestor
154762959|NCT06139692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154762960|NCT06139692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154762961|NCT06139692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154762962|NCT06139692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154762963|NCT06139692|Adrenergic Agents|adrenergic agents|mesh-ancestor
154762964|NCT06139692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154762965|NCT06139692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376655|NCT05730920|Anesthetics|anesthetics|mesh-ancestor
153836728|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394057|NCT01746043|Modafinil|modafinil|mesh-list
154762966|NCT06139692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154762967|NCT06139692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153837057|NCT02942043|Bevacizumab|bevacizumab|mesh-list
154762968|NCT06139692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153842655|NCT02935790|Nivolumab|nivolumab|mesh-list
154762969|NCT06139692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153377312|NCT04902911|Antibodies|antibodies|mesh-list
154762970|NCT06139692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154762971|NCT06139692|Anesthetics, General|anesthetics, general|mesh-ancestor
154762972|NCT06139692|Anesthetics|anesthetics|mesh-ancestor
154762973|NCT06139692|GABA Modulators|gaba modulators|mesh-ancestor
154762974|NCT06139692|GABA Agents|gaba agents|mesh-ancestor
154762975|NCT06125483|Fludarabine|fludarabine|mesh-list
154762976|NCT06125483|Melphalan|melphalan|mesh-list
154762977|NCT06125483|Busulfan|busulfan|mesh-list
154762978|NCT06125483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154762979|NCT06125483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762980|NCT06125483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154762981|NCT06125483|Immunologic Factors|immunologic factors|mesh-ancestor
154762982|NCT06125483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762983|NCT06125483|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154762984|NCT06125483|Alkylating Agents|alkylating agents|mesh-ancestor
154514914|NCT01377987|Diuretics|diuretics|mesh-ancestor
154762985|NCT06125483|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154762987|NCT06098677|Antioxidants|antioxidants|mesh-ancestor
154762988|NCT06098677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154762989|NCT06098677|Protective Agents|protective agents|mesh-ancestor
154762990|NCT06098677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762991|NCT06084676|Immunomodulating Agents|immunomodulating agents|mesh-list
154762992|NCT06084676|Immunologic Factors|immunologic factors|mesh-ancestor
154762993|NCT06084676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154762994|NCT06081166|Calcium, Dietary|calcium, dietary|mesh-list
154762995|NCT06081166|Atorvastatin|atorvastatin|mesh-list
154762996|NCT06081166|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154762997|NCT06081166|Calcium|calcium|mesh-list
154762998|NCT06081166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154762999|NCT06081166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763000|NCT06081166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154763001|NCT06081166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154763002|NCT06081166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154763003|NCT06081166|Antimetabolites|antimetabolites|mesh-ancestor
154763004|NCT06081166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763005|NCT06081166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153378105|NCT03128021|Analgesics|analgesics|mesh-ancestor
154763006|NCT06081166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154763007|NCT06081166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763008|NCT06076304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154763009|NCT06076304|Amoxicillin|amoxicillin|mesh-list
153732153|NCT00155064|Losartan|losartan|mesh-list
154258317|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763010|NCT06076304|Clavulanic Acid|clavulanic acid|mesh-list
154763011|NCT06076304|Clavulanic Acids|clavulanic acids|mesh-list
154763012|NCT06076304|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154763013|NCT06076304|Budesonide|budesonide|mesh-list
154763014|NCT06076304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763015|NCT06076304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154763016|NCT06076304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154763017|NCT06076304|Autonomic Agents|autonomic agents|mesh-ancestor
154763018|NCT06076304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763019|NCT06076304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763020|NCT06076304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154763021|NCT06076304|Respiratory System Agents|respiratory system agents|mesh-ancestor
154763022|NCT06076304|Glucocorticoids|glucocorticoids|mesh-ancestor
154763023|NCT06076304|Hormones|hormones|mesh-ancestor
154763024|NCT06076304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763025|NCT06076304|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154763026|NCT06076304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763027|NCT06076304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763028|NCT06063538|Amiodarone|amiodarone|mesh-list
154763029|NCT06063538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154763030|NCT06063538|Vasodilator Agents|vasodilator agents|mesh-ancestor
154763031|NCT06063538|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154763032|NCT06063538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154763033|NCT06063538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763034|NCT06063538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154763035|NCT06063538|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154763036|NCT06063538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154763037|NCT06063538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763038|NCT06063538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154763039|NCT06063538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154763040|NCT06063538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154763041|NCT06059495|Dostarlimab|dostarlimab|mesh-list
154763042|NCT06059495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763043|NCT06050785|Vancomycin|vancomycin|mesh-list
154763044|NCT06050785|Gentamicins|gentamicins|mesh-list
154763045|NCT06050785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154763046|NCT06050785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763047|NCT06050785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154763048|NCT06050785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763049|NCT06050785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763050|NCT06044740|Sevoflurane|sevoflurane|mesh-list
154763051|NCT06044740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154763052|NCT06044740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154763053|NCT06044740|Anesthetics, General|anesthetics, general|mesh-ancestor
154763054|NCT06044740|Anesthetics|anesthetics|mesh-ancestor
154763055|NCT06044740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154763056|NCT06044740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763057|NCT06038968|Methotrexate|methotrexate|mesh-list
154763058|NCT06038968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154763059|NCT06038968|Abortifacient Agents|abortifacient agents|mesh-ancestor
154763060|NCT06038968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154763061|NCT06038968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763062|NCT06038968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763063|NCT06038968|Antimetabolites|antimetabolites|mesh-ancestor
154763064|NCT06038968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763065|NCT06038968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763066|NCT06038968|Dermatologic Agents|dermatologic agents|mesh-ancestor
154763067|NCT06038968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763068|NCT06038968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154763069|NCT06038968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763070|NCT06038968|Immunologic Factors|immunologic factors|mesh-ancestor
154763071|NCT06038968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763072|NCT06038968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154763073|NCT06015724|Nivolumab|nivolumab|mesh-list
154763074|NCT06015724|Daratumumab|daratumumab|mesh-list
154763075|NCT06015724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763076|NCT06015724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763077|NCT06015724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763078|NCT06015724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838338|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
154763079|NCT06014853|Abiraterone Acetate|abiraterone acetate|mesh-list
154763080|NCT06014853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763081|NCT06014853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154763082|NCT06014853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763083|NCT06014853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763084|NCT06014853|Hormone Antagonists|hormone antagonists|mesh-ancestor
153844479|NCT01268683|Glyburide|glyburide|mesh-list
154763085|NCT06014853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763086|NCT06014853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385046|NCT04310085|Artemether|artemether|mesh-list
154763087|NCT06014853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154763088|NCT06013865|Empagliflozin|empagliflozin|mesh-list
154763089|NCT06013865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154763090|NCT06013865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763091|NCT06013865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154763092|NCT06013865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763093|NCT06012669|Lactoferrin|lactoferrin|mesh-list
154763094|NCT06012669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763095|NCT06003608|Levodopa|levodopa|mesh-list
154763096|NCT06003608|Carbidopa|carbidopa|mesh-list
154763097|NCT06003608|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154763098|NCT06003608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154763099|NCT06003608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154763100|NCT06003608|Dopamine Agents|dopamine agents|mesh-ancestor
154763101|NCT06003608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154763102|NCT06003608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763103|NCT06003608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763104|NCT06003608|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154763105|NCT06003608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763106|NCT06003608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154763107|NCT06003608|Immunologic Factors|immunologic factors|mesh-ancestor
154763108|NCT06003608|Dopamine Agonists|dopamine agonists|mesh-ancestor
154763109|NCT05986084|Cabotegravir|cabotegravir|mesh-list
154763110|NCT05986084|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154763111|NCT05986084|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154763112|NCT05986084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846672|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
154763113|NCT05986084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763114|NCT05986084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154763115|NCT05986084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154763116|NCT05986084|Antiviral Agents|antiviral agents|mesh-ancestor
154763117|NCT05986084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763118|NCT05946551|Cetirizine|cetirizine|mesh-list
154763119|NCT05946551|Famotidine|famotidine|mesh-list
154763120|NCT05946551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154763121|NCT05946551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154763122|NCT05946551|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154763123|NCT05946551|Histamine Antagonists|histamine antagonists|mesh-ancestor
154763124|NCT05946551|Histamine Agents|histamine agents|mesh-ancestor
154763125|NCT05946551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380055|NCT05197751|Antacids|antacids|mesh-ancestor
154763126|NCT05946551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763127|NCT05946551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763128|NCT05946551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154763129|NCT05946551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154515065|NCT05110209|Bevacizumab|bevacizumab|mesh-list
154763130|NCT05946551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154763131|NCT05889052|Pyrimethamine|pyrimethamine|mesh-list
154763132|NCT05889052|Sulfadoxine|sulfadoxine|mesh-list
153394833|NCT01804465|Ipilimumab|ipilimumab|mesh-list
154763133|NCT05889052|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154763134|NCT05889052|Antimalarials|antimalarials|mesh-ancestor
154763135|NCT05889052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154763136|NCT05889052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154763137|NCT05889052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387693|NCT00000237|Buprenorphine|buprenorphine|mesh-list
154763138|NCT05889052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154763139|NCT05889052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258381|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
154763140|NCT05889052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394926|NCT02533505|Budesonide|budesonide|mesh-list
154763141|NCT05889052|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154763143|NCT05879835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154763144|NCT05879835|Anticoagulants|anticoagulants|mesh-ancestor
154763145|NCT05879835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154763146|NCT05879835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154258384|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
154763147|NCT05879835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763148|NCT05875571|Ketorolac|ketorolac|mesh-list
154763149|NCT05875571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154763150|NCT05875571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154763151|NCT05875571|Analgesics|analgesics|mesh-ancestor
154258388|NCT03307174|Analgesics|analgesics|mesh-ancestor
154763152|NCT05875571|Sensory System Agents|sensory system agents|mesh-ancestor
154763153|NCT05875571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763154|NCT05875571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763155|NCT05875571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154763156|NCT05875571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763157|NCT05875571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154763158|NCT05875571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763159|NCT05875571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763160|NCT05856357|Pyrimethamine|pyrimethamine|mesh-list
154763161|NCT05856357|Sulfadoxine|sulfadoxine|mesh-list
154763162|NCT05856357|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154763163|NCT05856357|Antimalarials|antimalarials|mesh-ancestor
154763164|NCT05856357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154763165|NCT05856357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154763166|NCT05856357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763167|NCT05856357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154763168|NCT05856357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763169|NCT05856357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763170|NCT05856357|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154763171|NCT05840510|Sirolimus|sirolimus|mesh-list
154763172|NCT05840510|Adagrasib|adagrasib|mesh-list
154763173|NCT05840510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154763174|NCT05840510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763175|NCT05840510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154763176|NCT05840510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763177|NCT05840510|Antifungal Agents|antifungal agents|mesh-ancestor
154763178|NCT05840510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763179|NCT05840510|Immunologic Factors|immunologic factors|mesh-ancestor
154763180|NCT05840510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763181|NCT05798793|Cisplatin|cisplatin|mesh-list
154763182|NCT05798793|Docetaxel|docetaxel|mesh-list
154763183|NCT05798793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763184|NCT05798793|Tubulin Modulators|tubulin modulators|mesh-ancestor
154763185|NCT05798793|Antimitotic Agents|antimitotic agents|mesh-ancestor
154763186|NCT05798793|Mitosis Modulators|mitosis modulators|mesh-ancestor
154763187|NCT05798793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763188|NCT05796752|Memantine|memantine|mesh-list
154763189|NCT05796752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154763190|NCT05796752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154763191|NCT05796752|Dopamine Agents|dopamine agents|mesh-ancestor
154763192|NCT05796752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154763193|NCT05796752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763194|NCT05796752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763195|NCT05796752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154763196|NCT05796752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154763197|NCT05789615|Letermovir|letermovir|mesh-list
154763198|NCT05789615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154763199|NCT05789615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763200|NCT05789615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763201|NCT05789615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763202|NCT05789615|Antiviral Agents|antiviral agents|mesh-ancestor
154763203|NCT05789615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763204|NCT05785832|Insulin|insulin|mesh-list
154763205|NCT05785832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154763206|NCT05785832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763207|NCT05780463|Remdesivir|remdesivir|mesh-list
154763208|NCT05780463|Antimetabolites|antimetabolites|mesh-ancestor
154763209|NCT05780463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763210|NCT05780463|Antiviral Agents|antiviral agents|mesh-ancestor
154763211|NCT05780463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763212|NCT05780424|Remdesivir|remdesivir|mesh-list
154763213|NCT05780424|Antimetabolites|antimetabolites|mesh-ancestor
154763214|NCT05780424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763215|NCT05780424|Antiviral Agents|antiviral agents|mesh-ancestor
154763216|NCT05780424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763217|NCT05769842|Propofol|propofol|mesh-list
154763218|NCT05769842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154763219|NCT05769842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154763220|NCT05769842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763221|NCT05769842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154763222|NCT05769842|Anesthetics, General|anesthetics, general|mesh-ancestor
154763223|NCT05769842|Anesthetics|anesthetics|mesh-ancestor
154763224|NCT05761223|Pembrolizumab|pembrolizumab|mesh-list
154763225|NCT05761223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763226|NCT05761223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763227|NCT05761223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763228|NCT05761223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763229|NCT05746520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154763230|NCT05746520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154763231|NCT05746520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763232|NCT05746520|Antitubercular Agents|antitubercular agents|mesh-ancestor
154763233|NCT05733624|Cyclosporine|cyclosporine|mesh-list
154763234|NCT05733624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154763235|NCT05733624|Cyclosporins|cyclosporins|mesh-list
154763236|NCT05733624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763237|NCT05733624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763238|NCT05733624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763239|NCT05733624|Immunologic Factors|immunologic factors|mesh-ancestor
154763240|NCT05733624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763241|NCT05733624|Antifungal Agents|antifungal agents|mesh-ancestor
154763242|NCT05733624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763243|NCT05733624|Dermatologic Agents|dermatologic agents|mesh-ancestor
154763244|NCT05733624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763245|NCT05733624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154763246|NCT05733624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154258461|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154763247|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
154763248|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154763249|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
154763250|NCT05645029|Methamphetamine|methamphetamine|mesh-list
154763251|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
154763252|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154763253|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763254|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
154763255|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
154763256|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154763257|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763258|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
154763259|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
154763260|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763261|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
154763262|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154763263|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763264|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154763265|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154763266|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154763267|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154763268|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154763269|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
154763270|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154763271|NCT05645029|Protective Agents|protective agents|mesh-ancestor
154763272|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154763273|NCT05612594|Bexagliflozin|bexagliflozin|mesh-list
154763274|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154763275|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763276|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
154763277|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
154763278|NCT05577507|Calcium|calcium|mesh-list
154763279|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154763280|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763281|NCT05577507|Antacids|antacids|mesh-ancestor
154763282|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763283|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154763284|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154763285|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154763286|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
154763287|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154763288|NCT05557110|Blinatumomab|blinatumomab|mesh-list
153848575|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
154763289|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763290|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
154763291|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763292|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763293|NCT05547321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763294|NCT05547321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763295|NCT05497778|Paclitaxel|paclitaxel|mesh-list
154763296|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154763297|NCT05497778|Gemcitabine|gemcitabine|mesh-list
154763298|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154763299|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763300|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
154763301|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154763302|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154763303|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763304|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763305|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
154763306|NCT05423262|Nivolumab|nivolumab|mesh-list
154763307|NCT05423262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763308|NCT05423262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763309|NCT05423262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763310|NCT05423262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763311|NCT05386576|Venetoclax|venetoclax|mesh-list
154763312|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763313|NCT05359835|Edetic Acid|edetic acid|mesh-list
154763314|NCT05359835|Calcium|calcium|mesh-list
154763315|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
154763316|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154763317|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763318|NCT05359835|Antidotes|antidotes|mesh-ancestor
154763319|NCT05359835|Protective Agents|protective agents|mesh-ancestor
154763320|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
154763321|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
154763322|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763323|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154763324|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
154763325|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154763326|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
154763327|NCT05347485|Fludarabine|fludarabine|mesh-list
154258542|NCT06192615|Analgesics|analgesics|mesh-ancestor
154763328|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763329|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
154763330|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763331|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763332|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154763333|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
154763334|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763335|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763336|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154763337|NCT05321251|Insulin|insulin|mesh-list
153382659|NCT02007863|Melphalan|melphalan|mesh-list
154763338|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154763339|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763340|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154763341|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154763342|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763343|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763344|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154763345|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
154763346|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763347|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763348|NCT05288816|Ravulizumab|ravulizumab|mesh-list
154763349|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154763350|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763351|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
154763352|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763353|NCT05274243|Phenol|phenol|mesh-list
154763354|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154763355|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763356|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
154763357|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154763358|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154763359|NCT05265247|Esomeprazole|esomeprazole|mesh-list
154763360|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154763361|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154763362|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154763363|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763364|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763365|NCT05202860|Vaccines|vaccines|mesh-list
154763366|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
154763367|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258582|NCT06191770|Narcotics|narcotics|mesh-ancestor
154763368|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
154763369|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154763370|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763371|NCT05074355|Azacitidine|azacitidine|mesh-list
154763372|NCT05074355|Venetoclax|venetoclax|mesh-list
154763373|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763374|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
154763375|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763376|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763377|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763378|NCT05033743|Secnidazole|secnidazole|mesh-list
154763379|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154763380|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154763381|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763382|NCT04993027|Vancomycin|vancomycin|mesh-list
154763383|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154763384|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763385|NCT04984278|Nabiximols|nabiximols|mesh-list
154763386|NCT04984278|Analgesics|analgesics|mesh-ancestor
154763387|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
154763388|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763389|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763390|NCT04962126|Atezolizumab|atezolizumab|mesh-list
154763391|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
154763392|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154763393|NCT04962126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763394|NCT04962126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763395|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763396|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763397|NCT04925193|Dexamethasone|dexamethasone|mesh-list
154763398|NCT04925193|Daratumumab|daratumumab|mesh-list
154763399|NCT04925193|Pomalidomide|pomalidomide|mesh-list
154763400|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154763401|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
154763402|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
154763403|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763404|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763405|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154763406|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
154763407|NCT04925193|Hormones|hormones|mesh-ancestor
154763408|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763409|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154763410|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763411|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
154763412|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154763413|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154763414|NCT04925193|Growth Substances|growth substances|mesh-ancestor
154763415|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
154763416|NCT04872400|Vancomycin|vancomycin|mesh-list
154763417|NCT04872400|Tobramycin|tobramycin|mesh-list
154763418|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154763419|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763420|NCT04857138|Atezolizumab|atezolizumab|mesh-list
154763421|NCT04857138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763422|NCT04857138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763423|NCT04857138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763424|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763425|NCT04832399|Natalizumab|natalizumab|mesh-list
154763426|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
154763427|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763428|NCT04806919|Progesterone|progesterone|mesh-list
154763429|NCT04806919|Progestins|progestins|mesh-ancestor
154763430|NCT04806919|Hormones|hormones|mesh-ancestor
154763431|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763432|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763433|NCT04730258|Azacitidine|azacitidine|mesh-list
154763434|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763435|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
154763436|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763437|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763438|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763439|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
154763440|NCT04715191|Fludarabine|fludarabine|mesh-list
154763441|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
154763442|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763443|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
154763444|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763445|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763446|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154763447|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
154763448|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763449|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763450|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154763451|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763452|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
154763453|NCT04690504|Melatonin|melatonin|mesh-list
154763454|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
154763455|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763456|NCT04690504|Protective Agents|protective agents|mesh-ancestor
154763457|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763458|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154763459|NCT04659343|Autoantibodies|autoantibodies|mesh-list
154763460|NCT04659343|Immunologic Factors|immunologic factors|mesh-ancestor
154763461|NCT04659343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763462|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
154763463|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763464|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
154763465|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763466|NCT04570956|Tamoxifen|tamoxifen|mesh-list
154763467|NCT04570956|Afimoxifene|afimoxifene|mesh-list
154763468|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154763469|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
154763470|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763471|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763472|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154763473|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763474|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154258669|NCT05906836|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153395522|NCT02562521|Nicotine|nicotine|mesh-list
153845494|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
153845495|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386026|NCT01882868|Leucovorin|leucovorin|mesh-list
154763475|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154763476|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154763477|NCT04559529|Levetiracetam|levetiracetam|mesh-list
154763478|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
154763479|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
154763480|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
154763481|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
154258697|NCT05859412|Glucocorticoids|glucocorticoids|mesh-ancestor
154763482|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763483|NCT04502407|Cisplatin|cisplatin|mesh-list
154763484|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763485|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
154763486|NCT04475939|Niraparib|niraparib|mesh-list
154763487|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763488|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850200|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154763489|NCT04475939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763490|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763491|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154763492|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763493|NCT04450329|Aflibercept|aflibercept|mesh-list
154763494|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154763495|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154763496|NCT04450329|Growth Substances|growth substances|mesh-ancestor
154763497|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763498|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
154763499|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763500|NCT04423718|Aflibercept|aflibercept|mesh-list
154763501|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154763502|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154763503|NCT04423718|Growth Substances|growth substances|mesh-ancestor
154763504|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763505|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
154763506|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515440|NCT06322953|Rivaroxaban|rivaroxaban|mesh-list
154763508|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
154763509|NCT04345718|Narcotics|narcotics|mesh-ancestor
154763510|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154763511|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763512|NCT04345718|Analgesics|analgesics|mesh-ancestor
154763513|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
154763514|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763515|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154763516|NCT04305587|Clopidogrel|clopidogrel|mesh-list
154763517|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154763518|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154763519|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154763520|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154763521|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
154763522|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154763523|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763524|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763525|NCT04231851|Cytarabine|cytarabine|mesh-list
154763526|NCT04231851|Daunorubicin|daunorubicin|mesh-list
154258698|NCT05859412|Hormones|hormones|mesh-ancestor
154763527|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763528|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
154763529|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763530|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763531|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
154763532|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763533|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763534|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
154763535|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763536|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154763537|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154763538|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154763539|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763540|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154763541|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
154763542|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763543|NCT04125927|Cysteamine|cysteamine|mesh-list
154763544|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154763545|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763546|NCT04078152|Durvalumab|durvalumab|mesh-list
154763547|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763548|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763549|NCT04071236|Avelumab|avelumab|mesh-list
154763550|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154763551|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154763552|NCT04071236|Peposertib|peposertib|mesh-list
154763553|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763554|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763555|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
154763556|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763557|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258725|NCT05770037|Alectinib|alectinib|mesh-list
154763558|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763559|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763560|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
154763561|NCT04009109|Dexamethasone|dexamethasone|mesh-list
154763562|NCT04009109|Lenalidomide|lenalidomide|mesh-list
154763563|NCT04009109|Daratumumab|daratumumab|mesh-list
154763564|NCT04009109|Ixazomib|ixazomib|mesh-list
154763565|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154763566|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
154763567|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
154763568|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763569|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763570|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154763571|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
154763572|NCT04009109|Hormones|hormones|mesh-ancestor
154763573|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763574|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154763575|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763576|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
154763577|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154763578|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154763579|NCT04009109|Growth Substances|growth substances|mesh-ancestor
154763580|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
154515520|NCT06214897|Nootropic Agents|nootropic agents|mesh-ancestor
154763581|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
154763582|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763583|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763584|NCT03980769|Fludarabine|fludarabine|mesh-list
154763585|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
154763586|NCT03980769|Thiotepa|thiotepa|mesh-list
154763587|NCT03980769|Treosulfan|treosulfan|mesh-list
154763588|NCT03980769|Busulfan|busulfan|mesh-list
154763589|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154763590|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
154763591|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763592|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763593|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
154763594|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763595|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763596|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
154763597|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763598|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154763599|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
154763600|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154763601|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154763602|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
154763603|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763604|NCT03867201|Erenumab|erenumab|mesh-list
154763605|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154763606|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763607|NCT03867201|Analgesics|analgesics|mesh-ancestor
154763608|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
154763609|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763610|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763611|NCT03800693|Leucovorin|leucovorin|mesh-list
154763612|NCT03800693|Fluorouracil|fluorouracil|mesh-list
154763613|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
154763614|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
154763615|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763616|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763617|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763618|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763619|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
154763620|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763621|NCT03800693|Antidotes|antidotes|mesh-ancestor
154763622|NCT03800693|Protective Agents|protective agents|mesh-ancestor
154763623|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
154763624|NCT03800693|Vitamins|vitamins|mesh-ancestor
154763625|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
154763626|NCT03736863|Apatinib|apatinib|mesh-list
154763627|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763628|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154763629|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763630|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763631|NCT03672695|Venetoclax|venetoclax|mesh-list
154763632|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763633|NCT03650114|Ofatumumab|ofatumumab|mesh-list
154763634|NCT03650114|Vaccines|vaccines|mesh-list
154763635|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154763636|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153390933|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
154763637|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
154763638|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763639|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763640|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154763641|NCT03534284|Trazodone|trazodone|mesh-list
154763642|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154763643|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154763644|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154763645|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763646|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154763647|NCT03534284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154763648|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154763649|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154763650|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763651|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154763652|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
154763653|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154763654|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
154763655|NCT03509012|Paclitaxel|paclitaxel|mesh-list
154763656|NCT03509012|Etoposide|etoposide|mesh-list
154763657|NCT03509012|Cisplatin|cisplatin|mesh-list
154763658|NCT03509012|Carboplatin|carboplatin|mesh-list
154763659|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
154763660|NCT03509012|Pemetrexed|pemetrexed|mesh-list
154763661|NCT03509012|Durvalumab|durvalumab|mesh-list
154763662|NCT03509012|Tremelimumab|tremelimumab|mesh-list
154763663|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154763664|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763665|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
154763666|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
154763667|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
154763668|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763669|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154763670|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154763671|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763672|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154763673|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154763674|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763675|NCT03444298|Vitamin E|vitamin e|mesh-list
154763676|NCT03444298|Tocopherols|tocopherols|mesh-list
154763677|NCT03444298|Tocotrienols|tocotrienols|mesh-list
154763678|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
154763679|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
154763680|NCT03444298|Vitamins|vitamins|mesh-ancestor
154763681|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
154763682|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763683|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
154763684|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763685|NCT03444298|Protective Agents|protective agents|mesh-ancestor
154763686|NCT03391479|Avelumab|avelumab|mesh-list
154763687|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763688|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763689|NCT03376659|Bevacizumab|bevacizumab|mesh-list
154763690|NCT03376659|Durvalumab|durvalumab|mesh-list
154763691|NCT03376659|Capecitabine|capecitabine|mesh-list
154763692|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763693|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763694|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154763695|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154763696|NCT03376659|Growth Substances|growth substances|mesh-ancestor
154763697|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258777|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
154763698|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
154763699|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763700|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
154763701|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763702|NCT03375463|Tirzepatide|tirzepatide|mesh-list
154763703|NCT03375463|Incretins|incretins|mesh-ancestor
154763704|NCT03375463|Hormones|hormones|mesh-ancestor
154763705|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763706|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763707|NCT03358875|Docetaxel|docetaxel|mesh-list
154763708|NCT03358875|Tislelizumab|tislelizumab|mesh-list
154763709|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763710|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
154763711|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
154763712|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
154763713|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763714|NCT03358875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763715|NCT03324373|Everolimus|everolimus|mesh-list
154763716|NCT03324373|Lenvatinib|lenvatinib|mesh-list
154763717|NCT03324373|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154763718|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154763719|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763720|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763721|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763722|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
154258782|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258783|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154258784|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258785|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
154258786|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
154258787|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154258788|NCT05643066|Ketamine|ketamine|mesh-list
154258789|NCT05643066|Propofol|propofol|mesh-list
154258790|NCT05643066|Esketamine|esketamine|mesh-list
154763723|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390013|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
154763724|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763725|NCT03237780|Atezolizumab|atezolizumab|mesh-list
154763726|NCT03237780|Halichondrin B|halichondrin b|mesh-list
154763727|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153390214|NCT05751044|Cytarabine|cytarabine|mesh-list
154763728|NCT03237780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763729|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763730|NCT03237780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763731|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763732|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
154763733|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763734|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
154763735|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
154763736|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
154763737|NCT03209401|Carboplatin|carboplatin|mesh-list
154763738|NCT03209401|Niraparib|niraparib|mesh-list
154763739|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763740|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154763741|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763742|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763743|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154763744|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154763745|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
154763746|NCT02789345|Osimertinib|osimertinib|mesh-list
154763747|NCT02789345|Ramucirumab|ramucirumab|mesh-list
154763748|NCT02789345|Necitumumab|necitumumab|mesh-list
154763749|NCT02789345|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154763750|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154763751|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763752|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763753|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763754|NCT02789345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154763755|NCT02789345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154763756|NCT02789345|Growth Substances|growth substances|mesh-ancestor
154763757|NCT02789345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763758|NCT02789345|Growth Inhibitors|growth inhibitors|mesh-ancestor
154763759|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763760|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
154763761|NCT02714881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154763762|NCT02714881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154763763|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763764|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
154763765|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763766|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763767|NCT02647437|Levetiracetam|levetiracetam|mesh-list
154763768|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
154763769|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
154763770|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
154763771|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763772|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763773|NCT02628067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763774|NCT02628067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763775|NCT02229123|Levetiracetam|levetiracetam|mesh-list
154763776|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
154763777|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
154763778|NCT02180711|Rituximab|rituximab|mesh-list
154763779|NCT02180711|Lenalidomide|lenalidomide|mesh-list
154763780|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
154763781|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763782|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763783|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
154763784|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763785|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763786|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154763787|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154763788|NCT02180711|Growth Substances|growth substances|mesh-ancestor
154763789|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
154763790|NCT02180711|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154763791|NCT02180711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154763792|NCT02180711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763793|NCT02180711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763794|NCT02159755|Palbociclib|palbociclib|mesh-list
154763795|NCT02159755|Ibrutinib|ibrutinib|mesh-list
154763796|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763797|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154763798|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763799|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763800|NCT02159755|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154763801|NCT01881048|Celecoxib|celecoxib|mesh-list
154763802|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154763803|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154763804|NCT01881048|Analgesics|analgesics|mesh-ancestor
154763805|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
154763806|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763807|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515754|NCT05907122|Nivolumab|nivolumab|mesh-list
154763808|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154763809|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763810|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154763811|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154763812|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763813|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763814|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
154763816|NCT01822652|Fludarabine|fludarabine|mesh-list
154763817|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
154763818|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763819|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
154763820|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763821|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154763822|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154763823|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
154763824|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763825|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763826|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154763827|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154763828|NCT01822652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154763829|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763830|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
154763831|NCT01792583|Modafinil|modafinil|mesh-list
154763832|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154763833|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763834|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154763835|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154763836|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154763837|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763838|NCT01721798|Copper|copper|mesh-list
154763839|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
154763840|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154763841|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
154763842|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154763843|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763844|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154763845|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154763846|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154763847|NCT01721798|Trace Elements|trace elements|mesh-ancestor
154763848|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
154763849|NCT01038778|Aldesleukin|aldesleukin|mesh-list
154763850|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
154763851|NCT01038778|Interleukin-2|interleukin-2|mesh-list
154763852|NCT01038778|Entinostat|entinostat|mesh-list
154763853|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154763854|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154763855|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763856|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154763857|NCT01038778|Analgesics|analgesics|mesh-ancestor
154763858|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
154763859|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763860|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763861|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154763862|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154763863|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
154763864|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763865|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154763866|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763867|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
154763868|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763869|NCT00980954|Paclitaxel|paclitaxel|mesh-list
154763870|NCT00980954|Carboplatin|carboplatin|mesh-list
154763871|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154763872|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763873|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
154763874|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
154763875|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
154763876|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763877|NCT00716066|Cytarabine|cytarabine|mesh-list
154763878|NCT00716066|Prednisone|prednisone|mesh-list
154763879|NCT00716066|Cortisone|cortisone|mesh-list
154763880|NCT00716066|Etoposide|etoposide|mesh-list
154763881|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
154763882|NCT00716066|Melphalan|melphalan|mesh-list
154763883|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
154763884|NCT00716066|Carmustine|carmustine|mesh-list
154763885|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
154763886|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154763887|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
154763888|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154763889|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154763890|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
154763891|NCT00716066|Hormones|hormones|mesh-ancestor
154763892|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763893|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763894|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154763895|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763896|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154763897|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154763898|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154763899|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763900|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763901|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154763902|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
154763903|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
154763904|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763905|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154763906|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
154763907|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154763908|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
154763909|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154763910|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
154763911|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
154763912|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
154763913|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
154763914|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
154763915|NCT00031512|Pleconaril|pleconaril|mesh-list
154763916|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
154763917|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763918|NCT01605227|Prednisone|prednisone|mesh-list
154763919|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154763920|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
154763921|NCT01605227|Hormones|hormones|mesh-ancestor
154763922|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763923|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763924|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153851130|NCT06021717|Narcotics|narcotics|mesh-ancestor
154763925|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154763926|NCT02446548|Losartan|losartan|mesh-list
154763927|NCT02446548|Aliskiren|aliskiren|mesh-list
154763928|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154763929|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154763930|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154763931|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154763932|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763933|NCT02446548|Renin Inhibitors|renin inhibitors|mesh-ancestor
154763934|NCT02446548|Protease Inhibitors|protease inhibitors|mesh-ancestor
154763935|NCT02446548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763936|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154763937|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154763938|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763939|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
154763940|NCT03199170|Morphine|morphine|mesh-list
154763941|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154763942|NCT03199170|Narcotics|narcotics|mesh-ancestor
154763943|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154763944|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763945|NCT03199170|Analgesics|analgesics|mesh-ancestor
154763946|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
154763947|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154763948|NCT03118128|Metformin|metformin|mesh-list
154763949|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154763950|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763951|NCT03194724|Vitamin A|vitamin a|mesh-list
154763952|NCT03194724|Vitamins|vitamins|mesh-ancestor
154763953|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
154763954|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763955|NCT01709513|Atorvastatin|atorvastatin|mesh-list
154763956|NCT01709513|Ezetimibe|ezetimibe|mesh-list
154763957|NCT01709513|Alirocumab|alirocumab|mesh-list
154763958|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154763959|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154763960|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
154763961|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763962|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154763963|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154763964|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154763965|NCT01709513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154763966|NCT01709513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154763967|NCT01709513|Protease Inhibitors|protease inhibitors|mesh-ancestor
153851311|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
154763968|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
154763969|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154763970|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154763971|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154763972|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
154763973|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
154763974|NCT02446002|Lofexidine|lofexidine|mesh-list
154763975|NCT02446002|Clonidine|clonidine|mesh-list
154763976|NCT02446002|Naltrexone|naltrexone|mesh-list
154763977|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154763978|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154763979|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763980|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
154763981|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851337|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154763982|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154763983|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154763984|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154763985|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154763986|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
154763987|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154763988|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154763989|NCT02446002|Analgesics|analgesics|mesh-ancestor
154258915|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154258916|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154258917|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154258918|NCT05550714|Anesthetics|anesthetics|mesh-list
154258919|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258920|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258921|NCT05467891|Letrozole|letrozole|mesh-list
153391650|NCT02987348|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153391651|NCT02987348|Glucagon|glucagon|mesh-list
153391652|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153391653|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153391679|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153391680|NCT01658839|Travoprost|travoprost|mesh-list
154763990|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
154763991|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
154763992|NCT01605071|Estradiol|estradiol|mesh-list
154763993|NCT01605071|Estrogens|estrogens|mesh-ancestor
154763994|NCT01605071|Hormones|hormones|mesh-ancestor
154763995|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154763996|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154763997|NCT04345198|Epinephrine|epinephrine|mesh-list
154763998|NCT04345198|Racepinephrine|racepinephrine|mesh-list
154763999|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
154764000|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154764001|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153851424|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154764002|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
154764003|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764004|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764005|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764006|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154764007|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154764008|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
154764009|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764010|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154258922|NCT05467891|Fulvestrant|fulvestrant|mesh-list
154258923|NCT05467891|Anastrozole|anastrozole|mesh-list
154258924|NCT05467891|Exemestane|exemestane|mesh-list
154258925|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258926|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154258927|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154258928|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258929|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258930|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154258931|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
153732671|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153851906|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392153|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
153732723|NCT00141986|Vitamins|vitamins|mesh-list
153732724|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
153732725|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851953|NCT01316523|Growth Substances|growth substances|mesh-ancestor
153851954|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
153852005|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392204|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154764011|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
154764012|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
154764013|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
154764014|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154764015|NCT03192618|Leucovorin|leucovorin|mesh-list
154764016|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
154764017|NCT03192618|Calcium|calcium|mesh-list
154764018|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
154764019|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154764020|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764021|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258936|NCT05417100|Methadone|methadone|mesh-list
154764022|NCT03192618|Antidotes|antidotes|mesh-ancestor
154764023|NCT03192618|Protective Agents|protective agents|mesh-ancestor
154764024|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
154764025|NCT03192618|Vitamins|vitamins|mesh-ancestor
154764026|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
154764027|NCT04113226|Rituximab|rituximab|mesh-list
154764028|NCT04113226|Lenalidomide|lenalidomide|mesh-list
154764029|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154764030|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764031|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
154764032|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764033|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764034|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154764035|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154764036|NCT04113226|Growth Substances|growth substances|mesh-ancestor
154764037|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
154764038|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154764039|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154764040|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764041|NCT02444364|Incretins|incretins|mesh-ancestor
154764042|NCT02444364|Hormones|hormones|mesh-ancestor
154764043|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764044|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154764045|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
154764046|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764047|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764048|NCT05039476|Vitamin A|vitamin a|mesh-list
154764049|NCT05039476|Vitamins|vitamins|mesh-ancestor
154764050|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
154764051|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764052|NCT00356356|Etanercept|etanercept|mesh-list
154764053|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154764054|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154764055|NCT00356356|Analgesics|analgesics|mesh-ancestor
154764056|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
154764057|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764058|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764059|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764060|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764061|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764062|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764063|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
154764064|NCT02443818|Sirolimus|sirolimus|mesh-list
154764065|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154764066|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764067|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154764068|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764069|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
154764070|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764071|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
154764072|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764073|NCT01705691|Paclitaxel|paclitaxel|mesh-list
154764074|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
154764075|NCT01705691|Doxorubicin|doxorubicin|mesh-list
154764076|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154764077|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764078|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
154764079|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
154764080|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
154764081|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764082|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764083|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
154764084|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764085|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764086|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154764087|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
154764088|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154764089|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154764090|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154764091|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154764092|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391773|NCT00000327|Heroin|heroin|mesh-list
154764093|NCT04016974|Semaglutide|semaglutide|mesh-list
154764094|NCT04016974|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154764095|NCT04016974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154764096|NCT04016974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764097|NCT02450058|Paclitaxel|paclitaxel|mesh-list
154764098|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
154764099|NCT02450058|Fluorouracil|fluorouracil|mesh-list
154764100|NCT02450058|Epirubicin|epirubicin|mesh-list
154764101|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154764102|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764103|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
154764104|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
154764105|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
154764106|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764107|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764108|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
154764109|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764110|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764111|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154258972|NCT05342597|Edaravone|edaravone|mesh-list
154764112|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
154764113|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154516036|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
154764114|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
154764115|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154764116|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154764117|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154258980|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
154764118|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154764119|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764120|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154764121|NCT02445300|Laxatives|laxatives|mesh-ancestor
154764122|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764124|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
154764125|NCT02445066|Vitamins|vitamins|mesh-ancestor
154764126|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
154764127|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258988|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258989|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258990|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153853371|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853372|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853373|NCT04634071|Bupropion|bupropion|mesh-list
153853374|NCT04634071|Nicotine|nicotine|mesh-list
153853375|NCT04634071|Varenicline|varenicline|mesh-list
153853376|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154764128|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154764129|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154764130|NCT03197298|Clopidogrel|clopidogrel|mesh-list
154764131|NCT03197298|Ticagrelor|ticagrelor|mesh-list
154764132|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154764133|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154764134|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154764135|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154764136|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
154764137|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764138|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764139|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764140|NCT00357448|Interleukin-2|interleukin-2|mesh-list
154258994|NCT05223647|Durvalumab|durvalumab|mesh-list
154258995|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764141|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
154764142|NCT00357448|Immunotoxins|immunotoxins|mesh-list
154764143|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764144|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154764145|NCT00357448|Analgesics|analgesics|mesh-ancestor
154764146|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
154764147|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764148|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764149|NCT00357448|Immunoconjugates|immunoconjugates|mesh-ancestor
154764150|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
154764151|NCT05715658|Dabigatran|dabigatran|mesh-list
154764152|NCT05715658|Antithrombins|antithrombins|mesh-ancestor
154764153|NCT05715658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154764154|NCT05715658|Protease Inhibitors|protease inhibitors|mesh-ancestor
154764155|NCT05715658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764156|NCT05715658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764157|NCT05715658|Anticoagulants|anticoagulants|mesh-ancestor
154764158|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154764159|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154764160|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154764161|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154764162|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764163|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764164|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764165|NCT02443194|Analgesics|analgesics|mesh-ancestor
154764166|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
154764167|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764168|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
154764169|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154764170|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
154764171|NCT03193944|Vitamin D|vitamin d|mesh-list
154764172|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
154764173|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
154764174|NCT03193944|Vitamins|vitamins|mesh-list
154764175|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
154764176|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764177|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154764178|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154764179|NCT00357604|Ritonavir|ritonavir|mesh-list
154764180|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154764181|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
154764182|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154764183|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154764184|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154764185|NCT00357604|Norgestimate|norgestimate|mesh-list
154259018|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154259019|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
154259020|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
154259021|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154259022|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154259027|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154764186|NCT00357604|Norgestrel|norgestrel|mesh-list
154764187|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154764188|NCT00357604|Estradiol|estradiol|mesh-list
154764189|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154764190|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154764191|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154764193|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764194|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764195|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154764196|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154764197|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
154764198|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764199|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154764200|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154764201|NCT00357604|Estrogens|estrogens|mesh-ancestor
154764202|NCT00357604|Hormones|hormones|mesh-ancestor
154764203|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764204|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764205|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154764206|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
154764207|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154764208|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154764209|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154764210|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154764211|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154764212|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154764213|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154764214|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154764215|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154764216|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764217|NCT03193788|Folic Acid|folic acid|mesh-list
154764218|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
154764219|NCT03193788|Dexamethasone|dexamethasone|mesh-list
154764220|NCT03193788|Pemetrexed|pemetrexed|mesh-list
154764221|NCT03193788|Vitamins|vitamins|mesh-ancestor
154764222|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
154764223|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764224|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764225|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
154764226|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
154764227|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764228|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764229|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
154764230|NCT03193788|Hormones|hormones|mesh-ancestor
154764231|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764232|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154259033|NCT05151328|Plecanatide|plecanatide|mesh-list
154764233|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764234|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764235|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764236|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154764237|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154764238|NCT03193788|Hematinics|hematinics|mesh-ancestor
154764239|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
154764240|NCT02442648|Rituximab|rituximab|mesh-list
154764241|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154764242|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764243|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
154764244|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764245|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764246|NCT00356824|Artesunate|artesunate|mesh-list
154764247|NCT00356824|Amodiaquine|amodiaquine|mesh-list
154764248|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
154764249|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153392280|NCT01621009|Bupropion|bupropion|mesh-list
154764250|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154764251|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764252|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764253|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
154764254|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
154764255|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154764256|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
154764257|NCT01705145|Ivacaftor|ivacaftor|mesh-list
154764258|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154764259|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154764260|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764261|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154764262|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154764263|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
154764264|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154764265|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
154764266|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764267|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154764268|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154764269|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154764270|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154764271|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764272|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
154764273|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
154764274|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154764275|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154764276|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764277|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764278|NCT02442492|Urological Agents|urological agents|mesh-ancestor
154764279|NCT01704755|Ribavirin|ribavirin|mesh-list
154764280|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
154764281|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764282|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
154764283|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764284|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
154764285|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154764286|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154764287|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
154764288|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764289|NCT04166669|Itraconazole|itraconazole|mesh-list
154764290|NCT04166669|Rifampin|rifampin|mesh-list
154764291|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
154764292|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764293|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154764294|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154764295|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764296|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764297|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154764298|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
154764299|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764300|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855462|NCT01220128|Epirubicin|epirubicin|mesh-list
154764301|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154764302|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154764303|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
154764304|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154764305|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
154764306|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154764307|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154764308|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154764309|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154764310|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154764311|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154764312|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154764313|NCT03193710|Remifentanil|remifentanil|mesh-list
154764314|NCT03193710|Propofol|propofol|mesh-list
154764315|NCT03193710|Sevoflurane|sevoflurane|mesh-list
154764316|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154764317|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154764318|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764319|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154764320|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
154764321|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
154764322|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154764323|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154764324|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154764325|NCT03193710|Narcotics|narcotics|mesh-ancestor
154764326|NCT03193710|Analgesics|analgesics|mesh-ancestor
154764327|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
154764328|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764329|NCT01704599|Vitamins|vitamins|mesh-list
154764330|NCT01704599|Folic Acid|folic acid|mesh-list
154764331|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
154764332|NCT01704599|Pyridoxine|pyridoxine|mesh-list
154764333|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
154764334|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
154764335|NCT01704599|Adalimumab|adalimumab|mesh-list
154764336|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
154764337|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764338|NCT01704599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154764339|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764340|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764341|NCT01704599|Hematinics|hematinics|mesh-ancestor
154764342|NCT03196362|Metformin|metformin|mesh-list
154764343|NCT03196362|Pioglitazone|pioglitazone|mesh-list
154764344|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154764345|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764347|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
154764348|NCT02449278|Doxorubicin|doxorubicin|mesh-list
154764349|NCT02449278|Vincristine|vincristine|mesh-list
154764350|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764351|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
154764352|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764353|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764354|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154764355|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
154764356|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764357|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764358|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154764359|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154764360|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154764361|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154764362|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764363|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764364|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
154764365|NCT02449278|Hormones|hormones|mesh-ancestor
154764366|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764367|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154764368|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154764369|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
154764370|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
154764371|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
154764372|NCT03599518|Gefitinib|gefitinib|mesh-list
154764373|NCT03599518|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154764374|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154764375|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764376|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764377|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764378|NCT03099486|Leucovorin|leucovorin|mesh-list
154764379|NCT03099486|Antidotes|antidotes|mesh-ancestor
154764380|NCT03099486|Protective Agents|protective agents|mesh-ancestor
154764381|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764382|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
154764383|NCT03099486|Vitamins|vitamins|mesh-ancestor
154764384|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
154764385|NCT00358228|Rimonabant|rimonabant|mesh-list
154764386|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154764387|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154764388|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154764389|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764390|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764391|NCT00358228|Hormones|hormones|mesh-ancestor
154764392|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764393|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764394|NCT05710198|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154764395|NCT05710198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154764396|NCT05710198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154764397|NCT05710198|Nootropic Agents|nootropic agents|mesh-ancestor
154764398|NCT01336530|Oxethazaine|oxethazaine|mesh-list
154764399|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154764400|NCT01336530|Antacids|antacids|mesh-list
154764401|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154764402|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154764403|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
154764404|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764405|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764406|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764407|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
154764408|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
154764409|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154764410|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
154764411|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764412|NCT00777348|Reproterol|reproterol|mesh-list
154764413|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154764414|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154764415|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
154764416|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764417|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516337|NCT04887831|Avelumab|avelumab|mesh-list
154764418|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764419|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154764420|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
154764421|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764422|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154764423|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
154764424|NCT03836560|Nicotine|nicotine|mesh-list
154764425|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154764426|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
154764427|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764428|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764429|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154764430|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154764431|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
154764432|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764433|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764434|NCT04483596|Melatonin|melatonin|mesh-list
154764435|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
154764436|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764437|NCT04483596|Protective Agents|protective agents|mesh-ancestor
154764438|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764439|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154764440|NCT05721586|Listerine|listerine|mesh-list
154764441|NCT05721586|Fluorides|fluorides|mesh-list
154764442|NCT05721586|Fluorides, Topical|fluorides, topical|mesh-list
154764443|NCT05721586|Sodium Fluoride|sodium fluoride|mesh-list
154764444|NCT05721586|Cariostatic Agents|cariostatic agents|mesh-ancestor
154764445|NCT05721586|Protective Agents|protective agents|mesh-ancestor
154764446|NCT05721586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764447|NCT05721586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154764448|NCT05721586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764449|NCT02978482|Durvalumab|durvalumab|mesh-list
154764450|NCT02978482|Tremelimumab|tremelimumab|mesh-list
154764451|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154764452|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154764453|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764454|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
154764455|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764456|NCT00357682|Aspirin|aspirin|mesh-list
154764457|NCT00357682|Esomeprazole|esomeprazole|mesh-list
154764458|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154764459|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154764460|NCT00357682|Analgesics|analgesics|mesh-ancestor
154764461|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
154764462|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764463|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764464|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764465|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764466|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154764467|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154764468|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764469|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154764470|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154764471|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764472|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
154764473|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154764474|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764475|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154764476|NCT00105027|Triamcinolone|triamcinolone|mesh-list
154764477|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154764478|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154764479|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154764480|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764481|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
154764482|NCT00105027|Hormones|hormones|mesh-ancestor
154764483|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764484|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764485|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764486|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
154764487|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764488|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764489|NCT03145012|Ranitidine|ranitidine|mesh-list
154764490|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154764491|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154764492|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764493|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154764494|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
154764496|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764497|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764498|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764499|NCT03832660|Valsartan|valsartan|mesh-list
154764500|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154764501|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154764502|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154764503|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154764504|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764505|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154764506|NCT00030147|Estradiol|estradiol|mesh-list
154764507|NCT00030147|Estrogens|estrogens|mesh-ancestor
154764508|NCT00030147|Hormones|hormones|mesh-ancestor
154764509|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764510|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764511|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154764512|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
154764513|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154764514|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154764515|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154764516|NCT02709486|Tanezumab|tanezumab|mesh-list
154764517|NCT02709486|Analgesics|analgesics|mesh-ancestor
154764518|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
154764519|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764520|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764521|NCT00106431|Romidepsin|romidepsin|mesh-list
154764522|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154764523|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764524|NCT00106431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154764525|NCT00106431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764526|NCT00106431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764527|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154764528|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
154259121|NCT05015439|Cannabidiol|cannabidiol|mesh-list
154764529|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154764530|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
154764531|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764532|NCT03833596|Prednisone|prednisone|mesh-list
154764533|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764534|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
154764535|NCT03833596|Hormones|hormones|mesh-ancestor
154764536|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764537|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764538|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154764539|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764540|NCT02831998|Ethanol|ethanol|mesh-list
154764541|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
154764542|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154764543|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154764544|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764545|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154764546|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764547|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
154764548|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
154764549|NCT02434614|Cisplatin|cisplatin|mesh-list
154764550|NCT02434614|Docetaxel|docetaxel|mesh-list
154764551|NCT02434614|Fluorouracil|fluorouracil|mesh-list
154764552|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764553|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
154764554|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
154764555|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
154764556|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764557|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
154764558|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154764559|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764560|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
154764561|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764562|NCT05720260|Durvalumab|durvalumab|mesh-list
154764563|NCT05720260|Fulvestrant|fulvestrant|mesh-list
154764564|NCT05720260|Goserelin|goserelin|mesh-list
154764565|NCT05720260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516491|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764566|NCT05720260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764567|NCT05720260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154764568|NCT05720260|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154764569|NCT05720260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154764570|NCT05720260|Hormone Antagonists|hormone antagonists|mesh-ancestor
154764571|NCT05720260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764572|NCT05720260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764573|NCT05720026|Docetaxel|docetaxel|mesh-list
154764574|NCT05720026|Trastuzumab|trastuzumab|mesh-list
154764575|NCT05720026|Pertuzumab|pertuzumab|mesh-list
154764576|NCT05720026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764577|NCT05720026|Tubulin Modulators|tubulin modulators|mesh-ancestor
154764578|NCT05720026|Antimitotic Agents|antimitotic agents|mesh-ancestor
154764579|NCT05720026|Mitosis Modulators|mitosis modulators|mesh-ancestor
154764580|NCT05720026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764581|NCT05720026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154764582|NCT04483674|Tenofovir|tenofovir|mesh-list
154764583|NCT04483674|Emtricitabine|emtricitabine|mesh-list
154764584|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
154764585|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764586|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154764587|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154764588|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764589|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764590|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154764591|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154764592|NCT02438982|Rituximab|rituximab|mesh-list
154764593|NCT02438982|Tacrolimus|tacrolimus|mesh-list
154764594|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154764595|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154764596|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764597|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
154764598|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764599|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764600|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764601|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764602|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764603|NCT02425774|Prucalopride|prucalopride|mesh-list
154764604|NCT02425774|Laxatives|laxatives|mesh-ancestor
154764605|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764606|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154764607|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154764608|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
154764609|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764610|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764611|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764612|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
154764613|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154764614|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154764615|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154764616|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154764617|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764618|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
154764619|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764620|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764621|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154764622|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764623|NCT03117894|Acetaminophen|acetaminophen|mesh-list
154764624|NCT03117894|Etoricoxib|etoricoxib|mesh-list
154764625|NCT03117894|Morphine|morphine|mesh-list
154764626|NCT03117894|Remifentanil|remifentanil|mesh-list
154764627|NCT03117894|Ondansetron|ondansetron|mesh-list
154764628|NCT03117894|Propofol|propofol|mesh-list
154764629|NCT03117894|Ropivacaine|ropivacaine|mesh-list
154764630|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154764631|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154764632|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764633|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154764634|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
154764635|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
154764636|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154764637|NCT03117894|Narcotics|narcotics|mesh-ancestor
154764638|NCT03117894|Analgesics|analgesics|mesh-ancestor
154764639|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
154764640|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764641|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
154764642|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154764643|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
154764644|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
154764645|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
154764646|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764647|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
154764648|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
154764649|NCT03117894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154764650|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154764651|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
154764652|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764653|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764654|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154764655|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764656|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764657|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154764658|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154764659|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764660|NCT00357292|Azithromycin|azithromycin|mesh-list
154764661|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154764662|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764663|NCT03187548|Calcium|calcium|mesh-list
154764664|NCT03187548|Caseins|caseins|mesh-list
154764665|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154764666|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764667|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
154764668|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
154764669|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764670|NCT02042326|Sirolimus|sirolimus|mesh-list
154764671|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154764672|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764673|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154764674|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764675|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
154764676|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764677|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
154764678|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764679|NCT05718544|Sufentanil|sufentanil|mesh-list
154764680|NCT05718544|Dexmedetomidine|dexmedetomidine|mesh-list
154764681|NCT05718544|Esketamine|esketamine|mesh-list
154764682|NCT05718544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154764683|NCT05718544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154764684|NCT05718544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764685|NCT05718544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154764686|NCT05718544|Analgesics|analgesics|mesh-ancestor
154764687|NCT05718544|Sensory System Agents|sensory system agents|mesh-ancestor
154764688|NCT05718544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764689|NCT05718544|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154764690|NCT05718544|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154764691|NCT05718544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154764692|NCT05718544|Adrenergic Agents|adrenergic agents|mesh-ancestor
154764693|NCT05718544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764694|NCT05718544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764695|NCT05718544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154764696|NCT05718544|Narcotics|narcotics|mesh-ancestor
154764697|NCT05718544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154764698|NCT05718544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154764699|NCT05718544|Anesthetics, General|anesthetics, general|mesh-ancestor
154764700|NCT05718544|Anesthetics|anesthetics|mesh-ancestor
154764701|NCT05718544|Antidepressive Agents|antidepressive agents|mesh-ancestor
154764702|NCT05718544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154764703|NCT05616598|Ribavirin|ribavirin|mesh-list
154764704|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
154764705|NCT05616598|Simeprevir|simeprevir|mesh-list
154764706|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
154259184|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
154764707|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764708|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
154764709|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764710|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
154764711|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764712|NCT03187392|Lidocaine|lidocaine|mesh-list
154764713|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
154764714|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
154764715|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154764716|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764717|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
154764718|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516647|NCT04302025|Alectinib|alectinib|mesh-list
154764719|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154764720|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154764721|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154764722|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154764723|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764724|NCT01464268|Riboflavin|riboflavin|mesh-list
154764725|NCT01464268|Dextrans|dextrans|mesh-list
154764726|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
154764727|NCT01464268|Vitamins|vitamins|mesh-ancestor
154764728|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
154764729|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764730|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154764731|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
154764732|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
154764733|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
154764734|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
154764735|NCT00215787|Lansoprazole|lansoprazole|mesh-list
154764736|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
154764737|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154764738|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764739|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154764740|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764741|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764742|NCT00216099|Folic Acid|folic acid|mesh-list
154764743|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
154764744|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
154764745|NCT00216099|Pemetrexed|pemetrexed|mesh-list
154764746|NCT00216099|Vitamins|vitamins|mesh-ancestor
154764747|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
154764748|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764749|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764750|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764751|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764752|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154764753|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154764754|NCT00216099|Hematinics|hematinics|mesh-ancestor
154764755|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
154764756|NCT00039195|Prednisone|prednisone|mesh-list
154764757|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
154764758|NCT00039195|Ifosfamide|ifosfamide|mesh-list
154764759|NCT00039195|Rituximab|rituximab|mesh-list
154764760|NCT00039195|Carboplatin|carboplatin|mesh-list
154764761|NCT00039195|Doxorubicin|doxorubicin|mesh-list
154764762|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154764763|NCT00039195|Etoposide|etoposide|mesh-list
154764764|NCT00039195|Vincristine|vincristine|mesh-list
154764765|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764766|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
154764767|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764768|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764769|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154764770|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
154764771|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764772|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764773|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154764774|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154764775|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154764776|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154764777|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154764778|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764779|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764780|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
154764781|NCT00039195|Hormones|hormones|mesh-ancestor
154764782|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764783|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154764784|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154764785|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
154764786|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
154764787|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
154764788|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
154764789|NCT05591170|Vitamin D|vitamin d|mesh-list
154764790|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154764791|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764792|NCT05591170|Vitamins|vitamins|mesh-ancestor
154764793|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
154764794|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154764795|NCT00218439|Paroxetine|paroxetine|mesh-list
154764796|NCT00218439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154259218|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
154764797|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154764798|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154764799|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764800|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764801|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
154764802|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764803|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154764804|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
154764805|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154764806|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154764807|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154764808|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764809|NCT04344730|Dexamethasone|dexamethasone|mesh-list
154764810|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
154764811|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764812|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
154764813|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
154764814|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764815|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764816|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764817|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
154764818|NCT04344730|Hormones|hormones|mesh-ancestor
154764819|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764820|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154764821|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764822|NCT05716672|Lazertinib|lazertinib|mesh-list
154764823|NCT05716672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154764824|NCT05716672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764825|NCT05716672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860375|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860376|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154259227|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
154860377|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154860378|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154860379|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860380|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154860381|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154860382|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154860383|NCT03122444|Imipramine|imipramine|mesh-list
154860384|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154860385|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
154860386|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154860387|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154860388|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154860389|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860390|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860391|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
154860392|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860393|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860394|NCT02169427|Opicapone|opicapone|mesh-list
154860395|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154860396|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860397|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860398|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154860399|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154860400|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
154860401|NCT03454048|Piperaquine|piperaquine|mesh-list
154860402|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
154860403|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154860404|NCT03454048|Atovaquone|atovaquone|mesh-list
154860405|NCT03454048|Proguanil|proguanil|mesh-list
154860406|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154860407|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
154860408|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154860409|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154860410|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860411|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154860412|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860413|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860414|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154860415|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
154860416|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153392750|NCT04342247|Hormones|hormones|mesh-ancestor
154516794|NCT04113616|Decitabine|decitabine|mesh-list
154764826|NCT00358384|Betamethasone|betamethasone|mesh-list
154764827|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
154764828|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154764829|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
154764830|NCT00358384|Calcipotriene|calcipotriene|mesh-list
154764831|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154764832|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764833|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
154764834|NCT00358384|Hormones|hormones|mesh-ancestor
154764835|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764836|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764837|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154764838|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
154764839|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
154764840|NCT02959060|Rifampin|rifampin|mesh-list
154764841|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154764842|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
154764843|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154764844|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764845|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
154764846|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154764847|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764848|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764849|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154764850|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154764851|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154764852|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154764853|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154764854|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154764855|NCT00109005|Lenalidomide|lenalidomide|mesh-list
154764856|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
154764857|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259251|NCT04542733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154764858|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154764859|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154764860|NCT00109005|Growth Substances|growth substances|mesh-ancestor
154764861|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
154764862|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764863|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
154764864|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764865|NCT05547100|Olanzapine|olanzapine|mesh-list
154764866|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
154764867|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
154764868|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764869|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764870|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764871|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154764872|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154764873|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154764874|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154764875|NCT05547100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154764876|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154764877|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154764878|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764879|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764880|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
154764881|NCT00109473|Prednisone|prednisone|mesh-list
154764882|NCT00109473|Hormones|hormones|mesh-list
154764883|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764884|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
154764885|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764886|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764887|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154764888|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764889|NCT00044655|Olanzapine|olanzapine|mesh-list
154764890|NCT00044655|Risperidone|risperidone|mesh-list
154764891|NCT00044655|Aripiprazole|aripiprazole|mesh-list
154764892|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154764893|NCT00044655|Ziprasidone|ziprasidone|mesh-list
154764894|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154764895|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
154764896|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764897|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764898|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764899|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154764901|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732883|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
154764902|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154764903|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154764904|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
154764905|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
154764906|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
154764907|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764908|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154764909|NCT00044655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154764910|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154764911|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154764912|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
154764913|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
154764914|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154764915|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154764916|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154764917|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154764918|NCT05130892|Tranilast|tranilast|mesh-list
154764919|NCT05130892|Colchicine|colchicine|mesh-list
154764920|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
154764921|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154764922|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
154764923|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
154764924|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
154764925|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764926|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764927|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154764928|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154764929|NCT05130892|Analgesics|analgesics|mesh-ancestor
154764930|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
154764931|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764932|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764933|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154764934|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154764935|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154764936|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154764937|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154764938|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
154764939|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
154764940|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764941|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154764942|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154764943|NCT00223665|Leuprolide|leuprolide|mesh-list
154764944|NCT00223665|Flutamide|flutamide|mesh-list
154764945|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154764946|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
154764947|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154764948|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764949|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154764950|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764951|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
154764952|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
154764953|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154764954|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
154764955|NCT05311540|Astringents|astringents|mesh-ancestor
154764956|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764957|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
154764958|NCT00223821|Oxybutynin|oxybutynin|mesh-list
154764959|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
154764960|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
154764961|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154764962|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764963|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154764964|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154764965|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
154764966|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154764967|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764968|NCT00223821|Urological Agents|urological agents|mesh-ancestor
154764969|NCT00359164|Bevacizumab|bevacizumab|mesh-list
154764970|NCT00359164|Verteporfin|verteporfin|mesh-list
154764971|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154764972|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764973|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154764974|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154764975|NCT00359164|Growth Substances|growth substances|mesh-ancestor
154764976|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764977|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
154764978|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154764979|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
154764980|NCT00224289|Latanoprost|latanoprost|mesh-list
154764981|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154764982|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154764983|NCT00045435|Cyclosporine|cyclosporine|mesh-list
154764984|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
154764985|NCT00045435|Fludarabine|fludarabine|mesh-list
154764986|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
154764987|NCT00045435|Cyclosporins|cyclosporins|mesh-list
154764988|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154764989|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154764990|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
154764991|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154764992|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154764993|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
154764994|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154764995|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154764996|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
154764997|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154764998|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
154764999|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765000|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154765001|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154765002|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154765003|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
154765004|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154765005|NCT00111657|Rasburicase|rasburicase|mesh-list
154765006|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
154765007|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765008|NCT02097303|Prednisone|prednisone|mesh-list
154765009|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
154765010|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154765011|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154765012|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
154765013|NCT02097303|Hormones|hormones|mesh-ancestor
154765014|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765015|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765016|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154765017|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765018|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154765019|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765020|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765021|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
154765022|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154765023|NCT00703326|Docetaxel|docetaxel|mesh-list
154765024|NCT00703326|Ramucirumab|ramucirumab|mesh-list
154765025|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765026|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
154765027|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
154765028|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
154765029|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765030|NCT00703326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154765031|NCT00703326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154765032|NCT00703326|Growth Substances|growth substances|mesh-ancestor
154765033|NCT00703326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259304|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154765034|NCT00703326|Growth Inhibitors|growth inhibitors|mesh-ancestor
154765035|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
154765036|NCT02097537|Miotics|miotics|mesh-ancestor
154765037|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
154765038|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765039|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765040|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154765041|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154765042|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
154765043|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154765044|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154765045|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
154765046|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765047|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765048|NCT02097849|Interferons|interferons|mesh-list
154517017|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
154765049|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154765050|NCT02097849|Vaccines|vaccines|mesh-list
154765051|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154765052|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
154765053|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765054|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765055|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
154765056|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765057|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154765058|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154765059|NCT00047697|Donepezil|donepezil|mesh-list
154765060|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154765061|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765062|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765063|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
154765064|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259332|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
154765065|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765066|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
154765067|NCT02437812|Metformin|metformin|mesh-list
154765068|NCT02437812|Paclitaxel|paclitaxel|mesh-list
154765069|NCT02437812|Carboplatin|carboplatin|mesh-list
154765070|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154765071|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765072|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154765073|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
154765074|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
154765075|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765076|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154765077|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765078|NCT00112593|Cyclosporine|cyclosporine|mesh-list
154765079|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
154765080|NCT00112593|Fludarabine|fludarabine|mesh-list
154765081|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
154765082|NCT00112593|Cyclosporins|cyclosporins|mesh-list
154765083|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765084|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154765085|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
154765086|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765087|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154765088|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
154765089|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765090|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765091|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
154765092|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765093|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
154765094|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765095|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154765096|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154765097|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154765098|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
154765099|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154765100|NCT05280106|Citric Acid|citric acid|mesh-list
154765101|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
154765102|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
154765103|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
154765104|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154765105|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
154765106|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
154765107|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765108|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154765109|NCT00112671|Sorafenib|sorafenib|mesh-list
154765110|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765111|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154765112|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765113|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765114|NCT02437656|Metformin|metformin|mesh-list
154765115|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154765116|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765117|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
154765118|NCT05273632|Oxytocin|oxytocin|mesh-list
154765119|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
154765120|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154765121|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765122|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154765123|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154765124|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765125|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
154765126|NCT05273632|Coagulants|coagulants|mesh-ancestor
154765127|NCT02429622|Paclitaxel|paclitaxel|mesh-list
154765128|NCT02429622|Nedaplatin|nedaplatin|mesh-list
154765129|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154765130|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765131|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
154765132|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
154765133|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
154765134|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765135|NCT02429466|Guadecitabine|guadecitabine|mesh-list
154765136|NCT02429466|Azacitidine|azacitidine|mesh-list
154765137|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765138|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154765139|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
154765140|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765141|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765142|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
154765143|NCT02429388|Spironolactone|spironolactone|mesh-list
154765144|NCT02429388|Diuretics|diuretics|mesh-list
154765145|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
154765146|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154765147|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
154765148|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765149|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765150|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
154765151|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154765152|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765153|NCT02429232|Pioglitazone|pioglitazone|mesh-list
154765154|NCT02429232|Linagliptin|linagliptin|mesh-list
154765155|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154765156|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765157|NCT02429232|Incretins|incretins|mesh-ancestor
154765158|NCT02429232|Hormones|hormones|mesh-ancestor
154765159|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765160|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154765161|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
154765162|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765163|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765164|NCT03189732|Metformin|metformin|mesh-list
154765165|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154765166|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765167|NCT02437032|Menotropins|menotropins|mesh-list
154765168|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154765169|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
154765170|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154765171|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765172|NCT05232994|Metformin|metformin|mesh-list
154765173|NCT05232994|Esomeprazole|esomeprazole|mesh-list
154765174|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154765175|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765176|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154765177|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154765178|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154765179|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765180|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765181|NCT02436798|Ondansetron|ondansetron|mesh-list
154765182|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
154765183|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
154765184|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765185|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765186|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154765187|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
154765188|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
154765189|NCT02436798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154765190|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154765191|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
154765192|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765193|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765194|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
154765195|NCT03185130|Promethazine|promethazine|mesh-list
154765196|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
154259382|NCT04348045|Durvalumab|durvalumab|mesh-list
154765197|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154765198|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154765199|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765200|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765201|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
154765203|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
154765204|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765205|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
154765206|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
154765207|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154765208|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154765209|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
154765210|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
154765211|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765212|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765213|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154765214|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
154765215|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
154765216|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154765217|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154765218|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154765219|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154765220|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
154765221|NCT00358618|Propofol|propofol|mesh-list
154765222|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154765223|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765224|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765225|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154765226|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
154765227|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
154765228|NCT02428764|Carboplatin|carboplatin|mesh-list
154765229|NCT02428764|Gemcitabine|gemcitabine|mesh-list
154765230|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
154765231|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765232|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154765233|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
154765234|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765235|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765236|NCT00358696|Tenofovir|tenofovir|mesh-list
154259383|NCT04348045|Olaparib|olaparib|mesh-list
154765237|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
154765238|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765239|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154765240|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154765241|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765242|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765243|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154765244|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154765245|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154765246|NCT05429476|Plasminogen|plasminogen|mesh-list
154765247|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154765248|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154765249|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765250|NCT00360178|Amlodipine|amlodipine|mesh-list
154765251|NCT00360178|Valsartan|valsartan|mesh-list
154765252|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154765253|NCT00360178|Candesartan|candesartan|mesh-list
154765254|NCT00360178|Candesartan cilexetil|candesartan cilexetil|mesh-list
154765255|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154765256|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154765257|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154765258|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765259|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154765260|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259390|NCT04348045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765261|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
154765262|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154765263|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154765264|NCT00360178|Diuretics|diuretics|mesh-ancestor
154765265|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
154765266|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154765267|NCT00421720|Sufentanil|sufentanil|mesh-list
154765268|NCT00421720|Remifentanil|remifentanil|mesh-list
154765269|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154765270|NCT00421720|Narcotics|narcotics|mesh-ancestor
154765271|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765272|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765273|NCT00421720|Analgesics|analgesics|mesh-ancestor
154765274|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
154765275|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517239|NCT03199885|Atezolizumab|atezolizumab|mesh-list
154765276|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154765277|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154765278|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
154765279|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
154765280|NCT05008276|Dextrans|dextrans|mesh-list
154765281|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
154765282|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
154765283|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
154765284|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
154765285|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765286|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154765287|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154765288|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765289|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765290|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
154765291|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154765292|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154765293|NCT04492306|Protective Agents|protective agents|mesh-ancestor
154765294|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765295|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154765296|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
154765297|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765298|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
154765299|NCT02977312|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154765300|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154259399|NCT04239703|Antibodies|antibodies|mesh-list
154765301|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765302|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765303|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765304|NCT04907110|Niacinamide|niacinamide|mesh-list
154765305|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
154765306|NCT04907110|Vitamins|vitamins|mesh-ancestor
154765307|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
154765308|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765309|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
154765310|NCT04394416|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154765311|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154765312|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765313|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765314|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765315|NCT02977000|Propranolol|propranolol|mesh-list
154765316|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154765317|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154765318|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
154765319|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765320|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765321|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765322|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154765323|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154765324|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
154765325|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
154765326|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154765327|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765328|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
154765329|NCT00112827|Melphalan|melphalan|mesh-list
154765330|NCT00112827|Lenalidomide|lenalidomide|mesh-list
154765331|NCT00112827|Lenograstim|lenograstim|mesh-list
154765332|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154765333|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
154765334|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765335|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765336|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154765337|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
154765338|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765339|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765340|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154765341|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154765342|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154765343|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154765344|NCT00112827|Growth Substances|growth substances|mesh-ancestor
154765345|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
154765346|NCT04752111|Esmolol|esmolol|mesh-list
154765347|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154765348|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154765349|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154765350|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
154765351|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765352|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765353|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765355|NCT00226239|Cetuximab|cetuximab|mesh-list
154765356|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765357|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
154765358|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
154765359|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
154765360|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765361|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765362|NCT00227019|Vitamins|vitamins|mesh-list
154765363|NCT00227019|Folic Acid|folic acid|mesh-list
154765364|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
154765365|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
154765366|NCT00227019|Dexamethasone|dexamethasone|mesh-list
154765367|NCT00227019|Bevacizumab|bevacizumab|mesh-list
154765368|NCT00227019|Pemetrexed|pemetrexed|mesh-list
154765369|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765370|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765371|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154765372|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154765373|NCT00227019|Growth Substances|growth substances|mesh-ancestor
154765374|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765375|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
154765376|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
154765377|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154765378|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
154765379|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
154765380|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765381|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154765382|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
154765383|NCT00227019|Hormones|hormones|mesh-ancestor
154765384|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765385|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154765386|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765387|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765388|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154765389|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154765390|NCT00227019|Hematinics|hematinics|mesh-ancestor
154765391|NCT00113217|Bevacizumab|bevacizumab|mesh-list
154765392|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765393|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765394|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154765395|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154765396|NCT00113217|Growth Substances|growth substances|mesh-ancestor
154765397|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765398|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
154765399|NCT04718116|Tramadol|tramadol|mesh-list
154765400|NCT04718116|Tapentadol|tapentadol|mesh-list
154765401|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154765402|NCT04718116|Narcotics|narcotics|mesh-ancestor
154765403|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765404|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765405|NCT04718116|Analgesics|analgesics|mesh-ancestor
154765406|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
154765407|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765408|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154765409|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154765410|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154765411|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765412|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
154765413|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765414|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
154765415|NCT04276792|Narcotics|narcotics|mesh-ancestor
154765416|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765417|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765418|NCT04276792|Analgesics|analgesics|mesh-ancestor
154765419|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
154765420|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765421|NCT00053703|Olanzapine|olanzapine|mesh-list
154765422|NCT00053703|Risperidone|risperidone|mesh-list
154765423|NCT00053703|Molindone|molindone|mesh-list
154765424|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154765425|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
154765426|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765427|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765428|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765429|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154765430|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154765431|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765432|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154765433|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154765435|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
154765436|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
154765437|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765438|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154765439|NCT00053703|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154765440|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154765441|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154765442|NCT02975440|Rifampin|rifampin|mesh-list
154765443|NCT02975440|Midazolam|midazolam|mesh-list
154765444|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154765445|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154765446|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765447|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765448|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154765449|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154765450|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154765451|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154765452|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
154765453|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
154765454|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
154765455|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
154765456|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765457|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765458|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154765459|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
154765460|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154765461|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765462|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
154765463|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154765464|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765465|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154765466|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154765467|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154765468|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154765469|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154765470|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154765471|NCT00231309|Lenograstim|lenograstim|mesh-list
154765472|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154765473|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
154765474|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765475|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
154765476|NCT04267120|Lenvatinib|lenvatinib|mesh-list
154765477|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765478|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765479|NCT04267120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154765480|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765481|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154765482|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765483|NCT00232479|Carboplatin|carboplatin|mesh-list
154765484|NCT00232479|Docetaxel|docetaxel|mesh-list
154765485|NCT00232479|Trastuzumab|trastuzumab|mesh-list
154765486|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765487|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
154765488|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
154765489|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
154765490|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765491|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765492|NCT00233103|Sertraline|sertraline|mesh-list
154765493|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
154765494|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154765495|NCT00233103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154765496|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154765497|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154259469|NCT03854019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154765498|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517480|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
154765499|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765500|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
154765501|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259480|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154765503|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154765504|NCT00703014|Ganirelix|ganirelix|mesh-list
154765505|NCT00703014|Progestins|progestins|mesh-ancestor
154765506|NCT00703014|Hormones|hormones|mesh-ancestor
154765507|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765508|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765509|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
154765510|NCT02433522|Rituximab|rituximab|mesh-list
154765511|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765512|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765513|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
154765514|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765515|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765516|NCT02433912|Acetaminophen|acetaminophen|mesh-list
154765517|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
154765518|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154765519|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154765520|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765521|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
154765522|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
154765523|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154765524|NCT02433912|Analgesics|analgesics|mesh-ancestor
154765525|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
154765526|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765527|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765528|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
154765529|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
154765530|NCT02436486|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154765531|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154765532|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765533|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154765534|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154765535|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259484|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154765536|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765537|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765538|NCT02436486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765539|NCT02436486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154765540|NCT02436486|Serotonin Agents|serotonin agents|mesh-ancestor
154765541|NCT02436486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765542|NCT04342858|Listerine|listerine|mesh-list
154765543|NCT04342858|Fluorides|fluorides|mesh-list
154765544|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
154765545|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
154765546|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765547|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
154765548|NCT04342858|Protective Agents|protective agents|mesh-ancestor
154765549|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154765550|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765551|NCT02429076|Propofol|propofol|mesh-list
154765552|NCT02429076|Sevoflurane|sevoflurane|mesh-list
154765553|NCT02429076|Methylphenidate|methylphenidate|mesh-list
154765554|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154765555|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765556|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765557|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154765558|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
154765559|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
154765560|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154765561|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154765562|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154765563|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154765564|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154765565|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154765566|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765567|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
154765568|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765569|NCT00255177|Mifepristone|mifepristone|mesh-list
154765570|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154765571|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
154765572|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154765573|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765574|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154765575|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154765576|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154765577|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
154765578|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154765579|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154765580|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
154765581|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765582|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
154765583|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154765584|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154765585|NCT04670224|Anesthetics|anesthetics|mesh-list
154765586|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765587|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765588|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
154765589|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
154765590|NCT00361114|Dapsone|dapsone|mesh-list
154765591|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154765592|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
154765593|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
154765594|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154765595|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154765596|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765597|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154765598|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765599|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765600|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154765601|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
154765602|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154765603|NCT00702624|Hormones|hormones|mesh-list
154765604|NCT00702624|Progesterone|progesterone|mesh-list
154765605|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154765606|NCT00702624|Ganirelix|ganirelix|mesh-list
154765607|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765608|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765609|NCT00702624|Progestins|progestins|mesh-ancestor
154765610|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
154765611|NCT03915496|Abrocitinib|abrocitinib|mesh-list
154765612|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154765613|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765614|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765615|NCT00702546|Hormones|hormones|mesh-list
154765616|NCT00702546|Progesterone|progesterone|mesh-list
154765617|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154765618|NCT00702546|Ganirelix|ganirelix|mesh-list
154765619|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765620|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765621|NCT00702546|Progestins|progestins|mesh-ancestor
154765622|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
154765623|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
154765624|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154765625|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
154765626|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765627|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765628|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154765629|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
154765630|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
154765631|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154765632|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
154765633|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765634|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765635|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
154765636|NCT02428686|Hematinics|hematinics|mesh-ancestor
154765637|NCT02432976|Insulin|insulin|mesh-list
154765638|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154765639|NCT02432976|Exenatide|exenatide|mesh-list
154765640|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
154765641|NCT02432976|Incretins|incretins|mesh-list
154765642|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154765643|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765644|NCT02432976|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154765645|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154765646|NCT02432976|Hormones|hormones|mesh-ancestor
154259533|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765647|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765648|NCT02428374|Clopidogrel|clopidogrel|mesh-list
154765649|NCT02428374|Ticagrelor|ticagrelor|mesh-list
154765650|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154765651|NCT02428374|Simvastatin|simvastatin|mesh-list
154765652|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154765653|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153853125|NCT05289648|Niraparib|niraparib|mesh-list
154765654|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154765655|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154765656|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
154765657|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765658|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765659|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765660|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154765661|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154765662|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
154765663|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154765664|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154765665|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765666|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154765667|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
154765668|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154765669|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
154765670|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765671|NCT04606576|Insulin|insulin|mesh-list
154765672|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154765673|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154765674|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765675|NCT02428062|Phenylephrine|phenylephrine|mesh-list
154765676|NCT02428062|Dopamine|dopamine|mesh-list
154765677|NCT02428062|Epinephrine|epinephrine|mesh-list
154765678|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
154765679|NCT02428062|Norepinephrine|norepinephrine|mesh-list
154765680|NCT02428062|Ephedrine|ephedrine|mesh-list
154765681|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154765682|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765683|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154765684|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154765685|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154765686|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765687|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765688|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154765689|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154765690|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
154765691|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765692|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154765693|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
154765694|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
154765695|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
154765696|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154765697|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
154765698|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154765699|NCT02428062|Protective Agents|protective agents|mesh-ancestor
154765700|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154765701|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
154765702|NCT04594798|Prednisone|prednisone|mesh-list
154765703|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
154765704|NCT04594798|Rituximab|rituximab|mesh-list
154765705|NCT04594798|Doxorubicin|doxorubicin|mesh-list
154765706|NCT04594798|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154765707|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154765708|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
154765709|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765710|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765711|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154765712|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
154765713|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765714|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765715|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154765716|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765717|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154765718|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154765719|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154765720|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765721|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154765722|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
154765723|NCT04594798|Hormones|hormones|mesh-ancestor
154765724|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765725|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154765726|NCT04594798|Immunoconjugates|immunoconjugates|mesh-ancestor
154765727|NCT02432664|Midazolam|midazolam|mesh-list
154765728|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154765729|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154765730|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765731|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765732|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154765733|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154765734|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154765735|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154765736|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
154765737|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
154765738|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
154765739|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
154765740|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765741|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765742|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
154765743|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765744|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765745|NCT03189186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154765746|NCT03189186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765747|NCT00361894|Enoxaparin|enoxaparin|mesh-list
154765748|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
154765749|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154765750|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
154765751|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154765752|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
154765753|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765754|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765755|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
154765756|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154765757|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154765758|NCT03185988|Trastuzumab|trastuzumab|mesh-list
154765759|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765760|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765761|NCT00361348|Heparin|heparin|mesh-list
154765762|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
154765763|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154765764|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154765765|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765766|NCT02431728|Melatonin|melatonin|mesh-list
154765767|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
154765768|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765769|NCT02431728|Protective Agents|protective agents|mesh-ancestor
154765770|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765771|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154765772|NCT04343326|Menthol|menthol|mesh-list
154765773|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
154765774|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
154765775|NCT00362206|Simvastatin|simvastatin|mesh-list
154765776|NCT00362206|Pravastatin|pravastatin|mesh-list
154765777|NCT00362206|Fenofibrate|fenofibrate|mesh-list
154765778|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154765779|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154765780|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
154765781|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765782|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154765783|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154765784|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765785|NCT02314468|Glycerol|glycerol|mesh-list
154765786|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154765787|NCT02314468|Protective Agents|protective agents|mesh-ancestor
154765788|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765789|NCT01704287|Paclitaxel|paclitaxel|mesh-list
154765790|NCT01704287|Carboplatin|carboplatin|mesh-list
154765791|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
154765792|NCT01704287|Temozolomide|temozolomide|mesh-list
154765793|NCT01704287|Dacarbazine|dacarbazine|mesh-list
154765794|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154765795|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765796|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
154765797|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
154765798|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
154765799|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259596|NCT03404193|Venetoclax|venetoclax|mesh-list
154765800|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765801|NCT01704287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154765802|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154765803|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
154765804|NCT00362752|Norfloxacin|norfloxacin|mesh-list
154765805|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154765806|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765807|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154765808|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154765809|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765810|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765811|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765812|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154765813|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154765814|NCT00118209|Prednisone|prednisone|mesh-list
154765815|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
154765816|NCT00118209|Rituximab|rituximab|mesh-list
154765817|NCT00118209|Doxorubicin|doxorubicin|mesh-list
154765818|NCT00118209|Etoposide|etoposide|mesh-list
154765819|NCT00118209|Vincristine|vincristine|mesh-list
154765820|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154765821|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
154765822|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765823|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765824|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154765825|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
154765826|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393610|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765827|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765828|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154765829|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765830|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154765831|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154765832|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154765833|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765834|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154765835|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
154765836|NCT00118209|Hormones|hormones|mesh-ancestor
154765837|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765838|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154765839|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154765840|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
154765841|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
154765842|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
154765843|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
154765844|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765845|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765846|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154765847|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765848|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
154765849|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
154765850|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154765851|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154765852|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765853|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765854|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765855|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765856|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
154765857|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
154765858|NCT01682837|Citric Acid|citric acid|mesh-list
154765859|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
154765860|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
154765861|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154765862|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
154765863|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
154765864|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765865|NCT01682837|Diuretics|diuretics|mesh-ancestor
154765866|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
154765867|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765868|NCT01682837|Expectorants|expectorants|mesh-ancestor
154765869|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
154765870|NCT01682837|Cathartics|cathartics|mesh-ancestor
154765871|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154765872|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
154765873|NCT02213068|Abatacept|abatacept|mesh-list
154765874|NCT02213068|Tacrolimus|tacrolimus|mesh-list
154765875|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154765876|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
154765877|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765878|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154765879|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765880|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765881|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154765882|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765883|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154765884|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
154765885|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154765886|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154765887|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154765888|NCT02213068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154765889|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765890|NCT00702234|Progesterone|progesterone|mesh-list
154765891|NCT00702234|Progestins|progestins|mesh-ancestor
154765892|NCT00702234|Hormones|hormones|mesh-ancestor
154765893|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765894|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765895|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
154765896|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154765897|NCT04483284|Estrogens|estrogens|mesh-ancestor
154765898|NCT04483284|Hormones|hormones|mesh-ancestor
154765899|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765900|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765901|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154765902|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765903|NCT00235833|Adalimumab|adalimumab|mesh-list
154765904|NCT00235833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154765905|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154765906|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154765907|NCT00255801|Doxorubicin|doxorubicin|mesh-list
154765908|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154765909|NCT00255801|Bexarotene|bexarotene|mesh-list
154765910|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154765911|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765912|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154765913|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154765914|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765915|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765916|NCT02431416|Hormones|hormones|mesh-list
154765917|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765918|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765919|NCT01682759|Metformin|metformin|mesh-list
154765920|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
154765921|NCT01682759|Glimepiride|glimepiride|mesh-list
154765922|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154765923|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765924|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154765925|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154765926|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
154765927|NCT01682681|Topiramate|topiramate|mesh-list
154765928|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
154765929|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154259639|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
154765930|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765931|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
154765932|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154765933|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154765934|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154765935|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154765936|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765937|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
154765938|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765939|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765940|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154765941|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765942|NCT03183024|Benralizumab|benralizumab|mesh-list
154765943|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154765944|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
154765945|NCT00240981|Testosterone|testosterone|mesh-list
154765946|NCT00240981|Androgens|androgens|mesh-ancestor
154765947|NCT00240981|Hormones|hormones|mesh-ancestor
154765948|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765949|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765950|NCT01682213|Dabrafenib|dabrafenib|mesh-list
154765951|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765952|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154765953|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259654|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154860417|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154765954|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765956|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
154765957|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765958|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154765959|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154765960|NCT02126553|Growth Substances|growth substances|mesh-ancestor
154765961|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
154765962|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765963|NCT01703741|Testosterone|testosterone|mesh-list
154765964|NCT01703741|Androgens|androgens|mesh-ancestor
154765965|NCT01703741|Hormones|hormones|mesh-ancestor
154765966|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154765967|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765968|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
154765969|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154765970|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154765971|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154765972|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154765973|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154765974|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765975|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
154765976|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154765977|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765978|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154765979|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765980|NCT02430714|Lenvatinib|lenvatinib|mesh-list
154765981|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154765982|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154765983|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154765984|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154765985|NCT02425254|Acetaminophen|acetaminophen|mesh-list
154765986|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154765987|NCT02425254|Analgesics|analgesics|mesh-ancestor
154765988|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
154765989|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765990|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765991|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
154765992|NCT02426736|Dexamethasone|dexamethasone|mesh-list
154765993|NCT02426736|Bupivacaine|bupivacaine|mesh-list
154765994|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154765995|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
154765996|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
154765997|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154765998|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154765999|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766000|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
154766001|NCT02426736|Hormones|hormones|mesh-ancestor
154766002|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154766003|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154766004|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766005|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
154766006|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
154766007|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766008|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
154766009|NCT03182634|Fulvestrant|fulvestrant|mesh-list
154766010|NCT03182634|Olaparib|olaparib|mesh-list
154766011|NCT03182634|Neratinib|neratinib|mesh-list
154766012|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154766013|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766014|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154766015|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154766016|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
154766017|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154766018|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766019|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154766020|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766021|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766022|NCT03182634|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154766023|NCT03182634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154766024|NCT03182322|Insulin|insulin|mesh-list
154766025|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154766026|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518026|NCT01517100|Analgesics|analgesics|mesh-ancestor
154766027|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
154766028|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766029|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
154766030|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154766031|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154766032|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766033|NCT03185364|Urological Agents|urological agents|mesh-ancestor
154766034|NCT02424552|Vitamin D|vitamin d|mesh-list
154766035|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
154766036|NCT02424552|Vitamins|vitamins|mesh-ancestor
154766037|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
154766038|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766039|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154766040|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154766041|NCT03182088|Norepinephrine|norepinephrine|mesh-list
154766042|NCT03182088|Bupivacaine|bupivacaine|mesh-list
154766043|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
154766044|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
154766045|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766046|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766047|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
154766048|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766049|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154766050|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154766051|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
154766052|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766053|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259698|NCT01758328|Busulfan|busulfan|mesh-list
154766054|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
154766055|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
154766056|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154766057|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
154766058|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154766059|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
154766060|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154766061|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766062|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154766063|NCT02425722|Linaclotide|linaclotide|mesh-list
154766064|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154766065|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
154766066|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766067|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766068|NCT02061514|Propofol|propofol|mesh-list
154766069|NCT02061514|Desflurane|desflurane|mesh-list
154766070|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154766071|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766072|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766073|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154766074|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
154766075|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
154766076|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154766077|NCT03183492|Vaccines|vaccines|mesh-list
154766078|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
154766079|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766080|NCT02424318|Topiramate|topiramate|mesh-list
154766081|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
154766082|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154766083|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766084|NCT03179280|Insulin|insulin|mesh-list
154766085|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
154766086|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154766087|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766088|NCT01681433|Prednisone|prednisone|mesh-list
154259708|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
154766089|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
154766090|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154766091|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
154766092|NCT01681433|Hormones|hormones|mesh-ancestor
154766093|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154766094|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766095|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154766096|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766097|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154766098|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766099|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766100|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
154766101|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154766102|NCT01703117|Riluzole|riluzole|mesh-list
154766103|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
154766104|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154766105|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154766106|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766107|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766108|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766109|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154766110|NCT01703117|Protective Agents|protective agents|mesh-ancestor
154766111|NCT01702961|Cytarabine|cytarabine|mesh-list
154766112|NCT01702961|Etoposide|etoposide|mesh-list
154766113|NCT01702961|Rituximab|rituximab|mesh-list
154766114|NCT01702961|Melphalan|melphalan|mesh-list
154766115|NCT01702961|Carmustine|carmustine|mesh-list
154766116|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154766117|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766118|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154766119|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154766120|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766121|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766122|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154766123|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
154766124|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
154766125|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766126|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154766127|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
154766128|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766129|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154766130|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766131|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154766132|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
154766133|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154766134|NCT01702025|Aminophylline|aminophylline|mesh-list
154766135|NCT01702025|Methazolamide|methazolamide|mesh-list
154766136|NCT01702025|Theophylline|theophylline|mesh-list
154766137|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154766138|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
154766139|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766140|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766141|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154766142|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
154766143|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154766144|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766145|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766146|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
154766147|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154766148|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154766149|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
154766150|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766151|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154766152|NCT01702025|Protective Agents|protective agents|mesh-ancestor
154766153|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154766154|NCT01702025|Diuretics|diuretics|mesh-ancestor
154766155|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
154766156|NCT01592747|Memantine|memantine|mesh-list
154766157|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154766158|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154766159|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
154766160|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766161|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766162|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766163|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154766164|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154766165|NCT02425488|Coal Tar|coal tar|mesh-list
154766166|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
154766167|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766168|NCT02426112|Azithromycin|azithromycin|mesh-list
154766169|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154766170|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766171|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
154766172|NCT03117192|Astringents|astringents|mesh-ancestor
154766173|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766174|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766175|NCT04768439|Vitamin D|vitamin d|mesh-list
154766176|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
154766177|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
154518166|NCT05396937|Bevacizumab|bevacizumab|mesh-list
154766178|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154766179|NCT04768439|Calcitriol|calcitriol|mesh-list
154766180|NCT04768439|Vitamins|vitamins|mesh-list
154766181|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
154766182|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766183|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154766184|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154766185|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154766186|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766187|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766188|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154766189|NCT02421042|Lenvatinib|lenvatinib|mesh-list
154766190|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766191|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154766192|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766193|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766194|NCT03181464|Lidocaine|lidocaine|mesh-list
154766195|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
154766196|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
154766197|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766198|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766199|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
154766200|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766201|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154766202|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154766203|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154766204|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766205|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766206|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
154766207|NCT02423928|Ipilimumab|ipilimumab|mesh-list
154766208|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154766209|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
154766210|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766211|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766212|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154766213|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
154766214|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766215|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766216|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154766217|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154766218|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154766219|NCT03106740|Minocycline|minocycline|mesh-list
154766220|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154766221|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766222|NCT03106818|Ketorolac|ketorolac|mesh-list
154766223|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
154766224|NCT03106818|Bupivacaine|bupivacaine|mesh-list
153733236|NCT00143975|Cytarabine|cytarabine|mesh-list
154766225|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
154766226|NCT03106818|Anesthetics|anesthetics|mesh-list
154766227|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766228|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766229|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
154766230|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766231|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154766232|NCT03106818|Analgesics|analgesics|mesh-ancestor
154766233|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154766234|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154766235|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766236|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154766237|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766238|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766239|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154766240|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
154766241|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154766242|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766243|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154766244|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
154766245|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154766246|NCT01592045|Aldesleukin|aldesleukin|mesh-list
154766247|NCT01592045|Molgramostim|molgramostim|mesh-list
154766248|NCT01592045|Dinutuximab|dinutuximab|mesh-list
154766249|NCT01592045|Isotretinoin|isotretinoin|mesh-list
154766250|NCT01592045|Sargramostim|sargramostim|mesh-list
154766251|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766252|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154518242|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259782|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766253|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154766254|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
154766255|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766256|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766257|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
154766258|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766260|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766261|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154766262|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766263|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766264|NCT01590797|Metformin|metformin|mesh-list
154766265|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154766266|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154766267|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766268|NCT01590797|Incretins|incretins|mesh-ancestor
154766269|NCT01590797|Hormones|hormones|mesh-ancestor
154766270|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154766271|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154766272|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
154766273|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766274|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766275|NCT02415192|Amlodipine|amlodipine|mesh-list
154766276|NCT02415192|Valsartan|valsartan|mesh-list
154766277|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154766278|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154766279|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766280|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766281|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154766282|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766283|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
154766284|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154766285|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154766286|NCT02415270|Menthol|menthol|mesh-list
154766287|NCT02415270|Nicotine|nicotine|mesh-list
154766288|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154766289|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
154766290|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766291|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766292|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154766293|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154766294|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766295|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766296|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766297|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
154766298|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766299|NCT02415114|Resveratrol|resveratrol|mesh-list
154766300|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
154766301|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766302|NCT02415114|Protective Agents|protective agents|mesh-ancestor
154766303|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766304|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766305|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154766306|NCT03178422|Nicotine|nicotine|mesh-list
154766307|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154766308|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
154766309|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766310|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766311|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154766312|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154766313|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766314|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766315|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766316|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154766317|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154766318|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766319|NCT02414880|Rocuronium|rocuronium|mesh-list
154766320|NCT02414880|Neostigmine|neostigmine|mesh-list
154766321|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154766322|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154766323|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154766324|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766325|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518330|NCT03463317|Analgesics|analgesics|mesh-ancestor
154766326|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154766327|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766328|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766329|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766330|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766331|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154766332|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
154766333|NCT02423694|Dexetimide|dexetimide|mesh-list
154766334|NCT02423694|Citalopram|citalopram|mesh-list
154766335|NCT02423694|Escitalopram|escitalopram|mesh-list
154766336|NCT02423694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154766337|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154766338|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766339|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766340|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766341|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
154766342|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766343|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154766344|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154766345|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
154766346|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
154766347|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766348|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154766349|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154766350|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766351|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154766352|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
154766353|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154766354|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
154766355|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154766356|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
154766357|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766358|NCT02420418|Expectorants|expectorants|mesh-ancestor
154766359|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
154766360|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154766361|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
154766362|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766363|NCT02420418|Protective Agents|protective agents|mesh-ancestor
154766364|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766365|NCT02420418|Antidotes|antidotes|mesh-ancestor
154766366|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
154766367|NCT02414802|Heparin|heparin|mesh-list
154766368|NCT02414802|Calcium heparin|calcium heparin|mesh-list
154766369|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154766370|NCT02414802|Tinzaparin|tinzaparin|mesh-list
154766371|NCT02414802|Dalteparin|dalteparin|mesh-list
154766372|NCT02414802|Calcium|calcium|mesh-list
154766373|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154766374|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766375|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154766376|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
154766377|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154766378|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154766379|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766380|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
154766381|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154766382|NCT01701401|Ledipasvir|ledipasvir|mesh-list
154766383|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
154766384|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766385|NCT04482504|Vitamin D|vitamin d|mesh-list
154766386|NCT04482504|Vitamins|vitamins|mesh-ancestor
154766387|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
154766388|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766389|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154766390|NCT02414568|Prednisone|prednisone|mesh-list
154766391|NCT02414568|Doxorubicin|doxorubicin|mesh-list
154766392|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154766393|NCT02414568|Vinblastine|vinblastine|mesh-list
154766394|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154766395|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766396|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154766397|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154766398|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766399|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518402|NCT02979197|Celecoxib|celecoxib|mesh-list
154766400|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154766401|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
154766402|NCT02414568|Hormones|hormones|mesh-ancestor
154766403|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154766404|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766405|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154766406|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154766407|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
154766408|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154766409|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
154766410|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
154766411|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
154766412|NCT04348877|Antibodies|antibodies|mesh-list
154766413|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
154766414|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766415|NCT03176628|Niacinamide|niacinamide|mesh-list
154766416|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
154766417|NCT03176628|Vitamins|vitamins|mesh-ancestor
154766418|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
154766419|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766420|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
154766421|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154766422|NCT02414490|Antibodies|antibodies|mesh-list
154766423|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
154766424|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154766425|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
154766426|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766427|NCT01590017|Cisplatin|cisplatin|mesh-list
154259845|NCT01185860|Ritonavir|ritonavir|mesh-list
154766428|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766429|NCT01700621|Vaccines|vaccines|mesh-list
154766430|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
154766431|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766432|NCT03178500|Clomiphene|clomiphene|mesh-list
154766433|NCT03178500|Enclomiphene|enclomiphene|mesh-list
154766434|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
154766435|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154766436|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
154766437|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154766438|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766439|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154766440|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
154766441|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154766442|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154766443|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154766444|NCT01700387|Topiramate|topiramate|mesh-list
154766445|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
154766446|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154766447|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154766448|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154766449|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766450|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766451|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766452|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766453|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766454|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154766455|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766456|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
154766457|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154766458|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
154766459|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154766460|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154766461|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154766462|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766463|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766464|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766465|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766466|NCT01587989|Methotrexate|methotrexate|mesh-list
154766467|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154766468|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
154766469|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154766470|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766471|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154766472|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
154766473|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766474|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766475|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766476|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766477|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154766478|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154766479|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
154766480|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766481|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154766482|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154766483|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154766484|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154766485|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154766486|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154766487|NCT01697969|Analgesics|analgesics|mesh-ancestor
154766488|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
154766489|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766490|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766491|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154766492|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766493|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154766494|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154766495|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154766496|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
154766497|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
154766498|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733294|NCT05147194|Trimetazidine|trimetazidine|mesh-list
154766499|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766500|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
154766501|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154766502|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766503|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766504|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766505|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766506|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766507|NCT01697579|Ondansetron|ondansetron|mesh-list
154766508|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
154766509|NCT01697579|Aprepitant|aprepitant|mesh-list
154766510|NCT01697579|Serotonin|serotonin|mesh-list
154766511|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
154766512|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
154766513|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766514|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766515|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766516|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
154766517|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766518|NCT01697579|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154766519|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154766520|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
154766521|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766522|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766523|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154766524|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154766525|NCT01586195|Vemurafenib|vemurafenib|mesh-list
154766526|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766527|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154766528|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766529|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766530|NCT01697345|Testosterone|testosterone|mesh-list
154766531|NCT01697345|Androgens|androgens|mesh-ancestor
154766532|NCT01697345|Hormones|hormones|mesh-ancestor
154766533|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259883|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154766534|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766535|NCT02441062|Edotreotide|edotreotide|mesh-list
154766536|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154766537|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766538|NCT02442700|Pitavastatin|pitavastatin|mesh-list
154766539|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154766540|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154766541|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154766542|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
153733299|NCT00144209|Pramipexole|pramipexole|mesh-list
153394414|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394415|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153394416|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153394417|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
153394418|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394419|NCT02452931|Leuprolide|leuprolide|mesh-list
153394420|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153394421|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
153394425|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399718|NCT02938949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399719|NCT02938949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154766543|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766544|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766545|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154766546|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
154766547|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154766548|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766549|NCT00568672|Olanzapine|olanzapine|mesh-list
154766550|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
154766551|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
154766552|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766553|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766554|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766555|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154766556|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154766557|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766558|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154766559|NCT00568672|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154766560|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154766561|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766562|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766563|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766564|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
154766565|NCT02448862|Fentanyl|fentanyl|mesh-list
154766566|NCT02448862|Analgesics|analgesics|mesh-list
154766567|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154766568|NCT02448862|Narcotics|narcotics|mesh-ancestor
154766569|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766570|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766571|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
154766572|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766573|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154766574|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154766575|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
154766576|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
154766577|NCT01697267|Rituximab|rituximab|mesh-list
154766578|NCT01697267|Azathioprine|azathioprine|mesh-list
154766579|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154766580|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766581|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
154766582|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766583|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766584|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
154766585|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766586|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154766587|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154766588|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
154766589|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154766590|NCT00362986|Protective Agents|protective agents|mesh-ancestor
154766591|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766592|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766593|NCT00363376|Zonisamide|zonisamide|mesh-list
154766594|NCT00363376|Olanzapine|olanzapine|mesh-list
154766595|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
154766596|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
154766597|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766598|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766599|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766600|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154766601|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154766602|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766603|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154766604|NCT00363376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154766605|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153854360|NCT04640870|Afatinib|afatinib|mesh-list
154766606|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766607|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766608|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766609|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
154766610|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
154766611|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154766612|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154766613|NCT02451202|Rocuronium|rocuronium|mesh-list
154766614|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154766615|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154766616|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154766617|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766618|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766619|NCT02452060|Ketamine|ketamine|mesh-list
154766620|NCT02452060|Analgesics|analgesics|mesh-ancestor
154766621|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
154766622|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766623|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766624|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154766625|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154766626|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
154766627|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
154766628|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766629|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154766630|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154766631|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766632|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766633|NCT01696955|Cetuximab|cetuximab|mesh-list
154766634|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154766635|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766636|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
154766637|NCT02452528|Promethazine|promethazine|mesh-list
154766638|NCT02452528|Tenofovir|tenofovir|mesh-list
154766639|NCT02452528|Entecavir|entecavir|mesh-list
154766640|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
154766641|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766642|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154766643|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154766644|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766645|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859766|NCT00538499|Fentanyl|fentanyl|mesh-list
154766646|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154766647|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154766648|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154766649|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154766650|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766651|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766652|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
154766653|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
154766654|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
153399126|NCT02815709|Morphine|morphine|mesh-list
153854498|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854499|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
153854500|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153854501|NCT01229254|Amiodarone|amiodarone|mesh-list
153854502|NCT01229254|Betrixaban|betrixaban|mesh-list
153854503|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153854504|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
153394754|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
153400157|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153400158|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
154766655|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766656|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
154766657|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
154766658|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766659|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154766660|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
154766661|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
154766662|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766663|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154766664|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
153854508|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154766665|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766666|NCT02702388|Lenvatinib|lenvatinib|mesh-list
154766667|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766668|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154766669|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766670|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766671|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
154766672|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
154766673|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154766674|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154766675|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766676|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766677|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154766678|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154766679|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
154766680|NCT01696877|Molgramostim|molgramostim|mesh-list
154766681|NCT01696877|Sargramostim|sargramostim|mesh-list
154766682|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154766683|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
154766684|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766685|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766686|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154766687|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
154766688|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766689|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766690|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154766691|NCT02416102|Losartan|losartan|mesh-list
154766692|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154766693|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154766694|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154766695|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154766696|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766697|NCT02414256|Anesthetics|anesthetics|mesh-list
154766698|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766699|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766700|NCT02458768|Menotropins|menotropins|mesh-list
154766701|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154766702|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
154766703|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154766704|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766705|NCT02418676|Insulin|insulin|mesh-list
154766706|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154766707|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766708|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154766709|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766710|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154766711|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
154766712|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766713|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
154766714|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154766715|NCT02422836|Protective Agents|protective agents|mesh-ancestor
154259951|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
154766716|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766717|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766718|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
154766719|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154766720|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
154766721|NCT00707304|Lactoferrin|lactoferrin|mesh-list
154766722|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
154766723|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766724|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766725|NCT02423980|Glucagon|glucagon|mesh-list
154766726|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154766727|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766728|NCT02423980|Hormones|hormones|mesh-ancestor
153399196|NCT02823431|Lidocaine|lidocaine|mesh-list
153854587|NCT01235689|Prednisone|prednisone|mesh-list
154766729|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154766730|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766731|NCT02423980|Incretins|incretins|mesh-ancestor
154766732|NCT03176316|Naloxone|naloxone|mesh-list
154766733|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154766734|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766735|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
154766736|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766737|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
154766738|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154766739|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
154766740|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766741|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766742|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154766743|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
154766744|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766745|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766746|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154766747|NCT02974426|Cisplatin|cisplatin|mesh-list
154766748|NCT02974426|Carboplatin|carboplatin|mesh-list
154766749|NCT02974426|Pemetrexed|pemetrexed|mesh-list
154766750|NCT02974426|Vinorelbine|vinorelbine|mesh-list
154766751|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766752|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766753|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766754|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154766755|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154766756|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154766757|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
154766758|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
154766759|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
154766760|NCT02413554|Rivastigmine|rivastigmine|mesh-list
154766761|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154766762|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766763|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766764|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766765|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766766|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766767|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154766768|NCT02413554|Protective Agents|protective agents|mesh-ancestor
154766769|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
154766770|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154766771|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
154766772|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154766773|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
154766774|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766775|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766776|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
154766777|NCT02465632|Clindamycin|clindamycin|mesh-list
154766778|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
154766779|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
154766780|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154766781|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154766782|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154766783|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154766784|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766785|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766786|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154766787|NCT02703636|Rivastigmine|rivastigmine|mesh-list
154766788|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154766789|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766790|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766791|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766792|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766793|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766794|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154766795|NCT02703636|Protective Agents|protective agents|mesh-ancestor
154766796|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
154766797|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154766798|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154766799|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766800|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
154766801|NCT02422056|Coagulants|coagulants|mesh-ancestor
154766802|NCT02466958|Milnacipran|milnacipran|mesh-list
154766803|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
154766804|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154766805|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154766806|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766807|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766808|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766809|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766810|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
154766811|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154766812|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154766813|NCT02466958|Analgesics|analgesics|mesh-ancestor
154766814|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
154766815|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766816|NCT02467504|Folic Acid|folic acid|mesh-list
154766817|NCT02467504|Loxoprofen|loxoprofen|mesh-list
154766818|NCT02467504|Hematinics|hematinics|mesh-ancestor
154766819|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
154766820|NCT02467504|Vitamins|vitamins|mesh-ancestor
154766821|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
154766822|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766823|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154766824|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154766825|NCT02467504|Analgesics|analgesics|mesh-ancestor
154766826|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
154766827|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766828|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154766829|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766830|NCT02413086|Chitosan|chitosan|mesh-list
154766831|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154766832|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154766833|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
154766834|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766835|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154766836|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
154766837|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
154766838|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
154766839|NCT02413086|Coagulants|coagulants|mesh-ancestor
154766840|NCT02468830|Mirabegron|mirabegron|mesh-list
154766841|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154766842|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154766843|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154766844|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
154766845|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766846|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766847|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766848|NCT02468830|Urological Agents|urological agents|mesh-ancestor
153733308|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
154766849|NCT02470234|Methylphenidate|methylphenidate|mesh-list
154766850|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154766851|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766852|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154766853|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154766854|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766855|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766856|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
154766857|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766858|NCT02418702|Ketamine|ketamine|mesh-list
153863661|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
153863663|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863664|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863665|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
153404047|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153404048|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404049|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153404050|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153404051|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404054|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766859|NCT02418702|Analgesics|analgesics|mesh-ancestor
154766860|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
154766861|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766862|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766863|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154766864|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154766865|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
154766866|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
154766867|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395238|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395239|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395240|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153395241|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
153395242|NCT02547623|Hormones|hormones|mesh-ancestor
153395243|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395244|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153395245|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733403|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153733404|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733405|NCT00507091|Antidotes|antidotes|mesh-ancestor
153404145|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153863779|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863780|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153404163|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153404164|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153404165|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
153404166|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404167|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404168|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153404169|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153404170|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153404171|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153404172|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153404173|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863806|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863807|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766868|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154766869|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154766870|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766871|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766872|NCT02412930|Tramadol|tramadol|mesh-list
154766873|NCT02412930|Bupivacaine|bupivacaine|mesh-list
154766874|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
154766875|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
154766876|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766877|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766878|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
154766879|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766880|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154259976|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259977|NCT01182974|Acetaminophen|acetaminophen|mesh-list
154259978|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154259979|NCT01182974|Analgesics|analgesics|mesh-ancestor
154259980|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
154259981|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766881|NCT02412930|Narcotics|narcotics|mesh-ancestor
154766882|NCT02412930|Analgesics|analgesics|mesh-ancestor
154766883|NCT02432716|Insulin|insulin|mesh-list
154766884|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154766885|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
154766886|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154766887|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766888|NCT02418624|Carboplatin|carboplatin|mesh-list
154766889|NCT02418624|Olaparib|olaparib|mesh-list
154766890|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766891|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154766892|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766893|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766894|NCT02440204|Remifentanil|remifentanil|mesh-list
154766895|NCT02440204|Sevoflurane|sevoflurane|mesh-list
154766896|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154766897|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154766898|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
154766899|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
154766900|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766901|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766902|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154766903|NCT02440204|Narcotics|narcotics|mesh-ancestor
154766904|NCT02440204|Analgesics|analgesics|mesh-ancestor
154766905|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
154766906|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766907|NCT02410590|Atropine|atropine|mesh-list
154259990|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
154259991|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259992|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259993|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154259994|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
154259995|NCT03856502|Hormones|hormones|mesh-ancestor
154259996|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259997|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154259998|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259999|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
154260000|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733310|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
153733311|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395385|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395386|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
154766908|NCT02410590|Rocuronium|rocuronium|mesh-list
154766909|NCT02410590|Cisatracurium|cisatracurium|mesh-list
154766910|NCT02410590|Succinylcholine|succinylcholine|mesh-list
154766911|NCT02410590|Neostigmine|neostigmine|mesh-list
154766912|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154766913|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154766914|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154766915|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733312|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
153395434|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
153863855|NCT01967810|Growth Substances|growth substances|mesh-ancestor
153863856|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404242|NCT05721872|Protective Agents|protective agents|mesh-ancestor
153404243|NCT05721872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404244|NCT02408965|Methylergonovine|methylergonovine|mesh-list
153404246|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153404247|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404248|NCT03216356|Cycloserine|cycloserine|mesh-list
153404249|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153404250|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404251|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153404252|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
153404253|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153404254|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
153364983|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364988|NCT04347512|Azithromycin|azithromycin|mesh-list
153863875|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
153863876|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153863877|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863878|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404265|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404266|NCT00356954|Vitamins|vitamins|mesh-ancestor
153404267|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
153404268|NCT02358889|Ranibizumab|ranibizumab|mesh-list
153404269|NCT02358889|hI-con1|hi-con1|mesh-list
153404270|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
153404271|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153404272|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825020|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
153863879|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153863880|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153863939|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
154766916|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766917|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154766918|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154766919|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154766920|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
154766921|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154766922|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
154766923|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
154766924|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
153395518|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
153395519|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395520|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395521|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153855274|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855275|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153855276|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855277|NCT01220557|Insulin|insulin|mesh-list
153863979|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153863980|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153863981|NCT01164007|Growth Substances|growth substances|mesh-ancestor
153863982|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863983|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
153863984|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153863985|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
153365006|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
153404383|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
153404384|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
153404385|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864017|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153404441|NCT03417193|Anesthetics|anesthetics|mesh-list
153404442|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404443|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404470|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154766925|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154518922|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
154766926|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154766927|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
154766928|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766929|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766930|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153733313|NCT05149339|Vitamin D|vitamin d|mesh-list
153395584|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153404480|NCT05718661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404481|NCT05718661|Adrenergic Agents|adrenergic agents|mesh-ancestor
153404482|NCT05718661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153864081|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153864247|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864248|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153864249|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
153864250|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864251|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864252|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864253|NCT00564408|Analgesics|analgesics|mesh-ancestor
153864254|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
153864255|NCT00564408|Protective Agents|protective agents|mesh-ancestor
153864256|NCT01773785|Docetaxel|docetaxel|mesh-list
153864257|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864258|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
153864259|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
153864260|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
153864261|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864262|NCT01758458|Interferons|interferons|mesh-list
153864271|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
153864272|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864273|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864275|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153864276|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
153864277|NCT04608981|Prednisolone|prednisolone|mesh-list
153864278|NCT04608981|Diclofenac|diclofenac|mesh-list
153864279|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864280|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
153864281|NCT04608981|Hormones|hormones|mesh-ancestor
154766931|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766932|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154766933|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154766934|NCT02517580|Vitamin K|vitamin k|mesh-list
154766935|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
154766936|NCT02517580|Vitamins|vitamins|mesh-ancestor
154766937|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
154766938|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766939|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154766940|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154766941|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766942|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
154766943|NCT02517580|Coagulants|coagulants|mesh-ancestor
154766944|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
153395739|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404869|NCT00003387|Carboplatin|carboplatin|mesh-list
153404870|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153404871|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404872|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
153404873|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404874|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
153864465|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
153864466|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864467|NCT01632137|Rebamipide|rebamipide|mesh-list
153864468|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153864649|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153405052|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
153405053|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405054|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405055|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
153405057|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153405058|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
153405059|NCT03441581|Eluxadoline|eluxadoline|mesh-list
153405061|NCT02265510|Dexamethasone|dexamethasone|mesh-list
154766945|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154766946|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
154766947|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154766948|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766949|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154766950|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
154766951|NCT02412150|Remifentanil|remifentanil|mesh-list
154766952|NCT02412150|Desflurane|desflurane|mesh-list
153855624|NCT00449501|Hormones|hormones|mesh-ancestor
153864873|NCT01159600|Empagliflozin|empagliflozin|mesh-list
153864874|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153864875|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864876|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153864878|NCT04631627|Aspirin|aspirin|mesh-list
154766953|NCT02412150|Anesthetics|anesthetics|mesh-list
154766954|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
154766955|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154766956|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766957|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766958|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154766959|NCT02412150|Analgesics|analgesics|mesh-ancestor
154766960|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
154766961|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766962|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154766963|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154766964|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154766965|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395930|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405457|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405458|NCT03450083|Benralizumab|benralizumab|mesh-list
153405459|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153405460|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
153405461|NCT03580343|Tofacitinib|tofacitinib|mesh-list
153405462|NCT03580343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153405463|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153865217|NCT04627181|Vitamins|vitamins|mesh-ancestor
153865572|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865573|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153865574|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406024|NCT05613426|Protease Inhibitors|protease inhibitors|mesh-ancestor
153406026|NCT05603065|Tislelizumab|tislelizumab|mesh-list
153406027|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153406028|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406029|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
153406030|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
154766966|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154766967|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766968|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154766969|NCT02412150|Narcotics|narcotics|mesh-ancestor
154766970|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
154766971|NCT02523196|Cholic Acids|cholic acids|mesh-list
154766972|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154766973|NCT02418078|Anesthetics|anesthetics|mesh-list
153855838|NCT00450203|Bevacizumab|bevacizumab|mesh-list
153855839|NCT00450203|Capecitabine|capecitabine|mesh-list
153855840|NCT00450203|Epirubicin|epirubicin|mesh-list
154766974|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154766975|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766976|NCT03175926|Budesonide|budesonide|mesh-list
154766977|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154766978|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154766979|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
154766980|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154766981|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766982|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154766983|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
154766984|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
154766985|NCT03175926|Hormones|hormones|mesh-ancestor
154766986|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154766987|NCT02524054|Furosemide|furosemide|mesh-list
154766988|NCT02524054|Diuretics|diuretics|mesh-ancestor
154766989|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
154766990|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154766991|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154766992|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154766993|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154766994|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
154766995|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154766996|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
154766997|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856013|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153856014|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
153856015|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856016|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856017|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153856018|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153856019|NCT02930954|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153856020|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153406551|NCT04297592|Cefadroxil|cefadroxil|mesh-list
153406552|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153866147|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153406600|NCT04268121|Etoposide|etoposide|mesh-list
153406601|NCT04268121|Etoposide phosphate|etoposide phosphate|mesh-list
153406602|NCT04268121|Carboplatin|carboplatin|mesh-list
153406603|NCT04268121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406604|NCT04268121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153406622|NCT04194528|Acetaminophen|acetaminophen|mesh-list
153406623|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153406624|NCT04194528|Oxycodone|oxycodone|mesh-list
153406625|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153825539|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
153825540|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
153866201|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866202|NCT00568113|Antidotes|antidotes|mesh-ancestor
153866203|NCT00568152|Aspirin|aspirin|mesh-list
153866204|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153866205|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406638|NCT04189614|Immunoconjugates|immunoconjugates|mesh-ancestor
153406639|NCT04189614|Immunologic Factors|immunologic factors|mesh-ancestor
153406640|NCT04189614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406642|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154766998|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154766999|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154767000|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
154767001|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518996|NCT01063283|Bevacizumab|bevacizumab|mesh-list
154767002|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767003|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154767004|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
154767005|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154260004|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260005|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
154260006|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153406643|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866229|NCT04610879|Analgesics|analgesics|mesh-ancestor
153866230|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
153866231|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406665|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406666|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406667|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153406668|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
153406669|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406670|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406671|NCT04085458|Factor VIII|factor viii|mesh-list
154767006|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
154767007|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767008|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
154767009|NCT02417610|Protective Agents|protective agents|mesh-ancestor
154767010|NCT03116490|Anesthetics|anesthetics|mesh-list
154767011|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767012|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767013|NCT02417298|Ketamine|ketamine|mesh-list
154767014|NCT02417298|Analgesics|analgesics|mesh-ancestor
154767015|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
154767016|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767017|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767018|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154767019|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154767020|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
153856175|NCT02927405|Analgesics|analgesics|mesh-ancestor
153856176|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
153396416|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396417|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153396418|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
153396419|NCT02279641|Protective Agents|protective agents|mesh-ancestor
153396420|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396421|NCT02629991|Oxytocin|oxytocin|mesh-list
153396422|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
153396423|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153396424|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396425|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153396426|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153396427|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153396428|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
153866279|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866280|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153866281|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153866459|NCT00568347|Xhance|xhance|mesh-list
154767021|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
154767022|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767023|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154767024|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154767025|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767026|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767027|NCT02525536|Trebananib|trebananib|mesh-list
154767028|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154767029|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154767030|NCT02525536|Growth Substances|growth substances|mesh-ancestor
154767031|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767032|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
154767033|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767034|NCT02411994|Artesunate|artesunate|mesh-list
154767035|NCT02411994|Lumefantrine|lumefantrine|mesh-list
154767036|NCT02411994|Artemether|artemether|mesh-list
154767037|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154767038|NCT02411994|Pyronaridine|pyronaridine|mesh-list
154767039|NCT02411994|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154767040|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
154767041|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154767042|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154767043|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767044|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767045|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
154767046|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
154767047|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154767048|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
154767049|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
154767050|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154767051|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154767052|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154260007|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154260008|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260009|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260010|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154260011|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154260012|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260013|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
154260014|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399887|NCT01980589|Hormones|hormones|mesh-ancestor
154767053|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
154767054|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767055|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767056|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767057|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
154767058|NCT03177720|Imipenem|imipenem|mesh-list
154767059|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154767060|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767061|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154767062|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154260016|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154260017|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
154260018|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260019|NCT01093638|Insulin|insulin|mesh-list
154260020|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154260021|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260022|NCT01287962|Apatinib|apatinib|mesh-list
154260023|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260024|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153733318|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153866468|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866469|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
153866470|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153866597|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153866598|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
153866599|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153866600|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153407205|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153867134|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153407597|NCT00060346|Vincristine|vincristine|mesh-list
153407598|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153825613|NCT01340872|Ferric maltol|ferric maltol|mesh-list
153825614|NCT01340872|Hematinics|hematinics|mesh-ancestor
153825615|NCT00469781|Bromfenac|bromfenac|mesh-list
153825616|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
153825617|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153825618|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
153825619|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153825620|NCT00469781|Prednisolone|prednisolone|mesh-list
153825644|NCT00474695|Growth Substances|growth substances|mesh-ancestor
154767063|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767064|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767065|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767066|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154767067|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154767068|NCT02411604|Tacrolimus|tacrolimus|mesh-list
154767069|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154767070|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
154767071|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767072|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154767073|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767074|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767075|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
154767076|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154767077|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
154767078|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767080|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154767081|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154767082|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767083|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
154767084|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
154767085|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
154767086|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154767087|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767088|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
154767089|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
154767090|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154767091|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767092|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767093|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154767094|NCT03174678|Analgesics|analgesics|mesh-ancestor
154767095|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
154767096|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767097|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154767098|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154767099|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154767100|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
154767101|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767102|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767103|NCT02409498|Bupivacaine|bupivacaine|mesh-list
154767104|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
154767105|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
154260036|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
154260037|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825653|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825654|NCT00474773|Celecoxib|celecoxib|mesh-list
153825655|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153408103|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153408104|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
153408105|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767106|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767107|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767108|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
154767109|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767110|NCT02409186|Paclitaxel|paclitaxel|mesh-list
154767111|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154767112|NCT02409186|Cisplatin|cisplatin|mesh-list
154767113|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
154767114|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154767115|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767116|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767117|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154767118|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767119|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767120|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154767121|NCT02410746|Ibuprofen|ibuprofen|mesh-list
154767122|NCT02410746|Morphine|morphine|mesh-list
154260038|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260039|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154260040|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
154260041|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399957|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
154767123|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
154767124|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154767125|NCT02410746|Narcotics|narcotics|mesh-ancestor
154767126|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767127|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767128|NCT02410746|Analgesics|analgesics|mesh-ancestor
154767129|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
154767130|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767131|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154767132|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154767133|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154767134|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154767135|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154767136|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767137|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767138|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
154767139|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
154767140|NCT03177174|Docetaxel|docetaxel|mesh-list
154767141|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767142|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767143|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
154767144|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767145|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767146|NCT03177252|Lidocaine|lidocaine|mesh-list
154767147|NCT03177252|Bupivacaine|bupivacaine|mesh-list
154519143|NCT03445611|Lidocaine|lidocaine|mesh-list
154767148|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
154767149|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
154767150|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767151|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767152|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
154767153|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767154|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154767155|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154767156|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154767157|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154767158|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767159|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
154767160|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154767161|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767162|NCT02408562|Becaplermin|becaplermin|mesh-list
154767163|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
154767164|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154767165|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154767166|NCT02408562|Growth Substances|growth substances|mesh-ancestor
154767167|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767168|NCT02701764|Pregabalin|pregabalin|mesh-list
154767169|NCT02701764|Analgesics|analgesics|mesh-ancestor
154767170|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
154260055|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767171|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767172|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767173|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
154767174|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154767175|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154767176|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767177|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154767178|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154767179|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154767180|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767181|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154767182|NCT03174288|Spironolactone|spironolactone|mesh-list
154767183|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154767184|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
154767185|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260067|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
154767186|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767187|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154767188|NCT03174288|Diuretics|diuretics|mesh-ancestor
154767189|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
154767190|NCT02532010|Cytarabine|cytarabine|mesh-list
154767191|NCT02532010|Decitabine|decitabine|mesh-list
154767192|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154767193|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
154767194|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767195|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767196|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
154767197|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767198|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154767199|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
154767200|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767201|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767202|NCT02406300|Bupivacaine|bupivacaine|mesh-list
153871750|NCT01086410|Xhance|xhance|mesh-list
154767203|NCT02406300|Ropivacaine|ropivacaine|mesh-list
154767204|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
154767205|NCT02406300|Sevoflurane|sevoflurane|mesh-list
154767206|NCT02406300|Desflurane|desflurane|mesh-list
154767207|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
154767208|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
154767209|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767210|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767211|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
154767212|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767213|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154767214|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154767215|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
154767216|NCT02538016|Tolvaptan|tolvaptan|mesh-list
154767217|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154767218|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767219|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
154767220|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767221|NCT02406144|Dexamethasone|dexamethasone|mesh-list
154767222|NCT02406144|Lenalidomide|lenalidomide|mesh-list
154767223|NCT02406144|Ixazomib|ixazomib|mesh-list
154767224|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154767225|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
154519217|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767226|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
154767227|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767228|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767229|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767230|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
154767231|NCT02406144|Hormones|hormones|mesh-ancestor
154767232|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154767233|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154767234|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767235|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
154767236|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154767237|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154767238|NCT02406144|Growth Substances|growth substances|mesh-ancestor
154767239|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
154767240|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
154767241|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767242|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767243|NCT02416752|Remifentanil|remifentanil|mesh-list
154767244|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154767245|NCT02416752|Narcotics|narcotics|mesh-ancestor
154767246|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767247|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767248|NCT02416752|Analgesics|analgesics|mesh-ancestor
154767249|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
154767250|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767251|NCT02405910|Paclitaxel|paclitaxel|mesh-list
154767252|NCT02405910|Gemcitabine|gemcitabine|mesh-list
154767253|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154767254|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767255|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767256|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
154767257|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767258|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767259|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154767260|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
154767261|NCT02539108|Vaccines|vaccines|mesh-list
154767262|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
154767263|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767264|NCT02406066|Oxazepam|oxazepam|mesh-list
154767265|NCT02406066|Metyrapone|metyrapone|mesh-list
154767266|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
153857209|NCT06226350|Antibodies|antibodies|mesh-list
154767267|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767268|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767269|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154767270|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767271|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767272|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154767273|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154767274|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154767275|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
154767276|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
154767277|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767278|NCT02408328|Caffeine|caffeine|mesh-list
154767279|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
154767280|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767281|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154767282|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767283|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154767284|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767285|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154767286|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154767287|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
154767288|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767289|NCT02539342|Calcium|calcium|mesh-list
154767290|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154767291|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767292|NCT02405988|Remifentanil|remifentanil|mesh-list
154767293|NCT02405988|Naloxone|naloxone|mesh-list
154767294|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154767295|NCT02405988|Narcotics|narcotics|mesh-ancestor
154767296|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260089|NCT02530632|Propofol|propofol|mesh-list
154767297|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767298|NCT02405988|Analgesics|analgesics|mesh-ancestor
154767299|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
154767300|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767301|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154767302|NCT02542150|Ethanol|ethanol|mesh-list
154767303|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154767304|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767305|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767306|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767307|NCT02542462|Vaccines|vaccines|mesh-list
154767308|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
154767309|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767310|NCT03173898|Anesthetics|anesthetics|mesh-list
154767311|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767312|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767313|NCT02408172|Metoprolol|metoprolol|mesh-list
154767314|NCT02408172|Amlodipine|amlodipine|mesh-list
154767315|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154767316|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154767317|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154767318|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767319|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154767320|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767321|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
154767322|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154767323|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
154767324|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
154767325|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767326|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154767327|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154767328|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154767329|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
154767330|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767331|NCT04481100|Itraconazole|itraconazole|mesh-list
154767332|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
154767333|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767334|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154767335|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154260105|NCT00072384|Carboplatin|carboplatin|mesh-list
154767336|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767337|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767338|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154767339|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
154767340|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154767341|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767342|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154767343|NCT02405598|Albuterol|albuterol|mesh-list
154767344|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154767345|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
154767346|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767347|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767348|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154767349|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
154767350|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
153397659|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
153397660|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767351|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154767352|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154767353|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154767354|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154767355|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
154767356|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767357|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767358|NCT03173508|Acetazolamide|acetazolamide|mesh-list
153873096|NCT02212340|Analgesics|analgesics|mesh-ancestor
154767359|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
154767360|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154767361|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767362|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767363|NCT03173508|Diuretics|diuretics|mesh-ancestor
154767364|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
154767365|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767366|NCT03173430|Blinatumomab|blinatumomab|mesh-list
154767367|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767368|NCT02407782|Ivermectin|ivermectin|mesh-list
154767369|NCT02407782|Permethrin|permethrin|mesh-list
154767370|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154767371|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767372|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767373|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767374|NCT02405364|Dexamethasone|dexamethasone|mesh-list
154767375|NCT02405364|Lenalidomide|lenalidomide|mesh-list
154767376|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154767377|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
154767378|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
154767379|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767380|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767381|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767382|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
154767383|NCT02405364|Hormones|hormones|mesh-ancestor
154767384|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154767385|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154767386|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767387|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
154767388|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154767389|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154767390|NCT02405364|Growth Substances|growth substances|mesh-ancestor
154767391|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
154767392|NCT02405130|Epinephrine|epinephrine|mesh-list
154767393|NCT02405130|Racepinephrine|racepinephrine|mesh-list
154767394|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
154767395|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154767396|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154767397|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
154767398|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767399|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767400|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767401|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154767402|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154767403|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
154767404|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767405|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154767406|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
154767407|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
154767408|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
154767409|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154767410|NCT03171090|Anesthetics|anesthetics|mesh-list
154767411|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
154767412|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857637|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
154767413|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767414|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
154767415|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767416|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154767417|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
154767418|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767419|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154767420|NCT02407626|Propofol|propofol|mesh-list
154767421|NCT02407626|Sevoflurane|sevoflurane|mesh-list
154767422|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154767423|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767424|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767425|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154767426|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
154767427|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
154767428|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154767429|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154767430|NCT02407392|Acetic Acid|acetic acid|mesh-list
154767431|NCT02407392|Retinol acetate|retinol acetate|mesh-list
154767432|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154767433|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767434|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154767435|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
154767436|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767437|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154767438|NCT02407392|Protective Agents|protective agents|mesh-ancestor
154767439|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767440|NCT02551432|Paclitaxel|paclitaxel|mesh-list
154767441|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
154767442|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154767443|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767444|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767445|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
154767446|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767447|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767448|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154767449|NCT02551432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154767450|NCT02407548|Vitamin E|vitamin e|mesh-list
154767451|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
154767452|NCT02407548|Ubiquinone|ubiquinone|mesh-list
154767453|NCT02407548|Vitamins|vitamins|mesh-ancestor
154767454|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
154767455|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767456|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
154767457|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767458|NCT02407548|Protective Agents|protective agents|mesh-ancestor
154767459|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
154767460|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
154767461|NCT01695317|Vitamins|vitamins|mesh-ancestor
154767462|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
154767463|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767464|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
154767465|NCT02551744|Pantoprazole|pantoprazole|mesh-list
154767466|NCT02551744|Famotidine|famotidine|mesh-list
154767467|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154767468|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
154767469|NCT02551744|Histamine|histamine|mesh-list
154767470|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154767471|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767472|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767473|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767474|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
154767475|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
154767476|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767477|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733337|NCT00144326|Bromides|bromides|mesh-list
154767478|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
154767479|NCT04743544|Voriconazole|voriconazole|mesh-list
154767480|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
154767481|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767482|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154767483|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154767484|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767485|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767486|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154767487|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
154767488|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154767489|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767490|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154767491|NCT04481802|Acemannan|acemannan|mesh-list
154767492|NCT04481802|Biafine|biafine|mesh-list
154767493|NCT04481802|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154767494|NCT04481802|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154260175|NCT01187264|Methotrexate|methotrexate|mesh-list
154260181|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
154767495|NCT04481802|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154767496|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154767497|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
154767498|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767499|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767500|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
154767501|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767502|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767503|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154767504|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767505|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767506|NCT02407314|Aspirin|aspirin|mesh-list
154767507|NCT02407314|Ticagrelor|ticagrelor|mesh-list
154767508|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154767509|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154767510|NCT02407314|Analgesics|analgesics|mesh-ancestor
154767511|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
153857786|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153857789|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
154767512|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767513|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767514|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154767515|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154767516|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154767517|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154767518|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767519|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154767520|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154767521|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767522|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
154767523|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154260184|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
154767524|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154767525|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154519517|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
154767526|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
154767527|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767528|NCT02407080|Interferons|interferons|mesh-list
154767529|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
154767530|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
154767531|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154767532|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767533|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
154767534|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767535|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
154767536|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767537|NCT04743622|Latanoprost|latanoprost|mesh-list
154767538|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154767539|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154767540|NCT02701296|Epinephrine|epinephrine|mesh-list
154767541|NCT02701296|Ropivacaine|ropivacaine|mesh-list
154767542|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
154767543|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
154767544|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767545|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767546|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
154767547|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767548|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154767549|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154767550|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
154767551|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767552|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767553|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154767554|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154767555|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
154767556|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154767557|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
154767558|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
154260191|NCT01183676|Valproic Acid|valproic acid|mesh-list
154767559|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
154767560|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154767561|NCT02558374|Timolol|timolol|mesh-list
154767562|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154767563|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154767564|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767565|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154767566|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154767567|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
154767568|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767569|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767570|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154767571|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154767572|NCT01582451|Insulin|insulin|mesh-list
154767573|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154767574|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
154767575|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154767576|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767577|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154767578|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154767579|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767580|NCT03168828|Trospium chloride|trospium chloride|mesh-list
154767581|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
154767582|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
154767583|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767584|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767585|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154767586|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154767587|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
154767588|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767589|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767590|NCT03168828|Urological Agents|urological agents|mesh-ancestor
154767591|NCT02562898|Paclitaxel|paclitaxel|mesh-list
154767592|NCT02562898|Gemcitabine|gemcitabine|mesh-list
154767593|NCT02562898|Ibrutinib|ibrutinib|mesh-list
154767594|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154767595|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767596|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767597|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
154767598|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767599|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767600|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154767601|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
154767602|NCT02562898|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154767603|NCT02562898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154767604|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767605|NCT03168594|Cisplatin|cisplatin|mesh-list
154767606|NCT03168594|Irinotecan|irinotecan|mesh-list
154767607|NCT03168594|Etoposide|etoposide|mesh-list
154767608|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767609|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154767610|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154767611|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767612|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767613|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154767614|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154767615|NCT02563834|Insulin|insulin|mesh-list
154767616|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154767617|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767618|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
154767619|NCT02564926|Glimepiride|glimepiride|mesh-list
154767620|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154767621|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767622|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154767623|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857920|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857921|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154767624|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154767625|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154767626|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
154767627|NCT02567968|Caffeine|caffeine|mesh-list
154767628|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
154767629|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767630|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154767631|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767632|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154767633|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767634|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154767635|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154767636|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
154767637|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767638|NCT02571634|Fentanyl|fentanyl|mesh-list
154767639|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154767640|NCT02571634|Narcotics|narcotics|mesh-ancestor
154767641|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767642|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767643|NCT02571634|Analgesics|analgesics|mesh-ancestor
154767644|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
154767645|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767646|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154767647|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154767648|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
153400764|NCT02996591|Analgesics|analgesics|mesh-ancestor
153857980|NCT03142893|Ganirelix|ganirelix|mesh-list
153857981|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153857982|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
153857983|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
153857984|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398235|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398236|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398237|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154767649|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
154767650|NCT02404038|NuvaRing|nuvaring|mesh-list
154767651|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154767652|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154767653|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
154767654|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154767655|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767656|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154767657|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153398263|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398264|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
153858004|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153858005|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858006|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858007|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
153858008|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153858009|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858010|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827723|NCT00480623|Satraplatin|satraplatin|mesh-list
153827725|NCT01240655|Paclitaxel|paclitaxel|mesh-list
153443057|NCT02058966|Methamphetamine|methamphetamine|mesh-list
153443058|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153443085|NCT02040870|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153443086|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443088|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443089|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444449|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
153444450|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444451|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153444452|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
153444453|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
153444454|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154767658|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154767659|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154767660|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154767661|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154767662|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154767663|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154767664|NCT02574598|Docetaxel|docetaxel|mesh-list
154767665|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
154767666|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767667|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767668|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
154767669|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767670|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767671|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154767672|NCT02574598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154767673|NCT02574832|Lidocaine|lidocaine|mesh-list
154767674|NCT02574832|Fentanyl|fentanyl|mesh-list
154767675|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
154767676|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
154767677|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767678|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767679|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
154767680|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767681|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154767682|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154767683|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154767684|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154767685|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767686|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154767687|NCT02574832|Narcotics|narcotics|mesh-ancestor
154767688|NCT02574832|Analgesics|analgesics|mesh-ancestor
154767689|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154767690|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154767691|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
154767692|NCT02406690|Leuprolide|leuprolide|mesh-list
154767693|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154767694|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154767695|NCT02406690|Estradiol|estradiol|mesh-list
154767696|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154767697|NCT02406690|Progesterone|progesterone|mesh-list
153398303|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398304|NCT02741687|Insulin|insulin|mesh-list
153398305|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153398306|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
153398307|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153398308|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
153398309|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
153398310|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
154767698|NCT02406690|Estrogens|estrogens|mesh-ancestor
154767699|NCT02406690|Hormones|hormones|mesh-ancestor
154767700|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154767701|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767702|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154767703|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
154767704|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154767705|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153858073|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858074|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858075|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858076|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
153858078|NCT02402660|Retinol acetate|retinol acetate|mesh-list
153858079|NCT02402660|Vitamins|vitamins|mesh-ancestor
153858080|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
153858082|NCT02402660|Protective Agents|protective agents|mesh-ancestor
153783689|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367909|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827964|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827965|NCT01240824|Protective Agents|protective agents|mesh-ancestor
153827966|NCT01240941|Exemestane|exemestane|mesh-list
153827967|NCT01240941|Goserelin|goserelin|mesh-list
153367967|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
153367968|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367969|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
153367970|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153367971|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153367972|NCT02179892|Acetaminophen|acetaminophen|mesh-list
153367973|NCT02179892|Dexamethasone|dexamethasone|mesh-list
153367974|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
153367975|NCT02179892|Bupivacaine|bupivacaine|mesh-list
153367976|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153367977|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
153367978|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
154767706|NCT02406690|Progestins|progestins|mesh-ancestor
154767707|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154767708|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
154767709|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154767710|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767711|NCT02575300|Ibrutinib|ibrutinib|mesh-list
154767712|NCT02575300|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154767713|NCT02575300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154767714|NCT02575300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767715|NCT02575300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767716|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
154767717|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
153733346|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153858083|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153858084|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858085|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153858095|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153858096|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
153398354|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153398355|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153398356|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398357|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
153398358|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
153398359|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767718|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
154767719|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767720|NCT02974348|Acetaminophen|acetaminophen|mesh-list
154767721|NCT02974348|Amoxicillin|amoxicillin|mesh-list
154767722|NCT02974348|Artesunate|artesunate|mesh-list
154767723|NCT02974348|Lumefantrine|lumefantrine|mesh-list
154767724|NCT02974348|Piperaquine|piperaquine|mesh-list
154767725|NCT02974348|Artenimol|artenimol|mesh-list
154767726|NCT02974348|Mefloquine|mefloquine|mesh-list
154767727|NCT02974348|Quinine|quinine|mesh-list
154767728|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154767729|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767730|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154767731|NCT02974348|Analgesics|analgesics|mesh-ancestor
154767732|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
154767733|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767734|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767735|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
154767736|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
154767737|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154767738|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154767739|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767740|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
154767741|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
154767742|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154767743|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
154767744|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154767745|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154767746|NCT03170310|Apatinib|apatinib|mesh-list
154767747|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767748|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154767749|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767750|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767751|NCT00364000|Calcium|calcium|mesh-list
154767752|NCT00364000|Sevelamer|sevelamer|mesh-list
154767753|NCT00364000|Calcium acetate|calcium acetate|mesh-list
154767754|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154767755|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260217|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260218|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154260226|NCT01290380|Vadimezan|vadimezan|mesh-list
154767756|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
154767757|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
154767758|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767759|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
154767760|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154767761|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767762|NCT02403804|Betaine|betaine|mesh-list
154767763|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767764|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
154767765|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154767766|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
154767767|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767768|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154767769|NCT03169764|Leucovorin|leucovorin|mesh-list
154767770|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
154767771|NCT03169764|Bevacizumab|bevacizumab|mesh-list
154767772|NCT03169764|Capecitabine|capecitabine|mesh-list
154767773|NCT03169764|Nivolumab|nivolumab|mesh-list
154767774|NCT03169764|Fluorouracil|fluorouracil|mesh-list
154767775|NCT03169764|Cetuximab|cetuximab|mesh-list
154767776|NCT03169764|Fulvestrant|fulvestrant|mesh-list
154767777|NCT03169764|Avelumab|avelumab|mesh-list
154767778|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767779|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767780|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154767781|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
154767782|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767783|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154767784|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154767785|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
154767786|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154767787|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154767788|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154767789|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154767790|NCT03169764|Growth Substances|growth substances|mesh-ancestor
154767791|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
154767792|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154767793|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
154260228|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
154767794|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154767795|NCT03169764|Antidotes|antidotes|mesh-ancestor
154767796|NCT03169764|Protective Agents|protective agents|mesh-ancestor
154767797|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
154767798|NCT03169764|Vitamins|vitamins|mesh-ancestor
154767799|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
154767800|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154767801|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154767802|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154767803|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
153398403|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153398405|NCT02295553|Propofol|propofol|mesh-list
153398406|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153398407|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398408|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398409|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153398410|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
153398411|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
153398412|NCT02295553|Analgesics|analgesics|mesh-ancestor
153398413|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
153439863|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
153898594|NCT01263704|Fludarabine|fludarabine|mesh-list
154767804|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154767805|NCT02399592|Bevacizumab|bevacizumab|mesh-list
154767806|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154767807|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767808|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154767809|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154767810|NCT02399592|Growth Substances|growth substances|mesh-ancestor
154767811|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767812|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
154767813|NCT03801304|Atezolizumab|atezolizumab|mesh-list
154767814|NCT03801304|Vinorelbine|vinorelbine|mesh-list
154260236|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154260237|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
153733350|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
153359690|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153813217|NCT00332891|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153359715|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359716|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767815|NCT03801304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154767816|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767817|NCT03801304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154767818|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767819|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154767820|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767821|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
154767822|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767823|NCT02696850|Budesonide|budesonide|mesh-list
154767824|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154767825|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154767826|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
154767827|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767828|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767829|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154767830|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
154767831|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
154767832|NCT02696850|Hormones|hormones|mesh-ancestor
154767833|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154767834|NCT00365170|Insulin|insulin|mesh-list
154767835|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154767836|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
154767837|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154767838|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767839|NCT02403648|Glucagon|glucagon|mesh-list
154767840|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154767841|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767842|NCT02403648|Hormones|hormones|mesh-ancestor
154260238|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260239|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
154260240|NCT03852914|Protective Agents|protective agents|mesh-ancestor
154260241|NCT03853538|Petrolatum|petrolatum|mesh-list
154260242|NCT03853538|Emollients|emollients|mesh-ancestor
154260243|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
154260244|NCT01290458|Vitamins|vitamins|mesh-list
154260245|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
154260246|NCT01290458|Vitamin E|vitamin e|mesh-list
154260247|NCT01290458|Tocopherols|tocopherols|mesh-list
154260248|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
154260249|NCT01290458|Antioxidants|antioxidants|mesh-list
153733352|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
153733353|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153858214|NCT00352534|Doxorubicin|doxorubicin|mesh-list
153858215|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153858216|NCT00352534|Vincristine|vincristine|mesh-list
153858217|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153858218|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858221|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767843|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154767844|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767845|NCT02403648|Incretins|incretins|mesh-ancestor
154767846|NCT02396862|Factor VIII|factor viii|mesh-list
154767847|NCT02396862|Coagulants|coagulants|mesh-ancestor
154767848|NCT02377492|Vasopressins|vasopressins|mesh-list
154767849|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
154767850|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
154767851|NCT02377492|Coagulants|coagulants|mesh-ancestor
154767852|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154767853|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154767854|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
154767855|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767856|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154767857|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154767858|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
154767859|NCT02601976|Ribavirin|ribavirin|mesh-list
154767860|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154767861|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
154767862|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767863|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
154767864|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767865|NCT02603926|Pregnanolone|pregnanolone|mesh-list
154767866|NCT02603926|Brexanolone|brexanolone|mesh-list
154767867|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
154767868|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767869|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767870|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
154767871|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767872|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767873|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
154767874|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
154767875|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
154767876|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154767877|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
154767878|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767879|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260250|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
154260251|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767880|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154767881|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
154767882|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
154767883|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154767884|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
154767885|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767886|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767887|NCT02395926|Choline|choline|mesh-list
154767888|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
154767889|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154767890|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
154767891|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767892|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767893|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154767894|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
154767895|NCT02402868|Ketamine|ketamine|mesh-list
154767896|NCT02402868|Analgesics|analgesics|mesh-ancestor
154767897|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
154767898|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154767899|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767900|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154767901|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154767902|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
154767903|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
154767904|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154767905|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154767906|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154767907|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767908|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767909|NCT02402712|Docetaxel|docetaxel|mesh-list
154767910|NCT02402712|Trastuzumab|trastuzumab|mesh-list
154767911|NCT02402712|Pertuzumab|pertuzumab|mesh-list
154767912|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767913|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
154767914|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
154767915|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
154767916|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767917|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154767918|NCT02395458|Amoxicillin|amoxicillin|mesh-list
154767919|NCT02395458|Metronidazole|metronidazole|mesh-list
154767920|NCT02395458|Clarithromycin|clarithromycin|mesh-list
154767921|NCT02395458|Omeprazole|omeprazole|mesh-list
154767922|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154767923|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767924|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154767925|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154767926|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154767927|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154767928|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154767929|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767930|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767931|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154767932|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154767933|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154767934|NCT02402400|Ticagrelor|ticagrelor|mesh-list
154767935|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154767936|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154767937|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154767938|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154767939|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
154767940|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767941|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767942|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767943|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154767944|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
154767945|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154767946|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154767947|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767948|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
154767949|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154767950|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767951|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154767952|NCT02395068|Irinotecan|irinotecan|mesh-list
154767953|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
154767954|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154767955|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154767956|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767957|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767958|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767959|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154767960|NCT02616250|Ivermectin|ivermectin|mesh-list
154767961|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154767962|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154767963|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154767964|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154767965|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154767966|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154767967|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154767968|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
154767969|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858287|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
153858288|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858289|NCT00555594|Bevacizumab|bevacizumab|mesh-list
153858290|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858291|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858292|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153858293|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153858294|NCT00555594|Growth Substances|growth substances|mesh-ancestor
153359720|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153898755|NCT05938374|Fluzoparib|fluzoparib|mesh-list
154767970|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767971|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767972|NCT02698410|Temozolomide|temozolomide|mesh-list
154767973|NCT02698410|Lanreotide|lanreotide|mesh-list
154767974|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154767975|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
154767976|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767977|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767978|NCT00365638|Simvastatin|simvastatin|mesh-list
153858314|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153858315|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858316|NCT02909933|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153858317|NCT02909933|Incretins|incretins|mesh-ancestor
153858318|NCT02909933|Hormones|hormones|mesh-ancestor
153858319|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153858320|NCT02910245|Prednisone|prednisone|mesh-list
153858321|NCT02910245|Mesalamine|mesalamine|mesh-list
153858322|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
153398582|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
153813225|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153813226|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767979|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154767980|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154767981|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
154767982|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154767983|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154767984|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154767985|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767986|NCT02699892|Rituximab|rituximab|mesh-list
154767987|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153733357|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153398614|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153398615|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
153398616|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
153398617|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153398618|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398619|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398624|NCT04258397|Pirfenidone|pirfenidone|mesh-list
153813232|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
153359727|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
153898956|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153813240|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899023|NCT04520490|Exenatide|exenatide|mesh-list
154767988|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767989|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
154767990|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154767991|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154767992|NCT05731258|Doxorubicin|doxorubicin|mesh-list
154767993|NCT05731258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154767994|NCT05731258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154767995|NCT05731258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154767996|NCT05731258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154767997|NCT05731258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153858364|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153858365|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
153858366|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153858367|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858368|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858369|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
153858370|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858371|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858372|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
153448662|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
153813241|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153359734|NCT04254107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260293|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154767998|NCT05731258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154767999|NCT05731258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768000|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
154768001|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154768002|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768003|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154768004|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768005|NCT05730634|Atorvastatin|atorvastatin|mesh-list
154768006|NCT05730634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154768007|NCT05730634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154768008|NCT05730634|Antimetabolites|antimetabolites|mesh-ancestor
154768009|NCT05730634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768010|NCT05730634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154768011|NCT05730634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154768012|NCT05730634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768013|NCT05705830|Serotonin|serotonin|mesh-list
154768014|NCT05705830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154768015|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154768016|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
154768017|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768018|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768019|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768020|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154768021|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768022|NCT05745714|Cytarabine|cytarabine|mesh-list
154768023|NCT05745714|Dexamethasone|dexamethasone|mesh-list
154768024|NCT05745714|Cyclophosphamide|cyclophosphamide|mesh-list
154768025|NCT05745714|Venetoclax|venetoclax|mesh-list
154768026|NCT05745714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768027|NCT05745714|Immunologic Factors|immunologic factors|mesh-ancestor
154768028|NCT05745714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768029|NCT05745714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154768030|NCT05745714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154260294|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
154260295|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260296|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154260297|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153398697|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768031|NCT05745714|Alkylating Agents|alkylating agents|mesh-ancestor
154768032|NCT05745714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768033|NCT05745714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768034|NCT05745714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154768035|NCT05745714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768036|NCT05745714|Antiemetics|antiemetics|mesh-ancestor
154768037|NCT05745714|Autonomic Agents|autonomic agents|mesh-ancestor
154768038|NCT05745714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768039|NCT05745714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154768040|NCT05745714|Glucocorticoids|glucocorticoids|mesh-ancestor
154768041|NCT05745714|Hormones|hormones|mesh-ancestor
154768042|NCT05745714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768043|NCT05745714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153398698|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
153398699|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398700|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
153398701|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153398702|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
153398703|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398704|NCT01993849|Expectorants|expectorants|mesh-ancestor
153398705|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
153398706|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153398707|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
153398708|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858438|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
153813257|NCT00435747|Analgesics|analgesics|mesh-ancestor
153359750|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813258|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
154768044|NCT05745714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154768045|NCT05745714|Antimetabolites|antimetabolites|mesh-ancestor
154768046|NCT05745714|Antiviral Agents|antiviral agents|mesh-ancestor
154768047|NCT05745714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768048|NCT02974270|Leuprolide|leuprolide|mesh-list
154768049|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154768050|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
154768051|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154768052|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768053|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153401204|NCT05717582|Androgens|androgens|mesh-list
153858459|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153858460|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153858461|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858462|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858463|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153858464|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
153398729|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153398730|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153398731|NCT04982237|Growth Substances|growth substances|mesh-ancestor
153440486|NCT00003151|Tetracycline|tetracycline|mesh-list
153813259|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768054|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768055|NCT03167268|Lycopene|lycopene|mesh-list
154768056|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154520045|NCT03616405|Antacids|antacids|mesh-ancestor
154768057|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
154768058|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768059|NCT03167268|Protective Agents|protective agents|mesh-ancestor
154768060|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768061|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154768062|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154768063|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768064|NCT02393898|Paclitaxel|paclitaxel|mesh-list
154768065|NCT02393898|Bevacizumab|bevacizumab|mesh-list
154768066|NCT02393898|Carboplatin|carboplatin|mesh-list
154768067|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154768068|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768069|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
154768070|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
154768071|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
154768072|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768073|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154260301|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154260302|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260303|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260304|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260305|NCT01184378|Caseins|caseins|mesh-list
154260306|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
154260307|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
154260308|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260309|NCT03852602|Analgesics|analgesics|mesh-list
153733358|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733359|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398768|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398769|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
153398770|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398771|NCT02788097|Progesterone|progesterone|mesh-list
153398772|NCT02788097|Progestins|progestins|mesh-ancestor
153398773|NCT02788097|Hormones|hormones|mesh-ancestor
153398774|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398775|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398776|NCT02789033|Isosorbide|isosorbide|mesh-list
153899159|NCT06268769|Tacrolimus|tacrolimus|mesh-list
154768074|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154768075|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154768076|NCT02393898|Growth Substances|growth substances|mesh-ancestor
154768077|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768078|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
154768079|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154768080|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154768081|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154768082|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768083|NCT04145674|Methadone|methadone|mesh-list
154768084|NCT04145674|D-methadone|d-methadone|mesh-list
153401251|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153398801|NCT02278315|Dexamethasone|dexamethasone|mesh-list
153398802|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398803|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
153398804|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
153398805|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398806|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398807|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153398808|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
153858518|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858519|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
154768085|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154768086|NCT04145674|Narcotics|narcotics|mesh-ancestor
154768087|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768088|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768089|NCT04145674|Analgesics|analgesics|mesh-ancestor
154768090|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
154768091|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768092|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
154768093|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768094|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154768095|NCT02394054|Vasopressins|vasopressins|mesh-list
154768096|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
154768097|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
154768098|NCT02394054|Coagulants|coagulants|mesh-ancestor
154768099|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154768100|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154260310|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
154260311|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260312|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260313|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153858549|NCT00555087|Androgens|androgens|mesh-ancestor
154768101|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
153398865|NCT02895035|Phenylephrine|phenylephrine|mesh-list
154768102|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768103|NCT02393664|Bupivacaine|bupivacaine|mesh-list
154768104|NCT02393664|Propofol|propofol|mesh-list
154768105|NCT02393664|Sevoflurane|sevoflurane|mesh-list
154768106|NCT02393664|Rocuronium|rocuronium|mesh-list
154768107|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768108|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
154768109|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768110|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768111|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
154768112|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398866|NCT02895035|Epinephrine|epinephrine|mesh-list
153398867|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
153398868|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153398869|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153398870|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
153398871|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398872|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858594|NCT00556062|Vaccines|vaccines|mesh-list
153858595|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
154768113|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154768114|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154768115|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
154768116|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154768117|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154768118|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154768119|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154768120|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154768121|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154768122|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154768123|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401309|NCT00355628|Fentanyl|fentanyl|mesh-list
153858607|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
153858608|NCT04932083|Midazolam|midazolam|mesh-list
153858609|NCT04932083|Fentanyl|fentanyl|mesh-list
153858610|NCT04932083|Nalbuphine|nalbuphine|mesh-list
153858611|NCT04932083|Bupivacaine|bupivacaine|mesh-list
153858612|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
153858613|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
153858614|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858615|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858616|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
153858617|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858620|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153448809|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
153813271|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359755|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768124|NCT02397486|Vitamin E|vitamin e|mesh-list
154768125|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
154768126|NCT02397486|Vitamins|vitamins|mesh-ancestor
154768127|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
154768128|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768129|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
154768130|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768131|NCT02397486|Protective Agents|protective agents|mesh-ancestor
154768132|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154768133|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768134|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154768135|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154768136|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
154260314|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
154260315|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154260316|NCT02459392|Prednisolone|prednisolone|mesh-list
154260317|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
154260318|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
154260319|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154260320|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
154260321|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154260322|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
153398919|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153398920|NCT01938001|Rituximab|rituximab|mesh-list
153398921|NCT01938001|Lenalidomide|lenalidomide|mesh-list
153398923|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440664|NCT00004099|Vitamins|vitamins|mesh-ancestor
154768137|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154768138|NCT02393586|Amoxicillin|amoxicillin|mesh-list
154768139|NCT02393586|Rifampin|rifampin|mesh-list
154768140|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154768141|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
154768142|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
154768143|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154768144|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768145|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154768146|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
154768147|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
154768148|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154768149|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768150|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768151|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154768152|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154768153|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154768154|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154768155|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154768156|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154768157|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154768158|NCT02393430|Rebamipide|rebamipide|mesh-list
154768159|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154768160|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154768161|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
154768162|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768163|NCT02393430|Protective Agents|protective agents|mesh-ancestor
154768164|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768165|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768166|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
154768167|NCT03453892|Nivolumab|nivolumab|mesh-list
154768168|NCT03453892|Ipilimumab|ipilimumab|mesh-list
154768169|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154768170|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768171|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154768172|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768173|NCT00367120|Amoxicillin|amoxicillin|mesh-list
154768174|NCT00367120|Azithromycin|azithromycin|mesh-list
154768175|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
154768176|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
154768177|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154768178|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154768179|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768180|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154768181|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768182|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768183|NCT02397330|Morphine|morphine|mesh-list
154768184|NCT02397330|Bupivacaine|bupivacaine|mesh-list
154768185|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768186|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
153858692|NCT01785771|Incretins|incretins|mesh-ancestor
153858693|NCT01785771|Hormones|hormones|mesh-ancestor
153858694|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153858695|NCT01784874|Vaccines|vaccines|mesh-list
153858696|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
153858697|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858698|NCT04607252|Metformin|metformin|mesh-list
153858699|NCT04607252|Megestrol|megestrol|mesh-list
153858700|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
153858707|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153813274|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899356|NCT06267066|Petrolatum|petrolatum|mesh-list
154768187|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768188|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768189|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
154768190|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768191|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154768192|NCT02397330|Narcotics|narcotics|mesh-ancestor
154768193|NCT02397330|Analgesics|analgesics|mesh-ancestor
154768194|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
154768195|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154768196|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
154768197|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768198|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768199|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154768200|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768201|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154768202|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
154768203|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768204|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768205|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154768206|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
154768207|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
154768208|NCT03081052|Protective Agents|protective agents|mesh-ancestor
154768209|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154768210|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
154768211|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
154768212|NCT00422344|Sunitinib|sunitinib|mesh-list
154768213|NCT00422344|Everolimus|everolimus|mesh-list
154768214|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768215|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154768216|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154768217|NCT00422344|Growth Substances|growth substances|mesh-ancestor
154768218|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768219|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
154768220|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154768221|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768222|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768223|NCT00422344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154768224|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768225|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
154768226|NCT00367276|Drospirenone|drospirenone|mesh-list
154768227|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154768228|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
154768229|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768230|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768231|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154768232|NCT00367276|Diuretics|diuretics|mesh-ancestor
154768233|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
154768234|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
154768235|NCT02546986|Azacitidine|azacitidine|mesh-list
154768236|NCT02546986|Cc-486|cc-486|mesh-list
154768237|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154768238|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768239|NCT02546986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154768240|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768241|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154768242|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
154768243|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768244|NCT02689206|Glycine|glycine|mesh-list
154768245|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
154768246|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768247|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768248|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768249|NCT01695239|Adalimumab|adalimumab|mesh-list
154768250|NCT01695239|Ixekizumab|ixekizumab|mesh-list
154768251|NCT01695239|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154768252|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768253|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154768254|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
154260358|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154260359|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154007303|NCT00631085|Vitamin E|vitamin e|mesh-list
154260360|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260361|NCT00053352|Etoposide|etoposide|mesh-list
154260362|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
154260363|NCT00053352|Bleomycin|bleomycin|mesh-list
154260364|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260365|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154260366|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154260367|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154260368|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260369|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260370|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154260371|NCT01193816|Loxapine|loxapine|mesh-list
154768255|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154768256|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154768257|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768258|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154768259|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154768260|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768261|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768262|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
153858777|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153858778|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153858779|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858780|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153858781|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858782|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
153399056|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
153399057|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
153399059|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
154768263|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768264|NCT04317430|Niclosamide|niclosamide|mesh-list
154768265|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
154768266|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154768267|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
154768268|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154768269|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768270|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
154768271|NCT04277884|Firibastat|firibastat|mesh-list
154768272|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154768273|NCT00367822|Ropinirole|ropinirole|mesh-list
154768274|NCT00367822|Lisuride|lisuride|mesh-list
154768275|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154768276|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154768277|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
154768278|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
154768279|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768280|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768281|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768282|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154768283|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
154768284|NCT02643862|Omalizumab|omalizumab|mesh-list
154768285|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154768286|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154768287|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768288|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
154768289|NCT01694771|Olodaterol|olodaterol|mesh-list
154768290|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154260372|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154260373|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154260374|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260375|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260376|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154260377|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154260378|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
154260379|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733365|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
153858807|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399081|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399083|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153399084|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399085|NCT02902913|Analgesics|analgesics|mesh-ancestor
153399086|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
153399087|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399088|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399089|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399090|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399095|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
154263538|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154768291|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
154768292|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768293|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768294|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154768295|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768296|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
154768297|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154768298|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
154768299|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768300|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768301|NCT02651272|Macitentan|macitentan|mesh-list
154768302|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154768303|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154768304|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768305|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154768306|NCT01582061|Pasireotide|pasireotide|mesh-list
154768307|NCT01582061|Hormones|hormones|mesh-ancestor
154768308|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768309|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768310|NCT01693523|Minocycline|minocycline|mesh-list
154768311|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154768312|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768313|NCT03924323|Escitalopram|escitalopram|mesh-list
154768314|NCT03924323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154768315|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154768316|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768317|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768318|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768319|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
154768320|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768321|NCT01581281|Topiramate|topiramate|mesh-list
154768322|NCT01581281|Amitriptyline|amitriptyline|mesh-list
154263539|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154263540|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263541|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263542|NCT05315713|Atezolizumab|atezolizumab|mesh-list
154263543|NCT05315713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263544|NCT05315713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768323|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
154768324|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154768325|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768326|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154768327|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
154768328|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154768329|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154768330|NCT01581281|Analgesics|analgesics|mesh-ancestor
154768331|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
154768332|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768333|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154768334|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154768335|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768336|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768337|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
154768338|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768339|NCT02692716|Semaglutide|semaglutide|mesh-list
154768340|NCT02692716|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154768341|NCT02692716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154768342|NCT02692716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768343|NCT01580969|Minocycline|minocycline|mesh-list
154768344|NCT01580969|Bevacizumab|bevacizumab|mesh-list
154768345|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154768346|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768347|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154768348|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154768349|NCT01580969|Growth Substances|growth substances|mesh-ancestor
154768350|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768351|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
154768352|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154768353|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768354|NCT02696226|Aspirin|aspirin|mesh-list
154768355|NCT02696226|Warfarin|warfarin|mesh-list
154768356|NCT02696226|Clopidogrel|clopidogrel|mesh-list
154768357|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154768358|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154768360|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
154768361|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768362|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768363|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768364|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154768365|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154768366|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154260381|NCT05571202|Anesthetics|anesthetics|mesh-list
154768367|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768368|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154768369|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154768370|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768371|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
154768372|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154768373|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154768374|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154768375|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
154768376|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768377|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
154768378|NCT03167112|Leucovorin|leucovorin|mesh-list
154768379|NCT03167112|Fluorouracil|fluorouracil|mesh-list
154768380|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
154768381|NCT03167112|Irinotecan|irinotecan|mesh-list
154768382|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
154768383|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768384|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154768385|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768386|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768387|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
154768388|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768389|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154768390|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154768391|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768392|NCT03167112|Antidotes|antidotes|mesh-ancestor
154768393|NCT03167112|Protective Agents|protective agents|mesh-ancestor
154768394|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
154768395|NCT03167112|Vitamins|vitamins|mesh-ancestor
154768396|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
154768397|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
154768398|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
154768399|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154768400|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
154768401|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768402|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768403|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154768404|NCT03167034|Acetazolamide|acetazolamide|mesh-list
154768405|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
154768406|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154768407|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768408|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768409|NCT03167034|Diuretics|diuretics|mesh-ancestor
154768410|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
154768411|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768412|NCT01578551|Metformin|metformin|mesh-list
154768413|NCT01578551|Biguanides|biguanides|mesh-list
154768414|NCT01578551|Paclitaxel|paclitaxel|mesh-list
154768415|NCT01578551|Bevacizumab|bevacizumab|mesh-list
154768416|NCT01578551|Carboplatin|carboplatin|mesh-list
154768417|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154768418|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768419|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
154768420|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
154768421|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858873|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858874|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858875|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858876|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
153858877|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858878|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
153858879|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858880|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
153858881|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858882|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153858883|NCT01712451|Fluticasone|fluticasone|mesh-list
153858884|NCT01712451|Xhance|xhance|mesh-list
153858885|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153858886|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813278|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813279|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153359797|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359798|NCT03860987|Prednisone|prednisone|mesh-list
153359799|NCT03860987|Goserelin|goserelin|mesh-list
153359800|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153359801|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
153359802|NCT03860987|Hormones|hormones|mesh-ancestor
153359803|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813301|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813302|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813303|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153813304|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
153813305|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154768422|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768423|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154768424|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154768425|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154768426|NCT01578551|Growth Substances|growth substances|mesh-ancestor
154768427|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768428|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
154768429|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154768430|NCT01692197|Cytarabine|cytarabine|mesh-list
154768431|NCT01692197|Dexamethasone|dexamethasone|mesh-list
154768432|NCT01692197|Idarubicin|idarubicin|mesh-list
154768433|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768434|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
154520421|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
154260419|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154260420|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154260421|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260422|NCT01294826|Cetuximab|cetuximab|mesh-list
154260423|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263549|NCT05295173|Reteplase|reteplase|mesh-list
153813309|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
153813310|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153813311|NCT00333164|Protective Agents|protective agents|mesh-ancestor
153813312|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153813313|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153813314|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813315|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
153813316|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813317|NCT01052493|Hormones|hormones|mesh-ancestor
153813318|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813319|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813320|NCT00333242|Levomethorphan|levomethorphan|mesh-list
153359804|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359805|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153359806|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359807|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
153813326|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813327|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813328|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359813|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153899546|NCT06191692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736408|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
153813329|NCT00333242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153813330|NCT00333242|Narcotics|narcotics|mesh-ancestor
153359814|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
154768435|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
154768436|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768437|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768438|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154768439|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
154768440|NCT01692197|Hormones|hormones|mesh-ancestor
154768441|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263550|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154263551|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154263552|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263553|NCT05232344|Estradiol|estradiol|mesh-list
154263554|NCT05232344|Progesterone|progesterone|mesh-list
154263555|NCT05232344|Estrogens|estrogens|mesh-ancestor
154263556|NCT05232344|Hormones|hormones|mesh-ancestor
153733369|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
153813333|NCT00333242|Sensory System Agents|sensory system agents|mesh-ancestor
154768442|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154768443|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768444|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154768445|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
154768446|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768447|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
154768448|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768449|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768450|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
154768451|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154768452|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154768453|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154768454|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768455|NCT01691885|Fluticasone|fluticasone|mesh-list
154768456|NCT01691885|Xhance|xhance|mesh-list
154768457|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768458|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154768459|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
154768460|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768461|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768462|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154768463|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768464|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
154768465|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154768466|NCT03166800|Ubiquinone|ubiquinone|mesh-list
154768467|NCT03166800|Micronutrients|micronutrients|mesh-ancestor
154768468|NCT03166800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768469|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
154768470|NCT03166254|Vaccines|vaccines|mesh-list
154768471|NCT03166254|Poly ICLC|poly iclc|mesh-list
154768472|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
154768473|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768474|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154768475|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768476|NCT03166254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154768477|NCT03166254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768478|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
154768479|NCT02651428|Taurolidine|taurolidine|mesh-list
154768480|NCT02651428|Heparin|heparin|mesh-list
154768481|NCT02651428|Calcium heparin|calcium heparin|mesh-list
154768482|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
154768483|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768484|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154768485|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154768486|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768487|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154768488|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768489|NCT02686164|Lenvatinib|lenvatinib|mesh-list
154768490|NCT02686164|Midazolam|midazolam|mesh-list
154768491|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154768492|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154768493|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768494|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768495|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154768496|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154768497|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154768498|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154768499|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
154768500|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
154768501|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
154768502|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
154768503|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768504|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768505|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768506|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154768507|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768508|NCT02651584|Buprenorphine|buprenorphine|mesh-list
154768509|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154768510|NCT02651584|Narcotics|narcotics|mesh-ancestor
154768511|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860418|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
154768512|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768513|NCT02651584|Analgesics|analgesics|mesh-ancestor
154768514|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
154768515|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768516|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154768517|NCT02685072|Progesterone|progesterone|mesh-list
154768518|NCT02685072|Progestins|progestins|mesh-ancestor
154768519|NCT02685072|Hormones|hormones|mesh-ancestor
154768520|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768521|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768522|NCT02653144|Dexamethasone|dexamethasone|mesh-list
154768523|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
154768524|NCT02653144|Ropivacaine|ropivacaine|mesh-list
154768525|NCT02653144|Anesthetics|anesthetics|mesh-list
154768526|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768527|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
154768528|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
154768529|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768530|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768531|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154768532|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
154768533|NCT02653144|Hormones|hormones|mesh-ancestor
154768534|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768535|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154768536|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768537|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154768538|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768539|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154768540|NCT02653144|Analgesics|analgesics|mesh-ancestor
154768541|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
154768542|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154260451|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
154768543|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154768544|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154768545|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
154768546|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768547|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768548|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768549|NCT00118365|Eflornithine|eflornithine|mesh-list
154768550|NCT00118365|Sulindac|sulindac|mesh-list
154768551|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768552|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154768553|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154768554|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154768555|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768556|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154768557|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768558|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768559|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154768560|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154768561|NCT00118365|Analgesics|analgesics|mesh-ancestor
154768562|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
154768563|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768564|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768565|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768566|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154768567|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154768568|NCT03165240|Eplerenone|eplerenone|mesh-list
154768569|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154768570|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
154768571|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768572|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768573|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154768574|NCT03165240|Diuretics|diuretics|mesh-ancestor
154768575|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
154768576|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154768577|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
154260473|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768578|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154768579|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
154768580|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768581|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768582|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154768583|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768584|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
154768585|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154768586|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
154768587|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768588|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768589|NCT03028909|Oseltamivir|oseltamivir|mesh-list
154768590|NCT03028909|MEDI8852|medi8852|mesh-list
154768591|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
154768592|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768593|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768594|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768595|NCT02654860|Acetaminophen|acetaminophen|mesh-list
154768596|NCT02654860|Bupivacaine|bupivacaine|mesh-list
154768597|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768598|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
154768599|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768600|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768601|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
154768602|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768603|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154768604|NCT02654860|Analgesics|analgesics|mesh-ancestor
154768605|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
154768606|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
154768607|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154768608|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
154768609|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768610|NCT01587001|Expectorants|expectorants|mesh-ancestor
154768611|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768612|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154768613|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
154768614|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768615|NCT01587001|Protective Agents|protective agents|mesh-ancestor
154768616|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768617|NCT01587001|Antidotes|antidotes|mesh-ancestor
154768618|NCT01568047|Levodopa|levodopa|mesh-list
154768619|NCT01568047|Carbidopa|carbidopa|mesh-list
154768620|NCT01568047|Opicapone|opicapone|mesh-list
154768621|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154768622|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154768623|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
154768624|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768625|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768626|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768627|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154768628|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768629|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154768630|NCT01688921|Vaccines|vaccines|mesh-list
154768631|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
154768632|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768633|NCT00118755|Bevacizumab|bevacizumab|mesh-list
154768634|NCT00118755|Capecitabine|capecitabine|mesh-list
154768635|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
154768636|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154768637|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768638|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153399546|NCT02018653|Calcium|calcium|mesh-list
154768639|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154768640|NCT00118755|Growth Substances|growth substances|mesh-ancestor
154768641|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768642|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
154768643|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154768644|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
154768645|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768646|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154768647|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154768648|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154768649|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768650|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768651|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154768652|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154768653|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154768654|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
154768655|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768656|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768657|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154768658|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154768659|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
154768660|NCT02662036|Bupivacaine|bupivacaine|mesh-list
154768661|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768662|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
154768663|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768664|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768665|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
154768666|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768667|NCT01687673|Sirolimus|sirolimus|mesh-list
154768668|NCT01687673|Sorafenib|sorafenib|mesh-list
154768669|NCT01687673|Temsirolimus|temsirolimus|mesh-list
154768670|NCT01687673|MTOR Inhibitors|mtor inhibitors|mesh-list
154768671|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768672|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154768673|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768674|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768675|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768676|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
154768677|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768678|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154768679|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768680|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154768681|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
154768682|NCT00121251|Gemcitabine|gemcitabine|mesh-list
154768683|NCT00121251|Capecitabine|capecitabine|mesh-list
154768684|NCT00121251|Sorafenib|sorafenib|mesh-list
154260499|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
154768685|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154768686|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
154768687|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768688|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768689|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154768690|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768691|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
154768692|NCT02664220|Povidone|povidone|mesh-list
154768693|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
154768694|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
154768695|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154768696|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768697|NCT04339348|Lidocaine|lidocaine|mesh-list
154768698|NCT04339348|Prilocaine|prilocaine|mesh-list
154768699|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154768700|NCT04339348|Misoprostol|misoprostol|mesh-list
154383961|NCT03228862|Vitamin D|vitamin d|mesh-list
154768701|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768702|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
154768703|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768704|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768705|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
154768706|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768707|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154768708|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154768709|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154768710|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768711|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768712|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154768713|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
153859410|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154768714|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154768715|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154768716|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154768717|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
154768718|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154768719|NCT02664922|Ketamine|ketamine|mesh-list
154768720|NCT02664922|Remifentanil|remifentanil|mesh-list
154768721|NCT02664922|Propofol|propofol|mesh-list
154768722|NCT02664922|Sevoflurane|sevoflurane|mesh-list
154768723|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154768724|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768725|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768726|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154768727|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
154768728|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
154768729|NCT02664922|Analgesics|analgesics|mesh-ancestor
154768730|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
154768731|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768732|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154768733|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154768734|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154768735|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768736|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768737|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154520729|NCT02355236|Celecoxib|celecoxib|mesh-list
154768738|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154768739|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154768740|NCT02664922|Narcotics|narcotics|mesh-ancestor
154768741|NCT02666950|Cytarabine|cytarabine|mesh-list
154768742|NCT02666950|Adavosertib|adavosertib|mesh-list
154768743|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154768744|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
154768745|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768746|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768747|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
154768748|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768749|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768750|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
154768751|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768752|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768753|NCT02668432|Amiodarone|amiodarone|mesh-list
154768754|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154768755|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
154768756|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154768757|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768758|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768759|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154768760|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154768761|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154768762|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768763|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154768764|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154768765|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154768766|NCT01687283|Fluticasone|fluticasone|mesh-list
154768767|NCT01687283|Xhance|xhance|mesh-list
154768768|NCT01687283|Budesonide|budesonide|mesh-list
154768769|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768770|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154768771|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
154768772|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768773|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768774|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154768775|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768776|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
154260539|NCT04728646|Dexamethasone|dexamethasone|mesh-list
154768777|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154768778|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
154768779|NCT01687283|Hormones|hormones|mesh-ancestor
154768780|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768781|NCT02684370|Ustekinumab|ustekinumab|mesh-list
154768782|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154768783|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
154768784|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
154768785|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768786|NCT02669914|Durvalumab|durvalumab|mesh-list
154768787|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154768788|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768789|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
154768790|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154768791|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154768792|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154768793|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859544|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
154768794|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768795|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
154768796|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768797|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768798|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154768799|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768800|NCT04739410|Ivermectin|ivermectin|mesh-list
154768801|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154768802|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768803|NCT02691936|Estrogens|estrogens|mesh-list
154768804|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154768805|NCT02691936|Hormones|hormones|mesh-ancestor
154768806|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768807|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768808|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
154768809|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154768810|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
154768811|NCT04707742|Povidone|povidone|mesh-list
154520799|NCT02359370|Analgesics|analgesics|mesh-ancestor
154768812|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
153859560|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
154768813|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
154768814|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154768815|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768817|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
154768818|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154768819|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768820|NCT00367978|Amlodipine|amlodipine|mesh-list
154768821|NCT00367978|Benazepril|benazepril|mesh-list
154768822|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154768823|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153859591|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768824|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768825|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768826|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154768827|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768828|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
154768829|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154768830|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
154768831|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768832|NCT00368056|Eszopiclone|eszopiclone|mesh-list
154768833|NCT00368056|Zopiclone|zopiclone|mesh-list
154768834|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153399937|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
154768835|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768836|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768837|NCT01685801|Ivacaftor|ivacaftor|mesh-list
154768838|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154768839|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768840|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768841|NCT01684943|Insulin|insulin|mesh-list
154768842|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154768843|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768844|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
154768845|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154768846|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154768847|NCT05339542|Prednisolone|prednisolone|mesh-list
154768848|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
154768849|NCT05339542|Lidocaine|lidocaine|mesh-list
154768850|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154768851|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
154768852|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768853|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
154768854|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768855|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768856|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
154768857|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768858|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154768859|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154768860|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154768861|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154768862|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768863|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768864|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
154768865|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
154768866|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154768867|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
154768868|NCT05339542|Hormones|hormones|mesh-ancestor
154768869|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154768870|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154768871|NCT05339542|Protective Agents|protective agents|mesh-ancestor
154768872|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154768873|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768874|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
154768875|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154768876|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768877|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154768878|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154768879|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768880|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768881|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768882|NCT00368602|Timolol|timolol|mesh-list
154768883|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154768884|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
154768885|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
154768886|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860419|NCT01924286|Prednisone|prednisone|mesh-list
154768887|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768888|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768889|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154768890|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154768891|NCT01683071|Bupivacaine|bupivacaine|mesh-list
153859738|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
154768892|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768893|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
154768894|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768895|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768896|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
154768897|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768899|NCT04707508|Valsartan|valsartan|mesh-list
154768900|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154768901|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768902|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154768903|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154768904|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154768905|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768906|NCT01567865|Vaccines|vaccines|mesh-list
154768907|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
154768908|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768909|NCT05049226|Vaccines|vaccines|mesh-list
154768910|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
154768911|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768912|NCT01567163|Docetaxel|docetaxel|mesh-list
154768913|NCT01567163|Ramucirumab|ramucirumab|mesh-list
154768914|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768915|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154768916|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154768917|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154768918|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768919|NCT01567163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154768920|NCT01567163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154768921|NCT01567163|Growth Substances|growth substances|mesh-ancestor
154768922|NCT01567163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768923|NCT01567163|Growth Inhibitors|growth inhibitors|mesh-ancestor
154768924|NCT05002114|Cannabidiol|cannabidiol|mesh-list
154768925|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
154768926|NCT04338802|Nintedanib|nintedanib|mesh-list
154768927|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768928|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154768929|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154768930|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768931|NCT04395508|Trastuzumab|trastuzumab|mesh-list
154768932|NCT04395508|Pertuzumab|pertuzumab|mesh-list
154768933|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154768934|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768935|NCT00368914|Sirolimus|sirolimus|mesh-list
154768936|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154768937|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154768938|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154768939|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154768940|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
154768941|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768942|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
154768943|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768944|NCT01567085|Eculizumab|eculizumab|mesh-list
154260563|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154768945|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154768946|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154768947|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
154768948|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768949|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
154768950|NCT04344184|Vitamins|vitamins|mesh-ancestor
154768951|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
154768952|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768953|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
153400238|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
154768954|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768955|NCT04344184|Protective Agents|protective agents|mesh-ancestor
154768956|NCT01566773|Bromides|bromides|mesh-list
154768957|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
154768958|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154768959|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
154768960|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768961|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768962|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154768963|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
154385540|NCT02448550|Heparin|heparin|mesh-list
154768964|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
154768965|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154768966|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
154768967|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768968|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768969|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
154768970|NCT04134442|Bupivacaine|bupivacaine|mesh-list
154768971|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
154768972|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
154768973|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154768974|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768975|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
154768976|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768977|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
154768978|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
154768979|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
154768980|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154768981|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
154768982|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154768983|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154768984|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154768985|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
154768986|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154768987|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154768988|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154768989|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
154768990|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154768991|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154768992|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154768993|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
154768994|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154768996|NCT03417388|Losartan|losartan|mesh-list
154768997|NCT03417388|Lisinopril|lisinopril|mesh-list
154768998|NCT03417388|Atorvastatin|atorvastatin|mesh-list
154768999|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154769000|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154769001|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769002|NCT03417388|Analgesics|analgesics|mesh-ancestor
154769003|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
154769004|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769005|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769006|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769007|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769008|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154769009|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154769010|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769011|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154769012|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154769013|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769014|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
154769015|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154769016|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154769017|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
154385738|NCT02443012|Analgesics|analgesics|mesh-ancestor
154769018|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154769019|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154769020|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154769021|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154769022|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154769023|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154769024|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154769025|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
154769026|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154769027|NCT03417388|Protective Agents|protective agents|mesh-ancestor
154769028|NCT02691702|Melatonin|melatonin|mesh-list
154769029|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
154769030|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769031|NCT02691702|Protective Agents|protective agents|mesh-ancestor
154769032|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769033|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769034|NCT01564277|Allopurinol|allopurinol|mesh-list
154769035|NCT01564277|Rasburicase|rasburicase|mesh-list
154521021|NCT03613207|Lidocaine|lidocaine|mesh-list
154769036|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
154769037|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769038|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769039|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
154769040|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769041|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154769043|NCT01564277|Protective Agents|protective agents|mesh-ancestor
154769044|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769045|NCT01563185|Ibuprofen|ibuprofen|mesh-list
154769046|NCT01563185|Famotidine|famotidine|mesh-list
154769047|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154769048|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769049|NCT01563185|Analgesics|analgesics|mesh-ancestor
154769050|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
153860174|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
154769051|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769052|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769053|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769054|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769055|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154769056|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769057|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769058|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154769059|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769060|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154769061|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
154769062|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
154769063|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769064|NCT02974660|Protamines|protamines|mesh-list
154769065|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
154769066|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769067|NCT02974660|Coagulants|coagulants|mesh-ancestor
154769068|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
154769069|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
154769070|NCT01563029|Fluticasone|fluticasone|mesh-list
154769071|NCT01563029|Xhance|xhance|mesh-list
154769072|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769073|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154769074|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
154769075|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769076|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769077|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154769078|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
154769079|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
154769080|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154769081|NCT03293368|Triamcinolone|triamcinolone|mesh-list
154769082|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154769083|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154769084|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154769085|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769086|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
154769087|NCT03293368|Hormones|hormones|mesh-ancestor
154769088|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769089|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860214|NCT02300142|Vaccines|vaccines|mesh-list
154769090|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769091|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
154769092|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769093|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769094|NCT03273712|Octreotide|octreotide|mesh-list
154769095|NCT03273712|Edotreotide|edotreotide|mesh-list
154769096|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769097|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154769098|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769099|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154769100|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769101|NCT04113317|Lenograstim|lenograstim|mesh-list
154769102|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154769103|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
154260609|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769104|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769105|NCT04341844|Methylene Blue|methylene blue|mesh-list
154769106|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769107|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769108|NCT01561313|Adalimumab|adalimumab|mesh-list
154769109|NCT01561313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154769110|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521099|NCT03392571|Paclitaxel|paclitaxel|mesh-list
154769111|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769112|NCT01561079|Buprenorphine|buprenorphine|mesh-list
154769113|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154769114|NCT01561079|Narcotics|narcotics|mesh-ancestor
153733391|NCT00507052|Antidotes|antidotes|mesh-ancestor
154769115|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769116|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769117|NCT01561079|Analgesics|analgesics|mesh-ancestor
154769118|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
154769119|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769120|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154769121|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
153860335|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
154769122|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154769123|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154769124|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154769125|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154769126|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154769127|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
154769128|NCT01559675|Prednisolone|prednisolone|mesh-list
154769129|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
154769130|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154769131|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
154769132|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769133|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
154769134|NCT01559675|Hormones|hormones|mesh-ancestor
154769135|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769136|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769137|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154769138|NCT01559675|Protective Agents|protective agents|mesh-ancestor
154769139|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154769140|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769141|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
154769142|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
154769143|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769144|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769145|NCT01374906|Pasireotide|pasireotide|mesh-list
154769146|NCT01374906|Hormones|hormones|mesh-ancestor
154769147|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769148|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769149|NCT00362596|Acyclovir|acyclovir|mesh-list
154769150|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
154769151|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769152|NCT02974504|Linagliptin|linagliptin|mesh-list
154769153|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154260623|NCT01191710|Progestins|progestins|mesh-ancestor
154260634|NCT03852056|Protective Agents|protective agents|mesh-ancestor
154769154|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769155|NCT02974504|Incretins|incretins|mesh-ancestor
154769156|NCT02974504|Hormones|hormones|mesh-ancestor
154769157|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769158|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154769159|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
154769160|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769161|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769162|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
154769163|NCT03013504|Docetaxel|docetaxel|mesh-list
154769164|NCT03013504|Trastuzumab|trastuzumab|mesh-list
154769165|NCT03013504|Epirubicin|epirubicin|mesh-list
154769166|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769167|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
154769168|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769169|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769170|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154769171|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
154769172|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769173|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769174|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154769175|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
154769176|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
154769177|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
154769178|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769179|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154769180|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154769181|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154769182|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769183|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
154769184|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154769185|NCT02683746|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154769186|NCT02683746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154769187|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769188|NCT02683746|Incretins|incretins|mesh-ancestor
154769189|NCT02683746|Hormones|hormones|mesh-ancestor
154260635|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769190|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769191|NCT02691468|Silicon|silicon|mesh-list
154769192|NCT02691468|Trace Elements|trace elements|mesh-ancestor
154769193|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
154769194|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769195|NCT03162120|Metoprolol|metoprolol|mesh-list
154769196|NCT03162120|Flecainide|flecainide|mesh-list
154769197|NCT03162120|Ranolazine|ranolazine|mesh-list
154769198|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154769199|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154769200|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
154769201|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
154769202|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769203|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860524|NCT00544232|Hematinics|hematinics|mesh-ancestor
154769204|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154769205|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154769206|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154769207|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
154769208|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769209|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769210|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154769211|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154769212|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153400972|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
154769213|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
154769214|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154769215|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
154769216|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733393|NCT00507091|Fluorouracil|fluorouracil|mesh-list
154769217|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769218|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154769219|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
154769220|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
153402792|NCT04853043|Cetuximab|cetuximab|mesh-list
154769221|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154769222|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
154769223|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769224|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769225|NCT03114228|Midostaurin|midostaurin|mesh-list
154769226|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769227|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154769228|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769229|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769230|NCT02678286|Meloxicam|meloxicam|mesh-list
153733395|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
153861486|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769231|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154769232|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769233|NCT02678286|Analgesics|analgesics|mesh-ancestor
154769234|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
154769235|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769236|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769237|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769238|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769239|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154769240|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154769241|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769242|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769243|NCT03164694|Carboplatin|carboplatin|mesh-list
154769244|NCT03164694|Pemetrexed|pemetrexed|mesh-list
154769245|NCT03164694|Apatinib|apatinib|mesh-list
154769246|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769247|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769248|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769249|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154769250|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154769251|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154769252|NCT02930902|Paclitaxel|paclitaxel|mesh-list
154769253|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154769254|NCT02930902|Gemcitabine|gemcitabine|mesh-list
154769255|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
154769256|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154769257|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769258|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
154769259|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
154387060|NCT01375920|Metyrapone|metyrapone|mesh-list
154521244|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154769260|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
154769261|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769262|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154769263|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
154769264|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769265|NCT02930902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154769266|NCT02767804|Crizotinib|crizotinib|mesh-list
154769267|NCT02767804|Ensartinib|ensartinib|mesh-list
154769268|NCT02767804|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154769269|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153863085|NCT05423015|Levan|levan|mesh-list
154769270|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769271|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769272|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769273|NCT02741128|Vaccines|vaccines|mesh-list
154769274|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
154769275|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769276|NCT01566721|Trastuzumab|trastuzumab|mesh-list
154769277|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769278|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769279|NCT01541215|Metformin|metformin|mesh-list
154769280|NCT01541215|Liraglutide|liraglutide|mesh-list
154769281|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154769282|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769283|NCT01541215|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154769284|NCT01541215|Incretins|incretins|mesh-ancestor
154769285|NCT01541215|Hormones|hormones|mesh-ancestor
154769286|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769287|NCT01585987|Ipilimumab|ipilimumab|mesh-list
154769288|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769289|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769290|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154769291|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769292|NCT01585831|Testosterone|testosterone|mesh-list
154769293|NCT01585831|Androgens|androgens|mesh-ancestor
154769294|NCT01585831|Hormones|hormones|mesh-ancestor
154769295|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769296|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769297|NCT01565941|Insulin|insulin|mesh-list
154769298|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154769299|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154769300|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769301|NCT01558271|Liraglutide|liraglutide|mesh-list
154769302|NCT01558271|Dulaglutide|dulaglutide|mesh-list
154769303|NCT01558271|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154769304|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154769305|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769306|NCT01558271|Incretins|incretins|mesh-ancestor
154769307|NCT01558271|Hormones|hormones|mesh-ancestor
154769308|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769309|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
154769310|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154260686|NCT01297010|Hormones|hormones|mesh-ancestor
154769311|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154769312|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
154769313|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769314|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769315|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769316|NCT01565707|Urological Agents|urological agents|mesh-ancestor
154769317|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154769318|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154769319|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154769320|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404692|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769321|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403391|NCT03846310|Pemetrexed|pemetrexed|mesh-list
154769322|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
154769323|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733409|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
154769324|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769325|NCT04756271|Antibodies|antibodies|mesh-list
154769326|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
154769327|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
154769328|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769329|NCT01538719|Rilonacept|rilonacept|mesh-list
154389082|NCT03657095|Beraprost|beraprost|mesh-list
154769330|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769331|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
154769332|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154769333|NCT01537783|Mupirocin|mupirocin|mesh-list
154769334|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154769335|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769336|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
154769337|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
154769338|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154769339|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154769340|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865039|NCT01157182|Estradiol|estradiol|mesh-list
154769341|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389797|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389821|NCT02399800|Hormones|hormones|mesh-ancestor
154769343|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154769344|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769345|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769346|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154769347|NCT01556165|Protective Agents|protective agents|mesh-ancestor
154769348|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769349|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
154769350|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
154769351|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
154769352|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769353|NCT01537549|Protective Agents|protective agents|mesh-ancestor
154769354|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769355|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
154769356|NCT01537549|Vitamins|vitamins|mesh-ancestor
154769357|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
154769358|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
154769359|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
154769360|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154769361|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
153406609|NCT04252612|Pramlintide|pramlintide|mesh-list
154769362|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154769363|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390791|NCT05913388|Pembrolizumab|pembrolizumab|mesh-list
154769364|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154769365|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154750543|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750544|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750545|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154769366|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154750546|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750547|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
154750548|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154750549|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154750550|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750551|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750552|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154750553|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
154750554|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
154750555|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154750556|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750557|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154750558|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154391756|NCT04963296|Hormones|hormones|mesh-ancestor
154750559|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750560|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750561|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750562|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154750563|NCT05713578|Docetaxel|docetaxel|mesh-list
154769367|NCT01583179|Buprenorphine|buprenorphine|mesh-list
154750564|NCT05713578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750565|NCT05713578|Tubulin Modulators|tubulin modulators|mesh-ancestor
154750566|NCT05713578|Antimitotic Agents|antimitotic agents|mesh-ancestor
154750567|NCT05713578|Mitosis Modulators|mitosis modulators|mesh-ancestor
154769368|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154750568|NCT05713578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750569|NCT02485548|Fluorouracil|fluorouracil|mesh-list
154750570|NCT02485548|Raltitrexed|raltitrexed|mesh-list
153926320|NCT02646319|Sirolimus|sirolimus|mesh-list
153404289|NCT02802566|Vitamins|vitamins|mesh-list
153412143|NCT00005583|Doxorubicin|doxorubicin|mesh-list
154750571|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750572|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
154769369|NCT01583179|Narcotics|narcotics|mesh-ancestor
154750573|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750574|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154750575|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750576|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
154750577|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412934|NCT02498522|Metformin|metformin|mesh-list
154750578|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154750579|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750580|NCT02479074|Prednisolone|prednisolone|mesh-list
153927688|NCT02844322|Rituximab|rituximab|mesh-list
154750581|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154750582|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
154750583|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154750584|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
153928165|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154750585|NCT02479074|Montelukast|montelukast|mesh-list
154750586|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154750587|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
154750588|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750589|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
154750590|NCT02479074|Hormones|hormones|mesh-ancestor
154260708|NCT01295606|Cefazolin|cefazolin|mesh-list
154750591|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750592|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750593|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750594|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750595|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
154750596|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
154750597|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750598|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750599|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154750600|NCT02479074|Protective Agents|protective agents|mesh-ancestor
153414346|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
154750601|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154750602|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
154750603|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154750604|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
154750605|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154750606|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154750607|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750608|NCT02481180|T0001|t0001|mesh-list
154750609|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154750610|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750611|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750612|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
154750613|NCT02480946|Methotrexate|methotrexate|mesh-list
154750614|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154750615|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
154750616|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154750617|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750618|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154750619|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
154750620|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750621|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750622|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
154750623|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750624|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154750625|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750626|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
154750627|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750628|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154750629|NCT01769170|Cidofovir|cidofovir|mesh-list
154750630|NCT01769170|Brincidofovir|brincidofovir|mesh-list
154750631|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
154750632|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750633|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260712|NCT01192724|Cilostazol|cilostazol|mesh-list
154750634|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750635|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
154750636|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154750637|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750638|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154750639|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154750640|NCT02726022|Ribavirin|ribavirin|mesh-list
154750641|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154750642|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
154750643|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750644|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
154750645|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750646|NCT02478294|Warfarin|warfarin|mesh-list
154750647|NCT02478294|Anticoagulants|anticoagulants|mesh-list
154750648|NCT01770652|Deferiprone|deferiprone|mesh-list
154750649|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154750650|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
154750651|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
154750652|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750653|NCT03316482|Leuprolide|leuprolide|mesh-list
154750654|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154750655|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
154750656|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154750657|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750658|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750659|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750660|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154750661|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154750662|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750663|NCT01772758|Antioxidants|antioxidants|mesh-list
154260728|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
154750664|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750665|NCT01772758|Protective Agents|protective agents|mesh-ancestor
154750666|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750667|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
154750668|NCT02485080|Simeprevir|simeprevir|mesh-list
154750669|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
154750670|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750671|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
154750672|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750673|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750674|NCT02480400|Dexetimide|dexetimide|mesh-list
154750675|NCT02480400|Citalopram|citalopram|mesh-list
154750676|NCT02480400|Escitalopram|escitalopram|mesh-list
154750677|NCT02480400|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154750678|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154750679|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154750680|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260744|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
154750681|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929673|NCT02830126|Anesthetics|anesthetics|mesh-list
154750682|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
154750683|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750684|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154750685|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153929998|NCT05660278|Caseins|caseins|mesh-list
154750686|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
154750687|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
154750688|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424644|NCT00377468|Hormones|hormones|mesh-ancestor
154750689|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153930521|NCT05660122|Fexuprazan|fexuprazan|mesh-list
154750690|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154750691|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
154750692|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154750693|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
154750694|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154750695|NCT02725710|Gabapentin|gabapentin|mesh-list
154750696|NCT02725710|Analgesics|analgesics|mesh-ancestor
153930957|NCT02821468|Analgesics|analgesics|mesh-ancestor
154750697|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
154750698|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260754|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931365|NCT00633802|Risperidone|risperidone|mesh-list
154750699|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750700|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
154750701|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154750702|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153439334|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750703|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750704|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154750705|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154750706|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154750707|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750708|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750709|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
154750710|NCT02256358|Midazolam|midazolam|mesh-list
154750711|NCT02256358|Ketamine|ketamine|mesh-list
154750712|NCT02256358|Analgesics|analgesics|mesh-ancestor
154750713|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
153932503|NCT02624401|Esketamine|esketamine|mesh-list
154750714|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750715|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932681|NCT02795884|Vinorelbine|vinorelbine|mesh-list
153932693|NCT02795572|Vitamin D|vitamin d|mesh-list
153932799|NCT01148693|Gentamicins|gentamicins|mesh-list
154750716|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153932994|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
153933214|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
153933316|NCT00869089|Analgesics|analgesics|mesh-ancestor
154750717|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154750718|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
154750719|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
153933593|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
153933819|NCT04230070|Estradiol|estradiol|mesh-list
153933911|NCT02618395|Hydrocodone|hydrocodone|mesh-list
153406253|NCT05093582|Cromakalim|cromakalim|mesh-list
154750720|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750721|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154750722|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153934310|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
153934311|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934312|NCT02779192|Protective Agents|protective agents|mesh-ancestor
153934313|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934314|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934315|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153934316|NCT05020210|Sivelestat|sivelestat|mesh-list
153934317|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153934318|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
153934319|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934320|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934321|NCT04227808|Lenvatinib|lenvatinib|mesh-list
154750723|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750724|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750725|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154750726|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154750727|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154750728|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154750729|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154750730|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
154750731|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
154750732|NCT01825408|Azithromycin|azithromycin|mesh-list
154750733|NCT01825408|Doxycycline|doxycycline|mesh-list
154750734|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154750735|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154750736|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750737|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
154750738|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154750739|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154750740|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154750741|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750742|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934407|NCT01196078|Vinorelbine|vinorelbine|mesh-list
154750744|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750745|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
153934680|NCT01075152|Lamivudine|lamivudine|mesh-list
154750746|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
154750747|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750748|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750749|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750750|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
154750751|NCT04945824|Hormones|hormones|mesh-ancestor
154750752|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750753|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750754|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750755|NCT04937634|Melphalan|melphalan|mesh-list
154750756|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154750757|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
153935133|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
154750758|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750759|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750760|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153692850|NCT00200434|Nebivolol|nebivolol|mesh-list
154750761|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750762|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
153935434|NCT00422565|Sirolimus|sirolimus|mesh-list
154750763|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750764|NCT02262130|Omalizumab|omalizumab|mesh-list
154750765|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154750766|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154750767|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
154750768|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
154750769|NCT04887870|Nivolumab|nivolumab|mesh-list
154750770|NCT04887870|Ipilimumab|ipilimumab|mesh-list
153820851|NCT00465075|Hormones|hormones|mesh-ancestor
154750771|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406680|NCT03974217|Talazoparib|talazoparib|mesh-list
154750772|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750773|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153936114|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154769370|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769371|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750774|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750775|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
154750776|NCT01827358|Mupirocin|mupirocin|mesh-list
154750777|NCT01827358|Calcium|calcium|mesh-list
154750778|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154750779|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750780|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154750781|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154750782|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750783|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154750784|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769372|NCT01583179|Analgesics|analgesics|mesh-ancestor
154769373|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
154750785|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750786|NCT01780324|Lidocaine|lidocaine|mesh-list
154750787|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
154750788|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
153406972|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
154750789|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750790|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750791|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
154750792|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750793|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153938043|NCT02714842|Diclofenac|diclofenac|mesh-list
154750794|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154750795|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154750796|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154750797|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750798|NCT02472600|Colistin|colistin|mesh-list
154750799|NCT02472600|Polymyxins|polymyxins|mesh-list
154750800|NCT02472600|Neomycin|neomycin|mesh-list
154750801|NCT02472600|Omeprazole|omeprazole|mesh-list
154750802|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154750803|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750804|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154750805|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939237|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
154769374|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769375|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154769376|NCT01582945|Ketamine|ketamine|mesh-list
154750806|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750807|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154750808|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750809|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154750810|NCT01781806|Tenofovir|tenofovir|mesh-list
154750811|NCT01781806|Emtricitabine|emtricitabine|mesh-list
154750812|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
154750813|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939795|NCT04309643|Estradiol|estradiol|mesh-list
153939866|NCT01114217|Hematinics|hematinics|mesh-ancestor
154750814|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154750815|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154750816|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502740|NCT02448290|Docetaxel|docetaxel|mesh-list
154750817|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750818|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154750819|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154750820|NCT02477514|Tedizolid|tedizolid|mesh-list
154750821|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
154750822|NCT02477514|Midazolam|midazolam|mesh-list
154750823|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154750824|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154750825|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154750826|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750827|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940794|NCT00833755|Ketamine|ketamine|mesh-list
154750828|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153941122|NCT00705445|Zinc|zinc|mesh-list
154750829|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154750830|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154769377|NCT01582945|Analgesics|analgesics|mesh-ancestor
154750831|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153941615|NCT00631527|Leuprolide|leuprolide|mesh-list
154750832|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
154750833|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
154750834|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
154750835|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
154750836|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750837|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750838|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154750839|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154750840|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
154750841|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154769378|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
153942339|NCT02687854|Apixaban|apixaban|mesh-list
154750842|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154750843|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750844|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153942613|NCT04187014|Coagulants|coagulants|mesh-ancestor
153942614|NCT02686840|Misoprostol|misoprostol|mesh-list
154750845|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750846|NCT02472054|Cyclosporine|cyclosporine|mesh-list
154750847|NCT02472054|Prednisolone|prednisolone|mesh-list
153942943|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
153408341|NCT02975570|Linezolid|linezolid|mesh-list
154750848|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154750849|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
154750850|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154750851|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
154750852|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
154750853|NCT02472054|Cyclosporins|cyclosporins|mesh-list
154750854|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154750855|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
153943453|NCT02672566|Enoxaparin|enoxaparin|mesh-list
154750856|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750857|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750858|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154750859|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
154750860|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750861|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
154750862|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750863|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
153408550|NCT04564872|Hormones|hormones|mesh-ancestor
154750864|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154750865|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154750866|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153408653|NCT05369364|Hormones|hormones|mesh-ancestor
154750867|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
154750868|NCT02472054|Hormones|hormones|mesh-ancestor
154750869|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750870|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750871|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750872|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
154750873|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
153944578|NCT00702871|Ranitidine|ranitidine|mesh-list
154750874|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750875|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750876|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154750877|NCT02472054|Protective Agents|protective agents|mesh-ancestor
154750878|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154750879|NCT01782898|Esmolol|esmolol|mesh-list
154750880|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154750881|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153944909|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154750882|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153945118|NCT02658214|Gemcitabine|gemcitabine|mesh-list
154750883|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
154260778|NCT01193192|Vitamins|vitamins|mesh-list
154750884|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750885|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750886|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750887|NCT02475876|Clindamycin|clindamycin|mesh-list
154750888|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
154750889|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
153945607|NCT02640976|Cetrorelix|cetrorelix|mesh-list
153823102|NCT00456482|Hormones|hormones|mesh-ancestor
153945832|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154769379|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750890|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154750891|NCT02475876|Trimethoprim|trimethoprim|mesh-list
154750892|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
154750893|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946281|NCT02867280|Sorafenib|sorafenib|mesh-list
154750894|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154750895|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154750896|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769380|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750897|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750898|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154750899|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
154750900|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154750901|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154750902|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154750903|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154750904|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154750905|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154750906|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
154750907|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154750908|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154750909|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750910|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
154750911|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750912|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750913|NCT01783054|Gemcitabine|gemcitabine|mesh-list
154750914|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154750915|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
154750916|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750917|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750918|NCT02725008|Dexamethasone|dexamethasone|mesh-list
154750919|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750920|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
154750921|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
154750922|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750923|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824071|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
154750924|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750925|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
154750926|NCT02725008|Hormones|hormones|mesh-ancestor
154750927|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750928|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750929|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750930|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
154750931|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154750932|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750933|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750934|NCT02471820|Dexamethasone|dexamethasone|mesh-list
154750935|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
154750936|NCT02471820|Lenalidomide|lenalidomide|mesh-list
154750937|NCT02471820|Doxorubicin|doxorubicin|mesh-list
154750938|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154750939|NCT02471820|BB 1101|bb 1101|mesh-list
154750940|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154750941|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
154750942|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
154750943|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750944|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750945|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750946|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
154750947|NCT02471820|Hormones|hormones|mesh-ancestor
154750948|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154750949|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154750950|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750951|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
154750952|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750953|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750954|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
154750955|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154750956|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154750957|NCT02471820|Growth Substances|growth substances|mesh-ancestor
154750958|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
154750959|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154750960|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154750961|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154750962|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
154750963|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154750964|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154750965|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154502891|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
154750966|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154750967|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750969|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750970|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750971|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154750972|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750973|NCT01783912|Nicotine|nicotine|mesh-list
154750974|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154750975|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
154750976|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154750977|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750978|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154750979|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154750980|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
154750981|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154750982|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750983|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
154750984|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154750985|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
154750986|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154750987|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154750988|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154750989|NCT01833988|Pancrelipase|pancrelipase|mesh-list
154750990|NCT01833988|Pancreatin|pancreatin|mesh-list
154750991|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154750992|NCT05363436|Oxycodone|oxycodone|mesh-list
154750993|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154750994|NCT05363436|Narcotics|narcotics|mesh-ancestor
154750995|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154750996|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154750997|NCT05363436|Analgesics|analgesics|mesh-ancestor
154750998|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
154750999|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751000|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154751001|NCT02474706|Imipenem|imipenem|mesh-list
154751002|NCT02474706|Cefoxitin|cefoxitin|mesh-list
154751003|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154751004|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751005|NCT01784770|Azithromycin|azithromycin|mesh-list
154751006|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154751007|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751008|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154751009|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154751010|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751011|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154751012|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751013|NCT04491786|Gabapentin|gabapentin|mesh-list
154751014|NCT04491786|Nefopam|nefopam|mesh-list
154751015|NCT04491786|Analgesics|analgesics|mesh-ancestor
154751016|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
154751017|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751018|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751019|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
154751020|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154751021|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154751022|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751023|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154751024|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154751025|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154751026|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751027|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751028|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
154751029|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154751030|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154751031|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154751032|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751033|NCT02470026|Yohimbine|yohimbine|mesh-list
154751034|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
154751035|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
154751036|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751037|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751038|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154751039|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154751040|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153365286|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
154751041|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
154751042|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751043|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751044|NCT02470026|Urological Agents|urological agents|mesh-ancestor
154751045|NCT01807949|Ivacaftor|ivacaftor|mesh-list
154751046|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154751047|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154751048|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751049|NCT02989558|Aspirin|aspirin|mesh-list
154751050|NCT02989558|Clopidogrel|clopidogrel|mesh-list
154751051|NCT02989558|Ticagrelor|ticagrelor|mesh-list
154751052|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154751053|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154751054|NCT02989558|Analgesics|analgesics|mesh-ancestor
154751055|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
154751056|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365401|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154751057|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751058|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751059|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751060|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154260781|NCT01193270|Vitamin E|vitamin e|mesh-list
154751061|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154751062|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751063|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154751064|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154751065|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751066|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
154751067|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154751068|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154751069|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154751070|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
154751071|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751072|NCT01806779|Bupropion|bupropion|mesh-list
154751073|NCT01806779|Nicotine|nicotine|mesh-list
154751074|NCT01806779|Varenicline|varenicline|mesh-list
154751075|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154751076|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
154751077|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751078|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751079|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154751080|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154751081|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
154751082|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751083|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751084|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154751085|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
154751086|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154751087|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154751088|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154751089|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154751090|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
154751091|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154751092|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153948762|NCT02496585|Hormones|hormones|mesh-ancestor
154751093|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751094|NCT01878526|Domperidone|domperidone|mesh-list
154751095|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
154751096|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
154751097|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751098|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950009|NCT04825093|Vitamin D|vitamin d|mesh-list
154751099|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154751100|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154751101|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
154751102|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751103|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751104|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154751105|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
153950366|NCT01144364|Rituximab|rituximab|mesh-list
154751106|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751107|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154751108|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
154751109|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751110|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
154751111|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154503040|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
154751112|NCT01806623|Fluconazole|fluconazole|mesh-list
154751113|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
154751114|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751115|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153440474|NCT00004039|Hormones|hormones|mesh-ancestor
154751116|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153440574|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
153951038|NCT00960804|Tanezumab|tanezumab|mesh-list
154751117|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410364|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
154751118|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951326|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751119|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154751120|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
154769381|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154751121|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751122|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751123|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154751124|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154751125|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154751126|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
154751127|NCT01806545|Coagulants|coagulants|mesh-ancestor
154751128|NCT01847014|Macitentan|macitentan|mesh-list
154260787|NCT01193270|Protective Agents|protective agents|mesh-ancestor
153441266|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154751129|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154751130|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154751131|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751132|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154751133|NCT01847638|Nepafenac|nepafenac|mesh-list
154751134|NCT01847638|Bromfenac|bromfenac|mesh-list
154751135|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154260789|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154751136|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154751137|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154751138|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154751139|NCT01847638|Analgesics|analgesics|mesh-ancestor
154751140|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
154260797|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154751141|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900038|NCT05610163|Irinotecan|irinotecan|mesh-list
154751142|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751143|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751144|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751145|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
154751146|NCT02474628|Calcium|calcium|mesh-list
154751147|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154751148|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751149|NCT02474628|Antacids|antacids|mesh-ancestor
154751150|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751151|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154751152|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
153410815|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
154751153|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153410834|NCT02975323|Carvedilol|carvedilol|mesh-list
154751154|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410850|NCT00003597|Carboplatin|carboplatin|mesh-list
153953566|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
154751155|NCT03099564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154769382|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153900528|NCT04428307|Artemisinins|artemisinins|mesh-list
154751156|NCT03099564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751157|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
154751158|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154751159|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154751160|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154751161|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154769383|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
154769384|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
153411058|NCT00003639|Idarubicin|idarubicin|mesh-list
154751162|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442097|NCT00004825|Insulin|insulin|mesh-list
153733431|NCT05148169|Sulforaphane|sulforaphane|mesh-list
153900785|NCT03642665|Hormones|hormones|mesh-ancestor
154751163|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
154751164|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751165|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751166|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154751167|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751168|NCT05328310|Nebivolol|nebivolol|mesh-list
154751169|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154751170|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
154751171|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154751172|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154751173|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154751174|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
154751175|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751176|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751177|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751178|NCT01797484|Ranolazine|ranolazine|mesh-list
154751179|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154751180|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154769385|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751181|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751182|NCT01798264|Exenatide|exenatide|mesh-list
154751183|NCT01798264|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154751184|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154260821|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
154260826|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
154751185|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751186|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154751187|NCT01798264|Incretins|incretins|mesh-ancestor
154751188|NCT01798264|Hormones|hormones|mesh-ancestor
154751189|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751190|NCT05326984|Metformin|metformin|mesh-list
154751191|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154751192|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751193|NCT01800838|Silicon|silicon|mesh-list
154751194|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
154751195|NCT01800838|Trace Elements|trace elements|mesh-ancestor
154751196|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
154751197|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751198|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
154751199|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154751200|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154751201|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751202|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
154751203|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154751204|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154751205|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
154751206|NCT01781975|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153956185|NCT00860470|Iron|iron|mesh-list
154751207|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154751208|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751209|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751210|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751211|NCT01855360|Doxycycline|doxycycline|mesh-list
154751212|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154751213|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154751214|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751215|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
154751216|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154751217|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154751218|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
153901718|NCT05888350|Beclomethasone|beclomethasone|mesh-list
154751219|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154751220|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154751221|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
154751222|NCT04351126|Bromocriptine|bromocriptine|mesh-list
154751223|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154751224|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154751225|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
154769386|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154751226|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751227|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751228|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
154751229|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
153901849|NCT05444777|Ketamine|ketamine|mesh-list
153957354|NCT04260828|Aspirin|aspirin|mesh-list
154751230|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443338|NCT02006706|Methotrexate|methotrexate|mesh-list
154751231|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751232|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751233|NCT01804673|Fentanyl|fentanyl|mesh-list
154751234|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154751235|NCT01804673|Narcotics|narcotics|mesh-ancestor
154751236|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957750|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154751237|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751238|NCT01804673|Analgesics|analgesics|mesh-ancestor
154751239|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
154751240|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751241|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154751242|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154751243|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
154751244|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
154751245|NCT01856530|Oxytocin|oxytocin|mesh-list
154751246|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
154751247|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154751248|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751249|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
154751250|NCT05302336|Docetaxel|docetaxel|mesh-list
154751251|NCT05302336|Doxorubicin|doxorubicin|mesh-list
154751252|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154751253|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154751254|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
154751255|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751256|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751257|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154751258|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
154751259|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503190|NCT00391209|Insulin|insulin|mesh-list
154751260|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751261|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154751262|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154751263|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154751264|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154751265|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154751266|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154751267|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154751268|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751270|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154751271|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154751272|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751273|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751274|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154751275|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
154751276|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
154751277|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751278|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751279|NCT01857232|Dexamethasone|dexamethasone|mesh-list
154751280|NCT01857232|Ondansetron|ondansetron|mesh-list
154751281|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
154751282|NCT01857232|Aprepitant|aprepitant|mesh-list
154751283|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751284|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
154751285|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
154260864|NCT01189448|Spiramycin|spiramycin|mesh-list
154751286|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751287|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751288|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154751289|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
154751290|NCT01857232|Hormones|hormones|mesh-ancestor
154751291|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751292|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154751293|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751294|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
154751295|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
154751296|NCT01857232|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154751297|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154751298|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
154751299|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751300|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751301|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154751302|NCT01766128|Zonisamide|zonisamide|mesh-list
154751303|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
154751304|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154751305|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154751306|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751307|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154751308|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751309|NCT02859558|Tenofovir|tenofovir|mesh-list
154751310|NCT02859558|Emtricitabine|emtricitabine|mesh-list
154751311|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154751312|NCT02859558|Cobicistat|cobicistat|mesh-list
154751313|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154751314|NCT02859558|Elvitegravir|elvitegravir|mesh-list
154751315|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154751316|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
154751317|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751318|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154751319|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154751320|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751321|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751322|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154751323|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154751324|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154751325|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154751326|NCT01860586|Bevacizumab|bevacizumab|mesh-list
154751327|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154751328|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751329|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154751330|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154751331|NCT01860586|Growth Substances|growth substances|mesh-ancestor
154751332|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751333|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
154751334|NCT00705432|Ribavirin|ribavirin|mesh-list
154751335|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154751336|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
154751337|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751338|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
154751339|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751340|NCT00704964|Ribavirin|ribavirin|mesh-list
154751341|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154751342|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
154751343|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
154751344|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751345|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
154751346|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751347|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
154260941|NCT03850886|Niacin|niacin|mesh-list
154751348|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751349|NCT00704808|Temozolomide|temozolomide|mesh-list
154751350|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154751351|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
154751352|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751353|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751354|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154751355|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
154751356|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751357|NCT01862536|Tadalafil|tadalafil|mesh-list
154751358|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
154751359|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154751360|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154751361|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751362|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751363|NCT01862536|Urological Agents|urological agents|mesh-ancestor
154751364|NCT01862614|Epinephrine|epinephrine|mesh-list
154751365|NCT01862614|Racepinephrine|racepinephrine|mesh-list
154751366|NCT01862614|Carticaine|carticaine|mesh-list
154751367|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
154751368|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154751369|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154751370|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
154751371|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751372|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751373|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751374|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154751375|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154751376|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
154751377|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751378|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154751379|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
154751380|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
154751381|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
154751382|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154751383|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
154751384|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
154751385|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751386|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
154751387|NCT02470650|Ritonavir|ritonavir|mesh-list
154751388|NCT02470650|Darunavir|darunavir|mesh-list
154751389|NCT02470650|Tenofovir|tenofovir|mesh-list
154751390|NCT02470650|Lamivudine|lamivudine|mesh-list
154751391|NCT02470650|Emtricitabine|emtricitabine|mesh-list
154751392|NCT02470650|Abacavir|abacavir|mesh-list
154751393|NCT02470650|Cobicistat|cobicistat|mesh-list
154751394|NCT02470650|Rilpivirine|rilpivirine|mesh-list
154751395|NCT02470650|Elvitegravir|elvitegravir|mesh-list
154751396|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154751397|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154751398|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
154751399|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751400|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751401|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154751402|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154751403|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
154751404|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751405|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154751406|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154751407|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154751408|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154751409|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154751410|NCT01866592|Adalimumab|adalimumab|mesh-list
154751411|NCT01866592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154751412|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751414|NCT01375608|Decitabine|decitabine|mesh-list
154751415|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154751416|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
154751417|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751418|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751419|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751420|NCT01868776|Lidocaine|lidocaine|mesh-list
154751421|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
154751422|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
154751423|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751424|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751425|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
154751426|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751427|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154751428|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154261004|NCT02532413|Entecavir|entecavir|mesh-list
154751429|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154751430|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154751431|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751432|NCT00704418|Bromfenac|bromfenac|mesh-list
154751433|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154751434|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154751435|NCT00704418|Analgesics|analgesics|mesh-ancestor
154751436|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
154751437|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751438|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751439|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751440|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751441|NCT01869634|Ritonavir|ritonavir|mesh-list
154751442|NCT01869634|Darunavir|darunavir|mesh-list
154751443|NCT01869634|Emtricitabine|emtricitabine|mesh-list
154751444|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154751445|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154751446|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
154751447|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751448|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751449|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154751450|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154751451|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
154751452|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751453|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154751454|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154751455|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154751456|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154751457|NCT02047578|Busulfan|busulfan|mesh-list
154751458|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
154751459|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751460|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154751461|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
154751462|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751463|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154751464|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751465|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154751466|NCT01874392|Insulin|insulin|mesh-list
154751467|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154751468|NCT01874392|Pancrelipase|pancrelipase|mesh-list
154751469|NCT01874392|Pancreatin|pancreatin|mesh-list
154751470|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154751471|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751472|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154751473|NCT00576654|Irinotecan|irinotecan|mesh-list
154751474|NCT00576654|Camptothecin|camptothecin|mesh-list
154751475|NCT00576654|Veliparib|veliparib|mesh-list
154751476|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154751477|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154751478|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751479|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751480|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751481|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154751482|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154751483|NCT03314064|Dolutegravir|dolutegravir|mesh-list
154751484|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154751485|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154751486|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751487|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751488|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154751489|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154261074|NCT00333359|Gabapentin|gabapentin|mesh-list
154751490|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
154751491|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751492|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
154751493|NCT00552058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154751494|NCT00552058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751495|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154751496|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
154751497|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751498|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751499|NCT02473302|Tocopherols|tocopherols|mesh-list
154751500|NCT02473302|Vitamin E|vitamin e|mesh-list
154751501|NCT02473302|Tocotrienols|tocotrienols|mesh-list
154751502|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
154751503|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
154751504|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751505|NCT02473302|Protective Agents|protective agents|mesh-ancestor
154751506|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751507|NCT02473302|Vitamins|vitamins|mesh-ancestor
154751508|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
154751509|NCT05747326|Capecitabine|capecitabine|mesh-list
154751510|NCT05747326|Vinorelbine|vinorelbine|mesh-list
154751511|NCT05747326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154751512|NCT05747326|Antimetabolites|antimetabolites|mesh-ancestor
154751513|NCT05747326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751514|NCT05747326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751515|NCT05747326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154751516|NCT05747326|Tubulin Modulators|tubulin modulators|mesh-ancestor
154751517|NCT05747326|Antimitotic Agents|antimitotic agents|mesh-ancestor
154751518|NCT05747326|Mitosis Modulators|mitosis modulators|mesh-ancestor
154751519|NCT03108300|Doxorubicin|doxorubicin|mesh-list
154751520|NCT03108300|Propranolol|propranolol|mesh-list
154751521|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154751522|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751523|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154751524|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154751525|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751526|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751527|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154751528|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154751529|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
154751530|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751531|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751532|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154751533|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154751534|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
154751535|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
154751536|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154751537|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751538|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154751539|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751540|NCT02989012|Oseltamivir|oseltamivir|mesh-list
154751541|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
154751542|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751543|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751544|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751545|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154751546|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154751547|NCT03832894|Estradiol|estradiol|mesh-list
154751548|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154751549|NCT03832894|Progesterone|progesterone|mesh-list
154751550|NCT03832894|Estrogens|estrogens|mesh-ancestor
154751551|NCT03832894|Hormones|hormones|mesh-ancestor
154751552|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751553|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751554|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154751555|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
154751556|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154751557|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154751558|NCT03832894|Progestins|progestins|mesh-ancestor
154751559|NCT02989324|Misoprostol|misoprostol|mesh-list
154751560|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154751561|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
154751562|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154751563|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751564|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154751565|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154751566|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
154751567|NCT00550732|Posaconazole|posaconazole|mesh-list
154751568|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
154751569|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751570|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154751571|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154751572|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154261144|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
154751573|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154751574|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154751575|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751576|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751577|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154751578|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
154751579|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751580|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751581|NCT03311022|Nefopam|nefopam|mesh-list
154751582|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154751583|NCT03311022|Analgesics|analgesics|mesh-ancestor
154751584|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
154751585|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751586|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751587|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
154751588|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154751589|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751590|NCT00559936|Bevacizumab|bevacizumab|mesh-list
154751591|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154751592|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751593|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154751594|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154751595|NCT00559936|Growth Substances|growth substances|mesh-ancestor
154751596|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751597|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
154751598|NCT05353192|Hormones|hormones|mesh-list
154751599|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751600|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751601|NCT03310242|Vitamin D|vitamin d|mesh-list
154751602|NCT03310242|Vitamins|vitamins|mesh-ancestor
154751603|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
154751604|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751605|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154751606|NCT00557128|Lisinopril|lisinopril|mesh-list
154751607|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154751608|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
154751609|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751610|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751611|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154751612|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154751613|NCT00557128|Protective Agents|protective agents|mesh-ancestor
154751614|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751615|NCT03312582|Metformin|metformin|mesh-list
154751616|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154751617|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751618|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
154751619|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154751620|NCT04350580|Antibodies|antibodies|mesh-list
154751621|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
154751622|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751623|NCT00558064|Amlodipine|amlodipine|mesh-list
154751624|NCT00558064|Telmisartan|telmisartan|mesh-list
154751625|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154751626|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154751627|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154751628|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154751629|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751630|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154751631|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751632|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
154751633|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154751634|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154751635|NCT03312426|Linrodostat|linrodostat|mesh-list
154751636|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751637|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751638|NCT03309618|Valsartan|valsartan|mesh-list
154751639|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154751640|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154751641|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154751642|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751643|NCT03303924|Sulbactam|sulbactam|mesh-list
154751644|NCT03303924|Durlobactam|durlobactam|mesh-list
154751645|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154751646|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751647|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154751648|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751649|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751650|NCT00557830|Sorafenib|sorafenib|mesh-list
154751651|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751652|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154751653|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751654|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751655|NCT00557440|Fluticasone|fluticasone|mesh-list
154751656|NCT00557440|Xhance|xhance|mesh-list
154751657|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
154751658|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154751659|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154751660|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751661|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154751662|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
154751663|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751664|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751665|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154751666|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
154751667|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
154751668|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154751669|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154751670|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154751671|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154751672|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
154751673|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751674|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751675|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
154751676|NCT00557440|Hormones|hormones|mesh-ancestor
154751677|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751678|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
154751679|NCT03311178|Dobutamine|dobutamine|mesh-list
154751680|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154751681|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
154751682|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
154751683|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751684|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751685|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154751686|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154751687|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154751688|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
154751689|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751690|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751691|NCT03311178|Protective Agents|protective agents|mesh-ancestor
154751692|NCT02469012|Ribavirin|ribavirin|mesh-list
154751693|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
154751694|NCT02469012|Ledipasvir|ledipasvir|mesh-list
154751695|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
154751696|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751697|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
154751698|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751699|NCT02468856|Modafinil|modafinil|mesh-list
154751700|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154751701|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751702|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154751703|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154751704|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154751705|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751706|NCT03303378|Melatonin|melatonin|mesh-list
154751707|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
154751708|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751709|NCT03303378|Protective Agents|protective agents|mesh-ancestor
154503639|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751710|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751711|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751712|NCT04491474|Lidocaine|lidocaine|mesh-list
154751713|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
154751714|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
154751715|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751716|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751717|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
154751718|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751719|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154751720|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154751721|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154751722|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154751723|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751724|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
154751725|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154751726|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751727|NCT03308604|Cisplatin|cisplatin|mesh-list
154751728|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751729|NCT00553306|Aldesleukin|aldesleukin|mesh-list
154751730|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
154751731|NCT00553306|Interleukin-2|interleukin-2|mesh-list
154751732|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154751733|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
154751734|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751735|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751736|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154751737|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
154751738|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751739|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751740|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154751741|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154751742|NCT00553306|Analgesics|analgesics|mesh-ancestor
154751743|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
154751744|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751745|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154751746|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154751747|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
154751748|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751749|NCT02722044|Adalimumab|adalimumab|mesh-list
153958679|NCT04309773|Bezafibrate|bezafibrate|mesh-list
154751750|NCT02722044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154751751|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751752|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751753|NCT05728008|Ustekinumab|ustekinumab|mesh-list
154751754|NCT05728008|Tofacitinib|tofacitinib|mesh-list
154751755|NCT05728008|Dermatologic Agents|dermatologic agents|mesh-ancestor
154751756|NCT05728008|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154751757|NCT05728008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154751758|NCT05728008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751759|NCT05728008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751760|NCT02988700|Bupivacaine|bupivacaine|mesh-list
154751761|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
154751762|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
154751763|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751764|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751765|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
154751766|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751767|NCT03308214|Imipenem|imipenem|mesh-list
154751768|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154751769|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154751770|NCT03308136|Lidocaine|lidocaine|mesh-list
154751771|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
154751772|NCT03308136|Anesthetics|anesthetics|mesh-list
154751773|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751774|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751775|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
154751776|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751777|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154751778|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154751779|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154751780|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154751781|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751782|NCT02466984|Metoclopramide|metoclopramide|mesh-list
154751783|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
154751784|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
154751785|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751786|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751787|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154751788|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154751789|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154751790|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
154751791|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751792|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751793|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
154751794|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154751795|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751796|NCT03307902|Imiquimod|imiquimod|mesh-list
154751797|NCT03307902|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154751798|NCT03307902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751799|NCT03307902|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154751800|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
154751801|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751802|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154751803|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751804|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
154751805|NCT03302364|Risperidone|risperidone|mesh-list
154751806|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154751807|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
154751808|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751809|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751810|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751811|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154751812|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154751813|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751814|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154751815|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154751816|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
154751817|NCT02467920|Exenatide|exenatide|mesh-list
154751818|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154751819|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751820|NCT02467920|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154751821|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154751822|NCT02467920|Incretins|incretins|mesh-ancestor
154751823|NCT02467920|Hormones|hormones|mesh-ancestor
154751824|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751825|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
154751826|NCT03307590|Bupivacaine|bupivacaine|mesh-list
154751827|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
154751828|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
154751829|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751830|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751831|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
154751832|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751833|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154751834|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154751835|NCT03307590|Analgesics|analgesics|mesh-ancestor
154261395|NCT01204190|Hormones|hormones|mesh-ancestor
154751836|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154751837|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154751838|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154751839|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
154751840|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154751841|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751842|NCT03302208|Pregabalin|pregabalin|mesh-list
154751843|NCT03302208|Analgesics|analgesics|mesh-ancestor
154751844|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
154751845|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751846|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751847|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
154751848|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154751849|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154751850|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751851|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154751852|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154751853|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154751854|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751855|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154751856|NCT03307512|Insulin|insulin|mesh-list
154751857|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154503792|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
154751858|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
154751859|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154751860|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751861|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154751862|NCT02466828|Hematinics|hematinics|mesh-ancestor
154751863|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154751864|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154751865|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154751866|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
154751867|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751868|NCT00553462|Paclitaxel|paclitaxel|mesh-list
154751869|NCT00553462|Carboplatin|carboplatin|mesh-list
154751870|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154751871|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154751872|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154751873|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751874|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
154751875|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
154751876|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
154261436|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751877|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751878|NCT00553462|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154751879|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154751880|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751881|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154751882|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
154751883|NCT03301974|Coagulants|coagulants|mesh-ancestor
154751884|NCT03306732|Thiamine|thiamine|mesh-list
154751885|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
154751886|NCT03306732|Vitamins|vitamins|mesh-ancestor
154751887|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
154751888|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751889|NCT00553150|Everolimus|everolimus|mesh-list
154751890|NCT00553150|Temozolomide|temozolomide|mesh-list
154751891|NCT00553150|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154751892|NCT00553150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154751893|NCT00553150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751894|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751895|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154751896|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
154751897|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751898|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751899|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154751900|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
154751901|NCT04630834|Acetaminophen|acetaminophen|mesh-list
154751902|NCT04630834|Ibuprofen|ibuprofen|mesh-list
154751903|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154751904|NCT04630834|Analgesics|analgesics|mesh-ancestor
154751905|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
154751906|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751907|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751908|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
154751909|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154751910|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154751911|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751912|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154751913|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751914|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751915|NCT03301350|Paclitaxel|paclitaxel|mesh-list
154751916|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
154751917|NCT03301350|Carboplatin|carboplatin|mesh-list
154751918|NCT03301350|Doxorubicin|doxorubicin|mesh-list
154751919|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154751920|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751921|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
154751922|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
154751923|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
154751924|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751925|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154751926|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
154751927|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751928|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154751929|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154751930|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
154751931|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154751932|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154751933|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154751934|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154751935|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751936|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
154751937|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154751938|NCT02722278|Testosterone|testosterone|mesh-list
154751939|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
154751940|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
154751941|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154751942|NCT02722278|Androgens|androgens|mesh-ancestor
154751943|NCT02722278|Hormones|hormones|mesh-ancestor
154751944|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751945|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751946|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154751947|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751948|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
154751949|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154751950|NCT03300960|Ganirelix|ganirelix|mesh-list
154751951|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
154751952|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751953|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261515|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
154751954|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154751955|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
154751956|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154751957|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154751958|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154751959|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154751960|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751961|NCT02485444|Oxytocin|oxytocin|mesh-list
154751962|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
154751963|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154751964|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751965|NCT04490694|Lenvatinib|lenvatinib|mesh-list
154751966|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751967|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154751968|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751969|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751970|NCT02359474|Trabectedin|trabectedin|mesh-list
154751971|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154751972|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
154751973|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751974|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154751975|NCT02467686|Tamoxifen|tamoxifen|mesh-list
154751976|NCT02467686|Exemestane|exemestane|mesh-list
154751977|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154751978|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154751979|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
154751980|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154751981|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751982|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154751983|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261556|NCT03833570|Melatonin|melatonin|mesh-list
154751984|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154751985|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154751986|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154751987|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154751988|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154751989|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154751990|NCT05707962|Magnesium Sulfate|magnesium sulfate|mesh-list
154751991|NCT05707962|Neuroprotective Agents|neuroprotective agents|mesh-list
154751992|NCT05707962|Analgesics|analgesics|mesh-ancestor
154751993|NCT05707962|Sensory System Agents|sensory system agents|mesh-ancestor
154751994|NCT05707962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154751995|NCT05707962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154751996|NCT05707962|Anesthetics|anesthetics|mesh-ancestor
154751997|NCT05707962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154751998|NCT05707962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154751999|NCT05707962|Anticonvulsants|anticonvulsants|mesh-ancestor
154752000|NCT05707962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154752001|NCT05707962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154752002|NCT05707962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752003|NCT05707962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154752004|NCT05707962|Tocolytic Agents|tocolytic agents|mesh-ancestor
154752005|NCT05707962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154752006|NCT05707962|Protective Agents|protective agents|mesh-ancestor
154752007|NCT04058470|Prednisone|prednisone|mesh-list
154752008|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
154752009|NCT04058470|Rituximab|rituximab|mesh-list
154752010|NCT04058470|Doxorubicin|doxorubicin|mesh-list
154752011|NCT04058470|Vincristine|vincristine|mesh-list
154752012|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154752013|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
154752014|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752015|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752016|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154752017|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
154752018|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752019|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752020|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154752021|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154752022|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154752023|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154752024|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154752025|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752026|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752027|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
154752028|NCT04058470|Hormones|hormones|mesh-ancestor
154752029|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752030|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154752031|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154752032|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154752033|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154752034|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154752035|NCT02720484|Nivolumab|nivolumab|mesh-list
154752036|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154752037|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752038|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154752039|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752040|NCT05438550|Amoxicillin|amoxicillin|mesh-list
154752041|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154752042|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752043|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154752044|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
154752045|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154752046|NCT03299712|Protective Agents|protective agents|mesh-ancestor
154752047|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752048|NCT02466438|Tazobactam|tazobactam|mesh-list
154752049|NCT02466438|Piperacillin|piperacillin|mesh-list
154752050|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154752051|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154752052|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752053|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154752054|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752055|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752056|NCT05587062|Aflibercept|aflibercept|mesh-list
154752057|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154752058|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154752059|NCT05587062|Growth Substances|growth substances|mesh-ancestor
154752060|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752061|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
154752062|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752063|NCT02463006|Methamphetamine|methamphetamine|mesh-list
154752064|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154752065|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752066|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
154752067|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
154752068|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752069|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
154752070|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752071|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752072|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
154752073|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154752074|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154752075|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154752076|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154752077|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154752078|NCT02466204|Hormones|hormones|mesh-ancestor
154752079|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752080|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752081|NCT02715804|Paclitaxel|paclitaxel|mesh-list
154752082|NCT02715804|Gemcitabine|gemcitabine|mesh-list
154752083|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154752084|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752085|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
154752086|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
154752087|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
154752088|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752089|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154752090|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
154752092|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154752093|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752094|NCT02462304|Bevacizumab|bevacizumab|mesh-list
154752095|NCT02462304|Ranibizumab|ranibizumab|mesh-list
154752096|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154752097|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752098|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154752099|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154752100|NCT02462304|Growth Substances|growth substances|mesh-ancestor
154752101|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752102|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
154752103|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
154752104|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154752105|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
154752106|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154752107|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752108|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154752109|NCT04645212|Aflibercept|aflibercept|mesh-list
154752110|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154752111|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154752112|NCT04645212|Growth Substances|growth substances|mesh-ancestor
154752113|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752114|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
154752115|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752116|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
154752117|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
154752118|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154752119|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154752120|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752121|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752122|NCT04489446|Urological Agents|urological agents|mesh-ancestor
154752123|NCT02717754|Oseltamivir|oseltamivir|mesh-list
154752124|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
154752125|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752126|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752127|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752128|NCT02717130|Aripiprazole|aripiprazole|mesh-list
154752129|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
154752130|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154752131|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154752132|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154752133|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752134|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752135|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
154752136|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
154752137|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752138|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752139|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154752140|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154752141|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
154752142|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154752143|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154752144|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154752145|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154752146|NCT02256696|Rifampin|rifampin|mesh-list
154752147|NCT02256696|Rifabutin|rifabutin|mesh-list
154752148|NCT02256696|Isoniazid|isoniazid|mesh-list
154752149|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
154752150|NCT02256696|Ethambutol|ethambutol|mesh-list
154752151|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154752152|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
154752153|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154752154|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752155|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
154752156|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154752157|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752158|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752159|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154261759|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
154752160|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154752161|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154752162|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154752163|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154752164|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154752165|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154752166|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154752167|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
154752168|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154752169|NCT01773473|Insulin|insulin|mesh-list
154752170|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154752171|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
154752172|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154752173|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752174|NCT01779869|Regadenoson|regadenoson|mesh-list
154752175|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154752176|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154752177|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
154752178|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
154752179|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752180|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752181|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752182|NCT01772537|Propofol|propofol|mesh-list
154752183|NCT01772537|Isoflurane|isoflurane|mesh-list
154752184|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154752185|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752186|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752187|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154752188|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
154752189|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
154752190|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154752191|NCT01772147|Fluticasone|fluticasone|mesh-list
154752193|NCT01772147|Bromides|bromides|mesh-list
154752194|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154752195|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752196|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154752197|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
154752198|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752199|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752200|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154752201|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
154752202|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
154752203|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154752204|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154752205|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154752206|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154752207|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
154752208|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752209|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752210|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
154752211|NCT01606787|Mannitol|mannitol|mesh-list
154752212|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154752213|NCT01606787|Diuretics|diuretics|mesh-ancestor
154752214|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
154752215|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752216|NCT01777997|Tenofovir|tenofovir|mesh-list
154752217|NCT01777997|Emtricitabine|emtricitabine|mesh-list
154752218|NCT01777997|Rilpivirine|rilpivirine|mesh-list
154752219|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
154752220|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752221|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154752222|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154752223|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752224|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752225|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154752226|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154752227|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154752228|NCT01770353|Hematinics|hematinics|mesh-ancestor
154752229|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154752230|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154752231|NCT01777763|Posaconazole|posaconazole|mesh-list
154752232|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
154752233|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752234|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154752235|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154752236|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154752237|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154752238|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154752239|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752240|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752241|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154752242|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
154752243|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752244|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752245|NCT01769339|Miconazole|miconazole|mesh-list
154752246|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
154752247|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752248|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
154752249|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752250|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154752251|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154752252|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752253|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752254|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154752255|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
154752256|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752257|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752258|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154752259|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154752260|NCT01777139|Ezogabine|ezogabine|mesh-list
154752261|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
154752262|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154752263|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752264|NCT01768637|Aspirin|aspirin|mesh-list
154752265|NCT01768637|Clopidogrel|clopidogrel|mesh-list
154752266|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154752267|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154752268|NCT01768637|Analgesics|analgesics|mesh-ancestor
154752269|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
154752270|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752271|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752272|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752273|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752274|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154752275|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154752276|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752277|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154752278|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154752279|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752280|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
154752281|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154752282|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154752283|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154752284|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
154752285|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752286|NCT01768559|Insulin|insulin|mesh-list
154752287|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154752288|NCT01768559|Metformin|metformin|mesh-list
154752289|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
154752290|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
154752291|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154752292|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752293|NCT00983619|Rituximab|rituximab|mesh-list
154752294|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154752295|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752296|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
154752297|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752298|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752299|NCT05608785|Capecitabine|capecitabine|mesh-list
154752300|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
154752301|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154752302|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
154752303|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752304|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504243|NCT02442362|Paclitaxel|paclitaxel|mesh-list
154752305|NCT01775501|Leucovorin|leucovorin|mesh-list
154752306|NCT01775501|Fluorouracil|fluorouracil|mesh-list
154752307|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
154752308|NCT01775501|Sorafenib|sorafenib|mesh-list
154752309|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
154752310|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752311|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154752312|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752313|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154752314|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
154752315|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752316|NCT01775501|Antidotes|antidotes|mesh-ancestor
154752317|NCT01775501|Protective Agents|protective agents|mesh-ancestor
154752318|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
154752319|NCT01775501|Vitamins|vitamins|mesh-ancestor
154752320|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
154752321|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154752322|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752323|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
154752324|NCT04346667|Chloroquine|chloroquine|mesh-list
154752325|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
154752326|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154752327|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154752328|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752329|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752330|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752331|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752332|NCT04346667|Amebicides|amebicides|mesh-ancestor
154752333|NCT01775189|Naltrexone|naltrexone|mesh-list
154752334|NCT01775189|Oxycodone|oxycodone|mesh-list
154752335|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154752336|NCT01775189|Narcotics|narcotics|mesh-ancestor
154752337|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752338|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752339|NCT01775189|Analgesics|analgesics|mesh-ancestor
154752340|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
154752341|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752342|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154752343|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154752344|NCT01881412|Fluticasone|fluticasone|mesh-list
154752345|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752346|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154752347|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
154752348|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752349|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752350|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154752351|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
154752352|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
154752353|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154752354|NCT03832816|Dronabinol|dronabinol|mesh-list
154752355|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
154752356|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752357|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154752358|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154752359|NCT03832816|Analgesics|analgesics|mesh-ancestor
154752360|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
154752361|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752362|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154752363|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154752364|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752365|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752366|NCT03832816|Hormones|hormones|mesh-ancestor
154752367|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752368|NCT04231084|Epoprostenol|epoprostenol|mesh-list
154752369|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
154752370|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
154752371|NCT04231084|Tezosentan|tezosentan|mesh-list
154752372|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154752373|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
154261941|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
154752374|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752375|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752376|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154752377|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
154752378|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154752379|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
154752380|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752381|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752382|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154752383|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
154752384|NCT04231084|Protective Agents|protective agents|mesh-ancestor
154752385|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154752386|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154752388|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
154752389|NCT01884844|Vitamins|vitamins|mesh-ancestor
154752390|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
154752391|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752392|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154752393|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154752394|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154752395|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752396|NCT04127721|Methotrexate|methotrexate|mesh-list
154752397|NCT04127721|Fludarabine|fludarabine|mesh-list
154752398|NCT04127721|Busulfan|busulfan|mesh-list
154752399|NCT04127721|Tacrolimus|tacrolimus|mesh-list
154752400|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154752401|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
154752402|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154752403|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752404|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154752405|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
154752406|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752407|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752408|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
154752409|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752410|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154752411|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154752412|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
154752413|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752414|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154752415|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154752416|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
154752417|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154752418|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154752419|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
154752420|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154752421|NCT04123743|Protective Agents|protective agents|mesh-ancestor
154752422|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752423|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
154752424|NCT02996721|Vitamin D|vitamin d|mesh-list
154752425|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
154752426|NCT02996721|Vitamins|vitamins|mesh-ancestor
154752427|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
154752428|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752429|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154752430|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154752431|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
154752432|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752433|NCT04126941|Calcium|calcium|mesh-list
154752434|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154752435|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752436|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
154752437|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
154752438|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154752439|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154752440|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752441|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752442|NCT04122105|Urological Agents|urological agents|mesh-ancestor
154752443|NCT04127019|Paclitaxel|paclitaxel|mesh-list
154752444|NCT04127019|Docetaxel|docetaxel|mesh-list
154752445|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
154752446|NCT04127019|Fluorouracil|fluorouracil|mesh-list
154752447|NCT04127019|Epirubicin|epirubicin|mesh-list
154752448|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154752449|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752450|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
154752451|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
154752452|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
154752453|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752454|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154752455|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
154752456|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752457|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752458|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154752460|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154752461|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
154752462|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154008938|NCT02821520|Verteporfin|verteporfin|mesh-list
154752463|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154752464|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154752465|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154752466|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752467|NCT02076646|Interleukin-2|interleukin-2|mesh-list
154752468|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752469|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154752470|NCT02076646|Analgesics|analgesics|mesh-ancestor
154752471|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
154752472|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752473|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752474|NCT04121091|Pramipexole|pramipexole|mesh-list
154752475|NCT04121091|Dexpramipexole|dexpramipexole|mesh-list
154752476|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
154752477|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752478|NCT04121091|Protective Agents|protective agents|mesh-ancestor
154752479|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752480|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154752481|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154752482|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
154752483|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
154752484|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752485|NCT03283605|Durvalumab|durvalumab|mesh-list
154752486|NCT03283605|Tremelimumab|tremelimumab|mesh-list
154752487|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154752488|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752489|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
154752490|NCT01896544|Vitamin D|vitamin d|mesh-list
154752491|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154752492|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752493|NCT01896544|Vitamins|vitamins|mesh-ancestor
154752494|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
154752495|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154752496|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
154752497|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
154752498|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154752499|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752500|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154752501|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752502|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154752503|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154752504|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752505|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752506|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154752507|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154752508|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752509|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
154752510|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752511|NCT01932112|Adenosine|adenosine|mesh-list
154752512|NCT01932112|Analgesics|analgesics|mesh-ancestor
154752513|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
154752514|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752515|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752516|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154752517|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
154752518|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154752519|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
154752520|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
154752521|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752522|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752523|NCT01897402|Vaccines|vaccines|mesh-list
154752524|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
154752525|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752526|NCT01897792|Vitamins|vitamins|mesh-list
154752527|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
154752528|NCT01897792|Vitamin E|vitamin e|mesh-list
154752529|NCT01897792|Tocopherols|tocopherols|mesh-list
154752530|NCT01897792|Tocotrienols|tocotrienols|mesh-list
154752531|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
154752532|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
154752533|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752534|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
154752535|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752536|NCT01897792|Protective Agents|protective agents|mesh-ancestor
154752537|NCT01933984|Fluticasone|fluticasone|mesh-list
154752538|NCT01933984|Fenoterol|fenoterol|mesh-list
154752539|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154752540|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
154752541|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752542|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
154752543|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752544|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752545|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154752546|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
154752547|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
154752548|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154752549|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154752550|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154752551|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154752552|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
154752553|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752554|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752555|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
154752556|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
154752557|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154752558|NCT04126083|Lofexidine|lofexidine|mesh-list
154752559|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154752560|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154752561|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752562|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
154752563|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752564|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154752565|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154752566|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154752567|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154752568|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752569|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752570|NCT01935622|Doxycycline|doxycycline|mesh-list
154752571|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154752572|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752573|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
154752574|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154752575|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154752576|NCT03010917|Ethanol|ethanol|mesh-list
154752577|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154752578|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752579|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752580|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752581|NCT02979561|Warfarin|warfarin|mesh-list
154752582|NCT02979561|Dabigatran|dabigatran|mesh-list
154752583|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
154752584|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
154752585|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154752586|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
154752587|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752588|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752589|NCT01937026|Probenecid|probenecid|mesh-list
154752590|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
154752591|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
154752592|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752593|NCT01937260|Brodalumab|brodalumab|mesh-list
154752594|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
154752595|NCT01902004|Memantine|memantine|mesh-list
154752596|NCT01902004|Escitalopram|escitalopram|mesh-list
154752597|NCT01902004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154752598|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154752599|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154752600|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752601|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752602|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
154752603|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752604|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154752605|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154752606|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
154752607|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154752608|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154752609|NCT01938040|Ibuprofen|ibuprofen|mesh-list
154752610|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154752611|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154752612|NCT01938040|Analgesics|analgesics|mesh-ancestor
154752613|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
154752614|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752615|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752616|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752617|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752618|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154752619|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752620|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752621|NCT03829839|Lorazepam|lorazepam|mesh-list
154752622|NCT03829839|Oxytocin|oxytocin|mesh-list
154752623|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
154752624|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154752625|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752626|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
154752627|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
154752628|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
154752629|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752630|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154752631|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154752632|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752633|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154752634|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154752635|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154752636|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
154752637|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
154752638|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752639|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752640|NCT01938664|Candesartan|candesartan|mesh-list
154752641|NCT01938664|Candesartan cilexetil|candesartan cilexetil|mesh-list
154752642|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154752643|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154752644|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154752645|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752646|NCT03829917|Paromomycin|paromomycin|mesh-list
154752647|NCT03829917|Miltefosine|miltefosine|mesh-list
154752648|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154752649|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752650|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154752651|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154752652|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
154752653|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752654|NCT02284126|Vancomycin|vancomycin|mesh-list
154752655|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154752656|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752657|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
154752658|NCT01736579|Antibodies|antibodies|mesh-list
154752659|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
154752660|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154752661|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154752662|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
154752663|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752664|NCT04124913|Progesterone|progesterone|mesh-list
154752665|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
154752666|NCT04124913|Progestins|progestins|mesh-ancestor
154752667|NCT04124913|Hormones|hormones|mesh-ancestor
154752668|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752669|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752670|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154752671|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154262218|NCT01203488|Vitamin A|vitamin a|mesh-list
154752672|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154752673|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
154752674|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752675|NCT02987920|Acetaminophen|acetaminophen|mesh-list
154752676|NCT02987920|Celecoxib|celecoxib|mesh-list
154752677|NCT02987920|Ketorolac|ketorolac|mesh-list
154752678|NCT02987920|Oxycodone|oxycodone|mesh-list
154752679|NCT02987920|Gabapentin|gabapentin|mesh-list
154752680|NCT02987920|Hydromorphone|hydromorphone|mesh-list
154752681|NCT02987920|Levomethorphan|levomethorphan|mesh-list
154752682|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
154752683|NCT02987920|Pantoprazole|pantoprazole|mesh-list
154752684|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154752685|NCT02987920|Analgesics|analgesics|mesh-ancestor
154752686|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
154752687|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752688|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752689|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
154752690|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154752691|NCT02987920|Narcotics|narcotics|mesh-ancestor
154752692|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752693|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154752694|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752695|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752696|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154752697|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154752698|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752699|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752700|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
154752701|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154752702|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154752703|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154752704|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154752705|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154752706|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752707|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
154752708|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154752709|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154752710|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154752711|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
154752712|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
154752713|NCT02974257|Thiamine|thiamine|mesh-list
154752714|NCT02974257|Vitamins|vitamins|mesh-ancestor
154752715|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
154752716|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752717|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
154752718|NCT01736189|Adalimumab|adalimumab|mesh-list
154752719|NCT01736189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154752720|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752721|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752722|NCT02970981|Nivolumab|nivolumab|mesh-list
154752723|NCT02970981|Ipilimumab|ipilimumab|mesh-list
154752724|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154752725|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752726|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154752727|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752728|NCT02983773|Dronabinol|dronabinol|mesh-list
154752729|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
154752730|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752731|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154752732|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154752733|NCT02983773|Analgesics|analgesics|mesh-ancestor
154752734|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
154752735|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752736|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154752737|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154752738|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752739|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752740|NCT02983773|Hormones|hormones|mesh-ancestor
154752741|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752742|NCT01941628|Rocuronium|rocuronium|mesh-list
154752743|NCT01941628|Succinylcholine|succinylcholine|mesh-list
154752744|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154262293|NCT03818048|Sevoflurane|sevoflurane|mesh-list
154752745|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154752746|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154752747|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752748|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752749|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154752750|NCT02987218|Propofol|propofol|mesh-list
154752751|NCT02987218|Desflurane|desflurane|mesh-list
154752752|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154752753|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752754|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752755|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154752756|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
154752757|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
154752758|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154752759|NCT01762943|Leuprolide|leuprolide|mesh-list
154752760|NCT01762943|Estradiol|estradiol|mesh-list
154752761|NCT01762943|Progesterone|progesterone|mesh-list
154752762|NCT01762943|Estrogens|estrogens|mesh-ancestor
154752763|NCT01762943|Hormones|hormones|mesh-ancestor
154262325|NCT01300676|Estradiol|estradiol|mesh-list
154752764|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752765|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752766|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154752767|NCT01762943|Progestins|progestins|mesh-ancestor
154752768|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154752769|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
154752770|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154752771|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752772|NCT04392063|Melatonin|melatonin|mesh-list
154752773|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
154752774|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752775|NCT04392063|Protective Agents|protective agents|mesh-ancestor
154752776|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752777|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752778|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
154752779|NCT01903798|Prednisolone|prednisolone|mesh-list
154752780|NCT01903798|Rilonacept|rilonacept|mesh-list
154752781|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154752782|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752783|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154752784|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
154752785|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154752786|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752787|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752788|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752789|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752790|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
154752791|NCT01903798|Hormones|hormones|mesh-ancestor
154752792|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752793|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752794|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154752795|NCT01945138|Insulin|insulin|mesh-list
154752796|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154752797|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154752798|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752799|NCT01734785|Empagliflozin|empagliflozin|mesh-list
154752800|NCT01734785|Linagliptin|linagliptin|mesh-list
154752801|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154752802|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752803|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154752804|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752805|NCT01734785|Incretins|incretins|mesh-ancestor
154752806|NCT01734785|Hormones|hormones|mesh-ancestor
154752807|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752808|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154262345|NCT01301222|Octreotide|octreotide|mesh-list
154752809|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
154752810|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752811|NCT03821415|Estradiol|estradiol|mesh-list
154752812|NCT03821415|Estrogens|estrogens|mesh-ancestor
154752813|NCT03821415|Hormones|hormones|mesh-ancestor
154752814|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752815|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752816|NCT01734395|Galantamine|galantamine|mesh-list
154752817|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154752818|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752819|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752820|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
154752821|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752822|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752823|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154752824|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
154752825|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752826|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
154752827|NCT01945294|Interferons|interferons|mesh-list
154752828|NCT01945294|Ribavirin|ribavirin|mesh-list
154752829|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
154752830|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
154752831|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154752832|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752833|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
154752834|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752835|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
154752836|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752837|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
154752838|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752839|NCT01947946|Benralizumab|benralizumab|mesh-list
154752840|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154504767|NCT05233514|Metformin|metformin|mesh-list
154262391|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154752841|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
154752842|NCT03820245|Lycopene|lycopene|mesh-list
154752843|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752844|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
154752845|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752846|NCT03820245|Protective Agents|protective agents|mesh-ancestor
154752847|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752848|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154752849|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154752850|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752851|NCT01597505|Vancomycin|vancomycin|mesh-list
154752852|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154752853|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752854|NCT03826485|Pranlukast|pranlukast|mesh-list
154752855|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154752856|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
154752857|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154752858|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
154752859|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752860|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752861|NCT03823989|Mitomycins|mitomycins|mesh-list
154752862|NCT03823989|Mitomycin|mitomycin|mesh-list
154752863|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154752864|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752865|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
154752866|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752867|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154752868|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752869|NCT01951066|Dexamethasone|dexamethasone|mesh-list
154752870|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154752871|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
154752872|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
154752873|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752874|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752875|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154752876|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
154752877|NCT01951066|Hormones|hormones|mesh-ancestor
154752878|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752879|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154752880|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752881|NCT05735626|Capsaicin|capsaicin|mesh-list
154752882|NCT05735626|Piperine|piperine|mesh-list
154752883|NCT05735626|Antipruritics|antipruritics|mesh-ancestor
154752884|NCT05735626|Dermatologic Agents|dermatologic agents|mesh-ancestor
154752885|NCT05735626|Sensory System Agents|sensory system agents|mesh-ancestor
154752886|NCT05735626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752887|NCT05735626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752888|NCT05735626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154752889|NCT05735626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752890|NCT05735626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752891|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154752892|NCT01951768|Gentamicins|gentamicins|mesh-list
154752893|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752894|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154752895|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752896|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752897|NCT05735470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154752898|NCT05735470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154752899|NCT03825861|Folfirinox|folfirinox|mesh-list
154752900|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752901|NCT01760447|Metformin|metformin|mesh-list
154752902|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154752903|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154752904|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752905|NCT01760447|Incretins|incretins|mesh-ancestor
154752906|NCT01760447|Hormones|hormones|mesh-ancestor
154752907|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154752908|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154752909|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
154752910|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752911|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752912|NCT01915108|Remifentanil|remifentanil|mesh-list
154752913|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154752914|NCT01915108|Narcotics|narcotics|mesh-ancestor
154752915|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752916|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752917|NCT01915108|Analgesics|analgesics|mesh-ancestor
154752918|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
154262465|NCT00301067|Calcitriol|calcitriol|mesh-list
154752919|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752920|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
154752921|NCT03825471|Anesthetics|anesthetics|mesh-list
154752922|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154752923|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752924|NCT03825471|Narcotics|narcotics|mesh-ancestor
154752925|NCT03825471|Analgesics|analgesics|mesh-ancestor
154752926|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
154752927|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752928|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154752929|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154752930|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752931|NCT01450215|Lenalidomide|lenalidomide|mesh-list
154752932|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
154752933|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752934|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154752935|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154752936|NCT01450215|Growth Substances|growth substances|mesh-ancestor
154752937|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
154752938|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752939|NCT01917214|Sunitinib|sunitinib|mesh-list
154752940|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752941|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154752942|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154752943|NCT01917214|Growth Substances|growth substances|mesh-ancestor
154752944|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752945|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
154752946|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154752947|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154752948|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752949|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
154752950|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154752951|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
154752952|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752953|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752954|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154752955|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
154752956|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752957|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752958|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154752959|NCT01732913|Rituximab|rituximab|mesh-list
154752960|NCT01732913|Idelalisib|idelalisib|mesh-list
154752961|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154752962|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154752963|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
154752964|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752965|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154752966|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769387|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154752967|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752968|NCT03824925|Zinc|zinc|mesh-list
154752969|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
154752970|NCT03824925|Trace Elements|trace elements|mesh-ancestor
154752971|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
154752972|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752973|NCT03824925|Astringents|astringents|mesh-ancestor
154752974|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
154752975|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154752976|NCT03825081|Pilocarpine|pilocarpine|mesh-list
154752977|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154752978|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154752979|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154752980|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154752981|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154752982|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154752983|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154752984|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752985|NCT03825081|Miotics|miotics|mesh-ancestor
154752986|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
154752987|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752988|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154752989|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154752990|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
154752991|NCT01920802|Olanzapine|olanzapine|mesh-list
154752993|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
154752994|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
154752995|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154752996|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154752997|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154752998|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154752999|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154753000|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753001|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753002|NCT01920802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154753003|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154753004|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154753005|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753006|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753007|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
154753008|NCT01451229|Higenamine|higenamine|mesh-list
154753009|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154753010|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753011|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753012|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753013|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753014|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753015|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154753016|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753017|NCT01451229|Analgesics|analgesics|mesh-ancestor
154753018|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
154753019|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753020|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154753021|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753022|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154753023|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154753024|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154753025|NCT01451229|Protective Agents|protective agents|mesh-ancestor
154753026|NCT03054519|Metformin|metformin|mesh-list
154753027|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154753028|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753029|NCT01921894|Vitamin D|vitamin d|mesh-list
154753030|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
154753031|NCT01921894|Vitamins|vitamins|mesh-ancestor
154753032|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
154753033|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753034|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154753035|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154753036|NCT01452009|Travoprost|travoprost|mesh-list
154753037|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154753038|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154753039|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154753040|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154753041|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
154753042|NCT03824379|Cathartics|cathartics|mesh-ancestor
154753043|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154753044|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753045|NCT01957930|Insulin|insulin|mesh-list
154753046|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154753047|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154262603|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
154753048|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753049|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154753050|NCT01732757|Dextrans|dextrans|mesh-list
154753051|NCT01732757|Alcaftadine|alcaftadine|mesh-list
154753052|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
154753053|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
154753054|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
154753055|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154753056|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753057|NCT01732757|Analgesics|analgesics|mesh-ancestor
154753058|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
154753059|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753060|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753061|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154753062|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753063|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154753064|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154753065|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154753066|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
154753067|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
154753068|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753069|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753070|NCT01758731|Cetuximab|cetuximab|mesh-list
154753071|NCT01758731|Olaparib|olaparib|mesh-list
154753072|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154753073|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753074|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154753075|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753076|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753077|NCT01452477|Tanshinone|tanshinone|mesh-list
154753078|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753079|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154753080|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753081|NCT01452477|Analgesics|analgesics|mesh-ancestor
154753082|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
154753083|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753084|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753085|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154753086|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753087|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
154753088|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154753089|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753090|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753091|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
154753092|NCT01452633|Bupivacaine|bupivacaine|mesh-list
154753093|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
154753094|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
154753095|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753096|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753097|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
154753098|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753099|NCT01606319|Acetaminophen|acetaminophen|mesh-list
154753100|NCT01606319|Ibuprofen|ibuprofen|mesh-list
154753101|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154753102|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154753103|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753104|NCT01606319|Analgesics|analgesics|mesh-ancestor
154753105|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
154753106|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753107|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753108|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
154753109|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753110|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154753111|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753112|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753113|NCT01452711|Lansoprazole|lansoprazole|mesh-list
154753114|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
154753115|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154753116|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154753117|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154753118|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753119|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753120|NCT02630121|Phenylephrine|phenylephrine|mesh-list
154753121|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
154753122|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154753123|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753124|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753125|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753126|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753127|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753128|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
154753129|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
154753130|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753131|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
154753132|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154753133|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
154753134|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154753135|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
154753136|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154753137|NCT02630121|Protective Agents|protective agents|mesh-ancestor
154753138|NCT02956785|Dinoprostone|dinoprostone|mesh-list
154753139|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
154753140|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154753141|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753142|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
154753143|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154753144|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753145|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
154753146|NCT02947581|Albendazole|albendazole|mesh-list
154753147|NCT02947581|Praziquantel|praziquantel|mesh-list
154753148|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
154753149|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154753150|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753151|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
154753152|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154753153|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154753154|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
154753155|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
154753156|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
154753157|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753158|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753159|NCT01453881|Beclomethasone|beclomethasone|mesh-list
154753160|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
154753161|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154753162|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
154753163|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753164|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753165|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154753166|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
154753167|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154753168|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154753169|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753170|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753171|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753172|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753173|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154753174|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
154753175|NCT01453881|Hormones|hormones|mesh-ancestor
154753176|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154753177|NCT04391361|Atropine|atropine|mesh-list
154753178|NCT04391361|Scopolamine|scopolamine|mesh-list
154753179|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
154753180|NCT04391361|Edaravone|edaravone|mesh-list
154753181|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154753182|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753183|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753184|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753185|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753186|NCT04391361|Analgesics|analgesics|mesh-ancestor
154753187|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
154753188|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753189|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154753190|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154753191|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753192|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753193|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753194|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753195|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154753196|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154753197|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154753198|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
154753199|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154753200|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
154753201|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
154753202|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
154753203|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154753204|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154753205|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
154753206|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
154753207|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154753208|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154753209|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
154753210|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154753211|NCT04391361|Protective Agents|protective agents|mesh-ancestor
154753212|NCT04273191|Brexanolone|brexanolone|mesh-list
154753213|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
154753214|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753215|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753216|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753217|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
154753218|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
154753219|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
154753220|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
154753221|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753222|NCT01454115|BMS 708163|bms 708163|mesh-list
154753223|NCT01454115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154262779|NCT06291727|Bupivacaine|bupivacaine|mesh-list
154753224|NCT01454115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413461|NCT02541565|Prednisone|prednisone|mesh-list
153959952|NCT06276010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959963|NCT06275555|Heparin|heparin|mesh-list
154753225|NCT01454115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753226|NCT01455597|Estradiol|estradiol|mesh-list
154753227|NCT01455597|Estrogens|estrogens|mesh-ancestor
154753228|NCT01455597|Hormones|hormones|mesh-ancestor
154753229|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154753230|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753231|NCT01453101|Fludarabine|fludarabine|mesh-list
154753232|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
154753233|NCT01453101|Bortezomib|bortezomib|mesh-list
154753234|NCT01453101|Melphalan|melphalan|mesh-list
154753235|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753236|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154753237|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
154753238|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753239|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753240|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
154753241|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753242|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154753243|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
154753244|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154753245|NCT02085447|Haloperidol|haloperidol|mesh-list
154753246|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154753247|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
154753248|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
154753249|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154753250|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753251|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753252|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154262798|NCT06291337|Naproxen|naproxen|mesh-list
154753253|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154753254|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154753255|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
154753256|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753257|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753258|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154753259|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154753260|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
154753261|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
154753262|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
154753263|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753264|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154753265|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154753266|NCT04847193|Xanthohumol|xanthohumol|mesh-list
154753267|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753268|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154753269|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154753270|NCT04847193|Growth Substances|growth substances|mesh-ancestor
154753271|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753272|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
154753273|NCT04273035|Midazolam|midazolam|mesh-list
154753274|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154753275|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753276|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753277|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753278|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154753279|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154753280|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753281|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154753282|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
154753283|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
154753284|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
154753285|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
154753286|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753287|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753288|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
154753289|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154753290|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
154753291|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753292|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753293|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154753294|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
154753295|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154753296|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
154753297|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262843|NCT06291077|Abatacept|abatacept|mesh-list
154753298|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753299|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154753300|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
154753301|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
154753302|NCT02836899|Protective Agents|protective agents|mesh-ancestor
154753303|NCT02902029|Atezolizumab|atezolizumab|mesh-list
154753304|NCT02902029|Vemurafenib|vemurafenib|mesh-list
154753305|NCT02902029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154753306|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753307|NCT02902029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154753308|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753309|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154753310|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753311|NCT02933697|Apixaban|apixaban|mesh-list
154753312|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
154753313|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154753314|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
154753315|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154753316|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
154753317|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753318|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753319|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
154753320|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
154753321|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154753322|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
154753323|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753324|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753325|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154753326|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
154753327|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
154753328|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154753329|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
154753330|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753331|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753332|NCT01455441|Liraglutide|liraglutide|mesh-list
153444365|NCT01169753|Modafinil|modafinil|mesh-list
154753333|NCT01455441|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154753334|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154753335|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753336|NCT01455441|Incretins|incretins|mesh-ancestor
154753337|NCT01455441|Hormones|hormones|mesh-ancestor
154753338|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154753339|NCT01455831|Tinzaparin|tinzaparin|mesh-list
154753340|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154753341|NCT01455831|Dalteparin|dalteparin|mesh-list
154753342|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
154753343|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154753344|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154753345|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753346|NCT04840641|Efavirenz|efavirenz|mesh-list
154753347|NCT04840641|Floxacillin|floxacillin|mesh-list
154753348|NCT04840641|Losartan|losartan|mesh-list
154753349|NCT04840641|Metoprolol|metoprolol|mesh-list
154753350|NCT04840641|Midazolam|midazolam|mesh-list
154753351|NCT04840641|Caffeine|caffeine|mesh-list
154753352|NCT04840641|Omeprazole|omeprazole|mesh-list
154753353|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154753354|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753355|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753356|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753357|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154753358|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154753359|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753360|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154753361|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
154753362|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
154753363|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
154753364|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
154753365|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262916|NCT06290102|Xhance|xhance|mesh-list
153444398|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
154753366|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753367|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154753368|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154753369|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154753370|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154753371|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154753372|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154753374|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154753375|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154753376|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
154262935|NCT06290063|Cannabidiol|cannabidiol|mesh-list
154753377|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154753378|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154753379|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154753380|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154753381|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154753382|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
154753383|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753384|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154753385|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154753386|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154753387|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154753388|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154753389|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154753390|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
154753391|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
154753392|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753393|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154753394|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154753395|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154753396|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753397|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154753398|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154753399|NCT01455909|Exenatide|exenatide|mesh-list
154753400|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154753401|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753402|NCT01455909|Incretins|incretins|mesh-ancestor
154753403|NCT01455909|Hormones|hormones|mesh-ancestor
154753404|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154753405|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154753406|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
154753407|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753408|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753409|NCT01455909|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154753410|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154753411|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154753412|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154753413|NCT02555787|Tacrolimus|tacrolimus|mesh-list
154753414|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753415|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
154753416|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753417|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154753418|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753419|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753420|NCT01730729|Cabergoline|cabergoline|mesh-list
154753421|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154753422|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154753423|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
154753424|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
154753425|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753426|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753427|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753428|NCT01756157|Complement C1s|complement c1s|mesh-list
154753429|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154753430|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154753431|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
154753432|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753433|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154753434|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753435|NCT01756079|Ribavirin|ribavirin|mesh-list
154753436|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154753437|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
154753438|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753439|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
154262980|NCT06288516|Benralizumab|benralizumab|mesh-list
154753440|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753441|NCT04272645|Atezolizumab|atezolizumab|mesh-list
154753442|NCT04272645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154753443|NCT04272645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753444|NCT04272645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154753445|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753446|NCT04390815|Insulin|insulin|mesh-list
154753447|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154753448|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154753449|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753450|NCT01456611|Diclofenac|diclofenac|mesh-list
154753451|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154753452|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753453|NCT01456611|Analgesics|analgesics|mesh-ancestor
154753454|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
154753455|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753456|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903307|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753457|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154753458|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753459|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154753460|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753461|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753462|NCT01456689|Midazolam|midazolam|mesh-list
154753463|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154753464|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753465|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753466|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753467|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154753468|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154753469|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753470|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154753471|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
154753472|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
154753473|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
154753474|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
154753475|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753476|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753477|NCT05826821|Pirfenidone|pirfenidone|mesh-list
154753478|NCT05826821|Analgesics|analgesics|mesh-ancestor
154753479|NCT05826821|Sensory System Agents|sensory system agents|mesh-ancestor
154753480|NCT05826821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753481|NCT05826821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753482|NCT05826821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154753483|NCT05826821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753484|NCT05826821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154753485|NCT05826821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753486|NCT05826821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753487|NCT05826444|Calcium|calcium|mesh-list
154753488|NCT05826444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154753489|NCT05826444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753490|NCT05826249|Ritonavir|ritonavir|mesh-list
154753491|NCT05826249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154753492|NCT05826249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154753493|NCT05826249|Protease Inhibitors|protease inhibitors|mesh-ancestor
154753494|NCT05826249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753495|NCT05826249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753496|NCT05826249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154753497|NCT05826249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154753498|NCT05826249|Antiviral Agents|antiviral agents|mesh-ancestor
154753499|NCT05826249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753500|NCT05826249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154753501|NCT05826249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154753502|NCT05825872|Lidocaine|lidocaine|mesh-list
154753503|NCT05825872|Bupivacaine|bupivacaine|mesh-list
154753504|NCT05825872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154753505|NCT05825872|Anesthetics, Local|anesthetics, local|mesh-ancestor
154753506|NCT05825872|Anesthetics|anesthetics|mesh-ancestor
154753507|NCT05825872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753508|NCT05825872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753509|NCT05825872|Sensory System Agents|sensory system agents|mesh-ancestor
154753510|NCT05825872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753511|NCT05825872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154753512|NCT05825872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154753513|NCT05825872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154753514|NCT05825872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154753515|NCT05825872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753516|NCT05825599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154753517|NCT05825599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154753518|NCT05825586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154753519|NCT05825586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153961848|NCT00705796|Androgens|androgens|mesh-ancestor
153961954|NCT00909480|Insulin|insulin|mesh-list
154753520|NCT05825378|Dexamethasone|dexamethasone|mesh-list
154753521|NCT05825378|Ropivacaine|ropivacaine|mesh-list
154753522|NCT05825378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154753523|NCT05825378|Antiemetics|antiemetics|mesh-ancestor
154753524|NCT05825378|Autonomic Agents|autonomic agents|mesh-ancestor
154753525|NCT05825378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753526|NCT05825378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753527|NCT05825378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154753528|NCT05825378|Glucocorticoids|glucocorticoids|mesh-ancestor
154753529|NCT05825378|Hormones|hormones|mesh-ancestor
154753530|NCT05825378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154753531|NCT05825378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154753532|NCT05825378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753533|NCT05825378|Anesthetics, Local|anesthetics, local|mesh-ancestor
154753534|NCT05825378|Anesthetics|anesthetics|mesh-ancestor
154753535|NCT05825378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753536|NCT05825378|Sensory System Agents|sensory system agents|mesh-ancestor
154753537|NCT05824897|Vitamin D|vitamin d|mesh-list
154753538|NCT05824897|Vitamins|vitamins|mesh-ancestor
154753539|NCT05824897|Micronutrients|micronutrients|mesh-ancestor
154753540|NCT05824897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753541|NCT05824897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154753542|NCT05823844|Suvorexant|suvorexant|mesh-list
154753543|NCT05823844|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154753544|NCT05823844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753545|NCT05823844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753546|NCT05823844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753547|NCT05823844|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154753548|NCT05823844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753549|NCT05823844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753550|NCT05823662|Silodosin|silodosin|mesh-list
154263094|NCT06138691|Anesthetics|anesthetics|mesh-ancestor
154753551|NCT05823662|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154753552|NCT05823662|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154753553|NCT05823662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154753554|NCT05823662|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753555|NCT05823662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263114|NCT06091085|Natriuretic Agents|natriuretic agents|mesh-ancestor
154769388|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962445|NCT00762229|Ezetimibe|ezetimibe|mesh-list
154753556|NCT05823662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753557|NCT05823662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753558|NCT05823662|Urological Agents|urological agents|mesh-ancestor
154753559|NCT05823363|Bupivacaine|bupivacaine|mesh-list
154753560|NCT05823363|Anesthetics, Local|anesthetics, local|mesh-ancestor
154753561|NCT05823363|Anesthetics|anesthetics|mesh-ancestor
154753562|NCT05823363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753563|NCT05823363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753564|NCT05823363|Sensory System Agents|sensory system agents|mesh-ancestor
154753565|NCT05823363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753566|NCT05821543|Metformin|metformin|mesh-list
154753567|NCT05821543|Sibutramine|sibutramine|mesh-list
154753568|NCT05821543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154263128|NCT06067893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153963100|NCT04460872|Androgens|androgens|mesh-ancestor
154753569|NCT05821543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753570|NCT05821543|Antidepressive Agents|antidepressive agents|mesh-ancestor
154753571|NCT05821543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753572|NCT05821543|Appetite Depressants|appetite depressants|mesh-ancestor
154753573|NCT05821543|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154753574|NCT05811949|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154753575|NCT05811949|Dermatologic Agents|dermatologic agents|mesh-ancestor
154753576|NCT05811949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753577|NCT05811949|Immunologic Factors|immunologic factors|mesh-ancestor
154753578|NCT05811949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753579|NCT05800639|Anesthetics|anesthetics|mesh-list
154753580|NCT05800639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964033|NCT04302116|Hormones|hormones|mesh-ancestor
154753581|NCT05800639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753582|NCT05753618|Lenograstim|lenograstim|mesh-list
154753583|NCT05753618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154753584|NCT05753618|Immunologic Factors|immunologic factors|mesh-ancestor
154753585|NCT05753618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753586|NCT05752461|Enoxaparin|enoxaparin|mesh-list
154753587|NCT05752461|Enoxaparin sodium|enoxaparin sodium|mesh-list
154753588|NCT05752461|Anticoagulants|anticoagulants|mesh-ancestor
154753589|NCT05752461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154753590|NCT05752461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154263143|NCT06046482|Tubulin Modulators|tubulin modulators|mesh-ancestor
154753591|NCT05752461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753592|NCT05724550|Neostigmine|neostigmine|mesh-list
153964881|NCT00902538|Diuretics|diuretics|mesh-ancestor
153964964|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
154753593|NCT05724550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154753594|NCT05724550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753595|NCT05724550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753596|NCT05724550|Cholinergic Agents|cholinergic agents|mesh-ancestor
154753597|NCT05724550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753598|NCT05724550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753599|NCT05724550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154753600|NCT05724550|Autonomic Agents|autonomic agents|mesh-ancestor
154753601|NCT05724550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753602|NCT05659329|Gentamicins|gentamicins|mesh-list
154753603|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154753604|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753605|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154753606|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753607|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753608|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
154753609|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154753610|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753611|NCT05496036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153965306|NCT02776059|Prednisolone|prednisolone|mesh-list
154753612|NCT05496036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753613|NCT05320068|Vancomycin|vancomycin|mesh-list
154753614|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154753615|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753616|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
154753617|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154753618|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753619|NCT05204160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263166|NCT05964413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753620|NCT05204160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753621|NCT05161637|Bupivacaine|bupivacaine|mesh-list
154753622|NCT05161637|Ropivacaine|ropivacaine|mesh-list
153965787|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
154753623|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
154753624|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
154263171|NCT05945485|Vaccines|vaccines|mesh-list
154753625|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753626|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753627|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
154753628|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966263|NCT02755545|Adapalene|adapalene|mesh-list
154753629|NCT04903353|Risperidone|risperidone|mesh-list
154753630|NCT04903353|Aripiprazole|aripiprazole|mesh-list
154753631|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154753632|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
154753633|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753634|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904601|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
154753635|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966892|NCT06178848|Anesthetics|anesthetics|mesh-ancestor
154753636|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154753637|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154753638|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753639|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154263180|NCT05919823|Autonomic Agents|autonomic agents|mesh-ancestor
154753640|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154753641|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
154753642|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
154753643|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
153967945|NCT00782574|Olaparib|olaparib|mesh-list
154753644|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153968205|NCT00734851|Docetaxel|docetaxel|mesh-list
154753645|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154753646|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154753647|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153968548|NCT00586105|Sorafenib|sorafenib|mesh-list
154753648|NCT04831047|Phenylephrine|phenylephrine|mesh-list
154753649|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
154753650|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154753651|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154753652|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154753653|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753654|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753655|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905080|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153969172|NCT04087915|Protease Inhibitors|protease inhibitors|mesh-ancestor
154753656|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753657|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753658|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
154753659|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
154753660|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753661|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
153969864|NCT00612651|Lonafarnib|lonafarnib|mesh-list
153970007|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
154753662|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153416443|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
153416465|NCT05243953|Cromakalim|cromakalim|mesh-list
154753663|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
153970362|NCT01024946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154753664|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153905458|NCT01108341|Ofatumumab|ofatumumab|mesh-list
154753665|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
154753666|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154753667|NCT04831047|Protective Agents|protective agents|mesh-ancestor
154753668|NCT04775680|Antibodies|antibodies|mesh-list
154753669|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
154753670|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971190|NCT00718549|Cladribine|cladribine|mesh-list
154753671|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
153416747|NCT04845139|Nivolumab|nivolumab|mesh-list
154753672|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154263193|NCT05900388|Rivaroxaban|rivaroxaban|mesh-list
154753673|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753674|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753675|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753676|NCT04700514|Analgesics|analgesics|mesh-ancestor
154753677|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
154753678|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753679|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154753680|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154753681|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753682|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753683|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357387|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
153905738|NCT01092663|Incretins|incretins|mesh-ancestor
153784085|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
153730811|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
153730812|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730813|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730814|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731051|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731052|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153731054|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
153731152|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
153731153|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731154|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731155|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
153731156|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
153360239|NCT00802412|Topiramate|topiramate|mesh-list
153731157|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731158|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153731159|NCT00136526|Estrogens|estrogens|mesh-ancestor
153782700|NCT04561687|Budesonide|budesonide|mesh-list
153563574|NCT01664728|Hormones|hormones|mesh-ancestor
153563872|NCT01666522|Vitamin D|vitamin d|mesh-list
153564095|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
153564245|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564321|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
153564397|NCT01670552|Naproxen|naproxen|mesh-list
153564470|NCT01674556|Gemcitabine|gemcitabine|mesh-list
153564542|NCT01677260|Metformin|metformin|mesh-list
153459801|NCT05972512|Biotin|biotin|mesh-list
153736461|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
153745633|NCT03406507|Ravulizumab|ravulizumab|mesh-list
153735397|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753902|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754873|NCT02589600|Vitamins|vitamins|mesh-ancestor
153755162|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755163|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755164|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154753684|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753685|NCT04669145|Ropivacaine|ropivacaine|mesh-list
154753686|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
154753687|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
153786328|NCT01689298|Oxytocin|oxytocin|mesh-list
154753688|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758842|NCT04636957|Hormones|hormones|mesh-ancestor
154753689|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447645|NCT00002723|Suramin|suramin|mesh-list
154753690|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
154753691|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753692|NCT04650074|Lidocaine|lidocaine|mesh-list
153759319|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
154753693|NCT04650074|Ketamine|ketamine|mesh-list
153417622|NCT02766673|Albuterol|albuterol|mesh-list
154753694|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
154753695|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
154263198|NCT05900388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753696|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760047|NCT00209469|Alendronate|alendronate|mesh-list
153760347|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154753697|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753698|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
154753699|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753700|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154753701|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154753702|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153761799|NCT00212043|Carboplatin|carboplatin|mesh-list
153762177|NCT00189644|Fluorouracil|fluorouracil|mesh-list
153762178|NCT00189644|Epirubicin|epirubicin|mesh-list
153762179|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753703|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762346|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
154753704|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753705|NCT04650074|Analgesics|analgesics|mesh-ancestor
154753706|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153762790|NCT06112808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762805|NCT06111573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753707|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154753708|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
153736466|NCT02397720|Ipilimumab|ipilimumab|mesh-list
154753709|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153763933|NCT05918718|Hormone Antagonists|hormone antagonists|mesh-ancestor
154263203|NCT05878405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154753710|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154753711|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753712|NCT04620304|UB-421|ub-421|mesh-list
154753713|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153764963|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
154753714|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
154753715|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753716|NCT04578886|Guanfacine|guanfacine|mesh-list
154753717|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154753718|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154753719|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154753720|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753721|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753722|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753723|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906780|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753724|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753725|NCT04550585|Insulin|insulin|mesh-list
154753726|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153767122|NCT00192842|Curcumin|curcumin|mesh-list
154753727|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154753728|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753729|NCT04545515|Ivacaftor|ivacaftor|mesh-list
154753730|NCT04545515|Elexacaftor|elexacaftor|mesh-list
154753731|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154753732|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906898|NCT02848183|Analgesics|analgesics|mesh-ancestor
153418371|NCT00374192|Eszopiclone|eszopiclone|mesh-list
153906942|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768284|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
154753733|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753734|NCT04512066|Risperidone|risperidone|mesh-list
153768428|NCT00472186|Lansoprazole|lansoprazole|mesh-list
154753735|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154753736|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
154753737|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768720|NCT00196469|Heparin|heparin|mesh-list
154753738|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753739|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753740|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154505680|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753742|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753743|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753744|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154753745|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
154753746|NCT04421092|Lidocaine|lidocaine|mesh-list
153769343|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753747|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
154753748|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
154753749|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153907156|NCT03987685|Topotecan|topotecan|mesh-list
153769646|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753750|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753751|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
154753752|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753753|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154753754|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154753755|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154753756|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770272|NCT00411125|Katacalcin|katacalcin|mesh-list
154753757|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753758|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154753759|NCT04406727|UB-421|ub-421|mesh-list
154753760|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
154753761|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753762|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
154753763|NCT04364945|Remifentanil|remifentanil|mesh-list
153770858|NCT01083316|Bortezomib|bortezomib|mesh-list
154753764|NCT04364945|Sevoflurane|sevoflurane|mesh-list
154753765|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153907354|NCT02842567|Vitamin E|vitamin e|mesh-list
153771063|NCT00237627|Doxorubicin|doxorubicin|mesh-list
154753766|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753767|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907400|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153771389|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735856|NCT04079712|Ipilimumab|ipilimumab|mesh-list
154753768|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753769|NCT04364945|Analgesics|analgesics|mesh-ancestor
154753770|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
153907446|NCT00095017|Etoricoxib|etoricoxib|mesh-list
154753771|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753772|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153418911|NCT05828199|Analgesics|analgesics|mesh-ancestor
153772168|NCT05425654|Vincristine|vincristine|mesh-list
154753773|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154263229|NCT05790486|Nicotine|nicotine|mesh-list
154753774|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753775|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753776|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907597|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
154753777|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753778|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154753779|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154753780|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
154753781|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
153449280|NCT00004061|Ifosfamide|ifosfamide|mesh-list
154753782|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154753783|NCT04364945|Narcotics|narcotics|mesh-ancestor
154753784|NCT04235608|Propofol|propofol|mesh-list
154753785|NCT04235608|Sevoflurane|sevoflurane|mesh-list
154753786|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153773128|NCT04667299|Antacids|antacids|mesh-ancestor
154753787|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773249|NCT00240942|Letrozole|letrozole|mesh-list
154753788|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773621|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
153773823|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
153773998|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
153774000|NCT00218153|Naltrexone|naltrexone|mesh-list
154753789|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154753790|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
154753791|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
153774361|NCT00219245|Protective Agents|protective agents|mesh-ancestor
154753792|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153419242|NCT05091866|Progestins|progestins|mesh-list
153774641|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
154263234|NCT05790486|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153774768|NCT00220298|Testosterone|testosterone|mesh-list
153449567|NCT00003305|Leucovorin|leucovorin|mesh-list
153774909|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154753793|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154753794|NCT04161027|Pregabalin|pregabalin|mesh-list
154753795|NCT04161027|Analgesics|analgesics|mesh-ancestor
153449644|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153775346|NCT06176729|Rituximab|rituximab|mesh-list
153775482|NCT06062810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753796|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
154753797|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419377|NCT04670978|Bevacizumab|bevacizumab|mesh-list
154753798|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753799|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
154753800|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153776152|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776260|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153776355|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753801|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153776670|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753802|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776953|NCT00563758|Tegaserod|tegaserod|mesh-list
153419611|NCT02429687|Paclitaxel|paclitaxel|mesh-list
153777068|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753803|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154753804|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154753805|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153735861|NCT04075240|Aspirin|aspirin|mesh-list
153777326|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735862|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
153777512|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
154753806|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753807|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753808|NCT04019964|Nivolumab|nivolumab|mesh-list
154753809|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154753810|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753811|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154753812|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753813|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153735865|NCT04075240|Analgesics|analgesics|mesh-ancestor
154753814|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153778257|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
154753815|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753816|NCT03889756|Midazolam|midazolam|mesh-list
154753817|NCT03889756|Ketamine|ketamine|mesh-list
154753818|NCT03889756|Analgesics|analgesics|mesh-ancestor
154753819|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
154753820|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753821|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753822|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153419804|NCT03054805|Antacids|antacids|mesh-ancestor
153908743|NCT02823691|Metformin|metformin|mesh-list
153778872|NCT00569296|Aldesleukin|aldesleukin|mesh-list
153778873|NCT00569296|Sargramostim|sargramostim|mesh-list
154753823|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154753824|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
154753825|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
154753826|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753827|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154753828|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153779691|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
153779887|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154753829|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753830|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753831|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153908995|NCT02874963|Thymol|thymol|mesh-list
153420021|NCT02997722|Ketamine|ketamine|mesh-list
154753832|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753833|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154753834|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153780392|NCT00191191|Pemetrexed|pemetrexed|mesh-list
154753835|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753836|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
154753837|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
154753838|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
154753839|NCT03845114|Insulin|insulin|mesh-list
154753840|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154753841|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154753842|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753843|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
154753844|NCT03778502|Apixaban|apixaban|mesh-list
154753845|NCT03778502|Edoxaban|edoxaban|mesh-list
154753846|NCT03778502|Dabigatran|dabigatran|mesh-list
154753847|NCT03778502|Anticoagulants|anticoagulants|mesh-list
154753848|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154753849|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
154753850|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153781283|NCT00410540|Morphine|morphine|mesh-list
154753851|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
153420154|NCT03068312|Ivacaftor|ivacaftor|mesh-list
154753852|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753853|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753854|NCT03775200|Psilocybin|psilocybin|mesh-list
154753855|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
154753856|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753857|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753858|NCT03689855|Atezolizumab|atezolizumab|mesh-list
154753859|NCT03689855|Ramucirumab|ramucirumab|mesh-list
154753860|NCT03689855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154753861|NCT03689855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753862|NCT03689855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154753863|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263254|NCT05739955|Disinfectants|disinfectants|mesh-list
154753864|NCT03689855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154753865|NCT03689855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154753866|NCT03689855|Growth Substances|growth substances|mesh-ancestor
154753867|NCT03689855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753868|NCT03689855|Growth Inhibitors|growth inhibitors|mesh-ancestor
154753869|NCT03635996|Etripamil|etripamil|mesh-list
154753870|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153569225|NCT04390763|Spartalizumab|spartalizumab|mesh-list
154753871|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909457|NCT00953524|Vaccines|vaccines|mesh-list
153420306|NCT00375050|Riluzole|riluzole|mesh-list
153569999|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570000|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154753872|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753873|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153909576|NCT04303065|Hormones|hormones|mesh-ancestor
153571007|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154753874|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753875|NCT03613181|Paclitaxel|paclitaxel|mesh-list
154753876|NCT03613181|Capecitabine|capecitabine|mesh-list
154753877|NCT03613181|Methotrexate|methotrexate|mesh-list
154753878|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154753879|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753880|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
154753881|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
154753882|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
153909710|NCT00627471|Insulin|insulin|mesh-list
153573913|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574455|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
153575213|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575264|NCT01705002|Capecitabine|capecitabine|mesh-list
154753883|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753884|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154753885|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
154753886|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154753887|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
153420497|NCT03098420|Bupivacaine|bupivacaine|mesh-list
153578483|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
153420519|NCT03098420|Narcotics|narcotics|mesh-ancestor
154753888|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154753889|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753890|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
154753891|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753892|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154753893|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753894|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
154753895|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154753896|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154753897|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
154753898|NCT03468478|Sirolimus|sirolimus|mesh-list
154263275|NCT05727163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263276|NCT05727163|Glucocorticoids|glucocorticoids|mesh-ancestor
154753899|NCT03468478|Everolimus|everolimus|mesh-list
154753900|NCT03468478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153579315|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153579317|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753901|NCT03468478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154753902|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753903|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579690|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153579832|NCT01742429|Antacids|antacids|mesh-ancestor
153579833|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154753904|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154753905|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
154753906|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753907|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753908|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153451814|NCT01916226|Cetirizine|cetirizine|mesh-list
153451872|NCT01914666|Analgesics|analgesics|mesh-ancestor
154753909|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154753910|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
153420788|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
154753911|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154753912|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753913|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
154753914|NCT03409367|Emollients|emollients|mesh-list
154753915|NCT03409367|Petrolatum|petrolatum|mesh-list
154753916|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
154753917|NCT03168464|Nivolumab|nivolumab|mesh-list
154753918|NCT03168464|Ipilimumab|ipilimumab|mesh-list
154753919|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263288|NCT05727163|Antidotes|antidotes|mesh-ancestor
154753920|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753921|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263292|NCT05727163|Micronutrients|micronutrients|mesh-ancestor
153582114|NCT04408118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154753922|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753923|NCT03164447|UB-421|ub-421|mesh-list
153420871|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
153582397|NCT03636295|Warfarin|warfarin|mesh-list
154753924|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154753925|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
153582662|NCT00415233|Hormones|hormones|mesh-list
154753926|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154753927|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154753928|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154753929|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753930|NCT02875262|Deferoxamine|deferoxamine|mesh-list
153582905|NCT01751828|Sertraline|sertraline|mesh-list
154753931|NCT02875262|Siderophores|siderophores|mesh-ancestor
154753932|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153583133|NCT01754116|Midazolam|midazolam|mesh-list
154753933|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
154753934|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
153583271|NCT01755117|Ropivacaine|ropivacaine|mesh-list
153808792|NCT06024174|Cetuximab|cetuximab|mesh-list
153583693|NCT01757236|Vancomycin|vancomycin|mesh-list
153583800|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584093|NCT01759589|Sevoflurane|sevoflurane|mesh-list
153584094|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153584095|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584231|NCT01760148|Interferons|interferons|mesh-list
153584604|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421190|NCT06205485|Leucovorin|leucovorin|mesh-list
153584853|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584910|NCT01763463|Hormones|hormones|mesh-ancestor
153585031|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154753935|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753936|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
154753937|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154753938|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753939|NCT02818920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154753940|NCT02818920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753941|NCT02811510|Dronabinol|dronabinol|mesh-list
154263297|NCT05727163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154753942|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
154753943|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753944|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154753945|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753946|NCT02811510|Analgesics|analgesics|mesh-ancestor
154753947|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
154753948|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753949|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154753950|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154753951|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154753952|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753953|NCT02811510|Hormones|hormones|mesh-ancestor
154753954|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154753955|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
154753956|NCT02786264|Propofol|propofol|mesh-list
154753957|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753958|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753959|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753960|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753961|NCT02786264|Analgesics|analgesics|mesh-ancestor
154753962|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
153421269|NCT06100237|Daratumumab|daratumumab|mesh-list
154753963|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753964|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153585842|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
153747432|NCT00165399|Docetaxel|docetaxel|mesh-list
153586057|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586058|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421364|NCT05973851|Ketamine|ketamine|mesh-list
153586257|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153586258|NCT01771081|Growth Substances|growth substances|mesh-ancestor
153586407|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753965|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154753966|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154753967|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
154753968|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586823|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753969|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586987|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
154753970|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154753971|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
154753973|NCT02778971|Flutemetamol|flutemetamol|mesh-list
154753974|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154753975|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753976|NCT02444546|Sargramostim|sargramostim|mesh-list
154753977|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
154753978|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753979|NCT01948505|Acetaminophen|acetaminophen|mesh-list
154753980|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154753981|NCT01948505|Analgesics|analgesics|mesh-ancestor
153421510|NCT05839054|Methamphetamine|methamphetamine|mesh-list
154753982|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
154753983|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154753984|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154753985|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
154753986|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154753987|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154753988|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753989|NCT01160926|Cediranib|cediranib|mesh-list
154753990|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154753991|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154753992|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154753993|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154753994|NCT01126957|Fentanyl|fentanyl|mesh-list
153588619|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153588813|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588814|NCT01795248|Incretins|incretins|mesh-ancestor
154753995|NCT01126957|Ketamine|ketamine|mesh-list
154753996|NCT01126957|Propofol|propofol|mesh-list
154753997|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154753998|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154753999|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754000|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154754001|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
154754002|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
154754003|NCT01126957|Analgesics|analgesics|mesh-ancestor
154754004|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
154754005|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421707|NCT05554406|Venetoclax|venetoclax|mesh-list
153589377|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
153589381|NCT01802944|Insulin|insulin|mesh-list
154754006|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153589625|NCT01805258|Efavirenz|efavirenz|mesh-list
153589626|NCT01805258|Nevirapine|nevirapine|mesh-list
154754007|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154754008|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154754009|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735940|NCT03974854|Gemcitabine|gemcitabine|mesh-list
154754010|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754011|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154754012|NCT01126957|Narcotics|narcotics|mesh-ancestor
153590296|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
153590807|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590808|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590809|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
154754013|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154754014|NCT00811122|Corticosterone|corticosterone|mesh-list
154754015|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154754016|NCT00651885|Treprostinil|treprostinil|mesh-list
154754017|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154754018|NCT01457001|Vitamin D|vitamin d|mesh-list
154754019|NCT01457001|Vitamins|vitamins|mesh-ancestor
154754020|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
154754021|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754022|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153593111|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
153593112|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
154754023|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
154754024|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154754025|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153594607|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
153594608|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754026|NCT01457469|Nicotine|nicotine|mesh-list
154754027|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153596808|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
153596809|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596855|NCT01864616|Vitamins|vitamins|mesh-ancestor
153598501|NCT05563558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153598503|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154754028|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
153599089|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754029|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263346|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731552|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754030|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754031|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154754032|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154754033|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
154754034|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754035|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754036|NCT01457547|Edetic Acid|edetic acid|mesh-list
154754037|NCT01457547|Vaccines|vaccines|mesh-list
154754038|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
154754039|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
153599909|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599910|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600250|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154754040|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505977|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600557|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754041|NCT01457547|Antidotes|antidotes|mesh-ancestor
154754042|NCT01457547|Protective Agents|protective agents|mesh-ancestor
154754043|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
154754044|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
154754045|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754046|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153600944|NCT01887613|Gabapentin|gabapentin|mesh-list
154754047|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
153422389|NCT04008030|Vitamins|vitamins|mesh-ancestor
153601205|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601311|NCT01889004|Propofol|propofol|mesh-list
153752460|NCT04409860|Paclitaxel|paclitaxel|mesh-list
153601408|NCT01889680|Growth Substances|growth substances|mesh-ancestor
153601530|NCT01894789|Clopidogrel|clopidogrel|mesh-list
153601531|NCT01894789|Ticagrelor|ticagrelor|mesh-list
153601532|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154754048|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154754049|NCT01457859|Triclosan|triclosan|mesh-list
154754050|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154754051|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754052|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154754053|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154754054|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
154754055|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754056|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154754057|NCT01890993|Liraglutide|liraglutide|mesh-list
154754058|NCT01890993|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154754059|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154754060|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754061|NCT01890993|Incretins|incretins|mesh-ancestor
154754062|NCT01890993|Hormones|hormones|mesh-ancestor
154754063|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263355|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754064|NCT01457937|Interferons|interferons|mesh-list
154754065|NCT01457937|Ribavirin|ribavirin|mesh-list
154754066|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154754067|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754068|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
153601840|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754069|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754070|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
154754071|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754072|NCT04272255|Scopolamine|scopolamine|mesh-list
153602090|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
153602146|NCT01902550|Metoprolol|metoprolol|mesh-list
154754073|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154754074|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154754075|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
154754076|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
154754077|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602400|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
153602501|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154754078|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754079|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154754080|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
154754081|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154754082|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
153602870|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
153602873|NCT01907776|Arbekacin|arbekacin|mesh-list
154754083|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754084|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603188|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603310|NCT01910766|Clomiphene|clomiphene|mesh-list
154263381|NCT05630677|Rabeprazole|rabeprazole|mesh-list
153603464|NCT01911598|Carboplatin|carboplatin|mesh-list
153603509|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603510|NCT01911949|Epinephrine|epinephrine|mesh-list
154754085|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154754086|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
154754087|NCT01458015|Oxycodone|oxycodone|mesh-list
154754088|NCT01458015|Tapentadol|tapentadol|mesh-list
153603767|NCT01913808|Iron|iron|mesh-list
153683885|NCT00134875|Buprenorphine|buprenorphine|mesh-list
153603933|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
154754089|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154754090|NCT01458015|Narcotics|narcotics|mesh-ancestor
154754091|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154754092|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754093|NCT01458015|Analgesics|analgesics|mesh-ancestor
154754094|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
154754095|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754096|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153604458|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153604600|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154263387|NCT05626322|Lenalidomide|lenalidomide|mesh-list
154754097|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154754098|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153604966|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154754099|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754100|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
154754101|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754102|NCT01891227|Capecitabine|capecitabine|mesh-list
154754103|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154754104|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154754105|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
154754106|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754107|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263390|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154754108|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154754109|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
154754110|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
154754111|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154754112|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154506053|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754113|NCT04391439|Prednisolone|prednisolone|mesh-list
154754114|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
153606085|NCT01936233|Aspirin|aspirin|mesh-list
154754115|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154754116|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
154754117|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153606455|NCT05679388|Ritonavir|ritonavir|mesh-list
153606594|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
154754119|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
153686286|NCT00083538|Hormones|hormones|mesh-ancestor
153423265|NCT03424681|Modafinil|modafinil|mesh-list
153606965|NCT04419181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606966|NCT04388852|Ipilimumab|ipilimumab|mesh-list
153686620|NCT00158509|Valacyclovir|valacyclovir|mesh-list
154754120|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263400|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
154754121|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754122|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154754123|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
154754124|NCT04391439|Hormones|hormones|mesh-ancestor
153607739|NCT00080886|Etoposide|etoposide|mesh-list
154754125|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754126|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153687247|NCT00053105|Hormones|hormones|mesh-ancestor
153607949|NCT01937806|Tenofovir|tenofovir|mesh-list
154754127|NCT04391439|Protective Agents|protective agents|mesh-ancestor
153608427|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754128|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154754129|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754130|NCT02884245|Estrogens|estrogens|mesh-list
154754131|NCT02884245|Hormones|hormones|mesh-ancestor
154754132|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754133|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609000|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153609001|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153609138|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153609139|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154754134|NCT01891461|Hemostatics|hemostatics|mesh-list
154754135|NCT01891461|Coagulants|coagulants|mesh-ancestor
154754136|NCT04272567|Norepinephrine|norepinephrine|mesh-list
154754137|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154754138|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154754139|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
154754140|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754141|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423655|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
154754142|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754143|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
154754144|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
154754145|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754146|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154754147|NCT01891851|Ritonavir|ritonavir|mesh-list
154754148|NCT01891851|Simeprevir|simeprevir|mesh-list
153423710|NCT03588806|Oxycodone|oxycodone|mesh-list
153610099|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153610100|NCT03626922|Hematinics|hematinics|mesh-ancestor
153610188|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
153610189|NCT02900560|Azacitidine|azacitidine|mesh-list
153610407|NCT01946607|Citalopram|citalopram|mesh-list
153610830|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610848|NCT01948245|Taurolidine|taurolidine|mesh-list
154754149|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154754150|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154754151|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
154754152|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754153|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754154|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154263406|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611362|NCT05875714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611370|NCT05875675|Pioglitazone|pioglitazone|mesh-list
153611505|NCT05874505|Adalimumab|adalimumab|mesh-list
153611506|NCT05874505|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153611650|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
153611790|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
153611794|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
153611928|NCT03150810|Temozolomide|temozolomide|mesh-list
153612093|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153612094|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612095|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153690554|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153612289|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
154754155|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154754156|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
154263407|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153612485|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
154754157|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754158|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153612750|NCT01956201|Atorvastatin|atorvastatin|mesh-list
154754159|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154754160|NCT01459419|Antibodies|antibodies|mesh-list
153612979|NCT01957943|SMOFlipid|smoflipid|mesh-list
153613068|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
154754161|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154754162|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
154754163|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754164|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154754165|NCT01892241|Entecavir|entecavir|mesh-list
154754166|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
154754167|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754168|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
154754169|NCT04391127|Ivermectin|ivermectin|mesh-list
154754170|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
153735998|NCT03922542|Riboflavin|riboflavin|mesh-list
154754171|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154754172|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154754173|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754174|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754175|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754176|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154754177|NCT01459809|Metformin|metformin|mesh-list
153613904|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
154754178|NCT01459809|Glimepiride|glimepiride|mesh-list
154754179|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154754180|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754181|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153692249|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
153614287|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
153614436|NCT01968044|Incretins|incretins|mesh-ancestor
153614533|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154754182|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154754183|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
154754184|NCT01459887|Prednisone|prednisone|mesh-list
154754185|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
154754186|NCT01459887|Doxorubicin|doxorubicin|mesh-list
154754187|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154754188|NCT01459887|Vincristine|vincristine|mesh-list
154506130|NCT02407340|Oxytocin|oxytocin|mesh-list
154754189|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154754190|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
154263415|NCT05608564|Metronidazole|metronidazole|mesh-list
153615195|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615196|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153615421|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
154754191|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754192|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263417|NCT05608564|Piperacillin|piperacillin|mesh-list
153615968|NCT01979965|Ranolazine|ranolazine|mesh-list
153616218|NCT06328179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154754193|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154754194|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
154754195|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754196|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754197|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153617278|NCT05649137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153617791|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754198|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154754199|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154754200|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153618525|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618529|NCT02828358|Leucovorin|leucovorin|mesh-list
154754201|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754202|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154754203|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
154754204|NCT01459887|Hormones|hormones|mesh-ancestor
154754205|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754206|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154754207|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154754208|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
154754209|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
154754210|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
154754211|NCT02876211|Vitamin D|vitamin d|mesh-list
154263418|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153618838|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
153618839|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618840|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357596|NCT01274624|Fluorouracil|fluorouracil|mesh-list
153358421|NCT01338857|Sorafenib|sorafenib|mesh-list
153358646|NCT00799604|Clevidipine|clevidipine|mesh-list
153359015|NCT06212830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153378592|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378669|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153379109|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153379187|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
153380779|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
153380862|NCT03129945|Indomethacin|indomethacin|mesh-list
153381155|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
153382269|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
153382727|NCT03258645|Dabigatran|dabigatran|mesh-list
153383096|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
153383169|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383620|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
153384901|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153385134|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
153385197|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385885|NCT02301390|Amiodarone|amiodarone|mesh-list
153385951|NCT02749617|Apixaban|apixaban|mesh-list
153386024|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386103|NCT05289050|Ketamine|ketamine|mesh-list
153386845|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
153387229|NCT02973399|Ibrutinib|ibrutinib|mesh-list
153387546|NCT00000213|Fluoxetine|fluoxetine|mesh-list
153387817|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
153387966|NCT00359879|Hormones|hormones|mesh-ancestor
154754212|NCT02876211|Vitamins|vitamins|mesh-ancestor
154754213|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
154754214|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754215|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154754216|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
154754217|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154754218|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154754219|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
154754220|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736005|NCT03901469|Talazoparib|talazoparib|mesh-list
154754221|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754222|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154754223|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
154754224|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154754225|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154754226|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154754227|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
154754228|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263419|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781758|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263420|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153731570|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153626792|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263421|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154754229|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754230|NCT01893723|Remifentanil|remifentanil|mesh-list
154754231|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154754232|NCT01893723|Narcotics|narcotics|mesh-ancestor
154754233|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154754234|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754235|NCT01893723|Analgesics|analgesics|mesh-ancestor
154754236|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
154754237|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263422|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153626794|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754238|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
154754239|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154754240|NCT02669901|Naloxone|naloxone|mesh-list
154754241|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154754242|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754243|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
154754244|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754245|NCT01893099|Sorafenib|sorafenib|mesh-list
154754246|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754247|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154754248|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754249|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754250|NCT02327403|Abatacept|abatacept|mesh-list
154754251|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263423|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781771|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403419|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
154754252|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754253|NCT02327403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154754254|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754255|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154754256|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
154754257|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754258|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154754259|NCT01893177|Vaccines|vaccines|mesh-list
154754260|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
154754261|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754262|NCT05740150|Taurolidine|taurolidine|mesh-list
153696311|NCT00239278|Budesonide|budesonide|mesh-list
153781783|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153781784|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754263|NCT05740150|Heparin|heparin|mesh-list
154754264|NCT05740150|Calcium heparin|calcium heparin|mesh-list
154754265|NCT05740150|Anticoagulants|anticoagulants|mesh-ancestor
154754266|NCT05740150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754267|NCT05740150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154754268|NCT05740150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154754269|NCT05740150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754270|NCT05740150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153781785|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
153781786|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154754271|NCT05740150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754272|NCT05734612|Colchicine|colchicine|mesh-list
154754273|NCT05734612|Gout Suppressants|gout suppressants|mesh-ancestor
154754274|NCT05734612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154754275|NCT05734612|Tubulin Modulators|tubulin modulators|mesh-ancestor
154754276|NCT05734612|Antimitotic Agents|antimitotic agents|mesh-ancestor
154754277|NCT05734612|Mitosis Modulators|mitosis modulators|mesh-ancestor
154754278|NCT05734612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425353|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153408962|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
154754279|NCT05734612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754280|NCT02349867|Gemcitabine|gemcitabine|mesh-list
154754281|NCT02349867|Sorafenib|sorafenib|mesh-list
154754282|NCT02349867|Vorinostat|vorinostat|mesh-list
154754283|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154754284|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
154754285|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754286|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754287|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696719|NCT00241423|Incretins|incretins|mesh-ancestor
154754288|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754289|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154754290|NCT02629419|Amphotericin B|amphotericin b|mesh-list
154754291|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154754292|NCT02629419|Amebicides|amebicides|mesh-ancestor
154754293|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154754294|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154754295|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754296|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154754297|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
154754298|NCT02334735|Vaccines|vaccines|mesh-list
154754299|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154754300|NCT02334735|Poly ICLC|poly iclc|mesh-list
154754301|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
154263424|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754302|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754303|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154754304|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
154754305|NCT02329600|Triamcinolone|triamcinolone|mesh-list
154754306|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154754307|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154754308|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154754309|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154754310|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
153697021|NCT00243880|Lovastatin|lovastatin|mesh-list
153413114|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782003|NCT04566211|Amoxicillin|amoxicillin|mesh-list
154754311|NCT02329600|Hormones|hormones|mesh-ancestor
154754312|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754313|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754314|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154754315|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
154754316|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754317|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754318|NCT02620761|Fenoldopam|fenoldopam|mesh-list
154754319|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154754320|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
154754321|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
154754322|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
154754323|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263425|NCT05592379|Psilocybin|psilocybin|mesh-list
154263426|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
153782006|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153697741|NCT00068081|Capsaicin|capsaicin|mesh-list
153782007|NCT04566211|Pantoprazole|pantoprazole|mesh-list
153425638|NCT00691652|Clofarabine|clofarabine|mesh-list
153698057|NCT00251017|Vancomycin|vancomycin|mesh-list
154263427|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754324|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754325|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754326|NCT04758273|Vaccines|vaccines|mesh-list
154754327|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
154754328|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754329|NCT01729871|Vitamin K|vitamin k|mesh-list
154754330|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
154754331|NCT01729871|Vitamins|vitamins|mesh-ancestor
154754332|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
153698436|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754333|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754334|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154754335|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
154754336|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154754337|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
154754338|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754339|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754340|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
154506275|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
153698541|NCT00254254|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153736010|NCT03899077|Goserelin|goserelin|mesh-list
153810916|NCT00331188|Analgesics|analgesics|mesh-ancestor
153782018|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153417748|NCT04507022|Progesterone|progesterone|mesh-list
153731582|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731583|NCT00138632|Vatalanib|vatalanib|mesh-list
154754341|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154754342|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154754343|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
154754344|NCT01729871|Coagulants|coagulants|mesh-ancestor
154754346|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
154754347|NCT02611323|Venetoclax|venetoclax|mesh-list
154754348|NCT02611323|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154754349|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154754350|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754351|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
154754352|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263428|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154754353|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154754354|NCT02611323|Immunoconjugates|immunoconjugates|mesh-ancestor
154754355|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
154754356|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754357|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154754358|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754359|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754360|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
154754361|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736012|NCT03899077|Leuprolide|leuprolide|mesh-list
153626805|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754362|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754363|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154754364|NCT01729559|Heparin|heparin|mesh-list
154754365|NCT01729559|Enoxaparin|enoxaparin|mesh-list
154754366|NCT01729559|Calcium heparin|calcium heparin|mesh-list
154754367|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
154754368|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
154754369|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154754370|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154754371|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754372|NCT01926496|Imiquimod|imiquimod|mesh-list
154754373|NCT01926496|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153699563|NCT00261586|Aspirin|aspirin|mesh-list
154754374|NCT01926496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754375|NCT01926496|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154754376|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
154754377|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754378|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154754379|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754380|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
154263429|NCT05577702|Paclitaxel|paclitaxel|mesh-list
154263430|NCT05577702|Carboplatin|carboplatin|mesh-list
154754381|NCT04559555|Nilotinib|nilotinib|mesh-list
154754382|NCT04559555|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154754383|NCT04559555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154754384|NCT04559555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754385|NCT04559555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754386|NCT01728779|Nelfinavir|nelfinavir|mesh-list
154754387|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154754388|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154754389|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
154754390|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754391|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754392|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154754393|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154754394|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
154754395|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754396|NCT01927120|Sirolimus|sirolimus|mesh-list
154754397|NCT01927120|Aldesleukin|aldesleukin|mesh-list
154263431|NCT05577702|Pemetrexed|pemetrexed|mesh-list
153781805|NCT00266721|Pancrelipase|pancrelipase|mesh-list
153781807|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731596|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153731597|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731598|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731599|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153731600|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
153731601|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153426124|NCT00379964|Caspofungin|caspofungin|mesh-list
154754398|NCT01927120|Tacrolimus|tacrolimus|mesh-list
154754399|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154754400|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
154754401|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754402|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154754403|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754404|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754405|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154754406|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263432|NCT05577702|Tislelizumab|tislelizumab|mesh-list
153426143|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
153781810|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154754407|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154754408|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754409|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
154754410|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154754411|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154754412|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
154754413|NCT01728623|Lenvatinib|lenvatinib|mesh-list
154754414|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754415|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154754416|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754417|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754418|NCT02573337|Lidocaine|lidocaine|mesh-list
154754419|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
154754420|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
154754421|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154754422|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263433|NCT05577702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153781812|NCT04558684|Immunomodulating Agents|immunomodulating agents|mesh-list
154754423|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
154754424|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754425|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154754426|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154754427|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154754428|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154754429|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754430|NCT01728077|Brivaracetam|brivaracetam|mesh-list
154263434|NCT05577702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754431|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
154754432|NCT01606007|Metformin|metformin|mesh-list
154754433|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
154754434|NCT01606007|Saxagliptin|saxagliptin|mesh-list
154754435|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154754436|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754437|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154754438|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754439|NCT01606007|Incretins|incretins|mesh-ancestor
154754440|NCT01606007|Hormones|hormones|mesh-ancestor
154754441|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754442|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154754443|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
154754444|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754445|NCT01928290|Leucovorin|leucovorin|mesh-list
154754446|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
154754447|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
154754448|NCT01928290|Fluorouracil|fluorouracil|mesh-list
154754449|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
154754450|NCT01928290|Trastuzumab|trastuzumab|mesh-list
154754451|NCT01928290|Irinotecan|irinotecan|mesh-list
154754452|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
154754453|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
154754454|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754455|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700915|NCT00270907|Gemcitabine|gemcitabine|mesh-list
153731609|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153731610|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754456|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754457|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154754458|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
154754459|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754460|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154754461|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154754462|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154754463|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754464|NCT01928290|Antidotes|antidotes|mesh-ancestor
154255945|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731617|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154754465|NCT01928290|Protective Agents|protective agents|mesh-ancestor
154754466|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
154754467|NCT01928290|Vitamins|vitamins|mesh-ancestor
154754468|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
154754469|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
154754470|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
154754471|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154754472|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154754473|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754474|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154754475|NCT02282319|Analgesics|analgesics|mesh-ancestor
154754476|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
154754477|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255946|NCT01157312|Citric Acid|citric acid|mesh-list
153731618|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153731619|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731620|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153731621|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153731622|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154754478|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154754479|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154754480|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154754481|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
154754482|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754483|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754484|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
154754485|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
154754486|NCT02278965|Metformin|metformin|mesh-list
153426291|NCT00000776|Amebicides|amebicides|mesh-ancestor
153731623|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153731624|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153731625|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154754487|NCT02278965|Biguanides|biguanides|mesh-list
154754488|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154754489|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754490|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
154754491|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
154754492|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154754493|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426318|NCT00000800|Methadone|methadone|mesh-list
153701503|NCT00108537|Bupropion|bupropion|mesh-list
153424892|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
153782020|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153424967|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154754494|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754495|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
154754496|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154754497|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154754498|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754499|NCT02983383|Anesthetics|anesthetics|mesh-list
154754500|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154754501|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754502|NCT02748369|Glucagon|glucagon|mesh-list
154754503|NCT02748369|Hormones|hormones|mesh-list
154754504|NCT02748369|Somatostatin|somatostatin|mesh-list
154754505|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154255947|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
153782022|NCT00259779|Prednisolone|prednisolone|mesh-list
154754506|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754507|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154754508|NCT01928680|Capecitabine|capecitabine|mesh-list
154754509|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754510|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154754511|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
154754512|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754513|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
154255948|NCT01157312|Clomiphene|clomiphene|mesh-list
153782024|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
153702221|NCT00281944|Vitamins|vitamins|mesh-ancestor
154754514|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154754515|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754516|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154754517|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154754518|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754519|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754520|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255949|NCT01157312|Enclomiphene|enclomiphene|mesh-list
154754521|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154754522|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154754523|NCT02283814|Topiramate|topiramate|mesh-list
154754524|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154754525|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
154754526|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154754527|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754528|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154754529|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154255950|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
154255951|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
154255952|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153731635|NCT00154401|Hormones|hormones|mesh-ancestor
153426394|NCT02921906|Acetaminophen|acetaminophen|mesh-list
153489097|NCT05495568|Adalimumab|adalimumab|mesh-list
154754530|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154754531|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754532|NCT02462421|Canagliflozin|canagliflozin|mesh-list
154754533|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154754534|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754535|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154754536|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754537|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
154754538|NCT02727387|Temozolomide|temozolomide|mesh-list
154754539|NCT02727387|Melphalan|melphalan|mesh-list
154754540|NCT02727387|Busulfan|busulfan|mesh-list
154754541|NCT02727387|Ifosfamide|ifosfamide|mesh-list
154754542|NCT02727387|Irinotecan|irinotecan|mesh-list
154754543|NCT02727387|Etoposide|etoposide|mesh-list
154754544|NCT02727387|Vincristine|vincristine|mesh-list
154754545|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154255953|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
154255954|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
153782026|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
154754546|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
154754547|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754548|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154754549|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154754550|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
154754551|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754552|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754553|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154754554|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154754555|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154754556|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426581|NCT00000878|Lamivudine|lamivudine|mesh-list
153426597|NCT00001736|Cysteamine|cysteamine|mesh-list
153489100|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153626811|NCT02019160|Protective Agents|protective agents|mesh-ancestor
153703163|NCT00078182|Tenofovir|tenofovir|mesh-list
154754557|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154754558|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154754559|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154754560|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154754561|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154754562|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
154754563|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154754564|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
154754565|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754566|NCT02445651|Expectorants|expectorants|mesh-ancestor
154754567|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
154263435|NCT05577702|Tubulin Modulators|tubulin modulators|mesh-ancestor
154754568|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154754569|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
154754570|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754571|NCT02445651|Protective Agents|protective agents|mesh-ancestor
154754572|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754573|NCT02445651|Antidotes|antidotes|mesh-ancestor
154754574|NCT02284516|Lifitegrast|lifitegrast|mesh-list
154754575|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154754576|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154754577|NCT02721537|Niacinamide|niacinamide|mesh-list
154754578|NCT02721537|Niacin|niacin|mesh-list
154255955|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754579|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
154754580|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
154754581|NCT02721537|Vitamins|vitamins|mesh-ancestor
154754582|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
154754583|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754584|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154754585|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
154754586|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754587|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154754588|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
154754589|NCT02185209|Amoxicillin|amoxicillin|mesh-list
154754590|NCT02185209|Metronidazole|metronidazole|mesh-list
153426719|NCT00000920|Ritonavir|ritonavir|mesh-list
154754591|NCT02185209|Penicillin V|penicillin v|mesh-list
154754592|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154754593|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754594|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154754595|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154754596|NCT01894035|Iloprost|iloprost|mesh-list
154754597|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154754598|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
154754599|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
154754600|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153489102|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
153489103|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427898|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
154255956|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154754601|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154754602|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154754603|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
154754604|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754605|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754606|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754607|NCT02716311|Cetuximab|cetuximab|mesh-list
154754608|NCT02716311|Afatinib|afatinib|mesh-list
154754609|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255957|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
153781818|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489104|NCT05358834|Protective Agents|protective agents|mesh-ancestor
154754610|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754611|NCT02716311|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154754612|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154754613|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754614|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754615|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
154754616|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154754617|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154754618|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754619|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
154754620|NCT05439694|Coagulants|coagulants|mesh-ancestor
154754621|NCT02290444|Hormones|hormones|mesh-list
154754622|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154754623|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154754624|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
154754625|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754626|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754627|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754628|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754629|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154754630|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
154754631|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754632|NCT01752023|Itraconazole|itraconazole|mesh-list
154754633|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154754634|NCT01752023|Cisplatin|cisplatin|mesh-list
154754635|NCT01752023|Gemcitabine|gemcitabine|mesh-list
154754636|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426887|NCT00000242|Carbamazepine|carbamazepine|mesh-list
153704766|NCT00306358|Vitamins|vitamins|mesh-ancestor
154754637|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154754638|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
154754639|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754640|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
154754641|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754642|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154754643|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154754644|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754645|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154754646|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
154263436|NCT05577702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705028|NCT00081302|Paclitaxel|paclitaxel|mesh-list
154769389|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769390|NCT01565083|Trastuzumab|trastuzumab|mesh-list
154769391|NCT01565083|Pertuzumab|pertuzumab|mesh-list
154769392|NCT01565083|Vinorelbine|vinorelbine|mesh-list
154769393|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769394|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769395|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154769396|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
154769397|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705197|NCT00303550|Linezolid|linezolid|mesh-list
154769398|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154769399|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769400|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
154769401|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769402|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154769403|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154769404|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
154769405|NCT01537081|Guaifenesin|guaifenesin|mesh-list
154769406|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154769407|NCT01537081|Expectorants|expectorants|mesh-ancestor
153705558|NCT00305734|Bortezomib|bortezomib|mesh-list
154754647|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754648|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754649|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154754650|NCT02986906|Triamcinolone|triamcinolone|mesh-list
154754651|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154754652|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
154754653|NCT02986906|Hormones|hormones|mesh-ancestor
154754654|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754655|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754656|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
154754657|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
154754658|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154754659|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154754660|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263437|NCT05577702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153781823|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
154754661|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754662|NCT01726049|Urological Agents|urological agents|mesh-ancestor
154754663|NCT02162667|Trastuzumab|trastuzumab|mesh-list
154754664|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154754665|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754666|NCT01605617|Fesoterodine|fesoterodine|mesh-list
154754667|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154754668|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154263438|NCT05577702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754669|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
154754670|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754671|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754672|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754673|NCT01605617|Urological Agents|urological agents|mesh-ancestor
154754674|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
154754675|NCT05402020|Olodaterol|olodaterol|mesh-list
154754676|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154754677|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
154754678|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754679|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754680|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154754681|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
154754682|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
154255958|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153489106|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153781824|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
153626812|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754683|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154754684|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
154754685|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754686|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754687|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154754688|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
154754689|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154754690|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154754691|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154754692|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754693|NCT01751867|Decitabine|decitabine|mesh-list
154754694|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154754695|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
154769408|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
154263439|NCT05577702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769409|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154769410|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154769411|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154769412|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769413|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769414|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769415|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
153706496|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
153539888|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154769416|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154769417|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
154769418|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
154769419|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769420|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
154769421|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154769422|NCT01555073|Celecoxib|celecoxib|mesh-list
154769423|NCT01555073|Pregabalin|pregabalin|mesh-list
154769424|NCT01555073|Analgesics|analgesics|mesh-ancestor
154769425|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
154769426|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769427|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769428|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
154769429|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154769430|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154769431|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769432|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154769433|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154769434|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154769435|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769436|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154769437|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154769438|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769439|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769440|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769441|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154769442|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154769443|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769444|NCT01582243|Vildagliptin|vildagliptin|mesh-list
154769445|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154769446|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427271|NCT00001094|Lamivudine|lamivudine|mesh-list
153489108|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
154754696|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754697|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754698|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754699|NCT02418195|Ketamine|ketamine|mesh-list
154754700|NCT02418195|Analgesics|analgesics|mesh-ancestor
154754701|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
154754702|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754703|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754704|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154754705|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154754706|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
154754707|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
154754708|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154754709|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154754710|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154754711|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769447|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153427276|NCT00001094|Saquinavir|saquinavir|mesh-list
154769448|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
154769449|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769450|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769451|NCT01536535|Prednisone|prednisone|mesh-list
154769452|NCT01536535|Mesalamine|mesalamine|mesh-list
154769453|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769454|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
154769455|NCT01536535|Hormones|hormones|mesh-ancestor
154769456|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769457|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769458|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154769459|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769460|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154769461|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769462|NCT01536535|Analgesics|analgesics|mesh-ancestor
154769463|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
154769464|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769465|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769466|NCT01553747|Eluxadoline|eluxadoline|mesh-list
154769467|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769468|NCT01536379|Belimumab|belimumab|mesh-list
154769469|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154255959|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430539|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
153781825|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154754712|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754713|NCT05633914|Paclitaxel|paclitaxel|mesh-list
154754714|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154754715|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754716|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
154754717|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
154754718|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
154754719|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754720|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154754721|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154754722|NCT05382364|Tucatinib|tucatinib|mesh-list
154754723|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754724|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154255960|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154255961|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
154754725|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754726|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754727|NCT02712801|Ritonavir|ritonavir|mesh-list
154754728|NCT02712801|Lopinavir|lopinavir|mesh-list
154754729|NCT02712801|Lamivudine|lamivudine|mesh-list
154754730|NCT02712801|Zidovudine|zidovudine|mesh-list
154754731|NCT02712801|Nevirapine|nevirapine|mesh-list
154754732|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154754733|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154754734|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
154255962|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153539889|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154754735|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754736|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754737|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154754738|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154754739|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
154754740|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754741|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154754742|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153707686|NCT06002646|Chromium|chromium|mesh-list
154754743|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154754744|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154754745|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
154754746|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154754747|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154754748|NCT02712723|Letrozole|letrozole|mesh-list
154754749|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754750|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154754751|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154754752|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769470|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
153707766|NCT06000137|Autonomic Agents|autonomic agents|mesh-ancestor
153781827|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153431812|NCT05818150|Hormones|hormones|mesh-ancestor
154754753|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754754|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154754755|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
154754756|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754757|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754758|NCT01751087|Vitamins|vitamins|mesh-list
154754759|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
154754760|NCT01751087|Misoprostol|misoprostol|mesh-list
154754761|NCT01751087|Mifepristone|mifepristone|mesh-list
154754762|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
154754763|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754764|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153707876|NCT05998551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707877|NCT05998551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153489149|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153489150|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153489151|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153489152|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
153489153|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
153489154|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489155|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489156|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153489157|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
153489193|NCT03149874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489194|NCT02834052|Poly I-C|poly i-c|mesh-list
153489195|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
153489196|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153489197|NCT02834052|Poly ICLC|poly iclc|mesh-list
153489198|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489222|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489223|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489224|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153489225|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489226|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
153489227|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489228|NCT02460042|Paclitaxel|paclitaxel|mesh-list
153489229|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153489230|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754765|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
153489381|NCT05352282|Narcotics|narcotics|mesh-ancestor
154754766|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153489616|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
154754767|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154754768|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154754769|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
154754770|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
153708586|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754771|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153708804|NCT05065424|Atropine|atropine|mesh-list
154754772|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154754773|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153427764|NCT00000578|Beclomethasone|beclomethasone|mesh-list
153490532|NCT05419674|Amoxicillin|amoxicillin|mesh-list
153490535|NCT05419674|Bismuth|bismuth|mesh-list
154754774|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154754775|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
153736029|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
154754776|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153490771|NCT05281770|Erenumab|erenumab|mesh-list
153490883|NCT02655354|Analgesics|analgesics|mesh-ancestor
154754777|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154754778|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
153427892|NCT00002162|Zalcitabine|zalcitabine|mesh-list
153427965|NCT00002168|Lamivudine|lamivudine|mesh-list
153491605|NCT06085365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153491732|NCT06082817|Hormones|hormones|mesh-ancestor
154255971|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491964|NCT05032183|Vincristine|vincristine|mesh-list
154769471|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769472|NCT01536067|Bortezomib|bortezomib|mesh-list
154769473|NCT01536067|Ofatumumab|ofatumumab|mesh-list
153710400|NCT00091104|Aldesleukin|aldesleukin|mesh-list
153492445|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153710700|NCT00123201|Hormones|hormones|mesh-ancestor
154769474|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769475|NCT04410211|Midazolam|midazolam|mesh-list
154769476|NCT04410211|Sevoflurane|sevoflurane|mesh-list
153492937|NCT02911818|Incretins|incretins|mesh-ancestor
154769477|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154769478|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154769479|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711771|NCT00318175|Bosentan|bosentan|mesh-list
153428698|NCT03342157|Sennosides|sennosides|mesh-list
154769480|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769481|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154769482|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154769483|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154754779|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754780|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
154754781|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154754782|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153494993|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
153495096|NCT04422210|Etoposide|etoposide|mesh-list
154754783|NCT02393157|Carboplatin|carboplatin|mesh-list
154754784|NCT02393157|Etoposide|etoposide|mesh-list
154754785|NCT02393157|Ifosfamide|ifosfamide|mesh-list
154754786|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
154521470|NCT03401619|Vitamins|vitamins|mesh-ancestor
153495711|NCT00000924|Nelfinavir|nelfinavir|mesh-list
153495973|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496110|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496129|NCT00002046|Zidovudine|zidovudine|mesh-list
153496195|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
154263445|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
153496282|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154754787|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496535|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153497075|NCT00002586|Vitamins|vitamins|mesh-ancestor
153497217|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754788|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154754789|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154754790|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154754791|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769484|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154754792|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754793|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154754794|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
154754795|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154754796|NCT01750697|Rituximab|rituximab|mesh-list
154754797|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153498244|NCT00003120|Paclitaxel|paclitaxel|mesh-list
153498542|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
153498546|NCT00003396|Melphalan|melphalan|mesh-list
154769485|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
153498791|NCT00003678|Tamoxifen|tamoxifen|mesh-list
154769487|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
154769488|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
153499063|NCT00003906|Tamoxifen|tamoxifen|mesh-list
154255979|NCT01263860|Ribavirin|ribavirin|mesh-list
154754798|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715899|NCT00420589|Hormones|hormones|mesh-ancestor
154754799|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
154255982|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
154754800|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754801|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499645|NCT00004404|Miconazole|miconazole|mesh-list
153499795|NCT00004644|Acyclovir|acyclovir|mesh-list
153499796|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
154754802|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
154754803|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154754804|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
153888939|NCT01294683|Niacin|niacin|mesh-list
154255986|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
153811185|NCT00324467|Rituximab|rituximab|mesh-list
154754805|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754806|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
154754807|NCT02127723|Protective Agents|protective agents|mesh-ancestor
154754808|NCT05586711|Estradiol|estradiol|mesh-list
154754809|NCT05586711|Estrogens|estrogens|mesh-ancestor
154754810|NCT05586711|Hormones|hormones|mesh-ancestor
154255989|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502323|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
154769489|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717472|NCT00429871|Docetaxel|docetaxel|mesh-list
154769490|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255991|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154769491|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154769492|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154769493|NCT01582009|Everolimus|everolimus|mesh-list
153505047|NCT02659306|Metformin|metformin|mesh-list
154754811|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754812|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754813|NCT01724489|Hormones|hormones|mesh-list
154754814|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505413|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
154754815|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754816|NCT01996293|Lamotrigine|lamotrigine|mesh-list
154754817|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
154754818|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154754819|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154754820|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754821|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154754822|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754823|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154754824|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154256005|NCT01264094|Clevudine|clevudine|mesh-list
154754825|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507125|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154754826|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507519|NCT06104111|Vitamin D|vitamin d|mesh-list
153719157|NCT00102284|Levodopa|levodopa|mesh-list
154256008|NCT03884348|Amoxicillin|amoxicillin|mesh-list
154754827|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154754828|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154754829|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154754830|NCT05304364|Naltrexone|naltrexone|mesh-list
154754831|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154754832|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154754833|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754834|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
154769494|NCT01582009|Panobinostat|panobinostat|mesh-list
154769495|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153511136|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
154754835|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754836|NCT01724177|Lenalidomide|lenalidomide|mesh-list
154754837|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
154754838|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769496|NCT01582009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154754839|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154754840|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154754841|NCT01724177|Growth Substances|growth substances|mesh-ancestor
154754842|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430911|NCT00000301|Amantadine|amantadine|mesh-list
153512344|NCT01412892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154754843|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754844|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153512592|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
153720973|NCT00441532|Lidocaine|lidocaine|mesh-list
153512793|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
154754845|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754846|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154754847|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
154754848|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754849|NCT01530009|Amoxicillin|amoxicillin|mesh-list
154754850|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154754851|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514103|NCT01424176|Protective Agents|protective agents|mesh-ancestor
154754852|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
154754853|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153514744|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154754854|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754855|NCT01724021|Prednisone|prednisone|mesh-list
154754856|NCT01724021|Prednisolone|prednisolone|mesh-list
154256024|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
154754857|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154754858|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
153515388|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
154754859|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154754860|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
154754861|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
154754862|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154754863|NCT01724021|Rituximab|rituximab|mesh-list
154754864|NCT01724021|Vincristine|vincristine|mesh-list
154754865|NCT01724021|Doxorubicin|doxorubicin|mesh-list
154754866|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154754867|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154754868|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
154754869|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154754870|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
154754871|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754872|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154754873|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154754874|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
154754875|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722764|NCT04729140|Doxycycline|doxycycline|mesh-list
154754876|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754877|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154754878|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518758|NCT01447394|Ribavirin|ribavirin|mesh-list
153518927|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
154754879|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154754880|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
154754881|NCT01724021|Hormones|hormones|mesh-ancestor
154754882|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519320|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153519704|NCT05620901|Protective Agents|protective agents|mesh-ancestor
154754883|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154754884|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153520270|NCT06248593|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154754885|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
154754886|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
154754887|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
154754888|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
154754889|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
153723843|NCT00445900|Prednisone|prednisone|mesh-list
153521118|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521119|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754890|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754891|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154754892|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154754893|NCT01724021|Protective Agents|protective agents|mesh-ancestor
153522108|NCT04892732|Hormones|hormones|mesh-ancestor
154754894|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154754895|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154754896|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154754897|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754898|NCT05197504|Bevacizumab|bevacizumab|mesh-list
154754899|NCT05197504|Atezolizumab|atezolizumab|mesh-list
154754900|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154754901|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754902|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154754903|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154754904|NCT05197504|Growth Substances|growth substances|mesh-ancestor
154754905|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754906|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
154754907|NCT05197504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154769497|NCT01582009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256045|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154754908|NCT05197504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754909|NCT02293096|Metoprolol|metoprolol|mesh-list
154754910|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
154754911|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154754912|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154754913|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
154754914|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
154754915|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754916|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769498|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754917|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154754918|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154754919|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154754920|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
154754921|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524911|NCT01468389|Capecitabine|capecitabine|mesh-list
154754922|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754923|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
153525114|NCT06077019|Autonomic Agents|autonomic agents|mesh-ancestor
154754924|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
154754925|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154754926|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154754927|NCT01722071|Oxytocin|oxytocin|mesh-list
154754928|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
154754929|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154754930|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754931|NCT04155580|Decitabine|decitabine|mesh-list
154754932|NCT04155580|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154754933|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154754934|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
154754935|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754936|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754937|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754938|NCT01721759|Nivolumab|nivolumab|mesh-list
154754939|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154754940|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754941|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154754942|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754943|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
154506875|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154754944|NCT04776850|Dexamethasone|dexamethasone|mesh-list
153526251|NCT04332341|Niacin|niacin|mesh-list
154754945|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
154754946|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
154754947|NCT04776850|Busulfan|busulfan|mesh-list
154754948|NCT04776850|Rituximab|rituximab|mesh-list
154754949|NCT04776850|Fludarabine|fludarabine|mesh-list
154754950|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
154754951|NCT04776850|Bortezomib|bortezomib|mesh-list
153527334|NCT01471067|Rituximab|rituximab|mesh-list
153527897|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527916|NCT01475227|Astringents|astringents|mesh-ancestor
153527917|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
153527918|NCT01475266|Apaziquone|apaziquone|mesh-list
154754952|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154754953|NCT04776850|Tacrolimus|tacrolimus|mesh-list
154754954|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
154256085|NCT01264328|Paclitaxel|paclitaxel|mesh-list
153528476|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153528477|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154754955|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154754956|NCT04776850|Antibodies|antibodies|mesh-list
154754957|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
154754958|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154754959|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
154754960|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153726724|NCT01241110|Ofloxacin|ofloxacin|mesh-list
154754961|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154754962|NCT04776850|BB 1101|bb 1101|mesh-list
154754963|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154754964|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
153529076|NCT01482156|Dactolisib|dactolisib|mesh-list
154754965|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754966|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154754967|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154754968|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
154754969|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154754970|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154754971|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154754972|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154754973|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
154754974|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
154754975|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154754976|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154754977|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
154754978|NCT04776850|Hormones|hormones|mesh-ancestor
154754979|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154754980|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154754981|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
154754982|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154754983|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154754984|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
154754985|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154256094|NCT01157858|Everolimus|everolimus|mesh-list
154754986|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154754987|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154754988|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
154754989|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154754990|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154754991|NCT04132648|Curcumin|curcumin|mesh-list
154754992|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154754993|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154754994|NCT04132648|Analgesics|analgesics|mesh-ancestor
154754995|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
154754996|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529702|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
153529703|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
153529704|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153529874|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529875|NCT01487564|Analgesics|analgesics|mesh-ancestor
153529876|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
154754997|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154754998|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154754999|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755000|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755001|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736135|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530371|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
153727691|NCT02274454|Oxytocin|oxytocin|mesh-list
153530498|NCT01490749|Everolimus|everolimus|mesh-list
154755002|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530725|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530816|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154755003|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
154755004|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154755005|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
154755006|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755007|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755008|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153728206|NCT04726982|Acetazolamide|acetazolamide|mesh-list
153531212|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153531213|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154755009|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
154755010|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
153531395|NCT01496326|Ibuprofen|ibuprofen|mesh-list
154755011|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154755012|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
154755013|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256125|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
154256126|NCT01260818|Coagulants|coagulants|mesh-ancestor
154256127|NCT01262612|Cediranib|cediranib|mesh-list
154256128|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532273|NCT01501370|Dexamethasone|dexamethasone|mesh-list
154256129|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153532493|NCT01501890|Progestins|progestins|mesh-ancestor
154755014|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755015|NCT04095208|Nivolumab|nivolumab|mesh-list
154755016|NCT04095208|Relatlimab|relatlimab|mesh-list
154755017|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154755018|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755019|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154755020|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755021|NCT02292082|Cefazolin|cefazolin|mesh-list
154755022|NCT02292082|Dexamethasone|dexamethasone|mesh-list
154755023|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
154755024|NCT02292082|Midazolam|midazolam|mesh-list
154755025|NCT02292082|Morphine|morphine|mesh-list
154755026|NCT02292082|Bupivacaine|bupivacaine|mesh-list
154755027|NCT02292082|Propofol|propofol|mesh-list
154755028|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755029|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
154755030|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
154755031|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755032|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755033|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154755034|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
154755035|NCT02292082|Hormones|hormones|mesh-ancestor
154755036|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533825|NCT01508000|Bevacizumab|bevacizumab|mesh-list
154755037|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154755038|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534185|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153534186|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154755039|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
154755040|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
154755041|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755042|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
154755043|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153534651|NCT01512173|Propranolol|propranolol|mesh-list
154755044|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154755045|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
154755046|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154755047|NCT02292082|Narcotics|narcotics|mesh-ancestor
154755048|NCT02292082|Analgesics|analgesics|mesh-ancestor
154755049|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154755050|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154755051|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154755052|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154755053|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
154755054|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
154755055|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256150|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755056|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755057|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154755058|NCT02292082|Protective Agents|protective agents|mesh-ancestor
154755059|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154256152|NCT01264640|Aspirin|aspirin|mesh-list
154755060|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755061|NCT05072704|Sufentanil|sufentanil|mesh-list
154755062|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
154755063|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154755064|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755065|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755066|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154755067|NCT05072704|Analgesics|analgesics|mesh-ancestor
154755068|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
154755069|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755070|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154755071|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154755072|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154755073|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
153535833|NCT01518595|Bosentan|bosentan|mesh-list
154755074|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755075|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755076|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154755077|NCT05072704|Narcotics|narcotics|mesh-ancestor
154755078|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154755079|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154755080|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
154755081|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
154755082|NCT04607122|Landiolol|landiolol|mesh-list
154755083|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154755084|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154755085|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
154755086|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755087|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755088|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755089|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154755090|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
154755091|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154755092|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
154755093|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154755094|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
154755095|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755096|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755097|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
154507020|NCT02304237|Progesterone|progesterone|mesh-list
154755098|NCT01516593|Cytarabine|cytarabine|mesh-list
154755099|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154755100|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
154755101|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755102|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755103|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
154755104|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755105|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755106|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
154755107|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755108|NCT02042391|Cytarabine|cytarabine|mesh-list
154755109|NCT02042391|Prednisone|prednisone|mesh-list
154755110|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
154755111|NCT02042391|Rituximab|rituximab|mesh-list
154755112|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
154755113|NCT02042391|Doxorubicin|doxorubicin|mesh-list
154755114|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154755115|NCT02042391|Vincristine|vincristine|mesh-list
154755116|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755117|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
154755118|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755119|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537957|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
154755120|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154755121|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
154755122|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256190|NCT01261130|Antacids|antacids|mesh-ancestor
154755123|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755124|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153538330|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538331|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
154755125|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154755126|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755127|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
154755128|NCT02042391|Hormones|hormones|mesh-ancestor
154755129|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154755130|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154755131|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154755132|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
154256193|NCT01158248|Panitumumab|panitumumab|mesh-list
154755133|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
154755134|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755135|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154755136|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154755137|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154755138|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755139|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154755140|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
154755141|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
154755142|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
154755143|NCT02461836|Gemcitabine|gemcitabine|mesh-list
154755144|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154755145|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
154755146|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755147|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755148|NCT01986946|Hydromorphone|hydromorphone|mesh-list
154755149|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154755150|NCT01986946|Narcotics|narcotics|mesh-ancestor
153539610|NCT01534585|Paclitaxel|paclitaxel|mesh-list
154755151|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755152|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755153|NCT01986946|Analgesics|analgesics|mesh-ancestor
154755154|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
153539861|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
154755155|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755156|NCT03437200|Nivolumab|nivolumab|mesh-list
154755157|NCT03437200|Ipilimumab|ipilimumab|mesh-list
154182417|NCT05392946|Hormones|hormones|mesh-ancestor
154755158|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154755159|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755160|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154755161|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755162|NCT01903473|Sirolimus|sirolimus|mesh-list
154755163|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154755164|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755165|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154755166|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755167|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
154755168|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755169|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
154755170|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755171|NCT02715726|Atorvastatin|atorvastatin|mesh-list
154755172|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154507100|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755174|NCT02715726|Ezetimibe|ezetimibe|mesh-list
154755175|NCT02715726|Alirocumab|alirocumab|mesh-list
154755176|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154755177|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154755178|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154755179|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
154755180|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183025|NCT02937818|Tremelimumab|tremelimumab|mesh-list
153791751|NCT06290050|Repaglinide|repaglinide|mesh-list
154183353|NCT06040034|Anesthetics, Local|anesthetics, local|mesh-ancestor
154755181|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154256234|NCT03879590|Doxofylline|doxofylline|mesh-list
154183577|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755182|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154755183|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755184|NCT02715726|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154755185|NCT02715726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154183799|NCT04278404|Analgesics|analgesics|mesh-ancestor
154755186|NCT02715726|Protease Inhibitors|protease inhibitors|mesh-ancestor
154755187|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
154755188|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755189|NCT01893567|Clobetasol|clobetasol|mesh-list
154184178|NCT05994638|Vitamins|vitamins|mesh-ancestor
154755190|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755191|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
154755192|NCT01893567|Hormones|hormones|mesh-ancestor
154769499|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769500|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769501|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
154755193|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154755194|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755195|NCT04249596|Tianeptine|tianeptine|mesh-list
154755196|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154755197|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
154755198|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154755199|NCT01476501|Vitamin D|vitamin d|mesh-list
154755200|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
154755201|NCT01476501|Vitamins|vitamins|mesh-ancestor
154755202|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
154755203|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755204|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154755205|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154755206|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154755207|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154755208|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755209|NCT02464020|Vancomycin|vancomycin|mesh-list
154755210|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154755211|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755212|NCT04756089|Oxytocin|oxytocin|mesh-list
154755213|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
154755214|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154755215|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755216|NCT03397888|Betrixaban|betrixaban|mesh-list
154755217|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154755218|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
154755219|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154755220|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154755221|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755222|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755223|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
154755224|NCT01886859|Lenalidomide|lenalidomide|mesh-list
154755225|NCT01886859|Ibrutinib|ibrutinib|mesh-list
154755226|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
154755227|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755228|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154755229|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154755230|NCT01886859|Growth Substances|growth substances|mesh-ancestor
154755231|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
154755232|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755233|NCT01886859|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154755234|NCT01886859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154755235|NCT01886859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755236|NCT01886859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755237|NCT01989910|Efavirenz|efavirenz|mesh-list
154755238|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
154755239|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154755240|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154755241|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755242|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755243|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
154755244|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755245|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154755246|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154755247|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154755248|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154755249|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154755250|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154755251|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154755252|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154755253|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154755254|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154755255|NCT02464722|Epinephrine|epinephrine|mesh-list
154755256|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
154755257|NCT02464722|Remifentanil|remifentanil|mesh-list
154755258|NCT02464722|Propofol|propofol|mesh-list
154755259|NCT02464722|Rocuronium|rocuronium|mesh-list
154755260|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154755261|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755262|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755263|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154185441|NCT01051648|Hormones|hormones|mesh-ancestor
154755264|NCT02464722|Analgesics|analgesics|mesh-ancestor
154755265|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
154755266|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755267|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154185589|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755268|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154755269|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154755270|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
154755271|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755272|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755273|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154755274|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
154755275|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
154755276|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154755277|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154755278|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
154755279|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154755280|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
154755281|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
154755282|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
154755283|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154755284|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154755285|NCT02464722|Narcotics|narcotics|mesh-ancestor
154256323|NCT03879356|Antidotes|antidotes|mesh-ancestor
154755286|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154755287|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154755288|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154755289|NCT01991548|Insulin|insulin|mesh-list
154755290|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154755291|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755292|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
154755293|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154755294|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755295|NCT02461914|Warfarin|warfarin|mesh-list
154755296|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
154755297|NCT01991860|Amisulpride|amisulpride|mesh-list
154755298|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154186431|NCT00514020|Leucovorin|leucovorin|mesh-list
154755299|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154755300|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755301|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755302|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154755303|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154755304|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
154755305|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755306|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755307|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154755308|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
154755309|NCT02463552|Naproxen|naproxen|mesh-list
154755310|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154755311|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154755312|NCT02463552|Analgesics|analgesics|mesh-ancestor
154755313|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
154187370|NCT00338962|Desipramine|desipramine|mesh-list
154187460|NCT03038100|Growth Substances|growth substances|mesh-ancestor
154755314|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187555|NCT00928967|Interferons|interferons|mesh-list
154187629|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
154187634|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
154755315|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187746|NCT01015248|Rituximab|rituximab|mesh-list
154755316|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755317|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755318|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
154755319|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154755320|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187977|NCT01018836|Riluzole|riluzole|mesh-list
153797405|NCT00265031|Bleomycin|bleomycin|mesh-list
154188189|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755321|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755322|NCT01992016|Ranolazine|ranolazine|mesh-list
154188365|NCT04013477|Donepezil|donepezil|mesh-list
154507256|NCT02306733|Oxytocin|oxytocin|mesh-list
154755323|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154188454|NCT04012619|Cisplatin|cisplatin|mesh-list
154755324|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154755325|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755326|NCT01871571|Leucovorin|leucovorin|mesh-list
154755327|NCT01871571|Bevacizumab|bevacizumab|mesh-list
154188738|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154188821|NCT01012934|Alendronate|alendronate|mesh-list
154188822|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154256349|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798413|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
154755328|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154755329|NCT01871571|Fluorouracil|fluorouracil|mesh-list
154755330|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
154755331|NCT01871571|Antibodies|antibodies|mesh-list
154755332|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
154755333|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154755334|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
154189308|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189523|NCT00488982|Docetaxel|docetaxel|mesh-list
154189625|NCT06313801|Antidotes|antidotes|mesh-ancestor
154189703|NCT06312982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799264|NCT00273962|Albuterol|albuterol|mesh-list
154189815|NCT06312254|Anticonvulsants|anticonvulsants|mesh-ancestor
154189924|NCT06311604|Isoflurane|isoflurane|mesh-list
154190008|NCT06310837|Adalimumab|adalimumab|mesh-list
154190122|NCT06305520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755335|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755336|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154755337|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154190447|NCT06246968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755338|NCT01871571|Growth Substances|growth substances|mesh-ancestor
154190569|NCT06186700|Antioxidants|antioxidants|mesh-ancestor
154190851|NCT06099782|Pembrolizumab|pembrolizumab|mesh-list
154755339|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755340|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
154755341|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
154191187|NCT05941585|Antimetabolites|antimetabolites|mesh-ancestor
154755342|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
154191584|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755343|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256356|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
154191877|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154755344|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154755345|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755346|NCT01871571|Antidotes|antidotes|mesh-ancestor
154192144|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
154755347|NCT01871571|Protective Agents|protective agents|mesh-ancestor
154755348|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
154755349|NCT01871571|Vitamins|vitamins|mesh-ancestor
154755350|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
154192547|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154192678|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154192679|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755351|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
154192862|NCT04622917|Prednisolone|prednisolone|mesh-list
154256362|NCT01265576|Etodolac|etodolac|mesh-list
154755352|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154755353|NCT01992172|Protective Agents|protective agents|mesh-ancestor
154755354|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755355|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154755356|NCT03296982|Enoxaparin|enoxaparin|mesh-list
154755357|NCT03296982|Edoxaban|edoxaban|mesh-list
154755358|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
154755359|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154755360|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154755361|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755362|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154755363|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
154755364|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154755365|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
154755366|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755367|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154755368|NCT01895829|Hematinics|hematinics|mesh-ancestor
154755369|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154755370|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154755371|NCT03298698|Prednisone|prednisone|mesh-list
154755372|NCT03298698|Prednisolone|prednisolone|mesh-list
154755373|NCT03298698|Rituximab|rituximab|mesh-list
154256365|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803453|NCT00323583|Leucovorin|leucovorin|mesh-list
154755374|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154755375|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194013|NCT01885689|Sirolimus|sirolimus|mesh-list
154194114|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755376|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
153804014|NCT00325104|Hormones|hormones|mesh-list
154755377|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194352|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
154194459|NCT01020630|Growth Substances|growth substances|mesh-ancestor
154194460|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194461|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
154755378|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755379|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194682|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153804595|NCT00295958|Immunotoxins|immunotoxins|mesh-list
154755380|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
154755381|NCT03298698|Hormones|hormones|mesh-ancestor
154195010|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
154256370|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154195112|NCT00454194|Pemetrexed|pemetrexed|mesh-list
154769502|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195352|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769503|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769504|NCT01553591|Eluxadoline|eluxadoline|mesh-list
154769505|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154195968|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
154769506|NCT01581931|Metformin|metformin|mesh-list
154769507|NCT01581931|Linagliptin|linagliptin|mesh-list
154196162|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
154196378|NCT00951431|Esomeprazole|esomeprazole|mesh-list
154196492|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
154755382|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154755383|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154755384|NCT02463942|Doxycycline|doxycycline|mesh-list
154755385|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154755386|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755387|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
154755388|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154755389|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154755390|NCT03298542|Golimumab|golimumab|mesh-list
154755391|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154755392|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769508|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154755393|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807710|NCT00310934|Narcotics|narcotics|mesh-ancestor
154755394|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
154755395|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755396|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
154755397|NCT03296670|Alprostadil|alprostadil|mesh-list
154755398|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
154755399|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153808038|NCT00313001|Hormones|hormones|mesh-ancestor
154197451|NCT00547703|Nortriptyline|nortriptyline|mesh-list
154755400|NCT03296670|Urological Agents|urological agents|mesh-ancestor
154755401|NCT03298464|Pioglitazone|pioglitazone|mesh-list
154755402|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154755403|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755404|NCT01852071|Busulfan|busulfan|mesh-list
154755405|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
154755406|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755407|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755408|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
154755409|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256386|NCT03883022|Vancomycin|vancomycin|mesh-list
154755410|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154755411|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755412|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154755413|NCT04084548|Lidocaine|lidocaine|mesh-list
154755414|NCT04084548|Ketamine|ketamine|mesh-list
154256390|NCT01159652|Zolpidem|zolpidem|mesh-list
154197982|NCT00963443|Aspirin|aspirin|mesh-list
154197983|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
154755415|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
154755416|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
154198473|NCT03933449|Paclitaxel|paclitaxel|mesh-list
154198585|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154755417|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153810141|NCT00317681|Tacrolimus|tacrolimus|mesh-list
153432140|NCT05262556|Nivolumab|nivolumab|mesh-list
154256395|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154755418|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755419|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
154256397|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
154755420|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755421|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154755422|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154755423|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154755424|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154755425|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755426|NCT04084548|Analgesics|analgesics|mesh-ancestor
154755427|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154755428|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154755429|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
154755430|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154755431|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154755432|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755433|NCT02059642|Metadoxine|metadoxine|mesh-list
154755434|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154755435|NCT03296358|Dexamethasone|dexamethasone|mesh-list
154755436|NCT03296358|Prednisolone|prednisolone|mesh-list
154755437|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755438|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
154755439|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
154755440|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736373|NCT02903160|Prednisone|prednisone|mesh-list
154200123|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
154755441|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755442|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154755443|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
154755444|NCT03296358|Hormones|hormones|mesh-ancestor
154755445|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154755446|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154755447|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755448|NCT04756323|Vaccines|vaccines|mesh-list
154755449|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
154200815|NCT01050777|Paromomycin|paromomycin|mesh-list
154200910|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755450|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755451|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
154755452|NCT00469755|Adapalene|adapalene|mesh-list
154755453|NCT00469755|Tazarotene|tazarotene|mesh-list
154755454|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154755455|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154755456|NCT00469755|Analgesics|analgesics|mesh-ancestor
153948219|NCT04500756|Metformin|metformin|mesh-list
154755457|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
154755458|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755459|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201349|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
154755460|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201458|NCT01564199|Fluticasone|fluticasone|mesh-list
154755461|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755462|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
154201644|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
154755463|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
154755464|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
154755465|NCT00469755|Vitamins|vitamins|mesh-ancestor
154201834|NCT01052259|Gusperimus|gusperimus|mesh-list
154755466|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
154755467|NCT00453531|Acetylcholine|acetylcholine|mesh-list
154202161|NCT00992069|Efavirenz|efavirenz|mesh-list
154202162|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154202163|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154202164|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202165|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202166|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
154202167|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202168|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154202169|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154202170|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154202171|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154202172|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154202173|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154755468|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
154755469|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154755470|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
154755471|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755472|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755473|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755474|NCT03295968|Ibuprofen|ibuprofen|mesh-list
154755475|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154755476|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154755477|NCT03295968|Analgesics|analgesics|mesh-ancestor
154755478|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
154755479|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755480|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755481|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154202212|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154202213|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
154755483|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154755484|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769509|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769510|NCT01581931|Incretins|incretins|mesh-ancestor
154755485|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755486|NCT03298074|Etoposide|etoposide|mesh-list
154755487|NCT03298074|Apatinib|apatinib|mesh-list
153433214|NCT01263691|Vaccines|vaccines|mesh-list
154755488|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154755489|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202683|NCT01055301|Thalidomide|thalidomide|mesh-list
154769511|NCT01581931|Hormones|hormones|mesh-ancestor
154755490|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154755491|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154755492|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202959|NCT01005641|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203063|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154203064|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
154755493|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755494|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203258|NCT00469898|Irinotecan|irinotecan|mesh-list
154755495|NCT01992874|Niacinamide|niacinamide|mesh-list
154755496|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
154755497|NCT01992874|Vitamins|vitamins|mesh-ancestor
154755498|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
153433570|NCT02994836|Adalimumab|adalimumab|mesh-list
154203549|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154203550|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
154755499|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755500|NCT04755543|Fluorouracil|fluorouracil|mesh-list
154755501|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755502|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
154203655|NCT00434148|Hormones|hormones|mesh-ancestor
154755503|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755504|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154755505|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755506|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
154755507|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755508|NCT01993108|Naltrexone|naltrexone|mesh-list
154755509|NCT01993108|Methylphenidate|methylphenidate|mesh-list
154755510|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154755511|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154755512|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755513|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
154755514|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755515|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154755516|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154755517|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154755518|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204459|NCT00449150|Cetrorelix|cetrorelix|mesh-list
154204460|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154755519|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755520|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
154755521|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755522|NCT02307526|Bromides|bromides|mesh-list
154755523|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154755524|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
154755525|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154755526|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755527|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755528|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
154755529|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205024|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
154755530|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755531|NCT01371201|Sunitinib|sunitinib|mesh-list
154755532|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205126|NCT00436826|Interferons|interferons|mesh-list
154755533|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154755534|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154755535|NCT01371201|Growth Substances|growth substances|mesh-ancestor
154755536|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755537|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
154755538|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154755539|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755540|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755541|NCT00436527|Metronidazole|metronidazole|mesh-list
154755542|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755543|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154755544|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154755545|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154755546|NCT02307916|Mitogens|mitogens|mesh-list
154755547|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
154205764|NCT00414440|Everolimus|everolimus|mesh-list
154205832|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154205834|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
154205968|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154205969|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206089|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154206090|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
154206187|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
154206280|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206303|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206460|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206461|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755548|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755549|NCT00419367|Vorinostat|vorinostat|mesh-list
154755550|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507476|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
154206576|NCT00288639|Pregabalin|pregabalin|mesh-list
154755551|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154755552|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755553|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755554|NCT01994746|Glucagon|glucagon|mesh-list
154755555|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154755556|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154755557|NCT01994746|Hormones|hormones|mesh-ancestor
154755558|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206828|NCT00429572|Fludarabine|fludarabine|mesh-list
154755559|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755560|NCT01994746|Incretins|incretins|mesh-ancestor
154755561|NCT00291525|Warfarin|warfarin|mesh-list
154755562|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
154755563|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
154755564|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154755565|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755566|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755567|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154755568|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154755569|NCT01337349|Protective Agents|protective agents|mesh-ancestor
154755570|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755571|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
154755572|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154755573|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
154755574|NCT01999348|Timolol|timolol|mesh-list
154755575|NCT01999348|Bimatoprost|bimatoprost|mesh-list
154207581|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
154755576|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154755577|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154755578|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
154256424|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755579|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755580|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755581|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755582|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154755583|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154755584|NCT00280761|Capecitabine|capecitabine|mesh-list
154755585|NCT00280761|Fluorouracil|fluorouracil|mesh-list
154755586|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154755587|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
154755588|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208316|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755589|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755590|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755591|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
154755592|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755593|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154755594|NCT02463318|Melatonin|melatonin|mesh-list
154755595|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
154208683|NCT00266877|Neratinib|neratinib|mesh-list
154208759|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
154755596|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755597|NCT02463318|Protective Agents|protective agents|mesh-ancestor
154755598|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755599|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153435674|NCT00002569|Vincristine|vincristine|mesh-list
154209093|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
154209109|NCT00189202|Sirolimus|sirolimus|mesh-list
154755600|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154755601|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755602|NCT01436968|Valacyclovir|valacyclovir|mesh-list
154755603|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
154755604|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755605|NCT02462772|Cabotegravir|cabotegravir|mesh-list
154755606|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154755607|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154209618|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755608|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154755609|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154755610|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154755611|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154755612|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755613|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755614|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154210021|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210022|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
154210160|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
154210162|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
154755615|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154755616|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
154755617|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755618|NCT02716194|Factor VIII|factor viii|mesh-list
154755619|NCT02716194|Coagulants|coagulants|mesh-ancestor
154755620|NCT02461056|Ibuprofen|ibuprofen|mesh-list
154755621|NCT02461056|Hydromorphone|hydromorphone|mesh-list
154755622|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154755623|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154507544|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154755624|NCT02461056|Analgesics|analgesics|mesh-ancestor
154755625|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
154210580|NCT00170950|Benazepril|benazepril|mesh-list
154755626|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755627|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755628|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755629|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755630|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154755631|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210840|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154210980|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154210981|NCT00128830|Etravirine|etravirine|mesh-list
154210982|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
154755632|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755633|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154755634|NCT02461056|Narcotics|narcotics|mesh-ancestor
154755635|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755637|NCT01173172|Trace Elements|trace elements|mesh-ancestor
154755638|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
154755639|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755640|NCT00003270|Cyclosporine|cyclosporine|mesh-list
154755641|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
154755642|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
154755643|NCT00003270|Busulfan|busulfan|mesh-list
154755644|NCT00003270|Cyclosporins|cyclosporins|mesh-list
154755645|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154755646|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755647|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
154755648|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436968|NCT00003650|Cytarabine|cytarabine|mesh-list
154755649|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755650|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154755651|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
154755652|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755653|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755654|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154755655|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755656|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
154212130|NCT02531451|Analgesics|analgesics|mesh-ancestor
154755657|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755658|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
154755659|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154755660|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755661|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
154755662|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
154755663|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755664|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437264|NCT00002785|Hormones|hormones|mesh-ancestor
154755665|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
154755666|NCT00003270|Hormones|hormones|mesh-ancestor
153959622|NCT02818803|Propolis|propolis|mesh-list
154212780|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212781|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154212868|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212872|NCT05169684|Docetaxel|docetaxel|mesh-list
154755667|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154755668|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154755669|NCT00003270|Protective Agents|protective agents|mesh-ancestor
154755670|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
154755671|NCT02005354|Anesthetics|anesthetics|mesh-list
154263453|NCT05546866|Osimertinib|osimertinib|mesh-list
154755672|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
154755673|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755674|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755675|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
154755676|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755677|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154755678|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
154755679|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154755680|NCT02005354|Analgesics|analgesics|mesh-ancestor
154755681|NCT03290820|Aspirin|aspirin|mesh-list
154213973|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437893|NCT00005000|Lamivudine|lamivudine|mesh-list
154214193|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214195|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154214288|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438051|NCT00004430|Prednisolone|prednisolone|mesh-list
154755682|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154755683|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154755684|NCT03290820|Analgesics|analgesics|mesh-ancestor
154755685|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
154755686|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755687|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755688|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755689|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755690|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154755691|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154755692|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438178|NCT00005060|Docetaxel|docetaxel|mesh-list
154755693|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154755694|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154755695|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755696|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
154755697|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154755698|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
154507624|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755699|NCT03773484|Narcotics|narcotics|mesh-ancestor
154215361|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154755700|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154215440|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
154215705|NCT00321828|Leucovorin|leucovorin|mesh-list
154755701|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755703|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
154755704|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755705|NCT03283410|Propofol|propofol|mesh-list
154755706|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154755707|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216317|NCT00335972|Analgesics|analgesics|mesh-ancestor
154755708|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755709|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154755710|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
154755711|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
154755712|NCT04318704|Ifenprodil|ifenprodil|mesh-list
154755713|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154755714|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154755715|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
154755716|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755717|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755718|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755719|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
154755720|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154755721|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154755722|NCT03283176|Folic Acid|folic acid|mesh-list
154755723|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
154755724|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
154755725|NCT03283176|Vitamins|vitamins|mesh-ancestor
154755726|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
154755727|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755728|NCT03283176|Hematinics|hematinics|mesh-ancestor
154755729|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
154755730|NCT03290430|Nicotine|nicotine|mesh-list
154755731|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154755732|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
154755733|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755734|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755735|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154755736|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154755737|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
154755738|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217375|NCT05308602|Vaccines|vaccines|mesh-list
154755739|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755740|NCT03294798|Interferons|interferons|mesh-list
154755741|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
154755742|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
154755743|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154755744|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755745|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
154755746|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755747|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
154755748|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755749|NCT04488744|Nicotine|nicotine|mesh-list
154755750|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154755751|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
154755752|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755753|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755754|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154217692|NCT04262154|Prednisone|prednisone|mesh-list
154217775|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217776|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217799|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217800|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217801|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217802|NCT03611881|Nicotine|nicotine|mesh-list
154217803|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154217804|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
154217805|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217806|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217807|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154217808|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154217809|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
154217810|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217812|NCT03603912|Metformin|metformin|mesh-list
154755755|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154755756|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
154755757|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755758|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755759|NCT02005666|Clindamycin|clindamycin|mesh-list
154755760|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
154755761|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
154755762|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154755763|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154755764|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755765|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154755766|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755767|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755768|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
154755769|NCT03283020|Naltrexone|naltrexone|mesh-list
154755770|NCT03283020|Remifentanil|remifentanil|mesh-list
154755771|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
154755772|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154755773|NCT03283020|Narcotics|narcotics|mesh-ancestor
154755774|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755775|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755776|NCT03283020|Analgesics|analgesics|mesh-ancestor
154755777|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
154755778|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755779|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154755780|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154755781|NCT00494182|Paclitaxel|paclitaxel|mesh-list
154755782|NCT00494182|Carboplatin|carboplatin|mesh-list
154755783|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154755784|NCT00494182|Sorafenib|sorafenib|mesh-list
154755785|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154755786|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755787|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
154755788|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
154755789|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
154755790|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755791|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154755792|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755793|NCT02006056|Ondansetron|ondansetron|mesh-list
154755794|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
154755795|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
154755796|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755797|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755798|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154755799|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
154755800|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
154755801|NCT02006056|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154755802|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154755803|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
154755804|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755805|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755806|NCT03290196|Bupivacaine|bupivacaine|mesh-list
154755807|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
154755808|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
154755809|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755810|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966070|NCT02764749|Phenol|phenol|mesh-list
154755811|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
154755812|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755813|NCT02006836|Insulin|insulin|mesh-list
154755814|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154755815|NCT02006836|Metformin|metformin|mesh-list
154755816|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
154755817|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154755818|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755819|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
154219553|NCT01066962|Ritonavir|ritonavir|mesh-list
154755820|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154755821|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755822|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154755823|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154755824|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755825|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755826|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755827|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154755828|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154755829|NCT03294486|Flucytosine|flucytosine|mesh-list
154755830|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
154755831|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755832|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
154220295|NCT01064726|Xhance|xhance|mesh-list
154755833|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755834|NCT03294252|Leucovorin|leucovorin|mesh-list
154755835|NCT03294252|Folic Acid|folic acid|mesh-list
154755836|NCT03294252|Fluorouracil|fluorouracil|mesh-list
154220367|NCT00301964|Antibodies|antibodies|mesh-list
154755837|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
154755838|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
154755839|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
154755840|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440102|NCT00003625|Cyclosporine|cyclosporine|mesh-list
153810887|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
154755841|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154755842|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220920|NCT00493649|Docetaxel|docetaxel|mesh-list
154755843|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154221120|NCT01021865|Glucagon|glucagon|mesh-list
154755844|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
154755845|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755846|NCT03294252|Antidotes|antidotes|mesh-ancestor
153440319|NCT00003985|KRN 7000|krn 7000|mesh-list
154755847|NCT03294252|Protective Agents|protective agents|mesh-ancestor
154755848|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
154755849|NCT03294252|Vitamins|vitamins|mesh-ancestor
154755850|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
154755851|NCT03294252|Hematinics|hematinics|mesh-ancestor
154755852|NCT03294174|Ropivacaine|ropivacaine|mesh-list
154755853|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
154755854|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
154221375|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
154755855|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755856|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755857|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
154221491|NCT03962296|Calcium|calcium|mesh-list
154755858|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755859|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
154755860|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
154755861|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154221688|NCT01090960|Ipatasertib|ipatasertib|mesh-list
154755862|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154755863|NCT03289338|Prednisolone|prednisolone|mesh-list
154755864|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
154755865|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154755866|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
154755867|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154755868|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
154755869|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
154222185|NCT00066742|Tirapazamine|tirapazamine|mesh-list
154755870|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755871|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222390|NCT00065182|Docetaxel|docetaxel|mesh-list
154755872|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154755873|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
154755874|NCT03289338|Hormones|hormones|mesh-ancestor
153440733|NCT00003187|Hormones|hormones|mesh-ancestor
154222461|NCT00286442|Metformin|metformin|mesh-list
154755875|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154755876|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154755877|NCT03289338|Protective Agents|protective agents|mesh-ancestor
154755878|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154755879|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222791|NCT06200584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755880|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154755881|NCT02069704|Leucovorin|leucovorin|mesh-list
154755882|NCT02069704|Folic Acid|folic acid|mesh-list
154755883|NCT02069704|Bevacizumab|bevacizumab|mesh-list
154755884|NCT02069704|Fluorouracil|fluorouracil|mesh-list
154755885|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
154755886|NCT02069704|Irinotecan|irinotecan|mesh-list
154755887|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
154755888|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154755889|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223412|NCT04601740|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154755890|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154755891|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154223752|NCT02470299|Ketorolac|ketorolac|mesh-list
154755892|NCT02069704|Growth Substances|growth substances|mesh-ancestor
154755893|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223934|NCT01024205|Sunitinib|sunitinib|mesh-list
154755894|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
154755895|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
154224154|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224186|NCT01073904|Norgestrel|norgestrel|mesh-list
154224259|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
154224350|NCT01070732|Acetaminophen|acetaminophen|mesh-list
154224427|NCT03973086|Protective Agents|protective agents|mesh-ancestor
154224429|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
154256444|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154224604|NCT06186154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224605|NCT06186154|Vitamin B Complex|vitamin b complex|mesh-ancestor
154755896|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755897|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154755898|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154755899|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
154755900|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154755901|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154755902|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154755903|NCT02069704|Antidotes|antidotes|mesh-ancestor
154755904|NCT02069704|Protective Agents|protective agents|mesh-ancestor
154755905|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
154138806|NCT00480532|Estradiol|estradiol|mesh-list
154755906|NCT02069704|Vitamins|vitamins|mesh-ancestor
154755907|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
154755908|NCT02069704|Hematinics|hematinics|mesh-ancestor
154755909|NCT02314546|Lidocaine|lidocaine|mesh-list
154755910|NCT02314546|Midazolam|midazolam|mesh-list
154755911|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154139459|NCT00939588|Telmisartan|telmisartan|mesh-list
154755912|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154755913|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256450|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
154755914|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755915|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154755916|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154755917|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140287|NCT00560352|Hormones|hormones|mesh-ancestor
154755918|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154755919|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
154755920|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
154755921|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
154141403|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755922|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
154755923|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141525|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755924|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755925|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
154141795|NCT00940680|Losartan|losartan|mesh-list
154755926|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
154755927|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141921|NCT00950196|Amantadine|amantadine|mesh-list
154755928|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154755929|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154755930|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154507843|NCT03943888|Atropine|atropine|mesh-list
154755931|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154755932|NCT03289260|Imiquimod|imiquimod|mesh-list
154755933|NCT03289260|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154755934|NCT03289260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755935|NCT03289260|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154755936|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
153442784|NCT02082522|Cisplatin|cisplatin|mesh-list
154755937|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755938|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154755939|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755940|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
154143186|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154143292|NCT01472562|Growth Substances|growth substances|mesh-ancestor
153442929|NCT02044302|Morphine|morphine|mesh-list
153811008|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154143434|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
154143435|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
154143436|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143437|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143438|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
154143439|NCT00132301|Hormones|hormones|mesh-ancestor
154143440|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143441|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143442|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143443|NCT00519831|Cetuximab|cetuximab|mesh-list
154143444|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143445|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143446|NCT04303845|Erenumab|erenumab|mesh-list
154143449|NCT04303845|Analgesics|analgesics|mesh-ancestor
154755942|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154755943|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755944|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
154755945|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755946|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154755947|NCT03289026|Aripiprazole|aripiprazole|mesh-list
154755948|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
154755949|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154755950|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154755951|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154755952|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154755953|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755954|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
154755955|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
154755956|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154755957|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755958|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154755959|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154755960|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
154755961|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154143662|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
154755962|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154256454|NCT03878888|Bupivacaine|bupivacaine|mesh-list
154755963|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154755964|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154755965|NCT02460510|Mannitol|mannitol|mesh-list
154755966|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154755967|NCT02460510|Diuretics|diuretics|mesh-ancestor
154755968|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
154755969|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755970|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
154755971|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154755972|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154755973|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154755974|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154755975|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154755976|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
154755977|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144376|NCT00467584|Aspirin|aspirin|mesh-list
154755978|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755979|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154755980|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755981|NCT03288870|Docetaxel|docetaxel|mesh-list
154755982|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154755983|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
154144644|NCT00718757|Hormones|hormones|mesh-ancestor
154755984|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
154755985|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
154755986|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144977|NCT00715715|Prednisone|prednisone|mesh-list
154755987|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
154755988|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
154755989|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154755990|NCT02460354|Metformin|metformin|mesh-list
154755991|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154145176|NCT00123955|Spironolactone|spironolactone|mesh-list
154755992|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154755993|NCT02008942|Aspirin|aspirin|mesh-list
154755994|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154755995|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154755996|NCT02008942|Analgesics|analgesics|mesh-ancestor
154755997|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
154755998|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154755999|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756000|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756001|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145787|NCT01010451|Calcium|calcium|mesh-list
154756002|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154756003|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154756004|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756005|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154507921|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
154756006|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154756007|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756008|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
154756009|NCT03288636|Ritonavir|ritonavir|mesh-list
154756010|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154756011|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154756012|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
154756013|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146453|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154756014|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756015|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154756016|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154756017|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
154756018|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756019|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154756020|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154756021|NCT03293472|Bupivacaine|bupivacaine|mesh-list
154756022|NCT03293472|Ropivacaine|ropivacaine|mesh-list
154756023|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
154756024|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
154756025|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756026|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756027|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
154756028|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756029|NCT02071810|Opicapone|opicapone|mesh-list
154147185|NCT01011699|Niacin|niacin|mesh-list
154147267|NCT01080469|Tacrolimus|tacrolimus|mesh-list
154147274|NCT01079065|Famotidine|famotidine|mesh-list
154147454|NCT06140576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153444051|NCT01928940|Trametinib|trametinib|mesh-list
154756030|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154756031|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756032|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756033|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154756034|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154148414|NCT05527054|Diuretics|diuretics|mesh-list
154148491|NCT05462496|Metronidazole|metronidazole|mesh-list
154756035|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
153444335|NCT02693717|Pemetrexed|pemetrexed|mesh-list
154756036|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153444380|NCT02634827|Decitabine|decitabine|mesh-list
154756037|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756038|NCT01959490|Paclitaxel|paclitaxel|mesh-list
154756039|NCT01959490|Docetaxel|docetaxel|mesh-list
154756040|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
154756041|NCT01959490|Bevacizumab|bevacizumab|mesh-list
154756042|NCT01959490|Carboplatin|carboplatin|mesh-list
154756043|NCT01959490|Doxorubicin|doxorubicin|mesh-list
154149592|NCT03442569|Nivolumab|nivolumab|mesh-list
154756044|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154756045|NCT01959490|Trastuzumab|trastuzumab|mesh-list
154756046|NCT01959490|Pertuzumab|pertuzumab|mesh-list
154256470|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154756047|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154756048|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756049|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
154756050|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
154756051|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
154756052|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756053|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154756054|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
154756055|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756056|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154756057|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154756058|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
154756059|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154756060|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154150370|NCT00937664|Gemcitabine|gemcitabine|mesh-list
154756061|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153444882|NCT00625703|Linezolid|linezolid|mesh-list
154150853|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154756062|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154151268|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
154756063|NCT01959490|Growth Substances|growth substances|mesh-ancestor
154756064|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
154151888|NCT00954200|Ibuprofen|ibuprofen|mesh-list
154756065|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154756066|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154756067|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154756068|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756069|NCT03288402|Caffeine|caffeine|mesh-list
154756070|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154756071|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756072|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154756073|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756074|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756075|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154756076|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154756077|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
154152011|NCT00949494|Hylan|hylan|mesh-list
154756078|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756079|NCT02011516|Baclofen|baclofen|mesh-list
154152175|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756080|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154507998|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
154152784|NCT04011098|Narcotics|narcotics|mesh-ancestor
154153043|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
154756081|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756082|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154756083|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153516|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
154756084|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154756085|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
154756086|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
154756087|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756088|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756089|NCT04349410|Interferons|interferons|mesh-list
154154441|NCT00545064|Timolol|timolol|mesh-list
154756090|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
154756091|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
154756092|NCT04349410|Remdesivir|remdesivir|mesh-list
154756093|NCT04349410|Azithromycin|azithromycin|mesh-list
154756094|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
154756095|NCT04349410|Doxycycline|doxycycline|mesh-list
154756096|NCT04349410|Clindamycin|clindamycin|mesh-list
154756097|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
154756098|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
154756099|NCT04349410|Primaquine|primaquine|mesh-list
154756100|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
154756101|NCT04349410|Losartan|losartan|mesh-list
154756102|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756103|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
154156552|NCT06265545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756104|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756105|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756106|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
154756107|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
154756108|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756109|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756110|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154756111|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
154756112|NCT04349410|Hormones|hormones|mesh-ancestor
154158577|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158911|NCT03646123|Immunotoxins|immunotoxins|mesh-ancestor
154756113|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756114|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154256493|NCT01160042|Metformin|metformin|mesh-list
154756115|NCT04349410|Protective Agents|protective agents|mesh-ancestor
154756116|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
154756117|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154159827|NCT04005222|Trace Elements|trace elements|mesh-ancestor
154756118|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
154160188|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
154756119|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154160336|NCT00490815|Hormones|hormones|mesh-ancestor
154756120|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154756121|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756122|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756123|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161561|NCT04008290|Hormones|hormones|mesh-ancestor
154756124|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154161734|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756125|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154756126|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154162149|NCT00977444|Hormones|hormones|mesh-ancestor
154756127|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154162224|NCT04007588|Linrodostat|linrodostat|mesh-list
154756128|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154756129|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
154756130|NCT03287388|Rocuronium|rocuronium|mesh-list
154756131|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154756132|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154163113|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
154756133|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154756134|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163382|NCT00766025|Calcium|calcium|mesh-list
154756135|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756136|NCT03293004|Vitamins|vitamins|mesh-list
154756137|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
154756138|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
154164501|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
154164680|NCT00057811|Antidotes|antidotes|mesh-ancestor
154756139|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756140|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
154756141|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756142|NCT03293004|Protective Agents|protective agents|mesh-ancestor
154756143|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
154756144|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
154165358|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756145|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165793|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
154165913|NCT00999440|Methadone|methadone|mesh-list
154756146|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756147|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756148|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
154756149|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
154756150|NCT03282162|Oxytocin|oxytocin|mesh-list
154756151|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
154167112|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154756152|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154756153|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756154|NCT03287076|Exenatide|exenatide|mesh-list
154756155|NCT03287076|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154756156|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154756157|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756158|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154756159|NCT03287076|Incretins|incretins|mesh-ancestor
154756160|NCT03287076|Hormones|hormones|mesh-ancestor
154168381|NCT06333262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153621807|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
154168578|NCT06331182|Ketamine|ketamine|mesh-list
154168822|NCT06227832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169224|NCT05901961|Zinc|zinc|mesh-list
154256505|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154256506|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154256507|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
154170015|NCT05249426|Cetuximab|cetuximab|mesh-list
154256508|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
154170378|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
154170746|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
154756161|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756162|NCT02460276|Rituximab|rituximab|mesh-list
154756163|NCT02460276|Lenalidomide|lenalidomide|mesh-list
154756164|NCT02460276|Ibrutinib|ibrutinib|mesh-list
154756165|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154756166|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756167|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
153923742|NCT00968253|Doxorubicin|doxorubicin|mesh-list
153924057|NCT04920682|Iodine|iodine|mesh-list
153924326|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
153924330|NCT01221272|Ranolazine|ranolazine|mesh-list
153924774|NCT02659657|Analgesics|analgesics|mesh-ancestor
154756168|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924927|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
154756169|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154756170|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154756171|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154756172|NCT02460276|Growth Substances|growth substances|mesh-ancestor
154756173|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
154756174|NCT02460276|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153925431|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153925432|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925434|NCT02653261|Coagulants|coagulants|mesh-ancestor
153925435|NCT02653339|Loratadine|loratadine|mesh-list
153925436|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
153925437|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
153925438|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153925439|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153925447|NCT00649597|Benazepril|benazepril|mesh-list
153782208|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154756175|NCT02460276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154756176|NCT02460276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756177|NCT02460276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756178|NCT02460432|Paclitaxel|paclitaxel|mesh-list
154756179|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154756180|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756181|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
154756182|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
154756183|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
154756184|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756185|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
154756186|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154756187|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756188|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154756189|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
154756190|NCT03281928|Diuretics|diuretics|mesh-ancestor
154756191|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
154256515|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153782224|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
153782225|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782227|NCT04673812|Bupivacaine|bupivacaine|mesh-list
154756192|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756193|NCT03281928|Expectorants|expectorants|mesh-ancestor
154756194|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
154756195|NCT03286764|Peppermint oil|peppermint oil|mesh-list
154756196|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
154756197|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
154756198|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756199|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782233|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
153782234|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782235|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153782236|NCT04673812|Narcotics|narcotics|mesh-ancestor
153782237|NCT04673812|Analgesics|analgesics|mesh-ancestor
154756200|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154756201|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
154756202|NCT03281694|Nicotine|nicotine|mesh-list
154756203|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154756204|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
154756205|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756206|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756207|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153448733|NCT00002831|Decitabine|decitabine|mesh-list
153782251|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782260|NCT00233012|Topiramate|topiramate|mesh-list
153782261|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
153387582|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153782267|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
153782268|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756208|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154756209|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
154756210|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756211|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756212|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
154756213|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154756214|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
154756215|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154756216|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756217|NCT03291054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153782273|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756218|NCT03291054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756219|NCT03286296|Antibodies|antibodies|mesh-list
154756220|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154756221|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
154756222|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756223|NCT03285906|Apatinib|apatinib|mesh-list
154756224|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756225|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154756226|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256516|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782284|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153782288|NCT04672759|Durvalumab|durvalumab|mesh-list
153782312|NCT04671589|Meropenem|meropenem|mesh-list
153782313|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153782323|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
153782324|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782325|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782326|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387589|NCT01645176|Atorvastatin|atorvastatin|mesh-list
154256517|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
153782337|NCT00233558|Methotrexate|methotrexate|mesh-list
153360241|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153782387|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
154756227|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756228|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154756229|NCT01895205|Hematinics|hematinics|mesh-ancestor
154756230|NCT01748175|Triamcinolone|triamcinolone|mesh-list
154756231|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154756232|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154756233|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154756234|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756236|NCT01748175|Hormones|hormones|mesh-ancestor
154256518|NCT03876704|Vitamins|vitamins|mesh-list
154256519|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
153782396|NCT04670497|Bupivacaine|bupivacaine|mesh-list
153782397|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
153782398|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
154256520|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369253|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
153782434|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782435|NCT00260364|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153736409|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
153449101|NCT00003215|Hormones|hormones|mesh-ancestor
153782445|NCT00233792|MTOR Inhibitors|mtor inhibitors|mesh-list
153782446|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153782447|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782448|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153387591|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153387592|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
153449214|NCT00004001|Prednisone|prednisone|mesh-list
153782459|NCT00556192|Rituximab|rituximab|mesh-list
153782460|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153731840|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153731841|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153731842|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153731843|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153731844|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370216|NCT02620865|Calcium|calcium|mesh-list
153782471|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
154256521|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153731848|NCT00406341|Difluprednate|difluprednate|mesh-list
153731849|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
153731850|NCT00406341|Hormones|hormones|mesh-ancestor
153370471|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153782473|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153782474|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153782475|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
154256522|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
153782476|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
153782477|NCT00260520|Dalteparin|dalteparin|mesh-list
153782479|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153782480|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
153782481|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153782482|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153731864|NCT00161577|Analgesics|analgesics|mesh-ancestor
153731865|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
153731866|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731867|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731868|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731869|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731870|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153731871|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731872|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731873|NCT00404261|Fluticasone|fluticasone|mesh-list
153731874|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153370881|NCT01231412|Cyclosporine|cyclosporine|mesh-list
153782483|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449447|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
153731884|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153731885|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153731886|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153731887|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153731888|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
153731889|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782484|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
153782485|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153731894|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
153731895|NCT00406380|Bevacizumab|bevacizumab|mesh-list
153731896|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153731897|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731906|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731907|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731908|NCT00161655|Etanercept|etanercept|mesh-list
153731909|NCT00161655|Methotrexate|methotrexate|mesh-list
153731910|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153731911|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
153731912|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153782489|NCT00233909|Immunologic Factors|immunologic factors|mesh-ancestor
153360254|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731919|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545931|NCT06287775|Immunoglobulins|immunoglobulins|mesh-list
153545932|NCT06287775|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153545933|NCT06287775|Immunoglobulin G|immunoglobulin g|mesh-list
153545934|NCT06287775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153545935|NCT06287775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545936|NCT06287775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545937|NCT06287775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545967|NCT06276361|Serotonin Agents|serotonin agents|mesh-ancestor
153546236|NCT06172296|Vitamin A|vitamin a|mesh-list
153546399|NCT06108297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546401|NCT06108297|Antimanic Agents|antimanic agents|mesh-ancestor
154256523|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547619|NCT05369832|Ozanimod|ozanimod|mesh-list
153908011|NCT00961636|Niacin|niacin|mesh-list
153548027|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782520|NCT04669990|Remdesivir|remdesivir|mesh-list
153449695|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
153548559|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549016|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549328|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549329|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549334|NCT04191304|Benralizumab|benralizumab|mesh-list
153549483|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154756237|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756238|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550038|NCT03604991|Paclitaxel|paclitaxel|mesh-list
153550117|NCT03530397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550779|NCT02451111|Rituximab|rituximab|mesh-list
154256525|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551709|NCT01572688|Melphalan|melphalan|mesh-list
154756239|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256526|NCT03878264|Cortisone|cortisone|mesh-list
154756240|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
154756241|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450179|NCT00004817|Phenytoin|phenytoin|mesh-list
153540892|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
153540959|NCT01541943|Losartan|losartan|mesh-list
153541117|NCT01542827|Analgesics|analgesics|mesh-list
153541404|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541405|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153541406|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153541744|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153542010|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542011|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756242|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756243|NCT04755387|Ticagrelor|ticagrelor|mesh-list
154756244|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154256528|NCT03882164|Tacrolimus|tacrolimus|mesh-list
153542616|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
153542618|NCT01552967|Capecitabine|capecitabine|mesh-list
154756245|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154756246|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153544282|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153544739|NCT05570084|Urological Agents|urological agents|mesh-ancestor
154756247|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153545032|NCT02583282|Doxycycline|doxycycline|mesh-list
153545360|NCT06308978|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154756248|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
154756249|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756250|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756251|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756252|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
154756253|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154756254|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154756255|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
154756256|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756257|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154256531|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545630|NCT06304324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545632|NCT06304324|Glucocorticoids|glucocorticoids|mesh-ancestor
153545633|NCT06304324|Hormones|hormones|mesh-ancestor
153545634|NCT06304324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153545670|NCT06304181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545671|NCT06304181|Antipyretics|antipyretics|mesh-ancestor
153545672|NCT06304181|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153545673|NCT06304181|Diuretics|diuretics|mesh-ancestor
153545714|NCT06303167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545716|NCT06303076|Tizanidine|tizanidine|mesh-list
153619200|NCT01983449|Dexamethasone|dexamethasone|mesh-list
153619507|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
153619508|NCT01985256|Flucytosine|flucytosine|mesh-list
153619509|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
153619850|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
153619851|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
153620150|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
154756258|NCT03285360|Fluorides|fluorides|mesh-list
154756259|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
154756260|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
153620669|NCT01993589|Analgesics|analgesics|mesh-list
154756261|NCT03285360|Protective Agents|protective agents|mesh-ancestor
154756262|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756263|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154756264|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154756265|NCT00160173|Estradiol|estradiol|mesh-list
154756266|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153622126|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622294|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
154756267|NCT00160173|Estrogens|estrogens|mesh-ancestor
154756268|NCT00160173|Hormones|hormones|mesh-ancestor
153622575|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
153622895|NCT05878639|Lactulose|lactulose|mesh-list
153622896|NCT05878639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154756269|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756270|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756271|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154756272|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
154756273|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153623125|NCT05413343|Avibactam|avibactam|mesh-list
153451300|NCT00003671|Vincristine|vincristine|mesh-list
153623278|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153623279|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
153623461|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623784|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623828|NCT03994172|Teriparatide|teriparatide|mesh-list
153624316|NCT02169089|Diuretics|diuretics|mesh-ancestor
153624448|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
154756274|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154756275|NCT00136695|Anastrozole|anastrozole|mesh-list
153624995|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153625239|NCT02332980|Ibrutinib|ibrutinib|mesh-list
153625241|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625450|NCT02009618|Rifaximin|rifaximin|mesh-list
153625661|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625663|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
154756276|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154756277|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756278|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153626342|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
154756279|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153736991|NCT06176235|Dexamethasone|dexamethasone|mesh-list
154756280|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737164|NCT05839314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737368|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737369|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
153737698|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154256535|NCT01160276|Cyclosporine|cyclosporine|mesh-list
153738292|NCT02774421|Trastuzumab|trastuzumab|mesh-list
153738552|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738553|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
153738943|NCT00471523|Clomiphene|clomiphene|mesh-list
153738944|NCT00471523|Enclomiphene|enclomiphene|mesh-list
154756281|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756282|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154756283|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
154756284|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756285|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756286|NCT02459574|Amiodarone|amiodarone|mesh-list
154756287|NCT02459574|Flecainide|flecainide|mesh-list
154756288|NCT02459574|Sotalol|sotalol|mesh-list
154756289|NCT02459574|Propafenone|propafenone|mesh-list
154756290|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154756291|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
154756292|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154756293|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756294|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154756295|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154756296|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
153743176|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153743177|NCT00168714|Interferons|interferons|mesh-list
153580214|NCT01744249|Axitinib|axitinib|mesh-list
153743178|NCT00168714|Interferon-beta|interferon-beta|mesh-list
153743179|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
153743180|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743181|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
153743352|NCT00145379|Metformin|metformin|mesh-list
153743353|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743354|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743366|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756297|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743632|NCT00174642|Insulin|insulin|mesh-list
154256546|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743784|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153743785|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153743786|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
153743787|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743788|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743789|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743790|NCT00174798|Urological Agents|urological agents|mesh-ancestor
153743792|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153744112|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
153744145|NCT00175383|Hormones|hormones|mesh-list
153744146|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153744147|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744148|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744149|NCT02938468|Dexamethasone|dexamethasone|mesh-list
153744150|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744151|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
153744152|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
153744153|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744161|NCT02938507|Solabegron|solabegron|mesh-list
153744169|NCT00169728|Vaccines|vaccines|mesh-list
153744747|NCT02925832|Ropivacaine|ropivacaine|mesh-list
153744748|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
153744749|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
153744750|NCT02925832|Anesthetics|anesthetics|mesh-list
153744751|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744753|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
153744801|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744802|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745246|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745247|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
153745248|NCT05291650|Protective Agents|protective agents|mesh-ancestor
153745249|NCT05291650|Hormones|hormones|mesh-ancestor
154756298|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756299|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
154756300|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154756301|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154756302|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154756303|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154756304|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154756305|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756306|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154756307|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154756308|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154756309|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154756310|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
154756311|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
154256547|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
154027576|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756312|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756313|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
154756314|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154756315|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154756316|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756317|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
154756318|NCT03280212|Coagulants|coagulants|mesh-ancestor
154756319|NCT03536520|Acetazolamide|acetazolamide|mesh-list
154756320|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
154756321|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154256548|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027874|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
154027875|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027876|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154756322|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756323|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756324|NCT03536520|Diuretics|diuretics|mesh-ancestor
154756325|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
154756326|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756327|NCT01673217|Doxorubicin|doxorubicin|mesh-list
154028256|NCT02825147|Dexamethasone|dexamethasone|mesh-list
154756328|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154756329|NCT01673217|Decitabine|decitabine|mesh-list
154756330|NCT01673217|Azacitidine|azacitidine|mesh-list
154756331|NCT01673217|Vaccines|vaccines|mesh-list
154756332|NCT01673217|Sargramostim|sargramostim|mesh-list
154756333|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
154756334|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
154756335|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756336|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154029942|NCT02682134|Lidocaine|lidocaine|mesh-list
154029943|NCT02682134|BB 1101|bb 1101|mesh-list
154030162|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030617|NCT02690129|Hormones|hormones|mesh-ancestor
154756337|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756338|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154256550|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
154756339|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153911349|NCT04224649|Lidocaine|lidocaine|mesh-list
154756340|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256552|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
153453156|NCT01766310|Folic Acid|folic acid|mesh-list
153453352|NCT01774968|Insulin|insulin|mesh-list
154033592|NCT01120249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033698|NCT04234607|Etoposide|etoposide|mesh-list
154033838|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033865|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
154256553|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034709|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035321|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035791|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154035792|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154035937|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036157|NCT02616003|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154036160|NCT02616003|Incretins|incretins|mesh-ancestor
154756341|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256554|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154037099|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756342|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154756343|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
154756344|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154756345|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154756346|NCT01668849|Fentanyl|fentanyl|mesh-list
154039389|NCT06260124|TEMPO|tempo|mesh-list
153454621|NCT01554618|Exenatide|exenatide|mesh-list
154756347|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154756348|NCT01668849|Narcotics|narcotics|mesh-ancestor
154756349|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756350|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462616|NCT03059004|TEMPO|tempo|mesh-list
154040480|NCT03282981|Timolol|timolol|mesh-list
154756351|NCT01668849|Analgesics|analgesics|mesh-ancestor
154756352|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
154040810|NCT01386385|Paclitaxel|paclitaxel|mesh-list
154041043|NCT02535156|Risperidone|risperidone|mesh-list
153454958|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
154041452|NCT02652884|Hormones|hormones|mesh-ancestor
154756353|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041697|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154756354|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154756355|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154756356|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
154042553|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
154756357|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
153466331|NCT00354978|Leucovorin|leucovorin|mesh-list
154043062|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043067|NCT02737709|Paclitaxel|paclitaxel|mesh-list
154256557|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154043170|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153466872|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154043581|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154043692|NCT00723658|Cytarabine|cytarabine|mesh-list
154043938|NCT00692016|Naproxen|naproxen|mesh-list
154044101|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154044200|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154256558|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154044307|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
154756358|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154756359|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044429|NCT02974049|Filaricides|filaricides|mesh-ancestor
154756360|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756361|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154756362|NCT01252719|Vancomycin|vancomycin|mesh-list
154044801|NCT02723981|Clopidogrel|clopidogrel|mesh-list
154044802|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
154756363|NCT01252719|Oritavancin|oritavancin|mesh-list
154756364|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153455768|NCT04964947|Tobramycin|tobramycin|mesh-list
154045277|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468911|NCT05899816|KHK4083|khk4083|mesh-list
154045536|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
154045656|NCT00996151|Androgens|androgens|mesh-ancestor
153469141|NCT05520775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154045813|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154045958|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045965|NCT00856245|Rituximab|rituximab|mesh-list
154046294|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
154046409|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
154046519|NCT00656552|Escitalopram|escitalopram|mesh-list
153456009|NCT04110132|Bupivacaine|bupivacaine|mesh-list
154046963|NCT03999775|Calcium|calcium|mesh-list
153456164|NCT03584373|Acetaminophen|acetaminophen|mesh-list
154756365|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756366|NCT01230411|Ibuprofen|ibuprofen|mesh-list
154756367|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154756368|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154756369|NCT01230411|Analgesics|analgesics|mesh-ancestor
154756370|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
154047627|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154047775|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154047925|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
153628952|NCT02040909|Propofol|propofol|mesh-list
153629056|NCT02041767|Ertapenem|ertapenem|mesh-list
154048229|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048443|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048444|NCT02638376|Riboflavin|riboflavin|mesh-list
154048448|NCT02638376|Vitamins|vitamins|mesh-ancestor
153456356|NCT01868438|Artesunate|artesunate|mesh-list
154756371|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756372|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756373|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756374|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154756375|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154049375|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
154049376|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154049384|NCT00613769|Metronidazole|metronidazole|mesh-list
154049732|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049842|NCT02701673|Belinostat|belinostat|mesh-list
154050016|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050040|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
154050361|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154756376|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456664|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154050640|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050928|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154050929|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050930|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
154050992|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
154051132|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051134|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153456871|NCT01442376|Ondansetron|ondansetron|mesh-list
154051347|NCT05996471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154051348|NCT05996471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154051355|NCT05974345|Ezetimibe|ezetimibe|mesh-list
153630987|NCT00006096|Cisplatin|cisplatin|mesh-list
154051605|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052220|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
154052221|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154052697|NCT01791478|Letrozole|letrozole|mesh-list
154052875|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154756377|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756378|NCT03283800|Copper|copper|mesh-list
154756379|NCT03283800|Trace Elements|trace elements|mesh-ancestor
154053599|NCT04210739|Betamethasone|betamethasone|mesh-list
154756380|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
154508294|NCT05225597|Carbachol|carbachol|mesh-list
154054181|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154054182|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
153632053|NCT00006010|Docetaxel|docetaxel|mesh-list
154054324|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
154054507|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
154054854|NCT00694694|Artesunate|artesunate|mesh-list
154756381|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756382|NCT01962688|Diuretics|diuretics|mesh-list
154756383|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
154756384|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756385|NCT03274596|Vitamin E|vitamin e|mesh-list
154055620|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154055861|NCT02614118|Acetaminophen|acetaminophen|mesh-list
154055862|NCT02614118|Ketorolac|ketorolac|mesh-list
154055863|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154756386|NCT03274596|Vitamins|vitamins|mesh-ancestor
154056308|NCT00861614|Ipilimumab|ipilimumab|mesh-list
154056615|NCT00640679|Clopidogrel|clopidogrel|mesh-list
154056733|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
154756387|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
154756388|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756389|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
153633286|NCT00006220|Tretinoin|tretinoin|mesh-list
153633504|NCT00006337|Levodopa|levodopa|mesh-list
154057490|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154756390|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756391|NCT03274596|Protective Agents|protective agents|mesh-ancestor
154756392|NCT01963078|Oxytocin|oxytocin|mesh-list
154756393|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
154756394|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154058586|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058587|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058588|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058589|NCT00600353|Dexamethasone|dexamethasone|mesh-list
154058590|NCT00600353|Aprepitant|aprepitant|mesh-list
154256563|NCT01160432|Methadone|methadone|mesh-list
154059973|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154060579|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154060878|NCT00858273|Protective Agents|protective agents|mesh-ancestor
154061097|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
154061098|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756395|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756396|NCT03269760|Zolpidem|zolpidem|mesh-list
154256564|NCT01160432|Naloxone|naloxone|mesh-list
154061386|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154061420|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061566|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154061568|NCT00843024|Naproxen|naproxen|mesh-list
154756397|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154756398|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153634983|NCT00000640|Dapsone|dapsone|mesh-list
154061797|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756399|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061923|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
154756400|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756401|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154756402|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
154756403|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
154756404|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457950|NCT03596892|Decitabine|decitabine|mesh-list
154062548|NCT05957094|Citalopram|citalopram|mesh-list
154756405|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756406|NCT03269916|Hormones|hormones|mesh-list
154756407|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154756408|NCT03269916|Estrogens|estrogens|mesh-list
154256568|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256570|NCT01160432|Narcotics|narcotics|mesh-ancestor
154756409|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756410|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756411|NCT02346916|Capsaicin|capsaicin|mesh-list
154756412|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
154756413|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
153458178|NCT04192812|Leuprolide|leuprolide|mesh-list
154063435|NCT00755170|Growth Substances|growth substances|mesh-ancestor
154063605|NCT00822120|Etoposide|etoposide|mesh-list
154756414|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
154756415|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756416|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064027|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154064028|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
154064152|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
154756417|NCT02458482|Albuterol|albuterol|mesh-list
154756418|NCT02458482|Ipratropium|ipratropium|mesh-list
154256572|NCT01160432|Analgesics|analgesics|mesh-ancestor
154756419|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154064477|NCT00679601|Tavaborole|tavaborole|mesh-list
154756420|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
153637358|NCT00000882|Lamivudine|lamivudine|mesh-list
154064792|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154756421|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154756422|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756423|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154756424|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
154065154|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065155|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
154065569|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154756425|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
154756426|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154756427|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154756428|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154066621|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756429|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154067139|NCT04030988|Hormones|hormones|mesh-ancestor
154756430|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
154756431|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154756432|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756433|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154756434|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
154756435|NCT03273192|Adalimumab|adalimumab|mesh-list
154756436|NCT03273192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154756437|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154756438|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069495|NCT01023919|Sirolimus|sirolimus|mesh-list
154756439|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154756440|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154756441|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756442|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
154756443|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
154756444|NCT02349178|Etoposide|etoposide|mesh-list
154756445|NCT02349178|Clofarabine|clofarabine|mesh-list
154070030|NCT00810940|Mannitol|mannitol|mesh-list
154070174|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153613021|NCT01958684|Copper|copper|mesh-list
154070444|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
154756446|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070834|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
154756447|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
154756448|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756449|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640735|NCT01807429|Narcotics|narcotics|mesh-ancestor
154756450|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154756451|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
154756452|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756453|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756454|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154071878|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
154072207|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154072808|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154072809|NCT00786474|Dalteparin|dalteparin|mesh-list
154072810|NCT00786474|Tinzaparin|tinzaparin|mesh-list
154073197|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
154073198|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073547|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756455|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153730005|NCT00140517|Amebicides|amebicides|mesh-ancestor
154756456|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154756457|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154756458|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756459|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154756460|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
154756461|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154756462|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756463|NCT05075460|Azacitidine|azacitidine|mesh-list
154756464|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154756465|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
154756466|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756467|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756468|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756469|NCT01966978|Insulin|insulin|mesh-list
154756470|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154756471|NCT01966978|Metformin|metformin|mesh-list
154756472|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
154756473|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
154074338|NCT00708539|Hormones|hormones|mesh-ancestor
154074404|NCT04450394|Insulin|insulin|mesh-list
153642461|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
154074815|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154074817|NCT04091178|Vitamin D|vitamin d|mesh-list
154075325|NCT05754242|Vitamins|vitamins|mesh-ancestor
154756474|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153642842|NCT00089401|Melphalan|melphalan|mesh-list
154756475|NCT01966978|Liraglutide|liraglutide|mesh-list
154256595|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
154756476|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
154756477|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154756478|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075641|NCT00735072|Maraviroc|maraviroc|mesh-list
154756479|NCT01966978|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154756480|NCT01966978|Incretins|incretins|mesh-ancestor
154756481|NCT01966978|Hormones|hormones|mesh-ancestor
154075954|NCT01024777|Vitamin D|vitamin d|mesh-list
154756482|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154756483|NCT03269214|Phenytoin|phenytoin|mesh-list
154756484|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
153459427|NCT00004092|Paclitaxel|paclitaxel|mesh-list
154756485|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154756486|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154256599|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
154756487|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256601|NCT01267058|Vaccines|vaccines|mesh-list
154756488|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076480|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154076556|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
154076634|NCT02603198|Nordefrin|nordefrin|mesh-list
154256602|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
154756489|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154076862|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077014|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756490|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153645733|NCT00111319|Bortezomib|bortezomib|mesh-list
154756491|NCT05074602|Fluconazole|fluconazole|mesh-list
154756492|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
153459887|NCT05540288|Nalmefene|nalmefene|mesh-list
154077562|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077642|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077719|NCT02587845|Coagulants|coagulants|mesh-ancestor
154077798|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077878|NCT00782210|Olodaterol|olodaterol|mesh-list
154756493|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756494|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154078110|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
154256606|NCT02526914|Oxytocin|oxytocin|mesh-list
154078266|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154256607|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
154078415|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154078420|NCT00759902|Morphine|morphine|mesh-list
153647376|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154256608|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078648|NCT04076709|Anesthetics|anesthetics|mesh-list
154756495|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154756496|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756497|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648200|NCT00020917|Irinotecan|irinotecan|mesh-list
154256610|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
154079134|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
154079283|NCT05674539|Vidarabine|vidarabine|mesh-list
154256611|NCT02526914|Coagulants|coagulants|mesh-ancestor
154756498|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154079514|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079515|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079593|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
154756499|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
154256613|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154079750|NCT00442117|Hormones|hormones|mesh-ancestor
154079824|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
154079825|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154256614|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
154756500|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080189|NCT06240130|Eusol|eusol|mesh-list
153650272|NCT00028717|Hormones|hormones|mesh-ancestor
154081268|NCT04633252|Prednisone|prednisone|mesh-list
154081532|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081719|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081791|NCT03333343|Nazartinib|nazartinib|mesh-list
154081985|NCT02283177|Daunorubicin|daunorubicin|mesh-list
154256617|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
154082155|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756501|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082248|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
154756502|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154756503|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154756504|NCT02457312|Letrozole|letrozole|mesh-list
154756505|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154756506|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154082609|NCT00468481|Drospirenone|drospirenone|mesh-list
154756507|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154756508|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154756509|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756510|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154756511|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
153652801|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
154256622|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154256623|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154256624|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083921|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
154084563|NCT00738621|BB 1101|bb 1101|mesh-list
154256625|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154084859|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085013|NCT00740883|Warfarin|warfarin|mesh-list
153461596|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
153461612|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
153461644|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
153461670|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
154085725|NCT02565693|Aspirin|aspirin|mesh-list
154085866|NCT00721214|Azacitidine|azacitidine|mesh-list
153360304|NCT05089526|Lidocaine|lidocaine|mesh-list
153360381|NCT00806234|Metformin|metformin|mesh-list
154086485|NCT00752037|Lopinavir|lopinavir|mesh-list
154086500|NCT00716144|R 115866|r 115866|mesh-list
154086575|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
153656074|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
153656227|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154756512|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087016|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
154756513|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087364|NCT00680745|Metformin|metformin|mesh-list
154756514|NCT03268902|Niacinamide|niacinamide|mesh-list
154756515|NCT03268902|Niacin|niacin|mesh-list
154756516|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
154756517|NCT03268902|Azithromycin|azithromycin|mesh-list
154756518|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
153554444|NCT01597726|Misoprostol|misoprostol|mesh-list
154756519|NCT03268902|Vitamins|vitamins|mesh-ancestor
154756520|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
154088647|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
154756521|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154756522|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154756523|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154756524|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
154756525|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154756526|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
154756527|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154756528|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154756529|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
153360772|NCT01368809|Fentanyl|fentanyl|mesh-list
154756530|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154756531|NCT02458716|Leuprolide|leuprolide|mesh-list
154756532|NCT02458716|Bicalutamide|bicalutamide|mesh-list
154787157|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
154787158|NCT03020030|Pegaspargase|pegaspargase|mesh-list
154787159|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
154787160|NCT03020030|Razoxane|razoxane|mesh-list
154787161|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
154787162|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787163|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
154787164|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787165|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154787166|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154787167|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
154787168|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539120|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154787169|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787170|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154787171|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154787172|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
154787173|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
154787174|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787175|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154787176|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
154787178|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787179|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154787180|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154787181|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154787182|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154787183|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787184|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154787185|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
154787186|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154787187|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154787188|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
154787189|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
154787190|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154787191|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154787192|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154787193|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
154787194|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787195|NCT03020030|Antidotes|antidotes|mesh-ancestor
154787196|NCT03020030|Protective Agents|protective agents|mesh-ancestor
154391949|NCT04685135|Docetaxel|docetaxel|mesh-list
154787197|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
154787198|NCT03020030|Vitamins|vitamins|mesh-ancestor
154787199|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
154787200|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787201|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787202|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787203|NCT03020030|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154787204|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154787205|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154787206|NCT02989636|Nivolumab|nivolumab|mesh-list
154787207|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787208|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787209|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154787210|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787211|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
154787212|NCT02955290|Nivolumab|nivolumab|mesh-list
154787213|NCT02955290|Vaccines|vaccines|mesh-list
154787214|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154787215|NCT02955290|Mitogens|mitogens|mesh-list
154787216|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
154787217|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787218|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787219|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787220|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154787221|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787222|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787223|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154787224|NCT02924311|Aflibercept|aflibercept|mesh-list
154787225|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787226|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787227|NCT02924311|Growth Substances|growth substances|mesh-ancestor
154787228|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787229|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787230|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787231|NCT02921893|Dexamethasone|dexamethasone|mesh-list
154787232|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
154787233|NCT02921893|Lenalidomide|lenalidomide|mesh-list
154787234|NCT02921893|Ixazomib|ixazomib|mesh-list
154787235|NCT02921893|Ichthammol|ichthammol|mesh-list
154787236|NCT02921893|BB 1101|bb 1101|mesh-list
154787237|NCT02921893|Glycine|glycine|mesh-list
154787238|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154787239|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
154787240|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
154787241|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787242|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787243|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154787244|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
154787245|NCT02921893|Hormones|hormones|mesh-ancestor
154787246|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787247|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154787248|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787249|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
154787250|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787251|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787252|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
154787253|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787254|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787255|NCT02921893|Growth Substances|growth substances|mesh-ancestor
154787256|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787257|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
154787258|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
154787259|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787260|NCT02893917|Olaparib|olaparib|mesh-list
154787261|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154787262|NCT02893917|Cediranib|cediranib|mesh-list
154787263|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787264|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787265|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787266|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154787267|NCT02854527|Metformin|metformin|mesh-list
154787268|NCT02854527|Digoxin|digoxin|mesh-list
154787269|NCT02854527|Furosemide|furosemide|mesh-list
154787270|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154787271|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154787272|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787273|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154787274|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154787275|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
154787276|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787277|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154787278|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154787279|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787280|NCT02854527|Diuretics|diuretics|mesh-ancestor
154787281|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
154787282|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154787283|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154787284|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154787285|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154787286|NCT02854527|Protective Agents|protective agents|mesh-ancestor
154787287|NCT02839707|Bevacizumab|bevacizumab|mesh-list
154787288|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154787289|NCT02839707|Atezolizumab|atezolizumab|mesh-list
154787290|NCT02839707|Doxorubicin|doxorubicin|mesh-list
154787291|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154787292|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
154787293|NCT02839707|Antibodies|antibodies|mesh-list
154787294|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
154787295|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154787296|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
154787297|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787298|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787299|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787300|NCT02839707|Growth Substances|growth substances|mesh-ancestor
154787301|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787302|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787303|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
154787304|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154787305|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154787306|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154787307|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787308|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787309|NCT02839707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154787310|NCT02830477|Factor VIII|factor viii|mesh-list
154787311|NCT02830477|Coagulants|coagulants|mesh-ancestor
154787312|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
154787313|NCT02828592|Fludarabine|fludarabine|mesh-list
154787314|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
154787315|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787316|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
154787317|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787318|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154787319|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154787320|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
154787321|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787322|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787323|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154787324|NCT02800486|Cetuximab|cetuximab|mesh-list
154787325|NCT02800486|Mannitol|mannitol|mesh-list
154787326|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787327|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787328|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154787329|NCT02800486|Diuretics|diuretics|mesh-ancestor
154787330|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
154787331|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787332|NCT02772081|Poractant alfa|poractant alfa|mesh-list
154787333|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154787334|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
154787335|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
154787336|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154787337|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
154787338|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154787339|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
154787340|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787341|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787342|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
154787343|NCT02705859|Trastuzumab|trastuzumab|mesh-list
154787344|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787345|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787346|NCT02633137|Cytarabine|cytarabine|mesh-list
154787347|NCT02633137|Lenalidomide|lenalidomide|mesh-list
154787348|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154787349|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
154787350|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787351|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787352|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
154392086|NCT04439539|Tenofovir|tenofovir|mesh-list
154787353|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787354|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787355|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
154787356|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787357|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787358|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787359|NCT02633137|Growth Substances|growth substances|mesh-ancestor
154787360|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787361|NCT02584478|Paclitaxel|paclitaxel|mesh-list
154787362|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154787363|NCT02584478|Carboplatin|carboplatin|mesh-list
154787364|NCT02584478|Doxorubicin|doxorubicin|mesh-list
154787365|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154787366|NCT02584478|Topotecan|topotecan|mesh-list
154787367|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154787368|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787369|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787370|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787371|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787372|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787373|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154787374|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154787375|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154787376|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787377|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154787378|NCT02581891|Aflibercept|aflibercept|mesh-list
154787379|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787380|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787381|NCT02581891|Growth Substances|growth substances|mesh-ancestor
154787382|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787383|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787384|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787385|NCT02574845|Metformin|metformin|mesh-list
154787386|NCT02574845|Furosemide|furosemide|mesh-list
154787387|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154787388|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154787389|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787390|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154787391|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154787392|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
154787393|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787394|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154392150|NCT04300114|Fluzoparib|fluzoparib|mesh-list
154787395|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154787396|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787397|NCT02574845|Diuretics|diuretics|mesh-ancestor
154787398|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
154787399|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154787400|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154787401|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
154787402|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787403|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787404|NCT02521844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154787405|NCT02521844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787406|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
154787407|NCT02344355|Temozolomide|temozolomide|mesh-list
154787408|NCT02344355|Vitamins|vitamins|mesh-ancestor
154787409|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
154787410|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787411|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154787412|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
154787413|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787414|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787415|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
154787416|NCT02344355|Protective Agents|protective agents|mesh-ancestor
154787417|NCT02289924|Aflibercept|aflibercept|mesh-list
154787418|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787419|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787420|NCT02289924|Growth Substances|growth substances|mesh-ancestor
154787421|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787422|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787423|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787424|NCT02279537|Aflibercept|aflibercept|mesh-list
154787425|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787426|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392164|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787427|NCT02279537|Growth Substances|growth substances|mesh-ancestor
154787428|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787429|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787430|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787431|NCT02256865|Ketoconazole|ketoconazole|mesh-list
154787432|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
154787433|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154787434|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154787435|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154787436|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
154787437|NCT02256865|Testosterone|testosterone|mesh-list
154787438|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
154787439|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
154787440|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154787441|NCT02256865|Androgens|androgens|mesh-ancestor
154787442|NCT02256865|Hormones|hormones|mesh-ancestor
154787443|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787444|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787445|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154787446|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787447|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
154787448|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154787449|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
154787450|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787451|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154787452|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154787453|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787454|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787455|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154787456|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
154787457|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154787458|NCT02193191|Plerixafor|plerixafor|mesh-list
154787459|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154787460|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154787461|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
154787462|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787463|NCT02162849|Nicotine|nicotine|mesh-list
154787464|NCT02162849|Varenicline|varenicline|mesh-list
154787465|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154787466|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
154787467|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787468|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787469|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154787470|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154787471|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
154787472|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539422|NCT02094157|Heparin|heparin|mesh-list
154787473|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787474|NCT02101905|Lapatinib|lapatinib|mesh-list
154787475|NCT02101905|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154787476|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154787477|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787478|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787479|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787480|NCT02070549|Trametinib|trametinib|mesh-list
154787481|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787482|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154787483|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787484|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787485|NCT01957436|Docetaxel|docetaxel|mesh-list
154787486|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
154787487|NCT01957436|Androgens|androgens|mesh-list
154787488|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787489|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787490|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787491|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787492|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787493|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154787494|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787495|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
154787496|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787497|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787498|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154787499|NCT01957436|Hormones|hormones|mesh-ancestor
154787500|NCT01783925|Aflibercept|aflibercept|mesh-list
154787501|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787502|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787503|NCT01783925|Growth Substances|growth substances|mesh-ancestor
154787504|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787505|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787506|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787507|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154787508|NCT01624805|Cyclosporine|cyclosporine|mesh-list
154787509|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
154787510|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154787511|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154787512|NCT01624805|Prednisolone|prednisolone|mesh-list
154787513|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
154787514|NCT01624805|Lenograstim|lenograstim|mesh-list
154787515|NCT01624805|Cyclosporins|cyclosporins|mesh-list
154787516|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
154787517|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154787518|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154787519|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
154787520|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154787521|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
154787522|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787523|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787524|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787525|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787526|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
154787527|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787528|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
154787529|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154787530|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154787531|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154787532|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
154787533|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
154787534|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787535|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154787536|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
154787537|NCT01624805|Hormones|hormones|mesh-ancestor
154787538|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787539|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154787540|NCT01624805|Protective Agents|protective agents|mesh-ancestor
154392281|NCT04192981|GDC-0084|gdc-0084|mesh-list
154787541|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154787542|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787543|NCT01587352|Vorinostat|vorinostat|mesh-list
154787544|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787545|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154787546|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787547|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787548|NCT01453660|Cisplatin|cisplatin|mesh-list
154787549|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787550|NCT01434316|Veliparib|veliparib|mesh-list
154787551|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154787552|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787553|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787554|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787555|NCT01351896|Lenalidomide|lenalidomide|mesh-list
154787556|NCT01351896|Vaccines|vaccines|mesh-list
154787557|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154787558|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
154787559|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787560|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787561|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787562|NCT01351896|Growth Substances|growth substances|mesh-ancestor
154787563|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787564|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787565|NCT01347294|Bleomycin|bleomycin|mesh-list
154787566|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154392323|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
154787567|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787568|NCT01281176|Paclitaxel|paclitaxel|mesh-list
154787569|NCT01281176|Carboplatin|carboplatin|mesh-list
154787570|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154787571|NCT01281176|Vorinostat|vorinostat|mesh-list
154787572|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154787573|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787574|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787575|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787576|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787577|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787578|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154787579|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787580|NCT01133990|Leucovorin|leucovorin|mesh-list
154787581|NCT01133990|Bevacizumab|bevacizumab|mesh-list
154787582|NCT01133990|Fluorouracil|fluorouracil|mesh-list
154787583|NCT01133990|Irinotecan|irinotecan|mesh-list
154787584|NCT01133990|Calcium|calcium|mesh-list
154787585|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
154787586|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787587|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787588|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787589|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787590|NCT01133990|Growth Substances|growth substances|mesh-ancestor
154787591|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787592|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787593|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154787594|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
154787595|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787596|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154787597|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787598|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
154787599|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154787600|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154787601|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787602|NCT01133990|Antidotes|antidotes|mesh-ancestor
154787603|NCT01133990|Protective Agents|protective agents|mesh-ancestor
154787604|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
154787605|NCT01133990|Vitamins|vitamins|mesh-ancestor
154787606|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
154787607|NCT00910429|Riociguat|riociguat|mesh-list
154787608|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
154787609|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787610|NCT00863681|Riociguat|riociguat|mesh-list
154787611|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
154787612|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787613|NCT00802230|Terbutaline|terbutaline|mesh-list
154787614|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154787615|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
154787616|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787617|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787618|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154787619|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
154787620|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
154787621|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
154787622|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154787623|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154787624|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154787625|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154787626|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
154860503|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
154787627|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787628|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787629|NCT00734149|Prednisone|prednisone|mesh-list
154787630|NCT00734149|Bortezomib|bortezomib|mesh-list
154787631|NCT00734149|Melphalan|melphalan|mesh-list
154787632|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154787633|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
154787634|NCT00734149|Hormones|hormones|mesh-ancestor
154787635|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787636|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787637|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154787638|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787639|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154787640|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
154787641|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787642|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154787643|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787644|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
154787645|NCT00587431|Docetaxel|docetaxel|mesh-list
154787646|NCT00587431|Leuprolide|leuprolide|mesh-list
154787647|NCT00587431|Testosterone|testosterone|mesh-list
154787648|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787649|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787650|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787651|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787652|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787653|NCT00587431|Androgens|androgens|mesh-ancestor
154787654|NCT00587431|Hormones|hormones|mesh-ancestor
154787655|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787656|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787657|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154787658|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154787659|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
154787660|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154787661|NCT00514618|Misoprostol|misoprostol|mesh-list
154392378|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787662|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154787663|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
154787664|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154787665|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787666|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154787667|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154787668|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
154787669|NCT00227253|Hormones|hormones|mesh-list
154787670|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787671|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787672|NCT00097786|Nateglinide|nateglinide|mesh-list
154787673|NCT00097786|Valsartan|valsartan|mesh-list
154787674|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154787675|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154787676|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154787677|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787678|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154787679|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787680|NCT04018105|Metformin|metformin|mesh-list
154787681|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154787682|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787684|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
154787685|NCT05632549|Vitamins|vitamins|mesh-ancestor
154787686|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
154787687|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787688|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154787689|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154787690|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154787691|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154787692|NCT03597997|Propofol|propofol|mesh-list
154787693|NCT03597997|Sevoflurane|sevoflurane|mesh-list
154787694|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154787695|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154787696|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787697|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154787698|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
154787699|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
154787700|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154539642|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
154787701|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154787702|NCT01277835|Lidocaine|lidocaine|mesh-list
154787703|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
154787704|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
154787705|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154787706|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787707|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
154787708|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787709|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154787710|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154787711|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154787712|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154787713|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787714|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
154787715|NCT01431287|Olodaterol|olodaterol|mesh-list
154392439|NCT03765567|Vancomycin|vancomycin|mesh-list
154787716|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154787717|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
154787718|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787719|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787720|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154787721|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
154787722|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
154787723|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154787724|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
154787725|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787726|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787727|NCT05632159|Anesthetics|anesthetics|mesh-list
154787728|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154787729|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787730|NCT04017013|Lidocaine|lidocaine|mesh-list
154787731|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
154787732|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
154787733|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154787734|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787735|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
154787736|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787737|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154787738|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154787739|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154787740|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154787741|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787742|NCT01277913|Vitamin D|vitamin d|mesh-list
154787743|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
154787744|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
154787745|NCT01277913|Vitamins|vitamins|mesh-list
154787746|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
154787747|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787748|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154787749|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154787750|NCT00729807|Pentamidine|pentamidine|mesh-list
154787751|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
154787752|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787753|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154787754|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154787755|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154787756|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154787757|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154787758|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787759|NCT03592693|Vitamins|vitamins|mesh-list
154787760|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
154787761|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
154787762|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787763|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154787764|NCT00730353|Paclitaxel|paclitaxel|mesh-list
154787765|NCT00730353|Sunitinib|sunitinib|mesh-list
154787766|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154787767|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787768|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787769|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787770|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787771|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787772|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787773|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154539718|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154787774|NCT00730353|Growth Substances|growth substances|mesh-ancestor
154787775|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787776|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787777|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154787778|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787780|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
154787781|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
154787782|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787783|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787784|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
154787785|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787786|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787787|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
154787788|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154787789|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154787790|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154787791|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
154787792|NCT01272609|Timolol|timolol|mesh-list
154787793|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154787794|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154787795|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154787796|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787797|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787798|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787799|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154787800|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154787801|NCT03595189|Cilastatin|cilastatin|mesh-list
154787802|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
154787803|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787804|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787805|NCT01410227|Factor VIII|factor viii|mesh-list
154787806|NCT01410227|Coagulants|coagulants|mesh-ancestor
154787807|NCT01274559|Niacin|niacin|mesh-list
154787808|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154787809|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
154787810|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787811|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154787812|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
154787813|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
154787814|NCT01274559|Vitamins|vitamins|mesh-ancestor
154787815|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
154787816|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787817|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
154787818|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
154787819|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154787820|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154787821|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392535|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787822|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787823|NCT01409993|Urological Agents|urological agents|mesh-ancestor
154787824|NCT01409915|Molgramostim|molgramostim|mesh-list
154787825|NCT01409915|Sargramostim|sargramostim|mesh-list
154787826|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
154787827|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787828|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787829|NCT01272921|Bupivacaine|bupivacaine|mesh-list
154787830|NCT01272921|Ropivacaine|ropivacaine|mesh-list
154787831|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
154787832|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
154787833|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154787834|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787835|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
154787836|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787837|NCT01409837|Lisinopril|lisinopril|mesh-list
154787838|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154787839|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
154787840|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787841|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787842|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154787843|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154787844|NCT01409837|Protective Agents|protective agents|mesh-ancestor
154787845|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787846|NCT01278459|Atorvastatin|atorvastatin|mesh-list
154787847|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154787848|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154787849|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
154539790|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787850|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787851|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154787852|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154787853|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787854|NCT00731055|Varenicline|varenicline|mesh-list
154787855|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154787856|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154787857|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
154787858|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787859|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787860|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787861|NCT03594565|Fluticasone|fluticasone|mesh-list
154787862|NCT03594565|Xhance|xhance|mesh-list
154787863|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154787864|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154787865|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
154787866|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787867|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787868|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154787869|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
154787870|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
154787871|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154787872|NCT01430585|Letrozole|letrozole|mesh-list
154787873|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787874|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154787875|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154787876|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787877|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787878|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154787879|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
154787880|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787881|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787882|NCT04005859|Lidocaine|lidocaine|mesh-list
154787883|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
154787884|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
154787885|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154787886|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787887|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
154787888|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787889|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154787890|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154787891|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154787892|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154787893|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787894|NCT05633719|Carboplatin|carboplatin|mesh-list
154787895|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787896|NCT01408901|Molgramostim|molgramostim|mesh-list
154787897|NCT01408901|Sargramostim|sargramostim|mesh-list
154787898|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
154787899|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787900|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787901|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
154787902|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
154787903|NCT02080195|Fludarabine|fludarabine|mesh-list
154787904|NCT02080195|Tacrolimus|tacrolimus|mesh-list
154787905|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
154787906|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154787907|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787908|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
154787909|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787910|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154787911|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154787912|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
154787913|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787914|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787915|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154787916|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154787917|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787918|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154787919|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154787920|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
154787921|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154787922|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787923|NCT04044131|Sorbitol|sorbitol|mesh-list
154787924|NCT04044131|Cathartics|cathartics|mesh-ancestor
154787925|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154787926|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
154787927|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
154787928|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
154787929|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154787930|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154787931|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154787932|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787933|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
154787934|NCT01428713|Coagulants|coagulants|mesh-ancestor
154787935|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154787936|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787937|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154787938|NCT01408043|Plerixafor|plerixafor|mesh-list
154787939|NCT01408043|Etoposide|etoposide|mesh-list
154787940|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
154787941|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154787942|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787943|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154787944|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154787945|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787946|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787947|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154787948|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154787949|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
154787950|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787951|NCT03598621|Semaglutide|semaglutide|mesh-list
154787952|NCT03598621|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154787953|NCT03598621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154787954|NCT03598621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787955|NCT00219349|Escitalopram|escitalopram|mesh-list
154787956|NCT00219349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154787957|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154787958|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154787959|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787960|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787961|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
154787962|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787963|NCT00218257|Progesterone|progesterone|mesh-list
154787964|NCT00218257|Progestins|progestins|mesh-ancestor
154787965|NCT00218257|Hormones|hormones|mesh-ancestor
154787966|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154787967|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787968|NCT01523366|Clopidogrel|clopidogrel|mesh-list
154787969|NCT01523366|Ticagrelor|ticagrelor|mesh-list
154787970|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154787971|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154787972|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154787973|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154787974|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
154787975|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787976|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787977|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787978|NCT03024697|Anesthetics|anesthetics|mesh-list
154787979|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
154787980|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154787981|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787982|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
154787983|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154787984|NCT01427933|Ramucirumab|ramucirumab|mesh-list
154787985|NCT01427933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154787986|NCT01427933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154787987|NCT01427933|Growth Substances|growth substances|mesh-ancestor
154787988|NCT01427933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787989|NCT01427933|Growth Inhibitors|growth inhibitors|mesh-ancestor
154787990|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787991|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154787992|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787993|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
154787994|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154787995|NCT01406873|Mexiletine|mexiletine|mesh-list
154787996|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154539942|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787997|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154787998|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154787999|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154788000|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788002|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
154788003|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154788004|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154788005|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788006|NCT01406015|Spironolactone|spironolactone|mesh-list
154788007|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154788008|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
154788009|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788010|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788011|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154788012|NCT01406015|Diuretics|diuretics|mesh-ancestor
154788013|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
154788014|NCT00215137|Escitalopram|escitalopram|mesh-list
154788015|NCT00215137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154788016|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154788017|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154788018|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788019|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788020|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
154788021|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788022|NCT04406779|Hormones|hormones|mesh-list
154788023|NCT04406779|Autoantibodies|autoantibodies|mesh-list
154788024|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788025|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788026|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
154788027|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154788028|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788029|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788030|NCT03598075|Pramlintide|pramlintide|mesh-list
154788031|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154788032|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788033|NCT03597919|Vaccines|vaccines|mesh-list
154788034|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
154788035|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788036|NCT04001413|Durvalumab|durvalumab|mesh-list
154788037|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788038|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788039|NCT01677858|Dexamethasone|dexamethasone|mesh-list
154788040|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788041|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
154788042|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
154788043|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788044|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788045|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788046|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
154788047|NCT01677858|Hormones|hormones|mesh-ancestor
154788048|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788049|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154788050|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788051|NCT03027284|Gemcitabine|gemcitabine|mesh-list
154788052|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788053|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154788054|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
154788055|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788056|NCT03592069|Amoxicillin|amoxicillin|mesh-list
154788057|NCT03592069|Metronidazole|metronidazole|mesh-list
154788058|NCT03592069|Clarithromycin|clarithromycin|mesh-list
154788059|NCT03592069|Esomeprazole|esomeprazole|mesh-list
154788060|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154788061|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788062|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154788063|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154788064|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154788065|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788066|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154788067|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788068|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788069|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154788070|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154788071|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154788072|NCT03591991|Empagliflozin|empagliflozin|mesh-list
154788073|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154788074|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788075|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154788076|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788077|NCT03591913|Misoprostol|misoprostol|mesh-list
154788078|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154788079|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
154788080|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154788081|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788082|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154788083|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788084|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
154788085|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154788086|NCT04198129|Amoxicillin|amoxicillin|mesh-list
154788087|NCT04198129|Clindamycin|clindamycin|mesh-list
154788088|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
154788089|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
154788090|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154788091|NCT04198129|Ampicillin|ampicillin|mesh-list
154788092|NCT04198129|Sultamicillin|sultamicillin|mesh-list
154788093|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154788094|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788095|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
154788096|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154788097|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788098|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788099|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154788100|NCT03591757|Tolcapone|tolcapone|mesh-list
154788101|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154788102|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154788103|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154788104|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788105|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788106|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
154788107|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154788108|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154788109|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
154788110|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154788111|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788112|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
154788113|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
154788114|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154788115|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
154788116|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788117|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
154788118|NCT04438434|Protective Agents|protective agents|mesh-ancestor
154788119|NCT03591679|Oxytocin|oxytocin|mesh-list
154788120|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
154788121|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154788122|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788123|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154788124|NCT04197817|Antibodies|antibodies|mesh-list
154788125|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
154788126|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154788127|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
154788128|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788129|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788130|NCT04585854|Caffeine|caffeine|mesh-list
154788131|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154788132|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788133|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154788134|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788135|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788136|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154788137|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154788138|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
154788139|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788140|NCT03481842|Axitinib|axitinib|mesh-list
154788141|NCT03481842|Afatinib|afatinib|mesh-list
154788142|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788143|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154540092|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
154788144|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860504|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788145|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788146|NCT03481842|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154788147|NCT04197739|Amikacin|amikacin|mesh-list
154788148|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154788149|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788150|NCT04197349|Sumatriptan|sumatriptan|mesh-list
154788151|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154788152|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154788153|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154788154|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
154788155|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788156|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788157|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788158|NCT03422094|Nivolumab|nivolumab|mesh-list
154788159|NCT03422094|Ipilimumab|ipilimumab|mesh-list
154788160|NCT03422094|Poly ICLC|poly iclc|mesh-list
154788161|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788162|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788163|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788164|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788165|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
154788166|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
154788167|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788168|NCT04356534|Antibodies|antibodies|mesh-list
154788169|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
154788170|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788171|NCT03591289|Bromides|bromides|mesh-list
154788172|NCT03591289|Rocuronium|rocuronium|mesh-list
154788173|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
154788174|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154788175|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154788176|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154788177|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788178|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788179|NCT02471118|Adalimumab|adalimumab|mesh-list
154788180|NCT02471118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154788181|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788182|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154788183|NCT04197115|Vitamins|vitamins|mesh-list
154788184|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
154788185|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
154788186|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
154788187|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154788188|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154788189|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154788190|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
154788191|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788192|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788193|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
154788194|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788195|NCT04197115|Protective Agents|protective agents|mesh-ancestor
154788196|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
154788197|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154788198|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
154788199|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788200|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788201|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154788202|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
154788203|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
154788204|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154788205|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
154788206|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788207|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788208|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154788209|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788210|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
154788211|NCT03590587|Hormones|hormones|mesh-ancestor
154788212|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788213|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788214|NCT03590431|Iodine|iodine|mesh-list
154788215|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
154788216|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154788217|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788218|NCT03590431|Trace Elements|trace elements|mesh-ancestor
154788219|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
154788220|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788221|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
154788222|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788223|NCT05102448|Methotrexate|methotrexate|mesh-list
154788224|NCT05102448|Tofacitinib|tofacitinib|mesh-list
154788225|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154788226|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
154788227|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154788228|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788229|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154788230|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
154788231|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788232|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788233|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
154788234|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788235|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154788236|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154788237|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
154788238|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027434|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
154788239|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154788240|NCT05102448|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154788241|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154788242|NCT03599323|Clotrimazole|clotrimazole|mesh-list
154788243|NCT03599323|Miconazole|miconazole|mesh-list
154788244|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154788245|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788246|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
154788247|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154788248|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154788249|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788250|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788251|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154788252|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
154788253|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788254|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788255|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154788256|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154788257|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154788258|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154788259|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
154788260|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788261|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788262|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154788263|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
154788264|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154788265|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154788266|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154788267|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
154788268|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788269|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788270|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
154788271|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154788272|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788273|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788274|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154788275|NCT05102058|Analgesics|analgesics|mesh-ancestor
154788276|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
154788277|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788278|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154788279|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154788280|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154788281|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
154788282|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788283|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788284|NCT03956797|Anesthetics|anesthetics|mesh-list
154788285|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788286|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788287|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
154788288|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154788289|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154788290|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154788291|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154788292|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788293|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
154788294|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788295|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788296|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154788297|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788299|NCT04195243|Empagliflozin|empagliflozin|mesh-list
154788300|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154788301|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788302|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154788303|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788304|NCT04195321|Phenylephrine|phenylephrine|mesh-list
154788305|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
154788306|NCT04195321|Norepinephrine|norepinephrine|mesh-list
154788307|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154788308|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
154788309|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
154788310|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788311|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788312|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
154788313|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154788314|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
154788315|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
154788316|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154788317|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154788318|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154788319|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
154788320|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788321|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788322|NCT04195321|Protective Agents|protective agents|mesh-ancestor
154788323|NCT06012682|Metformin|metformin|mesh-list
154788324|NCT06012682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154788325|NCT06012682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788326|NCT06012552|Tianeptine|tianeptine|mesh-list
154788327|NCT06012552|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154788328|NCT06012552|Antidepressive Agents|antidepressive agents|mesh-ancestor
154788329|NCT06012552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154788330|NCT06012500|Xenon|xenon|mesh-list
154788331|NCT06012500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154788332|NCT06012500|Anesthetics, General|anesthetics, general|mesh-ancestor
154788333|NCT06012500|Anesthetics|anesthetics|mesh-ancestor
154788334|NCT06012500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788335|NCT06012500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788336|NCT06012383|Bortezomib|bortezomib|mesh-list
154788337|NCT06012383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788338|NCT06012097|Diclofenac|diclofenac|mesh-list
154788339|NCT06012097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154788340|NCT06012097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154788341|NCT06012097|Analgesics|analgesics|mesh-ancestor
154788342|NCT06012097|Sensory System Agents|sensory system agents|mesh-ancestor
154788343|NCT06012097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788344|NCT06012097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172180|NCT03839355|Warfarin|warfarin|mesh-list
154788345|NCT06012097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788346|NCT06012097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154788347|NCT06012097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154788348|NCT06012097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788349|NCT06012097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788350|NCT06011980|Growth Inhibitors|growth inhibitors|mesh-list
154788351|NCT06011980|Growth Substances|growth substances|mesh-ancestor
154788352|NCT06011980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788353|NCT06011460|Clozapine|clozapine|mesh-list
154788354|NCT06011460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154788355|NCT06011460|Serotonin Agents|serotonin agents|mesh-ancestor
154788356|NCT06011460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788357|NCT06011460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788358|NCT06011460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788359|NCT06011460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154788360|NCT06011460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154788361|NCT06011460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788362|NCT06011460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154788363|NCT06011460|GABA Antagonists|gaba antagonists|mesh-ancestor
154788364|NCT06011460|GABA Agents|gaba agents|mesh-ancestor
154788365|NCT06011421|Anesthetics|anesthetics|mesh-list
154540325|NCT02460627|Lidocaine|lidocaine|mesh-list
154788366|NCT06011421|Anesthetics, Local|anesthetics, local|mesh-list
154788367|NCT06011421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788368|NCT06011421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788369|NCT06011421|Sensory System Agents|sensory system agents|mesh-ancestor
154788370|NCT06011421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788371|NCT06011343|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154788372|NCT06011343|Tofacitinib|tofacitinib|mesh-list
154788373|NCT06011343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154788374|NCT06011343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154788375|NCT06011343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788376|NCT06011343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788377|NCT06011343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154788378|NCT06011343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154788379|NCT06011343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788380|NCT06011083|Betamethasone|betamethasone|mesh-list
154788381|NCT06011083|Betamethasone Valerate|betamethasone valerate|mesh-list
154788382|NCT06011083|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154788383|NCT06011083|Betamethasone benzoate|betamethasone benzoate|mesh-list
154788384|NCT06011083|Calcipotriene|calcipotriene|mesh-list
154788385|NCT06011083|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154788386|NCT06011083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788387|NCT06011083|Glucocorticoids|glucocorticoids|mesh-ancestor
154788388|NCT06011083|Hormones|hormones|mesh-ancestor
154788389|NCT06011083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788390|NCT06011083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788391|NCT06011083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154788392|NCT06011083|Respiratory System Agents|respiratory system agents|mesh-ancestor
154788393|NCT06011083|Dermatologic Agents|dermatologic agents|mesh-ancestor
154788394|NCT06011005|Benzocaine|benzocaine|mesh-list
154788395|NCT06011005|Ethyl Chloride|ethyl chloride|mesh-list
154788396|NCT06011005|Anesthetics, Local|anesthetics, local|mesh-ancestor
154788397|NCT06011005|Anesthetics|anesthetics|mesh-ancestor
154788398|NCT06011005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788399|NCT06011005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788400|NCT06011005|Sensory System Agents|sensory system agents|mesh-ancestor
154788401|NCT06011005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788402|NCT06010992|Nitazoxanide|nitazoxanide|mesh-list
154788403|NCT06010992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154788404|NCT06010992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788405|NCT06010745|Biotin|biotin|mesh-list
154788406|NCT06010745|Silicon|silicon|mesh-list
154788407|NCT06010745|Vitamin B Complex|vitamin b complex|mesh-ancestor
154788408|NCT06010745|Vitamins|vitamins|mesh-ancestor
154788409|NCT06010745|Micronutrients|micronutrients|mesh-ancestor
154788410|NCT06010745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788411|NCT06010745|Trace Elements|trace elements|mesh-ancestor
154788412|NCT06010368|Tranexamic Acid|tranexamic acid|mesh-list
154788413|NCT06010368|Oxytocin|oxytocin|mesh-list
154788414|NCT06010368|Oxytocics|oxytocics|mesh-ancestor
154788415|NCT06010368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154788416|NCT06010368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788417|NCT06010368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154788418|NCT06010368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154172267|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
154788419|NCT06010368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788420|NCT06010368|Hemostatics|hemostatics|mesh-ancestor
154788421|NCT06010368|Coagulants|coagulants|mesh-ancestor
154788422|NCT06010121|Vitamin D|vitamin d|mesh-list
154788423|NCT06010121|Ergocalciferols|ergocalciferols|mesh-list
154788424|NCT06010121|Cholecalciferol|cholecalciferol|mesh-list
154788425|NCT06010121|Vitamins|vitamins|mesh-list
154788426|NCT06010121|Micronutrients|micronutrients|mesh-ancestor
154788427|NCT06010121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788428|NCT06010121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154788429|NCT06010121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154788430|NCT06008990|Buprenorphine|buprenorphine|mesh-list
154788431|NCT06008990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154788432|NCT06008990|Narcotics|narcotics|mesh-ancestor
154788433|NCT06008990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788434|NCT06008990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788435|NCT06008990|Analgesics|analgesics|mesh-ancestor
154788436|NCT06008990|Sensory System Agents|sensory system agents|mesh-ancestor
154788437|NCT06008990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788438|NCT06008990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154788439|NCT06008002|Tramadol|tramadol|mesh-list
154788440|NCT06008002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154788441|NCT06008002|Narcotics|narcotics|mesh-ancestor
154788442|NCT06008002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540388|NCT03095144|Anesthetics|anesthetics|mesh-list
154788443|NCT06008002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788444|NCT06008002|Analgesics|analgesics|mesh-ancestor
154788445|NCT06008002|Sensory System Agents|sensory system agents|mesh-ancestor
154788446|NCT06008002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788447|NCT05935774|Atezolizumab|atezolizumab|mesh-list
154788448|NCT05935774|Trabedersen|trabedersen|mesh-list
154788449|NCT05935774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788450|NCT05935774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788451|NCT05935774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788452|NCT05935774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788453|NCT05926440|Vaccines|vaccines|mesh-list
154788454|NCT05926440|Somatomedin B|somatomedin b|mesh-list
154788455|NCT05926440|Immunologic Factors|immunologic factors|mesh-ancestor
154788456|NCT05926440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788457|NCT05926440|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154788458|NCT05926440|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154788459|NCT05926440|Protease Inhibitors|protease inhibitors|mesh-ancestor
154788460|NCT05926440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788461|NCT05926440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788462|NCT05802693|Mitogens|mitogens|mesh-list
154172310|NCT01047748|Digoxin|digoxin|mesh-list
154788463|NCT05802693|Mitosis Modulators|mitosis modulators|mesh-ancestor
154788464|NCT05802693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788465|NCT05799521|Glycine|glycine|mesh-list
154788466|NCT05799521|Glycine Agents|glycine agents|mesh-ancestor
154788467|NCT05799521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788468|NCT05799521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788469|NCT05799521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788470|NCT05784870|Ferrous succinate|ferrous succinate|mesh-list
154788471|NCT05784870|Hematinics|hematinics|mesh-ancestor
154788472|NCT05767684|Nivolumab|nivolumab|mesh-list
154788473|NCT05767684|Lenvatinib|lenvatinib|mesh-list
154788474|NCT05767684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788475|NCT05767684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788476|NCT05767684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788477|NCT05767684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788478|NCT05767684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154788479|NCT05767684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788480|NCT05734794|Rituximab|rituximab|mesh-list
154788481|NCT05734794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788482|NCT05734794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788483|NCT05734794|Immunologic Factors|immunologic factors|mesh-ancestor
154788484|NCT05734794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788485|NCT05734794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154788486|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
154788487|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154788488|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788489|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788490|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154788491|NCT05705128|Analgesics|analgesics|mesh-ancestor
154788492|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
154788493|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788494|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154788495|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154788496|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154788497|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
154788498|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788499|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788500|NCT05630859|Vaccines|vaccines|mesh-list
154788501|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
154788502|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788503|NCT05575518|Rifamycins|rifamycins|mesh-list
154788504|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
154788505|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154788506|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788507|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154788508|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788509|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788510|NCT05442983|Probenecid|probenecid|mesh-list
154788511|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
154788512|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
154788513|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154788514|NCT05404945|Doxorubicin|doxorubicin|mesh-list
154788515|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
154788516|NCT05404945|Dacarbazine|dacarbazine|mesh-list
154788517|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154788518|NCT05404945|Vinblastine|vinblastine|mesh-list
154788519|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154788520|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788521|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154788522|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154788523|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788524|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788525|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788526|NCT05404945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788527|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154788528|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
154788529|NCT05404945|Immunotoxins|immunotoxins|mesh-ancestor
154788530|NCT05404945|Immunoconjugates|immunoconjugates|mesh-ancestor
154788531|NCT05404945|Immunologic Factors|immunologic factors|mesh-ancestor
154788532|NCT05404945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788533|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154788534|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
154788535|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
154788536|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
154788537|NCT05305989|Belumosudil|belumosudil|mesh-list
154788538|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154788539|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788540|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788541|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
154788542|NCT05279456|Paraproteins|paraproteins|mesh-list
154788543|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
154788544|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788545|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
154788546|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154788547|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788548|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788549|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154788550|NCT05276830|Analgesics|analgesics|mesh-ancestor
154788551|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
154788552|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788553|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154172390|NCT00635219|Analgesics|analgesics|mesh-ancestor
154788554|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154788555|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154788556|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
154788557|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788558|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788559|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154788560|NCT05194735|Aldesleukin|aldesleukin|mesh-list
154788561|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788562|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154788563|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154788564|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
154788565|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788566|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154788567|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788568|NCT05070364|Interferons|interferons|mesh-list
154788569|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788570|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
154788571|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788572|NCT05060068|Ketamine|ketamine|mesh-list
154788573|NCT05060068|Esketamine|esketamine|mesh-list
154788574|NCT05060068|Analgesics|analgesics|mesh-ancestor
154788575|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
154788576|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788577|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788578|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154788579|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154788580|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
154788581|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
154788582|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788583|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154788584|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154788585|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788586|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788587|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
154788588|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154788589|NCT05043350|Loratadine|loratadine|mesh-list
154788590|NCT05043350|Famotidine|famotidine|mesh-list
154788591|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154788592|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788593|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154540536|NCT03293277|Analgesics|analgesics|mesh-ancestor
154788594|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
154788595|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
154788596|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788597|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788598|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788599|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
154788600|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
154788601|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154172434|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
154788602|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154788603|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154788605|NCT04985266|Letrozole|letrozole|mesh-list
154788606|NCT04985266|Fulvestrant|fulvestrant|mesh-list
154788607|NCT04985266|Palbociclib|palbociclib|mesh-list
154788608|NCT04985266|Anastrozole|anastrozole|mesh-list
154788609|NCT04985266|Exemestane|exemestane|mesh-list
154788610|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788611|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154788612|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154788613|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788614|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788615|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154788616|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
154788617|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788618|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788619|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154788620|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154788621|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154788622|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154788623|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154788624|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154788625|NCT04896697|Atezolizumab|atezolizumab|mesh-list
154788626|NCT04896697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788627|NCT04896697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788628|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788629|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788630|NCT04862468|Dexamethasone|dexamethasone|mesh-list
154788631|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788632|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
154788633|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
154788634|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788635|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788636|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788637|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
154788638|NCT04862468|Hormones|hormones|mesh-ancestor
154788639|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788640|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154788641|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788642|NCT04814927|Copper|copper|mesh-list
154788643|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154788644|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
154788645|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
154788646|NCT04814927|Etonogestrel|etonogestrel|mesh-list
154172485|NCT01026597|Alirocumab|alirocumab|mesh-list
154788647|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154788648|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
154788649|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154788650|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788651|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154788652|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154788653|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154788654|NCT04814927|Trace Elements|trace elements|mesh-ancestor
154788655|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
154788656|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154788657|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154788658|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154788659|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788660|NCT04747912|Dexamethasone|dexamethasone|mesh-list
154788661|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
154788662|NCT04747912|Methotrexate|methotrexate|mesh-list
154788663|NCT04747912|Vincristine|vincristine|mesh-list
154788664|NCT04747912|Dasatinib|dasatinib|mesh-list
154788665|NCT04747912|Ponatinib|ponatinib|mesh-list
154788666|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154788667|NCT04747912|BB 1101|bb 1101|mesh-list
154788668|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788669|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
154788670|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
154788671|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540610|NCT01652716|Exenatide|exenatide|mesh-list
154788672|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788673|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788674|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
154788675|NCT04747912|Hormones|hormones|mesh-ancestor
154788676|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788677|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154788678|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788679|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
154788680|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788681|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788682|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154788683|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
154788684|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154788685|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154788686|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
154788687|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
154788688|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154788689|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154788690|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
154788691|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154788692|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154788693|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154788694|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
154788695|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
154788696|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
154788697|NCT04747912|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154788698|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154788699|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788700|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154788701|NCT04747912|Immunotoxins|immunotoxins|mesh-ancestor
154788702|NCT04747912|Immunoconjugates|immunoconjugates|mesh-ancestor
154788703|NCT04603911|Dexamethasone|dexamethasone|mesh-list
154788704|NCT04603911|Clonidine|clonidine|mesh-list
154788705|NCT04603911|Epinephrine|epinephrine|mesh-list
154788706|NCT04603911|Bupivacaine|bupivacaine|mesh-list
154788707|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788708|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
154788709|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
154788710|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788711|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788712|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788713|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
154788714|NCT04603911|Hormones|hormones|mesh-ancestor
154788715|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788716|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154788717|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788718|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
154788719|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
154788720|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788721|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
154788722|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154788723|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154788724|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
154788725|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788726|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788727|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154788728|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154788729|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154788730|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
154788731|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
154788732|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
154788733|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154788734|NCT04603911|Analgesics|analgesics|mesh-ancestor
154788735|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154788736|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
154788737|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154788738|NCT04597424|Doxycycline|doxycycline|mesh-list
154788739|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154788740|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788741|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
154788742|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154788743|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154788744|NCT04501978|Remdesivir|remdesivir|mesh-list
154788745|NCT04501978|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154788746|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
154788747|NCT04501978|Sotrovimab|sotrovimab|mesh-list
154788748|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
154788749|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788750|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
154788751|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788752|NCT04342819|Empagliflozin|empagliflozin|mesh-list
154788753|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154788754|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788755|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154788756|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788757|NCT04187248|Asparaginase|asparaginase|mesh-list
154788758|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788759|NCT04156087|Gemcitabine|gemcitabine|mesh-list
154788761|NCT04156087|Tremelimumab|tremelimumab|mesh-list
154788762|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154788763|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
154788764|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788765|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788766|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788767|NCT04112212|Vedolizumab|vedolizumab|mesh-list
154788768|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788769|NCT04107077|Mitomycins|mitomycins|mesh-list
154788770|NCT04107077|Mitomycin|mitomycin|mesh-list
154788771|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788772|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154788773|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
154788774|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788775|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154788776|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788777|NCT04051320|Leuprolide|leuprolide|mesh-list
154788778|NCT04051320|Estradiol|estradiol|mesh-list
154788779|NCT04051320|Progesterone|progesterone|mesh-list
154788780|NCT04051320|Estrogens|estrogens|mesh-ancestor
154788781|NCT04051320|Hormones|hormones|mesh-ancestor
154788782|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788783|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788784|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154788785|NCT04051320|Progestins|progestins|mesh-ancestor
154788786|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154788787|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
154788788|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154788789|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788790|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
154788791|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788792|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788793|NCT03990961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788794|NCT03990961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788795|NCT03841526|Insulin|insulin|mesh-list
154788796|NCT03841526|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154788797|NCT03841526|Glucagon|glucagon|mesh-list
154788798|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154788799|NCT03841526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154788800|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788801|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788802|NCT03841526|Hormones|hormones|mesh-ancestor
154788803|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788804|NCT03841526|Incretins|incretins|mesh-ancestor
154788805|NCT03834506|Dexamethasone|dexamethasone|mesh-list
154788806|NCT03834506|Prednisone|prednisone|mesh-list
154788807|NCT03834506|Docetaxel|docetaxel|mesh-list
154788808|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
154788809|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154788810|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
154788811|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
154788812|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788813|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788814|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154788815|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
154788816|NCT03834506|Hormones|hormones|mesh-ancestor
154788817|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788818|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154788819|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788820|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
154788821|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
154788822|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
154788823|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788824|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788825|NCT03834506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788826|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
154788827|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154788828|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154788829|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
154788830|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788831|NCT03474744|Rituximab|rituximab|mesh-list
154788832|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788833|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788834|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
154788835|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788836|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154788837|NCT03367871|Paclitaxel|paclitaxel|mesh-list
154788838|NCT03367871|Bevacizumab|bevacizumab|mesh-list
154788839|NCT03367871|Carboplatin|carboplatin|mesh-list
154788840|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
154788841|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154788842|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788843|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
154788844|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
154788845|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
154788846|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788847|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788848|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154788849|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154788850|NCT03367871|Growth Substances|growth substances|mesh-ancestor
154788851|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788852|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
154788853|NCT03367871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788854|NCT03340064|Levetiracetam|levetiracetam|mesh-list
154788855|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
154788856|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
154788857|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
154788858|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788859|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788860|NCT03277638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154172701|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
154788861|NCT03277638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788862|NCT03180684|Imiquimod|imiquimod|mesh-list
154788863|NCT03180684|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154788864|NCT03180684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788865|NCT03180684|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154788866|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
154788867|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788868|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154788869|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788870|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
154788871|NCT03161652|Ranibizumab|ranibizumab|mesh-list
154788872|NCT03161652|Dopamine|dopamine|mesh-list
154788873|NCT03161652|Sulpiride|sulpiride|mesh-list
154788874|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154788875|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154788876|NCT03161652|Growth Substances|growth substances|mesh-ancestor
154788877|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788878|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
154788879|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788880|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154788881|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
154788882|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
154788883|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154788884|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
154788885|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154788886|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788887|NCT03161652|Protective Agents|protective agents|mesh-ancestor
154788888|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154788889|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154172744|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
154172773|NCT01024179|Sirolimus|sirolimus|mesh-list
154788890|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154788891|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154788892|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154788893|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154788894|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
154788895|NCT03131037|Valacyclovir|valacyclovir|mesh-list
154788896|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
154788897|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788898|NCT02992457|Interferons|interferons|mesh-list
154788899|NCT02992457|Ribavirin|ribavirin|mesh-list
154788901|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
154788902|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154788903|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
154788904|NCT02992457|Ledipasvir|ledipasvir|mesh-list
154788905|NCT02992457|Simeprevir|simeprevir|mesh-list
154788906|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154788907|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788908|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
154788909|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788910|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
154788911|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788912|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
154788913|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788914|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
154788915|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788916|NCT02829424|Methotrexate|methotrexate|mesh-list
154788917|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154788918|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
154788919|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154788920|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788921|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154788922|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
154788923|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788924|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788925|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
154788926|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788927|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154788928|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154788929|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
154788930|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154788931|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154788932|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
154788933|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788934|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788935|NCT02740920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788936|NCT02740920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788937|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
154788938|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154788939|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788940|NCT02515227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154788941|NCT02515227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788942|NCT02369458|Mitomycins|mitomycins|mesh-list
154788943|NCT02369458|Mitomycin|mitomycin|mesh-list
154788944|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154788945|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788946|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
154788947|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788948|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154788949|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788950|NCT02122172|Afatinib|afatinib|mesh-list
154788951|NCT02122172|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154788952|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154788953|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788954|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788955|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788956|NCT02052609|Brodalumab|brodalumab|mesh-list
154788957|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
154788958|NCT02031939|Capecitabine|capecitabine|mesh-list
154788959|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
154788960|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154788961|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
154788962|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788963|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788964|NCT01997190|Valacyclovir|valacyclovir|mesh-list
154788965|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
154788966|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788967|NCT01028963|Pioglitazone|pioglitazone|mesh-list
154788968|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154788969|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788970|NCT00754845|Letrozole|letrozole|mesh-list
154788971|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154788972|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154788973|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154788974|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788975|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788976|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154788977|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
154788978|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154788979|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154788980|NCT00751270|Valacyclovir|valacyclovir|mesh-list
154788981|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
154788982|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788983|NCT00638612|Valacyclovir|valacyclovir|mesh-list
154788984|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
154788985|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788986|NCT00634231|Valacyclovir|valacyclovir|mesh-list
154788987|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
154788988|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788989|NCT00555555|Factor VIII|factor viii|mesh-list
154788990|NCT00555555|Coagulants|coagulants|mesh-ancestor
154788991|NCT00312039|Lamivudine|lamivudine|mesh-list
154788992|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
154788993|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154788994|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154788995|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154788996|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154788997|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
154788998|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154788999|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154789000|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154789001|NCT00083174|Exemestane|exemestane|mesh-list
154789002|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789003|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154789004|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154789005|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789006|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789007|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154789008|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
154789009|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789010|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789011|NCT00066573|Anastrozole|anastrozole|mesh-list
154789012|NCT00066573|Exemestane|exemestane|mesh-list
154789013|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154789014|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789015|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154789016|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154789017|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789018|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789019|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154789020|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
154789021|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789022|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789023|NCT03965845|Palbociclib|palbociclib|mesh-list
154789024|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789025|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154789026|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789027|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789028|NCT04766359|Paclitaxel|paclitaxel|mesh-list
154789029|NCT04766359|Cisplatin|cisplatin|mesh-list
154789030|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154789031|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789032|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789033|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154789034|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154789035|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154789036|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789037|NCT04020601|Ropivacaine|ropivacaine|mesh-list
154789038|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
154789039|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
154789040|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789041|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789042|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
154789043|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789044|NCT04193137|Captopril|captopril|mesh-list
154789045|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154789046|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
154789047|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789048|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789049|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154789050|NCT05060484|Vaccines|vaccines|mesh-list
154789051|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
154789052|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789053|NCT04193059|Paclitaxel|paclitaxel|mesh-list
154789054|NCT04193059|Docetaxel|docetaxel|mesh-list
154789055|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
154789056|NCT04193059|Carboplatin|carboplatin|mesh-list
154789057|NCT04193059|Trastuzumab|trastuzumab|mesh-list
154789058|NCT04193059|Epirubicin|epirubicin|mesh-list
154789059|NCT04193059|Pertuzumab|pertuzumab|mesh-list
154789060|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789061|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789062|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
154789063|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
154789064|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
154789065|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789066|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154789067|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
154789068|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789069|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154789070|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154789071|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
154789072|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154789073|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154789074|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154789075|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154789076|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154789077|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789078|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154789079|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154789080|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
154789081|NCT05092074|Velpatasvir|velpatasvir|mesh-list
154789082|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
154789083|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789084|NCT02080273|Listerine|listerine|mesh-list
154789085|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
154789086|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
154789087|NCT02080273|Protective Agents|protective agents|mesh-ancestor
154789088|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789089|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154789090|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789091|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
154789092|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154789093|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
154789094|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
154789095|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789096|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789097|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154789098|NCT04199143|Analgesics|analgesics|mesh-ancestor
154789099|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
154789100|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789101|NCT04616274|Venetoclax|venetoclax|mesh-list
154789102|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789103|NCT04613622|Venetoclax|venetoclax|mesh-list
154789104|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789105|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154789106|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154789107|NCT05096676|Oxytocin|oxytocin|mesh-list
154789108|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
154789109|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154789110|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789111|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
154789112|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154789113|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789114|NCT03948763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154789115|NCT03948763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789116|NCT05096520|Lidocaine|lidocaine|mesh-list
154789117|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
154789118|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
154789119|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789120|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789121|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
154789122|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789123|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154789124|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154789125|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154789126|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154789127|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789128|NCT03832465|Levofloxacin|levofloxacin|mesh-list
154789129|NCT03832465|Ofloxacin|ofloxacin|mesh-list
154789130|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154789131|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154789132|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789133|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154789134|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154789135|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154789136|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789137|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789138|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789139|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154789140|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154789141|NCT04190173|Prucalopride|prucalopride|mesh-list
154789142|NCT04190173|Laxatives|laxatives|mesh-ancestor
154789143|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789144|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154789145|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154789146|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
154789147|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789148|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789149|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172999|NCT00446199|Estradiol|estradiol|mesh-list
154789150|NCT01272219|Liraglutide|liraglutide|mesh-list
154789151|NCT01272219|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154789152|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154789153|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789154|NCT01272219|Incretins|incretins|mesh-ancestor
154789155|NCT01272219|Hormones|hormones|mesh-ancestor
154789156|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789157|NCT04097600|Semaglutide|semaglutide|mesh-list
154789158|NCT04097600|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154789159|NCT04097600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154789160|NCT04097600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789161|NCT04020133|Epinephrine|epinephrine|mesh-list
154789162|NCT04020133|Bupivacaine|bupivacaine|mesh-list
154789163|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
154789164|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
154789165|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789166|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789167|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
154789168|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789169|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154789170|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154789171|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
154789172|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789173|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789174|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154789175|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154789176|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
154789177|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154789178|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
154789179|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
154789180|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
154789181|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154789182|NCT04565574|Rifampin|rifampin|mesh-list
154789183|NCT04565574|Rabeprazole|rabeprazole|mesh-list
154789184|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154789185|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789186|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154789187|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789188|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789189|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154789190|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
154789191|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154789192|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789193|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
154789194|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154789195|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154789196|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154789197|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154789198|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154789199|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154789201|NCT01270971|Tavaborole|tavaborole|mesh-list
154789202|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154789203|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
154789204|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789205|NCT04026841|Antibodies|antibodies|mesh-list
154789206|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
154789207|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789208|NCT04128774|Dexamethasone|dexamethasone|mesh-list
154789209|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
154789210|NCT04128774|BB 1101|bb 1101|mesh-list
154789211|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154789212|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
154789213|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
154789214|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789215|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789216|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789217|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
154789218|NCT04128774|Hormones|hormones|mesh-ancestor
154789219|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789220|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154789221|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789222|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
154789223|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789224|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789225|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
154789226|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154789227|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
154789228|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789229|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
154789230|NCT00732225|Protective Agents|protective agents|mesh-ancestor
154789231|NCT04026685|Phenylephrine|phenylephrine|mesh-list
154789232|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
154789233|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154789234|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
154789235|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
154789236|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789237|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789238|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
154789239|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154789240|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
154789241|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
154789242|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154789243|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154789244|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154789245|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
154789246|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789247|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789248|NCT04026685|Protective Agents|protective agents|mesh-ancestor
154789249|NCT00751179|Bromides|bromides|mesh-list
154789250|NCT00751179|Rocuronium|rocuronium|mesh-list
154789251|NCT00751179|Succinylcholine|succinylcholine|mesh-list
154789252|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
154789253|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154789254|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154789255|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154789256|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789257|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789258|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154789259|NCT01273233|Vaccines|vaccines|mesh-list
154789260|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
154789261|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789262|NCT01277211|NuvaRing|nuvaring|mesh-list
154789263|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154789264|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
154789265|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154789266|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789267|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
154789268|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154789269|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
154789270|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789271|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789272|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154789273|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
154789274|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154789275|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
154789276|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789277|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789278|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154789279|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
154789280|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
154789281|NCT04022161|Protective Agents|protective agents|mesh-ancestor
154789282|NCT01676220|Insulin|insulin|mesh-list
154789283|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154789284|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
154789285|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154789286|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789287|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154789288|NCT01275105|Phenylephrine|phenylephrine|mesh-list
154789289|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
154789290|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154789291|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154789292|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154789293|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154789294|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
154789295|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789296|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789297|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789298|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
154789299|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
154789300|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789301|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
154789302|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154789303|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
154789304|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154789305|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
154789306|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154789307|NCT01275105|Protective Agents|protective agents|mesh-ancestor
154789308|NCT01270347|Levofloxacin|levofloxacin|mesh-list
154789309|NCT01270347|Ofloxacin|ofloxacin|mesh-list
154789310|NCT01270347|Tobramycin|tobramycin|mesh-list
154789311|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154789312|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154789313|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789314|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154789315|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154789316|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154789317|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789318|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789319|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789320|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154789321|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154789322|NCT03608436|Bromides|bromides|mesh-list
154789323|NCT03608436|Rocuronium|rocuronium|mesh-list
154789324|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
154789325|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154789326|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154789327|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154789328|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789329|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789330|NCT04025671|Naloxone|naloxone|mesh-list
154789331|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154789332|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789333|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
154789334|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789335|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154789336|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
154789337|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789338|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
154789339|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789340|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154789341|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
154789342|NCT03412188|Hormones|hormones|mesh-ancestor
154789343|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789344|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154789345|NCT03412188|Protective Agents|protective agents|mesh-ancestor
154173178|NCT01045642|Omeprazole|omeprazole|mesh-list
154789346|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154789347|NCT01278849|Vadimezan|vadimezan|mesh-list
154541286|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789348|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789349|NCT04949412|Vitamin D|vitamin d|mesh-list
154789350|NCT04949412|Vitamins|vitamins|mesh-ancestor
154789352|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789353|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154789354|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154789355|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
154789356|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154789357|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
154789358|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789359|NCT01485614|Metformin|metformin|mesh-list
154789360|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154789361|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154789362|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789363|NCT01485614|Incretins|incretins|mesh-ancestor
154789364|NCT01485614|Hormones|hormones|mesh-ancestor
154789365|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789366|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154789367|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
154789368|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789369|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789370|NCT00722553|Vitamins|vitamins|mesh-list
154789371|NCT00722553|Folic Acid|folic acid|mesh-list
154789372|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
154789373|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
154789374|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
154789375|NCT00722553|Aminopterin|aminopterin|mesh-list
154789376|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
154789377|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789378|NCT00722553|Hematinics|hematinics|mesh-ancestor
154789379|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154789380|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789381|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789382|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789383|NCT03022747|Allopurinol|allopurinol|mesh-list
154789384|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
154789385|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789386|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789387|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
154789388|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154789389|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154789390|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
154789391|NCT03022747|Protective Agents|protective agents|mesh-ancestor
154789392|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789393|NCT03928015|Analgesics|analgesics|mesh-list
154789394|NCT03928015|Dronabinol|dronabinol|mesh-list
154789395|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
154789396|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789397|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789398|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
154789399|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154789400|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154789401|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154789402|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154789403|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789404|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789405|NCT03928015|Hormones|hormones|mesh-ancestor
154789406|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789407|NCT00735969|Ribavirin|ribavirin|mesh-list
154789408|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
154789409|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789410|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
154789411|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789412|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
154789413|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789414|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
154789415|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154789416|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154789417|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789418|NCT03229512|Urological Agents|urological agents|mesh-ancestor
154789419|NCT01279083|Timolol|timolol|mesh-list
154789420|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154789421|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789422|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154789423|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154789424|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154789425|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789426|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789427|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154789428|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154789429|NCT03022201|Domperidone|domperidone|mesh-list
154789430|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
154789431|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
154789432|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789433|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789434|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789435|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154789436|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
154789437|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789438|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789439|NCT04716114|Cytarabine|cytarabine|mesh-list
154789440|NCT04716114|Fludarabine|fludarabine|mesh-list
154789441|NCT04716114|Azacitidine|azacitidine|mesh-list
154789442|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
154789443|NCT04716114|Aclarubicin|aclarubicin|mesh-list
154789444|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789445|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154789446|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
154789447|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789448|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154789449|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
154789450|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789451|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
154789452|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789453|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789454|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789455|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154789456|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154789457|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154789458|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154789459|NCT00752973|Malathion|malathion|mesh-list
154789460|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154789461|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789462|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789463|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
154789464|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789465|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789466|NCT04025593|Prednisone|prednisone|mesh-list
154789467|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
154789468|NCT04025593|Rituximab|rituximab|mesh-list
154789469|NCT04025593|Doxorubicin|doxorubicin|mesh-list
154789470|NCT04025593|Vincristine|vincristine|mesh-list
154789471|NCT04025593|Lenalidomide|lenalidomide|mesh-list
154789472|NCT04025593|Decitabine|decitabine|mesh-list
154789473|NCT04025593|Ibrutinib|ibrutinib|mesh-list
154789474|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154789475|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
154789476|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789477|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154789478|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154789479|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
154789480|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789481|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789482|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154789483|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154789484|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154789485|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154789486|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154789487|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789488|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154789489|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
154789490|NCT04025593|Hormones|hormones|mesh-ancestor
154789491|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789492|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154789493|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789494|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
154789495|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
154789496|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
154789497|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154789498|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154789499|NCT04025593|Growth Substances|growth substances|mesh-ancestor
154789500|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
154789501|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154789502|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
154789503|NCT04025593|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154789504|NCT04025593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154789505|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154789506|NCT01279707|Epratuzumab|epratuzumab|mesh-list
154789507|NCT01279707|Veltuzumab|veltuzumab|mesh-list
154789508|NCT01279707|Antibodies|antibodies|mesh-list
154789509|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
154789510|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154789511|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
154173363|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789512|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789513|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789514|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
154789515|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154789516|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
154789517|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154789518|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789519|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154789520|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154789521|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154789522|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
154789523|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789524|NCT03022123|Prednisone|prednisone|mesh-list
154789525|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
154789526|NCT03022123|Doxorubicin|doxorubicin|mesh-list
154789527|NCT03022123|Vincristine|vincristine|mesh-list
154789528|NCT03022123|Epirubicin|epirubicin|mesh-list
154789529|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154789530|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
154789531|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789532|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154789533|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154789534|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
154789535|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789536|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789537|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154789538|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154789539|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154789540|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154789541|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789542|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154789543|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
154789544|NCT03022123|Hormones|hormones|mesh-ancestor
154789545|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789546|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154789547|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789548|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
154789549|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
154789550|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
154789551|NCT01520870|Dacomitinib|dacomitinib|mesh-list
154789552|NCT01520870|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154789553|NCT01520870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154789554|NCT01520870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789555|NCT01520870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789556|NCT00722865|Bevacizumab|bevacizumab|mesh-list
154789557|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154789558|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789559|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154789560|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154789561|NCT00722865|Growth Substances|growth substances|mesh-ancestor
154789562|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789563|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
154789564|NCT02700529|Ubenimex|ubenimex|mesh-list
154789565|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154789566|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
154789567|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173395|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154789568|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154789569|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789570|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154789571|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789572|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
154789573|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789574|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789575|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154789576|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154789577|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
154789578|NCT00723099|Cyclosporine|cyclosporine|mesh-list
154789579|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
154789580|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
154789581|NCT00723099|Fludarabine|fludarabine|mesh-list
154789582|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
154789583|NCT00723099|Cyclosporins|cyclosporins|mesh-list
154789584|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154789585|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
154789586|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789587|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154789588|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154789589|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
154789590|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789591|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789592|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154789593|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154789594|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
154789595|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789596|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
154789597|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789598|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
154789599|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154789600|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154789601|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154789602|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
154789603|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154789604|NCT01508936|Reslizumab|reslizumab|mesh-list
154789605|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154789606|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
154789607|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
154789608|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154789609|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
154789610|NCT04146259|Calcium|calcium|mesh-list
154789611|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154173452|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
154789612|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789613|NCT04146259|Antacids|antacids|mesh-ancestor
154789614|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789615|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789616|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154789617|NCT04146259|Vitamins|vitamins|mesh-ancestor
154789618|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
154789619|NCT05100186|Dexamethasone|dexamethasone|mesh-list
154789620|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154789621|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
154789622|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
154789623|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789624|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789625|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789626|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
154789627|NCT05100186|Hormones|hormones|mesh-ancestor
154789628|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789629|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154789630|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789631|NCT04323462|Insulin|insulin|mesh-list
154789632|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154789633|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
154789634|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154789635|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789636|NCT00723177|Ibudilast|ibudilast|mesh-list
154789637|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154789638|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
154789639|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789640|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789641|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154789642|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
154789643|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154789644|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789645|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789646|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154789647|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
154789648|NCT04318392|Dimercaprol|dimercaprol|mesh-list
154789649|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
154789650|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
154789651|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789652|NCT04698434|Esketamine|esketamine|mesh-list
154789653|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
154789654|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154789656|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
154789657|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789658|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
154789659|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154789660|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
154789661|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154789662|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154789663|NCT04142749|Protective Agents|protective agents|mesh-ancestor
154789664|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789665|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789666|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154789667|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154789668|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789669|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789670|NCT01508702|Lesinurad|lesinurad|mesh-list
154789671|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
154789672|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154789673|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
154789674|NCT04024813|Seladelpar|seladelpar|mesh-list
154789675|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154789676|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
154789677|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789678|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154789679|NCT01276041|Paclitaxel|paclitaxel|mesh-list
154789680|NCT01276041|Trastuzumab|trastuzumab|mesh-list
154789681|NCT01276041|Pertuzumab|pertuzumab|mesh-list
154789682|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789683|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789684|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
154789685|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
154789686|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
154789687|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789688|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154789689|NCT04150770|Infliximab|infliximab|mesh-list
154789690|NCT04150770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154789691|NCT04150770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154789692|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
154789693|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789694|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154789695|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
154789696|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
154789697|NCT04026438|Protective Agents|protective agents|mesh-ancestor
154789698|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789699|NCT01275339|Tadalafil|tadalafil|mesh-list
154789700|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
154789701|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154789702|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154789703|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789704|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789705|NCT01275339|Urological Agents|urological agents|mesh-ancestor
154789706|NCT01520402|Warfarin|warfarin|mesh-list
154789707|NCT01520402|Anticoagulants|anticoagulants|mesh-list
154789708|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
154789709|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154789710|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789711|NCT01279473|Nilotinib|nilotinib|mesh-list
154789712|NCT01279473|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154789713|NCT01279473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154789714|NCT01279473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789715|NCT01279473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789716|NCT05108220|Cannabidiol|cannabidiol|mesh-list
154789717|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
154789718|NCT03027674|Nifedipine|nifedipine|mesh-list
154789719|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
154789720|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
154789721|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154789722|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154789723|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789724|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789725|NCT03027674|Urological Agents|urological agents|mesh-ancestor
154789726|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154789727|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154789728|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154789729|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789730|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
154789731|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154789733|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154789734|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154789735|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
154789736|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789737|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789738|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789739|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154789740|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
154789741|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789742|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154789743|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
154789744|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
154789745|NCT04023565|Perindopril|perindopril|mesh-list
154789746|NCT04023565|Moxonidine|moxonidine|mesh-list
154789747|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154789748|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
154789749|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789750|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789751|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154789752|NCT01506908|Nicotine|nicotine|mesh-list
154789753|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154789754|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
154789755|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789756|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789757|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154789758|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154789759|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
154789760|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789761|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789762|NCT01519778|Tedizolid|tedizolid|mesh-list
154789763|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154789764|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789765|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
154789766|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154789767|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154789768|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789769|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154789770|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789771|NCT04149067|Incretins|incretins|mesh-ancestor
154789772|NCT04149067|Hormones|hormones|mesh-ancestor
154173610|NCT01028547|Dexamethasone|dexamethasone|mesh-list
154789773|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789774|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154789775|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
154789776|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789777|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
154789778|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
154789779|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789780|NCT05087862|Anesthetics|anesthetics|mesh-list
154789781|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
154789782|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789783|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789784|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
154789785|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789786|NCT01519700|Lenograstim|lenograstim|mesh-list
154789787|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154789788|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
154789789|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789790|NCT04143685|Misoprostol|misoprostol|mesh-list
154789791|NCT04143685|Oxytocin|oxytocin|mesh-list
154789792|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
154789793|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154789794|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789795|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154789796|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
154789797|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154789798|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789799|NCT04148599|Lidocaine|lidocaine|mesh-list
154789800|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
154789801|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
154789802|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
154789803|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789804|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173649|NCT03891264|Cannabidiol|cannabidiol|mesh-list
154789805|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
154789806|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789807|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154789808|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154789809|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154789810|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154789811|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789812|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154789813|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154789815|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154789816|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154789817|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154789818|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
154789819|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789820|NCT04930458|Listerine|listerine|mesh-list
154789821|NCT04930458|Calcium|calcium|mesh-list
154789822|NCT04930458|Fluorides|fluorides|mesh-list
154789823|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
154789824|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
154789825|NCT04930458|Caseins|caseins|mesh-list
154789826|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154789827|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789828|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
154789829|NCT04930458|Protective Agents|protective agents|mesh-ancestor
154789830|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154789831|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789832|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
154789833|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
154789834|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789835|NCT04917588|Lidocaine|lidocaine|mesh-list
154789836|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
154789837|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
154789838|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789839|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789840|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
154789841|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789842|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154789843|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154789844|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154789845|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154789846|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789847|NCT04022317|Insulin|insulin|mesh-list
154789848|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154789849|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789850|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
154789851|NCT05099250|Bupivacaine|bupivacaine|mesh-list
154789852|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
154789853|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
154789854|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789855|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789856|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
154789857|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789858|NCT05099250|Analgesics|analgesics|mesh-ancestor
154789859|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154789860|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
154789861|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154789862|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154789863|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789864|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154789865|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
154789866|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154789867|NCT04143451|Imiquimod|imiquimod|mesh-list
154789868|NCT04143451|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154789869|NCT04143451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789870|NCT04143451|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154789871|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
154789872|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789873|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154789874|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789875|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
154789876|NCT05105412|Gemcitabine|gemcitabine|mesh-list
154789877|NCT05105412|Lenalidomide|lenalidomide|mesh-list
154789878|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154789879|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
154789880|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789881|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789882|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
154789883|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789884|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154789885|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154789886|NCT05105412|Growth Substances|growth substances|mesh-ancestor
154789887|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
154789889|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154789890|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154789891|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789892|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154789893|NCT04766047|Analgesics|analgesics|mesh-ancestor
154789894|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
154789895|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154789896|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154789897|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154789898|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154789899|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154789900|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789901|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789902|NCT02080819|Levodopa|levodopa|mesh-list
154789903|NCT02080819|Carbidopa|carbidopa|mesh-list
154789904|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154789905|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154789906|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
154789907|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154789908|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789909|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789910|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154789911|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789912|NCT05104788|Carboplatin|carboplatin|mesh-list
154789913|NCT05104788|Pemetrexed|pemetrexed|mesh-list
154789914|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789915|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789916|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789917|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154789918|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154789919|NCT04405843|Ivermectin|ivermectin|mesh-list
154789920|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154789921|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789922|NCT04316364|Paclitaxel|paclitaxel|mesh-list
154789923|NCT04316364|Carboplatin|carboplatin|mesh-list
154789924|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789925|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789926|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
154789927|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
154789928|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
154789929|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789930|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
154789931|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154789932|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789933|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
154789934|NCT04018872|Itraconazole|itraconazole|mesh-list
154789935|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
154789936|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789937|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154789938|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154789939|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789940|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789941|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154789942|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
154789943|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154789944|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789945|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154789946|NCT05076786|Carboplatin|carboplatin|mesh-list
154789947|NCT05076786|Etoposide|etoposide|mesh-list
154789948|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789949|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789950|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154789951|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154789952|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789953|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789954|NCT03476317|Vancomycin|vancomycin|mesh-list
154789955|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
154789956|NCT03476317|Neomycin|neomycin|mesh-list
154789957|NCT03476317|Fluconazole|fluconazole|mesh-list
154789958|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154789959|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154789960|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789961|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154789962|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154789963|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154789964|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789965|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789966|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154789967|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154789968|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
154789969|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154789970|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154789971|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
154789972|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173806|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
154789973|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789974|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154789975|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154789976|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154789977|NCT03476317|Laxatives|laxatives|mesh-ancestor
154789978|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154789979|NCT02658084|Trastuzumab|trastuzumab|mesh-list
154789980|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154789981|NCT02658084|Vinorelbine|vinorelbine|mesh-list
154789982|NCT02658084|Maytansine|maytansine|mesh-list
154789983|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154789984|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154789985|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154789986|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
154789987|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
154789988|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
154789989|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154789990|NCT02658084|Immunotoxins|immunotoxins|mesh-ancestor
154789991|NCT02658084|Immunoconjugates|immunoconjugates|mesh-ancestor
154789992|NCT02658084|Immunologic Factors|immunologic factors|mesh-ancestor
154789993|NCT02658084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154789994|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154789995|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154789996|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154789997|NCT03588715|Interferons|interferons|mesh-list
154789998|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
154789999|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
154790000|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154790001|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
154790002|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790003|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
154790004|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790005|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
154790006|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790007|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
154790008|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790009|NCT04140409|Octreotide|octreotide|mesh-list
154790010|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790011|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154790012|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790013|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
154790014|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154790015|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154790016|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154790017|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154790018|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790019|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
154790020|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790021|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173851|NCT01000116|Coagulants|coagulants|mesh-ancestor
154790022|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154790023|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790024|NCT04642950|Sargramostim|sargramostim|mesh-list
154790025|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
154790026|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790027|NCT04374240|Tretazicar|tretazicar|mesh-list
154790028|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790029|NCT05109390|Cyclosporine|cyclosporine|mesh-list
154790030|NCT05109390|Simethicone|simethicone|mesh-list
154790031|NCT05109390|Omeprazole|omeprazole|mesh-list
154790032|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
154790033|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
154790034|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154790035|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
154790036|NCT05109390|Antacids|antacids|mesh-list
154790037|NCT05109390|Tacrolimus|tacrolimus|mesh-list
154790038|NCT05109390|Cyclosporins|cyclosporins|mesh-list
154790039|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790040|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154790041|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
154790042|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154790043|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790044|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790045|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
154790046|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790047|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
154790048|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154790049|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790050|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154790051|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
154790052|NCT05109390|Emollients|emollients|mesh-ancestor
154790053|NCT04030182|Vitamin D|vitamin d|mesh-list
154790054|NCT04030182|Vitamins|vitamins|mesh-ancestor
154790055|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
154790056|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790057|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154790058|NCT03661632|Nivolumab|nivolumab|mesh-list
154790059|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154790060|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790061|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154790062|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790063|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
154790064|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154790065|NCT04748250|Estrogens|estrogens|mesh-ancestor
154790066|NCT04748250|Hormones|hormones|mesh-ancestor
154790067|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790068|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790069|NCT04726878|Acetaminophen|acetaminophen|mesh-list
154790070|NCT04726878|Oxycodone|oxycodone|mesh-list
154790071|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790072|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790073|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154790074|NCT04726878|Analgesics|analgesics|mesh-ancestor
154790075|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
154790076|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790077|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
154790078|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154790079|NCT04726878|Narcotics|narcotics|mesh-ancestor
154790080|NCT04525638|Nivolumab|nivolumab|mesh-list
154790081|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154790082|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154790083|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790084|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154790085|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790086|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154790087|NCT01482962|Gemcitabine|gemcitabine|mesh-list
154790088|NCT01482962|Romidepsin|romidepsin|mesh-list
154790089|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154790090|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
154790091|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790092|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790093|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154790094|NCT01482962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154790095|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790096|NCT04701060|Apatinib|apatinib|mesh-list
154790097|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790098|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154790099|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790100|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790101|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154790102|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
154790103|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790104|NCT05116098|Protective Agents|protective agents|mesh-ancestor
154790105|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790106|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154790107|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154173943|NCT01031667|Cilostazol|cilostazol|mesh-list
154790108|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790109|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154790110|NCT04464408|Favipiravir|favipiravir|mesh-list
154790111|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
154790112|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790113|NCT04339218|Carboplatin|carboplatin|mesh-list
154790114|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
154790115|NCT04339218|Pemetrexed|pemetrexed|mesh-list
154790116|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790117|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154790118|NCT04339218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154790119|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790120|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790121|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154790122|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154790123|NCT03895801|Prednisone|prednisone|mesh-list
154790124|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
154790125|NCT03895801|Vilobelimab|vilobelimab|mesh-list
154790126|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790127|NCT03895801|Hormones|hormones|mesh-ancestor
154790128|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790129|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790130|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154790131|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790132|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154790133|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154790134|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
154790135|NCT03021421|Bupivacaine|bupivacaine|mesh-list
154790136|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
154790137|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
154790138|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790139|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790140|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
154173991|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
154790141|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790142|NCT04521582|Amlodipine|amlodipine|mesh-list
154790143|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154790144|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154790145|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154790146|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790147|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154790148|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790149|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
154790150|NCT03588091|Docetaxel|docetaxel|mesh-list
154790151|NCT03588091|Trastuzumab|trastuzumab|mesh-list
154790152|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790153|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
154790154|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
154790155|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
154790156|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790157|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154790158|NCT04436172|Anesthetics|anesthetics|mesh-list
154790159|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790160|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790161|NCT03587779|Sevoflurane|sevoflurane|mesh-list
154790162|NCT03587779|Desflurane|desflurane|mesh-list
154790163|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154790164|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154790165|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
154790166|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
154790167|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790168|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790169|NCT04405921|Azithromycin|azithromycin|mesh-list
154790170|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
154790171|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154790172|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790173|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
154790174|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154790175|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154790176|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790177|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790178|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154790179|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154790180|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154790181|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
154790182|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790183|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154790184|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
154790185|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790186|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790187|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154790188|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154790189|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154790190|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
154790191|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154790192|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154790193|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
154790194|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
154790195|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
154790196|NCT03581149|Laxatives|laxatives|mesh-list
154790197|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790198|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
154790199|NCT03581149|Protective Agents|protective agents|mesh-ancestor
154790200|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790201|NCT03581149|Vitamins|vitamins|mesh-ancestor
154790202|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
154790203|NCT03581149|Cathartics|cathartics|mesh-ancestor
154790204|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790205|NCT05583409|Osimertinib|osimertinib|mesh-list
154790206|NCT05583409|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154790207|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154790208|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790209|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790210|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790211|NCT03020953|Estrogens|estrogens|mesh-list
154790212|NCT03020953|Hormones|hormones|mesh-ancestor
154790213|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790214|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790215|NCT03580681|Vitamin E|vitamin e|mesh-list
154790216|NCT03580681|Vitamins|vitamins|mesh-ancestor
154790217|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
154790218|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790219|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
154174067|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154790220|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790221|NCT03580681|Protective Agents|protective agents|mesh-ancestor
154790222|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
154790223|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154790224|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
154790225|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790226|NCT03069300|Expectorants|expectorants|mesh-ancestor
154790227|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
154790228|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154790229|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
154790230|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790231|NCT03069300|Protective Agents|protective agents|mesh-ancestor
154790232|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790233|NCT03069300|Antidotes|antidotes|mesh-ancestor
154790234|NCT05582317|Simvastatin|simvastatin|mesh-list
154790235|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154790236|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154790237|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
154790238|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790239|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154790240|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154790241|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790242|NCT03891355|Dexamethasone|dexamethasone|mesh-list
154790243|NCT03891355|Lenalidomide|lenalidomide|mesh-list
154790244|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790245|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
154790246|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
154790247|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790248|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790249|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790250|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
154790251|NCT03891355|Hormones|hormones|mesh-ancestor
154790252|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790253|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154790254|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790255|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
154790257|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154790258|NCT03891355|Growth Substances|growth substances|mesh-ancestor
154790259|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
154790260|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
154790261|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154790262|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790263|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154790264|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
154790265|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154790266|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790267|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790268|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790269|NCT02936388|Cisplatin|cisplatin|mesh-list
154790270|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790271|NCT03586141|Chrysarobin|chrysarobin|mesh-list
154790272|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154790273|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154790274|NCT03586141|Analgesics|analgesics|mesh-ancestor
154790275|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
154790276|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790277|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790278|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790279|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154790280|NCT03020563|Bupivacaine|bupivacaine|mesh-list
154790281|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
154790282|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
154790283|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790284|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790285|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
154790286|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790287|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
154790288|NCT04591626|Dulaglutide|dulaglutide|mesh-list
154790289|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154790290|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790291|NCT04591626|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154790292|NCT03580135|Propolis|propolis|mesh-list
154790293|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790294|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154790295|NCT03585829|Prednisolone|prednisolone|mesh-list
154790296|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
154790297|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790298|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
154790299|NCT03585829|Hormones|hormones|mesh-ancestor
154790300|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790301|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790302|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154790303|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790304|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154790305|NCT03585751|Simvastatin|simvastatin|mesh-list
154790306|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790307|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154790308|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154790309|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
154790310|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790311|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154790312|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154790313|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790314|NCT03583333|Linezolid|linezolid|mesh-list
154790315|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154790316|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790317|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154790318|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790319|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790320|NCT03585673|Docetaxel|docetaxel|mesh-list
154790321|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
154790322|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790323|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154790324|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154790325|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154790326|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790327|NCT01602510|Lamotrigine|lamotrigine|mesh-list
154790328|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
154790329|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154542267|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
154790330|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154790331|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790332|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154790333|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790334|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154790335|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154790336|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790337|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154790338|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154790339|NCT05701813|Inositol|inositol|mesh-list
154790340|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
154790341|NCT05701813|Vitamins|vitamins|mesh-ancestor
154790342|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
154790343|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790344|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
154790345|NCT03586219|Narcotics|narcotics|mesh-ancestor
154790346|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790347|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790348|NCT03586219|Analgesics|analgesics|mesh-ancestor
154790349|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
154790350|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790351|NCT05118984|Azithromycin|azithromycin|mesh-list
154790352|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154790353|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790354|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154790355|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154790356|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790357|NCT02802852|Lenograstim|lenograstim|mesh-list
154790358|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154790359|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
154790360|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790361|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
154790362|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154790363|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
154790364|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790365|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154790366|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154790367|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
154790368|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790369|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790370|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154790371|NCT05118048|Chrysarobin|chrysarobin|mesh-list
154790372|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154790373|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154790374|NCT05118048|Analgesics|analgesics|mesh-ancestor
154790375|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
154790376|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790377|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790378|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790379|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154790380|NCT04405375|Dexamethasone|dexamethasone|mesh-list
154790381|NCT04405375|Etoposide|etoposide|mesh-list
154790382|NCT04405375|Pegaspargase|pegaspargase|mesh-list
154790383|NCT04405375|Gemcitabine|gemcitabine|mesh-list
154790384|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790385|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
154790386|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
154790387|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790388|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790389|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790390|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
154790391|NCT04405375|Hormones|hormones|mesh-ancestor
154790392|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790393|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154790394|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790395|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154790396|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154790397|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154790398|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790399|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790400|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154790401|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
154790402|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
154790403|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
154790404|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790405|NCT03029611|Paclitaxel|paclitaxel|mesh-list
154790406|NCT03029611|Carboplatin|carboplatin|mesh-list
154790407|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154790408|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154790409|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790410|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
154790411|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
154790412|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
154790413|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790414|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
154790415|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154790416|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
154790417|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790418|NCT03589495|Expectorants|expectorants|mesh-ancestor
154790419|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
154790420|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154790421|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
154790422|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790423|NCT03589495|Protective Agents|protective agents|mesh-ancestor
154790424|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790425|NCT03589495|Antidotes|antidotes|mesh-ancestor
154790426|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154790427|NCT03159559|Alprostadil|alprostadil|mesh-list
154790428|NCT03159559|Clopidogrel|clopidogrel|mesh-list
154790429|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174268|NCT00998166|Pemetrexed|pemetrexed|mesh-list
154790430|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790431|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154790432|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154790433|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154790434|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154790435|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
154790436|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790437|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
154790438|NCT03159559|Urological Agents|urological agents|mesh-ancestor
154790439|NCT03159403|Oritavancin|oritavancin|mesh-list
154790440|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154790441|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790442|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
154790443|NCT03583567|Ranitidine|ranitidine|mesh-list
154790444|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154790445|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154790446|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790447|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154790448|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
154790449|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
154790450|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790451|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790452|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790453|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
154790454|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
154790455|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154790456|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154790457|NCT03583489|Ondansetron|ondansetron|mesh-list
154790458|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
154790459|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
154790460|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790461|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790462|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790463|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
154790464|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
154790465|NCT03583489|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154790466|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154790467|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
154790468|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790469|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790470|NCT03158935|Aldesleukin|aldesleukin|mesh-list
154790471|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
154790472|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
154790473|NCT03158935|Fludarabine|fludarabine|mesh-list
154790474|NCT03158935|Interleukin-2|interleukin-2|mesh-list
154790475|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154790476|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
154790477|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790478|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154790479|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154790480|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
154860505|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154790481|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790482|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790483|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154790484|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154790485|NCT03158935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154790486|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154790488|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
154790489|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790490|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154790491|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154790492|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
154790493|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790494|NCT04818372|Dexamethasone|dexamethasone|mesh-list
154790495|NCT04818372|Lenalidomide|lenalidomide|mesh-list
154790496|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790497|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
154790498|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
154790499|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790500|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790501|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790502|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
154790503|NCT04818372|Hormones|hormones|mesh-ancestor
154174346|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154790504|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790505|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154790506|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790507|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
154790508|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154790509|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154790510|NCT04818372|Growth Substances|growth substances|mesh-ancestor
154790511|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
154790512|NCT01462578|Azacitidine|azacitidine|mesh-list
154790513|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154790514|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
154790515|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790516|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790517|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790518|NCT03059173|Inositol|inositol|mesh-list
154790519|NCT03059173|Clomiphene|clomiphene|mesh-list
154790520|NCT03059173|Enclomiphene|enclomiphene|mesh-list
154790521|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
154790522|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154790523|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
154790524|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790525|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790526|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154790527|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
154790528|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154790529|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154790530|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154790531|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
154790532|NCT03059173|Vitamins|vitamins|mesh-ancestor
154790533|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
154790534|NCT05122338|Lidocaine|lidocaine|mesh-list
154790535|NCT05122338|Ropivacaine|ropivacaine|mesh-list
154790536|NCT05122338|Esketamine|esketamine|mesh-list
154790537|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
154790538|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
154790539|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790540|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790541|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
154790542|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790543|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154790544|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154790545|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154790546|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154790547|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790548|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
154790549|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154790550|NCT03157843|Heparin|heparin|mesh-list
154790551|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154790552|NCT03157843|Tinzaparin|tinzaparin|mesh-list
154790553|NCT03157843|Dalteparin|dalteparin|mesh-list
154790554|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
154790555|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154790556|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154790557|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790558|NCT03589027|Ritonavir|ritonavir|mesh-list
154790559|NCT03589027|Darunavir|darunavir|mesh-list
154790560|NCT03589027|Rilpivirine|rilpivirine|mesh-list
154790561|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
154790562|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154790563|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154790564|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
154790565|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790566|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790567|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154790568|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154790569|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
154790570|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790571|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154790572|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154790573|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154790574|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
154790575|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154790576|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790577|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154790578|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154790579|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154790580|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154790581|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154790582|NCT03874494|Aripiprazole|aripiprazole|mesh-list
154790583|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
154790584|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
154790585|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154790586|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154790587|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154790588|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790589|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790590|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
154790591|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
154790592|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790593|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790594|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154790595|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154790596|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
154790597|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154790598|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154790599|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154790600|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154790601|NCT03156439|Huperzine A|huperzine a|mesh-list
154790602|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154790603|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790604|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790605|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
154790606|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790607|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790608|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154790609|NCT03156439|Protective Agents|protective agents|mesh-ancestor
154790610|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
154790611|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154790612|NCT03156361|Insulin|insulin|mesh-list
154790613|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154790614|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
154790615|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154174469|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154790616|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790617|NCT05690035|Tislelizumab|tislelizumab|mesh-list
154790618|NCT05690035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154790619|NCT05690035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790620|NCT05002530|Vitamin D|vitamin d|mesh-list
154790621|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
154790622|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
154790623|NCT05002530|Vitamins|vitamins|mesh-list
154790624|NCT05002530|Tretinoin|tretinoin|mesh-list
154790625|NCT05002530|Isotretinoin|isotretinoin|mesh-list
154790626|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
154790627|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790628|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154790629|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154790630|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790631|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
154790632|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
154790633|NCT03583021|Neostigmine|neostigmine|mesh-list
154790634|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154790635|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790636|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790637|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
154790638|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790639|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790640|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154790641|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
154790642|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790643|NCT03155971|Paclitaxel|paclitaxel|mesh-list
154790644|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154790645|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790646|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
154790647|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
154790648|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
154790649|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790650|NCT03582319|Formaldehyde|formaldehyde|mesh-list
154790651|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
154790652|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790653|NCT00307242|Adefovir|adefovir|mesh-list
154790654|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154790655|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
154790656|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790657|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154790658|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154790659|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790660|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790661|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154790662|NCT03582007|Murepavadin|murepavadin|mesh-list
154790663|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790664|NCT02895373|Alprostadil|alprostadil|mesh-list
154174493|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154790665|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154790666|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
154790667|NCT02895373|Urological Agents|urological agents|mesh-ancestor
154790668|NCT05698771|Niacinamide|niacinamide|mesh-list
154790669|NCT05698771|Niacin|niacin|mesh-list
154790670|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
154790671|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
154790672|NCT05698771|Vitamins|vitamins|mesh-ancestor
154790673|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
154790674|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790675|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154790676|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
154790677|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790678|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154790679|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
154790680|NCT03156907|Buprenorphine|buprenorphine|mesh-list
154790681|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154790682|NCT03156907|Narcotics|narcotics|mesh-ancestor
154790683|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790684|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790685|NCT03156907|Analgesics|analgesics|mesh-ancestor
154790686|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
154790687|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790688|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154790689|NCT03156829|Betamethasone|betamethasone|mesh-list
154790690|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790691|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
154790692|NCT03156829|Hormones|hormones|mesh-ancestor
154790693|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790694|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790695|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154790696|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
154790697|NCT05229276|Bone wax|bone wax|mesh-list
154790698|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
154790699|NCT05229276|Coagulants|coagulants|mesh-ancestor
154790700|NCT03581773|Folic Acid|folic acid|mesh-list
154790701|NCT03581773|Hematinics|hematinics|mesh-ancestor
154790702|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
154790703|NCT03581773|Vitamins|vitamins|mesh-ancestor
154790704|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
154790705|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790706|NCT04425174|Anesthetics|anesthetics|mesh-list
154790707|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790708|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790709|NCT05119452|Adalimumab|adalimumab|mesh-list
154790710|NCT05119452|Infliximab|infliximab|mesh-list
154790711|NCT05119452|Golimumab|golimumab|mesh-list
154790712|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
154790713|NCT05119452|Etanercept|etanercept|mesh-list
154790714|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
154790715|NCT05119452|Tofacitinib|tofacitinib|mesh-list
154790716|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154790717|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790718|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
154790719|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790720|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154790721|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154790722|NCT05119452|Analgesics|analgesics|mesh-ancestor
154790723|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
154790724|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790725|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790726|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154790727|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
154790728|NCT05119452|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154790729|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154790730|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790731|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790732|NCT02788591|Esomeprazole|esomeprazole|mesh-list
154790733|NCT02788591|Omeprazole|omeprazole|mesh-list
154790734|NCT02788591|Pantoprazole|pantoprazole|mesh-list
154790735|NCT02788591|Lansoprazole|lansoprazole|mesh-list
154790736|NCT02788591|Sucralfate|sucralfate|mesh-list
154790737|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154790738|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154790739|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790740|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790741|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790742|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
154790743|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
154790744|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154790745|NCT03076164|Trametinib|trametinib|mesh-list
154790746|NCT03076164|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154790747|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154790748|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790749|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790750|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790751|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
154790752|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
154790753|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154790754|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154790755|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790756|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154790757|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154790758|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790759|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790760|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790761|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154790762|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
154790763|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154790764|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790765|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154790766|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154790767|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154790768|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
154790769|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154790770|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154790771|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154790772|NCT01670773|Analgesics|analgesics|mesh-ancestor
154790773|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
154790774|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790775|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790776|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790777|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154790778|NCT05228418|Naltrexone|naltrexone|mesh-list
154790779|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154790780|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154790781|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790782|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
154790783|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790784|NCT01676233|Insulin|insulin|mesh-list
154790785|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154790786|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
154790787|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154790788|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790790|NCT01670929|Progestins|progestins|mesh-ancestor
154790791|NCT01670929|Hormones|hormones|mesh-ancestor
154790792|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790793|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790794|NCT02673996|Phenylephrine|phenylephrine|mesh-list
154790795|NCT02673996|Isoproterenol|isoproterenol|mesh-list
154790796|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
154790797|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154790798|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
154790799|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
154790800|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790801|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790802|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
154790803|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154790804|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
154790805|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
154790806|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154790807|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154790808|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154790809|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154790810|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790811|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790812|NCT02673996|Protective Agents|protective agents|mesh-ancestor
154790813|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154790814|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154790815|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154790816|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
154790817|NCT04746937|Norfloxacin|norfloxacin|mesh-list
154790818|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154790819|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790820|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154790821|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154790822|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154790823|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790824|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790825|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790826|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154790827|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154790828|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
154790829|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154790830|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154790831|NCT05220319|Prednisolone|prednisolone|mesh-list
154790832|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
154790833|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154790834|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
154790835|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790836|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
154790837|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
154790838|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790839|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790840|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154790841|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
154790842|NCT05220319|Hormones|hormones|mesh-ancestor
154790843|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790844|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154790845|NCT05220319|Protective Agents|protective agents|mesh-ancestor
154790846|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154790847|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790848|NCT03155035|Vitamin D|vitamin d|mesh-list
154790849|NCT03155035|Albendazole|albendazole|mesh-list
154790850|NCT03155035|Calcium|calcium|mesh-list
154790851|NCT03155035|Vitamins|vitamins|mesh-ancestor
154790852|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
154790853|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790854|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154790855|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154790856|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
154790857|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154790858|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790859|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
154790860|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154790861|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154790862|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
154542802|NCT03257319|Analgesics|analgesics|mesh-ancestor
154790863|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
154790864|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
154790865|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790866|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154790867|NCT03154723|Vitamin A|vitamin a|mesh-list
154790868|NCT03154723|Vitamins|vitamins|mesh-ancestor
154790869|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
154790870|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790871|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154790872|NCT04080908|Hematinics|hematinics|mesh-ancestor
154790873|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154790874|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154790875|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
154790876|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154790877|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790878|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154790879|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790880|NCT03154567|Yohimbine|yohimbine|mesh-list
154790881|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
154790882|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
154790883|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790884|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790885|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154790886|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154790887|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154790888|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
154790889|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790890|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790891|NCT03154567|Urological Agents|urological agents|mesh-ancestor
154790892|NCT04310748|Anesthetics|anesthetics|mesh-list
154790893|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790894|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790895|NCT03154645|Ibuprofen|ibuprofen|mesh-list
154790896|NCT03154645|Acetazolamide|acetazolamide|mesh-list
154790897|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154790898|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154790899|NCT03154645|Analgesics|analgesics|mesh-ancestor
154790900|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
154790901|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790902|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790903|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154790904|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154790905|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154790906|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790907|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790908|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
154790909|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154790910|NCT03154645|Diuretics|diuretics|mesh-ancestor
154790911|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
154790912|NCT01671709|Montelukast|montelukast|mesh-list
154790913|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154790914|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
154790915|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154790916|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
154790917|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790918|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790919|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154790920|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154790921|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790922|NCT05222256|Simendan|simendan|mesh-list
154790923|NCT05222256|Epinephrine|epinephrine|mesh-list
154790924|NCT05222256|Racepinephrine|racepinephrine|mesh-list
154790925|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
154790926|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154790927|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154790928|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154790929|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790930|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790931|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790932|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154790933|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154790934|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
154790935|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154790936|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154790937|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
154790938|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
154790939|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
154790940|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154790941|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154790942|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
154790943|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154790944|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154790945|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790946|NCT05222256|Protective Agents|protective agents|mesh-ancestor
154790947|NCT01671787|Tenofovir|tenofovir|mesh-list
154790948|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
154790949|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790950|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154790951|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154790952|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154790953|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790954|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154790955|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154790956|NCT05229510|Ribavirin|ribavirin|mesh-list
154790957|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
154790958|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790959|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
154790960|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154790961|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154790962|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154790963|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
154790964|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
154790965|NCT00698022|Risperidone|risperidone|mesh-list
154790966|NCT00698022|Mifepristone|mifepristone|mesh-list
154790967|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154790968|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
154790969|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154790970|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154790971|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154790972|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154790973|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154790974|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790975|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154790976|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154790977|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
154790978|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154790979|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
154790980|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154790981|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154790982|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154790983|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154790984|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
154790985|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154790986|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154790987|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
154790988|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154790989|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
154790990|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154790991|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154790992|NCT02570503|Ketorolac|ketorolac|mesh-list
154790993|NCT02570503|Clonidine|clonidine|mesh-list
154790994|NCT02570503|Epinephrine|epinephrine|mesh-list
154790995|NCT02570503|Ropivacaine|ropivacaine|mesh-list
154790996|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
154790997|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
154790998|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154790999|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791000|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
154791001|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791002|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154791003|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154174832|NCT05887778|Hormones|hormones|mesh-ancestor
154791004|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
154791005|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791006|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791007|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154791008|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154791009|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
154791010|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154791011|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
154791012|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
154791013|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
154791014|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154791015|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154791016|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154791017|NCT02570503|Analgesics|analgesics|mesh-ancestor
154791018|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791019|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791020|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154791021|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791022|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154791023|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
154791024|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154791025|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
154791026|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154791027|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791028|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791029|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154791030|NCT02492269|Analgesics|analgesics|mesh-ancestor
154791031|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
154791032|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791033|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154791034|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154791035|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154791036|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
154791037|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791038|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791039|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
154791040|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154791041|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
154791042|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791043|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
154791044|NCT05561179|Protective Agents|protective agents|mesh-ancestor
154791045|NCT02467153|Vitamin D|vitamin d|mesh-list
154791046|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
154791047|NCT02467153|Vitamins|vitamins|mesh-ancestor
154791048|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
154791049|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791050|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154791051|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154791052|NCT04933903|Nivolumab|nivolumab|mesh-list
154791053|NCT04933903|Ipilimumab|ipilimumab|mesh-list
154791054|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154791055|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791056|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154791057|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791058|NCT03153163|Trastuzumab|trastuzumab|mesh-list
154791059|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154791060|NCT03153163|Maytansine|maytansine|mesh-list
154791061|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154791062|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791063|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154791064|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154791065|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154791066|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154791067|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791068|NCT03153163|Immunotoxins|immunotoxins|mesh-ancestor
154791069|NCT03153163|Immunoconjugates|immunoconjugates|mesh-ancestor
154791070|NCT03153163|Immunologic Factors|immunologic factors|mesh-ancestor
154791071|NCT03153163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791072|NCT03153085|Ipilimumab|ipilimumab|mesh-list
154791073|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154791074|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791075|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154791076|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791077|NCT03463525|Osimertinib|osimertinib|mesh-list
154791078|NCT03463525|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154791079|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154791080|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791081|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791082|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791083|NCT01675128|Irinotecan|irinotecan|mesh-list
154791084|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154791085|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154791086|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543047|NCT03243903|Insulin|insulin|mesh-list
154791087|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791088|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791090|NCT02626507|Goserelin|goserelin|mesh-list
154791091|NCT02626507|Palbociclib|palbociclib|mesh-list
154791092|NCT02626507|Gedatolisib|gedatolisib|mesh-list
154791093|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154791094|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791095|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154791096|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154791097|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
154791098|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791099|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791100|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154791101|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791102|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791103|NCT03243175|Apixaban|apixaban|mesh-list
154791104|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154791105|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
154791106|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154791107|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
154791108|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791109|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791110|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
154791111|NCT04764955|Vitamin D|vitamin d|mesh-list
154791112|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
154791113|NCT04764955|Vitamins|vitamins|mesh-ancestor
154791114|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
154791115|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791116|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154791117|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154791118|NCT01674127|Methyldopa|methyldopa|mesh-list
154791119|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154791120|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
154791121|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
154791122|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791123|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791124|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154791125|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154791126|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154791127|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
154791128|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791129|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791130|NCT02081443|Ticagrelor|ticagrelor|mesh-list
154791131|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154791132|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154791133|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154791134|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154791135|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
154791136|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791137|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791138|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791139|NCT01674205|Vaccines|vaccines|mesh-list
154791140|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
154791141|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791142|NCT01674283|Glucagon|glucagon|mesh-list
154791143|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154791144|NCT01674283|Hormones|hormones|mesh-ancestor
154791145|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791146|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791147|NCT04404517|Adalimumab|adalimumab|mesh-list
154791148|NCT04404517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154791149|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791150|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791151|NCT01674517|Montelukast|montelukast|mesh-list
154791152|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154791153|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
154791154|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154791155|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
154791156|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791157|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791158|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154791159|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154791160|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791162|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791163|NCT01670071|Risperidone|risperidone|mesh-list
154791164|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154791165|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154791166|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
154791167|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791168|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791169|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791170|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154791171|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154791172|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791173|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154791174|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154791175|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
154791176|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154791177|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154791178|NCT01427309|Vaccines|vaccines|mesh-list
154791179|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
154791180|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791181|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
154791182|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154791183|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154791184|NCT03852901|Empagliflozin|empagliflozin|mesh-list
154791185|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154791186|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791187|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154791188|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791189|NCT01675999|Leucovorin|leucovorin|mesh-list
154791190|NCT01675999|Cetuximab|cetuximab|mesh-list
154791191|NCT01675999|Fluorouracil|fluorouracil|mesh-list
154791192|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
154791193|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154791194|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791195|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
154791196|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791197|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154791198|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791199|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
154791200|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791201|NCT01675999|Antidotes|antidotes|mesh-ancestor
154791202|NCT01675999|Protective Agents|protective agents|mesh-ancestor
154791203|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
154791204|NCT01675999|Vitamins|vitamins|mesh-ancestor
154791205|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
154791206|NCT01425359|Ranolazine|ranolazine|mesh-list
154791207|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154791208|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154791209|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791210|NCT04404751|Folic Acid|folic acid|mesh-list
154791211|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
154791212|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
154791213|NCT04404751|Iron|iron|mesh-list
154791214|NCT04404751|Vitamins|vitamins|mesh-ancestor
154791215|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
154791216|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791217|NCT04404751|Trace Elements|trace elements|mesh-ancestor
154791218|NCT04404751|Hematinics|hematinics|mesh-ancestor
154791219|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
154791220|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
154791221|NCT01403051|Vitamin D|vitamin d|mesh-list
154791222|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
154791223|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
154791224|NCT01403051|Vitamins|vitamins|mesh-list
154791225|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
154791226|NCT01403051|Calcium|calcium|mesh-list
154791227|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
154791228|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791229|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154791230|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154791231|NCT01403051|Antacids|antacids|mesh-ancestor
154791232|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791233|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543178|NCT00075803|Fluconazole|fluconazole|mesh-list
154791234|NCT03873337|Nicotine|nicotine|mesh-list
154791235|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154791236|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
154175064|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
154791237|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791238|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791239|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154791240|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154791241|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
154791242|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791243|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791245|NCT04115748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154791246|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791247|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791248|NCT04747015|Oxytocin|oxytocin|mesh-list
154791249|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
154791250|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154791251|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791252|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
154791253|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154791254|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791255|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791256|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154791257|NCT04747171|Analgesics|analgesics|mesh-ancestor
154791258|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
154791259|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791260|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154791261|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154791262|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154791263|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
154791264|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791265|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791266|NCT02082769|Allopurinol|allopurinol|mesh-list
154791267|NCT02082769|Febuxostat|febuxostat|mesh-list
154791268|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
154791269|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791270|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791271|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
154791272|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791273|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154791274|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
154791275|NCT02082769|Protective Agents|protective agents|mesh-ancestor
154791276|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791277|NCT03751423|Fentanyl|fentanyl|mesh-list
154791278|NCT03751423|Ketamine|ketamine|mesh-list
154791279|NCT03751423|Morphine|morphine|mesh-list
154791280|NCT03751423|Analgesics|analgesics|mesh-ancestor
154791281|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
154791282|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791283|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791284|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154791285|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154791286|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
154791287|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
154791288|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791289|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154791290|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154791291|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791292|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791293|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154791294|NCT03751423|Narcotics|narcotics|mesh-ancestor
154791295|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154791296|NCT03745729|Allopurinol|allopurinol|mesh-list
154791297|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
154791298|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791299|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791300|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
154791301|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791302|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154791303|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
154791304|NCT03745729|Protective Agents|protective agents|mesh-ancestor
154791305|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791306|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
154791307|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154791308|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
154791309|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791310|NCT04904952|Expectorants|expectorants|mesh-ancestor
154791311|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
154791312|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154791313|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
154791314|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791315|NCT04904952|Protective Agents|protective agents|mesh-ancestor
154791316|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791317|NCT04904952|Antidotes|antidotes|mesh-ancestor
154791318|NCT03661411|Aspirin|aspirin|mesh-list
154791319|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154791320|NCT03661411|Clopidogrel|clopidogrel|mesh-list
154791321|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154791322|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154791323|NCT03661411|Analgesics|analgesics|mesh-ancestor
154791324|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
154791325|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791326|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175156|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154791327|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791328|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791329|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154791330|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154791331|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791332|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154791333|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154791334|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791335|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
154791336|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154791337|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154791338|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154791339|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
154791340|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791341|NCT03742297|Dexamethasone|dexamethasone|mesh-list
154791342|NCT03742297|Prednisone|prednisone|mesh-list
154791343|NCT03742297|Lenalidomide|lenalidomide|mesh-list
154791344|NCT03742297|Bortezomib|bortezomib|mesh-list
154791345|NCT03742297|Melphalan|melphalan|mesh-list
154791346|NCT03742297|Daratumumab|daratumumab|mesh-list
154791347|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791348|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
154791349|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
154791350|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791351|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791352|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154791353|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
154791354|NCT03742297|Hormones|hormones|mesh-ancestor
154791355|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791356|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154791357|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791358|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
154791359|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154791360|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154791361|NCT03742297|Growth Substances|growth substances|mesh-ancestor
154791362|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
154791363|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154791364|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
154791365|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791366|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154791367|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791368|NCT01677403|Tobramycin|tobramycin|mesh-list
154791369|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154791370|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791371|NCT03441750|Metformin|metformin|mesh-list
154791372|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154791373|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791374|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154791375|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154791376|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154791377|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791378|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791379|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154791380|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154791381|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791382|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
154791383|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791384|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154791385|NCT03657433|Hematinics|hematinics|mesh-ancestor
154791386|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154791387|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154791388|NCT03651895|Metformin|metformin|mesh-list
154791389|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154791390|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791391|NCT03807037|Tocotrienols|tocotrienols|mesh-list
154791393|NCT03807037|Tocopherols|tocopherols|mesh-list
154791394|NCT03807037|Tocovid|tocovid|mesh-list
154791395|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
154791396|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791397|NCT03807037|Protective Agents|protective agents|mesh-ancestor
154791398|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791399|NCT03807037|Vitamins|vitamins|mesh-ancestor
154791400|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
154791401|NCT03805399|Sirolimus|sirolimus|mesh-list
154791402|NCT03805399|Paclitaxel|paclitaxel|mesh-list
154791403|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154791404|NCT03805399|Capecitabine|capecitabine|mesh-list
154791405|NCT03805399|Everolimus|everolimus|mesh-list
154791406|NCT03805399|Apatinib|apatinib|mesh-list
154791407|NCT03805399|Temsirolimus|temsirolimus|mesh-list
154791408|NCT03805399|MTOR Inhibitors|mtor inhibitors|mesh-list
154791409|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154791410|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154791411|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791412|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
154791413|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
154791414|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
154791415|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791416|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154791417|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
154791418|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154791419|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791420|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791421|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
154791422|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791423|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154791424|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791425|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154791426|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
154791427|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154791428|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
154791429|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791430|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154791431|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154791432|NCT03637075|Insulin|insulin|mesh-list
154791433|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154791434|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791435|NCT04403503|Thrombin|thrombin|mesh-list
154791436|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154791437|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
154791438|NCT04403503|Coagulants|coagulants|mesh-ancestor
154791439|NCT00249795|Irbesartan|irbesartan|mesh-list
154791440|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154791441|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154791442|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154791443|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791444|NCT04404127|Basiliximab|basiliximab|mesh-list
154791445|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791446|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
154791447|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791448|NCT02651220|Adapalene|adapalene|mesh-list
154791449|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154791450|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154791451|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
154791452|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154791453|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154791454|NCT02651220|Analgesics|analgesics|mesh-ancestor
154791455|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
154791456|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791457|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791458|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791459|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791460|NCT01279551|Lidocaine|lidocaine|mesh-list
154791461|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
154791462|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
154791463|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
154791464|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791465|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791466|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
154791467|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791468|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154175307|NCT03026790|Analgesics|analgesics|mesh-ancestor
154791469|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154791470|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154791471|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154791472|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791473|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
154791474|NCT00780403|Cetirizine|cetirizine|mesh-list
154791475|NCT00780403|Desloratadine|desloratadine|mesh-list
154791476|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154791477|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154791478|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154791479|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
154791480|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
154791481|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791482|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791483|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791484|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154791485|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
154791486|NCT01979796|Nicotine|nicotine|mesh-list
154791487|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154791488|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
154791489|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791490|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791491|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154791492|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154791493|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
154791494|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791495|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791496|NCT03628339|Tepotinib|tepotinib|mesh-list
154791497|NCT03628339|Midazolam|midazolam|mesh-list
154175358|NCT02425826|Apremilast|apremilast|mesh-list
154791498|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154791499|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154791500|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791501|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791502|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154791503|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154791504|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154791505|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154791506|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
154791507|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
154791508|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
154791509|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
154791510|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791511|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791512|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791513|NCT04412694|Dexamethasone|dexamethasone|mesh-list
154791514|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
154791515|NCT04412694|BB 1101|bb 1101|mesh-list
154791516|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791517|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
154791518|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
154791519|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791520|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791521|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154791522|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
154791523|NCT04412694|Hormones|hormones|mesh-ancestor
154791524|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791525|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154791526|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791527|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
154791528|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791529|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791530|NCT03627715|Propagermanium|propagermanium|mesh-list
154791531|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791532|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
154791533|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
154791534|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791535|NCT00246753|Lapatinib|lapatinib|mesh-list
154791536|NCT00246753|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154791537|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154791538|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791539|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791540|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791541|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
154791542|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154791543|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154791544|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
154791545|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791546|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791547|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791548|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
154791549|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
154791550|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791551|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
154791552|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154791553|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
154791554|NCT03600480|Semaglutide|semaglutide|mesh-list
154791555|NCT03600480|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154791556|NCT03600480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154791557|NCT03600480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791558|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
154791559|NCT00246129|Daclizumab|daclizumab|mesh-list
154791560|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154791561|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791562|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791563|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
154791564|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791565|NCT01274247|Benzocaine|benzocaine|mesh-list
154791566|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
154791567|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
154791568|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791569|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791570|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
154791571|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791572|NCT01279629|Tazarotene|tazarotene|mesh-list
154791573|NCT01279629|Calcipotriene|calcipotriene|mesh-list
154791574|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
154791575|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
154791576|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154791577|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154791578|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
154175411|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
154791579|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791580|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791581|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154791582|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
154791583|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
154791584|NCT01274325|Hormones|hormones|mesh-ancestor
154791585|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791586|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
154791587|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
154791588|NCT04502394|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154791589|NCT04502394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154791590|NCT04502394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791591|NCT04502394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791592|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791593|NCT01274403|Thalidomide|thalidomide|mesh-list
154791594|NCT01274403|Prednisone|prednisone|mesh-list
154791595|NCT01274403|Melphalan|melphalan|mesh-list
154791596|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791597|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
154791598|NCT01274403|Hormones|hormones|mesh-ancestor
154791599|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791600|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791601|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154791602|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791603|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154791604|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
154791605|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791606|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154791607|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791608|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
154791609|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
154791610|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154791611|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791612|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154791613|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154791614|NCT01274403|Growth Substances|growth substances|mesh-ancestor
154791615|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
154791617|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791618|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
154791619|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
154791620|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
154791621|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791622|NCT01274481|Iloprost|iloprost|mesh-list
154791623|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154791624|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
154791625|NCT00245583|Topiramate|topiramate|mesh-list
154791626|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
154791627|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154791628|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791629|NCT01379989|Carboplatin|carboplatin|mesh-list
154791630|NCT01379989|Doxorubicin|doxorubicin|mesh-list
154791631|NCT01379989|Trabectedin|trabectedin|mesh-list
154791632|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791633|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154791634|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154791635|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154791636|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791637|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791638|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154791639|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
154791640|NCT02652156|Bupivacaine|bupivacaine|mesh-list
154791641|NCT02652156|Ropivacaine|ropivacaine|mesh-list
154791642|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
154791643|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
154791644|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791645|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791646|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
154791647|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791648|NCT03699865|Nicotine|nicotine|mesh-list
154791649|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154791650|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
154791651|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791652|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791653|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154791654|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154791655|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
154791656|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791657|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791658|NCT00754923|Sorafenib|sorafenib|mesh-list
154791659|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791660|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154791661|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791662|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791663|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154791664|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
154791665|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154791666|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154791667|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154791668|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791669|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791670|NCT02117076|Gabapentin|gabapentin|mesh-list
154791671|NCT02117076|Analgesics|analgesics|mesh-ancestor
154791672|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
154791673|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791674|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791675|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
154791676|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154791677|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154791678|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791679|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154791680|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154791681|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154791682|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791683|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791684|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
154791685|NCT01274793|Mosapride|mosapride|mesh-list
154791686|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791687|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154791688|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154791689|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
154791690|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791691|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791692|NCT00746889|Triamcinolone|triamcinolone|mesh-list
154791693|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154791694|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154791695|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154791696|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791697|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
154791698|NCT00746889|Hormones|hormones|mesh-ancestor
154791699|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791700|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791701|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791702|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
154791703|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791704|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791705|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
154791706|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
154791707|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
154791708|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154791709|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154791710|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
154791711|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
154791712|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791713|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791714|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791715|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154791716|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
154791717|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154791718|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154791719|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
154791720|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154791721|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154791722|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154791723|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791724|NCT00244881|Cediranib|cediranib|mesh-list
154791725|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791726|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791727|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791728|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154791729|NCT00530517|Sumatriptan|sumatriptan|mesh-list
154791730|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154791731|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154791732|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154791733|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
154791734|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791735|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791736|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791737|NCT05123976|Olanzapine|olanzapine|mesh-list
154791738|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
154791739|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
154791740|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791741|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791742|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154791743|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154791744|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154791745|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154791746|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154791747|NCT05123976|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154791748|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154791749|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154791750|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791751|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791752|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
154791753|NCT00005803|Cytarabine|cytarabine|mesh-list
154791754|NCT00005803|Cyclosporine|cyclosporine|mesh-list
154175619|NCT03742336|Dabigatran|dabigatran|mesh-list
154791755|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
154791756|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
154791757|NCT00005803|Melphalan|melphalan|mesh-list
154791758|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
154791759|NCT00005803|Carmustine|carmustine|mesh-list
154791760|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154791761|NCT00005803|Fludarabine|fludarabine|mesh-list
154791762|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
154791763|NCT00005803|Etoposide|etoposide|mesh-list
154791764|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
154791765|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
154791766|NCT00005803|Cyclosporins|cyclosporins|mesh-list
154791767|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791768|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
154791769|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791770|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791771|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154791772|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
154791773|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791774|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791775|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154791776|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154791778|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154791779|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154791780|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154791781|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791782|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
154791783|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791784|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
154791785|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
154791786|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154791787|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154791788|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154791789|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
154791790|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154791791|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
154791792|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
154791793|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
154791794|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
154791795|NCT00244725|Warfarin|warfarin|mesh-list
154791796|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
154791797|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
154791798|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154791799|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791800|NCT04185012|Benralizumab|benralizumab|mesh-list
154791801|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154791802|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
154791803|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
154791804|NCT01275183|Cisplatin|cisplatin|mesh-list
154791805|NCT01275183|Docetaxel|docetaxel|mesh-list
154791806|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791807|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
154791808|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
154791809|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
154791810|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791811|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154791812|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154791813|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
154791814|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791815|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154791816|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154791817|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791818|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
154791819|NCT05126004|Azacitidine|azacitidine|mesh-list
154791820|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154791821|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154791822|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
154791823|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791824|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791825|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791826|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
154791827|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791828|NCT05126004|Expectorants|expectorants|mesh-ancestor
154791829|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
154791830|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154791831|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
154791832|NCT05126004|Protective Agents|protective agents|mesh-ancestor
154791833|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791834|NCT05126004|Antidotes|antidotes|mesh-ancestor
154791835|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
154791836|NCT00350701|Testosterone|testosterone|mesh-list
154791837|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
154175684|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154175685|NCT00423189|Growth Substances|growth substances|mesh-ancestor
154791838|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
154791839|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154791840|NCT00350701|Androgens|androgens|mesh-ancestor
154791841|NCT00350701|Hormones|hormones|mesh-ancestor
154791842|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791843|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791844|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154791846|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
154791847|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
154791848|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154791849|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154791850|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154791851|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154791852|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791853|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
154791854|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791855|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791856|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154791857|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791858|NCT01505114|Tenofovir|tenofovir|mesh-list
154791859|NCT01505114|Emtricitabine|emtricitabine|mesh-list
154791860|NCT01505114|Maraviroc|maraviroc|mesh-list
154791861|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
154791862|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791863|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154791864|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154791865|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791866|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791867|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154791868|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154791869|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154791870|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154791871|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154791872|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
154791873|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154791874|NCT00243867|Paclitaxel|paclitaxel|mesh-list
154791875|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154791876|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791877|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
154791878|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
154791879|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
154791880|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791881|NCT01679899|Vildagliptin|vildagliptin|mesh-list
154791882|NCT01679899|Gliclazide|gliclazide|mesh-list
154791883|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154791884|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791885|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154791886|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
154791887|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791888|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791889|NCT01276821|Epinephrine|epinephrine|mesh-list
154791890|NCT01276821|Racepinephrine|racepinephrine|mesh-list
154791891|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
154791892|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154791893|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154791894|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
154791895|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791896|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791897|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791898|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154791899|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154791900|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
154791901|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791902|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154791903|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
154791904|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
154791905|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
154791906|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154791907|NCT00245037|Cyclosporine|cyclosporine|mesh-list
154791908|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
154791909|NCT00245037|Methotrexate|methotrexate|mesh-list
154791910|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
154791911|NCT00245037|Fludarabine|fludarabine|mesh-list
154791912|NCT00245037|Busulfan|busulfan|mesh-list
154791913|NCT00245037|Phenytoin|phenytoin|mesh-list
154791914|NCT00245037|Cyclosporins|cyclosporins|mesh-list
154791915|NCT00245037|Lenograstim|lenograstim|mesh-list
154791916|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154791917|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
154791918|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154791919|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791920|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154791921|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
154791922|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791923|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791924|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
154791925|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791926|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154791927|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154791928|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
154791929|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791930|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154791931|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
154791932|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154791933|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154791934|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154175753|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154791935|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154791936|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
154791937|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154791938|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
154791939|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154791940|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154791941|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154791942|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
154791943|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154791944|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154791945|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154791946|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154791947|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154791948|NCT00241839|Allopurinol|allopurinol|mesh-list
154791949|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
154791950|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
154791951|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791952|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791953|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
154791954|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154791955|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154791956|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
154791957|NCT00241839|Protective Agents|protective agents|mesh-ancestor
154791958|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791959|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154791960|NCT00241839|Diuretics|diuretics|mesh-ancestor
154791961|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
154791962|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154791963|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154791964|NCT05347381|Dexamethasone|dexamethasone|mesh-list
154791965|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154791966|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
154791967|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
154791968|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154791969|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791970|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154791971|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
154791972|NCT05347381|Hormones|hormones|mesh-ancestor
154791973|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791974|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154791975|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154791976|NCT02651688|Enclomiphene|enclomiphene|mesh-list
154791977|NCT02651688|Clomiphene|clomiphene|mesh-list
154791978|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
154791979|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154791980|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
154791981|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154791982|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791983|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154791984|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
154791985|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154791986|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154175832|NCT00825149|Doxorubicin|doxorubicin|mesh-list
154791987|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154791988|NCT01276353|Donepezil|donepezil|mesh-list
154791989|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154791990|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154791991|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154791992|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
154791993|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154791994|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154791995|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
154791996|NCT03807921|Aspirin|aspirin|mesh-list
154791997|NCT03807921|Warfarin|warfarin|mesh-list
154791998|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154791999|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792000|NCT03807921|Analgesics|analgesics|mesh-ancestor
154792001|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
154792002|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792003|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792004|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792005|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792006|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154792007|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154792008|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792009|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154792010|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154792011|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792012|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
154792013|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
154792014|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154792015|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154792016|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154792017|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154792018|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154792019|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154792020|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792021|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792022|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792023|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
154792024|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792025|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
154792026|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154792027|NCT00762177|Triclosan|triclosan|mesh-list
154792028|NCT00762177|Fluorides|fluorides|mesh-list
154792029|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
154792030|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
154792031|NCT00762177|Protective Agents|protective agents|mesh-ancestor
154792032|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792033|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154792034|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792035|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154792036|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154792037|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
154792038|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792039|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154792040|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154792041|NCT02536794|Durvalumab|durvalumab|mesh-list
154792042|NCT02536794|Ipilimumab|ipilimumab|mesh-list
154792043|NCT02536794|Tremelimumab|tremelimumab|mesh-list
154792044|NCT02536794|Antibodies|antibodies|mesh-list
154792045|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
154792046|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154792047|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
154792048|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792049|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792050|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154792051|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792052|NCT00777855|Rifampin|rifampin|mesh-list
154792053|NCT00777855|Warfarin|warfarin|mesh-list
154792054|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
154792055|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154792056|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
154792057|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154792058|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792059|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
154792060|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154792061|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792062|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792063|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154792064|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154792065|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154792066|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154792067|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154792068|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154792069|NCT03523429|Blinatumomab|blinatumomab|mesh-list
154792070|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792071|NCT02403193|Spartalizumab|spartalizumab|mesh-list
154792072|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154792073|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792074|NCT02403193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154792075|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792076|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
154792077|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
154792078|NCT03807297|Propofol|propofol|mesh-list
154792079|NCT03807297|Sevoflurane|sevoflurane|mesh-list
154792080|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154792081|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792082|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792083|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792084|NCT03807297|Analgesics|analgesics|mesh-ancestor
154792085|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
154792086|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792087|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154792088|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154792089|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154792090|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
154792091|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792092|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792093|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154792094|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
154792095|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
154792096|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154792097|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154792098|NCT05387148|Cannabidiol|cannabidiol|mesh-list
154792099|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
154792100|NCT03809637|Pemetrexed|pemetrexed|mesh-list
154792101|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792102|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792103|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792104|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154792105|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154792106|NCT03513445|Epinephrine|epinephrine|mesh-list
154792107|NCT03513445|Morphine|morphine|mesh-list
154792108|NCT03513445|Ropivacaine|ropivacaine|mesh-list
154792109|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154792110|NCT03513445|Narcotics|narcotics|mesh-ancestor
154792111|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792112|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792113|NCT03513445|Analgesics|analgesics|mesh-ancestor
154792114|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
154792115|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792116|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154792117|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154792118|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
154792119|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792120|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792121|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154792122|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154792123|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
154792124|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154792125|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
154792126|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
154792127|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
154792128|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154792129|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
154792130|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
154792131|NCT03802071|Doxorubicin|doxorubicin|mesh-list
154792132|NCT03802071|Durvalumab|durvalumab|mesh-list
154792133|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154792134|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792135|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154792136|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154792137|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792138|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792139|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154792140|NCT00758667|Mesna|mesna|mesh-list
154792141|NCT00758667|Protective Agents|protective agents|mesh-ancestor
154792142|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792143|NCT05041920|Omeprazole|omeprazole|mesh-list
154792144|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154544082|NCT03576755|Diuretics|diuretics|mesh-ancestor
154792145|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154792146|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154792147|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792148|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792149|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154792150|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154792151|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792152|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
154792153|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
154792154|NCT04412850|Analgesics|analgesics|mesh-ancestor
154792155|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
154792156|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792157|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792158|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
154792159|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792160|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154792161|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
154792162|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154792163|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792164|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792165|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154792166|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
154792167|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154792168|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154792169|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154792170|NCT00778167|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154792171|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154792172|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792173|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175997|NCT00833729|Analgesics|analgesics|mesh-ancestor
154792174|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792175|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
154792176|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792177|NCT00778869|Infliximab|infliximab|mesh-list
154792178|NCT00778869|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154792179|NCT00778869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792180|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
154792181|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154792182|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792183|NCT05008536|Fludarabine|fludarabine|mesh-list
154792184|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
154792185|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792186|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792187|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154792188|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
154792189|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792190|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792191|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154792192|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
154792193|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154792194|NCT04345419|Remdesivir|remdesivir|mesh-list
154792195|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
154792196|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176044|NCT00356590|Etanercept|etanercept|mesh-list
154792197|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
154792198|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792199|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
154792200|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154792201|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792202|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792203|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
154792204|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792205|NCT00759603|Rituximab|rituximab|mesh-list
154792206|NCT00759603|Lenalidomide|lenalidomide|mesh-list
154792207|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154792208|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792209|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
154792210|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792211|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792212|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154792213|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154792214|NCT00759603|Growth Substances|growth substances|mesh-ancestor
154792215|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
154792216|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154792217|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154544159|NCT03269994|Tazobactam|tazobactam|mesh-list
154792218|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154792219|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792220|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792221|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154792222|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154792223|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154792224|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
154792225|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792226|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792227|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154792228|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154792229|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
154792230|NCT03510390|Metformin|metformin|mesh-list
154792231|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154792232|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792233|NCT03806673|Bupivacaine|bupivacaine|mesh-list
154792234|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
154792235|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
154792236|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792237|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792238|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
154792239|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792240|NCT03291990|Temozolomide|temozolomide|mesh-list
154792241|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154792242|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
154792243|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792244|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792245|NCT03806595|Lidocaine|lidocaine|mesh-list
154792246|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154792247|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
154792248|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
154792249|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792250|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792251|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
154792252|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792253|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154792254|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154792255|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154792256|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792257|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792258|NCT03807999|Paclitaxel|paclitaxel|mesh-list
154792259|NCT03807999|Gemcitabine|gemcitabine|mesh-list
154792260|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154792261|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792262|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
154792263|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
154792264|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
154792265|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792266|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154792267|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
154792268|NCT04762147|Acetaminophen|acetaminophen|mesh-list
154792269|NCT04762147|Fentanyl|fentanyl|mesh-list
154792270|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154792271|NCT04762147|Narcotics|narcotics|mesh-ancestor
154792272|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792273|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792274|NCT04762147|Analgesics|analgesics|mesh-ancestor
154792275|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
154792276|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792277|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154176131|NCT00837941|Pregabalin|pregabalin|mesh-list
154792278|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154792279|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
154792280|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
154792281|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792282|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
154792283|NCT04273737|Amantadine|amantadine|mesh-list
154792284|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154792285|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154792286|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
154792287|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792288|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
154792289|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792290|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792291|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792292|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792293|NCT04273737|Analgesics|analgesics|mesh-ancestor
154792294|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
154792295|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792296|NCT04183062|Gemcitabine|gemcitabine|mesh-list
154792297|NCT04183062|Docetaxel|docetaxel|mesh-list
154792298|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154792299|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
154792300|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792301|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792302|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
154792303|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154792304|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
154792305|NCT04325880|Tamsulosin|tamsulosin|mesh-list
154792306|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
154792307|NCT04325880|Mirabegron|mirabegron|mesh-list
154792308|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154792309|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154792310|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154792311|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
154792312|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792313|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792314|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792315|NCT04325880|Urological Agents|urological agents|mesh-ancestor
154792316|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154792317|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154792318|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
154792319|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154792320|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154792321|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154792322|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154792323|NCT04846218|Progesterone|progesterone|mesh-list
154792324|NCT04846218|Progestins|progestins|mesh-ancestor
154792325|NCT04846218|Hormones|hormones|mesh-ancestor
154792326|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154792327|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792328|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
154792329|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154792330|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
154792331|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154792332|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154792333|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154792334|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792335|NCT04152486|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154792336|NCT04152486|Antiviral Agents|antiviral agents|mesh-ancestor
154792337|NCT04152486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792338|NCT02512692|Gemcitabine|gemcitabine|mesh-list
154792339|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792340|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154792341|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
154792342|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792343|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154792344|NCT01594398|Exemestane|exemestane|mesh-list
154792345|NCT01594398|Entinostat|entinostat|mesh-list
154792346|NCT01594398|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154792347|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154792348|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792349|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792350|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792351|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154792352|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154792353|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154792354|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
154792355|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154792356|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792357|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154792358|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
154792359|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
154792360|NCT00782379|Busulfan|busulfan|mesh-list
154792361|NCT00782379|Fludarabine|fludarabine|mesh-list
154792362|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
154792363|NCT00782379|Tacrolimus|tacrolimus|mesh-list
154792364|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154792365|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
154792366|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792367|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792368|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154792369|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
154792370|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792371|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792372|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154792373|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154792374|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
154792375|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154792376|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792377|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154792378|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154792379|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
154792380|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154792381|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792382|NCT04572828|Naproxen|naproxen|mesh-list
154792383|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154792384|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792385|NCT04572828|Analgesics|analgesics|mesh-ancestor
154792386|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
154792387|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792388|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792389|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792390|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792391|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
154792392|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154792393|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792394|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792395|NCT05134350|Omeprazole|omeprazole|mesh-list
154792396|NCT05134350|Pirtobrutinib|pirtobrutinib|mesh-list
154792397|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154792398|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154792399|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154792400|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792401|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792402|NCT05134350|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154792403|NCT05134350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154792404|NCT05134194|Gemcitabine|gemcitabine|mesh-list
154792405|NCT05134194|Capecitabine|capecitabine|mesh-list
154792406|NCT05134194|Vinorelbine|vinorelbine|mesh-list
154792407|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154792408|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
154792409|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792410|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792411|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154792412|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
154792413|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
154792414|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
154792415|NCT00761085|Morphine|morphine|mesh-list
154792416|NCT00761085|Methadone|methadone|mesh-list
154792417|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154792418|NCT00761085|Narcotics|narcotics|mesh-ancestor
154792419|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792420|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792421|NCT00761085|Analgesics|analgesics|mesh-ancestor
154792422|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
154792423|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792424|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
154792425|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
154792426|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
154792427|NCT02145039|Fludarabine|fludarabine|mesh-list
154792428|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154792429|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
154792430|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792431|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792432|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154792433|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
154792434|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792435|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792436|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154792437|NCT03806049|Paclitaxel|paclitaxel|mesh-list
154792438|NCT03806049|Bevacizumab|bevacizumab|mesh-list
154792439|NCT03806049|Carboplatin|carboplatin|mesh-list
154792440|NCT03806049|Niraparib|niraparib|mesh-list
154792441|NCT03806049|Dostarlimab|dostarlimab|mesh-list
154792442|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154544384|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154792443|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792444|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
154792445|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
154792446|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
154792447|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792448|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154792449|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154792450|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154792451|NCT03806049|Growth Substances|growth substances|mesh-ancestor
154792452|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792453|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
154792454|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154792455|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792456|NCT00089479|Capecitabine|capecitabine|mesh-list
154792458|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154792459|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
154792460|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792461|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792462|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
154792463|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
154792464|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
154792465|NCT01463306|Pregabalin|pregabalin|mesh-list
154792466|NCT01463306|Analgesics|analgesics|mesh-ancestor
154792467|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
154792468|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792469|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792470|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
154792471|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154792472|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792473|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792474|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154792475|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154792476|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154792477|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792478|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154792479|NCT05055726|Benzydamine|benzydamine|mesh-list
154792480|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792481|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
154792482|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154792483|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154792484|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154792485|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792486|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792487|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
154792488|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792489|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792490|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154792491|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792492|NCT03451591|Cilostazol|cilostazol|mesh-list
154792493|NCT03451591|Isosorbide|isosorbide|mesh-list
154792494|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154792495|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154792496|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154792497|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
154792498|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792499|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792500|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154792501|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
154792502|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154792503|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154792504|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792505|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154792506|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
154792507|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154792508|NCT03451591|Protective Agents|protective agents|mesh-ancestor
154792509|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154792510|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154792511|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792512|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154792513|NCT03451591|Diuretics|diuretics|mesh-ancestor
154792514|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
154792515|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154792516|NCT05744115|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154792517|NCT05744115|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154792518|NCT05744115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792519|NCT01677559|Paclitaxel|paclitaxel|mesh-list
154792520|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154792521|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792522|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
154792523|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
154792524|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
154792525|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792526|NCT05132712|Losartan|losartan|mesh-list
154792527|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154792528|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154792529|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154792530|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154792531|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792532|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
154792533|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154792534|NCT02149173|Fluorides|fluorides|mesh-list
154792535|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154792536|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792537|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
154792538|NCT02149173|Protective Agents|protective agents|mesh-ancestor
154792539|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792540|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
154792541|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
154792542|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792543|NCT04789434|Tislelizumab|tislelizumab|mesh-list
154792544|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154792545|NCT04789434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154792546|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792547|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792548|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
154792549|NCT03805503|Procaine|procaine|mesh-list
154792550|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
154792551|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
154792552|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792553|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792554|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
154792555|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792556|NCT01504412|Pregabalin|pregabalin|mesh-list
154792557|NCT01504412|Analgesics|analgesics|mesh-ancestor
154792558|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
154792559|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176386|NCT00839501|Acetazolamide|acetazolamide|mesh-list
154792560|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792561|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
154792562|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154792563|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792564|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792565|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154792566|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154792567|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154792568|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792569|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154792570|NCT04702464|Fluconazole|fluconazole|mesh-list
154792571|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
154792572|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792573|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154792574|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154792575|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792576|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792577|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154792578|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
154792579|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154792580|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792581|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154792582|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154792583|NCT00088465|Olanzapine|olanzapine|mesh-list
154792584|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
154792585|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
154792586|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792587|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792588|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154792589|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154792590|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154792591|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792592|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154792593|NCT00088465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154792594|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154792595|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792596|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792597|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792598|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
154792599|NCT04405674|Paclitaxel|paclitaxel|mesh-list
154792600|NCT04405674|Bevacizumab|bevacizumab|mesh-list
154792601|NCT04405674|Carboplatin|carboplatin|mesh-list
154792602|NCT04405674|Pemetrexed|pemetrexed|mesh-list
154792603|NCT04405674|Tislelizumab|tislelizumab|mesh-list
154792604|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154792605|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792606|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
154792607|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
154792608|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
154792609|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792610|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154792611|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154792612|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154792613|NCT04405674|Growth Substances|growth substances|mesh-ancestor
154792614|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792615|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
154792616|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792617|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154792618|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154792619|NCT00088153|Progesterone|progesterone|mesh-list
154792620|NCT00088153|Estrogens|estrogens|mesh-list
154792621|NCT00088153|Progestins|progestins|mesh-ancestor
154792622|NCT00088153|Hormones|hormones|mesh-ancestor
154792623|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154792624|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792625|NCT02074358|Apixaban|apixaban|mesh-list
154792626|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154792627|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
154792628|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154792629|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
154792630|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792631|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792632|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
154792633|NCT05743725|Magnesium Sulfate|magnesium sulfate|mesh-list
154792634|NCT05743725|Dexmedetomidine|dexmedetomidine|mesh-list
154792635|NCT05743725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154792636|NCT05743725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792637|NCT05743725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792638|NCT05743725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792639|NCT05743725|Analgesics|analgesics|mesh-ancestor
154792640|NCT05743725|Sensory System Agents|sensory system agents|mesh-ancestor
154792641|NCT05743725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792642|NCT05743725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154792643|NCT05743725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154792644|NCT05743725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154792645|NCT05743725|Adrenergic Agents|adrenergic agents|mesh-ancestor
154792646|NCT05743725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792647|NCT05743725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792648|NCT05743725|Anesthetics|anesthetics|mesh-ancestor
154792649|NCT05743725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154792650|NCT05743725|Anticonvulsants|anticonvulsants|mesh-ancestor
154792651|NCT05743725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154792652|NCT05743725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792653|NCT05743725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154792654|NCT05743725|Tocolytic Agents|tocolytic agents|mesh-ancestor
154792655|NCT05743725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154792656|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
154792657|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154792658|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792659|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792660|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792661|NCT04912518|Analgesics|analgesics|mesh-ancestor
154544615|NCT04699058|Antibodies|antibodies|mesh-list
154792662|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
154792663|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792664|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154792665|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154792666|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154792667|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
154792668|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792669|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792671|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154792672|NCT01502228|Sunitinib|sunitinib|mesh-list
154792673|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792674|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154792675|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154792676|NCT01502228|Growth Substances|growth substances|mesh-ancestor
154792677|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792678|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
154792679|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154792680|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792681|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792682|NCT05011812|Ritonavir|ritonavir|mesh-list
154792683|NCT05011812|Midazolam|midazolam|mesh-list
154792684|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154792685|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154792686|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792687|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792688|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154792689|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154792690|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154792691|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154792692|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
154792693|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
154792694|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
154792695|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
154792696|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792697|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792698|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154792699|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154792700|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
154792701|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792702|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154792703|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154792704|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
154792705|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792706|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154792707|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154792708|NCT05535231|Curcumin|curcumin|mesh-list
154792709|NCT05535231|Turmeric extract|turmeric extract|mesh-list
154792710|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154792711|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792712|NCT05535231|Analgesics|analgesics|mesh-ancestor
154792713|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
154792714|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792715|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792716|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792717|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792718|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792719|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792720|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792721|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
154792722|NCT05535231|Protective Agents|protective agents|mesh-ancestor
154792723|NCT01502072|Ribavirin|ribavirin|mesh-list
154792724|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
154792725|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792726|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
154792727|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792728|NCT01462370|Acetaminophen|acetaminophen|mesh-list
154792729|NCT01462370|Ibuprofen|ibuprofen|mesh-list
154792730|NCT01462370|Etoricoxib|etoricoxib|mesh-list
154792731|NCT01462370|Caffeine|caffeine|mesh-list
154792732|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792733|NCT01462370|Analgesics|analgesics|mesh-ancestor
154792734|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
154792735|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792736|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792737|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
154792738|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154792739|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792741|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154792742|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792743|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792744|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154792745|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154792746|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154792747|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154792748|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
154792749|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792750|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154792751|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
154792752|NCT01479764|Neostigmine|neostigmine|mesh-list
154792753|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154792754|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792755|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792756|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
154792757|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792758|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792759|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154792760|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
154792761|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792762|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154792763|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154792764|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154792765|NCT01479530|Rasagiline|rasagiline|mesh-list
154792766|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154792767|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792768|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792769|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154792770|NCT01479530|Protective Agents|protective agents|mesh-ancestor
154792771|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792772|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154792773|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154792774|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154792775|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154792776|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792777|NCT01479374|Analgesics|analgesics|mesh-ancestor
154792778|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
154792779|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792780|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792781|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792782|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792783|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154792784|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154792785|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154792786|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
154792787|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
154792788|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792789|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792790|NCT00087529|Rituximab|rituximab|mesh-list
154792791|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154792792|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792793|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
154792794|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792795|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792796|NCT00794313|Topiramate|topiramate|mesh-list
154792797|NCT00794313|Amantadine|amantadine|mesh-list
154792798|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
154792799|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154792800|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792801|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154792802|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154792803|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
154792804|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792805|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
154792806|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792807|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792808|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792809|NCT00794313|Analgesics|analgesics|mesh-ancestor
154792810|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
154792811|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792812|NCT05743101|Levofloxacin|levofloxacin|mesh-list
154792813|NCT05743101|Ofloxacin|ofloxacin|mesh-list
154792814|NCT05743101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154792815|NCT05743101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154792816|NCT05743101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154792817|NCT05743101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154792818|NCT05743101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154792819|NCT05743101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792820|NCT05743101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792821|NCT05743101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792822|NCT05743101|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154792823|NCT05743101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154792824|NCT01500434|Aspirin|aspirin|mesh-list
154792825|NCT01500434|Ticlopidine|ticlopidine|mesh-list
154792826|NCT01500434|Clopidogrel|clopidogrel|mesh-list
154792827|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154792828|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154792829|NCT01500434|Analgesics|analgesics|mesh-ancestor
154792830|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
154792831|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792832|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792833|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792834|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792835|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154792836|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154792837|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792838|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154792839|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154792840|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792841|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
154792842|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154792843|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154792844|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154792845|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
154792846|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792847|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154792848|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154792849|NCT00087139|Epothilones|epothilones|mesh-list
154792850|NCT00087139|Epothilone B|epothilone b|mesh-list
154792851|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
154792852|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
154792853|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
154792854|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792855|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792856|NCT00794547|Calcitriol|calcitriol|mesh-list
154792857|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154792858|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792859|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154792860|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972185|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
154792861|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792862|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154792863|NCT00794547|Vitamins|vitamins|mesh-ancestor
154792864|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
154792865|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154792866|NCT00786825|Somatostatin|somatostatin|mesh-list
154792867|NCT00786825|Hormones|hormones|mesh-ancestor
154792868|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154792869|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792870|NCT00768261|Memantine|memantine|mesh-list
154792871|NCT00768261|Donepezil|donepezil|mesh-list
154792872|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154792873|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792874|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792875|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
154792876|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792877|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792878|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
154792879|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154792880|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154792881|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
154792882|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154792883|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154792884|NCT03804723|Prednisone|prednisone|mesh-list
154792885|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792886|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
154792887|NCT03804723|Hormones|hormones|mesh-ancestor
154792888|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154792889|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792890|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154792891|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792893|NCT00797277|Haloperidol|haloperidol|mesh-list
154792894|NCT00797277|Olanzapine|olanzapine|mesh-list
154792895|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
154792896|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
154792897|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
154792898|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154792899|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792900|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154792901|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154792902|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154792903|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792904|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154792905|NCT00797277|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154792906|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154792907|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154792908|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792909|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792910|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
154792911|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154792912|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
154792913|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154792914|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
154792915|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154792916|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154792917|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
154792918|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
154792919|NCT03837015|Estradiol|estradiol|mesh-list
154792920|NCT03837015|Estrogens|estrogens|mesh-ancestor
154792921|NCT03837015|Hormones|hormones|mesh-ancestor
154792922|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154792923|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792924|NCT01500278|Adalimumab|adalimumab|mesh-list
154792925|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
154792926|NCT01500278|Methotrexate|methotrexate|mesh-list
154792927|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154792928|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
154792929|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154792930|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792931|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154792932|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
154792933|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792934|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792935|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
154792936|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792937|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154792938|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154792939|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
154792940|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792941|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154792942|NCT01500278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154792943|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154792944|NCT00086281|Zolpidem|zolpidem|mesh-list
154792945|NCT00086281|Modafinil|modafinil|mesh-list
154792946|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154792947|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792948|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154792949|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154792950|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154792951|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792952|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154792953|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154792954|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154792955|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154792956|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
154792957|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
154792958|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154792959|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
154792960|NCT00787761|Busulfan|busulfan|mesh-list
154792961|NCT00787761|Methotrexate|methotrexate|mesh-list
154792962|NCT00787761|Fludarabine|fludarabine|mesh-list
154792964|NCT00787761|Tacrolimus|tacrolimus|mesh-list
154792965|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
154792966|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154792967|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154792968|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
154792969|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154792970|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154792971|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154792972|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
154792973|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792974|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154792975|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154792976|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154792977|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
154792978|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154792979|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154792980|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
154792981|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
154792982|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792983|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154792984|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154792985|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154792986|NCT01478828|Lovastatin|lovastatin|mesh-list
154792987|NCT01478828|L 647318|l 647318|mesh-list
154792988|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
154792989|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154792990|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154792991|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
154792992|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154792993|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154792994|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154792995|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154792996|NCT00085423|Aldesleukin|aldesleukin|mesh-list
154792997|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
154792998|NCT00085423|Fludarabine|fludarabine|mesh-list
154792999|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
154793000|NCT00085423|Interleukin-2|interleukin-2|mesh-list
154793001|NCT00085423|Molgramostim|molgramostim|mesh-list
154793002|NCT00085423|Sargramostim|sargramostim|mesh-list
154793003|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793004|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
154793005|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793006|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793007|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154793008|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
154793009|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793010|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793011|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154793012|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154793013|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
154793014|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793015|NCT00085423|Analgesics|analgesics|mesh-ancestor
154793016|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
154793017|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793018|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154793019|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154793020|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
154793021|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793022|NCT04079192|Umirolimus|umirolimus|mesh-list
154793023|NCT04079192|Paclitaxel|paclitaxel|mesh-list
154793024|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154793025|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793026|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
154793027|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
154793028|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
154793029|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793030|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793031|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793032|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
154793033|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793034|NCT03087877|Acetaminophen|acetaminophen|mesh-list
154793035|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793036|NCT03087877|Analgesics|analgesics|mesh-ancestor
154793037|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
154793038|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793039|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793040|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
154793041|NCT05742477|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154793042|NCT05742477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793043|NCT03447379|Aspirin|aspirin|mesh-list
154793044|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154793045|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793046|NCT03447379|Analgesics|analgesics|mesh-ancestor
154793047|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
154793048|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793049|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793050|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793051|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793052|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154793053|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154793054|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793055|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154793056|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154793057|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793058|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
154793059|NCT05740449|Venetoclax|venetoclax|mesh-list
154793060|NCT05740449|Decitabine|decitabine|mesh-list
154793061|NCT05740449|Navitoclax|navitoclax|mesh-list
154793062|NCT05740449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793063|NCT05740449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154793064|NCT05740449|Antimetabolites|antimetabolites|mesh-ancestor
154793065|NCT05740449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793066|NCT05740449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793067|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
154793068|NCT01677949|Etoposide|etoposide|mesh-list
154793069|NCT01677949|Clofarabine|clofarabine|mesh-list
154793070|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793071|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
154793072|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793073|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793074|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154793075|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
154793076|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793077|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793078|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154793079|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154793080|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154793081|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154793082|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793083|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154793084|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
154793085|NCT03483883|Gemcitabine|gemcitabine|mesh-list
154793086|NCT03483883|Avelumab|avelumab|mesh-list
154793087|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154793088|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
154793089|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793090|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793091|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793092|NCT00799227|Dexamethasone|dexamethasone|mesh-list
154793093|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793094|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
154793095|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
154793096|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793097|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793098|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154793099|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
154793100|NCT00799227|Hormones|hormones|mesh-ancestor
154793101|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793102|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154793103|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793104|NCT03439267|Calcium|calcium|mesh-list
154793105|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154793106|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793107|NCT00770133|Ketotifen|ketotifen|mesh-list
154793108|NCT00770133|Naphazoline|naphazoline|mesh-list
154793109|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
154793110|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
154793111|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154793112|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
154793113|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
154793114|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793115|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793116|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793117|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154793118|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154793119|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154793120|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
154793121|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
154793122|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154793123|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
154793124|NCT00770757|Pomalidomide|pomalidomide|mesh-list
154793125|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
154793126|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793127|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154793128|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154793129|NCT00770757|Growth Substances|growth substances|mesh-ancestor
154793130|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
154793131|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793132|NCT01425281|Everolimus|everolimus|mesh-list
154793133|NCT01425281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154793134|NCT01425281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154793135|NCT01425281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793136|NCT01425281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793137|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793138|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
154793139|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793140|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793141|NCT04384653|Furosemide|furosemide|mesh-list
154793142|NCT04384653|Diuretics|diuretics|mesh-ancestor
154793143|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
154793144|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793145|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154793146|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154793147|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793148|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
154793149|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
154793150|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154793151|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793152|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793153|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793154|NCT04113720|Analgesics|analgesics|mesh-ancestor
154793155|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
154793156|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793157|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154793158|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154793159|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154793160|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
154793161|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793162|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793163|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
154793164|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
154793165|NCT01402817|Sunitinib|sunitinib|mesh-list
154793166|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793167|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154793168|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154793169|NCT01402817|Growth Substances|growth substances|mesh-ancestor
154793170|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793171|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
154793172|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154793173|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793174|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793175|NCT01425203|Ribavirin|ribavirin|mesh-list
154793176|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154793177|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
154793178|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793179|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
154793180|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793181|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
154793182|NCT04215120|Hematinics|hematinics|mesh-ancestor
154793183|NCT00081289|Leucovorin|leucovorin|mesh-list
154793184|NCT00081289|Folic Acid|folic acid|mesh-list
154793185|NCT00081289|Capecitabine|capecitabine|mesh-list
154793186|NCT00081289|Fluorouracil|fluorouracil|mesh-list
154793187|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
154793188|NCT00081289|Irinotecan|irinotecan|mesh-list
154793189|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
154793190|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154793191|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
154793192|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793193|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793194|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793195|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
154793196|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793197|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154793198|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154793199|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793200|NCT00081289|Antidotes|antidotes|mesh-ancestor
154793201|NCT00081289|Protective Agents|protective agents|mesh-ancestor
154793202|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
154793204|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
154793205|NCT00081289|Hematinics|hematinics|mesh-ancestor
154793206|NCT01478594|Bevacizumab|bevacizumab|mesh-list
154793207|NCT01478594|Tivozanib|tivozanib|mesh-list
154793208|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793209|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793210|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154793211|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154793212|NCT01478594|Growth Substances|growth substances|mesh-ancestor
154793213|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793214|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
154793215|NCT01478594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154793216|NCT01478594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793217|NCT01478594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793218|NCT01424813|Albuterol|albuterol|mesh-list
154793219|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154793220|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
154793221|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793222|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793223|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154793224|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
154793225|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
154793226|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154793227|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154793228|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154793229|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154793230|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
154793231|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793232|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793233|NCT03389022|Ketamine|ketamine|mesh-list
154793234|NCT03389022|Analgesics|analgesics|mesh-ancestor
154793235|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
154793236|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793237|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793238|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154793239|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154793240|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
154793241|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
154793242|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793243|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154793244|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154793245|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793246|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793247|NCT00080899|Fenretinide|fenretinide|mesh-list
154793248|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793249|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154793250|NCT00080899|Protective Agents|protective agents|mesh-ancestor
153972584|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154793251|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793252|NCT03627858|Beclomethasone|beclomethasone|mesh-list
154793253|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
154793254|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
154793255|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154793256|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
154793257|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793258|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793259|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154793260|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
154793261|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154793262|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154793263|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154545210|NCT02259959|Olodaterol|olodaterol|mesh-list
154793264|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
154793265|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793266|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793267|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793268|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
154793269|NCT03627858|Hormones|hormones|mesh-ancestor
154793270|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793271|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154793272|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154793273|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154793274|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
154793275|NCT03086785|Apatinib|apatinib|mesh-list
154793276|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793277|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154793278|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793279|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793280|NCT03259698|Tenofovir|tenofovir|mesh-list
154793281|NCT03259698|Emtricitabine|emtricitabine|mesh-list
154793282|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154793283|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
154793284|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793285|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154793286|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154793287|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793288|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793289|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154793290|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154793291|NCT00089635|Panitumumab|panitumumab|mesh-list
154793292|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793293|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793294|NCT03445728|Nicorandil|nicorandil|mesh-list
154793295|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154793296|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154793297|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
154793298|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
154793299|NCT03445728|Vitamins|vitamins|mesh-ancestor
154793300|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
154793301|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793302|NCT02795520|OTS167|ots167|mesh-list
154793303|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154793304|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793305|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793306|NCT03159000|Lidocaine|lidocaine|mesh-list
154793307|NCT03159000|Bupivacaine|bupivacaine|mesh-list
154793308|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
154793309|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
154793310|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793311|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793312|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
154793313|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793314|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154793315|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154793316|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154793317|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154793318|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793319|NCT00086671|Antibodies|antibodies|mesh-list
154793320|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154793321|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
154793322|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793323|NCT02010606|Bevacizumab|bevacizumab|mesh-list
154793324|NCT02010606|Temozolomide|temozolomide|mesh-list
154793325|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793326|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793327|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154793328|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154793329|NCT02010606|Growth Substances|growth substances|mesh-ancestor
154793330|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793331|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
154793332|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154793333|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
154793334|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793335|NCT00084253|Ritonavir|ritonavir|mesh-list
154793336|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154793337|NCT00084253|Lamivudine|lamivudine|mesh-list
154793338|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154793339|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154545356|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154545357|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154545358|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154545359|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545360|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545362|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154545363|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154545364|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545365|NCT03819413|Antibodies|antibodies|mesh-list
154545366|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
154545367|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
154545368|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545369|NCT02394028|Etrolizumab|etrolizumab|mesh-list
154545370|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545371|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
154545372|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545373|NCT02819297|Laxatives|laxatives|mesh-list
154545374|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154558077|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154558079|NCT02407899|Hormones|hormones|mesh-ancestor
154558080|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558081|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
154558082|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558083|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558084|NCT02417493|Epinephrine|epinephrine|mesh-list
154558085|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154558086|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154558087|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558088|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558089|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558090|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558091|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154558092|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154558093|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
154558094|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558095|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154558096|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
154558097|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
154558098|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
154558099|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154558100|NCT05540600|Digoxin|digoxin|mesh-list
154558101|NCT05540600|Bisoprolol|bisoprolol|mesh-list
154558102|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154558103|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154558104|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558105|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558106|NCT05540600|Protective Agents|protective agents|mesh-ancestor
154558107|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558108|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154558109|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
154558110|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
154558111|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558112|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154558113|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154558114|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154558115|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
154793340|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
154793341|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793342|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793343|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154793344|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154793345|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
154793346|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793347|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154793348|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154793349|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154793350|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154793351|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
154793352|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154793353|NCT02951364|Ledipasvir|ledipasvir|mesh-list
154793354|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
154793355|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793356|NCT01678417|Rituximab|rituximab|mesh-list
154793357|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793358|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793359|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
154793360|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793361|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793362|NCT00083941|Interleukin-2|interleukin-2|mesh-list
154793363|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793364|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793365|NCT00083941|Analgesics|analgesics|mesh-ancestor
154793366|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
154793367|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793368|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793369|NCT01678495|Plasminogen|plasminogen|mesh-list
154793370|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154793371|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154793372|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154793373|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793374|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
154793375|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793376|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154793377|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793378|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793379|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
154793380|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793381|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793382|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154793383|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154793384|NCT01678651|Hormones|hormones|mesh-ancestor
154793385|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793386|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793387|NCT04094090|Riboflavin|riboflavin|mesh-list
154793388|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
154793389|NCT04094090|Vitamins|vitamins|mesh-ancestor
154793390|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
154793391|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793392|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154793393|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
154793394|NCT04670796|Trastuzumab|trastuzumab|mesh-list
154793395|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793396|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793397|NCT01019616|Paclitaxel|paclitaxel|mesh-list
154793398|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154793399|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793400|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
154793401|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
154793402|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
154793403|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793404|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
154793405|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793406|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793407|NCT03083197|Azithromycin|azithromycin|mesh-list
154793408|NCT03083197|Doxycycline|doxycycline|mesh-list
154793409|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154793410|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793411|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
154793412|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154793413|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154793414|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154793415|NCT03086239|Immunoconjugates|immunoconjugates|mesh-ancestor
154793416|NCT03086239|Immunologic Factors|immunologic factors|mesh-ancestor
154793417|NCT03086239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793418|NCT01678963|Squalamine|squalamine|mesh-list
154793419|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154793420|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793421|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154793422|NCT01678963|Protective Agents|protective agents|mesh-ancestor
154793423|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793424|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793425|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154793426|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154793427|NCT01678963|Growth Substances|growth substances|mesh-ancestor
154793428|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
154793429|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154793430|NCT00790335|Plasminogen|plasminogen|mesh-list
154793431|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154793432|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154793433|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793434|NCT05136534|Anesthetics|anesthetics|mesh-list
154793435|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793436|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793437|NCT05135442|Bortezomib|bortezomib|mesh-list
154793438|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793439|NCT05130684|Paclitaxel|paclitaxel|mesh-list
154793440|NCT05130684|Cisplatin|cisplatin|mesh-list
154793441|NCT05130684|Nivolumab|nivolumab|mesh-list
154793442|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154793443|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793444|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
154793445|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
154793446|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
154793447|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793448|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793449|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154793450|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
154793451|NCT04402411|Narcotics|narcotics|mesh-ancestor
154793452|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793453|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793454|NCT04402411|Analgesics|analgesics|mesh-ancestor
154793455|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
154793456|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793457|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
154793458|NCT05265507|Ondansetron|ondansetron|mesh-list
154793459|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
154793460|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
154793461|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793462|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793463|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154793464|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
154793465|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
154793466|NCT05265507|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154793467|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154793468|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
154793469|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793470|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793471|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154793472|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154793473|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154793474|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
154793475|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154793476|NCT05135286|Carbachol|carbachol|mesh-list
154793477|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154793478|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154793479|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154793480|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154793481|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
154793482|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793483|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793484|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793485|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154793486|NCT05135286|Miotics|miotics|mesh-ancestor
154793487|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
154793488|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793489|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154793490|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
154793491|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793492|NCT05135286|Analgesics|analgesics|mesh-ancestor
154793493|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
154793494|NCT05135286|Protective Agents|protective agents|mesh-ancestor
154793495|NCT03089671|Vitamins|vitamins|mesh-list
154793496|NCT03089671|Riboflavin|riboflavin|mesh-list
154793497|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
154793498|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
154793499|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793500|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154793501|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
153972912|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793502|NCT05136924|Varenicline|varenicline|mesh-list
154793503|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154793504|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154793505|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
154793506|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545451|NCT02047565|Edoxaban|edoxaban|mesh-list
154793507|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793508|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793509|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
154793510|NCT00791037|Sargramostim|sargramostim|mesh-list
154793511|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793512|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
154793513|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793514|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793515|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154793516|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
154793517|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793518|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793519|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154793520|NCT04403191|Ondansetron|ondansetron|mesh-list
154793521|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
154793522|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
154793523|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793524|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793525|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154793526|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
154793527|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
154793528|NCT04403191|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154793529|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154793530|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
154793531|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793532|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793533|NCT04383093|Tadalafil|tadalafil|mesh-list
154793534|NCT04383093|Tamsulosin|tamsulosin|mesh-list
154793535|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
154793536|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154793537|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154793538|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793539|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793540|NCT04383093|Urological Agents|urological agents|mesh-ancestor
154793541|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154793542|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154793543|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154793544|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
154793545|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793546|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793547|NCT05301660|Nicotine|nicotine|mesh-list
154793548|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154793549|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
154793550|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793551|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793552|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154793553|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154793554|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
154793555|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793556|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793557|NCT01401959|Trastuzumab|trastuzumab|mesh-list
154793558|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154793559|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793560|NCT04767035|Midazolam|midazolam|mesh-list
154793561|NCT04767035|Ketamine|ketamine|mesh-list
154793562|NCT04767035|Analgesics|analgesics|mesh-ancestor
154793563|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
154793564|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793565|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793566|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154793567|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154793568|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
154793569|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
154793570|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793571|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154793572|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154793573|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793574|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793575|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154793576|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154793577|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154793578|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154793579|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154793580|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
154793581|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
154793582|NCT03081169|Heparin|heparin|mesh-list
154793583|NCT03081169|Enoxaparin|enoxaparin|mesh-list
154793584|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
154793585|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
154793586|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153972999|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154793587|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154793588|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793589|NCT03803163|Treprostinil|treprostinil|mesh-list
154793590|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154793591|NCT05287308|Paclitaxel|paclitaxel|mesh-list
154793592|NCT05287308|Docetaxel|docetaxel|mesh-list
154793593|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154793594|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
154793595|NCT05287308|Doxorubicin|doxorubicin|mesh-list
154793596|NCT05287308|Epirubicin|epirubicin|mesh-list
154793597|NCT05287308|Pirarubicin|pirarubicin|mesh-list
154793598|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154793599|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793600|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
154793601|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
154793602|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
154793603|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793604|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793605|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
154793606|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793607|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793608|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154793609|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
154793610|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154793611|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154793612|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154793613|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154793614|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793615|NCT00801723|Budesonide|budesonide|mesh-list
154793616|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793617|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154793618|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
154793619|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793620|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793621|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154793622|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
154793623|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
154793624|NCT00801723|Hormones|hormones|mesh-ancestor
154793625|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793626|NCT05346211|Curcumin|curcumin|mesh-list
154793627|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154793628|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793629|NCT05346211|Analgesics|analgesics|mesh-ancestor
154793630|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
154793631|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793632|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793633|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793634|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793635|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793636|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793637|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793638|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
154793639|NCT05694897|Bupivacaine|bupivacaine|mesh-list
154793640|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
154793641|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
154793642|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793643|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793644|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
154793645|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793646|NCT05694897|Analgesics|analgesics|mesh-ancestor
154793647|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154793648|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
154793649|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154793650|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154793651|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793652|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154793653|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
154793654|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154793655|NCT01478048|Dexamethasone|dexamethasone|mesh-list
154793656|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
154793657|NCT01478048|Bortezomib|bortezomib|mesh-list
154545610|NCT03562169|Ixazomib|ixazomib|mesh-list
154793658|NCT01478048|Elotuzumab|elotuzumab|mesh-list
154793660|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793661|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
154793662|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
154793663|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793664|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793665|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154793666|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
154793667|NCT01478048|Hormones|hormones|mesh-ancestor
154793668|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793669|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154793670|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793671|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
154793672|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793673|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793674|NCT04585776|Insulin|insulin|mesh-list
154793675|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154793676|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793677|NCT01401647|Lidocaine|lidocaine|mesh-list
154793678|NCT01401647|Amiodarone|amiodarone|mesh-list
154793679|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
154793680|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
154793681|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793682|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793683|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
154793684|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793685|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154793686|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154793687|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154793688|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973086|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
154793689|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793690|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
154793691|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154793692|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154793693|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154793694|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793695|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154793696|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154793697|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154793698|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154793699|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154793700|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154793701|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793702|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793703|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154793704|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154793705|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154793706|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154793707|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
154793708|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793709|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793710|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154793711|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154793712|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
154793713|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154793714|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154793715|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
154793716|NCT03088891|Antioxidants|antioxidants|mesh-list
154793717|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793718|NCT03088891|Protective Agents|protective agents|mesh-ancestor
154793719|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793720|NCT01477892|Remifentanil|remifentanil|mesh-list
154793721|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154793722|NCT01477892|Narcotics|narcotics|mesh-ancestor
154793723|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793724|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793725|NCT01477892|Analgesics|analgesics|mesh-ancestor
154793726|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
154793727|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793728|NCT00801801|Docetaxel|docetaxel|mesh-list
154793729|NCT00801801|Sorafenib|sorafenib|mesh-list
154793730|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793731|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
154793732|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
154793733|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
154793734|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793735|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154793736|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793737|NCT01499576|Acetic Acid|acetic acid|mesh-list
154793738|NCT01499576|Retinol acetate|retinol acetate|mesh-list
154793739|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154793740|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793741|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154793742|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
154793743|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793744|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154793745|NCT01499576|Protective Agents|protective agents|mesh-ancestor
154793746|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793747|NCT00802113|Fludarabine|fludarabine|mesh-list
154793748|NCT00802113|Busulfan|busulfan|mesh-list
154793749|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154793750|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793751|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793752|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793753|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
154793754|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793755|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
154793756|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154793757|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154793758|NCT03084601|Calcium|calcium|mesh-list
154793759|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154793760|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793761|NCT00791973|Fluticasone|fluticasone|mesh-list
154793762|NCT00791973|Xhance|xhance|mesh-list
154793763|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793764|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154793765|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
154793766|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793767|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793768|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154793769|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
154793770|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
154793771|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154793772|NCT00773955|Acetic Acid|acetic acid|mesh-list
154793773|NCT00773955|Retinol acetate|retinol acetate|mesh-list
154793774|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
154793775|NCT00773955|Gossypol|gossypol|mesh-list
154793776|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154793777|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793778|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154793779|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
154793780|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793781|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154793782|NCT00773955|Protective Agents|protective agents|mesh-ancestor
154793783|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793784|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154793785|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
154793786|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154793787|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154793788|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154793789|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154793790|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154793791|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
154793792|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154793793|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793794|NCT01498952|Sorafenib|sorafenib|mesh-list
154793795|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793796|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154793797|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793798|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793799|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
154793800|NCT04499196|Hormones|hormones|mesh-ancestor
154793801|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793802|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793803|NCT04608266|Camostat|camostat|mesh-list
154793804|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
154793805|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793806|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793807|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154793808|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154793810|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154793811|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
154793812|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793813|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793814|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154793815|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154793816|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154793817|NCT01421303|Etanercept|etanercept|mesh-list
154793818|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154793819|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793820|NCT01421303|Analgesics|analgesics|mesh-ancestor
154793821|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
154793822|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793823|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793824|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793825|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793826|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154793827|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154793828|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
154793829|NCT03703375|Gemcitabine|gemcitabine|mesh-list
154793830|NCT03703375|Azacitidine|azacitidine|mesh-list
154793831|NCT03703375|Romidepsin|romidepsin|mesh-list
154793832|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154793833|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
154793834|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793835|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793836|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793837|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154793838|NCT03703375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154793839|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154793840|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154793841|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154793842|NCT05303688|Analgesics|analgesics|mesh-ancestor
154793843|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
154793844|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793845|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793846|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793847|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793848|NCT04383717|Azithromycin|azithromycin|mesh-list
154793849|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
154793850|NCT04383717|Levamisole|levamisole|mesh-list
154793851|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
154793852|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154793853|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793854|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
154793855|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154793856|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154793857|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793858|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793859|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154793860|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154793861|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
154793862|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793863|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
154793864|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
154793865|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
154793866|NCT01400243|Nicotine|nicotine|mesh-list
154793867|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154793868|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
154793869|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793870|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793871|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154793872|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154793873|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
154793874|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793875|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793876|NCT00809055|Caffeine|caffeine|mesh-list
154793877|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
154793878|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793879|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154793880|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545819|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154793881|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154793882|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793883|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154793884|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154793885|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
154793886|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154793887|NCT01421225|Insulin|insulin|mesh-list
154793888|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154793889|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154793890|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793891|NCT03082885|Thymalfasin|thymalfasin|mesh-list
154793892|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154793893|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
154793894|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793895|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154793896|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
154793897|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793898|NCT05688631|Antioxidants|antioxidants|mesh-list
154793899|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793900|NCT05688631|Protective Agents|protective agents|mesh-ancestor
154793901|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793902|NCT04348032|Apatinib|apatinib|mesh-list
154793903|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154793904|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154793905|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793906|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793907|NCT01474772|Pregabalin|pregabalin|mesh-list
154793908|NCT01474772|Analgesics|analgesics|mesh-ancestor
154793909|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
154793910|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793911|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793912|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
154793913|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154793914|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154793915|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793916|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154793917|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154793918|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154793919|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793920|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154793921|NCT03082339|Cortisone|cortisone|mesh-list
154793922|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154793923|NCT03801759|Adefovir|adefovir|mesh-list
154793924|NCT03801759|Digoxin|digoxin|mesh-list
154793925|NCT03801759|Furosemide|furosemide|mesh-list
154793926|NCT03801759|Diuretics|diuretics|mesh-ancestor
154793927|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
154793928|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793929|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154793930|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154793931|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793932|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154793933|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154793934|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793935|NCT03801759|Protective Agents|protective agents|mesh-ancestor
154793936|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
154793937|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793938|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154793939|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154793940|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
154793941|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154793942|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793943|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154793944|NCT03082573|Hormones|hormones|mesh-ancestor
154793945|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154793946|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793947|NCT01497938|Insulin|insulin|mesh-list
154793948|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154793949|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793950|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154793951|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
154793952|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793953|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154793954|NCT04301310|Rifampin|rifampin|mesh-list
154545899|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
154793955|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154793956|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
154793957|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154793958|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793959|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
154793960|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154793961|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793962|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793963|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154793964|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154793965|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154793966|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154793967|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154793968|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154793969|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
154793970|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793971|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
154793972|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
154793973|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
154793974|NCT00804609|Lidocaine|lidocaine|mesh-list
154793975|NCT00804609|Morphine|morphine|mesh-list
154793976|NCT00804609|Anesthetics|anesthetics|mesh-list
154793977|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
154793978|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154793979|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154793980|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
154793981|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154793982|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154793983|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154793984|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154793985|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973373|NCT01064297|Lamotrigine|lamotrigine|mesh-list
154793986|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154793987|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154793988|NCT00804609|Narcotics|narcotics|mesh-ancestor
154793989|NCT00804609|Analgesics|analgesics|mesh-ancestor
154793990|NCT03082183|Rifampin|rifampin|mesh-list
154793991|NCT03082183|BI 425809|bi 425809|mesh-list
154793992|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154793993|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
154793994|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154793995|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154793996|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
154793997|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154793998|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154793999|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794000|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154794001|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154794002|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154794003|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154794004|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154794005|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154794006|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
154794007|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154794008|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154794009|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794010|NCT00810303|Efavirenz|efavirenz|mesh-list
154794011|NCT00810303|Ezetimibe|ezetimibe|mesh-list
154794012|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154794013|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154794014|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
154794015|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794016|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154794017|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154794018|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154794019|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794020|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
154794021|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794022|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154794023|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154794024|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154794025|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154794026|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154545976|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
154794027|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154794028|NCT04401085|Antibodies|antibodies|mesh-list
154794029|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
154794030|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794031|NCT04227756|Psilocybin|psilocybin|mesh-list
154794032|NCT04227756|Mescaline|mescaline|mesh-list
154794033|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
154794034|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794035|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154794036|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154794037|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
154794038|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794039|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794040|NCT01460342|Tadalafil|tadalafil|mesh-list
154794041|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
154794042|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154794043|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154794044|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794045|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794046|NCT01460342|Urological Agents|urological agents|mesh-ancestor
154794047|NCT00775671|Metoprolol|metoprolol|mesh-list
154794048|NCT00775671|Nebivolol|nebivolol|mesh-list
154794049|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154794050|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154794051|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
154794052|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
154794053|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794054|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794055|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154794056|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154794057|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154794058|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
154794059|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794060|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794061|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
154794062|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154794063|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154794064|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154794065|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154794066|NCT03800745|Laxatives|laxatives|mesh-ancestor
154794067|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154794068|NCT01459796|Rilonacept|rilonacept|mesh-list
154794069|NCT01459796|Allopurinol|allopurinol|mesh-list
154794070|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
154794071|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794072|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794073|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
154794074|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794075|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154794076|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
154794077|NCT01459796|Protective Agents|protective agents|mesh-ancestor
154794078|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794079|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794080|NCT04721691|Cannabidiol|cannabidiol|mesh-list
154794081|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
154794082|NCT04760821|Trimetazidine|trimetazidine|mesh-list
154794083|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
154794084|NCT04382079|Propolis|propolis|mesh-list
154794085|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794086|NCT05688007|Hormones|hormones|mesh-list
154794087|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
154794088|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794089|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794090|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154794091|NCT01459718|Deferasirox|deferasirox|mesh-list
154794092|NCT01459718|Deferoxamine|deferoxamine|mesh-list
154794093|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154794094|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
154794095|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
154794096|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794097|NCT01459718|Siderophores|siderophores|mesh-ancestor
154794098|NCT04918407|Empagliflozin|empagliflozin|mesh-list
154794099|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154794100|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794101|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154794102|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794103|NCT04916769|Bosutinib|bosutinib|mesh-list
154794104|NCT04916769|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154794105|NCT04916769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154794106|NCT04916769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794107|NCT04916769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794108|NCT04989660|Phenol|phenol|mesh-list
153973535|NCT06250062|Antibodies|antibodies|mesh-list
154794109|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154794110|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794111|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
154794112|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154794113|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154794114|NCT03081325|Immunomodulating Agents|immunomodulating agents|mesh-list
154794115|NCT03081325|Immunologic Factors|immunologic factors|mesh-ancestor
154794116|NCT03081325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794117|NCT04384731|Poractant alfa|poractant alfa|mesh-list
154794118|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154794119|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
154794120|NCT05042466|Psilocybin|psilocybin|mesh-list
154794121|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
154794122|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794123|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154794124|NCT05615467|Metformin|metformin|mesh-list
154794125|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154794126|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794127|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
154794128|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154794129|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794130|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794131|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154794132|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154794133|NCT03800433|Protective Agents|protective agents|mesh-ancestor
154794134|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794135|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
154794136|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154794137|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
154794138|NCT03395899|Bevacizumab|bevacizumab|mesh-list
154794139|NCT03395899|Atezolizumab|atezolizumab|mesh-list
154794140|NCT03395899|Ipatasertib|ipatasertib|mesh-list
154794141|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154794142|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794143|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154794144|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154794145|NCT03395899|Growth Substances|growth substances|mesh-ancestor
154794146|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794147|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
154794148|NCT03395899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154794149|NCT03395899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794150|NCT03395899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154794151|NCT03395899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794152|NCT04608201|Nicotine|nicotine|mesh-list
154794153|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154794154|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
154794155|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794156|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794157|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154794158|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154794159|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
154794160|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794161|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794162|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
154794163|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
154794164|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154794165|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154794166|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794167|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794168|NCT04110444|Urological Agents|urological agents|mesh-ancestor
154794169|NCT04951986|Levofloxacin|levofloxacin|mesh-list
154794170|NCT04951986|Rifampin|rifampin|mesh-list
154794171|NCT04951986|Isoniazid|isoniazid|mesh-list
154794172|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
154794173|NCT04951986|Ethambutol|ethambutol|mesh-list
154794174|NCT04951986|Prednisone|prednisone|mesh-list
154794175|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794176|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
154794177|NCT04951986|Hormones|hormones|mesh-ancestor
154794178|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794179|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794180|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154794181|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794182|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154794183|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794184|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154794185|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154794186|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154794187|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794188|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794189|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154794190|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154794191|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154794192|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
154794193|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
154794194|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154794195|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154794196|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154794197|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154794198|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154794199|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154794200|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154794201|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154794202|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154794203|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
154794204|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154794205|NCT04278859|Antibodies|antibodies|mesh-list
154794206|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154794207|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
154794208|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794209|NCT01474538|Insulin|insulin|mesh-list
154794210|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154794211|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
154794212|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
154794213|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154794214|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794215|NCT04278703|Oxycodone|oxycodone|mesh-list
154794216|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154794217|NCT04278703|Narcotics|narcotics|mesh-ancestor
154794218|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973614|NCT06249555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154794219|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794220|NCT04278703|Analgesics|analgesics|mesh-ancestor
154794221|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
154794222|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794223|NCT02647788|Acetaminophen|acetaminophen|mesh-list
154794224|NCT02647788|Ibuprofen|ibuprofen|mesh-list
154794225|NCT02647788|Codeine|codeine|mesh-list
154794226|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154794227|NCT02647788|Analgesics|analgesics|mesh-ancestor
154794228|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
154794229|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794230|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794231|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
154794232|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154794233|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794234|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794235|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154794236|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794237|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794238|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154794239|NCT02647788|Narcotics|narcotics|mesh-ancestor
154794240|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794241|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
154794242|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
154794243|NCT04382859|Bupivacaine|bupivacaine|mesh-list
154794244|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
154794245|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
154794246|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794247|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794248|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
154794249|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794250|NCT03318133|Anesthetics|anesthetics|mesh-list
154546190|NCT02059967|Carboplatin|carboplatin|mesh-list
154794251|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794252|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794253|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154794254|NCT04134663|Oxytocin|oxytocin|mesh-list
154794255|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
154794256|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154794257|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794258|NCT05431764|Gemcitabine|gemcitabine|mesh-list
154794259|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154794260|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794261|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794262|NCT05431764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154794263|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154794264|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
154794265|NCT04311411|Liraglutide|liraglutide|mesh-list
154794266|NCT04311411|Tirzepatide|tirzepatide|mesh-list
154794267|NCT04311411|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154794268|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154794269|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794270|NCT04311411|Incretins|incretins|mesh-ancestor
154794271|NCT04311411|Hormones|hormones|mesh-ancestor
154794272|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794273|NCT00843531|Everolimus|everolimus|mesh-list
154794274|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154794275|NCT00843531|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154794276|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154794277|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794278|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794279|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154794280|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
154794281|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794282|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794283|NCT00843531|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154794284|NCT00812877|Calcium|calcium|mesh-list
154794285|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154794286|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794287|NCT00813111|Epinephrine|epinephrine|mesh-list
154794288|NCT00813111|Bupivacaine|bupivacaine|mesh-list
154794289|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154794290|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
154794291|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794292|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794293|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
154794294|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794295|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154794296|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154794297|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
154794298|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794299|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794300|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154794301|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154794302|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
154794303|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154794304|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
154794305|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
154794306|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
154794307|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154794308|NCT00845481|Calcitriol|calcitriol|mesh-list
154794309|NCT00845481|Betamethasone|betamethasone|mesh-list
154794310|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794311|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
154794312|NCT00845481|Hormones|hormones|mesh-ancestor
154794313|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794314|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794315|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154794316|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
154794317|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154794318|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154794319|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154794320|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794321|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154794322|NCT00845481|Vitamins|vitamins|mesh-ancestor
154794323|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
154794324|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154794325|NCT03641001|Micronutrients|micronutrients|mesh-list
154794326|NCT03641001|Trace Elements|trace elements|mesh-list
154794327|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794328|NCT01421069|Etanercept|etanercept|mesh-list
154794329|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154794330|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154794331|NCT01421069|Analgesics|analgesics|mesh-ancestor
154794332|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
154794333|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794334|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794335|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973732|NCT06248112|Valsartan|valsartan|mesh-list
154794336|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794337|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154794338|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154794339|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
154794340|NCT04276233|Albuterol|albuterol|mesh-list
154794341|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154794342|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
154794343|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794344|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794345|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154794346|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
154794347|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
154794348|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154794349|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154794350|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154794351|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154794352|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
154794353|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794354|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794355|NCT04681430|Gabexate|gabexate|mesh-list
154794356|NCT04681430|Camostat|camostat|mesh-list
154794357|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
154794358|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794359|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794360|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154794361|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154794362|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
154794363|NCT00814671|Rifampin|rifampin|mesh-list
154794364|NCT00814671|Rifapentine|rifapentine|mesh-list
154794365|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154794366|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
154794367|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154794368|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794369|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
154794370|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154794371|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794372|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794373|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154794374|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154794375|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154794376|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154794377|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154794378|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154794379|NCT03379051|Lenalidomide|lenalidomide|mesh-list
154794380|NCT03379051|Venetoclax|venetoclax|mesh-list
154794381|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
154794382|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794383|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154794384|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154794385|NCT03379051|Growth Substances|growth substances|mesh-ancestor
154794386|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
154794387|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794388|NCT01473836|Metronidazole|metronidazole|mesh-list
154794389|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
154794390|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794391|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154794392|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154794393|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154794394|NCT01473836|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154794395|NCT01473836|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154794396|NCT03340909|Prednisolone|prednisolone|mesh-list
154794397|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794398|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
154794399|NCT03340909|Hormones|hormones|mesh-ancestor
154794400|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794401|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794402|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154794403|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794405|NCT05686915|Chromium|chromium|mesh-list
154794406|NCT05686915|Trace Elements|trace elements|mesh-ancestor
154794407|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
154794408|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794409|NCT03674151|Povidone|povidone|mesh-list
154794410|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
154794411|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
154794412|NCT03643965|Budesonide|budesonide|mesh-list
154794413|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794414|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154794415|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
154794416|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794417|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794418|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154794419|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
154794420|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
154794421|NCT03643965|Hormones|hormones|mesh-ancestor
154794422|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794423|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
154794424|NCT01420679|Aminopterin|aminopterin|mesh-list
154794425|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154794426|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794427|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794428|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794429|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154794430|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154794431|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154794432|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
154794433|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794434|NCT04401007|Lidocaine|lidocaine|mesh-list
154794435|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
154794436|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
154794437|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794438|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794439|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
154794440|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794441|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154794442|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154794443|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154794444|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154794445|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794446|NCT01496846|Lidocaine|lidocaine|mesh-list
154794447|NCT01496846|Carticaine|carticaine|mesh-list
154794448|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
154794449|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
154794450|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794451|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794452|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
154794453|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794454|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154794455|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154794456|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154794457|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154794458|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794459|NCT00964002|Efavirenz|efavirenz|mesh-list
154794460|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154794461|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154794462|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794463|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794464|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
154794465|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794466|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154794467|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154794468|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154794469|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154794470|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154794471|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154794472|NCT00818337|Aspirin|aspirin|mesh-list
154794473|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154794474|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154794475|NCT00818337|Analgesics|analgesics|mesh-ancestor
154794476|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
154794477|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794478|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794479|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794480|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794481|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154794482|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154794483|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794484|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154794485|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154794486|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794488|NCT02577120|Decanoic acid|decanoic acid|mesh-list
154794489|NCT02577120|Petrolatum|petrolatum|mesh-list
154794490|NCT02577120|Emollients|emollients|mesh-ancestor
154794491|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
154794492|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
154794493|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794494|NCT01399697|Methotrexate|methotrexate|mesh-list
154794495|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154794496|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
154794497|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154794498|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794499|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154794500|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
154794501|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794502|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794503|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
154794504|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794505|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154794506|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154794507|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
154794508|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794509|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154794510|NCT00853671|Adenosine|adenosine|mesh-list
154794511|NCT00853671|Analgesics|analgesics|mesh-ancestor
154794512|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
154794513|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794514|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794515|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154794516|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
154794517|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154794518|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
154794519|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
154794520|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794521|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794522|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154794523|NCT00818805|Tranilast|tranilast|mesh-list
154794524|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154794525|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154794526|NCT00818805|Analgesics|analgesics|mesh-ancestor
154794527|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
154794528|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794529|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794530|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794531|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794532|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154794533|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154794534|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154794535|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
154794536|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
154794537|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794538|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794539|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154794540|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154794541|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154794542|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154794543|NCT00854061|Prednisone|prednisone|mesh-list
154794544|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
154794545|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154794546|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
154794547|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154794548|NCT00854061|Prednisolone|prednisolone|mesh-list
154794549|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154794550|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
154794551|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794552|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
154794553|NCT00854061|Hormones|hormones|mesh-ancestor
154794554|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794555|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794556|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154794557|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794558|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
154794559|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
154794560|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794561|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154794562|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154794563|NCT00854061|Protective Agents|protective agents|mesh-ancestor
154794564|NCT01473602|Vitamin D|vitamin d|mesh-list
154794565|NCT01473602|Teriparatide|teriparatide|mesh-list
154794566|NCT01473602|Calcium|calcium|mesh-list
154794567|NCT01473602|Vitamins|vitamins|mesh-ancestor
154794568|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
154794569|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794570|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154794571|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154794572|NCT03336073|Dexamethasone|dexamethasone|mesh-list
154794573|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
154794574|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973976|NCT06034418|Glucocorticoids|glucocorticoids|mesh-ancestor
154794575|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
154794576|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794577|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794578|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154794579|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
154794580|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794581|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794582|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154794583|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794584|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
154794585|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
154794586|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794587|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154794588|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
154794589|NCT03336073|Hormones|hormones|mesh-ancestor
154794590|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794591|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154794592|NCT01496612|Buspirone|buspirone|mesh-list
154794593|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154794594|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154794595|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794596|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794597|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154794598|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154794599|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
154794600|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794601|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794602|NCT00790218|Adenosine|adenosine|mesh-list
154794603|NCT00790218|Analgesics|analgesics|mesh-ancestor
154794604|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
154794605|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794606|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794607|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154794608|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
154794609|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154794610|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
154794611|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
154794612|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794613|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794614|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
154794615|NCT00818961|Busulfan|busulfan|mesh-list
154794616|NCT00818961|Rituximab|rituximab|mesh-list
154794617|NCT00818961|Methotrexate|methotrexate|mesh-list
154794618|NCT00818961|Fludarabine|fludarabine|mesh-list
154794619|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
154794620|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
154794621|NCT00818961|Tacrolimus|tacrolimus|mesh-list
154794622|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154794623|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
154794624|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794625|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794626|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154794627|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
154794628|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794630|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154794631|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154794632|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154794633|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
154794634|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154794635|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154794636|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
154794637|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
154794638|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794639|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154794640|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154794641|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154794642|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
154794643|NCT05431218|Vitamin D|vitamin d|mesh-list
154794644|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154794645|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794646|NCT05431218|Vitamins|vitamins|mesh-ancestor
154794647|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
154794648|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154794649|NCT05431062|Bupivacaine|bupivacaine|mesh-list
154794650|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
154794651|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
154794652|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794653|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794654|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
154794655|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794656|NCT00819507|Fluocinonide|fluocinonide|mesh-list
154794657|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794658|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
154794659|NCT00819507|Hormones|hormones|mesh-ancestor
154794660|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794661|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794662|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154794663|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154794664|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
154794665|NCT03696121|Coagulants|coagulants|mesh-ancestor
154794666|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154794667|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
154794668|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794669|NCT01457924|Ofatumumab|ofatumumab|mesh-list
154794670|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154794671|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794672|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
154794673|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794674|NCT05237115|Amoxicillin|amoxicillin|mesh-list
154794675|NCT05237115|Clarithromycin|clarithromycin|mesh-list
154794676|NCT05237115|Esomeprazole|esomeprazole|mesh-list
154794677|NCT05237115|Bismuth|bismuth|mesh-list
154794678|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154794679|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794680|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154794681|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154794682|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154794683|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794684|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794685|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154794686|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154794687|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154794688|NCT05237115|Antacids|antacids|mesh-ancestor
154794689|NCT04040621|Ceftazidime|ceftazidime|mesh-list
154794690|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154794691|NCT04040621|Avibactam|avibactam|mesh-list
154794692|NCT04040621|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154794693|NCT04040621|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154794694|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154794695|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794696|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154794697|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794698|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794699|NCT00856791|ON 01910|on 01910|mesh-list
154794700|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794701|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154794702|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794703|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794704|NCT00857493|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154794705|NCT00857493|Antiviral Agents|antiviral agents|mesh-ancestor
154794706|NCT00857493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794707|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
154794708|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154794709|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154794710|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794711|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
154794712|NCT05236569|Coagulants|coagulants|mesh-ancestor
154794713|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
154794714|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154794715|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794716|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794717|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154794718|NCT00857727|Analgesics|analgesics|mesh-ancestor
154794719|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
154794720|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794721|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154794722|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154794723|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154794724|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154794725|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794726|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794727|NCT00857961|Testosterone|testosterone|mesh-list
154794728|NCT00857961|Androgens|androgens|mesh-ancestor
154794730|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794731|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794732|NCT03839433|Ciclesonide|ciclesonide|mesh-list
154794733|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
154794734|NCT03839433|Hormones|hormones|mesh-ancestor
154794735|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794736|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794737|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154794738|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154794739|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154794740|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
154794741|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794742|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794743|NCT00824733|Trastuzumab|trastuzumab|mesh-list
154794744|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154794745|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794746|NCT02150499|Albuterol|albuterol|mesh-list
154794747|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154794748|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
154794749|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794750|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794751|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154794752|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
154794753|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
154794754|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154794755|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154794756|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154794757|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154794758|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
154794759|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794760|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794761|NCT03287947|Nintedanib|nintedanib|mesh-list
154794762|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794763|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154794764|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794765|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794766|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
154794767|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154794768|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
154794769|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794770|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
154794771|NCT05685667|Protective Agents|protective agents|mesh-ancestor
154794772|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
154794773|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154794774|NCT00859131|Daclizumab|daclizumab|mesh-list
154794775|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
154794776|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794777|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154794778|NCT00859833|Adenosine|adenosine|mesh-list
154794779|NCT00859833|Regadenoson|regadenoson|mesh-list
154794780|NCT00859833|Analgesics|analgesics|mesh-ancestor
154794781|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
154794782|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794783|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794784|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154794785|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
154794786|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154794787|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
154794788|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
154794789|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794790|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794791|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154794792|NCT02154477|Insulin|insulin|mesh-list
154794793|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154794794|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794795|NCT00860379|Selenium|selenium|mesh-list
154794796|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
154794797|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794798|NCT00860379|Protective Agents|protective agents|mesh-ancestor
154794799|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794800|NCT00860379|Trace Elements|trace elements|mesh-ancestor
154794801|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
154794802|NCT00860457|Rituximab|rituximab|mesh-list
154794803|NCT00860457|Fludarabine|fludarabine|mesh-list
154794804|NCT00860457|Lenalidomide|lenalidomide|mesh-list
154794805|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154794806|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794807|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
154794808|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794809|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794810|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154794811|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154794812|NCT00860457|Growth Substances|growth substances|mesh-ancestor
154794813|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
154794814|NCT00827073|Lidocaine|lidocaine|mesh-list
154794815|NCT00827073|Tetracaine|tetracaine|mesh-list
154794816|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
154794817|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
154794818|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794819|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794820|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
154794821|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794822|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154794823|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154794824|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154794825|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154794826|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794827|NCT00860847|Ubiquinone|ubiquinone|mesh-list
154794828|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
154794829|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
154794830|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794831|NCT00860847|Vitamins|vitamins|mesh-ancestor
154794832|NCT04347733|Triamcinolone|triamcinolone|mesh-list
154794833|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154794834|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154794835|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154794836|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154794837|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
154794838|NCT04347733|Hormones|hormones|mesh-ancestor
154794839|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794840|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794841|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154794842|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
154794843|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794844|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794845|NCT02155101|Ritonavir|ritonavir|mesh-list
154794846|NCT02155101|Lopinavir|lopinavir|mesh-list
154794847|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154794848|NCT02155101|Darunavir|darunavir|mesh-list
154794849|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154794850|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154546785|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154794851|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
154794852|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794853|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794854|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154794855|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154794856|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
154794857|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794858|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154794859|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154794860|NCT02155257|Gabapentin|gabapentin|mesh-list
154794861|NCT02155257|Modafinil|modafinil|mesh-list
154794862|NCT02155257|Analgesics|analgesics|mesh-ancestor
154794863|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
154794864|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794865|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794866|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
154794867|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154794868|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154794869|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794870|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154794871|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154794872|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154794873|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794874|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794875|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
154794876|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154794877|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154794878|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154794879|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154794880|NCT03243019|Sirolimus|sirolimus|mesh-list
154794881|NCT03243019|Temsirolimus|temsirolimus|mesh-list
154794882|NCT03243019|MTOR Inhibitors|mtor inhibitors|mesh-list
154794883|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154794884|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794885|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154794886|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794887|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
154794888|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154794889|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
154794890|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794891|NCT03243019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154794892|NCT03243019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794893|NCT03243019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794894|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
154794895|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
154794896|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154794897|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154794898|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794899|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154794900|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794901|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154794902|NCT01673646|Pasireotide|pasireotide|mesh-list
154794903|NCT01673646|Hormones|hormones|mesh-ancestor
154794904|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794905|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794906|NCT00862563|Topiramate|topiramate|mesh-list
154794907|NCT00862563|Zonisamide|zonisamide|mesh-list
154794908|NCT00862563|Levetiracetam|levetiracetam|mesh-list
154794909|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
154794910|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154794911|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794912|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
154794913|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154794914|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154794915|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794916|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154794917|NCT04278937|Azithromycin|azithromycin|mesh-list
154794918|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154794919|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794920|NCT02647944|Liraglutide|liraglutide|mesh-list
154794921|NCT02647944|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154794922|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154794923|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794924|NCT02647944|Incretins|incretins|mesh-ancestor
154794925|NCT02647944|Hormones|hormones|mesh-ancestor
154546860|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
154794926|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154794927|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
154794928|NCT04278547|Valganciclovir|valganciclovir|mesh-list
154794929|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
154794930|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794931|NCT00863109|Ribavirin|ribavirin|mesh-list
154794932|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154794933|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
154794934|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794935|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
154794936|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154794937|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154794938|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154794939|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794940|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
154794941|NCT05246371|Propofol|propofol|mesh-list
154794942|NCT05246371|Desflurane|desflurane|mesh-list
154794943|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154794944|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794945|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794946|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154794947|NCT05246371|Analgesics|analgesics|mesh-ancestor
154794948|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
154794949|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794950|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154794951|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154794952|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154794953|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
154794954|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154794955|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794956|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154794957|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
154794958|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
154794959|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154794960|NCT00863265|Ezetimibe|ezetimibe|mesh-list
154794961|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154794962|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154794963|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
154794964|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794965|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154794966|NCT00831675|Vaccines|vaccines|mesh-list
154794967|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
154794968|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794969|NCT01397825|Rituximab|rituximab|mesh-list
154794970|NCT01397825|Vincristine|vincristine|mesh-list
154794971|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154794972|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154794973|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
154794974|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794975|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153974384|NCT05453851|Pancreatin|pancreatin|mesh-list
154794976|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154794977|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154794978|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154794979|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154794980|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154794981|NCT05353764|Ropivacaine|ropivacaine|mesh-list
154794982|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
154794983|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
154794984|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154794985|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794986|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
154794987|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794988|NCT00831987|Vaccines|vaccines|mesh-list
154794989|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
154794990|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794991|NCT05239884|Nicotine|nicotine|mesh-list
154794992|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154794993|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
154794994|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154794995|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154794996|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154794997|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154794998|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
154794999|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795000|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795001|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
154795002|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
154795003|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795004|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
154795005|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795006|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154795007|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154795008|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
154795009|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795010|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795011|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154795012|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154795013|NCT03836352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154795014|NCT01397201|Fluticasone|fluticasone|mesh-list
154795015|NCT01397201|Xhance|xhance|mesh-list
154795016|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154795017|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154795018|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
154795019|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795020|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795021|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154795022|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795023|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
154795024|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154795025|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154795026|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154795027|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
154795028|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154795029|NCT00834171|Tobramycin|tobramycin|mesh-list
154795030|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795031|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795032|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154795033|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154795034|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795035|NCT00835185|Leucovorin|leucovorin|mesh-list
154795036|NCT00835185|Folic Acid|folic acid|mesh-list
154795037|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
154795038|NCT00835185|Necitumumab|necitumumab|mesh-list
154795039|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
154795040|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154795041|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795042|NCT00835185|Antidotes|antidotes|mesh-ancestor
154795043|NCT00835185|Protective Agents|protective agents|mesh-ancestor
154795044|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795045|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
154795046|NCT00835185|Vitamins|vitamins|mesh-ancestor
154795047|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
154795048|NCT00835185|Hematinics|hematinics|mesh-ancestor
154795049|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154795050|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
154795051|NCT04399525|Cetirizine|cetirizine|mesh-list
154795052|NCT04399525|Loratadine|loratadine|mesh-list
154795053|NCT04399525|Levocetirizine|levocetirizine|mesh-list
154795054|NCT04399525|Desloratadine|desloratadine|mesh-list
154795055|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154795056|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154795057|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
154795058|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
154795059|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795060|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795061|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795062|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154795063|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154795064|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
154795065|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
154795066|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
154795067|NCT00864123|Cycloserine|cycloserine|mesh-list
154795068|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154795069|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795070|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154795071|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
154795072|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795073|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
154795074|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795075|NCT03858465|Phenylephrine|phenylephrine|mesh-list
154795076|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
154547014|NCT04951856|Evolocumab|evolocumab|mesh-list
154795077|NCT03858465|Ephedrine|ephedrine|mesh-list
154795078|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154795079|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
154795080|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
154795081|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795082|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795083|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
154795084|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154795085|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
154795086|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795087|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154795088|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154795089|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154795090|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795091|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795092|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795093|NCT03858465|Protective Agents|protective agents|mesh-ancestor
154795094|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154795096|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154795097|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
154795098|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154795099|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795100|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
154795101|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154795102|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154795103|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154795104|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795105|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795106|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154795107|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154795108|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154795109|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795110|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
154795111|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
154795112|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795113|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795114|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795115|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
154795116|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
154795117|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154795118|NCT04797013|Plasminogen|plasminogen|mesh-list
154795119|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154795120|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154795121|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795122|NCT00838695|Phenylephrine|phenylephrine|mesh-list
154795123|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
154795124|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154795125|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
154795126|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
154795127|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795128|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795129|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
154795130|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154795131|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
154795132|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795133|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154795134|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154795135|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154795136|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795137|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795138|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795139|NCT00838695|Protective Agents|protective agents|mesh-ancestor
154795140|NCT01396265|Rifampin|rifampin|mesh-list
154795141|NCT01396265|Afatinib|afatinib|mesh-list
154795142|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154795143|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
154795144|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795145|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795146|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
154795147|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154795148|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795149|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795150|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154795151|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154795152|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154547092|NCT02081027|Riluzole|riluzole|mesh-list
154795153|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154795154|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154795155|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154795156|NCT01396265|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154795157|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154795158|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795159|NCT04760431|Paclitaxel|paclitaxel|mesh-list
154795160|NCT04760431|Docetaxel|docetaxel|mesh-list
154795161|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154795162|NCT04760431|Trastuzumab|trastuzumab|mesh-list
154795163|NCT04760431|Pertuzumab|pertuzumab|mesh-list
154795164|NCT04760431|Taxane|taxane|mesh-list
154795165|NCT04760431|Tucatinib|tucatinib|mesh-list
153974561|NCT04964414|Hormones|hormones|mesh-ancestor
154795166|NCT04760431|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154795167|NCT04760431|Neratinib|neratinib|mesh-list
154795168|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154795169|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795170|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
154795171|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
154795172|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
154795173|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795174|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154795175|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154795176|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795177|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154795178|NCT00839319|Testosterone|testosterone|mesh-list
154795179|NCT00839319|Acyline|acyline|mesh-list
154795180|NCT00839319|Androgens|androgens|mesh-ancestor
154795181|NCT00839319|Hormones|hormones|mesh-ancestor
154795182|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795183|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795184|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154795185|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
154795186|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154795187|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154795188|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154795189|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154795190|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795191|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154795192|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154795193|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154795194|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154795195|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795196|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795197|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795198|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154795199|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154795200|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
154795201|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154795202|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154795203|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
154795204|NCT02647866|KHK4083|khk4083|mesh-list
154795205|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
154795206|NCT02246127|Everolimus|everolimus|mesh-list
154795207|NCT02246127|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154795208|NCT02246127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154795209|NCT02246127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795210|NCT02246127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795211|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795212|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
154795213|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795214|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795215|NCT04277923|SMOFlipid|smoflipid|mesh-list
154795216|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154795217|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154795218|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154795219|NCT00870363|Efavirenz|efavirenz|mesh-list
154795220|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154795221|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
154795222|NCT00870363|Maraviroc|maraviroc|mesh-list
154795223|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154795224|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795225|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795226|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
154795227|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795228|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154795229|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154795230|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154795231|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154795232|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154795233|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154795234|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154795235|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154795236|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154795237|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154795238|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154795239|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154795240|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154795241|NCT03104634|Bromides|bromides|mesh-list
154795242|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
154795243|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154795244|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
154795245|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795246|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795247|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154795248|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795249|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154795250|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154795251|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154795252|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795253|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795254|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795255|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
154795256|NCT00871689|Aldesleukin|aldesleukin|mesh-list
154795257|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
154795258|NCT00871689|Fludarabine|fludarabine|mesh-list
154795259|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
154795260|NCT00871689|Interleukin-2|interleukin-2|mesh-list
154795261|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795262|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
154795263|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795264|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154795265|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154795266|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
154795267|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795268|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795269|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154795270|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154795271|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
154795272|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
154795273|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795274|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154795275|NCT00871689|Analgesics|analgesics|mesh-ancestor
154795276|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
154795277|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795278|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154795279|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154795280|NCT02084797|Vasopressins|vasopressins|mesh-list
154795281|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
154795282|NCT02084797|Tolvaptan|tolvaptan|mesh-list
154795283|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
154795284|NCT02084797|Coagulants|coagulants|mesh-ancestor
154795285|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154795286|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154795287|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
154795288|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795289|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154795290|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795291|NCT00873327|Tazobactam|tazobactam|mesh-list
154795292|NCT00873327|Piperacillin|piperacillin|mesh-list
154795293|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154795294|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795295|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795296|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154795297|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795298|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795299|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
154795300|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154795301|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795302|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
154795303|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154795304|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795305|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154795306|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795307|NCT00841971|Fluconazole|fluconazole|mesh-list
154795308|NCT00841971|Anidulafungin|anidulafungin|mesh-list
154795309|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
154795310|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795311|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154795312|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154795313|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795314|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795315|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154795316|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
154795317|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795318|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795319|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154795320|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154795321|NCT00842751|Finasteride|finasteride|mesh-list
154795322|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154795323|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154795324|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795325|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795326|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
154795327|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795328|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795329|NCT00842751|Urological Agents|urological agents|mesh-ancestor
154795330|NCT03104010|Hormones|hormones|mesh-list
154795331|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795332|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795333|NCT04399213|Histamine|histamine|mesh-list
154795334|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
154795335|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
154795336|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
154795337|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795338|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795339|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795340|NCT02154243|Midodrine|midodrine|mesh-list
154795341|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
154795342|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
154795343|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795344|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795345|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154795346|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154795347|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154795348|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153974747|NCT04659603|Gemcitabine|gemcitabine|mesh-list
154795349|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795350|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795351|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795352|NCT03995004|Dexamethasone|dexamethasone|mesh-list
154795353|NCT03995004|Melatonin|melatonin|mesh-list
154795354|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
154795355|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154795356|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
154795357|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
154795358|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795359|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795360|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154795361|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
154795362|NCT03995004|Hormones|hormones|mesh-ancestor
154795363|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795364|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154795365|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795366|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
154795367|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795368|NCT03995004|Protective Agents|protective agents|mesh-ancestor
154795369|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154795370|NCT03995004|Cathartics|cathartics|mesh-ancestor
154795371|NCT03216447|Tacrolimus|tacrolimus|mesh-list
154795372|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795373|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
154795374|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795375|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154795376|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795377|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795378|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
154795379|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795380|NCT03957876|Cytarabine|cytarabine|mesh-list
154795381|NCT03957876|Daunorubicin|daunorubicin|mesh-list
154795382|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154795383|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
154795384|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795385|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795386|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
154795387|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795388|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795389|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
154795390|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795391|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154795392|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154795393|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154795394|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795395|NCT03837925|Atorvastatin|atorvastatin|mesh-list
154795396|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154795397|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154795398|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
154795399|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795400|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154795401|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154795402|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795403|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
154795404|NCT04398589|Ropivacaine|ropivacaine|mesh-list
154795405|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154795406|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154795407|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795408|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154795409|NCT04398589|Analgesics|analgesics|mesh-ancestor
154795410|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
154795411|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795412|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153974809|NCT04494425|Capecitabine|capecitabine|mesh-list
154795413|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154795414|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154795415|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795416|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795417|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795418|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
154795419|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
154795420|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
154795421|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
154795422|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154795423|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154795424|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795425|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795426|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154795427|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154795428|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795429|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795430|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795431|NCT00875277|Betamethasone|betamethasone|mesh-list
154795432|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
154795433|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154795434|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
154795435|NCT00875277|Calcipotriene|calcipotriene|mesh-list
154795436|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154795437|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154795438|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
154795439|NCT00875277|Hormones|hormones|mesh-ancestor
154795440|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795441|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795442|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154795443|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795444|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
154795445|NCT04457245|Fluorides|fluorides|mesh-list
154795446|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
154795447|NCT04457245|Protective Agents|protective agents|mesh-ancestor
154795448|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795449|NCT01395017|Dasatinib|dasatinib|mesh-list
154795450|NCT01395017|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154795451|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154795452|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795453|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795454|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795455|NCT03235986|Poractant alfa|poractant alfa|mesh-list
154795456|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154795457|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795458|NCT03600090|Paclitaxel|paclitaxel|mesh-list
154795459|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154795460|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795461|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
154795462|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
154795463|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
154795464|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795465|NCT02912988|Letrozole|letrozole|mesh-list
154795466|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795467|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154795468|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154795469|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795470|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795471|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154795472|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
154795473|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795474|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795475|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154795476|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154795477|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154795478|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154795479|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795480|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
154795481|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795482|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795483|NCT00876915|Dalteparin|dalteparin|mesh-list
154795484|NCT00876915|Tinzaparin|tinzaparin|mesh-list
154795485|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154795486|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
154795487|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154795488|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154795489|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795490|NCT02854488|Ipilimumab|ipilimumab|mesh-list
154795491|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154795492|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795493|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154795494|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795495|NCT00896181|Carboplatin|carboplatin|mesh-list
154795496|NCT00896181|Docetaxel|docetaxel|mesh-list
154795497|NCT00896181|Fluorouracil|fluorouracil|mesh-list
154795498|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795499|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
154795500|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
154795501|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
154795502|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795503|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
154795504|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154795505|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795506|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
154795507|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795508|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154795509|NCT02647320|Firuglipel|firuglipel|mesh-list
154795510|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154795511|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795512|NCT02647320|Incretins|incretins|mesh-ancestor
154795513|NCT02647320|Hormones|hormones|mesh-ancestor
154795514|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795515|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154795516|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
154795517|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795518|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795519|NCT03457896|Trastuzumab|trastuzumab|mesh-list
154795520|NCT03457896|Cetuximab|cetuximab|mesh-list
154795521|NCT03457896|Neratinib|neratinib|mesh-list
154795522|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154795523|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795524|NCT03457896|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154795525|NCT03457896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974951|NCT04276363|Nicotine|nicotine|mesh-list
154795526|NCT03457896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795527|NCT03457896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795528|NCT04380597|Betamethasone|betamethasone|mesh-list
154795529|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
154795530|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154795531|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
154795532|NCT04380597|Calcipotriene|calcipotriene|mesh-list
154795533|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154795534|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154795535|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
154795536|NCT04380597|Hormones|hormones|mesh-ancestor
154795537|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795538|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795539|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154795540|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795541|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
154795542|NCT03214731|Artesunate|artesunate|mesh-list
154795543|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
154795544|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154795545|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154795546|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795547|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795548|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
154795549|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
154795550|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154795551|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
154795552|NCT04424862|Cyclosporine|cyclosporine|mesh-list
154795553|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
154795554|NCT04424862|Prednisone|prednisone|mesh-list
154795555|NCT04424862|Cyclosporins|cyclosporins|mesh-list
154795556|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154795557|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
154795558|NCT04424862|Hormones|hormones|mesh-ancestor
154795559|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795560|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795561|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154795562|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795563|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795564|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795565|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795566|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
154795567|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
154795568|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795569|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
154795570|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154795571|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154795572|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154795573|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154795574|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
154795575|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795576|NCT00882687|Lifitegrast|lifitegrast|mesh-list
154795577|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154795578|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154795579|NCT04313166|Copper|copper|mesh-list
154795580|NCT04313166|Trace Elements|trace elements|mesh-ancestor
154795581|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
154795582|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795583|NCT00883233|Adapalene|adapalene|mesh-list
154795584|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154795585|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154795586|NCT00883233|Analgesics|analgesics|mesh-ancestor
154795587|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
154795588|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795589|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795590|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154795591|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154795592|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
154795593|NCT01394939|Irinotecan|irinotecan|mesh-list
154795594|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154795595|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154795596|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795597|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795598|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795599|NCT01394627|Eplerenone|eplerenone|mesh-list
154795600|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154795601|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
154795602|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795603|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795604|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154795605|NCT01394627|Diuretics|diuretics|mesh-ancestor
154795606|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
154795607|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154795608|NCT02288377|Lanreotide|lanreotide|mesh-list
154795609|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795610|NCT04133532|Metoprolol|metoprolol|mesh-list
154795611|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154795612|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154795613|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
154795614|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
154795615|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795616|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795617|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154795618|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154795619|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154795620|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795621|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795622|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795623|NCT01391663|Alogliptin|alogliptin|mesh-list
154795624|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154795625|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795626|NCT01391663|Incretins|incretins|mesh-ancestor
154795627|NCT01391663|Hormones|hormones|mesh-ancestor
154795628|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795629|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154795630|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
154795631|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795632|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795633|NCT05072106|Bosentan|bosentan|mesh-list
154795634|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154795635|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154795636|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795637|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154795638|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
154795639|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795640|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
154795641|NCT05071482|Flumatinib|flumatinib|mesh-list
154795642|NCT05071482|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154795643|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154795644|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795645|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795646|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795647|NCT03213249|Gentamicins|gentamicins|mesh-list
154795648|NCT03213249|Cefazolin|cefazolin|mesh-list
154795649|NCT03213249|Bacitracin|bacitracin|mesh-list
154795650|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795651|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795652|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154795653|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975079|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154795654|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795655|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154795656|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
154795657|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154795658|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154795659|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795660|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154795661|NCT03317067|Analgesics|analgesics|mesh-ancestor
154795662|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
154795663|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795664|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154795665|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154795666|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154795667|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795668|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795669|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795670|NCT04440007|Abivertinib|abivertinib|mesh-list
154795671|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795672|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795673|NCT04440007|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154795674|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154795675|NCT05312541|Bupivacaine|bupivacaine|mesh-list
154795676|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
154795677|NCT05312541|Anesthetics|anesthetics|mesh-list
154795678|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154795679|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795680|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
154795681|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795682|NCT04398823|Polidocanol|polidocanol|mesh-list
154795683|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154795684|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154795685|NCT04410913|Psilocybin|psilocybin|mesh-list
154795686|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
154795687|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795688|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154795689|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
154795690|NCT02013336|Irinotecan|irinotecan|mesh-list
154795691|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795692|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
154795693|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795694|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154795695|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154795696|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
154795697|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795698|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795699|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154795700|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154795701|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154795702|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795703|NCT04397653|Ezetimibe|ezetimibe|mesh-list
154795704|NCT04397653|Evolocumab|evolocumab|mesh-list
154795705|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154795706|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154795707|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
154795708|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795709|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154795710|NCT04397653|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154795711|NCT04397653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154795712|NCT04397653|Protease Inhibitors|protease inhibitors|mesh-ancestor
154795713|NCT04397653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795714|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
154795715|NCT03212781|Dextrans|dextrans|mesh-list
154795716|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
154795717|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
154795718|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
154795719|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
154795720|NCT03212781|Trace Elements|trace elements|mesh-ancestor
154795721|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
154795722|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795723|NCT03212781|Hematinics|hematinics|mesh-ancestor
154795724|NCT03212937|Carboplatin|carboplatin|mesh-list
154795725|NCT03212937|Etoposide|etoposide|mesh-list
154795726|NCT03212937|Ifosfamide|ifosfamide|mesh-list
154795727|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795728|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154795729|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154795730|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154795731|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795732|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795733|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154795734|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
154795735|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
154795736|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154795737|NCT04397341|Docetaxel|docetaxel|mesh-list
154795738|NCT04397341|Fluorouracil|fluorouracil|mesh-list
154795739|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795740|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
154795741|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
154795742|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
154795743|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795744|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
154795745|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154795746|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795747|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
154795748|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795749|NCT03940326|Levetiracetam|levetiracetam|mesh-list
154547695|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
154795750|NCT03940326|Valproic Acid|valproic acid|mesh-list
154795751|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
154795752|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
154795753|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795754|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795755|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
154795756|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795757|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795758|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
154795759|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154795760|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154795761|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154795762|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
154795763|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
154795764|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154795765|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154795766|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795767|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795768|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795769|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154795770|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154795771|NCT01473524|Cathartics|cathartics|mesh-ancestor
154795772|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154795773|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154795774|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
154795775|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795776|NCT03696355|GDC-0084|gdc-0084|mesh-list
154795777|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795778|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795779|NCT03882996|Atorvastatin|atorvastatin|mesh-list
154795780|NCT03882996|Ezetimibe|ezetimibe|mesh-list
154795781|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154795782|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154795783|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
154795784|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795785|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154795786|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154795787|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795788|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154795789|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154795790|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154795791|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154795792|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795793|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154795794|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154795795|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154795796|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154795797|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795798|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795799|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795800|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154795801|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154795802|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
154795803|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154795804|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154795805|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
154795806|NCT05070468|Dexamethasone|dexamethasone|mesh-list
154795807|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154795808|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
154795809|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
154795810|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795811|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795812|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154795813|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
154795814|NCT05070468|Hormones|hormones|mesh-ancestor
154795815|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154795816|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154795817|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795818|NCT01390181|Losartan|losartan|mesh-list
154795819|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154795820|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154795821|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154795822|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154795823|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795824|NCT02641080|Aspirin|aspirin|mesh-list
154795825|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154795826|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154795827|NCT02641080|Analgesics|analgesics|mesh-ancestor
154795828|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
154795829|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795830|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795831|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154795832|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154795833|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154795834|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154795835|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795836|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154795837|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154795838|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795839|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
154795840|NCT03101280|Atezolizumab|atezolizumab|mesh-list
154795841|NCT03101280|Rucaparib|rucaparib|mesh-list
154795842|NCT03101280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154795843|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795844|NCT03101280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154795845|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795846|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154795847|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795848|NCT04015739|Bevacizumab|bevacizumab|mesh-list
154795849|NCT04015739|Durvalumab|durvalumab|mesh-list
154795850|NCT04015739|Olaparib|olaparib|mesh-list
154795851|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154795852|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795853|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154795854|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154795855|NCT04015739|Growth Substances|growth substances|mesh-ancestor
154795856|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795857|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
154795858|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154795859|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795860|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795861|NCT03867318|Atorvastatin|atorvastatin|mesh-list
154795862|NCT03867318|Ezetimibe|ezetimibe|mesh-list
154795863|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154795864|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154795865|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
154795866|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795867|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154795868|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154795869|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795870|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154795871|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795872|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154795873|NCT04381377|Bromides|bromides|mesh-list
154795874|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
154795875|NCT01457846|Paclitaxel|paclitaxel|mesh-list
154795876|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154795877|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795878|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
154795879|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
154795880|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
154795881|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795882|NCT04032119|Epinephrine|epinephrine|mesh-list
154795883|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154795884|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154795885|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
154795886|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795887|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795888|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795889|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154795890|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154795891|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
154795892|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795893|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154795894|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
154795895|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
154795896|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
154795897|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154795898|NCT03211455|Lidocaine|lidocaine|mesh-list
154547836|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154795899|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
154795900|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
154795901|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154795902|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795903|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
154795904|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154795905|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154795906|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154795907|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154795908|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154795909|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795910|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
153975336|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795911|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154795912|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795913|NCT03172819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154795914|NCT03172819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795915|NCT01389323|Interferons|interferons|mesh-list
154795916|NCT01389323|Ribavirin|ribavirin|mesh-list
154795917|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
154795918|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
154795919|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154795920|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795921|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
154795922|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795923|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
154795924|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795925|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
154795926|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795927|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154795928|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
154795929|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154795930|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154795931|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795932|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
154795933|NCT02638389|Sirolimus|sirolimus|mesh-list
154795934|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154795935|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795936|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154795937|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795938|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
154795939|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795940|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
154795941|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795942|NCT01494584|Ezogabine|ezogabine|mesh-list
154795943|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
154795944|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154795945|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795946|NCT03211143|Esomeprazole|esomeprazole|mesh-list
154795947|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154795948|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154795949|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154795950|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795951|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795952|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154795953|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154795954|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154795955|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
154795956|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154795957|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795958|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154795959|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154795960|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
154795961|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154795962|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154795963|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
154795964|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
154795965|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154795966|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154795967|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154795968|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795969|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154795970|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154795971|NCT00893997|Vaccines|vaccines|mesh-list
154795972|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
154795973|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795974|NCT00512317|Ganaxolone|ganaxolone|mesh-list
154795975|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
154795976|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154795977|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795978|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795979|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
154795980|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
154795981|NCT01494506|Leucovorin|leucovorin|mesh-list
154795982|NCT01494506|Fluorouracil|fluorouracil|mesh-list
154795983|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
154795984|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154795985|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154795986|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154795987|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154795988|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
154795989|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154795990|NCT01494506|Antidotes|antidotes|mesh-ancestor
154795991|NCT01494506|Protective Agents|protective agents|mesh-ancestor
154795992|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
154795993|NCT01494506|Vitamins|vitamins|mesh-ancestor
154795994|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
154795995|NCT03024905|Misoprostol|misoprostol|mesh-list
154795996|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154795997|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
154795998|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154795999|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796000|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154796001|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154796002|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
154796003|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
154796004|NCT02643420|Docetaxel|docetaxel|mesh-list
154796005|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154796006|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
154796007|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796008|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154796009|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154796010|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
154796011|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796012|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796013|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154796014|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
154796015|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
154796016|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
154796017|NCT01830465|Rituximab|rituximab|mesh-list
154796018|NCT01830465|Bortezomib|bortezomib|mesh-list
154796019|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796020|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796021|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
154796022|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796023|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154796024|NCT00894465|Midazolam|midazolam|mesh-list
154796025|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154796026|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154796027|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796028|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796029|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154796030|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154796031|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154796032|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154796033|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
154796034|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
154796035|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
154796036|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
154796037|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796038|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796039|NCT01456130|Alogliptin|alogliptin|mesh-list
154796040|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
154796041|NCT01456130|Secretagogues|secretagogues|mesh-list
154796042|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154796043|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796044|NCT01456130|Incretins|incretins|mesh-ancestor
154796045|NCT01456130|Hormones|hormones|mesh-ancestor
154796046|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796047|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154796048|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
154796049|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796050|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796051|NCT03219645|Aspirin|aspirin|mesh-list
154796052|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154796053|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796054|NCT03219645|Analgesics|analgesics|mesh-ancestor
154796055|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
154796056|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796057|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796058|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796059|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154796060|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154796061|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154796062|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796063|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154796064|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154796065|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796066|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
154796067|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
154796068|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154796069|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796070|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154796071|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154796072|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796073|NCT01387607|Pregabalin|pregabalin|mesh-list
154796074|NCT01387607|Analgesics|analgesics|mesh-ancestor
154796075|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
154796076|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796077|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796078|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
154796079|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154796080|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796081|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796082|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154796083|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154796084|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154796085|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796086|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154796087|NCT05069454|Vaccines|vaccines|mesh-list
154796088|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
154796089|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796090|NCT05069688|Rifampin|rifampin|mesh-list
154796091|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154796092|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
154796093|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154796094|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796095|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
154796096|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154796097|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975523|NCT06043674|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154796098|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796099|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154796100|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154796101|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154796102|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154796103|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154796104|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154796105|NCT01830777|Cytarabine|cytarabine|mesh-list
154796106|NCT01830777|Etoposide|etoposide|mesh-list
154796107|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
154796108|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154796109|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154796110|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796111|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154796112|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154796113|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796114|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796115|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154796116|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
154796117|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
154796118|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796119|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154796120|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
154796121|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796122|NCT01830777|Analgesics|analgesics|mesh-ancestor
154796123|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
154796124|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548072|NCT04934618|Irinotecan|irinotecan|mesh-list
154796125|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796127|NCT01830777|Immunoconjugates|immunoconjugates|mesh-ancestor
154796128|NCT03218631|Oxandrolone|oxandrolone|mesh-list
154796129|NCT03218631|Androgens|androgens|mesh-ancestor
154796130|NCT03218631|Hormones|hormones|mesh-ancestor
154796131|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796132|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796133|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
154796134|NCT03451045|Dronabinol|dronabinol|mesh-list
154796135|NCT03451045|Lenabasum|lenabasum|mesh-list
154796136|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154796137|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154796138|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796139|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796140|NCT03451045|Hormones|hormones|mesh-ancestor
154796141|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796142|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796143|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
154796144|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154796145|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796146|NCT03451045|Analgesics|analgesics|mesh-ancestor
154796147|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
154796148|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796149|NCT01831011|Aspirin|aspirin|mesh-list
154796150|NCT01831011|Cinepazide|cinepazide|mesh-list
154796151|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
154796152|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154796153|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796154|NCT01831011|Analgesics|analgesics|mesh-ancestor
154796155|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
154796156|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796157|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796158|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796159|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154796160|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154796161|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154796162|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796163|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154796164|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154796165|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796166|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
154796167|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
154796168|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154796169|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
154796170|NCT03218709|Vitamins|vitamins|mesh-list
154796171|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
154796172|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796173|NCT03218553|Dexamethasone|dexamethasone|mesh-list
154796174|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796175|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
154796176|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
154796177|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796178|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796179|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154796180|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
154796181|NCT03218553|Hormones|hormones|mesh-ancestor
154796182|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796183|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154796184|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796185|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
154796186|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796187|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
154796188|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154796189|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154796190|NCT01831323|Rifaximin|rifaximin|mesh-list
154796191|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154796192|NCT01831323|Mesalamine|mesalamine|mesh-list
154796193|NCT01831323|Psyllium|psyllium|mesh-list
154796194|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796195|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154796196|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154796197|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796198|NCT01831323|Analgesics|analgesics|mesh-ancestor
154796199|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
154548134|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154796200|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796201|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796202|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154796203|NCT01831323|Cathartics|cathartics|mesh-ancestor
154796204|NCT03221400|Leucovorin|leucovorin|mesh-list
154796205|NCT03221400|Folic Acid|folic acid|mesh-list
154796206|NCT03221400|Fluorouracil|fluorouracil|mesh-list
154796207|NCT03221400|Niraparib|niraparib|mesh-list
154796208|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
154796209|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
154796210|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796211|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154796212|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796213|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154796214|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
154796215|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796216|NCT03221400|Antidotes|antidotes|mesh-ancestor
154796217|NCT03221400|Protective Agents|protective agents|mesh-ancestor
154796218|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
154796219|NCT03221400|Vitamins|vitamins|mesh-ancestor
154796220|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
154796221|NCT03221400|Hematinics|hematinics|mesh-ancestor
154796222|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154796223|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796224|NCT01384877|Lidocaine|lidocaine|mesh-list
154796225|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
154796226|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
154796227|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796228|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796229|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
154796230|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796231|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154796232|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154796233|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154796234|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796235|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796236|NCT00114517|Hormones|hormones|mesh-list
154796237|NCT00114517|Estradiol|estradiol|mesh-list
154796238|NCT00114517|Estrogens|estrogens|mesh-list
154796239|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796240|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796241|NCT01831479|Olmesartan|olmesartan|mesh-list
154796242|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154796243|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154796244|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154796245|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154796246|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
154796247|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796248|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154796249|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154796250|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796251|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154796252|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154796253|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154796254|NCT03099720|Ropivacaine|ropivacaine|mesh-list
154796255|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
154796256|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
154796257|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796258|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796259|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
154796260|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796261|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
154796262|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154796263|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796264|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796265|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796266|NCT03025295|Analgesics|analgesics|mesh-ancestor
154796267|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
154796268|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796269|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154796270|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154796271|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154796272|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
154796273|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796274|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796275|NCT01471574|Interferons|interferons|mesh-list
154796276|NCT01471574|Ribavirin|ribavirin|mesh-list
154796277|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
154796278|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
154796279|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154796280|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796281|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
154796282|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796283|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
154796284|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796285|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
154796286|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796287|NCT01383707|Leucovorin|leucovorin|mesh-list
154796288|NCT01383707|Bevacizumab|bevacizumab|mesh-list
154796289|NCT01383707|Fluorouracil|fluorouracil|mesh-list
154796290|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
154796291|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
154796292|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796293|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796294|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154796295|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154796296|NCT01383707|Growth Substances|growth substances|mesh-ancestor
154796297|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796298|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
154796299|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
154796300|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796301|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154796302|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154796303|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
154796304|NCT01383707|Antidotes|antidotes|mesh-ancestor
154796305|NCT01383707|Protective Agents|protective agents|mesh-ancestor
154796306|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
154796307|NCT01383707|Vitamins|vitamins|mesh-ancestor
154796308|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
154796309|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
154796310|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154796311|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
154796312|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154796313|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
154796314|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796315|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796316|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
154796317|NCT03306901|Fluorouracil|fluorouracil|mesh-list
154796318|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796319|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
154796320|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796321|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154796322|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154796323|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
154796324|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796325|NCT01455428|Pregabalin|pregabalin|mesh-list
154796326|NCT01455428|Analgesics|analgesics|mesh-ancestor
154796327|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
154796328|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796329|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796330|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
154796331|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154796332|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796333|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796334|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153975784|NCT04641975|Mirabegron|mirabegron|mesh-list
154796335|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154796336|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154796337|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796338|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154796339|NCT01831947|Ranibizumab|ranibizumab|mesh-list
154796340|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154796341|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154796342|NCT01831947|Growth Substances|growth substances|mesh-ancestor
154796343|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796344|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
154796345|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796346|NCT01383161|Curcumin|curcumin|mesh-list
154796347|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154796348|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796349|NCT01383161|Analgesics|analgesics|mesh-ancestor
154796350|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
154796351|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796352|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796353|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796354|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154796355|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796356|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796357|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796358|NCT00894699|Sufentanil|sufentanil|mesh-list
154796359|NCT00894699|Triazolam|triazolam|mesh-list
154796360|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154796361|NCT00894699|Narcotics|narcotics|mesh-ancestor
154796362|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796363|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796364|NCT00894699|Analgesics|analgesics|mesh-ancestor
154796365|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
154796366|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796367|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154796368|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154796369|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
154796370|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
154796371|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154796372|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154796373|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154796374|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
154796375|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
154796376|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796377|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796378|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
154796379|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796380|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796381|NCT03087019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154796382|NCT03087019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796383|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154796384|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
154796385|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154796386|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154796387|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
154796388|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796389|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
154796390|NCT01382225|Protective Agents|protective agents|mesh-ancestor
154796391|NCT01381679|Ezetimibe|ezetimibe|mesh-list
154796392|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154796393|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154796394|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
154796395|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796396|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154796397|NCT01832415|Bevacizumab|bevacizumab|mesh-list
154796398|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796399|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796400|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154796401|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154796402|NCT01832415|Growth Substances|growth substances|mesh-ancestor
154796403|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796404|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
154796405|NCT01455194|Ciclesonide|ciclesonide|mesh-list
154796406|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
154796407|NCT01455194|Hormones|hormones|mesh-ancestor
154796408|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796409|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796410|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154796411|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
154796412|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154796413|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796414|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796415|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796416|NCT03216759|Analgesics|analgesics|mesh-ancestor
154796417|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
154796418|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796419|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154796420|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154796421|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154796422|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
154796423|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796424|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796425|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154796426|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154796427|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154796428|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796429|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796431|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796432|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154796433|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154796434|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154796435|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154796436|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796437|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154796438|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
154796439|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796440|NCT05368805|Dabigatran|dabigatran|mesh-list
154796441|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154796442|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154796443|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154796444|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
154796445|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796446|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154796447|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154796448|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796449|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
154796450|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154796451|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
154796452|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
154796453|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
154796454|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
154796455|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796456|NCT01839981|Protective Agents|protective agents|mesh-ancestor
154796457|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796458|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
154796459|NCT01839981|Vitamins|vitamins|mesh-ancestor
154796460|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
154796461|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
154796462|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
154796463|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154796464|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
154796465|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796466|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796467|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154796468|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
154796469|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154796470|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154796471|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154796472|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
154796473|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796474|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796475|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154796476|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154796477|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154796478|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
154796479|NCT01494350|Gentamicins|gentamicins|mesh-list
154796480|NCT01494350|Paromomycin|paromomycin|mesh-list
154796481|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154796482|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796483|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154796484|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796485|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796486|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154796487|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154796488|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154796489|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796490|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
154796491|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
154796492|NCT03258385|Vitamins|vitamins|mesh-ancestor
154796493|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
154796494|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796495|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
154796496|NCT03258385|Hematinics|hematinics|mesh-ancestor
154796497|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
154796498|NCT03024515|Narcotics|narcotics|mesh-ancestor
154796499|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548441|NCT02148913|Melphalan|melphalan|mesh-list
154796500|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796502|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
154796503|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796504|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
154796505|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154796506|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154796507|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796508|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796509|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
154796510|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796511|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796512|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
154796513|NCT04287829|Lenvatinib|lenvatinib|mesh-list
154796514|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796515|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796516|NCT04287829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154796517|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796518|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154796519|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796520|NCT05367869|Methylene Blue|methylene blue|mesh-list
154796521|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796522|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796523|NCT01720095|Niacin|niacin|mesh-list
154796524|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
154796525|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154796526|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
154796527|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796528|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154796529|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
154796530|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
154796531|NCT01720095|Vitamins|vitamins|mesh-ancestor
154796532|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
154796533|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796534|NCT03836157|Bevacizumab|bevacizumab|mesh-list
154796535|NCT03836157|Maytansine|maytansine|mesh-list
154796536|NCT03836157|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154796537|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796538|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796539|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154796540|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154796541|NCT03836157|Growth Substances|growth substances|mesh-ancestor
154796542|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796543|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
154796544|NCT03836157|Immunoconjugates|immunoconjugates|mesh-ancestor
154796545|NCT03836157|Immunologic Factors|immunologic factors|mesh-ancestor
154796546|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154796547|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
154796548|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
154796549|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
154796550|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796551|NCT03080545|Calcitriol|calcitriol|mesh-list
154796552|NCT03080545|Betamethasone|betamethasone|mesh-list
154796553|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154796554|NCT03080545|Calcipotriene|calcipotriene|mesh-list
154796555|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796556|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
154796557|NCT03080545|Hormones|hormones|mesh-ancestor
154796558|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796559|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796560|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154796561|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
154796562|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154796563|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154796564|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796565|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796566|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154796567|NCT03080545|Vitamins|vitamins|mesh-ancestor
154796568|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
154796569|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154796570|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
154796571|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
154796572|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154796573|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154796574|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796576|NCT03101124|Coagulants|coagulants|mesh-ancestor
154796577|NCT02985203|Vinorelbine|vinorelbine|mesh-list
154796578|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154796579|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796580|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
154796581|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
154796582|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
154796583|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796584|NCT01833039|Ibrutinib|ibrutinib|mesh-list
154796585|NCT01833039|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154796586|NCT01833039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154796587|NCT01833039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796588|NCT01833039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796589|NCT05247619|Paclitaxel|paclitaxel|mesh-list
154796590|NCT05247619|Bevacizumab|bevacizumab|mesh-list
154796591|NCT05247619|Carboplatin|carboplatin|mesh-list
154796592|NCT05247619|Tislelizumab|tislelizumab|mesh-list
154796593|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154796594|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796595|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
154796596|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
154796597|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
154796598|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796599|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796600|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154796601|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154796602|NCT05247619|Growth Substances|growth substances|mesh-ancestor
154796603|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796604|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
154796605|NCT00805584|Desloratadine|desloratadine|mesh-list
154796606|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154796607|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
154796608|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796609|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796610|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796611|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154796612|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154796613|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
154796614|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
154796615|NCT01833351|Vitamins|vitamins|mesh-list
154796616|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
154796617|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
154796618|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796619|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
154796620|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796621|NCT01833351|Protective Agents|protective agents|mesh-ancestor
154796622|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
154796623|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796624|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154796625|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154796626|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154796627|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796628|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796629|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
154796630|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796631|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796632|NCT00795522|Desloratadine|desloratadine|mesh-list
154796633|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154796634|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
154796635|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796636|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796637|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796638|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154796639|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154796640|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
154796641|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
154796642|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
154796643|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154796644|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154796645|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154548593|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154796646|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796647|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796648|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
154796649|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796650|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796651|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154796652|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796654|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
154796655|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
154796656|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796657|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796658|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154796659|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154796660|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154796661|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796662|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154796663|NCT05243251|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154796664|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154796665|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796666|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796667|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796668|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
154796669|NCT05242705|Cystatins|cystatins|mesh-list
154796670|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154796671|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
154796672|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796673|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796674|NCT00216671|Risperidone|risperidone|mesh-list
154796675|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154796676|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
154796677|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796678|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796679|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796680|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154796681|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154796682|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796683|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154796684|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154796685|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
154796686|NCT00783354|Loratadine|loratadine|mesh-list
154796687|NCT00783354|Desloratadine|desloratadine|mesh-list
154796688|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154796689|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
154796690|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796691|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796692|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796693|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154796694|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154796695|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
154796696|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
154796697|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
154796698|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
154796699|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154796700|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
154796701|NCT01833663|Estrogens|estrogens|mesh-list
154796702|NCT01833663|Hormones|hormones|mesh-ancestor
154796703|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796704|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796705|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154796706|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154796707|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
154796708|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796709|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796710|NCT01833663|Urological Agents|urological agents|mesh-ancestor
154796711|NCT01720875|Dexamethasone|dexamethasone|mesh-list
154796712|NCT01720875|Bortezomib|bortezomib|mesh-list
154796713|NCT01720875|Vorinostat|vorinostat|mesh-list
154796714|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796715|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
154796716|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
154796717|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796718|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796719|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154796720|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
154796721|NCT01720875|Hormones|hormones|mesh-ancestor
154796722|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796723|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154796724|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796725|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154796726|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796727|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796728|NCT04277143|Daptomycin|daptomycin|mesh-list
154796729|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154796730|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796731|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
154796732|NCT00750750|Amoxicillin|amoxicillin|mesh-list
154796733|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154796734|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796735|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796736|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
154796737|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154796738|NCT05066802|Folfirinox|folfirinox|mesh-list
154796739|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796740|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154796741|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796742|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796743|NCT05248633|Dexamethasone|dexamethasone|mesh-list
154796744|NCT05248633|Lenalidomide|lenalidomide|mesh-list
154796745|NCT05248633|Bortezomib|bortezomib|mesh-list
154796746|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796747|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
154796748|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
154796749|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796750|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796751|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154796752|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
154796753|NCT05248633|Hormones|hormones|mesh-ancestor
154796754|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796755|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154796756|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796757|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
154796758|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154796759|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154796760|NCT05248633|Growth Substances|growth substances|mesh-ancestor
154796761|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
154796762|NCT00216203|Pemetrexed|pemetrexed|mesh-list
154796763|NCT00216203|Cetuximab|cetuximab|mesh-list
154796764|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796765|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796766|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796767|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154796768|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154796769|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154796770|NCT01727271|Interferons|interferons|mesh-list
154796771|NCT01727271|Tenofovir|tenofovir|mesh-list
154796772|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
154796773|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
154796774|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154796775|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796776|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
154796777|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796778|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154796779|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154796780|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796781|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796782|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154796783|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154796784|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
154796785|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796786|NCT00653796|Atorvastatin|atorvastatin|mesh-list
154796787|NCT00653796|Ezetimibe|ezetimibe|mesh-list
154796788|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154796789|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154796790|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
154796791|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796792|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154796793|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153976274|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
154796794|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796795|NCT01833819|Lidocaine|lidocaine|mesh-list
154796796|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
154796797|NCT01833819|Remifentanil|remifentanil|mesh-list
154796798|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
154796799|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
154796800|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796801|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796802|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
154796803|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796804|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154796805|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154796806|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154796807|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154796808|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796809|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154796810|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796811|NCT01833819|Analgesics|analgesics|mesh-ancestor
154796812|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154796813|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154796814|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154796815|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
154796816|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796817|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154796818|NCT01833819|Narcotics|narcotics|mesh-ancestor
154796820|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
154796821|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
154796822|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796823|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154796824|NCT00651144|Ezetimibe|ezetimibe|mesh-list
154796825|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154796826|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154796827|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
154796828|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796829|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154796830|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154796831|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796832|NCT01721031|Tramadol|tramadol|mesh-list
154796833|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154796834|NCT01721031|Narcotics|narcotics|mesh-ancestor
154796835|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796836|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796837|NCT01721031|Analgesics|analgesics|mesh-ancestor
154796838|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
154796839|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796840|NCT03218683|Venetoclax|venetoclax|mesh-list
154796841|NCT03218683|AZD5991|azd5991|mesh-list
154796842|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796843|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
154796844|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
154796845|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796846|NCT00370890|Gemcitabine|gemcitabine|mesh-list
154796847|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796848|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154796849|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
154796850|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796851|NCT02669953|Aflibercept|aflibercept|mesh-list
154796852|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154796853|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154796854|NCT02669953|Growth Substances|growth substances|mesh-ancestor
154796855|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796856|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
154796857|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796858|NCT01721655|Spironolactone|spironolactone|mesh-list
154796859|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154796860|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
154796861|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796862|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796863|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154796864|NCT01721655|Diuretics|diuretics|mesh-ancestor
154796865|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
154796866|NCT00904995|Voriconazole|voriconazole|mesh-list
154796867|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
154796868|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796869|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154796870|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154796871|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796872|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796873|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154796874|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
154796875|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796876|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796877|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154796879|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
154796880|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796881|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154796882|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154796883|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796884|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154796885|NCT05249725|Protective Agents|protective agents|mesh-ancestor
154796886|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796887|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154796888|NCT05249725|Antacids|antacids|mesh-ancestor
154796889|NCT01834209|Prednisone|prednisone|mesh-list
154796890|NCT01834209|Prednisolone|prednisolone|mesh-list
154796891|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
154796892|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796893|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
154796894|NCT01834209|Hormones|hormones|mesh-ancestor
154796895|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154796896|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796897|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154796898|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796899|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154796900|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154796901|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796902|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
154796903|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154796904|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
154796905|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154796906|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796907|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154796908|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154796909|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976389|NCT00628706|Hormones|hormones|mesh-ancestor
154796910|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796911|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796912|NCT02488135|Hemostatics|hemostatics|mesh-list
154796913|NCT02488135|Coagulants|coagulants|mesh-ancestor
154796914|NCT01727973|Doxycycline|doxycycline|mesh-list
154796915|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154796916|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796917|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
154796918|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154796919|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154796920|NCT03100734|Etanercept|etanercept|mesh-list
154796921|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154796922|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154796923|NCT03100734|Analgesics|analgesics|mesh-ancestor
154796924|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
154796925|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796926|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796927|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154796928|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154796929|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154796930|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154796931|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
154796932|NCT05243706|Loratadine|loratadine|mesh-list
154796933|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
154796934|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
154796935|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154796936|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154796937|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154796938|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
154796939|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
154796940|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796941|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796942|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796943|NCT01728051|Melphalan|melphalan|mesh-list
154796944|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154796945|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
154796946|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796947|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796948|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154796949|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154796950|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
154796951|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796952|NCT01722201|Risperidone|risperidone|mesh-list
154796953|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154796954|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
154796955|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154796956|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796957|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796958|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154796959|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154796960|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796961|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154796962|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154796963|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
154796964|NCT01722513|Alprostadil|alprostadil|mesh-list
154796965|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154796966|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
154796967|NCT01722513|Urological Agents|urological agents|mesh-ancestor
154796968|NCT01728441|Paclitaxel|paclitaxel|mesh-list
154796969|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154796970|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154796971|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154796972|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154796973|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154796974|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154796975|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154796976|NCT03099408|Metronidazole|metronidazole|mesh-list
154796977|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796978|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154796979|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154796980|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154796981|NCT04984200|Mydriatics|mydriatics|mesh-list
154796982|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
154796983|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796984|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796985|NCT00912873|Ropivacaine|ropivacaine|mesh-list
154796986|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
154796987|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
154796988|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154796989|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154796990|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
154796991|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154796992|NCT01494038|Isoniazid|isoniazid|mesh-list
154796993|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
154796994|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154796995|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154796996|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154796997|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154796998|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
154796999|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797000|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154797001|NCT05059782|Coal Tar|coal tar|mesh-list
154797002|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
154797003|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
154797004|NCT05242081|Sufentanil|sufentanil|mesh-list
154797005|NCT05242081|Ketamine|ketamine|mesh-list
154797006|NCT05242081|Esketamine|esketamine|mesh-list
154797007|NCT05242081|Analgesics|analgesics|mesh-ancestor
154797008|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
154797009|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797010|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797011|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154797012|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154797013|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
154797014|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
154797015|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154797016|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154797017|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154797018|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797019|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797020|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154797022|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154797023|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
154797024|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154797025|NCT04412304|Dalteparin|dalteparin|mesh-list
154797026|NCT04412304|Tinzaparin|tinzaparin|mesh-list
154797027|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154797028|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
154797029|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154797030|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154797031|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797032|NCT00915603|Paclitaxel|paclitaxel|mesh-list
154797033|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154797034|NCT00915603|Bevacizumab|bevacizumab|mesh-list
154797035|NCT00915603|Everolimus|everolimus|mesh-list
154797036|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154797037|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797038|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
154797039|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
154797040|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797041|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797042|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154797043|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154797044|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154797045|NCT00915603|Growth Substances|growth substances|mesh-ancestor
154797046|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797047|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
154797048|NCT00915603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154797049|NCT00915603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154797050|NCT00915603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797051|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797052|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
154797053|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154797054|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154797055|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
154797056|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797057|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797058|NCT01929421|Gemcitabine|gemcitabine|mesh-list
154797059|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154797060|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
154797061|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797062|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797063|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
154797064|NCT04474002|Cathartics|cathartics|mesh-ancestor
154797065|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154797066|NCT01929577|Peficitinib|peficitinib|mesh-list
154797067|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797068|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797069|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797070|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
154797071|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797072|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154797073|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797074|NCT03836703|Iron|iron|mesh-list
154797075|NCT03836703|Trace Elements|trace elements|mesh-ancestor
154797076|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
154797077|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797078|NCT02398825|Ponatinib|ponatinib|mesh-list
154797079|NCT02398825|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154797080|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154797081|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797082|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797083|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797084|NCT01723059|Amoxicillin|amoxicillin|mesh-list
154797085|NCT01723059|Metronidazole|metronidazole|mesh-list
154797086|NCT01723059|Clarithromycin|clarithromycin|mesh-list
154797087|NCT01723059|Omeprazole|omeprazole|mesh-list
154797088|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154797089|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797090|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154797091|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154797092|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154797093|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154797094|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154797095|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797096|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797097|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154797098|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154797099|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154797100|NCT04379271|Calcium|calcium|mesh-list
154797101|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154797102|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797103|NCT01728909|Oxytocin|oxytocin|mesh-list
154797104|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
154797105|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154797106|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797107|NCT01922713|Vitamin A|vitamin a|mesh-list
154797108|NCT01922713|Beta Carotene|beta carotene|mesh-list
154797109|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
154797110|NCT01922713|Vitamins|vitamins|mesh-ancestor
154797111|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
154797112|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797113|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
154797114|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797115|NCT01922713|Protective Agents|protective agents|mesh-ancestor
154797116|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154797117|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797118|NCT01922713|Provitamins|provitamins|mesh-ancestor
154797119|NCT05061732|Amoxicillin|amoxicillin|mesh-list
154797120|NCT05061732|Metronidazole|metronidazole|mesh-list
154797121|NCT05061732|Clarithromycin|clarithromycin|mesh-list
154797122|NCT05061732|Doxycycline|doxycycline|mesh-list
154797123|NCT05061732|Levofloxacin|levofloxacin|mesh-list
154797124|NCT05061732|Tetracycline|tetracycline|mesh-list
154797125|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
154797126|NCT05061732|Rabeprazole|rabeprazole|mesh-list
154797127|NCT05061732|Bismuth|bismuth|mesh-list
154797128|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797129|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154797130|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797131|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154797132|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154797133|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154797134|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797135|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154797136|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154797137|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
154797138|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154797139|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154797140|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154797141|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797142|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154797143|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154797144|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154797145|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154797146|NCT05061732|Antacids|antacids|mesh-ancestor
154797147|NCT05061732|Diuretics|diuretics|mesh-ancestor
154797148|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
154797149|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797150|NCT05061732|Expectorants|expectorants|mesh-ancestor
154797151|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797152|NCT02391571|Naltrexone|naltrexone|mesh-list
154797153|NCT02391571|Oxycodone|oxycodone|mesh-list
154797154|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154797155|NCT02391571|Narcotics|narcotics|mesh-ancestor
154797156|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154797157|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797158|NCT02391571|Analgesics|analgesics|mesh-ancestor
154797159|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
154797160|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797161|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154797162|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154797163|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
154797164|NCT01728987|Vitamin D|vitamin d|mesh-list
154797165|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154797166|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797167|NCT01728987|Vitamins|vitamins|mesh-ancestor
154797168|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
154797169|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154797170|NCT01834989|Mitogens|mitogens|mesh-list
154797171|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797172|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797173|NCT01835067|Ranibizumab|ranibizumab|mesh-list
154549128|NCT03202719|Vaccines|vaccines|mesh-list
154797174|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154797175|NCT01835067|Plasminogen|plasminogen|mesh-list
154797176|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154797177|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154797178|NCT01835067|Growth Substances|growth substances|mesh-ancestor
154797179|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797180|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
154797181|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797182|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154797183|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154797184|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797185|NCT03100422|Armin|armin|mesh-list
154797186|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154797187|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797188|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797189|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
154797190|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797191|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797192|NCT00639769|Cisplatin|cisplatin|mesh-list
154797193|NCT00639769|Irinotecan|irinotecan|mesh-list
154797194|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797195|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154797196|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154797197|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797198|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797199|NCT01723371|Carvedilol|carvedilol|mesh-list
154797200|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154797201|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154797202|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
154797203|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797204|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797205|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797206|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154797207|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
154797208|NCT01723371|Protective Agents|protective agents|mesh-ancestor
154797209|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154797210|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154797211|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154797212|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
154797213|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154797214|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154797215|NCT00639457|Pioglitazone|pioglitazone|mesh-list
154797216|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154797217|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797218|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
154797219|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154797220|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154797221|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154797222|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797223|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
154797224|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797225|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797226|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154797227|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797228|NCT01723527|Buprenorphine|buprenorphine|mesh-list
154797229|NCT01723527|Methadone|methadone|mesh-list
154797230|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154797231|NCT01723527|Narcotics|narcotics|mesh-ancestor
154797232|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154797233|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797234|NCT01723527|Analgesics|analgesics|mesh-ancestor
154797235|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
154797236|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797237|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154797238|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
154797239|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797240|NCT00639223|Pravastatin|pravastatin|mesh-list
154797241|NCT00639223|Red yeast rice|red yeast rice|mesh-list
154797242|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154797243|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154797244|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
154797245|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797246|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154797247|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154797248|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797250|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797251|NCT03519984|Cytarabine|cytarabine|mesh-list
154797252|NCT03519984|Vincristine|vincristine|mesh-list
154797253|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154797254|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
153976724|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797255|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797256|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797257|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
154797258|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797259|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797260|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
154797261|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797262|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154797263|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
154797264|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
154797265|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797266|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154797267|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
154797268|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797269|NCT01835691|Vitamin D|vitamin d|mesh-list
154797270|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
154797271|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
154797272|NCT01835691|Vitamins|vitamins|mesh-list
154797273|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
154797274|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797275|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154797276|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154797277|NCT01729767|Acyclovir|acyclovir|mesh-list
154797278|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
154797279|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797280|NCT00913263|Flutamide|flutamide|mesh-list
154797281|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
154797282|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
154797283|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
154797284|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797285|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797286|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154797287|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797288|NCT04377867|Abatacept|abatacept|mesh-list
154797289|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154797290|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797291|NCT04377867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154797292|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797293|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797294|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
154797295|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797296|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797297|NCT00637273|Pioglitazone|pioglitazone|mesh-list
154797298|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154797299|NCT00637273|Exenatide|exenatide|mesh-list
154797300|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154797301|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797302|NCT00637273|Incretins|incretins|mesh-ancestor
154797303|NCT00637273|Hormones|hormones|mesh-ancestor
154797304|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797305|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154797306|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
154797307|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797308|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797309|NCT00637273|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154797310|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154797311|NCT01923259|Donepezil|donepezil|mesh-list
154797312|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154797313|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797314|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797315|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
154797316|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797317|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797318|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
154797319|NCT01923337|Irinotecan|irinotecan|mesh-list
154797320|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154797321|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154549277|NCT02150707|Incretins|incretins|mesh-ancestor
154797322|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797323|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797325|NCT03098160|Ipilimumab|ipilimumab|mesh-list
154797326|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154797327|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797328|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154797329|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797330|NCT01724385|Bevacizumab|bevacizumab|mesh-list
154797331|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154797332|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797333|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154797334|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154797335|NCT01724385|Growth Substances|growth substances|mesh-ancestor
154797336|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797337|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
154797338|NCT04377789|Quercetin|quercetin|mesh-list
154797339|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
154797340|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797341|NCT04377789|Protective Agents|protective agents|mesh-ancestor
154797342|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797343|NCT00988117|Rivastigmine|rivastigmine|mesh-list
154797344|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154797345|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797346|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797347|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
154797348|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797349|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797350|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154797351|NCT00988117|Protective Agents|protective agents|mesh-ancestor
154797352|NCT01728753|Favipiravir|favipiravir|mesh-list
154797353|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
154797354|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797355|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
154797356|NCT01724619|Androgens|androgens|mesh-ancestor
154797357|NCT01724619|Hormones|hormones|mesh-ancestor
154797358|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797359|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797360|NCT05045508|Varenicline|varenicline|mesh-list
154797361|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154797362|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154797363|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
154797364|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797365|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797366|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797367|NCT00637195|Vaccines|vaccines|mesh-list
154797368|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
154797369|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797370|NCT05045274|Aspirin|aspirin|mesh-list
154797371|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
154797372|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
154797373|NCT05045274|Giapreza|giapreza|mesh-list
154797374|NCT05045274|Clopidogrel|clopidogrel|mesh-list
154797375|NCT05045274|Ticagrelor|ticagrelor|mesh-list
154797376|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154797377|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154797378|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
154797379|NCT05045274|Diuretics|diuretics|mesh-list
154797380|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154797381|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154797382|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154797383|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
154797384|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154797385|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154797386|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154797387|NCT05045274|Analgesics|analgesics|mesh-ancestor
154797388|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
154797389|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797390|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797391|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154797392|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797393|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154797394|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154797395|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797396|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154797397|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154797398|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
154797399|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154797400|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154797401|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154797402|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
154797403|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797404|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154797405|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154797406|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154797407|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154797408|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
154797409|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154797410|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
154797411|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154797412|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
154797413|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154797414|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154797415|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
154797416|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
154797417|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797418|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154797419|NCT05045274|Hormones|hormones|mesh-ancestor
154797420|NCT01721733|Ubiquinone|ubiquinone|mesh-list
154797421|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
154797422|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797423|NCT01720485|Prednisolone|prednisolone|mesh-list
154797424|NCT01720485|Betamethasone|betamethasone|mesh-list
154797425|NCT01720485|Desloratadine|desloratadine|mesh-list
154797426|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154797427|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154797428|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
154797429|NCT01720485|Hormones|hormones|mesh-ancestor
154797430|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797431|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797432|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154797433|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797434|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797435|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797436|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154797437|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
153976945|NCT00999518|Tanezumab|tanezumab|mesh-list
154797438|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797439|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797440|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154797441|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154797442|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
154797443|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
154797444|NCT01726725|Desflurane|desflurane|mesh-list
154797445|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154797446|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
154797447|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
154797448|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154797449|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797450|NCT05044728|Paclitaxel|paclitaxel|mesh-list
154797451|NCT05044728|Carboplatin|carboplatin|mesh-list
154797452|NCT05044728|Antibodies|antibodies|mesh-list
154797453|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154797454|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797455|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
154797456|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
154797457|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797458|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797459|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
154797460|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797461|NCT05054478|Daratumumab|daratumumab|mesh-list
154797462|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797463|NCT01041807|Losartan|losartan|mesh-list
154797464|NCT01041807|Amlodipine|amlodipine|mesh-list
154797465|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154797466|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154797467|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154797468|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797469|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154797470|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797471|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
154797472|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154797473|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154797474|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154797475|NCT01724931|Aminopterin|aminopterin|mesh-list
154797476|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154797477|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797478|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797479|NCT00635089|Reslizumab|reslizumab|mesh-list
154797480|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797481|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797482|NCT01725009|Levetiracetam|levetiracetam|mesh-list
154797483|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
154797484|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
154797485|NCT01725087|Tapentadol|tapentadol|mesh-list
154797486|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154797487|NCT01725087|Narcotics|narcotics|mesh-ancestor
154797488|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154797489|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797490|NCT01725087|Analgesics|analgesics|mesh-ancestor
154797491|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
154797492|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797493|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154797494|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154797495|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154797496|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797497|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
154797498|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797499|NCT00634543|Acetaminophen|acetaminophen|mesh-list
154797500|NCT00634543|Gabapentin|gabapentin|mesh-list
154797501|NCT00634543|Tramadol|tramadol|mesh-list
154797502|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154797503|NCT00634543|Analgesics|analgesics|mesh-ancestor
154797504|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
153976970|NCT02873273|Hormones|hormones|mesh-ancestor
154797505|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797506|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797507|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
154797508|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
154797509|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154797510|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154797511|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154797512|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154797513|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154797514|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154797515|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797516|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797517|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
154797518|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154797519|NCT00634543|Narcotics|narcotics|mesh-ancestor
154797520|NCT05054322|Fluticasone|fluticasone|mesh-list
154797521|NCT05054322|Xhance|xhance|mesh-list
154797522|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154797523|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154797524|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
154797525|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797526|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797527|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797528|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797529|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
154797530|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154797531|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154797532|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
154797533|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797534|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
154797535|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154797536|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
154797537|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797538|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797539|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797540|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797541|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
154797542|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154797543|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
154797544|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797545|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797546|NCT04759729|Vitamin D|vitamin d|mesh-list
154549497|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
154797547|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
154797548|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
154797549|NCT04759729|Vitamins|vitamins|mesh-list
154797550|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
154797551|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797552|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154797553|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154797554|NCT05053386|Epirubicin|epirubicin|mesh-list
154797555|NCT05053386|Idarubicin|idarubicin|mesh-list
154797556|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154797557|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797558|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154797559|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154797560|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797561|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797562|NCT01725243|Carbetocin|carbetocin|mesh-list
154797563|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
154797564|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154797565|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797566|NCT01725477|Methylene Blue|methylene blue|mesh-list
154797567|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797568|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797569|NCT03096990|Apremilast|apremilast|mesh-list
154797570|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154797571|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154797572|NCT03096990|Analgesics|analgesics|mesh-ancestor
154797573|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
154797574|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797575|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797576|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154797577|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797578|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154797579|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154797580|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797581|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797582|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
154797583|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154797584|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797585|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
154797586|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
154797587|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
154797588|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
154797589|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797590|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797591|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
154797592|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154797593|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154797594|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
154797595|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797596|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154797597|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154797598|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797599|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797600|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
154797601|NCT03836781|Ketorolac|ketorolac|mesh-list
154797602|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154797603|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797604|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
154797605|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154797606|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154797607|NCT03836781|Analgesics|analgesics|mesh-ancestor
154797608|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
154797609|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797610|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797611|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154797612|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797613|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154797614|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797615|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797616|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154797617|NCT01360866|Fluoxetine|fluoxetine|mesh-list
154797618|NCT01360866|Paroxetine|paroxetine|mesh-list
154797619|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154797620|NCT01360866|Sertraline|sertraline|mesh-list
154797621|NCT01360866|Escitalopram|escitalopram|mesh-list
154797622|NCT01360866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154797623|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154797624|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154797625|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797626|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797627|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
154797628|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797629|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797630|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154797631|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
154797632|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977104|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797633|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154797635|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
154797636|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
154797637|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154797638|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154797639|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797640|NCT00984061|Clarithromycin|clarithromycin|mesh-list
154797641|NCT00984061|Colchicine|colchicine|mesh-list
154797642|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154797643|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797644|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154797645|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797646|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797647|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154797648|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154797649|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
154797650|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797651|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
154797652|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
154797653|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797654|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797655|NCT01046643|Estradiol|estradiol|mesh-list
154797656|NCT01046643|Progesterone|progesterone|mesh-list
154797657|NCT01046643|Estrogens|estrogens|mesh-ancestor
154797658|NCT01046643|Hormones|hormones|mesh-ancestor
154797659|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797660|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797661|NCT01046643|Progestins|progestins|mesh-ancestor
154797662|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
154797663|NCT03096756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154797664|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
154797665|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797666|NCT03096756|Protective Agents|protective agents|mesh-ancestor
154797667|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797668|NCT00983905|Colchicine|colchicine|mesh-list
154797669|NCT00983905|Theophylline|theophylline|mesh-list
154797670|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
154797671|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797672|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
154797673|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
154797674|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797675|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797676|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797677|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154797678|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
154797679|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797680|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797681|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797682|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797683|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154797684|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797685|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
154797686|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154797687|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154797688|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
154797689|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797690|NCT01046565|Adapalene|adapalene|mesh-list
154797691|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154797692|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154797693|NCT01046565|Analgesics|analgesics|mesh-ancestor
154797694|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
154797695|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549647|NCT02438397|Metformin|metformin|mesh-list
154797696|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797697|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154797698|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797699|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
154797700|NCT01046253|Lansoprazole|lansoprazole|mesh-list
154797701|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
154797702|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154797703|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154797704|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154797705|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797706|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797707|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154797708|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154797709|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154797710|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154797711|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797712|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797713|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797714|NCT05050656|Analgesics|analgesics|mesh-ancestor
154797715|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
154797716|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797717|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
154797718|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154797719|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
154797720|NCT00983515|Ritonavir|ritonavir|mesh-list
154797721|NCT00983515|Colchicine|colchicine|mesh-list
154797722|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154797723|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154797724|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
154797725|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797726|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797727|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154797728|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154797729|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
154797730|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797731|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154797732|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154797733|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
154797734|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797735|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
154797736|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
154797737|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797738|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797739|NCT05033574|Hormones|hormones|mesh-list
154797740|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797741|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797742|NCT04434378|Tamsulosin|tamsulosin|mesh-list
154797743|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154797744|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154797745|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154797746|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
154797747|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797748|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797749|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797750|NCT04434378|Urological Agents|urological agents|mesh-ancestor
154797751|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
154797752|NCT00981799|Methotrexate|methotrexate|mesh-list
154797753|NCT00981799|Etoposide|etoposide|mesh-list
154797754|NCT00981799|Lenograstim|lenograstim|mesh-list
154797755|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797756|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
154797757|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797758|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797759|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154797760|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
154797761|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797762|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797763|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154797764|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154797765|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
154797766|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154797767|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154797768|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
154797769|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
154797770|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797771|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154797772|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154797773|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154797774|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154797775|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154797776|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154797777|NCT05033106|Bevacizumab|bevacizumab|mesh-list
154797778|NCT05033106|Ranibizumab|ranibizumab|mesh-list
154797779|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154797780|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797781|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154797782|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154797783|NCT05033106|Growth Substances|growth substances|mesh-ancestor
154797784|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797785|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
154797786|NCT03095040|Everolimus|everolimus|mesh-list
154797787|NCT03095040|Vorolanib|vorolanib|mesh-list
154797788|NCT03095040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154797789|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154797790|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797791|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797792|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797793|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
154797794|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797795|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797796|NCT03096522|Phenytoin|phenytoin|mesh-list
154797797|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
153977287|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
154797798|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154797799|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154797800|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154797801|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797802|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154797803|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154797804|NCT01045161|Bromides|bromides|mesh-list
154797805|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
154797806|NCT05032248|Tacrolimus|tacrolimus|mesh-list
154797807|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797808|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
154797809|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797810|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154797811|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797812|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797813|NCT00633217|Fluticasone|fluticasone|mesh-list
154797814|NCT00633217|Xhance|xhance|mesh-list
154797815|NCT00633217|Norflurane|norflurane|mesh-list
154797816|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154797817|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154797818|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154797819|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154797820|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
154797821|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797822|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797823|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797824|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797825|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
154797826|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154797827|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154797828|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154797829|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154797830|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
154797831|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797832|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797833|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
154797834|NCT00633217|Hormones|hormones|mesh-ancestor
154797835|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797836|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
154797837|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
154797838|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154797839|NCT01673490|Tamsulosin|tamsulosin|mesh-list
154797840|NCT01673490|Dutasteride|dutasteride|mesh-list
154797841|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154797842|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154797843|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154797844|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
154797845|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797846|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797847|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797848|NCT01673490|Urological Agents|urological agents|mesh-ancestor
154797849|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154797850|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154797851|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797852|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
154797853|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797854|NCT00633061|Enoxaparin|enoxaparin|mesh-list
154797855|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
154797856|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154797857|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154797858|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797859|NCT00632827|Leucovorin|leucovorin|mesh-list
154797860|NCT00632827|Cytarabine|cytarabine|mesh-list
154797861|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
154797862|NCT00632827|Carmustine|carmustine|mesh-list
154797863|NCT00632827|Gemcitabine|gemcitabine|mesh-list
154797864|NCT00632827|Doxorubicin|doxorubicin|mesh-list
154797865|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154797866|NCT00632827|Methotrexate|methotrexate|mesh-list
154797867|NCT00632827|Etoposide|etoposide|mesh-list
154797868|NCT00632827|Vincristine|vincristine|mesh-list
154797869|NCT00632827|Vinorelbine|vinorelbine|mesh-list
154797870|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
154797871|NCT00632827|Lenograstim|lenograstim|mesh-list
154797872|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154797873|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
154797874|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797875|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797876|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154797877|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
154797878|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797879|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797880|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154797881|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154797882|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
154797883|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154797884|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154797885|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154797886|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797887|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154797888|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
154797889|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154797890|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
154797891|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154797892|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154797893|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154797894|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
154797895|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797896|NCT00632827|Antidotes|antidotes|mesh-ancestor
154797897|NCT00632827|Protective Agents|protective agents|mesh-ancestor
154797898|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
154797899|NCT00632827|Vitamins|vitamins|mesh-ancestor
154797900|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
154797901|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
154797902|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
154797903|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
154797904|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154797905|NCT00214019|Fluticasone|fluticasone|mesh-list
154797906|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154797907|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154797908|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154797909|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154797910|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
154797911|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154797912|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797913|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797914|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797915|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
154797916|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154797917|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154797918|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154797919|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154797920|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
154797921|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154797922|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797923|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
154797924|NCT00214019|Hormones|hormones|mesh-ancestor
154797925|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797926|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
154797927|NCT03097848|Sorafenib|sorafenib|mesh-list
154797928|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797929|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154797930|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797931|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797932|NCT05047848|Fulvestrant|fulvestrant|mesh-list
154797933|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154797934|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797935|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154797936|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154797937|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
154797938|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797939|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797940|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
154797941|NCT00210119|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154797942|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154797943|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797944|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977464|NCT01018511|Tamsulosin|tamsulosin|mesh-list
154797945|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797946|NCT01044459|Bromides|bromides|mesh-list
154797947|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
154797948|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154797949|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
154797950|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
154797951|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797952|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797953|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154797954|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154797955|NCT01837329|Growth Substances|growth substances|mesh-ancestor
154797956|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797957|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
154797958|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797959|NCT05040906|Rituximab|rituximab|mesh-list
154797960|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154797961|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797962|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
154797963|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797964|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154797965|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
154797966|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154797967|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154797968|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154797969|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
154797970|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154797971|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154797972|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797973|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797974|NCT05040828|Montelukast|montelukast|mesh-list
154797975|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154797976|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
154797977|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154797978|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
154797979|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154797980|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797981|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154797982|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154797983|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797984|NCT00983437|Modafinil|modafinil|mesh-list
154797985|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154797986|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154797987|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154797988|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154797989|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154797990|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797991|NCT03599609|Simvastatin|simvastatin|mesh-list
154797992|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154797993|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154797994|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
154797995|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154797996|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154797997|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154797998|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154797999|NCT05040594|Lidocaine|lidocaine|mesh-list
154798000|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
154798001|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
154798002|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977484|NCT02269267|Dasatinib|dasatinib|mesh-list
154798003|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798004|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
154798005|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798006|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154798007|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154798008|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154798009|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154798010|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798011|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
154798012|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154798013|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798014|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154798015|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798016|NCT03598673|Nebivolol|nebivolol|mesh-list
154798017|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154798018|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
154798019|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154798020|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154798021|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154798022|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
154798023|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798024|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798025|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798026|NCT05039580|Dexamethasone|dexamethasone|mesh-list
154798027|NCT05039580|Antibodies|antibodies|mesh-list
154798028|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154798029|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
154798030|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798031|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154798032|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
154798033|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
154798034|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798035|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154798036|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
154798037|NCT05039580|Hormones|hormones|mesh-ancestor
154798038|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798039|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154798040|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798041|NCT05025228|Acetaminophen|acetaminophen|mesh-list
154798042|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154798043|NCT05025228|Analgesics|analgesics|mesh-ancestor
154798044|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
154798045|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798046|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798047|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
154798048|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
154798049|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977545|NCT00779584|Gemcitabine|gemcitabine|mesh-list
154798050|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
154798051|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798052|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798053|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154798054|NCT05024604|Progesterone|progesterone|mesh-list
154798055|NCT05024604|Progestins|progestins|mesh-ancestor
154798056|NCT05024604|Hormones|hormones|mesh-ancestor
154798057|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798058|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798059|NCT03597893|Oxytocin|oxytocin|mesh-list
154798060|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
154798061|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154798062|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798063|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154798064|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
154798065|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798066|NCT05024448|Prednisone|prednisone|mesh-list
154798067|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154798068|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
154798069|NCT05024448|Hormones|hormones|mesh-ancestor
154798070|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798071|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798072|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154798073|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798074|NCT03596957|Tolvaptan|tolvaptan|mesh-list
154798075|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154798076|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798077|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
154798078|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798079|NCT03408015|Lifitegrast|lifitegrast|mesh-list
154798080|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154798081|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154798082|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
154798083|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154798084|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
154798085|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154798086|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154798087|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798088|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154798089|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798090|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154798091|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798092|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154798093|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798094|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798095|NCT03596099|Acetic Acid|acetic acid|mesh-list
154798096|NCT03596099|Retinol acetate|retinol acetate|mesh-list
154798097|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154798098|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798099|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154798100|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
154798101|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798102|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154798103|NCT03596099|Protective Agents|protective agents|mesh-ancestor
154798104|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798105|NCT01041417|Molgramostim|molgramostim|mesh-list
154798106|NCT01041417|Sargramostim|sargramostim|mesh-list
154798107|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
154798108|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798109|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798110|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
154798111|NCT03595397|Fentanyl|fentanyl|mesh-list
154798112|NCT03595397|Bupivacaine|bupivacaine|mesh-list
154798113|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
154798114|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
154798115|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798116|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798117|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
154798118|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798119|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154798120|NCT03595397|Narcotics|narcotics|mesh-ancestor
154798121|NCT03595397|Analgesics|analgesics|mesh-ancestor
154798122|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154798123|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154798124|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
154798125|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154798126|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
154798127|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154798128|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154798129|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798130|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154798131|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
154798132|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154798133|NCT03595319|Sevoflurane|sevoflurane|mesh-list
154798134|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154798135|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154798136|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
154798137|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
154798138|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798139|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798140|NCT01040871|Prednisone|prednisone|mesh-list
154798141|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
154798142|NCT01040871|Rituximab|rituximab|mesh-list
154550114|NCT01596062|Everolimus|everolimus|mesh-list
154798144|NCT01040871|Vincristine|vincristine|mesh-list
154798145|NCT01040871|Bortezomib|bortezomib|mesh-list
154798146|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154798147|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
154798148|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798149|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798150|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154798151|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
154798152|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798153|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798154|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154798155|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154798156|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154798157|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154798158|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154798159|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798160|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154798161|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
154798162|NCT01040871|Hormones|hormones|mesh-ancestor
154798163|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798164|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154798165|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154798166|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
154798167|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
154798168|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
154798169|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
154798170|NCT01040169|Calcium|calcium|mesh-list
154798171|NCT01040169|Fluorides|fluorides|mesh-list
154798172|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154798173|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798174|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
154798175|NCT01040169|Protective Agents|protective agents|mesh-ancestor
154798176|NCT01040169|Antacids|antacids|mesh-ancestor
154798177|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798178|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154798179|NCT01044381|Luliconazole|luliconazole|mesh-list
154798180|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
154798181|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798182|NCT03594461|Aflibercept|aflibercept|mesh-list
154798183|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154798184|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154798185|NCT03594461|Growth Substances|growth substances|mesh-ancestor
154798186|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798187|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
154798188|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798189|NCT03407703|Grazoprevir|grazoprevir|mesh-list
154798190|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154798191|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
154798192|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798193|NCT03594149|Levofloxacin|levofloxacin|mesh-list
154798194|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154798195|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798196|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154798197|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154798198|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154798199|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798200|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798201|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798202|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154798203|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154798204|NCT00916539|Calpastatin|calpastatin|mesh-list
154798205|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154798206|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
154798207|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798208|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798209|NCT03593447|Ribavirin|ribavirin|mesh-list
154798210|NCT03593447|Yimitasvir|yimitasvir|mesh-list
154798211|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
154798212|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798213|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
154798214|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798215|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154798216|NCT03593291|Dalteparin|dalteparin|mesh-list
154798217|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
154798218|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154798219|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154798220|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798221|NCT03593135|Metformin|metformin|mesh-list
154798222|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154798223|NCT03593135|Acetic Acid|acetic acid|mesh-list
154798224|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154798225|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798226|NCT03593135|Incretins|incretins|mesh-ancestor
154798227|NCT03593135|Hormones|hormones|mesh-ancestor
154798228|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798229|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154798230|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
154798231|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798232|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798233|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154798234|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798235|NCT03592901|Anesthetics|anesthetics|mesh-list
154798236|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798237|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798238|NCT03830385|Carboplatin|carboplatin|mesh-list
154798239|NCT03830385|Bleomycin|bleomycin|mesh-list
154798240|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798241|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154798242|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
154798243|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
154798244|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154798245|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154798246|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798247|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798248|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798249|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798250|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
154798251|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154798252|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798253|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154798254|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798255|NCT03406689|Nepafenac|nepafenac|mesh-list
154798256|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
154798257|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154798258|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154798259|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154798260|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154798261|NCT03406689|Analgesics|analgesics|mesh-ancestor
154798262|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
154798263|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798264|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798265|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154798266|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798267|NCT03406533|Midazolam|midazolam|mesh-list
154798268|NCT03406533|Fentanyl|fentanyl|mesh-list
154798269|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
154798270|NCT03406533|Remifentanil|remifentanil|mesh-list
154798271|NCT03406533|Propofol|propofol|mesh-list
154798272|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154798273|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798274|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798275|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154798276|NCT03406533|Analgesics|analgesics|mesh-ancestor
154798277|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
154798278|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798279|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154798280|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154798281|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154798282|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154798283|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798284|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798285|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154798286|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
154798287|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
154798288|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154798289|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154798290|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154798291|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154798292|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
154798293|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
154798294|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154798296|NCT03591341|Melatonin|melatonin|mesh-list
154798297|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
154798298|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798299|NCT03591341|Protective Agents|protective agents|mesh-ancestor
154798300|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798301|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798302|NCT04377399|Vitamin D|vitamin d|mesh-list
154798303|NCT04377399|Vitamins|vitamins|mesh-ancestor
154798304|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
154798305|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798306|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154798307|NCT03400995|Ziresovir|ziresovir|mesh-list
154798308|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
154798309|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798310|NCT03590873|Vasopressins|vasopressins|mesh-list
154798311|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
154798312|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798313|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
154798314|NCT03590873|Coagulants|coagulants|mesh-ancestor
154798315|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154798316|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154798317|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
154798318|NCT02155335|Golimumab|golimumab|mesh-list
154798319|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154798320|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154798321|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154798322|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154798323|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
154798324|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798325|NCT05024526|Edaravone|edaravone|mesh-list
154798326|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154798327|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
154798328|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798329|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154798330|NCT05024526|Protective Agents|protective agents|mesh-ancestor
154798331|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798332|NCT03597035|Spironolactone|spironolactone|mesh-list
154798333|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154798334|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
154798335|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798336|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798337|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154798338|NCT03597035|Diuretics|diuretics|mesh-ancestor
154798339|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
154798340|NCT03400683|Letrozole|letrozole|mesh-list
154798341|NCT03400683|Misoprostol|misoprostol|mesh-list
154798342|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798343|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154798344|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154798345|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798346|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798347|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154798348|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
154798349|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798350|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798351|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154798352|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
154798353|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154798354|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154798355|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154798356|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
154798357|NCT05037240|Quercetin|quercetin|mesh-list
154798358|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
154798359|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798360|NCT05037240|Protective Agents|protective agents|mesh-ancestor
154798361|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798362|NCT05037006|Anesthetics|anesthetics|mesh-list
154798363|NCT05037006|Sevoflurane|sevoflurane|mesh-list
154798364|NCT05037006|Neostigmine|neostigmine|mesh-list
154798365|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798366|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798367|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154798368|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154798369|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
154798370|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154798371|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798372|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798373|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
154798374|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798375|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154798376|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
154798377|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798378|NCT03093090|Furosemide|furosemide|mesh-list
154798379|NCT03093090|Diuretics|diuretics|mesh-ancestor
154798380|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
154798381|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798382|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154798383|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154798384|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798385|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
154798386|NCT03093168|Fludarabine|fludarabine|mesh-list
154798387|NCT03093168|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154798388|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154798389|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
154798390|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798391|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798392|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154798393|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
154798394|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798395|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798396|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154798397|NCT03093168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154798398|NCT04377321|Colchicine|colchicine|mesh-list
154798399|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
154798400|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798401|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
154798402|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
154798403|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
154798404|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798405|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798406|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
154798407|NCT05018364|Hematinics|hematinics|mesh-ancestor
154798408|NCT03593213|Cariprazine|cariprazine|mesh-list
154798409|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154798410|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154798411|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798412|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798413|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154798414|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154798415|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154798416|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
154798417|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798418|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798419|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798420|NCT03595163|Folic Acid|folic acid|mesh-list
154798421|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
154798422|NCT03595163|Propofol|propofol|mesh-list
154798423|NCT03595163|Sevoflurane|sevoflurane|mesh-list
154798424|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154798425|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798426|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798427|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154798428|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
154798429|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
154798430|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154798431|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154798432|NCT03595163|Hematinics|hematinics|mesh-ancestor
154798433|NCT03595163|Vitamins|vitamins|mesh-ancestor
154798434|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
154798435|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154798436|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154798437|NCT04199819|Entecavir|entecavir|mesh-list
154798438|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
154798439|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798440|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
154798441|NCT00918723|Rituximab|rituximab|mesh-list
154798442|NCT00918723|Fludarabine|fludarabine|mesh-list
154798443|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
154798444|NCT00918723|Vorinostat|vorinostat|mesh-list
154550405|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
154798445|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154798446|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
154798447|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798448|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798449|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154798450|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
154798451|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798452|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798453|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154798454|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154798455|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154798456|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
154798457|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154798458|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798459|NCT04192331|Paclitaxel|paclitaxel|mesh-list
154798460|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154798461|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154798462|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798463|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
154798464|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
154798465|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
154798466|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798467|NCT00919035|Temsirolimus|temsirolimus|mesh-list
154798468|NCT00919035|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154798469|NCT00919035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154798470|NCT00919035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798471|NCT00919035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798472|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154798473|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
154798474|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798475|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798476|NCT04374981|Celecoxib|celecoxib|mesh-list
154798477|NCT04374981|Montelukast|montelukast|mesh-list
154798478|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154798479|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154798480|NCT04374981|Analgesics|analgesics|mesh-ancestor
154798481|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
154798482|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798483|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798484|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154798485|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798486|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154798487|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154798488|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798489|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798490|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154798491|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
154798492|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154798493|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
154798494|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798495|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154798496|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154798497|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154798498|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
154798499|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154798500|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
154798501|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798502|NCT03090516|Donepezil|donepezil|mesh-list
154798503|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154798504|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798505|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798506|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
154798507|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798508|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798509|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
154798510|NCT03092310|Pancrelipase|pancrelipase|mesh-list
154798511|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154798512|NCT03405207|Vitamin D|vitamin d|mesh-list
154798513|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
154798514|NCT03405207|Vitamins|vitamins|mesh-ancestor
154798515|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
154798516|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798517|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154798518|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154798519|NCT04197323|Alprostadil|alprostadil|mesh-list
154798520|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154798521|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
154798522|NCT04197323|Urological Agents|urological agents|mesh-ancestor
154798523|NCT04196855|Teriparatide|teriparatide|mesh-list
154798524|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154798525|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798526|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154798527|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
154798528|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154798529|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154798530|NCT04196309|Heparin|heparin|mesh-list
154798531|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154798532|NCT04196309|Tinzaparin|tinzaparin|mesh-list
154798533|NCT04196309|Dalteparin|dalteparin|mesh-list
154798534|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
154798535|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154798536|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154798537|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798538|NCT03090048|Vitamin A|vitamin a|mesh-list
154798539|NCT03090048|Azithromycin|azithromycin|mesh-list
154798540|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
154798541|NCT03090048|Vitamins|vitamins|mesh-ancestor
154798542|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
154798543|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798544|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154798545|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798546|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
154798547|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798548|NCT03090048|Protective Agents|protective agents|mesh-ancestor
154798549|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154798550|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798551|NCT04195997|Heparin|heparin|mesh-list
154798552|NCT04195997|Bivalirudin|bivalirudin|mesh-list
154798553|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
154798554|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154798555|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154798556|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798557|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
154798558|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154798559|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
154798560|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798561|NCT05023122|Vitamin D|vitamin d|mesh-list
154798562|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
154798563|NCT05023122|Calcium|calcium|mesh-list
154798564|NCT05023122|Vitamins|vitamins|mesh-ancestor
154798565|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
154798566|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798567|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154798568|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154798569|NCT04195373|Flucytosine|flucytosine|mesh-list
154798570|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
154798571|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798572|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
154798573|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798574|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154798575|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154798576|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
154798577|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154798578|NCT04194905|Estradiol|estradiol|mesh-list
154798579|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154798580|NCT04194905|Estrogens|estrogens|mesh-ancestor
154798581|NCT04194905|Hormones|hormones|mesh-ancestor
154798582|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798583|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798584|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154798585|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
154798586|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154798587|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154798588|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154798589|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154798590|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154798591|NCT05017428|Niacinamide|niacinamide|mesh-list
154798592|NCT05017428|Niacin|niacin|mesh-list
154798593|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
154798594|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
154798595|NCT05017428|Vitamins|vitamins|mesh-ancestor
154798596|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
154798597|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798598|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154798599|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
154798600|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798601|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154798602|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
154798603|NCT04196231|Insulin|insulin|mesh-list
154798604|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154798605|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154798606|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798607|NCT00013611|Aldesleukin|aldesleukin|mesh-list
154798608|NCT00013611|Interleukin-2|interleukin-2|mesh-list
154798609|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798610|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154798611|NCT00013611|Analgesics|analgesics|mesh-ancestor
154798612|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
154798613|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798614|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798615|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154798616|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154798617|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
154798618|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798619|NCT04194515|Metformin|metformin|mesh-list
154798620|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154798621|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798622|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154798623|NCT03094182|Hematinics|hematinics|mesh-ancestor
154798624|NCT05022030|Cetuximab|cetuximab|mesh-list
154798625|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154798626|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798627|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
154798628|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154798629|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154798630|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798631|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
154798632|NCT04192643|Coagulants|coagulants|mesh-ancestor
154798633|NCT00010257|Paclitaxel|paclitaxel|mesh-list
154798634|NCT00010257|Carboplatin|carboplatin|mesh-list
154798635|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154798636|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798637|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
154798638|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
154798639|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
154798640|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798641|NCT05022186|Cannabidiol|cannabidiol|mesh-list
154798642|NCT05022186|Tramiprosate|tramiprosate|mesh-list
154798643|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
154798644|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
154798645|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
154798646|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798647|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798648|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798649|NCT02240043|Hormones|hormones|mesh-list
154798650|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798651|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798652|NCT03404037|Endostatins|endostatins|mesh-list
154798653|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798654|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154798655|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154798656|NCT03404037|Growth Substances|growth substances|mesh-ancestor
154798657|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798658|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
154798659|NCT02240199|Lidocaine|lidocaine|mesh-list
154798660|NCT02240199|Pregabalin|pregabalin|mesh-list
154798661|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
154798662|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
154798663|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798664|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798665|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
154798666|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798667|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154798668|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154798669|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154550633|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
154798670|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154798671|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798672|NCT02240199|Analgesics|analgesics|mesh-ancestor
154798673|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
154798674|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154798675|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154798676|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154798677|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154798678|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154798679|NCT04190927|Estradiol|estradiol|mesh-list
154798680|NCT04190927|Progesterone|progesterone|mesh-list
154798681|NCT04190927|Estrogens|estrogens|mesh-ancestor
154798682|NCT04190927|Hormones|hormones|mesh-ancestor
154798683|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798684|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798685|NCT04190927|Progestins|progestins|mesh-ancestor
154798686|NCT00919191|Adapalene|adapalene|mesh-list
154798687|NCT00919191|Tretinoin|tretinoin|mesh-list
154798688|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154798689|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
154798690|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154798691|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154798692|NCT00919191|Analgesics|analgesics|mesh-ancestor
154798693|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
154798694|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798695|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798696|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154798697|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798698|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798699|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
154798700|NCT05021406|Carvedilol|carvedilol|mesh-list
154798701|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154798702|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154798703|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
154798704|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798705|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798706|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798707|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154798708|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
154798709|NCT05021406|Protective Agents|protective agents|mesh-ancestor
154798710|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154798711|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154798712|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154798713|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
154798714|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154798715|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154798716|NCT04766177|Bumetanide|bumetanide|mesh-list
154798717|NCT04766177|Diuretics|diuretics|mesh-ancestor
154798718|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
154798719|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798720|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154798721|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154798722|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798723|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
154798724|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
154798725|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154798726|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154798727|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798728|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798729|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798730|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798731|NCT05016180|Ropivacaine|ropivacaine|mesh-list
154798732|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
154798733|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
154798734|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798735|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798736|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
154798737|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798738|NCT03023501|Gabapentin|gabapentin|mesh-list
154798739|NCT03023501|Analgesics|analgesics|mesh-ancestor
154798740|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
154798741|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798742|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798743|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
154798744|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154798745|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154798746|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798747|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154798748|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154798749|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154798750|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798751|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798752|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
154798753|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
154798754|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154798755|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154798756|NCT05015322|Prednisolone|prednisolone|mesh-list
154798757|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
154798758|NCT05015322|Bupivacaine|bupivacaine|mesh-list
154798759|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154798760|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
154798761|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
154798762|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
154798763|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798764|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798765|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
154798766|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798767|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154798768|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
154798769|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
154798770|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154798771|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
154798772|NCT05015322|Hormones|hormones|mesh-ancestor
154798773|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798774|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154798775|NCT05015322|Protective Agents|protective agents|mesh-ancestor
154798776|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154798777|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798778|NCT00919503|Cyclosporine|cyclosporine|mesh-list
154798779|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
154798780|NCT00919503|Methotrexate|methotrexate|mesh-list
154798781|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
154798782|NCT00919503|Fludarabine|fludarabine|mesh-list
154798783|NCT00919503|Treosulfan|treosulfan|mesh-list
154798784|NCT00919503|Busulfan|busulfan|mesh-list
154798785|NCT00919503|Tacrolimus|tacrolimus|mesh-list
154798786|NCT00919503|Cyclosporins|cyclosporins|mesh-list
154798787|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
154798788|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154798789|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154798790|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
154798791|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154798792|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798793|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154798794|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
154798795|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798796|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798797|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
154798798|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798799|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154798800|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154798801|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
154798802|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798803|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154798804|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154798805|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
154798806|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798807|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154798808|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154798809|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
154798810|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154798811|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154798812|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
154798813|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154798814|NCT05020704|Empagliflozin|empagliflozin|mesh-list
154798815|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154798816|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798817|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154798818|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798819|NCT02979665|Ranibizumab|ranibizumab|mesh-list
154798820|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154798821|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154798822|NCT02979665|Growth Substances|growth substances|mesh-ancestor
154550782|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798823|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798824|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
154798826|NCT03092076|Ticagrelor|ticagrelor|mesh-list
154798827|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154798828|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154798829|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154798830|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154798831|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
154798832|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798833|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798834|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798835|NCT04193501|Melatonin|melatonin|mesh-list
154798836|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
154798837|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798838|NCT04193501|Protective Agents|protective agents|mesh-ancestor
154798839|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798840|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798841|NCT04374279|Bicalutamide|bicalutamide|mesh-list
154798842|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
154798843|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
154798844|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798845|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798846|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798847|NCT02240433|Sorafenib|sorafenib|mesh-list
154798848|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798849|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154798850|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798851|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798852|NCT03403647|Vitamin D|vitamin d|mesh-list
154798853|NCT03403647|Vitamins|vitamins|mesh-ancestor
154798854|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
154798855|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798856|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154798857|NCT05014464|Crizotinib|crizotinib|mesh-list
154798858|NCT05014464|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154798859|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154798860|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798861|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798862|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798863|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
154798864|NCT03403101|Irinotecan|irinotecan|mesh-list
154798865|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798866|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154798867|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154798868|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798869|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798870|NCT00211757|Valproic Acid|valproic acid|mesh-list
154798871|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
154798872|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798873|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798874|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
154798875|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798876|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798877|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
154798878|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154798879|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798880|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154798881|NCT04373967|Metformin|metformin|mesh-list
154798882|NCT04373967|Liraglutide|liraglutide|mesh-list
154798883|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154798884|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798885|NCT04373967|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154798886|NCT04373967|Incretins|incretins|mesh-ancestor
154798887|NCT04373967|Hormones|hormones|mesh-ancestor
154798888|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154798889|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
154798890|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154798891|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
154798892|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798893|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
154798894|NCT04026191|Protective Agents|protective agents|mesh-ancestor
154798895|NCT04022057|Ropivacaine|ropivacaine|mesh-list
154798896|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
154798897|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
154798898|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798899|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798900|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
154798901|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798902|NCT00921843|Methadone|methadone|mesh-list
154798903|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154798904|NCT00921843|Narcotics|narcotics|mesh-ancestor
154798905|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798906|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798907|NCT00921843|Analgesics|analgesics|mesh-ancestor
154798908|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
154798909|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798910|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
154798911|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
154798912|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
154798913|NCT04020653|Lumefantrine|lumefantrine|mesh-list
154798914|NCT04020653|Artemether|artemether|mesh-list
154798915|NCT04020653|Artemisinins|artemisinins|mesh-list
154798916|NCT04020653|Artemisinin|artemisinin|mesh-list
154798917|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154798918|NCT04020653|Citric Acid|citric acid|mesh-list
154798919|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
154798920|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
154798921|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154798922|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
154798923|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
154798924|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798925|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
154798926|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154798927|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154798928|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798929|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154798930|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
154798931|NCT04020653|Trace Elements|trace elements|mesh-ancestor
154798932|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
154798933|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798934|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
154798935|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
154798936|NCT05008458|Coagulants|coagulants|mesh-ancestor
154798937|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154798938|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154798939|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
154798940|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798941|NCT02080637|Ambrisentan|ambrisentan|mesh-list
154798942|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154798943|NCT05019690|Paclitaxel|paclitaxel|mesh-list
154798944|NCT05019690|Apatinib|apatinib|mesh-list
154798945|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154798946|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154798947|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798948|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
154798949|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
154798950|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
153978456|NCT00719173|Aprepitant|aprepitant|mesh-list
154798951|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798952|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154798953|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798954|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
154798955|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154798956|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154798957|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798958|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154798959|NCT04029467|Analgesics|analgesics|mesh-ancestor
154798960|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
154798961|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154798962|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154798963|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154798964|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154798965|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
154798966|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154798967|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798968|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154798969|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
154798970|NCT03402321|Coagulants|coagulants|mesh-ancestor
154798971|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
154798972|NCT03402165|Ledipasvir|ledipasvir|mesh-list
154798973|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154798974|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
154798975|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154798976|NCT03402087|Leucovorin|leucovorin|mesh-list
154798977|NCT03402087|Methotrexate|methotrexate|mesh-list
154798979|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154798980|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
154798981|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154798982|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154798983|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154798984|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
154798985|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154798986|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154798987|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
154798988|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154798989|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154798990|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154798991|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
154798992|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154798993|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154798994|NCT03402087|Antidotes|antidotes|mesh-ancestor
154798995|NCT03402087|Protective Agents|protective agents|mesh-ancestor
154798996|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
154798997|NCT03402087|Vitamins|vitamins|mesh-ancestor
154798998|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
154798999|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154799000|NCT04020263|Simendan|simendan|mesh-list
154799001|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154799002|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
154799003|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154799004|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154799005|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799006|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799007|NCT04020263|Protective Agents|protective agents|mesh-ancestor
154799008|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799009|NCT05008068|Simvastatin|simvastatin|mesh-list
154799010|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154799011|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154799012|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
154799013|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799014|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154799015|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154799016|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799017|NCT00925119|Atenolol|atenolol|mesh-list
154799018|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154799019|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154799020|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
154799021|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
154799022|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799023|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799024|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154799025|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154799026|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154799027|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799028|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799029|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799030|NCT04020809|Atezolizumab|atezolizumab|mesh-list
154799031|NCT04020809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154799032|NCT04020809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799033|NCT04020809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799034|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799035|NCT04027751|Tropisetron|tropisetron|mesh-list
154799036|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
154799037|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
154799038|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799039|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799040|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799041|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154799042|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154799043|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
154799044|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799045|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799046|NCT05018988|Vitamin D|vitamin d|mesh-list
154799047|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
154799048|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
154799049|NCT05018988|Vitamins|vitamins|mesh-list
154799050|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
154799051|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799052|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154799053|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154799055|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154799056|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799057|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154799058|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154799059|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799060|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799061|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799062|NCT04434144|Azithromycin|azithromycin|mesh-list
154799063|NCT04434144|Doxycycline|doxycycline|mesh-list
154799064|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
154799065|NCT04434144|Ivermectin|ivermectin|mesh-list
154799066|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154799067|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799068|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
154799069|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154799070|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154799071|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799072|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799073|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799074|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
154799075|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154799076|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978542|NCT02686047|Hylan|hylan|mesh-list
154799077|NCT04027283|Erythritol|erythritol|mesh-list
154799078|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
154799079|NCT04028141|Ketamine|ketamine|mesh-list
154799080|NCT04028141|Propofol|propofol|mesh-list
154799081|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154799082|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799083|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799084|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154799085|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
154799086|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
154799087|NCT04028141|Analgesics|analgesics|mesh-ancestor
154799088|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
154799089|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799090|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154799091|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154799092|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154799093|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799094|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799095|NCT03401541|Vitamin D|vitamin d|mesh-list
154799096|NCT03401541|Calcifediol|calcifediol|mesh-list
154799097|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
154799098|NCT03401541|Vitamins|vitamins|mesh-ancestor
154799099|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
154799100|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799101|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154799102|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154799103|NCT03953261|Curcumin|curcumin|mesh-list
154799104|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154799105|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154799106|NCT03953261|Analgesics|analgesics|mesh-ancestor
154799107|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
154799108|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799109|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799110|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154799111|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799112|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799113|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799114|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799115|NCT02242149|Diacerein|diacerein|mesh-list
154799116|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154799117|NCT03022565|Vorinostat|vorinostat|mesh-list
154799118|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799119|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154799120|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799121|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799122|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
154799123|NCT03079050|Lansoprazole|lansoprazole|mesh-list
154799124|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154799125|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799126|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154799127|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799128|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799129|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
154799130|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154799131|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799132|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799133|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154799134|NCT03834129|Analgesics|analgesics|mesh-ancestor
154799135|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
154799136|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799137|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154799138|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154799139|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154799140|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799141|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799142|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799143|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
154799144|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154799145|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799146|NCT03022409|Olaparib|olaparib|mesh-list
154799147|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154799148|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799149|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799150|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799151|NCT03833895|Phenylephrine|phenylephrine|mesh-list
154799152|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
154799153|NCT03833895|Norepinephrine|norepinephrine|mesh-list
154799154|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154799155|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
154799156|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
154799157|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799158|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799159|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
154799160|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154799161|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
154799162|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
154799163|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154799164|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154799165|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154799166|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799167|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799168|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799169|NCT03833895|Protective Agents|protective agents|mesh-ancestor
154799170|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154799171|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154799172|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
154799173|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799174|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799175|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154799176|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
154799177|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154799178|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154799179|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154799180|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799181|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799182|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799183|NCT05000892|Paclitaxel|paclitaxel|mesh-list
154799184|NCT05000892|Carboplatin|carboplatin|mesh-list
154799185|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154799186|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799187|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
154799188|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
154799189|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
154799190|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799191|NCT04372407|Itraconazole|itraconazole|mesh-list
154799192|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
154799193|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799194|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154799195|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154799196|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799197|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799198|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154799199|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
154860506|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153978669|NCT00714025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799200|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154799201|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799202|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154799203|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154799204|NCT02242383|Telmisartan|telmisartan|mesh-list
154799205|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154799206|NCT02242383|Diuretics|diuretics|mesh-ancestor
154799207|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
154799208|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799209|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154799210|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154799211|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799212|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154799213|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154799214|NCT04366089|Azithromycin|azithromycin|mesh-list
154799215|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
154799216|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154799217|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799218|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
154799219|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154799220|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154799221|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799222|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799223|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799224|NCT03079830|Pirinitramide|pirinitramide|mesh-list
154799225|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154799226|NCT03079830|Narcotics|narcotics|mesh-ancestor
154799227|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799228|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799229|NCT03079830|Analgesics|analgesics|mesh-ancestor
154799230|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
154799231|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799232|NCT02242695|Clotrimazole|clotrimazole|mesh-list
154799233|NCT02242695|Dequalinium|dequalinium|mesh-list
154799234|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154799235|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799236|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
154799237|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154799238|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154799239|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799240|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799241|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154799242|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
154799243|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154799244|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799245|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
154799246|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799247|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799248|NCT04999800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154799249|NCT04999800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799250|NCT02242851|Telmisartan|telmisartan|mesh-list
154799251|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154799252|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154799253|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154799254|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799255|NCT04999878|Dexamethasone|dexamethasone|mesh-list
154799256|NCT04999878|Gemcitabine|gemcitabine|mesh-list
154799257|NCT04999878|Etoposide|etoposide|mesh-list
154799258|NCT04999878|Cisplatin|cisplatin|mesh-list
154799259|NCT04999878|Pegaspargase|pegaspargase|mesh-list
154799260|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154799261|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
154799262|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
153978731|NCT02600806|Azithromycin|azithromycin|mesh-list
154799263|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799264|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799265|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799266|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
154799267|NCT04999878|Hormones|hormones|mesh-ancestor
154799268|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154799269|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154799270|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799271|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154551240|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
154799272|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
154799273|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799274|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154799275|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154799276|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154799277|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799278|NCT02242929|Imiquimod|imiquimod|mesh-list
154799279|NCT02242929|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154799280|NCT02242929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799281|NCT02242929|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154799282|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
154799283|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799284|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154799285|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799286|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
154799287|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
154799288|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154799289|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
154799290|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799291|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154799292|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
154799293|NCT05006898|Pilocarpine|pilocarpine|mesh-list
154799294|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154799295|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154799296|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154799297|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154799298|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799299|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799300|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799301|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799302|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
154799303|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
154799304|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799305|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
154799306|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154799307|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
154799308|NCT05006898|Miotics|miotics|mesh-ancestor
154799309|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154799310|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154799311|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
154799312|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
154799313|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154799314|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154799315|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799316|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154799317|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154799318|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799319|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799320|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799321|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154799322|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
154799323|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154799324|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799325|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154799326|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154799327|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154799328|NCT04365309|Aspirin|aspirin|mesh-list
154799329|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154799330|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154799331|NCT04365309|Analgesics|analgesics|mesh-ancestor
154799332|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
154799333|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799334|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799335|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154799336|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799337|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154799338|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154799339|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799340|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154799341|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154799342|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799343|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
154799344|NCT02243553|Vitamin K|vitamin k|mesh-list
154799345|NCT02243553|Ritonavir|ritonavir|mesh-list
154799346|NCT02243553|Tipranavir|tipranavir|mesh-list
154799347|NCT02243553|Digoxin|digoxin|mesh-list
154799348|NCT02243553|Midazolam|midazolam|mesh-list
154799349|NCT02243553|Levomethorphan|levomethorphan|mesh-list
154799350|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
154799351|NCT02243553|Caffeine|caffeine|mesh-list
154799352|NCT02243553|Omeprazole|omeprazole|mesh-list
154799353|NCT02243553|Warfarin|warfarin|mesh-list
154799354|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154799355|NCT02243553|Vitamins|vitamins|mesh-ancestor
154799356|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
154799357|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799358|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154799359|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154799360|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799361|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154799362|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154799363|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154799364|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154799365|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
154799366|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
154799367|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
154799368|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
154799369|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799370|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799371|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154799372|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154799373|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
154799374|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799375|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154799376|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154799377|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
154799378|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799379|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154799380|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154799381|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
154799382|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154799383|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154799384|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154799385|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154799386|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
154799387|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154799388|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799389|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154799390|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154799391|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154799392|NCT02243553|Protective Agents|protective agents|mesh-ancestor
154799393|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154799394|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154799395|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
154799396|NCT02243553|Coagulants|coagulants|mesh-ancestor
154799397|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
154799398|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
154799399|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154799400|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154799401|NCT02243553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154799402|NCT02243553|Narcotics|narcotics|mesh-ancestor
154799403|NCT02243553|Analgesics|analgesics|mesh-ancestor
154799404|NCT02243553|Sensory System Agents|sensory system agents|mesh-ancestor
154799405|NCT02243553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799406|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
154799407|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154799408|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
154799409|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154799410|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799411|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154799412|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154799413|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154799414|NCT05006664|Prednisone|prednisone|mesh-list
154799415|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
154799416|NCT05006664|Doxorubicin|doxorubicin|mesh-list
154799417|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154799418|NCT05006664|Etoposide|etoposide|mesh-list
154799419|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
154799420|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154799421|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154799422|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
154799423|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551380|NCT02098499|Promethazine|promethazine|mesh-list
154799424|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799425|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154799426|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
154799427|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799428|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799429|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154799430|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154799431|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154799432|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154799433|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799434|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154799435|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
154799436|NCT05006664|Hormones|hormones|mesh-ancestor
154799437|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154799438|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154799439|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154799440|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799441|NCT05006664|Immunotoxins|immunotoxins|mesh-ancestor
154799442|NCT05006664|Immunoconjugates|immunoconjugates|mesh-ancestor
154799443|NCT04346901|Methimazole|methimazole|mesh-list
154799444|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
154799445|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
154799446|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154799447|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978912|NCT02684409|Sumatriptan|sumatriptan|mesh-list
154799448|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154799449|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799450|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799451|NCT02244021|Immunotoxins|immunotoxins|mesh-ancestor
154799452|NCT02244021|Immunoconjugates|immunoconjugates|mesh-ancestor
154799453|NCT02244021|Immunologic Factors|immunologic factors|mesh-ancestor
154799454|NCT02244021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799455|NCT04364451|Asparaginase|asparaginase|mesh-list
154799456|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799457|NCT02245269|Ritonavir|ritonavir|mesh-list
154799458|NCT02245269|Tipranavir|tipranavir|mesh-list
154799459|NCT02245269|Atorvastatin|atorvastatin|mesh-list
154799460|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154799461|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154799462|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
154799463|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799464|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154799465|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154799466|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799467|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154799468|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154799469|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
154799470|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154799471|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154799472|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
154799473|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799474|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154799475|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154799476|NCT04364139|Metoprolol|metoprolol|mesh-list
154799477|NCT04364139|Amlodipine|amlodipine|mesh-list
154799478|NCT04364139|Ramipril|ramipril|mesh-list
154799479|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154799480|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154799481|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154799482|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799483|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154799484|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799485|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
154799486|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154799487|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
154799488|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
154799489|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799490|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154799491|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154799492|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154799493|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799494|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799495|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154799496|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
154799497|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551477|NCT02103023|Imiquimod|imiquimod|mesh-list
154799498|NCT02244255|Tamsulosin|tamsulosin|mesh-list
154799499|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154799500|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154799501|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154799502|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799503|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799504|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799505|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799506|NCT02244255|Urological Agents|urological agents|mesh-ancestor
154799507|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
154799508|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
154799509|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154799510|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154799511|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799512|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799513|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799514|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799515|NCT00923949|Pioglitazone|pioglitazone|mesh-list
154799516|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154799517|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799518|NCT04376541|Fentanyl|fentanyl|mesh-list
154799519|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154799520|NCT04376541|Narcotics|narcotics|mesh-ancestor
154799521|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799522|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799523|NCT04376541|Analgesics|analgesics|mesh-ancestor
154799524|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
154799525|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799526|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154799527|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154799528|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
154799529|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
154799530|NCT04376307|Anesthetics|anesthetics|mesh-list
154799531|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799532|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799533|NCT02244489|Capecitabine|capecitabine|mesh-list
154799534|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
154799535|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154799536|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154799537|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
154799538|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799539|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799540|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154799541|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799542|NCT02244567|Metformin|metformin|mesh-list
154799543|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799544|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154799545|NCT04376073|Niraparib|niraparib|mesh-list
154799546|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154799547|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799548|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799549|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799550|NCT04999176|Enoxaparin|enoxaparin|mesh-list
154799551|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
154799552|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154799553|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
154799554|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154799555|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
154799556|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799557|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799558|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
154799559|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154799560|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154799561|NCT04363203|Azithromycin|azithromycin|mesh-list
154799562|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
154799563|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154799564|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799565|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
154799566|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154799567|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154799568|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979040|NCT02684019|Analgesics|analgesics|mesh-ancestor
154799569|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799570|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799571|NCT02244879|Resveratrol|resveratrol|mesh-list
154799572|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
154551532|NCT03554447|Protective Agents|protective agents|mesh-ancestor
154799573|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799574|NCT02244879|Protective Agents|protective agents|mesh-ancestor
154799575|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799576|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799577|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154799578|NCT04362735|Vedolizumab|vedolizumab|mesh-list
154799579|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799580|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
154799581|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154799582|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
154799583|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799584|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799585|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154799586|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
154799587|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154799588|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
154799589|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799590|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799591|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154799592|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
154799593|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
154799594|NCT04375995|Protective Agents|protective agents|mesh-ancestor
154799595|NCT04365231|Azithromycin|azithromycin|mesh-list
154799596|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
154799597|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154799598|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799599|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
154799600|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154799601|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154799602|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799603|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799604|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799605|NCT04993014|Trastuzumab|trastuzumab|mesh-list
154799606|NCT04993014|Pertuzumab|pertuzumab|mesh-list
154799607|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799608|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799609|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
154799610|NCT05005494|Analgesics|analgesics|mesh-ancestor
154799611|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
154799612|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799613|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799614|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
154799615|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799616|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154799617|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
154799618|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154799619|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154799620|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799621|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154799622|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
154799623|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154799624|NCT04025567|Vancomycin|vancomycin|mesh-list
154799625|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154799626|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799627|NCT03074994|Anesthetics|anesthetics|mesh-list
154799628|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
154799629|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799630|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799631|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
154799632|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799633|NCT04025177|Indomethacin|indomethacin|mesh-list
154799634|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154799635|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154799636|NCT04025177|Analgesics|analgesics|mesh-ancestor
154799637|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
154799638|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799639|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799640|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154799641|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799642|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
154799643|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
154799644|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154799645|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154799646|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860507|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799647|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799648|NCT02985281|Ribavirin|ribavirin|mesh-list
154799649|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
154799650|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
154799651|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799652|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
154799653|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799654|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
154799655|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
154799656|NCT00927849|Glycerol|glycerol|mesh-list
154799657|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154799658|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154799659|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799660|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
154799661|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799662|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799663|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154799664|NCT00927849|Protective Agents|protective agents|mesh-ancestor
154799665|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
154799666|NCT04149587|Brodalumab|brodalumab|mesh-list
154799667|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154799668|NCT02985125|Everolimus|everolimus|mesh-list
154799669|NCT02985125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154799670|NCT02985125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154799671|NCT02985125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799672|NCT02985125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799673|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154799674|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
154799675|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799676|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799677|NCT00936741|Mifepristone|mifepristone|mesh-list
154799678|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154799679|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
154799680|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154799681|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799682|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154799683|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154799684|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154799685|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
154799686|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154799687|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154799688|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
154799689|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154799690|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
154799691|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154799692|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154799693|NCT04024865|Domperidone|domperidone|mesh-list
154799694|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
154799695|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
154799696|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799697|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799698|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799699|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154799700|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
154799701|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799702|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799703|NCT04024241|Cytarabine|cytarabine|mesh-list
154799704|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
154799705|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154799706|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
154799707|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799708|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799709|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
154799710|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799711|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154799712|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
154799713|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799714|NCT04024241|Analgesics|analgesics|mesh-ancestor
154799715|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
154799716|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799717|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154799718|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154799719|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799720|NCT04996290|Ropivacaine|ropivacaine|mesh-list
154799721|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
154799722|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
154799723|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799724|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799725|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
154799726|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799727|NCT04023617|Docetaxel|docetaxel|mesh-list
154799728|NCT04023617|Nivolumab|nivolumab|mesh-list
154799729|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799730|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
154799731|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
154799732|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
154799733|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799734|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799735|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154799736|NCT04023149|Aldesleukin|aldesleukin|mesh-list
154799737|NCT04023149|Interleukin-2|interleukin-2|mesh-list
154799738|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799739|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154799740|NCT04023149|Analgesics|analgesics|mesh-ancestor
154799741|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
154799742|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799743|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799744|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154799745|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154799746|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
154799747|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799748|NCT04149275|Nivolumab|nivolumab|mesh-list
154799749|NCT04149275|Ipilimumab|ipilimumab|mesh-list
154799750|NCT04149275|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154799751|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799752|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799753|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154799754|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799755|NCT04149275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154799756|NCT04149275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799757|NCT04148963|Loxapine|loxapine|mesh-list
154799758|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154799759|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154799760|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979228|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799761|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799762|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154799763|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154799764|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
154799765|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799766|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799767|NCT04022837|Pantoprazole|pantoprazole|mesh-list
154799768|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154799769|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799770|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154799771|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799772|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799773|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
154799774|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154799775|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154799776|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799777|NCT04148885|Paclitaxel|paclitaxel|mesh-list
154799778|NCT04148885|Carboplatin|carboplatin|mesh-list
154799779|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154799780|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799781|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
154799782|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
154799783|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
154799784|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799785|NCT04022525|Leflunomide|leflunomide|mesh-list
154799786|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799787|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799788|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154799789|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
154799790|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799791|NCT04022291|Insulin|insulin|mesh-list
154799792|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154799793|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154799794|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799795|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
154799796|NCT03074448|Cathartics|cathartics|mesh-ancestor
154799797|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799798|NCT04021433|Ketamine|ketamine|mesh-list
154799799|NCT04021433|Analgesics|analgesics|mesh-ancestor
154799800|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
154799801|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799802|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799803|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154799804|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154799805|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
154799806|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
154799807|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799808|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154799809|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154799810|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799811|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799812|NCT04147481|Anesthetics|anesthetics|mesh-list
154799813|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
154799814|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799815|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799816|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
154799817|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799818|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
154799819|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154799820|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154799821|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154799822|NCT04148261|Epinephrine|epinephrine|mesh-list
154799823|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154799824|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154799825|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799826|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799827|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799828|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799829|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154799830|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154799831|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
154799832|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799833|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154799834|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
154799835|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
154799836|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
154799837|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154799838|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154799839|NCT03072264|Fluoxetine|fluoxetine|mesh-list
154799840|NCT03072264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154799841|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154799842|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154799843|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799844|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799845|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
154799846|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799847|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154799848|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
154799849|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154799850|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154799851|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154799852|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799853|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
154799854|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
154799855|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154799856|NCT04991064|Protective Agents|protective agents|mesh-ancestor
154799857|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799858|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
154799859|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154799860|NCT00928083|Artefenomel|artefenomel|mesh-list
154799861|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
154799862|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154799863|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154799864|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799865|NCT04996446|Tislelizumab|tislelizumab|mesh-list
154799866|NCT04996446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799867|NCT04996446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799868|NCT04361721|Erenumab|erenumab|mesh-list
154799869|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154799870|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799871|NCT04361721|Analgesics|analgesics|mesh-ancestor
154799872|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
154799873|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799874|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799875|NCT04361643|Lenalidomide|lenalidomide|mesh-list
154799876|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
154799877|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979360|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
154799878|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154799879|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154799880|NCT04361643|Growth Substances|growth substances|mesh-ancestor
154799881|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
154799882|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799883|NCT04406051|Norepinephrine|norepinephrine|mesh-list
154799884|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154799885|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154799886|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
154799887|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799888|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799889|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799890|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
154799891|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
154799892|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799893|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154799894|NCT04991298|Midazolam|midazolam|mesh-list
154799895|NCT04991298|Fentanyl|fentanyl|mesh-list
154799896|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154799897|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154799898|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154799899|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799900|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154799901|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154799902|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154799903|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154799904|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
154799905|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
154799906|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
154799907|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
154799908|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154799909|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799910|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154799911|NCT04991298|Narcotics|narcotics|mesh-ancestor
154799912|NCT04991298|Analgesics|analgesics|mesh-ancestor
154799913|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
154799914|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154799915|NCT04361175|Letrozole|letrozole|mesh-list
154799916|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799917|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799918|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154799919|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154799920|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799921|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154799922|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
154799923|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154799924|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799925|NCT04368819|Allopurinol|allopurinol|mesh-list
154799926|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
154799927|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799928|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799929|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
154799930|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799931|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154799932|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
154799933|NCT04368819|Protective Agents|protective agents|mesh-ancestor
154799934|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799935|NCT04368585|Simethicone|simethicone|mesh-list
154799936|NCT04368585|Omeprazole|omeprazole|mesh-list
154799937|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154799938|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154799939|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
154799940|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
154799941|NCT04368585|TEMPO|tempo|mesh-list
154799942|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154799943|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154799944|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154799945|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860508|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154799946|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799947|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
154799948|NCT04368585|Emollients|emollients|mesh-ancestor
154799949|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
154799950|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154799951|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
154799952|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799953|NCT04368585|Antacids|antacids|mesh-ancestor
154799954|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
154799955|NCT04368585|Protective Agents|protective agents|mesh-ancestor
154799956|NCT04361331|Lenvatinib|lenvatinib|mesh-list
154799957|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799958|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154799959|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799960|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799961|NCT04990830|Heparin|heparin|mesh-list
154799962|NCT04990830|Enoxaparin|enoxaparin|mesh-list
154799963|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154799964|NCT04990830|Tinzaparin|tinzaparin|mesh-list
154799965|NCT04990830|Dalteparin|dalteparin|mesh-list
154799966|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
154799967|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
154799968|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154799969|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154799970|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799971|NCT04361409|Rituximab|rituximab|mesh-list
154799972|NCT04361409|Gemcitabine|gemcitabine|mesh-list
154799973|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154799974|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799975|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
154799976|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799977|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799978|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154799979|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
154799980|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799981|NCT04368273|Antibodies|antibodies|mesh-list
154799982|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
154799983|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154799984|NCT04995354|Mitogens|mitogens|mesh-list
154799985|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
154799986|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799987|NCT04368351|Azithromycin|azithromycin|mesh-list
154799988|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
154799989|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154799990|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154799991|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
154799992|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154799993|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154799994|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154799995|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154799996|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154799997|NCT04360317|Docetaxel|docetaxel|mesh-list
154799998|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154799999|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
154800000|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
154800001|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
154800002|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800003|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154800004|NCT03074136|Eusol|eusol|mesh-list
154800005|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
153979475|NCT00640575|Triamcinolone|triamcinolone|mesh-list
154800006|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800007|NCT04146155|Liraglutide|liraglutide|mesh-list
154800008|NCT04146155|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154800009|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800010|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800011|NCT04146155|Incretins|incretins|mesh-ancestor
154800012|NCT04146155|Hormones|hormones|mesh-ancestor
154800013|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800014|NCT04990752|Urinastatin|urinastatin|mesh-list
154800015|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154800016|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154800017|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
154800018|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800019|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800020|NCT02245191|Phenylephrine|phenylephrine|mesh-list
154800021|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
154800022|NCT02245191|Ephedrine|ephedrine|mesh-list
154800023|NCT02245191|Metaraminol|metaraminol|mesh-list
154800024|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154800025|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
154800026|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
154800027|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800028|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800029|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
154800030|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154800031|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
154800032|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
154800033|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154800034|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154800035|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154800036|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
154800037|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800038|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800039|NCT02245191|Protective Agents|protective agents|mesh-ancestor
154800040|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154800041|NCT04145921|Tacrine|tacrine|mesh-list
154800042|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154800043|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800044|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800045|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
154800046|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800047|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800048|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154800049|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
154800050|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800051|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
154800052|NCT04145687|Metformin|metformin|mesh-list
154800053|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800054|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800055|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
154800056|NCT04359615|Favipiravir|favipiravir|mesh-list
154800057|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
154800058|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154800059|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154800060|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800061|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800062|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800063|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800064|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
154800065|NCT02635386|Metformin|metformin|mesh-list
154800066|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
154800067|NCT02635386|Exenatide|exenatide|mesh-list
154800068|NCT02635386|Topiramate|topiramate|mesh-list
153979548|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154800069|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154800070|NCT02635386|Phentermine|phentermine|mesh-list
154800071|NCT02635386|Glucagon|glucagon|mesh-list
154800072|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154800073|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800074|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800075|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800076|NCT02635386|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154800077|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154800078|NCT02635386|Incretins|incretins|mesh-ancestor
154800079|NCT02635386|Hormones|hormones|mesh-ancestor
154800080|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800081|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
154800082|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800083|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154800084|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
154800085|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
154800086|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
154800087|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800088|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
154800089|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800090|NCT00934635|Risperidone|risperidone|mesh-list
154800091|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154800092|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154800093|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
154800094|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800095|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800096|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800097|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154800098|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154552057|NCT06098833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800099|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800100|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154800101|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154800102|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
154800103|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154800104|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154800105|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
154800106|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
154800107|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154800108|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154800109|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800110|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800111|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800112|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800113|NCT03922997|Atezolizumab|atezolizumab|mesh-list
154800114|NCT03922997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154800115|NCT03922997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800116|NCT03922997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154800117|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800118|NCT04356417|Antimalarials|antimalarials|mesh-list
154800119|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154800120|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154800121|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800122|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154800123|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154800124|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800125|NCT04355949|Vitamin D|vitamin d|mesh-list
154800126|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
154800127|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
154800128|NCT04355949|Vitamins|vitamins|mesh-list
154800129|NCT04355949|Folic Acid|folic acid|mesh-list
154800130|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
154800131|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
154800132|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
154800133|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
154800134|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800135|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154800136|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154800137|NCT04355949|Hematinics|hematinics|mesh-ancestor
154800138|NCT05580887|Paclitaxel|paclitaxel|mesh-list
154800139|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
154800140|NCT05580887|Carboplatin|carboplatin|mesh-list
154800141|NCT05580887|Doxorubicin|doxorubicin|mesh-list
154800142|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154800143|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800144|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
154800145|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
154800146|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
154800147|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800148|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154800149|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
154800150|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800151|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800152|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154800153|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
154800154|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154800155|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154800156|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154800157|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154800158|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800159|NCT04994262|Menthol|menthol|mesh-list
154800160|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
154800161|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
154800162|NCT00939159|Panobinostat|panobinostat|mesh-list
154800163|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800164|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154800165|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800166|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800167|NCT04144439|Butyric Acid|butyric acid|mesh-list
154800168|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
154800169|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
154800170|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800171|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800172|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800173|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
154800174|NCT04994574|Olodaterol|olodaterol|mesh-list
154800175|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154800176|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
154800177|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800178|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800179|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154800180|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
154800181|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
154800182|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154800183|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
154800184|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800185|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800187|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154800188|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154800189|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
154800190|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800191|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800192|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154800193|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
154800194|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
154800195|NCT04355637|Hormones|hormones|mesh-ancestor
154800196|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800197|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
154800198|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800199|NCT03076710|Bupivacaine|bupivacaine|mesh-list
154800200|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
154800201|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
154800202|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800203|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800204|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
154800205|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800206|NCT04143581|Empagliflozin|empagliflozin|mesh-list
154800207|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154800208|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800209|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800210|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800211|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154800212|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154800213|NCT03071172|Progesterone|progesterone|mesh-list
154800214|NCT03071172|Hormones|hormones|mesh-ancestor
154800215|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800216|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800217|NCT03071172|Progestins|progestins|mesh-ancestor
154800218|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
154800219|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154800220|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
154800221|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154800222|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154800223|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154800224|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800225|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
154800226|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154800227|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
154800228|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154800229|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154800230|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154800231|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154800232|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800233|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
154800234|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800235|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800236|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154800237|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800238|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
154800239|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154800240|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154800241|NCT04355247|Prednisolone|prednisolone|mesh-list
154800242|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
154800243|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154800244|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
154800245|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154800246|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
154800247|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
154800248|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552207|NCT05781035|Dexmedetomidine|dexmedetomidine|mesh-list
154800249|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800250|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800251|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
154800252|NCT04355247|Hormones|hormones|mesh-ancestor
154800253|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800254|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154800255|NCT04355247|Protective Agents|protective agents|mesh-ancestor
154800256|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154800257|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800258|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
154800259|NCT03903809|Hematinics|hematinics|mesh-ancestor
154800260|NCT04987554|Immunoferon|immunoferon|mesh-list
154800261|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154800262|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
154800263|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800264|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
154800265|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154800266|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800267|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800268|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154800269|NCT04358367|Analgesics|analgesics|mesh-ancestor
154800270|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
154800271|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800272|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154800273|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154800274|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154800275|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
154800276|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800277|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800278|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
154800279|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
154800280|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800281|NCT03917303|Adalimumab|adalimumab|mesh-list
154800282|NCT03917303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154800283|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154800284|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800285|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154800286|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154800287|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800288|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
154800289|NCT05583149|Fludarabine|fludarabine|mesh-list
154800290|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
154800291|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154800292|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
154800293|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800294|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800295|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154800296|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
154800297|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800298|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800299|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154800300|NCT05583149|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154800301|NCT05583149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154800302|NCT05583149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800303|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
154800304|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800305|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
154800306|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
154800307|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
154800308|NCT04989270|Anesthetics|anesthetics|mesh-list
154800309|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800310|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800311|NCT04346823|Sevoflurane|sevoflurane|mesh-list
154800312|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154800313|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154800314|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
154800315|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
154800316|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800317|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800318|NCT05582837|Topiramate|topiramate|mesh-list
154800319|NCT05582837|Nortriptyline|nortriptyline|mesh-list
154800320|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
154800321|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800322|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800323|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154800324|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
154800325|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154800326|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154800327|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154800328|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154800329|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800330|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
154800331|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800332|NCT05003700|Lenvatinib|lenvatinib|mesh-list
154800333|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800334|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154800335|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800336|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800337|NCT04143191|Sorafenib|sorafenib|mesh-list
154800338|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800339|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154800340|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800341|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800342|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154800343|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154800344|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800345|NCT04461288|Nicotine|nicotine|mesh-list
154800346|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154800347|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
154800348|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800349|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800350|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154800351|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154800352|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
154800353|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800354|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800355|NCT05582135|Morphine|morphine|mesh-list
154800356|NCT05582135|Esketamine|esketamine|mesh-list
154800357|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154800358|NCT05582135|Narcotics|narcotics|mesh-ancestor
154800359|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800360|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800361|NCT05582135|Analgesics|analgesics|mesh-ancestor
154800362|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
154800363|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800364|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
154800365|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154800366|NCT03070704|Liraglutide|liraglutide|mesh-list
154800367|NCT03070704|Xultophy|xultophy|mesh-list
154800368|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800369|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800370|NCT03070704|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154800371|NCT03070704|Incretins|incretins|mesh-ancestor
154800372|NCT03070704|Hormones|hormones|mesh-ancestor
154800373|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800374|NCT03069768|Varenicline|varenicline|mesh-list
154800375|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154800376|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154800377|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
154800378|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800379|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800380|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800381|NCT04141553|Diltiazem|diltiazem|mesh-list
154800382|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154800383|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154800384|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154800385|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800386|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154800387|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800388|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
154800389|NCT04141163|Metformin|metformin|mesh-list
154800390|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800391|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800392|NCT00942825|Cisplatin|cisplatin|mesh-list
154800393|NCT00942825|Pemetrexed|pemetrexed|mesh-list
154800394|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800395|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800396|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800397|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154800398|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154800399|NCT04544943|Gentamicins|gentamicins|mesh-list
154800400|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154800401|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800402|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154800403|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800404|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800405|NCT04140461|Amphotericin B|amphotericin b|mesh-list
154800406|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154800407|NCT04140461|Flucytosine|flucytosine|mesh-list
154800408|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800409|NCT04140461|Amebicides|amebicides|mesh-ancestor
154800410|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154800411|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154800412|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154800413|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
154800414|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
154800415|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800416|NCT03021629|Vitamin D|vitamin d|mesh-list
154800417|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154800418|NCT03021629|Vitamins|vitamins|mesh-ancestor
154800419|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
154800420|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800421|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154800422|NCT03021395|Decitabine|decitabine|mesh-list
154800423|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154800424|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
154800425|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800426|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800427|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800428|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154800429|NCT03021317|Hormones|hormones|mesh-ancestor
154800430|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800431|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800432|NCT04987632|Letrozole|letrozole|mesh-list
154800433|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800434|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154800435|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154800436|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800437|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800438|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154800439|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
154800440|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800441|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800442|NCT03032367|Bedaquiline|bedaquiline|mesh-list
154800443|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
154800444|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154800445|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800446|NCT02634606|Tocotrienols|tocotrienols|mesh-list
154800447|NCT02634606|Vitamin E|vitamin e|mesh-list
154800448|NCT02634606|Tocopherols|tocopherols|mesh-list
154800449|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
154800450|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800451|NCT02634606|Protective Agents|protective agents|mesh-ancestor
154800452|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800453|NCT02634606|Vitamins|vitamins|mesh-ancestor
154800454|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
154800455|NCT05002686|Paclitaxel|paclitaxel|mesh-list
154800456|NCT05002686|Capecitabine|capecitabine|mesh-list
154800457|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
154800458|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154800459|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800460|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
154800461|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
154800462|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
154800463|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800464|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154800465|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
154800466|NCT03588689|Ropivacaine|ropivacaine|mesh-list
154800467|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
154800468|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
154800469|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800470|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552437|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154800471|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
154800472|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800473|NCT04985526|Octenidine|octenidine|mesh-list
154800474|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800475|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154800476|NCT03588611|Hirudins|hirudins|mesh-list
154800477|NCT03588611|Bivalirudin|bivalirudin|mesh-list
154800478|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
153979967|NCT00727831|Leucovorin|leucovorin|mesh-list
154800479|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154800480|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
154800481|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800482|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800483|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
154800484|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154800485|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154800486|NCT03588533|Capecitabine|capecitabine|mesh-list
154800487|NCT03588533|Trastuzumab|trastuzumab|mesh-list
154800488|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800489|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154800490|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
154800491|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800492|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154800493|NCT00939705|Topiramate|topiramate|mesh-list
154800494|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
154800495|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800496|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800497|NCT05001672|Tenofovir|tenofovir|mesh-list
154800498|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
154800499|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980016|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154800500|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154800501|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154800502|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800503|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800504|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154800505|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154800506|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154800507|NCT04354545|Lifitegrast|lifitegrast|mesh-list
154800508|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154800509|NCT03587285|Goserelin|goserelin|mesh-list
154800510|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
154800511|NCT03587285|Bicalutamide|bicalutamide|mesh-list
154800512|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154800513|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800514|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154800515|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800516|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800517|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
154800518|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800519|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800520|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154800521|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
154800522|NCT03587129|Apatinib|apatinib|mesh-list
154800523|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800524|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154800525|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800526|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800527|NCT02245503|Tamsulosin|tamsulosin|mesh-list
154800528|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154800529|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154800530|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154800531|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
154800532|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800533|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800534|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800535|NCT02245503|Urological Agents|urological agents|mesh-ancestor
154800536|NCT03586817|Palonosetron|palonosetron|mesh-list
154800537|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
154800538|NCT03586817|Aprepitant|aprepitant|mesh-list
154800539|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
154800540|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
154800541|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800542|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800543|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800544|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154800545|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154800546|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
154800547|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552556|NCT04102020|Cc-486|cc-486|mesh-list
154800548|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800549|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154800551|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800552|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154800553|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
154800554|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
154800555|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
154800556|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800557|NCT03585725|Ribavirin|ribavirin|mesh-list
154800558|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
154800559|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800560|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
154800561|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800562|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154800563|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154800564|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154800565|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154800566|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800567|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
154800568|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800569|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800570|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154800571|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800572|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
154800573|NCT03585179|Hydroquinone|hydroquinone|mesh-list
154800574|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154800575|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154800576|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800577|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
154800578|NCT03585179|Coagulants|coagulants|mesh-ancestor
154800579|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
154800580|NCT03585179|Protective Agents|protective agents|mesh-ancestor
154800581|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800582|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154800583|NCT03585101|Grazoprevir|grazoprevir|mesh-list
154800584|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154800585|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
154800586|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800587|NCT03584087|Terlipressin|terlipressin|mesh-list
154800588|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154800589|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154800590|NCT03031353|Misoprostol|misoprostol|mesh-list
154800591|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154800592|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
154800593|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154800594|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800595|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154800596|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800597|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
154800598|NCT05702957|Letrozole|letrozole|mesh-list
154800599|NCT05702957|Clomiphene|clomiphene|mesh-list
154800600|NCT05702957|Enclomiphene|enclomiphene|mesh-list
154800601|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
154800602|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800603|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800604|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154800605|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154800606|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800607|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154800608|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
154800609|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800610|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800611|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154800612|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
154800613|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154800614|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154800615|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154800616|NCT04405505|Paclitaxel|paclitaxel|mesh-list
154800617|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154800618|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800619|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
154800620|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
154800621|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
154800622|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800624|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
154800625|NCT03580733|Clotrimazole|clotrimazole|mesh-list
154800626|NCT03580733|Miconazole|miconazole|mesh-list
154800627|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800628|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800629|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800630|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154800631|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154800632|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154800633|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154800634|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
154800635|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800636|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800637|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154800638|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154800639|NCT00951561|Ibuprofen|ibuprofen|mesh-list
154800640|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154800641|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154800642|NCT00951561|Analgesics|analgesics|mesh-ancestor
154800643|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
154800644|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800645|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800646|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154800647|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800648|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154800649|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800650|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800651|NCT03031119|Atorvastatin|atorvastatin|mesh-list
154800652|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154800653|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154800654|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
154800655|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980165|NCT04289090|Propofol|propofol|mesh-list
154800656|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154800657|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154800658|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800659|NCT03581903|Vaccines|vaccines|mesh-list
154800660|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
154800661|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800662|NCT02783547|Azacitidine|azacitidine|mesh-list
154800663|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154800664|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
154800665|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800666|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800667|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800668|NCT02555007|Vinorelbine|vinorelbine|mesh-list
154800669|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154800670|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800671|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
154800672|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
154800673|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
154800674|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800675|NCT03898037|Metformin|metformin|mesh-list
154800676|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800677|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800678|NCT03068208|Methylene Blue|methylene blue|mesh-list
154800679|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800680|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800681|NCT03067974|Ketamine|ketamine|mesh-list
154800682|NCT03067974|Analgesics|analgesics|mesh-ancestor
154800683|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
154800684|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800685|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800686|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154800687|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154800688|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
154800689|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
154800690|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800691|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154800692|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154800693|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800694|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800695|NCT03582137|Cannabidiol|cannabidiol|mesh-list
154800696|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
154800697|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
154800698|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154800699|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
154800700|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800701|NCT04405193|Expectorants|expectorants|mesh-ancestor
154800702|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
154800703|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154800704|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
154800705|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800706|NCT04405193|Protective Agents|protective agents|mesh-ancestor
154800707|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800708|NCT04405193|Antidotes|antidotes|mesh-ancestor
154800709|NCT05227833|Pantoprazole|pantoprazole|mesh-list
154800710|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154800711|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800712|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154800713|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800714|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800715|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
154800716|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154800717|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154800718|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800719|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154800720|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154800721|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
154800722|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800723|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800724|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154800725|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
154800726|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800727|NCT04405271|Tenofovir|tenofovir|mesh-list
154800728|NCT04405271|Emtricitabine|emtricitabine|mesh-list
154800729|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154800730|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
154800731|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800732|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154800733|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154800734|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800735|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800736|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154800737|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154800738|NCT03034941|Metformin|metformin|mesh-list
154800739|NCT03034941|Liraglutide|liraglutide|mesh-list
154800740|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154800741|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800742|NCT03034941|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154800743|NCT03034941|Incretins|incretins|mesh-ancestor
154800744|NCT03034941|Hormones|hormones|mesh-ancestor
154800745|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800746|NCT03030105|Scopolamine|scopolamine|mesh-list
154800747|NCT03030105|Donepezil|donepezil|mesh-list
154800748|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154800749|NCT03030105|BPN14770|bpn14770|mesh-list
154800750|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154800751|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800752|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800753|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
154800754|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800755|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800756|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
154800757|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154800758|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
154800759|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
154800760|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800761|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800762|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
154800763|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154800764|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154800765|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
154800766|NCT03030105|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154800767|NCT03030105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154800768|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
154800769|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
154800771|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
154800772|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
153980256|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
154800773|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800774|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800775|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
154800776|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800777|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154800778|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154800779|NCT03067896|Analgesics|analgesics|mesh-ancestor
154800780|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154800781|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154800782|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154800783|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
154800784|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800785|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800786|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154800787|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
154800788|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154800789|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154800790|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154800791|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
154800792|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154800793|NCT03034707|Biotin|biotin|mesh-list
154800794|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
154800795|NCT03034707|Vitamins|vitamins|mesh-ancestor
154800796|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
154800797|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800798|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
154800799|NCT03067740|Bupivacaine|bupivacaine|mesh-list
154800800|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
154800801|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
154800802|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800803|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800804|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
154800805|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800806|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154800807|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154800808|NCT03067740|Analgesics|analgesics|mesh-ancestor
154800809|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154800810|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154800811|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154800812|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
154800813|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800814|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800815|NCT05730114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154800816|NCT03027843|Hormones|hormones|mesh-list
154800817|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800818|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800819|NCT03068832|Poly I-C|poly i-c|mesh-list
154800820|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154800821|NCT03068832|Poly ICLC|poly iclc|mesh-list
154800822|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
154800823|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
154800824|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800825|NCT03068832|Laxatives|laxatives|mesh-ancestor
154800826|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800827|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
154800828|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800829|NCT03033537|Verapamil|verapamil|mesh-list
154800830|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
154800831|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154800832|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800833|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154800834|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154800835|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800836|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
154800837|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
154800838|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154800839|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800840|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154800841|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154800842|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800843|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800844|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800845|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154800846|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154800847|NCT03069144|Calcitriol|calcitriol|mesh-list
154800848|NCT03069144|Calcipotriene|calcipotriene|mesh-list
154800849|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
154800850|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154800851|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800852|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154800853|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154800854|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800855|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154800856|NCT03069144|Vitamins|vitamins|mesh-ancestor
154800857|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
154800858|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154800859|NCT03017703|Eplerenone|eplerenone|mesh-list
154800860|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154800861|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
154800862|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800863|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800864|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154800865|NCT03017703|Diuretics|diuretics|mesh-ancestor
154800866|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
154800867|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154800868|NCT01670669|Prucalopride|prucalopride|mesh-list
154800869|NCT01670669|Laxatives|laxatives|mesh-ancestor
154800870|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800871|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154800872|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154800873|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
154800874|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800875|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800876|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800877|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
154800878|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
154800879|NCT00946023|Rituximab|rituximab|mesh-list
154800880|NCT00946023|Fludarabine|fludarabine|mesh-list
154800881|NCT00946023|Tacrolimus|tacrolimus|mesh-list
154800882|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154800883|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
154800884|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800885|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800886|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154800887|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
154800888|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800889|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800890|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154800891|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154800892|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154800893|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800894|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154800895|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154800896|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
154800897|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154800898|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800899|NCT01672151|Sirolimus|sirolimus|mesh-list
154800900|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154800901|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154800902|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154800903|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800904|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
154800905|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154800906|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
154800907|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800908|NCT01672229|Bortezomib|bortezomib|mesh-list
154800909|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800910|NCT01672307|Minoxidil|minoxidil|mesh-list
154800911|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154800912|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
154800913|NCT03067194|Celecoxib|celecoxib|mesh-list
154800914|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154800915|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154800916|NCT03067194|Analgesics|analgesics|mesh-ancestor
154800917|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
154800918|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800919|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800920|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154800921|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800922|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154800923|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154800924|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800925|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800926|NCT05629494|Ibuprofen|ibuprofen|mesh-list
154800927|NCT05629494|Naproxen|naproxen|mesh-list
154800928|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154800929|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154800930|NCT05629494|Analgesics|analgesics|mesh-ancestor
154800931|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
154800932|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800933|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800934|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154800935|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154800936|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154800937|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800938|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800939|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
154800940|NCT00952653|Midazolam|midazolam|mesh-list
154800941|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154800942|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154800943|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154800944|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154800945|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800946|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154800947|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154800948|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154800949|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154800950|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
154800951|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
154800952|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
154800953|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
154800954|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154800955|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800956|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154800957|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154800958|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154800959|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
154800960|NCT01673087|Dexamethasone|dexamethasone|mesh-list
154800961|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154800962|NCT01673087|Cosyntropin|cosyntropin|mesh-list
154800963|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
154800964|NCT01673087|Metyrapone|metyrapone|mesh-list
154800965|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154800966|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
154800967|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
154800968|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154800969|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800970|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154800971|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
154800972|NCT01673087|Hormones|hormones|mesh-ancestor
154800973|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800974|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154800975|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800976|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
154800977|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800978|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800979|NCT02299505|Ceritinib|ceritinib|mesh-list
154800980|NCT02299505|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154800981|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154800982|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154800983|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800984|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800985|NCT01673399|Atosiban|atosiban|mesh-list
154800986|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
154800987|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154800988|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154800989|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
154800990|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154800991|NCT02235701|Ifosfamide|ifosfamide|mesh-list
154800992|NCT02235701|Doxorubicin|doxorubicin|mesh-list
154800993|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154800994|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
154800995|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154800996|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154800997|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154800998|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154800999|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154801000|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801001|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154801003|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
154801004|NCT01674257|Protective Agents|protective agents|mesh-ancestor
154801005|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801006|NCT01674257|Hematinics|hematinics|mesh-ancestor
154801007|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154801008|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154801009|NCT01674413|Adalimumab|adalimumab|mesh-list
154801010|NCT01674413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154801011|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801012|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801013|NCT00953121|Bevacizumab|bevacizumab|mesh-list
154801014|NCT00953121|Carboplatin|carboplatin|mesh-list
154801015|NCT00953121|Irinotecan|irinotecan|mesh-list
154801016|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154801017|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801018|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154801019|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154801020|NCT00953121|Growth Substances|growth substances|mesh-ancestor
154801021|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801022|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
154801023|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154801024|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154801025|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801026|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801027|NCT03017391|Dexamethasone|dexamethasone|mesh-list
154801028|NCT03017391|Metoclopramide|metoclopramide|mesh-list
154801029|NCT03017391|Granisetron|granisetron|mesh-list
154801030|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801031|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
154801032|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
154801033|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801034|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801035|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154801036|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
154801037|NCT03017391|Hormones|hormones|mesh-ancestor
154801038|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154801039|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154801040|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801041|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154801042|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154801043|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
154801044|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801045|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801046|NCT03017391|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154801047|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154801048|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
154801049|NCT00953199|Lidocaine|lidocaine|mesh-list
154801050|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
154801051|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
154801052|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801053|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801054|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
154801055|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801056|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154801057|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154801058|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154801059|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154801060|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801061|NCT03033147|Amoxicillin|amoxicillin|mesh-list
154801062|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
154801063|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
154801064|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154801065|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801066|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801067|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154801068|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801069|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801070|NCT01675895|Lidocaine|lidocaine|mesh-list
154801071|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
154801072|NCT01675895|Anesthetics|anesthetics|mesh-list
154801073|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
154801074|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801075|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801076|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
154801077|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801078|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154801079|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154801080|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154801081|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154801082|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801083|NCT01675973|Ranolazine|ranolazine|mesh-list
154801084|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154801085|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154801086|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801087|NCT04764851|Ecopipam|ecopipam|mesh-list
154801088|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154801089|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154801090|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801091|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801092|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154801093|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154801094|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
154801095|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801096|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801097|NCT00956085|Memantine|memantine|mesh-list
154801098|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154801099|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154801100|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
154801101|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801102|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801103|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801104|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154801105|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154801106|NCT01005459|Bupivacaine|bupivacaine|mesh-list
154801107|NCT01005459|Tetracaine|tetracaine|mesh-list
154801108|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
154801109|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
154801110|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801111|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801112|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
154801113|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801114|NCT01676285|Metoprolol|metoprolol|mesh-list
154801115|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154801116|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154801117|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
154801118|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
154801119|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801120|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801121|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154801122|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154801123|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154801124|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
154801125|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801126|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801127|NCT01676363|Diflunisal|diflunisal|mesh-list
154801128|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154801129|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154801130|NCT01676363|Analgesics|analgesics|mesh-ancestor
154801131|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
154801132|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801133|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801134|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801135|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801136|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154801137|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801138|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801139|NCT00956709|Ropivacaine|ropivacaine|mesh-list
154801140|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
154801141|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
154801142|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
154801143|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801144|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801145|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
154801146|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801147|NCT00957333|Ketamine|ketamine|mesh-list
154801148|NCT00957333|Analgesics|analgesics|mesh-ancestor
154801149|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
154801150|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801151|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801152|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154801153|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154801154|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
154801155|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
154801156|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801157|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154801158|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154801159|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801160|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801161|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154801162|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154801163|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154801164|NCT02159547|Analgesics|analgesics|mesh-ancestor
154801165|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
154801166|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801167|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801168|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801169|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801170|NCT00958035|Bimatoprost|bimatoprost|mesh-list
154801171|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154801172|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154801173|NCT01011075|Paclitaxel|paclitaxel|mesh-list
154801174|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
154801175|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154801176|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801177|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
154801178|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
154801179|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
154801180|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801181|NCT01011075|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154801182|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154801183|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801184|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
154801185|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
154801186|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154801187|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154801188|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801189|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
154801190|NCT00958581|Coagulants|coagulants|mesh-ancestor
154801191|NCT01012089|Daptomycin|daptomycin|mesh-list
154801192|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801193|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801194|NCT04265651|Infigratinib|infigratinib|mesh-list
154801195|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801196|NCT04055753|Doxorubicin|doxorubicin|mesh-list
154801197|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154801198|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801199|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154801200|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154801201|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801202|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801203|NCT04764383|Histamine|histamine|mesh-list
154801204|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
154801205|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
154801206|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801207|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801208|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801209|NCT03016611|Ticagrelor|ticagrelor|mesh-list
154801210|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154801211|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154801212|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154553194|NCT02429193|Prednisone|prednisone|mesh-list
154801213|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154801214|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154801215|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
154801216|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801217|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801218|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801219|NCT00961233|Budesonide|budesonide|mesh-list
154801220|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801221|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154801222|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
154801223|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801224|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801225|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154801226|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
154801227|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
154801228|NCT00961233|Hormones|hormones|mesh-ancestor
154801229|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154801230|NCT00962871|Tenofovir|tenofovir|mesh-list
154801231|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154801232|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
154801233|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980736|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
154801234|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154801235|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154801236|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801237|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801238|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154801239|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154801240|NCT01014351|Paclitaxel|paclitaxel|mesh-list
154801241|NCT01014351|Carboplatin|carboplatin|mesh-list
154801242|NCT01014351|Everolimus|everolimus|mesh-list
154801243|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154801244|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801245|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
154801246|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
154801247|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
154801248|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801249|NCT01014351|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154801250|NCT01014351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154801251|NCT01014351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801252|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154801253|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
154801254|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801255|NCT01014741|Ibutilide|ibutilide|mesh-list
154801256|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154801257|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
154801258|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154801259|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
154801260|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801261|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801262|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154801263|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
154801264|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801265|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801266|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154801267|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
154801268|NCT00962949|Giapreza|giapreza|mesh-list
154801269|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
154801270|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154801271|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154801272|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
154801273|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801274|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801275|NCT01244789|Paclitaxel|paclitaxel|mesh-list
154801276|NCT01244789|Carboplatin|carboplatin|mesh-list
154801277|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154801278|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801279|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
154801280|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
154801281|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
154801282|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801283|NCT02631876|Paclitaxel|paclitaxel|mesh-list
154801284|NCT02631876|Maytansine|maytansine|mesh-list
154801285|NCT02631876|Doxorubicin|doxorubicin|mesh-list
154801286|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154801287|NCT02631876|Topotecan|topotecan|mesh-list
154801288|NCT02631876|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154801289|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154801290|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801291|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
154801292|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
154801293|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
153980783|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154801294|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801295|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154801296|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154801297|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154801298|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801299|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154801300|NCT02631876|Immunoconjugates|immunoconjugates|mesh-ancestor
154801301|NCT02631876|Immunologic Factors|immunologic factors|mesh-ancestor
154801302|NCT02631876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801303|NCT03156179|Calcium|calcium|mesh-list
154801304|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154801305|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801306|NCT04436796|Pancrelipase|pancrelipase|mesh-list
154801307|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154801308|NCT02081963|Amikacin|amikacin|mesh-list
154801309|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801310|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801311|NCT04765085|Aripiprazole|aripiprazole|mesh-list
154801312|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
154801313|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154801314|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154801315|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154801316|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801317|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801318|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
154801319|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
154801320|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801321|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801322|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154801323|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154801324|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
154801325|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154801326|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154801327|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154801328|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154801329|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154801330|NCT02633046|Hormones|hormones|mesh-ancestor
154801331|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154801332|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801333|NCT01676597|Rifaximin|rifaximin|mesh-list
154801334|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
154801335|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801336|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801337|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154801338|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154801339|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801340|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801341|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154801342|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154801343|NCT01676597|Protective Agents|protective agents|mesh-ancestor
154801344|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801345|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
154801346|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154801347|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
154801348|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154801349|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
154801350|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801351|NCT04364802|Iodine|iodine|mesh-list
154801352|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
154801353|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
154801354|NCT04364802|Povidone|povidone|mesh-list
154801355|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154801356|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801357|NCT04364802|Trace Elements|trace elements|mesh-ancestor
154801358|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
154801359|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801360|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
154801361|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
154801362|NCT03155087|Metformin|metformin|mesh-list
154801363|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154801364|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801365|NCT00963105|Lenalidomide|lenalidomide|mesh-list
154801366|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
154801367|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801368|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154801369|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154801370|NCT00963105|Growth Substances|growth substances|mesh-ancestor
154801371|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
154801372|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801373|NCT04879992|Amoxicillin|amoxicillin|mesh-list
154801374|NCT04879992|Metronidazole|metronidazole|mesh-list
154801375|NCT04879992|Tetracycline|tetracycline|mesh-list
154801376|NCT04879992|Rifabutin|rifabutin|mesh-list
154801377|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
154801378|NCT04879992|Esomeprazole|esomeprazole|mesh-list
154801379|NCT04879992|Bismuth|bismuth|mesh-list
154801380|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801381|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801382|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801383|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154801384|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154801385|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154801386|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154801387|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154801388|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801389|NCT04879992|Antacids|antacids|mesh-ancestor
154801390|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154801391|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154801392|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
154801393|NCT04879992|Diuretics|diuretics|mesh-ancestor
154801394|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
154801395|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801396|NCT04879992|Expectorants|expectorants|mesh-ancestor
154801397|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
154801398|NCT01016691|Bimatoprost|bimatoprost|mesh-list
154801399|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154801400|NCT04181736|Guanfacine|guanfacine|mesh-list
154801401|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154801402|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154801403|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154801404|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154801405|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
154801406|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801407|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801408|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801409|NCT04404491|Capecitabine|capecitabine|mesh-list
154801410|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154801411|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
154801412|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801413|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801414|NCT03155009|Alectinib|alectinib|mesh-list
154801415|NCT03155009|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154801416|NCT03155009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154801417|NCT03155009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801418|NCT03155009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801419|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154801420|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
154801421|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801422|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154801423|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154801424|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
154801425|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801426|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801427|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154801428|NCT03858491|Cobicistat|cobicistat|mesh-list
154801429|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154801430|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154801431|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
154801432|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801433|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154801434|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154801435|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801436|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801437|NCT01672788|Metformin|metformin|mesh-list
154801438|NCT01672788|Empagliflozin|empagliflozin|mesh-list
154801439|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154801440|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801441|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154801442|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801443|NCT02705963|Trametinib|trametinib|mesh-list
154801444|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154801445|NCT02705963|Norethindrone|norethindrone|mesh-list
154801446|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
154801447|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
154801448|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
154801449|NCT02705963|Estradiol|estradiol|mesh-list
154801450|NCT02705963|Estrogens|estrogens|mesh-ancestor
154801451|NCT02705963|Hormones|hormones|mesh-ancestor
154801452|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154801453|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801454|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154801455|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154801456|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154801457|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801458|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154801459|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801460|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801461|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154801462|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154801463|NCT03065868|Clarithromycin|clarithromycin|mesh-list
154801464|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801465|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801466|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154801467|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801468|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801469|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154801470|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154801471|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154801472|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154801473|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
154801474|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154801475|NCT03830723|Hormones|hormones|mesh-ancestor
154801476|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980958|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
154801477|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801478|NCT03814109|Niacin|niacin|mesh-list
154801479|NCT03814109|Indapamide|indapamide|mesh-list
154801480|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154801481|NCT03814109|Diuretics|diuretics|mesh-ancestor
154801482|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
154801483|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801484|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154801485|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154801486|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801487|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154801488|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
154801489|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154801490|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
154801491|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
154801492|NCT03814109|Vitamins|vitamins|mesh-ancestor
154801493|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
154801494|NCT01016769|Sirolimus|sirolimus|mesh-list
154801495|NCT01016769|Paclitaxel|paclitaxel|mesh-list
154801496|NCT01016769|Carboplatin|carboplatin|mesh-list
154801497|NCT01016769|Temsirolimus|temsirolimus|mesh-list
154801498|NCT01016769|MTOR Inhibitors|mtor inhibitors|mesh-list
154801499|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154801500|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801501|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
154801502|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
154801503|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
154801504|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801505|NCT01016769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154801506|NCT01016769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801507|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154801508|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
154801509|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801510|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801511|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801512|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154801513|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
154801514|NCT03019809|Plerixafor|plerixafor|mesh-list
154801515|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154801516|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154801517|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
154801518|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801519|NCT00964353|Warfarin|warfarin|mesh-list
154801520|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
154801521|NCT00964431|Celecoxib|celecoxib|mesh-list
154801522|NCT00964431|Indomethacin|indomethacin|mesh-list
154801523|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154801524|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154801525|NCT00964431|Analgesics|analgesics|mesh-ancestor
154801526|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
153981022|NCT02665845|Mesalamine|mesalamine|mesh-list
154801527|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801528|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801529|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801530|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801531|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154801532|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154801533|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801534|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801535|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
154801536|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
154801537|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154801538|NCT05475054|Liver Extracts|liver extracts|mesh-list
154801539|NCT05475054|Hematinics|hematinics|mesh-ancestor
154801540|NCT01017003|Colchicine|colchicine|mesh-list
154801541|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
154801542|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801543|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
154801544|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
154801545|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
154801546|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801547|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801548|NCT01017237|Midazolam|midazolam|mesh-list
154801549|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
154801550|NCT01017237|Ketamine|ketamine|mesh-list
154801551|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154801552|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801553|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801554|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154801555|NCT01017237|Analgesics|analgesics|mesh-ancestor
154801556|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
154801557|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801558|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154801559|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154801560|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154801561|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
154801562|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801563|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801564|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154801565|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154801566|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
154801567|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
154801568|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154801569|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154801570|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154801571|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154801572|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154801573|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154801574|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
154801575|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
154801576|NCT04442412|Vitamin D|vitamin d|mesh-list
154801577|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
154801578|NCT04442412|Vitamins|vitamins|mesh-ancestor
154801579|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
154801580|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801581|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154801582|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154801583|NCT01018095|Metronidazole|metronidazole|mesh-list
154801584|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801585|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801586|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154801587|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154801588|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
154801589|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
154801590|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801591|NCT03788759|Protective Agents|protective agents|mesh-ancestor
154801592|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801593|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
154801594|NCT03788759|Vitamins|vitamins|mesh-ancestor
154801595|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
154801597|NCT00967551|Trace Elements|trace elements|mesh-list
154801598|NCT00967551|Micronutrients|micronutrients|mesh-list
154801599|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801600|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154801601|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154801602|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154801603|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
154801604|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801605|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801606|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
154801607|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801608|NCT00970203|Vaccines|vaccines|mesh-list
154801609|NCT00970203|Androgens|androgens|mesh-list
154801610|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
154801611|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801612|NCT00970203|Hormones|hormones|mesh-ancestor
154801613|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154801614|NCT00971295|Metformin|metformin|mesh-list
154801615|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154801616|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154801617|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801618|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
154801619|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154801620|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154801621|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154801622|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801623|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154801624|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
154801625|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154801626|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154801627|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154801628|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801629|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801630|NCT00971841|Paclitaxel|paclitaxel|mesh-list
154801631|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154801632|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801633|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
154801634|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
154801635|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
154801636|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801637|NCT02246049|Leucovorin|leucovorin|mesh-list
154801638|NCT02246049|Bevacizumab|bevacizumab|mesh-list
154801639|NCT02246049|Fluorouracil|fluorouracil|mesh-list
154801640|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
154801641|NCT02246049|Irinotecan|irinotecan|mesh-list
154801642|NCT02246049|Calcium|calcium|mesh-list
154801643|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
154801644|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154801645|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801646|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153981136|NCT02662725|Ipilimumab|ipilimumab|mesh-list
154801647|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154801648|NCT02246049|Growth Substances|growth substances|mesh-ancestor
154801649|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801650|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
154801651|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154801652|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
154801653|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801654|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154801655|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154801656|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
154801657|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154801658|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154801659|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801660|NCT02246049|Antidotes|antidotes|mesh-ancestor
154801661|NCT02246049|Protective Agents|protective agents|mesh-ancestor
154801662|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
154801663|NCT02246049|Vitamins|vitamins|mesh-ancestor
154801664|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
154801665|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
154801666|NCT05395143|Astringents|astringents|mesh-ancestor
154801667|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801668|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
154801669|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
154801670|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801671|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
154801672|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
154801673|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801674|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801675|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154801676|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
154801677|NCT05394909|Hormones|hormones|mesh-ancestor
154801678|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154801679|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154801680|NCT05394909|Protective Agents|protective agents|mesh-ancestor
154801681|NCT05394597|ethyl-3-(N-n-butyl-N-acetyl)aminopropionate|ethyl-3-(n-n-butyl-n-acetyl)aminopropionate|mesh-list
154801682|NCT05394597|Insect Repellents|insect repellents|mesh-ancestor
154801683|NCT05394597|Protective Agents|protective agents|mesh-ancestor
154801684|NCT05394597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801685|NCT02159859|Ertapenem|ertapenem|mesh-list
154801686|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154801687|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801688|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154801689|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154801690|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801691|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
154801692|NCT02083679|Paclitaxel|paclitaxel|mesh-list
154801693|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154801694|NCT02083679|Cisplatin|cisplatin|mesh-list
154801695|NCT02083679|Carboplatin|carboplatin|mesh-list
154801696|NCT02083679|Gemcitabine|gemcitabine|mesh-list
154801697|NCT02083679|Pemetrexed|pemetrexed|mesh-list
154801698|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154801699|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154801700|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801701|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
154801702|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
154801703|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
154801704|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801705|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154801706|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
154801707|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801708|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154801709|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154801710|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
154801711|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801713|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154801714|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
154801715|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801716|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154801717|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
154801718|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
154801719|NCT01672710|Vitamins|vitamins|mesh-ancestor
154801720|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
154801721|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801722|NCT03766763|Venetoclax|venetoclax|mesh-list
154801723|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801724|NCT04790448|Irinotecan|irinotecan|mesh-list
154801725|NCT04790448|Camptothecin|camptothecin|mesh-list
154801726|NCT04790448|Cetuximab|cetuximab|mesh-list
154801727|NCT04790448|Vemurafenib|vemurafenib|mesh-list
154801728|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154801729|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154801730|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801731|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801732|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801733|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154801734|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154801735|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154801736|NCT00976521|Abciximab|abciximab|mesh-list
154801737|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
154801738|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154801739|NCT04410588|Fentanyl|fentanyl|mesh-list
154801740|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
154801741|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154801742|NCT04410588|Narcotics|narcotics|mesh-ancestor
154801743|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801744|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801745|NCT04410588|Analgesics|analgesics|mesh-ancestor
154801746|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
154801747|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801748|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154801749|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154801750|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
154801751|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
154801752|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
154801753|NCT05303220|Branebrutinib|branebrutinib|mesh-list
154801754|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154801755|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801756|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801757|NCT04444830|Ketorolac|ketorolac|mesh-list
154801758|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154801759|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154801760|NCT04444830|Analgesics|analgesics|mesh-ancestor
154801761|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
154801762|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801763|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801764|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801765|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801766|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154801767|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801768|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801769|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154801770|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154801771|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
154801772|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801773|NCT03738917|Levomethorphan|levomethorphan|mesh-list
154801774|NCT03738917|Bromides|bromides|mesh-list
154801775|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
154801776|NCT03738917|Ipratropium|ipratropium|mesh-list
154801777|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154801778|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
154801779|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
154801780|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
154801781|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154801782|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154801783|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801784|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801785|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801786|NCT03738917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154801787|NCT03738917|Narcotics|narcotics|mesh-ancestor
154801788|NCT03738917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801789|NCT03738917|Analgesics|analgesics|mesh-ancestor
154801790|NCT03738917|Sensory System Agents|sensory system agents|mesh-ancestor
154801791|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801792|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154801793|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
154801794|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154801795|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
154801796|NCT00976599|Methotrexate|methotrexate|mesh-list
154801797|NCT00976599|Tofacitinib|tofacitinib|mesh-list
154801798|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154801799|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
154801800|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154801801|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801802|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154801803|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
154801804|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801805|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801806|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
154801807|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801808|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154801809|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154801810|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
154801811|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801812|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154801813|NCT00976599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154801814|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154801815|NCT02630472|Quinine|quinine|mesh-list
154801816|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
154801817|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154801818|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154801819|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154801820|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154801821|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801822|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154801823|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801824|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153981307|NCT02654379|Rituximab|rituximab|mesh-list
154801825|NCT02630472|Analgesics|analgesics|mesh-ancestor
154801826|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
154801827|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154801828|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
154801829|NCT05264922|Coagulants|coagulants|mesh-ancestor
154801830|NCT00977769|Oxytocin|oxytocin|mesh-list
154801831|NCT00977769|Carbetocin|carbetocin|mesh-list
154801832|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
154801833|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154801834|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801835|NCT03725501|Ranibizumab|ranibizumab|mesh-list
154801836|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154801837|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154801838|NCT03725501|Growth Substances|growth substances|mesh-ancestor
154801839|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801840|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
154801841|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801842|NCT00979017|Bevacizumab|bevacizumab|mesh-list
154801843|NCT00979017|Irinotecan|irinotecan|mesh-list
154801844|NCT00979017|Temozolomide|temozolomide|mesh-list
154801845|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154801846|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801847|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154801848|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154801849|NCT00979017|Growth Substances|growth substances|mesh-ancestor
154801850|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801851|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
154801852|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154801853|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154801854|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801855|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801856|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154801857|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
154801858|NCT01670526|Rivastigmine|rivastigmine|mesh-list
154801859|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154801860|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801861|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801862|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
154801863|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154801864|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801865|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154801866|NCT01670526|Protective Agents|protective agents|mesh-ancestor
154801867|NCT00945035|Etoricoxib|etoricoxib|mesh-list
154801868|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154801869|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154801870|NCT00945035|Analgesics|analgesics|mesh-ancestor
154801871|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
154801872|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801873|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801874|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801875|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801876|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154801877|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154801878|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801879|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801880|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
154801881|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154801882|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801883|NCT03720431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154801884|NCT03720431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801885|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154801886|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154801887|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
154801888|NCT05176548|Paraproteins|paraproteins|mesh-list
154801889|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
154801890|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801891|NCT00979875|Insulin|insulin|mesh-list
154801892|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154801893|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
154801894|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
154801895|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
154801896|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154801897|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801898|NCT03710603|Dexamethasone|dexamethasone|mesh-list
154801899|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
154801900|NCT03710603|Lenalidomide|lenalidomide|mesh-list
154801901|NCT03710603|Bortezomib|bortezomib|mesh-list
154801902|NCT03710603|Daratumumab|daratumumab|mesh-list
154801903|NCT03710603|BB 1101|bb 1101|mesh-list
154801904|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801905|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
154801906|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
154801907|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801908|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801909|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154801910|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
154801911|NCT03710603|Hormones|hormones|mesh-ancestor
154801912|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154801913|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154801914|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801915|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
154801916|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801917|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801918|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
154801919|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154801920|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154801921|NCT03710603|Growth Substances|growth substances|mesh-ancestor
154801922|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
154801923|NCT02630706|Metformin|metformin|mesh-list
154801924|NCT02630706|Glimepiride|glimepiride|mesh-list
154801925|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
154801926|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154801927|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801928|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154801929|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154801930|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
154801931|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154801932|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801933|NCT04763057|Calcium|calcium|mesh-list
154801934|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154801935|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801936|NCT03702179|Durvalumab|durvalumab|mesh-list
154801937|NCT03702179|Tremelimumab|tremelimumab|mesh-list
154801938|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154801939|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801940|NCT01677143|Bupivacaine|bupivacaine|mesh-list
154801941|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
154801942|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
154801943|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154801944|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801945|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
154801946|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801947|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
154801948|NCT03692663|Fludarabine|fludarabine|mesh-list
154801949|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154801950|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
154801951|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801952|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801953|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154801954|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
153981426|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154801955|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801956|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801957|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154801958|NCT02084069|Atorvastatin|atorvastatin|mesh-list
154801959|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154801960|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154801961|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
154801962|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801963|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154801964|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154801965|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801966|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154801967|NCT00981045|Hematinics|hematinics|mesh-ancestor
154801968|NCT00981435|Prednisolone|prednisolone|mesh-list
154801969|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
154801970|NCT00981435|Ketorolac|ketorolac|mesh-list
154801971|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
154801972|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154801973|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
154801974|NCT00981435|Hormones|hormones|mesh-ancestor
154801975|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154801976|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801977|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154801978|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154801979|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154801980|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154801981|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154801982|NCT00981435|Analgesics|analgesics|mesh-ancestor
154801983|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
154801984|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154801985|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154801986|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154801987|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154801988|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154801989|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154801990|NCT00981669|Vaccines|vaccines|mesh-list
154801991|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
154801992|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154801993|NCT00981825|Listerine|listerine|mesh-list
154801994|NCT00981825|Triclosan|triclosan|mesh-list
154801995|NCT00981825|Fluorides|fluorides|mesh-list
154801996|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
154801997|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
154801998|NCT00981825|Protective Agents|protective agents|mesh-ancestor
154801999|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802000|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154802001|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802002|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154802003|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154802004|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
154802005|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802006|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154802007|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154802008|NCT00983307|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154802009|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154802010|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802011|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802012|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802013|NCT04762745|Thalidomide|thalidomide|mesh-list
154802014|NCT04762745|Dexamethasone|dexamethasone|mesh-list
154802015|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
154802016|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154802017|NCT04762745|Pomalidomide|pomalidomide|mesh-list
154802018|NCT04762745|BB 1101|bb 1101|mesh-list
154802019|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802020|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
154802021|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
154802022|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802023|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802024|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154802025|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
154802026|NCT04762745|Hormones|hormones|mesh-ancestor
154802027|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802028|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154802029|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802030|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
154802031|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802032|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802033|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154802034|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
154802035|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
154802036|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154802037|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154802038|NCT04762745|Growth Substances|growth substances|mesh-ancestor
154802039|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
154802040|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802041|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
154802042|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154802043|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802044|NCT00983541|Gemcitabine|gemcitabine|mesh-list
154802045|NCT00983541|Fluorouracil|fluorouracil|mesh-list
154802046|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154802047|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
154802048|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802049|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802050|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154554036|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
154802051|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
154802052|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802053|NCT03667703|Famotidine|famotidine|mesh-list
154802054|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154802055|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154802056|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154802057|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
154802058|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
154802059|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802060|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802061|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802062|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
154802063|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
154802064|NCT03062904|Miotics|miotics|mesh-ancestor
154802065|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
154802066|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802067|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802068|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154802069|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154802070|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
154802071|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154802072|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154802073|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
154802074|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802075|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802076|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154802077|NCT00986583|Succinylcholine|succinylcholine|mesh-list
154802078|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154802079|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154802080|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154802081|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802082|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802083|NCT05056974|UB-421|ub-421|mesh-list
154802084|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154802085|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
154802086|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802087|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154802088|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154802089|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802090|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802091|NCT04762511|Vaccines|vaccines|mesh-list
154802092|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
154802093|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802094|NCT04762901|Paclitaxel|paclitaxel|mesh-list
154802095|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
154802096|NCT04762901|Carboplatin|carboplatin|mesh-list
154802097|NCT04762901|Doxorubicin|doxorubicin|mesh-list
154802098|NCT04762901|Niraparib|niraparib|mesh-list
154802099|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154802100|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802101|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
154802102|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
154802103|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
154802104|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802105|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802106|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
154802107|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802108|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802109|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154802110|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
154802111|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154802112|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154802113|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154802114|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154802115|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802116|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154802117|NCT00988143|Vaccines|vaccines|mesh-list
154802118|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
154802119|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802120|NCT03018171|Clonidine|clonidine|mesh-list
154802121|NCT03018171|Sufentanil|sufentanil|mesh-list
154802122|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154802123|NCT03018171|Narcotics|narcotics|mesh-ancestor
154802124|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802125|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802126|NCT03018171|Analgesics|analgesics|mesh-ancestor
154802127|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
154802128|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554105|NCT02114645|Leuprolide|leuprolide|mesh-list
154802129|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154802130|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154802131|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
154802132|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
154802133|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154802134|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
154802135|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
154802136|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154802137|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154802138|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154802139|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
154802140|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802141|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802142|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154802143|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154802144|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154802145|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154802146|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802147|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802148|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802149|NCT00989157|Analgesics|analgesics|mesh-ancestor
154802150|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
154802151|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802152|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
154802153|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154802154|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
154802156|NCT00990561|Halobetasol|halobetasol|mesh-list
154802157|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154802158|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802159|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
154802160|NCT00990561|Hormones|hormones|mesh-ancestor
154802161|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802162|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802163|NCT03018015|Ibuprofen|ibuprofen|mesh-list
154802164|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802165|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802166|NCT03018015|Analgesics|analgesics|mesh-ancestor
154802167|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
154802168|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802169|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802170|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802171|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802172|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154802173|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802174|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802175|NCT03609593|Rituximab|rituximab|mesh-list
154802176|NCT03609593|Venetoclax|venetoclax|mesh-list
154802177|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154802178|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154802179|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802180|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
154802181|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802182|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802183|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154802184|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
154802185|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802186|NCT00004547|Paclitaxel|paclitaxel|mesh-list
154802187|NCT00004547|Cisplatin|cisplatin|mesh-list
154802188|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154802189|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802190|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
154802191|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
154802192|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
154802193|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802194|NCT00005669|Metformin|metformin|mesh-list
154802195|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154802196|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802197|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
154802198|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154802199|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154802200|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802201|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154802202|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802203|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154802205|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
154802206|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154802207|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802208|NCT02628600|Amikacin|amikacin|mesh-list
154802209|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154802210|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802211|NCT00006101|Eflornithine|eflornithine|mesh-list
154802212|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802213|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154802214|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154802215|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154802216|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802217|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154802218|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802219|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802220|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
154802221|NCT00591318|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154802222|NCT00591318|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154802223|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154802224|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802225|NCT00991029|Clopidogrel|clopidogrel|mesh-list
154802226|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154802227|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154802228|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154802229|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154802230|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
154802231|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802232|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802233|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802234|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
154802235|NCT00991809|Promethazine|promethazine|mesh-list
154802236|NCT00991809|Alfentanil|alfentanil|mesh-list
154802237|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154802238|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154802239|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802240|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802241|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
154802242|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
154802243|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
154802244|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802245|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
154802246|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
154802247|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154802248|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154802249|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
154802250|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
154802251|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802252|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802253|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154802254|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
154802255|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
154802256|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154802257|NCT00991809|Narcotics|narcotics|mesh-ancestor
154802258|NCT00991809|Analgesics|analgesics|mesh-ancestor
154802259|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154802260|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
154802261|NCT02627274|Trastuzumab|trastuzumab|mesh-list
154802262|NCT02627274|Cetuximab|cetuximab|mesh-list
154802263|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154802264|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802265|NCT04982016|Methamphetamine|methamphetamine|mesh-list
154802266|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154802267|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802268|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
154802269|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
154802270|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802271|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
154802272|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802273|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802274|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154802275|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154554252|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
154802276|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154802277|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154802278|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154802280|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802281|NCT00929253|Buprenorphine|buprenorphine|mesh-list
154802282|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154802283|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154802284|NCT00929253|Narcotics|narcotics|mesh-ancestor
154802285|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802286|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802287|NCT00929253|Analgesics|analgesics|mesh-ancestor
154802288|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
154802289|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802290|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154802291|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
154802292|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
154802293|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154802294|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154802295|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802296|NCT04374903|Sirolimus|sirolimus|mesh-list
154802297|NCT04374903|Azithromycin|azithromycin|mesh-list
154802298|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
154802299|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154802300|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802301|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154802302|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802303|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
154802304|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802305|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
154802306|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802307|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802308|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802309|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
154802310|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154802311|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154802312|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802313|NCT03062982|Fluzoparib|fluzoparib|mesh-list
154802314|NCT03062982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154802315|NCT03062982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802316|NCT03062982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802317|NCT03062982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802318|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
154802319|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
154802320|NCT03062436|Protective Agents|protective agents|mesh-ancestor
154802321|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802322|NCT00997113|Alfentanil|alfentanil|mesh-list
154802323|NCT00997113|Propofol|propofol|mesh-list
154802324|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154802325|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802326|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802327|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154802328|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
154802329|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
154802330|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154802331|NCT00997113|Narcotics|narcotics|mesh-ancestor
154802332|NCT00997113|Analgesics|analgesics|mesh-ancestor
154802333|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
154802334|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802335|NCT04981704|Itraconazole|itraconazole|mesh-list
154802336|NCT04981704|Phenytoin|phenytoin|mesh-list
154802337|NCT04981704|Paroxetine|paroxetine|mesh-list
154802338|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
154802339|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802340|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154802341|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154802342|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802343|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802344|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154802345|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
154802346|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802347|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802348|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154554332|NCT01359644|Ribavirin|ribavirin|mesh-list
154802349|NCT04981704|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154802350|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154802351|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154802352|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802353|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
154802354|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154802355|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
154802356|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154802357|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154802358|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
154802359|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154802360|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154802361|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154802362|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154802363|NCT02163837|Rifaximin|rifaximin|mesh-list
154802364|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154802365|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802366|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154802367|NCT04974060|Remifentanil|remifentanil|mesh-list
154802368|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154802369|NCT04974060|Narcotics|narcotics|mesh-ancestor
154802370|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802371|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802372|NCT04974060|Analgesics|analgesics|mesh-ancestor
154802373|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
154802374|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802375|NCT01021761|Ketorolac|ketorolac|mesh-list
154802376|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154802377|NCT01021761|Nepafenac|nepafenac|mesh-list
154802378|NCT01021761|Bromfenac|bromfenac|mesh-list
154802379|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802380|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802381|NCT01021761|Analgesics|analgesics|mesh-ancestor
154802382|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
154802383|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802384|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802385|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802386|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802387|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154802388|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802389|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802390|NCT04973904|Paclitaxel|paclitaxel|mesh-list
154802391|NCT04973904|Bevacizumab|bevacizumab|mesh-list
154802392|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154802393|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802394|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154802395|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
154802396|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
154802397|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802398|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154802399|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154802400|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154802401|NCT04973904|Growth Substances|growth substances|mesh-ancestor
154802402|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802403|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
154802404|NCT00998049|Plerixafor|plerixafor|mesh-list
154802405|NCT00998049|Lenograstim|lenograstim|mesh-list
154802406|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154802407|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
154802408|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802409|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154802410|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154802411|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
154802412|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802413|NCT00998205|Atropine|atropine|mesh-list
154802414|NCT00998205|Dobutamine|dobutamine|mesh-list
154802415|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154802416|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154802417|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154802418|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
154802419|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802420|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802421|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154802422|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
154802423|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
154802424|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
154802425|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154802426|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154802427|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
154802428|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802429|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802430|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154802431|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
154802432|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154802433|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154802434|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154802435|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
154802436|NCT00998205|Protective Agents|protective agents|mesh-ancestor
154802437|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
154802438|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
154802439|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154802440|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154802441|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802442|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802443|NCT02626182|Urological Agents|urological agents|mesh-ancestor
154802444|NCT01023477|Chloroquine|chloroquine|mesh-list
154802445|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154802446|NCT01023477|Amebicides|amebicides|mesh-ancestor
154802447|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154802448|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154802449|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802450|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
154802451|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802452|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802453|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802454|NCT01023477|Analgesics|analgesics|mesh-ancestor
154802455|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
154802456|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802457|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802458|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802459|NCT01023477|Filaricides|filaricides|mesh-ancestor
154802460|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
154802461|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
154802462|NCT01023711|Vaccines|vaccines|mesh-list
154802463|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
154802464|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802465|NCT01001403|Nafamostat|nafamostat|mesh-list
154802466|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802467|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802468|NCT01001403|Analgesics|analgesics|mesh-ancestor
154802469|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
154802470|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802471|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802472|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802473|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802474|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
154802475|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
154802476|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802477|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802478|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153981955|NCT02864264|Interferons|interferons|mesh-list
154802479|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154802480|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154802481|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802482|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
154802483|NCT01024335|Naltrexone|naltrexone|mesh-list
154802484|NCT01024335|Dronabinol|dronabinol|mesh-list
154802485|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154802486|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154802487|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802488|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
154802489|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802490|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
154802491|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154802492|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802493|NCT01024335|Analgesics|analgesics|mesh-ancestor
154802494|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154802495|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154802496|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802497|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802498|NCT01024335|Hormones|hormones|mesh-ancestor
154802499|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802500|NCT01001559|Norepinephrine|norepinephrine|mesh-list
154802501|NCT01001559|Serotonin|serotonin|mesh-list
154802502|NCT01001559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154802503|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
154802504|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154802505|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154802506|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
154802507|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802508|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802509|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802510|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
154802511|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
154802512|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802513|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154802514|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154802515|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
154802516|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154802517|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154802519|NCT01025427|Emtricitabine|emtricitabine|mesh-list
154802520|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
154802521|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
154802522|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802523|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154802524|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154802525|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802526|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802527|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154802528|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154802529|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154802530|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154802531|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
154802532|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154802533|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802534|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802535|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802536|NCT02162433|Analgesics|analgesics|mesh-ancestor
154802537|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
153982015|NCT00654459|Policosanol|policosanol|mesh-list
154802538|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802539|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154802540|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154802541|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154802542|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
154802543|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802544|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802545|NCT01004991|Prednisone|prednisone|mesh-list
154802546|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
154802547|NCT01004991|Rituximab|rituximab|mesh-list
154802548|NCT01004991|Doxorubicin|doxorubicin|mesh-list
154802549|NCT01004991|Vincristine|vincristine|mesh-list
154802550|NCT01004991|Azacitidine|azacitidine|mesh-list
154802551|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802552|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
154802553|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802554|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802555|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154802556|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
154802557|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802558|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802559|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154802560|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154802561|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154802562|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154802563|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154802564|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802565|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802566|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
154802567|NCT01004991|Hormones|hormones|mesh-ancestor
154802568|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802569|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154802570|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154802571|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154802572|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154802573|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154802574|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154802575|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
154802576|NCT03063060|Vitamin D|vitamin d|mesh-list
154802577|NCT03063060|Calcium|calcium|mesh-list
154802578|NCT03063060|Vitamins|vitamins|mesh-ancestor
154802579|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
154802580|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802581|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154802582|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154802583|NCT03115047|Meperidine|meperidine|mesh-list
154802584|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
154802585|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154802586|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802587|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802588|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802589|NCT03115047|Analgesics|analgesics|mesh-ancestor
154802590|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
154802591|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802592|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154802593|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154802594|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154802595|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154802596|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802597|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802598|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154802599|NCT03115047|Narcotics|narcotics|mesh-ancestor
154802600|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154802601|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154802602|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802603|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
154802604|NCT03015519|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154802605|NCT03015519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154802606|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802607|NCT01030653|Voriconazole|voriconazole|mesh-list
154802608|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
154802609|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802610|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154802611|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154802612|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802613|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802614|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154802615|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
154802616|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802617|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802618|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154802619|NCT01031043|Bethanechol|bethanechol|mesh-list
154802620|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154802621|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
154802622|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802623|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802624|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154802625|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154802626|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
154802627|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802628|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802629|NCT01050153|Aspirin|aspirin|mesh-list
154802630|NCT01050153|Dalteparin|dalteparin|mesh-list
154802631|NCT01050153|Tinzaparin|tinzaparin|mesh-list
154802632|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154802633|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802634|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802635|NCT01050153|Analgesics|analgesics|mesh-ancestor
154802636|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
154802637|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802638|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802639|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802640|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802641|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154802642|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154802643|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802644|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154802645|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154802646|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802647|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
154802648|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
154802649|NCT04358133|Morphine|morphine|mesh-list
154802650|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154802652|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802653|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802654|NCT04358133|Analgesics|analgesics|mesh-ancestor
154802655|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
154802656|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802657|NCT01032759|Memantine|memantine|mesh-list
154802658|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154802659|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154802660|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
154802661|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802662|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802663|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802664|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154802665|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154802666|NCT01032993|Ubiquinone|ubiquinone|mesh-list
154802667|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
154802668|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
154802669|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802670|NCT01032993|Vitamins|vitamins|mesh-ancestor
154802671|NCT01033773|Metformin|metformin|mesh-list
154802672|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154802673|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802674|NCT01053507|Naproxen|naproxen|mesh-list
154802675|NCT01053507|Sumatriptan|sumatriptan|mesh-list
154802676|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802677|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802678|NCT01053507|Analgesics|analgesics|mesh-ancestor
154802679|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
154802680|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802681|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802682|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802683|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802684|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
154802685|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154802686|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802687|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802688|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154802689|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154802690|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154802691|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
154802692|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802693|NCT01053819|Etanercept|etanercept|mesh-list
154802694|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802695|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802696|NCT01053819|Analgesics|analgesics|mesh-ancestor
154802697|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
154802698|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802699|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802700|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802701|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802702|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154802703|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802704|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
154802705|NCT01054911|Sunitinib|sunitinib|mesh-list
154802706|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802707|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154802708|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154802709|NCT01054911|Growth Substances|growth substances|mesh-ancestor
154802710|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802711|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
154802712|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154802713|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802714|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802715|NCT01055223|Troglitazone|troglitazone|mesh-list
154802716|NCT01055223|Amiloride|amiloride|mesh-list
154802717|NCT01055223|Spironolactone|spironolactone|mesh-list
154802718|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154802719|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
154802720|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802721|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802722|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154802723|NCT01055223|Diuretics|diuretics|mesh-ancestor
154802724|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
154802725|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154802726|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154802727|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154802728|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802729|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154802731|NCT02168361|Interferons|interferons|mesh-list
154802732|NCT02168361|Ribavirin|ribavirin|mesh-list
154802733|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
154802734|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
154802735|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
154802736|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154802737|NCT02168361|Simeprevir|simeprevir|mesh-list
154802738|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802739|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
154802740|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802741|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
154802742|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802743|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
154802744|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802745|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
154802746|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802747|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154802748|NCT01360554|Dacomitinib|dacomitinib|mesh-list
154802749|NCT01360554|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153982241|NCT03588884|Vitamins|vitamins|mesh-ancestor
154802750|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154802751|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802752|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802753|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802754|NCT01055769|Linezolid|linezolid|mesh-list
154802755|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154802756|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802757|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154802758|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802759|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802760|NCT01057017|Panitumumab|panitumumab|mesh-list
154802761|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154802762|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802763|NCT04972032|Estrogens|estrogens|mesh-list
154802764|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
154802765|NCT04972032|Hormones|hormones|mesh-ancestor
154802766|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802767|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802768|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154802769|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
154802770|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
154802771|NCT04972032|Protective Agents|protective agents|mesh-ancestor
154802772|NCT04152564|Bupivacaine|bupivacaine|mesh-list
154802773|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
154802774|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
154802775|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
154802776|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802777|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802778|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
154802779|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802780|NCT04977960|Canrenone|canrenone|mesh-list
154802781|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
154802782|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154802783|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
154802784|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802785|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802786|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154802787|NCT04977960|Diuretics|diuretics|mesh-ancestor
154802788|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
154802789|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
154802790|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154802791|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802792|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
154802793|NCT01062009|Astringents|astringents|mesh-ancestor
154802794|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802795|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
154802796|NCT01062165|Caspofungin|caspofungin|mesh-list
154802797|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
154802798|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802799|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802800|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802801|NCT04041843|Apixaban|apixaban|mesh-list
154802802|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154802803|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
154802804|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154802805|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
154802806|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802807|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802808|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
154802809|NCT01068873|Ritonavir|ritonavir|mesh-list
154802810|NCT01068873|Lopinavir|lopinavir|mesh-list
154802811|NCT01068873|Maraviroc|maraviroc|mesh-list
154802812|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154802813|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154802814|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
154802815|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802816|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802817|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154802818|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154802819|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
154802820|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802821|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154802822|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154802823|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154802824|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154802825|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154802826|NCT01072773|Dexamethasone|dexamethasone|mesh-list
154802827|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
154802828|NCT01072773|Bortezomib|bortezomib|mesh-list
154802829|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802830|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
154802831|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802832|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802833|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154802834|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
154802835|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802836|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802837|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154802838|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802839|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
154802840|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
154802841|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802842|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154802843|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
154802844|NCT01072773|Hormones|hormones|mesh-ancestor
154802845|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154802846|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154802847|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154802848|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154802849|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154802850|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
154802851|NCT01074177|Afatinib|afatinib|mesh-list
154802852|NCT01074177|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154802853|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154802854|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802855|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802856|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802857|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
154802858|NCT01076283|Baclofen|baclofen|mesh-list
154802859|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154802860|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802861|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154802862|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802863|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154802864|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
154802865|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
154802866|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802867|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802868|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
154802869|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
154802870|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154802871|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154802872|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
154802873|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
154802874|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154802875|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
154802876|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154802877|NCT01076985|Ritonavir|ritonavir|mesh-list
154802878|NCT01076985|Lopinavir|lopinavir|mesh-list
154802879|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154802880|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154802881|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
154802882|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802883|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802884|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154802885|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154802886|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
154802887|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802888|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154802889|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154802890|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
154802891|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154802892|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154802893|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154802894|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154802895|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802896|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802897|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802898|NCT05539911|Fentanyl|fentanyl|mesh-list
154802899|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154802900|NCT05539911|Narcotics|narcotics|mesh-ancestor
154802901|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154802902|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802903|NCT05539911|Analgesics|analgesics|mesh-ancestor
154802904|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
154802905|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802906|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154802907|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154802908|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
154802909|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
154802910|NCT03589833|Methotrexate|methotrexate|mesh-list
154802911|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154802912|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
154802913|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154802914|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802915|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154802916|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
154802917|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802918|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802919|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
154802920|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802921|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154802922|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802923|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
154802924|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802925|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154802926|NCT01077921|Propranolol|propranolol|mesh-list
154802927|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154802928|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154802929|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
154802930|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802931|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802932|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802933|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154802934|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154802935|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
154802936|NCT04970238|Simendan|simendan|mesh-list
154802937|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154802938|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
154802939|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154802940|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154802941|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802942|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802943|NCT04970238|Protective Agents|protective agents|mesh-ancestor
154802944|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802945|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154802946|NCT02169453|Opicapone|opicapone|mesh-list
154802947|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154802948|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
154802949|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802950|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154802952|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
154802953|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
154802954|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154802955|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802956|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154802957|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802958|NCT01765296|Celecoxib|celecoxib|mesh-list
154802959|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802960|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802961|NCT01765296|Analgesics|analgesics|mesh-ancestor
154802962|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
154802963|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802964|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802965|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802966|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802967|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154802968|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154802969|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802970|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802971|NCT01081041|Carboplatin|carboplatin|mesh-list
154802972|NCT01081041|Fluorouracil|fluorouracil|mesh-list
154802973|NCT01081041|Cetuximab|cetuximab|mesh-list
154802974|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802975|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
154802976|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802977|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154802978|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154802979|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
154802980|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802981|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154802982|NCT03022617|Apremilast|apremilast|mesh-list
154802983|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154802984|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154802985|NCT03022617|Analgesics|analgesics|mesh-ancestor
154802986|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
154802987|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154802988|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154802989|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154802990|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154802991|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154802992|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154802993|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154802994|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154802995|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
154802996|NCT02089685|Ipilimumab|ipilimumab|mesh-list
154802997|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154802998|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154802999|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154803000|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803001|NCT01088295|Telmisartan|telmisartan|mesh-list
154803002|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154803003|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154803004|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154803005|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803006|NCT03013335|Nivolumab|nivolumab|mesh-list
154803007|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803008|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803009|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154803010|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803011|NCT04730531|Epinephrine|epinephrine|mesh-list
154803012|NCT04730531|Bupivacaine|bupivacaine|mesh-list
154803013|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803014|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
154803015|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803016|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803017|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
154803018|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803019|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154803020|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154803021|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
154803022|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803023|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803024|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154803025|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154803026|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
154803027|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154803028|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
154803029|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
154803030|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
154803031|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154803032|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154803033|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154803034|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803035|NCT05853224|Lidocaine|lidocaine|mesh-list
154803036|NCT05853224|Hyaluronic Acid|hyaluronic acid|mesh-list
154803037|NCT05853224|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803038|NCT05853224|Anesthetics|anesthetics|mesh-ancestor
154803039|NCT05853224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803040|NCT05853224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803041|NCT05853224|Sensory System Agents|sensory system agents|mesh-ancestor
154803042|NCT05853224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803043|NCT05853224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154803044|NCT05853224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154803045|NCT05853224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154803046|NCT05853224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154803047|NCT05853224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803048|NCT05853224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154803049|NCT05853224|Immunologic Factors|immunologic factors|mesh-ancestor
154803050|NCT05853224|Viscosupplements|viscosupplements|mesh-ancestor
154803051|NCT05853224|Protective Agents|protective agents|mesh-ancestor
154803052|NCT05853172|Paclitaxel|paclitaxel|mesh-list
154803053|NCT05853172|Apatinib|apatinib|mesh-list
154803054|NCT05853172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154803055|NCT05853172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803056|NCT05853172|Tubulin Modulators|tubulin modulators|mesh-ancestor
154803057|NCT05853172|Antimitotic Agents|antimitotic agents|mesh-ancestor
154803058|NCT05853172|Mitosis Modulators|mitosis modulators|mesh-ancestor
154803059|NCT05853172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803060|NCT05853172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154803061|NCT05853172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803062|NCT05853263|Acetaminophen|acetaminophen|mesh-list
154803063|NCT05853263|Morphine|morphine|mesh-list
154803064|NCT05853263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154803065|NCT05853263|Narcotics|narcotics|mesh-ancestor
154803066|NCT05853263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803067|NCT05853263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803068|NCT05853263|Analgesics|analgesics|mesh-ancestor
154803069|NCT05853263|Sensory System Agents|sensory system agents|mesh-ancestor
154803070|NCT05853263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803071|NCT05853263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154803072|NCT05853263|Antipyretics|antipyretics|mesh-ancestor
154803073|NCT05852847|Danazol|danazol|mesh-list
154803074|NCT05852847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154803075|NCT05852847|Hormone Antagonists|hormone antagonists|mesh-ancestor
154803076|NCT05852847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803077|NCT05852847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803078|NCT05852704|Dapagliflozin|dapagliflozin|mesh-list
154803079|NCT05852704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154803080|NCT05852704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803081|NCT05852704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154803082|NCT05852704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803083|NCT05852496|Vitamin D|vitamin d|mesh-list
154803084|NCT05852496|Vitamins|vitamins|mesh-ancestor
154803085|NCT05852496|Micronutrients|micronutrients|mesh-ancestor
154803086|NCT05852496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803087|NCT05852496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154803088|NCT05852197|Anticoagulants|anticoagulants|mesh-list
154803089|NCT05852197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154803090|NCT05852119|Anticoagulants|anticoagulants|mesh-list
154803091|NCT05852093|Celecoxib|celecoxib|mesh-list
154803092|NCT05852093|Buprenorphine|buprenorphine|mesh-list
154803093|NCT05852093|Tizanidine|tizanidine|mesh-list
154803094|NCT05852093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154803095|NCT05852093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154803096|NCT05852093|Analgesics|analgesics|mesh-ancestor
154803097|NCT05852093|Sensory System Agents|sensory system agents|mesh-ancestor
154803098|NCT05852093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803099|NCT05852093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803100|NCT05852093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803101|NCT05852093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803102|NCT05852093|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154803103|NCT05852093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154803104|NCT05852093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803105|NCT05852093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803106|NCT05852093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154803108|NCT05852093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803109|NCT05852093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154803110|NCT05852093|Anticonvulsants|anticonvulsants|mesh-ancestor
154803111|NCT05852093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154803112|NCT05852093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154803113|NCT05852093|Parasympatholytics|parasympatholytics|mesh-ancestor
154803114|NCT05852093|Autonomic Agents|autonomic agents|mesh-ancestor
154803115|NCT05852093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154803116|NCT05852093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154803117|NCT05852093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154803118|NCT05852093|Adrenergic Agents|adrenergic agents|mesh-ancestor
154803119|NCT05852093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803120|NCT05845762|Obinutuzumab|obinutuzumab|mesh-list
154803121|NCT05845762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803122|NCT05845762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803123|NCT05830396|Ambroxol|ambroxol|mesh-list
154803124|NCT05830396|Expectorants|expectorants|mesh-ancestor
154803125|NCT05830396|Respiratory System Agents|respiratory system agents|mesh-ancestor
154803126|NCT05810311|Darbepoetin alfa|darbepoetin alfa|mesh-list
154803127|NCT05810311|Hematinics|hematinics|mesh-ancestor
154803128|NCT05809297|Ciclopirox|ciclopirox|mesh-list
154803129|NCT05809297|Chitosan|chitosan|mesh-list
154803130|NCT05809297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154803131|NCT05809297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154803132|NCT05809297|Antimetabolites|antimetabolites|mesh-ancestor
154803133|NCT05809297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803134|NCT05809297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154803135|NCT05809297|Chelating Agents|chelating agents|mesh-ancestor
154803136|NCT05809297|Sequestering Agents|sequestering agents|mesh-ancestor
154803137|NCT05809297|Hemostatics|hemostatics|mesh-ancestor
154803138|NCT05809297|Coagulants|coagulants|mesh-ancestor
154803139|NCT05809297|Antifungal Agents|antifungal agents|mesh-ancestor
154803140|NCT05809297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803141|NCT05745987|Vaccines|vaccines|mesh-list
154803142|NCT05745987|Immunologic Factors|immunologic factors|mesh-ancestor
154803143|NCT05745987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803144|NCT05736198|Dexmedetomidine|dexmedetomidine|mesh-list
154803145|NCT05736198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154803146|NCT05736198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803147|NCT05736198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803148|NCT05736198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154803149|NCT05736198|Analgesics|analgesics|mesh-ancestor
154803150|NCT05736198|Sensory System Agents|sensory system agents|mesh-ancestor
154803151|NCT05736198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803152|NCT05736198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154803153|NCT05736198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154803154|NCT05736198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154803155|NCT05736198|Adrenergic Agents|adrenergic agents|mesh-ancestor
154803156|NCT05736198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803157|NCT05736198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803158|NCT05729503|Lidocaine|lidocaine|mesh-list
154803159|NCT05729503|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803160|NCT05729503|Anesthetics|anesthetics|mesh-ancestor
154803161|NCT05729503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803162|NCT05729503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803163|NCT05729503|Sensory System Agents|sensory system agents|mesh-ancestor
154803164|NCT05729503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803165|NCT05729503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154803166|NCT05729503|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154803167|NCT05729503|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154803168|NCT05729503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154803169|NCT05729503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803170|NCT05725876|Ustekinumab|ustekinumab|mesh-list
154803171|NCT05725876|Dermatologic Agents|dermatologic agents|mesh-ancestor
154803172|NCT05720390|Quinine|quinine|mesh-list
154803173|NCT05720390|Antimalarials|antimalarials|mesh-ancestor
154803174|NCT05720390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154803175|NCT05720390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154803176|NCT05720390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803177|NCT05720390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154803178|NCT05720390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803179|NCT05720390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154803180|NCT05720390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803181|NCT05720390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154803182|NCT05720390|Analgesics|analgesics|mesh-ancestor
154803183|NCT05720390|Sensory System Agents|sensory system agents|mesh-ancestor
154803184|NCT05711641|Lidocaine|lidocaine|mesh-list
154803185|NCT05711641|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803186|NCT05711641|Anesthetics|anesthetics|mesh-ancestor
154803187|NCT05711641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803188|NCT05711641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803189|NCT05711641|Sensory System Agents|sensory system agents|mesh-ancestor
154803190|NCT05711641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803191|NCT05711641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154803192|NCT05711641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154803193|NCT05711641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154803194|NCT05711641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154803195|NCT05711641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803196|NCT05693467|Dexamethasone|dexamethasone|mesh-list
154803197|NCT05693467|Ropivacaine|ropivacaine|mesh-list
154803198|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803199|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
154803200|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
154803201|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803202|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803203|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154803204|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
154803205|NCT05693467|Hormones|hormones|mesh-ancestor
154803206|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803207|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154803208|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803209|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803210|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
154803211|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803212|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
154803213|NCT05658887|Gabapentin|gabapentin|mesh-list
154803214|NCT05658887|Analgesics|analgesics|mesh-ancestor
154803215|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
154803216|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803217|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803218|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
154803219|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154803220|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154803221|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803222|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154803223|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154803224|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154803225|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803226|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803227|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
154803228|NCT05652283|Pamiparib|pamiparib|mesh-list
154803229|NCT05652283|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154803230|NCT05652283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803231|NCT05652283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803232|NCT05652283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803233|NCT05572255|Cenobamate|cenobamate|mesh-list
154803234|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
154803235|NCT05531123|Gemcitabine|gemcitabine|mesh-list
154803236|NCT05531123|Tislelizumab|tislelizumab|mesh-list
154803237|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803238|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154803239|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
154803240|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803241|NCT05531123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803242|NCT05483465|Niacinamide|niacinamide|mesh-list
154803243|NCT05483465|Niacin|niacin|mesh-list
154803244|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
154803245|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
154803246|NCT05483465|Vitamins|vitamins|mesh-ancestor
154803247|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
154803248|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803249|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154803250|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
154803251|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803252|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154803253|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
154803254|NCT05477108|Budesonide|budesonide|mesh-list
154803255|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
154803256|NCT05477108|Charcoal|charcoal|mesh-list
154803257|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803258|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154803259|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
154803260|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803261|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803262|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154803263|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
154803264|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
154803265|NCT05477108|Hormones|hormones|mesh-ancestor
154803266|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803267|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154803268|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154803269|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154803270|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
154803271|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803272|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803273|NCT05477108|Antidotes|antidotes|mesh-ancestor
154803274|NCT05477108|Protective Agents|protective agents|mesh-ancestor
154803275|NCT05464979|Midazolam|midazolam|mesh-list
154803276|NCT05464979|Fentanyl|fentanyl|mesh-list
154803277|NCT05464979|Ketamine|ketamine|mesh-list
154803278|NCT05464979|Esketamine|esketamine|mesh-list
154803279|NCT05464979|Analgesics|analgesics|mesh-ancestor
154803280|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
154803281|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803282|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803283|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154803284|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153982759|NCT04430452|Durvalumab|durvalumab|mesh-list
154803285|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
154803286|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
154803287|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803288|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154803289|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154803290|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803291|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803292|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154803293|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154803294|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154803295|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154803296|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154803297|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
154803298|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
154803299|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154803300|NCT05464979|Narcotics|narcotics|mesh-ancestor
154803301|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
154803302|NCT05442463|Captopril|captopril|mesh-list
154803303|NCT05442463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154803304|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
154803305|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803306|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803307|NCT05442463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154803308|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
154803309|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154803310|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154803311|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803312|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
154803313|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154803314|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154803315|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803316|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
154803317|NCT05368753|Lidocaine|lidocaine|mesh-list
154803318|NCT05368753|Ropivacaine|ropivacaine|mesh-list
154803319|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803320|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
154803321|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803322|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803323|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
154803324|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803325|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154803326|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154803327|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154803328|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154803329|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803331|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154803332|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803333|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154803334|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803335|NCT05250895|Misonidazole|misonidazole|mesh-list
154803336|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803337|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154803338|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154803339|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803340|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154803341|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154803342|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803343|NCT05219409|Incretins|incretins|mesh-ancestor
154803344|NCT05219409|Hormones|hormones|mesh-ancestor
154803345|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803346|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154803347|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
154803348|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803349|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803350|NCT05196932|Antibodies|antibodies|mesh-list
154803351|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
154803352|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803353|NCT05189756|Aprepitant|aprepitant|mesh-list
154803354|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
154803355|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
154803356|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
154803357|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803358|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803359|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154803360|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154803361|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803362|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803363|NCT05181150|Glucagon|glucagon|mesh-list
154803364|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154803365|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154803366|NCT05181150|Hormones|hormones|mesh-ancestor
154803367|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803368|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803369|NCT05181150|Incretins|incretins|mesh-ancestor
154803370|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
154803371|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
154803372|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803373|NCT05151159|Antibodies|antibodies|mesh-list
154803374|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
154803375|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803376|NCT05144529|Nivolumab|nivolumab|mesh-list
154803377|NCT05144529|Ipilimumab|ipilimumab|mesh-list
154803378|NCT05144529|Evolocumab|evolocumab|mesh-list
154803379|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803380|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803381|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154803382|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803383|NCT05144529|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154803384|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154803385|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154803386|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
154803387|NCT05144529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154803388|NCT05144529|Protease Inhibitors|protease inhibitors|mesh-ancestor
154803389|NCT05144529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803390|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154803391|NCT05132920|Dexamethasone|dexamethasone|mesh-list
154803392|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803393|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
154803394|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
154803395|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803396|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803397|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154803398|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
154803399|NCT05132920|Hormones|hormones|mesh-ancestor
154803400|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803401|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154803403|NCT05129085|Dexamethasone|dexamethasone|mesh-list
154803404|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803405|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
154803406|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
154803407|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803408|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803409|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154803410|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
154803411|NCT05129085|Hormones|hormones|mesh-ancestor
154803412|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803413|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154803414|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803415|NCT05099471|Dexamethasone|dexamethasone|mesh-list
154803416|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
154803417|NCT05099471|Rituximab|rituximab|mesh-list
154803418|NCT05099471|Venetoclax|venetoclax|mesh-list
154803419|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154803420|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
154803421|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803422|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803423|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154803424|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
154803425|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803426|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803427|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154803428|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803429|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803430|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
154803431|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
154803432|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803433|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154803434|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
154803435|NCT05099471|Hormones|hormones|mesh-ancestor
154803436|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982915|NCT02723955|Paclitaxel|paclitaxel|mesh-list
154803437|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154803438|NCT05087693|Albuterol|albuterol|mesh-list
154803439|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154803440|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
154803441|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803442|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803443|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154803444|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
154803445|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
154803446|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154803447|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154803448|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154803449|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154803450|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154803451|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803452|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803453|NCT05081583|Midazolam|midazolam|mesh-list
154803454|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154803455|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154803456|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803457|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803458|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154803459|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154803460|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154803461|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154803462|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
154803463|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
154803464|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
154803465|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
154803466|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803467|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803468|NCT05070754|Cantharidin|cantharidin|mesh-list
154803469|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803470|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803471|NCT05052099|Bevacizumab|bevacizumab|mesh-list
154803472|NCT05052099|Atezolizumab|atezolizumab|mesh-list
154803473|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803474|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803475|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154555456|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
154803476|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154803477|NCT05052099|Growth Substances|growth substances|mesh-ancestor
154803478|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803479|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
154803480|NCT05052099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154803481|NCT05052099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803482|NCT05037487|Dronabinol|dronabinol|mesh-list
154803483|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
154803484|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803485|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154803486|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154803487|NCT05037487|Analgesics|analgesics|mesh-ancestor
154803488|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
154803489|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803490|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154803491|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154803492|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803493|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803494|NCT05037487|Hormones|hormones|mesh-ancestor
154803495|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803496|NCT05001074|Tacrolimus|tacrolimus|mesh-list
154803497|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154803498|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
154803499|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803500|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154803501|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803502|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803503|NCT04985890|UB-421|ub-421|mesh-list
154803504|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154803505|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
154803506|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803507|NCT04964388|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154803508|NCT04964388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154803509|NCT04964388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803510|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154803511|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
154803512|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154803513|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803514|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154803515|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154803516|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154803517|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803518|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
154803519|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803520|NCT04899115|Vancomycin|vancomycin|mesh-list
154803521|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154803522|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803523|NCT04868903|Vitamin D|vitamin d|mesh-list
154803524|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
154803525|NCT04868903|Vitamins|vitamins|mesh-ancestor
154803526|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
154803527|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803528|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154803529|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154803530|NCT04859530|Lugol's solution|lugol's solution|mesh-list
154803531|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
154803532|NCT04859530|Coagulants|coagulants|mesh-ancestor
154803533|NCT04851301|Naloxone|naloxone|mesh-list
154803534|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154803535|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803536|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
154803537|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803538|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
154803539|NCT04801966|Nivolumab|nivolumab|mesh-list
154803540|NCT04801966|Atezolizumab|atezolizumab|mesh-list
154803541|NCT04801966|Olaparib|olaparib|mesh-list
154803542|NCT04801966|Palbociclib|palbociclib|mesh-list
154803543|NCT04801966|Trametinib|trametinib|mesh-list
154803544|NCT04801966|Dabrafenib|dabrafenib|mesh-list
154803545|NCT04801966|Vemurafenib|vemurafenib|mesh-list
154803546|NCT04801966|Talazoparib|talazoparib|mesh-list
154803547|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803548|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803549|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154803550|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555525|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803551|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154803552|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803553|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154803554|NCT04789915|Memantine|memantine|mesh-list
154803555|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154803556|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154803557|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
154803558|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803559|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803560|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803561|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154803562|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154803563|NCT04771299|Cariprazine|cariprazine|mesh-list
154803564|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154803565|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154803566|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803567|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803568|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154803569|NCT04704063|Vitamin E|vitamin e|mesh-list
154803570|NCT04704063|Tocopherols|tocopherols|mesh-list
154803571|NCT04704063|Tocotrienols|tocotrienols|mesh-list
154803572|NCT04704063|Tocovid|tocovid|mesh-list
154803573|NCT04704063|Vitamins|vitamins|mesh-ancestor
154803574|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
154803575|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803576|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
154803577|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803578|NCT04704063|Protective Agents|protective agents|mesh-ancestor
154803579|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
154803580|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154803581|NCT04703036|Glycine|glycine|mesh-list
154803582|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
154803583|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803584|NCT04703036|Expectorants|expectorants|mesh-ancestor
154803585|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
154803586|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154803587|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
154803588|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803589|NCT04703036|Protective Agents|protective agents|mesh-ancestor
154803590|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803591|NCT04703036|Antidotes|antidotes|mesh-ancestor
154803592|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
154803593|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803594|NCT04636255|Calcium|calcium|mesh-list
154803595|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154803596|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803597|NCT04635176|Dexamethasone|dexamethasone|mesh-list
154803598|NCT04635176|Epinephrine|epinephrine|mesh-list
154803599|NCT04635176|Bupivacaine|bupivacaine|mesh-list
154803600|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803601|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
154803602|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
154803603|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803604|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803605|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154803606|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
154803607|NCT04635176|Hormones|hormones|mesh-ancestor
154803608|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803609|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154803610|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803611|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803612|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
154803613|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803614|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
154803615|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154803616|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154803617|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
154803618|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803619|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803620|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154803621|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154803622|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154803623|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
154803624|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
154803625|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
154803626|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154555603|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154803628|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
154803629|NCT04625907|Temozolomide|temozolomide|mesh-list
154803630|NCT04625907|Ifosfamide|ifosfamide|mesh-list
154803631|NCT04625907|Doxorubicin|doxorubicin|mesh-list
154803632|NCT04625907|Irinotecan|irinotecan|mesh-list
154803633|NCT04625907|Vincristine|vincristine|mesh-list
154803634|NCT04625907|Vinorelbine|vinorelbine|mesh-list
154803635|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154803636|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
154803637|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803638|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803639|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154803640|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
154803641|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803642|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803643|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154803644|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154803645|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154803646|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154803647|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803648|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154803649|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154803650|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
154803651|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
154803652|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
154803653|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154803654|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803655|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154803656|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154803657|NCT04574713|Candesartan|candesartan|mesh-list
154803658|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
154803659|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154803660|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154803661|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154803662|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803663|NCT04569877|Molgramostim|molgramostim|mesh-list
154803664|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154803665|NCT04569877|Sargramostim|sargramostim|mesh-list
154803666|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803667|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
154803668|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803669|NCT04550234|Allopurinol|allopurinol|mesh-list
154803670|NCT04550234|Verinurad|verinurad|mesh-list
154803671|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
154803672|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803673|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803674|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
154803675|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803676|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154803677|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
154803678|NCT04550234|Protective Agents|protective agents|mesh-ancestor
154803679|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803680|NCT04541797|Empagliflozin|empagliflozin|mesh-list
154803681|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154803682|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803683|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154803684|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803685|NCT04540666|Propofol|propofol|mesh-list
154803686|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154803687|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803688|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803689|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154803690|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
154803691|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
154803692|NCT04530383|Metformin|metformin|mesh-list
154803693|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154803694|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803695|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
154803696|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154803697|NCT04431245|Entecavir|entecavir|mesh-list
154803698|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
154803699|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803700|NCT04421248|Methylphenidate|methylphenidate|mesh-list
154803701|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154803702|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803703|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154803704|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154803705|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154803706|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803707|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
154803708|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803709|NCT04303689|Colchicine|colchicine|mesh-list
154803710|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
154803711|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803712|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
154803713|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
154803714|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
154803715|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803716|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803717|NCT04217278|Cytarabine|cytarabine|mesh-list
154803718|NCT04217278|Fludarabine|fludarabine|mesh-list
154803719|NCT04217278|Busulfan|busulfan|mesh-list
154803720|NCT04217278|Thiotepa|thiotepa|mesh-list
154803721|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803722|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154803723|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
154803724|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803725|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154803726|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
154803727|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803728|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
154803729|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803730|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
154803731|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154803732|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154803733|NCT04202809|Durvalumab|durvalumab|mesh-list
154803734|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803735|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803736|NCT04177953|Carboplatin|carboplatin|mesh-list
154803737|NCT04177953|Nivolumab|nivolumab|mesh-list
154803738|NCT04177953|Pemetrexed|pemetrexed|mesh-list
154803739|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803740|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803741|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154803742|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803743|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803744|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154803745|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154803746|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154803747|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
154803748|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803749|NCT04061512|Dexamethasone|dexamethasone|mesh-list
154803750|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
154803751|NCT04061512|Rituximab|rituximab|mesh-list
154803752|NCT04061512|Ibrutinib|ibrutinib|mesh-list
154803753|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154803754|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
154803755|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803756|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803757|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154803758|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
154803759|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803760|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803761|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154803762|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803763|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803764|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
154803765|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
154803766|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803767|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154803768|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
154803769|NCT04061512|Hormones|hormones|mesh-ancestor
154803770|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154803771|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154803772|NCT04061512|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154803773|NCT04061512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154803774|NCT04061512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803775|NCT04019548|Cisplatin|cisplatin|mesh-list
154803776|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803777|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
154803778|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154803779|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154803780|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
154803781|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
154803782|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803783|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803784|NCT04002271|Propofol|propofol|mesh-list
154803785|NCT04002271|Sevoflurane|sevoflurane|mesh-list
154803786|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
154803787|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803788|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803789|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154803790|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154803791|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
154803792|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154803793|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154803794|NCT03972592|Sirolimus|sirolimus|mesh-list
154803795|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154803796|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803797|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154803798|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803799|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
154803800|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154803801|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
154803802|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803803|NCT03875872|Propofol|propofol|mesh-list
154803804|NCT03875872|Anesthetics|anesthetics|mesh-list
154803805|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
154803806|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154803807|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803808|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803809|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154803810|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
154803811|NCT03859908|Ethanol|ethanol|mesh-list
154803812|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
154803813|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154803814|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154803815|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803816|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803817|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803818|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
154803819|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
154803820|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
154803821|NCT03797196|Everolimus|everolimus|mesh-list
154803822|NCT03797196|Tacrolimus|tacrolimus|mesh-list
154803823|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154803824|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
154803825|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803826|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154803827|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803828|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803829|NCT03797196|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154803830|NCT03797196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154803831|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803832|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154803833|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154803834|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
154803835|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154803836|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803837|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
154803838|NCT03775382|Vitamins|vitamins|mesh-ancestor
154803839|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
154803840|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803841|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
154803842|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803843|NCT03775382|Protective Agents|protective agents|mesh-ancestor
154803844|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
154803845|NCT03747432|Propofol|propofol|mesh-list
154803846|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154803847|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803848|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803849|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154803850|NCT03747432|Analgesics|analgesics|mesh-ancestor
154803851|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
154803852|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803853|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154803854|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154803855|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154803856|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
154803857|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803858|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803859|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154803860|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
154803861|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
154803862|NCT03724019|Ketamine|ketamine|mesh-list
154803863|NCT03724019|Analgesics|analgesics|mesh-ancestor
154803864|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
154803865|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803866|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803867|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154803868|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154803869|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
154803870|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
154803871|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803872|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154803873|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154803874|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803875|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803876|NCT03697512|Rituximab|rituximab|mesh-list
154803877|NCT03697512|Ibrutinib|ibrutinib|mesh-list
154803878|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803879|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803880|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
154803881|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803882|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803883|NCT03697512|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154803884|NCT03697512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154803885|NCT03697512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803886|NCT03697512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803887|NCT03667651|Decanoic acid|decanoic acid|mesh-list
154803888|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
154803889|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154803890|NCT03649633|Vitamins|vitamins|mesh-list
154803891|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
154803892|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
154803893|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803894|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803895|NCT03620903|Rituximab|rituximab|mesh-list
154803896|NCT03620903|Bortezomib|bortezomib|mesh-list
154803897|NCT03620903|Ibrutinib|ibrutinib|mesh-list
154803898|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803899|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803900|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
154803901|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803902|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803903|NCT03620903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154803904|NCT03620903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154803905|NCT03620903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803906|NCT03620903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803907|NCT03497156|Lercanidipine|lercanidipine|mesh-list
154803908|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154803909|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154803910|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154803911|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803912|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153983379|NCT03896815|INCB054329|incb054329|mesh-list
154803913|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803914|NCT03471117|Pioglitazone|pioglitazone|mesh-list
154803915|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154803916|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803917|NCT03435939|Losartan|losartan|mesh-list
154803918|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154803919|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154803920|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154803921|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154803922|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803923|NCT03422393|Venetoclax|venetoclax|mesh-list
154803924|NCT03422393|Ibrutinib|ibrutinib|mesh-list
154803925|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803926|NCT03422393|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154803927|NCT03422393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154803928|NCT03422393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803929|NCT03422393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803931|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154803932|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154803933|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154803934|NCT03377543|Analgesics|analgesics|mesh-ancestor
154803935|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
154803936|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803937|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803938|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154803939|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154803940|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154803941|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803942|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154803943|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154803944|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154803945|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
154803946|NCT03365908|Ropivacaine|ropivacaine|mesh-list
154803947|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803948|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
154803949|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803950|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803951|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
154803952|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803953|NCT03362047|Macitentan|macitentan|mesh-list
154803954|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154803955|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154803956|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803957|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154803958|NCT03337919|Nivolumab|nivolumab|mesh-list
154803959|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154803960|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154803961|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154803962|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803963|NCT03236324|Epinephrine|epinephrine|mesh-list
154803964|NCT03236324|Bupivacaine|bupivacaine|mesh-list
154803965|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
154803966|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
153983438|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
154803967|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154803968|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803969|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
154803970|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803971|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154803972|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154803973|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
154803974|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154803975|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154803976|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154803977|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154803978|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
154803979|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154803980|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
154803981|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
154803982|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
154803983|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154803984|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
154803985|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154803986|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803987|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
154803988|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154803989|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154803990|NCT03229538|Prednisolone|prednisolone|mesh-list
154803991|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
154803992|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154803993|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
154803994|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154803995|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
154803996|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
154803997|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154803998|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154803999|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154804000|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
154804001|NCT03229538|Hormones|hormones|mesh-ancestor
154804002|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154804003|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154804004|NCT03229538|Protective Agents|protective agents|mesh-ancestor
154804005|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154804006|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804007|NCT03148795|Talazoparib|talazoparib|mesh-list
154804008|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154804009|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804010|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804011|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804012|NCT03070054|Epinephrine|epinephrine|mesh-list
154804013|NCT03070054|Bupivacaine|bupivacaine|mesh-list
154804014|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
154804015|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
154804016|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804017|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804018|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
154804019|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804020|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154804021|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154804022|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
154804023|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804024|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804025|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154804026|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154804027|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
154804028|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154804029|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
154804030|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
154804031|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
154804032|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154804033|NCT03040778|Vitamin E|vitamin e|mesh-list
154804034|NCT03040778|Tocopherols|tocopherols|mesh-list
154804035|NCT03040778|Tocotrienols|tocotrienols|mesh-list
154804036|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
154804037|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
154804038|NCT03040778|Vitamins|vitamins|mesh-ancestor
154804039|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
154804040|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804041|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
154804042|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804043|NCT03040778|Protective Agents|protective agents|mesh-ancestor
154804044|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154804045|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804046|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154804047|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154804048|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
154804049|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154804050|NCT02959047|Alirocumab|alirocumab|mesh-list
154804051|NCT02959047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154804052|NCT02959047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154804053|NCT02959047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154804054|NCT02959047|Antimetabolites|antimetabolites|mesh-ancestor
154804055|NCT02959047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804056|NCT02959047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154804057|NCT02959047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154804058|NCT02959047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804059|NCT02959047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154804060|NCT02895750|Metformin|metformin|mesh-list
154804061|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154804062|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804063|NCT02895360|Lisavanbulin|lisavanbulin|mesh-list
154804064|NCT02895360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154804065|NCT02895360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804066|NCT02895360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804067|NCT02895360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804068|NCT02890784|Dasatinib|dasatinib|mesh-list
154804069|NCT02890784|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154804070|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154804071|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804072|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804073|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556049|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
154804074|NCT02863809|Riboflavin|riboflavin|mesh-list
154804075|NCT02863809|Dextrans|dextrans|mesh-list
154804076|NCT02863809|Vitamins|vitamins|mesh-ancestor
154804077|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
154804078|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804079|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
154804080|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154804081|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804082|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
154804083|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
154804084|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
154804085|NCT02823028|Nicotine|nicotine|mesh-list
154804086|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154804087|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
154804088|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804089|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804090|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154804091|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154804092|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
154804093|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804094|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804095|NCT02768363|Valacyclovir|valacyclovir|mesh-list
154804096|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
154804097|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804098|NCT02729805|Ketamine|ketamine|mesh-list
154804099|NCT02729805|Analgesics|analgesics|mesh-ancestor
154804100|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
154804101|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804102|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804103|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154804104|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154804105|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
154804106|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
154804107|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804108|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154804109|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154804110|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804111|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804112|NCT02521311|Clemastine|clemastine|mesh-list
154804113|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
154804114|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804115|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154804116|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
154804117|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
154804118|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804119|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804120|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804121|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154804122|NCT02437045|Meropenem|meropenem|mesh-list
154804123|NCT02437045|Tazobactam|tazobactam|mesh-list
154804124|NCT02437045|Piperacillin|piperacillin|mesh-list
154804125|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154804126|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154804127|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804128|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154804129|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804130|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804131|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
154804132|NCT02308527|Temozolomide|temozolomide|mesh-list
154804133|NCT02308527|Bevacizumab|bevacizumab|mesh-list
154804134|NCT02308527|Irinotecan|irinotecan|mesh-list
154804135|NCT02308527|Topotecan|topotecan|mesh-list
154804136|NCT02308527|Dinutuximab|dinutuximab|mesh-list
154804137|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154804138|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
154804139|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804140|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804141|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154804142|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
153983605|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154804143|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804144|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804145|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154804146|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804147|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154804148|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154804149|NCT02308527|Growth Substances|growth substances|mesh-ancestor
154804150|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
154804151|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154804152|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154804153|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804154|NCT02289079|Bupivacaine|bupivacaine|mesh-list
154804155|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
154804156|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
154804157|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804158|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804159|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
154804160|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804161|NCT02131753|Cladribine|cladribine|mesh-list
154804162|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804163|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154804164|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
154804165|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804166|NCT02058706|Leuprolide|leuprolide|mesh-list
154804167|NCT02058706|Goserelin|goserelin|mesh-list
154804168|NCT02058706|Bicalutamide|bicalutamide|mesh-list
154804169|NCT02058706|Androgens|androgens|mesh-list
154804170|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154804171|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
154804172|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154804173|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804174|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154804175|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804176|NCT02058706|Hormones|hormones|mesh-ancestor
154804177|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154804178|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
154804179|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
154804180|NCT01657604|Nilotinib|nilotinib|mesh-list
154804181|NCT01657604|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154804182|NCT01657604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154804183|NCT01657604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804184|NCT01657604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804185|NCT01644110|Pomalidomide|pomalidomide|mesh-list
154804186|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
154804187|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804188|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154804189|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154804190|NCT01644110|Growth Substances|growth substances|mesh-ancestor
154804191|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
154804192|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804193|NCT01478542|Rituximab|rituximab|mesh-list
154804194|NCT01478542|Vincristine|vincristine|mesh-list
154804195|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804196|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804197|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
154804198|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804199|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804200|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154804201|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
154804202|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
154804203|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
154804204|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804205|NCT01406678|Sufentanil|sufentanil|mesh-list
154804206|NCT01406678|Dsuvia|dsuvia|mesh-list
154804207|NCT01406678|Isoflurane|isoflurane|mesh-list
154804208|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
154804209|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804210|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804211|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154804212|NCT01406678|Narcotics|narcotics|mesh-ancestor
154804213|NCT01406678|Analgesics|analgesics|mesh-ancestor
154804214|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
154804215|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804216|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154804217|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154804218|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
154804219|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154804220|NCT01397929|Lisavanbulin|lisavanbulin|mesh-list
154804221|NCT01397929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154804222|NCT01397929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804223|NCT01397929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804224|NCT01397929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804225|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154804226|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804227|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804228|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804229|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154804230|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154556196|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
154804231|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154804232|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804233|NCT00695214|Propofol|propofol|mesh-list
154804234|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154804235|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804236|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804237|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154804238|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
154804239|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
154804240|NCT00678327|Prednisolone|prednisolone|mesh-list
154804241|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
154804242|NCT00678327|Dacarbazine|dacarbazine|mesh-list
154804243|NCT00678327|Doxorubicin|doxorubicin|mesh-list
154804244|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154804245|NCT00678327|Etoposide|etoposide|mesh-list
154804246|NCT00678327|Vincristine|vincristine|mesh-list
154804247|NCT00678327|Bleomycin|bleomycin|mesh-list
154804248|NCT00678327|Vinblastine|vinblastine|mesh-list
154804249|NCT00678327|Procarbazine|procarbazine|mesh-list
154804250|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154804251|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
154804252|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804253|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804254|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154804255|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
154804256|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804257|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804258|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154804259|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154804260|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154804261|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154804262|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804263|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154804264|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
154804265|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
154804266|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
154804267|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804268|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
154804269|NCT00678327|Hormones|hormones|mesh-ancestor
154804270|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154804271|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154804272|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
154804273|NCT00602667|Cisplatin|cisplatin|mesh-list
154804274|NCT00602667|Carboplatin|carboplatin|mesh-list
154804275|NCT00602667|Methotrexate|methotrexate|mesh-list
154804276|NCT00602667|Etoposide|etoposide|mesh-list
154804277|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
154804278|NCT00602667|Vincristine|vincristine|mesh-list
154804279|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154804280|NCT00602667|Topotecan|topotecan|mesh-list
154804281|NCT00602667|Vinblastine|vinblastine|mesh-list
154804282|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154804283|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
154804284|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804285|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804286|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154804287|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
154804288|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804289|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804290|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154804291|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154804292|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
154804293|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154804294|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154804295|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
154804296|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804297|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804298|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154804299|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154804300|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154804301|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154804302|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154804303|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
154804304|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
154804305|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154804306|NCT00602667|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154804307|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154804308|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154804309|NCT00519675|Alitretinoin|alitretinoin|mesh-list
154804310|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804311|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804313|NCT00492999|Dexamethasone|dexamethasone|mesh-list
154804314|NCT00492999|Fluorouracil|fluorouracil|mesh-list
154804315|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
154804316|NCT00492999|Irinotecan|irinotecan|mesh-list
154804317|NCT00492999|Floxuridine|floxuridine|mesh-list
154804318|NCT00492999|Calcium|calcium|mesh-list
154804319|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
154804320|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804321|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
154804322|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
154804323|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804324|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804325|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154804326|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
154804327|NCT00492999|Hormones|hormones|mesh-ancestor
154804328|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154804329|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154804330|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804331|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154804332|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
154804333|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804334|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154804335|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983783|NCT04298021|Durvalumab|durvalumab|mesh-list
154804336|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
154804337|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154804338|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154804339|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804340|NCT00492999|Antidotes|antidotes|mesh-ancestor
154804341|NCT00492999|Protective Agents|protective agents|mesh-ancestor
154804342|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
154804343|NCT00492999|Vitamins|vitamins|mesh-ancestor
154804344|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
154804345|NCT00413439|Isavuconazole|isavuconazole|mesh-list
154804346|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
154804347|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804348|NCT00374075|Valproic Acid|valproic acid|mesh-list
154804349|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
154804350|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804351|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804352|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
154804353|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804354|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804355|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
154804356|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154804357|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804358|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154804359|NCT00309621|Alitretinoin|alitretinoin|mesh-list
154804360|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804361|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804362|NCT00124475|Alitretinoin|alitretinoin|mesh-list
154804363|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804364|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804365|NCT00124436|Alitretinoin|alitretinoin|mesh-list
154804366|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804367|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804368|NCT00112931|Rituximab|rituximab|mesh-list
154804369|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804370|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804371|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
154804372|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804373|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804374|NCT00110110|Cyclosporine|cyclosporine|mesh-list
154804375|NCT00110110|Carboplatin|carboplatin|mesh-list
154804376|NCT00110110|Etoposide|etoposide|mesh-list
154804377|NCT00110110|Vincristine|vincristine|mesh-list
154804378|NCT00110110|Cyclosporins|cyclosporins|mesh-list
154804379|NCT00110110|Lenograstim|lenograstim|mesh-list
154804380|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804381|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154804382|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154804383|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154804384|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804385|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804386|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154804387|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
154804388|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804389|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154804390|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154804391|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154804392|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154804393|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
154804394|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804395|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804396|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804397|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154804398|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154804399|NCT05307003|Trazodone|trazodone|mesh-list
154804400|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
154804401|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154804402|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154804403|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154804404|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804405|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804406|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154804407|NCT05307003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154804408|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154804409|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154804410|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804411|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804412|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
154804413|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154804414|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
154804415|NCT03153917|Melatonin|melatonin|mesh-list
154804416|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
154804417|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804418|NCT03153917|Protective Agents|protective agents|mesh-ancestor
154804419|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804420|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804421|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804422|NCT01096875|Atorvastatin|atorvastatin|mesh-list
154804423|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154804424|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154804425|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
154804426|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804427|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154804428|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154804429|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804430|NCT01097343|Clopidogrel|clopidogrel|mesh-list
154804431|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154804432|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154804433|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154804434|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154804435|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
154804436|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804437|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804438|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804439|NCT03580187|Morphine|morphine|mesh-list
154804440|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154804441|NCT03580187|Narcotics|narcotics|mesh-ancestor
154804442|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804443|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804444|NCT03580187|Analgesics|analgesics|mesh-ancestor
154804445|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
154804446|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804447|NCT01098747|Ibuprofen|ibuprofen|mesh-list
154804448|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154804449|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154804450|NCT01098747|Analgesics|analgesics|mesh-ancestor
154804451|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
154804452|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804453|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804454|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804455|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804456|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154804457|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804458|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804459|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
154804460|NCT02085161|Olodaterol|olodaterol|mesh-list
154804461|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154556420|NCT02134067|Paclitaxel|paclitaxel|mesh-list
154804462|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
153983921|NCT00958568|Olanzapine|olanzapine|mesh-list
154804463|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804464|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804465|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154804466|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
154804467|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
154804468|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154804469|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
154804470|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804471|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804472|NCT01034553|Bortezomib|bortezomib|mesh-list
154804473|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804474|NCT01035333|Orlistat|orlistat|mesh-list
154804475|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804476|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804477|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154804478|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154804479|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
154804480|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154804481|NCT03152981|Remifentanil|remifentanil|mesh-list
154804482|NCT03152981|Propofol|propofol|mesh-list
154804483|NCT03152981|Desflurane|desflurane|mesh-list
154804484|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154804485|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804486|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804487|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154804488|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
154804489|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
154804490|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154804491|NCT03152981|Narcotics|narcotics|mesh-ancestor
154804492|NCT03152981|Analgesics|analgesics|mesh-ancestor
154804493|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
154804494|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804495|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154804496|NCT03572387|Azacitidine|azacitidine|mesh-list
154804497|NCT03572387|Tretinoin|tretinoin|mesh-list
154804498|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154804499|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
154804500|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804501|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804502|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804503|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
154804504|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804505|NCT04728971|Caspofungin|caspofungin|mesh-list
154804506|NCT04728971|Micafungin|micafungin|mesh-list
154804507|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
154804508|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804509|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804510|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804511|NCT03568643|Amoxicillin|amoxicillin|mesh-list
154804512|NCT03568643|Azithromycin|azithromycin|mesh-list
154804513|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154804514|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804515|NCT01100931|Paclitaxel|paclitaxel|mesh-list
154804516|NCT01100931|Carboplatin|carboplatin|mesh-list
154804517|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154804518|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804519|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
154804520|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
154804521|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154804522|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804523|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
154804524|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
154804525|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154804526|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154804527|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804528|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
154804529|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154804530|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154804531|NCT03013959|Analgesics|analgesics|mesh-ancestor
154804532|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
154804533|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804534|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804535|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804536|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154556506|NCT04090190|Oxybutynin|oxybutynin|mesh-list
154804537|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
154804538|NCT02246595|Vilobelimab|vilobelimab|mesh-list
154804539|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154804540|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154804541|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
154804542|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804543|NCT01106859|Zolpidem|zolpidem|mesh-list
154804544|NCT01106859|Zopiclone|zopiclone|mesh-list
154804545|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154804546|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154804547|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804548|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804549|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154804550|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
154804551|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
154804552|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804553|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804554|NCT01042509|Rituximab|rituximab|mesh-list
154804555|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
154804556|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804557|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804558|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
154804559|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804560|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804561|NCT02179671|Docetaxel|docetaxel|mesh-list
154804562|NCT02179671|Gefitinib|gefitinib|mesh-list
154804563|NCT02179671|Tremelimumab|tremelimumab|mesh-list
154804564|NCT02179671|Osimertinib|osimertinib|mesh-list
154804565|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804566|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
154804567|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
154804568|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
153984032|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
154804569|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804570|NCT02179671|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154804571|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154804572|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804573|NCT01110135|Dexamethasone|dexamethasone|mesh-list
154804574|NCT01110135|Etoposide|etoposide|mesh-list
154804575|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
154804576|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154804577|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804578|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
154804579|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
154804580|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804581|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804582|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154804583|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
154804584|NCT01110135|Hormones|hormones|mesh-ancestor
154804585|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154804586|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154804587|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804588|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154804589|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154804590|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154804591|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804592|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804593|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154804594|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
154804595|NCT01112241|Albuterol|albuterol|mesh-list
154804596|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
154804597|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154804598|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
154804599|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804600|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804601|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154804602|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
154804603|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
154804604|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154804605|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
154804606|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804607|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804608|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
154804609|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154804610|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154804611|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154804612|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154804613|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
154804614|NCT03013881|Trastuzumab|trastuzumab|mesh-list
154804615|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804616|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804617|NCT02174913|Fentanyl|fentanyl|mesh-list
154804618|NCT02174913|Propofol|propofol|mesh-list
154804619|NCT02174913|Atracurium|atracurium|mesh-list
154804620|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154804621|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804622|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804623|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154804624|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
154804625|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
154804626|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154804627|NCT02174913|Narcotics|narcotics|mesh-ancestor
154804628|NCT02174913|Analgesics|analgesics|mesh-ancestor
154804629|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
154804630|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804631|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154804632|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154804633|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154804634|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154804635|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154804636|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154804637|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
154804638|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984077|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804639|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804640|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
154804641|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154804642|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154804643|NCT01114503|Prednisolone|prednisolone|mesh-list
154804644|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
154804645|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154804646|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
154804647|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804648|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
154804649|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
154804650|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804651|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804652|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154804653|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
154804654|NCT01114503|Hormones|hormones|mesh-ancestor
154804655|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154804656|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154804657|NCT01114503|Protective Agents|protective agents|mesh-ancestor
154804658|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154804659|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804660|NCT03015831|Colchicine|colchicine|mesh-list
154804661|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
154804662|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804663|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
154804664|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
154804665|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
154804666|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804667|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804668|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
154804669|NCT01114581|Guaifenesin|guaifenesin|mesh-list
154804670|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154804671|NCT01114581|Expectorants|expectorants|mesh-ancestor
154804672|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
154804673|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154804674|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154804675|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154804676|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804677|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804678|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804679|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
154804680|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154804681|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
154804682|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
154804683|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804684|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
154804685|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154804686|NCT01114893|Travoprost|travoprost|mesh-list
154804687|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154804688|NCT01114971|Labetalol|labetalol|mesh-list
154804689|NCT01114971|Fentanyl|fentanyl|mesh-list
154804690|NCT01114971|Esmolol|esmolol|mesh-list
154804691|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154804692|NCT01114971|Narcotics|narcotics|mesh-ancestor
154804693|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804694|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804695|NCT01114971|Analgesics|analgesics|mesh-ancestor
154804696|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
154804697|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804698|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154804699|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154804700|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
154804701|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
154804702|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154804703|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154804704|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154804705|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
154804706|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804707|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804708|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154804709|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
154804710|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
154804711|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154804712|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154804713|NCT01044693|Metoprolol|metoprolol|mesh-list
154804714|NCT01044693|Nebivolol|nebivolol|mesh-list
154804715|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
154804716|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
154804717|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154804718|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154804719|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804720|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804721|NCT01044693|Urological Agents|urological agents|mesh-ancestor
154804722|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154804723|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154804724|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
154804725|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
154804726|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804727|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804728|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154804729|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154804730|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154804731|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154804732|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804733|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154804734|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154804735|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154804736|NCT01115517|Bevacizumab|bevacizumab|mesh-list
154804737|NCT01115517|Mitomycins|mitomycins|mesh-list
154804738|NCT01115517|Mitomycin|mitomycin|mesh-list
154804739|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804740|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804741|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154804742|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154804743|NCT01115517|Growth Substances|growth substances|mesh-ancestor
154804744|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804745|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
154804746|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154804747|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
154804748|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804749|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154804750|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804751|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
154804752|NCT03015675|Vitamins|vitamins|mesh-ancestor
154804753|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
154804754|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804755|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
153984200|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804756|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804757|NCT03015675|Protective Agents|protective agents|mesh-ancestor
154804758|NCT01044771|Tenofovir|tenofovir|mesh-list
154804759|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
154804760|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
154804761|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804762|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154804763|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154804764|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804765|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804766|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154804767|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154804768|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154804769|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154804770|NCT01115673|Acetaminophen|acetaminophen|mesh-list
154804771|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154804772|NCT01115673|Analgesics|analgesics|mesh-ancestor
154804773|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
154804774|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804775|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804776|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
154804777|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154804778|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
154804779|NCT01118091|Aldesleukin|aldesleukin|mesh-list
154804780|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804781|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154804782|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154804783|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
154804784|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804785|NCT01045551|Apremilast|apremilast|mesh-list
154804786|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154804787|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154804788|NCT01045551|Analgesics|analgesics|mesh-ancestor
154804789|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
154804790|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804791|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804792|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804793|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804794|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154804795|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154804796|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804797|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804798|NCT01047189|Clindamycin|clindamycin|mesh-list
154804799|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
154804800|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
154804801|NCT01047189|Tretinoin|tretinoin|mesh-list
154804802|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154804803|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804804|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154804805|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804806|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804807|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804808|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
154804809|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804810|NCT03012945|Anesthetics|anesthetics|mesh-list
154804811|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804812|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804813|NCT01121211|Testosterone|testosterone|mesh-list
154804814|NCT01121211|Androgens|androgens|mesh-ancestor
154804815|NCT01121211|Hormones|hormones|mesh-ancestor
154804816|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154804817|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804818|NCT01162551|Sirolimus|sirolimus|mesh-list
154804819|NCT01162551|Methotrexate|methotrexate|mesh-list
154804820|NCT01162551|Temsirolimus|temsirolimus|mesh-list
154804821|NCT01162551|MTOR Inhibitors|mtor inhibitors|mesh-list
154804822|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154804823|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
154804824|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154804825|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804826|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154804827|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
154804828|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804829|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804830|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804831|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804832|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154804833|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154804834|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
154804835|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804836|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154804837|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154804838|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804839|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154804840|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
154804841|NCT01162551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154804842|NCT01163097|Heparin|heparin|mesh-list
154804843|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
154804844|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154804845|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154804846|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804848|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154804849|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
154804850|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804851|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154804852|NCT03088137|Hormones|hormones|mesh-ancestor
154804853|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154804854|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804855|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
154804856|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154804857|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
154804858|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804859|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804860|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153984324|NCT02563795|Fentanyl|fentanyl|mesh-list
154804861|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154804862|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154804863|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
154804864|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804865|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804866|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154804867|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
154804868|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
154804869|NCT01165047|Protective Agents|protective agents|mesh-ancestor
154804870|NCT01165983|Aliskiren|aliskiren|mesh-list
154804871|NCT01165983|Renin Inhibitors|renin inhibitors|mesh-ancestor
154804872|NCT01165983|Protease Inhibitors|protease inhibitors|mesh-ancestor
154804873|NCT01165983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804874|NCT01165983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804875|NCT01166139|Nilotinib|nilotinib|mesh-list
154804876|NCT01166139|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154804877|NCT01166139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154804878|NCT01166139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804879|NCT01166139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804880|NCT01166997|Heparin|heparin|mesh-list
154804881|NCT01166997|Calcium heparin|calcium heparin|mesh-list
154804882|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
154804883|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154804884|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154804885|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804886|NCT01170117|Olanzapine|olanzapine|mesh-list
154804887|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
154804888|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
154804889|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804890|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804891|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154804892|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154804893|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154804894|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804895|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154804896|NCT01170117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154804897|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154804898|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154804899|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804900|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804901|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
154804902|NCT01172145|Modafinil|modafinil|mesh-list
154804903|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154804904|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804905|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154804906|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154804907|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154804908|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804909|NCT01175343|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154804910|NCT01175343|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154804911|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804912|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804913|NCT01176435|Levodopa|levodopa|mesh-list
154804914|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154804915|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154804916|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
154804917|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984371|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
154804918|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804919|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804920|NCT01176591|Aprepitant|aprepitant|mesh-list
154804921|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
154804922|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
154804923|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
154804924|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804925|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804926|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154804927|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154804928|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154804929|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804930|NCT01176981|Methotrexate|methotrexate|mesh-list
154804931|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154804932|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
154804933|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154804934|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804935|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154804936|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
154804937|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804938|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804939|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
154804940|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804941|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154804942|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154804943|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
154804944|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804945|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154804946|NCT01126593|Bupivacaine|bupivacaine|mesh-list
154804947|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
154804948|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
154804949|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154804950|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804951|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
154804952|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804953|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154804954|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154804955|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804956|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804957|NCT01126671|Vitamin D|vitamin d|mesh-list
154804958|NCT01126671|Vitamins|vitamins|mesh-ancestor
154804959|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
154804960|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804961|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154804962|NCT01182675|Plerixafor|plerixafor|mesh-list
154804963|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
154804964|NCT01182675|Lenograstim|lenograstim|mesh-list
154804965|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154804966|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
154804967|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154804968|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154804969|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154804970|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154804971|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154804972|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
154804973|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154804974|NCT01129245|Celecoxib|celecoxib|mesh-list
154804975|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154804976|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154804977|NCT01129245|Analgesics|analgesics|mesh-ancestor
154804978|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
154804979|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154804980|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984431|NCT00689221|Temozolomide|temozolomide|mesh-list
154804981|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154804982|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154804983|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154804984|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154804985|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804986|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804987|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154804988|NCT01183533|Plasminogen|plasminogen|mesh-list
154804989|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154804990|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154804991|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154804992|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154804993|NCT01188369|Simendan|simendan|mesh-list
154804994|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154804995|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
154804996|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154804997|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154804998|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154804999|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805000|NCT01188369|Protective Agents|protective agents|mesh-ancestor
154805001|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805002|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
154805003|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
154805004|NCT01135329|Busulfan|busulfan|mesh-list
154805005|NCT01135329|Fludarabine|fludarabine|mesh-list
154805006|NCT01135329|Tacrolimus|tacrolimus|mesh-list
154805007|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805008|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
154805009|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805010|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805011|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154805012|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
154805013|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805014|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805015|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154805016|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154805017|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805018|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154805019|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154805020|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
154805021|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154805022|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805023|NCT03012009|Lidocaine|lidocaine|mesh-list
154805024|NCT03012009|Epinephrine|epinephrine|mesh-list
154805025|NCT03012009|Racepinephrine|racepinephrine|mesh-list
154805026|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
154805027|NCT03012009|Anesthetics|anesthetics|mesh-list
154805028|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154805029|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
154805030|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805031|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805032|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
154805033|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805034|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154805035|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154805036|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154805037|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154805038|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805039|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154805040|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154805041|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
154805042|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805043|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154805044|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154805045|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
154805046|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154805047|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
154805048|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
154805049|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
154805050|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154805051|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154805052|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
154805053|NCT04403555|Ivermectin|ivermectin|mesh-list
154805054|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154805055|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805056|NCT03565835|Prednisone|prednisone|mesh-list
154805057|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
154805058|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805059|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
154805060|NCT03565835|Hormones|hormones|mesh-ancestor
154805061|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805062|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805063|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805064|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805065|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154805066|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805067|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805068|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
154805069|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154805071|NCT01624259|Liraglutide|liraglutide|mesh-list
154805072|NCT01624259|Dulaglutide|dulaglutide|mesh-list
154805073|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154805074|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805075|NCT01624259|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154805076|NCT01624259|Incretins|incretins|mesh-ancestor
154805077|NCT01624259|Hormones|hormones|mesh-ancestor
154805078|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805079|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
154805080|NCT02081183|Prednisone|prednisone|mesh-list
154805081|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
154805082|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805083|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
154805084|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805085|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805086|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154805087|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
154805088|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805089|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805090|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154805091|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805092|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
154805093|NCT02081183|Hormones|hormones|mesh-ancestor
154805094|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805095|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805096|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154805097|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154805098|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
154805099|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154805100|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805101|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805102|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
154805103|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154805104|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154805105|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805106|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
154805107|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154805108|NCT02079077|Aspirin|aspirin|mesh-list
154805109|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
154805110|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
154805111|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154805112|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154805113|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805114|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805115|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805116|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805117|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154805118|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154805119|NCT02079077|Analgesics|analgesics|mesh-ancestor
154805120|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
154805121|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805122|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805123|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805124|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154805125|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154805126|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154805127|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154805128|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
154805129|NCT03547271|Vaccines|vaccines|mesh-list
154805130|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154805131|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
154805132|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805133|NCT01191255|Sevelamer|sevelamer|mesh-list
154805134|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
154805135|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
154805136|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805137|NCT02078219|Allopurinol|allopurinol|mesh-list
154805138|NCT02078219|Verinurad|verinurad|mesh-list
154557099|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805139|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
154805140|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805141|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805142|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
154805143|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805144|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154805145|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
154805146|NCT02078219|Protective Agents|protective agents|mesh-ancestor
154805147|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805148|NCT03536039|Prednisone|prednisone|mesh-list
154805149|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
154805150|NCT03536039|Rituximab|rituximab|mesh-list
154805151|NCT03536039|Doxorubicin|doxorubicin|mesh-list
154805152|NCT03536039|Vincristine|vincristine|mesh-list
154805153|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805154|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
154805155|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805156|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805157|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154805158|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
154805159|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805160|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805161|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154805162|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154805163|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154805164|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154805165|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805166|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805167|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805168|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
154805169|NCT03536039|Hormones|hormones|mesh-ancestor
154805170|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805171|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805172|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154805173|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
154805174|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
154805175|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
154805176|NCT02075255|Benralizumab|benralizumab|mesh-list
154805177|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154805178|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
154805179|NCT03532217|Nivolumab|nivolumab|mesh-list
154805180|NCT03532217|Ipilimumab|ipilimumab|mesh-list
154805181|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154805182|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805183|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154805184|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805185|NCT03529487|Phenylephrine|phenylephrine|mesh-list
154805186|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
154805187|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154805188|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154805189|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
154805190|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805191|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805192|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805193|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
154805194|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
154805195|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805196|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
154805197|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154805198|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
154805199|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154805200|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
154805201|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154805202|NCT03529487|Protective Agents|protective agents|mesh-ancestor
154805203|NCT03527147|Rituximab|rituximab|mesh-list
154805204|NCT03527147|Magrolimab|magrolimab|mesh-list
154805205|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
154805206|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154805207|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805208|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
154805209|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805210|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805211|NCT03527147|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154805212|NCT03527147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154805213|NCT03527147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805214|NCT03527147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805215|NCT01677611|Resveratrol|resveratrol|mesh-list
154805216|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
154805217|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805218|NCT01677611|Protective Agents|protective agents|mesh-ancestor
154805219|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805220|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805221|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154805222|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
154805223|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154805224|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805225|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154805226|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805227|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805228|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805229|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805230|NCT01193049|Prednisone|prednisone|mesh-list
154805231|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805232|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
154805233|NCT01193049|Hormones|hormones|mesh-ancestor
154805234|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805235|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805236|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805237|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805238|NCT01679951|Methotrexate|methotrexate|mesh-list
154805239|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154805240|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
153984724|NCT00954512|Antidotes|antidotes|mesh-ancestor
154805241|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154805242|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805243|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805244|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
154805245|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805246|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805247|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
154805248|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805249|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154805250|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805251|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
154805252|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805253|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154805254|NCT01194297|Vaccines|vaccines|mesh-list
154805255|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
154805256|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805257|NCT01194453|Folic Acid|folic acid|mesh-list
154805258|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
154805259|NCT01194453|Dexamethasone|dexamethasone|mesh-list
154805260|NCT01194453|Cisplatin|cisplatin|mesh-list
154805261|NCT01194453|Gemcitabine|gemcitabine|mesh-list
154805262|NCT01194453|Vitamins|vitamins|mesh-ancestor
154805263|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
154805264|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805265|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805266|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805267|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
154805268|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
154805269|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805270|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154805271|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
154805272|NCT01194453|Hormones|hormones|mesh-ancestor
154805273|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805274|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805275|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805276|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
154805277|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805278|NCT01194453|Hematinics|hematinics|mesh-ancestor
154805279|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
154805280|NCT01195467|Tenofovir|tenofovir|mesh-list
154805281|NCT01195467|Emtricitabine|emtricitabine|mesh-list
154805282|NCT01195467|Efavirenz|efavirenz|mesh-list
154805283|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154805284|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
154805285|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
154805286|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805287|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154805288|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154805289|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860509|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154805290|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805291|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154805292|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154805293|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154805294|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154805295|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154805296|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154805297|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154805298|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154805299|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154805300|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154805301|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154805302|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
154805303|NCT01195779|Vaccines|vaccines|mesh-list
154805304|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
154805305|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805306|NCT02405585|Leucovorin|leucovorin|mesh-list
154805307|NCT02405585|Gemcitabine|gemcitabine|mesh-list
154805308|NCT02405585|Fluorouracil|fluorouracil|mesh-list
154805309|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
154805310|NCT02405585|Irinotecan|irinotecan|mesh-list
154805311|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805312|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
154805313|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805314|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805315|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805316|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
154805317|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805318|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154805319|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805320|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805321|NCT02405585|Antidotes|antidotes|mesh-ancestor
154805322|NCT02405585|Protective Agents|protective agents|mesh-ancestor
154805323|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
154805324|NCT02405585|Vitamins|vitamins|mesh-ancestor
154805325|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
154805326|NCT03491345|Avelumab|avelumab|mesh-list
154805327|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154805328|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805329|NCT00089999|Lapatinib|lapatinib|mesh-list
154805330|NCT00089999|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154805331|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154805332|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805333|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805334|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805335|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
154805336|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
154805337|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
154805338|NCT00089843|Testosterone|testosterone|mesh-list
154805339|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
154805340|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
154805341|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154805342|NCT00089843|Androgens|androgens|mesh-ancestor
154805343|NCT00089843|Hormones|hormones|mesh-ancestor
154805344|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805345|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805346|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805347|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805348|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
154805349|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154805350|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154805351|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805352|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154805353|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154805354|NCT01677923|Metformin|metformin|mesh-list
154805355|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154805356|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805357|NCT00089297|Paclitaxel|paclitaxel|mesh-list
154805358|NCT00089297|Carboplatin|carboplatin|mesh-list
154805359|NCT00089297|Cetuximab|cetuximab|mesh-list
154805360|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154805361|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984806|NCT00687193|Tofacitinib|tofacitinib|mesh-list
154805362|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
154805363|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
154805364|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
154860510|NCT01921010|Niacin|niacin|mesh-list
154557334|NCT02253953|Ritonavir|ritonavir|mesh-list
154805365|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805366|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154805367|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154805368|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154805369|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805370|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805371|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154805372|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154805373|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805374|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
154805375|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805376|NCT00088907|Docetaxel|docetaxel|mesh-list
154805377|NCT00088907|Gefitinib|gefitinib|mesh-list
154805378|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805379|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
154805380|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
154805381|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
154805382|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805383|NCT00088907|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154805384|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154805385|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805386|NCT00088829|Paclitaxel|paclitaxel|mesh-list
154805387|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154805388|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154805389|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805390|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
154805391|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
154805392|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
154805393|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805394|NCT00088595|Pasireotide|pasireotide|mesh-list
154805395|NCT00088595|Hormones|hormones|mesh-ancestor
154805396|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805397|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805398|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
154805399|NCT01678079|Calcium|calcium|mesh-list
154805400|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154805401|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805402|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154805403|NCT01678235|Insulin|insulin|mesh-list
154805404|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154805405|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
154805406|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
154805407|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154805408|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805409|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
154805410|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154805411|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
153984891|NCT02593162|Ribavirin|ribavirin|mesh-list
154805412|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805413|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
154805414|NCT01197495|Protective Agents|protective agents|mesh-ancestor
154805415|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154805416|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154805417|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154805418|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805419|NCT03011931|Simvastatin|simvastatin|mesh-list
154805420|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154805421|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154805422|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
154805423|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805424|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154805425|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154805426|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805427|NCT02185131|Mirtazapine|mirtazapine|mesh-list
154805428|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
154805429|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154805430|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154805431|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
154805432|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
154805433|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805434|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805435|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805436|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154805437|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154860511|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
154805438|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805439|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154805440|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154805441|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154805442|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
154805443|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154805444|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154805445|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
154805446|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154805448|NCT00085709|Daunorubicin|daunorubicin|mesh-list
154805449|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
154805450|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805451|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
154805452|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805453|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805454|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
154805455|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805456|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805457|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
154805458|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805459|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154805460|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154805461|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805462|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805463|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154805464|NCT00085709|Immunotoxins|immunotoxins|mesh-ancestor
154805465|NCT00085709|Immunoconjugates|immunoconjugates|mesh-ancestor
154805466|NCT01201863|Testosterone|testosterone|mesh-list
154805467|NCT01201863|Androgens|androgens|mesh-ancestor
154805468|NCT01201863|Hormones|hormones|mesh-ancestor
154805469|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805470|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805471|NCT01202253|Anidulafungin|anidulafungin|mesh-list
154805472|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
154805473|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805474|NCT01678703|Misoprostol|misoprostol|mesh-list
154805475|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154805476|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
154805477|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154805478|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805479|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154805480|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154805481|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
154805482|NCT00085631|Cisplatin|cisplatin|mesh-list
154805483|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805484|NCT01141491|Vaccines|vaccines|mesh-list
154805485|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154805486|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
154805487|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805488|NCT01141569|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154805489|NCT01141569|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154805490|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805491|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805492|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154805493|NCT01141725|Idarubicin|idarubicin|mesh-list
154805494|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154805495|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
154805496|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805497|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805498|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154805499|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154805500|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805501|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805502|NCT01202721|Atenolol|atenolol|mesh-list
154805503|NCT01202721|Telmisartan|telmisartan|mesh-list
154805504|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154805505|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154805506|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154805507|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805508|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154805509|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
154805510|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
154805511|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805512|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805513|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154805514|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154805515|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154805516|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
154805517|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805518|NCT00084617|Capecitabine|capecitabine|mesh-list
154805519|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
154805520|NCT00084617|Irinotecan|irinotecan|mesh-list
154805521|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805522|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
153984982|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805523|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805524|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805525|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154805526|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805527|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805528|NCT01203189|Ketoconazole|ketoconazole|mesh-list
154805529|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
154805530|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805531|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154805532|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154805533|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805534|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805535|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154805536|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
154805537|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805538|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805539|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154805540|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
154805541|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154805542|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805543|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
154805544|NCT01679327|Leucovorin|leucovorin|mesh-list
154805545|NCT01679327|Bevacizumab|bevacizumab|mesh-list
154805546|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
154805547|NCT01679327|Calcium|calcium|mesh-list
154805548|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
154805549|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154805550|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805551|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154805552|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154805553|NCT01679327|Growth Substances|growth substances|mesh-ancestor
154805554|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805555|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
154805556|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154805557|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154805558|NCT01679327|Antidotes|antidotes|mesh-ancestor
154805559|NCT01679327|Protective Agents|protective agents|mesh-ancestor
154805560|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
154805561|NCT01679327|Vitamins|vitamins|mesh-ancestor
154805562|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
154805563|NCT01206387|Desoximetasone|desoximetasone|mesh-list
154805564|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805565|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
154805566|NCT01206387|Hormones|hormones|mesh-ancestor
154805567|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805568|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805569|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154805570|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154805571|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154805572|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154805573|NCT01679639|Rifampin|rifampin|mesh-list
154805574|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154805575|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
154805576|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154805577|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805578|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
154805579|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154805580|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805581|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805582|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153985036|NCT00630890|Capecitabine|capecitabine|mesh-list
154805583|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154557548|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805584|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154805585|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154805586|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154805587|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154805588|NCT01679795|Tibolone|tibolone|mesh-list
154805589|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
154805590|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
154805591|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805592|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805593|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154805594|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805595|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805596|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154805597|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
154805598|NCT01679795|Hormones|hormones|mesh-ancestor
154805599|NCT01207401|Lidocaine|lidocaine|mesh-list
154805600|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
154805601|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
154805602|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805603|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805604|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
154805605|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805606|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154805607|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154805608|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154805609|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154805610|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805611|NCT04761731|Tacrolimus|tacrolimus|mesh-list
154805612|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805613|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
154805614|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805615|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154805616|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805617|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805618|NCT03087539|Abciximab|abciximab|mesh-list
154805619|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
154805620|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154805621|NCT03087149|Vitamin D|vitamin d|mesh-list
154805622|NCT03087149|Vitamins|vitamins|mesh-ancestor
154805623|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
154805624|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805625|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154805626|NCT03086681|Cisplatin|cisplatin|mesh-list
154805627|NCT03086681|Endostar protein|endostar protein|mesh-list
154805628|NCT03086681|Endostatins|endostatins|mesh-list
154805629|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805630|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154805631|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154805632|NCT03086681|Growth Substances|growth substances|mesh-ancestor
154805633|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805634|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
154805635|NCT03086759|Triamcinolone|triamcinolone|mesh-list
154805636|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154805637|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154805638|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154805639|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805640|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
154805641|NCT03086759|Hormones|hormones|mesh-ancestor
154805642|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805643|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805644|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805645|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
154805646|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805647|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805648|NCT03086291|Simvastatin|simvastatin|mesh-list
154805649|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154805650|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154805651|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
154805652|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805653|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154805654|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154805655|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805656|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154805657|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154805658|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805659|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805660|NCT01209195|Paclitaxel|paclitaxel|mesh-list
154805661|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154805662|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805663|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
154805664|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
154805665|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
154805666|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805667|NCT03084809|Leucovorin|leucovorin|mesh-list
154805668|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
154805669|NCT03084809|Fluorouracil|fluorouracil|mesh-list
154805670|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
154805671|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805672|NCT03084809|Antidotes|antidotes|mesh-ancestor
154805673|NCT03084809|Protective Agents|protective agents|mesh-ancestor
154805674|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805675|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
154805676|NCT03084809|Vitamins|vitamins|mesh-ancestor
154805677|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
154805678|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
154805679|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805680|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805681|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805682|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
154805683|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
154805684|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154805685|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154805686|NCT01144143|Prednisolone|prednisolone|mesh-list
154805687|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
154805688|NCT01144143|Infliximab|infliximab|mesh-list
154805689|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154805690|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
154805691|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805692|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
154805693|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
154805694|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805695|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805696|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154805697|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
154805698|NCT01144143|Hormones|hormones|mesh-ancestor
154805699|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805700|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154805701|NCT01144143|Protective Agents|protective agents|mesh-ancestor
154805702|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805703|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805704|NCT01144143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154805705|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
154805706|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805707|NCT03084575|Glycerol|glycerol|mesh-list
154805708|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154805709|NCT03084575|Protective Agents|protective agents|mesh-ancestor
154805710|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805711|NCT01212471|Bromfenac|bromfenac|mesh-list
154805712|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154805713|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154805714|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154805715|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154805716|NCT01212471|Analgesics|analgesics|mesh-ancestor
154805717|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
154805718|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805719|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805720|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805721|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805722|NCT03084419|Abatacept|abatacept|mesh-list
154805723|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154805724|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805725|NCT03084419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154805726|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805727|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805728|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
154805729|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805730|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805731|NCT03084029|Oxytocin|oxytocin|mesh-list
154805732|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
154805733|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154805734|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805735|NCT04278053|Inositol|inositol|mesh-list
154805736|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
154805737|NCT04278053|Vitamins|vitamins|mesh-ancestor
154805738|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
154805739|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805740|NCT05346107|Paclitaxel|paclitaxel|mesh-list
154805741|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
154805742|NCT05346107|Doxorubicin|doxorubicin|mesh-list
154805743|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154805744|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154805745|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805746|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154805747|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154805748|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154805749|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805750|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805751|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
154805752|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805753|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805754|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154805755|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
154805756|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154805757|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154805758|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154805759|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805760|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805761|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154805762|NCT00083915|Thalidomide|thalidomide|mesh-list
154805763|NCT00083915|Dexamethasone|dexamethasone|mesh-list
154805764|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
154805765|NCT00083915|Melphalan|melphalan|mesh-list
154805766|NCT00083915|Cisplatin|cisplatin|mesh-list
154805767|NCT00083915|Doxorubicin|doxorubicin|mesh-list
154805768|NCT00083915|Etoposide|etoposide|mesh-list
154805769|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154805770|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805771|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
154805772|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805773|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805774|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154805775|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
154805776|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805777|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805778|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154805779|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805780|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
154805781|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
154805782|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805783|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154805784|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
154805785|NCT00083915|Hormones|hormones|mesh-ancestor
154805786|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805787|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805788|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154805789|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154805790|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805791|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805792|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154805793|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
154805794|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154805795|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805796|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154805797|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154805798|NCT00083915|Growth Substances|growth substances|mesh-ancestor
154805799|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
154805800|NCT04401839|Oxytocin|oxytocin|mesh-list
154805801|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
154805802|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154805803|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805804|NCT04761185|Raltitrexed|raltitrexed|mesh-list
154805805|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805806|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
154805807|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805808|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805809|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154805810|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805811|NCT01144455|Gemcitabine|gemcitabine|mesh-list
154805812|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
154805813|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154805814|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
154805815|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805816|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805817|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154805818|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
154805819|NCT03080675|Vitamins|vitamins|mesh-list
154805820|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
154805821|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805822|NCT03080363|Lidocaine|lidocaine|mesh-list
154805823|NCT03080363|Bupivacaine|bupivacaine|mesh-list
154805824|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
154805825|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
154805826|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805827|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805828|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
154805829|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805830|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154805831|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154805832|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154805833|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154805834|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805835|NCT01145001|Nicotine|nicotine|mesh-list
154805836|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154805837|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
154805838|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805839|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805840|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154805841|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154805842|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
154805843|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805844|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805845|NCT03011463|Clarithromycin|clarithromycin|mesh-list
154805846|NCT03011463|Ranitidine|ranitidine|mesh-list
154805847|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154805848|NCT03011463|Trospium chloride|trospium chloride|mesh-list
154805849|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154805850|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805851|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154805852|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805853|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805854|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154805855|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154805856|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154805857|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154805858|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154805859|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
154805860|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
154805861|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805862|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805863|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
154805864|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
154805865|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805866|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154805867|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154805868|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
154805869|NCT03011463|Urological Agents|urological agents|mesh-ancestor
154805870|NCT01214109|Pramipexole|pramipexole|mesh-list
154805871|NCT01214109|Dexpramipexole|dexpramipexole|mesh-list
154805872|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
154805873|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805874|NCT01214109|Protective Agents|protective agents|mesh-ancestor
154805875|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805876|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154805877|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154805878|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
154805879|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
154805880|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805881|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154805882|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805883|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805884|NCT01215123|Bevacizumab|bevacizumab|mesh-list
154805885|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154860512|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154805886|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805887|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154805888|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154805889|NCT01215123|Growth Substances|growth substances|mesh-ancestor
154805890|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805891|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
154805892|NCT05688449|Fentanyl|fentanyl|mesh-list
154805893|NCT05688449|Bupivacaine|bupivacaine|mesh-list
154805894|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
154805895|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
154805896|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805897|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805898|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
154805899|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805900|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154805901|NCT05688449|Narcotics|narcotics|mesh-ancestor
154805902|NCT05688449|Analgesics|analgesics|mesh-ancestor
154805903|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154805904|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154805905|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
154805906|NCT04401137|Topiramate|topiramate|mesh-list
154805907|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
154805908|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154805909|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805910|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154805911|NCT02189889|Hematinics|hematinics|mesh-ancestor
154805912|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154805913|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154805914|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154805915|NCT01148745|Hematinics|hematinics|mesh-ancestor
154805916|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154805917|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154805918|NCT04761029|Tramadol|tramadol|mesh-list
154805919|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154805920|NCT04761029|Narcotics|narcotics|mesh-ancestor
154805921|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805922|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805923|NCT04761029|Analgesics|analgesics|mesh-ancestor
154805924|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
154805925|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805926|NCT05687981|Dexamethasone|dexamethasone|mesh-list
154805927|NCT05687981|Bupivacaine|bupivacaine|mesh-list
154805928|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154805929|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
154805930|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
154805931|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154805932|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805933|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154805934|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
154805935|NCT05687981|Hormones|hormones|mesh-ancestor
154805936|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154805937|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154805938|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805939|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
154805940|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
154805941|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805942|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
154805943|NCT05687747|FAPI-46|fapi-46|mesh-list
154805944|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154805945|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805946|NCT05687669|Phentolamine|phentolamine|mesh-list
154805947|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
154805948|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154805949|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154805950|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
154805951|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154805952|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805953|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805954|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154805955|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
154805956|NCT04400747|Vitamin D|vitamin d|mesh-list
154805957|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
154805958|NCT04400747|Vitamins|vitamins|mesh-ancestor
154805959|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
154805960|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805961|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154805962|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154805963|NCT02190903|Anesthetics|anesthetics|mesh-list
154805964|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154805965|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805967|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154805968|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154805969|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805970|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805971|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154805972|NCT01149759|Cyclosporine|cyclosporine|mesh-list
154805973|NCT01149759|Cyclosporins|cyclosporins|mesh-list
154805974|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154805975|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154805976|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154805977|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
154805978|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805979|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
154805980|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805981|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
154805982|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154805983|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154805984|NCT01216761|Iodine|iodine|mesh-list
154805985|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
154805986|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154805987|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
154805988|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
154805989|NCT01216761|Povidone|povidone|mesh-list
154805990|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154805991|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154805992|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
154805993|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
154805994|NCT01216761|Trace Elements|trace elements|mesh-ancestor
154805995|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
154805996|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154805997|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
154805998|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
154805999|NCT04279379|Decitabine|decitabine|mesh-list
154806000|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154806001|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
154806002|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806003|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806004|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806005|NCT01150461|Losartan|losartan|mesh-list
154806006|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
154806007|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153985459|NCT00721396|Vaccines|vaccines|mesh-list
154806008|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154806009|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154806010|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154806011|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806012|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154806013|NCT01218399|Budesonide|budesonide|mesh-list
154806014|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154806015|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806016|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154806017|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
154806018|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806019|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806020|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154806021|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
154806022|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
154806023|NCT01218399|Hormones|hormones|mesh-ancestor
154806024|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806025|NCT01219881|Sevoflurane|sevoflurane|mesh-list
154806026|NCT01219881|Desflurane|desflurane|mesh-list
154806027|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154806028|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154806029|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
154806030|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
154806031|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806032|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806033|NCT01220973|Celecoxib|celecoxib|mesh-list
154806034|NCT01220973|Atorvastatin|atorvastatin|mesh-list
154806035|NCT01220973|Calcium|calcium|mesh-list
154806036|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154806037|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806038|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154558003|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
154806039|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154806040|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
154806041|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806042|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154806043|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154806044|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806045|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154806046|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806047|NCT01220973|Analgesics|analgesics|mesh-ancestor
154806048|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
154806049|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806050|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806051|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154806052|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154806053|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154806054|NCT05375747|Propofol|propofol|mesh-list
154806055|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154806056|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806057|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806058|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154806059|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
154806060|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
154806061|NCT01221207|Calpastatin|calpastatin|mesh-list
154806062|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154806063|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
154806064|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806065|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806066|NCT03296813|Torsemide|torsemide|mesh-list
154806067|NCT03296813|Furosemide|furosemide|mesh-list
154806068|NCT03296813|Diuretics|diuretics|mesh-ancestor
154806069|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
154806070|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806071|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154806072|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806073|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806074|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154806075|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
154806076|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154806077|NCT04400045|Treosulfan|treosulfan|mesh-list
154806078|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154806079|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
154806080|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806081|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806082|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154806083|NCT01222689|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154806084|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154806085|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806086|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806087|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806088|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154806089|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154806090|NCT01153581|Estradiol|estradiol|mesh-list
154806091|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154806092|NCT01153581|Progesterone|progesterone|mesh-list
154806093|NCT01153581|Ganirelix|ganirelix|mesh-list
154806094|NCT01153581|Estrogens|estrogens|mesh-ancestor
154806095|NCT01153581|Hormones|hormones|mesh-ancestor
154806096|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806097|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806098|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154806099|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
154806100|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154806101|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154806102|NCT01153581|Progestins|progestins|mesh-ancestor
154806103|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
154806105|NCT04278599|Trace Elements|trace elements|mesh-ancestor
154806106|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
154806107|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806108|NCT05277623|Mannitol|mannitol|mesh-list
154806109|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154806110|NCT05277623|Diuretics|diuretics|mesh-ancestor
154806111|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
154806112|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558078|NCT02407899|Incretins|incretins|mesh-ancestor
154806113|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154806114|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154806115|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154806116|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806117|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806118|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154806119|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806120|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806121|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
154806122|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806123|NCT04760327|Cisplatin|cisplatin|mesh-list
154806124|NCT04760327|Bleomycin|bleomycin|mesh-list
154806125|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806126|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154806127|NCT01225263|Vitamin D|vitamin d|mesh-list
154806128|NCT01225263|Simvastatin|simvastatin|mesh-list
154806129|NCT01225263|Vitamins|vitamins|mesh-ancestor
154806130|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
154806131|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806132|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154806133|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154806134|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154806135|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
154806136|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806137|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154806138|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154806139|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806140|NCT04278287|Paclitaxel|paclitaxel|mesh-list
154806141|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154806142|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154806143|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806144|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
154806145|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
154806146|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
154806147|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806148|NCT05162027|Erenumab|erenumab|mesh-list
154806149|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154806150|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806151|NCT05162027|Analgesics|analgesics|mesh-ancestor
154806152|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
154806153|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806154|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806155|NCT03278717|Olaparib|olaparib|mesh-list
154806156|NCT03278717|Cediranib|cediranib|mesh-list
154806157|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154806158|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806159|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806160|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806161|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154806162|NCT01227993|Finasteride|finasteride|mesh-list
154806163|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154806164|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154806165|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806166|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806167|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
153985643|NCT00685945|Diuretics|diuretics|mesh-ancestor
154806168|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806169|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806170|NCT01227993|Urological Agents|urological agents|mesh-ancestor
154806171|NCT01155999|Tobramycin|tobramycin|mesh-list
154806172|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154806173|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806174|NCT03275597|Durvalumab|durvalumab|mesh-list
154806175|NCT03275597|Tremelimumab|tremelimumab|mesh-list
154806176|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154806177|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806178|NCT01228149|Acetazolamide|acetazolamide|mesh-list
154806179|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
154806180|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154806181|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806182|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806183|NCT01228149|Diuretics|diuretics|mesh-ancestor
154806184|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
154806185|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806186|NCT04989413|Dronabinol|dronabinol|mesh-list
154806187|NCT04989413|Cannabidiol|cannabidiol|mesh-list
154806188|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
154806189|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
154806190|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806191|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806192|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806193|NCT04989413|Analgesics|analgesics|mesh-ancestor
154806194|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
154806195|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806196|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154806197|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154806198|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806199|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806200|NCT04989413|Hormones|hormones|mesh-ancestor
154806201|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806202|NCT02192541|Aflibercept|aflibercept|mesh-list
154806203|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154806204|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154806205|NCT02192541|Growth Substances|growth substances|mesh-ancestor
154806206|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806207|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
154806208|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806209|NCT01156701|Zanamivir|zanamivir|mesh-list
154806210|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
154806211|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806212|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806213|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806214|NCT06222580|Gilteritinib|gilteritinib|mesh-list
154806215|NCT06222580|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154806216|NCT06222580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154806217|NCT06222580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806218|NCT06222580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806219|NCT06222567|Benzocaine|benzocaine|mesh-list
154806220|NCT06222567|Anesthetics, Local|anesthetics, local|mesh-ancestor
154806221|NCT06222567|Anesthetics|anesthetics|mesh-ancestor
154806222|NCT06222567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806223|NCT06222567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806224|NCT06222567|Sensory System Agents|sensory system agents|mesh-ancestor
154806225|NCT06222567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806226|NCT06222476|Gliclazide|gliclazide|mesh-list
154806227|NCT06222476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154806228|NCT06222476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806229|NCT06222372|Rifampin|rifampin|mesh-list
154806230|NCT06222372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154806231|NCT06222372|Antitubercular Agents|antitubercular agents|mesh-ancestor
154806232|NCT06222372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154806233|NCT06222372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806234|NCT06222372|Leprostatic Agents|leprostatic agents|mesh-ancestor
154806235|NCT06222372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154806236|NCT06222372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806237|NCT06222372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806238|NCT06222372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154806239|NCT06222372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154806240|NCT06222372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154806241|NCT06222372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154806242|NCT06222372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154806243|NCT06222372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154806244|NCT06222320|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154806245|NCT06222320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806246|NCT06222320|Analgesics|analgesics|mesh-ancestor
154806247|NCT06222320|Sensory System Agents|sensory system agents|mesh-ancestor
154806248|NCT06222320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806249|NCT06222320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806250|NCT06222320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154806251|NCT06222320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806252|NCT06222320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154806253|NCT06222294|Propofol|propofol|mesh-list
154806254|NCT06222294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154806255|NCT06222294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806256|NCT06222294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806257|NCT06222294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154806258|NCT06222294|Anesthetics, General|anesthetics, general|mesh-ancestor
154806259|NCT06222294|Anesthetics|anesthetics|mesh-ancestor
154558231|NCT02170909|Dabigatran|dabigatran|mesh-list
154806260|NCT06222268|Dronabinol|dronabinol|mesh-list
154806261|NCT06222268|Cannabidiol|cannabidiol|mesh-list
154806262|NCT06222268|Anticonvulsants|anticonvulsants|mesh-ancestor
154806263|NCT06222268|Hallucinogens|hallucinogens|mesh-ancestor
154806264|NCT06222268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806265|NCT06222268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806266|NCT06222268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806267|NCT06222268|Analgesics|analgesics|mesh-ancestor
154806268|NCT06222268|Sensory System Agents|sensory system agents|mesh-ancestor
154806269|NCT06222268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806270|NCT06222268|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154806271|NCT06222268|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154806272|NCT06222268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806273|NCT06222268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806274|NCT06222268|Hormones|hormones|mesh-ancestor
154806275|NCT06222268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806276|NCT06221826|Emoxypine succinate|emoxypine succinate|mesh-list
154806277|NCT06221826|Antioxidants|antioxidants|mesh-ancestor
154806278|NCT06221826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806279|NCT06221826|Protective Agents|protective agents|mesh-ancestor
154806280|NCT06221826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806281|NCT06221826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154806282|NCT06221826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806283|NCT06221761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154806284|NCT06221761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154806285|NCT06221761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806286|NCT06221761|Antitubercular Agents|antitubercular agents|mesh-ancestor
154806287|NCT06221748|Paclitaxel|paclitaxel|mesh-list
154806288|NCT06221748|Disitamab vedotin|disitamab vedotin|mesh-list
154806289|NCT06221748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154806290|NCT06221748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806291|NCT06221748|Tubulin Modulators|tubulin modulators|mesh-ancestor
154806292|NCT06221748|Antimitotic Agents|antimitotic agents|mesh-ancestor
154806293|NCT06221748|Mitosis Modulators|mitosis modulators|mesh-ancestor
154806294|NCT06221748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806295|NCT06221748|Immunoconjugates|immunoconjugates|mesh-ancestor
154806296|NCT06221748|Immunologic Factors|immunologic factors|mesh-ancestor
154806297|NCT06221748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806298|NCT06221722|Fluoxetine|fluoxetine|mesh-list
154806299|NCT06221722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154806300|NCT06221722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154806301|NCT06221722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806302|NCT06221722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806303|NCT06221722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806304|NCT06221722|Serotonin Agents|serotonin agents|mesh-ancestor
154806305|NCT06221722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806306|NCT06221722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154806307|NCT06221722|Antidepressive Agents|antidepressive agents|mesh-ancestor
154806308|NCT06221722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806309|NCT06221722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154806310|NCT06221722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154806311|NCT06221722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806312|NCT06221527|Hyaluronic Acid|hyaluronic acid|mesh-list
154806313|NCT06221527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154806314|NCT06221527|Immunologic Factors|immunologic factors|mesh-ancestor
154806315|NCT06221527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806316|NCT06221527|Viscosupplements|viscosupplements|mesh-ancestor
154806317|NCT06221527|Protective Agents|protective agents|mesh-ancestor
154806318|NCT06221371|Tenecteplase|tenecteplase|mesh-list
154806319|NCT06221371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154806320|NCT06221371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154806321|NCT06221371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806322|NCT06221345|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154806323|NCT06221345|Lubricant Eye Drops|lubricant eye drops|mesh-list
154806324|NCT06221345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154806325|NCT06221241|Pregabalin|pregabalin|mesh-list
154806326|NCT06221241|Analgesics|analgesics|mesh-ancestor
154806327|NCT06221241|Sensory System Agents|sensory system agents|mesh-ancestor
154806328|NCT06221241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806329|NCT06221241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806330|NCT06221241|Anticonvulsants|anticonvulsants|mesh-ancestor
154558306|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806331|NCT06221241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154806332|NCT06221241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806333|NCT06221241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806334|NCT06221241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154806335|NCT06221241|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154806336|NCT06221241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154806337|NCT06221241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806338|NCT06221241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806339|NCT06221072|Zoledronic Acid|zoledronic acid|mesh-list
154806340|NCT06221072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154806341|NCT06221072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806342|NCT06220942|Phenylephrine|phenylephrine|mesh-list
154806343|NCT06220942|Oxymetazoline|oxymetazoline|mesh-list
154806344|NCT06220942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154806345|NCT06220942|Mydriatics|mydriatics|mesh-ancestor
154806346|NCT06220942|Autonomic Agents|autonomic agents|mesh-ancestor
154806347|NCT06220942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806348|NCT06220942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806349|NCT06220942|Sympathomimetics|sympathomimetics|mesh-ancestor
154806350|NCT06220942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154806351|NCT06220942|Nasal Decongestants|nasal decongestants|mesh-ancestor
154806352|NCT06220942|Respiratory System Agents|respiratory system agents|mesh-ancestor
154806353|NCT06220942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154806354|NCT06220942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154806355|NCT06220942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154806356|NCT06220942|Adrenergic Agents|adrenergic agents|mesh-ancestor
154806357|NCT06220942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806358|NCT06220942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806359|NCT06220942|Protective Agents|protective agents|mesh-ancestor
154806360|NCT06220929|Ceftriaxone|ceftriaxone|mesh-list
154806361|NCT06220929|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154806362|NCT06220929|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154806363|NCT06220929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154806364|NCT06220929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806365|NCT06220877|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154806366|NCT06220877|Cellulose, Oxidized|cellulose, oxidized|mesh-list
154806367|NCT06220877|Hemostatics|hemostatics|mesh-ancestor
154806368|NCT06220877|Coagulants|coagulants|mesh-ancestor
154806369|NCT06220721|Nifedipine|nifedipine|mesh-list
154806370|NCT06220721|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154806371|NCT06220721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806372|NCT06220721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806373|NCT06220721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154806374|NCT06220721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806375|NCT06220721|Vasodilator Agents|vasodilator agents|mesh-ancestor
154806376|NCT06220721|Tocolytic Agents|tocolytic agents|mesh-ancestor
154806377|NCT06220721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154806378|NCT06220643|Triamcinolone|triamcinolone|mesh-list
154806379|NCT06220643|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154806380|NCT06220643|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154806381|NCT06220643|Lidocaine|lidocaine|mesh-list
154806382|NCT06220643|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154806383|NCT06220643|Anesthetics, Local|anesthetics, local|mesh-ancestor
154806384|NCT06220643|Anesthetics|anesthetics|mesh-ancestor
154806385|NCT06220643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806386|NCT06220643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806387|NCT06220643|Sensory System Agents|sensory system agents|mesh-ancestor
154806388|NCT06220643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806389|NCT06220643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154806390|NCT06220643|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154806391|NCT06220643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154806392|NCT06220643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806393|NCT06220643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806394|NCT06220643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806395|NCT06220643|Glucocorticoids|glucocorticoids|mesh-ancestor
154806396|NCT06220643|Hormones|hormones|mesh-ancestor
154806397|NCT06220643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806398|NCT06220643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154806399|NCT06220643|Immunologic Factors|immunologic factors|mesh-ancestor
154806400|NCT06220643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806401|NCT06220487|Prednisone|prednisone|mesh-list
154806402|NCT06220487|Blinatumomab|blinatumomab|mesh-list
154806403|NCT06220487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806404|NCT06220487|Glucocorticoids|glucocorticoids|mesh-ancestor
154806405|NCT06220487|Hormones|hormones|mesh-ancestor
153985872|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806406|NCT06220487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558385|NCT06110494|Eusol|eusol|mesh-list
154806407|NCT06220487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806408|NCT06220487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154806409|NCT06220487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806410|NCT06218628|Talazoparib|talazoparib|mesh-list
154806411|NCT06218628|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154806412|NCT06218628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806413|NCT06218628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806414|NCT06218628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806415|NCT06217731|Clonazepam|clonazepam|mesh-list
154806416|NCT06217731|Anticonvulsants|anticonvulsants|mesh-ancestor
154806417|NCT06217731|GABA Modulators|gaba modulators|mesh-ancestor
154806418|NCT06217731|GABA Agents|gaba agents|mesh-ancestor
154806419|NCT06217731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806420|NCT06217731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806421|NCT06217731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806422|NCT06216769|Rivaroxaban|rivaroxaban|mesh-list
154806423|NCT06216769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154806424|NCT06216769|Antithrombins|antithrombins|mesh-ancestor
154806425|NCT06216769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154806426|NCT06216769|Protease Inhibitors|protease inhibitors|mesh-ancestor
154806427|NCT06216769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806428|NCT06216769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806429|NCT06216769|Anticoagulants|anticoagulants|mesh-ancestor
154806430|NCT06209619|Rituximab|rituximab|mesh-list
154806431|NCT06209619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154806432|NCT06209619|Antibodies|antibodies|mesh-list
154806433|NCT06209619|Immunoglobulins|immunoglobulins|mesh-list
154806434|NCT06209619|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154806435|NCT06209619|Immunologic Factors|immunologic factors|mesh-ancestor
154806436|NCT06209619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806437|NCT06209619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806438|NCT06209619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154806439|NCT06205199|Hydromorphone|hydromorphone|mesh-list
154806440|NCT06205199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154806441|NCT06205199|Narcotics|narcotics|mesh-ancestor
154806442|NCT06205199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806443|NCT06205199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806444|NCT06205199|Analgesics|analgesics|mesh-ancestor
154806445|NCT06205199|Sensory System Agents|sensory system agents|mesh-ancestor
154806446|NCT06205199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806447|NCT06170489|Gemcitabine|gemcitabine|mesh-list
154806448|NCT06170489|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154806449|NCT06170489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154806450|NCT06170489|Antimetabolites|antimetabolites|mesh-ancestor
154806451|NCT06170489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806452|NCT06170489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806453|NCT06170489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154806454|NCT06170489|Alkylating Agents|alkylating agents|mesh-ancestor
154806455|NCT06127316|Carbon Fiber|carbon fiber|mesh-list
154806456|NCT06127316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154806457|NCT06127316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806458|NCT06124898|Ethanol|ethanol|mesh-list
154806459|NCT06124898|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154806460|NCT06124898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806461|NCT06124898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985935|NCT04614545|Phentermine|phentermine|mesh-list
154806462|NCT06124898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806463|NCT06116669|Vaccines|vaccines|mesh-list
154806464|NCT06116669|Immunologic Factors|immunologic factors|mesh-ancestor
154806465|NCT06116669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806466|NCT06115135|Venetoclax|venetoclax|mesh-list
154806467|NCT06115135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806468|NCT06100952|Riboflavin|riboflavin|mesh-list
154806469|NCT06100952|Vitamin B Complex|vitamin b complex|mesh-ancestor
154806470|NCT06100952|Vitamins|vitamins|mesh-ancestor
154806471|NCT06100952|Micronutrients|micronutrients|mesh-ancestor
154806472|NCT06100952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806473|NCT06100952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154806474|NCT06100952|Dermatologic Agents|dermatologic agents|mesh-ancestor
154806475|NCT06100939|Riboflavin|riboflavin|mesh-list
154806476|NCT06100939|Vitamin B Complex|vitamin b complex|mesh-ancestor
154806477|NCT06100939|Vitamins|vitamins|mesh-ancestor
154806478|NCT06100939|Micronutrients|micronutrients|mesh-ancestor
154806479|NCT06100939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806480|NCT06100939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154806481|NCT06100939|Dermatologic Agents|dermatologic agents|mesh-ancestor
154806482|NCT06065657|Ethanol|ethanol|mesh-list
154806483|NCT06065657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154806484|NCT06065657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806485|NCT06065657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806486|NCT06065657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806487|NCT06039995|Chlorhexidine|chlorhexidine|mesh-list
154806488|NCT06039995|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154806489|NCT06039995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154806490|NCT06039995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806491|NCT06039995|Disinfectants|disinfectants|mesh-ancestor
154806492|NCT06039995|Dermatologic Agents|dermatologic agents|mesh-ancestor
154806493|NCT06027268|Carboplatin|carboplatin|mesh-list
154806494|NCT06027268|Gemcitabine|gemcitabine|mesh-list
154806495|NCT06027268|Pembrolizumab|pembrolizumab|mesh-list
153985995|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
154806496|NCT06027268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806497|NCT06027268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154806498|NCT06027268|Antimetabolites|antimetabolites|mesh-ancestor
154806499|NCT06027268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806500|NCT06027268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154806501|NCT06027268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154806502|NCT06021925|Antibodies|antibodies|mesh-list
154806503|NCT06021925|Immunologic Factors|immunologic factors|mesh-ancestor
154806504|NCT06021925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806505|NCT05989347|Dapagliflozin|dapagliflozin|mesh-list
154806506|NCT05989347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154806507|NCT05989347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806508|NCT05989347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154806509|NCT05989347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806510|NCT05985343|Glycopyrrolate|glycopyrrolate|mesh-list
154806511|NCT05985343|Neostigmine|neostigmine|mesh-list
154806512|NCT05985343|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154806513|NCT05985343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806514|NCT05985343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806515|NCT05985343|Cholinergic Agents|cholinergic agents|mesh-ancestor
154806516|NCT05985343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806517|NCT05985343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806518|NCT05985343|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154806519|NCT05985343|Autonomic Agents|autonomic agents|mesh-ancestor
154806520|NCT05985343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806521|NCT05985343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154806522|NCT05985343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154806523|NCT05985343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154806524|NCT05955261|Cytarabine|cytarabine|mesh-list
154806525|NCT05955261|Fludarabine|fludarabine|mesh-list
154806526|NCT05955261|Fludarabine phosphate|fludarabine phosphate|mesh-list
154806527|NCT05955261|Etoposide|etoposide|mesh-list
154806528|NCT05955261|Azacitidine|azacitidine|mesh-list
154806529|NCT05955261|Daunorubicin|daunorubicin|mesh-list
154806530|NCT05955261|Venetoclax|venetoclax|mesh-list
154806531|NCT05955261|Mitoxantrone|mitoxantrone|mesh-list
154806532|NCT05955261|Idarubicin|idarubicin|mesh-list
154806533|NCT05955261|Gemtuzumab|gemtuzumab|mesh-list
154806534|NCT05955261|Gilteritinib|gilteritinib|mesh-list
154806535|NCT05955261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806536|NCT05955261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154806537|NCT05955261|Antimetabolites|antimetabolites|mesh-ancestor
154806538|NCT05955261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806539|NCT05955261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154806540|NCT05955261|Immunologic Factors|immunologic factors|mesh-ancestor
154806541|NCT05955261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806542|NCT05955261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154806543|NCT05955261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154806544|NCT05955261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154806545|NCT05955261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806546|NCT05955261|Antiviral Agents|antiviral agents|mesh-ancestor
154806547|NCT05955261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806548|NCT05955261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154806549|NCT05955261|Analgesics|analgesics|mesh-ancestor
154806550|NCT05955261|Sensory System Agents|sensory system agents|mesh-ancestor
154806551|NCT05955261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806552|NCT05955261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154806553|NCT05955261|Immunotoxins|immunotoxins|mesh-ancestor
154806554|NCT05955261|Immunoconjugates|immunoconjugates|mesh-ancestor
154806555|NCT05955261|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154806556|NCT05955261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154806557|NCT05926570|Cinacalcet|cinacalcet|mesh-list
153986020|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806558|NCT05926570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154806559|NCT05926570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806560|NCT05926570|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154806561|NCT05926570|Hormone Antagonists|hormone antagonists|mesh-ancestor
154806562|NCT05926570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806563|NCT05919537|Paclitaxel|paclitaxel|mesh-list
154806564|NCT05919537|Docetaxel|docetaxel|mesh-list
154806565|NCT05919537|Gemcitabine|gemcitabine|mesh-list
154806566|NCT05919537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154806567|NCT05919537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806568|NCT05919537|Tubulin Modulators|tubulin modulators|mesh-ancestor
154806569|NCT05919537|Antimitotic Agents|antimitotic agents|mesh-ancestor
154806570|NCT05919537|Mitosis Modulators|mitosis modulators|mesh-ancestor
154806571|NCT05919537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806572|NCT05919537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154806573|NCT05919537|Antimetabolites|antimetabolites|mesh-ancestor
154806574|NCT05860933|Itraconazole|itraconazole|mesh-list
154806575|NCT05860933|Carbamazepine|carbamazepine|mesh-list
154806576|NCT05860933|Antifungal Agents|antifungal agents|mesh-ancestor
154806577|NCT05860933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806578|NCT05860933|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154806579|NCT05860933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154806580|NCT05860933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806581|NCT05860933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806582|NCT05860933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154806583|NCT05860933|Hormone Antagonists|hormone antagonists|mesh-ancestor
154806584|NCT05860933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806585|NCT05860933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806586|NCT05860933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154806587|NCT05860933|Anticonvulsants|anticonvulsants|mesh-ancestor
154806588|NCT05860933|Antimanic Agents|antimanic agents|mesh-ancestor
154806589|NCT05860933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154806590|NCT05860933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806591|NCT05860933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806592|NCT05860933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806593|NCT05860933|Analgesics|analgesics|mesh-ancestor
154806594|NCT05860933|Sensory System Agents|sensory system agents|mesh-ancestor
154806595|NCT05860933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806596|NCT05860933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154806597|NCT05860933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806598|NCT05860933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154806599|NCT05860933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154806600|NCT05846620|Dimercaprol|dimercaprol|mesh-list
154806601|NCT05846620|Chelating Agents|chelating agents|mesh-ancestor
154806602|NCT05846620|Sequestering Agents|sequestering agents|mesh-ancestor
154806603|NCT05846620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806604|NCT05757167|Lumefantrine|lumefantrine|mesh-list
154806605|NCT05757167|Artemether|artemether|mesh-list
154806606|NCT05757167|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154806607|NCT05757167|Antimalarials|antimalarials|mesh-ancestor
154806608|NCT05757167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154806609|NCT05757167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154806610|NCT05757167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806611|NCT05748834|Doxorubicin|doxorubicin|mesh-list
154806612|NCT05748834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154806613|NCT05748834|Tucatinib|tucatinib|mesh-list
154806614|NCT05748834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154806615|NCT05748834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806616|NCT05748834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154806617|NCT05748834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154806618|NCT05748834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986083|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154806619|NCT05748834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806620|NCT05748834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154806621|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
154806622|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154806623|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154806624|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154806625|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
154806626|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806627|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806628|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806629|NCT05651607|Cannabidiol|cannabidiol|mesh-list
154806630|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
154806631|NCT05639322|Ketamine|ketamine|mesh-list
154806632|NCT05639322|Analgesics|analgesics|mesh-ancestor
154806633|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
154806634|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806635|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558602|NCT05993975|Bupivacaine|bupivacaine|mesh-list
154806636|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154806637|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154806638|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
154806639|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
154806640|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806641|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154806642|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154806643|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806644|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806645|NCT05617820|Estradiol|estradiol|mesh-list
154806646|NCT05617820|Estrogens|estrogens|mesh-ancestor
154806647|NCT05617820|Hormones|hormones|mesh-ancestor
154806648|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806649|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806650|NCT05590585|Emollients|emollients|mesh-list
154806651|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
154806652|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
154806653|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154806654|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806655|NCT05576077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154806656|NCT05576077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806657|NCT05381974|Psilocybin|psilocybin|mesh-list
154806658|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
154806659|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806660|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806661|NCT05379959|Methamphetamine|methamphetamine|mesh-list
154806662|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154806663|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806664|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
154806665|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
154806666|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806667|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
154806668|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806669|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806670|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
154806671|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154806672|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154806673|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806674|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154806675|NCT05344625|Ketamine|ketamine|mesh-list
154806676|NCT05344625|Analgesics|analgesics|mesh-ancestor
154806677|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
154806678|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806679|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806680|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154806681|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154806682|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
154806683|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
154806684|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806685|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154806686|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154806687|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806688|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806689|NCT05331144|Losartan|losartan|mesh-list
154806690|NCT05331144|Amlodipine|amlodipine|mesh-list
154806691|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
154806692|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
154806693|NCT05331144|Giapreza|giapreza|mesh-list
154806694|NCT05331144|Calcium|calcium|mesh-list
154806695|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154806696|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
154806697|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154806698|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806699|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154806700|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806701|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806702|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
154806703|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154806704|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154806705|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154806706|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154806707|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
154806708|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806709|NCT05331131|Ketamine|ketamine|mesh-list
154806710|NCT05331131|Analgesics|analgesics|mesh-ancestor
154806711|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
154806712|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806713|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806714|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154806715|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154806716|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
154806717|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
154806718|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806719|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154806720|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154806721|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806722|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806723|NCT05324384|Sirolimus|sirolimus|mesh-list
154806724|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154806725|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806726|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154806727|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806728|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
154806729|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154806730|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
154806731|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806732|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
154806733|NCT05279898|Ketamine|ketamine|mesh-list
154806734|NCT05279898|Remifentanil|remifentanil|mesh-list
154806735|NCT05279898|Propofol|propofol|mesh-list
154806736|NCT05279898|Ropivacaine|ropivacaine|mesh-list
154806737|NCT05279898|Rocuronium|rocuronium|mesh-list
154806738|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154806739|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806740|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806741|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806742|NCT05279898|Analgesics|analgesics|mesh-ancestor
154806743|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
154806744|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806745|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154806746|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154806747|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154806748|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
154806749|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806750|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806751|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154806752|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
154806753|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
154806754|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154806755|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154806756|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154806757|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
154806758|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154806759|NCT05279898|Narcotics|narcotics|mesh-ancestor
154806760|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154806761|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154806762|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154806763|NCT05254184|Nivolumab|nivolumab|mesh-list
154806764|NCT05254184|Ipilimumab|ipilimumab|mesh-list
154806765|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154806766|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806767|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154806768|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806769|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
154806770|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154806771|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806772|NCT05239624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154806773|NCT05239624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806774|NCT05223231|Antibodies|antibodies|mesh-list
154806775|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
154806776|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
154806777|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806778|NCT05209412|Aspirin|aspirin|mesh-list
154806779|NCT05209412|Paclitaxel|paclitaxel|mesh-list
154806780|NCT05209412|Clopidogrel|clopidogrel|mesh-list
154806781|NCT05209412|Ticagrelor|ticagrelor|mesh-list
154806782|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154806783|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806784|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
154806785|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
154806786|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
154806787|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806788|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154806789|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806790|NCT05209412|Analgesics|analgesics|mesh-ancestor
154806791|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
154806792|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806793|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806794|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806795|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154806796|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154806797|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154806798|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154806799|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153986268|NCT00725608|Naloxone|naloxone|mesh-list
154806800|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806801|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
154806802|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154806803|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154806804|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154806805|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
154806806|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806807|NCT05183126|Paclitaxel|paclitaxel|mesh-list
154806808|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154806809|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154806810|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806811|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
154806812|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
154806813|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
154806814|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806815|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154806816|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
154806817|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806818|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806819|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
154806820|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806821|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806822|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154806823|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154806824|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806825|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
154806826|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154806827|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
154806828|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806829|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806830|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
154806831|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806832|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806833|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154806834|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154806835|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806836|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
154806837|NCT05137054|Lenalidomide|lenalidomide|mesh-list
154806838|NCT05137054|Pomalidomide|pomalidomide|mesh-list
154806839|NCT05137054|Bortezomib|bortezomib|mesh-list
154806840|NCT05137054|Daratumumab|daratumumab|mesh-list
154806841|NCT05137054|Cemiplimab|cemiplimab|mesh-list
154806842|NCT05137054|Nirogacestat|nirogacestat|mesh-list
154806843|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
154806844|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806845|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154806846|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154806847|NCT05137054|Growth Substances|growth substances|mesh-ancestor
154806848|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
154806849|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806850|NCT05137054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154806851|NCT05137054|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154806852|NCT05137054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806853|NCT05137054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806854|NCT05058924|Aspirin|aspirin|mesh-list
154806855|NCT05058924|Heparin|heparin|mesh-list
154806856|NCT05058924|Calcium heparin|calcium heparin|mesh-list
154806857|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154806858|NCT05058924|Tinzaparin|tinzaparin|mesh-list
154558826|NCT05367336|Fentanyl|fentanyl|mesh-list
154806859|NCT05058924|Dalteparin|dalteparin|mesh-list
154806860|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154806861|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806862|NCT05058924|Analgesics|analgesics|mesh-ancestor
154806863|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
154806864|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806865|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806866|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806867|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154806868|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154806869|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154806870|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806871|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154806872|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154806873|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806874|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
154806875|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
154806876|NCT05029726|Clonidine|clonidine|mesh-list
154806877|NCT05029726|Epinephrine|epinephrine|mesh-list
154806878|NCT05029726|Bupivacaine|bupivacaine|mesh-list
154806879|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
154806880|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
154806881|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806882|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806883|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
154806884|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806885|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154806886|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154806887|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
154806888|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806889|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806890|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154806891|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154806892|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
154806893|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154806894|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
154806895|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
154806896|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
154806897|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154806898|NCT05029726|Analgesics|analgesics|mesh-ancestor
154806899|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154806900|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
154806901|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154806902|NCT05006573|Benralizumab|benralizumab|mesh-list
154806903|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154806904|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
154806905|NCT05003076|Methamphetamine|methamphetamine|mesh-list
154806906|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154806907|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806908|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
154806909|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
154806910|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806911|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
154806912|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806913|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806914|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
154806915|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154806916|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154806917|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806918|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154806919|NCT04995653|Vancomycin|vancomycin|mesh-list
154806920|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154806921|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154806922|NCT04990258|Infliximab|infliximab|mesh-list
154806923|NCT04990258|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154806924|NCT04990258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806925|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
154806926|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154806927|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154806928|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154806929|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
154806930|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806931|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806932|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
154806933|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860513|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
154806934|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806935|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154806936|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154806937|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154806938|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
154806939|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154806940|NCT04964544|Calcium|calcium|mesh-list
154806941|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154806942|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806943|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154806944|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154806945|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
154806946|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806947|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154806948|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154806949|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154806950|NCT04957368|Midazolam|midazolam|mesh-list
154806951|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
154806952|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154806953|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154806954|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154806955|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806956|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154806957|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154806958|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154806959|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154806960|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
154806961|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
154806962|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
154806963|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
154806964|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154806965|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806966|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154806967|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154806968|NCT04957368|Analgesics|analgesics|mesh-ancestor
154806969|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
154806970|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806971|NCT04884763|Erenumab|erenumab|mesh-list
154806972|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154806973|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806974|NCT04884763|Analgesics|analgesics|mesh-ancestor
154806975|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
154806976|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154806977|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806978|NCT04787744|Prednisone|prednisone|mesh-list
154806979|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
154806980|NCT04787744|Docetaxel|docetaxel|mesh-list
154806981|NCT04787744|Leuprolide|leuprolide|mesh-list
154806982|NCT04787744|Goserelin|goserelin|mesh-list
154806983|NCT04787744|Bicalutamide|bicalutamide|mesh-list
154806984|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154806985|NCT04787744|Flutamide|flutamide|mesh-list
154806986|NCT04787744|Nilutamide|nilutamide|mesh-list
154806987|NCT04787744|Relugolix|relugolix|mesh-list
154806988|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154806989|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154806990|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154806991|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154806992|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154806993|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154806994|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
154806995|NCT04787744|Hormones|hormones|mesh-ancestor
154806996|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154806997|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154806998|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154806999|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
154807000|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
154807001|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807002|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154807003|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154807004|NCT04787744|Protective Agents|protective agents|mesh-ancestor
154807005|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154807006|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
154558971|NCT04932135|Hormones|hormones|mesh-list
154807007|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154807008|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
154807009|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
154807010|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
154807011|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154807012|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
154807013|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154807014|NCT04784143|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807016|NCT04784143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807017|NCT04784143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807018|NCT04784143|Serotonin Agents|serotonin agents|mesh-ancestor
154807019|NCT04784143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807020|NCT04784143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807021|NCT04784143|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807022|NCT04784143|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807023|NCT04784143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807024|NCT04784143|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807025|NCT04775173|Sirolimus|sirolimus|mesh-list
154807026|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154807027|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807028|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154807029|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807030|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
154807031|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807032|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
154807033|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807034|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
154807035|NCT04767984|Atorvastatin|atorvastatin|mesh-list
154807036|NCT04767984|Calcium|calcium|mesh-list
154807037|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154807038|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807039|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154807040|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154807041|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154807042|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
154807043|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807044|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154807045|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154807046|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807047|NCT04726969|Ivermectin|ivermectin|mesh-list
154807048|NCT04726969|Albendazole|albendazole|mesh-list
154807049|NCT04726969|Moxidectin|moxidectin|mesh-list
154807050|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154807051|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807052|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
154807053|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
154807054|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154807055|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154807056|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
154807057|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
154807058|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
154807059|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807060|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807061|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
154807062|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807063|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
154807064|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807065|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807066|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
154807067|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807068|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807069|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807070|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807071|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807072|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807073|NCT04707391|Vaccines|vaccines|mesh-list
154807074|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
154807075|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807076|NCT04703868|Rabeprazole|rabeprazole|mesh-list
154807077|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154807078|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154807079|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154807080|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807081|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986547|NCT04051099|Propofol|propofol|mesh-list
154807082|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154807083|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807084|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807086|NCT04639414|Empagliflozin|empagliflozin|mesh-list
154807087|NCT04639414|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154807088|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154807089|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807090|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154807091|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807092|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
154807093|NCT04613596|Adagrasib|adagrasib|mesh-list
154807094|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807095|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807096|NCT04613596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807097|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807098|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
154807099|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807100|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807101|NCT04592653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807102|NCT04592653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807103|NCT04491942|Cisplatin|cisplatin|mesh-list
154807104|NCT04491942|Gemcitabine|gemcitabine|mesh-list
154807105|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807106|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154807107|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
154807108|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807109|NCT04488601|Sirolimus|sirolimus|mesh-list
154807110|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154807111|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807112|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154807113|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807114|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
154807115|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807116|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
154807117|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807118|NCT04465760|Antibodies|antibodies|mesh-list
154807119|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
154807120|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
154807121|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807122|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807123|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
154807124|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807125|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807126|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
154807127|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807128|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807129|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807130|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807131|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807132|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807133|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
154807134|NCT04402138|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154807135|NCT04402138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807136|NCT04402138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807137|NCT04402138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807138|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807139|NCT04400695|Paclitaxel|paclitaxel|mesh-list
154807140|NCT04400695|Vinorelbine|vinorelbine|mesh-list
154807141|NCT04400695|Docetaxel|docetaxel|mesh-list
154807142|NCT04400695|Capecitabine|capecitabine|mesh-list
154807143|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154807144|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807145|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
154807146|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
154807147|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
154807148|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807149|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154807150|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
154807151|NCT04335539|Cefiderocol|cefiderocol|mesh-list
154807152|NCT04335539|Siderophores|siderophores|mesh-ancestor
154807153|NCT04335539|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154807154|NCT04335539|Chelating Agents|chelating agents|mesh-ancestor
154807155|NCT04335539|Sequestering Agents|sequestering agents|mesh-ancestor
154559119|NCT04519476|Lenalidomide|lenalidomide|mesh-list
154807156|NCT04335539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807157|NCT04335539|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154807158|NCT04335539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154807159|NCT04335539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807160|NCT04300790|Tamoxifen|tamoxifen|mesh-list
154807161|NCT04300790|Metformin|metformin|mesh-list
154807162|NCT04300790|Vildagliptin|vildagliptin|mesh-list
154807163|NCT04300790|Letrozole|letrozole|mesh-list
154807164|NCT04300790|Fulvestrant|fulvestrant|mesh-list
154807165|NCT04300790|Exemestane|exemestane|mesh-list
154807166|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154807167|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807168|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807169|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154807170|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154807171|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807172|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807173|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154807174|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
154807175|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807176|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154807177|NCT04300790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154807178|NCT04300790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154807179|NCT04300790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154807180|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154807181|NCT04300790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154807182|NCT04300790|Protease Inhibitors|protease inhibitors|mesh-ancestor
154807183|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154807184|NCT04257500|Etonogestrel|etonogestrel|mesh-list
154807185|NCT04257500|NuvaRing|nuvaring|mesh-list
154807186|NCT04257500|Estradiol|estradiol|mesh-list
154807187|NCT04257500|Estrogens|estrogens|mesh-ancestor
154807188|NCT04257500|Hormones|hormones|mesh-ancestor
154807189|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807190|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807191|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154807192|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
154807193|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154807194|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154807195|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154807196|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154807197|NCT04254913|Edaravone|edaravone|mesh-list
154807198|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154807199|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
154807200|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807201|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154807202|NCT04254913|Protective Agents|protective agents|mesh-ancestor
153986674|NCT04007809|Glucagon|glucagon|mesh-list
154807203|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807204|NCT04247646|Melatonin|melatonin|mesh-list
154807205|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
154807206|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807207|NCT04247646|Protective Agents|protective agents|mesh-ancestor
154807208|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807209|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154807210|NCT04215991|Cefiderocol|cefiderocol|mesh-list
154807211|NCT04215991|Siderophores|siderophores|mesh-ancestor
154807212|NCT04215991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154807213|NCT04215991|Chelating Agents|chelating agents|mesh-ancestor
154807214|NCT04215991|Sequestering Agents|sequestering agents|mesh-ancestor
154807215|NCT04215991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807216|NCT04215991|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154807217|NCT04215991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154807218|NCT04215991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807219|NCT04176224|Edaravone|edaravone|mesh-list
154807220|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154807221|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
154807222|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807223|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154807224|NCT04176224|Protective Agents|protective agents|mesh-ancestor
154807225|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807226|NCT04166487|Paclitaxel|paclitaxel|mesh-list
154807227|NCT04166487|Carboplatin|carboplatin|mesh-list
154807228|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
154807229|NCT04166487|Pemetrexed|pemetrexed|mesh-list
154807230|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154807231|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807232|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
154807233|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
154807234|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
154807235|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807236|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807237|NCT04166487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807238|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807239|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154807240|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154807241|NCT04160091|FX006|fx006|mesh-list
154807242|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807243|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
154807244|NCT04160091|Hormones|hormones|mesh-ancestor
154807245|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807246|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807247|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807248|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
154807249|NCT04113018|Dexamethasone|dexamethasone|mesh-list
154807250|NCT04113018|Lenalidomide|lenalidomide|mesh-list
154807251|NCT04113018|Daratumumab|daratumumab|mesh-list
154807252|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807253|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
154807254|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
154807255|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807256|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807257|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154807258|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
154807259|NCT04113018|Hormones|hormones|mesh-ancestor
154807260|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807261|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153986738|NCT02560207|Cefotaxime|cefotaxime|mesh-list
154807262|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807263|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
154807264|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154807265|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154807266|NCT04113018|Growth Substances|growth substances|mesh-ancestor
154807267|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
154807268|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
154807269|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807270|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807271|NCT04093167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807272|NCT04093167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807273|NCT04092179|Venetoclax|venetoclax|mesh-list
154807274|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807275|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807276|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
154807277|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807278|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807279|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
154807280|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807281|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807282|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807283|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807284|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807285|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807286|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807287|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
154807288|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807289|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807290|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
154807291|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807292|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807293|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807294|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807295|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807296|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807297|NCT04068948|Midazolam|midazolam|mesh-list
154807298|NCT04068948|Meperidine|meperidine|mesh-list
154807299|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
154807300|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154807301|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154807302|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154807303|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807304|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154807305|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154807307|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154807308|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
154807309|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
154807310|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
154807311|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
154807312|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807313|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807314|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154807315|NCT04068948|Narcotics|narcotics|mesh-ancestor
154807316|NCT04068948|Analgesics|analgesics|mesh-ancestor
154807317|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
154807318|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807319|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
154807320|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
154807321|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154807322|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
154807323|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
154807324|NCT04065074|FX006|fx006|mesh-list
154807325|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807326|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
154807327|NCT04065074|Hormones|hormones|mesh-ancestor
154807328|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807329|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807330|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807331|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
154807332|NCT04056962|Tacrolimus|tacrolimus|mesh-list
154807333|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807334|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
154807335|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807336|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154807337|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807338|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807339|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
154807340|NCT04025216|Fludarabine|fludarabine|mesh-list
154807341|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807342|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
154807343|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807344|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154807345|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154807346|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
154807347|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807348|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807349|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154807350|NCT04021121|Linezolid|linezolid|mesh-list
154807351|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154807352|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807353|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154807354|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807355|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807356|NCT03950739|Treprostinil|treprostinil|mesh-list
154807357|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154807358|NCT03874338|Colchicine|colchicine|mesh-list
154807359|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
154807360|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154807361|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
154807362|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
154807363|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
153986858|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807364|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807365|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807366|NCT03793010|FX006|fx006|mesh-list
154807367|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807368|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
154807369|NCT03793010|Hormones|hormones|mesh-ancestor
154807370|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807371|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807372|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807373|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
154807374|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154807375|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
154807376|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807377|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154559358|NCT03323476|Hormones|hormones|mesh-ancestor
154807378|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154807379|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
154807380|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807381|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807382|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154807383|NCT03761511|Niacinamide|niacinamide|mesh-list
154807385|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
154807386|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
154807387|NCT03761511|Vitamins|vitamins|mesh-ancestor
154807388|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
154807389|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807390|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154807391|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
154807392|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807393|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154807394|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
154807395|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
154807396|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807397|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807398|NCT03727880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807399|NCT03727880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807400|NCT03615534|Niacin|niacin|mesh-list
154807401|NCT03615534|Fenofibrate|fenofibrate|mesh-list
154807402|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154807403|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
154807404|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807405|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154807406|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
154807407|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
154807408|NCT03615534|Vitamins|vitamins|mesh-ancestor
154807409|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
154807410|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807411|NCT03609047|Paclitaxel|paclitaxel|mesh-list
154807412|NCT03609047|Docetaxel|docetaxel|mesh-list
154807413|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
154807414|NCT03609047|Doxorubicin|doxorubicin|mesh-list
154807415|NCT03609047|Epirubicin|epirubicin|mesh-list
154807416|NCT03609047|Palbociclib|palbociclib|mesh-list
154807417|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154807418|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807419|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
154807420|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
154807421|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
154807422|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807423|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807424|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
154807425|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807426|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154807427|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154807428|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
154807429|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154807430|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154807431|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154807432|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154807433|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807434|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807435|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807436|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
154807437|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807438|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807439|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
154807440|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807441|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807442|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807443|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807444|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807445|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807446|NCT03599622|Deucravacitinib|deucravacitinib|mesh-list
154807447|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
154807448|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807449|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807450|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807451|NCT03584516|Prednisone|prednisone|mesh-list
154807452|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
154807453|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154807454|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154559417|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807455|NCT03584516|Prednisolone|prednisolone|mesh-list
154807456|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
154807457|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154807458|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
154807459|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807460|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
154807461|NCT03584516|Hormones|hormones|mesh-ancestor
154807462|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807463|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807464|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154807465|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807466|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
154807467|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
154807468|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807469|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154807470|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154807471|NCT03584516|Protective Agents|protective agents|mesh-ancestor
154807472|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807473|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
154807474|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807475|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807476|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
154807477|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807478|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807479|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807480|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807481|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807482|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807483|NCT03529942|FX006|fx006|mesh-list
154807484|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807485|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
154807486|NCT03529942|Hormones|hormones|mesh-ancestor
154807487|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807488|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807489|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807490|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
154807491|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807492|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
154807493|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807494|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807495|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
154807496|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807497|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807498|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807499|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807500|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807501|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807502|NCT03476369|Fentanyl|fentanyl|mesh-list
154807503|NCT03476369|Ticagrelor|ticagrelor|mesh-list
154807504|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154807505|NCT03476369|Narcotics|narcotics|mesh-ancestor
154807506|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154807507|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807508|NCT03476369|Analgesics|analgesics|mesh-ancestor
154807509|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
154807510|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807511|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154807512|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154807513|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
154807514|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
154807515|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154807516|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154807517|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154807518|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154807519|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
154807520|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807521|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807522|NCT03442413|Nicotine|nicotine|mesh-list
154807523|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154807524|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
154807525|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807526|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807527|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154807528|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154807529|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
154807530|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807531|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807532|NCT03432949|Dexamethasone|dexamethasone|mesh-list
154807533|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
154807534|NCT03432949|BB 1101|bb 1101|mesh-list
154807535|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807536|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
154807537|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
154807538|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807539|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807540|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154807541|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
154807542|NCT03432949|Hormones|hormones|mesh-ancestor
154807543|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807544|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154807545|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807546|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
154807547|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807548|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807549|NCT03382262|Triamcinolone|triamcinolone|mesh-list
154807550|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154807551|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154807552|NCT03382262|FX006|fx006|mesh-list
154807553|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154807554|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807555|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
154807556|NCT03382262|Hormones|hormones|mesh-ancestor
154807557|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807558|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807559|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807560|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
154807561|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807562|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807563|NCT03381274|Osimertinib|osimertinib|mesh-list
154807564|NCT03381274|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154807565|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807566|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807567|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807568|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807569|NCT03378076|Triamcinolone|triamcinolone|mesh-list
154807570|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154807571|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154807572|NCT03378076|FX006|fx006|mesh-list
154807573|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154807574|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807575|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
154807576|NCT03378076|Hormones|hormones|mesh-ancestor
154807577|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807578|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807579|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807580|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
154807581|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807582|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807583|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807584|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
154807585|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807586|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807587|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
154807588|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807589|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807590|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807591|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807592|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807593|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807594|NCT03197194|Aspirin|aspirin|mesh-list
154807595|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154807596|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154807597|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154807598|NCT03197194|Analgesics|analgesics|mesh-ancestor
154807599|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
154807600|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807601|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807602|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807603|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154807604|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154807605|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154807606|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807607|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154807608|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154807609|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807610|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
154807611|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807612|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
154807613|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807614|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807615|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
154807616|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807617|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807618|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807619|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807620|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807621|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807622|NCT03099356|Sirolimus|sirolimus|mesh-list
154807623|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
154807624|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807625|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
154807626|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807627|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154807628|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154807629|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
154807630|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807631|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807632|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154807633|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154807634|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807635|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154807636|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
154807637|NCT03089957|Urinastatin|urinastatin|mesh-list
154807638|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154807639|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154807640|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
154807641|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807642|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807643|NCT03046446|FX006|fx006|mesh-list
154807644|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807645|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
154807646|NCT03046446|Hormones|hormones|mesh-ancestor
154807647|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807648|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807649|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807650|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
154807651|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
154807652|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
154807653|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807654|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
154807655|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807656|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154807657|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154807658|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
154807659|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807660|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807661|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154807662|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807663|NCT03029403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807664|NCT02925234|Bevacizumab|bevacizumab|mesh-list
154807665|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
154807666|NCT02925234|Nivolumab|nivolumab|mesh-list
154807667|NCT02925234|Trastuzumab|trastuzumab|mesh-list
154807668|NCT02925234|Ipilimumab|ipilimumab|mesh-list
154807669|NCT02925234|Atezolizumab|atezolizumab|mesh-list
154807670|NCT02925234|Durvalumab|durvalumab|mesh-list
154807671|NCT02925234|Pertuzumab|pertuzumab|mesh-list
154807672|NCT02925234|Panitumumab|panitumumab|mesh-list
154807673|NCT02925234|Sunitinib|sunitinib|mesh-list
154807674|NCT02925234|Lenvatinib|lenvatinib|mesh-list
154807675|NCT02925234|Olaparib|olaparib|mesh-list
154807676|NCT02925234|Palbociclib|palbociclib|mesh-list
154807677|NCT02925234|Trametinib|trametinib|mesh-list
154807678|NCT02925234|Niraparib|niraparib|mesh-list
154807679|NCT02925234|Axitinib|axitinib|mesh-list
154807680|NCT02925234|Afatinib|afatinib|mesh-list
154807681|NCT02925234|Dabrafenib|dabrafenib|mesh-list
154807682|NCT02925234|Vemurafenib|vemurafenib|mesh-list
154807684|NCT02925234|Talazoparib|talazoparib|mesh-list
154807685|NCT02925234|Rucaparib|rucaparib|mesh-list
154807686|NCT02925234|Tepotinib|tepotinib|mesh-list
154807687|NCT02925234|Nilotinib|nilotinib|mesh-list
154807688|NCT02925234|Alectinib|alectinib|mesh-list
154807689|NCT02925234|Dacomitinib|dacomitinib|mesh-list
154807690|NCT02925234|Entrectinib|entrectinib|mesh-list
154807691|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807692|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807693|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154807694|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154807695|NCT02925234|Growth Substances|growth substances|mesh-ancestor
154807696|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807697|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
154807698|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807699|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807700|NCT02925234|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154807701|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807702|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807703|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154807704|NCT02917993|Osimertinib|osimertinib|mesh-list
154807705|NCT02917993|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154807706|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807707|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807708|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807709|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807710|NCT02876172|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807711|NCT02876172|Hallucinogens|hallucinogens|mesh-ancestor
154807712|NCT02876172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807713|NCT02876172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807714|NCT02876172|Serotonin Agents|serotonin agents|mesh-ancestor
154807715|NCT02876172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807716|NCT02876172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807717|NCT02876172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807718|NCT02876172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807719|NCT02876172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807720|NCT02876172|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807721|NCT02861898|Cetuximab|cetuximab|mesh-list
154807722|NCT02861898|Mannitol|mannitol|mesh-list
154807723|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807724|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807725|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154807726|NCT02861898|Diuretics|diuretics|mesh-ancestor
154807727|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
154807728|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807729|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
154807730|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807731|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807732|NCT02799095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807733|NCT02799095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807734|NCT02762370|Triamcinolone|triamcinolone|mesh-list
154807735|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154807736|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154807737|NCT02762370|FX006|fx006|mesh-list
154807738|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154807739|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807740|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
154807741|NCT02762370|Hormones|hormones|mesh-ancestor
154807742|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807743|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807744|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807745|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
154807746|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807747|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807748|NCT02734069|Carboplatin|carboplatin|mesh-list
154807749|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807750|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
154807751|NCT02717611|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154807752|NCT02717611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807753|NCT02717611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807754|NCT02717611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807755|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807756|NCT02648997|Nivolumab|nivolumab|mesh-list
154807757|NCT02648997|Ipilimumab|ipilimumab|mesh-list
154807758|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807759|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807760|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807761|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807762|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
154807763|NCT02518945|Liraglutide|liraglutide|mesh-list
154807764|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154807765|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807766|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154807767|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807768|NCT02518945|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154807769|NCT02518945|Incretins|incretins|mesh-ancestor
154807771|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807772|NCT02513394|Palbociclib|palbociclib|mesh-list
154807773|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807774|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807775|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807776|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807777|NCT02492074|Dronabinol|dronabinol|mesh-list
154807778|NCT02492074|Cannabidiol|cannabidiol|mesh-list
154807779|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
154807780|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
154807781|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807782|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807783|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154807784|NCT02492074|Analgesics|analgesics|mesh-ancestor
154807785|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
154807786|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154807787|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154807788|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154807789|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807790|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807791|NCT02492074|Hormones|hormones|mesh-ancestor
154807792|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807793|NCT02468583|Triamcinolone|triamcinolone|mesh-list
154807794|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154807795|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154807796|NCT02468583|FX006|fx006|mesh-list
154807797|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154807798|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807799|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
154807800|NCT02468583|Hormones|hormones|mesh-ancestor
154807801|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807802|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807803|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807804|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
154807805|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807806|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807807|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807808|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
154807809|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807810|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807811|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
154807812|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807813|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807814|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807815|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807816|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807817|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807818|NCT02151084|Gemcitabine|gemcitabine|mesh-list
154807819|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807820|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154807821|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
154807822|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807823|NCT02116972|FX006|fx006|mesh-list
154807824|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154807825|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
154807826|NCT02116972|Hormones|hormones|mesh-ancestor
154807827|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154807828|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559800|NCT05698394|Esketamine|esketamine|mesh-list
154807829|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807830|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
154807831|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807832|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
154807833|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807834|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807835|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
154807836|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807837|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807838|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807839|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807840|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807841|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807842|NCT02009449|Leucovorin|leucovorin|mesh-list
154807843|NCT02009449|Paclitaxel|paclitaxel|mesh-list
154807844|NCT02009449|Docetaxel|docetaxel|mesh-list
154807845|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154807846|NCT02009449|Carboplatin|carboplatin|mesh-list
154807847|NCT02009449|Gemcitabine|gemcitabine|mesh-list
154807848|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
154807849|NCT02009449|Capecitabine|capecitabine|mesh-list
154807850|NCT02009449|Nivolumab|nivolumab|mesh-list
154807851|NCT02009449|Fluorouracil|fluorouracil|mesh-list
154807852|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
154807853|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
154807854|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154807855|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807856|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
154807857|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
154807858|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
154807859|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807860|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154807861|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
154807862|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807863|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807864|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807865|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
154807866|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807867|NCT02009449|Antidotes|antidotes|mesh-ancestor
154807868|NCT02009449|Protective Agents|protective agents|mesh-ancestor
154807869|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
154807870|NCT02009449|Vitamins|vitamins|mesh-ancestor
154807871|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
154807872|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807873|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
154807874|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807875|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807876|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
154807877|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807878|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807879|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807880|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807881|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807882|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807883|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
154807884|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
154807885|NCT01904136|Melphalan|melphalan|mesh-list
154807886|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
154807887|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154807888|NCT01904136|Fludarabine|fludarabine|mesh-list
154807889|NCT01904136|Tacrolimus|tacrolimus|mesh-list
154807890|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154807891|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
154807892|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807893|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154807894|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153987382|NCT00602186|Prazosin|prazosin|mesh-list
154807895|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
154807896|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807897|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807898|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154807899|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154807900|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807901|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154807902|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154807903|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
154807904|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154807905|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807906|NCT01894633|Chloroquine|chloroquine|mesh-list
154807907|NCT01894633|Amebicides|amebicides|mesh-ancestor
154807908|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154807909|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154807910|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154807911|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
154807912|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154807913|NCT01864096|Metformin|metformin|mesh-list
154807914|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154807915|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807916|NCT01828099|Carboplatin|carboplatin|mesh-list
154807917|NCT01828099|Pemetrexed|pemetrexed|mesh-list
154807918|NCT01828099|Ceritinib|ceritinib|mesh-list
154807919|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807920|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807921|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807922|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154807923|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154807924|NCT01828099|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154807925|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154807926|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807927|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
154807928|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807929|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807930|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
154807931|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807932|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807933|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807934|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807935|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807936|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807937|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154807938|NCT01769222|Ipilimumab|ipilimumab|mesh-list
154807939|NCT01769222|Antibodies|antibodies|mesh-list
154807940|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
154807941|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154807942|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
154807943|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807944|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807945|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154807946|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807947|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807948|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
154807949|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807950|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807951|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
154807952|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807953|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807954|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807955|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807956|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807957|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807958|NCT01605318|Irinotecan|irinotecan|mesh-list
154807959|NCT01605318|Labetuzumab|labetuzumab|mesh-list
154807960|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
154807961|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
154807962|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807963|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154807964|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154807965|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154807966|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807967|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807968|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807969|NCT01458327|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807970|NCT01458327|Hallucinogens|hallucinogens|mesh-ancestor
154807971|NCT01458327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807972|NCT01458327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807973|NCT01458327|Serotonin Agents|serotonin agents|mesh-ancestor
154807974|NCT01458327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807975|NCT01458327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807976|NCT01458327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807977|NCT01458327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807978|NCT01458327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807979|NCT01458327|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807980|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154807981|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
154807982|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807983|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154807984|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
154807985|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154807986|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154807987|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154807988|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154807989|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154807990|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
154807991|NCT01386710|Bevacizumab|bevacizumab|mesh-list
154807992|NCT01386710|Carboplatin|carboplatin|mesh-list
154807993|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154807994|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154807995|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154807996|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154807997|NCT01386710|Growth Substances|growth substances|mesh-ancestor
154807998|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154807999|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
154808000|NCT01269853|Bevacizumab|bevacizumab|mesh-list
154808001|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154808002|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808003|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154808004|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154808005|NCT01269853|Growth Substances|growth substances|mesh-ancestor
154808006|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808007|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
154808008|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154808009|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
154808010|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808011|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808012|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
154808013|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808014|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808015|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154808016|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154808017|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154808018|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
154808019|NCT01207492|Nilotinib|nilotinib|mesh-list
154808020|NCT01207492|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154808021|NCT01207492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154808022|NCT01207492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808023|NCT01207492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808024|NCT01083966|Bevacizumab|bevacizumab|mesh-list
154808025|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154808026|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808027|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154808028|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154808029|NCT01083966|Growth Substances|growth substances|mesh-ancestor
154808030|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808031|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
154808032|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154808033|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
154808034|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808035|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808036|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
154808037|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808038|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808039|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154808040|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154808041|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154808042|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154808043|NCT03266081|Bupivacaine|bupivacaine|mesh-list
154808044|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808045|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
154808046|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808047|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808048|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
154808049|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808050|NCT03010995|Prazosin|prazosin|mesh-list
154808051|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154560028|NCT03106623|Mirabegron|mirabegron|mesh-list
154808052|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154808053|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154808054|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154808055|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
154808056|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808057|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808058|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808059|NCT01230177|Etanercept|etanercept|mesh-list
154808060|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154808061|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154808062|NCT01230177|Analgesics|analgesics|mesh-ancestor
153987516|NCT05678647|Iron|iron|mesh-list
154808063|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
154808064|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808065|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808066|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154808067|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154808068|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154808069|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808070|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
154808071|NCT02984657|Anesthetics|anesthetics|mesh-list
154808072|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808073|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808074|NCT01158651|Everolimus|everolimus|mesh-list
154808075|NCT01158651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154808076|NCT01158651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154808077|NCT01158651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808078|NCT01158651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808079|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808080|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
154808081|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808082|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808083|NCT04852679|Lanreotide|lanreotide|mesh-list
154808084|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808085|NCT03262103|Poly I-C|poly i-c|mesh-list
154808086|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154808087|NCT03262103|Poly ICLC|poly iclc|mesh-list
154808088|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
154808089|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
154808090|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808091|NCT03262103|Laxatives|laxatives|mesh-ancestor
154808092|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154808093|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
154808094|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808095|NCT04775225|Lidocaine|lidocaine|mesh-list
154808096|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808097|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
154808098|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808099|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808100|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
154808101|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808102|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154808103|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154808104|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154808105|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154808106|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808107|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
154808108|NCT04685915|Ibrutinib|ibrutinib|mesh-list
154808109|NCT04685915|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154808110|NCT04685915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154808111|NCT04685915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808112|NCT04685915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808113|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808114|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154808115|NCT04399187|Eusol|eusol|mesh-list
154808116|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
154808117|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808118|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
154808119|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154808120|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808121|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
154808122|NCT04746365|Ivermectin|ivermectin|mesh-list
154808123|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
154808124|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154808125|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154808126|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808127|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808128|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808129|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154808130|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
154808131|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154808132|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808133|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808134|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154808135|NCT04399343|Analgesics|analgesics|mesh-ancestor
154808136|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
154808137|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808138|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154808139|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154808140|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154808141|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
154808142|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808143|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808144|NCT03676049|Cannabidiol|cannabidiol|mesh-list
154808145|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
154808146|NCT03233633|Cannabidiol|cannabidiol|mesh-list
154808147|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
154808148|NCT02984345|Caseins|caseins|mesh-list
154808149|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
154808150|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
154808151|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808152|NCT01232205|Micronutrients|micronutrients|mesh-list
154808153|NCT01232205|Trace Elements|trace elements|mesh-list
154808154|NCT01232205|Antioxidants|antioxidants|mesh-list
154808155|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808156|NCT01232205|Protective Agents|protective agents|mesh-ancestor
154808157|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808158|NCT04584125|Riboflavin|riboflavin|mesh-list
154808159|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
154808160|NCT04584125|Dextrans|dextrans|mesh-list
154808161|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154808162|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154808163|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
154808164|NCT04584125|Vitamins|vitamins|mesh-ancestor
154808165|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
154808166|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808167|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154808168|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
154808169|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
154808170|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
154808171|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
154808172|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
154808173|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154808174|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808175|NCT01158885|Cytarabine|cytarabine|mesh-list
154808176|NCT01158885|Methotrexate|methotrexate|mesh-list
154808177|NCT01158885|Clofarabine|clofarabine|mesh-list
154808178|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154808179|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
154808180|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154808181|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808182|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154808183|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
154808184|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808185|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808186|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
154808187|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808188|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154808189|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808190|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
154808191|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154808192|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154808193|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
154808194|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808195|NCT01232829|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154808196|NCT01232829|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154808197|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808198|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808199|NCT01233921|Mitogens|mitogens|mesh-list
154808200|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
154808201|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808202|NCT03226301|Venetoclax|venetoclax|mesh-list
154808203|NCT03226301|Ibrutinib|ibrutinib|mesh-list
154808204|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808205|NCT03226301|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154808206|NCT03226301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154808207|NCT03226301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808208|NCT03226301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808209|NCT01236105|Charcoal|charcoal|mesh-list
154808210|NCT01236105|Antidotes|antidotes|mesh-ancestor
154808211|NCT01236105|Protective Agents|protective agents|mesh-ancestor
154808212|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808213|NCT04533347|Tafenoquine|tafenoquine|mesh-list
154808214|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
154808215|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154808216|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154808217|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808218|NCT01160445|Aldesleukin|aldesleukin|mesh-list
154808219|NCT01160445|Zanolimumab|zanolimumab|mesh-list
154808220|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808221|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154808222|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154808223|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
154808224|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808225|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154808227|NCT01237041|Niacinamide|niacinamide|mesh-list
154808228|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
154808229|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154808230|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
154808231|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808232|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154808233|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
154808234|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
154808235|NCT01237041|Vitamins|vitamins|mesh-ancestor
154808236|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
154808237|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808238|NCT01237197|Exenatide|exenatide|mesh-list
154808239|NCT01237197|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154808240|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154808241|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808242|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154808243|NCT01237197|Incretins|incretins|mesh-ancestor
154808244|NCT01237197|Hormones|hormones|mesh-ancestor
154808245|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154808246|NCT01237353|Rabeprazole|rabeprazole|mesh-list
154808247|NCT01237353|Betaine|betaine|mesh-list
154808248|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154808249|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154808250|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154808251|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808252|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808253|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
154808254|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154808255|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
154808256|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154808257|NCT03010761|Moclobemide|moclobemide|mesh-list
154808258|NCT03010761|Escitalopram|escitalopram|mesh-list
154808259|NCT03010761|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154808260|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154808261|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154808262|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808263|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808264|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
154808265|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808266|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
154808267|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808268|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154808269|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808270|NCT01243593|Anesthetics|anesthetics|mesh-list
154808271|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808272|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808273|NCT04362761|Ivacaftor|ivacaftor|mesh-list
154808274|NCT04362761|Elexacaftor|elexacaftor|mesh-list
154808275|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154808276|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154808277|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808278|NCT01162005|Tacrolimus|tacrolimus|mesh-list
154808279|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808281|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808282|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154808283|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808284|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808285|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154808286|NCT01244451|Ofatumumab|ofatumumab|mesh-list
154808287|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154808288|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
154808289|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808290|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808291|NCT01246401|Naltrexone|naltrexone|mesh-list
154808292|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154808293|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154808294|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808295|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
154808296|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808297|NCT01281501|Scopolamine|scopolamine|mesh-list
154808298|NCT01281501|Pantoprazole|pantoprazole|mesh-list
154808299|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
154808300|NCT01281501|Antacids|antacids|mesh-list
154808301|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154808302|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154808303|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154808304|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808305|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808306|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154808307|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
153987784|NCT03841201|Nivolumab|nivolumab|mesh-list
154808308|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
154808309|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808310|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808311|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
154808312|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154808313|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
154808314|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808315|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154808316|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
154808317|NCT03353831|Bevacizumab|bevacizumab|mesh-list
154808318|NCT03353831|Atezolizumab|atezolizumab|mesh-list
154808319|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154808320|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808321|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154808322|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154808323|NCT03353831|Growth Substances|growth substances|mesh-ancestor
154808324|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808325|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
154808326|NCT03353831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154808327|NCT03353831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808328|NCT01246713|Acetaminophen|acetaminophen|mesh-list
154808329|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154808330|NCT01246713|Analgesics|analgesics|mesh-ancestor
154808331|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
154808332|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808333|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808334|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
154808335|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154808336|NCT01246791|Norethindrone|norethindrone|mesh-list
154808337|NCT01246791|Norinyl|norinyl|mesh-list
154808338|NCT01246791|Estradiol|estradiol|mesh-list
154808339|NCT01246791|Estrogens|estrogens|mesh-ancestor
154808340|NCT01246791|Hormones|hormones|mesh-ancestor
154808341|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154808342|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808343|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154808344|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
154808345|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154808346|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154808347|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154808348|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154808349|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154808350|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154808351|NCT04319081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154808352|NCT04319081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154808353|NCT04319081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154808354|NCT04319081|Antimetabolites|antimetabolites|mesh-ancestor
154808355|NCT04319081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808356|NCT04319081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154808357|NCT04319081|Protease Inhibitors|protease inhibitors|mesh-ancestor
154808358|NCT04319081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808359|NCT04319081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153987830|NCT03617731|Bortezomib|bortezomib|mesh-list
154808360|NCT05345639|Ropivacaine|ropivacaine|mesh-list
154808361|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
154808362|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808363|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808364|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808365|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
154808366|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808367|NCT04303325|Esketamine|esketamine|mesh-list
154808368|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
154808369|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808370|NCT04746209|Blinatumomab|blinatumomab|mesh-list
154808371|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808372|NCT04168931|Trastuzumab|trastuzumab|mesh-list
154808373|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154808374|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808375|NCT03211949|Mepivacaine|mepivacaine|mesh-list
154808376|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808377|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
154808378|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808379|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808380|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
154808381|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808382|NCT01285635|Docetaxel|docetaxel|mesh-list
154808383|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808384|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
154808385|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
154808386|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
154808387|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808388|NCT01286259|Disulfiram|disulfiram|mesh-list
154808389|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154808390|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154808391|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808392|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808393|NCT01286805|Bupivacaine|bupivacaine|mesh-list
154808394|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808395|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
154808396|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808397|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808398|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
154808399|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808400|NCT01288521|Ketoconazole|ketoconazole|mesh-list
154808401|NCT01288521|Tacrolimus|tacrolimus|mesh-list
154808402|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808403|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
154808404|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808405|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154808406|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808407|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808408|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
154808409|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808410|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154808411|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154808412|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154808413|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
154808414|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154808415|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154808416|NCT00632749|Cytarabine|cytarabine|mesh-list
154808417|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154808418|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
154808419|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987877|NCT03263117|Anesthetics|anesthetics|mesh-list
154808420|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808421|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
154808422|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808423|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808424|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
154808425|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808426|NCT01289067|Satraplatin|satraplatin|mesh-list
154808427|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560392|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808428|NCT00632359|Lenalidomide|lenalidomide|mesh-list
154808429|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
154808430|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808431|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154808432|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154808433|NCT00632359|Growth Substances|growth substances|mesh-ancestor
154808434|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
154808435|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808436|NCT03954899|Melatonin|melatonin|mesh-list
154808437|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
154808438|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808439|NCT03954899|Protective Agents|protective agents|mesh-ancestor
154808440|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808441|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808442|NCT03934307|Irbesartan|irbesartan|mesh-list
154808443|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154808444|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154808445|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154808446|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808447|NCT03924635|Budesonide|budesonide|mesh-list
154808448|NCT03924635|Albuterol|albuterol|mesh-list
154808449|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
154808450|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154808451|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154808452|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154808453|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
154808454|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808455|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808456|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154808457|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
154808458|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
154808459|NCT03924635|Hormones|hormones|mesh-ancestor
154808460|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154808461|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154808462|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154808463|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154808464|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
154808465|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808466|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808467|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
154808468|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154808469|NCT04398251|Febuxostat|febuxostat|mesh-list
154808470|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
154808471|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154808472|NCT00632203|Temozolomide|temozolomide|mesh-list
154808473|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154808474|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
154808475|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808476|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808477|NCT01289457|Cytarabine|cytarabine|mesh-list
154808478|NCT01289457|Fludarabine|fludarabine|mesh-list
154808479|NCT01289457|Idarubicin|idarubicin|mesh-list
154808480|NCT01289457|Clofarabine|clofarabine|mesh-list
154808481|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987943|NCT02337634|Silymarin|silymarin|mesh-list
154808482|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154808483|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
154808484|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808485|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808486|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
154808487|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808488|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
154808489|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808490|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154808491|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154808492|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154808493|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808494|NCT03830333|Metronidazole|metronidazole|mesh-list
154808495|NCT03830333|Meropenem|meropenem|mesh-list
154808496|NCT03830333|Tazobactam|tazobactam|mesh-list
154808497|NCT03830333|Ceftolozane|ceftolozane|mesh-list
154808498|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154808499|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808500|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154808501|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154808502|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154808503|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154808504|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808505|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808506|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154808507|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
154808508|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154808509|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
154808510|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808511|NCT01251315|Expectorants|expectorants|mesh-ancestor
154808512|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
154808513|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154808514|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
154808515|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808516|NCT01251315|Protective Agents|protective agents|mesh-ancestor
154808517|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808518|NCT01251315|Antidotes|antidotes|mesh-ancestor
154808519|NCT01290237|Vancomycin|vancomycin|mesh-list
154808520|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154808521|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808522|NCT01251393|Biperiden|biperiden|mesh-list
154808523|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154808524|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154808525|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
154808526|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
154808527|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808528|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808529|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154808530|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154808531|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
154808532|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808533|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808534|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154808535|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
154808536|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154808537|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154808538|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808539|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808540|NCT00631969|Urological Agents|urological agents|mesh-ancestor
154808541|NCT01255137|Axitinib|axitinib|mesh-list
154808542|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808543|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154808544|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808545|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808546|NCT01255449|Albuterol|albuterol|mesh-list
154808547|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154808548|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
154808549|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808550|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808551|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154808552|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
154808553|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
154808554|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154808555|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154808556|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154808557|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154808558|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
154808559|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808560|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808561|NCT00631657|Mirtazapine|mirtazapine|mesh-list
154808562|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
154808563|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808564|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154808565|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
154808566|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
154808567|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808568|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808569|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808570|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154808571|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154808572|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808573|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154808574|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154808575|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154808576|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
154808577|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154808578|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154808579|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
154808580|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154808581|NCT01257087|Insulin|insulin|mesh-list
154808582|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154808583|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
154808584|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154808585|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808586|NCT00631189|Atorvastatin|atorvastatin|mesh-list
154808587|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154808588|NCT00631189|Pravastatin|pravastatin|mesh-list
154808589|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154808590|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154808591|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
154808592|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808593|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154808594|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154808595|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808596|NCT00630877|Aspirin|aspirin|mesh-list
154808597|NCT00630877|Niacin|niacin|mesh-list
154808598|NCT00630877|Niacinamide|niacinamide|mesh-list
154808599|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
154808600|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154808601|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154808602|NCT00630877|Analgesics|analgesics|mesh-ancestor
153988068|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154808603|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
154808604|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808605|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808606|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154808607|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154808608|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154808609|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154808610|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808611|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154808612|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154808613|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808614|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
154808615|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154808616|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
154808617|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154808618|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
154808619|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
154808620|NCT00630877|Vitamins|vitamins|mesh-ancestor
154808621|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
154808622|NCT04557163|Itraconazole|itraconazole|mesh-list
154808623|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
154808624|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808625|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154808626|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154808627|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808628|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808629|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154808630|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
154808631|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154808632|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808633|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154808634|NCT02915783|Everolimus|everolimus|mesh-list
154808635|NCT02915783|Lenvatinib|lenvatinib|mesh-list
154808636|NCT02915783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154808637|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154808638|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808639|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808640|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808641|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
154808642|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808643|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808644|NCT02736149|Ubenimex|ubenimex|mesh-list
154808645|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154808646|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
154808647|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808648|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154808649|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808650|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154808651|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808652|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560620|NCT02175901|Antacids|antacids|mesh-ancestor
154808653|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808654|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808655|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154808656|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154808657|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
154808658|NCT02307149|Ipilimumab|ipilimumab|mesh-list
154808659|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154808660|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808661|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154808662|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808663|NCT04397393|Midazolam|midazolam|mesh-list
154808664|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154808665|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154808666|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808667|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808668|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154808669|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154808670|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808671|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154808672|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
154808673|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
154808674|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
154808675|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
154808676|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808677|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808678|NCT01176461|Nivolumab|nivolumab|mesh-list
154808679|NCT01176461|Vaccines|vaccines|mesh-list
154808680|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154808681|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
154808682|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808683|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154808684|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808685|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154808686|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808687|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154808688|NCT00630331|Vaccines|vaccines|mesh-list
154808689|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
154808690|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808691|NCT04555291|Ropivacaine|ropivacaine|mesh-list
154808692|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808693|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
154808694|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808695|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808696|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
154808697|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808698|NCT04275115|Midazolam|midazolam|mesh-list
154808699|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154808700|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154808701|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808702|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808703|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154808704|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154808705|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808706|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154808707|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
154808708|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
154808709|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
154808710|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
154808711|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808712|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808713|NCT00633997|Vildagliptin|vildagliptin|mesh-list
154808714|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154808715|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808716|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154808717|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
154808718|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808719|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808720|NCT04559347|Bupivacaine|bupivacaine|mesh-list
154808721|NCT04559347|Ropivacaine|ropivacaine|mesh-list
154808722|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808723|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
154808724|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808725|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808726|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
154808727|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808728|NCT00631111|Aspirin|aspirin|mesh-list
154808730|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808731|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154808732|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154808733|NCT00631111|Analgesics|analgesics|mesh-ancestor
154808734|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
154808735|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808736|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154808737|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154808738|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154808739|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154808740|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808741|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154808742|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154808743|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808744|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
154808745|NCT00630799|Leuprolide|leuprolide|mesh-list
154808746|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154808747|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
154808748|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154808749|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808750|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154808751|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808752|NCT01925287|Curcumin|curcumin|mesh-list
154808753|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154808754|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154808755|NCT01925287|Analgesics|analgesics|mesh-ancestor
154808756|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
154808757|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808758|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808759|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154808760|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154808761|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808762|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808763|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808764|NCT01924273|Talaporfin|talaporfin|mesh-list
154808765|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808766|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154808767|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
154808768|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
154808769|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808770|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
154808771|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808772|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
154808773|NCT04276649|Antacids|antacids|mesh-ancestor
154808774|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808775|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154808776|NCT04553419|Cephalexin|cephalexin|mesh-list
154808777|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154808778|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808779|NCT04346407|Dronabinol|dronabinol|mesh-list
154808780|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
154808781|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808782|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808783|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154808784|NCT04346407|Analgesics|analgesics|mesh-ancestor
154808785|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
154808786|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808787|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153988242|NCT04077892|Budesonide|budesonide|mesh-list
154808788|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154808789|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808790|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808791|NCT04346407|Hormones|hormones|mesh-ancestor
154808792|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154808793|NCT04397549|Morphine|morphine|mesh-list
154808794|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154808795|NCT04397549|Narcotics|narcotics|mesh-ancestor
154808796|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808797|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808798|NCT04397549|Analgesics|analgesics|mesh-ancestor
154808799|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
154808800|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808801|NCT03080441|Midodrine|midodrine|mesh-list
154808802|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
154808803|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
154808804|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808805|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808806|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154808807|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154808808|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154808809|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154808810|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
154808811|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808812|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808813|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
154808814|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154808815|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
154808816|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154808817|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
154808818|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808819|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808820|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
154808821|NCT01920919|Dexamethasone|dexamethasone|mesh-list
154808822|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154808823|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
154808824|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
154808825|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808826|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808827|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154808828|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
154808829|NCT01920919|Hormones|hormones|mesh-ancestor
154808830|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154808831|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154808832|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808833|NCT01925911|Midazolam|midazolam|mesh-list
154808834|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154808835|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154808836|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808837|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808838|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154808839|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154808840|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808841|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154808842|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
154808843|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
154808844|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
154808845|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
154808846|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808847|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808848|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154808849|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808850|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154808851|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808852|NCT01921231|Bupivacaine|bupivacaine|mesh-list
154808853|NCT01921231|Prilocaine|prilocaine|mesh-list
154808854|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808855|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
154808856|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808857|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808858|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
154808859|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808860|NCT03056833|Paclitaxel|paclitaxel|mesh-list
154808861|NCT03056833|Carboplatin|carboplatin|mesh-list
154808862|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154808863|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808864|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
154808865|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
154808866|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
154808867|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808868|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154808869|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
154808870|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154808871|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154808872|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154808873|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808874|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808875|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
154808876|NCT03148457|Apixaban|apixaban|mesh-list
154808877|NCT03148457|Edoxaban|edoxaban|mesh-list
154808878|NCT03148457|Dabigatran|dabigatran|mesh-list
154808879|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154808880|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
154808881|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154808882|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
154808883|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808884|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808885|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
154808886|NCT01926379|Isoniazid|isoniazid|mesh-list
154808887|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
154808888|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154808889|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808890|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154808891|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154808892|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
154808893|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808894|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154808895|NCT03351647|Ustekinumab|ustekinumab|mesh-list
154808896|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
154808897|NCT02392637|Paclitaxel|paclitaxel|mesh-list
154808898|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154808899|NCT02392637|Cisplatin|cisplatin|mesh-list
154808900|NCT02392637|Gemcitabine|gemcitabine|mesh-list
154808901|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154808902|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808903|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
154808904|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
154808905|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
154808906|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808907|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154808908|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
154808909|NCT05600881|Methylphenidate|methylphenidate|mesh-list
153988367|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154808910|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154808911|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808912|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154808913|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154808914|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154808915|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808916|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
154808917|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808918|NCT01926769|Metformin|metformin|mesh-list
154808919|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154808920|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808921|NCT04394143|Mannitol|mannitol|mesh-list
154808922|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154808923|NCT04394143|Diuretics|diuretics|mesh-ancestor
154808924|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
154808925|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808926|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154808927|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
154808928|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808929|NCT01926847|Riociguat|riociguat|mesh-list
154808930|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
154808931|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808932|NCT05586815|Minocycline|minocycline|mesh-list
154808933|NCT05586815|Colistin|colistin|mesh-list
154808934|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154808935|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154808936|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
154808937|NCT05607901|Tacrolimus|tacrolimus|mesh-list
154808938|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808939|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
154808940|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808941|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154808942|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154808943|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808944|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154808945|NCT03133325|Lidocaine|lidocaine|mesh-list
154808946|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
154808947|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
154808948|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808949|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808950|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
154808951|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154808952|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154808953|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154808954|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154808955|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154808956|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808957|NCT00638963|Temozolomide|temozolomide|mesh-list
154808958|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154808959|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
154808960|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808961|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808962|NCT04278677|Melatonin|melatonin|mesh-list
154808963|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
154808964|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808965|NCT04278677|Protective Agents|protective agents|mesh-ancestor
154808966|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808967|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154808968|NCT00638027|Memantine|memantine|mesh-list
154808969|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154808970|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154808971|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
154808972|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154808973|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808974|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808975|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154808976|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154808977|NCT03342911|Paclitaxel|paclitaxel|mesh-list
154808978|NCT03342911|Carboplatin|carboplatin|mesh-list
154808979|NCT03342911|Nivolumab|nivolumab|mesh-list
154808980|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154808981|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154808982|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
154808983|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
154808984|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
154808985|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808986|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154808987|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154808988|NCT01927315|Fenofibrate|fenofibrate|mesh-list
154808989|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154808990|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
154808991|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154808992|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154808993|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
154808994|NCT00636155|Rituximab|rituximab|mesh-list
154808995|NCT00636155|Fludarabine|fludarabine|mesh-list
154808996|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154808997|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
154808998|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154808999|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809000|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154809001|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
154809002|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809003|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809004|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154809005|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809006|NCT00634907|Warfarin|warfarin|mesh-list
154809007|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
154809008|NCT04124497|Dexamethasone|dexamethasone|mesh-list
154809009|NCT04124497|Daratumumab|daratumumab|mesh-list
154809010|NCT04124497|Pomalidomide|pomalidomide|mesh-list
154809011|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809012|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
154809013|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
154809014|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809015|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809016|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154809017|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
154809018|NCT04124497|Hormones|hormones|mesh-ancestor
154809019|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988487|NCT00771043|Natalizumab|natalizumab|mesh-list
154809020|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154809021|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809022|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
154809023|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154809024|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154809025|NCT04124497|Growth Substances|growth substances|mesh-ancestor
154809026|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
154809027|NCT04127851|Cyclosporine|cyclosporine|mesh-list
154809028|NCT04127851|Cyclosporins|cyclosporins|mesh-list
154809029|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809030|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809031|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809032|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
154809033|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809034|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
154809035|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809036|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
154809037|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809038|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154809039|NCT06255067|Minocycline|minocycline|mesh-list
154809040|NCT06255067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154809041|NCT06255067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809042|NCT06254781|Luspatercept|luspatercept|mesh-list
154809043|NCT06254781|Hematinics|hematinics|mesh-ancestor
154809044|NCT06254703|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154809045|NCT06254703|Natriuretic Agents|natriuretic agents|mesh-ancestor
154809046|NCT06254703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809048|NCT06254690|Trastuzumab|trastuzumab|mesh-list
154809049|NCT06254690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809050|NCT06254690|Tubulin Modulators|tubulin modulators|mesh-ancestor
154809051|NCT06254690|Antimitotic Agents|antimitotic agents|mesh-ancestor
154809052|NCT06254690|Mitosis Modulators|mitosis modulators|mesh-ancestor
154809053|NCT06254690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809054|NCT06254690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809055|NCT06254664|Tiotropium Bromide|tiotropium bromide|mesh-list
154809056|NCT06254664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154809057|NCT06254664|Autonomic Agents|autonomic agents|mesh-ancestor
154809058|NCT06254664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809059|NCT06254664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809060|NCT06254664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154809061|NCT06254664|Respiratory System Agents|respiratory system agents|mesh-ancestor
154809062|NCT06254664|Parasympatholytics|parasympatholytics|mesh-ancestor
154809063|NCT06254664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154809064|NCT06254664|Cholinergic Agents|cholinergic agents|mesh-ancestor
154809065|NCT06254664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809066|NCT06254664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809067|NCT06254599|Crizotinib|crizotinib|mesh-list
154809068|NCT06254599|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154809069|NCT06254599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154809070|NCT06254599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809071|NCT06254599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809072|NCT06254599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809073|NCT06254560|Rituximab|rituximab|mesh-list
154809074|NCT06254560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809075|NCT06254560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809076|NCT06254560|Immunologic Factors|immunologic factors|mesh-ancestor
154809077|NCT06254560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809078|NCT06254560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809079|NCT06254521|Tislelizumab|tislelizumab|mesh-list
154809080|NCT06254521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809081|NCT06254521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809082|NCT06254495|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154809083|NCT06254495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809084|NCT06254495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809085|NCT06254495|Immunotoxins|immunotoxins|mesh-ancestor
154809086|NCT06254495|Immunoconjugates|immunoconjugates|mesh-ancestor
154809087|NCT06254495|Immunologic Factors|immunologic factors|mesh-ancestor
154809088|NCT06254495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809089|NCT06254404|Protamines|protamines|mesh-list
154809090|NCT06254404|Heparin Antagonists|heparin antagonists|mesh-ancestor
154809091|NCT06254404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809092|NCT06254404|Coagulants|coagulants|mesh-ancestor
154809093|NCT06254391|Aspirin|aspirin|mesh-list
154809094|NCT06254391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154809095|NCT06254391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154809096|NCT06254391|Analgesics|analgesics|mesh-ancestor
154809097|NCT06254391|Sensory System Agents|sensory system agents|mesh-ancestor
154809098|NCT06254391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809099|NCT06254391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809100|NCT06254391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809101|NCT06254391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809102|NCT06254391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154809103|NCT06254391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154809104|NCT06254391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809105|NCT06254391|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154809106|NCT06254391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154809107|NCT06254391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809108|NCT06254391|Antipyretics|antipyretics|mesh-ancestor
154809109|NCT06254326|Vaccines|vaccines|mesh-list
154809110|NCT06254326|Immunologic Factors|immunologic factors|mesh-ancestor
154809111|NCT06254326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809112|NCT06254235|Octreotide|octreotide|mesh-list
154809113|NCT06254235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154809114|NCT06254235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154809115|NCT06254235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809116|NCT06254183|Gabapentin|gabapentin|mesh-list
154809117|NCT06254183|Analgesics|analgesics|mesh-ancestor
154809118|NCT06254183|Sensory System Agents|sensory system agents|mesh-ancestor
154809119|NCT06254183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809120|NCT06254183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809121|NCT06254183|Anticonvulsants|anticonvulsants|mesh-ancestor
154809122|NCT06254183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154809123|NCT06254183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154809124|NCT06254183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809125|NCT06254183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154809126|NCT06254183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154809127|NCT06254183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154809128|NCT06254183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809129|NCT06254183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809130|NCT06254183|Antimanic Agents|antimanic agents|mesh-ancestor
154809131|NCT06254066|Fluzoparib|fluzoparib|mesh-list
154809132|NCT06254066|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154809133|NCT06254066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809134|NCT06254066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809135|NCT06254066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809136|NCT06254027|Amorolfine|amorolfine|mesh-list
154809137|NCT06254027|Antifungal Agents|antifungal agents|mesh-ancestor
154809138|NCT06254027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809139|NCT06253975|Hyaluronic Acid|hyaluronic acid|mesh-list
154809140|NCT06253975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154809141|NCT06253975|Immunologic Factors|immunologic factors|mesh-ancestor
154809142|NCT06253975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809143|NCT06253975|Viscosupplements|viscosupplements|mesh-ancestor
154809144|NCT06253975|Protective Agents|protective agents|mesh-ancestor
154809145|NCT06253806|Mepivacaine|mepivacaine|mesh-list
154809146|NCT06253806|Anesthetics, Local|anesthetics, local|mesh-ancestor
154809147|NCT06253806|Anesthetics|anesthetics|mesh-ancestor
154809148|NCT06253806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809149|NCT06253806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809150|NCT06253806|Sensory System Agents|sensory system agents|mesh-ancestor
154809151|NCT06253806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809152|NCT06253715|Moxifloxacin|moxifloxacin|mesh-list
154809153|NCT06253715|Rifampin|rifampin|mesh-list
154809154|NCT06253715|Isoniazid|isoniazid|mesh-list
154809155|NCT06253715|Pyrazinamide|pyrazinamide|mesh-list
154809156|NCT06253715|Ethambutol|ethambutol|mesh-list
154809157|NCT06253715|Rifapentine|rifapentine|mesh-list
154809158|NCT06253715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154809159|NCT06253715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809160|NCT06253715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154809161|NCT06253715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154809162|NCT06253715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809163|NCT06253715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809164|NCT06253715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809165|NCT06253715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154809166|NCT06253715|Antitubercular Agents|antitubercular agents|mesh-ancestor
154809167|NCT06253715|Leprostatic Agents|leprostatic agents|mesh-ancestor
154809168|NCT06253715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154809169|NCT06253715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154809170|NCT06253715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154809171|NCT06253715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154809172|NCT06253715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154809173|NCT06253715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154809174|NCT06253715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154809175|NCT06253715|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154809176|NCT06253715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154809177|NCT06253715|Antimetabolites|antimetabolites|mesh-ancestor
154809178|NCT06253715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154809179|NCT06253702|Indomethacin|indomethacin|mesh-list
154809180|NCT06253702|Anastrozole|anastrozole|mesh-list
154561142|NCT05981352|Viscosupplements|viscosupplements|mesh-ancestor
154809181|NCT06253702|Estradiol|estradiol|mesh-list
154809182|NCT06253702|Testosterone|testosterone|mesh-list
154809183|NCT06253702|Estrogens|estrogens|mesh-ancestor
154809184|NCT06253702|Hormones|hormones|mesh-ancestor
154809185|NCT06253702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809186|NCT06253702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809187|NCT06253702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154809188|NCT06253702|Androgens|androgens|mesh-ancestor
154809189|NCT06253702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154809190|NCT06253702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809191|NCT06253702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154809192|NCT06253702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154809193|NCT06253702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809194|NCT06253702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809195|NCT06253702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154809196|NCT06253702|Hormone Antagonists|hormone antagonists|mesh-ancestor
154809197|NCT06253702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154809198|NCT06253702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154809199|NCT06253702|Analgesics|analgesics|mesh-ancestor
154809200|NCT06253702|Sensory System Agents|sensory system agents|mesh-ancestor
154809201|NCT06253702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809202|NCT06253702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809203|NCT06253702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809204|NCT06253702|Gout Suppressants|gout suppressants|mesh-ancestor
154809205|NCT06253702|Tocolytic Agents|tocolytic agents|mesh-ancestor
154809206|NCT06253702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154809207|NCT06253637|Daratumumab|daratumumab|mesh-list
154809208|NCT06253637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809209|NCT06253598|Lenvatinib|lenvatinib|mesh-list
154809210|NCT06253598|Tislelizumab|tislelizumab|mesh-list
154809211|NCT06253598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809212|NCT06253598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154809213|NCT06253598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809214|NCT06253598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809215|NCT06253598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809216|NCT06253429|Thioctic Acid|thioctic acid|mesh-list
154809217|NCT06253429|Captopril|captopril|mesh-list
154809218|NCT06253429|Antioxidants|antioxidants|mesh-ancestor
154809219|NCT06253429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809220|NCT06253429|Protective Agents|protective agents|mesh-ancestor
154809221|NCT06253429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809222|NCT06253429|Vitamin B Complex|vitamin b complex|mesh-ancestor
154809223|NCT06253429|Vitamins|vitamins|mesh-ancestor
154809224|NCT06253429|Micronutrients|micronutrients|mesh-ancestor
154809225|NCT06253429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154809226|NCT06253429|Protease Inhibitors|protease inhibitors|mesh-ancestor
154809227|NCT06253429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809228|NCT06253429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154809229|NCT06253247|Calcium|calcium|mesh-list
154809230|NCT06253247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154809231|NCT06253247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809232|NCT06253195|Letrozole|letrozole|mesh-list
154809233|NCT06253195|Fulvestrant|fulvestrant|mesh-list
154809234|NCT06253195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809235|NCT06253195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154809236|NCT06253195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154809237|NCT06253195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809238|NCT06253195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809239|NCT06253195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154809240|NCT06253195|Hormone Antagonists|hormone antagonists|mesh-ancestor
154809241|NCT06253195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809242|NCT06253195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809243|NCT06253195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154809244|NCT06253195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154809245|NCT06253117|Pirfenidone|pirfenidone|mesh-list
154809246|NCT06253117|Analgesics|analgesics|mesh-ancestor
154809247|NCT06253117|Sensory System Agents|sensory system agents|mesh-ancestor
154809248|NCT06253117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809249|NCT06253117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809250|NCT06253117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154809251|NCT06253117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154809252|NCT06253117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809253|NCT06253117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809254|NCT06253117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809255|NCT06252961|Levamisole|levamisole|mesh-list
154561217|NCT05846698|Anabolic Agents|anabolic agents|mesh-ancestor
154809256|NCT06252961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154809258|NCT06252961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809259|NCT06252961|Antinematodal Agents|antinematodal agents|mesh-ancestor
154809260|NCT06252961|Anthelmintics|anthelmintics|mesh-ancestor
154809261|NCT06252961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154809262|NCT06252961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809263|NCT06252961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809264|NCT06252870|Vidarabine|vidarabine|mesh-list
154809265|NCT06252870|Cyclophosphamide|cyclophosphamide|mesh-list
154809266|NCT06252870|Busulfan|busulfan|mesh-list
154809267|NCT06252870|Thiotepa|thiotepa|mesh-list
154809268|NCT06252870|Methotrexate|methotrexate|mesh-list
154809269|NCT06252870|Fludarabine|fludarabine|mesh-list
154809270|NCT06252870|Fludarabine phosphate|fludarabine phosphate|mesh-list
154809271|NCT06252870|Clofarabine|clofarabine|mesh-list
154809272|NCT06252870|Thymoglobulin|thymoglobulin|mesh-list
154809273|NCT06252870|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154809274|NCT06252870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809275|NCT06252870|Immunologic Factors|immunologic factors|mesh-ancestor
154809276|NCT06252870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809277|NCT06252870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809278|NCT06252870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154809279|NCT06252870|Alkylating Agents|alkylating agents|mesh-ancestor
154809280|NCT06252870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809281|NCT06252870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809282|NCT06252870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154809283|NCT06252870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154809284|NCT06252870|Abortifacient Agents|abortifacient agents|mesh-ancestor
154809285|NCT06252870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154809286|NCT06252870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154809287|NCT06252870|Antimetabolites|antimetabolites|mesh-ancestor
154809288|NCT06252870|Dermatologic Agents|dermatologic agents|mesh-ancestor
154809289|NCT06252870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809290|NCT06252870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154809291|NCT06252870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154809292|NCT06252870|Antiviral Agents|antiviral agents|mesh-ancestor
154809293|NCT06252870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809294|NCT06252727|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154809295|NCT06252727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154809296|NCT06252727|Dermatologic Agents|dermatologic agents|mesh-ancestor
154809297|NCT06252675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154809298|NCT06252675|Obinutuzumab|obinutuzumab|mesh-list
154809299|NCT06252675|Antibodies|antibodies|mesh-list
154809300|NCT06252675|Immunoglobulins|immunoglobulins|mesh-list
154809301|NCT06252675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154809302|NCT06252675|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154809303|NCT06252675|Pirtobrutinib|pirtobrutinib|mesh-list
154809304|NCT06252675|Immunologic Factors|immunologic factors|mesh-ancestor
154809305|NCT06252675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809306|NCT06252675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809307|NCT06252675|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154809308|NCT06252675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154809309|NCT06252675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809310|NCT06252675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809311|NCT06252662|Dexmedetomidine|dexmedetomidine|mesh-list
154809312|NCT06252662|Bupivacaine|bupivacaine|mesh-list
154809313|NCT06252662|Anesthetics, Local|anesthetics, local|mesh-ancestor
154809314|NCT06252662|Anesthetics|anesthetics|mesh-ancestor
154809315|NCT06252662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809316|NCT06252662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809317|NCT06252662|Sensory System Agents|sensory system agents|mesh-ancestor
154809318|NCT06252662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809319|NCT06252662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154809320|NCT06252662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154809321|NCT06252662|Analgesics|analgesics|mesh-ancestor
154809322|NCT06252662|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154809323|NCT06252662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154809324|NCT06252662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154809325|NCT06252662|Adrenergic Agents|adrenergic agents|mesh-ancestor
154809326|NCT06252662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809327|NCT06252662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809328|NCT06252649|Bevacizumab|bevacizumab|mesh-list
154809329|NCT06252649|Panitumumab|panitumumab|mesh-list
154809330|NCT06252649|Sotorasib|sotorasib|mesh-list
154809331|NCT06252649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809332|NCT06252649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809333|NCT06252649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154809334|NCT06252649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154809335|NCT06252649|Growth Substances|growth substances|mesh-ancestor
154809336|NCT06252649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809337|NCT06252649|Growth Inhibitors|growth inhibitors|mesh-ancestor
154809338|NCT06252649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809339|NCT06252649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809340|NCT06252571|Melatonin|melatonin|mesh-list
154809341|NCT06252571|Antioxidants|antioxidants|mesh-ancestor
154809342|NCT06252571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809343|NCT06252571|Protective Agents|protective agents|mesh-ancestor
154809344|NCT06252571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809345|NCT06252571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809346|NCT06252493|Glucagon|glucagon|mesh-list
154809347|NCT06252493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154809348|NCT06252493|Hormones|hormones|mesh-ancestor
154809349|NCT06252493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809350|NCT06252493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809351|NCT06251375|Dexmedetomidine|dexmedetomidine|mesh-list
154809352|NCT06251375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154809353|NCT06251375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809354|NCT06251375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809355|NCT06251375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154809356|NCT06251375|Analgesics|analgesics|mesh-ancestor
154809357|NCT06251375|Sensory System Agents|sensory system agents|mesh-ancestor
154809358|NCT06251375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809359|NCT06251375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154809360|NCT06251375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154809361|NCT06251375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154809362|NCT06251375|Adrenergic Agents|adrenergic agents|mesh-ancestor
154809363|NCT06251375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809364|NCT06251375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809365|NCT06250959|Doxorubicin|doxorubicin|mesh-list
154809366|NCT06250959|Blinatumomab|blinatumomab|mesh-list
154809367|NCT06250959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154809368|NCT06250959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809369|NCT06250959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154809370|NCT06250959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154809371|NCT06250959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809372|NCT06250959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809373|NCT06250543|Lidocaine|lidocaine|mesh-list
154809374|NCT06250543|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154809375|NCT06250543|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154809376|NCT06250543|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154809377|NCT06250543|Anesthetics, Local|anesthetics, local|mesh-ancestor
154809378|NCT06250543|Anesthetics|anesthetics|mesh-ancestor
154809379|NCT06250543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809380|NCT06250543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809381|NCT06250543|Sensory System Agents|sensory system agents|mesh-ancestor
154809382|NCT06250543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809383|NCT06250543|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154809384|NCT06250543|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154809385|NCT06250543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154809386|NCT06250543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154809387|NCT06250543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809388|NCT06250543|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154809389|NCT06250543|Cholinergic Agents|cholinergic agents|mesh-ancestor
154809390|NCT06250543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809391|NCT06250543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154809392|NCT06250257|Bromocriptine|bromocriptine|mesh-list
154809393|NCT06250257|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154809394|NCT06250257|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154809395|NCT06250257|Hormone Antagonists|hormone antagonists|mesh-ancestor
154809396|NCT06250257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809397|NCT06250257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809398|NCT06250257|Dopamine Agonists|dopamine agonists|mesh-ancestor
154809399|NCT06250257|Dopamine Agents|dopamine agents|mesh-ancestor
154809400|NCT06250257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809401|NCT06250257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809402|NCT06247930|Vitamin D|vitamin d|mesh-list
154809403|NCT06247930|Ergocalciferols|ergocalciferols|mesh-list
154809404|NCT06247930|Cholecalciferol|cholecalciferol|mesh-list
154561373|NCT05033665|Benzocaine|benzocaine|mesh-list
154809405|NCT06247930|Vitamins|vitamins|mesh-list
154809406|NCT06247930|Micronutrients|micronutrients|mesh-ancestor
154809407|NCT06247930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809408|NCT06247930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154809409|NCT06247930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154809410|NCT06232655|Azacitidine|azacitidine|mesh-list
154809411|NCT06232655|Venetoclax|venetoclax|mesh-list
154809412|NCT06232655|Cladribine|cladribine|mesh-list
154809413|NCT06232655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154809414|NCT06232655|Antimetabolites|antimetabolites|mesh-ancestor
154809415|NCT06232655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809416|NCT06232655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809417|NCT06232655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809418|NCT06232655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809419|NCT06232655|Immunologic Factors|immunologic factors|mesh-ancestor
154809420|NCT06232655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809421|NCT06228586|Vaccines|vaccines|mesh-list
154809422|NCT06228586|Immunologic Factors|immunologic factors|mesh-ancestor
154809423|NCT06228586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809424|NCT06149559|Rozanolixizumab|rozanolixizumab|mesh-list
154809425|NCT06149559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809426|NCT06149559|Immunologic Factors|immunologic factors|mesh-ancestor
154809427|NCT06149559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809428|NCT06140927|Ketamine|ketamine|mesh-list
154809429|NCT06140927|Analgesics|analgesics|mesh-ancestor
154809430|NCT06140927|Sensory System Agents|sensory system agents|mesh-ancestor
154809431|NCT06140927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809432|NCT06140927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809433|NCT06140927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154809434|NCT06140927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154809435|NCT06140927|Anesthetics, General|anesthetics, general|mesh-ancestor
154809436|NCT06140927|Anesthetics|anesthetics|mesh-ancestor
154809437|NCT06140927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809438|NCT06140927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154809439|NCT06140927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154809440|NCT06140927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809441|NCT06140927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809442|NCT06134648|Vaccines|vaccines|mesh-list
154809443|NCT06134648|Immunologic Factors|immunologic factors|mesh-ancestor
154809444|NCT06134648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809445|NCT06107803|Olanzapine|olanzapine|mesh-list
154809446|NCT06107803|Antiemetics|antiemetics|mesh-ancestor
154809447|NCT06107803|Autonomic Agents|autonomic agents|mesh-ancestor
154809448|NCT06107803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809449|NCT06107803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809450|NCT06107803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154809451|NCT06107803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154809452|NCT06107803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154809453|NCT06107803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809454|NCT06107803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154809455|NCT06107803|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154809456|NCT06107803|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154809457|NCT06107803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154809458|NCT06107803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809459|NCT06107803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809460|NCT06107803|Serotonin Agents|serotonin agents|mesh-ancestor
154809461|NCT06095375|Temozolomide|temozolomide|mesh-list
154809462|NCT06095375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154809463|NCT06095375|Alkylating Agents|alkylating agents|mesh-ancestor
154809464|NCT06095375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809465|NCT06095375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809466|NCT06073704|Anti-Infective Agents|anti-infective agents|mesh-list
154809467|NCT06073704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154809468|NCT06069856|Iron|iron|mesh-list
154809469|NCT06069856|Trace Elements|trace elements|mesh-list
154809470|NCT06069856|Folic Acid|folic acid|mesh-list
154809471|NCT06069856|Micronutrients|micronutrients|mesh-list
154809472|NCT06069856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809473|NCT06069856|Hematinics|hematinics|mesh-ancestor
154809474|NCT06069856|Vitamin B Complex|vitamin b complex|mesh-ancestor
154809475|NCT06069856|Vitamins|vitamins|mesh-ancestor
154809476|NCT06043427|Paclitaxel|paclitaxel|mesh-list
154809477|NCT06043427|Ramucirumab|ramucirumab|mesh-list
154809478|NCT06043427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154809479|NCT06043427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809480|NCT06043427|Tubulin Modulators|tubulin modulators|mesh-ancestor
154809481|NCT06043427|Antimitotic Agents|antimitotic agents|mesh-ancestor
154809482|NCT06043427|Mitosis Modulators|mitosis modulators|mesh-ancestor
154809483|NCT06043427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809484|NCT06043427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154809485|NCT06043427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154809486|NCT06043427|Growth Substances|growth substances|mesh-ancestor
154809487|NCT06043427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809488|NCT06043427|Growth Inhibitors|growth inhibitors|mesh-ancestor
154809489|NCT06007911|Cytarabine|cytarabine|mesh-list
154809490|NCT06007911|Venetoclax|venetoclax|mesh-list
154809491|NCT06007911|Mitoxantrone|mitoxantrone|mesh-list
154809492|NCT06007911|Cladribine|cladribine|mesh-list
154809493|NCT06007911|Navitoclax|navitoclax|mesh-list
154809494|NCT06007911|Lenograstim|lenograstim|mesh-list
154809495|NCT06007911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154809496|NCT06007911|Antimetabolites|antimetabolites|mesh-ancestor
154809497|NCT06007911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809498|NCT06007911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809499|NCT06007911|Antiviral Agents|antiviral agents|mesh-ancestor
154809500|NCT06007911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809501|NCT06007911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809502|NCT06007911|Immunologic Factors|immunologic factors|mesh-ancestor
154809503|NCT06007911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809504|NCT06007911|Analgesics|analgesics|mesh-ancestor
154809505|NCT06007911|Sensory System Agents|sensory system agents|mesh-ancestor
154809506|NCT06007911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809507|NCT06007911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154809508|NCT06007911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154809509|NCT06007911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809510|NCT06007911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154809511|NCT05988814|Folfirinox|folfirinox|mesh-list
154809512|NCT05988814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809513|NCT05981573|Methadone|methadone|mesh-list
154809514|NCT05981573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154809515|NCT05981573|Narcotics|narcotics|mesh-ancestor
154809516|NCT05981573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809517|NCT05981573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809518|NCT05981573|Analgesics|analgesics|mesh-ancestor
154809519|NCT05981573|Sensory System Agents|sensory system agents|mesh-ancestor
154809520|NCT05981573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809521|NCT05981573|Antitussive Agents|antitussive agents|mesh-ancestor
154809522|NCT05981573|Respiratory System Agents|respiratory system agents|mesh-ancestor
154809523|NCT05957432|Amoxicillin|amoxicillin|mesh-list
154809524|NCT05957432|Clarithromycin|clarithromycin|mesh-list
154809525|NCT05957432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154809526|NCT05957432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809527|NCT05957432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154809528|NCT05957432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809529|NCT05957432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809530|NCT05957432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154809531|NCT05957432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154809532|NCT05931393|Nivolumab|nivolumab|mesh-list
154809533|NCT05931393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809534|NCT05931393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809535|NCT05931393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809536|NCT05931393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809537|NCT05931276|Metoprolol|metoprolol|mesh-list
154809538|NCT05931276|Carvedilol|carvedilol|mesh-list
154809539|NCT05931276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154809540|NCT05931276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154809541|NCT05931276|Sympatholytics|sympatholytics|mesh-ancestor
154809542|NCT05931276|Autonomic Agents|autonomic agents|mesh-ancestor
154809543|NCT05931276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809544|NCT05931276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809545|NCT05931276|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154809546|NCT05931276|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154809547|NCT05931276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154809548|NCT05931276|Adrenergic Agents|adrenergic agents|mesh-ancestor
154809549|NCT05931276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809550|NCT05931276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809551|NCT05931276|Antioxidants|antioxidants|mesh-ancestor
154809552|NCT05931276|Protective Agents|protective agents|mesh-ancestor
154809553|NCT05931276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154809554|NCT05931276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154561522|NCT03450707|Thiamine|thiamine|mesh-list
154809555|NCT05931276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154809556|NCT05931276|Vasodilator Agents|vasodilator agents|mesh-ancestor
154809557|NCT05931276|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154809559|NCT05914805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154809560|NCT05911828|Ferroquine|ferroquine|mesh-list
154809561|NCT05911828|Antimalarials|antimalarials|mesh-ancestor
154809562|NCT05911828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154809563|NCT05911828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154809564|NCT05911828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809565|NCT05910450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154809566|NCT05872204|Letrozole|letrozole|mesh-list
154809567|NCT05872204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809568|NCT05872204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154809569|NCT05872204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154809570|NCT05872204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809571|NCT05872204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809572|NCT05872204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154809573|NCT05872204|Hormone Antagonists|hormone antagonists|mesh-ancestor
154809574|NCT05872204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809575|NCT05872204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809576|NCT05855811|Dostarlimab|dostarlimab|mesh-list
154809577|NCT05855811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809578|NCT05854966|Metformin|metformin|mesh-list
154809579|NCT05854966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154809580|NCT05854966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809581|NCT05829434|Cytarabine|cytarabine|mesh-list
154809582|NCT05829434|Magrolimab|magrolimab|mesh-list
154809583|NCT05829434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154809584|NCT05829434|Antimetabolites|antimetabolites|mesh-ancestor
154809585|NCT05829434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809586|NCT05829434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809587|NCT05829434|Antiviral Agents|antiviral agents|mesh-ancestor
154809588|NCT05829434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809589|NCT05829434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809590|NCT05829434|Immunologic Factors|immunologic factors|mesh-ancestor
154809591|NCT05829434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809592|NCT05829434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809593|NCT05776823|Naloxone|naloxone|mesh-list
154809594|NCT05776823|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154809595|NCT05776823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809596|NCT05776823|Sensory System Agents|sensory system agents|mesh-ancestor
154809597|NCT05776823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809598|NCT05776056|Methylphenidate|methylphenidate|mesh-list
154809599|NCT05776056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154809600|NCT05776056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809601|NCT05776056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154809602|NCT05776056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154809603|NCT05776056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154809604|NCT05776056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809605|NCT05776056|Dopamine Agents|dopamine agents|mesh-ancestor
154809606|NCT05776056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809607|NCT05764707|Acetaminophen|acetaminophen|mesh-list
154809608|NCT05764707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154809609|NCT05764707|Analgesics|analgesics|mesh-ancestor
154809610|NCT05764707|Sensory System Agents|sensory system agents|mesh-ancestor
154809611|NCT05764707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809612|NCT05764707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809613|NCT05764707|Antipyretics|antipyretics|mesh-ancestor
154809614|NCT05720325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154809615|NCT05720325|Immunologic Factors|immunologic factors|mesh-ancestor
154809616|NCT05720325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809617|NCT05704985|Paclitaxel|paclitaxel|mesh-list
154809618|NCT05704985|Carboplatin|carboplatin|mesh-list
154809619|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
154809620|NCT05704985|Capecitabine|capecitabine|mesh-list
154809621|NCT05704985|Nivolumab|nivolumab|mesh-list
154809622|NCT05704985|Fluorouracil|fluorouracil|mesh-list
154809623|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
154809624|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154809625|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154809626|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809627|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
154809628|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
154809629|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
154809630|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809631|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809632|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154809633|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
154809634|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809635|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
154809636|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809638|NCT05686993|Cinnarizine|cinnarizine|mesh-list
154809639|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154809640|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154809641|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809642|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154809643|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809644|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
154809645|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
154809646|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154809647|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154809648|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
154809649|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
154809650|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809651|NCT05641324|Dexamethasone|dexamethasone|mesh-list
154809652|NCT05641324|Lenalidomide|lenalidomide|mesh-list
154809653|NCT05641324|Daratumumab|daratumumab|mesh-list
154809654|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809655|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
154809656|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
154809657|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809658|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809659|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154809660|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
154809661|NCT05641324|Hormones|hormones|mesh-ancestor
154809662|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809663|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154809664|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809665|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
154809666|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154809667|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154809668|NCT05641324|Growth Substances|growth substances|mesh-ancestor
154809669|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
154809670|NCT05609942|Azacitidine|azacitidine|mesh-list
154809671|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154809672|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
154809673|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809674|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809675|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809676|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
154809677|NCT05578872|Ipilimumab|ipilimumab|mesh-list
154809678|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809679|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809680|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809681|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809682|NCT05563766|Itraconazole|itraconazole|mesh-list
154809683|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
154809684|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154809685|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154809686|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154809687|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809688|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809689|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154809690|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
154809691|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809692|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809693|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154809694|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
154809695|NCT05559619|Vitamin D|vitamin d|mesh-list
154809696|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
154809697|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
154809698|NCT05559619|Calcium|calcium|mesh-list
154809699|NCT05559619|Vitamins|vitamins|mesh-ancestor
154809700|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
154809701|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809702|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154809703|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154809704|NCT05559619|Antacids|antacids|mesh-ancestor
154809705|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809706|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154809707|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
154809708|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
154809709|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
154809710|NCT05524935|Olaparib|olaparib|mesh-list
154809711|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989165|NCT02557087|Meperidine|meperidine|mesh-list
154809712|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809713|NCT05524935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809714|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809715|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154809716|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809717|NCT05464836|Venetoclax|venetoclax|mesh-list
154809718|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809719|NCT05408065|Triamcinolone|triamcinolone|mesh-list
154809720|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154809721|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154809722|NCT05408065|Cortisone|cortisone|mesh-list
154809723|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
154809724|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154809725|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809726|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
154809727|NCT05408065|Hormones|hormones|mesh-ancestor
154809728|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809729|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809730|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809731|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
154809732|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809733|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809734|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154809735|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
154809736|NCT05408065|Protective Agents|protective agents|mesh-ancestor
154809737|NCT05378464|Trastuzumab|trastuzumab|mesh-list
154809738|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809739|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809740|NCT05341115|Leuprolide|leuprolide|mesh-list
154809741|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154809742|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
154809743|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154809744|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809745|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154809746|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809747|NCT05320731|Lidocaine|lidocaine|mesh-list
154809748|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
154809749|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
154809750|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809751|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809752|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
154809753|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809754|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154809755|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154809756|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154809757|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154809758|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809759|NCT05271578|Nicotine|nicotine|mesh-list
154809760|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154809761|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
154809762|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809763|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809764|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154809765|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154809766|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
154809767|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809768|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809769|NCT05245071|Maytansine|maytansine|mesh-list
154809770|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154809771|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809772|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
154809773|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
154809774|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
154809775|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809776|NCT05214183|Rituximab|rituximab|mesh-list
154809777|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
154809778|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809779|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561742|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
154809780|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
154809781|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809782|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809783|NCT05214183|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154809784|NCT05214183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154809785|NCT05214183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809786|NCT05214183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809788|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809789|NCT05187429|Nivolumab|nivolumab|mesh-list
154809790|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809791|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809792|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809793|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809794|NCT05180773|Bromocriptine|bromocriptine|mesh-list
154809795|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
154809796|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154809797|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
154809798|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154809799|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
154809800|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809801|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809802|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
154809803|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154809804|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154809805|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
154809806|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809807|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809808|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
154809809|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
154809810|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809811|NCT05128162|Psilocybin|psilocybin|mesh-list
154809812|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
154809813|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809814|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154809815|NCT05060549|Cariprazine|cariprazine|mesh-list
154809816|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154809817|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154809818|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809819|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809820|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154809821|NCT05033041|Metoclopramide|metoclopramide|mesh-list
154809822|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
154809823|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
154809824|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809825|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809826|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154809827|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154809828|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154809829|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
154809830|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154809831|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809832|NCT05022927|Bevacizumab|bevacizumab|mesh-list
154809833|NCT05022927|Atezolizumab|atezolizumab|mesh-list
154809834|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809835|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989305|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
154809836|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154809837|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154809838|NCT05022927|Growth Substances|growth substances|mesh-ancestor
154809839|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809840|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
154809841|NCT05022927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809842|NCT05022927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809843|NCT05020145|Vaccines|vaccines|mesh-list
154809844|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
154809845|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809846|NCT04846855|Anesthetics|anesthetics|mesh-list
154809847|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
154809848|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154809849|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809850|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
154809851|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154809852|NCT04844528|Niacinamide|niacinamide|mesh-list
154561818|NCT02630459|Analgesics|analgesics|mesh-ancestor
154809853|NCT04844528|Niacin|niacin|mesh-list
154809854|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
154809855|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
154809857|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
154809858|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809859|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154809860|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
154809861|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809862|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154809863|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
154809864|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
154809865|NCT04740814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154809866|NCT04740814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809867|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809868|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
154809869|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809870|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809871|NCT04717375|Carboplatin|carboplatin|mesh-list
154809872|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
154809873|NCT04717375|Pemetrexed|pemetrexed|mesh-list
154809874|NCT04717375|Cetuximab|cetuximab|mesh-list
154809875|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809876|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809877|NCT04717375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809878|NCT04717375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809879|NCT04717375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809880|NCT04717375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154809881|NCT04717375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154809882|NCT04706741|Prednisone|prednisone|mesh-list
154809883|NCT04706741|Prednisolone|prednisolone|mesh-list
154809884|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154809885|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
154809886|NCT04706741|Hormones|hormones|mesh-ancestor
154809887|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809888|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809889|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154809890|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809891|NCT04691648|Gilteritinib|gilteritinib|mesh-list
154809892|NCT04691648|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154809893|NCT04691648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154809894|NCT04691648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809895|NCT04691648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809896|NCT04657068|Gemcitabine|gemcitabine|mesh-list
154809897|NCT04657068|Irinotecan|irinotecan|mesh-list
154809898|NCT04657068|Camptothecin|camptothecin|mesh-list
154809899|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154809900|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
154809901|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809902|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809903|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154809904|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154809905|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809906|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154809907|NCT04593927|Siponimod|siponimod|mesh-list
154809908|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154809909|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809910|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809911|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
154809912|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809913|NCT04537624|Semaglutide|semaglutide|mesh-list
154809914|NCT04537624|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154809915|NCT04537624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154809916|NCT04537624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809917|NCT04460807|Exemestane|exemestane|mesh-list
154809918|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809919|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154809920|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154809921|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809922|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809923|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154809924|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
154809925|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809926|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809927|NCT04446793|Bevacizumab|bevacizumab|mesh-list
154809928|NCT04446793|Onvansertib|onvansertib|mesh-list
154809929|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809930|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809931|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154809932|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154809933|NCT04446793|Growth Substances|growth substances|mesh-ancestor
154809934|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809935|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
154809936|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154809937|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809938|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809939|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
154809940|NCT04416984|Fludarabine|fludarabine|mesh-list
154809941|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154809942|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
154809943|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809944|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154809945|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154809946|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
154809947|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809948|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809949|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154809950|NCT04398459|Ibrutinib|ibrutinib|mesh-list
154809951|NCT04398459|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154809952|NCT04398459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154809953|NCT04398459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809954|NCT04398459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809955|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154809956|NCT04390646|Hormones|hormones|mesh-ancestor
154809957|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154809958|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154809959|NCT04349267|Nivolumab|nivolumab|mesh-list
154809960|NCT04349267|Cetuximab|cetuximab|mesh-list
154809961|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809962|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809963|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809964|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809965|NCT04294160|Tislelizumab|tislelizumab|mesh-list
154809966|NCT04294160|Spartalizumab|spartalizumab|mesh-list
154809967|NCT04294160|Trametinib|trametinib|mesh-list
154809968|NCT04294160|Dabrafenib|dabrafenib|mesh-list
154809969|NCT04294160|Naporafenib|naporafenib|mesh-list
154809970|NCT04294160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809971|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809972|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154809973|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809974|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809975|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809976|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
154809977|NCT04287816|Antithrombins|antithrombins|mesh-list
154809978|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154809979|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
154809980|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809981|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809982|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
154809983|NCT04216953|Atezolizumab|atezolizumab|mesh-list
154809984|NCT04216953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154809985|NCT04216953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809986|NCT04216953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809987|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809988|NCT04163432|Carboplatin|carboplatin|mesh-list
154809989|NCT04163432|Pemetrexed|pemetrexed|mesh-list
154809990|NCT04163432|Durvalumab|durvalumab|mesh-list
154809991|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154809992|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154809993|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154809994|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154809995|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154809996|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154809997|NCT04144023|Molgramostim|molgramostim|mesh-list
154809998|NCT04144023|Vaccines|vaccines|mesh-list
154809999|NCT04144023|Sargramostim|sargramostim|mesh-list
154810000|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
154810001|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810002|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810003|NCT04141644|Ipilimumab|ipilimumab|mesh-list
154810004|NCT04141644|Osimertinib|osimertinib|mesh-list
154810005|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810006|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810007|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154810008|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810009|NCT04141644|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154810010|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810011|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810012|NCT04106856|Losartan|losartan|mesh-list
154810013|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154810014|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154810015|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154810016|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154810017|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810018|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
154810019|NCT04088864|Fludarabine|fludarabine|mesh-list
154810020|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810021|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
154810022|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810023|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810024|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810025|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
154810026|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810027|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810028|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154810029|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
154810030|NCT04070443|Ponatinib|ponatinib|mesh-list
154810031|NCT04070443|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154810032|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810033|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810034|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810035|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810036|NCT03993132|Liraglutide|liraglutide|mesh-list
154810037|NCT03993132|Empagliflozin|empagliflozin|mesh-list
154810038|NCT03993132|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154810039|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154810040|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810041|NCT03993132|Incretins|incretins|mesh-ancestor
154810042|NCT03993132|Hormones|hormones|mesh-ancestor
154810043|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810044|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154810045|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810046|NCT03928093|Pregabalin|pregabalin|mesh-list
154810047|NCT03928093|Analgesics|analgesics|mesh-ancestor
154810048|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
154810049|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810050|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810051|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
154810052|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154810053|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154810054|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810055|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154810056|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154810057|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154810058|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810059|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154810060|NCT03900949|Cytarabine|cytarabine|mesh-list
154810061|NCT03900949|Daunorubicin|daunorubicin|mesh-list
154810062|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
154810063|NCT03900949|Midostaurin|midostaurin|mesh-list
154810064|NCT03900949|Calicheamicins|calicheamicins|mesh-list
154810065|NCT03900949|Staurosporine|staurosporine|mesh-list
154810066|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810067|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
154810068|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810069|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810070|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
154810071|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810072|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810073|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
154810074|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562042|NCT06219486|Hemostatics|hemostatics|mesh-ancestor
154810075|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154810076|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810077|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810078|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810079|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810081|NCT03900949|Immunoconjugates|immunoconjugates|mesh-ancestor
154810082|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810083|NCT03899467|Androgens|androgens|mesh-list
154810084|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
154810085|NCT03899467|Hormones|hormones|mesh-ancestor
154810086|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810087|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810088|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
154810089|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
154810090|NCT03878199|Cytarabine|cytarabine|mesh-list
154810091|NCT03878199|Daunorubicin|daunorubicin|mesh-list
154810092|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154810093|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810094|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
154810095|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810096|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810097|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
154810098|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810099|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810100|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
154810101|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810102|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154810103|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810104|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810105|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810106|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810107|NCT03839459|Denosumab|denosumab|mesh-list
154810108|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154810109|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810110|NCT03818685|Capecitabine|capecitabine|mesh-list
154810111|NCT03818685|Nivolumab|nivolumab|mesh-list
154810112|NCT03818685|Ipilimumab|ipilimumab|mesh-list
154810113|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810114|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
154810115|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810116|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810117|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810118|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154810119|NCT03811834|Mobocertinib|mobocertinib|mesh-list
154810120|NCT03811834|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154810121|NCT03811834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810122|NCT03811834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810123|NCT03811834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810124|NCT03786081|Bevacizumab|bevacizumab|mesh-list
154810125|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
154810126|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
154810127|NCT03786081|Carboplatin|carboplatin|mesh-list
154810128|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810129|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810130|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154810131|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154810132|NCT03786081|Growth Substances|growth substances|mesh-ancestor
154810133|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810134|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
154810135|NCT03786081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154810136|NCT03786081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810137|NCT03752398|Ipilimumab|ipilimumab|mesh-list
154810138|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810139|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810140|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154810141|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810142|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154810143|NCT03539614|Prazosin|prazosin|mesh-list
154810144|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154810145|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154810146|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154810147|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154562120|NCT06218524|Dopamine Agents|dopamine agents|mesh-ancestor
154810148|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
154810149|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810150|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810151|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810153|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
154810154|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810155|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810156|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
154810157|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810158|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810159|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810160|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154810161|NCT03535350|Temozolomide|temozolomide|mesh-list
154810162|NCT03535350|Ibrutinib|ibrutinib|mesh-list
154810163|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810164|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
154810165|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810166|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810167|NCT03535350|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154810168|NCT03535350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810169|NCT03535350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810170|NCT03495388|Oxycodone|oxycodone|mesh-list
154810171|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154810172|NCT03495388|Narcotics|narcotics|mesh-ancestor
154810173|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810174|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810175|NCT03495388|Analgesics|analgesics|mesh-ancestor
154810176|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
154810177|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810178|NCT03467360|Etoposide|etoposide|mesh-list
154810179|NCT03467360|Acetazolamide|acetazolamide|mesh-list
154810180|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154810181|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810182|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810183|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810184|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810185|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810186|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
154810187|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154810188|NCT03467360|Diuretics|diuretics|mesh-ancestor
154810189|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
154810190|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810191|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
154810192|NCT03384537|Listerine|listerine|mesh-list
154810193|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154810194|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810195|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
154810196|NCT03365609|Bismuth|bismuth|mesh-list
154810197|NCT03365609|Antacids|antacids|mesh-ancestor
154810198|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810199|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810200|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154810201|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154810202|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810203|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154810204|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154810205|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154810206|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810207|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
154810208|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810209|NCT03326245|Methylphenidate|methylphenidate|mesh-list
154810210|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154810211|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810212|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154810213|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154810214|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154810215|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810216|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
154810217|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810218|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154810219|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810220|NCT03250832|Bevacizumab|bevacizumab|mesh-list
154810221|NCT03250832|Dostarlimab|dostarlimab|mesh-list
154810222|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810223|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810224|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154810225|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154810226|NCT03250832|Growth Substances|growth substances|mesh-ancestor
154810227|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810228|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
154810229|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
154810230|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
154810231|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154810232|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154810233|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810234|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810235|NCT03199612|Urological Agents|urological agents|mesh-ancestor
154810236|NCT03174275|Paclitaxel|paclitaxel|mesh-list
154810237|NCT03174275|Carboplatin|carboplatin|mesh-list
154810238|NCT03174275|Durvalumab|durvalumab|mesh-list
154810239|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154810240|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810241|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
154810242|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
154810243|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
154810244|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810245|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810246|NCT03173092|Dexamethasone|dexamethasone|mesh-list
154810247|NCT03173092|Lenalidomide|lenalidomide|mesh-list
154810248|NCT03173092|Ixazomib|ixazomib|mesh-list
154810249|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154810250|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
154810251|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
154810252|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810253|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810254|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810255|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
154810256|NCT03173092|Hormones|hormones|mesh-ancestor
154810257|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810258|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154810259|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810260|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
154810261|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154810262|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154810263|NCT03173092|Growth Substances|growth substances|mesh-ancestor
154810264|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
154810265|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
154810266|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810267|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810268|NCT03164057|Cytarabine|cytarabine|mesh-list
154810269|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
154810270|NCT03164057|Methotrexate|methotrexate|mesh-list
154810271|NCT03164057|Azacitidine|azacitidine|mesh-list
154810272|NCT03164057|Decitabine|decitabine|mesh-list
154810273|NCT03164057|Fludarabine|fludarabine|mesh-list
154810274|NCT03164057|Etoposide|etoposide|mesh-list
154810275|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
154810276|NCT03164057|Sorafenib|sorafenib|mesh-list
154810277|NCT03164057|Daunorubicin|daunorubicin|mesh-list
154810278|NCT03164057|Asparaginase|asparaginase|mesh-list
154810279|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
154810280|NCT03164057|Idarubicin|idarubicin|mesh-list
154810281|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
154810282|NCT03164057|Razoxane|razoxane|mesh-list
154810283|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
154810284|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154810285|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
154810286|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154810287|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810288|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810289|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
154810290|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810291|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810292|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
154810293|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810294|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154810295|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810296|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
154810297|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810298|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154810299|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154810300|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810301|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810302|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
154810303|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810304|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810305|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154810306|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154810307|NCT03164057|Analgesics|analgesics|mesh-ancestor
154810308|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
154810309|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810310|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154810311|NCT03164057|Protective Agents|protective agents|mesh-ancestor
154810312|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
154810313|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
154810314|NCT03023124|Doxorubicin|doxorubicin|mesh-list
154810315|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154810316|NCT03023124|Dacarbazine|dacarbazine|mesh-list
154810317|NCT03023124|Trabectedin|trabectedin|mesh-list
154810318|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154810319|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810320|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810321|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810322|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810323|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810324|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810325|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
154810326|NCT02987686|Infliximab|infliximab|mesh-list
154810327|NCT02987686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154810328|NCT02987686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154810329|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
154810330|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810331|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810332|NCT02845882|Cytarabine|cytarabine|mesh-list
154810333|NCT02845882|Dexamethasone|dexamethasone|mesh-list
154810334|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
154810335|NCT02845882|Prednisone|prednisone|mesh-list
154810336|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
154810337|NCT02845882|Ifosfamide|ifosfamide|mesh-list
154810338|NCT02845882|Doxorubicin|doxorubicin|mesh-list
154810339|NCT02845882|Methotrexate|methotrexate|mesh-list
154810340|NCT02845882|Etoposide|etoposide|mesh-list
154810341|NCT02845882|Vincristine|vincristine|mesh-list
154810342|NCT02845882|Daunorubicin|daunorubicin|mesh-list
154810343|NCT02845882|Asparaginase|asparaginase|mesh-list
154810344|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
154810345|NCT02845882|Vindesine|vindesine|mesh-list
154810346|NCT02845882|Pegaspargase|pegaspargase|mesh-list
154810347|NCT02845882|BB 1101|bb 1101|mesh-list
154810348|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810349|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
154810350|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810351|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810352|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810353|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
154810354|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810355|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810356|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154810357|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154810358|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
154810359|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
154810360|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810361|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810362|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
154810363|NCT02845882|Hormones|hormones|mesh-ancestor
154810364|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810365|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154810366|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
154810367|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810368|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154810369|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810370|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810371|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154810372|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
154810373|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154810374|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810375|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
154810376|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
154810377|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154810379|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154810380|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
154810381|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810382|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
154810383|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
154810384|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
154810385|NCT02671890|Gemcitabine|gemcitabine|mesh-list
154810386|NCT02671890|Disulfiram|disulfiram|mesh-list
154810387|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810388|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
154810389|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810390|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810391|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154810392|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154810393|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810394|NCT02667730|Acetaminophen|acetaminophen|mesh-list
154810395|NCT02667730|Celecoxib|celecoxib|mesh-list
154810396|NCT02667730|Naproxen|naproxen|mesh-list
154810397|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154810398|NCT02667730|Analgesics|analgesics|mesh-ancestor
154810399|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
154810400|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810401|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810402|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
154810403|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154810404|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154810405|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810406|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154810407|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154810408|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810409|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810410|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
154810411|NCT02537418|Durvalumab|durvalumab|mesh-list
154810412|NCT02537418|Tremelimumab|tremelimumab|mesh-list
154810413|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810414|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810415|NCT02422641|Methotrexate|methotrexate|mesh-list
154810416|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154810417|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
154810418|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154810419|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810420|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810421|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
154810422|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810423|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810424|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
154810425|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810426|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154810427|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810428|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
154810429|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810430|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154810431|NCT02405676|Cytarabine|cytarabine|mesh-list
154810432|NCT02405676|Prednisone|prednisone|mesh-list
154810433|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
154810434|NCT02405676|Ifosfamide|ifosfamide|mesh-list
154810435|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
154810436|NCT02405676|Rituximab|rituximab|mesh-list
154810437|NCT02405676|Methotrexate|methotrexate|mesh-list
154810438|NCT02405676|Etoposide|etoposide|mesh-list
154810439|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
154810440|NCT02405676|Vincristine|vincristine|mesh-list
154810441|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810442|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
154810443|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810444|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810445|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810446|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
154810447|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810448|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810449|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154810450|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810451|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154810452|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
154810453|NCT02405676|Hormones|hormones|mesh-ancestor
154810454|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810455|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154810456|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154810457|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
154810458|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154810459|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810460|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
154810461|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
154810462|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810463|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154810464|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154810465|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154810466|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810467|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810468|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
154810469|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810470|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
154810471|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
154810472|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
154810473|NCT02358031|Carboplatin|carboplatin|mesh-list
154810474|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
154810476|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810477|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810478|NCT02358031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154810479|NCT02358031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810480|NCT02231775|Trametinib|trametinib|mesh-list
154810481|NCT02231775|Dabrafenib|dabrafenib|mesh-list
154810482|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810483|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810484|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810485|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810486|NCT02037919|Etonogestrel|etonogestrel|mesh-list
154810487|NCT02037919|Desogestrel|desogestrel|mesh-list
154810488|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154810489|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
154810490|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154810491|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810492|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154810493|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154810494|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154810495|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154810496|NCT02037919|Progestins|progestins|mesh-ancestor
154810497|NCT02037919|Hormones|hormones|mesh-ancestor
154810498|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810499|NCT01949662|Lorazepam|lorazepam|mesh-list
154810500|NCT01949662|Haloperidol|haloperidol|mesh-list
154810501|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
154810502|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
154810503|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
154810504|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810505|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810506|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810507|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154810508|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154810509|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810510|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154810511|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154810512|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
154810513|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810514|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810515|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154810516|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
154810517|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154810518|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154810519|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
154810520|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
154810521|NCT01872260|Letrozole|letrozole|mesh-list
154810522|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810523|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154810524|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154810525|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810526|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810527|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154810528|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
154810529|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810530|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810531|NCT01430351|Metformin|metformin|mesh-list
154810532|NCT01430351|Mefloquine|mefloquine|mesh-list
154810533|NCT01430351|Temozolomide|temozolomide|mesh-list
154810534|NCT01430351|Memantine|memantine|mesh-list
154810535|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154810536|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810537|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810538|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
154810539|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810540|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810541|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154810542|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154810543|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
154810544|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810545|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154810546|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154810547|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
154810548|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154810549|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154810550|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810551|NCT00930332|Methadone|methadone|mesh-list
154810552|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154810553|NCT00930332|Narcotics|narcotics|mesh-ancestor
154810554|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810555|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810556|NCT00930332|Analgesics|analgesics|mesh-ancestor
154810557|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
154810558|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810559|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
154810560|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
154810561|NCT00749515|Deferasirox|deferasirox|mesh-list
154810562|NCT00749515|Deferoxamine|deferoxamine|mesh-list
154810563|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154810564|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
154810565|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
154810566|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810567|NCT00749515|Siderophores|siderophores|mesh-ancestor
154810568|NCT00482755|Sunitinib|sunitinib|mesh-list
154810569|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990025|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
154810570|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154810571|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154810572|NCT00482755|Growth Substances|growth substances|mesh-ancestor
154810573|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810574|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
154810575|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810576|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810577|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810578|NCT00365157|Halichondrin B|halichondrin b|mesh-list
154810579|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
154810580|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
154810581|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
154810582|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810583|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810584|NCT00099437|Fulvestrant|fulvestrant|mesh-list
154810585|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154810586|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810587|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154810588|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154810589|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
154810590|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810591|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810592|NCT04394533|Bupivacaine|bupivacaine|mesh-list
154810593|NCT04394533|Prilocaine|prilocaine|mesh-list
154810594|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
154810595|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
154810596|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810597|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810598|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
154810599|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810600|NCT05602129|Heparin|heparin|mesh-list
154810601|NCT05602129|Calcium heparin|calcium heparin|mesh-list
154810602|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
154810603|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154810604|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154810605|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810607|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154810608|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154810609|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810610|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810611|NCT04129255|Octreotide|octreotide|mesh-list
154810612|NCT04129255|Somatostatin|somatostatin|mesh-list
154810613|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810614|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154810615|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810616|NCT04129255|Hormones|hormones|mesh-ancestor
154810617|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810618|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810619|NCT04129489|Cannabidiol|cannabidiol|mesh-list
154810620|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
154810621|NCT04128787|Omeprazole|omeprazole|mesh-list
154810622|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154810623|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810624|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154810625|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810626|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810627|NCT04394377|Heparin|heparin|mesh-list
154810628|NCT04394377|Enoxaparin|enoxaparin|mesh-list
154810629|NCT04394377|Calcium heparin|calcium heparin|mesh-list
154810630|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
154810631|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
154810632|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
154810633|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154810634|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154810635|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810636|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154810637|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
154810638|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154810639|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
154810640|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810641|NCT02984293|Atorvastatin|atorvastatin|mesh-list
154810642|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154810643|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154810644|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
154810645|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810646|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154810647|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154810648|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810649|NCT01929187|Amorolfine|amorolfine|mesh-list
154810650|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
154810651|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810652|NCT00634751|Capecitabine|capecitabine|mesh-list
154810653|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
154810654|NCT00634751|Sorafenib|sorafenib|mesh-list
154810655|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154810656|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
154810657|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810658|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810659|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810660|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810661|NCT04396067|Tretinoin|tretinoin|mesh-list
154810662|NCT04396067|Isotretinoin|isotretinoin|mesh-list
154810663|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810664|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
154810665|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
154810666|NCT05608213|Lenvatinib|lenvatinib|mesh-list
154810667|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810668|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810669|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810670|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810671|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154810672|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154810673|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810674|NCT03015259|Budesonide|budesonide|mesh-list
154810675|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
154810676|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154810677|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154810678|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154810679|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
154810680|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810681|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810683|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
154810684|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
154810685|NCT03015259|Hormones|hormones|mesh-ancestor
154810686|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810687|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154810688|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154810689|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154810690|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
154810691|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810692|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810693|NCT03236545|Estradiol|estradiol|mesh-list
154810694|NCT03236545|Estrogens|estrogens|mesh-list
154810695|NCT03236545|Hormones|hormones|mesh-ancestor
154810696|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810697|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810698|NCT04126993|Apatinib|apatinib|mesh-list
154810699|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810700|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154810701|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810702|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810703|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154810704|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154810705|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154810706|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154810707|NCT03828175|Anesthetics|anesthetics|mesh-list
154810708|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810709|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810710|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
154810711|NCT04392973|Favipiravir|favipiravir|mesh-list
154810712|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
154810713|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154810714|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154810715|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810716|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810717|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810718|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810719|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
154810720|NCT00634049|Isavuconazole|isavuconazole|mesh-list
154810721|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
154810722|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810723|NCT04123249|Propofol|propofol|mesh-list
154810724|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
154810725|NCT04123249|Anesthetics|anesthetics|mesh-list
154810726|NCT04123249|Sevoflurane|sevoflurane|mesh-list
154810727|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154810728|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810729|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810730|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
154810731|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154810732|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154810733|NCT03336203|Allopurinol|allopurinol|mesh-list
154810734|NCT03336203|Febuxostat|febuxostat|mesh-list
154810735|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
154810736|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810737|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810738|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
154810739|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810740|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154810741|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
154810742|NCT03336203|Protective Agents|protective agents|mesh-ancestor
154810743|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810744|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
154810745|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810746|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810747|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810748|NCT04274257|Rituximab|rituximab|mesh-list
154810749|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810750|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810751|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
154810752|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810753|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810754|NCT03831815|Rocuronium|rocuronium|mesh-list
154810755|NCT03831815|Cisatracurium|cisatracurium|mesh-list
154810756|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153990210|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
154810757|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154810758|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154810759|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810760|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810761|NCT00632099|Progesterone|progesterone|mesh-list
154810762|NCT00632099|Progestins|progestins|mesh-ancestor
154810763|NCT00632099|Hormones|hormones|mesh-ancestor
154810764|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810765|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810766|NCT03827629|Naloxone|naloxone|mesh-list
154810767|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154810768|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810769|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
154810770|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810771|NCT00631475|Bosentan|bosentan|mesh-list
154810772|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154810773|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154810774|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810775|NCT03826615|Gabapentin|gabapentin|mesh-list
154810776|NCT03826615|Analgesics|analgesics|mesh-ancestor
154810777|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
154810778|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810779|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810780|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
154810781|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154810782|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154810783|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810784|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154810785|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154810786|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154810787|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810788|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810789|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
154810790|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
154810791|NCT04124887|Listerine|listerine|mesh-list
154810792|NCT04124887|Calcium|calcium|mesh-list
154810793|NCT04124887|Fluorides|fluorides|mesh-list
154810794|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
154810795|NCT04124887|Caseins|caseins|mesh-list
154810796|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154810797|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810798|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154810799|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
154810800|NCT04124887|Protective Agents|protective agents|mesh-ancestor
154810801|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154810802|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810803|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
154810804|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
154810805|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810806|NCT04121767|Warfarin|warfarin|mesh-list
154810807|NCT04121767|Edoxaban|edoxaban|mesh-list
154810808|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
154810809|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154810810|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
154810811|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154810812|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
154810813|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810814|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810815|NCT04121689|Caseins|caseins|mesh-list
154810816|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
154810817|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
154810818|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810819|NCT03830827|Vortioxetine|vortioxetine|mesh-list
154810820|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
154810821|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154810822|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154810823|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154810824|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810825|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810826|NCT03830827|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154810827|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154810828|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154810829|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562790|NCT05445804|Cannabidiol|cannabidiol|mesh-list
154810830|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810832|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154810833|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154810834|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154810835|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154810836|NCT03098485|Azithromycin|azithromycin|mesh-list
154810837|NCT03098485|Levofloxacin|levofloxacin|mesh-list
154810838|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
154810839|NCT03098485|Cefpodoxime Proxetil|cefpodoxime proxetil|mesh-list
154810840|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154810841|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810842|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154810843|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810844|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810845|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810846|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810847|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810848|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154810849|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154810850|NCT03098485|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154810851|NCT04121533|Vitamin D|vitamin d|mesh-list
154810852|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
154810853|NCT04121533|Vitamins|vitamins|mesh-ancestor
154810854|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
154810855|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810856|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154810857|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154810858|NCT03822169|Choline|choline|mesh-list
154810859|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
154810860|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154810861|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
154810862|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810863|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810864|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154810865|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
154810866|NCT03825601|Flumazenil|flumazenil|mesh-list
154810867|NCT03825601|Antidotes|antidotes|mesh-ancestor
154810868|NCT03825601|Protective Agents|protective agents|mesh-ancestor
154810869|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810870|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
154810871|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
154810872|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810873|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810874|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154810875|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154810876|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810877|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154810878|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154810879|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810880|NCT03064867|Rituximab|rituximab|mesh-list
154810881|NCT03064867|Carboplatin|carboplatin|mesh-list
154810882|NCT03064867|Etoposide|etoposide|mesh-list
154810883|NCT03064867|Venetoclax|venetoclax|mesh-list
154810884|NCT03064867|Ifosfamide|ifosfamide|mesh-list
154810885|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810886|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810887|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
154810888|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810889|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810890|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154810891|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154810892|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154810893|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154810894|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810895|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810896|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
154810897|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
154810898|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154810899|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154810900|NCT03824665|Fentanyl|fentanyl|mesh-list
154810901|NCT03824665|Nalbuphine|nalbuphine|mesh-list
154810902|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154810903|NCT03824665|Narcotics|narcotics|mesh-ancestor
154810904|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154810905|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810906|NCT03824665|Analgesics|analgesics|mesh-ancestor
154810907|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
154810908|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810909|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154810910|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154810911|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
154810912|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
154810913|NCT04120831|Abatacept|abatacept|mesh-list
154810914|NCT04120831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154810915|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810916|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
154810917|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810918|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810919|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154810920|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810921|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810922|NCT00631163|Deferasirox|deferasirox|mesh-list
154810923|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154810924|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
154810925|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
154810926|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810927|NCT04120519|Thalidomide|thalidomide|mesh-list
154810928|NCT04120519|Dexamethasone|dexamethasone|mesh-list
154810929|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
154810930|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154810931|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
154810932|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810933|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154810934|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154810935|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
154810936|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810937|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810938|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154810939|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154810940|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
153990395|NCT00787111|Fluoxetine|fluoxetine|mesh-list
154810941|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
154810942|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810943|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154810944|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
154810945|NCT04120519|Hormones|hormones|mesh-ancestor
154810946|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810947|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154810948|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
154810949|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154810950|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154810951|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154810952|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154810953|NCT04120519|Growth Substances|growth substances|mesh-ancestor
154810954|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
154810955|NCT00631007|Pioglitazone|pioglitazone|mesh-list
154810956|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154810957|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810958|NCT00630539|Tamoxifen|tamoxifen|mesh-list
154810959|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154810960|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
154810961|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154810962|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810963|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154810964|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154810965|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154810966|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154810967|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154810968|NCT00634829|Albuterol|albuterol|mesh-list
154810969|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154810970|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
154810971|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810972|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810973|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154810974|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
154810975|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
154810976|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154810977|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154810978|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154810980|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
154810981|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810982|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810983|NCT00634517|Albuterol|albuterol|mesh-list
154810984|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154810985|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
154810986|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154810987|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154810988|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154810989|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
154810990|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
154810991|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154810992|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154810993|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154810994|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154810995|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
154810996|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154810997|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154810998|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
154810999|NCT01920113|Remifentanil|remifentanil|mesh-list
154811000|NCT01920113|Propofol|propofol|mesh-list
154811001|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154811002|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811003|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811004|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154811005|NCT01920113|Analgesics|analgesics|mesh-ancestor
154811006|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
154811007|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811008|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154811009|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154811010|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154811011|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
154811012|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811013|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811014|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154811015|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
154811016|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
154811017|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154811018|NCT01920113|Narcotics|narcotics|mesh-ancestor
154811019|NCT01920191|Poly ICLC|poly iclc|mesh-list
154811020|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
154811021|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
154811022|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811023|NCT01920269|Mitomycins|mitomycins|mesh-list
154811024|NCT01920269|Mitomycin|mitomycin|mesh-list
154811025|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154811026|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811027|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
154811028|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811029|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154811030|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811031|NCT01920503|Doxorubicin|doxorubicin|mesh-list
154811032|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154811033|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811034|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154811035|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154811036|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811037|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811038|NCT01293825|Ziprasidone|ziprasidone|mesh-list
154811039|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154811040|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
154811041|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811042|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811043|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811044|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154811045|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154811046|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811047|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154811048|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154811049|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
154811050|NCT03009513|Glimepiride|glimepiride|mesh-list
154811051|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154563018|NCT05047978|Caseins|caseins|mesh-list
154811052|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154811053|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811054|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154811055|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
154811056|NCT02983591|Misoprostol|misoprostol|mesh-list
154811057|NCT02983591|Oxytocin|oxytocin|mesh-list
154811058|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
154811059|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154811060|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811061|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154811062|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
154811063|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154811064|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154811065|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
154811066|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154811067|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811068|NCT01263717|Hormones|hormones|mesh-list
154811069|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154811070|NCT01263717|Tesamorelin|tesamorelin|mesh-list
154811071|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811072|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811073|NCT01263717|Growth Substances|growth substances|mesh-ancestor
154811074|NCT04120753|Amlodipine|amlodipine|mesh-list
154811075|NCT04120753|Olmesartan|olmesartan|mesh-list
154811076|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154811077|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154811078|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811079|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811080|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154811081|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811082|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
154811083|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154811084|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154811085|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
154811086|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
154811087|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154811088|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811089|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811090|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154811091|NCT01921361|Analgesics|analgesics|mesh-ancestor
154811092|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
154811093|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811094|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154811095|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154811096|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154811097|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
154811098|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811099|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811100|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
154811101|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
154811102|NCT01921673|Docetaxel|docetaxel|mesh-list
154811103|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811104|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154811105|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154811106|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154811107|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811108|NCT01921985|Terlipressin|terlipressin|mesh-list
154811109|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154811110|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154811111|NCT02943733|Temozolomide|temozolomide|mesh-list
154811112|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154811113|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
154811114|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811115|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811116|NCT01922141|Amlodipine|amlodipine|mesh-list
154811117|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154811118|NCT01922141|Ramipril|ramipril|mesh-list
154811119|NCT01922141|Aliskiren|aliskiren|mesh-list
154811120|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154811121|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154811122|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811123|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811124|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154811125|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811126|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
154811127|NCT01922141|Diuretics|diuretics|mesh-ancestor
154811128|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
154811129|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154811130|NCT01922141|Renin Inhibitors|renin inhibitors|mesh-ancestor
154811131|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
154811132|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811133|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154811134|NCT02856295|Enoxaparin|enoxaparin|mesh-list
154811135|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
154811136|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154811137|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154811138|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811139|NCT01266447|Topotecan|topotecan|mesh-list
154811140|NCT01266447|Veliparib|veliparib|mesh-list
154811141|NCT01266447|Lenograstim|lenograstim|mesh-list
154811142|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154811143|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
154811144|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811145|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154811146|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154811147|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811148|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811149|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811150|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154811151|NCT01922375|Naftopidil|naftopidil|mesh-list
154811152|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154811153|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154811154|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
154811155|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811156|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811157|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811158|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154811159|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154811160|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811161|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154811162|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154811163|NCT03823339|Liraglutide|liraglutide|mesh-list
154811164|NCT03823339|Xultophy|xultophy|mesh-list
154811165|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154811166|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811167|NCT03823339|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154811168|NCT03823339|Incretins|incretins|mesh-ancestor
154811169|NCT03823339|Hormones|hormones|mesh-ancestor
154811170|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811171|NCT01922687|Amlodipine|amlodipine|mesh-list
154811172|NCT01922687|Atorvastatin|atorvastatin|mesh-list
154811173|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154811174|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154811175|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
154811176|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811177|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154811178|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154811179|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811180|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154811181|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154811182|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811183|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154811184|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811185|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
154811186|NCT01268553|Treprostinil|treprostinil|mesh-list
154811187|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154811188|NCT01922999|Melatonin|melatonin|mesh-list
154811189|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
154811190|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811191|NCT01922999|Protective Agents|protective agents|mesh-ancestor
154811192|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811193|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811194|NCT01268943|Capecitabine|capecitabine|mesh-list
154811195|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154811196|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
154811197|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811198|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811199|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154811200|NCT01923077|Simvastatin|simvastatin|mesh-list
154811201|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154811202|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154811203|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
154811204|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811205|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154811206|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154811207|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811208|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
154811209|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154811210|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154811211|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154811212|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811213|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811214|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
154811215|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811216|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811217|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154811218|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811219|NCT01297335|Clonidine|clonidine|mesh-list
154811220|NCT01297335|Analgesics|analgesics|mesh-ancestor
154811221|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
154811222|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811223|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811224|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154811225|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
154811226|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
154811227|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154811228|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154811229|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154811230|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
154811231|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811232|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811233|NCT05498129|Micronutrients|micronutrients|mesh-list
154811234|NCT05498129|Trace Elements|trace elements|mesh-list
154811235|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811236|NCT01270659|Acetaminophen|acetaminophen|mesh-list
154811237|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154811238|NCT01270659|Fentanyl|fentanyl|mesh-list
154811239|NCT01270659|Oxycodone|oxycodone|mesh-list
154811240|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154811241|NCT01270659|Narcotics|narcotics|mesh-ancestor
154811242|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811243|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811244|NCT01270659|Analgesics|analgesics|mesh-ancestor
154811245|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
154811246|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811247|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154811248|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154811249|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
154811250|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
154811251|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154811252|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
154811253|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154811254|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990716|NCT00662311|Paclitaxel|paclitaxel|mesh-list
154811255|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154811256|NCT01271907|Aldesleukin|aldesleukin|mesh-list
154811257|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
154811258|NCT01271907|Fludarabine|fludarabine|mesh-list
154811259|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154811260|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
154811261|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811262|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154811263|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154811264|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
154811265|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811266|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811267|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154811268|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154811269|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154811270|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
154811271|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811272|NCT01929941|Paclitaxel|paclitaxel|mesh-list
154811273|NCT01929941|Gemcitabine|gemcitabine|mesh-list
154811274|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154811275|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811276|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
154811277|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
154811278|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
154811279|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811280|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154811281|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
154811282|NCT01922843|Calcitriol|calcitriol|mesh-list
154811283|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154811284|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811285|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154811286|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811287|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811288|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154811289|NCT01922843|Vitamins|vitamins|mesh-ancestor
154811290|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
154811291|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154811292|NCT01302483|Lidocaine|lidocaine|mesh-list
154811293|NCT01302483|Phenylephrine|phenylephrine|mesh-list
154811294|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
154811295|NCT01302483|Tetracaine|tetracaine|mesh-list
154811296|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
154811297|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
154811298|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811299|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811300|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
154811301|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811302|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154811303|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154811304|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154811305|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811306|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811307|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154811308|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154811309|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
154811310|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811311|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
154811312|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
154811313|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
154811314|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154811315|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
154811316|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154811317|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
154811318|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154811319|NCT01302483|Protective Agents|protective agents|mesh-ancestor
154811320|NCT04769583|Metronidazole|metronidazole|mesh-list
154811321|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811322|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990776|NCT00795223|Morphine|morphine|mesh-list
154811323|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154811324|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154811325|NCT01279317|Acetic Acid|acetic acid|mesh-list
154811326|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154811327|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811328|NCT01304589|Milnacipran|milnacipran|mesh-list
154811329|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
154811330|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154811331|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154811332|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811333|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811334|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811335|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811336|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154811337|NCT01304589|Analgesics|analgesics|mesh-ancestor
154811338|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
154811339|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811340|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
154811341|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154811342|NCT01280409|Metformin|metformin|mesh-list
154811343|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154811344|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811345|NCT01926197|Leucovorin|leucovorin|mesh-list
154811346|NCT01926197|Fluorouracil|fluorouracil|mesh-list
154811347|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
154811348|NCT01926197|Irinotecan|irinotecan|mesh-list
154811349|NCT01926197|Camptothecin|camptothecin|mesh-list
154811350|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
154811351|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811352|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154811353|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811354|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154811355|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
154811356|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811357|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154811358|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154811359|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811360|NCT01926197|Antidotes|antidotes|mesh-ancestor
154811361|NCT01926197|Protective Agents|protective agents|mesh-ancestor
154811362|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
154811363|NCT01926197|Vitamins|vitamins|mesh-ancestor
154811364|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
154811365|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154811366|NCT01923545|Lenograstim|lenograstim|mesh-list
154811367|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154811368|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
154811369|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811370|NCT01925027|Sirolimus|sirolimus|mesh-list
154811371|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154811372|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811373|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154811374|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811375|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
154811376|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154811377|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
154811378|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811379|NCT01305213|Bevacizumab|bevacizumab|mesh-list
154811380|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154811381|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
154811382|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
154811383|NCT01305213|Antibodies|antibodies|mesh-list
154811384|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
154811385|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154811386|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
154811387|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811388|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154811389|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154811390|NCT01305213|Growth Substances|growth substances|mesh-ancestor
154811391|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811392|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
154811393|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
154811394|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154811395|NCT00989963|Beraprost|beraprost|mesh-list
154811396|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154811397|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
154811398|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154811399|NCT01339299|Hormones|hormones|mesh-list
154811400|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811401|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811402|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154811403|NCT01307007|Dextrans|dextrans|mesh-list
154811404|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
154811405|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
154811406|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
154811407|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
154811408|NCT01307007|Hematinics|hematinics|mesh-ancestor
154811409|NCT02197455|Tofacitinib|tofacitinib|mesh-list
154811410|NCT02197455|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154811411|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154811412|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811413|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811414|NCT03101501|Mitomycins|mitomycins|mesh-list
154811415|NCT03101501|Mitomycin|mitomycin|mesh-list
154811416|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154811417|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811418|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
154811419|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811420|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154811421|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811422|NCT01923623|Ropivacaine|ropivacaine|mesh-list
154811423|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
154811424|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
154811425|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811426|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811427|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
154811428|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811429|NCT01923857|Enclomiphene|enclomiphene|mesh-list
154811430|NCT01923857|Clomiphene|clomiphene|mesh-list
154811431|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
154811432|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154811433|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154811434|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811435|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811436|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154811437|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
154811438|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154811439|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154811440|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154811442|NCT03100253|Infliximab|infliximab|mesh-list
154811443|NCT03100253|Golimumab|golimumab|mesh-list
154811444|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
154811445|NCT03100253|Etanercept|etanercept|mesh-list
154811446|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154811447|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811448|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154811449|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
154811450|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154811451|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154811452|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154811453|NCT03100253|Analgesics|analgesics|mesh-ancestor
154811454|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
154811455|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811456|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811457|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154811458|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
154811459|NCT01924091|Dapivirine|dapivirine|mesh-list
154811460|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154811461|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154811462|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
154811463|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811464|NCT03485729|TIC10 compound|tic10 compound|mesh-list
154811465|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811466|NCT01924325|Aspirin|aspirin|mesh-list
154811467|NCT01924325|Apixaban|apixaban|mesh-list
154811468|NCT01924325|Clopidogrel|clopidogrel|mesh-list
154811469|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154811470|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154811471|NCT01924325|Analgesics|analgesics|mesh-ancestor
154811472|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
154811473|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811474|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811475|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811476|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154811477|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154811478|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154811479|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811480|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154811481|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154811482|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811483|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
154811484|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154811485|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154811486|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154811487|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
154811488|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811489|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154811490|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
154811491|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154811492|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
154811493|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
154811494|NCT01924481|Theobromine|theobromine|mesh-list
154811495|NCT01924481|Caffeine|caffeine|mesh-list
154811496|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154811497|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811498|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154811499|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811500|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811501|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154811502|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154811503|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
154811504|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811505|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154811506|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
154811507|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811508|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154811509|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
154811510|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
154811511|NCT01924637|Insulin|insulin|mesh-list
154811512|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154811513|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
154811514|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
154811515|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154811516|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154811517|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811518|NCT01925729|Phenylephrine|phenylephrine|mesh-list
154811519|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
154811520|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
154811521|NCT01925729|Ephedrine|ephedrine|mesh-list
154811522|NCT01925729|Histamine|histamine|mesh-list
154811523|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154811524|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
154811525|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811526|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811527|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154811528|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
154811529|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
154811530|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154811531|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154811532|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
154811533|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
154811534|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811535|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811536|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
154811537|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
154811538|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154811539|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154811540|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154811541|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
154811542|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154811543|NCT01925729|Protective Agents|protective agents|mesh-ancestor
154811544|NCT01926587|Azacitidine|azacitidine|mesh-list
154811545|NCT01926587|ON 01910|on 01910|mesh-list
154811546|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154811547|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
154811548|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811549|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811550|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811551|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154811552|NCT01922765|Amoxicillin|amoxicillin|mesh-list
154811553|NCT01922765|Metronidazole|metronidazole|mesh-list
154811554|NCT01922765|Clarithromycin|clarithromycin|mesh-list
154811555|NCT01922765|Rabeprazole|rabeprazole|mesh-list
154811556|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154811557|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811558|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154811559|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154811560|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154811561|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811562|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811563|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154811564|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154811565|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154811566|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154811567|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154811568|NCT01926665|Dexamethasone|dexamethasone|mesh-list
154811569|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811570|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
154811571|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
154811572|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811573|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811574|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154811575|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
154811576|NCT01926665|Hormones|hormones|mesh-ancestor
154811577|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811578|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154811579|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811580|NCT01926821|Sizofiran|sizofiran|mesh-list
154811581|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154811582|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
154563550|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
154811583|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811584|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154811585|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811586|NCT01926899|Bortezomib|bortezomib|mesh-list
154811587|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811588|NCT03430661|Clopidogrel|clopidogrel|mesh-list
154811589|NCT03430661|Ticagrelor|ticagrelor|mesh-list
154811590|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154811591|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154811592|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154811593|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154811594|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154811595|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
154811596|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811597|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811598|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811599|NCT01927835|Vaccines|vaccines|mesh-list
154811600|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
154811601|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811602|NCT01927913|Deferasirox|deferasirox|mesh-list
154811603|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154811604|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
154811605|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
154811606|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811607|NCT01928069|Montelukast|montelukast|mesh-list
154811608|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154811609|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
154811610|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154811611|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
154811612|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811613|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811614|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154811615|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154811616|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811617|NCT01928459|Infigratinib|infigratinib|mesh-list
154811618|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811619|NCT01928537|ON 01910|on 01910|mesh-list
154811620|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811621|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154811622|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811623|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811624|NCT01307397|Vemurafenib|vemurafenib|mesh-list
154811625|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811626|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154811627|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811628|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811629|NCT01929161|Oxytocin|oxytocin|mesh-list
154811630|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
154811631|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154811632|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811633|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
154811634|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811635|NCT04552535|Afatinib|afatinib|mesh-list
154811636|NCT04552535|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154811637|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154811638|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811639|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811640|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811641|NCT02197767|Rituximab|rituximab|mesh-list
154811642|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154811643|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811644|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
154811645|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811646|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154811647|NCT01342029|Ranolazine|ranolazine|mesh-list
154811648|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154811649|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811650|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811651|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154811652|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
154811653|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
154811654|NCT05601479|Vitamins|vitamins|mesh-ancestor
154811655|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
154811656|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811657|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
154811658|NCT04275245|Meplazumab|meplazumab|mesh-list
154811659|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
154811660|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811661|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
154811662|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
154811663|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811664|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154811665|NCT04394897|Remifentanil|remifentanil|mesh-list
154811666|NCT04394897|Propofol|propofol|mesh-list
154811667|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154811668|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811669|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811670|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154811671|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
154811672|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
154811673|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154811674|NCT04394897|Narcotics|narcotics|mesh-ancestor
154811675|NCT04394897|Analgesics|analgesics|mesh-ancestor
154811676|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
154811677|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811678|NCT05607641|Ketorolac|ketorolac|mesh-list
154811679|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154811680|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154811681|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154811682|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154811683|NCT05607641|Analgesics|analgesics|mesh-ancestor
154811684|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
154811685|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811686|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811687|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811688|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154811689|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154811690|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811691|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811692|NCT05603039|Bevacizumab|bevacizumab|mesh-list
154811693|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154811694|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811695|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154811696|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154811697|NCT05603039|Growth Substances|growth substances|mesh-ancestor
154811698|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811699|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154811700|NCT05609903|Paclitaxel|paclitaxel|mesh-list
154811701|NCT05609903|Atezolizumab|atezolizumab|mesh-list
154811702|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154811703|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811704|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
154811705|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
154811706|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
154811707|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811708|NCT05609903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154811709|NCT05609903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154811710|NCT04161599|Metronidazole|metronidazole|mesh-list
154811711|NCT04161599|Cefuroxime|cefuroxime|mesh-list
154811712|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
154811713|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
154811714|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
154811715|NCT04161599|Citric Acid|citric acid|mesh-list
154811716|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
154811717|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811718|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154811719|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154811720|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154811721|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
154811722|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154811723|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
154811724|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
154811725|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811726|NCT04161599|Cathartics|cathartics|mesh-ancestor
154811727|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154811728|NCT04161599|Antacids|antacids|mesh-ancestor
154811729|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154811730|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154811731|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563692|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154811732|NCT05601167|Ritonavir|ritonavir|mesh-list
154811733|NCT05601167|Nirmatrelvir|nirmatrelvir|mesh-list
154811734|NCT05601167|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154811735|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154811736|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154811737|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
154811738|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811739|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811740|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154811741|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154811742|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
154811743|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811744|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154811745|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154811746|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154811747|NCT05605613|Antibodies|antibodies|mesh-list
154811748|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
154811749|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811750|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811751|NCT05605613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154811752|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811753|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
154811754|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154811755|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811756|NCT04393883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154811757|NCT04393883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811758|NCT05603975|Esketamine|esketamine|mesh-list
154811759|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
154811760|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154811761|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
154811762|NCT04120363|Testosterone|testosterone|mesh-list
154811763|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
154811764|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
154811765|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154811766|NCT04120363|Androgens|androgens|mesh-ancestor
154811767|NCT04120363|Hormones|hormones|mesh-ancestor
154811768|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811769|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811770|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154811771|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811772|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
154811773|NCT04125745|CXA-10|cxa-10|mesh-list
154811774|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811775|NCT04393805|Heparin|heparin|mesh-list
154811776|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154811777|NCT04393805|Tinzaparin|tinzaparin|mesh-list
154811778|NCT04393805|Dalteparin|dalteparin|mesh-list
154811779|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
154811780|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154811781|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154811782|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811783|NCT04122755|Buprenorphine|buprenorphine|mesh-list
154811784|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154811785|NCT04122755|Narcotics|narcotics|mesh-ancestor
154811786|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811787|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811788|NCT04122755|Analgesics|analgesics|mesh-ancestor
154811789|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
154811790|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811791|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154811792|NCT04129697|Dexamethasone|dexamethasone|mesh-list
154811793|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
154811794|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153991245|NCT00793663|Ondansetron|ondansetron|mesh-list
154811795|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154811796|NCT04129697|Prednisolone|prednisolone|mesh-list
154811797|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
154811798|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154811799|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
154811800|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811801|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
154811802|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
154811803|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811804|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811805|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154811806|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
154811807|NCT04129697|Hormones|hormones|mesh-ancestor
154811808|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811809|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154811810|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811811|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154811812|NCT04129697|Protective Agents|protective agents|mesh-ancestor
154811813|NCT05793892|Lidocaine|lidocaine|mesh-list
154811814|NCT05793892|Tetracaine|tetracaine|mesh-list
154811815|NCT05793892|Anesthetics, Local|anesthetics, local|mesh-ancestor
154811816|NCT05793892|Anesthetics|anesthetics|mesh-ancestor
154811817|NCT05793892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811818|NCT05793892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811819|NCT05793892|Sensory System Agents|sensory system agents|mesh-ancestor
154811820|NCT05793892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811821|NCT05793892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154811822|NCT05793892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154811823|NCT05793892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154811824|NCT05793892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811825|NCT05793892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811826|NCT05793359|Methylprednisolone|methylprednisolone|mesh-list
154811827|NCT05793359|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154811828|NCT05793359|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154811829|NCT05793359|Prednisolone|prednisolone|mesh-list
154811830|NCT05793359|Prednisolone acetate|prednisolone acetate|mesh-list
154811831|NCT05793359|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154811832|NCT05793359|Prednisolone phosphate|prednisolone phosphate|mesh-list
154811833|NCT05793359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811834|NCT05793359|Antiemetics|antiemetics|mesh-ancestor
154811835|NCT05793359|Autonomic Agents|autonomic agents|mesh-ancestor
154811836|NCT05793359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811837|NCT05793359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811838|NCT05793359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154811839|NCT05793359|Glucocorticoids|glucocorticoids|mesh-ancestor
154811840|NCT05793359|Hormones|hormones|mesh-ancestor
154811841|NCT05793359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811842|NCT05793359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154811843|NCT05793359|Protective Agents|protective agents|mesh-ancestor
154811844|NCT05793359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154811845|NCT05793359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811846|NCT05793268|Tenofovir|tenofovir|mesh-list
154811847|NCT05793268|Entecavir|entecavir|mesh-list
154811848|NCT05793268|Antiviral Agents|antiviral agents|mesh-ancestor
154811849|NCT05793268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811850|NCT05793268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154811851|NCT05793268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154811852|NCT05793268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811853|NCT05793268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811854|NCT05793268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154811855|NCT05793268|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154811856|NCT05792995|Pembrolizumab|pembrolizumab|mesh-list
154811857|NCT05792995|Nivolumab|nivolumab|mesh-list
154811858|NCT05792995|Durvalumab|durvalumab|mesh-list
154811859|NCT05792995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154811860|NCT05792995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811861|NCT05792995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154811862|NCT05792995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811863|NCT05792878|Interferons|interferons|mesh-list
154811864|NCT05792878|Interferon-alpha|interferon-alpha|mesh-list
154811865|NCT05792878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811866|NCT05792878|Antiviral Agents|antiviral agents|mesh-ancestor
154811867|NCT05792878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811868|NCT05792878|Immunologic Factors|immunologic factors|mesh-ancestor
154811869|NCT05792878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811870|NCT05792865|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154811871|NCT05792865|Antiviral Agents|antiviral agents|mesh-ancestor
154811872|NCT05792865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811873|NCT05792761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154811874|NCT05792761|Antiviral Agents|antiviral agents|mesh-ancestor
154811875|NCT05792761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811876|NCT05792748|Hemostatics|hemostatics|mesh-list
154811877|NCT05792748|Coagulants|coagulants|mesh-ancestor
154811878|NCT05792644|Crizotinib|crizotinib|mesh-list
154811879|NCT05792644|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154811880|NCT05792644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154811881|NCT05792644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811882|NCT05792644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811883|NCT05792644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811884|NCT05792410|Bevacizumab|bevacizumab|mesh-list
154811886|NCT05792410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154811887|NCT05792410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811888|NCT05792410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154811889|NCT05792410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154811890|NCT05792410|Growth Substances|growth substances|mesh-ancestor
154811891|NCT05792410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811892|NCT05792410|Growth Inhibitors|growth inhibitors|mesh-ancestor
154811893|NCT05792410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154811894|NCT05792410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154811895|NCT05792410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154811896|NCT05792410|Hormone Antagonists|hormone antagonists|mesh-ancestor
154811897|NCT05792410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811898|NCT05792111|Triamcinolone|triamcinolone|mesh-list
154811899|NCT05792111|Lidocaine|lidocaine|mesh-list
154811900|NCT05792111|Bupivacaine|bupivacaine|mesh-list
154811901|NCT05792111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154811902|NCT05792111|Anesthetics|anesthetics|mesh-ancestor
154811903|NCT05792111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811904|NCT05792111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811905|NCT05792111|Sensory System Agents|sensory system agents|mesh-ancestor
154811906|NCT05792111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811907|NCT05792111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154811908|NCT05792111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154811909|NCT05792111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154811910|NCT05792111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154811911|NCT05792111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811912|NCT05792111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811913|NCT05792111|Glucocorticoids|glucocorticoids|mesh-ancestor
154811914|NCT05792111|Hormones|hormones|mesh-ancestor
154811915|NCT05792111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154811916|NCT05789732|Tadalafil|tadalafil|mesh-list
154811917|NCT05789732|Silodosin|silodosin|mesh-list
154811918|NCT05789732|Vasodilator Agents|vasodilator agents|mesh-ancestor
154811919|NCT05789732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154811920|NCT05789732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154811921|NCT05789732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991365|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154811922|NCT05789732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811923|NCT05789732|Urological Agents|urological agents|mesh-ancestor
154811924|NCT05789732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154811925|NCT05789732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154811926|NCT05789732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154811927|NCT05789732|Adrenergic Agents|adrenergic agents|mesh-ancestor
154811928|NCT05789732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154811929|NCT05789732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811930|NCT05761080|Amoxicillin|amoxicillin|mesh-list
154811931|NCT05761080|Clavulanic Acids|clavulanic acids|mesh-list
154811932|NCT05761080|Clavulanic Acid|clavulanic acid|mesh-list
154811933|NCT05761080|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154811934|NCT05761080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154811935|NCT05761080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811936|NCT05761080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811937|NCT05761080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811938|NCT05761080|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154811939|NCT05743764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154811940|NCT05743764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154811941|NCT05737186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154811942|NCT05737186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811943|NCT05737186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154811944|NCT05737186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811945|NCT05700669|Olaparib|olaparib|mesh-list
154811946|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154811947|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811948|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811949|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811950|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154811951|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154811952|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154811953|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
154811954|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811955|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154811956|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154811957|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811959|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
154811960|NCT05456932|Ferric maltol|ferric maltol|mesh-list
154811961|NCT05456932|Trace Elements|trace elements|mesh-ancestor
154811962|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
154811963|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811964|NCT05456932|Hematinics|hematinics|mesh-ancestor
154811965|NCT05447780|Anesthetics|anesthetics|mesh-list
154811966|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811967|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811968|NCT05437289|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154811969|NCT05437289|Antiviral Agents|antiviral agents|mesh-ancestor
154811970|NCT05437289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811971|NCT05389930|Ethanol|ethanol|mesh-list
154811972|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154811973|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154811974|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154811975|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811976|NCT05382546|Ketorolac|ketorolac|mesh-list
154811977|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154811978|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154811979|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154811980|NCT05382546|Analgesics|analgesics|mesh-ancestor
154811981|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
154811982|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154811983|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154811984|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154811985|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154811986|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154811987|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811988|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811989|NCT05278351|Irinotecan|irinotecan|mesh-list
154811990|NCT05278351|Cetuximab|cetuximab|mesh-list
154811991|NCT05278351|Tislelizumab|tislelizumab|mesh-list
154811992|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154811993|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154811994|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154811995|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154811996|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154811997|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154811998|NCT05263700|FAPI-46|fapi-46|mesh-list
154811999|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154812000|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812001|NCT05257447|Baclofen|baclofen|mesh-list
154812002|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
154812003|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154812004|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812005|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154812006|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812007|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154812008|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
154812009|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
154812010|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154812011|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812012|NCT05211154|Diclofenac|diclofenac|mesh-list
154812013|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154812014|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154812015|NCT05211154|Analgesics|analgesics|mesh-ancestor
154812016|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
154812017|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812018|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812019|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812020|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812021|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154812022|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812023|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812024|NCT05128344|Vigabatrin|vigabatrin|mesh-list
154812025|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
154812026|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812027|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812028|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
154812029|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563998|NCT02185651|Miglustat|miglustat|mesh-list
154812030|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812031|NCT05071833|Peppermint oil|peppermint oil|mesh-list
154812032|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
154812033|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
154812034|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812035|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812036|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154812037|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
154812038|NCT04729101|Lansoprazole|lansoprazole|mesh-list
154812039|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
154812040|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154812041|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154812042|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154812043|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812044|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812045|NCT04670081|Niacinamide|niacinamide|mesh-list
154812046|NCT04670081|Niacin|niacin|mesh-list
154812047|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
154812048|NCT04670081|Psilocybin|psilocybin|mesh-list
154812049|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
154812050|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812051|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154812052|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
154812053|NCT04670081|Vitamins|vitamins|mesh-ancestor
154812054|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
154812055|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154812056|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
154812057|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812058|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154812059|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
154812060|NCT04648280|Fostemsavir|fostemsavir|mesh-list
154812061|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154812062|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154812063|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
154812064|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812065|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154812066|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154812067|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812068|NCT04601961|Propofol|propofol|mesh-list
154812069|NCT04601961|Sevoflurane|sevoflurane|mesh-list
154812070|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154812071|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812072|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812073|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154812074|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
154812075|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
154812076|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154812077|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154812078|NCT04513314|Valproic Acid|valproic acid|mesh-list
154812079|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154812080|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
154812081|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154812082|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154812083|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154812084|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812085|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812086|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
154812087|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812088|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812089|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
154812090|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154812091|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
154812092|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
154812093|NCT04469868|Narcotics|narcotics|mesh-ancestor
154812094|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812095|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812096|NCT04469868|Analgesics|analgesics|mesh-ancestor
154812097|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
154812098|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812099|NCT04451187|Zopiclone|zopiclone|mesh-list
154812100|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154812101|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812102|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812103|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
154812104|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154812105|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812106|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154812107|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812108|NCT04282629|Milrinone|milrinone|mesh-list
154812109|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154812110|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154812111|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
154812112|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154812113|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154812114|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812115|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812116|NCT04282629|Protective Agents|protective agents|mesh-ancestor
154812117|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812118|NCT04275492|Pramipexole|pramipexole|mesh-list
154812119|NCT04275492|Dexpramipexole|dexpramipexole|mesh-list
154812120|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
154812121|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812122|NCT04275492|Protective Agents|protective agents|mesh-ancestor
154812123|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812124|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154812125|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154812126|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
154812127|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
154812128|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154812129|NCT04265105|Fluticasone|fluticasone|mesh-list
154812130|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812131|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154812132|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
154812133|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812134|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812135|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154812136|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
154812137|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
154812138|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154812139|NCT04246229|Bilirubin|bilirubin|mesh-list
154812140|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
154812141|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812142|NCT04246229|Protective Agents|protective agents|mesh-ancestor
154812143|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812144|NCT04031833|Amphotericin B|amphotericin b|mesh-list
154812145|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154812146|NCT04031833|Amebicides|amebicides|mesh-ancestor
154812147|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154812148|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154812149|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812150|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154812151|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
154812152|NCT03908307|Dexamethasone|dexamethasone|mesh-list
154812153|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
154812154|NCT03908307|BB 1101|bb 1101|mesh-list
154812155|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812156|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
154812157|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
154812158|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812159|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812160|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154812161|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
154812162|NCT03908307|Hormones|hormones|mesh-ancestor
154812163|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812164|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812165|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812166|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
154812167|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812168|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812169|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154812170|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
154812171|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812172|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
154812173|NCT03684590|Narcotics|narcotics|mesh-ancestor
154812174|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812175|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812176|NCT03684590|Analgesics|analgesics|mesh-ancestor
154812177|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
154812178|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812179|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154564145|NCT02256943|Amitriptyline|amitriptyline|mesh-list
154812180|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
154812181|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154812182|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
154812183|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812185|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812186|NCT03385304|Iodine|iodine|mesh-list
154812187|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
154812188|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154812189|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
154812190|NCT03385304|Povidone|povidone|mesh-list
154812191|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154812192|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812193|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
154812194|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
154812195|NCT03385304|Trace Elements|trace elements|mesh-ancestor
154812196|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
154812197|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812198|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
154812199|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
154812200|NCT03285568|Palbociclib|palbociclib|mesh-list
154812201|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812202|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154812203|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812204|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812205|NCT03117816|Interferons|interferons|mesh-list
154812206|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
154812207|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
154812208|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812209|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
154812210|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812211|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
154812212|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812213|NCT03038802|Vaccines|vaccines|mesh-list
154812214|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
154812215|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812216|NCT02938793|Durvalumab|durvalumab|mesh-list
154812217|NCT02938793|Tremelimumab|tremelimumab|mesh-list
154812218|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812219|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812220|NCT02837094|Insulin|insulin|mesh-list
154812221|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154812222|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812223|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
154812224|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154812225|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154812226|NCT02836925|Ledipasvir|ledipasvir|mesh-list
154812227|NCT02836925|Velpatasvir|velpatasvir|mesh-list
154812228|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
154812229|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812230|NCT02728037|Lidocaine|lidocaine|mesh-list
154812231|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
154812232|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
154812233|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
154812234|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812235|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812236|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
154812237|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812238|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154812239|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154812240|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154812241|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154812242|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812243|NCT02728037|Analgesics|analgesics|mesh-ancestor
154812244|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
154812245|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154812246|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154812247|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
154812248|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154812249|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154812250|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
154812251|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812252|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
154812253|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812254|NCT00545077|Bevacizumab|bevacizumab|mesh-list
154812255|NCT00545077|Letrozole|letrozole|mesh-list
154812256|NCT00545077|Fulvestrant|fulvestrant|mesh-list
154812257|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812258|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812259|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154812260|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154812262|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812263|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
154812264|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154812265|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154812266|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812267|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812268|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154812269|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
154812270|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812271|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812272|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154812273|NCT00251433|Docetaxel|docetaxel|mesh-list
154812274|NCT00251433|Trastuzumab|trastuzumab|mesh-list
154812275|NCT00251433|Lapatinib|lapatinib|mesh-list
154812276|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812277|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
154812278|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
154812279|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
154812280|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812281|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812282|NCT00251433|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154812283|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154812284|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812285|NCT00130533|Capecitabine|capecitabine|mesh-list
154812286|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154812287|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
154812288|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812289|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812290|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
154812291|NCT00129935|Docetaxel|docetaxel|mesh-list
154812292|NCT00129935|Capecitabine|capecitabine|mesh-list
154812293|NCT00129935|Epirubicin|epirubicin|mesh-list
154812294|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812295|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
154812296|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812297|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812298|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154812299|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
154812300|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812301|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812302|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154812303|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
154812304|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
154812305|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
153991744|NCT00794443|Diphosphonates|diphosphonates|mesh-list
154812306|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154812307|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
154812308|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154812309|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154812310|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154812311|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812312|NCT02760667|Cisplatin|cisplatin|mesh-list
154812313|NCT02760667|Carboplatin|carboplatin|mesh-list
154812314|NCT02760667|Docetaxel|docetaxel|mesh-list
154812315|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812316|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
154812317|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
154812318|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154812319|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812320|NCT04127357|Fluorides|fluorides|mesh-list
154812321|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
154812322|NCT04127357|Protective Agents|protective agents|mesh-ancestor
154812323|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812324|NCT01450111|Lacosamide|lacosamide|mesh-list
154812325|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
154812326|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154812327|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154812328|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154812329|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812330|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154812331|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154812332|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812333|NCT02697253|Incretins|incretins|mesh-ancestor
154812334|NCT02697253|Hormones|hormones|mesh-ancestor
154812335|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812336|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154812337|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
154812338|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812339|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812340|NCT02660905|Tenofovir|tenofovir|mesh-list
154812341|NCT02660905|Emtricitabine|emtricitabine|mesh-list
154812342|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
154812343|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154812344|NCT02660905|Rilpivirine|rilpivirine|mesh-list
154812345|NCT02660905|Ledipasvir|ledipasvir|mesh-list
154812346|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
154812347|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812348|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154812349|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154812350|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812351|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812352|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154812353|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154812354|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154812355|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154812356|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812357|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812358|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154812359|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
154812360|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812361|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812362|NCT01450345|Pregabalin|pregabalin|mesh-list
154812363|NCT01450345|Analgesics|analgesics|mesh-ancestor
154812364|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
154812365|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812366|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812367|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
154812368|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154812369|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154812370|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812371|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154812372|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154812373|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154812374|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812375|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154812376|NCT03822559|Timolol|timolol|mesh-list
154812377|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154812378|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154812379|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154812380|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154812381|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
154812382|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154812383|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812384|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812385|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154812386|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154812387|NCT01647828|Paclitaxel|paclitaxel|mesh-list
154812388|NCT01647828|Gemcitabine|gemcitabine|mesh-list
154812389|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154812390|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812391|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
154812392|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
154812393|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
154812394|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812395|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154812396|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
154812397|NCT03825367|Nivolumab|nivolumab|mesh-list
154812398|NCT03825367|Azacitidine|azacitidine|mesh-list
154812399|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812400|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812401|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154812402|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812403|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154812404|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
154812405|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812406|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
154564367|NCT02191657|Deferiprone|deferiprone|mesh-list
154812407|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154812408|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154812409|NCT04273321|Prednisolone|prednisolone|mesh-list
154812410|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
154812411|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154812412|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
154812413|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812414|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
154812415|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
154812416|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812417|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812418|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154812419|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
154812421|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812422|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154812423|NCT04273321|Protective Agents|protective agents|mesh-ancestor
154812424|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812425|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812426|NCT01243476|Lenalidomide|lenalidomide|mesh-list
154812427|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
154812428|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812429|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154812430|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154812431|NCT01243476|Growth Substances|growth substances|mesh-ancestor
154812432|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
154812433|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812434|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
154812435|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154812436|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154812437|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
154812438|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812439|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154812440|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154812441|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812442|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812443|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
154812444|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812445|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812446|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
154812447|NCT01454011|Testosterone|testosterone|mesh-list
154812448|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
154812449|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
154812450|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154812451|NCT01454011|Androgens|androgens|mesh-ancestor
154812452|NCT01454011|Hormones|hormones|mesh-ancestor
154812453|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812454|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812455|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812456|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812457|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
154812458|NCT03060018|Oxitropium|oxitropium|mesh-list
154812459|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
154812460|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
154812461|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812462|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812463|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
154812464|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154812465|NCT04975932|Estrogens|estrogens|mesh-ancestor
154812466|NCT04975932|Hormones|hormones|mesh-ancestor
154812467|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812468|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812469|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812470|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812471|NCT01454479|Lapatinib|lapatinib|mesh-list
154812472|NCT01454479|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154812473|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154812474|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812475|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812476|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812477|NCT03061032|Ribavirin|ribavirin|mesh-list
154812478|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
154564442|NCT02188225|Fluoxetine|fluoxetine|mesh-list
154812479|NCT03061032|Ledipasvir|ledipasvir|mesh-list
154812480|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
154812481|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812482|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
154812483|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812484|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
154812485|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154812486|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154812487|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812488|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
154812489|NCT02911831|Coagulants|coagulants|mesh-ancestor
154812490|NCT03061734|Acetaminophen|acetaminophen|mesh-list
154812491|NCT03061734|Naltrexone|naltrexone|mesh-list
154812492|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154812493|NCT03061734|Analgesics|analgesics|mesh-ancestor
154812494|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
154812495|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812496|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812497|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
154812498|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154812499|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154812500|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
154812501|NCT03061656|Melphalan|melphalan|mesh-list
154812502|NCT03061656|Thiotepa|thiotepa|mesh-list
154812503|NCT03061656|Carboplatin|carboplatin|mesh-list
154812504|NCT03061656|Etoposide|etoposide|mesh-list
154812505|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812506|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
154812507|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812508|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812509|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154812510|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
154812511|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812512|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812513|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154812514|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154812515|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154812516|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154812517|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812518|NCT02906761|Aspirin|aspirin|mesh-list
154812519|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154812520|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154812521|NCT02906761|Analgesics|analgesics|mesh-ancestor
154812522|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
154812523|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812524|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812525|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812526|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812527|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154812528|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154812529|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812530|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154812531|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154812532|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812533|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
154812534|NCT01455025|Plerixafor|plerixafor|mesh-list
154812535|NCT01455025|Lenograstim|lenograstim|mesh-list
154812536|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154812537|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
154812538|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812539|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154812540|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154812541|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
154812542|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812543|NCT03060798|Desflurane|desflurane|mesh-list
154812544|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154812545|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
154812546|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
154812547|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812548|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812549|NCT01451593|Phenytoin|phenytoin|mesh-list
154812550|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
154812551|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154812552|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154812553|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154812554|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812555|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154812556|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154812557|NCT01455103|BMS-936559|bms-936559|mesh-list
154812558|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154812559|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812560|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812561|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
154812562|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812563|NCT04975074|Iron|iron|mesh-list
154812564|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
154812565|NCT04975074|Trace Elements|trace elements|mesh-ancestor
154812566|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
154812567|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812568|NCT04975074|Hematinics|hematinics|mesh-ancestor
154812569|NCT04963998|Copper|copper|mesh-list
154812570|NCT04963998|Trace Elements|trace elements|mesh-ancestor
154812571|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
154812572|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812573|NCT01451905|Liraglutide|liraglutide|mesh-list
154812574|NCT01451905|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154812575|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154812576|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812577|NCT01451905|Incretins|incretins|mesh-ancestor
154812578|NCT01451905|Hormones|hormones|mesh-ancestor
154812579|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812580|NCT01455649|Cyclosporine|cyclosporine|mesh-list
154812581|NCT01455649|Everolimus|everolimus|mesh-list
154812582|NCT01455649|Tacrolimus|tacrolimus|mesh-list
154812583|NCT01455649|Cyclosporins|cyclosporins|mesh-list
154812584|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154812585|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153992038|NCT00689637|Warfarin|warfarin|mesh-list
154812586|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
154812587|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812588|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812589|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812590|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
154812591|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812592|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
154812593|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812594|NCT01455649|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154812595|NCT01455649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154812596|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812597|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154812598|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
154812599|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812600|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154812601|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154812602|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
154812603|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154812604|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812605|NCT01455883|Glimepiride|glimepiride|mesh-list
154812606|NCT01455883|Exenatide|exenatide|mesh-list
154812607|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154812608|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154812609|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812610|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812611|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
154812612|NCT01455883|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154812613|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154812614|NCT01455883|Incretins|incretins|mesh-ancestor
154812615|NCT01455883|Hormones|hormones|mesh-ancestor
154812616|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812617|NCT01452217|Secretin|secretin|mesh-list
154812618|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154812619|NCT01452217|Hormones|hormones|mesh-ancestor
154812620|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812621|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812622|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154812623|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154812624|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812625|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812626|NCT04954560|Losartan|losartan|mesh-list
154812627|NCT04954560|Eprosartan|eprosartan|mesh-list
154812628|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154812629|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154812630|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154812631|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154564616|NCT05509478|Lenvatinib|lenvatinib|mesh-list
154812632|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812633|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
154812634|NCT01456117|Pioglitazone|pioglitazone|mesh-list
154812635|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154812636|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812637|NCT03829345|Olaparib|olaparib|mesh-list
154812638|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154812639|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812640|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812641|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812642|NCT01456351|Rituximab|rituximab|mesh-list
154812643|NCT01456351|Fludarabine|fludarabine|mesh-list
154812644|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154812645|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812646|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812647|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
154812648|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812649|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812650|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992100|NCT04136613|Copper|copper|mesh-list
154812651|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154812652|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
154812653|NCT01452685|Leuprolide|leuprolide|mesh-list
154812654|NCT01452685|Relugolix|relugolix|mesh-list
154812655|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154812656|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
154812657|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154812658|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812659|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812660|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812661|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
154812662|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
154812663|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812664|NCT01452763|Lansoprazole|lansoprazole|mesh-list
154812665|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
154812666|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154812667|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154812668|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154812669|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812670|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812671|NCT04954014|Bevacizumab|bevacizumab|mesh-list
154812672|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812673|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812674|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154812675|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154812676|NCT04954014|Growth Substances|growth substances|mesh-ancestor
154812677|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812678|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
154812679|NCT00988559|Imiquimod|imiquimod|mesh-list
154812680|NCT00988559|Vaccines|vaccines|mesh-list
154812681|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
154812682|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812683|NCT00988559|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154812684|NCT00988559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812685|NCT00988559|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154812686|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154812687|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812688|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
154812689|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154812690|NCT00988169|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154812691|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154812692|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812693|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812694|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812695|NCT02967133|Paclitaxel|paclitaxel|mesh-list
154812696|NCT02967133|Nivolumab|nivolumab|mesh-list
154812697|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154812698|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812699|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
154812700|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
154812701|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
154812702|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812703|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154812704|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154812705|NCT04961970|Leucovorin|leucovorin|mesh-list
154812706|NCT04961970|Gemcitabine|gemcitabine|mesh-list
154812707|NCT04961970|Fluorouracil|fluorouracil|mesh-list
154812708|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
154812709|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812710|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154812711|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
154812712|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812713|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812714|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
154812715|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812716|NCT04961970|Antidotes|antidotes|mesh-ancestor
154812717|NCT04961970|Protective Agents|protective agents|mesh-ancestor
154812718|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
154812719|NCT04961970|Vitamins|vitamins|mesh-ancestor
154812720|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
154812721|NCT01311687|Dexamethasone|dexamethasone|mesh-list
154812722|NCT01311687|Pomalidomide|pomalidomide|mesh-list
154812723|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812724|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
154812725|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
154812726|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812727|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812728|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154812729|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
154812730|NCT01311687|Hormones|hormones|mesh-ancestor
154812731|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812732|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812733|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812734|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
154812735|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154812736|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154812737|NCT01311687|Growth Substances|growth substances|mesh-ancestor
154812738|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
154812739|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
154812740|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154812741|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
154812742|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812743|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
154812744|NCT00988091|Protective Agents|protective agents|mesh-ancestor
154812745|NCT04965324|Anesthetics|anesthetics|mesh-list
154812746|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812747|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812748|NCT04961268|Acetaminophen|acetaminophen|mesh-list
154812749|NCT04961268|Ibuprofen|ibuprofen|mesh-list
154812750|NCT04961268|Tramadol|tramadol|mesh-list
154812751|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154812752|NCT04961268|Analgesics|analgesics|mesh-ancestor
154812753|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
154812754|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812755|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812756|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
154812757|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154812758|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812759|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812760|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154812761|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812762|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812763|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154812764|NCT04961268|Narcotics|narcotics|mesh-ancestor
154812765|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812766|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154812767|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
154812768|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812769|NCT01346397|Cyclosporine|cyclosporine|mesh-list
154812770|NCT01346397|Tacrolimus|tacrolimus|mesh-list
154812771|NCT01346397|Cyclosporins|cyclosporins|mesh-list
154812772|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812773|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
154812774|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812775|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154812776|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812777|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812778|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
154812779|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812780|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
154812781|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812782|NCT01347255|Betamethasone|betamethasone|mesh-list
154812783|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
154812784|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154812785|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
154812786|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154812787|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812789|NCT01347255|Hormones|hormones|mesh-ancestor
154812790|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812791|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812792|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154812793|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
154812794|NCT04392427|Ribavirin|ribavirin|mesh-list
154812795|NCT04392427|Ivermectin|ivermectin|mesh-list
154812796|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
154812797|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
154812798|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812799|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
154812800|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812801|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154812802|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
154812803|NCT01457131|Fludarabine|fludarabine|mesh-list
154812804|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812805|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
154812806|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812807|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812808|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154812809|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
154812810|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812811|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812812|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154812813|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
154812814|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
154812815|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154812816|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154812817|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812818|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154812819|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812820|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812821|NCT01455337|Prednisolone|prednisolone|mesh-list
154812822|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
154812823|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154812824|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
154812825|NCT01455337|Hormones|hormones|mesh-ancestor
154812826|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812827|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812828|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812829|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812830|NCT01455337|Protective Agents|protective agents|mesh-ancestor
154812831|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154812832|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812833|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812834|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154812835|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154812836|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
154812837|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154812838|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
154812839|NCT03059316|Labetalol|labetalol|mesh-list
154812840|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
154812841|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
154812842|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154812843|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154812844|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
154812845|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154812846|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812847|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812848|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154812849|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
154812850|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
154812851|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812852|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154812853|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154812854|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154812855|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154812856|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
154812857|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812858|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154812859|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
154564825|NCT02196805|Probucol|probucol|mesh-list
154812860|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812861|NCT04943952|Asparaginase|asparaginase|mesh-list
154812862|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812863|NCT01352637|Cycloserine|cycloserine|mesh-list
154812864|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154812865|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812866|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154812867|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
154812868|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154812869|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
154812870|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812871|NCT03058536|Progesterone|progesterone|mesh-list
154812872|NCT03058536|Progestins|progestins|mesh-ancestor
154812873|NCT03058536|Hormones|hormones|mesh-ancestor
154812874|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812875|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812876|NCT01314417|Methotrexate|methotrexate|mesh-list
154812877|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154812878|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
154812879|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154812880|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812881|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154812882|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
154812883|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812884|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812885|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
154812886|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154812887|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154812888|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812889|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
154812890|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154812891|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154812892|NCT01457911|Metformin|metformin|mesh-list
154812893|NCT01457911|Glimepiride|glimepiride|mesh-list
154812894|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154812895|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812896|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154812897|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154812898|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
154812899|NCT02893423|Ropivacaine|ropivacaine|mesh-list
154812900|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
154812901|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
154812902|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812903|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812904|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
154812905|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812906|NCT05586919|Ethanol|ethanol|mesh-list
154812907|NCT05586919|Polidocanol|polidocanol|mesh-list
154812908|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154812909|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812910|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812911|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812912|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154812913|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154812914|NCT01890889|Ezetimibe|ezetimibe|mesh-list
154812915|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154812916|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154812917|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
154812918|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812919|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154812920|NCT04951752|Ropivacaine|ropivacaine|mesh-list
154812921|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
154812922|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
154812923|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812924|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812925|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
154812926|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812927|NCT01315665|Sulforaphane|sulforaphane|mesh-list
154812928|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154812929|NCT01315665|Protective Agents|protective agents|mesh-ancestor
154812930|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812931|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812932|NCT01454089|Carboplatin|carboplatin|mesh-list
154812933|NCT01454089|Gemcitabine|gemcitabine|mesh-list
154812934|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812935|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154812936|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
154812937|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812938|NCT01457989|Ezogabine|ezogabine|mesh-list
154812939|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
154812940|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154812941|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812942|NCT01458067|GSK2636771|gsk2636771|mesh-list
154812943|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812944|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154812945|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749977|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
154812946|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812947|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154812948|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154812949|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812950|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
154812951|NCT04959786|Ribavirin|ribavirin|mesh-list
154812952|NCT04959786|Ivermectin|ivermectin|mesh-list
154812953|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
154812954|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
154812955|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812956|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
154812957|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154812958|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154812959|NCT01452451|Exenatide|exenatide|mesh-list
154812960|NCT01452451|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154812961|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154812962|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812963|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154812964|NCT01452451|Incretins|incretins|mesh-ancestor
154812965|NCT01452451|Hormones|hormones|mesh-ancestor
154812966|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812967|NCT04951128|Anesthetics|anesthetics|mesh-list
154812968|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
154812969|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
154812970|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812971|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812972|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154812973|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154812974|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154812975|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
154812976|NCT04951128|Coagulants|coagulants|mesh-ancestor
154812977|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
154812978|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154812979|NCT01458301|Leuprolide|leuprolide|mesh-list
154812980|NCT01458301|Relugolix|relugolix|mesh-list
154812981|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154812982|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
154812983|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154812984|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812985|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154812986|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154812987|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
154812988|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
154812989|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154812990|NCT03059238|Celecoxib|celecoxib|mesh-list
154812991|NCT03059238|Parecoxib|parecoxib|mesh-list
154812992|NCT03059238|Oxycodone|oxycodone|mesh-list
154812993|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154812994|NCT03059238|Narcotics|narcotics|mesh-ancestor
154812995|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154812996|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154812997|NCT03059238|Analgesics|analgesics|mesh-ancestor
154812998|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
154812999|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813000|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154813001|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813002|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813003|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154813004|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154813005|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154813006|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813007|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813008|NCT01891201|Oxytocin|oxytocin|mesh-list
154813009|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
154813010|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154564969|NCT05261581|Analgesics|analgesics|mesh-list
154813011|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813012|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
154813013|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154813014|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154813015|NCT04942002|Prednisolone|prednisolone|mesh-list
154813016|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
154813017|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154813018|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
154813019|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813020|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
154813021|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
154813022|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813023|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813024|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813025|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
154813026|NCT04942002|Hormones|hormones|mesh-ancestor
154813027|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154813028|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154813029|NCT04942002|Protective Agents|protective agents|mesh-ancestor
154813030|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154813031|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813032|NCT01891435|Acetaminophen|acetaminophen|mesh-list
154813033|NCT01891435|Diclofenac|diclofenac|mesh-list
154813034|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813035|NCT01891435|Analgesics|analgesics|mesh-ancestor
154813036|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
154813037|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813038|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813039|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
154813040|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154813041|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813042|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154813043|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154813044|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813045|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813046|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154813047|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154813048|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154813049|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
154813050|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813051|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813052|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154813053|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154813054|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
154813055|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813056|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154813057|NCT04941846|Nimodipine|nimodipine|mesh-list
154813058|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154813059|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154813060|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813061|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813062|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154813063|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813064|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
154813065|NCT01891513|Losartan|losartan|mesh-list
154813066|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154813067|NCT01891513|Perindopril|perindopril|mesh-list
154813068|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154813069|NCT01891513|Diuretics|diuretics|mesh-list
154813070|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
154813071|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154813072|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154813073|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154813074|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154813075|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813076|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
154813077|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813078|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813079|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
154813080|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813081|NCT04843423|Cariprazine|cariprazine|mesh-list
154813082|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154813083|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154813084|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813085|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813086|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154813088|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
154813089|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813090|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813091|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813092|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
154813093|NCT04421196|Analgesics|analgesics|mesh-list
154813094|NCT04421196|Narcotics|narcotics|mesh-ancestor
154813095|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813096|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813097|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
154813098|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813099|NCT01459315|Dolutegravir|dolutegravir|mesh-list
154813100|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154813101|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154813102|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813103|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813104|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154813105|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154813106|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
154813107|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813108|NCT04948788|Gemcitabine|gemcitabine|mesh-list
154813109|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
154813110|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154813111|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
154813112|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813113|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813114|NCT02865811|Doxorubicin|doxorubicin|mesh-list
154813115|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154813116|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
154813117|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154813118|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813119|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154813120|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154813121|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813122|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813123|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154813124|NCT02865811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154813125|NCT03058224|Acetaminophen|acetaminophen|mesh-list
154813126|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813127|NCT03058224|Analgesics|analgesics|mesh-ancestor
154813128|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
154813129|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992567|NCT04525274|Analgesics|analgesics|mesh-ancestor
154813130|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813131|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
154813132|NCT04957212|Carboplatin|carboplatin|mesh-list
154813133|NCT04957212|Docetaxel|docetaxel|mesh-list
154813134|NCT04957212|Trastuzumab|trastuzumab|mesh-list
154813135|NCT04957212|Pertuzumab|pertuzumab|mesh-list
154813136|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813137|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
154813138|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
154813139|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
154813140|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813141|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154813142|NCT04390789|Calcium|calcium|mesh-list
154813143|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154813144|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813145|NCT04947774|Immunomodulating Agents|immunomodulating agents|mesh-list
154813146|NCT04947774|Immunologic Factors|immunologic factors|mesh-ancestor
154813147|NCT04947774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813148|NCT04948164|Naproxen|naproxen|mesh-list
154813149|NCT04948164|Sumatriptan|sumatriptan|mesh-list
154813150|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154813151|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813152|NCT04948164|Analgesics|analgesics|mesh-ancestor
154813153|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
154813154|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813155|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813156|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813157|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154813158|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
154813159|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154813160|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813161|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813162|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154813163|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154813164|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154813165|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
154813166|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813167|NCT02808871|Pirfenidone|pirfenidone|mesh-list
154813168|NCT02808871|Analgesics|analgesics|mesh-ancestor
154813169|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
154813170|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813171|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813172|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154813173|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813174|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813175|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154813176|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813178|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
154813179|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813180|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813181|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154813182|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154813183|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
154813184|NCT01459627|Ticagrelor|ticagrelor|mesh-list
154813185|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154813186|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154813187|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154813188|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154813189|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154813190|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
154813191|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813192|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813193|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813194|NCT02467621|Pantoprazole|pantoprazole|mesh-list
154813195|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154813196|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813197|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154813198|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813199|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813200|NCT04937946|Fentanyl|fentanyl|mesh-list
154813201|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154813202|NCT04937946|Narcotics|narcotics|mesh-ancestor
154813203|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813204|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813205|NCT04937946|Analgesics|analgesics|mesh-ancestor
154813206|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
154813207|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813208|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154813209|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154813210|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
154813211|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
154813212|NCT05160987|Midazolam|midazolam|mesh-list
154813213|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154813214|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154813215|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813216|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813217|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154813218|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154813219|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154813220|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154813221|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
154813222|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
154813223|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
154813224|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
154813225|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813226|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813227|NCT01892995|Ketamine|ketamine|mesh-list
154813228|NCT01892995|Analgesics|analgesics|mesh-ancestor
154813229|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
154813230|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813231|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813232|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154813233|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154813234|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
154813235|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
154813236|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813237|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154813238|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154813239|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813240|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813241|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
154813242|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154813243|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154813244|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154813245|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813246|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813247|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
154813248|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813249|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813250|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154813251|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813252|NCT02181075|Doxorubicin|doxorubicin|mesh-list
154813253|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154813254|NCT02181075|Liver Extracts|liver extracts|mesh-list
154813255|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154813256|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813257|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154813258|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154813259|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813260|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813261|NCT02181075|Hematinics|hematinics|mesh-ancestor
154813262|NCT01359735|Bacitracin|bacitracin|mesh-list
154813263|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154813264|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813265|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154813266|NCT01361217|Midazolam|midazolam|mesh-list
154813267|NCT01361217|Levomethorphan|levomethorphan|mesh-list
154813268|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
154813269|NCT01361217|Caffeine|caffeine|mesh-list
154813270|NCT01361217|Fluoxetine|fluoxetine|mesh-list
154813271|NCT01361217|Omeprazole|omeprazole|mesh-list
154813272|NCT01361217|Lovastatin|lovastatin|mesh-list
154813273|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154813274|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154813275|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813276|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813277|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154813278|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154813279|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154813280|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154813281|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
154813282|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
154813283|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
154813284|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
154813285|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813286|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813287|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154813288|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154813289|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813290|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154813291|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154813292|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
154813293|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154813294|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813295|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154813296|NCT01361217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154813297|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154813298|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813299|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
154813300|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154813301|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
154813302|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154813303|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154813304|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
154813305|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
154813306|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154813307|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154813308|NCT01361217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154813309|NCT01361217|Narcotics|narcotics|mesh-ancestor
154813310|NCT01361217|Analgesics|analgesics|mesh-ancestor
154813311|NCT01361217|Sensory System Agents|sensory system agents|mesh-ancestor
154813312|NCT01361217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813313|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154813314|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154813315|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
154813316|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154813317|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154813318|NCT04271839|Fluticasone|fluticasone|mesh-list
154813319|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
154813320|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813321|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154813322|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
154813323|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813324|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813325|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154813326|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
154813327|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
154813328|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154813329|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154813330|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154813331|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154813332|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
154813333|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813334|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813335|NCT04945434|Methamphetamine|methamphetamine|mesh-list
154813336|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154813337|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813338|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
154813339|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
154813340|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813341|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
154813342|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813343|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813344|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
154813345|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154813346|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154813347|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813348|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154813349|NCT04408560|Acetaminophen|acetaminophen|mesh-list
154813350|NCT04408560|Analgesics|analgesics|mesh-list
154813351|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813352|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
154813353|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813354|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813355|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
154813356|NCT04844905|Ivermectin|ivermectin|mesh-list
154813357|NCT04844905|Piperaquine|piperaquine|mesh-list
154813358|NCT04844905|Artenimol|artenimol|mesh-list
154813359|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154813360|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813361|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
154813362|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154813363|NCT04418856|Methamphetamine|methamphetamine|mesh-list
154813364|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154813365|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813366|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
154813367|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
154813368|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813369|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
154813370|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813371|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813372|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
154813373|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154813374|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154813375|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813376|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154813377|NCT01454635|Sertraline|sertraline|mesh-list
154813378|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
154813379|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154813380|NCT01454635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154813381|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154813382|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813383|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813384|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813385|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
154813386|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813387|NCT02196831|Tesamorelin|tesamorelin|mesh-list
154813388|NCT02196831|Growth Substances|growth substances|mesh-ancestor
154813389|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813390|NCT04944966|Lumefantrine|lumefantrine|mesh-list
154813391|NCT04944966|Artemether|artemether|mesh-list
154813392|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154813393|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
154813394|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154813395|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154813396|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813397|NCT04955262|Nivolumab|nivolumab|mesh-list
154813398|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154813399|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813400|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154813401|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813402|NCT01363479|Dexamethasone|dexamethasone|mesh-list
154813403|NCT01363479|Palonosetron|palonosetron|mesh-list
154813404|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813405|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
154813406|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
154813407|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813408|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813409|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813410|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
154813411|NCT01363479|Hormones|hormones|mesh-ancestor
154813412|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154813413|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154813414|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813415|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154813416|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154813417|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
154813418|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813419|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813420|NCT01893385|Vitamin D|vitamin d|mesh-list
154813421|NCT01893385|Vitamins|vitamins|mesh-ancestor
154813422|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
154813423|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813424|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154813425|NCT04935450|Dimercaprol|dimercaprol|mesh-list
154813426|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
154813427|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
154813428|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813429|NCT02181231|Buprenorphine|buprenorphine|mesh-list
154813430|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154813431|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154813432|NCT02181231|Narcotics|narcotics|mesh-ancestor
154813433|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813434|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813435|NCT02181231|Analgesics|analgesics|mesh-ancestor
154813436|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
154813437|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813438|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154813439|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154813440|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154813441|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813442|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992894|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
154813443|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813444|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154813445|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
154813446|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154813447|NCT01364259|Amifostine|amifostine|mesh-list
154813448|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154813449|NCT01364259|Protective Agents|protective agents|mesh-ancestor
154813450|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813451|NCT01321437|Axitinib|axitinib|mesh-list
154813452|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813453|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154813454|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813455|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813456|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
154813457|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813458|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
154813459|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154813460|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154813461|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813462|NCT01365585|Urological Agents|urological agents|mesh-ancestor
154813463|NCT04407390|Niacinamide|niacinamide|mesh-list
154813464|NCT04407390|Niacin|niacin|mesh-list
154813465|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
154813466|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
154813467|NCT04407390|Vitamins|vitamins|mesh-ancestor
154813468|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
154813469|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813470|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154813471|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
154813472|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813473|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154813474|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
154813475|NCT02181387|Acetaminophen|acetaminophen|mesh-list
154813476|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813477|NCT02181387|Analgesics|analgesics|mesh-ancestor
154813478|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
154813479|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813480|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813481|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
154813482|NCT04351347|Ivermectin|ivermectin|mesh-list
154813483|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154813484|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813485|NCT04932564|Leflunomide|leflunomide|mesh-list
154813486|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813487|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813488|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154813489|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
154813490|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813491|NCT04921566|Torsemide|torsemide|mesh-list
154813492|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154813493|NCT04921566|Diuretics|diuretics|mesh-ancestor
154813494|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
154813495|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813496|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154813497|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813498|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813499|NCT02655601|Manganese|manganese|mesh-list
154813500|NCT02655601|Temozolomide|temozolomide|mesh-list
154813501|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154813502|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
154813503|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813504|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813505|NCT02655601|Trace Elements|trace elements|mesh-ancestor
154813506|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
154813507|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813508|NCT02652247|Dimercaprol|dimercaprol|mesh-list
154813509|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
154813510|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
154813511|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813512|NCT01365819|Varenicline|varenicline|mesh-list
154813513|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154813514|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154813515|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
154813516|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813517|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813518|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813519|NCT02635555|Phenylephrine|phenylephrine|mesh-list
154813520|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
154813521|NCT02635555|Ephedrine|ephedrine|mesh-list
154813522|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154813523|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
154813524|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
154813525|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813526|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813527|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
154813528|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154813529|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
154813530|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
154813531|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154813532|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154813533|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154813534|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
154813535|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813536|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813537|NCT02635555|Protective Agents|protective agents|mesh-ancestor
154813538|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154813540|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154813541|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154813542|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
154813543|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813544|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813545|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813546|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154813547|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154813548|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
154813549|NCT02849899|Vildagliptin|vildagliptin|mesh-list
154813550|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154813551|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813552|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154813553|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
154813554|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813555|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813556|NCT01369875|Aldesleukin|aldesleukin|mesh-list
154813557|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
154813558|NCT01369875|Fludarabine|fludarabine|mesh-list
154813559|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154813560|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
154813561|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813562|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154813563|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154813564|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
154813565|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992999|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
154813566|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813567|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154813568|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154813569|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154813570|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
154813571|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813572|NCT02620189|Adalimumab|adalimumab|mesh-list
154813573|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
154813574|NCT02620189|Etanercept|etanercept|mesh-list
154813575|NCT02620189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154813576|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813577|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154813578|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154813579|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813580|NCT02620189|Analgesics|analgesics|mesh-ancestor
154813581|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
154813582|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813583|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813584|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813585|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154813586|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
154813587|NCT02763319|Rituximab|rituximab|mesh-list
154813588|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154813589|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154813590|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813591|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
154813592|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813593|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154813594|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154813595|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
154813596|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813597|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
154813598|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154813599|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154813600|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
154813601|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813602|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154813603|NCT02594371|Paclitaxel|paclitaxel|mesh-list
154813604|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154813605|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154813606|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813607|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
154813608|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
154813609|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
154813610|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813611|NCT02197065|Atorvastatin|atorvastatin|mesh-list
154813612|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154813613|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154813614|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
154813615|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813616|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154813617|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154813618|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813619|NCT01375491|Doxycycline|doxycycline|mesh-list
154813620|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154813621|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813622|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
154813623|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154813624|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154813625|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
154813626|NCT02591251|Povidone|povidone|mesh-list
154813627|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154813628|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
154813629|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
153750642|NCT00545389|Analgesics|analgesics|mesh-ancestor
154813630|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154813631|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813632|NCT01325181|Ranibizumab|ranibizumab|mesh-list
154813633|NCT01325181|Verteporfin|verteporfin|mesh-list
154813634|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154813635|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154813636|NCT01325181|Growth Substances|growth substances|mesh-ancestor
154813637|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813638|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
154813639|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813640|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154813641|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
154813642|NCT02588443|Paclitaxel|paclitaxel|mesh-list
154813643|NCT02588443|Gemcitabine|gemcitabine|mesh-list
154813644|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154813645|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813646|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
154813647|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
154813648|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
154813649|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813650|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154813651|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
154813652|NCT02582359|Cytarabine|cytarabine|mesh-list
154813653|NCT02582359|Daunorubicin|daunorubicin|mesh-list
154813654|NCT02582359|Ixazomib|ixazomib|mesh-list
154813655|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154813656|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
154813657|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813658|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813659|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
154813660|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813661|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154813662|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
154813663|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813664|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154813665|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154813666|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154813667|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813668|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
154813669|NCT05021809|Calcium|calcium|mesh-list
154813670|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154813671|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813672|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
154813673|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154813674|NCT02730715|Basiliximab|basiliximab|mesh-list
154813675|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
154813676|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813677|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154813678|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
154813679|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
154813680|NCT04919460|Coagulants|coagulants|mesh-ancestor
154813681|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
154813682|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813683|NCT04037241|Leucovorin|leucovorin|mesh-list
154813684|NCT04037241|Paclitaxel|paclitaxel|mesh-list
154813685|NCT04037241|Gemcitabine|gemcitabine|mesh-list
154813686|NCT04037241|Capecitabine|capecitabine|mesh-list
154813687|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154813688|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813689|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
154813690|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
154813691|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
154813692|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813693|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154813694|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
154813695|NCT04037241|Antidotes|antidotes|mesh-ancestor
154813696|NCT04037241|Protective Agents|protective agents|mesh-ancestor
154813697|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813698|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
154813699|NCT04037241|Vitamins|vitamins|mesh-ancestor
154813700|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
154813701|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154813702|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154813703|NCT04912128|Growth Substances|growth substances|mesh-ancestor
154813704|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813705|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
154813706|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813707|NCT01327677|Fentanyl|fentanyl|mesh-list
154813708|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154813709|NCT01327677|Narcotics|narcotics|mesh-ancestor
154813710|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813711|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813712|NCT01327677|Analgesics|analgesics|mesh-ancestor
154813713|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
154813714|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813715|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154813716|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154813717|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
154813718|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
154813719|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
154813720|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154813721|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154813722|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154813723|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813724|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813725|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
154813726|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813727|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813728|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154813729|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813730|NCT04918914|Dapsone|dapsone|mesh-list
154813731|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813732|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
154813733|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154813734|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154813735|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154813736|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813737|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813738|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
154813739|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154813740|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
154813741|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154813742|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154813743|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813744|NCT05586763|Promethazine|promethazine|mesh-list
154813745|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
154813746|NCT05586763|Metoclopramide|metoclopramide|mesh-list
154813747|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
154813748|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
154813749|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813750|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813751|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813752|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154813753|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154813754|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
154813755|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813756|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813757|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
154813758|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
154813759|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154813760|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
154813761|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
154813762|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154813763|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154813764|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154813765|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813766|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
154813767|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
154813768|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
154813769|NCT01328769|Febuxostat|febuxostat|mesh-list
154813770|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
154813771|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154813772|NCT02552641|Amoxicillin|amoxicillin|mesh-list
154813773|NCT02552641|Clarithromycin|clarithromycin|mesh-list
154813774|NCT02552641|Esomeprazole|esomeprazole|mesh-list
154813775|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154813776|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813777|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154813778|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813779|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154813780|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813781|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813782|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154813783|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154813784|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154813785|NCT02620020|Fasinumab|fasinumab|mesh-list
154813786|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154813787|NCT02620020|Analgesics|analgesics|mesh-ancestor
154813788|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
154813789|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813790|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813791|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
154813792|NCT01378299|Testosterone|testosterone|mesh-list
154813793|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
154813794|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
154813795|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154813796|NCT01378299|Androgens|androgens|mesh-ancestor
154813797|NCT01378299|Hormones|hormones|mesh-ancestor
154813798|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154813799|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813800|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154813801|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813802|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
154813803|NCT04929522|Anesthetics|anesthetics|mesh-list
154813804|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813805|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813806|NCT02549833|Poly I-C|poly i-c|mesh-list
154813807|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154813808|NCT02549833|Poly ICLC|poly iclc|mesh-list
154813809|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
154813810|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
154813811|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813812|NCT02549833|Laxatives|laxatives|mesh-ancestor
154813813|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813814|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
154813815|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813816|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154813817|NCT02542969|Simvastatin|simvastatin|mesh-list
154813818|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154813819|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154813820|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
154813821|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813822|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154813823|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154813824|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813825|NCT03054168|Goserelin|goserelin|mesh-list
154813826|NCT03054168|Testosterone|testosterone|mesh-list
154813827|NCT03054168|Hormones|hormones|mesh-ancestor
154813828|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154813829|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813830|NCT03054168|Androgens|androgens|mesh-ancestor
154813831|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154813832|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813833|NCT04757779|Docetaxel|docetaxel|mesh-list
154813834|NCT04757779|Irinotecan|irinotecan|mesh-list
154813835|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813836|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
154813837|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
154813838|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
154813839|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813840|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154813841|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154813842|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813843|NCT03053856|Paclitaxel|paclitaxel|mesh-list
154813844|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
154813845|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154813846|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813847|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
154813848|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
154813849|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
154813850|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813851|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154813852|NCT03053856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154813853|NCT02489695|Axitinib|axitinib|mesh-list
154813854|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813855|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154813856|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813857|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813858|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
154813859|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154813860|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
154813861|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813862|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813863|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154813864|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
154813865|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154813866|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
154813867|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813868|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813869|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154813870|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
154813871|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
154813872|NCT03053388|Protective Agents|protective agents|mesh-ancestor
154813873|NCT03053544|Metformin|metformin|mesh-list
154813874|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154813875|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813876|NCT02384083|Dexamethasone|dexamethasone|mesh-list
154813877|NCT02384083|Pomalidomide|pomalidomide|mesh-list
154813878|NCT02384083|Filanesib|filanesib|mesh-list
154813879|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813880|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
154813881|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
154813882|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813883|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813884|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813885|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
154813886|NCT02384083|Hormones|hormones|mesh-ancestor
154813887|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154813888|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154813889|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813890|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
154813891|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154813892|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154813893|NCT02384083|Growth Substances|growth substances|mesh-ancestor
154813894|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
154813895|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
154813896|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154813897|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813898|NCT04926480|Anesthetics|anesthetics|mesh-list
154813899|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154813900|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813901|NCT02380573|Methylene Blue|methylene blue|mesh-list
154813902|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813903|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813904|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
154813905|NCT02461537|Analgesics|analgesics|mesh-ancestor
154813906|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
154813907|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154813908|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813909|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813910|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154813911|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154813912|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813913|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813914|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154813915|NCT05028673|Antacids|antacids|mesh-list
154813916|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154813917|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154813918|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
154813919|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813920|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813921|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154813922|NCT04916574|Antibodies|antibodies|mesh-list
154813923|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
154813924|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813925|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
154813926|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154813927|NCT02460445|Cyproterone|cyproterone|mesh-list
154813928|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154813929|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154813930|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154813931|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
154813932|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154813933|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813934|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154813935|NCT02460445|Estrogens|estrogens|mesh-ancestor
154813936|NCT02460445|Hormones|hormones|mesh-ancestor
154813937|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154813938|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
154813939|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
154813940|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813941|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154813942|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
154813943|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154813944|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813945|NCT05023837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154813946|NCT05023837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813947|NCT02358967|Vitamin E|vitamin e|mesh-list
154813948|NCT02358967|Tocopherols|tocopherols|mesh-list
154813949|NCT02358967|Tocotrienols|tocotrienols|mesh-list
154813950|NCT02358967|Vitamins|vitamins|mesh-ancestor
154813951|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
154813952|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813953|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
154813954|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993389|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
154813955|NCT02358967|Protective Agents|protective agents|mesh-ancestor
154813956|NCT03052998|Ivermectin|ivermectin|mesh-list
154813957|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
154813958|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154813959|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154813960|NCT05586061|Tislelizumab|tislelizumab|mesh-list
154813961|NCT05586061|Disitamab vedotin|disitamab vedotin|mesh-list
154813962|NCT05586061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154813963|NCT05586061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813964|NCT05586061|Immunoconjugates|immunoconjugates|mesh-ancestor
154813965|NCT05586061|Immunologic Factors|immunologic factors|mesh-ancestor
154813966|NCT05586061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813967|NCT02354131|Bevacizumab|bevacizumab|mesh-list
154813968|NCT02354131|Niraparib|niraparib|mesh-list
154813969|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154813970|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813971|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154813972|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154813973|NCT02354131|Growth Substances|growth substances|mesh-ancestor
154813974|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154813975|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
154813976|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154813977|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154813978|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813979|NCT02352337|Gemcitabine|gemcitabine|mesh-list
154813980|NCT02352337|Folfirinox|folfirinox|mesh-list
154813981|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154813982|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
154813983|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813984|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154813985|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
154813986|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154813987|NCT02827201|Paclitaxel|paclitaxel|mesh-list
154813988|NCT02827201|Gemcitabine|gemcitabine|mesh-list
154813989|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154813990|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558116|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154813991|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
154813992|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
154813993|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
154813994|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154813995|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154813996|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
154813997|NCT01378377|Niacinamide|niacinamide|mesh-list
154813998|NCT01378377|Sirolimus|sirolimus|mesh-list
154813999|NCT01378377|Temsirolimus|temsirolimus|mesh-list
154814000|NCT01378377|MTOR Inhibitors|mtor inhibitors|mesh-list
154814001|NCT01378377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154814002|NCT01378377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814003|NCT01378377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814004|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814005|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
154814006|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814007|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814008|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154814009|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814010|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154814011|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
154814012|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
154814013|NCT01378377|Vitamins|vitamins|mesh-ancestor
154814014|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
154814015|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
154814016|NCT04907838|BQ 788|bq 788|mesh-list
154814017|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154814018|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154814019|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814020|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154814021|NCT03056274|Metformin|metformin|mesh-list
154814022|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154814023|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154814024|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814025|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154814026|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154814027|NCT03056118|Aspirin|aspirin|mesh-list
154814028|NCT03056118|Clopidogrel|clopidogrel|mesh-list
154814029|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154814030|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814031|NCT03056118|Analgesics|analgesics|mesh-ancestor
154814032|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
154814033|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814034|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814035|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814036|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814037|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154814038|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154814039|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814040|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154814041|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154814042|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814043|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
154814044|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154814045|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154814046|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154814047|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
154814048|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814049|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154814050|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154814051|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
154814052|NCT00987935|Sorafenib|sorafenib|mesh-list
154814053|NCT00987935|Nintedanib|nintedanib|mesh-list
154814054|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814055|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154814056|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814057|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814058|NCT00987467|Cyclosporine|cyclosporine|mesh-list
154814059|NCT00987467|Cyclosporins|cyclosporins|mesh-list
154814060|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814061|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814062|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814063|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
154814064|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814065|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
154566025|NCT00343408|Vitamins|vitamins|mesh-ancestor
154814066|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814067|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
154814068|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814069|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154814070|NCT05874440|Tenofovir|tenofovir|mesh-list
154814071|NCT05874440|Antiviral Agents|antiviral agents|mesh-ancestor
154814072|NCT05874440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814073|NCT05874440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154814074|NCT05874440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154814075|NCT05874440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814076|NCT05874440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814077|NCT05874440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154814078|NCT05874440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154814079|NCT05874180|Metformin|metformin|mesh-list
154814080|NCT05874180|Linagliptin|linagliptin|mesh-list
154814081|NCT05874180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154814082|NCT05874180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814083|NCT05874180|Incretins|incretins|mesh-ancestor
154814084|NCT05874180|Hormones|hormones|mesh-ancestor
154814085|NCT05874180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814086|NCT05874180|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154814087|NCT05874180|Protease Inhibitors|protease inhibitors|mesh-ancestor
154814088|NCT05874180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814089|NCT05874180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814090|NCT05874167|Metformin|metformin|mesh-list
154814091|NCT05874167|Linagliptin|linagliptin|mesh-list
154814092|NCT05874167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154814093|NCT05874167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814094|NCT05874167|Incretins|incretins|mesh-ancestor
154814095|NCT05874167|Hormones|hormones|mesh-ancestor
154814096|NCT05874167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814097|NCT05874167|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154814098|NCT05874167|Protease Inhibitors|protease inhibitors|mesh-ancestor
154814099|NCT05874167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814100|NCT05874167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814101|NCT05873972|Cetuximab|cetuximab|mesh-list
154814102|NCT05873972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814103|NCT05873972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814104|NCT05873738|Nicotine|nicotine|mesh-list
154814105|NCT05873738|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154814106|NCT05873738|Autonomic Agents|autonomic agents|mesh-ancestor
154814107|NCT05873738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814108|NCT05873738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814109|NCT05873738|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154814110|NCT05873738|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154814111|NCT05873738|Cholinergic Agents|cholinergic agents|mesh-ancestor
154814112|NCT05873738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814113|NCT05873738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814114|NCT05873673|Ubiquinone|ubiquinone|mesh-list
154814115|NCT05873673|Coenzyme Q10|coenzyme q10|mesh-list
154814116|NCT05873673|Micronutrients|micronutrients|mesh-ancestor
154814117|NCT05873673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814118|NCT05873673|Vitamins|vitamins|mesh-ancestor
154814119|NCT05872698|Carvedilol|carvedilol|mesh-list
154814120|NCT05872698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154814121|NCT05872698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154814122|NCT05872698|Adrenergic Agents|adrenergic agents|mesh-ancestor
154814123|NCT05872698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814124|NCT05872698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814125|NCT05872698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814126|NCT05872698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154814127|NCT05872698|Antioxidants|antioxidants|mesh-ancestor
154814128|NCT05872698|Protective Agents|protective agents|mesh-ancestor
154814129|NCT05872698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154814130|NCT05872698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814131|NCT05872698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154814132|NCT05872698|Vasodilator Agents|vasodilator agents|mesh-ancestor
154814133|NCT05872698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154814134|NCT05872698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154814135|NCT05872568|Mycophenolic Acid|mycophenolic acid|mesh-list
154814136|NCT05872568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154814137|NCT05872568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814138|NCT05872568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154814139|NCT05872568|Antitubercular Agents|antitubercular agents|mesh-ancestor
154814140|NCT05872568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153993571|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154814141|NCT05872568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814142|NCT05872568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814143|NCT05872568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814144|NCT05872087|Midazolam|midazolam|mesh-list
154814145|NCT05872087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154814146|NCT05872087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154814147|NCT05872087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814148|NCT05872087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814149|NCT05872087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154814150|NCT05872087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154814151|NCT05872087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154814152|NCT05872087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154814153|NCT05872087|Anesthetics, General|anesthetics, general|mesh-ancestor
154814154|NCT05872087|Anesthetics|anesthetics|mesh-ancestor
154814155|NCT05872087|GABA Modulators|gaba modulators|mesh-ancestor
154814156|NCT05872087|GABA Agents|gaba agents|mesh-ancestor
154814157|NCT05872087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814158|NCT05872087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814159|NCT05871619|Fluorides|fluorides|mesh-list
154814160|NCT05871619|Fluorides, Topical|fluorides, topical|mesh-list
154814161|NCT05871619|Cariostatic Agents|cariostatic agents|mesh-ancestor
154814162|NCT05871619|Protective Agents|protective agents|mesh-ancestor
154814163|NCT05871619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814164|NCT05869357|Turmeric extract|turmeric extract|mesh-list
154814165|NCT05869357|Antioxidants|antioxidants|mesh-ancestor
154814166|NCT05869357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814167|NCT05869357|Protective Agents|protective agents|mesh-ancestor
154814168|NCT05869357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814169|NCT05869188|Isotretinoin|isotretinoin|mesh-list
154814170|NCT05869188|Dermatologic Agents|dermatologic agents|mesh-ancestor
154814171|NCT05868889|Trabectedin|trabectedin|mesh-list
154814172|NCT05868889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154814173|NCT05868889|Alkylating Agents|alkylating agents|mesh-ancestor
154814174|NCT05868889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814175|NCT05868889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814176|NCT05868174|Peposertib|peposertib|mesh-list
154814177|NCT05868174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154814178|NCT05868174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814179|NCT05868174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814180|NCT05849740|Daratumumab|daratumumab|mesh-list
154814181|NCT05849740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814182|NCT05797467|Bevacizumab|bevacizumab|mesh-list
154814183|NCT05797467|Cetuximab|cetuximab|mesh-list
154814184|NCT05797467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814185|NCT05797467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814186|NCT05797467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154814187|NCT05797467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154814188|NCT05797467|Growth Substances|growth substances|mesh-ancestor
154814189|NCT05797467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814190|NCT05797467|Growth Inhibitors|growth inhibitors|mesh-ancestor
154814191|NCT05796973|Atorvastatin|atorvastatin|mesh-list
154814192|NCT05796973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154814193|NCT05796973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154814194|NCT05796973|Antimetabolites|antimetabolites|mesh-ancestor
154814195|NCT05796973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814196|NCT05796973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154814197|NCT05796973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154814198|NCT05796973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814199|NCT05733741|Benoxinate|benoxinate|mesh-list
154814200|NCT05733741|Hyaluronic Acid|hyaluronic acid|mesh-list
154814201|NCT05733741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154814202|NCT05733741|Immunologic Factors|immunologic factors|mesh-ancestor
154814203|NCT05733741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814204|NCT05733741|Viscosupplements|viscosupplements|mesh-ancestor
154814205|NCT05733741|Protective Agents|protective agents|mesh-ancestor
154814206|NCT05733741|Anesthetics, Local|anesthetics, local|mesh-ancestor
154814207|NCT05733741|Anesthetics|anesthetics|mesh-ancestor
154814208|NCT05733741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814209|NCT05733741|Sensory System Agents|sensory system agents|mesh-ancestor
154814210|NCT05733741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814211|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
154814212|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154814213|NCT05689463|Antibodies|antibodies|mesh-list
154814214|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
154814215|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814216|NCT05673577|Cetuximab|cetuximab|mesh-list
154558117|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
154814217|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814218|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814219|NCT05533164|Rituximab|rituximab|mesh-list
154814220|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814221|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814222|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
154814223|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814224|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814225|NCT05533125|Rituximab|rituximab|mesh-list
154814226|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814227|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814228|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
154814229|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814230|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814231|NCT05407584|Paclitaxel|paclitaxel|mesh-list
154814232|NCT05407584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154814233|NCT05407584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814234|NCT05407584|Tubulin Modulators|tubulin modulators|mesh-ancestor
154814235|NCT05407584|Antimitotic Agents|antimitotic agents|mesh-ancestor
154814236|NCT05407584|Mitosis Modulators|mitosis modulators|mesh-ancestor
154814237|NCT05407584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814238|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
154814239|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
154814240|NCT05294588|Cefixime|cefixime|mesh-list
154814241|NCT05294588|Vaccines|vaccines|mesh-list
154814242|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
154814243|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814244|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154814245|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814246|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154814247|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154814248|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814249|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814250|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814251|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154814252|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154814253|NCT05294588|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154814254|NCT05294588|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154814255|NCT05170139|Caffeine|caffeine|mesh-list
154814256|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154814257|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814258|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154814259|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814260|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814261|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154814262|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154814263|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
154814264|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814265|NCT05140811|Azacitidine|azacitidine|mesh-list
154814266|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154814267|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
154814268|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814269|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814270|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814271|NCT05046184|Midazolam|midazolam|mesh-list
154814272|NCT05046184|Ketamine|ketamine|mesh-list
154814273|NCT05046184|Analgesics|analgesics|mesh-ancestor
154814274|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
154814275|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814276|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814277|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154814278|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154814279|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
154814280|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
154814281|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814282|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154814283|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154814284|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814285|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814286|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154814287|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154814288|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154814289|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154814290|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154814291|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
154814292|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
154814293|NCT05020028|Cannabidiol|cannabidiol|mesh-list
154814294|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
154814295|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
154814296|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154814297|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814298|NCT04976868|Analgesics|analgesics|mesh-ancestor
154814299|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
154814300|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814301|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814302|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814303|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814304|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
154814305|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814306|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
154814307|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154814308|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814309|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814310|NCT04944654|Emtricitabine|emtricitabine|mesh-list
154814311|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
154814312|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814313|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154814314|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154814315|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814316|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814317|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154814318|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154814319|NCT04886232|Lidocaine|lidocaine|mesh-list
154814320|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
154814321|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
154814322|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814323|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814324|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
154814325|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814326|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154814327|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154814328|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154814329|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814330|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814331|NCT04885712|Metformin|metformin|mesh-list
154814332|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
154814333|NCT04885712|Pioglitazone|pioglitazone|mesh-list
154814334|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154814335|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814336|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154814337|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814338|NCT04843046|Pioglitazone|pioglitazone|mesh-list
154814339|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154814340|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814341|NCT04789499|Theophylline|theophylline|mesh-list
154814342|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154814343|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
154814344|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814345|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814346|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154814347|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
154814348|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154814349|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814350|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814351|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
154814352|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154814353|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154814354|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
154814355|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814356|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
154814357|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154814358|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
154814359|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814360|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
154814361|NCT04697823|Protective Agents|protective agents|mesh-ancestor
154814362|NCT04657016|Tirzepatide|tirzepatide|mesh-list
154814363|NCT04657016|Incretins|incretins|mesh-ancestor
154814364|NCT04657016|Hormones|hormones|mesh-ancestor
154814365|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814366|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814368|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814369|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814370|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
154814371|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
154814372|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154814373|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154814374|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814375|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814376|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814377|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814378|NCT04258423|Everolimus|everolimus|mesh-list
154814379|NCT04258423|Tacrolimus|tacrolimus|mesh-list
154814380|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814381|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
154814382|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814383|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154814384|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814385|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814386|NCT04258423|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154814387|NCT04258423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154814388|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814389|NCT04211987|Cytarabine|cytarabine|mesh-list
154814390|NCT04211987|Methotrexate|methotrexate|mesh-list
154814391|NCT04211987|Etoposide|etoposide|mesh-list
154814392|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154814393|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
154814394|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814395|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814396|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
154814397|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814398|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814399|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
154814400|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814401|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154814402|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154814403|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154814404|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814405|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154814406|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
154814407|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154814408|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
154814409|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154814410|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814411|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154814412|NCT04190433|Carvedilol|carvedilol|mesh-list
154814413|NCT04190433|Lisinopril|lisinopril|mesh-list
154814414|NCT04190433|Spironolactone|spironolactone|mesh-list
154814415|NCT04190433|Pravastatin|pravastatin|mesh-list
154814416|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154814417|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
154814418|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814419|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814420|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154814421|NCT04190433|Diuretics|diuretics|mesh-ancestor
154814422|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
154814423|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154814424|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154814425|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
154814426|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814427|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814428|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154814429|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
154814430|NCT04190433|Protective Agents|protective agents|mesh-ancestor
154814431|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154814432|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814433|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154814434|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
154814435|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154814436|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154814437|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154814438|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154814439|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
154566399|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
154814440|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154814441|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154814442|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814443|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154814444|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
154814445|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154814446|NCT04163900|Gemcitabine|gemcitabine|mesh-list
154814447|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814448|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154814449|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
154814450|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814451|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154814452|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
154814453|NCT04146038|Azacitidine|azacitidine|mesh-list
154814454|NCT04146038|Decitabine|decitabine|mesh-list
154814455|NCT04146038|Venetoclax|venetoclax|mesh-list
154814456|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154814457|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
154814458|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814459|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814460|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814461|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154814462|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814463|NCT04146038|Analgesics|analgesics|mesh-ancestor
154814464|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
154814465|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814466|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814467|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814468|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814469|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154814470|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
154814471|NCT04109885|Promethazine|promethazine|mesh-list
154814472|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
154814473|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154814474|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154814475|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814476|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814477|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
154814478|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
154814479|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
154814480|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814481|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
154814482|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
154814483|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154814484|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154814485|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
154814486|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
154814487|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814488|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814489|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154814490|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
154814491|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
154814492|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154814493|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154814494|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154814495|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154814496|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
154814497|NCT04087668|Anesthetics|anesthetics|mesh-list
154814498|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814499|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814500|NCT04006873|Ivacaftor|ivacaftor|mesh-list
154814501|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154814502|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814503|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814504|NCT03942419|Atropine|atropine|mesh-list
154814505|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154814506|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154814507|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154814508|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154814509|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154814510|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
154814511|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814512|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814513|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154814514|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
154814515|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
154814516|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
154814517|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154814518|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154814519|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
153993983|NCT00862719|Hormones|hormones|mesh-ancestor
154814520|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814521|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814522|NCT03820310|Immunomodulating Agents|immunomodulating agents|mesh-list
154814523|NCT03820310|Immunologic Factors|immunologic factors|mesh-ancestor
154814524|NCT03820310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814525|NCT03780673|Rifaximin|rifaximin|mesh-list
154814526|NCT03780673|Simvastatin|simvastatin|mesh-list
154814527|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154814528|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154814529|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
154814530|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814531|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154814532|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154814533|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814534|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154814535|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814536|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154814537|NCT03769311|Cetuximab|cetuximab|mesh-list
154814538|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814539|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814540|NCT03767335|Trastuzumab|trastuzumab|mesh-list
154814541|NCT03767335|Fulvestrant|fulvestrant|mesh-list
154814542|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814543|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814544|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154814545|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154814546|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154814547|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
154814548|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814549|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814550|NCT03745430|Ramucirumab|ramucirumab|mesh-list
154814551|NCT03745430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154814552|NCT03745430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154814553|NCT03745430|Growth Substances|growth substances|mesh-ancestor
154814554|NCT03745430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814555|NCT03745430|Growth Inhibitors|growth inhibitors|mesh-ancestor
154814556|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814557|NCT03651882|Oxytocin|oxytocin|mesh-list
154814558|NCT03651882|Carbetocin|carbetocin|mesh-list
154814559|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
154814560|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154814561|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814562|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
154814563|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154814564|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
154814565|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814566|NCT03636932|Expectorants|expectorants|mesh-ancestor
154814567|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
154814568|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154814569|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
154814570|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814571|NCT03636932|Protective Agents|protective agents|mesh-ancestor
154814572|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814573|NCT03636932|Antidotes|antidotes|mesh-ancestor
154814574|NCT05910125|Aspirin|aspirin|mesh-list
154814575|NCT05910125|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154814576|NCT05910125|Clopidogrel|clopidogrel|mesh-list
154814577|NCT05910125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154814578|NCT05910125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814579|NCT05910125|Analgesics|analgesics|mesh-ancestor
154814580|NCT05910125|Sensory System Agents|sensory system agents|mesh-ancestor
154814581|NCT05910125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814582|NCT05910125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814583|NCT05910125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814584|NCT05910125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814585|NCT05910125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154814586|NCT05910125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154814587|NCT05910125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814588|NCT05910125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154814589|NCT05910125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154566567|NCT02221063|Thiamine|thiamine|mesh-list
154814590|NCT05910125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814591|NCT05910125|Antipyretics|antipyretics|mesh-ancestor
154814592|NCT05910125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154814593|NCT05910125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154814594|NCT05910125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154814595|NCT05910125|Purinergic Agents|purinergic agents|mesh-ancestor
154814596|NCT05910125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814597|NCT05910034|Docetaxel|docetaxel|mesh-list
154814598|NCT05910034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814599|NCT05910034|Tubulin Modulators|tubulin modulators|mesh-ancestor
154814600|NCT05910034|Antimitotic Agents|antimitotic agents|mesh-ancestor
154814601|NCT05910034|Mitosis Modulators|mitosis modulators|mesh-ancestor
154814602|NCT05910034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814603|NCT05909852|Adalimumab|adalimumab|mesh-list
154814604|NCT05909852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154814605|NCT05909852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814606|NCT05909852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814607|NCT05909826|Dexamethasone|dexamethasone|mesh-list
154814608|NCT05909826|Cyclophosphamide|cyclophosphamide|mesh-list
154814609|NCT05909826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814610|NCT05909826|Immunologic Factors|immunologic factors|mesh-ancestor
154814611|NCT05909826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814612|NCT05909826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814613|NCT05909826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154814614|NCT05909826|Alkylating Agents|alkylating agents|mesh-ancestor
154814615|NCT05909826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814616|NCT05909826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814617|NCT05909826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154814618|NCT05909826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814619|NCT05909826|Antiemetics|antiemetics|mesh-ancestor
154814620|NCT05909826|Autonomic Agents|autonomic agents|mesh-ancestor
154814621|NCT05909826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814622|NCT05909826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154814623|NCT05909826|Glucocorticoids|glucocorticoids|mesh-ancestor
154814624|NCT05909826|Hormones|hormones|mesh-ancestor
154814625|NCT05909826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814626|NCT05909826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154814627|NCT05909462|Triamcinolone|triamcinolone|mesh-list
154814628|NCT05909462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154814629|NCT05909462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154814630|NCT05909462|Lidocaine|lidocaine|mesh-list
154814631|NCT05909462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154814632|NCT05909462|Anesthetics, Local|anesthetics, local|mesh-ancestor
154814633|NCT05909462|Anesthetics|anesthetics|mesh-ancestor
154814634|NCT05909462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814635|NCT05909462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814636|NCT05909462|Sensory System Agents|sensory system agents|mesh-ancestor
154814637|NCT05909462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814638|NCT05909462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154814639|NCT05909462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154814640|NCT05909462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154814641|NCT05909462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814642|NCT05909462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814643|NCT05909462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814644|NCT05909462|Glucocorticoids|glucocorticoids|mesh-ancestor
154814645|NCT05909462|Hormones|hormones|mesh-ancestor
154814646|NCT05909462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814647|NCT05909462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814648|NCT05909462|Immunologic Factors|immunologic factors|mesh-ancestor
154814649|NCT05909462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814650|NCT05909423|Pembrolizumab|pembrolizumab|mesh-list
154814651|NCT05909423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814652|NCT05909423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814653|NCT05909423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154814654|NCT05909423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814655|NCT05909293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154814656|NCT05909293|Venetoclax|venetoclax|mesh-list
154814657|NCT05909293|Antiemetics|antiemetics|mesh-list
154814658|NCT05909293|Lenograstim|lenograstim|mesh-list
154814659|NCT05909293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814660|NCT05909293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154814661|NCT05909293|Immunologic Factors|immunologic factors|mesh-ancestor
154814662|NCT05909293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814663|NCT05909293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814664|NCT05909293|Autonomic Agents|autonomic agents|mesh-ancestor
154814665|NCT05909293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814666|NCT05909293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154814668|NCT05909215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154814669|NCT05909215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814670|NCT05909215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814671|NCT05909215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814672|NCT05909215|Analgesics|analgesics|mesh-ancestor
154814673|NCT05909215|Sensory System Agents|sensory system agents|mesh-ancestor
154814674|NCT05909215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814675|NCT05909215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154814676|NCT05909215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154814677|NCT05909215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154814678|NCT05909215|Adrenergic Agents|adrenergic agents|mesh-ancestor
154814679|NCT05909215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814680|NCT05909215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814681|NCT05909072|Tranexamic Acid|tranexamic acid|mesh-list
154814682|NCT05909072|Hyaluronic Acid|hyaluronic acid|mesh-list
154814683|NCT05909072|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154814684|NCT05909072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154814685|NCT05909072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814686|NCT05909072|Hemostatics|hemostatics|mesh-ancestor
154814687|NCT05909072|Coagulants|coagulants|mesh-ancestor
154814688|NCT05909072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154814689|NCT05909072|Immunologic Factors|immunologic factors|mesh-ancestor
154814690|NCT05909072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814691|NCT05909072|Viscosupplements|viscosupplements|mesh-ancestor
154814692|NCT05909072|Protective Agents|protective agents|mesh-ancestor
154814693|NCT05908864|Magnesium Sulfate|magnesium sulfate|mesh-list
154814694|NCT05908864|Analgesics|analgesics|mesh-ancestor
154814695|NCT05908864|Sensory System Agents|sensory system agents|mesh-ancestor
154814696|NCT05908864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994158|NCT00654901|Vaccines|vaccines|mesh-list
154814697|NCT05908864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814698|NCT05908864|Anesthetics|anesthetics|mesh-ancestor
154814699|NCT05908864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814700|NCT05908864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154814701|NCT05908864|Anticonvulsants|anticonvulsants|mesh-ancestor
154814702|NCT05908864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154814703|NCT05908864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814704|NCT05908864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814705|NCT05908864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154814706|NCT05908864|Tocolytic Agents|tocolytic agents|mesh-ancestor
154814707|NCT05908864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154814708|NCT05908851|Ketorolac|ketorolac|mesh-list
154814709|NCT05908851|Epinephrine|epinephrine|mesh-list
154814710|NCT05908851|Morphine|morphine|mesh-list
154814711|NCT05908851|Ropivacaine|ropivacaine|mesh-list
154814712|NCT05908851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154814713|NCT05908851|Narcotics|narcotics|mesh-ancestor
154814714|NCT05908851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814715|NCT05908851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814716|NCT05908851|Analgesics|analgesics|mesh-ancestor
154814717|NCT05908851|Sensory System Agents|sensory system agents|mesh-ancestor
154814718|NCT05908851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814719|NCT05908851|Anesthetics, Local|anesthetics, local|mesh-ancestor
154814720|NCT05908851|Anesthetics|anesthetics|mesh-ancestor
154814721|NCT05908851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154814722|NCT05908851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154814723|NCT05908851|Adrenergic Agents|adrenergic agents|mesh-ancestor
154814724|NCT05908851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814725|NCT05908851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814726|NCT05908851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154814727|NCT05908851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154814728|NCT05908851|Autonomic Agents|autonomic agents|mesh-ancestor
154814729|NCT05908851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154814730|NCT05908851|Respiratory System Agents|respiratory system agents|mesh-ancestor
154814731|NCT05908851|Mydriatics|mydriatics|mesh-ancestor
154814732|NCT05908851|Sympathomimetics|sympathomimetics|mesh-ancestor
154814733|NCT05908851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154814734|NCT05908851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154814735|NCT05908851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814736|NCT05908851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814737|NCT05908851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814738|NCT05908851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154566697|NCT02399397|Fentanyl|fentanyl|mesh-list
154814739|NCT05908851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814740|NCT05906121|Lidocaine|lidocaine|mesh-list
154814741|NCT05906121|Ketamine|ketamine|mesh-list
154814742|NCT05906121|Anesthetics, Local|anesthetics, local|mesh-ancestor
154814743|NCT05906121|Anesthetics|anesthetics|mesh-ancestor
154814744|NCT05906121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814745|NCT05906121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814746|NCT05906121|Sensory System Agents|sensory system agents|mesh-ancestor
154814747|NCT05906121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814748|NCT05906121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154814749|NCT05906121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154814750|NCT05906121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154814751|NCT05906121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814752|NCT05906121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814753|NCT05906121|Analgesics|analgesics|mesh-ancestor
154814754|NCT05906121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154814755|NCT05906121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154814756|NCT05906121|Anesthetics, General|anesthetics, general|mesh-ancestor
154814757|NCT05906121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154814758|NCT05906121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154814759|NCT05906121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814760|NCT05904587|Imidacloprid|imidacloprid|mesh-list
154814761|NCT05904587|Cholinergic Agents|cholinergic agents|mesh-ancestor
154814762|NCT05904587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814763|NCT05904587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814764|NCT05904587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814765|NCT05904457|Bevacizumab|bevacizumab|mesh-list
154814766|NCT05904457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154814767|NCT05904457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814768|NCT05904457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814769|NCT05904457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154814770|NCT05904457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154814771|NCT05904457|Growth Substances|growth substances|mesh-ancestor
154814772|NCT05904457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814773|NCT05904457|Growth Inhibitors|growth inhibitors|mesh-ancestor
154814774|NCT05904457|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154814775|NCT05904457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154814776|NCT05904457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814777|NCT05904457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814778|NCT05904275|Dexamethasone|dexamethasone|mesh-list
154814779|NCT05904275|Ropivacaine|ropivacaine|mesh-list
154814780|NCT05904275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814781|NCT05904275|Antiemetics|antiemetics|mesh-ancestor
154814782|NCT05904275|Autonomic Agents|autonomic agents|mesh-ancestor
154814783|NCT05904275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814784|NCT05904275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814785|NCT05904275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154814786|NCT05904275|Glucocorticoids|glucocorticoids|mesh-ancestor
154814787|NCT05904275|Hormones|hormones|mesh-ancestor
154814788|NCT05904275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994252|NCT02551549|Rezafungin|rezafungin|mesh-list
154814789|NCT05904275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154814790|NCT05904275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814791|NCT05904275|Anesthetics, Local|anesthetics, local|mesh-ancestor
154814792|NCT05904275|Anesthetics|anesthetics|mesh-ancestor
154814793|NCT05904275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814794|NCT05904275|Sensory System Agents|sensory system agents|mesh-ancestor
154814795|NCT05904184|Calcium, Dietary|calcium, dietary|mesh-list
154814796|NCT05904184|Calcium|calcium|mesh-list
154814797|NCT05904184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154814798|NCT05904184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814799|NCT05904184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154814800|NCT05904119|Lomustine|lomustine|mesh-list
154814801|NCT05904119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154814802|NCT05904119|Alkylating Agents|alkylating agents|mesh-ancestor
154814803|NCT05904119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814804|NCT05904119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814805|NCT05904002|Budesonide|budesonide|mesh-list
154814806|NCT05904002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814807|NCT05904002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154814808|NCT05904002|Autonomic Agents|autonomic agents|mesh-ancestor
154814809|NCT05904002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814810|NCT05904002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814811|NCT05904002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154814812|NCT05904002|Respiratory System Agents|respiratory system agents|mesh-ancestor
154814813|NCT05904002|Glucocorticoids|glucocorticoids|mesh-ancestor
154814814|NCT05904002|Hormones|hormones|mesh-ancestor
154814815|NCT05904002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814816|NCT05903963|Midazolam|midazolam|mesh-list
154814817|NCT05903963|Dexmedetomidine|dexmedetomidine|mesh-list
154814818|NCT05903963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153994288|NCT00645853|Warfarin|warfarin|mesh-list
154814819|NCT05903963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814820|NCT05903963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814821|NCT05903963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814822|NCT05903963|Analgesics|analgesics|mesh-ancestor
154814823|NCT05903963|Sensory System Agents|sensory system agents|mesh-ancestor
154814824|NCT05903963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814825|NCT05903963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154814826|NCT05903963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154814827|NCT05903963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154814828|NCT05903963|Adrenergic Agents|adrenergic agents|mesh-ancestor
154814829|NCT05903963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814830|NCT05903963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814831|NCT05903963|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154814832|NCT05903963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154814833|NCT05903963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154814834|NCT05903963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154814835|NCT05903963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154814836|NCT05903963|Anesthetics, General|anesthetics, general|mesh-ancestor
154814837|NCT05903963|Anesthetics|anesthetics|mesh-ancestor
154814838|NCT05903963|GABA Modulators|gaba modulators|mesh-ancestor
154814839|NCT05903963|GABA Agents|gaba agents|mesh-ancestor
154814840|NCT05903937|Melphalan|melphalan|mesh-list
154814841|NCT05903937|Interleukin-2|interleukin-2|mesh-list
154814842|NCT05903937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154814843|NCT05903937|Alkylating Agents|alkylating agents|mesh-ancestor
154814844|NCT05903937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814845|NCT05903937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814846|NCT05903937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154814847|NCT05903937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814848|NCT05903937|Immunologic Factors|immunologic factors|mesh-ancestor
154814849|NCT05903937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814850|NCT05903937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814851|NCT05903937|Analgesics|analgesics|mesh-ancestor
154814852|NCT05903937|Sensory System Agents|sensory system agents|mesh-ancestor
154814853|NCT05903937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814854|NCT05903833|Pembrolizumab|pembrolizumab|mesh-list
154814855|NCT05903833|Lenvatinib|lenvatinib|mesh-list
154814856|NCT05903833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154814857|NCT05903833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814858|NCT05903833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154814859|NCT05903833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814860|NCT05903833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154814861|NCT05903833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814862|NCT05903755|Methamphetamine|methamphetamine|mesh-list
154814863|NCT05903755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154814864|NCT05903755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814865|NCT05903755|Sympathomimetics|sympathomimetics|mesh-ancestor
154814866|NCT05903755|Autonomic Agents|autonomic agents|mesh-ancestor
154814867|NCT05903755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814868|NCT05903755|Dopamine Agents|dopamine agents|mesh-ancestor
154814869|NCT05903755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814870|NCT05903755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814871|NCT05903755|Adrenergic Agents|adrenergic agents|mesh-ancestor
154814872|NCT05903755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154814873|NCT05903755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154814874|NCT05903755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814875|NCT05903755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154814876|NCT05903716|Isotretinoin|isotretinoin|mesh-list
154814877|NCT05903716|Hormones|hormones|mesh-list
154814878|NCT05903716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814879|NCT05903716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814880|NCT05903716|Dermatologic Agents|dermatologic agents|mesh-ancestor
154814881|NCT05903703|Canagliflozin|canagliflozin|mesh-list
154814882|NCT05903703|Gemcitabine|gemcitabine|mesh-list
154814883|NCT05903703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154814884|NCT05903703|Antimetabolites|antimetabolites|mesh-ancestor
154814885|NCT05903703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814886|NCT05903703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814887|NCT05903703|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154814888|NCT05903703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154814889|NCT05903703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814891|NCT05903456|Immunologic Factors|immunologic factors|mesh-list
154814892|NCT05903456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814893|NCT05903456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154814894|NCT05903456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814895|NCT05903456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814896|NCT05903456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814897|NCT05903326|Dexmedetomidine|dexmedetomidine|mesh-list
154814898|NCT05903326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154814899|NCT05903326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814900|NCT05903326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814901|NCT05903326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814902|NCT05903326|Analgesics|analgesics|mesh-ancestor
154814903|NCT05903326|Sensory System Agents|sensory system agents|mesh-ancestor
154814904|NCT05903326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814905|NCT05903326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154814906|NCT05903326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154814907|NCT05903326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154814908|NCT05903326|Adrenergic Agents|adrenergic agents|mesh-ancestor
154814909|NCT05903326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154814910|NCT05903326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814911|NCT05902728|Itraconazole|itraconazole|mesh-list
154814912|NCT05902728|Rifampin|rifampin|mesh-list
154814913|NCT05902728|Antifungal Agents|antifungal agents|mesh-ancestor
154814914|NCT05902728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154814915|NCT05902728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154814916|NCT05902728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154814917|NCT05902728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814918|NCT05902728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814919|NCT05902728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154814920|NCT05902728|Hormone Antagonists|hormone antagonists|mesh-ancestor
154814921|NCT05902728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814922|NCT05902728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814923|NCT05902728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154814924|NCT05902728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154814925|NCT05902728|Antitubercular Agents|antitubercular agents|mesh-ancestor
154814926|NCT05902728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154814927|NCT05902728|Leprostatic Agents|leprostatic agents|mesh-ancestor
154814928|NCT05902728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154814929|NCT05902728|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154814930|NCT05902728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154814931|NCT05902728|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154814932|NCT05902728|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154814933|NCT05902728|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154814934|NCT05902728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154814935|NCT05902468|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154814936|NCT05902468|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154814937|NCT05902468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154814938|NCT05902429|Cladribine|cladribine|mesh-list
154814939|NCT05902429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814940|NCT05902429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814941|NCT05902429|Immunologic Factors|immunologic factors|mesh-ancestor
154814942|NCT05902429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814943|NCT05901428|Cyclophosphamide|cyclophosphamide|mesh-list
154814944|NCT05901428|Carboplatin|carboplatin|mesh-list
154814945|NCT05901428|Docetaxel|docetaxel|mesh-list
154814946|NCT05901428|Epirubicin|epirubicin|mesh-list
154814947|NCT05901428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154814948|NCT05901428|Immunologic Factors|immunologic factors|mesh-ancestor
154814949|NCT05901428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814950|NCT05901428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154814951|NCT05901428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154814952|NCT05901428|Alkylating Agents|alkylating agents|mesh-ancestor
154814953|NCT05901428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814954|NCT05901428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154814955|NCT05901428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154814956|NCT05901428|Tubulin Modulators|tubulin modulators|mesh-ancestor
154814957|NCT05901428|Antimitotic Agents|antimitotic agents|mesh-ancestor
154814958|NCT05901428|Mitosis Modulators|mitosis modulators|mesh-ancestor
154814959|NCT05901428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154814960|NCT05901428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154814961|NCT05901428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154814962|NCT05901428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154814963|NCT05895643|Semaglutide|semaglutide|mesh-list
154814964|NCT05895643|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154814965|NCT05895643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154814966|NCT05895643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814967|NCT05895383|Nitrous Oxide|nitrous oxide|mesh-list
154814968|NCT05895383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154814969|NCT05895383|Anesthetics, General|anesthetics, general|mesh-ancestor
154814970|NCT05895383|Anesthetics|anesthetics|mesh-ancestor
154814971|NCT05895383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814972|NCT05895383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814973|NCT05895383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154814974|NCT05895383|Analgesics|analgesics|mesh-ancestor
154814975|NCT05895383|Sensory System Agents|sensory system agents|mesh-ancestor
154814976|NCT05895383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814977|NCT05861570|Triamcinolone|triamcinolone|mesh-list
154814978|NCT05861570|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154814979|NCT05861570|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154814980|NCT05861570|Lidocaine|lidocaine|mesh-list
154814981|NCT05861570|Hyaluronic Acid|hyaluronic acid|mesh-list
154814982|NCT05861570|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154814983|NCT05861570|Anesthetics, Local|anesthetics, local|mesh-ancestor
154814984|NCT05861570|Anesthetics|anesthetics|mesh-ancestor
154814985|NCT05861570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154814986|NCT05861570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814987|NCT05861570|Sensory System Agents|sensory system agents|mesh-ancestor
154814988|NCT05861570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154814989|NCT05861570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154814990|NCT05861570|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154814991|NCT05861570|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154814992|NCT05861570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154814993|NCT05861570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154814994|NCT05861570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154814995|NCT05861570|Glucocorticoids|glucocorticoids|mesh-ancestor
154814996|NCT05861570|Hormones|hormones|mesh-ancestor
154814997|NCT05861570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154814998|NCT05861570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994483|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154814999|NCT05861570|Immunologic Factors|immunologic factors|mesh-ancestor
154815000|NCT05861570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815001|NCT05861570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154815002|NCT05861570|Viscosupplements|viscosupplements|mesh-ancestor
154815003|NCT05861570|Protective Agents|protective agents|mesh-ancestor
154815004|NCT05857163|Amoxicillin|amoxicillin|mesh-list
154815005|NCT05857163|Clarithromycin|clarithromycin|mesh-list
154815006|NCT05857163|Potassium Citrate|potassium citrate|mesh-list
154815007|NCT05857163|Rabeprazole|rabeprazole|mesh-list
154815008|NCT05857163|Bismuth|bismuth|mesh-list
154815009|NCT05857163|Citric Acid|citric acid|mesh-list
154815010|NCT05857163|Sodium Citrate|sodium citrate|mesh-list
154815011|NCT05857163|Anticoagulants|anticoagulants|mesh-ancestor
154815012|NCT05857163|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154815013|NCT05857163|Chelating Agents|chelating agents|mesh-ancestor
154815014|NCT05857163|Sequestering Agents|sequestering agents|mesh-ancestor
154815015|NCT05857163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815016|NCT05857163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154815017|NCT05857163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815018|NCT05857163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154815019|NCT05857163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815020|NCT05857163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154815021|NCT05857163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154815022|NCT05857163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154815023|NCT05857163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154815024|NCT05857163|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154815025|NCT05857163|Antacids|antacids|mesh-ancestor
154815026|NCT05857163|Diuretics|diuretics|mesh-ancestor
154815027|NCT05857163|Natriuretic Agents|natriuretic agents|mesh-ancestor
154815028|NCT05857163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815029|NCT05857163|Expectorants|expectorants|mesh-ancestor
154815030|NCT05857163|Respiratory System Agents|respiratory system agents|mesh-ancestor
154815031|NCT05839301|Vaccines|vaccines|mesh-list
154815032|NCT05839301|Immunologic Factors|immunologic factors|mesh-ancestor
154815033|NCT05839301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815034|NCT05821556|Paclitaxel|paclitaxel|mesh-list
154815035|NCT05821556|Gemcitabine|gemcitabine|mesh-list
154815036|NCT05821556|Capecitabine|capecitabine|mesh-list
154815037|NCT05821556|Valproic Acid|valproic acid|mesh-list
154815038|NCT05821556|Simvastatin|simvastatin|mesh-list
154815039|NCT05821556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154815040|NCT05821556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815041|NCT05821556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154815042|NCT05821556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154815043|NCT05821556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154815044|NCT05821556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815045|NCT05821556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815046|NCT05821556|Antimetabolites|antimetabolites|mesh-ancestor
154815047|NCT05821556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154815048|NCT05821556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154815049|NCT05821556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154815050|NCT05821556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154815051|NCT05821556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815052|NCT05821556|Anticonvulsants|anticonvulsants|mesh-ancestor
154815053|NCT05821556|GABA Agents|gaba agents|mesh-ancestor
154815054|NCT05821556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815055|NCT05821556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815056|NCT05821556|Antimanic Agents|antimanic agents|mesh-ancestor
154815057|NCT05821556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154815058|NCT05821556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815059|NCT05821556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154815060|NCT05767359|Cyclophosphamide|cyclophosphamide|mesh-list
154815061|NCT05767359|Fludarabine|fludarabine|mesh-list
154815062|NCT05767359|Fludarabine phosphate|fludarabine phosphate|mesh-list
154815063|NCT05767359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154815064|NCT05767359|Immunologic Factors|immunologic factors|mesh-ancestor
154815065|NCT05767359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815066|NCT05767359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815067|NCT05767359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154815068|NCT05767359|Alkylating Agents|alkylating agents|mesh-ancestor
154815069|NCT05767359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815070|NCT05767359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815071|NCT05767359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154815072|NCT05767359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815073|NCT05767359|Antimetabolites|antimetabolites|mesh-ancestor
154815074|NCT05733286|Suvorexant|suvorexant|mesh-list
154815075|NCT05733286|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154815076|NCT05733286|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154815077|NCT05733286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815078|NCT05733286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815079|NCT05733286|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154815080|NCT05733286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815081|NCT05733286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815082|NCT05669625|Vaccines|vaccines|mesh-list
154815083|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
154815084|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815085|NCT05663411|Cinacalcet|cinacalcet|mesh-list
154815086|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154815087|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815088|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154815089|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
154815090|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154815091|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
154815092|NCT05634785|Fludarabine|fludarabine|mesh-list
154815093|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154815094|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
154815095|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815096|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815097|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154815098|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
154815099|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815100|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815101|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154815102|NCT05600231|Listerine|listerine|mesh-list
154815103|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154815104|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
154815105|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
154815106|NCT05600231|Protective Agents|protective agents|mesh-ancestor
154815107|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815108|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815109|NCT05510895|Cetuximab|cetuximab|mesh-list
154815110|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815111|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815112|NCT05489731|Osimertinib|osimertinib|mesh-list
154815113|NCT05489731|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154815114|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154815115|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815116|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815117|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815118|NCT05478291|Vitamin D|vitamin d|mesh-list
154815119|NCT05478291|Vitamins|vitamins|mesh-ancestor
154815120|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
154815121|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815122|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154815123|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154815124|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154815125|NCT05463367|Acetaminophen|acetaminophen|mesh-list
154815126|NCT05463367|Naproxen|naproxen|mesh-list
154815127|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154815128|NCT05463367|Oxymorphone|oxymorphone|mesh-list
154815129|NCT05463367|Morphine|morphine|mesh-list
154815130|NCT05463367|Oxycodone|oxycodone|mesh-list
154815131|NCT05463367|Tramadol|tramadol|mesh-list
154815132|NCT05463367|Hydrocodone|hydrocodone|mesh-list
154815133|NCT05463367|Codeine|codeine|mesh-list
154815134|NCT05463367|Levodopa|levodopa|mesh-list
154815135|NCT05463367|Carbidopa|carbidopa|mesh-list
154815136|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154815137|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154815138|NCT05463367|Narcotics|narcotics|mesh-ancestor
154815139|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815140|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815141|NCT05463367|Analgesics|analgesics|mesh-ancestor
154815142|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
154815143|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815144|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815145|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
154815146|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154815147|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154815148|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815149|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
154815150|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154815151|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815152|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815153|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154815154|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154815155|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
154815156|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815157|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154815158|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
154815159|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
154815160|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154815161|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
154815162|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
154815163|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154815164|NCT05382871|Vaccines|vaccines|mesh-list
154815165|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
154815166|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815167|NCT05374954|Vaccines|vaccines|mesh-list
154815168|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
154815169|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815170|NCT05363007|Leucovorin|leucovorin|mesh-list
154815171|NCT05363007|Irinotecan|irinotecan|mesh-list
154815172|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154815173|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154815174|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815175|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815176|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815177|NCT05363007|Antidotes|antidotes|mesh-ancestor
154815178|NCT05363007|Protective Agents|protective agents|mesh-ancestor
154815179|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815180|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
154815181|NCT05363007|Vitamins|vitamins|mesh-ancestor
154815182|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
154815183|NCT05351606|Bupropion|bupropion|mesh-list
154815184|NCT05351606|Nicotine|nicotine|mesh-list
154815185|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154815186|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
154815187|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815188|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815189|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154815191|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
154815192|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815193|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815194|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154815195|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
154815196|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154815197|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154815198|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154815199|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154815200|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
154815201|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154815202|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154815203|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815204|NCT05346159|Androgens|androgens|mesh-list
154815205|NCT05346159|Hormones|hormones|mesh-ancestor
154815206|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154815207|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815208|NCT05329090|Rituximab|rituximab|mesh-list
154815209|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815210|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815211|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
154815212|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815213|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815214|NCT05328154|Diphosphonates|diphosphonates|mesh-list
154815215|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153994662|NCT00809029|Hormones|hormones|mesh-ancestor
154815216|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815217|NCT05324059|Pregabalin|pregabalin|mesh-list
154815218|NCT05324059|Tramadol|tramadol|mesh-list
154815219|NCT05324059|Analgesics|analgesics|mesh-ancestor
154815220|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
154815221|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815222|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815223|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
154815224|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154815225|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154815226|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815227|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154815228|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154815229|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154815230|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815231|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154815232|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154815233|NCT05324059|Narcotics|narcotics|mesh-ancestor
154815234|NCT05303636|Drospirenone|drospirenone|mesh-list
154815235|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154815236|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
154815237|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154815238|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815239|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154815240|NCT05303636|Diuretics|diuretics|mesh-ancestor
154815241|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
154815242|NCT05226429|Vaccines|vaccines|mesh-list
154815243|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
154815244|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815245|NCT05212012|Methadone|methadone|mesh-list
154815246|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154815247|NCT05212012|Narcotics|narcotics|mesh-ancestor
154815248|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815249|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815250|NCT05212012|Analgesics|analgesics|mesh-ancestor
154815251|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
154815252|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815253|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
154815254|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
154815255|NCT05198804|Niraparib|niraparib|mesh-list
154815256|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154815257|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815258|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815259|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815260|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
154815261|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154815262|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815263|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815264|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815265|NCT05197439|Analgesics|analgesics|mesh-ancestor
154815266|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
154815267|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815268|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154815269|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154815270|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154815271|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
154815272|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815273|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815274|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154815275|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154815276|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815277|NCT05169060|Analgesics|analgesics|mesh-ancestor
154815278|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
154815279|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815280|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815281|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154815282|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815283|NCT05153408|Carboplatin|carboplatin|mesh-list
154815284|NCT05153408|Pemetrexed|pemetrexed|mesh-list
154815285|NCT05153408|Osimertinib|osimertinib|mesh-list
154815286|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815287|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815288|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815289|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154815290|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154815291|NCT05153408|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154815292|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154815293|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
154815294|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154815295|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815296|NCT05100628|Doxorubicin|doxorubicin|mesh-list
154815297|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154815298|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815299|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154815300|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154815301|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815302|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815303|NCT05091619|Vaccines|vaccines|mesh-list
154815304|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
154815305|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815306|NCT05089370|Nivolumab|nivolumab|mesh-list
154815307|NCT05089370|Decitabine|decitabine|mesh-list
154815308|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815309|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815310|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154815311|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815312|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815313|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
154815314|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815315|NCT05084911|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154815316|NCT05084911|Antiviral Agents|antiviral agents|mesh-ancestor
154815317|NCT05084911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815318|NCT05081388|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154815319|NCT05081388|Antiviral Agents|antiviral agents|mesh-ancestor
154815320|NCT05081388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815321|NCT05017246|Lidocaine|lidocaine|mesh-list
154815322|NCT05017246|Morphine|morphine|mesh-list
154815323|NCT05017246|Bupivacaine|bupivacaine|mesh-list
154815324|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
154815325|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
154815326|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815327|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815328|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
154815329|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994799|NCT00811603|Cefazolin|cefazolin|mesh-list
154815330|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154815331|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154815332|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154815333|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154815334|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815335|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154815336|NCT05017246|Narcotics|narcotics|mesh-ancestor
154815337|NCT05017246|Analgesics|analgesics|mesh-ancestor
154815338|NCT05007041|Vaccines|vaccines|mesh-list
154815339|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
154815340|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815341|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
154815342|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815343|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815344|NCT04883255|Dronabinol|dronabinol|mesh-list
154815345|NCT04883255|Cannabidiol|cannabidiol|mesh-list
154815346|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
154815347|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
154815348|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815349|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154815350|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815351|NCT04883255|Analgesics|analgesics|mesh-ancestor
154815352|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
154815353|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815354|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154815355|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154815356|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815357|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815358|NCT04883255|Hormones|hormones|mesh-ancestor
154815359|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154815360|NCT04880850|Insulin|insulin|mesh-list
153994829|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
154815361|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154815362|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
154815363|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
154815364|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154815365|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815366|NCT04868838|Daratumumab|daratumumab|mesh-list
154815367|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815368|NCT04863638|Vaccines|vaccines|mesh-list
154815369|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
154815370|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815371|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
154815372|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
154815373|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815374|NCT04790786|Sotrovimab|sotrovimab|mesh-list
154815375|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
154815376|NCT04790786|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154815377|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
154815378|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815379|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
154815380|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154815381|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
154815382|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154815383|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815384|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154815385|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154815386|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154815387|NCT04724252|Gabapentin|gabapentin|mesh-list
154815388|NCT04724252|Analgesics|analgesics|mesh-ancestor
154815389|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
154815390|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815391|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815392|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
154815393|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154815394|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154815395|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815396|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154815397|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154815398|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154815399|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815400|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815401|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
154815402|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
154815403|NCT04670068|Fludarabine|fludarabine|mesh-list
154815404|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154815405|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
154815406|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815407|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815408|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154815409|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
154815410|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815411|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815412|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154815413|NCT04618289|Vitamin D|vitamin d|mesh-list
154815414|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
154815415|NCT04618289|Vitamins|vitamins|mesh-ancestor
154815416|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
154815417|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815418|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154815419|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154815420|NCT04617795|Insulin|insulin|mesh-list
154815421|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154815422|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815423|NCT04588441|Adenosine|adenosine|mesh-list
154815424|NCT04588441|Analgesics|analgesics|mesh-ancestor
154815425|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
154815426|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815427|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815428|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154815429|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
154815430|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154815431|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
154815432|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
154815433|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815434|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815435|NCT04578015|Metronidazole|metronidazole|mesh-list
154815436|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815437|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154815438|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154815439|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154815440|NCT04510207|Vaccines|vaccines|mesh-list
154815441|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
154815442|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815443|NCT04445519|Latanoprost|latanoprost|mesh-list
154815444|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154815445|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154815446|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
154815447|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154815448|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815449|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815450|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815451|NCT04268303|Analgesics|analgesics|mesh-ancestor
154815452|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
154815453|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815454|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154815455|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154815456|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154815457|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
154815458|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815459|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815460|NCT04267497|Amphotericin B|amphotericin b|mesh-list
154815461|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154815462|NCT04267497|Amebicides|amebicides|mesh-ancestor
154815463|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154815464|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154815465|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815466|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154815467|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
154815468|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
154815469|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815470|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815471|NCT04266730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154815472|NCT04266730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815473|NCT04263831|Aldesleukin|aldesleukin|mesh-list
154815474|NCT04263831|Interleukin-2|interleukin-2|mesh-list
154815475|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815476|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815477|NCT04263831|Analgesics|analgesics|mesh-ancestor
154815478|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
154815479|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815480|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815481|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154815482|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154815483|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
154815484|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815485|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
154815486|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154815487|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154815488|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815489|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
154815490|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815491|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815492|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
154815493|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154815494|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154815495|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815496|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
154815497|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815498|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815499|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
154815500|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154815501|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154815502|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154815503|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815504|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
154815505|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815506|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
154815507|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815508|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815509|NCT04205227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154815510|NCT04205227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815511|NCT04117074|Bupivacaine|bupivacaine|mesh-list
154815512|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
154815513|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
154815514|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815515|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815516|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
154815517|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815518|NCT04094675|Sirolimus|sirolimus|mesh-list
154815519|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154815520|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815521|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154815522|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815523|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
154815524|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154815525|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
154815526|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815527|NCT04092452|PF-06700841|pf-06700841|mesh-list
154815528|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154815529|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995001|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154815530|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815531|NCT04029116|Fluconazole|fluconazole|mesh-list
154815532|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
154815533|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
154815534|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815535|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154815536|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154815537|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815538|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815539|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154815540|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
154815541|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154815542|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815543|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154815544|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154815545|NCT04025489|Vitamin D|vitamin d|mesh-list
154815546|NCT04025489|Vitamins|vitamins|mesh-ancestor
154815547|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
154815548|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815549|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154815550|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
154815551|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
154815552|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154815553|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
154815554|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154815555|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154815556|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815557|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154815558|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815559|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815560|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154815561|NCT03926026|Fluticasone|fluticasone|mesh-list
154815562|NCT03926026|Xhance|xhance|mesh-list
154815563|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154815564|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154815565|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
154815566|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815567|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815568|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154815569|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
154815570|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
154815571|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154815572|NCT03917082|Tamoxifen|tamoxifen|mesh-list
154815573|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154815574|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815575|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154815576|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
154815577|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154815578|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815579|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154815580|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815581|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154815582|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154815583|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154815584|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154815585|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815586|NCT03739996|Cabotegravir|cabotegravir|mesh-list
154815587|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154815588|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154815589|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154815590|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815591|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815592|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154815593|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154815594|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
154815595|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815596|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154815597|NCT03734029|Paclitaxel|paclitaxel|mesh-list
154815598|NCT03734029|Camptothecin|camptothecin|mesh-list
154815599|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154815600|NCT03734029|Gemcitabine|gemcitabine|mesh-list
154815601|NCT03734029|Capecitabine|capecitabine|mesh-list
154815602|NCT03734029|Trastuzumab|trastuzumab|mesh-list
154815603|NCT03734029|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154815604|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
154815605|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154815606|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815607|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
154815608|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
154815609|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
154815610|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815611|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815612|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
154815613|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815614|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
154815615|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815616|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154815617|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154815618|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815619|NCT03705962|Tobramycin|tobramycin|mesh-list
154815620|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154815621|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815622|NCT03693183|Ketorolac|ketorolac|mesh-list
154815623|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154815624|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154815625|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815626|NCT03693183|Analgesics|analgesics|mesh-ancestor
154815627|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
154815628|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815629|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815630|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154815631|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815632|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154815633|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815634|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815635|NCT03657797|Latanoprost|latanoprost|mesh-list
154815636|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154815637|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154815638|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
154815639|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815640|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815641|NCT03546361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154815642|NCT03546361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815643|NCT03473574|Gemcitabine|gemcitabine|mesh-list
154815644|NCT03473574|Durvalumab|durvalumab|mesh-list
154815645|NCT03473574|Tremelimumab|tremelimumab|mesh-list
154815646|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815647|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815648|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
154815649|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815650|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815651|NCT03472040|Berotralstat|berotralstat|mesh-list
154815652|NCT03472040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154815653|NCT03472040|Protease Inhibitors|protease inhibitors|mesh-ancestor
154815654|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815655|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815656|NCT03428126|Durvalumab|durvalumab|mesh-list
154815657|NCT03428126|Trametinib|trametinib|mesh-list
154815658|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815659|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815660|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154815661|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815662|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815663|NCT03416530|TIC10 compound|tic10 compound|mesh-list
154815664|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815665|NCT03345810|Paclitaxel|paclitaxel|mesh-list
154815666|NCT03345810|Vinorelbine|vinorelbine|mesh-list
154815667|NCT03345810|Carboplatin|carboplatin|mesh-list
154815668|NCT03345810|Gemcitabine|gemcitabine|mesh-list
154815669|NCT03345810|Durvalumab|durvalumab|mesh-list
154815670|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154815671|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815672|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
154815673|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
154815674|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
154815675|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815676|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815677|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
154815678|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815679|NCT03323385|Meloxicam|meloxicam|mesh-list
154815680|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154815681|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815682|NCT03323385|Analgesics|analgesics|mesh-ancestor
154815683|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
154815684|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815685|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815686|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154815687|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815688|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154815689|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154815690|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815691|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815692|NCT03295396|TIC10 compound|tic10 compound|mesh-list
154815693|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815694|NCT03215719|Cisplatin|cisplatin|mesh-list
154815695|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815696|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
154815697|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815698|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815699|NCT03197467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154815700|NCT03197467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815701|NCT03132636|Cemiplimab|cemiplimab|mesh-list
154815702|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815703|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815704|NCT03047993|Azacitidine|azacitidine|mesh-list
154815705|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815706|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
154815707|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815708|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815709|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815710|NCT03044587|Leucovorin|leucovorin|mesh-list
154815711|NCT03044587|Gemcitabine|gemcitabine|mesh-list
154815712|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815713|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815714|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
154815715|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815716|NCT03044587|Antidotes|antidotes|mesh-ancestor
154815717|NCT03044587|Protective Agents|protective agents|mesh-ancestor
154815718|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815719|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
154815720|NCT03044587|Vitamins|vitamins|mesh-ancestor
154815721|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
154815722|NCT02947620|Metformin|metformin|mesh-list
154815723|NCT02947620|Atorvastatin|atorvastatin|mesh-list
154815724|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154815725|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815726|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154815727|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154815728|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
154815729|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815730|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154815731|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154815732|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815733|NCT02869789|Nivolumab|nivolumab|mesh-list
154815734|NCT02869789|Ipilimumab|ipilimumab|mesh-list
154815735|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815736|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815737|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154815738|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815739|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
154815740|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154815741|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
154815742|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154815743|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815744|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154815745|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154815746|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154815747|NCT02760485|Ibrutinib|ibrutinib|mesh-list
154815748|NCT02760485|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154815749|NCT02760485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154815750|NCT02760485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815751|NCT02760485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815752|NCT02661282|Temozolomide|temozolomide|mesh-list
154815753|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153995240|NCT03718130|Vaccines|vaccines|mesh-list
154815754|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
154815755|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815756|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815757|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154815758|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154815759|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815760|NCT02634333|Aflibercept|aflibercept|mesh-list
154815761|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
154815762|NCT02634333|Mitogens|mitogens|mesh-list
154815763|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154815764|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154815765|NCT02634333|Growth Substances|growth substances|mesh-ancestor
154815766|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815767|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
154815768|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815769|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
154815770|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815771|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154815772|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154815773|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815774|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815775|NCT02450331|Atezolizumab|atezolizumab|mesh-list
154815776|NCT02450331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154815777|NCT02450331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995260|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154815778|NCT02450331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815779|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815780|NCT02391025|Citric Acid|citric acid|mesh-list
154815781|NCT02391025|Sodium Citrate|sodium citrate|mesh-list
154815782|NCT02391025|Anticoagulants|anticoagulants|mesh-ancestor
154567741|NCT02224105|Prednisolone|prednisolone|mesh-list
154815783|NCT02391025|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154815784|NCT02391025|Chelating Agents|chelating agents|mesh-ancestor
154815785|NCT02391025|Sequestering Agents|sequestering agents|mesh-ancestor
154815786|NCT02391025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815787|NCT02335944|Nazartinib|nazartinib|mesh-list
154815788|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815789|NCT02299518|Cytarabine|cytarabine|mesh-list
154815790|NCT02299518|Etoposide|etoposide|mesh-list
154815791|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
154815792|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
154815793|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154815794|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815795|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154815796|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154815797|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815798|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815799|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815800|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
154815801|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
154815802|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815803|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154815804|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
154815805|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815806|NCT02299518|Analgesics|analgesics|mesh-ancestor
154815807|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
154815808|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815809|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154815810|NCT02214550|Norinyl|norinyl|mesh-list
154815811|NCT02214550|Mestranol|mestranol|mesh-list
154815812|NCT02214550|Norethindrone|norethindrone|mesh-list
154815813|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154815814|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154815815|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154815816|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
154815817|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154815818|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815819|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154815820|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154815821|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154815822|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154815823|NCT02214550|Estrogens|estrogens|mesh-ancestor
154815824|NCT02214550|Hormones|hormones|mesh-ancestor
154815825|NCT02214550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154815826|NCT02200445|Aldesleukin|aldesleukin|mesh-list
154815827|NCT02200445|Interleukin-2|interleukin-2|mesh-list
154815828|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815829|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154815830|NCT02200445|Analgesics|analgesics|mesh-ancestor
154815831|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
154815832|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815833|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815834|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154815835|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154815836|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
154815837|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815838|NCT02058693|Amphetamine|amphetamine|mesh-list
154815839|NCT02058693|Adderall|adderall|mesh-list
154815840|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154815841|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815842|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
154815843|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
154815844|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815845|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
154815846|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815847|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815848|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154815849|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154815850|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154815851|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154815852|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154815853|NCT02047513|Paclitaxel|paclitaxel|mesh-list
154815854|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154815855|NCT02047513|Gemcitabine|gemcitabine|mesh-list
154815856|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154815857|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815858|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
154815859|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
154815860|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
154815861|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815862|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815863|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
154815864|NCT01991873|Leucovorin|leucovorin|mesh-list
154815865|NCT01991873|Folic Acid|folic acid|mesh-list
154815866|NCT01991873|Fluorouracil|fluorouracil|mesh-list
154815867|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
154815868|NCT01991873|Panitumumab|panitumumab|mesh-list
154815869|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
154815870|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
154815871|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995351|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
154815872|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815873|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815874|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154815875|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
154815876|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815877|NCT01991873|Antidotes|antidotes|mesh-ancestor
154815878|NCT01991873|Protective Agents|protective agents|mesh-ancestor
154815879|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
154815880|NCT01991873|Vitamins|vitamins|mesh-ancestor
154815881|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
154815882|NCT01991873|Hematinics|hematinics|mesh-ancestor
154815883|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815884|NCT01843556|Donepezil|donepezil|mesh-list
154815885|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154815886|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815887|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815888|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
154815889|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815890|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815891|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
154815892|NCT01618136|Paclitaxel|paclitaxel|mesh-list
154815893|NCT01618136|Carboplatin|carboplatin|mesh-list
154815894|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154815895|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815896|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
154815897|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
154815898|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
154815899|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815900|NCT01539031|Donepezil|donepezil|mesh-list
154815901|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154815902|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815903|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815904|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
154815905|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815906|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815907|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
154815908|NCT01328171|Folic Acid|folic acid|mesh-list
154815909|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
154815910|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
154815911|NCT01328171|Irinotecan|irinotecan|mesh-list
154815912|NCT01328171|Panitumumab|panitumumab|mesh-list
154815913|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815914|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154815915|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154815916|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995381|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
154815917|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815918|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815919|NCT01328171|Hematinics|hematinics|mesh-ancestor
154815920|NCT01328171|Vitamins|vitamins|mesh-ancestor
154815921|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
154815922|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815923|NCT01288963|Aldesleukin|aldesleukin|mesh-list
154815924|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815925|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154815926|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154815927|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
154815928|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815929|NCT01269190|Proflavine|proflavine|mesh-list
154815930|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154815931|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567890|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
154815932|NCT01248715|Oseltamivir|oseltamivir|mesh-list
154815933|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
154815934|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154815935|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815936|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815937|NCT00963040|Oxytocin|oxytocin|mesh-list
154815938|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
154815939|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154815940|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815941|NCT00941109|Decitabine|decitabine|mesh-list
154815942|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154815943|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
154815944|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815945|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815946|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815947|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
154815948|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154815949|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154815950|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154815951|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154815952|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815953|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
154815954|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154815955|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815956|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154815957|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154815958|NCT00812214|Eszopiclone|eszopiclone|mesh-list
154815959|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154815960|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154815961|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815962|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
154815963|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
154815964|NCT00444613|Vitamins|vitamins|mesh-ancestor
154815965|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
154815966|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815967|NCT00217425|Prednisone|prednisone|mesh-list
154815968|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
154815969|NCT00217425|Bevacizumab|bevacizumab|mesh-list
154815970|NCT00217425|Doxorubicin|doxorubicin|mesh-list
154815971|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154815972|NCT00217425|Vincristine|vincristine|mesh-list
154815973|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154815974|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
154815975|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154815976|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154815977|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154815978|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
154815979|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154815980|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154815981|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154815982|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154815983|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154815984|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154815985|NCT00217425|Growth Substances|growth substances|mesh-ancestor
154815986|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
154815987|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154815988|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154815989|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154815990|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154815991|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154815992|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
154815993|NCT00217425|Hormones|hormones|mesh-ancestor
154815994|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154815995|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154815996|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154815997|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
154815998|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
154815999|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
154816000|NCT00209599|Fospropofol|fospropofol|mesh-list
154816001|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154816002|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816003|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816004|NCT00060567|Irinotecan|irinotecan|mesh-list
154816005|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
154816006|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154816007|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154816008|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816009|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816010|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816011|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154816012|NCT00049348|Gemcitabine|gemcitabine|mesh-list
154816013|NCT00049348|Fluorouracil|fluorouracil|mesh-list
154816014|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
154816015|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816016|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154816017|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
154816018|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816019|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816020|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
154816021|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816022|NCT00049348|Hematinics|hematinics|mesh-ancestor
154816024|NCT00004125|Paclitaxel|paclitaxel|mesh-list
154816025|NCT00004125|Docetaxel|docetaxel|mesh-list
154816026|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
154816027|NCT00004125|Doxorubicin|doxorubicin|mesh-list
154816028|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154816029|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154816030|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816031|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
154816032|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154816033|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154816034|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816035|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816036|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
154816037|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816038|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816039|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154816040|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
154816041|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154816042|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154816043|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154816044|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154816045|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816046|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154816047|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
154816048|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816049|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154816050|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154816051|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154816052|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154816053|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154816054|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154816055|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816056|NCT03452865|Esomeprazole|esomeprazole|mesh-list
154816057|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154816058|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154816059|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154816060|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816061|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816062|NCT03446001|Methylene Blue|methylene blue|mesh-list
154816063|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816064|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816065|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154816066|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
154816067|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816068|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154816069|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154816070|NCT03102242|Atezolizumab|atezolizumab|mesh-list
154816071|NCT03102242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154816072|NCT03102242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816073|NCT03102242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816074|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816075|NCT03090776|Ketamine|ketamine|mesh-list
154816076|NCT03090776|Analgesics|analgesics|mesh-ancestor
154816077|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
154816078|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816079|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816080|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154816081|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154816082|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
154568038|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816083|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
154816084|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816085|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154816086|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154816087|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816088|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816089|NCT02994784|Melphalan|melphalan|mesh-list
154816090|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154816091|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
154816092|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816093|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816094|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154816095|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816096|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
154816097|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816098|NCT02966847|Anesthetics|anesthetics|mesh-list
154816099|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816100|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816101|NCT02884440|Ropivacaine|ropivacaine|mesh-list
154816102|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
154816103|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995563|NCT02030990|Hormones|hormones|mesh-ancestor
153567733|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816104|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816105|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
154816106|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
154816107|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816108|NCT02851303|Morphine|morphine|mesh-list
154816109|NCT02851303|Methadone|methadone|mesh-list
154816110|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154816111|NCT02851303|Narcotics|narcotics|mesh-ancestor
154816112|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816113|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816114|NCT02851303|Analgesics|analgesics|mesh-ancestor
154816115|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
154816116|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816117|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
154816118|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
154816119|NCT02775500|Apremilast|apremilast|mesh-list
154816120|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154816121|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154816122|NCT02775500|Analgesics|analgesics|mesh-ancestor
154816123|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
154816124|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816125|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816126|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816127|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816128|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154816129|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154816130|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816131|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816132|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
154816133|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154816134|NCT02549170|Antibodies|antibodies|mesh-list
154816135|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
154816136|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
154816137|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154816138|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
154816139|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816140|NCT02384122|Octreotide|octreotide|mesh-list
154816141|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154816142|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154816143|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816144|NCT02103361|Ustekinumab|ustekinumab|mesh-list
154816145|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
154816146|NCT01918397|Levofloxacin|levofloxacin|mesh-list
154816147|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154816148|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816149|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154816150|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154816151|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154816152|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816153|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816154|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816155|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154816156|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154816158|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154816159|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816160|NCT01611116|Sirolimus|sirolimus|mesh-list
154816161|NCT01611116|Temsirolimus|temsirolimus|mesh-list
154816162|NCT01611116|MTOR Inhibitors|mtor inhibitors|mesh-list
154816163|NCT01611116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154816164|NCT01611116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816165|NCT01611116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816166|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816167|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
154816168|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816169|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816170|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154816171|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816172|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154816173|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
154816174|NCT01576315|Itraconazole|itraconazole|mesh-list
154816175|NCT01576315|Voriconazole|voriconazole|mesh-list
154816176|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
154816177|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816178|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154816179|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154816180|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816181|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816182|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154816183|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
154816184|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816185|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816186|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154816187|NCT01388387|Tacrolimus|tacrolimus|mesh-list
154816188|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816189|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
154816190|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816191|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154816192|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816193|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816194|NCT01039090|Dopamine|dopamine|mesh-list
154816195|NCT01039090|Apomorphine|apomorphine|mesh-list
154816196|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
154816197|NCT01039090|Emetics|emetics|mesh-ancestor
154816198|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816199|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
154816200|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816201|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154816202|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
154816203|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816204|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816205|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154816206|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
154816207|NCT01039090|Protective Agents|protective agents|mesh-ancestor
154816208|NCT00819637|Albuterol|albuterol|mesh-list
154816209|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
154816210|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154816211|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
154816212|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816213|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816214|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154816215|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
154816216|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154816217|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154816218|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154816219|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
154816220|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816221|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816222|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
154816223|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154816224|NCT00593060|Sirolimus|sirolimus|mesh-list
154816225|NCT00593060|Cetuximab|cetuximab|mesh-list
154816226|NCT00593060|Temsirolimus|temsirolimus|mesh-list
154816227|NCT00593060|MTOR Inhibitors|mtor inhibitors|mesh-list
154816228|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816229|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816230|NCT00593060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154816231|NCT00593060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816232|NCT00593060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816233|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816234|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
154816235|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816236|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154816237|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816238|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154816239|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
154816240|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
154816241|NCT00287105|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154816242|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154816243|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816244|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816245|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816246|NCT01332357|Fluticasone|fluticasone|mesh-list
154816247|NCT01332357|Xhance|xhance|mesh-list
154816248|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154816249|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154816250|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816251|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154816252|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
154816253|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816254|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816255|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154816256|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
153995703|NCT00574405|Insulin|insulin|mesh-list
154816257|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
154816258|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154816259|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154816260|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154816261|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154816262|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
154816263|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816264|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816265|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
154816266|NCT01332357|Hormones|hormones|mesh-ancestor
154816267|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816268|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
154816269|NCT04914936|Rifampin|rifampin|mesh-list
154816270|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
154816271|NCT04914936|Omeprazole|omeprazole|mesh-list
154816272|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
154816273|NCT04914936|Calcium|calcium|mesh-list
154816274|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154816275|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816276|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154816277|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154816278|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154816279|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816280|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816281|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154816282|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
154816283|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154816284|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816285|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
154816286|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154816287|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154816288|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154816289|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154816290|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154816291|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154816292|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154816293|NCT04914936|Antacids|antacids|mesh-ancestor
154816294|NCT04914936|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154816295|NCT04914936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154816296|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816297|NCT03054948|SMOFlipid|smoflipid|mesh-list
154816298|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154816299|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154816300|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154816301|NCT00986921|Mifepristone|mifepristone|mesh-list
154816302|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154816303|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
154816304|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154816305|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816306|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154816307|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154816308|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154816309|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
154816310|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154816311|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154816312|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
154816313|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816314|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
154816315|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154816316|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154816317|NCT01383759|Dexamethasone|dexamethasone|mesh-list
154816318|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
154816319|NCT01383759|Bortezomib|bortezomib|mesh-list
154816320|NCT01383759|BB 1101|bb 1101|mesh-list
154816321|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816322|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
154816323|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
154816324|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816325|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816326|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154816327|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
154816328|NCT01383759|Hormones|hormones|mesh-ancestor
154816329|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816330|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154816331|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816332|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
154816333|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816334|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816335|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
154816336|NCT01384539|Vitamin D|vitamin d|mesh-list
154816337|NCT01384539|Calcitriol|calcitriol|mesh-list
154816338|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154816339|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816340|NCT01384539|Vitamins|vitamins|mesh-ancestor
154816341|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
154816342|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154816343|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154816344|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154816345|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816346|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154816347|NCT04902222|Morphine|morphine|mesh-list
154816348|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154816349|NCT04902222|Narcotics|narcotics|mesh-ancestor
154816350|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816351|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816352|NCT04902222|Analgesics|analgesics|mesh-ancestor
154816353|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
154816354|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816355|NCT04904406|Lamivudine|lamivudine|mesh-list
154816356|NCT04904406|Abacavir|abacavir|mesh-list
154816357|NCT04904406|Dolutegravir|dolutegravir|mesh-list
154816358|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154816359|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154816360|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816361|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816362|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
154816363|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816364|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154816365|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154816366|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154816367|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154816368|NCT00985751|Vaccines|vaccines|mesh-list
154816369|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154816370|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
154816371|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816372|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154816373|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154816374|NCT04884516|Vitamin A|vitamin a|mesh-list
154816375|NCT04884516|Vitamins|vitamins|mesh-ancestor
154816376|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
154816377|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816378|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
154816379|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
154816380|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154816381|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154816383|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816384|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816385|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816386|NCT04883736|Tretinoin|tretinoin|mesh-list
154816387|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816388|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
154816389|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
154816390|NCT01387815|Adalimumab|adalimumab|mesh-list
154816391|NCT01387815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154816392|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816393|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816394|NCT04883034|Analgesics|analgesics|mesh-list
154816395|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
154816396|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816397|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816398|NCT01596504|Metformin|metformin|mesh-list
154816399|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
154816400|NCT01596504|Liraglutide|liraglutide|mesh-list
154816401|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154816402|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816403|NCT01596504|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154816404|NCT01596504|Incretins|incretins|mesh-ancestor
154816405|NCT01596504|Hormones|hormones|mesh-ancestor
154816406|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816407|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154816408|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154816409|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816410|NCT01334229|Incretins|incretins|mesh-ancestor
154816411|NCT01334229|Hormones|hormones|mesh-ancestor
154816412|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816413|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154816414|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
154816415|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816416|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816417|NCT01390077|Nitisinone|nitisinone|mesh-list
154816418|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816419|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816420|NCT02292979|Doxorubicin|doxorubicin|mesh-list
154816421|NCT02292979|Bleomycin|bleomycin|mesh-list
154816422|NCT02292979|Dacarbazine|dacarbazine|mesh-list
154816423|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154816424|NCT02292979|Vinblastine|vinblastine|mesh-list
154816425|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154816426|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816427|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154816428|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154816429|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816430|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816431|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154816432|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
154816433|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816434|NCT02292979|Immunotoxins|immunotoxins|mesh-ancestor
154816435|NCT02292979|Immunoconjugates|immunoconjugates|mesh-ancestor
153995885|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
154816436|NCT02292979|Immunologic Factors|immunologic factors|mesh-ancestor
154816437|NCT02292979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816438|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154816439|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
154816440|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
154816441|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
154816442|NCT02394535|Paclitaxel|paclitaxel|mesh-list
154816443|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154816444|NCT02394535|Capecitabine|capecitabine|mesh-list
154816445|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154816446|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816447|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
154816448|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
154816449|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
154816450|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816451|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154816452|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
154816453|NCT02285959|Bevacizumab|bevacizumab|mesh-list
154816454|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816455|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816456|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154816457|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154816458|NCT02285959|Growth Substances|growth substances|mesh-ancestor
154816459|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816460|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
154816462|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154816463|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
154816464|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154816465|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816466|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154816467|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
154816468|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816469|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816470|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
154816471|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816472|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154816473|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816474|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
154816475|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816476|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154816477|NCT03051906|Cetuximab|cetuximab|mesh-list
154816478|NCT03051906|Durvalumab|durvalumab|mesh-list
154816479|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816480|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816481|NCT01390233|Dinoprostone|dinoprostone|mesh-list
154816482|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
154816483|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154816484|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816485|NCT03051360|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154816486|NCT03051360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154816487|NCT03051360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154816488|NCT03051360|Antimetabolites|antimetabolites|mesh-ancestor
154816489|NCT03051360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816490|NCT03051360|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154816491|NCT03051360|Protease Inhibitors|protease inhibitors|mesh-ancestor
154816492|NCT03051360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816493|NCT03051360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154816494|NCT05026567|Midazolam|midazolam|mesh-list
154816495|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154816496|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154816497|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816498|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816499|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154816500|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154816501|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154816502|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154816503|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
154816504|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
154816505|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
154816506|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
154816507|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816508|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816509|NCT01391013|Ritonavir|ritonavir|mesh-list
154816510|NCT01391013|Darunavir|darunavir|mesh-list
154816511|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154816512|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154816513|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154816514|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
154816515|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816516|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816517|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154816518|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154816519|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
154816520|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816521|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154816522|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154816523|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154816524|NCT01891747|Bevacizumab|bevacizumab|mesh-list
154816525|NCT01891747|Temozolomide|temozolomide|mesh-list
154816526|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816527|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816528|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154816529|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154816530|NCT01891747|Growth Substances|growth substances|mesh-ancestor
154568489|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
154816531|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816532|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
154816533|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154816534|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
154816535|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816536|NCT04899570|Prednisone|prednisone|mesh-list
154816537|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
154816538|NCT04899570|Rituximab|rituximab|mesh-list
154816539|NCT04899570|Epirubicin|epirubicin|mesh-list
154816540|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
154816541|NCT04899570|Vindesine|vindesine|mesh-list
154816542|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816543|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
154816544|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816545|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816546|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154816547|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
154816548|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816549|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816550|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154816551|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816552|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816553|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
154816554|NCT04899570|Hormones|hormones|mesh-ancestor
154816555|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816556|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154816557|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154816558|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154816559|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154816560|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816561|NCT04899570|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154816562|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154816563|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154816564|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
154816565|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
154816566|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
154816567|NCT02274415|Vaccines|vaccines|mesh-list
154816568|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154816569|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
154816570|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816571|NCT03049878|Acetaminophen|acetaminophen|mesh-list
154816572|NCT03049878|Codeine|codeine|mesh-list
154816573|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154816574|NCT03049878|Analgesics|analgesics|mesh-ancestor
154816575|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
154816576|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816577|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816578|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
154816579|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154816580|NCT03049878|Narcotics|narcotics|mesh-ancestor
154816581|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816582|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
154816583|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
154816584|NCT01391325|Allopurinol|allopurinol|mesh-list
154816585|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
154816586|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816587|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816588|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
154816589|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816590|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154816591|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
154816592|NCT01391325|Protective Agents|protective agents|mesh-ancestor
154816593|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816594|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
154816595|NCT04891458|Anesthetics|anesthetics|mesh-list
154816596|NCT04891458|Propofol|propofol|mesh-list
154816597|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816598|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816599|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154816600|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154816601|NCT04891458|Analgesics|analgesics|mesh-ancestor
154816602|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
154816603|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816604|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154816605|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154568567|NCT02233621|Estradiol|estradiol|mesh-list
154816606|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154816607|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
154816608|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816609|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816610|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154816611|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
154816612|NCT04899414|Dexamethasone|dexamethasone|mesh-list
154816613|NCT04899414|Azacitidine|azacitidine|mesh-list
154816614|NCT04899414|Tislelizumab|tislelizumab|mesh-list
154816615|NCT04899414|Pegaspargase|pegaspargase|mesh-list
154816616|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816617|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
154816618|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
154816619|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816620|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816621|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154816622|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
154816623|NCT04899414|Hormones|hormones|mesh-ancestor
154816624|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816625|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154816626|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816627|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154816628|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
154816629|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816630|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816631|NCT04899414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816632|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
154816633|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154816634|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154816635|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816636|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
154816637|NCT03008655|Coagulants|coagulants|mesh-ancestor
154816638|NCT05585671|Belimumab|belimumab|mesh-list
154816639|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816640|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
154816641|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816642|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154816643|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
154816644|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154816645|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
154816646|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816647|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816648|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154816649|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
154816650|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154816651|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154816652|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154816653|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
154816654|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816655|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816656|NCT01335789|Oxytocin|oxytocin|mesh-list
154816657|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
154816658|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154816659|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816660|NCT02202135|Vancomycin|vancomycin|mesh-list
154816661|NCT02202135|Ceftaroline|ceftaroline|mesh-list
154816662|NCT02202135|Aztreonam|aztreonam|mesh-list
154816663|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154816664|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816665|NCT02202135|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154816666|NCT05585281|Fluzoparib|fluzoparib|mesh-list
154816667|NCT05585281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154816668|NCT05585281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816669|NCT05585281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816670|NCT05585281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816671|NCT01335867|Vigabatrin|vigabatrin|mesh-list
154816672|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
154816673|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816674|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816675|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
154816676|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816677|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816678|NCT01894711|Trastuzumab|trastuzumab|mesh-list
154816679|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568661|NCT01337635|Vitamin D|vitamin d|mesh-list
154816680|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816681|NCT00985439|Celecoxib|celecoxib|mesh-list
154816682|NCT00985439|Diclofenac|diclofenac|mesh-list
154816683|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154816684|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154816685|NCT00985439|Analgesics|analgesics|mesh-ancestor
154816686|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
154816687|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816688|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816689|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816690|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816691|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154816692|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154816693|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816694|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816695|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
154816696|NCT02984111|Hematinics|hematinics|mesh-ancestor
154816697|NCT04412148|Triamcinolone|triamcinolone|mesh-list
154816698|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154816699|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154816700|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154816701|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816702|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
154816703|NCT04412148|Hormones|hormones|mesh-ancestor
154816704|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816705|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816706|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153996165|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
154816707|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
154816708|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816709|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816710|NCT04890522|Gemcitabine|gemcitabine|mesh-list
154816711|NCT04890522|Fluorouracil|fluorouracil|mesh-list
154816712|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816713|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154816714|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
154816715|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816716|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816717|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
154816718|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816719|NCT01525069|Dexamethasone|dexamethasone|mesh-list
154816720|NCT01525069|Gemcitabine|gemcitabine|mesh-list
154816721|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
154816722|NCT01525069|Floxuridine|floxuridine|mesh-list
154816723|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816724|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
154816725|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
154816726|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816727|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816728|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154816729|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
154816730|NCT01525069|Hormones|hormones|mesh-ancestor
154816731|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154816732|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154816733|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816734|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154816735|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
154816736|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816737|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154816738|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154816739|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154816740|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154816741|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154816742|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
154816743|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816744|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996203|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816745|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816746|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
154816747|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154816748|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154816749|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
154816750|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154816751|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816752|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154816753|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154816754|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154816755|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154816756|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816757|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154816758|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154816759|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816760|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816761|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816762|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
154816763|NCT01894867|Antacids|antacids|mesh-ancestor
154816764|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816765|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154816766|NCT01521403|Metronidazole|metronidazole|mesh-list
154816767|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816768|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154816769|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154816770|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154816771|NCT04881942|Menthol|menthol|mesh-list
154816772|NCT04881942|Nicotine|nicotine|mesh-list
154816773|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154816774|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
154816775|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816776|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816777|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154816778|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154816779|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
154816780|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816781|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816782|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
154816783|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
154816784|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
154816785|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816786|NCT04126811|Apatinib|apatinib|mesh-list
154816787|NCT04126811|Ifosfamide|ifosfamide|mesh-list
154816788|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
154816789|NCT04126811|Pirarubicin|pirarubicin|mesh-list
154816790|NCT04126811|Doxorubicin|doxorubicin|mesh-list
154816791|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816792|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154816793|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816794|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816795|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154816796|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
154816797|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154816798|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154816799|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154816800|NCT01406223|Bupropion|bupropion|mesh-list
154816801|NCT01406223|Nicotine|nicotine|mesh-list
154816802|NCT01406223|Varenicline|varenicline|mesh-list
154816803|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154816804|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
154816805|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816806|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816807|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154816808|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154816809|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
154816810|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816811|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816812|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154816813|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
154816814|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154816815|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154816816|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154816817|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154816818|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
154816819|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154816820|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154816821|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816822|NCT02230969|Interferons|interferons|mesh-list
154816823|NCT02230969|Interferon-beta|interferon-beta|mesh-list
154816824|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
154816825|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816826|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
154816827|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154816828|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
154816829|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816830|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154816831|NCT04881474|Ibuprofen|ibuprofen|mesh-list
154816832|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154816833|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154816834|NCT04881474|Analgesics|analgesics|mesh-ancestor
154816835|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
154816836|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816837|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816838|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154816839|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816840|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154816841|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816842|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816843|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154816844|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154816845|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154816846|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154816847|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816848|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816849|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816850|NCT00981149|Analgesics|analgesics|mesh-ancestor
154816851|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
154816852|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816853|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
154816854|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154816855|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
154816856|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
154816857|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154816858|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816859|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154816860|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816861|NCT01595646|Insulin|insulin|mesh-list
154816862|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154816863|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
154816864|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154816865|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816866|NCT01907191|Bupivacaine|bupivacaine|mesh-list
154816867|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
154816868|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
154816869|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154816870|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816871|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
154816872|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816873|NCT01395537|Paclitaxel|paclitaxel|mesh-list
154816874|NCT01395537|Carboplatin|carboplatin|mesh-list
154816875|NCT01395537|Lapatinib|lapatinib|mesh-list
154816876|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154816877|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816878|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
154816879|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
154816880|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
154816881|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816882|NCT01395537|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154816883|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154816884|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816885|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
154816886|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154816887|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154816888|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816889|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
154816890|NCT04898712|Coagulants|coagulants|mesh-ancestor
154816891|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154816892|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154816893|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
154816894|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816895|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
154816896|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154816897|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154816898|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816899|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
154816900|NCT02317549|Coagulants|coagulants|mesh-ancestor
154816901|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
154816902|NCT05583643|Atorvastatin|atorvastatin|mesh-list
154816903|NCT05583643|Calcium|calcium|mesh-list
154816904|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154816905|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816906|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154816907|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154816908|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154816909|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
154816910|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816911|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154816912|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154816913|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816914|NCT02225275|Lenalidomide|lenalidomide|mesh-list
154816915|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
154816916|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
154816917|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816918|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154816919|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154816920|NCT02225275|Growth Substances|growth substances|mesh-ancestor
154816921|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
154816922|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816923|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816924|NCT01897441|Paclitaxel|paclitaxel|mesh-list
154816925|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
154816926|NCT01897441|Doxorubicin|doxorubicin|mesh-list
154816927|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154816928|NCT01897441|Trastuzumab|trastuzumab|mesh-list
154816929|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154816930|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154816931|NCT01897441|Antibodies|antibodies|mesh-list
154816932|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
154816933|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154816934|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154816935|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816936|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154816937|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154816938|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154816939|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816940|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154816941|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
154816942|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816943|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154816944|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154816945|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
154816946|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154816947|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154816948|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154816949|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154816950|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816951|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154816952|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154816953|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
154816954|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816955|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154816956|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154816957|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
154816958|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
154816959|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816960|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816961|NCT04430556|Sertraline|sertraline|mesh-list
154816962|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
154816963|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154816964|NCT04430556|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154816965|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154816966|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154816967|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816968|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816969|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
154816970|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816971|NCT04897854|Folfirinox|folfirinox|mesh-list
154816972|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816973|NCT01892527|Cetuximab|cetuximab|mesh-list
154816974|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154816975|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816976|NCT01399827|Methylphenidate|methylphenidate|mesh-list
154816977|NCT01399827|Amphetamine|amphetamine|mesh-list
154816978|NCT01399827|Adderall|adderall|mesh-list
154816979|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154816980|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
154816981|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154816982|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154816983|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154816984|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154816985|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154816986|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154816987|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816988|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
154816989|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154816990|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154816991|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
154816992|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
154816993|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
154816994|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154816995|NCT04897386|Pemetrexed|pemetrexed|mesh-list
154816996|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154816997|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154816998|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154816999|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154817000|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154817001|NCT04879446|Mitogens|mitogens|mesh-list
154817002|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
154817003|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817004|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
154817005|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154817006|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154817007|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817008|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
154817009|NCT02618382|Coagulants|coagulants|mesh-ancestor
154817010|NCT02177071|Infliximab|infliximab|mesh-list
154817011|NCT02177071|Methotrexate|methotrexate|mesh-list
154817012|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
154817013|NCT02177071|Azathioprine|azathioprine|mesh-list
154817014|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154817015|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
154817016|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154817017|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817018|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154817019|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
154817020|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817021|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817022|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
154817023|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817024|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154817025|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154817026|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
154817027|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154817028|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154817029|NCT02177071|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154817030|NCT02177071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817031|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154817032|NCT04889196|Fluorides|fluorides|mesh-list
154817033|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
154817034|NCT04889196|Protective Agents|protective agents|mesh-ancestor
154817035|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817036|NCT03049176|Tenofovir|tenofovir|mesh-list
154817037|NCT03049176|Emtricitabine|emtricitabine|mesh-list
154817038|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154817039|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154817040|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
154817041|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817042|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154817043|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154817044|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817045|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817046|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154817047|NCT01895023|Midazolam|midazolam|mesh-list
154817048|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
154817049|NCT01895023|GABA Modulators|gaba modulators|mesh-list
154817050|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154817051|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817052|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817053|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154569015|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817054|NCT01895023|Analgesics|analgesics|mesh-ancestor
154817055|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
154817056|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817057|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154817058|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154817059|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154817060|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
154817061|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817062|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817063|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154817064|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154817065|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154817066|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154817067|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154817068|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
154817069|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
154817070|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
154817071|NCT04888728|Nebivolol|nebivolol|mesh-list
154817072|NCT04888728|Paroxetine|paroxetine|mesh-list
154817073|NCT04888728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154817074|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154817075|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154817076|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817077|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817078|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
154817079|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817080|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154817081|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
154817082|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154817083|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154817084|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154817085|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817086|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154817087|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
154817088|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154817089|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154817090|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154817091|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
154817092|NCT04125719|Nivolumab|nivolumab|mesh-list
154817093|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154817094|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817095|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154817096|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817097|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
154817098|NCT01428973|Sirolimus|sirolimus|mesh-list
154817099|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154817100|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817101|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154817102|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
154817103|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154817104|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817105|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817106|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817107|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
154817108|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154817109|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
154817110|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817111|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154817112|NCT01475643|Prednisolone|prednisolone|mesh-list
154817113|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154817114|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
154817115|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154817116|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
154817117|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154817118|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
154817119|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817120|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
154817121|NCT01475643|Hormones|hormones|mesh-ancestor
154817122|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817123|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817124|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154817125|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817126|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
154817127|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
154817128|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817129|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154817130|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154817131|NCT01475643|Protective Agents|protective agents|mesh-ancestor
154817132|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154817133|NCT03004001|Atorvastatin|atorvastatin|mesh-list
154817134|NCT03004001|Alirocumab|alirocumab|mesh-list
154817135|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154817136|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154817137|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154817138|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
154817139|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817140|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154817141|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154817142|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817143|NCT03004001|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154817144|NCT03004001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154817145|NCT03004001|Protease Inhibitors|protease inhibitors|mesh-ancestor
154817146|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
154817147|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817148|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154817149|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154817150|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154817151|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
154817152|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817153|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154817154|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153996604|NCT02993198|Carvedilol|carvedilol|mesh-list
154817155|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817156|NCT03237377|Durvalumab|durvalumab|mesh-list
154817157|NCT03237377|Tremelimumab|tremelimumab|mesh-list
154817158|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154817159|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817160|NCT04124081|Entecavir|entecavir|mesh-list
154817161|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
154817162|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817163|NCT04123925|Nivolumab|nivolumab|mesh-list
154817164|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154817165|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817166|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154817167|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817168|NCT04759079|Antiemetics|antiemetics|mesh-list
154817169|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
154817170|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817171|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817172|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154817173|NCT03048942|Paclitaxel|paclitaxel|mesh-list
154817174|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154817175|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817176|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
154817177|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
154817178|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
154817179|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817180|NCT04393025|Clopidogrel|clopidogrel|mesh-list
154817181|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817182|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817183|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154817184|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154817185|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154817186|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154817187|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
154817188|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817189|NCT05257902|Choline|choline|mesh-list
154817190|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
154817191|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154817192|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
154817193|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817194|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154817195|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154817196|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
154817197|NCT02143219|Leucovorin|leucovorin|mesh-list
154817198|NCT02143219|Folic Acid|folic acid|mesh-list
154817199|NCT02143219|Irinotecan|irinotecan|mesh-list
154817200|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
154817201|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
154817202|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154817203|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154817204|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817205|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817206|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817207|NCT02143219|Antidotes|antidotes|mesh-ancestor
154817208|NCT02143219|Protective Agents|protective agents|mesh-ancestor
154817209|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817210|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
154817211|NCT02143219|Vitamins|vitamins|mesh-ancestor
154817212|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
154817213|NCT02143219|Hematinics|hematinics|mesh-ancestor
154817214|NCT04122911|Temozolomide|temozolomide|mesh-list
154817215|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154817216|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
154817217|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817218|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817219|NCT04122599|Melatonin|melatonin|mesh-list
154817220|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
154817221|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817222|NCT04122599|Protective Agents|protective agents|mesh-ancestor
154817223|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817224|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817225|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154817226|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154817227|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
154817228|NCT03048474|Nivolumab|nivolumab|mesh-list
154817229|NCT03048474|Ipilimumab|ipilimumab|mesh-list
154817230|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154817231|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817232|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154817233|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817234|NCT04121975|Endostar protein|endostar protein|mesh-list
154817235|NCT04121975|Endostatins|endostatins|mesh-list
154817236|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817237|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154817238|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154817239|NCT04121975|Growth Substances|growth substances|mesh-ancestor
154817240|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817241|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
154817242|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
154817243|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154817244|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154817245|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817246|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
154817247|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817248|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817249|NCT03830957|Metoprolol|metoprolol|mesh-list
154817250|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154817251|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154817252|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
154817253|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
154817254|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817255|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817256|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154817257|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154817258|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154817259|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
153996724|NCT02839356|Epinephrine|epinephrine|mesh-list
154817260|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817261|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817262|NCT04121819|Cytarabine|cytarabine|mesh-list
154817263|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154817264|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
154817265|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817266|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817267|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
154817268|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817269|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154817270|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
154817271|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817272|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
154817273|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154817274|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154817275|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
154817276|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817277|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154817278|NCT05189730|Paclitaxel|paclitaxel|mesh-list
154817279|NCT05189730|Carboplatin|carboplatin|mesh-list
154817280|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154817281|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817282|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
154817283|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
154817284|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
154817285|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817286|NCT04121273|Immunomodulating Agents|immunomodulating agents|mesh-list
154817287|NCT04121273|Immunologic Factors|immunologic factors|mesh-ancestor
154817288|NCT04121273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817289|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
154817290|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154817291|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817292|NCT04121039|Apatinib|apatinib|mesh-list
154817293|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817294|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154817295|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817296|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817297|NCT01401543|Tadalafil|tadalafil|mesh-list
154817298|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
154817299|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154817300|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154817301|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817302|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817303|NCT01401543|Urological Agents|urological agents|mesh-ancestor
154817304|NCT04120259|Metformin|metformin|mesh-list
154817305|NCT04120259|Acetic Acid|acetic acid|mesh-list
154817306|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154817307|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817308|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154817309|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817310|NCT04392102|Niraparib|niraparib|mesh-list
154817311|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154817312|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817313|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817314|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817315|NCT05256342|Etoricoxib|etoricoxib|mesh-list
154817316|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154817317|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154817318|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154817319|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154817320|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817321|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817322|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817323|NCT05256342|Analgesics|analgesics|mesh-ancestor
154817324|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
154817325|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817326|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
154817327|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154817328|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
154817329|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154817330|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154817331|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817332|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154817333|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154817334|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154817335|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817336|NCT01895881|Estradiol|estradiol|mesh-list
154817337|NCT01895881|Estrogens|estrogens|mesh-ancestor
154817338|NCT01895881|Hormones|hormones|mesh-ancestor
154817339|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817340|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817341|NCT04537962|Listerine|listerine|mesh-list
154817342|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
154817343|NCT04537962|Fluorides|fluorides|mesh-list
154817344|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
154817345|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
154817346|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
154817347|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
154817348|NCT04537962|Protective Agents|protective agents|mesh-ancestor
154817349|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817350|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154817351|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569317|NCT02152475|Curcumin|curcumin|mesh-list
154817352|NCT04126733|Nivolumab|nivolumab|mesh-list
154817353|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154817354|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817355|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154817356|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817357|NCT04885764|Vaccines|vaccines|mesh-list
154817358|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
154817359|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817360|NCT04311606|Aflibercept|aflibercept|mesh-list
154817361|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154817362|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154817363|NCT04311606|Growth Substances|growth substances|mesh-ancestor
154817364|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817365|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
154817366|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817367|NCT02980835|Dexamethasone|dexamethasone|mesh-list
154817368|NCT02980835|Epinephrine|epinephrine|mesh-list
154817369|NCT02980835|Ropivacaine|ropivacaine|mesh-list
154817370|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817371|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
154817372|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
154817373|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817374|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817375|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154817376|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
154817377|NCT02980835|Hormones|hormones|mesh-ancestor
154817378|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817379|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154817380|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817381|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
154817382|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
154817383|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817384|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
154817385|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154817386|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154817387|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
154817388|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817389|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817390|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154817391|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154817392|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154817393|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
154817394|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
154817395|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
154817396|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154817397|NCT04871724|Fluconazole|fluconazole|mesh-list
154817398|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
154817399|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817400|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154817401|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154817402|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817403|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817404|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154817405|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
154817406|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817407|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817408|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154817409|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154817410|NCT04871802|Taxifolin|taxifolin|mesh-list
154817411|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154817412|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154817413|NCT04871802|Analgesics|analgesics|mesh-ancestor
154817414|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
154817415|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817416|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817417|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817418|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154817419|NCT04871646|Nafamostat|nafamostat|mesh-list
154817420|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154817421|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154817422|NCT04871646|Analgesics|analgesics|mesh-ancestor
154817423|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
154817424|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569388|NCT01037179|Analgesics|analgesics|mesh-ancestor
154817425|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817426|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817427|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154817428|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
154817429|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
154817430|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817431|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817432|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154817433|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154817434|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154817435|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154817436|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
154817437|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
154817438|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817439|NCT03827603|Ibrutinib|ibrutinib|mesh-list
154817440|NCT03827603|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154817441|NCT03827603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154817442|NCT03827603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817443|NCT03827603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817444|NCT03589014|Propranolol|propranolol|mesh-list
154817445|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154817446|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154817447|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
154817448|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817449|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817450|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817451|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154817452|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154817453|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
154817454|NCT04884906|Paclitaxel|paclitaxel|mesh-list
154817455|NCT04884906|Cisplatin|cisplatin|mesh-list
154817456|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154817457|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817458|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
154817459|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
154817460|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
154817461|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817462|NCT03046758|Metronidazole|metronidazole|mesh-list
154817463|NCT03046758|Fosfomycin|fosfomycin|mesh-list
154817464|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817465|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154817466|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154817467|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154817468|NCT03825887|Morphine|morphine|mesh-list
154817469|NCT03825887|Nalbuphine|nalbuphine|mesh-list
154817470|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154817471|NCT03825887|Narcotics|narcotics|mesh-ancestor
154817472|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817473|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817474|NCT03825887|Analgesics|analgesics|mesh-ancestor
154817475|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
154817476|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817477|NCT03825809|Acetaminophen|acetaminophen|mesh-list
154817478|NCT03825809|Celecoxib|celecoxib|mesh-list
154817479|NCT03825809|Ketorolac|ketorolac|mesh-list
154817480|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154817481|NCT03825809|Diazepam|diazepam|mesh-list
154817482|NCT03825809|Gabapentin|gabapentin|mesh-list
154817483|NCT03825809|Hydrocodone|hydrocodone|mesh-list
154817484|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154817485|NCT03825809|Analgesics|analgesics|mesh-ancestor
154817486|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
154817487|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817488|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817489|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
154817490|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154817491|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996969|NCT02836704|Metformin|metformin|mesh-list
154817492|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154817493|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154817494|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154817495|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817496|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817497|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
154817498|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154817499|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154817500|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817501|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154817502|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154817503|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154817504|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817505|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
154817506|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154817507|NCT03825809|Narcotics|narcotics|mesh-ancestor
154817508|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
154817509|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
154817510|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154817511|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
154817512|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
154817513|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154817514|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154817515|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154817516|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154817517|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154817518|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
154817519|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
154817520|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
154817521|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
154817522|NCT03824717|Ropivacaine|ropivacaine|mesh-list
154817523|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
154817524|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
154817525|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817526|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817527|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
154817528|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817529|NCT04392557|Metformin|metformin|mesh-list
154817530|NCT04392557|Pioglitazone|pioglitazone|mesh-list
154817531|NCT04392557|Alogliptin|alogliptin|mesh-list
154817532|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154817533|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817534|NCT04392557|Incretins|incretins|mesh-ancestor
154817535|NCT04392557|Hormones|hormones|mesh-ancestor
154817536|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817537|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154817538|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
154817539|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996999|NCT00703365|Gemcitabine|gemcitabine|mesh-list
154817540|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817541|NCT02115373|Tepotinib|tepotinib|mesh-list
154817542|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817543|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
154817544|NCT03824171|Vitamin D|vitamin d|mesh-list
154817545|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154817546|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154817547|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817548|NCT03824171|Vitamins|vitamins|mesh-ancestor
154817549|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
154817550|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154817551|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154817552|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
154817553|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817554|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154817555|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154817556|NCT02946125|Phenylephrine|phenylephrine|mesh-list
154817557|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
154817558|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154817559|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154817560|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
154817561|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
154817562|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817563|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817564|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
154817565|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154817566|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
154817567|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
154817568|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154817569|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154817570|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154817571|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
154817572|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817573|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817574|NCT02946125|Protective Agents|protective agents|mesh-ancestor
154817575|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154817576|NCT01895257|Leucovorin|leucovorin|mesh-list
154569538|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154817577|NCT01895257|Fluorouracil|fluorouracil|mesh-list
154817578|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
154817579|NCT01895257|Antidotes|antidotes|mesh-ancestor
154817580|NCT01895257|Protective Agents|protective agents|mesh-ancestor
154817581|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817582|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
154817584|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
154817585|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
154817586|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817587|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154817588|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817589|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154817590|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
154817591|NCT04392713|Ivermectin|ivermectin|mesh-list
154817592|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154817593|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817594|NCT03823625|Nivolumab|nivolumab|mesh-list
154817595|NCT03823625|Ipilimumab|ipilimumab|mesh-list
154817596|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154817597|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817598|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154817599|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817600|NCT02053909|Aspirin|aspirin|mesh-list
154817601|NCT02053909|Ticagrelor|ticagrelor|mesh-list
154817602|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154817603|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154817604|NCT02053909|Analgesics|analgesics|mesh-ancestor
154817605|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
154817606|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817607|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817608|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817609|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154817610|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154817611|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154817612|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817613|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154817614|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154817615|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817616|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
154817617|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154817618|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154817619|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154817620|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
154817621|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817622|NCT02863991|TIC10 compound|tic10 compound|mesh-list
154817623|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817624|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
154817625|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154817626|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154817627|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154817628|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154817629|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817630|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
154817631|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817632|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817633|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154817634|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817635|NCT03823781|Milrinone|milrinone|mesh-list
154817636|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154817637|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154817638|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
154817639|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154817640|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154817641|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817642|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817643|NCT03823781|Protective Agents|protective agents|mesh-ancestor
154817644|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817645|NCT03823079|Irinotecan|irinotecan|mesh-list
154817646|NCT03823079|Raltitrexed|raltitrexed|mesh-list
154817647|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154817648|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154817649|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817650|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817651|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817652|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154817653|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
154817654|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154817655|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
154817656|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154817657|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
154817658|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817659|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154817660|NCT02839265|Protective Agents|protective agents|mesh-ancestor
154817661|NCT00988247|Beclomethasone|beclomethasone|mesh-list
154817662|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817663|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
154817664|NCT00988247|Hormones|hormones|mesh-ancestor
154817665|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817666|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817667|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154817668|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
154817669|NCT02832401|Caffeine|caffeine|mesh-list
154817670|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154817671|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817672|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154817673|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817674|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817675|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154817676|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154817677|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
154817678|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817679|NCT03044808|Lidocaine|lidocaine|mesh-list
154817680|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
154817681|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
154817682|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817683|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817684|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
154817685|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817686|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154817687|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154817688|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154817689|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154817690|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817691|NCT04430166|Antibodies|antibodies|mesh-list
154817692|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154817693|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
154817694|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817695|NCT04877106|Metformin|metformin|mesh-list
154817696|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154817697|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154817698|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817699|NCT04877106|Incretins|incretins|mesh-ancestor
154817700|NCT04877106|Hormones|hormones|mesh-ancestor
154817701|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817702|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154817703|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
154817704|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817705|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817706|NCT00981617|ALKS-33|alks-33|mesh-list
154817707|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154817708|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817709|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
154817710|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817711|NCT04876716|Voriconazole|voriconazole|mesh-list
154817712|NCT04876716|Posaconazole|posaconazole|mesh-list
154817713|NCT04876716|Isavuconazole|isavuconazole|mesh-list
154817714|NCT04876716|Anidulafungin|anidulafungin|mesh-list
154817715|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
154817716|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817717|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154817718|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154817719|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817720|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817721|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154817722|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
154817723|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817724|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817725|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154817726|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154817727|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154817728|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154817729|NCT04865250|Paclitaxel|paclitaxel|mesh-list
154817730|NCT04865250|Carboplatin|carboplatin|mesh-list
154817731|NCT04865250|Atezolizumab|atezolizumab|mesh-list
154817732|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154817733|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817734|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
154817735|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
154817736|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
154817737|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817738|NCT04865250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154817739|NCT04865250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154817740|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
154817741|NCT04865562|Testosterone|testosterone|mesh-list
154817742|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
154817743|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
154817744|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154817745|NCT04865562|Androgens|androgens|mesh-ancestor
154817746|NCT04865562|Hormones|hormones|mesh-ancestor
154817747|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817748|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817749|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154817750|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817751|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
154817752|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154817753|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
154817754|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817755|NCT00984659|Fluticasone|fluticasone|mesh-list
154817756|NCT00984659|Xhance|xhance|mesh-list
154817757|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154817758|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817759|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154817760|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
154817761|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817762|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817763|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154817764|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
154817765|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
154817766|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154817767|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154817768|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154817769|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154817770|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
154817771|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817772|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817773|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
154817774|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154817775|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
154817776|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817777|NCT04864314|Protective Agents|protective agents|mesh-ancestor
154817778|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817779|NCT04874844|Antibodies|antibodies|mesh-list
154817780|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154817781|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
154817782|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817783|NCT03046290|Lidocaine|lidocaine|mesh-list
154817784|NCT03046290|Ropivacaine|ropivacaine|mesh-list
154817785|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
154817786|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
154817787|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817788|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817789|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
154817790|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817791|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154817792|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154817793|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154817794|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154817795|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817796|NCT04874688|Provitamins|provitamins|mesh-list
154817797|NCT04874688|Beta Carotene|beta carotene|mesh-list
154817798|NCT04874688|Vitamins|vitamins|mesh-ancestor
154817799|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
154817800|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817801|NCT02612064|Fluorides|fluorides|mesh-list
154817802|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
154817803|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
154817804|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
154817805|NCT02612064|Protective Agents|protective agents|mesh-ancestor
154817806|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817807|NCT04553003|Prednisone|prednisone|mesh-list
154817808|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
154817809|NCT04553003|Choline|choline|mesh-list
154817810|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
154817811|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
154817812|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817813|NCT04553003|Hormones|hormones|mesh-ancestor
154817814|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817815|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817816|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154817817|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817818|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
154817819|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
154817820|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817821|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154817822|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154817823|NCT04553003|Protective Agents|protective agents|mesh-ancestor
154817824|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
154817825|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154817826|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
154817827|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817828|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154817829|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
154817830|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
154817831|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
154817832|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154817833|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154817834|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817835|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
154817836|NCT03044184|Coagulants|coagulants|mesh-ancestor
154817837|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
154817838|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154817839|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154817840|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817841|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154817842|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154817843|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817844|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817845|NCT03047772|Atorvastatin|atorvastatin|mesh-list
154817846|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154817847|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154817848|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
154817849|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817850|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154817851|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154817852|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817853|NCT03047538|Amlodipine|amlodipine|mesh-list
154817854|NCT03047538|Perindopril|perindopril|mesh-list
154817855|NCT03047538|Atorvastatin|atorvastatin|mesh-list
154817856|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154817857|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154817858|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
154817859|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817860|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154817861|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154817862|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817863|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154817864|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154817865|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154817866|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154817867|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817868|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
154817869|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154817870|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
154817871|NCT01728805|Vorinostat|vorinostat|mesh-list
154817872|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
154817873|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817874|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154817875|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817876|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569841|NCT03738683|Tazobactam|tazobactam|mesh-list
154817878|NCT02921477|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154817879|NCT02921477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154817880|NCT02921477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997338|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154817881|NCT02921477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817882|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154817883|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154817884|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154817885|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154817886|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817887|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817888|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817889|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
154817890|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154817891|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
154817892|NCT03821987|Busulfan|busulfan|mesh-list
154817893|NCT03821987|Fludarabine|fludarabine|mesh-list
154817894|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
154817895|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154817896|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
154817897|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817898|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154817899|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154817900|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
154817901|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817902|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817903|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154817904|NCT04273763|Interferons|interferons|mesh-list
154817905|NCT04273763|Bromhexine|bromhexine|mesh-list
154817906|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817907|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
153997381|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817908|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817909|NCT04273763|Expectorants|expectorants|mesh-ancestor
154817910|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
154817911|NCT03820037|Opicapone|opicapone|mesh-list
154817912|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154817913|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817914|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817915|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154817916|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154817917|NCT03829007|Durvalumab|durvalumab|mesh-list
154817918|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154817919|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154817920|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817921|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
154817922|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817923|NCT02614560|Fludarabine|fludarabine|mesh-list
154817924|NCT02614560|Melphalan|melphalan|mesh-list
154817925|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817926|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817927|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154817928|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
154817929|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817930|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154817931|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
154817932|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154817933|NCT03828929|Thiamine|thiamine|mesh-list
154817934|NCT03828929|Vitamins|vitamins|mesh-ancestor
154817935|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
154817936|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817937|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
154817938|NCT04873440|Manganese|manganese|mesh-list
154817939|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817940|NCT04873440|Trace Elements|trace elements|mesh-ancestor
154817941|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
154817942|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
154817943|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
154817944|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153997410|NCT03972280|Lenograstim|lenograstim|mesh-list
154817945|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817946|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154817947|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154817948|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817949|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817950|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154817951|NCT04867980|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154817952|NCT04867980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154817953|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154817954|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154817955|NCT04391621|Triamcinolone|triamcinolone|mesh-list
154817956|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154817957|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154817958|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154817959|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154817960|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
154817962|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154817963|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817964|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154817965|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
154817966|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154817967|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817968|NCT01669122|Nicotine|nicotine|mesh-list
154817969|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154817970|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
154817971|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817972|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817973|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154817974|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154817975|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
154817976|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817977|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817978|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
154817979|NCT03629483|Ropivacaine|ropivacaine|mesh-list
154817980|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154817981|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154817982|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154817983|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154817984|NCT03629483|Analgesics|analgesics|mesh-ancestor
154817985|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
154817986|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154817987|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154817988|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154817989|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154817990|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
154817991|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154817992|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154817993|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
154817994|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
154817995|NCT04873284|Dexamethasone|dexamethasone|mesh-list
154817996|NCT04873284|Aprepitant|aprepitant|mesh-list
154817997|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
154817998|NCT04873284|Granisetron|granisetron|mesh-list
154817999|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154818000|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
154818001|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
154818002|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818003|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818004|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154818005|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
154818006|NCT04873284|Hormones|hormones|mesh-ancestor
154818007|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818008|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154818009|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818010|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154818011|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818012|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818013|NCT04873284|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154818014|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154818015|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
154818016|NCT01450865|Flupirtine|flupirtine|mesh-list
154818017|NCT01450865|Analgesics|analgesics|mesh-ancestor
154818018|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
154818019|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818020|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818021|NCT01308619|Doxycycline|doxycycline|mesh-list
154818022|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154818023|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818024|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
154818025|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154569995|NCT01112527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818026|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154818028|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154818029|NCT02611752|Narcotics|narcotics|mesh-ancestor
154818030|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818031|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818032|NCT02611752|Analgesics|analgesics|mesh-ancestor
154818033|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
154818034|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818035|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154818036|NCT01307605|Rituximab|rituximab|mesh-list
154818037|NCT01307605|Lenalidomide|lenalidomide|mesh-list
154818038|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154818039|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818040|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
154818041|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818042|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818043|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154818044|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154818045|NCT01307605|Growth Substances|growth substances|mesh-ancestor
154818046|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
154818047|NCT04758689|Methotrexate|methotrexate|mesh-list
154818048|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154818049|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
154818050|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154818051|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818052|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154818053|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
154818054|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818055|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818056|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
154818057|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818058|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154818059|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154818060|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
154818061|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818062|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154818063|NCT01451333|Efavirenz|efavirenz|mesh-list
154818064|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154818065|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154818066|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818067|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818068|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
154818069|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818070|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154818071|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154818072|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154818073|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154818074|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154818075|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154818076|NCT01702831|Lenalidomide|lenalidomide|mesh-list
154818077|NCT01702831|Melphalan|melphalan|mesh-list
154818078|NCT01702831|Busulfan|busulfan|mesh-list
154818079|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
154818080|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818081|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154818082|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154818083|NCT01702831|Growth Substances|growth substances|mesh-ancestor
154818084|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
154818085|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818086|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154818087|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
154818088|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818089|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154818090|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154818091|NCT03045510|Decitabine|decitabine|mesh-list
154818092|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154818093|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
154818094|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818095|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818096|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818097|NCT01451879|Miglustat|miglustat|mesh-list
154818098|NCT01451879|Rituximab|rituximab|mesh-list
154818099|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154818100|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818101|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
154818102|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818103|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818104|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818105|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818106|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154818107|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154818108|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
154818109|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818110|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154818111|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154818112|NCT03045198|Azithromycin|azithromycin|mesh-list
154818113|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154818114|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818115|NCT01452113|Vildagliptin|vildagliptin|mesh-list
154818116|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154818117|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818118|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154818119|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
154818120|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818121|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818122|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
154818123|NCT02022709|Sertraline|sertraline|mesh-list
154818124|NCT02022709|Fluoxetine|fluoxetine|mesh-list
154818125|NCT02022709|Paroxetine|paroxetine|mesh-list
154818126|NCT02022709|Citalopram|citalopram|mesh-list
154818127|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
154818128|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154818129|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154818130|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154818131|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154818132|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818133|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818134|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
154818135|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818136|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154818137|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154818138|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154818139|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818140|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154818141|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154818142|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818143|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154818144|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154818145|NCT02635841|Deferiprone|deferiprone|mesh-list
154818146|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154818147|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
154818148|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
154818149|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818150|NCT01452659|Relugolix|relugolix|mesh-list
154818151|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
154818152|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
154818153|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818154|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818155|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154818156|NCT01896349|Amitriptyline|amitriptyline|mesh-list
154818157|NCT01896349|Risperidone|risperidone|mesh-list
154818158|NCT01896349|Sulpiride|sulpiride|mesh-list
154818159|NCT01896349|Mirtazapine|mirtazapine|mesh-list
154818160|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
154818161|NCT01896349|Trazodone|trazodone|mesh-list
154818162|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
154818163|NCT01896349|Citalopram|citalopram|mesh-list
154818164|NCT01896349|Bupropion|bupropion|mesh-list
154818165|NCT01896349|Sertraline|sertraline|mesh-list
154818166|NCT01896349|Fluoxetine|fluoxetine|mesh-list
154818167|NCT01896349|Paroxetine|paroxetine|mesh-list
154818168|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154818169|NCT01896349|Nortriptyline|nortriptyline|mesh-list
154818170|NCT01896349|Imipramine|imipramine|mesh-list
154818171|NCT01896349|Clomipramine|clomipramine|mesh-list
154818172|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
154818173|NCT01896349|Escitalopram|escitalopram|mesh-list
154818174|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154818175|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
154818176|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818177|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818178|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818179|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154818180|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154818181|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818182|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154818183|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154818184|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
154818185|NCT01896349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154818186|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154818187|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154818188|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818189|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154818190|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154818191|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154818192|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154818193|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818194|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154818195|NCT01896349|Analgesics|analgesics|mesh-ancestor
154818196|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
154818197|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154818198|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
154818199|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
154818200|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154818201|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154818202|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154818203|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154818204|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
154818205|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154818206|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154818207|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154818208|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154818209|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154818210|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154818211|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154818212|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154818213|NCT01452737|Bisacodyl|bisacodyl|mesh-list
154818214|NCT01452737|Cathartics|cathartics|mesh-ancestor
154818215|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154818216|NCT01452737|Laxatives|laxatives|mesh-ancestor
154818217|NCT00595933|Muramidase|muramidase|mesh-list
154818218|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818219|NCT00580489|Fentanyl|fentanyl|mesh-list
154818220|NCT00580489|Morphine|morphine|mesh-list
154818221|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154818222|NCT00580489|Narcotics|narcotics|mesh-ancestor
154818223|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818224|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818225|NCT00580489|Analgesics|analgesics|mesh-ancestor
154818226|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
154818227|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818228|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154818229|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154818230|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
154818231|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
154818232|NCT01659307|Aspirin|aspirin|mesh-list
154818233|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154818234|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154818235|NCT01659307|Analgesics|analgesics|mesh-ancestor
154818236|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
154818237|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818238|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818239|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154818240|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818241|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154818242|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154818243|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818244|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154818245|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154818246|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818247|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
154818248|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
154818249|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154818250|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
154818251|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154818252|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818253|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154818254|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154818255|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154818257|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154818258|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818259|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818260|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154818261|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154818262|NCT04391231|Protective Agents|protective agents|mesh-ancestor
154818263|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818264|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
154818265|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154818266|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
154818267|NCT04872270|Caffeine|caffeine|mesh-list
154818268|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154818269|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818270|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154818271|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818272|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818273|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154818274|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154818275|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
154818276|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818277|NCT04872192|Anesthetics|anesthetics|mesh-list
154818278|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818279|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818280|NCT01454609|Clonidine|clonidine|mesh-list
154818281|NCT01454609|Bupivacaine|bupivacaine|mesh-list
154818282|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
154818283|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
154818284|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818285|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818286|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
154818287|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818288|NCT01454609|Analgesics|analgesics|mesh-ancestor
154818289|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154818290|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
154818291|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
154818292|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154818293|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154818294|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154818295|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154818296|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818297|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818298|NCT03042234|Insulin|insulin|mesh-list
154818299|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154818300|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154818301|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818302|NCT02905799|Resveratrol|resveratrol|mesh-list
154818303|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
154818304|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818305|NCT02905799|Protective Agents|protective agents|mesh-ancestor
154818306|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818307|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818308|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154818309|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154818310|NCT00469183|Tretinoin|tretinoin|mesh-list
154818311|NCT00469183|Hydroquinone|hydroquinone|mesh-list
154818312|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818313|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
154818314|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
154818315|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154818316|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
154818317|NCT00469183|Hormones|hormones|mesh-ancestor
154818318|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818319|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818320|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
154818321|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997772|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
154818322|NCT00469183|Protective Agents|protective agents|mesh-ancestor
154818323|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154818324|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154818325|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154818326|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154818327|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818328|NCT00468715|Bicalutamide|bicalutamide|mesh-list
154818329|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
154818330|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
154818331|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818332|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818333|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818334|NCT01456247|Lansoprazole|lansoprazole|mesh-list
154818335|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
154818336|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154818337|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154818338|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154818339|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818340|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818341|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154818342|NCT01456325|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154818343|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154818344|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818345|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818346|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818347|NCT04866498|Analgesics|analgesics|mesh-list
154818348|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
154818349|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818350|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818351|NCT04866654|Nivolumab|nivolumab|mesh-list
154818352|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154818353|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818354|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154818355|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818356|NCT01456715|Vaccines|vaccines|mesh-list
154818357|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
153997823|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
154818358|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818359|NCT01895569|Metformin|metformin|mesh-list
154818360|NCT01895569|Pioglitazone|pioglitazone|mesh-list
154818361|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154818362|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154818363|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818364|NCT01895569|Incretins|incretins|mesh-ancestor
154818365|NCT01895569|Hormones|hormones|mesh-ancestor
154818366|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818367|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154818368|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
154818369|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818370|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818371|NCT01457261|Albuterol|albuterol|mesh-list
154818372|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154818373|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
154818374|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818375|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818376|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154818377|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
154818378|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
154818379|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154818380|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154818381|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154818382|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154818383|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
154818384|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818385|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818386|NCT01457495|Edetic Acid|edetic acid|mesh-list
154818387|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
154818388|NCT01457495|Antidotes|antidotes|mesh-ancestor
154818389|NCT01457495|Protective Agents|protective agents|mesh-ancestor
154818390|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818391|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
154818392|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
154818393|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818394|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154818395|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
154818396|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154818397|NCT04778137|Omalizumab|omalizumab|mesh-list
154818398|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154818399|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154818400|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
154818402|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154818403|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
154818404|NCT02610816|Fluticasone|fluticasone|mesh-list
154818405|NCT02610816|Xhance|xhance|mesh-list
154818406|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154818407|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154818408|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
154818409|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818410|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818411|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154818412|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
154818413|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
154818414|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154818415|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
154818416|NCT00332605|Naltrexone|naltrexone|mesh-list
154818417|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154818418|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154818419|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154818420|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818421|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
154818422|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818423|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
154818424|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818425|NCT00332605|Expectorants|expectorants|mesh-ancestor
154818426|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
154818427|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154818428|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
154818429|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818430|NCT00332605|Protective Agents|protective agents|mesh-ancestor
154818431|NCT00332605|Antidotes|antidotes|mesh-ancestor
154818432|NCT01458743|Ceftaroline|ceftaroline|mesh-list
154818433|NCT01458743|Cephalosporins|cephalosporins|mesh-list
154818434|NCT01458743|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154818435|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154818436|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818437|NCT01415583|Dexamethasone|dexamethasone|mesh-list
154818438|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154818439|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
154818440|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
154818441|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818442|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818443|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154818444|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
154818445|NCT01415583|Hormones|hormones|mesh-ancestor
154818446|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818447|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154818448|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818449|NCT01458977|Tenofovir|tenofovir|mesh-list
154818450|NCT01458977|Emtricitabine|emtricitabine|mesh-list
154818451|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154818452|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
154818453|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818454|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154818455|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154818456|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818457|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818458|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154818459|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154818460|NCT02508311|Albuterol|albuterol|mesh-list
154818461|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154818462|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
154818463|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818464|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818465|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154818466|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
154818467|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
154818468|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154818469|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154818470|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154818471|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154818472|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
154818473|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818474|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818475|NCT00256399|Alfuzosin|alfuzosin|mesh-list
154818476|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154818477|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154818478|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154818479|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
154818480|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818481|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818482|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818483|NCT00256399|Urological Agents|urological agents|mesh-ancestor
154818484|NCT01459133|Insulin|insulin|mesh-list
154818485|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154818486|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818487|NCT01459211|Dexamethasone|dexamethasone|mesh-list
154818488|NCT01459211|Lenalidomide|lenalidomide|mesh-list
154818489|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154818490|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
154818491|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
154818492|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818493|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818494|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154818495|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
154818496|NCT01459211|Hormones|hormones|mesh-ancestor
154818497|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818498|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154818499|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818500|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
154818501|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154818502|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154818503|NCT01459211|Growth Substances|growth substances|mesh-ancestor
154818504|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
154818505|NCT00198991|Cytarabine|cytarabine|mesh-list
154818506|NCT00198991|Dexamethasone|dexamethasone|mesh-list
154818507|NCT00198991|Prednisolone|prednisolone|mesh-list
154818508|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
154818509|NCT00198991|Methotrexate|methotrexate|mesh-list
154818510|NCT00198991|Fludarabine|fludarabine|mesh-list
154818511|NCT00198991|Etoposide|etoposide|mesh-list
154818512|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
154818513|NCT00198991|Vincristine|vincristine|mesh-list
154818514|NCT00198991|Doxorubicin|doxorubicin|mesh-list
154818515|NCT00198991|Daunorubicin|daunorubicin|mesh-list
154818516|NCT00198991|Asparaginase|asparaginase|mesh-list
154818517|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
154818518|NCT00198991|Idarubicin|idarubicin|mesh-list
154818519|NCT00198991|Thioguanine|thioguanine|mesh-list
154818520|NCT00198991|Cladribine|cladribine|mesh-list
154818521|NCT00198991|Vindesine|vindesine|mesh-list
154818522|NCT00198991|Pegaspargase|pegaspargase|mesh-list
154818523|NCT00198991|Teniposide|teniposide|mesh-list
154818524|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154818525|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
154818526|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818527|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818528|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154818529|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
154818530|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818531|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818532|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154818533|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154818534|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
154818535|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
154818536|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818537|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154818538|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
154818539|NCT00198991|Hormones|hormones|mesh-ancestor
154818540|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818541|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154818542|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154818543|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
154818544|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154818545|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154818546|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
154818547|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
154818548|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818549|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154818550|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154818551|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154818552|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154818553|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154818554|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
154818555|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818556|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154818557|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154818558|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154818559|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154818560|NCT01459367|Lansoprazole|lansoprazole|mesh-list
154818561|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
154818562|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154818563|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154818564|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154818565|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818566|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818567|NCT04777591|Bupivacaine|bupivacaine|mesh-list
153998032|NCT00202904|Ezetimibe|ezetimibe|mesh-list
154818568|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
154818569|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
154818570|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818571|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818572|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
154818573|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818574|NCT01459601|Cabergoline|cabergoline|mesh-list
154818575|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154818576|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154818577|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
154818578|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
154818579|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818580|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818581|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818582|NCT01418001|Gemcitabine|gemcitabine|mesh-list
154818583|NCT01418001|Docetaxel|docetaxel|mesh-list
154818584|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154818585|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
154818586|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818587|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818588|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
154818589|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
154818590|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
154818591|NCT00394147|Gemcitabine|gemcitabine|mesh-list
154818592|NCT00394147|Pemetrexed|pemetrexed|mesh-list
154818593|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154818594|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
154818595|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818596|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818597|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818598|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154818599|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154818600|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154818601|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154818602|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154818603|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
154818604|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818605|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154818606|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154818607|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818608|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
154818609|NCT01542255|Dacarbazine|dacarbazine|mesh-list
154818610|NCT01542255|Vinblastine|vinblastine|mesh-list
154818611|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154818612|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
154818613|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818614|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818615|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154818616|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
154818617|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818618|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818619|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154818620|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154818621|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
154818622|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
154818623|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
154818624|NCT01456481|Midodrine|midodrine|mesh-list
154818625|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
154818626|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
154818627|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818628|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570591|NCT02163707|Psilocybin|psilocybin|mesh-list
154818629|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154818630|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154818631|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154818632|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154818633|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
154818634|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818635|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818636|NCT04776655|Leucovorin|leucovorin|mesh-list
154818637|NCT04776655|Bevacizumab|bevacizumab|mesh-list
154818638|NCT04776655|Cetuximab|cetuximab|mesh-list
154818639|NCT04776655|Fluorouracil|fluorouracil|mesh-list
154818640|NCT04776655|Irinotecan|irinotecan|mesh-list
154818641|NCT04776655|Calcium|calcium|mesh-list
154818642|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
154818643|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154818644|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818645|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154818646|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154818647|NCT04776655|Growth Substances|growth substances|mesh-ancestor
154818648|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818649|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
154818650|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154818651|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
154818652|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818653|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154818654|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154818655|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
154818656|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154818657|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154818658|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818659|NCT04776655|Antidotes|antidotes|mesh-ancestor
154818660|NCT04776655|Protective Agents|protective agents|mesh-ancestor
154818661|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
154818662|NCT04776655|Vitamins|vitamins|mesh-ancestor
154818663|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
154818664|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
154818665|NCT01455233|Besifloxacin|besifloxacin|mesh-list
154818666|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154818667|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154818668|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154818669|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154818670|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818671|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154818672|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154818673|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818674|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818675|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818676|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154818677|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
154818678|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154818679|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818680|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154818681|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154818682|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154818683|NCT01459679|Riboflavin|riboflavin|mesh-list
154818684|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154818685|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154818686|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
154818687|NCT01459679|Vitamins|vitamins|mesh-ancestor
154818688|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
154818689|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818690|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154818691|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
154818692|NCT00048295|Alicaforsen|alicaforsen|mesh-list
154818693|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154818694|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154818695|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
154818696|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818697|NCT01455857|Exenatide|exenatide|mesh-list
154818698|NCT01455857|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154818699|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154818700|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818701|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154818702|NCT01455857|Incretins|incretins|mesh-ancestor
154818703|NCT01455857|Hormones|hormones|mesh-ancestor
154818704|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818705|NCT03043248|Digoxin|digoxin|mesh-list
154818706|NCT03043248|Midazolam|midazolam|mesh-list
154818707|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154818708|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154818709|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818710|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818711|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154818712|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154818713|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154818714|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154818715|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
154818716|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
154818717|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
154818718|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
154818719|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818720|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818721|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154818722|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154818723|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818724|NCT03043248|Protective Agents|protective agents|mesh-ancestor
154818725|NCT04843631|Ustekinumab|ustekinumab|mesh-list
154818726|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
154818727|NCT03043326|Tenofovir|tenofovir|mesh-list
154818728|NCT03043326|Emtricitabine|emtricitabine|mesh-list
154818729|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
154818730|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818731|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154818732|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154818733|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818734|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818735|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154818736|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154818737|NCT04845737|Vitamin D|vitamin d|mesh-list
154818738|NCT04845737|Vitamins|vitamins|mesh-ancestor
154818739|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
154818740|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818741|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154818742|NCT04849715|Rituximab|rituximab|mesh-list
154818743|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154818744|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154818745|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818746|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
154818747|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818748|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818749|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154818750|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
154818751|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818752|NCT03044964|Ranolazine|ranolazine|mesh-list
154818753|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154818754|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154818755|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818756|NCT01419639|Everolimus|everolimus|mesh-list
154818757|NCT01419639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154818758|NCT01419639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154818759|NCT01419639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818760|NCT01419639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818761|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154818762|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
154818763|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818764|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818765|NCT02856893|Gefitinib|gefitinib|mesh-list
154818766|NCT02856893|Osimertinib|osimertinib|mesh-list
154818767|NCT02856893|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154818768|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154818769|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818770|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818771|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818772|NCT01419795|Rituximab|rituximab|mesh-list
154818773|NCT01419795|Lenalidomide|lenalidomide|mesh-list
154818774|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154818775|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818776|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
154818777|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818778|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998245|NCT00900146|Metformin|metformin|mesh-list
154818779|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154818780|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154818781|NCT01419795|Growth Substances|growth substances|mesh-ancestor
154818782|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
154818783|NCT04783753|Itraconazole|itraconazole|mesh-list
154818785|NCT04783753|Carbamazepine|carbamazepine|mesh-list
154818786|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
154818787|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818788|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154818789|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154818790|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818791|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818792|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154818793|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
154818794|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818795|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818796|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154818797|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
154818798|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
154818799|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154818800|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818801|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154818802|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154818803|NCT04783753|Analgesics|analgesics|mesh-ancestor
154818804|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
154818805|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818806|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154818807|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154818808|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154818809|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154818810|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154818811|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154818812|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
154818813|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818814|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154818815|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
154818816|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154818817|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154818818|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154818819|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154818820|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
154818821|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154818822|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154818823|NCT02856581|Varenicline|varenicline|mesh-list
154818824|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154818825|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154818826|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
154818827|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818828|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818829|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818830|NCT03042000|Capecitabine|capecitabine|mesh-list
154818831|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
154818832|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154818833|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
154818834|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818835|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818836|NCT01039285|Poractant alfa|poractant alfa|mesh-list
154818837|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154818838|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
154818839|NCT03043482|Calcitriol|calcitriol|mesh-list
154818840|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154818841|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818842|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154818843|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154818844|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818845|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154818846|NCT03043482|Vitamins|vitamins|mesh-ancestor
154818847|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
154818848|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154818849|NCT04775563|Vaccines|vaccines|mesh-list
154818850|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
154818851|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818852|NCT01480089|Ropivacaine|ropivacaine|mesh-list
154818853|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
154570818|NCT02164565|Coagulants|coagulants|mesh-ancestor
154818855|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818856|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818857|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
154818858|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818859|NCT03523975|Rituximab|rituximab|mesh-list
154818860|NCT03523975|Lenalidomide|lenalidomide|mesh-list
154818861|NCT03523975|Venetoclax|venetoclax|mesh-list
154818862|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154818863|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818864|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
154818865|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818866|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818867|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154818868|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154818869|NCT03523975|Growth Substances|growth substances|mesh-ancestor
154818870|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
154818871|NCT01542645|Fentanyl|fentanyl|mesh-list
154818872|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
154818873|NCT01542645|Methadone|methadone|mesh-list
154818874|NCT01542645|Narcotics|narcotics|mesh-ancestor
154818875|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818876|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818877|NCT01542645|Analgesics|analgesics|mesh-ancestor
154818878|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
154818879|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818880|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154818881|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154818882|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
154818883|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
154818884|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
154818885|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
154818886|NCT04857450|Ketamine|ketamine|mesh-list
154818887|NCT04857450|Etomidate|etomidate|mesh-list
154818888|NCT04857450|Analgesics|analgesics|mesh-ancestor
154818889|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
154818890|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818891|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818892|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154818893|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154818894|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
154818895|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
154818896|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818897|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154818898|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154818899|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818900|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818901|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154818902|NCT01420653|Acetaminophen|acetaminophen|mesh-list
154818903|NCT01420653|Ibuprofen|ibuprofen|mesh-list
154818904|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154818905|NCT01420653|Analgesics|analgesics|mesh-ancestor
154818906|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
154818907|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818908|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818909|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
154818910|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154818911|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154818912|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818913|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154818914|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818915|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818916|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154818917|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154818918|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154818919|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
154818920|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818921|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818922|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154818923|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154818924|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
154818925|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818926|NCT04844957|Vitamin D|vitamin d|mesh-list
154818927|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
154818928|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
154818929|NCT04844957|Vitamins|vitamins|mesh-list
154818930|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
154818931|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818932|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154818933|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154818934|NCT01421589|Hormones|hormones|mesh-list
154818935|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154818936|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818937|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
154818938|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154818939|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818940|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
154818941|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
154818942|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154818943|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154818944|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154818945|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818946|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818947|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154818948|NCT04390685|Tacrolimus|tacrolimus|mesh-list
154818949|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154818950|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
154818951|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818952|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154818953|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818954|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818955|NCT04848246|Bupropion|bupropion|mesh-list
154818956|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154818957|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
154818958|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154818959|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154818960|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154818961|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154818962|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818963|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
154818964|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154818965|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818966|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154818967|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154818968|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818969|NCT04774627|Olaparib|olaparib|mesh-list
154818970|NCT04774627|Niraparib|niraparib|mesh-list
154818971|NCT04774627|Talazoparib|talazoparib|mesh-list
154818972|NCT04774627|Veliparib|veliparib|mesh-list
154818973|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154818974|NCT04774627|Rucaparib|rucaparib|mesh-list
154818975|NCT04774627|Pamiparib|pamiparib|mesh-list
154818976|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154818977|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818978|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154818979|NCT01545765|Lidocaine|lidocaine|mesh-list
154818980|NCT01545765|Tetracaine|tetracaine|mesh-list
154818981|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
154818982|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
154818983|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154818984|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818985|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
154818986|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818987|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154818988|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154818989|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154818990|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154818991|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154818992|NCT04856124|Ketamine|ketamine|mesh-list
154818993|NCT04856124|Esketamine|esketamine|mesh-list
154818994|NCT04856124|Analgesics|analgesics|mesh-ancestor
154818995|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
154818996|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154818997|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154818998|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154818999|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154819000|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
154819001|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
154819002|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819003|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154558118|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154819004|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154819005|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819006|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819007|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
154819008|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154819009|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154819010|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154819011|NCT04847622|Remdesivir|remdesivir|mesh-list
154819012|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
154819013|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819014|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
154819015|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819016|NCT04781803|Cyclosporine|cyclosporine|mesh-list
154819017|NCT04781803|Cyclosporins|cyclosporins|mesh-list
154819018|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819019|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819020|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819021|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
154819022|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819023|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
154819024|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819025|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
154819026|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819027|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154819028|NCT01422369|Ritonavir|ritonavir|mesh-list
154819029|NCT01422369|Darunavir|darunavir|mesh-list
154819030|NCT01422369|Pitavastatin|pitavastatin|mesh-list
154819031|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154819032|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154819033|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
153998500|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
154819034|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819035|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819036|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154819037|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154819038|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
154819039|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819040|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154819041|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154819042|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154819043|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154819044|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154819045|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
154819046|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154819047|NCT05023343|Ropivacaine|ropivacaine|mesh-list
154819048|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
154819049|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
154819050|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819051|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819052|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
154819053|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819054|NCT04859556|Dipivefrin|dipivefrin|mesh-list
154819055|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154819056|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
154819057|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819058|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819059|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819060|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154819061|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154819062|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819063|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154819064|NCT04773301|Ropivacaine|ropivacaine|mesh-list
154819065|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
154819066|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
154819067|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
154819068|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819069|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819070|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
154819071|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819072|NCT04780945|Olaparib|olaparib|mesh-list
154819073|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154819074|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819075|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819076|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819077|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
154819078|NCT05021315|Povidone|povidone|mesh-list
154819079|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
154819080|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
154819081|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154819082|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819083|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
154819084|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154819085|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
154819086|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819087|NCT01427517|Expectorants|expectorants|mesh-ancestor
154819088|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
154819089|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154819090|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
154819091|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819092|NCT01427517|Protective Agents|protective agents|mesh-ancestor
154819093|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819094|NCT01427517|Antidotes|antidotes|mesh-ancestor
154819095|NCT02835131|Pasireotide|pasireotide|mesh-list
154819096|NCT02835131|Hormones|hormones|mesh-ancestor
154819097|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819098|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819099|NCT04846452|Paclitaxel|paclitaxel|mesh-list
154819100|NCT04846452|Carboplatin|carboplatin|mesh-list
154819101|NCT04846452|Pemetrexed|pemetrexed|mesh-list
154819102|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154819103|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819104|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
154819105|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
154819106|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
154819107|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819108|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819109|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154819110|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154819111|NCT04859244|Remdesivir|remdesivir|mesh-list
154819112|NCT04859244|GS-441524|gs-441524|mesh-list
154819113|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
154819114|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819115|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
154819116|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819117|NCT04779853|Antibodies|antibodies|mesh-list
154819118|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
154819119|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819120|NCT04855110|Warfarin|warfarin|mesh-list
154819121|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
154819122|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
154819123|NCT01485393|Zolpidem|zolpidem|mesh-list
154819124|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154819125|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819126|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819127|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154819128|NCT01485393|Analgesics|analgesics|mesh-ancestor
154819129|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
154819130|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819131|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154819132|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154819133|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154819134|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
154819135|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819136|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819137|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154819138|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154819139|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
154819140|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
154819141|NCT04772287|Paclitaxel|paclitaxel|mesh-list
154819142|NCT04772287|Vinorelbine|vinorelbine|mesh-list
154819143|NCT04772287|Docetaxel|docetaxel|mesh-list
154819144|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154819145|NCT04772287|Cisplatin|cisplatin|mesh-list
154819146|NCT04772287|Carboplatin|carboplatin|mesh-list
154819147|NCT04772287|Gemcitabine|gemcitabine|mesh-list
154819148|NCT04772287|Pemetrexed|pemetrexed|mesh-list
154819149|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154819150|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819151|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
154819152|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
154819153|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
154819154|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819155|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154819156|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
154819157|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819158|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154819159|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154819161|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154819162|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154819163|NCT01890005|Analgesics|analgesics|mesh-ancestor
154819164|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
154819165|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819166|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819167|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819168|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819169|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154819170|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154819171|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819172|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154819173|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154819174|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819175|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
154819176|NCT04854252|Fentanyl|fentanyl|mesh-list
154819177|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154819178|NCT04854252|Narcotics|narcotics|mesh-ancestor
154819179|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819180|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819181|NCT04854252|Analgesics|analgesics|mesh-ancestor
154819182|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
154819183|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819184|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154819185|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154819186|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
154819187|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
154819188|NCT03040830|Progesterone|progesterone|mesh-list
154819189|NCT03040830|Progestins|progestins|mesh-ancestor
154819190|NCT03040830|Hormones|hormones|mesh-ancestor
154819191|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819192|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819193|NCT04390295|Metformin|metformin|mesh-list
154819194|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154819195|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819196|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
154819197|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154819198|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819199|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154819200|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819201|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
154819202|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154819203|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154819204|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819205|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
154819206|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
154819207|NCT01890629|Metformin|metformin|mesh-list
154819208|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154819209|NCT01890629|Glimepiride|glimepiride|mesh-list
154819210|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154819211|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819212|NCT01890629|Incretins|incretins|mesh-ancestor
154819213|NCT01890629|Hormones|hormones|mesh-ancestor
154819214|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819215|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154819216|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
154819217|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819218|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819219|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154819220|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819221|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
154819222|NCT01890863|Fluticasone|fluticasone|mesh-list
154819223|NCT01890863|Xhance|xhance|mesh-list
154819224|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154819225|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154819226|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819227|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154819228|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
154819229|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819230|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819231|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154819232|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
154819233|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
154819234|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154819235|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154819236|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154819237|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154819238|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
154819239|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819240|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819241|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
154819242|NCT01890863|Hormones|hormones|mesh-ancestor
154819243|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819244|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
154819245|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
154819246|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
154819247|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
154819248|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154819249|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154819250|NCT01891019|Thalidomide|thalidomide|mesh-list
154819251|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819252|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
154819253|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819254|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
154819255|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154819256|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819257|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154819258|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154819259|NCT01891019|Growth Substances|growth substances|mesh-ancestor
154819260|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
154819261|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819262|NCT04374474|Budesonide|budesonide|mesh-list
154819263|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998728|NCT00573937|Morphine|morphine|mesh-list
154819264|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154819265|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
154819266|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819267|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819268|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154819269|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
154819270|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
154819271|NCT04374474|Hormones|hormones|mesh-ancestor
154819272|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819273|NCT02983097|Cytarabine|cytarabine|mesh-list
154819274|NCT02983097|Dexamethasone|dexamethasone|mesh-list
154819275|NCT02983097|Rituximab|rituximab|mesh-list
154819276|NCT02983097|Carboplatin|carboplatin|mesh-list
154819277|NCT02983097|Lenalidomide|lenalidomide|mesh-list
154819278|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154819279|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819280|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
154819281|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819282|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819283|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819284|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
154819285|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
154819286|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819287|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154819288|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
154819289|NCT02983097|Hormones|hormones|mesh-ancestor
154819290|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819291|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154819292|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154819293|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
154819294|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819295|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
154819296|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819297|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819298|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154819299|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154819300|NCT02983097|Growth Substances|growth substances|mesh-ancestor
154819301|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
154819302|NCT01891175|Anesthetics|anesthetics|mesh-list
154819303|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819304|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819305|NCT04771507|Ibrutinib|ibrutinib|mesh-list
154819306|NCT04771507|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154819307|NCT04771507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819308|NCT04771507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819309|NCT04771507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819310|NCT02347865|Denosumab|denosumab|mesh-list
154819311|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153998764|NCT02548195|Gemcitabine|gemcitabine|mesh-list
154819312|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819313|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
154819314|NCT01550367|Aldesleukin|aldesleukin|mesh-list
154819315|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
154819316|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154819317|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154819318|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819319|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819320|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819321|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819322|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819323|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154819324|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154819325|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
154819326|NCT01427595|Metformin|metformin|mesh-list
154819327|NCT01427595|Progesterone|progesterone|mesh-list
154819328|NCT01427595|Estradiol|estradiol|mesh-list
154819329|NCT01427595|Estrogens|estrogens|mesh-list
154819330|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154819331|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819332|NCT01427595|Progestins|progestins|mesh-ancestor
154819333|NCT01427595|Hormones|hormones|mesh-ancestor
154819334|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819335|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
154819336|NCT04390061|Tofacitinib|tofacitinib|mesh-list
154819337|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
154819338|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154819339|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154819340|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819341|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819342|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819343|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819344|NCT04390061|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154819345|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819346|NCT01892813|Bupropion|bupropion|mesh-list
154819347|NCT01892813|Nicotine|nicotine|mesh-list
154819348|NCT01892813|Varenicline|varenicline|mesh-list
154819349|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154819350|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
154819351|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819352|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819353|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154819354|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154819355|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
154819356|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819357|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819358|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154819359|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
154819360|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154819361|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154819362|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154819363|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819364|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
154819365|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154819366|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154819367|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819368|NCT00716443|Lidocaine|lidocaine|mesh-list
154819369|NCT00716443|Tetracaine|tetracaine|mesh-list
154819370|NCT00716443|Benzocaine|benzocaine|mesh-list
154819371|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
154819372|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
154819373|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819374|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819375|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
154819376|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819377|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154819378|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154819379|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154819380|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819381|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819382|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154819383|NCT00650143|Lenograstim|lenograstim|mesh-list
154571343|NCT02273635|Analgesics|analgesics|mesh-ancestor
154819384|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154819385|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819387|NCT00650143|Hormones|hormones|mesh-ancestor
154819388|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819389|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154819390|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
154819391|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819392|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819393|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154819394|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
154819395|NCT04770961|Ropivacaine|ropivacaine|mesh-list
154819396|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
154819397|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
154819398|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819399|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819400|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
154819401|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819402|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
154819403|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154819404|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
154819405|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154819406|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
154819407|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819408|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819409|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
154819410|NCT04769557|Acetaminophen|acetaminophen|mesh-list
154819411|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154819412|NCT04769557|Analgesics|analgesics|mesh-ancestor
154819413|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
154819414|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819415|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819416|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
154819417|NCT05606497|Dexamethasone|dexamethasone|mesh-list
154819418|NCT05606497|Betamethasone|betamethasone|mesh-list
154819419|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819420|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
154819421|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
154819422|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819423|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819424|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154819425|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
154819426|NCT05606497|Hormones|hormones|mesh-ancestor
154819427|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819428|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154819429|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819430|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154819431|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
154819432|NCT04778917|Heparin|heparin|mesh-list
154819433|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154819434|NCT04778917|Tinzaparin|tinzaparin|mesh-list
154819435|NCT04778917|Dalteparin|dalteparin|mesh-list
154819436|NCT04778917|Calcium heparin|calcium heparin|mesh-list
154819437|NCT04778917|Calcium|calcium|mesh-list
154819438|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154819439|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819440|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
154819441|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154819442|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154819443|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819444|NCT02213289|Nivolumab|nivolumab|mesh-list
154819445|NCT02213289|Trastuzumab|trastuzumab|mesh-list
154819446|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
154819447|NCT02213289|Ramucirumab|ramucirumab|mesh-list
154819448|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154819449|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819450|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153998898|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819451|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819452|NCT02213289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154819453|NCT02213289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154819454|NCT02213289|Growth Substances|growth substances|mesh-ancestor
154819455|NCT02213289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819456|NCT02213289|Growth Inhibitors|growth inhibitors|mesh-ancestor
154819457|NCT05606107|Tofacitinib|tofacitinib|mesh-list
154819458|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
154819459|NCT05606107|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154571416|NCT04481841|Vitamins|vitamins|mesh-list
154819460|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819461|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819462|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819463|NCT05606107|Hormones|hormones|mesh-ancestor
154819464|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819465|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819466|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
154819467|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
154819468|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
154819469|NCT00053989|Fludarabine|fludarabine|mesh-list
154819470|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
154819471|NCT00053989|Tacrolimus|tacrolimus|mesh-list
154819472|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154819473|NCT00053989|Sargramostim|sargramostim|mesh-list
154819474|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819475|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
154819476|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819477|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819478|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154819479|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
154819480|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819481|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819482|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154819483|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154819484|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
154819485|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154819486|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819487|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154819488|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154819489|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
154819490|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154819491|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819492|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819493|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
154819494|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
154819495|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819496|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154819497|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
154819498|NCT00053989|Hormones|hormones|mesh-ancestor
154819499|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819500|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154819501|NCT00053989|Protective Agents|protective agents|mesh-ancestor
154819502|NCT02740595|Nicotine|nicotine|mesh-list
154819503|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154819504|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
154819505|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819506|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819507|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154819508|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154819509|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
154819510|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819511|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819512|NCT02214615|Carbamazepine|carbamazepine|mesh-list
154819513|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
154819514|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
154819515|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154819516|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819517|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819518|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154819519|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154819520|NCT02214615|Analgesics|analgesics|mesh-ancestor
154819521|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
154819522|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819523|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154819524|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819525|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819526|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154819527|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154819528|NCT02661503|Dexamethasone|dexamethasone|mesh-list
154819529|NCT02661503|Prednisone|prednisone|mesh-list
154819530|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
154819531|NCT02661503|Dacarbazine|dacarbazine|mesh-list
154819532|NCT02661503|Doxorubicin|doxorubicin|mesh-list
154819533|NCT02661503|Etoposide|etoposide|mesh-list
154571493|NCT02404077|Clonidine|clonidine|mesh-list
154819534|NCT02661503|Vincristine|vincristine|mesh-list
154819535|NCT02661503|Bleomycin|bleomycin|mesh-list
154819536|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154819537|NCT02661503|Procarbazine|procarbazine|mesh-list
154819538|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819539|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
154819540|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819541|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819542|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154819543|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
154819544|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819545|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819546|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154819547|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819548|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
154819549|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
154819550|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819551|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154819552|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
154819553|NCT02661503|Hormones|hormones|mesh-ancestor
154819554|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819555|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154819556|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154819557|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154819558|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154819559|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819560|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154819561|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
154819562|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
154819563|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
154819564|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154819565|NCT02661503|Immunotoxins|immunotoxins|mesh-ancestor
154819566|NCT02661503|Immunoconjugates|immunoconjugates|mesh-ancestor
154819567|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154819568|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154819569|NCT03040752|Nifedipine|nifedipine|mesh-list
154819570|NCT03040752|Ritodrine|ritodrine|mesh-list
154819571|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154819572|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819573|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819574|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154819575|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819576|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
154819577|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
154819578|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154819579|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
153999045|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154819580|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
154819581|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819582|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154819583|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154819584|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154819585|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
154819586|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819587|NCT01668654|Ezogabine|ezogabine|mesh-list
154819588|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
154819589|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819590|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819591|NCT01431105|Atorvastatin|atorvastatin|mesh-list
154819592|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154819593|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154819594|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
154819595|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819596|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154819597|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154819598|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819599|NCT03038958|Prilocaine|prilocaine|mesh-list
154819600|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
154819601|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
154819602|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
154819603|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819604|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819605|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
154819606|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819607|NCT04840290|Paclitaxel|paclitaxel|mesh-list
154819608|NCT04840290|Carboplatin|carboplatin|mesh-list
153999085|NCT02547103|Mupirocin|mupirocin|mesh-list
154819609|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154819610|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819611|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
154819612|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
154819613|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
154819614|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819615|NCT02630069|Choline|choline|mesh-list
154819616|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154819617|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
154819618|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154819619|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
154819620|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819621|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154819622|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154819623|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
154819624|NCT01431339|Vancomycin|vancomycin|mesh-list
154819625|NCT01431339|Linezolid|linezolid|mesh-list
154819626|NCT01431339|Dalbavancin|dalbavancin|mesh-list
154819627|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154819628|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819629|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154819630|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819631|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819632|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
154819633|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
154819634|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154819635|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819636|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819637|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
154819638|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154819639|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819640|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819641|NCT04843644|Propolis|propolis|mesh-list
154819642|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819643|NCT02588105|Leucovorin|leucovorin|mesh-list
154819644|NCT02588105|Folic Acid|folic acid|mesh-list
154819645|NCT02588105|Fluorouracil|fluorouracil|mesh-list
154819646|NCT02588105|Irinotecan|irinotecan|mesh-list
154819647|NCT02588105|Olaparib|olaparib|mesh-list
154819648|NCT02588105|AZD0156|azd0156|mesh-list
154819649|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
154819650|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
154819651|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819652|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154819653|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819654|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819655|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
154819656|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819657|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154819658|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154819659|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819660|NCT02588105|Antidotes|antidotes|mesh-ancestor
154819661|NCT02588105|Protective Agents|protective agents|mesh-ancestor
154819662|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
154819663|NCT02588105|Vitamins|vitamins|mesh-ancestor
154819664|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
154819665|NCT02588105|Hematinics|hematinics|mesh-ancestor
154819666|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154819667|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819668|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154819669|NCT01488279|Dexamethasone|dexamethasone|mesh-list
154819670|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
154819671|NCT01488279|BB 1101|bb 1101|mesh-list
154819672|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819673|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
154819674|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
154819675|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999137|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
154819676|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819677|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154819678|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
154819679|NCT01488279|Hormones|hormones|mesh-ancestor
154819680|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819681|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154819682|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819683|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
154819684|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819685|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819686|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154819687|NCT01488279|Incretins|incretins|mesh-ancestor
154819688|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154819689|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
154819690|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
154819691|NCT03008109|Endostatins|endostatins|mesh-list
154819692|NCT03008109|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154819693|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819694|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154819695|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154819696|NCT03008109|Growth Substances|growth substances|mesh-ancestor
154819697|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819698|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
154819699|NCT03008109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819700|NCT03008109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819701|NCT03008109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819702|NCT02562443|ON 01910|on 01910|mesh-list
154819703|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999183|NCT00829179|Omalizumab|omalizumab|mesh-list
154819704|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819705|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819706|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819707|NCT04843098|Paclitaxel|paclitaxel|mesh-list
154819708|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154819709|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819710|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
154819711|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
154819712|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
154819713|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819714|NCT01490931|Ketorolac|ketorolac|mesh-list
154819715|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154819716|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154819717|NCT01490931|Analgesics|analgesics|mesh-ancestor
154819718|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
154819719|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819720|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819721|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819722|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819723|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154819724|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819725|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819726|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
154819727|NCT02562365|Carboplatin|carboplatin|mesh-list
154819728|NCT02562365|Etoposide|etoposide|mesh-list
154819729|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819730|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
154819731|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819732|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819733|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154819734|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
154819735|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819736|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819737|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154819738|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154819739|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154819740|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154819741|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819742|NCT01491633|Dasatinib|dasatinib|mesh-list
154819743|NCT01491633|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154819744|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819745|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819746|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819747|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819748|NCT01433913|Metformin|metformin|mesh-list
154819749|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154819750|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819751|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
154819752|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154819753|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154819754|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819755|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819756|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
154819757|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819758|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819759|NCT02508467|Fisogatinib|fisogatinib|mesh-list
154819760|NCT02508467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819761|NCT05586347|Nicardipine|nicardipine|mesh-list
154819762|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154819763|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154819764|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819765|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819766|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154819767|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819768|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
154819770|NCT01436799|Propofol|propofol|mesh-list
154819771|NCT01436799|Desflurane|desflurane|mesh-list
154819772|NCT01436799|Rocuronium|rocuronium|mesh-list
154819773|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154819774|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819775|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819776|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154819777|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
154819778|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
154819779|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154819780|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154819781|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154819782|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819783|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154819784|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154819785|NCT01436799|Narcotics|narcotics|mesh-ancestor
154819786|NCT01436799|Analgesics|analgesics|mesh-ancestor
154819787|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
154819788|NCT04851132|Durvalumab|durvalumab|mesh-list
154819789|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154819790|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819791|NCT02504489|Docetaxel|docetaxel|mesh-list
154819792|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819793|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154819794|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154819795|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154819796|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819797|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154819798|NCT02424617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154819799|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819800|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819801|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819802|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819803|NCT02415413|Dexamethasone|dexamethasone|mesh-list
154819804|NCT02415413|Lenalidomide|lenalidomide|mesh-list
154819805|NCT02415413|Melphalan|melphalan|mesh-list
154819806|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819807|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
154819808|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
154819809|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819810|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819811|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154819812|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
154819813|NCT02415413|Hormones|hormones|mesh-ancestor
154819814|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819815|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154819816|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819817|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
154819818|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154819819|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154819820|NCT02415413|Growth Substances|growth substances|mesh-ancestor
154819821|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
154819822|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154819823|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
154819824|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819825|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154819826|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819827|NCT01894061|Bevacizumab|bevacizumab|mesh-list
154819828|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154819829|NCT01894061|Antibodies|antibodies|mesh-list
154819830|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
154819831|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154819832|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819833|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154819834|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154819835|NCT01894061|Growth Substances|growth substances|mesh-ancestor
153999295|NCT00818649|Bortezomib|bortezomib|mesh-list
154819836|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819837|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
154819838|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
154819839|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
154819840|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154819841|NCT01561053|Antibodies|antibodies|mesh-list
154819842|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
154819843|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819844|NCT01561833|Sorafenib|sorafenib|mesh-list
154819845|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819846|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819847|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819848|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819849|NCT02607306|Insulin|insulin|mesh-list
154819850|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154819851|NCT02607306|Liraglutide|liraglutide|mesh-list
154819852|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
154819853|NCT02607306|Xultophy|xultophy|mesh-list
154819854|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154819855|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819856|NCT02607306|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154819857|NCT02607306|Incretins|incretins|mesh-ancestor
154819858|NCT02607306|Hormones|hormones|mesh-ancestor
154819859|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819860|NCT03040128|Minocycline|minocycline|mesh-list
154819861|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154819862|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154819863|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
154819864|NCT04850040|Apatinib|apatinib|mesh-list
154819865|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819866|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154819867|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819868|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819869|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
154819870|NCT03038334|Analgesics|analgesics|mesh-ancestor
154819871|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
154819872|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819873|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819874|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
154819875|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819876|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154819877|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
154819878|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154819879|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819880|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819881|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154819882|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
154819883|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154819884|NCT01441245|Furosemide|furosemide|mesh-list
154819885|NCT01441245|Diuretics|diuretics|mesh-ancestor
154819886|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
154819887|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819888|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154819889|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154819890|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819891|NCT01563081|Cetirizine|cetirizine|mesh-list
154819892|NCT01563081|Levocetirizine|levocetirizine|mesh-list
154819893|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154819894|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154819895|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
154819896|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
154819897|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819898|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819899|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819900|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154819901|NCT04833738|Triamcinolone|triamcinolone|mesh-list
154819902|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154819903|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154819904|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
154819905|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154819906|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819907|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
154819908|NCT04833738|Hormones|hormones|mesh-ancestor
154819909|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819910|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819911|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154819912|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
154819913|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819914|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819915|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154819916|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
154819917|NCT04833738|Protective Agents|protective agents|mesh-ancestor
154819918|NCT01441401|Gabapentin|gabapentin|mesh-list
154819919|NCT01441401|Analgesics|analgesics|mesh-ancestor
154819920|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
154819921|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819922|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819923|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
154819924|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154819925|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154819926|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819927|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154819928|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154819929|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154819930|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819931|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819932|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
154819933|NCT02268695|Docetaxel|docetaxel|mesh-list
154819934|NCT02268695|Cetuximab|cetuximab|mesh-list
154819935|NCT02268695|Lenograstim|lenograstim|mesh-list
154819936|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154819937|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
154819938|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
154819939|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
154819940|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819941|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153999393|NCT04238988|Carboplatin|carboplatin|mesh-list
154819942|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154819943|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
154819944|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819945|NCT01495923|Gabapentin|gabapentin|mesh-list
154819946|NCT01495923|Analgesics|analgesics|mesh-ancestor
154819947|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
154819948|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819949|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819950|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
154819951|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154819952|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154819953|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819954|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154819955|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154819956|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154819957|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154819958|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819959|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
154819960|NCT03037944|Drospirenone|drospirenone|mesh-list
154819961|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
154819962|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154819963|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154819964|NCT03037944|Estradiol|estradiol|mesh-list
154819965|NCT03037944|Estrogens|estrogens|mesh-ancestor
154819966|NCT03037944|Hormones|hormones|mesh-ancestor
154819967|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154819968|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819969|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154819970|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
154819971|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154819972|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154819973|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154819974|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154819975|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154819976|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154819977|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
154819978|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154819979|NCT03037944|Diuretics|diuretics|mesh-ancestor
154819980|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
154819981|NCT03039426|Diclofenac|diclofenac|mesh-list
154819982|NCT03039426|Bupivacaine|bupivacaine|mesh-list
154819983|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
154819984|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
154819985|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154819986|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154819987|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
154819988|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154819989|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154819990|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154819992|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154819993|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154819994|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154819995|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154819996|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154819997|NCT02205515|Everolimus|everolimus|mesh-list
154819998|NCT02205515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154819999|NCT02205515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820000|NCT02205515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820001|NCT02205515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820002|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820003|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
154820004|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820005|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820006|NCT04833036|Irinotecan|irinotecan|mesh-list
154820007|NCT04833036|Cetuximab|cetuximab|mesh-list
154820008|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154820009|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153999481|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
154820010|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820011|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820012|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820013|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154820014|NCT04832880|Remdesivir|remdesivir|mesh-list
154820015|NCT04832880|Dexamethasone|dexamethasone|mesh-list
154820016|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154820017|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
154820018|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
154820019|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820020|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820021|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154820022|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
154820023|NCT04832880|Hormones|hormones|mesh-ancestor
154820024|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154820025|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154820026|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820027|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
154820028|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820029|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
154820030|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820031|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
154820032|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154820033|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820034|NCT01894295|Vitamin D|vitamin d|mesh-list
154820035|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154820036|NCT01894295|Vitamins|vitamins|mesh-ancestor
154820037|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
154820038|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820039|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154820040|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153999506|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820041|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154820042|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
154820043|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820044|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820045|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820046|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
154820047|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
154820048|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154820049|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820050|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154820051|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154820052|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820053|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820054|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820055|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
154820056|NCT04824924|Venetoclax|venetoclax|mesh-list
154820057|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820058|NCT04553705|Quinine|quinine|mesh-list
154820059|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
154820060|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154820061|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154820062|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820063|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154820064|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820065|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153999534|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153999536|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
154820066|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820067|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154820068|NCT04553705|Analgesics|analgesics|mesh-ancestor
154820069|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
154820070|NCT02140151|Ranibizumab|ranibizumab|mesh-list
154820071|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154820072|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154820073|NCT02140151|Growth Substances|growth substances|mesh-ancestor
154820074|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820075|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
154820076|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820077|NCT02135315|Isosorbide|isosorbide|mesh-list
154820078|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154820079|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154820080|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154820081|NCT02135315|Diuretics|diuretics|mesh-ancestor
154820082|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
154820083|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820084|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
154820085|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154820086|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820087|NCT01894373|Immunomodulating Agents|immunomodulating agents|mesh-list
154820088|NCT01894373|Immunologic Factors|immunologic factors|mesh-ancestor
154820089|NCT01894373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820090|NCT04837170|Ketamine|ketamine|mesh-list
154820091|NCT04837170|Esketamine|esketamine|mesh-list
154820092|NCT04837170|Analgesics|analgesics|mesh-ancestor
154820093|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
154820094|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820095|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820096|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154820097|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154820098|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
154820099|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
154820100|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820101|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154820102|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154820103|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820104|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820105|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
154820106|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154820107|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154820108|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
154820109|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154820110|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
154820111|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154820112|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820113|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154820114|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153999561|NCT00963599|Loratadine|loratadine|mesh-list
154820115|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820116|NCT02099591|Naloxegol|naloxegol|mesh-list
154820117|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154820118|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820119|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
154820120|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820121|NCT01568073|Levodopa|levodopa|mesh-list
154820122|NCT01568073|Carbidopa|carbidopa|mesh-list
154820123|NCT01568073|Opicapone|opicapone|mesh-list
154820124|NCT01568073|Entacapone|entacapone|mesh-list
154820125|NCT01568073|Benserazide|benserazide|mesh-list
154820126|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154820127|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154820128|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
154820129|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820130|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820131|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820132|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154820133|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820134|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154820135|NCT04274933|Capecitabine|capecitabine|mesh-list
154558119|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
154820136|NCT04274933|Venetoclax|venetoclax|mesh-list
154820137|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154820138|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
154820139|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820140|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820141|NCT02603952|Oseltamivir|oseltamivir|mesh-list
154820142|NCT02603952|MEDI8852|medi8852|mesh-list
154820143|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
154820144|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820145|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820146|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820147|NCT01501929|Metoprolol|metoprolol|mesh-list
154820148|NCT01501929|Nebivolol|nebivolol|mesh-list
154820149|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154820150|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154820151|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
154820152|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
154820153|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820154|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820155|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154820156|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154820157|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154820158|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
154820159|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820160|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820161|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
154820162|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154820163|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154820164|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154820165|NCT02049593|Irinotecan|irinotecan|mesh-list
154820166|NCT02049593|Temozolomide|temozolomide|mesh-list
154820167|NCT02049593|Talazoparib|talazoparib|mesh-list
154820168|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154820169|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154820170|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154820171|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820172|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820173|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820174|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154820175|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
154820176|NCT02049047|Everolimus|everolimus|mesh-list
154820177|NCT02049047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154820178|NCT02049047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820179|NCT02049047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820180|NCT02049047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820181|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820182|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
154820183|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820184|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820185|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154820186|NCT04778358|Hormones|hormones|mesh-ancestor
154820187|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154820188|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820189|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154820190|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154820191|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820192|NCT01449747|Incretins|incretins|mesh-ancestor
154820193|NCT01449747|Hormones|hormones|mesh-ancestor
154820194|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154820195|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154820196|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
154820197|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820198|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820199|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
154820200|NCT03035838|Aprepitant|aprepitant|mesh-list
153999672|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
154820201|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
154820202|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
154820203|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820204|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820205|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154820206|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154820207|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820208|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820209|NCT01569087|Lenograstim|lenograstim|mesh-list
154820210|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154820211|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
154820212|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820213|NCT02024087|Sorafenib|sorafenib|mesh-list
154820214|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820215|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820216|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820217|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820218|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
154820219|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
154820220|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820221|NCT01895621|Protective Agents|protective agents|mesh-ancestor
154820222|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820223|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
154820224|NCT01895621|Vitamins|vitamins|mesh-ancestor
154820225|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
154820226|NCT01517711|Tramadol|tramadol|mesh-list
154820227|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154820228|NCT01517711|Narcotics|narcotics|mesh-ancestor
154820229|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820230|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820231|NCT01517711|Analgesics|analgesics|mesh-ancestor
154820232|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
154820233|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820234|NCT04836078|Chitosan|chitosan|mesh-list
154820235|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154820236|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154820237|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
154820238|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820239|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154820240|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
153999695|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
154820241|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
154820242|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
154820243|NCT04836078|Coagulants|coagulants|mesh-ancestor
154820244|NCT00055237|Bevacizumab|bevacizumab|mesh-list
154820245|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154820246|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820247|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154820248|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154820249|NCT00055237|Growth Substances|growth substances|mesh-ancestor
154820250|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820251|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
154820252|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
154820253|NCT04836156|Carboplatin|carboplatin|mesh-list
154820254|NCT04836156|Docetaxel|docetaxel|mesh-list
154820255|NCT04836156|Epirubicin|epirubicin|mesh-list
154820256|NCT04836156|Phenobarbital|phenobarbital|mesh-list
154820257|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820258|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
154820259|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820260|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154820261|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154820262|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
154820263|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820264|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820265|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154820266|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820267|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820268|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
154820269|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154820270|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154820271|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154820272|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820273|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
154820274|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999742|NCT00619099|Decitabine|decitabine|mesh-list
154820275|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820276|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154820277|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154820278|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820279|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
154820280|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
154820281|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154820282|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154820283|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154820284|NCT01502787|Metoprolol|metoprolol|mesh-list
154820285|NCT01502787|Nebivolol|nebivolol|mesh-list
154820286|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
154820287|NCT01502787|Giapreza|giapreza|mesh-list
154820288|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
154820289|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154820290|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154820292|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
154820293|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820294|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820295|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154820296|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154820297|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154820298|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
154820299|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820300|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820301|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
154820302|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154820303|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154820304|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153757416|NCT00373711|Iodine|iodine|mesh-list
154820305|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154820306|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154820307|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
154820308|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820309|NCT04835922|Anesthetics|anesthetics|mesh-list
154820310|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820311|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820312|NCT00153985|Fludarabine|fludarabine|mesh-list
154820313|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
154820314|NCT00153985|Busulfan|busulfan|mesh-list
154820315|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820316|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820317|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820318|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
154820319|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820320|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154820321|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
154820322|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154820323|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154820324|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
154820325|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154820326|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154820327|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
154820328|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154820329|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154820330|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154820331|NCT02318303|Analgesics|analgesics|mesh-ancestor
154820332|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
154820333|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820334|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820335|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154820336|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154820337|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154820338|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
154820339|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
154820340|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820341|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820342|NCT01451775|Empagliflozin|empagliflozin|mesh-list
153999799|NCT00621985|Dexamethasone|dexamethasone|mesh-list
154820343|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154820344|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820345|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154820346|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820347|NCT00156013|Clofarabine|clofarabine|mesh-list
154820348|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154820349|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
154820350|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820351|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820352|NCT01358669|Denosumab|denosumab|mesh-list
154820353|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154820354|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820355|NCT00156247|Acitretin|acitretin|mesh-list
154820356|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
154820357|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
154820358|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154820359|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
154820360|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154820361|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154820362|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154820363|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820364|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820365|NCT01573533|Rituximab|rituximab|mesh-list
154820366|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154820367|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820368|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
154820369|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820370|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154820371|NCT01455519|Hydromorphone|hydromorphone|mesh-list
154820372|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154820373|NCT01455519|Narcotics|narcotics|mesh-ancestor
154820374|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820375|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820376|NCT01455519|Analgesics|analgesics|mesh-ancestor
154820377|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
154820378|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820379|NCT00157573|Sargramostim|sargramostim|mesh-list
154820380|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
154820381|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820382|NCT04822038|Vitamin D|vitamin d|mesh-list
154820383|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
154820384|NCT04822038|Vitamins|vitamins|mesh-ancestor
154820385|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
154820386|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820387|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154820388|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154820389|NCT01576809|Acetaminophen|acetaminophen|mesh-list
154820390|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
154820391|NCT01576809|Phenylephrine|phenylephrine|mesh-list
154820392|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
154820393|NCT01576809|Guaifenesin|guaifenesin|mesh-list
154820394|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154820395|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154820396|NCT01576809|Analgesics|analgesics|mesh-ancestor
154820397|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
154820398|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820399|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820400|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
154820401|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154820402|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
154820403|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
154820404|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
154820405|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154820406|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
154820407|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
154820408|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154820409|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154820410|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154820411|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
154820412|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999883|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
154820413|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820414|NCT01576809|Protective Agents|protective agents|mesh-ancestor
154820415|NCT01576809|Expectorants|expectorants|mesh-ancestor
154820416|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
154820417|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154820418|NCT01456143|Proflavine|proflavine|mesh-list
154820419|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154820420|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820421|NCT01456299|Remifentanil|remifentanil|mesh-list
154820422|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154820423|NCT01456299|Narcotics|narcotics|mesh-ancestor
154820424|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820425|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820426|NCT01456299|Analgesics|analgesics|mesh-ancestor
154820427|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
154820428|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820429|NCT00158743|Digoxin|digoxin|mesh-list
154820430|NCT00158743|Antibodies|antibodies|mesh-list
154820431|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
154820432|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
154572398|NCT05149365|Hormones|hormones|mesh-ancestor
154820433|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820434|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154820435|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154820436|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820437|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820438|NCT00158743|Protective Agents|protective agents|mesh-ancestor
154820439|NCT00161473|Prazosin|prazosin|mesh-list
154820440|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154820441|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154820442|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154820443|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154820444|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
154820445|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820446|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820447|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820448|NCT01319981|Cytarabine|cytarabine|mesh-list
154820449|NCT01319981|Dexamethasone|dexamethasone|mesh-list
154820450|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
154820451|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154820452|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154820453|NCT01319981|Prednisolone|prednisolone|mesh-list
154820454|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
154820455|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
154820456|NCT01319981|Rituximab|rituximab|mesh-list
154820457|NCT01319981|Doxorubicin|doxorubicin|mesh-list
154820458|NCT01319981|Methotrexate|methotrexate|mesh-list
154820459|NCT01319981|Vincristine|vincristine|mesh-list
154820460|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
154820461|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154820462|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
154820463|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820464|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
154820465|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820466|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154820467|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154820468|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
154820469|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820470|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820471|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154820472|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154820473|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154820474|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
154820475|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
154820476|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820477|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154820478|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
154820479|NCT01319981|Hormones|hormones|mesh-ancestor
154820480|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154820481|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154820482|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154820483|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154820484|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154820485|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820486|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154820487|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
154820488|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154820489|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154820490|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
154820491|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
154820492|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154820493|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154820494|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
154820495|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820496|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154820497|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820498|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820499|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
154820500|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154820501|NCT01319981|Protective Agents|protective agents|mesh-ancestor
154820502|NCT01319981|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154820503|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820504|NCT01458561|Thrombin|thrombin|mesh-list
154820505|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154820506|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
154820507|NCT01458561|Coagulants|coagulants|mesh-ancestor
154820508|NCT00065611|Dexamethasone|dexamethasone|mesh-list
154820509|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154820510|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
154820511|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
154820512|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820513|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820514|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154820515|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
154820516|NCT00065611|Hormones|hormones|mesh-ancestor
154820517|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154820518|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154820519|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820520|NCT00066781|Gemcitabine|gemcitabine|mesh-list
154820521|NCT00066781|Irinotecan|irinotecan|mesh-list
154820522|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154820523|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
154820524|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820525|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820526|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154820527|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154820528|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820529|NCT01431755|Lidocaine|lidocaine|mesh-list
154820530|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
154820531|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
154820532|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
154820533|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820534|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820535|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
154820536|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820537|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154820538|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154820539|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154820540|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154820541|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820542|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154820543|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
154820544|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
154820545|NCT01431755|Protective Agents|protective agents|mesh-ancestor
154820546|NCT00066937|Benztropine|benztropine|mesh-list
154820547|NCT00066937|Nortriptyline|nortriptyline|mesh-list
154820548|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154820549|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
154820550|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154820551|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154820552|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154820553|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154820554|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820555|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
154820556|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820557|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820558|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154820559|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154820560|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
154820561|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
154820562|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820563|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154820564|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154820565|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
154820566|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154820567|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
154820568|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
154820569|NCT01064375|Molgramostim|molgramostim|mesh-list
154820570|NCT01064375|Sargramostim|sargramostim|mesh-list
154820571|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820572|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
154820573|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820574|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154820575|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154820576|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
154820577|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820578|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820579|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154820580|NCT01061411|Sunitinib|sunitinib|mesh-list
154820581|NCT01061411|Dalteparin|dalteparin|mesh-list
154820582|NCT01061411|Tinzaparin|tinzaparin|mesh-list
154820583|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154820584|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820585|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154820586|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154820587|NCT01061411|Growth Substances|growth substances|mesh-ancestor
154572546|NCT02385825|Vaccines|vaccines|mesh-list
154820588|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820589|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
154820590|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820591|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820592|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820593|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
154820594|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154820595|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154820596|NCT01505673|Liraglutide|liraglutide|mesh-list
154820597|NCT01505673|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154820598|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154820599|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820600|NCT01505673|Incretins|incretins|mesh-ancestor
154820601|NCT01505673|Hormones|hormones|mesh-ancestor
154820602|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154820603|NCT04834986|Lenvatinib|lenvatinib|mesh-list
154820604|NCT04834986|Tislelizumab|tislelizumab|mesh-list
154820605|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820606|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820607|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820608|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820609|NCT04834986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154820610|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
154820611|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154820612|NCT02247141|Antibodies|antibodies|mesh-list
154820613|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
154820614|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820615|NCT01896245|Sevoflurane|sevoflurane|mesh-list
154820616|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154820617|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154820618|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
154820619|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
154820620|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820621|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820622|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
154820623|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154820624|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
154820625|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820626|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
154820627|NCT04821804|Protective Agents|protective agents|mesh-ancestor
154820628|NCT04835064|Paclitaxel|paclitaxel|mesh-list
154820629|NCT04835064|Gemcitabine|gemcitabine|mesh-list
154820630|NCT04835064|Folfirinox|folfirinox|mesh-list
154820631|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154820632|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820633|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820634|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820635|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
154000098|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154820636|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820637|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154820638|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
154820639|NCT00819221|Doxorubicin|doxorubicin|mesh-list
154820640|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154820641|NCT00819221|Olaparib|olaparib|mesh-list
154820642|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154820643|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820644|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154820645|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154820646|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820647|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820648|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154820649|NCT01507779|Vaccines|vaccines|mesh-list
154820650|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
154820651|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820652|NCT01896323|Ketoconazole|ketoconazole|mesh-list
154820653|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
154820654|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820655|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154820656|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154820657|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820658|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820659|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154820660|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
154820661|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154820662|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820663|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154572604|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
154820664|NCT00068341|Carboplatin|carboplatin|mesh-list
154820665|NCT00068341|Docetaxel|docetaxel|mesh-list
154820666|NCT00068341|Trastuzumab|trastuzumab|mesh-list
154820667|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820668|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820669|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820670|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
154820671|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820672|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154820673|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
154820674|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154820675|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
154820676|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820677|NCT02605824|Expectorants|expectorants|mesh-ancestor
154820678|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
154820679|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154820680|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
154820681|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820682|NCT02605824|Protective Agents|protective agents|mesh-ancestor
154820683|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820684|NCT02605824|Antidotes|antidotes|mesh-ancestor
154820685|NCT01896661|Amlodipine|amlodipine|mesh-list
154820686|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
154820687|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
154820688|NCT01896661|Amiloride|amiloride|mesh-list
154820689|NCT01896661|Calcium|calcium|mesh-list
154820690|NCT01896661|Diuretics|diuretics|mesh-list
154820691|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154820692|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820693|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154820694|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154820695|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820696|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
154820697|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
154820698|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154820699|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154820700|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154820701|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154820702|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154820703|NCT01462773|Interferons|interferons|mesh-list
154820704|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
154820705|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
154820706|NCT01462773|Bortezomib|bortezomib|mesh-list
154820707|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820708|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
154820709|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000191|NCT00854035|Hormones|hormones|mesh-ancestor
154820710|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
154820711|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820712|NCT02096029|Nicotine|nicotine|mesh-list
154820713|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154820714|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
154820715|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820716|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820717|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154820718|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154820719|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
154820720|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820721|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820722|NCT02205801|Bupivacaine|bupivacaine|mesh-list
154820723|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
154820724|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
154820725|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820726|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820727|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
154820728|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820729|NCT02096107|Everolimus|everolimus|mesh-list
154820730|NCT02096107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154820731|NCT02096107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820732|NCT02096107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820733|NCT02096107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820734|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820735|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
154820736|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820737|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572684|NCT02185547|Sertraline|sertraline|mesh-list
154820738|NCT04834440|Ropivacaine|ropivacaine|mesh-list
154820739|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
154820740|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
154820741|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820742|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820743|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
154820744|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820745|NCT00068575|Interferons|interferons|mesh-list
154820746|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
154820747|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
154820748|NCT00068575|Cisplatin|cisplatin|mesh-list
154820749|NCT00068575|Fluorouracil|fluorouracil|mesh-list
154820750|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820751|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
154820752|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820753|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154820754|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820755|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
154820756|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000214|NCT00957905|Antidotes|antidotes|mesh-ancestor
154820757|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
154820758|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820759|NCT00784823|Bortezomib|bortezomib|mesh-list
154820760|NCT00784823|Melphalan|melphalan|mesh-list
154820761|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820762|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154820763|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
154820764|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820765|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154820766|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820767|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
154820768|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820769|NCT04428684|Goserelin|goserelin|mesh-list
154820770|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154820771|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820772|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154820773|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
154820774|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820775|NCT00773357|Guanfacine|guanfacine|mesh-list
154820776|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154820777|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154820778|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154820779|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154820780|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
154820781|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820782|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820783|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820784|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
154820785|NCT05617950|Salicylates|salicylates|mesh-list
154820786|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820787|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
154820788|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
154820789|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
154820790|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154820791|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154820792|NCT05617950|Analgesics|analgesics|mesh-ancestor
154820793|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
154820794|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820795|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820796|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154820797|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154820798|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154820799|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820800|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820801|NCT04834752|Esomeprazole|esomeprazole|mesh-list
154820802|NCT04834752|Omeprazole|omeprazole|mesh-list
154820803|NCT04834752|Rabeprazole|rabeprazole|mesh-list
154820804|NCT04834752|Pantoprazole|pantoprazole|mesh-list
154820805|NCT04834752|Lansoprazole|lansoprazole|mesh-list
154820806|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
154820807|NCT04834752|Famotidine|famotidine|mesh-list
154820808|NCT04834752|Ranitidine|ranitidine|mesh-list
154820809|NCT04834752|Cimetidine|cimetidine|mesh-list
154820810|NCT04834752|Nizatidine|nizatidine|mesh-list
154820811|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154820812|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154820813|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154820814|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820815|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820816|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154820817|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
154820819|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154820820|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820821|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154820822|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154820823|NCT04834674|Apatinib|apatinib|mesh-list
154820824|NCT04834674|Antibodies|antibodies|mesh-list
154820825|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
154820826|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820827|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820828|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820829|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820830|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820831|NCT04826406|Apatinib|apatinib|mesh-list
154820832|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820833|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820834|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820835|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820836|NCT05617872|Acetic Acid|acetic acid|mesh-list
154820837|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154820838|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820839|NCT00437255|Betamethasone|betamethasone|mesh-list
154820840|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
154820841|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154000313|NCT02806752|Triamcinolone|triamcinolone|mesh-list
154820842|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
154820843|NCT00437255|Clobetasol|clobetasol|mesh-list
154820844|NCT00437255|Calcipotriene|calcipotriene|mesh-list
154820845|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154820846|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154820847|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
154820848|NCT00437255|Hormones|hormones|mesh-ancestor
154820849|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154820850|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820851|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154820852|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
154820853|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
154820854|NCT02324673|Cannabidiol|cannabidiol|mesh-list
154820855|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
154820856|NCT00373217|Paclitaxel|paclitaxel|mesh-list
154820857|NCT00373217|Carboplatin|carboplatin|mesh-list
154820858|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154820859|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820860|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820861|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820862|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
154820863|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820864|NCT02605122|Amoxicillin|amoxicillin|mesh-list
154820865|NCT02605122|Azithromycin|azithromycin|mesh-list
154820866|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
154000341|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820867|NCT02605122|Erythromycin|erythromycin|mesh-list
154820868|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
154820869|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154820870|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
154820871|NCT02605122|Ampicillin|ampicillin|mesh-list
154820872|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
154820873|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
154820874|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154820875|NCT02605122|Solithromycin|solithromycin|mesh-list
154820876|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
154820877|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154820878|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154820879|NCT02605122|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154820880|NCT02605122|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154820881|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154820882|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154820883|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820884|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820885|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154820886|NCT01579305|Lidocaine|lidocaine|mesh-list
154820887|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
154820888|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
154820889|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820890|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820891|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
154820892|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820893|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154820894|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154820895|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154820896|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154820897|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820898|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
154820899|NCT00212147|Anesthetics|anesthetics|mesh-list
154820900|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820901|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820902|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154820903|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
154820904|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154820905|NCT00212147|Analgesics|analgesics|mesh-ancestor
154820906|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
154820907|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820908|NCT04820010|Insulin|insulin|mesh-list
154820909|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154820910|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820911|NCT04819776|Iloperidone|iloperidone|mesh-list
154820912|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154820913|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154820914|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820915|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820916|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154820917|NCT01454102|Paclitaxel|paclitaxel|mesh-list
154820918|NCT01454102|Bevacizumab|bevacizumab|mesh-list
154820919|NCT01454102|Carboplatin|carboplatin|mesh-list
154820920|NCT01454102|Gemcitabine|gemcitabine|mesh-list
154820921|NCT01454102|Nivolumab|nivolumab|mesh-list
154820922|NCT01454102|Pemetrexed|pemetrexed|mesh-list
154820923|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154820924|NCT01454102|Ipilimumab|ipilimumab|mesh-list
154820925|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154820926|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820927|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820928|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820929|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
154820930|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820931|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154820932|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154820933|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154820934|NCT01454102|Growth Substances|growth substances|mesh-ancestor
154820935|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820936|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
154820937|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154820938|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
154820939|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154820940|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820941|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154820942|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154820943|NCT01454102|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154820944|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154820945|NCT04192253|Paclitaxel|paclitaxel|mesh-list
154820946|NCT04192253|Carboplatin|carboplatin|mesh-list
154820947|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154820948|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820949|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820950|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820951|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
154820952|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820953|NCT04825938|Paclitaxel|paclitaxel|mesh-list
154820954|NCT04825938|Carboplatin|carboplatin|mesh-list
154820955|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154820956|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820957|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820958|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820959|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
154820960|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820961|NCT04826016|Paclitaxel|paclitaxel|mesh-list
154820962|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154820963|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820964|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
154820965|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
154820966|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
154820967|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572908|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154820968|NCT01509807|Morphine|morphine|mesh-list
154820969|NCT01509807|Bupivacaine|bupivacaine|mesh-list
154820970|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
154820971|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
154820972|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154820973|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820974|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
154820975|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154820976|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154820977|NCT01509807|Narcotics|narcotics|mesh-ancestor
154820978|NCT01509807|Analgesics|analgesics|mesh-ancestor
154820979|NCT00070135|Methotrexate|methotrexate|mesh-list
154820980|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
154820981|NCT00070135|Fludarabine|fludarabine|mesh-list
154820982|NCT00070135|Busulfan|busulfan|mesh-list
154820983|NCT00070135|Tacrolimus|tacrolimus|mesh-list
154820984|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154820985|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154820986|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
154820987|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154820988|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154820989|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154820990|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
154820991|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154820992|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154820993|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
154820994|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154820995|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154820996|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154820997|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
154820998|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154820999|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154821000|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154821001|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
154821002|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154821003|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154821004|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
154821005|NCT01583985|Narcotics|narcotics|mesh-ancestor
154821006|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821007|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821008|NCT01583985|Analgesics|analgesics|mesh-ancestor
154821009|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
154821010|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821011|NCT04816344|Anesthetics|anesthetics|mesh-list
154000476|NCT05980156|Antimalarials|antimalarials|mesh-ancestor
154821012|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821013|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821014|NCT01467999|Guanfacine|guanfacine|mesh-list
154821015|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154821016|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154821017|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154821018|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154821019|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
154821020|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821021|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821022|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821023|NCT05617482|Anesthetics|anesthetics|mesh-list
154821024|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821025|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821026|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
154821027|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154821028|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
154821029|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821030|NCT01470027|Expectorants|expectorants|mesh-ancestor
154821031|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
154821032|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154821033|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
154821034|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821035|NCT01470027|Protective Agents|protective agents|mesh-ancestor
154821036|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821037|NCT01470027|Antidotes|antidotes|mesh-ancestor
154821038|NCT01470651|Modafinil|modafinil|mesh-list
154821039|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154821040|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821041|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154821042|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154821043|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154821044|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821045|NCT01512225|Domperidone|domperidone|mesh-list
154821046|NCT01512225|Maleic acid|maleic acid|mesh-list
154821047|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821048|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821049|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
154821050|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
154821051|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821052|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821053|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154821054|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154821055|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
154821056|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821057|NCT01472445|Vitamin D|vitamin d|mesh-list
154821058|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
154821059|NCT01472445|Vitamins|vitamins|mesh-ancestor
154821060|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
154821061|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821062|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154821063|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154821064|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154821065|NCT04782089|Fluzoparib|fluzoparib|mesh-list
154821066|NCT04782089|Antibodies|antibodies|mesh-list
154821067|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
154821068|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821069|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821070|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821071|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821072|NCT02604342|Docetaxel|docetaxel|mesh-list
154821073|NCT02604342|Pemetrexed|pemetrexed|mesh-list
154821074|NCT02604342|Alectinib|alectinib|mesh-list
154821075|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821076|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
154821077|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
154821078|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
154821079|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821080|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821081|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154821082|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154821083|NCT02604342|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154821084|NCT02604342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154821085|NCT04781777|Insulin|insulin|mesh-list
154821086|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154821087|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821088|NCT04781075|Bupivacaine|bupivacaine|mesh-list
154821089|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
154821090|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
154821091|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821092|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821093|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
154821094|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821095|NCT01586091|Fexofenadine|fexofenadine|mesh-list
154821096|NCT01586091|Levocetirizine|levocetirizine|mesh-list
154821097|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154821098|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154821099|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
154821100|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
154821101|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821102|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821103|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821104|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154821105|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154821106|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
154821107|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
154821108|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154821109|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
154821110|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154000577|NCT05978401|Paclitaxel|paclitaxel|mesh-list
154821111|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821112|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154821113|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154821114|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154821115|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154821116|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154821117|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154821118|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821119|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
154821120|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
154821121|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154821122|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154821123|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821124|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821125|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821126|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821127|NCT01587027|Aminophylline|aminophylline|mesh-list
154821128|NCT01587027|Methazolamide|methazolamide|mesh-list
154821129|NCT01587027|Theophylline|theophylline|mesh-list
154821130|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154821131|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
154821132|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821133|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821134|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154821135|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
154821136|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154821137|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821138|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821139|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
154821140|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154821141|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154000605|NCT05978050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821142|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
154821143|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821144|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154821145|NCT01587027|Protective Agents|protective agents|mesh-ancestor
154821146|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154821147|NCT01587027|Diuretics|diuretics|mesh-ancestor
154821148|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
154821149|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
154821150|NCT01471340|Prednisone|prednisone|mesh-list
154821151|NCT01471340|Prednisolone|prednisolone|mesh-list
154821152|NCT01471340|Albuterol|albuterol|mesh-list
154821153|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
154821154|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
154821155|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821156|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
154821157|NCT01471340|Hormones|hormones|mesh-ancestor
154821158|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154821159|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821160|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154821161|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821162|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
154821163|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821164|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154821165|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154821166|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
154821167|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154821168|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154821169|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154821170|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
154821171|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821172|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821173|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
154821174|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154821175|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
154821176|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154821177|NCT04754789|Aspirin|aspirin|mesh-list
154821178|NCT04754789|Ticagrelor|ticagrelor|mesh-list
154821179|NCT04754789|Atorvastatin|atorvastatin|mesh-list
154821180|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154821181|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154821182|NCT04754789|Analgesics|analgesics|mesh-ancestor
154821183|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
154821184|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821185|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821186|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821187|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821188|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154821189|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154821190|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821191|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154821192|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154821193|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821194|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
154821195|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154821196|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154821197|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
154821198|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154821199|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154821200|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154821201|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154821202|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154821203|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
154821204|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821205|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154821206|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154821207|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154821208|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
154821209|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821210|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154821211|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154821212|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821213|NCT04815408|Paclitaxel|paclitaxel|mesh-list
154821214|NCT04815408|Carboplatin|carboplatin|mesh-list
154821215|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154821216|NCT04815408|Tislelizumab|tislelizumab|mesh-list
154821217|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154821218|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821219|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
154821220|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
154821221|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
154821222|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821223|NCT04815408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821224|NCT04778813|Artesunate|artesunate|mesh-list
154821225|NCT04778813|Lumefantrine|lumefantrine|mesh-list
154821226|NCT04778813|Artemether|artemether|mesh-list
154821227|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154821228|NCT04778813|Artenimol|artenimol|mesh-list
154821229|NCT04778813|Pyronaridine|pyronaridine|mesh-list
154000702|NCT05969587|Cysteamine|cysteamine|mesh-list
154821230|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
154821231|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154821232|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154821233|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821234|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821235|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
154821236|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
154821237|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154821238|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
154821239|NCT04817982|Dexamethasone|dexamethasone|mesh-list
154821240|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
154821241|NCT04817982|Lidocaine|lidocaine|mesh-list
154821242|NCT04817982|BB 1101|bb 1101|mesh-list
154821243|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821244|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
154821245|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
154821246|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821247|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821248|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154821249|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
154821250|NCT04817982|Hormones|hormones|mesh-ancestor
154821251|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154821252|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154821253|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821254|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
154821255|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821256|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821257|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
154821258|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
154821259|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821260|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
154821261|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154821262|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154821263|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154821264|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154821265|NCT04779047|Ritonavir|ritonavir|mesh-list
154821266|NCT04779047|Lopinavir|lopinavir|mesh-list
154821267|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
154821268|NCT04779047|Ivermectin|ivermectin|mesh-list
154573209|NCT02191709|Narcotics|narcotics|mesh-ancestor
154821269|NCT04779047|Remdesivir|remdesivir|mesh-list
154821270|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154821271|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154821273|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821274|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821275|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154821276|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154821277|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
154821278|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821279|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154821280|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154821281|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
154821282|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154821283|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154821284|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821285|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
154821286|NCT01515345|Clopidogrel|clopidogrel|mesh-list
154821287|NCT01515345|Ticagrelor|ticagrelor|mesh-list
154821288|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154821289|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154821290|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154821291|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154821292|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154821293|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
154821294|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821295|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821296|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821297|NCT01492400|Dexamethasone|dexamethasone|mesh-list
154821298|NCT01492400|Ranibizumab|ranibizumab|mesh-list
154821299|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821300|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
154821301|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
154821302|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821303|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821304|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154821305|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
154821306|NCT01492400|Hormones|hormones|mesh-ancestor
154821307|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154821308|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154821309|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821310|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154821311|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154821312|NCT01492400|Growth Substances|growth substances|mesh-ancestor
154821313|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
154821314|NCT00168337|Dexamethasone|dexamethasone|mesh-list
154821315|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821316|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
154821317|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
154821318|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821319|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821320|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154821321|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
154821322|NCT00168337|Hormones|hormones|mesh-ancestor
154821323|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154821324|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154821325|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821326|NCT01515657|Aspirin|aspirin|mesh-list
154821327|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154821328|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154821329|NCT01515657|Analgesics|analgesics|mesh-ancestor
154821330|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
154821331|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000811|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153631883|NCT00005968|Irofulven|irofulven|mesh-list
154821332|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821333|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821334|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821335|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154821336|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154821337|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821338|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154821339|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154821340|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821341|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
154821342|NCT01515891|Opicapone|opicapone|mesh-list
154821343|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154821344|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821345|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821346|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154821347|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154821348|NCT00073957|Cytarabine|cytarabine|mesh-list
154821349|NCT00073957|Rituximab|rituximab|mesh-list
154821350|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821351|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821352|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
154821353|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821354|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821355|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154821356|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
154821357|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821358|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
154821359|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821360|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821361|NCT04354428|Folic Acid|folic acid|mesh-list
154821362|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
154821363|NCT04354428|Ritonavir|ritonavir|mesh-list
154821364|NCT04354428|Lopinavir|lopinavir|mesh-list
154821365|NCT04354428|Azithromycin|azithromycin|mesh-list
154821366|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
154821367|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154821368|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154821369|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
154821370|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821371|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821372|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154821373|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154821374|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
154821375|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821376|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154821377|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154821378|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154821379|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
154821380|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154821381|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154821382|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821383|NCT04354428|Hematinics|hematinics|mesh-ancestor
154821384|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
154821385|NCT04354428|Vitamins|vitamins|mesh-ancestor
154821386|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
154821387|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821388|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
154821389|NCT04354428|Protective Agents|protective agents|mesh-ancestor
154821390|NCT02090075|Warfarin|warfarin|mesh-list
154821391|NCT02090075|Apixaban|apixaban|mesh-list
154821392|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
154821393|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154821394|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
154821395|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154821396|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
154821397|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821398|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821399|NCT04775303|Cyclosporine|cyclosporine|mesh-list
154821400|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154821401|NCT04775303|Cyclosporins|cyclosporins|mesh-list
154821402|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821403|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821404|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821405|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
154821406|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821407|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
154821408|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821409|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
154821410|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821411|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154000867|NCT04644315|Alectinib|alectinib|mesh-list
154821412|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154821413|NCT04816968|Vancomycin|vancomycin|mesh-list
154821414|NCT04816968|Meropenem|meropenem|mesh-list
154821415|NCT04816968|Tazobactam|tazobactam|mesh-list
154821416|NCT04816968|Piperacillin|piperacillin|mesh-list
154821417|NCT04816968|Cefepime|cefepime|mesh-list
154821418|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154821419|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154821420|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821421|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154821422|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821423|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821424|NCT02210247|Bupivacaine|bupivacaine|mesh-list
154821425|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
154821426|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
154821427|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821428|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821429|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
154821430|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821431|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154821432|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
154821433|NCT04806438|Lidocaine|lidocaine|mesh-list
154821434|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
154821435|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
154821436|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821437|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821438|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
154821439|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821440|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154821441|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154821442|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154821443|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154821444|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821445|NCT00074035|Pentostatin|pentostatin|mesh-list
154821446|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821447|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154821448|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821449|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821450|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154821451|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154821452|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
154821453|NCT00074815|Citalopram|citalopram|mesh-list
154821454|NCT00074815|Fluoxetine|fluoxetine|mesh-list
154821455|NCT00074815|Paroxetine|paroxetine|mesh-list
154821456|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154821457|NCT00074815|Sertraline|sertraline|mesh-list
154821458|NCT00074815|Clomipramine|clomipramine|mesh-list
154821459|NCT00074815|Escitalopram|escitalopram|mesh-list
154821460|NCT00074815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154821461|NCT00074815|Serotonin|serotonin|mesh-list
154821462|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154821463|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154821464|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821465|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821466|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
154821467|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821468|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154821469|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
154821470|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154821471|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154821472|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154821473|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821474|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154821475|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154821476|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154821477|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821478|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154821479|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154821480|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154821481|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154821482|NCT04772729|Insulin|insulin|mesh-list
154821483|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154821484|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
154821485|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154821486|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821487|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
154821488|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
154821489|NCT05562375|Coagulants|coagulants|mesh-ancestor
154821490|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
154821491|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821492|NCT00075829|Thalidomide|thalidomide|mesh-list
154821493|NCT00075829|Dexamethasone|dexamethasone|mesh-list
154821494|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821495|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
154573430|NCT02380131|Capecitabine|capecitabine|mesh-list
154821496|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
154821497|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821498|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821499|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154821500|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
154821501|NCT00075829|Hormones|hormones|mesh-ancestor
154821502|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154821503|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154821504|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821505|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821506|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
154821507|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
154821508|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154821509|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821510|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154821511|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154821512|NCT00075829|Growth Substances|growth substances|mesh-ancestor
154821513|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
154821514|NCT02218203|Lidocaine|lidocaine|mesh-list
154821515|NCT02218203|Levomethorphan|levomethorphan|mesh-list
154821516|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
154821517|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
154821518|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
154821519|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821520|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821521|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
154821522|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821523|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154821524|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154821525|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154821526|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154821527|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821528|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
154821529|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
154821530|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154821531|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154821532|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821533|NCT02218203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154821534|NCT02218203|Narcotics|narcotics|mesh-ancestor
154821535|NCT02218203|Analgesics|analgesics|mesh-ancestor
154821536|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
154821537|NCT04771715|Nivolumab|nivolumab|mesh-list
154821538|NCT04771715|Tislelizumab|tislelizumab|mesh-list
154001007|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821539|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821540|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821541|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154821542|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821543|NCT04771559|Antibodies|antibodies|mesh-list
154821544|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
154821545|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821546|NCT02592876|Rituximab|rituximab|mesh-list
154821547|NCT02592876|Carboplatin|carboplatin|mesh-list
154821548|NCT02592876|Etoposide|etoposide|mesh-list
154821549|NCT02592876|Ifosfamide|ifosfamide|mesh-list
154821550|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821551|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821552|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
154821553|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821554|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821555|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154821556|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154821557|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154821558|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821559|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821560|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154821561|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
154821562|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154821563|NCT02763137|Carbidopa|carbidopa|mesh-list
154821564|NCT02763137|Levodopa|levodopa|mesh-list
154821565|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154821566|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
154821567|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821568|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154821569|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154821570|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
154821571|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
154821572|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573511|NCT02371473|Acetazolamide|acetazolamide|mesh-list
154821573|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821574|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154821575|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821576|NCT01896739|Vaccines|vaccines|mesh-list
154821577|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
154821578|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821579|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
154821580|NCT00176839|Melphalan|melphalan|mesh-list
154821581|NCT00176839|Busulfan|busulfan|mesh-list
154821582|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154821583|NCT00176839|Lenograstim|lenograstim|mesh-list
154821584|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821585|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
154821586|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821587|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821588|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154821589|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
154821590|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001061|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154821591|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821592|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154821593|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154821594|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
154821595|NCT00176917|Busulfan|busulfan|mesh-list
154821596|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
154821597|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821598|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
154821599|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821600|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821601|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154821602|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
154821603|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821604|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821605|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154821606|NCT02664155|Vitamin K|vitamin k|mesh-list
154821607|NCT02664155|Heparin|heparin|mesh-list
154821608|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
154821609|NCT02664155|Apixaban|apixaban|mesh-list
154821610|NCT02664155|Vitamins|vitamins|mesh-ancestor
154821611|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
154821612|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821613|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
154821614|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154821615|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154821616|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821617|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154001085|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821618|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
154821619|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154821620|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
154821621|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821622|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154821623|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
154821624|NCT02664155|Coagulants|coagulants|mesh-ancestor
154821625|NCT04770389|Ezetimibe|ezetimibe|mesh-list
154821626|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154821627|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154821628|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
154821629|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821630|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154821631|NCT04753619|Niclosamide|niclosamide|mesh-list
154821632|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
154821633|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154821634|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
154821635|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154821636|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821637|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
154821638|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154821639|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821640|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821641|NCT01492088|Immunotoxins|immunotoxins|mesh-ancestor
154821642|NCT01492088|Immunoconjugates|immunoconjugates|mesh-ancestor
154821643|NCT01492088|Immunologic Factors|immunologic factors|mesh-ancestor
154821644|NCT01492088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821645|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
154821646|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154821647|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154821648|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821649|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
154821650|NCT04753151|Coagulants|coagulants|mesh-ancestor
154821651|NCT05606471|Semaglutide|semaglutide|mesh-list
154821652|NCT05606471|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154821653|NCT05606471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154821654|NCT05606471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821655|NCT05605925|Ivermectin|ivermectin|mesh-list
154821656|NCT05605925|Lumefantrine|lumefantrine|mesh-list
154821657|NCT05605925|Artemether|artemether|mesh-list
154821658|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154821659|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154821660|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821661|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
154821662|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154821663|NCT01520727|Opicapone|opicapone|mesh-list
154821664|NCT01520727|Entacapone|entacapone|mesh-list
154821665|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154821666|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821667|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821668|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154821669|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154821670|NCT01855607|Menthol|menthol|mesh-list
154821671|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
154821672|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
154821673|NCT01596699|Fludarabine|fludarabine|mesh-list
154821674|NCT01596699|Busulfan|busulfan|mesh-list
154821675|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
154821676|NCT01596699|Clofarabine|clofarabine|mesh-list
154821677|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821678|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154821679|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
154821680|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821681|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821682|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
154821683|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821684|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
154821685|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154821686|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154821687|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821688|NCT01148849|Margetuximab|margetuximab|mesh-list
154821689|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821690|NCT05566743|Capecitabine|capecitabine|mesh-list
154821691|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154821692|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
154821693|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821694|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821695|NCT05596721|Azithromycin|azithromycin|mesh-list
154821696|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154821697|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821698|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
154821699|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154821700|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154821701|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154821702|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154821703|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821704|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
154821705|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821706|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821707|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154821708|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821709|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154821710|NCT01525173|Bimatoprost|bimatoprost|mesh-list
154821711|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154821712|NCT01525173|Latanoprost|latanoprost|mesh-list
154821713|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154821714|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
154821715|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154821716|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154821717|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154821718|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154821719|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
154821720|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821721|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821722|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821723|NCT03007563|Bilirubin|bilirubin|mesh-list
154821724|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
154821725|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821726|NCT03007563|Protective Agents|protective agents|mesh-ancestor
154821727|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821729|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154821730|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154821731|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154821732|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154821733|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
154821734|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821735|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821736|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821737|NCT01894451|Bevacizumab|bevacizumab|mesh-list
154821738|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
154821739|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821740|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821741|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154821742|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154821743|NCT01894451|Growth Substances|growth substances|mesh-ancestor
154821744|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821745|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
154821746|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154821747|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821748|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
154821749|NCT01527045|Cyclosporine|cyclosporine|mesh-list
154821750|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
154821751|NCT01527045|Fludarabine|fludarabine|mesh-list
154821752|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
154821753|NCT01527045|Atorvastatin|atorvastatin|mesh-list
154821754|NCT01527045|Calcium|calcium|mesh-list
154821755|NCT01527045|Cyclosporins|cyclosporins|mesh-list
154821756|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154821757|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821758|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154821759|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821760|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154821761|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
154821762|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821763|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821764|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
154821765|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821766|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
154001239|NCT02803788|Ramosetron|ramosetron|mesh-list
154001256|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821767|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821768|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
154821769|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821770|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154821771|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154821772|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154821773|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154821774|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154821775|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154821776|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154821777|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
154821778|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154821779|NCT00078403|Ribavirin|ribavirin|mesh-list
154821780|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154821781|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
154821782|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821783|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
154821784|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821785|NCT01976585|Poly ICLC|poly iclc|mesh-list
154821786|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
154821787|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
154821788|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821789|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154821790|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
154821791|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154821792|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154821793|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154821794|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821795|NCT03001635|Oxytocin|oxytocin|mesh-list
154821796|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
154821797|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154821798|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821799|NCT02592798|Abatacept|abatacept|mesh-list
154821800|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154821801|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821802|NCT02592798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821803|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821804|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821805|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
154821806|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821807|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154821808|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154821810|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154821811|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154821812|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
154821813|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821814|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821815|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821816|NCT01530243|Urological Agents|urological agents|mesh-ancestor
154821817|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154821818|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154821819|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154821820|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154821821|NCT04797546|Morphine|morphine|mesh-list
154821822|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154821823|NCT04797546|Narcotics|narcotics|mesh-ancestor
154821824|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821825|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821826|NCT04797546|Analgesics|analgesics|mesh-ancestor
154821827|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
154821828|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821829|NCT02980809|Apatinib|apatinib|mesh-list
154821830|NCT02980809|Topotecan|topotecan|mesh-list
154821831|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821832|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154821833|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821834|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821835|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154821836|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154821837|NCT00078559|Acetaminophen|acetaminophen|mesh-list
154821838|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
154821839|NCT00078559|Promethazine|promethazine|mesh-list
154821840|NCT00078559|Sirolimus|sirolimus|mesh-list
154821841|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154821842|NCT00078559|Nystatin|nystatin|mesh-list
154821843|NCT00078559|Clotrimazole|clotrimazole|mesh-list
154821844|NCT00078559|Miconazole|miconazole|mesh-list
154821845|NCT00078559|Pentamidine|pentamidine|mesh-list
154821846|NCT00078559|Trimethoprim|trimethoprim|mesh-list
154821847|NCT00078559|Acyclovir|acyclovir|mesh-list
154821848|NCT00078559|Valganciclovir|valganciclovir|mesh-list
154821849|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
154821850|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
154821851|NCT00078559|Tacrolimus|tacrolimus|mesh-list
154821852|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154821853|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
154821854|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821855|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154821856|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001316|NCT00855049|Acetaminophen|acetaminophen|mesh-list
154821857|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821858|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154821859|NCT00078559|Analgesics|analgesics|mesh-ancestor
154821860|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
154821861|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821862|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
154821863|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154821864|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821865|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154821866|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821867|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
154821868|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821869|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
154821870|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
154821871|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154821872|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
154821873|NCT00078559|Hormones|hormones|mesh-ancestor
154821874|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154821875|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154821876|NCT00078559|Protective Agents|protective agents|mesh-ancestor
154821877|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154821878|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154821879|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154821880|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154821881|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
154821882|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
154821883|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154821884|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
154821885|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
154821886|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821887|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154821888|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
154821889|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
154821890|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154821891|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
154821892|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154821893|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154821894|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154821895|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154821896|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154821897|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154821898|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
154821899|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154821900|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154821901|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154821902|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
154821903|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154821904|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154821905|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154821906|NCT00078559|Ionophores|ionophores|mesh-ancestor
154821907|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154821908|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
154821909|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154821910|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821911|NCT00078715|Yohimbine|yohimbine|mesh-list
154821912|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
154821913|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
154821914|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821915|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821916|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154821917|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154821918|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154821919|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
154821920|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821921|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821922|NCT00078715|Urological Agents|urological agents|mesh-ancestor
154821923|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
154821924|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821925|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
154821926|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154821927|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154821928|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821929|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
154821930|NCT01530399|Coagulants|coagulants|mesh-ancestor
154821931|NCT02596620|Amoxicillin|amoxicillin|mesh-list
154821932|NCT02596620|Metronidazole|metronidazole|mesh-list
154821933|NCT02596620|Levofloxacin|levofloxacin|mesh-list
154821934|NCT02596620|Esomeprazole|esomeprazole|mesh-list
154821935|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154821936|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154821937|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154821938|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154821939|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154821940|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154821941|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154821942|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821943|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821944|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154821945|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154821946|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154821947|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821948|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154821949|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154821950|NCT01531959|Midodrine|midodrine|mesh-list
154573884|NCT02257463|Theophylline|theophylline|mesh-list
154821951|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
154821952|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
154821953|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154821954|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821955|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154821956|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154821957|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154821958|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154821959|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
154821960|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154821961|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821962|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
154821963|NCT01532349|Vitamin D|vitamin d|mesh-list
154821964|NCT01532349|Vitamins|vitamins|mesh-ancestor
154821965|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
154821966|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821967|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154821968|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154821969|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
154821970|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154821971|NCT01533207|Gemcitabine|gemcitabine|mesh-list
154821972|NCT01533207|Docetaxel|docetaxel|mesh-list
154821973|NCT01533207|Doxorubicin|doxorubicin|mesh-list
154821974|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154821975|NCT01533207|Lenograstim|lenograstim|mesh-list
154821976|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154821977|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
154821978|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154821979|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821980|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
154821981|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
154821982|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
154821983|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154821984|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154821985|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154821986|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821987|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154821988|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
154821989|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154821990|NCT00182767|Doxorubicin|doxorubicin|mesh-list
154821991|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154821992|NCT00182767|Epothilone B|epothilone b|mesh-list
154821993|NCT00182767|Epothilones|epothilones|mesh-list
154821994|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154821995|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154821996|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154821997|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154821998|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154821999|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822000|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
154822001|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
154822002|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
154001459|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
154822003|NCT01533597|Tamsulosin|tamsulosin|mesh-list
154822004|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
154822005|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154822006|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154822007|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154822008|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
154822009|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822010|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822011|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822012|NCT01533597|Urological Agents|urological agents|mesh-ancestor
154822013|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154822014|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154822015|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
154822016|NCT03006627|Morphine|morphine|mesh-list
154822017|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154822018|NCT03006627|Narcotics|narcotics|mesh-ancestor
154822019|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822020|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822021|NCT03006627|Analgesics|analgesics|mesh-ancestor
154822022|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
154822023|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822024|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
154822025|NCT04796688|Fludarabine|fludarabine|mesh-list
154822026|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154822027|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
154822028|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822029|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154822030|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154822031|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
154822032|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822033|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822034|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154822035|NCT01535001|Acetaminophen|acetaminophen|mesh-list
154822036|NCT01535001|Pantoprazole|pantoprazole|mesh-list
154822037|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154822038|NCT01535001|Analgesics|analgesics|mesh-ancestor
154822039|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
154822040|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822041|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822042|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
154822043|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154822044|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822045|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154822046|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001508|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
154822047|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822048|NCT03000777|Melatonin|melatonin|mesh-list
154822049|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
154822050|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822051|NCT03000777|Protective Agents|protective agents|mesh-ancestor
154822052|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822053|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822054|NCT03006003|Alendronate|alendronate|mesh-list
154822055|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154822056|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154822057|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822058|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154822059|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
154822060|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822061|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154822062|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154822063|NCT04426734|Dexamethasone|dexamethasone|mesh-list
154822064|NCT04426734|Prednisolone|prednisolone|mesh-list
154822065|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154822066|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
154822067|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154822068|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
154822069|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154822070|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
154822071|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154822072|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
154822073|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
154822074|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822075|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822076|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001525|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154822077|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
154822078|NCT04426734|Hormones|hormones|mesh-ancestor
154822079|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822080|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154822081|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822082|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154822083|NCT04426734|Protective Agents|protective agents|mesh-ancestor
154822084|NCT03006081|Aflibercept|aflibercept|mesh-list
154822085|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154822086|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154822087|NCT03006081|Growth Substances|growth substances|mesh-ancestor
154822088|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822089|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
154822090|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822091|NCT01535937|Midazolam|midazolam|mesh-list
154822092|NCT01535937|Ketamine|ketamine|mesh-list
154822093|NCT01535937|Analgesics|analgesics|mesh-ancestor
154822094|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
154822095|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822096|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822097|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154822098|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154822099|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
154822100|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
154001558|NCT02802540|Nabilone|nabilone|mesh-list
154822101|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822102|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154574036|NCT02206295|Selexipag|selexipag|mesh-list
154822103|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154822104|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822105|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822106|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154822107|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154822108|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154822109|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154822110|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154822111|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
154822112|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
154822113|NCT04813848|Fluorides|fluorides|mesh-list
154822114|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
154822115|NCT04813848|Protective Agents|protective agents|mesh-ancestor
154822116|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822117|NCT02999841|Vildagliptin|vildagliptin|mesh-list
154822118|NCT02999841|Acarbose|acarbose|mesh-list
154822119|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154822120|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822121|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154822122|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
154822123|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822124|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822125|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154822126|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
154822127|NCT01537029|Doxorubicin|doxorubicin|mesh-list
154822128|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154822129|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
154822130|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822131|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154822132|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154822133|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
154822134|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822135|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822136|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154822137|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154822138|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154822139|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154822140|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822141|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154822142|NCT01667562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154822143|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154822144|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822145|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822146|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822147|NCT04803318|Everolimus|everolimus|mesh-list
154822148|NCT04803318|Lenvatinib|lenvatinib|mesh-list
154822149|NCT04803318|Trametinib|trametinib|mesh-list
154822150|NCT04803318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154822151|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154822152|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822153|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822154|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154822155|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
154822156|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822157|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822158|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
154822159|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154822160|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
154822161|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822162|NCT04803162|Omeprazole|omeprazole|mesh-list
154822163|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154822164|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822165|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154822166|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822167|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822168|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154822169|NCT02999217|Hematinics|hematinics|mesh-ancestor
154822170|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154822171|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154822172|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
154822173|NCT02980965|Docetaxel|docetaxel|mesh-list
154822174|NCT02980965|Fluorouracil|fluorouracil|mesh-list
154822175|NCT02980965|Letrozole|letrozole|mesh-list
154822176|NCT02980965|Epirubicin|epirubicin|mesh-list
154822177|NCT02980965|Leuprolide|leuprolide|mesh-list
154822178|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154822179|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
154822180|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822181|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154822182|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154822183|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
154822184|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822185|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001653|NCT02939183|Dexamethasone|dexamethasone|mesh-list
154822186|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154822187|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
154822188|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
154822189|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
154822190|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
154822191|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154822192|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154822193|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154822194|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822195|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154822196|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
154822197|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822198|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154822199|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154822200|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154822201|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154822202|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
154822203|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154001665|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822204|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154822205|NCT01538745|Ketamine|ketamine|mesh-list
154822206|NCT01538745|Morphine|morphine|mesh-list
154822207|NCT01538745|Analgesics|analgesics|mesh-ancestor
154822208|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
154822209|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822210|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822211|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154822212|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154822213|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
154822214|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
154822215|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822216|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154822217|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154822218|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822219|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822220|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154822221|NCT01538745|Narcotics|narcotics|mesh-ancestor
154822222|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
154822223|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154822224|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
154822225|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822226|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
154822227|NCT04803240|Protective Agents|protective agents|mesh-ancestor
154822228|NCT01539135|Methylene Blue|methylene blue|mesh-list
154822229|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822230|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822231|NCT04426578|Perhexiline|perhexiline|mesh-list
154822232|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154822233|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154822234|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822235|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154822236|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822237|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
154822238|NCT04802928|Isoniazid|isoniazid|mesh-list
154822239|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
154822240|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154822241|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822242|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154822243|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154822244|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
154822245|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822246|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154822247|NCT05365425|Choline|choline|mesh-list
154822248|NCT05365425|Policosanol|policosanol|mesh-list
154822249|NCT05365425|Fenofibrate|fenofibrate|mesh-list
154822250|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154822251|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
154822252|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822253|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154822254|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
154822255|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822256|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
154822257|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154822258|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154822259|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154822260|NCT02595450|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154822261|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154822262|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822263|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822264|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822265|NCT04794738|Morphine|morphine|mesh-list
154822266|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154822267|NCT04794738|Narcotics|narcotics|mesh-ancestor
154822268|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822269|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822270|NCT04794738|Analgesics|analgesics|mesh-ancestor
154822271|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
154822272|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822273|NCT04794426|Fluorides|fluorides|mesh-list
154822274|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
154822275|NCT04794426|Protective Agents|protective agents|mesh-ancestor
154822276|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822277|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154822278|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154822279|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822280|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822281|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154822282|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154822283|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822284|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
154822285|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822286|NCT02591238|Melatonin|melatonin|mesh-list
154822287|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
154822288|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822289|NCT02591238|Protective Agents|protective agents|mesh-ancestor
154822290|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822291|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822292|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
154822293|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154822294|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
154822295|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822296|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822297|NCT04793256|Listerine|listerine|mesh-list
154822298|NCT04793256|Fluorides|fluorides|mesh-list
154822299|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
154822300|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
154822301|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
154822302|NCT04793256|Protective Agents|protective agents|mesh-ancestor
154822303|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822304|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154822305|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822306|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154822307|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
154822308|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154822309|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154822310|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154822311|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822312|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822313|NCT04792710|Metronidazole|metronidazole|mesh-list
154822314|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822315|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154822316|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154822317|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154822318|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154822319|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154822320|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822321|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001759|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
154822322|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154822323|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154822324|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822325|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
154822326|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822327|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
154822328|NCT03004209|Hematinics|hematinics|mesh-ancestor
154822329|NCT04800978|Durvalumab|durvalumab|mesh-list
154822330|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154822331|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822332|NCT04791774|Caseins|caseins|mesh-list
154822333|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
154822334|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
154822335|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822336|NCT00183469|Lamotrigine|lamotrigine|mesh-list
154822337|NCT00183469|Valproic Acid|valproic acid|mesh-list
154822338|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
154822339|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154822340|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154822341|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822342|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154822343|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822344|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154822345|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154822346|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822347|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001804|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154822348|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154822349|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822350|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
154822351|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822352|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
154822353|NCT02248155|Pramipexole|pramipexole|mesh-list
154822354|NCT02248155|Dexpramipexole|dexpramipexole|mesh-list
154822355|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
154822356|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822357|NCT02248155|Protective Agents|protective agents|mesh-ancestor
154822358|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822359|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154822360|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154822361|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
154822362|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
154822363|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822364|NCT02597946|Paclitaxel|paclitaxel|mesh-list
154822365|NCT02597946|Afatinib|afatinib|mesh-list
154822366|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154822367|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822368|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
154822369|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
154822370|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
154822371|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822372|NCT02597946|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154822373|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154822374|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822375|NCT02248233|Nimodipine|nimodipine|mesh-list
154822376|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154822377|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
154822378|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154822379|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154822380|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154822381|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822382|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154822383|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822384|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
154822385|NCT04790838|Fluticasone|fluticasone|mesh-list
154822386|NCT04790838|Xhance|xhance|mesh-list
154822387|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154822388|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154822389|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154822390|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154822391|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
154822392|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822393|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822394|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154822395|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
154822396|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154822397|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154822398|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154822399|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154822400|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154001859|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
154822401|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
154822402|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822403|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822404|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
154822405|NCT04790838|Hormones|hormones|mesh-ancestor
154822406|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822407|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
154822408|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154822409|NCT03003273|Amoxicillin|amoxicillin|mesh-list
154822410|NCT03003273|Levofloxacin|levofloxacin|mesh-list
154822411|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
154822412|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
154822413|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822414|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154822415|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154822416|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154822417|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822418|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822419|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822420|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154822421|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154822422|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154822423|NCT05571345|Oxycodone|oxycodone|mesh-list
154822424|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154822425|NCT05571345|Narcotics|narcotics|mesh-ancestor
154822426|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001886|NCT00864019|Sertraline|sertraline|mesh-list
154822427|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822428|NCT05571345|Analgesics|analgesics|mesh-ancestor
154822429|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
154822430|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822431|NCT02981121|Metformin|metformin|mesh-list
154822432|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154822433|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822434|NCT02597478|Fentanyl|fentanyl|mesh-list
154822435|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154822436|NCT02597478|Narcotics|narcotics|mesh-ancestor
154822437|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822438|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822439|NCT02597478|Analgesics|analgesics|mesh-ancestor
154822440|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
154822441|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822442|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154822443|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154822444|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
154822445|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
154822446|NCT04811274|Dimercaprol|dimercaprol|mesh-list
154822447|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
154822448|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
154822449|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822450|NCT04799184|Epinephrine|epinephrine|mesh-list
154822451|NCT04799184|Racepinephrine|racepinephrine|mesh-list
154822452|NCT04799184|Bupivacaine|bupivacaine|mesh-list
154822453|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
154822454|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
154822455|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
154822456|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
154001913|NCT00617461|Gabapentin|gabapentin|mesh-list
154822457|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822458|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822459|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
154822460|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822461|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154822462|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154822463|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
154822464|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822465|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822466|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154822467|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154822468|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
154822469|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154822470|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
154822471|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
154822472|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
154822473|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154822474|NCT05562297|Paclitaxel|paclitaxel|mesh-list
154822475|NCT05562297|Gemcitabine|gemcitabine|mesh-list
154822476|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154574405|NCT05791487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154822477|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822478|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
154822479|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
154822481|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822482|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154822483|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
154822484|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154822485|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154822486|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
154822487|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822488|NCT04790136|Cannabidiol|cannabidiol|mesh-list
154822489|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
154822490|NCT03003039|Rituximab|rituximab|mesh-list
154822491|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154822492|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822493|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
154822494|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822495|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154822496|NCT03002961|Buprenorphine|buprenorphine|mesh-list
154822497|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154822498|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154822499|NCT03002961|Narcotics|narcotics|mesh-ancestor
154822500|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822501|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822502|NCT03002961|Analgesics|analgesics|mesh-ancestor
154822503|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
154822504|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822505|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154822506|NCT03002805|Doxorubicin|doxorubicin|mesh-list
154822507|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154822508|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822509|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154822510|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154822511|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001964|NCT00616759|Propofol|propofol|mesh-list
154822512|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822513|NCT04214691|Acetaminophen|acetaminophen|mesh-list
154822514|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154822515|NCT04214691|Analgesics|analgesics|mesh-ancestor
154822516|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
154822517|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822518|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822519|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
154822520|NCT04786158|Apomorphine|apomorphine|mesh-list
154822521|NCT04786158|Emetics|emetics|mesh-ancestor
154822522|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822523|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
154822524|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822525|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822526|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
154822527|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
154822528|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822529|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822530|NCT03002493|Rifampin|rifampin|mesh-list
154822531|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154822532|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
154822533|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154822534|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822535|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
154822536|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154822537|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822538|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822539|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154822540|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154822541|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154001991|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154822542|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154822543|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154822544|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154822545|NCT04786470|Ropivacaine|ropivacaine|mesh-list
154822546|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
154822547|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
154822548|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822549|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822550|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
154822551|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822552|NCT02219997|Methamphetamine|methamphetamine|mesh-list
154822553|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
154822554|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154822555|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154822556|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154822557|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822558|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
154822559|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
154822560|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822561|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
154822562|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822563|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822564|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
154822565|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154822566|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154822567|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154822568|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154822569|NCT02219997|Hormones|hormones|mesh-ancestor
154822570|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002022|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822571|NCT04786002|Busulfan|busulfan|mesh-list
154822572|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
154822573|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822574|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154822575|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
154822576|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822577|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154822578|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822579|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154822580|NCT04785768|Morphine|morphine|mesh-list
154822581|NCT04785768|Hydromorphone|hydromorphone|mesh-list
154822582|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154822583|NCT04785768|Narcotics|narcotics|mesh-ancestor
154822584|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822585|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822586|NCT04785768|Analgesics|analgesics|mesh-ancestor
154822587|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
154822588|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822589|NCT02223351|Ritonavir|ritonavir|mesh-list
154822590|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154822591|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154822592|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
154822593|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822594|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822595|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154822596|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154822597|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
154822598|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822599|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154822600|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154822601|NCT02223429|Vasopressins|vasopressins|mesh-list
154822602|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
154822603|NCT02223429|Oxytocin|oxytocin|mesh-list
154822604|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822605|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
154822606|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154822607|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
154822608|NCT02223429|Coagulants|coagulants|mesh-ancestor
154822609|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154822610|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154822611|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
154822612|NCT03002649|Tofacitinib|tofacitinib|mesh-list
154822613|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822614|NCT03002649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154822615|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154822616|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822617|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
154822618|NCT04785222|Bupivacaine|bupivacaine|mesh-list
154822619|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
154822620|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
154822621|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822622|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822623|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
154822624|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822625|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154822626|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154822627|NCT04785222|Analgesics|analgesics|mesh-ancestor
154574554|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002087|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
154822628|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154822629|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154822630|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154822631|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
154822632|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822633|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822634|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
154822635|NCT04808856|Hormones|hormones|mesh-list
154822636|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154822637|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154822638|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
154822639|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822640|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822641|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154822642|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
154822643|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
154822644|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822645|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822646|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
154822647|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154822648|NCT04808856|Protective Agents|protective agents|mesh-ancestor
154822649|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822650|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822651|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
154822652|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154822653|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
154822654|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154822655|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154002130|NCT02794506|Propolis|propolis|mesh-list
154822656|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
154822657|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822658|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154822659|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154822660|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822661|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822662|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154822663|NCT04784910|Lansoprazole|lansoprazole|mesh-list
154822664|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
154822665|NCT04784910|Fexuprazan|fexuprazan|mesh-list
154822666|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154822667|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822668|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154822669|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822670|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822671|NCT01625013|Hylan|hylan|mesh-list
154822672|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
154822673|NCT01625013|Protective Agents|protective agents|mesh-ancestor
154822674|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822675|NCT00083551|Interferons|interferons|mesh-list
154822676|NCT00083551|Cytarabine|cytarabine|mesh-list
154822677|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
154822678|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
154822679|NCT00083551|Thalidomide|thalidomide|mesh-list
154822680|NCT00083551|Dexamethasone|dexamethasone|mesh-list
154822681|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
154002147|NCT02794584|Dsuvia|dsuvia|mesh-list
154822682|NCT00083551|Melphalan|melphalan|mesh-list
154822683|NCT00083551|Carmustine|carmustine|mesh-list
154822684|NCT00083551|Cisplatin|cisplatin|mesh-list
154822685|NCT00083551|Doxorubicin|doxorubicin|mesh-list
154822686|NCT00083551|Etoposide|etoposide|mesh-list
154822687|NCT00083551|Vincristine|vincristine|mesh-list
154822688|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154822689|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
154822690|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822691|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154822692|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154822693|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
154822694|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822695|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822696|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154822697|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154822698|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
154822699|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
154822700|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822701|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822702|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
154822703|NCT00083551|Hormones|hormones|mesh-ancestor
154822704|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822705|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154822706|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154822707|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154822708|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154822709|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822710|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154002169|NCT00871507|Incretins|incretins|mesh-ancestor
154822711|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
154822712|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822713|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154822714|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
154822715|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
154822716|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
154822717|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
154822718|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
154822719|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154822720|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154822721|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154822722|NCT00083551|Growth Substances|growth substances|mesh-ancestor
154822723|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
154822724|NCT01625169|Etravirine|etravirine|mesh-list
154822725|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154822726|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154822727|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822728|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822729|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
154822730|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822731|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154822732|NCT03933813|Hematinics|hematinics|mesh-ancestor
154822733|NCT01628601|Timolol|timolol|mesh-list
154822734|NCT01628601|Bimatoprost|bimatoprost|mesh-list
154822735|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154822736|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154822737|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
154002201|NCT00872131|Sertraline|sertraline|mesh-list
154822738|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822739|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822740|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822741|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154822742|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154822743|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
154822744|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822745|NCT01490918|Metformin|metformin|mesh-list
154822746|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154822747|NCT01490918|Acarbose|acarbose|mesh-list
154822748|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154822749|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822750|NCT01490918|Incretins|incretins|mesh-ancestor
154822751|NCT01490918|Hormones|hormones|mesh-ancestor
154822752|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822753|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154822754|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
154822755|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822756|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822757|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154822758|NCT02230995|Metformin|metformin|mesh-list
154822759|NCT02230995|Empagliflozin|empagliflozin|mesh-list
154822760|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154822761|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822762|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154822763|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822764|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
154822765|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154002217|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
154822766|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154822767|NCT02995083|Prednisolone|prednisolone|mesh-list
154822768|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
154822769|NCT02995083|Lidocaine|lidocaine|mesh-list
154822770|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154822771|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
154822772|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
154822773|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
154822774|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822775|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822776|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
154822777|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822778|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154822779|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154822780|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154822781|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154822782|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822783|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154822784|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
154822785|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
154822786|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822787|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
154822788|NCT02995083|Hormones|hormones|mesh-ancestor
154822789|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822790|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154822791|NCT02995083|Protective Agents|protective agents|mesh-ancestor
154822792|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154822793|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822794|NCT04426422|Metformin|metformin|mesh-list
154002252|NCT03847506|Amlodipine|amlodipine|mesh-list
154822795|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154822796|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822797|NCT01632423|Bimatoprost|bimatoprost|mesh-list
154822798|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154822799|NCT05466318|Cytarabine|cytarabine|mesh-list
154822800|NCT05466318|Gemcitabine|gemcitabine|mesh-list
154822801|NCT05466318|Etoposide|etoposide|mesh-list
154822802|NCT05466318|Melphalan|melphalan|mesh-list
154822803|NCT05466318|Busulfan|busulfan|mesh-list
154822804|NCT05466318|Carmustine|carmustine|mesh-list
154822805|NCT05466318|Cladribine|cladribine|mesh-list
154822806|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154822807|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
154822808|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822809|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822810|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154822811|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154822812|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154822813|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822814|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
154822815|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822816|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154822817|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
154822818|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822819|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154822820|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
154822821|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154822822|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154822823|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822824|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822825|NCT01469546|Axitinib|axitinib|mesh-list
154822826|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822827|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154822828|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822829|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822830|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154822831|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154822832|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154822833|NCT05613894|Pluvicto|pluvicto|mesh-list
154822834|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154822835|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822836|NCT00081263|Celecoxib|celecoxib|mesh-list
154822837|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154822838|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154822839|NCT00081263|Analgesics|analgesics|mesh-ancestor
154822840|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
154822841|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822842|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822843|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154822844|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154822845|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154822846|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154822847|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822848|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822849|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
154822850|NCT05087381|Niclosamide|niclosamide|mesh-list
154822851|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
154822852|NCT05087381|Bromhexine|bromhexine|mesh-list
154822853|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822854|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822855|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154822856|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154822857|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822858|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822859|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154822860|NCT05087381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154822861|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154822862|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154822863|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822864|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
154822865|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154822866|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
154822867|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154822868|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154822869|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154822870|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
154822871|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154822872|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
154822873|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154822874|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822875|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
154822876|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
154822877|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
154822878|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822879|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154822880|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
154822881|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
154822882|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154822883|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154822884|NCT05087381|Expectorants|expectorants|mesh-ancestor
154822885|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
154822886|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
154822887|NCT00080483|Testosterone|testosterone|mesh-list
154822888|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
154822889|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
154822890|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154822891|NCT00080483|Androgens|androgens|mesh-ancestor
154822893|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822894|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822895|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154822896|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822897|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
154822898|NCT05248620|Amoxicillin|amoxicillin|mesh-list
154822899|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154822900|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822901|NCT01639599|Dexamethasone|dexamethasone|mesh-list
154822902|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
154822903|NCT01639599|Haloperidol|haloperidol|mesh-list
154822904|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
154822905|NCT01639599|BB 1101|bb 1101|mesh-list
154822906|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154822907|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
154822908|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
154822909|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822910|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822911|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822912|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
154822913|NCT01639599|Hormones|hormones|mesh-ancestor
154822914|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154822915|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154822916|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822917|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
154822918|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822919|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822920|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154822921|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154822922|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822923|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154822924|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154822925|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
154822926|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822927|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154822928|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
154822929|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154822930|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822931|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154822932|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
154822933|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154822934|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822935|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002397|NCT05755659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154822936|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822937|NCT02227329|Ethanol|ethanol|mesh-list
154822938|NCT02227329|Heparin|heparin|mesh-list
154822939|NCT02227329|Calcium heparin|calcium heparin|mesh-list
154822940|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
154822941|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154822942|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154822943|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822944|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154822945|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822946|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822947|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822948|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154822949|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822950|NCT05615142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154822951|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154822952|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
154822953|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154822954|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154822955|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
154822956|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
154822957|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154822958|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154822959|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822960|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154822961|NCT03172897|Analgesics|analgesics|mesh-ancestor
154822962|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
154822963|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154822964|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154822965|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154822966|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154822967|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
154822968|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154822969|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822970|NCT00086723|Captopril|captopril|mesh-list
154822971|NCT00086723|Plasminogen|plasminogen|mesh-list
154822972|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154822973|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154822974|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154822975|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822976|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154822977|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
154822978|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154822979|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154822980|NCT05346419|Vitamin D|vitamin d|mesh-list
154822981|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
154822982|NCT05346419|Vitamins|vitamins|mesh-ancestor
154822983|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
154822984|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822985|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154822986|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154822987|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154002438|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154822988|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822989|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154822990|NCT00084409|Iloprost|iloprost|mesh-list
154822991|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154822992|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
154822993|NCT03831165|Acyclovir|acyclovir|mesh-list
154822994|NCT03831165|Melatonin|melatonin|mesh-list
154822995|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
154822996|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154822997|NCT03831165|Protective Agents|protective agents|mesh-ancestor
154822998|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154822999|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823000|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
154823001|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823002|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154823003|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154823004|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154823005|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823006|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823007|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154823008|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154823009|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154823010|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154823011|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
154823012|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823013|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002471|NCT02689986|Rituximab|rituximab|mesh-list
154823014|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154823015|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154823016|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
154823017|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154823018|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154823019|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
154823021|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
154823022|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823023|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
154823024|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154823025|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823026|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154823027|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823028|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154823029|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154823030|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823031|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823032|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823033|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154823034|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
154823035|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154823036|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154823037|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154823038|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154823039|NCT04773366|Cytarabine|cytarabine|mesh-list
154823040|NCT04773366|Prednisone|prednisone|mesh-list
154823041|NCT04773366|Vincristine|vincristine|mesh-list
154823042|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
154823043|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823044|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
154823045|NCT04773366|Hormones|hormones|mesh-ancestor
154823046|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154823047|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823048|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154823049|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823050|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823051|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
154823052|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823053|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
154823054|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823055|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823056|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
154823057|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154823058|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823059|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823060|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823061|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154823062|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823063|NCT04714541|Ketamine|ketamine|mesh-list
154823064|NCT04714541|Analgesics|analgesics|mesh-ancestor
154823065|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
154823066|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823067|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823068|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154823069|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154823070|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
154823071|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
154823072|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823073|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154823074|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154823075|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823076|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823077|NCT02414724|Gemcitabine|gemcitabine|mesh-list
154823078|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823079|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
154823080|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823081|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823082|NCT00187681|Metformin|metformin|mesh-list
154823083|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154823084|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823085|NCT00083759|Natalizumab|natalizumab|mesh-list
154823086|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
154823087|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823088|NCT02412228|Dexamethasone|dexamethasone|mesh-list
154823089|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
154823090|NCT02412228|Ixazomib|ixazomib|mesh-list
154823091|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823092|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
154823093|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823094|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823095|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823096|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
154823097|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823098|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823099|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154823100|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823101|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
154823102|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
154823103|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823104|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154823105|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
154823106|NCT02412228|Hormones|hormones|mesh-ancestor
154823107|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154823108|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154823109|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
154823110|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823111|NCT01646151|Bimatoprost|bimatoprost|mesh-list
154823112|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154823113|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154823114|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154823115|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823116|NCT01828710|Folic Acid|folic acid|mesh-list
154823117|NCT01828710|Inositol|inositol|mesh-list
154823118|NCT01828710|Hematinics|hematinics|mesh-ancestor
154823119|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
154823120|NCT01828710|Vitamins|vitamins|mesh-ancestor
154823121|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
154823122|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823123|NCT00088699|Ketamine|ketamine|mesh-list
154823124|NCT00088699|Analgesics|analgesics|mesh-ancestor
154823125|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
154823126|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823127|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823128|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154823129|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154823130|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
154823131|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
154823132|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823133|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154823134|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154823135|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823136|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823137|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
154823138|NCT00089011|Fludarabine|fludarabine|mesh-list
154823139|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
154823140|NCT00089011|Tacrolimus|tacrolimus|mesh-list
154823141|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823142|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823143|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
154823144|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823145|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823146|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
154823147|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823148|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154823149|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823150|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154823151|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154823152|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
154823153|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154823154|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823155|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
154823156|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
154823157|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154823158|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823159|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154823160|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
154823161|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154823162|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823163|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823164|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823165|NCT01898377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154823166|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154823168|NCT00347412|Carboplatin|carboplatin|mesh-list
154823169|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154823170|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823171|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823172|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823173|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823174|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823175|NCT00189475|Montelukast|montelukast|mesh-list
154823176|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154823177|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
154823178|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154823179|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
154823180|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154823181|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823182|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154823183|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154823184|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823185|NCT00091273|Sargramostim|sargramostim|mesh-list
154823186|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
154823187|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
154823188|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823189|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154823190|NCT00193375|Bevacizumab|bevacizumab|mesh-list
154823191|NCT00193375|Carboplatin|carboplatin|mesh-list
154823192|NCT00193375|Irinotecan|irinotecan|mesh-list
154823193|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823194|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823195|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154823196|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154823197|NCT00193375|Growth Substances|growth substances|mesh-ancestor
154823198|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823199|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
154823200|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154823201|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154823202|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823203|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823204|NCT00193453|Gemcitabine|gemcitabine|mesh-list
154823205|NCT00193453|Docetaxel|docetaxel|mesh-list
154823206|NCT00193453|Cetuximab|cetuximab|mesh-list
154823207|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823208|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
154823209|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823210|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823211|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823212|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823213|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823214|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823215|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
154823216|NCT05614518|Listerine|listerine|mesh-list
154823217|NCT05614518|Fluorides|fluorides|mesh-list
154823218|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
154823219|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
154823220|NCT05614518|Protective Agents|protective agents|mesh-ancestor
154823221|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823222|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154823223|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823224|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154823225|NCT00091507|Insulin|insulin|mesh-list
154823226|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154823227|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823228|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
154823229|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154823230|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
154823231|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823232|NCT05611086|Expectorants|expectorants|mesh-ancestor
154823233|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
154823234|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154823235|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
154823236|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823237|NCT05611086|Protective Agents|protective agents|mesh-ancestor
154823238|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823239|NCT05611086|Antidotes|antidotes|mesh-ancestor
154823240|NCT05614440|Tramadol|tramadol|mesh-list
154823241|NCT05614440|Anesthetics|anesthetics|mesh-list
154823242|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
154823243|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823244|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823245|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154823246|NCT05614440|Narcotics|narcotics|mesh-ancestor
154823247|NCT05614440|Analgesics|analgesics|mesh-ancestor
154823248|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
154823249|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823250|NCT05613192|Vitamin D|vitamin d|mesh-list
154823251|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
154823252|NCT05613192|Vitamins|vitamins|mesh-ancestor
154823253|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
154823254|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823255|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154823256|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154823257|NCT00194779|Tamoxifen|tamoxifen|mesh-list
154823258|NCT00194779|Vinorelbine|vinorelbine|mesh-list
154823259|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
154823260|NCT00194779|Doxorubicin|doxorubicin|mesh-list
154823261|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154823262|NCT00194779|Capecitabine|capecitabine|mesh-list
154823263|NCT00194779|Methotrexate|methotrexate|mesh-list
154823264|NCT00194779|Trastuzumab|trastuzumab|mesh-list
154823265|NCT00194779|Letrozole|letrozole|mesh-list
154823266|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154823267|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823268|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823269|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823270|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823271|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823272|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823273|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
154823274|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823275|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823276|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823277|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
154823278|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154823279|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154823280|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154823281|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154823282|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823283|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823284|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
154823285|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154823286|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
154823287|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154823288|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
154823289|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154823290|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154823291|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823292|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154823293|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154823294|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154823295|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
154823296|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154823297|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154823298|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154823299|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154823300|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154823301|NCT05474664|Camostat|camostat|mesh-list
154823302|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
154823303|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823304|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575232|NCT03533231|Metronidazole|metronidazole|mesh-list
154823305|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154823306|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154823307|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
154823308|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154823309|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
154823310|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
154823311|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823312|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823313|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823314|NCT02096575|Analgesics|analgesics|mesh-ancestor
154823315|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
154823316|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823317|NCT04338984|Fentanyl|fentanyl|mesh-list
154823318|NCT04338984|Ropivacaine|ropivacaine|mesh-list
154823319|NCT04338984|Anesthetics|anesthetics|mesh-list
154823320|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
154823321|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
154823322|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002778|NCT05753865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823323|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823324|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
154823325|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823326|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154823327|NCT04338984|Narcotics|narcotics|mesh-ancestor
154823328|NCT04338984|Analgesics|analgesics|mesh-ancestor
154823329|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154823330|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154823331|NCT00095563|Lapatinib|lapatinib|mesh-list
154823332|NCT00095563|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154823333|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154823334|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823335|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823336|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823337|NCT05473806|Pioglitazone|pioglitazone|mesh-list
154823338|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154823339|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823340|NCT00089609|Thalidomide|thalidomide|mesh-list
154823341|NCT00089609|Prednisone|prednisone|mesh-list
154823342|NCT00089609|Bevacizumab|bevacizumab|mesh-list
154823343|NCT00089609|Docetaxel|docetaxel|mesh-list
154823344|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823345|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823346|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154823347|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154823348|NCT00089609|Growth Substances|growth substances|mesh-ancestor
154823349|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823350|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
154823351|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823352|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823353|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823354|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823355|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823356|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
154823357|NCT00089609|Hormones|hormones|mesh-ancestor
154823358|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154823359|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154823360|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823361|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
154823362|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
154823363|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154823364|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823365|NCT04661514|Psilocybin|psilocybin|mesh-list
154823366|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
154823367|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823368|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154823369|NCT00195403|Etanercept|etanercept|mesh-list
154823370|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154823371|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823372|NCT00195403|Analgesics|analgesics|mesh-ancestor
154823373|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
154823374|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823375|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823376|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823377|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823378|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154823379|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823380|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
154823381|NCT04643327|Levetiracetam|levetiracetam|mesh-list
154823382|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
154823383|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
154823384|NCT00095875|Carboplatin|carboplatin|mesh-list
154823385|NCT00095875|Docetaxel|docetaxel|mesh-list
154823386|NCT00095875|Fluorouracil|fluorouracil|mesh-list
154823387|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823388|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823389|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823390|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823391|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823392|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
154823393|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823394|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823395|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
154823396|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823397|NCT03086993|Gemcitabine|gemcitabine|mesh-list
154823398|NCT03086993|Melphalan|melphalan|mesh-list
154823399|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823400|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823401|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
154823402|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823403|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823404|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
154823405|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154823406|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823407|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
154823408|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823409|NCT04089072|Phenylephrine|phenylephrine|mesh-list
154823410|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
154823411|NCT04089072|Methylene Blue|methylene blue|mesh-list
154823412|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154823413|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
154823414|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
154823415|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823416|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823417|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
154823418|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154823419|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
154823420|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
154823421|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154823422|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154823423|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154823424|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
154823425|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823426|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823427|NCT04089072|Protective Agents|protective agents|mesh-ancestor
154823428|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823429|NCT00006227|Paclitaxel|paclitaxel|mesh-list
154823430|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154823431|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823432|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823433|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823434|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823435|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823436|NCT00097669|Folic Acid|folic acid|mesh-list
154823437|NCT00097669|Hematinics|hematinics|mesh-ancestor
154002888|NCT02066220|Lomustine|lomustine|mesh-list
154823438|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
154823439|NCT00097669|Vitamins|vitamins|mesh-ancestor
154823440|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
154823441|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823442|NCT00010439|Alendronate|alendronate|mesh-list
154823443|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154823444|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823445|NCT00200161|Temozolomide|temozolomide|mesh-list
154823446|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823447|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
154823448|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823449|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823450|NCT00016913|Paclitaxel|paclitaxel|mesh-list
154823451|NCT00016913|Carboplatin|carboplatin|mesh-list
154823452|NCT00016913|Leuprolide|leuprolide|mesh-list
154823453|NCT00016913|Goserelin|goserelin|mesh-list
154823454|NCT00016913|Estramustine|estramustine|mesh-list
154823455|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154823456|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823457|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823458|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823459|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823460|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823461|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154823462|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
154823463|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154823464|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823465|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154823466|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823467|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
154823469|NCT00023309|Adefovir|adefovir|mesh-list
154823470|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154823471|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154823472|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154823473|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823474|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823475|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
154823476|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823477|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154823478|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154823479|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
154823480|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154002917|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
154823481|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154823482|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823483|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
154823484|NCT02233101|Coagulants|coagulants|mesh-ancestor
154823485|NCT00098059|Famciclovir|famciclovir|mesh-list
154823486|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
154823487|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823488|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154823489|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823490|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823491|NCT02440581|Alendronate|alendronate|mesh-list
154823492|NCT02440581|Teriparatide|teriparatide|mesh-list
154823493|NCT02440581|Cinacalcet|cinacalcet|mesh-list
154823494|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154823495|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823496|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154823497|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154823498|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
154823499|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154823500|NCT01359150|Tofacitinib|tofacitinib|mesh-list
154823501|NCT01359150|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154823502|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154002960|NCT05753397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823503|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823504|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823505|NCT00098371|Alvocidib|alvocidib|mesh-list
154823506|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823507|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
154823508|NCT00098371|Growth Substances|growth substances|mesh-ancestor
154823509|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823510|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154823511|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823512|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823513|NCT04745988|Leucovorin|leucovorin|mesh-list
154823514|NCT04745988|Docetaxel|docetaxel|mesh-list
154823515|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
154823516|NCT04745988|Fluorouracil|fluorouracil|mesh-list
154823517|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
154823518|NCT04745988|Lenvatinib|lenvatinib|mesh-list
154823519|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
154823520|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823521|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823522|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823523|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823524|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823525|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823526|NCT04745988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154823527|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
154823528|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823529|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823530|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
154823531|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823532|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154823533|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575473|NCT03522649|Leucovorin|leucovorin|mesh-list
154823535|NCT04745988|Protective Agents|protective agents|mesh-ancestor
154823536|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
154823537|NCT04745988|Vitamins|vitamins|mesh-ancestor
154823538|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
154823539|NCT01647945|Tacrolimus|tacrolimus|mesh-list
154823540|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823541|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
154823542|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823543|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154823544|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823545|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823546|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
154823547|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154823548|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154823549|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
154823550|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823551|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823552|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823553|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
154823554|NCT04351191|Chloroquine|chloroquine|mesh-list
154823555|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
154823556|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154823557|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154823558|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823559|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823560|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823561|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823562|NCT04351191|Amebicides|amebicides|mesh-ancestor
154823563|NCT01469000|Pemetrexed|pemetrexed|mesh-list
154823564|NCT01469000|Gefitinib|gefitinib|mesh-list
154823565|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823566|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823567|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823568|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154823569|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154823570|NCT01469000|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154823571|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154823572|NCT00201877|Rituximab|rituximab|mesh-list
154823573|NCT00201877|Bortezomib|bortezomib|mesh-list
154823574|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003032|NCT06166615|Ramosetron|ramosetron|mesh-list
154823575|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823576|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
154823577|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823578|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823579|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154823580|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
154823581|NCT01490060|Dexamethasone|dexamethasone|mesh-list
154823582|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
154823583|NCT01490060|Doxorubicin|doxorubicin|mesh-list
154823584|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154823585|NCT01490060|Vincristine|vincristine|mesh-list
154823586|NCT01490060|Ifosfamide|ifosfamide|mesh-list
154823587|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
154823588|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
154823589|NCT01490060|Aprepitant|aprepitant|mesh-list
154823590|NCT01490060|BB 1101|bb 1101|mesh-list
154823591|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823592|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
154823593|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
154823594|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823595|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823596|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154823597|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
154823598|NCT01490060|Hormones|hormones|mesh-ancestor
154823599|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154823600|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154823601|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823602|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
154823603|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823604|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823605|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154823606|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154823607|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154823608|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154823609|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
154823610|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
154823611|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
154823612|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823613|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
154823614|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154823615|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823616|NCT04090736|Azacitidine|azacitidine|mesh-list
154823617|NCT04090736|Pevonedistat|pevonedistat|mesh-list
154823618|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823619|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
154823620|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823621|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823622|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823623|NCT05557344|Acetaminophen|acetaminophen|mesh-list
154823624|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823625|NCT05557344|Analgesics|analgesics|mesh-ancestor
154823626|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
154823627|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823628|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823629|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
154823630|NCT00101413|Sorafenib|sorafenib|mesh-list
154823631|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823632|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154823633|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823634|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823635|NCT01452152|Clopidogrel|clopidogrel|mesh-list
154823636|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154823637|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154823638|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154823639|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154823640|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154823641|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
154823642|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823643|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823644|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823645|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
154823646|NCT01451762|Promethazine|promethazine|mesh-list
154003085|NCT06151483|Adrenergic Agents|adrenergic agents|mesh-list
154823647|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154823648|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154823649|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823650|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823651|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
154823652|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
154823653|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
154823654|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823655|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
154823656|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
154823657|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154823658|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154823659|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
154823660|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
154823661|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823662|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823663|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154823664|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
154823665|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
154823666|NCT01654107|Nicotine|nicotine|mesh-list
154823667|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154823668|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
154823669|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823670|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823671|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154823672|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154823673|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
154823674|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823675|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823676|NCT03085680|Curcumin|curcumin|mesh-list
154823677|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154823678|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823679|NCT03085680|Analgesics|analgesics|mesh-ancestor
154823680|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
154823681|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823682|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823683|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823684|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154575636|NCT05262413|Lenvatinib|lenvatinib|mesh-list
154823685|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823686|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823687|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823688|NCT01468844|Minocycline|minocycline|mesh-list
154823689|NCT01468844|Bevacizumab|bevacizumab|mesh-list
154823690|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823691|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823692|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154003147|NCT05928689|Propranolol|propranolol|mesh-list
154823693|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154823694|NCT01468844|Growth Substances|growth substances|mesh-ancestor
154823695|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823696|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
154823697|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154823698|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823699|NCT03029598|Carboplatin|carboplatin|mesh-list
154823700|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
154823701|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823702|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823703|NCT03029598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154823704|NCT03029598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823705|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154823706|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154823707|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154823708|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154823709|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823710|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823711|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823712|NCT01451606|Analgesics|analgesics|mesh-ancestor
154823713|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
154823714|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823715|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
154823716|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154823717|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
154823718|NCT00204373|Lansoprazole|lansoprazole|mesh-list
154003177|NCT05737628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823719|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
154823720|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154823721|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154823722|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154823723|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823724|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823725|NCT01655043|Regadenoson|regadenoson|mesh-list
154823726|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154823727|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154823728|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
154823729|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
154823730|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823731|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823732|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823733|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154823734|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154823735|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154823736|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
154823737|NCT00032591|Thrombin|thrombin|mesh-list
154823738|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
154823739|NCT00032591|Coagulants|coagulants|mesh-ancestor
154823740|NCT01660191|Atorvastatin|atorvastatin|mesh-list
154823741|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154823742|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154823743|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154823744|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
154823745|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823746|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154823747|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154823748|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823749|NCT00033917|Indomethacin|indomethacin|mesh-list
154823750|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154823751|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823752|NCT00033917|Analgesics|analgesics|mesh-ancestor
154823753|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
154823754|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823755|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823756|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823757|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823758|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
154823759|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
154823760|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154823761|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154823762|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823763|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823764|NCT00036569|Interferons|interferons|mesh-list
154823765|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
154823766|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823767|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
154823768|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823769|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
154823770|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823771|NCT01660893|Phenylephrine|phenylephrine|mesh-list
154823772|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
154823773|NCT01660893|Tetracaine|tetracaine|mesh-list
154823774|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
154823775|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
154823776|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823777|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823778|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
154823779|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823780|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154823781|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154823782|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
154823783|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823784|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823785|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
154823786|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
154823787|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
154823788|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154823789|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
154003260|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154823790|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154823791|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
154823792|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154823793|NCT01660893|Protective Agents|protective agents|mesh-ancestor
154823794|NCT01661283|Bevacizumab|bevacizumab|mesh-list
154823795|NCT01661283|Everolimus|everolimus|mesh-list
154823796|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823797|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823798|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154823799|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154823800|NCT01661283|Growth Substances|growth substances|mesh-ancestor
154823801|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823802|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
154823803|NCT01661283|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154823804|NCT01661283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154823805|NCT01661283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823806|NCT01661283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823807|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823808|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
154823809|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
154823810|NCT01946373|Fludarabine|fludarabine|mesh-list
154823811|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
154823812|NCT01946373|Interleukin-2|interleukin-2|mesh-list
154823813|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823814|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
154823815|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823816|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823817|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823818|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
154823819|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823820|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823821|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154823822|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823823|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
154823824|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823825|NCT01946373|Analgesics|analgesics|mesh-ancestor
154823826|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
154823827|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823828|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154823829|NCT01662297|Trazodone|trazodone|mesh-list
154823830|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
154823831|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154823832|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154575784|NCT04059445|Calcium|calcium|mesh-list
154823833|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154823834|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823835|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823836|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154823837|NCT01662297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154823838|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154823839|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154823840|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823841|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823842|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
154823843|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154823844|NCT01600287|Propofol|propofol|mesh-list
154823845|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154823846|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154823847|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823848|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154823849|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
154823850|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
154823851|NCT00040937|Thalidomide|thalidomide|mesh-list
154823852|NCT00040937|Dexamethasone|dexamethasone|mesh-list
154823853|NCT00040937|Prednisone|prednisone|mesh-list
154003317|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154823854|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
154823855|NCT00040937|Melphalan|melphalan|mesh-list
154823856|NCT00040937|Sargramostim|sargramostim|mesh-list
154823857|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823858|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
154823859|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823860|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823861|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823862|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
154823863|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823864|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823865|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154823866|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823867|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
154823868|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
154823869|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823870|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154823871|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
154823872|NCT00040937|Hormones|hormones|mesh-ancestor
154823873|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154823874|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154823875|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
154823876|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154823877|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823878|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154823879|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154823880|NCT00040937|Growth Substances|growth substances|mesh-ancestor
154823881|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
154823882|NCT04756895|Vancomycin|vancomycin|mesh-list
154823883|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154823884|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823885|NCT02234115|Leuprolide|leuprolide|mesh-list
154823886|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154823887|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
154823888|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154823889|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823890|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154823891|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823892|NCT02234427|Aspirin|aspirin|mesh-list
154823893|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154823894|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823895|NCT02234427|Analgesics|analgesics|mesh-ancestor
154823896|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
154823897|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823898|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823899|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823900|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823901|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154823902|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154823903|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823904|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154823905|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154823906|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823907|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
154575848|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823908|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
154823909|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154823910|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154823911|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823912|NCT01663935|Levodopa|levodopa|mesh-list
154823913|NCT01663935|Carbidopa|carbidopa|mesh-list
154823914|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154823915|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154823916|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
154823917|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823918|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823919|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823920|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154823921|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823922|NCT01664559|Ketorolac|ketorolac|mesh-list
154823923|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154823924|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823925|NCT01664559|Analgesics|analgesics|mesh-ancestor
154823926|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
154823927|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823928|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823929|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823930|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823931|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154823932|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823933|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823934|NCT00046475|Midodrine|midodrine|mesh-list
154823935|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
154823936|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
154823937|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823938|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823939|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154823940|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154823941|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154823942|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154823943|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
154823944|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823945|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823946|NCT01894685|Mesalamine|mesalamine|mesh-list
154823947|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154823948|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823949|NCT01894685|Analgesics|analgesics|mesh-ancestor
154823950|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
154823951|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823952|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823953|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823954|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823955|NCT01695291|Minocycline|minocycline|mesh-list
154823956|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154823957|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154823958|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
154823959|NCT00048737|Rituximab|rituximab|mesh-list
154823960|NCT00048737|Fludarabine|fludarabine|mesh-list
154823961|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
154823962|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154823963|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
154823964|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823965|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823966|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154823967|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
154823968|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823969|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154823970|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154823971|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154823972|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154823973|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
154823974|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
154823975|NCT01604109|Caseins|caseins|mesh-list
154823976|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154823977|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
154823978|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154823979|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823980|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823981|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
154823982|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
154823983|NCT01666197|Diclofenac|diclofenac|mesh-list
154823984|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154003447|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
154823985|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154823986|NCT01666197|Analgesics|analgesics|mesh-ancestor
154823987|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
154823988|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154823989|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154823990|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154823991|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154823992|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154823993|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154823994|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154823995|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154823996|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
154823997|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154823998|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154823999|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154824000|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824001|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824002|NCT00048815|Citalopram|citalopram|mesh-list
154824003|NCT00048815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154824004|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154824005|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154824006|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824007|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824008|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
154824009|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824010|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154824011|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
154824012|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154824013|NCT01605903|Acetaminophen|acetaminophen|mesh-list
154824014|NCT01605903|Ibuprofen|ibuprofen|mesh-list
154824015|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154824016|NCT01605903|Analgesics|analgesics|mesh-ancestor
154824017|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
154824018|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824019|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824020|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
154824021|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154824022|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824023|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824024|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154824025|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824026|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824027|NCT00048893|Metronidazole|metronidazole|mesh-list
154824028|NCT00048893|Paclitaxel|paclitaxel|mesh-list
154824029|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
154824030|NCT00048893|Doxorubicin|doxorubicin|mesh-list
154824031|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154824032|NCT00048893|Fludarabine|fludarabine|mesh-list
154824033|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
154824034|NCT00048893|Vaccines|vaccines|mesh-list
154824035|NCT00048893|Sargramostim|sargramostim|mesh-list
154824036|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
154824037|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824038|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154003500|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
154824039|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824040|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
154824041|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
154824042|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
154824043|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824044|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824045|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824046|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154824047|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
154824048|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154824049|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154824050|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154824051|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154824052|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824053|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824054|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
154824055|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824056|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154824057|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154824058|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154824059|NCT01607853|Calcitriol|calcitriol|mesh-list
154824060|NCT01607853|Betamethasone|betamethasone|mesh-list
154824061|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824062|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
154824063|NCT01607853|Hormones|hormones|mesh-ancestor
154824064|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824065|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824066|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154003529|NCT04803084|Protective Agents|protective agents|mesh-ancestor
154824067|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
154824068|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154824069|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154824070|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154824071|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824072|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154824073|NCT01607853|Vitamins|vitamins|mesh-ancestor
154824074|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
154824075|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154824076|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154824077|NCT01700517|Anesthetics|anesthetics|mesh-list
154824078|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824079|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824080|NCT00101647|Dasatinib|dasatinib|mesh-list
154824081|NCT00101647|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154824082|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154824083|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824084|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824085|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003553|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
153633957|NCT00008268|Melphalan|melphalan|mesh-list
154824086|NCT01669785|Listerine|listerine|mesh-list
154824087|NCT01669785|Fluorides|fluorides|mesh-list
154824088|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
154824089|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
154824090|NCT01669785|Protective Agents|protective agents|mesh-ancestor
154824091|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824092|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154824093|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824094|NCT03089645|Docetaxel|docetaxel|mesh-list
154824095|NCT03089645|Durvalumab|durvalumab|mesh-list
154824096|NCT03089645|Tremelimumab|tremelimumab|mesh-list
154824097|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154824098|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824099|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
154824100|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
154824101|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
154824102|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824103|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154824104|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
154824105|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824106|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
154824107|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154824108|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824109|NCT02587962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154824110|NCT02587962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824111|NCT01671423|Prednisone|prednisone|mesh-list
154824112|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824113|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
154824114|NCT01671423|Hormones|hormones|mesh-ancestor
154824115|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824116|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824117|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824118|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824119|NCT02092181|Mirabegron|mirabegron|mesh-list
154824120|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154824121|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154824122|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154824123|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
154824124|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824125|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824126|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824127|NCT02092181|Urological Agents|urological agents|mesh-ancestor
154824128|NCT01672827|Flutemetamol|flutemetamol|mesh-list
154824129|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154824130|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824131|NCT01700907|Sevoflurane|sevoflurane|mesh-list
154824132|NCT01700907|Desflurane|desflurane|mesh-list
154824133|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154824134|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154824135|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
154824136|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
154824137|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824138|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824139|NCT03089567|Listerine|listerine|mesh-list
154824140|NCT03089567|Fluorides|fluorides|mesh-list
154824141|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
154824142|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
154824143|NCT03089567|Protective Agents|protective agents|mesh-ancestor
154824144|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824145|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154824146|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824147|NCT03431987|Ethanol|ethanol|mesh-list
154824148|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154824149|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824150|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824151|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824152|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
154824153|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154824154|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
154824155|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824156|NCT01612221|Expectorants|expectorants|mesh-ancestor
154824157|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
154824158|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154824159|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
154824160|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824161|NCT01612221|Protective Agents|protective agents|mesh-ancestor
154824162|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824163|NCT01612221|Antidotes|antidotes|mesh-ancestor
154824164|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
154824165|NCT00105001|Sirolimus|sirolimus|mesh-list
154824166|NCT00105001|Fludarabine|fludarabine|mesh-list
154824167|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
154824168|NCT00105001|Tacrolimus|tacrolimus|mesh-list
154824169|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824170|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824171|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
154824172|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824173|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824174|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
154824175|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824176|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154824177|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824178|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154824179|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154824180|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
154824181|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154824182|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824183|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
154824184|NCT02642640|Melatonin|melatonin|mesh-list
154824185|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
154824186|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824187|NCT02642640|Protective Agents|protective agents|mesh-ancestor
154824188|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824189|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824190|NCT01701375|Palbociclib|palbociclib|mesh-list
154824191|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824192|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154824193|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824194|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824195|NCT05556408|Propofol|propofol|mesh-list
154824196|NCT05556408|Succinylcholine|succinylcholine|mesh-list
154824197|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154824198|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824199|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824200|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154824201|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
154824202|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
154824203|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154824204|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154824205|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154576143|NCT03521167|Gabapentin|gabapentin|mesh-list
154824206|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824207|NCT00054353|Cyclosporine|cyclosporine|mesh-list
154824208|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
154824209|NCT00054353|Fludarabine|fludarabine|mesh-list
154824210|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
154824212|NCT00054353|Cyclosporins|cyclosporins|mesh-list
154824213|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824214|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824215|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
154824216|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824217|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824218|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
154824219|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824220|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824221|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
154824222|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824223|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
154824224|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824225|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154824226|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154824227|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154824228|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
154824229|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154824230|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154824231|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
154824232|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154824233|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
154824234|NCT00208975|Rituximab|rituximab|mesh-list
154824235|NCT00208975|Fludarabine|fludarabine|mesh-list
154824236|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
154824237|NCT00208975|Sargramostim|sargramostim|mesh-list
154824238|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824239|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
154824240|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824241|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824242|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154824243|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
154824244|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824245|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824246|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154824247|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154824248|NCT00208975|Analgesics|analgesics|mesh-ancestor
154824249|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
154824250|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824251|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154824252|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154003707|NCT04430738|Vitamins|vitamins|mesh-ancestor
154824253|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824254|NCT01702233|Dexamethasone|dexamethasone|mesh-list
154824255|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
154824256|NCT01702233|BB 1101|bb 1101|mesh-list
154824257|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824258|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
154824259|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
154824260|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824261|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824262|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824263|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
154824264|NCT01702233|Hormones|hormones|mesh-ancestor
154824265|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824266|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824267|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824268|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
154824269|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824270|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824271|NCT00217399|Sorafenib|sorafenib|mesh-list
154824272|NCT00217399|Anastrozole|anastrozole|mesh-list
154824273|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824274|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154824275|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824276|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824277|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824278|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154824279|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154824280|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154824281|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
154824282|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824283|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824285|NCT04739670|Atezolizumab|atezolizumab|mesh-list
154824286|NCT04739670|Carboplatin|carboplatin|mesh-list
154824287|NCT04739670|Gemcitabine|gemcitabine|mesh-list
154824288|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154824289|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824290|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154824291|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154824292|NCT04739670|Growth Substances|growth substances|mesh-ancestor
154824293|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824294|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
154824295|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824296|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
154824297|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824298|NCT04739670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154824299|NCT05286619|Carboplatin|carboplatin|mesh-list
154824300|NCT05286619|Gemcitabine|gemcitabine|mesh-list
154824301|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
154824302|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824303|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824304|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
154824305|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824306|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003781|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
154824307|NCT05286619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154824308|NCT00559182|Omeprazole|omeprazole|mesh-list
154824309|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154824310|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824311|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154824312|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824313|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824314|NCT00218023|Naltrexone|naltrexone|mesh-list
154824315|NCT00218023|Levodopa|levodopa|mesh-list
154824316|NCT00218023|Carbidopa|carbidopa|mesh-list
154824317|NCT00218023|Modafinil|modafinil|mesh-list
154824318|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154824319|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154824320|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824321|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
154824322|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824323|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154824324|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154824325|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
154824326|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824327|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824328|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154824329|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003798|NCT04120246|Antibodies|antibodies|mesh-list
154824330|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154824331|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154824332|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154824333|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154824334|NCT00054665|Prednisone|prednisone|mesh-list
154824335|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
154824336|NCT00054665|Doxorubicin|doxorubicin|mesh-list
154824337|NCT00054665|Etoposide|etoposide|mesh-list
154824338|NCT00054665|Vincristine|vincristine|mesh-list
154824339|NCT00054665|Bortezomib|bortezomib|mesh-list
154824340|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824341|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
154824342|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824343|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824344|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154824345|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
154824346|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824347|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824348|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154824349|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154824350|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154824351|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154824352|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824353|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824354|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
154824355|NCT00054665|Hormones|hormones|mesh-ancestor
154824356|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824357|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824358|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154824359|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
154824360|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
154824361|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
154824362|NCT00476190|Cytarabine|cytarabine|mesh-list
154824363|NCT00476190|Dexamethasone|dexamethasone|mesh-list
154824364|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
154824365|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154824366|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154824367|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154824368|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
154824369|NCT00476190|Doxorubicin|doxorubicin|mesh-list
154824370|NCT00476190|Methotrexate|methotrexate|mesh-list
154824371|NCT00476190|Etoposide|etoposide|mesh-list
154824372|NCT00476190|Vincristine|vincristine|mesh-list
154824373|NCT00476190|Asparaginase|asparaginase|mesh-list
154824374|NCT00476190|Pegaspargase|pegaspargase|mesh-list
154824375|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824376|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
154824377|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824378|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824379|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154824380|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
154824381|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824382|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824383|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154824384|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824385|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
154824386|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
154824387|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824388|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824389|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
154824390|NCT00476190|Hormones|hormones|mesh-ancestor
154824391|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824392|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824393|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154824394|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154824395|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154824396|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824397|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154824398|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
154824399|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154824400|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824401|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
154824402|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
154824403|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154824404|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154824405|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154824406|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
154824407|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824408|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
154824409|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
154824410|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
154824411|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
154824412|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154824413|NCT05555316|Lenvatinib|lenvatinib|mesh-list
154824414|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824415|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154824416|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824417|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824418|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
154824419|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154824420|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
154824421|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824422|NCT00218491|Expectorants|expectorants|mesh-ancestor
154824423|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
154824424|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154824425|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
154824426|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824427|NCT00218491|Protective Agents|protective agents|mesh-ancestor
154824428|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824429|NCT00218491|Antidotes|antidotes|mesh-ancestor
154824430|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154824431|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154824432|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
154824433|NCT00221299|Hormones|hormones|mesh-list
154824434|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
154824435|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824436|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824437|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154824438|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154824439|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824440|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154824441|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154824442|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
154824443|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
154824444|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154824445|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824446|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824447|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154824448|NCT05554848|Analgesics|analgesics|mesh-ancestor
154824449|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
154824450|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824451|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154824452|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154824453|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154824454|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
154824455|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824456|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824457|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
154824458|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154824459|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
154824460|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154824461|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154003924|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
154824462|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154824463|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
154824464|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154824465|NCT00057785|Fluorouracil|fluorouracil|mesh-list
154824466|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824467|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
154824468|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824469|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824470|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824471|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
154824472|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824473|NCT05548998|Anesthetics|anesthetics|mesh-list
154824474|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824475|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824476|NCT01666782|Vaccines|vaccines|mesh-list
154824477|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
154824478|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824479|NCT00058019|Epothilones|epothilones|mesh-list
154824480|NCT00058019|Epothilone B|epothilone b|mesh-list
154824481|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
154824482|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
154824483|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
154824484|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824485|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824486|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154824487|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
154824488|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824489|NCT00110461|Aripiprazole|aripiprazole|mesh-list
154824490|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
154824491|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154824492|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154824493|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154824494|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824495|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824496|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
154824497|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
154824498|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824499|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824500|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154824501|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154824502|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
154824503|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154824504|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154824505|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154824506|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154824507|NCT00061373|Aspirin|aspirin|mesh-list
154824508|NCT00061373|Tinzaparin|tinzaparin|mesh-list
154824509|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154824510|NCT00061373|Dalteparin|dalteparin|mesh-list
154824511|NCT00061373|Eptifibatide|eptifibatide|mesh-list
154824512|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154824513|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154824514|NCT00061373|Analgesics|analgesics|mesh-ancestor
154824515|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
154824516|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824517|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824518|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824519|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824520|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154824521|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154824522|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824523|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154824524|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154824525|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824526|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
154824527|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
154824528|NCT01897337|Aprepitant|aprepitant|mesh-list
154824529|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
154824530|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
154824531|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824532|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824533|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824534|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154824535|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824536|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824537|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
154824538|NCT03089333|Glyburide|glyburide|mesh-list
154824539|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154824540|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824541|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154824542|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824543|NCT00112723|Alvocidib|alvocidib|mesh-list
154824544|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824545|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
154824546|NCT00112723|Growth Substances|growth substances|mesh-ancestor
154824547|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824548|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154824549|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824550|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824551|NCT04327206|Vaccines|vaccines|mesh-list
154824552|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
154824553|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
154824554|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824555|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154824556|NCT00115297|Montelukast|montelukast|mesh-list
154824557|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154824558|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
154824559|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154824560|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
154824561|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824562|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824563|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154824564|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154824565|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824566|NCT00116857|Sertraline|sertraline|mesh-list
154824567|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
154824568|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154824569|NCT00116857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154824570|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154824571|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154824572|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824573|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824574|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
154824575|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824576|NCT05547828|Tislelizumab|tislelizumab|mesh-list
154824577|NCT05547828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154824578|NCT05547828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824579|NCT01672983|Ritonavir|ritonavir|mesh-list
154824580|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154824581|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154824582|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
154824583|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824584|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824585|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154824586|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154824587|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
154824588|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824589|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154824590|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154824591|NCT00117715|Levomethorphan|levomethorphan|mesh-list
154824592|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
154824593|NCT00117715|Caffeine|caffeine|mesh-list
154824594|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154824595|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824596|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154824597|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824598|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824599|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154824600|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154824601|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
154824602|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824603|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
154824604|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
154824605|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154824606|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154824607|NCT00117715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154824608|NCT00117715|Narcotics|narcotics|mesh-ancestor
154824609|NCT00117715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824610|NCT00117715|Analgesics|analgesics|mesh-ancestor
154824611|NCT00117715|Sensory System Agents|sensory system agents|mesh-ancestor
154824612|NCT00117715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824613|NCT00228943|Tryptophan|tryptophan|mesh-list
154824614|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154824615|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
154824616|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154824617|NCT01879085|Gemcitabine|gemcitabine|mesh-list
154824618|NCT01879085|Docetaxel|docetaxel|mesh-list
154824619|NCT01879085|Vorinostat|vorinostat|mesh-list
154824620|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824621|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
154004085|NCT03117049|Paclitaxel|paclitaxel|mesh-list
154824622|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824623|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824624|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
154824625|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
154824626|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
154824627|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154824628|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824629|NCT01439204|Abatacept|abatacept|mesh-list
154824630|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154824631|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824632|NCT01439204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154824633|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824634|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824635|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
154824636|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824637|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824638|NCT00063635|Vitamin E|vitamin e|mesh-list
154824639|NCT00063635|Metformin|metformin|mesh-list
154824640|NCT00063635|Vitamins|vitamins|mesh-ancestor
154824641|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
154824642|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824643|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154824644|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
154004113|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
154824645|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824646|NCT00063635|Protective Agents|protective agents|mesh-ancestor
154824647|NCT01439126|Clonidine|clonidine|mesh-list
154824648|NCT01439126|Analgesics|analgesics|mesh-ancestor
154824649|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
154824650|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824651|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824652|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154824653|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
154824654|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
154824655|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154824656|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154824657|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154824658|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
154824659|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824660|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824661|NCT00066677|Docetaxel|docetaxel|mesh-list
154824662|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824663|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
154824664|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
154824665|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
154824666|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824667|NCT02334800|Palbociclib|palbociclib|mesh-list
154824668|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824669|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154824670|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824671|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824672|NCT01675635|Morphine|morphine|mesh-list
154824673|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154824674|NCT01675635|Narcotics|narcotics|mesh-ancestor
154824675|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824676|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824677|NCT01675635|Analgesics|analgesics|mesh-ancestor
154824678|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
154824679|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824680|NCT01615809|Amphotericin B|amphotericin b|mesh-list
154824681|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154824682|NCT01615809|Amebicides|amebicides|mesh-ancestor
154824683|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154824684|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154824685|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824686|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154824687|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
154824688|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
154824689|NCT01676415|Prednisone|prednisone|mesh-list
154824690|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
154824691|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154004158|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824692|NCT01676415|Hormones|hormones|mesh-ancestor
154824693|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824694|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824695|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824696|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824697|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
154824698|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154824699|NCT05547516|Gemcitabine|gemcitabine|mesh-list
154824700|NCT05547516|Epirubicin|epirubicin|mesh-list
154824701|NCT05547516|Mitomycins|mitomycins|mesh-list
154824702|NCT05547516|Mitomycin|mitomycin|mesh-list
154824703|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824704|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
154824705|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824706|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824707|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154824708|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154824709|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154824710|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824711|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
154824712|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154824713|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154004181|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824714|NCT01678443|Antibodies|antibodies|mesh-list
154824715|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
154824716|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154824717|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
154824718|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824719|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824720|NCT01707225|Octreotide|octreotide|mesh-list
154824721|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824722|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824723|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824724|NCT01707381|Timolol|timolol|mesh-list
154824725|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824726|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154824727|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154824728|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
154824729|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824730|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824731|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154824732|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154824733|NCT05552586|Melatonin|melatonin|mesh-list
154824734|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
154824735|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824736|NCT05552586|Protective Agents|protective agents|mesh-ancestor
154824737|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824738|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824739|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154824740|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824741|NCT00072449|Rituximab|rituximab|mesh-list
154824742|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154824743|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824744|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
154824745|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824746|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824747|NCT04756661|Misoprostol|misoprostol|mesh-list
154824748|NCT04756661|Oxytocin|oxytocin|mesh-list
154824749|NCT04756661|Carbetocin|carbetocin|mesh-list
154824750|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
154824751|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154824752|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824753|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154824754|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
154824755|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154824756|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824757|NCT01708629|Ustekinumab|ustekinumab|mesh-list
154824758|NCT01708629|Brodalumab|brodalumab|mesh-list
154824759|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154824760|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
154824761|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
154824762|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824763|NCT00073073|Vitamin D|vitamin d|mesh-list
154824764|NCT00073073|Exemestane|exemestane|mesh-list
154824765|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
154824766|NCT00073073|Calcium|calcium|mesh-list
154824767|NCT00073073|Vitamins|vitamins|mesh-ancestor
154824768|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
154824769|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824770|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154824771|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154824772|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824773|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154824774|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154824775|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824776|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824777|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154824778|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
154824779|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824780|NCT00073073|Antacids|antacids|mesh-ancestor
154824781|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824782|NCT01466660|Gefitinib|gefitinib|mesh-list
154824783|NCT01466660|Afatinib|afatinib|mesh-list
154824784|NCT01466660|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154824785|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154824786|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176569|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824787|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824788|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824789|NCT00075335|Plerixafor|plerixafor|mesh-list
154824790|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154824791|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154824792|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
154824793|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824794|NCT01466348|Acetaminophen|acetaminophen|mesh-list
154824795|NCT01466348|Caffeine|caffeine|mesh-list
154824796|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154824797|NCT01466348|Analgesics|analgesics|mesh-ancestor
154824798|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
154824799|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824800|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824801|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
154824802|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154824803|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154824804|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824805|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824806|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154824807|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154824808|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
154824809|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824810|NCT01466270|Donepezil|donepezil|mesh-list
154576759|NCT02296411|Bromides|bromides|mesh-list
154824811|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154824812|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824813|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004275|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
154824814|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
154824815|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824816|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824817|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
154824818|NCT02235987|Octreotide|octreotide|mesh-list
154824819|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824820|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824821|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824822|NCT01466192|Ribavirin|ribavirin|mesh-list
154824823|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154824824|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
154824825|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824826|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
154824827|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824828|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
154824829|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154824830|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154824831|NCT00120523|Analgesics|analgesics|mesh-ancestor
154824832|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
154824833|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824834|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824835|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824836|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824837|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
154824838|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824839|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
154824840|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154824841|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824842|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824843|NCT01438814|Metformin|metformin|mesh-list
154824844|NCT01438814|Linagliptin|linagliptin|mesh-list
154824845|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154824846|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824847|NCT01438814|Incretins|incretins|mesh-ancestor
154824848|NCT01438814|Hormones|hormones|mesh-ancestor
154824849|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824850|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154824851|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
154824852|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824853|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824854|NCT04425876|Fluzoparib|fluzoparib|mesh-list
154824855|NCT04425876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154824856|NCT04425876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824857|NCT04425876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824858|NCT04425876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824859|NCT01681095|Tryptophan|tryptophan|mesh-list
154824860|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154824861|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
154824862|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154824863|NCT00121225|Vorinostat|vorinostat|mesh-list
154824864|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824865|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154824866|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824867|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824868|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
154824869|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154824870|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824871|NCT05545800|Insulin|insulin|mesh-list
154824872|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154824873|NCT05545800|Metformin|metformin|mesh-list
154824874|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
154824875|NCT05545800|Empagliflozin|empagliflozin|mesh-list
154824876|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154824877|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824878|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154824879|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824880|NCT00230737|Melatonin|melatonin|mesh-list
154824881|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
154824882|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824883|NCT00230737|Protective Agents|protective agents|mesh-ancestor
154824884|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576820|NCT03446807|Droxidopa|droxidopa|mesh-list
154824885|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154824886|NCT04425564|Capecitabine|capecitabine|mesh-list
154824887|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
154824888|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154824889|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
154824890|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824891|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824892|NCT01686165|Rituximab|rituximab|mesh-list
154824893|NCT01686165|Belinostat|belinostat|mesh-list
154824894|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154824895|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154824896|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824897|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
154824898|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824899|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824900|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154824901|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824902|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824903|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
154824904|NCT00123643|Glyburide|glyburide|mesh-list
154824905|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154824906|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824907|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
154824908|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
154824909|NCT00235573|Vitamins|vitamins|mesh-ancestor
154824910|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
154824911|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824912|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
154824913|NCT00235573|Hematinics|hematinics|mesh-ancestor
154824914|NCT01687179|Sirolimus|sirolimus|mesh-list
154824915|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
154824916|NCT01687179|Temsirolimus|temsirolimus|mesh-list
154824917|NCT01687179|MTOR Inhibitors|mtor inhibitors|mesh-list
154824918|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154824919|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824920|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154824921|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824922|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
154824923|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824924|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
154824925|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824926|NCT01687179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154824927|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824928|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824929|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
154824930|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154824931|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154824932|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154824933|NCT00124579|Thalidomide|thalidomide|mesh-list
154824934|NCT00124579|Dexamethasone|dexamethasone|mesh-list
154824935|NCT00124579|Bortezomib|bortezomib|mesh-list
154824936|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154824937|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
154824938|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
154004355|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
154824939|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824940|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824941|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154824942|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
154824943|NCT00124579|Hormones|hormones|mesh-ancestor
154824944|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154824945|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154824946|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154824947|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154824948|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
154824949|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
154824950|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154824951|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154824952|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154824953|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154824954|NCT00124579|Growth Substances|growth substances|mesh-ancestor
154824955|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
154824956|NCT05550090|Immunomodulating Agents|immunomodulating agents|mesh-list
154004401|NCT02785068|Vitamins|vitamins|mesh-ancestor
154824957|NCT05550090|Immunologic Factors|immunologic factors|mesh-ancestor
154824958|NCT05550090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824959|NCT00124735|Rocuronium|rocuronium|mesh-list
154824960|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154824961|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154824962|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154824963|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824964|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824965|NCT00125515|Naltrexone|naltrexone|mesh-list
154824966|NCT00125515|Memantine|memantine|mesh-list
154824967|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154824968|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154824969|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824970|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
154824971|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154824972|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154824973|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154824974|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
154824975|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154824976|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824977|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154824978|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154824979|NCT00125593|Simvastatin|simvastatin|mesh-list
154824980|NCT00125593|Ezetimibe|ezetimibe|mesh-list
154824981|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154824982|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154824983|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
154824984|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824985|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154824986|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154824987|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154824988|NCT01689441|Calcitriol|calcitriol|mesh-list
154824989|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154824990|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154824991|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154824992|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154824993|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154824994|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154824995|NCT01689441|Vitamins|vitamins|mesh-ancestor
154824996|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
154824997|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154824998|NCT00236977|Iron|iron|mesh-list
154824999|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154825000|NCT00236977|Trace Elements|trace elements|mesh-ancestor
154825001|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
154825002|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825003|NCT00236977|Hematinics|hematinics|mesh-ancestor
154825004|NCT04753177|Paclitaxel|paclitaxel|mesh-list
154825005|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
154825006|NCT04753177|Doxorubicin|doxorubicin|mesh-list
154825007|NCT04753177|Fulvestrant|fulvestrant|mesh-list
154825008|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154825009|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154825010|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825011|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154825012|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154825013|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154825014|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825015|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825016|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
154825017|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825018|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825019|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825020|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
154825021|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154825022|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154825023|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154825024|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154825025|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825026|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154825027|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154825028|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154825029|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
154825030|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825031|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
154825032|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154825033|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
154825034|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154825035|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154825036|NCT01691313|Vanoxerine|vanoxerine|mesh-list
154825037|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154825038|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154825039|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825040|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825041|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
154825042|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825043|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825044|NCT00079001|Vitamin D|vitamin d|mesh-list
154825045|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
154825046|NCT00079001|Calcium|calcium|mesh-list
154825047|NCT00079001|Androgens|androgens|mesh-list
154825048|NCT00079001|Vitamins|vitamins|mesh-ancestor
154825049|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
154825050|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825051|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154825052|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154825053|NCT00079001|Hormones|hormones|mesh-ancestor
154825054|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825055|NCT00238615|Carboplatin|carboplatin|mesh-list
154825056|NCT00238615|Docetaxel|docetaxel|mesh-list
154825057|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825058|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
154825059|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
154825060|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
154825061|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825062|NCT02243943|Neostigmine|neostigmine|mesh-list
154825063|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154825064|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825065|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825066|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
154825067|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825068|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825069|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154825070|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
154825071|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825072|NCT03088631|Metformin|metformin|mesh-list
154825073|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154825074|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825075|NCT00131677|Tenofovir|tenofovir|mesh-list
154825076|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
154825077|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825078|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154825079|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154825080|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825081|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825082|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154825083|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154825084|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
154825085|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154825086|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
154825087|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004523|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154825088|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825089|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154825090|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
154825091|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154825092|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
154825093|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825094|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825095|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154825096|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
154825097|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
154825098|NCT00240487|Protective Agents|protective agents|mesh-ancestor
154825099|NCT02126917|Ethanol|ethanol|mesh-list
154825100|NCT02126917|Hydrocodone|hydrocodone|mesh-list
154825101|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154825102|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825103|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154825104|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825105|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154825106|NCT02126917|Narcotics|narcotics|mesh-ancestor
154825107|NCT02126917|Analgesics|analgesics|mesh-ancestor
154004551|NCT05031936|Ropivacaine|ropivacaine|mesh-list
154825108|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
154825109|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825110|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
154825111|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
154577048|NCT02293681|Infliximab|infliximab|mesh-list
154825112|NCT01895075|Budesonide|budesonide|mesh-list
154825114|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154825115|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
154825116|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825117|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825118|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154825119|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
154825120|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
154825121|NCT01895075|Hormones|hormones|mesh-ancestor
154825122|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825123|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
154825124|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
154825125|NCT03088709|Tacrolimus|tacrolimus|mesh-list
154825126|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825127|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
154825128|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825129|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825130|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825131|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
154825132|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825133|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825134|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154004566|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
154825135|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154825136|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825137|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154825138|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154825139|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
154825140|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154825141|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825142|NCT00084149|Ritonavir|ritonavir|mesh-list
154825143|NCT00084149|Lopinavir|lopinavir|mesh-list
154825144|NCT00084149|Lamivudine|lamivudine|mesh-list
154825145|NCT00084149|Zidovudine|zidovudine|mesh-list
154825146|NCT00084149|Abacavir|abacavir|mesh-list
154825147|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154825148|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154825149|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
154825150|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825151|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825152|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154825153|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154825154|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
154825155|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825156|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154825157|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154825158|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154825159|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154825160|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
154825161|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
154825162|NCT02959905|Fludarabine|fludarabine|mesh-list
154825163|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
154825164|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825165|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
154825166|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825167|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825168|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825169|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
154825170|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825171|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825172|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154825173|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154825174|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
154825175|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
154825176|NCT00134017|Busulfan|busulfan|mesh-list
154825177|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825178|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
154825179|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825180|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825181|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825182|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
154825183|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825184|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825185|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154825186|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
154825187|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
154825188|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154825189|NCT04783051|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154825190|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
154825191|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154825192|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154825193|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825194|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154825195|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825196|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825197|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154825198|NCT04783051|Antiviral Agents|antiviral agents|mesh-ancestor
154825200|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004637|NCT00634686|Calcium|calcium|mesh-list
154825201|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825202|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825203|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154825204|NCT00245557|Sertraline|sertraline|mesh-list
154825205|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
154825206|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154825207|NCT00245557|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154825208|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154825209|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825210|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825211|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825212|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
154825213|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825214|NCT00245635|Fluoxetine|fluoxetine|mesh-list
154825215|NCT00245635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154825216|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154825217|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825218|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825219|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825220|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
154825221|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825222|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154825223|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
154825224|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154825225|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154825226|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154825227|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825228|NCT00141115|Levetiracetam|levetiracetam|mesh-list
154825229|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
154825230|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
154825231|NCT00249379|Acamprosate|acamprosate|mesh-list
154825232|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154825233|NCT00141739|Etanercept|etanercept|mesh-list
154825234|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154825235|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154825236|NCT00141739|Analgesics|analgesics|mesh-ancestor
154825237|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
154825238|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825239|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825240|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825241|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825242|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154825243|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825244|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
154825245|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154825246|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
154825247|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825248|NCT00086957|Docetaxel|docetaxel|mesh-list
154825249|NCT00086957|Trastuzumab|trastuzumab|mesh-list
154825250|NCT00086957|Gefitinib|gefitinib|mesh-list
154825251|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825252|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
154825253|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
154825254|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
154825255|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825256|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825257|NCT00086957|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154825258|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154825259|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004691|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
154825260|NCT00144391|Testosterone|testosterone|mesh-list
154825261|NCT00144391|Androgens|androgens|mesh-ancestor
154825263|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825264|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825265|NCT00145249|Fluconazole|fluconazole|mesh-list
154825266|NCT00145249|Amphotericin B|amphotericin b|mesh-list
154825267|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154825268|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
154825269|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825270|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154825271|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154825272|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825273|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825274|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154825275|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
154825276|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825277|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825278|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154825279|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154825280|NCT00145249|Amebicides|amebicides|mesh-ancestor
154825281|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154825282|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154825283|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154825284|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154825285|NCT00153803|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154825286|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154825287|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825288|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825289|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825290|NCT00252967|Atorvastatin|atorvastatin|mesh-list
154825291|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154825292|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154825293|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
154825294|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825295|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154825296|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154825297|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825298|NCT00088985|Trastuzumab|trastuzumab|mesh-list
154825299|NCT00088985|Vinorelbine|vinorelbine|mesh-list
154825300|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825301|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825302|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154825303|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
154825304|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
154825305|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
154825306|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825307|NCT00156923|Naltrexone|naltrexone|mesh-list
154825308|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154825309|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154825310|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825311|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
154825312|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825313|NCT00093041|Zalutumumab|zalutumumab|mesh-list
154825314|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825315|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825316|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154825317|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
154825318|NCT01769885|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154004754|NCT04649203|Vitamins|vitamins|mesh-ancestor
154825319|NCT01769885|Tivozanib|tivozanib|mesh-list
154825320|NCT01769885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154825321|NCT01769885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825322|NCT01769885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825323|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154825324|NCT01895231|Hematinics|hematinics|mesh-ancestor
154825325|NCT04745663|Iodine|iodine|mesh-list
154825326|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
154825327|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
154825328|NCT04745663|Povidone|povidone|mesh-list
154825329|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154825330|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825331|NCT04745663|Trace Elements|trace elements|mesh-ancestor
154825332|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
154825333|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825334|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
154825335|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
154825336|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
154825337|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154825338|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154825339|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
154825340|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825341|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825342|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825343|NCT01747577|Urological Agents|urological agents|mesh-ancestor
154825344|NCT00159263|Budesonide|budesonide|mesh-list
154825345|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
154825346|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825347|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154825348|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
154825349|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825350|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825351|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154004785|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
154825352|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
154825353|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
154825354|NCT00159263|Hormones|hormones|mesh-ancestor
154825355|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825356|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154825357|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154825358|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154825359|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
154825360|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825361|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825362|NCT00159419|Alendronate|alendronate|mesh-list
154825363|NCT00159419|Pamidronate|pamidronate|mesh-list
154825364|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154825365|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825366|NCT00159965|Sertraline|sertraline|mesh-list
154825367|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
154825368|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154825369|NCT00159965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154825370|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154004816|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154825371|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825372|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825373|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825374|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
154825375|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825376|NCT00096161|Cyclosporine|cyclosporine|mesh-list
154825377|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
154825378|NCT00096161|Vidarabine|vidarabine|mesh-list
154825379|NCT00096161|Pentostatin|pentostatin|mesh-list
154825380|NCT00096161|Cyclosporins|cyclosporins|mesh-list
154825381|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825382|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825383|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825384|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
154825385|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825386|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
154825387|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825388|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
154825389|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825390|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154825391|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154825392|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825393|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154825394|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
154825395|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154825396|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154825397|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
154825398|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
154825399|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154825400|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825401|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
154825402|NCT01898039|Vaccines|vaccines|mesh-list
154825403|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
154825404|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825405|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825406|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825407|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825408|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
154577357|NCT05230797|Zinc|zinc|mesh-list
154825409|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825410|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825411|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154825412|NCT00099047|Celecoxib|celecoxib|mesh-list
154825413|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154825414|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154825415|NCT00099047|Analgesics|analgesics|mesh-ancestor
154825416|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
154825417|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825418|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825419|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825420|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825421|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154825422|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154825423|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825424|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004860|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154825425|NCT02851797|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154825426|NCT02851797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154825427|NCT02851797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825428|NCT02851797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825429|NCT00253435|Carboplatin|carboplatin|mesh-list
154825430|NCT00253435|Etoposide|etoposide|mesh-list
154825431|NCT00253435|Melphalan|melphalan|mesh-list
154825432|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825433|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154825434|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154825435|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154825436|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825437|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825438|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
154825439|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825440|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825441|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
154825442|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154825443|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825444|NCT00253513|Fludarabine|fludarabine|mesh-list
154825445|NCT00253513|Treosulfan|treosulfan|mesh-list
154825446|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825447|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825448|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825449|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
154825450|NCT05033847|Vaccines|vaccines|mesh-list
154825451|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
154825452|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825453|NCT02098993|Heparin|heparin|mesh-list
154825454|NCT02098993|Calcium heparin|calcium heparin|mesh-list
154825455|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
154825456|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154825457|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154825458|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825459|NCT00100841|Leucovorin|leucovorin|mesh-list
154825460|NCT00100841|Bevacizumab|bevacizumab|mesh-list
154825461|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154825462|NCT00100841|Cetuximab|cetuximab|mesh-list
154825463|NCT00100841|Fluorouracil|fluorouracil|mesh-list
154825464|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
154825465|NCT00100841|Antibodies|antibodies|mesh-list
154825466|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
154825467|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154825468|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
154825469|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825470|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154825471|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154825472|NCT00100841|Growth Substances|growth substances|mesh-ancestor
154825473|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825474|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
154825475|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
154825476|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
154825477|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825478|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154825479|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825480|NCT00100841|Antidotes|antidotes|mesh-ancestor
154825481|NCT00100841|Protective Agents|protective agents|mesh-ancestor
154825482|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
154825483|NCT00100841|Vitamins|vitamins|mesh-ancestor
154577429|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
154825484|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
154825486|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
154825487|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154825488|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154825489|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825490|NCT00445965|Antibodies|antibodies|mesh-list
154825491|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154825492|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
154825493|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825494|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
154825495|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154825496|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154825497|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154825498|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154825499|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825500|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825501|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
154825502|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825503|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825504|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154825505|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825506|NCT02240589|Memantine|memantine|mesh-list
154825507|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154825508|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154825509|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
154825510|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825511|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825512|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825513|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154825514|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154825515|NCT00258349|Trastuzumab|trastuzumab|mesh-list
154825516|NCT00258349|Vorinostat|vorinostat|mesh-list
154825517|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825518|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825519|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154825520|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825521|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825522|NCT01713621|Artefenomel|artefenomel|mesh-list
154825523|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
154825524|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154825525|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154825526|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825527|NCT00258817|Vaccines|vaccines|mesh-list
154825528|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
154825529|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825530|NCT00259285|Pemetrexed|pemetrexed|mesh-list
154825531|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825532|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825533|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825534|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154825535|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154825536|NCT01716039|Adalimumab|adalimumab|mesh-list
154825537|NCT01716039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154825538|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825539|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825540|NCT01716195|Paclitaxel|paclitaxel|mesh-list
154825541|NCT01716195|Carboplatin|carboplatin|mesh-list
154825542|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154825543|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825544|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
154825545|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
154825546|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
154825547|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825548|NCT02249481|Bupivacaine|bupivacaine|mesh-list
154825549|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154825550|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
154825551|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154825552|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825553|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
154825554|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825555|NCT01717053|Prednisone|prednisone|mesh-list
154825556|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
154825557|NCT01717053|Androgens|androgens|mesh-list
154825558|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825559|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
154825560|NCT01717053|Hormones|hormones|mesh-ancestor
154825561|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825562|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825563|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154825564|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825565|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154825566|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825567|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825568|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
154825569|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154825570|NCT01666314|Prednisone|prednisone|mesh-list
154825571|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005003|NCT00803595|Oseltamivir|oseltamivir|mesh-list
154825572|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
154825573|NCT01666314|Hormones|hormones|mesh-ancestor
154825574|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825575|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825576|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154825577|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825578|NCT01717209|Epoprostenol|epoprostenol|mesh-list
154825579|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
154825580|NCT01717209|Tezosentan|tezosentan|mesh-list
154825581|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154825582|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
154825583|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825584|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825585|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154825586|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
154825587|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154825588|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
154825589|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825590|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825591|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154825592|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
154825593|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
154825594|NCT01717209|Protective Agents|protective agents|mesh-ancestor
154825595|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154825596|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154825597|NCT00260689|Cyclosporine|cyclosporine|mesh-list
154825598|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
154825599|NCT00260689|Cyclosporins|cyclosporins|mesh-list
154825600|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154825601|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
154825602|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825603|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825604|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825605|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
154825606|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825607|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
154825608|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825609|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
154825610|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825611|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154825612|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825613|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825614|NCT00262639|Gabapentin|gabapentin|mesh-list
154825615|NCT00262639|Flumazenil|flumazenil|mesh-list
154825616|NCT00262639|Analgesics|analgesics|mesh-ancestor
154825617|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
154825618|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825619|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825620|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
154825621|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154825622|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154825623|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154825624|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154825625|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154825626|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154825627|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825628|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825629|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
154825630|NCT00262639|Antidotes|antidotes|mesh-ancestor
154825631|NCT00262639|Protective Agents|protective agents|mesh-ancestor
154825632|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
154825633|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
154577607|NCT02300623|Lamivudine|lamivudine|mesh-list
154825634|NCT01062451|Candesartan|candesartan|mesh-list
154825635|NCT01062451|Candesartan cilexetil|candesartan cilexetil|mesh-list
154005066|NCT04967508|Ustekinumab|ustekinumab|mesh-list
154825636|NCT01062451|Perindopril|perindopril|mesh-list
154825637|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154825638|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154825639|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154825640|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825641|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154825642|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
154825643|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825644|NCT04639843|Doxorubicin|doxorubicin|mesh-list
154825645|NCT04639843|Romidepsin|romidepsin|mesh-list
154825646|NCT04639843|Azacitidine|azacitidine|mesh-list
154825647|NCT04639843|Cc-486|cc-486|mesh-list
154825648|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154825649|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825650|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154825651|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154825652|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825653|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825654|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154825655|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
154005096|NCT04038307|Acetaminophen|acetaminophen|mesh-list
154825656|NCT04639843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154825657|NCT01718691|Rituximab|rituximab|mesh-list
154825658|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825659|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825660|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
154825661|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825662|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825663|NCT05699148|Ivacaftor|ivacaftor|mesh-list
154825664|NCT05699148|Elexacaftor|elexacaftor|mesh-list
154825665|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154825666|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825667|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825668|NCT04425642|Methamphetamine|methamphetamine|mesh-list
154825669|NCT04425642|SMOFlipid|smoflipid|mesh-list
154825670|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154825671|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825672|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
154825673|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
154825674|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825675|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
154825676|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825677|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825678|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
154825679|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154825680|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154825681|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825682|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154825683|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154825684|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154825685|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154825686|NCT00266851|Azithromycin|azithromycin|mesh-list
154825687|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154825688|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825689|NCT00015847|Interferons|interferons|mesh-list
154825690|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
154825691|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
154825692|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825693|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
154825694|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825695|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
154825696|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825697|NCT00015847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154825698|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154825699|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825700|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825701|NCT01665768|Rituximab|rituximab|mesh-list
154825702|NCT01665768|Everolimus|everolimus|mesh-list
154825703|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825704|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825705|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
154825706|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825707|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825708|NCT01665768|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154825709|NCT01665768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154825710|NCT01665768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825711|NCT01665768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825712|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825713|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154825714|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
154825715|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825716|NCT00017563|Docetaxel|docetaxel|mesh-list
154825717|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
154825718|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825719|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
154825720|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
154825721|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
154825722|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825723|NCT00017563|Analgesics|analgesics|mesh-ancestor
154825724|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
154825725|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825726|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005169|NCT02858843|Ivacaftor|ivacaftor|mesh-list
154825727|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154825728|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154825729|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825730|NCT00018031|Ribavirin|ribavirin|mesh-list
154825731|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154825732|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
154825733|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
154825734|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825735|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
154825736|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825737|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
154825738|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825739|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
154825740|NCT00267085|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154825741|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154825742|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825743|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825744|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825745|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
154825746|NCT04476511|Vitamin D|vitamin d|mesh-list
154825747|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154005187|NCT00952523|Tretinoin|tretinoin|mesh-list
154825748|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825749|NCT04476511|Vitamins|vitamins|mesh-ancestor
154825750|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
154825751|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154825752|NCT00026221|Interferons|interferons|mesh-list
154825753|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
154825754|NCT00026221|Bevacizumab|bevacizumab|mesh-list
154825755|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825756|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825757|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154825758|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154825759|NCT00026221|Growth Substances|growth substances|mesh-ancestor
154825760|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825761|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
154825762|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
154825763|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825764|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
154825765|NCT00028093|Ribavirin|ribavirin|mesh-list
154825766|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154825767|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
154825768|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
154825769|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825770|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
154825771|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825772|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
154825773|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825774|NCT01721967|Ranolazine|ranolazine|mesh-list
154825775|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154825776|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825777|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825778|NCT04026451|Propofol|propofol|mesh-list
154825779|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154825780|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154825781|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825782|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154825783|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
154825784|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
154005225|NCT02232737|Nicotine|nicotine|mesh-list
154825785|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
154825786|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154825787|NCT01722435|Narcotics|narcotics|mesh-ancestor
154825788|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154825789|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825790|NCT01722435|Analgesics|analgesics|mesh-ancestor
154825791|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
154825792|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825793|NCT00029107|Rituximab|rituximab|mesh-list
154825794|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154825795|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825796|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
154825797|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825798|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825799|NCT04389229|Aldesleukin|aldesleukin|mesh-list
154825800|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
154825801|NCT04389229|Fludarabine|fludarabine|mesh-list
154825802|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825803|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
154825804|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825805|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825806|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825807|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
154825808|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825809|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825810|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154825811|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154825812|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154825813|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
154825814|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825815|NCT00271219|Buprenorphine|buprenorphine|mesh-list
154825816|NCT00271219|Methadone|methadone|mesh-list
154825817|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154825818|NCT00271219|Narcotics|narcotics|mesh-ancestor
154005249|NCT00630929|Ibuprofen|ibuprofen|mesh-list
154825819|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154825820|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825821|NCT00271219|Analgesics|analgesics|mesh-ancestor
154825822|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
154825823|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825824|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154825825|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
154825826|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
154825827|NCT02240667|Vitamin K|vitamin k|mesh-list
154825828|NCT02240667|Dabigatran|dabigatran|mesh-list
154825829|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
154825830|NCT02240667|Vitamins|vitamins|mesh-ancestor
154825831|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
154825832|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825833|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
154825834|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154825835|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
154825836|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825837|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825838|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
154825839|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154825840|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154825841|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
154825842|NCT02240667|Coagulants|coagulants|mesh-ancestor
154825843|NCT00272311|Aspirin|aspirin|mesh-list
154825844|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154825845|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154825846|NCT00272311|Analgesics|analgesics|mesh-ancestor
154825847|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
154825848|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825849|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825850|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825851|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825852|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154825853|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154825854|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825855|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154825856|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154825857|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825858|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
154825859|NCT00038857|Fludarabine|fludarabine|mesh-list
154825860|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
154825861|NCT00038857|Melphalan|melphalan|mesh-list
154825862|NCT00038857|Thiotepa|thiotepa|mesh-list
154825863|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
154825864|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154825865|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825866|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154825867|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
154825868|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825869|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825870|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
154825871|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825872|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154825873|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
154825874|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154825875|NCT03097068|Ranibizumab|ranibizumab|mesh-list
154825876|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154825877|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154825878|NCT03097068|Growth Substances|growth substances|mesh-ancestor
154825879|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825880|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
154825881|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825882|NCT01729845|Cytarabine|cytarabine|mesh-list
154825883|NCT01729845|Etoposide|etoposide|mesh-list
154825884|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
154825885|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
154825886|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
154825887|NCT01729845|Decitabine|decitabine|mesh-list
154825888|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154005317|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
154825889|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825890|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154825891|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154825892|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825893|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825894|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154825895|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
154825896|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
154825897|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154825898|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154825899|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
154825900|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825901|NCT01729845|Analgesics|analgesics|mesh-ancestor
154825902|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
154825903|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825904|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
154005342|NCT02775474|Fentanyl|fentanyl|mesh-list
154825905|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
154825906|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
154825907|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
154825908|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
154825909|NCT01729923|Celecoxib|celecoxib|mesh-list
154825910|NCT01729923|Capecitabine|capecitabine|mesh-list
154825911|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154825912|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
154825913|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825914|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825915|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154825916|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154825917|NCT01729923|Analgesics|analgesics|mesh-ancestor
154825918|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
154825919|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825920|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825921|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825922|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154825923|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154005359|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825924|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154825925|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825926|NCT02584452|Dexamethasone|dexamethasone|mesh-list
154825927|NCT02584452|Fentanyl|fentanyl|mesh-list
154825928|NCT02584452|Bupivacaine|bupivacaine|mesh-list
154825929|NCT02584452|Ropivacaine|ropivacaine|mesh-list
154825930|NCT02584452|Mepivacaine|mepivacaine|mesh-list
154825931|NCT02584452|Propofol|propofol|mesh-list
154825932|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154825933|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
154825934|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
154825935|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154825936|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825937|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154825938|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
154825939|NCT02584452|Hormones|hormones|mesh-ancestor
154825940|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154825941|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154825942|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825943|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
154825944|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
154825945|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154825946|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
154825947|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154825948|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154825949|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
154825950|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154005381|NCT01778946|Nicotine|nicotine|mesh-list
154825951|NCT02584452|Narcotics|narcotics|mesh-ancestor
154825952|NCT02584452|Analgesics|analgesics|mesh-ancestor
154825953|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154825954|NCT05679102|Amlodipine|amlodipine|mesh-list
154825955|NCT05679102|Atorvastatin|atorvastatin|mesh-list
154825956|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154825957|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154825958|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
154825959|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825960|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154825961|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154825962|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154825963|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154825964|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154825965|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154825966|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154825967|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825968|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
154825969|NCT05588934|Caffeine|caffeine|mesh-list
154825970|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154825971|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825972|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154825973|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005401|NCT04813380|Immunomodulating Agents|immunomodulating agents|mesh-list
154825974|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825975|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154825976|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154825977|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
154825978|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154825979|NCT02243007|Paclitaxel|paclitaxel|mesh-list
154825980|NCT02243007|Gemcitabine|gemcitabine|mesh-list
154825981|NCT02243007|Capecitabine|capecitabine|mesh-list
154825982|NCT02243007|Folfirinox|folfirinox|mesh-list
154825983|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154825984|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154825985|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
154825986|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
154825987|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
154825988|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154825989|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154825990|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
154825991|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
154825992|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
154825993|NCT05536596|Melatonin|melatonin|mesh-list
154825994|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
154825995|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005431|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
154825996|NCT05536596|Protective Agents|protective agents|mesh-ancestor
154825997|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154825998|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154825999|NCT05536596|Hematinics|hematinics|mesh-ancestor
154826000|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
154826001|NCT05536596|Vitamins|vitamins|mesh-ancestor
154826002|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
154826003|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
154826004|NCT03469011|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154826005|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154826006|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826007|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826008|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826009|NCT03430791|Nivolumab|nivolumab|mesh-list
154826010|NCT03430791|Ipilimumab|ipilimumab|mesh-list
154826011|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154826012|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826013|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154826014|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826015|NCT05536128|Fulvestrant|fulvestrant|mesh-list
154826016|NCT05536128|Olaparib|olaparib|mesh-list
154826017|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154826018|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826019|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154826020|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154826021|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
154826022|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826023|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826024|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154826025|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826026|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826028|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154826029|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826030|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
154826031|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826032|NCT05316675|Isotretinoin|isotretinoin|mesh-list
154826033|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
154826034|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
154826035|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154005465|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826036|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826037|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154826038|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826039|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
154826040|NCT01736865|Vitamin D|vitamin d|mesh-list
154826041|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154826042|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826043|NCT01736865|Vitamins|vitamins|mesh-ancestor
154826044|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
154826045|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154826046|NCT01736943|Doxorubicin|doxorubicin|mesh-list
154826047|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154826048|NCT01736943|Bortezomib|bortezomib|mesh-list
154826049|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154826050|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826051|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154826052|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154826053|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826054|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826055|NCT01739361|Acetaminophen|acetaminophen|mesh-list
154826056|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154826057|NCT01739361|Analgesics|analgesics|mesh-ancestor
154826058|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
154826059|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826060|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826061|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
154826062|NCT01743729|Lifitegrast|lifitegrast|mesh-list
154826063|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154826064|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154826065|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
154826066|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154826067|NCT01744353|Paclitaxel|paclitaxel|mesh-list
154826068|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826069|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826070|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154826071|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
154826072|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
154826073|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
154826074|NCT01744821|Vitamin D|vitamin d|mesh-list
154826075|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
154826076|NCT01744821|Vitamins|vitamins|mesh-ancestor
154826077|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
154826078|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826079|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154826080|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154826081|NCT04369365|Azithromycin|azithromycin|mesh-list
154826082|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154826083|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826084|NCT01745055|Methotrexate|methotrexate|mesh-list
154826085|NCT01745055|Tofacitinib|tofacitinib|mesh-list
154826086|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154826087|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
154826088|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154826089|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826090|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154826091|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
154826092|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826093|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826094|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
154826095|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826096|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154826097|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154826098|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
154826099|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826100|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154826101|NCT01745055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154826102|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154826103|NCT01745133|Calcitriol|calcitriol|mesh-list
154826104|NCT01745133|Clobetasol|clobetasol|mesh-list
154826105|NCT01745133|Calcipotriene|calcipotriene|mesh-list
154826106|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154826107|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
154826108|NCT01745133|Hormones|hormones|mesh-ancestor
154826109|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826110|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826111|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
154826112|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154826113|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154826114|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154826115|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826116|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154826117|NCT01745133|Vitamins|vitamins|mesh-ancestor
154826118|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
154826119|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154826120|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
154826121|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154826122|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826123|NCT04246359|Interferons|interferons|mesh-list
154826124|NCT04246359|Rituximab|rituximab|mesh-list
154826125|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154826126|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826127|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
154826128|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826129|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826130|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
154826131|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826132|NCT05213169|Apomorphine|apomorphine|mesh-list
154826133|NCT05213169|Emetics|emetics|mesh-ancestor
154826134|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826135|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
154826136|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826137|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826138|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
154826139|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
154826140|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826141|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826142|NCT05192265|Artesunate|artesunate|mesh-list
154826143|NCT05192265|Lumefantrine|lumefantrine|mesh-list
154826144|NCT05192265|Artemether|artemether|mesh-list
154826145|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154826146|NCT05192265|Pyronaridine|pyronaridine|mesh-list
154826147|NCT05192265|Antimalarials|antimalarials|mesh-list
154826148|NCT05192265|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154826149|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154826150|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154826151|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826152|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826153|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
154826154|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
154826155|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154826156|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
154826157|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
154826158|NCT01748643|Rocuronium|rocuronium|mesh-list
154826159|NCT01748643|Neostigmine|neostigmine|mesh-list
154826160|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154826161|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154826162|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154826163|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826164|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826165|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154578105|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826166|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826167|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826168|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
154826169|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826170|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154826171|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
154826172|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154826173|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154826174|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154826175|NCT00106535|Methotrexate|methotrexate|mesh-list
154826176|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154826177|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
154826178|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154826179|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826180|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154826181|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
154826182|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826183|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826184|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
154826185|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826186|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154826187|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154826188|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
154826189|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826190|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154826191|NCT01748799|Ethanol|ethanol|mesh-list
154826192|NCT01748799|Nabiximols|nabiximols|mesh-list
154826193|NCT01748799|Dronabinol|dronabinol|mesh-list
154826194|NCT01748799|Cannabidiol|cannabidiol|mesh-list
154826195|NCT01748799|Peppermint oil|peppermint oil|mesh-list
154826196|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
154826197|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154826198|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826199|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826200|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826201|NCT01748799|Analgesics|analgesics|mesh-ancestor
154826202|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
154826203|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826204|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
154826205|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826206|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005634|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
154826207|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154826208|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154826209|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826210|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826211|NCT01748799|Hormones|hormones|mesh-ancestor
154826212|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826213|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
154826214|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
154826215|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826216|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
154826217|NCT04107051|Nalmefene|nalmefene|mesh-list
154826218|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154826219|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826220|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
154826221|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826222|NCT05696886|Meperidine|meperidine|mesh-list
154826223|NCT05696886|Tramadol|tramadol|mesh-list
154826224|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154826225|NCT05696886|Narcotics|narcotics|mesh-ancestor
154826226|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826227|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826228|NCT05696886|Analgesics|analgesics|mesh-ancestor
154826229|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
154826230|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826231|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154826232|NCT01748955|Bupropion|bupropion|mesh-list
154826233|NCT01748955|Paroxetine|paroxetine|mesh-list
154826234|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154826235|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
154826236|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826237|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154826238|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154826239|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154826240|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826241|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
154826242|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826243|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826244|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154826245|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154826246|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826247|NCT01748955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154826248|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
154826249|NCT05687448|Warfarin|warfarin|mesh-list
154005678|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
154826250|NCT05687448|Apixaban|apixaban|mesh-list
154826251|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
154826252|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154826253|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
154826254|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154826255|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
154826256|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826257|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826258|NCT01749501|Rocuronium|rocuronium|mesh-list
154826259|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154826260|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154826261|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154826262|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826263|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826264|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154826265|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154826266|NCT02255175|Estradiol|estradiol|mesh-list
154826267|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154826268|NCT02255175|Progesterone|progesterone|mesh-list
154826269|NCT02255175|Estrogens|estrogens|mesh-ancestor
154826270|NCT02255175|Hormones|hormones|mesh-ancestor
154826271|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826272|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826273|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154826274|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
154826275|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154826276|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154826277|NCT02255175|Progestins|progestins|mesh-ancestor
154826278|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154826279|NCT02585778|Alirocumab|alirocumab|mesh-list
154826280|NCT02585778|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154826281|NCT02585778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154826282|NCT02585778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154826283|NCT02585778|Antimetabolites|antimetabolites|mesh-ancestor
154826284|NCT02585778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826285|NCT02585778|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154826286|NCT02585778|Protease Inhibitors|protease inhibitors|mesh-ancestor
154826287|NCT02585778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826288|NCT02585778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154826289|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826290|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
154826291|NCT03899103|Rituximab|rituximab|mesh-list
154826292|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154826293|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826294|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
154826295|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826296|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826297|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154826298|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154826299|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
154826300|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154826301|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826302|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826303|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826304|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
154826305|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826306|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154826307|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826308|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826309|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
154826310|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826311|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826312|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154826313|NCT01438424|Lamivudine|lamivudine|mesh-list
154826314|NCT01438424|Entecavir|entecavir|mesh-list
154826315|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154826316|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154826317|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826318|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826319|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
154826320|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826321|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154826322|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154826324|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154826325|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154826326|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
154826327|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154826328|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
154826329|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
154826330|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826331|NCT05299866|Ketamine|ketamine|mesh-list
154826332|NCT05299866|Esketamine|esketamine|mesh-list
154826333|NCT05299866|Analgesics|analgesics|mesh-ancestor
154826334|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
154826335|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826336|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826337|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154826338|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154826339|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
154826340|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
154826341|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826342|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154826343|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154826344|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826345|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826346|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
154826347|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826348|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
154826349|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154826350|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
154826351|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826352|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826353|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
154826354|NCT02250807|Simeprevir|simeprevir|mesh-list
154826355|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
154826356|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826357|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
154826358|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826359|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826360|NCT00168389|Dexamethasone|dexamethasone|mesh-list
154826361|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154826362|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
154826363|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
154826364|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826365|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826366|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826367|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
154826368|NCT00168389|Hormones|hormones|mesh-ancestor
154826369|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826370|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154826371|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826372|NCT02252445|Propofol|propofol|mesh-list
154826373|NCT02252445|Sevoflurane|sevoflurane|mesh-list
154826374|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154826375|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826376|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826377|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154826378|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
154826379|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
154826380|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154826381|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154826382|NCT04592952|Calcitonin|calcitonin|mesh-list
154826383|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
154826384|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154826385|NCT04592952|Erenumab|erenumab|mesh-list
154826386|NCT04592952|Katacalcin|katacalcin|mesh-list
154826387|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154826388|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826389|NCT04592952|Analgesics|analgesics|mesh-ancestor
154826390|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
154826391|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826392|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826393|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154826394|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154826395|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
154826396|NCT00176423|Galantamine|galantamine|mesh-list
154005791|NCT02541643|Elotuzumab|elotuzumab|mesh-list
154826397|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154826398|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826399|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826400|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
154826401|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826402|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826403|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154826404|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
154826405|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826406|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
154826407|NCT02094443|Ribavirin|ribavirin|mesh-list
154826408|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
154826409|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826410|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
154826411|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826412|NCT00110513|Antithrombins|antithrombins|mesh-list
154826413|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
154826414|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154826415|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
154826416|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826417|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826418|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
154826419|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
154826420|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154826421|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
154826422|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826423|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826424|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154826425|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
154826426|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154826427|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
154826428|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826429|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826430|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154826431|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
154826432|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
154826433|NCT05691426|Protective Agents|protective agents|mesh-ancestor
154826434|NCT05696574|Misoprostol|misoprostol|mesh-list
154826435|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154826436|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
154826437|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154826438|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826439|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154826440|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154005880|NCT00884767|Vitamins|vitamins|mesh-ancestor
154826441|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
154826442|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
154826443|NCT00112151|Testosterone|testosterone|mesh-list
154826444|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
154826445|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
154826446|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154826447|NCT00112151|Androgens|androgens|mesh-ancestor
154826448|NCT00112151|Hormones|hormones|mesh-ancestor
154826449|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826450|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826451|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154826452|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826453|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
154826454|NCT05162742|Colchicine|colchicine|mesh-list
154826455|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
154826456|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826457|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
154826458|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
154826459|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
154826460|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826461|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826462|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
154826463|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154826464|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826465|NCT00113321|Decitabine|decitabine|mesh-list
154578412|NCT02317861|Febuxostat|febuxostat|mesh-list
154005894|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154826466|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154826467|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
154826468|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826469|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826470|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826471|NCT05669742|Empagliflozin|empagliflozin|mesh-list
154826472|NCT05669742|Olanzapine|olanzapine|mesh-list
154826473|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154826474|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826475|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154826476|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826477|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
154826478|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
154826479|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826480|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826481|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154826482|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154826483|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826484|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826485|NCT05669742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154826486|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154826487|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154826488|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826489|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
154826490|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
154826491|NCT00177047|Melphalan|melphalan|mesh-list
154826492|NCT00177047|Lenograstim|lenograstim|mesh-list
154826493|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154826494|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
154826495|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826496|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826497|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154826498|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
154826499|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826500|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826501|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154826502|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154826503|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
154826504|NCT00178841|Bexarotene|bexarotene|mesh-list
154826505|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154826506|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826507|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826508|NCT01756209|Acetaminophen|acetaminophen|mesh-list
154826509|NCT01756209|Ibuprofen|ibuprofen|mesh-list
154826510|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154826511|NCT01756209|Analgesics|analgesics|mesh-ancestor
154826512|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
154826513|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826514|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826515|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
154826516|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154826517|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154826518|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826519|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154826520|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826521|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826522|NCT00116207|Niacinamide|niacinamide|mesh-list
154826523|NCT00116207|Allopurinol|allopurinol|mesh-list
154826524|NCT00116207|Antioxidants|antioxidants|mesh-list
154826525|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
154005951|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
154826526|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826527|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826528|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
154826529|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826530|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154826531|NCT00116207|Protective Agents|protective agents|mesh-ancestor
154826532|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826533|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
154826534|NCT00116207|Vitamins|vitamins|mesh-ancestor
154826535|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
154826536|NCT04129398|Letermovir|letermovir|mesh-list
154826537|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154826538|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826539|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826540|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826541|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
154826542|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826543|NCT00178919|Trimethaphan|trimethaphan|mesh-list
154826544|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
154826545|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826546|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154826547|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154826548|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154826549|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
154826550|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826551|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826552|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154826553|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154826554|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
154826555|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826556|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
154826557|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154826558|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826559|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826560|NCT00122447|Aspirin|aspirin|mesh-list
154826561|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
154826562|NCT00122447|Olmesartan|olmesartan|mesh-list
154826563|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154826564|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154826565|NCT00122447|Analgesics|analgesics|mesh-ancestor
154005997|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154005998|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154826566|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
154826567|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826568|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826569|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154826570|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826571|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154826572|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154826573|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826574|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154826575|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154826576|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826577|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
154826578|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154826579|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154826580|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154826581|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
154826582|NCT00122447|Protective Agents|protective agents|mesh-ancestor
154826583|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
154826584|NCT00122447|Vitamins|vitamins|mesh-ancestor
154826585|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
154826586|NCT00125957|Bupropion|bupropion|mesh-list
154826587|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154826588|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
154826589|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826590|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154826591|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154826592|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154826593|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826594|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
154826595|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826596|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826597|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154826598|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154826599|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826600|NCT00183443|Valproic Acid|valproic acid|mesh-list
154826601|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154826602|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
154826603|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826604|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154826605|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154826606|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826607|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826608|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826609|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826610|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
154826611|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
154826612|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
154826613|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826614|NCT02579928|Midazolam|midazolam|mesh-list
154826615|NCT02579928|Ketamine|ketamine|mesh-list
154826616|NCT02579928|Analgesics|analgesics|mesh-ancestor
154826617|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
154826618|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826619|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826620|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154826621|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154826622|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
154826623|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
154826624|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826625|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154826626|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154826627|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826628|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826629|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154826630|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154826631|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154826632|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154826633|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826634|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
154826635|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
154826636|NCT00183677|Escitalopram|escitalopram|mesh-list
154826637|NCT00183677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154826638|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154826639|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154826640|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826641|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826642|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
154826643|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826644|NCT00186017|Olanzapine|olanzapine|mesh-list
154826645|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
154826646|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
154826647|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826648|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826649|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826650|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154826651|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154826652|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826653|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826654|NCT00186017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154826655|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154826656|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154826657|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826658|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826659|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
154826660|NCT00041119|Paclitaxel|paclitaxel|mesh-list
154826661|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
154826662|NCT00041119|Doxorubicin|doxorubicin|mesh-list
154826663|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154826664|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154826665|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826666|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
154826667|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
154826668|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
154826669|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826670|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154826671|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
154826672|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826673|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826674|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154826675|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
154826676|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154826677|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154826678|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154826679|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154826680|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826681|NCT00186875|Cytarabine|cytarabine|mesh-list
154826682|NCT00186875|Dexamethasone|dexamethasone|mesh-list
154826683|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
154826684|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
154826685|NCT00186875|Methotrexate|methotrexate|mesh-list
154826686|NCT00186875|Etoposide|etoposide|mesh-list
154826687|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
154826688|NCT00186875|Vincristine|vincristine|mesh-list
154826689|NCT00186875|Asparaginase|asparaginase|mesh-list
154826690|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
154826691|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
154826692|NCT00186875|Vinblastine|vinblastine|mesh-list
154826693|NCT00186875|Pegaspargase|pegaspargase|mesh-list
154826694|NCT00186875|Teniposide|teniposide|mesh-list
154826695|NCT00186875|BB 1101|bb 1101|mesh-list
154826696|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154826697|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
154826698|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826699|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826700|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154826701|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
154826702|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826703|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826704|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154826705|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154826707|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
154826708|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826709|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826710|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
154826711|NCT00186875|Hormones|hormones|mesh-ancestor
154826712|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826713|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154826714|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
154826715|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826716|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154826717|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
154826718|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154826719|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154826720|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
154826721|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154826722|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154826723|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154826724|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154826725|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154826726|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154826727|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
154826728|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826729|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
154826730|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
154826731|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
154826732|NCT00186875|Analgesics|analgesics|mesh-ancestor
154826733|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
154826734|NCT00551460|Methotrexate|methotrexate|mesh-list
154826735|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
154826736|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
154826737|NCT00551460|Tretinoin|tretinoin|mesh-list
154826738|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
154826739|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154826740|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
154826741|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154826742|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826743|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154826744|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
154826745|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826746|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826747|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
154826748|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826749|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154826750|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154826751|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
154826752|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826753|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154826754|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
154826755|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154826756|NCT00551460|Immunotoxins|immunotoxins|mesh-ancestor
154826757|NCT00551460|Immunoconjugates|immunoconjugates|mesh-ancestor
154826758|NCT04751227|Modafinil|modafinil|mesh-list
154826759|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154826760|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826761|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154826762|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154826763|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154826764|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826765|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
154826766|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154826767|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
154826768|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826769|NCT02579772|Expectorants|expectorants|mesh-ancestor
154578704|NCT02324491|CKD732|ckd732|mesh-list
154826770|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
154826771|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154826772|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
154826773|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826774|NCT02579772|Protective Agents|protective agents|mesh-ancestor
154826775|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826776|NCT02579772|Antidotes|antidotes|mesh-ancestor
154826777|NCT05535036|Dexamethasone|dexamethasone|mesh-list
154826778|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154826779|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
154826780|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
154826781|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826782|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826783|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826784|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
154826785|NCT05535036|Hormones|hormones|mesh-ancestor
154826786|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826787|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154826788|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826789|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154826790|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154826791|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154826792|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826793|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826794|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826795|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154826796|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154826797|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154826798|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
154826799|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826800|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826801|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154006229|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154826802|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154826803|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
154826804|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154826805|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154826806|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
154826807|NCT02989701|Plerixafor|plerixafor|mesh-list
154826808|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154826809|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154826810|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
154826811|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826812|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
154826813|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154826814|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
154826815|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826816|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826817|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154826818|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
154826819|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826820|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826821|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154826822|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
154826823|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
154826824|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154826825|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826826|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826827|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154826828|NCT04953156|Analgesics|analgesics|mesh-ancestor
154826829|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
154826830|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826831|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154826832|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154826833|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154826834|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
154826835|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826836|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826837|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
154826838|NCT01761747|Ponatinib|ponatinib|mesh-list
154826839|NCT01761747|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154826840|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154826841|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826842|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826843|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826844|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154826845|NCT00045487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154826846|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154826847|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826848|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826849|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826850|NCT00278863|Capecitabine|capecitabine|mesh-list
154826851|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154826852|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
154826853|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826854|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826855|NCT01762059|Pancrelipase|pancrelipase|mesh-list
154826856|NCT01762059|Pancreatin|pancreatin|mesh-list
154826857|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826858|NCT01808547|Bromfenac|bromfenac|mesh-list
154826859|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154826860|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154826861|NCT01808547|Analgesics|analgesics|mesh-ancestor
154826862|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
154826863|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826864|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826865|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154826866|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826867|NCT00187655|Cefotaxime|cefotaxime|mesh-list
154826868|NCT00187655|Cefoxitin|cefoxitin|mesh-list
154826869|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154826870|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826871|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154826872|NCT02991651|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154826873|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154826874|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826875|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826876|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826877|NCT02579616|Lenvatinib|lenvatinib|mesh-list
154826878|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826879|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154826880|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826881|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826882|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154826883|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154826884|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154826885|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154826886|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826887|NCT01790893|Aflibercept|aflibercept|mesh-list
154826888|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154826889|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154826890|NCT01790893|Growth Substances|growth substances|mesh-ancestor
154826891|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826892|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
154826893|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826894|NCT02256111|Androgens|androgens|mesh-list
154826895|NCT02256111|Hormones|hormones|mesh-ancestor
154826896|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826897|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826898|NCT01790971|Morphine|morphine|mesh-list
154826899|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154826900|NCT01790971|Narcotics|narcotics|mesh-ancestor
154826901|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826902|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826903|NCT01790971|Analgesics|analgesics|mesh-ancestor
154826904|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
154826905|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154826906|NCT00189137|Gemcitabine|gemcitabine|mesh-list
154826907|NCT00189137|Docetaxel|docetaxel|mesh-list
154826908|NCT00189137|Doxorubicin|doxorubicin|mesh-list
154826909|NCT00189137|Ifosfamide|ifosfamide|mesh-list
154826910|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154826911|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
154826912|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826913|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826914|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
154826915|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
154826916|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
154826917|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154558120|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826918|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154826920|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826921|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154826922|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
154826923|NCT02099461|Denosumab|denosumab|mesh-list
154826924|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154826925|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826926|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154826927|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154826928|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826929|NCT02256189|Incretins|incretins|mesh-ancestor
154826930|NCT02256189|Hormones|hormones|mesh-ancestor
154826931|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826932|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154826933|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
154826934|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826935|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826936|NCT00193037|Docetaxel|docetaxel|mesh-list
154826937|NCT00193037|Doxorubicin|doxorubicin|mesh-list
154826938|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154826939|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826940|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
154826941|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
154826942|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
154826943|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826944|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154826945|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154826946|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154826947|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826948|NCT02100007|Topotecan|topotecan|mesh-list
154826949|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154826950|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154826951|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826952|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826953|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154826954|NCT05392764|Empagliflozin|empagliflozin|mesh-list
154826955|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154826956|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826957|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154826958|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826959|NCT01809639|Progesterone|progesterone|mesh-list
154826960|NCT01809639|Progestins|progestins|mesh-ancestor
154826961|NCT01809639|Hormones|hormones|mesh-ancestor
154826962|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154826963|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826964|NCT01763931|Digoxin|digoxin|mesh-list
154826965|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154826966|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154826967|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826968|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826969|NCT01763931|Protective Agents|protective agents|mesh-ancestor
154826970|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826971|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154826972|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826973|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826974|NCT02783859|Amoxicillin|amoxicillin|mesh-list
154826975|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
154826976|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
154826977|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154826978|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154826979|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154826980|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154826981|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826982|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154826983|NCT01765803|Thioridazine|thioridazine|mesh-list
154826984|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154826985|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154826986|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154826987|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154826988|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154826989|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154826990|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
154826991|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154826992|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154826993|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
154826994|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154826995|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
154826996|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006392|NCT00891163|Lidocaine|lidocaine|mesh-list
154826997|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154826998|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154826999|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
154827000|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827001|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827002|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154827003|NCT01811355|Mexiletine|mexiletine|mesh-list
154827004|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154827005|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154827006|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154827007|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154827008|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827009|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
154827010|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154827011|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154827012|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154827013|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827014|NCT01767285|Etonogestrel|etonogestrel|mesh-list
154827015|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154827016|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
154827017|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154827018|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827019|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154827020|NCT01465802|Doxycycline|doxycycline|mesh-list
154827021|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
154827022|NCT01465802|Dacomitinib|dacomitinib|mesh-list
154827023|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154827024|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827025|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
154827026|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154827027|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154827028|NCT01465802|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154827029|NCT01465802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154827030|NCT01465802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827031|NCT01465802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827032|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827033|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
154827034|NCT01465802|Hormones|hormones|mesh-ancestor
154827035|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827036|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827037|NCT01813149|Clonidine|clonidine|mesh-list
154827038|NCT01813149|Phenylephrine|phenylephrine|mesh-list
154827039|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
154827040|NCT01813149|Anesthetics|anesthetics|mesh-list
154827041|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
154827042|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827043|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827044|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
154827045|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827046|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154827047|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
154827048|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
154827049|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
154827050|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154827051|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
154827052|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
154827053|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154827054|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154827055|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154827056|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
154827057|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827058|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827059|NCT01813149|Protective Agents|protective agents|mesh-ancestor
154827060|NCT01813149|Analgesics|analgesics|mesh-ancestor
154827061|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154827062|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
154827063|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154827064|NCT00137969|Acetaminophen|acetaminophen|mesh-list
154827065|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
154827066|NCT00137969|Promethazine|promethazine|mesh-list
154827067|NCT00137969|Prednisone|prednisone|mesh-list
154827068|NCT00137969|Rituximab|rituximab|mesh-list
154827069|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827070|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827071|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
154827072|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827073|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827074|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827075|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
154827076|NCT00137969|Hormones|hormones|mesh-ancestor
154827077|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827078|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154827079|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154827080|NCT00137969|Analgesics|analgesics|mesh-ancestor
154827081|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
154827082|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827083|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
154827084|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154827085|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154827086|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827087|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
154827088|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
154827089|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
154827090|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
154827091|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154827092|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154827093|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
154827094|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
154827095|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827096|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827097|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154827098|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
154827099|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
154827100|NCT01437878|Iloprost|iloprost|mesh-list
154827101|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154827102|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
154827103|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
154827104|NCT04767308|Fludarabine|fludarabine|mesh-list
154827105|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154827106|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
154827107|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827108|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827109|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154827110|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
154827111|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827112|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827113|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154827114|NCT00138125|Trastuzumab|trastuzumab|mesh-list
154827115|NCT00138125|Fulvestrant|fulvestrant|mesh-list
154827116|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827117|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827118|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154827119|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154827120|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154827121|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
154827122|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827123|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827124|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154827125|NCT01815333|Hematinics|hematinics|mesh-ancestor
154827126|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154827127|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154827128|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
154827129|NCT01465178|Vitamin D|vitamin d|mesh-list
154827130|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154827131|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827132|NCT01465178|Vitamins|vitamins|mesh-ancestor
154827133|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
154827134|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154827135|NCT00138203|Vorinostat|vorinostat|mesh-list
154827136|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827137|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154827138|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827139|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827140|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154827141|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154827142|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154827143|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827144|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827145|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154827146|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154827147|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827148|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
154827149|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827150|NCT00194129|Valproic Acid|valproic acid|mesh-list
154827151|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
154827152|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
154827153|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154827154|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827155|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827156|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
154827157|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154827158|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827159|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827160|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
154827161|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
154827162|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827163|NCT01817907|Trazodone|trazodone|mesh-list
154827164|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154827165|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154827166|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827167|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827168|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154827169|NCT01817907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154827170|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154827171|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154827172|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827173|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827174|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
154827175|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154827176|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
154827177|NCT01445678|Metronidazole|metronidazole|mesh-list
154827178|NCT01445678|Meropenem|meropenem|mesh-list
154827179|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827180|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154827181|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154827182|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154827183|NCT01818063|Paclitaxel|paclitaxel|mesh-list
154827184|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
154827185|NCT01818063|Carboplatin|carboplatin|mesh-list
154827186|NCT01818063|Doxorubicin|doxorubicin|mesh-list
154827187|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154827188|NCT01818063|Veliparib|veliparib|mesh-list
154827189|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154827190|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827191|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
154827192|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
154827193|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
154827194|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827195|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154827196|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
154827197|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827198|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827199|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154827200|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
154827201|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154827202|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154827203|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154827204|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154827205|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827206|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154827207|NCT01465022|Estrogens|estrogens|mesh-list
154827208|NCT01465022|Progestins|progestins|mesh-list
154827209|NCT01465022|Hormones|hormones|mesh-ancestor
154827210|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827211|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827212|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154827213|NCT02258217|Hormones|hormones|mesh-ancestor
154827214|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827215|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579154|NCT02262611|Telmisartan|telmisartan|mesh-list
154827216|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154827217|NCT01464788|Argatroban|argatroban|mesh-list
154827218|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154827219|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154827220|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827221|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
154827222|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154827223|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
154827224|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827225|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
154827226|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154827227|NCT01444898|Exenatide|exenatide|mesh-list
154827228|NCT01444898|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154827229|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154827230|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827231|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154827232|NCT01444898|Incretins|incretins|mesh-ancestor
154827233|NCT01444898|Hormones|hormones|mesh-ancestor
154827234|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827235|NCT00201773|Celecoxib|celecoxib|mesh-list
154827236|NCT00201773|Exemestane|exemestane|mesh-list
154827237|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154827238|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154827239|NCT00201773|Analgesics|analgesics|mesh-ancestor
154827240|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
154006645|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154827241|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827242|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827243|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827244|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827245|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154827246|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154827247|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827248|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827249|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827250|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154827251|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154827252|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154827253|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
154827254|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827255|NCT00256217|Anastrozole|anastrozole|mesh-list
154827256|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154827257|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827258|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154827259|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154827260|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827261|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827262|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154827263|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
154827264|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827265|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827266|NCT00256451|Ethanol|ethanol|mesh-list
154827267|NCT00256451|Naltrexone|naltrexone|mesh-list
154827268|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154827269|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827270|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827271|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827272|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154827273|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154827274|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
154827275|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827276|NCT03582618|Sorafenib|sorafenib|mesh-list
154827277|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827278|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154827279|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827280|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827281|NCT00257309|Tenecteplase|tenecteplase|mesh-list
154827282|NCT00257309|Clopidogrel|clopidogrel|mesh-list
154827283|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154827284|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154827285|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154827286|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154827287|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
154827288|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558121|NCT03177837|Acetazolamide|acetazolamide|mesh-list
154827289|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827290|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827291|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154827292|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154827293|NCT01444742|Cytarabine|cytarabine|mesh-list
154827294|NCT01444742|Clofarabine|clofarabine|mesh-list
154827295|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154827296|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
154827297|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827298|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827299|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
154827300|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827301|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154827302|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
154827303|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827304|NCT01770483|Interferons|interferons|mesh-list
154827305|NCT01770483|Ribavirin|ribavirin|mesh-list
154827306|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
154827307|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
154827308|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827309|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
154827310|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827311|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
154827312|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827313|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
154827314|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827315|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154827316|NCT00257933|Prednisolone|prednisolone|mesh-list
154827317|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154827318|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
154827319|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154827320|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
154827321|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154827322|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
154827323|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827324|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
154827325|NCT00257933|Hormones|hormones|mesh-ancestor
154827326|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827327|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827328|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154827329|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827330|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
154827331|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
154827332|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827333|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154827334|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154827335|NCT00257933|Protective Agents|protective agents|mesh-ancestor
154827336|NCT01734525|Anidulafungin|anidulafungin|mesh-list
154827337|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
154827338|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827339|NCT01819935|Vancomycin|vancomycin|mesh-list
154827340|NCT01819935|Linezolid|linezolid|mesh-list
154827341|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154827342|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827343|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154827344|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827345|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827346|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154827347|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154827348|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827349|NCT00264641|Insulin|insulin|mesh-list
154827350|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154827351|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154827352|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827353|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
154827354|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827355|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
154827356|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154827357|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154827358|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827359|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
154827360|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827361|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827362|NCT00266279|Capecitabine|capecitabine|mesh-list
154827363|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
154827364|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154827365|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
154827366|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827367|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827368|NCT01736085|Nicotine|nicotine|mesh-list
154827369|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154827370|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
154827371|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827372|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827373|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154827374|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154827375|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
154827376|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827377|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827378|NCT00210353|Rituximab|rituximab|mesh-list
154827379|NCT00210353|Chlorambucil|chlorambucil|mesh-list
154827380|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827381|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827382|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
154827383|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827384|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827385|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154827386|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
154827387|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827388|NCT00267059|Lenalidomide|lenalidomide|mesh-list
154827389|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
154827390|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827391|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154827392|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154827393|NCT00267059|Growth Substances|growth substances|mesh-ancestor
154827394|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
154827395|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827396|NCT00213239|Remifentanil|remifentanil|mesh-list
154827397|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154827398|NCT00213239|Narcotics|narcotics|mesh-ancestor
154827399|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827400|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827401|NCT00213239|Analgesics|analgesics|mesh-ancestor
154827402|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
154827403|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827404|NCT01444430|Budesonide|budesonide|mesh-list
154827405|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154827406|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006803|NCT02760420|Amoxicillin|amoxicillin|mesh-list
154827407|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154827408|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
154827409|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827410|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827411|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154827412|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
154827413|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
154827414|NCT01444430|Hormones|hormones|mesh-ancestor
154827415|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827416|NCT01774149|Diazepam|diazepam|mesh-list
154827417|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154827418|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
154827419|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
154827420|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
154827421|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827422|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827423|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154827424|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154827425|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827426|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154827427|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154827428|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154827429|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154827430|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154827431|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154827432|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
154827433|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
154827434|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
154827435|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
154827436|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827437|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827438|NCT01898507|Nicotine|nicotine|mesh-list
154827439|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154827440|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
154827441|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827442|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827443|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154827444|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154827445|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
154827446|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827447|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827448|NCT00267293|Acetaminophen|acetaminophen|mesh-list
154827449|NCT00267293|Ibuprofen|ibuprofen|mesh-list
154827450|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154827451|NCT00267293|Analgesics|analgesics|mesh-ancestor
154827452|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
154827453|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827454|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827455|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
154827456|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154827457|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827458|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827459|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154827460|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827461|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827462|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154827463|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
154827464|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154827465|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154827466|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827467|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154827468|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154827469|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154827470|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827471|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
154827472|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827473|NCT02579382|Vesatolimod|vesatolimod|mesh-list
154827474|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
154827475|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827476|NCT01774851|Paclitaxel|paclitaxel|mesh-list
154827477|NCT01774851|Trastuzumab|trastuzumab|mesh-list
154827478|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154827479|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827480|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
154827481|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
154827482|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
154827483|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827484|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827485|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
154827486|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
154827487|NCT02990013|Povidone|povidone|mesh-list
154827488|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154827489|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827490|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
154827491|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
154827492|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
154827493|NCT03440112|Clarithromycin|clarithromycin|mesh-list
154827494|NCT03440112|Flumazenil|flumazenil|mesh-list
154827495|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154827496|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827497|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154827498|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827499|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827500|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154827501|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154827502|NCT03440112|Antidotes|antidotes|mesh-ancestor
154827503|NCT03440112|Protective Agents|protective agents|mesh-ancestor
154827504|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827505|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
154827506|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
154006925|NCT02762838|Vitamins|vitamins|mesh-ancestor
154827507|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827508|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154827509|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
154827510|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154827511|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154827512|NCT01775865|Analgesics|analgesics|mesh-ancestor
154827513|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
154827514|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827515|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827516|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827517|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827518|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154827519|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827520|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827521|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154827522|NCT01419236|Testosterone|testosterone|mesh-list
154827523|NCT01419236|Androgens|androgens|mesh-ancestor
154827524|NCT01419236|Hormones|hormones|mesh-ancestor
154827525|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827526|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827527|NCT03323658|Bexarotene|bexarotene|mesh-list
154827528|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827529|NCT01443026|Lycopene|lycopene|mesh-list
154827530|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827531|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
154827532|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827533|NCT01443026|Protective Agents|protective agents|mesh-ancestor
154827534|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827535|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154827536|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154827537|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827538|NCT01879371|Ibuprofen|ibuprofen|mesh-list
154827539|NCT01879371|Caffeine|caffeine|mesh-list
154827540|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154827541|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154827542|NCT01879371|Analgesics|analgesics|mesh-ancestor
154827543|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
154827544|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827545|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827546|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827547|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827548|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154827549|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827550|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827551|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154827552|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154827553|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154827554|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154827555|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
154827556|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827557|NCT01733745|Vitamins|vitamins|mesh-list
154827558|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154827559|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
154827560|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827561|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154827562|NCT03276468|Atezolizumab|atezolizumab|mesh-list
154827563|NCT03276468|Venetoclax|venetoclax|mesh-list
154827564|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
154827565|NCT03276468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154006973|NCT00797823|Insulin|insulin|mesh-list
154827566|NCT03276468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827567|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827568|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827569|NCT01442714|Lenalidomide|lenalidomide|mesh-list
154827570|NCT01442714|Azacitidine|azacitidine|mesh-list
154827571|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
154827572|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827573|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154827574|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154827575|NCT01442714|Growth Substances|growth substances|mesh-ancestor
154827576|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
154827577|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827578|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154827579|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
154827580|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827581|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827582|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
154827583|NCT05328921|Histamine Antagonists|histamine antagonists|mesh-list
154827584|NCT05328921|Histamine Agents|histamine agents|mesh-ancestor
154827585|NCT05328921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827586|NCT05328921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827587|NCT05328921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827588|NCT05532852|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154827589|NCT05532852|Antiviral Agents|antiviral agents|mesh-ancestor
154827591|NCT05501574|Tacrolimus|tacrolimus|mesh-list
154827592|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154827593|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
154827594|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827595|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154827596|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827597|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827598|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154827599|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154827600|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154827601|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827602|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827603|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154827604|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154827605|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154827606|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154827607|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
154827608|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827609|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827610|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154827611|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154827612|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
154827613|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154827614|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154827615|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
154827616|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
154827617|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154827618|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827619|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
154827620|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154827621|NCT01828515|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154827622|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154827623|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154827624|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827625|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827626|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
154827627|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827628|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154827629|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154827630|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
154827631|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154827632|NCT01828593|Antibodies|antibodies|mesh-list
154827633|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
154827634|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827635|NCT01781169|Vitamin D|vitamin d|mesh-list
154827636|NCT01781169|Vitamins|vitamins|mesh-ancestor
154827637|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
154827638|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827639|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154827640|NCT00216125|Docetaxel|docetaxel|mesh-list
154827641|NCT00216125|Etoposide|etoposide|mesh-list
154827642|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827643|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
154827644|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154827645|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154827646|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827647|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154827648|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154827649|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154827650|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827651|NCT01781403|Capecitabine|capecitabine|mesh-list
154827652|NCT01781403|Temozolomide|temozolomide|mesh-list
154827653|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154827654|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
154827655|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827656|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827657|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154827658|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
154827659|NCT00218387|Modafinil|modafinil|mesh-list
154827660|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154827661|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827662|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154827663|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154827664|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154827665|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827667|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
154827668|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827669|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827670|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827671|NCT01898585|Vemurafenib|vemurafenib|mesh-list
154827672|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827673|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154827674|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827675|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827676|NCT00220961|Pioglitazone|pioglitazone|mesh-list
154827677|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154827678|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827679|NCT00222131|Esomeprazole|esomeprazole|mesh-list
154827680|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154827681|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154827682|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154827683|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827684|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827685|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154827686|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154827687|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154827688|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154827689|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
154827690|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827691|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827692|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154827693|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
154827694|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827695|NCT01782963|Dexamethasone|dexamethasone|mesh-list
154827696|NCT01782963|Lenalidomide|lenalidomide|mesh-list
154827697|NCT01782963|Bortezomib|bortezomib|mesh-list
154827698|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827699|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
154827700|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
154827701|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827702|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827703|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154827704|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
154827705|NCT01782963|Hormones|hormones|mesh-ancestor
154827706|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827707|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154827708|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827709|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
154827710|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154827711|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154827712|NCT01782963|Growth Substances|growth substances|mesh-ancestor
154827713|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
154827714|NCT01829217|Sunitinib|sunitinib|mesh-list
154827715|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827716|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154827717|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154827718|NCT01829217|Growth Substances|growth substances|mesh-ancestor
154827719|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827720|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
154827721|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154827722|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827723|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827724|NCT05327751|Celecoxib|celecoxib|mesh-list
154827725|NCT05327751|Capecitabine|capecitabine|mesh-list
154827726|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154827727|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
154827728|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827729|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827730|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154827731|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154827732|NCT05327751|Analgesics|analgesics|mesh-ancestor
154827733|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
154827734|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827735|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827736|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827737|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827738|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154827739|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154827740|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827741|NCT02096861|Infliximab|infliximab|mesh-list
154827742|NCT02096861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154827743|NCT02096861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827744|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
154827745|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154827746|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827747|NCT01829919|Paroxetine|paroxetine|mesh-list
154827748|NCT01829919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154827749|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154827750|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154827751|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827752|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827753|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
154827754|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827755|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154827756|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
154827757|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154827758|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154827759|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154827760|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827761|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
154827762|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154827763|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154827764|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
154827765|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
154827766|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827767|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827768|NCT00274781|Immunotoxins|immunotoxins|mesh-ancestor
154827769|NCT00274781|Immunoconjugates|immunoconjugates|mesh-ancestor
154827770|NCT00274781|Immunologic Factors|immunologic factors|mesh-ancestor
154827771|NCT00274781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827772|NCT00226577|Gemcitabine|gemcitabine|mesh-list
154827773|NCT00226577|Pemetrexed|pemetrexed|mesh-list
154827774|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154827775|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
154827776|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827777|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827778|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827779|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154827780|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154827781|NCT01830699|Triamcinolone|triamcinolone|mesh-list
154827782|NCT01830699|Rilonacept|rilonacept|mesh-list
154827783|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827784|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
154827785|NCT01830699|Hormones|hormones|mesh-ancestor
154827786|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827787|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827788|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
154827789|NCT00280241|Rituximab|rituximab|mesh-list
154827790|NCT00280241|Fludarabine|fludarabine|mesh-list
154827791|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154827792|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
154827793|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827794|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827795|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154827796|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
154827797|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827798|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827799|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154827800|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827801|NCT01899755|Adalimumab|adalimumab|mesh-list
154827802|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154827803|NCT01899755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154827804|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827805|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827806|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154827807|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154827808|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827809|NCT00229619|Rituximab|rituximab|mesh-list
154827810|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827811|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827812|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
154827813|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827814|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154827815|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154827817|NCT00281021|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154827818|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154827819|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827820|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827821|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827822|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154827823|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154827824|NCT00281021|Protective Agents|protective agents|mesh-ancestor
154827825|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827826|NCT01786161|Vancomycin|vancomycin|mesh-list
154827827|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154827828|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827829|NCT01786239|Risperidone|risperidone|mesh-list
154827830|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154827831|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
154827832|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827833|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827834|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827835|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154827836|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154827837|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154827838|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154827839|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154827840|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
154827841|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
154827842|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
154827843|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827844|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827845|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154827846|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
154827847|NCT01833741|Bimatoprost|bimatoprost|mesh-list
154827848|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154827849|NCT02261727|Prednisone|prednisone|mesh-list
154827850|NCT02261727|Cortisone|cortisone|mesh-list
154827851|NCT02261727|Theophylline|theophylline|mesh-list
154827852|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827853|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
154827854|NCT02261727|Hormones|hormones|mesh-ancestor
154827855|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827856|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827857|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154827858|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827859|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154827860|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
154827861|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827862|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154827863|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
154827864|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154827865|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827866|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827867|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
154827868|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154827869|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154827870|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
154827871|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154827872|NCT02261805|Doxorubicin|doxorubicin|mesh-list
154827873|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154827874|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827875|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154827876|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154827877|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827878|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827879|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154827880|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154827881|NCT05300841|Estradiol|estradiol|mesh-list
154827882|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154827883|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
154827884|NCT05300841|Estrogens|estrogens|mesh-ancestor
154827885|NCT05300841|Hormones|hormones|mesh-ancestor
154827886|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827887|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827888|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154827889|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
154827890|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154827891|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154827892|NCT05300841|Progestins|progestins|mesh-ancestor
154827893|NCT00232505|Carboplatin|carboplatin|mesh-list
154827894|NCT00232505|Cetuximab|cetuximab|mesh-list
154827895|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827896|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827897|NCT00232583|Metformin|metformin|mesh-list
154827898|NCT00232583|Pioglitazone|pioglitazone|mesh-list
154827899|NCT00232583|Glyburide|glyburide|mesh-list
154827900|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154827901|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827902|NCT00232739|Sirolimus|sirolimus|mesh-list
154827903|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154827904|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827905|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154827906|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827907|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
154827908|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154827909|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
154827910|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827911|NCT01789905|Tigecycline|tigecycline|mesh-list
154827912|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154827913|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827914|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154827915|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827916|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827917|NCT01790685|Dexamethasone|dexamethasone|mesh-list
154827918|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827919|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
154827920|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
154827921|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827922|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827923|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154827924|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
154827925|NCT01790685|Hormones|hormones|mesh-ancestor
154827926|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827927|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154827928|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827929|NCT01838655|Nitisinone|nitisinone|mesh-list
154827930|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827931|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827932|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154827933|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
154827934|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154827935|NCT00282971|Insulin|insulin|mesh-list
154827936|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154827937|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827938|NCT01791465|Exenatide|exenatide|mesh-list
154827939|NCT01791465|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154827940|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154827941|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827942|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154827943|NCT01791465|Incretins|incretins|mesh-ancestor
154827944|NCT01791465|Hormones|hormones|mesh-ancestor
154827945|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827946|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154827947|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154827948|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827949|NCT00285467|Vitamin D|vitamin d|mesh-list
154827950|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
154827951|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
154827952|NCT00285467|Vitamins|vitamins|mesh-ancestor
154827953|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
154827954|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827955|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154827956|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154827957|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154827958|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
154827959|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827960|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
154827961|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154827962|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827963|NCT01676753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154827964|NCT01676753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827965|NCT01794039|Dexamethasone|dexamethasone|mesh-list
154827966|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
154827967|NCT01794039|Lenalidomide|lenalidomide|mesh-list
154827968|NCT01794039|Pomalidomide|pomalidomide|mesh-list
154827970|NCT01794039|BB 1101|bb 1101|mesh-list
154827971|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154827972|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
154827973|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
154827974|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154827975|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154827976|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154827977|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
154827978|NCT01794039|Hormones|hormones|mesh-ancestor
154827979|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154827980|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154827981|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827982|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
154827983|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154827984|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154827985|NCT01794039|Growth Substances|growth substances|mesh-ancestor
154827986|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154827987|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
154827988|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154827989|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827990|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
154827991|NCT00281827|Thalidomide|thalidomide|mesh-list
154827992|NCT00281827|Carboplatin|carboplatin|mesh-list
154827993|NCT00281827|Gemcitabine|gemcitabine|mesh-list
154827994|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154827995|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154827996|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
154827997|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154827998|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154827999|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
154828000|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828001|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
154828002|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154828003|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828004|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154828005|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154828006|NCT00281827|Growth Substances|growth substances|mesh-ancestor
154828007|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
154828008|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
154828009|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154828010|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828011|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828012|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828013|NCT01898819|Analgesics|analgesics|mesh-ancestor
154828014|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
154828015|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828016|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154828017|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154828018|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154828019|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
154828020|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828021|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828022|NCT01794741|Fluticasone|fluticasone|mesh-list
154828023|NCT01794741|Xhance|xhance|mesh-list
154828024|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828025|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154828026|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
154828027|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828028|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828029|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154828030|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
154828031|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
154828032|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154828033|NCT04446871|Methylene Blue|methylene blue|mesh-list
154828034|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828035|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579995|NCT05414084|Phenol|phenol|mesh-list
154828036|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
154828037|NCT04085419|Denosumab|denosumab|mesh-list
154828038|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154828039|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828040|NCT02989623|Copper|copper|mesh-list
154828041|NCT02989623|Trace Elements|trace elements|mesh-ancestor
154828042|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
154828043|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828044|NCT00052429|Fluorouracil|fluorouracil|mesh-list
154828045|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828046|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
154828047|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828048|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154828049|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828050|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
154828051|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828052|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
154828053|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154828054|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828055|NCT03972397|Bupivacaine|bupivacaine|mesh-list
154828056|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
154828057|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
154828058|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828059|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828060|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
154828061|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828062|NCT00287053|Valproic Acid|valproic acid|mesh-list
154828063|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
154828064|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828065|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828066|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
154828067|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828068|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828069|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
154828070|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154828071|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828072|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154828073|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154828074|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154828075|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154828076|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154828077|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828078|NCT01435460|Analgesics|analgesics|mesh-ancestor
154828079|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
154828080|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828081|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828082|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828083|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828084|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154828085|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154828086|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
154828087|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
154828088|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828089|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828090|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
154828091|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154828092|NCT00236951|Hematinics|hematinics|mesh-ancestor
154828093|NCT00287287|Lenalidomide|lenalidomide|mesh-list
154828094|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
154828095|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828096|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154828097|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154828098|NCT00287287|Growth Substances|growth substances|mesh-ancestor
154828099|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
154828100|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828101|NCT04871061|Fentanyl|fentanyl|mesh-list
154828102|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154828103|NCT04871061|Narcotics|narcotics|mesh-ancestor
154828104|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828105|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828106|NCT04871061|Analgesics|analgesics|mesh-ancestor
154828107|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
154828108|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828109|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154828110|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154828111|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
154828112|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
154558122|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
154828114|NCT00287989|Carboplatin|carboplatin|mesh-list
154828115|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154828116|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154828117|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828118|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
154828119|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
154828120|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
154828121|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828122|NCT00287989|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154828123|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154828124|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828125|NCT00288067|Rituximab|rituximab|mesh-list
154828126|NCT00288067|Fenretinide|fenretinide|mesh-list
154828127|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154828128|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828129|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
154828130|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828131|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828132|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154828133|NCT00288067|Protective Agents|protective agents|mesh-ancestor
154828134|NCT00285779|Etanercept|etanercept|mesh-list
154828135|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154828136|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828137|NCT00285779|Analgesics|analgesics|mesh-ancestor
154828138|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
154828139|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828140|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828141|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828142|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828143|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828144|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828145|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
154828146|NCT01435382|Bococizumab|bococizumab|mesh-list
154828147|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154828148|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154828149|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
154828150|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828151|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154828152|NCT01801449|Rilonacept|rilonacept|mesh-list
154828153|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828154|NCT00286325|Rituximab|rituximab|mesh-list
154828155|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154828156|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828157|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
154828158|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828159|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828160|NCT00238355|Voriconazole|voriconazole|mesh-list
154828161|NCT00238355|Caspofungin|caspofungin|mesh-list
154828162|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
154828163|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828164|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154828165|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154828166|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828167|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828168|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154828169|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
154828170|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828171|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828172|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154828173|NCT01791439|Lidocaine|lidocaine|mesh-list
154828174|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
154828175|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
154828176|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828177|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828178|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
154828179|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828180|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154828181|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154828182|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154828183|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154828184|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828185|NCT00290329|Vaccines|vaccines|mesh-list
154828186|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
154828187|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828189|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154828190|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
154828191|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828192|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828193|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154828194|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154828195|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154828196|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154828197|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828198|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
154828199|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828200|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828201|NCT00287339|Esomeprazole|esomeprazole|mesh-list
154828202|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154828203|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828204|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154828205|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828206|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828207|NCT00291655|Levetiracetam|levetiracetam|mesh-list
154828208|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
154828209|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
154828210|NCT01846455|Promethazine|promethazine|mesh-list
154828211|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
154828212|NCT01846455|Buprenorphine|buprenorphine|mesh-list
154828213|NCT01846455|Naloxone|naloxone|mesh-list
154828214|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154828215|NCT01846455|Narcotics|narcotics|mesh-ancestor
154828216|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828217|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828218|NCT01846455|Analgesics|analgesics|mesh-ancestor
154828219|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
154828220|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828221|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154828222|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
154828223|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
154828224|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154828225|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
154828226|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
154828227|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828228|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828229|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154828230|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154828231|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154828232|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
154828233|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
154828234|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
154828235|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
154828236|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828237|NCT03366415|Cisplatin|cisplatin|mesh-list
154828238|NCT03366415|Gemcitabine|gemcitabine|mesh-list
154828239|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828240|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154828241|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
154828242|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828243|NCT00292591|Vitamin D|vitamin d|mesh-list
154828244|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
154828245|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
154828246|NCT00292591|Vitamins|vitamins|mesh-list
154828247|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
154828248|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828249|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154828250|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154828251|NCT01847001|Paclitaxel|paclitaxel|mesh-list
154828252|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154828253|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
154828254|NCT01847001|Doxorubicin|doxorubicin|mesh-list
154828255|NCT01847001|Trastuzumab|trastuzumab|mesh-list
154828256|NCT01847001|Pertuzumab|pertuzumab|mesh-list
154828257|NCT01847001|Propranolol|propranolol|mesh-list
154828258|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154828259|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828260|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
154828261|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
154828262|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
154828263|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828264|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828265|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
154828266|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828267|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828268|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154828269|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
154828270|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154828271|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154828272|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154828273|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154828274|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828275|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154828276|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154828277|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154828278|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
154828279|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828280|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154828281|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154828282|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
154828283|NCT01847469|Zonisamide|zonisamide|mesh-list
154828284|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
154828285|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154828286|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154828287|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828288|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154828289|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828290|NCT01804101|Cytarabine|cytarabine|mesh-list
154828291|NCT01804101|Daunorubicin|daunorubicin|mesh-list
154828292|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154828293|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
154828294|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828295|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828296|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
154828297|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828298|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828299|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
154828300|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828301|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154828302|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154828303|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154828304|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828305|NCT00287729|Pirfenidone|pirfenidone|mesh-list
154828306|NCT00287729|Analgesics|analgesics|mesh-ancestor
154828307|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
154828308|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828309|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828310|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154828311|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828312|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828313|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828314|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828315|NCT01433978|Maleic acid|maleic acid|mesh-list
154828316|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007718|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154828317|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828318|NCT00289211|Complement C1s|complement c1s|mesh-list
154828319|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154828320|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154828321|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
154828322|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828323|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154828324|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828325|NCT01619111|Lapatinib|lapatinib|mesh-list
154828326|NCT01619111|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154828327|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154828328|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828329|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828330|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828331|NCT01727193|Azathioprine|azathioprine|mesh-list
154828332|NCT01727193|Leflunomide|leflunomide|mesh-list
154828333|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
154828334|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828335|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154828336|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828337|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828339|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828340|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828341|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828342|NCT00181701|Paclitaxel|paclitaxel|mesh-list
154828343|NCT00181701|Carboplatin|carboplatin|mesh-list
154828344|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154828345|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828346|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
154828347|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
154828348|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
154828349|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828350|NCT01849419|Oxytocin|oxytocin|mesh-list
154828351|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
154828352|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154828353|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828354|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
154828355|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154828356|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828357|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154828358|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154828359|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154828360|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154828361|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828362|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828363|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828364|NCT01852383|Analgesics|analgesics|mesh-ancestor
154828365|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
154828366|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828367|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
154828368|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154828369|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
154828370|NCT04272333|Nivolumab|nivolumab|mesh-list
154828371|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154828372|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828373|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154828374|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828375|NCT02273115|Oxytocin|oxytocin|mesh-list
154828376|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
154828377|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154828378|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828379|NCT01853085|Bimatoprost|bimatoprost|mesh-list
154828380|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154828381|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154828382|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154828383|NCT02989467|Aprepitant|aprepitant|mesh-list
154828384|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
154828385|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
154828386|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828387|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828388|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828389|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154828390|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828391|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828392|NCT01853553|Spironolactone|spironolactone|mesh-list
154828393|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154828394|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
154828395|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828396|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828397|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154828398|NCT01853553|Diuretics|diuretics|mesh-ancestor
154828399|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
154828400|NCT05748561|Methylprednisolone|methylprednisolone|mesh-list
154828401|NCT05748561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154828402|NCT05748561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154828403|NCT05748561|Prednisolone|prednisolone|mesh-list
154828404|NCT05748561|Prednisolone acetate|prednisolone acetate|mesh-list
154828405|NCT05748561|Epoetin Alfa|epoetin alfa|mesh-list
154828406|NCT05748561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154828407|NCT05748561|Prednisolone phosphate|prednisolone phosphate|mesh-list
154828408|NCT05748561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828409|NCT05748561|Antiemetics|antiemetics|mesh-ancestor
154828410|NCT05748561|Autonomic Agents|autonomic agents|mesh-ancestor
154828411|NCT05748561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828412|NCT05748561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828413|NCT05748561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828415|NCT05748561|Hormones|hormones|mesh-ancestor
154828416|NCT05748561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828417|NCT05748561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154828418|NCT05748561|Protective Agents|protective agents|mesh-ancestor
154828419|NCT05748561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154828420|NCT05748561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828421|NCT05748561|Hematinics|hematinics|mesh-ancestor
154828422|NCT00290537|Paclitaxel|paclitaxel|mesh-list
154828423|NCT00290537|Carboplatin|carboplatin|mesh-list
154828424|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154828425|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828426|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
154828427|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
154828428|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
154828429|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828430|NCT00290615|Bevacizumab|bevacizumab|mesh-list
154828431|NCT00290615|Cetuximab|cetuximab|mesh-list
154828432|NCT00290615|Capecitabine|capecitabine|mesh-list
154828433|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
154828434|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154828435|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828436|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154828437|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154828438|NCT00290615|Growth Substances|growth substances|mesh-ancestor
154828439|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828440|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
154828441|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154828442|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
154828443|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828444|NCT01854177|Aprepitant|aprepitant|mesh-list
154828445|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
154828446|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
154828447|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
154828448|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828449|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828450|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828451|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154828452|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828453|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828454|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
154828455|NCT00243191|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154828456|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154828457|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828458|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828459|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828460|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
154828461|NCT00299221|Tacrolimus|tacrolimus|mesh-list
154828462|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828463|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
154828464|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828465|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154828466|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828467|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828468|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154828469|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828470|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154828471|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
154828472|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154828473|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828474|NCT03799731|Trifluridine|trifluridine|mesh-list
154828475|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
154828476|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828477|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
154828478|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828479|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
154828480|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828481|NCT00244985|Rituximab|rituximab|mesh-list
154828482|NCT00244985|Doxorubicin|doxorubicin|mesh-list
154828483|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154828484|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154828485|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580429|NCT03199755|Lumefantrine|lumefantrine|mesh-list
154828486|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
154828487|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828488|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828489|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154828490|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154828491|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154828492|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828493|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828494|NCT01857297|Vaccines|vaccines|mesh-list
154828495|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
154828496|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828497|NCT00300391|Haloperidol|haloperidol|mesh-list
154828498|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
154828499|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
154828500|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
154828501|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828502|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828503|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828504|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154828505|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154828506|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828507|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154828508|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154828509|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
154828510|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828511|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828512|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154828513|NCT01859013|Topiramate|topiramate|mesh-list
154828514|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
154828515|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154828516|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828517|NCT00294515|Valganciclovir|valganciclovir|mesh-list
154828518|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
154828519|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828520|NCT00300469|Atorvastatin|atorvastatin|mesh-list
154828521|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154828522|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154828523|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
154828524|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828525|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154828526|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154828527|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828528|NCT01859637|Lenograstim|lenograstim|mesh-list
154828529|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154828530|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
154828531|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828532|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
154828533|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154828534|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
154828535|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828536|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828537|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154828538|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154828539|NCT02117141|Hydrocodone|hydrocodone|mesh-list
154828540|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154828541|NCT02117141|Narcotics|narcotics|mesh-ancestor
154828542|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828543|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828544|NCT02117141|Analgesics|analgesics|mesh-ancestor
154828545|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
154828546|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828547|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
154828548|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
154828549|NCT00299741|Sunitinib|sunitinib|mesh-list
154828550|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828551|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154828552|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154828553|NCT00299741|Growth Substances|growth substances|mesh-ancestor
154828554|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828555|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
154828556|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154828557|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828558|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828559|NCT00328861|Aldesleukin|aldesleukin|mesh-list
154828560|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
154580502|NCT02285062|Hormones|hormones|mesh-ancestor
154828561|NCT00328861|Fludarabine|fludarabine|mesh-list
154828562|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828563|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
154828564|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828565|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828566|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154828567|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
154828568|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828569|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828570|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154828571|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154828572|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154828573|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
154828574|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828575|NCT00248807|Enalaprilat|enalaprilat|mesh-list
154828576|NCT00248807|Enalapril|enalapril|mesh-list
154828577|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154828578|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
154828579|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828580|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828581|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154828582|NCT01860807|Ibudilast|ibudilast|mesh-list
154828583|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154828584|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
154828585|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828586|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828587|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154828588|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
154828589|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154828590|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828591|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828592|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154828593|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
154828594|NCT00330421|Sorafenib|sorafenib|mesh-list
154828595|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828596|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154828597|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828598|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828599|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
154828600|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154828601|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154828602|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828603|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
154828604|NCT04350645|Coagulants|coagulants|mesh-ancestor
154828605|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154828606|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154828607|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828608|NCT00330733|Analgesics|analgesics|mesh-ancestor
154828609|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
154828610|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828611|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828612|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828613|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828614|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
154828615|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154828616|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828617|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154828618|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154828619|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828620|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828621|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828622|NCT05185973|Micronutrients|micronutrients|mesh-list
154828623|NCT05185973|Trace Elements|trace elements|mesh-list
154828624|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828625|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
154828626|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154828627|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828628|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
154008032|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
154828629|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154828630|NCT00251225|Docetaxel|docetaxel|mesh-list
154828631|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
154828632|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828633|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
154828634|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
154828635|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
154828636|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828637|NCT00251225|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154828638|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154828639|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828640|NCT02979327|Adderall|adderall|mesh-list
154828641|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154828642|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828643|NCT05951075|Vitamins|vitamins|mesh-list
154828644|NCT05951075|Micronutrients|micronutrients|mesh-ancestor
154828645|NCT05951075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828646|NCT05951062|Antihypertensive Agents|antihypertensive agents|mesh-list
154828647|NCT05950971|Amiodarone|amiodarone|mesh-list
154828648|NCT05950971|Diltiazem|diltiazem|mesh-list
154828649|NCT05950971|Esmolol|esmolol|mesh-list
154828650|NCT05950971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154828651|NCT05950971|Vasodilator Agents|vasodilator agents|mesh-ancestor
154828652|NCT05950971|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154828653|NCT05950971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154828654|NCT05950971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828655|NCT05950971|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154828656|NCT05950971|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154828657|NCT05950971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154828658|NCT05950971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828659|NCT05950971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154828660|NCT05950971|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154828661|NCT05950971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154828662|NCT05950971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154828663|NCT05950971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154828664|NCT05950971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154828665|NCT05950971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828666|NCT05950971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154828667|NCT05950971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154828668|NCT05950971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154828669|NCT05950971|Adrenergic Agents|adrenergic agents|mesh-ancestor
154828670|NCT05950971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828671|NCT05950711|Ketamine|ketamine|mesh-list
154828672|NCT05950711|Analgesics|analgesics|mesh-ancestor
154828673|NCT05950711|Sensory System Agents|sensory system agents|mesh-ancestor
154828674|NCT05950711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828675|NCT05950711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828676|NCT05950711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154828677|NCT05950711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154828678|NCT05950711|Anesthetics, General|anesthetics, general|mesh-ancestor
154828679|NCT05950711|Anesthetics|anesthetics|mesh-ancestor
154828680|NCT05950711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828681|NCT05950711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154828682|NCT05950711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154828683|NCT05950711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828684|NCT05950711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828685|NCT05950555|Dexmedetomidine|dexmedetomidine|mesh-list
154828686|NCT05950555|Ketamine|ketamine|mesh-list
154828687|NCT05950555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154828688|NCT05950555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828689|NCT05950555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828690|NCT05950555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828691|NCT05950555|Analgesics|analgesics|mesh-ancestor
154828692|NCT05950555|Sensory System Agents|sensory system agents|mesh-ancestor
154828693|NCT05950555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828694|NCT05950555|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154828695|NCT05950555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154828696|NCT05950555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154828697|NCT05950555|Adrenergic Agents|adrenergic agents|mesh-ancestor
154828698|NCT05950555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828699|NCT05950555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828700|NCT05950555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154828701|NCT05950555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154828702|NCT05950555|Anesthetics, General|anesthetics, general|mesh-ancestor
154828703|NCT05950555|Anesthetics|anesthetics|mesh-ancestor
154828704|NCT05950555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154828705|NCT05950555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154828706|NCT05950529|Sorbitol|sorbitol|mesh-list
154828707|NCT05950529|Cathartics|cathartics|mesh-ancestor
154580652|NCT05249972|Calcitriol|calcitriol|mesh-list
154828708|NCT05950529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828709|NCT05950516|Semaglutide|semaglutide|mesh-list
154828710|NCT05950516|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154828711|NCT05950516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154828712|NCT05950516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828713|NCT05950490|Methotrexate|methotrexate|mesh-list
154828714|NCT05950490|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154828715|NCT05950490|Abortifacient Agents|abortifacient agents|mesh-ancestor
154828716|NCT05950490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154828717|NCT05950490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828718|NCT05950490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154828719|NCT05950490|Antimetabolites|antimetabolites|mesh-ancestor
154828720|NCT05950490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828721|NCT05950490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828722|NCT05950490|Dermatologic Agents|dermatologic agents|mesh-ancestor
154828723|NCT05950490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828724|NCT05950490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154828725|NCT05950490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828726|NCT05950490|Immunologic Factors|immunologic factors|mesh-ancestor
154828727|NCT05950490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828728|NCT05950490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154828729|NCT05950204|Calcium, Dietary|calcium, dietary|mesh-list
154828731|NCT05950204|Ergocalciferols|ergocalciferols|mesh-list
154828732|NCT05950204|Cholecalciferol|cholecalciferol|mesh-list
154828733|NCT05950204|Vitamins|vitamins|mesh-list
154828734|NCT05950204|Calcium Carbonate|calcium carbonate|mesh-list
154828735|NCT05950204|Calcium|calcium|mesh-list
154828736|NCT05950204|Micronutrients|micronutrients|mesh-ancestor
154828737|NCT05950204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828738|NCT05950204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154828739|NCT05950204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154828740|NCT05950204|Antacids|antacids|mesh-ancestor
154828741|NCT05950204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828742|NCT05950204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828743|NCT05950152|Meloxicam|meloxicam|mesh-list
154828744|NCT05950152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154828745|NCT05950152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828746|NCT05950152|Analgesics|analgesics|mesh-ancestor
154828747|NCT05950152|Sensory System Agents|sensory system agents|mesh-ancestor
154828748|NCT05950152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828749|NCT05950152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828750|NCT05950152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828751|NCT05950152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828752|NCT05950152|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154828753|NCT05950152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154008154|NCT00635856|Gefitinib|gefitinib|mesh-list
154828754|NCT05950152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828755|NCT05950152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828756|NCT05950061|Dexetimide|dexetimide|mesh-list
154828757|NCT05950061|Citalopram|citalopram|mesh-list
154828758|NCT05950061|Sertraline|sertraline|mesh-list
154828759|NCT05950061|Escitalopram|escitalopram|mesh-list
154828760|NCT05950061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154828761|NCT05950061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154828762|NCT05950061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154828763|NCT05950061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828764|NCT05950061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828765|NCT05950061|Serotonin Agents|serotonin agents|mesh-ancestor
154828766|NCT05950061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828767|NCT05950061|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154828768|NCT05950061|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154828769|NCT05950061|Parasympatholytics|parasympatholytics|mesh-ancestor
154828770|NCT05950061|Autonomic Agents|autonomic agents|mesh-ancestor
154828771|NCT05950061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828772|NCT05950061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154828773|NCT05950061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154828774|NCT05950061|Cholinergic Agents|cholinergic agents|mesh-ancestor
154828775|NCT05950061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154828776|NCT05950061|Antidepressive Agents|antidepressive agents|mesh-ancestor
154828777|NCT05950061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154828778|NCT05949762|Azacitidine|azacitidine|mesh-list
154828779|NCT05949762|Venetoclax|venetoclax|mesh-list
154580723|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828780|NCT05949762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154828781|NCT05949762|Antimetabolites|antimetabolites|mesh-ancestor
154828782|NCT05949762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828783|NCT05949762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828784|NCT05949762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828785|NCT05949554|Ketamine|ketamine|mesh-list
154828786|NCT05949554|Analgesics|analgesics|mesh-ancestor
154828787|NCT05949554|Sensory System Agents|sensory system agents|mesh-ancestor
154828788|NCT05949554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828789|NCT05949554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828790|NCT05949554|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154828791|NCT05949554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154828792|NCT05949554|Anesthetics, General|anesthetics, general|mesh-ancestor
154828793|NCT05949554|Anesthetics|anesthetics|mesh-ancestor
154828794|NCT05949554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828795|NCT05949554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154828796|NCT05949554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154828797|NCT05949554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828798|NCT05949554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828799|NCT05949411|Lactulose|lactulose|mesh-list
154828800|NCT05949411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828801|NCT05949385|Itraconazole|itraconazole|mesh-list
154828802|NCT05949385|Antifungal Agents|antifungal agents|mesh-ancestor
154828803|NCT05949385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828804|NCT05949385|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154828805|NCT05949385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154828806|NCT05949385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828807|NCT05949385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828808|NCT05949385|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154828809|NCT05949385|Hormone Antagonists|hormone antagonists|mesh-ancestor
154828810|NCT05949385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828811|NCT05949385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828812|NCT05949385|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154828813|NCT05915442|Quemliclustat|quemliclustat|mesh-list
154828814|NCT05915442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154828815|NCT05915442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828816|NCT05915442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154828817|NCT05915442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828818|NCT05701956|Tenecteplase|tenecteplase|mesh-list
154828819|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154828820|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154828821|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828822|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
154828823|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
154828824|NCT05593627|Calcium|calcium|mesh-list
154828825|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154828826|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828827|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
154828828|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154828829|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828830|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828831|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
154828832|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154828833|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828834|NCT05593627|Antacids|antacids|mesh-ancestor
154828835|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828836|NCT05582096|Tirzepatide|tirzepatide|mesh-list
154828837|NCT05582096|Incretins|incretins|mesh-ancestor
154828838|NCT05582096|Hormones|hormones|mesh-ancestor
154828839|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828840|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828841|NCT05577715|Farletuzumab|farletuzumab|mesh-list
154828842|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828843|NCT05527834|Ceftibuten|ceftibuten|mesh-list
154828844|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154828845|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154828846|NCT05502250|Gemcitabine|gemcitabine|mesh-list
154828847|NCT05502250|Tislelizumab|tislelizumab|mesh-list
154828848|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828849|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154828850|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
154828851|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828852|NCT05502250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154580857|NCT01657760|Citalopram|citalopram|mesh-list
154828853|NCT05457868|Albuterol|albuterol|mesh-list
154828854|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154828855|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
154828856|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828857|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828858|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154828859|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
154828860|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
154828861|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154828862|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154828863|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154828864|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154828865|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
154828866|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828867|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828868|NCT05434065|Celecoxib|celecoxib|mesh-list
154828869|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154828870|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828871|NCT05434065|Analgesics|analgesics|mesh-ancestor
154828872|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
154828873|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828874|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828875|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828876|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154828877|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154828878|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154828879|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828880|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828881|NCT05398757|Midazolam|midazolam|mesh-list
154828882|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
154828883|NCT05398757|Propofol|propofol|mesh-list
154828884|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154828885|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828886|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828887|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154828888|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
154828889|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
154828890|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154828891|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154828892|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154828893|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154828894|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
154828895|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
154828896|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828897|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828898|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154828899|NCT05398757|Analgesics|analgesics|mesh-ancestor
154828900|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
154828901|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828902|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154828903|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154828904|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154828905|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
154828906|NCT05378269|Tamoxifen|tamoxifen|mesh-list
154828907|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154828908|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
154828909|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828910|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828911|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154828912|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828913|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154828914|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154828915|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154828916|NCT05323552|Curare|curare|mesh-list
154828917|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154828918|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154828919|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154828920|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828921|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828922|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154828923|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154828924|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
154828925|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828926|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828927|NCT05322954|Psilocybin|psilocybin|mesh-list
154828928|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
154828929|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828930|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154828931|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
154828932|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828933|NCT05274633|Ravulizumab|ravulizumab|mesh-list
154828934|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154828935|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154828936|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
154828937|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828938|NCT05224089|Dexamethasone|dexamethasone|mesh-list
154828939|NCT05224089|Epinephrine|epinephrine|mesh-list
154828940|NCT05224089|Bupivacaine|bupivacaine|mesh-list
154828941|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828942|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
154828943|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
154828944|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828945|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828946|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828947|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
154828948|NCT05224089|Hormones|hormones|mesh-ancestor
154828949|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828950|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154828951|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828952|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828953|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
154828954|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
154828955|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154828956|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
154828957|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154828958|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154828959|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
154828960|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154828961|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154828962|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154828963|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154828964|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
154828965|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
154828966|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
154828967|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154828968|NCT05205252|Dexamethasone|dexamethasone|mesh-list
154828969|NCT05205252|Lenalidomide|lenalidomide|mesh-list
154828970|NCT05205252|Daratumumab|daratumumab|mesh-list
154828971|NCT05205252|Pomalidomide|pomalidomide|mesh-list
154828972|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
154828973|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154828974|NCT05205252|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154828975|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154828976|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
154828977|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
154828978|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154828979|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828980|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154828981|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
154828982|NCT05205252|Hormones|hormones|mesh-ancestor
154828983|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154828984|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154828985|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154828986|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
154828987|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154828988|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154828989|NCT05205252|Growth Substances|growth substances|mesh-ancestor
154828990|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
154828991|NCT05205252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154828992|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154828993|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154828994|NCT05125237|Amiloride|amiloride|mesh-list
154828995|NCT05125237|Triamterene|triamterene|mesh-list
154828996|NCT05125237|Diuretics|diuretics|mesh-ancestor
154828997|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
154828998|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154828999|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154829000|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154829001|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154829002|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829003|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154829004|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154829006|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
154829007|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
154829008|NCT05125224|Calcium|calcium|mesh-list
154829009|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154829010|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829011|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154829012|NCT05125224|Diuretics|diuretics|mesh-ancestor
154829013|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
154829014|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154829015|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154829016|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829017|NCT06232564|Carboplatin|carboplatin|mesh-list
154829018|NCT06232564|Pembrolizumab|pembrolizumab|mesh-list
154829019|NCT06232564|Etoposide|etoposide|mesh-list
154829020|NCT06232564|Lenvatinib|lenvatinib|mesh-list
154829021|NCT06232564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829022|NCT06232564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829023|NCT06232564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829024|NCT06232564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829025|NCT06232564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154829026|NCT06232564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154829027|NCT06232564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154829028|NCT06232564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829029|NCT06232564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154829030|NCT06232473|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154829031|NCT06232473|Benztropine|benztropine|mesh-list
154829032|NCT06232473|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154829033|NCT06232473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154829034|NCT06232473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154829035|NCT06232473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829036|NCT06232473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829037|NCT06232473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829038|NCT06232473|Analgesics|analgesics|mesh-ancestor
154829039|NCT06232473|Sensory System Agents|sensory system agents|mesh-ancestor
154829040|NCT06232473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829041|NCT06232473|Antidepressive Agents|antidepressive agents|mesh-ancestor
154829042|NCT06232473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154829043|NCT06232473|Dopamine Agents|dopamine agents|mesh-ancestor
154829044|NCT06232473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154829045|NCT06232473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154829046|NCT06232473|Parasympatholytics|parasympatholytics|mesh-ancestor
154829047|NCT06232473|Autonomic Agents|autonomic agents|mesh-ancestor
154829048|NCT06232473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154829049|NCT06232473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154829050|NCT06232473|Cholinergic Agents|cholinergic agents|mesh-ancestor
154829051|NCT06232473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154829052|NCT06232239|Empagliflozin|empagliflozin|mesh-list
154829053|NCT06232239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154008455|NCT00904657|Sunitinib|sunitinib|mesh-list
154829054|NCT06232239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829055|NCT06232239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154829056|NCT06232239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829057|NCT06232122|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154829058|NCT06232122|FAPI-46|fapi-46|mesh-list
154829059|NCT06232122|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154829060|NCT06232122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829061|NCT06232109|Itraconazole|itraconazole|mesh-list
154829062|NCT06232109|Fluvoxamine|fluvoxamine|mesh-list
154829063|NCT06232109|Paroxetine|paroxetine|mesh-list
154829064|NCT06232109|Antifungal Agents|antifungal agents|mesh-ancestor
154829065|NCT06232109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829066|NCT06232109|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154829067|NCT06232109|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154829068|NCT06232109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829069|NCT06232109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829070|NCT06232109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154829071|NCT06232109|Hormone Antagonists|hormone antagonists|mesh-ancestor
154829072|NCT06232109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829073|NCT06232109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829074|NCT06232109|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154829075|NCT06232109|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154581024|NCT05209490|Iodine|iodine|mesh-list
154829076|NCT06232109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154829077|NCT06232109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154829078|NCT06232109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829079|NCT06232109|Serotonin Agents|serotonin agents|mesh-ancestor
154829080|NCT06232109|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154829081|NCT06232109|Antidepressive Agents|antidepressive agents|mesh-ancestor
154829082|NCT06232109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154829083|NCT06232109|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154829084|NCT06232109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154829085|NCT06232109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154829086|NCT06232109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829087|NCT06232109|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154829088|NCT06232109|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154829089|NCT06232044|Dexamethasone|dexamethasone|mesh-list
154829090|NCT06232044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829091|NCT06232044|Antiemetics|antiemetics|mesh-ancestor
154829092|NCT06232044|Autonomic Agents|autonomic agents|mesh-ancestor
154829093|NCT06232044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829094|NCT06232044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829095|NCT06232044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154829096|NCT06232044|Glucocorticoids|glucocorticoids|mesh-ancestor
154829097|NCT06232044|Hormones|hormones|mesh-ancestor
154829098|NCT06232044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829099|NCT06232044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154829100|NCT06232044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829101|NCT06232005|Mitomycins|mitomycins|mesh-list
154829102|NCT06232005|Mitomycin|mitomycin|mesh-list
154829103|NCT06232005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154829104|NCT06232005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829105|NCT06232005|Alkylating Agents|alkylating agents|mesh-ancestor
154829106|NCT06232005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829107|NCT06232005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154829108|NCT06232005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829109|NCT06231992|Analgesics, Opioid|analgesics, opioid|mesh-list
154829110|NCT06231992|Anesthetics|anesthetics|mesh-list
154829111|NCT06231992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829112|NCT06231992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829113|NCT06231992|Narcotics|narcotics|mesh-ancestor
154829114|NCT06231992|Analgesics|analgesics|mesh-ancestor
154829115|NCT06231992|Sensory System Agents|sensory system agents|mesh-ancestor
154829116|NCT06231992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829117|NCT06231979|Dexmedetomidine|dexmedetomidine|mesh-list
154829118|NCT06231979|Bupivacaine|bupivacaine|mesh-list
154829119|NCT06231979|Anesthetics, Local|anesthetics, local|mesh-ancestor
154829120|NCT06231979|Anesthetics|anesthetics|mesh-ancestor
154829121|NCT06231979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829122|NCT06231979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829123|NCT06231979|Sensory System Agents|sensory system agents|mesh-ancestor
154829124|NCT06231979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829125|NCT06231979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154829126|NCT06231979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154829127|NCT06231979|Analgesics|analgesics|mesh-ancestor
154829128|NCT06231979|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154829129|NCT06231979|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154829130|NCT06231979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154829131|NCT06231979|Adrenergic Agents|adrenergic agents|mesh-ancestor
154829132|NCT06231979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829133|NCT06231979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829134|NCT06231966|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154829135|NCT06231966|Ezetimibe|ezetimibe|mesh-list
154829136|NCT06231966|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154829137|NCT06231966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154829138|NCT06231966|Antimetabolites|antimetabolites|mesh-ancestor
154829139|NCT06231966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829140|NCT06231966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154829141|NCT06231966|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154829142|NCT06231966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829143|NCT06231693|Trastuzumab|trastuzumab|mesh-list
154829144|NCT06231693|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154829145|NCT06231693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829146|NCT06231693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829147|NCT06231693|Immunoconjugates|immunoconjugates|mesh-ancestor
154829148|NCT06231693|Immunologic Factors|immunologic factors|mesh-ancestor
154829149|NCT06231693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829150|NCT06231641|Lemborexant|lemborexant|mesh-list
154829151|NCT06231641|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154829152|NCT06231641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829153|NCT06231641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829154|NCT06231641|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154829155|NCT06231641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154829156|NCT06231641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829157|NCT06231641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829158|NCT06231563|Ketamine|ketamine|mesh-list
154829159|NCT06231563|Analgesics|analgesics|mesh-ancestor
154829160|NCT06231563|Sensory System Agents|sensory system agents|mesh-ancestor
154829161|NCT06231563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829162|NCT06231563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829163|NCT06231563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154829164|NCT06231563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154829165|NCT06231563|Anesthetics, General|anesthetics, general|mesh-ancestor
154829166|NCT06231563|Anesthetics|anesthetics|mesh-ancestor
154829167|NCT06231563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829168|NCT06231563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154829169|NCT06231563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154829170|NCT06231563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829171|NCT06231563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829172|NCT06231459|Evolocumab|evolocumab|mesh-list
154829173|NCT06231459|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154829174|NCT06231459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154829175|NCT06231459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154829176|NCT06231459|Antimetabolites|antimetabolites|mesh-ancestor
154829177|NCT06231459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829178|NCT06231459|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154829179|NCT06231459|Protease Inhibitors|protease inhibitors|mesh-ancestor
154829180|NCT06231459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008588|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829181|NCT06231459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154829182|NCT06231316|Norepinephrine|norepinephrine|mesh-list
154829183|NCT06231316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154829184|NCT06231316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154829185|NCT06231316|Adrenergic Agents|adrenergic agents|mesh-ancestor
154829186|NCT06231316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829187|NCT06231316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829188|NCT06231316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829189|NCT06231316|Sympathomimetics|sympathomimetics|mesh-ancestor
154829190|NCT06231316|Autonomic Agents|autonomic agents|mesh-ancestor
154829191|NCT06231316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829192|NCT06231316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154829193|NCT06231121|Faricimab|faricimab|mesh-list
154829194|NCT06231121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154829195|NCT06231121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154829196|NCT06231121|Growth Substances|growth substances|mesh-ancestor
154829197|NCT06231121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829198|NCT06231121|Growth Inhibitors|growth inhibitors|mesh-ancestor
154829199|NCT06231121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829200|NCT06231043|Diclofenac|diclofenac|mesh-list
154829201|NCT06231043|Tramadol|tramadol|mesh-list
154829202|NCT06231043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154829203|NCT06231043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154829204|NCT06231043|Analgesics|analgesics|mesh-ancestor
154829205|NCT06231043|Sensory System Agents|sensory system agents|mesh-ancestor
154829206|NCT06231043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829207|NCT06231043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829208|NCT06231043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829209|NCT06231043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829210|NCT06231043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154829211|NCT06231043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829212|NCT06231043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829213|NCT06231043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154829214|NCT06231043|Narcotics|narcotics|mesh-ancestor
154829215|NCT06231043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829216|NCT06231017|Cetuximab|cetuximab|mesh-list
154829217|NCT06231017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829218|NCT06231017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829219|NCT06230861|Quercetin|quercetin|mesh-list
154829220|NCT06230861|Antioxidants|antioxidants|mesh-ancestor
154829221|NCT06230861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829222|NCT06230861|Protective Agents|protective agents|mesh-ancestor
154829223|NCT06230861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829224|NCT06230640|Hemostatics|hemostatics|mesh-list
154829225|NCT06230640|Coagulants|coagulants|mesh-ancestor
154829226|NCT06230159|Menthol|menthol|mesh-list
154829227|NCT06230159|Antipruritics|antipruritics|mesh-ancestor
154829228|NCT06230159|Dermatologic Agents|dermatologic agents|mesh-ancestor
154829229|NCT06230146|Triamcinolone|triamcinolone|mesh-list
154829230|NCT06230146|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154829231|NCT06230146|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154829232|NCT06230146|Botulinum Toxins|botulinum toxins|mesh-list
154829233|NCT06230146|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154829234|NCT06230146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829235|NCT06230146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154829236|NCT06230146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154829237|NCT06230146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829238|NCT06230146|Cholinergic Agents|cholinergic agents|mesh-ancestor
154829239|NCT06230146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829240|NCT06230146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829241|NCT06230146|Glucocorticoids|glucocorticoids|mesh-ancestor
154829242|NCT06230146|Hormones|hormones|mesh-ancestor
154008650|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
154829243|NCT06230146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829244|NCT06230146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829245|NCT06230146|Immunologic Factors|immunologic factors|mesh-ancestor
154829246|NCT06230146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829247|NCT06228911|Triamcinolone|triamcinolone|mesh-list
154829248|NCT06228911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829249|NCT06228911|Glucocorticoids|glucocorticoids|mesh-ancestor
154829250|NCT06228911|Hormones|hormones|mesh-ancestor
154829251|NCT06228911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829252|NCT06228911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829253|NCT06226896|Dapagliflozin|dapagliflozin|mesh-list
154829254|NCT06226896|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154829255|NCT06226896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829256|NCT06226896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154829257|NCT06226896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829258|NCT06226025|Melatonin|melatonin|mesh-list
154829259|NCT06226025|Antioxidants|antioxidants|mesh-ancestor
154829260|NCT06226025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829261|NCT06226025|Protective Agents|protective agents|mesh-ancestor
154829262|NCT06226025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829263|NCT06226025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829264|NCT06225323|Lidocaine|lidocaine|mesh-list
154829265|NCT06225323|Anesthetics, Local|anesthetics, local|mesh-ancestor
154829266|NCT06225323|Anesthetics|anesthetics|mesh-ancestor
154829267|NCT06225323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829268|NCT06225323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829269|NCT06225323|Sensory System Agents|sensory system agents|mesh-ancestor
154829270|NCT06225323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829271|NCT06225323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154829272|NCT06225323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154829273|NCT06225323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154829274|NCT06225323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154829275|NCT06225323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829276|NCT06225284|Leuprolide|leuprolide|mesh-list
154829277|NCT06225284|Goserelin|goserelin|mesh-list
154829278|NCT06225284|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154829279|NCT06225284|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154829280|NCT06225284|Fertility Agents|fertility agents|mesh-ancestor
154829281|NCT06225284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154829282|NCT06225284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829283|NCT06225284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154829284|NCT06225284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829285|NCT06225284|Luteolytic Agents|luteolytic agents|mesh-ancestor
154829286|NCT06225284|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154829287|NCT06225284|Contraceptive Agents|contraceptive agents|mesh-ancestor
154829288|NCT06225284|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154829289|NCT06215833|Propofol|propofol|mesh-list
154829290|NCT06215833|Sevoflurane|sevoflurane|mesh-list
154829291|NCT06215833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154829292|NCT06215833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829293|NCT06215833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581248|NCT00838799|Pregabalin|pregabalin|mesh-list
154829294|NCT06215833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154829295|NCT06215833|Anesthetics, General|anesthetics, general|mesh-ancestor
154829296|NCT06215833|Anesthetics|anesthetics|mesh-ancestor
154829297|NCT06215833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154829299|NCT06201793|Minocycline|minocycline|mesh-list
154829300|NCT06201793|Mesalamine|mesalamine|mesh-list
154829301|NCT06201793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154829302|NCT06201793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829303|NCT06201793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154829304|NCT06201793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154829305|NCT06201793|Analgesics|analgesics|mesh-ancestor
154829306|NCT06201793|Sensory System Agents|sensory system agents|mesh-ancestor
154829307|NCT06201793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829308|NCT06201793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829309|NCT06201793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829310|NCT06201793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829311|NCT06197308|Amoxicillin|amoxicillin|mesh-list
154829312|NCT06197308|Vancomycin|vancomycin|mesh-list
154829313|NCT06197308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154829314|NCT06197308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829315|NCT06197295|Solifenacin Succinate|solifenacin succinate|mesh-list
154829316|NCT06197295|Estrogens|estrogens|mesh-list
154829317|NCT06197295|Hormones|hormones|mesh-ancestor
154829318|NCT06197295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829319|NCT06197295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829320|NCT06197295|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154829321|NCT06197295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154829322|NCT06197295|Cholinergic Agents|cholinergic agents|mesh-ancestor
154829323|NCT06197295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829324|NCT06197295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829325|NCT06197295|Urological Agents|urological agents|mesh-ancestor
154829326|NCT06190197|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154829327|NCT06190197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829328|NCT06190067|Azacitidine|azacitidine|mesh-list
154829329|NCT06190067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154829330|NCT06190067|Antimetabolites|antimetabolites|mesh-ancestor
154829331|NCT06190067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829332|NCT06190067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829333|NCT06190067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829334|NCT06186115|Hyaluronic Acid|hyaluronic acid|mesh-list
154829335|NCT06186115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154829336|NCT06186115|Immunologic Factors|immunologic factors|mesh-ancestor
154829337|NCT06186115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829338|NCT06186115|Viscosupplements|viscosupplements|mesh-ancestor
154829339|NCT06186115|Protective Agents|protective agents|mesh-ancestor
154829340|NCT06176027|Azacitidine|azacitidine|mesh-list
154829341|NCT06176027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154829342|NCT06176027|Antimetabolites|antimetabolites|mesh-ancestor
154829343|NCT06176027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829344|NCT06176027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829345|NCT06176027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829346|NCT06154226|Pantoprazole|pantoprazole|mesh-list
154829347|NCT06154226|Famotidine|famotidine|mesh-list
154829348|NCT06154226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154829349|NCT06154226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154829350|NCT06154226|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154829351|NCT06154226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829352|NCT06154226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829353|NCT06154226|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154829354|NCT06154226|Histamine Antagonists|histamine antagonists|mesh-ancestor
154829355|NCT06154226|Histamine Agents|histamine agents|mesh-ancestor
154829356|NCT06154226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829357|NCT06154226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829358|NCT06151288|Vaccines|vaccines|mesh-list
154829359|NCT06151288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154829360|NCT06151288|Immunologic Factors|immunologic factors|mesh-ancestor
154829361|NCT06151288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829362|NCT06120556|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154829363|NCT06120556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154829364|NCT06120556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829365|NCT06082271|Cortisone|cortisone|mesh-list
154829366|NCT06082271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829367|NCT06072534|Mivacurium|mivacurium|mesh-list
154829368|NCT06072534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154829369|NCT06072534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154829370|NCT06072534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154829371|NCT06072534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581320|NCT05200364|Bevacizumab|bevacizumab|mesh-list
154829372|NCT06072534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829373|NCT06069063|Zafirlukast|zafirlukast|mesh-list
154829374|NCT06069063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154829375|NCT06069063|Respiratory System Agents|respiratory system agents|mesh-ancestor
154829376|NCT06069063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154829377|NCT06069063|Hormone Antagonists|hormone antagonists|mesh-ancestor
154829378|NCT06069063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829379|NCT06069063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829380|NCT06056102|Cyclophosphamide|cyclophosphamide|mesh-list
154829381|NCT06056102|Fludarabine|fludarabine|mesh-list
154829382|NCT06056102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829383|NCT06056102|Immunologic Factors|immunologic factors|mesh-ancestor
154829384|NCT06056102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829385|NCT06056102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829386|NCT06056102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154829387|NCT06056102|Alkylating Agents|alkylating agents|mesh-ancestor
154829388|NCT06056102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829389|NCT06056102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829390|NCT06056102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154829391|NCT06042569|Cyclophosphamide|cyclophosphamide|mesh-list
154829392|NCT06042569|Docetaxel|docetaxel|mesh-list
154829393|NCT06042569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829394|NCT06042569|Immunologic Factors|immunologic factors|mesh-ancestor
154829395|NCT06042569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829396|NCT06042569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829397|NCT06042569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154829398|NCT06042569|Alkylating Agents|alkylating agents|mesh-ancestor
154829399|NCT06042569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829400|NCT06042569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829401|NCT06042569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154829402|NCT06042569|Tubulin Modulators|tubulin modulators|mesh-ancestor
154829403|NCT06042569|Antimitotic Agents|antimitotic agents|mesh-ancestor
154829404|NCT06042569|Mitosis Modulators|mitosis modulators|mesh-ancestor
154829405|NCT06035393|Glycopyrrolate|glycopyrrolate|mesh-list
154829406|NCT06035393|Bromides|bromides|mesh-list
154829407|NCT06035393|Maleic acid|maleic acid|mesh-list
154829408|NCT06035393|Anticonvulsants|anticonvulsants|mesh-ancestor
154829409|NCT06035393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829410|NCT06035393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829411|NCT06035393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154829412|NCT06035393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154829413|NCT06035393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154829414|NCT06035393|Cholinergic Agents|cholinergic agents|mesh-ancestor
154829415|NCT06035393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829416|NCT06035393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829417|NCT05980000|Pembrolizumab|pembrolizumab|mesh-list
154829418|NCT05980000|Ramucirumab|ramucirumab|mesh-list
154829419|NCT05980000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829420|NCT05980000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829421|NCT05980000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829422|NCT05980000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829423|NCT05980000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154829424|NCT05980000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154829425|NCT05980000|Growth Substances|growth substances|mesh-ancestor
154829426|NCT05980000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829427|NCT05980000|Growth Inhibitors|growth inhibitors|mesh-ancestor
154829428|NCT05977738|Pitavastatin|pitavastatin|mesh-list
154829429|NCT05977738|Calcium|calcium|mesh-list
154829430|NCT05977738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154829431|NCT05977738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829432|NCT05977738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154829433|NCT05977738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154829434|NCT05977738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154829435|NCT05977738|Antimetabolites|antimetabolites|mesh-ancestor
154829436|NCT05977738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829437|NCT05977738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829438|NCT05977738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154829439|NCT05969496|Pembrolizumab|pembrolizumab|mesh-list
154829440|NCT05969496|Axitinib|axitinib|mesh-list
154829441|NCT05969496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829442|NCT05969496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829443|NCT05969496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829444|NCT05969496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829445|NCT05969496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154829446|NCT05969496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829447|NCT05960929|Calfactant|calfactant|mesh-list
154829448|NCT05960929|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154829449|NCT05960929|Respiratory System Agents|respiratory system agents|mesh-ancestor
154829450|NCT05953142|Dobutamine|dobutamine|mesh-list
154829451|NCT05953142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154829452|NCT05953142|Sympathomimetics|sympathomimetics|mesh-ancestor
154829453|NCT05953142|Autonomic Agents|autonomic agents|mesh-ancestor
154829454|NCT05953142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829455|NCT05953142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829456|NCT05953142|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154829457|NCT05953142|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154829458|NCT05953142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154829459|NCT05953142|Adrenergic Agents|adrenergic agents|mesh-ancestor
154829460|NCT05953142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829461|NCT05953142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829462|NCT05953142|Protective Agents|protective agents|mesh-ancestor
154829463|NCT05939635|Morphine|morphine|mesh-list
154829464|NCT05939635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154829465|NCT05939635|Narcotics|narcotics|mesh-ancestor
154829466|NCT05939635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829467|NCT05939635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829468|NCT05939635|Analgesics|analgesics|mesh-ancestor
154829469|NCT05939635|Sensory System Agents|sensory system agents|mesh-ancestor
154829470|NCT05939635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829471|NCT05936190|Lidocaine|lidocaine|mesh-list
154829472|NCT05936190|Anesthetics, Local|anesthetics, local|mesh-ancestor
154829473|NCT05936190|Anesthetics|anesthetics|mesh-ancestor
154829474|NCT05936190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829475|NCT05936190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829476|NCT05936190|Sensory System Agents|sensory system agents|mesh-ancestor
154829477|NCT05936190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829478|NCT05936190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154829479|NCT05936190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154829480|NCT05936190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154829481|NCT05936190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154829482|NCT05936190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829483|NCT05858216|Chlorpheniramine|chlorpheniramine|mesh-list
154829484|NCT05858216|Antipruritics|antipruritics|mesh-ancestor
154829485|NCT05858216|Dermatologic Agents|dermatologic agents|mesh-ancestor
154829486|NCT05858216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154829487|NCT05858216|Histamine Antagonists|histamine antagonists|mesh-ancestor
154829488|NCT05858216|Histamine Agents|histamine agents|mesh-ancestor
154829489|NCT05858216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829490|NCT05858216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829491|NCT05858216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829492|NCT05858216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154829493|NCT05820451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154829494|NCT05807711|Vitamin B 12|vitamin b 12|mesh-list
154829495|NCT05807711|Vitamin B Complex|vitamin b complex|mesh-ancestor
154829496|NCT05807711|Vitamins|vitamins|mesh-ancestor
154829497|NCT05807711|Micronutrients|micronutrients|mesh-ancestor
154829498|NCT05807711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829499|NCT05803096|Nitrous Oxide|nitrous oxide|mesh-list
154829500|NCT05803096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154829501|NCT05803096|Anesthetics, General|anesthetics, general|mesh-ancestor
154829502|NCT05803096|Anesthetics|anesthetics|mesh-ancestor
154829503|NCT05803096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829504|NCT05803096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829505|NCT05803096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154829506|NCT05803096|Analgesics|analgesics|mesh-ancestor
154829507|NCT05803096|Sensory System Agents|sensory system agents|mesh-ancestor
154829508|NCT05803096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829509|NCT05787574|Dexamethasone|dexamethasone|mesh-list
154829510|NCT05787574|Fludarabine|fludarabine|mesh-list
154829511|NCT05787574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829512|NCT05787574|Antiemetics|antiemetics|mesh-ancestor
154829513|NCT05787574|Autonomic Agents|autonomic agents|mesh-ancestor
154829514|NCT05787574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829515|NCT05787574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829516|NCT05787574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154829517|NCT05787574|Glucocorticoids|glucocorticoids|mesh-ancestor
154829518|NCT05787574|Hormones|hormones|mesh-ancestor
154829519|NCT05787574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829520|NCT05787574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154829521|NCT05787574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829522|NCT05765812|Temozolomide|temozolomide|mesh-list
154829523|NCT05765812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154829524|NCT05765812|Alkylating Agents|alkylating agents|mesh-ancestor
154829525|NCT05765812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829526|NCT05765812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829527|NCT05716009|Gemtuzumab|gemtuzumab|mesh-list
154829528|NCT05716009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829529|NCT05716009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829530|NCT05716009|Immunotoxins|immunotoxins|mesh-ancestor
154829531|NCT05716009|Immunoconjugates|immunoconjugates|mesh-ancestor
154829532|NCT05716009|Immunologic Factors|immunologic factors|mesh-ancestor
154829533|NCT05716009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829534|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154829535|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154829536|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
154829537|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829538|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829539|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829540|NCT05670743|Fluorides|fluorides|mesh-list
154829541|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
154829542|NCT05670743|Protective Agents|protective agents|mesh-ancestor
154829543|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829544|NCT05662189|Exenatide|exenatide|mesh-list
154829545|NCT05662189|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154829546|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154829547|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829548|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154829549|NCT05662189|Incretins|incretins|mesh-ancestor
154829550|NCT05662189|Hormones|hormones|mesh-ancestor
154829551|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829552|NCT05579223|Hydromorphone|hydromorphone|mesh-list
154829553|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154829554|NCT05579223|Narcotics|narcotics|mesh-ancestor
154829555|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829556|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829557|NCT05579223|Analgesics|analgesics|mesh-ancestor
154829558|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
154829559|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829560|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
154829561|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154829562|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829563|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829564|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154008979|NCT04267913|Docetaxel|docetaxel|mesh-list
154829565|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154829566|NCT05558761|Protective Agents|protective agents|mesh-ancestor
154829567|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829568|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
154829569|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154829570|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
154829571|NCT05556681|Sirolimus|sirolimus|mesh-list
154829572|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154829573|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829574|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154829575|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829576|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
154829577|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829578|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
154829579|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829580|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
154829581|NCT05545969|Lenvatinib|lenvatinib|mesh-list
154829582|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829583|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829584|NCT05545969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829585|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829586|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154829587|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829588|NCT05544136|Carboplatin|carboplatin|mesh-list
154829589|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829590|NCT05521152|Norepinephrine|norepinephrine|mesh-list
154829591|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154829592|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154829593|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
154829594|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829595|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829596|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829597|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
154829598|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
154829599|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829600|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154829601|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
154829602|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154829603|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154829604|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829605|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
154829606|NCT05517590|Coagulants|coagulants|mesh-ancestor
154829607|NCT05504252|Nivolumab|nivolumab|mesh-list
154829608|NCT05504252|Fluorouracil|fluorouracil|mesh-list
154829609|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
154829610|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829611|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829612|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829613|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829614|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
154829615|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154829616|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829617|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
154829618|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829619|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
154829620|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154829621|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829622|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154829623|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829624|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154829625|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154829626|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829627|NCT05410418|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154829628|NCT05410418|Immunoconjugates|immunoconjugates|mesh-ancestor
154829629|NCT05410418|Immunologic Factors|immunologic factors|mesh-ancestor
154829630|NCT05410418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829631|NCT05408910|Rifaximin|rifaximin|mesh-list
154829632|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154829633|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829634|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154829635|NCT05395065|Listerine|listerine|mesh-list
154829636|NCT05395065|Fluorides|fluorides|mesh-list
154829637|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
154829638|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
154829639|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
154829640|NCT05395065|Protective Agents|protective agents|mesh-ancestor
154829641|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829642|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154829643|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829644|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154829645|NCT05387811|Diuretics|diuretics|mesh-list
154829646|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
154829647|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829648|NCT05382728|Osimertinib|osimertinib|mesh-list
154829649|NCT05382728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154829650|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154829651|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829652|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829653|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829654|NCT05373901|Tretinoin|tretinoin|mesh-list
154829655|NCT05373901|Dinutuximab|dinutuximab|mesh-list
154829656|NCT05373901|Isotretinoin|isotretinoin|mesh-list
154829657|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829658|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
154829659|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
154829660|NCT05325177|Ibuprofen|ibuprofen|mesh-list
154829661|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154829662|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154829663|NCT05325177|Analgesics|analgesics|mesh-ancestor
154829664|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
154829665|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829666|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829667|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829668|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829669|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154581629|NCT02365558|Omeprazole|omeprazole|mesh-list
154829670|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829671|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829672|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
154829673|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154829674|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
154829675|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829676|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829677|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154829678|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154829679|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154829680|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
154829681|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829682|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829683|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154829684|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
154829685|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
154829686|NCT05304039|Protective Agents|protective agents|mesh-ancestor
154829687|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
154829688|NCT05299164|Analgesics|analgesics|mesh-ancestor
154829689|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
154829690|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829691|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009108|NCT00908323|Vaccines|vaccines|mesh-list
154829692|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829693|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154829694|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154829695|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829696|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829697|NCT05299008|Bethanechol|bethanechol|mesh-list
154829698|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154829699|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
154829700|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829701|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829702|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154829703|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154829704|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
154829705|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829706|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829707|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
154829708|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
154829709|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154829710|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829711|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829712|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
154829713|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154829714|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829715|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829716|NCT05260528|Cytarabine|cytarabine|mesh-list
154829717|NCT05260528|Idarubicin|idarubicin|mesh-list
154829718|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154829719|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
154829720|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829721|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829722|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
154829723|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829724|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829725|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
154829726|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829727|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154829728|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154829729|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154829730|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829731|NCT05246670|Palmidrol|palmidrol|mesh-list
154829732|NCT05246670|Analgesics|analgesics|mesh-ancestor
154829733|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
154829734|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829735|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829736|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154829737|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154829738|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829739|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829740|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
154829741|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829742|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154829743|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154829744|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829745|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829746|NCT05246670|Hormones|hormones|mesh-ancestor
154829747|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829748|NCT05220046|Psilocybin|psilocybin|mesh-list
154829749|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
154829750|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829751|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154829752|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
154829753|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154829754|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829755|NCT05199662|Tenecteplase|tenecteplase|mesh-list
154829756|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154829757|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154829758|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829759|NCT05199194|Tenecteplase|tenecteplase|mesh-list
154829760|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154829761|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154829762|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829763|NCT05192213|Thiamine|thiamine|mesh-list
154829764|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
154829765|NCT05192213|Vitamins|vitamins|mesh-ancestor
154829766|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
154829767|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829768|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829769|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
154829770|NCT05183984|Bevacizumab|bevacizumab|mesh-list
154829771|NCT05183984|Niraparib|niraparib|mesh-list
154829772|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829773|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829774|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154829775|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154829776|NCT05183984|Growth Substances|growth substances|mesh-ancestor
154829777|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829778|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
154829779|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154829780|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829781|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829782|NCT05182151|Istradefylline|istradefylline|mesh-list
154829783|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154829784|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154829785|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154829786|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
154829787|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154829788|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829789|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829790|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
154829791|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154829792|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154829793|NCT05150704|Prednisolone|prednisolone|mesh-list
154829794|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
154829795|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154829796|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
154829797|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829798|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
154829799|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
154829800|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829801|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829802|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154829803|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
154829804|NCT05150704|Hormones|hormones|mesh-ancestor
154829805|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829806|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154829807|NCT05150704|Protective Agents|protective agents|mesh-ancestor
154829808|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154829809|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829810|NCT05150652|Tamoxifen|tamoxifen|mesh-list
154829811|NCT05150652|Letrozole|letrozole|mesh-list
154829812|NCT05150652|Anastrozole|anastrozole|mesh-list
154829813|NCT05150652|Exemestane|exemestane|mesh-list
154829814|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829815|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154829816|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154829817|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829818|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829819|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154829820|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
154009241|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
154829821|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829822|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829823|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154829824|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154829825|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154829826|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154829827|NCT05008926|Naloxegol|naloxegol|mesh-list
154829828|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154829829|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829830|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
154829831|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829832|NCT05008224|Prednisone|prednisone|mesh-list
154829833|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
154829834|NCT05008224|Dacarbazine|dacarbazine|mesh-list
154829835|NCT05008224|Doxorubicin|doxorubicin|mesh-list
154829836|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
154829837|NCT05008224|Etoposide|etoposide|mesh-list
154829838|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
154829839|NCT05008224|Vincristine|vincristine|mesh-list
154829840|NCT05008224|Bleomycin|bleomycin|mesh-list
154829841|NCT05008224|Vinblastine|vinblastine|mesh-list
154829842|NCT05008224|Procarbazine|procarbazine|mesh-list
154829843|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829844|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
154829845|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829846|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829847|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154829848|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
154829849|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829850|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829851|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154829852|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154829853|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154829854|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154829855|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829856|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829857|NCT05008224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829858|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829859|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
154829860|NCT05008224|Hormones|hormones|mesh-ancestor
154829861|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154829862|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154829863|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154829864|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
154829865|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
154829866|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
154829867|NCT04972292|Dipyrone|dipyrone|mesh-list
154829868|NCT04972292|Codeine|codeine|mesh-list
154829869|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154829870|NCT04972292|Narcotics|narcotics|mesh-ancestor
154829871|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154829872|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829873|NCT04972292|Analgesics|analgesics|mesh-ancestor
154829874|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
154829875|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154829876|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
154829877|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
154829878|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154829879|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154829880|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154829881|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154829882|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
154829883|NCT04968509|Ezetimibe|ezetimibe|mesh-list
154829884|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154829885|NCT04968509|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154829886|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154829887|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154829888|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
154829889|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829890|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154829891|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829892|NCT04968509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154829893|NCT04968509|Protease Inhibitors|protease inhibitors|mesh-ancestor
154829894|NCT04964960|Paclitaxel|paclitaxel|mesh-list
154829895|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154829896|NCT04964960|Carboplatin|carboplatin|mesh-list
154829897|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
154829898|NCT04964960|Pemetrexed|pemetrexed|mesh-list
154829899|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154829900|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829902|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
154829903|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
154829904|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829905|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829906|NCT04964960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829907|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829908|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154829909|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154829910|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
154829911|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829912|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829913|NCT04925986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829914|NCT04925986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829915|NCT04910815|Rifaximin|rifaximin|mesh-list
154829916|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154829917|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829918|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154829919|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
154829920|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154829921|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829922|NCT04875195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154829923|NCT04875195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829924|NCT04870671|Tenofovir|tenofovir|mesh-list
154829925|NCT04870671|Emtricitabine|emtricitabine|mesh-list
154829926|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
154829927|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829928|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154829929|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154829930|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829931|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829932|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154829933|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154829934|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
154829935|NCT04847063|Doxorubicin|doxorubicin|mesh-list
154829936|NCT04847063|Fluorouracil|fluorouracil|mesh-list
154829937|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
154829938|NCT04847063|Mitomycins|mitomycins|mesh-list
154829939|NCT04847063|Mitomycin|mitomycin|mesh-list
154829940|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829941|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154829942|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154829943|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154829944|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829945|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829946|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
154829947|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154829948|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829949|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
154829950|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829951|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
154829952|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154829953|NCT04847063|Antidotes|antidotes|mesh-ancestor
154829954|NCT04847063|Protective Agents|protective agents|mesh-ancestor
154829955|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
154829956|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
154829957|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154829958|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154829959|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
154829960|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
154829961|NCT04770623|Docetaxel|docetaxel|mesh-list
154829962|NCT04770623|Irinotecan|irinotecan|mesh-list
154829963|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829964|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
154829965|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
154829966|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
154829967|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829968|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154829969|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154829970|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829971|NCT04765514|Temozolomide|temozolomide|mesh-list
154829972|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154829973|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
154829974|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829975|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829976|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
154829977|NCT04725422|Pamidronate|pamidronate|mesh-list
154829978|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
154829979|NCT04725422|Adalimumab|adalimumab|mesh-list
154829980|NCT04725422|Infliximab|infliximab|mesh-list
154829981|NCT04725422|Golimumab|golimumab|mesh-list
154829982|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
154829983|NCT04725422|Etanercept|etanercept|mesh-list
154829984|NCT04725422|Methotrexate|methotrexate|mesh-list
154829985|NCT04725422|Leflunomide|leflunomide|mesh-list
154829986|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154829987|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
154829988|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154829989|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154829990|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154829991|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
154829992|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154829993|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154829994|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
154829995|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154829996|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154829997|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154829998|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
154829999|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830000|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154830001|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154830002|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830003|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830004|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154830005|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154830006|NCT04725422|Analgesics|analgesics|mesh-ancestor
154830007|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
154830008|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830009|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154830010|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830011|NCT04720131|Capecitabine|capecitabine|mesh-list
154830012|NCT04720131|Apatinib|apatinib|mesh-list
154830013|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830014|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
154830015|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830016|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830017|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154830018|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830019|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
154830020|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154830021|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830022|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154830023|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830024|NCT04665765|Rituximab|rituximab|mesh-list
154830025|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154830026|NCT04665765|Carboplatin|carboplatin|mesh-list
154830027|NCT04665765|Etoposide|etoposide|mesh-list
154830028|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
154830029|NCT04665765|Ifosfamide|ifosfamide|mesh-list
154830030|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
154830031|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
154830032|NCT04665765|Antibodies|antibodies|mesh-list
154830033|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
154830034|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154830035|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
154830036|NCT04665765|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154830037|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
154830038|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830039|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830040|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830041|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830042|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154830043|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154830044|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830045|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830046|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830047|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
154830048|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
154830049|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
154830050|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830051|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830052|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830054|NCT04657094|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154830055|NCT04657094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154830056|NCT04657094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830057|NCT04657094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830058|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830059|NCT04655144|Dexamethasone|dexamethasone|mesh-list
154830060|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830061|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
154830062|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
154830063|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830064|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830065|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830066|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
154830067|NCT04655144|Hormones|hormones|mesh-ancestor
154830068|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830069|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830070|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830071|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
154830072|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830073|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830074|NCT04609579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154830075|NCT04609579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830076|NCT04605731|Durvalumab|durvalumab|mesh-list
154830077|NCT04605731|Ipilimumab|ipilimumab|mesh-list
154830078|NCT04605731|Tremelimumab|tremelimumab|mesh-list
154830079|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
154830080|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154830081|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
154830082|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830083|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830084|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
154830085|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830086|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154830087|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830088|NCT04594733|Minocycline|minocycline|mesh-list
154830089|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154830090|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830091|NCT04556773|Paclitaxel|paclitaxel|mesh-list
154830092|NCT04556773|Capecitabine|capecitabine|mesh-list
154830093|NCT04556773|Trastuzumab|trastuzumab|mesh-list
154830094|NCT04556773|Durvalumab|durvalumab|mesh-list
154830095|NCT04556773|Fulvestrant|fulvestrant|mesh-list
154830096|NCT04556773|Anastrozole|anastrozole|mesh-list
154830097|NCT04556773|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154830098|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830099|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830100|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830101|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830102|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830103|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830104|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830105|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
154830106|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830107|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830108|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154830109|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154830110|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
154830111|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830112|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830113|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154830114|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154830115|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830116|NCT04556773|Immunoconjugates|immunoconjugates|mesh-ancestor
154830117|NCT04556773|Immunologic Factors|immunologic factors|mesh-ancestor
154830118|NCT04303195|Metopimazine|metopimazine|mesh-list
154830119|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
154830120|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
154830121|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830122|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830123|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830124|NCT04298567|Aspirin|aspirin|mesh-list
154830125|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
154830126|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154830127|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
154830128|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154830129|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
154830130|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830131|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830132|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
154830133|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154830134|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154830135|NCT04298567|Analgesics|analgesics|mesh-ancestor
154830136|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
154830137|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830138|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830139|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830140|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830141|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154830142|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154830143|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154830144|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154830145|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
154830146|NCT04220489|Ketamine|ketamine|mesh-list
154830147|NCT04220489|Analgesics|analgesics|mesh-ancestor
154830148|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
154830149|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830150|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830151|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154830152|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154830153|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
154830154|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
154830155|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154830156|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154830157|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154830158|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154830159|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830160|NCT04219540|Buprenorphine|buprenorphine|mesh-list
154830161|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154830162|NCT04219540|Narcotics|narcotics|mesh-ancestor
154830163|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154830164|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830165|NCT04219540|Analgesics|analgesics|mesh-ancestor
154830166|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
154830167|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830168|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154830169|NCT04195555|Ivosidenib|ivosidenib|mesh-list
154830170|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830171|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830172|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830173|NCT04177004|Sirolimus|sirolimus|mesh-list
154830174|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
154830175|NCT04177004|Etoposide|etoposide|mesh-list
154830176|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
154830177|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
154830178|NCT04177004|Tacrolimus|tacrolimus|mesh-list
154830179|NCT04177004|Mitogens|mitogens|mesh-list
154830180|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830181|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
154830182|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830183|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830184|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830185|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
154830186|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830187|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830188|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830189|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830190|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154830191|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154830192|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830193|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154830194|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154830195|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830196|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154830197|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
154830198|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830199|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
154830200|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
154830201|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830202|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830203|NCT04168112|Dexamethasone|dexamethasone|mesh-list
154830204|NCT04168112|Prednisolone|prednisolone|mesh-list
154830205|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154830206|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
154830207|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154830208|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
154830209|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154830210|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
154830211|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830212|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
154830213|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
154830214|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830215|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830216|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830217|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
154830218|NCT04168112|Hormones|hormones|mesh-ancestor
154830219|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830220|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830221|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830222|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154830223|NCT04168112|Protective Agents|protective agents|mesh-ancestor
154830224|NCT04131504|Adalimumab|adalimumab|mesh-list
154830225|NCT04131504|Infliximab|infliximab|mesh-list
154830226|NCT04131504|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154830227|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830228|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830229|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
154830230|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830231|NCT04036461|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154830232|NCT04036461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830233|NCT04036461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830234|NCT04005352|Aflibercept|aflibercept|mesh-list
154830235|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154830236|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154830237|NCT04005352|Growth Substances|growth substances|mesh-ancestor
154830238|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830239|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
154830240|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830241|NCT03964727|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154830242|NCT03964727|Immunoconjugates|immunoconjugates|mesh-ancestor
154830243|NCT03964727|Immunologic Factors|immunologic factors|mesh-ancestor
154830244|NCT03964727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830245|NCT03962920|Tigecycline|tigecycline|mesh-list
154830246|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154830247|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830248|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154830249|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830250|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830251|NCT03949517|Piperidine|piperidine|mesh-list
154830252|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154830253|NCT03949517|Bombesin|bombesin|mesh-list
154830254|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830255|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154830256|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154830257|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830258|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154830259|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154830260|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154830261|NCT03940586|Letermovir|letermovir|mesh-list
154830262|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154830263|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830264|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830265|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830266|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
154830267|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830268|NCT03865992|Curcumin|curcumin|mesh-list
154830269|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154830270|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154830271|NCT03865992|Analgesics|analgesics|mesh-ancestor
154830272|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
154830273|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830274|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830275|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830276|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830277|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830278|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830279|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830280|NCT03845582|Vitamin A|vitamin a|mesh-list
154830281|NCT03845582|Retinol acetate|retinol acetate|mesh-list
154830282|NCT03845582|Vitamins|vitamins|mesh-ancestor
154830283|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
154830284|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830285|NCT03845582|Protective Agents|protective agents|mesh-ancestor
154830286|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154830287|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830288|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154830289|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
154830290|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
154830291|NCT03789097|Poly ICLC|poly iclc|mesh-list
154830292|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830293|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830294|NCT03789097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154830295|NCT03789097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830296|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
154830297|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
154830298|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830299|NCT03769298|Tacrolimus|tacrolimus|mesh-list
154830300|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830301|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
154830302|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830303|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154830304|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830305|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830306|NCT03703297|Durvalumab|durvalumab|mesh-list
154830307|NCT03703297|Tremelimumab|tremelimumab|mesh-list
154830308|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830309|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830310|NCT03693677|Paclitaxel|paclitaxel|mesh-list
154830311|NCT03693677|Gemcitabine|gemcitabine|mesh-list
154830312|NCT03693677|Irinotecan|irinotecan|mesh-list
154830313|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830314|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830315|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830316|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830317|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830318|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830319|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830320|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
154830321|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154830322|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154830323|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830324|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
154830325|NCT03684213|Norepinephrine|norepinephrine|mesh-list
154830326|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
154830327|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
154830328|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830329|NCT03684213|Protective Agents|protective agents|mesh-ancestor
154830330|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830331|NCT03684213|Vitamins|vitamins|mesh-ancestor
154830332|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
154830333|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154830334|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154830335|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
154830336|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154830337|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
154830338|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
154830339|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830340|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154830341|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830342|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
154830343|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
154830344|NCT03674411|Melphalan|melphalan|mesh-list
154830345|NCT03674411|Busulfan|busulfan|mesh-list
154830346|NCT03674411|Fludarabine|fludarabine|mesh-list
154830347|NCT03674411|Tacrolimus|tacrolimus|mesh-list
154830348|NCT03674411|Lenograstim|lenograstim|mesh-list
154830349|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830350|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
154830351|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830352|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830353|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830354|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
154830355|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830356|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830357|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830358|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154830359|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830360|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154830361|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154830362|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
154830363|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154830364|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830365|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154830366|NCT03661320|Gemcitabine|gemcitabine|mesh-list
154830367|NCT03661320|Nivolumab|nivolumab|mesh-list
154830368|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830369|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830370|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
154830371|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830372|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830373|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154830374|NCT03571568|Rituximab|rituximab|mesh-list
154830375|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830376|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830377|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
154830378|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830379|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830380|NCT03570619|Nivolumab|nivolumab|mesh-list
154830381|NCT03570619|Ipilimumab|ipilimumab|mesh-list
154830382|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830383|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830384|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154830385|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830386|NCT03568461|Tisagenlecleucel|tisagenlecleucel|mesh-list
154830387|NCT03568461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830388|NCT03568461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830389|NCT03559049|Carboplatin|carboplatin|mesh-list
154830390|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
154830391|NCT03559049|Pemetrexed|pemetrexed|mesh-list
154830392|NCT03559049|Rucaparib|rucaparib|mesh-list
154830393|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830394|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830395|NCT03559049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154830396|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830397|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830398|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154830399|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154830400|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154830401|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
154830402|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154830403|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154830404|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154830405|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154830406|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830407|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
154830408|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154830409|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830410|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154830411|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830412|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
154830413|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154830414|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154830415|NCT03511625|Prednisolone|prednisolone|mesh-list
154830416|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
154830417|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154830418|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
154830419|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154830420|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830421|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
154830422|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
154830423|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830424|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830425|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830426|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
154830427|NCT03511625|Hormones|hormones|mesh-ancestor
154830428|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830429|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154830430|NCT03511625|Protective Agents|protective agents|mesh-ancestor
154830431|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830432|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830434|NCT03388190|Nivolumab|nivolumab|mesh-list
154830435|NCT03388190|Fluorouracil|fluorouracil|mesh-list
154830436|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
154830437|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
154830438|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830439|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830440|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154830441|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830442|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
154830443|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830444|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830445|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
154830446|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830447|NCT03388190|Antidotes|antidotes|mesh-ancestor
154830448|NCT03388190|Protective Agents|protective agents|mesh-ancestor
154830449|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
154830450|NCT03388190|Vitamins|vitamins|mesh-ancestor
154830451|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
154830452|NCT03306472|Letrozole|letrozole|mesh-list
154830453|NCT03306472|Megestrol|megestrol|mesh-list
154830454|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
154830455|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830456|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154830457|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154830458|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830459|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830460|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154830461|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
154830462|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830463|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830464|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154830465|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154830466|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154830467|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
154830468|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154830469|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154830470|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154009905|NCT02731560|Rituximab|rituximab|mesh-list
154830471|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830472|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
154830473|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154830474|NCT03288675|Serotonin|serotonin|mesh-list
154830475|NCT03288675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154830476|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154830477|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
154830478|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154830479|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830480|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830481|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154830482|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154830483|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
154830484|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830485|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830486|NCT03267888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154830487|NCT03267888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830488|NCT03151811|Dexamethasone|dexamethasone|mesh-list
154830489|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
154830490|NCT03151811|Melphalan|melphalan|mesh-list
154830491|NCT03151811|Pomalidomide|pomalidomide|mesh-list
154830492|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830493|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
154830494|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
154830495|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830496|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830497|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830498|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
154830499|NCT03151811|Hormones|hormones|mesh-ancestor
154830500|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830501|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830502|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830503|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830504|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
154830505|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830506|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830507|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830508|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
154830509|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154830510|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154830511|NCT03151811|Growth Substances|growth substances|mesh-ancestor
154830512|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
154830513|NCT03141970|Prednisone|prednisone|mesh-list
154830514|NCT03141970|Prednisolone|prednisolone|mesh-list
154830515|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830516|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
154830517|NCT03141970|Hormones|hormones|mesh-ancestor
154830518|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830519|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830520|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830521|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830522|NCT03016338|Niraparib|niraparib|mesh-list
154830523|NCT03016338|Dostarlimab|dostarlimab|mesh-list
154830524|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154830525|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830526|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830527|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830528|NCT03011814|Lenalidomide|lenalidomide|mesh-list
154830529|NCT03011814|Durvalumab|durvalumab|mesh-list
154830530|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
154830531|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154830532|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
154830533|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
154830534|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830535|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154830536|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154830537|NCT03011814|Growth Substances|growth substances|mesh-ancestor
154830538|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
154830539|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830540|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830541|NCT02970448|Temozolomide|temozolomide|mesh-list
154830542|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830543|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
154830544|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830545|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830546|NCT02950259|Indomethacin|indomethacin|mesh-list
154830547|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
154830548|NCT02950259|Omeprazole|omeprazole|mesh-list
154830549|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830550|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
154830551|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830552|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830553|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830554|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
154830555|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830556|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830557|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830558|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154830559|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830560|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154830561|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830562|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154830563|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154830564|NCT02950259|Analgesics|analgesics|mesh-ancestor
154830565|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
154830566|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830567|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830568|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
154830569|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
154830570|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154830571|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154830572|NCT02947685|Trastuzumab|trastuzumab|mesh-list
154830573|NCT02947685|Pertuzumab|pertuzumab|mesh-list
154830574|NCT02947685|Letrozole|letrozole|mesh-list
154830575|NCT02947685|Fulvestrant|fulvestrant|mesh-list
154830576|NCT02947685|Palbociclib|palbociclib|mesh-list
154830577|NCT02947685|Anastrozole|anastrozole|mesh-list
154830578|NCT02947685|Exemestane|exemestane|mesh-list
154830579|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830580|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830581|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154830582|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154830583|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830584|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830585|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154830586|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
154830587|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830588|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830589|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830590|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154830591|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154830592|NCT02865564|Gentamicins|gentamicins|mesh-list
154830593|NCT02865564|Ampicillin|ampicillin|mesh-list
154830594|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154830595|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830596|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154830597|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830598|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830599|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154830600|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830601|NCT02706951|Methotrexate|methotrexate|mesh-list
154830602|NCT02706951|Upadacitinib|upadacitinib|mesh-list
154830603|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154830604|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
154830605|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154830606|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830607|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830608|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
154830609|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830610|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830611|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
154830612|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830613|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154830614|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830615|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
154830616|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830617|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154830618|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154830619|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154830620|NCT02651662|Cemiplimab|cemiplimab|mesh-list
154830621|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830622|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830623|NCT02632305|Paclitaxel|paclitaxel|mesh-list
154830624|NCT02632305|Gemcitabine|gemcitabine|mesh-list
154830625|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830626|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830627|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830628|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830629|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830630|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830631|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830632|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
154830633|NCT02628405|Rituximab|rituximab|mesh-list
154830634|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154830635|NCT02628405|Carboplatin|carboplatin|mesh-list
154830636|NCT02628405|Etoposide|etoposide|mesh-list
154830637|NCT02628405|Lenalidomide|lenalidomide|mesh-list
154830638|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
154830639|NCT02628405|Ifosfamide|ifosfamide|mesh-list
154830640|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
154830641|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
154830642|NCT02628405|Antibodies|antibodies|mesh-list
154830643|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
154830644|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154830645|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
154830646|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830647|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830648|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830649|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830650|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154830651|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154830652|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830653|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830654|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154830655|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154830656|NCT02628405|Growth Substances|growth substances|mesh-ancestor
154830657|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
154830658|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830659|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
154830660|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
154830661|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
154830662|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830663|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830664|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830665|NCT02609386|Zinc|zinc|mesh-list
154830666|NCT02609386|Indomethacin|indomethacin|mesh-list
154830667|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
154830668|NCT02609386|Omeprazole|omeprazole|mesh-list
154830669|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154830670|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830671|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
154830672|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830673|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830674|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830675|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
154830676|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830677|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830678|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830679|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
154830680|NCT02609386|Trace Elements|trace elements|mesh-ancestor
154830681|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154830682|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830683|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830684|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154830685|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154830686|NCT02609386|Analgesics|analgesics|mesh-ancestor
154830687|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
154830688|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830689|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830690|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
154830691|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
154830692|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154830693|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154830694|NCT02576717|Ozanimod|ozanimod|mesh-list
154830695|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154830696|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830697|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830698|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
154830699|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830700|NCT02517307|Heparin|heparin|mesh-list
154830701|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154830702|NCT02517307|Glycerol|glycerol|mesh-list
154830703|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
154830704|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154830705|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154830706|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830707|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154830708|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154830709|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154830710|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154830711|NCT02517307|Protective Agents|protective agents|mesh-ancestor
154830712|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830713|NCT02499354|Iron|iron|mesh-list
154830714|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154830715|NCT02499354|Trace Elements|trace elements|mesh-ancestor
154830716|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
154830717|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830718|NCT02499354|Hematinics|hematinics|mesh-ancestor
154830719|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154830720|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154830721|NCT02488967|Paclitaxel|paclitaxel|mesh-list
154830722|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
154830723|NCT02488967|Carboplatin|carboplatin|mesh-list
154830724|NCT02488967|Doxorubicin|doxorubicin|mesh-list
154830725|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154830726|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154830727|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830728|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830729|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830730|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830731|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830732|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830733|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830734|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
154830735|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830736|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830737|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830738|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
154830739|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830740|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154830741|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154830742|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154830743|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830744|NCT02399410|Bevacizumab|bevacizumab|mesh-list
154830745|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
154830746|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830747|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830748|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154830749|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154830750|NCT02399410|Growth Substances|growth substances|mesh-ancestor
154830751|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830752|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
154830753|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154830754|NCT02369835|Eusol|eusol|mesh-list
154830755|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154830756|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
154830757|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830758|NCT02367859|Trametinib|trametinib|mesh-list
154830759|NCT02367859|Dabrafenib|dabrafenib|mesh-list
154830760|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830761|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154830762|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830763|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830764|NCT02362503|Fostemsavir|fostemsavir|mesh-list
154830765|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154830766|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154830767|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
154830768|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830769|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154830770|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154830771|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830772|NCT02337985|Prednisone|prednisone|mesh-list
154830773|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
154830774|NCT02337985|Rituximab|rituximab|mesh-list
154830775|NCT02337985|Doxorubicin|doxorubicin|mesh-list
154830776|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154830777|NCT02337985|Etoposide|etoposide|mesh-list
154830778|NCT02337985|Vincristine|vincristine|mesh-list
154830779|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830780|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
154830781|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830782|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830783|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830784|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
154830785|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830786|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830787|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830788|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830789|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154830790|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154830791|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154830792|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830793|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830794|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
154830795|NCT02337985|Hormones|hormones|mesh-ancestor
154830796|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830797|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830798|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830799|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830800|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830801|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830802|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
154830803|NCT02159495|Fludarabine|fludarabine|mesh-list
154830804|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
154830805|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830806|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
154582760|NCT05984173|Vitamin E|vitamin e|mesh-list
154830807|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830808|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830809|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830810|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
154830811|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830812|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830813|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830814|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830815|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
154830816|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
154830817|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154830818|NCT02153580|Fludarabine|fludarabine|mesh-list
154830819|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
154830820|NCT02153580|Etoposide|etoposide|mesh-list
154830821|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
154830822|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
154830823|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830824|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
154830825|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830826|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830827|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830828|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
154830829|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830830|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830831|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830832|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830833|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
154830834|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830835|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154830836|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154830837|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830838|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
154830839|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
154830840|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830841|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830842|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
154830843|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154830844|NCT02127164|Eusol|eusol|mesh-list
154830845|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
154830846|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830847|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
154830848|NCT02081755|Everolimus|everolimus|mesh-list
154830849|NCT02081755|Azathioprine|azathioprine|mesh-list
154830850|NCT02081755|Tacrolimus|tacrolimus|mesh-list
154830851|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830852|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
154830853|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830854|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154830855|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830856|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830857|NCT02081755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154830858|NCT02081755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154830859|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830860|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154830861|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154830862|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
154830863|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154830864|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830865|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
154830866|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830867|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830868|NCT01996696|Metformin|metformin|mesh-list
154830869|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154830870|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830871|NCT01984138|Estradiol|estradiol|mesh-list
154830872|NCT01984138|Estrogens|estrogens|mesh-ancestor
154830873|NCT01984138|Hormones|hormones|mesh-ancestor
154830874|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830875|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830876|NCT01907074|Cholic Acids|cholic acids|mesh-list
154830877|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830878|NCT01811498|Bevacizumab|bevacizumab|mesh-list
154830879|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830880|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830881|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154830882|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154830883|NCT01811498|Growth Substances|growth substances|mesh-ancestor
154830884|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830885|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
154830886|NCT01553149|Lenalidomide|lenalidomide|mesh-list
154830887|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
154830888|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830889|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154830890|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154830891|NCT01553149|Growth Substances|growth substances|mesh-ancestor
154830892|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
154830893|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830894|NCT01522469|Crenolanib|crenolanib|mesh-list
154830895|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830896|NCT01478737|Dexamethasone|dexamethasone|mesh-list
154830897|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
154830898|NCT01478737|BB 1101|bb 1101|mesh-list
154830899|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830900|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
154830901|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
154830902|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830903|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830904|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830905|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
154830906|NCT01478737|Hormones|hormones|mesh-ancestor
154830907|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154830908|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154830909|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830910|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
154830911|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830912|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830913|NCT01468337|Interferons|interferons|mesh-list
154830914|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
154830915|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830916|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
154830917|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830918|NCT01437449|Carboplatin|carboplatin|mesh-list
154830919|NCT01437449|Docetaxel|docetaxel|mesh-list
154830920|NCT01437449|Cetuximab|cetuximab|mesh-list
154830921|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830922|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
154830923|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
154830924|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
154010329|NCT05432089|Oxytocin|oxytocin|mesh-list
154830925|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830926|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830927|NCT01437189|Sertraline|sertraline|mesh-list
154830928|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
154830929|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154830930|NCT01437189|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154830931|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154830932|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154830933|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830934|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154830935|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
154830936|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830937|NCT01356290|Cytarabine|cytarabine|mesh-list
154830938|NCT01356290|Thalidomide|thalidomide|mesh-list
154830939|NCT01356290|Celecoxib|celecoxib|mesh-list
154830940|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
154830941|NCT01356290|Bevacizumab|bevacizumab|mesh-list
154830942|NCT01356290|Etoposide|etoposide|mesh-list
154830943|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
154830944|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
154830945|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154830946|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
154830947|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830948|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154830949|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154830950|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
154830951|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830952|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830953|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154830954|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154830955|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154830956|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154830957|NCT01356290|Growth Substances|growth substances|mesh-ancestor
154830958|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
154830959|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154830960|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154582894|NCT05736419|Autonomic Agents|autonomic agents|mesh-ancestor
154830961|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154830963|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154830964|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
154830965|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
154830966|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154830967|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154830968|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154830969|NCT01356290|Analgesics|analgesics|mesh-ancestor
154830970|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
154830971|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154830972|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154830973|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154830974|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154830975|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
154830976|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154830977|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154830978|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154830979|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154830980|NCT01341600|Omeprazole|omeprazole|mesh-list
154830981|NCT01341600|Clopidogrel|clopidogrel|mesh-list
154830982|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154830983|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154010406|NCT05084586|Epirubicin|epirubicin|mesh-list
154830984|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154830985|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154830986|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
154830987|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154830988|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830989|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154830990|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154830991|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154830992|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154830993|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830994|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154830995|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154830996|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154830997|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154830998|NCT01260870|Paclitaxel|paclitaxel|mesh-list
154830999|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154831000|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831001|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
154831002|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
154831003|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
154831004|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831005|NCT01120795|Interferons|interferons|mesh-list
154831006|NCT01120795|Ribavirin|ribavirin|mesh-list
154831007|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154831008|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
154831009|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831010|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
154831011|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831012|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
154831013|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831014|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
154831015|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831016|NCT00890604|Acetaminophen|acetaminophen|mesh-list
154831017|NCT00890604|Ibuprofen|ibuprofen|mesh-list
154831018|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154831019|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154831020|NCT00890604|Analgesics|analgesics|mesh-ancestor
154831021|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
154831022|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831023|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831024|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831025|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154831026|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154831027|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831028|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831029|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
154831030|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154831031|NCT00659776|Hematinics|hematinics|mesh-ancestor
154831032|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154831033|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154831034|NCT00617656|Cisplatin|cisplatin|mesh-list
154831035|NCT00617656|Gemcitabine|gemcitabine|mesh-list
154831036|NCT00617656|Docetaxel|docetaxel|mesh-list
154831037|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831038|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154831039|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
154831040|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831041|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
154831042|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
154831043|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
154831044|NCT00235053|Fluticasone|fluticasone|mesh-list
154831045|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154831046|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154831047|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831048|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154831049|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
154831050|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831051|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831052|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154831053|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
154831054|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
154831055|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154831056|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154831057|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154831058|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154831059|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
154831060|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831061|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831062|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
154831063|NCT00235053|Hormones|hormones|mesh-ancestor
154831064|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831065|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
154831066|NCT05016947|Dexamethasone|dexamethasone|mesh-list
154831067|NCT05016947|Venetoclax|venetoclax|mesh-list
154831068|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154831069|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831070|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
154831071|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
154831072|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831073|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831074|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831075|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
154831076|NCT05016947|Hormones|hormones|mesh-ancestor
154831077|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831078|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154831079|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831080|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831081|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154831082|NCT05016947|Immunotoxins|immunotoxins|mesh-ancestor
154831083|NCT05016947|Immunoconjugates|immunoconjugates|mesh-ancestor
154831084|NCT05016947|Immunologic Factors|immunologic factors|mesh-ancestor
154831085|NCT04963712|Thymalfasin|thymalfasin|mesh-list
154831086|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154831087|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
154831088|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831089|NCT04750616|Niacinamide|niacinamide|mesh-list
154831090|NCT04750616|Niacin|niacin|mesh-list
154831091|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
154831092|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
154831093|NCT04750616|Vitamins|vitamins|mesh-ancestor
154831094|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
154831095|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831096|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154831097|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
154831098|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831099|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154831100|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
154831101|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
154831102|NCT04697576|Nivolumab|nivolumab|mesh-list
154831103|NCT04697576|Ipilimumab|ipilimumab|mesh-list
154831104|NCT04697576|Relatlimab|relatlimab|mesh-list
154831105|NCT04697576|Vaccines|vaccines|mesh-list
154831106|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
154831107|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831108|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831109|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831110|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154831111|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831112|NCT04673422|Montelukast|montelukast|mesh-list
154831113|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154831114|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
154831115|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154831117|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831118|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831119|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154831120|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154831121|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831122|NCT04646356|Tacrolimus|tacrolimus|mesh-list
154831123|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154831124|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
154831125|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831126|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154831127|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831128|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831129|NCT04618016|Vitamins|vitamins|mesh-list
154831130|NCT04618016|Vitamin E|vitamin e|mesh-list
154831131|NCT04618016|Tocopherols|tocopherols|mesh-list
154831132|NCT04618016|Tocotrienols|tocotrienols|mesh-list
154831133|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
154831134|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
154831135|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831136|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
154831137|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831138|NCT04618016|Protective Agents|protective agents|mesh-ancestor
154831139|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
154831140|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154831141|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
154831142|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154831143|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
154831144|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831145|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831146|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
154831147|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154831148|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154831149|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154831150|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
154831151|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
154831152|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154831153|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154831154|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831155|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154831156|NCT04425018|Paclitaxel|paclitaxel|mesh-list
154831157|NCT04425018|Trastuzumab|trastuzumab|mesh-list
154831158|NCT04425018|Pertuzumab|pertuzumab|mesh-list
154831159|NCT04425018|Margetuximab|margetuximab|mesh-list
154831160|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154831161|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831162|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154831163|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
154831164|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154831165|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831166|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831167|NCT04300595|Anesthetics|anesthetics|mesh-list
154831168|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154831169|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831170|NCT04212026|Nivolumab|nivolumab|mesh-list
154831171|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831172|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831173|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154010578|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
154831174|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831175|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
154831176|NCT04187144|Gepotidacin|gepotidacin|mesh-list
154831177|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154831178|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831179|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154831180|NCT04187144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154831181|NCT04187144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831182|NCT04187144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831183|NCT04187144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831184|NCT04017468|Vancomycin|vancomycin|mesh-list
154831185|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154831186|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831187|NCT03976310|Benralizumab|benralizumab|mesh-list
154831188|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154831189|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
154831190|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
154831191|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154831192|NCT03949764|Velpatasvir|velpatasvir|mesh-list
154831193|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
154831194|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831195|NCT03930212|Progesterone|progesterone|mesh-list
154831196|NCT03930212|Progestins|progestins|mesh-ancestor
154831197|NCT03930212|Hormones|hormones|mesh-ancestor
154831198|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831199|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831200|NCT03893617|Propranolol|propranolol|mesh-list
154831201|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154831202|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154831203|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
154831204|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831205|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831206|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831207|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154831208|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154831209|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
154831210|NCT03856047|Liraglutide|liraglutide|mesh-list
154831211|NCT03856047|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154831212|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154831213|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831214|NCT03856047|Incretins|incretins|mesh-ancestor
154831215|NCT03856047|Hormones|hormones|mesh-ancestor
154831216|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831217|NCT03737136|Bortezomib|bortezomib|mesh-list
154831218|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831219|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
154831220|NCT03647163|Nivolumab|nivolumab|mesh-list
154831221|NCT03647163|Ipilimumab|ipilimumab|mesh-list
154831222|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831223|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831224|NCT03647163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154831225|NCT03647163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831226|NCT03635749|Atorvastatin|atorvastatin|mesh-list
154831227|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154831228|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831229|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831230|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154831231|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154831232|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
154831233|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154831234|NCT03599453|Interferons|interferons|mesh-list
154831235|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
154831236|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
154831237|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154831238|NCT03599453|Poly I-C|poly i-c|mesh-list
154831239|NCT03599453|Celecoxib|celecoxib|mesh-list
154831240|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
154831241|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
154831242|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
154831243|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831244|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831245|NCT03599453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154831246|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831247|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
154831248|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831249|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
154831250|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831251|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154831252|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154831253|NCT03599453|Analgesics|analgesics|mesh-ancestor
154831254|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
154831255|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831256|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831257|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154831258|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154831259|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154831260|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831261|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
154831262|NCT03573960|Lenvatinib|lenvatinib|mesh-list
154831263|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831264|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154831265|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831266|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831267|NCT03554291|Famotidine|famotidine|mesh-list
154831268|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154831269|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831270|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154831271|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
154831272|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
154831273|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831274|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831275|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831276|NCT03464461|Ketorolac|ketorolac|mesh-list
154831277|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154831278|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154831279|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154831280|NCT03464461|Analgesics|analgesics|mesh-ancestor
154831281|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
154831282|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831283|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831284|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831285|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154831286|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154831287|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831288|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831289|NCT03440437|Paclitaxel|paclitaxel|mesh-list
154831290|NCT03440437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154831291|NCT03440437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831292|NCT03440437|Tubulin Modulators|tubulin modulators|mesh-ancestor
154831293|NCT03440437|Antimitotic Agents|antimitotic agents|mesh-ancestor
154831294|NCT03440437|Mitosis Modulators|mitosis modulators|mesh-ancestor
154831295|NCT03440437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831296|NCT03374956|Liraglutide|liraglutide|mesh-list
154831297|NCT03374956|Topiramate|topiramate|mesh-list
154831298|NCT03374956|Phentermine|phentermine|mesh-list
154831299|NCT03374956|Naltrexone|naltrexone|mesh-list
154831300|NCT03374956|Bupropion|bupropion|mesh-list
154831301|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154831302|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154831303|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831304|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
154831305|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831306|NCT03374956|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154831307|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154831308|NCT03374956|Incretins|incretins|mesh-ancestor
154831309|NCT03374956|Hormones|hormones|mesh-ancestor
154831310|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831311|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154831312|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
154831313|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154831314|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154831315|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154831316|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154831317|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831318|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
154831319|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831320|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154831321|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154831322|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831323|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
154831324|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154831325|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
154831326|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154831327|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
154831328|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
154831329|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
154831330|NCT03334682|Doxycycline|doxycycline|mesh-list
154831331|NCT03334682|Spironolactone|spironolactone|mesh-list
154831332|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154831333|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831334|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
154831335|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154831336|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154831337|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154831338|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
154831339|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831340|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831341|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154831342|NCT03334682|Diuretics|diuretics|mesh-ancestor
154831343|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
154831344|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
154831345|NCT03112603|Sirolimus|sirolimus|mesh-list
154831346|NCT03112603|Infliximab|infliximab|mesh-list
154831347|NCT03112603|Rituximab|rituximab|mesh-list
154831348|NCT03112603|Methotrexate|methotrexate|mesh-list
154831349|NCT03112603|Everolimus|everolimus|mesh-list
154831350|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
154831351|NCT03112603|Pentostatin|pentostatin|mesh-list
154831352|NCT03112603|Ibrutinib|ibrutinib|mesh-list
154831353|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831354|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831355|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
154831356|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831357|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154831358|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154831359|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
154831360|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154831361|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154831362|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
154831363|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831364|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154831365|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831366|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154831367|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154831368|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154831369|NCT03112603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154831370|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154831371|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154831372|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154831373|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
154831374|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154831375|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831376|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
154831377|NCT03112603|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154831378|NCT03112603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154831379|NCT03112603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831380|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831381|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154831382|NCT03073317|Mitogens|mitogens|mesh-list
154831383|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
154831384|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831385|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
154831386|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831387|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831388|NCT02736266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154831389|NCT02736266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831390|NCT02627963|Sorafenib|sorafenib|mesh-list
154831391|NCT02627963|Tivozanib|tivozanib|mesh-list
154831392|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831393|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154831394|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831395|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831396|NCT02589691|Rocuronium|rocuronium|mesh-list
154831397|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154831398|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154831399|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154831400|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831401|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831402|NCT02585258|Prednisolone|prednisolone|mesh-list
154831403|NCT02585258|Glucocorticoids|glucocorticoids|mesh-list
154831404|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831405|NCT02585258|Hormones|hormones|mesh-ancestor
154831406|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831407|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831408|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154831409|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831410|NCT02203604|Aldesleukin|aldesleukin|mesh-list
154831411|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154831412|NCT02203604|Ipilimumab|ipilimumab|mesh-list
154583351|NCT02804022|Morphine|morphine|mesh-list
154831414|NCT02203604|Antibodies|antibodies|mesh-list
154831415|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
154831416|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154831417|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
154831418|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831419|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831420|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154831421|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831422|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154831423|NCT02203604|Analgesics|analgesics|mesh-ancestor
154831424|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
154831425|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831426|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154831427|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154831428|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
154831429|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831430|NCT01228240|Metformin|metformin|mesh-list
154831431|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154831432|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831433|NCT00701220|Atorvastatin|atorvastatin|mesh-list
154831434|NCT00701220|Calcium|calcium|mesh-list
154831435|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154831436|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831437|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154831438|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154831439|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
154831440|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831441|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154831442|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154831443|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831444|NCT00677924|Zalutumumab|zalutumumab|mesh-list
154831445|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831446|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831447|NCT00251303|Riluzole|riluzole|mesh-list
154831448|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
154831449|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154831450|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154831451|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831452|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831453|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831454|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154831455|NCT00251303|Protective Agents|protective agents|mesh-ancestor
154831456|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154831457|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
154831458|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831459|NCT00303823|Protective Agents|protective agents|mesh-ancestor
154831460|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831461|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154831462|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154831463|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831464|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154831465|NCT00300677|Voriconazole|voriconazole|mesh-list
154831466|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
154831467|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831468|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154831469|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154831470|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831471|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831472|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154831473|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
154831474|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831475|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831476|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154831477|NCT00559845|Paclitaxel|paclitaxel|mesh-list
154831478|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
154831479|NCT00559845|Bevacizumab|bevacizumab|mesh-list
154831480|NCT00559845|Fluorouracil|fluorouracil|mesh-list
154831481|NCT00559845|Epirubicin|epirubicin|mesh-list
154831482|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154831483|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831484|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
154831485|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
154831486|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
154831487|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831488|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154831489|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
154831490|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831491|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154010889|NCT02810132|Metformin|metformin|mesh-list
154831492|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154831493|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
154831494|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154831495|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154831496|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154831497|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154831498|NCT00559845|Growth Substances|growth substances|mesh-ancestor
154831499|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
154831500|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
154831501|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154831502|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154831503|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154831504|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154831505|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831506|NCT00304187|Erythromycin|erythromycin|mesh-list
154831507|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
154831508|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154831509|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
154831510|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154831511|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831512|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831513|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154831514|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831515|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831516|NCT00334633|Metronidazole|metronidazole|mesh-list
154831517|NCT00334633|Tinidazole|tinidazole|mesh-list
154831518|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831519|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154831520|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154831521|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154831522|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
154831523|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831524|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154831525|NCT01393964|Dexamethasone|dexamethasone|mesh-list
154831526|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
154831527|NCT01393964|Lenalidomide|lenalidomide|mesh-list
154831528|NCT01393964|Elotuzumab|elotuzumab|mesh-list
154831529|NCT01393964|BB 1101|bb 1101|mesh-list
154831530|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831531|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
154831532|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
154831533|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831534|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831535|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831536|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
154831537|NCT01393964|Hormones|hormones|mesh-ancestor
154831538|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831539|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154831540|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831541|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
154831542|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831543|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831544|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
154831545|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154831546|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154831547|NCT01393964|Growth Substances|growth substances|mesh-ancestor
154831548|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
154831549|NCT01790555|Diazepam|diazepam|mesh-list
154831550|NCT01790555|Dronabinol|dronabinol|mesh-list
154831551|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154831552|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
154831553|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
154831554|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
154831555|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831556|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831557|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831558|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154831559|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154831560|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154831561|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154831562|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154831563|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154831564|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154831565|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154831566|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
154831567|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
154831568|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
154831569|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
154831570|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831571|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831572|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
154831573|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154831574|NCT01790555|Analgesics|analgesics|mesh-ancestor
154831575|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
154831576|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154831577|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154831578|NCT01790555|Hormones|hormones|mesh-ancestor
154831579|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831580|NCT00335725|Hormones|hormones|mesh-list
154831581|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154831582|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831583|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831584|NCT01393730|Prednisone|prednisone|mesh-list
154831585|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
154831586|NCT01393730|Dutasteride|dutasteride|mesh-list
154831587|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831588|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
154831589|NCT01393730|Hormones|hormones|mesh-ancestor
154831590|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831591|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831592|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154831593|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831594|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154831595|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831596|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831597|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
154831598|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154831599|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154831600|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
154831601|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154831602|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831603|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154831604|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
154831605|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154831606|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831607|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831608|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831609|NCT00337987|Prednisone|prednisone|mesh-list
154831610|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
154831611|NCT00337987|Vincristine|vincristine|mesh-list
154831612|NCT00337987|Doxorubicin|doxorubicin|mesh-list
154831613|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154831614|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
154831615|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154831616|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
154831617|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831618|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154831619|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154831620|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
154831621|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831622|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831623|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154831624|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831625|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
154831626|NCT00337987|Hormones|hormones|mesh-ancestor
154831627|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831628|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154831629|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154831630|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
154831631|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
154831632|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
154831633|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154831634|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154831635|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154831637|NCT01393106|Idelalisib|idelalisib|mesh-list
154831638|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831639|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831640|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831641|NCT00553059|Dexamethasone|dexamethasone|mesh-list
154831642|NCT00553059|Dronabinol|dronabinol|mesh-list
154831643|NCT00553059|Palonosetron|palonosetron|mesh-list
154831644|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831645|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
154831646|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
154831647|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831648|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831649|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831650|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
154831651|NCT00553059|Hormones|hormones|mesh-ancestor
154831652|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831653|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154011063|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154831654|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831655|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154831656|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154831657|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
154831658|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831659|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831660|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
154831661|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154831662|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154831663|NCT00553059|Analgesics|analgesics|mesh-ancestor
154831664|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
154831665|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154831666|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154831667|NCT02989311|Iron|iron|mesh-list
154831668|NCT02989311|Trace Elements|trace elements|mesh-ancestor
154831669|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
154831670|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831671|NCT02015611|Vitamin D|vitamin d|mesh-list
154831672|NCT02015611|Vitamins|vitamins|mesh-ancestor
154831673|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
154831674|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831675|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154831676|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
154831677|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154831678|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154831679|NCT01413542|Enalaprilat|enalaprilat|mesh-list
154831680|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154831681|NCT01413542|Bradykinin|bradykinin|mesh-list
154831682|NCT01413542|Glucagon|glucagon|mesh-list
154831683|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154831684|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154831685|NCT01413542|Substance P|substance p|mesh-list
154831686|NCT01413542|Neurokinin A|neurokinin a|mesh-list
154831687|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154831688|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831689|NCT01413542|Incretins|incretins|mesh-ancestor
154831690|NCT01413542|Hormones|hormones|mesh-ancestor
154831691|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831692|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
154831693|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831694|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831695|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831696|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
154831697|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
154831698|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154831699|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831700|NCT01873989|Testosterone|testosterone|mesh-list
154831701|NCT01873989|Androgens|androgens|mesh-ancestor
154831702|NCT01873989|Hormones|hormones|mesh-ancestor
154831703|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831704|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831705|NCT01875159|Caffeine|caffeine|mesh-list
154831706|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
154831707|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831708|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154831709|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831710|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154831711|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831712|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154831713|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154831714|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
154831715|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831716|NCT01432574|Vaccines|vaccines|mesh-list
154831717|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
154011111|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
154831718|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831719|NCT00339079|Fluoxetine|fluoxetine|mesh-list
154831720|NCT00339079|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154831721|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154831722|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154831723|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831724|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831725|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
154831726|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831727|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154831728|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
154831729|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154831730|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154831731|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154831732|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831733|NCT01392560|Empagliflozin|empagliflozin|mesh-list
154831734|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154831735|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831736|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154831737|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831738|NCT00342355|Ritonavir|ritonavir|mesh-list
154831739|NCT00342355|Lopinavir|lopinavir|mesh-list
154831740|NCT00342355|Lamivudine|lamivudine|mesh-list
154831741|NCT00342355|Zidovudine|zidovudine|mesh-list
154831742|NCT00342355|Didanosine|didanosine|mesh-list
154831743|NCT00342355|Stavudine|stavudine|mesh-list
154831744|NCT00342355|Efavirenz|efavirenz|mesh-list
154831745|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154831746|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154831747|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
154831748|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831749|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831750|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154831751|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154831752|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
154831753|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831754|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154831755|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154831756|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154831757|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154831758|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
154831759|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154831760|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154831761|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154831762|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154831763|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154831764|NCT00306163|Fluticasone|fluticasone|mesh-list
154831765|NCT00306163|Ciclesonide|ciclesonide|mesh-list
154831766|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831767|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154831768|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
154831769|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831770|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831771|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154831772|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
154831773|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
154831774|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154831775|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
154831776|NCT00306163|Hormones|hormones|mesh-ancestor
154831777|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831778|NCT01861665|Bupivacaine|bupivacaine|mesh-list
154831779|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
154831780|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
154831781|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154831782|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831783|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
154831784|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583793|NCT02258074|Niacin|niacin|mesh-list
154831785|NCT00330161|Vorinostat|vorinostat|mesh-list
154831786|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831787|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154831788|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831789|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831791|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
154831792|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831793|NCT00309751|Atorvastatin|atorvastatin|mesh-list
154831794|NCT00309751|Pitavastatin|pitavastatin|mesh-list
154831795|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154831796|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154831797|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
154831798|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831799|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154831800|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154831801|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831802|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154831803|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154831804|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831805|NCT02988999|Erythritol|erythritol|mesh-list
154831806|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
154831807|NCT00313729|Temozolomide|temozolomide|mesh-list
154831808|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154831809|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
154831810|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831811|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831812|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154831813|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154831814|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831815|NCT05266651|Tadalafil|tadalafil|mesh-list
154831816|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
154831817|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154831818|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154831819|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831820|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831821|NCT05266651|Urological Agents|urological agents|mesh-ancestor
154831822|NCT05746689|Sirolimus|sirolimus|mesh-list
154831823|NCT05746689|Prednisone|prednisone|mesh-list
154831824|NCT05746689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831825|NCT05746689|Glucocorticoids|glucocorticoids|mesh-ancestor
154831826|NCT05746689|Hormones|hormones|mesh-ancestor
154831827|NCT05746689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831828|NCT05746689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831829|NCT05746689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154831830|NCT05746689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831831|NCT05746689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154831832|NCT05746689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831833|NCT05746689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154831834|NCT05746689|Antifungal Agents|antifungal agents|mesh-ancestor
154831835|NCT05746689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154831836|NCT05746689|Immunologic Factors|immunologic factors|mesh-ancestor
154831837|NCT01412060|Cariprazine|cariprazine|mesh-list
154831838|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154831839|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154831840|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154831841|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831842|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154831843|NCT00345865|Cytarabine|cytarabine|mesh-list
154831844|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
154831845|NCT00345865|Carmustine|carmustine|mesh-list
154831846|NCT00345865|Etoposide|etoposide|mesh-list
154831847|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154831848|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
154831849|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831850|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154831851|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154831852|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
154831853|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831854|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831855|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154831856|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154831857|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154831858|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154831859|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831860|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154831861|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
154831862|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
154831863|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154831864|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154831865|NCT00551421|Cetuximab|cetuximab|mesh-list
154831866|NCT00551421|Pertuzumab|pertuzumab|mesh-list
154831867|NCT00551421|Irinotecan|irinotecan|mesh-list
154831868|NCT00551421|Antibodies|antibodies|mesh-list
154831869|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
154831870|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154831871|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
154831872|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831873|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831874|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154831875|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154831876|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831877|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831878|NCT01791751|Clomiphene|clomiphene|mesh-list
154831879|NCT01791751|Enclomiphene|enclomiphene|mesh-list
154831880|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
154831881|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154831882|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
154831883|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831884|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831885|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154831886|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
154831887|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154831888|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154011281|NCT02812394|Levodopa|levodopa|mesh-list
154831889|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154831890|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
154831891|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
154831892|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
154831893|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154831894|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831895|NCT05266261|Vitamins|vitamins|mesh-ancestor
154831896|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
154831897|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154831898|NCT05266261|Antacids|antacids|mesh-ancestor
154831899|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831900|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831901|NCT05266105|Palbociclib|palbociclib|mesh-list
154831902|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831903|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154831904|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831905|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831906|NCT01891643|Dexamethasone|dexamethasone|mesh-list
154831907|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
154831908|NCT01891643|Lenalidomide|lenalidomide|mesh-list
154831909|NCT01891643|Elotuzumab|elotuzumab|mesh-list
154831910|NCT01891643|BB 1101|bb 1101|mesh-list
154831911|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154831912|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
154831913|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
154831914|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831915|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831916|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831917|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
154831918|NCT01891643|Hormones|hormones|mesh-ancestor
154831919|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154831920|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154831921|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831922|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
154831923|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831924|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831925|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
154831926|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154831927|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154831928|NCT01891643|Growth Substances|growth substances|mesh-ancestor
154831929|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
154831930|NCT05265793|Apatinib|apatinib|mesh-list
154831931|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154831932|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154831933|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154831934|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831935|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
154831936|NCT04005599|Remifentanil|remifentanil|mesh-list
154831937|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154831938|NCT04005599|Narcotics|narcotics|mesh-ancestor
154831939|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154831940|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831941|NCT04005599|Analgesics|analgesics|mesh-ancestor
154831942|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
154831943|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831944|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
154831945|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154831946|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
154831947|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154831948|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154831949|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831950|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154831951|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
154831952|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154831953|NCT00330863|Olanzapine|olanzapine|mesh-list
154831954|NCT00330863|Risperidone|risperidone|mesh-list
154831955|NCT00330863|Aripiprazole|aripiprazole|mesh-list
154831956|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154011349|NCT00936793|Hormones|hormones|mesh-ancestor
154831957|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154831958|NCT00330863|Ziprasidone|ziprasidone|mesh-list
154831959|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154831960|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
154831961|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154831962|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154831963|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831964|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154831965|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154831966|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154831967|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154831968|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154831969|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
154831970|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
154831971|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
154831972|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831973|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154831974|NCT00330863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154831975|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154831976|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154831977|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
154831978|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
154831979|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154831980|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154831981|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154831982|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154831983|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
154831984|NCT01899521|Astringents|astringents|mesh-ancestor
154831985|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831986|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
154831987|NCT01790009|Acetaminophen|acetaminophen|mesh-list
154831988|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154831989|NCT01790009|Analgesics|analgesics|mesh-ancestor
154831990|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
154831991|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154831992|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154831993|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
154831994|NCT05737329|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154831995|NCT05737329|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154831996|NCT05737329|Estradiol|estradiol|mesh-list
154831997|NCT05737329|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154831998|NCT05737329|Estrogens|estrogens|mesh-ancestor
154831999|NCT05737329|Hormones|hormones|mesh-ancestor
154832000|NCT05737329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154832001|NCT05737329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832002|NCT05737329|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154832003|NCT05737329|Contraceptive Agents|contraceptive agents|mesh-ancestor
154832004|NCT05737329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154832005|NCT05737329|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154832006|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
154832007|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154832008|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
154832009|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832010|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
154832011|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583962|NCT05944341|Lidocaine|lidocaine|mesh-list
154832012|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832013|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154832014|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154832015|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832016|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832017|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832018|NCT00332579|Naltrexone|naltrexone|mesh-list
154832019|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154832020|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154832021|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832022|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
154832023|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832024|NCT00318409|Bupropion|bupropion|mesh-list
154832025|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154832026|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
154832027|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832028|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154832029|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154832030|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832031|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832032|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
154832033|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832034|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832035|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154832036|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154832037|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832038|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
154832039|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154832040|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832041|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154832042|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
154832043|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154832044|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832045|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832046|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832047|NCT04129619|Ether|ether|mesh-list
154832048|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154832049|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
154832050|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
154832051|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832052|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832053|NCT00353119|Etanercept|etanercept|mesh-list
154832054|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154832055|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154832056|NCT00353119|Analgesics|analgesics|mesh-ancestor
154832057|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
154832058|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832059|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832060|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154832061|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832062|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154832063|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832064|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
154832065|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
154832066|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154832067|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832068|NCT00353977|Vaccines|vaccines|mesh-list
154832069|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
154832070|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832071|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
154832072|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154832073|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154832074|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154832075|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832076|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832077|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
154832078|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832079|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832080|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154832081|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832082|NCT01792375|Dinoprostone|dinoprostone|mesh-list
154832083|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
154011478|NCT05906199|Antipyretics|antipyretics|mesh-ancestor
154832084|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154584033|NCT05943379|Antimetabolites|antimetabolites|mesh-ancestor
154832085|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832086|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154832087|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
154832088|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832089|NCT00320671|Risperidone|risperidone|mesh-list
154832090|NCT00320671|Aripiprazole|aripiprazole|mesh-list
154832091|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154832092|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
154832093|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832094|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832095|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832096|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154832097|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154832098|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832099|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832100|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154832101|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
154832102|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
154832103|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
154832104|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154832105|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154832106|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154832107|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154832108|NCT00320749|Gemcitabine|gemcitabine|mesh-list
154832109|NCT00320749|Capecitabine|capecitabine|mesh-list
154832110|NCT00320749|Docetaxel|docetaxel|mesh-list
154832111|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832112|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
154832113|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832114|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832115|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
154832116|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
154832117|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
154832118|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
154832119|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
154832120|NCT00354913|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154832121|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154832122|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832123|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832124|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832125|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
154832126|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154832127|NCT01432262|Vaccines|vaccines|mesh-list
154832128|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154832129|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
154832130|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832131|NCT00322309|Mirtazapine|mirtazapine|mesh-list
154832132|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
154832133|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832134|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154832135|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
154832136|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
154832137|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832138|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832139|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832140|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154832141|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154832142|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832143|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154832144|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154832145|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154832146|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
154832147|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154832148|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154832149|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
154832150|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154832151|NCT04046744|Lidocaine|lidocaine|mesh-list
154832152|NCT04046744|Analgesics|analgesics|mesh-list
154832153|NCT04046744|Ropivacaine|ropivacaine|mesh-list
154832154|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
154832155|NCT04046744|Anesthetics|anesthetics|mesh-list
154832156|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832157|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832158|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
154832159|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832160|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154832161|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154832162|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154832163|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832164|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832165|NCT01431950|Fluticasone|fluticasone|mesh-list
154832166|NCT01431950|Xhance|xhance|mesh-list
154832167|NCT01431950|Albuterol|albuterol|mesh-list
154832168|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154832169|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154832170|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
154832171|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832172|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832173|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154832174|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
154832175|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
154832176|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154832177|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
154832178|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154832179|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154832180|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154832181|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154832182|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
154832183|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832184|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832185|NCT00551031|Vaccines|vaccines|mesh-list
154832186|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
154832187|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832188|NCT01431716|Epoprostenol|epoprostenol|mesh-list
154832189|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154832190|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154832191|NCT00550953|Amlodipine|amlodipine|mesh-list
154832192|NCT00550953|Telmisartan|telmisartan|mesh-list
154832193|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154832194|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154832195|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154832196|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832197|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832198|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154832199|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832200|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
154832201|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154832202|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154832203|NCT00322465|Azithromycin|azithromycin|mesh-list
154832204|NCT00322465|Doxycycline|doxycycline|mesh-list
154832205|NCT00322465|Tinidazole|tinidazole|mesh-list
154832206|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154832207|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832208|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
154832209|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154832210|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154832211|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
154832212|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832213|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154832214|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154832215|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
154832216|NCT03021993|Nivolumab|nivolumab|mesh-list
154832217|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154832218|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832219|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154832220|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832221|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154832222|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
154832223|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832224|NCT00558753|Pregabalin|pregabalin|mesh-list
154832225|NCT00558753|Analgesics|analgesics|mesh-ancestor
154832226|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
154832227|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832228|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832229|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
154832230|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154832231|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832232|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832233|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154832234|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154832235|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154832236|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832237|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832238|NCT00324259|Estradiol|estradiol|mesh-list
154832239|NCT00324259|Estrogens|estrogens|mesh-ancestor
154832240|NCT00324259|Hormones|hormones|mesh-ancestor
154832241|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154832242|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832243|NCT04600141|Heparin|heparin|mesh-list
154832244|NCT04600141|Calcium heparin|calcium heparin|mesh-list
154832245|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
154832246|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154832247|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154832248|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832249|NCT00324415|Fluorouracil|fluorouracil|mesh-list
154832250|NCT00324415|Cetuximab|cetuximab|mesh-list
154832251|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832252|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
154832253|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832254|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832255|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832256|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
154832257|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832258|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154832259|NCT00390559|Nicotine|nicotine|mesh-list
154832260|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154832261|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
154832262|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832263|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832264|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154832265|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154832266|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
154832267|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832268|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832269|NCT02107339|Methadone|methadone|mesh-list
154832270|NCT02107339|Hydromorphone|hydromorphone|mesh-list
154832271|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154832272|NCT02107339|Narcotics|narcotics|mesh-ancestor
154832273|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832274|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832275|NCT02107339|Analgesics|analgesics|mesh-ancestor
154832276|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
154832277|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832278|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
154832279|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
154832280|NCT00392041|Eszopiclone|eszopiclone|mesh-list
154832281|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154832282|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832283|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832284|NCT01390844|Ribavirin|ribavirin|mesh-list
154832285|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154832286|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
154832287|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832288|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
154832289|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832290|NCT00395161|Selenium|selenium|mesh-list
154832291|NCT00395161|Metoclopramide|metoclopramide|mesh-list
154832292|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
154832293|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832294|NCT00395161|Protective Agents|protective agents|mesh-ancestor
154832295|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832296|NCT00395161|Trace Elements|trace elements|mesh-ancestor
154832297|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
154832298|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
154832299|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
154832300|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832301|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154832302|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154832303|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154832304|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
154832305|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832306|NCT01409564|Cilostazol|cilostazol|mesh-list
154832307|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154832308|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
154832309|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832310|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832311|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154832312|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
154832313|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154832314|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154832315|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832316|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154832317|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
154832318|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154832319|NCT01409564|Protective Agents|protective agents|mesh-ancestor
154832320|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154832321|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154832322|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832323|NCT01794091|Eplerenone|eplerenone|mesh-list
154832324|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154832325|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
154832326|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154832327|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832328|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154832329|NCT01794091|Diuretics|diuretics|mesh-ancestor
154832330|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
154832331|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154832332|NCT01794169|Cytarabine|cytarabine|mesh-list
154832333|NCT01794169|Azacitidine|azacitidine|mesh-list
154832334|NCT01794169|Daunorubicin|daunorubicin|mesh-list
154832335|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832336|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
154832337|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832338|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832339|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
154832340|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011748|NCT04356690|Etoposide|etoposide|mesh-list
154832341|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832342|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
154832343|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832344|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832345|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154832346|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154832347|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154832348|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154832349|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
154832350|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832351|NCT01390220|Midazolam|midazolam|mesh-list
154832352|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154832353|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154832354|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832355|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832356|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154832357|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154832358|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832359|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154832360|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
154832361|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
154832362|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
154832363|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
154832364|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832365|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832366|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
154832367|NCT00357331|Diuretics|diuretics|mesh-ancestor
154832368|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
154832369|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832370|NCT00357331|Expectorants|expectorants|mesh-ancestor
154832371|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
154832372|NCT00550173|Pemetrexed|pemetrexed|mesh-list
154832373|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154832374|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832375|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832376|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832377|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154832378|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154832379|NCT00550173|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154832380|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154832381|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
154832382|NCT04163107|Dexamethasone|dexamethasone|mesh-list
154832383|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154832384|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
154832385|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
154832386|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832387|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832388|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154832389|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
154832390|NCT04163107|Hormones|hormones|mesh-ancestor
154832391|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154832392|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154832393|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832394|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
154832395|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154832396|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154832397|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832398|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832399|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832400|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832401|NCT01429298|Hydromorphone|hydromorphone|mesh-list
154832402|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154832403|NCT01429298|Narcotics|narcotics|mesh-ancestor
154832404|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832405|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832406|NCT01429298|Analgesics|analgesics|mesh-ancestor
154832407|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
154832408|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832409|NCT01408628|Insulin|insulin|mesh-list
154832410|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154832411|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832412|NCT01389752|Charcoal|charcoal|mesh-list
154832413|NCT01389752|Antidotes|antidotes|mesh-ancestor
154832414|NCT01389752|Protective Agents|protective agents|mesh-ancestor
154832415|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832416|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
154832417|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832418|NCT00358501|Defibrotide|defibrotide|mesh-list
154832419|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154832420|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154832421|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832422|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154832423|NCT01427972|Eplerenone|eplerenone|mesh-list
154832424|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154832425|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
154832426|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154832427|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832428|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154832429|NCT01427972|Diuretics|diuretics|mesh-ancestor
154832430|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
154832431|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154832432|NCT00336323|Bevacizumab|bevacizumab|mesh-list
154832433|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154832434|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832435|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154832436|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154832437|NCT00336323|Growth Substances|growth substances|mesh-ancestor
154832438|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832439|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
154832440|NCT01427738|Nystatin|nystatin|mesh-list
154832441|NCT01427738|Gentian Violet|gentian violet|mesh-list
154832442|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154832443|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832444|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
154832445|NCT01427738|Ionophores|ionophores|mesh-ancestor
154832446|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832447|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832448|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154832449|NCT01426958|Ritonavir|ritonavir|mesh-list
154832450|NCT01426958|Afatinib|afatinib|mesh-list
154832451|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154832452|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154832453|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
154832454|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832455|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832456|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154832457|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154011902|NCT03900715|Luspatercept|luspatercept|mesh-list
154832458|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
154832459|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832460|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154832461|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154832462|NCT01426958|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154832463|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154832464|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832465|NCT00397813|Cyclosporine|cyclosporine|mesh-list
154832466|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
154832467|NCT00397813|Fludarabine|fludarabine|mesh-list
154832468|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
154832469|NCT00397813|Cyclosporins|cyclosporins|mesh-list
154832470|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832471|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832472|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
154832473|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832474|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832475|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
154832476|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832477|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832478|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
154832479|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832480|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
154832481|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832482|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154832483|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154832484|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154832485|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
154832486|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154832487|NCT00398983|Decitabine|decitabine|mesh-list
154832488|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832489|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
154832490|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832491|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832492|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832493|NCT00358579|Vasopressins|vasopressins|mesh-list
154832494|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
154832495|NCT00358579|Epinephrine|epinephrine|mesh-list
154832496|NCT00358579|Racepinephrine|racepinephrine|mesh-list
154832497|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
154832498|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832499|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154832500|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154832501|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
154832502|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832503|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832504|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154832505|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154832506|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
154832507|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832508|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154832509|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
154832510|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
154832511|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
154832512|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154832513|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
154832514|NCT00358579|Coagulants|coagulants|mesh-ancestor
154832515|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154832516|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
154832517|NCT00338039|Gemcitabine|gemcitabine|mesh-list
154832518|NCT00338039|Capecitabine|capecitabine|mesh-list
154832519|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
154832520|NCT00338039|Cetuximab|cetuximab|mesh-list
154832521|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832522|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
154832523|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832524|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832525|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154832526|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
154832527|NCT00358657|Sirolimus|sirolimus|mesh-list
154832528|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
154832529|NCT00358657|Fludarabine|fludarabine|mesh-list
154832530|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
154832531|NCT00358657|Tacrolimus|tacrolimus|mesh-list
154832532|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832533|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
154832534|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832535|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832536|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154832537|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
154832538|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832539|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832540|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154832541|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832542|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
154832543|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154832544|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832545|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154832546|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154832547|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
154832548|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154832549|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832550|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
154832551|NCT00340379|Haloperidol|haloperidol|mesh-list
154832552|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
154832553|NCT00340379|Ziprasidone|ziprasidone|mesh-list
154832555|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
154832556|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832557|NCT00340379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154832558|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154832559|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832560|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832561|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832562|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
154832563|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832564|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
154832565|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
154832566|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832567|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154832568|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154832569|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154832570|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832571|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154832572|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
154832573|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154832574|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154832575|NCT00342563|Mecamylamine|mecamylamine|mesh-list
154832576|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154832577|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154832578|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
154832579|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832580|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832581|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154832582|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154832583|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
154832584|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832585|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832586|NCT00358735|Enoxaparin|enoxaparin|mesh-list
154832587|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
154832588|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154832589|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154832590|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832591|NCT00345371|Topiramate|topiramate|mesh-list
154832592|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
154832593|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154832594|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832595|NCT03006276|Celecoxib|celecoxib|mesh-list
154832596|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154832597|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154832598|NCT03006276|Analgesics|analgesics|mesh-ancestor
154832599|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
154832600|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832601|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832602|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154832603|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832604|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154832605|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154832606|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832607|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832608|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
154832609|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154832610|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832611|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154832612|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154832613|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154832614|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154832615|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832616|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832617|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832618|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
154832619|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154832620|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832621|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832622|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154832623|NCT00351299|Analgesics|analgesics|mesh-ancestor
154832624|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
154832625|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832626|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154832627|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154832628|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154832629|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
154832630|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832631|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832632|NCT00352001|Lenalidomide|lenalidomide|mesh-list
154832633|NCT00352001|Azacitidine|azacitidine|mesh-list
154832634|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
154832635|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832636|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154832637|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154832638|NCT00352001|Growth Substances|growth substances|mesh-ancestor
154832639|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
154832640|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832641|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832642|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
154832643|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832644|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832645|NCT00401401|Zalutumumab|zalutumumab|mesh-list
154832646|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832647|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154832648|NCT00352781|Nicotine|nicotine|mesh-list
154012093|NCT02768532|Vedolizumab|vedolizumab|mesh-list
154832649|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154832650|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
154832651|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832652|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832653|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154832654|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154832655|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
154832656|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832657|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832658|NCT01793753|Propofol|propofol|mesh-list
154832659|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154832660|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832661|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832662|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154832663|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
154832664|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
154832665|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
154832666|NCT00360685|Methotrexate|methotrexate|mesh-list
154832667|NCT00360685|Tacrolimus|tacrolimus|mesh-list
154832668|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154832669|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
154832670|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154832671|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832672|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832673|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
154832674|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832675|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832676|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
154832677|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832678|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154832679|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832680|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
154832681|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832682|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154832683|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154832684|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154832685|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154832686|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
154832687|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154832688|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832689|NCT00558519|Cytarabine|cytarabine|mesh-list
154832690|NCT00558519|Dexamethasone|dexamethasone|mesh-list
154832691|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
154832692|NCT00558519|Doxorubicin|doxorubicin|mesh-list
154832693|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154832694|NCT00558519|Methotrexate|methotrexate|mesh-list
154832695|NCT00558519|Vincristine|vincristine|mesh-list
154832696|NCT00558519|Daunorubicin|daunorubicin|mesh-list
154832697|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
154832698|NCT00558519|Pegaspargase|pegaspargase|mesh-list
154832699|NCT00558519|Thioguanine|thioguanine|mesh-list
154832700|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832701|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
154832702|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832703|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832704|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154832705|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
154832706|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832707|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832708|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154832709|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154832710|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
154832711|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
154832712|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832713|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154832714|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
154832715|NCT00558519|Hormones|hormones|mesh-ancestor
154832716|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154832717|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154832718|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154832719|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154832720|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154832721|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832722|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154832723|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
154832724|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154832725|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832726|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
154832727|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
154832728|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154832729|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154832730|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
154832731|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832732|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154832733|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
154832734|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
154832735|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
154832736|NCT00403117|Naltrexone|naltrexone|mesh-list
154832737|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154832738|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154832739|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832740|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
154832741|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832742|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
154832743|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154832744|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154832745|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154832746|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
154832747|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832748|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832749|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832750|NCT01389596|Pregabalin|pregabalin|mesh-list
154832751|NCT01389596|Analgesics|analgesics|mesh-ancestor
154012206|NCT01552434|Cetuximab|cetuximab|mesh-list
154832752|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
154832753|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832754|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832755|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
154832756|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154832757|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832758|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832759|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154832760|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154832761|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154584709|NCT00488267|Analgesics|analgesics|mesh-ancestor
154832762|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832763|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832765|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832766|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
154832767|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832768|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832769|NCT00407485|Aflibercept|aflibercept|mesh-list
154832770|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154832771|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154832772|NCT00407485|Growth Substances|growth substances|mesh-ancestor
154832773|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832774|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
154832775|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832776|NCT00354887|Capecitabine|capecitabine|mesh-list
154832777|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
154832778|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154832779|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
154832780|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832781|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832782|NCT02111863|Aldesleukin|aldesleukin|mesh-list
154832783|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
154832784|NCT02111863|Fludarabine|fludarabine|mesh-list
154832785|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832786|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
154832787|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832788|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832789|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154832790|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
154832791|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832792|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832793|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154832794|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154832795|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154832796|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
154832797|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154832798|NCT02660411|Propofol|propofol|mesh-list
154832799|NCT02660411|Sevoflurane|sevoflurane|mesh-list
154832800|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154832801|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832802|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832803|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154832804|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
154832805|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
154832806|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154832807|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154832808|NCT02078492|Ketorolac|ketorolac|mesh-list
154832809|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154832810|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154832811|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154832812|NCT02078492|Analgesics|analgesics|mesh-ancestor
154832813|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
154832814|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832815|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832816|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154832817|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832818|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154832819|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832820|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832821|NCT04528563|Ketorolac|ketorolac|mesh-list
154832822|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154832823|NCT04528563|Morphine|morphine|mesh-list
154832824|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154832825|NCT04528563|Narcotics|narcotics|mesh-ancestor
154832826|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832827|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832828|NCT04528563|Analgesics|analgesics|mesh-ancestor
154832829|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
154832830|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832831|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154832832|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154832833|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154832834|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832835|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154832836|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832837|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832838|NCT00355199|Rituximab|rituximab|mesh-list
154832839|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154832840|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832841|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
154832842|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832843|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832844|NCT01791647|Inositol|inositol|mesh-list
154832845|NCT01791647|Metformin|metformin|mesh-list
154832846|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154832847|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832848|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
154832849|NCT01791647|Vitamins|vitamins|mesh-ancestor
154832850|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
154832851|NCT00363883|Vorinostat|vorinostat|mesh-list
154832852|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832853|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154832854|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832855|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832856|NCT00364819|Rituximab|rituximab|mesh-list
154832857|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154832858|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832859|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
154832860|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832861|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832862|NCT04524351|Phenserine|phenserine|mesh-list
154832863|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154832864|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832865|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832866|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
154832867|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832868|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832869|NCT04523961|Lidocaine|lidocaine|mesh-list
154832870|NCT04523961|Tetracaine|tetracaine|mesh-list
154832871|NCT04523961|Prilocaine|prilocaine|mesh-list
154832872|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154832873|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
154832874|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
154832875|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832876|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832877|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
154832878|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832879|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154832880|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154832881|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154832882|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832883|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832884|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154832885|NCT01792505|Imiquimod|imiquimod|mesh-list
154832886|NCT01792505|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154832887|NCT01792505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832888|NCT01792505|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154832889|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
154832890|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832891|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154832892|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832893|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
154832894|NCT00365053|Belinostat|belinostat|mesh-list
154832895|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832896|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154832897|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832898|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832899|NCT00555789|Tacrolimus|tacrolimus|mesh-list
154832900|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832901|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
154832902|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832903|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154832904|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832905|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832906|NCT04288895|Vortioxetine|vortioxetine|mesh-list
154832907|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
154832908|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832909|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154832910|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154584857|NCT03336541|Ketamine|ketamine|mesh-list
154832911|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832912|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832913|NCT04288895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154832914|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154832915|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154832916|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832917|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832918|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
154832919|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154832920|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154832921|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154832922|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154832923|NCT00365209|Curcumin|curcumin|mesh-list
154832924|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154832925|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154832926|NCT00365209|Analgesics|analgesics|mesh-ancestor
154832927|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
154832928|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832929|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832930|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154832931|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154832932|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832933|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832934|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832935|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154832936|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154832937|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154832938|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
154832939|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154832940|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832941|NCT00409825|Progestins|progestins|mesh-ancestor
154832942|NCT00409825|Hormones|hormones|mesh-ancestor
154832943|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154832944|NCT00410059|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154832945|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154832946|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832947|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832948|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832949|NCT04749069|Remifentanil|remifentanil|mesh-list
154832950|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154832951|NCT04749069|Narcotics|narcotics|mesh-ancestor
154832952|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832953|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832954|NCT04749069|Analgesics|analgesics|mesh-ancestor
154832955|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
154832956|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832957|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154832958|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
154832959|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154832960|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154832961|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154832962|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154832963|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832964|NCT03239015|Trastuzumab|trastuzumab|mesh-list
154832965|NCT03239015|Everolimus|everolimus|mesh-list
154832966|NCT03239015|Olaparib|olaparib|mesh-list
154832967|NCT03239015|Palbociclib|palbociclib|mesh-list
154832968|NCT03239015|Gefitinib|gefitinib|mesh-list
154832969|NCT03239015|Afatinib|afatinib|mesh-list
154832970|NCT03239015|Dabrafenib|dabrafenib|mesh-list
154832971|NCT03239015|Vemurafenib|vemurafenib|mesh-list
154832972|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154832973|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154832974|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154832975|NCT03239015|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154832976|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154832977|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154832978|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832979|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154832980|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
154832981|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832982|NCT03239015|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154832983|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154832984|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154832985|NCT03239015|Growth Substances|growth substances|mesh-ancestor
154832986|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
154832987|NCT00356993|Nicotine|nicotine|mesh-list
154832988|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154832989|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
154832990|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154832991|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154832992|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154832993|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154832994|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
154832995|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154832996|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154832997|NCT01793077|Leuprolide|leuprolide|mesh-list
154832998|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154832999|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
154833000|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154833001|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833002|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833003|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833004|NCT00555477|Anastrozole|anastrozole|mesh-list
154833005|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833006|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833007|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154833008|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154833009|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833010|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833011|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154833012|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
154833013|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833014|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833015|NCT00365599|Tamoxifen|tamoxifen|mesh-list
154833016|NCT00365599|Vorinostat|vorinostat|mesh-list
154833017|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833018|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154833019|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
154833020|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833021|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833022|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833023|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833024|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154833025|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154833026|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154833027|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154833028|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833029|NCT00554619|Ambrisentan|ambrisentan|mesh-list
154833030|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154833031|NCT02104739|Exenatide|exenatide|mesh-list
154833032|NCT02104739|Saxagliptin|saxagliptin|mesh-list
154833033|NCT02104739|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154833034|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154833035|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833036|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154833037|NCT02104739|Incretins|incretins|mesh-ancestor
154833038|NCT02104739|Hormones|hormones|mesh-ancestor
154833039|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833040|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154833041|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
154833042|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012506|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
154833043|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833044|NCT00411619|Everolimus|everolimus|mesh-list
154833045|NCT00411619|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154833046|NCT00411619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833047|NCT00411619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833048|NCT00411619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833049|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833050|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
154833051|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833052|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833053|NCT00412087|Vitamin D|vitamin d|mesh-list
154833054|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
154833055|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
154833056|NCT00412087|Vitamins|vitamins|mesh-list
154833057|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
154833058|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833059|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154585008|NCT04470479|Miotics|miotics|mesh-ancestor
154833060|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154833061|NCT00312923|Policosanol|policosanol|mesh-list
154833062|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154833063|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154833064|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
154833065|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833066|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154833067|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154833068|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
154833069|NCT00412243|Clofarabine|clofarabine|mesh-list
154833070|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833071|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
154833072|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833073|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154833074|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154833075|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
154833076|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833077|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833078|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154833079|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833080|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
154833081|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154833082|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
154833083|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833084|NCT00315341|Buprenorphine|buprenorphine|mesh-list
154833086|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154833087|NCT00315341|Naloxone|naloxone|mesh-list
154833088|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154833089|NCT00315341|Narcotics|narcotics|mesh-ancestor
154833090|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833091|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833092|NCT00315341|Analgesics|analgesics|mesh-ancestor
154833093|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
154833094|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833095|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154833096|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
154833097|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
154833098|NCT02277249|Digoxin|digoxin|mesh-list
154833099|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154833100|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154833101|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833102|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833103|NCT02277249|Protective Agents|protective agents|mesh-ancestor
154833104|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833105|NCT04767542|Acetaminophen|acetaminophen|mesh-list
154833106|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833107|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154833108|NCT04767542|Analgesics|analgesics|mesh-ancestor
154833109|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
154833110|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833111|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
154833112|NCT01794533|Lidocaine|lidocaine|mesh-list
154833113|NCT01794533|Epinephrine|epinephrine|mesh-list
154833114|NCT01794533|Racepinephrine|racepinephrine|mesh-list
154833115|NCT01794533|Fentanyl|fentanyl|mesh-list
154833116|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
154833117|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
154833118|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
154833119|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833120|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833121|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
154833122|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833123|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154833124|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154833125|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154833126|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154833127|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833128|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154833129|NCT01794533|Narcotics|narcotics|mesh-ancestor
154833130|NCT01794533|Analgesics|analgesics|mesh-ancestor
154833131|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154833132|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154833133|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
154833134|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154585081|NCT02287259|Olanzapine|olanzapine|mesh-list
154833135|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154833136|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154833137|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833138|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154833139|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154833140|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
154833141|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154833142|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
154833143|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
154833144|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
154833145|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154833146|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154833147|NCT00412867|Plasminogen|plasminogen|mesh-list
154833148|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154833149|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154833150|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833151|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
154833152|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154833153|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833154|NCT00414271|Docetaxel|docetaxel|mesh-list
154833155|NCT00414271|Capecitabine|capecitabine|mesh-list
154833156|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833157|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
154833158|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
154833159|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
154833160|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833161|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833162|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
154833163|NCT00360971|Cisplatin|cisplatin|mesh-list
154833164|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833165|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
154833166|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154012619|NCT00002632|Paclitaxel|paclitaxel|mesh-list
154833167|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154833168|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154833169|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154833170|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833171|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
154833172|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833173|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833174|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154833175|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833176|NCT03636503|Rituximab|rituximab|mesh-list
154833177|NCT03636503|Avelumab|avelumab|mesh-list
154833178|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833179|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833180|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
154833181|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833182|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154833183|NCT03448159|Fluoxetine|fluoxetine|mesh-list
154833184|NCT03448159|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154833185|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154833186|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154833187|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833188|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833189|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
154833190|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833191|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154833192|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
154833193|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833194|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154833195|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154833196|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833197|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
154833198|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833199|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
154833200|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154833201|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
154833202|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154833203|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833204|NCT03438487|Vaccines|vaccines|mesh-list
154833205|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
154833206|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833207|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154833208|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833209|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833210|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
154833211|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154833212|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154833213|NCT01792037|Prednisolone|prednisolone|mesh-list
154833214|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
154833215|NCT01792037|Midazolam|midazolam|mesh-list
154833216|NCT01792037|Etomidate|etomidate|mesh-list
154833217|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154833218|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
154833219|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154833220|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154833221|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833222|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833223|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154833224|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154833225|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833226|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154833227|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
154833228|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
154833229|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
154833230|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
154833231|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833232|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833233|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833234|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
154833235|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
154833236|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833237|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154833238|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
154833239|NCT01792037|Hormones|hormones|mesh-ancestor
154833240|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833241|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154833242|NCT01792037|Protective Agents|protective agents|mesh-ancestor
154833243|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833244|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833245|NCT00373399|Dronabinol|dronabinol|mesh-list
154833246|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
154833247|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833248|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833249|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154833250|NCT00373399|Analgesics|analgesics|mesh-ancestor
154833251|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
154833252|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833253|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154833254|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154833255|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833256|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833257|NCT00373399|Hormones|hormones|mesh-ancestor
154833258|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833259|NCT00318929|Valproic Acid|valproic acid|mesh-list
154833260|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
154833261|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833262|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833263|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
154833264|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833265|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833266|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
154833267|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154833268|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833269|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833270|NCT00418093|Bevacizumab|bevacizumab|mesh-list
154833271|NCT00418093|Gemcitabine|gemcitabine|mesh-list
154833272|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
154833273|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833274|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833275|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833276|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833277|NCT00418093|Growth Substances|growth substances|mesh-ancestor
154833278|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833279|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833280|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833281|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
154833282|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833283|NCT03855371|Decitabine|decitabine|mesh-list
154833284|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
154833285|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833286|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
154833287|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833288|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833289|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833290|NCT03284723|Letrozole|letrozole|mesh-list
154833291|NCT03284723|Palbociclib|palbociclib|mesh-list
154833292|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833293|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154833294|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154833295|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012746|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
154833296|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833297|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154833298|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
154833299|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833300|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833301|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833302|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
154833303|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154833304|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833305|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154833306|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
154833307|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154833308|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833309|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833310|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833311|NCT00418951|Voriconazole|voriconazole|mesh-list
154833312|NCT00418951|Amphotericin B|amphotericin b|mesh-list
154833313|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154833314|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
154833315|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833316|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154833317|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154833318|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833319|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833320|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154833321|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
154833322|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833323|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833324|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154833325|NCT00418951|Amebicides|amebicides|mesh-ancestor
154833326|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154833327|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154833328|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154833329|NCT00363077|Vaccines|vaccines|mesh-list
154833330|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
154833331|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833332|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154833333|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154833334|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154833335|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154833336|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833337|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833338|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833339|NCT00375973|Analgesics|analgesics|mesh-ancestor
154833340|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
154833341|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833342|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
154833343|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833344|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
154833345|NCT00421603|Topiramate|topiramate|mesh-list
154833346|NCT00421603|Adderall|adderall|mesh-list
154833347|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
154833348|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154833349|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833350|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154833351|NCT00363779|Cyclosporine|cyclosporine|mesh-list
154833352|NCT00363779|Cyclosporins|cyclosporins|mesh-list
154833353|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833354|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012813|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
154833355|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833356|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
154833357|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833358|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
154833359|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833360|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
154833361|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154833362|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154833363|NCT01405820|Natalizumab|natalizumab|mesh-list
154833364|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
154833365|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833366|NCT01405742|Factor VIII|factor viii|mesh-list
154833367|NCT01405742|Coagulants|coagulants|mesh-ancestor
154833369|NCT01794767|Calcium heparin|calcium heparin|mesh-list
154833370|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
154833371|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154833372|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154833373|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833374|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
154833375|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154833376|NCT02076152|Bevacizumab|bevacizumab|mesh-list
154833377|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833378|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833379|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833380|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833381|NCT02076152|Growth Substances|growth substances|mesh-ancestor
154833382|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833383|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833384|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
154833385|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833386|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833387|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154833388|NCT00380029|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154833389|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833390|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833391|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833392|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833393|NCT01405508|Brivaracetam|brivaracetam|mesh-list
154833394|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
154833395|NCT00426283|Fluticasone|fluticasone|mesh-list
154833396|NCT00426283|Xhance|xhance|mesh-list
154833397|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833398|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154833399|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
154833400|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833401|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833402|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154833403|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
154833404|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
154833405|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154833406|NCT00322439|Etanercept|etanercept|mesh-list
154833407|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154833408|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154833409|NCT00322439|Analgesics|analgesics|mesh-ancestor
154833410|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
154833411|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833412|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833413|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833414|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154833415|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154833416|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833417|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
154833418|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
154833419|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833420|NCT00365261|Eszopiclone|eszopiclone|mesh-list
154833421|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154833422|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833423|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833424|NCT00426517|Sirolimus|sirolimus|mesh-list
154833425|NCT00426517|Busulfan|busulfan|mesh-list
154833426|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
154833427|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154833428|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833429|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154833430|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833431|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
154833432|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154558123|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154833433|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
154833434|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833435|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833436|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
154833437|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154833438|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154833439|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833440|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
154833441|NCT00365417|Bevacizumab|bevacizumab|mesh-list
154833442|NCT00365417|Docetaxel|docetaxel|mesh-list
154833443|NCT00365417|Doxorubicin|doxorubicin|mesh-list
154833444|NCT00365417|Capecitabine|capecitabine|mesh-list
154833445|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833446|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
154833447|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833448|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154833449|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154833450|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
154833451|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833452|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833453|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154833454|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833455|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833456|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833457|NCT00365417|Growth Substances|growth substances|mesh-ancestor
154833458|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833459|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
154833460|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
154833461|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
154833462|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154833463|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154833464|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154833465|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833466|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833467|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
154833468|NCT00427297|Ritonavir|ritonavir|mesh-list
154833469|NCT00427297|Lopinavir|lopinavir|mesh-list
154833470|NCT00427297|Tenofovir|tenofovir|mesh-list
154833471|NCT00427297|Lamivudine|lamivudine|mesh-list
154833472|NCT00427297|Zidovudine|zidovudine|mesh-list
154833473|NCT00427297|Nevirapine|nevirapine|mesh-list
154833474|NCT00427297|Abacavir|abacavir|mesh-list
154833475|NCT00427297|Didanosine|didanosine|mesh-list
154833476|NCT00427297|Stavudine|stavudine|mesh-list
154833477|NCT00427297|Efavirenz|efavirenz|mesh-list
154833478|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
154833479|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154833480|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154833481|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
154833482|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833483|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833484|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154833485|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154833486|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
154833487|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833488|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154833489|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154833490|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154833491|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154833492|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
154833493|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154833494|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154833495|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154833496|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154833497|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154833498|NCT00427765|Melphalan|melphalan|mesh-list
154833499|NCT00427765|Busulfan|busulfan|mesh-list
154833500|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154833501|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
154833502|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833503|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833504|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154833505|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833506|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
154833507|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833508|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
154833509|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
154833510|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833511|NCT00384865|Aspirin|aspirin|mesh-list
154833512|NCT00384865|Simvastatin|simvastatin|mesh-list
154833513|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154833514|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154833515|NCT00384865|Analgesics|analgesics|mesh-ancestor
154833516|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
154833517|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833518|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833519|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833520|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154833521|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154833522|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154833523|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833524|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154833525|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154833526|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833527|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
154833528|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154833529|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154833530|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
154833531|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154833532|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154833533|NCT00367601|Bevacizumab|bevacizumab|mesh-list
154833534|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154833535|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833536|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833537|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833538|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833539|NCT00367601|Growth Substances|growth substances|mesh-ancestor
154833540|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833541|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833542|NCT00367601|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154833543|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833544|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833545|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833546|NCT00385801|Risperidone|risperidone|mesh-list
154833547|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154833548|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
154833549|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013002|NCT00929201|Incretins|incretins|mesh-ancestor
154833550|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833551|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833552|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154833553|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154833554|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833555|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833556|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154833557|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
154833558|NCT00429403|Goserelin|goserelin|mesh-list
154833559|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833560|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833561|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
154833562|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154833563|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833564|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154833565|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154833566|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833567|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833568|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833569|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154833570|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154833571|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154833572|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154833573|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
154833574|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833575|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833576|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154833577|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154833578|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154833579|NCT00429949|Dasatinib|dasatinib|mesh-list
154833580|NCT00429949|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154833581|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833582|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585530|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
154833583|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833584|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833585|NCT02078726|Glucagon|glucagon|mesh-list
154833586|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154833587|NCT02078726|Hormones|hormones|mesh-ancestor
154833588|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833589|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833590|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
154833591|NCT00431041|Oxybutynin|oxybutynin|mesh-list
154833592|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154833593|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154833594|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
154833595|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833596|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833597|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833598|NCT00431041|Urological Agents|urological agents|mesh-ancestor
154833599|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
154833600|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
154833601|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833602|NCT00390611|Paclitaxel|paclitaxel|mesh-list
154833603|NCT00390611|Carboplatin|carboplatin|mesh-list
154833604|NCT00390611|Sorafenib|sorafenib|mesh-list
154833605|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154833606|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833607|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
154833608|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
154833609|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
154833610|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833611|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833612|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833613|NCT00391079|Nabiximols|nabiximols|mesh-list
154833614|NCT00391079|Analgesics|analgesics|mesh-ancestor
154833615|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
154833616|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833617|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833618|NCT00387751|Bevacizumab|bevacizumab|mesh-list
154833619|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154833620|NCT00387751|Sorafenib|sorafenib|mesh-list
154833621|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
154833622|NCT00387751|Antibodies|antibodies|mesh-list
154833623|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
154833624|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154833625|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
154833626|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833627|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833628|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833629|NCT00387751|Growth Substances|growth substances|mesh-ancestor
154833630|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833631|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833632|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
154833633|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833634|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833635|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833636|NCT01795235|Atenolol|atenolol|mesh-list
154833637|NCT01795235|Glucagon|glucagon|mesh-list
154833638|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154833639|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154833640|NCT01795235|Hormones|hormones|mesh-ancestor
154833641|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833642|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833643|NCT01795235|Incretins|incretins|mesh-ancestor
154833644|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154833645|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154833646|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
154833647|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
154833648|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833649|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154833650|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154833651|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154833652|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
154833653|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833654|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833655|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154833656|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154833657|NCT00387829|Estradiol|estradiol|mesh-list
154585613|NCT03472339|Diclofenac|diclofenac|mesh-list
154833658|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154833660|NCT00387829|Hormones|hormones|mesh-ancestor
154833661|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833662|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833663|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154833664|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
154833665|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154833666|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154833667|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
154833668|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833669|NCT00392951|Sirolimus|sirolimus|mesh-list
154833670|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154833671|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833672|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154013128|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
154833673|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833674|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
154833675|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833676|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
154833677|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833678|NCT01424930|Prednisone|prednisone|mesh-list
154833679|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833680|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
154833681|NCT01424930|Hormones|hormones|mesh-ancestor
154833682|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833683|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833684|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833685|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833686|NCT00389857|Vaccines|vaccines|mesh-list
154833687|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
154833688|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833689|NCT01795183|Amisulpride|amisulpride|mesh-list
154833690|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154833691|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154833692|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833693|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833694|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833695|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154833696|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
154833697|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833698|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833699|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154833700|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
154833701|NCT01424228|Prucalopride|prucalopride|mesh-list
154833702|NCT01424228|Laxatives|laxatives|mesh-ancestor
154833703|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154833704|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154833705|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154833706|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
154833707|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833708|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833709|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833710|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
154833711|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
154833712|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833713|NCT04750603|Fluticasone|fluticasone|mesh-list
154833714|NCT04750603|Xhance|xhance|mesh-list
154833715|NCT04750603|Albuterol|albuterol|mesh-list
154833716|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833717|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154833718|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
154833719|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833720|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833721|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154833722|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
154833723|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154833724|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154833725|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
154833726|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154833727|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154833728|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154833729|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154833730|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
154833731|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558124|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833732|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833733|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
154833734|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154833735|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833736|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154833737|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154833738|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833739|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833740|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833741|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
154833742|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154833743|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
154833744|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833745|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
154833746|NCT00436969|Protective Agents|protective agents|mesh-ancestor
154833747|NCT00455689|Leuprolide|leuprolide|mesh-list
154833748|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154833749|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
154833750|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154833751|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833752|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833753|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833754|NCT00394277|Ribavirin|ribavirin|mesh-list
154833755|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154833756|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
154833757|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
154833758|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833759|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
154833760|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833761|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
154833762|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833763|NCT00395057|Ranibizumab|ranibizumab|mesh-list
154833764|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833765|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833766|NCT00395057|Growth Substances|growth substances|mesh-ancestor
154833767|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833768|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833769|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833770|NCT00438451|Lamotrigine|lamotrigine|mesh-list
154833771|NCT00438451|Carbamazepine|carbamazepine|mesh-list
154833772|NCT00438451|Levetiracetam|levetiracetam|mesh-list
154833773|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
154833774|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
154833775|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154833776|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154833777|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833778|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154833779|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833780|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154833781|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154833782|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833783|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833784|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154833785|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
154833786|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154833787|NCT00438451|Analgesics|analgesics|mesh-ancestor
154833788|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
154833789|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154833790|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154833791|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154833792|NCT00456625|Vaccines|vaccines|mesh-list
154833793|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
154833794|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833795|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154833796|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154833797|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154833798|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154833799|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154833800|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
154833801|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833802|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833803|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833804|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154833805|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
154833806|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154833808|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154833809|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833810|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154833811|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833812|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833813|NCT01423604|Capecitabine|capecitabine|mesh-list
154833814|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833815|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
154833816|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833817|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833818|NCT01402544|Ranibizumab|ranibizumab|mesh-list
154833819|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833820|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833821|NCT01402544|Growth Substances|growth substances|mesh-ancestor
154833822|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833823|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833824|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833825|NCT00460993|Eszopiclone|eszopiclone|mesh-list
154833826|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154833827|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154833828|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833829|NCT00441883|Latanoprost|latanoprost|mesh-list
154833830|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154833831|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154833832|NCT00461773|Bevacizumab|bevacizumab|mesh-list
154833833|NCT00461773|Letrozole|letrozole|mesh-list
154833834|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833835|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833836|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833837|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833838|NCT00461773|Growth Substances|growth substances|mesh-ancestor
154833839|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833840|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833841|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154833842|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154833843|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833844|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833845|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154833846|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
154833847|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833848|NCT00461851|Carboplatin|carboplatin|mesh-list
154833849|NCT00461851|Gemcitabine|gemcitabine|mesh-list
154833850|NCT00461851|Sorafenib|sorafenib|mesh-list
154833851|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833852|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833853|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
154833854|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833855|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833856|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833857|NCT00442507|Bevacizumab|bevacizumab|mesh-list
154833858|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154833859|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154833860|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833861|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154833862|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154833863|NCT00442507|Growth Substances|growth substances|mesh-ancestor
154833864|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833865|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
154833866|NCT00442507|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154833867|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154833868|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833869|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833870|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
154833871|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833872|NCT01387022|Tenofovir|tenofovir|mesh-list
154833873|NCT01387022|Lamivudine|lamivudine|mesh-list
154833874|NCT01387022|Efavirenz|efavirenz|mesh-list
154833875|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
154833876|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833877|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154833878|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154585829|NCT02446418|Xhance|xhance|mesh-list
154833879|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833880|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833881|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154833882|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154833883|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154833884|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154833885|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154833886|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154833887|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154833888|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154833889|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
154833890|NCT00374231|Prednisone|prednisone|mesh-list
154833891|NCT00374231|Tacrolimus|tacrolimus|mesh-list
154833892|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833893|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
154833894|NCT00374231|Hormones|hormones|mesh-ancestor
154833895|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833896|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833897|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154833898|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833899|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833900|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
154833901|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154833902|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833903|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833904|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154833905|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154833906|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
154833907|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154833908|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154833909|NCT00400205|Docetaxel|docetaxel|mesh-list
154833910|NCT00400205|Fluorouracil|fluorouracil|mesh-list
154833911|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833912|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
154833913|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
154833914|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
154833915|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833916|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
154833917|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833918|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833919|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
154833920|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833921|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154833922|NCT01386554|Hormones|hormones|mesh-ancestor
154833923|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154833924|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833925|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
154833926|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154833927|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154833928|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
154833929|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833930|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154833931|NCT00448201|Methotrexate|methotrexate|mesh-list
154833932|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
154833933|NCT00448201|Fludarabine|fludarabine|mesh-list
154833934|NCT00448201|Busulfan|busulfan|mesh-list
154833935|NCT00448201|Tacrolimus|tacrolimus|mesh-list
154833936|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154833937|NCT00448201|Sargramostim|sargramostim|mesh-list
154833938|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154833939|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
154833940|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154833941|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833942|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154833943|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
154833944|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833945|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833946|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
154833947|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154833948|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154833949|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833950|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
154833951|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154833952|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154585903|NCT01601626|Rifampin|rifampin|mesh-list
154833953|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154833954|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
154833955|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154833956|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154833957|NCT05287607|Bilirubin|bilirubin|mesh-list
154833958|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
154833959|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833960|NCT05287607|Protective Agents|protective agents|mesh-ancestor
154833961|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833962|NCT00375713|Cetirizine|cetirizine|mesh-list
154833963|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
154833964|NCT00375713|Levocetirizine|levocetirizine|mesh-list
154833965|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154833966|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154833967|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154833968|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154833969|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
154833970|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
154833971|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833972|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833973|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833974|NCT00465595|Psilocybin|psilocybin|mesh-list
154833975|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154833976|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
154013446|NCT00939133|Tretinoin|tretinoin|mesh-list
154833977|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833978|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154833979|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154833980|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
154833981|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154833982|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833983|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154833984|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
154833985|NCT00376805|Fludarabine|fludarabine|mesh-list
154833986|NCT00376805|Interleukin-2|interleukin-2|mesh-list
154833987|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154833988|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
154833989|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154833990|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154833991|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154833992|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
154833993|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154833994|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154833995|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154833996|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154833997|NCT00376805|Analgesics|analgesics|mesh-ancestor
154833998|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
154833999|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834000|NCT00448357|Methotrexate|methotrexate|mesh-list
154834001|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
154834002|NCT00448357|Fludarabine|fludarabine|mesh-list
154834003|NCT00448357|Busulfan|busulfan|mesh-list
154834004|NCT00448357|Tacrolimus|tacrolimus|mesh-list
154834005|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154834006|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
154834007|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154834008|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
154834009|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154834010|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834011|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154834012|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
154834013|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834014|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834015|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
154834016|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834017|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154834018|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834019|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
154834020|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834021|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154834022|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154834023|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
154834024|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154834025|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154834026|NCT00450073|Vitamin D|vitamin d|mesh-list
154834027|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
154834028|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
154834029|NCT00450073|Vitamins|vitamins|mesh-list
154834030|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
154834031|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834032|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154834033|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154834034|NCT00467077|Interferons|interferons|mesh-list
154834035|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
154834036|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
154834037|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154834038|NCT00467077|Gefitinib|gefitinib|mesh-list
154834039|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834040|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
154834041|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834042|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
154013503|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834043|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834044|NCT00467077|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154834045|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154834046|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834047|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834048|NCT00467389|Donepezil|donepezil|mesh-list
154834049|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154834050|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834051|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834052|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
154834053|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834054|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834055|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
154834056|NCT00377741|Valganciclovir|valganciclovir|mesh-list
154834057|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
154834058|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834059|NCT00379145|Trabectedin|trabectedin|mesh-list
154834060|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154834061|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
154834062|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834063|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834064|NCT00382031|Zalutumumab|zalutumumab|mesh-list
154834065|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154834066|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834067|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834068|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
154834069|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834070|NCT00382265|Tamsulosin|tamsulosin|mesh-list
154834071|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154834072|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154834073|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154834074|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
154834075|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834076|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834077|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834078|NCT00382265|Urological Agents|urological agents|mesh-ancestor
154834079|NCT00383747|Nicotine|nicotine|mesh-list
154834080|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154834081|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
154834082|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834083|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834084|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154834085|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154834086|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
154834087|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834088|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834089|NCT01421342|Aripiprazole|aripiprazole|mesh-list
154834090|NCT01421342|Bupropion|bupropion|mesh-list
154834091|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
154834092|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154834093|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154834094|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154834095|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154834096|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154834097|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834098|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
154834099|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834100|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834101|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154834102|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154834103|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834104|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154834105|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154013569|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
154834106|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154834107|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
154834108|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154834109|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154834110|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
154834111|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154834112|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154834113|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154834114|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154834115|NCT00403403|Bevacizumab|bevacizumab|mesh-list
154834116|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834117|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834118|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834119|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834120|NCT00403403|Growth Substances|growth substances|mesh-ancestor
154834121|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834122|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834123|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
154834124|NCT00405353|Testosterone|testosterone|mesh-list
154834125|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
154834126|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
154834127|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154834128|NCT00405353|Androgens|androgens|mesh-ancestor
154834130|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834131|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834132|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154834133|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834134|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
154834135|NCT01384292|Naloxegol|naloxegol|mesh-list
154834136|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154834137|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834138|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
154834139|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834140|NCT00450463|Metronidazole|metronidazole|mesh-list
154834141|NCT00450463|Molgramostim|molgramostim|mesh-list
154834142|NCT00450463|Flutamide|flutamide|mesh-list
154834143|NCT00450463|Sargramostim|sargramostim|mesh-list
154834144|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
154834145|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834146|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834147|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834148|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154834149|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154834150|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154834151|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
154834152|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
154834153|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834154|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154834155|NCT00407381|Ranibizumab|ranibizumab|mesh-list
154834156|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834157|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834158|NCT00407381|Growth Substances|growth substances|mesh-ancestor
154834159|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834160|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834161|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834162|NCT00384449|Ranibizumab|ranibizumab|mesh-list
154834163|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834164|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834165|NCT00384449|Growth Substances|growth substances|mesh-ancestor
154834166|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834167|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834168|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834169|NCT00452335|Lubiprostone|lubiprostone|mesh-list
154834170|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154834171|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154834172|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834173|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
154834174|NCT00386243|Analgesics|analgesics|mesh-list
154834175|NCT00386243|Narcotics|narcotics|mesh-ancestor
154834176|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154834177|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834178|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
154834179|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834180|NCT01400516|Vitamin D|vitamin d|mesh-list
154834181|NCT01400516|Teriparatide|teriparatide|mesh-list
154834182|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154834183|NCT01400516|Calcium|calcium|mesh-list
154834184|NCT01400516|Vitamins|vitamins|mesh-ancestor
154834185|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
154834186|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834187|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154834188|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154834189|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834190|NCT01383356|Metformin|metformin|mesh-list
154834191|NCT01383356|Linagliptin|linagliptin|mesh-list
154834192|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834193|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834194|NCT01383356|Incretins|incretins|mesh-ancestor
154834195|NCT01383356|Hormones|hormones|mesh-ancestor
154834196|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834197|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154834198|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834199|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834200|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834201|NCT02111447|Propofol|propofol|mesh-list
154834202|NCT02111447|Sevoflurane|sevoflurane|mesh-list
154834203|NCT02111447|Isoflurane|isoflurane|mesh-list
154834204|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154834205|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154834206|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834207|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154834208|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
154834209|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
154834210|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154834211|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154834212|NCT05966454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154834213|NCT05966454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154834214|NCT05966454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834215|NCT05966454|Antitubercular Agents|antitubercular agents|mesh-ancestor
154834216|NCT05966441|Curcumin|curcumin|mesh-list
154834217|NCT05966441|Paclitaxel|paclitaxel|mesh-list
154834218|NCT05966441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154834219|NCT05966441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834220|NCT05966441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154834221|NCT05966441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154834222|NCT05966441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154834223|NCT05966441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834224|NCT05966441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154834225|NCT05966441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154834226|NCT05966441|Analgesics|analgesics|mesh-ancestor
154834227|NCT05966441|Sensory System Agents|sensory system agents|mesh-ancestor
154834228|NCT05966441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834229|NCT05966441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834230|NCT05966441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834231|NCT05966441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834232|NCT05966441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834233|NCT05966064|Denosumab|denosumab|mesh-list
154834234|NCT05966064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154834235|NCT05966064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834236|NCT05966012|Tranexamic Acid|tranexamic acid|mesh-list
154834237|NCT05966012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154013711|NCT00770913|Rabeprazole|rabeprazole|mesh-list
154834238|NCT05966012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154834239|NCT05966012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834240|NCT05966012|Hemostatics|hemostatics|mesh-ancestor
154834241|NCT05966012|Coagulants|coagulants|mesh-ancestor
154834242|NCT05965934|Dapagliflozin|dapagliflozin|mesh-list
154834243|NCT05965934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154834244|NCT05965934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834245|NCT05965934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834246|NCT05965934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834247|NCT05965388|Interferons|interferons|mesh-list
154834248|NCT05965388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834249|NCT05965388|Antiviral Agents|antiviral agents|mesh-ancestor
154834250|NCT05965388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834251|NCT05965284|Azathioprine|azathioprine|mesh-list
154586208|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834252|NCT05965284|Antimetabolites|antimetabolites|mesh-ancestor
154834253|NCT05965284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834254|NCT05965284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154834255|NCT05965284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834256|NCT05965284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834257|NCT05965284|Immunologic Factors|immunologic factors|mesh-ancestor
154834258|NCT05965284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834259|NCT05965284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834261|NCT05965154|Capecitabine|capecitabine|mesh-list
154834262|NCT05965154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834263|NCT05965154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834264|NCT05965154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834265|NCT05965154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834266|NCT05965154|Growth Substances|growth substances|mesh-ancestor
154834267|NCT05965154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834268|NCT05965154|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834269|NCT05965154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154834270|NCT05965154|Antimetabolites|antimetabolites|mesh-ancestor
154834271|NCT05965154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834272|NCT05965141|Bevacizumab|bevacizumab|mesh-list
154834273|NCT05965141|Carboplatin|carboplatin|mesh-list
154834274|NCT05965141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834275|NCT05965141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834276|NCT05965141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834277|NCT05965141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834278|NCT05965141|Growth Substances|growth substances|mesh-ancestor
154834279|NCT05965141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834280|NCT05965141|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834281|NCT05965076|Glycine|glycine|mesh-list
154834282|NCT05965076|Glycine Agents|glycine agents|mesh-ancestor
154834283|NCT05965076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834284|NCT05965076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834285|NCT05965076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834286|NCT05964985|Lidocaine|lidocaine|mesh-list
154834287|NCT05964985|Ropivacaine|ropivacaine|mesh-list
154834288|NCT05964985|Esketamine|esketamine|mesh-list
154834289|NCT05964985|Anesthetics, Local|anesthetics, local|mesh-ancestor
154834290|NCT05964985|Anesthetics|anesthetics|mesh-ancestor
154834291|NCT05964985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154834292|NCT05964985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834293|NCT05964985|Sensory System Agents|sensory system agents|mesh-ancestor
154834294|NCT05964985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834295|NCT05964985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154834296|NCT05964985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154834297|NCT05964985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154834298|NCT05964985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154834299|NCT05964985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834300|NCT05964985|Antidepressive Agents|antidepressive agents|mesh-ancestor
154834301|NCT05964985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154834302|NCT05964738|Diuretics|diuretics|mesh-list
154834303|NCT05964738|Natriuretic Agents|natriuretic agents|mesh-ancestor
154834304|NCT05964738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834305|NCT05964543|Capecitabine|capecitabine|mesh-list
154834306|NCT05964543|Oxaliplatin|oxaliplatin|mesh-list
154834307|NCT05964543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154834308|NCT05964543|Antimetabolites|antimetabolites|mesh-ancestor
154834309|NCT05964543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834310|NCT05964543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834311|NCT05961644|Cladribine|cladribine|mesh-list
154834312|NCT05961644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834313|NCT05961644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834314|NCT05961644|Immunologic Factors|immunologic factors|mesh-ancestor
154834315|NCT05961644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834316|NCT05939245|Furosemide|furosemide|mesh-list
154834317|NCT05939245|Diuretics|diuretics|mesh-ancestor
154834318|NCT05939245|Natriuretic Agents|natriuretic agents|mesh-ancestor
154834319|NCT05939245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834320|NCT05939245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154834321|NCT05939245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154834322|NCT05939245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834323|NCT05899933|Erythritol|erythritol|mesh-list
154834324|NCT05899933|Vasodilator Agents|vasodilator agents|mesh-ancestor
154834325|NCT05783921|Paclitaxel|paclitaxel|mesh-list
154834326|NCT05783921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154834327|NCT05783921|Cisplatin|cisplatin|mesh-list
154834328|NCT05783921|Carboplatin|carboplatin|mesh-list
154834329|NCT05783921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154834330|NCT05783921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834331|NCT05783921|Tubulin Modulators|tubulin modulators|mesh-ancestor
154834332|NCT05783921|Antimitotic Agents|antimitotic agents|mesh-ancestor
154834333|NCT05783921|Mitosis Modulators|mitosis modulators|mesh-ancestor
154834334|NCT05783921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834335|NCT05740098|Nicotine|nicotine|mesh-list
154834336|NCT05740098|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154834337|NCT05740098|Autonomic Agents|autonomic agents|mesh-ancestor
154834338|NCT05740098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834339|NCT05740098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834340|NCT05740098|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154834341|NCT05740098|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154834342|NCT05740098|Cholinergic Agents|cholinergic agents|mesh-ancestor
154834343|NCT05740098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834344|NCT05740098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834345|NCT05730413|Bisoprolol|bisoprolol|mesh-list
154834346|NCT05730413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154834347|NCT05730413|Sympatholytics|sympatholytics|mesh-ancestor
154834348|NCT05730413|Autonomic Agents|autonomic agents|mesh-ancestor
154834349|NCT05730413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834350|NCT05730413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834351|NCT05730413|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154834352|NCT05730413|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154834353|NCT05730413|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154834354|NCT05730413|Adrenergic Agents|adrenergic agents|mesh-ancestor
154834355|NCT05730413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834356|NCT05730413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834357|NCT05720455|Fexofenadine|fexofenadine|mesh-list
154834358|NCT05720455|Pseudoephedrine|pseudoephedrine|mesh-list
154834359|NCT05720455|Ephedrine|ephedrine|mesh-list
154834360|NCT05720455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154834361|NCT05720455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154834362|NCT05720455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154834363|NCT05720455|Histamine Antagonists|histamine antagonists|mesh-ancestor
154834364|NCT05720455|Histamine Agents|histamine agents|mesh-ancestor
154834365|NCT05720455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834366|NCT05720455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834367|NCT05720455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834368|NCT05720455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154834369|NCT05720455|Autonomic Agents|autonomic agents|mesh-ancestor
154834370|NCT05720455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834371|NCT05720455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154834372|NCT05720455|Respiratory System Agents|respiratory system agents|mesh-ancestor
154834373|NCT05720455|Nasal Decongestants|nasal decongestants|mesh-ancestor
154834374|NCT05720455|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154834375|NCT05720455|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154834376|NCT05720455|Sympathomimetics|sympathomimetics|mesh-ancestor
154834377|NCT05720455|Adrenergic Agents|adrenergic agents|mesh-ancestor
154834378|NCT05641753|Atorvastatin|atorvastatin|mesh-list
154834379|NCT05641753|Ezetimibe|ezetimibe|mesh-list
154834380|NCT05641753|Evolocumab|evolocumab|mesh-list
154834381|NCT05641753|Calcium|calcium|mesh-list
154834382|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154834383|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834384|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154834385|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154834386|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
154834387|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834388|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154834389|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154834390|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834391|NCT05641753|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154834392|NCT05641753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154834393|NCT05641753|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834394|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
154834395|NCT05626621|Azelastine|azelastine|mesh-list
154834396|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834397|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
154834398|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154013907|NCT00611039|Ritonavir|ritonavir|mesh-list
154834399|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154834400|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
154834401|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834402|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586365|NCT03531359|Midazolam|midazolam|mesh-list
154834403|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154834404|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
154834405|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154834406|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834407|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834408|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154834409|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154834410|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
154834411|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
154834412|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834413|NCT05593094|Trastuzumab|trastuzumab|mesh-list
154834414|NCT05593094|Pertuzumab|pertuzumab|mesh-list
154834415|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154834416|NCT05593094|Maytansine|maytansine|mesh-list
154834417|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834418|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834419|NCT05593094|Immunotoxins|immunotoxins|mesh-ancestor
154834420|NCT05593094|Immunoconjugates|immunoconjugates|mesh-ancestor
154834421|NCT05593094|Immunologic Factors|immunologic factors|mesh-ancestor
154834422|NCT05593094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834423|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
154834424|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
154834425|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
154834426|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834427|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154834428|NCT05591118|Anticoagulants|anticoagulants|mesh-list
154834429|NCT05577728|Semaglutide|semaglutide|mesh-list
154834430|NCT05577728|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154834431|NCT05577728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834432|NCT05577728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834433|NCT05541276|Melatonin|melatonin|mesh-list
154834434|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
154834435|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834436|NCT05541276|Protective Agents|protective agents|mesh-ancestor
154834437|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834438|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154834439|NCT05517174|Vaccines|vaccines|mesh-list
154834440|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
154834441|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834442|NCT05493761|Denosumab|denosumab|mesh-list
154834443|NCT05493761|Alendronate|alendronate|mesh-list
154834444|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154834445|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834446|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
154834447|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
154834448|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834449|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
154834450|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834451|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834452|NCT05434663|Granisetron|granisetron|mesh-list
154834453|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
154834454|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
154834455|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834456|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834457|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154834458|NCT05434663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154834459|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154834460|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
154834461|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834462|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834463|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154834464|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154834465|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
154013935|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
154834466|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834467|NCT05405257|Oxytocin|oxytocin|mesh-list
154834468|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
154834469|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154834470|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834471|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154834472|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154834473|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834474|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
154834475|NCT05375630|Vitamin K|vitamin k|mesh-list
154834476|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
154834477|NCT05375630|Vitamins|vitamins|mesh-ancestor
154834478|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
154834479|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834481|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154834482|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834483|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
154834484|NCT05375630|Coagulants|coagulants|mesh-ancestor
154834485|NCT05358535|Propofol|propofol|mesh-list
154834486|NCT05358535|Etomidate|etomidate|mesh-list
154834487|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154834488|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154834489|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834490|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154834491|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
154834492|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
154834493|NCT05349188|Melatonin|melatonin|mesh-list
154834494|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
154834495|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834496|NCT05349188|Protective Agents|protective agents|mesh-ancestor
154834497|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834498|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154834499|NCT05307627|Naltrexone|naltrexone|mesh-list
154834500|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154834501|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154834502|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834503|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
154834504|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834505|NCT05291338|Doxorubicin|doxorubicin|mesh-list
154834506|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
154834507|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154834508|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834509|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154834510|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154834511|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834512|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834513|NCT05268237|Liraglutide|liraglutide|mesh-list
154834514|NCT05268237|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154834515|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834516|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834517|NCT05268237|Incretins|incretins|mesh-ancestor
154834518|NCT05268237|Hormones|hormones|mesh-ancestor
154834519|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834520|NCT05177796|Paclitaxel|paclitaxel|mesh-list
154834521|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
154834522|NCT05177796|Carboplatin|carboplatin|mesh-list
154834523|NCT05177796|Doxorubicin|doxorubicin|mesh-list
154834524|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154834525|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
154834526|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154834527|NCT05177796|Daunorubicin|daunorubicin|mesh-list
154834528|NCT05177796|Panitumumab|panitumumab|mesh-list
154834529|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154834530|NCT05177796|Antibodies|antibodies|mesh-list
154834531|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
154834532|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154834533|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154834534|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834535|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
154834536|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
154834537|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
154834538|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834539|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834540|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
154834541|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834542|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834543|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154834544|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
154834545|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154834546|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154834547|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154834548|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154834549|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834550|NCT05177796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154834551|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
154834552|NCT05077215|Lenvatinib|lenvatinib|mesh-list
154834553|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834554|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834555|NCT05077215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154834556|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834557|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154834558|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834559|NCT05028829|Atorvastatin|atorvastatin|mesh-list
154834560|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154834561|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154834562|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
154834563|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834564|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154834565|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154834566|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834567|NCT04912505|Aspirin|aspirin|mesh-list
154834568|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154834569|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154834570|NCT04912505|Analgesics|analgesics|mesh-ancestor
154834571|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
154834572|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834573|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834574|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834575|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834576|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154834577|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154834578|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834579|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154834580|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154834581|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834582|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
154834583|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
154834584|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154834585|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154834586|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834587|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834588|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834589|NCT04882813|Incretins|incretins|mesh-ancestor
154834590|NCT04882813|Hormones|hormones|mesh-ancestor
154834591|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834592|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154834593|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834594|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834595|NCT04879407|Warfarin|warfarin|mesh-list
154834596|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
154834597|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
154834598|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154834599|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
154834600|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154834601|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834602|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834603|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834604|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
154834605|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154834606|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
154834607|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834608|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
154834609|NCT04839692|Protective Agents|protective agents|mesh-ancestor
154834610|NCT04736420|Warfarin|warfarin|mesh-list
154834611|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
154834612|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
154834613|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154834614|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
154834615|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154834616|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834617|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834618|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834619|NCT04715646|Brivaracetam|brivaracetam|mesh-list
154834620|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
154834621|NCT04691817|Atezolizumab|atezolizumab|mesh-list
154834622|NCT04691817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154834623|NCT04691817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834624|NCT04691817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834625|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834626|NCT04641351|Triamcinolone|triamcinolone|mesh-list
154834627|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154014125|NCT00943501|Hormones|hormones|mesh-ancestor
154834628|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154834629|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154834630|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834631|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
154834633|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834634|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834635|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834636|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
154834637|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834638|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834639|NCT04594811|Nivolumab|nivolumab|mesh-list
154834640|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834641|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834642|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154834643|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834644|NCT04593056|Warfarin|warfarin|mesh-list
154834645|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
154834646|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
154834647|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154834648|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
154834649|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154834650|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834651|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834652|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834653|NCT04566380|Bevacizumab|bevacizumab|mesh-list
154834654|NCT04566380|Nivolumab|nivolumab|mesh-list
154834655|NCT04566380|Capecitabine|capecitabine|mesh-list
154834656|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
154834657|NCT04566380|Temozolomide|temozolomide|mesh-list
154834658|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834659|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834660|NCT04566380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834661|NCT04566380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834662|NCT04566380|Growth Substances|growth substances|mesh-ancestor
154834663|NCT04566380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834664|NCT04566380|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834665|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154834666|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
154834667|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834668|NCT04566380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154834669|NCT04566380|Alkylating Agents|alkylating agents|mesh-ancestor
154834670|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154834671|NCT04561180|Dexamethasone|dexamethasone|mesh-list
154834672|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834673|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
154834674|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
154834675|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834676|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834677|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154834678|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
154834679|NCT04561180|Hormones|hormones|mesh-ancestor
154834680|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834681|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154834682|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834683|NCT04504396|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154834684|NCT04504396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834685|NCT04504396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834686|NCT04504370|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154834687|NCT04504370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834688|NCT04504370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834689|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154834690|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834691|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834692|NCT04495881|Incretins|incretins|mesh-ancestor
154834693|NCT04495881|Hormones|hormones|mesh-ancestor
154834694|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834695|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154834696|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834697|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834698|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834699|NCT04486625|Aztreonam|aztreonam|mesh-list
154834700|NCT04486625|Avibactam|avibactam|mesh-list
154834701|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154834702|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586668|NCT05152420|Apixaban|apixaban|mesh-list
154834703|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154834704|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834705|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834706|NCT04384107|Vaccines|vaccines|mesh-list
154834707|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154834708|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
154834709|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834710|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154834711|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154834712|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154834713|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834714|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834715|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
154834716|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834717|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154834718|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154834719|NCT04241601|Aldesleukin|aldesleukin|mesh-list
154834720|NCT04241601|Interleukin-2|interleukin-2|mesh-list
154834721|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834722|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154834723|NCT04241601|Analgesics|analgesics|mesh-ancestor
154834724|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
154834725|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834726|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834727|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154834728|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154834729|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
154834730|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834731|NCT04150965|Thalidomide|thalidomide|mesh-list
154834732|NCT04150965|Dexamethasone|dexamethasone|mesh-list
154834733|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
154834734|NCT04150965|Pomalidomide|pomalidomide|mesh-list
154834735|NCT04150965|Relatlimab|relatlimab|mesh-list
154834736|NCT04150965|Elotuzumab|elotuzumab|mesh-list
154834737|NCT04150965|BB 1101|bb 1101|mesh-list
154834738|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834739|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
154834740|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
154834741|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834742|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834743|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154834744|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
154834745|NCT04150965|Hormones|hormones|mesh-ancestor
154834746|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834747|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154834748|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834749|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834750|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834751|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834752|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
154834753|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834754|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834755|NCT04150965|Growth Substances|growth substances|mesh-ancestor
154834756|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834757|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834758|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
154834759|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154834760|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834761|NCT04150965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834762|NCT04150965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154834763|NCT04136353|Hormones|hormones|mesh-list
154834764|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154834765|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834766|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834767|NCT04072822|Prednisone|prednisone|mesh-list
154834768|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154834769|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834770|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
154834771|NCT04072822|Hormones|hormones|mesh-ancestor
154834772|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834773|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834774|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154834775|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834776|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834777|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154834778|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
154834779|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834780|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154834781|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
154834782|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834783|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154834784|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
154014277|NCT06004947|Rifampin|rifampin|mesh-list
154834785|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834786|NCT03667846|Topiramate|topiramate|mesh-list
154834787|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
154834788|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834789|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834790|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
154834791|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834792|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834793|NCT03658447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154834794|NCT03658447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834795|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154834796|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
154834797|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834798|NCT03531762|Tepotinib|tepotinib|mesh-list
154834799|NCT03531762|Omeprazole|omeprazole|mesh-list
154834800|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154834801|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154834802|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154834803|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834804|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834805|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834806|NCT03464045|Empagliflozin|empagliflozin|mesh-list
154834807|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154834808|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154834809|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834810|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154834811|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834812|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834813|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834814|NCT03462459|Vancomycin|vancomycin|mesh-list
154834815|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154834816|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834817|NCT03443869|Acyclovir|acyclovir|mesh-list
154834818|NCT03443869|Valganciclovir|valganciclovir|mesh-list
154834819|NCT03443869|Letermovir|letermovir|mesh-list
154834820|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
154834821|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834822|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154834823|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834824|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834825|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834826|NCT03253796|Golimumab|golimumab|mesh-list
154834827|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154834828|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154834829|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834830|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
154834831|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834832|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
154834833|NCT03241940|Fludarabine|fludarabine|mesh-list
154834834|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
154834835|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834836|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
154834837|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834838|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834839|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154834840|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
154834841|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834842|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834843|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154834844|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154834845|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
154834846|NCT03132116|Gentamicins|gentamicins|mesh-list
154834847|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154586817|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
154834848|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834849|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154834850|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834851|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834852|NCT03029143|Vedolizumab|vedolizumab|mesh-list
154834853|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154834854|NCT02959164|Gemcitabine|gemcitabine|mesh-list
154834855|NCT02959164|Decitabine|decitabine|mesh-list
154834856|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154834857|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
154834858|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834859|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834860|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834861|NCT02803502|Thrombin|thrombin|mesh-list
154834862|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
154834863|NCT02803502|Coagulants|coagulants|mesh-ancestor
154834864|NCT02763579|Carboplatin|carboplatin|mesh-list
154834865|NCT02763579|Etoposide|etoposide|mesh-list
154834866|NCT02763579|Atezolizumab|atezolizumab|mesh-list
154834867|NCT02763579|Antibodies|antibodies|mesh-list
154834868|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154834869|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
154834870|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834871|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834872|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154834873|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154834874|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154834875|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834876|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834877|NCT02763579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154834878|NCT02763579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834879|NCT02618577|Edoxaban|edoxaban|mesh-list
154834880|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154834881|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
154834882|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154834883|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
154834884|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834885|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834886|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
154834887|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
154834888|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154834889|NCT02572791|Mupirocin|mupirocin|mesh-list
154834890|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154834891|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834892|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
154834893|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
154834894|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154834895|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154834896|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834897|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834898|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154834899|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154834900|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
154834901|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154834902|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834903|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
154834904|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154834905|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
154834906|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154834907|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154834908|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154834909|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834910|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
154834911|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154834912|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834913|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
154834914|NCT00453193|Pentostatin|pentostatin|mesh-list
154834915|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834916|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834917|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154834918|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834919|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834920|NCT00387023|Rituximab|rituximab|mesh-list
154834921|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834922|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834923|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
154834924|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834925|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834926|NCT00472849|Cytarabine|cytarabine|mesh-list
154834927|NCT00472849|Rituximab|rituximab|mesh-list
154834928|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
154834929|NCT00472849|Fludarabine|fludarabine|mesh-list
154834930|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834931|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834932|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
154834933|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834934|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154834935|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154834936|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
154834937|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834938|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154834939|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
154834940|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834941|NCT00453895|Sunitinib|sunitinib|mesh-list
154834942|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834943|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834944|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834945|NCT00453895|Growth Substances|growth substances|mesh-ancestor
154834946|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834947|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834948|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154834949|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834950|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834951|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
154834952|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154834953|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154834954|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154834955|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154834956|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014442|NCT05874219|Neomycin|neomycin|mesh-list
154834957|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
154834958|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154834959|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834960|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154834961|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154834962|NCT00409565|Bevacizumab|bevacizumab|mesh-list
154834963|NCT00409565|Cetuximab|cetuximab|mesh-list
154834964|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154834965|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834966|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834967|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834968|NCT00409565|Growth Substances|growth substances|mesh-ancestor
154834969|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834970|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
154834971|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
154834972|NCT00475501|Finasteride|finasteride|mesh-list
154834973|NCT00475501|Testosterone|testosterone|mesh-list
154834974|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
154834975|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
154834976|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154834977|NCT00475501|Androgens|androgens|mesh-ancestor
154834978|NCT00475501|Hormones|hormones|mesh-ancestor
154834979|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154834980|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834981|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154834982|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834983|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
154834984|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154834985|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154834986|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154834987|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154834988|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
154834989|NCT00475501|Urological Agents|urological agents|mesh-ancestor
154834990|NCT00529555|Minocycline|minocycline|mesh-list
154834991|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154834992|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154834993|NCT00387335|Sunitinib|sunitinib|mesh-list
154834994|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154834995|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154834996|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154834997|NCT00387335|Growth Substances|growth substances|mesh-ancestor
154834998|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154834999|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
154586973|NCT02441114|Hormones|hormones|mesh-ancestor
154835000|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835001|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835002|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835003|NCT01797757|Orlistat|orlistat|mesh-list
154835004|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835005|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835006|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154835007|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154835008|NCT01796899|Brivaracetam|brivaracetam|mesh-list
154835009|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
154835010|NCT00477451|Alprazolam|alprazolam|mesh-list
154835011|NCT00477451|Doxapram|doxapram|mesh-list
154835012|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154835013|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835014|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835015|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154835016|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154835017|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154835018|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
154835019|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
154835020|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835021|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835022|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154835023|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
154835024|NCT00530803|Lidocaine|lidocaine|mesh-list
154835025|NCT00530803|Tetracaine|tetracaine|mesh-list
154835026|NCT00530803|Prilocaine|prilocaine|mesh-list
154835027|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154835028|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
154835029|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
154835030|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835031|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835032|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
154835033|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835034|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154835035|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154835036|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154835037|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835038|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835039|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154835040|NCT04372927|Cisplatin|cisplatin|mesh-list
154835041|NCT04372927|Etoposide|etoposide|mesh-list
154835042|NCT04372927|Pemetrexed|pemetrexed|mesh-list
154835043|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
154835044|NCT04372927|Durvalumab|durvalumab|mesh-list
154835045|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
154835046|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
154835047|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154835048|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
154835049|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835050|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154835051|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154835052|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154835053|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835054|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835055|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154835056|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154835057|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835058|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
154835059|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835060|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
154835061|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
154835062|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
154835063|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
154835064|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
154835065|NCT01381874|Prednisone|prednisone|mesh-list
154835066|NCT01381874|Prednisolone|prednisolone|mesh-list
154835067|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154835068|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
154835069|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154835070|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
154835071|NCT01381874|Exemestane|exemestane|mesh-list
154835072|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
154835073|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154587039|NCT04420624|Colchicine|colchicine|mesh-list
154835074|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
154835075|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835076|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
154835077|NCT01381874|Hormones|hormones|mesh-ancestor
154835078|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835079|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835080|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154835081|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835083|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
154835084|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835085|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835086|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154835087|NCT01381874|Protective Agents|protective agents|mesh-ancestor
154835088|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154835089|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154835090|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835091|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835092|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154835093|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
154835094|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154835095|NCT01399190|Bevacizumab|bevacizumab|mesh-list
154835096|NCT01399190|Capecitabine|capecitabine|mesh-list
154835097|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
154835098|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835099|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835100|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154835101|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154835102|NCT01399190|Growth Substances|growth substances|mesh-ancestor
154835103|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835104|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
154835105|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154835106|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
154835107|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835108|NCT01381718|Modafinil|modafinil|mesh-list
154835109|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154835110|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835111|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154835112|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154835113|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154835114|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835115|NCT00479089|Dexamethasone|dexamethasone|mesh-list
154835116|NCT00479089|Docetaxel|docetaxel|mesh-list
154835117|NCT00479089|Gefitinib|gefitinib|mesh-list
154835118|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835119|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
154835120|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
154835121|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835122|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835123|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835124|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
154835125|NCT00479089|Hormones|hormones|mesh-ancestor
154835126|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835127|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154835128|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835129|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
154835130|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
154835131|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
154835132|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835133|NCT00479089|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154835134|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835135|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835136|NCT01398956|Levetiracetam|levetiracetam|mesh-list
154835137|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
154835138|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
154835139|NCT00410423|Cytarabine|cytarabine|mesh-list
154835140|NCT00410423|Etoposide|etoposide|mesh-list
154835141|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
154835142|NCT00410423|Bortezomib|bortezomib|mesh-list
154835143|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154835144|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835145|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154835146|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154835147|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835148|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835149|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154835150|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
154835151|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
154835153|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154835154|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
154835155|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835156|NCT00410423|Analgesics|analgesics|mesh-ancestor
154835157|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
154835158|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835159|NCT00387959|Cyclosporine|cyclosporine|mesh-list
154835160|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
154835161|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
154835162|NCT00387959|Rituximab|rituximab|mesh-list
154835163|NCT00387959|Fludarabine|fludarabine|mesh-list
154835164|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
154835165|NCT00387959|Cyclosporins|cyclosporins|mesh-list
154835166|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154835167|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
154835168|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835169|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835170|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154835171|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
154835172|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835173|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835174|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154835175|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835176|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154835177|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
154835178|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835179|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
154835180|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835181|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
154835182|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154835183|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154835184|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154835185|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
154835186|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154835187|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
154835188|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154835189|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835190|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154835191|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154835192|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154835193|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154835194|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835195|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835196|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835197|NCT01381562|Meropenem|meropenem|mesh-list
154835198|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154835199|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835200|NCT01381016|Hormones|hormones|mesh-list
154835201|NCT01381016|Estradiol|estradiol|mesh-list
154835202|NCT01381016|Progesterone|progesterone|mesh-list
154835203|NCT01381016|Estrogens|estrogens|mesh-list
154014672|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154835204|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835205|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835206|NCT01381016|Progestins|progestins|mesh-ancestor
154835207|NCT00412451|Plasminogen|plasminogen|mesh-list
154835208|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154835209|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154835210|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835211|NCT01398410|Rabeprazole|rabeprazole|mesh-list
154835212|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154835213|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835214|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154835215|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835216|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835217|NCT00412529|Entecavir|entecavir|mesh-list
154835218|NCT00412529|Telbivudine|telbivudine|mesh-list
154835219|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
154835220|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835221|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154835222|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835223|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835224|NCT00412841|Atorvastatin|atorvastatin|mesh-list
154835225|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154835226|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154835227|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
154835228|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835229|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154835230|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154835231|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835232|NCT01796483|Clonidine|clonidine|mesh-list
154835233|NCT01796483|Analgesics|analgesics|mesh-ancestor
154835234|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
154835235|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835236|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835237|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154835238|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
154835239|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
154835240|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154835241|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154835242|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154835243|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
154835244|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835245|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835246|NCT00414167|Bupropion|bupropion|mesh-list
154835247|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154835248|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
154835249|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154835250|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154835251|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154835252|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835253|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835254|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
154835255|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835256|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835257|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154835258|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154835259|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835260|NCT01380782|Nintedanib|nintedanib|mesh-list
154835261|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835262|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835263|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835264|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835265|NCT00534001|Bupropion|bupropion|mesh-list
154835266|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154835267|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
154835268|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154835269|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154835270|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154835271|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835272|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835273|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
154835274|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835275|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835276|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154835277|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154835278|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835279|NCT00481351|Simvastatin|simvastatin|mesh-list
154835280|NCT00481351|Ezetimibe|ezetimibe|mesh-list
154835281|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154835282|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154835283|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
154835284|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835285|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154835286|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154835287|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835288|NCT00455975|Bevacizumab|bevacizumab|mesh-list
154835289|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835290|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835291|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154835292|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154835293|NCT00455975|Growth Substances|growth substances|mesh-ancestor
154835294|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835295|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
154835296|NCT05366192|Ritonavir|ritonavir|mesh-list
154835297|NCT05366192|Nirmatrelvir|nirmatrelvir|mesh-list
154835298|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154835299|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154835300|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
154835301|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835302|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835303|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154835304|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154835305|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
154835306|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835307|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154835308|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154835309|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
154835310|NCT04013672|Sargramostim|sargramostim|mesh-list
154835311|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154835312|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835313|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835314|NCT04013672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154835315|NCT04013672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835316|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
154835317|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835318|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154835319|NCT02078882|Abatacept|abatacept|mesh-list
154835320|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154835321|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835322|NCT02078882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835323|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835324|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154835325|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
154835326|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835327|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835328|NCT00458237|Trastuzumab|trastuzumab|mesh-list
154835329|NCT00458237|Everolimus|everolimus|mesh-list
154835330|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835331|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835332|NCT00458237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154835333|NCT00458237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835334|NCT00458237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835335|NCT00458237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835336|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154835337|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
154835338|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835339|NCT00418457|Anesthetics|anesthetics|mesh-list
154835340|NCT00418457|Propofol|propofol|mesh-list
154835341|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835342|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835343|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154835344|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154835345|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
154835346|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
154835347|NCT00482911|Lenalidomide|lenalidomide|mesh-list
154835348|NCT00482911|Sunitinib|sunitinib|mesh-list
154835349|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154835350|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
154835351|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835352|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835353|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154835354|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
154835355|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835356|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835357|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154835358|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154835359|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154835360|NCT00482911|Growth Substances|growth substances|mesh-ancestor
154835361|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
154835362|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835363|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835364|NCT01397162|Fluticasone|fluticasone|mesh-list
154835365|NCT01397162|Xhance|xhance|mesh-list
154835366|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835367|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154835368|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
154835369|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835370|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835371|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154835372|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
154835373|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
154587340|NCT03521219|Apatinib|apatinib|mesh-list
154835374|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154835375|NCT00483223|Carboplatin|carboplatin|mesh-list
154835376|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835377|NCT01397084|Esomeprazole|esomeprazole|mesh-list
154835378|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154835379|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835380|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154835381|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835382|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835383|NCT00420017|Amiodarone|amiodarone|mesh-list
154835384|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154835385|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
154835386|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154835387|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835388|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835389|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154835390|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154835391|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154835392|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835393|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154835394|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154835395|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154835396|NCT00484393|Tetracaine|tetracaine|mesh-list
154835397|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
154835398|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
154835399|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835400|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835401|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
154835402|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835403|NCT00485485|Docetaxel|docetaxel|mesh-list
154835404|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
154835405|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835406|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
154835407|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
154835408|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
154835409|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835410|NCT00485485|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154835411|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835412|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835413|NCT00422201|Mifepristone|mifepristone|mesh-list
154835414|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154835415|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
154835416|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154835417|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835418|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154835419|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154835420|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154835421|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
154835422|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154835423|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154835424|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
154835425|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835426|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
154835427|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154835428|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154835429|NCT01396148|Sunitinib|sunitinib|mesh-list
154835430|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835431|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154835432|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154835433|NCT01396148|Growth Substances|growth substances|mesh-ancestor
154835434|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835435|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
154835436|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835437|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835438|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835439|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
154835440|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154835441|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835442|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835443|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154835444|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587406|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
154835445|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154835446|NCT00486031|Balsalazide|balsalazide|mesh-list
154835447|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154835448|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154835449|NCT00486031|Analgesics|analgesics|mesh-ancestor
154835450|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
154835451|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835452|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835453|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835454|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835455|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835456|NCT04019834|Bupivacaine|bupivacaine|mesh-list
154835457|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
154835458|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
154835459|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835460|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835461|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
154835462|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835463|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154835464|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835465|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835466|NCT01396070|Immunotoxins|immunotoxins|mesh-ancestor
154835467|NCT01396070|Immunoconjugates|immunoconjugates|mesh-ancestor
154835468|NCT01396070|Immunologic Factors|immunologic factors|mesh-ancestor
154835469|NCT01396070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835470|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
154835471|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154835472|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835473|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835474|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154835475|NCT02108171|Analgesics|analgesics|mesh-ancestor
154835476|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
154835477|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835478|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154835479|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154835480|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154835481|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
154835482|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835483|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835485|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154835486|NCT03940807|Estrogens|estrogens|mesh-ancestor
154835487|NCT03940807|Hormones|hormones|mesh-ancestor
154835488|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835489|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835490|NCT00535873|Lenalidomide|lenalidomide|mesh-list
154835491|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
154835492|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835493|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154835494|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154835495|NCT00535873|Growth Substances|growth substances|mesh-ancestor
154835496|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
154835497|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835498|NCT00487669|Paclitaxel|paclitaxel|mesh-list
154835499|NCT00487669|Pemetrexed|pemetrexed|mesh-list
154835500|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
154835501|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154835502|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835503|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
154835504|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
154835505|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
154835506|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835507|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835508|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154835509|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154835510|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
154835511|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
154835512|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
154835513|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154835514|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154835515|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835516|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154835517|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154587480|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835519|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835520|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835521|NCT00536341|Rituximab|rituximab|mesh-list
154835522|NCT00536341|Fludarabine|fludarabine|mesh-list
154835523|NCT00536341|Lenalidomide|lenalidomide|mesh-list
154835524|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835525|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835526|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
154835527|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835528|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835529|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154835530|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154835531|NCT00536341|Growth Substances|growth substances|mesh-ancestor
154835532|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
154835533|NCT02122471|Plecanatide|plecanatide|mesh-list
154835534|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154835535|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
154835536|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835537|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835538|NCT00461591|Apaziquone|apaziquone|mesh-list
154835539|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835540|NCT00423683|PENTA|penta|mesh-list
154835541|NCT00423683|Fondaparinux|fondaparinux|mesh-list
154835542|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154835543|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
154835544|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154835545|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
154835546|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835547|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835548|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
154835549|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154835550|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154835551|NCT00424619|Vitamin D|vitamin d|mesh-list
154835552|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
154835553|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
154835554|NCT00424619|Vitamins|vitamins|mesh-list
154835555|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
154835556|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835557|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154835558|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154835559|NCT00425477|Bexarotene|bexarotene|mesh-list
154835560|NCT00425477|Sargramostim|sargramostim|mesh-list
154835561|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
154835562|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835563|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835564|NCT00427037|Vitamin D|vitamin d|mesh-list
154835565|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
154835566|NCT00427037|Vitamins|vitamins|mesh-ancestor
154835567|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
154835568|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835569|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154835570|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154835571|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
154835572|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154835573|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835574|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154835575|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835576|NCT00427661|Cyclosporine|cyclosporine|mesh-list
154835577|NCT00427661|Fludarabine|fludarabine|mesh-list
154835578|NCT00427661|Busulfan|busulfan|mesh-list
154835579|NCT00427661|Cyclosporins|cyclosporins|mesh-list
154835580|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835581|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835582|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154835583|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
154835584|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835585|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835586|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
154835587|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835588|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
154835589|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835590|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154835591|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
154835592|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154587564|NCT02461160|Midazolam|midazolam|mesh-list
154835593|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154835594|NCT00427973|Cediranib|cediranib|mesh-list
154835595|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835596|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835597|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835598|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835599|NCT01795703|Prednisolone|prednisolone|mesh-list
154835600|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835601|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
154835602|NCT01795703|Hormones|hormones|mesh-ancestor
154835603|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835604|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835605|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154835606|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835607|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
154835608|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
154835609|NCT00429143|Tacrolimus|tacrolimus|mesh-list
154835610|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154835611|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
154835612|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835613|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835614|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154835615|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
154835616|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835617|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835618|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154835619|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154835620|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835621|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154835622|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154835623|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
154835624|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154835625|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835626|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
154835627|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154835628|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154835629|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154835630|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835631|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835632|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
154835633|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835634|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835635|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154835636|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835637|NCT00433745|Vaccines|vaccines|mesh-list
154835638|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
154835639|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835640|NCT01395758|Gemcitabine|gemcitabine|mesh-list
154835641|NCT01395758|Docetaxel|docetaxel|mesh-list
154835642|NCT01395758|Pemetrexed|pemetrexed|mesh-list
154835643|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154835644|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154835645|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
154835646|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835647|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835648|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
154835649|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
154835650|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
154835651|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835652|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154835653|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154835654|NCT01395758|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154835655|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154835656|NCT00462605|Entinostat|entinostat|mesh-list
154835657|NCT00462605|Sargramostim|sargramostim|mesh-list
154835658|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154835659|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
154835660|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835661|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835662|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835663|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835664|NCT02120287|Bevacizumab|bevacizumab|mesh-list
154835665|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154835666|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835667|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154835668|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154835669|NCT02120287|Growth Substances|growth substances|mesh-ancestor
154835670|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835671|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
154835673|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
154835674|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835675|NCT00434993|Albuterol|albuterol|mesh-list
154835676|NCT00434993|Dimercaprol|dimercaprol|mesh-list
154835677|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154835678|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
154835679|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835680|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835681|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154835682|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
154835683|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
154835684|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154835685|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154835686|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154835687|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154835688|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
154835689|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835690|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835691|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
154835692|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
154835693|NCT01395524|Naloxegol|naloxegol|mesh-list
154835694|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154835695|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835696|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
154835697|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835698|NCT04338698|Azithromycin|azithromycin|mesh-list
154835699|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
154835700|NCT04338698|Oseltamivir|oseltamivir|mesh-list
154835701|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154835702|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835703|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
154835704|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154835705|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154835706|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835707|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835708|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835709|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
154835710|NCT00435539|Plasminogen|plasminogen|mesh-list
154835711|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
154835712|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154835713|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154835714|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835715|NCT00464711|Escitalopram|escitalopram|mesh-list
154835716|NCT00464711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154835717|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154835718|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835719|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835720|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835721|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
154835722|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835723|NCT02078180|Bupropion|bupropion|mesh-list
154835724|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154835725|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
154835726|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154835727|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154015229|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154835728|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154835729|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835730|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835731|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
154835732|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835733|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835734|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154835735|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154835736|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835737|NCT00535613|Propofol|propofol|mesh-list
154835738|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154835739|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835740|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835741|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154835742|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
154835744|NCT00466661|Acamprosate|acamprosate|mesh-list
154835745|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154835746|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154835747|NCT05360576|Etonogestrel|etonogestrel|mesh-list
154835748|NCT05360576|NuvaRing|nuvaring|mesh-list
154835749|NCT05360576|Estradiol|estradiol|mesh-list
154835750|NCT05360576|Estrogens|estrogens|mesh-ancestor
154835751|NCT05360576|Hormones|hormones|mesh-ancestor
154835752|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835753|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835754|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154835755|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
154835756|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154835757|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154835758|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154835759|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154835760|NCT00535925|Aspirin|aspirin|mesh-list
154835761|NCT00535925|Atenolol|atenolol|mesh-list
154835762|NCT00535925|Amlodipine|amlodipine|mesh-list
154835763|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154835764|NCT00535925|Clonidine|clonidine|mesh-list
154835765|NCT00535925|Ramipril|ramipril|mesh-list
154835766|NCT00535925|Irbesartan|irbesartan|mesh-list
154835767|NCT00535925|Doxazosin|doxazosin|mesh-list
154835768|NCT00535925|Furosemide|furosemide|mesh-list
154835769|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
154835770|NCT00535925|Simvastatin|simvastatin|mesh-list
154835771|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835772|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154835773|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154835774|NCT00535925|Analgesics|analgesics|mesh-ancestor
154835775|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
154835776|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835777|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835778|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154835779|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154835780|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154835781|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835782|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154835783|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154835784|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835785|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
154835786|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154835787|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154835788|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835789|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154835790|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
154835791|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154835792|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154835793|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
154835794|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154835795|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154835796|NCT00535925|Diuretics|diuretics|mesh-ancestor
154835797|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
154835798|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154835799|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154835800|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
154835801|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
154835802|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154835803|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154835804|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154835805|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
154835806|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835807|NCT00535925|Hematinics|hematinics|mesh-ancestor
154835808|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154835809|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
154835810|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154835811|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154835812|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154835813|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154835814|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154835815|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154835816|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154835817|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154587784|NCT03476811|Analgesics|analgesics|mesh-list
154835818|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154835819|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154835820|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
154835821|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835822|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835823|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835824|NCT01796093|Digoxin|digoxin|mesh-list
154835825|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154835826|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154835827|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835828|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835829|NCT01796093|Protective Agents|protective agents|mesh-ancestor
154835830|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835831|NCT00537511|Etoposide|etoposide|mesh-list
154835832|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
154835833|NCT00537511|Pomalidomide|pomalidomide|mesh-list
154835834|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835835|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154835836|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154835837|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154835838|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015355|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835839|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835840|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
154835841|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835842|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154835843|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154835844|NCT00537511|Growth Substances|growth substances|mesh-ancestor
154835845|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
154835846|NCT00435929|Ritonavir|ritonavir|mesh-list
154835847|NCT00435929|Saquinavir|saquinavir|mesh-list
154835848|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154835849|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154835850|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
154835851|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835852|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835853|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154835854|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154835855|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
154835856|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835857|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154835858|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154835859|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
154835860|NCT00436475|Vitamin D|vitamin d|mesh-list
154835861|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
154835862|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
154835863|NCT00436475|Vitamins|vitamins|mesh-list
154835864|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
154835865|NCT00436475|Calcium|calcium|mesh-list
154835866|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
154835867|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835868|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154835869|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154835870|NCT00436475|Antacids|antacids|mesh-ancestor
154835871|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835872|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835873|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
154835874|NCT00210626|Hematinics|hematinics|mesh-ancestor
154835875|NCT03595514|Dexamethasone|dexamethasone|mesh-list
154835876|NCT03595514|Lidocaine|lidocaine|mesh-list
154835877|NCT03595514|Epinephrine|epinephrine|mesh-list
154835878|NCT03595514|Bupivacaine|bupivacaine|mesh-list
154835879|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835880|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
154835881|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
154835882|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835883|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835884|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835885|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
154835886|NCT03595514|Hormones|hormones|mesh-ancestor
154835887|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835888|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154835889|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835890|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
154835891|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
154835892|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835893|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
154835894|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154835895|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154835896|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154835897|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154835898|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835899|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154835901|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
154835902|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835903|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154835904|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154835905|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154835906|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
154835907|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
154835908|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
154835909|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154835910|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
154835911|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
154835912|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835913|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
154835914|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835915|NCT03595046|Dexamethasone|dexamethasone|mesh-list
154835916|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
154835917|NCT03595046|Ropivacaine|ropivacaine|mesh-list
154835918|NCT03595046|BB 1101|bb 1101|mesh-list
154835919|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835920|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
154835921|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
154835922|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835923|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835924|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835925|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
154835926|NCT03595046|Hormones|hormones|mesh-ancestor
154835927|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835928|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154835929|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835930|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
154835931|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154835932|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835933|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
154835934|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
154835935|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835936|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
154835937|NCT00217022|Budesonide|budesonide|mesh-list
154835938|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154835939|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154835940|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
154835941|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835942|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835943|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154835944|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
154835945|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
154835946|NCT00217022|Hormones|hormones|mesh-ancestor
154835947|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835948|NCT03594968|Progesterone|progesterone|mesh-list
154835949|NCT03594968|Progestins|progestins|mesh-ancestor
154835950|NCT03594968|Hormones|hormones|mesh-ancestor
154835951|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154835952|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835953|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
154835954|NCT00538915|Antibodies|antibodies|mesh-list
154835955|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
154835956|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154835957|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154835958|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
154835959|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835960|NCT00490009|Acetaminophen|acetaminophen|mesh-list
154835961|NCT00490009|Iodine|iodine|mesh-list
154835962|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
154835963|NCT00490009|Promethazine|promethazine|mesh-list
154835964|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
154835965|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
154835966|NCT00490009|Lugol's solution|lugol's solution|mesh-list
154835967|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154835968|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154835969|NCT00490009|Analgesics|analgesics|mesh-ancestor
154587934|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
154835970|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
154835971|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154835972|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154835973|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
154835974|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154835975|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154835976|NCT00490009|Trace Elements|trace elements|mesh-ancestor
154835977|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
154835978|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154835979|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154835980|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154835981|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
154835982|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
154835983|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
154835984|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
154835985|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154835986|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154835987|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
154835988|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
154835989|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154835990|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154835991|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154835992|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
154835993|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
154835994|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154835995|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
154835996|NCT00490009|Coagulants|coagulants|mesh-ancestor
154835997|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
154835998|NCT03769532|Azacitidine|azacitidine|mesh-list
154835999|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154836000|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836001|NCT03769532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154836002|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836003|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836004|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
154836005|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836006|NCT00490477|Polymyxins|polymyxins|mesh-list
154836007|NCT00490477|Polymyxin B|polymyxin b|mesh-list
154836008|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154836009|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836010|NCT00492973|Cefuroxime|cefuroxime|mesh-list
154836011|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
154836012|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154836013|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154836014|NCT00492973|Prednisolone|prednisolone|mesh-list
154836015|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
154836016|NCT00492973|Clonidine|clonidine|mesh-list
154836017|NCT00492973|Epinephrine|epinephrine|mesh-list
154836018|NCT00492973|Morphine|morphine|mesh-list
154836019|NCT00492973|Bupivacaine|bupivacaine|mesh-list
154836020|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154836021|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
154836022|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
154836023|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
154836024|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836025|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836026|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
154836027|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836028|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154836029|NCT00492973|Narcotics|narcotics|mesh-ancestor
154836030|NCT00492973|Analgesics|analgesics|mesh-ancestor
154836031|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836032|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
154836033|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
154836034|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154836035|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
154836036|NCT00492973|Hormones|hormones|mesh-ancestor
154836037|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154836038|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154836039|NCT00492973|Protective Agents|protective agents|mesh-ancestor
154836040|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154836041|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836042|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154836043|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154836044|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
154836045|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836046|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836047|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154836048|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154836049|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154836050|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
154836051|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
154836052|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
154836053|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154836054|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154836055|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
154836056|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154836057|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154836058|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836059|NCT05630534|Minocycline|minocycline|mesh-list
154836060|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154836061|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836062|NCT00495079|Vincristine|vincristine|mesh-list
154836063|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154836064|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836065|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
154836066|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
154836067|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
154836068|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836069|NCT03594188|Anesthetics|anesthetics|mesh-list
154836070|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836071|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836072|NCT00539695|Aldesleukin|aldesleukin|mesh-list
154836073|NCT00539695|Interleukin-2|interleukin-2|mesh-list
154836074|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836075|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154836076|NCT00539695|Analgesics|analgesics|mesh-ancestor
154836077|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
154836078|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836079|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836080|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154836081|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154836082|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
154836083|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836084|NCT03593954|Ritonavir|ritonavir|mesh-list
154836085|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154836086|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154836087|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
154836088|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836089|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836090|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154836091|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154836092|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
154836093|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836094|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154836095|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154836096|NCT03590210|Nivolumab|nivolumab|mesh-list
154836097|NCT03590210|Trabectedin|trabectedin|mesh-list
154836098|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154836099|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836100|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154836101|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836102|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154836103|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
154836104|NCT05632328|Paclitaxel|paclitaxel|mesh-list
154836105|NCT05632328|Gemcitabine|gemcitabine|mesh-list
154836106|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154836107|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154836108|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836109|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
154836110|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
154836111|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
154836112|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836113|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836114|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
154836115|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
154836116|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836117|NCT03599726|Donepezil|donepezil|mesh-list
154836118|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154836119|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836120|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836121|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
154836122|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836123|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836124|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
154836125|NCT00466817|Valganciclovir|valganciclovir|mesh-list
154836126|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
154836127|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836128|NCT04406870|Sirolimus|sirolimus|mesh-list
154836129|NCT04406870|Propranolol|propranolol|mesh-list
154836130|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154836131|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836132|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154836133|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836134|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
154836135|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154836136|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
154836137|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836138|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836139|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154836140|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154836141|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
154836142|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836143|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154836144|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154836145|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
154836146|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154836147|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
154836148|NCT03985514|Tazobactam|tazobactam|mesh-list
154836149|NCT03985514|Piperacillin|piperacillin|mesh-list
154836150|NCT03985514|Metronidazole|metronidazole|mesh-list
154836151|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154836152|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154836153|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836154|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
154836155|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154836156|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154836157|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836158|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836159|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836160|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154836161|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154836162|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154836163|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154836164|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154836165|NCT00540007|Lenalidomide|lenalidomide|mesh-list
154836166|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
154836167|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836168|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154836169|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154836170|NCT00540007|Growth Substances|growth substances|mesh-ancestor
154836171|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
154836172|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836173|NCT02982889|Bupivacaine|bupivacaine|mesh-list
154836174|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
154836175|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
154836176|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
154836177|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836178|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836179|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
154836180|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836181|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154836182|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
154836183|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
154836184|NCT02982889|Protective Agents|protective agents|mesh-ancestor
154836185|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154836186|NCT03592082|Bismuth|bismuth|mesh-list
154836187|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154836188|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836189|NCT03592082|Antacids|antacids|mesh-ancestor
154836190|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836191|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154836192|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
154836193|NCT03598868|Vortioxetine|vortioxetine|mesh-list
154836194|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
154836195|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154836196|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154836197|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154588186|NCT04958967|Aflutinib|aflutinib|mesh-list
154836198|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836199|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836200|NCT03598868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154836201|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154836203|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836204|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836205|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
154836206|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154836207|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154836208|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154836209|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154836210|NCT00501631|Naltrexone|naltrexone|mesh-list
154836211|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154836212|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154836213|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836214|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
154836215|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836216|NCT05631704|Midazolam|midazolam|mesh-list
154836217|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154836218|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154836219|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836220|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836221|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154836222|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154836223|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154836224|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154836225|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
154836226|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
154836227|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
154836228|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
154836229|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836230|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836231|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
154836232|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154836233|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836234|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836235|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154836236|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154836237|NCT03591536|Protective Agents|protective agents|mesh-ancestor
154836238|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836239|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
154836240|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154836241|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
154836242|NCT00501943|Interferons|interferons|mesh-list
154836243|NCT00501943|Interferon-beta|interferon-beta|mesh-list
154836244|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
154836245|NCT00501943|Riluzole|riluzole|mesh-list
154836246|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836247|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
154836248|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836249|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
154015746|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836250|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836251|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154836252|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
154836253|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154836254|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154836255|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836256|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836257|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154836258|NCT00501943|Protective Agents|protective agents|mesh-ancestor
154836259|NCT03598634|Riboflavin|riboflavin|mesh-list
154836260|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
154836261|NCT03598634|Vitamins|vitamins|mesh-ancestor
154836262|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
154836263|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836264|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154836265|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
154836266|NCT03598556|Vitamin D|vitamin d|mesh-list
154836267|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
154836268|NCT03598556|Vitamins|vitamins|mesh-ancestor
154836269|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
154836270|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836271|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154836272|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154836273|NCT03024476|Olmesartan|olmesartan|mesh-list
154836274|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154836275|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154836276|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154836277|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836278|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
154836280|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154836281|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
154836282|NCT03590912|Prednisolone|prednisolone|mesh-list
154836283|NCT03590912|Phenylephrine|phenylephrine|mesh-list
154836284|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
154836285|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
154836286|NCT03590912|Levocetirizine|levocetirizine|mesh-list
154836287|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
154836288|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154836289|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836290|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836291|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
154836292|NCT03590912|Hormones|hormones|mesh-ancestor
154836293|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015799|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
154836294|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836295|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154836296|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836297|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
154836298|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836299|NCT03590912|Protective Agents|protective agents|mesh-ancestor
154836300|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
154836301|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154836302|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154836303|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
154836304|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836305|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836306|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154836307|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154836308|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
154836309|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
154836310|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154836311|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
154836312|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154836313|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
154836314|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154836315|NCT03590912|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154836316|NCT00503113|Alendronate|alendronate|mesh-list
154836317|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
154836318|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154836319|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836320|NCT00542971|Cytarabine|cytarabine|mesh-list
154836321|NCT00542971|Sorafenib|sorafenib|mesh-list
154836322|NCT00542971|Idarubicin|idarubicin|mesh-list
154836323|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836324|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
154836325|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836326|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836327|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
154836328|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836329|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154836330|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
154836331|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836332|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154836333|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836334|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154836335|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154836336|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154836337|NCT00504751|Dexamethasone|dexamethasone|mesh-list
154836338|NCT00504751|Rituximab|rituximab|mesh-list
154836339|NCT00504751|Etoposide|etoposide|mesh-list
154836340|NCT00504751|Bortezomib|bortezomib|mesh-list
154836341|NCT00504751|Ifosfamide|ifosfamide|mesh-list
154836342|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154836343|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836344|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
154836345|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836346|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154836347|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836348|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
154836349|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
154836350|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836351|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154836352|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
154836353|NCT00504751|Hormones|hormones|mesh-ancestor
154836354|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015847|NCT02600247|Narcotics|narcotics|mesh-ancestor
154836355|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154836356|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154836357|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154836358|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154836359|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836360|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836361|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154836362|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
154836363|NCT01013779|Carboplatin|carboplatin|mesh-list
154836364|NCT01013779|Etoposide|etoposide|mesh-list
154836365|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836366|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154836367|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154836368|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154836369|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836370|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836371|NCT05630846|Vaccines|vaccines|mesh-list
154836372|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
154836373|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836374|NCT00506155|Bevacizumab|bevacizumab|mesh-list
154836375|NCT00506155|Cisplatin|cisplatin|mesh-list
154836376|NCT00506155|Doxorubicin|doxorubicin|mesh-list
154836377|NCT00506155|Methotrexate|methotrexate|mesh-list
154836378|NCT00506155|Vinblastine|vinblastine|mesh-list
154836379|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154836380|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836381|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154836382|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154836383|NCT00506155|Growth Substances|growth substances|mesh-ancestor
154836384|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836385|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
154836386|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154836387|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154836388|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154836389|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836390|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836391|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154836392|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
154836393|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154836394|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836395|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
154836396|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
154836397|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154836398|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154836399|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
154836400|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154836401|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154836402|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154836403|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
154836404|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
154836405|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
154836406|NCT03590444|Ranibizumab|ranibizumab|mesh-list
154836407|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154836408|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154836409|NCT03590444|Growth Substances|growth substances|mesh-ancestor
154836410|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836411|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
154836412|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836413|NCT00506857|Fludarabine|fludarabine|mesh-list
154836414|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
154836415|NCT00506857|Busulfan|busulfan|mesh-list
154836416|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836417|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836418|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
154836419|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836420|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154836421|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
154836422|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836423|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
154836424|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154836425|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154836426|NCT04005170|Paclitaxel|paclitaxel|mesh-list
154836427|NCT04005170|Cisplatin|cisplatin|mesh-list
154836428|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154836429|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836430|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
154836431|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
154836432|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
154836433|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836434|NCT03597308|Acetaminophen|acetaminophen|mesh-list
154836435|NCT03597308|Ibuprofen|ibuprofen|mesh-list
154836436|NCT03597308|Oxycodone|oxycodone|mesh-list
154836437|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154836438|NCT03597308|Analgesics|analgesics|mesh-ancestor
154836439|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
154836440|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836441|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836442|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
154836443|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154836444|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836445|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154836446|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154836447|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836448|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836449|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154836450|NCT03597308|Narcotics|narcotics|mesh-ancestor
154836451|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836452|NCT04750135|Metformin|metformin|mesh-list
154836453|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154836454|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836455|NCT04003922|Adalimumab|adalimumab|mesh-list
154836456|NCT04003922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154836457|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836458|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154836459|NCT00558571|Empagliflozin|empagliflozin|mesh-list
154836460|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154836461|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836462|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154836463|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836464|NCT03970382|Aldesleukin|aldesleukin|mesh-list
154836465|NCT03970382|Nivolumab|nivolumab|mesh-list
154836466|NCT03970382|Interleukin-2|interleukin-2|mesh-list
154836467|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154836468|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836469|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154836470|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836471|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154836472|NCT03970382|Analgesics|analgesics|mesh-ancestor
154836473|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
154836474|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836475|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836476|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154836477|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154836478|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
154836479|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836480|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154015963|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
154836481|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154836482|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836483|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
154836484|NCT01797913|Gemcitabine|gemcitabine|mesh-list
154836485|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836486|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
154836487|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836488|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836489|NCT03596294|Rifampin|rifampin|mesh-list
154836490|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154836491|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
154836492|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154836493|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836494|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
154836495|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154836496|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836497|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836498|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154836499|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154836500|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154836501|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154836502|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154836503|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154836504|NCT00537407|Ribavirin|ribavirin|mesh-list
154836505|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154836506|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
154836507|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836508|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
154836509|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836510|NCT00214916|Insulin|insulin|mesh-list
154836511|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154836512|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154836513|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836514|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154836515|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154836516|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154836517|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154836518|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836519|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836520|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836521|NCT00438971|Analgesics|analgesics|mesh-ancestor
154836522|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
154836523|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836524|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
154836525|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154836526|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
154836527|NCT00219284|Levodopa|levodopa|mesh-list
154836528|NCT00219284|Carbidopa|carbidopa|mesh-list
154836529|NCT00219284|Entacapone|entacapone|mesh-list
154836530|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154836531|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154836532|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154836533|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
154836534|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836535|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836536|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836537|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154836538|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836539|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154836540|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154836541|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
154836542|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
154836543|NCT00509041|Dasatinib|dasatinib|mesh-list
154836544|NCT00509041|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154836545|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154836546|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836547|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836548|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836549|NCT00439673|Azacitidine|azacitidine|mesh-list
154836550|NCT00439673|Valproic Acid|valproic acid|mesh-list
154836551|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836552|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
154836553|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836554|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836555|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836556|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
154836557|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
154836558|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836559|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836560|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
154836561|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154836562|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836563|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154836564|NCT03596060|Fentanyl|fentanyl|mesh-list
154836565|NCT03596060|Morphine|morphine|mesh-list
154836566|NCT03596060|Propofol|propofol|mesh-list
154836567|NCT03596060|Rocuronium|rocuronium|mesh-list
154836568|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154836569|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836570|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836571|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154836572|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
154836573|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
154836574|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154836575|NCT03596060|Narcotics|narcotics|mesh-ancestor
154836576|NCT03596060|Analgesics|analgesics|mesh-ancestor
154836577|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
154836578|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836579|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154836580|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154836581|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154836582|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154836583|NCT00473837|Chloroquine|chloroquine|mesh-list
154836584|NCT00473837|Amebicides|amebicides|mesh-ancestor
154836585|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154836586|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154836587|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836588|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
154836589|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154836590|NCT00509197|Fluticasone|fluticasone|mesh-list
154836591|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836592|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154836593|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
154836594|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836595|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836596|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154836597|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
154836598|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
154836599|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154836600|NCT00442013|Lansoprazole|lansoprazole|mesh-list
154836601|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
154836602|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154836603|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154836604|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154836605|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836606|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836607|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
154836608|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154836609|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
154836610|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154836611|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836612|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154836613|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154836614|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154836615|NCT00509665|Gemcitabine|gemcitabine|mesh-list
154836616|NCT00509665|Doxorubicin|doxorubicin|mesh-list
154836617|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154836618|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836619|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
154836620|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836621|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836622|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154836623|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154836624|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154836625|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836626|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
154836627|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154836629|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154836630|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836631|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
154836632|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
154836633|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154836634|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154836635|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836636|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836637|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154836638|NCT00216476|Risperidone|risperidone|mesh-list
154836639|NCT00216476|Aripiprazole|aripiprazole|mesh-list
154836640|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154836641|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154836642|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
154836643|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836644|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836645|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836646|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154836647|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154836648|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836649|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154836650|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154836651|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
154588606|NCT02307227|Docetaxel|docetaxel|mesh-list
154836652|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
154836653|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
154836654|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154836655|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154836656|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154836657|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154836658|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154836659|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
154836660|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154836661|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154836662|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154836663|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154836664|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836665|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
154836666|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836667|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836668|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154836669|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836670|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154836671|NCT00216086|Capecitabine|capecitabine|mesh-list
154836672|NCT00216086|Irinotecan|irinotecan|mesh-list
154836673|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836674|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
154836675|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836676|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836677|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154836678|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154836679|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836680|NCT00474851|Norethindrone|norethindrone|mesh-list
154836681|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
154836682|NCT00474851|Estrogens|estrogens|mesh-list
154836683|NCT00474851|Hormones|hormones|mesh-ancestor
154836684|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154836685|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836686|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154836687|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154836688|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154836689|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
154836690|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154836691|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154836692|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154836693|NCT00215150|Ziprasidone|ziprasidone|mesh-list
154836694|NCT00215150|Sertraline|sertraline|mesh-list
154836695|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
154836696|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154836697|NCT00215150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154836698|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154836699|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154836700|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836701|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836702|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
154836703|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836704|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154836705|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154836706|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154836707|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836708|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154836709|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
154836710|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154836711|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836712|NCT04198844|Warfarin|warfarin|mesh-list
154836713|NCT04198844|Apixaban|apixaban|mesh-list
154836714|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
154836715|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154836716|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
154836717|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154836718|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
154836719|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836720|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836721|NCT03023852|Oseltamivir|oseltamivir|mesh-list
154836722|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
154836723|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836724|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836725|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836726|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
154836727|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154836728|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836729|NCT00516217|Galiximab|galiximab|mesh-list
154836730|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836731|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836732|NCT04001504|Vaccines|vaccines|mesh-list
154836733|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
154836734|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836735|NCT00516919|Orlistat|orlistat|mesh-list
154836736|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836737|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836738|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154836739|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154836740|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154836741|NCT00547105|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154836742|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154836743|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836744|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836745|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836746|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154836747|NCT04195100|Pilocarpine|pilocarpine|mesh-list
154836748|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154836749|NCT04195100|Miotics|miotics|mesh-ancestor
154836750|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
154836751|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836752|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836753|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154836754|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154836755|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
154836756|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836757|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836758|NCT06069453|Hyaluronic Acid|hyaluronic acid|mesh-list
154836759|NCT06069453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154836760|NCT06069453|Immunologic Factors|immunologic factors|mesh-ancestor
154836761|NCT06069453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836762|NCT06069453|Viscosupplements|viscosupplements|mesh-ancestor
154836763|NCT06069453|Protective Agents|protective agents|mesh-ancestor
154836764|NCT06069219|Sufentanil|sufentanil|mesh-list
154836765|NCT06069219|Dsuvia|dsuvia|mesh-list
154836766|NCT06069219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154836767|NCT06069219|Narcotics|narcotics|mesh-ancestor
154836768|NCT06069219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836769|NCT06069219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836770|NCT06069219|Analgesics|analgesics|mesh-ancestor
154836771|NCT06069219|Sensory System Agents|sensory system agents|mesh-ancestor
154836772|NCT06069219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836773|NCT06069219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154836774|NCT06069219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154836775|NCT06069219|Anesthetics, General|anesthetics, general|mesh-ancestor
154836776|NCT06069219|Anesthetics|anesthetics|mesh-ancestor
154836777|NCT06069141|Doxycycline|doxycycline|mesh-list
154836778|NCT06069141|Penicillins|penicillins|mesh-list
154836779|NCT06069141|Penicillin G|penicillin g|mesh-list
154836780|NCT06069141|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154836781|NCT06069141|Penicillin G Procaine|penicillin g procaine|mesh-list
154836782|NCT06069141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154836783|NCT06069141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836784|NCT06069141|Antimalarials|antimalarials|mesh-ancestor
154836785|NCT06069141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154836786|NCT06069141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154836787|NCT06068829|Rituximab|rituximab|mesh-list
154836788|NCT06068829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154836789|NCT06068829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836790|NCT06068829|Immunologic Factors|immunologic factors|mesh-ancestor
154836791|NCT06068829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836792|NCT06068829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154836793|NCT06068686|Glimepiride|glimepiride|mesh-list
154836794|NCT06068686|Vildagliptin|vildagliptin|mesh-list
154836795|NCT06068686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154836796|NCT06068686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154836797|NCT06068686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836798|NCT06068686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154836799|NCT06068686|Immunologic Factors|immunologic factors|mesh-ancestor
154836800|NCT06068686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154836801|NCT06068686|Protease Inhibitors|protease inhibitors|mesh-ancestor
154836802|NCT06068686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836803|NCT06068686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836804|NCT06068621|Cytarabine|cytarabine|mesh-list
154836805|NCT06068621|Azacitidine|azacitidine|mesh-list
154836806|NCT06068621|Venetoclax|venetoclax|mesh-list
154836807|NCT06068621|Aclacinomycins|aclacinomycins|mesh-list
154836808|NCT06068621|Lenograstim|lenograstim|mesh-list
154836809|NCT06068621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836810|NCT06068621|Antimetabolites|antimetabolites|mesh-ancestor
154836811|NCT06068621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836812|NCT06068621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836813|NCT06068621|Antiviral Agents|antiviral agents|mesh-ancestor
154836814|NCT06068621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836815|NCT06068621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154836816|NCT06068621|Immunologic Factors|immunologic factors|mesh-ancestor
154836817|NCT06068621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836818|NCT06068621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836819|NCT06068621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154836820|NCT06068621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154836821|NCT06068465|Pimavanserin|pimavanserin|mesh-list
154836822|NCT06068465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154836823|NCT06068465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154836824|NCT06068465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154836825|NCT06068465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154836826|NCT06068465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836827|NCT06068465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836828|NCT06068465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154836829|NCT06068465|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154836830|NCT06068465|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154836831|NCT06068465|Serotonin Agents|serotonin agents|mesh-ancestor
154836832|NCT06068465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836833|NCT06068465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836834|NCT06068439|Aspirin|aspirin|mesh-list
154836835|NCT06068439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154836836|NCT06068439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154836837|NCT06068439|Analgesics|analgesics|mesh-ancestor
154836838|NCT06068439|Sensory System Agents|sensory system agents|mesh-ancestor
154836839|NCT06068439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836840|NCT06068439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836841|NCT06068439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836842|NCT06068439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154836843|NCT06068439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154836844|NCT06068439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154836845|NCT06068439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836846|NCT06068439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154836847|NCT06068439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154836848|NCT06068439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836849|NCT06068439|Antipyretics|antipyretics|mesh-ancestor
154836850|NCT06068023|Leucovorin|leucovorin|mesh-list
154836851|NCT06068023|Capecitabine|capecitabine|mesh-list
154836852|NCT06068023|Fluorouracil|fluorouracil|mesh-list
154836853|NCT06068023|Oxaliplatin|oxaliplatin|mesh-list
154836854|NCT06068023|Irinotecan|irinotecan|mesh-list
154836855|NCT06068023|Folfirinox|folfirinox|mesh-list
154836856|NCT06068023|Levoleucovorin|levoleucovorin|mesh-list
154836857|NCT06068023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836858|NCT06068023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154836859|NCT06068023|Antimetabolites|antimetabolites|mesh-ancestor
154836860|NCT06068023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836861|NCT06068023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836862|NCT06068023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154836863|NCT06068023|Immunologic Factors|immunologic factors|mesh-ancestor
154836864|NCT06068023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154836865|NCT06068023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154836866|NCT06068023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836867|NCT06068023|Antidotes|antidotes|mesh-ancestor
154836868|NCT06068023|Protective Agents|protective agents|mesh-ancestor
154836869|NCT06068023|Vitamin B Complex|vitamin b complex|mesh-ancestor
154836870|NCT06068023|Vitamins|vitamins|mesh-ancestor
154836871|NCT06068023|Micronutrients|micronutrients|mesh-ancestor
154836872|NCT06067854|Anesthetics|anesthetics|mesh-list
154836873|NCT06067854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836874|NCT06067854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836875|NCT06067789|Anesthetics|anesthetics|mesh-list
154836876|NCT06067789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836877|NCT06067789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836878|NCT06067776|Cetuximab|cetuximab|mesh-list
154836879|NCT06067776|Osimertinib|osimertinib|mesh-list
154836880|NCT06067776|Tucatinib|tucatinib|mesh-list
154836881|NCT06067776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154836882|NCT06067776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836883|NCT06067776|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154836884|NCT06067776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154836885|NCT06067776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154836886|NCT06067776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836887|NCT06067529|Hormones|hormones|mesh-list
154836888|NCT06067529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154836889|NCT06067529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836890|NCT06067477|Vitamin D|vitamin d|mesh-list
154836891|NCT06067477|Vitamins|vitamins|mesh-ancestor
154836892|NCT06067477|Micronutrients|micronutrients|mesh-ancestor
154836893|NCT06067477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836894|NCT06067477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154836895|NCT06065163|Diuretics|diuretics|mesh-list
154836896|NCT06065163|Natriuretic Agents|natriuretic agents|mesh-ancestor
154836897|NCT06065163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836898|NCT06055491|Vitamin D|vitamin d|mesh-list
154836899|NCT06055491|Cholecalciferol|cholecalciferol|mesh-list
154836900|NCT06055491|Vitamins|vitamins|mesh-ancestor
154836901|NCT06055491|Micronutrients|micronutrients|mesh-ancestor
154836902|NCT06055491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836903|NCT06055491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154836904|NCT06055491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154836905|NCT05940545|Ribavirin|ribavirin|mesh-list
154836906|NCT05940545|Favipiravir|favipiravir|mesh-list
154836907|NCT05940545|Antimetabolites|antimetabolites|mesh-ancestor
154836908|NCT05940545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836909|NCT05940545|Antiviral Agents|antiviral agents|mesh-ancestor
154836910|NCT05940545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154836911|NCT05890352|Lenalidomide|lenalidomide|mesh-list
154836912|NCT05890352|Zanubrutinib|zanubrutinib|mesh-list
154836913|NCT05890352|Immunoglobulins|immunoglobulins|mesh-list
154836914|NCT05890352|Immunologic Factors|immunologic factors|mesh-ancestor
154836915|NCT05890352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836916|NCT05890352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154836917|NCT05890352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154836918|NCT05890352|Growth Substances|growth substances|mesh-ancestor
154836919|NCT05890352|Growth Inhibitors|growth inhibitors|mesh-ancestor
154836920|NCT05890352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836921|NCT05890352|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154836922|NCT05890352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154836923|NCT05890352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016409|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
154836924|NCT05890352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836925|NCT05803655|Oxymetazoline|oxymetazoline|mesh-list
154836926|NCT05803655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154836927|NCT05803655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154836928|NCT05803655|Adrenergic Agents|adrenergic agents|mesh-ancestor
154836929|NCT05803655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836930|NCT05803655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836931|NCT05803655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836932|NCT05803655|Sympathomimetics|sympathomimetics|mesh-ancestor
154836933|NCT05803655|Autonomic Agents|autonomic agents|mesh-ancestor
154836934|NCT05803655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836935|NCT05803655|Nasal Decongestants|nasal decongestants|mesh-ancestor
154836936|NCT05803655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154836937|NCT05803655|Respiratory System Agents|respiratory system agents|mesh-ancestor
154836938|NCT05726370|Carboplatin|carboplatin|mesh-list
154836939|NCT05726370|Docetaxel|docetaxel|mesh-list
154836940|NCT05726370|Pembrolizumab|pembrolizumab|mesh-list
154836941|NCT05726370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836942|NCT05726370|Tubulin Modulators|tubulin modulators|mesh-ancestor
154836943|NCT05726370|Antimitotic Agents|antimitotic agents|mesh-ancestor
154836944|NCT05726370|Mitosis Modulators|mitosis modulators|mesh-ancestor
154836945|NCT05726370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836946|NCT05726370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154836947|NCT05726370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154836948|NCT05720065|Botulinum Toxins|botulinum toxins|mesh-list
154836949|NCT05720065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154836950|NCT05720065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154836951|NCT05720065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154836952|NCT05720065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154836953|NCT05720065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836954|NCT05720065|Cholinergic Agents|cholinergic agents|mesh-ancestor
154836955|NCT05720065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836956|NCT05720065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836957|NCT05720065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154836958|NCT05720065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836960|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
154836961|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154836962|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836963|NCT05672927|Vaccines|vaccines|mesh-list
154836964|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
154836965|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836966|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
154836967|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154836968|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154836969|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836970|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154836971|NCT05672225|Analgesics|analgesics|mesh-ancestor
154836972|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
154836973|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154836974|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154836975|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154836976|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154836977|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
154836978|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154836979|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836980|NCT05659459|Pioglitazone|pioglitazone|mesh-list
154836981|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154836982|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836983|NCT05594784|Prednisone|prednisone|mesh-list
154836984|NCT05594784|Vincristine|vincristine|mesh-list
154836985|NCT05594784|Venetoclax|venetoclax|mesh-list
154836986|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154836987|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
154836988|NCT05594784|Hormones|hormones|mesh-ancestor
154836989|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154836990|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154836991|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154836992|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154836993|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154836994|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
154836995|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
154836996|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
154836997|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154836998|NCT05509647|Heparin|heparin|mesh-list
154836999|NCT05509647|Calcium heparin|calcium heparin|mesh-list
154837000|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
154837001|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154837002|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154837003|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837004|NCT05453929|Rocuronium|rocuronium|mesh-list
154837005|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154837006|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154837007|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154837008|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837009|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837010|NCT05449145|Vitamin D|vitamin d|mesh-list
154837011|NCT05449145|Vitamins|vitamins|mesh-ancestor
154837012|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
154837013|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837014|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154837015|NCT05426681|Glyburide|glyburide|mesh-list
154837016|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154837017|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837018|NCT05406726|Palmidrol|palmidrol|mesh-list
154837019|NCT05406726|Analgesics|analgesics|mesh-ancestor
154837020|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
154837021|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837022|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837023|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154837024|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154837025|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837026|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837027|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
154837028|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837029|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154837030|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154588981|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837031|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837032|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837034|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837035|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
154837036|NCT05369468|Bupivacaine|bupivacaine|mesh-list
154837037|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
154837038|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
154837039|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837040|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837041|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
154837042|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837043|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154837044|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154837045|NCT05369468|Analgesics|analgesics|mesh-ancestor
154837046|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154837047|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154837048|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154837049|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
154837050|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837051|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837052|NCT05368623|Mydriatics|mydriatics|mesh-list
154837053|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
154837054|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837055|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837056|NCT05272462|Minoxidil|minoxidil|mesh-list
154837057|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154837058|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
154837059|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
154837060|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154837061|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154837062|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154837063|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837064|NCT05137262|Cisplatin|cisplatin|mesh-list
154837065|NCT05137262|Doxorubicin|doxorubicin|mesh-list
154837066|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154837067|NCT05137262|Methotrexate|methotrexate|mesh-list
154837068|NCT05137262|Durvalumab|durvalumab|mesh-list
154837069|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
154837070|NCT05137262|Vinblastine|vinblastine|mesh-list
154837071|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837072|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154837073|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154837074|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154837075|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837076|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837077|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154837078|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
154837079|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154837080|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837081|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154837082|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
154837083|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
154837084|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154837085|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837086|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
154837087|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837088|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154837089|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837090|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154837091|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
154837092|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837093|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154837094|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154837095|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
154837096|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
154837097|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
154837098|NCT05129475|Ritonavir|ritonavir|mesh-list
154837099|NCT05129475|Nirmatrelvir|nirmatrelvir|mesh-list
154837100|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154837101|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154837102|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
154837103|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837104|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837105|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154837106|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154837107|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
154837108|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837109|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154837110|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154837111|NCT05062031|Atropine|atropine|mesh-list
154837112|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154837113|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154837114|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154837115|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154837116|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
154837117|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837118|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837119|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154837120|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
154837121|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
154837122|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
154837123|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154837124|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154837125|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
154837126|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837127|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837128|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154837129|NCT05022524|Acetic Acid|acetic acid|mesh-list
154837130|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154837131|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837132|NCT04988685|Sirolimus|sirolimus|mesh-list
154837133|NCT04988685|Paclitaxel|paclitaxel|mesh-list
154837134|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154837135|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837136|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
154837137|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
154837138|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
154837139|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837140|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154837141|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837142|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154837143|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
154837144|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837145|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
154837146|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837147|NCT04982029|Cannabidiol|cannabidiol|mesh-list
154837148|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
154837149|NCT04953130|Vaccines|vaccines|mesh-list
154837150|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
154837151|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837152|NCT04925505|Anesthetics|anesthetics|mesh-list
154837153|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837154|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837155|NCT04841265|Vitamin D|vitamin d|mesh-list
154837156|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
154837157|NCT04841265|Vitamins|vitamins|mesh-ancestor
154837158|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
154837159|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837160|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154837161|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154837162|NCT04730037|Warfarin|warfarin|mesh-list
154837163|NCT04730037|Edoxaban|edoxaban|mesh-list
154837164|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
154837165|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154837166|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
154837167|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154837168|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
154837169|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837170|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837171|NCT04719221|Evolocumab|evolocumab|mesh-list
154837172|NCT04719221|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154837173|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154837174|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154837175|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
154837176|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837177|NCT04719221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154837178|NCT04719221|Protease Inhibitors|protease inhibitors|mesh-ancestor
154589135|NCT04456777|Vortioxetine|vortioxetine|mesh-list
154837179|NCT04719221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837180|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154837181|NCT04696575|Lamivudine|lamivudine|mesh-list
154837182|NCT04696575|Carboplatin|carboplatin|mesh-list
154837183|NCT04696575|Etoposide|etoposide|mesh-list
154837184|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
154837185|NCT04696575|Atezolizumab|atezolizumab|mesh-list
154837186|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
154837187|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154837188|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837189|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154837190|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154837191|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154837192|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837193|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837194|NCT04696575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154837195|NCT04696575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837196|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154837197|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154837198|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
154837199|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837200|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154837201|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154837202|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
154016676|NCT02710656|Paclitaxel|paclitaxel|mesh-list
154837203|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837204|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
154837205|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
154837206|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
154837207|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
154837208|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
154837209|NCT04688788|Fexofenadine|fexofenadine|mesh-list
154837210|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
154837211|NCT04688788|Rituximab|rituximab|mesh-list
154837212|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
154837213|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837214|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837215|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
154837216|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837217|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837218|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837219|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
154837220|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
154837221|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837222|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154837223|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
154837224|NCT04688788|Hormones|hormones|mesh-ancestor
154837225|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837226|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154837227|NCT04688788|Protective Agents|protective agents|mesh-ancestor
154837228|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154837229|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154837230|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154837231|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
154837232|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
154837233|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837234|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837235|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
154837236|NCT04683679|Olaparib|olaparib|mesh-list
154837237|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837238|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837239|NCT04683679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154837240|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837241|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154837242|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837243|NCT04623775|Paclitaxel|paclitaxel|mesh-list
154837244|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154837245|NCT04623775|Carboplatin|carboplatin|mesh-list
154837246|NCT04623775|Nivolumab|nivolumab|mesh-list
154837247|NCT04623775|Pemetrexed|pemetrexed|mesh-list
154837248|NCT04623775|Relatlimab|relatlimab|mesh-list
154837249|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154837250|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837251|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
154837252|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
154837253|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
154837254|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837255|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837256|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154837257|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837258|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154837259|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154837260|NCT04586062|Plasminogen|plasminogen|mesh-list
154837261|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154837262|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154837263|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837264|NCT04578938|Ketamine|ketamine|mesh-list
154837265|NCT04578938|Analgesics|analgesics|mesh-ancestor
154837266|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
154837267|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837268|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837269|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154837270|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154837271|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
154837272|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
154837273|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837274|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154837275|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154837276|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837277|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837278|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
154837279|NCT04540380|Rituximab|rituximab|mesh-list
154837280|NCT04540380|Fludarabine|fludarabine|mesh-list
154837281|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837282|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
154837283|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837284|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837285|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154837286|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
154837287|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837288|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837289|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154837290|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837291|NCT04510662|Telmisartan|telmisartan|mesh-list
154837292|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154837293|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154837294|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154837295|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837296|NCT04428437|Lenvatinib|lenvatinib|mesh-list
154837297|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837298|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837299|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837300|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837301|NCT04415008|Cytarabine|cytarabine|mesh-list
154837302|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154837303|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
154837304|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837305|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837306|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
154837307|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837308|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837309|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
154837310|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837311|NCT04406857|Capecitabine|capecitabine|mesh-list
154837312|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
154837313|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154837314|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
154837315|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837316|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837317|NCT04393454|Sirolimus|sirolimus|mesh-list
154837318|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154837319|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837320|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154837321|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837322|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
154837323|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837324|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
154837325|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837326|NCT04367051|Spironolactone|spironolactone|mesh-list
154837327|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154837328|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
154837329|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837330|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837331|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154837332|NCT04367051|Diuretics|diuretics|mesh-ancestor
154837333|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
154837334|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
154837335|NCT04314219|Methotrexate|methotrexate|mesh-list
154837336|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837337|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
154837338|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837339|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837340|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154837341|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
154837342|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837343|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837344|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154837345|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154837346|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
154837347|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154837348|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154837349|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
154837350|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
154837351|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837352|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154837353|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154837354|NCT04230408|Paclitaxel|paclitaxel|mesh-list
154837355|NCT04230408|Carboplatin|carboplatin|mesh-list
154837356|NCT04230408|Durvalumab|durvalumab|mesh-list
154837357|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154837358|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837359|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
154837360|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
154837361|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
154837362|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837363|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837364|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154837365|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154837366|NCT04195698|Upadacitinib|upadacitinib|mesh-list
154837367|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154837368|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837369|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837370|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837371|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837372|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
154837373|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154837374|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
154837375|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837376|NCT04052776|Levodopa|levodopa|mesh-list
154837377|NCT04052776|Carbidopa|carbidopa|mesh-list
154837378|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154837379|NCT04052776|Buspirone|buspirone|mesh-list
154837380|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154837381|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154837382|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
154837383|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837384|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837385|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837386|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154837387|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837388|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154837389|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154837390|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837391|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154837392|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154837393|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
154837394|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154837395|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
154837396|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
154837397|NCT04035187|Itraconazole|itraconazole|mesh-list
154837398|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154837399|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154837400|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
154837401|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837402|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154837403|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154837404|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837405|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837406|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154837407|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
154837408|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837409|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837410|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154837411|NCT04002037|Dexamethasone|dexamethasone|mesh-list
154837412|NCT04002037|Triamcinolone|triamcinolone|mesh-list
154837413|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154837414|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154837415|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154837416|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837417|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
154837418|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
154837419|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837420|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837421|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154837422|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
154837423|NCT04002037|Hormones|hormones|mesh-ancestor
154837424|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837425|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154837426|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837427|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837428|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
154837429|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837430|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837431|NCT03985384|Semaglutide|semaglutide|mesh-list
154016942|NCT02693574|Amoxicillin|amoxicillin|mesh-list
154837432|NCT03985384|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154837433|NCT03985384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154837434|NCT03985384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837435|NCT03976245|Etanercept|etanercept|mesh-list
154837436|NCT03976245|Tofacitinib|tofacitinib|mesh-list
154837437|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154837438|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154837439|NCT03976245|Analgesics|analgesics|mesh-ancestor
154837440|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
154837441|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837442|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837443|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837444|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837445|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154837446|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837447|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
154837448|NCT03976245|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154837449|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837450|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837451|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837452|NCT03929640|Acetaminophen|acetaminophen|mesh-list
154837453|NCT03929640|Ibuprofen|ibuprofen|mesh-list
154837454|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154837455|NCT03929640|Analgesics|analgesics|mesh-ancestor
154837456|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
154837457|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837458|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837459|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
154837460|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154837461|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837462|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837463|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154837464|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837465|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837466|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154837467|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154837468|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154837469|NCT03709459|Doxycycline|doxycycline|mesh-list
154837470|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154837471|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837472|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
154837473|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154837474|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154837475|NCT03690986|Nivolumab|nivolumab|mesh-list
154837476|NCT03690986|Ipilimumab|ipilimumab|mesh-list
154837477|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837478|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837479|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154589439|NCT03502343|Paclitaxel|paclitaxel|mesh-list
154837480|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837481|NCT03597581|Bevacizumab|bevacizumab|mesh-list
154837482|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837483|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837484|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154837485|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154837486|NCT03597581|Growth Substances|growth substances|mesh-ancestor
154837487|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837488|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
154837489|NCT03569085|Sevoflurane|sevoflurane|mesh-list
154837491|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154837492|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154837493|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
154837494|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
154017000|NCT00920855|Bortezomib|bortezomib|mesh-list
154837495|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837496|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837497|NCT03483753|Vasopressins|vasopressins|mesh-list
154837498|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
154837499|NCT03483753|Norepinephrine|norepinephrine|mesh-list
154837500|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154837501|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154837502|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
154837503|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837504|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837505|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837506|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
154837507|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
154837508|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837509|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154837510|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
154837511|NCT03483753|Coagulants|coagulants|mesh-ancestor
154837512|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154837513|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
154837514|NCT03452891|Simvastatin|simvastatin|mesh-list
154837515|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154837516|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154837517|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
154837518|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837519|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154837520|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154837521|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837522|NCT03301038|Rifampin|rifampin|mesh-list
154837523|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154837524|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
154837525|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154837526|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837527|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
154837528|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154837529|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837530|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837531|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154837532|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154837533|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154837534|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154837535|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154837536|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154837537|NCT03296033|Enoxaparin|enoxaparin|mesh-list
154837538|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
154837539|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
154837540|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154837541|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154837542|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837543|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
154837544|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154837545|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837546|NCT03021330|Cytarabine|cytarabine|mesh-list
154837547|NCT03021330|Daunorubicin|daunorubicin|mesh-list
154837548|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154837549|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
154837550|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837551|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837552|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
154837553|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837554|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837555|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
154837556|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837557|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154837558|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154837559|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154837560|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837562|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154837563|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154837564|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154837565|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837566|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017109|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
154837567|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837568|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154837569|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
154837570|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837571|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154837572|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
154837573|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154837574|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
154837575|NCT03019081|Protective Agents|protective agents|mesh-ancestor
154837576|NCT03018418|Mitomycins|mitomycins|mesh-list
154837577|NCT03018418|Mitomycin|mitomycin|mesh-list
154837578|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154837579|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837580|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
154837581|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837582|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154837583|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837584|NCT02947386|Nivolumab|nivolumab|mesh-list
154837585|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
154837586|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837587|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837588|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154837589|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837590|NCT02874404|Ibrutinib|ibrutinib|mesh-list
154837591|NCT02874404|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154837592|NCT02874404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837593|NCT02874404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837594|NCT02874404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837595|NCT02824627|Oxytocin|oxytocin|mesh-list
154837596|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
154837597|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154837598|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837599|NCT02668666|Tamoxifen|tamoxifen|mesh-list
154837600|NCT02668666|Palbociclib|palbociclib|mesh-list
154837601|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154837602|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
154837603|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837604|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837605|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154837606|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837607|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154837608|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154837609|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154837610|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837611|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837612|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837613|NCT02364713|Paclitaxel|paclitaxel|mesh-list
154837614|NCT02364713|Bevacizumab|bevacizumab|mesh-list
154837615|NCT02364713|Gemcitabine|gemcitabine|mesh-list
154837616|NCT02364713|Doxorubicin|doxorubicin|mesh-list
154837617|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154837618|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154837619|NCT02364713|Topotecan|topotecan|mesh-list
154837620|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154837621|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
154837622|NCT02364713|Antibodies|antibodies|mesh-list
154837623|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
154837624|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154837625|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
154837626|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154837627|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837628|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
154837629|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
154837630|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
154837631|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837632|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154837633|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154837634|NCT02364713|Growth Substances|growth substances|mesh-ancestor
154837635|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837636|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
154837637|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
154837638|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154837639|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
154837640|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154837641|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154837642|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154837643|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837644|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154837645|NCT02186600|Vitamin D|vitamin d|mesh-list
154837646|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
154837647|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
154837648|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
154837649|NCT02186600|Calcium|calcium|mesh-list
154837650|NCT02186600|Vitamins|vitamins|mesh-ancestor
154837651|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
154837652|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837653|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154837654|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154837655|NCT02186600|Antacids|antacids|mesh-ancestor
154837656|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837657|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154837658|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154837659|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154837660|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
154837661|NCT01873833|Capecitabine|capecitabine|mesh-list
154837662|NCT01873833|Trastuzumab|trastuzumab|mesh-list
154837663|NCT01873833|Lapatinib|lapatinib|mesh-list
154837664|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837665|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
154837666|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837667|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837668|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154837669|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
154837670|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837671|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837672|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154837673|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154837674|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
154837675|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837676|NCT01873833|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154837677|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837678|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837679|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154837680|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154837681|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837682|NCT01393795|Capsaicin|capsaicin|mesh-list
154837683|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
154837684|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
154837685|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
154837686|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837687|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837688|NCT01198067|Pomalidomide|pomalidomide|mesh-list
154837689|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
154837690|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837691|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154837692|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154837693|NCT01198067|Growth Substances|growth substances|mesh-ancestor
154837694|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
154837695|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837696|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
154837697|NCT00928525|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154837698|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837699|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837700|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837701|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837702|NCT00754208|Methylphenidate|methylphenidate|mesh-list
154837703|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154837704|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837705|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154837706|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154837707|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154837708|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837709|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
154837710|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837711|NCT04193774|Anesthetics|anesthetics|mesh-list
154837713|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154837714|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
154837715|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837716|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837717|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154837718|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
154837719|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
154837720|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837721|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
154837722|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154837723|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154837724|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154837725|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837726|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154837727|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154837728|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837729|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837730|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837731|NCT02985242|Empagliflozin|empagliflozin|mesh-list
154837732|NCT02985242|Glimepiride|glimepiride|mesh-list
154837733|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154837734|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837735|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154837736|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837737|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154837738|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837739|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
154837740|NCT03023774|Lenograstim|lenograstim|mesh-list
154837741|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154837742|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
154837743|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837744|NCT04196426|Calcium|calcium|mesh-list
154837745|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154837746|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837747|NCT00518713|Clobazam|clobazam|mesh-list
154837748|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
154837749|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154837750|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154837751|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837752|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837753|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154837754|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154837755|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
154837756|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
154837757|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017254|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154837758|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837759|NCT03948464|Morphine|morphine|mesh-list
154837760|NCT03948464|Methadone|methadone|mesh-list
154837761|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154837762|NCT03948464|Narcotics|narcotics|mesh-ancestor
154837763|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837764|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837765|NCT03948464|Analgesics|analgesics|mesh-ancestor
154837766|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
154837767|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837768|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
154837769|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
154837770|NCT04196270|Ropivacaine|ropivacaine|mesh-list
154837771|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
154837772|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
154837773|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837774|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837775|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
154837776|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837777|NCT04020380|Azithromycin|azithromycin|mesh-list
154589735|NCT06228677|Racepinephrine|racepinephrine|mesh-list
154837778|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154837779|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837780|NCT00521989|Prednisolone|prednisolone|mesh-list
154837781|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154837782|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
154837783|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154837784|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
154837785|NCT00521989|Dipyridamole|dipyridamole|mesh-list
154837786|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154837787|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
154837788|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837789|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
154837790|NCT00521989|Hormones|hormones|mesh-ancestor
154837791|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837792|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837793|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154837794|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837795|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
154837796|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
154837797|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837798|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154837799|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154837800|NCT00521989|Protective Agents|protective agents|mesh-ancestor
154837801|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154837802|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837803|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837804|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154837805|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
154837806|NCT04029350|Osimertinib|osimertinib|mesh-list
154837807|NCT04029350|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154837808|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837809|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837810|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837811|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837812|NCT00548197|Bevacizumab|bevacizumab|mesh-list
154837813|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837814|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837815|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154837816|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154837817|NCT00548197|Growth Substances|growth substances|mesh-ancestor
154837818|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837819|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
154837820|NCT04029272|Metformin|metformin|mesh-list
154837821|NCT04029272|Exenatide|exenatide|mesh-list
154837822|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154837823|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837824|NCT04029272|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154837825|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154837826|NCT04029272|Incretins|incretins|mesh-ancestor
154837827|NCT04029272|Hormones|hormones|mesh-ancestor
154837828|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837829|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
154837830|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
154837831|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837832|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154837833|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837834|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837835|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
154837836|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837837|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154837838|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837839|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
154837840|NCT04028804|Fluorides|fluorides|mesh-list
154837841|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
154837842|NCT04028804|Protective Agents|protective agents|mesh-ancestor
154837843|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837844|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
154837845|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837846|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
154837847|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837848|NCT00524017|Cetuximab|cetuximab|mesh-list
154837849|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837850|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837851|NCT02985554|Nivolumab|nivolumab|mesh-list
154837852|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154837853|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837854|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154837855|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837856|NCT05560165|Listerine|listerine|mesh-list
154837857|NCT05560165|Anesthetics|anesthetics|mesh-list
154837858|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
154837859|NCT05560165|Fluorides|fluorides|mesh-list
154837860|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
154837861|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
154837862|NCT05560165|Protective Agents|protective agents|mesh-ancestor
154837863|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837864|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837865|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
154837866|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837867|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154837868|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837869|NCT00525421|Curcumin|curcumin|mesh-list
154837870|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154837871|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154837872|NCT00525421|Analgesics|analgesics|mesh-ancestor
154837873|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
154837874|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837875|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837876|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837877|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154837878|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837879|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837880|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837881|NCT00525733|Ritonavir|ritonavir|mesh-list
154837882|NCT00525733|Darunavir|darunavir|mesh-list
154837883|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
154837884|NCT00525733|Maraviroc|maraviroc|mesh-list
154837885|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154837886|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154837887|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
154837888|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837889|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837890|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154837891|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154837892|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
154837893|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837894|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154837895|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154837896|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154837897|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154837898|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154837899|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154837900|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154837901|NCT04028024|Urinastatin|urinastatin|mesh-list
154837902|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154837903|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154837904|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
154837905|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837906|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837907|NCT00526591|Everolimus|everolimus|mesh-list
154837908|NCT00526591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154837909|NCT00526591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154837910|NCT00526591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837911|NCT00526591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837912|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154837913|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
154837914|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837915|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837916|NCT04194086|Posaconazole|posaconazole|mesh-list
154837917|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
154837918|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837919|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154837920|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154837921|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154837922|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154837923|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154837924|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837925|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837926|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154837927|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
154837928|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837929|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837930|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
154837931|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154837932|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
154837933|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154837934|NCT04023266|Expectorants|expectorants|mesh-ancestor
154837935|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
154837936|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154837937|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
154837938|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837939|NCT04023266|Protective Agents|protective agents|mesh-ancestor
154837940|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837941|NCT04023266|Antidotes|antidotes|mesh-ancestor
154837942|NCT00475085|Dexamethasone|dexamethasone|mesh-list
154837944|NCT00475085|Palonosetron|palonosetron|mesh-list
154837945|NCT00475085|Granisetron|granisetron|mesh-list
154837946|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
154837947|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837948|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
154837949|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
154837950|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837951|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837952|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154837953|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
154837954|NCT00475085|Hormones|hormones|mesh-ancestor
154837955|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837956|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154837957|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837958|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154837959|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154837960|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837961|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154837962|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154837963|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
154837964|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154837965|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154837966|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154837967|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154837968|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154837969|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
154837970|NCT00551707|Prednisolone|prednisolone|mesh-list
154837971|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154837972|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
154837973|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154837974|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
154837975|NCT00551707|Dipyridamole|dipyridamole|mesh-list
154837976|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154837977|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
154837978|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154837979|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
154837980|NCT00551707|Hormones|hormones|mesh-ancestor
154837981|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154837982|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154837983|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154837984|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154837985|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
154837986|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
154837987|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154837988|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154837989|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154837990|NCT00551707|Protective Agents|protective agents|mesh-ancestor
154017486|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154837991|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154837992|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154837993|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154837994|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154837995|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
154837996|NCT04193930|Letrozole|letrozole|mesh-list
154837997|NCT04193930|Menotropins|menotropins|mesh-list
154837998|NCT04193930|Hormones|hormones|mesh-list
154837999|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154838000|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838001|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838002|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838003|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154838004|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154838005|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838006|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838007|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154838008|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
154838009|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154838011|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154838012|NCT00445211|Heparin|heparin|mesh-list
154838013|NCT00445211|Calcium heparin|calcium heparin|mesh-list
154838014|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
154838015|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154838016|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154838017|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838018|NCT04193852|Dienogest|dienogest|mesh-list
154838019|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154838020|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154838021|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154838022|NCT04193852|Estradiol|estradiol|mesh-list
154838023|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154838024|NCT04193852|Nandrolone|nandrolone|mesh-list
154838025|NCT04193852|Estrogens|estrogens|mesh-ancestor
154838026|NCT04193852|Hormones|hormones|mesh-ancestor
154838027|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838028|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838029|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154838030|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
154838031|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154838032|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154838033|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154838034|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154838035|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154838036|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
154838037|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154838038|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838039|NCT04193852|Androgens|androgens|mesh-ancestor
154838040|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
154838041|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
154838042|NCT00552409|Vitamin D|vitamin d|mesh-list
154838043|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154838044|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838045|NCT00552409|Vitamins|vitamins|mesh-ancestor
154838046|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
154838047|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154838048|NCT04028180|Picaridin|picaridin|mesh-list
154838049|NCT04028180|Insect Repellents|insect repellents|mesh-ancestor
154838050|NCT04028180|Protective Agents|protective agents|mesh-ancestor
154838051|NCT04028180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838052|NCT00553735|Cyclosporine|cyclosporine|mesh-list
154838053|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
154838054|NCT00553735|Cyclosporins|cyclosporins|mesh-list
154838055|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838056|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838057|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154838058|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
154838059|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838060|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
154838061|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838062|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
154838063|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838064|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154838065|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154838066|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154838067|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
154838068|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154838069|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154838070|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
154838071|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838072|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154838073|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154838074|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838075|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838076|NCT04027166|Methadone|methadone|mesh-list
154838077|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154838078|NCT04027166|Narcotics|narcotics|mesh-ancestor
154838079|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838080|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838082|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
154838083|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838084|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
154838085|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
154838086|NCT00543101|Darunavir|darunavir|mesh-list
154838087|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154838088|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154838089|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
154838090|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838091|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838092|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154838093|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154838094|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
154838095|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838096|NCT00553969|Carvedilol|carvedilol|mesh-list
154838097|NCT00553969|Lisinopril|lisinopril|mesh-list
154838098|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154838099|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154838100|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
154838101|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838102|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838103|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838104|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154838105|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
154838106|NCT00553969|Protective Agents|protective agents|mesh-ancestor
154838107|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154838108|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154838109|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154838110|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
154838111|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154838112|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154838113|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154838114|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
154838115|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838116|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154838117|NCT05533567|Sufentanil|sufentanil|mesh-list
154838118|NCT05533567|Dsuvia|dsuvia|mesh-list
154838119|NCT05533567|Propofol|propofol|mesh-list
154838120|NCT05533567|Cisatracurium|cisatracurium|mesh-list
154838121|NCT05533567|Atracurium|atracurium|mesh-list
154838122|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154838123|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838124|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838125|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154838126|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
154838127|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
154838128|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154838129|NCT05533567|Narcotics|narcotics|mesh-ancestor
154838130|NCT05533567|Analgesics|analgesics|mesh-ancestor
154838131|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
154838132|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838133|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154838134|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154838135|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154838136|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154838137|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154838138|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154838139|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
154838140|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838141|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838142|NCT04026464|Acetaminophen|acetaminophen|mesh-list
154838143|NCT04026464|Ibuprofen|ibuprofen|mesh-list
154838144|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154838145|NCT04026464|Analgesics|analgesics|mesh-ancestor
154838146|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
154838147|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838148|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838149|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
154838150|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154838151|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154838152|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590101|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154838153|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154838154|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838155|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838157|NCT04192916|Apixaban|apixaban|mesh-list
154838158|NCT04192916|Edoxaban|edoxaban|mesh-list
154838159|NCT04192916|Dabigatran|dabigatran|mesh-list
154838160|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154838161|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
154838162|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154838163|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
154838164|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838165|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838166|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
154838167|NCT01797991|Dexamethasone|dexamethasone|mesh-list
154838168|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
154838169|NCT01797991|BB 1101|bb 1101|mesh-list
154838170|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154838171|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
154838172|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
154838173|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838174|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838175|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154838176|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
154838177|NCT01797991|Hormones|hormones|mesh-ancestor
154838178|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838179|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154838180|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838181|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154838182|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838183|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838184|NCT00475319|Rebamipide|rebamipide|mesh-list
154838185|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154838186|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154838187|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
154838188|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838189|NCT00475319|Protective Agents|protective agents|mesh-ancestor
154838190|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838191|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838192|NCT04026074|Clonidine|clonidine|mesh-list
154838193|NCT04026074|Fentanyl|fentanyl|mesh-list
154838194|NCT04026074|Remifentanil|remifentanil|mesh-list
154838195|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154838196|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154838197|NCT04026074|Narcotics|narcotics|mesh-ancestor
154838198|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838199|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838200|NCT04026074|Analgesics|analgesics|mesh-ancestor
154838201|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
154838202|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838203|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154838204|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154838205|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
154838206|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
154838207|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154838208|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
154838209|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
154838210|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154838211|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154838212|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154838213|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
154838214|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838215|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838216|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
154838217|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154838218|NCT00555997|Ziprasidone|ziprasidone|mesh-list
154838219|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154838220|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
154838221|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838222|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838223|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838224|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154838225|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154838226|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838227|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154838228|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154838229|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
154590180|NCT05200442|Cetuximab|cetuximab|mesh-list
154838230|NCT00446147|Pyridoxine|pyridoxine|mesh-list
154838231|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
154838232|NCT00446147|Vitamins|vitamins|mesh-ancestor
154838233|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
154838234|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838235|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
154838236|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154838237|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
154838238|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154838239|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838240|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154838241|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154838242|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154838243|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154838244|NCT04192292|Gliclazide|gliclazide|mesh-list
154838245|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154838246|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154838247|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838248|NCT04192292|Incretins|incretins|mesh-ancestor
154838249|NCT04192292|Hormones|hormones|mesh-ancestor
154838250|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838251|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
154838252|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838253|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838254|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154838255|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154838256|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154838257|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
154838258|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838259|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838260|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838261|NCT00448175|Urological Agents|urological agents|mesh-ancestor
154838262|NCT04176835|Oxytocin|oxytocin|mesh-list
154838263|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
154838264|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154838265|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838266|NCT00476645|Fulvestrant|fulvestrant|mesh-list
154838267|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154838268|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838269|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154838270|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154838271|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
154838272|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838273|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838274|NCT00477191|Etanercept|etanercept|mesh-list
154838275|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154838276|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154838277|NCT00477191|Analgesics|analgesics|mesh-ancestor
154838278|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
154838279|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838280|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838281|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154838282|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838283|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154838284|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154838285|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
154838286|NCT04025918|Phenylephrine|phenylephrine|mesh-list
154838287|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
154838288|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154838289|NCT04025918|Ephedrine|ephedrine|mesh-list
154838290|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154838291|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
154838292|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
154838293|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838294|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838295|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
154838296|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
154838297|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
154838298|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154838299|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154838300|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154838301|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
154838302|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838303|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838304|NCT04025918|Protective Agents|protective agents|mesh-ancestor
154838305|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154838306|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
154838307|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154838308|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838309|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
154838310|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154838311|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838312|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154838313|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838314|NCT02115581|Ubiquinone|ubiquinone|mesh-list
154838315|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
154838316|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
154838317|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838318|NCT02115581|Vitamins|vitamins|mesh-ancestor
154838319|NCT00477659|Donepezil|donepezil|mesh-list
154838320|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154838321|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838322|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838323|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
154838324|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838325|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838326|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
154838327|NCT04191278|Varenicline|varenicline|mesh-list
154838328|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154838329|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154838330|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
154838331|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838332|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838333|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838334|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
154838335|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154838336|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154838337|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838338|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838339|NCT03988387|Tenofovir|tenofovir|mesh-list
154838340|NCT03988387|Emtricitabine|emtricitabine|mesh-list
154838341|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
154838342|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838343|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154838344|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154838345|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838346|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838347|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154838348|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154838349|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
154838350|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154838351|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
154838352|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838353|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838354|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154838355|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
154838356|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154838357|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
154838358|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838359|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838360|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154838361|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
154838362|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
154838363|NCT03748082|Protective Agents|protective agents|mesh-ancestor
154838364|NCT00478361|Paclitaxel|paclitaxel|mesh-list
154838365|NCT00478361|Gemcitabine|gemcitabine|mesh-list
154838366|NCT00478361|Doxorubicin|doxorubicin|mesh-list
154838367|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154838368|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154838369|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838370|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
154838371|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
154838372|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
154838373|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838374|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154838375|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
154838376|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154838377|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154838378|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154838379|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838380|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
154838381|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838382|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
154838383|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154838384|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154838385|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838386|NCT02129725|Urological Agents|urological agents|mesh-ancestor
154838388|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154838389|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838390|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154838391|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154838392|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838393|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838394|NCT03864211|Immunomodulating Agents|immunomodulating agents|mesh-list
154838395|NCT03864211|Immunologic Factors|immunologic factors|mesh-ancestor
154838396|NCT03864211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838397|NCT03842839|Albuterol|albuterol|mesh-list
154838398|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
154838399|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154838400|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
154838401|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838402|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838403|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154838404|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
154838405|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
154838406|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154838407|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
154838408|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838409|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838410|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
154838411|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154838412|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154838413|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154838414|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154838415|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
154838416|NCT00450983|Methotrexate|methotrexate|mesh-list
154838417|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
154838418|NCT00450983|Fludarabine|fludarabine|mesh-list
154838419|NCT00450983|Thiotepa|thiotepa|mesh-list
154838420|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
154838421|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154838422|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
154838423|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154838424|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838425|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154838426|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
154838427|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838428|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838429|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
154838430|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838431|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154838432|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154838433|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
154838434|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838435|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154838436|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154838437|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
154838438|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154838439|NCT01796405|Clofarabine|clofarabine|mesh-list
154838440|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154838441|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
154838442|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838443|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838444|NCT03649321|Paclitaxel|paclitaxel|mesh-list
154838445|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154838446|NCT03649321|Gemcitabine|gemcitabine|mesh-list
154838447|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154838448|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838449|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
154838450|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
154838451|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
154838452|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838453|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154590435|NCT04170855|Furosemide|furosemide|mesh-list
154838454|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
154838455|NCT04149938|Lidocaine|lidocaine|mesh-list
154838456|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
154838457|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
154838458|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838459|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838460|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
154838461|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838462|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154838463|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154838464|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154838465|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154838466|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838467|NCT01797601|Insulin|insulin|mesh-list
154838468|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154838469|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154838470|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838471|NCT02984930|Esomeprazole|esomeprazole|mesh-list
154838472|NCT02984930|Mosapride|mosapride|mesh-list
154017967|NCT00910455|SRX246|srx246|mesh-list
154838473|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154838474|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154838475|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154838476|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838477|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838478|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154838479|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
154838480|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838481|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838482|NCT02123017|Lactulose|lactulose|mesh-list
154838483|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154838484|NCT04149626|Midazolam|midazolam|mesh-list
154838485|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
154838486|NCT04149626|Remifentanil|remifentanil|mesh-list
154838487|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154838488|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838489|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838490|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154838491|NCT04149626|Analgesics|analgesics|mesh-ancestor
154838492|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
154838493|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838494|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154838495|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154838496|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154838497|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
154838498|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838499|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838500|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154838501|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154838502|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154838503|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154838504|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154838505|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
154838506|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
154838507|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
154838508|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
154838509|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154838510|NCT04149626|Narcotics|narcotics|mesh-ancestor
154838511|NCT00486863|Praziquantel|praziquantel|mesh-list
154838512|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
154838513|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154838514|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838515|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
154838516|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154838517|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838518|NCT00452387|Prednisone|prednisone|mesh-list
154838519|NCT00452387|Sorafenib|sorafenib|mesh-list
154838520|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
154838521|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154838522|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
154838523|NCT00452387|Hormones|hormones|mesh-ancestor
154838524|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838525|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838526|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154838527|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838528|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154838529|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838530|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838532|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
154838533|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838534|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154838535|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154838536|NCT00452543|Acamprosate|acamprosate|mesh-list
154838537|NCT00452543|Dexetimide|dexetimide|mesh-list
154838538|NCT00452543|Citalopram|citalopram|mesh-list
154838539|NCT00452543|Escitalopram|escitalopram|mesh-list
154838540|NCT00452543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154838541|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154838542|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154838543|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838544|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838545|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
154838546|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838547|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154838548|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154838549|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
154838550|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
154838551|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838552|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154838553|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154838554|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
154838555|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154838556|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
154838557|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154838558|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154838559|NCT04961359|Vaccines|vaccines|mesh-list
154838560|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
154838561|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838562|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154838563|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838564|NCT05621707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154838565|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838566|NCT04765904|Fluorides|fluorides|mesh-list
154838567|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
154838568|NCT04765904|Protective Agents|protective agents|mesh-ancestor
154838569|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838570|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
154838571|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154838572|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838573|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154838574|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838575|NCT00565669|Cyclosporine|cyclosporine|mesh-list
154838576|NCT00565669|Cyclosporins|cyclosporins|mesh-list
154838577|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838578|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838579|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154838580|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
154838581|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838582|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
154838583|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838584|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
154838585|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838586|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154838587|NCT04165135|Factor VIII|factor viii|mesh-list
154838588|NCT04165135|Coagulants|coagulants|mesh-ancestor
154838589|NCT02132533|Nifedipine|nifedipine|mesh-list
154838590|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154838591|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154838592|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838593|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154838594|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838595|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
154838596|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
154838597|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154838598|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154018082|NCT04172727|Bupivacaine|bupivacaine|mesh-list
154838599|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838600|NCT00567229|Rituximab|rituximab|mesh-list
154838601|NCT00567229|Lenalidomide|lenalidomide|mesh-list
154838602|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154838603|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838604|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
154838605|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838606|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838607|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154838608|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154838609|NCT00567229|Growth Substances|growth substances|mesh-ancestor
154838610|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
154838611|NCT04148846|Dexamethasone|dexamethasone|mesh-list
154838612|NCT04148846|Ketoprofen|ketoprofen|mesh-list
154838613|NCT04148846|Theophylline|theophylline|mesh-list
154838614|NCT04148846|Gabapentin|gabapentin|mesh-list
154838615|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154838616|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
154838617|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
154838618|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838619|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838620|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154838621|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
154838622|NCT04148846|Hormones|hormones|mesh-ancestor
154838623|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838624|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154838625|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838626|NCT04148846|Analgesics|analgesics|mesh-ancestor
154838627|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
154838628|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
154838629|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154838630|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154838631|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838632|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154838633|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154838634|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154838635|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838636|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838637|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
154838638|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154838639|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154838640|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838641|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154838642|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838643|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154838644|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154838645|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
154838646|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154838647|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
154838648|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154838649|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154838650|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
154838651|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
154838652|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154838653|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
154838654|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838655|NCT00568087|Expectorants|expectorants|mesh-ancestor
154838656|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
154838657|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154838658|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
154838659|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838660|NCT00568087|Protective Agents|protective agents|mesh-ancestor
154838661|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838662|NCT00568087|Antidotes|antidotes|mesh-ancestor
154838663|NCT00487721|Silymarin|silymarin|mesh-list
154838664|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
154838665|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838666|NCT00487721|Protective Agents|protective agents|mesh-ancestor
154838667|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838668|NCT00568633|Cyclosporine|cyclosporine|mesh-list
154838669|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
154838670|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
154838671|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154838672|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154838673|NCT00568633|Prednisolone|prednisolone|mesh-list
154838674|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
154838675|NCT00568633|Cyclosporins|cyclosporins|mesh-list
154838676|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
154590624|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
154838677|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154838678|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154838679|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
154838680|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838681|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838682|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154838683|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
154838684|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838685|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
154838686|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838687|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
154838688|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838689|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154838690|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154838691|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838692|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154838693|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
154838694|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154838695|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154838696|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
154838697|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
154838698|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838699|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154838700|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
154838702|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838703|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154838704|NCT00568633|Protective Agents|protective agents|mesh-ancestor
154838705|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154838706|NCT03022838|Caffeine|caffeine|mesh-list
154838707|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154838708|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838709|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154838710|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838711|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838712|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154838713|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154838714|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
154838715|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838716|NCT05363449|Naftifine|naftifine|mesh-list
154838717|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
154838718|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838719|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
154838720|NCT00489281|Sirolimus|sirolimus|mesh-list
154838721|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
154838722|NCT00489281|Fludarabine|fludarabine|mesh-list
154838723|NCT00489281|Levetiracetam|levetiracetam|mesh-list
154838724|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
154838725|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154838726|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154838727|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
154838728|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838729|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838730|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154838731|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
154838732|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838733|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838734|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154838735|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154838736|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154838737|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
154838738|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154838739|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838740|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838741|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
154838742|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
154838743|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
154838744|NCT05362513|Ivermectin|ivermectin|mesh-list
154838745|NCT05362513|Permethrin|permethrin|mesh-list
154838746|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154838747|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838748|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838749|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838750|NCT04457297|Trifluridine|trifluridine|mesh-list
154838751|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
154838752|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838753|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
154838754|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838755|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
154838756|NCT04146116|Povidone|povidone|mesh-list
154838757|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
154838758|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
154838759|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154838760|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838761|NCT04145804|Insulin|insulin|mesh-list
154838762|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154838763|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838764|NCT02120261|Triamcinolone|triamcinolone|mesh-list
154838765|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154838766|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154838767|NCT02120261|Lidocaine|lidocaine|mesh-list
154838768|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154838769|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
154838770|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
154838771|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838772|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838773|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
154838774|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838775|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154838776|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154838777|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154838778|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154838779|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838780|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154838781|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
154838782|NCT02120261|Hormones|hormones|mesh-ancestor
154838783|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154838784|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154838785|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
154838786|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838787|NCT00492089|Bevacizumab|bevacizumab|mesh-list
154838788|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154838789|NCT00492089|Antibodies|antibodies|mesh-list
154838790|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
154838791|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154838792|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838793|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154838794|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154838795|NCT00492089|Growth Substances|growth substances|mesh-ancestor
154838796|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838797|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
154838798|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
154838799|NCT01798537|Vancomycin|vancomycin|mesh-list
154838800|NCT01798537|Colistin|colistin|mesh-list
154838801|NCT01798537|Neomycin|neomycin|mesh-list
154838802|NCT01798537|Nystatin|nystatin|mesh-list
154838803|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154838804|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838805|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154838806|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838807|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838808|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
154838809|NCT01798537|Ionophores|ionophores|mesh-ancestor
154838810|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154838811|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154838812|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154838813|NCT01797341|Tacrolimus|tacrolimus|mesh-list
154838814|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154838815|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
154838816|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838817|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154838818|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838819|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838820|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154838821|NCT04145570|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154838822|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154838823|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838824|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838825|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838826|NCT04145492|Vitamin D|vitamin d|mesh-list
154838827|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
154838828|NCT04145492|Calcifediol|calcifediol|mesh-list
154838829|NCT04145492|Vitamins|vitamins|mesh-list
154838830|NCT04145492|Vitamin K|vitamin k|mesh-list
154838831|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
154838832|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
154838833|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838834|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154838835|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154838836|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154838837|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154018326|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
154838838|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838839|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
154838840|NCT04145492|Coagulants|coagulants|mesh-ancestor
154838841|NCT04147754|Morphine|morphine|mesh-list
154838842|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838843|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838844|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154838845|NCT04147754|Narcotics|narcotics|mesh-ancestor
154838846|NCT04147754|Analgesics|analgesics|mesh-ancestor
154838847|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
154838848|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838849|NCT00492401|Decitabine|decitabine|mesh-list
154838850|NCT00492401|Azacitidine|azacitidine|mesh-list
154838851|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154838852|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
154838853|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838854|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838855|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838856|NCT03674827|Immunomodulating Agents|immunomodulating agents|mesh-list
154838857|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
154838858|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838859|NCT04147286|Atorvastatin|atorvastatin|mesh-list
154838860|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154838861|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154838862|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
154838863|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838864|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154838865|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154838866|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838867|NCT00493181|Oprelvekin|oprelvekin|mesh-list
154838868|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838869|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
154838870|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
154838871|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154838872|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
154838873|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154838874|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838875|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154838876|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154838877|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154838878|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154838879|NCT00493805|Interferons|interferons|mesh-list
154838880|NCT00493805|Ribavirin|ribavirin|mesh-list
154838881|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
154838882|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
154838883|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154838884|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838885|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
154838886|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838887|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
154018405|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154838888|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838889|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
154838890|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838891|NCT04145102|Propolis|propolis|mesh-list
154838892|NCT04145102|Fluorides|fluorides|mesh-list
154838893|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
154838894|NCT04145102|Protective Agents|protective agents|mesh-ancestor
154838895|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838896|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838897|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154838898|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
154838899|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838900|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154838901|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838902|NCT03588494|Endostar protein|endostar protein|mesh-list
154838903|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154838904|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154838905|NCT03588494|Growth Substances|growth substances|mesh-ancestor
154838906|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838907|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
154838908|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838909|NCT00550277|Panobinostat|panobinostat|mesh-list
154838910|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838911|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154838912|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838913|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838915|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
154838916|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154838917|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838918|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838919|NCT04144712|Caffeine|caffeine|mesh-list
154838920|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
154838921|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018421|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838922|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154838923|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838924|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154838925|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838926|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154838927|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154838928|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
154838929|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838930|NCT03588338|Acetaminophen|acetaminophen|mesh-list
154838931|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154838932|NCT03588338|Analgesics|analgesics|mesh-ancestor
154838933|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
154838934|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838935|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838936|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
154838937|NCT05099185|Trace Elements|trace elements|mesh-list
154838938|NCT05099185|Micronutrients|micronutrients|mesh-list
154838939|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838940|NCT05068609|Nivolumab|nivolumab|mesh-list
154838941|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154838942|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838943|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154838944|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838945|NCT00496379|Epothilones|epothilones|mesh-list
154838946|NCT00496379|Sagopilone|sagopilone|mesh-list
154838947|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
154838948|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
154838949|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
154838950|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838951|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838952|NCT00497081|Mirtazapine|mirtazapine|mesh-list
154838953|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
154838954|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154838955|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154838956|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
154838957|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
154838958|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154838959|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838960|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838961|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154838962|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154838963|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154838964|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154838965|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154838966|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154838967|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154838968|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154838969|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154838970|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
154838971|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154838972|NCT01796951|Aspirin|aspirin|mesh-list
154838973|NCT01796951|Celecoxib|celecoxib|mesh-list
154838974|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154838975|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154838976|NCT01796951|Analgesics|analgesics|mesh-ancestor
154838977|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
154838978|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154838979|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154838980|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154838981|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154838982|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154838983|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154838984|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838985|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154838986|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154838987|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838988|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
154838989|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154838990|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
154838991|NCT04838041|Asciminib|asciminib|mesh-list
154838992|NCT04838041|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154838993|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154838994|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154838995|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154838996|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154838997|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
154838998|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154838999|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154018488|NCT02851290|Anesthetics|anesthetics|mesh-list
154839000|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154839001|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839002|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839003|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
154839004|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839005|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839006|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154839007|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839008|NCT03587558|Flecainide|flecainide|mesh-list
154839009|NCT03587558|Carvedilol|carvedilol|mesh-list
154839010|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154839011|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154839012|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
154839013|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839014|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839015|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839016|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154839017|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
154839018|NCT03587558|Protective Agents|protective agents|mesh-ancestor
154839019|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154839020|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839021|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154839022|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
154839023|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154839024|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154839025|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154839026|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154839027|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154839028|NCT04415905|Propofol|propofol|mesh-list
154839029|NCT04415905|Sevoflurane|sevoflurane|mesh-list
154839030|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154839031|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839032|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839033|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154839034|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
154839035|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
154839036|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154839037|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154839038|NCT02979704|Atorvastatin|atorvastatin|mesh-list
154839039|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154839040|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154839041|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154839042|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
154839043|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839044|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154839045|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154839046|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839047|NCT03587324|Clopidogrel|clopidogrel|mesh-list
154839048|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154839049|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154839050|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154839051|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154839052|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
154839053|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839054|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839055|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839056|NCT01798459|Methylphenidate|methylphenidate|mesh-list
154839057|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154839058|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839059|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154839060|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154839061|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839062|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839064|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839065|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
154839066|NCT00555321|Abatacept|abatacept|mesh-list
154839067|NCT00555321|Tacrolimus|tacrolimus|mesh-list
154839068|NCT00555321|Basiliximab|basiliximab|mesh-list
154839069|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839070|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
154839071|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839072|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154839073|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839074|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839075|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154018583|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839076|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839077|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154839078|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
154839079|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839080|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839081|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154839082|NCT00555321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839083|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839084|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
154839085|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154839086|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839087|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839088|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154839089|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154839090|NCT05583266|Protective Agents|protective agents|mesh-ancestor
154839091|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839092|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
154839093|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154839094|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
154839095|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
154839096|NCT04142840|Propofol|propofol|mesh-list
154839097|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154018608|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
154839098|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839099|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839100|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154839101|NCT04142840|Analgesics|analgesics|mesh-ancestor
154839102|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
154839103|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839104|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154839105|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154839106|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154839107|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
154839108|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839109|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839110|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154839111|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
154839112|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
154839113|NCT04142762|Itraconazole|itraconazole|mesh-list
154839114|NCT04142762|Rifampin|rifampin|mesh-list
154839115|NCT04142762|Midazolam|midazolam|mesh-list
154839116|NCT04142762|Esomeprazole|esomeprazole|mesh-list
154839117|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
154839118|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154839119|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154839120|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
154839121|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
154839122|NCT04142762|Estradiol|estradiol|mesh-list
154839123|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154018633|NCT00649623|Olmesartan|olmesartan|mesh-list
154839124|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154839125|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839126|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839127|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154839128|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154839129|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154839130|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154591116|NCT02322203|Niacin|niacin|mesh-list
154839131|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
154839132|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
154839133|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
154839134|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
154839135|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839136|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839137|NCT04142762|Estrogens|estrogens|mesh-ancestor
154839138|NCT04142762|Hormones|hormones|mesh-ancestor
154839139|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154839140|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154839141|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154839142|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154839143|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154839144|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154839145|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154839146|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839147|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
154839148|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839149|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154839150|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154839151|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154839152|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
154839153|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154839154|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154839155|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154839156|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
154839157|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839158|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
154839159|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154839160|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154839161|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154839162|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154839163|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154839164|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154839165|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154839166|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154839167|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154839168|NCT02139007|Alendronate|alendronate|mesh-list
154839169|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154839170|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839171|NCT01590277|Ethanol|ethanol|mesh-list
154839172|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154839173|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839174|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839175|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839176|NCT03586466|Buprenorphine|buprenorphine|mesh-list
154839177|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154839178|NCT03586466|Naloxone|naloxone|mesh-list
154839179|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154839180|NCT03586466|Narcotics|narcotics|mesh-ancestor
154839181|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839182|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018693|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154839183|NCT03586466|Analgesics|analgesics|mesh-ancestor
154839184|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
154839185|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839186|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154839187|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
154839188|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154839189|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
154839190|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839191|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839192|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154839193|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
154839194|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154839195|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
154839196|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839197|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839198|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154839199|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
154839200|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
154839201|NCT00570349|Protective Agents|protective agents|mesh-ancestor
154839202|NCT03586388|Immunomodulating Agents|immunomodulating agents|mesh-list
154591156|NCT02448329|Paclitaxel|paclitaxel|mesh-list
154839203|NCT03586388|Immunologic Factors|immunologic factors|mesh-ancestor
154839204|NCT03586388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839205|NCT02985086|Cefoxitin|cefoxitin|mesh-list
154839206|NCT02985086|Misoprostol|misoprostol|mesh-list
154839207|NCT02985086|Oxytocin|oxytocin|mesh-list
154839208|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
154839209|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154839210|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839211|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154018711|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
154839212|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
154839213|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154839214|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154839215|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839216|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839217|NCT00609739|Cytarabine|cytarabine|mesh-list
154839218|NCT00609739|Cyclosporine|cyclosporine|mesh-list
154839219|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
154839220|NCT00609739|Methotrexate|methotrexate|mesh-list
154839221|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
154839222|NCT00609739|Tretinoin|tretinoin|mesh-list
154839223|NCT00609739|Isotretinoin|isotretinoin|mesh-list
154839224|NCT00609739|Cyclosporins|cyclosporins|mesh-list
154839225|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154839226|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
154839227|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154839228|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839229|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839230|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
154839231|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839232|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839233|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
154839234|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839235|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154839236|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839237|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
154839238|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839239|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154839240|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
154839241|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839242|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
154839243|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154839244|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154839245|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
154839246|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
154839247|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839248|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154839249|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
154839250|NCT00609739|Hormones|hormones|mesh-ancestor
154839251|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154839252|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154839253|NCT00609739|Protective Agents|protective agents|mesh-ancestor
154839254|NCT00609739|Analgesics|analgesics|mesh-ancestor
154839255|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
154839256|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154839257|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154839258|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
154839259|NCT00610987|Cefazolin|cefazolin|mesh-list
154839260|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839261|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839262|NCT04140578|Ertapenem|ertapenem|mesh-list
154839263|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839264|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839265|NCT00574171|Capecitabine|capecitabine|mesh-list
154839266|NCT00574171|Lapatinib|lapatinib|mesh-list
154839267|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839268|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
154839269|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839270|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839271|NCT00574171|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154839272|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154839273|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839274|NCT03585998|Cisplatin|cisplatin|mesh-list
154591219|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
154839275|NCT03585998|Etoposide|etoposide|mesh-list
154839276|NCT03585998|Durvalumab|durvalumab|mesh-list
154839277|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839278|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154839279|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154839280|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154839281|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839282|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839283|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839284|NCT00612235|Lamotrigine|lamotrigine|mesh-list
154839285|NCT00612235|Carbamazepine|carbamazepine|mesh-list
154839286|NCT00612235|Levetiracetam|levetiracetam|mesh-list
154839287|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
154839288|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
154839289|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154839290|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839291|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839292|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154839293|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839294|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154839295|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154839296|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839297|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154839298|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154839299|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
154839300|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154839301|NCT00612235|Analgesics|analgesics|mesh-ancestor
154839302|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
154839303|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839304|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154839305|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154839306|NCT00575029|Megestrol|megestrol|mesh-list
154839307|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
154839308|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154839309|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154839310|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154839311|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
154839312|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154839313|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839314|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154839315|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154839316|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154839317|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839318|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
154839319|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154839320|NCT00499109|Carboplatin|carboplatin|mesh-list
154839321|NCT00499109|Gemcitabine|gemcitabine|mesh-list
154839322|NCT00499109|Docetaxel|docetaxel|mesh-list
154018828|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
154839323|NCT00499109|Vinorelbine|vinorelbine|mesh-list
154839324|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
154839325|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839326|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
154839327|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839328|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
154839329|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
154839330|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
154839331|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154839332|NCT03585530|Raltitrexed|raltitrexed|mesh-list
154839333|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839334|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
154839335|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839336|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839337|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154839338|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839339|NCT03021590|Amoxicillin|amoxicillin|mesh-list
154839340|NCT03021590|Clarithromycin|clarithromycin|mesh-list
154839341|NCT03021590|Levofloxacin|levofloxacin|mesh-list
154839342|NCT03021590|Tinidazole|tinidazole|mesh-list
154839343|NCT03021590|Esomeprazole|esomeprazole|mesh-list
154839344|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839345|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839346|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154839347|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154839348|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154839349|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839350|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839351|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154839352|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154839353|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154839354|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154839355|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154839356|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154839357|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839358|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154839359|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
154839360|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154839361|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154839362|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154839364|NCT02125721|Antidotes|antidotes|mesh-ancestor
154839365|NCT02125721|Protective Agents|protective agents|mesh-ancestor
154839366|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839367|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
154839368|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
154839369|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839370|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839371|NCT00552695|Lidocaine|lidocaine|mesh-list
154839372|NCT00552695|Tetracaine|tetracaine|mesh-list
154839373|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
154839374|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
154839375|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839376|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839377|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
154839378|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839379|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154018887|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154018895|NCT02751476|Disinfectants|disinfectants|mesh-list
154839380|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154839381|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154839382|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839383|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839384|NCT00615433|Olanzapine|olanzapine|mesh-list
154839385|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154839386|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
154839387|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
154839388|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839389|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839390|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154839391|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154839392|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154839393|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839394|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154839395|NCT00615433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154839396|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154839397|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839398|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839399|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839400|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
154839401|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154839402|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154839403|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154839404|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
154839405|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154839406|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154839407|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154839408|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154839409|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
154839410|NCT03585374|Acetaminophen|acetaminophen|mesh-list
154839411|NCT03585374|Ketoprofen|ketoprofen|mesh-list
154839412|NCT03585374|Morphine|morphine|mesh-list
154839413|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
154839414|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154839415|NCT03585374|Narcotics|narcotics|mesh-ancestor
154839416|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839417|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839418|NCT03585374|Analgesics|analgesics|mesh-ancestor
154839419|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
154839420|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839421|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154839422|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
154839423|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154839424|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154839425|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839426|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154839427|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839428|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591367|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
154839430|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
154839431|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
154839432|NCT00499343|Rituximab|rituximab|mesh-list
154839433|NCT00499343|Etoposide|etoposide|mesh-list
154839434|NCT00499343|Ifosfamide|ifosfamide|mesh-list
154839435|NCT00499343|Isophosphamide mustard|isophosphamide mustard|mesh-list
154839436|NCT00499343|Sargramostim|sargramostim|mesh-list
154839437|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839438|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839439|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
154839440|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839441|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839442|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154018941|NCT02705274|Bevacizumab|bevacizumab|mesh-list
154839443|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154839444|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154839445|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839446|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839447|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154839448|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
154839449|NCT00615589|Fludarabine|fludarabine|mesh-list
154839450|NCT00615589|Busulfan|busulfan|mesh-list
154839451|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839452|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839453|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839454|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
154839455|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839456|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
154018965|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154839457|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154839458|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154839459|NCT00499655|Celecoxib|celecoxib|mesh-list
154839460|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154839461|NCT00499655|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154839462|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154839463|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839464|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839465|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839466|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154839467|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154839468|NCT00499655|Analgesics|analgesics|mesh-ancestor
154839469|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
154839470|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839471|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839472|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154839473|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839474|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154839475|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154839476|NCT03585140|Doxycycline|doxycycline|mesh-list
154839477|NCT03585140|Adapalene|adapalene|mesh-list
154839478|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839479|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839480|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
154839481|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154839482|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154839483|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154839484|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154839485|NCT03585140|Analgesics|analgesics|mesh-ancestor
154839486|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
154839487|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839488|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839489|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154839490|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839491|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
154018980|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154839492|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154839493|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
154839494|NCT03584984|Coagulants|coagulants|mesh-ancestor
154839495|NCT00575887|Temozolomide|temozolomide|mesh-list
154839496|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154839497|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
154839498|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839499|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839500|NCT00575965|Simvastatin|simvastatin|mesh-list
154839501|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154839502|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154839503|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
154839504|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839505|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154839506|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154839507|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839508|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
154839509|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839510|NCT03623828|Apomorphine|apomorphine|mesh-list
154839512|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839513|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
154839514|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839515|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154839516|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
154839517|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
154839518|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839519|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019021|NCT04433858|Psilocybin|psilocybin|mesh-list
154839520|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
154839521|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839522|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
154839523|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839524|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839525|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154839526|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
154839527|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839528|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839529|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154839530|NCT03589898|Gabapentin|gabapentin|mesh-list
154839531|NCT03589898|Analgesics|analgesics|mesh-ancestor
154839532|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
154839533|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839534|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839535|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
154839536|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154839537|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154839538|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839539|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154839540|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154839541|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154839542|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839543|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839544|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
154839545|NCT00577135|Furosemide|furosemide|mesh-list
154839546|NCT00577135|Diuretics|diuretics|mesh-list
154839547|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154839548|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
154839549|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839550|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839551|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839552|NCT00502853|Rituximab|rituximab|mesh-list
154839553|NCT00502853|Methotrexate|methotrexate|mesh-list
154839554|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839555|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839556|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
154839557|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839558|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839559|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154839560|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
154839561|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154839562|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839563|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
154839564|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839565|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
154839566|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839567|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154839568|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839569|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154839570|NCT00617539|Irinotecan|irinotecan|mesh-list
154839571|NCT00617539|Temozolomide|temozolomide|mesh-list
154839572|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154839573|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154839574|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839575|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839576|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839577|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154839578|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
154839580|NCT03620123|Nivolumab|nivolumab|mesh-list
154839581|NCT03620123|Ipilimumab|ipilimumab|mesh-list
154839582|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839583|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
154839584|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
154839585|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
154839586|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839587|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839588|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154839589|NCT00578071|Capecitabine|capecitabine|mesh-list
154839590|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
154839591|NCT00578071|Panitumumab|panitumumab|mesh-list
154839592|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839593|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
154839594|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839595|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839596|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839597|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
154839598|NCT00555581|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154839599|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154839600|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839601|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839602|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839603|NCT00504023|Imiquimod|imiquimod|mesh-list
154839604|NCT00504023|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154839605|NCT00504023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839606|NCT00504023|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154839607|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
154839608|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839609|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154839610|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839611|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
154839612|NCT03589430|Protein C|protein c|mesh-list
154839613|NCT03589430|Antithrombins|antithrombins|mesh-list
154839614|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
154839615|NCT03589430|Protein S|protein s|mesh-list
154839616|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154839617|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
154839618|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839619|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839620|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
154839621|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154839622|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154839623|NCT05702762|Gentamicins|gentamicins|mesh-list
154839624|NCT05702762|Cephalexin|cephalexin|mesh-list
154839625|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
154839626|NCT05702762|Cefdinir|cefdinir|mesh-list
154839627|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154839628|NCT05702762|Trimethoprim|trimethoprim|mesh-list
154839629|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
154839630|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839631|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019134|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
154839632|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154839633|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839634|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839635|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154839636|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
154839637|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154839638|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154839639|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154839640|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154839641|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154839642|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154839643|NCT05702762|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154839644|NCT05702762|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154839645|NCT03580694|Cemiplimab|cemiplimab|mesh-list
154839646|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839647|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839648|NCT03583892|Gabapentin|gabapentin|mesh-list
154839649|NCT03583892|Analgesics|analgesics|mesh-ancestor
154839650|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
154839651|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591594|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
154839652|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839653|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
154839654|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154839655|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154839656|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839657|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154839658|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154839659|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154839660|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839661|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839662|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
154839663|NCT03589040|Darunavir|darunavir|mesh-list
154839664|NCT03589040|Rilpivirine|rilpivirine|mesh-list
154839665|NCT03589040|Etonogestrel|etonogestrel|mesh-list
154839666|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154839667|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154839668|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
154839669|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839670|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839671|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154839672|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154839673|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
154839674|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839675|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154839676|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154839677|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154839678|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
154839679|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154839680|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839681|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154839682|NCT03583424|Cytarabine|cytarabine|mesh-list
154839683|NCT03583424|Etoposide|etoposide|mesh-list
154839684|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
154839685|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
154839686|NCT03583424|Melphalan|melphalan|mesh-list
154839687|NCT03583424|Venetoclax|venetoclax|mesh-list
154839688|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
154839689|NCT03583424|Carmustine|carmustine|mesh-list
154839690|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154839691|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154839692|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839693|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154839694|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154839695|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839696|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839697|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839698|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
154839699|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
154839700|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839701|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839702|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
154839703|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839704|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154839705|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
154839706|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154839707|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
154839708|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
154839709|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
154839710|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
154839711|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
154839712|NCT00578305|Folic Acid|folic acid|mesh-list
154839713|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
154839714|NCT00578305|Rituximab|rituximab|mesh-list
154839715|NCT00578305|Methotrexate|methotrexate|mesh-list
154839716|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839717|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839718|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
154839719|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839720|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839721|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154839722|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
154839723|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154839724|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839725|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
154839726|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839727|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
154839728|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839729|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154839730|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839731|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154839732|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154839733|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
154839734|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
154839735|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839736|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154839737|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
154839738|NCT00578305|Hormones|hormones|mesh-ancestor
154839739|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154839740|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154839741|NCT00578305|Protective Agents|protective agents|mesh-ancestor
154839742|NCT00578305|Hematinics|hematinics|mesh-ancestor
154839743|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
154839744|NCT00578305|Vitamins|vitamins|mesh-ancestor
154839745|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
154839746|NCT00578461|Cytarabine|cytarabine|mesh-list
154839747|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
154839748|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839749|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
154839750|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839751|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839752|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154839753|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
154839754|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839755|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839756|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154839757|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839758|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
154839759|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
154839760|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839761|NCT03580070|Immunomodulating Agents|immunomodulating agents|mesh-list
154839762|NCT03580070|Immunologic Factors|immunologic factors|mesh-ancestor
154839763|NCT03580070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839764|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
154839765|NCT03156296|Bupivacaine|bupivacaine|mesh-list
154839766|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
154839767|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
154839768|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154839769|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839770|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
154839771|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839772|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154839773|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154839774|NCT03156296|Analgesics|analgesics|mesh-ancestor
154839775|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154839776|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154839777|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154839778|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
154839779|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839780|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839781|NCT00578539|Cytarabine|cytarabine|mesh-list
154839782|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
154839783|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
154839784|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839785|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
154839786|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839787|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839788|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154019288|NCT05322720|Paclitaxel|paclitaxel|mesh-list
154839789|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
154839790|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839791|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839792|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154839793|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839794|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
154839795|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
154839796|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839797|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839798|NCT00578617|Amiodarone|amiodarone|mesh-list
154839799|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839800|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154839801|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
154591744|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
154839802|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154839803|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839804|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154839805|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154839806|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154839807|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839808|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154839809|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154839810|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154839811|NCT00505895|Rituximab|rituximab|mesh-list
154839812|NCT00505895|Fludarabine|fludarabine|mesh-list
154839813|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
154839814|NCT00505895|Melphalan|melphalan|mesh-list
154839815|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839816|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839817|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
154839818|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839819|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839820|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839821|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
154839822|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839823|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839824|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154839825|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
154839826|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154839827|NCT03582332|Indomethacin|indomethacin|mesh-list
154839828|NCT03582332|Etoricoxib|etoricoxib|mesh-list
154839829|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154839830|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154839831|NCT03582332|Analgesics|analgesics|mesh-ancestor
154839832|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
154839833|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839834|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839835|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154839836|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839837|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
154839838|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
154839839|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154839840|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154839841|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839842|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839843|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154839844|NCT00619723|Choline|choline|mesh-list
154839845|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154839846|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
154839847|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154839848|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
154839849|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839850|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154839851|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154839852|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
154839853|NCT03582098|Rituximab|rituximab|mesh-list
154839854|NCT03582098|Idelalisib|idelalisib|mesh-list
154839855|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839856|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839857|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
154839858|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839859|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839860|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839861|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839862|NCT00555893|Oseltamivir|oseltamivir|mesh-list
154839863|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
154839864|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839865|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839866|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839867|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154839868|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154839869|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154839870|NCT00578929|Analgesics|analgesics|mesh-ancestor
154839871|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
154839872|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839873|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019378|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154839874|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154839875|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154839876|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154839877|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154839878|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154839879|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
154839880|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
154839881|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839882|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839883|NCT00556049|Gemcitabine|gemcitabine|mesh-list
154839884|NCT00556049|Sunitinib|sunitinib|mesh-list
154839885|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154839886|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
154839887|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839888|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839889|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154839890|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154839891|NCT00556049|Growth Substances|growth substances|mesh-ancestor
154839892|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839893|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
154839894|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154839895|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839896|NCT01797107|Azithromycin|azithromycin|mesh-list
154839897|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839898|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839899|NCT03155984|Antibodies|antibodies|mesh-list
154839900|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
154839901|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839902|NCT00620191|Metformin|metformin|mesh-list
154839903|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154839904|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839905|NCT00506597|Asparaginase|asparaginase|mesh-list
154839906|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839907|NCT03589976|Sirolimus|sirolimus|mesh-list
154839908|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154839909|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154839910|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154839911|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839912|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
154839913|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839914|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
154839915|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839916|NCT03581630|Naltrexone|naltrexone|mesh-list
154839917|NCT03581630|Bupropion|bupropion|mesh-list
154839918|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154839919|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154839920|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839921|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
154839922|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839923|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154839924|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
154839925|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154839926|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154839927|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154839928|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154839929|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839930|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
154839931|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839932|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154839933|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154839934|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839935|NCT00506675|Atropine|atropine|mesh-list
154839936|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154839937|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154839938|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154839939|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
154839940|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154839941|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839942|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154839943|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
154839944|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
154839945|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
154839946|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154591894|NCT03466021|Liraglutide|liraglutide|mesh-list
154839947|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154839948|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
154839949|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839950|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839952|NCT00507767|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154839953|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154839954|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839955|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839956|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839957|NCT00621049|Bevacizumab|bevacizumab|mesh-list
154839958|NCT00621049|Carboplatin|carboplatin|mesh-list
154839959|NCT00621049|Docetaxel|docetaxel|mesh-list
154839960|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154839961|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154839962|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839963|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154839964|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154839965|NCT00621049|Growth Substances|growth substances|mesh-ancestor
154839966|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839967|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
154839968|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
154839969|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
154839970|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
154839971|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839972|NCT00621049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154839973|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154839974|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154839975|NCT00508469|Timolol|timolol|mesh-list
154839976|NCT00508469|Travoprost|travoprost|mesh-list
154839977|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154839978|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154839979|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154839980|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154839981|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
154839982|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154839983|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154839984|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839985|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154839986|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154839987|NCT05702996|Eculizumab|eculizumab|mesh-list
154839988|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154839989|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154839990|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
154839991|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154839992|NCT00580333|Paclitaxel|paclitaxel|mesh-list
154839993|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
154839994|NCT00580333|Bevacizumab|bevacizumab|mesh-list
154839995|NCT00580333|Doxorubicin|doxorubicin|mesh-list
154839996|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154839997|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154839998|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
154839999|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
154840000|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
154840001|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840002|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154840003|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
154840004|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840005|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154840006|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154840007|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
154840008|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154840009|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840010|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154840011|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154840012|NCT00580333|Growth Substances|growth substances|mesh-ancestor
154840013|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
154840014|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154840015|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154840016|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154840017|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840018|NCT00580645|Varenicline|varenicline|mesh-list
154840019|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154840020|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154840021|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
154840022|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840023|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840024|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840025|NCT00580957|Trimethaphan|trimethaphan|mesh-list
154840026|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154840027|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154840028|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154840029|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
154840030|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840031|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840032|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154840033|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154840034|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
154840035|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840036|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840037|NCT00509249|Aflibercept|aflibercept|mesh-list
154840038|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
154840039|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154840040|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154840041|NCT00509249|Growth Substances|growth substances|mesh-ancestor
154840042|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840043|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
154840044|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840045|NCT00624013|Sertraline|sertraline|mesh-list
154840046|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
154840047|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154840048|NCT00624013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154840049|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154019551|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154840050|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840051|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840052|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840053|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
154840054|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840055|NCT02121041|Losartan|losartan|mesh-list
154840056|NCT02121041|Amlodipine|amlodipine|mesh-list
154840057|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
154840058|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154840059|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154840060|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840061|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840062|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154840063|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840064|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
154840065|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154840066|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154840067|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154840068|NCT02121041|Diuretics|diuretics|mesh-ancestor
154840069|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
154840070|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154840071|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
154840072|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154840073|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154840074|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154840075|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840076|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154840077|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154840078|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840079|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840080|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840081|NCT02133781|Vaccines|vaccines|mesh-list
154840082|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
154840083|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840084|NCT01855451|Cetuximab|cetuximab|mesh-list
154840085|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840086|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840087|NCT02134951|Ketamine|ketamine|mesh-list
154840088|NCT02134951|Analgesics|analgesics|mesh-ancestor
154840089|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
154840090|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840091|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840092|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154840093|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154019596|NCT00910091|Megestrol|megestrol|mesh-list
154840094|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
154840095|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
154840096|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840097|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154840098|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154840099|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840100|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840101|NCT03029780|Nivolumab|nivolumab|mesh-list
154840102|NCT03029780|Ipilimumab|ipilimumab|mesh-list
154840103|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840104|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840105|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154840106|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840107|NCT00624559|Celecoxib|celecoxib|mesh-list
154840108|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154840109|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154840110|NCT00624559|Analgesics|analgesics|mesh-ancestor
154840111|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
154840112|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840113|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840114|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840115|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154840116|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154840117|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154840118|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840119|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840120|NCT00510809|Ethanol|ethanol|mesh-list
154840121|NCT00510809|Policosanol|policosanol|mesh-list
154840122|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154840123|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154840124|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840125|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840126|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840127|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154840128|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154840129|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
154840130|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840131|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840132|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154840133|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154840134|NCT00625729|Aldesleukin|aldesleukin|mesh-list
154840135|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
154840136|NCT00625729|Rituximab|rituximab|mesh-list
154840137|NCT00625729|Fludarabine|fludarabine|mesh-list
154840138|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
154840139|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154840140|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
154840141|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840142|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154840143|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154840144|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
154840145|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840146|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840147|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154840148|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840149|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154840150|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
154840151|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154840152|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154840153|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
154840154|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840155|NCT00581971|Celecoxib|celecoxib|mesh-list
154840156|NCT00581971|Paclitaxel|paclitaxel|mesh-list
154840157|NCT00581971|Carboplatin|carboplatin|mesh-list
154840158|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154840159|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840160|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
154840161|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
154840162|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
154840163|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840164|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154840165|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154840166|NCT00581971|Analgesics|analgesics|mesh-ancestor
154840167|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
154840168|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840169|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840170|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840171|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154840172|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154840173|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154840174|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840175|NCT03029234|Dexamethasone|dexamethasone|mesh-list
154840176|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840177|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
154840178|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
154840179|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840180|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840181|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154840182|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
154840183|NCT03029234|Hormones|hormones|mesh-ancestor
154840184|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840185|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154840186|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840187|NCT01670318|Chromium|chromium|mesh-list
154840188|NCT01670318|Everolimus|everolimus|mesh-list
154840189|NCT01670318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154840190|NCT01670318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154840191|NCT01670318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840192|NCT01670318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840193|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154840194|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
154840195|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840196|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840197|NCT01670318|Trace Elements|trace elements|mesh-ancestor
154840198|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
154840199|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
154840200|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154840201|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
154840202|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840203|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840204|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154840205|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
154840206|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
154840207|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154840208|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
154840209|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840210|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840211|NCT03111992|Spartalizumab|spartalizumab|mesh-list
154840212|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154840213|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840214|NCT03111992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840215|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840216|NCT00626431|Leuprolide|leuprolide|mesh-list
154840217|NCT00626431|Hormones|hormones|mesh-list
154840218|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154840219|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840220|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840221|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154840222|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
154840223|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154840224|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154840225|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840226|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154840227|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154840228|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154840229|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840230|NCT00582205|Paclitaxel|paclitaxel|mesh-list
154840231|NCT00582205|Cisplatin|cisplatin|mesh-list
154840232|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154840233|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840234|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
154840235|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
154840236|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
154840237|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840238|NCT00626743|Amlodipine|amlodipine|mesh-list
154840239|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154840240|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154840241|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840242|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840243|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154840244|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840245|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
154840246|NCT03155048|Estradiol|estradiol|mesh-list
154840247|NCT03155048|Estrogens|estrogens|mesh-list
154840248|NCT03155048|Hormones|hormones|mesh-ancestor
154840249|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840250|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840251|NCT00627367|Hydromorphone|hydromorphone|mesh-list
154840252|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154840253|NCT00627367|Narcotics|narcotics|mesh-ancestor
154840254|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840255|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840256|NCT00627367|Analgesics|analgesics|mesh-ancestor
154840257|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
154840258|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840259|NCT00627679|Budesonide|budesonide|mesh-list
154840260|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840261|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154840262|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
154840263|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840264|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840265|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154840266|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
154840267|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
154840268|NCT00627679|Hormones|hormones|mesh-ancestor
154840269|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840270|NCT00514709|Vaccines|vaccines|mesh-list
154840271|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
154840272|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840273|NCT03154814|Urinastatin|urinastatin|mesh-list
154840274|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154840275|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154840276|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
154840277|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840278|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840279|NCT00515021|Eplerenone|eplerenone|mesh-list
154840280|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154840281|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
154840282|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840283|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840284|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154840285|NCT00515021|Diuretics|diuretics|mesh-ancestor
154840286|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
154840287|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154840288|NCT00515177|Eszopiclone|eszopiclone|mesh-list
154840289|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154840290|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840291|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840292|NCT01671410|Morphine|morphine|mesh-list
154840293|NCT01671410|Buprenorphine|buprenorphine|mesh-list
154840294|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154840295|NCT01671410|Narcotics|narcotics|mesh-ancestor
154840296|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840297|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840298|NCT01671410|Analgesics|analgesics|mesh-ancestor
154840299|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
154840300|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840301|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154840302|NCT00630253|Cyclosporine|cyclosporine|mesh-list
154840303|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
154840304|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
154840305|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
154840306|NCT00630253|Fludarabine|fludarabine|mesh-list
154840307|NCT00630253|Cyclosporins|cyclosporins|mesh-list
154840308|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154840309|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154840310|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
154840311|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840312|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154840313|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154840314|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
154840315|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840316|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840317|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154840318|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840319|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
154840320|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840321|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
154840322|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154840323|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154840324|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154840325|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
154840326|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154840327|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840328|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
154840329|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
154840330|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840331|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154840332|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
154840333|NCT00630253|Hormones|hormones|mesh-ancestor
154840334|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840335|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154840336|NCT00630253|Protective Agents|protective agents|mesh-ancestor
154840337|NCT01671722|Montelukast|montelukast|mesh-list
154840338|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154840339|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
154840340|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154840341|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
154840342|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840343|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840344|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154840345|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154840346|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840347|NCT00584701|Risperidone|risperidone|mesh-list
154840348|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154840349|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
154840350|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840351|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840352|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840353|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154840354|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154840355|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840356|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154840357|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154840358|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
154840359|NCT00630409|Gemcitabine|gemcitabine|mesh-list
154840360|NCT00630409|Doxorubicin|doxorubicin|mesh-list
154840361|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154840362|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
154840363|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840364|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840365|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154840366|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154840367|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154840368|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840369|NCT00630955|Memantine|memantine|mesh-list
154840370|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154840371|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154840372|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
154840373|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840374|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840375|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840376|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154840377|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154840378|NCT00584857|Paclitaxel|paclitaxel|mesh-list
154840379|NCT00584857|Carboplatin|carboplatin|mesh-list
154840380|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154840381|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840382|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
154840383|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
154840384|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
154840385|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840386|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
154840387|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154019896|NCT05580029|Hormones|hormones|mesh-ancestor
154840388|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
154840389|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840390|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840391|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154840392|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
154840393|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154840394|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
154840395|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840396|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592337|NCT01652690|Denosumab|denosumab|mesh-list
154840397|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154840398|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
154840399|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
154840400|NCT00585013|Protective Agents|protective agents|mesh-ancestor
154840401|NCT01672112|Oxycodone|oxycodone|mesh-list
154840402|NCT01672112|Codeine|codeine|mesh-list
154840403|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154840404|NCT01672112|Narcotics|narcotics|mesh-ancestor
154840405|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840406|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840407|NCT01672112|Analgesics|analgesics|mesh-ancestor
154840408|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
154840409|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840410|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
154840411|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
154840412|NCT00585637|Vitamin D|vitamin d|mesh-list
154840413|NCT00585637|Vitamins|vitamins|mesh-ancestor
154840414|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
154840415|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840416|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154840417|NCT03158792|Enoxaparin|enoxaparin|mesh-list
154840418|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
154840419|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
154840420|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154840421|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154840422|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840423|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154840424|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154840425|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
154840426|NCT03158480|Immunomodulating Agents|immunomodulating agents|mesh-list
154840427|NCT03158480|Immunologic Factors|immunologic factors|mesh-ancestor
154840428|NCT03158480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840429|NCT00633919|Prednisone|prednisone|mesh-list
154840430|NCT00633919|Budesonide|budesonide|mesh-list
154840431|NCT00633919|Albuterol|albuterol|mesh-list
154840432|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
154840433|NCT00633919|Desloratadine|desloratadine|mesh-list
154840434|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840435|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
154840436|NCT00633919|Hormones|hormones|mesh-ancestor
154840437|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840438|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840439|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154840440|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840441|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154840442|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
154840443|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840444|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154840445|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
154840446|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154840447|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154840448|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154840449|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
154840450|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840451|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840452|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
154840453|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154840454|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154840455|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
154840456|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154840457|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154840458|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
154840459|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
154840460|NCT03158246|Vitamin D|vitamin d|mesh-list
154840461|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
154840462|NCT03158246|Calcium|calcium|mesh-list
154840463|NCT03158246|Vitamins|vitamins|mesh-ancestor
154840464|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
154840465|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840466|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154840467|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154840468|NCT00515411|Leucovorin|leucovorin|mesh-list
154840469|NCT00515411|Cisplatin|cisplatin|mesh-list
154840470|NCT00515411|Docetaxel|docetaxel|mesh-list
154840471|NCT00515411|Fluorouracil|fluorouracil|mesh-list
154840472|NCT00515411|Trastuzumab|trastuzumab|mesh-list
154840473|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840474|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
154840475|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
154840476|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
154840477|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840478|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
154840479|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154840480|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154840481|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
154840482|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840483|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840484|NCT00515411|Antidotes|antidotes|mesh-ancestor
154840485|NCT00515411|Protective Agents|protective agents|mesh-ancestor
154840486|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
154840487|NCT00515411|Vitamins|vitamins|mesh-ancestor
154840488|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
154840489|NCT00586261|Pioglitazone|pioglitazone|mesh-list
154840490|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
154840491|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154840492|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840493|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
154840494|NCT00515723|Olanzapine|olanzapine|mesh-list
154840495|NCT00515723|Risperidone|risperidone|mesh-list
154840496|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154840497|NCT00515723|Ziprasidone|ziprasidone|mesh-list
154840498|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154840499|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
154840500|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840501|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840502|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840503|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154840504|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154840505|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840506|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154840507|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154840508|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
154840509|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
154840510|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
154840511|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840512|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154840513|NCT00515723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154840514|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154840515|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840516|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
154840517|NCT04405154|Cisplatin|cisplatin|mesh-list
154840518|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840519|NCT00586573|Memantine|memantine|mesh-list
154840520|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154840521|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154840522|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
154840523|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840524|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840525|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840526|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154840527|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154840528|NCT01799005|Micronutrients|micronutrients|mesh-list
154840529|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840530|NCT00515879|Cycloserine|cycloserine|mesh-list
154840531|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154840532|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840533|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154840534|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
154840535|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154840536|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
154840537|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840538|NCT03152942|Aminophylline|aminophylline|mesh-list
154840539|NCT03152942|Progesterone|progesterone|mesh-list
154840540|NCT03152942|Progestins|progestins|mesh-ancestor
154840541|NCT03152942|Hormones|hormones|mesh-ancestor
154840542|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840543|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840544|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154840545|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
154840546|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840547|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154840548|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
154840549|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154840550|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154840551|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840552|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840553|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154840554|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154020063|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020064|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154840555|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
154840556|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840557|NCT03152942|Protective Agents|protective agents|mesh-ancestor
154840559|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154840560|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840561|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154840562|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154840563|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840564|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840565|NCT01672346|Adenosine|adenosine|mesh-list
154840566|NCT01672346|Analgesics|analgesics|mesh-ancestor
154840567|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
154840568|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840569|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840570|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154840571|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
154840572|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154840573|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
154840574|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
154840575|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840576|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840577|NCT00516503|Ketamine|ketamine|mesh-list
154840578|NCT00516503|Amitriptyline|amitriptyline|mesh-list
154840579|NCT00516503|Baclofen|baclofen|mesh-list
154020092|NCT02739386|Ipilimumab|ipilimumab|mesh-list
154840580|NCT00516503|Analgesics|analgesics|mesh-ancestor
154840581|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
154840582|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840583|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840584|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154840585|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154840586|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
154840587|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
154840588|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840589|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154840590|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154840591|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840592|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840593|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154840594|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154840595|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154840596|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
154840597|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
154840598|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154840599|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
154840600|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154840601|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154840602|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154840603|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154840604|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840605|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
154840606|NCT03157310|Gefitinib|gefitinib|mesh-list
154840607|NCT03157310|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154840608|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154020115|NCT05628662|Insulin|insulin|mesh-list
154840609|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840610|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840611|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840612|NCT03157388|Vancomycin|vancomycin|mesh-list
154840613|NCT03157388|Gentamicins|gentamicins|mesh-list
154840614|NCT03157388|Meropenem|meropenem|mesh-list
154840615|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154840616|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840617|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154840618|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840619|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840620|NCT03156920|Sumatriptan|sumatriptan|mesh-list
154840621|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154840622|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154840623|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154840624|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
154840625|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840626|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840627|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840629|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154840630|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154840631|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154840632|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154840633|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154840634|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
154840635|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840636|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840637|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840638|NCT03156842|Amlodipine|amlodipine|mesh-list
154840639|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154840640|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154840641|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154840642|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840643|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840644|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154840645|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840646|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
154840647|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154840648|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154840649|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
154840650|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154840651|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154840652|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840653|NCT01672580|Vitamins|vitamins|mesh-list
154840654|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
154840655|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840656|NCT00636649|Escitalopram|escitalopram|mesh-list
154840657|NCT00636649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154840658|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154840659|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840660|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840661|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840662|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
154840663|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840664|NCT05061524|Omalizumab|omalizumab|mesh-list
154840665|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154840666|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154840667|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
154840668|NCT00636805|Dexamethasone|dexamethasone|mesh-list
154840669|NCT00636805|Palonosetron|palonosetron|mesh-list
154840670|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840671|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
154840672|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
154840673|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840674|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840675|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154840676|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
154840677|NCT00636805|Hormones|hormones|mesh-ancestor
154840678|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840679|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154840680|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840681|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154840682|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154840683|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
154840684|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840685|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840686|NCT05247151|Oxytocin|oxytocin|mesh-list
154840687|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
154840688|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154840689|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840690|NCT01676246|Flupirtine|flupirtine|mesh-list
154840691|NCT01676246|Analgesics|analgesics|mesh-ancestor
154840692|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
154840693|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840694|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840695|NCT00517595|Bevacizumab|bevacizumab|mesh-list
154840696|NCT00517595|Gemcitabine|gemcitabine|mesh-list
154840697|NCT00517595|Pemetrexed|pemetrexed|mesh-list
154840698|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840699|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840700|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154840701|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154840702|NCT00517595|Growth Substances|growth substances|mesh-ancestor
154840703|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840704|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
154840705|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154840706|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
154840707|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840708|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840709|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154840710|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154840711|NCT01672814|Riboflavin|riboflavin|mesh-list
154840712|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154840713|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154840714|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
154840715|NCT01672814|Vitamins|vitamins|mesh-ancestor
154840716|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
154840717|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840718|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154840719|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
154840720|NCT00524225|Oprelvekin|oprelvekin|mesh-list
154840721|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840722|NCT00669019|Saracatinib|saracatinib|mesh-list
154840723|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840724|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840725|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840726|NCT05560373|Huperzine A|huperzine a|mesh-list
154840727|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154840728|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840729|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840730|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
154840731|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840732|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840733|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154840734|NCT05560373|Protective Agents|protective agents|mesh-ancestor
154840735|NCT00670267|Nadolol|nadolol|mesh-list
154840736|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154840737|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154840738|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
154840739|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840740|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840741|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840742|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154840743|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154840744|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
154840745|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
154840746|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840747|NCT05621915|Nadroparin|nadroparin|mesh-list
154840748|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
154840749|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154840750|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154840751|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840752|NCT01673204|Calcitriol|calcitriol|mesh-list
154840753|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154840754|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840755|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154840756|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840757|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840758|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154840759|NCT01673204|Vitamins|vitamins|mesh-ancestor
154840760|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
154840761|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154840762|NCT00641563|Midazolam|midazolam|mesh-list
154840763|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
154840764|NCT00641563|Remifentanil|remifentanil|mesh-list
154840765|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154840766|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840767|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840768|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154840769|NCT00641563|Analgesics|analgesics|mesh-ancestor
154840770|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
154840771|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840772|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154840773|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154840774|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154840775|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
154840776|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840777|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840778|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154840779|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154840780|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154840781|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154840782|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154840783|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
154840784|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
154840785|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
154840786|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
154840787|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154840788|NCT00641563|Narcotics|narcotics|mesh-ancestor
154840789|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154840790|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154840791|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840792|NCT00641641|Tenofovir|tenofovir|mesh-list
154840793|NCT00641641|Emtricitabine|emtricitabine|mesh-list
154840794|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
154840795|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
154840796|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840797|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154840798|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154840799|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840800|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840801|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154840802|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154840803|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154840804|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154840805|NCT03152474|Vitamin A|vitamin a|mesh-list
154840806|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
154840807|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154840808|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154840809|NCT03152474|Prednisolone|prednisolone|mesh-list
154840810|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
154840811|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154840812|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
154840813|NCT03152474|Vitamins|vitamins|mesh-ancestor
154840814|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
154840815|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840816|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840817|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
154840818|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
154840819|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840820|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154840821|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
154840822|NCT03152474|Hormones|hormones|mesh-ancestor
154840823|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840824|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154840825|NCT03152474|Protective Agents|protective agents|mesh-ancestor
154840826|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154840827|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840828|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
154840829|NCT00641797|Promethazine|promethazine|mesh-list
154840830|NCT00641797|Meclizine|meclizine|mesh-list
154840831|NCT00641797|Lorazepam|lorazepam|mesh-list
154840832|NCT00641797|Ondansetron|ondansetron|mesh-list
154840833|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
154840834|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
154840835|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840836|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840837|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154840838|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
154840839|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
154840840|NCT00641797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154840841|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154840842|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
154840843|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840844|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840845|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154840846|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154840847|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840848|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
154840849|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
154840850|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
154840851|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154840852|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
154840853|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
154840854|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154840855|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
154840856|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154840857|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154840858|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154840859|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
154840860|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
154840861|NCT00641797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154840862|NCT00641797|Cholinergic Agents|cholinergic agents|mesh-ancestor
154840863|NCT04333459|Vaccines|vaccines|mesh-list
154840864|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
154840865|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840866|NCT00671515|Pioglitazone|pioglitazone|mesh-list
154840867|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154840868|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840869|NCT01893320|Decitabine|decitabine|mesh-list
154840870|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154840871|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
154840872|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840873|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840874|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840875|NCT00673075|Carvedilol|carvedilol|mesh-list
154840876|NCT00673075|Nebivolol|nebivolol|mesh-list
154840877|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154840878|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154840879|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
154840880|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840881|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840882|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840883|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154840884|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
154840885|NCT00673075|Protective Agents|protective agents|mesh-ancestor
154840886|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154840887|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154840888|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154840889|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
154840890|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154840891|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154840892|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154840893|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154840894|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154840895|NCT02250014|Sargramostim|sargramostim|mesh-list
154840896|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
154840897|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840898|NCT04022096|Lansoprazole|lansoprazole|mesh-list
154840899|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
154840900|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154840901|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154840902|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154840903|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840904|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840905|NCT00673153|Vorinostat|vorinostat|mesh-list
154840906|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
154840907|NCT00673153|Calicheamicins|calicheamicins|mesh-list
154840908|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840909|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154840910|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840911|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840912|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840913|NCT00673153|Immunotoxins|immunotoxins|mesh-ancestor
154840914|NCT00673153|Immunoconjugates|immunoconjugates|mesh-ancestor
154840915|NCT00673153|Immunologic Factors|immunologic factors|mesh-ancestor
154840916|NCT00673153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840917|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154840918|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154840919|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
154840920|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154840921|NCT00654511|Fentanyl|fentanyl|mesh-list
154840922|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
154840923|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154840924|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154840925|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840926|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154840927|NCT00654511|Analgesics|analgesics|mesh-ancestor
154840928|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
154840929|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840930|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154840931|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154840932|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154840933|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
154840934|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154840935|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840936|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154840937|NCT00654511|Narcotics|narcotics|mesh-ancestor
154840938|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154840939|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154840940|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
154840941|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
154840942|NCT01670084|Leucovorin|leucovorin|mesh-list
154840943|NCT01670084|Cytarabine|cytarabine|mesh-list
154840944|NCT01670084|Dexamethasone|dexamethasone|mesh-list
154840945|NCT01670084|Prednisone|prednisone|mesh-list
154840946|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
154840947|NCT01670084|Rituximab|rituximab|mesh-list
154840948|NCT01670084|Doxorubicin|doxorubicin|mesh-list
154840949|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154840950|NCT01670084|Methotrexate|methotrexate|mesh-list
154840951|NCT01670084|Vincristine|vincristine|mesh-list
154840952|NCT01670084|Nilotinib|nilotinib|mesh-list
154840953|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
154840954|NCT01670084|Mesna|mesna|mesh-list
154840955|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154840956|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
154840957|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154840958|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154840959|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154840960|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
154840961|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154840962|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154840963|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154840964|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154840965|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154840966|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
154840967|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
154840968|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154840969|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154840970|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
154840971|NCT01670084|Hormones|hormones|mesh-ancestor
154840972|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154840973|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154840974|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154840975|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154840976|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154840977|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154840978|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154840979|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
154840980|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154840981|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154840982|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
154840983|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
154840984|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154840985|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154840986|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
154840987|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154840988|NCT01670084|Antidotes|antidotes|mesh-ancestor
154840989|NCT01670084|Protective Agents|protective agents|mesh-ancestor
154840990|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
154840991|NCT01670084|Vitamins|vitamins|mesh-ancestor
154840992|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
154840993|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154840994|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
154840995|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
154840996|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
154840997|NCT01670084|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154840998|NCT01670084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154840999|NCT01670162|Aflibercept|aflibercept|mesh-list
154841000|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154841001|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154841002|NCT01670162|Growth Substances|growth substances|mesh-ancestor
154841003|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841004|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
154841005|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841006|NCT04345783|Apatinib|apatinib|mesh-list
154841007|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841008|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154841009|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841010|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841011|NCT00675259|Paclitaxel|paclitaxel|mesh-list
154841012|NCT00675259|Bevacizumab|bevacizumab|mesh-list
154841013|NCT00675259|Carboplatin|carboplatin|mesh-list
154841014|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154841015|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841016|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
154841017|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
154841018|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
154841019|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841020|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841021|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154841022|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154841023|NCT00675259|Growth Substances|growth substances|mesh-ancestor
154841024|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841025|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
154841026|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
154841027|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154841028|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841029|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154841030|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154841031|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841032|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841033|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841034|NCT01670240|Adalimumab|adalimumab|mesh-list
154841035|NCT01670240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154841036|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841037|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841038|NCT04404686|Indomethacin|indomethacin|mesh-list
154841039|NCT04404686|Nifedipine|nifedipine|mesh-list
154841040|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154841041|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841042|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841043|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154841044|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841045|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
154841046|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
154841047|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154841048|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154841049|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154841050|NCT04404686|Analgesics|analgesics|mesh-ancestor
154841051|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
154841052|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020541|NCT01959464|Hormones|hormones|mesh-ancestor
154841053|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841054|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841055|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
154841056|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154841057|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841058|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
154841059|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841060|NCT00658411|Deferoxamine|deferoxamine|mesh-list
154841061|NCT00658411|Siderophores|siderophores|mesh-ancestor
154841062|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154841063|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
154841064|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
154841065|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841066|NCT01674530|Lubiprostone|lubiprostone|mesh-list
154841067|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154841068|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841069|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841070|NCT00676897|Simvastatin|simvastatin|mesh-list
154841071|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154841072|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154841073|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
154841074|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841075|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154841076|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154841077|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841078|NCT02115074|Celecoxib|celecoxib|mesh-list
154841079|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154841080|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154841081|NCT02115074|Analgesics|analgesics|mesh-ancestor
154020578|NCT02724332|Sirolimus|sirolimus|mesh-list
154841082|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
154841083|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841084|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841085|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841086|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841087|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154841088|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154841089|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841090|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841091|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
154841092|NCT01674686|Atorvastatin|atorvastatin|mesh-list
154841093|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154841094|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154841095|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
154841096|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841097|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154841098|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154841099|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841100|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154841101|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154841102|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154841103|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154841104|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
154841105|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841106|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841107|NCT02082392|Escitalopram|escitalopram|mesh-list
154841108|NCT02082392|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154841109|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154841110|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841111|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841112|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841113|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
154841114|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860423|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860424|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860425|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154860426|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860427|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
154860428|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154860429|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
154860430|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860431|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860432|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154860433|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
154860434|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154860435|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
154860436|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860437|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860438|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154860439|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
154860440|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
154860441|NCT03455218|Protective Agents|protective agents|mesh-ancestor
154860442|NCT01050907|Miltefosine|miltefosine|mesh-list
154860443|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
154860444|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860445|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860446|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154020629|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154860447|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154860448|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154860449|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
154860450|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154860451|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154860452|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154860453|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860454|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860455|NCT04433845|Psilocybin|psilocybin|mesh-list
154860456|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
154860457|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860458|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154860459|NCT01920386|Acetaminophen|acetaminophen|mesh-list
154860460|NCT01920386|Tramadol|tramadol|mesh-list
154860461|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154860462|NCT01920386|Analgesics|analgesics|mesh-ancestor
154841115|NCT01674842|Cisplatin|cisplatin|mesh-list
154841116|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841117|NCT03161132|Doxorubicin|doxorubicin|mesh-list
154841118|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154841119|NCT03161132|Olaparib|olaparib|mesh-list
154841120|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154841121|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841122|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154841123|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154841124|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841125|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841126|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154841127|NCT03844256|Capecitabine|capecitabine|mesh-list
154841128|NCT03844256|Nivolumab|nivolumab|mesh-list
154841129|NCT03844256|Ipilimumab|ipilimumab|mesh-list
154841130|NCT03844256|Mitomycins|mitomycins|mesh-list
154841131|NCT03844256|Mitomycin|mitomycin|mesh-list
154841132|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154841133|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
154841134|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841135|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841136|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841137|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154841138|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154841139|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
154841140|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154841141|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841142|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
154841143|NCT01675076|Apixaban|apixaban|mesh-list
154841144|NCT01675076|Dabigatran|dabigatran|mesh-list
154841145|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154841146|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
154841147|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154841148|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
154841149|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841150|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841151|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
154841152|NCT03838796|Lenvatinib|lenvatinib|mesh-list
154841153|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841154|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154841155|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841156|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841157|NCT03719690|Tipifarnib|tipifarnib|mesh-list
154841158|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841159|NCT01675466|Anesthetics|anesthetics|mesh-list
154841160|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841161|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841162|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
154841163|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
154841164|NCT01676558|Rituximab|rituximab|mesh-list
154841165|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841166|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841167|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
154841168|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841169|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841170|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
154841171|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154841172|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154841173|NCT02510300|Ledipasvir|ledipasvir|mesh-list
154841174|NCT02510300|Velpatasvir|velpatasvir|mesh-list
154841175|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
154841176|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841177|NCT00678535|Capecitabine|capecitabine|mesh-list
154841178|NCT00678535|Cetuximab|cetuximab|mesh-list
154841179|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841180|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154841181|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
154841182|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841183|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841184|NCT00659737|Scopolamine|scopolamine|mesh-list
154841185|NCT00659737|Aprepitant|aprepitant|mesh-list
154841186|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
154841187|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154841188|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
154841189|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
154841190|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841191|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841192|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154841193|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154841194|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841195|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841196|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154841197|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
154841198|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154841199|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
154841200|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154841201|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
154841202|NCT04763876|Ketorolac|ketorolac|mesh-list
154841203|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154841204|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154841205|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154841206|NCT04763876|Analgesics|analgesics|mesh-ancestor
154841207|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
154841208|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841209|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841210|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841211|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841212|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154841213|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841214|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841215|NCT00680797|Testosterone|testosterone|mesh-list
154841216|NCT00680797|Estrogens|estrogens|mesh-list
154841217|NCT00680797|Androgens|androgens|mesh-ancestor
154841218|NCT00680797|Hormones|hormones|mesh-ancestor
154841219|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841220|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841221|NCT02984852|Tenofovir|tenofovir|mesh-list
154841222|NCT02984852|Emtricitabine|emtricitabine|mesh-list
154841223|NCT02984852|Darunavir|darunavir|mesh-list
154841224|NCT02984852|Cobicistat|cobicistat|mesh-list
154841225|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
154841226|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841227|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154841228|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154841229|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841230|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841231|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154841232|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154841233|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154841234|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154841235|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
154841236|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154841237|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154841238|NCT00660517|Fluticasone|fluticasone|mesh-list
154841239|NCT00660517|Xhance|xhance|mesh-list
154841240|NCT00660517|Azelastine|azelastine|mesh-list
154841241|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841242|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154841243|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
154841244|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841245|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841246|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154841247|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
154841248|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
154841249|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154841250|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154841251|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841252|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841253|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154841254|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154841255|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
154841256|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
154841257|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841258|NCT02141581|Vaccines|vaccines|mesh-list
154841259|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
154841260|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841261|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154841262|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154841263|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841264|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841265|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154841266|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841267|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841268|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
154841269|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841270|NCT03819530|Micronutrients|micronutrients|mesh-list
154841271|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841272|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154841273|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
154841274|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154841275|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154841276|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841277|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841278|NCT01931163|Everolimus|everolimus|mesh-list
154841279|NCT01931163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154841280|NCT01931163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154841281|NCT01931163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020789|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
154841282|NCT01931163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841283|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154841284|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
154841285|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841286|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841287|NCT04763486|Cefazolin|cefazolin|mesh-list
154841288|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154841289|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841290|NCT02988063|Polidocanol|polidocanol|mesh-list
154841291|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154841292|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154841293|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
154841294|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
154841295|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841296|NCT03744026|Carboplatin|carboplatin|mesh-list
154841297|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841298|NCT03869450|Lidocaine|lidocaine|mesh-list
154841299|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
154841300|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
154841301|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
154841302|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841303|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841304|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
154841305|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841306|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154841307|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154841308|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154841309|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841310|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841311|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154841312|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
154841313|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
154841314|NCT03869450|Protective Agents|protective agents|mesh-ancestor
154841315|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154841316|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154841317|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154841318|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841319|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841320|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
154841321|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841322|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841323|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154841324|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841325|NCT01101464|Asenapine|asenapine|mesh-list
154841326|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154841327|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154841328|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841329|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841330|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154841331|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154841332|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
154841333|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841334|NCT03725930|Clonidine|clonidine|mesh-list
154841335|NCT03725930|Analgesics|analgesics|mesh-ancestor
154841336|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
154841337|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841338|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841339|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154841340|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
154841341|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
154841342|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154841343|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154841344|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154841345|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
154841346|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841347|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841348|NCT03781388|Bupivacaine|bupivacaine|mesh-list
154841349|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
154841350|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
154841351|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841352|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841353|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
154841354|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841355|NCT03779048|Phentermine|phentermine|mesh-list
154841356|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154841357|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841358|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
154841359|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154841360|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
154841361|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
154841362|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841363|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
154841364|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841365|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841366|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
154841367|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
154841368|NCT03778580|Vitamins|vitamins|mesh-ancestor
154841369|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
154841370|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841371|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
154841372|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841373|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841374|NCT03722342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154841375|NCT03722342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841376|NCT03722108|Irinotecan|irinotecan|mesh-list
154841377|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154841378|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154841379|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020901|NCT02649465|Glimepiride|glimepiride|mesh-list
154841380|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841381|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841382|NCT03775070|Simvastatin|simvastatin|mesh-list
154841383|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154841384|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154841385|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
154841386|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841387|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154841388|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154841389|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841390|NCT02083406|Artefenomel|artefenomel|mesh-list
154841391|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
154841392|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154841393|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154841394|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841395|NCT03773666|Durvalumab|durvalumab|mesh-list
154841396|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841397|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841398|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
154841399|NCT04762784|Hormones|hormones|mesh-ancestor
154841400|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841401|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841402|NCT00003644|Paclitaxel|paclitaxel|mesh-list
154841403|NCT00003644|Carboplatin|carboplatin|mesh-list
154841404|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154020931|NCT02644785|Coagulants|coagulants|mesh-ancestor
154020932|NCT02644707|Selenium|selenium|mesh-list
154841405|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841406|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
154841407|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
154841408|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
154841409|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841410|NCT02142049|Lenalidomide|lenalidomide|mesh-list
154841411|NCT02142049|Ibrutinib|ibrutinib|mesh-list
154841412|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
154841413|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841414|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154841415|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154841416|NCT02142049|Growth Substances|growth substances|mesh-ancestor
154841417|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
154841418|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841419|NCT02142049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154841420|NCT02142049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154841421|NCT02142049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841422|NCT02142049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841423|NCT03715244|Anesthetics|anesthetics|mesh-list
154841424|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
154841425|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841426|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841427|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
154841428|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841429|NCT03714620|Ketamine|ketamine|mesh-list
154841430|NCT03714620|Analgesics|analgesics|mesh-ancestor
154020962|NCT00302744|Vitamins|vitamins|mesh-ancestor
154841431|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
154841432|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841433|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841434|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154841435|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154841436|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
154841437|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
154841438|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841439|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154841440|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154841441|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841442|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841443|NCT03629288|Azithromycin|azithromycin|mesh-list
154841444|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154841445|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841446|NCT04763096|Tacrolimus|tacrolimus|mesh-list
154841447|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154841448|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
154841449|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841450|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154841451|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841452|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841453|NCT00680953|Denosumab|denosumab|mesh-list
154841454|NCT00680953|Alendronate|alendronate|mesh-list
154841455|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154841456|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841457|NCT00660985|Adapalene|adapalene|mesh-list
154841458|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154841459|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154841460|NCT00660985|Analgesics|analgesics|mesh-ancestor
154841461|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
154841462|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841463|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841464|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841465|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841466|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
154841467|NCT03551522|Seladelpar|seladelpar|mesh-list
154841468|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154841469|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
154841470|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841471|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154841472|NCT03704714|Prednisone|prednisone|mesh-list
154841473|NCT03704714|Cortisone|cortisone|mesh-list
154841474|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
154841475|NCT03704714|Rituximab|rituximab|mesh-list
154841476|NCT03704714|Doxorubicin|doxorubicin|mesh-list
154841477|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154841478|NCT03704714|Nivolumab|nivolumab|mesh-list
154841479|NCT03704714|Vincristine|vincristine|mesh-list
154841480|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154841481|NCT03704714|Antibodies|antibodies|mesh-list
154841482|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
154841483|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154841484|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154841485|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
154841486|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841487|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841488|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154841489|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
154841490|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841491|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841492|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154841493|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154841494|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154841495|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154841496|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841497|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841498|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
154841499|NCT03704714|Hormones|hormones|mesh-ancestor
154841500|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841501|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154841502|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154841503|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154841504|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
154841505|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
154841506|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
154841507|NCT00661141|Ethanol|ethanol|mesh-list
154841508|NCT00661141|Fomepizole|fomepizole|mesh-list
154841509|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154841510|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841511|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841512|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841513|NCT00661141|Antidotes|antidotes|mesh-ancestor
154841514|NCT00661141|Protective Agents|protective agents|mesh-ancestor
154841515|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841516|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841517|NCT03616574|Trifluridine|trifluridine|mesh-list
154841518|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
154841519|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841520|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
154841521|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841522|NCT00681265|Glycerol|glycerol|mesh-list
154841523|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154841524|NCT00681265|Protective Agents|protective agents|mesh-ancestor
154841525|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841526|NCT01677104|Liraglutide|liraglutide|mesh-list
154841527|NCT01677104|Exenatide|exenatide|mesh-list
154841528|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154841529|NCT01677104|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154841530|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154841531|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841532|NCT01677104|Incretins|incretins|mesh-ancestor
154841533|NCT01677104|Hormones|hormones|mesh-ancestor
154841534|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841535|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154841536|NCT00661453|Valproic Acid|valproic acid|mesh-list
154841537|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
154841538|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841539|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841540|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
154841541|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841542|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021051|NCT02535975|Metformin|metformin|mesh-list
154841543|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
154841544|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154841545|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841546|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154841547|NCT03547622|Galantamine|galantamine|mesh-list
154841548|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154841549|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841550|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841551|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
154841552|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841553|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841554|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154841555|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
154841556|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841557|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
154841558|NCT00681889|Ranibizumab|ranibizumab|mesh-list
154841559|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154841560|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154841561|NCT00681889|Growth Substances|growth substances|mesh-ancestor
154841562|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841563|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154841564|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841565|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
154841566|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154841567|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154841568|NCT00682357|Prednisolone|prednisolone|mesh-list
154841569|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
154841570|NCT00682357|Lidocaine|lidocaine|mesh-list
154841571|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154841572|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
154841573|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
154841574|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
154841575|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841576|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841577|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
154841578|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841579|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154841580|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154841581|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154841582|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841583|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841584|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841585|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
154841586|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
154841587|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154841588|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
154841589|NCT00682357|Hormones|hormones|mesh-ancestor
154841590|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841591|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154841592|NCT00682357|Protective Agents|protective agents|mesh-ancestor
154841593|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154841594|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841595|NCT00662155|Zolpidem|zolpidem|mesh-list
154841596|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154841597|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154841598|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841599|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841600|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154841601|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
154841602|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
154841603|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841604|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841605|NCT03546608|Tepotinib|tepotinib|mesh-list
154841606|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841607|NCT00662545|Tenofovir|tenofovir|mesh-list
154841608|NCT00662545|Lamivudine|lamivudine|mesh-list
154841609|NCT00662545|Emtricitabine|emtricitabine|mesh-list
154021125|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841610|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154841611|NCT00662545|Entecavir|entecavir|mesh-list
154841612|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154841613|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
154841614|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841615|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154841616|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154841617|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841618|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841619|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154841620|NCT03539198|Nivolumab|nivolumab|mesh-list
154841621|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841622|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841623|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154841624|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841625|NCT00663169|Dexamethasone|dexamethasone|mesh-list
154841626|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
154841627|NCT00663169|BB 1101|bb 1101|mesh-list
154841628|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154841629|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841630|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
154841631|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
154841632|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841633|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841634|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154841635|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
154841636|NCT00663169|Hormones|hormones|mesh-ancestor
154841637|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841638|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154841639|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841640|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
154841641|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841642|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841643|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
154841644|NCT00663403|Daptomycin|daptomycin|mesh-list
154841645|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154841646|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841647|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
154841648|NCT00663793|Finasteride|finasteride|mesh-list
154841649|NCT00663793|Testosterone|testosterone|mesh-list
154841650|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
154841651|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
154841652|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154841653|NCT00663793|Acyline|acyline|mesh-list
154841654|NCT00663793|Androgens|androgens|mesh-ancestor
154841655|NCT00663793|Hormones|hormones|mesh-ancestor
154841656|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841657|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841658|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154841659|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841660|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
154841661|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154841662|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154841663|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841664|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841665|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
154841666|NCT00663793|Urological Agents|urological agents|mesh-ancestor
154841667|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154841668|NCT02336438|Cathartics|cathartics|mesh-ancestor
154841669|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154841670|NCT00667615|Prednisone|prednisone|mesh-list
154841671|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
154841672|NCT00667615|Rituximab|rituximab|mesh-list
154841673|NCT00667615|Etoposide|etoposide|mesh-list
154841674|NCT00667615|Vorinostat|vorinostat|mesh-list
154841675|NCT00667615|Lenograstim|lenograstim|mesh-list
154841676|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154841677|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
154841678|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841679|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841680|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154841681|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
154841682|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841683|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841684|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154841685|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841686|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841687|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
154841688|NCT00667615|Hormones|hormones|mesh-ancestor
154841689|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841690|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154841691|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154841692|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154841693|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154841694|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841695|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154841696|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154841697|NCT03683810|Lactoferrin|lactoferrin|mesh-list
154841698|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
154841699|NCT03683810|Hematinics|hematinics|mesh-ancestor
154841700|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841701|NCT01587235|Simvastatin|simvastatin|mesh-list
154841702|NCT01587235|Ezetimibe|ezetimibe|mesh-list
154841703|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154841704|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154841705|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154841706|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
154841707|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841708|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154841709|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154841710|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841711|NCT00705133|Treprostinil|treprostinil|mesh-list
154841712|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154841713|NCT00652717|Simvastatin|simvastatin|mesh-list
154841714|NCT00652717|Ezetimibe|ezetimibe|mesh-list
154841715|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154841716|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154841717|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
154841718|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841719|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154841720|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154841721|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841722|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
154841723|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841724|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
154841725|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154841726|NCT00684775|Naltrexone|naltrexone|mesh-list
154841727|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154841728|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154841729|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841730|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
154841731|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841732|NCT02258451|Everolimus|everolimus|mesh-list
154841733|NCT02258451|Exemestane|exemestane|mesh-list
154841734|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154841735|NCT02258451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154841736|NCT02258451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154841737|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841738|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841739|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154841740|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
154841741|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841742|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841743|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154841744|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154841745|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154841746|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
154841747|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841748|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
154841749|NCT02168270|Temozolomide|temozolomide|mesh-list
154841750|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154841751|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
154841752|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841753|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841754|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
154841755|NCT02168270|Protective Agents|protective agents|mesh-ancestor
154841756|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841757|NCT02168270|Vitamins|vitamins|mesh-ancestor
154841758|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
154841759|NCT00395473|Ezetimibe|ezetimibe|mesh-list
154841760|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154841761|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154841762|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
154021285|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
154841763|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841764|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154841765|NCT00393211|Etoricoxib|etoricoxib|mesh-list
154841766|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841767|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841768|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841769|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154841770|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154841771|NCT00393211|Analgesics|analgesics|mesh-ancestor
154841772|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
154841773|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841774|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841775|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154841776|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154841777|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841778|NCT03676556|Lidocaine|lidocaine|mesh-list
154841779|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
154841780|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
154841781|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841782|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841783|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
154841784|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841785|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154841786|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154841787|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154841788|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841789|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841790|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
154841791|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841792|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
154841793|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
154841794|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
154841795|NCT00269191|Ibuprofen|ibuprofen|mesh-list
154593771|NCT03463967|Lycopene|lycopene|mesh-list
154841796|NCT00269191|Etoricoxib|etoricoxib|mesh-list
154841797|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154841798|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154841799|NCT00269191|Analgesics|analgesics|mesh-ancestor
154841800|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
154841801|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841802|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841803|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841804|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841805|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154841806|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021349|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021362|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841807|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841808|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154841809|NCT00690235|Pramlintide|pramlintide|mesh-list
154841810|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154841811|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841812|NCT00092833|Ezetimibe|ezetimibe|mesh-list
154841813|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154841814|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154841815|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
154841816|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841817|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154841818|NCT01799083|Decitabine|decitabine|mesh-list
154841819|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154841820|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
154841821|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841822|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841823|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841824|NCT01799161|Theophylline|theophylline|mesh-list
154841825|NCT01799161|Vaccines|vaccines|mesh-list
154841826|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
154841827|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841828|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154841829|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
154841830|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841831|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154841832|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
154841833|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154841834|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841835|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841836|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
154841837|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154841838|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154841839|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
154841840|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841841|NCT00006110|Paclitaxel|paclitaxel|mesh-list
154841842|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
154841843|NCT00006110|Doxorubicin|doxorubicin|mesh-list
154841844|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154841845|NCT00006110|Trastuzumab|trastuzumab|mesh-list
154841846|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154841847|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841848|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154841849|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154841850|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154841851|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841852|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154841853|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
154841854|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841855|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841856|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154841857|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
154841858|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154841859|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154841860|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154841861|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154841862|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841863|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841864|NCT00692185|Olanzapine|olanzapine|mesh-list
154841865|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
154841866|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
154021393|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
154841867|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841868|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841869|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154841870|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154841871|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154841872|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154841873|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154841874|NCT00692185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154841875|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154841876|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841877|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841878|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841879|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
154841881|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
154841882|NCT00692341|Axitinib|axitinib|mesh-list
154841883|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841884|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154841885|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841886|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841887|NCT00694603|Cetuximab|cetuximab|mesh-list
154841888|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154841889|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841890|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
154841891|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154841892|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021421|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154841893|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841894|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154841895|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154841896|NCT00590161|Protective Agents|protective agents|mesh-ancestor
154841897|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841898|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
154841899|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154841900|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
154841901|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154841902|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154841903|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841904|NCT00006170|Bupropion|bupropion|mesh-list
154841905|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154841906|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
154841907|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154841908|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154841909|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154841910|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154841911|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841912|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
154841913|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841914|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841915|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154841916|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154841917|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841918|NCT02123849|Aspirin|aspirin|mesh-list
154841919|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154841920|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154841921|NCT02123849|Analgesics|analgesics|mesh-ancestor
154841922|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
154841923|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841924|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841925|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841926|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154841927|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154841928|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154841929|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841930|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154841931|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154841932|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841933|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
154841934|NCT05347160|Calcium|calcium|mesh-list
154841935|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154841936|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841937|NCT00671528|Gentamicins|gentamicins|mesh-list
154841938|NCT00671528|Clotrimazole|clotrimazole|mesh-list
154841939|NCT00671528|Miconazole|miconazole|mesh-list
154841940|NCT00671528|Betamethasone|betamethasone|mesh-list
154841941|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
154841942|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154593910|NCT05103501|Cisplatin|cisplatin|mesh-list
154841943|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
154841944|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154841945|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154841946|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
154841947|NCT00671528|Hormones|hormones|mesh-ancestor
154841948|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154841949|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841950|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154841951|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
154841952|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154841953|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154841954|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154841955|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841956|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841957|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154841958|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
154841959|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154841960|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154841961|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154841962|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
154841963|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154841964|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154841965|NCT00590863|Dexetimide|dexetimide|mesh-list
154841966|NCT00590863|Mirtazapine|mirtazapine|mesh-list
154841967|NCT00590863|Citalopram|citalopram|mesh-list
154841968|NCT00590863|Bupropion|bupropion|mesh-list
154841969|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154841970|NCT00590863|Escitalopram|escitalopram|mesh-list
154841971|NCT00590863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154841972|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154841973|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779038|NCT00254553|Hormones|hormones|mesh-ancestor
154841974|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154841975|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154841976|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
154841977|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154841978|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154841979|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154841980|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
154841981|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
154841982|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154841983|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154841984|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154841985|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
154841986|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154841987|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
154841988|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154841989|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154841990|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
154841991|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154841992|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154841993|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154841994|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154841995|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154841996|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
154841997|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
154841998|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154841999|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154842000|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842001|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154842002|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154842003|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154842004|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
154842005|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154842006|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154842007|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154842008|NCT00591019|Modafinil|modafinil|mesh-list
154842009|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154842010|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842011|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154842012|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154842013|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154860463|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
154842014|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842015|NCT02996695|Artesunate|artesunate|mesh-list
154842016|NCT02996695|Chloroquine|chloroquine|mesh-list
154842017|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
154842018|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154842019|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154842020|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842021|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842022|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
154842023|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
154842024|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154842025|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
154842026|NCT02996695|Amebicides|amebicides|mesh-ancestor
154842027|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154842028|NCT00359138|Cetirizine|cetirizine|mesh-list
154842029|NCT00359138|Loratadine|loratadine|mesh-list
154842030|NCT00359138|Levocetirizine|levocetirizine|mesh-list
154842031|NCT00359138|Desloratadine|desloratadine|mesh-list
154842032|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154842033|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154842034|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
154842035|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
154842036|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842037|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842038|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842039|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154842040|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154842041|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
154842042|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
154842043|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
154842044|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
154842045|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154842046|NCT05503979|Velpatasvir|velpatasvir|mesh-list
154842047|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
154842048|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842049|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
154842050|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154842051|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154842052|NCT00698035|Testosterone|testosterone|mesh-list
154842053|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
154842054|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
154842055|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154842056|NCT00698035|Estradiol|estradiol|mesh-list
154842057|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154842058|NCT00698035|Androgens|androgens|mesh-ancestor
154842059|NCT00698035|Hormones|hormones|mesh-ancestor
154842060|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842061|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021599|NCT02636829|Calcium|calcium|mesh-list
154842062|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154842063|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842064|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
154842065|NCT00698035|Estrogens|estrogens|mesh-ancestor
154842066|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154842067|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
154842068|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154842069|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154842070|NCT02129075|Poly I-C|poly i-c|mesh-list
154842071|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154842072|NCT02129075|Poly ICLC|poly iclc|mesh-list
154842073|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
154842074|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
154842075|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
154842076|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842077|NCT02129075|Laxatives|laxatives|mesh-ancestor
154842078|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842079|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
154842080|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842081|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154842082|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154842083|NCT02129075|Protective Agents|protective agents|mesh-ancestor
154842084|NCT02775903|Azacitidine|azacitidine|mesh-list
154842085|NCT02775903|Durvalumab|durvalumab|mesh-list
154842086|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154842087|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
154842088|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842089|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842090|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021638|NCT04470674|Carboplatin|carboplatin|mesh-list
154842091|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154842092|NCT01933425|Rocuronium|rocuronium|mesh-list
154842093|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154842094|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154842095|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154842096|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842097|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842098|NCT04239599|Leuprolide|leuprolide|mesh-list
154842099|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154842100|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
154842101|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154842102|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842103|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154842104|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842105|NCT03487016|Paclitaxel|paclitaxel|mesh-list
154842106|NCT03487016|Gemcitabine|gemcitabine|mesh-list
154842107|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
154842108|NCT03487016|Irinotecan|irinotecan|mesh-list
154842109|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154842110|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842111|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
154842112|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
154842113|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
154842114|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842115|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154842116|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
154842117|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154842118|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154842119|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842120|NCT05346926|Calpastatin|calpastatin|mesh-list
154842121|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154842122|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
154842123|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842124|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842125|NCT03023319|Pemetrexed|pemetrexed|mesh-list
154842126|NCT03023319|Bosutinib|bosutinib|mesh-list
154842127|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842128|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842129|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842130|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154842131|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154842132|NCT03023319|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154842133|NCT03023319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154842134|NCT02980653|Megestrol|megestrol|mesh-list
154842135|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
154842136|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154842137|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154842138|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154842139|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
154842140|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154842141|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842142|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154842143|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154842144|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154842145|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842146|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
154842147|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154842148|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154842149|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154842150|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842151|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
154842152|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
154842153|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842154|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154842155|NCT03087968|Prednisolone|prednisolone|mesh-list
154842156|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154842157|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
154842158|NCT03087968|Hormones|hormones|mesh-ancestor
154842159|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842160|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842161|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154842162|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842163|NCT03845049|Aflibercept|aflibercept|mesh-list
154842164|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154842165|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154842166|NCT03845049|Growth Substances|growth substances|mesh-ancestor
154842167|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842168|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
154842169|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842170|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154842171|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842172|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842173|NCT03790839|Incretins|incretins|mesh-ancestor
154842174|NCT03790839|Hormones|hormones|mesh-ancestor
154842175|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842176|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154842177|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
154842178|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021709|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154021710|NCT00656643|Sirolimus|sirolimus|mesh-list
154842179|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842180|NCT03088046|Progesterone|progesterone|mesh-list
154842181|NCT03088046|Progestins|progestins|mesh-ancestor
154842182|NCT03088046|Hormones|hormones|mesh-ancestor
154842183|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842184|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842185|NCT01677884|Bevacizumab|bevacizumab|mesh-list
154842186|NCT01677884|Capecitabine|capecitabine|mesh-list
154842187|NCT01677884|Irinotecan|irinotecan|mesh-list
154842188|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154842189|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842190|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154842191|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154842192|NCT01677884|Growth Substances|growth substances|mesh-ancestor
154842193|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842194|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
154842195|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154842196|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
154842197|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842198|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154842199|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154842200|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842201|NCT02124083|Vorinostat|vorinostat|mesh-list
154842202|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842203|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154842204|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842205|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842206|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
154842207|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154842208|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154842209|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842210|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
154842211|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
154842212|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842213|NCT00701389|Sumatriptan|sumatriptan|mesh-list
154842214|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154842215|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154842216|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154842217|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
154842218|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842219|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842220|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842221|NCT02336594|Verinurad|verinurad|mesh-list
154842222|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
154842223|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154842224|NCT01799317|Vitamin D|vitamin d|mesh-list
154842225|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
154842226|NCT01799317|Vitamins|vitamins|mesh-ancestor
154842227|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
154842228|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842229|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154842230|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154842231|NCT01677962|Poly ICLC|poly iclc|mesh-list
154842232|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
154842233|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
154842234|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842235|NCT00595153|Budesonide|budesonide|mesh-list
154842236|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154842237|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154842238|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
154842239|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842240|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842241|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154842242|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
154842243|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
154842244|NCT00595153|Hormones|hormones|mesh-ancestor
154842245|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842246|NCT02995291|Phentolamine|phentolamine|mesh-list
154842247|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154842248|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154842249|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
154842250|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842251|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842252|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842253|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154842254|NCT00595231|Rufinamide|rufinamide|mesh-list
154842255|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
154842256|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154842257|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154842258|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154842259|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842260|NCT02995057|Nickel|nickel|mesh-list
154842261|NCT02995057|Trace Elements|trace elements|mesh-ancestor
154842262|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
154842263|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842264|NCT02474173|Paclitaxel|paclitaxel|mesh-list
154842265|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154842266|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154842267|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842268|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
154842269|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
154842270|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
154842271|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842272|NCT03482102|Durvalumab|durvalumab|mesh-list
154842273|NCT03482102|Tremelimumab|tremelimumab|mesh-list
154842274|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154842275|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842276|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154842277|NCT02402270|Laxatives|laxatives|mesh-ancestor
154842278|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842279|NCT00701935|Exenatide|exenatide|mesh-list
154842280|NCT00701935|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154842281|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842282|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842283|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154842284|NCT00701935|Incretins|incretins|mesh-ancestor
154842285|NCT00701935|Hormones|hormones|mesh-ancestor
154842286|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842287|NCT02984696|Estradiol|estradiol|mesh-list
154842288|NCT02984696|Estrogens|estrogens|mesh-ancestor
154842289|NCT02984696|Hormones|hormones|mesh-ancestor
154842290|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842291|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842292|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154842293|NCT00596167|Vancomycin|vancomycin|mesh-list
154842294|NCT00596167|Levofloxacin|levofloxacin|mesh-list
154842295|NCT00596167|Gentamicins|gentamicins|mesh-list
154842296|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842297|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154842298|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154842299|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154842300|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842301|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842302|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842303|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154842304|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154842305|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154842306|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
154842307|NCT03087032|Liraglutide|liraglutide|mesh-list
154842308|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842309|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842310|NCT03087032|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154842311|NCT03087032|Incretins|incretins|mesh-ancestor
154842312|NCT03087032|Hormones|hormones|mesh-ancestor
154842313|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842314|NCT02994745|Atorvastatin|atorvastatin|mesh-list
154842315|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154842316|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154842317|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
154842318|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842319|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154842320|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154842321|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842322|NCT00703261|Atorvastatin|atorvastatin|mesh-list
154842323|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154842324|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154842325|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
154842326|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842327|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154842328|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154842329|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842330|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
154842331|NCT04346147|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154842332|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154842333|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842334|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842335|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842336|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154842337|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154842338|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
154842339|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
154842340|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
154842341|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842342|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154842343|NCT04200833|Golimumab|golimumab|mesh-list
154842344|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154842345|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154842346|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154842347|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
154842348|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842349|NCT01678352|Imiquimod|imiquimod|mesh-list
154842350|NCT01678352|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154842351|NCT01678352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842352|NCT01678352|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154842353|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
154842354|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842355|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154842356|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842357|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
154842358|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154842359|NCT01678430|Chlorambucil|chlorambucil|mesh-list
154842360|NCT01678430|Ofatumumab|ofatumumab|mesh-list
154842361|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154842362|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
154842363|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842364|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842365|NCT01678664|Doxorubicin|doxorubicin|mesh-list
154842366|NCT01678664|Everolimus|everolimus|mesh-list
154842367|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154842368|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842369|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154842370|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154842371|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842372|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842373|NCT01678664|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154842374|NCT01678664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154842375|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154842376|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
154842377|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842378|NCT00597493|Temozolomide|temozolomide|mesh-list
154842379|NCT00597493|Sorafenib|sorafenib|mesh-list
154842380|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154842381|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
154842382|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842383|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842384|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154842385|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842386|NCT03086954|Immunomodulating Agents|immunomodulating agents|mesh-list
154842387|NCT03086954|Immunologic Factors|immunologic factors|mesh-ancestor
154842388|NCT03086954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842389|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154842391|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
154842392|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021922|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842393|NCT04402112|Pitavastatin|pitavastatin|mesh-list
154842394|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154842395|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154842396|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154842397|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
154842398|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842399|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842400|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154842401|NCT00597727|Glycerol|glycerol|mesh-list
154842402|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154842403|NCT00597727|Protective Agents|protective agents|mesh-ancestor
154842404|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842405|NCT03474770|Huperzine A|huperzine a|mesh-list
154842406|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154842407|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842408|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842409|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
154842410|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842411|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842412|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154842413|NCT03474770|Protective Agents|protective agents|mesh-ancestor
154842414|NCT00707863|Escitalopram|escitalopram|mesh-list
154842415|NCT00707863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154842416|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154842417|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154842418|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842419|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842420|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
154842421|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842422|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154842423|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
154842424|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154842425|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
154842426|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842427|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
154842428|NCT00565643|Protective Agents|protective agents|mesh-ancestor
154842429|NCT00565643|Laxatives|laxatives|mesh-ancestor
154842430|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842431|NCT01798277|Amiodarone|amiodarone|mesh-list
154842432|NCT01798277|Sotalol|sotalol|mesh-list
154842433|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154842434|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
154842435|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154842436|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154842437|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842438|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154842439|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154842440|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154842441|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842442|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154842443|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154842444|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154842445|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154842446|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154842447|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
154842448|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842449|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842450|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
154842451|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
154842452|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842453|NCT00598507|Sagopilone|sagopilone|mesh-list
154842454|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842455|NCT00566813|Exenatide|exenatide|mesh-list
154842456|NCT00566813|Etanercept|etanercept|mesh-list
154842457|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154842458|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154842459|NCT00566813|Analgesics|analgesics|mesh-ancestor
154842460|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
154842461|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842462|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842463|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154842464|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154842465|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842466|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154842467|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
154842468|NCT00566813|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154842469|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842470|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154842471|NCT00566813|Incretins|incretins|mesh-ancestor
154842473|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842474|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
154842475|NCT00088166|Hormones|hormones|mesh-ancestor
154842476|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842477|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842478|NCT00566969|Carvedilol|carvedilol|mesh-list
154842479|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154842480|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154842481|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
154842482|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842483|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842484|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842485|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154842486|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
154842487|NCT00566969|Protective Agents|protective agents|mesh-ancestor
154842488|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154842489|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022015|NCT02630823|Paclitaxel|paclitaxel|mesh-list
154842490|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154842491|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
154842492|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154842493|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154842494|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
154842495|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154842496|NCT03086564|Estrogens|estrogens|mesh-ancestor
154842497|NCT03086564|Hormones|hormones|mesh-ancestor
154842498|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842499|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842500|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154842501|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842502|NCT00598663|Insulin|insulin|mesh-list
154842503|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154842504|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842505|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842506|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
154842507|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
154842508|NCT00704353|Hematinics|hematinics|mesh-ancestor
154842509|NCT00087698|Pemetrexed|pemetrexed|mesh-list
154842510|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842511|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842512|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842513|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154842514|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154842515|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
154842516|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154842517|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842518|NCT03755739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154842519|NCT03755739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842520|NCT05245721|Nalbuphine|nalbuphine|mesh-list
154842521|NCT05245721|Bupivacaine|bupivacaine|mesh-list
154842522|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
154842523|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
154842524|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842525|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842526|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
154842527|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842528|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154842529|NCT05245721|Narcotics|narcotics|mesh-ancestor
154842530|NCT05245721|Analgesics|analgesics|mesh-ancestor
154842531|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
154842532|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
153641932|NCT00084370|Celecoxib|celecoxib|mesh-list
154842533|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154842534|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842535|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842536|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
154842537|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154842538|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842539|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842541|NCT02987985|Dexamethasone|dexamethasone|mesh-list
154842542|NCT02987985|Lidocaine|lidocaine|mesh-list
154842543|NCT02987985|Fentanyl|fentanyl|mesh-list
154842544|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
154842545|NCT02987985|Ketamine|ketamine|mesh-list
154842546|NCT02987985|Gabapentin|gabapentin|mesh-list
154842547|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
154842548|NCT02987985|Ondansetron|ondansetron|mesh-list
154842549|NCT02987985|Sevoflurane|sevoflurane|mesh-list
154842550|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154842551|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
154842552|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
154842553|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842554|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842555|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842556|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
154842557|NCT02987985|Hormones|hormones|mesh-ancestor
154842558|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842559|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154842560|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842561|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
154842562|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
154842563|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842564|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
154842565|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154842566|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154842567|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154842568|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154842569|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842570|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154842571|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154842572|NCT02987985|Analgesics|analgesics|mesh-ancestor
154842573|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154842574|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154842575|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154842576|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
154842577|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842578|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154842579|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154842580|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
154842581|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154842582|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154842583|NCT02987985|Narcotics|narcotics|mesh-ancestor
154842584|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154842585|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
154842586|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154842587|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154842588|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
154842589|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154842590|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154842591|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154842592|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
154842593|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
154842594|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
154842595|NCT02987985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154842596|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154842597|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
154842598|NCT00708721|Clofarabine|clofarabine|mesh-list
154842599|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154842600|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
154842601|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842602|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842603|NCT00087152|Capecitabine|capecitabine|mesh-list
154842604|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
154842605|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154842606|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
154842607|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842608|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842609|NCT00087152|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154842610|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154842611|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842612|NCT05362799|Metformin|metformin|mesh-list
154842613|NCT05362799|Letrozole|letrozole|mesh-list
154842614|NCT05362799|Lactitol|lactitol|mesh-list
154842616|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842617|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842618|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154842619|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154842620|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842621|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842622|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154842623|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
154842624|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842625|NCT05362799|Cathartics|cathartics|mesh-ancestor
154842626|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842627|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
154842628|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154842629|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154842630|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842631|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
154842632|NCT01940523|Coagulants|coagulants|mesh-ancestor
154842633|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
154842634|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154842635|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
154842636|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
154842637|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842638|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842639|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154842640|NCT02994433|Analgesics|analgesics|mesh-ancestor
154842641|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
154842642|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842643|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154842644|NCT04388189|Bupropion|bupropion|mesh-list
154842645|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154842646|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
154842647|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154842648|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154842649|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154842650|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154842651|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842652|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
154842653|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842654|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842655|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154842656|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154842657|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842658|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154842659|NCT04388189|Analgesics|analgesics|mesh-ancestor
154842660|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
154842661|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842662|NCT00599053|Azithromycin|azithromycin|mesh-list
154842663|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154842664|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842665|NCT01941927|Trametinib|trametinib|mesh-list
154842666|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842667|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154842668|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842669|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842670|NCT05220917|Insulin|insulin|mesh-list
154842671|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154842672|NCT05220917|Metformin|metformin|mesh-list
154842673|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
154842674|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
154842675|NCT05220917|Pioglitazone|pioglitazone|mesh-list
154842676|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154842677|NCT05220917|Liraglutide|liraglutide|mesh-list
154842678|NCT05220917|Semaglutide|semaglutide|mesh-list
154842679|NCT05220917|Empagliflozin|empagliflozin|mesh-list
154842680|NCT05220917|Exenatide|exenatide|mesh-list
154842681|NCT05220917|Glimepiride|glimepiride|mesh-list
154842682|NCT05220917|Linagliptin|linagliptin|mesh-list
154842683|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
154842684|NCT05220917|Canagliflozin|canagliflozin|mesh-list
154842685|NCT05220917|Saxagliptin|saxagliptin|mesh-list
154842686|NCT05220917|Alogliptin|alogliptin|mesh-list
154842687|NCT05220917|Dulaglutide|dulaglutide|mesh-list
154842688|NCT05220917|Glyburide|glyburide|mesh-list
154842689|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
154842690|NCT05220917|Glipizide|glipizide|mesh-list
154842691|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
154842692|NCT05220917|Xultophy|xultophy|mesh-list
154842693|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154842694|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154842695|NCT05220917|Simvastatin|simvastatin|mesh-list
154842696|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842697|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842698|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154842699|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154842700|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
154842701|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842702|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154842703|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154842704|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842705|NCT05220917|Incretins|incretins|mesh-ancestor
154842706|NCT05220917|Hormones|hormones|mesh-ancestor
154842707|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842708|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
154842709|NCT05220917|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154842710|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154842711|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154842712|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154842713|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
154842714|NCT00086996|Fluorouracil|fluorouracil|mesh-list
154842715|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
154842716|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
154842717|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842718|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154842719|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842720|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154842721|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
154842722|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842723|NCT01943565|Hydromorphone|hydromorphone|mesh-list
154842724|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842725|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842726|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154842727|NCT01943565|Narcotics|narcotics|mesh-ancestor
154842728|NCT01943565|Analgesics|analgesics|mesh-ancestor
154842729|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
154842730|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842731|NCT03316859|Naloxegol|naloxegol|mesh-list
154842732|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154842733|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842734|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
154842735|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842736|NCT04401878|Lidocaine|lidocaine|mesh-list
154842737|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
154842738|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
154842739|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842740|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842741|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
154842742|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842743|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154842744|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154842745|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154842746|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154842747|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842748|NCT05362019|Norethindrone|norethindrone|mesh-list
154842749|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
154842750|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
154842751|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154842752|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154022272|NCT03555968|Hormones|hormones|mesh-ancestor
154842753|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154842754|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
154842755|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154842756|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842757|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154842758|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154842759|NCT03654105|Aspirin|aspirin|mesh-list
154842760|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154842761|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154842762|NCT03654105|Analgesics|analgesics|mesh-ancestor
154842763|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
154842764|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842765|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842767|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154842768|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154842769|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154842770|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842771|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154842772|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154842773|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842774|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
154842775|NCT04388111|Morphine|morphine|mesh-list
154842776|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154842777|NCT04388111|Narcotics|narcotics|mesh-ancestor
154842778|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842779|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842780|NCT04388111|Analgesics|analgesics|mesh-ancestor
154842781|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
154842782|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842783|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
154842784|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154842785|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842786|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
154842787|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
154842788|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
154842789|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
154842790|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154842791|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842792|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
154842793|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842794|NCT01944423|Cycloserine|cycloserine|mesh-list
154842795|NCT01944423|Nicotine|nicotine|mesh-list
154842796|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154842797|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
154022299|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842798|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842799|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842800|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154842801|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154842802|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
154842803|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842804|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842805|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154842806|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842807|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154842808|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
154842809|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154842810|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
154842811|NCT00600925|Gentamicins|gentamicins|mesh-list
154842812|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154842813|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842814|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154842815|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842816|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842817|NCT02338973|Interferons|interferons|mesh-list
154842818|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
154842819|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842820|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
154842821|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842822|NCT00601627|Gemcitabine|gemcitabine|mesh-list
154842823|NCT00601627|Capecitabine|capecitabine|mesh-list
154842824|NCT00601627|Fluorouracil|fluorouracil|mesh-list
154842825|NCT00601627|Panitumumab|panitumumab|mesh-list
154842826|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154842827|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
154842828|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842829|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842830|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154842831|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
154842832|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842833|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154842834|NCT01947153|Metformin|metformin|mesh-list
154842835|NCT01947153|Linagliptin|linagliptin|mesh-list
154842836|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842837|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842838|NCT01947153|Incretins|incretins|mesh-ancestor
154594810|NCT03436121|Analgesics|analgesics|mesh-ancestor
154842839|NCT01947153|Hormones|hormones|mesh-ancestor
154842840|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842841|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154842842|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
154842843|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842844|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842845|NCT02476409|Tolvaptan|tolvaptan|mesh-list
154842846|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154842847|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842848|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
154842849|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842850|NCT02993575|Floxacillin|floxacillin|mesh-list
154842851|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154842852|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842853|NCT00603187|Acyline|acyline|mesh-list
154842854|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
154842855|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842856|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842857|NCT01886937|Phentermine|phentermine|mesh-list
154842858|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154842859|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842860|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
154842861|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154842862|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
154842863|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
154842864|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842865|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
154842866|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842867|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842868|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
154842869|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154842870|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154842871|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842872|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
154842873|NCT02993341|Coagulants|coagulants|mesh-ancestor
154842874|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
154842875|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
154842876|NCT02987907|Dexamethasone|dexamethasone|mesh-list
154842877|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154842878|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
154842879|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
154842880|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842881|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842882|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842883|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
154842884|NCT02987907|Hormones|hormones|mesh-ancestor
154842885|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842886|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154842887|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842888|NCT01887171|Tacrolimus|tacrolimus|mesh-list
154842889|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154842890|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
154842891|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842892|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154842893|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842894|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842895|NCT00713479|Varenicline|varenicline|mesh-list
154842896|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154842897|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154842898|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
154842899|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842900|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842901|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842902|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
154842903|NCT04402580|Rituximab|rituximab|mesh-list
154022404|NCT05344742|Paclitaxel|paclitaxel|mesh-list
154842904|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154842905|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842906|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
154842907|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842908|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154842909|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154842910|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154842911|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
154842912|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154842913|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594889|NCT03431285|Narcotics|narcotics|mesh-ancestor
154842914|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842915|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842916|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
154842917|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842918|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842920|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
154842921|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842922|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842923|NCT04385719|Remdesivir|remdesivir|mesh-list
154842924|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
154842925|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842926|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
154842927|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154842928|NCT00082628|Hormones|hormones|mesh-list
154842929|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842930|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842931|NCT01275859|Letrozole|letrozole|mesh-list
154842932|NCT01275859|Lapatinib|lapatinib|mesh-list
154842933|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154842934|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154842935|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154842936|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842937|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842938|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154842939|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
154842940|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154842941|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842942|NCT01275859|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154842943|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154842944|NCT01950039|Betaine|betaine|mesh-list
154842945|NCT01950039|Glycine|glycine|mesh-list
154842946|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
154842947|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842948|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842949|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842950|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842951|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
154842952|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154842953|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
154842954|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154842955|NCT01275937|Esomeprazole|esomeprazole|mesh-list
154842956|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154842957|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154842958|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154842959|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842960|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842961|NCT02990455|Nicotine|nicotine|mesh-list
154842962|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154842963|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
154842964|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842965|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842966|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154842967|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154842968|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
154842969|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842970|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842971|NCT01889667|Insulin|insulin|mesh-list
154842972|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154842973|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154842974|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842975|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
154842976|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154842977|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154842978|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154842979|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154842980|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842981|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
154842982|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154842983|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154842984|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154842985|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154842986|NCT02130635|Nemiralisib|nemiralisib|mesh-list
154842987|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154842988|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154842989|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842991|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154842992|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
154842993|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154842994|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154842995|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154842996|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154842997|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154842998|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154842999|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843000|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154843001|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154843002|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154843003|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
154843004|NCT00557973|Baclofen|baclofen|mesh-list
154843005|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154843006|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843007|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154843008|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843009|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154843010|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
154843011|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
154843012|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843013|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843014|NCT00726739|Aldesleukin|aldesleukin|mesh-list
154843015|NCT00726739|Interleukin-2|interleukin-2|mesh-list
154843016|NCT00726739|Vaccines|vaccines|mesh-list
154843017|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
154843018|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843019|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843020|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154843021|NCT00726739|Analgesics|analgesics|mesh-ancestor
154843022|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
154022530|NCT00614978|Temozolomide|temozolomide|mesh-list
154843023|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843024|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154843025|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154843026|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
154843027|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843028|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154843029|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
154843030|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843031|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
154843032|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154843033|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154843034|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
154843035|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843036|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843037|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843038|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154843039|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
154843040|NCT02991781|Varenicline|varenicline|mesh-list
154843041|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154843042|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154843043|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
154843044|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843045|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843046|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843047|NCT01893801|Paclitaxel|paclitaxel|mesh-list
154843048|NCT01893801|Cisplatin|cisplatin|mesh-list
154843049|NCT01893801|Gemcitabine|gemcitabine|mesh-list
154843050|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154843051|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843052|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
154843053|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
154843054|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
154843055|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843056|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154843057|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
154843058|NCT00570089|Ranolazine|ranolazine|mesh-list
154843059|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154843060|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595062|NCT02412878|Hormones|hormones|mesh-ancestor
154843061|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843063|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
154843064|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154843065|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154843066|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843067|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843068|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
154843069|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843070|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154843071|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154843072|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154843073|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154843074|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154843075|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154843076|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154843077|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154843078|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
154843079|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154843080|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154843081|NCT00571259|Gentamicins|gentamicins|mesh-list
154843082|NCT00571259|Heparin|heparin|mesh-list
154843083|NCT00571259|Citric Acid|citric acid|mesh-list
154843084|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
154843085|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
154843086|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154843087|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
154843088|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
154843089|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843090|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154843091|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154843092|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154843093|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843094|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154843095|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843096|NCT01893879|Ketoprofen|ketoprofen|mesh-list
154843097|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154843098|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154843099|NCT01893879|Analgesics|analgesics|mesh-ancestor
154843100|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
154843101|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843102|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843103|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843104|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154843105|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154843106|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843107|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843108|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
154843109|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843110|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
154843111|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154843112|NCT00571961|Ritonavir|ritonavir|mesh-list
154843113|NCT00571961|Lopinavir|lopinavir|mesh-list
154843114|NCT00571961|Buprenorphine|buprenorphine|mesh-list
154843115|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154843116|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154843117|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
154843118|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843119|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843120|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154843121|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154843122|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
154843123|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843124|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154843125|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154843126|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154843127|NCT00571961|Narcotics|narcotics|mesh-ancestor
154843128|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843129|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843130|NCT00571961|Analgesics|analgesics|mesh-ancestor
154843131|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
154843132|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843133|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154843134|NCT00572117|Topiramate|topiramate|mesh-list
154843135|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
154843136|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154843137|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843138|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
154843139|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154843140|NCT01895127|Antibodies|antibodies|mesh-list
154843141|NCT01895127|Eculizumab|eculizumab|mesh-list
154843142|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
154843143|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843144|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154843145|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154843146|NCT01953081|Metoclopramide|metoclopramide|mesh-list
154843147|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
154843148|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
154843149|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843150|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843151|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154843152|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154843153|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154843154|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
154843155|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843156|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843157|NCT00572897|Fludarabine|fludarabine|mesh-list
154843158|NCT00572897|Melphalan|melphalan|mesh-list
154843159|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843160|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843161|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154843162|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
154843163|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843164|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154843165|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
154843166|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154843167|NCT01276717|Vorinostat|vorinostat|mesh-list
154843168|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843169|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154843170|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843171|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843172|NCT02991157|Nimodipine|nimodipine|mesh-list
154843173|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154843174|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154843175|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154843176|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843177|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154843178|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843179|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
154843180|NCT04386499|Folic Acid|folic acid|mesh-list
154843181|NCT04386499|Resveratrol|resveratrol|mesh-list
154843182|NCT04386499|Hematinics|hematinics|mesh-ancestor
154843183|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
154843184|NCT04386499|Vitamins|vitamins|mesh-ancestor
154843185|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
154843186|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843187|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
154843188|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843189|NCT04386499|Protective Agents|protective agents|mesh-ancestor
154843190|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843191|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154843192|NCT00573287|Risperidone|risperidone|mesh-list
154843193|NCT00573287|Clozapine|clozapine|mesh-list
154843194|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154843195|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
154843196|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843197|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843198|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843199|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154843200|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154843201|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843202|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154843203|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154843204|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
154843205|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
154843206|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
154843207|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
154843208|NCT01896921|Dolutegravir|dolutegravir|mesh-list
154843209|NCT01896921|Maraviroc|maraviroc|mesh-list
154843210|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154843211|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154843212|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
154843213|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843214|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154843215|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154843216|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843217|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843218|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154843219|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154843220|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154843221|NCT00749749|Bupivacaine|bupivacaine|mesh-list
154843222|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
154843223|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
154843224|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843225|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843226|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
154843227|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843228|NCT02991937|Tazobactam|tazobactam|mesh-list
154843229|NCT02991937|Piperacillin|piperacillin|mesh-list
154843230|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154843231|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154843232|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843233|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154843234|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843235|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843236|NCT00420667|Enoxaparin|enoxaparin|mesh-list
154843237|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
154843238|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154843239|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154843240|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843241|NCT01277107|Zaleplon|zaleplon|mesh-list
154843242|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
154843243|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154843244|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843245|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843246|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
154843247|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
154843248|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843249|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843250|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
154843251|NCT01277185|Calcium|calcium|mesh-list
154843252|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154843253|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843254|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154843255|NCT01274533|Lenalidomide|lenalidomide|mesh-list
154843256|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
154022773|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154843257|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843258|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154843259|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154843260|NCT01274533|Growth Substances|growth substances|mesh-ancestor
154843261|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
154843262|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843263|NCT01277497|Calcium|calcium|mesh-list
154843264|NCT01277497|Sevelamer|sevelamer|mesh-list
154843265|NCT01277497|Calcium acetate|calcium acetate|mesh-list
154843266|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154843267|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843268|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
154843269|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
154843270|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843271|NCT01270087|Adalimumab|adalimumab|mesh-list
154843272|NCT01270087|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154843273|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843274|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154843275|NCT01958073|Estradiol|estradiol|mesh-list
154843276|NCT01958073|Estrogens|estrogens|mesh-list
154843277|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154843278|NCT01958073|Hormones|hormones|mesh-ancestor
154843279|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843280|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843281|NCT01270165|Telbivudine|telbivudine|mesh-list
154843282|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
154843283|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843284|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154595255|NCT03441529|Tazobactam|tazobactam|mesh-list
154843285|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843286|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843288|NCT05740215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843289|NCT05740215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843290|NCT05740215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843291|NCT05740215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843292|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
154843293|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154843294|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154843295|NCT01277731|Prednisolone|prednisolone|mesh-list
154843296|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
154843297|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154843298|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
154843299|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843300|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
154843301|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
154022803|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154843302|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843303|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843304|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154843305|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
154843306|NCT01277731|Hormones|hormones|mesh-ancestor
154843307|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843308|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154843309|NCT01277731|Protective Agents|protective agents|mesh-ancestor
154843310|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154843311|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843312|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154843313|NCT00751777|Vaccines|vaccines|mesh-list
154843314|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
154843315|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843316|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154843317|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
154843318|NCT01902459|Coagulants|coagulants|mesh-ancestor
154843319|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
154843320|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154843321|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154843322|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154843323|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154843324|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843325|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
154843326|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843327|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843328|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154022851|NCT00906347|Misoprostol|misoprostol|mesh-list
154843329|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843330|NCT05735145|Paclitaxel|paclitaxel|mesh-list
154843331|NCT05735145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154843332|NCT05735145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154843333|NCT05735145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843334|NCT05735145|Tubulin Modulators|tubulin modulators|mesh-ancestor
154843335|NCT05735145|Antimitotic Agents|antimitotic agents|mesh-ancestor
154843336|NCT05735145|Mitosis Modulators|mitosis modulators|mesh-ancestor
154843337|NCT05735145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843338|NCT01903005|Buprenorphine|buprenorphine|mesh-list
154843339|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154843340|NCT01903005|Naloxone|naloxone|mesh-list
154843341|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154843342|NCT01903005|Narcotics|narcotics|mesh-ancestor
154843343|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843344|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843345|NCT01903005|Analgesics|analgesics|mesh-ancestor
154843346|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
154843347|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843348|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154843349|NCT00614029|Sumatriptan|sumatriptan|mesh-list
154022878|NCT00616070|Difluprednate|difluprednate|mesh-list
154843350|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154843351|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154843352|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154843353|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
154843354|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843355|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843356|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843357|NCT01905423|Albendazole|albendazole|mesh-list
154843358|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
154843359|NCT01905423|Piperazine|piperazine|mesh-list
154843360|NCT01905423|Mebendazole|mebendazole|mesh-list
154843361|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
154843362|NCT01905423|Citric Acid|citric acid|mesh-list
154843363|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
154843364|NCT01905423|DMP 777|dmp 777|mesh-list
154843365|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
154843366|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154843367|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
154843368|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
154843369|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843370|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
154843371|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154843372|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843373|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
154843374|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154843375|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154843376|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
154843377|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
154843378|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
154843379|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843380|NCT01905423|Filaricides|filaricides|mesh-ancestor
154843381|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
154843382|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154843383|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843384|NCT05734911|Niraparib|niraparib|mesh-list
154843385|NCT05734911|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154843386|NCT05734911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843387|NCT05734911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843388|NCT05734911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843389|NCT01906515|Chrysarobin|chrysarobin|mesh-list
154843390|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154843391|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154843392|NCT01906515|Analgesics|analgesics|mesh-ancestor
154843393|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
154843394|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843395|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843396|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843397|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154843398|NCT00730483|Doxorubicin|doxorubicin|mesh-list
154843399|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154843400|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154843401|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843402|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154843403|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154843404|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843405|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843406|NCT01907607|Palbociclib|palbociclib|mesh-list
154843407|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843408|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843409|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843410|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843412|NCT00753337|Trace Elements|trace elements|mesh-ancestor
154843413|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
154843414|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843415|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
154843416|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154843417|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
154843418|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
154843419|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843420|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843421|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154843422|NCT01911351|Analgesics|analgesics|mesh-ancestor
154843423|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
154843424|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843425|NCT04385407|Ribavirin|ribavirin|mesh-list
154843426|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
154843427|NCT04385407|Simeprevir|simeprevir|mesh-list
154843428|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
154843429|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843430|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
154843431|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843432|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
154843433|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843434|NCT00573989|Pemetrexed|pemetrexed|mesh-list
154843435|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154843436|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843437|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843438|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843439|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154843440|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154843441|NCT00573989|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154843442|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843443|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
154843444|NCT02286921|Testosterone|testosterone|mesh-list
154843445|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
154843446|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
154022973|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
154843447|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154843448|NCT02286921|Androgens|androgens|mesh-ancestor
154843449|NCT02286921|Hormones|hormones|mesh-ancestor
154843450|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843451|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843452|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154843453|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843454|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
154843455|NCT00574067|Buprenorphine|buprenorphine|mesh-list
154843456|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154843457|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154843458|NCT00574067|Narcotics|narcotics|mesh-ancestor
154843459|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843460|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843461|NCT00574067|Analgesics|analgesics|mesh-ancestor
154843462|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
154843463|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843464|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154843465|NCT01913535|Aticaprant|aticaprant|mesh-list
154843466|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154843467|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843468|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
154843469|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843470|NCT01914159|Ranibizumab|ranibizumab|mesh-list
154843471|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154843472|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154843473|NCT01914159|Growth Substances|growth substances|mesh-ancestor
154843474|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843475|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
154843476|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843477|NCT00576251|Tobramycin|tobramycin|mesh-list
154843478|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154843479|NCT00576251|Dexamethasone|dexamethasone|mesh-list
154843480|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843481|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
154843482|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
154843483|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843484|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843485|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154843486|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
154843487|NCT00576251|Hormones|hormones|mesh-ancestor
154843488|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843489|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154843490|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843491|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154843492|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843493|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154843494|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154843495|NCT00578279|Ethanol|ethanol|mesh-list
154843496|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154843497|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843498|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843499|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843500|NCT00578669|Fluoxetine|fluoxetine|mesh-list
154843501|NCT00578669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154843502|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154843503|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154843504|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843505|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023024|NCT04214054|Calcium|calcium|mesh-list
154843506|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
154843507|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843508|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154843509|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
154843510|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154843511|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154595475|NCT03435289|Gemcitabine|gemcitabine|mesh-list
154843512|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154843513|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843514|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
154843515|NCT00578903|Methotrexate|methotrexate|mesh-list
154843516|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
154843517|NCT00578903|Tacrolimus|tacrolimus|mesh-list
154843518|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154843519|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
154843520|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843521|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154843522|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154843523|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
154843524|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843525|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843526|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154843527|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154843528|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
154843529|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154843530|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154843531|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
154843532|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154843533|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843534|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154843535|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154843536|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154843537|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154843538|NCT01918761|Pemetrexed|pemetrexed|mesh-list
154843539|NCT01918761|Dacomitinib|dacomitinib|mesh-list
154843540|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843541|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843542|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843543|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154843544|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154843545|NCT01918761|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154843546|NCT01918761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843547|NCT00579137|Fludarabine|fludarabine|mesh-list
154843548|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
154843549|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843550|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154843551|NCT00580073|Leucovorin|leucovorin|mesh-list
154843552|NCT00580073|Fluorouracil|fluorouracil|mesh-list
154843553|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
154843554|NCT00580073|Cetuximab|cetuximab|mesh-list
154843555|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
154843556|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023074|NCT00618644|Ranibizumab|ranibizumab|mesh-list
154843557|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154843558|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843559|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154843560|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
154843561|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843562|NCT00580073|Antidotes|antidotes|mesh-ancestor
154843563|NCT00580073|Protective Agents|protective agents|mesh-ancestor
154843564|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
154843565|NCT00580073|Vitamins|vitamins|mesh-ancestor
154843566|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
154843567|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154843568|NCT00580151|Clonidine|clonidine|mesh-list
154843569|NCT00580151|Analgesics|analgesics|mesh-ancestor
154843570|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
154843571|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843572|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843573|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154843574|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
154843575|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
154843576|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154843577|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154843578|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154023100|NCT00907517|Cytarabine|cytarabine|mesh-list
154843579|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
154843580|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843581|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843582|NCT01919697|Plecanatide|plecanatide|mesh-list
154843583|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154843584|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
154843585|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843586|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154843587|NCT00580229|Prednisone|prednisone|mesh-list
154843588|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843589|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
154843590|NCT00580229|Hormones|hormones|mesh-ancestor
154843591|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843592|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843593|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154843594|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843595|NCT00580853|Bupropion|bupropion|mesh-list
154843596|NCT00580853|Varenicline|varenicline|mesh-list
154843597|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154843598|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
154176598|NCT00845351|Bexarotene|bexarotene|mesh-list
154843599|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154843600|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154843601|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154843602|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154843603|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843604|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
154843605|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843606|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843607|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154843608|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154843609|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843610|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154843611|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154843612|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
154843613|NCT05739045|Nivolumab|nivolumab|mesh-list
154843614|NCT05739045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154843615|NCT05739045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843616|NCT05739045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154843617|NCT05739045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843618|NCT00604019|Dopamine|dopamine|mesh-list
154843619|NCT00604019|Norepinephrine|norepinephrine|mesh-list
154843620|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154843621|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154843622|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
154843623|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843624|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843625|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843626|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
154843627|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
154843628|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843629|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154843630|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154843631|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
154843632|NCT00604019|Protective Agents|protective agents|mesh-ancestor
154843633|NCT01922115|Trospium chloride|trospium chloride|mesh-list
154843634|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
154843635|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
154843636|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843637|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843638|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154843639|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154843640|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
154843641|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843642|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843643|NCT01922115|Urological Agents|urological agents|mesh-ancestor
154843644|NCT00081770|Ribavirin|ribavirin|mesh-list
154843645|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154843646|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
154843647|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154843648|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
154843649|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843650|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
154843651|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843652|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
154843653|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843654|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154843655|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843656|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
154843657|NCT00605423|Hormones|hormones|mesh-ancestor
154843658|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023165|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154843659|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843660|NCT01923129|Prazosin|prazosin|mesh-list
154843661|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154843662|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154843663|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154843664|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154843665|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
154843666|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843667|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843668|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843669|NCT00581867|Insulin|insulin|mesh-list
154843670|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154843671|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
154843672|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154843673|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843674|NCT01925469|Benzocaine|benzocaine|mesh-list
154843675|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
154843676|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
154843677|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843678|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843679|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
154023197|NCT00618696|Antibodies|antibodies|mesh-list
154843680|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843681|NCT01925781|Nicotine|nicotine|mesh-list
154843682|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154843683|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
154843684|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843685|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843686|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154843687|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154843688|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
154843689|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843690|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843691|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154843692|NCT01927887|Hematinics|hematinics|mesh-ancestor
154843693|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154843694|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154843695|NCT00081458|Teduglutide|teduglutide|mesh-list
154843696|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154843697|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154843698|NCT00081458|Protective Agents|protective agents|mesh-ancestor
154843699|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843700|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
154843701|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
154843702|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
154843703|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843704|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843705|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154843706|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154843707|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154843708|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843709|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154843710|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154843711|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
154843712|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843713|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843714|NCT01929291|Vaccines|vaccines|mesh-list
154843715|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
154843716|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843717|NCT01929759|Tenofovir|tenofovir|mesh-list
154843718|NCT01929759|Emtricitabine|emtricitabine|mesh-list
154843719|NCT01929759|Cobicistat|cobicistat|mesh-list
154843720|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154843721|NCT01929759|Elvitegravir|elvitegravir|mesh-list
154843722|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
154843723|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843724|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154843725|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154843726|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843727|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843728|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154843729|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154843730|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154843731|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154843732|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154843733|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
154843734|NCT03437330|Empagliflozin|empagliflozin|mesh-list
154843735|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154843736|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843737|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154843738|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843739|NCT01271803|Vemurafenib|vemurafenib|mesh-list
154843740|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843741|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843742|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843743|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843744|NCT00585377|Bevacizumab|bevacizumab|mesh-list
154843745|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154843746|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154843747|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843748|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154843749|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154843750|NCT00585377|Growth Substances|growth substances|mesh-ancestor
154843751|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843752|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
154843753|NCT00585377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154843754|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843755|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843756|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843758|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154843759|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843760|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154843761|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154843762|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154843763|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843764|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
154843765|NCT03084380|Fludarabine|fludarabine|mesh-list
154843766|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154843767|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
154843768|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843769|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154843770|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154843771|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
154843772|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843773|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843774|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154843775|NCT00084344|Afimoxifene|afimoxifene|mesh-list
154843776|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843777|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154843778|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
154843779|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843780|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843781|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154843782|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154843783|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
154843784|NCT00611897|Ketamine|ketamine|mesh-list
154843785|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154843786|NCT00611897|Analgesics|analgesics|mesh-ancestor
154843787|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
154843788|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843789|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843790|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154843791|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154843792|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
154843793|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
154843794|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843795|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154843796|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154843797|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843798|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843799|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
154843800|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843801|NCT00611897|Expectorants|expectorants|mesh-ancestor
154843802|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
154843803|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154843804|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
154843805|NCT00611897|Protective Agents|protective agents|mesh-ancestor
154843806|NCT00611897|Antidotes|antidotes|mesh-ancestor
154843807|NCT03080324|Fentanyl|fentanyl|mesh-list
154843808|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154843809|NCT03080324|Narcotics|narcotics|mesh-ancestor
154595777|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
154843810|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843811|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843813|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
154843814|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843815|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154843816|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154843817|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
154843818|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
154843819|NCT03083834|Cosyntropin|cosyntropin|mesh-list
154843820|NCT03083834|Hormones|hormones|mesh-ancestor
154843821|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843822|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843823|NCT02780609|Dexamethasone|dexamethasone|mesh-list
154843824|NCT02780609|Melphalan|melphalan|mesh-list
154843825|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
154843826|NCT02780609|Aprepitant|aprepitant|mesh-list
154843827|NCT02780609|Antiemetics|antiemetics|mesh-list
154843828|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843829|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
154843830|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843831|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843832|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154843833|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
154843834|NCT02780609|Hormones|hormones|mesh-ancestor
154843835|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843836|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154843837|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843838|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154843839|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
154843840|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843841|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154843842|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154843843|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
154843844|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154843845|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843846|NCT03086096|Irinotecan|irinotecan|mesh-list
154843847|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154843848|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154843849|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843850|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843851|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843852|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154843853|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154843854|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154843855|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843856|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843857|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154843858|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154843859|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154843860|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154843861|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
154843862|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843863|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843864|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154843865|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154843866|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
154843867|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154843868|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154843869|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
154843870|NCT05346146|Paclitaxel|paclitaxel|mesh-list
154843871|NCT05346146|Gemcitabine|gemcitabine|mesh-list
154843872|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154843873|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843874|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
154843875|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
154843876|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
154843877|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843878|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154843879|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
154843880|NCT00613379|Leronlimab|leronlimab|mesh-list
154843881|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
154843882|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154843883|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154843884|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023405|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843885|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154843886|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154843887|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
154843888|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843889|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
154843890|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843891|NCT01271725|Paclitaxel|paclitaxel|mesh-list
154843892|NCT01271725|Vinorelbine|vinorelbine|mesh-list
154843893|NCT01271725|Afatinib|afatinib|mesh-list
154843894|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154843895|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843896|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
154843897|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
154843898|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
154843899|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843900|NCT01271725|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154843901|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843902|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843903|NCT00587483|Lidocaine|lidocaine|mesh-list
154843904|NCT00587483|Amiodarone|amiodarone|mesh-list
154843905|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
154843906|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
154023424|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154843907|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154843908|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843909|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
154843910|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843911|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154843912|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154843913|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154843914|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154843915|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843916|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
154843917|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154843918|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154843919|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154843920|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843921|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154843922|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154843923|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154843924|NCT03401060|Denosumab|denosumab|mesh-list
154843925|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154843926|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843927|NCT01270321|Everolimus|everolimus|mesh-list
154843928|NCT01270321|Pasireotide|pasireotide|mesh-list
154843929|NCT01270321|Somatostatin|somatostatin|mesh-list
154843930|NCT01270321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154843931|NCT01270321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843932|NCT01270321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843933|NCT01270321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843934|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154843935|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
154843936|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843937|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843938|NCT01270321|Hormones|hormones|mesh-ancestor
154843939|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154843940|NCT01271023|Insulin|insulin|mesh-list
154843941|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154843942|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843943|NCT03086486|Linezolid|linezolid|mesh-list
154843944|NCT03086486|Bedaquiline|bedaquiline|mesh-list
154843945|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154843946|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154843947|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154843948|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843949|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843950|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
154843951|NCT02287779|Volixibat|volixibat|mesh-list
154843952|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154843953|NCT00732901|Escitalopram|escitalopram|mesh-list
154843954|NCT00732901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154843955|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154843956|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860464|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154843957|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843958|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154843959|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
154843960|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843961|NCT03083210|Lanreotide|lanreotide|mesh-list
154843962|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843963|NCT00616109|Sunitinib|sunitinib|mesh-list
154843964|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843965|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154843966|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154843967|NCT00616109|Growth Substances|growth substances|mesh-ancestor
154843968|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843969|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
154843970|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154843971|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154843972|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843973|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154843974|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
154843975|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843976|NCT00249769|Vaccines|vaccines|mesh-list
154843977|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
154843978|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843979|NCT03837873|Cytarabine|cytarabine|mesh-list
154843980|NCT03837873|Dexamethasone|dexamethasone|mesh-list
154843981|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
154843982|NCT03837873|Rituximab|rituximab|mesh-list
154843983|NCT03837873|Doxorubicin|doxorubicin|mesh-list
154843984|NCT03837873|Etoposide|etoposide|mesh-list
154843985|NCT03837873|Vincristine|vincristine|mesh-list
154843986|NCT03837873|Lenalidomide|lenalidomide|mesh-list
154843987|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154843988|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
154843989|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154843990|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154843991|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154843992|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
154843993|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154843994|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154843995|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154843996|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154843997|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154843998|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
154843999|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
154844000|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844001|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154844002|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
154844003|NCT03837873|Hormones|hormones|mesh-ancestor
154844004|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844005|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154844006|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154844007|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154844008|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154844009|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844010|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154844011|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154844012|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
154844013|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
154844014|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844015|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
154844016|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
154844017|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
154844018|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154844019|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154844020|NCT03837873|Growth Substances|growth substances|mesh-ancestor
154844021|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
154844022|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154844023|NCT03082742|Furosemide|furosemide|mesh-list
154844024|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154844025|NCT03082742|Diuretics|diuretics|mesh-ancestor
154844026|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
154844027|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023537|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154844028|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154844029|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154844030|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844031|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154844032|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
154844033|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154844034|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154844035|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844036|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
154844037|NCT05434533|Coagulants|coagulants|mesh-ancestor
154844038|NCT03432650|Dexamethasone|dexamethasone|mesh-list
154844039|NCT03432650|Bupivacaine|bupivacaine|mesh-list
154844040|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844041|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
154844042|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
154844043|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844044|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844045|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154844046|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
154844047|NCT03432650|Hormones|hormones|mesh-ancestor
154844048|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844049|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154844050|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844051|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
154844052|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
154844053|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844054|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
154844055|NCT00248833|Vaccines|vaccines|mesh-list
154844056|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
154844057|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844058|NCT00668525|Dexetimide|dexetimide|mesh-list
154844059|NCT00668525|Citalopram|citalopram|mesh-list
154844060|NCT00668525|Escitalopram|escitalopram|mesh-list
154844061|NCT00668525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154844062|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154844063|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154844064|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844065|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844066|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
154844067|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844068|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154844069|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154844070|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
154844071|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
154844072|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844073|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154844074|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154844075|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
154844076|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154844077|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
154844078|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844079|NCT05688488|Curcumin|curcumin|mesh-list
154844080|NCT05688488|Mitomycins|mitomycins|mesh-list
154844081|NCT05688488|Mitomycin|mitomycin|mesh-list
154844082|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154844083|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844084|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
154844085|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844086|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154844087|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844088|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154844089|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154844090|NCT05688488|Analgesics|analgesics|mesh-ancestor
154844091|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
154844092|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844093|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844094|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154023610|NCT00880074|Alovudine|alovudine|mesh-list
154844095|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154844096|NCT00669383|Betamethasone|betamethasone|mesh-list
154844097|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844098|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
154844099|NCT00669383|Hormones|hormones|mesh-ancestor
154844100|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844101|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844102|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154844103|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
154844104|NCT00733993|Caffeine|caffeine|mesh-list
154844105|NCT00733993|Amphetamine|amphetamine|mesh-list
154844106|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154844107|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844108|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154844109|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844110|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844111|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154844112|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154844113|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
154844114|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844115|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
154844116|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
154844117|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844118|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
154023637|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
154023638|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844119|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
154844120|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154844121|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154844122|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154844123|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154844124|NCT01271257|Misoprostol|misoprostol|mesh-list
154844125|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154844126|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
154844127|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154844128|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844129|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154844130|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154844131|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
154844132|NCT03082352|Metoprolol|metoprolol|mesh-list
154844133|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154844134|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154844135|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
154844136|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
154844137|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844138|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844139|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154844140|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154844141|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154844142|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
154844143|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844144|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844145|NCT04768491|Dacomitinib|dacomitinib|mesh-list
154844146|NCT04768491|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154844147|NCT04768491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154844148|NCT04768491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844149|NCT04768491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844150|NCT03398252|Doxazosin|doxazosin|mesh-list
154844151|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154844152|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154844153|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154844154|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154844155|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
154844156|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844157|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844158|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844159|NCT02285283|Itraconazole|itraconazole|mesh-list
154844160|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
154844161|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844162|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154844163|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154844164|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844165|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844166|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154844167|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
154844168|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844169|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844170|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154844171|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
154844172|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154844173|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
154844174|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844175|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
154844176|NCT03429140|Protective Agents|protective agents|mesh-ancestor
154844177|NCT03081494|Spartalizumab|spartalizumab|mesh-list
154844178|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154844179|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844180|NCT03081494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154844181|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844182|NCT03081728|Acetaminophen|acetaminophen|mesh-list
154844183|NCT03081728|Diclofenac|diclofenac|mesh-list
154844184|NCT03081728|Ropivacaine|ropivacaine|mesh-list
154844185|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
154844186|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
154844187|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844188|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844189|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
154844190|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844191|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154844192|NCT03081728|Analgesics|analgesics|mesh-ancestor
154844193|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
154844194|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154844195|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844196|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154844197|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154844198|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844199|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844200|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154844201|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844202|NCT00618917|Manganese|manganese|mesh-list
154844203|NCT00618917|Paclitaxel|paclitaxel|mesh-list
154844204|NCT00618917|Carboplatin|carboplatin|mesh-list
154844205|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
154844206|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154844207|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844208|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
154844209|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
154844210|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
154844211|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844212|NCT00618917|Trace Elements|trace elements|mesh-ancestor
154844213|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
154844214|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844215|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154844216|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
154844217|NCT00618917|Protective Agents|protective agents|mesh-ancestor
154844218|NCT05736081|Dexamethasone|dexamethasone|mesh-list
154844219|NCT05736081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844220|NCT05736081|Antiemetics|antiemetics|mesh-ancestor
154844221|NCT05736081|Autonomic Agents|autonomic agents|mesh-ancestor
154844222|NCT05736081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844223|NCT05736081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844224|NCT05736081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154844225|NCT05736081|Glucocorticoids|glucocorticoids|mesh-ancestor
154844226|NCT05736081|Hormones|hormones|mesh-ancestor
154844227|NCT05736081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844228|NCT05736081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154844229|NCT05736081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844230|NCT00619073|Aspirin|aspirin|mesh-list
154844231|NCT00619073|Clopidogrel|clopidogrel|mesh-list
154844232|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154844233|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154844234|NCT00619073|Analgesics|analgesics|mesh-ancestor
154844235|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
154844236|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844237|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844238|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844239|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154844240|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154844241|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154844242|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844243|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154844244|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154844245|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844246|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
154844247|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154844248|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154844249|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154844250|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
154844251|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844252|NCT00670241|Betamethasone|betamethasone|mesh-list
154844253|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
154844254|NCT00670241|Calcipotriene|calcipotriene|mesh-list
154844255|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844256|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
154844258|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844259|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844260|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154844261|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
154844262|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
154844263|NCT03088670|Metformin|metformin|mesh-list
154844264|NCT03088670|Vildagliptin|vildagliptin|mesh-list
154844265|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154844266|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844267|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154844268|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
154844269|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844270|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844271|NCT03088358|Enoxaparin|enoxaparin|mesh-list
154844272|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
154844273|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154844274|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154844275|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844276|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154844277|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154844278|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154844279|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844280|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844281|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844282|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154844283|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154844284|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154844285|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
154844286|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844287|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844288|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154844289|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154844290|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
154844291|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154023813|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154844292|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154844293|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
154844294|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
154844295|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154844296|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154844297|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154844298|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844299|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844300|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844301|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154844302|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
154844303|NCT00621179|Leuprolide|leuprolide|mesh-list
154844304|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154844305|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
154844306|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154844307|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844308|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154844309|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844310|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
154844311|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
154844312|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154844313|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154023838|NCT00423995|Loratadine|loratadine|mesh-list
154844314|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844315|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154844316|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844317|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154844318|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154844319|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
154844320|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154844321|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
154844322|NCT00622895|Fludarabine|fludarabine|mesh-list
154844323|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
154844324|NCT00622895|Tacrolimus|tacrolimus|mesh-list
154844325|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844326|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154844327|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
154844328|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844330|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
154844331|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844332|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154844333|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844334|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154844335|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154844336|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
154844337|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154844338|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844339|NCT00672737|Remifentanil|remifentanil|mesh-list
154844340|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154844341|NCT00672737|Narcotics|narcotics|mesh-ancestor
154844342|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844343|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844344|NCT00672737|Analgesics|analgesics|mesh-ancestor
154844345|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
154844346|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844347|NCT00673127|Ketoconazole|ketoconazole|mesh-list
154844348|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
154844349|NCT00673127|Dutasteride|dutasteride|mesh-list
154844350|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844351|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
154844352|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844353|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154844354|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154844355|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844356|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844357|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154844358|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
154844359|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844360|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844361|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154023891|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844362|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154844363|NCT00246259|Risperidone|risperidone|mesh-list
154844364|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
154844365|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154844366|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
154844367|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844368|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844369|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844370|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154844371|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844372|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844373|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154844374|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
154844375|NCT00673439|PENTA|penta|mesh-list
154844376|NCT00673439|Warfarin|warfarin|mesh-list
154844377|NCT00673439|Fondaparinux|fondaparinux|mesh-list
154844378|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
154844379|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154844380|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
154844381|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154844382|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
154844383|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844384|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844385|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154844386|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154844387|NCT03316118|Bupivacaine|bupivacaine|mesh-list
154844388|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
154844389|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
154844390|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844391|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844392|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
154844393|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844394|NCT03029013|Apatinib|apatinib|mesh-list
154844395|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844396|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154844397|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844398|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844399|NCT00674219|Memantine|memantine|mesh-list
154844400|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154844401|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154844402|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
154844403|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844404|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844405|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844406|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154844407|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154844408|NCT00246025|Dabigatran|dabigatran|mesh-list
154844409|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
154844410|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154844411|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
154844412|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844413|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844414|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
154844415|NCT03311594|Ethanol|ethanol|mesh-list
154844416|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154844417|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844418|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844419|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844420|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154844421|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
154844422|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154844423|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154844424|NCT00624923|Analgesics|analgesics|mesh-ancestor
154844425|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
154844426|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844427|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844428|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844429|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154844430|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154844431|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844432|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844433|NCT05593653|Suvorexant|suvorexant|mesh-list
154023952|NCT02688738|Doxycycline|doxycycline|mesh-list
154844434|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154844435|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154844436|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844437|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844438|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154844439|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844440|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844441|NCT00735787|Adalimumab|adalimumab|mesh-list
154844442|NCT00735787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154844443|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844444|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154844445|NCT00628589|Loxapine|loxapine|mesh-list
154844446|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154844447|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154844448|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844449|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844450|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844451|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154844452|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
154844453|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844454|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844455|NCT01271569|Fospropofol|fospropofol|mesh-list
154844456|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154844457|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844458|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844459|NCT05686772|Dopamine|dopamine|mesh-list
154844460|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154844461|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
154844462|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
154844463|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844464|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844465|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
154844466|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844467|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844468|NCT05686772|Protective Agents|protective agents|mesh-ancestor
154844469|NCT04771871|Paclitaxel|paclitaxel|mesh-list
154844470|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
154844471|NCT04771871|Carboplatin|carboplatin|mesh-list
154844472|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154844473|NCT04771871|Epirubicin|epirubicin|mesh-list
154844474|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154844475|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844476|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
154844477|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
154844478|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
154844479|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844480|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154844481|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
154844482|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844483|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154844484|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154844485|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
154844486|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154844487|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154844488|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154844489|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154844490|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844491|NCT04386577|Vitamin D|vitamin d|mesh-list
154844492|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
154844493|NCT04386577|Vitamins|vitamins|mesh-ancestor
154844494|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
154844495|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844496|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154844497|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154844498|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
154844499|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154844500|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154844501|NCT04270669|Growth Substances|growth substances|mesh-ancestor
154844502|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844503|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
154844504|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844505|NCT05680454|Vaccines|vaccines|mesh-list
154844506|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
154844507|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844508|NCT04928703|Ketamine|ketamine|mesh-list
154844509|NCT04928703|Analgesics|analgesics|mesh-ancestor
154844510|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
154844511|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844512|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844513|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154844514|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154844515|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
154844516|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
154844517|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844518|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154844519|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154844520|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844521|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844522|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
154844523|NCT04278950|Povidone|povidone|mesh-list
154844524|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
154844525|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
154844526|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154844527|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844528|NCT00755755|Iron|iron|mesh-list
154844529|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
154844530|NCT00755755|Trace Elements|trace elements|mesh-ancestor
154844531|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
154844532|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844533|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154844534|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
154844535|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154844536|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154844537|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
154844538|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154844539|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844540|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154844541|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844542|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154844543|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
154844544|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844545|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154844546|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154844547|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844548|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844549|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154844550|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
154844551|NCT00755911|Coagulants|coagulants|mesh-ancestor
154596534|NCT04640571|Cathartics|cathartics|mesh-ancestor
154844552|NCT00737737|Morphine|morphine|mesh-list
154024072|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154844553|NCT00737737|Oxycodone|oxycodone|mesh-list
154844554|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154844555|NCT00737737|Narcotics|narcotics|mesh-ancestor
154844556|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844557|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844558|NCT00737737|Analgesics|analgesics|mesh-ancestor
154844559|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
154844560|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844561|NCT00245011|Ifosfamide|ifosfamide|mesh-list
154844562|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
154844563|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844564|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154844565|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
154844566|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844567|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844568|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154844569|NCT00245011|Analgesics|analgesics|mesh-ancestor
154844570|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
154844571|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844572|NCT00629525|Everolimus|everolimus|mesh-list
154844573|NCT00629525|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154844574|NCT00629525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154844575|NCT00629525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844576|NCT00629525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844577|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154844578|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
154844579|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844580|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844581|NCT00244855|Dexamethasone|dexamethasone|mesh-list
154844582|NCT00244855|Rituximab|rituximab|mesh-list
154844583|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154844584|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844585|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
154844586|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844587|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154844588|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844589|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
154844590|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
154844591|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844592|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154844593|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
154844594|NCT00244855|Hormones|hormones|mesh-ancestor
154844595|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844596|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154844597|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
154844598|NCT00737893|Hematinics|hematinics|mesh-ancestor
154844599|NCT00631319|Hydromorphone|hydromorphone|mesh-list
154844600|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154844601|NCT00631319|Narcotics|narcotics|mesh-ancestor
154844602|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844603|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844604|NCT00631319|Analgesics|analgesics|mesh-ancestor
154844605|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
154844606|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844607|NCT00244621|Candesartan|candesartan|mesh-list
154844608|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
154844609|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154844610|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154844611|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154844612|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844613|NCT00680225|Ranibizumab|ranibizumab|mesh-list
154844614|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154844615|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154844616|NCT00680225|Growth Substances|growth substances|mesh-ancestor
154844617|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844618|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
154844619|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844620|NCT04603391|Cannabidiol|cannabidiol|mesh-list
154844621|NCT04603391|Methylphenidate|methylphenidate|mesh-list
154844622|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154844623|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844624|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154844625|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154844626|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860465|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844627|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844628|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
154844629|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844630|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
154844632|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154844633|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844634|NCT02291133|Bleomycin|bleomycin|mesh-list
154844635|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154844636|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844637|NCT00680459|Ethanol|ethanol|mesh-list
154844638|NCT00680459|Heparin|heparin|mesh-list
154844639|NCT00680459|Anticoagulants|anticoagulants|mesh-list
154844640|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154844641|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154844642|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844643|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154844644|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844645|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844646|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844647|NCT00632411|Nicotine|nicotine|mesh-list
154844648|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154844649|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
154844650|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844651|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844652|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154844653|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154844654|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
154844655|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024182|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
154844656|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844657|NCT00632489|Capecitabine|capecitabine|mesh-list
154844658|NCT00632489|Lapatinib|lapatinib|mesh-list
154844659|NCT00632489|Panobinostat|panobinostat|mesh-list
154844660|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154844661|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
154844662|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844663|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844664|NCT00632489|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154844665|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154844666|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844667|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154844668|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
154844669|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
154844670|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844671|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
154844672|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844673|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844674|NCT01798979|Midazolam|midazolam|mesh-list
154844675|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154844676|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154844677|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844678|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844679|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154844680|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154844681|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844682|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154844683|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
154844684|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
154844685|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
154844686|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
154844687|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844688|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844689|NCT00738361|Paclitaxel|paclitaxel|mesh-list
154844690|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154844691|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154844692|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844693|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
154844694|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
154844695|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
154844696|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844697|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154844698|NCT01279213|Clozapine|clozapine|mesh-list
154844699|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154844700|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154844701|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844702|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844703|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844704|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154844705|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154844706|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
154844707|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844708|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844709|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154844710|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154844711|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
154844712|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
154844713|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
154844714|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154844715|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154844716|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154844717|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154844718|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844719|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024239|NCT02685306|Paclitaxel|paclitaxel|mesh-list
154844720|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844721|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154844722|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
154844723|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154844724|NCT01279291|Paclitaxel|paclitaxel|mesh-list
154844725|NCT01279291|Carboplatin|carboplatin|mesh-list
154844726|NCT01279291|Gemcitabine|gemcitabine|mesh-list
154844727|NCT01279291|Doxorubicin|doxorubicin|mesh-list
154844728|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154844729|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154844730|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844731|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
154844732|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
154844733|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
154844734|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844735|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154844736|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
154844737|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154844738|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154844739|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154844740|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844741|NCT04367883|Amantadine|amantadine|mesh-list
154844742|NCT04367883|Histamine Antagonists|histamine antagonists|mesh-list
154844743|NCT04367883|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154844744|NCT04367883|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154844745|NCT04367883|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154844746|NCT04367883|Antiviral Agents|antiviral agents|mesh-ancestor
154844747|NCT04367883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844748|NCT04367883|Dopamine Agents|dopamine agents|mesh-ancestor
154844749|NCT04367883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844750|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844751|NCT04367883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844752|NCT04367883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154844753|NCT04367883|Analgesics|analgesics|mesh-ancestor
154844754|NCT04367883|Sensory System Agents|sensory system agents|mesh-ancestor
154844755|NCT04367883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844756|NCT04367883|Histamine Agents|histamine agents|mesh-ancestor
154844757|NCT04329039|Somatostatin|somatostatin|mesh-list
154844758|NCT04329039|Hormones|hormones|mesh-ancestor
154844759|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844760|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844761|NCT00635609|Doxycycline|doxycycline|mesh-list
154844762|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154844763|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844764|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
154844765|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154844766|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154844767|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
154844768|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154844769|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154844770|NCT05315336|Antibodies|antibodies|mesh-list
154844771|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
154844772|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844773|NCT04746495|Eplerenone|eplerenone|mesh-list
154844774|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154844775|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
154596757|NCT03406819|Nitroprusside|nitroprusside|mesh-list
154024292|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844776|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844777|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844778|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154844780|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
154844781|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154844782|NCT03347786|Verapamil|verapamil|mesh-list
154844783|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154844784|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154844785|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154844786|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844787|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154844788|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844789|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
154844790|NCT03286634|Cytarabine|cytarabine|mesh-list
154844791|NCT03286634|Prednisolone|prednisolone|mesh-list
154844792|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
154844793|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
154844794|NCT03286634|Methotrexate|methotrexate|mesh-list
154844795|NCT03286634|Vincristine|vincristine|mesh-list
154844796|NCT03286634|Daunorubicin|daunorubicin|mesh-list
154844797|NCT03286634|Asparaginase|asparaginase|mesh-list
154844798|NCT03286634|Epirubicin|epirubicin|mesh-list
154844799|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
154844800|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154844801|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
154844802|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844803|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154844804|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154844805|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
154844806|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844807|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844808|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154844809|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154844810|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
154844811|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154844812|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154844813|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
154844814|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
154844815|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844816|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154844817|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154844818|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
154844819|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844820|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154844821|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
154844822|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
154844823|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
154844824|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844825|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
154844826|NCT03286634|Hormones|hormones|mesh-ancestor
154844827|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154844828|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154024352|NCT04182828|Lidocaine|lidocaine|mesh-list
154844829|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154844830|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154844831|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154844832|NCT00637247|Gemcitabine|gemcitabine|mesh-list
154844833|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154844834|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
154844835|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844836|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844837|NCT04998032|Metformin|metformin|mesh-list
154844838|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154844839|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844840|NCT04388033|Temozolomide|temozolomide|mesh-list
154844841|NCT04388033|Interleukin-12|interleukin-12|mesh-list
154844842|NCT04388033|Vaccines|vaccines|mesh-list
154844843|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
154844844|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844845|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154844846|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
154844847|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844848|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844849|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154596831|NCT05168059|Clevidipine|clevidipine|mesh-list
154844850|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154844851|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154844852|NCT04388033|Growth Substances|growth substances|mesh-ancestor
154844853|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
154844854|NCT02980731|Venetoclax|venetoclax|mesh-list
154844855|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844856|NCT04725591|Insulin|insulin|mesh-list
154844857|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154844858|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844859|NCT02980497|Ethanol|ethanol|mesh-list
154844860|NCT02980497|Listerine|listerine|mesh-list
154844861|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154844862|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
154844863|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154844864|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844865|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844866|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
154844867|NCT02980497|Protective Agents|protective agents|mesh-ancestor
154844868|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
154844869|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154844870|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
154844871|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844872|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844873|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154844874|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
154844875|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154844876|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
154844877|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844878|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844879|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154844880|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
154844881|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
154844882|NCT02652429|Protective Agents|protective agents|mesh-ancestor
154844883|NCT02294253|Buprenorphine|buprenorphine|mesh-list
154844884|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154844885|NCT02294253|Naloxone|naloxone|mesh-list
154844886|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154844887|NCT02294253|Narcotics|narcotics|mesh-ancestor
154844888|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844889|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844890|NCT02294253|Analgesics|analgesics|mesh-ancestor
154844891|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
154844892|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844893|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154844894|NCT00684983|Capecitabine|capecitabine|mesh-list
154844895|NCT00684983|Lapatinib|lapatinib|mesh-list
154844896|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154844897|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154844898|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
154844899|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844900|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024426|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
154844901|NCT00684983|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154844902|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154844903|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844904|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
154844905|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844906|NCT00638651|Imiquimod|imiquimod|mesh-list
154844907|NCT00638651|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154844908|NCT00638651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844909|NCT00638651|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154844910|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
154844911|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844912|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154844913|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844914|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
154844915|NCT00685139|Zonisamide|zonisamide|mesh-list
154844916|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
154844917|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154844918|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154844919|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844920|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154844921|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844922|NCT00685295|Fentanyl|fentanyl|mesh-list
154844923|NCT00685295|Oxycodone|oxycodone|mesh-list
154024445|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844924|NCT00685295|Lansoprazole|lansoprazole|mesh-list
154596902|NCT03397537|Letrozole|letrozole|mesh-list
154844925|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
154844926|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154844927|NCT00685295|Narcotics|narcotics|mesh-ancestor
154844928|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844929|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844930|NCT00685295|Analgesics|analgesics|mesh-ancestor
154844931|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
154844932|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844933|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154844934|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154844935|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
154844936|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
154844937|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154844938|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154844939|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154844940|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844941|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844942|NCT00686231|Lidocaine|lidocaine|mesh-list
154844943|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
154844944|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
154844945|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
154844946|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154844947|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844948|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
154844949|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154844950|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154844951|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154844952|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154844953|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154844954|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844955|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
154844956|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154844957|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154844958|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844959|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
154844960|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154844961|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154844962|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154844963|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154844964|NCT03335540|Nivolumab|nivolumab|mesh-list
154844965|NCT03335540|Ipilimumab|ipilimumab|mesh-list
154844966|NCT03335540|Relatlimab|relatlimab|mesh-list
154844967|NCT03335540|Linrodostat|linrodostat|mesh-list
154844968|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154844969|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844970|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154844971|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844972|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844973|NCT00643097|Temozolomide|temozolomide|mesh-list
154844974|NCT00643097|Sargramostim|sargramostim|mesh-list
154844975|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154844976|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
154844977|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844978|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154844979|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
154844980|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844981|NCT03333668|Guanfacine|guanfacine|mesh-list
154844982|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154844983|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154844984|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154844985|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154844986|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154024512|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
154844987|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154844988|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154844989|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
154844990|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154844991|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154844992|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154844993|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154844994|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154844995|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
154844996|NCT03280160|Ofatumumab|ofatumumab|mesh-list
154596972|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154844997|NCT03280160|Ibrutinib|ibrutinib|mesh-list
154844998|NCT03280160|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154844999|NCT03280160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154845000|NCT03280160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845001|NCT03280160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845002|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845003|NCT05502146|Norepinephrine|norepinephrine|mesh-list
154845004|NCT05502146|Bupivacaine|bupivacaine|mesh-list
154845005|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
154845006|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
154845007|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845008|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845009|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
154845010|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845011|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154845012|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845013|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845014|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845015|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845016|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
154845017|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
154845018|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154845019|NCT04027361|Amphetamine|amphetamine|mesh-list
154845020|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154845021|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845022|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
154845023|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
154845024|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845025|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
154845026|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845027|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845028|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845029|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154845030|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154845031|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845032|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154845033|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
154845034|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
154845035|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
154845036|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845037|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845038|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
154845039|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845041|NCT03793439|Tofacitinib|tofacitinib|mesh-list
154845042|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845043|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
154845044|NCT03793439|Hormones|hormones|mesh-ancestor
154845045|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845046|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845047|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154845048|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845049|NCT03793439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154845050|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154845051|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845052|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845053|NCT00687167|Zonisamide|zonisamide|mesh-list
154845054|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
154845055|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154845056|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845057|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845058|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154845059|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845060|NCT00687713|Bupropion|bupropion|mesh-list
154845061|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154845062|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
154845063|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154845064|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154845065|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154845066|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845067|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845068|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
154845069|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845070|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845071|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154845072|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154845073|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845074|NCT02304159|Ribavirin|ribavirin|mesh-list
154845075|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
154845076|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
154845077|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845078|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
154845079|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154845080|NCT02143973|Nalbuphine|nalbuphine|mesh-list
154845081|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154845082|NCT02143973|Narcotics|narcotics|mesh-ancestor
154845083|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845084|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845085|NCT02143973|Analgesics|analgesics|mesh-ancestor
154845086|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
154845087|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845088|NCT03028701|Budesonide|budesonide|mesh-list
154845089|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
154845090|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845091|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154845092|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
154845093|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845094|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845095|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154845096|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
154845097|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
154845098|NCT03028701|Hormones|hormones|mesh-ancestor
154845099|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845100|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154845101|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154845102|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845103|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
154024629|NCT02842931|Prednisone|prednisone|mesh-list
154845104|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845105|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845106|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
154845107|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154845108|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
154845109|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845110|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845111|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154845112|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
154845113|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154845114|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
154845115|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845116|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845117|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154845118|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
154845119|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
154845120|NCT02267655|Protective Agents|protective agents|mesh-ancestor
154845121|NCT04858958|Aflutinib|aflutinib|mesh-list
154845122|NCT04858958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154845123|NCT04858958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845124|NCT04858958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845125|NCT00690833|Desonide|desonide|mesh-list
154845126|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845127|NCT00644657|Clopidogrel|clopidogrel|mesh-list
154845128|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154845129|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154845130|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154845131|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154845132|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
154845133|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845134|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845135|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845136|NCT04613024|Topiramate|topiramate|mesh-list
154845137|NCT04613024|Gabapentin|gabapentin|mesh-list
154845138|NCT04613024|Analgesics|analgesics|mesh-ancestor
154845139|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
154845140|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845141|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845142|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
154845143|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154845144|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154845145|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845146|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154845147|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154845148|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154845149|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845150|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845151|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
154845152|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154845153|NCT01933815|Bevacizumab|bevacizumab|mesh-list
154845154|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154845155|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845156|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154845157|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154845158|NCT01933815|Growth Substances|growth substances|mesh-ancestor
154845159|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845160|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
154845161|NCT03480971|Tempol|tempol|mesh-list
154845162|NCT03480971|TEMPO|tempo|mesh-list
154845163|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
154845164|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845165|NCT03480971|Protective Agents|protective agents|mesh-ancestor
154845166|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845167|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154845168|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845169|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154845170|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154845171|NCT00646763|Lenograstim|lenograstim|mesh-list
154845172|NCT00646763|Sargramostim|sargramostim|mesh-list
154845173|NCT00646763|Mitogens|mitogens|mesh-list
154845174|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154845175|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
154845176|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845177|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
154845178|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845179|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
154845180|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154845181|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845182|NCT03237572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154845183|NCT03237572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845184|NCT02986347|Epinephrine|epinephrine|mesh-list
154845185|NCT02986347|Racepinephrine|racepinephrine|mesh-list
154845186|NCT02986347|Anesthetics|anesthetics|mesh-list
154845187|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
154845188|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845189|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845190|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154845191|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845192|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845193|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845194|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845195|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154845196|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154845197|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
154845198|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845199|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154845200|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
154845201|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
154845202|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
154845203|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154845204|NCT00649961|Melatonin|melatonin|mesh-list
154845205|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
154845206|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845207|NCT00649961|Protective Agents|protective agents|mesh-ancestor
154845208|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845209|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845210|NCT01781637|Omalizumab|omalizumab|mesh-list
154845211|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154845212|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154845213|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
154845214|NCT00652145|Mesalamine|mesalamine|mesh-list
154845215|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154845216|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845217|NCT00652145|Analgesics|analgesics|mesh-ancestor
154845218|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
154845219|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597197|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845220|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845221|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845222|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154845223|NCT03231722|Leucovorin|leucovorin|mesh-list
154845224|NCT03231722|Fluorouracil|fluorouracil|mesh-list
154845225|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
154845226|NCT03231722|Irinotecan|irinotecan|mesh-list
154845227|NCT03231722|Panitumumab|panitumumab|mesh-list
154845228|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
154845229|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
154845230|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845231|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154845232|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845233|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154845234|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
154845235|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845236|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154845237|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154845238|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845239|NCT03231722|Antidotes|antidotes|mesh-ancestor
154845240|NCT03231722|Protective Agents|protective agents|mesh-ancestor
154845241|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
154845242|NCT03231722|Vitamins|vitamins|mesh-ancestor
154845243|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
154845244|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154845245|NCT02298933|Eculizumab|eculizumab|mesh-list
154845246|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154845247|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154845248|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
154024751|NCT00896051|Tenofovir|tenofovir|mesh-list
154845249|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845250|NCT02959775|Vaccines|vaccines|mesh-list
154845251|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
154845252|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845253|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154845254|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
154845255|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845256|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154845257|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154845258|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154845259|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154845260|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845261|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845262|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845263|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845264|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845265|NCT00693719|Irinotecan|irinotecan|mesh-list
154845266|NCT00693719|Etoposide|etoposide|mesh-list
154845267|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154845268|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154845269|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845270|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845271|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845272|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154845273|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154845274|NCT00653861|Lidocaine|lidocaine|mesh-list
154845275|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
154845276|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
154024796|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
154845277|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845278|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845279|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
154845280|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845281|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154845282|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154845283|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154845284|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845285|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845286|NCT00654329|Fentanyl|fentanyl|mesh-list
154845287|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
154845288|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154845289|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845290|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845291|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845292|NCT00654329|Analgesics|analgesics|mesh-ancestor
154845293|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
154845294|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845295|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154845296|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154845297|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845298|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845299|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845300|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845301|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154845302|NCT00654329|Narcotics|narcotics|mesh-ancestor
154845303|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154845304|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154845305|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
154845306|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
154845307|NCT00695435|Tobramycin|tobramycin|mesh-list
154845308|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154845309|NCT00695435|Dexamethasone|dexamethasone|mesh-list
154845310|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154845311|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845312|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
154845313|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
154845314|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845315|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845316|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845317|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
154845318|NCT00695435|Hormones|hormones|mesh-ancestor
154845319|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845320|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154845321|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845322|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154845323|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154845324|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154845325|NCT00654953|Gabapentin|gabapentin|mesh-list
154845326|NCT00654953|Sertraline|sertraline|mesh-list
154845327|NCT00654953|Analgesics|analgesics|mesh-ancestor
154845328|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
154845329|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845330|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845331|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
154845332|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154845333|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154845334|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845335|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154845336|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154845337|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154845338|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845339|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845340|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
154845341|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
154845342|NCT00654953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154845343|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154845344|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845345|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
154845346|NCT01790165|Terbinafine|terbinafine|mesh-list
154845347|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
154845348|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154845349|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845350|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845351|NCT02299089|Octreotide|octreotide|mesh-list
154845352|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845353|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154845354|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845355|NCT00655811|Capsaicin|capsaicin|mesh-list
154845356|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
154845357|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154845358|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
154845359|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596955|NCT01865500|Budesonide|budesonide|mesh-list
154845360|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845361|NCT03931551|Trastuzumab|trastuzumab|mesh-list
154845362|NCT03931551|Olaparib|olaparib|mesh-list
154845363|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154845364|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845365|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154845366|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845367|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845368|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154860466|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
154845369|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154845370|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154845371|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845372|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845373|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845374|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845375|NCT00696293|Analgesics|analgesics|mesh-ancestor
154845376|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
154845377|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845378|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
154845379|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154845380|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
154845381|NCT00696449|Adapalene|adapalene|mesh-list
154845382|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154024911|NCT05314764|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154845383|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845384|NCT00696449|Analgesics|analgesics|mesh-ancestor
154845385|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
154845386|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845387|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845388|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845389|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154845390|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
154845391|NCT00696761|Alfuzosin|alfuzosin|mesh-list
154845392|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154845393|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154845394|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154845395|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845396|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845397|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845398|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845399|NCT00696761|Urological Agents|urological agents|mesh-ancestor
154845400|NCT00656201|Progesterone|progesterone|mesh-list
154845401|NCT00656201|Progestins|progestins|mesh-ancestor
154845402|NCT00656201|Hormones|hormones|mesh-ancestor
154845403|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845404|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845405|NCT00759291|Acipimox|acipimox|mesh-list
154845406|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154845407|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
154845408|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845409|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154845410|NCT00756405|Antioxidants|antioxidants|mesh-list
154845411|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845412|NCT00756405|Protective Agents|protective agents|mesh-ancestor
154845413|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845414|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154845415|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154845416|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154845417|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154845418|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154845419|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154845420|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845421|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845422|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845423|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845424|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845425|NCT03889275|Durvalumab|durvalumab|mesh-list
154024970|NCT02670954|Tramadol|tramadol|mesh-list
154845426|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154845427|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845428|NCT00657917|Gentamicins|gentamicins|mesh-list
154845429|NCT00657917|Paromomycin|paromomycin|mesh-list
154845430|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154845431|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154845432|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154845433|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845434|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845435|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154845436|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154845437|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
154845438|NCT01959945|Vaccines|vaccines|mesh-list
154845439|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
154845440|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845441|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
154597427|NCT03398993|Clomiphene|clomiphene|mesh-list
154845442|NCT01959945|Coagulants|coagulants|mesh-ancestor
154845443|NCT00700661|Montelukast|montelukast|mesh-list
154845444|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154845445|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
154845446|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154845447|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
154845448|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845449|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845450|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154845451|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154845452|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845453|NCT00652847|Ezetimibe|ezetimibe|mesh-list
154845454|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154845455|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154845456|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
154845457|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845458|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154845459|NCT00652301|Simvastatin|simvastatin|mesh-list
154845460|NCT00652301|Ezetimibe|ezetimibe|mesh-list
154845461|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154845462|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154845463|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
154845464|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845465|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154845466|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154845467|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845468|NCT01961271|Buprenorphine|buprenorphine|mesh-list
154845469|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154845470|NCT01961271|Narcotics|narcotics|mesh-ancestor
154845471|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845472|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845473|NCT01961271|Analgesics|analgesics|mesh-ancestor
154845474|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
154845475|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845476|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154845477|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
154845478|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154845479|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154845480|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
154845481|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845482|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154845483|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154845484|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845485|NCT01963845|Incretins|incretins|mesh-ancestor
154845486|NCT01963845|Hormones|hormones|mesh-ancestor
154845487|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845488|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154845489|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
154845490|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845491|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845492|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154845493|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154845494|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154845495|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154845496|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845497|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845498|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845499|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845500|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845501|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
154845502|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154845503|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
154845504|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845505|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845506|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154845507|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845508|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
154845509|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154845510|NCT04575584|Molnupiravir|molnupiravir|mesh-list
154845511|NCT04575584|Antiviral Agents|antiviral agents|mesh-ancestor
154845512|NCT04575584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154845513|NCT04277702|Montelukast|montelukast|mesh-list
154845514|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154845515|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
154845516|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154845517|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
154845518|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845519|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845520|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154845521|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154845522|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845523|NCT00699491|Sirolimus|sirolimus|mesh-list
154845524|NCT00699491|Temsirolimus|temsirolimus|mesh-list
154845525|NCT00699491|MTOR Inhibitors|mtor inhibitors|mesh-list
154845526|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154845527|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154845528|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154845529|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154845530|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845531|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
154845532|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154845533|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
154845534|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845535|NCT00699491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154845536|NCT00699491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845537|NCT00699491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845538|NCT03721965|Prednisone|prednisone|mesh-list
154845539|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
154845540|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845541|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
154845542|NCT03721965|Hormones|hormones|mesh-ancestor
154845543|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845544|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845545|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154845546|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845547|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
154845548|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
154845549|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845550|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845551|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154845552|NCT03721965|Protective Agents|protective agents|mesh-ancestor
154845553|NCT04399148|Ketotifen|ketotifen|mesh-list
154845554|NCT04399148|Aprepitant|aprepitant|mesh-list
154845555|NCT04399148|Desloratadine|desloratadine|mesh-list
154845556|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
154845557|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
154845558|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845559|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845560|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845561|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154845562|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845563|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845564|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154845565|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
154845566|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154845567|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154845568|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
154845569|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
154845570|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
154845571|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
154845572|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154845573|NCT04672382|Morphine|morphine|mesh-list
154845574|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154845575|NCT04672382|Narcotics|narcotics|mesh-ancestor
154845576|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845577|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845578|NCT04672382|Analgesics|analgesics|mesh-ancestor
154845579|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
154845580|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845581|NCT00699803|Prednisone|prednisone|mesh-list
154845582|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
154845583|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154845584|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
154845585|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154845586|NCT00699803|Prednisolone|prednisolone|mesh-list
154845587|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154845588|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
154597575|NCT02421263|Psilocybin|psilocybin|mesh-list
154845589|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845590|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
154845591|NCT00699803|Hormones|hormones|mesh-ancestor
154845592|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845593|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845594|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154845595|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845596|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
154845597|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
154845598|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845599|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845600|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154845601|NCT00699803|Protective Agents|protective agents|mesh-ancestor
154845602|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
154845603|NCT01967433|Promethazine|promethazine|mesh-list
154845604|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154845605|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154845606|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845607|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845608|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
154845609|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
154845610|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
154845611|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845612|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
154845613|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
154845614|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845615|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154845616|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
154845617|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
154845618|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845619|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845620|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154845621|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
154845622|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
154845623|NCT00551447|Simvastatin|simvastatin|mesh-list
154845624|NCT00551447|Ezetimibe|ezetimibe|mesh-list
154845625|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154845626|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154845627|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
154845628|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845629|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154845630|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154845631|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845632|NCT01968057|Cyclosporine|cyclosporine|mesh-list
154845633|NCT01968057|Cyclosporins|cyclosporins|mesh-list
154845634|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845635|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845636|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154845637|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
154845638|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845639|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
154845640|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154845641|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
154845642|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154845643|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154845644|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
154845645|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
154845646|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154845647|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154845648|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845649|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154845650|NCT00658697|Bevacizumab|bevacizumab|mesh-list
154845651|NCT00658697|Docetaxel|docetaxel|mesh-list
154845652|NCT00658697|Bicalutamide|bicalutamide|mesh-list
154845653|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154845654|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845655|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154845656|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154845657|NCT00658697|Growth Substances|growth substances|mesh-ancestor
154845658|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845659|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
154845660|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
154845661|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
154845662|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
154845663|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845664|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
154845665|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
154860467|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154845666|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845668|NCT03873116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154845669|NCT03873116|Protease Inhibitors|protease inhibitors|mesh-ancestor
154845670|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845671|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845672|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
154845673|NCT04399226|Ketamine|ketamine|mesh-list
154845674|NCT04399226|Propofol|propofol|mesh-list
154845675|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154845676|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845677|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845678|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845679|NCT04399226|Analgesics|analgesics|mesh-ancestor
154845680|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
154845681|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845682|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154845683|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154845684|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845685|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845686|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845687|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845688|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154845689|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
154845690|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
154845691|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154845692|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154845693|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154845694|NCT00659165|Insulin|insulin|mesh-list
154845695|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154845696|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
154845697|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
154845698|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154845699|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845700|NCT00542087|Diclofenac|diclofenac|mesh-list
154845701|NCT00542087|Etoricoxib|etoricoxib|mesh-list
154845702|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154845703|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845704|NCT00542087|Analgesics|analgesics|mesh-ancestor
154845705|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
154845706|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845707|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845708|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845709|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154845710|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154845711|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845712|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845713|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154845714|NCT00541697|Atorvastatin|atorvastatin|mesh-list
154845715|NCT00541697|Simvastatin|simvastatin|mesh-list
154845716|NCT00541697|Ezetimibe|ezetimibe|mesh-list
154845717|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154845718|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154845719|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
154845720|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845721|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154845722|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154845723|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845724|NCT03223376|Paclitaxel|paclitaxel|mesh-list
154845725|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154845726|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154845727|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845728|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
154845729|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
154845730|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
154025250|NCT04173858|Naloxegol|naloxegol|mesh-list
154845731|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845732|NCT00395603|Atorvastatin|atorvastatin|mesh-list
154845733|NCT00395603|Simvastatin|simvastatin|mesh-list
154845734|NCT00395603|Ezetimibe|ezetimibe|mesh-list
154845735|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154845736|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154845737|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
154845738|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597726|NCT00271817|Vitamins|vitamins|mesh-ancestor
154845739|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154845740|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154845741|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845742|NCT00659633|Lidocaine|lidocaine|mesh-list
154845743|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
154845744|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
154845745|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154845746|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845747|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
154845748|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845749|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154845750|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154845751|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154845752|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845753|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845754|NCT00328523|Ezetimibe|ezetimibe|mesh-list
154845755|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154845756|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154845757|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
154845758|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845759|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154845760|NCT00701675|Sertraline|sertraline|mesh-list
154845761|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
154845762|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154845763|NCT00701675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154845764|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154845765|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845766|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845767|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845768|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
154845769|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845770|NCT04639310|Ezogabine|ezogabine|mesh-list
154845771|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
154845772|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845773|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845774|NCT02300727|Curcumin|curcumin|mesh-list
154845775|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154845776|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845777|NCT02300727|Analgesics|analgesics|mesh-ancestor
154845778|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
154845779|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845780|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845781|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845782|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154845783|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845784|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845785|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845786|NCT00250445|Diclofenac|diclofenac|mesh-list
154845787|NCT00250445|Etoricoxib|etoricoxib|mesh-list
154845788|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154845789|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845790|NCT00250445|Analgesics|analgesics|mesh-ancestor
154845791|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
154845792|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845793|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845794|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845795|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154845796|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154845797|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845798|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845799|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154845800|NCT00242489|Diclofenac|diclofenac|mesh-list
154845801|NCT00242489|Etoricoxib|etoricoxib|mesh-list
154845802|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154845803|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845804|NCT00242489|Analgesics|analgesics|mesh-ancestor
154845805|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
154845806|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845807|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845808|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845809|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154845810|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154845811|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860468|NCT01920386|Narcotics|narcotics|mesh-ancestor
154845812|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845813|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154845814|NCT00659945|Ondansetron|ondansetron|mesh-list
154845815|NCT00659945|Aprepitant|aprepitant|mesh-list
154845816|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
154845817|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
154845818|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845819|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845820|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845821|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
154845822|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
154845823|NCT00659945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154845824|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154845825|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
154845826|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845827|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845828|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154845829|NCT04387565|Vanadium|vanadium|mesh-list
154845830|NCT04387565|Trace Elements|trace elements|mesh-ancestor
154845831|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
154845832|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845833|NCT02141555|Misoprostol|misoprostol|mesh-list
154845834|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154845835|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
154845836|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154845837|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845838|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154845839|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845840|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
154845841|NCT01799057|Metformin|metformin|mesh-list
154845842|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154845843|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845844|NCT00588965|Propranolol|propranolol|mesh-list
154845845|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154845846|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154845847|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845848|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845849|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845850|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845851|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153568041|NCT04458545|Heroin|heroin|mesh-list
154845852|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154845853|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
154845854|NCT00702299|Paclitaxel|paclitaxel|mesh-list
154845855|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154845856|NCT00702299|Cisplatin|cisplatin|mesh-list
154845857|NCT00702299|Pemetrexed|pemetrexed|mesh-list
154845858|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154845859|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845860|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
154845861|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
154845862|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
154845863|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845864|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845865|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154845866|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154845867|NCT00661583|Ranibizumab|ranibizumab|mesh-list
154845868|NCT00661583|Mitomycins|mitomycins|mesh-list
154845869|NCT00661583|Mitomycin|mitomycin|mesh-list
154845870|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154845871|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154845872|NCT00661583|Growth Substances|growth substances|mesh-ancestor
154845873|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845874|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
154845875|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845876|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154845877|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
154845878|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845879|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154845880|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845881|NCT00661895|Metoprolol|metoprolol|mesh-list
154845882|NCT00661895|Atenolol|atenolol|mesh-list
154845883|NCT00661895|Amlodipine|amlodipine|mesh-list
154845884|NCT00661895|Valsartan|valsartan|mesh-list
154845885|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154845886|NCT00661895|Clonidine|clonidine|mesh-list
154845887|NCT00661895|Lisinopril|lisinopril|mesh-list
154845888|NCT00661895|Doxazosin|doxazosin|mesh-list
154597878|NCT02732015|Ifosfamide|ifosfamide|mesh-list
154845890|NCT00661895|Nifedipine|nifedipine|mesh-list
154845891|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154845892|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154845893|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154845894|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845895|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154845896|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845897|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
154845898|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154845899|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154845900|NCT00661895|Diuretics|diuretics|mesh-ancestor
154845901|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
154845902|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154845903|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154845904|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
154845905|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
154845906|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025430|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154845907|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154845908|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154845909|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154845910|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
154845911|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154845912|NCT00661895|Analgesics|analgesics|mesh-ancestor
154845913|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
154845914|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154845915|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154845916|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154845917|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
154845918|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154845919|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154845920|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
154845921|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845922|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154845923|NCT00661895|Protective Agents|protective agents|mesh-ancestor
154845924|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154845925|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154845926|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
154845927|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154845928|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845929|NCT02301039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154845930|NCT02301039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845931|NCT00662675|Pancrelipase|pancrelipase|mesh-list
154845932|NCT00662675|Pancreatin|pancreatin|mesh-list
154845933|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154845934|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
154845935|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154845936|NCT00591305|Protective Agents|protective agents|mesh-ancestor
154845937|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845938|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154845939|NCT01799603|Simeprevir|simeprevir|mesh-list
154845940|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
154845941|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154845942|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
154845943|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845944|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845945|NCT00666029|Atorvastatin|atorvastatin|mesh-list
154845946|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154845947|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154845948|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
154845949|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845950|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154845951|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154845952|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845953|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
154845954|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154845955|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154845956|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845957|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
154845958|NCT04372940|Coagulants|coagulants|mesh-ancestor
154845959|NCT00592475|Conivaptan|conivaptan|mesh-list
154845960|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154845961|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845962|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
154845963|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845964|NCT01989195|Manganese|manganese|mesh-list
154845965|NCT01989195|Trace Elements|trace elements|mesh-ancestor
154845966|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
154845967|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845968|NCT00592943|Modafinil|modafinil|mesh-list
154845969|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154845970|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845971|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154845972|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154845973|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154845974|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845975|NCT01973205|Aspirin|aspirin|mesh-list
154845976|NCT01973205|Acetaminophen|acetaminophen|mesh-list
154845977|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154845978|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154845979|NCT01973205|Analgesics|analgesics|mesh-ancestor
154845980|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
154845981|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154845982|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845983|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154845984|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154845985|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154845986|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154845987|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154845988|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154845989|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154845990|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154845991|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
154845992|NCT01990677|Eplerenone|eplerenone|mesh-list
154845993|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154845994|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
154845995|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154845996|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154845997|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154845998|NCT01990677|Diuretics|diuretics|mesh-ancestor
154845999|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
154846000|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154846001|NCT00593645|Cytarabine|cytarabine|mesh-list
154846002|NCT00593645|Clofarabine|clofarabine|mesh-list
154846003|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
154846004|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154846005|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846006|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
154846007|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846008|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846009|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
154846010|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846011|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846012|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
154846013|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846014|NCT03219086|Bupivacaine|bupivacaine|mesh-list
154846015|NCT03219086|Prilocaine|prilocaine|mesh-list
154846016|NCT03219086|Anesthetics|anesthetics|mesh-list
154846017|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
154846018|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846019|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846020|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
154846021|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846022|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
154846023|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154846024|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
154846025|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846026|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846027|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154846028|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
154846029|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154846030|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
154846031|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846032|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846033|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154846034|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
154846035|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
154846036|NCT04398290|Protective Agents|protective agents|mesh-ancestor
154846037|NCT04397510|Heparin|heparin|mesh-list
154846038|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
154846039|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154846040|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154846041|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846042|NCT00704717|Ribavirin|ribavirin|mesh-list
154846043|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154846044|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
154846045|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
154846046|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846047|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
154846048|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846049|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
154846050|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846051|NCT03708224|Atezolizumab|atezolizumab|mesh-list
154846052|NCT03708224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154846053|NCT03708224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846054|NCT03708224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846055|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846056|NCT03632642|Floxacillin|floxacillin|mesh-list
154846057|NCT03632642|Penicillin G|penicillin g|mesh-list
154846058|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154846059|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
154846060|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154846061|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846062|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154846063|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154846064|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154846065|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
154846066|NCT04317404|Triamcinolone|triamcinolone|mesh-list
154846067|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154846068|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154846069|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154846070|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846071|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
154846072|NCT04317404|Hormones|hormones|mesh-ancestor
154846073|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154846074|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846075|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846076|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
154846077|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846078|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846079|NCT04399070|Ketamine|ketamine|mesh-list
154846080|NCT04399070|Esketamine|esketamine|mesh-list
154846081|NCT04399070|Analgesics|analgesics|mesh-ancestor
154846082|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
154846083|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846084|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846085|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154846086|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154846087|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
154846088|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
154846089|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846090|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154846091|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154846092|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846093|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846094|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
154846095|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154846096|NCT00667589|Fluocinonide|fluocinonide|mesh-list
154846097|NCT00667589|Tazarotene|tazarotene|mesh-list
154846098|NCT00667589|Emollients|emollients|mesh-list
154846099|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
154846100|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
154846101|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846102|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
154846103|NCT00667589|Hormones|hormones|mesh-ancestor
154846104|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154846105|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846106|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154846107|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
154846108|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
154846109|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154846110|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846111|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846112|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
154025639|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154846114|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846115|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846116|NCT03173612|Cytarabine|cytarabine|mesh-list
154846117|NCT03173612|Etoposide|etoposide|mesh-list
154846118|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
154846119|NCT03173612|Idarubicin|idarubicin|mesh-list
154846120|NCT03173612|Dasatinib|dasatinib|mesh-list
154846121|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
154846122|NCT03173612|Lenograstim|lenograstim|mesh-list
154846123|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154846124|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846125|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846126|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154846127|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846128|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846129|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846130|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
154846131|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
154846132|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846133|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846134|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
154846135|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846136|NCT03173612|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154846137|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154846138|NCT03173612|Analgesics|analgesics|mesh-ancestor
154846139|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
154846140|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846141|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154846142|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154846143|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154846144|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154846145|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
154846146|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846147|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846148|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154846149|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
154846150|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154846151|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154846152|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154846153|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
154846154|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846155|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846156|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
154846157|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154846158|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025687|NCT02658864|Lafutidine|lafutidine|mesh-list
154025692|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
154846159|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846160|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154846161|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846162|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846163|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846164|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154846165|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154846166|NCT00705107|Ribavirin|ribavirin|mesh-list
154846167|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154846168|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
154846169|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
154846170|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846171|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
154846172|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846173|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
154846174|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846175|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154846176|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154846177|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154846178|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
154846179|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846180|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154846181|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154846182|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846183|NCT00240097|Carboplatin|carboplatin|mesh-list
154846184|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
154846185|NCT00240097|Irinotecan|irinotecan|mesh-list
154846186|NCT00240097|Etoposide|etoposide|mesh-list
154846187|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846188|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154846189|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154846190|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846191|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846192|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154846193|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846194|NCT04270487|Octylonium|octylonium|mesh-list
154846195|NCT04270487|Bromides|bromides|mesh-list
154846196|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
154846197|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154846198|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154846199|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846200|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154846201|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846202|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154846203|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
154846204|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
154846205|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846206|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154846207|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154846208|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
154846209|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846210|NCT00739999|Atorvastatin|atorvastatin|mesh-list
154846211|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154846212|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154846213|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
154846214|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846215|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154846216|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154846217|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846218|NCT02997995|Durvalumab|durvalumab|mesh-list
154846219|NCT02997995|Tremelimumab|tremelimumab|mesh-list
154846220|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846221|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846222|NCT03620162|Vaccines|vaccines|mesh-list
154846223|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
154846224|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846225|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
154846226|NCT00742573|Bupropion|bupropion|mesh-list
154846227|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154846228|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154846229|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154846230|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846231|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846232|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846233|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
154846234|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154846235|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154846236|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154846237|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154846238|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846239|NCT03809923|Lidocaine|lidocaine|mesh-list
154846240|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
154846241|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
154846242|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
154846243|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846244|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846245|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
154025767|NCT00633425|Glimepiride|glimepiride|mesh-list
154846246|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846247|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154846248|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154846249|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154846250|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154846251|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846252|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154846253|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154846254|NCT03809923|Analgesics|analgesics|mesh-ancestor
154846255|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154846256|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154846257|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154846258|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154846259|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846260|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
154846261|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154846263|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
154846264|NCT00602225|Cytarabine|cytarabine|mesh-list
154846265|NCT00602225|Clofarabine|clofarabine|mesh-list
154846266|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846267|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
154846268|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846269|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846270|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
154846271|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846272|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846273|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
154846274|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846275|NCT00602771|Etoposide|etoposide|mesh-list
154846276|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
154846277|NCT00602771|Tipifarnib|tipifarnib|mesh-list
154846278|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154846279|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846280|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846281|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154846282|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846283|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846284|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
154846285|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154846286|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846287|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154846288|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846289|NCT04248998|Metformin|metformin|mesh-list
154846290|NCT04248998|Paclitaxel|paclitaxel|mesh-list
154846291|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
154846292|NCT04248998|Doxorubicin|doxorubicin|mesh-list
154846293|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154846294|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846295|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
154846296|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
154846297|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
154846298|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846299|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846300|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
154846301|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846302|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846303|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154846304|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
154846305|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154846306|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154846307|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154846308|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846309|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154846310|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846311|NCT00714233|Metformin|metformin|mesh-list
154846312|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
154846313|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
154846314|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154846315|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154846316|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154025828|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846317|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846318|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154846319|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154846320|NCT00746395|Lubiprostone|lubiprostone|mesh-list
154846321|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154846322|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154846323|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846324|NCT01276067|Donepezil|donepezil|mesh-list
154846325|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154846326|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846327|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846328|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
154846329|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846330|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846331|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
154846332|NCT04183868|Empagliflozin|empagliflozin|mesh-list
154846333|NCT04183868|Glimepiride|glimepiride|mesh-list
154846334|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154846335|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846336|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154846337|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846338|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154846339|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846340|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
154846342|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
154846343|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
154846344|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846345|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846346|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
154846347|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846348|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154846349|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154846350|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154846351|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154846352|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846353|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
154846354|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154846355|NCT02990507|Testosterone|testosterone|mesh-list
154846356|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
154846357|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
154846358|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154846359|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846360|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
154846361|NCT02990507|Hormones|hormones|mesh-ancestor
154846362|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154846363|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846364|NCT02990507|Androgens|androgens|mesh-ancestor
154846365|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
154846366|NCT03331484|Ticagrelor|ticagrelor|mesh-list
154846367|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154846368|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
154846369|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154846370|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
154846371|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846372|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846373|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
154846374|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154846375|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154846376|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154025870|NCT04169256|Bupivacaine|bupivacaine|mesh-list
154846377|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154846378|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
154846379|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846380|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846381|NCT00721513|Docetaxel|docetaxel|mesh-list
154846382|NCT00721513|Fluorouracil|fluorouracil|mesh-list
154846383|NCT00721513|Cetuximab|cetuximab|mesh-list
154846384|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846385|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
154846386|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
154846387|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
154846388|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846389|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
154846390|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846391|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846392|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
154846393|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846394|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846395|NCT00706121|Vitamins|vitamins|mesh-list
154846396|NCT00706121|Vitamin E|vitamin e|mesh-list
154846397|NCT00706121|Tocopherols|tocopherols|mesh-list
154846398|NCT00706121|Tocotrienols|tocotrienols|mesh-list
154846399|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
154846400|NCT00706121|Selenium|selenium|mesh-list
154846401|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
154846402|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846403|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
154846404|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846405|NCT00706121|Protective Agents|protective agents|mesh-ancestor
154846406|NCT00706121|Trace Elements|trace elements|mesh-ancestor
154846407|NCT00746863|Bupivacaine|bupivacaine|mesh-list
154846408|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
154846409|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
154598393|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846410|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846411|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846412|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
154846413|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846414|NCT04385563|Docetaxel|docetaxel|mesh-list
154846415|NCT04385563|Trastuzumab|trastuzumab|mesh-list
154846416|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846417|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
154846418|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
154846419|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
154846420|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846421|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846422|NCT03568838|Enoxaparin|enoxaparin|mesh-list
154846423|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
154846424|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154846425|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154846426|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846427|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
154846428|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
154846429|NCT00726713|Vitamins|vitamins|mesh-ancestor
154846430|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
154846431|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846432|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
154846433|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154846434|NCT00759187|Triclosan|triclosan|mesh-list
154846435|NCT00759187|Fluorides|fluorides|mesh-list
154846436|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
154846437|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
154846438|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
154846439|NCT00759187|Protective Agents|protective agents|mesh-ancestor
154846440|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846441|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154846442|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846443|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
154846444|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
154846445|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154846446|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154846447|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
154846448|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846449|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154846450|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
154846451|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
154846452|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154846453|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154846454|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846455|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846456|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846457|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846458|NCT01279915|Linaclotide|linaclotide|mesh-list
154846459|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154846460|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
154846461|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846462|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154846463|NCT03809455|Fentanyl|fentanyl|mesh-list
154846464|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154846465|NCT03809455|Narcotics|narcotics|mesh-ancestor
154846466|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846467|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846468|NCT03809455|Analgesics|analgesics|mesh-ancestor
154846469|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
154846470|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846471|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154846472|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154846473|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
154846474|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
154846475|NCT02997059|Fluconazole|fluconazole|mesh-list
154846476|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
154846477|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846478|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154846479|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154846480|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846481|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846482|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154846483|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
154846484|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154846485|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846486|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154846487|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154846489|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154846490|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
154846491|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154025994|NCT00649740|Topiramate|topiramate|mesh-list
154846492|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846493|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846494|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
154846495|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846496|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846497|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154846498|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846499|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154846500|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846501|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
154846502|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846503|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154846504|NCT03085628|Oxytocin|oxytocin|mesh-list
154846505|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
154846506|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154846507|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846508|NCT01276613|Gemcitabine|gemcitabine|mesh-list
154846509|NCT01276613|Losartan|losartan|mesh-list
154846510|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846511|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
154846512|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846513|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846514|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154846515|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154846516|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154846517|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154846518|NCT01276691|Aspirin|aspirin|mesh-list
154846519|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154846520|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154846521|NCT01276691|Analgesics|analgesics|mesh-ancestor
154846522|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
154846523|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846524|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846525|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846526|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846527|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154846528|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154846529|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846530|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154846531|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154846532|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846533|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
154846534|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
154846535|NCT03081416|Dexamethasone|dexamethasone|mesh-list
154846536|NCT03081416|Ketorolac|ketorolac|mesh-list
154846537|NCT03081416|Ketamine|ketamine|mesh-list
154846538|NCT03081416|Metoclopramide|metoclopramide|mesh-list
154846539|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846540|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
154846541|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
154846542|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846543|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846544|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154846545|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
154846546|NCT03081416|Hormones|hormones|mesh-ancestor
154846547|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154846548|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154846549|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846550|NCT03081416|Analgesics|analgesics|mesh-ancestor
154846551|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
154846552|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154846553|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154846554|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
154846555|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
154846556|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846557|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154846558|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154846559|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846560|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846561|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154846562|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154846563|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846564|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154846565|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846566|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154846567|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154846568|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
154846569|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154846570|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154846571|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
154846572|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154846573|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
154846574|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
154846575|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154846577|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
154846578|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154846579|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154846580|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154846581|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846582|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026093|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846583|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
154846584|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
154846585|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846586|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846587|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154846588|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154846589|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
154846590|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154846591|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154846592|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154846593|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154846594|NCT01276769|Paclitaxel|paclitaxel|mesh-list
154846595|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154846596|NCT01276769|Carboplatin|carboplatin|mesh-list
154846597|NCT01276769|Epirubicin|epirubicin|mesh-list
154846598|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154846599|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846600|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
154846601|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
154846602|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
154846603|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846604|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154846605|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846606|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154846607|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846608|NCT01279681|Leucovorin|leucovorin|mesh-list
154846609|NCT01279681|Bevacizumab|bevacizumab|mesh-list
154846610|NCT01279681|Capecitabine|capecitabine|mesh-list
154846611|NCT01279681|Fluorouracil|fluorouracil|mesh-list
154846612|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
154846613|NCT01279681|Calcium|calcium|mesh-list
154846614|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
154846615|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846616|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846617|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154846618|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154846619|NCT01279681|Growth Substances|growth substances|mesh-ancestor
154846620|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846621|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
154846622|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154846623|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846624|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
154846625|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846626|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846627|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
154846628|NCT01279681|Antidotes|antidotes|mesh-ancestor
154846629|NCT01279681|Protective Agents|protective agents|mesh-ancestor
154846630|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
154846631|NCT01279681|Vitamins|vitamins|mesh-ancestor
154598620|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846632|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
154846633|NCT01276925|Bupivacaine|bupivacaine|mesh-list
154846634|NCT01276925|Ropivacaine|ropivacaine|mesh-list
154846636|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
154846637|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846638|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846639|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
154846640|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846641|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
154846642|NCT00728507|Rifampin|rifampin|mesh-list
154846643|NCT00728507|Isoniazid|isoniazid|mesh-list
154846644|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
154846645|NCT00728507|Ethambutol|ethambutol|mesh-list
154846646|NCT00728507|Rifapentine|rifapentine|mesh-list
154846647|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154846648|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846649|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846650|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154026146|NCT00620594|Dactolisib|dactolisib|mesh-list
154846651|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846652|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846653|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846654|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154846655|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
154846656|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
154846657|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154846658|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154846659|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154846660|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154846661|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154846662|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154846663|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154846664|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154846665|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154846666|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
154846667|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154846668|NCT01279057|Fluticasone|fluticasone|mesh-list
154846669|NCT01279057|Xhance|xhance|mesh-list
154846670|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846671|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154846672|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
154846673|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846674|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846675|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154026204|NCT02651610|Taxane|taxane|mesh-list
154846676|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
154846677|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
154846678|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154846679|NCT04384783|Hormones|hormones|mesh-list
154846680|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154846681|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846682|NCT03186326|Bevacizumab|bevacizumab|mesh-list
154846683|NCT03186326|Cetuximab|cetuximab|mesh-list
154846684|NCT03186326|Avelumab|avelumab|mesh-list
154846685|NCT03186326|Panitumumab|panitumumab|mesh-list
154846686|NCT03186326|Aflibercept|aflibercept|mesh-list
154846687|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846688|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846689|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154846690|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154846691|NCT03186326|Growth Substances|growth substances|mesh-ancestor
154846692|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846693|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
154846694|NCT02999633|Acetaminophen|acetaminophen|mesh-list
154846695|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
154846696|NCT02999633|Promethazine|promethazine|mesh-list
154846697|NCT02999633|Dexamethasone|dexamethasone|mesh-list
154846698|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
154846699|NCT02999633|Ranitidine|ranitidine|mesh-list
154846700|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154846701|NCT02999633|BB 1101|bb 1101|mesh-list
154846702|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846703|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
154846704|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
154846705|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846706|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846707|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154846708|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
154846709|NCT02999633|Hormones|hormones|mesh-ancestor
154846710|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598696|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
154846711|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154846712|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846713|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
154846714|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846715|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846716|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154846717|NCT02999633|Analgesics|analgesics|mesh-ancestor
154846718|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
154846719|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
154846720|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154846721|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154846722|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846723|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
154846724|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
154846725|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154846726|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
154846727|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
154846728|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846729|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154846730|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
154846731|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
154846732|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154846733|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154846734|NCT02991599|Vaccines|vaccines|mesh-list
154846735|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
154846736|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846737|NCT02996513|Vitamin A|vitamin a|mesh-list
154846738|NCT02996513|Vitamins|vitamins|mesh-ancestor
154846739|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
154846740|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846741|NCT04276688|Interferons|interferons|mesh-list
154846742|NCT04276688|Ritonavir|ritonavir|mesh-list
154846743|NCT04276688|Ribavirin|ribavirin|mesh-list
154846744|NCT04276688|Lopinavir|lopinavir|mesh-list
154846745|NCT04276688|Interferon-beta|interferon-beta|mesh-list
154846746|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
154846747|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846748|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
154846749|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846750|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154846751|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154846752|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
154846753|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846754|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846755|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154846756|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154846757|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154846758|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154846759|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
154846760|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
154846761|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846762|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154846763|NCT01277627|Efavirenz|efavirenz|mesh-list
154846764|NCT01277627|Nevirapine|nevirapine|mesh-list
154846765|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154846766|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
154846767|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154846768|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154846769|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846770|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846771|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
154846772|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846773|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154846774|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154846775|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154846776|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154846777|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154846778|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154846779|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154846780|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154846781|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154846782|NCT01270451|Insulin|insulin|mesh-list
154846783|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154846784|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846785|NCT00706979|Nicotine|nicotine|mesh-list
154846786|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154846787|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
154846788|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846789|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846790|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154846791|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154846792|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
154846793|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846794|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846796|NCT01278017|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154846797|NCT01278017|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154846798|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154846799|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846800|NCT00716963|Fluticasone|fluticasone|mesh-list
154846801|NCT00716963|Xhance|xhance|mesh-list
154846802|NCT00716963|Budesonide|budesonide|mesh-list
154846803|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846804|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154846805|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
154846806|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846807|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846808|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154846809|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
154846810|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
154846811|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154846812|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
154846813|NCT00716963|Hormones|hormones|mesh-ancestor
154846814|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154846815|NCT01270997|Etanercept|etanercept|mesh-list
154846816|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154846817|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154846818|NCT01270997|Analgesics|analgesics|mesh-ancestor
154846819|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
154846820|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846821|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846822|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846823|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846824|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154846825|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846826|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
154846827|NCT01278745|Rituximab|rituximab|mesh-list
154846828|NCT01278745|Tacrolimus|tacrolimus|mesh-list
154846829|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846830|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846831|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
154846832|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846833|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846834|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846835|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154846836|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846837|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846838|NCT02995655|Azacitidine|azacitidine|mesh-list
154846839|NCT02995655|Heparin|heparin|mesh-list
154846840|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846841|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
154846842|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846843|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846844|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846845|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
154846846|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154846847|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154846848|NCT01271153|Dobutamine|dobutamine|mesh-list
154846849|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154846850|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
154846851|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
154846852|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846853|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846854|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154846855|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154846856|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154846857|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
154846858|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846859|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846860|NCT01271153|Protective Agents|protective agents|mesh-ancestor
154846861|NCT03809065|Labetalol|labetalol|mesh-list
154846862|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
154846863|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
154846864|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154846865|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154846866|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
154846867|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846868|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846869|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846870|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154846871|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
154846872|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
154846873|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846874|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154846875|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154846877|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846878|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154846879|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846880|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846881|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154846882|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154846883|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154846884|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154846885|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154846886|NCT01272089|Analgesics|analgesics|mesh-ancestor
154846887|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
154846888|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846889|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846890|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846891|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846892|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154846893|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154846894|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154846895|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
154846896|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
154846897|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154846898|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846899|NCT00748657|Bevacizumab|bevacizumab|mesh-list
154846900|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154846901|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
154846902|NCT00748657|Antibodies|antibodies|mesh-list
154846903|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
154846904|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154846905|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
154846906|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846907|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154846908|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154846909|NCT00748657|Growth Substances|growth substances|mesh-ancestor
154846910|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846911|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
154846912|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
154846913|NCT02994953|Avelumab|avelumab|mesh-list
154846914|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154846915|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846916|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846917|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
154846918|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846919|NCT01272973|Semaglutide|semaglutide|mesh-list
154846920|NCT01272973|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154846921|NCT01272973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154846922|NCT01272973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846923|NCT01273051|Capecitabine|capecitabine|mesh-list
154846924|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154846925|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
154846926|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846927|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846928|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
154846929|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154846930|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
154846931|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154846932|NCT02994875|Expectorants|expectorants|mesh-ancestor
154846933|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
154846934|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154846935|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
154846936|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598934|NCT03370705|Captopril|captopril|mesh-list
154846937|NCT02994875|Protective Agents|protective agents|mesh-ancestor
154846938|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846939|NCT02994875|Antidotes|antidotes|mesh-ancestor
154846940|NCT03809143|Buprenorphine|buprenorphine|mesh-list
154846941|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154846942|NCT03809143|Narcotics|narcotics|mesh-ancestor
154846943|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846944|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846945|NCT03809143|Analgesics|analgesics|mesh-ancestor
154846946|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
154846947|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154846948|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154846949|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
154846950|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
154846951|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154846952|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154846953|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846954|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846955|NCT02390960|Urological Agents|urological agents|mesh-ancestor
154846956|NCT00720473|Lamotrigine|lamotrigine|mesh-list
154846957|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
154846958|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154846959|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154846960|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846961|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154846962|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846963|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154846964|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154846965|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154846966|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154846967|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154846968|NCT00637832|Prednisolone|prednisolone|mesh-list
154846969|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
154846970|NCT00637832|Rituximab|rituximab|mesh-list
154846971|NCT00637832|Doxorubicin|doxorubicin|mesh-list
154846972|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154846973|NCT00637832|Vincristine|vincristine|mesh-list
154846974|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154846975|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
154846976|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154846977|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154846978|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154846979|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
154846980|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154846981|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154846982|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154846983|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154846984|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154846985|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154846986|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154846987|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154846988|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154846989|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
154846990|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
154846991|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
154846992|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154846993|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
154846994|NCT00637832|Hormones|hormones|mesh-ancestor
154846995|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154846996|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154846997|NCT00720629|Methotrexate|methotrexate|mesh-list
154846998|NCT00720629|Tacrolimus|tacrolimus|mesh-list
154846999|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
154847000|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154847001|NCT00720629|Visilizumab|visilizumab|mesh-list
154847002|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154847003|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
154847004|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154847005|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847006|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154847007|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
154847008|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847009|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847010|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
154847011|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847012|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154847013|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847014|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
154847015|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847016|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154847017|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154847018|NCT01276327|Pioglitazone|pioglitazone|mesh-list
154847019|NCT01276327|Linagliptin|linagliptin|mesh-list
154847020|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154847021|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847022|NCT01276327|Incretins|incretins|mesh-ancestor
154847023|NCT01276327|Hormones|hormones|mesh-ancestor
154847024|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847025|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154847026|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
154847027|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847028|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847029|NCT05245760|Paclitaxel|paclitaxel|mesh-list
154847030|NCT05245760|Carboplatin|carboplatin|mesh-list
154847031|NCT05245760|Tislelizumab|tislelizumab|mesh-list
154847032|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154847033|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847034|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
154847035|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
154847036|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
154847037|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847038|NCT05245760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154847039|NCT02674958|Aspirin|aspirin|mesh-list
154847040|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154847041|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847042|NCT02674958|Analgesics|analgesics|mesh-ancestor
154847043|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
154847044|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847045|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847046|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847047|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847048|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154847049|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154847050|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847051|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154847052|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154847053|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847054|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
154847055|NCT00760435|Infliximab|infliximab|mesh-list
154847056|NCT00760435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154847057|NCT00760435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847058|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
154847059|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847060|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847061|NCT03808129|Lidocaine|lidocaine|mesh-list
154847062|NCT03808129|Bupivacaine|bupivacaine|mesh-list
154026558|NCT06095427|Denosumab|denosumab|mesh-list
154847063|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
154847064|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
154847065|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847066|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847067|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
154847068|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847069|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154847070|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154847071|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154847072|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154847073|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847074|NCT00749125|Escitalopram|escitalopram|mesh-list
154847075|NCT00749125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154847076|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154847077|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154847078|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847079|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847080|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
154847081|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847082|NCT02144675|Cytarabine|cytarabine|mesh-list
154847083|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
154847084|NCT02144675|Salicylates|salicylates|mesh-list
154847085|NCT02144675|Idarubicin|idarubicin|mesh-list
154847086|NCT02144675|Choline|choline|mesh-list
154847087|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154847088|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
154847089|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847090|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847091|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
154847092|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847093|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847094|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
154847095|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847096|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154847097|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154847098|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154847099|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847100|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
154847101|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154847102|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847103|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154847104|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
154847105|NCT02144675|Analgesics|analgesics|mesh-ancestor
154847106|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
154847107|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847108|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154847109|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847110|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847111|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847112|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154847113|NCT01272557|Doxorubicin|doxorubicin|mesh-list
154847114|NCT01272557|Sorafenib|sorafenib|mesh-list
154847115|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154847116|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847117|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154847118|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154847119|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847120|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847121|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154847122|NCT00639002|Dexamethasone|dexamethasone|mesh-list
154847123|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847124|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
154847125|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
154847126|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847127|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847128|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847129|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
154847130|NCT00639002|Hormones|hormones|mesh-ancestor
154847131|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847132|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847133|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847134|NCT00761137|Tropicamide|tropicamide|mesh-list
154847135|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
154847136|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
154847137|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847138|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847139|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154847140|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154847141|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
154847142|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847143|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847144|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154847145|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154847146|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847147|NCT01273493|Dexamethasone|dexamethasone|mesh-list
154847148|NCT01273493|Trabectedin|trabectedin|mesh-list
154847149|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847150|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
154847151|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
154847152|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847153|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847154|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847155|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
154847156|NCT01273493|Hormones|hormones|mesh-ancestor
154847157|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847158|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847159|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847160|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154847161|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
154847162|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847163|NCT00638456|Budesonide|budesonide|mesh-list
154847164|NCT00638456|Lansoprazole|lansoprazole|mesh-list
154847165|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
154847166|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847167|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154847168|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
154847169|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847170|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847171|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154847172|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
154847173|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
154847174|NCT00638456|Hormones|hormones|mesh-ancestor
154847175|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847176|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154847177|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847178|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154847179|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847180|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847181|NCT01273571|Metformin|metformin|mesh-list
154847182|NCT01273571|Canagliflozin|canagliflozin|mesh-list
154847183|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154847184|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847185|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154847186|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847187|NCT02147899|Secnidazole|secnidazole|mesh-list
154847188|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154847189|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154847190|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847191|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
154847192|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154847193|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847194|NCT02565992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154847195|NCT02565992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847196|NCT00762619|Triclosan|triclosan|mesh-list
154847197|NCT00762619|Fluorides|fluorides|mesh-list
154847198|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
154847199|NCT00762619|Protective Agents|protective agents|mesh-ancestor
154847200|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847201|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154847202|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847203|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154847204|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154847205|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
154847206|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847207|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154847208|NCT00735449|Timolol|timolol|mesh-list
154847209|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154847210|NCT00735449|Latanoprost|latanoprost|mesh-list
154847211|NCT00735449|Maleic acid|maleic acid|mesh-list
154847212|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847213|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847214|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154847215|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154847216|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
154847217|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847218|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847219|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154847220|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154847221|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154847222|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154847223|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154847224|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154847225|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154847226|NCT01273831|Cisatracurium|cisatracurium|mesh-list
154847227|NCT01273831|Atracurium|atracurium|mesh-list
154847228|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154847229|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154847230|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847231|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847232|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154847233|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154847234|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154847235|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
154847236|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847237|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847238|NCT00735917|Saracatinib|saracatinib|mesh-list
154847239|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154847240|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154847241|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847242|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847243|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847244|NCT00736073|Aprepitant|aprepitant|mesh-list
154847245|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
154847246|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
154847247|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847248|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847249|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847250|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154847251|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026724|NCT06081257|Antioxidants|antioxidants|mesh-ancestor
154847252|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847253|NCT00736229|Exenatide|exenatide|mesh-list
154847254|NCT00736229|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154847255|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154847256|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847257|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154847258|NCT00736229|Incretins|incretins|mesh-ancestor
154847259|NCT00736229|Hormones|hormones|mesh-ancestor
154847260|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847261|NCT00737243|Paclitaxel|paclitaxel|mesh-list
154847262|NCT00737243|Bevacizumab|bevacizumab|mesh-list
154847263|NCT00737243|Carboplatin|carboplatin|mesh-list
154847264|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154847265|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154847266|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847267|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
154847268|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
154847269|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154847270|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847271|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154847272|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154847273|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154847274|NCT00737243|Growth Substances|growth substances|mesh-ancestor
154847275|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847276|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
154847277|NCT00737243|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154847278|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154847279|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847280|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
154847281|NCT00707759|Prednisone|prednisone|mesh-list
154847282|NCT00707759|Prednisolone|prednisolone|mesh-list
154847283|NCT00707759|Tacrolimus|tacrolimus|mesh-list
154847284|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847285|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
154847286|NCT00707759|Hormones|hormones|mesh-ancestor
154847287|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847288|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847289|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847290|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847291|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847292|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
154847293|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154847294|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847295|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847296|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154847297|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154847298|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
154847299|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154026790|NCT05804123|Acetylcysteine|acetylcysteine|mesh-list
154847300|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847301|NCT01273727|Dexamethasone|dexamethasone|mesh-list
154847302|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
154847303|NCT01273727|BB 1101|bb 1101|mesh-list
154847304|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847305|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
154847306|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
154847307|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847308|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847309|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847310|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
154847312|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847313|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847314|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847315|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
154847316|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847317|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847318|NCT00708071|Thrombin|thrombin|mesh-list
154847319|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154847320|NCT00708071|Aprotinin|aprotinin|mesh-list
154847321|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
154847322|NCT00708071|Coagulants|coagulants|mesh-ancestor
154847323|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154847324|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154847325|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
154847326|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847327|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847328|NCT02994485|Simvastatin|simvastatin|mesh-list
154847329|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154847330|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154847331|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
154847332|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847333|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154847334|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154847335|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847336|NCT02994173|Ketamine|ketamine|mesh-list
154847337|NCT02994173|Oxycodone|oxycodone|mesh-list
154847338|NCT02994173|Esketamine|esketamine|mesh-list
154847339|NCT02994173|Analgesics|analgesics|mesh-ancestor
154847340|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
154847341|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847342|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847343|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154847344|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154847345|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
154847346|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
154847347|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847348|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154847349|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154847350|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847351|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847352|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154847353|NCT02994173|Narcotics|narcotics|mesh-ancestor
154847354|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
154847355|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154847356|NCT00723749|Buprenorphine|buprenorphine|mesh-list
154026843|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154026845|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
154847357|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154847358|NCT00723749|Naloxone|naloxone|mesh-list
154847359|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154847360|NCT00723749|Narcotics|narcotics|mesh-ancestor
154847361|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847362|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847363|NCT00723749|Analgesics|analgesics|mesh-ancestor
154847364|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
154847365|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847366|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154847367|NCT00723827|Temozolomide|temozolomide|mesh-list
154847368|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154847369|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
154847370|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847371|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847372|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
154847373|NCT00779311|Bevacizumab|bevacizumab|mesh-list
154847374|NCT00779311|Sorafenib|sorafenib|mesh-list
154847375|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154847376|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847377|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154847378|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154847379|NCT00779311|Growth Substances|growth substances|mesh-ancestor
154847380|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847381|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
154847382|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154847383|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847384|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847385|NCT01274039|Acetazolamide|acetazolamide|mesh-list
154847386|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
154847387|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154847388|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847389|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847390|NCT01274039|Diuretics|diuretics|mesh-ancestor
154847391|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
154847392|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847393|NCT01274195|Busulfan|busulfan|mesh-list
154847394|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
154847395|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847396|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847397|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
154847398|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847399|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154847400|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847401|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154847402|NCT00779701|Insulin|insulin|mesh-list
154847403|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154847404|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847405|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
154847406|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154847407|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154847408|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847409|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154847410|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154847411|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154847412|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154847413|NCT03809221|Hormones|hormones|mesh-list
154847414|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154847415|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847416|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847417|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
154847418|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154847419|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
154847420|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154847421|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154847422|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847423|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847424|NCT02993159|Tamoxifen|tamoxifen|mesh-list
154847425|NCT02993159|Afimoxifene|afimoxifene|mesh-list
154847426|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154847427|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
154847428|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847429|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847430|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847431|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847432|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154847433|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154847434|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154847435|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154847436|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
154847437|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847438|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
154847439|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154847440|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847441|NCT00762853|Triclosan|triclosan|mesh-list
154847442|NCT00762853|Fluorides|fluorides|mesh-list
154847443|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
154847444|NCT00762853|Protective Agents|protective agents|mesh-ancestor
154847445|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847446|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154847447|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847448|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154847449|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154847450|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
154847451|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847452|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154847453|NCT00724009|Clofarabine|clofarabine|mesh-list
154847454|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154847455|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
154847456|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847457|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847458|NCT01279499|Remifentanil|remifentanil|mesh-list
154847459|NCT01279499|Propofol|propofol|mesh-list
154847461|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154847462|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847463|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847464|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154847465|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
154847466|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
154847467|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154847468|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154847469|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154847470|NCT01279499|Narcotics|narcotics|mesh-ancestor
154847471|NCT01279499|Analgesics|analgesics|mesh-ancestor
154847472|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
154847473|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847474|NCT02992925|Vaccines|vaccines|mesh-list
154847475|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
154847476|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847477|NCT00780715|Metformin|metformin|mesh-list
154847478|NCT00780715|Pioglitazone|pioglitazone|mesh-list
154847479|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154847480|NCT00780715|Gliclazide|gliclazide|mesh-list
154847481|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154847482|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847483|NCT00780715|Incretins|incretins|mesh-ancestor
154847484|NCT00780715|Hormones|hormones|mesh-ancestor
154847485|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847486|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154847487|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
154847488|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847489|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847490|NCT00740831|Leuprolide|leuprolide|mesh-list
154847491|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
154847492|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154847493|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
154847494|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154847495|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847496|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847497|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847498|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154847499|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
154847500|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154847501|NCT01275287|Eculizumab|eculizumab|mesh-list
154847502|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154847503|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847504|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
154847505|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847506|NCT01275443|Rilpivirine|rilpivirine|mesh-list
154847507|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154847508|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154847509|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847510|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847511|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
154847512|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847513|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154847514|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154847515|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154847516|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154847517|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847518|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154847519|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154847520|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154847521|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847522|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
154847523|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847524|NCT00741455|Cyclosporine|cyclosporine|mesh-list
154847525|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
154847526|NCT00741455|Methotrexate|methotrexate|mesh-list
154847527|NCT00741455|Fludarabine|fludarabine|mesh-list
154847528|NCT00741455|Cyclosporins|cyclosporins|mesh-list
154847529|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847530|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
154847531|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847532|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847533|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154847534|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
154847535|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847536|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847537|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154847538|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154847539|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
154847540|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154847541|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154847542|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
154847543|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
154847544|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847545|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154847546|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154847547|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
154847548|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847549|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154847550|NCT00742313|Hemostatics|hemostatics|mesh-list
154847551|NCT00742313|Coagulants|coagulants|mesh-ancestor
154847552|NCT00742469|Rifaximin|rifaximin|mesh-list
154847553|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154847554|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847555|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847556|NCT01275599|Buprenorphine|buprenorphine|mesh-list
154847557|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154847558|NCT01275599|Naloxone|naloxone|mesh-list
154847559|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154847560|NCT01275599|Narcotics|narcotics|mesh-ancestor
154847561|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847562|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847563|NCT01275599|Analgesics|analgesics|mesh-ancestor
154847564|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
154847565|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847566|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154847567|NCT00782821|Rituximab|rituximab|mesh-list
154847568|NCT00782821|Bortezomib|bortezomib|mesh-list
154847569|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
154847570|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154847571|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154847572|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847573|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
154847574|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847575|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847576|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847577|NCT00743093|Acetaminophen|acetaminophen|mesh-list
154847578|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847579|NCT00743093|Analgesics|analgesics|mesh-ancestor
154847580|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
154847581|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847582|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847583|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
154847584|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
154847585|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154847586|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847587|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847588|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847589|NCT03805945|Analgesics|analgesics|mesh-ancestor
154847590|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
154847591|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847592|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154847593|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154847594|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154027039|NCT04907825|Warfarin|warfarin|mesh-list
154847595|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154847596|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847597|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847598|NCT02992301|Alirocumab|alirocumab|mesh-list
154847599|NCT02992301|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154847600|NCT02992301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154847601|NCT02992301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154847602|NCT02992301|Antimetabolites|antimetabolites|mesh-ancestor
154847603|NCT02992301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847604|NCT02992301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154847605|NCT02992301|Protease Inhibitors|protease inhibitors|mesh-ancestor
154847606|NCT02992301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847607|NCT02992301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154847608|NCT00743717|Cobalt|cobalt|mesh-list
154847609|NCT00743717|Trace Elements|trace elements|mesh-ancestor
154847610|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
154847611|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847612|NCT00744965|Glyburide|glyburide|mesh-list
154847613|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154847614|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847615|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
154847616|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
154847617|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154847618|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154847619|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847620|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847621|NCT00763867|Urological Agents|urological agents|mesh-ancestor
154847622|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
154847623|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154847624|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
154847625|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847626|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
154847627|NCT00711347|Protective Agents|protective agents|mesh-ancestor
154847628|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
154847629|NCT01276223|Difluprednate|difluprednate|mesh-list
154847630|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
154847631|NCT01276223|Hormones|hormones|mesh-ancestor
154847632|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847633|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847634|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847635|NCT00784225|Vitamins|vitamins|mesh-list
154847636|NCT00784225|Vitamin E|vitamin e|mesh-list
154847637|NCT00784225|Tocopherols|tocopherols|mesh-list
154847638|NCT00784225|Tocotrienols|tocotrienols|mesh-list
154847639|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
154847640|NCT00784225|Selenium|selenium|mesh-list
154847641|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
154847642|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847643|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
154847644|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847645|NCT00784225|Protective Agents|protective agents|mesh-ancestor
154847646|NCT00784225|Trace Elements|trace elements|mesh-ancestor
154847647|NCT02991911|MEDI3726|medi3726|mesh-list
154847648|NCT02991911|Immunoconjugates|immunoconjugates|mesh-ancestor
154847649|NCT02991911|Immunologic Factors|immunologic factors|mesh-ancestor
154847650|NCT02991911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847651|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
154847652|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154847653|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847654|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
154847655|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
154847656|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154847657|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154847658|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847659|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847660|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847661|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847662|NCT01273181|Aldesleukin|aldesleukin|mesh-list
154847663|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
154847664|NCT01273181|Fludarabine|fludarabine|mesh-list
154847665|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847666|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
154847667|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847668|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847669|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154847670|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
154847671|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847672|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847673|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154847674|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154847675|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154847676|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
154847677|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847678|NCT01272947|Diclofenac|diclofenac|mesh-list
154847679|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154847680|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847681|NCT01272947|Analgesics|analgesics|mesh-ancestor
154847682|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
154847683|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847684|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847685|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847686|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847687|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154847688|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860469|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847689|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847690|NCT01279343|Misoprostol|misoprostol|mesh-list
154847691|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154847692|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
154847693|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154847694|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847695|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154847696|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847697|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
154847698|NCT01278797|Amlodipine|amlodipine|mesh-list
154847699|NCT01278797|Telmisartan|telmisartan|mesh-list
154847700|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154847701|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154847702|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154847703|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154847704|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847705|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154847706|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847707|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
154847708|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154847709|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154847710|NCT01272635|Azithromycin|azithromycin|mesh-list
154847711|NCT01272635|Prednisolone|prednisolone|mesh-list
154847712|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154847713|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
154847714|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154847715|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
154847716|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154847717|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
154847718|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847719|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
154847720|NCT01272635|Hormones|hormones|mesh-ancestor
154847721|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847722|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847723|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847724|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847725|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
154847726|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
154847727|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847728|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847729|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154847730|NCT01272635|Protective Agents|protective agents|mesh-ancestor
154847731|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154847732|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847733|NCT04387097|Remifentanil|remifentanil|mesh-list
154847734|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154847735|NCT04387097|Narcotics|narcotics|mesh-ancestor
154847736|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847737|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847738|NCT04387097|Analgesics|analgesics|mesh-ancestor
154847739|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
154847740|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847741|NCT01270841|Enclomiphene|enclomiphene|mesh-list
154847742|NCT01270841|Clomiphene|clomiphene|mesh-list
154847743|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
154847744|NCT01270841|Testosterone|testosterone|mesh-list
154847745|NCT01270841|Androgens|androgens|mesh-ancestor
154847746|NCT01270841|Hormones|hormones|mesh-ancestor
154847747|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847748|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847749|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154847750|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
154847751|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154847752|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
154847753|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154847754|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154847755|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154847756|NCT01278407|Donepezil|donepezil|mesh-list
154847757|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154847758|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847759|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847760|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
154847761|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847762|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847763|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
154847764|NCT01278173|Vigabatrin|vigabatrin|mesh-list
154847765|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
154847766|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847767|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847768|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
154847769|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847770|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847771|NCT00784303|Lenvatinib|lenvatinib|mesh-list
154847772|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847773|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154847774|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847775|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847776|NCT00750815|Dexamethasone|dexamethasone|mesh-list
154847777|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
154847778|NCT00750815|Doxorubicin|doxorubicin|mesh-list
154847779|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154847780|NCT00750815|Bortezomib|bortezomib|mesh-list
154847781|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847782|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
154847783|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847784|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847785|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154847786|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
154027226|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
154847787|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847788|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847789|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154847790|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847791|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
154847792|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
154847793|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847794|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847795|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
154847796|NCT00750815|Hormones|hormones|mesh-ancestor
154847797|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847798|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847799|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154847800|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154847801|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154847802|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847803|NCT00784849|Methylene Blue|methylene blue|mesh-list
154847804|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847805|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847806|NCT01277861|Fentanyl|fentanyl|mesh-list
154847807|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154847808|NCT01277861|Narcotics|narcotics|mesh-ancestor
154847809|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847810|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847811|NCT01277861|Analgesics|analgesics|mesh-ancestor
154847812|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
154847813|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847814|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154847815|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154847816|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
154847817|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
154847818|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154847819|NCT00786487|Glycerol|glycerol|mesh-list
154847820|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154847821|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154847822|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154847823|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154847824|NCT00786487|Protective Agents|protective agents|mesh-ancestor
154847825|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847826|NCT03805633|Pancrelipase|pancrelipase|mesh-list
154847827|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847828|NCT01276847|Etanercept|etanercept|mesh-list
154847829|NCT01276847|Ustekinumab|ustekinumab|mesh-list
154847830|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154847831|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847832|NCT01276847|Analgesics|analgesics|mesh-ancestor
154847833|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
154847834|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847835|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847836|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847837|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847838|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154847839|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847840|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
154027300|NCT03777319|Hormones|hormones|mesh-ancestor
154847841|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
154847842|NCT00945269|Aldesleukin|aldesleukin|mesh-list
154847843|NCT00945269|Interleukin-2|interleukin-2|mesh-list
154847844|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
154847845|NCT00945269|Immunotoxins|immunotoxins|mesh-list
154847846|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847847|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847848|NCT00945269|Analgesics|analgesics|mesh-ancestor
154847849|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
154847850|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847851|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847852|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154847853|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154847854|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
154847855|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847856|NCT00945269|Immunoconjugates|immunoconjugates|mesh-ancestor
154847857|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
154847858|NCT01272791|Gemcitabine|gemcitabine|mesh-list
154847859|NCT01272791|Bavituximab|bavituximab|mesh-list
154847860|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154847861|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
154847862|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847863|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847864|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154847865|NCT00765661|Tacrolimus|tacrolimus|mesh-list
154847866|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847867|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
154847868|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847869|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154847870|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847871|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847872|NCT00765895|Nortriptyline|nortriptyline|mesh-list
154847873|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154847874|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
154847875|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154847876|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154847877|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154847878|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154847879|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847880|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
154847881|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847882|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847883|NCT01276457|Cyclosporine|cyclosporine|mesh-list
154847884|NCT01276457|Everolimus|everolimus|mesh-list
154847885|NCT01276457|Cyclosporins|cyclosporins|mesh-list
154847886|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847887|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847888|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154847889|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
154847890|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847891|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
154847892|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847893|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
154847894|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847895|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154847896|NCT01276457|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154847897|NCT01276457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154847898|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847899|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154847900|NCT03804931|Prednisone|prednisone|mesh-list
154847901|NCT03804931|Mesalamine|mesalamine|mesh-list
154847902|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847903|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
154847904|NCT03804931|Hormones|hormones|mesh-ancestor
154847905|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154847906|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847907|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847908|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847909|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154847910|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847911|NCT03804931|Analgesics|analgesics|mesh-ancestor
154847912|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
154847913|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847914|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599898|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154847915|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
154847916|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154847917|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847918|NCT02991131|Linezolid|linezolid|mesh-list
154847919|NCT02991131|Tedizolid|tedizolid|mesh-list
154847920|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
154847921|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154847922|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847923|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154847924|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847925|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847926|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154847927|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
154847928|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154847929|NCT00766753|Vaccines|vaccines|mesh-list
154847930|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
154847931|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847932|NCT00767767|Thiopental|thiopental|mesh-list
154847933|NCT00767767|Propofol|propofol|mesh-list
154847934|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154847935|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154847936|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847937|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154847938|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
154847939|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
154847940|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
154847941|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
154847942|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
154847943|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154847944|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847945|NCT00761345|Gemcitabine|gemcitabine|mesh-list
154847946|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154847947|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154847948|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
154847949|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847950|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847951|NCT00761345|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154847952|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154847953|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847954|NCT00762515|Triclosan|triclosan|mesh-list
154847955|NCT00762515|Fluorides|fluorides|mesh-list
154847956|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
154847957|NCT00762515|Protective Agents|protective agents|mesh-ancestor
154847958|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847959|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154847960|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154847961|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154847962|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154847963|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
154847964|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847965|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154847966|NCT00753935|Aspirin|aspirin|mesh-list
154847967|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154847968|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154847969|NCT00753935|Analgesics|analgesics|mesh-ancestor
154847970|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
154847971|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154847972|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154847973|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154847974|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154847975|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154847976|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154847977|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847978|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154847979|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154847980|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154847981|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
154847982|NCT00779285|Doxorubicin|doxorubicin|mesh-list
154847983|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154847984|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154847985|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847986|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154847987|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154847988|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599982|NCT02889237|Vitamin D|vitamin d|mesh-list
154847989|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154847990|NCT00786643|Leucovorin|leucovorin|mesh-list
154847991|NCT00786643|Interferons|interferons|mesh-list
154847992|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
154847993|NCT00786643|Bevacizumab|bevacizumab|mesh-list
154847994|NCT00786643|Fluorouracil|fluorouracil|mesh-list
154847995|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
154847996|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154847997|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154847998|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154847999|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154848000|NCT00786643|Growth Substances|growth substances|mesh-ancestor
154848001|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848002|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
154848003|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
154848004|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848005|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154848006|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848007|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
154848008|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
154848009|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848010|NCT00786643|Antidotes|antidotes|mesh-ancestor
154848011|NCT00786643|Protective Agents|protective agents|mesh-ancestor
154848012|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
154848013|NCT00786643|Vitamins|vitamins|mesh-ancestor
154848014|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
154848015|NCT01276379|Leucovorin|leucovorin|mesh-list
154848016|NCT01276379|Folic Acid|folic acid|mesh-list
154848017|NCT01276379|Fluorouracil|fluorouracil|mesh-list
154848018|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
154848019|NCT01276379|Irinotecan|irinotecan|mesh-list
154848020|NCT01276379|Cetuximab|cetuximab|mesh-list
154848021|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
154848022|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
154848023|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848024|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154848025|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848026|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848027|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
154848028|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848029|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154848030|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154848031|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848032|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154848033|NCT01276379|Antidotes|antidotes|mesh-ancestor
154848034|NCT01276379|Protective Agents|protective agents|mesh-ancestor
154848035|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
154848036|NCT01276379|Vitamins|vitamins|mesh-ancestor
154848037|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
154848038|NCT01276379|Hematinics|hematinics|mesh-ancestor
154848039|NCT01275547|Midazolam|midazolam|mesh-list
154848040|NCT01275547|Ketamine|ketamine|mesh-list
154848041|NCT01275547|Morphine|morphine|mesh-list
154848042|NCT01275547|Esketamine|esketamine|mesh-list
154848043|NCT01275547|Analgesics|analgesics|mesh-ancestor
154848044|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
154848045|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848046|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848047|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154848048|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154848049|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
154848050|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
154848051|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848052|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154848053|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154848054|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848055|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848056|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154848057|NCT01275547|Narcotics|narcotics|mesh-ancestor
154848058|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154848059|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154848060|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154848061|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154848062|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154848063|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
154848064|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
154848065|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
154848066|NCT00789685|Interferons|interferons|mesh-list
154848067|NCT00789685|Interferon-beta|interferon-beta|mesh-list
154848068|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848069|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
154848070|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848071|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
154848072|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848073|NCT02149303|Dabigatran|dabigatran|mesh-list
154848074|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
154848075|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154848076|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
154848077|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848078|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848079|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
154848080|NCT03803449|Midazolam|midazolam|mesh-list
154848081|NCT03803449|Fentanyl|fentanyl|mesh-list
154848082|NCT03803449|Propofol|propofol|mesh-list
154848083|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154848084|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848085|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848086|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154848087|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
154848088|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
154848089|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154848090|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154848091|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154848092|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154848093|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
154848094|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
154848095|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848096|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848097|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154848098|NCT03803449|Narcotics|narcotics|mesh-ancestor
154848099|NCT03803449|Analgesics|analgesics|mesh-ancestor
154848100|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
154848101|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848102|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
154848103|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154848104|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848105|NCT00789997|Levofloxacin|levofloxacin|mesh-list
154848106|NCT00789997|Prednisone|prednisone|mesh-list
154848107|NCT00789997|Etanercept|etanercept|mesh-list
154848108|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848109|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
154848110|NCT00789997|Hormones|hormones|mesh-ancestor
154848111|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848112|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848113|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154848114|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848115|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154848116|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848117|NCT00789997|Analgesics|analgesics|mesh-ancestor
154848118|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
154848119|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848120|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848121|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154848122|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848123|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
154848124|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154848125|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848126|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154848127|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154848128|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154848129|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848130|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848131|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154848132|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154848133|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
154848134|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154848135|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
154848136|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848137|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848138|NCT03803215|Theophylline|theophylline|mesh-list
154848139|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154848140|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
154848141|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848142|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848143|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154848144|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
154848145|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154848146|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848147|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848148|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
154848149|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154848150|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154848151|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
154848152|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848153|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154848154|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154848155|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
154848156|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848157|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848158|NCT03802747|Durvalumab|durvalumab|mesh-list
154848159|NCT03802747|Tremelimumab|tremelimumab|mesh-list
154848160|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154848161|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154848162|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848163|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
154848164|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848165|NCT00791323|Ketorolac|ketorolac|mesh-list
154848166|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154848167|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
154848168|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154848169|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154848170|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848171|NCT00791323|Analgesics|analgesics|mesh-ancestor
154848172|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
154848173|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848174|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848175|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848176|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848177|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154848178|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848179|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848180|NCT00772915|Dexamethasone|dexamethasone|mesh-list
154848181|NCT00772915|Lenalidomide|lenalidomide|mesh-list
154848182|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848183|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
154848184|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
154848185|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848186|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848187|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154848188|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
154848189|NCT00772915|Hormones|hormones|mesh-ancestor
154848190|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848191|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154848192|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848193|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
154848194|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154848195|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154848196|NCT00772915|Growth Substances|growth substances|mesh-ancestor
154848197|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
154848198|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
154176915|NCT00618995|Niacin|niacin|mesh-list
154848199|NCT03801733|Atorvastatin|atorvastatin|mesh-list
154848200|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154848201|NCT03801733|Simvastatin|simvastatin|mesh-list
154848202|NCT03801733|Pravastatin|pravastatin|mesh-list
154848203|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154848204|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154848205|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
154848206|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848207|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154848208|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154848209|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848210|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848211|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154848212|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848213|NCT03801733|Analgesics|analgesics|mesh-ancestor
154848214|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
154848215|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848216|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848217|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848218|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848219|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154848220|NCT00775411|Dexamethasone|dexamethasone|mesh-list
154600196|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154848221|NCT00775411|Ranibizumab|ranibizumab|mesh-list
154848222|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848223|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
154848224|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
154848225|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848226|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848227|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154848228|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
154848229|NCT00775411|Hormones|hormones|mesh-ancestor
154848230|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848231|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154848232|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848233|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154848234|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154848235|NCT00775411|Growth Substances|growth substances|mesh-ancestor
154848236|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
154848237|NCT03801499|Lenvatinib|lenvatinib|mesh-list
154848238|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848239|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154848240|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848241|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848242|NCT00808405|Acyclovir|acyclovir|mesh-list
154848243|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
154848244|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848245|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
154848246|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
154848247|NCT00775645|Vitamins|vitamins|mesh-ancestor
154848248|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
154848249|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848250|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
154848251|NCT01974687|Itraconazole|itraconazole|mesh-list
154848252|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
154848253|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
154848254|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848255|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154848256|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154848257|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848258|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848259|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154848260|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
154848261|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848262|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848263|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154848264|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
154848265|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
154848266|NCT00795145|Linezolid|linezolid|mesh-list
154848267|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154848268|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848269|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154848270|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154848271|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848272|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848273|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848274|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154848275|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
154848276|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154848277|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848278|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
154848279|NCT00809185|Everolimus|everolimus|mesh-list
154848280|NCT00809185|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154848281|NCT00809185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154848282|NCT00809185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848283|NCT00809185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848284|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848285|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
154848286|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848287|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848288|NCT03800953|Avelumab|avelumab|mesh-list
154848289|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154848290|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848291|NCT00795769|Ondansetron|ondansetron|mesh-list
154848292|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
154848293|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
154848294|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848295|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848296|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154848297|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
154848298|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
154848299|NCT00795769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154848300|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154848301|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
154848302|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848303|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848304|NCT01975935|Amlexanox|amlexanox|mesh-list
154848305|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154848306|NCT02305017|Acetaminophen|acetaminophen|mesh-list
154848307|NCT02305017|Opicapone|opicapone|mesh-list
154848308|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848309|NCT02305017|Analgesics|analgesics|mesh-ancestor
154848310|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
154848311|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848312|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848313|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
154848314|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154848315|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848316|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848317|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154848318|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154848319|NCT01976871|Rotigotine|rotigotine|mesh-list
154848320|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
154848321|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
154848322|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848323|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848324|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848325|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
154848326|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154848327|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
154848328|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848329|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848330|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154848331|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
154848332|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154848333|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
154848334|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848335|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848336|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154848337|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
154848338|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
154848339|NCT03602781|Protective Agents|protective agents|mesh-ancestor
154848340|NCT02280239|Acetaminophen|acetaminophen|mesh-list
154848341|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848342|NCT02280239|Analgesics|analgesics|mesh-ancestor
154848343|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
154848344|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848345|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848346|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
154848347|NCT01993875|Lubiprostone|lubiprostone|mesh-list
154848348|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154848349|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154848350|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848351|NCT00796705|Adalimumab|adalimumab|mesh-list
154848352|NCT00796705|Etanercept|etanercept|mesh-list
154848353|NCT00796705|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154848354|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848355|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848356|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154848357|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848358|NCT00796705|Analgesics|analgesics|mesh-ancestor
154848359|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
154848360|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848361|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848362|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154848363|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848364|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
154848365|NCT00809809|Zinc|zinc|mesh-list
154848366|NCT00809809|Trace Elements|trace elements|mesh-ancestor
154848367|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
154848368|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848369|NCT00248651|Amitriptyline|amitriptyline|mesh-list
154848370|NCT00248651|Escitalopram|escitalopram|mesh-list
154848371|NCT00248651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154848372|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154848373|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154848374|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848375|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848376|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
154848377|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848378|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848379|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
154848380|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154848381|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154848382|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848383|NCT00248651|Analgesics|analgesics|mesh-ancestor
154848384|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
154848385|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154848386|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
154848387|NCT03800797|Loxoprofen|loxoprofen|mesh-list
154848388|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154848389|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848390|NCT03800797|Analgesics|analgesics|mesh-ancestor
154848391|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
154848392|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848393|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848394|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848395|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848396|NCT04383067|Aldesleukin|aldesleukin|mesh-list
154848397|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848398|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154848399|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154848400|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
154848401|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848402|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154848403|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
154848404|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154848405|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154848406|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848407|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
154848408|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848409|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848410|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154848411|NCT00248495|Pemetrexed|pemetrexed|mesh-list
154848412|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848413|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848414|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848415|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154848416|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154848417|NCT03809767|Antibodies|antibodies|mesh-list
154848418|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154848419|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
154848420|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848421|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
154848422|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154848423|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848424|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848425|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848426|NCT03800641|Analgesics|analgesics|mesh-ancestor
154848427|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
154848428|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848429|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154848430|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154848431|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154848432|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
154848433|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848434|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848435|NCT03807011|Fentanyl|fentanyl|mesh-list
154848436|NCT03807011|Remifentanil|remifentanil|mesh-list
154848437|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154848438|NCT03807011|Narcotics|narcotics|mesh-ancestor
154848439|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848440|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848441|NCT03807011|Analgesics|analgesics|mesh-ancestor
154848442|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
154848443|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848444|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154848445|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154848446|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
154600436|NCT05060523|Tolvaptan|tolvaptan|mesh-list
154848447|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
154848448|NCT02986503|Cisplatin|cisplatin|mesh-list
154848449|NCT02986503|Doxorubicin|doxorubicin|mesh-list
154848450|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154848451|NCT02986503|Methotrexate|methotrexate|mesh-list
154848452|NCT02986503|Ifosfamide|ifosfamide|mesh-list
154848453|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
154848454|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848455|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154848456|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154848457|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154848458|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848459|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848460|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154848461|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
154848462|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154848463|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848464|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154848465|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
154848466|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
154848467|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154848468|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848469|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
154848470|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848471|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154848472|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154848473|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
154848474|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
154848475|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154848476|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154848477|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
154848478|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848479|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154848480|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154848481|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848482|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848483|NCT00763061|Timolol|timolol|mesh-list
154848484|NCT00763061|Travoprost|travoprost|mesh-list
154848485|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154848486|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154848487|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154848488|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154848489|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
154848490|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848491|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848492|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848493|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154848494|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154848495|NCT03806335|Anesthetics|anesthetics|mesh-list
154848496|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848497|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848498|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
154848499|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154848500|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848501|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848502|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848503|NCT03806777|Analgesics|analgesics|mesh-ancestor
154848504|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
154848505|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848506|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154848507|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154848508|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154848509|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
154848510|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848511|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848512|NCT00754247|Vitamin E|vitamin e|mesh-list
154848513|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
154848514|NCT00754247|Vitamins|vitamins|mesh-ancestor
154848515|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
154848516|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848517|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848518|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
154848519|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848520|NCT00754247|Protective Agents|protective agents|mesh-ancestor
154848521|NCT02305329|Opicapone|opicapone|mesh-list
154600491|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154848522|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154848523|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848524|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848525|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154848526|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154848527|NCT01979445|Clopidogrel|clopidogrel|mesh-list
154848528|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154848530|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154848531|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154848532|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154848533|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154848534|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
154848535|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848536|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848537|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848538|NCT03802565|Tolperisone|tolperisone|mesh-list
154848539|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154848540|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848541|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154848542|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848543|NCT04382443|Colchicine|colchicine|mesh-list
154848544|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
154848545|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848546|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
154848547|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
154848548|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
154848549|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848550|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848551|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154848552|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154848553|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
154848554|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154848555|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154848556|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848557|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
154848558|NCT01981863|Coagulants|coagulants|mesh-ancestor
154848559|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
154848560|NCT00245765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154848561|NCT00245765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848562|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848563|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
154848564|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848565|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848566|NCT01995045|Triamcinolone|triamcinolone|mesh-list
154848567|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154848568|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154848569|NCT01995045|Bupivacaine|bupivacaine|mesh-list
154848570|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154848571|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
154177240|NCT00526656|Sunitinib|sunitinib|mesh-list
154848572|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
154848573|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848574|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848575|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
154848576|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848577|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848578|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
154848579|NCT01995045|Hormones|hormones|mesh-ancestor
154848580|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848581|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848582|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
154848583|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848584|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848585|NCT01982643|Naltrexone|naltrexone|mesh-list
154848586|NCT01982643|Bupropion|bupropion|mesh-list
154848587|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154848588|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154848589|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848590|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
154848591|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848592|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154848593|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
154848594|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154848595|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154848596|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154848597|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177307|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154848598|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848599|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
154848600|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848601|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154848602|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154848603|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848604|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154848605|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154848606|NCT00797797|Milnacipran|milnacipran|mesh-list
154848607|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
154848608|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154848609|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154848610|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154848611|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848612|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848613|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848614|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848615|NCT00797797|Analgesics|analgesics|mesh-ancestor
154848616|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
154848617|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848618|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
154848619|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154848620|NCT03496233|Grazoprevir|grazoprevir|mesh-list
154848621|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154848622|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
154848623|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848624|NCT04482673|Vitamin D|vitamin d|mesh-list
154848625|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
154848626|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
154848627|NCT04482673|Vitamins|vitamins|mesh-list
154848628|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
154848629|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848630|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154848631|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154848632|NCT00245063|Cediranib|cediranib|mesh-list
154848633|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848634|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848635|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848636|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154848637|NCT02151487|Dexamethasone|dexamethasone|mesh-list
154848638|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
154848639|NCT02151487|Clonidine|clonidine|mesh-list
154848640|NCT02151487|Ropivacaine|ropivacaine|mesh-list
154848641|NCT02151487|BB 1101|bb 1101|mesh-list
154848642|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848643|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
154848644|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
154848645|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848646|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848647|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154848648|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
154848649|NCT02151487|Hormones|hormones|mesh-ancestor
154848650|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848651|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154848652|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848653|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
154177339|NCT03998436|Esmolol|esmolol|mesh-list
154848654|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848655|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848656|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
154848657|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
154848658|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848659|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
154848660|NCT02151487|Analgesics|analgesics|mesh-ancestor
154848661|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154848662|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
154848663|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154848664|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154848665|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154848666|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
154848667|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848668|NCT05318339|Trastuzumab|trastuzumab|mesh-list
154848669|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154848670|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848671|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
154848672|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154848673|NCT00764309|Dasatinib|dasatinib|mesh-list
154848674|NCT00764309|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154848675|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154848676|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848677|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848678|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848679|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
154848680|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154848681|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
154848682|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848683|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848684|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154848685|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
154848686|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154848687|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
154848688|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848689|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848690|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154848691|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
154848692|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
154848693|NCT02151877|Protective Agents|protective agents|mesh-ancestor
154848694|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154848695|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154848696|NCT00799435|Exenatide|exenatide|mesh-list
154848697|NCT00799435|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154848698|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154848699|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848700|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154848701|NCT00799435|Incretins|incretins|mesh-ancestor
154848702|NCT00799435|Hormones|hormones|mesh-ancestor
154848703|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848704|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
154848705|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154848706|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848707|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848708|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848709|NCT04329091|Analgesics|analgesics|mesh-ancestor
154848710|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
154848711|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848712|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154848713|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154848714|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154848715|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
154848716|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848717|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848718|NCT04382209|Meperidine|meperidine|mesh-list
154848719|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154848720|NCT04382209|Narcotics|narcotics|mesh-ancestor
154848721|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848722|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848723|NCT04382209|Analgesics|analgesics|mesh-ancestor
154848724|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
154848725|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848726|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154848727|NCT03417921|Paclitaxel|paclitaxel|mesh-list
154848728|NCT03417921|Gemcitabine|gemcitabine|mesh-list
154848729|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154848730|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848731|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
154848732|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
154848733|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
154848734|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848735|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154848736|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
154848737|NCT03378297|Aspirin|aspirin|mesh-list
154848738|NCT03378297|Metformin|metformin|mesh-list
154848739|NCT03378297|Letrozole|letrozole|mesh-list
154848740|NCT03378297|Olaparib|olaparib|mesh-list
154848741|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154848742|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848743|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848744|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154848745|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154600722|NCT06138600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154848746|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848747|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848748|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154848749|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
154848750|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848751|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154848752|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154848753|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848755|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
154848756|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848757|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848758|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848759|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154848760|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154848761|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154848762|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154848763|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
154848764|NCT03367689|Olaparib|olaparib|mesh-list
154848765|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154848766|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848767|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848768|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848769|NCT00243659|Factor VIII|factor viii|mesh-list
154848770|NCT00243659|Coagulants|coagulants|mesh-ancestor
154848771|NCT00814177|Warfarin|warfarin|mesh-list
154848772|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
154848773|NCT00243347|Cediranib|cediranib|mesh-list
154848774|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848775|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154848776|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848777|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848778|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
154848779|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154848780|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154848781|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848782|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
154177462|NCT04732182|Donepezil|donepezil|mesh-list
154848783|NCT03364491|Coagulants|coagulants|mesh-ancestor
154848784|NCT04294069|Azithromycin|azithromycin|mesh-list
154848785|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154848786|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848787|NCT01997229|Eculizumab|eculizumab|mesh-list
154848788|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154848789|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848790|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
154848791|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848792|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
154848793|NCT00800839|Busulfan|busulfan|mesh-list
154848794|NCT00800839|Fludarabine|fludarabine|mesh-list
154848795|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
154848796|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848797|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
154848798|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848799|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848800|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154848801|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
154848802|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848803|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848804|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154848805|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154848806|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
154848807|NCT00814255|Adalimumab|adalimumab|mesh-list
154848808|NCT00814255|Losartan|losartan|mesh-list
154848809|NCT00814255|Lisinopril|lisinopril|mesh-list
154848810|NCT00814255|Atorvastatin|atorvastatin|mesh-list
154848811|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154848812|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154848813|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
154848814|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848815|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154848816|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154848817|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848818|NCT00814255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154848819|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848820|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848821|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154848822|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154848823|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154848824|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154848825|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154848826|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
154848827|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154848828|NCT00814255|Protective Agents|protective agents|mesh-ancestor
154848829|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848830|NCT02000973|Lidocaine|lidocaine|mesh-list
154848831|NCT02000973|Bupivacaine|bupivacaine|mesh-list
154848832|NCT02000973|Ropivacaine|ropivacaine|mesh-list
154848833|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
154848834|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
154848835|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848836|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848837|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
154848838|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848839|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154848840|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154848841|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154848842|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154848843|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848844|NCT02002767|Velpatasvir|velpatasvir|mesh-list
154848845|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
154848846|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848847|NCT01985685|Thiamine|thiamine|mesh-list
154848848|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
154848849|NCT01985685|Vitamins|vitamins|mesh-ancestor
154848850|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
154848851|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848852|NCT00815347|Bosentan|bosentan|mesh-list
154848853|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154848854|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154848855|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848856|NCT01985763|Genistein|genistein|mesh-list
154848857|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154848858|NCT01985763|Protective Agents|protective agents|mesh-ancestor
154848859|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848860|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848861|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154848862|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848863|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848864|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
154848865|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154848866|NCT01985763|Estrogens|estrogens|mesh-ancestor
154848867|NCT01985763|Hormones|hormones|mesh-ancestor
154848868|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848869|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
154848870|NCT02061969|Linagliptin|linagliptin|mesh-list
154848871|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154848872|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848873|NCT02061969|Incretins|incretins|mesh-ancestor
154848874|NCT02061969|Hormones|hormones|mesh-ancestor
154848875|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848876|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154848877|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
154848878|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848879|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848880|NCT02003625|Meloxicam|meloxicam|mesh-list
154848881|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154848882|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154848883|NCT02003625|Analgesics|analgesics|mesh-ancestor
154848884|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
154848885|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848886|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848887|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848888|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848889|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154848890|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154848891|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848892|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848893|NCT04037683|Misoprostol|misoprostol|mesh-list
154848894|NCT04037683|Oxytocin|oxytocin|mesh-list
154848895|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
154848896|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154848897|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848898|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154848899|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
154848900|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154848901|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154848902|NCT02396511|Bevacizumab|bevacizumab|mesh-list
154848903|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154848904|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848905|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154848906|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154848907|NCT02396511|Growth Substances|growth substances|mesh-ancestor
154848908|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848909|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
154848910|NCT00816829|Fenofibrate|fenofibrate|mesh-list
154848911|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154848912|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
154848913|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848914|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154848915|NCT02062359|Aldesleukin|aldesleukin|mesh-list
154848916|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
154848917|NCT02062359|Fludarabine|fludarabine|mesh-list
154848918|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154848919|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
154848920|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848921|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154848922|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154848923|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
154848924|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848925|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154848926|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154848927|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154848928|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154848929|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
154848930|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848931|NCT02397291|Inositol|inositol|mesh-list
154848932|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
154848933|NCT02397291|Vitamins|vitamins|mesh-ancestor
154848934|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
154848935|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848936|NCT00816907|Metformin|metformin|mesh-list
154848937|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154848938|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848939|NCT00817219|Betamethasone|betamethasone|mesh-list
154848940|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
154848941|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154848942|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
154848943|NCT00817219|Calcipotriene|calcipotriene|mesh-list
154848944|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154848945|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154848946|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
154848947|NCT00817219|Hormones|hormones|mesh-ancestor
154848948|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154848949|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848950|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154848951|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
154848952|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
154848953|NCT00817843|Simvastatin|simvastatin|mesh-list
154848954|NCT00817843|Ezetimibe|ezetimibe|mesh-list
154848955|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154848956|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154848957|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
154848958|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848959|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154848960|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154848961|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154848962|NCT00817999|Clopidogrel|clopidogrel|mesh-list
154848963|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154848964|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154848965|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154848966|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154848967|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
154848968|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848969|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848970|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848971|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154848972|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154848973|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154848974|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
154848976|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
154848977|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
154848978|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848979|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848980|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
154848981|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154848982|NCT03839251|Aripiprazole|aripiprazole|mesh-list
154848983|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
154848984|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154848985|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154848986|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154848987|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154848988|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154848989|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
154848990|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
154848991|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154848992|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154848993|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154848994|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154848995|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
154848996|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154848997|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154848998|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154848999|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154849000|NCT00819403|Simvastatin|simvastatin|mesh-list
154849001|NCT00819403|Ezetimibe|ezetimibe|mesh-list
154849002|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154849003|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154849004|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154849005|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
154849006|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849007|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154849008|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154849009|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849010|NCT02010021|Letrozole|letrozole|mesh-list
154849011|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849012|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154849013|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154849014|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849015|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849016|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154849017|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
154849018|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849019|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849020|NCT02062905|Dexamethasone|dexamethasone|mesh-list
154849021|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849022|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
154849023|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
154849024|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849025|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849026|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849027|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
154849028|NCT02062905|Hormones|hormones|mesh-ancestor
154849029|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177706|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154849030|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154849031|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849032|NCT00820573|Metformin|metformin|mesh-list
154849033|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154849034|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154849035|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849036|NCT00820573|Incretins|incretins|mesh-ancestor
154849037|NCT00820573|Hormones|hormones|mesh-ancestor
154849038|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849039|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154849040|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
154849041|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849042|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849043|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
154849044|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154849045|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154849046|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154849047|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154849048|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849049|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
154849050|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849051|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849052|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154849053|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849054|NCT02010645|Decitabine|decitabine|mesh-list
154849055|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154849056|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
154849057|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849058|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849059|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849060|NCT02065479|Ticagrelor|ticagrelor|mesh-list
154849061|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154849062|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154849063|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154849064|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154849065|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154849066|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
154849067|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849068|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849069|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849070|NCT05236621|Dexamethasone|dexamethasone|mesh-list
154849071|NCT05236621|Pomalidomide|pomalidomide|mesh-list
154849072|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849073|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
154849074|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
154849075|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849076|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849077|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849078|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
154849079|NCT05236621|Hormones|hormones|mesh-ancestor
154849080|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849081|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154849082|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849083|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
154849084|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154849085|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154849086|NCT05236621|Growth Substances|growth substances|mesh-ancestor
154849087|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
154849088|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
154849089|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154849090|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849091|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849092|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849093|NCT02066727|Analgesics|analgesics|mesh-ancestor
154849094|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
154849095|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849096|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154849097|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154849098|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154849099|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154849100|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849101|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849102|NCT04349241|Favipiravir|favipiravir|mesh-list
154849103|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
154849104|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849105|NCT02812615|Micronutrients|micronutrients|mesh-list
154849106|NCT02812615|Trace Elements|trace elements|mesh-list
154849107|NCT02812615|Albendazole|albendazole|mesh-list
154849108|NCT02812615|Pyrantel|pyrantel|mesh-list
154849109|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
154849110|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
154849111|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154849112|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849113|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
154849114|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154849115|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154849116|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
154849117|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
154849118|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
154849119|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849120|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849121|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849122|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
154849123|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154849124|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154849125|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154849126|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849127|NCT02151253|Modafinil|modafinil|mesh-list
154849128|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154849129|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849130|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154849131|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154849132|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154849133|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849134|NCT02069847|Budesonide|budesonide|mesh-list
154849135|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849136|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154849137|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
154849138|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849139|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849140|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154849141|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
154849142|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
154849143|NCT02069847|Hormones|hormones|mesh-ancestor
154849144|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849145|NCT02070237|Enoxaparin|enoxaparin|mesh-list
154849146|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
154849147|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154849148|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154849149|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849150|NCT02071095|Poly I-C|poly i-c|mesh-list
154849151|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154849152|NCT02071095|Poly ICLC|poly iclc|mesh-list
154849153|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
154849154|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
154849155|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849156|NCT02071095|Laxatives|laxatives|mesh-ancestor
154849157|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849158|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
154849159|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849160|NCT02348359|Ranibizumab|ranibizumab|mesh-list
154849161|NCT02348359|Aflibercept|aflibercept|mesh-list
154177841|NCT00516048|Incretins|incretins|mesh-ancestor
154849162|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849163|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154849164|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154849165|NCT02348359|Growth Substances|growth substances|mesh-ancestor
154849166|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849167|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
154849168|NCT02406885|Apixaban|apixaban|mesh-list
154849169|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154849170|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
154849171|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154849172|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
154849173|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849174|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849175|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
154849176|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
154849177|NCT02408445|Testosterone|testosterone|mesh-list
154849178|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
154849179|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
154849180|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154849181|NCT02408445|Androgens|androgens|mesh-ancestor
154849182|NCT02408445|Hormones|hormones|mesh-ancestor
154849183|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849184|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849185|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154849186|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849187|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
154849188|NCT00388921|Vitamin A|vitamin a|mesh-list
154849189|NCT00388921|Vitamins|vitamins|mesh-ancestor
154849190|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
154849191|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849192|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
154849193|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154849194|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154849195|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154849196|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
154849197|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849198|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849199|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849200|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
154849201|NCT00142285|Astringents|astringents|mesh-ancestor
154849202|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849203|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
154849204|NCT02342379|Bevacizumab|bevacizumab|mesh-list
154849205|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154849206|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849207|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154849208|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154849209|NCT02342379|Growth Substances|growth substances|mesh-ancestor
154849210|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849211|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
154849212|NCT02019069|Cytarabine|cytarabine|mesh-list
154849213|NCT02019069|Daunorubicin|daunorubicin|mesh-list
154849214|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154849215|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
154849216|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849217|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849218|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
154849219|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849220|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154849221|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
154849222|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849223|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154849224|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154849225|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154849226|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849227|NCT00821821|Edaravone|edaravone|mesh-list
154849228|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154849229|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
154849230|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849231|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154849232|NCT00821821|Protective Agents|protective agents|mesh-ancestor
154849233|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849234|NCT00816751|Lidocaine|lidocaine|mesh-list
154849235|NCT00816751|Vasopressins|vasopressins|mesh-list
154849236|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
154849237|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
154849238|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
154849239|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849240|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849241|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
154849242|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849243|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154849244|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154849245|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154849246|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154849247|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849248|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
154849249|NCT00816751|Coagulants|coagulants|mesh-ancestor
154849250|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154849251|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154849252|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
154849253|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
154849254|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154849255|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154849256|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154849257|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154849258|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849259|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
154849260|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849261|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849262|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154849263|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849264|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
154849265|NCT02410707|Propofol|propofol|mesh-list
154849266|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154849267|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849268|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849269|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154849270|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
154849271|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
154849272|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154849273|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849274|NCT02410707|Analgesics|analgesics|mesh-ancestor
154849275|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
154849276|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849277|NCT02343081|Temozolomide|temozolomide|mesh-list
154849278|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154849279|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
154849280|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849281|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849282|NCT00823303|Calcitriol|calcitriol|mesh-list
154849283|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154849284|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849285|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154849286|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154849287|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849288|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154849289|NCT00823303|Vitamins|vitamins|mesh-ancestor
154849290|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
154849291|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154849292|NCT00823459|Everolimus|everolimus|mesh-list
154849293|NCT00823459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154849294|NCT00823459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154849295|NCT00823459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849296|NCT00823459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849297|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154849298|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
154849299|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849300|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849301|NCT00825565|Allantoin|allantoin|mesh-list
154849302|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
154849303|NCT00803647|Leucovorin|leucovorin|mesh-list
154849304|NCT00803647|Fluorouracil|fluorouracil|mesh-list
154849305|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
154849306|NCT00803647|Cetuximab|cetuximab|mesh-list
154849307|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
154849308|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849309|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154849310|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849311|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154849312|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
154849313|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849314|NCT00803647|Antidotes|antidotes|mesh-ancestor
154849315|NCT00803647|Protective Agents|protective agents|mesh-ancestor
154849316|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
154849317|NCT00803647|Vitamins|vitamins|mesh-ancestor
154849318|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
154849319|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154849320|NCT00827983|Progesterone|progesterone|mesh-list
154849321|NCT00827983|Progestins|progestins|mesh-ancestor
154849322|NCT00827983|Hormones|hormones|mesh-ancestor
154849323|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849324|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849325|NCT02346903|Capsaicin|capsaicin|mesh-list
154849326|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
154849327|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154849328|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
154849329|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849330|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849331|NCT02347605|Nicotine|nicotine|mesh-list
154849332|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154849333|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
154849334|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849335|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849336|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154849337|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154849338|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
154849339|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849340|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849341|NCT02153671|Vaccines|vaccines|mesh-list
154849342|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
154849343|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849344|NCT02413203|Celecoxib|celecoxib|mesh-list
154849345|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154860470|NCT03460990|Ivacaftor|ivacaftor|mesh-list
154849346|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849347|NCT02413203|Analgesics|analgesics|mesh-ancestor
154849348|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
154849349|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849350|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849351|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849352|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849353|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154849354|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154849355|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849356|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849357|NCT02153983|Colchicine|colchicine|mesh-list
154849358|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
154849359|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849360|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
154849361|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
154849362|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
154849363|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849364|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849365|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
154849366|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154849367|NCT02348775|Glycine|glycine|mesh-list
154849368|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
154849369|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849370|NCT02348775|Expectorants|expectorants|mesh-ancestor
154849371|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
154849372|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154849373|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
154849374|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849375|NCT02348775|Protective Agents|protective agents|mesh-ancestor
154849376|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849377|NCT02348775|Antidotes|antidotes|mesh-ancestor
154849378|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
154849379|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849380|NCT00828061|Prednisone|prednisone|mesh-list
154849381|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849382|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
154849383|NCT00828061|Hormones|hormones|mesh-ancestor
154849384|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849385|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849386|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154849387|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849388|NCT00849121|Vaccines|vaccines|mesh-list
154849389|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
154849390|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849391|NCT02023125|Esomeprazole|esomeprazole|mesh-list
154849392|NCT02023125|Alectinib|alectinib|mesh-list
154849393|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154849394|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849395|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154849396|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849397|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849398|NCT02023125|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154849399|NCT02023125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154849400|NCT02349477|Gabapentin|gabapentin|mesh-list
154849401|NCT02349477|Analgesics|analgesics|mesh-ancestor
154849402|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
154849403|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849404|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849405|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
154849406|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154849407|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154849408|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849409|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154849410|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154849411|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154849412|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849413|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849414|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
154849415|NCT00828295|Palonosetron|palonosetron|mesh-list
154849416|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
154849417|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
154849418|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849419|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849420|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601357|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
154860471|NCT03460990|VX-659|vx-659|mesh-list
154849421|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154849422|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154849423|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
154849424|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849425|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849427|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154849428|NCT02350569|Ledipasvir|ledipasvir|mesh-list
154849429|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
154849430|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849431|NCT02351115|Alprazolam|alprazolam|mesh-list
154849432|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154849433|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849434|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849435|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154849436|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154849437|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154849438|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
154849439|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
154849440|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849441|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849442|NCT02025075|Rocuronium|rocuronium|mesh-list
154849443|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154849444|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154849445|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154849446|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849447|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849448|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
154849449|NCT00242567|Androgens|androgens|mesh-list
154849450|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154849451|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849452|NCT00242567|Hormones|hormones|mesh-ancestor
154849453|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849454|NCT00241631|Fluticasone|fluticasone|mesh-list
154849455|NCT00241631|Xhance|xhance|mesh-list
154849456|NCT00241631|Theophylline|theophylline|mesh-list
154849457|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849458|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154849459|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
154849460|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849461|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849462|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154849463|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
154849464|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
154849465|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154849466|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154849467|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849468|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849469|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
154849470|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154849471|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154849472|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
154849473|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849474|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
154849475|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
154849476|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154849477|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849478|NCT02351739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154849479|NCT02351739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849480|NCT02351739|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154849481|NCT02351739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154849482|NCT02351739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849483|NCT00240071|Tamoxifen|tamoxifen|mesh-list
154849484|NCT00240071|Bevacizumab|bevacizumab|mesh-list
154849485|NCT00240071|Letrozole|letrozole|mesh-list
154849486|NCT00240071|Exemestane|exemestane|mesh-list
154849487|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154849488|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849489|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154849490|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154849491|NCT00240071|Growth Substances|growth substances|mesh-ancestor
154849492|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849493|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
154849494|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154849495|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154849496|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849497|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849498|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154849499|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
154849500|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849501|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154849502|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154849503|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154849504|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154849505|NCT02352363|Levodopa|levodopa|mesh-list
154849506|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154849507|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154849508|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
154849509|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849510|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849511|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849512|NCT00765947|Amlodipine|amlodipine|mesh-list
154849513|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154849514|NCT00765947|Aliskiren|aliskiren|mesh-list
154849515|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154849516|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154849517|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154849518|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849519|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154849520|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849521|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
154849522|NCT00765947|Diuretics|diuretics|mesh-ancestor
154849523|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
154849524|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154849525|NCT00765947|Renin Inhibitors|renin inhibitors|mesh-ancestor
154849526|NCT00765947|Protease Inhibitors|protease inhibitors|mesh-ancestor
154849527|NCT00765947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849528|NCT00766649|Sirolimus|sirolimus|mesh-list
154849529|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154849530|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849531|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154849532|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849533|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
154849534|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154849535|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
154849536|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849537|NCT02352831|Capecitabine|capecitabine|mesh-list
154849538|NCT02352831|Tosedostat|tosedostat|mesh-list
154849539|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154849540|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
154849541|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849542|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849543|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849544|NCT02353299|Zolpidem|zolpidem|mesh-list
154849545|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154849546|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154849547|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849548|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849549|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154849550|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
154849551|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
154849552|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849553|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849554|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154849555|NCT00756977|Laxatives|laxatives|mesh-ancestor
154849556|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849557|NCT00783965|Tazarotene|tazarotene|mesh-list
154849558|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
154849559|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
154849560|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
154849561|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154849562|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849563|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849564|NCT00421551|Ritonavir|ritonavir|mesh-list
154849565|NCT00421551|Darunavir|darunavir|mesh-list
154849566|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154849567|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154849568|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
154849569|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860472|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154849570|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849571|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154849572|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154849573|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
154849574|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849575|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154849576|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154849577|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
154849578|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154849579|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
154849580|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154849582|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154849583|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154849584|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154849585|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154849586|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
154849587|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849588|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849589|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849590|NCT02029755|Anesthetics|anesthetics|mesh-list
154849591|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
154849592|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849593|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849594|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
154849595|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849596|NCT03804749|Suramin|suramin|mesh-list
154849597|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
154849598|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
154849599|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154849600|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849601|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849602|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154849603|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154849604|NCT02312739|Ketorolac|ketorolac|mesh-list
154849605|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154849606|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
154849607|NCT02312739|Analgesics|analgesics|mesh-list
154849608|NCT02312739|Lorazepam|lorazepam|mesh-list
154849609|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154849610|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849611|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
154849612|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849613|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849614|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849615|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849616|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154849617|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849618|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849619|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154849620|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
154849621|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
154849622|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849623|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
154849624|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
154849625|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
154849626|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849627|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154849628|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154849629|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154849630|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154849631|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
154849632|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
154849633|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849634|NCT02351037|Azacitidine|azacitidine|mesh-list
154849635|NCT02351037|Ibrutinib|ibrutinib|mesh-list
154849636|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154849637|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
154849638|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849639|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849640|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849641|NCT02351037|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154849642|NCT02351037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154849643|NCT05718609|Amoxicillin|amoxicillin|mesh-list
154849644|NCT05718609|Clarithromycin|clarithromycin|mesh-list
154849645|NCT05718609|Furazolidone|furazolidone|mesh-list
154849647|NCT05718609|Bismuth|bismuth|mesh-list
154849648|NCT05718609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154849649|NCT05718609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849650|NCT05718609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154849651|NCT05718609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849652|NCT05718609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925344|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
154849653|NCT05718609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154849654|NCT05718609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154849655|NCT05718609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154849656|NCT05718609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849657|NCT05718609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154849658|NCT05718609|Antacids|antacids|mesh-ancestor
154849659|NCT05718609|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154849660|NCT05718609|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154849661|NCT05718609|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154849662|NCT05718609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154849663|NCT05718609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154849664|NCT05718609|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154849665|NCT02359305|Acetaminophen|acetaminophen|mesh-list
154849666|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849667|NCT02359305|Analgesics|analgesics|mesh-ancestor
154849668|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
154849669|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849670|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849671|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
154849672|NCT02360319|Aripiprazole|aripiprazole|mesh-list
154849673|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
154849674|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
154849675|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154849676|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154849677|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849678|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849679|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
154849680|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
154849681|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849682|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849683|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154849684|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154849685|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
154849686|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154849687|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154849688|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154849689|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154849690|NCT05718531|Aspirin|aspirin|mesh-list
154849691|NCT05718531|Rivaroxaban|rivaroxaban|mesh-list
154849692|NCT05718531|Clopidogrel|clopidogrel|mesh-list
154849693|NCT05718531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154849694|NCT05718531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849695|NCT05718531|Analgesics|analgesics|mesh-ancestor
154849696|NCT05718531|Sensory System Agents|sensory system agents|mesh-ancestor
154849697|NCT05718531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849698|NCT05718531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849699|NCT05718531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849700|NCT05718531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849701|NCT05718531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154849702|NCT05718531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154849703|NCT05718531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849704|NCT05718531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154849705|NCT05718531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154849706|NCT05718531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849707|NCT05718531|Antipyretics|antipyretics|mesh-ancestor
154849708|NCT05718531|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154849709|NCT05718531|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154849710|NCT05718531|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154849711|NCT05718531|Purinergic Agents|purinergic agents|mesh-ancestor
154849712|NCT05718531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849713|NCT05718531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154849714|NCT05718531|Antithrombins|antithrombins|mesh-ancestor
154849715|NCT05718531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154849716|NCT05718531|Protease Inhibitors|protease inhibitors|mesh-ancestor
154849717|NCT05718531|Anticoagulants|anticoagulants|mesh-ancestor
154849718|NCT02360631|Varenicline|varenicline|mesh-list
154849719|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154849720|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154849721|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
154849722|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849723|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849724|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849725|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
154849726|NCT00355095|Hematinics|hematinics|mesh-ancestor
154849727|NCT02366871|Enoxaparin|enoxaparin|mesh-list
154849728|NCT02366871|Apixaban|apixaban|mesh-list
154849729|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
154849730|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154849731|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154849732|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849733|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154849734|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
154849735|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154849736|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
154849737|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849738|NCT02368431|Zonisamide|zonisamide|mesh-list
154849739|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
154849740|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154849741|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154849742|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849743|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154849744|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849745|NCT03836651|Antioxidants|antioxidants|mesh-list
154849746|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849747|NCT03836651|Protective Agents|protective agents|mesh-ancestor
154849748|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849749|NCT02037555|Antithrombins|antithrombins|mesh-list
154849750|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
154849751|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154849752|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
154849753|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849754|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849755|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
154849756|NCT03804359|Rituximab|rituximab|mesh-list
154849757|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154849758|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849759|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
154849760|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849761|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849762|NCT02369211|Acetaminophen|acetaminophen|mesh-list
154849763|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849764|NCT02369211|Analgesics|analgesics|mesh-ancestor
154849765|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
154849766|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849767|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849768|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
154849769|NCT02038023|Iron|iron|mesh-list
154849770|NCT02038023|Dextrans|dextrans|mesh-list
154849771|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
154849772|NCT02038023|Trace Elements|trace elements|mesh-ancestor
154849773|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
154849774|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849775|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
154849776|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
154849777|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
154849778|NCT02038023|Hematinics|hematinics|mesh-ancestor
154849779|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
154849780|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154849781|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
154849782|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849783|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849784|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154849785|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
154849786|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154849787|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
154849788|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849789|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849790|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154849791|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
154849792|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
154849793|NCT04384133|Protective Agents|protective agents|mesh-ancestor
154849794|NCT02038179|Allopurinol|allopurinol|mesh-list
154849795|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
154849796|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849797|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849799|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849800|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154849801|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
154849802|NCT02038179|Protective Agents|protective agents|mesh-ancestor
154849803|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849804|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154849805|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154849806|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154849807|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
154849808|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849809|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849810|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849811|NCT00768521|Urological Agents|urological agents|mesh-ancestor
154849812|NCT00768599|Econazole|econazole|mesh-list
154849813|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
154849814|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849815|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154849816|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154849817|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849818|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849819|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154849820|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
154849821|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849822|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849823|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
154849824|NCT02370693|Bortezomib|bortezomib|mesh-list
154849825|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154849826|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849827|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154849828|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
154849829|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154849830|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849831|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849832|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849833|NCT02039115|Prednisone|prednisone|mesh-list
154849834|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849835|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
154849836|NCT02039115|Hormones|hormones|mesh-ancestor
154849837|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849838|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849839|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154849840|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849841|NCT00759473|Cycloserine|cycloserine|mesh-list
154849842|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154849843|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849844|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154849845|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
154849846|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154849847|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
154178512|NCT00879047|Ethanol|ethanol|mesh-list
154849848|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849849|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154849850|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849851|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849852|NCT03809273|Trimetazidine|trimetazidine|mesh-list
154849853|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
154849854|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154849855|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154849856|NCT00354627|Etravirine|etravirine|mesh-list
154849857|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154849858|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154849859|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154849860|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849861|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
154849862|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849863|NCT00770861|Nebivolol|nebivolol|mesh-list
154849864|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154849865|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
154849866|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154849867|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154849868|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154849869|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
154849870|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849871|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849872|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849874|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
154849875|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
154849876|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
154849877|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
154849878|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849879|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849880|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849881|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154849882|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849883|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849884|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
154849885|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
154849886|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154849887|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
154849888|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
154849889|NCT03803267|Fentanyl|fentanyl|mesh-list
154849890|NCT03803267|Propofol|propofol|mesh-list
154849891|NCT03803267|Atracurium|atracurium|mesh-list
154849892|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
154849893|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849894|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849895|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154849896|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154849897|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
154849898|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154849899|NCT03803267|Narcotics|narcotics|mesh-ancestor
154849900|NCT03803267|Analgesics|analgesics|mesh-ancestor
154849901|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
154849902|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849903|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154849904|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154849905|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154849906|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154849907|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154849908|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154849909|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
154849910|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849911|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849912|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154849913|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
154849914|NCT03808649|Mannitol|mannitol|mesh-list
154849915|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154849916|NCT03808649|Diuretics|diuretics|mesh-ancestor
154849917|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
154849918|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849919|NCT00788255|Oxytocin|oxytocin|mesh-list
154849920|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
154849921|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154849922|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849923|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154849924|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
154849925|NCT02379195|Fludarabine|fludarabine|mesh-list
154849926|NCT02379195|Interleukin-2|interleukin-2|mesh-list
154849927|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154849928|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
154849929|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849930|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849931|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154849932|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
154849933|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849934|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849935|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154849936|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849937|NCT02379195|Analgesics|analgesics|mesh-ancestor
154849938|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
154849939|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849940|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
154849941|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154849942|NCT00771875|Acetaminophen|acetaminophen|mesh-list
154849943|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
154849944|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
154849945|NCT00771875|Rituximab|rituximab|mesh-list
154849946|NCT00771875|Bortezomib|bortezomib|mesh-list
154849947|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
154849948|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154849949|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154849950|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
154849951|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154849952|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154849953|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
154849954|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849955|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849956|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849957|NCT00771875|Analgesics|analgesics|mesh-ancestor
154849958|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
154849959|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849960|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
154849961|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849962|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
154849963|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
154849964|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154849965|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
154849966|NCT00771875|Hormones|hormones|mesh-ancestor
154849967|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154849968|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154849969|NCT00771875|Protective Agents|protective agents|mesh-ancestor
154849970|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154849971|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154849972|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154849973|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849974|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
154849975|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
154849976|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
154849977|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154849978|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849979|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154849980|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154849981|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154849982|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154849983|NCT00760019|Analgesics|analgesics|mesh-ancestor
154849984|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
154849985|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154849986|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849987|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154849988|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154849989|NCT00789113|Lamotrigine|lamotrigine|mesh-list
154849990|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
154849991|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154849992|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154849993|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154849994|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154849995|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154849996|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154849997|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154849998|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154849999|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850000|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154850001|NCT03808259|Ketamine|ketamine|mesh-list
154850002|NCT03808259|Esketamine|esketamine|mesh-list
154850003|NCT03808259|Analgesics|analgesics|mesh-ancestor
154850004|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
154850005|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850006|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850007|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154850008|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154850009|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
154850010|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
154850011|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850012|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154850013|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154850014|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850015|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850016|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
154850017|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850018|NCT02051595|Vancomycin|vancomycin|mesh-list
154850019|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154850020|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850021|NCT05742503|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154850022|NCT05742503|Medroxyprogesterone|medroxyprogesterone|mesh-list
154850023|NCT05742503|Etonogestrel|etonogestrel|mesh-list
154850024|NCT05742503|Norgestrel|norgestrel|mesh-list
154850025|NCT05742503|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154850026|NCT05742503|Contraceptive Agents|contraceptive agents|mesh-ancestor
154850027|NCT05742503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154850028|NCT05742503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850029|NCT05742503|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154850030|NCT05742503|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154850031|NCT05742503|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154850032|NCT05742503|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154850033|NCT05742503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154850034|NCT05742503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850035|NCT05742503|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154850036|NCT02388321|Fentanyl|fentanyl|mesh-list
154850037|NCT02388321|Ketamine|ketamine|mesh-list
154850038|NCT02388321|Analgesics|analgesics|mesh-ancestor
154850039|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
154850040|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850041|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850042|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154850043|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154850044|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
154850045|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
154850046|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850047|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154850048|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154850049|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850050|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850051|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850052|NCT02388321|Narcotics|narcotics|mesh-ancestor
154850053|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154850054|NCT05742425|Bevacizumab|bevacizumab|mesh-list
154850055|NCT05742425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154850056|NCT05742425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850057|NCT05742425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154850058|NCT05742425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154850059|NCT05742425|Growth Substances|growth substances|mesh-ancestor
154850060|NCT05742425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850061|NCT05742425|Growth Inhibitors|growth inhibitors|mesh-ancestor
154850062|NCT02313675|Acetaminophen|acetaminophen|mesh-list
154850063|NCT02313675|Ketorolac|ketorolac|mesh-list
154850064|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154850065|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850066|NCT02313675|Analgesics|analgesics|mesh-ancestor
154850067|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
154850068|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850069|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850070|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
154850071|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154850072|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850073|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850074|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154850075|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850076|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850077|NCT03801629|Morphine|morphine|mesh-list
154850078|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850079|NCT03801629|Narcotics|narcotics|mesh-ancestor
154850080|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850081|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850082|NCT03801629|Analgesics|analgesics|mesh-ancestor
154850083|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
154850084|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850085|NCT05741021|Paclitaxel|paclitaxel|mesh-list
154850086|NCT05741021|Carboplatin|carboplatin|mesh-list
154850087|NCT05741021|Pemetrexed|pemetrexed|mesh-list
154850088|NCT05741021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154850089|NCT05741021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850090|NCT05741021|Tubulin Modulators|tubulin modulators|mesh-ancestor
154850091|NCT05741021|Antimitotic Agents|antimitotic agents|mesh-ancestor
154850092|NCT05741021|Mitosis Modulators|mitosis modulators|mesh-ancestor
154850093|NCT05741021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850094|NCT05741021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850095|NCT05741021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154850096|NCT05741021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154850097|NCT04383977|Etoposide|etoposide|mesh-list
154850098|NCT04383977|Apatinib|apatinib|mesh-list
154602044|NCT02506699|Analgesics|analgesics|mesh-list
154850099|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154850100|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850101|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154850102|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154850103|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850104|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850105|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154850106|NCT02389959|Bevacizumab|bevacizumab|mesh-list
154850107|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154850108|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850109|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154850110|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154850111|NCT02389959|Growth Substances|growth substances|mesh-ancestor
154850112|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850113|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
154850114|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
154850115|NCT00775931|Busulfan|busulfan|mesh-list
154850116|NCT00775931|Fludarabine|fludarabine|mesh-list
154850117|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
154850118|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
154850119|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154850120|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
154850121|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850122|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850123|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154850124|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
154850125|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850126|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850127|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154850128|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154850129|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
154850130|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154850131|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154850132|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154850133|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154850134|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
154850135|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850136|NCT05734235|Vitamins|vitamins|mesh-list
154850137|NCT05734235|Vitamin E|vitamin e|mesh-list
154850138|NCT05734235|Micronutrients|micronutrients|mesh-ancestor
154850139|NCT05734235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850140|NCT05734235|Antioxidants|antioxidants|mesh-ancestor
154850141|NCT05734235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850142|NCT05734235|Protective Agents|protective agents|mesh-ancestor
154850143|NCT05732129|Irinotecan|irinotecan|mesh-list
154850144|NCT05732129|Fluzoparib|fluzoparib|mesh-list
154850145|NCT05732129|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154850146|NCT05732129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154850147|NCT05732129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850148|NCT05732129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850149|NCT05732129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850150|NCT05732129|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154850151|NCT02394951|Pregabalin|pregabalin|mesh-list
154850152|NCT02394951|Analgesics|analgesics|mesh-ancestor
154850153|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
154850154|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850155|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850156|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
154850157|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154850158|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850159|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178826|NCT05879627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850160|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154850161|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154850162|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154850163|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850164|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850165|NCT03838367|Leronlimab|leronlimab|mesh-list
154850166|NCT03838367|Carboplatin|carboplatin|mesh-list
154850167|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
154850168|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850169|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154850170|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154850171|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850172|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154850173|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154850175|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850176|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
154850177|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850178|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
154850179|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154850180|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
154850181|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850182|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
154850183|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154850184|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154850185|NCT04345445|Prednisolone|prednisolone|mesh-list
154850186|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
154850187|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154850188|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
154850189|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850190|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
154850191|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
154850192|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850193|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850194|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154850195|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
154850196|NCT04345445|Hormones|hormones|mesh-ancestor
154850197|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850198|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154850199|NCT04345445|Protective Agents|protective agents|mesh-ancestor
154850200|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154850201|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850202|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
154850203|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154850204|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850205|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154850206|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154850207|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850208|NCT00795275|Incretins|incretins|mesh-ancestor
154850209|NCT00795275|Hormones|hormones|mesh-ancestor
154850210|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850211|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154850212|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
154850213|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850214|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850215|NCT00777335|Panobinostat|panobinostat|mesh-list
154850216|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850217|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154850218|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850219|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850220|NCT05644587|Buprenorphine|buprenorphine|mesh-list
154850221|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154850222|NCT05644587|Naloxone|naloxone|mesh-list
154850223|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850224|NCT05644587|Narcotics|narcotics|mesh-ancestor
154850225|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850226|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850227|NCT05644587|Analgesics|analgesics|mesh-ancestor
154850228|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
154850229|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850230|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154850231|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
154850232|NCT00355407|Hematinics|hematinics|mesh-ancestor
154850233|NCT00355251|Atorvastatin|atorvastatin|mesh-list
154850234|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154850235|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154850236|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
154850237|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850238|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154850239|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154850240|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850241|NCT03832127|Fludarabine|fludarabine|mesh-list
154850242|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850243|NCT00791219|Itraconazole|itraconazole|mesh-list
154850244|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154850245|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
154850246|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850247|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154850248|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154850249|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850250|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850251|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154850252|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
154850253|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850254|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850255|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154850256|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
154850257|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154850258|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
154850259|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850260|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
154850261|NCT00797459|Protective Agents|protective agents|mesh-ancestor
154850263|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154850264|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154850265|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850266|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850267|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154850268|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154850269|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850270|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154850271|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
154850272|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
154850273|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
154850274|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
154850275|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850276|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850277|NCT00355953|Genistein|genistein|mesh-list
154850278|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154850279|NCT00355953|Protective Agents|protective agents|mesh-ancestor
154850280|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850281|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850282|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154850283|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178945|NCT05846906|Sequestering Agents|sequestering agents|mesh-ancestor
154850284|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850285|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
154850286|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154850287|NCT00355953|Estrogens|estrogens|mesh-ancestor
154850288|NCT00355953|Hormones|hormones|mesh-ancestor
154850289|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850290|NCT05416073|Sufentanil|sufentanil|mesh-list
154850291|NCT05416073|Esketamine|esketamine|mesh-list
154850292|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850293|NCT05416073|Narcotics|narcotics|mesh-ancestor
154850294|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850295|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850296|NCT05416073|Analgesics|analgesics|mesh-ancestor
154850297|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
154850298|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850299|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154850300|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154850301|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
154850302|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
154850303|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
154850304|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850305|NCT05664971|Paclitaxel|paclitaxel|mesh-list
154850306|NCT05664971|Etoposide|etoposide|mesh-list
154850307|NCT05664971|Docetaxel|docetaxel|mesh-list
154850308|NCT05664971|Carboplatin|carboplatin|mesh-list
154850309|NCT05664971|Pemetrexed|pemetrexed|mesh-list
154850310|NCT05664971|Antibodies|antibodies|mesh-list
154850311|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154850312|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154850313|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850314|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
154850315|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
154850316|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
154850317|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850318|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
154850319|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850320|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154850321|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154850322|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850323|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154850324|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154850325|NCT05590299|Immunomodulating Agents|immunomodulating agents|mesh-list
154850326|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
154850327|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850328|NCT04812509|Denosumab|denosumab|mesh-list
154850329|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154850330|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850331|NCT05446623|Sufentanil|sufentanil|mesh-list
154850332|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
154850333|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154850334|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850335|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850336|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850337|NCT05446623|Analgesics|analgesics|mesh-ancestor
154850338|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
154850339|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850340|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154850341|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154850342|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154850343|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
154850344|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850345|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850346|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850347|NCT05446623|Narcotics|narcotics|mesh-ancestor
154850348|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154850349|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154850350|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
154850351|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
154850352|NCT00792077|Lenalidomide|lenalidomide|mesh-list
154850353|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
154850354|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850355|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154850356|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154850357|NCT00792077|Growth Substances|growth substances|mesh-ancestor
154850358|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
154850359|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850360|NCT02979015|Alirocumab|alirocumab|mesh-list
154850361|NCT02979015|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154850362|NCT02979015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154850363|NCT02979015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154850364|NCT02979015|Antimetabolites|antimetabolites|mesh-ancestor
154850365|NCT02979015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850366|NCT02979015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154850367|NCT02979015|Protease Inhibitors|protease inhibitors|mesh-ancestor
154850368|NCT02979015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850369|NCT02979015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154850370|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154850371|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
154850372|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154850373|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850374|NCT00799643|Analgesics|analgesics|mesh-ancestor
154850375|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
154850376|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850377|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850378|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850379|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850380|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154850381|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850382|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850383|NCT03835013|Exenatide|exenatide|mesh-list
154850384|NCT03835013|Glucagon|glucagon|mesh-list
154850385|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154850386|NCT03835013|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154850387|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154850388|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850389|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154850390|NCT03835013|Incretins|incretins|mesh-ancestor
154850391|NCT03835013|Hormones|hormones|mesh-ancestor
154850392|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850393|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154850394|NCT00800345|Topotecan|topotecan|mesh-list
154850395|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154850396|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154850397|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850398|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850400|NCT03806751|Acetazolamide|acetazolamide|mesh-list
154850401|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
154850402|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154850403|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850404|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850405|NCT03806751|Diuretics|diuretics|mesh-ancestor
154850406|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
154179072|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
154850407|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850408|NCT04383197|Semaglutide|semaglutide|mesh-list
154850409|NCT04383197|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154850410|NCT04383197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154850411|NCT04383197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850412|NCT03973229|Estradiol|estradiol|mesh-list
154850413|NCT03973229|Estrogens|estrogens|mesh-ancestor
154850414|NCT03973229|Hormones|hormones|mesh-ancestor
154850415|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850416|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850417|NCT03782103|Ethanol|ethanol|mesh-list
154850418|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
154850419|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154850420|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154850421|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850422|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850423|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850424|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
154850425|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
154850426|NCT00810719|Gemcitabine|gemcitabine|mesh-list
154850427|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154850428|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154850429|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
154850430|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850431|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850432|NCT00810719|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154850433|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154850434|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850435|NCT03761277|Morphine|morphine|mesh-list
154850436|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850437|NCT03761277|Narcotics|narcotics|mesh-ancestor
154850438|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850439|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850440|NCT03761277|Analgesics|analgesics|mesh-ancestor
154850441|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
154850442|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850443|NCT00810797|Exemestane|exemestane|mesh-list
154850444|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850445|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154850446|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154850447|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850448|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850449|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154850450|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
154850451|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850452|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850453|NCT00355641|Ropinirole|ropinirole|mesh-list
154850454|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154850455|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154850456|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
154850457|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
154850458|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850459|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179130|NCT05608200|Lenvatinib|lenvatinib|mesh-list
154850460|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850461|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
154850462|NCT00356733|Hematinics|hematinics|mesh-ancestor
154850463|NCT04591925|Insulin|insulin|mesh-list
154850464|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154850465|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154850466|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850467|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154850468|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154850469|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154850470|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
154850471|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154850472|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154850473|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154850474|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850475|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850476|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
154850477|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850478|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850479|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154850480|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850482|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154850483|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154850484|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
154850485|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850486|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850487|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850488|NCT00802685|Ibuprofen|ibuprofen|mesh-list
154850489|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154850490|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850491|NCT00802685|Analgesics|analgesics|mesh-ancestor
154850492|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
154850493|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850494|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850495|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850496|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850497|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154850498|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850499|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850500|NCT00802919|Varenicline|varenicline|mesh-list
154850501|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154850502|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154850503|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
154850504|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850505|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850506|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850507|NCT00803543|Valacyclovir|valacyclovir|mesh-list
154850508|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
154850509|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850510|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
154850511|NCT04099641|Bavituximab|bavituximab|mesh-list
154850512|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154850513|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850514|NCT04099641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154850515|NCT04099641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850516|NCT05051735|Acetaminophen|acetaminophen|mesh-list
154850517|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850518|NCT05051735|Analgesics|analgesics|mesh-ancestor
154850519|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
154850520|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850521|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850522|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
154850523|NCT03357627|Venetoclax|venetoclax|mesh-list
154850524|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850525|NCT04923113|Amoxicillin|amoxicillin|mesh-list
154850526|NCT04923113|Minocycline|minocycline|mesh-list
154850527|NCT04923113|Rabeprazole|rabeprazole|mesh-list
154850528|NCT04923113|Bismuth|bismuth|mesh-list
154850529|NCT04923113|Antibodies|antibodies|mesh-list
154850530|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
154850531|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850532|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154850533|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850534|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154850535|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154850536|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154850537|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850538|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850539|NCT04923113|Antacids|antacids|mesh-ancestor
154850540|NCT00805493|Riluzole|riluzole|mesh-list
154850541|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
154850542|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154850543|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154850544|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850545|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850546|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850547|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154602502|NCT03121417|Nivolumab|nivolumab|mesh-list
154850548|NCT00805493|Protective Agents|protective agents|mesh-ancestor
154850549|NCT03236649|Sorafenib|sorafenib|mesh-list
154850550|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850551|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154850552|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850553|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850554|NCT00807209|Fentanyl|fentanyl|mesh-list
154850555|NCT00807209|Bupivacaine|bupivacaine|mesh-list
154850556|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
154850557|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
154850558|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850559|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850560|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
154850561|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850562|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850563|NCT00807209|Narcotics|narcotics|mesh-ancestor
154850564|NCT00807209|Analgesics|analgesics|mesh-ancestor
154850565|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154850566|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154850567|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
154850568|NCT00807989|Lamotrigine|lamotrigine|mesh-list
154850569|NCT00807989|Carbamazepine|carbamazepine|mesh-list
154850570|NCT00807989|Valproic Acid|valproic acid|mesh-list
154850571|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
154850572|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154850573|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850574|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850575|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154850576|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850577|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154850578|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154850579|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850580|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850581|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154850582|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850583|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
154850584|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850585|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
154850586|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850587|NCT00807989|Analgesics|analgesics|mesh-ancestor
154850588|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
154850589|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850590|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154850591|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154850592|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154850593|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
154850594|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154850595|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154850596|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
154850597|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850598|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154850599|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154850600|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850601|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850602|NCT04845490|Mitomycins|mitomycins|mesh-list
154850603|NCT04845490|Mitomycin|mitomycin|mesh-list
154850604|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154850605|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850606|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
154850607|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850608|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154850609|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850610|NCT00357045|Paroxetine|paroxetine|mesh-list
154850611|NCT00357045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154850612|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154850613|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850614|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850615|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850616|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
154850617|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850618|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154850619|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
154850620|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850621|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154850622|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154850623|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850624|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
154850625|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154850626|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154850627|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850628|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850629|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154850630|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850631|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850632|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
154850633|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850634|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154850635|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154850636|NCT04819360|Urological Agents|urological agents|mesh-ancestor
154850637|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154850638|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154850639|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154850640|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
154179320|NCT06013150|Autonomic Agents|autonomic agents|mesh-ancestor
154850641|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850642|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154850643|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154850644|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850645|NCT04436458|Niclosamide|niclosamide|mesh-list
154850646|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
154850647|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154850648|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
154850649|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154850650|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850651|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
154850652|NCT03834753|Bevacizumab|bevacizumab|mesh-list
154850653|NCT03834753|Ranibizumab|ranibizumab|mesh-list
154850654|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154850655|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850656|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154850657|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154850658|NCT03834753|Growth Substances|growth substances|mesh-ancestor
154850659|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850660|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
154850661|NCT00845039|Irinotecan|irinotecan|mesh-list
154850662|NCT00845039|Cetuximab|cetuximab|mesh-list
154850663|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154850664|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154850665|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154850666|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850667|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850668|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850669|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154850670|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
154850671|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850672|NCT00845195|Azelastine|azelastine|mesh-list
154850673|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154850674|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154850675|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
154850676|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850677|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850678|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154850679|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
154850680|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154850681|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850682|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850683|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154850684|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154850685|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154850686|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
154850687|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
154850688|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850689|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154850690|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850691|NCT00845195|Analgesics|analgesics|mesh-ancestor
154850692|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
154850693|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850694|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850695|NCT00845507|Exenatide|exenatide|mesh-list
154850696|NCT00845507|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154850698|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850699|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154850700|NCT00845507|Incretins|incretins|mesh-ancestor
154850701|NCT00845507|Hormones|hormones|mesh-ancestor
154850702|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850703|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
154850704|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154850705|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850706|NCT03761914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154850707|NCT03761914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850708|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
154850709|NCT00845663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154850710|NCT00845663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850711|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154850712|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
154850713|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850714|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850715|NCT03092895|Apatinib|apatinib|mesh-list
154850716|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850717|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154850718|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850719|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850720|NCT03839771|Ivosidenib|ivosidenib|mesh-list
154850721|NCT03839771|Glycine|glycine|mesh-list
154850722|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850723|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850724|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850725|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
154850726|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850727|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850728|NCT02593396|Bupropion|bupropion|mesh-list
154850729|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154850730|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
154850731|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850732|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154850733|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154850734|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850735|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850736|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
154850737|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850738|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850739|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154850740|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154850741|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850742|NCT00848783|Capecitabine|capecitabine|mesh-list
154850743|NCT00848783|Irinotecan|irinotecan|mesh-list
154850744|NCT00848783|Floxuridine|floxuridine|mesh-list
154850745|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850746|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154850747|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
154850748|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850749|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154850750|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154850751|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850752|NCT05372536|Cytarabine|cytarabine|mesh-list
154850753|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154850754|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
154850755|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850756|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850757|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
154850758|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850759|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154850760|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
154850761|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850762|NCT00849251|Dexamethasone|dexamethasone|mesh-list
154850763|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
154850764|NCT00849251|Doxorubicin|doxorubicin|mesh-list
154850765|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154850766|NCT00849251|Bortezomib|bortezomib|mesh-list
154850767|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154850768|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
154850769|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850770|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850771|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154850772|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
154850773|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850774|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850775|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154850776|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850777|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
154850778|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
154850779|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850780|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154850781|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
154850782|NCT00849251|Hormones|hormones|mesh-ancestor
154850783|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850784|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154850785|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154850786|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154850787|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154179480|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179481|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154179482|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154179483|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
154179484|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
154179485|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179486|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154179487|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154179488|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179489|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179490|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
154179493|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154850788|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850789|NCT00850889|Lidocaine|lidocaine|mesh-list
154850790|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
154850791|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
154850792|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
154850793|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850794|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850795|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
154850796|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850797|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154850798|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154850799|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154850800|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850801|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850802|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154850803|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
154850804|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
154850805|NCT00850889|Protective Agents|protective agents|mesh-ancestor
154850806|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
154850807|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154850808|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850809|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
154850810|NCT00851357|Nicotine|nicotine|mesh-list
154850811|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154850812|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
154850813|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850814|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850815|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154850816|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154850817|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
154850818|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850819|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850820|NCT05105074|Morphine|morphine|mesh-list
154850821|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850822|NCT05105074|Narcotics|narcotics|mesh-ancestor
154850823|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850824|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850825|NCT05105074|Analgesics|analgesics|mesh-ancestor
154850826|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
154850827|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850828|NCT00364702|Methylphenidate|methylphenidate|mesh-list
154850829|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154850830|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850831|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154850832|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154850833|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850834|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850835|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
154850836|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850837|NCT00852761|Clobetasol|clobetasol|mesh-list
154850838|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850839|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
154850840|NCT00852761|Hormones|hormones|mesh-ancestor
154850841|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154850842|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850843|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
154850844|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
154850845|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154850846|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
154850847|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850848|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850849|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154850850|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
154850851|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154850853|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850854|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850855|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154850856|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
154850857|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
154850858|NCT03839537|Protective Agents|protective agents|mesh-ancestor
154850859|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
154850860|NCT04082806|Trazodone|trazodone|mesh-list
154850861|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154850862|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154850863|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850864|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850865|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850866|NCT04082806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154850867|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154850868|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154850869|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850870|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154850871|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
154850872|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154850873|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
154850874|NCT00365950|Warfarin|warfarin|mesh-list
154850875|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
154850876|NCT02487797|Oxytocin|oxytocin|mesh-list
154850877|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
154850878|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154850879|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850880|NCT01733693|Buprenorphine|buprenorphine|mesh-list
154850881|NCT01733693|Methadone|methadone|mesh-list
154850882|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154850883|NCT01733693|Narcotics|narcotics|mesh-ancestor
154850884|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850885|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850886|NCT01733693|Analgesics|analgesics|mesh-ancestor
154850887|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
154850888|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850889|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154850890|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
154850891|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
154850892|NCT00855413|Ritonavir|ritonavir|mesh-list
154850893|NCT00855413|Darunavir|darunavir|mesh-list
154850894|NCT00855413|Etravirine|etravirine|mesh-list
154850895|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154850896|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154850897|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
154850898|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850899|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850900|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154850901|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154850902|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
154850903|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850904|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154850905|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154850906|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154850907|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154850908|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
154850909|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154850910|NCT00366262|Naproxen|naproxen|mesh-list
154850911|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154850912|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850913|NCT00366262|Analgesics|analgesics|mesh-ancestor
154850914|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
154850915|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850916|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850917|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850918|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850919|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
154850921|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850922|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850923|NCT00818363|Bupivacaine|bupivacaine|mesh-list
154850924|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
154850925|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
154850926|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850927|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850928|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
154850929|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850930|NCT00828841|Paclitaxel|paclitaxel|mesh-list
154850931|NCT00828841|Carboplatin|carboplatin|mesh-list
154850932|NCT00828841|Gemcitabine|gemcitabine|mesh-list
154850933|NCT00828841|Cetuximab|cetuximab|mesh-list
154850934|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154850935|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850936|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
154850937|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
154850938|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
154850939|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850940|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154850941|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
154850942|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154850943|NCT05445310|Aflutinib|aflutinib|mesh-list
154850944|NCT05445310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154850945|NCT05445310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850946|NCT05445310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850947|NCT00858689|Minocycline|minocycline|mesh-list
154850948|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154850949|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154850950|NCT00821795|Insulin|insulin|mesh-list
154850951|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
154850952|NCT00821795|Protamines|protamines|mesh-list
154850953|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154850954|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850955|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
154850956|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850957|NCT00821795|Coagulants|coagulants|mesh-ancestor
154850958|NCT00833365|Ibuprofen|ibuprofen|mesh-list
154850959|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154850960|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850961|NCT00833365|Analgesics|analgesics|mesh-ancestor
154850962|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
154850963|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154850964|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850965|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154850966|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154850967|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154850968|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850969|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850970|NCT00821951|Vorinostat|vorinostat|mesh-list
154850971|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850972|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154850973|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850974|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850975|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154850976|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
154850977|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154850978|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154850979|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154850980|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850981|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850982|NCT00860015|Gemcitabine|gemcitabine|mesh-list
154850983|NCT00860015|Pemetrexed|pemetrexed|mesh-list
154850984|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154850985|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
154850986|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154850987|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154850988|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154850989|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154850990|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154850991|NCT00853333|Midazolam|midazolam|mesh-list
154850992|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
154850993|NCT00853333|Propofol|propofol|mesh-list
154850994|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154850995|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154850996|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154850997|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154850998|NCT00853333|Analgesics|analgesics|mesh-ancestor
154850999|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
154851000|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851001|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154851002|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154851003|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154851004|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
154851005|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851006|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851007|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154851008|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
154851009|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
154851010|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154851011|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154851012|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154851013|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154851014|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
154851015|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
154851016|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154851017|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154851018|NCT00822107|Diuretics|diuretics|mesh-ancestor
154851019|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
154851020|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851021|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154851022|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851023|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851024|NCT05236907|Midazolam|midazolam|mesh-list
154851025|NCT05236907|Melatonin|melatonin|mesh-list
154851026|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154851027|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154851028|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851029|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851030|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154851031|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154851032|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154851033|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154851034|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
154851035|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
154851036|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
154851037|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
154851038|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851039|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851040|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
154851041|NCT05236907|Protective Agents|protective agents|mesh-ancestor
154851042|NCT05217706|Ketamine|ketamine|mesh-list
154851043|NCT05217706|Analgesics|analgesics|mesh-ancestor
154851044|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
154851045|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851046|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851047|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154851048|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154179716|NCT02675465|Miglustat|miglustat|mesh-list
154851049|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
154851050|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
154851051|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851052|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154851053|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154851054|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851055|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851056|NCT00833443|Bupropion|bupropion|mesh-list
154851057|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154851058|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
154851059|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154851060|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154851061|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154851062|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851063|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851064|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
154851065|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851066|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851067|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154851068|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154851069|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851070|NCT05207722|Aldesleukin|aldesleukin|mesh-list
154851071|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
154851072|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
154851073|NCT05207722|Trastuzumab|trastuzumab|mesh-list
154851074|NCT05207722|Fludarabine|fludarabine|mesh-list
154851075|NCT05207722|Interleukin-2|interleukin-2|mesh-list
154851076|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154851077|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
154851078|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851079|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154851080|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154851081|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
154851082|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851083|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851084|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154851085|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154851086|NCT05207722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154851087|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154851088|NCT05207722|Analgesics|analgesics|mesh-ancestor
154851089|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
154851090|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851091|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154851092|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154851093|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
154851094|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851095|NCT00860171|Iodine|iodine|mesh-list
154851096|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
154851097|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154851098|NCT00860171|Antibodies|antibodies|mesh-list
154851099|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
154851100|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154851101|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
154851102|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851103|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851104|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154851105|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851106|NCT00860171|Trace Elements|trace elements|mesh-ancestor
154851107|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
154851108|NCT00366418|Rituximab|rituximab|mesh-list
154851109|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154851110|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851111|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
154851112|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851113|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154851114|NCT00823043|Timolol|timolol|mesh-list
154851115|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851116|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154851117|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154851118|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
154179775|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
154851119|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851120|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851121|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154851122|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154851123|NCT00862745|Fesoterodine|fesoterodine|mesh-list
154851124|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154851125|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154851126|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
154851127|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851128|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851129|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851130|NCT00862745|Urological Agents|urological agents|mesh-ancestor
154851131|NCT02150759|Fentanyl|fentanyl|mesh-list
154851132|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
154851133|NCT02150759|Ketamine|ketamine|mesh-list
154851134|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154851135|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851136|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851137|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154851138|NCT02150759|Analgesics|analgesics|mesh-ancestor
154851139|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
154851140|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851141|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154851142|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154851143|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154851144|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
154851145|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851146|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851147|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154851148|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154851149|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
154851150|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
154851151|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154851152|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154851153|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154851154|NCT02150759|Narcotics|narcotics|mesh-ancestor
154851155|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154851156|NCT04991350|Bevacizumab|bevacizumab|mesh-list
154851157|NCT04991350|Ranibizumab|ranibizumab|mesh-list
154851158|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154851159|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851160|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154851161|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154851162|NCT04991350|Growth Substances|growth substances|mesh-ancestor
154851163|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851164|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
154851165|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154851166|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
154851167|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851168|NCT04952194|Levodopa|levodopa|mesh-list
154851169|NCT04952194|Carbidopa|carbidopa|mesh-list
154851170|NCT04952194|Entacapone|entacapone|mesh-list
154851171|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154851172|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154851173|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
154851174|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851175|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851176|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851177|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154851178|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851179|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154851180|NCT00835159|Rivastigmine|rivastigmine|mesh-list
154851181|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154851182|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851183|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851184|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
154851185|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851186|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851187|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154851188|NCT00835159|Protective Agents|protective agents|mesh-ancestor
154851189|NCT04860856|Ropivacaine|ropivacaine|mesh-list
154851190|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
154851191|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
154851192|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851193|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851194|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
154851195|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851196|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
154851197|NCT00827099|Fludarabine|fludarabine|mesh-list
154851198|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
154851199|NCT00827099|Melphalan|melphalan|mesh-list
154851200|NCT00827099|Tacrolimus|tacrolimus|mesh-list
154851201|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154851202|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851203|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154851204|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
154851205|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851206|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154851207|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
154851208|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851209|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154851210|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851211|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154851212|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154851213|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
154851214|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154851215|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851216|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154851217|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
154851218|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154851219|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154851220|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154851221|NCT00366652|Desipramine|desipramine|mesh-list
154851222|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154851223|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154851224|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851225|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851226|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851227|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851228|NCT00366652|Analgesics|analgesics|mesh-ancestor
154851229|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
154851230|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851231|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
154851232|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154851233|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
154851234|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154851235|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851236|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154851237|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
154851238|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
154851239|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154851240|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851241|NCT02617888|Bismuth|bismuth|mesh-list
154851242|NCT02617888|Antacids|antacids|mesh-ancestor
154851243|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851244|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154851245|NCT02625298|Pemetrexed|pemetrexed|mesh-list
154851246|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851247|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851248|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851249|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154851250|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154851251|NCT00858013|Glimepiride|glimepiride|mesh-list
154851252|NCT00858013|Nateglinide|nateglinide|mesh-list
154851253|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154851254|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154851255|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851256|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154851257|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
154851258|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
154851259|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154851260|NCT00835861|Insulin|insulin|mesh-list
154851261|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154851262|NCT00835861|Metformin|metformin|mesh-list
154851263|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
154851264|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
154851265|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154851266|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851267|NCT00804973|Sumatriptan|sumatriptan|mesh-list
154851268|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154851269|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154851270|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154851271|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
154851272|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851273|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851274|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851275|NCT02628106|Alprostadil|alprostadil|mesh-list
154851276|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154851277|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
154851278|NCT02628106|Urological Agents|urological agents|mesh-ancestor
154851279|NCT02629354|Ibuprofen|ibuprofen|mesh-list
154851280|NCT02629354|Caffeine|caffeine|mesh-list
154851281|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154851282|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154851283|NCT02629354|Analgesics|analgesics|mesh-ancestor
154851284|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
154851285|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851286|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851287|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154851288|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154851289|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154851290|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851291|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851292|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154851293|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154851294|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154603253|NCT02487823|Bicalutamide|bicalutamide|mesh-list
154851295|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154851296|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
154851297|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851298|NCT02834247|Nivolumab|nivolumab|mesh-list
154851299|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154851300|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179977|NCT04998786|Ixazomib|ixazomib|mesh-list
154851301|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154851302|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851303|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
154851304|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
154851305|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154851306|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851307|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851308|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154851309|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851310|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154851311|NCT02630992|Amoxicillin|amoxicillin|mesh-list
154851312|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
154851313|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
154851314|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154851315|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154851316|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851317|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154851318|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851319|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851320|NCT00836407|Ipilimumab|ipilimumab|mesh-list
154851321|NCT00836407|Vaccines|vaccines|mesh-list
154851322|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
154851323|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851324|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154851325|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851326|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154851327|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851328|NCT02631772|Ribavirin|ribavirin|mesh-list
154851329|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
154851330|NCT02631772|Ledipasvir|ledipasvir|mesh-list
154851331|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
154851332|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851333|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
154851334|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851335|NCT02633488|Metformin|metformin|mesh-list
154851336|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154851337|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851338|NCT00859339|Gemcitabine|gemcitabine|mesh-list
154851339|NCT00859339|Sunitinib|sunitinib|mesh-list
154851340|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851341|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154851342|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
154851343|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851344|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154851345|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154851346|NCT00859339|Growth Substances|growth substances|mesh-ancestor
154851347|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851348|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
154851349|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154851350|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851351|NCT00859495|Doxorubicin|doxorubicin|mesh-list
154851352|NCT00859495|Pemetrexed|pemetrexed|mesh-list
154851353|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851354|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154851355|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154851356|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154851357|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851358|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851359|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154851360|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154851361|NCT00355719|Ritonavir|ritonavir|mesh-list
154851362|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154851363|NCT00355719|Nevirapine|nevirapine|mesh-list
154851364|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154851365|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154851366|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
154851367|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851368|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851369|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154851370|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154851371|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
154851372|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851373|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154851374|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154851375|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154851376|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154851377|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154851378|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154851380|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
154851381|NCT00859651|Vitamins|vitamins|mesh-ancestor
154851382|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
154851383|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851384|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154851385|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154851386|NCT02633956|Atorvastatin|atorvastatin|mesh-list
154851387|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154851388|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154851389|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
154851390|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851391|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154851392|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154851393|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851394|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154851395|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
154851396|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851397|NCT00806221|Emollients|emollients|mesh-list
154851398|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
154851399|NCT02635828|Promethazine|promethazine|mesh-list
154851400|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
154851401|NCT02635828|Dexamethasone|dexamethasone|mesh-list
154851402|NCT02635828|Palonosetron|palonosetron|mesh-list
154851403|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154851404|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
154851405|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
154851406|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851407|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851408|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154851409|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
154851410|NCT02635828|Hormones|hormones|mesh-ancestor
154851411|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154851412|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154851413|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851414|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154851415|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154851416|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
154851417|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851418|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851419|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
154851420|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
154851421|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154851422|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
154851423|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
154851424|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154851425|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154851426|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154851427|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851428|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
154851429|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
154851430|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
154851431|NCT02638168|Methylphenidate|methylphenidate|mesh-list
154851432|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154851433|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851434|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154851435|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154851436|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851437|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851438|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
154851439|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851440|NCT00837031|Gemcitabine|gemcitabine|mesh-list
154851441|NCT00837031|Lenalidomide|lenalidomide|mesh-list
154851442|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154603392|NCT04493515|Oxytocin|oxytocin|mesh-list
154851443|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
154851444|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851445|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851446|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
154851447|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851448|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154851449|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154851450|NCT00837031|Growth Substances|growth substances|mesh-ancestor
154851451|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
154851452|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154851453|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154851455|NCT04344483|Epinephrine|epinephrine|mesh-list
154851456|NCT04344483|Racepinephrine|racepinephrine|mesh-list
154851457|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
154851458|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
154851459|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
154851460|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851461|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851462|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
154851463|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851464|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154851465|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154851466|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154851467|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851468|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851469|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154851470|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154851471|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
154851472|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851473|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154851474|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154851475|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
154851476|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154851477|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
154851478|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
154851479|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
154851480|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154851481|NCT02154763|Ropivacaine|ropivacaine|mesh-list
154851482|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
154851483|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
154851484|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851485|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851486|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
154851487|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851488|NCT02641522|Siltuximab|siltuximab|mesh-list
154851489|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851490|NCT04964427|Methylphenidate|methylphenidate|mesh-list
154851491|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154851492|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851493|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154851494|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154851495|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851496|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851497|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
154851498|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851499|NCT00357669|Brivaracetam|brivaracetam|mesh-list
154851500|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
154851501|NCT00863551|Trospium chloride|trospium chloride|mesh-list
154851502|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
154851503|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
154851504|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851505|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851506|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154851507|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154851508|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
154851509|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851510|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851511|NCT00863551|Urological Agents|urological agents|mesh-ancestor
154851512|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
154851513|NCT03838575|Gentamicins|gentamicins|mesh-list
154851514|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
154851515|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154851516|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154603480|NCT02490085|Insulin|insulin|mesh-list
154851517|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
154851518|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154851519|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851520|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851521|NCT02620774|Tazobactam|tazobactam|mesh-list
154851522|NCT02620774|Ceftolozane|ceftolozane|mesh-list
154851523|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154851524|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154851525|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851526|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154851527|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851528|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851529|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154851530|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154851531|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154851532|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154851533|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
154851534|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851535|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154851536|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154851537|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851538|NCT04339816|Azithromycin|azithromycin|mesh-list
154851539|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
154851540|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154851541|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851542|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
154851543|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154851544|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154851545|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851546|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851547|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154851548|NCT05588908|Betamethasone|betamethasone|mesh-list
154851549|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154851550|NCT05588908|Antibodies|antibodies|mesh-list
154851551|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
154851552|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154851553|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
154851554|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851555|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851556|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154851557|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
154851558|NCT05588908|Hormones|hormones|mesh-ancestor
154851559|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154851560|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154851561|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
154851562|NCT05588830|Belimumab|belimumab|mesh-list
154851563|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154851564|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
154851565|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851566|NCT04740190|Carboplatin|carboplatin|mesh-list
154851567|NCT04740190|Talazoparib|talazoparib|mesh-list
154851568|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851569|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154851570|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851571|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851572|NCT00865969|Belinostat|belinostat|mesh-list
154851573|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851574|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154851575|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851576|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851577|NCT05588518|Propolis|propolis|mesh-list
154851578|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851579|NCT00866749|Cytarabine|cytarabine|mesh-list
154851580|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
154851581|NCT00866749|Doxorubicin|doxorubicin|mesh-list
154851582|NCT00866749|Methotrexate|methotrexate|mesh-list
154851583|NCT00866749|Vincristine|vincristine|mesh-list
154851584|NCT00866749|Daunorubicin|daunorubicin|mesh-list
154851585|NCT00866749|Asparaginase|asparaginase|mesh-list
154851586|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
154851587|NCT00866749|Thioguanine|thioguanine|mesh-list
154851588|NCT00866749|Pegaspargase|pegaspargase|mesh-list
154851589|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154851590|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
154851591|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851592|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154851593|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154851594|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
154851595|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851596|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851597|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154851598|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154851599|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154851600|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154851601|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851602|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154851603|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
154851604|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154851605|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154851606|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
154851607|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154851608|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154851609|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154851610|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
154851611|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851612|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154851613|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
154851614|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
154851615|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
154851616|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
154851617|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154851618|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
154851619|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851620|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154851621|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154851622|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
154851623|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851624|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851625|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154851626|NCT05587426|Iproplatin|iproplatin|mesh-list
154851627|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851628|NCT00867139|Oseltamivir|oseltamivir|mesh-list
154851629|NCT00867139|Ribavirin|ribavirin|mesh-list
154851630|NCT00867139|Zanamivir|zanamivir|mesh-list
154851631|NCT00867139|Amantadine|amantadine|mesh-list
154851632|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
154851633|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
154851634|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154851635|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851636|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851637|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
154851638|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154851639|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154851640|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
154851641|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851642|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851643|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154851644|NCT00867139|Analgesics|analgesics|mesh-ancestor
154851645|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
154851646|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851647|NCT05342818|Ondansetron|ondansetron|mesh-list
154851648|NCT05342818|Metoclopramide|metoclopramide|mesh-list
154851649|NCT05342818|Neostigmine|neostigmine|mesh-list
154851650|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
154851651|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
154851652|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851653|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851654|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154851655|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
154851656|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
154851657|NCT05342818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154851658|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154851659|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
154851660|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851661|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851662|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154851663|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851664|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
154851665|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154851666|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154851667|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154851668|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
154603618|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
154851669|NCT00867217|Vitamin D|vitamin d|mesh-list
154851670|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
154851671|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
154851672|NCT00867217|Vitamins|vitamins|mesh-list
154851673|NCT00867217|Letrozole|letrozole|mesh-list
154851674|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
154851675|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851676|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154851677|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154851678|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851679|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154851680|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154851681|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851682|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851683|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154851684|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
154851685|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154851686|NCT00867451|Melatonin|melatonin|mesh-list
154851687|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
154851688|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851689|NCT00867451|Protective Agents|protective agents|mesh-ancestor
154851690|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851691|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851692|NCT00867529|Rituximab|rituximab|mesh-list
154851693|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154851694|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851695|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
154851696|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851697|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154851698|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
154851699|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
154851700|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851701|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154851702|NCT00889915|Methylphenidate|methylphenidate|mesh-list
154851703|NCT00889915|Amphetamine|amphetamine|mesh-list
154851704|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154851705|NCT00889915|Adderall|adderall|mesh-list
154851706|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154851707|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851708|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154851709|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154851710|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851711|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851712|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
154851713|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851714|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
154851715|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
154851716|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851717|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
154851718|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154851719|NCT00841087|Insulin|insulin|mesh-list
154851720|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154851721|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
154851722|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
154851723|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154851724|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851725|NCT02685436|Domperidone|domperidone|mesh-list
154851726|NCT02685436|Omeprazole|omeprazole|mesh-list
154851727|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154851728|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154851729|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154851730|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851731|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851732|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
154851733|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
154851734|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851735|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851736|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154851737|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
154851738|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851739|NCT00841555|Temozolomide|temozolomide|mesh-list
154851740|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154851741|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
154851742|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851743|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851744|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154851745|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
154851746|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
154851747|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
154851748|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851749|NCT00868309|Antivenins|antivenins|mesh-list
154851750|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
154851751|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851752|NCT00368134|Vildagliptin|vildagliptin|mesh-list
154851753|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154851754|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851755|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154851756|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
154851757|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851758|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851759|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
154851760|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154851761|NCT02697292|Antibodies|antibodies|mesh-list
154851762|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
154851763|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154851764|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
154851765|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851766|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
154851767|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154851768|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851769|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154851770|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851771|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154851772|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154851773|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154851774|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851775|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851776|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154851777|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154851778|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154851779|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154851780|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
154851781|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851782|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180435|NCT03306446|Adalimumab|adalimumab|mesh-list
154851783|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154851784|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154851785|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
154851786|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154851787|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154851788|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
154851789|NCT02701582|Phenylephrine|phenylephrine|mesh-list
154851790|NCT02701582|Epinephrine|epinephrine|mesh-list
154851791|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
154851792|NCT02701582|Synephrine|synephrine|mesh-list
154851793|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154851794|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154851795|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
154851796|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851797|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851798|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851799|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154851800|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154851801|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
154851802|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851803|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154851804|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
154851805|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
154851806|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
154851807|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154851808|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154851809|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
154851810|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154851811|NCT02701582|Protective Agents|protective agents|mesh-ancestor
154851812|NCT00869791|Levodopa|levodopa|mesh-list
154851813|NCT00869791|Carbidopa|carbidopa|mesh-list
154851814|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154851815|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154851816|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154851817|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
154851818|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851819|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851820|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851821|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154851822|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851823|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154851824|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
154851825|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
154851826|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154851827|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154851828|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154851829|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
154851830|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851831|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154851832|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154851833|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851834|NCT00895531|Morphine|morphine|mesh-list
154851835|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154851836|NCT00895531|Narcotics|narcotics|mesh-ancestor
154851837|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851838|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851839|NCT00895531|Analgesics|analgesics|mesh-ancestor
154851840|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
154851841|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851842|NCT03215875|Torsemide|torsemide|mesh-list
154851843|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154851844|NCT03215875|Diuretics|diuretics|mesh-ancestor
154851845|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
154851846|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851847|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154851848|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851849|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851850|NCT02710630|Dabigatran|dabigatran|mesh-list
154851851|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
154851852|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154851853|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
154851854|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851855|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851856|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
154851857|NCT02715700|Methadone|methadone|mesh-list
154851858|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154851859|NCT02715700|Narcotics|narcotics|mesh-ancestor
154851860|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851861|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851862|NCT02715700|Analgesics|analgesics|mesh-ancestor
154851863|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
154851864|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851865|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
154851866|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
154851867|NCT00895921|Olanzapine|olanzapine|mesh-list
154851868|NCT00895921|Aripiprazole|aripiprazole|mesh-list
154851869|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
154851870|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
154851871|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851872|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851873|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154851874|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154851875|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154851876|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851877|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154851878|NCT00895921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154851879|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154851880|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851881|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851882|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851883|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
154851884|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
154851885|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
154851886|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
154851887|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154851888|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154851889|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154851890|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154851891|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154851892|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154603847|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851893|NCT00883675|Carboplatin|carboplatin|mesh-list
154851894|NCT00883675|Docetaxel|docetaxel|mesh-list
154851895|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851896|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
154851897|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
154851898|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
154851899|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851900|NCT03215407|Betamethasone|betamethasone|mesh-list
154851901|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154851902|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
154851903|NCT03215407|Hormones|hormones|mesh-ancestor
154851904|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154851905|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851906|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154851907|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
154851908|NCT05310331|Paclitaxel|paclitaxel|mesh-list
154851909|NCT05310331|Antibodies|antibodies|mesh-list
154851910|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154851911|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851912|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
154851913|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
154851914|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
154851915|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851916|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
154851917|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851918|NCT00885079|Rebamipide|rebamipide|mesh-list
154851919|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154851920|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154851921|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154851922|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154851923|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
154851924|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851925|NCT00885079|Protective Agents|protective agents|mesh-ancestor
154851926|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851927|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154851928|NCT00896779|Ranibizumab|ranibizumab|mesh-list
154851929|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154851930|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154851931|NCT00896779|Growth Substances|growth substances|mesh-ancestor
154851932|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851933|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
154851934|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154851935|NCT03214939|Immunomodulating Agents|immunomodulating agents|mesh-list
154851936|NCT03214939|Immunologic Factors|immunologic factors|mesh-ancestor
154851937|NCT03214939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851938|NCT02726620|Lidocaine|lidocaine|mesh-list
154851939|NCT02726620|Atropine|atropine|mesh-list
154851940|NCT02726620|Terlipressin|terlipressin|mesh-list
154851941|NCT02726620|Phenylephrine|phenylephrine|mesh-list
154851942|NCT02726620|Dobutamine|dobutamine|mesh-list
154851943|NCT02726620|Dopamine|dopamine|mesh-list
154851944|NCT02726620|Milrinone|milrinone|mesh-list
154851945|NCT02726620|Isoproterenol|isoproterenol|mesh-list
154851946|NCT02726620|Vasopressins|vasopressins|mesh-list
154851947|NCT02726620|Epinephrine|epinephrine|mesh-list
154851948|NCT02726620|Norepinephrine|norepinephrine|mesh-list
154851949|NCT02726620|Ephedrine|ephedrine|mesh-list
154851950|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
154851951|NCT02726620|Bupivacaine|bupivacaine|mesh-list
154851952|NCT02726620|Ropivacaine|ropivacaine|mesh-list
154851953|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
154851954|NCT02726620|Tetracaine|tetracaine|mesh-list
154851955|NCT02726620|Prilocaine|prilocaine|mesh-list
154851956|NCT02726620|Mepivacaine|mepivacaine|mesh-list
154851957|NCT02726620|Benzocaine|benzocaine|mesh-list
154851958|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
154851959|NCT02726620|Procaine|procaine|mesh-list
154851960|NCT02726620|Anesthetics|anesthetics|mesh-list
154851961|NCT02726620|Propofol|propofol|mesh-list
154851962|NCT02726620|Sevoflurane|sevoflurane|mesh-list
154851963|NCT02726620|Desflurane|desflurane|mesh-list
154851964|NCT02726620|Isoflurane|isoflurane|mesh-list
154851965|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154851966|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
154851967|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154851968|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154851969|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154851970|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
154851971|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154851972|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154851973|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154603920|NCT02479165|Oxycodone|oxycodone|mesh-list
154851974|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154851975|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154851976|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154851977|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154851978|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154851979|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
154851980|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154851981|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154851982|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154851983|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154851984|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
154851985|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154851986|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154851987|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154851988|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
154851989|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154851990|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
154851991|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
154851992|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
154851993|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154851994|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154851995|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
154851996|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154851997|NCT02726620|Protective Agents|protective agents|mesh-ancestor
154851998|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154851999|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
154852000|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154852001|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154852002|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
154852003|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
154852004|NCT02726620|Coagulants|coagulants|mesh-ancestor
154852005|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154852006|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
154852007|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154852008|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154852009|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154852010|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
154852011|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
154852012|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154852013|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154852014|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852015|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154852016|NCT00887575|Paclitaxel|paclitaxel|mesh-list
154852017|NCT00887575|Carboplatin|carboplatin|mesh-list
154852018|NCT00887575|Sunitinib|sunitinib|mesh-list
154852019|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154852020|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852021|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
154852022|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
154852023|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
154852024|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852025|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154852026|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154852027|NCT00887575|Growth Substances|growth substances|mesh-ancestor
154852028|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852029|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
154852030|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154852031|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852032|NCT03352843|Primaquine|primaquine|mesh-list
154852033|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
154852034|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154852035|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154852036|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852037|NCT03238027|Durvalumab|durvalumab|mesh-list
154852038|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154852039|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852040|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
154852041|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154852042|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154852043|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
154852044|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852045|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154852046|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154852047|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852048|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852049|NCT00887965|Denosumab|denosumab|mesh-list
154852050|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154852051|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852052|NCT02729038|Gepotidacin|gepotidacin|mesh-list
154852053|NCT02729038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154852054|NCT02729038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852055|NCT02729038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852056|NCT02729038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852057|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
154852058|NCT05311813|Enoxaparin|enoxaparin|mesh-list
154852059|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
154852060|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154852061|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154852062|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852063|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852064|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852065|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154852066|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
154852067|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154852068|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154852069|NCT03214627|Iron|iron|mesh-list
154852070|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154852071|NCT03214627|Hematinics|hematinics|mesh-list
154852072|NCT03214627|Trace Elements|trace elements|mesh-ancestor
154852073|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
154852074|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852075|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154852076|NCT00888511|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154852077|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154852078|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852079|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852080|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852081|NCT03214393|Antibodies|antibodies|mesh-list
154852082|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
154852083|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852084|NCT00888979|Nicotine|nicotine|mesh-list
154852085|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154852086|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
154852087|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852088|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852089|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154852090|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154852091|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
154852092|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852093|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852094|NCT03214159|Ritonavir|ritonavir|mesh-list
154852095|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154852096|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154852097|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
154852098|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852099|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852100|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154852101|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154852102|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
154852103|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852104|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154852105|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154852106|NCT02737072|Durvalumab|durvalumab|mesh-list
154852107|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154852108|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852109|NCT05446480|Desloratadine|desloratadine|mesh-list
154852110|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154852111|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
154852112|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852113|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852114|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852115|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154852116|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154852117|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
154852118|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
154852119|NCT03213145|Rifampin|rifampin|mesh-list
154852120|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154852121|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
154852122|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154852123|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852124|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
154852125|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154852126|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852127|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852129|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154852130|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154852131|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154852132|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154852133|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154852134|NCT02722564|Ethanol|ethanol|mesh-list
154852135|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154852136|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852137|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852138|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852139|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
154852140|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154852141|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
154852142|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852143|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852144|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154852145|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
154852146|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154852147|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
154180814|NCT00530348|Interferon-beta|interferon-beta|mesh-list
154852148|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852149|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852150|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154852151|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
154852152|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
154852153|NCT05446090|Protective Agents|protective agents|mesh-ancestor
154852154|NCT05444998|Paclitaxel|paclitaxel|mesh-list
154852155|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154852156|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852157|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
154852158|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
154852159|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
154852160|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852161|NCT05444842|Insulin|insulin|mesh-list
154852162|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154852163|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852164|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852165|NCT04381741|Antibodies|antibodies|mesh-list
154852166|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154852167|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
154852168|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852169|NCT05444452|Sirolimus|sirolimus|mesh-list
154852170|NCT05444452|Everolimus|everolimus|mesh-list
154852171|NCT05444452|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154852172|NCT05444452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154852173|NCT05444452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852174|NCT05444452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852175|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154852176|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
154852177|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852178|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852179|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154852180|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852181|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154852182|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
154852183|NCT05444374|Bevacizumab|bevacizumab|mesh-list
154852184|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154852185|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852186|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154852187|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154852188|NCT05444374|Growth Substances|growth substances|mesh-ancestor
154852189|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852190|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
154852191|NCT05444218|Amoxicillin|amoxicillin|mesh-list
154852192|NCT05444218|Metronidazole|metronidazole|mesh-list
154852193|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154852194|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852195|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154852196|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154852197|NCT01830361|Midostaurin|midostaurin|mesh-list
154852198|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852199|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154852200|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852201|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852202|NCT01830517|Losartan|losartan|mesh-list
154852203|NCT01830517|Amlodipine|amlodipine|mesh-list
154852204|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154852205|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154852206|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154852207|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852208|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154852209|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852210|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
154852211|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154852212|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154852213|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154852214|NCT03212833|Insulin|insulin|mesh-list
154852215|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852216|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852217|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
154852218|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
154852219|NCT05443360|Calcium|calcium|mesh-list
154852220|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154852221|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852222|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154852223|NCT05443360|Antacids|antacids|mesh-ancestor
154852224|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852225|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154852226|NCT05443282|Hormones|hormones|mesh-list
154852227|NCT05443282|Estradiol|estradiol|mesh-list
154852228|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154852229|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154852230|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852231|NCT05443282|Estrogens|estrogens|mesh-ancestor
154852232|NCT00904345|Cetuximab|cetuximab|mesh-list
154852233|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154852234|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852235|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
154852236|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154852237|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852238|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154852239|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154852240|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852241|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852242|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852243|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154852244|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154852245|NCT01830829|Tamsulosin|tamsulosin|mesh-list
154852246|NCT01830829|Dutasteride|dutasteride|mesh-list
154852247|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154852248|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154852249|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154852250|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
154852251|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852252|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852253|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852254|NCT01830829|Urological Agents|urological agents|mesh-ancestor
154852255|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154852256|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154852257|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852258|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
154852259|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154852260|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
154852261|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154852262|NCT03212755|Antibodies|antibodies|mesh-list
154852263|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
154852264|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
154852265|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852266|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
154852267|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154852268|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154852269|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852270|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
154852271|NCT05437822|Coagulants|coagulants|mesh-ancestor
154852272|NCT03212599|Disulfiram|disulfiram|mesh-list
154604224|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154852273|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154852274|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154852275|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852276|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852277|NCT03212053|Hemostatics|hemostatics|mesh-list
154852278|NCT03212053|Coagulants|coagulants|mesh-ancestor
154852279|NCT05311189|Trastuzumab|trastuzumab|mesh-list
154852280|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154852281|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852282|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
154852283|NCT00369772|Hematinics|hematinics|mesh-ancestor
154852284|NCT03211897|Midazolam|midazolam|mesh-list
154852285|NCT03211897|Haloperidol|haloperidol|mesh-list
154852286|NCT03211897|Olanzapine|olanzapine|mesh-list
154852287|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
154852288|NCT03211897|Ziprasidone|ziprasidone|mesh-list
154852289|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154852290|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154852291|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852292|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852293|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154852294|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154852295|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154852296|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154852297|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
154852298|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
154852299|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
154852300|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
154852301|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852302|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852303|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
154852304|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
154852305|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852306|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154852307|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154852308|NCT03211897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154852309|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154852310|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154852311|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
154852312|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154852313|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
154852314|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154852315|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154852316|NCT01831687|Etodolac|etodolac|mesh-list
154852317|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154852318|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154852319|NCT01831687|Analgesics|analgesics|mesh-ancestor
154852320|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
154852321|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852322|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852323|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154852324|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154852325|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154852326|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154852327|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852328|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852329|NCT05441254|Paclitaxel|paclitaxel|mesh-list
154852330|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154852331|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852332|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
154852333|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
154852334|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
154852335|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852336|NCT00369148|Nateglinide|nateglinide|mesh-list
154852337|NCT00369148|Mitiglinide|mitiglinide|mesh-list
154852338|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852339|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852340|NCT01832467|Cetuximab|cetuximab|mesh-list
154852341|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154852342|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852343|NCT03211351|Dextrans|dextrans|mesh-list
154852344|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
154852345|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
154852346|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
154852347|NCT01832623|Vitamin D|vitamin d|mesh-list
154852348|NCT01832623|Vitamins|vitamins|mesh-ancestor
154852349|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
154852350|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852351|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154852352|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154852353|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154852354|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852356|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852357|NCT02470390|Fentanyl|fentanyl|mesh-list
154852358|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154852359|NCT02470390|Narcotics|narcotics|mesh-ancestor
154852360|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852361|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852362|NCT02470390|Analgesics|analgesics|mesh-ancestor
154852363|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
154852364|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852365|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154852366|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154852367|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
154852368|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
154852369|NCT00363532|Calcitonin|calcitonin|mesh-list
154852370|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
154852371|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154852372|NCT00363532|Katacalcin|katacalcin|mesh-list
154852373|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154852374|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852375|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154852376|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
154852377|NCT00363610|Pegaspargase|pegaspargase|mesh-list
154852378|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852379|NCT00363688|Penicillins|penicillins|mesh-list
154852380|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154852381|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852382|NCT01832935|Insulin|insulin|mesh-list
154852383|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154852384|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
154852385|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
154852386|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
154852387|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
154852388|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852389|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852390|NCT04380181|Milrinone|milrinone|mesh-list
154852391|NCT04380181|Epinephrine|epinephrine|mesh-list
154852392|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154852393|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154852394|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
154852395|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852396|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852397|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852398|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154852399|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154852400|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
154852401|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852402|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154852403|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
154852404|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
154852405|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
154852406|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154852407|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154852408|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154852409|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
154852410|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154852411|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154852412|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852413|NCT04380181|Protective Agents|protective agents|mesh-ancestor
154852414|NCT01833559|Insulin|insulin|mesh-list
154852415|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154852416|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
154852417|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852418|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852419|NCT05394142|Metformin|metformin|mesh-list
154852420|NCT05394142|Pioglitazone|pioglitazone|mesh-list
154852421|NCT05394142|Spironolactone|spironolactone|mesh-list
154852422|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852423|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852424|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154852425|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
154852426|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154852427|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154852428|NCT05394142|Diuretics|diuretics|mesh-ancestor
154852429|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
154852430|NCT00901225|Plerixafor|plerixafor|mesh-list
154852431|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154852432|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154852433|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
154852434|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852435|NCT05393050|Methotrexate|methotrexate|mesh-list
154852436|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154852437|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
154852438|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154852439|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852440|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154852441|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
154852442|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852443|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852444|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
154852445|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852446|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154852447|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154852448|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
154852449|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154852450|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154852451|NCT03166228|Glycine|glycine|mesh-list
154852452|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
154852453|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852454|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852455|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852456|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
154852457|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154852458|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
154852459|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154852460|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852461|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154852462|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154852463|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154852464|NCT03154996|Topotecan|topotecan|mesh-list
154852465|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154852466|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154852467|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852468|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852469|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852470|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
154852471|NCT02475070|Vildagliptin|vildagliptin|mesh-list
154852472|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154852473|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852474|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852475|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852476|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154852477|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
154852478|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852479|NCT00902161|Propranolol|propranolol|mesh-list
154852480|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154852481|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154852482|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
154852483|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852484|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852485|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852486|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154852487|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154852488|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
154852489|NCT01834183|Gemcitabine|gemcitabine|mesh-list
154852490|NCT01834183|Tivozanib|tivozanib|mesh-list
154852491|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154852492|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
154852493|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852494|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852495|NCT01834183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154852496|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852497|NCT02478580|Modafinil|modafinil|mesh-list
154852498|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154604450|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
154852499|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852500|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154852501|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154852502|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154852503|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852504|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154852506|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852507|NCT03210025|Methyldopa|methyldopa|mesh-list
154852508|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154852509|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
154852510|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
154852511|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852512|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852513|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154852514|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154852515|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154852516|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
154852517|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852518|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852519|NCT03219853|Selenium|selenium|mesh-list
154852520|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
154852521|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852522|NCT03219853|Protective Agents|protective agents|mesh-ancestor
154852523|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852524|NCT03219853|Trace Elements|trace elements|mesh-ancestor
154852525|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
154852526|NCT02480998|Vaccines|vaccines|mesh-list
154852527|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
154852528|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852529|NCT03215797|Phenylephrine|phenylephrine|mesh-list
154852530|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
154852531|NCT03215797|Norepinephrine|norepinephrine|mesh-list
154852532|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
154852533|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154852534|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
154852535|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
154852536|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852537|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852538|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
154852539|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154852540|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
154852541|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
154852542|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154852543|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154852544|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
154852545|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852546|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852547|NCT03215797|Protective Agents|protective agents|mesh-ancestor
154852548|NCT02485834|Docetaxel|docetaxel|mesh-list
154852549|NCT02485834|Capecitabine|capecitabine|mesh-list
154852550|NCT02485834|Irinotecan|irinotecan|mesh-list
154852551|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852552|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
154852553|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
154852554|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
154852555|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852556|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154852557|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
154852558|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154852559|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154852560|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852561|NCT01834885|Fluticasone|fluticasone|mesh-list
154852562|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154852563|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154852564|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154852565|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154852566|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
154852567|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852568|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852569|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154852570|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
154852571|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
154852572|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154852573|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154852574|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154852575|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154852576|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
154852577|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852578|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852579|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
154852580|NCT01834885|Hormones|hormones|mesh-ancestor
154852581|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154852582|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
154852583|NCT01834963|Interferons|interferons|mesh-list
154852584|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
154852585|NCT01834963|Cisplatin|cisplatin|mesh-list
154852586|NCT01834963|Fluorouracil|fluorouracil|mesh-list
154852587|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852588|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
154852589|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852590|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154852591|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154852592|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
154852593|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852594|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
154852595|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852596|NCT04380103|Bevacizumab|bevacizumab|mesh-list
154852597|NCT04380103|Capecitabine|capecitabine|mesh-list
154852598|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
154852599|NCT04380103|Irinotecan|irinotecan|mesh-list
154852600|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154852601|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852602|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154852603|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154852604|NCT04380103|Growth Substances|growth substances|mesh-ancestor
154852605|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852606|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
154852607|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154852608|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
154852609|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852610|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154852611|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154852612|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852613|NCT01954966|Progesterone|progesterone|mesh-list
154852614|NCT01954966|Progestins|progestins|mesh-ancestor
154852615|NCT01954966|Hormones|hormones|mesh-ancestor
154852616|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154852617|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852618|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154852619|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154852620|NCT03836599|Allopurinol|allopurinol|mesh-list
154852621|NCT03836599|Verinurad|verinurad|mesh-list
154852622|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
154852623|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852624|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852625|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
154852626|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154852627|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154852628|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
154852629|NCT03836599|Protective Agents|protective agents|mesh-ancestor
154852630|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852631|NCT01839097|Prednisone|prednisone|mesh-list
154852632|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
154852633|NCT01839097|Doxorubicin|doxorubicin|mesh-list
154852634|NCT01839097|Vincristine|vincristine|mesh-list
154852635|NCT01839097|Belinostat|belinostat|mesh-list
154852636|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154852637|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
154852638|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852639|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154852640|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154852641|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
154181303|NCT00887081|Ribavirin|ribavirin|mesh-list
154852642|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852643|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852644|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154852645|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154852646|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154852647|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154852648|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604606|NCT03306745|Folic Acid|folic acid|mesh-list
154852649|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154852650|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
154852651|NCT01839097|Hormones|hormones|mesh-ancestor
154852652|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154852653|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154852654|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154852655|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
154852656|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
154852657|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
154852658|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154852659|NCT01835665|Nimodipine|nimodipine|mesh-list
154852660|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154852661|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154852662|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154852663|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852664|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154852665|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852666|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
154852667|NCT01839175|Vaccines|vaccines|mesh-list
154852668|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154852669|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
154852670|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852671|NCT01839253|Atenolol|atenolol|mesh-list
154852672|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154852673|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154852674|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154852675|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
154852676|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
154852677|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852678|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852679|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154852680|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154852681|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154852682|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
154852683|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852684|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852685|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
154852686|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852687|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
154852688|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154852689|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
154852690|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852691|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154852692|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154852693|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
154852694|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852695|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852696|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154852697|NCT01839643|Meloxicam|meloxicam|mesh-list
154852698|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154852699|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154852700|NCT01839643|Analgesics|analgesics|mesh-ancestor
154852701|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
154852702|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852703|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852704|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154852705|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154852706|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154852707|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154852708|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852709|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852710|NCT04380025|Pycnogenols|pycnogenols|mesh-list
154852711|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154852712|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
154852713|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852714|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
154852715|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852716|NCT04380025|Protective Agents|protective agents|mesh-ancestor
154852717|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154852718|NCT01836679|Paclitaxel|paclitaxel|mesh-list
154852719|NCT01836679|Carboplatin|carboplatin|mesh-list
154852720|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154852721|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852722|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
154852723|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
154852724|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
154852725|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852727|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154852728|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154852729|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154852730|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154852731|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154852732|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852733|NCT00369538|Diuretics|diuretics|mesh-ancestor
154852734|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
154852735|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852736|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154852737|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154852738|NCT02489734|Sevoflurane|sevoflurane|mesh-list
154852739|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154852740|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154852741|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
154852742|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
154852743|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852744|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852745|NCT02490670|Cephalexin|cephalexin|mesh-list
154852746|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154852747|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852748|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
154852749|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154852750|NCT05451472|Calcium|calcium|mesh-list
154852751|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
154852752|NCT05451472|Hormones|hormones|mesh-list
154852753|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154852754|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852755|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154852756|NCT03218059|Methotrexate|methotrexate|mesh-list
154852757|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154852758|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
154852759|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154852760|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852761|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154852762|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
154852763|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852764|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852765|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
154852766|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852767|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154852768|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154852769|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
154852770|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154852771|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154852772|NCT01839955|Quinacrine|quinacrine|mesh-list
154852773|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154852774|NCT01839955|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154852775|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154852776|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852777|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852778|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852779|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
154852780|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154852781|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
154852782|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154852783|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852784|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
154852785|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154852786|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
154852787|NCT02494102|Modafinil|modafinil|mesh-list
154852788|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154852789|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852790|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154852791|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154852792|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154852793|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852794|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
154852795|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154852797|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154852798|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154852799|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852800|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
154852801|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852802|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852803|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154852804|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852805|NCT01838395|Cytarabine|cytarabine|mesh-list
154852806|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154852807|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
154852808|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852809|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852810|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
154852811|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852812|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154852813|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
154852814|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852815|NCT00422578|Tadalafil|tadalafil|mesh-list
154852816|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
154852817|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154852818|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154852819|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852820|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852821|NCT00422578|Urological Agents|urological agents|mesh-ancestor
154852822|NCT02494180|Midazolam|midazolam|mesh-list
154852823|NCT02494180|Fentanyl|fentanyl|mesh-list
154852824|NCT02494180|Diazepam|diazepam|mesh-list
154852825|NCT02494180|Meperidine|meperidine|mesh-list
154852826|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154852827|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154852828|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852829|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852830|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154852831|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154852832|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154852833|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154852834|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
154852835|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
154852836|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
154852837|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
154852838|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852839|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852840|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154852841|NCT02494180|Narcotics|narcotics|mesh-ancestor
154852842|NCT02494180|Analgesics|analgesics|mesh-ancestor
154852843|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
154852844|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852845|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
154852846|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
154852847|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
154852848|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154852849|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154852850|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154852851|NCT05032690|Bosutinib|bosutinib|mesh-list
154852852|NCT05032690|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154852853|NCT05032690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154852854|NCT05032690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852855|NCT05032690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852856|NCT02494336|Ropivacaine|ropivacaine|mesh-list
154852857|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
154852858|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
154852859|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852860|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852861|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
154852862|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852863|NCT02495038|Rocuronium|rocuronium|mesh-list
154852864|NCT02495038|Atracurium|atracurium|mesh-list
154852865|NCT02495038|Cisatracurium|cisatracurium|mesh-list
154852866|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154852867|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154604826|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154852868|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154852869|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852870|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852871|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154852872|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154852873|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
154852874|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852875|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852876|NCT04956484|Belimumab|belimumab|mesh-list
154852877|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154852878|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
154852879|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852880|NCT05450458|Sorbitol|sorbitol|mesh-list
154852881|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
154852882|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154852883|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
154852884|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852885|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
154852886|NCT05450458|Protective Agents|protective agents|mesh-ancestor
154852887|NCT05450458|Cathartics|cathartics|mesh-ancestor
154852888|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154852889|NCT01720615|Remifentanil|remifentanil|mesh-list
154852890|NCT01720615|Propofol|propofol|mesh-list
154852891|NCT01720615|Sevoflurane|sevoflurane|mesh-list
154852892|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154852893|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852894|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852895|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154852896|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
154852897|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
154852898|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154852899|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154852900|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154852901|NCT01720615|Narcotics|narcotics|mesh-ancestor
154852902|NCT01720615|Analgesics|analgesics|mesh-ancestor
154852903|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
154852904|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852905|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
154852906|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
154852907|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154852908|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
154852909|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852910|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852911|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154852912|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
154852913|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
154852914|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154852915|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
154852916|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852917|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852918|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154852919|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154852920|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
154852921|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154852922|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852923|NCT02504554|Vancomycin|vancomycin|mesh-list
154852924|NCT02504554|Omeprazole|omeprazole|mesh-list
154852925|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154852926|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154852927|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154852928|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154852929|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154852930|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852931|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852932|NCT01838473|Lobeline|lobeline|mesh-list
154852933|NCT01838473|Nicotine|nicotine|mesh-list
154852934|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154852935|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
154852936|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852937|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852938|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154852939|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154852940|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
154852941|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852942|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852943|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
154852944|NCT04937452|Rotigotine|rotigotine|mesh-list
154852945|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
154604901|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
154852946|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
154852947|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154852948|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852949|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852950|NCT01838707|Fentanyl|fentanyl|mesh-list
154852951|NCT01838707|Morphine|morphine|mesh-list
154852952|NCT01838707|Bupivacaine|bupivacaine|mesh-list
154852953|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
154852954|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
154852955|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852956|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852957|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
154852958|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852959|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154852960|NCT01838707|Narcotics|narcotics|mesh-ancestor
154852961|NCT01838707|Analgesics|analgesics|mesh-ancestor
154852962|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154852963|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154852964|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
154852965|NCT02506114|Ipilimumab|ipilimumab|mesh-list
154852966|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154852967|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852968|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154852969|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852970|NCT04920994|Bupivacaine|bupivacaine|mesh-list
154852971|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
154852972|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
154852973|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852974|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852975|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
154852976|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852977|NCT02506660|Dexamethasone|dexamethasone|mesh-list
154852978|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
154852979|NCT02506660|Bupivacaine|bupivacaine|mesh-list
154852980|NCT02506660|BB 1101|bb 1101|mesh-list
154852981|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154852982|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
154852983|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
154852984|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154852985|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154852986|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154852987|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
154852988|NCT02506660|Hormones|hormones|mesh-ancestor
154181662|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154852989|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154852990|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154852991|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154852992|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
154852993|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154852994|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154852995|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
154852996|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
154852997|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154852998|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
154852999|NCT02509624|Selonsertib|selonsertib|mesh-list
154853000|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154853001|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853002|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853003|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154853004|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154853005|NCT01726075|Somatostatin|somatostatin|mesh-list
154853006|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154853007|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154853008|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154853009|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154853010|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154853011|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
154853012|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853013|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853014|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853015|NCT01726075|Hormones|hormones|mesh-ancestor
154853016|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853017|NCT00369694|Terlipressin|terlipressin|mesh-list
154853018|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154853019|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154853020|NCT01721707|Latanoprost|latanoprost|mesh-list
154853021|NCT01721707|Brinzolamide|brinzolamide|mesh-list
154853022|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154853023|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154853024|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154853025|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853026|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853027|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
154853028|NCT05448586|Narcotics|narcotics|mesh-ancestor
154853029|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853030|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853031|NCT05448586|Analgesics|analgesics|mesh-ancestor
154853032|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
154853033|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853034|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
154853035|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
154853036|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154853037|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154853038|NCT01726465|Prednisolone|prednisolone|mesh-list
154853039|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
154853040|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154853041|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
154853042|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154853043|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853044|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
154853045|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
154853046|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853047|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853048|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154853049|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
154853050|NCT01726465|Hormones|hormones|mesh-ancestor
154853051|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853052|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154853053|NCT01726465|Protective Agents|protective agents|mesh-ancestor
154853054|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154853055|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853056|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
154853057|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853058|NCT01726465|Expectorants|expectorants|mesh-ancestor
154853059|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
154853060|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154853061|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
154853062|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853063|NCT01726465|Antidotes|antidotes|mesh-ancestor
154853064|NCT01720303|Insulin|insulin|mesh-list
154853065|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154853066|NCT01720303|Repaglinide|repaglinide|mesh-list
154853067|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
154853068|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
154853069|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
154853070|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154853071|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853072|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154853073|NCT00912301|Cathartics|cathartics|mesh-ancestor
154853074|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154853075|NCT04850638|Furosemide|furosemide|mesh-list
154853076|NCT04850638|Diuretics|diuretics|mesh-ancestor
154853077|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
154853078|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853079|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154853080|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154853081|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853082|NCT01726777|Vitamin D|vitamin d|mesh-list
154853083|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
154853084|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
154853085|NCT01726777|Vitamins|vitamins|mesh-list
154853086|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
154853087|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853088|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154853089|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154853090|NCT05532306|Ribavirin|ribavirin|mesh-list
154853091|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
154853092|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853093|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
154853094|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853095|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
154853096|NCT01722409|Sevoflurane|sevoflurane|mesh-list
154853097|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154853098|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853099|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853100|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154853101|NCT01722409|Analgesics|analgesics|mesh-ancestor
154853102|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
154853103|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853104|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154853105|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154853106|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154853107|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
154853108|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853109|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181783|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853110|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154853111|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154853112|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
154853113|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
154853114|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154853115|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
154853116|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154853117|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
154853118|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853119|NCT01727401|PENTA|penta|mesh-list
154853120|NCT01727401|Fondaparinux|fondaparinux|mesh-list
154853121|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154853122|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
154853123|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154853124|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
154853125|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853126|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853127|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
154853128|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154853129|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154853130|NCT02513212|Fluorides|fluorides|mesh-list
154853131|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
154853132|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
154853133|NCT02513212|Protective Agents|protective agents|mesh-ancestor
154853134|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853135|NCT03409081|Gilteritinib|gilteritinib|mesh-list
154853136|NCT03409081|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154853137|NCT03409081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154853138|NCT03409081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853139|NCT03409081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853140|NCT02513446|Itraconazole|itraconazole|mesh-list
154853141|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
154853142|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853143|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154853144|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154853145|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853146|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853147|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154853148|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
154853149|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853150|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853151|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154853152|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154853153|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154853154|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853155|NCT00363844|Incretins|incretins|mesh-ancestor
154853156|NCT00363844|Hormones|hormones|mesh-ancestor
154853157|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853158|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154853159|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
154853160|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853161|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853162|NCT04687800|Dexamethasone|dexamethasone|mesh-list
154853163|NCT04687800|Difluprednate|difluprednate|mesh-list
154853164|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853165|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
154853166|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
154853167|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853168|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853169|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154853170|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
154853171|NCT04687800|Hormones|hormones|mesh-ancestor
154853172|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853173|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154853174|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853175|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
154853176|NCT00864383|Rifampin|rifampin|mesh-list
154853177|NCT00864383|Isoniazid|isoniazid|mesh-list
154853178|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
154853179|NCT00864383|Ethambutol|ethambutol|mesh-list
154853180|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853181|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853182|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154853183|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154853184|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853185|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853186|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853187|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154853188|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
154853189|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
154853190|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154853191|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154853192|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154853193|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154853194|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154853195|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154853196|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154853197|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154853198|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154853199|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
154853200|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154853201|NCT05532072|Sirolimus|sirolimus|mesh-list
154853202|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
154853203|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154853204|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154853205|NCT05532072|Prednisolone|prednisolone|mesh-list
154853206|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
154853207|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154853208|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
154853209|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853210|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853211|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154853212|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853213|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
154853214|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154853215|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
154853216|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853217|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853218|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
154853219|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
154853220|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853221|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154853222|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
154853223|NCT05532072|Hormones|hormones|mesh-ancestor
154853224|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853225|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154853226|NCT05532072|Protective Agents|protective agents|mesh-ancestor
154853227|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154853228|NCT00864539|Vitamin D|vitamin d|mesh-list
154853229|NCT00864539|Calcium|calcium|mesh-list
154853230|NCT00864539|Vitamins|vitamins|mesh-ancestor
154853231|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
154853232|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853233|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154853234|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154853235|NCT00827255|Cyclosporine|cyclosporine|mesh-list
154853236|NCT00827255|Cyclosporins|cyclosporins|mesh-list
154853237|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181902|NCT06180707|Listerine|listerine|mesh-list
154853238|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853239|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154853240|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
154853241|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853242|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
154853243|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853244|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
154853245|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154853246|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154853247|NCT02153489|Bromides|bromides|mesh-list
154853248|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
154853249|NCT00866879|Sirolimus|sirolimus|mesh-list
154853250|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853251|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853252|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154853253|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853254|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
154853255|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154853256|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
154853257|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853259|NCT02311920|Ipilimumab|ipilimumab|mesh-list
154853260|NCT02311920|Temozolomide|temozolomide|mesh-list
154853261|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853262|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853263|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154853264|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853265|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154853266|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
154853267|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
154853268|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
154853269|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154853270|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
154853271|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853272|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154853273|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154853274|NCT00828191|Progesterone|progesterone|mesh-list
154853275|NCT00828191|Progestins|progestins|mesh-ancestor
154853276|NCT00828191|Hormones|hormones|mesh-ancestor
154853277|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853278|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853279|NCT00867659|Cetrorelix|cetrorelix|mesh-list
154853280|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154853281|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
154853282|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154853283|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853284|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
154853285|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853286|NCT05531058|Vaccines|vaccines|mesh-list
154853287|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
154853288|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853289|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
154853290|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154853291|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154853292|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853293|NCT00828347|Vitamins|vitamins|mesh-ancestor
154853294|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
154853295|NCT00829049|Adapalene|adapalene|mesh-list
154853296|NCT00829049|Tazarotene|tazarotene|mesh-list
154853297|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154853298|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154853299|NCT00829049|Analgesics|analgesics|mesh-ancestor
154853300|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
154853301|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853302|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853303|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853304|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154853305|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
154181965|NCT06179719|Propofol|propofol|mesh-list
154853306|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
154853307|NCT01727557|Anesthetics|anesthetics|mesh-list
154853308|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853309|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853310|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154853311|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853312|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154853313|NCT00913003|Lidocaine|lidocaine|mesh-list
154853314|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
154853315|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
154853316|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853317|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853318|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
154853319|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853320|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154853321|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154853322|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154853323|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154853324|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853325|NCT00869141|Timolol|timolol|mesh-list
154853326|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154853327|NCT00869141|Dorzolamide|dorzolamide|mesh-list
154853328|NCT00869141|Brinzolamide|brinzolamide|mesh-list
154853329|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154853330|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154853331|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
154853332|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853333|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853334|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853335|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154853336|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154853337|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154853338|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154853339|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154853340|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154853341|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853342|NCT01722799|Paclitaxel|paclitaxel|mesh-list
154853343|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154853344|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853345|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
154853346|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
154853347|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
154853348|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853349|NCT01606176|Nabiximols|nabiximols|mesh-list
154853350|NCT01606176|Analgesics|analgesics|mesh-ancestor
154853351|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
154853352|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853353|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853354|NCT00913081|Quercetin|quercetin|mesh-list
154853355|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
154853356|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853357|NCT00913081|Protective Agents|protective agents|mesh-ancestor
154853358|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853359|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
154853360|NCT04077424|Vaccines|vaccines|mesh-list
154853361|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
154853362|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853363|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
154853364|NCT04077424|Coagulants|coagulants|mesh-ancestor
154853365|NCT01727869|Cetuximab|cetuximab|mesh-list
154853366|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154853367|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853368|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853369|NCT01727869|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154853370|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154853371|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853372|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853373|NCT00371020|Heparin|heparin|mesh-list
154853374|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154853375|NCT00371020|Tinzaparin|tinzaparin|mesh-list
154853376|NCT00371020|Dalteparin|dalteparin|mesh-list
154853377|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
154853378|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154853379|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154853380|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853381|NCT04476628|Budesonide|budesonide|mesh-list
154853382|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853383|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154853384|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
154853385|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853386|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853387|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154853388|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
154853389|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
154853390|NCT04476628|Hormones|hormones|mesh-ancestor
154853391|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853392|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154853393|NCT01728181|Tivozanib|tivozanib|mesh-list
154853394|NCT01728181|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154853395|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154853396|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853397|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853398|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853399|NCT04378231|Amoxicillin|amoxicillin|mesh-list
154853400|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
154853401|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
154853402|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154853403|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853404|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853405|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154853406|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853407|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853409|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154853410|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
154853411|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853412|NCT01728571|Vitamin D|vitamin d|mesh-list
154853413|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
154853414|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
154853415|NCT01728571|Vitamins|vitamins|mesh-list
154853416|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
154853417|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853418|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154853419|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154853420|NCT00832637|Gemcitabine|gemcitabine|mesh-list
154853421|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154182112|NCT06060587|Docetaxel|docetaxel|mesh-list
154853422|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853423|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154853424|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
154853425|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853426|NCT00832637|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154853427|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154853428|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853429|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154853430|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853431|NCT00370240|Ropivacaine|ropivacaine|mesh-list
154853432|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
154853433|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
154853434|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853435|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182164|NCT05904886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182165|NCT05896748|Rilpivirine|rilpivirine|mesh-list
154182166|NCT05896748|Cabotegravir|cabotegravir|mesh-list
154182167|NCT05896748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154182168|NCT05896748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154182169|NCT05896748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182170|NCT05896748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182171|NCT05896748|Antiviral Agents|antiviral agents|mesh-ancestor
154182172|NCT05896748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182173|NCT05896748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154182174|NCT05896748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154182175|NCT05896748|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154182176|NCT05896748|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154182177|NCT05888532|Copper|copper|mesh-list
154182178|NCT05888532|Trace Elements|trace elements|mesh-ancestor
154853436|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
154853437|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853438|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
154853439|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154853440|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
154853441|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853442|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
154853443|NCT03408145|Protective Agents|protective agents|mesh-ancestor
154853444|NCT02475772|Cisplatin|cisplatin|mesh-list
154853445|NCT02475772|Doxorubicin|doxorubicin|mesh-list
154853446|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154853447|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853448|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154853449|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154853450|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154853451|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853452|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853453|NCT00915655|Ritonavir|ritonavir|mesh-list
154853454|NCT00915655|Darunavir|darunavir|mesh-list
154853455|NCT00915655|Lamivudine|lamivudine|mesh-list
154853456|NCT00915655|Zidovudine|zidovudine|mesh-list
154853457|NCT00915655|Abacavir|abacavir|mesh-list
154853458|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154853459|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154853460|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
154853461|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853462|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853463|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154853464|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154853465|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
154853466|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853467|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154853468|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154853469|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154853470|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154853471|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
154853472|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
154853473|NCT03835507|Hematinics|hematinics|mesh-ancestor
154853474|NCT05524974|Paclitaxel|paclitaxel|mesh-list
154853475|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
154853476|NCT05524974|Apatinib|apatinib|mesh-list
154853477|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154853478|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853479|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
154853480|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
154853481|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
154853482|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853483|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154853484|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853485|NCT00870467|Adalimumab|adalimumab|mesh-list
154853486|NCT00870467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154853487|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853488|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154853489|NCT00370318|Acetaminophen|acetaminophen|mesh-list
154853490|NCT00370318|Vaccines|vaccines|mesh-list
154853491|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154853492|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
154853493|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853494|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154853495|NCT00370318|Analgesics|analgesics|mesh-ancestor
154853496|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
154853497|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853498|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
154853499|NCT01728961|Lumefantrine|lumefantrine|mesh-list
154853500|NCT01728961|Artemether|artemether|mesh-list
154853501|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154853502|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
154853503|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154853504|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154853505|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853506|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
154853507|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154853508|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853509|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
154853510|NCT00872027|Escitalopram|escitalopram|mesh-list
154853511|NCT00872027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154853512|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154853513|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154853514|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853515|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853516|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
154853517|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853518|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
154853519|NCT01854814|Losartan|losartan|mesh-list
154853520|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154853521|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853522|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154853523|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
154853524|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853525|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853526|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853527|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853528|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154853529|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154853530|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154853531|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154853532|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
154853533|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853534|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853535|NCT01723657|Immunotoxins|immunotoxins|mesh-ancestor
154853536|NCT01723657|Immunoconjugates|immunoconjugates|mesh-ancestor
154853537|NCT01723657|Immunologic Factors|immunologic factors|mesh-ancestor
154853538|NCT01723657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853539|NCT02576652|Tetracycline|tetracycline|mesh-list
154853540|NCT02576652|Demeclocycline|demeclocycline|mesh-list
154853541|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853542|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853543|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154853544|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853545|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853546|NCT01743742|Vitamins|vitamins|mesh-list
154853547|NCT01743742|Vitamin E|vitamin e|mesh-list
154853548|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
154853549|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853550|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
154853551|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853552|NCT01743742|Protective Agents|protective agents|mesh-ancestor
154853553|NCT01723735|Ezetimibe|ezetimibe|mesh-list
154853554|NCT01723735|Alirocumab|alirocumab|mesh-list
154853555|NCT01723735|Fenofibrate|fenofibrate|mesh-list
154853556|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154853557|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154853558|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
154853559|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853560|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154853561|NCT01723735|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154853562|NCT01723735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154853563|NCT01723735|Protease Inhibitors|protease inhibitors|mesh-ancestor
154853564|NCT01723735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853565|NCT00872729|Cysteamine|cysteamine|mesh-list
154853566|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154853567|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853568|NCT04640376|Acetaminophen|acetaminophen|mesh-list
154853569|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154853570|NCT04640376|Analgesics|analgesics|mesh-ancestor
154853571|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
154853572|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853573|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853574|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
154853575|NCT00832871|Mifepristone|mifepristone|mesh-list
154853576|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154853577|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
154853578|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154853579|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853580|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154853581|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154853582|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154853583|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
154853584|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154853585|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154853586|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
154853587|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853588|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
154853589|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154853590|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154853591|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154853592|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853593|NCT05530200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853594|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853595|NCT01729663|Interferons|interferons|mesh-list
154853596|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
154853597|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
154853598|NCT01729663|Molgramostim|molgramostim|mesh-list
154853599|NCT01729663|Sargramostim|sargramostim|mesh-list
154853600|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
154853601|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853602|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
154853603|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853604|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
154853605|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853606|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154853607|NCT05530122|Adalimumab|adalimumab|mesh-list
154853608|NCT05530122|Infliximab|infliximab|mesh-list
154853609|NCT05530122|Golimumab|golimumab|mesh-list
154853610|NCT05530122|Ustekinumab|ustekinumab|mesh-list
154853611|NCT05530122|Vedolizumab|vedolizumab|mesh-list
154853612|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154853613|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853614|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154853615|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
154853616|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154853617|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154853618|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
154263679|NCT05039177|Cetuximab|cetuximab|mesh-list
154853619|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853620|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
154853621|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
154853622|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154853623|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154853624|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853625|NCT05529888|Isotretinoin|isotretinoin|mesh-list
154853626|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
154853627|NCT05518578|Huperzine A|huperzine a|mesh-list
154853628|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154853629|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853630|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853631|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
154853632|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853633|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853634|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154853635|NCT05518578|Protective Agents|protective agents|mesh-ancestor
154853636|NCT05518500|Vaccines|vaccines|mesh-list
154853637|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
154853638|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853639|NCT03058978|Etonogestrel|etonogestrel|mesh-list
154853640|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154853641|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
154853642|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154853643|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853644|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154853645|NCT00212134|Dipivefrin|dipivefrin|mesh-list
154853646|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154853647|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154853648|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853649|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853650|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853651|NCT00913627|Ibuprofen|ibuprofen|mesh-list
154853652|NCT00913627|Naproxen|naproxen|mesh-list
154853653|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154853654|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154853655|NCT00913627|Analgesics|analgesics|mesh-ancestor
154853656|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
154853657|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853658|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853659|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853660|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154853661|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154853662|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853663|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853664|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
154853665|NCT04297176|Vancomycin|vancomycin|mesh-list
154853666|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853667|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853668|NCT05523102|Acetaminophen|acetaminophen|mesh-list
154853669|NCT05523102|Ketorolac|ketorolac|mesh-list
154853670|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154853671|NCT05523102|Analgesics|analgesics|mesh-ancestor
154853672|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
154853673|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853674|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853675|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
154853676|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154853677|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853678|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154853679|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154853680|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853681|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853682|NCT03407209|Anesthetics|anesthetics|mesh-list
154853683|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
154853684|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853685|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853686|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
154853687|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853688|NCT03999268|Insulin|insulin|mesh-list
154853689|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154853690|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853691|NCT01729897|Fentanyl|fentanyl|mesh-list
154853692|NCT01729897|Propofol|propofol|mesh-list
154853693|NCT01729897|Etomidate|etomidate|mesh-list
154853694|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154853695|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853696|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853697|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154853698|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
154853699|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
154853700|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154853701|NCT01729897|Narcotics|narcotics|mesh-ancestor
154853702|NCT01729897|Analgesics|analgesics|mesh-ancestor
154853703|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
154853704|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853705|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154853706|NCT01048177|Lidocaine|lidocaine|mesh-list
154853707|NCT01048177|Heparin|heparin|mesh-list
154605666|NCT03363191|Xhance|xhance|mesh-list
154853708|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
154853709|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
154853710|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853711|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853712|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
154853713|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853714|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154853715|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154853716|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154853717|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154853718|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853719|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
154853720|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154853721|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154853722|NCT02740582|Tolcapone|tolcapone|mesh-list
154853723|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154853724|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154853725|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154853726|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853727|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853728|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
154853729|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154853730|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154853731|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154853732|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853733|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
154853734|NCT05453266|Coagulants|coagulants|mesh-ancestor
154853735|NCT02740660|Caffeine|caffeine|mesh-list
154853736|NCT02740660|Albuterol|albuterol|mesh-list
154853737|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154853738|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853739|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154853740|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853741|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853742|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154853743|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154853744|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
154853745|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853746|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154853747|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
154853748|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853749|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154853750|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
154853751|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
154853752|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154853753|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154853754|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154853755|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154853756|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
154853757|NCT03929068|Levodopa|levodopa|mesh-list
154853758|NCT03929068|Carbidopa|carbidopa|mesh-list
154853759|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154853760|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154853761|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154853762|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
154853763|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853764|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853765|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853766|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154853767|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853768|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154853769|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
154853770|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
154853771|NCT05516784|Clopidogrel|clopidogrel|mesh-list
154853772|NCT05516784|Ticagrelor|ticagrelor|mesh-list
154853773|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154853774|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154853775|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154853776|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154853777|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
154853778|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853779|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853780|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853781|NCT02571972|Timolol|timolol|mesh-list
154853782|NCT02571972|Dorzolamide|dorzolamide|mesh-list
154853783|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154853784|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154853785|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
154853786|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853787|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853788|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853789|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154853790|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154853791|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154853792|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853793|NCT04996134|Domperidone|domperidone|mesh-list
154853794|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
154853795|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
154853796|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853797|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853798|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154853799|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154853800|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
154853801|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853802|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853803|NCT00371332|Minocycline|minocycline|mesh-list
154853804|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853805|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853806|NCT00842075|Pramlintide|pramlintide|mesh-list
154853807|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154853808|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853809|NCT00879359|Paclitaxel|paclitaxel|mesh-list
154853810|NCT00879359|Bevacizumab|bevacizumab|mesh-list
154853811|NCT00879359|Carboplatin|carboplatin|mesh-list
154853812|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154853813|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853814|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154853815|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154853816|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154853817|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853818|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853819|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154853820|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154853821|NCT00879359|Growth Substances|growth substances|mesh-ancestor
154853822|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853823|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
154853824|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154853825|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
154853826|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154853827|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154853828|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154853829|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853830|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853831|NCT00880997|Doxazosin|doxazosin|mesh-list
154853832|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154853833|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154853834|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154853835|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154853836|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
154853837|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853838|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853839|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853840|NCT00883103|Lidocaine|lidocaine|mesh-list
154853841|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
154853842|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
154853843|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853844|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853845|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
154853846|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263911|NCT04490057|Bupropion|bupropion|mesh-list
154853847|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154853848|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154853849|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154853850|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154853851|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853852|NCT02742532|Oxytocin|oxytocin|mesh-list
154853853|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
154853854|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154853855|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853856|NCT05521386|Caffeine|caffeine|mesh-list
154853857|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154853858|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853859|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154853860|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853861|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853862|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154853863|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154853864|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
154853865|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154853866|NCT00370630|Triamcinolone|triamcinolone|mesh-list
154853867|NCT00370630|Bevacizumab|bevacizumab|mesh-list
154853868|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853869|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853870|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154853871|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154853872|NCT00370630|Growth Substances|growth substances|mesh-ancestor
154853873|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853874|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
154853875|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853876|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
154853877|NCT00370630|Hormones|hormones|mesh-ancestor
154853878|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853879|NCT04984980|Bevacizumab|bevacizumab|mesh-list
154853880|NCT04984980|Gemcitabine|gemcitabine|mesh-list
154853881|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
154853882|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263965|NCT04456699|Vitamins|vitamins|mesh-ancestor
154853883|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853884|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154853885|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154853886|NCT04984980|Growth Substances|growth substances|mesh-ancestor
154853887|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853888|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
154853889|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154853890|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
154853891|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853892|NCT00370786|Bevacizumab|bevacizumab|mesh-list
154853893|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853894|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853895|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154853896|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154853897|NCT00370786|Growth Substances|growth substances|mesh-ancestor
154853898|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853899|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
154853900|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154853901|NCT03387670|Simvastatin|simvastatin|mesh-list
154853902|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154853903|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154853904|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
154264003|NCT04314843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264004|NCT04314843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264005|NCT04282018|Tislelizumab|tislelizumab|mesh-list
154264006|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
154264007|NCT04282018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264008|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264009|NCT04282018|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264010|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264011|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264012|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264013|NCT04266795|Azacitidine|azacitidine|mesh-list
154264014|NCT04266795|Venetoclax|venetoclax|mesh-list
154264015|NCT04266795|Pevonedistat|pevonedistat|mesh-list
154264016|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154264017|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
154264018|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264019|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264020|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264021|NCT04256733|Capsaicin|capsaicin|mesh-list
154264022|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
154264023|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
154264024|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
153605466|NCT01932554|Ibuprofen|ibuprofen|mesh-list
153813344|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359826|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853905|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853906|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154853907|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154853908|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853909|NCT04979832|Metronidazole|metronidazole|mesh-list
154853910|NCT04979832|Fosfomycin|fosfomycin|mesh-list
154853911|NCT04979832|Molgramostim|molgramostim|mesh-list
154853912|NCT04979832|Sargramostim|sargramostim|mesh-list
154853913|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853914|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154853915|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154853916|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154853917|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
154853918|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853919|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853920|NCT02740114|Oxycodone|oxycodone|mesh-list
154853921|NCT02740114|Bupivacaine|bupivacaine|mesh-list
154853922|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
154853923|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
154853924|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154853925|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853926|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
154853927|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853928|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154853929|NCT02740114|Narcotics|narcotics|mesh-ancestor
154853930|NCT02740114|Analgesics|analgesics|mesh-ancestor
154853931|NCT00371410|Triamcinolone|triamcinolone|mesh-list
154853932|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154853933|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154853934|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154853935|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853936|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
154853937|NCT00371410|Hormones|hormones|mesh-ancestor
154853938|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154853939|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853940|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154853941|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
154853942|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853943|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853944|NCT04295850|Aspirin|aspirin|mesh-list
154853945|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154853946|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154853947|NCT04295850|Analgesics|analgesics|mesh-ancestor
154853948|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
154853949|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154853950|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853951|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154853952|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154853953|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154853954|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154853955|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853956|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154853957|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154853958|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853959|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
154853960|NCT02166905|Poly I-C|poly i-c|mesh-list
154853961|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154853962|NCT02166905|Poly ICLC|poly iclc|mesh-list
154853963|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
154853964|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
154853965|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853966|NCT02166905|Laxatives|laxatives|mesh-ancestor
154853967|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154853968|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
154853969|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853970|NCT02743078|Bevacizumab|bevacizumab|mesh-list
154853971|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853972|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853973|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154853974|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154853975|NCT02743078|Growth Substances|growth substances|mesh-ancestor
154853976|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853977|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
154853978|NCT03323398|Durvalumab|durvalumab|mesh-list
154853979|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154853980|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853981|NCT00890981|Denosumab|denosumab|mesh-list
154853982|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154853983|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154853984|NCT05515770|Cabotegravir|cabotegravir|mesh-list
154853985|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154853986|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154853987|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154853988|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154853989|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154853990|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154853991|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
154853992|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853993|NCT04480138|Interferons|interferons|mesh-list
154853994|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154853995|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
154853996|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154853997|NCT00371488|Lapatinib|lapatinib|mesh-list
154853998|NCT00371488|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154853999|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154854000|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854001|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854002|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854003|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
154854004|NCT00883415|Hematinics|hematinics|mesh-ancestor
154854005|NCT04337632|Paclitaxel|paclitaxel|mesh-list
154854006|NCT04337632|Carboplatin|carboplatin|mesh-list
154605962|NCT03536455|Acetazolamide|acetazolamide|mesh-list
154854007|NCT04337632|Doxorubicin|doxorubicin|mesh-list
154854008|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154854009|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154854010|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854011|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
154854012|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
154854013|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
154854014|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854015|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154854016|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154854017|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154854018|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854019|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154854020|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854021|NCT05349058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854022|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854023|NCT05348980|Phenylephrine|phenylephrine|mesh-list
154854024|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
154854025|NCT05348980|Synephrine|synephrine|mesh-list
154854026|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154854027|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
154854028|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
154854029|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854030|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854031|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
154854032|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154854033|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
154854034|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854035|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154854036|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154854037|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154854038|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854039|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854040|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854041|NCT05348980|Protective Agents|protective agents|mesh-ancestor
154854042|NCT00884585|Cyclosporine|cyclosporine|mesh-list
154854043|NCT00884585|Cyclosporins|cyclosporins|mesh-list
154854044|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854045|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854046|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154854047|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
154854048|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854049|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
154854050|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854051|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
154854052|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854053|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154854054|NCT00884897|Oxytocin|oxytocin|mesh-list
154854055|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
154854056|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154854057|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854058|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
154854059|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154854060|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154854061|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154854062|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154854063|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854064|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
154854065|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854066|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854067|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154854068|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854069|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
154854070|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154854071|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854072|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854073|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854074|NCT03384563|Analgesics|analgesics|mesh-ancestor
154854075|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
154854076|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854077|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154854078|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154854079|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154854080|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854081|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854082|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854083|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
154854084|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
154854085|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854086|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154854087|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854089|NCT02748070|Prednisone|prednisone|mesh-list
154854090|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854091|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
154854092|NCT02748070|Hormones|hormones|mesh-ancestor
154854093|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854094|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854095|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154854096|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854097|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154854098|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
154854099|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854100|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854101|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854102|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
154854103|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154854104|NCT05311709|Sotorasib|sotorasib|mesh-list
154854105|NCT05311709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154854106|NCT05311709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854107|NCT05311709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854108|NCT05311709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854109|NCT05310383|Tislelizumab|tislelizumab|mesh-list
154854110|NCT05310383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854111|NCT05310383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854112|NCT05310305|Antibodies|antibodies|mesh-list
154854113|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
154854114|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854115|NCT05519670|Niraparib|niraparib|mesh-list
154854116|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154854117|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854118|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854119|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854120|NCT05519592|Ropivacaine|ropivacaine|mesh-list
154854121|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
154854122|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
154854123|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854124|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854125|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
154854126|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854127|NCT05519514|Budesonide|budesonide|mesh-list
154854128|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854129|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154854130|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
154854131|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854132|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854133|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854134|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854135|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
154854136|NCT05519514|Hormones|hormones|mesh-ancestor
154854137|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854138|NCT02756572|Cytarabine|cytarabine|mesh-list
154854139|NCT02756572|Cyclosporine|cyclosporine|mesh-list
154854140|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
154854141|NCT02756572|Sirolimus|sirolimus|mesh-list
154854142|NCT02756572|Fludarabine|fludarabine|mesh-list
154854143|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
154854144|NCT02756572|Melphalan|melphalan|mesh-list
154854145|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
154854146|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
154854147|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154854148|NCT02756572|Cladribine|cladribine|mesh-list
154854149|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154854150|NCT02756572|Cyclosporins|cyclosporins|mesh-list
154854151|NCT02756572|Lenograstim|lenograstim|mesh-list
154854152|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854153|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154854154|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
154854155|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854156|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154854157|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
154854158|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854159|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
154854160|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854161|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154854162|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854163|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
154854164|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
154854165|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854166|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154854167|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154854168|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154854169|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
154854170|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154854171|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154854172|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
154854173|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154854174|NCT02756572|Analgesics|analgesics|mesh-ancestor
154854175|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
154854176|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854177|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154854178|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154854179|NCT01049035|Vaccines|vaccines|mesh-list
154854180|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154854181|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
154854182|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854183|NCT05131698|Lenvatinib|lenvatinib|mesh-list
154854184|NCT05131698|Tislelizumab|tislelizumab|mesh-list
154854185|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854186|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154854187|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854188|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854189|NCT05131698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854190|NCT01724983|Fentanyl|fentanyl|mesh-list
154854191|NCT01724983|Ketamine|ketamine|mesh-list
154854192|NCT01724983|Analgesics|analgesics|mesh-ancestor
154854193|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
154854194|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854195|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854196|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154854197|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154854198|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
154854199|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
154854200|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854201|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154854202|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154854203|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854204|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854205|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154854206|NCT01724983|Narcotics|narcotics|mesh-ancestor
154854207|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154854208|NCT02973958|Acetaminophen|acetaminophen|mesh-list
154854209|NCT02973958|Ibuprofen|ibuprofen|mesh-list
154854210|NCT02973958|Ketorolac|ketorolac|mesh-list
154854211|NCT02973958|Bupivacaine|bupivacaine|mesh-list
154854212|NCT02973958|Sevoflurane|sevoflurane|mesh-list
154854213|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
154854214|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
154854215|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854216|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854217|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
154854218|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854219|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854220|NCT02973958|Analgesics|analgesics|mesh-ancestor
154854221|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
154854222|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154854223|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264290|NCT03878524|Antibodies|antibodies|mesh-list
154854224|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854225|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154854226|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854227|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854228|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154854229|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154854230|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
154854231|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
154854232|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154854233|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154854234|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
154854235|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854236|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854237|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854238|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854239|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154854240|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154854241|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154854242|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854243|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854244|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854245|NCT05513976|Febuxostat|febuxostat|mesh-list
154854246|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
154854247|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854248|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
154854249|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154854250|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154854251|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
154854252|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854253|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154854254|NCT05348434|Ether|ether|mesh-list
154854255|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154854256|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
154854257|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
154854258|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854259|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854260|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
154854261|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854262|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
154854263|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154854264|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
154854265|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854266|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
154854267|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154854268|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
154854269|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854270|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854271|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854272|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854273|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154854274|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154854275|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154854276|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854277|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854278|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854279|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
154854280|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154854281|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154854282|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154854283|NCT02760862|Mannitol|mannitol|mesh-list
154264357|NCT03869190|Niraparib|niraparib|mesh-list
154854284|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854285|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154854286|NCT02760862|Diuretics|diuretics|mesh-ancestor
154854287|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
154854288|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854289|NCT05720559|Folic Acid|folic acid|mesh-list
154854290|NCT05720559|Vitamin A|vitamin a|mesh-list
154854291|NCT05720559|Metronidazole|metronidazole|mesh-list
154854292|NCT05720559|Capecitabine|capecitabine|mesh-list
154854293|NCT05720559|Oxaliplatin|oxaliplatin|mesh-list
154854294|NCT05720559|Cetuximab|cetuximab|mesh-list
154854295|NCT05720559|Vitamins|vitamins|mesh-ancestor
154854296|NCT05720559|Micronutrients|micronutrients|mesh-ancestor
154854297|NCT05720559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854298|NCT05720559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154854299|NCT05720559|Antimetabolites|antimetabolites|mesh-ancestor
154854300|NCT05720559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854301|NCT05720559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854302|NCT05720559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854303|NCT05720559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854304|NCT05720559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154854305|NCT05720559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154854306|NCT05720559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154854307|NCT05720559|Hematinics|hematinics|mesh-ancestor
154854308|NCT05720559|Vitamin B Complex|vitamin b complex|mesh-ancestor
154854309|NCT02761252|Montelukast|montelukast|mesh-list
154854310|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854311|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854312|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154854314|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854315|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854316|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154854317|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154854318|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854319|NCT05714475|Pancrelipase|pancrelipase|mesh-list
154854320|NCT05714475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154854321|NCT05443984|Esomeprazole|esomeprazole|mesh-list
154854322|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154854323|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154854324|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154854325|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854326|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854327|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
154854328|NCT01725607|Anesthetics|anesthetics|mesh-list
154854329|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854330|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854331|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154854332|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854333|NCT01725607|Analgesics|analgesics|mesh-ancestor
154854334|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
154854335|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854336|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154854337|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154854338|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154854339|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854340|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854341|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854342|NCT03304379|Celecoxib|celecoxib|mesh-list
154854343|NCT03304379|Diclofenac|diclofenac|mesh-list
154854344|NCT03304379|Fasinumab|fasinumab|mesh-list
154854345|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154854346|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854347|NCT03304379|Analgesics|analgesics|mesh-ancestor
154854348|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
154854349|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854350|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854351|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854352|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854353|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154854354|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154854355|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854356|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854357|NCT00915967|Vancomycin|vancomycin|mesh-list
154854358|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154854359|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854360|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154854361|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854362|NCT05513664|Osimertinib|osimertinib|mesh-list
154854363|NCT05513664|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154854364|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154854365|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854366|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854367|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854368|NCT03216395|Epinephrine|epinephrine|mesh-list
154854369|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154854370|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154854371|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854372|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854373|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854374|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854375|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154854376|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154854377|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
154854378|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854379|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854380|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854381|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
154854382|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
154854383|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154606332|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854384|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154854385|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854386|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
154854387|NCT02767492|Hormones|hormones|mesh-ancestor
154854388|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854389|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854390|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154854391|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
154854392|NCT01044433|Capecitabine|capecitabine|mesh-list
154854393|NCT01044433|Lapatinib|lapatinib|mesh-list
154854394|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154854395|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
154854396|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854397|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854398|NCT01044433|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154854399|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154854400|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854401|NCT03400969|Glycerol|glycerol|mesh-list
154854402|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154854403|NCT03400969|Protective Agents|protective agents|mesh-ancestor
154854404|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854405|NCT01043185|Lesogaberan|lesogaberan|mesh-list
154854406|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154854407|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154854408|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
154854409|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
154854410|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854411|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854412|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854413|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154854414|NCT01042093|Clonidine|clonidine|mesh-list
154854415|NCT01042093|Epinephrine|epinephrine|mesh-list
154854416|NCT01042093|Ropivacaine|ropivacaine|mesh-list
154854417|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
154854418|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
154854419|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854420|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854421|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
154854422|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854423|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154854424|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154854425|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854426|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854427|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854428|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154854429|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154854430|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
154854431|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854432|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854433|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
154854434|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
154854435|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154854436|NCT01042093|Analgesics|analgesics|mesh-ancestor
154854437|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154854438|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
154854439|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154854440|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154854441|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854442|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854443|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854444|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154854445|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854446|NCT03400735|Cefdinir|cefdinir|mesh-list
154854447|NCT03400735|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154854448|NCT03400735|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154854449|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154854450|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854451|NCT04737928|Latanoprost|latanoprost|mesh-list
154854452|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154854453|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154854454|NCT01041859|Tapentadol|tapentadol|mesh-list
154854455|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154854456|NCT01041859|Narcotics|narcotics|mesh-ancestor
154854457|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854458|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854459|NCT01041859|Analgesics|analgesics|mesh-ancestor
154854460|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
154854461|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854462|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154854463|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154854464|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154854465|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854466|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854467|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854468|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154854469|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
154854470|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854471|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154854472|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
154854473|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854475|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154854476|NCT01040845|Norethindrone|norethindrone|mesh-list
154854477|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
154854478|NCT01040845|Estradiol|estradiol|mesh-list
154854479|NCT01040845|Estrogens|estrogens|mesh-ancestor
154854480|NCT01040845|Hormones|hormones|mesh-ancestor
154854481|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854482|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854483|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154854484|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
154854485|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154854486|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154854487|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
154854488|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854489|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
154854490|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
154854491|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
154854492|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854493|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854494|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154854495|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154854496|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154854497|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154854498|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154854499|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
154854500|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854501|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854502|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154854503|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154854504|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154854505|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
154854506|NCT01040689|Olodaterol|olodaterol|mesh-list
154854507|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154854508|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
154854509|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854510|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854511|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854512|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854513|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
154854514|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154854515|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
154854516|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854517|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854518|NCT00372658|Lidocaine|lidocaine|mesh-list
154854519|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
154854520|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
154854521|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854522|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854523|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
154854524|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854525|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154854526|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154854527|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154854528|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154854529|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854530|NCT03400189|Sulthiame|sulthiame|mesh-list
154854531|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
154854532|NCT01043029|Pioglitazone|pioglitazone|mesh-list
154854533|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154854534|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854535|NCT04282954|Esomeprazole|esomeprazole|mesh-list
154854536|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154854537|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154854538|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154854539|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854540|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854541|NCT05337436|Calcium|calcium|mesh-list
154854542|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154854543|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854544|NCT04755712|Sufentanil|sufentanil|mesh-list
154854545|NCT04755712|Morphine|morphine|mesh-list
154854546|NCT04755712|Bupivacaine|bupivacaine|mesh-list
154854547|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
154854548|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
154854549|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854550|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854551|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
154854552|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854553|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154854554|NCT04755712|Narcotics|narcotics|mesh-ancestor
154854555|NCT04755712|Analgesics|analgesics|mesh-ancestor
154854556|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154854557|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154854558|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
154854559|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154854560|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854561|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854562|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154854563|NCT05456698|Immunotoxins|immunotoxins|mesh-ancestor
154854564|NCT05456698|Immunoconjugates|immunoconjugates|mesh-ancestor
154854565|NCT05456698|Immunologic Factors|immunologic factors|mesh-ancestor
154854566|NCT05456698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854567|NCT02973724|Remifentanil|remifentanil|mesh-list
154854568|NCT02973724|Propofol|propofol|mesh-list
154854569|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
154854570|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854571|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854572|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154854573|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154854574|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
154854575|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154854576|NCT02973724|Narcotics|narcotics|mesh-ancestor
154854577|NCT02973724|Analgesics|analgesics|mesh-ancestor
154854578|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
154854579|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854580|NCT05455918|Paclitaxel|paclitaxel|mesh-list
154854581|NCT05455918|Ifosfamide|ifosfamide|mesh-list
154854582|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154854583|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854584|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
154854585|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
154854586|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
154854587|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854588|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154854589|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
154854590|NCT00889187|Capecitabine|capecitabine|mesh-list
154854591|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154854592|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
154854593|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854594|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854595|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154854596|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154854597|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154854598|NCT04334824|Diuretics|diuretics|mesh-ancestor
154854599|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
154854600|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854601|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154854602|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154854603|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854604|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
154854605|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854606|NCT05314127|Fluorouracil|fluorouracil|mesh-list
154854607|NCT05314127|Imiquimod|imiquimod|mesh-list
154854608|NCT05314127|Tazarotene|tazarotene|mesh-list
154854609|NCT05314127|Petrolatum|petrolatum|mesh-list
154854610|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
154854611|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854612|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154854613|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854614|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154854615|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
154854616|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854617|NCT05314127|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154854618|NCT05314127|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154854619|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154854620|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
154854621|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
154854622|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
154854623|NCT05314127|Emollients|emollients|mesh-ancestor
154854624|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
154854625|NCT04225078|Loperamide|loperamide|mesh-list
154854626|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
154854627|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154854628|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854629|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154854630|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154854631|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854632|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854633|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854634|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154854635|NCT00373048|Mefloquine|mefloquine|mesh-list
154854636|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
154854637|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154854638|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154854639|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854640|NCT00372892|Rituximab|rituximab|mesh-list
154854641|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854642|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854643|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
154854644|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854645|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854646|NCT00895817|Fluticasone|fluticasone|mesh-list
154854647|NCT00895817|Esomeprazole|esomeprazole|mesh-list
154854648|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854649|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154854650|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
154854651|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854652|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854653|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154854654|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154854655|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
154854656|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154854657|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154854658|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154854659|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154854660|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854661|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854662|NCT03020303|Spironolactone|spironolactone|mesh-list
154854663|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154854664|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
154854665|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854666|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854667|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154854668|NCT03020303|Diuretics|diuretics|mesh-ancestor
154854669|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
154854670|NCT04825522|Vancomycin|vancomycin|mesh-list
154854671|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154854672|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854673|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
154854674|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854675|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154854676|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
154854677|NCT00373282|Triamcinolone|triamcinolone|mesh-list
154854678|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154854679|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154854680|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154854681|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854682|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
154854683|NCT00373282|Hormones|hormones|mesh-ancestor
154854684|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854685|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854686|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154854687|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
154854688|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854689|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854691|NCT04382027|Vitamin K|vitamin k|mesh-list
154854692|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
154854693|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
154854694|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854695|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154854696|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154854697|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854698|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
154854699|NCT04382027|Coagulants|coagulants|mesh-ancestor
154854700|NCT00896441|Citalopram|citalopram|mesh-list
154854701|NCT00896441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154854702|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154854703|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154854704|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854705|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854706|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
154854707|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854708|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154854709|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
154854710|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154854711|NCT03400111|Acetaminophen|acetaminophen|mesh-list
154854712|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854713|NCT03400111|Analgesics|analgesics|mesh-ancestor
154854714|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
154854715|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854716|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854717|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
154854718|NCT03404791|Gemcitabine|gemcitabine|mesh-list
154854719|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154854720|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
154264786|NCT02520791|Antibodies|antibodies|mesh-list
154854721|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854722|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854723|NCT00918931|Obatoclax|obatoclax|mesh-list
154854724|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854725|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854726|NCT03404011|Glycerol|glycerol|mesh-list
154854727|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154854728|NCT03404011|Protective Agents|protective agents|mesh-ancestor
154854729|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854730|NCT01830491|Aspirin|aspirin|mesh-list
154854731|NCT01830491|Clopidogrel|clopidogrel|mesh-list
154854732|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154854733|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854734|NCT01830491|Analgesics|analgesics|mesh-ancestor
154854735|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
154854736|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854737|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854738|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854739|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854740|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154854741|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154854742|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854743|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154854744|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154854745|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854746|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
154854747|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154854748|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154854749|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154854750|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
154854751|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854752|NCT02778880|Fentanyl|fentanyl|mesh-list
154854753|NCT02778880|Ketamine|ketamine|mesh-list
154854754|NCT02778880|Analgesics|analgesics|mesh-ancestor
154854755|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
154854756|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854757|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854758|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154854759|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154606707|NCT03257683|Ranolazine|ranolazine|mesh-list
154854760|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
154854761|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
154854762|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854763|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154854764|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154854765|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854766|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854767|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154854768|NCT02778880|Narcotics|narcotics|mesh-ancestor
154854769|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154854770|NCT05310929|Labetalol|labetalol|mesh-list
154854771|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
154854772|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
154854773|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154854774|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154854775|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
154854776|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854777|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854778|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854779|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154854780|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
154854781|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
154854782|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854783|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154854784|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154854785|NCT00891995|Insulin|insulin|mesh-list
154854786|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154854787|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854788|NCT02781454|Mexiletine|mexiletine|mesh-list
154854789|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154854790|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154854791|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154854792|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154854793|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854794|NCT00892697|Ribavirin|ribavirin|mesh-list
154854795|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154854796|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
154854797|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854798|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
154854799|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854800|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154854801|NCT02155465|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154854802|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154854803|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854804|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854805|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854806|NCT01831193|Curcumin|curcumin|mesh-list
154854807|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154854808|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854809|NCT01831193|Analgesics|analgesics|mesh-ancestor
154854810|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
154854811|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854812|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854813|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854814|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854815|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854816|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854817|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854818|NCT01831505|Prednisolone|prednisolone|mesh-list
154854819|NCT01831505|Rituximab|rituximab|mesh-list
154854820|NCT01831505|Doxorubicin|doxorubicin|mesh-list
154854821|NCT01831505|Vincristine|vincristine|mesh-list
154854822|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154854823|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854824|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854825|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
154854826|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854827|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154854828|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154854829|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154854830|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154854831|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854832|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854833|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154854834|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
154854835|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
154854836|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
154854837|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154854838|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
154854840|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154854841|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154854842|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154854843|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
154854844|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154854845|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854846|NCT03214055|Mannitol|mannitol|mesh-list
154854847|NCT03214055|Diuretics|diuretics|mesh-list
154854848|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154854849|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
154854850|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854851|NCT03405337|Factor VIII|factor viii|mesh-list
154854852|NCT03405337|Coagulants|coagulants|mesh-ancestor
154854853|NCT01831661|Metformin|metformin|mesh-list
154854854|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154854855|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854856|NCT03400267|Acetaminophen|acetaminophen|mesh-list
154854857|NCT03400267|Fentanyl|fentanyl|mesh-list
154854858|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154854859|NCT03400267|Narcotics|narcotics|mesh-ancestor
154854860|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854861|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854862|NCT03400267|Analgesics|analgesics|mesh-ancestor
154854863|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
154854864|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854865|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154854866|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154854867|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
154854868|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
154854869|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154854870|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
154854871|NCT01832051|Trastuzumab|trastuzumab|mesh-list
154854872|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154854873|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854874|NCT01832129|Vitamins|vitamins|mesh-list
154854875|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
154854876|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
154854877|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
154854878|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
154854879|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854880|NCT01832129|Hematinics|hematinics|mesh-ancestor
154854881|NCT02903446|Denosumab|denosumab|mesh-list
154854882|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154854883|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854884|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
154854885|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154854886|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154854887|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854888|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854889|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154854890|NCT01832285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154854891|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154854892|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154854893|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854894|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854895|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
154854896|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154854897|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
154854898|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154854899|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154854900|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854901|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154854902|NCT01832363|Xenon|xenon|mesh-list
154854903|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154854904|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
154854905|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
154854906|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854907|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854908|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
154854909|NCT02903836|Nafithromycin|nafithromycin|mesh-list
154606853|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854910|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154854911|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854912|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154854913|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154854914|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854915|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854916|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854917|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154854919|NCT00014911|Pentamidine|pentamidine|mesh-list
154854920|NCT00014911|Trimethoprim|trimethoprim|mesh-list
154854921|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
154854922|NCT00014911|Ganciclovir|ganciclovir|mesh-list
154854923|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154854924|NCT00014911|Tacrolimus|tacrolimus|mesh-list
154854925|NCT00014911|Daclizumab|daclizumab|mesh-list
154854926|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154854927|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
154854928|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854929|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154854930|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854931|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854932|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154854933|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854934|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154854935|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854936|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
154854937|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154854938|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
154854939|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154854940|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154854941|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154854942|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154854943|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154854944|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154854945|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
154854946|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154854947|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154854948|NCT01832675|Bupivacaine|bupivacaine|mesh-list
154854949|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
154854950|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
154854951|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854952|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854953|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
154854954|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854955|NCT03213587|Apatinib|apatinib|mesh-list
154854956|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154854957|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154854958|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854959|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854960|NCT00013897|Lamivudine|lamivudine|mesh-list
154854961|NCT00013897|Zidovudine|zidovudine|mesh-list
154854962|NCT00013897|Efavirenz|efavirenz|mesh-list
154854963|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154854964|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154854965|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154854966|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154854967|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154854968|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854969|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
154854970|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154854971|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154854972|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154854973|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
154854974|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154854975|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154854976|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154854977|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154854978|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154854979|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154854980|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154854981|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154854982|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
154854983|NCT03219983|Bupivacaine|bupivacaine|mesh-list
154854984|NCT03219983|Ropivacaine|ropivacaine|mesh-list
154854985|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
154854986|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
154854987|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154854988|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854989|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
154854990|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154854991|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154854992|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154854993|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154854994|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154854995|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154854996|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154854997|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154854998|NCT04347577|Analgesics|analgesics|mesh-ancestor
154854999|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
154855000|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855001|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
154855002|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154855003|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
154855004|NCT02240017|Carboplatin|carboplatin|mesh-list
154855005|NCT02240017|Gemcitabine|gemcitabine|mesh-list
154855006|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855007|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154855008|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
154855009|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855010|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
154855011|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855012|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
154855013|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
154855014|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
154855015|NCT03219593|Apatinib|apatinib|mesh-list
154855016|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855017|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154855018|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855019|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855020|NCT03836807|Ketoprofen|ketoprofen|mesh-list
154855021|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
154855022|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154855023|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855024|NCT03836807|Analgesics|analgesics|mesh-ancestor
154855025|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
154855026|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855027|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855028|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855029|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855030|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154855031|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855032|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855033|NCT02240173|Haloperidol|haloperidol|mesh-list
154855034|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
154855035|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
154855036|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
154855037|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265106|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154855038|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855039|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154855040|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154855041|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154855042|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855043|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154855044|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154855045|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
154855046|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855047|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855048|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154855049|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
154855050|NCT02240641|Lacidipine|lacidipine|mesh-list
154855051|NCT02240641|Diuretics|diuretics|mesh-list
154855052|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154855053|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154855054|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154855055|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154855056|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
154855057|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855058|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154855059|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
154855060|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855061|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855062|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
154855063|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154855064|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855065|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154855066|NCT03219671|Nivolumab|nivolumab|mesh-list
154855067|NCT03219671|Ipilimumab|ipilimumab|mesh-list
154855068|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855069|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855070|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154855071|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855072|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
154855073|NCT03404635|Apixaban|apixaban|mesh-list
154855074|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154855075|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
154855076|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154855077|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
154855078|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855079|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855080|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
154855081|NCT01832987|Trimethoprim|trimethoprim|mesh-list
154855082|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154855083|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
154855084|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154855085|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855086|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
154855087|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154855088|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154855089|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154855090|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855091|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855092|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154855093|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154855094|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154855095|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154855096|NCT03404479|Celecoxib|celecoxib|mesh-list
154855097|NCT03404479|Diacerein|diacerein|mesh-list
154855098|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154855099|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855100|NCT03404479|Analgesics|analgesics|mesh-ancestor
154855101|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
154855102|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855103|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855104|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855105|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855106|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154855107|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154855108|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855109|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855110|NCT04380467|Vitamin D|vitamin d|mesh-list
154855111|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
154855112|NCT04380467|Vitamins|vitamins|mesh-ancestor
154855113|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
154855114|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855115|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154855116|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154855117|NCT03218657|Cyclosporine|cyclosporine|mesh-list
154855118|NCT03218657|Levamisole|levamisole|mesh-list
154855119|NCT03218657|Cyclosporins|cyclosporins|mesh-list
154855120|NCT03218657|Androgens|androgens|mesh-list
154855121|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855122|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855123|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855124|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
154855125|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855126|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
154855127|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855128|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
154855129|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855130|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154855131|NCT03218657|Hormones|hormones|mesh-ancestor
154855132|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607099|NCT03363503|Xhance|xhance|mesh-list
154855133|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154855134|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
154855135|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
154855136|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154855137|NCT02240719|Everolimus|everolimus|mesh-list
154855138|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154855139|NCT02240719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154855140|NCT02240719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154855141|NCT02240719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855142|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855143|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855144|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
154265215|NCT00120952|Cobalt|cobalt|mesh-list
154855145|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855146|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855147|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154855148|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
154855149|NCT01833299|Sorafenib|sorafenib|mesh-list
154855150|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
154855151|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855152|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154855153|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855154|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855155|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154855156|NCT01833299|Estrogens|estrogens|mesh-ancestor
154855157|NCT01833299|Hormones|hormones|mesh-ancestor
154855158|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855159|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855160|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154855161|NCT03213041|Carboplatin|carboplatin|mesh-list
154855162|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
154855163|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855164|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855165|NCT03213041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154855166|NCT03213041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855167|NCT02240875|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154855168|NCT02240875|Antiviral Agents|antiviral agents|mesh-ancestor
154855169|NCT02240875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855170|NCT01833611|Entecavir|entecavir|mesh-list
154855171|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
154855172|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855173|NCT02240953|Warfarin|warfarin|mesh-list
154855174|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
154855175|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
154855176|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154855177|NCT02241031|Oprelvekin|oprelvekin|mesh-list
154855178|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855179|NCT03212807|Lenalidomide|lenalidomide|mesh-list
154855180|NCT03212807|Durvalumab|durvalumab|mesh-list
154855181|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
154855182|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855183|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154855184|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154855185|NCT03212807|Growth Substances|growth substances|mesh-ancestor
154855186|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
154855187|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855188|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855189|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
154855190|NCT01833767|Interleukin-2|interleukin-2|mesh-list
154855191|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855192|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
154855193|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855194|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855195|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154855196|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
154855197|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855198|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855199|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154855200|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855201|NCT01833767|Analgesics|analgesics|mesh-ancestor
154855202|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
154855203|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855204|NCT03213353|Acetaminophen|acetaminophen|mesh-list
154855205|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
154855206|NCT03213353|Phenylephrine|phenylephrine|mesh-list
154855207|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
154855208|NCT03213353|Guaifenesin|guaifenesin|mesh-list
154855209|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154855210|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855211|NCT03213353|Analgesics|analgesics|mesh-ancestor
154855212|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
154855213|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855214|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855215|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
154855216|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154855217|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
154855218|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
154855219|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
154855220|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154855221|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
154855222|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
154855223|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154855224|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154855225|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154855226|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
154855227|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855228|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855229|NCT03213353|Protective Agents|protective agents|mesh-ancestor
154855230|NCT03213353|Expectorants|expectorants|mesh-ancestor
154855231|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
154855232|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154855233|NCT01834235|Paclitaxel|paclitaxel|mesh-list
154855234|NCT01834235|Gemcitabine|gemcitabine|mesh-list
154855235|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154855236|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855237|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
154855238|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
154855239|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
154855240|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855241|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154855242|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
154855243|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
154855244|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154855245|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855246|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855247|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855248|NCT03211871|Analgesics|analgesics|mesh-ancestor
154855249|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
154855250|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855251|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154855252|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154855253|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154855254|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
154855255|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855256|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855257|NCT03838133|Bupivacaine|bupivacaine|mesh-list
154855258|NCT03838133|Ropivacaine|ropivacaine|mesh-list
154855259|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
154855260|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
154855261|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855262|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855263|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
154855264|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855265|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154855266|NCT03217409|Ezetimibe|ezetimibe|mesh-list
154855267|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154855268|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154855269|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
154855270|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265339|NCT01333774|Acarbose|acarbose|mesh-list
154855271|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154855272|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154855273|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855274|NCT00895193|Aspirin|aspirin|mesh-list
154855275|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154855276|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855277|NCT00895193|Analgesics|analgesics|mesh-ancestor
154855278|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
154855279|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855280|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855281|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855282|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855283|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154855284|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154855285|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855286|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154855287|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154855288|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855289|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
154855290|NCT01834547|Caffeine|caffeine|mesh-list
154855291|NCT01834547|Methylphenidate|methylphenidate|mesh-list
154855292|NCT01834547|Modafinil|modafinil|mesh-list
154855293|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154855294|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855295|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154855296|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855297|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855298|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154855299|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154855300|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
154855301|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855302|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154855303|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154855304|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855305|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
154855306|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154855307|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154855308|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154855309|NCT03216941|Ketamine|ketamine|mesh-list
154855310|NCT03216941|Olanzapine|olanzapine|mesh-list
154855311|NCT03216941|Analgesics|analgesics|mesh-ancestor
154855312|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
154855313|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855314|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855315|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154855316|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154855317|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
154855318|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
154855319|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855320|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154855321|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154855322|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855323|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855324|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
154855325|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
154855326|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154855327|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154855328|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154855329|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154855330|NCT03216941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154855331|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154855332|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855333|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
154855334|NCT03216707|Capsaicin|capsaicin|mesh-list
154855335|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
154855336|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
153606857|NCT04624750|Mexiletine|mexiletine|mesh-list
154855337|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
154855338|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855339|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855340|NCT01838993|Lidocaine|lidocaine|mesh-list
154855341|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
154855342|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
154855343|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855344|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855345|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
154855346|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855347|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154855348|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154855349|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154855350|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855351|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855352|NCT03211013|Oxytocin|oxytocin|mesh-list
154855353|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
154855354|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154855355|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855356|NCT01835561|Thalidomide|thalidomide|mesh-list
154855357|NCT01835561|Pomalidomide|pomalidomide|mesh-list
154855358|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
154855359|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855360|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154855361|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154855362|NCT01835561|Growth Substances|growth substances|mesh-ancestor
154855363|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265465|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265466|NCT02795182|Tislelizumab|tislelizumab|mesh-list
154265467|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
154265468|NCT02795182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154265469|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265470|NCT02795182|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154265471|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154265472|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012385|NCT00027859|Ketoconazole|ketoconazole|mesh-list
154265473|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265474|NCT03054766|Ranibizumab|ranibizumab|mesh-list
154265475|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154855364|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855365|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855366|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
154855367|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154855368|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855370|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
154855371|NCT01835639|Vitamins|vitamins|mesh-ancestor
154855372|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
154855373|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855374|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154855375|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154855376|NCT01839149|Oxytocin|oxytocin|mesh-list
154855377|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
154855378|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154855379|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855380|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
154855381|NCT01839383|Calcium|calcium|mesh-list
154855382|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154855383|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855384|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154855385|NCT00901199|Deferasirox|deferasirox|mesh-list
154855386|NCT00901199|Deferoxamine|deferoxamine|mesh-list
154855387|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154855388|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
154855389|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
154855390|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855391|NCT00901199|Siderophores|siderophores|mesh-ancestor
154855392|NCT01836341|Carboplatin|carboplatin|mesh-list
154855393|NCT01836341|Pemetrexed|pemetrexed|mesh-list
154855394|NCT01836341|Afatinib|afatinib|mesh-list
154855395|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855396|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855397|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855398|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154855399|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154855400|NCT01836341|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154855401|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154855402|NCT00906503|Dexamethasone|dexamethasone|mesh-list
154855403|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154855404|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855405|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
154855406|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
154855407|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855408|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855409|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154855410|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
154855411|NCT00906503|Hormones|hormones|mesh-ancestor
154855412|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855413|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154855414|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855415|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154855416|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855417|NCT01836575|Carboplatin|carboplatin|mesh-list
154855418|NCT01836575|Pemetrexed|pemetrexed|mesh-list
154855419|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855420|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855421|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855422|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154855423|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154855424|NCT01836653|Bevacizumab|bevacizumab|mesh-list
154855425|NCT01836653|Cetuximab|cetuximab|mesh-list
154855426|NCT01836653|Fluorouracil|fluorouracil|mesh-list
154855427|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
154855428|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855429|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855430|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154855431|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154855432|NCT01836653|Growth Substances|growth substances|mesh-ancestor
154855433|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855435|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
154855436|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855437|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154855438|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855439|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
154855440|NCT03836885|Apremilast|apremilast|mesh-list
154855441|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154855442|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855443|NCT03836885|Analgesics|analgesics|mesh-ancestor
154855444|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
154855445|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855446|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855447|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855448|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855449|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154855450|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154855451|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855452|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855453|NCT01837043|Cyclosporine|cyclosporine|mesh-list
154855454|NCT01837043|Abatacept|abatacept|mesh-list
154855455|NCT01837043|Tacrolimus|tacrolimus|mesh-list
154855456|NCT01837043|Cyclosporins|cyclosporins|mesh-list
154855457|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154855458|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855459|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
154855460|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855461|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855462|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855463|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
154855464|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855465|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
154855466|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855467|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154855468|NCT01837043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855469|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855470|NCT01839773|Paclitaxel|paclitaxel|mesh-list
154855471|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154855472|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154855473|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855474|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
154855475|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
154855476|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
154855477|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855478|NCT00909155|Fluoxetine|fluoxetine|mesh-list
154855479|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154855480|NCT00909155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154855481|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154855482|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855483|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855484|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855485|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
154855486|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855487|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154855488|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
154855489|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154855490|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154855491|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154855492|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855493|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154855494|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
154855495|NCT01839851|Hormones|hormones|mesh-ancestor
154855496|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265556|NCT01331590|Hormones|hormones|mesh-ancestor
154855497|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855498|NCT01839929|Tacrolimus|tacrolimus|mesh-list
154855499|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855500|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
154855501|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855502|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154855503|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855504|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855505|NCT04373083|Cemiplimab|cemiplimab|mesh-list
154855506|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855507|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855508|NCT03210545|Betamethasone|betamethasone|mesh-list
154855509|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855510|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
154855511|NCT03210545|Hormones|hormones|mesh-ancestor
154855512|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855513|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855514|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154855515|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
154855516|NCT04372849|Insulin|insulin|mesh-list
154855517|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154855518|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855519|NCT03403777|Avelumab|avelumab|mesh-list
154855520|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855521|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855522|NCT02241421|Amoxicillin|amoxicillin|mesh-list
154855523|NCT02241421|Vancomycin|vancomycin|mesh-list
154855524|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154855525|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855526|NCT01837199|Amoxicillin|amoxicillin|mesh-list
154855527|NCT01837199|Metronidazole|metronidazole|mesh-list
154855528|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154855529|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855530|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154855531|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154855532|NCT00926185|Lifitegrast|lifitegrast|mesh-list
154855533|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154855534|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154855535|NCT02241499|Fluorouracil|fluorouracil|mesh-list
154855536|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
154855537|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
154855538|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855539|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154855540|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855541|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855542|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
154855543|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855544|NCT01837667|Docetaxel|docetaxel|mesh-list
154855545|NCT01837667|LB100|lb100|mesh-list
154855546|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855547|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
154855548|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
154855549|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154855550|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855551|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855552|NCT03833947|Dexamethasone|dexamethasone|mesh-list
154855553|NCT03833947|Lidocaine|lidocaine|mesh-list
154855554|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855555|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
154855556|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
154855557|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855558|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855559|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154855560|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
154855561|NCT03833947|Hormones|hormones|mesh-ancestor
154265628|NCT02913664|Losartan|losartan|mesh-list
154855562|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855563|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154855564|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855565|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
154855566|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
154855567|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855568|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
154855569|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154855570|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154855571|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154855572|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855573|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855574|NCT03219437|Methotrexate|methotrexate|mesh-list
154855575|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154855576|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
154855577|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154855578|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855579|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154855580|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
154855581|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855582|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855583|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
154855584|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855585|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154855586|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855587|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
154855588|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855589|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154855590|NCT03212963|Clobetasol|clobetasol|mesh-list
154855591|NCT03212963|Halobetasol|halobetasol|mesh-list
154855592|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154855593|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855594|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
154855595|NCT03212963|Hormones|hormones|mesh-ancestor
154855596|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855597|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855598|NCT03218969|Ecopipam|ecopipam|mesh-list
154855599|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154855600|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154855601|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855602|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855603|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154855604|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154855605|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
154855606|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855607|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855608|NCT01830101|Temozolomide|temozolomide|mesh-list
154855609|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154855610|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
154855611|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855612|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855613|NCT01830335|Indomethacin|indomethacin|mesh-list
154855614|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154855615|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855616|NCT01830335|Analgesics|analgesics|mesh-ancestor
154855617|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
154855618|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855619|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855620|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855621|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855622|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
154855623|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
154855624|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154855625|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154855626|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855627|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855628|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
154855629|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154855630|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154855631|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855632|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154855633|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154855634|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855635|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855636|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855637|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855638|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
154855639|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
154855640|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154855641|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
154855642|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855643|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855644|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154855645|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
154855646|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
154855647|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154855648|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
154855649|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855650|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855651|NCT04371757|Doxazosin|doxazosin|mesh-list
154855652|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
154855653|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154855654|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154855655|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154855656|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154855657|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855658|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855659|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855660|NCT04371601|Oseltamivir|oseltamivir|mesh-list
154855662|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855663|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855664|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
154855665|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855666|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855667|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855668|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
154855669|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
154855670|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154855671|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154855672|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855673|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855674|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855675|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855676|NCT02242357|Telmisartan|telmisartan|mesh-list
154855677|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154855678|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154855679|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154855680|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855681|NCT03409835|Ramosetron|ramosetron|mesh-list
154855682|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
154855683|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
154855684|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855685|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855686|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154855687|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154855688|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
154855689|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154265753|NCT01340326|Valsartan|valsartan|mesh-list
154855690|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855691|NCT02242513|Lidocaine|lidocaine|mesh-list
154855692|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
154855693|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
154855694|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855695|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855696|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
154855697|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855698|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154855699|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154855700|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154855701|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855702|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855703|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154855704|NCT03409679|Murepavadin|murepavadin|mesh-list
154855705|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855706|NCT04371367|Avdoralimab|avdoralimab|mesh-list
154855707|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855708|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
154855709|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855710|NCT02242591|Ropivacaine|ropivacaine|mesh-list
154855711|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
154855712|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
154855713|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855714|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855715|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
154855716|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855717|NCT02982577|Pilocarpine|pilocarpine|mesh-list
154855718|NCT02982577|Miotics|miotics|mesh-ancestor
154855719|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
154855720|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855721|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855722|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154855723|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154855724|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
154855725|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855726|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855727|NCT01726205|Pregabalin|pregabalin|mesh-list
154855728|NCT01726205|Ropivacaine|ropivacaine|mesh-list
154855729|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
154855730|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
154855731|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855732|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855733|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
154855734|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855735|NCT01726205|Analgesics|analgesics|mesh-ancestor
154855736|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
154855737|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154855738|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855739|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855740|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154855741|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154855742|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154855743|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154855744|NCT02242825|Telmisartan|telmisartan|mesh-list
154855745|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154855746|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154855747|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154855748|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154855749|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855750|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154855751|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855752|NCT02242825|Diuretics|diuretics|mesh-ancestor
154855753|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
154855754|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855756|NCT04370977|Lumefantrine|lumefantrine|mesh-list
154855757|NCT04370977|Artemether|artemether|mesh-list
154855758|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154855759|NCT04370977|Amodiaquine|amodiaquine|mesh-list
154855760|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
154855761|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154855762|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154855763|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855764|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855765|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
154855766|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
154855767|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154855768|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
154855769|NCT01726283|Riboflavin|riboflavin|mesh-list
154855770|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
154855771|NCT01726283|Vitamins|vitamins|mesh-ancestor
154855772|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
154855773|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855774|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154855775|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
154855776|NCT04370431|Edaravone|edaravone|mesh-list
154855777|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154855778|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
154855779|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855780|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154855781|NCT04370431|Protective Agents|protective agents|mesh-ancestor
154855782|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855783|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154855784|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855785|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855786|NCT03835871|Beclomethasone|beclomethasone|mesh-list
154855787|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855788|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
154855789|NCT03835871|Hormones|hormones|mesh-ancestor
154855790|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855791|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855792|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154855793|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
154855794|NCT03402295|Thalidomide|thalidomide|mesh-list
154855795|NCT03402295|Dexamethasone|dexamethasone|mesh-list
154855796|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
154855797|NCT03402295|Bortezomib|bortezomib|mesh-list
154855798|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855799|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
154855800|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855801|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855802|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154855803|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
154855804|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855805|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855806|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154855807|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855808|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
154855809|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
154855810|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855811|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154855812|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
154855813|NCT03402295|Hormones|hormones|mesh-ancestor
154855814|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855815|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154855816|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
154855817|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154855818|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855819|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154855820|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154855821|NCT03402295|Growth Substances|growth substances|mesh-ancestor
154855822|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
154855823|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154855824|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154855825|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855826|NCT02244073|Insulin|insulin|mesh-list
154855827|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154855828|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154855829|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855830|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154855831|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
154855832|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154855833|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
154855834|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154855835|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855836|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154855837|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154855838|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855839|NCT03401827|Paclitaxel|paclitaxel|mesh-list
154855840|NCT03401827|Gemcitabine|gemcitabine|mesh-list
154855841|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154855842|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855843|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
154855844|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
154855845|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
154855846|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855847|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154855848|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
154855849|NCT00909545|Isradipine|isradipine|mesh-list
154855850|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154855851|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154855852|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855853|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855854|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154855855|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855856|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
154855857|NCT02244229|Tamsulosin|tamsulosin|mesh-list
154855858|NCT02244229|Finasteride|finasteride|mesh-list
154855859|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154855860|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154855861|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154855862|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
154855863|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855864|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855865|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855866|NCT02244229|Urological Agents|urological agents|mesh-ancestor
154855867|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154855868|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154855869|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855870|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
154855871|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154855872|NCT02157103|Bevacizumab|bevacizumab|mesh-list
154855873|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855874|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855875|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154607827|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
154855876|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154855877|NCT02157103|Growth Substances|growth substances|mesh-ancestor
154855878|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855879|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
154855880|NCT00924001|Aldesleukin|aldesleukin|mesh-list
154855881|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
154855882|NCT00924001|Fludarabine|fludarabine|mesh-list
154855883|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154855884|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
154855885|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855886|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855887|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154855888|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
154855889|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855890|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855891|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154855892|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154855893|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154855894|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
154855895|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855896|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
154855897|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
154855898|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154855899|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855900|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855901|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855903|NCT03401593|Fentanyl|fentanyl|mesh-list
154855904|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154855905|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154855906|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855907|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855908|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154855909|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154855910|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154855911|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154855912|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
154855913|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
154855914|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
154855915|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
154855916|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855917|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855918|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154855919|NCT03401593|Narcotics|narcotics|mesh-ancestor
154855920|NCT03401593|Analgesics|analgesics|mesh-ancestor
154855921|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
154855922|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855923|NCT03401515|Propranolol|propranolol|mesh-list
154855924|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154855925|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154855926|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
154855927|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154855928|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855929|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855930|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154855931|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154855932|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
154266010|NCT05226442|Heparin|heparin|mesh-list
154855933|NCT01726829|Pancrelipase|pancrelipase|mesh-list
154855934|NCT01726829|Pancreatin|pancreatin|mesh-list
154855935|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154855936|NCT03834233|Nivolumab|nivolumab|mesh-list
154855937|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154855938|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855939|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154855940|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855941|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
154855942|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154855943|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154855944|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855945|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
154855946|NCT04367155|Coagulants|coagulants|mesh-ancestor
154855947|NCT01727453|Warfarin|warfarin|mesh-list
154855948|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
154855949|NCT01727531|Chloroquine|chloroquine|mesh-list
154607900|NCT00707993|Alogliptin|alogliptin|mesh-list
154855950|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154855951|NCT01727531|Amebicides|amebicides|mesh-ancestor
154855952|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154855953|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154855954|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855955|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
154855956|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154855957|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154855958|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154855959|NCT01727531|Analgesics|analgesics|mesh-ancestor
154855960|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
154855961|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855962|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855963|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154855964|NCT01727531|Filaricides|filaricides|mesh-ancestor
154855965|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
154855966|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
154855967|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
154855968|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154855969|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154855970|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154855971|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154855972|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154855973|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154855974|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855975|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154855976|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154855977|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
154855978|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154855979|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855980|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154855981|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154855982|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154855983|NCT00929071|Lidocaine|lidocaine|mesh-list
154855984|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
154855985|NCT00929071|Anesthetics|anesthetics|mesh-list
154855986|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154855987|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154855988|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
154855989|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154855990|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154855991|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154855992|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154855993|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154855994|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154855995|NCT01721525|Ribavirin|ribavirin|mesh-list
154855996|NCT01721525|Paclitaxel|paclitaxel|mesh-list
154855997|NCT01721525|Carboplatin|carboplatin|mesh-list
154855998|NCT01721525|Afatinib|afatinib|mesh-list
154855999|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154856000|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856001|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
154856002|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
154856003|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
154856004|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856005|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
154856006|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
154856007|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856008|NCT01721525|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154856009|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154856010|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856011|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
154856012|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154856013|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154856014|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856015|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
154856016|NCT01727843|Coagulants|coagulants|mesh-ancestor
154856017|NCT01721915|Vitamin D|vitamin d|mesh-list
154856018|NCT01721915|Vitamins|vitamins|mesh-ancestor
154856019|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
154856020|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856021|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154856022|NCT04357483|Thrombin|thrombin|mesh-list
154856023|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
154856024|NCT04357483|Coagulants|coagulants|mesh-ancestor
154856025|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
154856026|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154856027|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856028|NCT04366609|Methylphenidate|methylphenidate|mesh-list
154856029|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154856030|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856031|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154856032|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154856033|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154856034|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856035|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
154856036|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856037|NCT03407105|Ipilimumab|ipilimumab|mesh-list
154856038|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856039|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856040|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154856041|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856042|NCT01728233|Dacomitinib|dacomitinib|mesh-list
154856043|NCT01728233|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154856044|NCT01728233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154856045|NCT01728233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856046|NCT01728233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856047|NCT01722227|Liraglutide|liraglutide|mesh-list
154856048|NCT01722227|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154856049|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154266124|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
154856050|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856051|NCT01722227|Incretins|incretins|mesh-ancestor
154856052|NCT01722227|Hormones|hormones|mesh-ancestor
154856053|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856054|NCT01722305|Dexamethasone|dexamethasone|mesh-list
154856055|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
154856056|NCT01722305|Pomalidomide|pomalidomide|mesh-list
154856057|NCT01722305|Ichthammol|ichthammol|mesh-list
154856058|NCT01722305|BB 1101|bb 1101|mesh-list
154856059|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154856060|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
154856061|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
154856062|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856063|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856064|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154856065|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
154856066|NCT01722305|Hormones|hormones|mesh-ancestor
154856067|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856068|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154856069|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856070|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
154856071|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856072|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856073|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
154856074|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154856075|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154856076|NCT01722305|Growth Substances|growth substances|mesh-ancestor
154856077|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
154856078|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
154856079|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154856080|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154856081|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856082|NCT04365517|Incretins|incretins|mesh-ancestor
154856083|NCT04365517|Hormones|hormones|mesh-ancestor
154856084|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856085|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154856086|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
154856087|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856088|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856089|NCT03406871|Nivolumab|nivolumab|mesh-list
154856090|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856091|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856092|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154856093|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856094|NCT04357093|Listerine|listerine|mesh-list
154856095|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
154856096|NCT04357093|Fluorides|fluorides|mesh-list
154856097|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
154856098|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
154856099|NCT04357093|Protective Agents|protective agents|mesh-ancestor
154856100|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856101|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154856102|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856103|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154856104|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856105|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
154856106|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856107|NCT03406793|Iron|iron|mesh-list
154856108|NCT03406793|Zinc|zinc|mesh-list
154856109|NCT03406793|Trace Elements|trace elements|mesh-ancestor
154856110|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
154856111|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856112|NCT04365127|Progesterone|progesterone|mesh-list
154856113|NCT04365127|Progestins|progestins|mesh-ancestor
154856114|NCT04365127|Hormones|hormones|mesh-ancestor
154856115|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856116|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856117|NCT00929383|Hemostatics|hemostatics|mesh-list
154856118|NCT00929383|Coagulants|coagulants|mesh-ancestor
154856119|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
154856120|NCT01722539|Piperaquine|piperaquine|mesh-list
154856121|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
154856122|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154856123|NCT01722539|Albendazole|albendazole|mesh-list
154856124|NCT01722539|Praziquantel|praziquantel|mesh-list
154856125|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
154856126|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154856127|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154856128|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856129|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154856130|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856131|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856132|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154856133|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
154856134|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
154856135|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154856136|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
154856137|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
154856138|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
154856139|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856140|NCT03406403|Anesthetics|anesthetics|mesh-list
154856141|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856142|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856143|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
154856144|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
154856145|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
154856146|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154856147|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154856148|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856149|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856150|NCT03406169|Urological Agents|urological agents|mesh-ancestor
154856151|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154856152|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154856153|NCT03406169|Protective Agents|protective agents|mesh-ancestor
154856154|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856155|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154856156|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
154856157|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
154856158|NCT04357015|Carbetocin|carbetocin|mesh-list
154856159|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154856160|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154856161|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856162|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
154856163|NCT04357015|Coagulants|coagulants|mesh-ancestor
154856164|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
154856165|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154856166|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856167|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154856168|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154856169|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154856170|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856171|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
154856172|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
154856173|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
154856174|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154856175|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154856176|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856177|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856178|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856179|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856180|NCT02245243|Delafloxacin|delafloxacin|mesh-list
154856181|NCT02245243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856182|NCT01728935|Tenofovir|tenofovir|mesh-list
154856183|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
154856184|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856185|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154856186|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154856187|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856188|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856189|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154856190|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154856191|NCT03833999|Ondansetron|ondansetron|mesh-list
154856192|NCT03833999|Lactulose|lactulose|mesh-list
154856193|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
154856194|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
154856195|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856196|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856197|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154856198|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
154856199|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
154856200|NCT03833999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154856201|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154856202|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
154856203|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856204|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856205|NCT04379219|Methotrexate|methotrexate|mesh-list
154856206|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154856207|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
154856208|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154856209|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856210|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154856211|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
154856212|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856213|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856214|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
154856215|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856216|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154856217|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856218|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
154856219|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856220|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154856221|NCT04347031|Azithromycin|azithromycin|mesh-list
154856222|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
154856223|NCT04347031|Mefloquine|mefloquine|mesh-list
154856224|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154856225|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856226|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
154856227|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154856228|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154856229|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856230|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856231|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856232|NCT02906566|Vitamin A|vitamin a|mesh-list
154856233|NCT02906566|Vitamins|vitamins|mesh-ancestor
154856234|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
154856235|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856236|NCT00913133|Desirudin|desirudin|mesh-list
154856237|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
154856238|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154856239|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154856240|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856241|NCT00373126|Nicotine|nicotine|mesh-list
154856242|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154856243|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
154856244|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856245|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856246|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154856247|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154856248|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
154856249|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856250|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856251|NCT04378283|Lidocaine|lidocaine|mesh-list
154856252|NCT04378283|Epinephrine|epinephrine|mesh-list
154856253|NCT04378283|Tetracaine|tetracaine|mesh-list
154856254|NCT04378283|Anesthetics|anesthetics|mesh-list
154856255|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
154856256|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856257|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856258|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
154856259|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856260|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154856261|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154856262|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154856263|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154856264|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856265|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154856266|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154856267|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
154856268|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856269|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154856270|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154856271|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
154856272|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154856273|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
154856274|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
154856275|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
154856276|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154856277|NCT04355845|Sumatriptan|sumatriptan|mesh-list
154856278|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154856279|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154856280|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154856281|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
154856282|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856283|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856284|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856285|NCT02789410|Morphine|morphine|mesh-list
154856286|NCT02789410|Hydromorphone|hydromorphone|mesh-list
154856287|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154856288|NCT02789410|Narcotics|narcotics|mesh-ancestor
154856289|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856290|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856291|NCT02789410|Analgesics|analgesics|mesh-ancestor
154856292|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
154856293|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856294|NCT01729481|Leucovorin|leucovorin|mesh-list
154856295|NCT01729481|Folic Acid|folic acid|mesh-list
154856296|NCT01729481|Gemcitabine|gemcitabine|mesh-list
154856297|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
154856298|NCT01729481|Irinotecan|irinotecan|mesh-list
154856299|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
154856300|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154856301|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
154856302|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856303|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856304|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154856305|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154856306|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856307|NCT01729481|Antidotes|antidotes|mesh-ancestor
154856308|NCT01729481|Protective Agents|protective agents|mesh-ancestor
154856309|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856310|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
154856311|NCT01729481|Vitamins|vitamins|mesh-ancestor
154856312|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
154856313|NCT01729481|Hematinics|hematinics|mesh-ancestor
154856314|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
154856315|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154856316|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
154856317|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856318|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856319|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154856320|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
154856321|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
154856322|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154856323|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
154856324|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856325|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856326|NCT02793154|Exenatide|exenatide|mesh-list
154856327|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
154856328|NCT02793154|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154856329|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154856330|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856331|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154856332|NCT02793154|Incretins|incretins|mesh-ancestor
154608288|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
154856333|NCT02793154|Hormones|hormones|mesh-ancestor
154856334|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856335|NCT01723553|Corticosterone|corticosterone|mesh-list
154856336|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154856337|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154856338|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154856339|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154856340|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856341|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856342|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154856343|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154856344|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856345|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
154856346|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856347|NCT02909140|Lidocaine|lidocaine|mesh-list
154856348|NCT02909140|Phenylephrine|phenylephrine|mesh-list
154856349|NCT02909140|Epinephrine|epinephrine|mesh-list
154856350|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
154856351|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
154856352|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
154856353|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
154856354|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856355|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856356|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
154856357|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856358|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154856359|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154856360|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154856361|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154856362|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856363|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154856364|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154856365|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
154856366|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856367|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154856368|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154856369|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
154856370|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154856371|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
154856372|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
154856373|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
154856374|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154856375|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154856376|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
154856377|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154856378|NCT02909140|Protective Agents|protective agents|mesh-ancestor
154856379|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
154856380|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154856381|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154856382|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
154856383|NCT01724879|Dasatinib|dasatinib|mesh-list
154856384|NCT01724879|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154856385|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154856386|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856387|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856388|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856389|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
154856390|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856391|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
154856392|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856393|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856394|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154856395|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
154856396|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856397|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856398|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154856399|NCT03403985|Calcium|calcium|mesh-list
154856400|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154856401|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856402|NCT04364425|Triamcinolone|triamcinolone|mesh-list
154856403|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154856404|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154608353|NCT03120923|Lidocaine|lidocaine|mesh-list
154856405|NCT04364425|Lidocaine|lidocaine|mesh-list
154856406|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154856407|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
154856408|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
154856409|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856410|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856411|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
154856412|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856413|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154856414|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154856415|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154856416|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154856417|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856418|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154856419|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
154856420|NCT04364425|Hormones|hormones|mesh-ancestor
154856421|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856422|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856423|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
154856424|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856425|NCT02911324|Nabilone|nabilone|mesh-list
154856426|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
154856427|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
154856428|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856429|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856430|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154856431|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154856432|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154856433|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856434|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154856435|NCT01729403|Metformin|metformin|mesh-list
154856436|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154856437|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856438|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154856439|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856440|NCT04355455|Citalopram|citalopram|mesh-list
154856441|NCT04355455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154856442|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154856443|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154856444|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856445|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856446|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
154856447|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856448|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154856449|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
154856450|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154856451|NCT00913913|Bevacizumab|bevacizumab|mesh-list
154856452|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856453|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856454|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154856455|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154856456|NCT00913913|Growth Substances|growth substances|mesh-ancestor
154856457|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856458|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
154856459|NCT00373594|Rituximab|rituximab|mesh-list
154856460|NCT00373594|Fludarabine|fludarabine|mesh-list
154856461|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856462|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856463|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
154856464|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856465|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856466|NCT03403829|Gemcitabine|gemcitabine|mesh-list
154856467|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154856468|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
154856469|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856470|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856471|NCT04364113|Benzocaine|benzocaine|mesh-list
154856472|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
154856473|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
154856474|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856475|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856476|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
154856477|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856478|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
154856479|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154608425|NCT03095001|Growth Substances|growth substances|mesh-ancestor
154856480|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856481|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
154856482|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154856483|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154856484|NCT03834935|Analgesics|analgesics|mesh-ancestor
154856485|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
154856486|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856487|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856488|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154856489|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856490|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
154856491|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856492|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
154856493|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154856494|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856495|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856496|NCT02796352|Interleukin-2|interleukin-2|mesh-list
154856497|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856498|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154856499|NCT02796352|Analgesics|analgesics|mesh-ancestor
154856500|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
154856501|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856502|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856503|NCT00939367|Zolpidem|zolpidem|mesh-list
154856504|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154856505|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154856506|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856507|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856508|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154856509|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
154856510|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
154856511|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856512|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856513|NCT04347187|Anticoagulants|anticoagulants|mesh-list
154856514|NCT00920075|Alendronate|alendronate|mesh-list
154856515|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154856516|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856517|NCT04364035|Vesatolimod|vesatolimod|mesh-list
154856518|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
154856519|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856520|NCT03403439|Itraconazole|itraconazole|mesh-list
154856521|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
154856522|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856523|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154856524|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154856525|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856526|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856527|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154856528|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
154856529|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856530|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856531|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154856532|NCT04346797|Eculizumab|eculizumab|mesh-list
154856533|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154856534|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856535|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
154856536|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856537|NCT04364581|Letrozole|letrozole|mesh-list
154856538|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856539|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154856540|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154856541|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856542|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856543|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154856544|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
154856545|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856546|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856547|NCT01049009|Metoprolol|metoprolol|mesh-list
154856548|NCT01049009|Nebivolol|nebivolol|mesh-list
154856549|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154856550|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154856551|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
154856552|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
154856553|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856554|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856555|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154856556|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154856557|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154856558|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
154856559|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856560|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856561|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
154856562|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154856563|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154856564|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154856565|NCT02850874|Gemcitabine|gemcitabine|mesh-list
154856566|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154856567|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
154856568|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856569|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856570|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154856571|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154856572|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154856573|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154856574|NCT02920918|Canagliflozin|canagliflozin|mesh-list
154856575|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154856576|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856577|NCT02920918|Incretins|incretins|mesh-ancestor
154856578|NCT02920918|Hormones|hormones|mesh-ancestor
154856579|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856580|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154856581|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
154856582|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856583|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856584|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154856585|NCT03403049|Gemcitabine|gemcitabine|mesh-list
154856586|NCT03403049|Capecitabine|capecitabine|mesh-list
154856587|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154856588|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856589|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154856590|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
154856591|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856592|NCT03403049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154856593|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154856594|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856595|NCT00944047|Paclitaxel|paclitaxel|mesh-list
154856596|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
154856597|NCT00944047|Doxorubicin|doxorubicin|mesh-list
154856598|NCT00944047|Trastuzumab|trastuzumab|mesh-list
154856599|NCT00944047|Mitogens|mitogens|mesh-list
154856600|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154856601|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856602|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
154856603|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
154856604|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
154856605|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856606|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856607|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
154856608|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856609|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856610|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154856611|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
154856612|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154856613|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154856614|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154856615|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154856616|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856617|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856618|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
154856619|NCT02921386|Testosterone|testosterone|mesh-list
154856620|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
154856621|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
154856622|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154856623|NCT02921386|Androgens|androgens|mesh-ancestor
154856624|NCT02921386|Hormones|hormones|mesh-ancestor
154856625|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856626|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608572|NCT03336125|Vitamins|vitamins|mesh-ancestor
154856627|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154856628|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856629|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
154856630|NCT03402815|Maraviroc|maraviroc|mesh-list
154856631|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154856632|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154856633|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856634|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154856635|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154856636|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
154856637|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856638|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154856639|NCT02245555|Tamsulosin|tamsulosin|mesh-list
154856640|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154856641|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154856642|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154856643|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
154856644|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856645|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856646|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856647|NCT02245555|Urological Agents|urological agents|mesh-ancestor
154856648|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
154856649|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
154856650|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154856651|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154856652|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856653|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856654|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856655|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856656|NCT02802514|Exenatide|exenatide|mesh-list
154856657|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
154856658|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154856659|NCT02802514|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154856660|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154856661|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856662|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154856663|NCT02802514|Incretins|incretins|mesh-ancestor
154856664|NCT02802514|Hormones|hormones|mesh-ancestor
154856665|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856666|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
154856667|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
154856668|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154856669|NCT00944671|Famotidine|famotidine|mesh-list
154856670|NCT00944671|Calcium|calcium|mesh-list
154856671|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154856672|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856673|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154856674|NCT00944671|Antacids|antacids|mesh-ancestor
154856675|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856676|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154856677|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154856678|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154856679|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
154856680|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
154856681|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856682|NCT00944749|Cyclosporine|cyclosporine|mesh-list
154856683|NCT00944749|Cyclosporins|cyclosporins|mesh-list
154856684|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856685|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856686|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856687|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
154856688|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856689|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
154266784|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
154856690|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856691|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154856692|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856693|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154856694|NCT01047293|Leucovorin|leucovorin|mesh-list
154856695|NCT01047293|Bevacizumab|bevacizumab|mesh-list
154856696|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
154856697|NCT01047293|Everolimus|everolimus|mesh-list
154856698|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856699|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856700|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154856701|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154856702|NCT01047293|Growth Substances|growth substances|mesh-ancestor
154856703|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856704|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
154856705|NCT01047293|Antidotes|antidotes|mesh-ancestor
154856706|NCT01047293|Protective Agents|protective agents|mesh-ancestor
154856707|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
154856709|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
154856710|NCT01047293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154856711|NCT01047293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154856712|NCT01047293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856713|NCT01047293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856714|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856715|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
154856716|NCT01045967|Lansoprazole|lansoprazole|mesh-list
154856717|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
154856718|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154856719|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154856720|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154856721|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856722|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856723|NCT02808052|Minocycline|minocycline|mesh-list
154856724|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154856725|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856726|NCT02924350|Fluorides|fluorides|mesh-list
154856727|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
154856728|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
154856729|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
154856730|NCT02924350|Protective Agents|protective agents|mesh-ancestor
154856731|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856732|NCT00945139|Bevacizumab|bevacizumab|mesh-list
154856733|NCT00945139|Doxorubicin|doxorubicin|mesh-list
154856734|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856735|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856736|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154856737|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154856738|NCT00945139|Growth Substances|growth substances|mesh-ancestor
154856739|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856740|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
154856741|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154856742|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154856743|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154856744|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856745|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856746|NCT02812342|Tofacitinib|tofacitinib|mesh-list
154856747|NCT02812342|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154856748|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154856749|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856750|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856751|NCT03871465|Triamcinolone|triamcinolone|mesh-list
154856752|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154856753|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154856754|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154856755|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154856756|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
154856757|NCT03871465|Hormones|hormones|mesh-ancestor
154856758|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856759|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856760|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856761|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
154856762|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856763|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856764|NCT00931489|Ranibizumab|ranibizumab|mesh-list
154856765|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154856766|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154856767|NCT00931489|Growth Substances|growth substances|mesh-ancestor
154856768|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856769|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
154856770|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856771|NCT04363255|Cisplatin|cisplatin|mesh-list
154856772|NCT04363255|Carboplatin|carboplatin|mesh-list
154856773|NCT04363255|Etoposide|etoposide|mesh-list
154856774|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
154856775|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856776|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154856777|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154856778|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154856779|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856780|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856781|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
154856782|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154856783|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154856784|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154856785|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154856786|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856787|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
154856788|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154856789|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856790|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154856791|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856792|NCT03490825|Melatonin|melatonin|mesh-list
154856793|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
154856794|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856795|NCT03490825|Protective Agents|protective agents|mesh-ancestor
154856796|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856797|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154856798|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154856799|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856800|NCT03317899|Lenograstim|lenograstim|mesh-list
154856801|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154856802|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
154856803|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856804|NCT04353505|Dexamethasone|dexamethasone|mesh-list
154856805|NCT04353505|Ketorolac|ketorolac|mesh-list
154856806|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154856807|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
154856808|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
154856809|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856810|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856811|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154856812|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
154856813|NCT04353505|Hormones|hormones|mesh-ancestor
154856814|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856815|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154856816|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856817|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154856818|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154856819|NCT04353505|Analgesics|analgesics|mesh-ancestor
154856820|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
154856821|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856822|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154856823|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856824|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856825|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154856826|NCT02929927|Eusol|eusol|mesh-list
154856827|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
154856828|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856829|NCT04362241|Prednisolone|prednisolone|mesh-list
154856830|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154856831|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
154856832|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154856833|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
154856834|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154856835|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
154856836|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154856837|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
154856838|NCT04362241|Hormones|hormones|mesh-ancestor
154856839|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856840|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856841|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154856842|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856843|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
154856844|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
154856845|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856846|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154856847|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154856848|NCT04362241|Protective Agents|protective agents|mesh-ancestor
154856849|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
154856850|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
154856851|NCT01384513|Busulfan|busulfan|mesh-list
154856852|NCT01384513|Fludarabine|fludarabine|mesh-list
154856853|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
154856854|NCT01384513|Tacrolimus|tacrolimus|mesh-list
154856855|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154856856|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
154856857|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856858|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856859|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154856860|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
154856861|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856862|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856863|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154856864|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154856865|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
154856866|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856867|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154856868|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856869|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154856870|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154856871|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
154856872|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154856874|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
154856875|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
154856876|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266953|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
154856877|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856878|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
154856879|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856880|NCT02933320|Rituximab|rituximab|mesh-list
154856881|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856882|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856883|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
154856884|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856885|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856886|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
154856887|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
154856888|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154856889|NCT03035305|Amodiaquine|amodiaquine|mesh-list
154856890|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
154856891|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154856892|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154856893|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856894|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154856895|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856896|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856897|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154856898|NCT03034759|Insulin|insulin|mesh-list
154856899|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154856900|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856901|NCT02158273|Fenofibrate|fenofibrate|mesh-list
154856902|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154856903|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
154856904|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856905|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154856906|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154856907|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154856908|NCT04361461|Azithromycin|azithromycin|mesh-list
154856909|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
154856910|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154856911|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856912|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
154856913|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154856914|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154856915|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856916|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856917|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856918|NCT03002506|Tazobactam|tazobactam|mesh-list
154856919|NCT03002506|Ceftolozane|ceftolozane|mesh-list
154856920|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154856921|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154856922|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856923|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154856924|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856925|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856926|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154856927|NCT02822950|Ceftazidime|ceftazidime|mesh-list
154856928|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154856929|NCT02822950|Avibactam|avibactam|mesh-list
154856930|NCT02822950|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154856932|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154856933|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856934|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154856935|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856936|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856937|NCT02935738|Prednisolone|prednisolone|mesh-list
154856938|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154856939|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
154856940|NCT02935738|Hormones|hormones|mesh-ancestor
154856941|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154856942|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856943|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154856944|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856945|NCT00939991|Bevacizumab|bevacizumab|mesh-list
154856946|NCT00939991|Temozolomide|temozolomide|mesh-list
154856947|NCT00939991|Vorinostat|vorinostat|mesh-list
154856948|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856949|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856950|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154856951|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154856952|NCT00939991|Growth Substances|growth substances|mesh-ancestor
154856953|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856954|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
154856955|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154856956|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
154856957|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856958|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154856959|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856960|NCT04361305|Tadalafil|tadalafil|mesh-list
154856961|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
154856962|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154856963|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154856964|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856965|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856966|NCT04361305|Urological Agents|urological agents|mesh-ancestor
154856967|NCT04361149|Capsaicin|capsaicin|mesh-list
154856968|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
154856969|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
154856970|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
154856971|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154856972|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154856973|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154856974|NCT00947167|Pertuzumab|pertuzumab|mesh-list
154856975|NCT00947167|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154856976|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154856977|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856978|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856979|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154856980|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154856981|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
154856982|NCT04360759|Chloroquine|chloroquine|mesh-list
154856983|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
154856984|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154856985|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154856986|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154856987|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856988|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856989|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154856990|NCT04360759|Amebicides|amebicides|mesh-ancestor
154856991|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154856992|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154856993|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154856994|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
154856995|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154856996|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154856997|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154856998|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154856999|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
154857000|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857001|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
154857002|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154857003|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154857004|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154857005|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857006|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857007|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
154857008|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857009|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857010|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154857011|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857012|NCT03033121|Hormones|hormones|mesh-list
154857013|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857014|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857015|NCT03033199|Dexamethasone|dexamethasone|mesh-list
154857016|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857017|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
154857018|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
154857019|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857020|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857021|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154857022|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
154857023|NCT03033199|Hormones|hormones|mesh-ancestor
154857024|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857025|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154857026|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857027|NCT00940927|Albuterol|albuterol|mesh-list
154857028|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154857029|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
154857030|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857031|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857032|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154857033|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
154857034|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
154857035|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154857036|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154857037|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154857038|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154857039|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857040|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857041|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857042|NCT00934375|Donepezil|donepezil|mesh-list
154857043|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154857044|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857045|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857046|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
154857047|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857048|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857049|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
154857050|NCT03002974|Triamcinolone|triamcinolone|mesh-list
154857051|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154857052|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154857053|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154857054|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154857055|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857056|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
154857057|NCT03002974|Hormones|hormones|mesh-ancestor
154857058|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857059|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857060|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154857061|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
154857062|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857063|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857064|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857065|NCT02245477|Mitogens|mitogens|mesh-list
154857066|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
154857067|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
154857068|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857069|NCT02245477|Growth Substances|growth substances|mesh-ancestor
154857070|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857071|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
154857072|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154857073|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154857074|NCT02825212|Ledipasvir|ledipasvir|mesh-list
154857075|NCT02825212|Velpatasvir|velpatasvir|mesh-list
154857076|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
154857077|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857078|NCT00373672|Modafinil|modafinil|mesh-list
154857079|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154857080|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857081|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154857082|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154857083|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154857084|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857085|NCT03008590|Naltrexone|naltrexone|mesh-list
154857086|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154857087|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154857088|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857089|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
154857090|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857091|NCT04359511|Prednisone|prednisone|mesh-list
154857092|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
154857093|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857094|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
154857095|NCT04359511|Hormones|hormones|mesh-ancestor
154857096|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857097|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857098|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154857099|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857100|NCT03032419|Vaccines|vaccines|mesh-list
154857101|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
154857102|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857103|NCT00373906|Bortezomib|bortezomib|mesh-list
154857104|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857105|NCT00955513|Diclofenac|diclofenac|mesh-list
154857106|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154857107|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154857108|NCT00955513|Analgesics|analgesics|mesh-ancestor
154857109|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
154857110|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857111|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857112|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857113|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857114|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154857115|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857116|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857117|NCT00935311|Acetaminophen|acetaminophen|mesh-list
154857118|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154857119|NCT00935311|Hydrocodone|hydrocodone|mesh-list
154857120|NCT00935311|Oxycodone|oxycodone|mesh-list
154857121|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154857122|NCT00935311|Analgesics|analgesics|mesh-ancestor
154857123|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
154857124|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857125|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857126|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
154857127|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154857128|NCT00935311|Narcotics|narcotics|mesh-ancestor
154857129|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857130|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
154857131|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
154857132|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154857133|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857134|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857135|NCT02946034|Ribavirin|ribavirin|mesh-list
154857136|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
154857137|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857138|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
154857139|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857140|NCT00955747|Tagatose|tagatose|mesh-list
154857141|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154857142|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
154857143|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
154857144|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857145|NCT02946892|Carvedilol|carvedilol|mesh-list
154857146|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154857147|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154857148|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857149|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857150|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857151|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857152|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154857154|NCT02946892|Protective Agents|protective agents|mesh-ancestor
154857155|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154857156|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857157|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154857158|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
154857159|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154857160|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154857161|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
154857162|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
154857163|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154857164|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154857165|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857166|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857167|NCT03402191|Urological Agents|urological agents|mesh-ancestor
154857168|NCT03402113|Midazolam|midazolam|mesh-list
154857169|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
154857170|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154857171|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857172|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857173|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154857174|NCT03402113|Analgesics|analgesics|mesh-ancestor
154857175|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
154857176|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857177|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154857178|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154857179|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154857180|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857181|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857182|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857183|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154857184|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154857185|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154857186|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154857187|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154857188|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
154857189|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
154857190|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
154857191|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
154857192|NCT03031405|Oxytocin|oxytocin|mesh-list
154857193|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
154857194|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154857195|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857196|NCT03031249|Cytarabine|cytarabine|mesh-list
154857197|NCT03031249|Tretinoin|tretinoin|mesh-list
154857198|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
154857199|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154857200|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
154857201|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857202|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857203|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
154857204|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857205|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154857206|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
154857207|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857208|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
154857209|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
154857210|NCT02980315|Immunomodulating Agents|immunomodulating agents|mesh-list
154857211|NCT02980315|Immunologic Factors|immunologic factors|mesh-ancestor
154857212|NCT02980315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857213|NCT01042535|Tryptophan|tryptophan|mesh-list
154857214|NCT01042535|Vaccines|vaccines|mesh-list
154857215|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
154857216|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857217|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154857218|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
154857219|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154857220|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154857221|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
154857222|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154857223|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154857224|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
154857225|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857226|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
154609186|NCT04338022|Teriflunomide|teriflunomide|mesh-list
154857227|NCT03031327|Protective Agents|protective agents|mesh-ancestor
154857228|NCT03401957|Cetuximab|cetuximab|mesh-list
154857229|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154857230|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857231|NCT04358965|Misoprostol|misoprostol|mesh-list
154857232|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
154857233|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154857234|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154857235|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857236|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
154857237|NCT04358965|Coagulants|coagulants|mesh-ancestor
154857238|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154857239|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
154857240|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154857241|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857242|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154857243|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154857244|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
154857245|NCT01041287|Metoprolol|metoprolol|mesh-list
154857246|NCT01041287|Nebivolol|nebivolol|mesh-list
154857247|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154857248|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154857249|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
154857250|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
154857251|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857252|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857253|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154857254|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154857255|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154857256|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857257|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857258|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857259|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
154857260|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154857261|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154857262|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154857263|NCT03016741|Prednisone|prednisone|mesh-list
154857264|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
154857265|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857266|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
154857267|NCT03016741|Hormones|hormones|mesh-ancestor
154857268|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857269|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857270|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154857271|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857272|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154857273|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857274|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857275|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
154857276|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154857277|NCT01042925|Paclitaxel|paclitaxel|mesh-list
154857278|NCT01042925|Trastuzumab|trastuzumab|mesh-list
154857279|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154857280|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857281|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
154857282|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
154857283|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
154857284|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857285|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154857286|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
154857287|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154857288|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
154857289|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857290|NCT03400709|Expectorants|expectorants|mesh-ancestor
154857291|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
154857292|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154857293|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
154857294|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857295|NCT03400709|Protective Agents|protective agents|mesh-ancestor
154857296|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857297|NCT03400709|Antidotes|antidotes|mesh-ancestor
154857298|NCT02049957|Fulvestrant|fulvestrant|mesh-list
154857299|NCT02049957|Exemestane|exemestane|mesh-list
154857300|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154857301|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609264|NCT06338293|Antimetabolites|antimetabolites|mesh-ancestor
154857302|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154857303|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154857304|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
154857305|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857306|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857307|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154857308|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154857309|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857310|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857311|NCT03030937|Irinotecan|irinotecan|mesh-list
154857312|NCT03030937|Apatinib|apatinib|mesh-list
154857313|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154857314|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154857315|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857316|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857317|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857318|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154857319|NCT00950365|Pemetrexed|pemetrexed|mesh-list
154857320|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154857321|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857322|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857323|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857324|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154857325|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154857326|NCT00950365|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154857327|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154857328|NCT01908465|Ebastine|ebastine|mesh-list
154857329|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154857330|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
154857331|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
154857332|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857333|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857334|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857335|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154857336|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
154857337|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857338|NCT02246023|Propofol|propofol|mesh-list
154857339|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154857340|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857341|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857342|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154857343|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
154857344|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
154857345|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154857346|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857347|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154857348|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857349|NCT00357825|Reboxetine|reboxetine|mesh-list
154857350|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
154857351|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154857352|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154857353|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154857354|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857355|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857356|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857357|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857358|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857359|NCT03400241|Bromides|bromides|mesh-list
154857360|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
154857361|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154857362|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
154857363|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857364|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857365|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154857366|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
154857367|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
154857368|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154857369|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
154857370|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857371|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857372|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
154609331|NCT06337539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857373|NCT05706987|Lidocaine|lidocaine|mesh-list
154857374|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
154857375|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
154857376|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857377|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857378|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
154857379|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857380|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154857381|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154857382|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154857383|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857384|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857385|NCT00729573|Tenofovir|tenofovir|mesh-list
154857386|NCT00729573|Emtricitabine|emtricitabine|mesh-list
154857387|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154857388|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
154857389|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857390|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154857391|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154857392|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857393|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857394|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154857395|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154857396|NCT02951182|Ivacaftor|ivacaftor|mesh-list
154857397|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154857398|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857399|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857400|NCT02959359|Ribavirin|ribavirin|mesh-list
154857401|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
154857402|NCT02959359|Ledipasvir|ledipasvir|mesh-list
154857403|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
154857404|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857405|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
154857406|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857407|NCT02829034|Ranolazine|ranolazine|mesh-list
154857408|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154857409|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857410|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857411|NCT00924209|Bevacizumab|bevacizumab|mesh-list
154857412|NCT00924209|Gemcitabine|gemcitabine|mesh-list
154857413|NCT00924209|Etoposide|etoposide|mesh-list
154857414|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154857415|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857416|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154857417|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154857418|NCT00924209|Growth Substances|growth substances|mesh-ancestor
154857419|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857420|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
154857421|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154857422|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
154857423|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857424|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154857425|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154857426|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154857427|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857428|NCT05719467|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154857429|NCT05719467|Parasympatholytics|parasympatholytics|mesh-ancestor
154857430|NCT05719467|Autonomic Agents|autonomic agents|mesh-ancestor
154857431|NCT05719467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857432|NCT05719467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857433|NCT05719467|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154857434|NCT05719467|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154857435|NCT05719467|Cholinergic Agents|cholinergic agents|mesh-ancestor
154857436|NCT05719467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857437|NCT05719467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857438|NCT03408119|Vitamin D|vitamin d|mesh-list
154857439|NCT03408119|Calcium|calcium|mesh-list
154857440|NCT03408119|Vitamins|vitamins|mesh-ancestor
154857441|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
154857442|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857443|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154857444|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154857445|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154857446|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
154857447|NCT04374929|Hormones|hormones|mesh-ancestor
154857448|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857449|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857450|NCT05717361|Lidocaine|lidocaine|mesh-list
154857451|NCT05717361|Ketamine|ketamine|mesh-list
154857452|NCT05717361|Remifentanil|remifentanil|mesh-list
154857453|NCT05717361|Anesthetics, Local|anesthetics, local|mesh-ancestor
154857454|NCT05717361|Anesthetics|anesthetics|mesh-ancestor
154857455|NCT05717361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857456|NCT05717361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857457|NCT05717361|Sensory System Agents|sensory system agents|mesh-ancestor
154857458|NCT05717361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857459|NCT05717361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154857460|NCT05717361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154857461|NCT05717361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154857462|NCT05717361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857463|NCT05717361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857464|NCT05717361|Analgesics|analgesics|mesh-ancestor
154857465|NCT05717361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154857466|NCT05717361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154857467|NCT05717361|Anesthetics, General|anesthetics, general|mesh-ancestor
154857468|NCT05717361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154857469|NCT05717361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154857470|NCT05717361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857471|NCT05717361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154857472|NCT05717361|Narcotics|narcotics|mesh-ancestor
154857473|NCT02951884|Bupivacaine|bupivacaine|mesh-list
154857474|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
154857475|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
154857476|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857477|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857478|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
154857479|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857480|NCT02978001|Glycerol|glycerol|mesh-list
154857481|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154857482|NCT02978001|Protective Agents|protective agents|mesh-ancestor
154857483|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857484|NCT02978313|Cetuximab|cetuximab|mesh-list
154857485|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154857486|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857487|NCT00014495|Cytarabine|cytarabine|mesh-list
154857488|NCT00014495|Bismuth|bismuth|mesh-list
154857489|NCT00014495|Antibodies|antibodies|mesh-list
154857490|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154857491|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
154857492|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857493|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154857494|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
154857495|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857496|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857497|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
154857498|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857499|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154857500|NCT00014495|Antacids|antacids|mesh-ancestor
154857501|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154857502|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
154857503|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154857504|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154857505|NCT04374071|Prednisolone|prednisolone|mesh-list
154857506|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
154857507|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154857508|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
154857509|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857510|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
154857511|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
154857512|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857513|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857514|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154857515|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
154857516|NCT04374071|Hormones|hormones|mesh-ancestor
154857517|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857518|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154857519|NCT04374071|Protective Agents|protective agents|mesh-ancestor
154857520|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154857521|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609479|NCT06336486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154857522|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
154857524|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154857525|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857526|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154857527|NCT03030703|Inositol|inositol|mesh-list
154857528|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
154857529|NCT03030703|Vitamins|vitamins|mesh-ancestor
154857530|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
154857531|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857532|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154857533|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154857534|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
154857535|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
154857536|NCT03030469|Analgesics|analgesics|mesh-list
154857537|NCT03030469|Narcotics|narcotics|mesh-ancestor
154857538|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857539|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857540|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
154857541|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857542|NCT00952081|Clevidipine|clevidipine|mesh-list
154857543|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154857544|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857545|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857546|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154857547|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857548|NCT05716347|Vaccines|vaccines|mesh-list
154857549|NCT05716347|Immunologic Factors|immunologic factors|mesh-ancestor
154857550|NCT05716347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857551|NCT02959840|Ondansetron|ondansetron|mesh-list
154857552|NCT02959840|Metoclopramide|metoclopramide|mesh-list
154857553|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
154857554|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
154857555|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857556|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857557|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154857558|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
154857559|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
154857560|NCT02959840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154857561|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154857562|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
154857563|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857564|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857565|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154857566|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154857567|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
154857568|NCT04358341|Doxorubicin|doxorubicin|mesh-list
154857569|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154857570|NCT04358341|Fluorouracil|fluorouracil|mesh-list
154857571|NCT04358341|Irinotecan|irinotecan|mesh-list
154857572|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154857573|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857574|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154857575|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154857576|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857577|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857578|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
154857579|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154857580|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154857581|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
154857582|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857583|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154857584|NCT02978547|Metformin|metformin|mesh-list
154857585|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154857586|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857587|NCT02959996|Bupivacaine|bupivacaine|mesh-list
154857588|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
154857589|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
154857590|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857591|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857592|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
154857593|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857594|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
154857595|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154857596|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154857597|NCT00929981|Prednisolone|prednisolone|mesh-list
154857598|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
154857599|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154857600|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
154857601|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857602|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
154857603|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
154857604|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857605|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857606|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154857607|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
154857608|NCT00929981|Hormones|hormones|mesh-ancestor
154857609|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857610|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154857611|NCT00929981|Protective Agents|protective agents|mesh-ancestor
154857612|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154857613|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857614|NCT00961441|Levetiracetam|levetiracetam|mesh-list
154857615|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
154857616|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
154857617|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
154857618|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
154857619|NCT02240459|Fesoterodine|fesoterodine|mesh-list
154857620|NCT02240459|Oxybutynin|oxybutynin|mesh-list
154857621|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154857622|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154857623|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
154857624|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857625|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857626|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857627|NCT02240459|Urological Agents|urological agents|mesh-ancestor
154857628|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
154857629|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
154857630|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857631|NCT02240537|Sargramostim|sargramostim|mesh-list
154857632|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154857633|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
154857634|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857635|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154857636|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154857637|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154857638|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857639|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154857640|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857641|NCT02240927|Enoxaparin|enoxaparin|mesh-list
154857642|NCT02240927|Warfarin|warfarin|mesh-list
154857643|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
154857644|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
154857645|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154857646|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154857647|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857648|NCT03038308|Ropinirole|ropinirole|mesh-list
154857649|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154857650|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154857651|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
154857652|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
154857653|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857654|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857655|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857656|NCT04358497|Ibuprofen|ibuprofen|mesh-list
154857657|NCT04358497|Polidocanol|polidocanol|mesh-list
154857658|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154857659|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154857660|NCT04358497|Analgesics|analgesics|mesh-ancestor
154857661|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
154857662|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857663|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857664|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857665|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857666|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154857667|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857668|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857669|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154857670|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154857671|NCT02851108|Primaquine|primaquine|mesh-list
154857672|NCT02851108|Phenothiazine|phenothiazine|mesh-list
154857673|NCT02851108|Methylene Blue|methylene blue|mesh-list
154267746|NCT03777644|Analgesics|analgesics|mesh-ancestor
154857674|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
154857675|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154857676|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154857677|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857678|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857679|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857680|NCT00930293|Dexetimide|dexetimide|mesh-list
154857681|NCT00930293|Citalopram|citalopram|mesh-list
154857682|NCT00930293|Escitalopram|escitalopram|mesh-list
154857683|NCT00930293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154857684|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154857685|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857686|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857687|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857688|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
154857689|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857690|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154857691|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
154857692|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154857693|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154857694|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154857695|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
154857696|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
154857697|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857698|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154857699|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154857700|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
154857701|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154857702|NCT02855086|Cetuximab|cetuximab|mesh-list
154857703|NCT02855086|Antibodies|antibodies|mesh-list
154857704|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
154857705|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154857706|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
154857707|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857708|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857709|NCT05368857|Afamelanotide|afamelanotide|mesh-list
154857710|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
154857711|NCT04347005|Allopurinol|allopurinol|mesh-list
154857712|NCT04347005|Febuxostat|febuxostat|mesh-list
154857713|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
154857714|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857715|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857716|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
154857717|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857718|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154857719|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
154857720|NCT04347005|Protective Agents|protective agents|mesh-ancestor
154857721|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857722|NCT00358293|Tizanidine|tizanidine|mesh-list
154857723|NCT00358293|Analgesics|analgesics|mesh-ancestor
154857724|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
154857725|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857726|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857727|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
154857728|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154857729|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154857730|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
154857731|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
154857732|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154857733|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154857734|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154857735|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857736|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267812|NCT01346800|Ritonavir|ritonavir|mesh-list
154857737|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857738|NCT02241083|Dopamine|dopamine|mesh-list
154857739|NCT02241083|Norepinephrine|norepinephrine|mesh-list
154857740|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154857741|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154857742|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857743|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857744|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857745|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857746|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
154857747|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
154857748|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857749|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154857750|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154857751|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
154857752|NCT02241083|Protective Agents|protective agents|mesh-ancestor
154857753|NCT04372589|Heparin|heparin|mesh-list
154857754|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
154857755|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154857756|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154857757|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857758|NCT04364399|Vaccines|vaccines|mesh-list
154857759|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
154857760|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857761|NCT02982551|Insulin|insulin|mesh-list
154857762|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154857763|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857764|NCT02965924|Phenylephrine|phenylephrine|mesh-list
154857765|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
154857766|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154857767|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
154857768|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
154857769|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857770|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857771|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
154857772|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154857773|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
154857774|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
154857775|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154857776|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154857777|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154857778|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857779|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857780|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857781|NCT02965924|Protective Agents|protective agents|mesh-ancestor
154857782|NCT04364321|Diazepam|diazepam|mesh-list
154857783|NCT04364321|Clonazepam|clonazepam|mesh-list
154857784|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154857785|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
154857786|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
154857787|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
154857788|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857789|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857790|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154857791|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154857792|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857793|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154267869|NCT01431508|Losartan|losartan|mesh-list
154857794|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154857795|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154857796|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154857797|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154857798|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154857799|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
154857800|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
154857801|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
154857802|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
154857803|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857804|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857805|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154857806|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154857807|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857808|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857809|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857810|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857811|NCT05528913|Benralizumab|benralizumab|mesh-list
154857812|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154857813|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
154857814|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154857815|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857816|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
154857817|NCT04371965|Povidone|povidone|mesh-list
154857818|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
154857819|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
154857820|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154857821|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857822|NCT02959125|Micronutrients|micronutrients|mesh-list
154857823|NCT02959125|Trace Elements|trace elements|mesh-list
154857824|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857825|NCT02972554|Propranolol|propranolol|mesh-list
154857826|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154857827|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154857828|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857829|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857830|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857831|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857832|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154857833|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154857834|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
154857836|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154857837|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857838|NCT00359151|Celecoxib|celecoxib|mesh-list
154857839|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154857840|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154857841|NCT00359151|Analgesics|analgesics|mesh-ancestor
154857842|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
154857843|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857844|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857845|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857846|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857847|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154857848|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154857849|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857850|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857851|NCT00374686|Valganciclovir|valganciclovir|mesh-list
154857852|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
154857853|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857854|NCT04371575|Carbamazepine|carbamazepine|mesh-list
154857855|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
154857856|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
154857857|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
154857858|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154857859|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267924|NCT00536380|Loratadine|loratadine|mesh-list
154857860|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857861|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154857862|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154857863|NCT04371575|Analgesics|analgesics|mesh-ancestor
154857864|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
154857865|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857866|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154857867|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857868|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857869|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154857870|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154857871|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154857872|NCT00359229|Zolpidem|zolpidem|mesh-list
154857873|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154857874|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154857875|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857876|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857877|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154857878|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
154857879|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
154857880|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857881|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857882|NCT04371341|Bupivacaine|bupivacaine|mesh-list
154857883|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
154857884|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
154857885|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857886|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857887|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
154857888|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857889|NCT00374764|Risperidone|risperidone|mesh-list
154857890|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154857891|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
154857892|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857893|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857894|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857895|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154857896|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154857897|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857898|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154857899|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154857900|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
154857901|NCT04371185|Ustekinumab|ustekinumab|mesh-list
154857902|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
154857903|NCT01005355|Ramucirumab|ramucirumab|mesh-list
154857904|NCT01005355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154857905|NCT01005355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154857906|NCT01005355|Growth Substances|growth substances|mesh-ancestor
154857907|NCT01005355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857908|NCT01005355|Growth Inhibitors|growth inhibitors|mesh-ancestor
154857909|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857910|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
154857911|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154857912|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154857913|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
154857914|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857915|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857916|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154857917|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
154857918|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
154857919|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154857920|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
154857921|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154857922|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857923|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154857924|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154857925|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154857926|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
154857927|NCT05285943|Betamethasone|betamethasone|mesh-list
154857928|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
154857929|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154857930|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
154857931|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154857932|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154857933|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
154857934|NCT05285943|Hormones|hormones|mesh-ancestor
154857935|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857936|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857937|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154857938|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
154857939|NCT03030001|Antibodies|antibodies|mesh-list
154857940|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
154857941|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857942|NCT02242331|Telmisartan|telmisartan|mesh-list
154857943|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154857944|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154857945|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154857946|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857947|NCT03030157|Pirarubicin|pirarubicin|mesh-list
154857948|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154857949|NCT00359385|Alendronate|alendronate|mesh-list
154857950|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154857951|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857952|NCT03029455|Ivacaftor|ivacaftor|mesh-list
154857953|NCT03029455|VX-659|vx-659|mesh-list
154857954|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154857955|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857956|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857957|NCT02245789|Remifentanil|remifentanil|mesh-list
154857958|NCT02245789|Propofol|propofol|mesh-list
154857959|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
154857960|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154857961|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857962|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154857963|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154857964|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
154857965|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154857966|NCT02245789|Narcotics|narcotics|mesh-ancestor
154857967|NCT02245789|Analgesics|analgesics|mesh-ancestor
154857968|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
154857969|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154857970|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
154857971|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
154857972|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154857973|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154609928|NCT06096844|Mitosis Modulators|mitosis modulators|mesh-ancestor
154857974|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857975|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860473|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857976|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857977|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857978|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
154857979|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
154857980|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154857981|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154857982|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154857983|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154857984|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857985|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154857986|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154857987|NCT02242877|Telmisartan|telmisartan|mesh-list
154857988|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154857989|NCT02242877|Diuretics|diuretics|mesh-ancestor
154857990|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
154268051|NCT01352572|Milnacipran|milnacipran|mesh-list
154857991|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154857992|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154857993|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154857994|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154857995|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154857996|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154857997|NCT01007071|Hormones|hormones|mesh-list
154857998|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154857999|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858000|NCT05475639|Diclofenac|diclofenac|mesh-list
154858001|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154858002|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858003|NCT05475639|Analgesics|analgesics|mesh-ancestor
154858004|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
154858005|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858006|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858007|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858008|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858009|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154858010|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858011|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858012|NCT02242955|Diazepam|diazepam|mesh-list
154858013|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154858014|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
154858015|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
154858016|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
154858017|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858018|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858019|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154858020|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154858021|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858022|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154858023|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154858024|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154858025|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154858026|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154858027|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154858028|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
154858029|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
154858030|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
154858031|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
154858032|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858033|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858034|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
154858035|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154858036|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858037|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154858038|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858039|NCT01008319|Citric Acid|citric acid|mesh-list
154858040|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
154858041|NCT01008319|Clomiphene|clomiphene|mesh-list
154858042|NCT01008319|Enclomiphene|enclomiphene|mesh-list
154858043|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
154858044|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
154858045|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154858046|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
154858047|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
154858048|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858049|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154858050|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
154268120|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
154858051|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154858052|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858053|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154858054|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
154858055|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154858056|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154858057|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154858058|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
154858059|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154858060|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858061|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154858062|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154858063|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858064|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858065|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858066|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
154858067|NCT00358683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154858068|NCT00358683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858069|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154858070|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
154858071|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858072|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858073|NCT00967369|Carboplatin|carboplatin|mesh-list
154858074|NCT00967369|Etoposide|etoposide|mesh-list
154858075|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
154858076|NCT00967369|Bortezomib|bortezomib|mesh-list
154858077|NCT00967369|Ifosfamide|ifosfamide|mesh-list
154858078|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
154858079|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
154858080|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858081|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154858082|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154858083|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154858084|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858085|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858086|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154858087|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
154858088|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
154858089|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
154858090|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858091|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858092|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858093|NCT02245295|Anesthetics|anesthetics|mesh-list
154858094|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858095|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858096|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
154858097|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858098|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
154858099|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154858100|NCT00968071|Decitabine|decitabine|mesh-list
154858101|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
154858102|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154858103|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
154858104|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858105|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858106|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858107|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154858108|NCT00968071|Immunotoxins|immunotoxins|mesh-ancestor
154858109|NCT00968071|Immunoconjugates|immunoconjugates|mesh-ancestor
154858110|NCT00968071|Immunologic Factors|immunologic factors|mesh-ancestor
154858111|NCT00968071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858112|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
154858113|NCT00971737|Trastuzumab|trastuzumab|mesh-list
154858114|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154858115|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
154858116|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858117|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858118|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154858119|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
154858120|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858121|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858122|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154858123|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154858124|NCT04368377|Aspirin|aspirin|mesh-list
154858125|NCT04368377|PENTA|penta|mesh-list
154858126|NCT04368377|Tirofiban|tirofiban|mesh-list
154858127|NCT04368377|Fondaparinux|fondaparinux|mesh-list
154858128|NCT04368377|Clopidogrel|clopidogrel|mesh-list
154858129|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154858130|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154858131|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154858132|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154858133|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
154858134|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858135|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858136|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858137|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154858138|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858139|NCT04368377|Analgesics|analgesics|mesh-ancestor
154858140|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
154858141|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858142|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858143|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858144|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154858145|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154858146|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154858147|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858148|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
154858149|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154858150|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
154858151|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154858152|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
154858153|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
154858154|NCT04361513|Triamcinolone|triamcinolone|mesh-list
154858155|NCT04361513|Bupivacaine|bupivacaine|mesh-list
154858156|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
154858157|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
154858158|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858159|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858160|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
154858161|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858162|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858163|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
154858164|NCT04361513|Hormones|hormones|mesh-ancestor
154858165|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154858166|NCT05595993|Cilostazol|cilostazol|mesh-list
154858167|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154858168|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
154858169|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858170|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858171|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154858172|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
154858173|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154858174|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154268248|NCT04351256|Durvalumab|durvalumab|mesh-list
154858175|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858176|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154858177|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
154858178|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154858179|NCT05595993|Protective Agents|protective agents|mesh-ancestor
154858180|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154858181|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154858182|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858183|NCT00972205|Paclitaxel|paclitaxel|mesh-list
154858184|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154858185|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154858186|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858187|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858188|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858189|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858190|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858191|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154858192|NCT00928421|Polidocanol|polidocanol|mesh-list
154858193|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154858194|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154858195|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154858196|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154858197|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154858198|NCT00932321|Norethindrone|norethindrone|mesh-list
154858199|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
154858200|NCT00932321|Estradiol|estradiol|mesh-list
154858201|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154858202|NCT00932321|Estrogens|estrogens|mesh-ancestor
154858203|NCT00932321|Hormones|hormones|mesh-ancestor
154858204|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154858205|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858206|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154858207|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
154858208|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154858209|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154858210|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154858211|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154858212|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154858213|NCT01011829|Varenicline|varenicline|mesh-list
154858214|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154858215|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154858216|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154858217|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858218|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858219|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858220|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154858221|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
154858222|NCT00932477|Glycerol|glycerol|mesh-list
154858223|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154858224|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154858225|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154858226|NCT00932477|Protective Agents|protective agents|mesh-ancestor
154858227|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858228|NCT00932477|Laxatives|laxatives|mesh-ancestor
154858229|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154858230|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
154858231|NCT00972439|Norinyl|norinyl|mesh-list
154858232|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
154858233|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154858234|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858235|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154858236|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154858237|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154858238|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154858239|NCT00358371|Floxacillin|floxacillin|mesh-list
154858240|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154858241|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858242|NCT02989714|Nivolumab|nivolumab|mesh-list
154858243|NCT02989714|Interleukin-2|interleukin-2|mesh-list
154858244|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154858245|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858246|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154858247|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858248|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858249|NCT02989714|Analgesics|analgesics|mesh-ancestor
154858250|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
154858251|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858252|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858253|NCT02881996|Acetaminophen|acetaminophen|mesh-list
154858254|NCT02881996|Ketorolac|ketorolac|mesh-list
154858255|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858256|NCT02881996|Analgesics|analgesics|mesh-ancestor
154858257|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
154858258|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858259|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858260|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
154858261|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154858262|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858263|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858264|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154858265|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858266|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858267|NCT04367831|Heparin|heparin|mesh-list
154858268|NCT04367831|Calcium heparin|calcium heparin|mesh-list
154858269|NCT04367831|Enoxaparin|enoxaparin|mesh-list
154858270|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
154858271|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
154858272|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154858273|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154858274|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858275|NCT03051646|Aspirin|aspirin|mesh-list
154858276|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154858277|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858278|NCT03051646|Analgesics|analgesics|mesh-ancestor
154858279|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
154858280|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858281|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858282|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858283|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858284|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154858285|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154858286|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858287|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154858288|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154858289|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858290|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
154858291|NCT04344405|Vitamin D|vitamin d|mesh-list
154858292|NCT04344405|Vitamins|vitamins|mesh-ancestor
154858293|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
154858294|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858295|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154858296|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
154858297|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154858298|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154858299|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858300|NCT02993302|Vitamins|vitamins|mesh-ancestor
154858301|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
154858302|NCT00359853|Norfloxacin|norfloxacin|mesh-list
154858303|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154858304|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858305|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154858306|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154858307|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858308|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858309|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858310|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154858311|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154858312|NCT05168709|Vaccines|vaccines|mesh-list
154858313|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
154858314|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858315|NCT03111316|Dinoprostone|dinoprostone|mesh-list
154858316|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
154858317|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154858318|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858319|NCT03054844|Lidocaine|lidocaine|mesh-list
154858320|NCT03054844|Midazolam|midazolam|mesh-list
154858321|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
154858322|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
154858323|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858324|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858325|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
154858326|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858327|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154858328|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154858329|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154858330|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154858331|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858332|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154858333|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154858334|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154858335|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154858336|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154858337|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154858338|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
154858339|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
154858340|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
154858341|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858342|NCT00359697|Mannitol|mannitol|mesh-list
154858343|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154858344|NCT00359697|Diuretics|diuretics|mesh-ancestor
154858345|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
154858346|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858347|NCT03111628|Omalizumab|omalizumab|mesh-list
154858348|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154858349|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154858350|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
154858351|NCT05120505|Metformin|metformin|mesh-list
154858352|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154858353|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858354|NCT02977533|Acyclovir|acyclovir|mesh-list
154858355|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
154858356|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858357|NCT01012297|Bevacizumab|bevacizumab|mesh-list
154858358|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154858359|NCT01012297|Gemcitabine|gemcitabine|mesh-list
154858360|NCT01012297|Docetaxel|docetaxel|mesh-list
154858361|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
154858362|NCT01012297|Antibodies|antibodies|mesh-list
154858363|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
154858364|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154858365|NCT01012297|Lenograstim|lenograstim|mesh-list
154858366|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
154858367|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858368|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154858369|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154858370|NCT01012297|Growth Substances|growth substances|mesh-ancestor
154858371|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858372|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
154858373|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
154858374|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154858375|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
154858376|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858377|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858378|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858379|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858380|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154858381|NCT00923117|Sunitinib|sunitinib|mesh-list
154858382|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268435|NCT03465280|Interferons|interferons|mesh-list
154858383|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154858384|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154858385|NCT00923117|Growth Substances|growth substances|mesh-ancestor
154858386|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858387|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
154858388|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154858389|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858390|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858391|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
154858392|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154858393|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154858394|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154858395|NCT02977611|Hematinics|hematinics|mesh-ancestor
154858396|NCT04360655|Antibodies|antibodies|mesh-list
154858397|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154858398|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
154858399|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858400|NCT00375232|Montelukast|montelukast|mesh-list
154858401|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154858402|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
154858403|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154858404|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
154858405|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154858406|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858407|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154858408|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154858409|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858410|NCT00975637|Brodalumab|brodalumab|mesh-list
154858411|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154858412|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
154858413|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
154858414|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858415|NCT02244437|Acetaminophen|acetaminophen|mesh-list
154858416|NCT02244437|Ibuprofen|ibuprofen|mesh-list
154858417|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858418|NCT02244437|Analgesics|analgesics|mesh-ancestor
154858419|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
154858420|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858421|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858422|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
154858423|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154858424|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858425|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858426|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154858427|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858428|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858429|NCT03023527|Dexamethasone|dexamethasone|mesh-list
154858430|NCT03023527|Nivolumab|nivolumab|mesh-list
154858431|NCT03023527|Pomalidomide|pomalidomide|mesh-list
154858433|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858434|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
154858435|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
154858436|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858437|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858438|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154858439|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
154858440|NCT03023527|Hormones|hormones|mesh-ancestor
154858441|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154858442|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154858443|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858444|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154858445|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154858446|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858447|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
154858448|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154858449|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154858450|NCT03023527|Growth Substances|growth substances|mesh-ancestor
154858451|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
154858452|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
154858453|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154858454|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858455|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858456|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858457|NCT02244515|Analgesics|analgesics|mesh-ancestor
154858458|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
154858459|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858460|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154858461|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154858462|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154858463|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
154858464|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858465|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858466|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
154858467|NCT04360031|Tacrolimus|tacrolimus|mesh-list
154858468|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154858469|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
154858470|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858471|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154858472|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858473|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858474|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154858475|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858476|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154858477|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
154858478|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154858479|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858480|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
154858481|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
154858482|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
154858483|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858484|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858485|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154858486|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154858487|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154858488|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858489|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154858490|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154858491|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
154858492|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858493|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858494|NCT03023059|Levodopa|levodopa|mesh-list
154858495|NCT03023059|Carbidopa|carbidopa|mesh-list
154858496|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154858497|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154858498|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154858499|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
154858500|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858501|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858502|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858503|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154858504|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858505|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154858506|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
154858507|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
154858508|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
154858509|NCT02244827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154858510|NCT02244827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858511|NCT02244827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858512|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154858513|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858514|NCT04359485|Glycolic acid|glycolic acid|mesh-list
154858515|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
154858516|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
154858517|NCT02976987|Cidofovir|cidofovir|mesh-list
154858518|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
154858519|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858520|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858521|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858522|NCT02244281|Tamsulosin|tamsulosin|mesh-list
154858523|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154858524|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154858525|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154858526|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
154858527|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858528|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858529|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858530|NCT02244281|Urological Agents|urological agents|mesh-ancestor
154858531|NCT00361413|Alefacept|alefacept|mesh-list
154858532|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
154858533|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
154858534|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858535|NCT03062488|Acetaminophen|acetaminophen|mesh-list
154858536|NCT03062488|Fentanyl|fentanyl|mesh-list
154858537|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154858538|NCT03062488|Narcotics|narcotics|mesh-ancestor
154858539|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858540|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858541|NCT03062488|Analgesics|analgesics|mesh-ancestor
154858542|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
154858543|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858544|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154858545|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154858546|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
154858547|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
154858548|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858549|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
154858550|NCT00936299|Bupropion|bupropion|mesh-list
154858551|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154858552|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
154858553|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154858554|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154858555|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154858556|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154858557|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858558|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
154858559|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858560|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858561|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154858562|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154858563|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858564|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154858565|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154858566|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858567|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858568|NCT03117634|Aflibercept|aflibercept|mesh-list
154858569|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154858570|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154858571|NCT03117634|Growth Substances|growth substances|mesh-ancestor
154858572|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858573|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
154858574|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858575|NCT00937235|Varenicline|varenicline|mesh-list
154858576|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154858577|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154610531|NCT05645406|Estrogens|estrogens|mesh-ancestor
154858578|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
154858579|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858580|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858581|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858582|NCT01014403|Enoxaparin|enoxaparin|mesh-list
154858583|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
154858584|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154858585|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154858586|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858587|NCT05405608|Ondansetron|ondansetron|mesh-list
154858588|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
154858589|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
154858590|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858591|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858592|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154858593|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
154858594|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
154858595|NCT05405608|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154858596|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154858597|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
154858598|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858599|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858600|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
154858601|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154858602|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154858603|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154858604|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154858605|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858606|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
154858607|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858608|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858609|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154858610|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858611|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
154858612|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154858613|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154858614|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858615|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
154858616|NCT00375466|Coagulants|coagulants|mesh-ancestor
154858617|NCT00976183|Vorinostat|vorinostat|mesh-list
154858618|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858619|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154858620|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858621|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858622|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
154858623|NCT04357535|Giapreza|giapreza|mesh-list
154858624|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154858625|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
154858626|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154858627|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154858628|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858629|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154858630|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154858631|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
154858632|NCT01015807|Clonidine|clonidine|mesh-list
154858633|NCT01015807|Bupivacaine|bupivacaine|mesh-list
154858634|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
154858635|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
154858636|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858637|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858638|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
154858639|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858640|NCT01015807|Analgesics|analgesics|mesh-ancestor
154858641|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154858642|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
154858643|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
154858644|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154858645|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154858646|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154858647|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
154858648|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858649|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858650|NCT01575925|Thalidomide|thalidomide|mesh-list
154610609|NCT05582434|Analgesics|analgesics|mesh-ancestor
154858651|NCT01575925|Dexamethasone|dexamethasone|mesh-list
154858652|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
154858654|NCT01575925|BB 1101|bb 1101|mesh-list
154858655|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858656|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
154858657|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
154858658|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858659|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858660|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154858661|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
154858662|NCT01575925|Hormones|hormones|mesh-ancestor
154858663|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154858664|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154858665|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858666|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
154858667|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858668|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858669|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
154858670|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154858671|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154858672|NCT01575925|Growth Substances|growth substances|mesh-ancestor
154858673|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
154858674|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154858675|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
154858676|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154858677|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858678|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
154858679|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154858680|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858681|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858682|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858683|NCT00936377|Analgesics|analgesics|mesh-ancestor
154858684|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
154858685|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858686|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154858687|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154858688|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154858689|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
154858690|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858691|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858692|NCT04359095|Tenofovir|tenofovir|mesh-list
154858693|NCT04359095|Emtricitabine|emtricitabine|mesh-list
154858694|NCT04359095|Colchicine|colchicine|mesh-list
154858695|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154858696|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
154858697|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858698|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154858699|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154858700|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858701|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858702|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154858703|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154858704|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154858705|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154858706|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
154858707|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154858708|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154858709|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
154858710|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858711|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858712|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858713|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858714|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858715|NCT02163421|Vedolizumab|vedolizumab|mesh-list
154858716|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154858717|NCT02982395|Ethanol|ethanol|mesh-list
154858718|NCT02982395|Docetaxel|docetaxel|mesh-list
154858719|NCT02982395|Mitomycins|mitomycins|mesh-list
154858720|NCT02982395|Mitomycin|mitomycin|mesh-list
154858721|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858722|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858723|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858724|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858725|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858726|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610678|NCT05445778|Bevacizumab|bevacizumab|mesh-list
154858727|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
154858728|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154858729|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858730|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154858731|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858732|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858733|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858734|NCT02982005|Brodalumab|brodalumab|mesh-list
154858735|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
154858736|NCT04736836|Rifaximin|rifaximin|mesh-list
154858737|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154858738|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858739|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154858740|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154858741|NCT03126370|Emtricitabine|emtricitabine|mesh-list
154858742|NCT03126370|Tenofovir|tenofovir|mesh-list
154858743|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154858744|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
154858745|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154858746|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154858747|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858748|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858749|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
154858750|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858751|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154858752|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154858753|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154858754|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154858755|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154858756|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154858757|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154858758|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858759|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
154858760|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858761|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858762|NCT00979615|Azelastine|azelastine|mesh-list
154858763|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154858764|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154858765|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
154858766|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858767|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858768|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154858769|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
154858770|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154858771|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858772|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858773|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154858774|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154858775|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154858776|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
154858777|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
154858778|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858779|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154858780|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154858781|NCT00979615|Analgesics|analgesics|mesh-ancestor
154858782|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
154858783|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154858784|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858785|NCT03126682|Bupropion|bupropion|mesh-list
154858786|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154858787|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
154858788|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154858789|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154858790|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154858791|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154858792|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858793|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
154858794|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858795|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858796|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154858797|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154858798|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858799|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154858800|NCT05236738|Cobicistat|cobicistat|mesh-list
154858801|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154858802|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154858803|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
154858804|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858805|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858807|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154858808|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
154858809|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858810|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154858811|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154858812|NCT00980395|Rituximab|rituximab|mesh-list
154858813|NCT00980395|Bortezomib|bortezomib|mesh-list
154858814|NCT00980395|Cladribine|cladribine|mesh-list
154858815|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154858816|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858817|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
154858818|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858819|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154858820|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154858821|NCT02976597|Morphine|morphine|mesh-list
154858822|NCT02976597|Bupivacaine|bupivacaine|mesh-list
154858823|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
154858824|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
154858825|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858826|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858827|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
154858828|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154858829|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154858830|NCT02976597|Narcotics|narcotics|mesh-ancestor
154858831|NCT02976597|Analgesics|analgesics|mesh-ancestor
154858832|NCT03020329|Paclitaxel|paclitaxel|mesh-list
154858833|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154858834|NCT03020329|Cisplatin|cisplatin|mesh-list
154858835|NCT03020329|Fluorouracil|fluorouracil|mesh-list
154858836|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154858837|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858838|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858839|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858840|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858841|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858842|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
154858843|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154858844|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154858845|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
154858846|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858847|NCT00980785|Ramipril|ramipril|mesh-list
154858848|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154858849|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
154858850|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858851|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858852|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154858853|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154858854|NCT03126760|Hormones|hormones|mesh-ancestor
154858855|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154858856|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858857|NCT00982033|Aliskiren|aliskiren|mesh-list
154858858|NCT00982033|Renin Inhibitors|renin inhibitors|mesh-ancestor
154858859|NCT00982033|Protease Inhibitors|protease inhibitors|mesh-ancestor
154858860|NCT00982033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858861|NCT00982033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858862|NCT05026905|Leucovorin|leucovorin|mesh-list
154858863|NCT05026905|Paclitaxel|paclitaxel|mesh-list
154858864|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154858865|NCT05026905|Gemcitabine|gemcitabine|mesh-list
154858866|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
154858867|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154858868|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858869|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858870|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858871|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858872|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268982|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154268983|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154268984|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154268985|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
154268986|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154268987|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154268988|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
154268989|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
154268990|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154268991|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268992|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154268993|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
154268994|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268995|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
154268996|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
154268997|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
153610463|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
153813345|NCT00333476|Squalamine|squalamine|mesh-list
153813346|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153813347|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813348|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154858873|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154858874|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
154858875|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858876|NCT05026905|Antidotes|antidotes|mesh-ancestor
154858877|NCT05026905|Protective Agents|protective agents|mesh-ancestor
154858878|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
154858879|NCT05026905|Vitamins|vitamins|mesh-ancestor
154858880|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
154858881|NCT00982189|Lisinopril|lisinopril|mesh-list
154858882|NCT00982189|Pravastatin|pravastatin|mesh-list
154858883|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154858884|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154858885|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
154858886|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858887|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154858888|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154858889|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858890|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154858891|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
154858892|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154858893|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154858894|NCT00982189|Protective Agents|protective agents|mesh-ancestor
154858895|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858896|NCT03128008|Paclitaxel|paclitaxel|mesh-list
154858897|NCT03128008|Carboplatin|carboplatin|mesh-list
154858898|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154858899|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858900|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858901|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858902|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858903|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858904|NCT05017311|Escitalopram|escitalopram|mesh-list
154858905|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
154858906|NCT05017311|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154858907|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154858908|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154858909|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858910|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858911|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
154858912|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858913|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
154858914|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
154858915|NCT00360087|Bosentan|bosentan|mesh-list
154858916|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154858917|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154858918|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858919|NCT00982423|Furosemide|furosemide|mesh-list
154858920|NCT00982423|Diuretics|diuretics|mesh-ancestor
154858921|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
154858922|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858923|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154858924|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154858925|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858926|NCT04719819|Anesthetics|anesthetics|mesh-list
154858927|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154858928|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858929|NCT02981719|Gemcitabine|gemcitabine|mesh-list
154858930|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154858931|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
154858932|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858933|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858934|NCT03073876|Donepezil|donepezil|mesh-list
154858935|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154858936|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858937|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858938|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
154858939|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154858940|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858941|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
154858942|NCT04718961|Volixibat|volixibat|mesh-list
154858943|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154858944|NCT03130738|Miconazole|miconazole|mesh-list
154858945|NCT03130738|Clotrimazole|clotrimazole|mesh-list
154858946|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
154858947|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858948|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154858949|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154858950|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610912|NCT04928846|Docetaxel|docetaxel|mesh-list
154858951|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858953|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
154858954|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154858955|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858956|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154858957|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154858958|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154858959|NCT00984139|Vaccines|vaccines|mesh-list
154858960|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
154858961|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858962|NCT04672395|Vaccines|vaccines|mesh-list
154858963|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
154858964|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
154858965|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154858966|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154858967|NCT03131206|Alectinib|alectinib|mesh-list
154858968|NCT03131206|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154858969|NCT03131206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154858970|NCT03131206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858971|NCT03131206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858972|NCT00985543|Ritonavir|ritonavir|mesh-list
154858973|NCT00985543|Lopinavir|lopinavir|mesh-list
154858974|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154858975|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154858976|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
154858977|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154858978|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858979|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154858980|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154858981|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
154858982|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154858983|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154858984|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154858985|NCT05394415|Paclitaxel|paclitaxel|mesh-list
154858986|NCT05394415|Carboplatin|carboplatin|mesh-list
154858987|NCT05394415|Tislelizumab|tislelizumab|mesh-list
154269057|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154858988|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154858989|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154858990|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
154858991|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
154858992|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
154858993|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858994|NCT05394415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154858995|NCT04352959|Betadex|betadex|mesh-list
154858996|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
154858997|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154858998|NCT00360945|Temozolomide|temozolomide|mesh-list
154858999|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859000|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154859001|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
154859002|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859003|NCT03019237|Omalizumab|omalizumab|mesh-list
154859004|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154859005|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154859006|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
154859007|NCT00361023|Losartan|losartan|mesh-list
154859008|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154859009|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859010|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154859011|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154859012|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859013|NCT00986401|Metformin|metformin|mesh-list
154859014|NCT00986401|Trospium chloride|trospium chloride|mesh-list
154859015|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154859016|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859017|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
154859018|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
154859019|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859020|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154859021|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154859022|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
154859023|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859024|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859025|NCT00986401|Urological Agents|urological agents|mesh-ancestor
154859026|NCT00375076|Enoxaparin|enoxaparin|mesh-list
154859027|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
154859028|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154859029|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154859030|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859031|NCT00987415|Allopurinol|allopurinol|mesh-list
154859032|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
154859033|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859034|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859035|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
154859036|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154859037|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154859038|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
154859039|NCT00987415|Protective Agents|protective agents|mesh-ancestor
154859040|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859041|NCT04807504|Ropivacaine|ropivacaine|mesh-list
154859042|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
154859043|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
154859044|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859045|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859046|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
154859047|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859048|NCT04707118|Paclitaxel|paclitaxel|mesh-list
154859049|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154859050|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154859051|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859052|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154859053|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154859054|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154859055|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859056|NCT03086356|Dabigatran|dabigatran|mesh-list
154859057|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
154859058|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154859059|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
154859060|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859061|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859062|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
154859063|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
154859064|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154859065|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154859066|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859067|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
154859068|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
154859069|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
154859070|NCT03140722|Hematinics|hematinics|mesh-ancestor
154859071|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154859072|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
154859073|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154859074|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154859075|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154859076|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859077|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859078|NCT00375622|Tamoxifen|tamoxifen|mesh-list
154859079|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154859080|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
154859081|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154859082|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859083|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154859084|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859085|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154859086|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154859087|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154859088|NCT03087604|Lidocaine|lidocaine|mesh-list
154859089|NCT03087604|Epinephrine|epinephrine|mesh-list
154859090|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
154859091|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
154859092|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859093|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859094|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
154859095|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859096|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154859097|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154859098|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154859099|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859100|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859101|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154859102|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154859103|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859104|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859105|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154859106|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154859107|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
154859108|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154859109|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
154859110|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
154859111|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
154859112|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154859113|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154859114|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
154859116|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154859117|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
154859118|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859119|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
154859120|NCT00987727|Protective Agents|protective agents|mesh-ancestor
154859121|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154859122|NCT00987727|Laxatives|laxatives|mesh-ancestor
154859123|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154859124|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154859125|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154859126|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154859127|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859128|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859129|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154859130|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859131|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859132|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
154859133|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859134|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
154859135|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154859136|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859137|NCT04913337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154859138|NCT04913337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859139|NCT05386459|Interferons|interferons|mesh-list
154859140|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
154859141|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859142|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
154859143|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859144|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
154859145|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154859146|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154859147|NCT03018535|Prednisolone|prednisolone|mesh-list
154859148|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
154859149|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
154859150|NCT03018535|Rituximab|rituximab|mesh-list
154859151|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154859152|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
154859153|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154859154|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
154859155|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859156|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154859157|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154859158|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
154859159|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859160|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859161|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154859162|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154859163|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154859164|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
154859165|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
154859166|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859167|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154859168|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
154859169|NCT03018535|Hormones|hormones|mesh-ancestor
154859170|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154859171|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154859172|NCT03018535|Protective Agents|protective agents|mesh-ancestor
154611127|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
154859173|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154859174|NCT00989911|Bosentan|bosentan|mesh-list
154859175|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859176|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154859177|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859178|NCT02977065|Atorvastatin|atorvastatin|mesh-list
154859179|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154859180|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154859181|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154859182|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
154859183|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859184|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154859185|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154859186|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859187|NCT03146806|Ketamine|ketamine|mesh-list
154859188|NCT03146806|Analgesics|analgesics|mesh-ancestor
154859189|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
154859190|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859191|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859192|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154859193|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154859194|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
154859195|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
154859196|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859197|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154859198|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154859199|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859200|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859201|NCT04706806|Acetic Acid|acetic acid|mesh-list
154859202|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154859203|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859204|NCT02975583|Vorapaxar|vorapaxar|mesh-list
154859205|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154859206|NCT03095638|Dolutegravir|dolutegravir|mesh-list
154859207|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154859208|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154859209|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859210|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859211|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154859212|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154859213|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
154859214|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859215|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
154859216|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
154859217|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859218|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
154859219|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154859220|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
154859221|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859222|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859223|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154859224|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
154859225|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154859226|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
154859227|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859228|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859229|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154859230|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
154859231|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
154859232|NCT04450108|Protective Agents|protective agents|mesh-ancestor
154859233|NCT03891849|Octreotide|octreotide|mesh-list
154859234|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154859235|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154859236|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859237|NCT04341831|Teicoplanin|teicoplanin|mesh-list
154859238|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154859239|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859240|NCT00361959|Fluticasone|fluticasone|mesh-list
154859241|NCT00361959|Xhance|xhance|mesh-list
154859242|NCT00361959|Bromides|bromides|mesh-list
154859243|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
154859244|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154859245|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611202|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
154859246|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154859247|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
154859248|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859249|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859250|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154859251|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
154859252|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
154859253|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154859254|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
154859255|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154859256|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
154859257|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859258|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859259|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154859260|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154859261|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154859262|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859263|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
154859264|NCT03158116|Aztreonam|aztreonam|mesh-list
154859265|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154859266|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859267|NCT03096730|Sufentanil|sufentanil|mesh-list
154859268|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
154859269|NCT03096730|Remifentanil|remifentanil|mesh-list
154859270|NCT03096730|Dsuvia|dsuvia|mesh-list
154859271|NCT03096730|Nalmefene|nalmefene|mesh-list
154859272|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154859273|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859274|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859275|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154859276|NCT03096730|Analgesics|analgesics|mesh-ancestor
154859277|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
154859278|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859279|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154859280|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154859281|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154859282|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859283|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859284|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859285|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154859286|NCT03096730|Narcotics|narcotics|mesh-ancestor
154859287|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154859288|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154859289|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
154859290|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
154859291|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154859292|NCT00362037|Irbesartan|irbesartan|mesh-list
154859293|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859294|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154859295|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154859296|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859297|NCT03161158|Diuretics|diuretics|mesh-list
154859298|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
154859299|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859300|NCT03161938|Dexamethasone|dexamethasone|mesh-list
154859301|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154859302|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
154269371|NCT06159348|Analgesics|analgesics|mesh-ancestor
154859303|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
154859304|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859305|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859306|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154859307|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
154859308|NCT03161938|Hormones|hormones|mesh-ancestor
154859309|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154859310|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154859311|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859312|NCT03321045|Trastuzumab|trastuzumab|mesh-list
154859313|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154859314|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859315|NCT00989989|Ranibizumab|ranibizumab|mesh-list
154859316|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154859317|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154859318|NCT00989989|Growth Substances|growth substances|mesh-ancestor
154859319|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859320|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
154859321|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859322|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
154859323|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154859324|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
154859325|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859326|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154859327|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154859328|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
154859329|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859330|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859331|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154859332|NCT03018301|Ketamine|ketamine|mesh-list
154859333|NCT03018301|Analgesics|analgesics|mesh-ancestor
154859334|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
154859335|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859336|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859337|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154859338|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154859339|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
154859340|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
154859341|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859342|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154859343|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154859344|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859345|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859346|NCT00990769|Anesthetics|anesthetics|mesh-list
154859347|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859348|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859349|NCT00991081|Bupropion|bupropion|mesh-list
154859350|NCT00991081|Nicotine|nicotine|mesh-list
154859351|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154859352|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
154859353|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859354|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859355|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154859356|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154859357|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
154859358|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859359|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859360|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154859361|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
154859362|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154859363|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154859364|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154859365|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859366|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
154859367|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154859368|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154859369|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859370|NCT03168022|Amitriptyline|amitriptyline|mesh-list
154859371|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
154859372|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154859373|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
154859374|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154859375|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154859376|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859377|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154859378|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859379|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154859380|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859381|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154859382|NCT03168022|Analgesics|analgesics|mesh-ancestor
154859383|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
154859384|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154859385|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154859386|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859387|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859388|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859389|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859390|NCT03102190|Verapamil|verapamil|mesh-list
154859391|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154859392|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154859393|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859394|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859395|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154859396|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859397|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
154859398|NCT03102736|Nitroprusside|nitroprusside|mesh-list
154859399|NCT03102736|Ketamine|ketamine|mesh-list
154859400|NCT03102736|Analgesics|analgesics|mesh-ancestor
154859401|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
154859402|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859403|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859404|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154859405|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154859406|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
154859407|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
154859408|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859409|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154859410|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154859411|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859412|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859413|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859414|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
154859415|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154859416|NCT03743103|Nitroprusside|nitroprusside|mesh-list
154859417|NCT03743103|Esmolol|esmolol|mesh-list
154859418|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859419|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
154859420|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154859421|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859422|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154859423|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154859424|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154859425|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859426|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859427|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859428|NCT04049266|Aflibercept|aflibercept|mesh-list
154859429|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154859430|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154859431|NCT04049266|Growth Substances|growth substances|mesh-ancestor
154859432|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859433|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
154859434|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859435|NCT00362505|Clevudine|clevudine|mesh-list
154859436|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
154859437|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859438|NCT00993187|Metformin|metformin|mesh-list
154859439|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154859440|NCT00993187|Glimepiride|glimepiride|mesh-list
154859441|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154859442|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859443|NCT00993187|Incretins|incretins|mesh-ancestor
154859444|NCT00993187|Hormones|hormones|mesh-ancestor
154859445|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154859446|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154859447|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
154859448|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859449|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859450|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154859451|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154859452|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
154859453|NCT03173170|Itraconazole|itraconazole|mesh-list
154859454|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
154859455|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859456|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154859457|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154859458|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859459|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859460|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154859461|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154859462|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154859463|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859464|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154859465|NCT03106870|Insulin|insulin|mesh-list
154859466|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154859467|NCT03106870|Metformin|metformin|mesh-list
154859468|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
154859469|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154859470|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859471|NCT00375310|Gemcitabine|gemcitabine|mesh-list
154859472|NCT00375310|Sorafenib|sorafenib|mesh-list
154859473|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154859474|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
154859475|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859476|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859477|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154859478|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859479|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154859480|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154859481|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
154859482|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859483|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154859484|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154859485|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
154859486|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
154859487|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859488|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859489|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
154859490|NCT04736914|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154859491|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154859492|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859493|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859494|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859495|NCT00362583|Fentanyl|fentanyl|mesh-list
154859496|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154859497|NCT00362583|Narcotics|narcotics|mesh-ancestor
154859498|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859499|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859500|NCT00362583|Analgesics|analgesics|mesh-ancestor
154859501|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
154859502|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859503|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154859504|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154859505|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
154859506|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
154859507|NCT00657241|Valsartan|valsartan|mesh-list
154859508|NCT00657241|Carvedilol|carvedilol|mesh-list
154859509|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859510|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154859511|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154859512|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859513|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154859514|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154859515|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859516|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859517|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859518|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
154859519|NCT00657241|Protective Agents|protective agents|mesh-ancestor
154859520|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154859521|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859522|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154859523|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
154859524|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154859525|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154859526|NCT04342065|Celecoxib|celecoxib|mesh-list
154859527|NCT04342065|Pregabalin|pregabalin|mesh-list
154859528|NCT04342065|Analgesics|analgesics|mesh-ancestor
154859529|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
154859530|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859531|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859532|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
154859533|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154859534|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859535|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859536|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154859537|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154859538|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154859539|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859540|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154859541|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154859542|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154859543|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154859544|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154859545|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154859546|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154859547|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859548|NCT03179410|Avelumab|avelumab|mesh-list
154859549|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154859550|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859551|NCT00478465|Valganciclovir|valganciclovir|mesh-list
154859552|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
154859553|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859554|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
154859555|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154859556|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
154859557|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859558|NCT00421785|Expectorants|expectorants|mesh-ancestor
154859559|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
154859560|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154859561|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
154859562|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859563|NCT00421785|Protective Agents|protective agents|mesh-ancestor
154859564|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859565|NCT00421785|Antidotes|antidotes|mesh-ancestor
154859566|NCT00421863|Amlodipine|amlodipine|mesh-list
154859567|NCT00421863|Telmisartan|telmisartan|mesh-list
154859568|NCT00421863|Clonidine|clonidine|mesh-list
154859569|NCT00421863|Ramipril|ramipril|mesh-list
154859570|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859571|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154859572|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859573|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859574|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154859575|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859576|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
154859577|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154859578|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154859579|NCT00421863|Analgesics|analgesics|mesh-ancestor
154859580|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
154269701|NCT06024928|Insulin|insulin|mesh-list
154859581|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859582|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
154859583|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
154859584|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154859585|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154859586|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154859587|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859588|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859589|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154859590|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
154859591|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859592|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154859593|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154859594|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154859595|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859596|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859597|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859598|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859599|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859600|NCT05363722|Bevacizumab|bevacizumab|mesh-list
154859601|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154859602|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859603|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154859604|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154859605|NCT05363722|Growth Substances|growth substances|mesh-ancestor
154859606|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859607|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
154859608|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154859609|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859610|NCT03127137|Triamcinolone|triamcinolone|mesh-list
154859611|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154859612|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154859613|NCT03127137|Lidocaine|lidocaine|mesh-list
154859614|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154859615|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
154859616|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
154859617|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859618|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859619|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
154859620|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859621|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154859622|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154859623|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154859624|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859625|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859626|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154859627|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
154859628|NCT03127137|Hormones|hormones|mesh-ancestor
154859629|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154859630|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154859631|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
154859632|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859633|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
154859634|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154859635|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154859636|NCT03122847|Prednisolone|prednisolone|mesh-list
154859637|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
154859638|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154859639|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
154859640|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154859641|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
154859642|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
154859643|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859644|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859645|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154859646|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
154859647|NCT03122847|Hormones|hormones|mesh-ancestor
154859648|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154859649|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154859650|NCT03122847|Protective Agents|protective agents|mesh-ancestor
154859651|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154859652|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859653|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
154859654|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
154859655|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154859656|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154859657|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859658|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859659|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859660|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154859661|NCT03525028|Metformin|metformin|mesh-list
154859662|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154859663|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859664|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154859665|NCT00754312|Entinostat|entinostat|mesh-list
154859666|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859667|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154859668|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859669|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859670|NCT04736524|Antibodies|antibodies|mesh-list
154859671|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
154859672|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859673|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
154859674|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154859675|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154859676|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154859677|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154859678|NCT03410446|Ketamine|ketamine|mesh-list
154859679|NCT03410446|Analgesics|analgesics|mesh-ancestor
154859680|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
154859681|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859682|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859683|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154859684|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154859685|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
154859686|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
154859687|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859688|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154859689|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154859690|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859691|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611647|NCT03440567|Carboplatin|carboplatin|mesh-list
154859692|NCT00375388|Metformin|metformin|mesh-list
154859693|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154859694|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859695|NCT00375778|Memantine|memantine|mesh-list
154859696|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154859697|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154859698|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
154859699|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859700|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859701|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859702|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154859703|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154859704|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154859705|NCT00994123|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154859706|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154859707|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859708|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859709|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859710|NCT03001726|Docetaxel|docetaxel|mesh-list
154859711|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
154859712|NCT03001726|Tegafur|tegafur|mesh-list
154859713|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859714|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
154859715|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
154859716|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
154859717|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859718|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154859719|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
154859720|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
154859721|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154859722|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
154859723|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859724|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859725|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
154859726|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859727|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
154859728|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154859729|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859730|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154859731|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
154859732|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154859733|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859734|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859735|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859736|NCT04353193|Octreotide|octreotide|mesh-list
154859737|NCT04353193|Terlipressin|terlipressin|mesh-list
154859738|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154859739|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154859740|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859741|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859742|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154859743|NCT01023841|Bimatoprost|bimatoprost|mesh-list
154859744|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154859745|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154859746|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859747|NCT00635648|Caspofungin|caspofungin|mesh-list
154859748|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
154859749|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859750|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859751|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859752|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
154859753|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154859754|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
154859755|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
154859756|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
154859757|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154859758|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
154859759|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859760|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859761|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859762|NCT05240456|Urological Agents|urological agents|mesh-ancestor
154859763|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154859764|NCT03574779|Paclitaxel|paclitaxel|mesh-list
154859765|NCT03574779|Bevacizumab|bevacizumab|mesh-list
154859766|NCT03574779|Carboplatin|carboplatin|mesh-list
154859767|NCT03574779|Niraparib|niraparib|mesh-list
154859768|NCT03574779|Dostarlimab|dostarlimab|mesh-list
154859769|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154859770|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859771|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
154859772|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
154859773|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
154859774|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859775|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154859776|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154859777|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154859778|NCT03574779|Growth Substances|growth substances|mesh-ancestor
154269851|NCT05702879|Prednisolone|prednisolone|mesh-list
154859779|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859780|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
154859781|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154859782|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859783|NCT04341883|Paclitaxel|paclitaxel|mesh-list
154859784|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154859785|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154859786|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859787|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
154859788|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
154859789|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
154859790|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859791|NCT00995761|Cisplatin|cisplatin|mesh-list
154859792|NCT00995761|Docetaxel|docetaxel|mesh-list
154859793|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859794|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
154859795|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
154859796|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
154859797|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859798|NCT00362271|Aripiprazole|aripiprazole|mesh-list
154859799|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154859800|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
154859801|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154859802|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154859803|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154859804|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859805|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859806|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
154859807|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
154859808|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859809|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859810|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154859811|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154859812|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
154859813|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154859814|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154859815|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154859816|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154859817|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154859818|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154859819|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154859820|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154859821|NCT00635102|Cycloserine|cycloserine|mesh-list
154859822|NCT00635102|Glycine|glycine|mesh-list
154859823|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154859824|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859825|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154859826|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
154859827|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154859828|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
154859829|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859830|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
154859831|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859832|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859833|NCT03041883|Riboflavin|riboflavin|mesh-list
154269921|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
154859834|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
154859835|NCT03041883|Vitamins|vitamins|mesh-ancestor
154859836|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
154859837|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859838|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154859839|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
154859840|NCT03034005|Budesonide|budesonide|mesh-list
154859841|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154859842|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154859843|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
154859844|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859845|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859846|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154859847|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
154859848|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
154859850|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154859851|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154859852|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154859853|NCT00635024|Melphalan|melphalan|mesh-list
154859854|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154859855|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154859856|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
154859857|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859858|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859859|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154859860|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154859861|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
154859862|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859863|NCT03182920|Lasmiditan|lasmiditan|mesh-list
154859864|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154859865|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
154859866|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859867|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859868|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859869|NCT03187678|Selexipag|selexipag|mesh-list
154859870|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859871|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154859872|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
154859873|NCT03192826|Dipivefrin|dipivefrin|mesh-list
154859874|NCT03192826|Brinzolamide|brinzolamide|mesh-list
154859875|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154859876|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154859877|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154859878|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154859879|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
154859880|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859881|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859882|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859883|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154859884|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154859885|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154859886|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859887|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
154859888|NCT03287674|Nivolumab|nivolumab|mesh-list
154859889|NCT03287674|Fludarabine|fludarabine|mesh-list
154859890|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
154859891|NCT03287674|Ipilimumab|ipilimumab|mesh-list
154859892|NCT03287674|Interleukin-2|interleukin-2|mesh-list
154859893|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154859894|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
154859895|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859896|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154859897|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154859898|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
154859899|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859900|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859901|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154859902|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154859903|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154859904|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154859905|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
154859906|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154859907|NCT03287674|Analgesics|analgesics|mesh-ancestor
154859908|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
154859909|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859910|NCT00634244|Cytarabine|cytarabine|mesh-list
154859911|NCT00634244|Sirolimus|sirolimus|mesh-list
154859912|NCT00634244|Carboplatin|carboplatin|mesh-list
154859913|NCT00634244|Etoposide|etoposide|mesh-list
154859914|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
154859915|NCT00634244|Topotecan|topotecan|mesh-list
154859916|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
154859917|NCT00634244|Alvocidib|alvocidib|mesh-list
154611889|NCT02964182|Nicotine|nicotine|mesh-list
154859919|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154859920|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154859921|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154859922|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859923|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859924|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154859925|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
154859926|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
154859927|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154859928|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154859929|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
154859930|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859931|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154859932|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154859933|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
154859934|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154859935|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154859936|NCT00634244|Analgesics|analgesics|mesh-ancestor
154859937|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
154859938|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859939|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
154859940|NCT00634244|Growth Substances|growth substances|mesh-ancestor
154859941|NCT01922804|Vitamins|vitamins|mesh-list
154859942|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
154859943|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859944|NCT03289858|Bupivacaine|bupivacaine|mesh-list
154859945|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
154859946|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
154859947|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154859948|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859949|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
154859950|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859951|NCT03418714|Salvinorin A|salvinorin a|mesh-list
154859952|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
154859953|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859954|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154859955|NCT03421210|Nicotine|nicotine|mesh-list
154859956|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154270036|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
154859957|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
154859958|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859959|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859960|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154859961|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154859962|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
154859963|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154859964|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859965|NCT03294850|Cholic Acids|cholic acids|mesh-list
154859966|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154859967|NCT00996931|Lenalidomide|lenalidomide|mesh-list
154859968|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
154859969|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859970|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154859971|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154859972|NCT00996931|Growth Substances|growth substances|mesh-ancestor
154859973|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
154859974|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859975|NCT00634088|Capecitabine|capecitabine|mesh-list
154859976|NCT00634088|Lapatinib|lapatinib|mesh-list
154859977|NCT00634088|Epothilones|epothilones|mesh-list
154859978|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154859979|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
154859980|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154859981|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154859982|NCT00634088|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154859983|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154859984|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154859985|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
154859986|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
154859987|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
154859988|NCT03428230|Acetaminophen|acetaminophen|mesh-list
154859989|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
154859990|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154859991|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154859992|NCT03428230|Analgesics|analgesics|mesh-ancestor
154859993|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
154859994|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154859995|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154859996|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
154859997|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
154859998|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
154859999|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860000|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
154860001|NCT03296800|Rifampin|rifampin|mesh-list
154860002|NCT03296800|Probenecid|probenecid|mesh-list
154860003|NCT03296800|Verapamil|verapamil|mesh-list
154860004|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154860005|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
154860006|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154860007|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860008|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
154860009|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154860010|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860011|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860012|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154860013|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154860014|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154270098|NCT04616248|Poly ICLC|poly iclc|mesh-list
154860015|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154860016|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154860017|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154860018|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154860019|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154860020|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860021|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154860022|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860023|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
154860024|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
154860025|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
154860026|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860027|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154860028|NCT00634010|Morphine|morphine|mesh-list
154860029|NCT00634010|Methadone|methadone|mesh-list
154860030|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154860031|NCT00634010|Narcotics|narcotics|mesh-ancestor
154860032|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860033|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860034|NCT00634010|Analgesics|analgesics|mesh-ancestor
154860035|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
154860036|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860037|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
154860038|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
154860039|NCT00633932|Esomeprazole|esomeprazole|mesh-list
154860040|NCT00633932|Omeprazole|omeprazole|mesh-list
154860041|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154860042|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154860043|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154860044|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860045|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860046|NCT01028677|Oxytocin|oxytocin|mesh-list
154860047|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
154860048|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154860049|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860050|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
154860051|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860052|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
154860053|NCT01000285|Prednisone|prednisone|mesh-list
154860054|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
154860055|NCT01000285|Doxorubicin|doxorubicin|mesh-list
154860056|NCT01000285|Etoposide|etoposide|mesh-list
154860057|NCT01000285|Vincristine|vincristine|mesh-list
154860058|NCT01000285|Bortezomib|bortezomib|mesh-list
154860059|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154860060|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
154860061|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860062|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860063|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154860064|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
154860065|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860066|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860067|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154860068|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154860069|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154860070|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154860071|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860072|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860073|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
154860074|NCT01000285|Hormones|hormones|mesh-ancestor
154860075|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860076|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154860077|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154860078|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
154860079|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
154860080|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
154860081|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154860082|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154860083|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
154860084|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860085|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154860086|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154860087|NCT01000987|Varenicline|varenicline|mesh-list
154860088|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154860089|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154860090|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
154860091|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860092|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860093|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860094|NCT00633464|Cetuximab|cetuximab|mesh-list
154860095|NCT00633464|Epothilones|epothilones|mesh-list
154860096|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154860097|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860098|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
154860099|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
154860100|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
154860101|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860102|NCT03437044|Clopidogrel|clopidogrel|mesh-list
154860103|NCT03437044|Ticagrelor|ticagrelor|mesh-list
154860104|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154860105|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154860106|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154860107|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154860108|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
154860109|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860110|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860111|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860112|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154860113|NCT01923194|Hormones|hormones|mesh-ancestor
154860114|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860115|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860116|NCT03303196|Pancrelipase|pancrelipase|mesh-list
154860117|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154860118|NCT00633152|Linezolid|linezolid|mesh-list
154860119|NCT00633152|Ceftaroline|ceftaroline|mesh-list
154860120|NCT00633152|Cephalosporins|cephalosporins|mesh-list
154860121|NCT00633152|Aztreonam|aztreonam|mesh-list
154860122|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154860123|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860124|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154860125|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860126|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860127|NCT00633152|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154860128|NCT01030783|Sorafenib|sorafenib|mesh-list
154860129|NCT01030783|Tivozanib|tivozanib|mesh-list
154860130|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860131|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154860132|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860133|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860134|NCT00633074|Vaccines|vaccines|mesh-list
154860135|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
154860136|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860137|NCT01929278|Clindamycin|clindamycin|mesh-list
154860138|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
154860139|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
154860140|NCT01929278|Tretinoin|tretinoin|mesh-list
154860141|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154860142|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860143|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154860144|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860145|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860146|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860147|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
154860148|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
154860149|NCT03210376|Neostigmine|neostigmine|mesh-list
154860150|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860151|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154860152|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860153|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860154|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
154860155|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860156|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154860157|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
154860158|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860159|NCT01929512|Metformin|metformin|mesh-list
154860160|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154860161|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154860162|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860163|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154860164|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154860165|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
154860166|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860167|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154860168|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154860169|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860170|NCT03211234|Ranibizumab|ranibizumab|mesh-list
154860171|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154860172|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154860173|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154860174|NCT03211234|Growth Substances|growth substances|mesh-ancestor
154860175|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860176|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
154860177|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860178|NCT03105518|Acetaminophen|acetaminophen|mesh-list
154860179|NCT03105518|Fentanyl|fentanyl|mesh-list
154860180|NCT03105518|Oxycodone|oxycodone|mesh-list
154860181|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154860182|NCT03105518|Narcotics|narcotics|mesh-ancestor
154860183|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860184|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860185|NCT03105518|Analgesics|analgesics|mesh-ancestor
154860186|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
154860187|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860188|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154860189|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154860190|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
154860191|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
154860192|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154860193|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
154860194|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
154860195|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
154860196|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860197|NCT01929668|Protective Agents|protective agents|mesh-ancestor
154860198|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860199|NCT01929668|Vitamins|vitamins|mesh-ancestor
154860200|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
154860201|NCT01929746|Daclizumab|daclizumab|mesh-list
154860202|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154860203|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
154860204|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860205|NCT03506048|Lenvatinib|lenvatinib|mesh-list
154860206|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860207|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154860208|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860209|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860210|NCT02161705|Ropivacaine|ropivacaine|mesh-list
154558125|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558126|NCT03177837|Diuretics|diuretics|mesh-ancestor
154558127|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
154558128|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558129|NCT02414373|Bupivacaine|bupivacaine|mesh-list
154558130|NCT02414373|Ropivacaine|ropivacaine|mesh-list
154558131|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558132|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
154558133|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558134|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860211|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
154860212|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
154860213|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501112|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154501113|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154501114|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154501115|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154501116|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154501117|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154501118|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154501119|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501120|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
154501121|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501122|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
154501123|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154501124|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
154501125|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501126|NCT03976973|Expectorants|expectorants|mesh-ancestor
154501127|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
154501128|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154501129|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
154501130|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501131|NCT03976973|Protective Agents|protective agents|mesh-ancestor
154501132|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501133|NCT03976973|Antidotes|antidotes|mesh-ancestor
154501134|NCT04066751|Ivacaftor|ivacaftor|mesh-list
154501135|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154501136|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154501137|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501138|NCT02550106|Omalizumab|omalizumab|mesh-list
154501139|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154501140|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154501141|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
154501142|NCT03237260|Vedolizumab|vedolizumab|mesh-list
154501143|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501144|NCT03247400|Atorvastatin|atorvastatin|mesh-list
154501145|NCT03247400|Simvastatin|simvastatin|mesh-list
154501146|NCT03247400|Calcium|calcium|mesh-list
154501147|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154501148|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501149|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154501150|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501151|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
154501152|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501153|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501154|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154501155|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501156|NCT02453516|Epinephrine|epinephrine|mesh-list
154501157|NCT02453516|Ropivacaine|ropivacaine|mesh-list
154501158|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
154501159|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
154501160|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501161|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501162|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
154501163|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501164|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154501165|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154501166|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
154501167|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501168|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501169|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154501170|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154501171|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
154501172|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154501173|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
154501174|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
154501175|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
154501176|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154501177|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
154501178|NCT03716609|Citric Acid|citric acid|mesh-list
154501179|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
154501180|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
154501181|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154501182|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
154501183|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
154501184|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501185|NCT03716609|Cathartics|cathartics|mesh-ancestor
154501186|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501187|NCT03709355|Clarithromycin|clarithromycin|mesh-list
154501189|NCT03709355|Rifabutin|rifabutin|mesh-list
154501190|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
154501191|NCT03709355|Omeprazole|omeprazole|mesh-list
154501192|NCT03709355|Atorvastatin|atorvastatin|mesh-list
154501193|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
154501194|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154501195|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154501196|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154501197|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501198|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
154501199|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501200|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501201|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154501202|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501203|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154501204|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501205|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154501206|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501207|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501208|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154501209|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154501210|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154501211|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154501212|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
154501213|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154501214|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501215|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154501216|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154501217|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154501218|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154501219|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
154501220|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
154501221|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154501222|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154501223|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154501224|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154501225|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154501226|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154501227|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154501228|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154501229|NCT03709355|Estrogens|estrogens|mesh-ancestor
154501230|NCT03709355|Hormones|hormones|mesh-ancestor
154501231|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501232|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154501233|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154501234|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
154501235|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154501236|NCT05209217|Ketamine|ketamine|mesh-list
154501237|NCT05209217|Analgesics|analgesics|mesh-ancestor
154501238|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
154501239|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501240|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501241|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154501242|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154501243|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
154501244|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
154501245|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501246|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154501247|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154501248|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501249|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501250|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154501251|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154501252|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154501253|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501254|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501255|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154501256|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154501257|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154501258|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
154501259|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253797|NCT01140620|Ketamine|ketamine|mesh-list
154501260|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501261|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154501263|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
154501264|NCT00700622|Insulin|insulin|mesh-list
154501265|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154501266|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
154501267|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
154501268|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154501269|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501270|NCT03628625|Letrozole|letrozole|mesh-list
154501271|NCT03628625|Misoprostol|misoprostol|mesh-list
154501272|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501273|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154501274|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154501275|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501276|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501277|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154501278|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
154501279|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501280|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501281|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154501282|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
154501283|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154501284|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154501285|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501286|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
154501287|NCT02553928|Memantine|memantine|mesh-list
154501288|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154501289|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154501290|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
154501291|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501292|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501293|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501294|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154270486|NCT02960230|Nivolumab|nivolumab|mesh-list
154501295|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154501296|NCT03908255|Vitamins|vitamins|mesh-list
154501297|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
154501298|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501299|NCT03246776|Triclosan|triclosan|mesh-list
154501300|NCT03246776|Halometasone|halometasone|mesh-list
154501301|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154501302|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501303|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154501304|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501305|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
154501306|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501307|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501308|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501309|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
154501310|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
154501311|NCT03246776|Hormones|hormones|mesh-ancestor
154501312|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501313|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501314|NCT03246386|Posaconazole|posaconazole|mesh-list
154501315|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
154501316|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501317|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154501318|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154501319|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154501320|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154501321|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154501322|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501323|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501324|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154501325|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
154501326|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501327|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501328|NCT03851081|Vincristine|vincristine|mesh-list
154501329|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154501330|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154501331|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501332|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
154501333|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
154860214|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501334|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
154501335|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501336|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154501337|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154501338|NCT03851081|Immunotoxins|immunotoxins|mesh-ancestor
154501339|NCT03851081|Immunoconjugates|immunoconjugates|mesh-ancestor
154501340|NCT03851081|Immunologic Factors|immunologic factors|mesh-ancestor
154501341|NCT03851081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501342|NCT03239600|Methotrexate|methotrexate|mesh-list
154501343|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154501344|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
154501345|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154501346|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501347|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154501348|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
154501349|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501350|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501351|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
154501352|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501353|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154501354|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154501355|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
154501356|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154501357|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154501358|NCT02966093|Lenvatinib|lenvatinib|mesh-list
154501359|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501360|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154501361|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501362|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501363|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
154501364|NCT03229616|Busulfan|busulfan|mesh-list
154501365|NCT03229616|Etoposide|etoposide|mesh-list
154501366|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154501367|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
154501368|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501369|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154501370|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154501371|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
154501372|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501373|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501374|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154501375|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154501376|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154501377|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154501378|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501379|NCT03234764|Immunomodulating Agents|immunomodulating agents|mesh-list
154501380|NCT03234764|Immunologic Factors|immunologic factors|mesh-ancestor
154501381|NCT03234764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501382|NCT03234842|Paclitaxel|paclitaxel|mesh-list
154501383|NCT03234842|Carboplatin|carboplatin|mesh-list
154501384|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154501385|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501386|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
154501387|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
154501388|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
154501389|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501390|NCT03229148|Anesthetics|anesthetics|mesh-list
154501391|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501392|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501393|NCT03228992|Ibuprofen|ibuprofen|mesh-list
154501394|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154501395|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154501396|NCT03228992|Analgesics|analgesics|mesh-ancestor
154501397|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
154501398|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501399|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501400|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501401|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270593|NCT01788020|Dexamethasone|dexamethasone|mesh-list
154501402|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154501403|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501404|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501405|NCT02452502|Atorvastatin|atorvastatin|mesh-list
154501406|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154501407|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501408|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
154501409|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501410|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501411|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154501412|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501413|NCT03234296|Metronidazole|metronidazole|mesh-list
154501414|NCT03234296|Levofloxacin|levofloxacin|mesh-list
154501415|NCT03234296|Ertapenem|ertapenem|mesh-list
154501416|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501417|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501418|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154501419|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154501420|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154501421|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154501422|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154501423|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501424|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501425|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501426|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154501427|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154501428|NCT03228368|Atezolizumab|atezolizumab|mesh-list
154501429|NCT03228368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154501430|NCT03228368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501431|NCT03228368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154501432|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501433|NCT03665129|Avdoralimab|avdoralimab|mesh-list
154501434|NCT03665129|Durvalumab|durvalumab|mesh-list
154501435|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154501436|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501437|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501438|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
154501439|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501440|NCT03235700|Nicorandil|nicorandil|mesh-list
154501441|NCT03235700|Adenosine|adenosine|mesh-list
154501442|NCT03235700|Analgesics|analgesics|mesh-ancestor
154501443|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
154501444|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501445|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501446|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154501447|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
154501448|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154270659|NCT03949686|Bupivacaine|bupivacaine|mesh-list
154501449|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
154501450|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
154501451|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501452|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501453|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154501454|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
154501455|NCT03235700|Vitamins|vitamins|mesh-ancestor
154501456|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
154501457|NCT03234062|Choline|choline|mesh-list
154501458|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
154501459|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501460|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
154501461|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501462|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501463|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501464|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
154501465|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
154501466|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154501467|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154501468|NCT03235778|Analgesics|analgesics|mesh-ancestor
154501469|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
154501470|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501471|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501472|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501473|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154501474|NCT04439513|Hemostatics|hemostatics|mesh-list
154501475|NCT04439513|Coagulants|coagulants|mesh-ancestor
154501476|NCT02452970|Gemcitabine|gemcitabine|mesh-list
154501477|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501478|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154501479|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
154501480|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501481|NCT03227900|Lidocaine|lidocaine|mesh-list
154501482|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
154225337|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
154501483|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
154501484|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501485|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501486|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
154501487|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501488|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154501489|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154501490|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154501491|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154501492|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501493|NCT03120182|Aspirin|aspirin|mesh-list
154501494|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154501495|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154501496|NCT03120182|Analgesics|analgesics|mesh-ancestor
154501497|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
154501498|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501499|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501500|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501501|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154501502|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154501503|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154270701|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501504|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501505|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154501506|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154501507|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501508|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
154501509|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
154501510|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154501511|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154501512|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501513|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
154501514|NCT02074436|Coagulants|coagulants|mesh-ancestor
154501515|NCT03227432|Dexamethasone|dexamethasone|mesh-list
154501516|NCT03227432|Nivolumab|nivolumab|mesh-list
154501517|NCT03227432|Pomalidomide|pomalidomide|mesh-list
154501518|NCT03227432|Elotuzumab|elotuzumab|mesh-list
154501519|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501520|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
154501521|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
154501522|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501523|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501524|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501525|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
154501526|NCT03227432|Hormones|hormones|mesh-ancestor
154501527|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501528|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154501529|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501530|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154501531|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154501532|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501533|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
154501534|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154501535|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154501536|NCT03227432|Growth Substances|growth substances|mesh-ancestor
154501537|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
154501538|NCT03222518|Acetaminophen|acetaminophen|mesh-list
154501539|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154501540|NCT03222518|Piroxicam|piroxicam|mesh-list
154501541|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154501542|NCT03222518|Analgesics|analgesics|mesh-ancestor
154501543|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
154501544|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501545|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501546|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
154501547|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501548|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154501549|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154501550|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501551|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501552|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154501553|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154501554|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154501555|NCT03222206|Analgesics|analgesics|mesh-ancestor
154501556|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
154501557|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501558|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501560|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154501562|NCT03221816|Pyridoxine|pyridoxine|mesh-list
154501563|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
154501564|NCT03221816|Hematinics|hematinics|mesh-ancestor
154501565|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
154501566|NCT03221816|Vitamins|vitamins|mesh-ancestor
154501567|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
154501568|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501569|NCT03119636|Levodopa|levodopa|mesh-list
154501570|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154501571|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154501572|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
154501573|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501574|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501575|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501576|NCT03226340|Niacin|niacin|mesh-list
154501577|NCT03226340|Amlodipine|amlodipine|mesh-list
154501578|NCT03226340|Telmisartan|telmisartan|mesh-list
154501579|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
154501580|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154501581|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154501582|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154501583|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501584|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154501585|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501586|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
154501587|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154501588|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154501589|NCT03226340|Diuretics|diuretics|mesh-ancestor
154501590|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
154501591|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154501592|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501593|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
154501594|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501595|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
154501596|NCT03226340|Vitamins|vitamins|mesh-ancestor
154501597|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
154501598|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
154501599|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154501600|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154501601|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
154501602|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501603|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501604|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501605|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
154501606|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
154501607|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501608|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
154501609|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154501610|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
154501611|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154501612|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
154501613|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501614|NCT03232034|Calcium|calcium|mesh-list
154501615|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154501616|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501617|NCT03225950|Antibodies|antibodies|mesh-list
154501618|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
154501619|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501620|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
154501621|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154501622|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154501623|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501624|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
154501625|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501626|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501627|NCT03232112|Exenatide|exenatide|mesh-list
154501628|NCT03232112|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154501629|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154501630|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501631|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154501632|NCT03232112|Incretins|incretins|mesh-ancestor
154501633|NCT03232112|Hormones|hormones|mesh-ancestor
154501634|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501637|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
154501638|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154501639|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501640|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154501641|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
154501642|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501643|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501644|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154501645|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
154501646|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
154501647|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154501648|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154501649|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154501650|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154501651|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
154501652|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501653|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501654|NCT05202314|Immunomodulating Agents|immunomodulating agents|mesh-list
154501655|NCT05202314|Immunologic Factors|immunologic factors|mesh-ancestor
154501656|NCT05202314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501657|NCT03225326|Carticaine|carticaine|mesh-list
154501658|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
154501659|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
154501660|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501661|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501662|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
154501663|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501664|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
154501665|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154501666|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501667|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501668|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154501669|NCT03220880|Analgesics|analgesics|mesh-ancestor
154501670|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
154501671|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501672|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154501673|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154501674|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154501675|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
154501676|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501677|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501678|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
154501679|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501680|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501681|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154501682|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154501683|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501684|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501685|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501686|NCT02614547|Brexanolone|brexanolone|mesh-list
154501687|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
154501688|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501689|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501690|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501691|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
154501692|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
154501693|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
154501694|NCT04472481|Vitamin D|vitamin d|mesh-list
154501695|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154501696|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501697|NCT04472481|Vitamins|vitamins|mesh-ancestor
154501698|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
154501699|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154501700|NCT04681079|Albuterol|albuterol|mesh-list
154501701|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154501702|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
154501703|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501704|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501705|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154501706|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
154501707|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
154501708|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154501709|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154501710|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154501711|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154501712|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
154501713|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501714|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501715|NCT00580125|Aripiprazole|aripiprazole|mesh-list
154501716|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
154501717|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154501718|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154501719|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154501720|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501721|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501722|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
154501723|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
154501724|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501725|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501726|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154501727|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154501728|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
154501729|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154501730|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154501731|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154501732|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154501733|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
154501734|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154501735|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501736|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501737|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154501738|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154501739|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501740|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501741|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501742|NCT00667953|Temozolomide|temozolomide|mesh-list
154501743|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
154501744|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154501745|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
154501746|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501747|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501748|NCT00667953|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154501749|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154501750|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501751|NCT00578955|Azithromycin|azithromycin|mesh-list
154501752|NCT00578955|Dexamethasone|dexamethasone|mesh-list
154501753|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
154501755|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501756|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
154501757|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
154501758|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501759|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501760|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501761|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
154501762|NCT00578955|Hormones|hormones|mesh-ancestor
154501763|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501764|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154501765|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501766|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
154501767|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501768|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501769|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501770|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501771|NCT00576537|Immunomodulating Agents|immunomodulating agents|mesh-list
154501772|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
154501773|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501774|NCT02282241|Melatonin|melatonin|mesh-list
154501775|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
154501776|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501777|NCT02282241|Protective Agents|protective agents|mesh-ancestor
154501778|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501779|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501780|NCT02424851|Thalidomide|thalidomide|mesh-list
154225642|NCT03965949|Hormones|hormones|mesh-list
154336686|NCT05850091|Colchicine|colchicine|mesh-list
154501781|NCT02424851|Dexamethasone|dexamethasone|mesh-list
154501782|NCT02424851|Bortezomib|bortezomib|mesh-list
154501783|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154501784|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501785|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
154501786|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
154501787|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501788|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501789|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501790|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
154501791|NCT02424851|Hormones|hormones|mesh-ancestor
154501792|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501793|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154501794|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501795|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154501796|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
154501797|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501798|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154501799|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
154501800|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
154501801|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501802|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501803|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154501804|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154501805|NCT02424851|Growth Substances|growth substances|mesh-ancestor
154501806|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
154501807|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
154501808|NCT02284035|Lamivudine|lamivudine|mesh-list
154501809|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154501810|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154501811|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
154501812|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501813|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154501814|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154501815|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501816|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501817|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154501818|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154501819|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154501820|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
154501821|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154501822|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154501823|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501824|NCT00484419|Incretins|incretins|mesh-ancestor
154501825|NCT00484419|Hormones|hormones|mesh-ancestor
154501826|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501827|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154501828|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
154501829|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501830|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501831|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154501832|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154501833|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
154501834|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501835|NCT02273895|Scopolamine|scopolamine|mesh-list
154501836|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154501837|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154501838|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
154501839|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
154501840|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501841|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501842|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501843|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
154501844|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154501845|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
154501846|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501847|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501848|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154501849|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
154501850|NCT00480831|Paclitaxel|paclitaxel|mesh-list
154501851|NCT00480831|Bevacizumab|bevacizumab|mesh-list
154501852|NCT00480831|Carboplatin|carboplatin|mesh-list
154501853|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154501854|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501855|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
154501856|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
154501857|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
154501858|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501859|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154501860|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154501861|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154501862|NCT00480831|Growth Substances|growth substances|mesh-ancestor
154501863|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501864|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
154501865|NCT03220256|Lamotrigine|lamotrigine|mesh-list
154501866|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
154501867|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154501868|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154501869|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501870|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154501871|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501872|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154501873|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154501874|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501875|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154501876|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154501877|NCT03220490|Timolol|timolol|mesh-list
154501878|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154501879|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154501880|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154501881|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
154501882|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501883|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501884|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501885|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154501886|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154501887|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154501888|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154501889|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154501890|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154501891|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154501892|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154501893|NCT02553772|Laxatives|laxatives|mesh-ancestor
154501894|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501895|NCT03119714|Pemirolast|pemirolast|mesh-list
154501896|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
154501897|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
154501898|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501899|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501900|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501901|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154501902|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
154501903|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501904|NCT05468554|Metformin|metformin|mesh-list
154501905|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154501906|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501907|NCT04617821|Paclitaxel|paclitaxel|mesh-list
154501908|NCT04617821|Gemcitabine|gemcitabine|mesh-list
154501909|NCT04617821|Folfirinox|folfirinox|mesh-list
154501910|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154501911|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501912|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
154501913|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
154501914|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
154501915|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501916|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154501917|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
154501918|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
154501919|NCT03219008|Mirtazapine|mirtazapine|mesh-list
154501920|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
154501921|NCT03219008|Fluoxetine|fluoxetine|mesh-list
154501922|NCT03219008|Bupropion|bupropion|mesh-list
154501923|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
154501924|NCT03219008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154501925|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154501926|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154501927|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501928|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501929|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
154501930|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501931|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154501932|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
154501933|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154501934|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154501935|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154501936|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501937|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
154501938|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154501939|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501940|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154501941|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
154501942|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
154501943|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154501944|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154501945|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154501946|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154501947|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
154501948|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154501949|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154501950|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154501951|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154501952|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154501953|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154501954|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
154501955|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154501956|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154501957|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501958|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
154501959|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
154501960|NCT00562497|Prednisone|prednisone|mesh-list
154501961|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
154501962|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154501963|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
154501964|NCT00562497|Hormones|hormones|mesh-ancestor
154501965|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501966|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501967|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154501968|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501969|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
154501970|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
154501971|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501972|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154501973|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154501974|NCT00562497|Protective Agents|protective agents|mesh-ancestor
154501975|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
154501976|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501977|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154501978|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154501979|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
154501980|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501981|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501982|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154501983|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
154501984|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154501985|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154501986|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154501987|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
154501988|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501989|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501990|NCT01503515|Fluconazole|fluconazole|mesh-list
154501991|NCT01503515|Voriconazole|voriconazole|mesh-list
154501992|NCT01503515|Caspofungin|caspofungin|mesh-list
154501993|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
154501994|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501995|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154501996|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154501997|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501998|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501999|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154502000|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
154502001|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502002|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502003|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154502004|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154502005|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154502006|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
154502007|NCT00468273|Antibodies|antibodies|mesh-list
154502008|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
154502009|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154502010|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154502011|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
154502012|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502013|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
154502014|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154502015|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
154502016|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502017|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154502018|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502019|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
154502020|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502021|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
154502022|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154502023|NCT03217916|Protective Agents|protective agents|mesh-ancestor
154502024|NCT00468117|Etanercept|etanercept|mesh-list
154502025|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154502026|NCT00468117|Basiliximab|basiliximab|mesh-list
154502027|NCT00468117|Daclizumab|daclizumab|mesh-list
154502028|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154502029|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154502030|NCT00468117|Analgesics|analgesics|mesh-ancestor
154502031|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
154502032|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502033|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502034|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502035|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502036|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502037|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502038|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
154502039|NCT00468039|Metformin|metformin|mesh-list
154502040|NCT00468039|Vildagliptin|vildagliptin|mesh-list
154502041|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154502042|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502043|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154502044|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
154502045|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502046|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502047|NCT02742519|Ivacaftor|ivacaftor|mesh-list
154502048|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154502049|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154502050|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502051|NCT01375010|Vitamin D|vitamin d|mesh-list
154502052|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
154502053|NCT01375010|Vitamins|vitamins|mesh-list
154502054|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
154502055|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502056|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154502057|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154502058|NCT03231176|Capecitabine|capecitabine|mesh-list
154502059|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154502060|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
154502061|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502062|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502063|NCT00467025|Sorafenib|sorafenib|mesh-list
154502064|NCT00467025|Trebananib|trebananib|mesh-list
154502065|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502066|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154502067|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502068|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502069|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154502070|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154502071|NCT00467025|Growth Substances|growth substances|mesh-ancestor
154502072|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502073|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
154502074|NCT03230786|Metformin|metformin|mesh-list
154502075|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154502076|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502077|NCT02451098|Atorvastatin|atorvastatin|mesh-list
154502078|NCT02451098|Ezetimibe|ezetimibe|mesh-list
154502079|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154502080|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154502081|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
154502082|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502083|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154502084|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154502085|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502086|NCT00546273|Vaccines|vaccines|mesh-list
154502087|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
154502088|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502089|NCT02452112|Lidocaine|lidocaine|mesh-list
154502090|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
154502091|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
154502092|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502093|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502094|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
154502095|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502096|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154502097|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154502098|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154502099|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271283|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
154502100|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502101|NCT00659061|Micronutrients|micronutrients|mesh-list
154502102|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502103|NCT02451956|Paclitaxel|paclitaxel|mesh-list
154502104|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154502105|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502106|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
154502107|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
154502108|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
154502109|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502110|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
154502111|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154502112|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
154502113|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502114|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502115|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154502116|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
154502117|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154502118|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
154502119|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502120|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502121|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154502122|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
154502123|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
154502124|NCT02725372|Protective Agents|protective agents|mesh-ancestor
154502125|NCT02450786|Donepezil|donepezil|mesh-list
154502126|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154502127|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502128|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502129|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
154502130|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502131|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502132|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
154502133|NCT03214718|Nilotinib|nilotinib|mesh-list
154502134|NCT03214718|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154502135|NCT03214718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154502136|NCT03214718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502137|NCT03214718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502138|NCT00539721|Ondansetron|ondansetron|mesh-list
154502139|NCT00539721|Rolapitant|rolapitant|mesh-list
154502140|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
154502141|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
154502142|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502143|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502144|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502145|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
154502146|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
154502147|NCT00539721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154502148|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154502149|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
154502150|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502151|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502152|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154502153|NCT00464061|Volinanserin|volinanserin|mesh-list
154226024|NCT01323335|Rasburicase|rasburicase|mesh-list
154502155|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
154502156|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502157|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502158|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502159|NCT03230630|Melatonin|melatonin|mesh-list
154502160|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
154502161|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502162|NCT03230630|Protective Agents|protective agents|mesh-ancestor
154502163|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502164|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502165|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154502166|NCT00460941|Incretins|incretins|mesh-ancestor
154502167|NCT00460941|Hormones|hormones|mesh-ancestor
154502168|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502169|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502170|NCT00460317|Paclitaxel|paclitaxel|mesh-list
154502171|NCT00460317|Carboplatin|carboplatin|mesh-list
154502172|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
154502173|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154502174|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502175|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
154502176|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
154502177|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
154502178|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502179|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154502180|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502181|NCT03213548|Daminozide|daminozide|mesh-list
154502182|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154502183|NCT03213548|Growth Substances|growth substances|mesh-ancestor
154502184|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502185|NCT00534027|Conatumumab|conatumumab|mesh-list
154502186|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502187|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502188|NCT02548078|Vaccines|vaccines|mesh-list
154502189|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
154502190|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502191|NCT00532311|Atorvastatin|atorvastatin|mesh-list
154502192|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154502193|NCT00532311|Simvastatin|simvastatin|mesh-list
154502194|NCT00532311|Pravastatin|pravastatin|mesh-list
154502195|NCT00532311|Lovastatin|lovastatin|mesh-list
154502196|NCT00532311|L 647318|l 647318|mesh-list
154502197|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
154502198|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154502199|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154502200|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154502201|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
154502202|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502203|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154502204|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502205|NCT03230474|Morphine|morphine|mesh-list
154502206|NCT03230474|Naloxone|naloxone|mesh-list
154502207|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154502208|NCT03230474|Narcotics|narcotics|mesh-ancestor
154502209|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502210|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502211|NCT03230474|Analgesics|analgesics|mesh-ancestor
154502212|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
154502213|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502214|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154502215|NCT00529503|Rituximab|rituximab|mesh-list
154502216|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
154502217|NCT00529503|Carboplatin|carboplatin|mesh-list
154502218|NCT00529503|Etoposide|etoposide|mesh-list
154502219|NCT00529503|Ifosfamide|ifosfamide|mesh-list
154502220|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502221|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502222|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
154502223|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502224|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502225|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154226090|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154502226|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154502227|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154502228|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337123|NCT04385277|Sargramostim|sargramostim|mesh-list
154502229|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502230|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154502231|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
154271416|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502232|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154502233|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154502234|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
154502235|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502236|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502237|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154502238|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
154502239|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
154502240|NCT05459194|Hormones|hormones|mesh-ancestor
154502241|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502242|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
154502243|NCT05476198|Anesthetics|anesthetics|mesh-list
154502244|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502245|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502246|NCT02280057|Metformin|metformin|mesh-list
154502247|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154502248|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502249|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154502250|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
154502251|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502252|NCT02282709|Asunaprevir|asunaprevir|mesh-list
154502253|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
154502254|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502255|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502256|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
154502257|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154502258|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502259|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502260|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154502261|NCT02282787|Analgesics|analgesics|mesh-ancestor
154502262|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
154502263|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502264|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154502265|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154502266|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154502267|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
154502268|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502269|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502270|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
154502271|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154502272|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502273|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154502274|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154502275|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154502276|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502277|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
154502278|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502279|NCT00458601|Temozolomide|temozolomide|mesh-list
154502280|NCT00458601|Molgramostim|molgramostim|mesh-list
154502281|NCT00458601|Rindopepimut|rindopepimut|mesh-list
154502282|NCT00458601|Sargramostim|sargramostim|mesh-list
154502283|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154502284|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
154502285|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502286|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502287|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
154502288|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502289|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154226163|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226164|NCT00441545|Sevelamer|sevelamer|mesh-list
154226165|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
154226166|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
154226167|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226168|NCT00436553|Ranibizumab|ranibizumab|mesh-list
154226169|NCT00436553|Verteporfin|verteporfin|mesh-list
154226170|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154226171|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154226172|NCT00436553|Growth Substances|growth substances|mesh-ancestor
154226173|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502291|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154502292|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
154502293|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154502294|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502295|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154502296|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
154502297|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502298|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502299|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
154502300|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502301|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154502302|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502303|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
154502304|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502305|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154502306|NCT03230162|Heparin|heparin|mesh-list
154502307|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154502308|NCT03230162|Tinzaparin|tinzaparin|mesh-list
154502309|NCT03230162|Dalteparin|dalteparin|mesh-list
154502310|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
154502311|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
154502312|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154502313|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154502314|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502315|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
154502316|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154502317|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154502318|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502319|NCT03230162|Urological Agents|urological agents|mesh-ancestor
154502320|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
154502321|NCT00455559|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154502322|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154502323|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502324|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502325|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502326|NCT02916433|Octreotide|octreotide|mesh-list
154502327|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502328|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154502329|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502330|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154502331|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502332|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154502333|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502334|NCT04059523|Tretinoin|tretinoin|mesh-list
154502335|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502336|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
154502337|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
154502338|NCT00657501|Testosterone|testosterone|mesh-list
154502339|NCT00657501|Androgens|androgens|mesh-ancestor
154502340|NCT00657501|Hormones|hormones|mesh-ancestor
154502341|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502342|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502343|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
154502344|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
154502345|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154502346|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502347|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
154502348|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154502349|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154502350|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154502351|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502352|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502353|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502354|NCT03229694|Bosentan|bosentan|mesh-list
154502355|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
154502356|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154502357|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502358|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154502359|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154502360|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502361|NCT03209648|Itraconazole|itraconazole|mesh-list
154502362|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
154253798|NCT01140620|Risperidone|risperidone|mesh-list
154502363|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502364|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154502365|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154502367|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502368|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154502370|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502371|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502372|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154502373|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
154502374|NCT04058899|Nalbuphine|nalbuphine|mesh-list
154502375|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154502376|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502377|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502378|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154502379|NCT04058899|Analgesics|analgesics|mesh-ancestor
154502380|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
154502381|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502382|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154502383|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154502384|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154502385|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
154502386|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502387|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502388|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154502389|NCT04058899|Narcotics|narcotics|mesh-ancestor
154502390|NCT00657189|Sifalimumab|sifalimumab|mesh-list
154502391|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154502392|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
154502393|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502394|NCT03209180|Carvedilol|carvedilol|mesh-list
154502395|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154502396|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154502397|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
154502398|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502399|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502400|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502401|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154502402|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
154502403|NCT03209180|Protective Agents|protective agents|mesh-ancestor
154502404|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154502405|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154502406|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154502407|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
154271606|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502408|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154502409|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154502410|NCT03215017|Loperamide|loperamide|mesh-list
154502411|NCT03215017|Sorbitol|sorbitol|mesh-list
154502412|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
154502413|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502414|NCT03215017|Cathartics|cathartics|mesh-ancestor
154502415|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
154502416|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502417|NCT02280447|Vaccines|vaccines|mesh-list
154502418|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
154502419|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502420|NCT00528333|Cytarabine|cytarabine|mesh-list
154502421|NCT00528333|Lintuzumab|lintuzumab|mesh-list
154502422|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154502423|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
154502424|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502425|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502426|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
154502427|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502428|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502429|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
154502430|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502431|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502432|NCT00526227|Clotrimazole|clotrimazole|mesh-list
154502433|NCT00526227|Miconazole|miconazole|mesh-list
154502434|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154502435|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502436|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
154502437|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154502438|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154502439|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502440|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502441|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154502442|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
154502443|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502444|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502445|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154502446|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154502448|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154502449|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
154502450|NCT00524277|Molgramostim|molgramostim|mesh-list
154502451|NCT00524277|Vaccines|vaccines|mesh-list
154502452|NCT00524277|Sargramostim|sargramostim|mesh-list
154502453|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
154502454|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502455|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502456|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154502457|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154502458|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154502459|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
154502460|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502461|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154502462|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154502463|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502464|NCT00650949|Carboplatin|carboplatin|mesh-list
154502465|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502466|NCT00520923|Olanzapine|olanzapine|mesh-list
154502467|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
154502468|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
154502469|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502470|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502471|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502472|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154502473|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154502474|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502475|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154271669|NCT03122860|Lorecivivint|lorecivivint|mesh-list
154502476|NCT00520923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154502477|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154502478|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154502479|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502480|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502481|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
154502482|NCT00514371|Bortezomib|bortezomib|mesh-list
154502483|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502484|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154502485|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502486|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154502487|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154502488|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502489|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154502490|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
154502491|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154502492|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154502493|NCT02286453|Diclofenac|diclofenac|mesh-list
154502494|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154502495|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154502496|NCT02286453|Analgesics|analgesics|mesh-ancestor
154502497|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
154502498|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502499|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502500|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502501|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502502|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154502503|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502504|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502505|NCT00385515|Meclocycline|meclocycline|mesh-list
154502506|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154502507|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502508|NCT02286609|Deflazacort|deflazacort|mesh-list
154502509|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502510|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502511|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
154502512|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502514|NCT00508989|Acetylcholine|acetylcholine|mesh-list
154502515|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154502516|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
154502517|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502518|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154502519|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
154502520|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
154502521|NCT00508989|Vitamins|vitamins|mesh-ancestor
154502522|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
154502523|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502524|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154502525|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
154502526|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502527|NCT03104842|Dexamethasone|dexamethasone|mesh-list
154502528|NCT03104842|Lenalidomide|lenalidomide|mesh-list
154502529|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502530|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
154502531|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
154502532|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502533|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502534|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502535|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
154502536|NCT03104842|Hormones|hormones|mesh-ancestor
154502537|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502538|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154502539|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502540|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
154502541|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154502542|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154502543|NCT03104842|Growth Substances|growth substances|mesh-ancestor
154502544|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
154502545|NCT00436683|Sevelamer|sevelamer|mesh-list
154502546|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
154502547|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
154502548|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502549|NCT00434811|Sirolimus|sirolimus|mesh-list
154502550|NCT00434811|Etanercept|etanercept|mesh-list
154502551|NCT00434811|Tacrolimus|tacrolimus|mesh-list
154502552|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154502553|NCT00434811|Basiliximab|basiliximab|mesh-list
154502554|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502555|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
154502556|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502557|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154502558|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502559|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502560|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154502561|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502562|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154502563|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502564|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
154502565|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154502566|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154502567|NCT00434811|Analgesics|analgesics|mesh-ancestor
154502568|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
154502569|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502570|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502571|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502572|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502573|NCT03133845|Midazolam|midazolam|mesh-list
154502574|NCT03133845|Fentanyl|fentanyl|mesh-list
154502575|NCT03133845|Morphine|morphine|mesh-list
154502576|NCT03133845|Anesthetics|anesthetics|mesh-list
154502577|NCT03133845|Propofol|propofol|mesh-list
154502578|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502579|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502580|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154502581|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154502582|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
154502583|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154502584|NCT03133845|Narcotics|narcotics|mesh-ancestor
154502585|NCT03133845|Analgesics|analgesics|mesh-ancestor
154502586|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
154502587|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502588|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154502589|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154502590|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154502591|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154502592|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
154502593|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
154502594|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502595|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502596|NCT00120393|Ritonavir|ritonavir|mesh-list
154502597|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154502598|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154502599|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154271801|NCT02529774|Leucovorin|leucovorin|mesh-list
154502600|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
154502601|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502602|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502603|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154502604|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154502605|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
154502606|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502607|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154502608|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154502609|NCT05726019|Colchicine|colchicine|mesh-list
154502610|NCT05726019|Gout Suppressants|gout suppressants|mesh-ancestor
154502611|NCT05726019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502612|NCT05726019|Tubulin Modulators|tubulin modulators|mesh-ancestor
154502613|NCT05726019|Antimitotic Agents|antimitotic agents|mesh-ancestor
154502614|NCT05726019|Mitosis Modulators|mitosis modulators|mesh-ancestor
154502615|NCT05726019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502616|NCT05726019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502617|NCT00116415|Lamivudine|lamivudine|mesh-list
154502618|NCT00116415|Efavirenz|efavirenz|mesh-list
154502619|NCT00116415|Didanosine|didanosine|mesh-list
154502620|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154502621|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154502622|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502623|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502624|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
154502625|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502626|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154502627|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154502628|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154502629|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154502630|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154502631|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154502632|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154502633|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154502634|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
154502635|NCT03207698|Metformin|metformin|mesh-list
154502636|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154502637|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502638|NCT03208712|Atezolizumab|atezolizumab|mesh-list
154502639|NCT03208712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154502640|NCT03208712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502641|NCT03208712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502642|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502643|NCT03201380|Choline|choline|mesh-list
154502644|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
154502645|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154502646|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
154502647|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502648|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502649|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154502650|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
154502651|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
154502652|NCT03208556|Fludarabine|fludarabine|mesh-list
154502653|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502654|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
154502655|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502656|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502657|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154502658|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
154502659|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502660|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502661|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154502662|NCT00429429|Immunomodulating Agents|immunomodulating agents|mesh-list
154502663|NCT00429429|Immunologic Factors|immunologic factors|mesh-ancestor
154502664|NCT00429429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502665|NCT03201146|Cisplatin|cisplatin|mesh-list
154502666|NCT03201146|Carboplatin|carboplatin|mesh-list
154502667|NCT03201146|Pemetrexed|pemetrexed|mesh-list
154502668|NCT03201146|Apatinib|apatinib|mesh-list
154502669|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502670|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502671|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502672|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154502673|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154502674|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154502675|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154502676|NCT00370383|Satraplatin|satraplatin|mesh-list
154502677|NCT00370383|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154502678|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154502679|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502680|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502681|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502682|NCT00367887|Ribavirin|ribavirin|mesh-list
154502683|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
154502684|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154502685|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
154502686|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
154502687|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502688|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
154502689|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502690|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502691|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
154502692|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502693|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154502694|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154502695|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502696|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
154502697|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502698|NCT03207308|Vitamin A|vitamin a|mesh-list
154502699|NCT03207308|Vitamins|vitamins|mesh-ancestor
154502700|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
154502701|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502702|NCT00366795|Satavaptan|satavaptan|mesh-list
154502703|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154502704|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502705|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
154502706|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502707|NCT00422019|Rilotumumab|rilotumumab|mesh-list
154502708|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154502709|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502710|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502711|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
154502712|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502713|NCT03207542|Daratumumab|daratumumab|mesh-list
154502714|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502715|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
154502716|NCT00360867|Imetelstat|imetelstat|mesh-list
154502717|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154502718|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502719|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502720|NCT02287389|Mitomycins|mitomycins|mesh-list
154502721|NCT02287389|Mitomycin|mitomycin|mesh-list
154502722|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154502723|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502724|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
154502725|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502726|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154502727|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502728|NCT00057993|Trastuzumab|trastuzumab|mesh-list
154502729|NCT00057993|Exemestane|exemestane|mesh-list
154502730|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502731|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502732|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154502733|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154502734|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502735|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502736|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154502737|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
154502738|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502739|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502741|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502742|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
154502743|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
154502744|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
154502745|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502746|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154502747|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154502748|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154502749|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154502750|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502751|NCT00055575|Scopolamine|scopolamine|mesh-list
154502752|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154502753|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154502754|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
154502755|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
154502756|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502757|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502758|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502759|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
154502760|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154502761|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
154502762|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502763|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502764|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154502765|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
154502766|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
154502767|NCT00051129|Anecortave|anecortave|mesh-list
154502768|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154502769|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154502770|NCT00051129|Growth Substances|growth substances|mesh-ancestor
154502771|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502772|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
154502773|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502774|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502775|NCT03200600|Dexamethasone|dexamethasone|mesh-list
154502776|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
154502777|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
154502778|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154502779|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154502780|NCT03200600|BB 1101|bb 1101|mesh-list
154502781|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502782|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
154502783|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
154502784|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502785|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502786|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154502787|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
154502788|NCT03200600|Hormones|hormones|mesh-ancestor
154502789|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154502790|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154502791|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502792|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
154502793|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502794|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502795|NCT03200600|Analgesics|analgesics|mesh-ancestor
154502796|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
154502797|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154502798|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154502799|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502800|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154502801|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
154502802|NCT02547454|Hematinics|hematinics|mesh-ancestor
154502803|NCT00049959|Verteporfin|verteporfin|mesh-list
154502804|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154502805|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
154502806|NCT03119324|Nimesulide|nimesulide|mesh-list
154502807|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154502808|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154502809|NCT03119324|Analgesics|analgesics|mesh-ancestor
154502810|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
154502811|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502812|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502813|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502814|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502815|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154502816|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502817|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502819|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154502820|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154502821|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154502822|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502823|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154502824|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502825|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
154502826|NCT03134001|Analgesics|analgesics|mesh-list
154502827|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
154502828|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502829|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502830|NCT01969409|Rituximab|rituximab|mesh-list
154502831|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502832|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502833|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
154502834|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502835|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502836|NCT05218577|Selenium|selenium|mesh-list
154502837|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
154502838|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502839|NCT05218577|Protective Agents|protective agents|mesh-ancestor
154502840|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502841|NCT05218577|Trace Elements|trace elements|mesh-ancestor
154502842|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
154502843|NCT00150813|Levetiracetam|levetiracetam|mesh-list
154502844|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
154502845|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
154502846|NCT02712788|Milrinone|milrinone|mesh-list
154502847|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154502848|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154502849|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
154502850|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154272050|NCT01114854|Topiramate|topiramate|mesh-list
154502851|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154502852|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502853|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502854|NCT02712788|Protective Agents|protective agents|mesh-ancestor
154502855|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502856|NCT00035529|Abatacept|abatacept|mesh-list
154502857|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154502858|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502859|NCT00035529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502860|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502861|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502862|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
154502863|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502864|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502865|NCT00356109|Insulin|insulin|mesh-list
154502866|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154502867|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
154502868|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154502869|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502870|NCT03206138|Imiquimod|imiquimod|mesh-list
154502871|NCT03206138|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154502872|NCT03206138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502873|NCT03206138|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154502874|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
154502875|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502876|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154502877|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502878|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
154502879|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
154502880|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154502881|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
154502882|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502883|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154502884|NCT00006225|Protective Agents|protective agents|mesh-ancestor
154502885|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
154502886|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502887|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
154502888|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
154502889|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502890|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502892|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154502893|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154502894|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
154502895|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502896|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502897|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502898|NCT04477265|Urological Agents|urological agents|mesh-ancestor
154502899|NCT00353457|Capecitabine|capecitabine|mesh-list
154502900|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
154502901|NCT00353457|Cetuximab|cetuximab|mesh-list
154502902|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154502903|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
154502904|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272107|NCT03792672|Ketamine|ketamine|mesh-list
154502905|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502906|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154502907|NCT00411099|Agomelatine|agomelatine|mesh-list
154502908|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154502909|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502910|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502911|NCT03195530|Propofol|propofol|mesh-list
154502912|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154502913|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154502914|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502915|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154502916|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
154502917|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
154502918|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
154502919|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154502920|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154502921|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154502922|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
154502923|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502924|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154502925|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154502926|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502927|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502928|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154502929|NCT00406809|Navitoclax|navitoclax|mesh-list
154502930|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502931|NCT03200210|Febuxostat|febuxostat|mesh-list
154502932|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
154502933|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154502934|NCT00004899|Etoposide|etoposide|mesh-list
154502935|NCT00004899|Busulfan|busulfan|mesh-list
154502936|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154502937|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502938|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154502939|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154502940|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502941|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502942|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
154502943|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502944|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
154502945|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502946|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154502947|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154502948|NCT03199976|Fluticasone|fluticasone|mesh-list
154502949|NCT03199976|Xhance|xhance|mesh-list
154502950|NCT03199976|Bromides|bromides|mesh-list
154502951|NCT03199976|Albuterol|albuterol|mesh-list
154502952|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
154502953|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154502954|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154502955|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
154502956|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154502957|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502958|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154502959|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
154502960|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
154502961|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154502962|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
154502963|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154502964|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
154226848|NCT01099150|Protective Agents|protective agents|mesh-ancestor
154502965|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154502966|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502967|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
154502968|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
154502969|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154502970|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154502971|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154502972|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154502973|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
154502974|NCT00369317|Cytarabine|cytarabine|mesh-list
154502975|NCT00369317|Etoposide|etoposide|mesh-list
154502976|NCT00369317|Daunorubicin|daunorubicin|mesh-list
154502977|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
154502978|NCT00369317|Asparaginase|asparaginase|mesh-list
154502979|NCT00369317|Thioguanine|thioguanine|mesh-list
154502980|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154502981|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502982|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154502983|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154502984|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154502985|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502986|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154502987|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
154502988|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
154502989|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154502990|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154502991|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
154502992|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154502993|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154502994|NCT02447666|Azacitidine|azacitidine|mesh-list
154502995|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154502996|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
154502997|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154502998|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154502999|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503000|NCT04469829|Methotrexate|methotrexate|mesh-list
154503001|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154503002|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
154503003|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154503004|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503005|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154503006|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
154503007|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503008|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503009|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
154503010|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503011|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154503012|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503013|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
154503014|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503015|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154503016|NCT00405951|Docetaxel|docetaxel|mesh-list
154503017|NCT00405951|Obatoclax|obatoclax|mesh-list
154503018|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503019|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
154503020|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
154503021|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503022|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503023|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503024|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154503025|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154503026|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503027|NCT03669757|Betamethasone|betamethasone|mesh-list
154503028|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
154503029|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154503030|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
154503031|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154503032|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503033|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
154503034|NCT03669757|Hormones|hormones|mesh-ancestor
154503035|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503036|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503037|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154503038|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
154503039|NCT03913091|Bupivacaine|bupivacaine|mesh-list
154226920|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154503041|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
154503042|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503043|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503044|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
154503045|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503046|NCT00330369|Darusentan|darusentan|mesh-list
154503047|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154503048|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503049|NCT03199664|Tacrolimus|tacrolimus|mesh-list
154503050|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503051|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
154503052|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503053|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154503054|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503055|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503056|NCT02447510|Mitogens|mitogens|mesh-list
154503057|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503058|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503059|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
154503060|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503061|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
154503062|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503063|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503064|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154503065|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
154503066|NCT05216237|Apatinib|apatinib|mesh-list
154503067|NCT05216237|Tegafur|tegafur|mesh-list
154503068|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503069|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154503070|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503071|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503072|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154503073|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
154503074|NCT00322257|Insulin|insulin|mesh-list
154503075|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154503076|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
154503077|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
154503078|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154503079|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503080|NCT00312975|Tremelimumab|tremelimumab|mesh-list
154503081|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503082|NCT03199820|Dinoprostone|dinoprostone|mesh-list
154503083|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
154503084|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154503085|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503086|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154503087|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
154503088|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503089|NCT03199430|Protective Agents|protective agents|mesh-ancestor
154503090|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503091|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154503092|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154503093|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503094|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154503095|NCT02287857|Tenofovir|tenofovir|mesh-list
154503096|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
154503097|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503098|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154503099|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154503100|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503101|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503102|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154503103|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154503104|NCT01318499|Nepafenac|nepafenac|mesh-list
154503105|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154503106|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154503107|NCT01318499|Analgesics|analgesics|mesh-ancestor
154503108|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
154503109|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503110|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503111|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503112|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503113|NCT00397293|Topotecan|topotecan|mesh-list
154503114|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154503115|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154503116|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503117|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503118|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503120|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
154503121|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
154503122|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154503123|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503124|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
154503125|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
154503126|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503127|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503128|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503129|NCT03204734|Capecitabine|capecitabine|mesh-list
154503130|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154503131|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
154503132|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503133|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503134|NCT00396357|Metformin|metformin|mesh-list
154503135|NCT00396357|Vildagliptin|vildagliptin|mesh-list
154503136|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154503137|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503138|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154503139|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
154503140|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503141|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503142|NCT00394563|Tanezumab|tanezumab|mesh-list
154503143|NCT00394563|Analgesics|analgesics|mesh-ancestor
154503144|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
154503145|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503146|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503147|NCT02449538|Everolimus|everolimus|mesh-list
154503148|NCT02449538|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154503149|NCT02449538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154503150|NCT02449538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503151|NCT02449538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503152|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503153|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
154503154|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503155|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503156|NCT02446652|Paclitaxel|paclitaxel|mesh-list
154503157|NCT02446652|Carboplatin|carboplatin|mesh-list
154503158|NCT02446652|Hydralazine|hydralazine|mesh-list
154503159|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154503160|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503161|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
154503162|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
154503163|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503164|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503165|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154503166|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
154503167|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154503168|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154503169|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154503170|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503171|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503172|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154503173|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154503174|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154503175|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
154503176|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503177|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503178|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154503179|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154503180|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
154503181|NCT00299325|Rimonabant|rimonabant|mesh-list
154503182|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154503183|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154503184|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154503185|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503186|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503187|NCT00299325|Hormones|hormones|mesh-ancestor
154503188|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503189|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503191|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154503192|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154503193|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503194|NCT02446574|Paclitaxel|paclitaxel|mesh-list
154503195|NCT02446574|Cisplatin|cisplatin|mesh-list
154503196|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154503197|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503198|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
154503199|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
154503200|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503201|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503202|NCT01775813|Metformin|metformin|mesh-list
154503203|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154503204|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503205|NCT00287547|Abatacept|abatacept|mesh-list
154503206|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154503207|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503208|NCT00287547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154503209|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503210|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503211|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
154503212|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503213|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503214|NCT03204578|Midazolam|midazolam|mesh-list
154503215|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154503216|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154503217|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503218|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503219|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154503220|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154503221|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154503222|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154503223|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
154503224|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
154503225|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
154503226|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
154503227|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503228|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503229|NCT01694069|Tazobactam|tazobactam|mesh-list
154503230|NCT01694069|Piperacillin|piperacillin|mesh-list
154503231|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154503232|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154503233|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503234|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154503235|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503236|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503237|NCT03204032|Thalidomide|thalidomide|mesh-list
154503238|NCT03204032|Temozolomide|temozolomide|mesh-list
154503239|NCT03204032|Tegafur|tegafur|mesh-list
154503240|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154503241|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
154503242|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503243|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503244|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503245|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
154503246|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503247|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
154503248|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154503249|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503250|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154503251|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154503252|NCT03204032|Growth Substances|growth substances|mesh-ancestor
154503253|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
154503254|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154503255|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
154503256|NCT02285751|Aspirin|aspirin|mesh-list
154503257|NCT02285751|Clopidogrel|clopidogrel|mesh-list
154503258|NCT02285751|Ticagrelor|ticagrelor|mesh-list
154503259|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154503260|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154503261|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154227148|NCT00022672|Trastuzumab|trastuzumab|mesh-list
154503262|NCT02285751|Analgesics|analgesics|mesh-ancestor
154503263|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
154503264|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503265|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503266|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503267|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503269|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154503270|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503271|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154503272|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154503273|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503274|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
154503275|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154503276|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154503277|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154503278|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
154503279|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503280|NCT02446730|Clopidogrel|clopidogrel|mesh-list
154272474|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154503281|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154503282|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154503283|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154503284|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154503285|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
154503286|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503287|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503288|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503289|NCT05114915|Docetaxel|docetaxel|mesh-list
154503290|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503291|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
154503292|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
154503293|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503294|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503295|NCT03532035|Brincidofovir|brincidofovir|mesh-list
154503296|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
154503297|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503298|NCT00282867|Insulin|insulin|mesh-list
154503299|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154503300|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503301|NCT03198338|Bupivacaine|bupivacaine|mesh-list
154503302|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
154503303|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
154503304|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503305|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503306|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
154503307|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503308|NCT05222633|Ranibizumab|ranibizumab|mesh-list
154503309|NCT05222633|Aflibercept|aflibercept|mesh-list
154503310|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154503311|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154503312|NCT05222633|Growth Substances|growth substances|mesh-ancestor
154503313|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503314|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
154503315|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503316|NCT05222243|Calcium|calcium|mesh-list
154503317|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154503318|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503319|NCT04469283|Caffeine|caffeine|mesh-list
154503320|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154503321|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503322|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154503323|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503324|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503325|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154503326|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154503327|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
154503328|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503329|NCT02285829|Bromides|bromides|mesh-list
154503330|NCT02285829|Rocuronium|rocuronium|mesh-list
154503331|NCT02285829|Cisatracurium|cisatracurium|mesh-list
154503332|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
154503333|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154503334|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154503335|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154503336|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503337|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503338|NCT03203408|Hylan|hylan|mesh-list
154503339|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
154503340|NCT03203408|Protective Agents|protective agents|mesh-ancestor
154503341|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503343|NCT02285985|Incretins|incretins|mesh-ancestor
154503344|NCT02285985|Hormones|hormones|mesh-ancestor
154503345|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503346|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272536|NCT01216644|Vitamins|vitamins|mesh-ancestor
154503347|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154503348|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
154503349|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503350|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503351|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154503352|NCT02445872|Dexamethasone|dexamethasone|mesh-list
154503353|NCT02445872|Aprepitant|aprepitant|mesh-list
154503354|NCT02445872|Palonosetron|palonosetron|mesh-list
154503355|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503356|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
154503357|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
154503358|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503359|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503360|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154503361|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
154503362|NCT02445872|Hormones|hormones|mesh-ancestor
154503363|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503364|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154503365|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503366|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154503367|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503368|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503369|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154503370|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154503371|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
154503372|NCT05221775|Lenvatinib|lenvatinib|mesh-list
154503373|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503374|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154503375|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503376|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503377|NCT04700423|Ivermectin|ivermectin|mesh-list
154503378|NCT04700423|Albendazole|albendazole|mesh-list
154503379|NCT04700423|Moxidectin|moxidectin|mesh-list
154503380|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154503381|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503382|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
154503383|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
154503384|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154503385|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154503386|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
154503387|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
154503388|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503389|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503390|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503391|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
154503392|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
154503393|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
154503394|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
154503395|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503396|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
154503397|NCT02445716|Testosterone|testosterone|mesh-list
154503398|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
154503399|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
154503400|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154503401|NCT02445716|Androgens|androgens|mesh-ancestor
154503402|NCT02445716|Hormones|hormones|mesh-ancestor
154503403|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503404|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503405|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154503406|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503407|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
154503408|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
154503409|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154503410|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227294|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
154503411|NCT03197636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154503412|NCT03197636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503413|NCT05724381|Phenol|phenol|mesh-list
154503414|NCT05724381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154503415|NCT05724381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503416|NCT05724381|Disinfectants|disinfectants|mesh-ancestor
154503417|NCT05724381|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154503418|NCT05724381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154503420|NCT03194594|Ketamine|ketamine|mesh-list
154503421|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503422|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
154503423|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
154503424|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503425|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503426|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154503427|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
154503428|NCT03194594|Hormones|hormones|mesh-ancestor
154503429|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503430|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154503431|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503432|NCT03194594|Analgesics|analgesics|mesh-ancestor
154503433|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
154503434|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154503435|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154503436|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
154503437|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
154503438|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503439|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154503440|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154503441|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503442|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503443|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
154503444|NCT04407377|Tolperisone|tolperisone|mesh-list
154503445|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154503446|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
154503447|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154503448|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154503449|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503450|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154503451|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503452|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154503453|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503454|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
154503455|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154503456|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154503457|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154503458|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154503459|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503460|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
154503461|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503462|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503463|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154503464|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503465|NCT00257205|Temozolomide|temozolomide|mesh-list
154503466|NCT00257205|Dacarbazine|dacarbazine|mesh-list
154503467|NCT00257205|Tremelimumab|tremelimumab|mesh-list
154503468|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154503469|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
154503470|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503471|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503472|NCT03194204|Doxycycline|doxycycline|mesh-list
154503473|NCT03194204|Uric Acid|uric acid|mesh-list
154503474|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
154503475|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154503476|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503477|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
154503478|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154503479|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154503480|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
154503481|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503482|NCT03194204|Protective Agents|protective agents|mesh-ancestor
154503483|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503484|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
154503485|NCT03197480|Aflibercept|aflibercept|mesh-list
154503486|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154503487|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154503488|NCT03197480|Growth Substances|growth substances|mesh-ancestor
154503489|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503490|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
154503491|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503492|NCT00151281|Thalidomide|thalidomide|mesh-list
154503493|NCT00151281|Prednisone|prednisone|mesh-list
154503494|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
154503495|NCT00151281|Rituximab|rituximab|mesh-list
154503496|NCT00151281|Etoposide|etoposide|mesh-list
154503497|NCT00151281|Procarbazine|procarbazine|mesh-list
154503498|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503499|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
154503500|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503501|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503502|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154503503|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
154503504|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503505|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503506|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154503507|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154503508|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503509|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
154503510|NCT00151281|Hormones|hormones|mesh-ancestor
154503511|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503512|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154503513|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154503514|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154503515|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154503516|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503517|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
154503518|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154503519|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503520|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154503521|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154503522|NCT00151281|Growth Substances|growth substances|mesh-ancestor
154503523|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
154503524|NCT03202862|Fulvestrant|fulvestrant|mesh-list
154503525|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154503526|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503527|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154503528|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154503529|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
154503530|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503531|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503532|NCT03202940|Alectinib|alectinib|mesh-list
154503533|NCT03202940|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154503534|NCT03202940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154503535|NCT03202940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503536|NCT03202940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503537|NCT00255099|Etravirine|etravirine|mesh-list
154503538|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154503539|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154503540|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503541|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503542|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
154503543|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503544|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
154503545|NCT00231153|Povidone|povidone|mesh-list
154503546|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
154503547|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
154503548|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154503549|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503550|NCT03202784|Berotralstat|berotralstat|mesh-list
154503551|NCT03202784|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154503552|NCT03202784|Protease Inhibitors|protease inhibitors|mesh-ancestor
154503553|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503554|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503555|NCT05220527|Triamcinolone|triamcinolone|mesh-list
154503556|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
154503557|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503558|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
154503559|NCT05220527|Hormones|hormones|mesh-ancestor
154503560|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503561|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227458|NCT01103206|Cinacalcet|cinacalcet|mesh-list
154503562|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
154503563|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154503564|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
154503565|NCT05220527|Protective Agents|protective agents|mesh-ancestor
154503567|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
154503568|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
154503569|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503570|NCT05723991|Gemcitabine|gemcitabine|mesh-list
154503571|NCT05723991|Disitamab vedotin|disitamab vedotin|mesh-list
154503572|NCT05723991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154503573|NCT05723991|Antimetabolites|antimetabolites|mesh-ancestor
154503574|NCT05723991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503575|NCT05723991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503576|NCT05723991|Immunoconjugates|immunoconjugates|mesh-ancestor
154503577|NCT05723991|Immunologic Factors|immunologic factors|mesh-ancestor
154272775|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154503578|NCT05723991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503579|NCT01318109|Metformin|metformin|mesh-list
154503580|NCT01318109|Alogliptin|alogliptin|mesh-list
154503581|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154503582|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503583|NCT01318109|Incretins|incretins|mesh-ancestor
154503584|NCT01318109|Hormones|hormones|mesh-ancestor
154503585|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503586|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154503587|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
154503588|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503589|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503590|NCT05720871|Capsaicin|capsaicin|mesh-list
154503591|NCT05720871|Antipruritics|antipruritics|mesh-ancestor
154503592|NCT05720871|Dermatologic Agents|dermatologic agents|mesh-ancestor
154503593|NCT05720871|Sensory System Agents|sensory system agents|mesh-ancestor
154503594|NCT05720871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503595|NCT05720871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503596|NCT05636267|Carboplatin|carboplatin|mesh-list
154503597|NCT05636267|Pemetrexed|pemetrexed|mesh-list
154503598|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503599|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503600|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503601|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154503602|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154503603|NCT03873311|Cytarabine|cytarabine|mesh-list
154503604|NCT03873311|Azacitidine|azacitidine|mesh-list
154503605|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154503606|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
154503607|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503608|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503609|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
154503610|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503611|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503612|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
154503613|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503614|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503615|NCT00162279|Abatacept|abatacept|mesh-list
154503616|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154503617|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503618|NCT00162279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154503619|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503620|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503621|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
154503622|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503623|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503624|NCT00145431|Atorvastatin|atorvastatin|mesh-list
154503625|NCT00145431|Torcetrapib|torcetrapib|mesh-list
154503626|NCT00145431|Fenofibrate|fenofibrate|mesh-list
154503627|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154503628|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154503629|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
154503630|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503631|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154503632|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154503633|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503634|NCT00135369|Lamivudine|lamivudine|mesh-list
154503635|NCT00135369|Efavirenz|efavirenz|mesh-list
154503636|NCT00135369|Stavudine|stavudine|mesh-list
154503637|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154272835|NCT01219764|Amoxicillin|amoxicillin|mesh-list
154503638|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154503640|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503641|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
154503642|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503643|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154503644|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154503645|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154503646|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154503647|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154503648|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154503649|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154503650|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154503651|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
154503652|NCT03530319|Azithromycin|azithromycin|mesh-list
154503653|NCT03530319|Doxycycline|doxycycline|mesh-list
154503654|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154503655|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503656|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
154503657|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154503658|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154503659|NCT02445404|Dexamethasone|dexamethasone|mesh-list
154503660|NCT02445404|Prednisone|prednisone|mesh-list
154503661|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
154503662|NCT02445404|Ifosfamide|ifosfamide|mesh-list
154503663|NCT02445404|Carboplatin|carboplatin|mesh-list
154503664|NCT02445404|Etoposide|etoposide|mesh-list
154503665|NCT02445404|Vincristine|vincristine|mesh-list
154503666|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503667|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
154503668|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503669|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503670|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154503671|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
154503672|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503673|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503674|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154503675|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503676|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
154503677|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
154503678|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503679|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154503680|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
154503681|NCT02445404|Hormones|hormones|mesh-ancestor
154503682|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503683|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154503684|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503685|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154503686|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154503687|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154503688|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
154503689|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
154503690|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503691|NCT05726175|Disitamab vedotin|disitamab vedotin|mesh-list
154503692|NCT05726175|Immunoconjugates|immunoconjugates|mesh-ancestor
154503693|NCT05726175|Immunologic Factors|immunologic factors|mesh-ancestor
154503694|NCT05726175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503695|NCT03530085|Fludarabine|fludarabine|mesh-list
154503696|NCT03530085|Busulfan|busulfan|mesh-list
154503697|NCT03530085|Decitabine|decitabine|mesh-list
154503698|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503699|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154503700|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
154503701|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503702|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503703|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
154503704|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503705|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
154503706|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154503707|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154503708|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503709|NCT03197012|Octreotide|octreotide|mesh-list
154503710|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154503711|NCT03197012|Edotreotide|edotreotide|mesh-list
154503712|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
154503713|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
154227595|NCT00260832|Cytarabine|cytarabine|mesh-list
154503714|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503715|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154503716|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154503717|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154503718|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503719|NCT03530007|Ondansetron|ondansetron|mesh-list
154503720|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
154503721|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
154503722|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503723|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503724|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154503725|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
154503726|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
154503727|NCT03530007|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154503728|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154503729|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
154503730|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503731|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503732|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
154503733|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154503734|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154503735|NCT03529929|Prednisolone|prednisolone|mesh-list
154503736|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
154503737|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154503738|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
154503739|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503740|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
154503741|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
154503742|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503743|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503744|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154503745|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
154503746|NCT03529929|Hormones|hormones|mesh-ancestor
154503747|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154503748|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154503749|NCT03529929|Protective Agents|protective agents|mesh-ancestor
154503750|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154503751|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503752|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
154503753|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154503754|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
154503755|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503756|NCT03525561|Acetazolamide|acetazolamide|mesh-list
154503757|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
154503758|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154503759|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503760|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503761|NCT03525561|Diuretics|diuretics|mesh-ancestor
154503762|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
154503763|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503764|NCT03527355|Vaccines|vaccines|mesh-list
154503765|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
154503766|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503767|NCT05707169|Lidocaine|lidocaine|mesh-list
154503768|NCT05707169|Epinephrine|epinephrine|mesh-list
154503769|NCT05707169|Racepinephrine|racepinephrine|mesh-list
154503770|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
154503771|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
154503772|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
154503773|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
154503774|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503775|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503776|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
154503777|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503778|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154503779|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154503780|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154503781|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154503782|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503783|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154503784|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154503785|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
154503786|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503787|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154503788|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154503789|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
154503790|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154503791|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
154503793|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
154503794|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154503795|NCT02712008|Aflibercept|aflibercept|mesh-list
154503796|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154503797|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154503798|NCT02712008|Growth Substances|growth substances|mesh-ancestor
154503799|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503800|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
154503801|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503802|NCT05130515|Niraparib|niraparib|mesh-list
154503803|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154503804|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503805|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503806|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503807|NCT02450084|Fentanyl|fentanyl|mesh-list
154503808|NCT02450084|Ropivacaine|ropivacaine|mesh-list
154503809|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
154503810|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
154503811|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503812|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503813|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
154503814|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503815|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154503816|NCT02450084|Narcotics|narcotics|mesh-ancestor
154503817|NCT02450084|Analgesics|analgesics|mesh-ancestor
154503818|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154503819|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154503820|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
154503821|NCT03201770|Artesunate|artesunate|mesh-list
154503822|NCT03201770|Pyronaridine|pyronaridine|mesh-list
154503823|NCT03201770|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154503824|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
154503825|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154503826|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154503827|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503828|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503829|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
154503830|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
154503831|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154503832|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
154503833|NCT04176393|Ivosidenib|ivosidenib|mesh-list
154503834|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503835|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503836|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503837|NCT02449070|Nicorandil|nicorandil|mesh-list
154503838|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154503839|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154503840|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
154503841|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
154503842|NCT02449070|Vitamins|vitamins|mesh-ancestor
154503843|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
154503844|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503845|NCT03529149|Diltiazem|diltiazem|mesh-list
154503846|NCT03529149|Urapidil|urapidil|mesh-list
154503847|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154503848|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154503849|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154503850|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503851|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154503852|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503853|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
154503854|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154503855|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
154503856|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503857|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154503858|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154503859|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154503860|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
154503861|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
154503862|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154503863|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
154503864|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154503865|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
154503866|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503867|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503868|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
154503869|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154503870|NCT02711306|Cathartics|cathartics|mesh-ancestor
154503871|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154503872|NCT03193112|Agomelatine|agomelatine|mesh-list
154503873|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154503874|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503875|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503876|NCT03196154|Insulin|insulin|mesh-list
154503877|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154503878|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503879|NCT03193424|Docetaxel|docetaxel|mesh-list
154503880|NCT03193424|Apatinib|apatinib|mesh-list
154503881|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503882|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
154503883|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
154503884|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
154503885|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503886|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154503887|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503888|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
154503889|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154503890|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154503891|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154503892|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154503893|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503894|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
154503895|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503896|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503897|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154503898|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503899|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
154503900|NCT03118076|Ropivacaine|ropivacaine|mesh-list
154503901|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154503902|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503903|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503904|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154503905|NCT03118076|Analgesics|analgesics|mesh-ancestor
154503906|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
154503907|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503908|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154503909|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154503910|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154503911|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
154503912|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503913|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503914|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
154503915|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
154503916|NCT03528915|Rifamycins|rifamycins|mesh-list
154503917|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
154503918|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154503919|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503920|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503921|NCT03192878|Infliximab|infliximab|mesh-list
154503922|NCT03192878|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154503923|NCT03192878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503924|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
154503925|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154503926|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154503927|NCT00294320|Imiquimod|imiquimod|mesh-list
154503928|NCT00294320|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154503929|NCT00294320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503930|NCT00294320|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154503931|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
154503932|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503933|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154503934|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503935|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
154503936|NCT03526575|Zaleplon|zaleplon|mesh-list
154503937|NCT03526575|Zolpidem|zolpidem|mesh-list
154503938|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154503939|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154503940|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503941|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503942|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154503943|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
154503944|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
154503945|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154503946|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503947|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
154503948|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
154503950|NCT00189254|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154503951|NCT00189254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503952|NCT00189254|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154503953|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
154503954|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503955|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154503956|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503957|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
154503958|NCT03526419|Bupivacaine|bupivacaine|mesh-list
154503959|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
154503960|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
154503961|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154503962|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503963|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
154503964|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503965|NCT03192644|Leucovorin|leucovorin|mesh-list
154503966|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
154503967|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
154503968|NCT03192644|Epirubicin|epirubicin|mesh-list
154503969|NCT03192644|Calcium|calcium|mesh-list
154503970|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
154503971|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154503972|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154503973|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503974|NCT03192644|Antidotes|antidotes|mesh-ancestor
154503975|NCT03192644|Protective Agents|protective agents|mesh-ancestor
154503976|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
154503977|NCT03192644|Vitamins|vitamins|mesh-ancestor
154503978|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
154503979|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154503980|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154503981|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154503982|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154503983|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154503984|NCT03110055|Grazoprevir|grazoprevir|mesh-list
154503985|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154503986|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
154503987|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154503988|NCT01190852|Fluticasone|fluticasone|mesh-list
154503989|NCT01190852|Azelastine|azelastine|mesh-list
154503990|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154503991|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154503992|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
154503993|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154503994|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154503995|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154503996|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
154503997|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154503998|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154503999|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154504000|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504001|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504002|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154504003|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154504004|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
154504005|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
154504006|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504007|NCT02710214|Estrogens|estrogens|mesh-list
154504008|NCT02710214|Hormones|hormones|mesh-ancestor
154504009|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504010|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504011|NCT05561205|Methylphenidate|methylphenidate|mesh-list
154504012|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154504013|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504014|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154504015|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154504016|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227892|NCT01107808|Vitamin D|vitamin d|mesh-list
154504017|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504018|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
154504019|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504020|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
154338921|NCT01233583|Adalimumab|adalimumab|mesh-list
154504021|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154504022|NCT03052517|Growth Substances|growth substances|mesh-ancestor
154504023|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504024|NCT02443844|Tamsulosin|tamsulosin|mesh-list
154504025|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154504026|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154504027|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154504028|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
154504029|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504030|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504031|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504032|NCT02443844|Urological Agents|urological agents|mesh-ancestor
154504033|NCT02440100|Midazolam|midazolam|mesh-list
154504034|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154504035|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154504036|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504037|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504038|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154504039|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154504040|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504041|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154504042|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
154504043|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
154504044|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
154504045|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
154504046|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504047|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504048|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
154504049|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
154504050|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504051|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
154504052|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504053|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504054|NCT02439944|Nicotine|nicotine|mesh-list
154504055|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154504056|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
154504057|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504058|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504059|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154504060|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154504061|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
154504062|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504063|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504064|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
154504065|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504066|NCT03190616|Apatinib|apatinib|mesh-list
154504067|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504068|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154504069|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504070|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504071|NCT02443922|Metformin|metformin|mesh-list
154504072|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154504073|NCT02443922|Glimepiride|glimepiride|mesh-list
154504074|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154504075|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504076|NCT02443922|Incretins|incretins|mesh-ancestor
154504077|NCT02443922|Hormones|hormones|mesh-ancestor
154504078|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504079|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154504080|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
154504081|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504082|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504083|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154504084|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154504085|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
154504086|NCT04799847|Catumaxomab|catumaxomab|mesh-list
154504087|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504088|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
154504089|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154504090|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154504091|NCT02439866|Prednisolone|prednisolone|mesh-list
154504092|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
154504093|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154504094|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
154504095|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504096|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
154504098|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504099|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504100|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504101|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
154504102|NCT02439866|Hormones|hormones|mesh-ancestor
154273300|NCT05731804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154504103|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504104|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154504105|NCT02439866|Protective Agents|protective agents|mesh-ancestor
154504106|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504107|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504108|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
154504109|NCT02439788|Fludarabine|fludarabine|mesh-list
154504110|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154504111|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
154504112|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504113|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504114|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154504115|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
154504116|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504117|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504118|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154504119|NCT03188198|Prednisone|prednisone|mesh-list
154504120|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
154504121|NCT03188198|Rituximab|rituximab|mesh-list
154504122|NCT03188198|Doxorubicin|doxorubicin|mesh-list
154504123|NCT03188198|Etoposide|etoposide|mesh-list
154504124|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
154504125|NCT03188198|Vincristine|vincristine|mesh-list
154504126|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154504127|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
154504128|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504129|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504130|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154504131|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
154504132|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504133|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504134|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154504135|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154504136|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154504137|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154504138|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154504139|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504140|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504141|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
154504142|NCT03188198|Hormones|hormones|mesh-ancestor
154504143|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504144|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504145|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154504146|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
154504147|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
154504148|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
154504149|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
154504150|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154504151|NCT03188276|Ledipasvir|ledipasvir|mesh-list
154504152|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
154504153|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504154|NCT03190304|Enalapril|enalapril|mesh-list
154504155|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154504156|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154504157|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
154504158|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504159|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154504160|NCT02439632|Levofloxacin|levofloxacin|mesh-list
154504161|NCT02439632|Ofloxacin|ofloxacin|mesh-list
154504162|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
154504163|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
154504164|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154504165|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504166|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154504167|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154504168|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154504169|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504170|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504171|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504172|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154504173|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154504174|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154504176|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154504177|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504178|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
154504179|NCT02741271|Prednisone|prednisone|mesh-list
154504180|NCT02741271|Prednisolone|prednisolone|mesh-list
154504181|NCT02741271|Albuterol|albuterol|mesh-list
154504182|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504183|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
154504184|NCT02741271|Hormones|hormones|mesh-ancestor
154504185|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504186|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504187|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504188|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504189|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
154504190|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504191|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154504192|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154504193|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
154504194|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
154504195|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154504196|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154504197|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154504198|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154504199|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
154504200|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504201|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504202|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
154504203|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154504204|NCT02443142|Acetaminophen|acetaminophen|mesh-list
154504205|NCT02443142|Ibuprofen|ibuprofen|mesh-list
154504206|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154504207|NCT02443142|Analgesics|analgesics|mesh-ancestor
154504208|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
154504209|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504210|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504211|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
154504212|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154504213|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504214|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504215|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154504216|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504217|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504218|NCT03524079|Ajmaline|ajmaline|mesh-list
154504219|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154504220|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154504221|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154273412|NCT01131234|Cediranib|cediranib|mesh-list
154504222|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154504223|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504224|NCT02438852|Ropivacaine|ropivacaine|mesh-list
154504225|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
154504226|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
154504227|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504228|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504229|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
154504230|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504231|NCT02442674|Tolvaptan|tolvaptan|mesh-list
154504232|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154504233|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504234|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
154504235|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504236|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
154504237|NCT02442752|Lansoprazole|lansoprazole|mesh-list
154504238|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154504239|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504240|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154228123|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
154504241|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504242|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504244|NCT02442362|Fluorouracil|fluorouracil|mesh-list
154504245|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
154504246|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154504247|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504248|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
154504249|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
154504250|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
154504251|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504252|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
154504253|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154504254|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154504255|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
154504256|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504257|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
154504258|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154504259|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504260|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504261|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154504262|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154504263|NCT02433860|Nicotine|nicotine|mesh-list
154504264|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154504265|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
154504266|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504267|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504268|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154504269|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154504270|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
154504271|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504272|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504273|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
154504274|NCT03523455|Hematinics|hematinics|mesh-ancestor
154504275|NCT03189836|Rituximab|rituximab|mesh-list
154504276|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154504277|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504278|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
154504279|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504280|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504281|NCT04466943|Rocuronium|rocuronium|mesh-list
154504282|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154504283|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154504284|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154504285|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504286|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504287|NCT02442440|Anisodamine|anisodamine|mesh-list
154504288|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154504289|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154504290|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
154504291|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504292|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504293|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504294|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154504295|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154504296|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154504297|NCT02442440|Analgesics|analgesics|mesh-ancestor
154504298|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
154504299|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504300|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504301|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504302|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154504303|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504304|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
154504305|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
154504306|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
154504307|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154504308|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
154273521|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273522|NCT05415748|Urological Agents|urological agents|mesh-ancestor
154273523|NCT03774576|Itraconazole|itraconazole|mesh-list
154273524|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
154273525|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273526|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154273527|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154273528|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273529|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504309|NCT02442440|Protective Agents|protective agents|mesh-ancestor
154504310|NCT03187496|Midazolam|midazolam|mesh-list
154504311|NCT03187496|Caffeine|caffeine|mesh-list
154504312|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154504313|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154504314|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154504315|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504316|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504317|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154504318|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154504319|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504320|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154504322|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
154504323|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
154504324|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
154504325|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504326|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504327|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154504328|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154504329|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
154504330|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154504331|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154504332|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504333|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154504334|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154504335|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154504336|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154504337|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
154504338|NCT02438072|Fexofenadine|fexofenadine|mesh-list
154504339|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
154504340|NCT02438072|Midazolam|midazolam|mesh-list
154504341|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
154504342|NCT02438072|Caffeine|caffeine|mesh-list
154504343|NCT02438072|Bupropion|bupropion|mesh-list
154504344|NCT02438072|Omeprazole|omeprazole|mesh-list
154504345|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154504346|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154504347|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504348|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504349|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154504350|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154504351|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504352|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154504353|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
154504354|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
154504355|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
154504356|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
154504357|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504358|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504359|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154504360|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154504361|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504362|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154504363|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154504364|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
154504365|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154504366|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504367|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154504368|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154504369|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
154504370|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154504371|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154504372|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154504373|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
154273552|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
154504374|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154504375|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154504376|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
154504377|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
154504378|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154504379|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154504380|NCT02438072|Analgesics|analgesics|mesh-ancestor
154504381|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
154504382|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504383|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154504384|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154504385|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504386|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504387|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154504388|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154504389|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154504390|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154504391|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
154504392|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
154504393|NCT03522987|Escitalopram|escitalopram|mesh-list
154504394|NCT03522987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154504395|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154504396|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154504397|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504398|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504399|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
154504400|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504401|NCT02433626|Cisplatin|cisplatin|mesh-list
154504402|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504403|NCT02442128|Fentanyl|fentanyl|mesh-list
154504404|NCT02442128|Propofol|propofol|mesh-list
154504405|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154504406|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504407|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504408|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154504409|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
154504410|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
154504411|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154504412|NCT02442128|Narcotics|narcotics|mesh-ancestor
154504413|NCT02442128|Analgesics|analgesics|mesh-ancestor
154504414|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
154504415|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504416|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154504417|NCT04465773|Remifentanil|remifentanil|mesh-list
154504418|NCT04465773|Propofol|propofol|mesh-list
154504419|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
154504420|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504421|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504422|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154504423|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154504424|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
154504425|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154504426|NCT04465773|Narcotics|narcotics|mesh-ancestor
154504427|NCT04465773|Analgesics|analgesics|mesh-ancestor
154504428|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
154504429|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504430|NCT02709746|Vortioxetine|vortioxetine|mesh-list
154504431|NCT02709746|Fluoxetine|fluoxetine|mesh-list
154504432|NCT02709746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154504433|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154504434|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154504435|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504436|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504437|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
154504438|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504439|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154504440|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
154504441|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504442|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154504443|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154504444|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504445|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154504446|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154504447|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504448|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154504449|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154504450|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154504451|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154504452|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
154504453|NCT02441894|Promethazine|promethazine|mesh-list
154504454|NCT02441894|Dexamethasone|dexamethasone|mesh-list
154504455|NCT02441894|Prednisolone|prednisolone|mesh-list
154504456|NCT02441894|Ondansetron|ondansetron|mesh-list
154504457|NCT02441894|Metoclopramide|metoclopramide|mesh-list
154504458|NCT02441894|Granisetron|granisetron|mesh-list
154504459|NCT02441894|Ranitidine|ranitidine|mesh-list
154504460|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154504461|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504462|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
154504463|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
154504464|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504465|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504466|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504467|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
154504468|NCT02441894|Hormones|hormones|mesh-ancestor
154504469|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504470|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504471|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504472|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
154504473|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
154504474|NCT02441894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154504475|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154504476|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
154504477|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504478|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273668|NCT01130376|Aldesleukin|aldesleukin|mesh-list
154504479|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154504480|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154504481|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504482|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
154504483|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
154504484|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
154504485|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154504486|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
154504487|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
154504488|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154504489|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154504490|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154504491|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
154504492|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154504493|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154504494|NCT02433704|Cefazolin|cefazolin|mesh-list
154504495|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154504496|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504497|NCT05453825|Paclitaxel|paclitaxel|mesh-list
154504498|NCT05453825|Irinotecan|irinotecan|mesh-list
154504499|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154504500|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504501|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154504502|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154504503|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154504504|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504505|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154504506|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154504507|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504508|NCT02441816|Aflibercept|aflibercept|mesh-list
154504509|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154504510|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154504511|NCT02441816|Growth Substances|growth substances|mesh-ancestor
154504512|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504513|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
154504514|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504515|NCT02433314|Brexanolone|brexanolone|mesh-list
154504516|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
154504517|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504518|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504519|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504520|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
154504521|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
154504522|NCT02290431|Dexamethasone|dexamethasone|mesh-list
154504523|NCT02290431|Bortezomib|bortezomib|mesh-list
154504524|NCT02290431|Panobinostat|panobinostat|mesh-list
154504525|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504526|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
154504527|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
154504528|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504529|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504530|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504531|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
154504532|NCT02290431|Hormones|hormones|mesh-ancestor
154504533|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504534|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504535|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504536|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154504537|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504538|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504539|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
154504540|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154504541|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
154504542|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504543|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504544|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154504545|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
154860215|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
154504546|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504547|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504548|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154504550|NCT02436980|Tramadol|tramadol|mesh-list
154504551|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154504552|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154504553|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504554|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504555|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154504556|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154504557|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504558|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154504559|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
154504560|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
154504561|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
154504562|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
154504563|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504564|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504565|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154504566|NCT02436980|Narcotics|narcotics|mesh-ancestor
154504567|NCT02436980|Analgesics|analgesics|mesh-ancestor
154504568|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
154504569|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504570|NCT02436902|Sorafenib|sorafenib|mesh-list
154504571|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
154504572|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504573|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154504574|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504575|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504576|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154504577|NCT02436902|Estrogens|estrogens|mesh-ancestor
154504578|NCT02436902|Hormones|hormones|mesh-ancestor
154504579|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273764|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
154504580|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504581|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504582|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
154504583|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154504584|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
154504585|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504586|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504587|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154504588|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
154504589|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154504590|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
154504591|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504592|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504593|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154504594|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
154504595|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
154504596|NCT02436512|Protective Agents|protective agents|mesh-ancestor
154504597|NCT04466241|Ritonavir|ritonavir|mesh-list
154504598|NCT04466241|Lopinavir|lopinavir|mesh-list
154504599|NCT04466241|Telmisartan|telmisartan|mesh-list
154504600|NCT04466241|Atorvastatin|atorvastatin|mesh-list
154504601|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154504602|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154504603|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
154504604|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504605|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154504606|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154504607|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504608|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154504609|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154504610|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
154504611|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154504612|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154504613|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
154504614|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504615|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154504616|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154504617|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154504618|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154504619|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154504620|NCT02440880|Dexamethasone|dexamethasone|mesh-list
154504621|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
154504622|NCT02440880|BB 1101|bb 1101|mesh-list
154504623|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504624|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
154504625|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
154504626|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504627|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504628|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504629|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
154504630|NCT02440880|Hormones|hormones|mesh-ancestor
154273819|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154504631|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504632|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504633|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504634|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
154504635|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504636|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504637|NCT03186482|Rifampin|rifampin|mesh-list
154504638|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154504639|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154504640|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
154504641|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154504642|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504643|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
154504644|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154504645|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504646|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504647|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154504648|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154504649|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154504650|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154504651|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154504652|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154504653|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
154504654|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154504655|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154504656|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154504657|NCT03522207|Trazodone|trazodone|mesh-list
154504658|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154504659|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154504660|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504661|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504662|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504663|NCT03522207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154504664|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154504665|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154504666|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504667|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504668|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
154504669|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154504670|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
154504671|NCT03528057|Hemostatics|hemostatics|mesh-list
154504672|NCT03528057|Coagulants|coagulants|mesh-ancestor
154504673|NCT02707952|Ritonavir|ritonavir|mesh-list
154504674|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154504675|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154504676|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
154504677|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504678|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504679|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154504680|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154504681|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
154504682|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504683|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154504684|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154504685|NCT02291211|Cisplatin|cisplatin|mesh-list
154504686|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504687|NCT05392101|Deferasirox|deferasirox|mesh-list
154504688|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154504689|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
154504690|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
154504691|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504692|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154273869|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504693|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154504694|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154504695|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154504696|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504697|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504698|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504699|NCT02291367|Analgesics|analgesics|mesh-ancestor
154504700|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
154504701|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504702|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
154504703|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504704|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
154504705|NCT02440958|Folfirinox|folfirinox|mesh-list
154504706|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504707|NCT02432534|Atorvastatin|atorvastatin|mesh-list
154504708|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154504709|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154504710|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
154504711|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504712|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154504713|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154504714|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504715|NCT02432612|Nabiximols|nabiximols|mesh-list
154504716|NCT02432612|Analgesics|analgesics|mesh-ancestor
154504717|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
154504718|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504719|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504720|NCT05705843|Vancomycin|vancomycin|mesh-list
154504721|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154504722|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504723|NCT02436044|Leucovorin|leucovorin|mesh-list
154504724|NCT02436044|Fluorouracil|fluorouracil|mesh-list
154504725|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
154504726|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
154504727|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
154504728|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504729|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154504730|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504731|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154504732|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
154504733|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504734|NCT02436044|Antidotes|antidotes|mesh-ancestor
154504735|NCT02436044|Protective Agents|protective agents|mesh-ancestor
154504736|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
154504737|NCT02436044|Vitamins|vitamins|mesh-ancestor
154504738|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
154504739|NCT02435732|Heparin|heparin|mesh-list
154504740|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
154504741|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154504742|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154504743|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504744|NCT02435654|Olanzapine|olanzapine|mesh-list
154504745|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
154504746|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
154504747|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504748|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504749|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504750|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154504751|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154504752|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504753|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504754|NCT02435654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154504755|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154504756|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154504757|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504758|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504759|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
154504760|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
154504761|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154504762|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154504763|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
154504764|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504765|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504766|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504768|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154504769|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504770|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154504771|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154504772|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504773|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154504774|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504775|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504776|NCT02435186|Paclitaxel|paclitaxel|mesh-list
154504777|NCT02435186|Cisplatin|cisplatin|mesh-list
154504778|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154504779|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504780|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154504781|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154504782|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154504783|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504784|NCT02435108|Crizotinib|crizotinib|mesh-list
154504785|NCT02435108|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154504786|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154504787|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504788|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504789|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504790|NCT02434952|Primaquine|primaquine|mesh-list
154504791|NCT02434952|Piperaquine|piperaquine|mesh-list
154504792|NCT02434952|Artenimol|artenimol|mesh-list
154504793|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
154504794|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154504795|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154504796|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504797|NCT03626753|Acetaminophen|acetaminophen|mesh-list
154504798|NCT03626753|Piroxicam|piroxicam|mesh-list
154504799|NCT03626753|Nefopam|nefopam|mesh-list
154504800|NCT03626753|Proroxan|proroxan|mesh-list
154504801|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154504802|NCT03626753|Analgesics|analgesics|mesh-ancestor
154504803|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
154504804|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504805|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504806|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
154504807|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154504808|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504809|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504810|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154504811|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504812|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504813|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154504814|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154504815|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
154504816|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504817|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154504818|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
154504819|NCT02440256|Narcotics|narcotics|mesh-ancestor
154504820|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504821|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504822|NCT02440256|Analgesics|analgesics|mesh-ancestor
154504823|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
154504824|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504825|NCT03185624|Rifaximin|rifaximin|mesh-list
154504826|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274001|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
154504827|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504828|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504829|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
154504830|NCT02707640|Pirfenidone|pirfenidone|mesh-list
154504831|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154504832|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
154504833|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504834|NCT02707640|Expectorants|expectorants|mesh-ancestor
154504835|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
154504836|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154504837|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
154504838|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504839|NCT02707640|Protective Agents|protective agents|mesh-ancestor
154504840|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504841|NCT02707640|Antidotes|antidotes|mesh-ancestor
154504842|NCT02707640|Analgesics|analgesics|mesh-ancestor
154504843|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
154504844|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504845|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154504846|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154504847|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504848|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154504849|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504850|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
154504851|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154504852|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504853|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154504854|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504855|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
154504856|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154504857|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154504858|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154504859|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
154504860|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504861|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504862|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504863|NCT03188978|Atorvastatin|atorvastatin|mesh-list
154504864|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154504865|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154504866|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
154504867|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504868|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154504869|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154504870|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154504871|NCT02431286|Dexamethasone|dexamethasone|mesh-list
154504872|NCT02431286|Aprepitant|aprepitant|mesh-list
154504873|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504874|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
154504875|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
154504876|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504877|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504878|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504879|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
154504880|NCT02431286|Hormones|hormones|mesh-ancestor
154504881|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504882|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504883|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504884|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154504885|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504886|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504887|NCT02431208|Dexamethasone|dexamethasone|mesh-list
154504888|NCT02431208|Lenalidomide|lenalidomide|mesh-list
154504889|NCT02431208|Atezolizumab|atezolizumab|mesh-list
154504890|NCT02431208|Daratumumab|daratumumab|mesh-list
154504891|NCT02431208|Pomalidomide|pomalidomide|mesh-list
154504892|NCT02431208|Antibodies|antibodies|mesh-list
154504893|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154504894|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
154504895|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504896|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504897|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
154504898|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
154504899|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504900|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504901|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
154504902|NCT02431208|Hormones|hormones|mesh-ancestor
154504903|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504904|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154504905|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504906|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154504907|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154504908|NCT02431208|Growth Substances|growth substances|mesh-ancestor
154504909|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
154504910|NCT02431208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154504911|NCT02431208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504912|NCT02431208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154504913|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
154504914|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
154274119|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154274120|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274121|NCT05308212|Vaccines|vaccines|mesh-list
154274122|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
154274123|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274124|NCT01138488|Insulin|insulin|mesh-list
154274125|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
154274126|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154274127|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504915|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154504916|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
154504917|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
154228795|NCT01217398|Temozolomide|temozolomide|mesh-list
154504918|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504919|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504920|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154504921|NCT03107078|Hormones|hormones|mesh-ancestor
154504922|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154504923|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154504924|NCT03107078|Protective Agents|protective agents|mesh-ancestor
154504925|NCT02430350|Edaravone|edaravone|mesh-list
154504926|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154504927|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
154504928|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504929|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154504930|NCT02430350|Protective Agents|protective agents|mesh-ancestor
154504931|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504932|NCT02429960|Remifentanil|remifentanil|mesh-list
154504933|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154504934|NCT02429960|Narcotics|narcotics|mesh-ancestor
154504935|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504936|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504937|NCT02429960|Analgesics|analgesics|mesh-ancestor
154504938|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
154504939|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504940|NCT02429804|Listerine|listerine|mesh-list
154504941|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
154504942|NCT02429804|Fluorides|fluorides|mesh-list
154504943|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
154504944|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154504945|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
154504946|NCT02429804|Protective Agents|protective agents|mesh-ancestor
154504947|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504948|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154504949|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504950|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154504951|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504952|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
154504953|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
154504954|NCT03185156|Propofol|propofol|mesh-list
154504955|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154504956|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504957|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504958|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154504959|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
154504960|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
154504961|NCT02429726|Cisplatin|cisplatin|mesh-list
154504962|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504963|NCT02429882|Brodalumab|brodalumab|mesh-list
154504964|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
154504965|NCT02430896|Methylphenidate|methylphenidate|mesh-list
154504966|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154504967|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154504968|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504969|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154504970|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154504971|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154504972|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154504973|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
154504974|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154504975|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154504976|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
154504977|NCT03184844|Thalidomide|thalidomide|mesh-list
154504978|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154504979|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
154504980|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504981|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
154504982|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154504983|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154504984|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154504985|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154504986|NCT03184844|Growth Substances|growth substances|mesh-ancestor
154504987|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
154504988|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154504989|NCT02425202|Ketamine|ketamine|mesh-list
154504990|NCT02425202|Analgesics|analgesics|mesh-ancestor
154504991|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
154504992|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154504993|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154504994|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154504995|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154504996|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
154504997|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
154504998|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154504999|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154505000|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154505001|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505002|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505003|NCT03182504|Meropenem|meropenem|mesh-list
154505004|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154505005|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505006|NCT02428946|Bromocriptine|bromocriptine|mesh-list
154505007|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154505008|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154505009|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
154505010|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505011|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505012|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
154505013|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
154505014|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505015|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505016|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
154505017|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154505018|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154505019|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505020|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
154505021|NCT02428868|Coagulants|coagulants|mesh-ancestor
154505022|NCT03181880|Bromides|bromides|mesh-list
154505023|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
154505024|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154505025|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
154505026|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505027|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505028|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154505029|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
154505030|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154505031|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154505032|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154505033|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
154505034|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505035|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505036|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
154505037|NCT03178994|Ketoconazole|ketoconazole|mesh-list
154505038|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
154505039|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505040|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154505041|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154505042|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505043|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505044|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154505045|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
154505046|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505047|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505048|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154505049|NCT03182114|Bupivacaine|bupivacaine|mesh-list
154505050|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
154505051|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
154505052|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505053|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505054|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
154505055|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505056|NCT02428322|Vitamin D|vitamin d|mesh-list
154505057|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
154505058|NCT02428322|Vitamins|vitamins|mesh-ancestor
154505059|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
154505060|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505061|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154505062|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154505063|NCT03053063|Selonsertib|selonsertib|mesh-list
154505064|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154505065|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505066|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505067|NCT00702338|Hormones|hormones|mesh-list
154505068|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154505069|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505070|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505072|NCT02427932|Ampicillin|ampicillin|mesh-list
154505073|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154505074|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505075|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154505076|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505077|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505078|NCT03626519|Menthol|menthol|mesh-list
154505079|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
154505080|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
154505081|NCT03184766|Ibuprofen|ibuprofen|mesh-list
154505082|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
154505083|NCT03184766|Ephedrine|ephedrine|mesh-list
154505084|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154505085|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154505086|NCT03184766|Analgesics|analgesics|mesh-ancestor
154505087|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
154505088|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505089|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505090|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505091|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505092|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154505093|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505094|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505095|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154505096|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
154505097|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154505098|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
154505099|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
154505100|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154505101|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154505102|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
154505103|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
154505104|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505105|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154505106|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
154505107|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154505108|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154505109|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154505110|NCT02420834|Laxatives|laxatives|mesh-ancestor
154505111|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505112|NCT02423954|Sirolimus|sirolimus|mesh-list
154505113|NCT02423954|Capecitabine|capecitabine|mesh-list
154505114|NCT02423954|Nivolumab|nivolumab|mesh-list
154505115|NCT02423954|Irinotecan|irinotecan|mesh-list
154505116|NCT02423954|Temsirolimus|temsirolimus|mesh-list
154505117|NCT02423954|MTOR Inhibitors|mtor inhibitors|mesh-list
154505118|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154505119|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
154505120|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505121|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505122|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154505123|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154505124|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154505125|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154505126|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505127|NCT02423954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154505128|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154505129|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
154505130|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505131|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154505132|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274326|NCT03917394|Iron|iron|mesh-list
154505133|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154505134|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
154505135|NCT02427308|Miltefosine|miltefosine|mesh-list
154505136|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
154505137|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505138|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505139|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154505140|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154505141|NCT03178292|Levofloxacin|levofloxacin|mesh-list
154505142|NCT03178292|Ofloxacin|ofloxacin|mesh-list
154505143|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154505144|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505145|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154505146|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154505147|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154505148|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505149|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505150|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505151|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154505152|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154505153|NCT02427386|Estradiol|estradiol|mesh-list
154505154|NCT02427386|Estrogens|estrogens|mesh-list
154505155|NCT02427386|Hormones|hormones|mesh-ancestor
154505156|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505157|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505158|NCT03181178|Micronutrients|micronutrients|mesh-list
154505159|NCT03181178|Trace Elements|trace elements|mesh-list
154505160|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505161|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
154505162|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154505163|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154505164|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154505165|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505166|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
154505167|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505168|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505169|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
154505170|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
154505171|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505172|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154505173|NCT03180944|Lugol's solution|lugol's solution|mesh-list
154505174|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154505175|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
154505176|NCT03180944|Coagulants|coagulants|mesh-ancestor
154505177|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
154505178|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154505179|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505180|NCT04322669|Pidotimod|pidotimod|mesh-list
154505181|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154505182|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
154505183|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505184|NCT03180476|Apatinib|apatinib|mesh-list
154505185|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505186|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154505187|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505188|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505189|NCT03180632|Lorazepam|lorazepam|mesh-list
154505190|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
154505191|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
154505192|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
154505193|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505194|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505195|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505196|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154505197|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505198|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154505199|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154505200|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154505201|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
154505202|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
154505203|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505204|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505205|NCT02420132|Ranibizumab|ranibizumab|mesh-list
154505206|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154505207|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154505208|NCT02420132|Growth Substances|growth substances|mesh-ancestor
154505209|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505210|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
154505211|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505212|NCT03183752|Metformin|metformin|mesh-list
154505213|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154505214|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505215|NCT04287179|Semaglutide|semaglutide|mesh-list
154505216|NCT04287179|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154505217|NCT04287179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154505218|NCT04287179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505219|NCT03183674|Oxytocin|oxytocin|mesh-list
154505220|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
154505221|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154505222|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505223|NCT03117530|Minocycline|minocycline|mesh-list
154505224|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154505225|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505226|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
154505227|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154505228|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
154505229|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505230|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
154505231|NCT03889925|Protective Agents|protective agents|mesh-ancestor
154505232|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154505234|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154505235|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154505236|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
154505237|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505238|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154505239|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505240|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154505241|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505242|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
154505243|NCT02426840|Vitamin D|vitamin d|mesh-list
154505244|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
154505245|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
154505246|NCT02426840|Vitamins|vitamins|mesh-list
154505247|NCT02426840|Calcium|calcium|mesh-list
154505248|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
154505249|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505250|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154505251|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154505252|NCT03178526|Lovastatin|lovastatin|mesh-list
154505253|NCT03178526|L 647318|l 647318|mesh-list
154505254|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
154505255|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154505256|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154505257|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
154505258|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505259|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154505260|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154505261|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505262|NCT02423642|Heparin|heparin|mesh-list
154505263|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
154505264|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505265|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154505266|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154505267|NCT03180242|Trastuzumab|trastuzumab|mesh-list
154505268|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154505269|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505270|NCT00709904|Semuloparin|semuloparin|mesh-list
154505271|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154505272|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154505273|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154505274|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505275|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
154505276|NCT03183596|Dexamethasone|dexamethasone|mesh-list
154505277|NCT03183596|Bupivacaine|bupivacaine|mesh-list
154505278|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505279|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
154505280|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
154505281|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505282|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505283|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505284|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
154505285|NCT03183596|Hormones|hormones|mesh-ancestor
154505286|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505287|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154505288|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505289|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
154505290|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
154505291|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505292|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
154505293|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
154505294|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505295|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
154505296|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
154505297|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
154505298|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
154505299|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
154505300|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154505301|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154505302|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505303|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505304|NCT04325243|Urological Agents|urological agents|mesh-ancestor
154505305|NCT02419820|Aspirin|aspirin|mesh-list
154505306|NCT02419820|Clopidogrel|clopidogrel|mesh-list
154505307|NCT02419820|APD791|apd791|mesh-list
154505308|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154505309|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154505310|NCT02419820|Analgesics|analgesics|mesh-ancestor
154505311|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
154505312|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505313|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505314|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505315|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505316|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154505317|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154505318|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505319|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154505320|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154505321|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505322|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
154505323|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154505324|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154505325|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154505326|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
154505327|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505328|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154505329|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154505330|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
154505331|NCT02419352|Atropine|atropine|mesh-list
154505332|NCT02419352|Neostigmine|neostigmine|mesh-list
154505333|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154505334|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154505335|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154505336|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
154505337|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505338|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505339|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154505340|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
154505341|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
154505342|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
154505343|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154505344|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154505345|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
154505346|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505347|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505348|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154505349|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505350|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154505351|NCT03365687|Vitamin D|vitamin d|mesh-list
154505352|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
154505353|NCT03365687|Vitamins|vitamins|mesh-ancestor
154505354|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
154505355|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505356|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154505357|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154505358|NCT02419118|Dexamethasone|dexamethasone|mesh-list
154505359|NCT02419118|Lenalidomide|lenalidomide|mesh-list
154505360|NCT02419118|Daratumumab|daratumumab|mesh-list
154505361|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505362|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
154505363|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
154505364|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505365|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505366|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505367|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
154505368|NCT02419118|Hormones|hormones|mesh-ancestor
154274545|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154505369|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505370|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154505371|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505372|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
154505373|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154505374|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154505375|NCT02419118|Growth Substances|growth substances|mesh-ancestor
154505376|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154505377|NCT02426294|Pioglitazone|pioglitazone|mesh-list
154505378|NCT02426294|Glimepiride|glimepiride|mesh-list
154505379|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154505380|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505381|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154505382|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154505383|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
154505384|NCT02426450|Leucovorin|leucovorin|mesh-list
154505385|NCT02426450|Fluorouracil|fluorouracil|mesh-list
154505386|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
154505387|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
154505388|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505389|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154505390|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505391|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154505392|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
154505393|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505394|NCT02426450|Antidotes|antidotes|mesh-ancestor
154505395|NCT02426450|Protective Agents|protective agents|mesh-ancestor
154505396|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
154505397|NCT02426450|Vitamins|vitamins|mesh-ancestor
154505398|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
154505399|NCT02426060|Warfarin|warfarin|mesh-list
154505400|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
154505401|NCT02422784|Vitamin D|vitamin d|mesh-list
154505402|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
154505403|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
154505404|NCT02422784|Vitamins|vitamins|mesh-list
154505405|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
154505406|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505407|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154505408|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154505409|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
154505410|NCT03740009|Estrogens|estrogens|mesh-list
154505411|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154505412|NCT03740009|Hormones|hormones|mesh-ancestor
154505413|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505414|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505415|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154505416|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154505417|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
154505418|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154505419|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
154505420|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154505421|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
154505422|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
154505423|NCT03182894|Azacitidine|azacitidine|mesh-list
154505424|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154505425|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505426|NCT03182894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154505427|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505428|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154505429|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
154505430|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505431|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154505432|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154505433|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154274606|NCT03389724|Captopril|captopril|mesh-list
154505434|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
154505435|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505436|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154505437|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154505438|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505439|NCT02423096|Haloperidol|haloperidol|mesh-list
154505440|NCT02423096|Olanzapine|olanzapine|mesh-list
154505441|NCT02423096|Risperidone|risperidone|mesh-list
154505442|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154505443|NCT02423096|Sulpiride|sulpiride|mesh-list
154505444|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154505445|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
154505446|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505447|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505448|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505449|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154505450|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154505451|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860216|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505452|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154505453|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154505454|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
154505455|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
154505456|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
154505457|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505458|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505459|NCT02423096|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154505460|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154505461|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154505462|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
154505463|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154505464|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154505465|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
154505466|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154505467|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505468|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505469|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154505470|NCT02423018|Pregabalin|pregabalin|mesh-list
154505471|NCT02423018|Analgesics|analgesics|mesh-ancestor
154505472|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
154505473|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505474|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505475|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
154505476|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154505477|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154505478|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505479|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154505480|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154505481|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154505482|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505483|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154505484|NCT05691959|Calcium|calcium|mesh-list
154505485|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154505486|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505487|NCT02422706|Metronidazole|metronidazole|mesh-list
154505488|NCT02422706|Clarithromycin|clarithromycin|mesh-list
154505489|NCT02422706|Levofloxacin|levofloxacin|mesh-list
154505490|NCT02422706|Ofloxacin|ofloxacin|mesh-list
154505491|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
154505492|NCT02422706|Doxycycline|doxycycline|mesh-list
154505493|NCT02422706|Omeprazole|omeprazole|mesh-list
154274674|NCT05848505|Dexmedetomidine|dexmedetomidine|mesh-list
154505494|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505495|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154505496|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154505497|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154505498|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154505499|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505500|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154505501|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505502|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505503|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154505504|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154505505|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154505506|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154505507|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154505508|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154505509|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505510|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154505511|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
154505512|NCT03058757|Mitomycins|mitomycins|mesh-list
154505513|NCT03058757|Mitomycin|mitomycin|mesh-list
154505514|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154505515|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505516|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
154505517|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505518|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154505519|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505520|NCT03138889|Paclitaxel|paclitaxel|mesh-list
154505521|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154505522|NCT03138889|Carboplatin|carboplatin|mesh-list
154505523|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
154505524|NCT03138889|Pemetrexed|pemetrexed|mesh-list
154505525|NCT03138889|Atezolizumab|atezolizumab|mesh-list
154505526|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154505527|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505528|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
154505529|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
154505530|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
154505531|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505532|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154505533|NCT03138889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154505534|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505535|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154505536|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154505537|NCT01881763|Ketamine|ketamine|mesh-list
154505538|NCT01881763|Methohexital|methohexital|mesh-list
154505539|NCT01881763|Analgesics|analgesics|mesh-ancestor
154505540|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
154505541|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505542|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505543|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154505544|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154505545|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
154505546|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
154505547|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505548|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154505549|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154274730|NCT05846243|Vaccines|vaccines|mesh-list
154505550|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505551|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505552|NCT03669601|Gemcitabine|gemcitabine|mesh-list
154505553|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154505554|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
154505555|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505556|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505557|NCT02416388|Cytarabine|cytarabine|mesh-list
154505558|NCT02416388|Cyclosporine|cyclosporine|mesh-list
154505559|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
154505560|NCT02416388|Dexamethasone|dexamethasone|mesh-list
154505561|NCT02416388|Methotrexate|methotrexate|mesh-list
154505562|NCT02416388|Daunorubicin|daunorubicin|mesh-list
154505563|NCT02416388|Venetoclax|venetoclax|mesh-list
154505564|NCT02416388|Idarubicin|idarubicin|mesh-list
154505565|NCT02416388|Cyclosporins|cyclosporins|mesh-list
154505566|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505567|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
154505568|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
154505569|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505570|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505571|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505572|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
154505573|NCT02416388|Hormones|hormones|mesh-ancestor
154505574|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505575|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154505576|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505577|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154505578|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
154505579|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154505580|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154505581|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
154505582|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505583|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
154505584|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505585|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154505586|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154505587|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
154505588|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505589|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154505590|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
154505591|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505592|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
154505593|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154505594|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154505595|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154505596|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154505597|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154505598|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
154505599|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229469|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
154505600|NCT02886065|Lenalidomide|lenalidomide|mesh-list
154505601|NCT02886065|Poly ICLC|poly iclc|mesh-list
154505602|NCT02886065|Citarinostat|citarinostat|mesh-list
154505603|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
154505604|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505605|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154505606|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154505607|NCT02886065|Growth Substances|growth substances|mesh-ancestor
154505608|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
154505609|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505610|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
154505611|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154505612|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505613|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505614|NCT03392441|Insulin|insulin|mesh-list
154505615|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154505616|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505617|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
154505618|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505619|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
154505620|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154505621|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154505622|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505623|NCT03177824|Urological Agents|urological agents|mesh-ancestor
154505624|NCT02416232|Trametinib|trametinib|mesh-list
154505625|NCT02416232|Dabrafenib|dabrafenib|mesh-list
154505626|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505627|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154505628|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505629|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505630|NCT04482842|Warfarin|warfarin|mesh-list
154505631|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
154505632|NCT02415920|Oxytocin|oxytocin|mesh-list
154505633|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
154505634|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154505635|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505636|NCT03389243|Acetaminophen|acetaminophen|mesh-list
154505637|NCT03389243|Dipyrone|dipyrone|mesh-list
154505638|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154505639|NCT03389243|Analgesics|analgesics|mesh-ancestor
154505640|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
154505641|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505642|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505643|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
154505644|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154505645|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505646|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505647|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
154505648|NCT02421926|Dasatinib|dasatinib|mesh-list
154505649|NCT02421926|Nilotinib|nilotinib|mesh-list
154505650|NCT02421926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154505651|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154505652|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505653|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505654|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505655|NCT02410460|Lidocaine|lidocaine|mesh-list
154505656|NCT02410460|Clonidine|clonidine|mesh-list
154505657|NCT02410460|Midazolam|midazolam|mesh-list
154505658|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
154505659|NCT02410460|Scopolamine|scopolamine|mesh-list
154505660|NCT02410460|Ketamine|ketamine|mesh-list
154505661|NCT02410460|Ondansetron|ondansetron|mesh-list
154505662|NCT02410460|Metoclopramide|metoclopramide|mesh-list
154505663|NCT02410460|Bupivacaine|bupivacaine|mesh-list
154505664|NCT02410460|Propofol|propofol|mesh-list
154505665|NCT02410460|Sevoflurane|sevoflurane|mesh-list
154505666|NCT02410460|Desflurane|desflurane|mesh-list
154505667|NCT02410460|Famotidine|famotidine|mesh-list
154505668|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154505669|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
154505670|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
154505671|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505672|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505673|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
154505674|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505675|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154229548|NCT03927352|Adalimumab|adalimumab|mesh-list
154505676|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154505677|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154505678|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154505679|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274844|NCT05843617|Vitamins|vitamins|mesh-list
154505681|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154505682|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
154505683|NCT02410460|Analgesics|analgesics|mesh-ancestor
154505684|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154505685|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154505686|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154505687|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505688|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154505689|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154505690|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154505691|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154505692|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
154505693|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
154505694|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154505695|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154505696|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
154505697|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
154505698|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505699|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
154505700|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
154505701|NCT02410460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154505702|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154505703|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
154505704|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154505705|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
154505706|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154505707|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154505708|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154505709|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
154505710|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154505711|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154505712|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
154505713|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154505714|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154505715|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
154505716|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
154505717|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154505718|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154505719|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
154505720|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
154505721|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
154505722|NCT02410226|Anesthetics|anesthetics|mesh-list
154505723|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505724|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505725|NCT03116672|Diclofenac|diclofenac|mesh-list
154505726|NCT03116672|Ketorolac|ketorolac|mesh-list
154505727|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154505728|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154505729|NCT03116672|Analgesics|analgesics|mesh-ancestor
154505730|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
154505731|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505732|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505733|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505734|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505735|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154505736|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505737|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505738|NCT03174860|Diclofenac|diclofenac|mesh-list
154505739|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154505740|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154505741|NCT03174860|Analgesics|analgesics|mesh-ancestor
154505742|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
154505743|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505744|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505745|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505746|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505747|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154505748|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505749|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505750|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154505751|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154505752|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505753|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154505754|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505755|NCT02417090|Metformin|metformin|mesh-list
154505756|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154505757|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505758|NCT00703820|Cytarabine|cytarabine|mesh-list
154505759|NCT00703820|Etoposide|etoposide|mesh-list
154505760|NCT00703820|Daunorubicin|daunorubicin|mesh-list
154505761|NCT00703820|Clofarabine|clofarabine|mesh-list
154505762|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154505763|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505764|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154505765|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154505766|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505767|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505768|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154505769|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
154505770|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
154505771|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505772|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154505773|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
154505774|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505775|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154505776|NCT03177980|Clonidine|clonidine|mesh-list
154505777|NCT03177980|Fentanyl|fentanyl|mesh-list
154505778|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154505779|NCT03177980|Narcotics|narcotics|mesh-ancestor
154505780|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154505781|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505782|NCT03177980|Analgesics|analgesics|mesh-ancestor
154505783|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
154505784|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505785|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154505786|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154505787|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
154505788|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
154505789|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154505790|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
154505791|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
154505792|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154505793|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154505794|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154505795|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
154274969|NCT05823506|Tadalafil|tadalafil|mesh-list
154505796|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154505797|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505798|NCT03177434|Lactulose|lactulose|mesh-list
154505799|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505800|NCT02587325|Sirolimus|sirolimus|mesh-list
154505801|NCT02587325|Temsirolimus|temsirolimus|mesh-list
154505802|NCT02587325|MTOR Inhibitors|mtor inhibitors|mesh-list
154505803|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154505804|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505805|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154505806|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505807|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
154505808|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154505809|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
154505810|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505811|NCT02587325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154505812|NCT02587325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505813|NCT02587325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505814|NCT02414984|Golimumab|golimumab|mesh-list
154505815|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154505816|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505817|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154505818|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
154505819|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505820|NCT02415062|Donepezil|donepezil|mesh-list
154505821|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154505822|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505823|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505824|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
154505825|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229694|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505826|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505827|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
154505828|NCT02408978|Naproxen|naproxen|mesh-list
154505829|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154505830|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154505831|NCT02408978|Analgesics|analgesics|mesh-ancestor
154505832|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
154505833|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505834|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505835|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505836|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505837|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
154505838|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154505839|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505840|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505841|NCT02408744|Pirfenidone|pirfenidone|mesh-list
154505842|NCT02408744|Analgesics|analgesics|mesh-ancestor
154505843|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
154505844|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505845|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505846|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154505847|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154505848|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505849|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505850|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505851|NCT03174080|Fluorides|fluorides|mesh-list
154505852|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
154505853|NCT03174080|Protective Agents|protective agents|mesh-ancestor
154505854|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505855|NCT03116516|Amlodipine|amlodipine|mesh-list
154505856|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154505857|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154275027|NCT05805072|Antimetabolites|antimetabolites|mesh-ancestor
154505858|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154505859|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154505860|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505861|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154505862|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505863|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
154505864|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154505865|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154505866|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
154505867|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154505868|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154505869|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505870|NCT01564537|Dexamethasone|dexamethasone|mesh-list
154505871|NCT01564537|Lenalidomide|lenalidomide|mesh-list
154505872|NCT01564537|Ixazomib|ixazomib|mesh-list
154505873|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505874|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
154505875|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
154505876|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505877|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505878|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154505879|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
154505880|NCT01564537|Hormones|hormones|mesh-ancestor
154505881|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505882|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154505883|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505884|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
154505885|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154505886|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154505887|NCT01564537|Growth Substances|growth substances|mesh-ancestor
154505888|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
154505889|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
154505890|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505891|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505892|NCT03174236|Metronidazole|metronidazole|mesh-list
154505893|NCT03174236|Gentamicins|gentamicins|mesh-list
154505894|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
154505895|NCT03174236|Penicillins|penicillins|mesh-list
154505896|NCT03174236|Penicillin G|penicillin g|mesh-list
154505897|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154505898|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
154505899|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154505900|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154505901|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154505902|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154505903|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154505904|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505905|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505906|NCT03174236|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154505907|NCT03174236|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154505908|NCT03172052|Streptokinase|streptokinase|mesh-list
154505909|NCT03172052|Mesna|mesna|mesh-list
154505910|NCT03172052|Protective Agents|protective agents|mesh-ancestor
154505911|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505912|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154505913|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154505914|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505915|NCT02408354|Glycerol|glycerol|mesh-list
154505916|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154505917|NCT02408354|Protective Agents|protective agents|mesh-ancestor
154505918|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505919|NCT03176264|Bevacizumab|bevacizumab|mesh-list
154505920|NCT03176264|Spartalizumab|spartalizumab|mesh-list
154505921|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154505922|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505923|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154505924|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154505925|NCT03176264|Growth Substances|growth substances|mesh-ancestor
154505926|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505927|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
154505928|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154505929|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505930|NCT02406170|Paclitaxel|paclitaxel|mesh-list
154505931|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154505932|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505933|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
154505934|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
154505935|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
154505936|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505937|NCT02413658|Phenytoin|phenytoin|mesh-list
154505938|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
154505939|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154505940|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154505941|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154505942|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505943|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154505944|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154505945|NCT02406014|Diclofenac|diclofenac|mesh-list
154505946|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154505947|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154505948|NCT02406014|Analgesics|analgesics|mesh-ancestor
154505949|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
154505950|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154505951|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505952|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505953|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505954|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154505955|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505956|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505957|NCT02406092|Prednisone|prednisone|mesh-list
154505958|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
154505959|NCT02406092|Rituximab|rituximab|mesh-list
154505960|NCT02406092|Doxorubicin|doxorubicin|mesh-list
154505961|NCT02406092|Fludarabine|fludarabine|mesh-list
154505962|NCT02406092|Vincristine|vincristine|mesh-list
154505963|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154505964|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
154505965|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505966|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154505967|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154505968|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
154505969|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154505970|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505971|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154505972|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154505973|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154505974|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154505975|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154505976|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505978|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
154505979|NCT02406092|Hormones|hormones|mesh-ancestor
154505980|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505981|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154860218|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154505982|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154505983|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
154505984|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
154505985|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
154505986|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
154505987|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
154505988|NCT02405858|Prednisolone|prednisolone|mesh-list
154505989|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
154505990|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154505991|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
154505993|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154505994|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154505995|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154505996|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154505997|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154505998|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154505999|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506000|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
154506001|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154506002|NCT03171740|Midazolam|midazolam|mesh-list
154506003|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
154506004|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154506005|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154506006|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506007|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506008|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506009|NCT03171740|Analgesics|analgesics|mesh-ancestor
154506010|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
154506011|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506012|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154506013|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154506014|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154506015|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506016|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506017|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506018|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154506019|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154506020|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154506021|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154506022|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154506023|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
154506024|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
154506025|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
154506026|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
154506027|NCT03176186|Xenon|xenon|mesh-list
154506028|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154506029|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
154506030|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
154506031|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506032|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506033|NCT04482764|Valproic Acid|valproic acid|mesh-list
154506034|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
154506035|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506036|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506037|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
154506038|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506039|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506040|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
154506041|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154506042|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506043|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154506044|NCT02408042|Rituximab|rituximab|mesh-list
154506045|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
154506046|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154506047|NCT02408042|Carboplatin|carboplatin|mesh-list
154506048|NCT02408042|Etoposide|etoposide|mesh-list
154506049|NCT02408042|Ifosfamide|ifosfamide|mesh-list
154506050|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154506051|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506052|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
154506054|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506055|NCT02408042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154506056|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506057|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154506058|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154506059|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154506060|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506061|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154506062|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
154506063|NCT02408042|Immunotoxins|immunotoxins|mesh-ancestor
154506064|NCT02408042|Immunoconjugates|immunoconjugates|mesh-ancestor
154506065|NCT03172988|Dexamethasone|dexamethasone|mesh-list
154506066|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
154506067|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
154506068|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154506069|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154506070|NCT03172988|BB 1101|bb 1101|mesh-list
154506071|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506072|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
154506073|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
154506074|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506075|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506076|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506077|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
154506078|NCT03172988|Hormones|hormones|mesh-ancestor
154506079|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506080|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154506081|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506082|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
154506083|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506084|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506085|NCT03172988|Analgesics|analgesics|mesh-ancestor
154506086|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
154506087|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154506088|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506089|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506090|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154506091|NCT03042611|Apatinib|apatinib|mesh-list
154506092|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506093|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154506094|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506095|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506096|NCT03171584|Itraconazole|itraconazole|mesh-list
154506097|NCT03171584|Fluconazole|fluconazole|mesh-list
154506098|NCT03171584|Terbinafine|terbinafine|mesh-list
154506099|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
154506100|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506101|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154506102|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154506103|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506104|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506105|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154506106|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
154506107|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506108|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506109|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154506110|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154506111|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154506112|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
154506113|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154506114|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
154506115|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506116|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506117|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154506118|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154506119|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154506120|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154506121|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154506122|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154506123|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506124|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506125|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506126|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506127|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
154506128|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506129|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154506131|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
154506132|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506133|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506134|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154506135|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506136|NCT02405156|Letrozole|letrozole|mesh-list
154506137|NCT02405156|Misoprostol|misoprostol|mesh-list
154506138|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506139|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154506140|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154506141|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506142|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506143|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154506144|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
154506145|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506146|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506147|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154506148|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
154506149|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506150|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154506151|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506152|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
154506153|NCT02411942|Adapalene|adapalene|mesh-list
154506154|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154506155|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506156|NCT02411942|Analgesics|analgesics|mesh-ancestor
154506157|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
154506158|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506159|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506160|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506161|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506162|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
154506163|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154506164|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154506165|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506166|NCT02406950|Incretins|incretins|mesh-ancestor
154506167|NCT02406950|Hormones|hormones|mesh-ancestor
154506168|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506169|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154506170|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
154506171|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506172|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506173|NCT02406872|Propofol|propofol|mesh-list
154506174|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154506175|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506176|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506177|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154506178|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
154506179|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
154506180|NCT03172676|Amoxicillin|amoxicillin|mesh-list
154506181|NCT03172676|Clarithromycin|clarithromycin|mesh-list
154506182|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154506183|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154506184|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506185|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154506186|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506187|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506188|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154506189|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154506190|NCT02404844|Tamoxifen|tamoxifen|mesh-list
154506191|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154506192|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
154506193|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506194|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506195|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154506196|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506197|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154506198|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154506199|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154506200|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
154506201|NCT04482296|Astringents|astringents|mesh-ancestor
154506202|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506203|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
154506204|NCT03116282|Ethanol|ethanol|mesh-list
154506205|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154506206|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506207|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506208|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506209|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
154506210|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154506211|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
154506212|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506213|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
154506214|NCT02404454|Protective Agents|protective agents|mesh-ancestor
154506215|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
154506216|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154506217|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506218|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
154506219|NCT02411786|Molgramostim|molgramostim|mesh-list
154506220|NCT02411786|Sargramostim|sargramostim|mesh-list
154506221|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
154506222|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506223|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506225|NCT02404376|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154506226|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154506227|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506228|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154506229|NCT02404376|Incretins|incretins|mesh-ancestor
154506230|NCT02404376|Hormones|hormones|mesh-ancestor
154506231|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506232|NCT04466085|Vaccines|vaccines|mesh-list
154506233|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
154506234|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506235|NCT03517995|Sulforaphane|sulforaphane|mesh-list
154506236|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154506237|NCT03517995|Protective Agents|protective agents|mesh-ancestor
154506238|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506239|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506240|NCT02411630|Tenofovir|tenofovir|mesh-list
154506241|NCT02411630|Emtricitabine|emtricitabine|mesh-list
154506242|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
154506243|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506244|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154506245|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154506246|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506247|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506248|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154506249|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154506250|NCT02411318|Ethanol|ethanol|mesh-list
154506251|NCT02411318|Caffeine|caffeine|mesh-list
154506252|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154506253|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506254|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154506255|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506256|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506257|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154506258|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154506259|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
154506260|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506261|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154506262|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506263|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506264|NCT03133299|Vitamin D|vitamin d|mesh-list
154506265|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
154506266|NCT03133299|Vitamins|vitamins|mesh-ancestor
154506267|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
154506268|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506269|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154506270|NCT03133299|Hormones|hormones|mesh-ancestor
154506271|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506272|NCT04465695|Interferons|interferons|mesh-list
154506273|NCT04465695|Interferon-beta|interferon-beta|mesh-list
154506274|NCT04465695|Clofazimine|clofazimine|mesh-list
154506276|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506277|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
154506278|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506279|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
154506280|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506281|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154506282|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506283|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
154506284|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154506285|NCT03115736|Tenofovir|tenofovir|mesh-list
154506286|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
154506287|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506288|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154506289|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154506290|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506291|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506292|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154506293|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154506294|NCT04465851|Curcumin|curcumin|mesh-list
154506295|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154506296|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506297|NCT04465851|Analgesics|analgesics|mesh-ancestor
154506298|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
154506299|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506300|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506301|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506302|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506303|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506304|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506305|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506306|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
154506307|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154506308|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506309|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
154506310|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
154506311|NCT02404142|Atracurium|atracurium|mesh-list
154506312|NCT02404142|Curare|curare|mesh-list
154506313|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154506314|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154506315|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154506316|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506317|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506318|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154506319|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154506320|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
154506321|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506322|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506323|NCT03522051|Calcium|calcium|mesh-list
154506324|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154506325|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506326|NCT03171974|Dexamethasone|dexamethasone|mesh-list
154506327|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506328|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
154506329|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
154506330|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506331|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506332|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506333|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
154506334|NCT03171974|Hormones|hormones|mesh-ancestor
154506335|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506336|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154506337|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506338|NCT02292069|Amlodipine|amlodipine|mesh-list
154506339|NCT02292069|Atorvastatin|atorvastatin|mesh-list
154506340|NCT02292069|Calcium|calcium|mesh-list
154506341|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154506342|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506343|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154506344|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154506345|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
154506346|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506347|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154506348|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154506349|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506350|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154506351|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154506352|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154506353|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
154506354|NCT02404064|Metronidazole|metronidazole|mesh-list
154506355|NCT02404064|Cefotaxime|cefotaxime|mesh-list
154506356|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506357|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154506358|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154506359|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154506360|NCT02294643|Aspirin|aspirin|mesh-list
154506361|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
154506362|NCT02294643|Clopidogrel|clopidogrel|mesh-list
154506363|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154506364|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506365|NCT02294643|Analgesics|analgesics|mesh-ancestor
154506366|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
154506367|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506368|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506369|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506370|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506371|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154506372|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154506373|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506374|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154506375|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154506376|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506377|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
154506378|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154506379|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154506380|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154506381|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
154506382|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506383|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154506384|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
154506385|NCT02410694|Thalidomide|thalidomide|mesh-list
154275548|NCT04761614|Riluzole|riluzole|mesh-list
154506386|NCT02410694|Dexamethasone|dexamethasone|mesh-list
154506387|NCT02410694|Ixazomib|ixazomib|mesh-list
154506388|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506389|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
154506390|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
154506391|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506392|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506393|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506394|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
154506395|NCT02410694|Hormones|hormones|mesh-ancestor
154506396|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506397|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154506398|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506399|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154506400|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
154506401|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
154506402|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154506403|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506404|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154506405|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154506406|NCT02410694|Growth Substances|growth substances|mesh-ancestor
154506407|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
154506408|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
154506409|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506410|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506411|NCT03521895|Aflibercept|aflibercept|mesh-list
154506412|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154506413|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154506414|NCT03521895|Growth Substances|growth substances|mesh-ancestor
154506415|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506416|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
154506417|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506418|NCT02401880|Empagliflozin|empagliflozin|mesh-list
154506419|NCT02401880|Linagliptin|linagliptin|mesh-list
154506420|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154506421|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506422|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154506423|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230299|NCT01141192|Vitamin D|vitamin d|mesh-list
154506424|NCT02401880|Incretins|incretins|mesh-ancestor
154506425|NCT02401880|Hormones|hormones|mesh-ancestor
154506426|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506427|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154506428|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
154506429|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506430|NCT03170726|Ibuprofen|ibuprofen|mesh-list
154506431|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154506432|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154506433|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506434|NCT03170726|Analgesics|analgesics|mesh-ancestor
154506435|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
154506436|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506437|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506438|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506439|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506440|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154506441|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506442|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506443|NCT03175016|Irinotecan|irinotecan|mesh-list
154506444|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154506445|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154506446|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506447|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506448|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506449|NCT03520257|Apatinib|apatinib|mesh-list
154506450|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506451|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154506452|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506453|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506454|NCT02292303|Zinc|zinc|mesh-list
154506455|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
154506456|NCT02292303|Trace Elements|trace elements|mesh-ancestor
154506457|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
154506458|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506459|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
154506460|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
154506461|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154506462|NCT02292303|Protective Agents|protective agents|mesh-ancestor
154506463|NCT02294955|Amiodarone|amiodarone|mesh-list
154506464|NCT02294955|Flecainide|flecainide|mesh-list
154506465|NCT02294955|Sotalol|sotalol|mesh-list
154506466|NCT02294955|Dronedarone|dronedarone|mesh-list
154506467|NCT02294955|Propafenone|propafenone|mesh-list
154506468|NCT02294955|Disopyramide|disopyramide|mesh-list
154506469|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154506470|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
154506471|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154506472|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154506473|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506474|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154506475|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154506476|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154506477|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506478|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154506479|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154506480|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154506481|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154506482|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154506483|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154506484|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506485|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506486|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506487|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
154506488|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
154506489|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506490|NCT02396888|Insulin|insulin|mesh-list
154506491|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154506492|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506493|NCT03517683|Methamphetamine|methamphetamine|mesh-list
154506494|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154506495|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506496|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
154506497|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
154506498|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506499|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
154506500|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506501|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506502|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506503|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154506504|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154341417|NCT00783536|Etanercept|etanercept|mesh-list
154860219|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
154506505|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154506507|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
154506508|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154506509|NCT02164643|Flutemetamol|flutemetamol|mesh-list
154506510|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154506511|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506512|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154506513|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154506514|NCT02292459|Laxatives|laxatives|mesh-ancestor
154506515|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506516|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154506517|NCT03170336|Amiloride|amiloride|mesh-list
154506518|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154506519|NCT03170336|Diuretics|diuretics|mesh-ancestor
154506520|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
154506521|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506522|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154506523|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154506524|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506525|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154506526|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154506527|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154506528|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154506529|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154506530|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154506531|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154506532|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506533|NCT02295189|Triamcinolone|triamcinolone|mesh-list
154506534|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154506535|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154506536|NCT02295189|Ketorolac|ketorolac|mesh-list
154506537|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154506538|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154506539|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506540|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
154506541|NCT02295189|Hormones|hormones|mesh-ancestor
154506542|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506543|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506544|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154506545|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
154506546|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506547|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506548|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154506549|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506550|NCT02295189|Analgesics|analgesics|mesh-ancestor
154506551|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
154506552|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506553|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506554|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154506555|NCT03519633|Neostigmine|neostigmine|mesh-list
154506556|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154506557|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506558|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506559|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
154506560|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506561|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506562|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154506563|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
154506564|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506565|NCT02289027|Vaccines|vaccines|mesh-list
154506566|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
154506567|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506568|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
154506569|NCT02396030|Analgesics|analgesics|mesh-ancestor
154506570|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
154506571|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230448|NCT01076439|Analgesics|analgesics|mesh-ancestor
154506572|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506573|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
154506574|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506575|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154506576|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
154506577|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154506578|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154506579|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506580|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154506581|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
154506582|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506583|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
154506584|NCT02289261|Morphine|morphine|mesh-list
154506585|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154506586|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506587|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506588|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506589|NCT02289261|Analgesics|analgesics|mesh-ancestor
154506590|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
154506591|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506592|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154506593|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154506594|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154506595|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506596|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506597|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506598|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154506599|NCT02289261|Narcotics|narcotics|mesh-ancestor
154506600|NCT03168074|Lenvatinib|lenvatinib|mesh-list
154506601|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506602|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154506603|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506604|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506605|NCT02396108|Paclitaxel|paclitaxel|mesh-list
154506606|NCT02396108|Carboplatin|carboplatin|mesh-list
154506607|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154506608|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506609|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
154506610|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
154506611|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
154506612|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506613|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
154506614|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154506615|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154506616|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506617|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
154506618|NCT02403596|Coagulants|coagulants|mesh-ancestor
154506619|NCT02289495|Ritonavir|ritonavir|mesh-list
154506620|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
154506621|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154506622|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154506623|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
154506624|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506625|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506626|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154506627|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154506628|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
154506629|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506630|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154506631|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154506632|NCT01774721|Gefitinib|gefitinib|mesh-list
154506633|NCT01774721|Dacomitinib|dacomitinib|mesh-list
154506634|NCT01774721|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154506635|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154506636|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506637|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506638|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506639|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154506640|NCT02395952|Laxatives|laxatives|mesh-ancestor
154506641|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506642|NCT03516903|Folic Acid|folic acid|mesh-list
154506643|NCT03516903|Methotrexate|methotrexate|mesh-list
154506644|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154506645|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
154506646|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506647|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506648|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154506649|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
154506650|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506651|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506653|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506654|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154506655|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154506656|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
154506657|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506658|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154506659|NCT03516903|Hematinics|hematinics|mesh-ancestor
154506660|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
154506661|NCT03516903|Vitamins|vitamins|mesh-ancestor
154506662|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
154506663|NCT03516747|Hormones|hormones|mesh-list
154506664|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
154506665|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506666|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506667|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154506668|NCT03516669|Amoxicillin|amoxicillin|mesh-list
154506669|NCT03516669|Clarithromycin|clarithromycin|mesh-list
154506670|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154506671|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506672|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154506673|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506674|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506675|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154506676|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154506677|NCT02289807|Cisplatin|cisplatin|mesh-list
154506678|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506679|NCT02298153|Atezolizumab|atezolizumab|mesh-list
154506680|NCT02298153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154506681|NCT02298153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506682|NCT02298153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154506683|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506684|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154506685|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
154506686|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506687|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
154506688|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154506689|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506690|NCT02296047|Bromides|bromides|mesh-list
154506691|NCT02296047|Albuterol|albuterol|mesh-list
154506692|NCT02296047|Ipratropium|ipratropium|mesh-list
154506693|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
154506694|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154506695|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
154506696|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506697|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506698|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154506699|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154506700|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
154506701|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506702|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154506703|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154506704|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154506705|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506706|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506707|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506708|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154506709|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
154506710|NCT02293785|Oxycodone|oxycodone|mesh-list
154506711|NCT02293785|Naloxone|naloxone|mesh-list
154506712|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154506713|NCT02293785|Narcotics|narcotics|mesh-ancestor
154506714|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506715|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506716|NCT02293785|Analgesics|analgesics|mesh-ancestor
154506717|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
154506718|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506719|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154506720|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
154506721|NCT01162109|Astringents|astringents|mesh-ancestor
154506722|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506723|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
154506724|NCT02296203|Irinotecan|irinotecan|mesh-list
154506725|NCT02296203|Cetuximab|cetuximab|mesh-list
154506726|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154506727|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154506728|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506729|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506730|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506731|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154506732|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
154506733|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154506734|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506735|NCT02296281|Pirfenidone|pirfenidone|mesh-list
154506736|NCT02296281|Analgesics|analgesics|mesh-ancestor
154506737|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
154506738|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506739|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506740|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154506741|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506742|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154506743|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506744|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506745|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154506746|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154506747|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154506748|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
154506749|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506750|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154506751|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154506752|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506753|NCT03513549|Loxapine|loxapine|mesh-list
154506754|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154506755|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154506756|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506757|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506758|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154506759|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154506760|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
154506761|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506762|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506763|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154506764|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154506765|NCT03513393|Velpatasvir|velpatasvir|mesh-list
154506766|NCT03513393|Omeprazole|omeprazole|mesh-list
154506767|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154506768|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506769|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154506770|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506771|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506772|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
154506773|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506774|NCT02299401|Misoprostol|misoprostol|mesh-list
154506775|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154506776|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
154506777|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506778|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506779|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154506780|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506781|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
154506782|NCT02699450|Ranibizumab|ranibizumab|mesh-list
154506783|NCT02699450|Faricimab|faricimab|mesh-list
154506784|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154506785|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154506786|NCT02699450|Growth Substances|growth substances|mesh-ancestor
154506787|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506788|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
154506789|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506790|NCT02299557|Phenylephrine|phenylephrine|mesh-list
154506791|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
154506792|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154506793|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154506794|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506795|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506796|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230670|NCT01588925|BB 1101|bb 1101|mesh-list
154506797|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506798|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
154506799|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
154506800|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506801|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
154506802|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154506803|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
154506804|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154506805|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
154506806|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154506807|NCT02299557|Protective Agents|protective agents|mesh-ancestor
154506808|NCT02302989|Ranibizumab|ranibizumab|mesh-list
154506809|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154506810|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154506811|NCT02302989|Growth Substances|growth substances|mesh-ancestor
154506812|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506813|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
154506814|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506815|NCT02296671|Leucovorin|leucovorin|mesh-list
154506816|NCT02296671|Fluorouracil|fluorouracil|mesh-list
154506817|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
154506818|NCT02296671|Pemetrexed|pemetrexed|mesh-list
154506819|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
154506820|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506821|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154506822|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506823|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154506824|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
154506825|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506826|NCT02296671|Antidotes|antidotes|mesh-ancestor
154506827|NCT02296671|Protective Agents|protective agents|mesh-ancestor
154506828|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
154506829|NCT02296671|Vitamins|vitamins|mesh-ancestor
154506830|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
154506831|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506832|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154506833|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154506834|NCT02296749|Sirolimus|sirolimus|mesh-list
154506835|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154506836|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506837|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154506838|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506839|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
154506840|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154506841|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
154506842|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506843|NCT04481750|Edaravone|edaravone|mesh-list
154506844|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154506845|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
154506846|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506847|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154506848|NCT04481750|Protective Agents|protective agents|mesh-ancestor
154506849|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506850|NCT02303223|Propofol|propofol|mesh-list
154506851|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154506852|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506853|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506854|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154506855|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
154506856|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
154506857|NCT03168698|Oxytocin|oxytocin|mesh-list
154506858|NCT03168698|Carbetocin|carbetocin|mesh-list
154506859|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
154506860|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506861|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506862|NCT04464135|Acetic Acid|acetic acid|mesh-list
154506863|NCT04464135|Retinol acetate|retinol acetate|mesh-list
154506864|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154506865|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506866|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154506867|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
154506868|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506869|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154506870|NCT04464135|Protective Agents|protective agents|mesh-ancestor
154506871|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506872|NCT03510351|Tazobactam|tazobactam|mesh-list
154506873|NCT03510351|Ceftolozane|ceftolozane|mesh-list
154506874|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154506876|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154506877|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154506878|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506879|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506880|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154506882|NCT02403284|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154506883|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154506884|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506885|NCT02403284|Incretins|incretins|mesh-ancestor
154506886|NCT02403284|Hormones|hormones|mesh-ancestor
154506887|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154506888|NCT02400866|Olanzapine|olanzapine|mesh-list
154506889|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
154506890|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
154506891|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506892|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506893|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154506894|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154506895|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154506896|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506897|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154506898|NCT02400866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154506899|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154506900|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154506901|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506902|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506903|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
154506904|NCT02400788|Sorafenib|sorafenib|mesh-list
154506905|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506906|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154506907|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154506908|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506909|NCT02403128|Aflibercept|aflibercept|mesh-list
154506910|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154506911|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154506912|NCT02403128|Growth Substances|growth substances|mesh-ancestor
154506913|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506914|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
154506915|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506916|NCT02297217|Paclitaxel|paclitaxel|mesh-list
154506917|NCT02297217|Carboplatin|carboplatin|mesh-list
154506918|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154506919|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506920|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
154506921|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
154506922|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
154506923|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506924|NCT03515577|Edetic Acid|edetic acid|mesh-list
154506925|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154506926|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
154506927|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
154506928|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506929|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
154506930|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154506931|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154506932|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
154506933|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154506934|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506935|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506936|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154506937|NCT02300649|Analgesics|analgesics|mesh-ancestor
154506938|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
154506939|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506940|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154506941|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154506942|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154506943|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506944|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506945|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506946|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154230823|NCT01037699|Hormones|hormones|mesh-list
154506947|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154506948|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
154506949|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154506950|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506951|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154506952|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154506953|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154506954|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506955|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154506956|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154506957|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154506959|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154506960|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154506961|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154506962|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
154506963|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506964|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506965|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506966|NCT02303769|Urological Agents|urological agents|mesh-ancestor
154506967|NCT02303847|Ketamine|ketamine|mesh-list
154506968|NCT02303847|Analgesics|analgesics|mesh-ancestor
154506969|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
154506970|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506971|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506972|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154506973|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154506974|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
154506975|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
154506976|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506977|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154506978|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154506979|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154506980|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154506981|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154506982|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
154506983|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154506984|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154506985|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154506986|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506987|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506988|NCT03511833|Ketamine|ketamine|mesh-list
154506989|NCT03511833|Morphine|morphine|mesh-list
154506990|NCT03511833|Analgesics|analgesics|mesh-ancestor
154506991|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
154506992|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154506993|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154506994|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154506995|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154506996|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
154506997|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
154506998|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154506999|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154507000|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154507001|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507002|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507003|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154507004|NCT03511833|Narcotics|narcotics|mesh-ancestor
154507005|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154507006|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507007|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507008|NCT02696798|Ixekizumab|ixekizumab|mesh-list
154507009|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
154507010|NCT02304081|Saxagliptin|saxagliptin|mesh-list
154507011|NCT02304081|Incretins|incretins|mesh-ancestor
154507012|NCT02304081|Hormones|hormones|mesh-ancestor
154507013|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507014|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507015|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154507016|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
154507017|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507018|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507019|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507021|NCT02304237|Progestins|progestins|mesh-ancestor
154507022|NCT02304237|Hormones|hormones|mesh-ancestor
154507023|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507024|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507025|NCT03515187|Bromides|bromides|mesh-list
154341923|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
154507026|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154507027|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154507028|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
154507029|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
154507030|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154507031|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
154507032|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507033|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
154507034|NCT03515187|Protective Agents|protective agents|mesh-ancestor
154507035|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
154507036|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154507037|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154507038|NCT02395016|Gemcitabine|gemcitabine|mesh-list
154507039|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
154507040|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507041|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
154507042|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507043|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507044|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507045|NCT04480268|Paclitaxel|paclitaxel|mesh-list
154507046|NCT04480268|Gemcitabine|gemcitabine|mesh-list
154507047|NCT04480268|Capecitabine|capecitabine|mesh-list
154507048|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154507049|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507050|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154507051|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154507052|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154507053|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507054|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507055|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
154507056|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154507057|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
154507058|NCT03510975|Coagulants|coagulants|mesh-ancestor
154507059|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154507060|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
154507061|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507062|NCT03169790|Leucovorin|leucovorin|mesh-list
154507063|NCT03169790|Paclitaxel|paclitaxel|mesh-list
154507064|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
154507065|NCT03169790|Bevacizumab|bevacizumab|mesh-list
154507066|NCT03169790|Rituximab|rituximab|mesh-list
154507067|NCT03169790|Capecitabine|capecitabine|mesh-list
154507068|NCT03169790|Fluorouracil|fluorouracil|mesh-list
154507069|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
154507070|NCT03169790|Avelumab|avelumab|mesh-list
154507071|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154507072|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507073|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
154507074|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
154507075|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
154507076|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507077|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154507078|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
154507079|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507080|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507081|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154507082|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
154507083|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154507084|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507085|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154507086|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154507087|NCT03169790|Growth Substances|growth substances|mesh-ancestor
154507088|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
154507089|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507090|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
154507091|NCT03169790|Antidotes|antidotes|mesh-ancestor
154507092|NCT03169790|Protective Agents|protective agents|mesh-ancestor
154507093|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
154507094|NCT03169790|Vitamins|vitamins|mesh-ancestor
154507095|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
154507096|NCT02304393|Atezolizumab|atezolizumab|mesh-list
154507097|NCT02304393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154507098|NCT02304393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507099|NCT02304393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507101|NCT02402972|Leucovorin|leucovorin|mesh-list
154507102|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
154507103|NCT02402972|Floxuridine|floxuridine|mesh-list
154507104|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
154507105|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507106|NCT02402972|Antidotes|antidotes|mesh-ancestor
154507107|NCT02402972|Protective Agents|protective agents|mesh-ancestor
154507108|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507109|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
154507110|NCT02402972|Vitamins|vitamins|mesh-ancestor
154507111|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
154507112|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507113|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
154507114|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507115|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
154507116|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507117|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154507118|NCT02394470|Protective Agents|protective agents|mesh-ancestor
154507119|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507120|NCT02304627|Insulin|insulin|mesh-list
154507121|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507122|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507123|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
154507124|NCT02394158|Metformin|metformin|mesh-list
154507125|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507126|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507127|NCT03508635|Prednisone|prednisone|mesh-list
154507128|NCT03508635|Cortisone|cortisone|mesh-list
154507129|NCT03508635|Mifepristone|mifepristone|mesh-list
154507130|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507131|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
154507132|NCT03508635|Hormones|hormones|mesh-ancestor
154507133|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507134|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507135|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154507136|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507137|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154507138|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
154507139|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507140|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154507141|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154507142|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154507143|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
154507144|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154507145|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154507146|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
154507147|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
154507148|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154507149|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154507150|NCT04481282|Terbutaline|terbutaline|mesh-list
154507151|NCT04481282|Danazol|danazol|mesh-list
154507152|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154507153|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
154507154|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507155|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507156|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154507157|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
154507158|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
154507159|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
154507160|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507161|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154507162|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154507163|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154507164|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
154507165|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507166|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507167|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154507168|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
154507169|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507170|NCT02541604|Atezolizumab|atezolizumab|mesh-list
154231047|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
154507171|NCT02541604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154507172|NCT02541604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507173|NCT02541604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507174|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507175|NCT02393846|Ketoprofen|ketoprofen|mesh-list
154507176|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154507177|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154507178|NCT02393846|Analgesics|analgesics|mesh-ancestor
154507179|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
154507180|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507181|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507182|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507183|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507184|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154507185|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507186|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507187|NCT02302209|Oxytocin|oxytocin|mesh-list
154507188|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
154507189|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507190|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507191|NCT02394002|Propofol|propofol|mesh-list
154507192|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154507193|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507194|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507195|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154507196|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
154507197|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
154507198|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154507199|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154507200|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154507201|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
154507202|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154507203|NCT02402348|Metformin|metformin|mesh-list
154507204|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507205|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507206|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154507207|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154507208|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
154507209|NCT02399462|Hormones|hormones|mesh-ancestor
154507210|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507211|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507212|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507213|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507214|NCT03505047|Copper|copper|mesh-list
154507215|NCT03505047|Trace Elements|trace elements|mesh-ancestor
154507216|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
154507217|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507218|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
154507219|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507220|NCT02546674|Nilotinib|nilotinib|mesh-list
154507221|NCT02546674|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154507222|NCT02546674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154507223|NCT02546674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507224|NCT02546674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507225|NCT02305485|Everolimus|everolimus|mesh-list
154507226|NCT02305485|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154507227|NCT02305485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154507228|NCT02305485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507229|NCT02305485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507230|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154507231|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
154507232|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507233|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507234|NCT02311569|Mirabegron|mirabegron|mesh-list
154507235|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154507236|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154507237|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154507238|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
154507239|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507240|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276421|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
154507241|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507242|NCT02311569|Urological Agents|urological agents|mesh-ancestor
154507243|NCT02393456|Oxytocin|oxytocin|mesh-list
154507244|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
154231121|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
154507245|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507246|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507247|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
154507248|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154507249|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154507250|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507251|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154507252|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154860220|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507253|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
154507254|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507255|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507257|NCT02306733|Ergonovine|ergonovine|mesh-list
154507258|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
154507259|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507260|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507261|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154507262|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
154507263|NCT03507465|Capecitabine|capecitabine|mesh-list
154507264|NCT03507465|Letrozole|letrozole|mesh-list
154507265|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507266|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
154507267|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507268|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507269|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154507270|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154507271|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507272|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154507273|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
154507274|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507275|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507276|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
154507277|NCT05476042|Hematinics|hematinics|mesh-ancestor
154507278|NCT03507387|Phenylephrine|phenylephrine|mesh-list
154507279|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
154507280|NCT03507387|Bupivacaine|bupivacaine|mesh-list
154507281|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
154507282|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
154507283|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507284|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507285|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
154507286|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507287|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154507288|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
154507289|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
154507290|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
154507291|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154507292|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
154507293|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
154507294|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154507295|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154507296|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154507297|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
154507298|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507299|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507300|NCT03507387|Protective Agents|protective agents|mesh-ancestor
154507301|NCT02694536|Gemcitabine|gemcitabine|mesh-list
154507302|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154507303|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507304|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
154507305|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507306|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507307|NCT02694536|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154507308|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154507309|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507310|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
154507311|NCT02312037|Antibodies|antibodies|mesh-list
154507312|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
154507313|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
154507314|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507315|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507316|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507317|NCT02312037|Immunotoxins|immunotoxins|mesh-ancestor
154507318|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
154507319|NCT03167918|Metformin|metformin|mesh-list
154507320|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
154507321|NCT03167918|Calcium|calcium|mesh-list
154507322|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507323|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507324|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154507325|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154507326|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
154507327|NCT03167918|Coagulants|coagulants|mesh-ancestor
154507328|NCT05745818|Colchicine|colchicine|mesh-list
154507329|NCT05745818|Gout Suppressants|gout suppressants|mesh-ancestor
154507330|NCT05745818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507331|NCT05745818|Tubulin Modulators|tubulin modulators|mesh-ancestor
154507332|NCT05745818|Antimitotic Agents|antimitotic agents|mesh-ancestor
154507333|NCT05745818|Mitosis Modulators|mitosis modulators|mesh-ancestor
154507334|NCT05745818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507335|NCT05745818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507336|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
154507337|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154507338|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154507339|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507340|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
154507341|NCT02393300|Coagulants|coagulants|mesh-ancestor
154507342|NCT03106610|Nivolumab|nivolumab|mesh-list
154507343|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507344|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507345|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154507346|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507347|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
154507348|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154507349|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154507350|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
154507351|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507352|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154507353|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154507354|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154507355|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154507356|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154507357|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507358|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154507359|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507360|NCT02312115|Furosemide|furosemide|mesh-list
154507361|NCT02312115|Diuretics|diuretics|mesh-ancestor
154507362|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
154507363|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507364|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154507365|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276533|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507366|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507367|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154507368|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154507369|NCT03026140|Celecoxib|celecoxib|mesh-list
154507370|NCT03026140|Nivolumab|nivolumab|mesh-list
154507371|NCT03026140|Ipilimumab|ipilimumab|mesh-list
154507372|NCT03026140|Relatlimab|relatlimab|mesh-list
154507373|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507374|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507375|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154507376|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507377|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154507378|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154507379|NCT03026140|Analgesics|analgesics|mesh-ancestor
154507380|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
154507381|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507382|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507383|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507384|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507385|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154507386|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154507387|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507388|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
154507389|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
154507390|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154507391|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
154507392|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154507393|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507394|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
154507395|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
154507396|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507397|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507398|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154507399|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
154507400|NCT02398994|Hormones|hormones|mesh-ancestor
154507401|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507402|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154507403|NCT02398994|Protective Agents|protective agents|mesh-ancestor
154507404|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
154507405|NCT02306889|Fenofibrate|fenofibrate|mesh-list
154507406|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154507407|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
154507408|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507409|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154507410|NCT02393144|Meperidine|meperidine|mesh-list
154507411|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
154507412|NCT02393144|Analgesics|analgesics|mesh-list
154507413|NCT02393144|Oxytocin|oxytocin|mesh-list
154507414|NCT02393144|Dinoprostone|dinoprostone|mesh-list
154507415|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
154507416|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507417|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507418|NCT02393144|Narcotics|narcotics|mesh-ancestor
154507419|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507420|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
154507421|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507422|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154507423|NCT02306031|Diclofenac|diclofenac|mesh-list
154507424|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
154507425|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154507426|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154507427|NCT02306031|Analgesics|analgesics|mesh-ancestor
154507428|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
154507429|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507430|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507431|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507432|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276604|NCT01720836|Poly ICLC|poly iclc|mesh-list
154507433|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154507434|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507435|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507436|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154507437|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154507438|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154507439|NCT02392910|Hematinics|hematinics|mesh-ancestor
154507440|NCT02307045|Nicotine|nicotine|mesh-list
154507441|NCT02307045|Varenicline|varenicline|mesh-list
154507442|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154507443|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
154507444|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507445|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507446|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154507447|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154507448|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
154507449|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507450|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507451|NCT03167372|Imidacloprid|imidacloprid|mesh-list
154507452|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
154507453|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507454|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507455|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507456|NCT03504345|Progesterone|progesterone|mesh-list
154507457|NCT03504345|Progestins|progestins|mesh-ancestor
154507458|NCT03504345|Hormones|hormones|mesh-ancestor
154507459|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507460|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507461|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
154507462|NCT02307201|Analgesics|analgesics|mesh-ancestor
154507463|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
154507464|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507465|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507466|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
154507467|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507468|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154507469|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
154507470|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154507471|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154507472|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507473|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154507474|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
154507475|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507477|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154507478|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507479|NCT03167216|Cetirizine|cetirizine|mesh-list
154507480|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
154507481|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154507482|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154507483|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154507484|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
154507485|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
154507486|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276664|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
154507487|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507488|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507489|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154507490|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
154507491|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507492|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154507493|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
154507494|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
154507495|NCT02393066|Propofol|propofol|mesh-list
154507496|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154507497|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507498|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507499|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154507500|NCT02393066|Analgesics|analgesics|mesh-ancestor
154507501|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
154507502|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507503|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154507504|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154507505|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154507506|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
154507507|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507508|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507509|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154507510|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
154507511|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
154507512|NCT02398838|Misoprostol|misoprostol|mesh-list
154507513|NCT02398838|Mifepristone|mifepristone|mesh-list
154507514|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154507515|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
154507516|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507517|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507518|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154507519|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154507520|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
154507521|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154507522|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154507523|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154507524|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154507525|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
154507526|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154507527|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154507528|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
154507529|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507530|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
154507531|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154507532|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154507533|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
154507534|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
154507535|NCT02398682|Protective Agents|protective agents|mesh-ancestor
154507536|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507537|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154507538|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
154507539|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276722|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
154507540|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507541|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507542|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507543|NCT03504033|Desflurane|desflurane|mesh-list
154231417|NCT01148446|Vincristine|vincristine|mesh-list
154507545|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
154507546|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
154507547|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507548|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507549|NCT03132519|Remifentanil|remifentanil|mesh-list
154507550|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154507551|NCT03132519|Narcotics|narcotics|mesh-ancestor
154507552|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507553|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860221|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507554|NCT03132519|Analgesics|analgesics|mesh-ancestor
154507555|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
154507556|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507557|NCT02398448|Allopurinol|allopurinol|mesh-list
154507558|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
154507559|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507560|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507561|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
154507562|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507563|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154507564|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
154507565|NCT02398448|Protective Agents|protective agents|mesh-ancestor
154507566|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507567|NCT02392520|Cetrorelix|cetrorelix|mesh-list
154507568|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154507569|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
154507570|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154507571|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507572|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
154507573|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507574|NCT02316249|Estradiol|estradiol|mesh-list
154507575|NCT02316249|Hormones|hormones|mesh-ancestor
154507576|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507577|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507578|NCT02316249|Estrogens|estrogens|mesh-ancestor
154507579|NCT02696096|Buprenorphine|buprenorphine|mesh-list
154507580|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154507581|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154507582|NCT02696096|Narcotics|narcotics|mesh-ancestor
154507583|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507584|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507585|NCT02696096|Analgesics|analgesics|mesh-ancestor
154507586|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
154507587|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507588|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154507589|NCT02316327|Bevacizumab|bevacizumab|mesh-list
154507590|NCT02316327|Gemcitabine|gemcitabine|mesh-list
154507591|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507592|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507593|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154507594|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154507595|NCT02316327|Growth Substances|growth substances|mesh-ancestor
154507596|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507597|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
154507598|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507599|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
154507600|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507601|NCT02392364|Aflibercept|aflibercept|mesh-list
154507602|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154507603|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154507604|NCT02392364|Growth Substances|growth substances|mesh-ancestor
154507605|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507606|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
154507607|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507608|NCT02392676|Olaparib|olaparib|mesh-list
154507609|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154507610|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507611|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507612|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507613|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154507614|NCT03106298|Hematinics|hematinics|mesh-ancestor
154507615|NCT02307591|Amiodarone|amiodarone|mesh-list
154507616|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154507617|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
154231493|NCT01251874|Alovudine|alovudine|mesh-list
154507618|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154507619|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154507620|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507621|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154507622|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154507623|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154507625|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154507626|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154507627|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154860222|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154507628|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
154507629|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507630|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507631|NCT03506997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154507632|NCT03506997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507633|NCT02398136|Midazolam|midazolam|mesh-list
154507634|NCT02398136|Ketamine|ketamine|mesh-list
154507635|NCT02398136|Analgesics|analgesics|mesh-ancestor
154507636|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
154507637|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507638|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507639|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154507640|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154507641|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
154507642|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
154507643|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507644|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154507645|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154507646|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507647|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507648|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154507649|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154507650|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154507651|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154507652|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154507653|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
154507654|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
154507655|NCT05745584|Mirabegron|mirabegron|mesh-list
154507656|NCT05745584|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154507657|NCT05745584|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154507658|NCT05745584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154507659|NCT05745584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154507660|NCT05745584|Adrenergic Agents|adrenergic agents|mesh-ancestor
154507661|NCT05745584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507662|NCT05745584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507663|NCT05745584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507664|NCT05745584|Urological Agents|urological agents|mesh-ancestor
154507665|NCT05745584|Cholinergic Agents|cholinergic agents|mesh-ancestor
154507666|NCT02312661|Metformin|metformin|mesh-list
154507667|NCT02312661|Paclitaxel|paclitaxel|mesh-list
154507668|NCT02312661|Carboplatin|carboplatin|mesh-list
154507669|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154507670|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507671|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
154507672|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
154507673|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
154507674|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507675|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507676|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507677|NCT02398058|Olaparib|olaparib|mesh-list
154507678|NCT02398058|Trabectedin|trabectedin|mesh-list
154507679|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154507680|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507681|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507682|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507683|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154507684|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
154507685|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
154507686|NCT03501615|Immunotoxins|immunotoxins|mesh-ancestor
154507687|NCT03501615|Immunoconjugates|immunoconjugates|mesh-ancestor
154507688|NCT03501615|Immunologic Factors|immunologic factors|mesh-ancestor
154507689|NCT03501615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231567|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507690|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507691|NCT03506919|Allopurinol|allopurinol|mesh-list
154507692|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
154276901|NCT05624606|Vaccines|vaccines|mesh-list
154507693|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507694|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507695|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
154507696|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507697|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154507698|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
154507699|NCT03506919|Protective Agents|protective agents|mesh-ancestor
154507700|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507701|NCT02545504|Leucovorin|leucovorin|mesh-list
154507702|NCT02545504|Fluorouracil|fluorouracil|mesh-list
154507703|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
154507704|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
154507705|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507706|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507707|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507708|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154507709|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
154507710|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507711|NCT02545504|Antidotes|antidotes|mesh-ancestor
154507712|NCT02545504|Protective Agents|protective agents|mesh-ancestor
154507713|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
154507714|NCT02545504|Vitamins|vitamins|mesh-ancestor
154507715|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
154507716|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
154507717|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154507718|NCT03506841|Protective Agents|protective agents|mesh-ancestor
154507719|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507720|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
154507721|NCT02397512|Lactulose|lactulose|mesh-list
154507722|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154507723|NCT02313051|Everolimus|everolimus|mesh-list
154507724|NCT02313051|Letrozole|letrozole|mesh-list
154276932|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276933|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
154276934|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154276935|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154276936|NCT05363488|Bosutinib|bosutinib|mesh-list
154276937|NCT05363488|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154276938|NCT05363488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276939|NCT05363488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276940|NCT05363488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276941|NCT05352828|Nivolumab|nivolumab|mesh-list
154276942|NCT05352828|Fludarabine|fludarabine|mesh-list
154276943|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154276944|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507725|NCT02313051|Goserelin|goserelin|mesh-list
154507726|NCT02313051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154507727|NCT02313051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154507728|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507729|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507730|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154507731|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
154507732|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507733|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507734|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154507735|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154507736|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154507737|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
154507738|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507739|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154507740|NCT02397590|Atorvastatin|atorvastatin|mesh-list
154507741|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154507742|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154507743|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
154507744|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507745|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154507746|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154507747|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507748|NCT02397356|Ketamine|ketamine|mesh-list
154507749|NCT02397356|Analgesics|analgesics|mesh-ancestor
154507750|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
154507751|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507752|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507753|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154507754|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154507755|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
154507756|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
154507757|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507758|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154507759|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154507760|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507761|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507762|NCT02307825|Azithromycin|azithromycin|mesh-list
154507763|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154507764|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154507765|NCT02540668|Warfarin|warfarin|mesh-list
154507766|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
154507767|NCT03506763|Diclofenac|diclofenac|mesh-list
154507768|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154507769|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154507770|NCT03506763|Analgesics|analgesics|mesh-ancestor
154507771|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
154507772|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507773|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507774|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507775|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507776|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154507777|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507778|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507779|NCT02441439|Iron|iron|mesh-list
154507780|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154507781|NCT02441439|Trace Elements|trace elements|mesh-ancestor
154507782|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
154507783|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507784|NCT02441439|Hematinics|hematinics|mesh-ancestor
154507785|NCT02308137|Domperidone|domperidone|mesh-list
154507786|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507787|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
154507788|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
154507789|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507790|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507791|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154507792|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154507793|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
154507794|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507795|NCT03501459|Rituximab|rituximab|mesh-list
154507796|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507797|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507798|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
154507799|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507800|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507801|NCT02317263|Testosterone|testosterone|mesh-list
154507802|NCT02317263|Androgens|androgens|mesh-ancestor
154507803|NCT02317263|Hormones|hormones|mesh-ancestor
154507804|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507805|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507806|NCT02317341|Midazolam|midazolam|mesh-list
154507807|NCT02317341|Ketamine|ketamine|mesh-list
154507808|NCT02317341|Analgesics|analgesics|mesh-ancestor
154507809|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
154507810|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507811|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507812|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154507813|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154507814|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
154507815|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
154507816|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507817|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154507818|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154507819|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507820|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507821|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154507822|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154507823|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154507824|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154507825|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154507826|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
154507827|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
154507828|NCT02317419|Paclitaxel|paclitaxel|mesh-list
154507829|NCT02317419|Gemcitabine|gemcitabine|mesh-list
154507830|NCT02317419|LMB-100|lmb-100|mesh-list
154507831|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154507832|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507833|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
154507834|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
154507835|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
154507836|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507837|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507838|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
154507839|NCT02317419|Immunoconjugates|immunoconjugates|mesh-ancestor
154231714|NCT03972462|MTOR Inhibitors|mtor inhibitors|mesh-list
154507840|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
154507841|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507842|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154507844|NCT03943888|Neostigmine|neostigmine|mesh-list
154507845|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154507846|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154507847|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154507848|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
154507849|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507850|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507851|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154507852|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
154507853|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
154507854|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
154507856|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154507857|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
154507858|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507859|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507860|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154507861|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507862|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154507863|NCT03502551|Ketamine|ketamine|mesh-list
154507864|NCT03502551|Analgesics|analgesics|mesh-ancestor
154507865|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
154507866|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507867|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507868|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154507869|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154507870|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
154507871|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
154507872|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507873|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154507874|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154507875|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507876|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507877|NCT02314377|Bevacizumab|bevacizumab|mesh-list
154507878|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507879|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507880|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154507881|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154507882|NCT02314377|Growth Substances|growth substances|mesh-ancestor
154507883|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507884|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
154507885|NCT02942290|Azacitidine|azacitidine|mesh-list
154507886|NCT02942290|Venetoclax|venetoclax|mesh-list
154507887|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154507888|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
154507889|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507890|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507891|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507892|NCT02540356|Antibodies|antibodies|mesh-list
154507893|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
154507894|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
154507895|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507896|NCT05463094|Metformin|metformin|mesh-list
154507897|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507898|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507899|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
154507900|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507901|NCT02392130|Clobetasol|clobetasol|mesh-list
154507902|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507903|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
154507904|NCT02392130|Hormones|hormones|mesh-ancestor
154507905|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507906|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507907|NCT05356091|Sevoflurane|sevoflurane|mesh-list
154507908|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154507909|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154507910|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
154507911|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
154507912|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507913|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507914|NCT05351021|Metformin|metformin|mesh-list
154507915|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154507916|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507917|NCT02688764|Calcium|calcium|mesh-list
154507918|NCT02688764|Calcium acetate|calcium acetate|mesh-list
154507919|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154507920|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507922|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
154507923|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507924|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
154507925|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154507926|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507927|NCT02688608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154507928|NCT02688608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507929|NCT02688530|Dexamethasone|dexamethasone|mesh-list
154507930|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
154507931|NCT02688530|BB 1101|bb 1101|mesh-list
154507932|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507933|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
154507934|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
154507935|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507936|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507937|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154507938|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
154507939|NCT02688530|Hormones|hormones|mesh-ancestor
154507940|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154507941|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154507942|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154507943|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
154507944|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507945|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507946|NCT05744804|Aspirin|aspirin|mesh-list
154507947|NCT05744804|Rivaroxaban|rivaroxaban|mesh-list
154507948|NCT05744804|Clopidogrel|clopidogrel|mesh-list
154507949|NCT05744804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154507950|NCT05744804|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154507951|NCT05744804|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154507952|NCT05744804|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154507953|NCT05744804|Purinergic Agents|purinergic agents|mesh-ancestor
154507954|NCT05744804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154507955|NCT05744804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507956|NCT05744804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507957|NCT05744804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154507958|NCT05744804|Antithrombins|antithrombins|mesh-ancestor
154507959|NCT05744804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154507960|NCT05744804|Protease Inhibitors|protease inhibitors|mesh-ancestor
154507961|NCT05744804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154507962|NCT05744804|Anticoagulants|anticoagulants|mesh-ancestor
154507963|NCT05744804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154507964|NCT05744804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154507965|NCT05744804|Analgesics|analgesics|mesh-ancestor
154507966|NCT05744804|Sensory System Agents|sensory system agents|mesh-ancestor
154507967|NCT05744804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507968|NCT05744804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154507969|NCT05744804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154507970|NCT05744804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154507971|NCT05744804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154507972|NCT05744804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154507973|NCT05744804|Antipyretics|antipyretics|mesh-ancestor
154507974|NCT05744726|Bone wax|bone wax|mesh-list
154507975|NCT05744726|Hemostatics|hemostatics|mesh-ancestor
154507976|NCT05744726|Coagulants|coagulants|mesh-ancestor
154507977|NCT05150795|Pregabalin|pregabalin|mesh-list
154507978|NCT05150795|Fentanyl|fentanyl|mesh-list
154507979|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154507980|NCT05150795|Narcotics|narcotics|mesh-ancestor
154507981|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154507982|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154507983|NCT05150795|Analgesics|analgesics|mesh-ancestor
154507984|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
154507985|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154507986|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154507987|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154507988|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
154507989|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
154507990|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
154507991|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154507992|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154507993|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154507994|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154507995|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154507996|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154507997|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154507999|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
154508000|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508001|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154508002|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154508003|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508004|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508005|NCT02533570|Immunotoxins|immunotoxins|mesh-ancestor
154508006|NCT02533570|Immunoconjugates|immunoconjugates|mesh-ancestor
154508007|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
154508008|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508009|NCT02268448|Clonidine|clonidine|mesh-list
154508010|NCT02268448|Naltrexone|naltrexone|mesh-list
154508011|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154508012|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154508013|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508014|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
154508015|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508016|NCT02268448|Analgesics|analgesics|mesh-ancestor
154508017|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154508018|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
154508019|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
154508020|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154508021|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154508022|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154508023|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
154508024|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508025|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508026|NCT05744570|Anesthetics|anesthetics|mesh-list
154508027|NCT05744570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508028|NCT05744570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508029|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
154508030|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154508031|NCT03036839|Ledipasvir|ledipasvir|mesh-list
154508032|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
154508033|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508034|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154508035|NCT04977791|Antibodies|antibodies|mesh-list
154508036|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154508037|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
154508038|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508039|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508040|NCT04977791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508041|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508042|NCT03625739|Amoxicillin|amoxicillin|mesh-list
154508043|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
154508044|NCT03625739|Levofloxacin|levofloxacin|mesh-list
154508045|NCT03625739|Isoniazid|isoniazid|mesh-list
154508046|NCT03625739|Cycloserine|cycloserine|mesh-list
154508047|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
154508048|NCT03625739|Imipenem|imipenem|mesh-list
154508049|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
154508050|NCT03625739|Amikacin|amikacin|mesh-list
154508051|NCT03625739|Ethambutol|ethambutol|mesh-list
154508052|NCT03625739|Bedaquiline|bedaquiline|mesh-list
154508053|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154508054|NCT03625739|Clofazimine|clofazimine|mesh-list
154508055|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
154508056|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154508057|NCT03625739|Streptomycin|streptomycin|mesh-list
154508058|NCT03625739|Ethionamide|ethionamide|mesh-list
154508059|NCT03625739|Kanamycin|kanamycin|mesh-list
154508060|NCT03625739|Capreomycin|capreomycin|mesh-list
154508061|NCT03625739|Thioacetazone|thioacetazone|mesh-list
154508062|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
154508063|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154508064|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508065|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154231937|NCT01151254|Sevoflurane|sevoflurane|mesh-list
154508066|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154508067|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508068|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508069|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508070|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154508071|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154508072|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154508073|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154508074|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
154508075|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154508076|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154508077|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
154508078|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154508079|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154508080|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508081|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154508082|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154508083|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154508084|NCT03904199|Insulin|insulin|mesh-list
154508085|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154508087|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508088|NCT01286207|Rizatriptan|rizatriptan|mesh-list
154508089|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154508090|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
154508091|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277250|NCT03025880|Gemcitabine|gemcitabine|mesh-list
154508092|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508093|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508094|NCT02236000|Neratinib|neratinib|mesh-list
154508095|NCT02236000|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154508096|NCT02236000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154508097|NCT02236000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508098|NCT02236000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508099|NCT05408026|Dexamethasone|dexamethasone|mesh-list
154508100|NCT05408026|Bortezomib|bortezomib|mesh-list
154508101|NCT05408026|Daratumumab|daratumumab|mesh-list
154508102|NCT05408026|Pomalidomide|pomalidomide|mesh-list
154508103|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508104|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
154508105|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
154508106|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508107|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508108|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508109|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
154508110|NCT05408026|Hormones|hormones|mesh-ancestor
154508111|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508112|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154508113|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508114|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
154508115|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154508116|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154508117|NCT05408026|Growth Substances|growth substances|mesh-ancestor
154508118|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
154508119|NCT04423510|Phenol|phenol|mesh-list
154508120|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154508121|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508122|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
154508123|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154508124|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154508125|NCT00968201|Montelukast|montelukast|mesh-list
154508126|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508127|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508128|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154508129|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508130|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508131|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508132|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154508133|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154508134|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508135|NCT00943397|Montelukast|montelukast|mesh-list
154508136|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508137|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508138|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154508139|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508140|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508141|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508142|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154508143|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154508144|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232029|NCT01153828|Mupirocin|mupirocin|mesh-list
154508145|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
154508146|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508147|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
154508148|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154508149|NCT00702845|Hormones|hormones|mesh-list
154508150|NCT00702845|Progesterone|progesterone|mesh-list
154508151|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154508152|NCT00702845|Ganirelix|ganirelix|mesh-list
154508153|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508154|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508155|NCT00702845|Progestins|progestins|mesh-ancestor
154508156|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508157|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154508158|NCT00647933|Lynestrenol|lynestrenol|mesh-list
154508159|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154508160|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154508161|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154508162|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
154508163|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154508164|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508165|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154508166|NCT00647933|Estrogens|estrogens|mesh-ancestor
154508167|NCT00647933|Hormones|hormones|mesh-ancestor
154508168|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508169|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154508170|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
154508171|NCT00641771|Vitamin D|vitamin d|mesh-list
154508172|NCT00641771|Alendronate|alendronate|mesh-list
154508173|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154508174|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508175|NCT00641771|Vitamins|vitamins|mesh-ancestor
154508176|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
154508177|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154508178|NCT00519857|Tibolone|tibolone|mesh-list
154508179|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
154508180|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508181|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508182|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508183|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154508184|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154508185|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508186|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154508187|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
154508188|NCT00519857|Hormones|hormones|mesh-ancestor
154508189|NCT00431093|Tibolone|tibolone|mesh-list
154508190|NCT00431093|Estradiol|estradiol|mesh-list
154508191|NCT00431093|Estrogens|estrogens|mesh-ancestor
154508192|NCT00431093|Hormones|hormones|mesh-ancestor
154508193|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508194|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508195|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
154508196|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508197|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154508198|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154508199|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508200|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154508201|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
154508202|NCT00092963|Rizatriptan|rizatriptan|mesh-list
154508203|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508204|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508205|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508206|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154508207|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
154508208|NCT00092885|Montelukast|montelukast|mesh-list
154508209|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508210|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508211|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154508212|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508213|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508214|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508215|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154508216|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154508217|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508218|NCT03673735|Durvalumab|durvalumab|mesh-list
154508219|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508220|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508221|NCT00092105|Montelukast|montelukast|mesh-list
154508222|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508223|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508224|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154508225|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508226|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508227|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508228|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154508229|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154508230|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508231|NCT00092027|Alendronate|alendronate|mesh-list
154508232|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508233|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154508235|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508236|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508237|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154508238|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508239|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508240|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508241|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154508242|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154508243|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508244|NCT02314533|Fenofibrate|fenofibrate|mesh-list
154508245|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154508246|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
154508247|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508248|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154508249|NCT03502395|Lidocaine|lidocaine|mesh-list
154508250|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
154508251|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
154508252|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508253|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508254|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
154508255|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508256|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154508257|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154508258|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154508259|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154508260|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508261|NCT02318043|Fluticasone|fluticasone|mesh-list
154508262|NCT02318043|Budesonide|budesonide|mesh-list
154508263|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154508264|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154508265|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508266|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154508267|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
154508268|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508269|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508270|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508271|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508272|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
154508273|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154508274|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
154508275|NCT02318043|Hormones|hormones|mesh-ancestor
154508276|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508277|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154508278|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154508279|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154508280|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
154508281|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508282|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508283|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
154508284|NCT03433313|Trastuzumab|trastuzumab|mesh-list
154508285|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508286|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508287|NCT02318121|Oxytocin|oxytocin|mesh-list
154508288|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
154508289|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154508290|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508291|NCT02318199|Anesthetics|anesthetics|mesh-list
154508292|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508293|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508295|NCT05225597|Epinephrine|epinephrine|mesh-list
154508296|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154508297|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154508298|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
154508299|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508300|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508301|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508302|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154508303|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154508304|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
154508305|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508306|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508307|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508308|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
154508309|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
154508310|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154508311|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154508312|NCT05225597|Miotics|miotics|mesh-ancestor
154508313|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154508314|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
154508315|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154508316|NCT05225597|Analgesics|analgesics|mesh-ancestor
154508317|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
154508318|NCT05225597|Protective Agents|protective agents|mesh-ancestor
154508319|NCT00543127|Fulvestrant|fulvestrant|mesh-list
154508320|NCT00543127|Anastrozole|anastrozole|mesh-list
154508321|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154508322|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508323|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154508324|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154508325|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508326|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508327|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508328|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154508329|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154508330|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508331|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508332|NCT02309385|Dexamethasone|dexamethasone|mesh-list
154508333|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
154508334|NCT02309385|Prednisolone|prednisolone|mesh-list
154508335|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154508336|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
154508337|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154508338|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
154508339|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154508340|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
154508341|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154508342|NCT02309385|BB 1101|bb 1101|mesh-list
154508343|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508344|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
154508345|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
154508346|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508347|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508348|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508349|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
154508350|NCT02309385|Hormones|hormones|mesh-ancestor
154508351|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508352|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154508353|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508354|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
154508355|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508356|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508357|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154508358|NCT02309385|Protective Agents|protective agents|mesh-ancestor
154508359|NCT02315001|Liraglutide|liraglutide|mesh-list
154508360|NCT02315001|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154508361|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154508362|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508363|NCT02315001|Incretins|incretins|mesh-ancestor
154508364|NCT02315001|Hormones|hormones|mesh-ancestor
154508365|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154232243|NCT03891472|Irinotecan|irinotecan|mesh-list
154508366|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
154508367|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508368|NCT03500367|Sirolimus|sirolimus|mesh-list
154508369|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154508370|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508371|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154508372|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508373|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
154508374|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154508375|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
154508376|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508377|NCT02318433|Dexamethasone|dexamethasone|mesh-list
154508378|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508379|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
154508381|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508382|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508383|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508384|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
154508385|NCT02318433|Hormones|hormones|mesh-ancestor
154508386|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508387|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154508388|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508389|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
154508390|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154508391|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
154508392|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508393|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
154508394|NCT02318511|Protective Agents|protective agents|mesh-ancestor
154508395|NCT02315391|Glycine|glycine|mesh-list
154508396|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
154508397|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508398|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508399|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508400|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
154508401|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154508402|NCT03022981|Velpatasvir|velpatasvir|mesh-list
154508403|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
154508404|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508405|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
154508406|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
154508407|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508408|NCT03502005|Tenofovir|tenofovir|mesh-list
154508409|NCT03502005|Emtricitabine|emtricitabine|mesh-list
154508410|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154508411|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
154508412|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508413|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154508414|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154508415|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508416|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508417|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154508418|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154508419|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154508420|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508421|NCT03669445|Dexamethasone|dexamethasone|mesh-list
154508422|NCT03669445|Lenalidomide|lenalidomide|mesh-list
154508423|NCT03669445|Daratumumab|daratumumab|mesh-list
154508424|NCT03669445|Ixazomib|ixazomib|mesh-list
154508425|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508426|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
154508427|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
154508428|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508429|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508430|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508431|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
154508432|NCT03669445|Hormones|hormones|mesh-ancestor
154508433|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508434|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154508435|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508436|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
154508437|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154508438|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154508439|NCT03669445|Growth Substances|growth substances|mesh-ancestor
154508440|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
154508441|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
154508442|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508443|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508444|NCT04462809|Talazoparib|talazoparib|mesh-list
154508445|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154508446|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508447|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508448|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508449|NCT02320773|Mirabegron|mirabegron|mesh-list
154508450|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154508451|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154508452|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154508453|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
154508454|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508455|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508456|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508457|NCT02320773|Urological Agents|urological agents|mesh-ancestor
154508458|NCT03377699|Insulin|insulin|mesh-list
154508459|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154508460|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
154508461|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
154508462|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154508463|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508464|NCT04463901|Mitomycins|mitomycins|mesh-list
154508465|NCT04463901|Mitomycin|mitomycin|mesh-list
154508466|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154508467|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508468|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
154508469|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508470|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154508471|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508472|NCT01314443|Vitamin E|vitamin e|mesh-list
154508473|NCT01314443|Tocopherols|tocopherols|mesh-list
154508474|NCT01314443|Tocotrienols|tocotrienols|mesh-list
154508475|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
154508476|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
154508477|NCT01314443|Nicotine|nicotine|mesh-list
154508478|NCT01314443|Vitamins|vitamins|mesh-ancestor
154508479|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
154508480|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508481|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154508482|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
154508483|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508484|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154508485|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154508486|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
154508487|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508488|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508489|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
154508490|NCT01314443|Protective Agents|protective agents|mesh-ancestor
154508491|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154508492|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154508493|NCT03498417|Antibodies|antibodies|mesh-list
154508494|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
154508495|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508496|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
154508497|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508498|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508499|NCT03212651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154508500|NCT03212651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508501|NCT02319135|Cytarabine|cytarabine|mesh-list
154508502|NCT02319135|Fludarabine|fludarabine|mesh-list
154508503|NCT02319135|Lenograstim|lenograstim|mesh-list
154508504|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508505|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154508506|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
154508507|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508508|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154508509|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
154508510|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508511|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
154508512|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508513|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154508514|NCT03499743|Celecoxib|celecoxib|mesh-list
154508515|NCT03499743|Scopolamine|scopolamine|mesh-list
154508516|NCT03499743|Bromides|bromides|mesh-list
154508517|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154508518|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154508519|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154508520|NCT03499743|Analgesics|analgesics|mesh-ancestor
154508521|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
154508522|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508523|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508524|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508525|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154508526|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154508527|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154508528|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508529|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508530|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
154508531|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154508532|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
154508533|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
154508534|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508535|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
154508536|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154508537|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
154508538|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508539|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154508540|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
154508541|NCT02310087|Vitamin E|vitamin e|mesh-list
154508542|NCT02310087|Vitamins|vitamins|mesh-ancestor
154508543|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
154508544|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508545|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
154508546|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508547|NCT02310087|Protective Agents|protective agents|mesh-ancestor
154508548|NCT02923921|Leucovorin|leucovorin|mesh-list
154508549|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
154508550|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508551|NCT02923921|Antidotes|antidotes|mesh-ancestor
154508552|NCT02923921|Protective Agents|protective agents|mesh-ancestor
154508553|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508554|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
154508555|NCT02923921|Vitamins|vitamins|mesh-ancestor
154508556|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
154508557|NCT02310243|Palbociclib|palbociclib|mesh-list
154508558|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508559|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154508560|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508561|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508562|NCT03497715|Ibuprofen|ibuprofen|mesh-list
154508563|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154508564|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154508565|NCT03497715|Analgesics|analgesics|mesh-ancestor
154508566|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
154508567|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508568|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508569|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154508570|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154508571|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154508572|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508573|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508574|NCT02321241|Aflibercept|aflibercept|mesh-list
154508575|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154508576|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154508577|NCT02321241|Growth Substances|growth substances|mesh-ancestor
154508578|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508579|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
154508580|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508581|NCT03583307|Sirolimus|sirolimus|mesh-list
154508582|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154508583|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508584|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154508585|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508586|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
154508587|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154508588|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
154508589|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508590|NCT03039023|Choline|choline|mesh-list
154508591|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
154508592|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154508593|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
154508594|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232461|NCT03882814|Analgesics|analgesics|mesh-ancestor
154508595|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508596|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154508597|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
154508599|NCT02321397|Naloxone|naloxone|mesh-list
154508600|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154508601|NCT02321397|Narcotics|narcotics|mesh-ancestor
154508602|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508603|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508604|NCT02321397|Analgesics|analgesics|mesh-ancestor
154508605|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
154508606|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508607|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154508608|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
154508609|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154508610|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154508611|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508612|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
154508613|NCT02319915|Coagulants|coagulants|mesh-ancestor
154508614|NCT04898309|Complement C1s|complement c1s|mesh-list
154508615|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154508616|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154508617|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
154508618|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508619|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154508620|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154508621|NCT03498963|Dimercaprol|dimercaprol|mesh-list
154508622|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
154508623|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
154508624|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508626|NCT02311101|Mitomycin|mitomycin|mesh-list
154508627|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154508628|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508629|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
154508630|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508631|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154508632|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508633|NCT04620187|Cisplatin|cisplatin|mesh-list
154508634|NCT04620187|Carboplatin|carboplatin|mesh-list
154508635|NCT04620187|Trastuzumab|trastuzumab|mesh-list
154508636|NCT04620187|Maytansine|maytansine|mesh-list
154508637|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508638|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508639|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154508640|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
154508641|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
154508642|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
154508643|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508644|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
154508645|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154508646|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
154508647|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508648|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
154508649|NCT03668665|Protective Agents|protective agents|mesh-ancestor
154508650|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154508651|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
154508652|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154508653|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
154508654|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508655|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508656|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508657|NCT03704909|Epinephrine|epinephrine|mesh-list
154508658|NCT03704909|Racepinephrine|racepinephrine|mesh-list
154508659|NCT03704909|Ephedrine|ephedrine|mesh-list
154508660|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
154508661|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154508662|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154508663|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
154508664|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508665|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508666|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508667|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154508668|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154508669|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
154508670|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508671|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508672|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508674|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
154508675|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154508676|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154508677|NCT03704831|Anesthetics|anesthetics|mesh-list
154508678|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
154508679|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508680|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508681|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
154508682|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508683|NCT03704675|Vactosertib|vactosertib|mesh-list
154508684|NCT03704675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154508685|NCT03704675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508686|NCT03704675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508687|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
154508688|NCT03494517|Analgesics|analgesics|mesh-ancestor
154508689|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
154508690|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508691|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508692|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
154508693|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508694|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154277917|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154508695|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
154508696|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154508697|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154508698|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508699|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154508700|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
154508701|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154508702|NCT02322645|Eszopiclone|eszopiclone|mesh-list
154508703|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154508704|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508705|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508707|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508708|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508709|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154508710|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508711|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154508712|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154508713|NCT03496389|Acetaminophen|acetaminophen|mesh-list
154508714|NCT03496389|Gabapentin|gabapentin|mesh-list
154508715|NCT03496389|Tramadol|tramadol|mesh-list
154508716|NCT03496389|Analgesics|analgesics|mesh-ancestor
154508717|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
154508718|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508719|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508720|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
154508721|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154508722|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154508723|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508724|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154508725|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154508726|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154508727|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277918|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154277919|NCT01375816|Growth Substances|growth substances|mesh-ancestor
154277920|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277921|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
154277922|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154277923|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
154277924|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508728|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508729|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
154508730|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154508731|NCT03496389|Narcotics|narcotics|mesh-ancestor
154508732|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154508733|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
154508734|NCT03491709|Cetuximab|cetuximab|mesh-list
154508735|NCT03491709|Antibodies|antibodies|mesh-list
154508736|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154508737|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
154508738|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508739|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508740|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508741|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
154508742|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154508743|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154508744|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508745|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
154508746|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508747|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508749|NCT02323191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154508750|NCT02323191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508751|NCT02323191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154508752|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508753|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154508754|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
154508755|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154508756|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
154508757|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508758|NCT02323347|Progesterone|progesterone|mesh-list
154508759|NCT02323347|Progestins|progestins|mesh-ancestor
154508760|NCT02323347|Hormones|hormones|mesh-ancestor
154508761|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508762|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508763|NCT03495765|Ranibizumab|ranibizumab|mesh-list
154508764|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154508765|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154508766|NCT03495765|Growth Substances|growth substances|mesh-ancestor
154508767|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508768|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
154508769|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508770|NCT03491475|Ajmaline|ajmaline|mesh-list
154508771|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154508772|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154508773|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154508774|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154508775|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508776|NCT03328845|Insulin|insulin|mesh-list
154508777|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154508778|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
154508779|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
154508780|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154508781|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508782|NCT02323737|Cisplatin|cisplatin|mesh-list
154508783|NCT02323737|Irinotecan|irinotecan|mesh-list
154508784|NCT02323737|Etoposide|etoposide|mesh-list
154508785|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508786|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154508787|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154508788|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508789|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508790|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154508791|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154508792|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
154508793|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
154508794|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508795|NCT03491085|Amoxicillin|amoxicillin|mesh-list
154508796|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
154508797|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
154508798|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154508799|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154508800|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508801|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154508802|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508803|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508804|NCT02323971|Ticagrelor|ticagrelor|mesh-list
154508805|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154508806|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154508807|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154508808|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154508809|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
154508810|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508811|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508812|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508813|NCT03148899|Oxytocin|oxytocin|mesh-list
154508814|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
154508815|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154508816|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508817|NCT03495063|Caffeine|caffeine|mesh-list
154508818|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154508819|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508820|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154508821|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508822|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508823|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154508824|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154508825|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
154508826|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508827|NCT03490617|Misoprostol|misoprostol|mesh-list
154508828|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154508829|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
154508830|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154508831|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508832|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154508833|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508834|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
154508835|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
154508836|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154508837|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154508838|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508839|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154508840|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154508841|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508842|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508843|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508844|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154508845|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
154508846|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154508847|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508848|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154508849|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154508850|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154508851|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
154508852|NCT03490539|Azathioprine|azathioprine|mesh-list
154508853|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154508854|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508855|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154508856|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
154508857|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154508858|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508859|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508860|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508861|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
154508862|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154508863|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154508864|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
154508865|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508866|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154508867|NCT03021187|Semaglutide|semaglutide|mesh-list
154508868|NCT03021187|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154508869|NCT03021187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154508870|NCT03021187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508871|NCT03493503|Albuterol|albuterol|mesh-list
154508872|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154508873|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
154508874|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508875|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508876|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508877|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508878|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
154508879|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154508880|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154508881|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154508882|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154508883|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
154508884|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508885|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508886|NCT03667963|Lactulose|lactulose|mesh-list
154508887|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508888|NCT03489837|Dipropizine|dipropizine|mesh-list
154508889|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
154508890|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
154232763|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508891|NCT03625505|Venetoclax|venetoclax|mesh-list
154508893|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508894|NCT03625505|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154508895|NCT03625505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154508896|NCT03625505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508897|NCT03625505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508898|NCT03493269|Midazolam|midazolam|mesh-list
154508899|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154508900|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154508901|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508902|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508903|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154508904|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154508905|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154508906|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154508907|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
154508908|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
154508909|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
154508910|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
154508911|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508912|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508913|NCT04257682|Bupivacaine|bupivacaine|mesh-list
154508914|NCT04257682|Ropivacaine|ropivacaine|mesh-list
154508915|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
154508916|NCT04257682|Mepivacaine|mepivacaine|mesh-list
154508917|NCT04257682|Anesthetics|anesthetics|mesh-list
154508918|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508919|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508920|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
154508921|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508922|NCT05404906|Azacitidine|azacitidine|mesh-list
154508923|NCT05404906|Venetoclax|venetoclax|mesh-list
154508924|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154508925|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
154508926|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508927|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154508928|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508929|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154508930|NCT03020407|Dopamine|dopamine|mesh-list
154508931|NCT03020407|Epinephrine|epinephrine|mesh-list
154508932|NCT03020407|Norepinephrine|norepinephrine|mesh-list
154508933|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154508934|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508935|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154508936|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154508937|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
154508938|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154508939|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508940|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508941|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154508942|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154508943|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
154508944|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508945|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154508946|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
154508947|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
154508948|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
154508949|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154508950|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
154508951|NCT03020407|Protective Agents|protective agents|mesh-ancestor
154508952|NCT03624959|Itraconazole|itraconazole|mesh-list
154508953|NCT03624959|Rifampin|rifampin|mesh-list
154508954|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
154508955|NCT03624959|Ozanimod|ozanimod|mesh-list
154508956|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
154508957|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154508958|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154508959|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154508960|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154508961|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508962|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154508963|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
154508964|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154508965|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508966|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154232855|NCT03876574|Hormones|hormones|mesh-ancestor
154508967|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154508968|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
154508969|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154508970|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
154508971|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154508972|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154508973|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154278133|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
154508974|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154508975|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154508976|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154508977|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154508978|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154508979|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154508980|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
154508981|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154508983|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154508984|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154508985|NCT02536846|Olanzapine|olanzapine|mesh-list
154508986|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
154508987|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
154508988|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154508989|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154508990|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154508991|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154508992|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154508993|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154508994|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154508995|NCT02536846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154508996|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154508997|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154508998|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154508999|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509000|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
154509001|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154509002|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509003|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154509004|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154509005|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509006|NCT05439460|Phenylephrine|phenylephrine|mesh-list
154509007|NCT05439460|Vasopressins|vasopressins|mesh-list
154509008|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
154509009|NCT05439460|Epinephrine|epinephrine|mesh-list
154509010|NCT05439460|Racepinephrine|racepinephrine|mesh-list
154509011|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
154509012|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
154509013|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154509014|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154509015|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
154509016|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509017|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509018|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509019|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154509020|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154509021|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
154509022|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509023|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154509024|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
154509025|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
154509026|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
154509027|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154509028|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154509029|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
154509030|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154509031|NCT05439460|Protective Agents|protective agents|mesh-ancestor
154509032|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
154509033|NCT05439460|Coagulants|coagulants|mesh-ancestor
154509034|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154509035|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
154509036|NCT01661140|Methotrexate|methotrexate|mesh-list
154278200|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154509037|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154509038|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
154509039|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154232910|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
154509040|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509041|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154509042|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
154509043|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509044|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509045|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
154509046|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509047|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154509048|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154509049|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
154509050|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509051|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154509052|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154509053|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154509054|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154509055|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
154509056|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509057|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154509058|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154509059|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509061|NCT05436886|Analgesics|analgesics|mesh-ancestor
154509062|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
154509063|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509064|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509065|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
154509066|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154509067|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154509068|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509069|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154509070|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154509071|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154509072|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509073|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509074|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
154509075|NCT01373151|Adalimumab|adalimumab|mesh-list
154509076|NCT01373151|Methotrexate|methotrexate|mesh-list
154509077|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154509078|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
154509079|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154509080|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509081|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154509082|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
154509083|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509084|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509085|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154509086|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509087|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154509088|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154509089|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
154509090|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509091|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154509092|NCT01373151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154509093|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509094|NCT01660906|Dasatinib|dasatinib|mesh-list
154509095|NCT01660906|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154509096|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154509097|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509098|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509099|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509100|NCT03666949|Anesthetics|anesthetics|mesh-list
154509101|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278262|NCT01252056|Cilostazol|cilostazol|mesh-list
154509102|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509103|NCT00886691|Bevacizumab|bevacizumab|mesh-list
154509104|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154509105|NCT00886691|Everolimus|everolimus|mesh-list
154509106|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
154509107|NCT00886691|Antibodies|antibodies|mesh-list
154509108|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
154509109|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154509110|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
154509111|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509112|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154232992|NCT01167010|Hormones|hormones|mesh-ancestor
154509114|NCT00886691|Growth Substances|growth substances|mesh-ancestor
154509115|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509116|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
154509117|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
154509118|NCT00886691|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154509119|NCT00886691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154509120|NCT00886691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509121|NCT00886691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509122|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154509123|NCT00960297|Paclitaxel|paclitaxel|mesh-list
154509124|NCT00960297|Bevacizumab|bevacizumab|mesh-list
154509125|NCT00960297|Carboplatin|carboplatin|mesh-list
154509126|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154509127|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509128|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
154509129|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
154509130|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
154509131|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509132|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509133|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154509134|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154509135|NCT00960297|Growth Substances|growth substances|mesh-ancestor
154509136|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509137|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
154509138|NCT05112861|Bevacizumab|bevacizumab|mesh-list
154509139|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509140|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509141|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154509142|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154509143|NCT05112861|Growth Substances|growth substances|mesh-ancestor
154509144|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509145|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
154509146|NCT03012061|Fluticasone|fluticasone|mesh-list
154509147|NCT03012061|Xhance|xhance|mesh-list
154509148|NCT03012061|Albuterol|albuterol|mesh-list
154509149|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509150|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154509151|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
154509152|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509153|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509154|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154509155|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
154509156|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
154509157|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154509158|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
154509159|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154509160|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154509161|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154509162|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154509163|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
154509164|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509165|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509166|NCT00408863|Tibolone|tibolone|mesh-list
154509167|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
154509168|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
154509169|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509170|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509171|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154509172|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154509173|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509174|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154509175|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
154509176|NCT00408863|Hormones|hormones|mesh-ancestor
154509177|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154509178|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
154509179|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154509180|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509181|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509182|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154509183|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154509184|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154509185|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
154509186|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509187|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509188|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154509189|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154509190|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
154509191|NCT03131973|Leucovorin|leucovorin|mesh-list
154509192|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
154509193|NCT03131973|Methotrexate|methotrexate|mesh-list
154509194|NCT03131973|Digoxin|digoxin|mesh-list
154509195|NCT03131973|Midazolam|midazolam|mesh-list
154509196|NCT03131973|Caffeine|caffeine|mesh-list
154509197|NCT03131973|Omeprazole|omeprazole|mesh-list
154509198|NCT03131973|Pravastatin|pravastatin|mesh-list
154509199|NCT03131973|Montelukast|montelukast|mesh-list
154509200|NCT03131973|Branebrutinib|branebrutinib|mesh-list
154509201|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154509202|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
154509203|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154509204|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509205|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154509206|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
154509207|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509208|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509209|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
154509210|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509211|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154509212|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154509213|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
154509214|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509215|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154509216|NCT03131973|Antidotes|antidotes|mesh-ancestor
154509217|NCT03131973|Protective Agents|protective agents|mesh-ancestor
154509218|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
154509219|NCT03131973|Vitamins|vitamins|mesh-ancestor
154509220|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
154509221|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154509222|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154509223|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509224|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154509225|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154509226|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154509227|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154509228|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
154509229|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
154509230|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
154509231|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
154509232|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509233|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154509234|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154509235|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154509236|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154509237|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
154509238|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154509239|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154509240|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154509241|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154509242|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
154509243|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154509244|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
154509245|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509246|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154509247|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154509248|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154509249|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154509250|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154509251|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154509252|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154509253|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154509254|NCT03131973|Analgesics|analgesics|mesh-ancestor
154509255|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
154509256|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509257|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154509258|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154509259|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509260|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154509261|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154509262|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
154509263|NCT05078931|Lenvatinib|lenvatinib|mesh-list
154509264|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509265|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509266|NCT05078931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154509267|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509268|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154509269|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509270|NCT04825197|Poractant alfa|poractant alfa|mesh-list
154509271|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154509272|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
154509274|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154509275|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
154509276|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509277|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154509278|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
154509279|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
154509280|NCT04703361|Vitamins|vitamins|mesh-ancestor
154509281|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
154509282|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509283|NCT03010423|Nicorandil|nicorandil|mesh-list
154509284|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154509285|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154860223|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
154509286|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
154509287|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
154509288|NCT03010423|Vitamins|vitamins|mesh-ancestor
154509289|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
154509290|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509291|NCT05576597|Butyric Acid|butyric acid|mesh-list
154509292|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
154509293|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
154509294|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509295|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509296|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509297|NCT03665779|Pyridoxine|pyridoxine|mesh-list
154509298|NCT03665779|Isosorbide|isosorbide|mesh-list
154509299|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154509300|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154509301|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
154509302|NCT03665779|Vitamins|vitamins|mesh-ancestor
154509303|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
154509304|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509305|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154509306|NCT03665779|Diuretics|diuretics|mesh-ancestor
154509307|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
154509308|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
154509309|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154509310|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509311|NCT03703505|Mitapivat|mitapivat|mesh-list
154509312|NCT03703505|Enzyme Activators|enzyme activators|mesh-ancestor
154509313|NCT03703505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509314|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154509315|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509316|NCT03703427|Capecitabine|capecitabine|mesh-list
154509317|NCT03703427|Vinorelbine|vinorelbine|mesh-list
154509318|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154509319|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
154509320|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509321|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509322|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154509323|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
154509324|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
154509325|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
154509326|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
154509327|NCT03703349|Analgesics|analgesics|mesh-ancestor
154509328|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
154509329|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509330|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509331|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
154509332|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509333|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154509334|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
154509335|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154509336|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154509337|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509338|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154509339|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
154509340|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154509341|NCT03008005|Dronabinol|dronabinol|mesh-list
154509342|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
154509343|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509344|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154509345|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154509346|NCT03008005|Analgesics|analgesics|mesh-ancestor
154509347|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
154509348|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509349|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154509350|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154509351|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509352|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509353|NCT03008005|Hormones|hormones|mesh-ancestor
154509354|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509355|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
154509356|NCT03666325|Cetuximab|cetuximab|mesh-list
154509357|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509358|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509359|NCT03666325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154509360|NCT03666325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860224|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154509361|NCT02440425|Paclitaxel|paclitaxel|mesh-list
154509362|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
154509363|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154509364|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509365|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
154509366|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
154509367|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
154509368|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509369|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509370|NCT02440425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154509371|NCT04182321|Metformin|metformin|mesh-list
154509372|NCT04182321|Entecavir|entecavir|mesh-list
154509373|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154509374|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509375|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
154509376|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509377|NCT03702959|Betamethasone|betamethasone|mesh-list
154509378|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509379|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
154509380|NCT03702959|Hormones|hormones|mesh-ancestor
154509381|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509382|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509383|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154509384|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
154509385|NCT03001219|Methotrexate|methotrexate|mesh-list
154509386|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154509387|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
154509388|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154509389|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509390|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154509391|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
154509392|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509393|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509394|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
154509395|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509396|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154509397|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154509398|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
154509399|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509400|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154509401|NCT03702803|Alprazolam|alprazolam|mesh-list
154509402|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154509403|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509404|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509405|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154509406|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154509407|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154509408|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
154509409|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
154509410|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509411|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509412|NCT03702647|Ropivacaine|ropivacaine|mesh-list
154509413|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
154509414|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
154509415|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509416|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509417|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
154509418|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509419|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154509420|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154509421|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509422|NCT03000673|Heparin|heparin|mesh-list
154509423|NCT03000673|Enoxaparin|enoxaparin|mesh-list
154509424|NCT03000673|Calcium heparin|calcium heparin|mesh-list
154509425|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
154509426|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154509427|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154509428|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509429|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
154509430|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154509431|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
154509432|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509433|NCT05423249|Protective Agents|protective agents|mesh-ancestor
154509434|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509436|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
154509437|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
154509438|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154509439|NCT02912455|Canagliflozin|canagliflozin|mesh-list
154509440|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154509441|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509442|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154509443|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509444|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
154509445|NCT03702491|Apatinib|apatinib|mesh-list
154509446|NCT03702491|Tegafur|tegafur|mesh-list
154509447|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509448|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154509449|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509450|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509451|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154509452|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
154509453|NCT03663751|Decitabine|decitabine|mesh-list
154509454|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154509455|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
154509456|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509457|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509458|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509459|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
154509460|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154509461|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154509462|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509463|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
154509464|NCT04054687|Coagulants|coagulants|mesh-ancestor
154509465|NCT03492489|Cemiplimab|cemiplimab|mesh-list
154509466|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509467|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509468|NCT02531698|Vaccines|vaccines|mesh-list
154509469|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
154509470|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509471|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
154509472|NCT04308837|Promethazine|promethazine|mesh-list
154509473|NCT04308837|Dexamethasone|dexamethasone|mesh-list
154509474|NCT04308837|Paclitaxel|paclitaxel|mesh-list
154509475|NCT04308837|Carboplatin|carboplatin|mesh-list
154509476|NCT04308837|Palonosetron|palonosetron|mesh-list
154509477|NCT04308837|Famotidine|famotidine|mesh-list
154509478|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154509479|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509480|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
154509481|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
154509482|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
154509483|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509484|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509485|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
154509486|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
154509487|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509488|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509489|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154509490|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
154509491|NCT04308837|Hormones|hormones|mesh-ancestor
154509492|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509493|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154509494|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154509495|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154509496|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509497|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
154509498|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
154509499|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
154509500|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154509501|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
154509502|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
154509503|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509504|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154509505|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
154509506|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
154509507|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154509508|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154509509|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
154509510|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154509511|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154509512|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
154509513|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154509514|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154509515|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154509516|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154509517|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509518|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
154509519|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509520|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509521|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154509522|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509523|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
154509524|NCT00403793|Etonogestrel|etonogestrel|mesh-list
154509525|NCT00403793|Testosterone|testosterone|mesh-list
154509526|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
154509527|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
154509528|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154509529|NCT00403793|Androgens|androgens|mesh-ancestor
154509530|NCT00403793|Hormones|hormones|mesh-ancestor
154509531|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509532|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509533|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154509534|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509535|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
154509536|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154509537|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
154509538|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154509539|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154509540|NCT03034577|Neostigmine|neostigmine|mesh-list
154509541|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154278704|NCT01149564|Ibuprofen|ibuprofen|mesh-list
154509542|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509543|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509544|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
154509545|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509546|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509547|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154509548|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
154509549|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509550|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154509551|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154509552|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154509553|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154509554|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154509555|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509556|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509557|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509558|NCT04364997|Analgesics|analgesics|mesh-ancestor
154509559|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
154509560|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509561|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
154509562|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154509563|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
154233436|NCT01169506|Trace Elements|trace elements|mesh-ancestor
154509564|NCT05417386|Leucovorin|leucovorin|mesh-list
154509565|NCT05417386|Capecitabine|capecitabine|mesh-list
154509566|NCT05417386|Fluorouracil|fluorouracil|mesh-list
154509567|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
154509568|NCT05417386|Irinotecan|irinotecan|mesh-list
154509569|NCT05417386|Folfirinox|folfirinox|mesh-list
154509570|NCT05417386|Camptothecin|camptothecin|mesh-list
154509571|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
154509572|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509573|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154509574|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
154509575|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509576|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509577|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154509578|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
154509579|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154509580|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154509581|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509582|NCT05417386|Antidotes|antidotes|mesh-ancestor
154509583|NCT05417386|Protective Agents|protective agents|mesh-ancestor
154509584|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
154509585|NCT05417386|Vitamins|vitamins|mesh-ancestor
154509586|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
154509587|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154509589|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154509590|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154509591|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154509592|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154509593|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
154509594|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509595|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509596|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509597|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
154509598|NCT03487107|Yimitasvir|yimitasvir|mesh-list
154509599|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
154509600|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509601|NCT02997163|Talazoparib|talazoparib|mesh-list
154509602|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154509603|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509604|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509605|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509606|NCT03705065|Bupivacaine|bupivacaine|mesh-list
154509607|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
154509608|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
154509609|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509610|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509611|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
154509612|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509613|NCT03702023|Acetaminophen|acetaminophen|mesh-list
154509614|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154509615|NCT03702023|Analgesics|analgesics|mesh-ancestor
154509616|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
154509617|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509618|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509619|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
154509620|NCT03698513|Aspirin|aspirin|mesh-list
154509621|NCT03698513|Clopidogrel|clopidogrel|mesh-list
154509622|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154509623|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154509624|NCT03698513|Analgesics|analgesics|mesh-ancestor
154509625|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
154509626|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509627|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509628|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509629|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509630|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154509631|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154509632|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509633|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154509634|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154509635|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509636|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
154509637|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154509638|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154509639|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154509640|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
154509641|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509642|NCT03698435|Valganciclovir|valganciclovir|mesh-list
154509643|NCT03698435|Ganciclovir|ganciclovir|mesh-list
154509644|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154509645|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
154509646|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509647|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154509648|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509649|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509650|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154509651|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154509652|NCT03697889|Naproxen|naproxen|mesh-list
154509653|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154509654|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154509655|NCT03697889|Analgesics|analgesics|mesh-ancestor
154509656|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
154509657|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509658|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509659|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509660|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509661|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
154509662|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154509663|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509664|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509665|NCT03692819|Amoxicillin|amoxicillin|mesh-list
154509666|NCT03692819|Metronidazole|metronidazole|mesh-list
154509667|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154509668|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509669|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154509670|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154509671|NCT00458536|Molgramostim|molgramostim|mesh-list
154509672|NCT00458536|Sargramostim|sargramostim|mesh-list
154509673|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
154509674|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509675|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509676|NCT03697655|Daratumumab|daratumumab|mesh-list
154509677|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509678|NCT02526550|Vaccines|vaccines|mesh-list
154509679|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
154509680|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509681|NCT05565352|Ketamine|ketamine|mesh-list
154509682|NCT05565352|Analgesics|analgesics|mesh-ancestor
154509683|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
154509684|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509685|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509686|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154509687|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154509688|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
154509689|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
154509690|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509691|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154509692|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154509693|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509694|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509695|NCT04423276|Donepezil|donepezil|mesh-list
154509696|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154509697|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509698|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509699|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
154509700|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509701|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509702|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
154509703|NCT03701087|Vitamin D|vitamin d|mesh-list
154509704|NCT03701087|Vitamins|vitamins|mesh-ancestor
154509705|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
154509706|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509707|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154509708|NCT03697265|Pregnanolone|pregnanolone|mesh-list
154509709|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
154509710|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278880|NCT05941806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154509711|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509712|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154509713|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154509714|NCT04336943|Durvalumab|durvalumab|mesh-list
154509715|NCT04336943|Olaparib|olaparib|mesh-list
154509716|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154509717|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
154509718|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154509719|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
154509720|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509721|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509722|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
154509723|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509724|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509725|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509726|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
154509727|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154509728|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154509729|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509730|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
154509731|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
154509732|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
154509733|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
154509734|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154509735|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509736|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509737|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
154509738|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154509739|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509740|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509741|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
154509742|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154509743|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154509744|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154509745|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509746|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
154509747|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509748|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509749|NCT03696095|Ropivacaine|ropivacaine|mesh-list
154509750|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
154509751|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
154509752|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509753|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509754|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
154509755|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509756|NCT03700229|Rituximab|rituximab|mesh-list
154509757|NCT03700229|Bortezomib|bortezomib|mesh-list
154509758|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509759|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509760|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
154509761|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509762|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509763|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154509764|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154278936|NCT05939219|Immunologic Factors|immunologic factors|mesh-ancestor
154509765|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509766|NCT03695705|Rifaximin|rifaximin|mesh-list
154509767|NCT03695705|Norfloxacin|norfloxacin|mesh-list
154509768|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154509769|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509770|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154509771|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154509772|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154509773|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509774|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509775|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509776|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154509777|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154509778|NCT03699839|Vaccines|vaccines|mesh-list
154509779|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
154509780|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509781|NCT04050215|Edetic Acid|edetic acid|mesh-list
154509782|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154509783|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
154509784|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
154509785|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509786|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
154509787|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154509788|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154509789|NCT03699449|Paclitaxel|paclitaxel|mesh-list
154509790|NCT03699449|Durvalumab|durvalumab|mesh-list
154509791|NCT03699449|Olaparib|olaparib|mesh-list
154509792|NCT03699449|Tremelimumab|tremelimumab|mesh-list
154509793|NCT03699449|Cediranib|cediranib|mesh-list
154509794|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154509795|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154509796|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509797|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
154509798|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
154509799|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
154509800|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509801|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154509802|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
154509803|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509804|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154509805|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509806|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154509807|NCT03699293|Aspirin|aspirin|mesh-list
154509808|NCT03699293|Celecoxib|celecoxib|mesh-list
154509809|NCT03699293|Naproxen|naproxen|mesh-list
154509810|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154509811|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154509812|NCT03699293|Analgesics|analgesics|mesh-ancestor
154509813|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
154509814|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509815|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509816|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509817|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509818|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154509819|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154509820|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509821|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154509822|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154509823|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509824|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
154509825|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154509826|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
154509827|NCT03029819|Nicotine|nicotine|mesh-list
154509828|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154509829|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
154509830|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509831|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509832|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154509833|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154509834|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
154509835|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509836|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509837|NCT03105830|Acetaminophen|acetaminophen|mesh-list
154509838|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154509839|NCT03105830|Analgesics|analgesics|mesh-ancestor
154509840|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
154509841|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509842|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509843|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
154509844|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
154509845|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154509846|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154509847|NCT03699215|Simendan|simendan|mesh-list
154509848|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154509849|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
154509850|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154509851|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154509852|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509853|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509854|NCT03699215|Protective Agents|protective agents|mesh-ancestor
154509855|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509856|NCT03694535|Mitomycins|mitomycins|mesh-list
154509857|NCT03694535|Mitomycin|mitomycin|mesh-list
154509858|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154509859|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509860|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
154509861|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509862|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154509863|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509864|NCT03115034|Melatonin|melatonin|mesh-list
154509865|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
154509866|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509867|NCT03115034|Protective Agents|protective agents|mesh-ancestor
154509868|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509869|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509870|NCT03027557|Denosumab|denosumab|mesh-list
154509871|NCT03027557|Cinacalcet|cinacalcet|mesh-list
154509872|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154509873|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509874|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154509875|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154509876|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
154509877|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509878|NCT03698825|Vactosertib|vactosertib|mesh-list
154509879|NCT03698825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154509880|NCT03698825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509881|NCT03698825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509882|NCT02691572|Acetaminophen|acetaminophen|mesh-list
154509883|NCT02691572|Ketorolac|ketorolac|mesh-list
154509884|NCT02691572|Fentanyl|fentanyl|mesh-list
154509885|NCT02691572|Bupivacaine|bupivacaine|mesh-list
154509886|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
154509887|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
154509888|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509889|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509890|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
154509891|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509892|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154509893|NCT02691572|Narcotics|narcotics|mesh-ancestor
154509894|NCT02691572|Analgesics|analgesics|mesh-ancestor
154509895|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154509896|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154509897|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
154509898|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154509899|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
154509900|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154509901|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509902|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509903|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154509904|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509905|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509906|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154509907|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154509908|NCT03693833|Cannabidiol|cannabidiol|mesh-list
154509909|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
154509910|NCT03693599|Carbetocin|carbetocin|mesh-list
154509911|NCT03693599|Syntometrine|syntometrine|mesh-list
154509912|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
154509913|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154509914|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509915|NCT04277663|Interferons|interferons|mesh-list
154509916|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509917|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
154509918|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509919|NCT04270643|Vitamin D|vitamin d|mesh-list
154509920|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
154509921|NCT04270643|Vitamins|vitamins|mesh-ancestor
154509922|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
154509923|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509924|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154509925|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154509926|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154509927|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154509928|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154509929|NCT02677844|Loperamide|loperamide|mesh-list
154509930|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
154509931|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154509932|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
154509933|NCT03687905|Chloroquine|chloroquine|mesh-list
154509934|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
154509935|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154509936|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154509937|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154509938|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509939|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509940|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154509941|NCT03687905|Amebicides|amebicides|mesh-ancestor
154509942|NCT03687515|Prednisone|prednisone|mesh-list
154509943|NCT03687515|Budesonide|budesonide|mesh-list
154233823|NCT01284166|Timolol|timolol|mesh-list
154509944|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154509945|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
154509946|NCT03687515|Hormones|hormones|mesh-ancestor
154509947|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509948|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509949|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154509950|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154509951|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154509953|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509954|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154509955|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
154509956|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154509957|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154509958|NCT02691494|Norethindrone|norethindrone|mesh-list
154509959|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
154509960|NCT02691494|Estradiol|estradiol|mesh-list
154509961|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154509962|NCT02691494|Estrogens|estrogens|mesh-ancestor
154509963|NCT02691494|Hormones|hormones|mesh-ancestor
154509964|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154509965|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509966|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154860225|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
154509967|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
154509968|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154509969|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154509970|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154509971|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154509972|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154509974|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154509975|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154509976|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154509977|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
154509978|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154509979|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509980|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154509981|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
154509982|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509983|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
154509984|NCT03691337|Bupivacaine|bupivacaine|mesh-list
154509985|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154509986|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
154509987|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
154509988|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154509989|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509990|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
154509991|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509992|NCT02681510|Nicotine|nicotine|mesh-list
154509993|NCT02681510|Varenicline|varenicline|mesh-list
154509994|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154509995|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
154509996|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154509997|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154509998|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154509999|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154510000|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
154510001|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510002|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510003|NCT03690323|Paclitaxel|paclitaxel|mesh-list
154510004|NCT03690323|Gemcitabine|gemcitabine|mesh-list
154510005|NCT03690323|Folfirinox|folfirinox|mesh-list
154510006|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154510007|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510008|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
154510009|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
154510010|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
154510011|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510012|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154510013|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
154510014|NCT03682211|Fentanyl|fentanyl|mesh-list
154510015|NCT03682211|Morphine|morphine|mesh-list
154510016|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154510017|NCT03682211|Narcotics|narcotics|mesh-ancestor
154510018|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510019|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510020|NCT03682211|Analgesics|analgesics|mesh-ancestor
154510021|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
154510022|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510023|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154510024|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154510025|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
154510027|NCT02690714|Plasminogen|plasminogen|mesh-list
154510028|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154510029|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154510030|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510031|NCT03690167|Mitogens|mitogens|mesh-list
154510032|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
154510033|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510034|NCT03165890|Acetazolamide|acetazolamide|mesh-list
154510035|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
154510036|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154510037|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510038|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510039|NCT03165890|Diuretics|diuretics|mesh-ancestor
154510040|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
154510041|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510042|NCT03681509|Pramipexole|pramipexole|mesh-list
154510043|NCT03681509|Dexpramipexole|dexpramipexole|mesh-list
154510044|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
154510045|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510046|NCT03681509|Protective Agents|protective agents|mesh-ancestor
154510047|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510048|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154510049|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154510050|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
154510051|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
154510052|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510053|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
154510054|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
154510055|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154510056|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510057|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510058|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
154510059|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154510060|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510061|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510062|NCT03161210|Anesthetics|anesthetics|mesh-list
154510063|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510064|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510065|NCT03164096|Bupivacaine|bupivacaine|mesh-list
154510066|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
154510067|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
154510068|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279228|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154510069|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510070|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
154510071|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510072|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
154510073|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154510074|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154510075|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510076|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154510077|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154510078|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510079|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
154510080|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
154510081|NCT03681431|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154510082|NCT03681431|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154510083|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154510084|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510085|NCT03681197|Metformin|metformin|mesh-list
154510086|NCT03681197|Clomiphene|clomiphene|mesh-list
154510087|NCT03681197|Enclomiphene|enclomiphene|mesh-list
154510088|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
154510089|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154510090|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510091|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154510092|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
154510093|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510094|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154510095|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
154233965|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154510096|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154510097|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154510098|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154510099|NCT03485703|Azithromycin|azithromycin|mesh-list
154510100|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154510101|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510102|NCT03165344|Prednisone|prednisone|mesh-list
154510103|NCT03165344|Triamcinolone|triamcinolone|mesh-list
154510104|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154510105|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154510106|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
154510107|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154510108|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154510109|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154510110|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
154510111|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154510112|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510113|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
154510114|NCT03165344|Hormones|hormones|mesh-ancestor
154510115|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860226|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510116|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510117|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154510118|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510119|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154510120|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
154510121|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510122|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510123|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154510124|NCT03165344|Antacids|antacids|mesh-ancestor
154510125|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154510126|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
154510127|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154510128|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154510129|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154510130|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510131|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510132|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510133|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
154510134|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
154510135|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510136|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
154510137|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154510138|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
154510139|NCT03689465|Cyclosporine|cyclosporine|mesh-list
154510140|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
154510141|NCT03689465|Methotrexate|methotrexate|mesh-list
154510142|NCT03689465|Cyclosporins|cyclosporins|mesh-list
154510143|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154510144|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
154510145|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154510146|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510147|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154510148|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
154510149|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510150|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510151|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154510152|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510153|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154510154|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154510155|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
154510156|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510157|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154510158|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
154510159|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510160|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154510161|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154510162|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154510163|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
154510164|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154510165|NCT03485625|Acetaminophen|acetaminophen|mesh-list
154510166|NCT03485625|Ketorolac|ketorolac|mesh-list
154510167|NCT03485625|Lidocaine|lidocaine|mesh-list
154510168|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
154510169|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
154510170|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510171|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510172|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
154510173|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510174|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154510175|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154510176|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154510177|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154510178|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510179|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154510180|NCT03485625|Analgesics|analgesics|mesh-ancestor
154510181|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
154510182|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154510183|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510184|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510185|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154510186|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510187|NCT03680885|Lidocaine|lidocaine|mesh-list
154510188|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
154510189|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
154510190|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510191|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510192|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
154510193|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510194|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154510195|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154510196|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154510197|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154510198|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510199|NCT03033069|Sertraline|sertraline|mesh-list
154510200|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
154510201|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
154510202|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154510203|NCT03033069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154510204|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154510205|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154510206|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510207|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510208|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
154510209|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510210|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
154510211|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
154510212|NCT03685409|Metformin|metformin|mesh-list
154510213|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154279409|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
154279410|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279411|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154279412|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154279413|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279414|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279415|NCT02759185|Hormones|hormones|mesh-ancestor
154279416|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279417|NCT02436993|Paclitaxel|paclitaxel|mesh-list
154279418|NCT02436993|Bevacizumab|bevacizumab|mesh-list
154279419|NCT02436993|Carboplatin|carboplatin|mesh-list
154279420|NCT02436993|Trastuzumab|trastuzumab|mesh-list
154279421|NCT02436993|Pertuzumab|pertuzumab|mesh-list
154279422|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154026292|NCT04965272|Cariprazine|cariprazine|mesh-list
154279423|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279434|NCT02193841|Calcium|calcium|mesh-list
154510214|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510215|NCT03165500|Midazolam|midazolam|mesh-list
154510216|NCT03165500|Diazepam|diazepam|mesh-list
154510217|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
154510218|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154510219|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154510220|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510221|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510222|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154510223|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154510224|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154510225|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154510226|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
154510227|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
154510228|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
154510229|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
154510230|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510231|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510232|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154510233|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154510234|NCT03165500|Analgesics|analgesics|mesh-ancestor
154510235|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
154510236|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510237|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
154510238|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
154510239|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
154510240|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154510241|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154510242|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154510243|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
154510244|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154510245|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234113|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
154510247|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154510248|NCT03163238|Analgesics|analgesics|mesh-ancestor
154510249|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
154510250|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510251|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154510252|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154510253|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154510254|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
154510255|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510256|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510257|NCT03486561|Ranolazine|ranolazine|mesh-list
154510258|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154510259|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154510260|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510261|NCT03680573|Allopurinol|allopurinol|mesh-list
154510262|NCT03680573|Nitroprusside|nitroprusside|mesh-list
154510263|NCT03680573|Nitroarginine|nitroarginine|mesh-list
154510264|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
154860227|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510265|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
154510266|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510267|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510268|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
154510269|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510270|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154510271|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
154510272|NCT03680573|Protective Agents|protective agents|mesh-ancestor
154510273|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510274|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154510275|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
154510276|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154510277|NCT03689075|Tacrolimus|tacrolimus|mesh-list
154510278|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154510279|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
154510280|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510281|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154510282|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510283|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510284|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
154510285|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154510286|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154510287|NCT03680495|Prednisolone|prednisolone|mesh-list
154510288|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
154510289|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154510290|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
154510291|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510292|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
154510293|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
154510294|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510295|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510296|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154510297|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
154510298|NCT03680495|Hormones|hormones|mesh-ancestor
154510299|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510300|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154510301|NCT03680495|Protective Agents|protective agents|mesh-ancestor
154510302|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154510303|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510304|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
154510305|NCT03492255|Prednisone|prednisone|mesh-list
154510306|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
154510307|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
154510308|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154510309|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
154510310|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510311|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510312|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154510313|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
154510314|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510315|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510316|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154510317|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510318|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
154234259|NCT01179412|Iodine|iodine|mesh-list
154510319|NCT03492255|Hormones|hormones|mesh-ancestor
154510320|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510321|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154510322|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154510323|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154510324|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
154510325|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154510326|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510328|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
154510329|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
154510330|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510331|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279499|NCT01639690|Busulfan|busulfan|mesh-list
154510332|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154510333|NCT03492255|Protective Agents|protective agents|mesh-ancestor
154510334|NCT03684863|Capecitabine|capecitabine|mesh-list
154510335|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154510336|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
154510337|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510338|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510339|NCT03680339|Misoprostol|misoprostol|mesh-list
154510340|NCT03680339|Oxytocin|oxytocin|mesh-list
154510342|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154510343|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510344|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154510345|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
154510346|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154510347|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154510348|NCT03680183|Entecavir|entecavir|mesh-list
154510349|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
154510350|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510351|NCT02136069|Infliximab|infliximab|mesh-list
154510352|NCT02136069|Etrolizumab|etrolizumab|mesh-list
154510353|NCT02136069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154510354|NCT02136069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510355|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154510356|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154510357|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510358|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
154510359|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510360|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154510361|NCT02917031|Saxagliptin|saxagliptin|mesh-list
154510362|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154510363|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510364|NCT02917031|Incretins|incretins|mesh-ancestor
154510365|NCT02917031|Hormones|hormones|mesh-ancestor
154510366|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510367|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154510368|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
154510369|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510370|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510371|NCT04460547|Interferons|interferons|mesh-list
154510372|NCT04460547|Interferon-beta|interferon-beta|mesh-list
154510373|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
154510374|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
154510375|NCT04460547|Ivermectin|ivermectin|mesh-list
154510376|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510377|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
154510378|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510379|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
154510380|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154510381|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154510382|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510383|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510384|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510385|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
154510386|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510387|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154510388|NCT03132051|Triamcinolone|triamcinolone|mesh-list
154510389|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154510390|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154510391|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154510392|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510393|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
154510394|NCT03132051|Hormones|hormones|mesh-ancestor
154510395|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510396|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510397|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154510398|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
154510399|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510400|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510401|NCT03684707|Metformin|metformin|mesh-list
154510402|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154510403|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510404|NCT01018563|Farletuzumab|farletuzumab|mesh-list
154510405|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510406|NCT02528188|Tanezumab|tanezumab|mesh-list
154510407|NCT02528188|Analgesics|analgesics|mesh-ancestor
154510408|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
154510409|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510410|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510411|NCT03684395|Warfarin|warfarin|mesh-list
154510412|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
154510413|NCT03684395|Dabigatran|dabigatran|mesh-list
154510414|NCT03684395|Apixaban|apixaban|mesh-list
154510415|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
154510416|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154510417|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
154510418|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154510420|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510421|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510422|NCT04460001|Triamcinolone|triamcinolone|mesh-list
154510423|NCT04460001|Ranibizumab|ranibizumab|mesh-list
154510424|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154510425|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154510426|NCT04460001|Growth Substances|growth substances|mesh-ancestor
154510427|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510428|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
154510429|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510430|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510431|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
154510432|NCT04460001|Hormones|hormones|mesh-ancestor
154510433|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510434|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
154510435|NCT03484845|Lactoferrin|lactoferrin|mesh-list
154510436|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510437|NCT03484845|Trace Elements|trace elements|mesh-ancestor
154510438|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
154510439|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510440|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
154510441|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154510442|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154510443|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510444|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
154510445|NCT03679481|Coagulants|coagulants|mesh-ancestor
154510446|NCT04461249|Travoprost|travoprost|mesh-list
154510447|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154510448|NCT04461249|Latanoprost|latanoprost|mesh-list
154510449|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154510450|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154510451|NCT05151549|Carboplatin|carboplatin|mesh-list
154510452|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510453|NCT05151393|Vitamin D|vitamin d|mesh-list
154510454|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
154510455|NCT05151393|Vitamins|vitamins|mesh-ancestor
154510456|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
154510457|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510458|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154510459|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154510460|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154510461|NCT03484611|Cetrorelix|cetrorelix|mesh-list
154510462|NCT03484611|Menotropins|menotropins|mesh-list
154510463|NCT03484611|Progesterone|progesterone|mesh-list
154510464|NCT03484611|Progestins|progestins|mesh-ancestor
154510465|NCT03484611|Hormones|hormones|mesh-ancestor
154510466|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510467|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510468|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154510469|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154510470|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
154510471|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
154510472|NCT03679325|Vitamin D|vitamin d|mesh-list
154510473|NCT03679325|Vitamins|vitamins|mesh-ancestor
154510474|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
154510475|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510476|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154510477|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
154510478|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154510479|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510480|NCT03878927|Immunotoxins|immunotoxins|mesh-ancestor
154510481|NCT03878927|Immunoconjugates|immunoconjugates|mesh-ancestor
154510482|NCT03878927|Immunologic Factors|immunologic factors|mesh-ancestor
154510483|NCT03878927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510484|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
154510485|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510486|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154510487|NCT03623711|Bupropion|bupropion|mesh-list
154510488|NCT03623711|Escitalopram|escitalopram|mesh-list
154510489|NCT03623711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154510490|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154510491|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154510492|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510493|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510494|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
154510495|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510496|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279677|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
154279678|NCT01257672|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154279679|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154279680|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
154279681|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279682|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279683|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154279684|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
154510497|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154510498|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
154510499|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154510500|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154510502|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154510503|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154510504|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510505|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154510506|NCT03623711|Analgesics|analgesics|mesh-ancestor
154510507|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
154510508|NCT05362474|Montelukast|montelukast|mesh-list
154510509|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154510510|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
154510511|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154510512|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
154510513|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510514|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510515|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154510516|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154510517|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510518|NCT05599516|Vaccines|vaccines|mesh-list
154510519|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
154510520|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510521|NCT05380024|Ensartinib|ensartinib|mesh-list
154510522|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510523|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154510524|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510525|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510526|NCT05342194|Gemcitabine|gemcitabine|mesh-list
154510527|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
154510528|NCT05342194|Lenvatinib|lenvatinib|mesh-list
154510529|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510530|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154510531|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
154510532|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510533|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154510534|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510535|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
154510536|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
154510537|NCT03623789|Hemostatics|hemostatics|mesh-list
154510538|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154510539|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154510540|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510541|NCT03623789|Coagulants|coagulants|mesh-ancestor
154510542|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
154510543|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154510544|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154510545|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510546|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154510547|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154510548|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234416|NCT01288924|Analgesics|analgesics|mesh-ancestor
154510549|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510550|NCT05306470|Lidocaine|lidocaine|mesh-list
154510551|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
154510552|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
154510553|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
154510554|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510555|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510556|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
154510557|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510558|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154510559|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154510560|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154510561|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154510562|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510563|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154510564|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154510565|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510566|NCT05339386|Xenon|xenon|mesh-list
154510567|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154510568|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
154510569|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
154510570|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510571|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510572|NCT05339074|Ketamine|ketamine|mesh-list
154510573|NCT05339074|Analgesics|analgesics|mesh-ancestor
154510574|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
154510575|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510576|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510577|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154510578|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154510579|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
154510580|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
154510581|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510582|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154510583|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154510584|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510585|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510586|NCT05560282|Fenfluramine|fenfluramine|mesh-list
154510587|NCT05560282|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154510588|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154510589|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154510590|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510591|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510592|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
154510593|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510594|NCT05338450|Clemastine|clemastine|mesh-list
154510595|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
154510596|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
154510597|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154279755|NCT01255644|Valganciclovir|valganciclovir|mesh-list
154510598|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
154510599|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
154510600|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510601|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510602|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510603|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154510604|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154510605|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154510606|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154510607|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
154510608|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510609|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154510610|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154510611|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510612|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154510613|NCT03676985|Antibodies|antibodies|mesh-list
154510614|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
154510615|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154510616|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
154510617|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510618|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510619|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154510621|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
154510622|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510623|NCT02988401|Insulin|insulin|mesh-list
154510624|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154510625|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510626|NCT05266456|Vaccines|vaccines|mesh-list
154510627|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154510628|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
154279814|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
154279815|NCT03892434|Bevacizumab|bevacizumab|mesh-list
154279816|NCT03892434|BB 1101|bb 1101|mesh-list
154279817|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279818|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279819|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154279820|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154279821|NCT03892434|Growth Substances|growth substances|mesh-ancestor
154279822|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279823|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
154279824|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154279825|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
154279826|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
154510629|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510630|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154510631|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
154510632|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510633|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510634|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154510635|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154510636|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154510637|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
154510638|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510639|NCT03484221|Capecitabine|capecitabine|mesh-list
154510640|NCT03484221|Fluorouracil|fluorouracil|mesh-list
154510641|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
154510642|NCT03484221|Irinotecan|irinotecan|mesh-list
154510643|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154510644|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
154510645|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510646|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510647|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154510648|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
154510649|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510650|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154510651|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154510652|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510653|NCT03857139|Nicotine|nicotine|mesh-list
154510654|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154510655|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
154510656|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279845|NCT03892122|Propofol|propofol|mesh-list
154279846|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154279847|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279848|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279849|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279850|NCT03892122|Analgesics|analgesics|mesh-ancestor
154279851|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
154279852|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279853|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154279854|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154279855|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154279856|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
154279857|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279858|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279859|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154279860|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
154279861|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
154279862|NCT01589562|Megestrol|megestrol|mesh-list
154510657|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510658|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154510659|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154510660|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
154510661|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510662|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510663|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
154510664|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154510665|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510666|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154510667|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154510668|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510669|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510670|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510671|NCT05255770|Benzocaine|benzocaine|mesh-list
154510672|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
154510673|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
154510674|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510675|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510676|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
154510677|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510678|NCT05322538|Vitamin D|vitamin d|mesh-list
154510679|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
154510680|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
154510681|NCT05322538|Vitamins|vitamins|mesh-list
154510682|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154510683|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
154510684|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510685|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154510686|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154510687|NCT03476655|Ibrutinib|ibrutinib|mesh-list
154279872|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154279873|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279874|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
154279875|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154279876|NCT01152372|Insulin|insulin|mesh-list
154279877|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154279878|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279879|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154279880|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
154279881|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154279882|NCT01259934|Interferons|interferons|mesh-list
154279883|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
154510688|NCT03476655|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154510689|NCT03476655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154510690|NCT03476655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510691|NCT03476655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510692|NCT04965220|Trametinib|trametinib|mesh-list
154510693|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510694|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154510695|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510696|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234563|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154510697|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
154510699|NCT03672149|Cefazolin|cefazolin|mesh-list
154510700|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154510701|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510702|NCT03672071|Ephedrine|ephedrine|mesh-list
154510703|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
154510704|NCT03672071|Norepinephrine|norepinephrine|mesh-list
154510705|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154510706|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510707|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
154510708|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
154510709|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510710|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154510711|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
154510712|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510713|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279904|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154279905|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154279906|NCT01151592|Hematinics|hematinics|mesh-ancestor
154279907|NCT01151670|Pioglitazone|pioglitazone|mesh-list
154279908|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154279909|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279910|NCT03888846|Colchicine|colchicine|mesh-list
154279911|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
154279912|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
154279913|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154279914|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
154279915|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
154279916|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
154279917|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279918|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279919|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154279920|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279921|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154279922|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154279923|NCT03888846|Protective Agents|protective agents|mesh-ancestor
154279924|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510714|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154510715|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154510716|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
154510717|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
154510718|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154510719|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154510720|NCT03480945|Nitroprusside|nitroprusside|mesh-list
154510721|NCT03480945|Serotonin|serotonin|mesh-list
154510722|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154510723|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
154510724|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510725|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510726|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510727|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154510728|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
154510729|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154510730|NCT03483207|Heparin|heparin|mesh-list
154510731|NCT03483207|Warfarin|warfarin|mesh-list
154510732|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
154510733|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154510734|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154510735|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510736|NCT05132985|Carboplatin|carboplatin|mesh-list
154510737|NCT05132985|Pemetrexed|pemetrexed|mesh-list
154510738|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510739|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510740|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510741|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154510742|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154510743|NCT03739593|Dexamethasone|dexamethasone|mesh-list
154510744|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
154510745|NCT03739593|BB 1101|bb 1101|mesh-list
154510746|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510747|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
154510748|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
154279931|NCT01153542|Ivacaftor|ivacaftor|mesh-list
154279932|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154279933|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154279934|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279935|NCT01152606|Trastuzumab|trastuzumab|mesh-list
154279936|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279937|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510749|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510750|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510751|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154510752|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
154510753|NCT03739593|Hormones|hormones|mesh-ancestor
154510754|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510755|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154510756|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510757|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
154510758|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510759|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510760|NCT03480867|Temozolomide|temozolomide|mesh-list
154510761|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154510762|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
154510763|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510764|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510765|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
154510766|NCT05254912|Petrolatum|petrolatum|mesh-list
154510767|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154510768|NCT05254912|Protective Agents|protective agents|mesh-ancestor
154510769|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510770|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
154510771|NCT05254912|Emollients|emollients|mesh-ancestor
154510772|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
154279963|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279964|NCT03885804|Analgesics|analgesics|mesh-ancestor
154279965|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
154279966|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279967|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154279968|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154279969|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154279970|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
154279971|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279972|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279973|NCT03885258|Melatonin|melatonin|mesh-list
154279974|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
154279975|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279976|NCT03885258|Protective Agents|protective agents|mesh-ancestor
154279977|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279978|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279979|NCT01262196|Chrysarobin|chrysarobin|mesh-list
154279980|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154279981|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279982|NCT01262196|Analgesics|analgesics|mesh-ancestor
154279983|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
154279984|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279985|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510773|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154510774|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510775|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510776|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154510777|NCT03480789|Analgesics|analgesics|mesh-ancestor
154510778|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
154510779|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510780|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154510781|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154510782|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154510783|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154510784|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510785|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510786|NCT03475407|Dexamethasone|dexamethasone|mesh-list
154510787|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
154510788|NCT03475407|BB 1101|bb 1101|mesh-list
154510789|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510790|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
154510791|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
154510792|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510793|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510794|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279987|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154279988|NCT03885180|Warfarin|warfarin|mesh-list
154279989|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
154279990|NCT03888144|Ketorolac|ketorolac|mesh-list
154279991|NCT03888144|Oxycodone|oxycodone|mesh-list
154279992|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154279993|NCT03888144|Narcotics|narcotics|mesh-ancestor
154279994|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279995|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279996|NCT03888144|Analgesics|analgesics|mesh-ancestor
154279997|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
154279998|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279999|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154280000|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154280001|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154280002|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154280003|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154280004|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280005|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280006|NCT03890406|Rocuronium|rocuronium|mesh-list
154280007|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154280008|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154280009|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153813358|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
154280010|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510795|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
154510796|NCT03475407|Hormones|hormones|mesh-ancestor
154510797|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510798|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154510799|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510800|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
154510801|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510802|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510803|NCT03655197|Doxycycline|doxycycline|mesh-list
154510804|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154510805|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510806|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
154510807|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154510808|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154510809|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
154510810|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154510811|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154510812|NCT05317624|Prednisolone|prednisolone|mesh-list
154510813|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
154510814|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154510815|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
154510816|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510817|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
154510818|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
154510819|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510820|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510821|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154510822|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
154510823|NCT05317624|Hormones|hormones|mesh-ancestor
154510824|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280011|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280012|NCT01154400|Caseins|caseins|mesh-list
154280013|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
154280014|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
154280015|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280016|NCT01152840|Everolimus|everolimus|mesh-list
154280017|NCT01152840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154280018|NCT01152840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154280019|NCT01152840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280020|NCT01152840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280021|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280022|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
154280023|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280039|NCT01260558|Sirolimus|sirolimus|mesh-list
154510825|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154510826|NCT05317624|Protective Agents|protective agents|mesh-ancestor
154510827|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154510828|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510829|NCT03475017|Curcumin|curcumin|mesh-list
154510830|NCT03475017|Piperine|piperine|mesh-list
154510831|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154510832|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154510833|NCT03475017|Analgesics|analgesics|mesh-ancestor
154510834|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
154510835|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510836|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510837|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510838|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510839|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510840|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510841|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510842|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154510843|NCT02674568|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154510844|NCT02674568|Immunoconjugates|immunoconjugates|mesh-ancestor
154510845|NCT02674568|Immunologic Factors|immunologic factors|mesh-ancestor
154510846|NCT02674568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510847|NCT03474939|Midazolam|midazolam|mesh-list
154510848|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154510849|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154510850|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510851|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510852|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154510853|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154510854|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154510855|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154280040|NCT01260558|Temsirolimus|temsirolimus|mesh-list
154280041|NCT01260558|MTOR Inhibitors|mtor inhibitors|mesh-list
154280042|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154280043|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280044|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154280045|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280046|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
154280047|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280048|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
154280049|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280050|NCT01260558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154280053|NCT01260714|Etoposide|etoposide|mesh-list
154510856|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
154510858|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
154510859|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
154510860|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510861|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510862|NCT03131583|Colchicine|colchicine|mesh-list
154510863|NCT03131583|Febuxostat|febuxostat|mesh-list
154510864|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
154510865|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510866|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
154510867|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
154510868|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
154510869|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510870|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510872|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154510873|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510874|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
154510875|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
154510876|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
154510877|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510878|NCT03480321|Cilostazol|cilostazol|mesh-list
154510879|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154510880|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
154510881|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510882|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510883|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154510884|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
154510885|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154280070|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
154280071|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
154280072|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
154280073|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
154280074|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
154280075|NCT03890094|Sufentanil|sufentanil|mesh-list
154280076|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154280077|NCT03890094|Narcotics|narcotics|mesh-ancestor
154280078|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280079|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280080|NCT03890094|Analgesics|analgesics|mesh-ancestor
154280081|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
154280082|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280083|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154280084|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154280085|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
154280086|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
154280087|NCT03887754|Risperidone|risperidone|mesh-list
154280088|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154510886|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154510887|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510888|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154510889|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
154510890|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154510891|NCT03480321|Protective Agents|protective agents|mesh-ancestor
154510892|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154510893|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154510894|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510895|NCT04928950|Charcoal|charcoal|mesh-list
154510896|NCT04928950|Antidotes|antidotes|mesh-ancestor
154510897|NCT04928950|Protective Agents|protective agents|mesh-ancestor
154510898|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510899|NCT02986269|Anesthetics|anesthetics|mesh-list
154510900|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510901|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510902|NCT03474237|Hormones|hormones|mesh-list
154510903|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510904|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510905|NCT03480165|Parecoxib|parecoxib|mesh-list
154510906|NCT03480165|Ropivacaine|ropivacaine|mesh-list
154510907|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
154510908|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
154510909|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510910|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510911|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
154510912|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510913|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154510914|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154510915|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510916|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510917|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154280099|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
154280100|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
154280101|NCT01262586|Glimepiride|glimepiride|mesh-list
154280102|NCT01262586|Vildagliptin|vildagliptin|mesh-list
154280103|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154280104|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154280133|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
154510918|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154510919|NCT03480165|Analgesics|analgesics|mesh-ancestor
154510920|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510921|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510922|NCT05311852|Palmidrol|palmidrol|mesh-list
154510923|NCT05311852|Antioxidants|antioxidants|mesh-list
154510924|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510925|NCT05311852|Protective Agents|protective agents|mesh-ancestor
154510926|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510927|NCT05311852|Analgesics|analgesics|mesh-ancestor
154510928|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
154510929|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510930|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154510931|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154510932|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154510933|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154510934|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
154510935|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510936|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154510937|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154510938|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154510939|NCT05311852|Hormones|hormones|mesh-ancestor
154280134|NCT01155960|Anastrozole|anastrozole|mesh-list
154280135|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154280136|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280137|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154280138|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154280139|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280140|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280141|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154280142|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
154280143|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280144|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280145|NCT03883776|Octreotide|octreotide|mesh-list
154280146|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
154280147|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154280148|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154280149|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280150|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154280151|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280152|NCT03886896|Lidocaine|lidocaine|mesh-list
154280153|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
154280154|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
153813361|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813362|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813363|NCT00432081|Indomethacin|indomethacin|mesh-list
154280155|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510940|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154510941|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154510942|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154510943|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154510944|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154510945|NCT03671915|Insulin|insulin|mesh-list
154510946|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154510947|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510948|NCT03302195|Heparin|heparin|mesh-list
154510949|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
154510950|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154510951|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154510952|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510953|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154510954|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
154510955|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154510956|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
154510957|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510958|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
154510959|NCT03114020|Protective Agents|protective agents|mesh-ancestor
154510960|NCT04460079|Lenograstim|lenograstim|mesh-list
154510961|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154510962|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
154510963|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510964|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154510965|NCT03473691|Immunoconjugates|immunoconjugates|mesh-ancestor
154510966|NCT03473691|Immunologic Factors|immunologic factors|mesh-ancestor
154510967|NCT03473691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510968|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154510969|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510970|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154510971|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
154510972|NCT03676361|Coagulants|coagulants|mesh-ancestor
154510973|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154510974|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
154280156|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280157|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
154280158|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510975|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510976|NCT05218486|Isotretinoin|isotretinoin|mesh-list
154510977|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
154510978|NCT05216770|Bupivacaine|bupivacaine|mesh-list
154510979|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
154510980|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
154510981|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154510982|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154510983|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
154510984|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154510985|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
154510986|NCT05236036|Temozolomide|temozolomide|mesh-list
154510987|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154510988|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
154510989|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154510990|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154510991|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154510992|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154510993|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
154510994|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154510995|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154510996|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154510997|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154510998|NCT02781779|Laxatives|laxatives|mesh-ancestor
154511000|NCT05270200|Azacitidine|azacitidine|mesh-list
154511001|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154511002|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
154511003|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511004|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511005|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511006|NCT03671057|Midazolam|midazolam|mesh-list
154511007|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154280189|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154280190|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280191|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154280192|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154280193|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
154280194|NCT01154790|Naproxen|naproxen|mesh-list
154280195|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154280196|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154280197|NCT01154790|Analgesics|analgesics|mesh-ancestor
154280198|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
154511008|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154511009|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511010|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511011|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154511012|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154511013|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154511014|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154511015|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
154511016|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
154511017|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
154511018|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
154511019|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511020|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511021|NCT03670901|Rituximab|rituximab|mesh-list
154511022|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511023|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511024|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
154511025|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511026|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511028|NCT05166616|Triptolide|triptolide|mesh-list
154511029|NCT05166616|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154511030|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154511031|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511032|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511033|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511034|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154511035|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
154511036|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154511037|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280222|NCT01263834|Mitomycin|mitomycin|mesh-list
154280223|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154280224|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280225|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154280226|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154280227|NCT01263834|Growth Substances|growth substances|mesh-ancestor
154280228|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280229|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
154280230|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154280231|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
154280232|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280233|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154280234|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511038|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154511039|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
154511040|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154511041|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511042|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
154511043|NCT05213728|Vaccines|vaccines|mesh-list
154511044|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
154511045|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511046|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
154511047|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154511048|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511049|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511050|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511051|NCT05165836|Analgesics|analgesics|mesh-ancestor
154511052|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
154511053|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511054|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154511055|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154511056|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154511057|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
154511058|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511059|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511060|NCT04238416|Lactulose|lactulose|mesh-list
154511061|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511062|NCT05226754|Diacerein|diacerein|mesh-list
154511063|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511064|NCT01657162|Alendronate|alendronate|mesh-list
154280251|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280252|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280253|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154280254|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
154280255|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280256|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280257|NCT01156350|Fludarabine|fludarabine|mesh-list
154280258|NCT01156350|Busulfan|busulfan|mesh-list
154280259|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280260|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280261|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280262|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
154280263|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280264|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
154280265|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154280266|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154280267|NCT03886662|LB100|lb100|mesh-list
154280268|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280269|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511065|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154511066|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511067|NCT05209906|Fentanyl|fentanyl|mesh-list
154511068|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154511069|NCT05209906|Narcotics|narcotics|mesh-ancestor
154511070|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511071|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511072|NCT05209906|Analgesics|analgesics|mesh-ancestor
154511073|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
154511074|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511075|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154511076|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154511077|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
154511078|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
154511079|NCT01373294|Lenalidomide|lenalidomide|mesh-list
154511080|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
154511081|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
154511082|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511083|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154511084|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154511085|NCT01373294|Growth Substances|growth substances|mesh-ancestor
154511086|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
154511087|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511088|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154280278|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280279|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
154280280|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280281|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
154280282|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280283|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280284|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
154280285|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
154280286|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
154280287|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280288|NCT01155258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154280289|NCT01155258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280290|NCT01156584|Flucytosine|flucytosine|mesh-list
154280291|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
154280292|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280293|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
154280294|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280295|NCT03879174|Tamoxifen|tamoxifen|mesh-list
154280296|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
154280297|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154280298|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280299|NCT03879174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154280300|NCT03879174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511089|NCT04422028|Desogestrel|desogestrel|mesh-list
154511090|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154511091|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154511092|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154511093|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
154511094|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154511095|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511096|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154511097|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154511098|NCT04422028|Progestins|progestins|mesh-ancestor
154511099|NCT04422028|Hormones|hormones|mesh-ancestor
154511100|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511101|NCT01656304|Bevacizumab|bevacizumab|mesh-list
154511102|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154511103|NCT01656304|Antibodies|antibodies|mesh-list
154511104|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
154511105|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154511106|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511107|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154511108|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154511109|NCT01656304|Growth Substances|growth substances|mesh-ancestor
154511110|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511111|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
154511112|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
154511113|NCT04421872|Anesthetics|anesthetics|mesh-list
154511114|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511115|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511116|NCT03023423|Atezolizumab|atezolizumab|mesh-list
154511117|NCT03023423|Daratumumab|daratumumab|mesh-list
154511118|NCT03023423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154511119|NCT03023423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511120|NCT03023423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511121|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511122|NCT03675191|Orlistat|orlistat|mesh-list
154511123|NCT03675191|Phentermine|phentermine|mesh-list
154511124|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511125|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511126|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154511127|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154280341|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511128|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154511129|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511130|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
154511131|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
154511132|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
154511133|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511134|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
154511135|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511136|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154511137|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511138|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511139|NCT03198689|Immunotoxins|immunotoxins|mesh-ancestor
154511140|NCT03198689|Immunoconjugates|immunoconjugates|mesh-ancestor
154511141|NCT03198689|Immunologic Factors|immunologic factors|mesh-ancestor
154511142|NCT03198689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511143|NCT04421716|Ursolic Acid|ursolic acid|mesh-list
154511144|NCT04421716|Curcumin|curcumin|mesh-list
154511145|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154511146|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511147|NCT04421716|Analgesics|analgesics|mesh-ancestor
154511148|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
154511149|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511150|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511151|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511152|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511153|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511154|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511155|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511156|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511157|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154511158|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154511159|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
154511160|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154511161|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511162|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
154280342|NCT03880968|Analgesics|analgesics|mesh-ancestor
154280343|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
154280344|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511163|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
154511164|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154511165|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
154511166|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154511167|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154511168|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511169|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154511170|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511171|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511172|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154511173|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154511174|NCT01126749|Gemcitabine|gemcitabine|mesh-list
154511175|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511176|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154511177|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
154511178|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511179|NCT03674333|Folic Acid|folic acid|mesh-list
154511180|NCT03674333|Hematinics|hematinics|mesh-ancestor
154511181|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
154511182|NCT03674333|Vitamins|vitamins|mesh-ancestor
154511183|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
154511184|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511185|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
154511186|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154511187|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154511188|NCT03674099|Prednisolone|prednisolone|mesh-list
154511189|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
154511190|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
154511191|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154511192|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
154511193|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511194|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
154511195|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
154511196|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511197|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511198|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511199|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
154511200|NCT03674099|Hormones|hormones|mesh-ancestor
154280375|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154511201|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511202|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154511203|NCT03674099|Protective Agents|protective agents|mesh-ancestor
154511204|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154511205|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511206|NCT03674099|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154511207|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154511208|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511209|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511210|NCT05124340|Vaccines|vaccines|mesh-list
154511211|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
154511212|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511213|NCT05084404|Guanabenz|guanabenz|mesh-list
154511214|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154511215|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154511216|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154511217|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154511218|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
154511219|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511220|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511221|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511222|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
154511223|NCT03473613|Cabergoline|cabergoline|mesh-list
154235090|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
154511224|NCT03473613|Calcium|calcium|mesh-list
154511225|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280408|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154280409|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154280410|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
154280411|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280412|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280413|NCT01266486|Metformin|metformin|mesh-list
154280414|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154280415|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280416|NCT01161888|Imiquimod|imiquimod|mesh-list
154280417|NCT01161888|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154280418|NCT01161888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280419|NCT01161888|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154280420|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
154280421|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280422|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154280423|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280424|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
154280425|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
154280426|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154280428|NCT03759600|Niraparib|niraparib|mesh-list
154511226|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511227|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154511228|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154511229|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154511230|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
154511231|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
154511232|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511233|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511235|NCT03670043|Psyllium|psyllium|mesh-list
154511236|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154511237|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511238|NCT03670043|Cathartics|cathartics|mesh-ancestor
154511239|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511240|NCT05561660|Aspirin|aspirin|mesh-list
154511241|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154511242|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511243|NCT05561660|Analgesics|analgesics|mesh-ancestor
154511244|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
154511245|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511246|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511247|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511248|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511249|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154511250|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154280435|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154280436|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154280437|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280438|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280439|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280440|NCT01158144|Paclitaxel|paclitaxel|mesh-list
154280441|NCT01158144|Carboplatin|carboplatin|mesh-list
154280442|NCT01158144|Endostar protein|endostar protein|mesh-list
154280443|NCT01158144|Endostatins|endostatins|mesh-list
154280444|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280445|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280446|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
154280447|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
154280448|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
154280449|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280450|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154280451|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154280452|NCT01158144|Growth Substances|growth substances|mesh-ancestor
154280453|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280454|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
154280455|NCT01264536|Lactoferrin|lactoferrin|mesh-list
154280456|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280457|NCT01160172|Vaccines|vaccines|mesh-list
154280458|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
154511251|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511252|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154511253|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154511254|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511255|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
154511256|NCT03042819|Doxorubicin|doxorubicin|mesh-list
154511257|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154511258|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511259|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154511260|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154511261|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511262|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511263|NCT02832687|Acetaminophen|acetaminophen|mesh-list
154511264|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511265|NCT02832687|Analgesics|analgesics|mesh-ancestor
154511266|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
154511267|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511268|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511269|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
154511271|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
154511272|NCT04372017|Vitamins|vitamins|mesh-ancestor
154511273|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
154511274|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511275|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154511276|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
154511277|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154511278|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154511279|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511280|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280459|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280460|NCT03878784|Sumatriptan|sumatriptan|mesh-list
154280461|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154280462|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154280463|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154280464|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
154280465|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280466|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280467|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280468|NCT01266720|Gemcitabine|gemcitabine|mesh-list
154280469|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154280470|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
154280471|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280472|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280473|NCT01589952|Interferons|interferons|mesh-list
154280474|NCT01589952|Entecavir|entecavir|mesh-list
154280488|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511281|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511282|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511283|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
154511284|NCT05233358|Nivolumab|nivolumab|mesh-list
154511285|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154511286|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511287|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511288|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511289|NCT02387918|Dexamethasone|dexamethasone|mesh-list
154511290|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511291|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
154511292|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
154511293|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511294|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511295|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511296|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
154511297|NCT02387918|Hormones|hormones|mesh-ancestor
154511298|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511299|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154511300|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511301|NCT04312971|Norepinephrine|norepinephrine|mesh-list
154511302|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154511303|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154511304|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
154511305|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511306|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511307|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511308|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
154511309|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
154280489|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280490|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154280491|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
154280492|NCT03876444|Hormones|hormones|mesh-ancestor
154280493|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280494|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154280495|NCT03876444|Protective Agents|protective agents|mesh-ancestor
154280496|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154280497|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280498|NCT01264692|Amlodipine|amlodipine|mesh-list
154280499|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154280500|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154280501|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154280504|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280516|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154280517|NCT01162746|Dexamethasone|dexamethasone|mesh-list
154511310|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511311|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154511312|NCT05231330|Fluorides|fluorides|mesh-list
154511313|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
154511314|NCT05231330|Protective Agents|protective agents|mesh-ancestor
154511315|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511316|NCT03179475|Oxycodone|oxycodone|mesh-list
154511317|NCT03179475|Naloxone|naloxone|mesh-list
154511318|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154511319|NCT03179475|Narcotics|narcotics|mesh-ancestor
154511320|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511321|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511322|NCT03179475|Analgesics|analgesics|mesh-ancestor
154511323|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
154511324|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511325|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154511326|NCT03105986|Probenecid|probenecid|mesh-list
154511327|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
154511328|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
154511329|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511330|NCT02391662|Paclitaxel|paclitaxel|mesh-list
154511331|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154511332|NCT02391662|Gemcitabine|gemcitabine|mesh-list
154511333|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154511334|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511335|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
154511336|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
154511337|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
154511338|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280518|NCT01162746|Ranibizumab|ranibizumab|mesh-list
154280519|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154280520|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
154280521|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
154280522|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280523|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280524|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154280525|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
154280526|NCT01162746|Hormones|hormones|mesh-ancestor
154280527|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280528|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154280529|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280530|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154280531|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154280532|NCT01162746|Growth Substances|growth substances|mesh-ancestor
154280533|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
154280534|NCT01268202|Pravastatin|pravastatin|mesh-list
154280535|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154511339|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154511340|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
154511341|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
154511342|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154511343|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
154511344|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154511345|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154511346|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511347|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
154511348|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
154511349|NCT05173324|Vaccines|vaccines|mesh-list
154511350|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
154511351|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511352|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
154511353|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154511354|NCT04223518|Antibodies|antibodies|mesh-list
154511355|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
154511356|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511357|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
154511358|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
154511359|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154511360|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154511361|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511362|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511363|NCT02387450|Urological Agents|urological agents|mesh-ancestor
154511364|NCT02390882|Tamsulosin|tamsulosin|mesh-list
154511365|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154511366|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154511367|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154511368|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
154511369|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280542|NCT01162824|Adenosine|adenosine|mesh-list
154027408|NCT02937272|Paclitaxel|paclitaxel|mesh-list
154280543|NCT01162824|Acetylcholine|acetylcholine|mesh-list
154280544|NCT01162824|Analgesics|analgesics|mesh-ancestor
154280545|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
154280546|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280547|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280548|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154280549|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
154280550|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154280551|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
154280552|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
154280553|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511370|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511371|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511372|NCT02390882|Urological Agents|urological agents|mesh-ancestor
154511373|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
154511374|NCT02387138|Irinotecan|irinotecan|mesh-list
154511375|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511376|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154511377|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154511378|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511379|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511380|NCT02387060|Fentanyl|fentanyl|mesh-list
154511381|NCT02387060|Bupivacaine|bupivacaine|mesh-list
154511382|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
154511383|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
154511384|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511385|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511386|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
154511387|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511388|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154511389|NCT02387060|Narcotics|narcotics|mesh-ancestor
154511390|NCT02387060|Analgesics|analgesics|mesh-ancestor
154511391|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154511392|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154511393|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
154511394|NCT01365052|Naproxen|naproxen|mesh-list
154511395|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154511396|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511397|NCT01365052|Analgesics|analgesics|mesh-ancestor
154511398|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
154511399|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511400|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511401|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511402|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511403|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
154511404|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154511405|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511406|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511407|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
154511408|NCT05155215|Fludarabine|fludarabine|mesh-list
154511409|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511410|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
154511411|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511412|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154280575|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
154511413|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154511414|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
154511415|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511416|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511417|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154511418|NCT03471585|Dronabinol|dronabinol|mesh-list
154511419|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
154511420|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511421|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154511422|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511423|NCT03471585|Analgesics|analgesics|mesh-ancestor
154511424|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
154511425|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511426|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154511427|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154511428|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511429|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511430|NCT03471585|Hormones|hormones|mesh-ancestor
154511431|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511432|NCT05072782|Infliximab|infliximab|mesh-list
154511433|NCT05072782|Methotrexate|methotrexate|mesh-list
154511434|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154511435|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
154511436|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154511437|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511438|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154511439|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
154511440|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511441|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511442|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
154511443|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511444|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154280614|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154280615|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154280616|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154280617|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154280618|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
154280619|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280620|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511445|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511446|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
154511447|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511448|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154511449|NCT05072782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154511450|NCT05072782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511451|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511452|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154511453|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
154511454|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
154511455|NCT03379389|Methenamine|methenamine|mesh-list
154511456|NCT03379389|Acriflavine|acriflavine|mesh-list
154511457|NCT03379389|Methylene Blue|methylene blue|mesh-list
154511458|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511459|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511460|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511461|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154511462|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154511463|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
154511464|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154511465|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511466|NCT03478605|Dexamethasone|dexamethasone|mesh-list
154511467|NCT03478605|Ondansetron|ondansetron|mesh-list
154511468|NCT03478605|Olanzapine|olanzapine|mesh-list
154511469|NCT03478605|Aprepitant|aprepitant|mesh-list
154511470|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511471|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
154511472|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
154511473|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511474|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511475|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511477|NCT03478605|Hormones|hormones|mesh-ancestor
154511478|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511479|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154511480|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511481|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
154511482|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
154511483|NCT03478605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154511484|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154511485|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
154511486|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280646|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154511487|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511488|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154511489|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154511490|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511491|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154511492|NCT03478605|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154511493|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154511494|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154511495|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154511496|NCT05258799|Cytarabine|cytarabine|mesh-list
154511497|NCT05258799|Decitabine|decitabine|mesh-list
154511498|NCT05258799|Aclarubicin|aclarubicin|mesh-list
154511499|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154511500|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
154511501|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511502|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511503|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
154511504|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511505|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511506|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
154511507|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511508|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280684|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280685|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280686|NCT01161186|Paclitaxel|paclitaxel|mesh-list
154280687|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154280688|NCT01161186|Gemcitabine|gemcitabine|mesh-list
154280689|NCT01161186|Capecitabine|capecitabine|mesh-list
154280690|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280691|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280692|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154280693|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154280694|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154280695|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280696|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154280697|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
154280698|NCT01159236|Paclitaxel|paclitaxel|mesh-list
154280699|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
154280700|NCT01159236|Bevacizumab|bevacizumab|mesh-list
154280701|NCT01159236|Doxorubicin|doxorubicin|mesh-list
154280702|NCT01159236|Fluorouracil|fluorouracil|mesh-list
154280703|NCT01159236|Epirubicin|epirubicin|mesh-list
154280704|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280705|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280706|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
154280707|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
154511509|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154511510|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154511511|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154511512|NCT04233892|Estrogens|estrogens|mesh-list
154511513|NCT04233892|Hormones|hormones|mesh-ancestor
154511514|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511515|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511516|NCT02386358|Benzonidazole|benzonidazole|mesh-list
154511517|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511518|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
154511519|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511520|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154511521|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154511522|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154511523|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511524|NCT03283371|Natalizumab|natalizumab|mesh-list
154511525|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
154511526|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511527|NCT05069350|Bupivacaine|bupivacaine|mesh-list
154280708|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
154280709|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280710|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280711|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
154280712|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280713|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154280714|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154280715|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
154280716|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154280717|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154280718|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154280719|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154280720|NCT01159236|Growth Substances|growth substances|mesh-ancestor
154280721|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
154280722|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154280723|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154280724|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154280725|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441423|NCT00003337|Epratuzumab|epratuzumab|mesh-list
153646459|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154511528|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
154511529|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
154511530|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511531|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511532|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
154511533|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511534|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
154511535|NCT03471351|Tenalisib|tenalisib|mesh-list
154511536|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511537|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511538|NCT03471351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154511539|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511540|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154511541|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511542|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
154511543|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154511544|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154511545|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511546|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
154511547|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
154511548|NCT02390258|S66913|s66913|mesh-list
154511549|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154511550|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154511551|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511552|NCT03059511|Nalbuphine|nalbuphine|mesh-list
154511553|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154511554|NCT03059511|Narcotics|narcotics|mesh-ancestor
154511555|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511556|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511557|NCT03059511|Analgesics|analgesics|mesh-ancestor
154511558|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
154280726|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
154280727|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154280728|NCT01267344|Gemcitabine|gemcitabine|mesh-list
154280729|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
154280730|NCT01267344|Cetuximab|cetuximab|mesh-list
154280731|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154280732|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
154280733|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280734|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280735|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154280736|NCT03879564|Ketamine|ketamine|mesh-list
154280737|NCT03879564|Analgesics|analgesics|mesh-ancestor
154280744|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
154511559|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511560|NCT04439786|Lidocaine|lidocaine|mesh-list
154511561|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
154511562|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
154511563|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511564|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511565|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
154511566|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511567|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154511568|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154511569|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154511570|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154511571|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511572|NCT02665286|Naproxen|naproxen|mesh-list
154511573|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154511574|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154511575|NCT02665286|Orphenadrine|orphenadrine|mesh-list
154511576|NCT02665286|Methocarbamol|methocarbamol|mesh-list
154511577|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154511578|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511579|NCT02665286|Analgesics|analgesics|mesh-ancestor
154511580|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
154511581|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511582|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511583|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511584|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
154511585|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154511586|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511587|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511588|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
154511589|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511590|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154511591|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154511592|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154511593|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154280757|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
154280758|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154280759|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511594|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
154511595|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
154511596|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154511597|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154511598|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154511599|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
154511600|NCT02390102|Hematinics|hematinics|mesh-ancestor
154235470|NCT01197040|Hormones|hormones|mesh-ancestor
154511601|NCT03663673|Decanoic acid|decanoic acid|mesh-list
154511602|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
154511603|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511604|NCT03664063|Azithromycin|azithromycin|mesh-list
154511605|NCT03664063|Ivermectin|ivermectin|mesh-list
154511606|NCT03664063|Albendazole|albendazole|mesh-list
154511607|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
154511608|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154511609|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511610|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154511611|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
154511612|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
154511613|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154511614|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154511615|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
154511616|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
154511617|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
154511618|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511619|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511620|NCT03664063|Filaricides|filaricides|mesh-ancestor
154511621|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
154511622|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154511623|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280793|NCT01267734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280794|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280795|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280796|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
154280797|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280798|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280799|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154280800|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154280801|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154280802|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154280803|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
154280804|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280805|NCT01164306|Nicotine|nicotine|mesh-list
154280806|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154280807|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
154280815|NCT01269450|Progesterone|progesterone|mesh-list
154280821|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
154280822|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154280823|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
154280824|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280825|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280826|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154280827|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
154511624|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
154511625|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154511626|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
154511627|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511628|NCT02911285|Expectorants|expectorants|mesh-ancestor
154511629|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
154511630|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154511631|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
154511632|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511633|NCT02911285|Protective Agents|protective agents|mesh-ancestor
154511634|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511635|NCT02911285|Antidotes|antidotes|mesh-ancestor
154511636|NCT04997902|Tipifarnib|tipifarnib|mesh-list
154511637|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511638|NCT01061515|Bevacizumab|bevacizumab|mesh-list
154511639|NCT01061515|Capecitabine|capecitabine|mesh-list
154511640|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
154511641|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511642|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511643|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154511644|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154511645|NCT01061515|Growth Substances|growth substances|mesh-ancestor
154511646|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511647|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
154511648|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154511649|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
154511650|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280828|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154280829|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
154280830|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280831|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280832|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154280833|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
154280834|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
154280835|NCT01269528|Protective Agents|protective agents|mesh-ancestor
154280836|NCT01269528|Miotics|miotics|mesh-ancestor
154280837|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154280838|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154280839|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154280840|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154511651|NCT01069939|Esomeprazole|esomeprazole|mesh-list
154511652|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154511653|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511654|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154511655|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511656|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511657|NCT01069705|Tobramycin|tobramycin|mesh-list
154511658|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154511659|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511660|NCT01069627|Bevacizumab|bevacizumab|mesh-list
154511661|NCT01069627|Fotemustine|fotemustine|mesh-list
154511662|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511663|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511664|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154511665|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154511666|NCT01069627|Growth Substances|growth substances|mesh-ancestor
154511667|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511668|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
154511669|NCT04057261|Liraglutide|liraglutide|mesh-list
154511670|NCT04057261|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154511671|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154511672|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511673|NCT04057261|Incretins|incretins|mesh-ancestor
154511674|NCT04057261|Hormones|hormones|mesh-ancestor
154235545|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
154511675|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511676|NCT01064245|Mannitol|mannitol|mesh-list
154511677|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
154511678|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154511679|NCT01064245|Diuretics|diuretics|mesh-ancestor
154511680|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
154511681|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511682|NCT01064245|Miotics|miotics|mesh-ancestor
154511683|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
154511684|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511685|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154511686|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154511687|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
154511688|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154511689|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154511690|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
154511691|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511692|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511693|NCT04056949|Paclitaxel|paclitaxel|mesh-list
154511694|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154511695|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280853|NCT01269606|Insulin|insulin|mesh-list
154511696|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511697|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
154511698|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
154511699|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
154511700|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511701|NCT03662425|Oxytocin|oxytocin|mesh-list
154511702|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
154511703|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154511704|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511705|NCT03673163|Lidocaine|lidocaine|mesh-list
154511706|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
154511707|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
154511708|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511709|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511710|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
154511711|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511712|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154511713|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154511714|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154511715|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154511716|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511717|NCT03662269|Indomethacin|indomethacin|mesh-list
154511718|NCT03662269|Omeprazole|omeprazole|mesh-list
154511719|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154511720|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511721|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154511722|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511723|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511724|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154511725|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511726|NCT03662269|Analgesics|analgesics|mesh-ancestor
154511727|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
154511728|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511729|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511730|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511731|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511732|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
154511733|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
154511734|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154511735|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154511736|NCT04056325|Ivermectin|ivermectin|mesh-list
154511737|NCT04056325|Moxidectin|moxidectin|mesh-list
154511738|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154511739|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511740|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
154511741|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
154511742|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154511743|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154511744|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154511745|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154511746|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
154511747|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511748|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511749|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511750|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154511751|NCT01585025|Cathartics|cathartics|mesh-ancestor
154511752|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511753|NCT00328653|Cyclosporine|cyclosporine|mesh-list
154511755|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511756|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511757|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511758|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
154511759|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511760|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
154511761|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511762|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
154511763|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511764|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154511765|NCT03662113|Domperidone|domperidone|mesh-list
154511766|NCT03662113|Simethicone|simethicone|mesh-list
154511767|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
154511768|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
154511769|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511770|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511771|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511772|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154511773|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
154511774|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511775|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280939|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280940|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280941|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
154280942|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280943|NCT01165476|Treprostinil|treprostinil|mesh-list
154280944|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154280945|NCT01283100|Dolutegravir|dolutegravir|mesh-list
154280946|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154280947|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154280948|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280949|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280950|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154280951|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154280952|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
154280953|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280954|NCT01269996|Metformin|metformin|mesh-list
154280955|NCT01269996|Gliclazide|gliclazide|mesh-list
154280956|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154280957|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280958|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154280959|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154280960|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511776|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
154511777|NCT03662113|Emollients|emollients|mesh-ancestor
154511778|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
154511780|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511781|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154511782|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511783|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511784|NCT05798546|Cyclophosphamide|cyclophosphamide|mesh-list
154511785|NCT05798546|Fludarabine|fludarabine|mesh-list
154511786|NCT05798546|Interleukin-2|interleukin-2|mesh-list
154511787|NCT05798546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511788|NCT05798546|Immunologic Factors|immunologic factors|mesh-ancestor
154511789|NCT05798546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511790|NCT05798546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511791|NCT05798546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154511792|NCT05798546|Alkylating Agents|alkylating agents|mesh-ancestor
154511793|NCT05798546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511794|NCT05798546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511795|NCT05798546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154511796|NCT05798546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511797|NCT05798546|Analgesics|analgesics|mesh-ancestor
154511798|NCT05798546|Sensory System Agents|sensory system agents|mesh-ancestor
154280966|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280967|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
154280968|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
154280969|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
154280970|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280971|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154280972|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280973|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
154280974|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154280975|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
154280976|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280977|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
154280978|NCT03871218|Protective Agents|protective agents|mesh-ancestor
154280979|NCT01281228|Exenatide|exenatide|mesh-list
154280980|NCT01281228|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154280981|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154280982|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280983|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154280984|NCT01281228|Incretins|incretins|mesh-ancestor
154280985|NCT01281228|Hormones|hormones|mesh-ancestor
154027852|NCT00652002|Budesonide|budesonide|mesh-list
154280986|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153449355|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
154511799|NCT05798546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511800|NCT05798195|Dexamethasone|dexamethasone|mesh-list
154511801|NCT05798195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154511802|NCT05798195|Antiemetics|antiemetics|mesh-ancestor
154511803|NCT05798195|Autonomic Agents|autonomic agents|mesh-ancestor
154511804|NCT05798195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511805|NCT05798195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511806|NCT05798195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511807|NCT05798195|Glucocorticoids|glucocorticoids|mesh-ancestor
154511808|NCT05798195|Hormones|hormones|mesh-ancestor
154511809|NCT05798195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511810|NCT05798195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154511811|NCT05798195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511812|NCT05797948|Cyclophosphamide|cyclophosphamide|mesh-list
154511813|NCT05797948|Fludarabine|fludarabine|mesh-list
154511814|NCT05797948|Lenalidomide|lenalidomide|mesh-list
154511815|NCT05797948|Azacitidine|azacitidine|mesh-list
154511816|NCT05797948|Obinutuzumab|obinutuzumab|mesh-list
154511817|NCT05797948|Zanubrutinib|zanubrutinib|mesh-list
154511818|NCT05797948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511819|NCT05797948|Immunologic Factors|immunologic factors|mesh-ancestor
154511820|NCT05797948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511821|NCT05797948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154511822|NCT05797948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154511823|NCT05797948|Alkylating Agents|alkylating agents|mesh-ancestor
154511824|NCT05797948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511825|NCT05797948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511826|NCT05797948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154511827|NCT05797948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154511828|NCT05797948|Antimetabolites|antimetabolites|mesh-ancestor
154511829|NCT05797948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154511830|NCT05797948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154511832|NCT05797948|Growth Inhibitors|growth inhibitors|mesh-ancestor
154511833|NCT05797948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511834|NCT05797948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511835|NCT05797948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154511836|NCT05797948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154511837|NCT05797818|Chlorhexidine|chlorhexidine|mesh-list
154511838|NCT05797818|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154511839|NCT05797818|Methylene Blue|methylene blue|mesh-list
154511840|NCT05797818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154511841|NCT05797818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511842|NCT05797818|Disinfectants|disinfectants|mesh-ancestor
154511843|NCT05797818|Dermatologic Agents|dermatologic agents|mesh-ancestor
154511844|NCT05797818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511845|NCT05797818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511846|NCT05797792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154511847|NCT05797792|Plasminogen|plasminogen|mesh-list
154511848|NCT05797792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154511849|NCT05797792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154511850|NCT05797792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511851|NCT05797753|Itraconazole|itraconazole|mesh-list
154511852|NCT05797753|Erythromycin|erythromycin|mesh-list
154511853|NCT05797753|Erythromycin Estolate|erythromycin estolate|mesh-list
154346748|NCT03738865|Glucagon|glucagon|mesh-list
154511854|NCT05797753|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154511855|NCT05797753|Erythromycin stearate|erythromycin stearate|mesh-list
154511856|NCT05797753|Antifungal Agents|antifungal agents|mesh-ancestor
154511857|NCT05797753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511858|NCT05797753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154281023|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154281024|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
154281025|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281026|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281027|NCT01271478|Telmisartan|telmisartan|mesh-list
154281028|NCT01271478|Captopril|captopril|mesh-list
154281029|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154281030|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154281031|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154281032|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281033|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154281034|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
154281035|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281036|NCT03871062|Anesthetics|anesthetics|mesh-list
154281037|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154281038|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281039|NCT01281696|Bevacizumab|bevacizumab|mesh-list
154281040|NCT01281696|Methotrexate|methotrexate|mesh-list
154281041|NCT01281696|Etoposide|etoposide|mesh-list
154281042|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281043|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281044|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154281045|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154511859|NCT05797753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154511860|NCT05797753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511861|NCT05797753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511862|NCT05797753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154511863|NCT05797753|Hormone Antagonists|hormone antagonists|mesh-ancestor
154511864|NCT05797753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511865|NCT05797753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511866|NCT05797753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154511867|NCT05797753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154511868|NCT05797753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511869|NCT05797753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154511871|NCT05797714|Antiviral Agents|antiviral agents|mesh-ancestor
154511872|NCT05797714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154511873|NCT05797714|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154511874|NCT05797714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154511875|NCT05797714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511876|NCT05797714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511877|NCT05797714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154511878|NCT05797714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154511879|NCT05797584|Dobutamine|dobutamine|mesh-list
154511880|NCT05797584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154511881|NCT05797584|Sympathomimetics|sympathomimetics|mesh-ancestor
154511882|NCT05797584|Autonomic Agents|autonomic agents|mesh-ancestor
154511883|NCT05797584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511884|NCT05797584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511885|NCT05797584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154511886|NCT05797584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154511887|NCT05797584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154511888|NCT05797584|Adrenergic Agents|adrenergic agents|mesh-ancestor
154511889|NCT05797584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511890|NCT05797584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511891|NCT05797584|Protective Agents|protective agents|mesh-ancestor
154511892|NCT05797493|Atezolizumab|atezolizumab|mesh-list
154511893|NCT05797493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154511894|NCT05797493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511895|NCT05797493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511896|NCT05797493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511897|NCT05797220|Diltiazem|diltiazem|mesh-list
154511898|NCT05797220|Botulinum Toxins|botulinum toxins|mesh-list
154511899|NCT05797220|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154511900|NCT05797220|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154511901|NCT05797220|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154235775|NCT04638790|Hormones|hormones|mesh-ancestor
154511902|NCT05797220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154511903|NCT05797220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511905|NCT05797220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281046|NCT01281696|Growth Substances|growth substances|mesh-ancestor
154511906|NCT05797220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511907|NCT05797220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154511908|NCT05797220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511909|NCT05797220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154511910|NCT05797220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154511911|NCT05797220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154511912|NCT05797220|Vasodilator Agents|vasodilator agents|mesh-ancestor
154511913|NCT05797077|Capecitabine|capecitabine|mesh-list
154511914|NCT05797077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154511915|NCT05797077|Antimetabolites|antimetabolites|mesh-ancestor
154511916|NCT05797077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511917|NCT05797077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511918|NCT05797038|Tacrolimus|tacrolimus|mesh-list
154511919|NCT05797038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154511920|NCT05797038|Immunologic Factors|immunologic factors|mesh-ancestor
154511921|NCT05797038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511922|NCT05797038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154511923|NCT05797038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511924|NCT05797038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511925|NCT05795933|Vitamin D|vitamin d|mesh-list
154511926|NCT05795933|Cholecalciferol|cholecalciferol|mesh-list
154511927|NCT05795933|Vitamins|vitamins|mesh-ancestor
154511928|NCT05795933|Micronutrients|micronutrients|mesh-ancestor
154511929|NCT05795933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281095|NCT05834855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281096|NCT05834855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281097|NCT05834764|Maleic acid|maleic acid|mesh-list
154281098|NCT05834764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281099|NCT05834764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281100|NCT05834647|Lidocaine|lidocaine|mesh-list
154281101|NCT05834647|Prilocaine|prilocaine|mesh-list
154281102|NCT05834647|Anesthetics, Local|anesthetics, local|mesh-ancestor
154281103|NCT05834647|Anesthetics|anesthetics|mesh-ancestor
154281104|NCT05834647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154281105|NCT05834647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281106|NCT05834647|Sensory System Agents|sensory system agents|mesh-ancestor
154281107|NCT05834647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281108|NCT05834647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154281109|NCT05834647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154281110|NCT05834647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154281111|NCT05834647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154281112|NCT05834647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281113|NCT05834582|Paclitaxel|paclitaxel|mesh-list
154281114|NCT05834582|Cyclophosphamide|cyclophosphamide|mesh-list
154281115|NCT05834582|Epirubicin|epirubicin|mesh-list
154281116|NCT05834582|Fluzoparib|fluzoparib|mesh-list
154281117|NCT05834582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154281118|NCT05834582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281119|NCT05834582|Tubulin Modulators|tubulin modulators|mesh-ancestor
154511930|NCT05795933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154511931|NCT05795933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154511932|NCT05714683|Semaglutide|semaglutide|mesh-list
154511933|NCT05714683|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154511934|NCT05714683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154511935|NCT05714683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511936|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
154511937|NCT05692999|Pemetrexed|pemetrexed|mesh-list
154511938|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511939|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511940|NCT05692999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154511941|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511942|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511943|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154511944|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154511945|NCT05661591|Fluconazole|fluconazole|mesh-list
154511946|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
154511947|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281120|NCT05834582|Antimitotic Agents|antimitotic agents|mesh-ancestor
154281121|NCT05834582|Mitosis Modulators|mitosis modulators|mesh-ancestor
154281122|NCT05834582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281123|NCT05834582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281124|NCT05834582|Immunologic Factors|immunologic factors|mesh-ancestor
154281125|NCT05834582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281126|NCT05834582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281127|NCT05834582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154281128|NCT05834582|Alkylating Agents|alkylating agents|mesh-ancestor
154281129|NCT05834582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154281130|NCT05834582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154281131|NCT05834582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154281132|NCT05834582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154281133|NCT05834582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281134|NCT05834582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154281135|NCT05834543|Paclitaxel|paclitaxel|mesh-list
154281136|NCT05834543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154281137|NCT05834543|Cisplatin|cisplatin|mesh-list
154281138|NCT05834543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154511948|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154511949|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154511950|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154511951|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511952|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154511953|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
154511954|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511955|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511956|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154511957|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154511958|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
154511959|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154511960|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154511961|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511962|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154511963|NCT05634148|Analgesics|analgesics|mesh-ancestor
154511964|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
154511965|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154511966|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154511967|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154511968|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154511969|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
154511970|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154511971|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154511972|NCT05622123|Exenatide|exenatide|mesh-list
154511973|NCT05622123|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154027995|NCT00887315|Docetaxel|docetaxel|mesh-list
154281139|NCT05834543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281140|NCT05834543|Tubulin Modulators|tubulin modulators|mesh-ancestor
154281141|NCT05834543|Antimitotic Agents|antimitotic agents|mesh-ancestor
154281142|NCT05834543|Mitosis Modulators|mitosis modulators|mesh-ancestor
154281143|NCT05834543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281145|NCT05834517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154281146|NCT05834517|Immunologic Factors|immunologic factors|mesh-ancestor
154281147|NCT05834517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281148|NCT05834517|Viscosupplements|viscosupplements|mesh-ancestor
154281149|NCT05834517|Protective Agents|protective agents|mesh-ancestor
154281150|NCT05834361|Carboprost|carboprost|mesh-list
154281151|NCT05834361|Carboprost tromethamine|carboprost tromethamine|mesh-list
154281152|NCT05834361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154281153|NCT05834361|Abortifacient Agents|abortifacient agents|mesh-ancestor
154281154|NCT05834361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154281157|NCT05834270|Tamsulosin|tamsulosin|mesh-list
154511974|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154511975|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511976|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154511978|NCT05622123|Hormones|hormones|mesh-ancestor
154511979|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154511980|NCT05594082|Trastuzumab|trastuzumab|mesh-list
154511981|NCT05594082|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154511982|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154511983|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154511984|NCT05594082|Immunoconjugates|immunoconjugates|mesh-ancestor
154511985|NCT05594082|Immunologic Factors|immunologic factors|mesh-ancestor
154511986|NCT05594082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511987|NCT05574374|Fexuprazan|fexuprazan|mesh-list
154511988|NCT05574374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154511989|NCT05506787|Esketamine|esketamine|mesh-list
154511990|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
154511991|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154511992|NCT05503511|Bumetanide|bumetanide|mesh-list
154511993|NCT05503511|Diuretics|diuretics|mesh-ancestor
154511994|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
154511995|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154511996|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154511997|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154511998|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860228|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154511999|NCT05503355|Venetoclax|venetoclax|mesh-list
154512000|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512001|NCT05445024|Sufentanil|sufentanil|mesh-list
154512002|NCT05445024|Nalbuphine|nalbuphine|mesh-list
154512003|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154512004|NCT05445024|Narcotics|narcotics|mesh-ancestor
154512005|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512006|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281168|NCT05834231|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154281169|NCT05834231|Dopamine Agents|dopamine agents|mesh-ancestor
154281170|NCT05834231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281171|NCT05834231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281172|NCT05834231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281173|NCT05834231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154281174|NCT05834231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154281175|NCT05830162|Amoxicillin|amoxicillin|mesh-list
154281176|NCT05830162|Clavulanic Acids|clavulanic acids|mesh-list
154512007|NCT05445024|Analgesics|analgesics|mesh-ancestor
154512008|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
154512009|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512010|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154512011|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154512012|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
154512013|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
154512014|NCT05429814|Menthol|menthol|mesh-list
154512015|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
154512016|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
154512017|NCT05420337|Morphine|morphine|mesh-list
154512018|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154512019|NCT05420337|Narcotics|narcotics|mesh-ancestor
154512020|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512021|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512022|NCT05420337|Analgesics|analgesics|mesh-ancestor
154512023|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
154512024|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512025|NCT05390905|Tramadol|tramadol|mesh-list
154512026|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154512027|NCT05390905|Narcotics|narcotics|mesh-ancestor
154512028|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512029|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512030|NCT05390905|Analgesics|analgesics|mesh-ancestor
154512031|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
154512032|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512033|NCT05366621|Denosumab|denosumab|mesh-list
154512034|NCT05366621|Diphosphonates|diphosphonates|mesh-list
154512035|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512036|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154512037|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
154512038|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154512039|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512040|NCT05325775|SR 142801|sr 142801|mesh-list
154512041|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154512042|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154512043|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512044|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281200|NCT05819918|Vitamins|vitamins|mesh-ancestor
154512045|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154512046|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
154512047|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
154512048|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
154512049|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512050|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512051|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512053|NCT05215548|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154512054|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154512055|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512056|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512057|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512058|NCT05209555|Pilocarpine|pilocarpine|mesh-list
154512059|NCT05209555|Miotics|miotics|mesh-ancestor
154512060|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
154512061|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512062|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512063|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154512064|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154512065|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
154512066|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512067|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512068|NCT05202145|Cyclosporine|cyclosporine|mesh-list
154512069|NCT05202145|Tacrolimus|tacrolimus|mesh-list
154512070|NCT05202145|Cyclosporins|cyclosporins|mesh-list
154512071|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512072|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
154512073|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281237|NCT05753098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154281238|NCT05753098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154281239|NCT05753098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154281240|NCT05726292|Androgens|androgens|mesh-list
154281241|NCT05726292|Hormones|hormones|mesh-ancestor
154281242|NCT05726292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281243|NCT05726292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281244|NCT05699811|Paclitaxel|paclitaxel|mesh-list
154281245|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
154281246|NCT05699811|Tislelizumab|tislelizumab|mesh-list
154281247|NCT05699811|Antibodies|antibodies|mesh-list
154281248|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154281249|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154281250|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281251|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
154512074|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154512075|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512076|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512077|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
154512078|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512079|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154512080|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512081|NCT05142904|Iodine|iodine|mesh-list
154512082|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
154512083|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154512084|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512085|NCT05142904|Trace Elements|trace elements|mesh-ancestor
154512086|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
154512087|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512088|NCT05042648|Buprenorphine|buprenorphine|mesh-list
154512089|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154512090|NCT05042648|Narcotics|narcotics|mesh-ancestor
154512091|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512092|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281265|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281266|NCT05692843|Cyclosporine|cyclosporine|mesh-list
154281267|NCT05692843|Cyclosporins|cyclosporins|mesh-list
154281268|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281269|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281270|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281271|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
154281272|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281273|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
154281274|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281275|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281276|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281277|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154281278|NCT05660616|Gemcitabine|gemcitabine|mesh-list
154281279|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154281280|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
154281281|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281282|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281283|NCT05659810|Gabapentin|gabapentin|mesh-list
154512093|NCT05042648|Analgesics|analgesics|mesh-ancestor
154512094|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
154512095|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512096|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154512097|NCT05036317|Empagliflozin|empagliflozin|mesh-list
154512098|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154512099|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512100|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154512101|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512102|NCT04990388|Acetaminophen|acetaminophen|mesh-list
154512103|NCT04990388|Antipyretics|antipyretics|mesh-list
154512104|NCT04990388|Cetirizine|cetirizine|mesh-list
154512105|NCT04990388|Ibuprofen|ibuprofen|mesh-list
154512106|NCT04990388|Famotidine|famotidine|mesh-list
154512107|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154512108|NCT04990388|Analgesics|analgesics|mesh-ancestor
154512109|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
154512110|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512111|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512112|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154512113|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512114|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512115|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154512116|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512117|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512118|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154512119|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154512120|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154512121|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
154512122|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
154236012|NCT02428270|Trametinib|trametinib|mesh-list
154281284|NCT05659810|Analgesics|analgesics|mesh-ancestor
154281285|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
154281286|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281287|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281288|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
154281289|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154281290|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154281291|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154281292|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154281293|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154281315|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154281316|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281317|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154281318|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
154281319|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281320|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281321|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281322|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512123|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512124|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154512125|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154512126|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154512127|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
154512128|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154512129|NCT04837131|Ixazomib|ixazomib|mesh-list
154512130|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512131|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
154512132|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512133|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512134|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
154512135|NCT04653818|Velpatasvir|velpatasvir|mesh-list
154512136|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154512137|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
154512138|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512139|NCT04578652|Metformin|metformin|mesh-list
154512140|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154512141|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512142|NCT04570631|Dexamethasone|dexamethasone|mesh-list
154512143|NCT04570631|Bortezomib|bortezomib|mesh-list
154512144|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512145|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
154512146|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
154512147|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512148|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512149|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154512150|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
154512151|NCT04570631|Hormones|hormones|mesh-ancestor
154558135|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
154512152|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512153|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154512154|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512155|NCT04430517|Niacinamide|niacinamide|mesh-list
154512157|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
154512158|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
154512159|NCT04430517|Vitamins|vitamins|mesh-ancestor
154512160|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
154512161|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512162|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154512163|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
154512164|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512165|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154512166|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
154512167|NCT04414943|Ketamine|ketamine|mesh-list
154512168|NCT04414943|Esketamine|esketamine|mesh-list
154512169|NCT04414943|Analgesics|analgesics|mesh-ancestor
154512170|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
154512171|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512172|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512173|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154512174|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154512175|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
154512176|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
154512177|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512178|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154512179|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154512180|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512181|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512182|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
154512183|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154512184|NCT04354025|Cytarabine|cytarabine|mesh-list
154512185|NCT04354025|Fludarabine|fludarabine|mesh-list
154512186|NCT04354025|Interleukin-2|interleukin-2|mesh-list
154512187|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512188|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154512189|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
154512190|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512191|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512192|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
154512193|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512194|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
154512195|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512196|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154281351|NCT05281614|Vedolizumab|vedolizumab|mesh-list
154281352|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154281353|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154281354|NCT05281614|Analgesics|analgesics|mesh-ancestor
154281355|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
154281356|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281357|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281358|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281359|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281360|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281361|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281362|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
154281363|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
154281364|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
154281365|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281366|NCT04955938|Ivosidenib|ivosidenib|mesh-list
154281367|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281368|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281369|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281370|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
154281373|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512197|NCT04354025|Analgesics|analgesics|mesh-ancestor
154512198|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
154512199|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512200|NCT04347720|Acetaminophen|acetaminophen|mesh-list
154512201|NCT04347720|Ibuprofen|ibuprofen|mesh-list
154512202|NCT04347720|Indomethacin|indomethacin|mesh-list
154512203|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154512204|NCT04347720|Analgesics|analgesics|mesh-ancestor
154512205|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
154512206|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512207|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512208|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
154512209|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154512210|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512211|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512212|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154512213|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512214|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512215|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
154512216|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
154512217|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154512218|NCT04325802|Naltrexone|naltrexone|mesh-list
154512219|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154512220|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154512221|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512222|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
154512223|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512224|NCT04285346|Ganaxolone|ganaxolone|mesh-list
154512225|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
154512226|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512227|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512228|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512229|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
154512230|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
154512231|NCT04241562|Mitogens|mitogens|mesh-list
154512232|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
154512233|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512234|NCT04209192|Amikacin|amikacin|mesh-list
154512235|NCT04209192|Fosfomycin|fosfomycin|mesh-list
154512236|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154512237|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512238|NCT04178148|Amikacin|amikacin|mesh-list
154512239|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154512240|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512241|NCT04126681|Interferons|interferons|mesh-list
154512242|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
154512243|NCT04126681|Dasatinib|dasatinib|mesh-list
154512244|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
154512245|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
154512246|NCT04126681|Nilotinib|nilotinib|mesh-list
154512247|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281425|NCT04536337|Entecavir|entecavir|mesh-list
154512248|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
154512249|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512250|NCT04126681|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154512251|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154512252|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512253|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512254|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
154512255|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154512256|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154512257|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154512258|NCT04118855|Axitinib|axitinib|mesh-list
154512259|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512260|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154512261|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512262|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512263|NCT04011150|Fentanyl|fentanyl|mesh-list
154512264|NCT04011150|Ropivacaine|ropivacaine|mesh-list
154512265|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
154512266|NCT04011150|Anesthetics|anesthetics|mesh-list
154512267|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512268|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512269|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
154512270|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512271|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154512272|NCT04011150|Narcotics|narcotics|mesh-ancestor
154281426|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
154281427|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281428|NCT04518644|Nilotinib|nilotinib|mesh-list
154281429|NCT04518644|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154281430|NCT04518644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154281431|NCT04518644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281432|NCT04518644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281433|NCT04515836|Olaparib|olaparib|mesh-list
154281434|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154281435|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281436|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281437|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281438|NCT04348006|Dexamethasone|dexamethasone|mesh-list
154281439|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
154281440|NCT04348006|Lenalidomide|lenalidomide|mesh-list
154281442|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281443|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
154281444|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281445|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281446|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154281447|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
154281448|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512273|NCT04011150|Analgesics|analgesics|mesh-ancestor
154512274|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154512275|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154512276|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
154512277|NCT03927378|Ketamine|ketamine|mesh-list
154512278|NCT03927378|Esketamine|esketamine|mesh-list
154512279|NCT03927378|Analgesics|analgesics|mesh-ancestor
154512280|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
154512281|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512282|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512283|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154512284|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154512285|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
154512286|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
154512287|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154281450|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154281451|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281452|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
154281453|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
154281454|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281455|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281456|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
154281457|NCT04348006|Hormones|hormones|mesh-ancestor
154281458|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281459|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281460|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154281461|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154281462|NCT04348006|Growth Substances|growth substances|mesh-ancestor
154281463|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
154281464|NCT04313972|Naltrexone|naltrexone|mesh-list
154281465|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154281466|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154512288|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154512289|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154512290|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512291|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512292|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
154512293|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154512294|NCT03875391|Oxytocin|oxytocin|mesh-list
154512295|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
154512296|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154512297|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512298|NCT03836066|Bevacizumab|bevacizumab|mesh-list
154512299|NCT03836066|Atezolizumab|atezolizumab|mesh-list
154512300|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154512301|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512302|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154512303|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154512304|NCT03836066|Growth Substances|growth substances|mesh-ancestor
154512305|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512306|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
154512307|NCT03836066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154512308|NCT03836066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512309|NCT03778242|Tranexamic Acid|tranexamic acid|mesh-list
154512310|NCT03778242|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154512311|NCT03778242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154281467|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281468|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
154281469|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281470|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
154281471|NCT04295863|Nivolumab|nivolumab|mesh-list
154281472|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281473|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281474|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154281475|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281476|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
154281477|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281478|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281479|NCT04231526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154281480|NCT04231526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281481|NCT04201873|Poly I-C|poly i-c|mesh-list
154281482|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
154281483|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154281484|NCT04201873|Vaccines|vaccines|mesh-list
154281485|NCT04201873|Poly ICLC|poly iclc|mesh-list
154281486|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
154281487|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281488|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154512312|NCT03778242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512313|NCT03778242|Hemostatics|hemostatics|mesh-ancestor
154512314|NCT03778242|Coagulants|coagulants|mesh-ancestor
154512315|NCT03772613|Heparin|heparin|mesh-list
154512316|NCT03772613|Calcium heparin|calcium heparin|mesh-list
154512317|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
154512318|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154512319|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154512320|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512321|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
154512322|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
154512323|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154512324|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154512325|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512326|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512327|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512328|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512329|NCT03261102|Adalimumab|adalimumab|mesh-list
154512330|NCT03261102|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154512331|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512332|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512333|NCT02848131|Dasatinib|dasatinib|mesh-list
154512334|NCT02848131|Quercetin|quercetin|mesh-list
154512335|NCT02848131|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154512336|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154512337|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512338|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512339|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512340|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
154512341|NCT02848131|Protective Agents|protective agents|mesh-ancestor
154512342|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512343|NCT02590601|Bromocriptine|bromocriptine|mesh-list
154512344|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154512345|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154512346|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
154512347|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512348|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512349|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
154512350|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
154512351|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512352|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512353|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154512354|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154512355|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
154512356|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512357|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154281536|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154512358|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512359|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154512360|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512361|NCT01693380|Vaccines|vaccines|mesh-list
154512362|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
154512363|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512364|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154512365|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154512366|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154512367|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512368|NCT01542879|Hematinics|hematinics|mesh-ancestor
154512369|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154512370|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154512371|NCT01492972|Leuprolide|leuprolide|mesh-list
154512372|NCT01492972|Goserelin|goserelin|mesh-list
154512373|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154512374|NCT01492972|Buserelin|buserelin|mesh-list
154512375|NCT01492972|Androgens|androgens|mesh-list
154512376|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154512377|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
154512378|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154512379|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512380|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154860229|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
154512381|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512382|NCT01492972|Hormones|hormones|mesh-ancestor
154281537|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
154281538|NCT03500445|Hormones|hormones|mesh-ancestor
154281539|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281540|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281541|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281542|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
154281543|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154281544|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154281545|NCT03500445|Growth Substances|growth substances|mesh-ancestor
154281546|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
154281547|NCT03494530|Edoxaban|edoxaban|mesh-list
154281548|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154281549|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
154281550|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154281551|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
154281552|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281553|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281554|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
154281555|NCT03466736|Flutemetamol|flutemetamol|mesh-list
154281556|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154281557|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281558|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
154281560|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154512383|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512384|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
154512385|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154512386|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
154512387|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154512388|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
154512389|NCT01256398|Leucovorin|leucovorin|mesh-list
154512390|NCT01256398|Folic Acid|folic acid|mesh-list
154512391|NCT01256398|Cytarabine|cytarabine|mesh-list
154281561|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281562|NCT03225547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154281563|NCT03225547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281564|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154281565|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
154281566|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153646461|NCT00115492|Fluticasone|fluticasone|mesh-list
154512392|NCT01256398|Dexamethasone|dexamethasone|mesh-list
154512393|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
154512394|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
154512395|NCT01256398|Melphalan|melphalan|mesh-list
154512396|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
154512397|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154512398|NCT01256398|Methotrexate|methotrexate|mesh-list
154512399|NCT01256398|Fludarabine|fludarabine|mesh-list
154512400|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
154512401|NCT01256398|Etoposide|etoposide|mesh-list
154512402|NCT01256398|Vincristine|vincristine|mesh-list
154512403|NCT01256398|Daunorubicin|daunorubicin|mesh-list
154512404|NCT01256398|Dasatinib|dasatinib|mesh-list
154512405|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
154512406|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
154512407|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
154512408|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154512409|NCT01256398|Tacrolimus|tacrolimus|mesh-list
154512410|NCT01256398|Antibodies|antibodies|mesh-list
154512411|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
154512412|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154512413|NCT01256398|Lenograstim|lenograstim|mesh-list
154512414|NCT01256398|BB 1101|bb 1101|mesh-list
154281567|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281568|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154281569|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154281570|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154281571|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
154281572|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154281573|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154281574|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
154281575|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281576|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
154281577|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154281578|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154281579|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
154281580|NCT02990533|Testosterone|testosterone|mesh-list
154281581|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
154281582|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
154281583|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154281584|NCT02990533|Androgens|androgens|mesh-ancestor
154281585|NCT02990533|Hormones|hormones|mesh-ancestor
154512415|NCT01256398|Calcium|calcium|mesh-list
154512416|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
154512417|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512418|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
154512419|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512420|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512421|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154512422|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
154512423|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512424|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512425|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154512426|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512427|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
154512428|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
154512429|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512430|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236290|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
154512431|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
154512432|NCT01256398|Hormones|hormones|mesh-ancestor
154512433|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512434|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154512435|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
154512436|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512437|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154281586|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281587|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281588|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281589|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281590|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
154281591|NCT02969837|Dexamethasone|dexamethasone|mesh-list
154281592|NCT02969837|Lenalidomide|lenalidomide|mesh-list
154281593|NCT02969837|Elotuzumab|elotuzumab|mesh-list
154281594|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281595|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
154281596|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
154281597|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281598|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281599|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281600|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
154281601|NCT02969837|Hormones|hormones|mesh-ancestor
154281602|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281603|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281604|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281605|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
154281606|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154281607|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154281610|NCT02776917|Paclitaxel|paclitaxel|mesh-list
154512438|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154512439|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154512440|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
154512441|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154512442|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154512444|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
154512445|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154512446|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154512447|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154512448|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154512449|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154512450|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
154512451|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512452|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154512453|NCT01256398|Antidotes|antidotes|mesh-ancestor
154512454|NCT01256398|Protective Agents|protective agents|mesh-ancestor
154512455|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
154512456|NCT01256398|Vitamins|vitamins|mesh-ancestor
154512457|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
154512458|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154512459|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
154512460|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
154512461|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
154512462|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154512463|NCT01256398|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154512464|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154512466|NCT01020383|Abciximab|abciximab|mesh-list
154281611|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154281612|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281613|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
154281614|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
154281615|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
154281616|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281617|NCT02751255|Tretinoin|tretinoin|mesh-list
154281618|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281619|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
154281620|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281621|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
154281622|NCT02707666|Pemetrexed|pemetrexed|mesh-list
154281623|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281624|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281625|NCT02707666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154281626|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281627|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281628|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154281629|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154281630|NCT02659293|Dexamethasone|dexamethasone|mesh-list
154281638|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
154512467|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
154512468|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154512469|NCT00889876|Metformin|metformin|mesh-list
154512470|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154512471|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512472|NCT00587067|Floxuridine|floxuridine|mesh-list
154512473|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154512474|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
154512475|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512476|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512477|NCT00453154|Cisplatin|cisplatin|mesh-list
154512478|NCT00453154|Carboplatin|carboplatin|mesh-list
154512479|NCT00453154|Etoposide|etoposide|mesh-list
154512480|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
154512481|NCT00453154|Sunitinib|sunitinib|mesh-list
154512482|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
154512483|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512484|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154512485|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154512486|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154512487|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512488|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512489|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154512490|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154512491|NCT00453154|Growth Substances|growth substances|mesh-ancestor
154512492|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512493|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
154512494|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154512495|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
154512496|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281639|NCT02659293|Hormones|hormones|mesh-ancestor
154281640|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281641|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281642|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281643|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
154281644|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154281645|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154281646|NCT02659293|Growth Substances|growth substances|mesh-ancestor
154281647|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
154281648|NCT02656511|Tenofovir|tenofovir|mesh-list
154281649|NCT02656511|Emtricitabine|emtricitabine|mesh-list
154281650|NCT02656511|Dolutegravir|dolutegravir|mesh-list
154281651|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
154281657|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154512497|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
154512498|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
154512499|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
154512500|NCT00309257|Valsartan|valsartan|mesh-list
154512501|NCT00309257|Benazepril|benazepril|mesh-list
154512502|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154512503|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154512504|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154512505|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512506|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154512507|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
154512508|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512509|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
154512510|NCT00258960|Doxorubicin|doxorubicin|mesh-list
154512511|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154512512|NCT00258960|Trastuzumab|trastuzumab|mesh-list
154512513|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512514|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
154512515|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512516|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512517|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154512518|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
154512519|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512520|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512521|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154512522|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154281666|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154281667|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
154281668|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281669|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154281670|NCT02572323|Tesamorelin|tesamorelin|mesh-list
154281671|NCT02572323|Growth Substances|growth substances|mesh-ancestor
154281672|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281673|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
154281674|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281675|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
154281676|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281677|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281678|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154281679|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
154281680|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281681|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281682|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154281683|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
154281684|NCT02431988|Fludarabine|fludarabine|mesh-list
154281685|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281692|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512523|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154512524|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154512525|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512526|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154512527|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
154512528|NCT00121992|Docetaxel|docetaxel|mesh-list
154512529|NCT00121992|Doxorubicin|doxorubicin|mesh-list
154512530|NCT00121992|Fluorouracil|fluorouracil|mesh-list
154512531|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512532|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
154512533|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512534|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512535|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154512536|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
154512537|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512538|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512539|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154512540|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
154512541|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
154512542|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
154512543|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154512544|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154512545|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154512546|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512547|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
154281693|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154281694|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
154281695|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281696|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281697|NCT02399371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154281698|NCT02399371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281699|NCT02389517|Dexamethasone|dexamethasone|mesh-list
154281700|NCT02389517|Lenalidomide|lenalidomide|mesh-list
154281702|NCT02389517|Glycine|glycine|mesh-list
154281703|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
154281704|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281705|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
154281706|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
154281707|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281708|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281709|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281710|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
154281711|NCT02389517|Hormones|hormones|mesh-ancestor
154281712|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281713|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281714|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281715|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
154281716|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154512548|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154512549|NCT00070564|Paclitaxel|paclitaxel|mesh-list
154512550|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
154512551|NCT00070564|Doxorubicin|doxorubicin|mesh-list
154512552|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154512553|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154512554|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512555|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
154512556|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
154512557|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
154512558|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512559|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512560|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
154512561|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512562|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512563|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154512564|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
154512565|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154512566|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154512567|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154512568|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154512569|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512570|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
154512571|NCT05158647|Analgesics|analgesics|mesh-ancestor
154512572|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
154512573|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512574|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512575|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
154512576|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512577|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154512578|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
154512579|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154512580|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154512581|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512582|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154512583|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
154281717|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154281755|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154512584|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154512585|NCT02738151|Insulin|insulin|mesh-list
154512586|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154512587|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
154512588|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154512589|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512590|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
154512591|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
154512592|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154512593|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154512594|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512595|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154512596|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154512597|NCT03471039|Growth Substances|growth substances|mesh-ancestor
154512598|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512599|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
154512600|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512601|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512602|NCT03472677|Capsaicin|capsaicin|mesh-list
154512603|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
154512604|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
154512605|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
154512606|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512607|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281756|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154281757|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
154281758|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281759|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281760|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
154281761|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
154281762|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281763|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154281764|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154281765|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
154281766|NCT02213913|Prednisone|prednisone|mesh-list
154281767|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
154281768|NCT02213913|Rituximab|rituximab|mesh-list
154281769|NCT02213913|Doxorubicin|doxorubicin|mesh-list
154281770|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154281771|NCT02213913|Etoposide|etoposide|mesh-list
154281772|NCT02213913|Vincristine|vincristine|mesh-list
154281773|NCT02213913|Lenalidomide|lenalidomide|mesh-list
154281774|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
154281775|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281776|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
154281777|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281778|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281779|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154281780|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
154512608|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154512609|NCT02673567|Antibodies|antibodies|mesh-list
154512610|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
154512611|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154512612|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
154512613|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512614|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512615|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154512616|NCT00702195|Hormones|hormones|mesh-ancestor
154512617|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512618|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512619|NCT02915159|Abatacept|abatacept|mesh-list
154512620|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154512621|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512622|NCT02915159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154512623|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512624|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512625|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
154512626|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512627|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512628|NCT03669263|Fentanyl|fentanyl|mesh-list
154512629|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154512630|NCT03669263|Narcotics|narcotics|mesh-ancestor
154512631|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512632|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512633|NCT03669263|Analgesics|analgesics|mesh-ancestor
154512634|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
154512635|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512636|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154512637|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154512638|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
154512639|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
154512640|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154512641|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154512642|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512643|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
154512644|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154512645|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512646|NCT02521870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154512647|NCT02521870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512648|NCT02385656|Modafinil|modafinil|mesh-list
154512649|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154512650|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512651|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154512652|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154512653|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154512654|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512655|NCT02389868|Lovastatin|lovastatin|mesh-list
154512656|NCT02389868|L 647318|l 647318|mesh-list
154512657|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
154512658|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154512659|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154512660|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
154512661|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512662|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154512663|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154512664|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512665|NCT03623087|Dexamethasone|dexamethasone|mesh-list
154512666|NCT03623087|Gemcitabine|gemcitabine|mesh-list
154512667|NCT03623087|Etoposide|etoposide|mesh-list
154512668|NCT03623087|Asparaginase|asparaginase|mesh-list
154512669|NCT03623087|Ifosfamide|ifosfamide|mesh-list
154512670|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512671|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512672|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
154512673|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
154512674|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512675|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512676|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154512677|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
154512678|NCT03623087|Hormones|hormones|mesh-ancestor
154512679|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512680|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154512681|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154512682|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
154512683|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512684|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154512685|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154281830|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154281831|NCT00800215|Lacosamide|lacosamide|mesh-list
154281832|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
154281833|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154281834|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154281835|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154281836|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281837|NCT00337649|Trastuzumab|trastuzumab|mesh-list
154281838|NCT00337649|Epothilones|epothilones|mesh-list
154281839|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
154281840|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281846|NCT00071084|Zanolimumab|zanolimumab|mesh-list
154281861|NCT01283646|Folic Acid|folic acid|mesh-list
154512686|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154512687|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512688|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154512689|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
154512690|NCT03113396|Baclofen|baclofen|mesh-list
154512691|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154512692|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512693|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154512694|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512695|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154512696|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
154512697|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
154512698|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512699|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512700|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
154512701|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512702|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
154512703|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512704|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512705|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154512706|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
154512707|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154512708|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
154512709|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512710|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154512711|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
154512712|NCT05062954|Procyanidin|procyanidin|mesh-list
154512713|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
154512714|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281862|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
154281863|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
154281864|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281865|NCT01283646|Hematinics|hematinics|mesh-ancestor
154281866|NCT01283724|Dienogest|dienogest|mesh-list
154281867|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154281868|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
154281869|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154281870|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281871|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154281872|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154281873|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154281874|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154281879|NCT01586442|Eplerenone|eplerenone|mesh-list
154281890|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154512715|NCT05062954|Protective Agents|protective agents|mesh-ancestor
154512716|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512717|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154512718|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154512719|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512720|NCT02389400|Methotrexate|methotrexate|mesh-list
154512721|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154512722|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
154512723|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154512724|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512725|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154512726|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
154512727|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512728|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512729|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
154512730|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512731|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154512732|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512733|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
154512734|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512735|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154512736|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
154512737|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154512738|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
154512739|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512740|NCT03669029|Golimumab|golimumab|mesh-list
154512741|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154512742|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154512743|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512744|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512745|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
154512746|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512747|NCT03668015|Sorbitol|sorbitol|mesh-list
154512748|NCT03668015|Cathartics|cathartics|mesh-ancestor
154512749|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281891|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
154281892|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154281893|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154281894|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154281895|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512750|NCT02385734|Mitogens|mitogens|mesh-list
154512751|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154512752|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512753|NCT02385500|Fesoterodine|fesoterodine|mesh-list
154512754|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154512755|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154512756|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
154512757|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512758|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860230|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
154512759|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512760|NCT02385500|Urological Agents|urological agents|mesh-ancestor
154512761|NCT02385422|Propranolol|propranolol|mesh-list
154512762|NCT02385422|Carvedilol|carvedilol|mesh-list
154512763|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154512764|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154512765|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
154512766|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512767|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512768|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512769|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154512770|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154512771|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
154512772|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
154512773|NCT02385422|Protective Agents|protective agents|mesh-ancestor
154512774|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154512775|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154512776|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154512777|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154512778|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154512779|NCT02520388|Methylphenidate|methylphenidate|mesh-list
154512780|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154512781|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512782|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154512783|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154512784|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154512785|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512786|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
154512787|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512788|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154512789|NCT03667937|Laxatives|laxatives|mesh-ancestor
154281930|NCT01167738|Metformin|metformin|mesh-list
154512790|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154512791|NCT03667235|Glutaral|glutaral|mesh-list
154512792|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
154512793|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154512794|NCT02668640|Adalimumab|adalimumab|mesh-list
154512795|NCT02668640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154512796|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512797|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512798|NCT05043766|Naltrexone|naltrexone|mesh-list
154512799|NCT05043766|Oxycodone|oxycodone|mesh-list
154512800|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154512801|NCT05043766|Narcotics|narcotics|mesh-ancestor
154512802|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512803|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512804|NCT05043766|Analgesics|analgesics|mesh-ancestor
154512805|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
154512806|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512807|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154512808|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154512809|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
154512810|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154512812|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154512813|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512814|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154512815|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512816|NCT03011333|Epinephrine|epinephrine|mesh-list
154512817|NCT03011333|Bupivacaine|bupivacaine|mesh-list
154512818|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
154512819|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
154512820|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512821|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512822|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
154512823|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512824|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154512825|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154512826|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
154512827|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512828|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282004|NCT01281852|Cisplatin|cisplatin|mesh-list
154282005|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154282006|NCT01281852|Veliparib|veliparib|mesh-list
154282007|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154512829|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154512830|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154512831|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
154512832|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154282008|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512833|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
154512834|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
154512835|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
154512836|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154512837|NCT04570397|Ravulizumab|ravulizumab|mesh-list
154512838|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154512839|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512840|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
154512841|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512842|NCT02385188|Acetaminophen|acetaminophen|mesh-list
154512843|NCT02385188|Imiquimod|imiquimod|mesh-list
154512844|NCT02385188|Lidocaine|lidocaine|mesh-list
154512845|NCT02385188|Petrolatum|petrolatum|mesh-list
154512846|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
154512847|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
154512848|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512849|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512850|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
154512851|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512852|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154512853|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154512854|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154512855|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154512856|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512857|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154512858|NCT02385188|Analgesics|analgesics|mesh-ancestor
154512859|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
154512860|NCT02385188|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154512861|NCT02385188|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154512862|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
154282009|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
154282010|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
154282011|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
154282012|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282013|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154282014|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282015|NCT01168440|Sunitinib|sunitinib|mesh-list
154512863|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154512864|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512865|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
154512866|NCT02385188|Emollients|emollients|mesh-ancestor
154512867|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
154512868|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154512869|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154512870|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154512871|NCT02384954|Rituximab|rituximab|mesh-list
154512872|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154512873|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512874|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
154512875|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512876|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154512877|NCT02384876|Ephedrine|ephedrine|mesh-list
154512878|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
154512879|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154512880|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154512881|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512882|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
154512883|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
154236737|NCT00142584|Metoprolol|metoprolol|mesh-list
154512884|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512885|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154512886|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
154512887|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512888|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512889|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154512890|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154512891|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
154512892|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
154512893|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
154512894|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
154512895|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154512896|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282033|NCT01170780|Hormones|hormones|mesh-ancestor
154282034|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154282035|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154282036|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282037|NCT01165944|Pramlintide|pramlintide|mesh-list
154282038|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154282067|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512897|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154512898|NCT02377388|Saxagliptin|saxagliptin|mesh-list
154512899|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154512900|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512901|NCT02377388|Incretins|incretins|mesh-ancestor
154512902|NCT02377388|Hormones|hormones|mesh-ancestor
154512903|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512904|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154512905|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
154512906|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512907|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512908|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154512909|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
154512910|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
154512911|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512912|NCT02382146|Dexamethasone|dexamethasone|mesh-list
154512913|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
154512914|NCT02382146|Ondansetron|ondansetron|mesh-list
154512915|NCT02382146|BB 1101|bb 1101|mesh-list
154512916|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512917|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
154512918|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
154512919|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512920|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512921|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154512922|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
154512923|NCT02382146|Hormones|hormones|mesh-ancestor
154282068|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282069|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
154282070|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282071|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154282072|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
154282073|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154282074|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154282075|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154282076|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282077|NCT01277016|Melphalan|melphalan|mesh-list
154282078|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154282079|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
154282080|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282081|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282082|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154282083|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154282084|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
154282090|NCT01171482|Sorafenib|sorafenib|mesh-list
154512924|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512925|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154512926|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512927|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
154512928|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512929|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512930|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
154512931|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
154512932|NCT02382146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154512933|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154512934|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
154512935|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154512936|NCT02382068|Dexamethasone|dexamethasone|mesh-list
154512937|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512938|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154512939|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
154512940|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
154512941|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512942|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512943|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154512944|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
154512945|NCT02382068|Hormones|hormones|mesh-ancestor
154512946|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154512947|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154512948|NCT02381600|Vitamin D|vitamin d|mesh-list
154512949|NCT02381600|Vitamins|vitamins|mesh-ancestor
154512950|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
154512951|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512952|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154512953|NCT03113084|Heparin|heparin|mesh-list
154512954|NCT03113084|Calcium heparin|calcium heparin|mesh-list
154512955|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
154512956|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154512957|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154512958|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236809|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
154512960|NCT02377076|Calcium|calcium|mesh-list
154512961|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154512962|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512963|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154512964|NCT04439474|Vitamin D|vitamin d|mesh-list
154512965|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
154512966|NCT04439474|Vitamins|vitamins|mesh-ancestor
154512967|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
154512968|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512969|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154512970|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154512971|NCT02662556|Sufentanil|sufentanil|mesh-list
154512972|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154512973|NCT02662556|Narcotics|narcotics|mesh-ancestor
154512974|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154512975|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512976|NCT02662556|Analgesics|analgesics|mesh-ancestor
154512977|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
154512978|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154512979|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154512980|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154512981|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
154860231|NCT01929824|Protective Agents|protective agents|mesh-ancestor
154512982|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
154512983|NCT02376452|Leucovorin|leucovorin|mesh-list
154512984|NCT02376452|Fluorouracil|fluorouracil|mesh-list
154512985|NCT02376452|Raltitrexed|raltitrexed|mesh-list
154512986|NCT02376452|Irinotecan|irinotecan|mesh-list
154512987|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
154512988|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154512989|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154512990|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154512991|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154512992|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
154512993|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154512994|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154512995|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154512996|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154512997|NCT02376452|Antidotes|antidotes|mesh-ancestor
154512998|NCT02376452|Protective Agents|protective agents|mesh-ancestor
154512999|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
154513000|NCT02376452|Vitamins|vitamins|mesh-ancestor
154513001|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
154513002|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154513003|NCT02516098|Scopolamine|scopolamine|mesh-list
154513004|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154513005|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154513006|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
154513007|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
154513008|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513009|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513010|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513011|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
154513012|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154282146|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154282147|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
154282183|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
154513013|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
154513014|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513015|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513016|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154513017|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
154513018|NCT02372318|Nalmefene|nalmefene|mesh-list
154513019|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154513020|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513021|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
154513022|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513023|NCT03105674|Anesthetics|anesthetics|mesh-list
154513024|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
154513025|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513026|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513027|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
154513028|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513029|NCT02380898|Ketorolac|ketorolac|mesh-list
154513030|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154513031|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154513032|NCT02380898|Analgesics|analgesics|mesh-ancestor
154513033|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
154513034|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236896|NCT01560052|Hormones|hormones|mesh-ancestor
154513035|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513036|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513037|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513038|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154513039|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513040|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513041|NCT02376296|Docetaxel|docetaxel|mesh-list
154513042|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513043|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
154513044|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
154282184|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154282185|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154282186|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154282187|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154282188|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282189|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513045|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
154513046|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513047|NCT01364428|Insulin|insulin|mesh-list
154513048|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154513049|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
154513050|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154513051|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513052|NCT02380586|Anesthetics|anesthetics|mesh-list
154513053|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513054|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513055|NCT02375828|Glyburide|glyburide|mesh-list
154513056|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154513057|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513058|NCT02371226|Insulin|insulin|mesh-list
154513059|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154513060|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154513061|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513062|NCT02371304|Capecitabine|capecitabine|mesh-list
154513063|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154513064|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
154513065|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513066|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513067|NCT02380352|Amoxicillin|amoxicillin|mesh-list
154513068|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154513069|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513070|NCT02380118|Midazolam|midazolam|mesh-list
154513071|NCT02380118|Haloperidol|haloperidol|mesh-list
154513072|NCT02380118|Olanzapine|olanzapine|mesh-list
154513073|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
154513074|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154513075|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154513076|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513077|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513078|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154513079|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154513080|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154513081|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154513082|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
154513083|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
154513084|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
154513085|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
154513086|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513087|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513088|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
154513089|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
154513090|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513091|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513092|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154513093|NCT02380118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154513094|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154513095|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513096|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
154513097|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154513098|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
154513099|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154513100|NCT03113708|Heparin|heparin|mesh-list
154513101|NCT03113708|Calcium heparin|calcium heparin|mesh-list
154513102|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
154513103|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154513104|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154513105|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513106|NCT02371148|Rituximab|rituximab|mesh-list
154513107|NCT02371148|Bortezomib|bortezomib|mesh-list
154513108|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154513109|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154513110|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513111|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
154513112|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513113|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513114|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154513115|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
154513116|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513117|NCT02375360|Immunomodulating Agents|immunomodulating agents|mesh-list
154513118|NCT02375360|Immunologic Factors|immunologic factors|mesh-ancestor
154513119|NCT02375360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513120|NCT02370680|Aspirin|aspirin|mesh-list
154513121|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154513122|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154513123|NCT02370680|Analgesics|analgesics|mesh-ancestor
154513124|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
154513125|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513126|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513127|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513128|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513129|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154513130|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154513131|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513132|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154513133|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154513134|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513135|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
154513136|NCT02370758|Valganciclovir|valganciclovir|mesh-list
154860232|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
154860233|NCT01031953|Aprepitant|aprepitant|mesh-list
154513137|NCT02370758|Ganciclovir|ganciclovir|mesh-list
154513138|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154513139|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
154513140|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513141|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154513142|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513143|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513144|NCT02379026|Vitamin D|vitamin d|mesh-list
154513145|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
154513146|NCT02379026|Vitamins|vitamins|mesh-ancestor
154513147|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
154513148|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513149|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154513150|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154513151|NCT02991859|Fluticasone|fluticasone|mesh-list
154513152|NCT02991859|Xhance|xhance|mesh-list
154513153|NCT02991859|Budesonide|budesonide|mesh-list
154513154|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513155|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154513156|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
154513157|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513158|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513159|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154513160|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
154513161|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
154513162|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154513163|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
154513164|NCT02991859|Hormones|hormones|mesh-ancestor
154513165|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513166|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
154513167|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154513168|NCT02374736|Antibodies|antibodies|mesh-list
154513169|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
154513170|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
154513171|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513172|NCT02369978|Benzonidazole|benzonidazole|mesh-list
154513173|NCT02369978|Nifurtimox|nifurtimox|mesh-list
154513174|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154513175|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
154513176|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513177|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154513178|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154513179|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154513180|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513181|NCT03661489|Propofol|propofol|mesh-list
154513182|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154513183|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513184|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513185|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154513186|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
154513187|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
154237038|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
154513188|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154513189|NCT04056169|Ezetimibe|ezetimibe|mesh-list
154513190|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154513191|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154513192|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
154513193|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513194|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154513195|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154513196|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513197|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154513198|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154513199|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
154513200|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513201|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154513202|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513203|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154513204|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513205|NCT03008915|Aspirin|aspirin|mesh-list
154513206|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154513207|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
154513208|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154513209|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154513210|NCT03008915|Analgesics|analgesics|mesh-ancestor
154513211|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
154513212|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513213|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513214|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513215|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513216|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154282346|NCT01288404|Hormones|hormones|mesh-ancestor
154513217|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154513218|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513219|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154513220|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154513221|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513222|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
154513223|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154513224|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154513225|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
154513226|NCT03622489|Acetaminophen|acetaminophen|mesh-list
154513227|NCT03622489|Dipyrone|dipyrone|mesh-list
154513228|NCT03622489|Ibuprofen|ibuprofen|mesh-list
154513229|NCT03622489|Morphine|morphine|mesh-list
154513230|NCT03622489|Tramadol|tramadol|mesh-list
154513231|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154513232|NCT03622489|Narcotics|narcotics|mesh-ancestor
154513233|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513234|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513235|NCT03622489|Analgesics|analgesics|mesh-ancestor
154513236|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
154513237|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513238|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154513239|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
154513240|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154513241|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513242|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513243|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154513244|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513245|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513246|NCT03667001|Lidocaine|lidocaine|mesh-list
154513247|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
154513248|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
154513249|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513250|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513251|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
154513252|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513253|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154513254|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154513255|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154513256|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513257|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513258|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
154513259|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
154513260|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154513261|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154513262|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513263|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513264|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513265|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513267|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
154513268|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
154513269|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513270|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513271|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
154282438|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513272|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513273|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154513274|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154513275|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154513276|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513277|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513278|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
154513279|NCT03591380|Belimumab|belimumab|mesh-list
154513280|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154513281|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
154513282|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513283|NCT04057469|Tulobuterol|tulobuterol|mesh-list
154513284|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154513285|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154513286|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
154860234|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
154513287|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513288|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513289|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513290|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154513291|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
154513292|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513293|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154513294|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
154513295|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
154513296|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154513297|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513298|NCT03658291|Levofloxacin|levofloxacin|mesh-list
154513299|NCT03658291|Ofloxacin|ofloxacin|mesh-list
154282439|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282440|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
154282441|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282442|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154282443|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154282444|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
154282445|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282446|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282447|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154282448|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154282449|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
154282450|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154282451|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
154282452|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
154282453|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
154513300|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154513301|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513302|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154513303|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154513304|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154513305|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513306|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513307|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513308|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154513309|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154513310|NCT03658213|Goserelin|goserelin|mesh-list
154513311|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154513312|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513313|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
154513314|NCT03006887|Lenvatinib|lenvatinib|mesh-list
154513315|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154513316|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513317|NCT03006887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154513318|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513319|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154282466|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282467|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154282468|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
154282469|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
154282470|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282471|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282472|NCT01285596|Mirabegron|mirabegron|mesh-list
154282473|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154282474|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154282475|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154282476|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
154282477|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282478|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282479|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282480|NCT01285596|Urological Agents|urological agents|mesh-ancestor
154282481|NCT00655876|Paclitaxel|paclitaxel|mesh-list
154282482|NCT00655876|Cetuximab|cetuximab|mesh-list
154282483|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154282484|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282485|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
154282486|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813378|NCT00333632|Midazolam|midazolam|mesh-list
154282487|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
154513320|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513321|NCT02377856|Interferons|interferons|mesh-list
154513322|NCT02377856|Ribavirin|ribavirin|mesh-list
154513323|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
154513324|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
154513325|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154513326|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513327|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
154513328|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513329|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
154513330|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513331|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
154513332|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513333|NCT02377778|Thiopental|thiopental|mesh-list
154513334|NCT02377778|Propofol|propofol|mesh-list
154513335|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154513336|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513337|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513338|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154513339|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
154513340|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
154513341|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
154282488|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282489|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282490|NCT01176318|Erdosteine|erdosteine|mesh-list
154282492|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
154282493|NCT01178658|Cytarabine|cytarabine|mesh-list
154282494|NCT01178658|Etoposide|etoposide|mesh-list
154282495|NCT01178658|Melphalan|melphalan|mesh-list
154282496|NCT01178658|Busulfan|busulfan|mesh-list
154282497|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154282498|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282499|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154282500|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154282501|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282502|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282503|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154282504|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
154282505|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
154282506|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282507|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154513342|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
154513343|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
154513344|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513345|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513346|NCT02514772|Rituximab|rituximab|mesh-list
154513347|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154513348|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513349|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
154513350|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513351|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513352|NCT03658057|Rocuronium|rocuronium|mesh-list
154513353|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154513354|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154513355|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154513356|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513357|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513358|NCT03657979|Ropivacaine|ropivacaine|mesh-list
154513359|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
154513360|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
154348219|NCT01190683|Vitamin D|vitamin d|mesh-list
154860235|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
154513361|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513362|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282508|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
154282509|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282510|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154282511|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
154282512|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154282513|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154282514|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282515|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154282516|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154282517|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154282518|NCT01174524|Gestodene|gestodene|mesh-list
154282519|NCT01174524|Femovan|femovan|mesh-list
154282520|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
154282521|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
154282522|NCT01174524|Estradiol|estradiol|mesh-list
154282523|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154282524|NCT01174524|Estrogens|estrogens|mesh-ancestor
154282525|NCT01174524|Hormones|hormones|mesh-ancestor
154282526|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154282527|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282528|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154282529|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154282530|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154513363|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
154513364|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513365|NCT03659851|Simendan|simendan|mesh-list
154513366|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154513367|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
154513368|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154513369|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154513370|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513371|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513372|NCT03659851|Protective Agents|protective agents|mesh-ancestor
154513373|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513374|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154513375|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513376|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154513377|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
154513378|NCT02368730|Coagulants|coagulants|mesh-ancestor
154513379|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154513380|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
154513381|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513382|NCT03659305|Bevacizumab|bevacizumab|mesh-list
154513383|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154513384|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513385|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154513386|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154513387|NCT03659305|Growth Substances|growth substances|mesh-ancestor
154513388|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513389|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
154513390|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154513391|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154282531|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154282532|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154282533|NCT01174524|Progestins|progestins|mesh-ancestor
154282534|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154282535|NCT02525172|Rituximab|rituximab|mesh-list
154282536|NCT02525172|Methotrexate|methotrexate|mesh-list
154282537|NCT02525172|Bortezomib|bortezomib|mesh-list
154282538|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
154282539|NCT02525172|Antibodies|antibodies|mesh-list
154282540|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
154282541|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154282542|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154282543|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282544|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282545|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
154282547|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513392|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
154513393|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154513394|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
154513395|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154513396|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513397|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154513398|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154513399|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513400|NCT02373722|Petrolatum|petrolatum|mesh-list
154513401|NCT02373722|Mineral Oil|mineral oil|mesh-list
154513402|NCT02373722|Emollients|emollients|mesh-ancestor
154513403|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
154513404|NCT03000179|Avelumab|avelumab|mesh-list
154513405|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154513406|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513407|NCT03658993|Rifaximin|rifaximin|mesh-list
154237259|NCT03714022|Abatacept|abatacept|mesh-list
154513408|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154513409|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513410|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513411|NCT02373410|Bupivacaine|bupivacaine|mesh-list
154513412|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
154513413|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
154513414|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513415|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513416|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
154513417|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282560|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282561|NCT03859362|Ertapenem|ertapenem|mesh-list
154282562|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154282563|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282564|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154282565|NCT01287546|Trametinib|trametinib|mesh-list
154282566|NCT01287546|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154282567|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154282568|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282569|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282570|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282572|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154282573|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282574|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154282575|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
154282576|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282577|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
154282578|NCT03193216|Antacids|antacids|mesh-ancestor
154282579|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282580|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154282585|NCT01568788|Vaccines|vaccines|mesh-list
154513418|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154513419|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513420|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
154513421|NCT02920177|Hormones|hormones|mesh-ancestor
154513422|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513423|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513424|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154513425|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
154513426|NCT03006341|Telmisartan|telmisartan|mesh-list
154513427|NCT03006341|Warfarin|warfarin|mesh-list
154513428|NCT03006341|Dabigatran|dabigatran|mesh-list
154513429|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
154513430|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154513431|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154513432|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154513433|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513434|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
154513435|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154513436|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
154513437|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513438|NCT05022784|Nintedanib|nintedanib|mesh-list
154513439|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513440|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154282586|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
154282587|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282588|NCT01287624|Paclitaxel|paclitaxel|mesh-list
154282589|NCT01287624|Gemcitabine|gemcitabine|mesh-list
154282590|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154282591|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282592|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
154282593|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
154282594|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
154282595|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282596|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154282597|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
154282598|NCT05597800|Nivolumab|nivolumab|mesh-list
154282599|NCT05597800|Ipilimumab|ipilimumab|mesh-list
154282600|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282601|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282602|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154282603|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282604|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
154282605|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
154282606|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154282607|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
154282608|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513441|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513442|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513443|NCT03665753|Ketorolac|ketorolac|mesh-list
154513444|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154513445|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154513446|NCT03665753|Analgesics|analgesics|mesh-ancestor
154513447|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
154513448|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513449|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513450|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513451|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513452|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154513453|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513454|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513455|NCT02512042|Brinzolamide|brinzolamide|mesh-list
154513456|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154513457|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513458|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513459|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154513460|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154513461|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513462|NCT01066897|Pramipexole|pramipexole|mesh-list
154513463|NCT01066897|Dexpramipexole|dexpramipexole|mesh-list
154513464|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
154513465|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513466|NCT01066897|Protective Agents|protective agents|mesh-ancestor
154282609|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
154282610|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282611|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282612|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
154282613|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154282614|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282615|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282616|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154282617|NCT01179438|Analgesics|analgesics|mesh-ancestor
154282618|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
154282619|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282620|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154282621|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154282622|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154282623|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
154282624|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282625|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282626|NCT03864666|Cilostazol|cilostazol|mesh-list
154282628|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
154513467|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513468|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154513469|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154513470|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
154513471|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
154513472|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513473|NCT02373254|Acetaminophen|acetaminophen|mesh-list
154513474|NCT02373254|Ibuprofen|ibuprofen|mesh-list
154513475|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154513476|NCT02373254|Hydrocodone|hydrocodone|mesh-list
154513477|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154513478|NCT02373254|Analgesics|analgesics|mesh-ancestor
154513479|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
154513480|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513481|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513482|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
154513483|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154513484|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513485|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513486|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154513487|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513488|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513489|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154513490|NCT02373254|Narcotics|narcotics|mesh-ancestor
154513491|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513492|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
154513493|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
154513494|NCT03657355|Zolpidem|zolpidem|mesh-list
154513495|NCT03657355|Suvorexant|suvorexant|mesh-list
154513496|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154513497|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154513498|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513499|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513500|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154282634|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154282635|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282636|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154282637|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
154282638|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154513501|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
154513502|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
154513503|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513504|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513505|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154513506|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
154513507|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154513508|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
154513509|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154513510|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513511|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154513512|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154513513|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154513514|NCT02365532|Dofetilide|dofetilide|mesh-list
154513515|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154513516|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154513517|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513518|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513519|NCT03113162|Cytarabine|cytarabine|mesh-list
154513520|NCT03113162|Etoposide|etoposide|mesh-list
154513521|NCT03113162|Melphalan|melphalan|mesh-list
154513522|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154513523|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513524|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154513525|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154513526|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282667|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154282668|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154282669|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154282670|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154282671|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282672|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154282673|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
154282674|NCT01179594|Entecavir|entecavir|mesh-list
154282675|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
154282676|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282677|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
154282678|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282679|NCT03751098|Phenylephrine|phenylephrine|mesh-list
154282680|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
154282681|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154282682|NCT03751098|Tropicamide|tropicamide|mesh-list
154282683|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154282684|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154282685|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
154282686|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
154282687|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282694|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154513527|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513528|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154513529|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
154513530|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
154513531|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513532|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154513533|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
154513534|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513535|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154513536|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
154513537|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154513538|NCT02356705|Lidocaine|lidocaine|mesh-list
154513539|NCT02356705|Midazolam|midazolam|mesh-list
154513540|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154513541|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154513542|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513543|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513544|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154513545|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154513546|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154513547|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154513548|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
154513549|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
154513550|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
154513551|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
154513552|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513553|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513554|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
154513555|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
154513556|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513557|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154513558|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154282695|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154282696|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
154282697|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282698|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282699|NCT03751098|Protective Agents|protective agents|mesh-ancestor
154282700|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154282701|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154282702|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
154282703|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154282704|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
154513559|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154513560|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513561|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
154513562|NCT02511184|Crizotinib|crizotinib|mesh-list
154513563|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154513564|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513565|NCT02511184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154513566|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513567|NCT02511184|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154513568|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154513569|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513570|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
154513571|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154513572|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154513573|NCT02367560|Prednisolone|prednisolone|mesh-list
154513574|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
154513575|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154513576|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
154513577|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513578|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
154513579|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
154513580|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513581|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513582|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513583|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
154513584|NCT02367560|Hormones|hormones|mesh-ancestor
154513585|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513586|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154513587|NCT02367560|Protective Agents|protective agents|mesh-ancestor
154513588|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154513589|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282724|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282725|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
154282726|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282727|NCT01288950|Vitamin D|vitamin d|mesh-list
154282728|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
154282729|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
154282730|NCT01288950|Vitamins|vitamins|mesh-list
154282731|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
154282732|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282733|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154282734|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154513590|NCT02372942|Progesterone|progesterone|mesh-list
154513591|NCT02372942|Progestins|progestins|mesh-ancestor
154513592|NCT02372942|Hormones|hormones|mesh-ancestor
154513593|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513594|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513595|NCT02364986|Interferons|interferons|mesh-list
154513596|NCT02364986|Interferon-beta|interferon-beta|mesh-list
154513597|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
154513598|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513599|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
154513600|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513601|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
154513602|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513603|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154513604|NCT02372786|Lidocaine|lidocaine|mesh-list
154513605|NCT02372786|Tetracaine|tetracaine|mesh-list
154513606|NCT02372786|Prilocaine|prilocaine|mesh-list
154513607|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
154513608|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
154513609|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513610|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513611|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
154513612|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513613|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154513614|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154513615|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154513616|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513617|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513618|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154513619|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154513620|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154513621|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513622|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513623|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513624|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513625|NCT02367404|Analgesics|analgesics|mesh-ancestor
154513626|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
154513627|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513628|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
154513629|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154513630|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
154513631|NCT02367248|Deferoxamine|deferoxamine|mesh-list
154513632|NCT02367248|Siderophores|siderophores|mesh-ancestor
154513633|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154513634|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
154513635|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
154513636|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513637|NCT02984995|Quizartinib|quizartinib|mesh-list
154513638|NCT02984995|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154513639|NCT02984995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154513640|NCT02984995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513641|NCT02984995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513642|NCT03656965|Acyclovir|acyclovir|mesh-list
154513643|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
154513644|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513645|NCT02384239|Tamoxifen|tamoxifen|mesh-list
154513646|NCT02384239|Fulvestrant|fulvestrant|mesh-list
154513647|NCT02384239|Palbociclib|palbociclib|mesh-list
154513648|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154513649|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
154513650|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154282763|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154513651|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513652|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154513653|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513654|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154513655|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154513656|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154513657|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154513658|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154513659|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513660|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513661|NCT02364752|Diuretics|diuretics|mesh-list
154513662|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154513663|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
154513664|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513665|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513666|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513667|NCT02372240|Dexamethasone|dexamethasone|mesh-list
154513668|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513669|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
154513670|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
154513671|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513672|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513673|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513674|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
154513675|NCT02372240|Hormones|hormones|mesh-ancestor
154513676|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513677|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154513678|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513679|NCT02364206|Temozolomide|temozolomide|mesh-list
154282818|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154282819|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154282820|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154282821|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
154282822|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
154282823|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154282824|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154282825|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154282826|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
154282827|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
154282828|NCT01180062|Latanoprost|latanoprost|mesh-list
154282829|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154282831|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
154513680|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154513681|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
154513682|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513683|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513684|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
154513685|NCT02366546|Fludarabine|fludarabine|mesh-list
154513686|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154513687|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
154513688|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513689|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513690|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154513691|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
154513692|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513693|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513694|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154513695|NCT02364362|Docetaxel|docetaxel|mesh-list
154513696|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513697|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
154513698|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
154513699|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
154513700|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513701|NCT03004469|Finasteride|finasteride|mesh-list
154513702|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154513703|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154513704|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513705|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513706|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
154513707|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513708|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282849|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282850|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282851|NCT01181154|Rituximab|rituximab|mesh-list
154282852|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282853|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282854|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
154282855|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282856|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154282857|NCT03101566|Gemcitabine|gemcitabine|mesh-list
154282858|NCT03101566|Nivolumab|nivolumab|mesh-list
154282859|NCT03101566|Ipilimumab|ipilimumab|mesh-list
154282860|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282861|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154513709|NCT03004469|Urological Agents|urological agents|mesh-ancestor
154513710|NCT02358824|Amlodipine|amlodipine|mesh-list
154513711|NCT02358824|Telmisartan|telmisartan|mesh-list
154513712|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154513713|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154513714|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513715|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513716|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154513717|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513718|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
154513719|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154513720|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154513721|NCT02359136|Epinephrine|epinephrine|mesh-list
154513722|NCT02359136|Analgesics|analgesics|mesh-list
154513723|NCT02359136|Anesthetics|anesthetics|mesh-list
154513724|NCT02359136|Ropivacaine|ropivacaine|mesh-list
154513725|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513726|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513727|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
154513728|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
154513729|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513730|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154513731|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154513732|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
154513733|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513734|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513735|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154513736|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154513737|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
154513738|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154513739|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
154513740|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
154513741|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
154513742|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154513743|NCT02998151|Minocycline|minocycline|mesh-list
154513744|NCT02998151|Acamprosate|acamprosate|mesh-list
154513745|NCT02998151|Baclofen|baclofen|mesh-list
154513746|NCT02998151|Lovastatin|lovastatin|mesh-list
154513747|NCT02998151|L 647318|l 647318|mesh-list
154513748|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
154513749|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154282884|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
154513750|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513751|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154513752|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513753|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154513754|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513755|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154513756|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
154513757|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
154513758|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513759|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513760|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154513761|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154513762|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
154513763|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154513764|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154513765|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513766|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154513767|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154513768|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154513769|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
154513770|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513771|NCT01069523|Guanfacine|guanfacine|mesh-list
154513772|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154513773|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154513774|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154513775|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154513776|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
154513777|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513778|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513779|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513780|NCT01069289|Budesonide|budesonide|mesh-list
154513781|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
154282922|NCT01181388|Tirofiban|tirofiban|mesh-list
154282923|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154282924|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154282925|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282926|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154282927|NCT01181544|Heparin|heparin|mesh-list
154282928|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
154282929|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154282930|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154513782|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154513783|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513784|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154513786|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513787|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513788|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154513789|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
154513790|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
154513791|NCT01069289|Hormones|hormones|mesh-ancestor
154513792|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513793|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154513794|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154513795|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154513796|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
154513797|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513798|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513799|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
154513800|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154513801|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513802|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154513803|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
154513804|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154513805|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513806|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513807|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513808|NCT02510794|Ranibizumab|ranibizumab|mesh-list
154513809|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154513810|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154513811|NCT02510794|Growth Substances|growth substances|mesh-ancestor
154513812|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513813|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
154513814|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513815|NCT04056923|Methylene Blue|methylene blue|mesh-list
154513816|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282956|NCT01289730|Etanercept|etanercept|mesh-list
154282957|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154513817|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513818|NCT03664115|Itraconazole|itraconazole|mesh-list
154513819|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
154513820|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154513821|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154513822|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154513823|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513824|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513825|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154513826|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
154513827|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513828|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282993|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
154282994|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282995|NCT01181934|Nicotine|nicotine|mesh-list
154282996|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154282997|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
154282998|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282999|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283000|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154283001|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154283002|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
154283003|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283004|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283005|NCT01187862|Efavirenz|efavirenz|mesh-list
154283006|NCT01187862|Losartan|losartan|mesh-list
154283007|NCT01187862|Metoprolol|metoprolol|mesh-list
154513829|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154513830|NCT04056845|Acetaminophen|acetaminophen|mesh-list
154513831|NCT04056845|Diclofenac|diclofenac|mesh-list
154513832|NCT04056845|Analgesics|analgesics|mesh-list
154513833|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154513834|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154513835|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
154513836|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513837|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513838|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513839|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513840|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154513841|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513842|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513843|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
154513844|NCT02510014|Buprenorphine|buprenorphine|mesh-list
154513845|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154513846|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154513847|NCT02510014|Narcotics|narcotics|mesh-ancestor
154513848|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513849|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513850|NCT02510014|Analgesics|analgesics|mesh-ancestor
154513851|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
154513852|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513853|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154513854|NCT02509312|Ketorolac|ketorolac|mesh-list
154513855|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237712|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154513856|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154513858|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
154513859|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513860|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513861|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513862|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154513863|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154513864|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513865|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513866|NCT02362958|Capecitabine|capecitabine|mesh-list
154513867|NCT02362958|Vinorelbine|vinorelbine|mesh-list
154513868|NCT02362958|Lapatinib|lapatinib|mesh-list
154513869|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154513870|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
154513871|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513872|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513873|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154513874|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
154513875|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
154513876|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
154513877|NCT02362958|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154513878|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154513879|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513880|NCT04973800|Simvastatin|simvastatin|mesh-list
154513881|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154513882|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154513884|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513885|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154513886|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154513887|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513888|NCT02519842|Dexamethasone|dexamethasone|mesh-list
154513889|NCT02519842|Ondansetron|ondansetron|mesh-list
154513890|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
154513891|NCT02519842|Aprepitant|aprepitant|mesh-list
154513892|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
154513893|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154513894|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
154513895|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
154283051|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283052|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154283053|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154283054|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154283055|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
154283056|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154283057|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154283058|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154283059|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
154283060|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283061|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
154283062|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154283063|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
154283064|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283065|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
154283066|NCT01185444|Protective Agents|protective agents|mesh-ancestor
154283067|NCT03857334|Cortivazol|cortivazol|mesh-list
154283068|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154283069|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
154283070|NCT01185678|Desogestrel|desogestrel|mesh-list
154283071|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
154283072|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154513896|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513897|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513898|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513899|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
154513900|NCT02519842|Hormones|hormones|mesh-ancestor
154513901|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513902|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154513903|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513904|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
154513905|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
154513906|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154513907|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
154513908|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513909|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513910|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154513911|NCT02509078|Cisatracurium|cisatracurium|mesh-list
154513912|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154513913|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154513914|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513915|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513916|NCT02993783|Vedolizumab|vedolizumab|mesh-list
154513917|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513918|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
154513919|NCT03661775|Analgesics|analgesics|mesh-ancestor
154513920|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
154513921|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154513922|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513923|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
154513924|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513925|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154513926|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
154513927|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154513928|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154513929|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513930|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154513931|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
154513932|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154513933|NCT03660761|Apatinib|apatinib|mesh-list
154513934|NCT03660761|Temozolomide|temozolomide|mesh-list
154513935|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513936|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154513937|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513938|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513939|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154513940|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
154513941|NCT02993471|Vitamin K|vitamin k|mesh-list
154513942|NCT02993471|Midazolam|midazolam|mesh-list
154513943|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
154513944|NCT02993471|Caffeine|caffeine|mesh-list
154513945|NCT02993471|Ixekizumab|ixekizumab|mesh-list
154513946|NCT02993471|Omeprazole|omeprazole|mesh-list
154513947|NCT02993471|Warfarin|warfarin|mesh-list
154513948|NCT02993471|Vitamins|vitamins|mesh-ancestor
154513949|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
154513950|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513951|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154513952|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154513953|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154513954|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154513955|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154513956|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154513957|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154513959|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
154513960|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
154513961|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
154513962|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154513963|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513964|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
154513965|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154513966|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154513967|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513968|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154513969|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154513970|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
154283114|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154283115|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283116|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154283117|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283118|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
154283119|NCT01182168|Gemcitabine|gemcitabine|mesh-list
154283120|NCT01182168|Everolimus|everolimus|mesh-list
154283121|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283122|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154283123|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
154283124|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513971|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154513972|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154513973|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154513974|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154513975|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154513976|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
154513977|NCT02993471|Coagulants|coagulants|mesh-ancestor
154513978|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
154513979|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
154513980|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154513981|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154513982|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
154513983|NCT01068743|Metformin|metformin|mesh-list
154513984|NCT01068743|Saxagliptin|saxagliptin|mesh-list
154513985|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154513986|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154513987|NCT01068743|Incretins|incretins|mesh-ancestor
154513988|NCT01068743|Hormones|hormones|mesh-ancestor
154513989|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154513990|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154513991|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
154513992|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513993|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513994|NCT03622541|Sorafenib|sorafenib|mesh-list
154513995|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154513996|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154513997|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154513998|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154513999|NCT03658733|Amoxicillin|amoxicillin|mesh-list
154514000|NCT03658733|Tetracycline|tetracycline|mesh-list
154514001|NCT03658733|Furazolidone|furazolidone|mesh-list
154514002|NCT03658733|Esomeprazole|esomeprazole|mesh-list
154514003|NCT03658733|Rabeprazole|rabeprazole|mesh-list
154514004|NCT03658733|Bismuth|bismuth|mesh-list
154514005|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154514006|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514007|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154514008|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154514009|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154283144|NCT01588626|Ticagrelor|ticagrelor|mesh-list
154283153|NCT01290120|Rituximab|rituximab|mesh-list
154283179|NCT01290276|Ondansetron|ondansetron|mesh-list
154514010|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514011|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514012|NCT03658733|Antacids|antacids|mesh-ancestor
154514013|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154514014|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154514015|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154514016|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154514017|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154514018|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154514019|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154514020|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
154514021|NCT04056143|Apixaban|apixaban|mesh-list
154514022|NCT04056143|Edoxaban|edoxaban|mesh-list
154514023|NCT04056143|Dabigatran|dabigatran|mesh-list
154514024|NCT04056143|Thromboplastin|thromboplastin|mesh-list
154514025|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154514026|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
154514027|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154514028|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
154514029|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514030|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514031|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
154514032|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
154514033|NCT04056143|Coagulants|coagulants|mesh-ancestor
154514034|NCT03661463|Aspirin|aspirin|mesh-list
154348889|NCT06107465|Nitroglycerin|nitroglycerin|mesh-list
154514035|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154514036|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514037|NCT03661463|Analgesics|analgesics|mesh-ancestor
154283180|NCT01290276|Methylphenidate|methylphenidate|mesh-list
154283181|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
154283182|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
154283183|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283184|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283185|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154283186|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
154283187|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
154283188|NCT01290276|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154283189|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154283190|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
154283191|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283192|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283193|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154283194|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154283195|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154283196|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154283197|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
154283198|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
154283205|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514038|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
154283206|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154514039|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514040|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514041|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154514042|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514043|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154514044|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154514045|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514046|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154514047|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154514048|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514049|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
154514050|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
154514051|NCT03658421|Morphine|morphine|mesh-list
154514052|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154514053|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514054|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514055|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514056|NCT03658421|Analgesics|analgesics|mesh-ancestor
154514057|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
154514058|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514059|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154514060|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154514061|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154514062|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
154283207|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283208|NCT01182636|Adapalene|adapalene|mesh-list
154283209|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154283210|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154283211|NCT01182636|Analgesics|analgesics|mesh-ancestor
154283212|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
154283213|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283214|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283215|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154283216|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154283217|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
154283218|NCT01290354|Lapatinib|lapatinib|mesh-list
154283219|NCT01290354|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154283220|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154283221|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283222|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283223|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283224|NCT01188408|Docetaxel|docetaxel|mesh-list
154283225|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283226|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283227|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283229|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514063|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514064|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514065|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154514066|NCT03658421|Narcotics|narcotics|mesh-ancestor
154514067|NCT03660293|Captopril|captopril|mesh-list
154514068|NCT03660293|Atorvastatin|atorvastatin|mesh-list
154514069|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154514070|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154514071|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
154514072|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514073|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154514074|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154514075|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514076|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154514077|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
154514078|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154514079|NCT02986139|Etanercept|etanercept|mesh-list
154514080|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154514081|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514082|NCT02986139|Analgesics|analgesics|mesh-ancestor
154514083|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
154514084|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514085|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514086|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154514087|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514088|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154514089|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154514090|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
154514092|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154514093|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
154514094|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
154514095|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
154514096|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154514097|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154283230|NCT01186146|Aspirin|aspirin|mesh-list
154283231|NCT01186146|Clopidogrel|clopidogrel|mesh-list
154283232|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154283233|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154283234|NCT01186146|Analgesics|analgesics|mesh-ancestor
154283235|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
154514098|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514099|NCT01066585|Ivermectin|ivermectin|mesh-list
154514100|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154514101|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514102|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
154514103|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154514104|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
154514105|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514106|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514107|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154514108|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
154514109|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514111|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154514112|NCT02980783|Lidocaine|lidocaine|mesh-list
154514113|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
154514114|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
154514115|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514116|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514117|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
154514118|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514119|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154514120|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154514121|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154514122|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154514123|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514124|NCT02989649|Metformin|metformin|mesh-list
154514125|NCT02989649|Pioglitazone|pioglitazone|mesh-list
154514126|NCT02989649|Alogliptin|alogliptin|mesh-list
154514127|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154514128|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514129|NCT02989649|Incretins|incretins|mesh-ancestor
154514130|NCT02989649|Hormones|hormones|mesh-ancestor
154514131|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514132|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154514133|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
154514134|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514135|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514136|NCT03659435|Rivastigmine|rivastigmine|mesh-list
154283299|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514137|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154514138|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514139|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514140|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
154514141|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514142|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514143|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154514144|NCT03659435|Protective Agents|protective agents|mesh-ancestor
154514145|NCT01067339|Darapladib|darapladib|mesh-list
154514146|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154514147|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514148|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514149|NCT04484675|Milrinone|milrinone|mesh-list
154514150|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154514151|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154514152|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
154514153|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154514154|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154514155|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514156|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514157|NCT04484675|Protective Agents|protective agents|mesh-ancestor
154238012|NCT01314898|Diuretics|diuretics|mesh-ancestor
154514158|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514159|NCT03658109|Lidocaine|lidocaine|mesh-list
154514160|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
154514161|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
154514162|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514163|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514164|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
154514165|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514166|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154283300|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154283301|NCT01183806|Rivastigmine|rivastigmine|mesh-list
154283302|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154283303|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283304|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283305|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
154283306|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283307|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283308|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154283309|NCT01183806|Protective Agents|protective agents|mesh-ancestor
154514167|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154514168|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154514169|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154514170|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514171|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
154514172|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154514173|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514174|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154514175|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514176|NCT03660917|Riluzole|riluzole|mesh-list
154514177|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
154514178|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154514179|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154514180|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514181|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514182|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514183|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154514184|NCT03660917|Protective Agents|protective agents|mesh-ancestor
154514185|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
154514186|NCT02977507|Hydroquinone|hydroquinone|mesh-list
154514187|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154514188|NCT02977507|Protective Agents|protective agents|mesh-ancestor
154514189|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514190|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
154514191|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
154514192|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514193|NCT04471415|Atezolizumab|atezolizumab|mesh-list
154514194|NCT04471415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154514195|NCT04471415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514196|NCT04471415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154283331|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283332|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154283333|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154283334|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154283335|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283336|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283337|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
154283338|NCT01290432|Folic Acid|folic acid|mesh-list
154283365|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514197|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514199|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
154514200|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514201|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514202|NCT03653845|Epinephrine|epinephrine|mesh-list
154514203|NCT03653845|Racepinephrine|racepinephrine|mesh-list
154514204|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
154514205|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154514206|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154514207|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
154514208|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514209|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514210|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514211|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154514212|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154514213|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
154514214|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514215|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154514216|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
154514217|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
154514218|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
154514219|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154514220|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154514221|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
154514222|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514223|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154514224|NCT01066039|Bisoprolol|bisoprolol|mesh-list
154514225|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154514226|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
154514227|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
154514228|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283366|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283367|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283368|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154283369|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154283370|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
154283371|NCT01292694|Losartan|losartan|mesh-list
154283372|NCT01292694|Captopril|captopril|mesh-list
154283373|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154283374|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154283375|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154283376|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154283381|NCT03851562|Alprostadil|alprostadil|mesh-list
154514229|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514230|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154514231|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154514232|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154514233|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
154514234|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514235|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514236|NCT04217967|Lenalidomide|lenalidomide|mesh-list
154514237|NCT04217967|Ixazomib|ixazomib|mesh-list
154514238|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
154514239|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514240|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154514241|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154514242|NCT04217967|Growth Substances|growth substances|mesh-ancestor
154514243|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
154514244|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514245|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
154514246|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514247|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514248|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154514249|NCT02919761|Hormones|hormones|mesh-ancestor
154514250|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154283396|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283397|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154283398|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154283399|NCT01191060|Growth Substances|growth substances|mesh-ancestor
154283400|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
154283401|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283402|NCT01291602|Avibactam|avibactam|mesh-list
154283403|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154283404|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283405|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283406|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154283407|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283408|NCT03851172|Ketorolac|ketorolac|mesh-list
154283409|NCT03851172|Nepafenac|nepafenac|mesh-list
154283410|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
154283411|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154283412|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154283413|NCT03851172|Analgesics|analgesics|mesh-ancestor
154283414|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
154283415|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283416|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283417|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154283418|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514251|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514252|NCT02910167|Acetaminophen|acetaminophen|mesh-list
154514253|NCT02910167|Scopolamine|scopolamine|mesh-list
154349111|NCT05932303|Analgesics|analgesics|mesh-ancestor
154514254|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154514255|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514257|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
154514258|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514259|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514260|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
154514261|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154514262|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
154514263|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
154514264|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154514265|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
154514266|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154514267|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
154514268|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514269|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514270|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154514271|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
154514272|NCT04458285|Valsartan|valsartan|mesh-list
154514273|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154514274|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154514275|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154514276|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154514277|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514278|NCT05156541|Interferons|interferons|mesh-list
154514279|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
154514280|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514281|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
154514282|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283420|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283421|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283422|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
154283423|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
154283424|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
154283425|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154283426|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154283427|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
154283428|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514283|NCT01067105|Ciclesonide|ciclesonide|mesh-list
154514284|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
154514285|NCT01067105|Hormones|hormones|mesh-ancestor
154514286|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514287|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514288|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154514289|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
154514290|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154514291|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154514292|NCT03470649|Hematinics|hematinics|mesh-ancestor
154514293|NCT02910011|Doxycycline|doxycycline|mesh-list
154514294|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154514295|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514296|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
154514297|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154514298|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154514299|NCT04456803|Sevelamer|sevelamer|mesh-list
154514300|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
154514301|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
154514302|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514303|NCT02908529|Oxybutynin|oxybutynin|mesh-list
154514304|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154514305|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154514306|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154514307|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154514308|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514309|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154514310|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514311|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514312|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
154514313|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
154514314|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514315|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154514316|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154514317|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
154283454|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154283455|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
154283456|NCT01293942|Bevacizumab|bevacizumab|mesh-list
154283457|NCT01293942|Capecitabine|capecitabine|mesh-list
154283458|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
154283459|NCT01293942|Irinotecan|irinotecan|mesh-list
154514318|NCT02908529|Urological Agents|urological agents|mesh-ancestor
154514320|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
154514321|NCT03469557|Tislelizumab|tislelizumab|mesh-list
154514322|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514323|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154514324|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
154514325|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514326|NCT03469557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154514327|NCT02643381|Ketamine|ketamine|mesh-list
154514328|NCT02643381|Etomidate|etomidate|mesh-list
154514329|NCT02643381|Analgesics|analgesics|mesh-ancestor
154349187|NCT05618236|Atropine|atropine|mesh-list
154514330|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
154514331|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514332|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514333|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154514334|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154514336|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
154514337|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514338|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154514339|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154514340|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514341|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514342|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154514343|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
154514344|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
154514345|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
154514346|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154514347|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154514348|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283489|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
154283490|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154283491|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
154283492|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
154283493|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283494|NCT01294176|Protective Agents|protective agents|mesh-ancestor
154283495|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283496|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
154283497|NCT01294176|Vitamins|vitamins|mesh-ancestor
154514349|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514350|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514351|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514352|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
154514353|NCT04328961|Protective Agents|protective agents|mesh-ancestor
154514354|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514355|NCT04328961|Vitamins|vitamins|mesh-ancestor
154514356|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
154514357|NCT00455403|Chloroquine|chloroquine|mesh-list
154514358|NCT00455403|Amebicides|amebicides|mesh-ancestor
154514359|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154514360|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154514361|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514362|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
154514363|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514364|NCT03470337|Wobenzym|wobenzym|mesh-list
154514365|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154514366|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
154514367|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514368|NCT03576261|Polygeline|polygeline|mesh-list
154514369|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
154514370|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
154514371|NCT03469323|Succinylcholine|succinylcholine|mesh-list
154514372|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154514373|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154514374|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154514375|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514376|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514377|NCT05160285|Nivolumab|nivolumab|mesh-list
154283520|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283521|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154283522|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154283523|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154283524|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154283525|NCT01194336|Huperzine A|huperzine a|mesh-list
154283526|NCT01194336|Donepezil|donepezil|mesh-list
154283527|NCT01194336|Galantamine|galantamine|mesh-list
154283528|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154283529|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283530|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283531|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
154283532|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283533|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283534|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
154283535|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154283536|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
154283537|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514378|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154514379|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514380|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154514381|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514382|NCT03471819|Serotonin|serotonin|mesh-list
154514383|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154514384|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
154514385|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514386|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514387|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514388|NCT03618693|Anesthetics|anesthetics|mesh-list
154514389|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514390|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514391|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
154514392|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154514393|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154514394|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514395|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
154514396|NCT01064167|Coagulants|coagulants|mesh-ancestor
154514397|NCT04205305|Labetalol|labetalol|mesh-list
154514398|NCT04205305|Nicardipine|nicardipine|mesh-list
154514399|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154514400|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154514401|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
154514402|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514403|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283548|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154283549|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
154283550|NCT01296438|Insulin|insulin|mesh-list
154283551|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154283552|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
154283553|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
154283554|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154283555|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154283556|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283557|NCT03850626|Immunomodulating Agents|immunomodulating agents|mesh-list
154283558|NCT03850626|Immunologic Factors|immunologic factors|mesh-ancestor
154283559|NCT03850626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283560|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154283561|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154283562|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
154283563|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154283564|NCT01294956|Laxatives|laxatives|mesh-ancestor
154283565|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154349259|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154514404|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514405|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154514407|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
154514408|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514409|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154514410|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154514411|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154514412|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154514413|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154514414|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
154514415|NCT03470103|Aflibercept|aflibercept|mesh-list
154514416|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154514417|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154514418|NCT03470103|Growth Substances|growth substances|mesh-ancestor
154514419|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514420|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
154514421|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514422|NCT01064947|Retapamulin|retapamulin|mesh-list
154514423|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154514424|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514425|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
154514426|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154514427|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154514428|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514429|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
154283576|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
154283577|NCT01293162|Vitamins|vitamins|mesh-ancestor
154283578|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
154283579|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283580|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154283581|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154283582|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
154283583|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283584|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154283585|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154283586|NCT01190670|Tacrolimus|tacrolimus|mesh-list
154283587|NCT01190670|Peficitinib|peficitinib|mesh-list
154283588|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154283589|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
154283590|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283591|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154283592|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283593|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283594|NCT01194882|Insulin|insulin|mesh-list
154283595|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154283596|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154283598|NCT01191684|Vaccines|vaccines|mesh-list
154514430|NCT03469947|Coagulants|coagulants|mesh-ancestor
154514431|NCT05157087|Omalizumab|omalizumab|mesh-list
154514432|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154514433|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154514434|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
154514435|NCT04054063|Etomidate|etomidate|mesh-list
154514436|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154514437|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514438|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514439|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154514440|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
154514441|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
154514442|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154514443|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154514444|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514445|NCT03652441|Immunotoxins|immunotoxins|mesh-ancestor
154514446|NCT03652441|Immunoconjugates|immunoconjugates|mesh-ancestor
154514447|NCT03652441|Immunologic Factors|immunologic factors|mesh-ancestor
154514448|NCT03652441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514449|NCT02918071|Benralizumab|benralizumab|mesh-list
154514450|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154514451|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
154514452|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
154514453|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
154514454|NCT05162625|Cefazolin|cefazolin|mesh-list
154514455|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154514456|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154283603|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154283604|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283605|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154283606|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283607|NCT01295268|Emu Oil|emu oil|mesh-list
154283608|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154283609|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
154283610|NCT01383694|Piperine|piperine|mesh-list
154283611|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154283612|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283613|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283614|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
154283615|NCT01191918|Donepezil|donepezil|mesh-list
154283616|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154283617|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283618|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283619|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
154283620|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283621|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283622|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
154283623|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
153442134|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
154283628|NCT03850314|Glycine|glycine|mesh-list
154514457|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238318|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
154514458|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514459|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154514460|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154514461|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514462|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514463|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514464|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154514465|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154514467|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154514468|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514469|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514470|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514471|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
154514472|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
154514473|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514474|NCT05009901|Protective Agents|protective agents|mesh-ancestor
154514475|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514476|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
154514477|NCT05009901|Vitamins|vitamins|mesh-ancestor
154514478|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
154514479|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
154514480|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154514482|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514483|NCT05162001|Disulfiram|disulfiram|mesh-list
154514484|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154283629|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
154283630|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283631|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283632|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283633|NCT01097746|Paclitaxel|paclitaxel|mesh-list
154283634|NCT01097746|Bevacizumab|bevacizumab|mesh-list
154283635|NCT01097746|Carboplatin|carboplatin|mesh-list
154283636|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154283637|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154283638|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
154283639|NCT01097746|Antibodies|antibodies|mesh-list
154283640|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
154283641|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154283642|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
154283643|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154283644|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283656|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154514485|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154514486|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514487|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514488|NCT03469167|Epinephrine|epinephrine|mesh-list
154514489|NCT03469167|CEGP-003|cegp-003|mesh-list
154514490|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154514491|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154514492|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
154514493|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514494|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514495|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514496|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154514497|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154514498|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
154514499|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514500|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154514501|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
154514502|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
154514503|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
154514504|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154514505|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
154514506|NCT03469167|Coagulants|coagulants|mesh-ancestor
154514507|NCT01063153|Methylphenidate|methylphenidate|mesh-list
154514508|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154514509|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514510|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154283657|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283658|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283659|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
154283660|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283661|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283662|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154283663|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
154283664|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283665|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
154283666|NCT01383538|Leucovorin|leucovorin|mesh-list
154283667|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
154283668|NCT01383538|Irinotecan|irinotecan|mesh-list
154283669|NCT01383538|Folfirinox|folfirinox|mesh-list
154283670|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283671|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154283672|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154283673|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283674|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283675|NCT01383538|Antidotes|antidotes|mesh-ancestor
154283676|NCT01383538|Protective Agents|protective agents|mesh-ancestor
154283677|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514511|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154514512|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154514513|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514514|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
154514515|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514516|NCT05161221|Acetaminophen|acetaminophen|mesh-list
154514517|NCT05161221|Naproxen|naproxen|mesh-list
154514518|NCT05161221|Oxycodone|oxycodone|mesh-list
154514519|NCT05161221|Bupivacaine|bupivacaine|mesh-list
154514520|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
154514521|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
154514522|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514523|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514524|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
154514525|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514526|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154514527|NCT05161221|Narcotics|narcotics|mesh-ancestor
154514528|NCT05161221|Analgesics|analgesics|mesh-ancestor
154514529|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154514530|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514531|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154514533|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
154514534|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154514535|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514536|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514537|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
154514538|NCT02505334|Liraglutide|liraglutide|mesh-list
154514539|NCT02505334|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154514540|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154514541|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514542|NCT02505334|Incretins|incretins|mesh-ancestor
154514543|NCT02505334|Hormones|hormones|mesh-ancestor
154283683|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154283684|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
154283685|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283686|NCT01383460|Hematinics|hematinics|mesh-ancestor
154283687|NCT01192230|Docetaxel|docetaxel|mesh-list
154283688|NCT01192230|Endostatins|endostatins|mesh-list
154283689|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283690|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283691|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283692|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
154283694|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154514544|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514545|NCT03469089|Ketamine|ketamine|mesh-list
154514546|NCT03469089|Modafinil|modafinil|mesh-list
154514547|NCT03469089|Analgesics|analgesics|mesh-ancestor
154514548|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
154514549|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514550|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514551|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154514552|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154514553|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
154514554|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
154514555|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514556|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154514557|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154514558|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514559|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514560|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154514561|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154514562|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154514563|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154514565|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
154514566|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
154514567|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514568|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514569|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
154514570|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514571|NCT02504320|Febuxostat|febuxostat|mesh-list
154514572|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
154514573|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514574|NCT05014516|Xenon|xenon|mesh-list
154514575|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154514576|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
154514577|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
154514578|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514579|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514580|NCT01061671|Simvastatin|simvastatin|mesh-list
154514581|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154514582|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154514583|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
154283715|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154514584|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514585|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154514586|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154514587|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514588|NCT04969120|Metoclopramide|metoclopramide|mesh-list
154514589|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
154514590|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
154514591|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514592|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514593|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154514594|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154514595|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154514596|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
154514597|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514598|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514599|NCT00709995|Sunitinib|sunitinib|mesh-list
154514600|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514601|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154514602|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154514603|NCT00709995|Growth Substances|growth substances|mesh-ancestor
154514604|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514605|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
154514606|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154514607|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514608|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514609|NCT02503540|Aflibercept|aflibercept|mesh-list
154514610|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154514611|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154514612|NCT02503540|Growth Substances|growth substances|mesh-ancestor
154283755|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283756|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
154283757|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283758|NCT05207644|Letrozole|letrozole|mesh-list
154283759|NCT05207644|Misoprostol|misoprostol|mesh-list
154283760|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283761|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154283762|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154283763|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283764|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283765|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154283766|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
154283767|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514613|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514614|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
154514615|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514617|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514618|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154514619|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514620|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514621|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
154514622|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154514623|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
154514624|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514625|NCT04455243|Expectorants|expectorants|mesh-ancestor
154514626|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
154514627|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154514628|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
154349492|NCT04327791|Baloxavir|baloxavir|mesh-list
154514629|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514630|NCT04455243|Protective Agents|protective agents|mesh-ancestor
154514631|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514632|NCT04455243|Antidotes|antidotes|mesh-ancestor
154514633|NCT04454775|Protein C|protein c|mesh-list
154514634|NCT04454775|Antithrombins|antithrombins|mesh-list
154514635|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
154514636|NCT04454775|Protein S|protein s|mesh-list
154514637|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154514638|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
154514639|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514640|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514641|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
154514642|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154514643|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154514644|NCT03651661|Insulin|insulin|mesh-list
154514645|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154514646|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154514647|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514648|NCT01060111|Topiramate|topiramate|mesh-list
154514649|NCT01060111|Propranolol|propranolol|mesh-list
154514650|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154514651|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154514652|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
154514653|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514654|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514655|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514656|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154514657|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154514658|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
154514659|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
154514660|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154514661|NCT02969863|Pancrelipase|pancrelipase|mesh-list
154514662|NCT02969863|Pancreatin|pancreatin|mesh-list
154514663|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154514664|NCT03651427|Estradiol|estradiol|mesh-list
154514665|NCT03651427|Estrogens|estrogens|mesh-ancestor
154514666|NCT03651427|Hormones|hormones|mesh-ancestor
154283785|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154283839|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154283840|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154514667|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514668|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514669|NCT05285293|Vitamin A|vitamin a|mesh-list
154514670|NCT05285293|Vitamins|vitamins|mesh-ancestor
154514671|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
154514672|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514673|NCT03650257|Temozolomide|temozolomide|mesh-list
154514674|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154514675|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
154514676|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514677|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514678|NCT03649243|Propolis|propolis|mesh-list
154514679|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238547|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
154514680|NCT03649165|Acetaminophen|acetaminophen|mesh-list
154514681|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514682|NCT03649165|Analgesics|analgesics|mesh-ancestor
154514683|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
154514684|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514685|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514686|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
154514687|NCT03649009|Thiamine|thiamine|mesh-list
154514688|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
154514689|NCT03649009|Metoclopramide|metoclopramide|mesh-list
154514690|NCT03649009|Vitamins|vitamins|mesh-ancestor
154514691|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
154514692|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514693|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154514694|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
154514695|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
154514696|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
154514697|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283841|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
154283842|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
154283843|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154283844|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154283845|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154283846|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154283847|NCT01197144|Adalimumab|adalimumab|mesh-list
154283848|NCT01197144|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154283849|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154283867|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514698|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154514699|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154514700|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154514701|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
154514702|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860236|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514703|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514704|NCT03650023|Chitosan|chitosan|mesh-list
154514705|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154514706|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154514707|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
154514708|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514709|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154514710|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
154514711|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
154514712|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
154514713|NCT03650023|Coagulants|coagulants|mesh-ancestor
154514714|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
154514715|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
154514716|NCT04054999|Methylene Blue|methylene blue|mesh-list
154514717|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514718|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514719|NCT04054999|Hematinics|hematinics|mesh-ancestor
154514720|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
154514721|NCT04054999|Vitamins|vitamins|mesh-ancestor
154514722|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
154283868|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154283869|NCT01193478|Ledipasvir|ledipasvir|mesh-list
154283870|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
154283871|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283872|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
154283873|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
154283874|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154283875|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154283876|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283877|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283878|NCT01295736|Urological Agents|urological agents|mesh-ancestor
154283879|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
154283880|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
154283881|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154283882|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154283883|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283884|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283885|NCT03733470|Urological Agents|urological agents|mesh-ancestor
154283886|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154283887|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154283888|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283890|NCT04731376|Testosterone|testosterone|mesh-list
154514723|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514724|NCT03649945|Docetaxel|docetaxel|mesh-list
154514725|NCT03649945|Endostar protein|endostar protein|mesh-list
154514726|NCT03649945|Nedaplatin|nedaplatin|mesh-list
154514727|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514728|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
154514729|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
154514730|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
154514731|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514732|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154514733|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154514734|NCT03649945|Growth Substances|growth substances|mesh-ancestor
154514735|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514736|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
154514737|NCT03650881|Adapalene|adapalene|mesh-list
154514738|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154514739|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
154514740|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154514741|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514742|NCT03650881|Analgesics|analgesics|mesh-ancestor
154514743|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
154514744|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514745|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514746|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154514747|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514748|NCT02904265|Acetazolamide|acetazolamide|mesh-list
154514749|NCT02904265|Diazepam|diazepam|mesh-list
154514750|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
154514751|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154514752|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514753|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514754|NCT02904265|Diuretics|diuretics|mesh-ancestor
154514755|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
154514756|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514757|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154514758|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
154514759|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
154514760|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514761|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154514762|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154514763|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514764|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154514765|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154514766|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154514767|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154514768|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154514769|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154514770|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
154514772|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
154514773|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
154514774|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514775|NCT03648229|Timolol|timolol|mesh-list
154514776|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154514777|NCT03648229|Latanoprost|latanoprost|mesh-list
154514778|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154514779|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154514780|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154514781|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
154514782|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514783|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514784|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514785|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154514786|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154514788|NCT03648697|Fludarabine|fludarabine|mesh-list
154514789|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154514790|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
154514791|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514792|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514793|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154514794|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
154514795|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514796|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514797|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154514798|NCT02967679|Biotin|biotin|mesh-list
154514799|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
154514800|NCT02967679|Vitamins|vitamins|mesh-ancestor
154514801|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
154514802|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283939|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154283940|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283941|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
154283942|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
154283943|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
154283944|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283945|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283946|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
154283947|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283948|NCT02729116|Ertapenem|ertapenem|mesh-list
154283949|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
154283950|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154283951|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283952|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154283953|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154283954|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283957|NCT01199562|Valganciclovir|valganciclovir|mesh-list
154514803|NCT04447053|Belimumab|belimumab|mesh-list
154514804|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154514805|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
154514806|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514807|NCT04361799|Insulin|insulin|mesh-list
154514808|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154514809|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514810|NCT05390073|Hormones|hormones|mesh-list
154514811|NCT05390073|Mitogens|mitogens|mesh-list
154514812|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514813|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514814|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
154514815|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514816|NCT03647839|Nivolumab|nivolumab|mesh-list
154514817|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154514818|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514819|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154514820|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514821|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154514822|NCT04454307|Tramadol|tramadol|mesh-list
154514823|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154514824|NCT04454307|Narcotics|narcotics|mesh-ancestor
154514825|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514826|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514827|NCT04454307|Analgesics|analgesics|mesh-ancestor
154514828|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
154514829|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514830|NCT05388123|Rituximab|rituximab|mesh-list
154514831|NCT05388123|Vemurafenib|vemurafenib|mesh-list
154514832|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154514833|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514834|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
154514835|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514836|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514837|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154514838|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514839|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514840|NCT04455711|Lidocaine|lidocaine|mesh-list
154514841|NCT04455711|Remifentanil|remifentanil|mesh-list
154514842|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
154514843|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
154514844|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514845|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514846|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
154514847|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514848|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154514849|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154514850|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154514851|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154514852|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514853|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154514854|NCT04455711|Narcotics|narcotics|mesh-ancestor
154514855|NCT04455711|Analgesics|analgesics|mesh-ancestor
154514856|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
154514857|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154514858|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154514859|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154514860|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154514861|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514862|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
154514863|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514864|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514865|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154514866|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514867|NCT05387967|Valsartan|valsartan|mesh-list
154514868|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154514869|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154514870|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154514871|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154514872|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514873|NCT03856359|Rifaximin|rifaximin|mesh-list
154514874|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154514875|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154514876|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154514877|NCT04052659|Azacitidine|azacitidine|mesh-list
154514878|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154514879|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
154514880|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514881|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514882|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514883|NCT02964247|Liraglutide|liraglutide|mesh-list
154514884|NCT02964247|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154514885|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154514886|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514887|NCT02964247|Incretins|incretins|mesh-ancestor
154514888|NCT02964247|Hormones|hormones|mesh-ancestor
154514889|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514890|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
154514891|NCT03654729|Edetic Acid|edetic acid|mesh-list
154514892|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
154514893|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154514894|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
154514895|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
154514896|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514897|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
154514898|NCT03654729|Vitamins|vitamins|mesh-ancestor
154514899|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
154514900|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514901|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
154514902|NCT04052269|Tadalafil|tadalafil|mesh-list
154514903|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
154514904|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154514905|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154514906|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514907|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514908|NCT04052269|Urological Agents|urological agents|mesh-ancestor
154514909|NCT01377987|Acetazolamide|acetazolamide|mesh-list
154514910|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
154514911|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154514912|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514913|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514915|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
154514916|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514917|NCT03645187|Celecoxib|celecoxib|mesh-list
154514918|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154514919|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514920|NCT03645187|Analgesics|analgesics|mesh-ancestor
154514921|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
154514922|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514923|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514924|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154514925|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514926|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154284054|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154284089|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514927|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154514928|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514929|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514930|NCT03645109|Vitamin D|vitamin d|mesh-list
154514931|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
154514932|NCT03645109|Vitamins|vitamins|mesh-ancestor
154514933|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
154860237|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514934|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514935|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154514936|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154514937|NCT04455555|Rotigotine|rotigotine|mesh-list
154514938|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
154514939|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
154514940|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154514941|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514942|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514943|NCT02898259|Rituximab|rituximab|mesh-list
154514944|NCT02898259|Lenalidomide|lenalidomide|mesh-list
154514945|NCT02898259|Ixazomib|ixazomib|mesh-list
154514946|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154514947|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154514948|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
154514949|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514950|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514951|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154514952|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154514953|NCT02898259|Growth Substances|growth substances|mesh-ancestor
154514954|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
154514955|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
154284090|NCT05111808|Methylene Blue|methylene blue|mesh-list
154284091|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284092|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284093|NCT01198392|Cisplatin|cisplatin|mesh-list
154284094|NCT01198392|Tegafur|tegafur|mesh-list
154284095|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284096|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284097|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
154284098|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284099|NCT01200264|Apremilast|apremilast|mesh-list
154284100|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154284101|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154284102|NCT01200264|Analgesics|analgesics|mesh-ancestor
154284115|NCT03630952|Aflibercept|aflibercept|mesh-list
154514956|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514957|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514958|NCT02963935|Liraglutide|liraglutide|mesh-list
154514959|NCT02963935|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154514960|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154514961|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514962|NCT02963935|Incretins|incretins|mesh-ancestor
154514963|NCT02963935|Hormones|hormones|mesh-ancestor
154514964|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514965|NCT03644641|Propofol|propofol|mesh-list
154514966|NCT03644641|Desflurane|desflurane|mesh-list
154514967|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154514968|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154514969|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514970|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154514971|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
154514972|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
154514973|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154514974|NCT05283421|Estrogens|estrogens|mesh-list
154514975|NCT05283421|Hormones|hormones|mesh-ancestor
154514976|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154514977|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514978|NCT02963701|Ibuprofen|ibuprofen|mesh-list
154514979|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
154514980|NCT02963701|Ephedrine|ephedrine|mesh-list
154514981|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154514982|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154514983|NCT02963701|Analgesics|analgesics|mesh-ancestor
154514984|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
154514985|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154514986|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154514987|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154514988|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154514989|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154284117|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154284118|NCT03630952|Growth Substances|growth substances|mesh-ancestor
154284119|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284120|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
154284121|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284122|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154514990|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154514991|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154514992|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154514993|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
154514994|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154514995|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
154514996|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
154514997|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154514998|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154514999|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
154515000|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
154515001|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515002|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
154515003|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154515004|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515005|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154515006|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154515007|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515008|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284151|NCT01198860|Vitamins|vitamins|mesh-ancestor
154284152|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
154284153|NCT01198938|Melatonin|melatonin|mesh-list
154284154|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
154284155|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284156|NCT01198938|Protective Agents|protective agents|mesh-ancestor
154284157|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284158|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284159|NCT01201044|Gemcitabine|gemcitabine|mesh-list
154284160|NCT01201044|Nedaplatin|nedaplatin|mesh-list
154284161|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284162|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
154284163|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284164|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284165|NCT03843060|Itraconazole|itraconazole|mesh-list
154284166|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
154284167|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284168|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154284169|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154284170|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646471|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
154284171|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515009|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515010|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154515011|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154515013|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
154515014|NCT03641053|Povidone|povidone|mesh-list
154515015|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154515016|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515017|NCT03641053|Trace Elements|trace elements|mesh-ancestor
154515018|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
154515019|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515020|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
154515021|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
154515022|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154515023|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
154515024|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515025|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154515026|NCT03468777|Lansoprazole|lansoprazole|mesh-list
154515027|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
154515028|NCT03468777|Ranitidine|ranitidine|mesh-list
154515029|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154515030|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154515031|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154515032|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154515033|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515034|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515035|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154515036|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
154515037|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
154515038|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515039|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515040|NCT03640377|Praziquantel|praziquantel|mesh-list
154515041|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
154515042|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154284172|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154284173|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
154284174|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284175|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284176|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154284177|NCT04427904|Lidocaine|lidocaine|mesh-list
154284178|NCT04427904|Epinephrine|epinephrine|mesh-list
154284179|NCT04427904|Racepinephrine|racepinephrine|mesh-list
154284180|NCT04427904|Bupivacaine|bupivacaine|mesh-list
154515043|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515044|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154515045|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
154515046|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515047|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
154515048|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
154515049|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154515050|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515051|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515052|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
154515053|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154515054|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154515055|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515056|NCT03632187|Abatacept|abatacept|mesh-list
154515057|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515058|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515059|NCT03632187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515060|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515061|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515062|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
154515063|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515064|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515066|NCT05110209|Ranibizumab|ranibizumab|mesh-list
154515067|NCT05110209|Aflibercept|aflibercept|mesh-list
154515068|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515069|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515070|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154515071|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154515072|NCT05110209|Growth Substances|growth substances|mesh-ancestor
154515073|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515074|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
154515075|NCT04454151|Azithromycin|azithromycin|mesh-list
154515076|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154515077|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515078|NCT05272683|Itraconazole|itraconazole|mesh-list
154515079|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
154515080|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515081|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154515082|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154515083|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515084|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515085|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154515086|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
154515087|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154515088|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515089|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154515090|NCT03934671|Antioxidants|antioxidants|mesh-list
154515091|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515092|NCT03934671|Protective Agents|protective agents|mesh-ancestor
154515093|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515094|NCT03130179|Nicotine|nicotine|mesh-list
154515095|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154515096|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
154515097|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515098|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515099|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154515100|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154515101|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
154515102|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515103|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515104|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154515105|NCT03466983|Hematinics|hematinics|mesh-ancestor
154515106|NCT05439213|Epinephrine|epinephrine|mesh-list
154515107|NCT05439213|Racepinephrine|racepinephrine|mesh-list
154515108|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154515109|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
154515110|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154515111|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154515112|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
154515113|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515114|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515115|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515116|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154515117|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154515118|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
154515119|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515120|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154515121|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
154515122|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
154515123|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
154515124|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154515125|NCT03466749|Paclitaxel|paclitaxel|mesh-list
154515126|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154515127|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515128|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
154515129|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
154515130|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
154515131|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515132|NCT03466437|Methamphetamine|methamphetamine|mesh-list
154515133|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154515134|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515135|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
154515136|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
154515137|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515138|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
154515139|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515140|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515141|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
154515142|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154515143|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154515144|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154515145|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154515146|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
154515147|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515148|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515149|NCT06326944|Acetaminophen|acetaminophen|mesh-list
154515150|NCT06326944|Fentanyl|fentanyl|mesh-list
154515151|NCT06326944|Meperidine|meperidine|mesh-list
154515152|NCT06326944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154515153|NCT06326944|Narcotics|narcotics|mesh-ancestor
154515154|NCT06326944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154515155|NCT06326944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284287|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284288|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154284289|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284290|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
154284291|NCT01203228|Busulfan|busulfan|mesh-list
154284292|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
154284293|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284294|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
154284295|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284296|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284297|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154284298|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
154515156|NCT06326944|Analgesics|analgesics|mesh-ancestor
154515157|NCT06326944|Sensory System Agents|sensory system agents|mesh-ancestor
154515158|NCT06326944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515159|NCT06326944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154515160|NCT06326944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154515161|NCT06326944|Anesthetics, General|anesthetics, general|mesh-ancestor
154515162|NCT06326944|Anesthetics|anesthetics|mesh-ancestor
154515163|NCT06326944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154515164|NCT06326944|Antipyretics|antipyretics|mesh-ancestor
154515165|NCT06326840|Metformin|metformin|mesh-list
154515166|NCT06326840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154515167|NCT06326840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515168|NCT06326814|Antibodies|antibodies|mesh-list
154515169|NCT06326814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154515170|NCT06326814|Immunologic Factors|immunologic factors|mesh-ancestor
154515171|NCT06326814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515172|NCT06326736|Gemcitabine|gemcitabine|mesh-list
154515173|NCT06326736|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154515174|NCT06326736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154515175|NCT06326736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154515176|NCT06326736|Antimetabolites|antimetabolites|mesh-ancestor
154515177|NCT06326736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284317|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154284318|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154284319|NCT01203306|Growth Substances|growth substances|mesh-ancestor
154284320|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284321|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
154284322|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284323|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
154284324|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284325|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154284326|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154284327|NCT01203384|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
154284328|NCT01203384|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154284329|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284330|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284331|NCT03724968|Nivolumab|nivolumab|mesh-list
154284332|NCT03724968|Ipilimumab|ipilimumab|mesh-list
154284333|NCT03724968|Relatlimab|relatlimab|mesh-list
154284334|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154284335|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813411|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813412|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
154515178|NCT06326736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515179|NCT06326736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515180|NCT06326697|Azacitidine|azacitidine|mesh-list
154515181|NCT06326697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154515182|NCT06326697|Antimetabolites|antimetabolites|mesh-ancestor
154515183|NCT06326697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515184|NCT06326697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515185|NCT06326697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515186|NCT06326671|Bromides|bromides|mesh-list
154515187|NCT06326671|Tiotropium Bromide|tiotropium bromide|mesh-list
154515188|NCT06326671|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154515189|NCT06326671|Autonomic Agents|autonomic agents|mesh-ancestor
154515190|NCT06326671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515191|NCT06326671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515192|NCT06326671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154515193|NCT06326671|Respiratory System Agents|respiratory system agents|mesh-ancestor
154515194|NCT06326671|Parasympatholytics|parasympatholytics|mesh-ancestor
154515195|NCT06326671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154515196|NCT06326671|Cholinergic Agents|cholinergic agents|mesh-ancestor
154284336|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154284337|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284338|NCT01204086|Fluoxetine|fluoxetine|mesh-list
154284339|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154284340|NCT01204086|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154284341|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154284342|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284343|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284344|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284345|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
154284346|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284347|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154284348|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
154284349|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154284350|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154284351|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154284352|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284353|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154515197|NCT06326671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515198|NCT06326671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515199|NCT06326671|Anticonvulsants|anticonvulsants|mesh-ancestor
154515200|NCT06326606|Psilocybin|psilocybin|mesh-list
154515201|NCT06326606|Hallucinogens|hallucinogens|mesh-ancestor
154515202|NCT06326606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515203|NCT06326606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154515204|NCT06326528|Dapagliflozin|dapagliflozin|mesh-list
154515205|NCT06326528|Empagliflozin|empagliflozin|mesh-list
154515206|NCT06326528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154515207|NCT06326528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515208|NCT06326528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154515209|NCT06326528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515210|NCT06326463|Cyclophosphamide|cyclophosphamide|mesh-list
154515211|NCT06326463|Fludarabine|fludarabine|mesh-list
154515212|NCT06326463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515213|NCT06326463|Immunologic Factors|immunologic factors|mesh-ancestor
154515214|NCT06326463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515215|NCT06326463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515216|NCT06326463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154284354|NCT03842202|Semaglutide|semaglutide|mesh-list
154284355|NCT03842202|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154284356|NCT03842202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154284357|NCT03842202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284358|NCT01201902|Vaccines|vaccines|mesh-list
154284359|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
154284360|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284361|NCT01204164|Dexamethasone|dexamethasone|mesh-list
154284362|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284363|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
154284364|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
154284365|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031220|NCT06321861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284366|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284367|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154284369|NCT01204164|Hormones|hormones|mesh-ancestor
154284370|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284371|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154515217|NCT06326463|Alkylating Agents|alkylating agents|mesh-ancestor
154515218|NCT06326463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515219|NCT06326463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515220|NCT06326463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154515221|NCT06326281|Anesthetics|anesthetics|mesh-list
154515222|NCT06326281|Anesthetics, Local|anesthetics, local|mesh-list
154515223|NCT06326281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154515224|NCT06326281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515225|NCT06326281|Sensory System Agents|sensory system agents|mesh-ancestor
154515226|NCT06326281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515227|NCT06326190|Sunitinib|sunitinib|mesh-list
154515228|NCT06326190|Everolimus|everolimus|mesh-list
154515229|NCT06326190|Octreotide|octreotide|mesh-list
154515230|NCT06326190|Hydroxyurea|hydroxyurea|mesh-list
154515231|NCT06326190|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154515232|NCT06326190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515233|NCT06326190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154515234|NCT06326190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154515235|NCT06326190|Growth Substances|growth substances|mesh-ancestor
154515236|NCT06326190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515237|NCT06326190|Growth Inhibitors|growth inhibitors|mesh-ancestor
154515238|NCT06326190|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154515239|NCT06326190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154515240|NCT06326190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515241|NCT06326190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515242|NCT06326190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515243|NCT06326190|Immunologic Factors|immunologic factors|mesh-ancestor
154515244|NCT06326190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154515245|NCT06326190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154515246|NCT06326190|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154515247|NCT06326190|Antisickling Agents|antisickling agents|mesh-ancestor
154515248|NCT06326190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154515249|NCT06326138|Edoxaban|edoxaban|mesh-list
154515250|NCT06326138|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154284372|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284373|NCT01206036|Sirolimus|sirolimus|mesh-list
154284374|NCT01206036|Docetaxel|docetaxel|mesh-list
154284375|NCT01206036|Temsirolimus|temsirolimus|mesh-list
154284376|NCT01206036|MTOR Inhibitors|mtor inhibitors|mesh-list
154284377|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284378|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
154284379|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
154284406|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154515251|NCT06326138|Antithrombins|antithrombins|mesh-ancestor
154515252|NCT06326138|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154515253|NCT06326138|Protease Inhibitors|protease inhibitors|mesh-ancestor
154515254|NCT06326138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515255|NCT06326138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515256|NCT06326138|Anticoagulants|anticoagulants|mesh-ancestor
154515257|NCT06326112|Metolazone|metolazone|mesh-list
154515258|NCT06326112|Furosemide|furosemide|mesh-list
154515259|NCT06326112|Diuretics|diuretics|mesh-ancestor
154515260|NCT06326112|Natriuretic Agents|natriuretic agents|mesh-ancestor
154515261|NCT06326112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515262|NCT06326112|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154515263|NCT06326112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154515264|NCT06326112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515265|NCT06326112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154515266|NCT06326112|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154515267|NCT06326086|Immunomodulating Agents|immunomodulating agents|mesh-list
154515268|NCT06326086|Immunologic Factors|immunologic factors|mesh-ancestor
154515269|NCT06326086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515270|NCT06326060|Tirzepatide|tirzepatide|mesh-list
154515271|NCT06326060|Incretins|incretins|mesh-ancestor
154515272|NCT06326060|Hormones|hormones|mesh-ancestor
154515273|NCT06326060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154515274|NCT06326060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515275|NCT06326034|Dapagliflozin|dapagliflozin|mesh-list
154515276|NCT06326034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154515277|NCT06326034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515278|NCT06326034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154284407|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284408|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154284409|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284410|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284411|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154284412|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154284413|NCT01203618|Farletuzumab|farletuzumab|mesh-list
154284414|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284415|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
154284416|NCT01206270|Castor Oil|castor oil|mesh-list
154284417|NCT01206270|Testosterone|testosterone|mesh-list
154284418|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
154284419|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
154284420|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154284421|NCT01206270|Androgens|androgens|mesh-ancestor
154515279|NCT06326034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515280|NCT06325956|Metformin|metformin|mesh-list
154515281|NCT06325956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154515282|NCT06325956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515283|NCT06325839|Oxytocin|oxytocin|mesh-list
154515284|NCT06325839|Oxytocics|oxytocics|mesh-ancestor
154515285|NCT06325839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154239148|NCT00130442|Dacarbazine|dacarbazine|mesh-list
154515286|NCT06325839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515287|NCT06325748|Cytarabine|cytarabine|mesh-list
154515288|NCT06325748|Fludarabine|fludarabine|mesh-list
154515289|NCT06325748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515290|NCT06325748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154515291|NCT06325748|Antimetabolites|antimetabolites|mesh-ancestor
154515292|NCT06325748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515293|NCT06325748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515294|NCT06325748|Immunologic Factors|immunologic factors|mesh-ancestor
154515295|NCT06325748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515296|NCT06325748|Antiviral Agents|antiviral agents|mesh-ancestor
154515297|NCT06325748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515298|NCT06325683|Nivolumab|nivolumab|mesh-list
154515299|NCT06325683|Relatlimab|relatlimab|mesh-list
154515300|NCT06325683|Lomustine|lomustine|mesh-list
154515301|NCT06325683|Immunoglobulins|immunoglobulins|mesh-list
154515302|NCT06325683|Immunoglobulin G|immunoglobulin g|mesh-list
154515303|NCT06325683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515304|NCT06325683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515305|NCT06325683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154284436|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284437|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154284438|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154284439|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154284440|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284441|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284442|NCT01298466|Pregabalin|pregabalin|mesh-list
154284443|NCT01298466|Analgesics|analgesics|mesh-ancestor
154284444|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
154284445|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284446|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284447|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
154284448|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154284449|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284450|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284451|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154284452|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154284453|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154284454|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284462|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154515306|NCT06325683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515307|NCT06325683|Immunologic Factors|immunologic factors|mesh-ancestor
154515308|NCT06325683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515309|NCT06325683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154515310|NCT06325683|Alkylating Agents|alkylating agents|mesh-ancestor
154515312|NCT06325605|Citalopram|citalopram|mesh-list
154515313|NCT06325605|Escitalopram|escitalopram|mesh-list
154515314|NCT06325605|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154515315|NCT06325605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154515316|NCT06325605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154515317|NCT06325605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515318|NCT06325605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515319|NCT06325605|Serotonin Agents|serotonin agents|mesh-ancestor
154515320|NCT06325605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515321|NCT06325605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154515322|NCT06325605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154515323|NCT06325605|Parasympatholytics|parasympatholytics|mesh-ancestor
154515324|NCT06325605|Autonomic Agents|autonomic agents|mesh-ancestor
154515325|NCT06325605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515326|NCT06325605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154515327|NCT06325605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154515328|NCT06325605|Cholinergic Agents|cholinergic agents|mesh-ancestor
154515329|NCT06325605|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154515330|NCT06325605|Antidepressive Agents|antidepressive agents|mesh-ancestor
154515331|NCT06325605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154515332|NCT06325501|Misoprostol|misoprostol|mesh-list
154515333|NCT06325501|Oxytocin|oxytocin|mesh-list
154515334|NCT06325501|Oxytocics|oxytocics|mesh-ancestor
154515335|NCT06325501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154284463|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284464|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154284465|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284466|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284467|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
154284468|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284469|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
154284470|NCT01204476|Everolimus|everolimus|mesh-list
154284471|NCT01204476|Octreotide|octreotide|mesh-list
154284472|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154284473|NCT01204476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154284474|NCT01204476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154284475|NCT01204476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284476|NCT01204476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515336|NCT06325501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515337|NCT06325501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154515338|NCT06325501|Abortifacient Agents|abortifacient agents|mesh-ancestor
154515339|NCT06325501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154515340|NCT06325501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154515341|NCT06325293|Azithromycin|azithromycin|mesh-list
154515342|NCT06325293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154515343|NCT06325293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515344|NCT06325098|Antibodies|antibodies|mesh-list
154515345|NCT06325098|Immunologic Factors|immunologic factors|mesh-ancestor
154515346|NCT06325098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515347|NCT06324994|Venetoclax|venetoclax|mesh-list
154515348|NCT06324994|Obinutuzumab|obinutuzumab|mesh-list
154515349|NCT06324994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515350|NCT06324994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515351|NCT06324942|Bupivacaine|bupivacaine|mesh-list
154515352|NCT06324942|Anesthetics, Local|anesthetics, local|mesh-ancestor
154515353|NCT06324942|Anesthetics|anesthetics|mesh-ancestor
154515354|NCT06324942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154515355|NCT06324942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515356|NCT06324942|Sensory System Agents|sensory system agents|mesh-ancestor
154515357|NCT06324942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515358|NCT06324877|Niacinamide|niacinamide|mesh-list
154515359|NCT06324877|Niacin|niacin|mesh-list
154515360|NCT06324877|Nicotinic Acids|nicotinic acids|mesh-list
154515361|NCT06324877|Vitamin B Complex|vitamin b complex|mesh-ancestor
154515362|NCT06324877|Vitamins|vitamins|mesh-ancestor
154515363|NCT06324877|Micronutrients|micronutrients|mesh-ancestor
154515364|NCT06324877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515365|NCT06324877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154515366|NCT06324877|Antimetabolites|antimetabolites|mesh-ancestor
154515367|NCT06324877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515368|NCT06324877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154515369|NCT06324877|Vasodilator Agents|vasodilator agents|mesh-ancestor
154515370|NCT06324812|Interleukin-4|interleukin-4|mesh-list
154515371|NCT06324812|Antibodies|antibodies|mesh-list
154515372|NCT06324812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154515373|NCT06324812|Immunologic Factors|immunologic factors|mesh-ancestor
154515374|NCT06324812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515375|NCT06324812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154515376|NCT06324812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515377|NCT06324812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515378|NCT06324760|Thioctic Acid|thioctic acid|mesh-list
154515379|NCT06324760|Vitamin B Complex|vitamin b complex|mesh-list
154515380|NCT06324760|Vitamins|vitamins|mesh-ancestor
154515381|NCT06324760|Micronutrients|micronutrients|mesh-ancestor
154515382|NCT06324760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515383|NCT06324760|Antioxidants|antioxidants|mesh-ancestor
154515384|NCT06324760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515385|NCT06324760|Protective Agents|protective agents|mesh-ancestor
154515386|NCT06324656|Phenol|phenol|mesh-list
154515387|NCT06324656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154515388|NCT06324656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515389|NCT06324656|Disinfectants|disinfectants|mesh-ancestor
154515390|NCT06324656|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154515391|NCT06324656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154515392|NCT06324565|Fibrin fragment D|fibrin fragment d|mesh-list
154515393|NCT06324565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154515394|NCT06324565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154515395|NCT06324565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515396|NCT06324565|Hemostatics|hemostatics|mesh-ancestor
154515397|NCT06324565|Coagulants|coagulants|mesh-ancestor
154515398|NCT06324474|Hyaluronic Acid|hyaluronic acid|mesh-list
154515399|NCT06324474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154515400|NCT06324474|Immunologic Factors|immunologic factors|mesh-ancestor
154515401|NCT06324474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515402|NCT06324474|Viscosupplements|viscosupplements|mesh-ancestor
154515403|NCT06324474|Protective Agents|protective agents|mesh-ancestor
154515404|NCT06324461|Semaglutide|semaglutide|mesh-list
154515405|NCT06324461|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154515406|NCT06324461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154515407|NCT06324461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515409|NCT06324435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154515410|NCT06324435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154515411|NCT06324435|Analgesics|analgesics|mesh-ancestor
154515412|NCT06324435|Sensory System Agents|sensory system agents|mesh-ancestor
154515413|NCT06324435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515414|NCT06324435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515415|NCT06324435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154515416|NCT06324435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515417|NCT06324435|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154515418|NCT06324435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154515419|NCT06324435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515420|NCT06324435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515421|NCT06324396|Sildenafil Citrate|sildenafil citrate|mesh-list
154515422|NCT06324396|Pravastatin|pravastatin|mesh-list
154515423|NCT06324396|Vasodilator Agents|vasodilator agents|mesh-ancestor
154515424|NCT06324396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154515425|NCT06324396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154515426|NCT06324396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515427|NCT06324396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515428|NCT06324396|Urological Agents|urological agents|mesh-ancestor
154284549|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
154284550|NCT01298934|Panobinostat|panobinostat|mesh-list
154284551|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284552|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154284553|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284554|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284555|NCT01299012|Liraglutide|liraglutide|mesh-list
154284556|NCT01299012|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154284557|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154284558|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284559|NCT01299012|Incretins|incretins|mesh-ancestor
154284560|NCT01299012|Hormones|hormones|mesh-ancestor
154515429|NCT06324396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154515430|NCT06324396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154515431|NCT06324396|Antimetabolites|antimetabolites|mesh-ancestor
154515432|NCT06324396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154515433|NCT06324396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154515434|NCT06324071|Superoxide Dismutase|superoxide dismutase|mesh-list
154515435|NCT06324071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154515436|NCT06324071|Antioxidants|antioxidants|mesh-ancestor
154515437|NCT06324071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515438|NCT06324071|Protective Agents|protective agents|mesh-ancestor
154515439|NCT06324071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515441|NCT06322953|Apixaban|apixaban|mesh-list
154515442|NCT06322953|Edoxaban|edoxaban|mesh-list
154515443|NCT06322953|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
154515444|NCT06322953|Dabigatran|dabigatran|mesh-list
154515445|NCT06322953|Anticoagulants|anticoagulants|mesh-list
154515446|NCT06322953|Antithrombins|antithrombins|mesh-ancestor
154515447|NCT06322953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154515448|NCT06322953|Protease Inhibitors|protease inhibitors|mesh-ancestor
154515449|NCT06322953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515450|NCT06322953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515451|NCT06321991|Vitamin E|vitamin e|mesh-list
154515452|NCT06321991|Petrolatum|petrolatum|mesh-list
154515453|NCT06321991|Vitamins|vitamins|mesh-ancestor
154515454|NCT06321991|Micronutrients|micronutrients|mesh-ancestor
154515455|NCT06321991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515456|NCT06321991|Antioxidants|antioxidants|mesh-ancestor
154515457|NCT06321991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515458|NCT06321991|Protective Agents|protective agents|mesh-ancestor
154515459|NCT06321991|Emollients|emollients|mesh-ancestor
154515460|NCT06321991|Dermatologic Agents|dermatologic agents|mesh-ancestor
154515461|NCT06311071|Calcium|calcium|mesh-list
154515462|NCT06311071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154515463|NCT06311071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284580|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284581|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284582|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154284583|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
154284584|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
154284585|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
154284586|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154284587|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154284613|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
154515464|NCT06307431|Pembrolizumab|pembrolizumab|mesh-list
154515465|NCT06307431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515466|NCT06307431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515467|NCT06307431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515468|NCT06307431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515469|NCT06283615|Vitamin D|vitamin d|mesh-list
154515470|NCT06283615|Ergocalciferols|ergocalciferols|mesh-list
154515471|NCT06283615|Cholecalciferol|cholecalciferol|mesh-list
154515472|NCT06283615|Vitamins|vitamins|mesh-list
154515473|NCT06283615|Micronutrients|micronutrients|mesh-ancestor
154515474|NCT06283615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515475|NCT06283615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154515476|NCT06283615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154515477|NCT06275841|Esomeprazole|esomeprazole|mesh-list
154515478|NCT06275841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154515479|NCT06275841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154515480|NCT06275841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154515481|NCT06275841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515482|NCT06275841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515483|NCT06262919|Trametinib|trametinib|mesh-list
154515484|NCT06262919|Dabrafenib|dabrafenib|mesh-list
154515485|NCT06262919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515486|NCT06262919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154515487|NCT06262919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515488|NCT06262919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515489|NCT06259552|Antibodies|antibodies|mesh-list
154284614|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
154284615|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
154284616|NCT02918292|Fludarabine|fludarabine|mesh-list
154284617|NCT02918292|Tacrolimus|tacrolimus|mesh-list
154284618|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
154284619|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154284620|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284621|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
154284622|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284623|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284624|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154284625|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
154284626|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284627|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284628|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154284629|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154284630|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284631|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154284632|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154284633|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
154284634|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154284636|NCT01207128|Voriconazole|voriconazole|mesh-list
154284639|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515490|NCT06259552|Immunologic Factors|immunologic factors|mesh-ancestor
154515491|NCT06259552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515492|NCT06250023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154515493|NCT06250023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515494|NCT06229145|Methotrexate|methotrexate|mesh-list
154515495|NCT06229145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154515496|NCT06229145|Abortifacient Agents|abortifacient agents|mesh-ancestor
154515497|NCT06229145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154515498|NCT06229145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515499|NCT06229145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154515500|NCT06229145|Antimetabolites|antimetabolites|mesh-ancestor
154515501|NCT06229145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515502|NCT06229145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515503|NCT06229145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154515504|NCT06229145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515505|NCT06229145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154515506|NCT06229145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515507|NCT06229145|Immunologic Factors|immunologic factors|mesh-ancestor
154515508|NCT06229145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515509|NCT06229145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154515510|NCT06224673|Immunoconjugates|immunoconjugates|mesh-list
154284640|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154284641|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154284642|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284643|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284644|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154284645|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
154284646|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284647|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284648|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154284649|NCT01299558|Fluticasone|fluticasone|mesh-list
154284650|NCT01299558|Xhance|xhance|mesh-list
154284651|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284652|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154284653|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
154284654|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284655|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284656|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154284657|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
154284658|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
154515511|NCT06224673|Immunologic Factors|immunologic factors|mesh-ancestor
154515512|NCT06224673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515513|NCT06214897|Choline|choline|mesh-list
154515514|NCT06214897|Lipotropic Agents|lipotropic agents|mesh-ancestor
154515515|NCT06214897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154515516|NCT06214897|Antimetabolites|antimetabolites|mesh-ancestor
154515517|NCT06214897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515518|NCT06214897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154515519|NCT06214897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154515521|NCT06194877|Panitumumab|panitumumab|mesh-list
154515522|NCT06194877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515523|NCT06194877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515524|NCT06177912|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154515525|NCT06177912|Immunologic Factors|immunologic factors|mesh-ancestor
154515526|NCT06177912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515527|NCT06157086|Ofatumumab|ofatumumab|mesh-list
154515528|NCT06157086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515529|NCT06141473|Teriflunomide|teriflunomide|mesh-list
154515530|NCT06141473|Cholestyramine Resin|cholestyramine resin|mesh-list
154515531|NCT06141473|Charcoal|charcoal|mesh-list
154515532|NCT06141473|Antidotes|antidotes|mesh-ancestor
154515533|NCT06141473|Protective Agents|protective agents|mesh-ancestor
154515534|NCT06141473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515535|NCT06141473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154515536|NCT06141473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154515537|NCT06141473|Analgesics|analgesics|mesh-ancestor
154515538|NCT06141473|Sensory System Agents|sensory system agents|mesh-ancestor
154515539|NCT06141473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515540|NCT06141473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154515541|NCT06141473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515542|NCT06141473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515543|NCT06141473|Immunologic Factors|immunologic factors|mesh-ancestor
154515544|NCT06141473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154284659|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154284660|NCT01207206|Ketamine|ketamine|mesh-list
154284661|NCT01207206|Analgesics|analgesics|mesh-ancestor
154284662|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
154284663|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284664|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284665|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154284666|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154284667|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
154515545|NCT06141473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154515546|NCT06141473|Antimetabolites|antimetabolites|mesh-ancestor
154515547|NCT06141473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515548|NCT06141473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154515549|NCT06125197|Pembrolizumab|pembrolizumab|mesh-list
154515550|NCT06125197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515551|NCT06125197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515552|NCT06125197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515553|NCT06125197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515554|NCT06111196|Pembrolizumab|pembrolizumab|mesh-list
154515555|NCT06111196|Antibodies|antibodies|mesh-list
154515556|NCT06111196|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154515557|NCT06111196|Immunologic Factors|immunologic factors|mesh-ancestor
154515558|NCT06111196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515559|NCT06111196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515560|NCT06111196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515561|NCT06111196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515562|NCT06111196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515563|NCT06109467|Leucovorin|leucovorin|mesh-list
154515564|NCT06109467|Pembrolizumab|pembrolizumab|mesh-list
154515565|NCT06109467|Trastuzumab|trastuzumab|mesh-list
154515566|NCT06109467|Fluorouracil|fluorouracil|mesh-list
154515567|NCT06109467|Oxaliplatin|oxaliplatin|mesh-list
154515568|NCT06109467|Neratinib|neratinib|mesh-list
154515569|NCT06109467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515570|NCT06109467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515571|NCT06109467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515572|NCT06109467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515573|NCT06109467|Antimetabolites|antimetabolites|mesh-ancestor
154515574|NCT06109467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154515575|NCT06109467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515576|NCT06109467|Immunologic Factors|immunologic factors|mesh-ancestor
154515577|NCT06109467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515578|NCT06109467|Antidotes|antidotes|mesh-ancestor
154515579|NCT06109467|Protective Agents|protective agents|mesh-ancestor
154515580|NCT06109467|Vitamin B Complex|vitamin b complex|mesh-ancestor
154515581|NCT06109467|Vitamins|vitamins|mesh-ancestor
154515582|NCT06109467|Micronutrients|micronutrients|mesh-ancestor
154515583|NCT06109467|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154515584|NCT06109467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154515585|NCT06109467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515586|NCT06107868|Paclitaxel|paclitaxel|mesh-list
154515587|NCT06107868|Carboplatin|carboplatin|mesh-list
154515588|NCT06107868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154515589|NCT06107868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515590|NCT06107868|Tubulin Modulators|tubulin modulators|mesh-ancestor
154515591|NCT06107868|Antimitotic Agents|antimitotic agents|mesh-ancestor
154515592|NCT06107868|Mitosis Modulators|mitosis modulators|mesh-ancestor
154515593|NCT06107868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515594|NCT06101342|Tenofovir|tenofovir|mesh-list
154515595|NCT06101342|Emtricitabine|emtricitabine|mesh-list
154515596|NCT06101342|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154515597|NCT06101342|Antiviral Agents|antiviral agents|mesh-ancestor
154515598|NCT06101342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515599|NCT06101342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154515600|NCT06101342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154515601|NCT06101342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515602|NCT06101342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515603|NCT06101342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154515604|NCT06101342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154515605|NCT06096337|Flecainide|flecainide|mesh-list
154515606|NCT06096337|Sotalol|sotalol|mesh-list
154515607|NCT06096337|Propafenone|propafenone|mesh-list
154515608|NCT06096337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154515609|NCT06096337|Dofetilide|dofetilide|mesh-list
154515610|NCT06096337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154515611|NCT06096337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154284736|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284737|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284738|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
154284739|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284740|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154284741|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154284742|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154284743|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284744|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284745|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154284746|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154284747|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284748|NCT03816072|Phenylephrine|phenylephrine|mesh-list
154284749|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
154284750|NCT03816072|Propofol|propofol|mesh-list
154284751|NCT03816072|Sevoflurane|sevoflurane|mesh-list
154284752|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154284753|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284754|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284755|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154284756|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
154284757|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
154515612|NCT06096337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154515613|NCT06096337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515614|NCT06096337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154515615|NCT06096337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154515616|NCT06096337|Adrenergic Agents|adrenergic agents|mesh-ancestor
154515617|NCT06096337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515618|NCT06096337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515619|NCT06096337|Sympatholytics|sympatholytics|mesh-ancestor
154515620|NCT06096337|Autonomic Agents|autonomic agents|mesh-ancestor
154515621|NCT06096337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515622|NCT06096337|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154515623|NCT06079879|Interferons|interferons|mesh-list
154515624|NCT06079879|Interferon-alpha|interferon-alpha|mesh-list
154515625|NCT06079879|Busulfan|busulfan|mesh-list
154515626|NCT06079879|Anagrelide|anagrelide|mesh-list
154515627|NCT06079879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515628|NCT06079879|Antiviral Agents|antiviral agents|mesh-ancestor
154515629|NCT06079879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515630|NCT06079879|Immunologic Factors|immunologic factors|mesh-ancestor
154515631|NCT06079879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515632|NCT06079879|Alkylating Agents|alkylating agents|mesh-ancestor
154515633|NCT06079879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515634|NCT06079879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515635|NCT06079879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154515636|NCT06079879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154284759|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154284760|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154284761|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
154284762|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
154284763|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284764|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
154284765|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154284766|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
154284767|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
154284768|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154284769|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154284770|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154284771|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
154284772|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284773|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284774|NCT03816072|Protective Agents|protective agents|mesh-ancestor
154284775|NCT01299948|Prednisolone|prednisolone|mesh-list
154284776|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284777|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
154284778|NCT01299948|Hormones|hormones|mesh-ancestor
154284779|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284780|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284782|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515637|NCT06079879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154515638|NCT06079879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154515639|NCT06079879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154515640|NCT06072963|Insulin|insulin|mesh-list
154515641|NCT06072963|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154515642|NCT06072963|Semaglutide|semaglutide|mesh-list
154515643|NCT06072963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154515644|NCT06072963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515645|NCT06072963|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154515646|NCT06055894|Curcumin|curcumin|mesh-list
154515647|NCT06055894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154515648|NCT06055894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154515649|NCT06055894|Analgesics|analgesics|mesh-ancestor
154515650|NCT06055894|Sensory System Agents|sensory system agents|mesh-ancestor
154515651|NCT06055894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515652|NCT06055894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515653|NCT06055894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154515654|NCT06055894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515655|NCT06055894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515656|NCT06055894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515657|NCT06055894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515658|NCT06055179|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154515659|NCT06055179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154515660|NCT06055179|Hormone Antagonists|hormone antagonists|mesh-ancestor
154515661|NCT06055179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284783|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
154284784|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284785|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284786|NCT01297452|Paclitaxel|paclitaxel|mesh-list
154284787|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154284788|NCT01297452|Carboplatin|carboplatin|mesh-list
154284789|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154284790|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284791|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
154284792|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
154284793|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
154284794|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284795|NCT01301586|Doxycycline|doxycycline|mesh-list
154284796|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154284797|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284798|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
154284799|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154284800|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154284801|NCT03815838|Fallypride|fallypride|mesh-list
154284802|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154284803|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154515662|NCT06055179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515663|NCT06055179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154515664|NCT06055179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154515665|NCT06055179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154239517|NCT03966950|Melatonin|melatonin|mesh-list
154515666|NCT06042309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154515667|NCT06039384|Adagrasib|adagrasib|mesh-list
154515668|NCT06039384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515669|NCT06029127|Docetaxel|docetaxel|mesh-list
154515670|NCT06029127|Ramucirumab|ramucirumab|mesh-list
154515671|NCT06029127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515672|NCT06029127|Tubulin Modulators|tubulin modulators|mesh-ancestor
154515673|NCT06029127|Antimitotic Agents|antimitotic agents|mesh-ancestor
154515674|NCT06029127|Mitosis Modulators|mitosis modulators|mesh-ancestor
154515675|NCT06029127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515676|NCT06029127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154515677|NCT06029127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154515678|NCT06029127|Growth Substances|growth substances|mesh-ancestor
154515679|NCT06029127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515680|NCT06029127|Growth Inhibitors|growth inhibitors|mesh-ancestor
154515681|NCT05997017|Sirolimus|sirolimus|mesh-list
154515682|NCT05997017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154515683|NCT05997017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515684|NCT05997017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154515685|NCT05997017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515686|NCT05997017|Antifungal Agents|antifungal agents|mesh-ancestor
154515687|NCT05997017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515688|NCT05997017|Immunologic Factors|immunologic factors|mesh-ancestor
154515689|NCT05997017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860238|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154515691|NCT05963204|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154515692|NCT05963204|Diuretics|diuretics|mesh-ancestor
154515693|NCT05963204|Natriuretic Agents|natriuretic agents|mesh-ancestor
154515694|NCT05963204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515695|NCT05945342|Dexetimide|dexetimide|mesh-list
154284809|NCT01205724|Coagulants|coagulants|mesh-ancestor
154284810|NCT01301820|Lenalidomide|lenalidomide|mesh-list
154284811|NCT01301820|Azacitidine|azacitidine|mesh-list
154284812|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
154284813|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515696|NCT05945342|Citalopram|citalopram|mesh-list
154515697|NCT05945342|Escitalopram|escitalopram|mesh-list
154515698|NCT05945342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154515699|NCT05945342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154515700|NCT05945342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154515701|NCT05945342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515702|NCT05945342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515703|NCT05945342|Serotonin Agents|serotonin agents|mesh-ancestor
154515704|NCT05945342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515705|NCT05945342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154515706|NCT05945342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154515707|NCT05945342|Parasympatholytics|parasympatholytics|mesh-ancestor
154515708|NCT05945342|Autonomic Agents|autonomic agents|mesh-ancestor
154515709|NCT05945342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515710|NCT05945342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154515711|NCT05945342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154515712|NCT05945342|Cholinergic Agents|cholinergic agents|mesh-ancestor
154515713|NCT05945342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154515714|NCT05945342|Antidepressive Agents|antidepressive agents|mesh-ancestor
154515715|NCT05945342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154515716|NCT05920356|Pembrolizumab|pembrolizumab|mesh-list
154515717|NCT05920356|Sotorasib|sotorasib|mesh-list
154515718|NCT05920356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515719|NCT05920356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515720|NCT05920356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515721|NCT05920356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515722|NCT05909397|Letrozole|letrozole|mesh-list
154515723|NCT05909397|Palbociclib|palbociclib|mesh-list
154515724|NCT05909397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515725|NCT05909397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154515726|NCT05909397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154515727|NCT05909397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515728|NCT05909397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515729|NCT05909397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154515730|NCT05909397|Hormone Antagonists|hormone antagonists|mesh-ancestor
154515731|NCT05909397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154515732|NCT05909397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515733|NCT05909397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154515734|NCT05907746|Mycophenolic Acid|mycophenolic acid|mesh-list
154515735|NCT05907746|Cyclophosphamide|cyclophosphamide|mesh-list
154515736|NCT05907746|Fludarabine|fludarabine|mesh-list
154515737|NCT05907746|Tacrolimus|tacrolimus|mesh-list
154515738|NCT05907746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239594|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
154515739|NCT05907746|Immunologic Factors|immunologic factors|mesh-ancestor
154515740|NCT05907746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515741|NCT05907746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515742|NCT05907746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154515743|NCT05907746|Alkylating Agents|alkylating agents|mesh-ancestor
154284844|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
154515744|NCT05907746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515745|NCT05907746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515746|NCT05907746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154515747|NCT05907746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154515748|NCT05907746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515749|NCT05907746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154515750|NCT05907746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154515751|NCT05907746|Antitubercular Agents|antitubercular agents|mesh-ancestor
154515752|NCT05907746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154515753|NCT05907746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515755|NCT05907122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515756|NCT05907122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515757|NCT05907122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515758|NCT05907122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515759|NCT05896566|Anastrozole|anastrozole|mesh-list
154515760|NCT05896566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154515761|NCT05896566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154515762|NCT05896566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515763|NCT05896566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154515764|NCT05896566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154515765|NCT05896566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515766|NCT05896566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515767|NCT05896566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154515768|NCT05896566|Hormone Antagonists|hormone antagonists|mesh-ancestor
154515769|NCT05896566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154515770|NCT05896566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515771|NCT05896566|Luteolytic Agents|luteolytic agents|mesh-ancestor
154515772|NCT05896566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154515773|NCT05896566|Contraceptive Agents|contraceptive agents|mesh-ancestor
154515774|NCT05896566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154515775|NCT05896566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154515776|NCT05888493|Prednisone|prednisone|mesh-list
154515777|NCT05888493|Prednisolone|prednisolone|mesh-list
154515778|NCT05888493|Cyclophosphamide|cyclophosphamide|mesh-list
154515779|NCT05888493|Rituximab|rituximab|mesh-list
154515780|NCT05888493|Doxorubicin|doxorubicin|mesh-list
154515781|NCT05888493|Vincristine|vincristine|mesh-list
154515782|NCT05888493|Lenalidomide|lenalidomide|mesh-list
154515783|NCT05888493|Tisagenlecleucel|tisagenlecleucel|mesh-list
154515784|NCT05888493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515785|NCT05888493|Immunologic Factors|immunologic factors|mesh-ancestor
154515786|NCT05888493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515787|NCT05888493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284904|NCT01560390|Ketamine|ketamine|mesh-list
154284936|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
154515788|NCT05888493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154515789|NCT05888493|Alkylating Agents|alkylating agents|mesh-ancestor
154515790|NCT05888493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515791|NCT05888493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515792|NCT05888493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154515793|NCT05888493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515794|NCT05888493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154515795|NCT05888493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154515796|NCT05888493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154515797|NCT05888493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515798|NCT05888493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154515799|NCT05888493|Glucocorticoids|glucocorticoids|mesh-ancestor
154515800|NCT05888493|Hormones|hormones|mesh-ancestor
154515801|NCT05888493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154515802|NCT05888493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154515803|NCT05888493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154515804|NCT05888493|Tubulin Modulators|tubulin modulators|mesh-ancestor
154515805|NCT05888493|Antimitotic Agents|antimitotic agents|mesh-ancestor
154515806|NCT05888493|Mitosis Modulators|mitosis modulators|mesh-ancestor
154515807|NCT05888493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154515808|NCT05888493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154515809|NCT05888493|Growth Substances|growth substances|mesh-ancestor
154515810|NCT05888493|Growth Inhibitors|growth inhibitors|mesh-ancestor
154515811|NCT05883449|Cyclophosphamide|cyclophosphamide|mesh-list
154515812|NCT05883449|Fludarabine|fludarabine|mesh-list
154515813|NCT05883449|Interleukin-2|interleukin-2|mesh-list
154515814|NCT05883449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515815|NCT05883449|Immunologic Factors|immunologic factors|mesh-ancestor
154515816|NCT05883449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284937|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284938|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284939|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284940|NCT03795792|Curcumin|curcumin|mesh-list
154284941|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154284942|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154284943|NCT03795792|Analgesics|analgesics|mesh-ancestor
154284944|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
154284945|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284946|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284947|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284948|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284949|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284950|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515817|NCT05883449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515818|NCT05883449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154515819|NCT05883449|Alkylating Agents|alkylating agents|mesh-ancestor
154515820|NCT05883449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515821|NCT05883449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515822|NCT05883449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154515823|NCT05883449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154515824|NCT05883449|Analgesics|analgesics|mesh-ancestor
154515825|NCT05883449|Sensory System Agents|sensory system agents|mesh-ancestor
154515826|NCT05883449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515827|NCT05862064|Paclitaxel|paclitaxel|mesh-list
154515828|NCT05862064|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154515829|NCT05862064|Cyclophosphamide|cyclophosphamide|mesh-list
154515830|NCT05862064|Epirubicin|epirubicin|mesh-list
154515831|NCT05862064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154515832|NCT05862064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515833|NCT05862064|Tubulin Modulators|tubulin modulators|mesh-ancestor
154515834|NCT05862064|Antimitotic Agents|antimitotic agents|mesh-ancestor
154515835|NCT05862064|Mitosis Modulators|mitosis modulators|mesh-ancestor
154515836|NCT05862064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515837|NCT05862064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154860239|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154515838|NCT05862064|Immunologic Factors|immunologic factors|mesh-ancestor
154515839|NCT05862064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284964|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284965|NCT01303614|Lidocaine|lidocaine|mesh-list
154284966|NCT01303614|Prilocaine|prilocaine|mesh-list
154284967|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154284968|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
154284969|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
154284970|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284971|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284972|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
154284973|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284974|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154284975|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154284976|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154284977|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284978|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284979|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154284980|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
154284981|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154284982|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
154284983|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
154284984|NCT03802422|Vitamins|vitamins|mesh-ancestor
154284985|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
154284986|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284988|NCT03802422|Hematinics|hematinics|mesh-ancestor
154515840|NCT05862064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515841|NCT05862064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154515842|NCT05862064|Alkylating Agents|alkylating agents|mesh-ancestor
154515843|NCT05862064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154515844|NCT05862064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154515845|NCT05862064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154515846|NCT05862064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154515847|NCT05862064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515848|NCT05861271|Capecitabine|capecitabine|mesh-list
154515849|NCT05861271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154515850|NCT05861271|Antimetabolites|antimetabolites|mesh-ancestor
154515851|NCT05861271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515852|NCT05861271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515853|NCT05849298|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154515854|NCT05849298|Pluvicto|pluvicto|mesh-list
154515855|NCT05849298|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154515856|NCT05849298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515857|NCT05837013|Anesthetics|anesthetics|mesh-list
154515858|NCT05837013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154515859|NCT05837013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515860|NCT05795153|Remibrutinib|remibrutinib|mesh-list
154515861|NCT05795153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154515862|NCT05795153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515863|NCT05795153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515864|NCT05789082|Carboplatin|carboplatin|mesh-list
154515865|NCT05789082|Pembrolizumab|pembrolizumab|mesh-list
154515866|NCT05789082|Pemetrexed|pemetrexed|mesh-list
154515867|NCT05789082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515868|NCT05789082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515869|NCT05789082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154284989|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
154284990|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154284991|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
154284992|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284993|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
154284994|NCT03801564|Protective Agents|protective agents|mesh-ancestor
154284995|NCT03813186|Decitabine|decitabine|mesh-list
154284996|NCT03813186|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154284997|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284998|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
154284999|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285000|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285001|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515870|NCT05789082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515871|NCT05789082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515872|NCT05789082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154515873|NCT05789082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154515874|NCT05786040|Rituximab|rituximab|mesh-list
154515875|NCT05786040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154515876|NCT05786040|Antibodies|antibodies|mesh-list
154515877|NCT05786040|Immunoglobulins|immunoglobulins|mesh-list
154515878|NCT05786040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154515879|NCT05786040|Immunologic Factors|immunologic factors|mesh-ancestor
154515880|NCT05786040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515881|NCT05786040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515882|NCT05786040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515883|NCT05781321|Temozolomide|temozolomide|mesh-list
154515884|NCT05781321|Levodopa|levodopa|mesh-list
154515885|NCT05781321|Fluorides|fluorides|mesh-list
154515886|NCT05781321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154515887|NCT05781321|Alkylating Agents|alkylating agents|mesh-ancestor
154515888|NCT05781321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239741|NCT00096486|Everolimus|everolimus|mesh-list
154515889|NCT05781321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515890|NCT05781321|Cariostatic Agents|cariostatic agents|mesh-ancestor
154515891|NCT05781321|Protective Agents|protective agents|mesh-ancestor
154515892|NCT05781321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515893|NCT05781321|Dopamine Agents|dopamine agents|mesh-ancestor
154515894|NCT05781321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154515895|NCT05781321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154515896|NCT05781321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154515897|NCT05750459|Artesunate|artesunate|mesh-list
154285017|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154285018|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
154285019|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
154285020|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285021|NCT03812796|Avelumab|avelumab|mesh-list
154285022|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285023|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285024|NCT05759104|Adalimumab|adalimumab|mesh-list
154285025|NCT05759104|Infliximab|infliximab|mesh-list
154285026|NCT05759104|Ustekinumab|ustekinumab|mesh-list
154285027|NCT05759104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154285028|NCT05759104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154285029|NCT05759104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154285030|NCT05759104|Dermatologic Agents|dermatologic agents|mesh-ancestor
154285031|NCT05759104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154285032|NCT01384240|Proflavine|proflavine|mesh-list
154285033|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154285034|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285035|NCT01381510|Finasteride|finasteride|mesh-list
154285036|NCT01381510|Dutasteride|dutasteride|mesh-list
154515898|NCT05750459|Antimalarials|antimalarials|mesh-ancestor
154515899|NCT05750459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154515900|NCT05750459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154515901|NCT05750459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515902|NCT05750459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515903|NCT05750459|Antiviral Agents|antiviral agents|mesh-ancestor
154515904|NCT05750459|Schistosomicides|schistosomicides|mesh-ancestor
154515905|NCT05750459|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154515906|NCT05750459|Anthelmintics|anthelmintics|mesh-ancestor
154515907|NCT05740982|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154515908|NCT05740982|Antiviral Agents|antiviral agents|mesh-ancestor
154515909|NCT05740982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515910|NCT05718323|Niraparib|niraparib|mesh-list
154515911|NCT05718323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154515912|NCT05718323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285045|NCT04258072|Vactosertib|vactosertib|mesh-list
154285046|NCT04258072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154285047|NCT04258072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285048|NCT04258072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285049|NCT02984800|Anesthetics|anesthetics|mesh-list
154285050|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285051|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285052|NCT04188730|Lofexidine|lofexidine|mesh-list
154285053|NCT04188730|Clonidine|clonidine|mesh-list
154285054|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154285055|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154285056|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285057|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
154285058|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285059|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154285060|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153813415|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813416|NCT00432120|Clopidogrel|clopidogrel|mesh-list
154285061|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154515913|NCT05718323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515914|NCT05718323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515915|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
154515916|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515917|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515918|NCT05705466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515919|NCT05705466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515920|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
154515921|NCT05681780|Nivolumab|nivolumab|mesh-list
154515922|NCT05681780|Fludarabine|fludarabine|mesh-list
154515923|NCT05681780|Interleukin-2|interleukin-2|mesh-list
154515924|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154515925|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
154515926|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515927|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515928|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154515929|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
154515930|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515931|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515932|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154515933|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515934|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154285062|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
154285063|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285064|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285065|NCT04188730|Analgesics|analgesics|mesh-ancestor
154285066|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
154285067|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
154285068|NCT01381432|Azathioprine|azathioprine|mesh-list
154285069|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
154285070|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285071|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154285072|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285073|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154285074|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
154285075|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285076|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154285077|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
154285078|NCT01381354|Riboflavin|riboflavin|mesh-list
154285079|NCT01381354|Thiamine|thiamine|mesh-list
154285080|NCT01381354|Niacinamide|niacinamide|mesh-list
154285081|NCT01381354|Niacin|niacin|mesh-list
154285082|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
154285083|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
154285084|NCT01381354|Ubiquinone|ubiquinone|mesh-list
154515935|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154515936|NCT05681780|Analgesics|analgesics|mesh-ancestor
154515937|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
154515938|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515939|NCT05679024|Apixaban|apixaban|mesh-list
154515940|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154515941|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
154515942|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154515943|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
154515944|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515945|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515946|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
154515947|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154515948|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154515949|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515950|NCT05645692|Atezolizumab|atezolizumab|mesh-list
154515951|NCT05645692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154515952|NCT05645692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515953|NCT05645692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154515954|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154515955|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154285085|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
154285086|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154285087|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154285088|NCT01381354|Vitamins|vitamins|mesh-ancestor
154285089|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
154285090|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285091|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
154285092|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285093|NCT01381354|Expectorants|expectorants|mesh-ancestor
154285094|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
154285095|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154285096|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
154285097|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285098|NCT01381354|Protective Agents|protective agents|mesh-ancestor
154285099|NCT01381354|Antidotes|antidotes|mesh-ancestor
154285100|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
154285101|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154285102|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
154285103|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154285104|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
154285105|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154515956|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154515957|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154515958|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
154515959|NCT05625347|Aspirin|aspirin|mesh-list
154515960|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154515961|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154239822|NCT04531540|Butenafine|butenafine|mesh-list
154515962|NCT05625347|Analgesics|analgesics|mesh-ancestor
154515963|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
154515964|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515965|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515966|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154515967|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515968|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154515969|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154515970|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515971|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154285106|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
154285107|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154285108|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
154285109|NCT01381276|Beta Carotene|beta carotene|mesh-list
154285110|NCT01381276|Vitamin A|vitamin a|mesh-list
154285111|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
154285112|NCT01381276|Carotenoids|carotenoids|mesh-list
154285113|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
154285114|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285115|NCT01381276|Protective Agents|protective agents|mesh-ancestor
154285116|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285117|NCT01381276|Provitamins|provitamins|mesh-ancestor
154285118|NCT01381276|Vitamins|vitamins|mesh-ancestor
154285119|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
154285120|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154285121|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285122|NCT01569256|Cabergoline|cabergoline|mesh-list
154285123|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154285124|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153813417|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154515972|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154515973|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515974|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
154515975|NCT05625334|Aspirin|aspirin|mesh-list
154515976|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154515977|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154515978|NCT05625334|Analgesics|analgesics|mesh-ancestor
154515979|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
154515980|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154515981|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154515982|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154515983|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154515984|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154515985|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154515986|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285125|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
154285126|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
154285127|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285128|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285129|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285130|NCT03794544|Durvalumab|durvalumab|mesh-list
154285131|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285132|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285133|NCT01380808|Capecitabine|capecitabine|mesh-list
154285134|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154285135|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
154285136|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285137|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285138|NCT03799224|Decitabine|decitabine|mesh-list
154285139|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154515987|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154515988|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154515989|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515990|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
154515991|NCT05607550|Aflutinib|aflutinib|mesh-list
154515992|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154515993|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154515994|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154515995|NCT05593575|Valsartan|valsartan|mesh-list
154515996|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154515997|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154515998|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154515999|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516000|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154516001|NCT05544968|Antibodies|antibodies|mesh-list
154516002|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154516003|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
154516004|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516005|NCT05539729|Vancomycin|vancomycin|mesh-list
154516006|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154516007|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516008|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
154516009|NCT05537766|Fludarabine|fludarabine|mesh-list
154516010|NCT05537766|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154516011|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516012|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
154516013|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516014|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516015|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154516016|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
154516017|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516018|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516019|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154516020|NCT05537766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285140|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
154285141|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285142|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285143|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285144|NCT03798912|Octreotide|octreotide|mesh-list
154516021|NCT05518877|Ketamine|ketamine|mesh-list
154516022|NCT05518877|Analgesics|analgesics|mesh-ancestor
154516023|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
154516024|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516025|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516026|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154516027|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154516028|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
154516029|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
154516030|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154516031|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154516032|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154516033|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516034|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516035|NCT05468619|Valacyclovir|valacyclovir|mesh-list
154239900|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
154516037|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516038|NCT05420636|Paclitaxel|paclitaxel|mesh-list
154516039|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516040|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516041|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
154516042|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
154285175|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285176|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285177|NCT03798522|Nalbuphine|nalbuphine|mesh-list
154285178|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154285179|NCT03798522|Narcotics|narcotics|mesh-ancestor
154285180|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285181|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285182|NCT03798522|Analgesics|analgesics|mesh-ancestor
154285183|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
154285184|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285185|NCT01308034|Sunitinib|sunitinib|mesh-list
154285186|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285187|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154285188|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154285189|NCT01308034|Growth Substances|growth substances|mesh-ancestor
154285190|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285191|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
154285192|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154032040|NCT06002477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285193|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285194|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285195|NCT01302210|Mupirocin|mupirocin|mesh-list
154516043|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
154516044|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516045|NCT05419726|Semaglutide|semaglutide|mesh-list
154516046|NCT05419726|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154516047|NCT05419726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154516048|NCT05419726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516049|NCT05417113|Bupivacaine|bupivacaine|mesh-list
154516050|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
154516051|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
154516052|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154516053|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516054|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
154516055|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516056|NCT05377034|Bevacizumab|bevacizumab|mesh-list
154516057|NCT05377034|Atezolizumab|atezolizumab|mesh-list
154516058|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516059|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516060|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154516061|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154516062|NCT05377034|Growth Substances|growth substances|mesh-ancestor
154516063|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285196|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154285197|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285198|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154285199|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285200|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285201|NCT00005044|Bicalutamide|bicalutamide|mesh-list
154285202|NCT00005044|Flutamide|flutamide|mesh-list
154285203|NCT00005044|Hormones|hormones|mesh-list
154285204|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154285205|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285206|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285207|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
154285208|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
154285209|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285210|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154285211|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154285212|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154285213|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154285214|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154285215|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516064|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
154516065|NCT05377034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516066|NCT05377034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516068|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516069|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516070|NCT05364424|Rituximab|rituximab|mesh-list
154516071|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
154516072|NCT05364424|Carboplatin|carboplatin|mesh-list
154516073|NCT05364424|Etoposide|etoposide|mesh-list
154516074|NCT05364424|Ifosfamide|ifosfamide|mesh-list
154516075|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516076|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516077|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
154516078|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516079|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516080|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516081|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154516082|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154516083|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285216|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285217|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285218|NCT03794154|Analgesics|analgesics|mesh-ancestor
154285219|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
154285220|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285221|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
154285222|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154285223|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
154285224|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
154285225|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
154285226|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154285227|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285228|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285229|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
154285230|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154285231|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285232|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285233|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
153813419|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153359886|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516084|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516085|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154516086|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
154516087|NCT05364073|Aflutinib|aflutinib|mesh-list
154516088|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516089|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516090|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516091|NCT05359237|Vincristine|vincristine|mesh-list
154516092|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516093|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516094|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
154516095|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
154516096|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
154516097|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516098|NCT05312970|Polidocanol|polidocanol|mesh-list
154516099|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154516100|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154516101|NCT05304767|Xanomeline|xanomeline|mesh-list
154285234|NCT02722668|Sirolimus|sirolimus|mesh-list
154285235|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
154285236|NCT02722668|Fludarabine|fludarabine|mesh-list
154285237|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154285238|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154285239|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
154285240|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285241|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154285242|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154285243|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
154285244|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285245|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285246|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154285247|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154285248|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154285249|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
154285250|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154285251|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813420|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153813421|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
153359887|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154285252|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516102|NCT05304767|Trospium chloride|trospium chloride|mesh-list
154516103|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
154516104|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
154516105|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516106|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516107|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154516108|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154516109|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
154239968|NCT00128102|Vorinostat|vorinostat|mesh-list
154516110|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516111|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516112|NCT05304767|Urological Agents|urological agents|mesh-ancestor
154516113|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154516114|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154516115|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154516116|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154516117|NCT05303597|Lidocaine|lidocaine|mesh-list
154516118|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
154516119|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
154516120|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154516121|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516122|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
154516123|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516124|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154516125|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154516126|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154516127|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154516128|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285253|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
154285254|NCT01303926|Paclitaxel|paclitaxel|mesh-list
154285255|NCT01303926|Bevacizumab|bevacizumab|mesh-list
154285256|NCT01303926|Carboplatin|carboplatin|mesh-list
154285257|NCT01303926|Pemetrexed|pemetrexed|mesh-list
154285258|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154285259|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285260|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
154285261|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
154285262|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
154285263|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285264|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285265|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154285266|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154285267|NCT01303926|Growth Substances|growth substances|mesh-ancestor
154285281|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
154516129|NCT05301842|Durvalumab|durvalumab|mesh-list
154516130|NCT05301842|Lenvatinib|lenvatinib|mesh-list
154516131|NCT05301842|Tremelimumab|tremelimumab|mesh-list
154516132|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516133|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516134|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516135|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516136|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516137|NCT05257213|Heparin|heparin|mesh-list
154516138|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
154516139|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154516140|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154516141|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516142|NCT05240898|Carboplatin|carboplatin|mesh-list
154516143|NCT05240898|Olaparib|olaparib|mesh-list
154516144|NCT05240898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516145|NCT05240898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154516146|NCT05240898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516147|NCT05240898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516148|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
154516149|NCT05239728|Belzutifan|belzutifan|mesh-list
154516150|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516151|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516152|NCT05239728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516153|NCT05239728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516154|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
154516155|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154285282|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154285283|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
154285284|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285285|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285286|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
154285287|NCT03717012|Nintedanib|nintedanib|mesh-list
154285288|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285289|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154285290|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285291|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285292|NCT01302756|Folic Acid|folic acid|mesh-list
154285293|NCT01302756|Hematinics|hematinics|mesh-ancestor
154285294|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
154285295|NCT01302756|Vitamins|vitamins|mesh-ancestor
154285296|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
154285297|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285298|NCT04893252|Durvalumab|durvalumab|mesh-list
154285299|NCT04893252|Vactosertib|vactosertib|mesh-list
154285300|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285301|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516156|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516157|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
154516158|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154516159|NCT05190705|Dexamethasone|dexamethasone|mesh-list
154516160|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
154516161|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154516162|NCT05190705|BB 1101|bb 1101|mesh-list
154516163|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154516164|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
154516165|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
154516166|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516167|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516168|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154516169|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
154516170|NCT05190705|Hormones|hormones|mesh-ancestor
154516171|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154516172|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154516173|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516174|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
154516175|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516176|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516177|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516178|NCT05180032|Denosumab|denosumab|mesh-list
154516179|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154516180|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516181|NCT05174611|Vitamin D|vitamin d|mesh-list
154516182|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
154240045|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
154516183|NCT05174611|Vitamins|vitamins|mesh-ancestor
154516184|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
154516185|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516186|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154516187|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154516188|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154285308|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285309|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285310|NCT01380496|Doxycycline|doxycycline|mesh-list
154285311|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154285312|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516189|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
154516190|NCT05174585|Antibodies|antibodies|mesh-list
154516191|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
154516192|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154516193|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
154516194|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516195|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516196|NCT05174585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516197|NCT05174585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516198|NCT05145413|Xanomeline|xanomeline|mesh-list
154516199|NCT05145413|Trospium chloride|trospium chloride|mesh-list
154516200|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
154516201|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
154516202|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516203|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516204|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154516205|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154516206|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
154516207|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516208|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516209|NCT05145413|Urological Agents|urological agents|mesh-ancestor
154516210|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154516211|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154516212|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154516213|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154516214|NCT05142228|Erenumab|erenumab|mesh-list
154516215|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154516216|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516217|NCT05142228|Analgesics|analgesics|mesh-ancestor
154516218|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
154516219|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032194|NCT05716906|Melatonin|melatonin|mesh-list
154285342|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154285343|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285344|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285345|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285346|NCT03792828|Analgesics|analgesics|mesh-ancestor
154285347|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
154285348|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285349|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
154285350|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154285374|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
154516220|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516221|NCT05140525|Macitentan|macitentan|mesh-list
154516222|NCT05140525|Riociguat|riociguat|mesh-list
154516223|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154516224|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154516225|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516226|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154516227|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
154516228|NCT05113966|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154516229|NCT05113966|Immunoconjugates|immunoconjugates|mesh-ancestor
154516230|NCT05113966|Immunologic Factors|immunologic factors|mesh-ancestor
154516231|NCT05113966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516232|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
154516233|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516234|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516235|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516236|NCT05071716|Rifaximin|rifaximin|mesh-list
154516237|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154516238|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516239|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154516240|NCT05059860|Insulin|insulin|mesh-list
154516241|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154516242|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516243|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
154516244|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516245|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516246|NCT05050916|Vitamin D|vitamin d|mesh-list
154516247|NCT05050916|Vitamins|vitamins|mesh-ancestor
154516248|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
154516249|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516250|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154516251|NCT05007106|Docetaxel|docetaxel|mesh-list
154516252|NCT05007106|Bevacizumab|bevacizumab|mesh-list
154516253|NCT05007106|Carboplatin|carboplatin|mesh-list
154516254|NCT05007106|Gemcitabine|gemcitabine|mesh-list
154516255|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
154285375|NCT03792984|Calcium|calcium|mesh-list
154285376|NCT03792984|Vitamins|vitamins|mesh-ancestor
154285377|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
154285378|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285379|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154516256|NCT05007106|Capecitabine|capecitabine|mesh-list
154516257|NCT05007106|Fluorouracil|fluorouracil|mesh-list
154516258|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
154516259|NCT05007106|Lenvatinib|lenvatinib|mesh-list
154516260|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516261|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
154516262|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
154516263|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
154516264|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516265|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516266|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154516267|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154516268|NCT05007106|Growth Substances|growth substances|mesh-ancestor
154516269|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516270|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
154516271|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516272|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
154516273|NCT05007106|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516274|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516275|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
154516276|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516277|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516278|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
154516279|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
154516280|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516281|NCT04991402|Dolutegravir|dolutegravir|mesh-list
154516282|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154516283|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154516284|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154516285|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516286|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516287|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154516288|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
154516289|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516291|NCT04989218|Gemcitabine|gemcitabine|mesh-list
154516292|NCT04989218|Durvalumab|durvalumab|mesh-list
154516293|NCT04989218|Tremelimumab|tremelimumab|mesh-list
154516294|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516295|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516296|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
154516297|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516298|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516299|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154516300|NCT04989127|Penicillins|penicillins|mesh-list
154516301|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154516302|NCT04989127|Analgesics|analgesics|mesh-list
154516303|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516304|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
154516305|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
154516306|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516307|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516308|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
154516309|NCT04976634|Lenvatinib|lenvatinib|mesh-list
154516310|NCT04976634|Belzutifan|belzutifan|mesh-list
154516311|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516312|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516313|NCT04976634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516314|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516315|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516316|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516317|NCT04976192|Omalizumab|omalizumab|mesh-list
154516318|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154516319|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154516320|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
154516321|NCT04960709|Durvalumab|durvalumab|mesh-list
154516322|NCT04960709|Tremelimumab|tremelimumab|mesh-list
154516323|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516324|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516325|NCT04901208|Nicotine|nicotine|mesh-list
154516326|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154516327|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
154516328|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516329|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516330|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154516331|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154285456|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285457|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285458|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154285459|NCT03810976|Gemcitabine|gemcitabine|mesh-list
154285460|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154285461|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
154285462|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285463|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285464|NCT05405244|Bromocriptine|bromocriptine|mesh-list
154285465|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285466|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154285467|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154285468|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
154285469|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285470|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
154285471|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
154285472|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285473|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285474|NCT03789006|Interleukin-2|interleukin-2|mesh-list
154285475|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
154285476|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154516332|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
154516333|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516334|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516335|NCT04887831|Carboplatin|carboplatin|mesh-list
154516336|NCT04887831|Gemcitabine|gemcitabine|mesh-list
154516338|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516339|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516340|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
154516341|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516342|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516343|NCT04877522|Niacinamide|niacinamide|mesh-list
154516344|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
154516345|NCT04877522|Dasatinib|dasatinib|mesh-list
154516346|NCT04877522|Nilotinib|nilotinib|mesh-list
154516347|NCT04877522|Bosutinib|bosutinib|mesh-list
154516348|NCT04877522|Asciminib|asciminib|mesh-list
154516349|NCT04877522|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154516350|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516351|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516352|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516353|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516354|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
154516355|NCT04877522|Vitamins|vitamins|mesh-ancestor
154516356|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
154516357|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516358|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154516359|NCT04876131|Gentamicins|gentamicins|mesh-list
154516360|NCT04876131|Cephalexin|cephalexin|mesh-list
154516361|NCT04876131|Penicillin G|penicillin g|mesh-list
154516362|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154516363|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
154516365|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154516366|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516367|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516368|NCT04870333|Ciclesonide|ciclesonide|mesh-list
154516369|NCT04870333|Sotrovimab|sotrovimab|mesh-list
154516370|NCT04870333|Niclosamide|niclosamide|mesh-list
154516371|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
154516372|NCT04870333|Hormones|hormones|mesh-ancestor
154516373|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154516374|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516375|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154516376|NCT04870333|Antiviral Agents|antiviral agents|mesh-ancestor
154516377|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516378|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
154516379|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154516380|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
154516381|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154516382|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
154516383|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
154516384|NCT04859946|Busulfan|busulfan|mesh-list
154516385|NCT04859946|Thiotepa|thiotepa|mesh-list
154516386|NCT04859946|Fludarabine|fludarabine|mesh-list
154516387|NCT04859946|Tacrolimus|tacrolimus|mesh-list
154516388|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516389|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
154516390|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516391|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516392|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154285524|NCT01379482|Irinotecan|irinotecan|mesh-list
154285525|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154285526|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285527|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
154285528|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
154285529|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
154285530|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285531|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154285532|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154285533|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154285534|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285535|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154285536|NCT05624424|Sufentanil|sufentanil|mesh-list
154285537|NCT05624424|Remifentanil|remifentanil|mesh-list
154285538|NCT05624424|Propofol|propofol|mesh-list
154285539|NCT05624424|Sevoflurane|sevoflurane|mesh-list
153901269|NCT02697344|Acetic Acid|acetic acid|mesh-list
154516393|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
154516394|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516395|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516396|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154516397|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154516398|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516399|NCT04809233|Tipifarnib|tipifarnib|mesh-list
154516400|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516401|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
154516402|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516403|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516404|NCT04808999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516405|NCT04808999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516406|NCT04806386|Psyllium|psyllium|mesh-list
154516407|NCT04806386|Cathartics|cathartics|mesh-ancestor
154516408|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154516409|NCT04778410|Cytarabine|cytarabine|mesh-list
154516410|NCT04778410|Etoposide|etoposide|mesh-list
154516411|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
154516412|NCT04778410|Azacitidine|azacitidine|mesh-list
154516413|NCT04778410|Venetoclax|venetoclax|mesh-list
154516414|NCT04778410|Cc-486|cc-486|mesh-list
154516415|NCT04778410|Magrolimab|magrolimab|mesh-list
154285540|NCT05624424|Cisatracurium|cisatracurium|mesh-list
154285541|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154285542|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285543|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285544|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154285545|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
154285546|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
154285547|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154285548|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154285549|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154285550|NCT05624424|Narcotics|narcotics|mesh-ancestor
154285551|NCT05624424|Analgesics|analgesics|mesh-ancestor
154285552|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
154285553|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285554|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154285555|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154285556|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154285557|NCT05461690|Niraparib|niraparib|mesh-list
154285558|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154285559|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285560|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516416|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516417|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516418|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154516419|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154516420|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516421|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516422|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516423|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
154516424|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
154516425|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516426|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516427|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
154516428|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516429|NCT04778410|Analgesics|analgesics|mesh-ancestor
154516430|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
154516431|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285561|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285562|NCT05456230|Midazolam|midazolam|mesh-list
154285563|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154285564|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154285565|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285566|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285567|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154285568|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154285569|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154285570|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154285571|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
154285572|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
154285573|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
154285574|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
154285575|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285576|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285577|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153813424|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516432|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516433|NCT04774718|Alectinib|alectinib|mesh-list
154516434|NCT04774718|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154516435|NCT04774718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516436|NCT04774718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516437|NCT04774718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516438|NCT04752384|Buprenorphine|buprenorphine|mesh-list
154516439|NCT04752384|Tramadol|tramadol|mesh-list
154516440|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154516441|NCT04752384|Narcotics|narcotics|mesh-ancestor
154516442|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154516443|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516444|NCT04752384|Analgesics|analgesics|mesh-ancestor
154516445|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
154516446|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516447|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154516448|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
154516449|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516450|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516451|NCT04738487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516452|NCT04738487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516453|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
154516454|NCT04710628|Lenvatinib|lenvatinib|mesh-list
154516455|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516456|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516457|NCT04710628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516458|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516459|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516460|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516461|NCT04707625|Aflibercept|aflibercept|mesh-list
154285578|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
154285579|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285580|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154285581|NCT01377376|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154285582|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154285583|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285584|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285585|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285586|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
154285587|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154285588|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285589|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285591|NCT03788538|Analgesics|analgesics|mesh-ancestor
154516462|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154516463|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154516464|NCT04707625|Growth Substances|growth substances|mesh-ancestor
154516465|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516466|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
154516467|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516468|NCT04702880|Carboplatin|carboplatin|mesh-list
154516469|NCT04702880|Nivolumab|nivolumab|mesh-list
154516470|NCT04702880|Etoposide|etoposide|mesh-list
154516471|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516472|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516473|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516474|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516475|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516476|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154516477|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154516478|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516479|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
154516480|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516481|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516482|NCT04691375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516483|NCT04691375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516484|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
154516485|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516486|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285608|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154285609|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154285610|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
154285611|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154285612|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285613|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154285614|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154285615|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154285616|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285617|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
154285618|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154285619|NCT03077698|Hormones|hormones|mesh-ancestor
154285620|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285621|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
154285622|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
154285623|NCT01377220|Choline|choline|mesh-list
154285624|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
154285625|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154285626|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
154285627|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285628|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154285634|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285635|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516487|NCT04682431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516488|NCT04682431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516489|NCT04675333|Carboplatin|carboplatin|mesh-list
154516490|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
154516492|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516493|NCT04675333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516494|NCT04675333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516495|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
154516496|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516497|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516498|NCT04675294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516499|NCT04675294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516500|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154516501|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516502|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
154516503|NCT04660539|Azathioprine|azathioprine|mesh-list
154516504|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154516505|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516506|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154516507|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
154516508|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154516509|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516510|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285636|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154285637|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
154285638|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154285639|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
154285640|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285641|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285642|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154285643|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
154285644|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
154285645|NCT03079102|Protective Agents|protective agents|mesh-ancestor
154285646|NCT03791424|Midazolam|midazolam|mesh-list
154285647|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154285648|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154285649|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285650|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285651|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154285652|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154285653|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154285654|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154285655|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
154285656|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
154516511|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516512|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
154516513|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516514|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516515|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
154516516|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516517|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516519|NCT04624204|Etoposide|etoposide|mesh-list
154516520|NCT04624204|Olaparib|olaparib|mesh-list
154516521|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516522|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516523|NCT04624204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516524|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516525|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516526|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154516527|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154516528|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516529|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154516530|NCT04593459|Metformin|metformin|mesh-list
154516531|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154516532|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516533|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
154516534|NCT04581382|Nivolumab|nivolumab|mesh-list
154516535|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516536|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285657|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
154285658|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
154285659|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285660|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285661|NCT03787992|Gefitinib|gefitinib|mesh-list
154285662|NCT03787992|Aflutinib|aflutinib|mesh-list
154285663|NCT03787992|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154285664|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154285665|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285666|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285667|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285668|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
154285669|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285670|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285671|NCT02434354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154285672|NCT02434354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285673|NCT05764018|Caffeine|caffeine|mesh-list
154285674|NCT05764018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154285675|NCT05764018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285676|NCT05764018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153813425|NCT00432198|Zolpidem|zolpidem|mesh-list
154516537|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516538|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516539|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154516540|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154516541|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
154516542|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
154516543|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516544|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516545|NCT04521621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516546|NCT04521621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516547|NCT04521231|Blinatumomab|blinatumomab|mesh-list
154516548|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516549|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
154516550|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
154516551|NCT04505254|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154516552|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516553|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516554|NCT04505254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516555|NCT04505254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516556|NCT04505254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285682|NCT05764018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285683|NCT01308528|Enoxaparin|enoxaparin|mesh-list
154285684|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
154285685|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
154285686|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154285687|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154285688|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285689|NCT03785496|Spartalizumab|spartalizumab|mesh-list
154285690|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154285691|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285692|NCT03785496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285693|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285694|NCT01307202|Gabapentin|gabapentin|mesh-list
154285695|NCT01307202|Analgesics|analgesics|mesh-ancestor
154285696|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
154285697|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285698|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285699|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
154285700|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154285701|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154285702|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442814|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285703|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154516557|NCT04482244|Cannabidiol|cannabidiol|mesh-list
154516558|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
154516559|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154516560|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154516561|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154516562|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
154516563|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516564|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516565|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154516566|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154516567|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
154516568|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516569|NCT04428151|Paclitaxel|paclitaxel|mesh-list
154516570|NCT04428151|Docetaxel|docetaxel|mesh-list
154516571|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
154516572|NCT04428151|Capecitabine|capecitabine|mesh-list
154516573|NCT04428151|Cetuximab|cetuximab|mesh-list
154516574|NCT04428151|Lenvatinib|lenvatinib|mesh-list
154516575|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516576|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516577|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
154516578|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
154516579|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
154285704|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154285705|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154285706|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285707|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285708|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
154285709|NCT01308606|Simeprevir|simeprevir|mesh-list
154285710|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
154285711|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285712|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
154285713|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285714|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285715|NCT04637386|Anesthetics|anesthetics|mesh-list
154285716|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
154285717|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285718|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285719|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
154285720|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285721|NCT01308684|Bevacizumab|bevacizumab|mesh-list
153359890|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516580|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516581|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516582|NCT04428151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516583|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516584|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
154516585|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516586|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516587|NCT04410796|Carboplatin|carboplatin|mesh-list
154516588|NCT04410796|Pemetrexed|pemetrexed|mesh-list
154516589|NCT04410796|Osimertinib|osimertinib|mesh-list
154516590|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516591|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516592|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516593|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154516594|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154516595|NCT04410796|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154516596|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516598|NCT04383275|Trastuzumab|trastuzumab|mesh-list
154516599|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516600|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
154516601|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285722|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285723|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285724|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154285725|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154285726|NCT01308684|Growth Substances|growth substances|mesh-ancestor
154285727|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285728|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
154285729|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
154285730|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154285731|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154285732|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285733|NCT03790566|Bupivacaine|bupivacaine|mesh-list
154285734|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
154285735|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
154285736|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285737|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285738|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
154285739|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285740|NCT04436224|Fentanyl|fentanyl|mesh-list
154285741|NCT04436224|Hydromorphone|hydromorphone|mesh-list
154285742|NCT04436224|Butorphanol|butorphanol|mesh-list
154285743|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153813426|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153359891|NCT03141359|Paclitaxel|paclitaxel|mesh-list
154516602|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516603|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516604|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
154516605|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516606|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516607|NCT04381650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516608|NCT04381650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516609|NCT04380753|Sotorasib|sotorasib|mesh-list
154516610|NCT04380753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516611|NCT04380753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516612|NCT04380753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516613|NCT04380753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516614|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
154516615|NCT04379596|Capecitabine|capecitabine|mesh-list
154516616|NCT04379596|Fluorouracil|fluorouracil|mesh-list
154516617|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
154516618|NCT04379596|Trastuzumab|trastuzumab|mesh-list
154285744|NCT04436224|Narcotics|narcotics|mesh-ancestor
154285745|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285746|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285747|NCT04436224|Analgesics|analgesics|mesh-ancestor
154285748|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
154285749|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285750|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154285751|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154285752|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
154285753|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
154285754|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
154285755|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
154285756|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154285757|NCT03785184|Dexamethasone|dexamethasone|mesh-list
154285758|NCT03785184|Lenalidomide|lenalidomide|mesh-list
154285759|NCT03785184|Venetoclax|venetoclax|mesh-list
154285760|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154285761|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
154285762|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
153442880|NCT02079246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516619|NCT04379596|Durvalumab|durvalumab|mesh-list
154516620|NCT04379596|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154516621|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516622|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516623|NCT04379596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516624|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516625|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516626|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
154516627|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516628|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
154516629|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516630|NCT04379596|Immunoconjugates|immunoconjugates|mesh-ancestor
154516631|NCT04353492|Ofatumumab|ofatumumab|mesh-list
154516632|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516633|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
154516634|NCT04346108|Antibodies|antibodies|mesh-list
154516635|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
154516636|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154240500|NCT03689374|Insulin|insulin|mesh-list
154516637|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154516638|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
154516639|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
154516640|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285763|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285764|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285765|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154285766|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
154285767|NCT03785184|Hormones|hormones|mesh-ancestor
154285768|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285769|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154285770|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285771|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
154285772|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154285773|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154285774|NCT03785184|Growth Substances|growth substances|mesh-ancestor
154285775|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
154285776|NCT03784794|Thrombin|thrombin|mesh-list
154285777|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
154285778|NCT03784794|Coagulants|coagulants|mesh-ancestor
154285779|NCT01378546|Amifampridine|amifampridine|mesh-list
154285780|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154285781|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285782|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285783|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154285784|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154285785|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285786|NCT05688384|Alfentanil|alfentanil|mesh-list
154516641|NCT04311723|Anesthetics|anesthetics|mesh-list
154516642|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154516643|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516644|NCT04302025|Atezolizumab|atezolizumab|mesh-list
154516645|NCT04302025|Vemurafenib|vemurafenib|mesh-list
154516646|NCT04302025|Pralsetinib|pralsetinib|mesh-list
154516648|NCT04302025|Entrectinib|entrectinib|mesh-list
154516649|NCT04302025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516650|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516651|NCT04302025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516652|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516653|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516654|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516655|NCT04302025|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154516656|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
154516657|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
154516658|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516659|NCT04286178|Vitamins|vitamins|mesh-ancestor
154516660|NCT04269928|Epinephrine|epinephrine|mesh-list
154516661|NCT04269928|Racepinephrine|racepinephrine|mesh-list
154516662|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
154516663|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154516664|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154285787|NCT05688384|Propofol|propofol|mesh-list
154285788|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154285789|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285790|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285791|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154285792|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
154285793|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
154285794|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154285795|NCT05688384|Narcotics|narcotics|mesh-ancestor
154285796|NCT05688384|Analgesics|analgesics|mesh-ancestor
154285797|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
154285798|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285799|NCT01307592|Rituximab|rituximab|mesh-list
154285800|NCT01307592|Gemcitabine|gemcitabine|mesh-list
154285801|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
154285802|NCT01307592|Lenalidomide|lenalidomide|mesh-list
154285803|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285804|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285805|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
154516665|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
154516666|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860240|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516667|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516668|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516669|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154516670|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154516671|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
154516672|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516673|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154516674|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
154516675|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
154516676|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
154516677|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154516678|NCT04216524|Cytarabine|cytarabine|mesh-list
154516679|NCT04216524|Dexamethasone|dexamethasone|mesh-list
154516680|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
154516681|NCT04216524|Prednisone|prednisone|mesh-list
154516682|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
154516683|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154516684|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154516685|NCT04216524|Prednisolone|prednisolone|mesh-list
154516686|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
154516687|NCT04216524|Cortisone|cortisone|mesh-list
154516688|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
154516689|NCT04216524|Rituximab|rituximab|mesh-list
154516690|NCT04216524|Doxorubicin|doxorubicin|mesh-list
154516691|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154516692|NCT04216524|Methotrexate|methotrexate|mesh-list
154516693|NCT04216524|Vincristine|vincristine|mesh-list
154516694|NCT04216524|Daunorubicin|daunorubicin|mesh-list
154516695|NCT04216524|Venetoclax|venetoclax|mesh-list
154516696|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
154516697|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154516698|NCT04216524|Antibodies|antibodies|mesh-list
154285806|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285807|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154285808|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154285809|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
154285810|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285811|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154285812|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154285813|NCT01307592|Growth Substances|growth substances|mesh-ancestor
154285814|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
154285824|NCT01378156|Vaccines|vaccines|mesh-list
154516699|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
154516700|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154516701|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154516702|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
154516703|NCT04216524|BB 1101|bb 1101|mesh-list
154516704|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516705|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
154516706|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516707|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516708|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154516709|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
154516710|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516711|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516712|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154516713|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154516714|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
154516715|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
154516716|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516717|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154516718|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
154516719|NCT04216524|Hormones|hormones|mesh-ancestor
154516720|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285838|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154285839|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285840|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285841|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154285842|NCT03687814|Laxatives|laxatives|mesh-ancestor
154285843|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154285844|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
154285845|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154285846|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285847|NCT03781596|Fluticasone|fluticasone|mesh-list
154285848|NCT03781596|Omeprazole|omeprazole|mesh-list
154285849|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154285850|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154285851|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
154285852|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285853|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285854|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154285855|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
154285856|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
154285857|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154285858|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154285859|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154285860|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154285861|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516721|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154516722|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
154516723|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516724|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154516725|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154516726|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154516727|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154516728|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
154516729|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154516730|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516731|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
154516732|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
154516733|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154516734|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154516735|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
154516736|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516737|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516738|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
154516739|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
154516740|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
154516741|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154516742|NCT04216524|Protective Agents|protective agents|mesh-ancestor
154516743|NCT04179175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154285862|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285863|NCT03781674|Progesterone|progesterone|mesh-list
154285864|NCT03781674|Progestins|progestins|mesh-ancestor
154285865|NCT03781674|Hormones|hormones|mesh-ancestor
154285866|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285867|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285868|NCT03786120|Zolpidem|zolpidem|mesh-list
154285869|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154285870|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154285871|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032721|NCT04850495|Doxorubicin|doxorubicin|mesh-list
154285873|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154285874|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
154285875|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
154285876|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285877|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285878|NCT01561014|Fluorouracil|fluorouracil|mesh-list
154285879|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
154285880|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154285881|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154285882|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
154285883|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450682|NCT05426031|Protamines|protamines|mesh-list
153442930|NCT02044302|Narcotics|narcotics|mesh-list
154516744|NCT04179175|Immunologic Factors|immunologic factors|mesh-ancestor
154516745|NCT04179175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516746|NCT04170153|Niraparib|niraparib|mesh-list
154516747|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154516748|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516749|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516750|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516751|NCT04161898|Prednisolone|prednisolone|mesh-list
154516752|NCT04161898|Upadacitinib|upadacitinib|mesh-list
154516753|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154516754|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
154516755|NCT04161898|Hormones|hormones|mesh-ancestor
154516756|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154516757|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516758|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154516759|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516760|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154516761|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516762|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516763|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285884|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154285885|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285886|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154285887|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
154285888|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285889|NCT01561014|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154285890|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154285891|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285892|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154285893|NCT01561092|Escitalopram|escitalopram|mesh-list
154285894|NCT01561092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154285895|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154285896|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154285897|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285898|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285899|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
154285900|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285901|NCT01316874|Valrubicin|valrubicin|mesh-list
154285902|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285903|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153813429|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359894|NCT03141359|Durvalumab|durvalumab|mesh-list
153359895|NCT03141359|Cisplatin|cisplatin|mesh-list
154516764|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516765|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
154516766|NCT04153565|Pemetrexed|pemetrexed|mesh-list
154516767|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516768|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516769|NCT04153565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516770|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516771|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516772|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154516773|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154516774|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
154516775|NCT04119024|Fludarabine|fludarabine|mesh-list
154516776|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
154516777|NCT04119024|Interleukin-2|interleukin-2|mesh-list
154516778|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516779|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
154516780|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516781|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516782|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154285904|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154285905|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285906|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285907|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154285908|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154285909|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154285910|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154285911|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285912|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285913|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285914|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
154285915|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154285916|NCT01309620|Zinc|zinc|mesh-list
154285917|NCT01309620|Trace Elements|trace elements|mesh-ancestor
154285918|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
154285919|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285920|NCT03783312|Acetaminophen|acetaminophen|mesh-list
154285921|NCT03783312|Ibuprofen|ibuprofen|mesh-list
153360623|NCT01332461|Xhance|xhance|mesh-list
154285922|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154516783|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
154516784|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516785|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516786|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154516787|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516788|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
154516789|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154516790|NCT04119024|Analgesics|analgesics|mesh-ancestor
154516791|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
154516792|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516793|NCT04113616|Cytarabine|cytarabine|mesh-list
154516795|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154516796|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
154516797|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516798|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516799|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
154516800|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516801|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516802|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
154516803|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516804|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516805|NCT04075136|Triamcinolone|triamcinolone|mesh-list
154516806|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154516807|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154516808|NCT04075136|Ranibizumab|ranibizumab|mesh-list
154516809|NCT04075136|Verteporfin|verteporfin|mesh-list
154516810|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154516811|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154516812|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154516813|NCT04075136|Growth Substances|growth substances|mesh-ancestor
154285923|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154285924|NCT03783312|Analgesics|analgesics|mesh-ancestor
154285925|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
154285926|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285927|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285928|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154285929|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154285930|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154285931|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285932|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285933|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
154285934|NCT03776916|Simethicone|simethicone|mesh-list
154285935|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
154032799|NCT04756804|Ethanol|ethanol|mesh-list
154285950|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154516814|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516815|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
154516816|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516817|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154516818|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
154516819|NCT04075136|Hormones|hormones|mesh-ancestor
154516820|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154516822|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
154516823|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516824|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516825|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154516826|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
154516827|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
154516828|NCT04042701|Trastuzumab|trastuzumab|mesh-list
154516829|NCT04042701|Camptothecin|camptothecin|mesh-list
154516830|NCT04042701|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154516831|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
154516832|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516833|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516834|NCT04042701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154285951|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
154285953|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
154285954|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154285955|NCT03776838|Fentanyl|fentanyl|mesh-list
154285956|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154285957|NCT03776838|Narcotics|narcotics|mesh-ancestor
154285958|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285959|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285960|NCT03776838|Analgesics|analgesics|mesh-ancestor
154285961|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
154285962|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285963|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154285964|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154285965|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
154285966|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
154285967|NCT03781050|Sirolimus|sirolimus|mesh-list
154285968|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154285969|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285970|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154285971|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901583|NCT05937282|Sensory System Agents|sensory system agents|mesh-ancestor
153450735|NCT05188326|Azacitidine|azacitidine|mesh-list
154285972|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
154516835|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516836|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
154516837|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516838|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154516839|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154516840|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154516841|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516842|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
154516843|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516844|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516845|NCT04032418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516846|NCT04032418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516847|NCT04002947|Rituximab|rituximab|mesh-list
154516848|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
154516849|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516850|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516851|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
154516852|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516853|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154285973|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154285974|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
154285975|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285976|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
154285977|NCT02865850|Hematinics|hematinics|mesh-ancestor
154285978|NCT01309698|Inositol|inositol|mesh-list
154285979|NCT01309698|Vildagliptin|vildagliptin|mesh-list
154285980|NCT01309698|Voglibose|voglibose|mesh-list
154285981|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154285982|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285983|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154285984|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
154285985|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285986|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285987|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154285988|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
154285989|NCT01309698|Vitamins|vitamins|mesh-ancestor
154285990|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
154285991|NCT01142284|Cilostazol|cilostazol|mesh-list
154285992|NCT01142284|Probucol|probucol|mesh-list
153813431|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
153813432|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
154516854|NCT04002947|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154516855|NCT04002947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516856|NCT04002947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516857|NCT04002947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516858|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154516859|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154516860|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516861|NCT03991832|Durvalumab|durvalumab|mesh-list
154516862|NCT03991832|Olaparib|olaparib|mesh-list
154516863|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516864|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516865|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154516866|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240719|NCT04428502|Analgesics|analgesics|mesh-ancestor
154516867|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516868|NCT03970954|Interleukin-2|interleukin-2|mesh-list
154516869|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516870|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154516871|NCT03970954|Analgesics|analgesics|mesh-ancestor
154516872|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
154516873|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516874|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516875|NCT03970447|Temozolomide|temozolomide|mesh-list
154516876|NCT03970447|Lomustine|lomustine|mesh-list
154516877|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
154516878|NCT03970447|GDC-0084|gdc-0084|mesh-list
154516879|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154516880|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
154516881|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516882|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516883|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516884|NCT03963375|Cladribine|cladribine|mesh-list
154516885|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516886|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516887|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
154516888|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516889|NCT03937713|Eszopiclone|eszopiclone|mesh-list
154516890|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154516891|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154516892|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516893|NCT03936777|Fenfluramine|fenfluramine|mesh-list
154516894|NCT03936777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154516895|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154516896|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154516897|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516898|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516899|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
154516900|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516901|NCT03933163|Resveratrol|resveratrol|mesh-list
154516902|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
154516903|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516904|NCT03933163|Protective Agents|protective agents|mesh-ancestor
154516905|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516906|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516907|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154516908|NCT03912428|Celecoxib|celecoxib|mesh-list
154516909|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154516910|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154516911|NCT03912428|Analgesics|analgesics|mesh-ancestor
154516912|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
154516913|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516914|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516915|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154516916|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516917|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154516918|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154516919|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286037|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286038|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
154286039|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286040|NCT05305560|Ivermectin|ivermectin|mesh-list
154286041|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154286042|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286043|NCT03776448|Charcoal|charcoal|mesh-list
154286044|NCT03776448|Antidotes|antidotes|mesh-ancestor
154286045|NCT03776448|Protective Agents|protective agents|mesh-ancestor
154286046|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286047|NCT03780270|Fluorides|fluorides|mesh-list
154286048|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
154286049|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
154286050|NCT03780270|Protective Agents|protective agents|mesh-ancestor
154286051|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286052|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
154286053|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154286054|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286055|NCT03072160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154286056|NCT03072160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286057|NCT05517486|Bupivacaine|bupivacaine|mesh-list
154286058|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
154286059|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
154286060|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154516920|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516921|NCT03910452|Sirolimus|sirolimus|mesh-list
154516922|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
154516923|NCT03910452|Busulfan|busulfan|mesh-list
154516924|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
154516925|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154516926|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
154516927|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516928|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516929|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154516930|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
154516931|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516932|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516933|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154516934|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154516935|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154516936|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154516937|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
154516938|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516939|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
154516940|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154516941|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
154516942|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154516943|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
154516944|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516945|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516946|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
154516947|NCT03885089|Infliximab|infliximab|mesh-list
154516948|NCT03885089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154286063|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286064|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
154286065|NCT01019356|Acarbose|acarbose|mesh-list
154286066|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154286067|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286068|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154286069|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286070|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286071|NCT01314066|Bevacizumab|bevacizumab|mesh-list
154286072|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154286073|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286074|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154286075|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154286076|NCT01314066|Growth Substances|growth substances|mesh-ancestor
154286091|NCT03776058|Cinacalcet|cinacalcet|mesh-list
154516949|NCT03885089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154516950|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
154516951|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154516952|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154516953|NCT03841617|Hormones|hormones|mesh-list
154516954|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154516955|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516956|NCT03836040|Erenumab|erenumab|mesh-list
154516957|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154516958|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154516959|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516960|NCT03836040|Analgesics|analgesics|mesh-ancestor
154516961|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
154516962|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516963|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516964|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
154516965|NCT03832998|Erenumab|erenumab|mesh-list
154516966|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154516967|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154516968|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286092|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154286093|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286094|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154286095|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
154286096|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286097|NCT05202496|Calcitriol|calcitriol|mesh-list
154286098|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154286099|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286100|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154286101|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286102|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286103|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154286104|NCT05202496|Vitamins|vitamins|mesh-ancestor
154286105|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
154286106|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154286107|NCT03779568|Bupivacaine|bupivacaine|mesh-list
154286108|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
154286109|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
154516969|NCT03832998|Analgesics|analgesics|mesh-ancestor
154516970|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
154516971|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154516972|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516973|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
154516974|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154516975|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154516976|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154516977|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154516978|NCT03755791|Sorafenib|sorafenib|mesh-list
154516979|NCT03755791|Atezolizumab|atezolizumab|mesh-list
154516980|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516981|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154516982|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516983|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154516984|NCT03755791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154516985|NCT03755791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154516986|NCT03748433|Insulin|insulin|mesh-list
154516987|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154516988|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154516989|NCT03737994|Cisplatin|cisplatin|mesh-list
154516990|NCT03737994|Carboplatin|carboplatin|mesh-list
154286110|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286111|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286112|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
154286113|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286114|NCT05201560|Fentanyl|fentanyl|mesh-list
154286115|NCT05201560|Butorphanol|butorphanol|mesh-list
154286116|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154286117|NCT05201560|Narcotics|narcotics|mesh-ancestor
154286118|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286119|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286120|NCT05201560|Analgesics|analgesics|mesh-ancestor
154286121|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
154286122|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286123|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154286124|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154286125|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
154286126|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
154286127|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
154286128|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
154286129|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154286130|NCT05201326|Bevacizumab|bevacizumab|mesh-list
154286131|NCT05201326|Irinotecan|irinotecan|mesh-list
153813433|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154516991|NCT03737994|Pemetrexed|pemetrexed|mesh-list
154516992|NCT03737994|Crizotinib|crizotinib|mesh-list
154516993|NCT03737994|Ceritinib|ceritinib|mesh-list
154516994|NCT03737994|Ensartinib|ensartinib|mesh-list
154516995|NCT03737994|Alectinib|alectinib|mesh-list
154516996|NCT03737994|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154516997|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154516998|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154516999|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517000|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154517001|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154517002|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517003|NCT03737370|Docetaxel|docetaxel|mesh-list
154517004|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517005|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517006|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517007|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517008|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517009|NCT03734653|Testosterone|testosterone|mesh-list
154517010|NCT03734653|Androgens|androgens|mesh-ancestor
154517011|NCT03734653|Hormones|hormones|mesh-ancestor
154517012|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517013|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517014|NCT03718559|Edoxaban|edoxaban|mesh-list
154517015|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154517016|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154517018|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154517019|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
154517020|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517021|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517022|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
154517023|NCT03706365|Prednisone|prednisone|mesh-list
154517024|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
154286132|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154286133|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286134|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154286135|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154286136|NCT05201326|Growth Substances|growth substances|mesh-ancestor
154286137|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286138|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
154286139|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154286140|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154286141|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517025|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517026|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
154517027|NCT03706365|Hormones|hormones|mesh-ancestor
154517028|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517029|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517030|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517031|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517032|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154517033|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517034|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517035|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
154517036|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154517037|NCT03701282|Venetoclax|venetoclax|mesh-list
154517038|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
154517039|NCT03701282|Ibrutinib|ibrutinib|mesh-list
154517040|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517041|NCT03701282|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154517042|NCT03701282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517043|NCT03701282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517044|NCT03701282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286163|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
154286164|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286165|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154286166|NCT03775590|Protective Agents|protective agents|mesh-ancestor
154286167|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286168|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
154286169|NCT03775746|Clopidogrel|clopidogrel|mesh-list
154286170|NCT03775746|Ticagrelor|ticagrelor|mesh-list
154033027|NCT03971071|Erenumab|erenumab|mesh-list
154286171|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154286172|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154286173|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154286174|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154286175|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
154286176|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286177|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286178|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286179|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154286181|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154286182|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
154286183|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813434|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517045|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517046|NCT03660826|Durvalumab|durvalumab|mesh-list
154517047|NCT03660826|Olaparib|olaparib|mesh-list
154517048|NCT03660826|Cediranib|cediranib|mesh-list
154517049|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154517050|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
154517051|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517052|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
154517053|NCT03660826|Maleic acid|maleic acid|mesh-list
154517054|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517055|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517056|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
154517057|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517058|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517059|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517060|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517061|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
154517062|NCT03644706|Diuretics|diuretics|mesh-ancestor
154517063|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
154517064|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517065|NCT03644706|Expectorants|expectorants|mesh-ancestor
154517066|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
154517067|NCT03641313|Irinotecan|irinotecan|mesh-list
154517068|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154517069|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154286184|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
154286185|NCT03779178|Landiolol|landiolol|mesh-list
154286186|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154286187|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154286188|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
154286189|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286190|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286191|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286192|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154286193|NCT03779100|Lenvatinib|lenvatinib|mesh-list
154286194|NCT03779100|Antibodies|antibodies|mesh-list
154286195|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
154286196|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
154286197|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286198|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286199|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154286200|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286201|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286202|NCT05711212|Xanthohumol|xanthohumol|mesh-list
154286203|NCT05711212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286204|NCT05711212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154286205|NCT05711212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154286206|NCT05711212|Growth Substances|growth substances|mesh-ancestor
154286207|NCT05711212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517070|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517071|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517072|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517073|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
154517074|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517075|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517076|NCT03632941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517077|NCT03632941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517078|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
154517079|NCT03590054|Abexinostat|abexinostat|mesh-list
154517080|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517081|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517082|NCT03590054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517083|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517084|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154517085|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517086|NCT03578367|Niacinamide|niacinamide|mesh-list
154517087|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
154517088|NCT03578367|Nilotinib|nilotinib|mesh-list
154517089|NCT03578367|Asciminib|asciminib|mesh-list
154517090|NCT03578367|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154517091|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517092|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517093|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517094|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517095|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
154517096|NCT03578367|Vitamins|vitamins|mesh-ancestor
154286208|NCT05711212|Growth Inhibitors|growth inhibitors|mesh-ancestor
154286209|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
154286210|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154286211|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
154286212|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154286213|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154286214|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286215|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
154286216|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
154286217|NCT03775356|Anesthetics|anesthetics|mesh-list
154286218|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286219|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286220|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
154286221|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
154286222|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154286223|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154286224|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154517097|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
154517098|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517099|NCT03573349|Ketamine|ketamine|mesh-list
154517100|NCT03573349|Analgesics|analgesics|mesh-ancestor
154517101|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
154517102|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517103|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517104|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154517105|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154517106|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
154517107|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
154517108|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154517109|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154517110|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154517111|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154517112|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517113|NCT03570892|Tisagenlecleucel|tisagenlecleucel|mesh-list
154517114|NCT03570892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517115|NCT03570892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517116|NCT03521830|Nivolumab|nivolumab|mesh-list
154517117|NCT03521830|Ipilimumab|ipilimumab|mesh-list
154517118|NCT03521830|Relatlimab|relatlimab|mesh-list
154517119|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517120|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517121|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517122|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517123|NCT03508570|Nivolumab|nivolumab|mesh-list
154517124|NCT03508570|Ipilimumab|ipilimumab|mesh-list
154517125|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517126|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517127|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517128|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517129|NCT03436654|Prednisone|prednisone|mesh-list
154517130|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
154517131|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517132|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
154517133|NCT03436654|Hormones|hormones|mesh-ancestor
154286238|NCT03778008|Lidocaine|lidocaine|mesh-list
154517134|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517135|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517136|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517137|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517138|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154517139|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517140|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517141|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
154517142|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154517143|NCT03423199|Tamoxifen|tamoxifen|mesh-list
154517144|NCT03423199|Goserelin|goserelin|mesh-list
154517145|NCT03423199|Palbociclib|palbociclib|mesh-list
154517146|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154517147|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
154517148|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517149|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517150|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517151|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517152|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154517153|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154517154|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154517155|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517156|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517157|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517158|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
154517159|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154517160|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154517161|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517162|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154241023|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
154517163|NCT03417999|Analgesics|analgesics|mesh-ancestor
154517164|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
154517165|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517166|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154517167|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154517168|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154517169|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
154517170|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154517171|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517172|NCT03370276|Nivolumab|nivolumab|mesh-list
154517173|NCT03370276|Cetuximab|cetuximab|mesh-list
154517174|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517175|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517176|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517177|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517178|NCT03295734|Losartan|losartan|mesh-list
154517179|NCT03295734|Perindopril|perindopril|mesh-list
154517180|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154517181|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154517182|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154517183|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154517184|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517185|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154517186|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
154517187|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517188|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
154517189|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517190|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517191|NCT03295227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517192|NCT03295227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517193|NCT03284385|Adavosertib|adavosertib|mesh-list
154517194|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517195|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517196|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154517197|NCT03258554|Cetuximab|cetuximab|mesh-list
154517198|NCT03258554|Durvalumab|durvalumab|mesh-list
154517199|NCT03258554|Antibodies|antibodies|mesh-list
154517200|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
154517201|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517202|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
154517203|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
154517204|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517205|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517206|NCT03233711|Nivolumab|nivolumab|mesh-list
154517207|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517208|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517209|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517210|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517211|NCT03215095|Durvalumab|durvalumab|mesh-list
154517212|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517213|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517214|NCT03206047|Poly I-C|poly i-c|mesh-list
154286360|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154517215|NCT03206047|Atezolizumab|atezolizumab|mesh-list
154517216|NCT03206047|Guadecitabine|guadecitabine|mesh-list
154517217|NCT03206047|Azacitidine|azacitidine|mesh-list
154517218|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154517219|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517220|NCT03206047|Poly ICLC|poly iclc|mesh-list
154517221|NCT03206047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517222|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517223|NCT03206047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517224|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517225|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
154517226|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517227|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
154517228|NCT03206047|Laxatives|laxatives|mesh-ancestor
154517229|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154517230|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
154517231|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517232|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154517233|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
154517234|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517235|NCT03199885|Paclitaxel|paclitaxel|mesh-list
154517236|NCT03199885|Docetaxel|docetaxel|mesh-list
154241095|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154517237|NCT03199885|Trastuzumab|trastuzumab|mesh-list
154517238|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154517240|NCT03199885|Pertuzumab|pertuzumab|mesh-list
154517241|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154517242|NCT03199885|Antibodies|antibodies|mesh-list
154517243|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
154517244|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517245|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517246|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517247|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517248|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517249|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517250|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517251|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
154286361|NCT02575144|Growth Substances|growth substances|mesh-ancestor
154286362|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
154286363|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286395|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517252|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517253|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517254|NCT03199885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517255|NCT03194893|Crizotinib|crizotinib|mesh-list
154517256|NCT03194893|Alectinib|alectinib|mesh-list
154517257|NCT03194893|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154517258|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517259|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517260|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517261|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517262|NCT03155620|Olaparib|olaparib|mesh-list
154517263|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154517264|NCT03155620|Palbociclib|palbociclib|mesh-list
154517265|NCT03155620|Vemurafenib|vemurafenib|mesh-list
154517266|NCT03155620|Tipifarnib|tipifarnib|mesh-list
154517267|NCT03155620|Ensartinib|ensartinib|mesh-list
154517268|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517269|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517270|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517271|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517272|NCT03092817|Dexamethasone|dexamethasone|mesh-list
154517273|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517274|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
154517275|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
154517276|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517277|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517278|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154517279|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
154517280|NCT03092817|Hormones|hormones|mesh-ancestor
154517281|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517282|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517283|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517284|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
154517285|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517286|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517287|NCT03043599|Nivolumab|nivolumab|mesh-list
154517288|NCT03043599|Ipilimumab|ipilimumab|mesh-list
154286396|NCT03771846|Leucovorin|leucovorin|mesh-list
154286398|NCT03771846|Fluorouracil|fluorouracil|mesh-list
154517289|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517290|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517291|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517292|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517293|NCT03017131|Aldesleukin|aldesleukin|mesh-list
154517294|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
154517295|NCT03017131|Decitabine|decitabine|mesh-list
154517296|NCT03017131|Interleukin-2|interleukin-2|mesh-list
154517297|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517298|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
154517299|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517300|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517301|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154517302|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
154517303|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517304|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517305|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154517306|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154517307|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
154517308|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517309|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154517310|NCT03017131|Analgesics|analgesics|mesh-ancestor
154517311|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
154517312|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517313|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154517314|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154517315|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
154517316|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517317|NCT03013218|Paclitaxel|paclitaxel|mesh-list
154517318|NCT03013218|Rituximab|rituximab|mesh-list
154517319|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
154517320|NCT03013218|Trastuzumab|trastuzumab|mesh-list
154517321|NCT03013218|Ramucirumab|ramucirumab|mesh-list
154517322|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517323|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517324|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517325|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517326|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517327|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517328|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517329|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
154517330|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517331|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517332|NCT03013218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517333|NCT03013218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154517334|NCT03013218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154517335|NCT03013218|Growth Substances|growth substances|mesh-ancestor
154517336|NCT03013218|Growth Inhibitors|growth inhibitors|mesh-ancestor
154517337|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154517338|NCT03008278|Olaparib|olaparib|mesh-list
154517339|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154517340|NCT03008278|Ramucirumab|ramucirumab|mesh-list
154517341|NCT03008278|Antibodies|antibodies|mesh-list
154517342|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
154517343|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517344|NCT03008278|Lexatumumab|lexatumumab|mesh-list
154517345|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
154517346|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517347|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517348|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517349|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517350|NCT03008278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154517351|NCT03008278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154517352|NCT03008278|Growth Substances|growth substances|mesh-ancestor
154517353|NCT03008278|Growth Inhibitors|growth inhibitors|mesh-ancestor
154517354|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
154517355|NCT03007147|Leucovorin|leucovorin|mesh-list
154517356|NCT03007147|Folic Acid|folic acid|mesh-list
154517357|NCT03007147|Cytarabine|cytarabine|mesh-list
154517358|NCT03007147|Dexamethasone|dexamethasone|mesh-list
154517359|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
154517360|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
154517361|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154517362|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154517363|NCT03007147|Prednisolone|prednisolone|mesh-list
154517364|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
154517365|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
154517366|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154517367|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154517368|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154517369|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
154517370|NCT03007147|Ifosfamide|ifosfamide|mesh-list
154517371|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
154517372|NCT03007147|Doxorubicin|doxorubicin|mesh-list
154517373|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154517374|NCT03007147|Methotrexate|methotrexate|mesh-list
154517375|NCT03007147|Etoposide|etoposide|mesh-list
154517376|NCT03007147|Vincristine|vincristine|mesh-list
154286480|NCT02083354|Trametinib|trametinib|mesh-list
154517377|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
154517378|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
154517379|NCT03007147|Daunorubicin|daunorubicin|mesh-list
154517380|NCT03007147|Asparaginase|asparaginase|mesh-list
154517381|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
154517382|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
154517383|NCT03007147|Pegaspargase|pegaspargase|mesh-list
154517384|NCT03007147|Thioguanine|thioguanine|mesh-list
154517385|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
154517386|NCT03007147|Razoxane|razoxane|mesh-list
154517387|NCT03007147|Azathioprine|azathioprine|mesh-list
154517388|NCT03007147|Lenograstim|lenograstim|mesh-list
154517389|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154241247|NCT00092534|Vaccines|vaccines|mesh-list
154517390|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
154517391|NCT03007147|BB 1101|bb 1101|mesh-list
154517392|NCT03007147|Calcium|calcium|mesh-list
154517393|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
154517394|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
154517395|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517396|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
154517397|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517398|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517399|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154517400|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
154517401|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517402|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517403|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154517404|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517405|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
154517406|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
154517407|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517408|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154517409|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
154517410|NCT03007147|Hormones|hormones|mesh-ancestor
154517411|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517412|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517413|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
154517414|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517415|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154517416|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154517417|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154286516|NCT03767322|Protective Agents|protective agents|mesh-ancestor
154517418|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154517419|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154517420|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154517421|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
154517422|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154517423|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154517424|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
154517425|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
154517426|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154517427|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154517428|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517429|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
154517430|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517431|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154517433|NCT03007147|Protective Agents|protective agents|mesh-ancestor
154517434|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
154517435|NCT03007147|Vitamins|vitamins|mesh-ancestor
154517436|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
154517437|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517438|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517439|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517440|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154517441|NCT03007147|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154517442|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517443|NCT03007147|Hematinics|hematinics|mesh-ancestor
154517444|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
154517445|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154517446|NCT02971501|Bevacizumab|bevacizumab|mesh-list
154517447|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154517448|NCT02971501|Osimertinib|osimertinib|mesh-list
154517449|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
154517450|NCT02971501|Antibodies|antibodies|mesh-list
154517451|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
154517452|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517453|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
154517454|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517455|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154517456|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154517457|NCT02971501|Growth Substances|growth substances|mesh-ancestor
154517458|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286563|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
154517459|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
154517460|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
154517461|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517462|NCT02971501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154517463|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517464|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517465|NCT02909686|Curcumin|curcumin|mesh-list
154517466|NCT02909686|Resveratrol|resveratrol|mesh-list
154517467|NCT02909686|Pycnogenols|pycnogenols|mesh-list
154517468|NCT02909686|Turmeric extract|turmeric extract|mesh-list
154517469|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154517470|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154517471|NCT02909686|Analgesics|analgesics|mesh-ancestor
154517472|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
154517473|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517474|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517475|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517476|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517477|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517478|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517479|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517481|NCT02909686|Protective Agents|protective agents|mesh-ancestor
154517482|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154517483|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154517484|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
154517485|NCT02908672|Atezolizumab|atezolizumab|mesh-list
154517486|NCT02908672|Vemurafenib|vemurafenib|mesh-list
154517487|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517488|NCT02908672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517489|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517490|NCT02908672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517491|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517492|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
154517493|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517494|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517495|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517496|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
154517497|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517498|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517499|NCT02882282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517500|NCT02882282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517501|NCT02784210|Prednisone|prednisone|mesh-list
154517502|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
154517503|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154517504|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154517505|NCT02784210|Prednisolone|prednisolone|mesh-list
154517506|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
154517507|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154517508|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
154517509|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517510|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
154517511|NCT02784210|Hormones|hormones|mesh-ancestor
154517512|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517513|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517514|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517515|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517516|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
154517517|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
154517518|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517519|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154517520|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154517521|NCT02784210|Protective Agents|protective agents|mesh-ancestor
154517522|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154517523|NCT02758717|Nivolumab|nivolumab|mesh-list
154517524|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154517525|NCT02758717|Antibodies|antibodies|mesh-list
154517526|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
154517527|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517528|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
154517529|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
154517530|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517531|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517532|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517533|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517534|NCT02758717|Immunotoxins|immunotoxins|mesh-ancestor
154517535|NCT02735239|Leucovorin|leucovorin|mesh-list
154517536|NCT02735239|Docetaxel|docetaxel|mesh-list
154517537|NCT02735239|Carboplatin|carboplatin|mesh-list
154517538|NCT02735239|Capecitabine|capecitabine|mesh-list
154517539|NCT02735239|Fluorouracil|fluorouracil|mesh-list
154517540|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
154517541|NCT02735239|Durvalumab|durvalumab|mesh-list
154517542|NCT02735239|Tremelimumab|tremelimumab|mesh-list
154517543|NCT02735239|Levoleucovorin|levoleucovorin|mesh-list
154517544|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517545|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241394|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517546|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517547|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517548|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517549|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517550|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154517551|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
154517552|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517553|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
154517554|NCT02735239|Antidotes|antidotes|mesh-ancestor
154517555|NCT02735239|Protective Agents|protective agents|mesh-ancestor
154517556|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
154517557|NCT02735239|Vitamins|vitamins|mesh-ancestor
154517558|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
154517559|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517560|NCT02595944|Nivolumab|nivolumab|mesh-list
154517561|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517562|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517563|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517564|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517565|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154517566|NCT02511028|Hematinics|hematinics|mesh-ancestor
154517567|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154517568|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154517569|NCT02455687|Budesonide|budesonide|mesh-list
154517570|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
154517571|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517572|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154517573|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
154517574|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517575|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517576|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154517577|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
154517578|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
154517579|NCT02455687|Hormones|hormones|mesh-ancestor
154517580|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517581|NCT02455687|Analgesics|analgesics|mesh-ancestor
154517582|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
154517583|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
154517584|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154517585|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154517586|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
154517587|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154517588|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154517589|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517590|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154517591|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
154517592|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154517593|NCT02421939|Cytarabine|cytarabine|mesh-list
154517594|NCT02421939|Fludarabine|fludarabine|mesh-list
154517595|NCT02421939|Etoposide|etoposide|mesh-list
154517596|NCT02421939|Azacitidine|azacitidine|mesh-list
154517597|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
154517598|NCT02421939|Idarubicin|idarubicin|mesh-list
154517599|NCT02421939|Lenograstim|lenograstim|mesh-list
154517600|NCT02421939|Gilteritinib|gilteritinib|mesh-list
154517601|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517602|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154517603|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
154286692|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154517604|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517605|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517606|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
154517607|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517608|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517609|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154517610|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154517611|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517612|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
154517613|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517614|NCT02421939|Analgesics|analgesics|mesh-ancestor
154517615|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
154517616|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517617|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154517618|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154517619|NCT02421939|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154517620|NCT02421939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517621|NCT02343042|Clarithromycin|clarithromycin|mesh-list
154517622|NCT02343042|Dexamethasone|dexamethasone|mesh-list
154517623|NCT02343042|Lenalidomide|lenalidomide|mesh-list
154517624|NCT02343042|Bortezomib|bortezomib|mesh-list
154517625|NCT02343042|Daratumumab|daratumumab|mesh-list
154517626|NCT02343042|Pomalidomide|pomalidomide|mesh-list
154517627|NCT02343042|Ixazomib|ixazomib|mesh-list
154517628|NCT02343042|Elotuzumab|elotuzumab|mesh-list
154517629|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517630|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
154517631|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
154517632|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517633|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517634|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154517635|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
154517636|NCT02343042|Hormones|hormones|mesh-ancestor
154517637|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517638|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517639|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517640|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
154517641|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154517642|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154517643|NCT02343042|Growth Substances|growth substances|mesh-ancestor
154517644|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
154517645|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154517646|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517647|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154517648|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517649|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517650|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154517651|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154517652|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
154517653|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
154517654|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517655|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517656|NCT02337686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154517657|NCT02337686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517658|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
154517659|NCT02306161|Ifosfamide|ifosfamide|mesh-list
154517660|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
154517661|NCT02306161|Doxorubicin|doxorubicin|mesh-list
154517662|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154517663|NCT02306161|Etoposide|etoposide|mesh-list
154517664|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
154517665|NCT02306161|Vincristine|vincristine|mesh-list
154517666|NCT02306161|Daunorubicin|daunorubicin|mesh-list
154517667|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
154517668|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517669|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517670|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
154517671|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517672|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517673|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154517674|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
154517675|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517676|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517677|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154517678|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154517679|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154517680|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154517681|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517682|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517683|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517684|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517685|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517686|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
154517687|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
154517688|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154517689|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517690|NCT02135874|Cytarabine|cytarabine|mesh-list
154286784|NCT04678492|Amoxicillin|amoxicillin|mesh-list
154286826|NCT05091528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517691|NCT02135874|Dexamethasone|dexamethasone|mesh-list
154517692|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
154517693|NCT02135874|Rituximab|rituximab|mesh-list
154517694|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154517695|NCT02135874|Vincristine|vincristine|mesh-list
154517696|NCT02135874|Sorafenib|sorafenib|mesh-list
154517697|NCT02135874|Idarubicin|idarubicin|mesh-list
154517698|NCT02135874|Clofarabine|clofarabine|mesh-list
154517699|NCT02135874|Antibodies|antibodies|mesh-list
154517700|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
154517701|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517702|NCT02135874|BB 1101|bb 1101|mesh-list
154517703|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
154517704|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517705|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517706|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517707|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517708|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
154517709|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
154517710|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517711|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154517712|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
154517713|NCT02135874|Hormones|hormones|mesh-ancestor
154517714|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517715|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517716|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
154517717|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517718|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517719|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154517720|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
154517721|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
154517722|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517723|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517724|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517725|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517726|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517727|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517728|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154286827|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154517729|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154517730|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154517731|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154517732|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
154517733|NCT02112916|Leucovorin|leucovorin|mesh-list
154517734|NCT02112916|Folic Acid|folic acid|mesh-list
154517735|NCT02112916|Cytarabine|cytarabine|mesh-list
154517736|NCT02112916|Dexamethasone|dexamethasone|mesh-list
154517737|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
154517738|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
154517739|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154517740|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154517741|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154517742|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
154517743|NCT02112916|Ifosfamide|ifosfamide|mesh-list
154517744|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
154517745|NCT02112916|Doxorubicin|doxorubicin|mesh-list
154517746|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154517747|NCT02112916|Methotrexate|methotrexate|mesh-list
154517748|NCT02112916|Etoposide|etoposide|mesh-list
154517749|NCT02112916|Vincristine|vincristine|mesh-list
154517750|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
154517751|NCT02112916|Bortezomib|bortezomib|mesh-list
154517752|NCT02112916|Daunorubicin|daunorubicin|mesh-list
154517753|NCT02112916|Asparaginase|asparaginase|mesh-list
154517754|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
154517755|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
154517756|NCT02112916|Pegaspargase|pegaspargase|mesh-list
154517757|NCT02112916|Thioguanine|thioguanine|mesh-list
154517758|NCT02112916|BB 1101|bb 1101|mesh-list
154517759|NCT02112916|Calcium|calcium|mesh-list
154517760|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
154517761|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
154517762|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517763|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
154517764|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517765|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517766|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154517767|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
154517768|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517769|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517770|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154517771|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517772|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
154517773|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
154517774|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517775|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154517776|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
154517777|NCT02112916|Hormones|hormones|mesh-ancestor
154517778|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241618|NCT01811368|Cyclosporine|cyclosporine|mesh-list
154517779|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517780|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
154517781|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517782|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154517783|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154517784|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154517785|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154517786|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154517787|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154517788|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
154517789|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154517790|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154517791|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
154517792|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
154517793|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154517794|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154517795|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517796|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
154517797|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517798|NCT02112916|Antidotes|antidotes|mesh-ancestor
154517799|NCT02112916|Protective Agents|protective agents|mesh-ancestor
154517800|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
154517801|NCT02112916|Vitamins|vitamins|mesh-ancestor
154517802|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
154517803|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517804|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517805|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517806|NCT02112916|Hematinics|hematinics|mesh-ancestor
154517807|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
154517808|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
154517809|NCT02101853|Leucovorin|leucovorin|mesh-list
154517810|NCT02101853|Folic Acid|folic acid|mesh-list
154517811|NCT02101853|Cytarabine|cytarabine|mesh-list
154517813|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
154517814|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
154517815|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154517816|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154517817|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154517818|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
154517819|NCT02101853|Methotrexate|methotrexate|mesh-list
154517820|NCT02101853|Etoposide|etoposide|mesh-list
154517821|NCT02101853|Vincristine|vincristine|mesh-list
154517822|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
154517823|NCT02101853|Asparaginase|asparaginase|mesh-list
154517824|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
154517825|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
154517826|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
154517827|NCT02101853|Pegaspargase|pegaspargase|mesh-list
154517828|NCT02101853|Thioguanine|thioguanine|mesh-list
154517829|NCT02101853|Blinatumomab|blinatumomab|mesh-list
154517830|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154517831|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
154517832|NCT02101853|Antibodies|antibodies|mesh-list
154517833|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
154517834|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154517835|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154517836|NCT02101853|BB 1101|bb 1101|mesh-list
154517837|NCT02101853|Calcium|calcium|mesh-list
154517838|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
154517839|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
154517840|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517841|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
154517842|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517843|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517844|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154517845|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
154517846|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517847|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517848|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154517849|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517850|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
154517851|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
154517852|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517853|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154517854|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
154517855|NCT02101853|Hormones|hormones|mesh-ancestor
154517856|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517857|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154517858|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
154517859|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517860|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154517861|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154517862|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154517863|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
154517864|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154517865|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154517866|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
154517867|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
154517868|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154517869|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154517870|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517871|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154517872|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154517873|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
154517874|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517875|NCT02101853|Antidotes|antidotes|mesh-ancestor
154517876|NCT02101853|Protective Agents|protective agents|mesh-ancestor
154517877|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
154517878|NCT02101853|Vitamins|vitamins|mesh-ancestor
154517879|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
154517880|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517881|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517882|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517883|NCT02101853|Hematinics|hematinics|mesh-ancestor
154517884|NCT02101853|Analgesics|analgesics|mesh-ancestor
154517885|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
154517886|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
154517887|NCT02062463|Budesonide|budesonide|mesh-list
154517888|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
154517889|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154517890|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154517891|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154517893|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517894|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517895|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154517896|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
154517897|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
154517898|NCT02062463|Hormones|hormones|mesh-ancestor
154517899|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154517900|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154517901|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154517902|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154517903|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
154517904|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154517905|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517906|NCT01950520|Topiramate|topiramate|mesh-list
154517907|NCT01950520|Phentermine|phentermine|mesh-list
154517908|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
154517909|NCT01950520|Propranolol|propranolol|mesh-list
154517910|NCT01950520|Pindolol|pindolol|mesh-list
154517911|NCT01950520|Naltrexone|naltrexone|mesh-list
154517912|NCT01950520|Caffeine|caffeine|mesh-list
154517913|NCT01950520|Dantrolene|dantrolene|mesh-list
154517914|NCT01950520|Mirabegron|mirabegron|mesh-list
154517915|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154517916|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154517917|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517918|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
154517919|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517920|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154517921|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154517922|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517923|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287006|NCT04387136|Analgesics|analgesics|mesh-ancestor
154517924|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154517925|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154517926|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
154517927|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154517928|NCT01950520|Analgesics|analgesics|mesh-ancestor
154517929|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
154517930|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154517931|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154517932|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
154517933|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154517934|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154517935|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154517936|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
154517937|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154517938|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154517939|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154517940|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
154517941|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154517942|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
154517943|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154517944|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154517945|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154517946|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154517947|NCT01950520|Urological Agents|urological agents|mesh-ancestor
154517948|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
154517949|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154517950|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
154517951|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
154517952|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154517953|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
154517954|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154517955|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154517956|NCT01924533|Paclitaxel|paclitaxel|mesh-list
154517957|NCT01924533|Olaparib|olaparib|mesh-list
154517958|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154517959|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517960|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
154517961|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
154517962|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
154517963|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517964|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154517965|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154517966|NCT01883297|Aldesleukin|aldesleukin|mesh-list
154517968|NCT01883297|Interleukin-2|interleukin-2|mesh-list
154517969|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154517970|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
154517971|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517972|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517973|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154517974|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
154517975|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154517976|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517977|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154517978|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154517979|NCT01883297|Analgesics|analgesics|mesh-ancestor
154517980|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
154517981|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517982|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154517983|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154517984|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
154517985|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154517986|NCT01842386|Rituximab|rituximab|mesh-list
154517987|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154517988|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154517989|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
154517990|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517991|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154517992|NCT01799538|Albuterol|albuterol|mesh-list
154517993|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154517994|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
154517995|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154517996|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154517997|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154517998|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
154517999|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
154518000|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154518001|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154518002|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154518003|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154518004|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
154518005|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518006|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518007|NCT01719692|Rituximab|rituximab|mesh-list
154518008|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518009|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287092|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
154518010|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
154518011|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518012|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518013|NCT01517100|Dronabinol|dronabinol|mesh-list
154518014|NCT01517100|Nabilone|nabilone|mesh-list
154518015|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
154518016|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
154518017|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518018|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518019|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154518020|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154518021|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154518022|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518023|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154518024|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
154518025|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518027|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
154518028|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154518029|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154518030|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518031|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518032|NCT01517100|Hormones|hormones|mesh-ancestor
154518033|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154518034|NCT01419561|Zidovudine|zidovudine|mesh-list
154518035|NCT01419561|Rituximab|rituximab|mesh-list
154518036|NCT01419561|Doxorubicin|doxorubicin|mesh-list
154518037|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154518038|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518039|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518040|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
154518041|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518042|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518043|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154518044|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154518045|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154518046|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518047|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518048|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
154518049|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154518050|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154518051|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
154518052|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518053|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154518054|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154518055|NCT01319565|Aldesleukin|aldesleukin|mesh-list
154518056|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
154518057|NCT01319565|Fludarabine|fludarabine|mesh-list
154518058|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518059|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
154518060|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518061|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518062|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154518063|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
154518064|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518065|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518066|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154518067|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154518068|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154518069|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
154518070|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518071|NCT00977977|Cyclosporine|cyclosporine|mesh-list
154518072|NCT00977977|Rituximab|rituximab|mesh-list
154518073|NCT00977977|Cyclosporins|cyclosporins|mesh-list
154518074|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518075|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518076|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
154518077|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518078|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518079|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518080|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518081|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518082|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
154518083|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518084|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
154518085|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154518086|NCT00923013|Rituximab|rituximab|mesh-list
154518087|NCT00923013|Cladribine|cladribine|mesh-list
154518088|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518089|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518090|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
154518091|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518092|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518093|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518094|NCT00382070|Letrozole|letrozole|mesh-list
154518095|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518096|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154518097|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154518098|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518099|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518100|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154518101|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
154518102|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154518103|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518104|NCT00350103|Lacosamide|lacosamide|mesh-list
154518105|NCT00350103|Anticonvulsants|anticonvulsants|mesh-ancestor
154518106|NCT00350103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154518107|NCT00350103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154518108|NCT00350103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154518109|NCT00350103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518110|NCT00065676|Quercetin|quercetin|mesh-list
154518111|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
154518112|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518113|NCT00065676|Protective Agents|protective agents|mesh-ancestor
154518114|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518115|NCT03465969|Tacrolimus|tacrolimus|mesh-list
154518116|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518117|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
154518118|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518119|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154518120|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518121|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518122|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154518123|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154518124|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
154518125|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154518126|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
154518127|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154518128|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518129|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154518130|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154518131|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518132|NCT03130101|Insulin|insulin|mesh-list
154518133|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154518134|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518135|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
154518136|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
154518137|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154518138|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
154518139|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518140|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518141|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518142|NCT02735577|Disulfiram|disulfiram|mesh-list
154518143|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154518144|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154518145|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518146|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518147|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154518148|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154518149|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
154518150|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154518151|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154518152|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518153|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
154518154|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
154518155|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154518156|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
154518157|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518158|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518159|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154518160|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
154518161|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
154518162|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154518163|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
154518164|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518165|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518167|NCT05396937|Atezolizumab|atezolizumab|mesh-list
154518168|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518169|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518170|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154518171|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154518172|NCT05396937|Growth Substances|growth substances|mesh-ancestor
154518173|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518174|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
154518175|NCT05396937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154518176|NCT05396937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518177|NCT03642145|Deflazacort|deflazacort|mesh-list
154518178|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154518179|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518180|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
154518181|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518182|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
154518183|NCT01064791|Tacrolimus|tacrolimus|mesh-list
154518184|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518185|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
154518186|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518187|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154518188|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518189|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518190|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154518191|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518192|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154518193|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
154518194|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154518195|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518197|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
154518198|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518199|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518200|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154518201|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154518202|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
154518203|NCT05161351|Vitamin D|vitamin d|mesh-list
154518204|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
154518205|NCT05161351|Baclofen|baclofen|mesh-list
154518206|NCT05161351|Vitamins|vitamins|mesh-ancestor
154518207|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
154518208|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518209|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154518210|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154518211|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154518212|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154518213|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518214|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154518215|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
154518216|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
154518217|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518218|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518219|NCT03465345|Metformin|metformin|mesh-list
154518220|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
154518221|NCT03465345|Procyanidin|procyanidin|mesh-list
154518222|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154518223|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518224|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
154518225|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518226|NCT03465345|Protective Agents|protective agents|mesh-ancestor
154518227|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154518228|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154518229|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518230|NCT02983799|Olaparib|olaparib|mesh-list
154518231|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154518232|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518233|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518234|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518235|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
154518236|NCT05385705|Trastuzumab|trastuzumab|mesh-list
154518237|NCT05385705|Interleukin-2|interleukin-2|mesh-list
154518238|NCT05385705|Pertuzumab|pertuzumab|mesh-list
154518239|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518240|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
154518241|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287296|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154518243|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154518244|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
154518245|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518246|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518247|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154518248|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518249|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518250|NCT05385705|Analgesics|analgesics|mesh-ancestor
154518251|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
154518252|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518253|NCT02186847|Metformin|metformin|mesh-list
154518254|NCT02186847|Paclitaxel|paclitaxel|mesh-list
154518255|NCT02186847|Carboplatin|carboplatin|mesh-list
154518256|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154518257|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518258|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
154518259|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
154518260|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
154518261|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518262|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154518263|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518264|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
154518265|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154518266|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518267|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518268|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518269|NCT05274789|Analgesics|analgesics|mesh-ancestor
154518270|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
154518271|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518272|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154518273|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154518274|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154518275|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154518276|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518277|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518278|NCT02353247|Norethindrone|norethindrone|mesh-list
154518279|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
154518280|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154518281|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154518282|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154518283|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
154518284|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154518285|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518286|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154518287|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154518288|NCT04343651|Leronlimab|leronlimab|mesh-list
154518289|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154518290|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154518291|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518292|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154518293|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154518294|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
154518295|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518296|NCT05226897|Metformin|metformin|mesh-list
154518297|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
154518298|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154518299|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518300|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154518301|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518302|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
154518303|NCT04453761|Vitamins|vitamins|mesh-ancestor
154518304|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
154518305|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518306|NCT03463317|Aspirin|aspirin|mesh-list
154518307|NCT03463317|Warfarin|warfarin|mesh-list
154518308|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
154518309|NCT03463317|Dabigatran|dabigatran|mesh-list
154518310|NCT03463317|Apixaban|apixaban|mesh-list
154518311|NCT03463317|Edoxaban|edoxaban|mesh-list
154518312|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
154518313|NCT03463317|Clopidogrel|clopidogrel|mesh-list
154518314|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154518315|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154518316|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154518317|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154518318|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
154518319|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518320|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518321|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518322|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
154518323|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154518324|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
154518325|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154518326|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
154518327|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518328|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154518329|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518331|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
154518332|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518333|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154518334|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518335|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154518336|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154518337|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154518338|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
154518339|NCT02906579|Praliciguat|praliciguat|mesh-list
154518340|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154518341|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
154518342|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518343|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154518344|NCT04975347|Naloxone|naloxone|mesh-list
154518345|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518346|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154518347|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
154518348|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518349|NCT03463083|Fentanyl|fentanyl|mesh-list
154518350|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
154518351|NCT03463083|Bupivacaine|bupivacaine|mesh-list
154518352|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
154518353|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
154518354|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518355|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518356|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
154518357|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518358|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154518359|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518360|NCT03463083|Analgesics|analgesics|mesh-ancestor
154518361|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154518362|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154518363|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154518364|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154518365|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518366|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518367|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154518368|NCT03463083|Narcotics|narcotics|mesh-ancestor
154518369|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154518370|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154518371|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
154518372|NCT04971837|Cannabidiol|cannabidiol|mesh-list
154518373|NCT04971837|Sorbitol|sorbitol|mesh-list
154518374|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
154518375|NCT04971837|Cathartics|cathartics|mesh-ancestor
154518376|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154518377|NCT01328535|Temozolomide|temozolomide|mesh-list
154518378|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154518379|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
154518380|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518381|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518382|NCT03463005|Propolis|propolis|mesh-list
154518383|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518384|NCT02522169|Infliximab|infliximab|mesh-list
154518385|NCT02522169|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154518386|NCT02522169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154518387|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
154287449|NCT04156646|Balovaptan|balovaptan|mesh-list
154518388|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154518389|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518390|NCT03656393|Carboplatin|carboplatin|mesh-list
154518391|NCT03656393|Vinorelbine|vinorelbine|mesh-list
154518392|NCT03656393|Gefitinib|gefitinib|mesh-list
154518393|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518394|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154518395|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
154518396|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
154518397|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
154518398|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518399|NCT03656393|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154518400|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518401|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518403|NCT02979197|Amlodipine|amlodipine|mesh-list
154518404|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154518405|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154518406|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154518407|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518408|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154518409|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518410|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
154518411|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154518412|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518413|NCT02979197|Analgesics|analgesics|mesh-ancestor
154518414|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
154518415|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518416|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154518417|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518418|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154518419|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154518420|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518422|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154518423|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518424|NCT03654365|Caffeine|caffeine|mesh-list
154518425|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154518426|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518427|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154518428|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518429|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518430|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154518431|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154518432|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
154518433|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518434|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
154518435|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154518436|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518437|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287502|NCT04225676|Tisagenlecleucel|tisagenlecleucel|mesh-list
154518438|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518439|NCT03655847|Analgesics|analgesics|mesh-ancestor
154518440|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
154518441|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518442|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154518443|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154518444|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154518445|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
154518446|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518447|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518448|NCT03655457|Poractant alfa|poractant alfa|mesh-list
154518449|NCT03655457|Beractant|beractant|mesh-list
154518450|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154518451|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
154518452|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154518453|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154518454|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
154518455|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518456|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154518457|NCT04453371|Plasminogen|plasminogen|mesh-list
154518458|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154518459|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154518460|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518461|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
154518462|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
154518463|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
154518464|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154518465|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
154518466|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154518467|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154518468|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518469|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154518470|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154518471|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518472|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518473|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518474|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518475|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154518476|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
154518477|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
154518478|NCT02980523|Protective Agents|protective agents|mesh-ancestor
154518479|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
154518480|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
154518481|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154518482|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154518483|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
154518484|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518485|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518486|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518487|NCT03468465|Urological Agents|urological agents|mesh-ancestor
154518488|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
154518489|NCT03460743|Vaccines|vaccines|mesh-list
154518490|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
154518491|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518492|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
154518493|NCT03460743|Coagulants|coagulants|mesh-ancestor
154518494|NCT02980133|Fluticasone|fluticasone|mesh-list
154518496|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154518497|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154518498|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154518499|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
154518500|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518501|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518502|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154518503|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
154518504|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
154518505|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154518506|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154518507|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154518508|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154518509|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
154518510|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518511|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518512|NCT03653663|Simvastatin|simvastatin|mesh-list
154518513|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154518514|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154518515|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
154518516|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518517|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154518518|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154518519|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518521|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
154518522|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518523|NCT03460275|Osimertinib|osimertinib|mesh-list
154518524|NCT03460275|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154518525|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518526|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518527|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287595|NCT04526574|Vaccines|vaccines|mesh-list
154518528|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518529|NCT03468231|Leucovorin|leucovorin|mesh-list
154518530|NCT03468231|Fluorouracil|fluorouracil|mesh-list
154518531|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
154518532|NCT03468231|Sorafenib|sorafenib|mesh-list
154518533|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
154518534|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518535|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154518536|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518537|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518538|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
154518539|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518540|NCT03468231|Antidotes|antidotes|mesh-ancestor
154518541|NCT03468231|Protective Agents|protective agents|mesh-ancestor
154518542|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
154518543|NCT03468231|Vitamins|vitamins|mesh-ancestor
154518544|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
154518545|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518546|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518547|NCT03468153|Immunomodulating Agents|immunomodulating agents|mesh-list
154518548|NCT03468153|Immunologic Factors|immunologic factors|mesh-ancestor
154518549|NCT03468153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518550|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
154518551|NCT03460041|Bupivacaine|bupivacaine|mesh-list
154518552|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
154518553|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
154518554|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518555|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518556|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
154518557|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518558|NCT03460041|Analgesics|analgesics|mesh-ancestor
154518559|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154518560|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
154518561|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154518562|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154518563|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518564|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154518565|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
154518566|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154518567|NCT02522013|Aminophylline|aminophylline|mesh-list
154518568|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154518569|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
154518570|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518571|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518572|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154518573|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
154518574|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154518575|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154518576|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518577|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518578|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154518579|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154518580|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
154518581|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518582|NCT02522013|Protective Agents|protective agents|mesh-ancestor
154518583|NCT02978417|Naltrexone|naltrexone|mesh-list
154518584|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154518585|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154518586|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518587|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
154518588|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518589|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
154518590|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154518591|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518592|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154518593|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518594|NCT03457467|Apatinib|apatinib|mesh-list
154518595|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518596|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518597|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518598|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518599|NCT05191875|Doxycycline|doxycycline|mesh-list
154518600|NCT05191875|Furazolidone|furazolidone|mesh-list
154518601|NCT05191875|Bismuth|bismuth|mesh-list
154518602|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154518603|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518604|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
154518605|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154518606|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154518607|NCT05191875|Antacids|antacids|mesh-ancestor
154518608|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518609|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154518610|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154518611|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154518612|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154518613|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154518614|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518615|NCT04370145|Meropenem|meropenem|mesh-list
154518616|NCT04370145|Tinidazole|tinidazole|mesh-list
154518617|NCT04370145|Teicoplanin|teicoplanin|mesh-list
154518618|NCT04370145|Sulperazone|sulperazone|mesh-list
154518619|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154518620|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518621|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
154518622|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518623|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154518624|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154518625|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154518626|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154518627|NCT03453723|Lidocaine|lidocaine|mesh-list
154518628|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
154518629|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
154518630|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518631|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518632|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
154518633|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518634|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154518635|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154518636|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154518637|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154518638|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518639|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
154518640|NCT04774965|Promethazine|promethazine|mesh-list
154518641|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154518642|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154518643|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518644|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518645|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
154518646|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
154518647|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
154518648|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518649|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
154518650|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
154518651|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154518652|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154518653|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
154518654|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
154518655|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518656|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518657|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154518658|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
154518659|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
154518660|NCT03452553|Doxorubicin|doxorubicin|mesh-list
154518661|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154518662|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518663|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154518664|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154518665|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518666|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518667|NCT03452475|Lumefantrine|lumefantrine|mesh-list
154518668|NCT03452475|Artemether|artemether|mesh-list
154518669|NCT03452475|Piperaquine|piperaquine|mesh-list
154518670|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154518671|NCT03452475|Mefloquine|mefloquine|mesh-list
154518672|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
154518673|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154518674|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154518675|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518676|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
154518677|NCT03451227|Remifentanil|remifentanil|mesh-list
154518678|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154518679|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518680|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518681|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518682|NCT03451227|Analgesics|analgesics|mesh-ancestor
154518683|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
154518684|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518685|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154518686|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154518687|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154518688|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
154518689|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518690|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518691|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154518692|NCT03451227|Narcotics|narcotics|mesh-ancestor
154518693|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
154518694|NCT02529813|Fludarabine|fludarabine|mesh-list
154518695|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
154242542|NCT03664024|Pemetrexed|pemetrexed|mesh-list
154518696|NCT02529813|Tisagenlecleucel|tisagenlecleucel|mesh-list
154518697|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154518698|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
154518699|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518700|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154518701|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154518702|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
154518703|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518704|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518705|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154518706|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154518707|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
154518708|NCT02529813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518709|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154287778|NCT03747978|Amlodipine|amlodipine|mesh-list
154518710|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154518711|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154518712|NCT05321511|Hormones|hormones|mesh-ancestor
154518713|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154518714|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518715|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
154518716|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154518717|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
154518718|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154518719|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154518720|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154518721|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518722|NCT02417103|Liraglutide|liraglutide|mesh-list
154518723|NCT02417103|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154518724|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154860241|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518725|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518726|NCT02417103|Incretins|incretins|mesh-ancestor
154518727|NCT02417103|Hormones|hormones|mesh-ancestor
154518728|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154518729|NCT02097225|Trametinib|trametinib|mesh-list
154518730|NCT02097225|Dabrafenib|dabrafenib|mesh-list
154518731|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518732|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518733|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518734|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518735|NCT02958865|PF-06700841|pf-06700841|mesh-list
154518736|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518737|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518738|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518739|NCT02501902|Paclitaxel|paclitaxel|mesh-list
154518740|NCT02501902|Palbociclib|palbociclib|mesh-list
154518741|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154518742|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518743|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
154518744|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
154518745|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
154518746|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518747|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518748|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518749|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
154518750|NCT05320575|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154518751|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518752|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518753|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518754|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518755|NCT03448731|Doxycycline|doxycycline|mesh-list
154518756|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154518757|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518758|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
154518759|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154518760|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154518761|NCT04452669|Epoprostenol|epoprostenol|mesh-list
154518762|NCT04452669|Tezosentan|tezosentan|mesh-list
154518763|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154518764|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154518765|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
154518766|NCT03719001|Clevidipine|clevidipine|mesh-list
154518767|NCT03719001|Phenylephrine|phenylephrine|mesh-list
154518768|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
154518769|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
154518770|NCT03719001|Calcium|calcium|mesh-list
154518771|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154518772|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518773|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154518774|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518775|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518776|NCT03719001|Analgesics|analgesics|mesh-ancestor
154518777|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
154518778|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518779|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154518780|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154518781|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154518782|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
154518783|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518784|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518785|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154518786|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
154518787|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
154518788|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
154518789|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154518790|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
154518791|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
154287862|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154518792|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154518793|NCT03719001|Protective Agents|protective agents|mesh-ancestor
154518794|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154518795|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154518796|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154518797|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154518798|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154518799|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154518800|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518801|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
154518802|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518803|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518804|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
154518805|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518806|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518807|NCT02499952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154518808|NCT02499952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518809|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
154518810|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518811|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518812|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
154518813|NCT03205605|Oxybutynin|oxybutynin|mesh-list
154518814|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
154518815|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
154518816|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518817|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518818|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154518819|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154518820|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
154518821|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518822|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518823|NCT03205605|Urological Agents|urological agents|mesh-ancestor
154518824|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154518825|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518826|NCT05006638|Atropine|atropine|mesh-list
154518827|NCT05006638|Ondansetron|ondansetron|mesh-list
154518828|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
154518829|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
154518830|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
154518831|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
154518832|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518833|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518834|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154518835|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
154518836|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
154518837|NCT05006638|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154518838|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154518839|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
154518840|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518841|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518842|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154518843|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154518844|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154518845|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154518846|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
154518847|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
154518848|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
154518849|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154518850|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154518851|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
154518852|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154518853|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154518854|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
154518855|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
154518856|NCT02498236|Oxytocin|oxytocin|mesh-list
154518857|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
154518858|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154518859|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518860|NCT01283997|Minocycline|minocycline|mesh-list
154518861|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154518862|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518863|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
154518864|NCT02496676|Analgesics|analgesics|mesh-ancestor
154518865|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
154518866|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518867|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518868|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
154518869|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518870|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154518871|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
154518872|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154860242|NCT01923584|Ubiquinone|ubiquinone|mesh-list
154860243|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
154518873|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154518874|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518875|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154518876|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
154287958|NCT04347954|Iodine|iodine|mesh-list
154518877|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154518878|NCT01160211|Trastuzumab|trastuzumab|mesh-list
154518879|NCT01160211|Lapatinib|lapatinib|mesh-list
154518880|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154518881|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154518882|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154518883|NCT01160211|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154518884|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154518885|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518886|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518887|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154518888|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154518889|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
154518890|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154518891|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518892|NCT03443271|Bupivacaine|bupivacaine|mesh-list
154518893|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
154518894|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
154518895|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154518896|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518897|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
154518898|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518899|NCT01064687|Metformin|metformin|mesh-list
154518900|NCT01064687|Pioglitazone|pioglitazone|mesh-list
154518901|NCT01064687|Exenatide|exenatide|mesh-list
154518902|NCT01064687|Dulaglutide|dulaglutide|mesh-list
154518903|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154518904|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518905|NCT01064687|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154518906|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154518907|NCT01064687|Incretins|incretins|mesh-ancestor
154518908|NCT01064687|Hormones|hormones|mesh-ancestor
154518909|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154518910|NCT03447873|Lamivudine|lamivudine|mesh-list
154518911|NCT03447873|Cobicistat|cobicistat|mesh-list
154518912|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154518913|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154518914|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154518915|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518916|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
154518917|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518918|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154518919|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154518920|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154518921|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154518923|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154518924|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154518925|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154518926|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154518927|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518928|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
154518929|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518930|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518931|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154518932|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518933|NCT03621995|Catalase|catalase|mesh-list
154518934|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
154518935|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518936|NCT03621995|Protective Agents|protective agents|mesh-ancestor
154518937|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518938|NCT03443037|Amantadine|amantadine|mesh-list
154518939|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154518940|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154518941|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
154518942|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518943|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
154518944|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518945|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518946|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518947|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154518948|NCT03443037|Analgesics|analgesics|mesh-ancestor
154518949|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
154518950|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518951|NCT03442491|Hemostatics|hemostatics|mesh-list
154518952|NCT03442491|Coagulants|coagulants|mesh-ancestor
154518953|NCT02918279|Liraglutide|liraglutide|mesh-list
154518954|NCT02918279|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154518955|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154518956|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518957|NCT02918279|Incretins|incretins|mesh-ancestor
154288032|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154518958|NCT02918279|Hormones|hormones|mesh-ancestor
154518959|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154518960|NCT02956837|Vaccines|vaccines|mesh-list
154518961|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
154518962|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518963|NCT03447093|Methimazole|methimazole|mesh-list
154518964|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
154518965|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
154518966|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
154518967|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154518968|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518969|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
154518970|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518971|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154518972|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154518973|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
154518974|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154518975|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
154518976|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518977|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
154518978|NCT03640351|Protective Agents|protective agents|mesh-ancestor
154518979|NCT03640273|Loratadine|loratadine|mesh-list
154518980|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
154518981|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
154518982|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154518983|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154518984|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154518985|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
154518986|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
154518987|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154518988|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154518989|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154518990|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
154518991|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154518992|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154518993|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154518994|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
154518995|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
154518997|NCT01063283|Carboplatin|carboplatin|mesh-list
154518998|NCT01063283|Pemetrexed|pemetrexed|mesh-list
154518999|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154519000|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519001|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154519002|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154519003|NCT01063283|Growth Substances|growth substances|mesh-ancestor
154519004|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519005|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
154519006|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519007|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519008|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154519009|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154519010|NCT01062971|Timolol|timolol|mesh-list
154519011|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154519012|NCT01062971|Dorzolamide|dorzolamide|mesh-list
154519013|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154519014|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154519015|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
154519016|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519017|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519018|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519019|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154519020|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154519021|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154519022|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154519023|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154519024|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154519025|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519026|NCT03446937|Dexamethasone|dexamethasone|mesh-list
154519027|NCT03446937|Betamethasone|betamethasone|mesh-list
154519028|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
154519029|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154519030|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
154519031|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
154519032|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154519033|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154519034|NCT03446937|BB 1101|bb 1101|mesh-list
154519035|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154519036|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
154519037|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
154519038|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519039|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519040|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288127|NCT04399122|Oxycodone|oxycodone|mesh-list
154519041|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
154519042|NCT03446937|Hormones|hormones|mesh-ancestor
154519043|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519044|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154519045|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519046|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154519047|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
154519048|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
154519049|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519050|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519051|NCT03652493|Carboplatin|carboplatin|mesh-list
154519052|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519053|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
154519054|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154519055|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154519056|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154519057|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154519058|NCT02493868|Sertraline|sertraline|mesh-list
154519059|NCT02493868|Esketamine|esketamine|mesh-list
154519060|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
154519061|NCT02493868|Escitalopram|escitalopram|mesh-list
154519062|NCT02493868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154519063|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154519064|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519065|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519066|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519067|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
154519068|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519069|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519070|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154519071|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519072|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154519073|NCT02493868|Analgesics|analgesics|mesh-ancestor
154519074|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
154519075|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
154519076|NCT03619057|Anesthetics|anesthetics|mesh-list
154519077|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519078|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519079|NCT04451655|Insulin|insulin|mesh-list
154519080|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154519081|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519082|NCT03446625|Resveratrol|resveratrol|mesh-list
154519083|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
154519084|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519085|NCT03446625|Protective Agents|protective agents|mesh-ancestor
154519086|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519087|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519088|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154519089|NCT02516410|Ivacaftor|ivacaftor|mesh-list
154519090|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154519091|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519092|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519093|NCT02493712|Mesalamine|mesalamine|mesh-list
154288155|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154519094|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154519095|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154519096|NCT02493712|Analgesics|analgesics|mesh-ancestor
154519097|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
154519098|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519099|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519100|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154519101|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154519103|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154519104|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519105|NCT02516332|Escitalopram|escitalopram|mesh-list
154519106|NCT02516332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154519107|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154519108|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519109|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519110|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519111|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
154519112|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519113|NCT03437655|Eugenol|eugenol|mesh-list
154519114|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
154519115|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
154519116|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
154519117|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154519118|NCT03437655|Protective Agents|protective agents|mesh-ancestor
154519119|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519120|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519121|NCT01062425|Temozolomide|temozolomide|mesh-list
154519122|NCT01062425|Cediranib|cediranib|mesh-list
154519123|NCT01062425|Maleic acid|maleic acid|mesh-list
154519124|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154519125|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
154519126|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519127|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519128|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519129|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154519130|NCT03437187|Analgesics|analgesics|mesh-list
154519131|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519132|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
154288211|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519133|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519134|NCT02491684|Interferons|interferons|mesh-list
154519135|NCT02491684|Interferon-beta|interferon-beta|mesh-list
154519136|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
154519137|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519138|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
154519139|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519140|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
154519141|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519142|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154519144|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154519145|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
154519146|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
154519147|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519148|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519149|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
154519150|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519151|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154519152|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154519153|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154519154|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519155|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519156|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
154519157|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154519158|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154519159|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519160|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
154519161|NCT04360629|Coagulants|coagulants|mesh-ancestor
154519162|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154519163|NCT03436719|Metronidazole|metronidazole|mesh-list
154519164|NCT03436719|Erythromycin|erythromycin|mesh-list
154519165|NCT03436719|Cefoperazone|cefoperazone|mesh-list
154519166|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154519167|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519168|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
154519169|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154519170|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154519171|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154519172|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154519173|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519174|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519175|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
154519176|NCT01061333|Nedocromil|nedocromil|mesh-list
154519177|NCT01061333|Montelukast|montelukast|mesh-list
154519178|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154519179|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
154519180|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154519181|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
154519182|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519183|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519184|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154519185|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154519186|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519187|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154519188|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
154519189|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154519190|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154519191|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
154519192|NCT02489968|Empagliflozin|empagliflozin|mesh-list
154519193|NCT02489968|Linagliptin|linagliptin|mesh-list
154519194|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154519195|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519196|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154519197|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519198|NCT02489968|Incretins|incretins|mesh-ancestor
154519199|NCT02489968|Hormones|hormones|mesh-ancestor
154519200|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519201|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154519202|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
154519203|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519204|NCT03436173|Fluoxetine|fluoxetine|mesh-list
154519205|NCT03436173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154519206|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154519207|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519208|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519209|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519210|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
154519211|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519212|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154519213|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
154519214|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519215|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154519216|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154519218|NCT03444831|Buspirone|buspirone|mesh-list
154519219|NCT03444831|Omeprazole|omeprazole|mesh-list
154519220|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154519221|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154519222|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154519223|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519224|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519225|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154519226|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154519227|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519228|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519229|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519230|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154519231|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
154519232|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519233|NCT01061177|Nilotinib|nilotinib|mesh-list
154519234|NCT01061177|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154519235|NCT01061177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154519236|NCT01061177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519237|NCT01061177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519238|NCT02481934|Lenalidomide|lenalidomide|mesh-list
154519239|NCT02481934|Bortezomib|bortezomib|mesh-list
154519240|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
154519241|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519242|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154519243|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154519244|NCT02481934|Growth Substances|growth substances|mesh-ancestor
154519245|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
154519246|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519247|NCT03444519|Mannitol|mannitol|mesh-list
154519249|NCT03444519|Diuretics|diuretics|mesh-ancestor
154519250|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
154519251|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519252|NCT03129009|Anesthetics|anesthetics|mesh-list
154519253|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519254|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519255|NCT02489500|Bortezomib|bortezomib|mesh-list
154519256|NCT02489500|Melphalan|melphalan|mesh-list
154519257|NCT02489500|Lenograstim|lenograstim|mesh-list
154519258|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519259|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154519260|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
154519261|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519262|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154519263|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154519264|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
154519265|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519266|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154519267|NCT04053959|Insulin|insulin|mesh-list
154519268|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154519269|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154519270|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519271|NCT03652571|Nortriptyline|nortriptyline|mesh-list
154519272|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154288346|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154519273|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
154519274|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519275|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154519276|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154519277|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519278|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519279|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
154519280|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519281|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519282|NCT03652103|Bupivacaine|bupivacaine|mesh-list
154519283|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
154519284|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
154519285|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519286|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519287|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
154519288|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519289|NCT03651947|Denosumab|denosumab|mesh-list
154519290|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154519291|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519292|NCT03651557|Salicylates|salicylates|mesh-list
154519293|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154519294|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154519295|NCT03651557|Analgesics|analgesics|mesh-ancestor
154519296|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
154519297|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519298|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519299|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154519300|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154519301|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154519302|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519303|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519304|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
154519305|NCT03432975|Povidone|povidone|mesh-list
154519306|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
154519307|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
154519308|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154519309|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519310|NCT02488330|Bevacizumab|bevacizumab|mesh-list
154519311|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154519312|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154519313|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519314|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154288389|NCT01971970|Adalimumab|adalimumab|mesh-list
154519315|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154519316|NCT02488330|Growth Substances|growth substances|mesh-ancestor
154519317|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519318|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
154519319|NCT02488330|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154519320|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154519321|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519322|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519324|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154519325|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
154519326|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154519327|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519328|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519329|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154519330|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154519331|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154519332|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519333|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154519334|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154519335|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154519336|NCT03432273|Nicotine|nicotine|mesh-list
154519337|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154519338|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
154519339|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519340|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519341|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154519342|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154519343|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
154519344|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519345|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519346|NCT02481310|Cytarabine|cytarabine|mesh-list
154519347|NCT02481310|Prednisone|prednisone|mesh-list
154519348|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
154519349|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154519350|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154519351|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154519352|NCT02481310|Cortisone|cortisone|mesh-list
154519353|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
154519354|NCT02481310|Rituximab|rituximab|mesh-list
154519355|NCT02481310|Doxorubicin|doxorubicin|mesh-list
154519356|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154519357|NCT02481310|Methotrexate|methotrexate|mesh-list
154519358|NCT02481310|Etoposide|etoposide|mesh-list
154519359|NCT02481310|Vincristine|vincristine|mesh-list
154519360|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
154519361|NCT02481310|Ixazomib|ixazomib|mesh-list
154519362|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
154519363|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154519364|NCT02481310|Antibodies|antibodies|mesh-list
154519365|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
154519366|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154519367|NCT02481310|Glycine|glycine|mesh-list
154519368|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154519369|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
154519370|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519371|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154519372|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154519373|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
154519374|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519375|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519376|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154519377|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154519378|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154519379|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154519380|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519381|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154519382|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
154519383|NCT02481310|Hormones|hormones|mesh-ancestor
154519384|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519385|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154519386|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154519387|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
154519388|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154519389|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154519390|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
154519391|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
154519392|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154519393|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154519394|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154519395|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
154519396|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519397|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
154519398|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
154519399|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
154519400|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
154519401|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
154519402|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
154519403|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519404|NCT03432195|Donepezil|donepezil|mesh-list
154519405|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154519406|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519407|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519408|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
154519409|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519410|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519411|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
154519412|NCT03431961|Triamcinolone|triamcinolone|mesh-list
154519413|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154519414|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154519415|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154519416|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154519417|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
154519418|NCT03431961|Hormones|hormones|mesh-ancestor
154519419|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519420|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519421|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154519422|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
154519423|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519424|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519425|NCT02480764|Valsartan|valsartan|mesh-list
154519426|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154519427|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154519428|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154519429|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154519430|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519431|NCT03434691|Remifentanil|remifentanil|mesh-list
154519432|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154519433|NCT03434691|Narcotics|narcotics|mesh-ancestor
154519434|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519435|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519436|NCT03434691|Analgesics|analgesics|mesh-ancestor
154519437|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
154519438|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519439|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154519440|NCT03434613|Ezetimibe|ezetimibe|mesh-list
154519441|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154519442|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154519443|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
154519444|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519445|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154519446|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154519447|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519448|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
154519449|NCT04953052|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154519450|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154519451|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519452|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519453|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519454|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
154519455|NCT03428685|Progestins|progestins|mesh-ancestor
154519456|NCT03428685|Hormones|hormones|mesh-ancestor
154519457|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519458|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519459|NCT05665647|Ritonavir|ritonavir|mesh-list
154519460|NCT05665647|Itraconazole|itraconazole|mesh-list
154519461|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154519462|NCT05665647|Rifampin|rifampin|mesh-list
154519463|NCT05665647|Midazolam|midazolam|mesh-list
154519464|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154519465|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154519466|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519467|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519468|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154519469|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154519470|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154860244|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860245|NCT00630344|Everolimus|everolimus|mesh-list
154519471|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154519472|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
154519473|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
154519474|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
154519475|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
154519476|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519477|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519478|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154519479|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154519480|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
154519481|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519482|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154519483|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154519484|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
154519485|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519486|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154519487|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154519488|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
154519489|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154519490|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154519491|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
154519492|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519493|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154519494|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
154288575|NCT05052970|Analgesics|analgesics|mesh-ancestor
154519495|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154519496|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
154519497|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154519498|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154519499|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154519500|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154519501|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154519502|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154519503|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154519504|NCT04941196|Ticagrelor|ticagrelor|mesh-list
154519505|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154519506|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154519507|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154519508|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154519509|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
154519510|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519511|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243345|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
154519512|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519513|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
154519514|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154519515|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154519516|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519518|NCT03431805|Coagulants|coagulants|mesh-ancestor
154519519|NCT03428607|Olaparib|olaparib|mesh-list
154519520|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154519521|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519522|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519523|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519524|NCT02521233|Losartan|losartan|mesh-list
154519525|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154519526|NCT02521233|Candesartan|candesartan|mesh-list
154519527|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
154519528|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
154519529|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154519530|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154519531|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154519532|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154519533|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519534|NCT02521233|Diuretics|diuretics|mesh-ancestor
154519535|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
154519536|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519537|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154519538|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519539|NCT03428529|Capecitabine|capecitabine|mesh-list
154519540|NCT03428529|Fluorouracil|fluorouracil|mesh-list
154519541|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154519542|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
154860246|NCT00630344|Bicalutamide|bicalutamide|mesh-list
154519543|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519544|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519545|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154519546|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
154519547|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519548|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
154519549|NCT03431649|Beraprost|beraprost|mesh-list
154519550|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519551|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
154519552|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154519553|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154519554|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519555|NCT03431649|Urological Agents|urological agents|mesh-ancestor
154519556|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154519557|NCT04450095|Ambrisentan|ambrisentan|mesh-list
154519558|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154519559|NCT03101475|Durvalumab|durvalumab|mesh-list
154519560|NCT03101475|Tremelimumab|tremelimumab|mesh-list
154519561|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154519562|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519563|NCT01060007|Leucovorin|leucovorin|mesh-list
154519564|NCT01060007|Capecitabine|capecitabine|mesh-list
154519565|NCT01060007|Fluorouracil|fluorouracil|mesh-list
154519566|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
154519567|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154519568|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
154519569|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519570|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519571|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154519572|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
154519573|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519574|NCT01060007|Antidotes|antidotes|mesh-ancestor
154519575|NCT01060007|Protective Agents|protective agents|mesh-ancestor
154519576|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
154519577|NCT01060007|Vitamins|vitamins|mesh-ancestor
154519578|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
154519579|NCT04175925|Famotidine|famotidine|mesh-list
154519580|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154519581|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154519582|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154519583|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
154519584|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
154519585|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519586|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243422|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
154519587|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519588|NCT02971007|Fluconazole|fluconazole|mesh-list
154519589|NCT02971007|Amphotericin B|amphotericin b|mesh-list
154519590|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154519591|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
154519592|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288671|NCT04933240|Estrogens|estrogens|mesh-ancestor
154519593|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154519594|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154519595|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519596|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519597|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154519598|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
154519599|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519600|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519601|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154519602|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154519603|NCT02971007|Amebicides|amebicides|mesh-ancestor
154519604|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154519605|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154519606|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154519607|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
154519608|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
154519609|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519610|NCT03428139|Protective Agents|protective agents|mesh-ancestor
154519611|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519612|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
154519613|NCT03428139|Vitamins|vitamins|mesh-ancestor
154519614|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
154519615|NCT03650543|Amoxicillin|amoxicillin|mesh-list
154519616|NCT03650543|Clarithromycin|clarithromycin|mesh-list
154519617|NCT03650543|Omeprazole|omeprazole|mesh-list
154860247|NCT00630344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154519618|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154519619|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519620|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154519621|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154519622|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154519623|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519624|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519625|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154519626|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154519627|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154519629|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
154519630|NCT02970305|Pimavanserin|pimavanserin|mesh-list
154519631|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154519632|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154519633|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154519634|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154519635|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519636|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519637|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519638|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154519639|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154519640|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
154519641|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519642|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519643|NCT03649763|Lidocaine|lidocaine|mesh-list
154519644|NCT03649763|Bupivacaine|bupivacaine|mesh-list
154519645|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
154519646|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
154519647|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519648|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519649|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
154519650|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519651|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154519652|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154519653|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154519654|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519655|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519656|NCT03427437|Epinephrine|epinephrine|mesh-list
154519657|NCT03427437|Racepinephrine|racepinephrine|mesh-list
154519658|NCT03427437|Bupivacaine|bupivacaine|mesh-list
154519659|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
154519660|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
154519661|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
154519662|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519663|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519664|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
154519665|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519666|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154519667|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154519668|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
154519669|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519670|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519671|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154519672|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154519673|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
154519674|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154519675|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
154519676|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
154519677|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
154519678|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154519679|NCT03427359|Capecitabine|capecitabine|mesh-list
154519680|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519681|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154519682|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
154519683|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519684|NCT05053659|Venetoclax|venetoclax|mesh-list
154519685|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154519686|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519687|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154519688|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154519689|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154519690|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519691|NCT03649139|Immunomodulating Agents|immunomodulating agents|mesh-list
154519692|NCT03649139|Immunologic Factors|immunologic factors|mesh-ancestor
154519693|NCT03649139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519695|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519696|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
154519697|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
154519698|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
154519699|NCT03423225|Tacrolimus|tacrolimus|mesh-list
154519700|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154519701|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
154519702|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519703|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154519704|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519705|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519706|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
154519707|NCT02521077|Vitamins|vitamins|mesh-ancestor
154519708|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
154519709|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519710|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
154519711|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519712|NCT02521077|Protective Agents|protective agents|mesh-ancestor
154519713|NCT03429621|Simethicone|simethicone|mesh-list
154519714|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
154519715|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519716|NCT03429621|Emollients|emollients|mesh-ancestor
154519717|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
154519718|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
154519719|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
154519720|NCT03426969|Melphalan|melphalan|mesh-list
154519721|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
154519722|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154519723|NCT03426969|Fludarabine|fludarabine|mesh-list
154519724|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
154519725|NCT03426969|Tacrolimus|tacrolimus|mesh-list
154519726|NCT03426969|Lenograstim|lenograstim|mesh-list
154519727|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154519728|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
154519729|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519730|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154519731|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154519732|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
154519733|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519734|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519735|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154519736|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154519737|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
154519738|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154519739|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154519740|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519741|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154519742|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154519743|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
154519744|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154519745|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519746|NCT03422445|Temozolomide|temozolomide|mesh-list
154519747|NCT03422445|Apatinib|apatinib|mesh-list
154519748|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154519749|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
154519750|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519751|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519752|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154519753|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519754|NCT03429309|Propofol|propofol|mesh-list
154519755|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154519756|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519757|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519758|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154519759|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
154519760|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
154519761|NCT03429075|Psilocybin|psilocybin|mesh-list
154519762|NCT03429075|Escitalopram|escitalopram|mesh-list
154519763|NCT03429075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154519764|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154519765|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519766|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519767|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519769|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519770|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519771|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
154519772|NCT03422289|Folic Acid|folic acid|mesh-list
154519773|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
154519774|NCT03422289|Inositol|inositol|mesh-list
154519775|NCT03422289|Hematinics|hematinics|mesh-ancestor
154519776|NCT03422289|Vitamins|vitamins|mesh-ancestor
154519777|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
154519778|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519779|NCT03422055|Fucoidan|fucoidan|mesh-list
154519780|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154519781|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154519782|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
154519783|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519784|NCT04449471|Naproxen|naproxen|mesh-list
154519785|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154519786|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154519787|NCT04449471|Analgesics|analgesics|mesh-ancestor
154519788|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
154519789|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519790|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519791|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154519792|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154519793|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
154519794|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154519795|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519796|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519797|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
154519798|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154519799|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
154519800|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
154519801|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519802|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519803|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154519804|NCT03127371|Analgesics|analgesics|mesh-ancestor
154519805|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
154519806|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519807|NCT03421821|Ropivacaine|ropivacaine|mesh-list
154519808|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
154519809|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
154519810|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519811|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519812|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
154519813|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519814|NCT03421743|Molgramostim|molgramostim|mesh-list
154519815|NCT03421743|Sargramostim|sargramostim|mesh-list
154519816|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519817|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
154519818|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519819|NCT01103349|Montelukast|montelukast|mesh-list
154519820|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154519821|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
154519822|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154519823|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
154519824|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519825|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519826|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154519827|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154519828|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519829|NCT03421275|Fentanyl|fentanyl|mesh-list
154519830|NCT03421275|Esketamine|esketamine|mesh-list
154519831|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154519832|NCT03421275|Narcotics|narcotics|mesh-ancestor
154519833|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519834|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519835|NCT03421275|Analgesics|analgesics|mesh-ancestor
154519836|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
154519837|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519838|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154519839|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154519840|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
154519841|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
154519842|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
154519843|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519844|NCT03416517|Irinotecan|irinotecan|mesh-list
154519845|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154519846|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154519847|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288911|NCT05598424|Protective Agents|protective agents|mesh-ancestor
154519848|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519849|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519851|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154519852|NCT03421119|Metformin|metformin|mesh-list
154519853|NCT03421119|Liraglutide|liraglutide|mesh-list
154519854|NCT03421119|Secretagogues|secretagogues|mesh-list
154519855|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154519856|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519857|NCT03421119|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154519858|NCT03421119|Incretins|incretins|mesh-ancestor
154519859|NCT03421119|Hormones|hormones|mesh-ancestor
154519860|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519861|NCT03426033|Warfarin|warfarin|mesh-list
154519862|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
154519863|NCT02432547|Aflibercept|aflibercept|mesh-list
154519864|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154519865|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154519866|NCT02432547|Growth Substances|growth substances|mesh-ancestor
154519867|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519868|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
154519869|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519870|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154519871|NCT02345733|Amoxicillin|amoxicillin|mesh-list
154519872|NCT02345733|Metronidazole|metronidazole|mesh-list
154519873|NCT02345733|Doxycycline|doxycycline|mesh-list
154519874|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519875|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154519876|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154519877|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
154519878|NCT03415269|Ambroxol|ambroxol|mesh-list
154519879|NCT03415269|Expectorants|expectorants|mesh-ancestor
154519880|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
154519881|NCT03618589|Pregabalin|pregabalin|mesh-list
154519882|NCT03618589|Analgesics|analgesics|mesh-ancestor
154519883|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
154519884|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519885|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519886|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
154519887|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154519888|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519889|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288971|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519890|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154519891|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154519892|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154519893|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519894|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519895|NCT03127449|Aflutinib|aflutinib|mesh-list
154519896|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154519897|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519898|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519899|NCT02521155|Fenbendazole|fenbendazole|mesh-list
154519900|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
154519901|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
154519902|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154519903|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519904|NCT03415191|Ketamine|ketamine|mesh-list
154519905|NCT03415191|Analgesics|analgesics|mesh-ancestor
154519906|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
154519907|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519908|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519909|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154519910|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154519911|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
154519912|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
154519913|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519914|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154519915|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154519916|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519917|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519918|NCT03419949|Pregabalin|pregabalin|mesh-list
154519919|NCT03419949|Lamotrigine|lamotrigine|mesh-list
154519920|NCT03419949|Analgesics|analgesics|mesh-ancestor
154519921|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
154519922|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519923|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519924|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
154519925|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154519926|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519927|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519928|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154519929|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154519930|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154519931|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519932|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154519933|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154519934|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154519935|NCT03414879|Lidocaine|lidocaine|mesh-list
154519936|NCT03414879|Ketamine|ketamine|mesh-list
154519937|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
154519938|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
154519939|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519940|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519941|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
154519942|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519943|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154519944|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154519945|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154519946|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154519947|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519948|NCT03414879|Analgesics|analgesics|mesh-ancestor
154519949|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154519950|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154519951|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
154519952|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154519953|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154519954|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154519955|NCT03419715|Bimatoprost|bimatoprost|mesh-list
154519956|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154519957|NCT03618355|Sirolimus|sirolimus|mesh-list
154519958|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154519959|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154519960|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154519961|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519962|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
154519963|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154519964|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
154243826|NCT05869201|Vaccines|vaccines|mesh-list
154519965|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519966|NCT03454165|Ibrutinib|ibrutinib|mesh-list
154519967|NCT03454165|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154519968|NCT03454165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154519969|NCT03454165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154519970|NCT03454165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154519971|NCT04448457|Sufentanil|sufentanil|mesh-list
154519972|NCT04448457|Oxycodone|oxycodone|mesh-list
154519973|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154519974|NCT04448457|Narcotics|narcotics|mesh-ancestor
154519975|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154519976|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519977|NCT04448457|Analgesics|analgesics|mesh-ancestor
154519978|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
154519979|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154519980|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154519981|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154519982|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
154519983|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
154519984|NCT05384743|Rituximab|rituximab|mesh-list
154519985|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154519986|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519987|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
154519988|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519989|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154519990|NCT03414333|Hormones|hormones|mesh-list
154519991|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154519992|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154519993|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
154519994|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154519995|NCT03616639|Morphine|morphine|mesh-list
154519996|NCT03616639|Oxycodone|oxycodone|mesh-list
154519997|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154519998|NCT03616639|Narcotics|narcotics|mesh-ancestor
154519999|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520000|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520001|NCT03616639|Analgesics|analgesics|mesh-ancestor
154520002|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
154520003|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520004|NCT03616561|Apremilast|apremilast|mesh-list
154520005|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154520006|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154520007|NCT03616561|Analgesics|analgesics|mesh-ancestor
154520008|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
154520009|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520010|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520011|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154520012|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154520013|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154520014|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154520015|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520016|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520017|NCT03615313|Antibodies|antibodies|mesh-list
154520018|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
154520019|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520020|NCT03617575|Lactoferrin|lactoferrin|mesh-list
154520021|NCT03617575|Fesoterodine|fesoterodine|mesh-list
154520022|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520023|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154520024|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154520025|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
154520026|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520027|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520028|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520029|NCT03617575|Urological Agents|urological agents|mesh-ancestor
154520030|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
154520031|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520032|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520033|NCT03616405|Amoxicillin|amoxicillin|mesh-list
154520034|NCT03616405|Tetracycline|tetracycline|mesh-list
154520035|NCT03616405|Furazolidone|furazolidone|mesh-list
154520036|NCT03616405|Rabeprazole|rabeprazole|mesh-list
154520037|NCT03616405|Bismuth|bismuth|mesh-list
154520038|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154520039|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520040|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154520041|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520042|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154520043|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520044|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520046|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154520047|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154520048|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154520049|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154520050|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154520051|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154520052|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154520053|NCT03419559|Durvalumab|durvalumab|mesh-list
154520054|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520055|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520056|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
154520057|NCT02873689|Lansoprazole|lansoprazole|mesh-list
154520058|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154520059|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520060|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154520061|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520062|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520063|NCT02873377|Nicotine|nicotine|mesh-list
154520064|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154520065|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
154520066|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520067|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520068|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154520069|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154520070|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
154520071|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520072|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520074|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
154520075|NCT03647579|Ketamine|ketamine|mesh-list
154520076|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154520077|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520078|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520079|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154520080|NCT03647579|Analgesics|analgesics|mesh-ancestor
154520081|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
154520082|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520083|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154520084|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154520085|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154520086|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
154520087|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520088|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520089|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154520090|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154520091|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
154520092|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
154520093|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154520094|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154520095|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154520096|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154520097|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154520098|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154520099|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
154520100|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
154520101|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
154520102|NCT04046861|Vitamins|vitamins|mesh-ancestor
154520103|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
154520104|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520105|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
154520106|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520107|NCT04046861|Protective Agents|protective agents|mesh-ancestor
154520108|NCT02236741|Pramipexole|pramipexole|mesh-list
154520109|NCT02236741|Dexpramipexole|dexpramipexole|mesh-list
154520110|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
154520111|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520112|NCT02236741|Protective Agents|protective agents|mesh-ancestor
154520113|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520114|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154520115|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154520116|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
154520117|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
154243937|NCT05642572|Osimertinib|osimertinib|mesh-list
154520118|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520119|NCT03648671|Rasagiline|rasagiline|mesh-list
154520120|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154520121|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520122|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520123|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154520124|NCT03648671|Protective Agents|protective agents|mesh-ancestor
154520125|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520126|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
154520127|NCT03647423|Cetuximab|cetuximab|mesh-list
154520128|NCT03647423|Avelumab|avelumab|mesh-list
154520129|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154520130|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
154520131|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520132|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154520133|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154520134|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
154520135|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520136|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520137|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154520138|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520139|NCT04052711|Minocycline|minocycline|mesh-list
154520140|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154520141|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520142|NCT03621683|Antioxidants|antioxidants|mesh-list
154520143|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520144|NCT03621683|Protective Agents|protective agents|mesh-ancestor
154520145|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520146|NCT03614065|Endostar protein|endostar protein|mesh-list
154520147|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154520148|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154520149|NCT03614065|Growth Substances|growth substances|mesh-ancestor
154520150|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289231|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154520151|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
154520152|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520153|NCT03621527|Remifentanil|remifentanil|mesh-list
154520154|NCT03621527|Anesthetics|anesthetics|mesh-list
154520155|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520156|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520157|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154520158|NCT03621527|Narcotics|narcotics|mesh-ancestor
154520159|NCT03621527|Analgesics|analgesics|mesh-ancestor
154520160|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
154520161|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520162|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154520163|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154520164|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520165|NCT03646721|Incretins|incretins|mesh-ancestor
154520166|NCT03646721|Hormones|hormones|mesh-ancestor
154520167|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154520168|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154520169|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
154520170|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520171|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520172|NCT03613753|Irinotecan|irinotecan|mesh-list
154520173|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154520174|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154520175|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520176|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520177|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520178|NCT04051853|Sorafenib|sorafenib|mesh-list
154520179|NCT04051853|Midazolam|midazolam|mesh-list
154520180|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154520181|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154520182|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520183|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520184|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154520185|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154520186|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154520187|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154520188|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
154520189|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
154520190|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
154520191|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
154244012|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
154520192|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520193|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520194|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520195|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154520196|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520197|NCT03643757|Bupivacaine|bupivacaine|mesh-list
154520198|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
154520199|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
154520200|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520201|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520202|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
154520203|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520204|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
154520205|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154520206|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
154520207|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520208|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520209|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154520210|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
154520211|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154520212|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
154520213|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520214|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520215|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154520216|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
154520217|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
154520218|NCT03718793|Protective Agents|protective agents|mesh-ancestor
154520219|NCT02962739|Tenofovir|tenofovir|mesh-list
154520220|NCT02962739|Emtricitabine|emtricitabine|mesh-list
154520221|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
154520222|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860248|NCT00630344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154520223|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154520224|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154520225|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520226|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520227|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154520228|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154520229|NCT01344629|Telmisartan|telmisartan|mesh-list
154520230|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154520231|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154520232|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154520233|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520234|NCT03642353|Listerine|listerine|mesh-list
154520235|NCT03642353|Triclosan|triclosan|mesh-list
154520236|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
154520237|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
154520238|NCT03642353|Protective Agents|protective agents|mesh-ancestor
154520239|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520240|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154520241|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520242|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154520243|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154520244|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
154520245|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520246|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154520247|NCT03424707|Eperisone|eperisone|mesh-list
154520248|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
154520249|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154520250|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154520251|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520252|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154520253|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520254|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154520255|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154520256|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520257|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
154520258|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
154520259|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
154520260|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154520261|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154520262|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
154520263|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520264|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520265|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520266|NCT03418935|Niacinamide|niacinamide|mesh-list
154520267|NCT03418935|Niacin|niacin|mesh-list
154520268|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
154520269|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
154520270|NCT03418935|Vitamins|vitamins|mesh-ancestor
154520271|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
154520272|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520273|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154520274|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
154520275|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520276|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154520277|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
154520278|NCT03413319|Tilavonemab|tilavonemab|mesh-list
154520279|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
154520280|NCT03424629|Methotrexate|methotrexate|mesh-list
154520281|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154520282|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
154520283|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154520284|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520285|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154520286|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
154520287|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520288|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520289|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
154520290|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520291|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154520292|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154520293|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
154520294|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154520295|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154520296|NCT03424473|Tucatinib|tucatinib|mesh-list
154520297|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520298|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154520299|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520300|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520301|NCT04448379|Osimertinib|osimertinib|mesh-list
154520302|NCT04448379|Afatinib|afatinib|mesh-list
154520303|NCT04448379|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154520304|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154520305|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520306|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520307|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520308|NCT04448223|Latanoprost|latanoprost|mesh-list
154520309|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154520310|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154520311|NCT03644147|Acetaminophen|acetaminophen|mesh-list
154520312|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154520313|NCT03644147|Analgesics|analgesics|mesh-ancestor
154520314|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
154520315|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520316|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520317|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
154520318|NCT02743923|Paclitaxel|paclitaxel|mesh-list
154520319|NCT02743923|Bevacizumab|bevacizumab|mesh-list
154520320|NCT02743923|Carboplatin|carboplatin|mesh-list
154520321|NCT02743923|Pemetrexed|pemetrexed|mesh-list
154520322|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154520323|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520324|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
154520325|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
154520326|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
154520327|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520328|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520329|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154520330|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154520331|NCT02743923|Growth Substances|growth substances|mesh-ancestor
154520332|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520333|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
154520334|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520335|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154520336|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154520337|NCT01065779|Alendronate|alendronate|mesh-list
154520338|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154520339|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520340|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154520341|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520342|NCT03570359|Interferons|interferons|mesh-list
154520343|NCT03570359|Interferon-beta|interferon-beta|mesh-list
154520344|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
154520345|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520346|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
154520347|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520348|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
154520349|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520350|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154520351|NCT02358200|Paclitaxel|paclitaxel|mesh-list
154520352|NCT02358200|Carboplatin|carboplatin|mesh-list
154520353|NCT02358200|Talazoparib|talazoparib|mesh-list
154520354|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154520355|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520356|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
154520357|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
154520358|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
154520359|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520360|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154520361|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520362|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
154520363|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
154520364|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520365|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154520366|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520367|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520368|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154520369|NCT03127605|Immunotoxins|immunotoxins|mesh-ancestor
154520370|NCT03127605|Immunoconjugates|immunoconjugates|mesh-ancestor
154520371|NCT03127605|Immunologic Factors|immunologic factors|mesh-ancestor
154860249|NCT00630344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520372|NCT03127605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520373|NCT03112538|Insulin|insulin|mesh-list
154520374|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154520375|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154520376|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520377|NCT05283551|Famciclovir|famciclovir|mesh-list
154520378|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
154520379|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520380|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154520381|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520382|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520383|NCT02357732|Nivolumab|nivolumab|mesh-list
154520384|NCT02357732|Trametinib|trametinib|mesh-list
154520385|NCT02357732|Dabrafenib|dabrafenib|mesh-list
154520386|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520387|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520388|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154520389|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520390|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154520391|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520392|NCT03112148|Tofacitinib|tofacitinib|mesh-list
154520393|NCT03112148|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154520394|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154520395|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520396|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520397|NCT03423849|Gemcitabine|gemcitabine|mesh-list
154520398|NCT03423849|Capecitabine|capecitabine|mesh-list
154520399|NCT03423849|Vinorelbine|vinorelbine|mesh-list
154520400|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520401|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154520402|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
154520403|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520404|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154520405|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
154520406|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
154520407|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
154520408|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154520409|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
154520410|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520411|NCT02362256|Clonidine|clonidine|mesh-list
154520412|NCT02362256|Naltrexone|naltrexone|mesh-list
154520413|NCT02362256|Lorazepam|lorazepam|mesh-list
154520414|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154520415|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154520416|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520417|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
154520418|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520419|NCT02362256|Analgesics|analgesics|mesh-ancestor
154520420|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154520422|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
154520423|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154520424|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154520425|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154520426|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154520427|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520428|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520429|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
154520430|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
154520431|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520432|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154520433|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520434|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154520435|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154520436|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154520437|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
154520438|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
154520439|NCT03412305|Amoxicillin|amoxicillin|mesh-list
154289505|NCT00043108|Paclitaxel|paclitaxel|mesh-list
154520440|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154520441|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520442|NCT02109081|Dexamethasone|dexamethasone|mesh-list
154520443|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154520444|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
154520445|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
154520446|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520447|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520448|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520449|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
154520450|NCT02109081|Hormones|hormones|mesh-ancestor
154520451|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154520452|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154520454|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154520455|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154520456|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154520457|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
154520458|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154520459|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
154520460|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154520461|NCT03397875|Protective Agents|protective agents|mesh-ancestor
154520462|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520463|NCT02362022|Morphine|morphine|mesh-list
154520464|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154520465|NCT02362022|Narcotics|narcotics|mesh-ancestor
154520466|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520467|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520468|NCT02362022|Analgesics|analgesics|mesh-ancestor
154520469|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
154520470|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520471|NCT03412071|Metronidazole|metronidazole|mesh-list
154520472|NCT03412071|Clindamycin|clindamycin|mesh-list
154520473|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
154520474|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
154520475|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154520476|NCT03412071|Tinidazole|tinidazole|mesh-list
154520477|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520478|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154520479|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154520480|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154520481|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154520482|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520483|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520484|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154520485|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
154520486|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154520487|NCT03397797|Rocuronium|rocuronium|mesh-list
154520488|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154520489|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154520490|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154520491|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520492|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520493|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154244317|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520494|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520495|NCT05170581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520496|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520497|NCT02351882|Nabilone|nabilone|mesh-list
154520498|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
154520499|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
154520500|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520501|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520502|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520503|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154520504|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154520505|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520506|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154520507|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
154520508|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
154520509|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
154520510|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520511|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520512|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
154520513|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520514|NCT05169801|Paclitaxel|paclitaxel|mesh-list
154520515|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154520516|NCT05169801|Carboplatin|carboplatin|mesh-list
154520517|NCT05169801|Bevacizumab|bevacizumab|mesh-list
154520518|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154520519|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520520|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
154520521|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
154520522|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
154520523|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355348|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
154520525|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154520526|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154520527|NCT05169801|Growth Substances|growth substances|mesh-ancestor
154520528|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520529|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
154520530|NCT04447443|Loperamide|loperamide|mesh-list
154520531|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
154520532|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520533|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154520534|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154520535|NCT01345253|Belimumab|belimumab|mesh-list
154520536|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154520537|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
154520538|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520539|NCT03397329|Mitapivat|mitapivat|mesh-list
154520540|NCT03397329|Enzyme Activators|enzyme activators|mesh-ancestor
154520541|NCT03397329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520542|NCT03150134|Cyclosporine|cyclosporine|mesh-list
154520543|NCT03150134|Cyclosporins|cyclosporins|mesh-list
154520544|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154520545|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520546|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520547|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
154520548|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520549|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
154520550|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520551|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
154520552|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154520553|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154520554|NCT03411369|Vitamins|vitamins|mesh-list
154520555|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
154520556|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520557|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154520558|NCT02351804|Dexamethasone|dexamethasone|mesh-list
154520559|NCT02351804|Ropivacaine|ropivacaine|mesh-list
154520560|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154520561|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
154520562|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
154520563|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520564|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520565|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520566|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
154520567|NCT02351804|Hormones|hormones|mesh-ancestor
154520568|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154520569|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154520570|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520571|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
154520572|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
154520573|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520574|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
154520575|NCT03640403|Artesunate|artesunate|mesh-list
154520576|NCT03640403|Piperaquine|piperaquine|mesh-list
154520577|NCT03640403|Amodiaquine|amodiaquine|mesh-list
154520578|NCT03640403|Artenimol|artenimol|mesh-list
154520579|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
154520580|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154520581|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154520582|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520583|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520584|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
154520585|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
154520586|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154520587|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
154520588|NCT02355938|Vancomycin|vancomycin|mesh-list
154520589|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
154520590|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154520591|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520592|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
154520593|NCT03397173|Azacitidine|azacitidine|mesh-list
154520594|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154520595|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
154520596|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520597|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520598|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520599|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
154520600|NCT03397173|Protective Agents|protective agents|mesh-ancestor
154520601|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520603|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
154520604|NCT03640247|Acetaminophen|acetaminophen|mesh-list
154520605|NCT03640247|Ibuprofen|ibuprofen|mesh-list
154520606|NCT03640247|Oxycodone|oxycodone|mesh-list
154520607|NCT03640247|Tramadol|tramadol|mesh-list
154520608|NCT03640247|Hydrocodone|hydrocodone|mesh-list
154520609|NCT03640247|Narcotics|narcotics|mesh-list
154520610|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154520611|NCT03640247|Analgesics|analgesics|mesh-ancestor
154520612|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
154520613|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520614|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520615|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
154520616|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154520617|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154520618|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154520619|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154520620|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520621|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520622|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154520623|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520624|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
154520625|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
154520626|NCT03394131|Insulin|insulin|mesh-list
154520627|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154520628|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154520629|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520630|NCT02360618|Metformin|metformin|mesh-list
154520631|NCT02360618|Simvastatin|simvastatin|mesh-list
154520632|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154520633|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520634|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154520635|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154520636|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
154520637|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520638|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154520639|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154520640|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520641|NCT01344161|Vitamin D|vitamin d|mesh-list
154520642|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
154520643|NCT01344161|Vitamins|vitamins|mesh-ancestor
154520644|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
154520645|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520646|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154244461|NCT05639686|Isoflurane|isoflurane|mesh-list
154520647|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154520648|NCT02451358|Vaccines|vaccines|mesh-list
154520649|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
154520650|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520651|NCT02360384|Linaclotide|linaclotide|mesh-list
154520652|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154520653|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
154520654|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520655|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520656|NCT03396861|Aflibercept|aflibercept|mesh-list
154520657|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154520658|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154520659|NCT03396861|Growth Substances|growth substances|mesh-ancestor
154520660|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520661|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
154520662|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520663|NCT02749721|Vortioxetine|vortioxetine|mesh-list
154520664|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
154520665|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154520666|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154520667|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154520668|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520669|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520670|NCT02749721|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154520671|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154520672|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154520673|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520674|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520675|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
154355496|NCT04921995|Tislelizumab|tislelizumab|mesh-list
154520676|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154520677|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154520678|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154520679|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154520680|NCT02351102|Valacyclovir|valacyclovir|mesh-list
154520681|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
154520682|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520683|NCT02351024|Naproxen|naproxen|mesh-list
154520684|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154520685|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154520686|NCT02351024|Analgesics|analgesics|mesh-ancestor
154520687|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
154520688|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520689|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520690|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154520691|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154520692|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
154520693|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154520694|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520695|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520696|NCT02355704|Atorvastatin|atorvastatin|mesh-list
154520697|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154520698|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154520699|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
154520700|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520701|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154520702|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154520703|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520704|NCT03396393|Artenimol|artenimol|mesh-list
154520705|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
154289760|NCT03728894|Midazolam|midazolam|mesh-list
154520706|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154520707|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154520708|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520709|NCT03393819|Ethanol|ethanol|mesh-list
154520710|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
154520711|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154520712|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520713|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520714|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520715|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
154520716|NCT03393507|Apatinib|apatinib|mesh-list
154520717|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520718|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154520719|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520720|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520721|NCT01348139|AZD-3199|azd-3199|mesh-list
154520722|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154520723|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154244540|NCT05525416|Propranolol|propranolol|mesh-list
154520724|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154520725|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
154520726|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520727|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520728|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520730|NCT02355236|Naproxen|naproxen|mesh-list
154520731|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154520732|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154520733|NCT02355236|Analgesics|analgesics|mesh-ancestor
154520734|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
154520735|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520736|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520737|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154520738|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154520739|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154520740|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154520741|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520742|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520743|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
154520744|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154520745|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520746|NCT02359604|Esomeprazole|esomeprazole|mesh-list
154520747|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154520748|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520749|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154520750|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520751|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520752|NCT03410511|Nicotine|nicotine|mesh-list
154520753|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154520754|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
154520755|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520756|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520757|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154520758|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154520759|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
154520760|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520761|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520762|NCT05169021|Folic Acid|folic acid|mesh-list
154520763|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
154520764|NCT05169021|Amlodipine|amlodipine|mesh-list
154520765|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
154520766|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154520767|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154520768|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520769|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154520770|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520771|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
154520772|NCT05169021|Hematinics|hematinics|mesh-ancestor
154520773|NCT05169021|Vitamins|vitamins|mesh-ancestor
154520774|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
154520775|NCT02359292|Charcoal|charcoal|mesh-list
154520776|NCT02359292|Antidotes|antidotes|mesh-ancestor
154520777|NCT02359292|Protective Agents|protective agents|mesh-ancestor
154520778|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520779|NCT02359214|Vitamin D|vitamin d|mesh-list
154520780|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
154520781|NCT02359214|Vitamins|vitamins|mesh-ancestor
154520782|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
154520783|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520784|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154520785|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154520786|NCT02359370|Lidocaine|lidocaine|mesh-list
154520787|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
154520788|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
154520789|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
154520790|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520791|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520792|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
154520793|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244614|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154244615|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
154244616|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154520794|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154520795|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154520796|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154520797|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154520798|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520800|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
154520801|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154520802|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154520803|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
154520804|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154520805|NCT02359448|Melatonin|melatonin|mesh-list
154520806|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
154520807|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520808|NCT02359448|Protective Agents|protective agents|mesh-ancestor
154520809|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520810|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520811|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154520812|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154520813|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
154520814|NCT02359526|Hormones|hormones|mesh-ancestor
154520815|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154520816|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520817|NCT03618953|Atezolizumab|atezolizumab|mesh-list
154520818|NCT03618953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154520819|NCT03618953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520820|NCT03618953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520821|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520822|NCT02354768|Lanreotide|lanreotide|mesh-list
154520824|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
154520825|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520826|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520827|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
154520828|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154520829|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154520830|NCT02354612|Bevacizumab|bevacizumab|mesh-list
154520831|NCT02354612|Capecitabine|capecitabine|mesh-list
154520832|NCT02354612|Axitinib|axitinib|mesh-list
154520833|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520834|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520835|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154520836|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154520837|NCT02354612|Growth Substances|growth substances|mesh-ancestor
154520838|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520839|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
154520840|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154520841|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
154520842|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520843|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154520844|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520845|NCT02348450|Irinotecan|irinotecan|mesh-list
154520846|NCT02348450|Etoposide|etoposide|mesh-list
154520847|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520848|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154520849|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154520850|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520851|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520852|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154520853|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154520854|NCT03393273|Elotuzumab|elotuzumab|mesh-list
154520855|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520856|NCT03613597|Etoposide|etoposide|mesh-list
154520857|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
154520858|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520859|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154520860|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154520861|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154520862|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520863|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520864|NCT02348372|Glycine|glycine|mesh-list
154520865|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
154520866|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520867|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520868|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520869|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154520870|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
154520871|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520872|NCT03614533|Vaccines|vaccines|mesh-list
154520873|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
154289946|NCT03737448|Trimetazidine|trimetazidine|mesh-list
154520874|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520875|NCT03147404|Avelumab|avelumab|mesh-list
154520876|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520877|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520878|NCT03614455|Itraconazole|itraconazole|mesh-list
154520879|NCT03614455|Posaconazole|posaconazole|mesh-list
154520880|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
154520881|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
154520882|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520883|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154520884|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154520885|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520886|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520887|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154520888|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
154520889|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154520890|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520891|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154520892|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154520893|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154520894|NCT03393117|Narcotics|narcotics|mesh-list
154520895|NCT03393117|Bupivacaine|bupivacaine|mesh-list
154520896|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
154520897|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
154520898|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520899|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520900|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
154520901|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520902|NCT03393117|Analgesics|analgesics|mesh-ancestor
154520903|NCT02032303|Ticagrelor|ticagrelor|mesh-list
154520904|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154520905|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154520906|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154520907|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154520908|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154520909|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
154520910|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520911|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520912|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520913|NCT04297293|Ramosetron|ramosetron|mesh-list
154520914|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
154520915|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
154520916|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520917|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520918|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520919|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154520920|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
154520921|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520922|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520923|NCT03392961|Insulin|insulin|mesh-list
154520924|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154520925|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520926|NCT02350946|Oxytocin|oxytocin|mesh-list
154520927|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
154520928|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154520929|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520930|NCT00000371|Cycloserine|cycloserine|mesh-list
154520931|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154520932|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154520933|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154520934|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
154520935|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154520936|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
154520937|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520938|NCT02350712|Carboplatin|carboplatin|mesh-list
154520939|NCT02350712|Cetuximab|cetuximab|mesh-list
154520940|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154520941|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154520942|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154520943|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154244762|NCT04543110|Durvalumab|durvalumab|mesh-list
154520944|NCT03618797|Fenofibrate|fenofibrate|mesh-list
154520945|NCT03618797|Pitavastatin|pitavastatin|mesh-list
154520946|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154520947|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
154520948|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520949|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154520950|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154520951|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154520952|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520953|NCT03149432|Gabapentin|gabapentin|mesh-list
154520954|NCT03149432|Analgesics|analgesics|mesh-ancestor
154520955|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
154520956|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520957|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520958|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
154520959|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154520960|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154290023|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
154520961|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520962|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154520963|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154520964|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154520965|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154520966|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520967|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
154520968|NCT05384483|Cariprazine|cariprazine|mesh-list
154520969|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154520970|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154520971|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154520972|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520973|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154520975|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154520976|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154520977|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154520978|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154520979|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520980|NCT03147092|Losartan|losartan|mesh-list
154520981|NCT03147092|Atenolol|atenolol|mesh-list
154520982|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154520983|NCT03147092|Clonidine|clonidine|mesh-list
154520984|NCT03147092|Captopril|captopril|mesh-list
154520985|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154520986|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154520987|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154520988|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154520989|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154520990|NCT03147092|Diuretics|diuretics|mesh-ancestor
154520991|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
154520992|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154520993|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154520994|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154520995|NCT03147092|Analgesics|analgesics|mesh-ancestor
154520996|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
154520997|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154520998|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
154520999|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
154521000|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154521001|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154521002|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154521003|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
154521004|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521005|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154521006|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154521007|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154521008|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154521009|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
154521010|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521011|NCT03149588|Propofol|propofol|mesh-list
154521012|NCT03149588|Sevoflurane|sevoflurane|mesh-list
154521013|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154521014|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521015|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521016|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154521017|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
154521018|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
154521019|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154521020|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154521022|NCT03613207|Prilocaine|prilocaine|mesh-list
154521023|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
154521024|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
154521025|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521026|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521027|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
154521028|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521029|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154521030|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154521031|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154521032|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154521033|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521034|NCT03612739|Azacitidine|azacitidine|mesh-list
154521035|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154521036|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
154521037|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521038|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521039|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521040|NCT02350400|Irinotecan|irinotecan|mesh-list
154521041|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154521042|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154521043|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521044|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521045|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521046|NCT03612817|Timolol|timolol|mesh-list
154521047|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154521048|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154521049|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
154521050|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521051|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521052|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521053|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154521054|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154521055|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
154521056|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521057|NCT03612349|Menthol|menthol|mesh-list
154521058|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
154521059|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
154521060|NCT03146858|Enoxaparin|enoxaparin|mesh-list
154521061|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
154521062|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154521063|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154290114|NCT03408340|Narcotics|narcotics|mesh-ancestor
154521064|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521065|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154521066|NCT03408405|Hormones|hormones|mesh-ancestor
154521067|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521068|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521069|NCT03408093|Interferons|interferons|mesh-list
154521070|NCT03408093|Interferon-beta|interferon-beta|mesh-list
154521071|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
154521072|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521073|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
154521074|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521075|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
154521076|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521077|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154521078|NCT04679623|Midazolam|midazolam|mesh-list
154521079|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154521080|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154521081|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521082|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521083|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154521084|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154521085|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154521086|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154521087|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
154521088|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
154521089|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
154521090|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
154521091|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521092|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521093|NCT02353988|Bicalutamide|bicalutamide|mesh-list
154521094|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
154521095|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
154521096|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521097|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521098|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521100|NCT03392571|Cisplatin|cisplatin|mesh-list
154521101|NCT03392571|Gemcitabine|gemcitabine|mesh-list
154521102|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154521103|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521104|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
154521105|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
154521106|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
154521107|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521108|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154521109|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
154521110|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
154521111|NCT04656067|Ethamsylate|ethamsylate|mesh-list
154521112|NCT04656067|Oxytocin|oxytocin|mesh-list
154521113|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
154521114|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154521115|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521116|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154521117|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154521118|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521119|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
154521120|NCT04656067|Coagulants|coagulants|mesh-ancestor
154521121|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
154521122|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
154521123|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521124|NCT03612037|Protective Agents|protective agents|mesh-ancestor
154521125|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521126|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
154521127|NCT03612037|Vitamins|vitamins|mesh-ancestor
154521128|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
154521129|NCT04447209|Chrysarobin|chrysarobin|mesh-list
154521130|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154521131|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154521132|NCT04447209|Analgesics|analgesics|mesh-ancestor
154521133|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
154521134|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521135|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521136|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521137|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521138|NCT04199624|Omeprazole|omeprazole|mesh-list
154521139|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521140|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154521141|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521142|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154521143|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521144|NCT03611491|Lidocaine|lidocaine|mesh-list
154521145|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
154521146|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
154521147|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521148|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521149|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
154521150|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521151|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154290218|NCT03566810|Metformin|metformin|mesh-list
154521152|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154521153|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154521154|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154521155|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521156|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154521157|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
154521158|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521159|NCT03611179|Bevacizumab|bevacizumab|mesh-list
154521160|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154521161|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521162|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154521163|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154521164|NCT03611179|Growth Substances|growth substances|mesh-ancestor
154521165|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521166|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
154521167|NCT03126123|Acetic Acid|acetic acid|mesh-list
154521168|NCT03126123|Retinol acetate|retinol acetate|mesh-list
154521169|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154521170|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521171|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154521172|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
154521173|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521174|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154521175|NCT03126123|Protective Agents|protective agents|mesh-ancestor
154521176|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521177|NCT02353676|Bupivacaine|bupivacaine|mesh-list
154521178|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
154521179|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
154521180|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521181|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521182|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
154521183|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521184|NCT05168007|Cariprazine|cariprazine|mesh-list
154521185|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154521186|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154521187|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521188|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521189|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154521190|NCT02032927|Acetaminophen|acetaminophen|mesh-list
154521191|NCT02032927|Oxycodone|oxycodone|mesh-list
154521192|NCT02032927|Codeine|codeine|mesh-list
154521193|NCT02032927|Naloxone|naloxone|mesh-list
154521194|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154521195|NCT02032927|Analgesics|analgesics|mesh-ancestor
154521196|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
154521197|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521198|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860250|NCT00630344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521199|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
154521200|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154521201|NCT02032927|Narcotics|narcotics|mesh-ancestor
154521202|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521203|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154521204|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
154521205|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
154521206|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154521207|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
154521208|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521209|NCT03392103|Raltitrexed|raltitrexed|mesh-list
154521210|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154521211|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
154521212|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521213|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521214|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154521215|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521216|NCT03610945|Fluconazole|fluconazole|mesh-list
154521217|NCT03610945|Quinidine|quinidine|mesh-list
154521218|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
154521219|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521220|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154521221|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154521222|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521223|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521224|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154521225|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
154521226|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521227|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521228|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154521229|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154521230|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154521231|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154521232|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154521233|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521234|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154521235|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
154521236|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154521237|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154521238|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154521239|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154521240|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
154521241|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154521242|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154521243|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154521245|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
154521246|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154521247|NCT05167851|Lazertinib|lazertinib|mesh-list
154521248|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154521249|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521250|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521251|NCT02236715|Ipratropium|ipratropium|mesh-list
154521252|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154521253|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
154521254|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521255|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521256|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154521257|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
154521258|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154521259|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
154521260|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521261|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521262|NCT03823365|Blinatumomab|blinatumomab|mesh-list
154521263|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521264|NCT03616691|Bevacizumab|bevacizumab|mesh-list
154521265|NCT03616691|Atezolizumab|atezolizumab|mesh-list
154521266|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154521267|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154521268|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521269|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154521270|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154521271|NCT03616691|Growth Substances|growth substances|mesh-ancestor
154521272|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521273|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
154521274|NCT03616691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154521275|NCT03616691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521276|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
154521277|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
154521278|NCT03158168|Astringents|astringents|mesh-ancestor
154521279|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521280|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
154521282|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154521283|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521284|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521285|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154521286|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521287|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
154521288|NCT03156062|Salicylates|salicylates|mesh-list
154521289|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521290|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
154521291|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
154521292|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
154521293|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154521294|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154521295|NCT03156062|Analgesics|analgesics|mesh-ancestor
154521296|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
154521297|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521298|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521299|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521300|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521301|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154521302|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521303|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521304|NCT03404739|Ceftazidime|ceftazidime|mesh-list
154521305|NCT03404739|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154521306|NCT03404739|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154521307|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154521308|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521309|NCT02031965|Dexamethasone|dexamethasone|mesh-list
154521310|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521311|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
154521312|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
154521313|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521314|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521315|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521316|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
154521317|NCT02031965|Hormones|hormones|mesh-ancestor
154290384|NCT02275546|NuvaRing|nuvaring|mesh-list
154290418|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
154521318|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521319|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154521320|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521321|NCT03149120|Nivolumab|nivolumab|mesh-list
154521322|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154521323|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521324|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154521325|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521326|NCT04849325|Sirolimus|sirolimus|mesh-list
154521327|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154521328|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521329|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154521330|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521331|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
154521332|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154521333|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
154521334|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521335|NCT03403023|Cyclosporine|cyclosporine|mesh-list
154521336|NCT03403023|Cyclosporins|cyclosporins|mesh-list
154521337|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521338|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521339|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154521340|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
154521341|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521342|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
154521343|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521344|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
154521345|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521346|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154521347|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
154521348|NCT02864407|Olodaterol|olodaterol|mesh-list
154521349|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154521350|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
154521351|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521352|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290419|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290420|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154290422|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
154521353|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154521354|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
154521355|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
154521356|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154521357|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
154521358|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521359|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521360|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154521361|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154521362|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521363|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154521364|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521365|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521366|NCT03394989|Fluticasone|fluticasone|mesh-list
154521368|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154521369|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154521370|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521371|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154521372|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
154521373|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521374|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521375|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154521376|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
154521377|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
154521378|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154521379|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154521380|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154521381|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154521382|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
154521383|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521384|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521385|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
154521386|NCT03394989|Hormones|hormones|mesh-ancestor
154521387|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521388|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
154521389|NCT02033239|Insulin|insulin|mesh-list
154521390|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154521391|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
154521392|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
154521393|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154521394|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154521395|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521396|NCT02486302|Etanercept|etanercept|mesh-list
154521397|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154521398|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154521399|NCT02486302|Analgesics|analgesics|mesh-ancestor
154521400|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
154521401|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521402|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521403|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521404|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521405|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521406|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154521407|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
154521408|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154521409|NCT02034097|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154521410|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154521411|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521412|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521413|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521414|NCT03615833|Vitamin D|vitamin d|mesh-list
154521415|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
154521416|NCT03615833|Vitamins|vitamins|mesh-ancestor
154521417|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
154521418|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521419|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154521420|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154521421|NCT02747875|Fentanyl|fentanyl|mesh-list
154521422|NCT02747875|Methadone|methadone|mesh-list
154521423|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154521424|NCT02747875|Narcotics|narcotics|mesh-ancestor
154521425|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521426|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521427|NCT02747875|Analgesics|analgesics|mesh-ancestor
154521428|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
154521429|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521430|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154521431|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154521432|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
154521433|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
154521434|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
154521435|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
154521436|NCT03394833|Polygeline|polygeline|mesh-list
154521437|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
154521438|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
154521439|NCT02347358|Plasminogen|plasminogen|mesh-list
154521440|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154521441|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154521442|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154521443|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521444|NCT03610321|Gefarnate|gefarnate|mesh-list
154521445|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154521446|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521447|NCT02236793|Becaplermin|becaplermin|mesh-list
154521448|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
154290502|NCT00620464|Hormones|hormones|mesh-ancestor
154521449|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154521450|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154521451|NCT02236793|Growth Substances|growth substances|mesh-ancestor
154521452|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521453|NCT02347046|Dotinurad|dotinurad|mesh-list
154521454|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
154521455|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
154521456|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521457|NCT03391245|Vitamin D|vitamin d|mesh-list
154521458|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154521459|NCT03391245|Calcifediol|calcifediol|mesh-list
154521460|NCT03391245|Vitamins|vitamins|mesh-ancestor
154521461|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
154521462|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521463|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154521464|NCT03401619|Vitamin D|vitamin d|mesh-list
154521465|NCT03401619|Calcitonin|calcitonin|mesh-list
154245293|NCT05615948|Ketamine|ketamine|mesh-list
154521466|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
154521467|NCT03401619|Diphosphonates|diphosphonates|mesh-list
154521468|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154521469|NCT03401619|Katacalcin|katacalcin|mesh-list
154521471|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
154521472|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521473|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154521474|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154521475|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
154521476|NCT03399903|Mesalamine|mesalamine|mesh-list
154521477|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154521478|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154521479|NCT03399903|Analgesics|analgesics|mesh-ancestor
154521480|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
154521481|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521482|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521483|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521484|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521485|NCT03146468|Nivolumab|nivolumab|mesh-list
154521486|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154521487|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521488|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154521489|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521490|NCT02353130|Memantine|memantine|mesh-list
154521491|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154521492|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154521493|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
154521494|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521495|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521496|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521497|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154521498|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154521499|NCT02033551|Paclitaxel|paclitaxel|mesh-list
154521500|NCT02033551|Carboplatin|carboplatin|mesh-list
154521502|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154521503|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521504|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
154521505|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
154521506|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
154521507|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521508|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154521509|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521510|NCT02450578|Atovaquone|atovaquone|mesh-list
154521511|NCT02450578|Proguanil|proguanil|mesh-list
154521512|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154521513|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521514|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
154521515|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154521516|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154521517|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521518|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521519|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
154521520|NCT02346890|Sevelamer|sevelamer|mesh-list
154521521|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
154521522|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
154521523|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521524|NCT03146390|Listerine|listerine|mesh-list
154521525|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
154521526|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154521527|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521528|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
154521529|NCT03146390|Protective Agents|protective agents|mesh-ancestor
154521530|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521531|NCT02859415|Plicamycin|plicamycin|mesh-list
154521532|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154521533|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521534|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154521535|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521536|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154521537|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521538|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521539|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154521540|NCT02871791|Everolimus|everolimus|mesh-list
154521541|NCT02871791|Palbociclib|palbociclib|mesh-list
154521542|NCT02871791|Exemestane|exemestane|mesh-list
154521543|NCT02871791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154521544|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154521545|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521546|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521547|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154521548|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
154521549|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521550|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521551|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154521552|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154521553|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154521554|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
154521555|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521556|NCT02346578|Flutamide|flutamide|mesh-list
154521557|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
154521558|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
154521559|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521560|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521561|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154521562|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521563|NCT03112382|Vitamins|vitamins|mesh-list
154521564|NCT03112382|Vitamin A|vitamin a|mesh-list
154521565|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
154521566|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
154521567|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521568|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
154521569|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521570|NCT03112382|Protective Agents|protective agents|mesh-ancestor
154521571|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154521572|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521573|NCT03399669|Gefitinib|gefitinib|mesh-list
154521574|NCT03399669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154356405|NCT03784066|Durvalumab|durvalumab|mesh-list
154521576|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521577|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521578|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521579|NCT03148574|Misoprostol|misoprostol|mesh-list
154521580|NCT03148574|Oxytocin|oxytocin|mesh-list
154521581|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
154521582|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154521583|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521584|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154521585|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
154521586|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154521587|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521588|NCT02343536|Prednisone|prednisone|mesh-list
154521589|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
154521590|NCT02343536|Rituximab|rituximab|mesh-list
154521591|NCT02343536|Vincristine|vincristine|mesh-list
154521592|NCT02343536|Azacitidine|azacitidine|mesh-list
154521593|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154521594|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
154521595|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521596|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521597|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154521598|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
154521599|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521600|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521601|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154521602|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154521603|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521604|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
154521605|NCT02343536|Hormones|hormones|mesh-ancestor
154521606|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521607|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154521608|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154521609|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
154521610|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
154521611|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
154521612|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154521613|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
154521614|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521615|NCT02343614|Celecoxib|celecoxib|mesh-list
154521616|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154521617|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154521618|NCT02343614|Analgesics|analgesics|mesh-ancestor
154521619|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
154521620|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521621|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521622|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521623|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521624|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154290678|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
154521625|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154521626|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521627|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521628|NCT02871635|Adalimumab|adalimumab|mesh-list
154521629|NCT02871635|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154521630|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521631|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521632|NCT03390465|Amlodipine|amlodipine|mesh-list
154521633|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154521634|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154521635|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154521636|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154521637|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521638|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154521639|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521640|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
154521641|NCT03390465|Diuretics|diuretics|mesh-ancestor
154521642|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
154521643|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154521644|NCT03390387|Dexamethasone|dexamethasone|mesh-list
154521645|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
154521646|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
154521647|NCT03390387|Bortezomib|bortezomib|mesh-list
154521648|NCT03390387|Daunorubicin|daunorubicin|mesh-list
154521649|NCT03390387|Idarubicin|idarubicin|mesh-list
154521651|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521652|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
154521653|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
154521654|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521655|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521656|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521657|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
154521658|NCT03390387|Hormones|hormones|mesh-ancestor
154521659|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521660|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154521661|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521662|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
154521663|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521664|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521665|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154521666|NCT03390387|Protective Agents|protective agents|mesh-ancestor
154521667|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154521668|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154521669|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154521670|NCT03146000|Meloxicam|meloxicam|mesh-list
154521671|NCT03146000|Lidocaine|lidocaine|mesh-list
154521672|NCT03146000|Prilocaine|prilocaine|mesh-list
154521673|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154521674|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
154521675|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
154521676|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521677|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290722|NCT03726242|Cromakalim|cromakalim|mesh-list
154521678|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
154521679|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521680|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154521681|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154521682|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154521683|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154521684|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521685|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154521686|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154521687|NCT03146000|Analgesics|analgesics|mesh-ancestor
154521688|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521689|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521690|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154521691|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154521692|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521693|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154245511|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154521694|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
154521695|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
154521696|NCT02346188|Trace Elements|trace elements|mesh-ancestor
154521697|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
154521698|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521699|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
154521700|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
154521701|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154521702|NCT02346188|Protective Agents|protective agents|mesh-ancestor
154521703|NCT02477332|Omalizumab|omalizumab|mesh-list
154521704|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154521705|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154521706|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
154521707|NCT02346110|Dexamethasone|dexamethasone|mesh-list
154521708|NCT02346110|Epinephrine|epinephrine|mesh-list
154521709|NCT02346110|Racepinephrine|racepinephrine|mesh-list
154521710|NCT02346110|Bupivacaine|bupivacaine|mesh-list
154521711|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
154521712|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521713|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
154521714|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
154521715|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521716|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521717|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521718|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
154521719|NCT02346110|Hormones|hormones|mesh-ancestor
154521720|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521721|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154521722|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521723|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
154521724|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
154860251|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154521725|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521726|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
154521727|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154521728|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154521729|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
154521730|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521731|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521732|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154521733|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154521734|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154521735|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
154521736|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
154521737|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
154521738|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154521739|NCT02348528|Dexamethasone|dexamethasone|mesh-list
154521740|NCT02348528|Lenalidomide|lenalidomide|mesh-list
154521741|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154521742|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
154521743|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
154521744|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521745|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521746|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521747|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
154521748|NCT02348528|Hormones|hormones|mesh-ancestor
154521749|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521750|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154521751|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521752|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
154521753|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154521754|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154521755|NCT02348528|Growth Substances|growth substances|mesh-ancestor
154521756|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
154521757|NCT02342600|Trametinib|trametinib|mesh-list
154521758|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521759|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154521760|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521761|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521762|NCT03147638|Warfarin|warfarin|mesh-list
154521763|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
154521764|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
154290818|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
154521765|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154521766|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154521767|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
154521768|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
154521769|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521770|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521771|NCT02862535|Nivolumab|nivolumab|mesh-list
154521772|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
154521773|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521774|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154521775|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154521776|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521777|NCT02033707|Scopolamine|scopolamine|mesh-list
154521778|NCT02033707|Hallucinogens|hallucinogens|mesh-list
154521779|NCT02033707|Nicotine|nicotine|mesh-list
154521780|NCT02033707|Histamine Antagonists|histamine antagonists|mesh-list
154521781|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154521782|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
154521783|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521784|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521785|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154521786|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154521787|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
154521788|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521789|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521790|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154521791|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
154521792|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521793|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
154521794|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154521795|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154521796|NCT02033707|Histamine Agents|histamine agents|mesh-ancestor
154521797|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154521798|NCT02039336|Docetaxel|docetaxel|mesh-list
154521799|NCT02039336|Dacomitinib|dacomitinib|mesh-list
154521800|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521801|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154521802|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154521803|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154521804|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521805|NCT02039336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154521806|NCT02039336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154521807|NCT02039336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521808|NCT04935476|Dapsone|dapsone|mesh-list
154521809|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521810|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
154521811|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154521812|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154521813|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154521814|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521815|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521816|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
154521817|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154521818|NCT02476006|Atorvastatin|atorvastatin|mesh-list
154521819|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154521820|NCT02476006|Simvastatin|simvastatin|mesh-list
154521821|NCT02476006|Ezetimibe|ezetimibe|mesh-list
154521822|NCT02476006|Alirocumab|alirocumab|mesh-list
154521823|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154521824|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154521825|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
154521826|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521827|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154521828|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154521829|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521830|NCT02476006|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154521831|NCT02476006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154521832|NCT02476006|Protease Inhibitors|protease inhibitors|mesh-ancestor
154521833|NCT02344940|Tamoxifen|tamoxifen|mesh-list
154521834|NCT02344940|Toremifene|toremifene|mesh-list
154521835|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154521836|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
154521837|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521838|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521839|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154521840|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521841|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154521842|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154521843|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154521844|NCT03615677|Esomeprazole|esomeprazole|mesh-list
154521845|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154521846|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521847|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154521848|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521849|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521850|NCT02344862|Dotinurad|dotinurad|mesh-list
154521851|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
154521852|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
154290901|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
154521853|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154521854|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
154521855|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154521856|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521857|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
154521858|NCT03614273|Epinephrine|epinephrine|mesh-list
154521859|NCT03614273|Racepinephrine|racepinephrine|mesh-list
154521860|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
154521861|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154521862|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154521863|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
154521864|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521865|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521866|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521867|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154521868|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154521869|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
154521870|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521871|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154521872|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
154521873|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
154521874|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
154521875|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154521876|NCT02336984|Trastuzumab|trastuzumab|mesh-list
154521877|NCT02336984|Pertuzumab|pertuzumab|mesh-list
154521878|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154521879|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521880|NCT03145610|Triclosan|triclosan|mesh-list
154521881|NCT03145610|Fluorides|fluorides|mesh-list
154521882|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
154521883|NCT03145610|Protective Agents|protective agents|mesh-ancestor
154521884|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521885|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154521886|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521887|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154521888|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154521889|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
154521890|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521891|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154521892|NCT02341586|Iron|iron|mesh-list
154521893|NCT02341586|Trace Elements|trace elements|mesh-ancestor
154521894|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
154521895|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521896|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154521897|NCT02336906|Laxatives|laxatives|mesh-ancestor
154521898|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154521899|NCT03613961|Anesthetics|anesthetics|mesh-list
154521900|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521901|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521902|NCT02341352|Fluorides|fluorides|mesh-list
154521903|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
154521904|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
154521905|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154521906|NCT02341352|Antibodies|antibodies|mesh-list
154521907|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
154521908|NCT02341352|Protective Agents|protective agents|mesh-ancestor
154521909|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521910|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
154521911|NCT02344550|Everolimus|everolimus|mesh-list
154521912|NCT02344550|Letrozole|letrozole|mesh-list
154521913|NCT02344550|Leuprolide|leuprolide|mesh-list
154521914|NCT02344550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154521915|NCT02344550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154521916|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521917|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521918|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154521919|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
154521920|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521921|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154521922|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154521923|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154521924|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154521925|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
154521926|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521927|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154521928|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
154521929|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154521930|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154521931|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
154521932|NCT02419612|Glimepiride|glimepiride|mesh-list
154521933|NCT02419612|Saxagliptin|saxagliptin|mesh-list
154521934|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154521935|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521936|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154521937|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521938|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154521939|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154521940|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
154521941|NCT02419612|Incretins|incretins|mesh-ancestor
154521942|NCT02419612|Hormones|hormones|mesh-ancestor
154521943|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154521944|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154521945|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
154521946|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154521947|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
154521948|NCT03612947|Bupivacaine|bupivacaine|mesh-list
154521949|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
154521950|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
154521951|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521952|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521953|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
154860252|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
154860253|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521954|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521955|NCT03612947|Analgesics|analgesics|mesh-ancestor
154521956|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154521957|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
154521958|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154521959|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154521960|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521961|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154521962|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
154521963|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154521964|NCT02344784|Methylphenidate|methylphenidate|mesh-list
154521965|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154521966|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521967|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154521968|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154521969|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154521970|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521971|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
154521972|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154521973|NCT02447848|Sufentanil|sufentanil|mesh-list
154521974|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154521975|NCT02447848|Narcotics|narcotics|mesh-ancestor
154521976|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154521977|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521978|NCT02447848|Analgesics|analgesics|mesh-ancestor
154521979|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
154521980|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521981|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154521982|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154521983|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
154521984|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
154521985|NCT02336516|Azithromycin|azithromycin|mesh-list
154521986|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154521987|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154521988|NCT05254652|Pregabalin|pregabalin|mesh-list
154521989|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154521990|NCT05254652|Analgesics|analgesics|mesh-ancestor
154521991|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
154521992|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154521993|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154521994|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
154521995|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154521996|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154521997|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154521998|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154521999|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154522000|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154522001|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522003|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154522004|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154522005|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522006|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
154522007|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
154522008|NCT02343926|Metformin|metformin|mesh-list
154522009|NCT02343926|Vildagliptin|vildagliptin|mesh-list
154522010|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154522011|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522012|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154522013|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
154522014|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522015|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522016|NCT03112226|Estradiol|estradiol|mesh-list
154522017|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
154522018|NCT03112226|Estrogens|estrogens|mesh-ancestor
154522019|NCT03112226|Hormones|hormones|mesh-ancestor
154522020|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522021|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522022|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
154522023|NCT02343692|Pancrelipase|pancrelipase|mesh-list
154522024|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154522025|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
154522026|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154522027|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154522028|NCT02332616|Prednisolone|prednisolone|mesh-list
154522029|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
154522030|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154522031|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
154522032|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522033|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
154522034|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
154522035|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522036|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522037|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154522038|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
154522039|NCT02332616|Hormones|hormones|mesh-ancestor
154522040|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522041|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154522042|NCT02332616|Protective Agents|protective agents|mesh-ancestor
154522043|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154522044|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522045|NCT03618173|Dexamethasone|dexamethasone|mesh-list
154522046|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
154522047|NCT03618173|BB 1101|bb 1101|mesh-list
154522048|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522049|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
154522050|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
154522051|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522052|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522053|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154522054|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
154522055|NCT03618173|Hormones|hormones|mesh-ancestor
154522056|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522057|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154522058|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522059|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
154522060|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522061|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522062|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
154522063|NCT02336048|Chlorambucil|chlorambucil|mesh-list
154522064|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154522065|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522066|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154522067|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
154522068|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522069|NCT03612401|Mirabegron|mirabegron|mesh-list
154522070|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154522071|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154522072|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154522073|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522074|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522075|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522076|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522077|NCT03612401|Urological Agents|urological agents|mesh-ancestor
154522079|NCT03612323|Carticaine|carticaine|mesh-list
154522080|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
154522081|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
154522082|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522083|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522084|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
154522085|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522086|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154522087|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522088|NCT03612323|Analgesics|analgesics|mesh-ancestor
154522089|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522090|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154522091|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154522092|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522093|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522094|NCT02994719|Amantadine|amantadine|mesh-list
154522095|NCT02994719|Levodopa|levodopa|mesh-list
154522096|NCT02994719|Carbidopa|carbidopa|mesh-list
154522097|NCT02994719|Pramipexole|pramipexole|mesh-list
154522098|NCT02994719|Ropinirole|ropinirole|mesh-list
154522099|NCT02994719|Entacapone|entacapone|mesh-list
154522100|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154522101|NCT02994719|Tolcapone|tolcapone|mesh-list
154522102|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154522103|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154522104|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
154522105|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522106|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522107|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522108|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154522109|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522110|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
154522111|NCT02994719|Protective Agents|protective agents|mesh-ancestor
154522112|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
154522113|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
154522114|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522115|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522116|NCT02994719|Analgesics|analgesics|mesh-ancestor
154522117|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
154522118|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522119|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154522120|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154522121|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
154522122|NCT02335736|Cetrorelix|cetrorelix|mesh-list
154522123|NCT02335736|Hormones|hormones|mesh-list
154522124|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
154522125|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522126|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291183|NCT03430856|Insulin|insulin|mesh-list
154522127|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154522128|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
154522129|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154522130|NCT03613259|Alovudine|alovudine|mesh-list
154522131|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
154522132|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522133|NCT02032355|Anesthetics|anesthetics|mesh-list
154522134|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522135|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522136|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
154522137|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154522138|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
154522139|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522140|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522141|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154522142|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
154522143|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
154522144|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154522145|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
154522146|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522147|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522148|NCT03612557|Penicillins|penicillins|mesh-list
154522149|NCT03612557|Penicillin G|penicillin g|mesh-list
154522150|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154522151|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
154522152|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154522153|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522155|NCT03067844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154522156|NCT03067844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154522157|NCT03067844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154522158|NCT03067844|Antimetabolites|antimetabolites|mesh-ancestor
154522159|NCT03067844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522160|NCT03067844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154522161|NCT03067844|Protease Inhibitors|protease inhibitors|mesh-ancestor
154522162|NCT03067844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522163|NCT03067844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154522164|NCT02340182|Metronidazole|metronidazole|mesh-list
154522165|NCT02340182|Vancomycin|vancomycin|mesh-list
154522166|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
154522167|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522168|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154522169|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154522170|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154522171|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154522172|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154522173|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522174|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522175|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522176|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154522177|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154522178|NCT02339714|Loratadine|loratadine|mesh-list
154522179|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
154522180|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
154522181|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154522182|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154522183|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154522184|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
154522185|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
154522186|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522187|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522188|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522189|NCT02335190|Lidocaine|lidocaine|mesh-list
154522190|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
154522191|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
154522192|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522193|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522194|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
154522195|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522196|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154522197|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154522198|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154522199|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154522200|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522201|NCT02339324|Interferons|interferons|mesh-list
154522202|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
154522203|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
154522204|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
154522205|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154522206|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522207|NCT02339324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154522208|NCT02339324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522209|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
154522210|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522211|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
154522212|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522213|NCT02418754|Aflibercept|aflibercept|mesh-list
154522214|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154522215|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154522216|NCT02418754|Growth Substances|growth substances|mesh-ancestor
154522217|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522218|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
154522219|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522220|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
154522221|NCT02334488|Everolimus|everolimus|mesh-list
154246040|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154522222|NCT02334488|Tacrolimus|tacrolimus|mesh-list
154522223|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154522224|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
154522225|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522226|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154522227|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522228|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522229|NCT02334488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154522230|NCT02334488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154522231|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522232|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154522233|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154522234|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
154522235|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154522236|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522237|NCT02862457|Paclitaxel|paclitaxel|mesh-list
154522238|NCT02862457|Cisplatin|cisplatin|mesh-list
154522239|NCT02862457|Carboplatin|carboplatin|mesh-list
154522240|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
154522241|NCT02862457|Pemetrexed|pemetrexed|mesh-list
154522242|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154522243|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522244|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
154522245|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
154522246|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
154522247|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522248|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154522249|NCT02862457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154522250|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522251|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154522252|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154522253|NCT02334254|Warfarin|warfarin|mesh-list
154522255|NCT02334254|Clopidogrel|clopidogrel|mesh-list
154522256|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154522257|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154522258|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154522259|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154522260|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
154522261|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522262|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522263|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522264|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
154522265|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154522266|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
154522267|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154522268|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
154522269|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522270|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
154522271|NCT02331602|Dabigatran|dabigatran|mesh-list
154522272|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154522273|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
154522274|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154522275|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
154522276|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522277|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522278|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
154522279|NCT02338934|Vitamin D|vitamin d|mesh-list
154522280|NCT02338934|Cinacalcet|cinacalcet|mesh-list
154522281|NCT02338934|Vitamins|vitamins|mesh-ancestor
154522282|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
154522283|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522284|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154522285|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154522286|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154522287|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
154522288|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522289|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154522290|NCT03861039|Tirzepatide|tirzepatide|mesh-list
154522291|NCT03861039|Incretins|incretins|mesh-ancestor
154522292|NCT03861039|Hormones|hormones|mesh-ancestor
154522293|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522294|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522295|NCT02334176|Lidocaine|lidocaine|mesh-list
154522296|NCT02334176|Epinephrine|epinephrine|mesh-list
154522297|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
154246123|NCT03391427|Lidocaine|lidocaine|mesh-list
154522298|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
154522299|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522300|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522301|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
154522302|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522303|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154522304|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154522305|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154522306|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154522307|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522308|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154522309|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154522310|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522311|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522312|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154291368|NCT03953001|Lidocaine|lidocaine|mesh-list
154522313|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154522314|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
154522315|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154522316|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
154522317|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
154522318|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
154522319|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154522320|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
154522321|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522322|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154522323|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154522324|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522325|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522326|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
154522327|NCT03609307|Bevacizumab|bevacizumab|mesh-list
154522328|NCT03609307|Propranolol|propranolol|mesh-list
154522329|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154522330|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522331|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154522332|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154522333|NCT03609307|Growth Substances|growth substances|mesh-ancestor
154522334|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522335|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
154522336|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154522337|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154522338|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522339|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522340|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522341|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154522342|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154522343|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
154522344|NCT03399435|Epinephrine|epinephrine|mesh-list
154522345|NCT03399435|Racepinephrine|racepinephrine|mesh-list
154522346|NCT03399435|Bupivacaine|bupivacaine|mesh-list
154522347|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
154522348|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
154522349|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
154522350|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
154522351|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522352|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522353|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
154522354|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522355|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154522356|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154522357|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522358|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522359|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522360|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154522361|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154522362|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
154522363|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154522364|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
154522365|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
154522366|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
154522367|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154522368|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154522369|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154522370|NCT01936688|Etanercept|etanercept|mesh-list
154522371|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154522372|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522373|NCT01936688|Analgesics|analgesics|mesh-ancestor
154246186|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
154522374|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
154522375|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522376|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522377|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522378|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154522379|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154522380|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154522381|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
154522382|NCT02338544|Adapalene|adapalene|mesh-list
154522383|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154522384|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
154522385|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154522386|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522387|NCT02338544|Analgesics|analgesics|mesh-ancestor
154522388|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
154522389|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522390|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522391|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522392|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154522393|NCT04446663|Paclitaxel|paclitaxel|mesh-list
154522394|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154522395|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154522396|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522397|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
154522398|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
154522399|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
154522400|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522401|NCT01861496|Cisplatin|cisplatin|mesh-list
154522402|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860254|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522403|NCT02520219|Endostar protein|endostar protein|mesh-list
154522404|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154522405|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154522406|NCT02520219|Growth Substances|growth substances|mesh-ancestor
154522407|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522408|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
154522409|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522410|NCT03394287|Apatinib|apatinib|mesh-list
154522411|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522412|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154522413|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522414|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522415|NCT02338622|Olaparib|olaparib|mesh-list
154522416|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154522417|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522418|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522419|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522420|NCT02338466|Tenecteplase|tenecteplase|mesh-list
154522421|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154522422|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154522423|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522424|NCT03394209|Oseltamivir|oseltamivir|mesh-list
154522425|NCT03394209|Favipiravir|favipiravir|mesh-list
154522426|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
154522427|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522428|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522429|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522430|NCT03399201|Anesthetics|anesthetics|mesh-list
154522431|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522432|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522433|NCT02520453|Durvalumab|durvalumab|mesh-list
154522434|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154522435|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522436|NCT03389763|Remifentanil|remifentanil|mesh-list
154522437|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154522438|NCT03389763|Narcotics|narcotics|mesh-ancestor
154522439|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522440|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522441|NCT03389763|Analgesics|analgesics|mesh-ancestor
154522442|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
154522443|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522444|NCT02866175|Vitamin K|vitamin k|mesh-list
154522445|NCT02866175|Edoxaban|edoxaban|mesh-list
154522446|NCT02866175|Clopidogrel|clopidogrel|mesh-list
154522447|NCT02866175|Ticagrelor|ticagrelor|mesh-list
154522448|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154522449|NCT02866175|Vitamins|vitamins|mesh-ancestor
154522450|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
154522451|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522452|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154522453|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154038357|NCT04153734|Paclitaxel|paclitaxel|mesh-list
154522454|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154522456|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
154522457|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522458|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522459|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154522460|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154522461|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
154522462|NCT02866175|Coagulants|coagulants|mesh-ancestor
154522463|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154522464|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
154522465|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154522466|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
154522467|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522468|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
154522469|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
154522470|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154522471|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
154522472|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522473|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
154522474|NCT02330822|Protective Agents|protective agents|mesh-ancestor
154522475|NCT02338310|Letrozole|letrozole|mesh-list
154522476|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154522477|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522478|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154522479|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522480|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522481|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154522482|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
154522483|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522484|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522485|NCT03389607|Anesthetics|anesthetics|mesh-list
154522486|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522487|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522488|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
154522489|NCT02817789|Clopidogrel|clopidogrel|mesh-list
154522490|NCT02817789|Ticagrelor|ticagrelor|mesh-list
154522491|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154522492|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154522493|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154522494|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154522495|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
154522496|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522497|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522498|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522499|NCT02817789|Analgesics|analgesics|mesh-ancestor
154522500|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
154291543|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522501|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522502|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154522503|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522504|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522505|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154522506|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154522507|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522508|NCT05383625|Vaccines|vaccines|mesh-list
154522509|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
154522510|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522511|NCT03389451|Edetic Acid|edetic acid|mesh-list
154522512|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154522513|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
154522514|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
154522515|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522516|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
154522517|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154522518|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154522519|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154522520|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154522521|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154246340|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
154522522|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154522523|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522524|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522525|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
154522526|NCT02330120|Propofol|propofol|mesh-list
154522527|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154522528|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522529|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522530|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522531|NCT02330120|Analgesics|analgesics|mesh-ancestor
154522532|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
154522533|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522534|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154522535|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154522536|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154522537|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522538|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522539|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522540|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154522541|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
154522542|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
154522543|NCT03389295|Cisplatin|cisplatin|mesh-list
154522544|NCT03389295|Docetaxel|docetaxel|mesh-list
154522545|NCT03389295|Fluorouracil|fluorouracil|mesh-list
154522546|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522547|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
154522548|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
154522549|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
154522550|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522551|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
154522552|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154522553|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154522554|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
154522555|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291604|NCT01097811|Erythromycin|erythromycin|mesh-list
154522556|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154522557|NCT03398811|Etonogestrel|etonogestrel|mesh-list
154522558|NCT03398811|Desogestrel|desogestrel|mesh-list
154522559|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
154522560|NCT03398811|Progesterone|progesterone|mesh-list
154522561|NCT03398811|Progestins|progestins|mesh-ancestor
154522562|NCT03398811|Hormones|hormones|mesh-ancestor
154522563|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522564|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522565|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154522566|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
154522567|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154522568|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154522569|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154522570|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154522571|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154522572|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154522573|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154522574|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522575|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
154522576|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154522577|NCT01300143|Estrogens|estrogens|mesh-ancestor
154522578|NCT01300143|Hormones|hormones|mesh-ancestor
154522579|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522580|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522581|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154522582|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522583|NCT01336205|Naloxegol|naloxegol|mesh-list
154522584|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154522585|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522586|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
154522587|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522588|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
154522589|NCT03610685|Prednisolone|prednisolone|mesh-list
154522590|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522591|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
154522592|NCT03610685|Hormones|hormones|mesh-ancestor
154522593|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522594|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522595|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154522596|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522597|NCT02327234|Ibuprofen|ibuprofen|mesh-list
154246413|NCT02244125|Dexamethasone|dexamethasone|mesh-list
154522598|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154522599|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522600|NCT02327234|Analgesics|analgesics|mesh-ancestor
154522601|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
154522602|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522603|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522604|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522605|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154522606|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154522607|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522608|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522609|NCT01123707|Aripiprazole|aripiprazole|mesh-list
154522610|NCT01123707|Escitalopram|escitalopram|mesh-list
154522611|NCT01123707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154522612|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154522613|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154522614|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522615|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522616|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
154522617|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522618|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
154522619|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154522620|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154522621|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154522622|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522623|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
154522624|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
154522625|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154522626|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154522627|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154522628|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154522629|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154522630|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154522631|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
154522632|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
154522633|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154522634|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
154522635|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522636|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522637|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154522638|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
154522639|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154522640|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154522641|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154522642|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522643|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522644|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522645|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154522646|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
154522647|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154522648|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
154522649|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154522650|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522651|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522652|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522653|NCT02327156|Analgesics|analgesics|mesh-ancestor
154522654|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
154522655|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522656|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154522657|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154522658|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154522659|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522660|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522661|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522662|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154522663|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
154522664|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154522665|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
154522666|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522667|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
154522668|NCT02039804|Protective Agents|protective agents|mesh-ancestor
154522669|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246488|NCT01504815|Cisplatin|cisplatin|mesh-list
154522671|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
154522672|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154522673|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154522674|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154522675|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154522676|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522677|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
154522678|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522679|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522680|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154522681|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522682|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522683|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154522684|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522685|NCT02327000|Pregabalin|pregabalin|mesh-list
154522686|NCT02327000|Analgesics|analgesics|mesh-ancestor
154522687|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
154522688|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522689|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522690|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
154522691|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154522692|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154522693|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522694|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154522695|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154522696|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154522697|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522698|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154860255|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
154522699|NCT02033603|Ropivacaine|ropivacaine|mesh-list
154522700|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
154522701|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
154522702|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522703|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522704|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
154522705|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522706|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
154522707|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154522708|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
154522709|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154522710|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522711|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154522712|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154522713|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154522714|NCT00862251|Atorvastatin|atorvastatin|mesh-list
154522715|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154522716|NCT00862251|Simvastatin|simvastatin|mesh-list
154522717|NCT00862251|Ezetimibe|ezetimibe|mesh-list
154522718|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154522719|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154522720|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
154522721|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522722|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154522723|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154522724|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522725|NCT00885963|Sapacitabine|sapacitabine|mesh-list
154522726|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522727|NCT00725127|Aspirin|aspirin|mesh-list
154522728|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154522729|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154522730|NCT00725127|Analgesics|analgesics|mesh-ancestor
154522731|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
154522732|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522733|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522734|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291788|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154522735|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154522736|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154522737|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154522738|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522739|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154522740|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154522741|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522742|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
154522743|NCT02328950|Cytarabine|cytarabine|mesh-list
154522745|NCT02328950|Busulfan|busulfan|mesh-list
154522746|NCT02328950|Fludarabine|fludarabine|mesh-list
154522747|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154522748|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
154522749|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522750|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154522751|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154522752|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
154522753|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522754|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522755|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154522756|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154522757|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
154522758|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
154522759|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522760|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
154522761|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154522762|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522763|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154522764|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522765|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
154522766|NCT03389061|Velpatasvir|velpatasvir|mesh-list
154522767|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154522768|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
154522769|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522770|NCT02038868|Tamsulosin|tamsulosin|mesh-list
154522771|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154522772|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154522773|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154522774|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522775|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522776|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522777|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522778|NCT02038868|Urological Agents|urological agents|mesh-ancestor
154522779|NCT02328794|Varenicline|varenicline|mesh-list
154522780|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154522781|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154522782|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
154522783|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522784|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522785|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522786|NCT03388827|Misoprostol|misoprostol|mesh-list
154522787|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154522788|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
154522789|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154522790|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522791|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154522792|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154522793|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
154522794|NCT02328716|Cisplatin|cisplatin|mesh-list
154522795|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522796|NCT00445107|Montelukast|montelukast|mesh-list
154522797|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154522798|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
154522799|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154522800|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
154522801|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522802|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522803|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154522804|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154522805|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522806|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
154522807|NCT05077592|Povidone|povidone|mesh-list
154522808|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
154522809|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
154522810|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154522811|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522812|NCT00038727|Metformin|metformin|mesh-list
154522813|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154522814|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522815|NCT02864381|Nivolumab|nivolumab|mesh-list
154522816|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154522817|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522818|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154522819|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522820|NCT05230472|Simvastatin|simvastatin|mesh-list
154522821|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154522822|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154522823|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
154522824|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522825|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154522826|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154522827|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522828|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
154522829|NCT03398031|Antacids|antacids|mesh-ancestor
154522830|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522831|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154522832|NCT02039960|Bupropion|bupropion|mesh-list
154522833|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154522834|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
154522835|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154522836|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154522837|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154522838|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154522839|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522840|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
154522841|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522842|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522843|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154522844|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154522845|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522846|NCT05383313|Midazolam|midazolam|mesh-list
154522848|NCT05383313|Psilocybin|psilocybin|mesh-list
154522849|NCT05383313|Analgesics|analgesics|mesh-ancestor
154522850|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
154522851|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522852|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522853|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154522854|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154522855|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
154522856|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
154522857|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522858|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154522859|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154522860|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522861|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522862|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154522863|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154522864|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154522865|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154522866|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154522867|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
154522868|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
154522869|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
154522870|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154522871|NCT03144128|Vitamin D|vitamin d|mesh-list
154522872|NCT03144128|Vitamins|vitamins|mesh-ancestor
154522873|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
154522874|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522875|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154522876|NCT02326610|Hormones|hormones|mesh-list
154522877|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522878|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522879|NCT00409773|Atorvastatin|atorvastatin|mesh-list
154522880|NCT00409773|Simvastatin|simvastatin|mesh-list
154522881|NCT00409773|Ezetimibe|ezetimibe|mesh-list
154522882|NCT00409773|Calcium|calcium|mesh-list
154522883|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154522884|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522885|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154522886|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154522887|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
154522888|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522889|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154522890|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154522891|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154522892|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154522893|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154522894|NCT02034422|Antioxidants|antioxidants|mesh-list
154522895|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522896|NCT02034422|Protective Agents|protective agents|mesh-ancestor
154522897|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522898|NCT02325986|Fluorouracil|fluorouracil|mesh-list
154522899|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522900|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
154522901|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522902|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154522903|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154522904|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
154522905|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522906|NCT00398151|Montelukast|montelukast|mesh-list
154522907|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154522908|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
154522909|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154522910|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
154522911|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522912|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291967|NCT03554772|Celecoxib|celecoxib|mesh-list
154522913|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154522914|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154522915|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522916|NCT03610139|Vitamin D|vitamin d|mesh-list
154522917|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
154522918|NCT03610139|Vitamins|vitamins|mesh-ancestor
154522919|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
154522920|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522921|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154522922|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154522923|NCT02327624|Clopidogrel|clopidogrel|mesh-list
154522924|NCT02327624|Ticagrelor|ticagrelor|mesh-list
154522925|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154522926|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154522927|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154522928|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154522929|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
154522930|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522931|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522932|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522933|NCT03388671|Bupivacaine|bupivacaine|mesh-list
154522934|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
154522935|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
154522936|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522937|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522938|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
154522939|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522940|NCT02327936|Fesoterodine|fesoterodine|mesh-list
154522941|NCT02327936|Oxybutynin|oxybutynin|mesh-list
154522942|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154522943|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154522944|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
154522945|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522946|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522947|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522948|NCT02327936|Urological Agents|urological agents|mesh-ancestor
154522949|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
154292009|NCT03553758|Ketamine|ketamine|mesh-list
154522950|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
154522951|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154522952|NCT03609827|Melphalan|melphalan|mesh-list
154522953|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154522954|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
154522955|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522956|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154522957|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154522958|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154522959|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
154522960|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522961|NCT02858401|Vesatolimod|vesatolimod|mesh-list
154522962|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
154522963|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154522964|NCT03144596|Tamsulosin|tamsulosin|mesh-list
154522965|NCT03144596|Alfuzosin|alfuzosin|mesh-list
154522966|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154522967|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154522968|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154522969|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
154522970|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154522971|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522972|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522973|NCT03144596|Urological Agents|urological agents|mesh-ancestor
154522974|NCT00127647|Montelukast|montelukast|mesh-list
154522975|NCT00127647|Pranlukast|pranlukast|mesh-list
154522976|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154522977|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
154522978|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154522979|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
154522980|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154522981|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522982|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154522983|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154522984|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522985|NCT03111446|Anesthetics|anesthetics|mesh-list
154522986|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154522987|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154522988|NCT02034071|Diazoxide|diazoxide|mesh-list
154522989|NCT02034071|Choline|choline|mesh-list
154522990|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
154522991|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154522992|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
154292044|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
154558136|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860256|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
154522993|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154522994|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154522995|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154522996|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
154522997|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154522998|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
154522999|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
154523000|NCT03609359|Lenvatinib|lenvatinib|mesh-list
154523001|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523002|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523003|NCT03609359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154523004|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523005|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154523006|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523007|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154523008|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154523009|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154523010|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
154523011|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523012|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154523013|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154523014|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523015|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
154523016|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154523017|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154523018|NCT04822376|Ansuvimab|ansuvimab|mesh-list
154523019|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
154523020|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523021|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
154523022|NCT05173545|Analgesics|analgesics|mesh-ancestor
154523023|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
154523024|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523025|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523026|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523027|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154523028|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154523029|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523030|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523031|NCT02327702|Emtricitabine|emtricitabine|mesh-list
154523032|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
154523033|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523034|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154523035|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154523036|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523037|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246870|NCT04225026|Protective Agents|protective agents|mesh-ancestor
154523038|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154523039|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154523041|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154523042|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523043|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523044|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523045|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
154523046|NCT03690765|Progestins|progestins|mesh-ancestor
154523047|NCT03690765|Hormones|hormones|mesh-ancestor
154523048|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523049|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523051|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154523052|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523053|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
154523054|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154523055|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154523056|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
154523057|NCT03143972|Remifentanil|remifentanil|mesh-list
154523058|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154523059|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523060|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523061|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154523062|NCT03143972|Analgesics|analgesics|mesh-ancestor
154523063|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
154523064|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523065|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154523066|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154523067|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154523068|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
154523069|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523070|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523071|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154523072|NCT03143972|Narcotics|narcotics|mesh-ancestor
154523073|NCT02237027|Tenofovir|tenofovir|mesh-list
154523074|NCT02237027|Emtricitabine|emtricitabine|mesh-list
154523075|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154523076|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
154523077|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523078|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154523079|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154523080|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523081|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523082|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154523083|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154523084|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154523085|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154523086|NCT03143738|Anesthetics|anesthetics|mesh-list
154523087|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523088|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523089|NCT04393753|Avelumab|avelumab|mesh-list
154523090|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523091|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523092|NCT04647903|Amphetamine|amphetamine|mesh-list
154523093|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
154523094|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154523095|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523096|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
154523097|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
154523098|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523099|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
154523100|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523101|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523102|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
154523103|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154523104|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154523105|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523106|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154523107|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154523108|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154523109|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154523110|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523111|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523112|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
154523113|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523114|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154292183|NCT03639610|Melphalan|melphalan|mesh-list
154523115|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154523116|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
154523117|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154523118|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523119|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154523120|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154523121|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523122|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523123|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523124|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154523125|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154523126|NCT03380325|Iloprost|iloprost|mesh-list
154523127|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154523128|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
154523129|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154523130|NCT02237053|Octreotide|octreotide|mesh-list
154523131|NCT02237053|Glucagon|glucagon|mesh-list
154523132|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523133|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154523134|NCT02237053|Hormones|hormones|mesh-ancestor
154523135|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523136|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154523137|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523138|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
154523139|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
154523140|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154523141|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154523142|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523143|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154523145|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154523146|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154523147|NCT04997174|Analgesics|analgesics|mesh-ancestor
154523148|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
154523149|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523150|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523151|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523152|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523153|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154523154|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154523155|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523156|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523157|NCT02237209|Vaccines|vaccines|mesh-list
154523158|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
154523159|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523160|NCT03387111|Leucovorin|leucovorin|mesh-list
154523161|NCT03387111|Paclitaxel|paclitaxel|mesh-list
154523162|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
154523163|NCT03387111|Bevacizumab|bevacizumab|mesh-list
154523164|NCT03387111|Capecitabine|capecitabine|mesh-list
154523165|NCT03387111|Fluorouracil|fluorouracil|mesh-list
154523166|NCT03387111|Cetuximab|cetuximab|mesh-list
154523167|NCT03387111|Avelumab|avelumab|mesh-list
154523168|NCT03387111|Necitumumab|necitumumab|mesh-list
154523169|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154523170|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523171|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
154523172|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
154523173|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
154523174|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523175|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154523176|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
154523177|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523178|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523179|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154523180|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
154523181|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154523182|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523183|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154523184|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154523185|NCT03387111|Growth Substances|growth substances|mesh-ancestor
154523187|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154523188|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
154523189|NCT03387111|Antidotes|antidotes|mesh-ancestor
154523190|NCT03387111|Protective Agents|protective agents|mesh-ancestor
154523191|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
154523192|NCT03387111|Vitamins|vitamins|mesh-ancestor
154523193|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
154523194|NCT03608293|Dimercaprol|dimercaprol|mesh-list
154523195|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
154523196|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
154523197|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523198|NCT03608501|Thalidomide|thalidomide|mesh-list
154523199|NCT03608501|Dexamethasone|dexamethasone|mesh-list
154523200|NCT03608501|Ixazomib|ixazomib|mesh-list
154523201|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523202|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
154523203|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
154523204|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523205|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523206|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154523207|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
154523208|NCT03608501|Hormones|hormones|mesh-ancestor
154523209|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523210|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154523211|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523212|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523213|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154523214|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
154523215|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
154523216|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154523217|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523218|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154523219|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154523220|NCT03608501|Growth Substances|growth substances|mesh-ancestor
154523221|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
154523222|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
154523223|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523224|NCT03608761|Rebamipide|rebamipide|mesh-list
154523225|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154523226|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154523227|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
154523228|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523229|NCT03608761|Protective Agents|protective agents|mesh-ancestor
154523230|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523231|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523232|NCT04554836|Cetuximab|cetuximab|mesh-list
154523233|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523234|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523235|NCT04536272|Heparin|heparin|mesh-list
154523236|NCT04536272|Calcium heparin|calcium heparin|mesh-list
154523237|NCT04536272|Enoxaparin|enoxaparin|mesh-list
154523238|NCT04536272|Nadroparin|nadroparin|mesh-list
154523239|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
154523240|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154523241|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154523242|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523243|NCT02731131|Ribavirin|ribavirin|mesh-list
154523244|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154523245|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
154523246|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523247|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
154523248|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523249|NCT04585724|Palbociclib|palbociclib|mesh-list
154523250|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523251|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154523252|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523253|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523254|NCT02237261|Prednisone|prednisone|mesh-list
154523255|NCT02237261|Bortezomib|bortezomib|mesh-list
154523256|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154523257|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523258|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
154523259|NCT02237261|Hormones|hormones|mesh-ancestor
154523260|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523261|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523262|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154523263|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523264|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154523265|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
154523266|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523268|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523269|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
154523270|NCT03386643|Hormones|hormones|mesh-ancestor
154523271|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523272|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523273|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
154523274|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154523275|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523276|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523277|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154523278|NCT05171985|Analgesics|analgesics|mesh-ancestor
154523279|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
154523280|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523281|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154523282|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154523283|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154523284|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
154523285|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523286|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523287|NCT02237365|Aspirin|aspirin|mesh-list
154523288|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154523289|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154523290|NCT02237365|Analgesics|analgesics|mesh-ancestor
154523291|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
154523292|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523293|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523294|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523295|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523296|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154523297|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154523298|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523299|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154523300|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154523301|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523302|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
154523303|NCT03383367|TEMPO|tempo|mesh-list
154523304|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
154523305|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523306|NCT03383367|Protective Agents|protective agents|mesh-ancestor
154523307|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523308|NCT02856113|Alogliptin|alogliptin|mesh-list
154523309|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154523310|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523311|NCT02856113|Incretins|incretins|mesh-ancestor
154523312|NCT02856113|Hormones|hormones|mesh-ancestor
154292372|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523313|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523314|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154523315|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
154523316|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523317|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523318|NCT03386565|Lidocaine|lidocaine|mesh-list
154523319|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154523320|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523321|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
154523322|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523323|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523324|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
154523325|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523326|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154523327|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154523328|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154523329|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523330|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523331|NCT02237339|Allopurinol|allopurinol|mesh-list
154523332|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
154523333|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523334|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523336|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523337|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154523338|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
154523339|NCT02237339|Protective Agents|protective agents|mesh-ancestor
154523340|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523341|NCT05171751|Octreotide|octreotide|mesh-list
154523342|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154523343|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154523344|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523345|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
154523346|NCT03971084|Caseins|caseins|mesh-list
154523347|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154523348|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
154523349|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523350|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523351|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523352|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
154523353|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
154523354|NCT03379779|Dimercaprol|dimercaprol|mesh-list
154523355|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
154523356|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
154523357|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523358|NCT04083014|Bortezomib|bortezomib|mesh-list
154523359|NCT04083014|Antibodies|antibodies|mesh-list
154523360|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
154523361|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523362|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523363|NCT03563066|Benralizumab|benralizumab|mesh-list
154523364|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154523365|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
154523366|NCT03140384|Misoprostol|misoprostol|mesh-list
154523367|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154523368|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
154523369|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154523370|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523371|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154523372|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154523373|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
154523374|NCT05117307|Bupivacaine|bupivacaine|mesh-list
154523375|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523376|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
154523377|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523378|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523379|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
154523380|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523381|NCT03739268|Sevelamer|sevelamer|mesh-list
154523382|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
154523383|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
154523384|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523385|NCT02787590|Simvastatin|simvastatin|mesh-list
154523386|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154523387|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154523388|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
154523389|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523390|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154523391|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154523392|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523393|NCT03382743|Lidocaine|lidocaine|mesh-list
154523394|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523395|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
154523396|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523397|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523398|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
154292459|NCT03675646|Analgesics|analgesics|mesh-ancestor
154523399|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523400|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154523401|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154523402|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154523403|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523404|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523405|NCT02854631|Prednisolone|prednisolone|mesh-list
154523406|NCT02854631|Selonsertib|selonsertib|mesh-list
154523407|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523408|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
154523409|NCT02854631|Hormones|hormones|mesh-ancestor
154523410|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523411|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523412|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154523413|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523414|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154523416|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523417|NCT03607643|Leucovorin|leucovorin|mesh-list
154523418|NCT03607643|Bevacizumab|bevacizumab|mesh-list
154523419|NCT03607643|Gemcitabine|gemcitabine|mesh-list
154523420|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
154523421|NCT03607643|Irinotecan|irinotecan|mesh-list
154523422|NCT03607643|Temozolomide|temozolomide|mesh-list
154523423|NCT03607643|Bortezomib|bortezomib|mesh-list
154523424|NCT03607643|Cannabidiol|cannabidiol|mesh-list
154523425|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523426|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523427|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154523428|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154523429|NCT03607643|Growth Substances|growth substances|mesh-ancestor
154523430|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523431|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
154523432|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154523433|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
154523434|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523435|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154523436|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154523437|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523438|NCT03607643|Antidotes|antidotes|mesh-ancestor
154523439|NCT03607643|Protective Agents|protective agents|mesh-ancestor
154523440|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
154523441|NCT03607643|Vitamins|vitamins|mesh-ancestor
154523442|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
154523443|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154523444|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
154523445|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
154523446|NCT02855359|Prednisone|prednisone|mesh-list
154523447|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
154523448|NCT02855359|Rituximab|rituximab|mesh-list
154523449|NCT02855359|Doxorubicin|doxorubicin|mesh-list
154523450|NCT02855359|Vincristine|vincristine|mesh-list
154523451|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154523452|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
154523453|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523454|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523455|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154523456|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
154523457|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523458|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523459|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154523460|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523461|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154523462|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154523463|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154523464|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523465|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523466|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
154523467|NCT02855359|Hormones|hormones|mesh-ancestor
154523468|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523469|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154523470|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154523471|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154523472|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154523473|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154523474|NCT05084456|Docetaxel|docetaxel|mesh-list
154523475|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523476|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
154523477|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
154523478|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
154523479|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523480|NCT03607903|Adalimumab|adalimumab|mesh-list
154523481|NCT03607903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154523482|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523483|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523484|NCT04438850|Ivermectin|ivermectin|mesh-list
154523485|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154523486|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523487|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154523488|NCT03385863|Poractant alfa|poractant alfa|mesh-list
154523489|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
154523490|NCT03382431|PC-786|pc-786|mesh-list
154523491|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
154523492|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523493|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523494|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523495|NCT03141632|Dulaglutide|dulaglutide|mesh-list
154523496|NCT03141632|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154523497|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154523498|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523499|NCT04282239|Lidocaine|lidocaine|mesh-list
154523500|NCT04282239|Epinephrine|epinephrine|mesh-list
154523501|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
154523502|NCT04282239|Ropivacaine|ropivacaine|mesh-list
154523503|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523504|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
154523505|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523506|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523507|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
154523508|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523509|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154523510|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154523511|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154523512|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523513|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523514|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154523515|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154523516|NCT04282239|Analgesics|analgesics|mesh-ancestor
154523517|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154523518|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154523519|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154523520|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
154523521|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523522|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154523523|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154523524|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
154523525|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154523526|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
154523527|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
154523528|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
154523529|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154523530|NCT03605173|Vitamin D|vitamin d|mesh-list
154523531|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
154523532|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
154523533|NCT03605173|Vitamins|vitamins|mesh-list
154523534|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
154523535|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523536|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154523537|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154523538|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
154523539|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
154523540|NCT03382275|Iron|iron|mesh-list
154523541|NCT03382275|Ferric maltol|ferric maltol|mesh-list
154523542|NCT03382275|Trace Elements|trace elements|mesh-ancestor
154523543|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
154523544|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523545|NCT03382275|Hematinics|hematinics|mesh-ancestor
154523546|NCT05080478|Clopidogrel|clopidogrel|mesh-list
154523547|NCT05080478|Ticagrelor|ticagrelor|mesh-list
154523548|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154523549|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154523550|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154523551|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154523552|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
154523553|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523554|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523555|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523556|NCT05082974|Varenicline|varenicline|mesh-list
154523557|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154523558|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154523559|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
154523560|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523561|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523562|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523563|NCT03604471|Atorvastatin|atorvastatin|mesh-list
154523564|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154523565|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154523566|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
154523567|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523568|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154523569|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154523570|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523571|NCT02237443|Bromides|bromides|mesh-list
154523572|NCT02237443|Rocuronium|rocuronium|mesh-list
154523573|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
154523574|NCT02237443|Succinylcholine|succinylcholine|mesh-list
154523575|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
154523576|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154523577|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154523578|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154523579|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523580|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523581|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154523582|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154523583|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154523584|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
154523585|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523586|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523587|NCT03141398|Pancrelipase|pancrelipase|mesh-list
154523588|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154523589|NCT03733418|Vitamin D|vitamin d|mesh-list
154523590|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
154523591|NCT03733418|Vitamins|vitamins|mesh-ancestor
154523592|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
154523593|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523594|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154523595|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154523596|NCT03607331|Citalopram|citalopram|mesh-list
154523597|NCT03607331|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154558137|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
154523598|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154523599|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523600|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523601|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523602|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
154523603|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523604|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154523605|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
154523606|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154523607|NCT03607955|Paclitaxel|paclitaxel|mesh-list
154523608|NCT03607955|Carboplatin|carboplatin|mesh-list
154523609|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154523610|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523611|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
154523612|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
154523613|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
154523614|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523615|NCT02067975|Tryptophan|tryptophan|mesh-list
154523616|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154523617|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
154523618|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154523619|NCT03143036|Thalidomide|thalidomide|mesh-list
154523620|NCT03143036|Dexamethasone|dexamethasone|mesh-list
154523621|NCT03143036|Daratumumab|daratumumab|mesh-list
154523622|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523623|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
154523624|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
154523625|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523626|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523627|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154523628|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
154523629|NCT03143036|Hormones|hormones|mesh-ancestor
154523630|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523631|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154523632|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523633|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154523634|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
154523635|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
154523636|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154523637|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523638|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154523639|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154523640|NCT03143036|Growth Substances|growth substances|mesh-ancestor
154523641|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
154523642|NCT05080010|Carboplatin|carboplatin|mesh-list
154523643|NCT05080010|Etoposide|etoposide|mesh-list
154523644|NCT05080010|Vincristine|vincristine|mesh-list
154523645|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523646|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154523647|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154523648|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154523649|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523650|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523651|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
154523652|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154523653|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154523654|NCT03385551|Estradiol|estradiol|mesh-list
154523655|NCT03385551|Estrogens|estrogens|mesh-ancestor
154523656|NCT03385551|Hormones|hormones|mesh-ancestor
154523657|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523658|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523659|NCT03606473|Amphetamine|amphetamine|mesh-list
154523660|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
154523661|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154523662|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523663|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
154523664|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
154523665|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523666|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
154523667|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523668|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523669|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
154523670|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154523671|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154523672|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523673|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154523675|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523676|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523677|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154523678|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523679|NCT03252626|Alprostadil|alprostadil|mesh-list
154523680|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154523681|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
154523682|NCT03252626|Urological Agents|urological agents|mesh-ancestor
154523683|NCT05072054|Atorvastatin|atorvastatin|mesh-list
154523684|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154523685|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154523686|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154523687|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
154523688|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523689|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154523690|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154523691|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523692|NCT03142880|Ropivacaine|ropivacaine|mesh-list
154523693|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523694|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
154523695|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523696|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523697|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
154292774|NCT01099059|Analgesics|analgesics|mesh-ancestor
154523698|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523699|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
154523700|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523701|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
154523702|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154523703|NCT03381495|Sufentanil|sufentanil|mesh-list
154523704|NCT03381495|Ropivacaine|ropivacaine|mesh-list
154523705|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523706|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
154523707|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523708|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247546|NCT00038948|Sirolimus|sirolimus|mesh-list
154523709|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
154523710|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523711|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154523712|NCT03381495|Narcotics|narcotics|mesh-ancestor
154523713|NCT03381495|Analgesics|analgesics|mesh-ancestor
154523714|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154523715|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154523716|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
154523717|NCT03059498|Bupivacaine|bupivacaine|mesh-list
154523718|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523719|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
154523720|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523721|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523722|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
154523723|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523724|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
154523725|NCT03142646|Fludarabine|fludarabine|mesh-list
154523726|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154523727|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
154523728|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523729|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523730|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154523731|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
154523732|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523733|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523734|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154523735|NCT03541083|Blinatumomab|blinatumomab|mesh-list
154523736|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523737|NCT03602027|Gefitinib|gefitinib|mesh-list
154523738|NCT03602027|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154292802|NCT01099137|Vildagliptin|vildagliptin|mesh-list
154523739|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154523740|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523741|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523742|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523743|NCT03141476|Cefuroxime|cefuroxime|mesh-list
154523744|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
154523745|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154523746|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523747|NCT03601871|Thalidomide|thalidomide|mesh-list
154860474|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523748|NCT03601871|Dexamethasone|dexamethasone|mesh-list
154523749|NCT03601871|Palonosetron|palonosetron|mesh-list
154523750|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
154523751|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523752|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
154523753|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
154523754|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523755|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523756|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154523757|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
154523758|NCT03601871|Hormones|hormones|mesh-ancestor
154523759|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154523760|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154523761|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523762|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154523763|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
154523764|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
154523765|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154523766|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523767|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154523768|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154523769|NCT03601871|Growth Substances|growth substances|mesh-ancestor
154523770|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
154523771|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154523772|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
154523773|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523774|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523775|NCT03380949|Remifentanil|remifentanil|mesh-list
154523776|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
154523777|NCT03380949|Narcotics|narcotics|mesh-ancestor
154523778|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523779|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523780|NCT03380949|Analgesics|analgesics|mesh-ancestor
154523781|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
154523782|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523783|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154523784|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154523785|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523786|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154247620|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
154523787|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154523789|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523790|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523791|NCT05078372|Midazolam|midazolam|mesh-list
154523792|NCT05078372|Ropivacaine|ropivacaine|mesh-list
154523793|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523794|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
154523795|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523796|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523797|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
154523798|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523799|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154523800|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154523801|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154523802|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154523803|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154523804|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154523805|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
154523806|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
154523807|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
154523808|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523809|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523810|NCT03380871|Carboplatin|carboplatin|mesh-list
154523811|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
154523812|NCT03380871|Pemetrexed|pemetrexed|mesh-list
154523813|NCT03380871|Poly ICLC|poly iclc|mesh-list
154523814|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523815|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523816|NCT03380871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154523817|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523818|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523819|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154523820|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154523821|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
154523822|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
154523823|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523824|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
154523825|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154523826|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523827|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523828|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154523829|NCT02237495|Analgesics|analgesics|mesh-ancestor
154523830|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
154523831|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523832|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154523833|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154292889|NCT00048165|Cyclosporine|cyclosporine|mesh-list
154523834|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154523835|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
154523836|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523837|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523838|NCT02486666|Enoxaparin|enoxaparin|mesh-list
154523839|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
154523840|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
154523841|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154523842|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154523843|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523844|NCT02237807|Dirithromycin|dirithromycin|mesh-list
154523845|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154523846|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523847|NCT03125187|Heparin|heparin|mesh-list
154523848|NCT03125187|Calcium heparin|calcium heparin|mesh-list
154523849|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
154523850|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154523851|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154523852|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523853|NCT02038946|Nivolumab|nivolumab|mesh-list
154523854|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523855|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523856|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154523857|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523858|NCT03377907|Lidocaine|lidocaine|mesh-list
154523859|NCT03377907|Ketamine|ketamine|mesh-list
154523860|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
154523861|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
154523862|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523863|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523864|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
154523865|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523866|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154523867|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154523868|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154523869|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523870|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523871|NCT03377907|Analgesics|analgesics|mesh-ancestor
154523872|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154523873|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154523874|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
154523875|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154523876|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154523877|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523878|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
154523879|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
154523880|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154523881|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523882|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
154523883|NCT03369795|Methotrexate|methotrexate|mesh-list
154523884|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154523885|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
154523886|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154523887|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523888|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154523889|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
154523890|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523891|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523892|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
154523893|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523894|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154860475|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154523895|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154523896|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
154523897|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523898|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154523899|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
154523900|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
154523901|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154523902|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154523903|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523904|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523905|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154523906|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154523907|NCT05393414|Acetaminophen|acetaminophen|mesh-list
154523908|NCT05393414|Ketorolac|ketorolac|mesh-list
154523909|NCT05393414|Morphine|morphine|mesh-list
154523910|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
154523911|NCT05393414|Narcotics|narcotics|mesh-ancestor
154523912|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154523913|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523914|NCT05393414|Analgesics|analgesics|mesh-ancestor
154523915|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
154523916|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523917|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154523918|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
154523919|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154523920|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154523921|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154523922|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154523923|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523924|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523925|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
154523926|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
154523927|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523928|NCT02034500|Vaccines|vaccines|mesh-list
154523929|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
154523930|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523931|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154523932|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
154523933|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
154523934|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523935|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154523936|NCT03955640|Olaparib|olaparib|mesh-list
154247776|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
154523937|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154523938|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154523939|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523940|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523941|NCT03369093|Amoxicillin|amoxicillin|mesh-list
154523942|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154523943|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523944|NCT03369015|Amphetamine|amphetamine|mesh-list
154523945|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
154523946|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154523947|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523948|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
154523949|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
154523950|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154523951|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
154523952|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154523953|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523954|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
154523955|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154523956|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154523957|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154523958|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154523959|NCT03890744|Docetaxel|docetaxel|mesh-list
154523960|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523961|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154523962|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154523963|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154523964|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523965|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154523966|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154523967|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154860476|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
154523969|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154523970|NCT03374007|Antibodies|antibodies|mesh-list
154523971|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
154523972|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154523973|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
154523974|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523975|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523976|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
154523977|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154523978|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154523979|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
154523980|NCT05392166|Calcium|calcium|mesh-list
154523981|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154523982|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523983|NCT03136640|Docetaxel|docetaxel|mesh-list
154523984|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523985|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
154523986|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
154523987|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
154523988|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523989|NCT02675439|Ipilimumab|ipilimumab|mesh-list
154523990|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154523991|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154523992|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154523993|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523994|NCT03604003|Losartan|losartan|mesh-list
154523995|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154523996|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154523997|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154523998|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154523999|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524000|NCT03368391|Lidocaine|lidocaine|mesh-list
154524001|NCT03368391|Phenylephrine|phenylephrine|mesh-list
154524002|NCT03368391|Epinephrine|epinephrine|mesh-list
154524003|NCT03368391|Racepinephrine|racepinephrine|mesh-list
154524004|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
154524005|NCT03368391|Tetracaine|tetracaine|mesh-list
154524006|NCT03368391|Mepivacaine|mepivacaine|mesh-list
154524007|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
154524008|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
154524009|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
154293077|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524010|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524011|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524012|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
154524013|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524014|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154524015|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154524016|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154524017|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524018|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524019|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154524020|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154524021|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
154524022|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524023|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154524024|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154524025|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
154524026|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154524027|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
154524029|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
154524030|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154524031|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
154524032|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154524033|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154524034|NCT03368391|Protective Agents|protective agents|mesh-ancestor
154524035|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154524036|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154524037|NCT03373305|Lenalidomide|lenalidomide|mesh-list
154524038|NCT03373305|Piperidine|piperidine|mesh-list
154524039|NCT03373305|Antibodies|antibodies|mesh-list
154524040|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
154524041|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154524042|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
154524043|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
154358857|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
154524044|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524045|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524046|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154524047|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154524048|NCT03373305|Growth Substances|growth substances|mesh-ancestor
154524049|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
154524050|NCT03373305|Immunotoxins|immunotoxins|mesh-ancestor
154524051|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154524052|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524053|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524054|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154524055|NCT03376737|Pemetrexed|pemetrexed|mesh-list
154524056|NCT03376737|Apatinib|apatinib|mesh-list
154524057|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524058|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524059|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524060|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154524061|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154524062|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154524063|NCT03373227|Tacrolimus|tacrolimus|mesh-list
154524064|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524065|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
154524066|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524067|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154524068|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524069|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524070|NCT02484716|Timolol|timolol|mesh-list
154524071|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154524072|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154524073|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
154524074|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524075|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524076|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524077|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154524078|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154524079|NCT03373149|Hormones|hormones|mesh-list
154524080|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154524081|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524082|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524083|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
154524084|NCT05386784|Vitamin D|vitamin d|mesh-list
154247918|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
154524085|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154524086|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154524087|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524088|NCT05386784|Vitamins|vitamins|mesh-ancestor
154524089|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
154524090|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154524091|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154524092|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
154524093|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524094|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154524095|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154524096|NCT03602287|Lidocaine|lidocaine|mesh-list
154524097|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
154524098|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
154524099|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524100|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524101|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
154293160|NCT03007966|Analgesics|analgesics|mesh-ancestor
154524102|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524103|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154524104|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154524105|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154524106|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524107|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524108|NCT03137498|Ketorolac|ketorolac|mesh-list
154524109|NCT03137498|Lidocaine|lidocaine|mesh-list
154524110|NCT03137498|Prilocaine|prilocaine|mesh-list
154524111|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
154524112|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
154524113|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524114|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524115|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
154524116|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524117|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154524118|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154524119|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154524120|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524121|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524122|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154524123|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154524124|NCT03137498|Analgesics|analgesics|mesh-ancestor
154524125|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524126|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154524127|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154524128|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524129|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154524130|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524131|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
154524132|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154524133|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524134|NCT03602131|Gemcitabine|gemcitabine|mesh-list
154524135|NCT03602131|Busulfan|busulfan|mesh-list
154524136|NCT03602131|Cladribine|cladribine|mesh-list
154524137|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154524138|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
154524139|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524140|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524141|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
154524142|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524143|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
154524144|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524145|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154524146|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154524147|NCT05851391|Anesthetics|anesthetics|mesh-list
154524148|NCT05851391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524149|NCT05851391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524150|NCT05851352|Antibodies|antibodies|mesh-list
154524151|NCT05851352|Immunologic Factors|immunologic factors|mesh-ancestor
154524152|NCT05851352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524153|NCT05851014|Letrozole|letrozole|mesh-list
154524154|NCT05851014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524155|NCT05851014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154524156|NCT05851014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154524157|NCT05851014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247993|NCT03538054|Narcotics|narcotics|mesh-ancestor
154524158|NCT05851014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524159|NCT05851014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154524160|NCT05851014|Hormone Antagonists|hormone antagonists|mesh-ancestor
154524161|NCT05851014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524162|NCT05851014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524163|NCT05850936|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154524164|NCT05850936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154524165|NCT05850871|Aztreonam|aztreonam|mesh-list
154524166|NCT05850871|Avibactam|avibactam|mesh-list
154524167|NCT05850871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154524168|NCT05850871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524169|NCT05850871|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154524170|NCT05850871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524171|NCT05850871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524172|NCT05850832|Magnesium Sulfate|magnesium sulfate|mesh-list
154524173|NCT05850832|Esmolol|esmolol|mesh-list
154524174|NCT05850832|Analgesics|analgesics|mesh-ancestor
154524175|NCT05850832|Sensory System Agents|sensory system agents|mesh-ancestor
154524176|NCT05850832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524177|NCT05850832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524178|NCT05850832|Anesthetics|anesthetics|mesh-ancestor
154524179|NCT05850832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524180|NCT05850832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154524181|NCT05850832|Anticonvulsants|anticonvulsants|mesh-ancestor
154524182|NCT05850832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154524183|NCT05850832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524184|NCT05850832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524185|NCT05850832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154524186|NCT05850832|Tocolytic Agents|tocolytic agents|mesh-ancestor
154524187|NCT05850832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154293257|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154524188|NCT05850832|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154524189|NCT05850832|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154524190|NCT05850832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154524191|NCT05850832|Adrenergic Agents|adrenergic agents|mesh-ancestor
154524192|NCT05850832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524193|NCT05850702|Lidocaine|lidocaine|mesh-list
154524194|NCT05850702|Anesthetics, Local|anesthetics, local|mesh-ancestor
154524195|NCT05850702|Anesthetics|anesthetics|mesh-ancestor
154524196|NCT05850702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524197|NCT05850702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524198|NCT05850702|Sensory System Agents|sensory system agents|mesh-ancestor
154524199|NCT05850702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524200|NCT05850702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154524201|NCT05850702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154524202|NCT05850702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154524203|NCT05850702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524204|NCT05850702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524205|NCT05850559|Mitogens|mitogens|mesh-list
154524206|NCT05850559|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524207|NCT05850559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524208|NCT05850507|Vaccines|vaccines|mesh-list
154524209|NCT05850507|Immunologic Factors|immunologic factors|mesh-ancestor
154524210|NCT05850507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524211|NCT05850468|Lidocaine|lidocaine|mesh-list
154524212|NCT05850468|Fentanyl|fentanyl|mesh-list
154524213|NCT05850468|Anesthetics|anesthetics|mesh-list
154524214|NCT05850468|Anesthetics, Local|anesthetics, local|mesh-ancestor
154524215|NCT05850468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524216|NCT05850468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524217|NCT05850468|Sensory System Agents|sensory system agents|mesh-ancestor
154524218|NCT05850468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524219|NCT05850468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154524220|NCT05850468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154524221|NCT05850468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154524222|NCT05850468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524223|NCT05850468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524224|NCT05850468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154524225|NCT05850468|Narcotics|narcotics|mesh-ancestor
154524226|NCT05850468|Analgesics|analgesics|mesh-ancestor
154524227|NCT05850468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154524228|NCT05850468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154524229|NCT05850468|Anesthetics, General|anesthetics, general|mesh-ancestor
154248067|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524231|NCT05850377|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154524232|NCT05850377|Dermatologic Agents|dermatologic agents|mesh-ancestor
154524233|NCT06042426|Acetaminophen|acetaminophen|mesh-list
154524234|NCT06042426|Dexamethasone|dexamethasone|mesh-list
154524235|NCT06042426|Morphine|morphine|mesh-list
154524236|NCT06042426|Oxycodone|oxycodone|mesh-list
154524237|NCT06042426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524238|NCT06042426|Antiemetics|antiemetics|mesh-ancestor
154524239|NCT06042426|Autonomic Agents|autonomic agents|mesh-ancestor
154524240|NCT06042426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524241|NCT06042426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524242|NCT06042426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154524243|NCT06042426|Glucocorticoids|glucocorticoids|mesh-ancestor
154524244|NCT06042426|Hormones|hormones|mesh-ancestor
154524245|NCT06042426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524246|NCT06042426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154524247|NCT06042426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524248|NCT06042426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154524249|NCT06042426|Narcotics|narcotics|mesh-ancestor
154524250|NCT06042426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524251|NCT06042426|Analgesics|analgesics|mesh-ancestor
154524252|NCT06042426|Sensory System Agents|sensory system agents|mesh-ancestor
154524253|NCT06042426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154524254|NCT06042426|Antipyretics|antipyretics|mesh-ancestor
154524255|NCT06042010|Triamcinolone|triamcinolone|mesh-list
154524256|NCT06042010|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154524257|NCT06042010|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154524258|NCT06042010|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154524259|NCT06042010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524260|NCT06042010|Glucocorticoids|glucocorticoids|mesh-ancestor
154524261|NCT06042010|Hormones|hormones|mesh-ancestor
154860477|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524262|NCT06042010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524263|NCT06042010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524264|NCT06042010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524265|NCT06042010|Immunologic Factors|immunologic factors|mesh-ancestor
154524266|NCT06042010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524267|NCT06042010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524268|NCT06041984|Glycopyrrolate|glycopyrrolate|mesh-list
154524269|NCT06041984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154524270|NCT06041984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154524271|NCT06041984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154524272|NCT06041984|Cholinergic Agents|cholinergic agents|mesh-ancestor
154524273|NCT06041984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524274|NCT06041984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524275|NCT06041984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524276|NCT06041750|Anesthetics|anesthetics|mesh-list
154524277|NCT06041750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524278|NCT06041750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524279|NCT06041724|Endostatins|endostatins|mesh-list
154524280|NCT06041724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524281|NCT06041724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154524282|NCT06041724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154524283|NCT06041724|Growth Substances|growth substances|mesh-ancestor
154524284|NCT06041724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524285|NCT06041724|Growth Inhibitors|growth inhibitors|mesh-ancestor
154524286|NCT06041529|Amlodipine|amlodipine|mesh-list
154524287|NCT06041529|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154524288|NCT06041529|Telmisartan|telmisartan|mesh-list
154524289|NCT06041529|Chlorthalidone|chlorthalidone|mesh-list
154524290|NCT06041529|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154524291|NCT06041529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154524292|NCT06041529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154524293|NCT06041529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524294|NCT06041529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524295|NCT06041529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154524296|NCT06041529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524297|NCT06041529|Vasodilator Agents|vasodilator agents|mesh-ancestor
154524298|NCT06041529|Diuretics|diuretics|mesh-ancestor
154524299|NCT06041529|Natriuretic Agents|natriuretic agents|mesh-ancestor
154524300|NCT06041529|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154524301|NCT06041529|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154524302|NCT06041529|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154524303|NCT06041490|Bevacizumab|bevacizumab|mesh-list
154248146|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
154524304|NCT06041490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524305|NCT06041490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524306|NCT06041490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154524307|NCT06041490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154524308|NCT06041490|Growth Substances|growth substances|mesh-ancestor
154524309|NCT06041490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524310|NCT06041490|Growth Inhibitors|growth inhibitors|mesh-ancestor
154524311|NCT06041477|Leucovorin|leucovorin|mesh-list
154524312|NCT06041477|Folic Acid|folic acid|mesh-list
154524313|NCT06041477|Oxaliplatin|oxaliplatin|mesh-list
154524314|NCT06041477|Lenvatinib|lenvatinib|mesh-list
154524315|NCT06041477|Antibodies|antibodies|mesh-list
154524316|NCT06041477|Immunoglobulins|immunoglobulins|mesh-list
154524317|NCT06041477|Immunologic Factors|immunologic factors|mesh-list
154524318|NCT06041477|Immunomodulating Agents|immunomodulating agents|mesh-list
154524319|NCT06041477|Levoleucovorin|levoleucovorin|mesh-list
154524320|NCT06041477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524321|NCT06041477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293387|NCT01101009|Diuretics|diuretics|mesh-ancestor
154524322|NCT06041477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154524323|NCT06041477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524324|NCT06041477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524325|NCT06041477|Antidotes|antidotes|mesh-ancestor
154524326|NCT06041477|Protective Agents|protective agents|mesh-ancestor
154524327|NCT06041477|Vitamin B Complex|vitamin b complex|mesh-ancestor
154524328|NCT06041477|Vitamins|vitamins|mesh-ancestor
154524329|NCT06041477|Micronutrients|micronutrients|mesh-ancestor
154524330|NCT06041477|Hematinics|hematinics|mesh-ancestor
154524331|NCT06041451|Methylprednisolone|methylprednisolone|mesh-list
154524332|NCT06041451|Immunoglobulins|immunoglobulins|mesh-list
154524333|NCT06041451|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154524334|NCT06041451|gamma-Globulins|gamma-globulins|mesh-list
154524335|NCT06041451|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154524336|NCT06041451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524337|NCT06041451|Antiemetics|antiemetics|mesh-ancestor
154524338|NCT06041451|Autonomic Agents|autonomic agents|mesh-ancestor
154524339|NCT06041451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524340|NCT06041451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524341|NCT06041451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154524342|NCT06041451|Glucocorticoids|glucocorticoids|mesh-ancestor
154524343|NCT06041451|Hormones|hormones|mesh-ancestor
154524344|NCT06041451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524345|NCT06041451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154524346|NCT06041451|Protective Agents|protective agents|mesh-ancestor
154524347|NCT06041451|Immunologic Factors|immunologic factors|mesh-ancestor
154524348|NCT06041399|Metformin|metformin|mesh-list
154524349|NCT06041399|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154524350|NCT06041399|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154524351|NCT06041399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524352|NCT06041399|Antimetabolites|antimetabolites|mesh-ancestor
154524353|NCT06041399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524354|NCT06041399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154524355|NCT06041178|Flurbiprofen|flurbiprofen|mesh-list
154524356|NCT06041178|Analgesics|analgesics|mesh-ancestor
154524357|NCT06041178|Sensory System Agents|sensory system agents|mesh-ancestor
154524358|NCT06041178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524359|NCT06041178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524360|NCT06041178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154524361|NCT06041178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154524362|NCT06041178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524363|NCT06041178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154524364|NCT06041178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154524365|NCT06041178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524366|NCT06041178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524367|NCT06041035|Paclitaxel|paclitaxel|mesh-list
154524368|NCT06041035|Gemcitabine|gemcitabine|mesh-list
154524369|NCT06041035|Capecitabine|capecitabine|mesh-list
154524370|NCT06041035|Oxaliplatin|oxaliplatin|mesh-list
154524371|NCT06041035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154524372|NCT06041035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524373|NCT06041035|Tubulin Modulators|tubulin modulators|mesh-ancestor
154524374|NCT06041035|Antimitotic Agents|antimitotic agents|mesh-ancestor
154524375|NCT06041035|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524376|NCT06041035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524377|NCT06041035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154524378|NCT06041035|Antimetabolites|antimetabolites|mesh-ancestor
154524379|NCT06040944|Antipsychotic Agents|antipsychotic agents|mesh-list
154524380|NCT06040944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154524381|NCT06040944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524382|NCT06040944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524384|NCT06040853|Tranexamic Acid|tranexamic acid|mesh-list
154524385|NCT06040853|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154524386|NCT06040853|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154524387|NCT06040853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524388|NCT06040853|Hemostatics|hemostatics|mesh-ancestor
154524389|NCT06040853|Coagulants|coagulants|mesh-ancestor
154524390|NCT06017323|Paclitaxel|paclitaxel|mesh-list
154524391|NCT06017323|Gemcitabine|gemcitabine|mesh-list
154524392|NCT06017323|Proglumide|proglumide|mesh-list
154524393|NCT06017323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154524394|NCT06017323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524395|NCT06017323|Tubulin Modulators|tubulin modulators|mesh-ancestor
154524396|NCT06017323|Antimitotic Agents|antimitotic agents|mesh-ancestor
154524397|NCT06017323|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524398|NCT06017323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524399|NCT06017323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154524400|NCT06017323|Antimetabolites|antimetabolites|mesh-ancestor
154524401|NCT06017323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154524402|NCT06017323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154524403|NCT06000501|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154524404|NCT06000501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154524405|NCT06000501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524406|NCT06000501|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154524407|NCT06000501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154524408|NCT06000501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524409|NCT06000501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524410|NCT06000501|Dopamine Agents|dopamine agents|mesh-ancestor
154524411|NCT06000501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524412|NCT05996874|Semaglutide|semaglutide|mesh-list
154524413|NCT05996874|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154524414|NCT05996874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154524415|NCT05996874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524416|NCT05987371|Albuterol|albuterol|mesh-list
154524417|NCT05987371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154524418|NCT05987371|Autonomic Agents|autonomic agents|mesh-ancestor
154524419|NCT05987371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524420|NCT05987371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524421|NCT05987371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154524422|NCT05987371|Respiratory System Agents|respiratory system agents|mesh-ancestor
154524423|NCT05987371|Tocolytic Agents|tocolytic agents|mesh-ancestor
154524424|NCT05987371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154524425|NCT05987371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154524426|NCT05987371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154524427|NCT05987371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154524428|NCT05987371|Adrenergic Agents|adrenergic agents|mesh-ancestor
154524429|NCT05987371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524430|NCT05987371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524431|NCT05944887|Lidocaine|lidocaine|mesh-list
154524432|NCT05944887|Propofol|propofol|mesh-list
154524433|NCT05944887|Anesthetics, Local|anesthetics, local|mesh-ancestor
154524434|NCT05944887|Anesthetics|anesthetics|mesh-ancestor
154524435|NCT05944887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524436|NCT05944887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524437|NCT05944887|Sensory System Agents|sensory system agents|mesh-ancestor
154524438|NCT05944887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524439|NCT05944887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154524440|NCT05944887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154524441|NCT05944887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154524442|NCT05944887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524443|NCT05944887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524444|NCT05944887|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154524445|NCT05944887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154524446|NCT05944887|Anesthetics, General|anesthetics, general|mesh-ancestor
154524447|NCT05914077|Secretin|secretin|mesh-list
154524448|NCT05914077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154524449|NCT05914077|Hormones|hormones|mesh-ancestor
154524450|NCT05914077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524451|NCT05914077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524452|NCT05896761|Rilpivirine|rilpivirine|mesh-list
154524453|NCT05896761|Cabotegravir|cabotegravir|mesh-list
154524454|NCT05896761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154524455|NCT05896761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154524457|NCT05896761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524458|NCT05896761|Antiviral Agents|antiviral agents|mesh-ancestor
154524459|NCT05896761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524460|NCT05896761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154524461|NCT05896761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154524462|NCT05896761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154524463|NCT05896761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154524464|NCT05892770|Zinc|zinc|mesh-list
154524465|NCT05892770|Botulinum Toxins|botulinum toxins|mesh-list
154524466|NCT05892770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154524467|NCT05892770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154524468|NCT05892770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154524469|NCT05892770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154040324|NCT03953300|Benralizumab|benralizumab|mesh-list
154524470|NCT05892770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524471|NCT05892770|Cholinergic Agents|cholinergic agents|mesh-ancestor
154524472|NCT05892770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524473|NCT05892770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524474|NCT05892770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154524475|NCT05892770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524476|NCT05892770|Trace Elements|trace elements|mesh-ancestor
154524477|NCT05892770|Micronutrients|micronutrients|mesh-ancestor
154524478|NCT05838664|Rivaroxaban|rivaroxaban|mesh-list
154524479|NCT05838664|Apixaban|apixaban|mesh-list
154524480|NCT05838664|Dabigatran|dabigatran|mesh-list
154524481|NCT05838664|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154524482|NCT05838664|Antithrombins|antithrombins|mesh-ancestor
154524483|NCT05838664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154524484|NCT05838664|Protease Inhibitors|protease inhibitors|mesh-ancestor
154524485|NCT05838664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524486|NCT05838664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524487|NCT05838664|Anticoagulants|anticoagulants|mesh-ancestor
154524488|NCT05735379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154524489|NCT05735379|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154860478|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
154524490|NCT05735379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524491|NCT05735379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524492|NCT05735379|Cholinergic Agents|cholinergic agents|mesh-ancestor
154524493|NCT05735379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524494|NCT05735379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524495|NCT05708638|Anesthetics|anesthetics|mesh-list
154524496|NCT05708638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524497|NCT05708638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524498|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154524499|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154524500|NCT05639712|Fentanyl|fentanyl|mesh-list
154524501|NCT05639712|Morphine|morphine|mesh-list
154524502|NCT05639712|Oxycodone|oxycodone|mesh-list
154524503|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154524504|NCT05639712|Narcotics|narcotics|mesh-ancestor
154524505|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524506|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524507|NCT05639712|Analgesics|analgesics|mesh-ancestor
154524508|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
154524509|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524510|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154524511|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154524512|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
154524513|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
154524514|NCT05611242|Salicylic Acid|salicylic acid|mesh-list
154524515|NCT05611242|Salicylates|salicylates|mesh-list
154524516|NCT05611242|Tirofiban|tirofiban|mesh-list
154524517|NCT05611242|Abciximab|abciximab|mesh-list
154524518|NCT05611242|Clopidogrel|clopidogrel|mesh-list
154524519|NCT05611242|Cangrelor|cangrelor|mesh-list
154524520|NCT05611242|Eptifibatide|eptifibatide|mesh-list
154524521|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154524522|NCT05611242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154524523|NCT05611242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154524524|NCT05611242|Analgesics|analgesics|mesh-ancestor
154524525|NCT05611242|Sensory System Agents|sensory system agents|mesh-ancestor
154524526|NCT05611242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524527|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524528|NCT05611242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524529|NCT05611242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154524530|NCT05611242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154524531|NCT05611242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154524532|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524533|NCT05611242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154524534|NCT05611242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524535|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154524536|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154524537|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154524538|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
154524539|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524540|NCT05611242|Anticoagulants|anticoagulants|mesh-ancestor
154524541|NCT05611242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524542|NCT05611242|Antifungal Agents|antifungal agents|mesh-ancestor
154524543|NCT05611242|Keratolytic Agents|keratolytic agents|mesh-ancestor
154524544|NCT05611242|Dermatologic Agents|dermatologic agents|mesh-ancestor
154524545|NCT05582694|UB-421|ub-421|mesh-list
154524546|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154524547|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
154524548|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524549|NCT05569772|Semaglutide|semaglutide|mesh-list
154524550|NCT05569772|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154524551|NCT05569772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154524552|NCT05569772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524553|NCT05567094|Dexamethasone|dexamethasone|mesh-list
154524554|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524555|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
154524556|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
154524557|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524558|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524559|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154524560|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
154524561|NCT05567094|Hormones|hormones|mesh-ancestor
154524562|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524563|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154524564|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524565|NCT05555888|Capecitabine|capecitabine|mesh-list
154524566|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
154524567|NCT05555888|Antibodies|antibodies|mesh-list
154524569|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524570|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154524571|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
154524572|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524573|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524574|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
154524575|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154524576|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154524577|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524578|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
154524579|NCT05554211|Coagulants|coagulants|mesh-ancestor
154524580|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154524581|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524582|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524583|NCT05442554|Immunotoxins|immunotoxins|mesh-ancestor
154524584|NCT05442554|Immunoconjugates|immunoconjugates|mesh-ancestor
154524585|NCT05442554|Immunologic Factors|immunologic factors|mesh-ancestor
154524586|NCT05442554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524587|NCT05439876|Melatonin|melatonin|mesh-list
154524588|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
154524589|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524590|NCT05439876|Protective Agents|protective agents|mesh-ancestor
154524591|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293651|NCT05975346|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154524592|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524593|NCT05412394|Prednisolone|prednisolone|mesh-list
154524594|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524595|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
154524596|NCT05412394|Hormones|hormones|mesh-ancestor
154524597|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524598|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524599|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154524600|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524601|NCT05408559|Sulforaphane|sulforaphane|mesh-list
154524602|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154524603|NCT05408559|Protective Agents|protective agents|mesh-ancestor
154524604|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524605|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524606|NCT05408091|Antibodies|antibodies|mesh-list
154524607|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154524608|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
154524609|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524610|NCT05319639|Leucovorin|leucovorin|mesh-list
154524611|NCT05319639|Paclitaxel|paclitaxel|mesh-list
154524612|NCT05319639|Fluorouracil|fluorouracil|mesh-list
154524613|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
154524614|NCT05319639|Irinotecan|irinotecan|mesh-list
154524615|NCT05319639|Tislelizumab|tislelizumab|mesh-list
154524616|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
154524617|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154524618|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524619|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
154524620|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
154524621|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524622|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524623|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
154524624|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154524625|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524626|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
154524627|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524628|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154524629|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154524630|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524631|NCT05319639|Antidotes|antidotes|mesh-ancestor
154524632|NCT05319639|Protective Agents|protective agents|mesh-ancestor
154524633|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
154524634|NCT05319639|Vitamins|vitamins|mesh-ancestor
154524635|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
154524636|NCT05319639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524637|NCT05260684|Trametinib|trametinib|mesh-list
154524638|NCT05260684|Dabrafenib|dabrafenib|mesh-list
154524639|NCT05260684|Vemurafenib|vemurafenib|mesh-list
154524640|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524641|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154524642|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524643|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524644|NCT05228925|Vitamin D|vitamin d|mesh-list
154524645|NCT05228925|Vitamins|vitamins|mesh-ancestor
154524646|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
154524647|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524648|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154524649|NCT05133531|Eculizumab|eculizumab|mesh-list
154524650|NCT05133531|Ravulizumab|ravulizumab|mesh-list
154524651|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154524652|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524653|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
154524654|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524655|NCT05102721|Avelumab|avelumab|mesh-list
154524656|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524657|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524658|NCT05048784|Sotorasib|sotorasib|mesh-list
154524659|NCT05048784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154524660|NCT05048784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524661|NCT05048784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524662|NCT05048784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524663|NCT05038228|Vitamin K|vitamin k|mesh-list
154524664|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
154524665|NCT05038228|Apixaban|apixaban|mesh-list
154524666|NCT05038228|Dabigatran|dabigatran|mesh-list
154524667|NCT05038228|Vitamins|vitamins|mesh-ancestor
154524668|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
154524669|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524670|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154524671|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
154524672|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154524673|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
154524674|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524675|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524676|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
154524677|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154524678|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154524679|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
154524680|NCT05038228|Coagulants|coagulants|mesh-ancestor
154524681|NCT05002569|Nivolumab|nivolumab|mesh-list
154524682|NCT05002569|Relatlimab|relatlimab|mesh-list
154524683|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524684|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293781|NCT05974410|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154524685|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154524686|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524687|NCT04894123|Trifluridine|trifluridine|mesh-list
154524688|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
154524689|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524690|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
154524691|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524692|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
154524693|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524694|NCT04884282|Docetaxel|docetaxel|mesh-list
154524695|NCT04884282|Nivolumab|nivolumab|mesh-list
154524696|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524697|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
154524698|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
154524699|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524700|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524701|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524702|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154524703|NCT04856904|Trifarotene|trifarotene|mesh-list
154524704|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
154524705|NCT04849845|Insulin|insulin|mesh-list
154524706|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154524707|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154524708|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524709|NCT04803877|Nivolumab|nivolumab|mesh-list
154524710|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524711|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524712|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154524713|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524714|NCT04758871|Progesterone|progesterone|mesh-list
154524715|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
154524716|NCT04758871|Progestins|progestins|mesh-ancestor
154524717|NCT04758871|Hormones|hormones|mesh-ancestor
154524718|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524719|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524720|NCT04737603|Buprenorphine|buprenorphine|mesh-list
154293782|NCT05974410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154293783|NCT05974410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524721|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154524722|NCT04737603|Naloxone|naloxone|mesh-list
154524723|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154524724|NCT04737603|Narcotics|narcotics|mesh-ancestor
154524725|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154524726|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524727|NCT04737603|Analgesics|analgesics|mesh-ancestor
154524728|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
154524729|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524730|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154524731|NCT04713787|Albendazole|albendazole|mesh-list
154524732|NCT04713787|Oxfendazole|oxfendazole|mesh-list
154524733|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
154524734|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154524735|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524736|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
154524737|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154524738|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154524739|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
154524740|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
154524741|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524742|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524743|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524744|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
154524745|NCT04626128|Aflibercept|aflibercept|mesh-list
154524746|NCT04626128|Axitinib|axitinib|mesh-list
154524747|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154524748|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154524749|NCT04626128|Growth Substances|growth substances|mesh-ancestor
154524750|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524751|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
154524752|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524753|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154524754|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524755|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524756|NCT04582435|Insulin|insulin|mesh-list
154524757|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154524758|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524759|NCT04421820|Leucovorin|leucovorin|mesh-list
154524760|NCT04421820|Fluorouracil|fluorouracil|mesh-list
154524761|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
154524762|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
154524763|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524764|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154524765|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524766|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524767|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
154524768|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524769|NCT04421820|Antidotes|antidotes|mesh-ancestor
154524770|NCT04421820|Protective Agents|protective agents|mesh-ancestor
154524771|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
154524773|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
154524774|NCT04367090|Docetaxel|docetaxel|mesh-list
154524775|NCT04367090|Trastuzumab|trastuzumab|mesh-list
154524776|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524777|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
154524778|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
154524779|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524780|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524781|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524782|NCT04337450|Lamivudine|lamivudine|mesh-list
154524783|NCT04337450|Dolutegravir|dolutegravir|mesh-list
154524784|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154524785|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154524786|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524787|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524788|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
154524789|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524790|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154524791|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154524792|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154524793|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154524794|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
154524795|NCT04321993|Remdesivir|remdesivir|mesh-list
154524796|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154524797|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524798|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
154524799|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524800|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154524801|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524803|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524804|NCT03978988|Aspirin|aspirin|mesh-list
154524805|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154524806|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154524807|NCT03978988|Analgesics|analgesics|mesh-ancestor
154293856|NCT05806164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154524808|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
154524809|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524810|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524811|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524812|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154524813|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154524814|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154524815|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524816|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154524817|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154524818|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524819|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
154524820|NCT03950427|Bupropion|bupropion|mesh-list
154524821|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154524822|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
154524823|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154524824|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154524825|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154524826|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524827|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524828|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
154524829|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524830|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524831|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154524832|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154524833|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524834|NCT03911505|Miglustat|miglustat|mesh-list
154524835|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524836|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524837|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154524838|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154524839|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
154524841|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154524842|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154524843|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524844|NCT03851588|Dolutegravir|dolutegravir|mesh-list
154524845|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154524846|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154524847|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524848|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524849|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154524850|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154524851|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
154524852|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524853|NCT03850444|Paclitaxel|paclitaxel|mesh-list
154524854|NCT03850444|Carboplatin|carboplatin|mesh-list
154524855|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
154524856|NCT03850444|Pemetrexed|pemetrexed|mesh-list
154524857|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154524858|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524859|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
154524860|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
154524861|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524862|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524863|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524864|NCT03850444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154293906|NCT05022563|Warfarin|warfarin|mesh-list
154524865|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524866|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154524867|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154524868|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
154524869|NCT03850379|Levofloxacin|levofloxacin|mesh-list
154524870|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154524871|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154524872|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154524873|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154524874|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524875|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524876|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524877|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154524878|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154524879|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154524880|NCT03824483|Venetoclax|venetoclax|mesh-list
154524881|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
154524882|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
154524883|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524884|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524885|NCT03824483|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154524886|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154524887|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524888|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524889|NCT03820141|Trastuzumab|trastuzumab|mesh-list
154524890|NCT03820141|Durvalumab|durvalumab|mesh-list
154524891|NCT03820141|Pertuzumab|pertuzumab|mesh-list
154524892|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524893|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524894|NCT03742245|Olaparib|olaparib|mesh-list
154524895|NCT03742245|Vorinostat|vorinostat|mesh-list
154524896|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154524897|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524898|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524899|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524900|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154524901|NCT03619551|Busulfan|busulfan|mesh-list
154524902|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
154524903|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524904|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524905|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
154524906|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524907|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154524908|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293969|NCT04764227|Paclitaxel|paclitaxel|mesh-list
154524909|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154524910|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154524911|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154524912|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
154524913|NCT03522753|Hormones|hormones|mesh-ancestor
154248819|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154248821|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
154248822|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154248823|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248824|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248825|NCT03406858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154248826|NCT03406858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248827|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
154248828|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248829|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154248830|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154248831|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
154248832|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248833|NCT01095926|Doxorubicin|doxorubicin|mesh-list
154248834|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154248835|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248836|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154248837|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154248838|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248839|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253701|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253702|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253703|NCT01133444|Urological Agents|urological agents|mesh-ancestor
154253704|NCT01137656|Acetylcholine|acetylcholine|mesh-list
154253705|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
154253706|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154253707|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
154253708|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253709|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253710|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253711|NCT00369785|Donepezil|donepezil|mesh-list
154253712|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154253713|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253714|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253715|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
154253716|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253717|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253718|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
154253719|NCT05476562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154253720|NCT05476562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253721|NCT05476562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253722|NCT05476562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253723|NCT01136252|Adalimumab|adalimumab|mesh-list
154253724|NCT01136252|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154253725|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253726|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154253727|NCT00369707|Rituximab|rituximab|mesh-list
154253728|NCT00369707|Bortezomib|bortezomib|mesh-list
154253729|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154253730|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253731|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
154524914|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154524915|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524916|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524917|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524918|NCT03471507|Diclofenac|diclofenac|mesh-list
154524919|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154524920|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154524921|NCT03471507|Analgesics|analgesics|mesh-ancestor
154524922|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
154524923|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524924|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524925|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154524926|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154524927|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154524928|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524929|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524930|NCT03459222|Nivolumab|nivolumab|mesh-list
154524931|NCT03459222|Ipilimumab|ipilimumab|mesh-list
154524932|NCT03459222|Relatlimab|relatlimab|mesh-list
154524933|NCT03459222|Linrodostat|linrodostat|mesh-list
154524934|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524935|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524936|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154524937|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524938|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524939|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
154524940|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154524941|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154524942|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154524943|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154524944|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524945|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
154524946|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154524947|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524948|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154524949|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154524950|NCT02743494|Nivolumab|nivolumab|mesh-list
154524951|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524952|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524953|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154524954|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524955|NCT02722538|Gemcitabine|gemcitabine|mesh-list
154524956|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154524957|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
154524958|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524959|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524960|NCT02531126|Ozanimod|ozanimod|mesh-list
154524961|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154524962|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524963|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154524964|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
154524965|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524966|NCT02401503|Venetoclax|venetoclax|mesh-list
154524967|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154524968|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
154524969|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860479|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524970|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154524971|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
154524972|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524973|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154524974|NCT02272998|Ponatinib|ponatinib|mesh-list
154524975|NCT02272998|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154524976|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154524977|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524978|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524979|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524980|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
154524981|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
154524982|NCT02272842|Vitamins|vitamins|mesh-ancestor
154524983|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
154524984|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154524985|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
154524986|NCT02272842|Hematinics|hematinics|mesh-ancestor
154524987|NCT02258659|Paclitaxel|paclitaxel|mesh-list
154524988|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154524989|NCT02258659|Carboplatin|carboplatin|mesh-list
154524990|NCT02258659|Fluorouracil|fluorouracil|mesh-list
154524991|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
154524992|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154524993|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154524994|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
154524995|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
154524996|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
154524997|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154524998|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
154524999|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525000|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525001|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
154525002|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525003|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
154525004|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525005|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154525006|NCT02064673|Curcumin|curcumin|mesh-list
154525007|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154525008|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154294118|NCT04186559|Protective Agents|protective agents|mesh-ancestor
154525010|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
154525011|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525012|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525013|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525014|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525015|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525016|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525017|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525018|NCT01990300|Pioglitazone|pioglitazone|mesh-list
154525019|NCT01990300|Alogliptin|alogliptin|mesh-list
154525020|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525021|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525022|NCT01990300|Incretins|incretins|mesh-ancestor
154525023|NCT01990300|Hormones|hormones|mesh-ancestor
154525024|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525025|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154525026|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
154525027|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525028|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525029|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154525030|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525031|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525032|NCT01909934|Immunotoxins|immunotoxins|mesh-ancestor
154525033|NCT01909934|Immunoconjugates|immunoconjugates|mesh-ancestor
154525034|NCT01909934|Immunologic Factors|immunologic factors|mesh-ancestor
154525035|NCT01909934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525036|NCT01740648|Fluorouracil|fluorouracil|mesh-list
154525037|NCT01740648|Trametinib|trametinib|mesh-list
154525038|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
154525039|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525040|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525041|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525042|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525043|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
154525044|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525045|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525046|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525048|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525049|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525050|NCT01638442|Tosedostat|tosedostat|mesh-list
154525051|NCT01638442|Glycine|glycine|mesh-list
154525052|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525053|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525054|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
154525055|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525056|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525057|NCT01076400|Topotecan|topotecan|mesh-list
154525058|NCT01076400|Adavosertib|adavosertib|mesh-list
154525059|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525060|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154525061|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154525062|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525063|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525064|NCT00934895|Paclitaxel|paclitaxel|mesh-list
154525065|NCT00934895|Everolimus|everolimus|mesh-list
154525066|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154525067|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154525068|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525069|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
154525070|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
154525071|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
154525072|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525073|NCT00934895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154525074|NCT00934895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525075|NCT00934895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525076|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525077|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
154525078|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525079|NCT00913497|Insulin|insulin|mesh-list
154525080|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154525081|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
154525082|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
154525083|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525084|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525085|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
154525086|NCT00556933|Sirolimus|sirolimus|mesh-list
154525087|NCT00556933|Tacrolimus|tacrolimus|mesh-list
154525088|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
154525089|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154525090|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525091|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
154525092|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525093|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154525094|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525095|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525096|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154525097|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525098|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154525099|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
154525100|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154525101|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525102|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
154525103|NCT00503880|Cytarabine|cytarabine|mesh-list
154525104|NCT00503880|Clofarabine|clofarabine|mesh-list
154525105|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525106|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
154525107|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525108|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525109|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
154525110|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525111|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525112|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
154525113|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525114|NCT00378326|Tacrolimus|tacrolimus|mesh-list
154525115|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525116|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
154525117|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525118|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154525119|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525120|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525121|NCT00106600|Pixantrone|pixantrone|mesh-list
154525122|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154525123|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154525124|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525125|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525126|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525128|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154525129|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
154525130|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525131|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154525132|NCT05850143|Dexamethasone|dexamethasone|mesh-list
154525133|NCT05850143|Prednisolone|prednisolone|mesh-list
154525134|NCT05850143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525135|NCT05850143|Antiemetics|antiemetics|mesh-ancestor
154525136|NCT05850143|Autonomic Agents|autonomic agents|mesh-ancestor
154525137|NCT05850143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525138|NCT05850143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525139|NCT05850143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525140|NCT05850143|Glucocorticoids|glucocorticoids|mesh-ancestor
154525141|NCT05850143|Hormones|hormones|mesh-ancestor
154525142|NCT05850143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525143|NCT05850143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154525144|NCT05850143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525145|NCT05850117|Amoxicillin|amoxicillin|mesh-list
154525146|NCT05850117|Metronidazole|metronidazole|mesh-list
154525147|NCT05850117|Levofloxacin|levofloxacin|mesh-list
154525148|NCT05850117|Ofloxacin|ofloxacin|mesh-list
154525149|NCT05850117|Tetracycline|tetracycline|mesh-list
154525150|NCT05850117|Esomeprazole|esomeprazole|mesh-list
154525151|NCT05850117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154525152|NCT05850117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525153|NCT05850117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154525154|NCT05850117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154525155|NCT05850117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154525156|NCT05850117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525157|NCT05850117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154525158|NCT05850117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525159|NCT05850117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525160|NCT05850117|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154525161|NCT05850117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154525162|NCT05850117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154525163|NCT05850117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525164|NCT05850117|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154525165|NCT05850117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154525166|NCT05850117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154525167|NCT05849883|Omeprazole|omeprazole|mesh-list
154525168|NCT05849883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154525169|NCT05849883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525170|NCT05849883|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154525171|NCT05849883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525172|NCT05849883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525173|NCT05849766|Dapagliflozin|dapagliflozin|mesh-list
154525174|NCT05849766|Carvedilol|carvedilol|mesh-list
154525175|NCT05849766|Ramipril|ramipril|mesh-list
154525176|NCT05849766|Spironolactone|spironolactone|mesh-list
154525177|NCT05849766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154525178|NCT05849766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525179|NCT05849766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525180|NCT05849766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525181|NCT05849766|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154525182|NCT05849766|Hormone Antagonists|hormone antagonists|mesh-ancestor
154525183|NCT05849766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525184|NCT05849766|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154525185|NCT05849766|Diuretics|diuretics|mesh-ancestor
154525186|NCT05849766|Natriuretic Agents|natriuretic agents|mesh-ancestor
154525187|NCT05849766|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154525188|NCT05849766|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154525189|NCT05849766|Adrenergic Agents|adrenergic agents|mesh-ancestor
154525190|NCT05849766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525191|NCT05849766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154525192|NCT05849766|Antioxidants|antioxidants|mesh-ancestor
154525193|NCT05849766|Protective Agents|protective agents|mesh-ancestor
154525194|NCT05849766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154525195|NCT05849766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860480|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
154525196|NCT05849766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154525197|NCT05849766|Vasodilator Agents|vasodilator agents|mesh-ancestor
154525198|NCT05849766|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154525199|NCT05849766|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154525200|NCT05849766|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154525201|NCT05849766|Protease Inhibitors|protease inhibitors|mesh-ancestor
154525202|NCT05849766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525203|NCT05849662|Cytarabine|cytarabine|mesh-list
154525204|NCT05849662|Fludarabine|fludarabine|mesh-list
154525205|NCT05849662|Azacitidine|azacitidine|mesh-list
154525206|NCT05849662|Trametinib|trametinib|mesh-list
154525207|NCT05849662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525208|NCT05849662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525209|NCT05849662|Antimetabolites|antimetabolites|mesh-ancestor
154525210|NCT05849662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525211|NCT05849662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525212|NCT05849662|Immunologic Factors|immunologic factors|mesh-ancestor
154525213|NCT05849662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525214|NCT05849662|Antiviral Agents|antiviral agents|mesh-ancestor
154525215|NCT05849662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525216|NCT05849662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525217|NCT05849662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525218|NCT05849597|Dexmedetomidine|dexmedetomidine|mesh-list
154525219|NCT05849597|Propofol|propofol|mesh-list
154525220|NCT05849597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154525221|NCT05849597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154525222|NCT05849597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525223|NCT05849597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154525224|NCT05849597|Analgesics|analgesics|mesh-ancestor
154525225|NCT05849597|Sensory System Agents|sensory system agents|mesh-ancestor
154525226|NCT05849597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525227|NCT05849597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154525228|NCT05849597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154525229|NCT05849597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154525230|NCT05849597|Adrenergic Agents|adrenergic agents|mesh-ancestor
154525231|NCT05849597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525232|NCT05849597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525233|NCT05849597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154525234|NCT05849597|Anesthetics, General|anesthetics, general|mesh-ancestor
154525235|NCT05849597|Anesthetics|anesthetics|mesh-ancestor
154525236|NCT05847283|Dydrogesterone|dydrogesterone|mesh-list
154525237|NCT05847283|Progestins|progestins|mesh-ancestor
154525238|NCT05847283|Hormones|hormones|mesh-ancestor
154525239|NCT05847283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525240|NCT05847283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525241|NCT05845580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154525242|NCT05845580|Red yeast rice|red yeast rice|mesh-list
154525243|NCT05845580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154525244|NCT05845580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154525245|NCT05845580|Antimetabolites|antimetabolites|mesh-ancestor
154525246|NCT05845580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525247|NCT05845580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525248|NCT05845580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154525249|NCT05843968|Mycophenolic Acid|mycophenolic acid|mesh-list
154525250|NCT05843968|Rituximab|rituximab|mesh-list
154525251|NCT05843968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525252|NCT05843968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525253|NCT05843968|Immunologic Factors|immunologic factors|mesh-ancestor
154525254|NCT05843968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525255|NCT05843968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525256|NCT05843968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154525257|NCT05843968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154525258|NCT05843968|Antitubercular Agents|antitubercular agents|mesh-ancestor
154525259|NCT05843968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154525260|NCT05843968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525261|NCT05843968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525262|NCT05843968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525263|NCT05841134|Capecitabine|capecitabine|mesh-list
154525264|NCT05841134|Oxaliplatin|oxaliplatin|mesh-list
154525265|NCT05841134|Tislelizumab|tislelizumab|mesh-list
154525266|NCT05841134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525267|NCT05841134|Antimetabolites|antimetabolites|mesh-ancestor
154525268|NCT05841134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525269|NCT05841134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525270|NCT05841134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525271|NCT05831878|Disitamab vedotin|disitamab vedotin|mesh-list
154525273|NCT05831878|Immunologic Factors|immunologic factors|mesh-ancestor
154525274|NCT05831878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525275|NCT05827705|Ephedrine|ephedrine|mesh-list
154525276|NCT05827705|Pseudoephedrine|pseudoephedrine|mesh-list
154525277|NCT05827705|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154525278|NCT05827705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525279|NCT05827705|Sympathomimetics|sympathomimetics|mesh-ancestor
154525280|NCT05827705|Autonomic Agents|autonomic agents|mesh-ancestor
154525281|NCT05827705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525282|NCT05827705|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154525283|NCT05827705|Adrenergic Agents|adrenergic agents|mesh-ancestor
154525284|NCT05827705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525285|NCT05827705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525286|NCT05827705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154525287|NCT05827705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154525288|NCT05827705|Respiratory System Agents|respiratory system agents|mesh-ancestor
154525289|NCT05827705|Nasal Decongestants|nasal decongestants|mesh-ancestor
154525290|NCT05816746|Decitabine|decitabine|mesh-list
154525291|NCT05816746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525292|NCT05816746|Antimetabolites|antimetabolites|mesh-ancestor
154525293|NCT05816746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525294|NCT05816746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525295|NCT05816746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525296|NCT05949229|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154525297|NCT05949229|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154525298|NCT05949229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154525299|NCT05949229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154525300|NCT05949229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525301|NCT05949229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525302|NCT05949229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525303|NCT05949229|Analgesics|analgesics|mesh-ancestor
154525304|NCT05949229|Sensory System Agents|sensory system agents|mesh-ancestor
154525305|NCT05949229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525306|NCT05949229|Antidepressive Agents|antidepressive agents|mesh-ancestor
154525307|NCT05949229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154525308|NCT05949229|Dopamine Agents|dopamine agents|mesh-ancestor
154525309|NCT05948449|Oxaliplatin|oxaliplatin|mesh-list
154525310|NCT05948449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525311|NCT05948228|Fluorides|fluorides|mesh-list
154525312|NCT05948228|Cariostatic Agents|cariostatic agents|mesh-ancestor
154525313|NCT05948228|Protective Agents|protective agents|mesh-ancestor
154525314|NCT05948228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525315|NCT05948072|Cetuximab|cetuximab|mesh-list
154525316|NCT05948072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525317|NCT05948072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525318|NCT05947825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154525319|NCT05947825|Paclitaxel|paclitaxel|mesh-list
154525320|NCT05947825|Gemcitabine|gemcitabine|mesh-list
154525321|NCT05947825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154525322|NCT05947825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525323|NCT05947825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154525324|NCT05947825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154525325|NCT05947825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154525326|NCT05947825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525327|NCT05947825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525328|NCT05947825|Antimetabolites|antimetabolites|mesh-ancestor
154525329|NCT05947825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525330|NCT05947825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525331|NCT05947825|Incretins|incretins|mesh-ancestor
154525332|NCT05947825|Hormones|hormones|mesh-ancestor
154525333|NCT05947825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525334|NCT05947825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154525335|NCT05947825|Protease Inhibitors|protease inhibitors|mesh-ancestor
154525336|NCT05947825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525337|NCT05947812|Tafenoquine|tafenoquine|mesh-list
154525338|NCT05947812|Antimalarials|antimalarials|mesh-ancestor
154525339|NCT05947812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154525340|NCT05947812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154525341|NCT05947812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525342|NCT05947708|Dialysis Solutions|dialysis solutions|mesh-list
154525343|NCT05947708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154525344|NCT05947669|Methylprednisolone|methylprednisolone|mesh-list
154525345|NCT05947669|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154360213|NCT04549376|Iodine|iodine|mesh-list
154525346|NCT05947669|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154525348|NCT05947669|Prednisolone acetate|prednisolone acetate|mesh-list
154525349|NCT05947669|Infliximab|infliximab|mesh-list
154525350|NCT05947669|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154525351|NCT05947669|Prednisolone phosphate|prednisolone phosphate|mesh-list
154525352|NCT05947669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525353|NCT05947669|Antiemetics|antiemetics|mesh-ancestor
154525354|NCT05947669|Autonomic Agents|autonomic agents|mesh-ancestor
154525355|NCT05947669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525356|NCT05947669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525357|NCT05947669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525358|NCT05947669|Glucocorticoids|glucocorticoids|mesh-ancestor
154525359|NCT05947669|Hormones|hormones|mesh-ancestor
154294460|NCT06324279|Oxytocics|oxytocics|mesh-ancestor
154525360|NCT05947669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525361|NCT05947669|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154525362|NCT05947669|Protective Agents|protective agents|mesh-ancestor
154525363|NCT05947669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154525364|NCT05947669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525365|NCT05947669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154525366|NCT05947669|Dermatologic Agents|dermatologic agents|mesh-ancestor
154525367|NCT05947669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525368|NCT05947643|Theophylline|theophylline|mesh-list
154525369|NCT05947643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154525370|NCT05947643|Autonomic Agents|autonomic agents|mesh-ancestor
154525371|NCT05947643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525372|NCT05947643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525373|NCT05947643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154525374|NCT05947643|Respiratory System Agents|respiratory system agents|mesh-ancestor
154525375|NCT05947643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154525376|NCT05947643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525377|NCT05947643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525378|NCT05947643|Vasodilator Agents|vasodilator agents|mesh-ancestor
154525379|NCT05947643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154525380|NCT05947643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154525381|NCT05947643|Purinergic Agents|purinergic agents|mesh-ancestor
154525382|NCT05947643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525383|NCT05947604|Midazolam|midazolam|mesh-list
154249215|NCT05840822|Cannabidiol|cannabidiol|mesh-list
154525384|NCT05947604|Levomethorphan|levomethorphan|mesh-list
154525385|NCT05947604|Dextromethorphan|dextromethorphan|mesh-list
154525386|NCT05947604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154525387|NCT05947604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154525388|NCT05947604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154525389|NCT05947604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525390|NCT05947604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154525391|NCT05947604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154525392|NCT05947604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154525393|NCT05947604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154525394|NCT05947604|Anesthetics, General|anesthetics, general|mesh-ancestor
154525395|NCT05947604|Anesthetics|anesthetics|mesh-ancestor
154525396|NCT05947604|GABA Modulators|gaba modulators|mesh-ancestor
154525397|NCT05947604|GABA Agents|gaba agents|mesh-ancestor
154525398|NCT05947604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525399|NCT05947604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525400|NCT05947604|Antitussive Agents|antitussive agents|mesh-ancestor
154294510|NCT06323837|Serotonin Agents|serotonin agents|mesh-ancestor
154525401|NCT05947604|Respiratory System Agents|respiratory system agents|mesh-ancestor
154525402|NCT05947604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154525403|NCT05947604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154525404|NCT05947604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154525405|NCT05947604|Narcotics|narcotics|mesh-ancestor
154525406|NCT05947604|Analgesics|analgesics|mesh-ancestor
154525407|NCT05947604|Sensory System Agents|sensory system agents|mesh-ancestor
154525408|NCT05947604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525409|NCT05947513|Curcumin|curcumin|mesh-list
154525410|NCT05947513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154525411|NCT05947513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154525412|NCT05947513|Analgesics|analgesics|mesh-ancestor
154525413|NCT05947513|Sensory System Agents|sensory system agents|mesh-ancestor
154525414|NCT05947513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525415|NCT05947513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525416|NCT05947513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525417|NCT05947513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525418|NCT05947513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525419|NCT05947513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360284|NCT03907163|Hormones|hormones|mesh-ancestor
154525420|NCT05947513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525421|NCT05947461|Diclofenac|diclofenac|mesh-list
154525422|NCT05947461|Indomethacin|indomethacin|mesh-list
154525423|NCT05947461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154525424|NCT05947461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154525425|NCT05947461|Analgesics|analgesics|mesh-ancestor
154525426|NCT05947461|Sensory System Agents|sensory system agents|mesh-ancestor
154525427|NCT05947461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525428|NCT05947461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525429|NCT05947461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525430|NCT05947461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525431|NCT05947461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154525432|NCT05947461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525433|NCT05947461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525434|NCT05947461|Gout Suppressants|gout suppressants|mesh-ancestor
154525435|NCT05947461|Tocolytic Agents|tocolytic agents|mesh-ancestor
154525436|NCT05947461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154525437|NCT05947383|Psilocybin|psilocybin|mesh-list
154525438|NCT05947383|Hallucinogens|hallucinogens|mesh-ancestor
154525439|NCT05947383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525440|NCT05947383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154525441|NCT05944445|Linezolid|linezolid|mesh-list
154525442|NCT05944445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154525443|NCT05944445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525444|NCT05944445|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154525445|NCT05944445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525446|NCT05944445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525447|NCT05944055|Vitamin D|vitamin d|mesh-list
154525448|NCT05944055|Vitamins|vitamins|mesh-ancestor
154525449|NCT05944055|Micronutrients|micronutrients|mesh-ancestor
154525450|NCT05944055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525451|NCT05944055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154525452|NCT05925049|Natalizumab|natalizumab|mesh-list
154525453|NCT05925049|Immunologic Factors|immunologic factors|mesh-ancestor
154525454|NCT05925049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525455|NCT05906459|Antibodies|antibodies|mesh-list
154525456|NCT05906459|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
154525457|NCT05906459|Immunologic Factors|immunologic factors|mesh-ancestor
154525458|NCT05906459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525459|NCT05862168|Paclitaxel|paclitaxel|mesh-list
154525460|NCT05862168|Fluorouracil|fluorouracil|mesh-list
154525461|NCT05862168|Tislelizumab|tislelizumab|mesh-list
154525462|NCT05862168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154525463|NCT05862168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525464|NCT05862168|Tubulin Modulators|tubulin modulators|mesh-ancestor
154525465|NCT05862168|Antimitotic Agents|antimitotic agents|mesh-ancestor
154525466|NCT05862168|Mitosis Modulators|mitosis modulators|mesh-ancestor
154525467|NCT05862168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525468|NCT05862168|Antimetabolites|antimetabolites|mesh-ancestor
154525469|NCT05862168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525470|NCT05862168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525471|NCT05862168|Immunologic Factors|immunologic factors|mesh-ancestor
154525472|NCT05862168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525473|NCT05862168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525474|NCT05855876|Ketamine|ketamine|mesh-list
154525475|NCT05855876|Analgesics|analgesics|mesh-ancestor
154525476|NCT05855876|Sensory System Agents|sensory system agents|mesh-ancestor
154525477|NCT05855876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525478|NCT05855876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525479|NCT05855876|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154525480|NCT05855876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154525481|NCT05855876|Anesthetics, General|anesthetics, general|mesh-ancestor
154525482|NCT05855876|Anesthetics|anesthetics|mesh-ancestor
154525483|NCT05855876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154525484|NCT05855876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154525485|NCT05855876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154525486|NCT05855876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525487|NCT05855876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525488|NCT05838287|Pioglitazone|pioglitazone|mesh-list
154525489|NCT05838287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525490|NCT05838287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525491|NCT05825066|Paclitaxel|paclitaxel|mesh-list
154525492|NCT05825066|Gemcitabine|gemcitabine|mesh-list
154294599|NCT06322706|Omeprazole|omeprazole|mesh-list
154525493|NCT05825066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154525494|NCT05825066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525495|NCT05825066|Tubulin Modulators|tubulin modulators|mesh-ancestor
154525496|NCT05825066|Antimitotic Agents|antimitotic agents|mesh-ancestor
154525497|NCT05825066|Mitosis Modulators|mitosis modulators|mesh-ancestor
154525498|NCT05825066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525499|NCT05825066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525500|NCT05825066|Antimetabolites|antimetabolites|mesh-ancestor
154525501|NCT05808010|Hydrotalcite|hydrotalcite|mesh-list
154525502|NCT05808010|Antacids|antacids|mesh-ancestor
154525503|NCT05808010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525504|NCT05808010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525505|NCT05799378|Hydroxychloroquine|hydroxychloroquine|mesh-list
154525506|NCT05799378|Antimalarials|antimalarials|mesh-ancestor
154525507|NCT05799378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154525508|NCT05799378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154525509|NCT05799378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525510|NCT05799378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525511|NCT05799378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525512|NCT05799378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525513|NCT05794958|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154525514|NCT05794958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525515|NCT05794958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525516|NCT05754203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154525517|NCT05754203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525518|NCT05754203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525519|NCT05754203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525520|NCT05718466|Bevacizumab|bevacizumab|mesh-list
154525521|NCT05718466|Carboplatin|carboplatin|mesh-list
154525522|NCT05718466|Irinotecan|irinotecan|mesh-list
154525523|NCT05718466|Etoposide|etoposide|mesh-list
154525524|NCT05718466|Temozolomide|temozolomide|mesh-list
154525525|NCT05718466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525526|NCT05718466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525527|NCT05718466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154525528|NCT05718466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154525529|NCT05718466|Growth Substances|growth substances|mesh-ancestor
154525530|NCT05718466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525531|NCT05718466|Growth Inhibitors|growth inhibitors|mesh-ancestor
154525532|NCT05718466|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154525533|NCT05718466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154525534|NCT05718466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525535|NCT05718466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525536|NCT05718466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154525537|NCT05718466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154525538|NCT05718466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154525539|NCT05718466|Alkylating Agents|alkylating agents|mesh-ancestor
154525540|NCT05680129|Metformin|metformin|mesh-list
154525541|NCT05680129|Dulaglutide|dulaglutide|mesh-list
154525542|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525543|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525544|NCT05680129|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154525545|NCT05640934|Melatonin|melatonin|mesh-list
154525546|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
154525547|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525548|NCT05640934|Protective Agents|protective agents|mesh-ancestor
154525549|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525550|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154525551|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
154525552|NCT05508009|Melphalan|melphalan|mesh-list
154525553|NCT05508009|Rituximab|rituximab|mesh-list
154525554|NCT05508009|Fludarabine|fludarabine|mesh-list
154525555|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525556|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
154525557|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525558|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525559|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154525560|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
154525561|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525562|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525563|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154525564|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525565|NCT05459298|Vitamin D|vitamin d|mesh-list
154525566|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
154525567|NCT05459298|Vitamins|vitamins|mesh-ancestor
154525568|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
154525569|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525570|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154525571|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154525572|NCT05400577|Sotorasib|sotorasib|mesh-list
154525573|NCT05400577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154525574|NCT05400577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525575|NCT05400577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525576|NCT05400577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525577|NCT05288777|Capecitabine|capecitabine|mesh-list
154525578|NCT05288777|Trastuzumab|trastuzumab|mesh-list
154525579|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154525580|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525581|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
154525582|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525583|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525584|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525585|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
154525586|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
154525587|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
154525588|NCT05288777|Immunotoxins|immunotoxins|mesh-ancestor
154525589|NCT05288777|Immunoconjugates|immunoconjugates|mesh-ancestor
154525590|NCT05288777|Immunologic Factors|immunologic factors|mesh-ancestor
154525591|NCT05288777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525592|NCT05254314|Semaglutide|semaglutide|mesh-list
154525593|NCT05254314|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154525594|NCT05254314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525595|NCT05254314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525596|NCT05156281|Teriflunomide|teriflunomide|mesh-list
154525597|NCT05156281|Remibrutinib|remibrutinib|mesh-list
154525598|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154525599|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154525600|NCT05156281|Analgesics|analgesics|mesh-ancestor
154525601|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
154525602|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525603|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525604|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525605|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525606|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525607|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
154525608|NCT05156281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525609|NCT05156281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249449|NCT03903133|Vitamin E|vitamin e|mesh-list
154525610|NCT05156281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525611|NCT05153174|Sulforaphane|sulforaphane|mesh-list
154525612|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154525613|NCT05153174|Protective Agents|protective agents|mesh-ancestor
154525614|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525615|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525616|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
154525617|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154525618|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
154525619|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525620|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525621|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154525622|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
154525623|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154525624|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
154525625|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525626|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525627|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154525628|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
154525629|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
154525630|NCT05101746|Protective Agents|protective agents|mesh-ancestor
154525631|NCT04938453|Nintedanib|nintedanib|mesh-list
154525632|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525633|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525634|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525635|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525636|NCT04778982|Fulvestrant|fulvestrant|mesh-list
154525637|NCT04778982|Palbociclib|palbociclib|mesh-list
154525638|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154525639|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525640|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154525641|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154525642|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
154525643|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525644|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525645|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525647|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525648|NCT04772781|Ibuprofen|ibuprofen|mesh-list
154525649|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154525650|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154525651|NCT04772781|Analgesics|analgesics|mesh-ancestor
154525652|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
154525653|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525654|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525655|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525656|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525657|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154525658|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525659|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525660|NCT04699877|Gilteritinib|gilteritinib|mesh-list
154525661|NCT04699877|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154525662|NCT04699877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525663|NCT04699877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525664|NCT04699877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525665|NCT04699591|Domperidone|domperidone|mesh-list
154294776|NCT06236438|Pemetrexed|pemetrexed|mesh-list
154525666|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
154525667|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
154525668|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525669|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525670|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525671|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154525672|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
154525673|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525674|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525675|NCT04679948|Midazolam|midazolam|mesh-list
154525676|NCT04679948|Caffeine|caffeine|mesh-list
154525677|NCT04679948|Omeprazole|omeprazole|mesh-list
154525678|NCT04679948|Warfarin|warfarin|mesh-list
154525679|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154525680|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154525681|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154525682|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249519|NCT03253133|Analgesics|analgesics|mesh-ancestor
154525683|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154525684|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154525685|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154525686|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154525687|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
154525688|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
154525689|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
154525690|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
154525691|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525692|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525693|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
154525694|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154525695|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154525696|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525697|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154525698|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154525699|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
154525700|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154525701|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525702|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154525703|NCT04647435|Tramadol|tramadol|mesh-list
154525704|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154525705|NCT04647435|Narcotics|narcotics|mesh-ancestor
154525706|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154525707|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525708|NCT04647435|Analgesics|analgesics|mesh-ancestor
154525709|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
154525710|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525711|NCT04637529|Ibuprofen|ibuprofen|mesh-list
154525712|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154525713|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154525714|NCT04637529|Analgesics|analgesics|mesh-ancestor
154525715|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
154525716|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525717|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525718|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525719|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525720|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154525721|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525722|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525723|NCT04625803|Apatinib|apatinib|mesh-list
154525724|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525725|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525726|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525727|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525728|NCT04446117|Prednisone|prednisone|mesh-list
154525729|NCT04446117|Atezolizumab|atezolizumab|mesh-list
154525730|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
154525731|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525732|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
154525733|NCT04446117|Hormones|hormones|mesh-ancestor
154525734|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525735|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525736|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154525737|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525738|NCT04446117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154525739|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525740|NCT04446117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525741|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154525742|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525743|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
154525744|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154525745|NCT04397003|Durvalumab|durvalumab|mesh-list
154525746|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525747|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525748|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
154525749|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154525750|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525751|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154525752|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154525753|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525754|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525755|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525756|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154294874|NCT06212622|Alfentanil|alfentanil|mesh-list
154525757|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154525758|NCT04112043|Niacinamide|niacinamide|mesh-list
154525759|NCT04112043|Niacin|niacin|mesh-list
154525760|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
154525761|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
154525762|NCT04112043|Vitamins|vitamins|mesh-ancestor
154525763|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
154525764|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525765|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154525766|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
154525767|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525768|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154525769|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
154525770|NCT03997968|Rituximab|rituximab|mesh-list
154525771|NCT03997968|Gemcitabine|gemcitabine|mesh-list
154525772|NCT03997968|Capecitabine|capecitabine|mesh-list
154525773|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154525774|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525775|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525776|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
154525777|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525778|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525779|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525780|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
154525781|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525782|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154525783|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
154525784|NCT03995706|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154525785|NCT03995706|Immunoconjugates|immunoconjugates|mesh-ancestor
154525786|NCT03995706|Immunologic Factors|immunologic factors|mesh-ancestor
154525787|NCT03995706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525788|NCT03984097|Dexamethasone|dexamethasone|mesh-list
154525789|NCT03984097|Lenalidomide|lenalidomide|mesh-list
154525790|NCT03984097|Bortezomib|bortezomib|mesh-list
154525791|NCT03984097|Pomalidomide|pomalidomide|mesh-list
154525792|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154525793|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
154525794|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
154525795|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525796|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525797|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525798|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
154525800|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525801|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154525802|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525803|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
154525804|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154525805|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154525806|NCT03984097|Growth Substances|growth substances|mesh-ancestor
154525807|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
154525808|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
154525809|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154525810|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154525811|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154525812|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525813|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
154525814|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525815|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525816|NCT03741478|Insulin|insulin|mesh-list
154525817|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154525818|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
154525819|NCT03741478|Olanzapine|olanzapine|mesh-list
154525820|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525821|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525822|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
154525823|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
154525824|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525825|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154525826|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154525827|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154525828|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154525829|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154525830|NCT03741478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154525831|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154525832|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154249667|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154525833|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525834|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525835|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
154525836|NCT03669367|Abatacept|abatacept|mesh-list
154525837|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154525838|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525839|NCT03669367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525840|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525841|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525842|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
154525843|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525844|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525845|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
154525846|NCT03630081|Meropenem|meropenem|mesh-list
154525847|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154525848|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525849|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154525850|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154525851|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525852|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525853|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525854|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154525855|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154525856|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
154525857|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154525858|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154525859|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525860|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154525861|NCT03522688|Analgesics|analgesics|mesh-ancestor
154525862|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
154525863|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525864|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154360731|NCT03893591|Dalteparin|dalteparin|mesh-list
154525865|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154525867|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154525868|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525869|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525870|NCT03493919|Vaccines|vaccines|mesh-list
154525871|NCT03493919|Immunologic Factors|immunologic factors|mesh-ancestor
154525872|NCT03493919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525873|NCT03326128|Bupropion|bupropion|mesh-list
154525874|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154525875|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
154525876|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154525877|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154525878|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154525879|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154525880|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525881|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
154525882|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525883|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525884|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154525885|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154525886|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525887|NCT03277924|Doxorubicin|doxorubicin|mesh-list
154525888|NCT03277924|Nivolumab|nivolumab|mesh-list
154525889|NCT03277924|Methotrexate|methotrexate|mesh-list
154525890|NCT03277924|Sunitinib|sunitinib|mesh-list
154525891|NCT03277924|Epirubicin|epirubicin|mesh-list
154525892|NCT03277924|Ifosfamide|ifosfamide|mesh-list
154525893|NCT03277924|Dacarbazine|dacarbazine|mesh-list
154525894|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525895|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154525896|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154525897|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154525898|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525899|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525900|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525901|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154525902|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154525903|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
154525904|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154525905|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525906|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525907|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
154525908|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
154525909|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154525910|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525911|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
154525912|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154525913|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154525914|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154525915|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154525916|NCT03277924|Growth Substances|growth substances|mesh-ancestor
154525917|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
154525918|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525919|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154525920|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
154525921|NCT03176134|Tedizolid|tedizolid|mesh-list
154525922|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
154525923|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154525924|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525925|NCT03152786|Propranolol|propranolol|mesh-list
154525926|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154525927|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154525928|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
154525929|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154525930|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525931|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295031|NCT06049212|Pembrolizumab|pembrolizumab|mesh-list
154525932|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154525933|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154525934|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
154525935|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
154525936|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154525937|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525938|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
154525939|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525941|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154525942|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
154525943|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525944|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525945|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154525946|NCT02538484|Letrozole|letrozole|mesh-list
154525947|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525948|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154525949|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154525950|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525951|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525952|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154525953|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
154525954|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154525955|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525956|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
154525957|NCT02484391|Cytarabine|cytarabine|mesh-list
154525958|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
154525959|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154525960|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
154525961|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525962|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525963|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
154525964|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154525965|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154525966|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
154525967|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525968|NCT02484391|Analgesics|analgesics|mesh-ancestor
154525969|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
154525970|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154525971|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154525972|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154525973|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525974|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
154525975|NCT02484391|Protective Agents|protective agents|mesh-ancestor
154525976|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
154525977|NCT02484391|Vitamins|vitamins|mesh-ancestor
154525978|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
154525979|NCT02478320|Ilorasertib|ilorasertib|mesh-list
154525980|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249820|NCT00396383|Plerixafor|plerixafor|mesh-list
154525981|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525982|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525983|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525984|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154525986|NCT02311998|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154525987|NCT02311998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154525988|NCT02311998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154525989|NCT02311998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154525990|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154525991|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154525992|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154525993|NCT02311998|Immunotoxins|immunotoxins|mesh-ancestor
154525994|NCT02311998|Immunoconjugates|immunoconjugates|mesh-ancestor
154525995|NCT02311998|Immunologic Factors|immunologic factors|mesh-ancestor
154525996|NCT02311998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154525997|NCT02252042|Docetaxel|docetaxel|mesh-list
154525998|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
154525999|NCT02252042|Methotrexate|methotrexate|mesh-list
154526000|NCT02252042|Cetuximab|cetuximab|mesh-list
154526001|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526002|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
154526003|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
154526004|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
154526005|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526006|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526007|NCT02252042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526008|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154526009|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
154526010|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154526011|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526012|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154526014|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
154526015|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526016|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154526017|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154526018|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
154526019|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526020|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154526021|NCT02099058|Nivolumab|nivolumab|mesh-list
154526022|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154526023|NCT02099058|Osimertinib|osimertinib|mesh-list
154526024|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154526025|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526026|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526027|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526028|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526029|NCT02099058|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154526030|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154526031|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526032|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
154526033|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526034|NCT01900847|Ketamine|ketamine|mesh-list
154526035|NCT01900847|Morphine|morphine|mesh-list
154526036|NCT01900847|Analgesics|analgesics|mesh-ancestor
154526037|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
154526038|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526039|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526040|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154526041|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154526042|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
154526043|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
154526044|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526045|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154526046|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154526047|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526048|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526049|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154526050|NCT01900847|Narcotics|narcotics|mesh-ancestor
154526051|NCT01710007|Atorvastatin|atorvastatin|mesh-list
154526052|NCT01710007|Pitavastatin|pitavastatin|mesh-list
154526053|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154526054|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154526055|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
154526056|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526057|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154526058|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154526059|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526060|NCT01357772|Tamoxifen|tamoxifen|mesh-list
154526061|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154526062|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
154526063|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526064|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526065|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154526066|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526067|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154526068|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154526069|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154526070|NCT00378482|Tremelimumab|tremelimumab|mesh-list
154526071|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526072|NCT05813860|Infliximab|infliximab|mesh-list
154526073|NCT05813860|Azathioprine|azathioprine|mesh-list
154526074|NCT05813860|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154526075|NCT05813860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526076|NCT05813860|Dermatologic Agents|dermatologic agents|mesh-ancestor
154526077|NCT05813860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526078|NCT05813860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526079|NCT05813860|Antimetabolites|antimetabolites|mesh-ancestor
154526080|NCT05813860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526081|NCT05813860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154526082|NCT05813860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526083|NCT05813860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154526084|NCT05813860|Immunologic Factors|immunologic factors|mesh-ancestor
154526085|NCT05813860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526086|NCT05788276|Dapagliflozin|dapagliflozin|mesh-list
154526087|NCT05788276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154526088|NCT05788276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526090|NCT05788276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526091|NCT05738694|Axitinib|axitinib|mesh-list
154526092|NCT05738694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526093|NCT05738694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154526094|NCT05738694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526095|NCT05738694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526096|NCT05731986|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
154526097|NCT05731986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154526098|NCT05731986|Immunologic Factors|immunologic factors|mesh-ancestor
154526099|NCT05731986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526100|NCT05725499|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
154526101|NCT05725499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154526102|NCT05725499|Immunologic Factors|immunologic factors|mesh-ancestor
154526103|NCT05725499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526104|NCT05708521|Hydromorphone|hydromorphone|mesh-list
154526105|NCT05708521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154526106|NCT05708521|Narcotics|narcotics|mesh-ancestor
154526107|NCT05708521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526108|NCT05708521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526109|NCT05708521|Analgesics|analgesics|mesh-ancestor
154526110|NCT05708521|Sensory System Agents|sensory system agents|mesh-ancestor
154526111|NCT05708521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526112|NCT05702359|Vitamin D|vitamin d|mesh-list
154526113|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
154526114|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
154526115|NCT05702359|Vitamins|vitamins|mesh-list
154526116|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
154526117|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295222|NCT05836571|Nivolumab|nivolumab|mesh-list
154526118|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154526119|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154526120|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
154526121|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526122|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526123|NCT05690282|Acetaminophen|acetaminophen|mesh-list
154526124|NCT05690282|Ibuprofen|ibuprofen|mesh-list
154526125|NCT05690282|Gabapentin|gabapentin|mesh-list
154526126|NCT05690282|Bupivacaine|bupivacaine|mesh-list
154526127|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
154526128|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
154526129|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526130|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526131|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
154526132|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526133|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154526134|NCT05690282|Analgesics|analgesics|mesh-ancestor
154526135|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
154526136|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154526137|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526138|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526139|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154526140|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526141|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526142|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
154526143|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154526144|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154526145|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154526146|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154526147|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154526148|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526149|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
154526150|NCT05677334|Insulin|insulin|mesh-list
154526151|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154526152|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526153|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526154|NCT05676645|Lumefantrine|lumefantrine|mesh-list
154526155|NCT05676645|Artemether|artemether|mesh-list
154526156|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154526157|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
154526158|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154526159|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154526160|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526161|NCT05597202|Semaglutide|semaglutide|mesh-list
154361032|NCT03894683|Melatonin|melatonin|mesh-list
154526162|NCT05597202|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154526163|NCT05597202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526164|NCT05597202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526165|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
154526166|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154526167|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
154526168|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526169|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
154526170|NCT05591651|Protective Agents|protective agents|mesh-ancestor
154526171|NCT05574504|Avelumab|avelumab|mesh-list
154526172|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154526173|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526174|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526175|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526176|NCT05545670|Allopurinol|allopurinol|mesh-list
154526177|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
154526178|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526179|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526180|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
154526181|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526182|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154526183|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
154526184|NCT05545670|Protective Agents|protective agents|mesh-ancestor
154526185|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526186|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154526187|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526188|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526189|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526190|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154526191|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
154526192|NCT05487794|Testosterone|testosterone|mesh-list
154526193|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
154526194|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
154526195|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154526196|NCT05487794|Androgens|androgens|mesh-ancestor
154526197|NCT05487794|Hormones|hormones|mesh-ancestor
154526198|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526199|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526200|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154526201|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526202|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
154526203|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
154526204|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154526205|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526206|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154526207|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154526208|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526209|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526210|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526212|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154526213|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526214|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526215|NCT05374499|Epinephrine|epinephrine|mesh-list
154526216|NCT05374499|Bupivacaine|bupivacaine|mesh-list
154526217|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
154526218|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
154526219|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526220|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526221|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
154526222|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526223|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154526224|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154526225|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
154526226|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526227|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526228|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154526229|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154526230|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
154526231|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154526232|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
154526233|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
154526234|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
154526235|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154526236|NCT05357690|Bupivacaine|bupivacaine|mesh-list
154860481|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154526237|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
154526239|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526240|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526241|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
154526242|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526243|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
154526244|NCT05341154|Ketamine|ketamine|mesh-list
154526245|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154526246|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526247|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526248|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154526249|NCT05341154|Analgesics|analgesics|mesh-ancestor
154526250|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
154526251|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526252|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154526253|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154526254|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154526255|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
154526256|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526257|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526258|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154526259|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154526260|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
154526261|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
154526262|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154526263|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154526264|NCT05330858|Rabeprazole|rabeprazole|mesh-list
154526265|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154526266|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526267|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154526268|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526269|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526270|NCT05328102|Lenalidomide|lenalidomide|mesh-list
154526271|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
154526272|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526273|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154526274|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154526275|NCT05328102|Growth Substances|growth substances|mesh-ancestor
154526276|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
154526277|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526278|NCT05317676|Palmidrol|palmidrol|mesh-list
154526279|NCT05317676|Analgesics|analgesics|mesh-ancestor
154526280|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
154526281|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526282|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526283|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154526284|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154526285|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526286|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526287|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
154526288|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526289|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154526290|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154526291|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526292|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526294|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526295|NCT05312268|Rasburicase|rasburicase|mesh-list
154526296|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
154526297|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526298|NCT05295927|Prednisone|prednisone|mesh-list
154526299|NCT05295927|Prednisolone|prednisolone|mesh-list
154526300|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
154526301|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526302|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
154526303|NCT05295927|Hormones|hormones|mesh-ancestor
154526304|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526305|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526306|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154526307|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526308|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154526309|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526310|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526311|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
154526312|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154526313|NCT05288673|Ravulizumab|ravulizumab|mesh-list
154526314|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154526315|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154526316|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
154526317|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526318|NCT05288660|Ravulizumab|ravulizumab|mesh-list
154526319|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154526320|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154526321|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
154526322|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526323|NCT05257460|Insulin|insulin|mesh-list
154526324|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154526325|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
154526326|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526327|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526328|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
154526329|NCT05254626|Pioglitazone|pioglitazone|mesh-list
154526330|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154526331|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526332|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526333|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526334|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
154526335|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526336|NCT05216653|Capecitabine|capecitabine|mesh-list
154526337|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
154526338|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154526339|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
154526340|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526341|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526342|NCT05211791|Anesthetics|anesthetics|mesh-list
154526343|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526344|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526345|NCT05150587|Rifaximin|rifaximin|mesh-list
154526346|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154526347|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526348|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526349|NCT05143229|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154526350|NCT05143229|Immunoconjugates|immunoconjugates|mesh-ancestor
154526351|NCT05143229|Immunologic Factors|immunologic factors|mesh-ancestor
154526352|NCT05143229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526353|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
154526354|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526355|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526356|NCT05120596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526357|NCT05120596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526358|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
154526359|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154526360|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526361|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526362|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154526363|NCT05099055|Analgesics|analgesics|mesh-ancestor
154526364|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
154526365|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526366|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154526367|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154526368|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154526369|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
154526370|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526371|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526372|NCT05024344|Dexamethasone|dexamethasone|mesh-list
154526373|NCT05024344|Ropivacaine|ropivacaine|mesh-list
154526374|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526375|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
154526376|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
154526377|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526378|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526379|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526380|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
154526381|NCT05024344|Hormones|hormones|mesh-ancestor
154526382|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526383|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154526384|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526385|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
154526386|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
154526387|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526388|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
154526389|NCT04997304|Albuterol|albuterol|mesh-list
154526390|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154526391|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
154526392|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526393|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526394|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154526395|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
154526396|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154526397|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154526398|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154526399|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
154526400|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526401|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526402|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
154526403|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154526404|NCT04991324|Vitamin D|vitamin d|mesh-list
154526405|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
154526406|NCT04991324|Vitamins|vitamins|mesh-ancestor
154526407|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
154526408|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526409|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154526410|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154526411|NCT04984616|Atorvastatin|atorvastatin|mesh-list
154526412|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154295507|NCT05537233|Semaglutide|semaglutide|mesh-list
154526413|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154526414|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
154526415|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526416|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154526417|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154526418|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526419|NCT04966481|Cetuximab|cetuximab|mesh-list
154526420|NCT04966481|Palbociclib|palbociclib|mesh-list
154526421|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526422|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526423|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154526424|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526425|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526426|NCT04871412|Vitamin D|vitamin d|mesh-list
154526427|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
154526428|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
154526429|NCT04871412|Vitamins|vitamins|mesh-list
154526430|NCT04871412|Curcumin|curcumin|mesh-list
154526431|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
154526432|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526433|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154526434|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154526435|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154526436|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154526437|NCT04871412|Analgesics|analgesics|mesh-ancestor
154526438|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
154526439|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526440|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526441|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526442|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526443|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526444|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526445|NCT04868877|Osimertinib|osimertinib|mesh-list
154526446|NCT04868877|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154526447|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154526448|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526449|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526450|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526451|NCT04818086|Buprenorphine|buprenorphine|mesh-list
154526452|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154526453|NCT04818086|Lemborexant|lemborexant|mesh-list
154526454|NCT04818086|Naloxone|naloxone|mesh-list
154526455|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154526456|NCT04818086|Narcotics|narcotics|mesh-ancestor
154295558|NCT05383183|Choline|choline|mesh-list
154295604|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526457|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526458|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526459|NCT04818086|Analgesics|analgesics|mesh-ancestor
154526460|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
154526461|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526462|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154526463|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154526464|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526465|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526466|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154526467|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154526468|NCT04799431|Poly I-C|poly i-c|mesh-list
154526469|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154526470|NCT04799431|Poly ICLC|poly iclc|mesh-list
154526471|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
154526472|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
154526473|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526474|NCT04799431|Laxatives|laxatives|mesh-ancestor
154526475|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526476|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
154526477|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526478|NCT04724668|Melatonin|melatonin|mesh-list
154526479|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
154526480|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526481|NCT04724668|Protective Agents|protective agents|mesh-ancestor
154526482|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526483|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526484|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
154526485|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154526486|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154526487|NCT04685772|Prednisolone|prednisolone|mesh-list
154526488|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
154526489|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154526490|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
154526491|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526492|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
154526493|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
154526494|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526495|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526496|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526497|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
154526498|NCT04685772|Hormones|hormones|mesh-ancestor
154526499|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526500|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154526501|NCT04685772|Protective Agents|protective agents|mesh-ancestor
154526502|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154526503|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526504|NCT04609189|Vitamin D|vitamin d|mesh-list
154526505|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
154526506|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
154526507|NCT04609189|Calcium|calcium|mesh-list
154526508|NCT04609189|Vitamins|vitamins|mesh-ancestor
154526509|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
154526510|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526511|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154526512|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154526513|NCT04609189|Antacids|antacids|mesh-ancestor
154526514|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526515|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526516|NCT04604795|Itraconazole|itraconazole|mesh-list
154526517|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
154526518|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526519|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154526520|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154526521|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526522|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526523|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154526524|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
154526525|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526526|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526527|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154526528|NCT04587128|Irinotecan|irinotecan|mesh-list
154526529|NCT04587128|Cetuximab|cetuximab|mesh-list
154526530|NCT04587128|Panitumumab|panitumumab|mesh-list
154526531|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154526532|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154526533|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526534|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860482|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526535|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526536|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526537|NCT04563273|Vaccines|vaccines|mesh-list
154526538|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
154526539|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
154526540|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526541|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154526542|NCT04552782|Ethanol|ethanol|mesh-list
154526543|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154526544|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526545|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526546|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526547|NCT04539977|Carboplatin|carboplatin|mesh-list
154526548|NCT04539977|Etoposide|etoposide|mesh-list
154526549|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
154526550|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526551|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154526552|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154526553|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154526554|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526555|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526556|NCT04535141|Olanzapine|olanzapine|mesh-list
154526557|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
154526558|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
154526559|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526560|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526561|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526562|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154526563|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154526564|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526565|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154526566|NCT04535141|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154526567|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154526568|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154526569|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526570|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526571|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
154526572|NCT04534023|Idebenone|idebenone|mesh-list
154526573|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
154526574|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526575|NCT04534023|Protective Agents|protective agents|mesh-ancestor
154526576|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526577|NCT04480918|Ketamine|ketamine|mesh-list
154526578|NCT04480918|Esketamine|esketamine|mesh-list
154250413|NCT01105832|Teriparatide|teriparatide|mesh-list
154526579|NCT04480918|Analgesics|analgesics|mesh-ancestor
154526580|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
154526581|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526582|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526583|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154526584|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154526585|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
154526586|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
154526587|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526588|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154526589|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154526590|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526591|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526592|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
154526593|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154526594|NCT04374500|Verapamil|verapamil|mesh-list
154526595|NCT04374500|Nitroprusside|nitroprusside|mesh-list
154526596|NCT04374500|Acetylcholine|acetylcholine|mesh-list
154526597|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
154526598|NCT04374500|Bradykinin|bradykinin|mesh-list
154526599|NCT04374500|Substance P|substance p|mesh-list
154526600|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154526601|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154526602|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154526603|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526604|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154526605|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526606|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154526607|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154860483|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526608|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154526609|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
154526610|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526611|NCT04326283|Trametinib|trametinib|mesh-list
154526612|NCT04326283|Riluzole|riluzole|mesh-list
154526613|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526614|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154526615|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526616|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526617|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
154526618|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154295727|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154526619|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154526620|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526621|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526622|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154526623|NCT04326283|Protective Agents|protective agents|mesh-ancestor
154526624|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154526625|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
154526626|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154526627|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154526628|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154526629|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526630|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526631|NCT04266353|Resveratrol|resveratrol|mesh-list
154526632|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
154526633|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526634|NCT04266353|Protective Agents|protective agents|mesh-ancestor
154526635|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526636|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526637|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154526638|NCT04231643|Dronabinol|dronabinol|mesh-list
154526639|NCT04231643|Cannabidiol|cannabidiol|mesh-list
154526640|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
154526641|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526642|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154526643|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154526644|NCT04231643|Analgesics|analgesics|mesh-ancestor
154526645|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
154526646|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526647|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154526648|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154526649|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526650|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526651|NCT04231643|Hormones|hormones|mesh-ancestor
154526652|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250489|NCT03403036|Brodalumab|brodalumab|mesh-list
154526653|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
154526654|NCT04171167|Fluticasone|fluticasone|mesh-list
154526655|NCT04171167|Xhance|xhance|mesh-list
154526656|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526657|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154526658|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
154526659|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526660|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526661|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154526662|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
154526663|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154526664|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154526665|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
154526666|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154526667|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526668|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526669|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526670|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
154526671|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154526672|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
154526673|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526674|NCT04119284|Protective Agents|protective agents|mesh-ancestor
154526675|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526676|NCT04117763|Empagliflozin|empagliflozin|mesh-list
154526677|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154526678|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526679|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526680|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526681|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
154526682|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
154526683|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526684|NCT04078880|Protective Agents|protective agents|mesh-ancestor
154526685|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526686|NCT04078880|Vitamins|vitamins|mesh-ancestor
154526687|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
154526688|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154526689|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154526690|NCT04071574|Cetrorelix|cetrorelix|mesh-list
154526691|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154526692|NCT04071574|Hormones|hormones|mesh-ancestor
154526693|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526694|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526695|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
154526696|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154526697|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
154526698|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154526699|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154526700|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154526701|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526702|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154526703|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
154526704|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
154526705|NCT04002362|Triamcinolone|triamcinolone|mesh-list
154526706|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154526707|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154526708|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154526709|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526710|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
154526711|NCT04002362|Hormones|hormones|mesh-ancestor
154526712|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526713|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526714|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154526715|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
154526716|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526717|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526718|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
154526719|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
154526720|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526721|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
154526722|NCT03970252|Leucovorin|leucovorin|mesh-list
154526723|NCT03970252|Folic Acid|folic acid|mesh-list
154526724|NCT03970252|Nivolumab|nivolumab|mesh-list
154526725|NCT03970252|Fluorouracil|fluorouracil|mesh-list
154526726|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
154526727|NCT03970252|Irinotecan|irinotecan|mesh-list
154526728|NCT03970252|Camptothecin|camptothecin|mesh-list
154526729|NCT03970252|Calcium|calcium|mesh-list
154526731|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154526732|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526733|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154526734|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526735|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526736|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526737|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526738|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
154526739|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154526740|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154526741|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
154526742|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154526743|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154526744|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526745|NCT03970252|Antidotes|antidotes|mesh-ancestor
154526746|NCT03970252|Protective Agents|protective agents|mesh-ancestor
154526747|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
154526748|NCT03970252|Vitamins|vitamins|mesh-ancestor
154526749|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
154526750|NCT03970252|Hematinics|hematinics|mesh-ancestor
154526751|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154526752|NCT03915613|Insulin|insulin|mesh-list
154526753|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154526754|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154526755|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526756|NCT03896633|Brinzolamide|brinzolamide|mesh-list
154526757|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154526758|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526759|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526760|NCT03890731|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154526761|NCT03890731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154526762|NCT03890731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526763|NCT03890731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526765|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526766|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154526767|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154526768|NCT03847311|Analgesics|analgesics|mesh-ancestor
154526769|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
154295868|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
154526770|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526771|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526772|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526773|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526774|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526775|NCT03845543|Paclitaxel|paclitaxel|mesh-list
154526776|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154526777|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526778|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
154526779|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
154526780|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
154526781|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526782|NCT03827889|Fluorides|fluorides|mesh-list
154526783|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
154526784|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
154526785|NCT03827889|Protective Agents|protective agents|mesh-ancestor
154526786|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526787|NCT03826563|Melatonin|melatonin|mesh-list
154526788|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
154526789|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526790|NCT03826563|Protective Agents|protective agents|mesh-ancestor
154526791|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526792|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154526793|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
154526794|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526795|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526796|NCT03823131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526797|NCT03823131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526798|NCT03822091|Terlipressin|terlipressin|mesh-list
154526799|NCT03822091|Norepinephrine|norepinephrine|mesh-list
154526800|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154526801|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154526802|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154526803|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154526804|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
154526805|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526806|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526807|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526808|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
154526809|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
154526810|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526812|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154526813|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
154526814|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526815|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154526816|NCT03664544|Protective Agents|protective agents|mesh-ancestor
154526817|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526818|NCT03521570|Nivolumab|nivolumab|mesh-list
154526819|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526820|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526821|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526822|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526823|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
154526824|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526825|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526826|NCT03468218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526827|NCT03468218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526828|NCT03408574|Mecamylamine|mecamylamine|mesh-list
154526829|NCT03408574|Nicotine|nicotine|mesh-list
154526830|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154526831|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
154526832|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526833|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526834|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154526835|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154526836|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
154526837|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526838|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526839|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154526840|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154526841|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154526842|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154526843|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
154526844|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526845|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526846|NCT03222570|Serotonin|serotonin|mesh-list
154526847|NCT03222570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154526848|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154526849|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
154526850|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526851|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526852|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526853|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154526854|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154526855|NCT03136328|Edotreotide|edotreotide|mesh-list
154526856|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154526857|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526858|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
154526859|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154526860|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526861|NCT02966782|Azacitidine|azacitidine|mesh-list
154526862|NCT02966782|Venetoclax|venetoclax|mesh-list
154526863|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154526864|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
154526865|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526866|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526867|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526868|NCT02925650|Phenserine|phenserine|mesh-list
154526869|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154526870|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526871|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526872|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
154526873|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526874|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526875|NCT02914938|Rituximab|rituximab|mesh-list
154526876|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
154526877|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526878|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526879|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
154526880|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526881|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526882|NCT02914938|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154526883|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154526884|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526885|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526886|NCT02849457|Vigabatrin|vigabatrin|mesh-list
154526887|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
154526888|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526889|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526890|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
154526891|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526892|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526893|NCT02802631|Minocycline|minocycline|mesh-list
154526894|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154526895|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526896|NCT02757898|Biotin|biotin|mesh-list
154526897|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
154526898|NCT02757898|Vitamins|vitamins|mesh-ancestor
154526899|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
154526900|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526901|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
154526902|NCT02730546|Leucovorin|leucovorin|mesh-list
154526903|NCT02730546|Folic Acid|folic acid|mesh-list
154526904|NCT02730546|Paclitaxel|paclitaxel|mesh-list
154526905|NCT02730546|Carboplatin|carboplatin|mesh-list
154526906|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
154526907|NCT02730546|Fluorouracil|fluorouracil|mesh-list
154526908|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
154526909|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154526910|NCT02730546|Calcium|calcium|mesh-list
154860484|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154526911|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
154526912|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154526913|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526914|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
154526915|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
154526916|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
154526917|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526918|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526919|NCT02730546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526920|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154526921|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526922|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154526923|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
154526924|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154526925|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154526926|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
154526927|NCT02730546|Antidotes|antidotes|mesh-ancestor
154526928|NCT02730546|Protective Agents|protective agents|mesh-ancestor
154526929|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
154526930|NCT02730546|Vitamins|vitamins|mesh-ancestor
154526931|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
154526932|NCT02730546|Hematinics|hematinics|mesh-ancestor
154526933|NCT02672098|Carboplatin|carboplatin|mesh-list
154526934|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526935|NCT02649335|Propranolol|propranolol|mesh-list
154526936|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154526937|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154526938|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
154526939|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154526940|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526941|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526942|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154526943|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154526944|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
154526945|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
154526946|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154526947|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526948|NCT02589496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154526949|NCT02589496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526950|NCT02309580|Ibrutinib|ibrutinib|mesh-list
154250793|NCT00348881|Vaccines|vaccines|mesh-list
154526951|NCT02309580|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154296049|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
154526952|NCT02309580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154526953|NCT02309580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154526954|NCT02309580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526955|NCT02213575|Minocycline|minocycline|mesh-list
154526956|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154526957|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526958|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
154526959|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154526960|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
154526961|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526962|NCT02133872|Minocycline|minocycline|mesh-list
154526963|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154526964|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154526965|NCT01820858|Paclitaxel|paclitaxel|mesh-list
154526966|NCT01820858|Carboplatin|carboplatin|mesh-list
154526967|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154526968|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526969|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
154526970|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
154526971|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
154526972|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526973|NCT01755897|Paclitaxel|paclitaxel|mesh-list
154526974|NCT01755897|Cisplatin|cisplatin|mesh-list
154526975|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154526976|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154526977|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
154526978|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
154526979|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
154526980|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154526981|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154526982|NCT01738607|Psyllium|psyllium|mesh-list
154526983|NCT01738607|Laxatives|laxatives|mesh-ancestor
154526984|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526985|NCT01738607|Cathartics|cathartics|mesh-ancestor
154526986|NCT01728259|Dexamethasone|dexamethasone|mesh-list
154526987|NCT01728259|Bortezomib|bortezomib|mesh-list
154526988|NCT01728259|Pomalidomide|pomalidomide|mesh-list
154526989|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154526990|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
154526991|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
154526992|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154526993|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154526994|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154526995|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
154526996|NCT01728259|Hormones|hormones|mesh-ancestor
154526997|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154526998|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154526999|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527000|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
154527001|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154527002|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154527003|NCT01728259|Growth Substances|growth substances|mesh-ancestor
154527004|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
154527005|NCT01722604|Brinzolamide|brinzolamide|mesh-list
154527006|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154527007|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527008|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527009|NCT01202994|Flutemetamol|flutemetamol|mesh-list
154527010|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154527011|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527012|NCT00930943|Oxymorphone|oxymorphone|mesh-list
154527013|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154527014|NCT00930943|Narcotics|narcotics|mesh-ancestor
154527015|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527016|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527017|NCT00930943|Analgesics|analgesics|mesh-ancestor
154527018|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
154527019|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527020|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154527021|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
154527022|NCT00670670|Caseins|caseins|mesh-list
154527023|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154527024|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
154527025|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527026|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527027|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527028|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
154527029|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
154527030|NCT00670618|Fluorides|fluorides|mesh-list
154527031|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
154527032|NCT00670618|Protective Agents|protective agents|mesh-ancestor
154527033|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527034|NCT00620425|Sumatriptan|sumatriptan|mesh-list
154527035|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154527036|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154527037|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154527038|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
154527039|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154296186|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154296187|NCT04572815|Growth Substances|growth substances|mesh-ancestor
154296188|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
154296189|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296190|NCT04550481|Lisinopril|lisinopril|mesh-list
154296191|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154296192|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
154527040|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527041|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527042|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
154527043|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154527044|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
154527045|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527046|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527047|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154527048|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
154527049|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154527050|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
154527051|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527052|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527053|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154527054|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
154527055|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
154527056|NCT00515281|Protective Agents|protective agents|mesh-ancestor
154527057|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154527058|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
154860485|NCT01920542|Analgesics|analgesics|mesh-ancestor
154527059|NCT00504582|Coagulants|coagulants|mesh-ancestor
154527060|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154527061|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
154527062|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527063|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154527064|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
154527065|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527066|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527067|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154527068|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154527069|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154527070|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
154527071|NCT00335114|Cyclosporine|cyclosporine|mesh-list
154527072|NCT00335114|Cyclosporins|cyclosporins|mesh-list
154527073|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527074|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527075|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154527076|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
154527077|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527078|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
154527079|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154527080|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
154527081|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154527082|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154527083|NCT03606577|Dexamethasone|dexamethasone|mesh-list
154527084|NCT03606577|Lenalidomide|lenalidomide|mesh-list
154527085|NCT03606577|Daratumumab|daratumumab|mesh-list
154527086|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527087|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
154527088|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
154527089|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527090|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527091|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154527092|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
154527093|NCT03606577|Hormones|hormones|mesh-ancestor
154527094|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527095|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154527096|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527097|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
154527098|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154527099|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154527100|NCT03606577|Growth Substances|growth substances|mesh-ancestor
154527101|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
154527102|NCT03601975|Gemcitabine|gemcitabine|mesh-list
154527103|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527104|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154250952|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
154527106|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527107|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154527108|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154527109|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527110|NCT03137186|Metformin|metformin|mesh-list
154527111|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154527112|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527113|NCT03137030|Acetaminophen|acetaminophen|mesh-list
154527114|NCT03137030|Hydrocodone|hydrocodone|mesh-list
154527115|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527116|NCT03137030|Analgesics|analgesics|mesh-ancestor
154527117|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
154527118|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527119|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527120|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
154527121|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154527122|NCT03137030|Narcotics|narcotics|mesh-ancestor
154527123|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527124|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
154527125|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
154527126|NCT03596749|Sevelamer|sevelamer|mesh-list
154527127|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
154527128|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
154527129|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527130|NCT01595061|Cisplatin|cisplatin|mesh-list
154527131|NCT01595061|Gemcitabine|gemcitabine|mesh-list
154527132|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527133|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154527134|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
154527135|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527137|NCT03367143|Etoposide|etoposide|mesh-list
154527138|NCT03367143|Lenalidomide|lenalidomide|mesh-list
154527139|NCT03367143|Ifosfamide|ifosfamide|mesh-list
154527140|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527141|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154527142|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154527143|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154527144|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527145|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527146|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
154527147|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527148|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154527149|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154527150|NCT03367143|Growth Substances|growth substances|mesh-ancestor
154527151|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
154527152|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154527153|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
154527154|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
154527155|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154527156|NCT04762316|Pyridoxal|pyridoxal|mesh-list
154527157|NCT04762316|Pyridoxine|pyridoxine|mesh-list
154527158|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
154527159|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
154527160|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
154527161|NCT04762316|Vitamins|vitamins|mesh-ancestor
154527162|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
154527163|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527164|NCT03372447|Thiamine|thiamine|mesh-list
154527165|NCT03372447|Pyridoxine|pyridoxine|mesh-list
154527166|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
154527167|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
154527168|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
154527169|NCT03372447|Vitamins|vitamins|mesh-ancestor
154527170|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
154527171|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527172|NCT03372447|Hematinics|hematinics|mesh-ancestor
154527173|NCT03376191|Apatinib|apatinib|mesh-list
154527174|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527175|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154527176|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527177|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527178|NCT03366597|Sevoflurane|sevoflurane|mesh-list
154527179|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154251020|NCT01209806|TEMPO|tempo|mesh-list
154527180|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154527181|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
154527182|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
154527183|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527184|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527185|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
154527186|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154527187|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
154527188|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
154527189|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527190|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527191|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
154527192|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527193|NCT03109886|Maleic acid|maleic acid|mesh-list
154527194|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527195|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527196|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
154527197|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154527198|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154527199|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154527200|NCT03110198|Mesalamine|mesalamine|mesh-list
154527201|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527202|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154527203|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527204|NCT03110198|Analgesics|analgesics|mesh-ancestor
154527205|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
154527206|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527207|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527208|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154527209|NCT04460781|Vaccines|vaccines|mesh-list
154527210|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
154527211|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527212|NCT03371589|Dexamethasone|dexamethasone|mesh-list
154527213|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527214|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
154527215|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
154527216|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527217|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527218|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154527219|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
154527220|NCT03371589|Hormones|hormones|mesh-ancestor
154527221|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527222|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154527223|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296323|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296324|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296325|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296326|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296327|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
154296328|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154296329|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154296339|NCT04064060|Luspatercept|luspatercept|mesh-list
154296340|NCT04064060|Hematinics|hematinics|mesh-ancestor
154527224|NCT03365817|Fentanyl|fentanyl|mesh-list
154527225|NCT03365817|Morphine|morphine|mesh-list
154527226|NCT03365817|Oxycodone|oxycodone|mesh-list
154527227|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
154527228|NCT03365817|Tramadol|tramadol|mesh-list
154527229|NCT03365817|Methadone|methadone|mesh-list
154527230|NCT03365817|Narcotics|narcotics|mesh-ancestor
154527231|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527232|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527233|NCT03365817|Analgesics|analgesics|mesh-ancestor
154527234|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
154527235|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527236|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154527237|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527238|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
154527239|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
154527240|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
154527241|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154527242|NCT02852005|Vaccines|vaccines|mesh-list
154527243|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
154527244|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527245|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
154527246|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154527247|NCT03365115|Fentanyl|fentanyl|mesh-list
154527248|NCT03365115|Morphine|morphine|mesh-list
154527249|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154527250|NCT03365115|Narcotics|narcotics|mesh-ancestor
154527251|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527252|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527253|NCT03365115|Analgesics|analgesics|mesh-ancestor
154527254|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
154527255|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251089|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154527256|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154527257|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527258|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
154527259|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
154527261|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
154527262|NCT02237755|Clomiphene|clomiphene|mesh-list
154527263|NCT02237755|Enclomiphene|enclomiphene|mesh-list
154527264|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
154527265|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
154527266|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154527267|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
154527268|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
154527269|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527270|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154527271|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154296361|NCT03968393|Dabigatran|dabigatran|mesh-list
154296369|NCT03907046|Aspirin|aspirin|mesh-list
154527272|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527273|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527274|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154527275|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
154527276|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154527277|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154527278|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154527279|NCT04524897|Triamcinolone|triamcinolone|mesh-list
154527280|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154527281|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154527282|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154527283|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527284|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
154527285|NCT04524897|Hormones|hormones|mesh-ancestor
154527286|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860486|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
154527287|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527288|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154527289|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
154527290|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527291|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527292|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
154527293|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154527294|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154527295|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527296|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
154527297|NCT03364569|Coagulants|coagulants|mesh-ancestor
154527298|NCT03363477|Enoxaparin|enoxaparin|mesh-list
154527299|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
154527300|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
154527301|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154527302|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154527303|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527304|NCT03593707|Metformin|metformin|mesh-list
154527305|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154527306|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527307|NCT03592537|Midazolam|midazolam|mesh-list
154527308|NCT03592537|Fentanyl|fentanyl|mesh-list
154527309|NCT03592537|Bupivacaine|bupivacaine|mesh-list
154296410|NCT03845140|Praziquantel|praziquantel|mesh-list
154527310|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
154527311|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
154527312|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527313|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527314|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
154527315|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527316|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154527317|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154527318|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154527319|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154527320|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154527321|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527322|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
154527323|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
154527324|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
154527325|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527326|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527327|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154527328|NCT03592537|Narcotics|narcotics|mesh-ancestor
154527329|NCT03592537|Analgesics|analgesics|mesh-ancestor
154527330|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
154527331|NCT03362853|Nemonoxacin|nemonoxacin|mesh-list
154527332|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154527333|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154527334|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154527335|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154527336|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527337|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527338|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527340|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
154527341|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154527342|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527343|NCT05063006|Methamphetamine|methamphetamine|mesh-list
154527344|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154527345|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527346|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
154527347|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
154527348|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527349|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
154527350|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527351|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527352|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
154527353|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154527354|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154527355|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154527356|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154527357|NCT03587077|Isosorbide|isosorbide|mesh-list
154527358|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154527359|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154527360|NCT03587077|Misoprostol|misoprostol|mesh-list
154527361|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154527362|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
154527363|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154527364|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527365|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154043252|NCT00536731|Hormones|hormones|mesh-ancestor
154527366|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154527367|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
154527368|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154527369|NCT03587077|Diuretics|diuretics|mesh-ancestor
154527370|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
154527371|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
154527372|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154527373|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527374|NCT02238457|Losartan|losartan|mesh-list
154527375|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154527376|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154527377|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154527378|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154527379|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527380|NCT02238535|Iloprost|iloprost|mesh-list
154527381|NCT02238535|Warfarin|warfarin|mesh-list
154527382|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
154527383|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154527384|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
154527385|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154527386|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154527387|NCT03909074|Vaccines|vaccines|mesh-list
154527388|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
154527389|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527390|NCT03138668|Ropivacaine|ropivacaine|mesh-list
154527391|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
154527392|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
154527393|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527394|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527395|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
154527396|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527397|NCT03371043|Analgesics|analgesics|mesh-list
154527398|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
154527399|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527400|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527401|NCT05013242|Goserelin|goserelin|mesh-list
154527402|NCT05013242|Dienogest|dienogest|mesh-list
154527403|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154527404|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527405|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154527406|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
154527407|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154527408|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527409|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154527410|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154527411|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154527412|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154527413|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
154527414|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527415|NCT03590275|Folfirinox|folfirinox|mesh-list
154527416|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527417|NCT05089448|Amlodipine|amlodipine|mesh-list
154527418|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154527419|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154527420|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154527421|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527422|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154527423|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527424|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
154527425|NCT02849509|Vitamin K|vitamin k|mesh-list
154527426|NCT02849509|Dabigatran|dabigatran|mesh-list
154527427|NCT02849509|Vitamins|vitamins|mesh-ancestor
154527428|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
154527429|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527430|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
154527431|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154527432|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
154527433|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527434|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527435|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
154527436|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154527437|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154527438|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
154527439|NCT02849509|Coagulants|coagulants|mesh-ancestor
154527440|NCT00151424|Olanzapine|olanzapine|mesh-list
154527441|NCT00151424|Asenapine|asenapine|mesh-list
154527442|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
154527443|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
154527444|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527445|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527446|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154527447|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154527448|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154527449|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527450|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154527451|NCT00151424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154527452|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154527453|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154527454|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527455|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527456|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
154527457|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
154527458|NCT03600727|Propofol|propofol|mesh-list
154527459|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154527460|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527461|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527462|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527463|NCT03600727|Analgesics|analgesics|mesh-ancestor
154527464|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
154527465|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527466|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154527467|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154527468|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154527469|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154527470|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527471|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527472|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527473|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
154527474|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
154527475|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
154527476|NCT03584893|Provitamins|provitamins|mesh-ancestor
154527477|NCT03584893|Vitamins|vitamins|mesh-ancestor
154527478|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
154527479|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527480|NCT03362073|Ketamine|ketamine|mesh-list
154527481|NCT03362073|Analgesics|analgesics|mesh-ancestor
154527482|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
154527483|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251314|NCT00353873|Xhance|xhance|mesh-list
154527484|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527485|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154527486|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527487|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
154527488|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
154527489|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527490|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154527491|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154527492|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527493|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527494|NCT03582865|Tamoxifen|tamoxifen|mesh-list
154527495|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154527496|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
154527497|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527498|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527499|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154527500|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527501|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154527502|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154527503|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154527504|NCT03136406|Leucovorin|leucovorin|mesh-list
154527505|NCT03136406|Paclitaxel|paclitaxel|mesh-list
154527506|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
154527507|NCT03136406|Bevacizumab|bevacizumab|mesh-list
154527508|NCT03136406|Capecitabine|capecitabine|mesh-list
154527509|NCT03136406|Fluorouracil|fluorouracil|mesh-list
154527510|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
154527511|NCT03136406|Avelumab|avelumab|mesh-list
154527512|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154527513|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527514|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
154527515|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
154527516|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
154527517|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527518|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154527519|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
154527520|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527521|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154527522|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154527523|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
154527524|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154527525|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154527526|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154527527|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154527528|NCT03136406|Growth Substances|growth substances|mesh-ancestor
154527529|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
154527530|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154527531|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
154527532|NCT03136406|Antidotes|antidotes|mesh-ancestor
154527533|NCT03136406|Protective Agents|protective agents|mesh-ancestor
154527534|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
154527535|NCT03136406|Vitamins|vitamins|mesh-ancestor
154527536|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
154527537|NCT03590197|Melatonin|melatonin|mesh-list
154527538|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
154527539|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527540|NCT03590197|Protective Agents|protective agents|mesh-ancestor
154527541|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527542|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527543|NCT03357315|Immunomodulating Agents|immunomodulating agents|mesh-list
154527544|NCT03357315|Immunologic Factors|immunologic factors|mesh-ancestor
154527545|NCT03357315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527546|NCT05057468|Cyclosporine|cyclosporine|mesh-list
154527547|NCT05057468|Rituximab|rituximab|mesh-list
154527548|NCT05057468|Cyclosporins|cyclosporins|mesh-list
154527549|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154527550|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527551|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
154527552|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527553|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154527554|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527555|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527556|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154527557|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
154527558|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154527559|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
154527560|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154527561|NCT02518503|Atorvastatin|atorvastatin|mesh-list
154251427|NCT01210742|Hylan|hylan|mesh-list
154527562|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154527563|NCT02518503|Simvastatin|simvastatin|mesh-list
154527564|NCT02518503|Pravastatin|pravastatin|mesh-list
154527565|NCT02518503|Lovastatin|lovastatin|mesh-list
154527566|NCT02518503|L 647318|l 647318|mesh-list
154527567|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
154527568|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154527569|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154527570|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
154527571|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527572|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154527573|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154527574|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527575|NCT03600493|Lidocaine|lidocaine|mesh-list
154527576|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
154527577|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
154527578|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
154527579|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527580|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527581|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
154527582|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296686|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
154527583|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154527584|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154527585|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154527586|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154527587|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527588|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154527589|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527590|NCT03600493|Analgesics|analgesics|mesh-ancestor
154527591|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154527592|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154527594|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
154527595|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527596|NCT03138356|Metformin|metformin|mesh-list
154527597|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
154527598|NCT03138356|Saxagliptin|saxagliptin|mesh-list
154527599|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154527600|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527601|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154527602|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527603|NCT03138356|Incretins|incretins|mesh-ancestor
154527604|NCT03138356|Hormones|hormones|mesh-ancestor
154527605|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527606|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154527607|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
154527608|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527609|NCT03137966|Deferoxamine|deferoxamine|mesh-list
154527610|NCT03137966|Siderophores|siderophores|mesh-ancestor
154527611|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154527612|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
154527613|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
154527614|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527615|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
154527616|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154527617|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
154527618|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527619|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
154527620|NCT04521387|Protective Agents|protective agents|mesh-ancestor
154527621|NCT03579979|Methylene Blue|methylene blue|mesh-list
154527622|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527623|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527624|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
154527625|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154527626|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154527627|NCT04509219|Prednisolone|prednisolone|mesh-list
154527628|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
154527629|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154527630|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
154527631|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527632|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
154527633|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
154527634|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527635|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527636|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154527637|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
154527638|NCT04509219|Hormones|hormones|mesh-ancestor
154527639|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527640|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154527641|NCT04509219|Protective Agents|protective agents|mesh-ancestor
154527642|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154527643|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527644|NCT04444635|Fentanyl|fentanyl|mesh-list
154527645|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154527646|NCT04444635|Narcotics|narcotics|mesh-ancestor
154527647|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527648|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527649|NCT04444635|Analgesics|analgesics|mesh-ancestor
154527650|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
154527651|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527652|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154527653|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527654|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
154527655|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
154527656|NCT03579823|Adalimumab|adalimumab|mesh-list
154527657|NCT03579823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154527658|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527659|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154527660|NCT04444011|Amoxicillin|amoxicillin|mesh-list
154527661|NCT04444011|Clarithromycin|clarithromycin|mesh-list
154527662|NCT04444011|Bismuth|bismuth|mesh-list
154527663|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154527664|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154527665|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154527666|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527667|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296759|NCT02394769|Analgesics|analgesics|mesh-ancestor
154527668|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154527669|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154527671|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154527672|NCT04443387|Vitamin D|vitamin d|mesh-list
154527673|NCT04443387|Vitamins|vitamins|mesh-ancestor
154527674|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
154527675|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527676|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154527677|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
154527678|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154527679|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527680|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527681|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527682|NCT02316236|Analgesics|analgesics|mesh-ancestor
154527683|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
154527684|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527685|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154527686|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154527687|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154527688|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
154527689|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527690|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527691|NCT04521075|Nivolumab|nivolumab|mesh-list
154527692|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154527693|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527694|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154527695|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527696|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
154527697|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154527698|NCT03601091|Midazolam|midazolam|mesh-list
154527699|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
154527700|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154527701|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527702|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527703|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527704|NCT03601091|Analgesics|analgesics|mesh-ancestor
154527705|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
154527706|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527707|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154527708|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154527709|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154527710|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
154527711|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154296802|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
154527712|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527713|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154527714|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154527715|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154527716|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154527717|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527718|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
154527719|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
154527720|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
154527721|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
154527722|NCT04508829|Antibodies|antibodies|mesh-list
154527723|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154527724|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
154527725|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527726|NCT04521309|Antibodies|antibodies|mesh-list
154527727|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
154527728|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527729|NCT04521153|Apatinib|apatinib|mesh-list
154527730|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527731|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154527732|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527733|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527734|NCT04362566|Bupivacaine|bupivacaine|mesh-list
154527735|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
154527736|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
154527737|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527738|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527739|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
154527740|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527741|NCT03579589|Neostigmine|neostigmine|mesh-list
154527742|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154527743|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860487|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527744|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527745|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
154527746|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527747|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527748|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154527749|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
154527750|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527751|NCT03600623|Paclitaxel|paclitaxel|mesh-list
154527752|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154527753|NCT03600623|Gemcitabine|gemcitabine|mesh-list
154527754|NCT03600623|Fluorouracil|fluorouracil|mesh-list
154527755|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
154527756|NCT03600623|Irinotecan|irinotecan|mesh-list
154527757|NCT03600623|Folfirinox|folfirinox|mesh-list
154527758|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154527759|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527760|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
154527761|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
154527762|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
154527763|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527764|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154527765|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
154527766|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154527767|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
154527768|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527769|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154527770|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154527771|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527772|NCT02848729|Acetaminophen|acetaminophen|mesh-list
154527773|NCT02848729|Morphine|morphine|mesh-list
154527774|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154527775|NCT02848729|Narcotics|narcotics|mesh-ancestor
154527776|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527777|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527778|NCT02848729|Analgesics|analgesics|mesh-ancestor
154527779|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
154527780|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527781|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527782|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
154527783|NCT03600467|Seviteronel|seviteronel|mesh-list
154527784|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527785|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154527786|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251614|NCT00337727|Hormones|hormones|mesh-ancestor
154527787|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527788|NCT04520919|Anesthetics|anesthetics|mesh-list
154527789|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527790|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527791|NCT03600311|Vitamin D|vitamin d|mesh-list
154527792|NCT03600311|Calcium|calcium|mesh-list
154527793|NCT03600311|Vitamins|vitamins|mesh-ancestor
154527794|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
154527795|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527796|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154527797|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154527798|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
154527799|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154527800|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
154527801|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
154527802|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154527803|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154527804|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527805|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527806|NCT03603119|Dexamethasone|dexamethasone|mesh-list
154527807|NCT03603119|Midazolam|midazolam|mesh-list
154527808|NCT03603119|Ondansetron|ondansetron|mesh-list
154527809|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527810|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
154527811|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
154527812|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527813|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527814|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154527815|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
154527816|NCT03603119|Hormones|hormones|mesh-ancestor
154527817|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527818|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154527819|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527820|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154527821|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154527822|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527823|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154527824|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154527825|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154527826|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527827|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
154527828|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
154527829|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
154527830|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
154527831|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527832|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527833|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
154527834|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
154527835|NCT03603119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154527836|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154527837|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
154527838|NCT03356769|Aspirin|aspirin|mesh-list
154527839|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
154527840|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154527841|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527842|NCT03356769|Analgesics|analgesics|mesh-ancestor
154527843|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
154527844|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527845|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527846|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527847|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154527848|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154296953|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
154527849|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154527850|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527851|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154527852|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154527853|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527854|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
154527855|NCT04508439|Heparin|heparin|mesh-list
154527856|NCT04508439|Enoxaparin|enoxaparin|mesh-list
154527857|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154527858|NCT04508439|Tinzaparin|tinzaparin|mesh-list
154527859|NCT04508439|Dalteparin|dalteparin|mesh-list
154527860|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
154527861|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154527862|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154527863|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527864|NCT02237651|Anesthetics|anesthetics|mesh-list
154527865|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527866|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527867|NCT02237729|Adalimumab|adalimumab|mesh-list
154527868|NCT02237729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154527869|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527870|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154527871|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
154527872|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
154527873|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154527874|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
154527875|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527876|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527877|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154527878|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
154527879|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154527880|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154527881|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154527882|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
154527883|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527884|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527885|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
154527886|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154527887|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
154527888|NCT03354117|Meloxicam|meloxicam|mesh-list
154527889|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
154527890|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154527891|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154527892|NCT03354117|Analgesics|analgesics|mesh-ancestor
154527893|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
154527894|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860488|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154527895|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527896|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154527897|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154527898|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154527899|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154527900|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527901|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527902|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154527903|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
154527904|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154527905|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154527906|NCT03360981|Incretins|incretins|mesh-list
154527907|NCT03360981|Hormones|hormones|mesh-ancestor
154527908|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154527909|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527910|NCT03597815|Aflibercept|aflibercept|mesh-list
154527911|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154527912|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154527913|NCT03597815|Growth Substances|growth substances|mesh-ancestor
154527914|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527915|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
154527916|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527917|NCT03595085|Streptokinase|streptokinase|mesh-list
154527918|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154527919|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154527920|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527921|NCT00158756|Vaccines|vaccines|mesh-list
154527922|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
154527923|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527924|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154527925|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
154527926|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154527927|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
154527928|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154527929|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527930|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154527931|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154527932|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527933|NCT04519125|Tenofovir|tenofovir|mesh-list
154527934|NCT04519125|Emtricitabine|emtricitabine|mesh-list
154527935|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
154527936|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154527937|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154527938|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154527939|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527940|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527941|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154527942|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154527943|NCT02730195|Pioglitazone|pioglitazone|mesh-list
154527944|NCT02730195|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154527945|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154527946|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527947|NCT02730195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154527948|NCT02730195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154527949|NCT02730195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527950|NCT03360279|Paclitaxel|paclitaxel|mesh-list
154527951|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154527952|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154527953|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
154527954|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
154527955|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
154527956|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527957|NCT03353103|Listerine|listerine|mesh-list
154527958|NCT03353103|Fluorides|fluorides|mesh-list
154527959|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
154527960|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
154527961|NCT03353103|Protective Agents|protective agents|mesh-ancestor
154527962|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527963|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154527964|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154527965|NCT03360123|Midazolam|midazolam|mesh-list
154527966|NCT03360123|Triazolam|triazolam|mesh-list
154527967|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154527968|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154527969|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154527970|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527971|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154527972|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154527973|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154527974|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154527975|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
154527976|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
154527977|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
154527978|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
154527979|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527980|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527981|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
154527982|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
154527983|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154527984|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154527985|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527986|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
154527987|NCT03360045|Coagulants|coagulants|mesh-ancestor
154527988|NCT03353025|Dopamine|dopamine|mesh-list
154527989|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
154527990|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154527991|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
154527992|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
154527993|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154527994|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154527995|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
154527996|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154527997|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154527998|NCT03353025|Protective Agents|protective agents|mesh-ancestor
154527999|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154528000|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154528001|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528002|NCT04506957|Chrysarobin|chrysarobin|mesh-list
154528003|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154528004|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154528005|NCT04506957|Analgesics|analgesics|mesh-ancestor
154528006|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
154528007|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528008|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528009|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528010|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154528011|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154528012|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154528013|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528014|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
154528015|NCT03352947|Trametinib|trametinib|mesh-list
154528016|NCT03352947|Dabrafenib|dabrafenib|mesh-list
154528017|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528018|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154528019|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528020|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528021|NCT02730351|Fluticasone|fluticasone|mesh-list
154528022|NCT02730351|Xhance|xhance|mesh-list
154528023|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528024|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154528025|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
154528026|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528027|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528028|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154528029|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
154528030|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
154528031|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154528032|NCT03359655|Scopolamine|scopolamine|mesh-list
154528033|NCT03359655|Bromides|bromides|mesh-list
154528034|NCT03359655|Misoprostol|misoprostol|mesh-list
154528035|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154528036|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154528037|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
154528038|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154528039|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528040|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154528041|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528042|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
154528043|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
154528044|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154528045|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
154528046|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
154528047|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528048|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
154528049|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154528050|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
154528051|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528052|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528053|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154528054|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
154528055|NCT03352869|Metformin|metformin|mesh-list
154528056|NCT03352869|Exenatide|exenatide|mesh-list
154528057|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154528058|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528059|NCT03352869|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154528060|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154528061|NCT03352869|Incretins|incretins|mesh-ancestor
154528062|NCT03352869|Hormones|hormones|mesh-ancestor
154528063|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528064|NCT03359499|Trimebutine|trimebutine|mesh-list
154528065|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528066|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
154528067|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
154528068|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528069|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528070|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
154528071|NCT03352479|Narcotics|narcotics|mesh-ancestor
154528072|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528073|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528074|NCT03352479|Analgesics|analgesics|mesh-ancestor
154528075|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
154528076|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528077|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
154528078|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154528079|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528080|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528081|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154528082|NCT03355053|Analgesics|analgesics|mesh-ancestor
154528083|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
154528084|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528085|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154528086|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154528087|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154528088|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
154528089|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528090|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528091|NCT03358953|Nicotine|nicotine|mesh-list
154528092|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154528093|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
154528094|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528095|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528096|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154528097|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154528098|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
154528099|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528100|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528101|NCT04509999|Bicalutamide|bicalutamide|mesh-list
154528102|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
154528103|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
154528104|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528105|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528106|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528107|NCT04505943|Isoniazid|isoniazid|mesh-list
154528108|NCT04505943|Misoprostol|misoprostol|mesh-list
154528109|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154528110|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
154528111|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154528112|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528113|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154528114|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528115|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
154528116|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
154528117|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154528118|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528119|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154528120|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154528121|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
154528122|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528123|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154528124|NCT03358719|Poly I-C|poly i-c|mesh-list
154528125|NCT03358719|Nivolumab|nivolumab|mesh-list
154528126|NCT03358719|Decitabine|decitabine|mesh-list
154528127|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154528128|NCT03358719|Poly ICLC|poly iclc|mesh-list
154528129|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154528130|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528131|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154528132|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528133|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154528134|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
154528135|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528136|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
154528137|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
154528138|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528139|NCT03358719|Laxatives|laxatives|mesh-ancestor
154528140|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528141|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
154528142|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528143|NCT04505475|Hemostatics|hemostatics|mesh-list
154528144|NCT04505475|Coagulants|coagulants|mesh-ancestor
154528145|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154528146|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154528147|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
154528148|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528149|NCT03350373|Dotinurad|dotinurad|mesh-list
154528150|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
154528151|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
154528152|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154528153|NCT03350295|Nifurtimox|nifurtimox|mesh-list
154528154|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154528155|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154528156|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154528157|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528158|NCT03349983|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154528159|NCT03349983|Antiviral Agents|antiviral agents|mesh-ancestor
154528160|NCT03349983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528161|NCT03349827|Apatinib|apatinib|mesh-list
154528162|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528163|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154528164|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528165|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528166|NCT04503915|Estrogens|estrogens|mesh-list
154528167|NCT04503915|Hormones|hormones|mesh-ancestor
154528168|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528169|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528170|NCT04504851|Rifampin|rifampin|mesh-list
154528171|NCT04504851|Isoniazid|isoniazid|mesh-list
154528172|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
154528173|NCT04504851|Ethambutol|ethambutol|mesh-list
154528174|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154528175|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154528176|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154528177|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
154528178|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528179|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154528180|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154528181|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528182|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154528183|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
154528184|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154528185|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528186|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
154528187|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154528188|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154528189|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154528190|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154528191|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154528192|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154528193|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154528194|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154528195|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154528196|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
154528197|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528198|NCT03030261|Dexamethasone|dexamethasone|mesh-list
154528199|NCT03030261|Pomalidomide|pomalidomide|mesh-list
154528200|NCT03030261|Elotuzumab|elotuzumab|mesh-list
154528201|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528202|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
154528203|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
154528204|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528205|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528206|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528207|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
154528208|NCT03030261|Hormones|hormones|mesh-ancestor
154528209|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528210|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154528211|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528212|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
154528213|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154528214|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154528215|NCT03030261|Growth Substances|growth substances|mesh-ancestor
154528216|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
154528217|NCT02176161|Metformin|metformin|mesh-list
154528218|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154528219|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528220|NCT03348735|Lidocaine|lidocaine|mesh-list
154528221|NCT03348735|Pregabalin|pregabalin|mesh-list
154528222|NCT03348735|Capsaicin|capsaicin|mesh-list
154528223|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
154528224|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
154528225|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528226|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528227|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
154528228|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528229|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154528230|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154528231|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154528232|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154528233|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528234|NCT03348735|Analgesics|analgesics|mesh-ancestor
154528235|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
154528236|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154528237|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154528238|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154528239|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154528240|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154528241|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
154528242|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
154528243|NCT01700673|Azacitidine|azacitidine|mesh-list
154528244|NCT01700673|Sargramostim|sargramostim|mesh-list
154528245|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154528246|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
154528247|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528248|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528249|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528250|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
154528251|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528253|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
154528254|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154528255|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154528256|NCT03898154|Prednisolone|prednisolone|mesh-list
154528257|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
154528258|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154528259|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
154528260|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528261|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
154528262|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
154528263|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528264|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528265|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528266|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
154528267|NCT03898154|Hormones|hormones|mesh-ancestor
154528268|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528269|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154528270|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528271|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154528272|NCT03898154|Protective Agents|protective agents|mesh-ancestor
154528273|NCT02517957|Loperamide|loperamide|mesh-list
154528274|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
154528275|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528276|NCT03348267|Caseins|caseins|mesh-list
154528277|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
154528278|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
154528279|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528280|NCT03136796|Meropenem|meropenem|mesh-list
154528281|NCT03136796|Piperacillin|piperacillin|mesh-list
154528282|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154528283|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528284|NCT05243745|Fluorides|fluorides|mesh-list
154528285|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
154528286|NCT05243745|Protective Agents|protective agents|mesh-ancestor
154528287|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528288|NCT04500717|Carboplatin|carboplatin|mesh-list
154528289|NCT04500717|Pemetrexed|pemetrexed|mesh-list
154528290|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528291|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528292|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528293|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154528294|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154528295|NCT01680458|Fluconazole|fluconazole|mesh-list
154528296|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
154528297|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297390|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154528298|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154528299|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154528300|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528301|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528302|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154528303|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
154528304|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528305|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528306|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154528307|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154528308|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154528309|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154528310|NCT03346317|Estradiol|estradiol|mesh-list
154528311|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154528312|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
154528313|NCT03346317|Estrogens|estrogens|mesh-ancestor
154528314|NCT03346317|Hormones|hormones|mesh-ancestor
154528315|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528316|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528317|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154252138|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
154528318|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
154528319|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154528320|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154528321|NCT03346317|Progestins|progestins|mesh-ancestor
154528322|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
154528323|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154528324|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
154528325|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528326|NCT01550432|Expectorants|expectorants|mesh-ancestor
154528327|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
154528328|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154528329|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
154528330|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528331|NCT01550432|Protective Agents|protective agents|mesh-ancestor
154528332|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528333|NCT01550432|Antidotes|antidotes|mesh-ancestor
154528334|NCT04502277|Fluconazole|fluconazole|mesh-list
154528335|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
154528336|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528337|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154528338|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154528339|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528340|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528341|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154528342|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
154528343|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528344|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528345|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154528346|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154528347|NCT05730608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154528348|NCT05730608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154528349|NCT05730608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528351|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528352|NCT04850144|Bromides|bromides|mesh-list
154528353|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
154528354|NCT04850144|Charcoal|charcoal|mesh-list
154528355|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154528356|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
154528357|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528358|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528359|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154528360|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
154528361|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
154528362|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154528363|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
154528364|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528365|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528366|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
154528367|NCT04850144|Antidotes|antidotes|mesh-ancestor
154528368|NCT04850144|Protective Agents|protective agents|mesh-ancestor
154528369|NCT04590794|Plasminogen|plasminogen|mesh-list
154528370|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154528371|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154528372|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528373|NCT00709761|Paclitaxel|paclitaxel|mesh-list
154528374|NCT00709761|Lapatinib|lapatinib|mesh-list
154528375|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154528376|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528377|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
154528378|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
154528379|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
154528380|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528381|NCT00709761|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154528382|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154528383|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528384|NCT02516631|Misoprostol|misoprostol|mesh-list
154528385|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154528386|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
154528387|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154528388|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528389|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154528390|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528391|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
154252214|NCT01215266|Sorafenib|sorafenib|mesh-list
154528392|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
154528393|NCT02516475|Astringents|astringents|mesh-ancestor
154528394|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528396|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154528397|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154528398|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154528399|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528400|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528401|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154528402|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154528403|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528404|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
154528405|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528406|NCT03423680|Aripiprazole|aripiprazole|mesh-list
154528407|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
154528408|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154528409|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154528410|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154528411|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528412|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528413|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
154528414|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
154528415|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528416|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528417|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154528418|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154528419|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
154528420|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154363296|NCT04050865|Hormones|hormones|mesh-ancestor
154528421|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154528422|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154528423|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154528424|NCT04443543|Capecitabine|capecitabine|mesh-list
154528425|NCT04443543|Fluorouracil|fluorouracil|mesh-list
154528426|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
154528427|NCT04443543|Irinotecan|irinotecan|mesh-list
154528428|NCT04443543|Tislelizumab|tislelizumab|mesh-list
154528429|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154528430|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
154528431|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528432|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528433|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154528434|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
154528435|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528436|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154528437|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154528438|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528439|NCT04443543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154528440|NCT02516085|Metformin|metformin|mesh-list
154528441|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154528442|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528443|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
154528444|NCT02515929|Procyanidin|procyanidin|mesh-list
154528445|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
154528446|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528447|NCT02515929|Protective Agents|protective agents|mesh-ancestor
154528448|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528449|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154528450|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154528451|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528452|NCT03347721|Lidocaine|lidocaine|mesh-list
154528453|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
154528454|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
154528455|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528456|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528457|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
154528458|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528459|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154528460|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154528461|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154528462|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154528463|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528464|NCT02848651|Atezolizumab|atezolizumab|mesh-list
154528465|NCT02848651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154528466|NCT02848651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528467|NCT02848651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154528468|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528470|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154528471|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
154528472|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
154528473|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528474|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
154528475|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528476|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
154528477|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528478|NCT04500561|Gemcitabine|gemcitabine|mesh-list
154528479|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
154528480|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154528481|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
154528482|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528483|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528484|NCT04507256|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154528485|NCT04507256|Antiviral Agents|antiviral agents|mesh-ancestor
154528486|NCT04507256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528487|NCT05094596|Montelukast|montelukast|mesh-list
154528488|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154528489|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
154528490|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154528491|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
154528492|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528493|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528494|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154528495|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154528496|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528498|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154528499|NCT01678820|Glimepiride|glimepiride|mesh-list
154528500|NCT01678820|Simvastatin|simvastatin|mesh-list
154528501|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154528502|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528503|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154528504|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154528505|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
154528506|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528507|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154528508|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154528509|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528510|NCT01678820|Incretins|incretins|mesh-ancestor
154528511|NCT01678820|Hormones|hormones|mesh-ancestor
154528512|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528513|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154528514|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
154528515|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154528516|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154528517|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
154528518|NCT02515695|Interferons|interferons|mesh-list
154528519|NCT02515695|Interferon-beta|interferon-beta|mesh-list
154528520|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
154528521|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528522|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
154528523|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528524|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
154528525|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528526|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154528527|NCT03346629|Misoprostol|misoprostol|mesh-list
154528528|NCT03346629|Mifepristone|mifepristone|mesh-list
154528529|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154528530|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
154528531|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154528532|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528533|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154528534|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528535|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
154528536|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154528537|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154528538|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154528539|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154528540|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
154528541|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154528542|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154528543|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
154528544|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528545|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
154528546|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154528547|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154528548|NCT04501965|Azithromycin|azithromycin|mesh-list
154528549|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
154528550|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154528551|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528552|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
154528553|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154528554|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154528555|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528556|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528557|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154528558|NCT03122067|Oxytocin|oxytocin|mesh-list
154528559|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
154528560|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154528561|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528562|NCT04536194|Dopamine|dopamine|mesh-list
154528563|NCT04536194|Norepinephrine|norepinephrine|mesh-list
154528564|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154528565|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154297660|NCT01105611|Ritonavir|ritonavir|mesh-list
154528566|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
154528567|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528568|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528569|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363438|NCT03745105|Dexamethasone|dexamethasone|mesh-list
154528570|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
154528571|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
154528572|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528573|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154528574|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154528575|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
154528576|NCT04536194|Protective Agents|protective agents|mesh-ancestor
154528578|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154528579|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528580|NCT03121833|Endostar protein|endostar protein|mesh-list
154528581|NCT03121833|Endostatins|endostatins|mesh-list
154528582|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154528583|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154528584|NCT03121833|Growth Substances|growth substances|mesh-ancestor
154528585|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528586|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
154528587|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528588|NCT03121521|Melatonin|melatonin|mesh-list
154528589|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
154528590|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528591|NCT03121521|Protective Agents|protective agents|mesh-ancestor
154528592|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528593|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528594|NCT02643056|Panitumumab|panitumumab|mesh-list
154528595|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154528596|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528597|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154528598|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154528599|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528600|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154528601|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528602|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528603|NCT02238145|Ipratropium|ipratropium|mesh-list
154528604|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154528605|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
154528606|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528607|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528608|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154528609|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
154528610|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154297702|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
154528611|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
154528612|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528613|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528614|NCT04550637|Apixaban|apixaban|mesh-list
154528615|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154528616|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
154528617|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154528618|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
154528619|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528620|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528621|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
154528623|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528624|NCT03574909|Aspirin|aspirin|mesh-list
154528625|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154528626|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154528627|NCT03574909|Analgesics|analgesics|mesh-ancestor
154528628|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
154528629|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528630|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528631|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528632|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154528633|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154528634|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154528635|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528636|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154528637|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154528638|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528639|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
154528640|NCT03579043|Cocaine|cocaine|mesh-list
154528641|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
154528642|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
154528643|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528644|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528645|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
154528646|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528647|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154528648|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154528649|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154528650|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154528651|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528652|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
154528653|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528654|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
154528655|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
154528656|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154528657|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154528658|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154528659|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154528660|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528661|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
154528662|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528663|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528664|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154528665|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528666|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
154528667|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
154528668|NCT02660138|Coagulants|coagulants|mesh-ancestor
154528669|NCT03576469|Complement C1s|complement c1s|mesh-list
154528670|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154528671|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154528672|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
154528673|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528674|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154528675|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154528676|NCT05097950|Acetaminophen|acetaminophen|mesh-list
154528677|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154528678|NCT05097950|Analgesics|analgesics|mesh-ancestor
154528679|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
154528680|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528681|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528682|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
154528683|NCT05097248|Doxorubicin|doxorubicin|mesh-list
154528684|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154528685|NCT05097248|Losartan|losartan|mesh-list
154528686|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154528687|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528688|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154528689|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154252508|NCT02946580|Naloxegol|naloxegol|mesh-list
154528690|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528691|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528692|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154528693|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154528694|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154528695|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154528697|NCT01603394|Analgesics|analgesics|mesh-ancestor
154528698|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
154297793|NCT02971228|Glucagon|glucagon|mesh-list
154528699|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528700|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528701|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
154528702|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154528703|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154528704|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528705|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154528706|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154528707|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154528708|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528709|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154528710|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
154528711|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154528712|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154528713|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154528714|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528715|NCT02729025|Evolocumab|evolocumab|mesh-list
154528716|NCT02729025|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154528717|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154528718|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154528719|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
154528720|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528721|NCT02729025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154528722|NCT02729025|Protease Inhibitors|protease inhibitors|mesh-ancestor
154528723|NCT02729025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528724|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154528726|NCT05599971|Digoxin|digoxin|mesh-list
154528727|NCT05599971|Furosemide|furosemide|mesh-list
154528728|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
154528729|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528730|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154528731|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528732|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154528733|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
154528734|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528735|NCT05599971|Diuretics|diuretics|mesh-ancestor
154528736|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
154528737|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154528738|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154528739|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154528740|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154528741|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528742|NCT05599971|Protective Agents|protective agents|mesh-ancestor
154297839|NCT02969590|Leuprolide|leuprolide|mesh-list
154528743|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
154528744|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154528745|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528746|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528747|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528748|NCT02511795|Olaparib|olaparib|mesh-list
154528749|NCT02511795|Adavosertib|adavosertib|mesh-list
154528750|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154528751|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528752|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528753|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528754|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
154528755|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
154528756|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528757|NCT04796636|Protective Agents|protective agents|mesh-ancestor
154528758|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528759|NCT04796636|Vitamins|vitamins|mesh-ancestor
154528760|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
154528761|NCT04501809|Misoprostol|misoprostol|mesh-list
154528762|NCT04501809|Oxytocin|oxytocin|mesh-list
154528763|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
154528764|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154528765|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528766|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154528767|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
154528768|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154528769|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528770|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
154528771|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
154528772|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154528773|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
154528774|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154528775|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528776|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154528777|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154528778|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154528779|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154528780|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528781|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154528782|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154528783|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528784|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528785|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528786|NCT02514681|Paclitaxel|paclitaxel|mesh-list
154528787|NCT02514681|Vinorelbine|vinorelbine|mesh-list
154528788|NCT02514681|Docetaxel|docetaxel|mesh-list
154528789|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154528790|NCT02514681|Gemcitabine|gemcitabine|mesh-list
154528791|NCT02514681|Capecitabine|capecitabine|mesh-list
154528792|NCT02514681|Trastuzumab|trastuzumab|mesh-list
154528793|NCT02514681|Pertuzumab|pertuzumab|mesh-list
154528794|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154528795|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528796|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
154528797|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
154528798|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
154528799|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528800|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154528801|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
154528802|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154528803|NCT02511639|Everolimus|everolimus|mesh-list
154528804|NCT02511639|Letrozole|letrozole|mesh-list
154528805|NCT02511639|Anastrozole|anastrozole|mesh-list
154528806|NCT02511639|Exemestane|exemestane|mesh-list
154528807|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154528808|NCT02511639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154528809|NCT02511639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154528810|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528811|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528812|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154528813|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
154528814|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528815|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528816|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154528817|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154528818|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
154528819|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528820|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154528821|NCT02514603|Prexasertib|prexasertib|mesh-list
154528822|NCT02514603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154528823|NCT02514603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528824|NCT02514603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528825|NCT02511483|Propranolol|propranolol|mesh-list
154528826|NCT02511483|Morphine|morphine|mesh-list
154528827|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154528828|NCT02511483|Narcotics|narcotics|mesh-ancestor
154528829|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528830|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528831|NCT02511483|Analgesics|analgesics|mesh-ancestor
154528832|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
154528833|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528834|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154528835|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154528836|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
154528837|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528838|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528839|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154528840|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154528841|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
154528842|NCT04429802|Prucalopride|prucalopride|mesh-list
154528843|NCT04429802|Laxatives|laxatives|mesh-ancestor
154528844|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528845|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154528846|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154528847|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
154528848|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528849|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528850|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528851|NCT02511405|Bevacizumab|bevacizumab|mesh-list
154528852|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154528853|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528854|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154528855|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154528856|NCT02511405|Growth Substances|growth substances|mesh-ancestor
154528857|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528858|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
154528859|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
154528860|NCT04387760|Favipiravir|favipiravir|mesh-list
154528861|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
154528862|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154528863|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154528864|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528865|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528866|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528867|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860489|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154528868|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
154528869|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
154528870|NCT05091086|Denosumab|denosumab|mesh-list
154528871|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154528872|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528873|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
154528874|NCT05091008|Ledipasvir|ledipasvir|mesh-list
154528875|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154528876|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
154528877|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528878|NCT02918084|Letrozole|letrozole|mesh-list
154528879|NCT02918084|Anastrozole|anastrozole|mesh-list
154528880|NCT02918084|Exemestane|exemestane|mesh-list
154528881|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528882|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154528883|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154528884|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528885|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528886|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154528887|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
154528888|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528889|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528890|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154528891|NCT01603082|Clopidogrel|clopidogrel|mesh-list
154528892|NCT01603082|Ticagrelor|ticagrelor|mesh-list
154528893|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154528894|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154528895|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154528896|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154528897|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
154528898|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154528899|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528900|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528901|NCT04499313|Dexamethasone|dexamethasone|mesh-list
154528902|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
154528903|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154528904|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154528905|NCT04499313|Prednisolone|prednisolone|mesh-list
154528906|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
154528907|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154528908|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
154528909|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528910|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
154528911|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
154528912|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252723|NCT01224860|Telmisartan|telmisartan|mesh-list
154528913|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528914|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154528915|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
154528916|NCT04499313|Hormones|hormones|mesh-ancestor
154528917|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154528918|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154528919|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528920|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154528921|NCT04499313|Protective Agents|protective agents|mesh-ancestor
154528922|NCT04331756|Anesthetics|anesthetics|mesh-list
154528923|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528924|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528925|NCT02510781|Carboplatin|carboplatin|mesh-list
154528926|NCT02510781|Docetaxel|docetaxel|mesh-list
154528927|NCT02510781|Trastuzumab|trastuzumab|mesh-list
154528928|NCT02510781|Epirubicin|epirubicin|mesh-list
154528929|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528930|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
154528931|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
154528932|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
154528933|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528934|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154528935|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154528936|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154528937|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154528938|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528939|NCT03121599|Alovudine|alovudine|mesh-list
154528940|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
154528941|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528942|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
154528943|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154528944|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
154528945|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
154528946|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
154528948|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528949|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154528950|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528951|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528952|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
154528953|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154528954|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
154528955|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528956|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
154528957|NCT02510235|Protective Agents|protective agents|mesh-ancestor
154528958|NCT05081336|Alirocumab|alirocumab|mesh-list
154528959|NCT05081336|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154528960|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154528961|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154528962|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
154528963|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528964|NCT05081336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154528965|NCT05081336|Protease Inhibitors|protease inhibitors|mesh-ancestor
154528966|NCT05081336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528967|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154528968|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154528969|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154528970|NCT03710876|Celecoxib|celecoxib|mesh-list
154528971|NCT03710876|Gemcitabine|gemcitabine|mesh-list
154528972|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154528973|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
154528974|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154528975|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528976|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154528977|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154528978|NCT03710876|Analgesics|analgesics|mesh-ancestor
154528979|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
154528980|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528981|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528982|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528983|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154528984|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154528985|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154528986|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528987|NCT02513433|Bupivacaine|bupivacaine|mesh-list
154528988|NCT02513433|Ropivacaine|ropivacaine|mesh-list
154528989|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
154528990|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
154528992|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154528993|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528994|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
154528995|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154528996|NCT02510157|Dexamethasone|dexamethasone|mesh-list
154528997|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528998|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
154528999|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
154529000|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529001|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529002|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529003|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
154529004|NCT02510157|Hormones|hormones|mesh-ancestor
154529005|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154529006|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154529007|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529008|NCT03345147|Vitamins|vitamins|mesh-list
154529009|NCT03345147|Vitamin A|vitamin a|mesh-list
154529010|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
154529011|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
154529012|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529013|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
154529014|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529015|NCT03345147|Protective Agents|protective agents|mesh-ancestor
154529016|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154529017|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529018|NCT03662919|Adalimumab|adalimumab|mesh-list
154529019|NCT03662919|Infliximab|infliximab|mesh-list
154529020|NCT03662919|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154529021|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154529022|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154529023|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
154529024|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529025|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
154298140|NCT03941925|Levan|levan|mesh-list
154529026|NCT05375240|Propranolol|propranolol|mesh-list
154529027|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154529028|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154529029|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
154529030|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529031|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529032|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529033|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529034|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154529035|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
154529036|NCT05375240|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154529037|NCT05375240|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154529038|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529039|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529040|NCT00406393|Sirolimus|sirolimus|mesh-list
154529041|NCT00406393|Methotrexate|methotrexate|mesh-list
154529042|NCT00406393|Tacrolimus|tacrolimus|mesh-list
154529043|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154529044|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
154529045|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529046|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529047|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154529048|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
154529049|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529050|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529051|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
154529052|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529053|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154529054|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154529055|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
154529056|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154529057|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154529058|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154529059|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529060|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529061|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154529062|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
154529063|NCT02513355|Cisplatin|cisplatin|mesh-list
154529064|NCT02513355|Endostar protein|endostar protein|mesh-list
154529065|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529066|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154529067|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154529068|NCT02513355|Growth Substances|growth substances|mesh-ancestor
154529069|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529070|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
154529071|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
154529072|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154529073|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154529074|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529075|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154529076|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154529077|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
154529078|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529079|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529080|NCT02509923|Rabeprazole|rabeprazole|mesh-list
154529081|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154529082|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529083|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154529084|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529085|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529086|NCT03578263|Oxytocin|oxytocin|mesh-list
154529087|NCT03578263|Carbetocin|carbetocin|mesh-list
154529088|NCT03578263|Ergonovine|ergonovine|mesh-list
154529089|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
154529090|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529091|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529092|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154529093|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
154529094|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154529095|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154529096|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154363965|NCT02954575|Factor VIII|factor viii|mesh-list
154860490|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154529097|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529098|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529099|NCT02845375|Neostigmine|neostigmine|mesh-list
154529100|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154529101|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529102|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529103|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
154529104|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529105|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529106|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154529107|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
154529108|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529109|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
154529110|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154529111|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154529112|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
154529113|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529114|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529115|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529116|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
154529117|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
154529118|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529119|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
154529120|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154529121|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
154529122|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
154529123|NCT03344679|Adenosine|adenosine|mesh-list
154529124|NCT03344679|Bupivacaine|bupivacaine|mesh-list
154529125|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
154529126|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
154529127|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529128|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529129|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
154529130|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529131|NCT03344679|Analgesics|analgesics|mesh-ancestor
154529132|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529133|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
154529134|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154529135|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154529136|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529137|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154529138|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
154529139|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529140|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
154529141|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154529142|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
154529143|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
154529144|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529145|NCT02259829|Amlodipine|amlodipine|mesh-list
154529146|NCT02259829|Telmisartan|telmisartan|mesh-list
154529147|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154529148|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154529149|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154529150|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154529151|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529152|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154529153|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529154|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
154529155|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154529156|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154529157|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
154529158|NCT03344523|Hematinics|hematinics|mesh-ancestor
154529159|NCT02658734|Trastuzumab|trastuzumab|mesh-list
154529160|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154529161|NCT02658734|Maytansine|maytansine|mesh-list
154529162|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529163|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529164|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154529165|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
154529166|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
154529167|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154529168|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529169|NCT02658734|Immunotoxins|immunotoxins|mesh-ancestor
154529170|NCT02658734|Immunoconjugates|immunoconjugates|mesh-ancestor
154529171|NCT02658734|Immunologic Factors|immunologic factors|mesh-ancestor
154529172|NCT02658734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529173|NCT03344445|Anesthetics|anesthetics|mesh-list
154529174|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529175|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529177|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154529178|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
154529179|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154529180|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529181|NCT03143985|Pomalidomide|pomalidomide|mesh-list
154529182|NCT03143985|Vactosertib|vactosertib|mesh-list
154529183|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
154529184|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529185|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154529186|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154529187|NCT03143985|Growth Substances|growth substances|mesh-ancestor
154529188|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
154529189|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529190|NCT03143985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154529191|NCT03143985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529192|NCT03143985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529193|NCT02605148|Vitamin D|vitamin d|mesh-list
154529194|NCT02605148|Vitamins|vitamins|mesh-ancestor
154529195|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
154529196|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529197|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154529198|NCT02395640|Capecitabine|capecitabine|mesh-list
154529199|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
154529200|NCT02395640|Epirubicin|epirubicin|mesh-list
154529201|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154529202|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
154529203|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529204|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529205|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154529206|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154529207|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154529208|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529209|NCT02509143|Ramosetron|ramosetron|mesh-list
154529210|NCT02509143|Antiemetics|antiemetics|mesh-list
154529211|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
154529212|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529213|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529214|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529215|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154529216|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
154529217|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529218|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529219|NCT05100446|Amoxicillin|amoxicillin|mesh-list
154529220|NCT05100446|Esomeprazole|esomeprazole|mesh-list
154529221|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529222|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529223|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154529224|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529225|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154529226|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529227|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529228|NCT02506803|Paclitaxel|paclitaxel|mesh-list
154529229|NCT02506803|Gemcitabine|gemcitabine|mesh-list
154529230|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154529231|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529232|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
154529233|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
154529234|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
154529235|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529236|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154529237|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
154529238|NCT02844439|XL647|xl647|mesh-list
154529239|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529240|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154529241|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529242|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529243|NCT04531592|Valproic Acid|valproic acid|mesh-list
154529244|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
154529245|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529246|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529247|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
154529248|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529249|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529250|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
154529251|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154529252|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529253|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154529254|NCT03571711|Meropenem|meropenem|mesh-list
154529255|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529256|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529257|NCT03570541|Acetaminophen|acetaminophen|mesh-list
154529258|NCT03570541|Morphine|morphine|mesh-list
154529259|NCT03570541|Ropivacaine|ropivacaine|mesh-list
154529260|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154529261|NCT03570541|Narcotics|narcotics|mesh-ancestor
154298345|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154529262|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529263|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529264|NCT03570541|Analgesics|analgesics|mesh-ancestor
154529265|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
154529266|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529267|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
154529268|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
154529269|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154529270|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
154529271|NCT00708435|Protein C|protein c|mesh-list
154529272|NCT00708435|Protein S|protein s|mesh-list
154529273|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
154529274|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154529275|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154529276|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529277|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
154529278|NCT02508753|Tazobactam|tazobactam|mesh-list
154529279|NCT02508753|Ceftolozane|ceftolozane|mesh-list
154529280|NCT02508753|Cephalosporins|cephalosporins|mesh-list
154529281|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529282|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529283|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154529284|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154529285|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529286|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529287|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529288|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154529289|NCT02506647|Insulin|insulin|mesh-list
154529290|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154529291|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
154529292|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154529293|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529294|NCT02571530|Trastuzumab|trastuzumab|mesh-list
154529295|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529296|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529297|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
154529298|NCT04379024|Estrogens|estrogens|mesh-list
154529299|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154529300|NCT04379024|Hormones|hormones|mesh-ancestor
154529301|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154529302|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529303|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154529304|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154529305|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
154529306|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154529307|NCT04497831|Morphine|morphine|mesh-list
154529308|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154529309|NCT04497831|Narcotics|narcotics|mesh-ancestor
154529310|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529311|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529312|NCT04497831|Analgesics|analgesics|mesh-ancestor
154529313|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
154529314|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529315|NCT04498689|Paclitaxel|paclitaxel|mesh-list
154529316|NCT04498689|Gemcitabine|gemcitabine|mesh-list
154529317|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154529318|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529319|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
154529320|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
154529321|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
154529322|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529323|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154529324|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
154529325|NCT05103098|Misoprostol|misoprostol|mesh-list
154529326|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154529327|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
154529328|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529329|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529330|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154529331|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529332|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
154529333|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154529334|NCT04272008|Estradiol|estradiol|mesh-list
154529335|NCT04272008|Estrogens|estrogens|mesh-ancestor
154529336|NCT04272008|Hormones|hormones|mesh-ancestor
154529337|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154529338|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529339|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154529340|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
154529341|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529342|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154529343|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154529344|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154529345|NCT05103020|Bevacizumab|bevacizumab|mesh-list
154529346|NCT05103020|Cetuximab|cetuximab|mesh-list
154529347|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
154529348|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529349|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529350|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154529351|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154529352|NCT05103020|Growth Substances|growth substances|mesh-ancestor
154529353|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529354|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
154529355|NCT02501109|Aripiprazole|aripiprazole|mesh-list
154529356|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
154529357|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154529358|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154529359|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154529360|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529361|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529362|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
154529363|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
154529364|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529365|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529366|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154529367|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154529368|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
154529369|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154529370|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154529371|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154529372|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154529374|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154529375|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529376|NCT02506335|Cholic Acids|cholic acids|mesh-list
154529377|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529378|NCT01353859|Methotrexate|methotrexate|mesh-list
154529379|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154529380|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
154529381|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529382|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529383|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154529384|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
154529385|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529386|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529387|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
154529388|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529389|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154529390|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154529391|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
154529392|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154529393|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154529394|NCT02238197|Ipratropium|ipratropium|mesh-list
154529395|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154529396|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
154529397|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529398|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529399|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154298480|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
154529400|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
154529401|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154529402|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
154529403|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529404|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529405|NCT03592199|Sunitinib|sunitinib|mesh-list
154529406|NCT03592199|Axitinib|axitinib|mesh-list
154529407|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529408|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154529409|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154529410|NCT03592199|Growth Substances|growth substances|mesh-ancestor
154529411|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529412|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
154529413|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154529414|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529415|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529416|NCT02245867|Antibodies|antibodies|mesh-list
154529417|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154529418|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
154529419|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529420|NCT02507583|Insulin|insulin|mesh-list
154529421|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154529422|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529423|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154529424|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
154529425|NCT02506023|Coagulants|coagulants|mesh-ancestor
154529426|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154529427|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
154529428|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529429|NCT02246179|Lidocaine|lidocaine|mesh-list
154529430|NCT02246179|Epinephrine|epinephrine|mesh-list
154529431|NCT02246179|Prilocaine|prilocaine|mesh-list
154529432|NCT02246179|Carticaine|carticaine|mesh-list
154529433|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154529434|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
154529435|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
154529436|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529437|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529438|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
154529439|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529440|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529441|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154529442|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154529443|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154529444|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529445|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154529446|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154529447|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
154529448|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529449|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154529450|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154529452|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154529453|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
154529454|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
154529455|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
154529456|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154529457|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154529458|NCT02238275|Telmisartan|telmisartan|mesh-list
154529459|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154529460|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154529461|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154529462|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529463|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
154529464|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154529465|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529466|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529467|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154529468|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154529469|NCT04394117|Losartan|losartan|mesh-list
154529470|NCT04394117|Valsartan|valsartan|mesh-list
154529471|NCT04394117|Telmisartan|telmisartan|mesh-list
154529472|NCT04394117|Candesartan|candesartan|mesh-list
154529473|NCT04394117|Olmesartan|olmesartan|mesh-list
154529474|NCT04394117|Irbesartan|irbesartan|mesh-list
154529475|NCT04394117|Eprosartan|eprosartan|mesh-list
154529476|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154529477|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154860491|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
154529478|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154529479|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529480|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529481|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
154529482|NCT02500563|Caseins|caseins|mesh-list
154529483|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
154529484|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
154529485|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529486|NCT02500329|Acarbose|acarbose|mesh-list
154529487|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154529488|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529489|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298571|NCT03937401|Oxytocin|oxytocin|mesh-list
154529490|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154529491|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529492|NCT02243137|Aspirin|aspirin|mesh-list
154529493|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
154529494|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154529495|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154529496|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154529497|NCT02243137|Analgesics|analgesics|mesh-ancestor
154529498|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
154529499|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529500|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529501|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154529502|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154529503|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154529504|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154529505|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529506|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154529507|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154529508|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529509|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
154529510|NCT03343977|Docetaxel|docetaxel|mesh-list
154529511|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529512|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
154529513|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
154529514|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
154529515|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529516|NCT02850965|Adalimumab|adalimumab|mesh-list
154529517|NCT02850965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154529518|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154529519|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154529520|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154529521|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154529522|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154529524|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529525|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154529526|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154529527|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529528|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
154529529|NCT01375959|Resveratrol|resveratrol|mesh-list
154529530|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
154529531|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529532|NCT01375959|Protective Agents|protective agents|mesh-ancestor
154529533|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529534|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529535|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154529536|NCT02238353|Fluticasone|fluticasone|mesh-list
154529537|NCT02238353|Azelastine|azelastine|mesh-list
154529538|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154529539|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154529540|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
154529541|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529542|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529543|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154529544|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
154529545|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
154529546|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154529547|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154529548|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529549|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529550|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154529551|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154529552|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
154529553|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
154529554|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529556|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
154529557|NCT04482686|Vitamins|vitamins|mesh-list
154529558|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
154529559|NCT04482686|Zinc|zinc|mesh-list
154529560|NCT04482686|Doxycycline|doxycycline|mesh-list
154529561|NCT04482686|Ivermectin|ivermectin|mesh-list
154529562|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
154529563|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
154529564|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529565|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154529566|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154529567|NCT04482686|Trace Elements|trace elements|mesh-ancestor
154529568|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
154529569|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529570|NCT04482686|Protective Agents|protective agents|mesh-ancestor
154529571|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529572|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529573|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
154529574|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154529575|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154529576|NCT04482686|Astringents|astringents|mesh-ancestor
154529577|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
154529578|NCT03580889|Atropine|atropine|mesh-list
154529579|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
154529580|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154529581|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529582|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154529583|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
154529584|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529585|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529586|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154529587|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
154529588|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
154529589|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
154529590|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154529591|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154529592|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
154529593|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529594|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529595|NCT02500017|Melatonin|melatonin|mesh-list
154529596|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
154253395|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
154529597|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529599|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529600|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529601|NCT02505633|Lidocaine|lidocaine|mesh-list
154529602|NCT02505633|Epinephrine|epinephrine|mesh-list
154529603|NCT02505633|Racepinephrine|racepinephrine|mesh-list
154529604|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
154529605|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
154529606|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
154529607|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529608|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529609|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
154529610|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529611|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529612|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154529613|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154529614|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154298704|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529615|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529616|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154529617|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154529618|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
154529619|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529620|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154529621|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154529622|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
154529623|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154529624|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
154529625|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
154529626|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
154529627|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154529628|NCT03587441|Neostigmine|neostigmine|mesh-list
154364496|NCT03361774|Fluorides|fluorides|mesh-list
154529630|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529631|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529632|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
154529633|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529634|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529635|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154529636|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
154529637|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529638|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
154529639|NCT05102396|Oxybutynin|oxybutynin|mesh-list
154529640|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
154529641|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
154529642|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529643|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529644|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154529645|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154529646|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
154529647|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529648|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529649|NCT05102396|Urological Agents|urological agents|mesh-ancestor
154529650|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154529651|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529652|NCT01165645|Ritonavir|ritonavir|mesh-list
154529653|NCT01165645|Lopinavir|lopinavir|mesh-list
154529654|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154529655|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154529656|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
154529657|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529658|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529659|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154529660|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154529661|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
154529662|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529663|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154529664|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154529665|NCT03569995|Cytarabine|cytarabine|mesh-list
154529666|NCT03569995|Rituximab|rituximab|mesh-list
154529667|NCT03569995|Methotrexate|methotrexate|mesh-list
154529668|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529669|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529670|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
154253479|NCT03926156|Warfarin|warfarin|mesh-list
154529671|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529672|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154529673|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154529674|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
154529675|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529676|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154529677|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
154529678|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529679|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
154529680|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529681|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154529682|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154529683|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154529684|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
154529685|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529687|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154529688|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
154529689|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529690|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529691|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154529692|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529693|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154529694|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529695|NCT02238509|Trastuzumab|trastuzumab|mesh-list
154529696|NCT02238509|Lapatinib|lapatinib|mesh-list
154529697|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529698|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529699|NCT02238509|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154529700|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154529701|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364562|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529702|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529704|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529705|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154529706|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
154529707|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
154529708|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529709|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529710|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154529711|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154529712|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154529713|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
154529714|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529715|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529716|NCT03573037|Anticoagulants|anticoagulants|mesh-list
154529717|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154529718|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529719|NCT03585413|Micronutrients|micronutrients|mesh-list
154529720|NCT03585413|Trace Elements|trace elements|mesh-list
154529721|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529722|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
154529723|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154529724|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
154529725|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529726|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
154529727|NCT03569683|Protective Agents|protective agents|mesh-ancestor
154529728|NCT00708201|Alvimopan|alvimopan|mesh-list
154529729|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529730|NCT03572959|Triamcinolone|triamcinolone|mesh-list
154529731|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154529732|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154529733|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154529734|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154529735|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
154529736|NCT03572959|Hormones|hormones|mesh-ancestor
154529737|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154529738|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529739|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154529740|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
154529741|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529742|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529743|NCT02500251|Rituximab|rituximab|mesh-list
154529744|NCT02500251|Bortezomib|bortezomib|mesh-list
154529745|NCT02500251|Belimumab|belimumab|mesh-list
154529746|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529747|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529748|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
154529749|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529750|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154529751|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154529752|NCT03568513|Curcumin|curcumin|mesh-list
154529753|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154529754|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154529755|NCT03568513|Analgesics|analgesics|mesh-ancestor
154529756|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
154529757|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529758|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529759|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154529760|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154529761|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529762|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529763|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529764|NCT02982668|Metoclopramide|metoclopramide|mesh-list
154529765|NCT02982668|Mosapride|mosapride|mesh-list
154529766|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
154529767|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
154529768|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529769|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529770|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154529771|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154529772|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154529773|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
154529774|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529775|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529776|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154529777|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
154529778|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154529779|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529780|NCT05354479|Acetaminophen|acetaminophen|mesh-list
154529781|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154529782|NCT05354479|Analgesics|analgesics|mesh-ancestor
154529783|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
154529784|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529785|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529786|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
154529787|NCT02505399|Clopidogrel|clopidogrel|mesh-list
154529788|NCT02505399|Ticagrelor|ticagrelor|mesh-list
154529789|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154529790|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154529791|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154529792|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154529793|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
154529794|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529795|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529796|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529797|NCT02728089|Tazobactam|tazobactam|mesh-list
154529798|NCT02728089|Ceftolozane|ceftolozane|mesh-list
154529799|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529800|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529801|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154529802|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529803|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529804|NCT05110118|Bevacizumab|bevacizumab|mesh-list
154529805|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
154529806|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529807|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529808|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154529809|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154529810|NCT05110118|Growth Substances|growth substances|mesh-ancestor
154529811|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529812|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154529813|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
154529814|NCT03572647|Hematinics|hematinics|mesh-ancestor
154529815|NCT02495181|Aflibercept|aflibercept|mesh-list
154529816|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154529817|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154529818|NCT02495181|Growth Substances|growth substances|mesh-ancestor
154253623|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
154529819|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529820|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
154529821|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529822|NCT02499861|Decitabine|decitabine|mesh-list
154529823|NCT02499861|Genistein|genistein|mesh-list
154529824|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154529825|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
154529826|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529827|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529828|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529829|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154529830|NCT02499861|Protective Agents|protective agents|mesh-ancestor
154529831|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529832|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154529833|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
154529834|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154529835|NCT02499861|Estrogens|estrogens|mesh-ancestor
154529836|NCT02499861|Hormones|hormones|mesh-ancestor
154529837|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154529838|NCT02840461|Ivermectin|ivermectin|mesh-list
154529839|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154529840|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529841|NCT05108714|Lidocaine|lidocaine|mesh-list
154529842|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
154529843|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
154529844|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529845|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529846|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
154529847|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529848|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529849|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154860492|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154529850|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154529851|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154298936|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529852|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529853|NCT02495415|Fenretinide|fenretinide|mesh-list
154529855|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529856|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154529857|NCT02495415|Protective Agents|protective agents|mesh-ancestor
154529858|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529859|NCT02505009|Tenofovir|tenofovir|mesh-list
154529860|NCT02505009|Entecavir|entecavir|mesh-list
154529861|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
154529862|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529863|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154529864|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154529865|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154529866|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529867|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154529868|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154529869|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
154529870|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154529871|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154529872|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154529873|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154529874|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
154529875|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529876|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529877|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529878|NCT02499627|Immunotoxins|immunotoxins|mesh-ancestor
154529879|NCT02499627|Immunoconjugates|immunoconjugates|mesh-ancestor
154529880|NCT02499627|Immunologic Factors|immunologic factors|mesh-ancestor
154529881|NCT02499627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529882|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154529883|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154529884|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
154529885|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529886|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529887|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154529888|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154529889|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154529890|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529891|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
154529892|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154529893|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
154529894|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529895|NCT02505087|Expectorants|expectorants|mesh-ancestor
154529896|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
154529897|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154529898|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
154529899|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529900|NCT02505087|Protective Agents|protective agents|mesh-ancestor
154529901|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529902|NCT02505087|Antidotes|antidotes|mesh-ancestor
154529903|NCT02839681|Maytansine|maytansine|mesh-list
154529904|NCT02839681|Anetumab ravtansine|anetumab ravtansine|mesh-list
154529905|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154529906|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529907|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
154529908|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
154529909|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
154529910|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529911|NCT02839681|Immunoconjugates|immunoconjugates|mesh-ancestor
154529912|NCT02839681|Immunologic Factors|immunologic factors|mesh-ancestor
154529913|NCT02839681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529914|NCT02504463|Naltrexone|naltrexone|mesh-list
154529915|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154529916|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154529917|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529918|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
154529919|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529920|NCT03566329|Lidocaine|lidocaine|mesh-list
154529921|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
154529922|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154529923|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
154529924|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529925|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529926|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
154529927|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529928|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529929|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154529930|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154529931|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154529932|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529934|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
154529935|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154529936|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154529937|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
154529938|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529939|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
154529940|NCT02499237|Denosumab|denosumab|mesh-list
154529941|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154529942|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529943|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
154529944|NCT02499393|Analgesics|analgesics|mesh-ancestor
154529945|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
154529946|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154529947|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529948|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
154529949|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529950|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154529951|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
154529952|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154529953|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154529954|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529955|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154529956|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
154529957|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154529958|NCT02504307|Sirolimus|sirolimus|mesh-list
154529959|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529960|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529961|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154529962|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529963|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
154529964|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154529965|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
154529966|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529967|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
154529968|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529969|NCT03567343|Melatonin|melatonin|mesh-list
154529970|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
154529971|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154529972|NCT03567343|Protective Agents|protective agents|mesh-ancestor
154529973|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529974|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154529975|NCT04595864|Leucovorin|leucovorin|mesh-list
154529976|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
154529977|NCT04595864|Calcium|calcium|mesh-list
154529978|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
154529979|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154529980|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529981|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529982|NCT04595864|Antidotes|antidotes|mesh-ancestor
154529983|NCT04595864|Protective Agents|protective agents|mesh-ancestor
154529984|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
154529985|NCT04595864|Vitamins|vitamins|mesh-ancestor
154529986|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
154529987|NCT04583462|Metformin|metformin|mesh-list
154529988|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154529989|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154529990|NCT04456322|Cisplatin|cisplatin|mesh-list
154529991|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
154529992|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529993|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154529994|NCT02503761|Meropenem|meropenem|mesh-list
154529995|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154529996|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154529997|NCT04097912|Aspirin|aspirin|mesh-list
154529998|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154529999|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530000|NCT04097912|Analgesics|analgesics|mesh-ancestor
154530001|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
154530002|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530003|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530005|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530006|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154530007|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154530008|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530009|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154530010|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154530011|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530012|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
154530013|NCT04966676|Nivolumab|nivolumab|mesh-list
154530014|NCT04966676|Ipilimumab|ipilimumab|mesh-list
154530015|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154530016|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530017|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154530018|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530019|NCT03340779|Dobutamine|dobutamine|mesh-list
154530020|NCT03340779|Norepinephrine|norepinephrine|mesh-list
154530021|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154530022|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154530023|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154530024|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530025|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530026|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530027|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
154530028|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
154530029|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530030|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154530031|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154530032|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154530033|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154530034|NCT03340779|Protective Agents|protective agents|mesh-ancestor
154530035|NCT04040738|Anesthetics|anesthetics|mesh-list
154530036|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530037|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530038|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
154530039|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154530040|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530041|NCT05087732|Lidocaine|lidocaine|mesh-list
154530042|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
154530043|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
154530044|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530045|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530046|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
154530047|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530048|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154530049|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154530050|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154530051|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154530052|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530054|NCT03340701|Progestins|progestins|mesh-ancestor
154530055|NCT03340701|Hormones|hormones|mesh-ancestor
154299133|NCT03648034|Ropivacaine|ropivacaine|mesh-list
154530056|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530057|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530058|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
154530059|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154530060|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
154530061|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530062|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530063|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154530064|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
154530065|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154530066|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
154530067|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530068|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530069|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154530070|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
154530071|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
154530072|NCT02498535|Protective Agents|protective agents|mesh-ancestor
154530073|NCT04727138|Midazolam|midazolam|mesh-list
154530074|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154530075|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530076|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530077|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530078|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154530079|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154530080|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154530081|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154530082|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
154530084|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
154530085|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
154530086|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530087|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530088|NCT02498457|Calcium|calcium|mesh-list
154530089|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154530090|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530091|NCT02498301|Rifaximin|rifaximin|mesh-list
154530092|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530093|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530094|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154530095|NCT03343665|Nivolumab|nivolumab|mesh-list
154530096|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154530097|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530098|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154530099|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530100|NCT02733614|SRX246|srx246|mesh-list
154530101|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154530102|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530103|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
154530104|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530105|NCT03342807|Insulin|insulin|mesh-list
154530106|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154530107|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530108|NCT04593914|Protective Agents|protective agents|mesh-list
154530109|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530110|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
154530111|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154530112|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530113|NCT03342651|Vitamin D|vitamin d|mesh-list
154530114|NCT03342651|Vitamins|vitamins|mesh-ancestor
154530115|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
154530116|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530117|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154530118|NCT04819568|Terlipressin|terlipressin|mesh-list
154530119|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154253924|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530120|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154530121|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
154530122|NCT02502981|Spironolactone|spironolactone|mesh-list
154530123|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154530124|NCT02502981|Diuretics|diuretics|mesh-list
154530125|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
154530126|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
154530127|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
154530128|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530129|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530130|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154530131|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
154530132|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154530133|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154530134|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530135|NCT02502981|Hormones|hormones|mesh-ancestor
154530136|NCT04230746|Trimethoprim|trimethoprim|mesh-list
154530137|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154530138|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
154530139|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154530140|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530141|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
154530142|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154530143|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154530144|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154530145|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530146|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530147|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154530148|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154530149|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154530150|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530151|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154530152|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154530153|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
154530154|NCT05111444|Paclitaxel|paclitaxel|mesh-list
154530155|NCT05111444|Capecitabine|capecitabine|mesh-list
154530156|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
154530157|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154530158|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530159|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
154530160|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
154530161|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
154299233|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530162|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530163|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154530164|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
154530165|NCT03769688|Metronidazole|metronidazole|mesh-list
154530166|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530167|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530168|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154530169|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154530170|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
154530171|NCT02502825|Miotics|miotics|mesh-ancestor
154530172|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
154530173|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530174|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530175|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154530176|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154530177|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
154530178|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154530179|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154530180|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
154530181|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530182|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530183|NCT02498145|Nicotine|nicotine|mesh-list
154530184|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154530185|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
154530186|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530187|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530188|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154530189|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154530190|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
154530191|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530192|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530193|NCT02497911|Bupivacaine|bupivacaine|mesh-list
154530194|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
154530195|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
154530196|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530197|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530198|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
154530199|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530200|NCT04187300|Semaglutide|semaglutide|mesh-list
154530201|NCT04187300|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154530202|NCT04187300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154530203|NCT04187300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530205|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530206|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
154530207|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
154530208|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
154530209|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154530210|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
154530211|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
154530212|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530213|NCT02493933|Expectorants|expectorants|mesh-ancestor
154530214|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
154530215|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154530216|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
154530217|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530218|NCT02493933|Protective Agents|protective agents|mesh-ancestor
154530219|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530220|NCT02493933|Antidotes|antidotes|mesh-ancestor
154530221|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154530222|NCT02493933|Estrogens|estrogens|mesh-ancestor
154530223|NCT02493933|Hormones|hormones|mesh-ancestor
154530224|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530225|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
154530226|NCT04314050|Tramadol|tramadol|mesh-list
154530228|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530229|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530230|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530231|NCT04314050|Analgesics|analgesics|mesh-ancestor
154530232|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
154530233|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530234|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154530235|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154530236|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154530237|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
154530238|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530239|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530240|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154530241|NCT04314050|Narcotics|narcotics|mesh-ancestor
154530242|NCT03343509|Metronidazole|metronidazole|mesh-list
154530243|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530244|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530245|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154530246|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154530247|NCT04516148|Clindamycin|clindamycin|mesh-list
154530248|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
154530249|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
154530250|NCT04516148|Cefazolin|cefazolin|mesh-list
154530251|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530252|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530253|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154530254|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530255|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530256|NCT02497053|Pemetrexed|pemetrexed|mesh-list
154530257|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530258|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530259|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530260|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154530261|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154530262|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154530263|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530264|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
154530265|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530266|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530267|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254083|NCT01144910|Miotics|miotics|mesh-ancestor
154530268|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530269|NCT03337581|Analgesics|analgesics|mesh-ancestor
154530270|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
154530271|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530272|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154530273|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154530274|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154530275|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154530276|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530277|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530278|NCT02496975|Cyclosporine|cyclosporine|mesh-list
154530279|NCT02496975|Cyclosporins|cyclosporins|mesh-list
154530280|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530281|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530282|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154530283|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
154530284|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530285|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
154530286|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530287|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
154530288|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530289|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154530290|NCT03337503|Dronabinol|dronabinol|mesh-list
154530291|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
154530292|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530293|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154299375|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
154530294|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530295|NCT03337503|Analgesics|analgesics|mesh-ancestor
154530296|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
154530297|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530298|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154530299|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154530300|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530301|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530302|NCT03337503|Hormones|hormones|mesh-ancestor
154530303|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530304|NCT01675622|Morphine|morphine|mesh-list
154530305|NCT01675622|Oxycodone|oxycodone|mesh-list
154530306|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154530307|NCT01675622|Narcotics|narcotics|mesh-ancestor
154530308|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530309|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530310|NCT01675622|Analgesics|analgesics|mesh-ancestor
154530311|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
154530312|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530313|NCT02496741|Metformin|metformin|mesh-list
154530314|NCT02496741|Chloroquine|chloroquine|mesh-list
154530315|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154530316|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530317|NCT02496741|Amebicides|amebicides|mesh-ancestor
154530318|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154530319|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154530320|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530321|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
154530322|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530323|NCT04496037|Rituximab|rituximab|mesh-list
154530324|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154530325|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530326|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
154530327|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530328|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530329|NCT02493465|Everolimus|everolimus|mesh-list
154530330|NCT02493465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154530331|NCT02493465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154530332|NCT02493465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530333|NCT02493465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530334|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154530335|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
154530336|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530337|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530338|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
154530339|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530340|NCT04495569|Antibodies|antibodies|mesh-list
154530341|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154530342|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
154254158|NCT01234454|Olanzapine|olanzapine|mesh-list
154530343|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530344|NCT03337191|Morphine|morphine|mesh-list
154530345|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
154530346|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154530347|NCT03337191|Narcotics|narcotics|mesh-ancestor
154530348|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530349|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530350|NCT03337191|Analgesics|analgesics|mesh-ancestor
154530351|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
154530352|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530353|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
154530354|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
154530355|NCT04494243|Rabeprazole|rabeprazole|mesh-list
154530356|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154530357|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154530358|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154530359|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530360|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530361|NCT03337035|Oxytocin|oxytocin|mesh-list
154530362|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
154530363|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154530364|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530365|NCT03330717|Anesthetics|anesthetics|mesh-list
154530366|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530367|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530368|NCT02655224|Relugolix|relugolix|mesh-list
154530369|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
154530370|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
154530371|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530372|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530373|NCT04494321|Budesonide|budesonide|mesh-list
154530374|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
154530375|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530376|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154530377|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
154530378|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530379|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530380|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154530381|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
154530382|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
154530383|NCT04494321|Hormones|hormones|mesh-ancestor
154530384|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530385|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154530386|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154530387|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154530388|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
154530389|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530390|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530391|NCT03330171|Vaccines|vaccines|mesh-list
154530392|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
154530393|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530394|NCT05118542|Methimazole|methimazole|mesh-list
154530395|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
154530396|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
154530397|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
154530398|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530399|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530400|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
154530401|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530402|NCT03336801|Propofol|propofol|mesh-list
154530403|NCT03336801|Sevoflurane|sevoflurane|mesh-list
154530404|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530405|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530406|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530407|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154530408|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
154530409|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
154530410|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154530411|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154530412|NCT05115578|Midazolam|midazolam|mesh-list
154530413|NCT05115578|Remifentanil|remifentanil|mesh-list
154530414|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154530415|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530416|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530417|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530418|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154530419|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154530420|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154530422|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
154530423|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
154530424|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
154530425|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
154530426|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530427|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530428|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154530429|NCT05115578|Narcotics|narcotics|mesh-ancestor
154530430|NCT05115578|Analgesics|analgesics|mesh-ancestor
154530431|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
154530432|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530433|NCT02636036|Nivolumab|nivolumab|mesh-list
154530434|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154530435|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530436|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154530437|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530438|NCT03329781|Curcumin|curcumin|mesh-list
154530439|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154530440|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530441|NCT03329781|Analgesics|analgesics|mesh-ancestor
154530442|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
154530443|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530444|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530445|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530446|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530447|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530448|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530449|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530450|NCT02437604|Fluticasone|fluticasone|mesh-list
154530451|NCT02437604|Xhance|xhance|mesh-list
154530452|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154530454|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530455|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154530456|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
154530457|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530458|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530459|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154530460|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
154530461|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
154530462|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154530463|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154530464|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154530465|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154530466|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
154530467|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530468|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530469|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
154530470|NCT02437604|Hormones|hormones|mesh-ancestor
154530471|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530472|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
154530473|NCT03329547|Cefixime|cefixime|mesh-list
154530474|NCT03329547|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154530475|NCT03329547|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154530476|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530477|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530478|NCT05463627|Metformin|metformin|mesh-list
154530479|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154530480|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530481|NCT01975298|Interferons|interferons|mesh-list
154530482|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
154530483|NCT01975298|Interferon-beta|interferon-beta|mesh-list
154299559|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
154530484|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530485|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
154530486|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530487|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154530488|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
154530489|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530490|NCT03324867|Insulin|insulin|mesh-list
154530491|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154530492|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154530493|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530494|NCT05084534|Midodrine|midodrine|mesh-list
154530495|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
154530496|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
154530497|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530498|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530499|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154530500|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154530501|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154530502|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154530503|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
154530504|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530505|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530506|NCT04645316|Propofol|propofol|mesh-list
154530507|NCT04645316|Sevoflurane|sevoflurane|mesh-list
154530508|NCT04645316|Desflurane|desflurane|mesh-list
154530509|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530510|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530511|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530512|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154530513|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
154530514|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
154530515|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154530516|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154530517|NCT02491515|Denosumab|denosumab|mesh-list
154530518|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154530519|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530520|NCT05113628|Methylene Blue|methylene blue|mesh-list
154530521|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530522|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530523|NCT04247750|Sirolimus|sirolimus|mesh-list
154530524|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530525|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530526|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154530527|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530528|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
154530529|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154530530|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
154530531|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530532|NCT02493231|Ketamine|ketamine|mesh-list
154530533|NCT02493231|Nefopam|nefopam|mesh-list
154530534|NCT02493231|Analgesics|analgesics|mesh-ancestor
154530535|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
154530536|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530537|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530538|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154530539|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154530540|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
154530541|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
154530542|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530543|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154530544|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154530545|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530546|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530547|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530548|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154530549|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154530550|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154530551|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154530552|NCT05112692|Cetrorelix|cetrorelix|mesh-list
154530553|NCT05112692|Menotropins|menotropins|mesh-list
154530554|NCT05112692|Estradiol|estradiol|mesh-list
154530555|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154530556|NCT05112692|Progesterone|progesterone|mesh-list
154530557|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
154530558|NCT05112692|Estrogens|estrogens|mesh-ancestor
154530559|NCT05112692|Hormones|hormones|mesh-ancestor
154530560|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530561|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530562|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154530563|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
154530564|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154530565|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154530566|NCT05112692|Progestins|progestins|mesh-ancestor
154530567|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
154530568|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154530569|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530570|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154530571|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
154254371|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
154530572|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
154530573|NCT03328533|Phenylephrine|phenylephrine|mesh-list
154530574|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
154530575|NCT03328533|Norepinephrine|norepinephrine|mesh-list
154530576|NCT03328533|Bupivacaine|bupivacaine|mesh-list
154530577|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
154530578|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
154530579|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530580|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530581|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
154530582|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530583|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154530584|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
154530585|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
154530586|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
154530587|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154530588|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
154530589|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
154530590|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154530591|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154530592|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154530593|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154530594|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530595|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530596|NCT03328533|Protective Agents|protective agents|mesh-ancestor
154530597|NCT05117372|Immunomodulating Agents|immunomodulating agents|mesh-list
154530598|NCT05117372|Immunologic Factors|immunologic factors|mesh-ancestor
154530599|NCT05117372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530600|NCT03324243|Cytarabine|cytarabine|mesh-list
154530601|NCT03324243|Fludarabine|fludarabine|mesh-list
154530602|NCT03324243|Crenolanib|crenolanib|mesh-list
154530603|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530604|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154530606|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530607|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154530608|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
154530609|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530610|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
154530611|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530612|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
154530613|NCT03328299|Bupivacaine|bupivacaine|mesh-list
154530614|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
154530615|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
154530616|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530617|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530618|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
154530619|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530620|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530621|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530622|NCT03328299|Analgesics|analgesics|mesh-ancestor
154530623|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154530624|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154530625|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154530626|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
154530627|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530628|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530629|NCT03564301|Metronidazole|metronidazole|mesh-list
154530630|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530631|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530632|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154530633|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154530634|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
154530635|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530636|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530637|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154530638|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154530639|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530640|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530641|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530642|NCT03327987|Vaccines|vaccines|mesh-list
154530643|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
154530644|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530645|NCT03335241|Doxorubicin|doxorubicin|mesh-list
154530646|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154530647|NCT03335241|Fludarabine|fludarabine|mesh-list
154530648|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154530649|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530650|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154530651|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154530652|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530653|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530654|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154530655|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154530656|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
154530657|NCT03120663|Amoxicillin|amoxicillin|mesh-list
154530658|NCT03120663|Clindamycin|clindamycin|mesh-list
154530659|NCT03120663|Meropenem|meropenem|mesh-list
154530660|NCT03120663|Tazobactam|tazobactam|mesh-list
154530661|NCT03120663|Piperacillin|piperacillin|mesh-list
154530662|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
154530663|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
154530664|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154530665|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154530666|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530667|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530668|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154530669|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530670|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530671|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154530672|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
154530673|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154530674|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154530675|NCT02578394|Prednisolone|prednisolone|mesh-list
154530676|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
154530677|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154530678|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154530679|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
154530680|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530681|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
154530682|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
154530683|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530684|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530685|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154530686|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
154530687|NCT02578394|Hormones|hormones|mesh-ancestor
154530688|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530689|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154530690|NCT02578394|Protective Agents|protective agents|mesh-ancestor
154530691|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154530692|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530693|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530694|NCT04493229|Oxytocin|oxytocin|mesh-list
154530695|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
154530696|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154530697|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530698|NCT03120273|Lansoprazole|lansoprazole|mesh-list
154530699|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
154530700|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154530701|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154530702|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154530703|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530704|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530705|NCT02122718|Allopurinol|allopurinol|mesh-list
154530706|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
154530707|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530708|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530709|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
154530710|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530711|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154530712|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
154530713|NCT02122718|Protective Agents|protective agents|mesh-ancestor
154530714|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530715|NCT04513652|Carticaine|carticaine|mesh-list
154530716|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
154530717|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
154530718|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530719|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530720|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
154530721|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254528|NCT01143974|Pemetrexed|pemetrexed|mesh-list
154530722|NCT00706797|Etanercept|etanercept|mesh-list
154530723|NCT00706797|Methotrexate|methotrexate|mesh-list
154530724|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154530725|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
154530726|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154530727|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530728|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154530729|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
154530730|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530731|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530732|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
154530733|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530734|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154530735|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154530736|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
154530737|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530738|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154530739|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154530740|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530741|NCT00706797|Analgesics|analgesics|mesh-ancestor
154530742|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
154530743|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530744|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530745|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154530746|NCT03323697|Escitalopram|escitalopram|mesh-list
154530747|NCT03323697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154530748|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154530749|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154530750|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530751|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530752|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
154530753|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530755|NCT00706641|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154530756|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154530757|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530758|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530759|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530760|NCT03335085|Oxytocin|oxytocin|mesh-list
154530761|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
154530762|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154530763|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530764|NCT03323619|Anesthetics|anesthetics|mesh-list
154530765|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530766|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530767|NCT03323541|Lenograstim|lenograstim|mesh-list
154530768|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154530769|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
154530770|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530771|NCT03335007|Aceclofenac|aceclofenac|mesh-list
154530772|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154530773|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530774|NCT03335007|Analgesics|analgesics|mesh-ancestor
154530775|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
154530776|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530777|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530778|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530779|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530780|NCT01362530|Ondansetron|ondansetron|mesh-list
154530781|NCT01362530|Aprepitant|aprepitant|mesh-list
154530782|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
154530783|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
154530784|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
154530785|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530786|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530787|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154530788|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
154530789|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
154530790|NCT01362530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154530791|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154530792|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
154530793|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530794|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530795|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154530796|NCT04494399|Interferons|interferons|mesh-list
154530797|NCT04494399|Ribavirin|ribavirin|mesh-list
154530798|NCT04494399|Interferon-beta|interferon-beta|mesh-list
154530799|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
154530800|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530801|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
154530802|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530803|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
154530804|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530805|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
154530806|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530807|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154530808|NCT01758614|Aspirin|aspirin|mesh-list
154530809|NCT01758614|Clopidogrel|clopidogrel|mesh-list
154530810|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154530811|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154530812|NCT01758614|Analgesics|analgesics|mesh-ancestor
154530813|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
154530814|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530815|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530816|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530817|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530818|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154530819|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154530820|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530821|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154530822|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154530823|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530824|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
154530825|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154530826|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154530827|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154530828|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
154530830|NCT02490657|Iloprost|iloprost|mesh-list
154530831|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154530832|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
154530833|NCT04323566|Rituximab|rituximab|mesh-list
154530834|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154530835|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530836|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
154530837|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530838|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530839|NCT03109119|Propofol|propofol|mesh-list
154530840|NCT03109119|Sevoflurane|sevoflurane|mesh-list
154530841|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530842|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530843|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530844|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154530845|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
154530846|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
154530847|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154530848|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154530849|NCT03326661|Clindamycin|clindamycin|mesh-list
154530850|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
154530851|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
154530852|NCT03326661|Penicillins|penicillins|mesh-list
154530853|NCT03326661|Metronidazole|metronidazole|mesh-list
154530854|NCT03326661|Penicillin V|penicillin v|mesh-list
154530855|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530856|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530857|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154530858|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530859|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530860|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154530861|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154530862|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154530863|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154530864|NCT02654054|Norethindrone|norethindrone|mesh-list
154530865|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
154530866|NCT02654054|Estradiol|estradiol|mesh-list
154530867|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154530868|NCT02654054|Estrogens|estrogens|mesh-ancestor
154530869|NCT02654054|Hormones|hormones|mesh-ancestor
154530870|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530871|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530872|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154530873|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
154530874|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154530875|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154530876|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154530877|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154530878|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154530879|NCT03186404|Atorvastatin|atorvastatin|mesh-list
154530880|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154530881|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154530882|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
154530883|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530884|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154530885|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154530886|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530887|NCT02492373|Clobetasol|clobetasol|mesh-list
154530888|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154530889|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
154530890|NCT02492373|Hormones|hormones|mesh-ancestor
154530891|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154530892|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530894|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
154530895|NCT03073070|Vitamins|vitamins|mesh-ancestor
154530896|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
154530897|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530898|NCT02905214|Sirolimus|sirolimus|mesh-list
154530899|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154530900|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154530901|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154530902|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530903|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
154530904|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154530905|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
154530906|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530907|NCT03333603|Esomeprazole|esomeprazole|mesh-list
154530908|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154530909|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154530910|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154530911|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530912|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530914|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154530915|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530916|NCT03333369|Levodopa|levodopa|mesh-list
154530917|NCT03333369|Benserazide|benserazide|mesh-list
154530918|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154530919|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154530920|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
154530921|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530922|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530923|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530924|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530925|NCT03325803|Lidocaine|lidocaine|mesh-list
154530926|NCT03325803|Prilocaine|prilocaine|mesh-list
154530927|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154530928|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
154530929|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
154530930|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530931|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530932|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
154530933|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530934|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154530935|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154530936|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154530937|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154530938|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530939|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154530940|NCT05465343|Aflutinib|aflutinib|mesh-list
154530941|NCT05465343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154530942|NCT05465343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530943|NCT05465343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530944|NCT03325491|Acipimox|acipimox|mesh-list
154530945|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154530946|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
154530947|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530948|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154530949|NCT04150562|Avelumab|avelumab|mesh-list
154530950|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154530951|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530952|NCT03325413|Anesthetics|anesthetics|mesh-list
154530953|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530954|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530956|NCT03325335|Remifentanil|remifentanil|mesh-list
154530957|NCT03325335|Propofol|propofol|mesh-list
154530958|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154530959|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154530960|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530961|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154530962|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
154530963|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
154530964|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154530965|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154530966|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154530967|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154530968|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
154530969|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
154530970|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154530971|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530972|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154530973|NCT03325335|Narcotics|narcotics|mesh-ancestor
154530974|NCT03325335|Analgesics|analgesics|mesh-ancestor
154530975|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
154530976|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154530977|NCT03332511|Nilotinib|nilotinib|mesh-list
154530978|NCT03332511|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154530979|NCT03332511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154530980|NCT03332511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154530981|NCT03332511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530982|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154530983|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
154300055|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
154530984|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
154530985|NCT05114720|Docetaxel|docetaxel|mesh-list
154530986|NCT05114720|Doxorubicin|doxorubicin|mesh-list
154530987|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154530988|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154530989|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154530990|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
154530991|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154530992|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154530993|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154530994|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
154530995|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154530996|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154530997|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154530998|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
154530999|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
154531000|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
154531001|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154531002|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154531003|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154531004|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531005|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531006|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154531007|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
154531008|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154531009|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154531010|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154531011|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154531012|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
154531013|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154531014|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154531015|NCT04493463|Prednisolone|prednisolone|mesh-list
154531016|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
154531017|NCT04493463|Ropivacaine|ropivacaine|mesh-list
154531018|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154531019|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
154531020|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
154531021|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
154531022|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531023|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531024|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
154531025|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531026|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531027|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
154531028|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
154531029|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154531030|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
154531031|NCT04493463|Hormones|hormones|mesh-ancestor
154531032|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531033|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154531034|NCT04493463|Protective Agents|protective agents|mesh-ancestor
154531035|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154531036|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531037|NCT04493073|Mitomycins|mitomycins|mesh-list
154531038|NCT04493073|Mitomycin|mitomycin|mesh-list
154531039|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154531040|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531041|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
154531042|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531043|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154531044|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531045|NCT00748904|Rifaximin|rifaximin|mesh-list
154531046|NCT00748904|Lactulose|lactulose|mesh-list
154531047|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154531048|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531049|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154531050|NCT03321903|Charcoal|charcoal|mesh-list
154531051|NCT03321903|Antidotes|antidotes|mesh-ancestor
154531052|NCT03321903|Protective Agents|protective agents|mesh-ancestor
154531053|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531054|NCT04411550|Pertuzumab|pertuzumab|mesh-list
154531055|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154531056|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531057|NCT03321825|Lidocaine|lidocaine|mesh-list
154531058|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
154531059|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
154531061|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531062|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531063|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
154531064|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531065|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154531066|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154531067|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154531068|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154531069|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531070|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154531071|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
154531072|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
154531073|NCT03321825|Protective Agents|protective agents|mesh-ancestor
154531074|NCT02492217|Adalimumab|adalimumab|mesh-list
154531075|NCT02492217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154531076|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531077|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154531078|NCT05229536|Vaccines|vaccines|mesh-list
154531079|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
154531080|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531081|NCT04810910|Molgramostim|molgramostim|mesh-list
154531082|NCT04810910|Sargramostim|sargramostim|mesh-list
154531083|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
154531084|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531085|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531086|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
154531087|NCT03320187|Dinoprostone|dinoprostone|mesh-list
154531088|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
154531089|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
154531090|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154531091|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531092|NCT03320109|Vitamin D|vitamin d|mesh-list
154531093|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
154531094|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
154531095|NCT03320109|Vitamins|vitamins|mesh-list
154531096|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
154531097|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531098|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154531099|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154531100|NCT04529876|Abatacept|abatacept|mesh-list
154531101|NCT04529876|Tofacitinib|tofacitinib|mesh-list
154531102|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154531103|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531104|NCT04529876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154531106|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154531107|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
154531108|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531109|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154531110|NCT04529876|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154531111|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154531112|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531113|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
154531114|NCT03320031|Linagliptin|linagliptin|mesh-list
154531115|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154531116|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531117|NCT03320031|Incretins|incretins|mesh-ancestor
154531118|NCT03320031|Hormones|hormones|mesh-ancestor
154531119|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531120|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154531121|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
154531122|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531123|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531124|NCT04510922|Droxidopa|droxidopa|mesh-list
154531125|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154531126|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154531127|NCT05465031|Valsartan|valsartan|mesh-list
154531128|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154531129|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154531130|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154531131|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154531132|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531133|NCT04510844|Evolocumab|evolocumab|mesh-list
154531134|NCT04510844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154531135|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154531136|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154531137|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
154531138|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531139|NCT04510844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154531140|NCT04510844|Protease Inhibitors|protease inhibitors|mesh-ancestor
154531141|NCT04510844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531142|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154531143|NCT05464953|Triamcinolone|triamcinolone|mesh-list
154531144|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154531145|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154531146|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154531147|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531148|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
154531149|NCT05464953|Hormones|hormones|mesh-ancestor
154531150|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531151|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531152|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154531153|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
154531154|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531155|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531156|NCT02491749|Anesthetics|anesthetics|mesh-list
154531157|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531158|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531159|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
154531160|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154531161|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531162|NCT04408898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154531163|NCT04408898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531164|NCT02490345|Gabapentin|gabapentin|mesh-list
154531165|NCT02490345|Analgesics|analgesics|mesh-ancestor
154531166|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
154531167|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531168|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531169|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
154531170|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154531171|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154531172|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531173|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154531174|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154531175|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154531176|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254973|NCT02889562|Warfarin|warfarin|mesh-list
154531177|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531179|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
154531180|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154531181|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154531182|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531183|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
154531184|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
154531185|NCT03319563|Epinephrine|epinephrine|mesh-list
154531186|NCT03319563|Anesthetics|anesthetics|mesh-list
154531187|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
154531188|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531189|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531190|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154531191|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154531192|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
154531193|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531194|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531195|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154531196|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154531197|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
154531198|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531199|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154531200|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
154531201|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
154531202|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
154531203|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154531204|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
154531205|NCT02485119|Anetumab ravtansine|anetumab ravtansine|mesh-list
154531206|NCT02485119|Immunoconjugates|immunoconjugates|mesh-ancestor
154531207|NCT02485119|Immunologic Factors|immunologic factors|mesh-ancestor
154531208|NCT02485119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531209|NCT02484573|Propranolol|propranolol|mesh-list
154531210|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154531211|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154531212|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
154531213|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531214|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531215|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531216|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154531217|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154531218|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
154531220|NCT02489955|Amikacin|amikacin|mesh-list
154531221|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154531222|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531223|NCT03734744|Vitamin D|vitamin d|mesh-list
154531224|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
154531225|NCT03734744|Vitamins|vitamins|mesh-ancestor
154531226|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
154531227|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531228|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154531229|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154531230|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154531231|NCT03576716|Calcifediol|calcifediol|mesh-list
154531232|NCT03576716|Vitamins|vitamins|mesh-ancestor
154531233|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
154531234|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531235|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154531236|NCT02487381|Dronabinol|dronabinol|mesh-list
154531237|NCT02487381|Cannabidiol|cannabidiol|mesh-list
154531238|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
154531239|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
154531240|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531241|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154531242|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154531243|NCT02487381|Analgesics|analgesics|mesh-ancestor
154531244|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
154531245|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531246|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154531247|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154531248|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531249|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531250|NCT02487381|Hormones|hormones|mesh-ancestor
154531251|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531252|NCT02487849|Carboplatin|carboplatin|mesh-list
154531253|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531254|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154531255|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531257|NCT04021550|Telmisartan|telmisartan|mesh-list
154531258|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154531259|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154531260|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154531261|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531262|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
154531263|NCT04021550|Protective Agents|protective agents|mesh-ancestor
154531264|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531265|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
154531266|NCT04021550|Vitamins|vitamins|mesh-ancestor
154531267|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
154531268|NCT02489487|Ritonavir|ritonavir|mesh-list
154531269|NCT02489487|Darunavir|darunavir|mesh-list
154531270|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
154531271|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154531272|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154531273|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
154531274|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531275|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531276|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154531277|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154531278|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
154531279|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531280|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154531281|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154531282|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154531283|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154531284|NCT02096354|Irinotecan|irinotecan|mesh-list
154531285|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531286|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154860493|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531287|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154531288|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531289|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531290|NCT03177746|Tadalafil|tadalafil|mesh-list
154531291|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
154531292|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154531293|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154531294|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531295|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531296|NCT03177746|Urological Agents|urological agents|mesh-ancestor
154531297|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154531298|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154531299|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154531300|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
154531301|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531302|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154531303|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154531304|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531305|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154531306|NCT02483715|Amoxicillin|amoxicillin|mesh-list
154531307|NCT02483715|Metronidazole|metronidazole|mesh-list
154531308|NCT02483715|Tetracycline|tetracycline|mesh-list
154531309|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154531310|NCT02483715|Rabeprazole|rabeprazole|mesh-list
154531311|NCT02483715|Bismuth|bismuth|mesh-list
154531312|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154531313|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531314|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
154531315|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154531316|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154531317|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154531318|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154531319|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531320|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531321|NCT02483715|Antacids|antacids|mesh-ancestor
154531322|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154531323|NCT02483793|Tamsulosin|tamsulosin|mesh-list
154531324|NCT02483793|Oxybutynin|oxybutynin|mesh-list
154531325|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154531326|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154531327|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154531328|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
154531329|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531330|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300407|NCT03764631|Empagliflozin|empagliflozin|mesh-list
154531331|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531332|NCT02483793|Urological Agents|urological agents|mesh-ancestor
154531333|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
154531334|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
154531335|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531336|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154531337|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154531338|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
154531339|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
154531340|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154531341|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
154531342|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531343|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
154531344|NCT03200288|Protective Agents|protective agents|mesh-ancestor
154531345|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
154531346|NCT03318471|Analgesics|analgesics|mesh-ancestor
154531347|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
154531348|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531349|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531350|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
154531351|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531352|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154531353|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
154531354|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154531355|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154531356|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531357|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154531358|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
154531359|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154531360|NCT02489409|Gemcitabine|gemcitabine|mesh-list
154531361|NCT02489409|Vinorelbine|vinorelbine|mesh-list
154531362|NCT02489409|Endostatins|endostatins|mesh-list
154531363|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154531364|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
154531365|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531366|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531367|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154531368|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
154531369|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
154531370|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
154531371|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154531372|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154531373|NCT02489409|Growth Substances|growth substances|mesh-ancestor
154531374|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531375|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
154531376|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
154531377|NCT03930602|Deucravacitinib|deucravacitinib|mesh-list
154531378|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154531379|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154531380|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531381|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531382|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154531383|NCT03930602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154531384|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154531385|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154531386|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531387|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531388|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
154531389|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154531390|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
154531391|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154531392|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154531393|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531394|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154531395|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
154531396|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154531397|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154531398|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154531399|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154531400|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
154531401|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531402|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154531403|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154531404|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531405|NCT02489019|Fentanyl|fentanyl|mesh-list
154531406|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154531407|NCT02489019|Narcotics|narcotics|mesh-ancestor
154531408|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531409|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531410|NCT02489019|Analgesics|analgesics|mesh-ancestor
154531411|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
154531412|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531413|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154531414|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154531415|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
154531416|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
154531417|NCT02604446|Oxycodone|oxycodone|mesh-list
154531418|NCT02604446|Tapentadol|tapentadol|mesh-list
154531419|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154531420|NCT02604446|Narcotics|narcotics|mesh-ancestor
154531421|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531422|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531423|NCT02604446|Analgesics|analgesics|mesh-ancestor
154531424|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
154531425|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531426|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154531427|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154531428|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154531429|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531430|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
154531431|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860494|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
154531432|NCT02847637|Factor VIII|factor viii|mesh-list
154531433|NCT02847637|Coagulants|coagulants|mesh-ancestor
154531435|NCT00584246|Analgesics|analgesics|mesh-ancestor
154531436|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
154531437|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531438|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531439|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
154531440|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154531441|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154531442|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531443|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154531444|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154531445|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154531446|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531447|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154531448|NCT05124314|Misoprostol|misoprostol|mesh-list
154531449|NCT05124314|Mifepristone|mifepristone|mesh-list
154531450|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154531451|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
154531452|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154531453|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531454|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154531455|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154531456|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
154531457|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154531458|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154531459|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154531460|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154531461|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
154531462|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154531463|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154531464|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
154531465|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531466|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
154531467|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154531468|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154531469|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
154531470|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
154531471|NCT03320967|Coagulants|coagulants|mesh-ancestor
154531472|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154531473|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154531474|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
154531475|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531476|NCT02483325|Fludarabine|fludarabine|mesh-list
154531478|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
154531479|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531480|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531481|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154531482|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
154531483|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531484|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
154531485|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154531486|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154531487|NCT04211090|Carboplatin|carboplatin|mesh-list
154531488|NCT04211090|Pemetrexed|pemetrexed|mesh-list
154531489|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531490|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531491|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531492|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154531493|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154531494|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
154531495|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154531496|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
154531497|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154531498|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
154531499|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531500|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531501|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
154531502|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
154531503|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154531504|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531505|NCT04538534|Nicardipine|nicardipine|mesh-list
154531506|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154531507|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154531508|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154531509|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531510|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154531511|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531512|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
154531513|NCT03318159|Posaconazole|posaconazole|mesh-list
154531514|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
154531515|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531516|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154531517|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154531518|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154531519|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154531520|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154531521|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531522|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531523|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154531524|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
154531525|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531526|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531527|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
154531528|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
154531529|NCT02724410|Amoxicillin|amoxicillin|mesh-list
154531530|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
154531531|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
154531532|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154531533|NCT02724410|Ertapenem|ertapenem|mesh-list
154531534|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154531535|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531536|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154531537|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531538|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531539|NCT02486601|Paclitaxel|paclitaxel|mesh-list
154531540|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154531541|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531542|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
154531543|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
154531544|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
154531545|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531546|NCT02487069|Cyclosporine|cyclosporine|mesh-list
154531547|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
154531548|NCT02487069|Methotrexate|methotrexate|mesh-list
154531549|NCT02487069|Cyclosporins|cyclosporins|mesh-list
154531550|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154531551|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154531552|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
154531553|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154531554|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531555|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154531556|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
154531557|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531558|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531559|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154531560|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531561|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154531562|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154531563|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
154531564|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154531565|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154531566|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
154531567|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531568|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154531569|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154531570|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154531571|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
154531572|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154531573|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
154531574|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300635|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531575|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531576|NCT03317847|Dexamethasone|dexamethasone|mesh-list
154531578|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154531579|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531580|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
154531581|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
154531582|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531583|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531584|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154531585|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
154531586|NCT03317847|Hormones|hormones|mesh-ancestor
154531587|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531588|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154531589|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531590|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154531591|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154531592|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154531593|NCT03317847|Analgesics|analgesics|mesh-ancestor
154531594|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
154531595|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154531596|NCT01342081|Timolol|timolol|mesh-list
154531597|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154531598|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154531599|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154531600|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154531601|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154531602|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531603|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531604|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531605|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154531606|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154531607|NCT03563833|Anesthetics|anesthetics|mesh-list
154531608|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531609|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531610|NCT02483169|Aspirin|aspirin|mesh-list
154531611|NCT02483169|Cilostazol|cilostazol|mesh-list
154531612|NCT02483169|Probucol|probucol|mesh-list
154531613|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154531614|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154531615|NCT02483169|Analgesics|analgesics|mesh-ancestor
154531616|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
154531617|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531618|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531619|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531620|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154531621|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154531622|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154531623|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531624|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154531625|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154531626|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531627|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
154531628|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154531629|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
154531630|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154531631|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
154531632|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
154531633|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154531634|NCT02483169|Protective Agents|protective agents|mesh-ancestor
154531635|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154531636|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154531637|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154531638|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154531639|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
154531640|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154531641|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
154531642|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
154531643|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154531644|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
154531645|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
154531646|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531647|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531648|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154531649|NCT02489097|Analgesics|analgesics|mesh-ancestor
154531650|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
154531651|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531652|NCT02203682|Doxycycline|doxycycline|mesh-list
154531653|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154531654|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531655|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
154531656|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154531657|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154531658|NCT02256800|Leucovorin|leucovorin|mesh-list
154531659|NCT02256800|Bevacizumab|bevacizumab|mesh-list
154531660|NCT02256800|Irinotecan|irinotecan|mesh-list
154531661|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154531662|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531663|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154531664|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154531665|NCT02256800|Growth Substances|growth substances|mesh-ancestor
154531666|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531667|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
154531668|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154531669|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154531670|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531671|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531672|NCT02256800|Antidotes|antidotes|mesh-ancestor
154531673|NCT02256800|Protective Agents|protective agents|mesh-ancestor
154531674|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
154531676|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
154531677|NCT01341457|Gemcitabine|gemcitabine|mesh-list
154531678|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154531679|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
154531680|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531681|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531682|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
154531683|NCT02488473|Ropivacaine|ropivacaine|mesh-list
154531684|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154531685|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531686|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531687|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154531688|NCT02488473|Analgesics|analgesics|mesh-ancestor
154531689|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
154531690|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531691|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154531692|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154531693|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154531694|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
154531695|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531696|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531697|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
154531698|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
154531699|NCT05128292|Selenium|selenium|mesh-list
154531700|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
154531701|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531702|NCT05128292|Protective Agents|protective agents|mesh-ancestor
154531703|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531704|NCT05128292|Trace Elements|trace elements|mesh-ancestor
154531705|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
154531706|NCT03971708|Lidocaine|lidocaine|mesh-list
154531707|NCT03971708|Ropivacaine|ropivacaine|mesh-list
154531708|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
154531709|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
154531710|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531711|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531712|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
154531713|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531714|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154531715|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154531716|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154531717|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300782|NCT03640468|Analgesics|analgesics|mesh-ancestor
154531718|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531719|NCT02832037|BI 425809|bi 425809|mesh-list
154531720|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
154531721|NCT02482857|Aspirin|aspirin|mesh-list
154531722|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154531723|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154531724|NCT02482857|Analgesics|analgesics|mesh-ancestor
154531725|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
154531726|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531727|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531728|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531729|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154531730|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154531731|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154531732|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531733|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154531734|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154531735|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531736|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
154531737|NCT02480049|Montelukast|montelukast|mesh-list
154531738|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154531739|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
154531740|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154531741|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
154531742|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531743|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531744|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154531745|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154531746|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531747|NCT02479971|Clindamycin|clindamycin|mesh-list
154531748|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
154531749|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
154531750|NCT02479971|Gentamicins|gentamicins|mesh-list
154531751|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154531752|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531753|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154531754|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531755|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531756|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
154531757|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
154531758|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531759|NCT02486055|Vitamins|vitamins|mesh-ancestor
154531760|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
154531761|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
154531762|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
154531763|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531764|NCT02485821|Misoprostol|misoprostol|mesh-list
154531765|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154531766|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154531767|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154531768|NCT02485821|Estradiol|estradiol|mesh-list
154531769|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154531770|NCT02485821|Estrogens|estrogens|mesh-ancestor
154531771|NCT02485821|Hormones|hormones|mesh-ancestor
154531772|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531773|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531774|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154531775|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
154531776|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154531777|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154531778|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154531779|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
154531780|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154531781|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154531782|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
154531783|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154531784|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154531785|NCT02479815|Micronutrients|micronutrients|mesh-list
154531786|NCT02479815|Trace Elements|trace elements|mesh-list
154531787|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531788|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154531789|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
154531790|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154531791|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531792|NCT04119830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154531793|NCT04119830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531794|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
154531795|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531796|NCT04049786|Metoprolol|metoprolol|mesh-list
154531797|NCT04049786|Carvedilol|carvedilol|mesh-list
154531798|NCT04049786|Midazolam|midazolam|mesh-list
154531799|NCT04049786|Simvastatin|simvastatin|mesh-list
154531800|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154531801|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154531802|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531803|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531804|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154531805|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154531806|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154531807|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154300866|NCT04484025|Ebselen|ebselen|mesh-list
154531808|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
154531809|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
154531810|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
154531811|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
154531812|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531813|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531814|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154531815|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154531816|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
154531817|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154531818|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154531819|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531820|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154531821|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154531822|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
154531823|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
154531824|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531825|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154531826|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154531827|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154531828|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
154531829|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
154531830|NCT04049786|Protective Agents|protective agents|mesh-ancestor
154531831|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154531832|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154531833|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154531834|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
154531835|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154531836|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154531837|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
154531838|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
154531839|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531840|NCT03316599|Paclitaxel|paclitaxel|mesh-list
154531841|NCT03316599|Gemcitabine|gemcitabine|mesh-list
154531842|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154531843|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531844|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
154531845|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
154531846|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
154531847|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531848|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154531849|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
154531850|NCT02482155|Ibuprofen|ibuprofen|mesh-list
154531851|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154531852|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154531854|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
154531855|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531856|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531857|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531858|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154531859|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154531860|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531861|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531862|NCT01675154|Orlistat|orlistat|mesh-list
154531863|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531864|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531865|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154531866|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154531867|NCT02485431|Deflazacort|deflazacort|mesh-list
154531868|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531869|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154531870|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
154531871|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531872|NCT02744755|Adalimumab|adalimumab|mesh-list
154531873|NCT02744755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154531874|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531875|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154531876|NCT03314493|Spironolactone|spironolactone|mesh-list
154531877|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154531878|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
154531879|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531880|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531881|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154531882|NCT03314493|Diuretics|diuretics|mesh-ancestor
154531883|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
154531884|NCT03912350|Balovaptan|balovaptan|mesh-list
154531885|NCT03912350|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154531886|NCT03912350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531887|NCT03912350|Natriuretic Agents|natriuretic agents|mesh-ancestor
154531888|NCT03912350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531890|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531891|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154531892|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531893|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531894|NCT02485041|Mirodenafil|mirodenafil|mesh-list
154531895|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154531896|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154531897|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531898|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531899|NCT02484963|Zolpidem|zolpidem|mesh-list
154531900|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154531901|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154531902|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531903|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531904|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154531905|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
154531906|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
154531907|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531908|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531909|NCT05713773|Caffeine|caffeine|mesh-list
154531910|NCT05713773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154531911|NCT05713773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531912|NCT05713773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154531913|NCT05713773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531914|NCT05713773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531915|NCT05713773|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154531916|NCT05713773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154531917|NCT05713773|Purinergic Agents|purinergic agents|mesh-ancestor
154531918|NCT05713773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531919|NCT02829775|Interferons|interferons|mesh-list
154531920|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
154531921|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
154531922|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154531923|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531924|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
154531925|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531926|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
154531927|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531928|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154531929|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154531930|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
154531931|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531932|NCT02476773|Antacids|antacids|mesh-ancestor
154531933|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531934|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154531935|NCT04500860|Tadalafil|tadalafil|mesh-list
154531936|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154531937|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
154531938|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154531939|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154531940|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154531941|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531942|NCT04500860|Urological Agents|urological agents|mesh-ancestor
154531943|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154531944|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154531945|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
154531946|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531947|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531948|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154531949|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531950|NCT02479581|Floxacillin|floxacillin|mesh-list
154531951|NCT02479581|Dexamethasone|dexamethasone|mesh-list
154531952|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
154301009|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
154531953|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154531954|NCT02479581|Scopolamine|scopolamine|mesh-list
154531955|NCT02479581|Morphine|morphine|mesh-list
154531956|NCT02479581|Anesthetics|anesthetics|mesh-list
154531957|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154531958|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
154860495|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154531959|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
154531960|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154531961|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154531962|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154531963|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
154531964|NCT02479581|Hormones|hormones|mesh-ancestor
154531965|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154531966|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154531967|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154531968|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531969|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154531970|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154531971|NCT02479581|Narcotics|narcotics|mesh-ancestor
154531972|NCT02479581|Analgesics|analgesics|mesh-ancestor
154531973|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
154531974|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154531975|NCT02479581|Protective Agents|protective agents|mesh-ancestor
154531976|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154531977|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
154531978|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154531979|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
154531980|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154531981|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154531982|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154531983|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531984|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
154531985|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
154531986|NCT02479347|Povidone|povidone|mesh-list
154531987|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154531988|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154531989|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
154531990|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
154531991|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
154531992|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
154531993|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154531994|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
154531995|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154531996|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
154301057|NCT01144065|Hormones|hormones|mesh-ancestor
154531997|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255804|NCT01259336|Itraconazole|itraconazole|mesh-list
154531998|NCT02481609|Expectorants|expectorants|mesh-ancestor
154531999|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
154532000|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154532001|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
154532002|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532003|NCT02481609|Protective Agents|protective agents|mesh-ancestor
154532004|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532006|NCT05373225|Acetic Acid|acetic acid|mesh-list
154532007|NCT05373225|Retinol acetate|retinol acetate|mesh-list
154532008|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154532009|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532010|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154532011|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
154532012|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532013|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154532014|NCT05373225|Protective Agents|protective agents|mesh-ancestor
154532015|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532016|NCT01355575|Rifaximin|rifaximin|mesh-list
154532017|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154532018|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532019|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532020|NCT05125640|Progesterone|progesterone|mesh-list
154532021|NCT05125640|Progestins|progestins|mesh-ancestor
154532022|NCT05125640|Hormones|hormones|mesh-ancestor
154532023|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532024|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532025|NCT03314259|Tamsulosin|tamsulosin|mesh-list
154532026|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154532027|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154532028|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154532029|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
154532030|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532031|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532032|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532033|NCT03314259|Urological Agents|urological agents|mesh-ancestor
154532034|NCT02481453|Sirolimus|sirolimus|mesh-list
154532035|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154860496|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154532036|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532037|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154532038|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532039|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
154532040|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154532041|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
154532042|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532043|NCT02825251|Insulin|insulin|mesh-list
154532044|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154532045|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
154532046|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
154532047|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154532048|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154532049|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532050|NCT03563365|Adapalene|adapalene|mesh-list
154532051|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154532052|NCT03563365|Resveratrol|resveratrol|mesh-list
154532053|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
154532054|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532055|NCT03563365|Protective Agents|protective agents|mesh-ancestor
154532056|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532057|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532058|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154532059|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
154532060|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154532061|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154532062|NCT03563365|Analgesics|analgesics|mesh-ancestor
154532063|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
154532064|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532065|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532066|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154532067|NCT02475915|Tenofovir|tenofovir|mesh-list
154532068|NCT02475915|Emtricitabine|emtricitabine|mesh-list
154532069|NCT02475915|Efavirenz|efavirenz|mesh-list
154532070|NCT02475915|Maraviroc|maraviroc|mesh-list
154532071|NCT02475915|Darunavir|darunavir|mesh-list
154532072|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
154532073|NCT02475915|Vorinostat|vorinostat|mesh-list
154532074|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
154532075|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532076|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154532077|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154532078|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532079|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532080|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154532081|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154532082|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
154532083|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154532084|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154532085|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154301146|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
154532086|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154532087|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154532088|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154532089|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154532090|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154532091|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154532092|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532093|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154532094|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154532095|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154532096|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154532097|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154532098|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154532099|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
154532100|NCT03833323|Treprostinil|treprostinil|mesh-list
154532101|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154532102|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
154532103|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154532104|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
154532105|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154532106|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154532107|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532108|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154860497|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
154532109|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532110|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154532111|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532113|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532114|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532115|NCT02478879|Teriparatide|teriparatide|mesh-list
154532116|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
154532117|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532118|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154532119|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154532120|NCT02478645|Ramosetron|ramosetron|mesh-list
154532121|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
154532122|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
154532123|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532124|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532125|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532126|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154532127|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
154532128|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532129|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532130|NCT05871957|Vitamin D|vitamin d|mesh-list
154532131|NCT05871957|Ergocalciferols|ergocalciferols|mesh-list
154532132|NCT05871957|Cholecalciferol|cholecalciferol|mesh-list
154532133|NCT05871957|Vitamins|vitamins|mesh-list
154532134|NCT05871957|Micronutrients|micronutrients|mesh-ancestor
154532135|NCT05871957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532136|NCT05871957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154532137|NCT05871957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154532138|NCT05871073|Dexamethasone|dexamethasone|mesh-list
154532139|NCT05871073|Ropivacaine|ropivacaine|mesh-list
154301186|NCT02860546|Nivolumab|nivolumab|mesh-list
154532140|NCT05871073|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154532141|NCT05871073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532142|NCT05871073|Antiemetics|antiemetics|mesh-ancestor
154532143|NCT05871073|Autonomic Agents|autonomic agents|mesh-ancestor
154532144|NCT05871073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532145|NCT05871073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532146|NCT05871073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532147|NCT05871073|Glucocorticoids|glucocorticoids|mesh-ancestor
154532148|NCT05871073|Hormones|hormones|mesh-ancestor
154532149|NCT05871073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532150|NCT05871073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532151|NCT05871073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255944|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532152|NCT05871073|Anesthetics, Local|anesthetics, local|mesh-ancestor
154532153|NCT05871073|Anesthetics|anesthetics|mesh-ancestor
154532154|NCT05871073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532155|NCT05871073|Sensory System Agents|sensory system agents|mesh-ancestor
154532156|NCT05871021|Bevacizumab|bevacizumab|mesh-list
154532157|NCT05871021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154532158|NCT05871021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532159|NCT05871021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154532160|NCT05871021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154532161|NCT05871021|Growth Substances|growth substances|mesh-ancestor
154532162|NCT05871021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532163|NCT05871021|Growth Inhibitors|growth inhibitors|mesh-ancestor
154532164|NCT05870969|Liver Extracts|liver extracts|mesh-list
154532165|NCT05870969|Hematinics|hematinics|mesh-ancestor
154532166|NCT05870501|Midazolam|midazolam|mesh-list
154532167|NCT05870501|Ketamine|ketamine|mesh-list
154532168|NCT05870501|Analgesics|analgesics|mesh-ancestor
154532169|NCT05870501|Sensory System Agents|sensory system agents|mesh-ancestor
154532170|NCT05870501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532171|NCT05870501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532172|NCT05870501|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154532173|NCT05870501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154532174|NCT05870501|Anesthetics, General|anesthetics, general|mesh-ancestor
154532175|NCT05870501|Anesthetics|anesthetics|mesh-ancestor
154532176|NCT05870501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532177|NCT05870501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154532178|NCT05870501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154532179|NCT05870501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532180|NCT05870501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532181|NCT05870501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154532182|NCT05870501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154532183|NCT05870501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154532184|NCT05870501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154532186|NCT05870501|GABA Modulators|gaba modulators|mesh-ancestor
154532187|NCT05870501|GABA Agents|gaba agents|mesh-ancestor
154301244|NCT01329783|Maraviroc|maraviroc|mesh-list
154532188|NCT05870475|Interferons|interferons|mesh-list
154532189|NCT05870475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532190|NCT05870475|Antiviral Agents|antiviral agents|mesh-ancestor
154532191|NCT05870475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532192|NCT05870436|Choline|choline|mesh-list
154532193|NCT05870436|Methacholine Chloride|methacholine chloride|mesh-list
154532194|NCT05870436|Lipotropic Agents|lipotropic agents|mesh-ancestor
154532195|NCT05870436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154532196|NCT05870436|Antimetabolites|antimetabolites|mesh-ancestor
154532197|NCT05870436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532198|NCT05870436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532199|NCT05870436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154532200|NCT05870436|Nootropic Agents|nootropic agents|mesh-ancestor
154532201|NCT05870436|Miotics|miotics|mesh-ancestor
154532202|NCT05870436|Autonomic Agents|autonomic agents|mesh-ancestor
154532203|NCT05870436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532204|NCT05870436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532205|NCT05870436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154532206|NCT05870436|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154532207|NCT05870436|Respiratory System Agents|respiratory system agents|mesh-ancestor
154532208|NCT05870436|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154532209|NCT05870436|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154532210|NCT05870436|Cholinergic Agents|cholinergic agents|mesh-ancestor
154532211|NCT05870436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532212|NCT05870423|Olaparib|olaparib|mesh-list
154532213|NCT05870423|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154532214|NCT05870423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532215|NCT05870423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532216|NCT05870423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532217|NCT05870358|Melatonin|melatonin|mesh-list
154532218|NCT05870358|Antioxidants|antioxidants|mesh-ancestor
154532219|NCT05870358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532220|NCT05870358|Protective Agents|protective agents|mesh-ancestor
154532221|NCT05870358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532222|NCT05870358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532223|NCT05870059|Chlorhexidine|chlorhexidine|mesh-list
154532224|NCT05870059|Propolis|propolis|mesh-list
154256019|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154532225|NCT05870059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154532226|NCT05870059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532227|NCT05870059|Disinfectants|disinfectants|mesh-ancestor
154532228|NCT05870007|Atorvastatin|atorvastatin|mesh-list
154532229|NCT05870007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154532230|NCT05870007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154532231|NCT05870007|Antimetabolites|antimetabolites|mesh-ancestor
154532232|NCT05870007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532233|NCT05870007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154532234|NCT05870007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154532235|NCT05870007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532236|NCT05866653|Lidocaine|lidocaine|mesh-list
154532237|NCT05866653|Anesthetics, Local|anesthetics, local|mesh-ancestor
154532238|NCT05866653|Anesthetics|anesthetics|mesh-ancestor
154532239|NCT05866653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532240|NCT05866653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532241|NCT05866653|Sensory System Agents|sensory system agents|mesh-ancestor
154532242|NCT05866653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532243|NCT05866653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154532244|NCT05866653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154532245|NCT05866653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154532246|NCT05866653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154532247|NCT05866653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532248|NCT05790577|Niacinamide|niacinamide|mesh-list
154532249|NCT05790577|Niacin|niacin|mesh-list
154532250|NCT05790577|Nicotinic Acids|nicotinic acids|mesh-list
154532251|NCT05790577|Metformin|metformin|mesh-list
154532252|NCT05790577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154532253|NCT05790577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532254|NCT05790577|Vitamin B Complex|vitamin b complex|mesh-ancestor
154532255|NCT05790577|Vitamins|vitamins|mesh-ancestor
154532256|NCT05790577|Micronutrients|micronutrients|mesh-ancestor
154532257|NCT05790577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154532258|NCT05790577|Antimetabolites|antimetabolites|mesh-ancestor
154532259|NCT05790577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532261|NCT05790577|Vasodilator Agents|vasodilator agents|mesh-ancestor
154532262|NCT05778838|Midodrine|midodrine|mesh-list
154532263|NCT05778838|Sympathomimetics|sympathomimetics|mesh-ancestor
154532264|NCT05778838|Autonomic Agents|autonomic agents|mesh-ancestor
154532265|NCT05778838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532266|NCT05778838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532267|NCT05778838|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154532268|NCT05778838|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154532269|NCT05778838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154532270|NCT05778838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154532271|NCT05778838|Adrenergic Agents|adrenergic agents|mesh-ancestor
154532272|NCT05778838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532273|NCT05778838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532274|NCT05757544|Ganaxolone|ganaxolone|mesh-list
154532275|NCT05757544|Neurosteroids|neurosteroids|mesh-ancestor
154532276|NCT05757544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532277|NCT05757544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532278|NCT05757544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532279|NCT05757544|GABA Modulators|gaba modulators|mesh-ancestor
154532280|NCT05757544|GABA Agents|gaba agents|mesh-ancestor
154532281|NCT05688943|Anesthetics|anesthetics|mesh-list
154532282|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532283|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532284|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
154532285|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532286|NCT05631405|Dexamethasone|dexamethasone|mesh-list
154532287|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532288|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
154532289|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
154532290|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532291|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532292|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532293|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
154532294|NCT05631405|Hormones|hormones|mesh-ancestor
154532295|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532296|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532297|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532298|NCT05621655|Vaccines|vaccines|mesh-list
154532299|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
154532300|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532301|NCT05586724|Norethindrone|norethindrone|mesh-list
154532302|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
154532303|NCT05586724|Progesterone|progesterone|mesh-list
154532304|NCT05586724|Estrogens|estrogens|mesh-list
154532305|NCT05586724|Progestins|progestins|mesh-ancestor
154532306|NCT05586724|Hormones|hormones|mesh-ancestor
154532307|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532308|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532309|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154532310|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154532311|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154532312|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
154532313|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154532314|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154532315|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154532316|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
154532317|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154532318|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
154532319|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532320|NCT05485558|Expectorants|expectorants|mesh-ancestor
154532321|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
154532322|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154532323|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
154532324|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532325|NCT05485558|Protective Agents|protective agents|mesh-ancestor
154532326|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532327|NCT05485558|Antidotes|antidotes|mesh-ancestor
154532328|NCT05383196|Paclitaxel|paclitaxel|mesh-list
154532329|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154532330|NCT05383196|Onvansertib|onvansertib|mesh-list
154532331|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154532332|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532333|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
154532334|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
154532335|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
154532336|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532337|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154532338|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532339|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
154532340|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154532341|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
154532342|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154532343|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532344|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154532345|NCT05179733|Rituximab|rituximab|mesh-list
154532346|NCT05179733|Lenalidomide|lenalidomide|mesh-list
154532347|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
154532348|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154532349|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532350|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
154532351|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532352|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154532353|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154532354|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154532355|NCT05179733|Growth Substances|growth substances|mesh-ancestor
154532356|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
154532357|NCT05179733|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154532358|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154532359|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532360|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532361|NCT05083247|Paclitaxel|paclitaxel|mesh-list
154532362|NCT05083247|Gemcitabine|gemcitabine|mesh-list
154532363|NCT05083247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154532364|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532365|NCT05083247|Tubulin Modulators|tubulin modulators|mesh-ancestor
154532366|NCT05083247|Antimitotic Agents|antimitotic agents|mesh-ancestor
154532367|NCT05083247|Mitosis Modulators|mitosis modulators|mesh-ancestor
154532368|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532369|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154532370|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
154532371|NCT05076110|Acetaminophen|acetaminophen|mesh-list
154532372|NCT05076110|Ibuprofen|ibuprofen|mesh-list
154532373|NCT05076110|Oxycodone|oxycodone|mesh-list
154532374|NCT05076110|Gabapentin|gabapentin|mesh-list
154532375|NCT05076110|Methocarbamol|methocarbamol|mesh-list
154532376|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154256168|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
154532377|NCT05076110|Analgesics|analgesics|mesh-ancestor
154532378|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
154532379|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532380|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532381|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
154532382|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154532383|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532384|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154532385|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154532386|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532387|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532388|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154532389|NCT05076110|Narcotics|narcotics|mesh-ancestor
154532390|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532391|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
154532392|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154532393|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154532394|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154532395|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154532396|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154532397|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532398|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
154532399|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154532400|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154532401|NCT05063838|Anesthetics|anesthetics|mesh-list
154532402|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532403|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532404|NCT05174650|Atezolizumab|atezolizumab|mesh-list
154532405|NCT05174650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154532406|NCT05174650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532407|NCT05174650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154532408|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532409|NCT04986579|Trastuzumab|trastuzumab|mesh-list
154532410|NCT04986579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154532411|NCT04986579|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154532412|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154532413|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532414|NCT04986579|Immunoconjugates|immunoconjugates|mesh-ancestor
154532415|NCT04986579|Immunologic Factors|immunologic factors|mesh-ancestor
154532416|NCT04986579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532417|NCT04939441|Tenofovir|tenofovir|mesh-list
154532418|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
154532419|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532420|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154532421|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154532422|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532423|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532424|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154532425|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154532426|NCT04937738|Leucovorin|leucovorin|mesh-list
154532427|NCT04937738|Docetaxel|docetaxel|mesh-list
154532428|NCT04937738|Capecitabine|capecitabine|mesh-list
154532429|NCT04937738|Fluorouracil|fluorouracil|mesh-list
154532430|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
154532431|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532432|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154532433|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154532434|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154532435|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532436|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154532437|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
154532438|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154532439|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
154532440|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532441|NCT04937738|Antidotes|antidotes|mesh-ancestor
154532442|NCT04937738|Protective Agents|protective agents|mesh-ancestor
154532443|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
154532444|NCT04937738|Vitamins|vitamins|mesh-ancestor
154532445|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
154532446|NCT04860505|Doxycycline|doxycycline|mesh-list
154532447|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154532448|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532449|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
154532450|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154532451|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154532452|NCT04724018|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154532453|NCT04724018|Immunoconjugates|immunoconjugates|mesh-ancestor
154532454|NCT04724018|Immunologic Factors|immunologic factors|mesh-ancestor
154532455|NCT04724018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532456|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154532457|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
154532458|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532459|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
154532460|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532461|NCT04653831|Pirfenidone|pirfenidone|mesh-list
154532462|NCT04653831|Analgesics|analgesics|mesh-ancestor
154532463|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
154532464|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532465|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532466|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154532467|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154532468|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532469|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154532470|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532471|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154532472|NCT04512638|Amoxicillin|amoxicillin|mesh-list
154532473|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
154532474|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154532475|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532476|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154532477|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
154532478|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
154532479|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
154532480|NCT04510428|Antibodies|antibodies|mesh-list
154532481|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
154532482|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154532483|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154532484|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
154532485|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532486|NCT04437303|Anticoagulants|anticoagulants|mesh-list
154532487|NCT04411693|Dexamethasone|dexamethasone|mesh-list
154532488|NCT04411693|Aflibercept|aflibercept|mesh-list
154532489|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532490|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
154532492|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532493|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532494|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532495|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
154532496|NCT04411693|Hormones|hormones|mesh-ancestor
154532497|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532498|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532499|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532500|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154532501|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154532502|NCT04411693|Growth Substances|growth substances|mesh-ancestor
154532503|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
154532504|NCT04380740|Abatacept|abatacept|mesh-list
154532505|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154532506|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532507|NCT04380740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154532508|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532509|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154532510|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
154532511|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532512|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154532513|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
154532514|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154532515|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154532516|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532517|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
154532518|NCT04274335|Coagulants|coagulants|mesh-ancestor
154532519|NCT04238767|Dolutegravir|dolutegravir|mesh-list
154532520|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154532521|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154532522|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532523|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532524|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154532525|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154532526|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
154532527|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532528|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154532529|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
154532530|NCT04177355|MEDI9197|medi9197|mesh-list
154532531|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154532532|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
154532533|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532535|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532536|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532537|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
154532538|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154532539|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154532540|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
154532541|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532542|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532543|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532544|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
154532545|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
154532546|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532547|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
154532548|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154532549|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
154532550|NCT04063865|Everolimus|everolimus|mesh-list
154532551|NCT04063865|Tacrolimus|tacrolimus|mesh-list
154532552|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154532553|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
154532554|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532555|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154532556|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532557|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532558|NCT04063865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154532559|NCT04063865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154532560|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532561|NCT03994211|Itraconazole|itraconazole|mesh-list
154532562|NCT03994211|Rifampin|rifampin|mesh-list
154532563|NCT03994211|Pamiparib|pamiparib|mesh-list
154532564|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
154532565|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532566|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154532567|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154532569|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532570|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154532571|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
154532572|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532573|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532574|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154532575|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154532576|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
154532577|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154532578|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
154532579|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154532580|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154532581|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154532582|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154532583|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154532584|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154532585|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154532586|NCT03994211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154532587|NCT03994211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532588|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
154532589|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154532590|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532591|NCT03910660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154532592|NCT03910660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532593|NCT03818607|Eculizumab|eculizumab|mesh-list
154532594|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154532595|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154532596|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
154532597|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532598|NCT03796156|Aspirin|aspirin|mesh-list
154532599|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154532600|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154532601|NCT03796156|Analgesics|analgesics|mesh-ancestor
154532602|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
154301644|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532603|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532604|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532605|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532606|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154532607|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154532608|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154532609|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532610|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154532611|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154532612|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532614|NCT03737292|Bupivacaine|bupivacaine|mesh-list
154532615|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
154532616|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
154532617|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532618|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532619|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
154532620|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532621|NCT03710460|Metformin|metformin|mesh-list
154532622|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
154532623|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154532624|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532625|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154532626|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532627|NCT03650894|Nivolumab|nivolumab|mesh-list
154532628|NCT03650894|Ipilimumab|ipilimumab|mesh-list
154532629|NCT03650894|Bicalutamide|bicalutamide|mesh-list
154532630|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154532631|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532632|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154532633|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532634|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
154532635|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
154532636|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367475|NCT03844217|Tryptophan|tryptophan|mesh-list
154532637|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532638|NCT03606694|Metformin|metformin|mesh-list
154532639|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154532640|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532641|NCT03544281|Dexamethasone|dexamethasone|mesh-list
154532642|NCT03544281|Lenalidomide|lenalidomide|mesh-list
154532643|NCT03544281|Bortezomib|bortezomib|mesh-list
154532644|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532645|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
154532646|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
154532647|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532648|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532649|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532650|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
154532651|NCT03544281|Hormones|hormones|mesh-ancestor
154532652|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532653|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532654|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532655|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
154532656|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154532657|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154532658|NCT03544281|Growth Substances|growth substances|mesh-ancestor
154532659|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
154532660|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154532661|NCT03387579|SMOFlipid|smoflipid|mesh-list
154532662|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154532663|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154532664|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154532665|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
154532666|NCT03339635|Testosterone|testosterone|mesh-list
154532667|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
154532668|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
154532669|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154532670|NCT03339635|Androgens|androgens|mesh-ancestor
154532671|NCT03339635|Hormones|hormones|mesh-ancestor
154532672|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532673|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532674|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532675|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532676|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
154532677|NCT03094884|Paclitaxel|paclitaxel|mesh-list
154532678|NCT03094884|Carboplatin|carboplatin|mesh-list
154532679|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154532680|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532681|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
154532682|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
154532683|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
154532684|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532686|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154532687|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532688|NCT02822144|Lidocaine|lidocaine|mesh-list
154532689|NCT02822144|Remifentanil|remifentanil|mesh-list
154532690|NCT02822144|Propofol|propofol|mesh-list
154532691|NCT02822144|Etomidate|etomidate|mesh-list
154532692|NCT02822144|Succinylcholine|succinylcholine|mesh-list
154532693|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
154532694|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
154532695|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532696|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532697|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
154532698|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532699|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154532700|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154532701|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154532702|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154532703|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532704|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154532705|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154532706|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
154532707|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154532708|NCT02822144|Narcotics|narcotics|mesh-ancestor
154532709|NCT02822144|Analgesics|analgesics|mesh-ancestor
154532710|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154532711|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154532712|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154532713|NCT02565680|Prednisone|prednisone|mesh-list
154532714|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532715|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
154532716|NCT02565680|Hormones|hormones|mesh-ancestor
154532717|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532718|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532719|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532720|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532721|NCT02422615|Fulvestrant|fulvestrant|mesh-list
154532722|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532723|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532724|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154532725|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154532726|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
154532727|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532728|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532729|NCT02382406|Paclitaxel|paclitaxel|mesh-list
154532730|NCT02382406|Carboplatin|carboplatin|mesh-list
154532731|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
154532732|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154532733|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532734|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
154532735|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
154532736|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
154532737|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532738|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154532739|NCT02382406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154532740|NCT02134327|Midazolam|midazolam|mesh-list
154532741|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
154532742|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154532743|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532744|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532745|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154532746|NCT02134327|Analgesics|analgesics|mesh-ancestor
154532747|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
154532748|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532749|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154532750|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154532751|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154532752|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
154532753|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532754|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532755|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154532756|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154532757|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154532758|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154532759|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154532760|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
154532761|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
154532762|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
154532763|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
154532764|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154532765|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154532766|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532767|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532768|NCT01880515|Tetracycline|tetracycline|mesh-list
154532769|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154532770|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532771|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154532772|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532773|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532774|NCT01780883|Melatonin|melatonin|mesh-list
154532775|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
154532776|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532777|NCT01780883|Protective Agents|protective agents|mesh-ancestor
154532778|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532779|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532780|NCT01668719|Dexamethasone|dexamethasone|mesh-list
154532781|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
154532782|NCT01668719|Lenalidomide|lenalidomide|mesh-list
154532783|NCT01668719|Bortezomib|bortezomib|mesh-list
154532784|NCT01668719|Elotuzumab|elotuzumab|mesh-list
154532785|NCT01668719|Ichthammol|ichthammol|mesh-list
154532786|NCT01668719|BB 1101|bb 1101|mesh-list
154532787|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154532788|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
154532789|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
154532791|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532792|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532793|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
154532794|NCT01668719|Hormones|hormones|mesh-ancestor
154532795|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532796|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532797|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532798|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
154532799|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154532800|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154532801|NCT01668719|Growth Substances|growth substances|mesh-ancestor
154532802|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
154532803|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
154532804|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532805|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532806|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154532807|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
154532808|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154532809|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532810|NCT01488045|Midazolam|midazolam|mesh-list
154532811|NCT01488045|Fentanyl|fentanyl|mesh-list
154532812|NCT01488045|Propofol|propofol|mesh-list
154532813|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154532814|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532815|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532816|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154532817|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
154532818|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
154532819|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154532820|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154532821|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154532822|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154532823|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
154532824|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
154532825|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532826|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532827|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154532828|NCT01488045|Narcotics|narcotics|mesh-ancestor
154532829|NCT01488045|Analgesics|analgesics|mesh-ancestor
154532830|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
154532831|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532832|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
154532833|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154532834|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532835|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
154532836|NCT00946712|Paclitaxel|paclitaxel|mesh-list
154532837|NCT00946712|Bevacizumab|bevacizumab|mesh-list
154532838|NCT00946712|Carboplatin|carboplatin|mesh-list
154532839|NCT00946712|Cetuximab|cetuximab|mesh-list
154532840|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154532841|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154532842|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
154532843|NCT00946712|Antibodies|antibodies|mesh-list
154532844|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
154532845|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154532846|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
154532847|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154532848|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532849|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
154532850|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
154532851|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
154532852|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532853|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154532854|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154532855|NCT00946712|Growth Substances|growth substances|mesh-ancestor
154532856|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532857|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
154532858|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
154532859|NCT00656669|Paclitaxel|paclitaxel|mesh-list
154532860|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
154532861|NCT00656669|Doxorubicin|doxorubicin|mesh-list
154532862|NCT00656669|Sunitinib|sunitinib|mesh-list
154532863|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154532864|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532865|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
154532866|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
154532867|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
154532868|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532869|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154532870|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
154532871|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532872|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154532873|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154532874|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
154532875|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154532876|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154532877|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154532878|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154532879|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532880|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154532881|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154532882|NCT00656669|Growth Substances|growth substances|mesh-ancestor
154532883|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
154532884|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154532886|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
154532887|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154532888|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154532889|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154532890|NCT01362296|Docetaxel|docetaxel|mesh-list
154532891|NCT01362296|Trametinib|trametinib|mesh-list
154532892|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532893|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
154532894|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
154532895|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
154532896|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532897|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154532898|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532899|NCT01338415|Bosentan|bosentan|mesh-list
154532900|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154532901|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154532902|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532903|NCT04353128|Melatonin|melatonin|mesh-list
154532904|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
154532905|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532906|NCT04353128|Protective Agents|protective agents|mesh-ancestor
154532907|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532908|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532909|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154532911|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154532912|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154532913|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
154532914|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532915|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532916|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154532917|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154532918|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
154532919|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154532920|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154532921|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154532922|NCT03562585|Antibodies|antibodies|mesh-list
154532923|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154532924|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
154532925|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532926|NCT05124938|Hormones|hormones|mesh-list
154532927|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532928|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532929|NCT02259985|Itasetron|itasetron|mesh-list
154532930|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
154532931|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
154532932|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532933|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532934|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532935|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154532936|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154532937|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
154532938|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532939|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532940|NCT01371643|Octreotide|octreotide|mesh-list
154532941|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532942|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154532943|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532944|NCT03023462|Droperidol|droperidol|mesh-list
154532945|NCT03023462|Oxycodone|oxycodone|mesh-list
154301993|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154301995|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154532946|NCT03023462|Ondansetron|ondansetron|mesh-list
154532947|NCT03023462|Ropivacaine|ropivacaine|mesh-list
154532948|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
154532949|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
154532950|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154532951|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532952|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
154532953|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154532954|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154532955|NCT03023462|Narcotics|narcotics|mesh-ancestor
154532956|NCT03023462|Analgesics|analgesics|mesh-ancestor
154532957|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
154532958|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
154532959|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154532960|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
154532961|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
154532962|NCT03023462|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154532963|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154532964|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
154532965|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154532966|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532967|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154532968|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154532969|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154532970|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154532971|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154532972|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154532973|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
154532974|NCT02824952|Osimertinib|osimertinib|mesh-list
154532975|NCT02824952|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154532976|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154532977|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532978|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532979|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154532980|NCT01371565|Mifepristone|mifepristone|mesh-list
154532981|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154532982|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
154532983|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154532984|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154532985|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154532986|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154532987|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154532988|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
154532989|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154532990|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154532991|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
154532992|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532993|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
154532994|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154532995|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154532996|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154532997|NCT02821819|Hormones|hormones|mesh-ancestor
154532998|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154532999|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533000|NCT04500548|Nivolumab|nivolumab|mesh-list
154533001|NCT04500548|Ipilimumab|ipilimumab|mesh-list
154533002|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533003|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533004|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154533005|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533006|NCT05707819|Antibodies|antibodies|mesh-list
154533007|NCT05707819|Immunologic Factors|immunologic factors|mesh-ancestor
154533008|NCT05707819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533009|NCT03034538|Zonisamide|zonisamide|mesh-list
154533010|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
154533011|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154533012|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154533013|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533014|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154533015|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533017|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154533018|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154533019|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
154533020|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154533021|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154533022|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533023|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154533024|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154533025|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
154533026|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533027|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
154533028|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533029|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533030|NCT05053880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154533031|NCT05053880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533032|NCT00094016|Beclomethasone|beclomethasone|mesh-list
154533033|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533034|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
154533035|NCT00094016|Hormones|hormones|mesh-ancestor
154533036|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533037|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533038|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154533039|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
154533040|NCT05134298|Meropenem|meropenem|mesh-list
154533041|NCT05134298|Tazobactam|tazobactam|mesh-list
154533042|NCT05134298|Piperacillin|piperacillin|mesh-list
154533043|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154533044|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154533045|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533046|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154533047|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533048|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533049|NCT05134220|Calcium|calcium|mesh-list
154533050|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154533051|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533052|NCT03954379|Dexamethasone|dexamethasone|mesh-list
154533053|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
154533054|NCT03954379|Analgesics|analgesics|mesh-list
154533055|NCT03954379|Anesthetics|anesthetics|mesh-list
154533056|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
154533057|NCT03954379|BB 1101|bb 1101|mesh-list
154533058|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533060|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
154533061|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533062|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533063|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154533064|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
154533065|NCT03954379|Hormones|hormones|mesh-ancestor
154533066|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533067|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154533068|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533069|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
154533070|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533071|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533072|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533073|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
154533074|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
154533075|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154533076|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154533077|NCT02036125|Prednisolone|prednisolone|mesh-list
154533078|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
154533079|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154533080|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
154533081|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533082|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
154533083|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
154533084|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533085|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533086|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154533087|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
154533088|NCT02036125|Hormones|hormones|mesh-ancestor
154533089|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533090|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154533091|NCT02036125|Protective Agents|protective agents|mesh-ancestor
154533092|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154533093|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533094|NCT05133752|Nemonoxacin|nemonoxacin|mesh-list
154533095|NCT05133752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154533096|NCT05133752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533097|NCT02818777|Cannabidiol|cannabidiol|mesh-list
154533098|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
154533099|NCT05128916|Terbinafine|terbinafine|mesh-list
154533100|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
154533101|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533102|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533103|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533104|NCT05133050|Ramipril|ramipril|mesh-list
154533105|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154533106|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
154533107|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533108|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533109|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154533110|NCT02817841|Drospirenone|drospirenone|mesh-list
154533111|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154533112|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
154533113|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302142|NCT03576040|Edotreotide|edotreotide|mesh-list
154533114|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533115|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154533116|NCT02817841|Diuretics|diuretics|mesh-ancestor
154533117|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
154533118|NCT05132270|Thalidomide|thalidomide|mesh-list
154533119|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
154533120|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154533121|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
154533122|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533123|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
154533124|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154533125|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533126|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154533127|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154533128|NCT05132270|Growth Substances|growth substances|mesh-ancestor
154533129|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
154533130|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533131|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
154533132|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533133|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533134|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154533135|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
154533136|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154533137|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
154533138|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154533139|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154533140|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533141|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154533142|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533143|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154533144|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533145|NCT05121038|Leucovorin|leucovorin|mesh-list
154533146|NCT05121038|Fluorouracil|fluorouracil|mesh-list
154533147|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
154533148|NCT05121038|Irinotecan|irinotecan|mesh-list
154533149|NCT05121038|Panitumumab|panitumumab|mesh-list
154533150|NCT05121038|Folfirinox|folfirinox|mesh-list
154533151|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
154533152|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533153|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154533154|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533155|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154533156|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
154533157|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533158|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154533159|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154533160|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533161|NCT05121038|Antidotes|antidotes|mesh-ancestor
154533162|NCT05121038|Protective Agents|protective agents|mesh-ancestor
154533163|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
154302197|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860498|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533164|NCT05121038|Vitamins|vitamins|mesh-ancestor
154533165|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
154533166|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533167|NCT05097794|Indapamide|indapamide|mesh-list
154533168|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154533169|NCT05097794|Diuretics|diuretics|mesh-ancestor
154533170|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
154533171|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533172|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154533173|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154533174|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533175|NCT02036281|Substance P|substance p|mesh-list
154533176|NCT02036281|Neurokinin A|neurokinin a|mesh-list
154533177|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533178|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533179|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533180|NCT02036359|Docetaxel|docetaxel|mesh-list
154533181|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154533182|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533183|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154533184|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154533185|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154533186|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533187|NCT02036359|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154533188|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154533189|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533190|NCT02036437|Misoprostol|misoprostol|mesh-list
154533191|NCT02036437|Dinoprostone|dinoprostone|mesh-list
154533192|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154533193|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
154533194|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154533195|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533196|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154533197|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154533198|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
154533199|NCT05027360|Nitroprusside|nitroprusside|mesh-list
154533200|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154533201|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
154533202|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154533203|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533204|NCT02036983|Anesthetics|anesthetics|mesh-list
154533205|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
154533206|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533207|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533208|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
154533209|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533210|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
154533211|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533212|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
154533213|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533214|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533215|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154533216|NCT05689177|Vaccines|vaccines|mesh-list
154533217|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
154533218|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533219|NCT04818320|Favipiravir|favipiravir|mesh-list
154533220|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
154533221|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533222|NCT02475135|Tenofovir|tenofovir|mesh-list
154533223|NCT02475135|Emtricitabine|emtricitabine|mesh-list
154533224|NCT02475135|Darunavir|darunavir|mesh-list
154533225|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154533226|NCT02475135|Cobicistat|cobicistat|mesh-list
154533227|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154533228|NCT02475135|Elvitegravir|elvitegravir|mesh-list
154533229|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154533230|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
154533231|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533232|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154533233|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154533234|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533235|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533236|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154533237|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154533238|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154533239|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154533240|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
154533241|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154533242|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154533243|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154533245|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154533246|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
154533247|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533248|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533249|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
154533250|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533251|NCT02814643|Benralizumab|benralizumab|mesh-list
154533252|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154302296|NCT03570346|Hemay005|hemay005|mesh-list
154533253|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
154533254|NCT02036827|Bromides|bromides|mesh-list
154533255|NCT02036827|Rocuronium|rocuronium|mesh-list
154533256|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
154533257|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154533258|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154533259|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154533260|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533261|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533262|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
154533263|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533264|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533265|NCT02475213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154533266|NCT02475213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533267|NCT05256056|Bupivacaine|bupivacaine|mesh-list
154533268|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
154533269|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
154533270|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533271|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533272|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
154533273|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533274|NCT02724111|Rocuronium|rocuronium|mesh-list
154533275|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154533276|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154533277|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154533278|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533279|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533280|NCT02480751|Beraprost|beraprost|mesh-list
154533281|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154533282|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
154533283|NCT04227314|Apremilast|apremilast|mesh-list
154533284|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154533286|NCT04227314|Analgesics|analgesics|mesh-ancestor
154533287|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
154533288|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533289|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533290|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533291|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154533292|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154533293|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154533294|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302337|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
154533295|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533296|NCT04223648|Nivolumab|nivolumab|mesh-list
154533297|NCT04223648|Ipilimumab|ipilimumab|mesh-list
154533298|NCT04223648|Durvalumab|durvalumab|mesh-list
154533299|NCT04223648|Tremelimumab|tremelimumab|mesh-list
154533300|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533301|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533302|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154533303|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533304|NCT02814175|Adalimumab|adalimumab|mesh-list
154533305|NCT02814175|Methotrexate|methotrexate|mesh-list
154533306|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154533307|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
154533308|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154533309|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533310|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154533311|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
154533312|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533313|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533314|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
154533315|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533316|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154533317|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154533318|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
154533319|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154533320|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154533321|NCT02814175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154533322|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533323|NCT02475057|Hormones|hormones|mesh-list
154533324|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154533325|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533326|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533327|NCT02474667|Mitogens|mitogens|mesh-list
154533328|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154533329|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533330|NCT03096080|XL647|xl647|mesh-list
154533331|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533332|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154533333|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533334|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533335|NCT01335997|Niacin|niacin|mesh-list
154533336|NCT01335997|Niacinamide|niacinamide|mesh-list
154533337|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
154533338|NCT01335997|Simvastatin|simvastatin|mesh-list
154533339|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154533340|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154533341|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
154533342|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533343|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154533344|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154533345|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533346|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
154533347|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
154533348|NCT01335997|Vitamins|vitamins|mesh-ancestor
154533349|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
154533350|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533351|NCT02048215|Ephedrine|ephedrine|mesh-list
154533352|NCT02048215|Caffeine|caffeine|mesh-list
154533353|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154257140|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
154302437|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533354|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533355|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154533356|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533357|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533358|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154533359|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154533360|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
154533361|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533362|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
154533363|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
154533364|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533365|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154533366|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
154533367|NCT04849832|Fesoterodine|fesoterodine|mesh-list
154533368|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154533369|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154533370|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
154533371|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533372|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533373|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533374|NCT04849832|Urological Agents|urological agents|mesh-ancestor
154533375|NCT02048293|Remifentanil|remifentanil|mesh-list
154533376|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154533377|NCT02048293|Narcotics|narcotics|mesh-ancestor
154533378|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533379|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533380|NCT02048293|Analgesics|analgesics|mesh-ancestor
154533381|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
154533382|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533383|NCT02050009|Metformin|metformin|mesh-list
154533384|NCT02050009|Paclitaxel|paclitaxel|mesh-list
154533385|NCT02050009|Carboplatin|carboplatin|mesh-list
154533386|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154533387|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533388|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
154533389|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
154533390|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
154558138|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533391|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533392|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533393|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533395|NCT03357380|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154533396|NCT03357380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533397|NCT03357380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533398|NCT04717154|Nivolumab|nivolumab|mesh-list
154533399|NCT04717154|Ipilimumab|ipilimumab|mesh-list
154533400|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533401|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533402|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154533403|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533404|NCT02474511|Anesthetics|anesthetics|mesh-list
154533405|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533406|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533407|NCT03108963|Metformin|metformin|mesh-list
154533408|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533409|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533410|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
154533411|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
154533412|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154533413|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154533414|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533415|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533416|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533417|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154533418|NCT02474433|Misoprostol|misoprostol|mesh-list
154533419|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154533420|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
154533421|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154533422|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533423|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154533424|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154533425|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
154533426|NCT04812002|Bevacizumab|bevacizumab|mesh-list
154533427|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154533428|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533429|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533430|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154257212|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154533431|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154533433|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533434|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
154533435|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533436|NCT03424460|Hemostatics|hemostatics|mesh-list
154533437|NCT03424460|Coagulants|coagulants|mesh-ancestor
154533438|NCT05712837|Salicylic Acid|salicylic acid|mesh-list
154533439|NCT05712837|Salicylates|salicylates|mesh-list
154533440|NCT05712837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533441|NCT05712837|Antifungal Agents|antifungal agents|mesh-ancestor
154533442|NCT05712837|Keratolytic Agents|keratolytic agents|mesh-ancestor
154533443|NCT05712837|Dermatologic Agents|dermatologic agents|mesh-ancestor
154533444|NCT05712837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154533445|NCT05712837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154533446|NCT05712837|Analgesics|analgesics|mesh-ancestor
154533447|NCT05712837|Sensory System Agents|sensory system agents|mesh-ancestor
154533448|NCT05712837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533449|NCT05712837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533450|NCT05712837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533451|NCT05712837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154533452|NCT05712837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154533453|NCT05712837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533454|NCT05712837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533455|NCT02472249|Norepinephrine|norepinephrine|mesh-list
154533456|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154533457|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154533458|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
154533459|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533460|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533461|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533462|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
154533463|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
154368291|NCT03343678|BI 836826|bi 836826|mesh-list
154533464|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533465|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154533466|NCT02313194|Buspirone|buspirone|mesh-list
154533467|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154533468|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154533469|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533470|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533471|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154533472|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154533473|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
154533474|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533475|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533476|NCT04435652|Paclitaxel|paclitaxel|mesh-list
154533477|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154533478|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154533479|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533480|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
154533481|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
154533482|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
154533483|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533484|NCT02473887|Ondansetron|ondansetron|mesh-list
154533485|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
154533486|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
154533487|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533488|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533489|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154533490|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
154533491|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
154533492|NCT02473887|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154533493|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154533494|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
154533495|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533496|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533497|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
154533498|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533499|NCT00071552|Fluticasone|fluticasone|mesh-list
154533500|NCT00071552|Xhance|xhance|mesh-list
154533501|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533502|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154533503|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
154533504|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257288|NCT01283204|Vitamins|vitamins|mesh-ancestor
154533505|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533506|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154533507|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
154533508|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
154533509|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154533510|NCT05164263|Empagliflozin|empagliflozin|mesh-list
154533511|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154533512|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533513|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533514|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533515|NCT04767711|Prednisolone|prednisolone|mesh-list
154533516|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533517|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
154533518|NCT04767711|Hormones|hormones|mesh-ancestor
154533519|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533520|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533521|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154533522|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533523|NCT02473809|Liraglutide|liraglutide|mesh-list
154533524|NCT02473809|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154533525|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533526|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533527|NCT02473809|Incretins|incretins|mesh-ancestor
154533528|NCT02473809|Hormones|hormones|mesh-ancestor
154533529|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533530|NCT03976934|Tamsulosin|tamsulosin|mesh-list
154533531|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154533532|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154533533|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154533534|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
154533535|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533536|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533537|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533538|NCT03976934|Urological Agents|urological agents|mesh-ancestor
154533539|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154533540|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154533541|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
154533542|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533543|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533544|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154533545|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
154533546|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
154533547|NCT02416180|Hormones|hormones|mesh-ancestor
154533548|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533549|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
154533550|NCT02473575|Caffeine|caffeine|mesh-list
154533551|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154533552|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533553|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154533554|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533555|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533556|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154533557|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154533558|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
154533559|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533560|NCT03770546|Betamethasone|betamethasone|mesh-list
154533561|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533562|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
154533563|NCT03770546|Hormones|hormones|mesh-ancestor
154533564|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533565|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533566|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154533567|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
154533568|NCT05341323|Ketamine|ketamine|mesh-list
154533569|NCT05341323|Bupivacaine|bupivacaine|mesh-list
154533570|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
154533571|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
154533572|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533573|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533574|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
154533575|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533576|NCT05341323|Analgesics|analgesics|mesh-ancestor
154533577|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154533578|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154533579|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
154533580|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154533581|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154533582|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533583|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533584|NCT04622865|Quercetin|quercetin|mesh-list
154533585|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
154533586|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533587|NCT04622865|Protective Agents|protective agents|mesh-ancestor
154533588|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533589|NCT02473185|Methylphenidate|methylphenidate|mesh-list
154533590|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154533591|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533592|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154533593|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154533594|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154533595|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533596|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
154533597|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533598|NCT02445586|Docetaxel|docetaxel|mesh-list
154533599|NCT02445586|Trastuzumab|trastuzumab|mesh-list
154533600|NCT02445586|Pertuzumab|pertuzumab|mesh-list
154533601|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533602|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
154533603|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
154533604|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
154533605|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533606|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533607|NCT02471547|Mitomycins|mitomycins|mesh-list
154533608|NCT02471547|Mitomycin|mitomycin|mesh-list
154533609|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154558139|NCT03173235|Vitamin D|vitamin d|mesh-list
154533610|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533611|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
154533612|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533613|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154533614|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533615|NCT02477631|Deferiprone|deferiprone|mesh-list
154533616|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154533617|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
154533618|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
154533619|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533620|NCT01674062|Trastuzumab|trastuzumab|mesh-list
154533621|NCT01674062|Pertuzumab|pertuzumab|mesh-list
154533622|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533623|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533624|NCT02472873|Ethanol|ethanol|mesh-list
154533625|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154533626|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533627|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533628|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533629|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
154533630|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154533631|NCT02472886|Ledipasvir|ledipasvir|mesh-list
154533632|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
154533633|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533634|NCT05283356|Ticagrelor|ticagrelor|mesh-list
154533635|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154533636|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154533637|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154533638|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154533639|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
154533640|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533641|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533642|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533643|NCT02472652|Aripiprazole|aripiprazole|mesh-list
154533644|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
154533645|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154533646|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154533647|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154533648|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533649|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533650|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
154533651|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
154533652|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533653|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533654|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154533655|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154533657|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154533658|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154533659|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154533660|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154533661|NCT05243186|Methylphenidate|methylphenidate|mesh-list
154533662|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154533663|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533664|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154533665|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154533666|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154533667|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533668|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
154533669|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533670|NCT02808182|Niacin|niacin|mesh-list
154533671|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
154533672|NCT02808182|Niacinamide|niacinamide|mesh-list
154533673|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154533674|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
154533675|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533676|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154533677|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
154533678|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
154533679|NCT02808182|Vitamins|vitamins|mesh-ancestor
154533680|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
154533681|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533682|NCT04695704|Montelukast|montelukast|mesh-list
154533683|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154533684|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154533685|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
154533686|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
154533687|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533688|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533689|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154533690|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154533691|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533693|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154533694|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
154533695|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154533696|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154533697|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
154533698|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533699|NCT05217758|Mifepristone|mifepristone|mesh-list
154533700|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154533701|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
154533702|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154533703|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533704|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154533705|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154533706|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154533707|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
154533708|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154533709|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154533710|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
154533711|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533712|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
154533713|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154533714|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154533715|NCT02051023|Fluorometholone|fluorometholone|mesh-list
154533716|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
154533717|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154533718|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154533719|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533720|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
154533721|NCT02051023|Hormones|hormones|mesh-ancestor
154533722|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257512|NCT01285544|Atorvastatin|atorvastatin|mesh-list
154533723|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533724|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154533725|NCT02415556|Insulin|insulin|mesh-list
154533726|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154533727|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533728|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533729|NCT02048683|Sevoflurane|sevoflurane|mesh-list
154533730|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154533731|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154533732|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
154533733|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
154533734|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154533735|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533736|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
154533737|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154533738|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154533739|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533740|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
154533741|NCT03108807|Coagulants|coagulants|mesh-ancestor
154533742|NCT02048761|Metformin|metformin|mesh-list
154533743|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533744|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533745|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154533746|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
154533747|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154533748|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154533749|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154533750|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533751|NCT02048917|Bupropion|bupropion|mesh-list
154533752|NCT02048917|Varenicline|varenicline|mesh-list
154533753|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154533754|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
154533755|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154533756|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154533757|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154533758|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154533759|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533760|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
154533761|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533762|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533763|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154533764|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154533765|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533766|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154533767|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154533768|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
154533769|NCT02472717|Liraglutide|liraglutide|mesh-list
154533770|NCT02472717|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154533771|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533772|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533773|NCT02472717|Incretins|incretins|mesh-ancestor
154533774|NCT02472717|Hormones|hormones|mesh-ancestor
154533775|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533776|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
154533777|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154533778|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154533779|NCT02049073|Prednisolone|prednisolone|mesh-list
154533780|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
154533781|NCT02049073|Zonisamide|zonisamide|mesh-list
154533782|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154533783|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
154533784|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533785|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
154533786|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
154533787|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533788|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533789|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154533790|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
154533791|NCT02049073|Hormones|hormones|mesh-ancestor
154533792|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533793|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154533794|NCT02049073|Protective Agents|protective agents|mesh-ancestor
154533795|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154533796|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533797|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
154533798|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154533799|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154533800|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533801|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154533802|NCT04518345|Azacitidine|azacitidine|mesh-list
154533803|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154533804|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
154533805|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533806|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533807|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533808|NCT02260063|Epinastine|epinastine|mesh-list
154533809|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154533810|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
154533811|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
154533812|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533813|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533814|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533815|NCT04398914|Paclitaxel|paclitaxel|mesh-list
154533816|NCT04398914|Trastuzumab|trastuzumab|mesh-list
154533817|NCT04398914|Pertuzumab|pertuzumab|mesh-list
154533818|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154533819|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533820|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
154533821|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
154533822|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
154533823|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533824|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533825|NCT03561649|Adalimumab|adalimumab|mesh-list
154533826|NCT03561649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154533827|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533828|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154533829|NCT02807623|Ibuprofen|ibuprofen|mesh-list
154860499|NCT01052701|Ribavirin|ribavirin|mesh-list
154860500|NCT01052701|Abacavir|abacavir|mesh-list
154533830|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154533831|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154533832|NCT02807623|Analgesics|analgesics|mesh-ancestor
154533833|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
154533834|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533835|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533836|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533837|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154533838|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154533839|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533840|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533841|NCT05137964|Vitamin D|vitamin d|mesh-list
154533842|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154533843|NCT05137964|Vitamins|vitamins|mesh-ancestor
154533844|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
154533845|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533846|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154533847|NCT04374578|Dulaglutide|dulaglutide|mesh-list
154533848|NCT04374578|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154533849|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533850|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533851|NCT02470923|Nicotine|nicotine|mesh-list
154533852|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154533853|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
154533854|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533855|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533856|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154533857|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154533858|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
154533859|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533860|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533861|NCT02049229|Everolimus|everolimus|mesh-list
154533862|NCT02049229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154533863|NCT02049229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154533864|NCT02049229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533865|NCT02049229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533866|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154533867|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
154533868|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533869|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533870|NCT02805907|Calcifediol|calcifediol|mesh-list
154533871|NCT02805907|Vitamins|vitamins|mesh-ancestor
154533872|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
154533873|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533874|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154533876|NCT02477397|Xhance|xhance|mesh-list
154533877|NCT02477397|Budesonide|budesonide|mesh-list
154533878|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
154533879|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154533880|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154533881|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154533882|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533883|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154533884|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
154533885|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533886|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533887|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154533888|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
154533889|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
154533890|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154533891|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
154533892|NCT02477397|Hormones|hormones|mesh-ancestor
154533893|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533894|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154533895|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154533896|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154533897|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
154533898|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533899|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533900|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
154533901|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154533902|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154533903|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154533904|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154533905|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533906|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533907|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533908|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154533909|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
154533910|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154533911|NCT02470767|Anticoagulants|anticoagulants|mesh-list
154533912|NCT02049541|Rituximab|rituximab|mesh-list
154533913|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154533914|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533915|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
154533916|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533917|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154533918|NCT02470611|Alendronate|alendronate|mesh-list
154533919|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154533920|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533921|NCT05305898|Metformin|metformin|mesh-list
154533922|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154533923|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533924|NCT02469831|Rocuronium|rocuronium|mesh-list
154533925|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154533926|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154533927|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154533928|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533929|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533930|NCT02995005|Tenofovir|tenofovir|mesh-list
154533931|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
154533932|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533933|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154533934|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154533935|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533936|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533937|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154533938|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154533939|NCT03561415|Posaconazole|posaconazole|mesh-list
154533940|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
154533941|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533942|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154533943|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154533944|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154533945|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154533946|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154533947|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533948|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533949|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154533950|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
154533951|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154533952|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533953|NCT02477007|Acetaminophen|acetaminophen|mesh-list
154533954|NCT02477007|Ibuprofen|ibuprofen|mesh-list
154303011|NCT01250535|Warfarin|warfarin|mesh-list
154533955|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154533956|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154533957|NCT02477007|Analgesics|analgesics|mesh-ancestor
154533958|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
154533959|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154533960|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533961|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154533962|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154533963|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154533964|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533965|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533966|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
154533967|NCT02052973|Propolis|propolis|mesh-list
154533968|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154533969|NCT02053519|Vitamin D|vitamin d|mesh-list
154533970|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
154533971|NCT02053519|Vitamins|vitamins|mesh-ancestor
154533972|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
154533973|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533974|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154533975|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154533976|NCT02053597|Paclitaxel|paclitaxel|mesh-list
154533977|NCT02053597|Doxorubicin|doxorubicin|mesh-list
154558140|NCT03173235|Vitamins|vitamins|mesh-ancestor
154860501|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
154533978|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154533979|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154533980|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
154533981|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
154533982|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
154533983|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533984|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154533985|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154533986|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154533987|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154533988|NCT02801617|Latanoprost|latanoprost|mesh-list
154533989|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154533990|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154533991|NCT02056249|Norepinephrine|norepinephrine|mesh-list
154533992|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154533993|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154533994|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
154533995|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154533996|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533997|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154533998|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
154533999|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
154534000|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534001|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154534002|NCT04140968|Progesterone|progesterone|mesh-list
154534003|NCT04140968|Progestins|progestins|mesh-ancestor
154534004|NCT04140968|Hormones|hormones|mesh-ancestor
154534005|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534006|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534007|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
154534008|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154534009|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534010|NCT04383938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154534011|NCT04383938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534012|NCT01334515|Isotretinoin|isotretinoin|mesh-list
154534013|NCT01334515|Sargramostim|sargramostim|mesh-list
154534014|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534015|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
154534016|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
154534017|NCT02415400|Aspirin|aspirin|mesh-list
154534018|NCT02415400|Vitamin K|vitamin k|mesh-list
154534019|NCT02415400|Apixaban|apixaban|mesh-list
154534020|NCT02415400|Vitamins|vitamins|mesh-ancestor
154534021|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
154534023|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154534024|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534025|NCT02415400|Analgesics|analgesics|mesh-ancestor
154534026|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
154534027|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534028|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154534029|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154534030|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154534031|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154534032|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534033|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154534034|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154534035|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534036|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
154534037|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154534038|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
154534039|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154534040|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
154534041|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
154534042|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154534043|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
154534044|NCT02415400|Coagulants|coagulants|mesh-ancestor
154534045|NCT02053675|Vasopressins|vasopressins|mesh-list
154534046|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
154534047|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
154534048|NCT02053675|Coagulants|coagulants|mesh-ancestor
154534049|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154534050|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154534051|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
154534052|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534053|NCT02037997|Docetaxel|docetaxel|mesh-list
154534054|NCT02037997|Pemetrexed|pemetrexed|mesh-list
154534055|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154534056|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534057|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
154534058|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
154534059|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
154534060|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534061|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534062|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154534063|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154534064|NCT02037997|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154534065|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154534066|NCT02056405|Mosapride|mosapride|mesh-list
154534067|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154534068|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154534069|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
154534070|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534071|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534072|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534073|NCT02056717|Dexamethasone|dexamethasone|mesh-list
154534074|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154534075|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
154534076|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
154534077|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534078|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534079|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154534080|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
154534081|NCT02056717|Hormones|hormones|mesh-ancestor
154534082|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534083|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154534084|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534085|NCT04194801|Fisogatinib|fisogatinib|mesh-list
154534086|NCT04194801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534087|NCT02802865|Letrozole|letrozole|mesh-list
154534088|NCT02802865|Clomiphene|clomiphene|mesh-list
154534089|NCT02802865|Enclomiphene|enclomiphene|mesh-list
154534090|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
154534091|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534092|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534093|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154534094|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154534095|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534096|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154534097|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
154534098|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534099|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534100|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154534102|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154534103|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154534104|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154534105|NCT02414932|Midazolam|midazolam|mesh-list
154534106|NCT02414932|Ketamine|ketamine|mesh-list
154534107|NCT02414932|Analgesics|analgesics|mesh-ancestor
154534108|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
154534109|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534110|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534111|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154534112|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154534113|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
154534114|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
154534115|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534116|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154534117|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154534118|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534119|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534120|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154534121|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154534122|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154534123|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154534124|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154534125|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
154534126|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
154534127|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
154534128|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154534129|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
154534130|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
154534131|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534132|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534134|NCT02476929|Analgesics|analgesics|mesh-ancestor
154534135|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
154534136|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534137|NCT02054143|Sevoflurane|sevoflurane|mesh-list
154534138|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154534139|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154534140|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
154534141|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
154534142|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534143|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534144|NCT02058667|Paclitaxel|paclitaxel|mesh-list
154534145|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154534146|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534147|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
154534148|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
154534149|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154534150|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534151|NCT02470455|Atorvastatin|atorvastatin|mesh-list
154534152|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154534153|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154534154|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
154534155|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534156|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154534157|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154534158|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534159|NCT02057263|Alendronate|alendronate|mesh-list
154534160|NCT02057263|Diphosphonates|diphosphonates|mesh-list
154534161|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154534162|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534163|NCT05550909|Artesunate|artesunate|mesh-list
154534164|NCT05550909|Lumefantrine|lumefantrine|mesh-list
154534165|NCT05550909|Artemether|artemether|mesh-list
154534166|NCT05550909|Primaquine|primaquine|mesh-list
154534167|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154534168|NCT05550909|Amodiaquine|amodiaquine|mesh-list
154534169|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
154534170|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
154534171|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154534172|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154534174|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534175|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
154534176|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
154534177|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154534178|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
154534179|NCT02054299|Thiamine|thiamine|mesh-list
154534180|NCT02054299|Proguanil|proguanil|mesh-list
154534181|NCT02054299|Sumatriptan|sumatriptan|mesh-list
154534182|NCT02054299|Amitriptyline|amitriptyline|mesh-list
154534183|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154534184|NCT02054299|Fenoterol|fenoterol|mesh-list
154534185|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154534186|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154534187|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154534188|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
154534189|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534190|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534191|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534192|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154534193|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
154534194|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154534195|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534196|NCT02054299|Analgesics|analgesics|mesh-ancestor
154534197|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
154534198|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534199|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154534200|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154534201|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154534202|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
154534203|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
154534204|NCT02054299|Vitamins|vitamins|mesh-ancestor
154534205|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
154534206|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154534207|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
154534208|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154534209|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154534210|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534211|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
154534212|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154534213|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
154534214|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154534215|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
154534216|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
154534217|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
154534218|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154534219|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154534220|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154534221|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154534222|NCT02058823|Amlodipine|amlodipine|mesh-list
154534223|NCT02058823|Valsartan|valsartan|mesh-list
154534224|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154534225|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154534226|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154534227|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534228|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154534229|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534230|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
154534231|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154534232|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154534233|NCT00704535|Ezetimibe|ezetimibe|mesh-list
154534234|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154534235|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154534236|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
154534237|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534238|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154534239|NCT02058901|Sunitinib|sunitinib|mesh-list
154534240|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534241|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154534242|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154534243|NCT02058901|Growth Substances|growth substances|mesh-ancestor
154534244|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534245|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
154534246|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154534247|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534248|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534250|NCT02058979|Cefazolin|cefazolin|mesh-list
154534251|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534252|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154534253|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
154534254|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534255|NCT03893955|Paclitaxel|paclitaxel|mesh-list
154534256|NCT03893955|Carboplatin|carboplatin|mesh-list
154303298|NCT03899571|Oseltamivir|oseltamivir|mesh-list
154534257|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154534258|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534259|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
154534260|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
154534261|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
154534262|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534263|NCT02648204|Semaglutide|semaglutide|mesh-list
154534264|NCT02648204|Dulaglutide|dulaglutide|mesh-list
154534265|NCT02648204|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154534266|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154534267|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534268|NCT03310749|Metformin|metformin|mesh-list
154534269|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154534270|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534271|NCT03310593|Cannabidiol|cannabidiol|mesh-list
154534272|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
154534273|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
154534274|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154534275|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534276|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
154534277|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
154534278|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154534279|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
154534280|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154534281|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
154534282|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534283|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534284|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
154534285|NCT02058277|Aprepitant|aprepitant|mesh-list
154534286|NCT02058277|Bosutinib|bosutinib|mesh-list
154534287|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
154860257|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534288|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
154534289|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534290|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534291|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154534292|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154534293|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534294|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534295|NCT02058277|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154534296|NCT02058277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154534297|NCT02058277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534298|NCT04813562|Vaccines|vaccines|mesh-list
154534299|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
154534300|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534301|NCT03314025|Tamsulosin|tamsulosin|mesh-list
154534302|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154534303|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154534304|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154534305|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
154303343|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154534306|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534307|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534308|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534309|NCT03314025|Urological Agents|urological agents|mesh-ancestor
154534310|NCT02055079|Sirolimus|sirolimus|mesh-list
154534311|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154534312|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534313|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154534314|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534315|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
154534316|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534317|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
154534318|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534319|NCT02470065|Afatinib|afatinib|mesh-list
154534320|NCT02470065|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154258109|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534321|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154534322|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534323|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534324|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534325|NCT03313869|Vitamin E|vitamin e|mesh-list
154534326|NCT03313869|Selenium|selenium|mesh-list
154534327|NCT03313869|Vitamins|vitamins|mesh-ancestor
154534328|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
154534329|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534330|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
154534331|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534332|NCT03313869|Protective Agents|protective agents|mesh-ancestor
154534333|NCT03313869|Trace Elements|trace elements|mesh-ancestor
154534334|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154534335|NCT00705159|Tobramycin|tobramycin|mesh-list
154534336|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154534337|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534338|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154534339|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154534340|NCT01673984|Goserelin|goserelin|mesh-list
154534341|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
154534342|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154534343|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
154534344|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154534345|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534346|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154534347|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154534348|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534349|NCT03313791|Caseins|caseins|mesh-list
154534350|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
154534351|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
154534352|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534353|NCT03310047|Lidocaine|lidocaine|mesh-list
154534354|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
154534355|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
154534356|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534357|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534358|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
154534359|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534360|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154534361|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154534362|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154534363|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154534364|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534365|NCT03313557|Adavosertib|adavosertib|mesh-list
154534366|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534367|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534368|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
154534369|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154534370|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534371|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534372|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534373|NCT03313479|Analgesics|analgesics|mesh-ancestor
154534374|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
154534375|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534376|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154534377|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154534378|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154534379|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
154534380|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534381|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534382|NCT03313401|Aflibercept|aflibercept|mesh-list
154534383|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154534384|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154534385|NCT03313401|Growth Substances|growth substances|mesh-ancestor
154534386|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534387|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
154534388|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534389|NCT03313323|Ipilimumab|ipilimumab|mesh-list
154534390|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154534391|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534392|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154534393|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534394|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154534395|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
154534396|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154534397|NCT05302232|Prednisolone|prednisolone|mesh-list
154534398|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
154534399|NCT05302232|Lidocaine|lidocaine|mesh-list
154534400|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154534401|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
154534402|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
154534403|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
154534404|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534405|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534406|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
154534407|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534408|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154534409|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154534410|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154534411|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154534412|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534413|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154534414|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
154534415|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
154534416|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154534417|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
154534418|NCT05302232|Hormones|hormones|mesh-ancestor
154534419|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534420|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154534421|NCT05302232|Protective Agents|protective agents|mesh-ancestor
154534422|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154534423|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534424|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154534425|NCT02468661|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154534426|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154534427|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534428|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534429|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534430|NCT03304431|Lidocaine|lidocaine|mesh-list
154534431|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
154534432|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
154860258|NCT01923818|Aspirin|aspirin|mesh-list
154534433|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534434|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534435|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
154534436|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534437|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154534438|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154534439|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154534440|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154534441|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534442|NCT04741334|Anticoagulants|anticoagulants|mesh-list
154534443|NCT04741334|Dicumarol|dicumarol|mesh-list
154534444|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154534445|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534446|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534447|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
154534448|NCT03309735|Progesterone|progesterone|mesh-list
154534449|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
154534450|NCT03309735|Progestins|progestins|mesh-ancestor
154534451|NCT03309735|Hormones|hormones|mesh-ancestor
154534452|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534453|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534454|NCT02926586|Cytarabine|cytarabine|mesh-list
154534455|NCT02926586|Fludarabine|fludarabine|mesh-list
154534456|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534457|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154534458|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
154534459|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534460|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534461|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
154534462|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534463|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
154534464|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534465|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
154534466|NCT04490967|Salicylates|salicylates|mesh-list
154534467|NCT04490967|Silybin|silybin|mesh-list
154534468|NCT04490967|Silymarin|silymarin|mesh-list
154534469|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
154534470|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534471|NCT04490967|Protective Agents|protective agents|mesh-ancestor
154534472|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534473|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534474|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
154534475|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
154534476|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
154534477|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154534478|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534479|NCT04490967|Analgesics|analgesics|mesh-ancestor
154534480|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
154534481|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534482|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154534483|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154534484|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154534485|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534486|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154534487|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534488|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154534489|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
154534490|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534491|NCT03312777|Tramadol|tramadol|mesh-list
154534492|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154534493|NCT03312777|Narcotics|narcotics|mesh-ancestor
154534494|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534495|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534496|NCT03312777|Analgesics|analgesics|mesh-ancestor
154303532|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
154534497|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
154534498|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534499|NCT02332928|Melatonin|melatonin|mesh-list
154534500|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
154534501|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534502|NCT02332928|Protective Agents|protective agents|mesh-ancestor
154534503|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534504|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534505|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
154534506|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
154534507|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154534508|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534509|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534510|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
154534511|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154534512|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534513|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534514|NCT01506986|Metronidazole|metronidazole|mesh-list
154534515|NCT01506986|Clarithromycin|clarithromycin|mesh-list
154534516|NCT01506986|Lansoprazole|lansoprazole|mesh-list
154534517|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
154534518|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534519|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154534520|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154534521|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154534522|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154534523|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534524|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534525|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154534526|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154534527|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154534528|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154534529|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154534530|NCT02714894|Clozapine|clozapine|mesh-list
154534531|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154534532|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
154534533|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534534|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534535|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534536|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154534537|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154534538|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534539|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154534540|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
154534541|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
154534542|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
154534543|NCT03303651|Narcotics|narcotics|mesh-ancestor
154534544|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534545|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534546|NCT03303651|Analgesics|analgesics|mesh-ancestor
154534547|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
154534548|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534549|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154534550|NCT03312153|Eusol|eusol|mesh-list
154534551|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
154534552|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534553|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
154534554|NCT03303573|Hematinics|hematinics|mesh-ancestor
154534555|NCT03303495|Leucovorin|leucovorin|mesh-list
154534556|NCT03303495|Bevacizumab|bevacizumab|mesh-list
154534557|NCT03303495|Fluorouracil|fluorouracil|mesh-list
154534558|NCT03303495|Irinotecan|irinotecan|mesh-list
154534559|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154534560|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534561|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154534562|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154534563|NCT03303495|Growth Substances|growth substances|mesh-ancestor
154534564|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534565|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
154534566|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
154534567|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534568|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154534569|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534570|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
154534571|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154534572|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154534573|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534574|NCT03303495|Antidotes|antidotes|mesh-ancestor
154534575|NCT03303495|Protective Agents|protective agents|mesh-ancestor
154534576|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
154534577|NCT03303495|Vitamins|vitamins|mesh-ancestor
154534578|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
154534579|NCT03308955|Tramadol|tramadol|mesh-list
154534580|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154860259|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
154534581|NCT03308955|Narcotics|narcotics|mesh-ancestor
154534582|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534583|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534584|NCT03308955|Analgesics|analgesics|mesh-ancestor
154534585|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
154534586|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534587|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154534588|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
154534589|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534590|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154534591|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154534593|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
154534594|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154534595|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534596|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
154534597|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154534598|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154534599|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154534600|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154534601|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534602|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
154534603|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534604|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534605|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154303644|NCT01152723|Nicotine|nicotine|mesh-list
154534606|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534607|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154534608|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154534609|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534610|NCT03308487|Vitamin D|vitamin d|mesh-list
154534611|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
154534612|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
154534613|NCT03308487|Vitamins|vitamins|mesh-list
154534614|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
154534615|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534616|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154534617|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154534618|NCT03308331|Nicotine|nicotine|mesh-list
154534619|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154534620|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
154534621|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534622|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534623|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154534624|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154534625|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
154534626|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534627|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534628|NCT02414854|Albuterol|albuterol|mesh-list
154534629|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154534630|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
154534631|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534632|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534633|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154534634|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
154534635|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
154534636|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154534637|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154534638|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154534639|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154534640|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
154534641|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534642|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534643|NCT03308253|Vancomycin|vancomycin|mesh-list
154534644|NCT03308253|Tobramycin|tobramycin|mesh-list
154534645|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154534646|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534647|NCT02467023|Lidocaine|lidocaine|mesh-list
154534648|NCT02467023|Fentanyl|fentanyl|mesh-list
154534649|NCT02467023|Midazolam|midazolam|mesh-list
154534650|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
154534651|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
154534652|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534653|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534654|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
154534655|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534656|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154534657|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154534658|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154534659|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154534661|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154534662|NCT02467023|Narcotics|narcotics|mesh-ancestor
154534663|NCT02467023|Analgesics|analgesics|mesh-ancestor
154534664|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154534665|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154534666|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
154534667|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154534668|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154534669|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154534670|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154534671|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
154534672|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
154534673|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534674|NCT02055703|Itraconazole|itraconazole|mesh-list
154534675|NCT02055703|Rifampin|rifampin|mesh-list
154534676|NCT02055703|Digoxin|digoxin|mesh-list
154534677|NCT02055703|Donepezil|donepezil|mesh-list
154534678|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
154534679|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534680|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154534681|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154534682|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534683|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534684|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154534685|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
154534686|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534687|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534688|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154534689|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154534690|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
154534691|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534692|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
154534693|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154534694|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
154534695|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154534696|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
154534697|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154534698|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154534699|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154534700|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154534701|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154534702|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154534703|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154534704|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154534705|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154534706|NCT02055703|Protective Agents|protective agents|mesh-ancestor
154534707|NCT02058433|Paclitaxel|paclitaxel|mesh-list
154534708|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154534709|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154534710|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534711|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
154534712|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
154534713|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
154303749|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154534714|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534715|NCT03561181|Vaccines|vaccines|mesh-list
154534716|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
154534717|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534718|NCT02060149|Minocycline|minocycline|mesh-list
154534719|NCT02060149|Sulbactam|sulbactam|mesh-list
154534720|NCT02060149|Cefoperazone|cefoperazone|mesh-list
154534721|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154534722|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154534723|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534724|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154534725|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534726|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534727|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
154534728|NCT03302403|Fludarabine|fludarabine|mesh-list
154534729|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534730|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
154534731|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534732|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154534733|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154534734|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
154534735|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534736|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534737|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154534738|NCT02038621|Paclitaxel|paclitaxel|mesh-list
154534739|NCT02038621|Capecitabine|capecitabine|mesh-list
154534740|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
154534741|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154534742|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534743|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
154534744|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
154534745|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
154534746|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534747|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154534748|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
154534749|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
154534750|NCT03332498|Ibrutinib|ibrutinib|mesh-list
154534751|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154534752|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534753|NCT03332498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154303809|NCT01157247|Analgesics|analgesics|mesh-ancestor
154534754|NCT03332498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534755|NCT03332498|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154534756|NCT03332498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154534757|NCT03332498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534758|NCT01334125|Metformin|metformin|mesh-list
154534759|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154534760|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534761|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154534762|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154534763|NCT01333501|Interferons|interferons|mesh-list
154534764|NCT01333501|Interferon-beta|interferon-beta|mesh-list
154534765|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154534766|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
154534767|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534768|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
154534769|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534770|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
154534771|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534772|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154534773|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534774|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534775|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154534776|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
154534777|NCT01362140|Hematinics|hematinics|mesh-ancestor
154534778|NCT03307941|Fluorouracil|fluorouracil|mesh-list
154534779|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
154534780|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
154534781|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534782|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154534783|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534784|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534785|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
154534786|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534787|NCT03307863|Topiramate|topiramate|mesh-list
154534788|NCT03307863|Carbamazepine|carbamazepine|mesh-list
154534789|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
154534790|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154534791|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534792|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
154534793|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154534794|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534795|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154534796|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534797|NCT03307863|Analgesics|analgesics|mesh-ancestor
154534798|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
154534799|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534800|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154534801|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154534802|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534803|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154534804|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154534805|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
154534806|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154534807|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558141|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
154534809|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534810|NCT04656470|Analgesics|analgesics|mesh-ancestor
154534811|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
154534812|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534813|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154534814|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154534815|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154534816|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
154534817|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534818|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534819|NCT05391074|Vitamins|vitamins|mesh-list
154534820|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
154534821|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534822|NCT02467647|Thalidomide|thalidomide|mesh-list
154534823|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534824|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
154534825|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534826|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
154534827|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154534828|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534829|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154534830|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154534831|NCT02467647|Growth Substances|growth substances|mesh-ancestor
154534832|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
154534833|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534834|NCT03263936|Cytarabine|cytarabine|mesh-list
154534835|NCT03263936|Fludarabine|fludarabine|mesh-list
154534836|NCT03263936|Decitabine|decitabine|mesh-list
154534837|NCT03263936|Vorinostat|vorinostat|mesh-list
154534838|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534839|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154534840|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
154534841|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534842|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534843|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
154534844|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534845|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
154534846|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534847|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534848|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154534849|NCT03307551|Propofol|propofol|mesh-list
154253732|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534850|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154534851|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154534852|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534853|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154534854|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
154534855|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
154534856|NCT02060305|Bevacizumab|bevacizumab|mesh-list
154534857|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154534858|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534859|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154303907|NCT01159587|Factor VIII|factor viii|mesh-list
154534860|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154534861|NCT02060305|Growth Substances|growth substances|mesh-ancestor
154534862|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534863|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
154534864|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154534865|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154534866|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534867|NCT02059759|Aldesleukin|aldesleukin|mesh-list
154534868|NCT02059759|Interleukin-2|interleukin-2|mesh-list
154534869|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534870|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534871|NCT02059759|Analgesics|analgesics|mesh-ancestor
154534872|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
154534873|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534874|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534875|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154534876|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154534877|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
154534878|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534879|NCT03103022|Acetaminophen|acetaminophen|mesh-list
154534880|NCT03103022|Ibuprofen|ibuprofen|mesh-list
154534881|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154534882|NCT03103022|Analgesics|analgesics|mesh-ancestor
154534883|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
154534884|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534885|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534887|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154534888|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154534889|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154534890|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154534891|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534892|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534893|NCT00702507|Miconazole|miconazole|mesh-list
154534894|NCT00702507|Clotrimazole|clotrimazole|mesh-list
154534895|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
154534896|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534897|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154534898|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154534899|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534900|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534901|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154534902|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
154534903|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534904|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534905|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154534906|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154534907|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154534908|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
154534909|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154534910|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154534911|NCT03301233|Estradiol|estradiol|mesh-list
154534912|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154534913|NCT03301233|Estrogens|estrogens|mesh-ancestor
154534914|NCT03301233|Hormones|hormones|mesh-ancestor
154534915|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534916|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534917|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154534918|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
154534919|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154534920|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154534921|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
154534922|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154534923|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154534925|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534926|NCT03301233|Urological Agents|urological agents|mesh-ancestor
154534927|NCT02581748|Trastuzumab|trastuzumab|mesh-list
154534928|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154534929|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534930|NCT03113942|Thalidomide|thalidomide|mesh-list
154534931|NCT03113942|Pomalidomide|pomalidomide|mesh-list
154534932|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
154534933|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534934|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154534935|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154534936|NCT03113942|Growth Substances|growth substances|mesh-ancestor
154534937|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
154534938|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534939|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154534940|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
154534941|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154534942|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154534943|NCT03104270|Dexamethasone|dexamethasone|mesh-list
154534944|NCT03104270|Pomalidomide|pomalidomide|mesh-list
154534945|NCT03104270|Elotuzumab|elotuzumab|mesh-list
154534946|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154534947|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
154534948|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
154534949|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154534950|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534951|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154534952|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
154534953|NCT03104270|Hormones|hormones|mesh-ancestor
154534954|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154534955|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369793|NCT03332602|Hematinics|hematinics|mesh-ancestor
154534956|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534957|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
154534958|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154534959|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154534960|NCT03104270|Growth Substances|growth substances|mesh-ancestor
154534961|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
154534962|NCT03300765|Apatinib|apatinib|mesh-list
154534963|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534964|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154534965|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534966|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534967|NCT04064918|Timolol|timolol|mesh-list
154534968|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534969|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154534970|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154534971|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
154534972|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154534973|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534974|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154534975|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154534976|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154534977|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154534978|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154534979|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
154534980|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534981|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154534982|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154534983|NCT02467946|Immunotoxins|immunotoxins|mesh-ancestor
154534984|NCT02467946|Immunoconjugates|immunoconjugates|mesh-ancestor
154534985|NCT02467946|Immunologic Factors|immunologic factors|mesh-ancestor
154534986|NCT02467946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154534987|NCT04688294|Valsartan|valsartan|mesh-list
154534988|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154534989|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154534990|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154534991|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154534992|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154534993|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
154534994|NCT03300609|Leucovorin|leucovorin|mesh-list
154534995|NCT03300609|Folic Acid|folic acid|mesh-list
154534996|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
154534997|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
154534998|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154534999|NCT03300609|Panitumumab|panitumumab|mesh-list
154535000|NCT03300609|Capecitabine|capecitabine|mesh-list
154535001|NCT03300609|Fluorouracil|fluorouracil|mesh-list
154535002|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
154535003|NCT03300609|Antibodies|antibodies|mesh-list
154535004|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
154535005|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154535006|NCT03300609|Calcium|calcium|mesh-list
154535007|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
154535008|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
154304059|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
154535009|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535010|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535011|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154535012|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154535013|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154535014|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
154535015|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535016|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154535017|NCT03300609|Antidotes|antidotes|mesh-ancestor
154535018|NCT03300609|Protective Agents|protective agents|mesh-ancestor
154535019|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
154535020|NCT03300609|Vitamins|vitamins|mesh-ancestor
154535021|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
154535022|NCT03300609|Hematinics|hematinics|mesh-ancestor
154535023|NCT00583778|Ipratropium|ipratropium|mesh-list
154535024|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154535025|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
154535026|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535027|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535028|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154535029|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
154535030|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154535031|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
154535032|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535033|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535034|NCT03300531|Betamethasone|betamethasone|mesh-list
154535035|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154535036|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
154535037|NCT03300531|Hormones|hormones|mesh-ancestor
154535038|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154535039|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535040|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154535041|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
154535042|NCT02467335|Fostemsavir|fostemsavir|mesh-list
154535043|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154535044|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154535045|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
154535046|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535047|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154535048|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154304104|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
154535049|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535050|NCT02809820|Metoprolol|metoprolol|mesh-list
154535051|NCT02809820|Carvedilol|carvedilol|mesh-list
154535052|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154535053|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154535054|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154535055|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
154535056|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
154535057|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535058|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535059|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154535060|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154535061|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
154535062|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535063|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535064|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
154535065|NCT02809820|Protective Agents|protective agents|mesh-ancestor
154535066|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154535067|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154535068|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154535069|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
154535070|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154535071|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154535072|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
154535073|NCT04491357|Calcium|calcium|mesh-list
154535074|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154535075|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535076|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154535077|NCT01673594|Naltrexone|naltrexone|mesh-list
154535078|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154535079|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154535080|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535081|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
154535082|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535083|NCT02786498|Vitamin D|vitamin d|mesh-list
154535084|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
154535085|NCT02786498|Vitamins|vitamins|mesh-ancestor
154535086|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
154535087|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535088|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154535089|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154535090|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154535091|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154535092|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535093|NCT02597660|Hormones|hormones|mesh-list
154535094|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154535095|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535096|NCT02419664|Edotreotide|edotreotide|mesh-list
154535097|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154535098|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535099|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
154535100|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154535101|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535102|NCT04435574|Lactoferrin|lactoferrin|mesh-list
154535103|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535104|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
154535105|NCT03104426|Hematinics|hematinics|mesh-ancestor
154535106|NCT02163356|Ketoconazole|ketoconazole|mesh-list
154535107|NCT02163356|Vincristine|vincristine|mesh-list
154535108|NCT02163356|Fenretinide|fenretinide|mesh-list
154535109|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154535110|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535111|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
154535112|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
154535113|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
154535114|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535115|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
154535116|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535117|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154535118|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154535119|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535120|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154535121|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
154535122|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154535123|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535124|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154535125|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154535126|NCT02163356|Protective Agents|protective agents|mesh-ancestor
154535127|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
154535128|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154535129|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
154535130|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
154535131|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535132|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535133|NCT03867110|Atorvastatin|atorvastatin|mesh-list
154535135|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154535136|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154535137|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
154535138|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535139|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154535140|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154535141|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535142|NCT03865082|Nivolumab|nivolumab|mesh-list
154535143|NCT03865082|Ipilimumab|ipilimumab|mesh-list
154535144|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154535145|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535146|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154535147|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535149|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
154304192|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
154535150|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154535151|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154535152|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535153|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535154|NCT03102398|Urological Agents|urological agents|mesh-ancestor
154535155|NCT01187810|Cytarabine|cytarabine|mesh-list
154535156|NCT01187810|Methotrexate|methotrexate|mesh-list
154535157|NCT01187810|Fenretinide|fenretinide|mesh-list
154535158|NCT01187810|Retinamide|retinamide|mesh-list
154535159|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154535160|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
154535161|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154535162|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535163|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154535164|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
154535165|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535166|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535167|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535168|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535169|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154535170|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154535171|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
154535172|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154535173|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154535174|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
154535175|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535176|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154535177|NCT01187810|Protective Agents|protective agents|mesh-ancestor
154535178|NCT03104036|Mesalamine|mesalamine|mesh-list
154535179|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154535180|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154535182|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
154535183|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535184|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535185|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154535186|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154535187|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
154535188|NCT03449888|Calcium|calcium|mesh-list
154535189|NCT03449888|Regadenoson|regadenoson|mesh-list
154535190|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154535191|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535192|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154535193|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154535194|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154535195|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
154535196|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
154535197|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535198|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535199|NCT03308396|Durvalumab|durvalumab|mesh-list
154535200|NCT03308396|Guadecitabine|guadecitabine|mesh-list
154535201|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154535202|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535203|NCT02720523|Upadacitinib|upadacitinib|mesh-list
154535204|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154535205|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154535206|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304244|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
154535207|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535208|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154535209|NCT02646332|Amoxicillin|amoxicillin|mesh-list
154535210|NCT02646332|Metronidazole|metronidazole|mesh-list
154535211|NCT02646332|Clarithromycin|clarithromycin|mesh-list
154535212|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
154535213|NCT02646332|Lansoprazole|lansoprazole|mesh-list
154535214|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154535215|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535216|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154535217|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154535218|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154535219|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535220|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259011|NCT05180318|Ketamine|ketamine|mesh-list
154535221|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154535222|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154535223|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154535224|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154535225|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154535226|NCT00015002|Betamethasone|betamethasone|mesh-list
154535227|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154535228|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
154535229|NCT00015002|Hormones|hormones|mesh-ancestor
154535230|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154535231|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535232|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154535233|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
154535234|NCT03103412|Tofacitinib|tofacitinib|mesh-list
154535235|NCT03103412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154535236|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154535237|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535238|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535239|NCT02061007|Misonidazole|misonidazole|mesh-list
154535240|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535241|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154535242|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154535243|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535244|NCT02086604|Lenalidomide|lenalidomide|mesh-list
154535245|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154535246|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
154535247|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535248|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154535249|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154535250|NCT02086604|Growth Substances|growth substances|mesh-ancestor
154535251|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
154535252|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535253|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154535254|NCT02086604|Immunotoxins|immunotoxins|mesh-ancestor
154535256|NCT03103568|Tolbutamide|tolbutamide|mesh-list
154535257|NCT03103568|Metoprolol|metoprolol|mesh-list
154535258|NCT03103568|Furosemide|furosemide|mesh-list
154535259|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
154535260|NCT03103568|Nitisinone|nitisinone|mesh-list
154535261|NCT03103568|Diuretics|diuretics|mesh-ancestor
154535262|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
154535263|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535264|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154535265|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154535266|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535267|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154535268|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154535269|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
154535270|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
154535271|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535272|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154535273|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154535274|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154535275|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
154535276|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535277|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154535278|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535279|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154535280|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154535281|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154535282|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154535283|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535284|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
154535285|NCT03103646|Itraconazole|itraconazole|mesh-list
154535286|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154535287|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
154535288|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535289|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154535290|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154535291|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535292|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535293|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154535294|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
154535295|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259102|NCT05031897|Melphalan|melphalan|mesh-list
154535296|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535297|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154535298|NCT01554410|Gemcitabine|gemcitabine|mesh-list
154535299|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535300|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154535301|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
154535302|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535303|NCT03299829|Trientine|trientine|mesh-list
154535304|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
154535305|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
154535306|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535307|NCT04968158|Acetaminophen|acetaminophen|mesh-list
154535308|NCT04968158|Etoricoxib|etoricoxib|mesh-list
154535309|NCT04968158|Tramadol|tramadol|mesh-list
154535310|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154535311|NCT04968158|Analgesics|analgesics|mesh-ancestor
154535312|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
154535313|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535314|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535315|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
154535316|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154535317|NCT04968158|Narcotics|narcotics|mesh-ancestor
154535318|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535319|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154535320|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154535321|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154535322|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154535323|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154535324|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535325|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535326|NCT02059915|Oxycodone|oxycodone|mesh-list
154535327|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154535328|NCT02059915|Narcotics|narcotics|mesh-ancestor
154535329|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535330|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535332|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
154535333|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535334|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
154535335|NCT02471404|Glimepiride|glimepiride|mesh-list
154535336|NCT02471404|Saxagliptin|saxagliptin|mesh-list
154535337|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154535338|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535339|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154535340|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535341|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154535342|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154535343|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
154535344|NCT02471404|Incretins|incretins|mesh-ancestor
154535345|NCT02471404|Hormones|hormones|mesh-ancestor
154535346|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154535347|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154535348|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
154535349|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535350|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
154535351|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154535352|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535353|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154535354|NCT02061475|Lidocaine|lidocaine|mesh-list
154535355|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
154535356|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
154535357|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535358|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535359|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
154535360|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535361|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154535362|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154535363|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154535364|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154535365|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535366|NCT03100994|Bupivacaine|bupivacaine|mesh-list
154535367|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
154535368|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
154535369|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535370|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535371|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
154535372|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535373|NCT04160936|Bupivacaine|bupivacaine|mesh-list
154535374|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
154535375|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
154535376|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535377|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535378|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
154535379|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535380|NCT03103334|Methotrexate|methotrexate|mesh-list
154535381|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154535382|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
154535383|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154535384|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535385|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154535386|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
154535387|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535388|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535389|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535390|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535391|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154535392|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154535393|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
154535394|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154535395|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154535396|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154535397|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
154535398|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535399|NCT00795158|Desloratadine|desloratadine|mesh-list
154535400|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154535401|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
154304449|NCT01161459|Prednisone|prednisone|mesh-list
154535402|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535403|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535404|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535405|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154535406|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154535407|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
154535408|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
154535410|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154535411|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535412|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535413|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
154535414|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535415|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535416|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154535417|NCT02063269|Protective Agents|protective agents|mesh-ancestor
154535418|NCT00794846|Cetirizine|cetirizine|mesh-list
154535419|NCT00794846|Desloratadine|desloratadine|mesh-list
154535420|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154535421|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154535422|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154535423|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
154535424|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
154535425|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535426|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535427|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535428|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154535429|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
154535430|NCT00794768|Fexofenadine|fexofenadine|mesh-list
154535431|NCT00794768|Desloratadine|desloratadine|mesh-list
154535432|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154535433|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
154535434|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535435|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535436|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535437|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154535438|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154535439|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
154535440|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
154535441|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154535442|NCT02060851|Iron|iron|mesh-list
154535443|NCT02060851|Trace Elements|trace elements|mesh-ancestor
154535444|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
154535445|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535447|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154535448|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
154304498|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
154535449|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535450|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535451|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535452|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154535453|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154535454|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
154535455|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
154535456|NCT02060929|Esketamine|esketamine|mesh-list
154535457|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
154535458|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154535459|NCT00757562|Desloratadine|desloratadine|mesh-list
154535460|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154535461|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
154535462|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535463|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535464|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535465|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154535466|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154535467|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
154535468|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
154535469|NCT03299517|Lidocaine|lidocaine|mesh-list
154535470|NCT03299517|Amiodarone|amiodarone|mesh-list
154535471|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154535472|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
154535473|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
154535474|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535475|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535476|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
154535477|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535478|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154535479|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154535480|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154535481|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535482|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
154535483|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154535484|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154535485|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154535486|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535487|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154535488|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154535489|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154535490|NCT00651404|Ezetimibe|ezetimibe|mesh-list
154535491|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154535492|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154535493|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
154535494|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535495|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154535496|NCT00651014|Ezetimibe|ezetimibe|mesh-list
154535497|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154535498|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154535499|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
154535500|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535501|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154535502|NCT04435418|Apixaban|apixaban|mesh-list
154535503|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154535504|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
154535505|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154535506|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
154535507|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535508|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535509|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
154535510|NCT02062255|Aspirin|aspirin|mesh-list
154535511|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154535512|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154535513|NCT02062255|Analgesics|analgesics|mesh-ancestor
154535514|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
154535515|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535516|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535517|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154535518|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154535519|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154535520|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154535521|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535522|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154535523|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154535524|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535525|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
154535526|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154535527|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535528|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154535529|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
154535530|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535531|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
154535532|NCT05547243|Vaccines|vaccines|mesh-list
154535533|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
154535534|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535535|NCT03100604|Sevoflurane|sevoflurane|mesh-list
154535536|NCT03100604|Desflurane|desflurane|mesh-list
154535537|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154535538|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154535539|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
154535540|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
154535541|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535542|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535543|NCT00398294|Simvastatin|simvastatin|mesh-list
154535544|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154535545|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154535546|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
154535547|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535548|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154535549|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154535550|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535551|NCT04823403|Nivolumab|nivolumab|mesh-list
154535552|NCT04823403|Ipilimumab|ipilimumab|mesh-list
154535553|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154535554|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535555|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154535556|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535557|NCT03493646|Azacitidine|azacitidine|mesh-list
154535558|NCT03493646|Cc-486|cc-486|mesh-list
154535559|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154535560|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
154535561|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535562|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535563|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535564|NCT05519865|Tislelizumab|tislelizumab|mesh-list
154535565|NCT05519865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154535566|NCT05519865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535567|NCT05244200|Insulin|insulin|mesh-list
154535568|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154535569|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535570|NCT01361594|Insulin|insulin|mesh-list
154535571|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154535572|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154535573|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535574|NCT04435028|Ketotifen|ketotifen|mesh-list
154535575|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
154535576|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535577|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154535578|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
154535579|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
154535580|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535581|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535582|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535583|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154535584|NCT05060198|Lumefantrine|lumefantrine|mesh-list
154535585|NCT05060198|Artemether|artemether|mesh-list
154535586|NCT05060198|Piperaquine|piperaquine|mesh-list
154535587|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154535588|NCT05060198|Artenimol|artenimol|mesh-list
154535589|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
154535590|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154535591|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154535592|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535593|NCT04478084|Vaccines|vaccines|mesh-list
154535594|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
154535595|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154535596|NCT04478084|Antibodies|antibodies|mesh-list
154535597|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
154535598|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535599|NCT03098888|Dimercaprol|dimercaprol|mesh-list
154535600|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
154535601|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
154535602|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535603|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
154535604|NCT03098810|Astringents|astringents|mesh-ancestor
154535605|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535606|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535607|NCT02464761|Verteporfin|verteporfin|mesh-list
154535608|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154535609|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535610|NCT02462889|Aflibercept|aflibercept|mesh-list
154535611|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154535612|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154535613|NCT02462889|Growth Substances|growth substances|mesh-ancestor
154535614|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535615|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154535616|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535617|NCT02462577|Morphine|morphine|mesh-list
154535618|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154535619|NCT02462577|Narcotics|narcotics|mesh-ancestor
154535620|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535621|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535622|NCT02462577|Analgesics|analgesics|mesh-ancestor
154535623|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
154535624|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535625|NCT02462499|Eplerenone|eplerenone|mesh-list
154535626|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154535627|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
154535628|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154535629|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535630|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154535632|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
154535633|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154535634|NCT02464683|Vitamin D|vitamin d|mesh-list
154535635|NCT02464683|Vitamins|vitamins|mesh-ancestor
154535636|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
154535637|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535638|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154535639|NCT02061631|Dexamethasone|dexamethasone|mesh-list
154535640|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
154535641|NCT02061631|Docetaxel|docetaxel|mesh-list
154535642|NCT02061631|BB 1101|bb 1101|mesh-list
154535643|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535644|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154535645|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
154535646|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
154535647|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535648|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535649|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154535650|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
154535651|NCT02061631|Hormones|hormones|mesh-ancestor
154535652|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154535653|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154535654|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
154535655|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535656|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535657|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
154535658|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
154535659|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
154535660|NCT03098342|Amorolfine|amorolfine|mesh-list
154535661|NCT03098342|Methylene Blue|methylene blue|mesh-list
154535662|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535663|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535664|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
154535665|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535666|NCT05059418|Clonazepam|clonazepam|mesh-list
154535667|NCT05059418|Capsaicin|capsaicin|mesh-list
154535668|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
154535669|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535670|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
154535671|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535672|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535673|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
154535674|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
154535675|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
154535676|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535677|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535678|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
154535679|NCT02062333|Esmolol|esmolol|mesh-list
154535680|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154535681|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535682|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535683|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154535684|NCT02062333|Analgesics|analgesics|mesh-ancestor
154535685|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
154535686|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535687|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154535688|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154535689|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154535690|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
154535691|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535692|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535693|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154535694|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154535695|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154535696|NCT02063425|Fluoxetine|fluoxetine|mesh-list
154535697|NCT02063425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154535698|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154535699|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154535700|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535701|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535702|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
154535703|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304737|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154535704|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154535705|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
154535707|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154535708|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154535709|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535710|NCT05071118|Pregabalin|pregabalin|mesh-list
154535711|NCT05071118|Analgesics|analgesics|mesh-ancestor
154535712|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
154535713|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535714|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535715|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
154535716|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154535717|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154535718|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535719|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154535720|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154535721|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154535722|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535723|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154535724|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
154535725|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
154535726|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154535727|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535728|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535729|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
154535730|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154535731|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535732|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535733|NCT05069870|Itraconazole|itraconazole|mesh-list
154535734|NCT05069870|Rifampin|rifampin|mesh-list
154535735|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
154535736|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
154535737|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535738|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154535739|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154535740|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535741|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535742|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154535743|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
154535744|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259532|NCT03711058|Nivolumab|nivolumab|mesh-list
154535745|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535746|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154535747|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154535748|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
154535749|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154535751|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154535752|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154535753|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154535754|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154535755|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154535756|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154535757|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154535758|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154535759|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
154535760|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154535761|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154535762|NCT05275491|Calcium|calcium|mesh-list
154535763|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
154535764|NCT05275491|Hormones|hormones|mesh-list
154535765|NCT05275491|Mitogens|mitogens|mesh-list
154535766|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154535767|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535768|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154535769|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
154535770|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535771|NCT02976753|Factor VIII|factor viii|mesh-list
154535772|NCT02976753|Coagulants|coagulants|mesh-ancestor
154535773|NCT04490421|Etoposide|etoposide|mesh-list
154535774|NCT04490421|Apatinib|apatinib|mesh-list
154535775|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535776|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154535777|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154535779|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535780|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535781|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154535782|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
154535783|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154535784|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535785|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154535786|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535787|NCT02462109|Lorazepam|lorazepam|mesh-list
154535788|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
154535789|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
154535790|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
154535791|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535792|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535793|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154535794|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154535795|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535796|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154535797|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154535798|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154535799|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
154535800|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
154535801|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535802|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535803|NCT02063581|Ipatasertib|ipatasertib|mesh-list
154535804|NCT02063581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535805|NCT02063581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154535806|NCT02063581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535807|NCT02063581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535808|NCT02056899|Gabapentin|gabapentin|mesh-list
154535809|NCT02056899|Analgesics|analgesics|mesh-ancestor
154535810|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
154535811|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535812|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535813|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
154535814|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154535815|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154535816|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535817|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154535818|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154535819|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154535820|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535821|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535822|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
154535823|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
154535824|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
154535825|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535826|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535827|NCT02462265|Analgesics|analgesics|mesh-ancestor
154535828|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
154535829|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535830|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154535831|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154535832|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535833|NCT02461875|Cabergoline|cabergoline|mesh-list
154535834|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154535835|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154535836|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
154535837|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
154535838|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535839|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535840|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535841|NCT02461719|Cyclosporine|cyclosporine|mesh-list
154535842|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154535843|NCT02461719|Cyclosporins|cyclosporins|mesh-list
154535844|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535845|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535846|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154535847|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
154535848|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535849|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
154535850|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535851|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154535852|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154535853|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154535854|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154535856|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154535857|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
154535858|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535859|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535860|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154535861|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154535862|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
154535863|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535864|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535865|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
154535866|NCT02064049|Velpatasvir|velpatasvir|mesh-list
154535867|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154535868|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
154535869|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535870|NCT02064829|Paclitaxel|paclitaxel|mesh-list
154535871|NCT02064829|genexol-PM|genexol-pm|mesh-list
154535872|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154535873|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154535874|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535875|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
154535876|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
154535877|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
154535878|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535879|NCT02064517|Calcium|calcium|mesh-list
154535880|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154535881|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535882|NCT02067949|Simvastatin|simvastatin|mesh-list
154535883|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154535884|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154535885|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
154535886|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535887|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154535888|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154535889|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535890|NCT02068339|Oltipraz|oltipraz|mesh-list
154535891|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
154259697|NCT01758328|Melphalan|melphalan|mesh-list
154535892|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535893|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
154535894|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154535895|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
154535896|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154535897|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154535898|NCT02068339|Protective Agents|protective agents|mesh-ancestor
154535899|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535900|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535901|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154535902|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154535903|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535904|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535905|NCT02065843|Midazolam|midazolam|mesh-list
154535906|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154535907|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154535908|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535909|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535910|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154535911|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154535912|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154535913|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154535914|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
154535915|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
154535916|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
154535917|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
154535918|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535919|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535920|NCT02066077|Propofol|propofol|mesh-list
154535921|NCT02066077|Etomidate|etomidate|mesh-list
154535922|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154535923|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535924|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535926|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
154535927|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
154535928|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154535929|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
154535930|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535931|NCT02065063|Palbociclib|palbociclib|mesh-list
154535932|NCT02065063|Trametinib|trametinib|mesh-list
154535933|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154535934|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154535935|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535936|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535937|NCT02069197|Orlistat|orlistat|mesh-list
154304980|NCT01165905|Gemcitabine|gemcitabine|mesh-list
154535938|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535939|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535940|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154535941|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154535942|NCT02069431|Oxytocin|oxytocin|mesh-list
154535943|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
154535944|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154535945|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535946|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
154535947|NCT01652872|Hematinics|hematinics|mesh-ancestor
154535948|NCT02065219|Bupivacaine|bupivacaine|mesh-list
154535949|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
154535950|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
154535951|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154535952|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535953|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
154535954|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535955|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
154535956|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154535957|NCT03560011|Antibodies|antibodies|mesh-list
154535958|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
154535959|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535960|NCT02069665|Ribavirin|ribavirin|mesh-list
154535961|NCT02069665|Ibuprofen|ibuprofen|mesh-list
154535962|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
154535963|NCT02069665|Albuterol|albuterol|mesh-list
154535964|NCT02069665|Guaifenesin|guaifenesin|mesh-list
154535965|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154535966|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
154535967|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154535968|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
154535969|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154535970|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154535971|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154535972|NCT02069665|Analgesics|analgesics|mesh-ancestor
154535973|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
154535974|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154535975|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154535976|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154535977|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154535978|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154535979|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154535980|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154535981|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
154535982|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154535983|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
154535984|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
154535985|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154535986|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154535987|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154535988|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154535989|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
154535990|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154535991|NCT02069665|Expectorants|expectorants|mesh-ancestor
154535992|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154535993|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
154535994|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154535995|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
154535996|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
154535997|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154535998|NCT04938856|Lamotrigine|lamotrigine|mesh-list
154535999|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
154536000|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154536001|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536002|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536003|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154536004|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536005|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154536006|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154536007|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536008|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154536009|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154536010|NCT02461329|Polygeline|polygeline|mesh-list
154536011|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
154536012|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
154536013|NCT02463825|Pimozide|pimozide|mesh-list
154536014|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154536015|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154536016|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536017|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536018|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154536019|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154536020|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
154536021|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536022|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536023|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154536024|NCT02069977|Aripiprazole|aripiprazole|mesh-list
154536025|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
154536026|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154536027|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154536028|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154536029|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536030|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536031|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
154536032|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
154536033|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536034|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536035|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154536036|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154536037|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
154536038|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154536039|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154536040|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154536041|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154536042|NCT04490031|Ketamine|ketamine|mesh-list
154253733|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536043|NCT04490031|Analgesics|analgesics|mesh-ancestor
154536044|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
154536045|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536046|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536047|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154536048|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154536049|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
154536050|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
154536051|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536052|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154536053|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154536054|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536055|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536056|NCT02443402|Insulin|insulin|mesh-list
154536057|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154536058|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
154536059|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154536060|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
154536061|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
154536062|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154536063|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536064|NCT02443402|Incretins|incretins|mesh-ancestor
154536065|NCT02443402|Hormones|hormones|mesh-ancestor
154536066|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536067|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154536068|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
154536069|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536070|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536071|NCT02067013|Ranibizumab|ranibizumab|mesh-list
154536072|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154536073|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154860260|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154536075|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536076|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
154536077|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536078|NCT03298581|Clobetasol|clobetasol|mesh-list
154536079|NCT03298581|Halobetasol|halobetasol|mesh-list
154536080|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154536081|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536082|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
154536083|NCT03298581|Hormones|hormones|mesh-ancestor
154536084|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536085|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536086|NCT01370005|Empagliflozin|empagliflozin|mesh-list
154536087|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154536088|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536089|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154536090|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536091|NCT02070133|Simvastatin|simvastatin|mesh-list
154536092|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154536093|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154536094|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
154536095|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536096|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154536097|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154536098|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536099|NCT02070289|PF-06372865|pf-06372865|mesh-list
154536100|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
154536101|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
154536102|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536103|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536104|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536105|NCT02071927|Azacitidine|azacitidine|mesh-list
154536106|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154536107|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
154536108|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536109|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536110|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536111|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
154536112|NCT02072083|Ketamine|ketamine|mesh-list
154536113|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154536114|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536115|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253734|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
154536116|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536117|NCT02072083|Analgesics|analgesics|mesh-ancestor
154536118|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
154536119|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536120|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154536121|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154536122|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154536123|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154536124|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536125|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536126|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154536127|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154536128|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
154536129|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
154536130|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154536131|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154536132|NCT02070679|Vitamin E|vitamin e|mesh-list
154536133|NCT02070679|Tocopherols|tocopherols|mesh-list
154536134|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
154536135|NCT02070679|Vitamins|vitamins|mesh-ancestor
154536136|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
154536137|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536138|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
154536139|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536140|NCT02070679|Protective Agents|protective agents|mesh-ancestor
154536141|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154536142|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
154536143|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154536144|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154536145|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154536146|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
154536147|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154536148|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536149|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154536150|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154536151|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154536152|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154536153|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536154|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154536155|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154536156|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536157|NCT02072317|Raltitrexed|raltitrexed|mesh-list
154536158|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154536159|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
154536160|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536161|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536162|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154536163|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536164|NCT01651000|Calcifediol|calcifediol|mesh-list
154536165|NCT01651000|Vitamins|vitamins|mesh-ancestor
154536166|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
154536167|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536168|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154536169|NCT02469610|Bupivacaine|bupivacaine|mesh-list
154536170|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
154536171|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
154536172|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536173|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536174|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
154536175|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536176|NCT02071069|Fluorouracil|fluorouracil|mesh-list
154536177|NCT02071069|Irinotecan|irinotecan|mesh-list
154536178|NCT02071069|Cetuximab|cetuximab|mesh-list
154536179|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
154536180|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536181|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154536182|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536183|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154536184|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
154536185|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536186|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154536187|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154536188|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305235|NCT01170819|Dinoprostone|dinoprostone|mesh-list
154536189|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154536190|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
154536191|NCT02076373|Hematinics|hematinics|mesh-ancestor
154536192|NCT02072785|Vincristine|vincristine|mesh-list
154536193|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154536194|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536195|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
154536196|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
154536197|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
154536198|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536199|NCT02469298|Oseltamivir|oseltamivir|mesh-list
154536200|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
154536201|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536202|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536203|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536204|NCT02076451|DS-8273a|ds-8273a|mesh-list
154536205|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154536206|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536207|NCT02071303|Celecoxib|celecoxib|mesh-list
154536208|NCT02071303|Tramadol|tramadol|mesh-list
154536209|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154536210|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536211|NCT02071303|Analgesics|analgesics|mesh-ancestor
154536212|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
154536213|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536214|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536215|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536216|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536217|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154536218|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154536219|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536220|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536221|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154536222|NCT02071303|Narcotics|narcotics|mesh-ancestor
154536223|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536225|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
154536226|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
154536227|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536228|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536229|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154536230|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154536231|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
154536232|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536233|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536234|NCT02411578|Glucagon|glucagon|mesh-list
154536235|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154536236|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154536237|NCT02411578|Hormones|hormones|mesh-ancestor
154536238|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536239|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536240|NCT02411578|Incretins|incretins|mesh-ancestor
154536241|NCT02076685|Isoniazid|isoniazid|mesh-list
154536242|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
154536243|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154536244|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536245|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154536246|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154536247|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
154536248|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536249|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154536250|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
154536251|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154536252|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
154536253|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536254|NCT05077917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154536255|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536256|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154536257|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
154536258|NCT02071459|Droxidopa|droxidopa|mesh-list
154536259|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154536260|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154536261|NCT02463747|Vancomycin|vancomycin|mesh-list
154536262|NCT02463747|Meropenem|meropenem|mesh-list
154536263|NCT02463747|Tazobactam|tazobactam|mesh-list
154536264|NCT02463747|Piperacillin|piperacillin|mesh-list
154536265|NCT02463747|Ceftazidime|ceftazidime|mesh-list
154536266|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154536267|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154536268|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536269|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154536270|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536271|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536272|NCT02463747|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154536273|NCT02463747|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154536274|NCT02071537|Chloroquine|chloroquine|mesh-list
154536275|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154536276|NCT02071537|Carboplatin|carboplatin|mesh-list
154536277|NCT02071537|Gemcitabine|gemcitabine|mesh-list
154536278|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536279|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154536280|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
154536281|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536282|NCT02071537|Amebicides|amebicides|mesh-ancestor
154536283|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154536284|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154536285|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536286|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
154536287|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536288|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154536289|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536290|NCT02071537|Analgesics|analgesics|mesh-ancestor
154536291|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
154536292|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536293|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536294|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536295|NCT02071537|Filaricides|filaricides|mesh-ancestor
154536296|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
154536297|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
154536298|NCT02076841|Interferons|interferons|mesh-list
154536299|NCT02076841|Interferon-beta|interferon-beta|mesh-list
154536300|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
154536301|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536302|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
154536303|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536304|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
154536305|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536306|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154536307|NCT02442310|Deferiprone|deferiprone|mesh-list
154536308|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154536309|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
154536310|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
154536311|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536312|NCT02071615|Caffeine|caffeine|mesh-list
154536313|NCT02071615|Methylphenidate|methylphenidate|mesh-list
154536314|NCT02071615|Modafinil|modafinil|mesh-list
154536315|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154536316|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536317|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154536318|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536319|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536320|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154536321|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154536322|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
154536323|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536324|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154536325|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154536326|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536327|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
154536328|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154536329|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154536330|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154536331|NCT02077231|Vitamins|vitamins|mesh-list
154536332|NCT02077231|Vitamin A|vitamin a|mesh-list
154536333|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
154536334|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
154536335|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536336|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
154536337|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536338|NCT02077231|Protective Agents|protective agents|mesh-ancestor
154536339|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154536340|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536341|NCT02077309|Linagliptin|linagliptin|mesh-list
154536342|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154536343|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536344|NCT02077309|Incretins|incretins|mesh-ancestor
154536346|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536347|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154536348|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
154536349|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536350|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536351|NCT01369849|Rituximab|rituximab|mesh-list
154536352|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154536353|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154536354|NCT01369849|Antibodies|antibodies|mesh-list
154536355|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
154536356|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154536357|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
154536358|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536359|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536360|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536361|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154536362|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
154536363|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536364|NCT02716779|Interferons|interferons|mesh-list
154536365|NCT02716779|Ribavirin|ribavirin|mesh-list
154536366|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536367|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
154536368|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536369|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
154536370|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536371|NCT02074189|Gemcitabine|gemcitabine|mesh-list
154536372|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536373|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154860261|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536374|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
154536375|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536376|NCT02463591|Thrombin|thrombin|mesh-list
154536377|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
154536378|NCT02463591|Coagulants|coagulants|mesh-ancestor
154536379|NCT02079961|Micronutrients|micronutrients|mesh-list
154536380|NCT02079961|Trace Elements|trace elements|mesh-list
154536381|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536382|NCT03298347|Caffeine|caffeine|mesh-list
154536383|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154536384|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536385|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154536386|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536387|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536388|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154536389|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154536390|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
154536391|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536392|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154536393|NCT02077777|Mesalamine|mesalamine|mesh-list
154536394|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154536395|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536396|NCT02077777|Analgesics|analgesics|mesh-ancestor
154536397|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
154536398|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536399|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536400|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536401|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536402|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
154536403|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154536404|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536405|NCT05036421|Empagliflozin|empagliflozin|mesh-list
154536406|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154536407|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536408|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154536409|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536410|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
154536411|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
154536412|NCT03298191|Ritodrine|ritodrine|mesh-list
154536413|NCT03298191|Calcium|calcium|mesh-list
154536414|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154536415|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536416|NCT03298191|Analgesics|analgesics|mesh-ancestor
154536417|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
154260216|NCT03856112|Hormones|hormones|mesh-ancestor
154536418|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536419|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
154536420|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536421|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154536422|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
154536423|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536424|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536425|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
154536426|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154536427|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
154536428|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
154536429|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154536430|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154536431|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154536432|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
154536433|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536434|NCT01369615|Oxycodone|oxycodone|mesh-list
154536435|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154536436|NCT01369615|Narcotics|narcotics|mesh-ancestor
154536437|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536438|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536439|NCT01369615|Analgesics|analgesics|mesh-ancestor
154536440|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
154536441|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536442|NCT02077933|Everolimus|everolimus|mesh-list
154536443|NCT02077933|Exemestane|exemestane|mesh-list
154536444|NCT02077933|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154536445|NCT02077933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154536446|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536447|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536448|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154536449|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
154536450|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536451|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536452|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154536453|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154536454|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154536455|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
154536456|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536457|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
154536458|NCT02078089|Morphine|morphine|mesh-list
154536459|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154536460|NCT02078089|Narcotics|narcotics|mesh-ancestor
154536461|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536462|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536463|NCT02078089|Analgesics|analgesics|mesh-ancestor
154536464|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
154536465|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536466|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
154536467|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154536468|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154536469|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536470|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536471|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154536472|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154536473|NCT02074891|Tenofovir|tenofovir|mesh-list
154536474|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
154536475|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536476|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154536477|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154536478|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536479|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536480|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154536481|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154536482|NCT02078167|Policosanol|policosanol|mesh-list
154536483|NCT02078167|Red yeast rice|red yeast rice|mesh-list
154536484|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154536485|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154536486|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154536487|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
154536488|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536489|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536490|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154536491|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154536493|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154536494|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
154536495|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536496|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154536497|NCT02075749|Triamcinolone|triamcinolone|mesh-list
154536498|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154536499|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154536500|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154536501|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536502|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
154536503|NCT02075749|Hormones|hormones|mesh-ancestor
154536504|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536505|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536506|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154536507|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
154536508|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536509|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536510|NCT02081287|Inositol|inositol|mesh-list
154536511|NCT02081287|Lamotrigine|lamotrigine|mesh-list
154536512|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
154536513|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154536514|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536515|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536516|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154536517|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536518|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154536519|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154536520|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536521|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154860262|NCT01923818|Analgesics|analgesics|mesh-ancestor
154536522|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154536523|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
154536524|NCT02081287|Vitamins|vitamins|mesh-ancestor
154536525|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
154536526|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154536527|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154536528|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154536529|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536530|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536531|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154536532|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536533|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536534|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
154536535|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536536|NCT04918069|Capsaicin|capsaicin|mesh-list
154536537|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
154536538|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154536539|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
154536540|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536541|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536542|NCT02083315|Morphine|morphine|mesh-list
154536543|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154536544|NCT02083315|Narcotics|narcotics|mesh-ancestor
154536545|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536546|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536547|NCT02083315|Analgesics|analgesics|mesh-ancestor
154536548|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
154536549|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536550|NCT03559387|Lenograstim|lenograstim|mesh-list
154536551|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154536552|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
154536553|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536554|NCT02079337|Rocuronium|rocuronium|mesh-list
154536555|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154536556|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154536557|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154536558|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536559|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536560|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
154536561|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154536562|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154536563|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154536564|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
154536565|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536566|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154536567|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154536568|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536569|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154536570|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536571|NCT02079727|Celecoxib|celecoxib|mesh-list
154536572|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154536573|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536574|NCT02079727|Analgesics|analgesics|mesh-ancestor
154536575|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
154536576|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536577|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536578|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536579|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536580|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154536581|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154536582|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536583|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536584|NCT02082067|Ketorolac|ketorolac|mesh-list
154536585|NCT02082067|Morphine|morphine|mesh-list
154536586|NCT02082067|Anesthetics|anesthetics|mesh-list
154536587|NCT02082067|Ropivacaine|ropivacaine|mesh-list
154536588|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
154536589|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
154536590|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536591|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536592|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154536593|NCT02082067|Narcotics|narcotics|mesh-ancestor
154536594|NCT02082067|Analgesics|analgesics|mesh-ancestor
154536595|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
154536596|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536597|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154536598|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536599|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536600|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536601|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154536602|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536603|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536604|NCT06131918|Thioctic Acid|thioctic acid|mesh-list
154536605|NCT06131918|Resveratrol|resveratrol|mesh-list
154536606|NCT06131918|Superoxide Dismutase|superoxide dismutase|mesh-list
154536607|NCT06131918|Antioxidants|antioxidants|mesh-ancestor
154536608|NCT06131918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536609|NCT06131918|Protective Agents|protective agents|mesh-ancestor
154536610|NCT06131918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536611|NCT06131918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536612|NCT06131918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154536613|NCT06131918|Vitamin B Complex|vitamin b complex|mesh-ancestor
154536614|NCT06131918|Vitamins|vitamins|mesh-ancestor
154536615|NCT06131918|Micronutrients|micronutrients|mesh-ancestor
154536616|NCT06131918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154536617|NCT06131476|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154536618|NCT06131476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154536619|NCT06131294|Fluorides|fluorides|mesh-list
154536620|NCT06131294|Cariostatic Agents|cariostatic agents|mesh-ancestor
154536621|NCT06131294|Protective Agents|protective agents|mesh-ancestor
154536622|NCT06131294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536623|NCT06131268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154536624|NCT06131268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154536625|NCT06131268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154536626|NCT06131268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536627|NCT06131268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536628|NCT06131268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536629|NCT06131268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536630|NCT06131268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154536631|NCT06131268|Antidepressive Agents|antidepressive agents|mesh-ancestor
154536632|NCT06131268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154536633|NCT06131255|Citalopram|citalopram|mesh-list
154536634|NCT06131255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154536635|NCT06131255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154536636|NCT06131255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536637|NCT06131255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536638|NCT06131255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536639|NCT06131255|Serotonin Agents|serotonin agents|mesh-ancestor
154536640|NCT06131255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536641|NCT06131255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154536642|NCT06131255|Antidepressive Agents|antidepressive agents|mesh-ancestor
154536643|NCT06131255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154536644|NCT06131021|Amoxicillin|amoxicillin|mesh-list
154536645|NCT06131021|Metronidazole|metronidazole|mesh-list
154536646|NCT06131021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154536647|NCT06131021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536648|NCT06131021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154536649|NCT06131021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154536650|NCT06130618|Lidocaine|lidocaine|mesh-list
154536651|NCT06130618|Anesthetics, Local|anesthetics, local|mesh-ancestor
154536652|NCT06130618|Anesthetics|anesthetics|mesh-ancestor
154536653|NCT06130618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536654|NCT06130618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536655|NCT06130618|Sensory System Agents|sensory system agents|mesh-ancestor
154536656|NCT06130618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536657|NCT06130618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154536658|NCT06130618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154536659|NCT06130618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154536660|NCT06130618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154536661|NCT06130618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536662|NCT06130449|Methyltestosterone|methyltestosterone|mesh-list
154536663|NCT06130449|Testosterone|testosterone|mesh-list
154536664|NCT06130449|Testosterone undecanoate|testosterone undecanoate|mesh-list
154536665|NCT06130449|Testosterone enanthate|testosterone enanthate|mesh-list
154536666|NCT06130449|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154536667|NCT06130449|Androgens|androgens|mesh-ancestor
154536668|NCT06130449|Hormones|hormones|mesh-ancestor
154536669|NCT06130449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536670|NCT06130449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536671|NCT06130449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154536672|NCT06130449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536673|NCT06130449|Anabolic Agents|anabolic agents|mesh-ancestor
154536674|NCT06130345|Vaccines|vaccines|mesh-list
154536675|NCT06130345|Immunologic Factors|immunologic factors|mesh-ancestor
154536676|NCT06130345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536677|NCT06129032|Anesthetics|anesthetics|mesh-list
154536678|NCT06129032|Anesthetics, Local|anesthetics, local|mesh-list
154536679|NCT06129032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536680|NCT06129032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536681|NCT06129032|Sensory System Agents|sensory system agents|mesh-ancestor
154536682|NCT06129032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536683|NCT06127940|Sotorasib|sotorasib|mesh-list
154536684|NCT06127940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154536685|NCT06127940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536686|NCT06127940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154536687|NCT06127940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536688|NCT06127901|Anesthetics|anesthetics|mesh-list
154536689|NCT06127901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536690|NCT06127901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536691|NCT06127693|Vaccines|vaccines|mesh-list
154536692|NCT06127693|Immunologic Factors|immunologic factors|mesh-ancestor
154536693|NCT06127693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536694|NCT06127628|Ropivacaine|ropivacaine|mesh-list
154536695|NCT06127628|Anesthetics, Local|anesthetics, local|mesh-ancestor
154536696|NCT06127628|Anesthetics|anesthetics|mesh-ancestor
154536697|NCT06127628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536698|NCT06127628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536699|NCT06127628|Sensory System Agents|sensory system agents|mesh-ancestor
154536700|NCT06127628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536701|NCT06127589|Nicotine|nicotine|mesh-list
154536702|NCT06127589|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154536703|NCT06127589|Autonomic Agents|autonomic agents|mesh-ancestor
154305716|NCT05707936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154536704|NCT06127589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536705|NCT06127589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536706|NCT06127589|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154536707|NCT06127589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154536708|NCT06127589|Cholinergic Agents|cholinergic agents|mesh-ancestor
154536709|NCT06127589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536710|NCT06127589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536711|NCT06127498|Antibodies|antibodies|mesh-list
154536712|NCT06127498|Immunoglobulins|immunoglobulins|mesh-list
154536713|NCT06127498|Immunologic Factors|immunologic factors|mesh-ancestor
154536714|NCT06127498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536715|NCT06127433|Insulin|insulin|mesh-list
154536716|NCT06127433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154536717|NCT06127433|Metformin|metformin|mesh-list
154536718|NCT06127433|Insulin Glargine|insulin glargine|mesh-list
154536719|NCT06127433|Dapagliflozin|dapagliflozin|mesh-list
154536720|NCT06127433|Insulin Aspart|insulin aspart|mesh-list
154536721|NCT06127433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154536722|NCT06127433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536723|NCT06127433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154536724|NCT06127433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536725|NCT06127407|Ivosidenib|ivosidenib|mesh-list
154536726|NCT06127407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536727|NCT06127407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536728|NCT06127407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536729|NCT06127381|Glycolic acid|glycolic acid|mesh-list
154536730|NCT06127381|Keratolytic Agents|keratolytic agents|mesh-ancestor
154536731|NCT06127381|Dermatologic Agents|dermatologic agents|mesh-ancestor
154536732|NCT06127355|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154536733|NCT06127355|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154536734|NCT06127355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154536735|NCT06127303|Immunomodulating Agents|immunomodulating agents|mesh-list
154536736|NCT06127303|Immunologic Factors|immunologic factors|mesh-ancestor
154536737|NCT06127303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536738|NCT06127264|Carbon Fiber|carbon fiber|mesh-list
154536739|NCT06127264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154536740|NCT06127264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536741|NCT06127212|Dapagliflozin|dapagliflozin|mesh-list
154536742|NCT06127212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154536743|NCT06127212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536744|NCT06127212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154536745|NCT06127212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536746|NCT06127160|Cephalexin|cephalexin|mesh-list
154860263|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
154536747|NCT06127160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154536748|NCT06127160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536749|NCT06126913|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154536750|NCT06126913|Antiviral Agents|antiviral agents|mesh-ancestor
154536751|NCT06126913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536752|NCT06126835|Ozanimod|ozanimod|mesh-list
154536753|NCT06126835|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154536754|NCT06126835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536755|NCT06126835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154536756|NCT06126835|Immunologic Factors|immunologic factors|mesh-ancestor
154536757|NCT06126835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536758|NCT06126731|Amoxicillin|amoxicillin|mesh-list
154536759|NCT06126731|Metronidazole|metronidazole|mesh-list
154536760|NCT06126731|Vancomycin|vancomycin|mesh-list
154536761|NCT06126731|Ciprofloxacin|ciprofloxacin|mesh-list
154536762|NCT06126731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154536763|NCT06126731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536764|NCT06126731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154536765|NCT06126731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154536766|NCT06126731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154536767|NCT06126731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154536768|NCT06126731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536769|NCT06126731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536770|NCT06126731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536771|NCT06126731|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154536772|NCT06126731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154536773|NCT06126705|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154536774|NCT06126705|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154536775|NCT06126705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536776|NCT06126640|Trastuzumab|trastuzumab|mesh-list
154536777|NCT06126640|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154536778|NCT06126640|Maytansine|maytansine|mesh-list
154536779|NCT06126640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154536780|NCT06126640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536781|NCT06126640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154536782|NCT06126640|Tubulin Modulators|tubulin modulators|mesh-ancestor
154536783|NCT06126640|Antimitotic Agents|antimitotic agents|mesh-ancestor
154536784|NCT06126640|Mitosis Modulators|mitosis modulators|mesh-ancestor
154536785|NCT06126640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536786|NCT06126640|Immunotoxins|immunotoxins|mesh-ancestor
154536787|NCT06126640|Immunoconjugates|immunoconjugates|mesh-ancestor
154536788|NCT06126640|Immunologic Factors|immunologic factors|mesh-ancestor
154536789|NCT06126640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260624|NCT01191710|Hormones|hormones|mesh-ancestor
154536790|NCT06126588|Everolimus|everolimus|mesh-list
154536791|NCT06126588|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154536792|NCT06126588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154536793|NCT06126588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536794|NCT06126588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536795|NCT06126588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154536796|NCT06126588|Immunologic Factors|immunologic factors|mesh-ancestor
154536797|NCT06126588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536798|NCT06126588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536799|NCT06126380|Tacrolimus|tacrolimus|mesh-list
154536800|NCT06126380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154536801|NCT06126380|Immunologic Factors|immunologic factors|mesh-ancestor
154536802|NCT06126380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536803|NCT06126380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154536804|NCT06126380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536805|NCT06126380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536806|NCT06126354|Insulin|insulin|mesh-list
154536807|NCT06126354|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154536808|NCT06126354|Dexamethasone|dexamethasone|mesh-list
154536809|NCT06126354|Dexamethasone acetate|dexamethasone acetate|mesh-list
154536810|NCT06126354|Octreotide|octreotide|mesh-list
154536811|NCT06126354|Glucagon|glucagon|mesh-list
154536812|NCT06126354|Hormones|hormones|mesh-list
154536813|NCT06126354|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154536814|NCT06126354|BB 1101|bb 1101|mesh-list
154536815|NCT06126354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154536816|NCT06126354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536817|NCT06126354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536818|NCT06126354|Antiemetics|antiemetics|mesh-ancestor
154536819|NCT06126354|Autonomic Agents|autonomic agents|mesh-ancestor
154536820|NCT06126354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536821|NCT06126354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154536823|NCT06126354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536824|NCT06126354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154536825|NCT06126354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536826|NCT06126354|Protease Inhibitors|protease inhibitors|mesh-ancestor
154536827|NCT06126354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536828|NCT06126354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536829|NCT06126354|Incretins|incretins|mesh-ancestor
154536830|NCT06126263|Clindamycin|clindamycin|mesh-list
154536831|NCT06126263|Clindamycin palmitate|clindamycin palmitate|mesh-list
154536832|NCT06126263|Clindamycin phosphate|clindamycin phosphate|mesh-list
154536833|NCT06126263|Linezolid|linezolid|mesh-list
154536834|NCT06126263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154536835|NCT06126263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536836|NCT06126263|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154536837|NCT06126263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536838|NCT06126263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536839|NCT06126042|Abatacept|abatacept|mesh-list
154536840|NCT06126042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154536841|NCT06126042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536842|NCT06126042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154536843|NCT06126042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536844|NCT06126042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154536845|NCT06126042|Immunologic Factors|immunologic factors|mesh-ancestor
154536846|NCT06126042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536847|NCT06126042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536848|NCT06126029|Metformin|metformin|mesh-list
154536849|NCT06126029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154536850|NCT06126029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536851|NCT06125665|Aminophylline|aminophylline|mesh-list
154536852|NCT06125665|Dexmedetomidine|dexmedetomidine|mesh-list
154536853|NCT06125665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154536854|NCT06125665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536855|NCT06125665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536856|NCT06125665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536857|NCT06125665|Analgesics|analgesics|mesh-ancestor
154536858|NCT06125665|Sensory System Agents|sensory system agents|mesh-ancestor
154536859|NCT06125665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536860|NCT06125665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154536861|NCT06125665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154536862|NCT06125665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154536863|NCT06125665|Adrenergic Agents|adrenergic agents|mesh-ancestor
154536864|NCT06125665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536865|NCT06125665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536866|NCT06125665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154536867|NCT06125665|Autonomic Agents|autonomic agents|mesh-ancestor
154536868|NCT06125665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154536869|NCT06125665|Respiratory System Agents|respiratory system agents|mesh-ancestor
154536870|NCT06125665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154536871|NCT06125665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154536872|NCT06125665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536873|NCT06125665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154536874|NCT06125665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154536875|NCT06125665|Purinergic Agents|purinergic agents|mesh-ancestor
154536876|NCT06125665|Protective Agents|protective agents|mesh-ancestor
154536877|NCT06124703|Prednisone|prednisone|mesh-list
154536878|NCT06124703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536879|NCT06124703|Glucocorticoids|glucocorticoids|mesh-ancestor
154536880|NCT06124703|Hormones|hormones|mesh-ancestor
154536881|NCT06124703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536882|NCT06124703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536883|NCT06124703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154536884|NCT06124703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536885|NCT06124066|Tamsulosin|tamsulosin|mesh-list
154536886|NCT06124066|Mirabegron|mirabegron|mesh-list
154536887|NCT06124066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154536888|NCT06124066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154536889|NCT06124066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154536890|NCT06124066|Adrenergic Agents|adrenergic agents|mesh-ancestor
154536891|NCT06124066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536892|NCT06124066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536893|NCT06124066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536894|NCT06124066|Urological Agents|urological agents|mesh-ancestor
154536895|NCT06124066|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154536896|NCT06124066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154536897|NCT06124066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154536898|NCT06121544|Flutemetamol|flutemetamol|mesh-list
154536899|NCT06121544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154536900|NCT06121544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536901|NCT06120842|Timolol|timolol|mesh-list
154536902|NCT06120842|Bimatoprost|bimatoprost|mesh-list
154536903|NCT06120842|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154536904|NCT06120842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154536905|NCT06120842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536906|NCT06120842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154536907|NCT06120842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154536908|NCT06120842|Adrenergic Agents|adrenergic agents|mesh-ancestor
154536909|NCT06120842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154536910|NCT06120842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536911|NCT06120842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154536912|NCT06120842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154536913|NCT06118957|Enoxaparin|enoxaparin|mesh-list
154536914|NCT06118957|Anticoagulants|anticoagulants|mesh-ancestor
154536915|NCT06118957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154536916|NCT06118957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154536917|NCT06118957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536918|NCT06105476|Vitamin A|vitamin a|mesh-list
154536919|NCT06105476|Ethanol|ethanol|mesh-list
154536920|NCT06105476|Retinol palmitate|retinol palmitate|mesh-list
154536921|NCT06105476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154536922|NCT06105476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536923|NCT06105476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536924|NCT06105476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536925|NCT06105476|Vitamins|vitamins|mesh-ancestor
154536926|NCT06105476|Micronutrients|micronutrients|mesh-ancestor
154536927|NCT06105476|Antioxidants|antioxidants|mesh-ancestor
154536928|NCT06105476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536929|NCT06105476|Protective Agents|protective agents|mesh-ancestor
154536930|NCT06105476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154536931|NCT06105476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536932|NCT06091956|Deucravacitinib|deucravacitinib|mesh-list
154536933|NCT06091956|Dermatologic Agents|dermatologic agents|mesh-ancestor
154536934|NCT06091956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154536935|NCT06091956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536936|NCT06091956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536937|NCT06088147|Triamcinolone|triamcinolone|mesh-list
154536938|NCT06088147|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154536939|NCT06088147|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154536940|NCT06088147|Methotrexate|methotrexate|mesh-list
154260743|NCT01192802|Albendazole|albendazole|mesh-list
154536942|NCT06088147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154536943|NCT06088147|Abortifacient Agents|abortifacient agents|mesh-ancestor
154536944|NCT06088147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154536945|NCT06088147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536946|NCT06088147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154536947|NCT06088147|Antimetabolites|antimetabolites|mesh-ancestor
154536948|NCT06088147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536949|NCT06088147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536950|NCT06088147|Dermatologic Agents|dermatologic agents|mesh-ancestor
154536951|NCT06088147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154536952|NCT06088147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154536953|NCT06088147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154536954|NCT06088147|Immunologic Factors|immunologic factors|mesh-ancestor
154536955|NCT06088147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536956|NCT06088147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154536957|NCT06088147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536958|NCT06088147|Glucocorticoids|glucocorticoids|mesh-ancestor
154536959|NCT06088147|Hormones|hormones|mesh-ancestor
154536960|NCT06088147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154536961|NCT06081114|Micronutrients|micronutrients|mesh-list
154536962|NCT06081114|Trace Elements|trace elements|mesh-list
154536963|NCT06081114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536964|NCT06069414|Anesthetics|anesthetics|mesh-list
154536965|NCT06069414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536966|NCT06069414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536967|NCT06067399|Chrysarobin|chrysarobin|mesh-list
154536968|NCT06067399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154536969|NCT06067399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154536971|NCT06067399|Sensory System Agents|sensory system agents|mesh-ancestor
154536972|NCT06067399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154536973|NCT06067399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536974|NCT06067399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154536975|NCT06067399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154536976|NCT06058962|Suramin|suramin|mesh-list
154536977|NCT06058962|Antinematodal Agents|antinematodal agents|mesh-ancestor
154536978|NCT06058962|Anthelmintics|anthelmintics|mesh-ancestor
154536979|NCT06058962|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154536980|NCT06058962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154536981|NCT06058962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536982|NCT06058962|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154536983|NCT06058962|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154536984|NCT06056310|Cisplatin|cisplatin|mesh-list
154536985|NCT06056310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536986|NCT06049953|Antipsychotic Agents|antipsychotic agents|mesh-list
154536987|NCT06049953|Antidepressive Agents|antidepressive agents|mesh-list
154536988|NCT06049953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154536989|NCT06049953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154536990|NCT06049953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154536991|NCT06049953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154536992|NCT06022757|Pembrolizumab|pembrolizumab|mesh-list
154536993|NCT06022757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154536994|NCT06022757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154536995|NCT06022757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154536996|NCT06022757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536997|NCT06016452|Chlorophyllin|chlorophyllin|mesh-list
154536998|NCT06016452|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154536999|NCT06016452|Protective Agents|protective agents|mesh-ancestor
154537000|NCT06016452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537001|NCT06011889|Etanercept|etanercept|mesh-list
154537002|NCT06011889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154537003|NCT06011889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154537004|NCT06011889|Analgesics|analgesics|mesh-ancestor
154537005|NCT06011889|Sensory System Agents|sensory system agents|mesh-ancestor
154537006|NCT06011889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537007|NCT06011889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537008|NCT06011889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537009|NCT06011889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537010|NCT06011889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154537011|NCT06011889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154537012|NCT06011889|Immunologic Factors|immunologic factors|mesh-ancestor
154537013|NCT06006026|Ropivacaine|ropivacaine|mesh-list
154537014|NCT06006026|Anesthetics, Local|anesthetics, local|mesh-ancestor
154537015|NCT06006026|Anesthetics|anesthetics|mesh-ancestor
154537016|NCT06006026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537017|NCT06006026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537018|NCT06006026|Sensory System Agents|sensory system agents|mesh-ancestor
154537019|NCT06006026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537020|NCT06002152|Bupivacaine|bupivacaine|mesh-list
154537021|NCT06002152|Anesthetics, Local|anesthetics, local|mesh-ancestor
154537022|NCT06002152|Anesthetics|anesthetics|mesh-ancestor
154537023|NCT06002152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537024|NCT06002152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537025|NCT06002152|Sensory System Agents|sensory system agents|mesh-ancestor
154537026|NCT06002152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537027|NCT05996523|Pembrolizumab|pembrolizumab|mesh-list
154537028|NCT05996523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537029|NCT05996523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537030|NCT05996523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154537031|NCT05996523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537032|NCT05978206|Nandrolone Decanoate|nandrolone decanoate|mesh-list
154537033|NCT05978206|Nandrolone|nandrolone|mesh-list
154537034|NCT05978206|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
154537035|NCT05978206|Androgens|androgens|mesh-ancestor
154537036|NCT05978206|Hormones|hormones|mesh-ancestor
154537037|NCT05978206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537038|NCT05978206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537039|NCT05978206|Anabolic Agents|anabolic agents|mesh-ancestor
154537040|NCT05978206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154537041|NCT05973006|Vaccines|vaccines|mesh-list
154537042|NCT05973006|Immunologic Factors|immunologic factors|mesh-ancestor
154537043|NCT05973006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537044|NCT05970354|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154537045|NCT05970354|Anesthetics, Local|anesthetics, local|mesh-ancestor
154537046|NCT05970354|Anesthetics|anesthetics|mesh-ancestor
154537047|NCT05970354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537048|NCT05970354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537049|NCT05970354|Sensory System Agents|sensory system agents|mesh-ancestor
154537050|NCT05970354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537051|NCT05970354|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154537052|NCT05967052|Pregabalin|pregabalin|mesh-list
154537053|NCT05967052|Analgesics|analgesics|mesh-ancestor
154537054|NCT05967052|Sensory System Agents|sensory system agents|mesh-ancestor
154537055|NCT05967052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537056|NCT05967052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537057|NCT05967052|Anticonvulsants|anticonvulsants|mesh-ancestor
154537058|NCT05967052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154537059|NCT05967052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154537060|NCT05967052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537061|NCT05967052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154537062|NCT05967052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154537063|NCT05967052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154537064|NCT05967052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537065|NCT05967052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154537066|NCT05966090|Vaccines|vaccines|mesh-list
154537067|NCT05966090|Immunologic Factors|immunologic factors|mesh-ancestor
154537068|NCT05966090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537069|NCT05964920|Methyltestosterone|methyltestosterone|mesh-list
154537070|NCT05964920|Testosterone|testosterone|mesh-list
154537071|NCT05964920|Testosterone undecanoate|testosterone undecanoate|mesh-list
154537072|NCT05964920|Testosterone enanthate|testosterone enanthate|mesh-list
154537073|NCT05964920|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154537074|NCT05964920|Androgens|androgens|mesh-ancestor
154537075|NCT05964920|Hormones|hormones|mesh-ancestor
154537076|NCT05964920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537077|NCT05964920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537078|NCT05964920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154537079|NCT05964920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537080|NCT05964920|Anabolic Agents|anabolic agents|mesh-ancestor
154537081|NCT05950724|Etanercept|etanercept|mesh-list
154537082|NCT05950724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154537083|NCT05950724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154537084|NCT05950724|Analgesics|analgesics|mesh-ancestor
154537085|NCT05950724|Sensory System Agents|sensory system agents|mesh-ancestor
154537086|NCT05950724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537087|NCT05950724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537088|NCT05950724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537089|NCT05950724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537090|NCT05950724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154537091|NCT05950724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154537092|NCT05950724|Immunologic Factors|immunologic factors|mesh-ancestor
154537093|NCT05929716|Rituximab|rituximab|mesh-list
154537094|NCT05929716|Magrolimab|magrolimab|mesh-list
154537095|NCT05929716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537096|NCT05929716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537097|NCT05929716|Immunologic Factors|immunologic factors|mesh-ancestor
154537098|NCT05929716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537099|NCT05929716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537100|NCT05914194|Mazindol|mazindol|mesh-list
154537101|NCT05914194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154537102|NCT05914194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537103|NCT05914194|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154537104|NCT05914194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154537105|NCT05914194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154537106|NCT05914194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537107|NCT05914194|Adrenergic Agents|adrenergic agents|mesh-ancestor
154537108|NCT05914194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537109|NCT05914194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154537110|NCT05914194|Dopamine Agents|dopamine agents|mesh-ancestor
154537111|NCT05909150|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154537112|NCT05908526|Suvorexant|suvorexant|mesh-list
154537113|NCT05908526|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154537114|NCT05908526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154537115|NCT05908526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537116|NCT05908526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537117|NCT05908526|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154537118|NCT05908526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537119|NCT05908526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537120|NCT05900284|Metformin|metformin|mesh-list
154537121|NCT05900284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154537122|NCT05900284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537123|NCT05900258|Tirbanibulin|tirbanibulin|mesh-list
154537124|NCT05900258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537125|NCT05900258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537126|NCT05893030|Anesthetics|anesthetics|mesh-list
154537127|NCT05893030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537128|NCT05893030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537129|NCT05833867|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154537130|NCT05833867|Immunoconjugates|immunoconjugates|mesh-ancestor
154537131|NCT05833867|Immunologic Factors|immunologic factors|mesh-ancestor
154537132|NCT05833867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537133|NCT05824338|Bupivacaine|bupivacaine|mesh-list
154537134|NCT05824338|Ropivacaine|ropivacaine|mesh-list
154537135|NCT05824338|Anesthetics|anesthetics|mesh-list
154537136|NCT05824338|Anesthetics, Local|anesthetics, local|mesh-ancestor
154537137|NCT05824338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537138|NCT05824338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537139|NCT05824338|Sensory System Agents|sensory system agents|mesh-ancestor
154537140|NCT05824338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537141|NCT05821309|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154537142|NCT05821309|Glycerol|glycerol|mesh-list
154537143|NCT05821309|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154537144|NCT05821309|Protective Agents|protective agents|mesh-ancestor
154537145|NCT05821309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537146|NCT05821309|Laxatives|laxatives|mesh-ancestor
154537147|NCT05821309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154537148|NCT05815680|Metformin|metformin|mesh-list
154537149|NCT05815680|Digoxin|digoxin|mesh-list
154537150|NCT05815680|Warfarin|warfarin|mesh-list
154537151|NCT05815680|Atorvastatin|atorvastatin|mesh-list
154537152|NCT05815680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154537153|NCT05815680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537154|NCT05815680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154537155|NCT05815680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154537156|NCT05815680|Antimetabolites|antimetabolites|mesh-ancestor
154537157|NCT05815680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537158|NCT05815680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154537159|NCT05815680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154537160|NCT05815680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537161|NCT05815680|Anticoagulants|anticoagulants|mesh-ancestor
154537162|NCT05815680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154537163|NCT05815680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154537164|NCT05815680|Protective Agents|protective agents|mesh-ancestor
154537165|NCT05803551|Ketamine|ketamine|mesh-list
154537166|NCT05803551|Analgesics|analgesics|mesh-ancestor
154537167|NCT05803551|Sensory System Agents|sensory system agents|mesh-ancestor
154537168|NCT05803551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537169|NCT05803551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537170|NCT05803551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154537171|NCT05803551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154537172|NCT05803551|Anesthetics, General|anesthetics, general|mesh-ancestor
154537173|NCT05803551|Anesthetics|anesthetics|mesh-ancestor
154537174|NCT05803551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537175|NCT05803551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154537176|NCT05803551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154537177|NCT05803551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537178|NCT05803551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537179|NCT05800860|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154537180|NCT05800860|Hallucinogens|hallucinogens|mesh-ancestor
154537181|NCT05800860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537182|NCT05800860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154537183|NCT05800860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154537184|NCT05800860|Serotonin Agents|serotonin agents|mesh-ancestor
154537185|NCT05800860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537186|NCT05800860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537187|NCT05800860|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154537188|NCT05789342|Itraconazole|itraconazole|mesh-list
154537189|NCT05789342|Oseltamivir|oseltamivir|mesh-list
154537191|NCT05789342|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154537192|NCT05789342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154537193|NCT05789342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154537194|NCT05789342|Antimetabolites|antimetabolites|mesh-ancestor
154537195|NCT05789342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537196|NCT05789342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154537197|NCT05789342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154537198|NCT05789342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537199|NCT05789342|Antifungal Agents|antifungal agents|mesh-ancestor
154537200|NCT05789342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537201|NCT05789342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154537202|NCT05789342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154537203|NCT05789342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154537204|NCT05789342|Hormone Antagonists|hormone antagonists|mesh-ancestor
154537205|NCT05789342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537206|NCT05789342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537207|NCT05789342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154537208|NCT05789342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154537209|NCT05789342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154537210|NCT05789342|Protective Agents|protective agents|mesh-ancestor
154537211|NCT05789342|Antiviral Agents|antiviral agents|mesh-ancestor
154537212|NCT05742568|Amoxicillin|amoxicillin|mesh-list
154537213|NCT05742568|Clarithromycin|clarithromycin|mesh-list
154537214|NCT05742568|Esomeprazole|esomeprazole|mesh-list
154537215|NCT05742568|Bismuth|bismuth|mesh-list
154537216|NCT05742568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154537217|NCT05742568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537218|NCT05742568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154537219|NCT05742568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154537220|NCT05742568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154537221|NCT05742568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537222|NCT05742568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537223|NCT05742568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154537224|NCT05742568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154537225|NCT05742568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154537226|NCT05742568|Antacids|antacids|mesh-ancestor
154537227|NCT05729594|Bimatoprost|bimatoprost|mesh-list
154537228|NCT05729594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154537229|NCT05727527|Anesthetics|anesthetics|mesh-list
154537230|NCT05727527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537231|NCT05727527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537232|NCT05727475|Fluorides|fluorides|mesh-list
154537233|NCT05727475|Cariostatic Agents|cariostatic agents|mesh-ancestor
154537234|NCT05727475|Protective Agents|protective agents|mesh-ancestor
154537235|NCT05727475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537236|NCT05722782|Acetaminophen|acetaminophen|mesh-list
154537237|NCT05722782|Piroxicam|piroxicam|mesh-list
154537238|NCT05722782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154537239|NCT05722782|Analgesics|analgesics|mesh-ancestor
154261044|NCT02918500|Nicotine|nicotine|mesh-list
154537240|NCT05722782|Sensory System Agents|sensory system agents|mesh-ancestor
154537241|NCT05722782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537242|NCT05722782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537243|NCT05722782|Antipyretics|antipyretics|mesh-ancestor
154537244|NCT05722782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154537245|NCT05722782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537246|NCT05722782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537247|NCT05722782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154537248|NCT05722782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537249|NCT05722782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537250|NCT05722327|Irinotecan|irinotecan|mesh-list
154537251|NCT05722327|Cetuximab|cetuximab|mesh-list
154537252|NCT05722327|Adagrasib|adagrasib|mesh-list
154537253|NCT05722327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154537254|NCT05722327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154537255|NCT05722327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537256|NCT05722327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537257|NCT05722327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537258|NCT05722327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537259|NCT05708755|Valganciclovir|valganciclovir|mesh-list
154537260|NCT05708755|Antiviral Agents|antiviral agents|mesh-ancestor
154537261|NCT05708755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537262|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
154537263|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154537264|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537265|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154537266|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537267|NCT05677633|Sargramostim|sargramostim|mesh-list
154537268|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
154537269|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537270|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
154537271|NCT05667727|Epinephrine|epinephrine|mesh-list
154537273|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154537274|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154537275|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154537276|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537277|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537278|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537279|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154537280|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154537281|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
154537282|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537283|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154537284|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
154537285|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
154537286|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
154537287|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154537288|NCT05667727|Tocolytic Agents|tocolytic agents|mesh-ancestor
154537289|NCT05667727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154537290|NCT05667727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154537291|NCT05649085|Cobalt|cobalt|mesh-list
154537292|NCT05649085|Chromium|chromium|mesh-list
154537293|NCT05649085|Trace Elements|trace elements|mesh-ancestor
154537294|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
154537295|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537296|NCT05637567|Aspirin|aspirin|mesh-list
154537297|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154537298|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154537299|NCT05637567|Analgesics|analgesics|mesh-ancestor
154537300|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
154537301|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537302|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537303|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537304|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537305|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154537306|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154537307|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537308|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154537309|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154537310|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537311|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
154537312|NCT05630638|Dolutegravir|dolutegravir|mesh-list
154537313|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154537314|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154261119|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
154537315|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537316|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537317|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154537318|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154537319|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
154537320|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537321|NCT05618002|Clonidine|clonidine|mesh-list
154537322|NCT05618002|Lemborexant|lemborexant|mesh-list
154537323|NCT05618002|Zopiclone|zopiclone|mesh-list
154537324|NCT05618002|Analgesics|analgesics|mesh-ancestor
154537325|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
154537326|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537327|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537328|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154537329|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
154537330|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
154537331|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154537332|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154537333|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154537334|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
154537335|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537336|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537337|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154537338|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154537339|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154537340|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537341|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
154537342|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537343|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537344|NCT05585034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154537345|NCT05585034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537346|NCT05579769|Cyclosporine|cyclosporine|mesh-list
154537347|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
154537348|NCT05579769|Busulfan|busulfan|mesh-list
154537349|NCT05579769|Thiotepa|thiotepa|mesh-list
154537350|NCT05579769|Methotrexate|methotrexate|mesh-list
154537351|NCT05579769|Fludarabine|fludarabine|mesh-list
154537352|NCT05579769|Cyclosporins|cyclosporins|mesh-list
154537353|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
154537354|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154537355|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154537356|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
154537357|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537358|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537359|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154537360|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
154537361|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537362|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537363|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154537364|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154537365|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
154537366|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154537367|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154537368|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
154537369|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
154537370|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537371|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154537372|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154537373|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
154537374|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537375|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154537376|NCT05562999|Bromides|bromides|mesh-list
154537377|NCT05562999|Rocuronium|rocuronium|mesh-list
154537378|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
154537379|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154537380|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154537381|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154537382|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537383|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537384|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154537385|NCT05515874|Hematinics|hematinics|mesh-ancestor
154537386|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154537387|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154537388|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
154537389|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154537390|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537391|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154537392|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
154537393|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537394|NCT05472792|Tamoxifen|tamoxifen|mesh-list
154537395|NCT05472792|Toremifene|toremifene|mesh-list
154537396|NCT05472792|Letrozole|letrozole|mesh-list
154537397|NCT05472792|Fulvestrant|fulvestrant|mesh-list
154537398|NCT05472792|Anastrozole|anastrozole|mesh-list
154537399|NCT05472792|Exemestane|exemestane|mesh-list
154537400|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537401|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154537402|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154537403|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537404|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537405|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154537406|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
154537407|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537408|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537409|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154537410|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154537411|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154537412|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154537413|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154537414|NCT05463783|Tenofovir|tenofovir|mesh-list
154537415|NCT05463783|Emtricitabine|emtricitabine|mesh-list
154537416|NCT05463783|Darunavir|darunavir|mesh-list
154537417|NCT05463783|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154537418|NCT05463783|Cobicistat|cobicistat|mesh-list
154537419|NCT05463783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154860264|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537420|NCT05463783|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154537421|NCT05463783|Antiviral Agents|antiviral agents|mesh-ancestor
154537422|NCT05463783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537423|NCT05463783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154537424|NCT05463783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154537425|NCT05463783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537426|NCT05463783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537427|NCT05463783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154537428|NCT05463783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154537429|NCT05463783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154537430|NCT05463783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154537431|NCT05463783|Protease Inhibitors|protease inhibitors|mesh-ancestor
154537432|NCT05463783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154537433|NCT05463783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154537435|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154537436|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537437|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537438|NCT05427981|Buprenorphine|buprenorphine|mesh-list
154537439|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154537440|NCT05427981|Narcotics|narcotics|mesh-ancestor
154537441|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537442|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537443|NCT05427981|Analgesics|analgesics|mesh-ancestor
154537444|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
154537445|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537446|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154537447|NCT05419466|Melatonin|melatonin|mesh-list
154537448|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
154537449|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537450|NCT05419466|Protective Agents|protective agents|mesh-ancestor
154537451|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537452|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537453|NCT05400915|Paclitaxel|paclitaxel|mesh-list
154537454|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154537455|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537456|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
154537457|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
154537458|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
154537459|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537460|NCT05391230|Permethrin|permethrin|mesh-list
154537461|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537462|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537463|NCT05386706|Metformin|metformin|mesh-list
154537464|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154537465|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537466|NCT05376319|Rituximab|rituximab|mesh-list
154537467|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
154537468|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537469|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537470|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
154537471|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537472|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537473|NCT05367271|Dexamethasone|dexamethasone|mesh-list
154537474|NCT05367271|Cortisone|cortisone|mesh-list
154537475|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154537476|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
154537477|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154537478|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537479|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
154537480|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
154537481|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537482|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537483|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154537484|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
154537485|NCT05367271|Hormones|hormones|mesh-ancestor
154537486|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537487|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154537488|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537489|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154537490|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154537491|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537492|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
154537493|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537494|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154537496|NCT05322473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154537497|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537498|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537499|NCT05316220|Mesalamine|mesalamine|mesh-list
154537500|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154537501|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154537502|NCT05316220|Analgesics|analgesics|mesh-ancestor
154537503|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
154537504|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537505|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537506|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537507|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537508|NCT05311085|Nicotine|nicotine|mesh-list
154537509|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154537510|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
154537511|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306530|NCT04914741|Hormones|hormones|mesh-ancestor
154537512|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537513|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154537514|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154537515|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
154537516|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537517|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537518|NCT05304390|Carbon Monoxide|carbon monoxide|mesh-list
154537519|NCT05304390|Antimetabolites|antimetabolites|mesh-ancestor
154537520|NCT05304390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537521|NCT05304390|Gasotransmitters|gasotransmitters|mesh-ancestor
154537522|NCT05304390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537523|NCT05304390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537524|NCT05289908|Folic Acid|folic acid|mesh-list
154537525|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
154537526|NCT05289908|Dexamethasone|dexamethasone|mesh-list
154537527|NCT05289908|Pemetrexed|pemetrexed|mesh-list
154537528|NCT05289908|Vitamins|vitamins|mesh-ancestor
154537529|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
154537530|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537531|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537532|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
154537533|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
154537534|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537535|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154537536|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
154537537|NCT05289908|Hormones|hormones|mesh-ancestor
154537538|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537539|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154537540|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537541|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537542|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537543|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154537544|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154537545|NCT05289908|Hematinics|hematinics|mesh-ancestor
154537546|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
154537547|NCT05267054|Rituximab|rituximab|mesh-list
154537548|NCT05267054|Tislelizumab|tislelizumab|mesh-list
154537549|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537550|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537551|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
154537552|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537553|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537554|NCT05265208|Capecitabine|capecitabine|mesh-list
154537555|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154537556|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
154537557|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537558|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537559|NCT05264025|Fexofenadine|fexofenadine|mesh-list
154537560|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154537561|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154537562|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154537563|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
154537564|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
154537565|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537566|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537567|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537568|NCT05219877|Levofloxacin|levofloxacin|mesh-list
154537569|NCT05219877|Ofloxacin|ofloxacin|mesh-list
154537570|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154537571|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537572|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154537573|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154537574|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154537576|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537577|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537578|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154537579|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154537580|NCT05199051|Cytarabine|cytarabine|mesh-list
154537581|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
154537582|NCT05199051|Gilteritinib|gilteritinib|mesh-list
154537583|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154537584|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
154537585|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537586|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537587|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
154537588|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537589|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154537590|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
154537591|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537592|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537593|NCT05199051|Immunotoxins|immunotoxins|mesh-ancestor
154537594|NCT05199051|Immunoconjugates|immunoconjugates|mesh-ancestor
154537595|NCT05199051|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154537596|NCT05199051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154537597|NCT05199051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537598|NCT05188053|Ketorolac|ketorolac|mesh-list
154537599|NCT05188053|Epinephrine|epinephrine|mesh-list
154537600|NCT05188053|Ropivacaine|ropivacaine|mesh-list
154537601|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
154537602|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
154537603|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537604|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537605|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
154537606|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537607|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154537608|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154537609|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
154537610|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537611|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537612|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154537613|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154537614|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
154537615|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154537616|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
154537617|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
154537618|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
154537619|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154537620|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154537621|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154537622|NCT05188053|Analgesics|analgesics|mesh-ancestor
154537623|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537624|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537625|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154537626|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537627|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
154537628|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537629|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537630|NCT05141357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154537631|NCT05141357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537632|NCT05141149|Gemcitabine|gemcitabine|mesh-list
154537633|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154537634|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
154537635|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537636|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537637|NCT05137184|Fentanyl|fentanyl|mesh-list
154537638|NCT05137184|Morphine|morphine|mesh-list
154537639|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
154537640|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154537641|NCT05137184|Narcotics|narcotics|mesh-ancestor
154537642|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154537643|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537644|NCT05137184|Analgesics|analgesics|mesh-ancestor
154537645|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
154537646|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537647|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154537648|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154537649|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
154537650|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
154537651|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154537652|NCT05052827|Caseins|caseins|mesh-list
154537653|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
154537654|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
154537655|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537656|NCT05047770|Vaccines|vaccines|mesh-list
154537657|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
154537658|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537659|NCT05034627|Asparaginase|asparaginase|mesh-list
154537660|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537661|NCT04976816|Triamcinolone|triamcinolone|mesh-list
154537662|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154537663|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154537664|NCT04976816|Betamethasone|betamethasone|mesh-list
154537665|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
154537666|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154537667|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
154537668|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154537669|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154537670|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537671|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
154537672|NCT04976816|Hormones|hormones|mesh-ancestor
154537673|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537674|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537675|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154537676|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
154537677|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537678|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537679|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154537680|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
154537681|NCT04971356|Aspirin|aspirin|mesh-list
154537682|NCT04971356|Ticagrelor|ticagrelor|mesh-list
154537683|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154537684|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154537685|NCT04971356|Analgesics|analgesics|mesh-ancestor
154537686|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
154537687|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537688|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537689|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253735|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
154537690|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537691|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154537692|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154537693|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537694|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154537695|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154537696|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537697|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
154537698|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154537699|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154537700|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154537701|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
154537702|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537703|NCT04965701|Osimertinib|osimertinib|mesh-list
154537704|NCT04965701|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154537705|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154537706|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537707|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537708|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537709|NCT04961593|Caspofungin|caspofungin|mesh-list
154537710|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
154537711|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537712|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537713|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537714|NCT04961580|Ceftazidime|ceftazidime|mesh-list
154537715|NCT04961580|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154537716|NCT04961580|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154860265|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537717|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154537718|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537720|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154537721|NCT04961190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154537722|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154537723|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154537724|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537725|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537726|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
154537727|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537728|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154537729|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
154537730|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154537731|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154537732|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154537733|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537734|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154537735|NCT04952597|Tislelizumab|tislelizumab|mesh-list
154537736|NCT04952597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537737|NCT04952597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537738|NCT04952129|Selenium|selenium|mesh-list
154537739|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
154537740|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
154537741|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537742|NCT04952129|Protective Agents|protective agents|mesh-ancestor
154537743|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537744|NCT04952129|Trace Elements|trace elements|mesh-ancestor
154537745|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
154537746|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154537747|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537748|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
154537749|NCT04941703|Cathartics|cathartics|mesh-ancestor
154537750|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154537751|NCT04903002|Oxytocin|oxytocin|mesh-list
154537752|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
154537753|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154537754|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537755|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
154537756|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537757|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
154537758|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154537759|NCT04850222|Fluoxetine|fluoxetine|mesh-list
154537760|NCT04850222|Calcium|calcium|mesh-list
154537761|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154537762|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537763|NCT04850222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154537764|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154537765|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154537766|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537767|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537768|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
154537769|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154537770|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
154537771|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154537772|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154537773|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154537774|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537775|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
154537776|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537777|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
154537778|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154537779|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
154537780|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537781|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537782|NCT04811027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154537783|NCT04811027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537784|NCT04762888|Edetic Acid|edetic acid|mesh-list
154537785|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154537786|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
154537787|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
154537788|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537789|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
154537790|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154537791|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154537792|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
154537793|NCT04740307|Lenvatinib|lenvatinib|mesh-list
154537794|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537795|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537796|NCT04740307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154537797|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537798|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154537799|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537800|NCT04728230|Carboplatin|carboplatin|mesh-list
154537801|NCT04728230|Etoposide|etoposide|mesh-list
154537802|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
154537803|NCT04728230|Durvalumab|durvalumab|mesh-list
154537804|NCT04728230|Olaparib|olaparib|mesh-list
154537805|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
154537806|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
154537807|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154537808|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
154537809|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537810|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154537811|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154537812|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154537813|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537814|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537815|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537816|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
154537817|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537818|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154537819|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
154537820|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
154537821|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
154537822|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
154537823|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
154537824|NCT04727424|Budesonide|budesonide|mesh-list
154537825|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
154537826|NCT04727424|Fluoxetine|fluoxetine|mesh-list
154537827|NCT04727424|Maleic acid|maleic acid|mesh-list
154537828|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537829|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154537830|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
154537831|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537832|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537833|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154537834|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
154537835|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
154537836|NCT04727424|Hormones|hormones|mesh-ancestor
154537837|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537838|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537839|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537840|NCT04727424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154537841|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154537842|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154537843|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537844|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
154537845|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154537846|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
154537847|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154537848|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154537849|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154537850|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154537851|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154537852|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306864|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
154537853|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154537854|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154537855|NCT04697602|Colchicine|colchicine|mesh-list
154537856|NCT04697602|Febuxostat|febuxostat|mesh-list
154537857|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
154537858|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537859|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
154537860|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
154537861|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
154537862|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537863|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537864|NCT04688151|Rituximab|rituximab|mesh-list
154537865|NCT04688151|Durvalumab|durvalumab|mesh-list
154537866|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
154537867|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537868|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537869|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
154537870|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537871|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537872|NCT04688151|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154537873|NCT04688151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154537874|NCT04688151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537875|NCT04688151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537876|NCT04638686|Lamivudine|lamivudine|mesh-list
154537877|NCT04638686|Dolutegravir|dolutegravir|mesh-list
154537878|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154537879|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154537880|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537881|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537882|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
154537883|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154537884|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154537885|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154537886|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154537887|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154537888|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154537889|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154537890|NCT04624672|Semaglutide|semaglutide|mesh-list
154537891|NCT04624672|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154537892|NCT04624672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154537893|NCT04624672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537894|NCT04590404|Nicotine|nicotine|mesh-list
154537895|NCT04590404|Varenicline|varenicline|mesh-list
154537896|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154537897|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
154537898|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537899|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537900|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154537901|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154537902|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
154537903|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537904|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537905|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
154537906|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154537907|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537908|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154537909|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537910|NCT04544683|Dexamethasone|dexamethasone|mesh-list
154537911|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
154537912|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154537913|NCT04544683|BB 1101|bb 1101|mesh-list
154537914|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537915|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
154537917|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537918|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537919|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154537920|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
154537921|NCT04544683|Hormones|hormones|mesh-ancestor
154537922|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537923|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154537924|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537925|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
154537926|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306938|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
154537927|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537928|NCT04519164|Eplerenone|eplerenone|mesh-list
154537929|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
154537930|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154537931|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
154537932|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154537933|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537934|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154537935|NCT04519164|Diuretics|diuretics|mesh-ancestor
154537936|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
154537937|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154537938|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154537939|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154537940|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537941|NCT04509674|Empagliflozin|empagliflozin|mesh-list
154537942|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154537943|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537944|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154537945|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537946|NCT04447352|Leucovorin|leucovorin|mesh-list
154537947|NCT04447352|Docetaxel|docetaxel|mesh-list
154537948|NCT04447352|Fluorouracil|fluorouracil|mesh-list
154537949|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
154537950|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537951|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
154537952|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
154537953|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
154537954|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537955|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
154537956|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154537957|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154537958|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
154537959|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537960|NCT04447352|Antidotes|antidotes|mesh-ancestor
154537961|NCT04447352|Protective Agents|protective agents|mesh-ancestor
154537962|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
154537963|NCT04447352|Vitamins|vitamins|mesh-ancestor
154537964|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
154537965|NCT04420351|Aspirin|aspirin|mesh-list
154537966|NCT04420351|Clopidogrel|clopidogrel|mesh-list
154537967|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154537968|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154537969|NCT04420351|Analgesics|analgesics|mesh-ancestor
154537970|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
154537971|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154537972|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154537973|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154537974|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154537975|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154537976|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154537977|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537978|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154537979|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154537980|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537981|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
154537982|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154537983|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154537984|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154537985|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
154537986|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154537987|NCT04396496|Daratumumab|daratumumab|mesh-list
154537988|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537989|NCT04375267|Olaparib|olaparib|mesh-list
154537990|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154537991|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154537992|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154537993|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537994|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154537995|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154537996|NCT04329806|Amlodipine|amlodipine|mesh-list
154537997|NCT04329806|Moxonidine|moxonidine|mesh-list
154537998|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154537999|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154538000|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154538001|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538002|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154538003|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538004|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
154538005|NCT04325217|Nintedanib|nintedanib|mesh-list
154538006|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538007|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538008|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538009|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538010|NCT04324840|Temozolomide|temozolomide|mesh-list
154538011|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154538012|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
154538013|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538014|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538015|NCT04314895|Paclitaxel|paclitaxel|mesh-list
154538016|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154538017|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538018|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538019|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538020|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538021|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538022|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538023|NCT04310176|Bevacizumab|bevacizumab|mesh-list
154538024|NCT04310176|Capecitabine|capecitabine|mesh-list
154538025|NCT04310176|Fluorouracil|fluorouracil|mesh-list
154538026|NCT04310176|Valproic Acid|valproic acid|mesh-list
154538027|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538028|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538029|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154538030|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154538031|NCT04310176|Growth Substances|growth substances|mesh-ancestor
154538032|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538033|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
154538034|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538035|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
154538036|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538037|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538038|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
154538039|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
154538040|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538041|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
154538042|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538043|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
154538044|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154538045|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154538046|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154538047|NCT04296175|Paclitaxel|paclitaxel|mesh-list
154538048|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154538049|NCT04296175|Carboplatin|carboplatin|mesh-list
154538050|NCT04296175|Epirubicin|epirubicin|mesh-list
154538051|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538052|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538053|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538054|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538055|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538056|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538057|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154538058|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154538059|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154538060|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538061|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
154538062|NCT04291001|Etonogestrel|etonogestrel|mesh-list
154538063|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154538064|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
154538066|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538067|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154538068|NCT04275232|Plasminogen|plasminogen|mesh-list
154538069|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154538070|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154538071|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538072|NCT04226248|Rivastigmine|rivastigmine|mesh-list
154538073|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154538074|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307084|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154538075|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538076|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
154538077|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538078|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538079|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154538080|NCT04226248|Protective Agents|protective agents|mesh-ancestor
154538081|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
154538082|NCT04208347|Apatinib|apatinib|mesh-list
154538083|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538084|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538085|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538086|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538087|NCT04179019|Amlodipine|amlodipine|mesh-list
154538088|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154538089|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154538090|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154538091|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538092|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154538093|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538094|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
154538095|NCT04153136|Valsartan|valsartan|mesh-list
154538096|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154538097|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154538098|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154538099|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154538100|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538101|NCT04103489|Eculizumab|eculizumab|mesh-list
154538102|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154538103|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538104|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
154538105|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538106|NCT04099355|Dronabinol|dronabinol|mesh-list
154538107|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
154538108|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538109|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154538110|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154538111|NCT04099355|Analgesics|analgesics|mesh-ancestor
154538112|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
154538113|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538114|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154538115|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154538116|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538117|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538118|NCT04099355|Hormones|hormones|mesh-ancestor
154538119|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538120|NCT04099251|Nivolumab|nivolumab|mesh-list
154538121|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538122|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538123|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538124|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538125|NCT04070573|Aspirin|aspirin|mesh-list
154538126|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154538127|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154538128|NCT04070573|Analgesics|analgesics|mesh-ancestor
154538129|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
154538130|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538131|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538132|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538133|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154538134|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154538135|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154538136|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538137|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154538138|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154538139|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538140|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
154538141|NCT04066491|Gemcitabine|gemcitabine|mesh-list
154538142|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538143|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538144|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
154538145|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538146|NCT04062266|Azacitidine|azacitidine|mesh-list
154538147|NCT04062266|Venetoclax|venetoclax|mesh-list
154538148|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538149|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
154538150|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538151|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538152|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538153|NCT04045665|Anticoagulants|anticoagulants|mesh-list
154538154|NCT04034459|Leucovorin|leucovorin|mesh-list
154538155|NCT04034459|Folic Acid|folic acid|mesh-list
154538156|NCT04034459|Bevacizumab|bevacizumab|mesh-list
154538157|NCT04034459|Cetuximab|cetuximab|mesh-list
154538158|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
154538159|NCT04034459|Irinotecan|irinotecan|mesh-list
154538160|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
154538161|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538162|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538163|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154538164|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154538165|NCT04034459|Growth Substances|growth substances|mesh-ancestor
154538167|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
154538168|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154538169|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154538170|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538171|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538172|NCT04034459|Antidotes|antidotes|mesh-ancestor
154538173|NCT04034459|Protective Agents|protective agents|mesh-ancestor
154538174|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
154538175|NCT04034459|Vitamins|vitamins|mesh-ancestor
154538176|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
154538177|NCT04034459|Hematinics|hematinics|mesh-ancestor
154538178|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154538179|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
154538180|NCT04023227|Valsartan|valsartan|mesh-list
154538181|NCT04023227|Enalapril|enalapril|mesh-list
154538182|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154538183|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154538184|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154538185|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154538186|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538187|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154538188|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
154538189|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538190|NCT03999749|Nivolumab|nivolumab|mesh-list
154538191|NCT03999749|Ipilimumab|ipilimumab|mesh-list
154538192|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538193|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538194|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538195|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538196|NCT03945513|Dienogest|dienogest|mesh-list
154538197|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154538198|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154538199|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154538200|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154538201|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
154538202|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154538203|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538204|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154538205|NCT03945513|Estrogens|estrogens|mesh-ancestor
154538206|NCT03945513|Hormones|hormones|mesh-ancestor
154538207|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538208|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154538209|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
154538210|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154538211|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538212|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
154538213|NCT03941262|Avelumab|avelumab|mesh-list
154538214|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538215|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538216|NCT03941262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538217|NCT03941262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538218|NCT03932643|TIC10 compound|tic10 compound|mesh-list
154538219|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538220|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
154538221|NCT03926091|Docetaxel|docetaxel|mesh-list
154538222|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538223|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
154538224|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538225|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154538226|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154538227|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
154538228|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538229|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538230|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154538231|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538232|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538233|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538234|NCT03913559|Acetaminophen|acetaminophen|mesh-list
154538235|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
154538236|NCT03913559|Promethazine|promethazine|mesh-list
154538237|NCT03913559|Cytarabine|cytarabine|mesh-list
154538238|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
154538239|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154538240|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
154538242|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154538243|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154538244|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
154538245|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154538246|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538247|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538248|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
154538249|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538250|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538251|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
154538252|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538253|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154538254|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538255|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
154538256|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154538257|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154538258|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
154538259|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154538260|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154538261|NCT03913559|Analgesics|analgesics|mesh-ancestor
154538262|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
154538263|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538264|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
154538265|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538266|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
154538267|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
154538268|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154538269|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
154538270|NCT03913559|Hormones|hormones|mesh-ancestor
154538271|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538272|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154538273|NCT03913559|Protective Agents|protective agents|mesh-ancestor
154538274|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154538275|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154538276|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154538277|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154538278|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
154538279|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
154538280|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154538281|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
154538282|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
154538283|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538284|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154538285|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
154538286|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538287|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154538288|NCT03913559|Immunotoxins|immunotoxins|mesh-ancestor
154538289|NCT03913559|Immunoconjugates|immunoconjugates|mesh-ancestor
154538290|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
154538291|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154538292|NCT03883828|Mupirocin|mupirocin|mesh-list
154538293|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154538294|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154538295|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
154538296|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
154538297|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154538298|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154538299|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538300|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538301|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
154538302|NCT03835819|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154538303|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538304|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538305|NCT03835819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538306|NCT03835819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538307|NCT03835819|Immunoconjugates|immunoconjugates|mesh-ancestor
154538308|NCT03835819|Immunologic Factors|immunologic factors|mesh-ancestor
154538309|NCT03835819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538310|NCT03832361|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154538311|NCT03832361|Immunoconjugates|immunoconjugates|mesh-ancestor
154538312|NCT03832361|Immunologic Factors|immunologic factors|mesh-ancestor
154538313|NCT03832361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538314|NCT03828292|Dexamethasone|dexamethasone|mesh-list
154538315|NCT03828292|Bortezomib|bortezomib|mesh-list
154538316|NCT03828292|Pomalidomide|pomalidomide|mesh-list
154538317|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538319|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
154538320|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538321|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538322|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154538323|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
154538324|NCT03828292|Hormones|hormones|mesh-ancestor
154538325|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538326|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154538327|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538328|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
154538329|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154538330|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154538331|NCT03828292|Growth Substances|growth substances|mesh-ancestor
154538332|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
154538333|NCT03825250|Valproic Acid|valproic acid|mesh-list
154538334|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
154538335|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538336|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538337|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
154538338|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538339|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538340|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
154538341|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154538342|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154538343|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154538344|NCT03805100|Ranibizumab|ranibizumab|mesh-list
154538345|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154538346|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154538347|NCT03805100|Growth Substances|growth substances|mesh-ancestor
154538348|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538349|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
154538350|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538351|NCT03794999|Benralizumab|benralizumab|mesh-list
154538352|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154538353|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
154538354|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
154538355|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154538356|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
154538357|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538358|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
154538359|NCT03777917|Protective Agents|protective agents|mesh-ancestor
154538360|NCT03698851|Methamphetamine|methamphetamine|mesh-list
154262165|NCT00303953|Belinostat|belinostat|mesh-list
154538361|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154538362|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538363|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
154538364|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
154538365|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538366|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
154538367|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538368|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538369|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
154538370|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154538371|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154538372|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154538373|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154538374|NCT03697850|Atezolizumab|atezolizumab|mesh-list
154538375|NCT03697850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538376|NCT03697850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538377|NCT03697850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538378|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538379|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
154538380|NCT03693014|Nivolumab|nivolumab|mesh-list
154538381|NCT03693014|Ipilimumab|ipilimumab|mesh-list
154538382|NCT03693014|Atezolizumab|atezolizumab|mesh-list
154538383|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538384|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538385|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538386|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538387|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
154538388|NCT03602235|Melphalan|melphalan|mesh-list
154538389|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154538390|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
154538391|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538392|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538393|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154538394|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538395|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
154538396|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538397|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
154538398|NCT03602235|Protective Agents|protective agents|mesh-ancestor
154538399|NCT03602235|Vitamins|vitamins|mesh-ancestor
154538400|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
154538401|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
154538402|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
154538403|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538404|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538405|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538406|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
154538407|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
154538408|NCT03583359|Lidocaine|lidocaine|mesh-list
154538409|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
154538410|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
154538411|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154538412|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538413|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
154538414|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538415|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154538416|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154538417|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154538418|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154538419|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538420|NCT03575013|Docetaxel|docetaxel|mesh-list
154538421|NCT03575013|Avelumab|avelumab|mesh-list
154538422|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538423|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538424|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538425|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538426|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538427|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538428|NCT03548428|Atezolizumab|atezolizumab|mesh-list
154538429|NCT03548428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538430|NCT03548428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538431|NCT03548428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538432|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538433|NCT03537651|Ivacaftor|ivacaftor|mesh-list
154538434|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154538435|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154538436|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253736|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154538438|NCT03503786|Carboplatin|carboplatin|mesh-list
154538439|NCT03503786|Avelumab|avelumab|mesh-list
154538440|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538441|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538442|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538443|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538444|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538445|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538446|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538447|NCT03493542|Vaccines|vaccines|mesh-list
154538448|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
154538449|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538450|NCT03425643|Gemcitabine|gemcitabine|mesh-list
154538451|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
154538452|NCT03425643|Pemetrexed|pemetrexed|mesh-list
154538453|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538454|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538455|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
154538456|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538457|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538458|NCT03425643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538459|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538460|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154538461|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154538462|NCT03400176|Ibrutinib|ibrutinib|mesh-list
154538463|NCT03400176|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154538464|NCT03400176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538465|NCT03400176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538466|NCT03400176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538467|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
154538468|NCT03342079|Anesthetics|anesthetics|mesh-list
154538469|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
154538470|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154538471|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538472|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
154538473|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538474|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154538475|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
154538476|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154538477|NCT03342079|Analgesics|analgesics|mesh-ancestor
154538478|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
154538479|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
154538480|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538481|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538482|NCT03332017|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154538483|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538484|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538485|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538486|NCT03277170|Montelukast|montelukast|mesh-list
154538487|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154538488|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
154538489|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154538490|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154538491|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538492|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538493|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154538494|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154538495|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538496|NCT03199300|Trastuzumab|trastuzumab|mesh-list
154538497|NCT03199300|Bleomycin|bleomycin|mesh-list
154538498|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538499|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538500|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154538501|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154538502|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154538503|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538504|NCT03104400|Adalimumab|adalimumab|mesh-list
154538505|NCT03104400|Upadacitinib|upadacitinib|mesh-list
154538506|NCT03104400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154307540|NCT04781426|Tenofovir|tenofovir|mesh-list
154538507|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538508|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154538509|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154253737|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154538510|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538511|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538512|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538513|NCT03092674|Cytarabine|cytarabine|mesh-list
154538514|NCT03092674|Nivolumab|nivolumab|mesh-list
154538515|NCT03092674|Azacitidine|azacitidine|mesh-list
154538516|NCT03092674|Decitabine|decitabine|mesh-list
154538517|NCT03092674|Midostaurin|midostaurin|mesh-list
154538518|NCT03092674|Staurosporine|staurosporine|mesh-list
154538519|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538520|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538521|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538522|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538523|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538524|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
154538525|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
154538526|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154538527|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538528|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
154538529|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538530|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538531|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538532|NCT02974725|Trametinib|trametinib|mesh-list
154538533|NCT02974725|Naporafenib|naporafenib|mesh-list
154538534|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538535|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538536|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538537|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538538|NCT02932618|Factor VIII|factor viii|mesh-list
154538539|NCT02932618|Coagulants|coagulants|mesh-ancestor
154538540|NCT02922764|Carboplatin|carboplatin|mesh-list
154538541|NCT02922764|Docetaxel|docetaxel|mesh-list
154538542|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
154538543|NCT02922764|Pemetrexed|pemetrexed|mesh-list
154538544|NCT02922764|Ipilimumab|ipilimumab|mesh-list
154538545|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538546|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538547|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538548|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538549|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538550|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538551|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538552|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538553|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154538554|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154538555|NCT02878798|Topiramate|topiramate|mesh-list
154538556|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
154538557|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154538558|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538559|NCT02854436|Niraparib|niraparib|mesh-list
154538560|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154538561|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538562|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538563|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538564|NCT02845323|Nivolumab|nivolumab|mesh-list
154538565|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538566|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538567|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538568|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538569|NCT02826434|Durvalumab|durvalumab|mesh-list
154538570|NCT02826434|Poly ICLC|poly iclc|mesh-list
154538571|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538572|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538573|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
154538574|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
154538575|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538576|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
154538577|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154538578|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154538579|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538580|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154538581|NCT02819141|Analgesics|analgesics|mesh-ancestor
154538582|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
154538583|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538584|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154262390|NCT00302081|Ribavirin|ribavirin|mesh-list
154538585|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154538586|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154538587|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
154538588|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538589|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538590|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154538591|NCT02725177|Hormones|hormones|mesh-ancestor
154538592|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538593|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538594|NCT02624596|Midazolam|midazolam|mesh-list
154538595|NCT02624596|Ketamine|ketamine|mesh-list
154538596|NCT02624596|Analgesics|analgesics|mesh-ancestor
154538597|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
154538598|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538599|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538600|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154538601|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154538602|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
154538603|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
154538604|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154538605|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154538606|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154538607|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538608|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538609|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154538610|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154538611|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154538612|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154538613|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154538614|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
154538615|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
154538616|NCT02624128|Cetuximab|cetuximab|mesh-list
154538617|NCT02624128|Valproic Acid|valproic acid|mesh-list
154538618|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538619|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538620|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
154538621|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538622|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538623|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
154538624|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538625|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538626|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
154538627|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154538628|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154538629|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154538630|NCT02621151|Gemcitabine|gemcitabine|mesh-list
154538631|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
154538632|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538633|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
154538634|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538635|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538636|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538637|NCT02621151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538638|NCT02578368|Leucovorin|leucovorin|mesh-list
154538639|NCT02578368|Docetaxel|docetaxel|mesh-list
154538640|NCT02578368|Fluorouracil|fluorouracil|mesh-list
154538641|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
154538642|NCT02578368|Trastuzumab|trastuzumab|mesh-list
154538643|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
154538644|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538645|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538646|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538647|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538648|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538649|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538650|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
154538651|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538652|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538653|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
154538654|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538655|NCT02578368|Antidotes|antidotes|mesh-ancestor
154538656|NCT02578368|Protective Agents|protective agents|mesh-ancestor
154538657|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
154538658|NCT02578368|Vitamins|vitamins|mesh-ancestor
154538659|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
154538660|NCT02570542|Cytarabine|cytarabine|mesh-list
154538661|NCT02570542|Plerixafor|plerixafor|mesh-list
154262508|NCT00300365|Niacin|niacin|mesh-list
154538662|NCT02570542|Etoposide|etoposide|mesh-list
154538663|NCT02570542|Melphalan|melphalan|mesh-list
154538664|NCT02570542|Carmustine|carmustine|mesh-list
154538665|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538666|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538667|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154538668|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154538669|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538670|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538671|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538672|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
154538673|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
154538674|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154538675|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538676|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
154538677|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538678|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154538679|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
154538680|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154538681|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154538682|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154538683|NCT02488759|Nivolumab|nivolumab|mesh-list
154538684|NCT02488759|Ipilimumab|ipilimumab|mesh-list
154538685|NCT02488759|Relatlimab|relatlimab|mesh-list
154538686|NCT02488759|Daratumumab|daratumumab|mesh-list
154538687|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538688|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538689|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538690|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538692|NCT02483247|Doxorubicin|doxorubicin|mesh-list
154538693|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
154538694|NCT02483247|Capecitabine|capecitabine|mesh-list
154538695|NCT02483247|Nivolumab|nivolumab|mesh-list
154538696|NCT02483247|Sunitinib|sunitinib|mesh-list
154538697|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538698|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538699|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538700|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538701|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538702|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538703|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154538704|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154538705|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154538706|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538707|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538708|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538709|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538710|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
154538711|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154538712|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154538713|NCT02483247|Growth Substances|growth substances|mesh-ancestor
154538714|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538715|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
154538716|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538717|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
154538718|NCT02467361|Nivolumab|nivolumab|mesh-list
154538719|NCT02467361|Ipilimumab|ipilimumab|mesh-list
154538720|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538721|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538722|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154538723|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538724|NCT02368301|Dexamethasone|dexamethasone|mesh-list
154538725|NCT02368301|Lenalidomide|lenalidomide|mesh-list
154538726|NCT02368301|Elotuzumab|elotuzumab|mesh-list
154538727|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538728|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
154538729|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
154538730|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538731|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538732|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154538733|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
154538734|NCT02368301|Hormones|hormones|mesh-ancestor
154538735|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538736|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154262534|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154538737|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538738|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
154538739|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154538740|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154538741|NCT02368301|Growth Substances|growth substances|mesh-ancestor
154538742|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
154538743|NCT02352558|Dexamethasone|dexamethasone|mesh-list
154538744|NCT02352558|Bortezomib|bortezomib|mesh-list
154538745|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
154538746|NCT02352558|Ibrutinib|ibrutinib|mesh-list
154538747|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538748|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
154538749|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
154538750|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538751|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538752|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154538753|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
154538754|NCT02352558|Hormones|hormones|mesh-ancestor
154538755|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538756|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154538757|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538758|NCT02352558|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154538759|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538760|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538761|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538762|NCT02264665|Everolimus|everolimus|mesh-list
154538763|NCT02264665|Sunitinib|sunitinib|mesh-list
154538764|NCT02264665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154538765|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538766|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860266|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538767|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538768|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538769|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
154538770|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538771|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538772|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154538773|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154538774|NCT02264665|Growth Substances|growth substances|mesh-ancestor
154538775|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
154538776|NCT02207062|Ibrutinib|ibrutinib|mesh-list
154538777|NCT02207062|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154538778|NCT02207062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538779|NCT02207062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538780|NCT02207062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538781|NCT02047474|Leucovorin|leucovorin|mesh-list
154538782|NCT02047474|Fluorouracil|fluorouracil|mesh-list
154538783|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
154538784|NCT02047474|Irinotecan|irinotecan|mesh-list
154538785|NCT02047474|Calcium|calcium|mesh-list
154538786|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
154538787|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154538788|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538789|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
154538790|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538791|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538792|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538793|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538794|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
154538795|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154538796|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154538797|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538798|NCT02047474|Antidotes|antidotes|mesh-ancestor
154538799|NCT02047474|Protective Agents|protective agents|mesh-ancestor
154538800|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
154538801|NCT02047474|Vitamins|vitamins|mesh-ancestor
154538802|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
154538803|NCT01972217|Prednisone|prednisone|mesh-list
154538804|NCT01972217|Prednisolone|prednisolone|mesh-list
154538805|NCT01972217|Olaparib|olaparib|mesh-list
154538806|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538807|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
154538808|NCT01972217|Hormones|hormones|mesh-ancestor
154538809|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538810|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538811|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154538812|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538813|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154538814|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538815|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538816|NCT01934452|Sunitinib|sunitinib|mesh-list
154538817|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538818|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154538819|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154538820|NCT01934452|Growth Substances|growth substances|mesh-ancestor
154538821|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538822|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
154538823|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538824|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538825|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538826|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
154538827|NCT01864109|Temozolomide|temozolomide|mesh-list
154538828|NCT01864109|Ifosfamide|ifosfamide|mesh-list
154538829|NCT01864109|Doxorubicin|doxorubicin|mesh-list
154538830|NCT01864109|Irinotecan|irinotecan|mesh-list
154538831|NCT01864109|Etoposide|etoposide|mesh-list
154538832|NCT01864109|Vincristine|vincristine|mesh-list
154538833|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
154538834|NCT01864109|Razoxane|razoxane|mesh-list
154538835|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538836|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
154538837|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538838|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154538839|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154538840|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
154538841|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538842|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538843|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154538844|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154538845|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154538846|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154538847|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538848|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154538849|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538850|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538851|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538852|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538853|NCT01864109|Protective Agents|protective agents|mesh-ancestor
154538854|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154538855|NCT01809691|Bicalutamide|bicalutamide|mesh-list
154538856|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
154538857|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
154538858|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538859|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538860|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538861|NCT01786265|Prednisone|prednisone|mesh-list
154538862|NCT01786265|Cortisone|cortisone|mesh-list
154538863|NCT01786265|Leuprolide|leuprolide|mesh-list
154538864|NCT01786265|Goserelin|goserelin|mesh-list
154538865|NCT01786265|Flutamide|flutamide|mesh-list
154538866|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
154538867|NCT01786265|Bicalutamide|bicalutamide|mesh-list
154538868|NCT01786265|Nilutamide|nilutamide|mesh-list
154538869|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538870|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
154538871|NCT01786265|Hormones|hormones|mesh-ancestor
154538872|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154538873|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538874|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154538875|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538876|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154538877|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
154538878|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154538879|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154538880|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307887|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154538881|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538882|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
154538883|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154538884|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
154538885|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154538886|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154538887|NCT01619176|Methotrexate|methotrexate|mesh-list
154538888|NCT01619176|Leflunomide|leflunomide|mesh-list
154538889|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154538890|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
154538891|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154538892|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538893|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538895|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538896|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538897|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
154538898|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538899|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154538900|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538901|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
154538902|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154538903|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154538904|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154538905|NCT01619176|Analgesics|analgesics|mesh-ancestor
154538906|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
154538907|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538908|NCT01481974|Treprostinil|treprostinil|mesh-list
154538909|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154538910|NCT01413516|Varenicline|varenicline|mesh-list
154538911|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154538912|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154538913|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
154538914|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538915|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538916|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538917|NCT01106534|Aspirin|aspirin|mesh-list
154538918|NCT01106534|Everolimus|everolimus|mesh-list
154538919|NCT01106534|Clopidogrel|clopidogrel|mesh-list
154538920|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154538921|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154538922|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154538923|NCT01106534|Analgesics|analgesics|mesh-ancestor
154538924|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
154538925|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154538926|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538927|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154538928|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154538929|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154538930|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154538931|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538932|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154538933|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154538934|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538935|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
154538936|NCT01106534|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154538937|NCT01106534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154538938|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154538939|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
154538940|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538941|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154538942|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154538943|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154538944|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
154538945|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538946|NCT01098955|Varenicline|varenicline|mesh-list
154538947|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154538948|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154538949|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
154538950|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154538951|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538952|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538953|NCT01009788|Temozolomide|temozolomide|mesh-list
154538954|NCT01009788|Veliparib|veliparib|mesh-list
154538955|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154538956|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
154538957|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538958|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538959|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154538960|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538961|NCT00997009|Paclitaxel|paclitaxel|mesh-list
154538962|NCT00997009|Carboplatin|carboplatin|mesh-list
154538963|NCT00997009|Cetuximab|cetuximab|mesh-list
154538964|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538965|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538966|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
154262761|NCT06291948|Adalimumab|adalimumab|mesh-list
154538967|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538968|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538969|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538970|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154538972|NCT00657878|Carboplatin|carboplatin|mesh-list
154538973|NCT00657878|Gemcitabine|gemcitabine|mesh-list
154538974|NCT00657878|Doxorubicin|doxorubicin|mesh-list
154538975|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154538976|NCT00657878|Topotecan|topotecan|mesh-list
154538977|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538978|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154538979|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538980|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
154538981|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
154538982|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154538983|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154538984|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
154538985|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154538986|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154538987|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154538988|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154538989|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154538990|NCT00513526|Vaccines|vaccines|mesh-list
154538991|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
154538992|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154538993|NCT00412594|Rituximab|rituximab|mesh-list
154538994|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154538996|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154538997|NCT00412594|Antibodies|antibodies|mesh-list
154538998|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
154538999|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154539000|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
154539001|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539002|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539003|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154539004|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539005|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154539006|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
154539007|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539008|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
154539009|NCT00321555|Immunotoxins|immunotoxins|mesh-list
154539010|NCT00321555|Immunoconjugates|immunoconjugates|mesh-ancestor
154539011|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
154539012|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539013|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
154539014|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154539015|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
154539016|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154539017|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539018|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154539019|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154539020|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154539021|NCT00047060|Cyclosporine|cyclosporine|mesh-list
154539022|NCT00047060|Fludarabine|fludarabine|mesh-list
154539023|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
154539024|NCT00047060|Cyclosporins|cyclosporins|mesh-list
154539025|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539026|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539027|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539028|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
154539029|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539030|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539031|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
154539032|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539033|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
154539034|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154539035|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154539036|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154539037|NCT02084563|Cytarabine|cytarabine|mesh-list
154539038|NCT02084563|Decitabine|decitabine|mesh-list
154539039|NCT02084563|Daunorubicin|daunorubicin|mesh-list
154539040|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154539041|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
154539042|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262836|NCT06291103|Tacrolimus|tacrolimus|mesh-list
154539043|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539045|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539046|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539047|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
154539048|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539049|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154539050|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154539051|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154539052|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539053|NCT02084719|Antibodies|antibodies|mesh-list
154539054|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
154539055|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539056|NCT02084875|Tofacitinib|tofacitinib|mesh-list
154539057|NCT02084875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154539058|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154539059|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539060|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539061|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
154539062|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154539063|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539064|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
154539065|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154539066|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539067|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154539068|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154539069|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539070|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539071|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860267|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154539073|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154539074|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154539075|NCT02085109|Theobromine|theobromine|mesh-list
154539076|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154539077|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
154539078|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539079|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539080|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154539081|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
154539082|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
154539083|NCT03557983|Fenofibrate|fenofibrate|mesh-list
154539084|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539085|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
154539086|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539087|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539088|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
154539089|NCT03558919|Mirabegron|mirabegron|mesh-list
154539090|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154539091|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154539092|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
154539093|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539094|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539095|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539096|NCT03558919|Urological Agents|urological agents|mesh-ancestor
154539097|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154539098|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154539099|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154539100|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
154539101|NCT02085577|Acetaminophen|acetaminophen|mesh-list
154539102|NCT02085577|Sufentanil|sufentanil|mesh-list
154539103|NCT02085577|Ketamine|ketamine|mesh-list
154539104|NCT02085577|Morphine|morphine|mesh-list
154539105|NCT02085577|Dsuvia|dsuvia|mesh-list
154539106|NCT02085577|Ondansetron|ondansetron|mesh-list
154539107|NCT02085577|Analgesics|analgesics|mesh-ancestor
154539108|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
154539109|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539110|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539111|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154539112|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154539113|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
154539114|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
154539115|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154539116|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154539117|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154539118|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539119|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539121|NCT02085577|Narcotics|narcotics|mesh-ancestor
154539122|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154539123|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
154539124|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
154539125|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
154539126|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539127|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
154539128|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
154539129|NCT02085577|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154539130|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154539131|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
154539132|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154539133|NCT02085655|Thalidomide|thalidomide|mesh-list
154539134|NCT02085655|Dexamethasone|dexamethasone|mesh-list
154539135|NCT02085655|Gemcitabine|gemcitabine|mesh-list
154539136|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
154539137|NCT02085655|Methotrexate|methotrexate|mesh-list
154539138|NCT02085655|Pegaspargase|pegaspargase|mesh-list
154539139|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154539140|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
154539141|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
154539142|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539143|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539144|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539145|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
154539146|NCT02085655|Hormones|hormones|mesh-ancestor
154539147|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539148|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154539149|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539150|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154539151|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
154539152|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539153|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154539154|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
154539155|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154539156|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
154539157|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539158|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154539159|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539160|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
154539161|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154539162|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154539163|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
154539164|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154539165|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539166|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154539167|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154539168|NCT02085655|Growth Substances|growth substances|mesh-ancestor
154539169|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
154539170|NCT02085967|Itraconazole|itraconazole|mesh-list
154539171|NCT02085967|Rifampin|rifampin|mesh-list
154539172|NCT02085967|Midazolam|midazolam|mesh-list
154539173|NCT02085967|Bupropion|bupropion|mesh-list
154539174|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154539175|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154539176|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154539177|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539178|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154539179|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154539180|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154539181|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154539182|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
154539183|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
154539184|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
154539185|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
154539186|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539187|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539188|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154539189|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
154539190|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154539191|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154539192|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154539193|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
154539194|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154539195|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154539196|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539197|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
154539198|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539199|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154539200|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154539201|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
154539202|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539203|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154539204|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154539205|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
154539206|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154539207|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
154539208|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154539209|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154539210|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154539211|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154539212|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154539213|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154539214|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154539215|NCT02091505|Ranibizumab|ranibizumab|mesh-list
154539216|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154539217|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154539218|NCT02091505|Growth Substances|growth substances|mesh-ancestor
154539219|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539220|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
154860268|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154539221|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539222|NCT02091817|Oxytocin|oxytocin|mesh-list
154539223|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
154539224|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154539225|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539226|NCT02086279|Hormones|hormones|mesh-list
154539227|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539228|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539229|NCT02091973|Everolimus|everolimus|mesh-list
154539230|NCT02091973|Tacrolimus|tacrolimus|mesh-list
154539231|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539232|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
154539233|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539234|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154539235|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539236|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539237|NCT02091973|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154539238|NCT02091973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154539239|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539240|NCT03558295|Anticoagulants|anticoagulants|mesh-list
154539241|NCT02089399|Olmesartan|olmesartan|mesh-list
154539242|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154539243|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154539244|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539245|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
154539246|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539247|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539248|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154539249|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539250|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154539251|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154539252|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154539253|NCT03557437|Amoxicillin|amoxicillin|mesh-list
154539254|NCT03557437|Metronidazole|metronidazole|mesh-list
154539255|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
154539256|NCT03557437|Esomeprazole|esomeprazole|mesh-list
154539257|NCT03557437|Bismuth|bismuth|mesh-list
154539258|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539259|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154539260|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539261|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154539262|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154539263|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154539264|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539265|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154539266|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539267|NCT03557437|Antacids|antacids|mesh-ancestor
154539268|NCT03557437|Diuretics|diuretics|mesh-ancestor
154539269|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
154539270|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539271|NCT03557437|Expectorants|expectorants|mesh-ancestor
154539272|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
154539273|NCT02089633|BCT-100|bct-100|mesh-list
154539274|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539275|NCT02086747|Acetaminophen|acetaminophen|mesh-list
154539276|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154539277|NCT02086747|Analgesics|analgesics|mesh-ancestor
154539278|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
154539279|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539280|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539281|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
154539282|NCT02086825|Rifaximin|rifaximin|mesh-list
154539283|NCT02086825|Lactulose|lactulose|mesh-list
154539284|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154539285|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539286|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539287|NCT02086903|Clopidogrel|clopidogrel|mesh-list
154539288|NCT02086903|Ticagrelor|ticagrelor|mesh-list
154539289|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154539290|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154539291|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154539292|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154539293|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
154539294|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539295|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539296|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539297|NCT02087215|Boron|boron|mesh-list
154539298|NCT02087215|Trace Elements|trace elements|mesh-ancestor
154539300|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539301|NCT02087527|Dexamethasone|dexamethasone|mesh-list
154539302|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154539303|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
154539304|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
154539305|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539306|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539307|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539308|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
154539309|NCT02087527|Hormones|hormones|mesh-ancestor
154539310|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539311|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154539312|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539313|NCT02087683|Vitamin D|vitamin d|mesh-list
154539314|NCT02087683|Vitamins|vitamins|mesh-ancestor
154539315|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
154539316|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539317|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154539318|NCT02092363|Paclitaxel|paclitaxel|mesh-list
154539319|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154539320|NCT02092363|Carboplatin|carboplatin|mesh-list
154539321|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154539322|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154539323|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539324|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
154539325|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
154539326|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
154539327|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539328|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
154308338|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
154539329|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539330|NCT03558139|Avelumab|avelumab|mesh-list
154539331|NCT03558139|Magrolimab|magrolimab|mesh-list
154539332|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154539333|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539334|NCT02089867|Ezetimibe|ezetimibe|mesh-list
154539335|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154539336|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539337|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
154539338|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539339|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539340|NCT02092597|Exenatide|exenatide|mesh-list
154539341|NCT02092597|Linagliptin|linagliptin|mesh-list
154539342|NCT02092597|Gliclazide|gliclazide|mesh-list
154539343|NCT02092597|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154263134|NCT06067893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154539344|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154539345|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539346|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154539347|NCT02092597|Incretins|incretins|mesh-ancestor
154539348|NCT02092597|Hormones|hormones|mesh-ancestor
154539349|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539350|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154539351|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
154539352|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539353|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539354|NCT02093143|Remifentanil|remifentanil|mesh-list
154539355|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154539356|NCT02093143|Narcotics|narcotics|mesh-ancestor
154539357|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154539358|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539359|NCT02093143|Analgesics|analgesics|mesh-ancestor
154539360|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
154539361|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539362|NCT02093299|Clopidogrel|clopidogrel|mesh-list
154539363|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154539364|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154539365|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154539366|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154539367|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
154539368|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539369|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539370|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539371|NCT00454753|Dasatinib|dasatinib|mesh-list
154539372|NCT00454753|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154860269|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154539373|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154539374|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539375|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539376|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539377|NCT02093533|Eculizumab|eculizumab|mesh-list
154539378|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154539379|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539380|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
154539381|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539382|NCT03297879|Metformin|metformin|mesh-list
154539383|NCT03297879|Exenatide|exenatide|mesh-list
154539384|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154539385|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539386|NCT03297879|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154539387|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154539388|NCT03297879|Incretins|incretins|mesh-ancestor
154539389|NCT03297879|Hormones|hormones|mesh-ancestor
154539390|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539391|NCT02093845|Everolimus|everolimus|mesh-list
154539392|NCT02093845|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154539393|NCT02093845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154539394|NCT02093845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539395|NCT02093845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539396|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539397|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
154539398|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539399|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539400|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
154539401|NCT04489797|Rabeprazole|rabeprazole|mesh-list
154539402|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154539403|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539404|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154539405|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539406|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539407|NCT04489797|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154539408|NCT04489797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154539409|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539410|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154539411|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154539412|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539413|NCT02096419|Clopidogrel|clopidogrel|mesh-list
154539414|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154539415|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154539416|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154539417|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154539418|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
154263227|NCT05809986|Ofatumumab|ofatumumab|mesh-list
154539419|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539420|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539421|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539423|NCT02094157|Calcium heparin|calcium heparin|mesh-list
154539424|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154539425|NCT02094157|Tinzaparin|tinzaparin|mesh-list
154539426|NCT02094157|Dalteparin|dalteparin|mesh-list
154539427|NCT02094157|Warfarin|warfarin|mesh-list
154539428|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
154539429|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154539430|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154539431|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539432|NCT02094313|Atorvastatin|atorvastatin|mesh-list
154539433|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
154539434|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539435|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
154539436|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539437|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539438|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154539439|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539440|NCT02094391|Ipilimumab|ipilimumab|mesh-list
154539441|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154539442|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539443|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154539444|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539445|NCT02094469|Cilostazol|cilostazol|mesh-list
154539446|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154539448|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539449|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539450|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154539451|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
154539452|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154539453|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154539454|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539455|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154539456|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
154539457|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154539458|NCT02094469|Protective Agents|protective agents|mesh-ancestor
154539459|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154539460|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154539461|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539462|NCT02094703|Levofloxacin|levofloxacin|mesh-list
154539463|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
154539464|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154539465|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539466|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154539467|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154539468|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154539469|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539470|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539471|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539472|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154539473|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154539474|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154539475|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154539476|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
154539477|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539478|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539479|NCT02094703|Urological Agents|urological agents|mesh-ancestor
154539480|NCT02098837|Dolutegravir|dolutegravir|mesh-list
154539481|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154539482|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154539483|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539484|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539485|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154539486|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154539487|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
154539488|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539489|NCT02098915|Metoclopramide|metoclopramide|mesh-list
154539490|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
154539491|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
154253738|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539492|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539493|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539494|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539495|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154539496|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154539497|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
154539498|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539499|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539500|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
154539501|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154539502|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539503|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154539504|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539505|NCT02095405|Caffeine|caffeine|mesh-list
154539506|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154539507|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539508|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154539509|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539510|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539511|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154539512|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154539513|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
154539514|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539515|NCT02096965|Tolvaptan|tolvaptan|mesh-list
154539516|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154860270|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539517|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539518|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
154539519|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539520|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
154539521|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154539522|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539523|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
154539524|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154539525|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539526|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
154539527|NCT02095717|Curcumin|curcumin|mesh-list
154539528|NCT02095717|Docetaxel|docetaxel|mesh-list
154539529|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539530|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
154539531|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
154539532|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
154539533|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539534|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154539535|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154539536|NCT02095717|Analgesics|analgesics|mesh-ancestor
154539537|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
154539538|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539539|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539540|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154539541|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154539542|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539543|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
154539544|NCT03099824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154539545|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
154539546|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539547|NCT03099824|Protective Agents|protective agents|mesh-ancestor
154539548|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539549|NCT02718417|Paclitaxel|paclitaxel|mesh-list
154539550|NCT02718417|Carboplatin|carboplatin|mesh-list
154539551|NCT02718417|Avelumab|avelumab|mesh-list
154539552|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154539553|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154539554|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539555|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
154539556|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
154539557|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
154539558|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539559|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154539560|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
154539561|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539562|NCT05067530|Paclitaxel|paclitaxel|mesh-list
154539563|NCT05067530|Carboplatin|carboplatin|mesh-list
154539564|NCT05067530|Palbociclib|palbociclib|mesh-list
154539565|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154539566|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539567|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
154539568|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
154539569|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
154539570|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539571|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154539572|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539573|NCT02640404|Vaccines|vaccines|mesh-list
154539574|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
154539575|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539576|NCT03097406|Imidacloprid|imidacloprid|mesh-list
154539577|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
154539578|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539579|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539580|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539581|NCT03099590|Puerarin|puerarin|mesh-list
154539582|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
154539583|NCT05054426|Methotrexate|methotrexate|mesh-list
154539584|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154539585|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
154539586|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154539587|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539588|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154539589|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
154539590|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539591|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539592|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
154539593|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539594|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154539595|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539596|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
154539597|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154539598|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154539599|NCT00701727|Ezetimibe|ezetimibe|mesh-list
154539600|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154539601|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539602|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
154539603|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539604|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539605|NCT02463513|Vitamins|vitamins|mesh-list
154539606|NCT02463513|Riboflavin|riboflavin|mesh-list
154539607|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
154539608|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
154539609|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539610|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154539611|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
154539612|NCT04155008|Dexamethasone|dexamethasone|mesh-list
154539613|NCT04155008|Dronabinol|dronabinol|mesh-list
154539614|NCT04155008|Mirtazapine|mirtazapine|mesh-list
154539615|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154539616|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
154539617|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
154539618|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539619|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539620|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539621|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
154539622|NCT04155008|Hormones|hormones|mesh-ancestor
154539623|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539624|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154539625|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539626|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
154539627|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154539628|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154539629|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
154539630|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
154539631|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539632|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539633|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154539634|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154539635|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154539636|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154539637|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154539638|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154539639|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
154263443|NCT05561309|Ropivacaine|ropivacaine|mesh-list
154539640|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154539641|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154539643|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154539644|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
154539645|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154539646|NCT04155008|Analgesics|analgesics|mesh-ancestor
154539647|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
154539648|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154539649|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154539650|NCT05044364|Clevidipine|clevidipine|mesh-list
154539651|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154539652|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154539653|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539654|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154539655|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539656|NCT05054114|Interferons|interferons|mesh-list
154539657|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
154539658|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539659|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
154539660|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539661|NCT04665531|Ropivacaine|ropivacaine|mesh-list
154539662|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
154539663|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
154539664|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154539665|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539666|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
154860271|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154539667|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539668|NCT01369069|Insulin|insulin|mesh-list
154539669|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154539670|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154539671|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539672|NCT02097433|Dacomitinib|dacomitinib|mesh-list
154539673|NCT02097433|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154539674|NCT02097433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154539675|NCT02097433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539676|NCT02097433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539677|NCT02097511|Metoprolol|metoprolol|mesh-list
154539678|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
154539679|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154539680|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154539681|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
154539682|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
154539683|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539684|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539685|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154539686|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154539687|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154539688|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
154539689|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539690|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539691|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154539692|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154539693|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154539694|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154539695|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
154539696|NCT03957681|Brodalumab|brodalumab|mesh-list
154539697|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
154539698|NCT05043740|Evolocumab|evolocumab|mesh-list
154539699|NCT05043740|Alirocumab|alirocumab|mesh-list
154539700|NCT05043740|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154539701|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154539702|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539703|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
154539704|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539705|NCT05043740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154539706|NCT05043740|Protease Inhibitors|protease inhibitors|mesh-ancestor
154539707|NCT05043740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539708|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539709|NCT03928275|Aldesleukin|aldesleukin|mesh-list
154539710|NCT03928275|Interleukin-2|interleukin-2|mesh-list
154539711|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
154539712|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539713|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154539714|NCT03928275|Analgesics|analgesics|mesh-ancestor
154539715|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
154539716|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539717|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539719|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154539720|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
154539721|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539722|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154539723|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
154539724|NCT05043896|Tadalafil|tadalafil|mesh-list
154539725|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
154539726|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154539727|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154539728|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539729|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539730|NCT05043896|Urological Agents|urological agents|mesh-ancestor
154539731|NCT03096704|Vitamin D|vitamin d|mesh-list
154539732|NCT03096704|Vitamins|vitamins|mesh-ancestor
154539733|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
154539734|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539735|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154539736|NCT02099695|Oxybutynin|oxybutynin|mesh-list
154539737|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
154539738|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
154539739|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539740|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539741|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154539742|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154539743|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
154539744|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539745|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539746|NCT02099695|Urological Agents|urological agents|mesh-ancestor
154539747|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
154539748|NCT05066516|Linagliptin|linagliptin|mesh-list
154539749|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154539750|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539751|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154539752|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539753|NCT05066516|Incretins|incretins|mesh-ancestor
154539754|NCT05066516|Hormones|hormones|mesh-ancestor
154539755|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539756|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154539757|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
154539758|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539759|NCT02097589|Atorvastatin|atorvastatin|mesh-list
154539760|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154539761|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
154539762|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539763|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154539764|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539765|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
154539766|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539767|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539768|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154539769|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539770|NCT03836001|Serlopitant|serlopitant|mesh-list
154539771|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154539772|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539773|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539774|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539775|NCT02465866|Promethazine|promethazine|mesh-list
154539776|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
154539777|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
154539778|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154539779|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
154539780|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
154539781|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539782|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539783|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539784|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154539785|NCT05052008|Erenumab|erenumab|mesh-list
154539786|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154539787|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539788|NCT05052008|Analgesics|analgesics|mesh-ancestor
154539789|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
154539791|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539792|NCT05066360|Hormones|hormones|mesh-list
154539793|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539794|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539795|NCT02439970|Valganciclovir|valganciclovir|mesh-list
154539796|NCT02439970|Brincidofovir|brincidofovir|mesh-list
154539797|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
154539798|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539799|NCT03290859|Propofol|propofol|mesh-list
154539800|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154539801|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154539802|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539803|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154539804|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
154539805|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
154539806|NCT02102815|Dexamethasone|dexamethasone|mesh-list
154539807|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154539808|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
154539809|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
154539810|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539811|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539812|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539813|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
154539814|NCT02102815|Hormones|hormones|mesh-ancestor
154539815|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539816|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154539817|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539818|NCT04935112|Pantoprazole|pantoprazole|mesh-list
154539819|NCT04935112|Famotidine|famotidine|mesh-list
154539820|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154539821|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539822|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154539823|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539824|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539825|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154539826|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
154539827|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
154539828|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539829|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539830|NCT02102971|Liver Extracts|liver extracts|mesh-list
154539831|NCT02102971|Hematinics|hematinics|mesh-ancestor
154539832|NCT03555487|Choline|choline|mesh-list
154539833|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
154539834|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539835|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
154539836|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539837|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539838|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539839|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
154539840|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154539841|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154539842|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539843|NCT02103049|Ezetimibe|ezetimibe|mesh-list
154539844|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154539845|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539846|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
154539847|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539848|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539849|NCT03099278|Ezetimibe|ezetimibe|mesh-list
154539850|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154539851|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154539852|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
154539853|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539854|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539856|NCT02103205|Lactoferrin|lactoferrin|mesh-list
154539857|NCT02103205|Trace Elements|trace elements|mesh-ancestor
154539858|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
154539859|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539860|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539861|NCT03290703|Rabeprazole|rabeprazole|mesh-list
154539862|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154539863|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539864|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154263674|NCT05047250|Atezolizumab|atezolizumab|mesh-list
154539865|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539866|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539867|NCT02408068|Dexamethasone|dexamethasone|mesh-list
154539868|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
154539869|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154539870|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154539871|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154539872|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154539873|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
154539874|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
154539875|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539876|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539877|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539878|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
154539879|NCT02408068|Hormones|hormones|mesh-ancestor
154539880|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539881|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154539882|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539883|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
154539884|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154539885|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
154539886|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539887|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
154539888|NCT02465853|Protective Agents|protective agents|mesh-ancestor
154539889|NCT02465385|Linaclotide|linaclotide|mesh-list
154539890|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154539891|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
154539892|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539893|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539895|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
154539896|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154308916|NCT03280550|Omalizumab|omalizumab|mesh-list
154539897|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
154539898|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539899|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539900|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154539901|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
154539902|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
154539903|NCT03290625|Ketamine|ketamine|mesh-list
154539904|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154539905|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154539906|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539907|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154539908|NCT03290625|Analgesics|analgesics|mesh-ancestor
154539909|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
154539910|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539911|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154539912|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154539913|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154539914|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
154539915|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154539916|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539917|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154539918|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154539919|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
154539920|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
154539921|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154539922|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154539923|NCT02250781|TIC10 compound|tic10 compound|mesh-list
154539924|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539925|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
154539926|NCT03099122|Prednisone|prednisone|mesh-list
154539927|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
154539928|NCT03099122|Tacrolimus|tacrolimus|mesh-list
154539929|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
154539930|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154539931|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
154539932|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154539933|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
154539934|NCT03099122|Hormones|hormones|mesh-ancestor
154539935|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539936|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539937|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154539938|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154539939|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154539940|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
154539941|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154539943|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539944|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154539945|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154539946|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
154539947|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154539948|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539949|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
154539950|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
154539951|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154539952|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539953|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154539954|NCT03099122|Protective Agents|protective agents|mesh-ancestor
154539955|NCT04335201|Defibrotide|defibrotide|mesh-list
154539956|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154539957|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154539958|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539959|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154539960|NCT03295851|Iron|iron|mesh-list
154539961|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
154539962|NCT03295851|Trace Elements|trace elements|mesh-ancestor
154539963|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
154539964|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539965|NCT03096470|Anesthetics|anesthetics|mesh-list
154539966|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154539967|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539968|NCT02100553|Itraconazole|itraconazole|mesh-list
154539969|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154539970|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
154539971|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539972|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154539973|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154539974|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539975|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539976|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154539977|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
154539978|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154539979|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154539980|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154539981|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154539982|NCT02100787|Laxatives|laxatives|mesh-ancestor
154539983|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154539984|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154539985|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154539986|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539987|NCT04718805|Darunavir|darunavir|mesh-list
154539988|NCT04718805|Cobicistat|cobicistat|mesh-list
154539989|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154539990|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154539991|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154539992|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
154539993|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154539994|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154539995|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154539996|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154539997|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
154539998|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154539999|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154540000|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154540001|NCT05042336|Lenvatinib|lenvatinib|mesh-list
154540002|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540003|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154540004|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540005|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540006|NCT03096392|Insulin|insulin|mesh-list
154540007|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154540008|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
154540009|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154540010|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540011|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
154540012|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154540013|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154540014|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540015|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540016|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540017|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154540018|NCT02460393|Antibodies|antibodies|mesh-list
154540019|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
154540020|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154540021|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
154540022|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540023|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540024|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154540025|NCT02250859|Minocycline|minocycline|mesh-list
154540026|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540027|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
154540028|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154540029|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540030|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
154540031|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
154540032|NCT03295383|Rituximab|rituximab|mesh-list
154540033|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540034|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
154540035|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540036|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154540037|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154540038|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
154540039|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540040|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540041|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154540042|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154540043|NCT02101255|Fluorides|fluorides|mesh-list
154540044|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
154540046|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540047|NCT05063318|Itraconazole|itraconazole|mesh-list
154540048|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
154540049|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540050|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154540051|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154540052|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540053|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540054|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154540055|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
154540056|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540057|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540058|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154540059|NCT02104297|Remifentanil|remifentanil|mesh-list
154540060|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154540061|NCT02104297|Narcotics|narcotics|mesh-ancestor
154540062|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540063|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540064|NCT02104297|Analgesics|analgesics|mesh-ancestor
154540065|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
154540066|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540067|NCT02106481|Ropivacaine|ropivacaine|mesh-list
154540068|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154540069|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
154540070|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540071|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540072|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
154540073|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540074|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154540075|NCT02106559|Trioxsalen|trioxsalen|mesh-list
154540076|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540077|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
154540078|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154540079|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
154540080|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154540081|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154540082|NCT05047874|Prednisolone|prednisolone|mesh-list
154540083|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
154540084|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154540085|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
154540086|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540087|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
154540088|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
154540089|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540090|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540091|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154540093|NCT05047874|Hormones|hormones|mesh-ancestor
154540094|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540095|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154540096|NCT05047874|Protective Agents|protective agents|mesh-ancestor
154540097|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154540098|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540099|NCT04488705|Albuterol|albuterol|mesh-list
154540100|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154540101|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
154540102|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540103|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540104|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154540105|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
154540106|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
154540107|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154540108|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154540109|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154540110|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154540111|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
154540112|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540113|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540114|NCT02106637|Varenicline|varenicline|mesh-list
154540115|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154540116|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154540117|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
154540118|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374981|NCT05704049|Hormones|hormones|mesh-ancestor
154540119|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540120|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540121|NCT05047328|Inolimomab|inolimomab|mesh-list
154540122|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540123|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
154540124|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540125|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
154540126|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154540127|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
154540128|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154540129|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540130|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154540131|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154540132|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154540133|NCT02106793|Mitomycins|mitomycins|mesh-list
154540134|NCT02106793|Mitomycin|mitomycin|mesh-list
154540135|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154540136|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540137|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
154540138|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540139|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154540140|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540141|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154540142|NCT02104843|Asunaprevir|asunaprevir|mesh-list
154540143|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154540144|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154540145|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
154540146|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540147|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154540148|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154540149|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540150|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
154540151|NCT05041790|Choline|choline|mesh-list
154540152|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
154540153|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154540154|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
154540155|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540156|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154540157|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154540158|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
154540159|NCT02105077|Anesthetics|anesthetics|mesh-list
154540160|NCT02105077|Xenon|xenon|mesh-list
154540161|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540162|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253739|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540163|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154540164|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
154540165|NCT02101567|Oxytocin|oxytocin|mesh-list
154540166|NCT02101567|Carbetocin|carbetocin|mesh-list
154540167|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
154540168|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154540169|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540170|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
154540171|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
154540172|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154540173|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154540174|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540175|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540176|NCT02106871|Urological Agents|urological agents|mesh-ancestor
154540177|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
154540178|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540179|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
154540180|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
154540181|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
154540182|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154540183|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154540184|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540185|NCT02407990|Tislelizumab|tislelizumab|mesh-list
154540186|NCT02407990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154540187|NCT02407990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540188|NCT02105155|Tacrolimus|tacrolimus|mesh-list
154540189|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540190|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
154540191|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540192|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154540193|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540194|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540195|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154540196|NCT03294525|Mirtazapine|mirtazapine|mesh-list
154540197|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
154540198|NCT03294525|Escitalopram|escitalopram|mesh-list
154540199|NCT03294525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154540200|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154540201|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154540202|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540203|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540204|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
154540205|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540206|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540207|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154540208|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154540209|NCT03294525|Analgesics|analgesics|mesh-ancestor
154540210|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
154540211|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
154540212|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154540213|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
154540214|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
154540215|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154540216|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154540217|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540218|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154540219|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154540220|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154540221|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
154540222|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154540223|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154540224|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154540225|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
154540226|NCT05036174|Promethazine|promethazine|mesh-list
154540227|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154540228|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154540229|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540230|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540231|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
154540232|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
154540233|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
154540234|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540235|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
154540236|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
154264047|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
154540237|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154540238|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154540239|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
154540240|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
154540241|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540242|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540243|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154540244|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
154540245|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
154540246|NCT03283059|Donepezil|donepezil|mesh-list
154540247|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154540248|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540249|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540250|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
154540251|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540252|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540253|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
154540254|NCT05060588|Valsartan|valsartan|mesh-list
154540255|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154540256|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154540257|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154540258|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154540259|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540260|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154540261|NCT02105311|Travoprost|travoprost|mesh-list
154540262|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154540263|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154540264|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860272|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154540266|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154540267|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
154540268|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540269|NCT03282825|Paclitaxel|paclitaxel|mesh-list
154540270|NCT03282825|Decitabine|decitabine|mesh-list
154540271|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154540272|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540273|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154540274|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154540275|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154540276|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540277|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154540278|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
154540279|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540280|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154540281|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154540282|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154540283|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
154540284|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540285|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154540286|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154540287|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540288|NCT05039606|Nedaplatin|nedaplatin|mesh-list
154540289|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540290|NCT03288051|Dobutamine|dobutamine|mesh-list
154540291|NCT03288051|Norepinephrine|norepinephrine|mesh-list
154540292|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154540293|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154540294|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
154540295|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540296|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540297|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540298|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
154540299|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
154540300|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540301|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154540302|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154540303|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154540304|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154540305|NCT03288051|Protective Agents|protective agents|mesh-ancestor
154540306|NCT05035472|Phenylephrine|phenylephrine|mesh-list
154540307|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
154540308|NCT05035472|Norepinephrine|norepinephrine|mesh-list
154540309|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154540310|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154540311|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
154540312|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
154540313|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540314|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540315|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
154540316|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
154540317|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
154540318|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154540319|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154540320|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154540321|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
154540322|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540323|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540324|NCT05035472|Protective Agents|protective agents|mesh-ancestor
154540326|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
154540327|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
154540328|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540329|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540330|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
154540331|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540332|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154540333|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154540334|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154540335|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154540336|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540337|NCT02107729|Lidocaine|lidocaine|mesh-list
154540338|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
154540339|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
154540340|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540341|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540342|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
154540343|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540344|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154540345|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154540346|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154540347|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154540348|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540350|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540351|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540352|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540353|NCT02107807|Lactitol|lactitol|mesh-list
154540354|NCT02107807|Vaccines|vaccines|mesh-list
154540355|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
154540356|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540357|NCT02107807|Cathartics|cathartics|mesh-ancestor
154540358|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154540359|NCT01673282|Lacosamide|lacosamide|mesh-list
154540360|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
154540361|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154540362|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154540363|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154540364|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540365|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154540366|NCT02113735|Hormones|hormones|mesh-ancestor
154540367|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540368|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540369|NCT02113813|Naquotinib|naquotinib|mesh-list
154540370|NCT02113813|Midazolam|midazolam|mesh-list
154540371|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154540372|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154540373|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540374|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540375|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154540376|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154540377|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154540378|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154540379|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
154540380|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
154540381|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
154540382|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
154540383|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540384|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540385|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540386|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154540387|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540389|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540390|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540391|NCT03095222|Ketamine|ketamine|mesh-list
154540392|NCT03095222|Analgesics|analgesics|mesh-ancestor
154540393|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
154540394|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540395|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540396|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154540397|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154540398|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
154540399|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
154540400|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540401|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154540402|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154540403|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540404|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540405|NCT02113891|Eculizumab|eculizumab|mesh-list
154540406|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154540407|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540408|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
154540409|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540410|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
154540411|NCT03095378|Tetracycline|tetracycline|mesh-list
154540412|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154540413|NCT03095378|Citric Acid|citric acid|mesh-list
154540414|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
154540415|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154540416|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540417|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540418|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
154540419|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154540420|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
154540421|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
154540422|NCT05025098|Azacitidine|azacitidine|mesh-list
154540423|NCT05025098|Venetoclax|venetoclax|mesh-list
154540424|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154540425|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
154540426|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540427|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540428|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540429|NCT02114359|Cisplatin|cisplatin|mesh-list
154540430|NCT02114359|Capecitabine|capecitabine|mesh-list
154540431|NCT02114359|Fluorouracil|fluorouracil|mesh-list
154540432|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
154540433|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540434|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154540435|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
154540436|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540437|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540438|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
154540439|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540440|NCT02110303|Ticagrelor|ticagrelor|mesh-list
154540441|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154540442|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154540443|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154540444|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154540445|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
154540446|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540447|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540448|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540449|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
154540450|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154540451|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
154540452|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540453|NCT02108353|Melatonin|melatonin|mesh-list
154540454|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
154540455|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540456|NCT02108353|Protective Agents|protective agents|mesh-ancestor
154540457|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540458|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540459|NCT04157751|Empagliflozin|empagliflozin|mesh-list
154264274|NCT03878524|Pertuzumab|pertuzumab|mesh-list
154540460|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154540461|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540462|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154540463|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540464|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
154540465|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154540466|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540467|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154540468|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154540469|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540470|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540471|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540472|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154540473|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154540474|NCT02110459|Murepavadin|murepavadin|mesh-list
154540475|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154540476|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540477|NCT03287505|Aripiprazole|aripiprazole|mesh-list
154540478|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
154540479|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154540480|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154540481|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154540482|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540483|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540484|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
154540485|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
154540486|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540487|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540488|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154540489|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154540490|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
154540491|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154540492|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154540493|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154540494|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154540495|NCT03090698|Triamcinolone|triamcinolone|mesh-list
154540496|NCT03090698|Hylan|hylan|mesh-list
154540497|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540498|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
154540499|NCT03090698|Hormones|hormones|mesh-ancestor
154540500|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540501|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540502|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
154540503|NCT03090698|Protective Agents|protective agents|mesh-ancestor
154540504|NCT03293511|Oxytocin|oxytocin|mesh-list
154540505|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
154540506|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154540507|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540508|NCT02251171|Ritonavir|ritonavir|mesh-list
154540509|NCT02251171|Tipranavir|tipranavir|mesh-list
154540510|NCT02251171|Rifabutin|rifabutin|mesh-list
154540511|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154540512|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154540513|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
154540514|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540515|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540516|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154540517|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154540518|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
154540519|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540520|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154540521|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154540522|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154540523|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154540524|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
154540525|NCT02110537|Flecainide|flecainide|mesh-list
154540526|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154540527|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154540528|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154540529|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154540530|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540531|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
154540532|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154540533|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540534|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540535|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154540537|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
154540538|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540539|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154540540|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154540541|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154540542|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
154540543|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540544|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540545|NCT02108743|Albuterol|albuterol|mesh-list
154540546|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154540547|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
154540548|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540549|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540550|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154540551|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
154540552|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
154540553|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154540554|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154540555|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154540556|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154540557|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
154540558|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540559|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540560|NCT03292965|Neostigmine|neostigmine|mesh-list
154540561|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154540562|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540563|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540564|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
154540565|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540566|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540567|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154540569|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540570|NCT05024084|Anesthetics|anesthetics|mesh-list
154540571|NCT05024084|Sevoflurane|sevoflurane|mesh-list
154540572|NCT05024084|Desflurane|desflurane|mesh-list
154540573|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540574|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540575|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154540576|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154540577|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
154540578|NCT02109289|Etanercept|etanercept|mesh-list
154540579|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154540580|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154540581|NCT02109289|Analgesics|analgesics|mesh-ancestor
154540582|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
154540583|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540584|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540585|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540586|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154540587|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154540588|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540589|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
154540590|NCT03553303|Valsartan|valsartan|mesh-list
154540591|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154540592|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154540593|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154540594|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154540595|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540596|NCT03286959|Calcium|calcium|mesh-list
154309621|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
154540597|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154540598|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540599|NCT03292575|Anticoagulants|anticoagulants|mesh-list
154540600|NCT02115529|Nabilone|nabilone|mesh-list
154540601|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
154540602|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
154540603|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540604|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540605|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154264428|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
154540606|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154540607|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154540608|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540609|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154540611|NCT01652716|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154540612|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154540613|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540614|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154540615|NCT01652716|Incretins|incretins|mesh-ancestor
154540616|NCT01652716|Hormones|hormones|mesh-ancestor
154540617|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540618|NCT02459613|Annexin A5|annexin a5|mesh-list
154540619|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540620|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540621|NCT02251249|Acetaminophen|acetaminophen|mesh-list
154540622|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154540623|NCT02251249|Analgesics|analgesics|mesh-ancestor
154540624|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
154540625|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540626|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540627|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
154540628|NCT03292263|Nivolumab|nivolumab|mesh-list
154540629|NCT03292263|Melphalan|melphalan|mesh-list
154540630|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154540631|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540632|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154540633|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540634|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154540635|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
154540636|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154540637|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540638|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
154540639|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540641|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154540642|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540643|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154540644|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540645|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540646|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154540647|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154540648|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
154540649|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540650|NCT03286803|Vaccines|vaccines|mesh-list
154540651|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
154540652|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540653|NCT03292185|Insulin|insulin|mesh-list
154540654|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154540655|NCT03292185|Liraglutide|liraglutide|mesh-list
154540656|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
154540657|NCT03292185|Xultophy|xultophy|mesh-list
154540658|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154540659|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540660|NCT03292185|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154540661|NCT03292185|Incretins|incretins|mesh-ancestor
154540662|NCT03292185|Hormones|hormones|mesh-ancestor
154540663|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540664|NCT02109679|Metformin|metformin|mesh-list
154540665|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154540666|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540667|NCT05023304|Prednisolone|prednisolone|mesh-list
154540668|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540669|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
154540670|NCT05023304|Hormones|hormones|mesh-ancestor
154540671|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540672|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540673|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154540674|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540675|NCT02109913|Everolimus|everolimus|mesh-list
154540676|NCT02109913|Exemestane|exemestane|mesh-list
154540677|NCT02109913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154540678|NCT02109913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154540679|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540680|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540681|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540682|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
154540683|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540684|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540685|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154540686|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154540687|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154540688|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
154540689|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540690|NCT02116231|Cisplatin|cisplatin|mesh-list
154540691|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540692|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
154540693|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154540694|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
154540695|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
154540696|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154540697|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
154540698|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540699|NCT02116465|Levodopa|levodopa|mesh-list
154540700|NCT02116465|Carbidopa|carbidopa|mesh-list
154540701|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154540702|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154540703|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154540704|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
154540705|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540706|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540707|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540708|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154540709|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540710|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154540711|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
154540712|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
154540713|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154540714|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154540715|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
154540716|NCT02119117|Vitamins|vitamins|mesh-ancestor
154540717|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
154540718|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540719|NCT05016128|Ketamine|ketamine|mesh-list
154540720|NCT05016128|Esketamine|esketamine|mesh-list
154540721|NCT05016128|Analgesics|analgesics|mesh-ancestor
154540722|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
154540723|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540724|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540725|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154540726|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154540727|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
154540728|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
154540729|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540730|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154540731|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154540732|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540733|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540734|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
154540735|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154540736|NCT02111317|Verapamil|verapamil|mesh-list
154540737|NCT02111317|Peficitinib|peficitinib|mesh-list
154540738|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154540739|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154540740|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154540741|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540742|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154540743|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540744|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
154540745|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540746|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540747|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
154540748|NCT03553615|Ivermectin|ivermectin|mesh-list
154540749|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154540750|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540751|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
154540752|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154540753|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154264579|NCT03377361|Trametinib|trametinib|mesh-list
154540754|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540755|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154540756|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154540757|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540758|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540759|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540760|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154540761|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
154540762|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154540763|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540764|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154540765|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154540766|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154540767|NCT02111473|Testosterone|testosterone|mesh-list
154540768|NCT02111473|Androgens|androgens|mesh-ancestor
154540769|NCT02111473|Hormones|hormones|mesh-ancestor
154540770|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540771|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540772|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
154540773|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154540774|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154540775|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
154540776|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540777|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540778|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540779|NCT02119273|Prednisone|prednisone|mesh-list
154540780|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540781|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
154540782|NCT02119273|Hormones|hormones|mesh-ancestor
154540783|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540784|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540785|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154540786|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540787|NCT05029076|Liraglutide|liraglutide|mesh-list
154540788|NCT05029076|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154540789|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154540790|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540791|NCT05029076|Incretins|incretins|mesh-ancestor
154540792|NCT05029076|Hormones|hormones|mesh-ancestor
154540793|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540794|NCT05016440|Lisinopril|lisinopril|mesh-list
154540795|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154540796|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
154540797|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540798|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540799|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154540800|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154540801|NCT05016440|Protective Agents|protective agents|mesh-ancestor
154540802|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540803|NCT02111629|Fluconazole|fluconazole|mesh-list
154540804|NCT02111629|Secnidazole|secnidazole|mesh-list
154540805|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
154540806|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540807|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154540808|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154540809|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540810|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540811|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154540812|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
154540813|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540814|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540815|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154540816|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154540817|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154540818|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154540819|NCT02111707|Indomethacin|indomethacin|mesh-list
154540820|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154540821|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154540822|NCT02111707|Analgesics|analgesics|mesh-ancestor
154540823|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
154540824|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540825|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540826|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540827|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154540828|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
154540829|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
154540830|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154540831|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154540832|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540833|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540834|NCT03552601|Methamphetamine|methamphetamine|mesh-list
154540835|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154540836|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540837|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
154540838|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
154540839|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540840|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
154540841|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540842|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540843|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
154540844|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154540845|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154540846|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154540847|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154540848|NCT05021588|Anticoagulants|anticoagulants|mesh-list
154540849|NCT03087890|Trimethoprim|trimethoprim|mesh-list
154540850|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154540851|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
154540852|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154540853|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154540854|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
154540855|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154540856|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154375719|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
154860273|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540857|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154540858|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540859|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540860|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154540861|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154540862|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154540863|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154540864|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
154540865|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540866|NCT02117401|Midazolam|midazolam|mesh-list
154540867|NCT02117401|Ketamine|ketamine|mesh-list
154540868|NCT02117401|Remifentanil|remifentanil|mesh-list
154540869|NCT02117401|Propofol|propofol|mesh-list
154540870|NCT02117401|Mivacurium|mivacurium|mesh-list
154540871|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154540872|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154540873|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540874|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154540875|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
154540876|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
154540877|NCT02117401|Analgesics|analgesics|mesh-ancestor
154540878|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
154540879|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540880|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154540881|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154540882|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154540883|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154540884|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540885|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154540886|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154540887|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154540888|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154540889|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
154540890|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
154540891|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154540892|NCT02117401|Narcotics|narcotics|mesh-ancestor
154540893|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154540894|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154540895|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154540896|NCT04434404|Silymarin|silymarin|mesh-list
154540897|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
154540898|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540899|NCT04434404|Protective Agents|protective agents|mesh-ancestor
154540900|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540901|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
154540902|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154540903|NCT02251483|Antibodies|antibodies|mesh-list
154540904|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
154540905|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540906|NCT02117869|Furocoumarins|furocoumarins|mesh-list
154540907|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
154540908|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154540909|NCT02120599|Folic Acid|folic acid|mesh-list
154540910|NCT02120599|Hematinics|hematinics|mesh-ancestor
154540911|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
154540912|NCT02120599|Vitamins|vitamins|mesh-ancestor
154540913|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
154540914|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540915|NCT02112097|Etanercept|etanercept|mesh-list
154540916|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154540917|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154540918|NCT02112097|Analgesics|analgesics|mesh-ancestor
154540919|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
154540920|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540921|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540922|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540923|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154540924|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154540925|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540926|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
154540927|NCT02112175|Lenalidomide|lenalidomide|mesh-list
154540928|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
154540929|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540930|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154540931|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154540932|NCT02112175|Growth Substances|growth substances|mesh-ancestor
154540933|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
154860274|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
154540934|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540935|NCT03553537|Prednisone|prednisone|mesh-list
154540936|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
154540937|NCT03553537|Doxorubicin|doxorubicin|mesh-list
154540938|NCT03553537|Vincristine|vincristine|mesh-list
154540939|NCT03553537|Decitabine|decitabine|mesh-list
154540940|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540941|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
154540942|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540943|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154540944|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154540945|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
154540946|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540947|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540948|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154540949|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154540950|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154540951|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154540952|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540953|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540954|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
154540955|NCT03553537|Hormones|hormones|mesh-ancestor
154540956|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154540957|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154540958|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154540959|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
154540960|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
154540961|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
154540962|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154540963|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
154540964|NCT03086174|Antibodies|antibodies|mesh-list
154540965|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154540966|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
154540967|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540968|NCT03085784|Aflibercept|aflibercept|mesh-list
154540969|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154540970|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154540971|NCT03085784|Growth Substances|growth substances|mesh-ancestor
154540972|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540973|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
154540974|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540975|NCT05021276|Basiliximab|basiliximab|mesh-list
154540976|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154540977|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
154540978|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540979|NCT05014490|Etoricoxib|etoricoxib|mesh-list
154540980|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154540981|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154540982|NCT05014490|Analgesics|analgesics|mesh-ancestor
154540983|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
154540984|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154540985|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540986|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154540987|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154540988|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154540989|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154540990|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154540991|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154540992|NCT05020964|Trastuzumab|trastuzumab|mesh-list
154540993|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154540994|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154540995|NCT05014100|Lenalidomide|lenalidomide|mesh-list
154540996|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
154540997|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154540998|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154540999|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154541000|NCT05014100|Growth Substances|growth substances|mesh-ancestor
154541001|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
154541002|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541003|NCT05027126|Folic Acid|folic acid|mesh-list
154541004|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
154541005|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154541006|NCT05027126|Vitamins|vitamins|mesh-ancestor
154541007|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
154541008|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541009|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154541010|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541011|NCT05027126|Analgesics|analgesics|mesh-ancestor
154541012|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
154541013|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541014|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541015|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541016|NCT05027126|Hematinics|hematinics|mesh-ancestor
154541017|NCT02120677|Itraconazole|itraconazole|mesh-list
154541018|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
154541019|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541020|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154541021|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154541022|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541023|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541024|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154541025|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
154541026|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541027|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541028|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154541029|NCT02120911|Trastuzumab|trastuzumab|mesh-list
154541030|NCT02120911|Pertuzumab|pertuzumab|mesh-list
154541031|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154541032|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541033|NCT02112487|Macitentan|macitentan|mesh-list
154541034|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154541035|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154541036|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541037|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154541038|NCT03094442|Dexamethasone|dexamethasone|mesh-list
154541039|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541040|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
154541041|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
154541042|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541043|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541044|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154541045|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
154541046|NCT03094442|Hormones|hormones|mesh-ancestor
154541047|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541048|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154541049|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541050|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
154541051|NCT02406742|Ibrutinib|ibrutinib|mesh-list
154541052|NCT02406742|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154541053|NCT02406742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154541054|NCT02406742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541055|NCT02406742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541056|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154541057|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541058|NCT02112643|Selenium|selenium|mesh-list
154541059|NCT02112643|Selenic Acid|selenic acid|mesh-list
154541060|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
154541061|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541062|NCT02112643|Protective Agents|protective agents|mesh-ancestor
154541063|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541064|NCT02112643|Trace Elements|trace elements|mesh-ancestor
154541065|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
154541066|NCT02714595|Cefiderocol|cefiderocol|mesh-list
154541067|NCT02714595|Siderophores|siderophores|mesh-ancestor
154541068|NCT02714595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154541069|NCT02714595|Chelating Agents|chelating agents|mesh-ancestor
154541070|NCT02714595|Sequestering Agents|sequestering agents|mesh-ancestor
154541071|NCT02714595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541072|NCT02714595|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154541073|NCT02714595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154541074|NCT02714595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541075|NCT02112721|Vitamin D|vitamin d|mesh-list
154541076|NCT02112721|Vitamins|vitamins|mesh-ancestor
154541077|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
154541078|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541079|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154541080|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154541081|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
154541082|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541083|NCT02122939|Escitalopram|escitalopram|mesh-list
154860275|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154541084|NCT02122939|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154541085|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154541086|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154541087|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541088|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541089|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
154541090|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541091|NCT04434248|Ritonavir|ritonavir|mesh-list
154541092|NCT04434248|Lopinavir|lopinavir|mesh-list
154541093|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
154541094|NCT04434248|Chloroquine|chloroquine|mesh-list
154541095|NCT04434248|Favipiravir|favipiravir|mesh-list
154541096|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154541097|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154541098|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
154541099|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541100|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541101|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154541102|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154541103|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
154541104|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541105|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154541106|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154541107|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
154541108|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154541109|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154541110|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541111|NCT04434248|Amebicides|amebicides|mesh-ancestor
154541112|NCT02121457|Selenium|selenium|mesh-list
154541113|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
154541114|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541115|NCT02121457|Protective Agents|protective agents|mesh-ancestor
154541116|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541117|NCT02121457|Trace Elements|trace elements|mesh-ancestor
154541118|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
154541119|NCT02251795|Aspirin|aspirin|mesh-list
154541120|NCT02251795|Ritonavir|ritonavir|mesh-list
154541121|NCT02251795|Darunavir|darunavir|mesh-list
154541122|NCT02251795|Tipranavir|tipranavir|mesh-list
154541123|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154541124|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541125|NCT02251795|Analgesics|analgesics|mesh-ancestor
154541126|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
154541127|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264957|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154541128|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541129|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541130|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541131|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154541132|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154541133|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541134|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154541135|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154541136|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541137|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
154541138|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154541139|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154541140|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
154541141|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154541142|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154541143|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
154541144|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541145|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154541146|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154541147|NCT05013164|Leucovorin|leucovorin|mesh-list
154541148|NCT05013164|Folic Acid|folic acid|mesh-list
154541149|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
154541150|NCT05013164|Antidotes|antidotes|mesh-ancestor
154541151|NCT05013164|Protective Agents|protective agents|mesh-ancestor
154541152|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541153|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
154541154|NCT05013164|Vitamins|vitamins|mesh-ancestor
154541155|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
154541156|NCT05013164|Hematinics|hematinics|mesh-ancestor
154541157|NCT02251951|Paclitaxel|paclitaxel|mesh-list
154541158|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154541159|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541160|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
154541161|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
154541162|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
154541163|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541164|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154541165|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154541166|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
154541167|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541168|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154541169|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154541170|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
154541171|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
154541172|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541173|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541174|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
154541176|NCT02121613|Urological Agents|urological agents|mesh-ancestor
154541177|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154541178|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154541179|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154541180|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541181|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541182|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541183|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541184|NCT03091712|Insulin|insulin|mesh-list
154541185|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154541186|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541187|NCT03552211|Biotin|biotin|mesh-list
154541188|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
154541189|NCT03552211|Vitamins|vitamins|mesh-ancestor
154541190|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
154541191|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541192|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
154541193|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541194|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154541195|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154541196|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
154541197|NCT03281187|Testosterone|testosterone|mesh-list
154541198|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
154541199|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
154541200|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154541201|NCT03281187|Androgens|androgens|mesh-ancestor
154541202|NCT03281187|Hormones|hormones|mesh-ancestor
154541203|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541204|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265031|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541205|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154541206|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541207|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
154541208|NCT03291249|Omeprazole|omeprazole|mesh-list
154541209|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154541210|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154541211|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154541212|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541213|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541214|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
154541215|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
154541216|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154541217|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541218|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541219|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541220|NCT05013320|Analgesics|analgesics|mesh-ancestor
154541221|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
154541222|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541223|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154541224|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154541225|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154541226|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541227|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541228|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541229|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154541230|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154541231|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154541232|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
154541233|NCT02437162|Golimumab|golimumab|mesh-list
154860276|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
154541234|NCT02437162|Ustekinumab|ustekinumab|mesh-list
154541235|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
154541236|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154541237|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541238|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154541239|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
154541240|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541241|NCT03291093|Flutemetamol|flutemetamol|mesh-list
154541242|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154541243|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541244|NCT02123563|Listerine|listerine|mesh-list
154541245|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154541246|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541247|NCT02122003|Sorafenib|sorafenib|mesh-list
154541248|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541249|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154541250|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541251|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541252|NCT03079388|Azithromycin|azithromycin|mesh-list
154541253|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
154541254|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
154541255|NCT03079388|Albendazole|albendazole|mesh-list
154541256|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154541257|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154541258|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541259|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
154541260|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154541261|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154541262|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154541263|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541264|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541265|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154541266|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
154541267|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
154541268|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154541269|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
154541270|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
154541271|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
154541272|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541273|NCT03079544|Asparaginase|asparaginase|mesh-list
154541274|NCT03079544|Pegaspargase|pegaspargase|mesh-list
154541275|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541276|NCT03286101|Ivermectin|ivermectin|mesh-list
154541277|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154541278|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541279|NCT02437084|Atorvastatin|atorvastatin|mesh-list
154541280|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154541281|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154541282|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
154541283|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541284|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154541285|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154541287|NCT05009498|Vitamin D|vitamin d|mesh-list
154541288|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
154541289|NCT05009498|Vitamins|vitamins|mesh-ancestor
154541290|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
154541291|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541292|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154541293|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154541294|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154541295|NCT02406586|Carvedilol|carvedilol|mesh-list
154541296|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154541297|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154541298|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154541299|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541300|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541301|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541302|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541303|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154541304|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
154541305|NCT02406586|Protective Agents|protective agents|mesh-ancestor
154541306|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154541307|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154541308|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154541309|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
154541310|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154541312|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154541313|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154541314|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154541315|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154541316|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541317|NCT02406586|Analgesics|analgesics|mesh-ancestor
154541318|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
154541319|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541320|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541321|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541322|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
154541323|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154541324|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541325|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541326|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541327|NCT03091166|Analgesics|analgesics|mesh-ancestor
154541328|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
154541329|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541330|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154541331|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154541332|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154541333|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541334|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541335|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541336|NCT02122393|Sertraline|sertraline|mesh-list
154541337|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
154541338|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154541339|NCT02122393|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154541340|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154541341|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154541342|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541343|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541344|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
154541345|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541346|NCT03821883|Aspirin|aspirin|mesh-list
154541347|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154541348|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541349|NCT03821883|Analgesics|analgesics|mesh-ancestor
154541350|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
154541351|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541352|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541353|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541354|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541355|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154541356|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154541357|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541358|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154541359|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154541360|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541361|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
154541362|NCT03080480|Pioglitazone|pioglitazone|mesh-list
154541363|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154541364|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541365|NCT02126761|Vaccines|vaccines|mesh-list
154541366|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
154541367|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541368|NCT03605277|Asciminib|asciminib|mesh-list
154541369|NCT03605277|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154541370|NCT03605277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154541371|NCT03605277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541372|NCT03605277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541373|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154541374|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154541375|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154541376|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154541377|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541378|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541379|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541380|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541381|NCT03280641|Warfarin|warfarin|mesh-list
154541382|NCT03280641|Dabigatran|dabigatran|mesh-list
154541383|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
154541384|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
154541385|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154541386|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
154541387|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541388|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541389|NCT03285165|Propofol|propofol|mesh-list
154541390|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154541391|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541392|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541393|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154541394|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
154541395|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
154541396|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
154541397|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154541398|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541399|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541400|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541401|NCT03285087|Analgesics|analgesics|mesh-ancestor
154541402|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
154541403|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541404|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154541405|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154541406|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154541407|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541408|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541409|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541410|NCT02122627|Vitamin D|vitamin d|mesh-list
154541411|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
154541412|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
154541413|NCT02122627|Vitamins|vitamins|mesh-list
154541414|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
154541415|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541416|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154541417|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154541418|NCT02122705|Remifentanil|remifentanil|mesh-list
154541419|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154541420|NCT02122705|Narcotics|narcotics|mesh-ancestor
154541421|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541422|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541423|NCT02122705|Analgesics|analgesics|mesh-ancestor
154541424|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
154541425|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541426|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154541427|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154541428|NCT03384225|Cytarabine|cytarabine|mesh-list
154541429|NCT03384225|Fludarabine|fludarabine|mesh-list
154541430|NCT03384225|Busulfan|busulfan|mesh-list
154541431|NCT03384225|Cladribine|cladribine|mesh-list
154265254|NCT00269399|Vancomycin|vancomycin|mesh-list
154541432|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541433|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154541434|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
154541435|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541436|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154541437|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
154541438|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541439|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
154541440|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541441|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
154541442|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154541443|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154541444|NCT05019326|Andrographolide|andrographolide|mesh-list
154541445|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541446|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154541447|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541448|NCT05019326|Analgesics|analgesics|mesh-ancestor
154541449|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
154541450|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541451|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541452|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541453|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154541454|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154541455|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541456|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
154541457|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154541459|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154541460|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154541461|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
154541462|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
154541463|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541464|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541465|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154541466|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154541467|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154541468|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541469|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541470|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541471|NCT03079076|Bupivacaine|bupivacaine|mesh-list
154541472|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
154541473|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
154541474|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541475|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541476|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
154541477|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541478|NCT03271749|Anesthetics|anesthetics|mesh-list
154541479|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541480|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541481|NCT03280407|Leucovorin|leucovorin|mesh-list
154541482|NCT03280407|Capecitabine|capecitabine|mesh-list
154541483|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
154541484|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
154541485|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154541486|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
154541487|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541488|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541489|NCT03280407|Antidotes|antidotes|mesh-ancestor
154541490|NCT03280407|Protective Agents|protective agents|mesh-ancestor
154541491|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541492|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
154541493|NCT03280407|Vitamins|vitamins|mesh-ancestor
154541494|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
154541495|NCT03078842|Zinc|zinc|mesh-list
154541496|NCT03078842|Trace Elements|trace elements|mesh-ancestor
154541497|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
154541498|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541499|NCT05007860|Vaccines|vaccines|mesh-list
154541500|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
154541501|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541502|NCT03270033|Dexamethasone|dexamethasone|mesh-list
154541503|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
154541504|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
154541505|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154541506|NCT03270033|BB 1101|bb 1101|mesh-list
154541507|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541508|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
154541509|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
154541510|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541511|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541512|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154541513|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
154541514|NCT03270033|Hormones|hormones|mesh-ancestor
154541515|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541516|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154541517|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541518|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
154541519|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541520|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541521|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154541522|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541523|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541524|NCT03270033|Analgesics|analgesics|mesh-ancestor
154541525|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
154541526|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154541527|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154541528|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154541529|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541530|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541531|NCT03280095|Acetaminophen|acetaminophen|mesh-list
154541532|NCT03280095|Codeine|codeine|mesh-list
154541533|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541534|NCT03280095|Analgesics|analgesics|mesh-ancestor
154541535|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
154541536|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541537|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541538|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
154541539|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154541540|NCT03280095|Narcotics|narcotics|mesh-ancestor
154541541|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541542|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
154541543|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
154541544|NCT04463030|Vitamins|vitamins|mesh-list
154541545|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
154541546|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
154541547|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541548|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
154541549|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541550|NCT04463030|Protective Agents|protective agents|mesh-ancestor
154541551|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
154541552|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
154541553|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541554|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
154541555|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541556|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541557|NCT05010356|Insulin|insulin|mesh-list
154541558|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154541559|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541560|NCT03269955|Thrombin|thrombin|mesh-list
154541561|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
154541562|NCT03269955|Coagulants|coagulants|mesh-ancestor
154541563|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
154541564|NCT05006846|Narcotics|narcotics|mesh-ancestor
154541565|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541566|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541567|NCT05006846|Analgesics|analgesics|mesh-ancestor
154541568|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
154541569|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541570|NCT02457520|Isotretinoin|isotretinoin|mesh-list
154541571|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
154541572|NCT02457585|Infliximab|infliximab|mesh-list
154541573|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154541574|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541575|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
154541576|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154541577|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541578|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
154541579|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
154541580|NCT02457507|Vitamins|vitamins|mesh-ancestor
154541581|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
154541582|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265399|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154541583|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
154541584|NCT02457507|Hematinics|hematinics|mesh-ancestor
154541585|NCT03265197|Lidocaine|lidocaine|mesh-list
154541586|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
154541587|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
154541588|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541589|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541590|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
154541591|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541592|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154541593|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154541594|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154541595|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154541596|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541597|NCT03078374|Warfarin|warfarin|mesh-list
154541598|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
154541599|NCT02788279|Atezolizumab|atezolizumab|mesh-list
154541600|NCT02788279|Antibodies|antibodies|mesh-list
154541601|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
154541602|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541603|NCT02788279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154541604|NCT02788279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541605|NCT02788279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154541606|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541607|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154541608|NCT03264651|Anastrozole|anastrozole|mesh-list
154541609|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154541610|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541611|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154541612|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154541613|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541614|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541615|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154541616|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
154541617|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541618|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541619|NCT03078062|Dexamethasone|dexamethasone|mesh-list
154541620|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541621|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
154541622|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
154541623|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541624|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541625|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154541626|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
154541627|NCT03078062|Hormones|hormones|mesh-ancestor
154541628|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541629|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154541630|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541631|NCT02435992|Ozanimod|ozanimod|mesh-list
154541632|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154541633|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541634|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154541635|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
154541636|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541637|NCT02457351|Itraconazole|itraconazole|mesh-list
154541638|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
154541639|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541640|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154541641|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154541642|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541643|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541644|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154541645|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
154541646|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541647|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541648|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154541649|NCT02788513|BI 425809|bi 425809|mesh-list
154541650|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
154541651|NCT03077828|Carboplatin|carboplatin|mesh-list
154541652|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
154541653|NCT03077828|Etoposide|etoposide|mesh-list
154541654|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
154541655|NCT03077828|Ifosfamide|ifosfamide|mesh-list
154541656|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
154541657|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
154541658|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541659|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154541660|NCT03077828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154541661|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541662|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154541663|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154541664|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154541665|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541666|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154541667|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
154541668|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
154541669|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
154541670|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
154541671|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
154541672|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
154541673|NCT02126995|Metadoxine|metadoxine|mesh-list
154541674|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154541675|NCT05257291|Melatonin|melatonin|mesh-list
154541676|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
154541677|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541678|NCT05257291|Protective Agents|protective agents|mesh-ancestor
154541679|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541680|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541681|NCT04930900|Epinephrine|epinephrine|mesh-list
154541682|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154541683|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154541684|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541685|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860277|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154541686|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541687|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541688|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154541689|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154541690|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
154541691|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541692|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154541693|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
154541694|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
154541695|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
154541696|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154541697|NCT02458209|Bococizumab|bococizumab|mesh-list
154541698|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154541699|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154541700|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
154541701|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541702|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154541703|NCT02127151|Talazoparib|talazoparib|mesh-list
154541704|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154541705|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541706|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541707|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541709|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154541710|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541711|NCT03077516|Analgesics|analgesics|mesh-ancestor
154541712|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
154541713|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541714|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541715|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541716|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541717|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154541718|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154541719|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541720|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541721|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154541722|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154541723|NCT04993040|Paclitaxel|paclitaxel|mesh-list
154541724|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154541725|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541726|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
154541727|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
154541728|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
154541729|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541730|NCT03072992|Curcumin|curcumin|mesh-list
154541731|NCT03072992|Paclitaxel|paclitaxel|mesh-list
154541732|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154541733|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541734|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
154541735|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
154541736|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
154541737|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541738|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154541739|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541740|NCT03072992|Analgesics|analgesics|mesh-ancestor
154541741|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
154541742|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541743|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541744|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541745|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541746|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541747|NCT03267771|Progesterone|progesterone|mesh-list
154541748|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
154541749|NCT03267771|Progestins|progestins|mesh-ancestor
154541750|NCT03267771|Hormones|hormones|mesh-ancestor
154541751|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541752|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541753|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
154541754|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154541755|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154541756|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541757|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
154541758|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
154541759|NCT02456961|Riboflavin|riboflavin|mesh-list
154541760|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
154541761|NCT02456961|Vitamins|vitamins|mesh-ancestor
154541762|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
154541763|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541764|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154541765|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
154541766|NCT03551197|Budesonide|budesonide|mesh-list
154541767|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
154541768|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154541769|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154541770|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
154541771|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541772|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541773|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154541774|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
154541775|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
154541776|NCT03551197|Hormones|hormones|mesh-ancestor
154541777|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541778|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154541779|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154541780|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154541781|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541782|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541783|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541784|NCT02456883|Gilteritinib|gilteritinib|mesh-list
154541785|NCT02456883|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154541786|NCT02456883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154541787|NCT02456883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541788|NCT02456883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541789|NCT02435836|Aripiprazole|aripiprazole|mesh-list
154541790|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
154541791|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154541792|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154541793|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154541794|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541795|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541796|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
154541797|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
154541798|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541799|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541800|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154541801|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154541802|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
154541803|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154541804|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154541805|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154541806|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154265622|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541807|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154541808|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154541809|NCT05075265|Methadone|methadone|mesh-list
154541810|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154541811|NCT05075265|Narcotics|narcotics|mesh-ancestor
154541812|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541813|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541814|NCT05075265|Analgesics|analgesics|mesh-ancestor
154541815|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
154541816|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541817|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
154541818|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
154541819|NCT02127541|Exenatide|exenatide|mesh-list
154541820|NCT02127541|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154541821|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154541822|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541823|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154541824|NCT02127541|Incretins|incretins|mesh-ancestor
154541825|NCT02127541|Hormones|hormones|mesh-ancestor
154541826|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541827|NCT03263871|Micronutrients|micronutrients|mesh-list
154541828|NCT03263871|Trace Elements|trace elements|mesh-list
154541829|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541830|NCT04992182|Vaccines|vaccines|mesh-list
154541831|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
154541832|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860278|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
154541833|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
154541834|NCT02124655|Listerine|listerine|mesh-list
154541835|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154541836|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541837|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
154541838|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
154541839|NCT03263715|Hormones|hormones|mesh-ancestor
154541840|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154541841|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541842|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
154541843|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154541844|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
154541845|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541846|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541847|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154541848|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
154541849|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541850|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541851|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154541852|NCT02456740|Erenumab|erenumab|mesh-list
154541853|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154541854|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541855|NCT02456740|Analgesics|analgesics|mesh-ancestor
154541856|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
154541857|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541858|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541859|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154541860|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154541861|NCT03266601|Interferons|interferons|mesh-list
154541862|NCT03266601|Ribavirin|ribavirin|mesh-list
154541863|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541864|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
154541865|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541866|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
154541867|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541868|NCT02458755|Atorvastatin|atorvastatin|mesh-list
154541869|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154541870|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154541871|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154541872|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
154541873|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541874|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154541875|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154541876|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541877|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
154541878|NCT04462406|Nivolumab|nivolumab|mesh-list
154541879|NCT04462406|Ipilimumab|ipilimumab|mesh-list
154541880|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154541881|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541882|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154541883|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541884|NCT02400580|Acetaminophen|acetaminophen|mesh-list
154541885|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154541886|NCT02400580|Analgesics|analgesics|mesh-ancestor
154541887|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
154541888|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541889|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541890|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
154541891|NCT03262857|Lidocaine|lidocaine|mesh-list
154541892|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
154541893|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
154541894|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
154541895|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541896|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541897|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
154541898|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541899|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154541900|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154541901|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154541902|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154541903|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541904|NCT03262857|Analgesics|analgesics|mesh-ancestor
154541905|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
154541906|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154541907|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154541909|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154541910|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
154541911|NCT02127697|Albuterol|albuterol|mesh-list
154541912|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154541913|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
154541914|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541915|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541916|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154541917|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
154541918|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
154541919|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154541920|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154541921|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154541922|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154541923|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
154541924|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541925|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541926|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154541927|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154541928|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154541929|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
154541930|NCT02127775|Lesinurad|lesinurad|mesh-list
154541931|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
154541932|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154541933|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
154541934|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
154541935|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154541936|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
154541937|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154541938|NCT02252341|Expectorants|expectorants|mesh-ancestor
154541939|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
154541940|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154541941|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
154541942|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541943|NCT02252341|Protective Agents|protective agents|mesh-ancestor
154541944|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541945|NCT02252341|Antidotes|antidotes|mesh-ancestor
154541946|NCT02127853|Gabapentin|gabapentin|mesh-list
154541947|NCT02127853|Analgesics|analgesics|mesh-ancestor
154541948|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
154541949|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541950|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541951|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
154541952|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154541953|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154541954|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541955|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154541956|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154541957|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154541958|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541959|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541960|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
154541961|NCT03266445|Buprenorphine|buprenorphine|mesh-list
154541962|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154541963|NCT03266445|Naloxone|naloxone|mesh-list
154541964|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154541965|NCT03266445|Narcotics|narcotics|mesh-ancestor
154541966|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541967|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541968|NCT03266445|Analgesics|analgesics|mesh-ancestor
154541969|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
154541970|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541971|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154541972|NCT01367119|Ketamine|ketamine|mesh-list
154541973|NCT01367119|Methohexital|methohexital|mesh-list
154541974|NCT01367119|Analgesics|analgesics|mesh-ancestor
154541975|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
154541976|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154541977|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154541978|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154541979|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154541980|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
154541981|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
154541982|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154541983|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154541984|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154541985|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154541986|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541987|NCT02252107|Decitabine|decitabine|mesh-list
154541988|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154541989|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
154541990|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541991|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541992|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541993|NCT03262545|Apatinib|apatinib|mesh-list
154541994|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154541995|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154541996|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154541997|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154541998|NCT03262077|Methylene Blue|methylene blue|mesh-list
154541999|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542000|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542001|NCT03265899|Lactitol|lactitol|mesh-list
154542002|NCT03265899|Oxytocin|oxytocin|mesh-list
154542003|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
154542004|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154542005|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542006|NCT03265899|Cathartics|cathartics|mesh-ancestor
154542007|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154542008|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
154542009|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
154542010|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542011|NCT02125201|Fentanyl|fentanyl|mesh-list
154542012|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154542013|NCT02125201|Narcotics|narcotics|mesh-ancestor
154542014|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542015|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542016|NCT02125201|Analgesics|analgesics|mesh-ancestor
154542017|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
154542018|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542019|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154542020|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154542021|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
154542022|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
154542023|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
154542024|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542025|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154542026|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542027|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542028|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
154542029|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154542030|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542031|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154542032|NCT03074942|Reslizumab|reslizumab|mesh-list
154542033|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154542034|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
154542035|NCT02125435|ASP2408|asp2408|mesh-list
154542036|NCT02125435|Immunoconjugates|immunoconjugates|mesh-ancestor
154542037|NCT02125435|Immunologic Factors|immunologic factors|mesh-ancestor
154542038|NCT02125435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542039|NCT02458911|Paclitaxel|paclitaxel|mesh-list
154542040|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154542041|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542042|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
154542043|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
154542044|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
154542045|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542046|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
154542047|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
154542048|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542049|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
154542050|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542051|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542052|NCT02128243|Leucovorin|leucovorin|mesh-list
154542053|NCT02128243|Cisplatin|cisplatin|mesh-list
154542054|NCT02128243|Docetaxel|docetaxel|mesh-list
154542055|NCT02128243|Capecitabine|capecitabine|mesh-list
154542056|NCT02128243|Fluorouracil|fluorouracil|mesh-list
154542057|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
154542058|NCT02128243|Epirubicin|epirubicin|mesh-list
154860279|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
154542059|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
154542060|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542061|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
154542062|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
154542063|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154542064|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542065|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542066|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
154542067|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542068|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
154542069|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542070|NCT02128243|Antidotes|antidotes|mesh-ancestor
154542071|NCT02128243|Protective Agents|protective agents|mesh-ancestor
154542072|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
154542073|NCT02128243|Vitamins|vitamins|mesh-ancestor
154542074|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
154542075|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154542076|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154542077|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154542078|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542079|NCT03072290|Triamcinolone|triamcinolone|mesh-list
154542080|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154542081|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154542082|NCT03072290|Lidocaine|lidocaine|mesh-list
154542083|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154311106|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
154542084|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
154542085|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
154542086|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542087|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542088|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
154542089|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542090|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154542091|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154542092|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154542093|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154542094|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542095|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542096|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
154542097|NCT03072290|Hormones|hormones|mesh-ancestor
154542098|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154542099|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542100|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
154542101|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542102|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154542103|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154542104|NCT02132689|Heparin|heparin|mesh-list
154542105|NCT02132689|Calcium heparin|calcium heparin|mesh-list
154542106|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154542107|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542108|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
154542109|NCT02128321|Repaglinide|repaglinide|mesh-list
154542110|NCT02128321|Isavuconazole|isavuconazole|mesh-list
154542111|NCT02128321|Caffeine|caffeine|mesh-list
154542112|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154542113|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542114|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154542115|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542116|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542117|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154542118|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154542119|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
154542120|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542121|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154542122|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
154542123|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542124|NCT02457975|Ranibizumab|ranibizumab|mesh-list
154542125|NCT02457975|Aflibercept|aflibercept|mesh-list
154542126|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542127|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154542128|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154542129|NCT02457975|Growth Substances|growth substances|mesh-ancestor
154542130|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542131|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
154542132|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154542133|NCT03074864|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154860280|NCT02169115|Omalizumab|omalizumab|mesh-list
154860281|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154542134|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154542135|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542136|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542137|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542138|NCT02125903|Ropivacaine|ropivacaine|mesh-list
154542139|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
154542140|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
154542141|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542142|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542143|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
154542144|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542145|NCT04997564|Tenofovir|tenofovir|mesh-list
154542146|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
154542147|NCT04997564|Velpatasvir|velpatasvir|mesh-list
154542148|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154542149|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
154542150|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542151|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154542152|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154542153|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311180|NCT04646109|Azithromycin|azithromycin|mesh-list
154542154|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542155|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154542156|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154542157|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
154542158|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154542159|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154542160|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542161|NCT03842943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154542162|NCT03842943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542163|NCT02126137|Ezetimibe|ezetimibe|mesh-list
154542164|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154542165|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154542166|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
154542167|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542168|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154542170|NCT02126293|Trace Elements|trace elements|mesh-ancestor
154542171|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
154542172|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542173|NCT03261921|Dexamethasone|dexamethasone|mesh-list
154542174|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
154542175|NCT03261921|Bupivacaine|bupivacaine|mesh-list
154542176|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542177|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
154542178|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
154542179|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542180|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542181|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154542182|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
154542183|NCT03261921|Hormones|hormones|mesh-ancestor
154542184|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154542185|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154542186|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542187|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
154542188|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
154542189|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542190|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
154542191|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154542192|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154542193|NCT03261921|Analgesics|analgesics|mesh-ancestor
154542194|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154542195|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154542196|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154542197|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
154542198|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542199|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542200|NCT02635724|Peramivir|peramivir|mesh-list
154542201|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
154542202|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542203|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542204|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542205|NCT02133469|Vaccines|vaccines|mesh-list
154542206|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154542207|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
154542208|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542210|NCT02126527|Auranofin|auranofin|mesh-list
154542211|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154542212|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542213|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154542214|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542215|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
154542216|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542217|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
154542218|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542219|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154542220|NCT02133625|Pioglitazone|pioglitazone|mesh-list
154542221|NCT02133625|Carboplatin|carboplatin|mesh-list
154542222|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542223|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154542224|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542225|NCT02260687|Aflibercept|aflibercept|mesh-list
154542226|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154542227|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154542228|NCT02260687|Growth Substances|growth substances|mesh-ancestor
154542229|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542230|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
154542231|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542232|NCT03071822|Dexamethasone|dexamethasone|mesh-list
154542233|NCT03071822|Gemcitabine|gemcitabine|mesh-list
154542234|NCT03071822|Etoposide|etoposide|mesh-list
154542235|NCT03071822|Asparaginase|asparaginase|mesh-list
154542236|NCT03071822|Ifosfamide|ifosfamide|mesh-list
154542237|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542238|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542239|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
154542240|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
154542241|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542242|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542243|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154542244|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
154542245|NCT03071822|Hormones|hormones|mesh-ancestor
154542246|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154542247|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154542248|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542249|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
154542250|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542251|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154542252|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154542253|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154542254|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542255|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154542256|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
154542257|NCT04991012|Triamcinolone|triamcinolone|mesh-list
154542258|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154542259|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154542260|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154542261|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542262|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
154542263|NCT04991012|Hormones|hormones|mesh-ancestor
154542264|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154542265|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542266|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542268|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542269|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542270|NCT02252731|Warfarin|warfarin|mesh-list
154542271|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
154542272|NCT02128633|Listerine|listerine|mesh-list
154542273|NCT02128633|Fluorides|fluorides|mesh-list
154542274|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
154542275|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
154542276|NCT02128633|Protective Agents|protective agents|mesh-ancestor
154542277|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542278|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154542279|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542280|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
154542281|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
154542282|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154542283|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154542284|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377152|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
154542285|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542286|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542287|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154542288|NCT03252561|Anesthetics|anesthetics|mesh-list
154542289|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
154542290|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542291|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542292|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
154542293|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542294|NCT02252263|Elotuzumab|elotuzumab|mesh-list
154542295|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542296|NCT04996550|Metoprolol|metoprolol|mesh-list
154542297|NCT04996550|Carvedilol|carvedilol|mesh-list
154542298|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154542299|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154542300|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
154542301|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
154542302|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542303|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542304|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154542305|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154542306|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154542307|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
154542308|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542309|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542310|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
154542311|NCT04996550|Protective Agents|protective agents|mesh-ancestor
154542312|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154542313|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154542314|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154542315|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
154542316|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154542317|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154542318|NCT03252171|Immunomodulating Agents|immunomodulating agents|mesh-list
154542319|NCT03252171|Immunologic Factors|immunologic factors|mesh-ancestor
154542320|NCT03252171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542321|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154542322|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
154542323|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542324|NCT02135965|Caffeine|caffeine|mesh-list
154542325|NCT02135965|Albuterol|albuterol|mesh-list
154542326|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154542327|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542328|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154542329|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542330|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542331|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154542332|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154542333|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
154542334|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542335|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154542336|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
154542337|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542338|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154542339|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
154542340|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
154542341|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154542342|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154542343|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154542344|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154542345|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
154542346|NCT02455401|Remifentanil|remifentanil|mesh-list
154542347|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154542348|NCT02455401|Narcotics|narcotics|mesh-ancestor
154542349|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542350|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542351|NCT02455401|Analgesics|analgesics|mesh-ancestor
154542352|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
154542353|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542354|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
154542355|NCT03260829|Vitamins|vitamins|mesh-ancestor
154542356|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
154542357|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542358|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
154558142|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542359|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542360|NCT03260829|Protective Agents|protective agents|mesh-ancestor
154542361|NCT02134093|Midazolam|midazolam|mesh-list
154542362|NCT02134093|Sufentanil|sufentanil|mesh-list
154542363|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
154542364|NCT02134093|Remifentanil|remifentanil|mesh-list
154542365|NCT02134093|Anesthetics|anesthetics|mesh-list
154542366|NCT02134093|Propofol|propofol|mesh-list
154542367|NCT02134093|Etomidate|etomidate|mesh-list
154542368|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
154542369|NCT02134093|Rocuronium|rocuronium|mesh-list
154542370|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542371|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542372|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154542373|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154542374|NCT02134093|Analgesics|analgesics|mesh-ancestor
154542375|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
154542376|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542377|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154542378|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154542379|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154542380|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
154542381|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542382|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542383|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154542384|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
154542385|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154542386|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154542387|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154542388|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154542389|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
154542390|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
154542391|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154542392|NCT02134093|Narcotics|narcotics|mesh-ancestor
154542393|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154542394|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154542395|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154542396|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154542397|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154542398|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
154542399|NCT03074786|Tenofovir|tenofovir|mesh-list
154542400|NCT03074786|Emtricitabine|emtricitabine|mesh-list
154542401|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154542402|NCT03074786|Dapivirine|dapivirine|mesh-list
154542403|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
154542404|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542405|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154542406|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154542407|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542408|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542409|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154542410|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154542411|NCT03070028|Phenol|phenol|mesh-list
154542412|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154542413|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542414|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
154542415|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154542416|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154542417|NCT03260439|Tramadol|tramadol|mesh-list
154542418|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154542419|NCT03260439|Narcotics|narcotics|mesh-ancestor
154542420|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542421|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542422|NCT03260439|Analgesics|analgesics|mesh-ancestor
154542423|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
154542424|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542425|NCT02634788|Buprenorphine|buprenorphine|mesh-list
154542426|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154542427|NCT02634788|Narcotics|narcotics|mesh-ancestor
154542428|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542429|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542430|NCT02634788|Analgesics|analgesics|mesh-ancestor
154542431|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
154860282|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154542432|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542433|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154542434|NCT03260283|Fentanyl|fentanyl|mesh-list
154542435|NCT03260283|Meperidine|meperidine|mesh-list
154542436|NCT03260283|Ropivacaine|ropivacaine|mesh-list
154542437|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
154542438|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
154542439|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542440|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542441|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
154542442|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542443|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154542444|NCT03260283|Narcotics|narcotics|mesh-ancestor
154542445|NCT03260283|Analgesics|analgesics|mesh-ancestor
154542446|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154542447|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154542448|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
154542449|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
154542450|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154542451|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154542452|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542453|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
154542454|NCT03251469|Coagulants|coagulants|mesh-ancestor
154542455|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
154542456|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154542457|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
154542458|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542459|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
154542460|NCT04986644|Protective Agents|protective agents|mesh-ancestor
154542461|NCT02785939|Docetaxel|docetaxel|mesh-list
154542462|NCT02785939|Palbociclib|palbociclib|mesh-list
154542463|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542464|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
154542465|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
154542466|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
154542467|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542468|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154542469|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542470|NCT03583229|Aspirin|aspirin|mesh-list
154542471|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154542472|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154542473|NCT03583229|Analgesics|analgesics|mesh-ancestor
154542474|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
154542475|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542476|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542477|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542478|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154542479|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154542480|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154542481|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542482|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154542483|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154542484|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542485|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
154542486|NCT02259803|Amlodipine|amlodipine|mesh-list
154542487|NCT02259803|Telmisartan|telmisartan|mesh-list
154542488|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154542489|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154542490|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154542491|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154542492|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542493|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154542494|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542495|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
154542496|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154542497|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154542498|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
154542499|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542500|NCT03069950|Leucovorin|leucovorin|mesh-list
154542501|NCT03069950|Dexamethasone|dexamethasone|mesh-list
154542502|NCT03069950|Fluorouracil|fluorouracil|mesh-list
154542503|NCT03069950|Irinotecan|irinotecan|mesh-list
154542504|NCT03069950|Panitumumab|panitumumab|mesh-list
154542505|NCT03069950|Floxuridine|floxuridine|mesh-list
154542506|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542507|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
154542508|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
154542509|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542510|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542511|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154542512|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
154860283|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154542513|NCT03069950|Hormones|hormones|mesh-ancestor
154542514|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154542515|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154542516|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542517|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
154542518|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542519|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542520|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542521|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
154542522|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154542523|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154542524|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542525|NCT03069950|Antidotes|antidotes|mesh-ancestor
154542526|NCT03069950|Protective Agents|protective agents|mesh-ancestor
154542527|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
154542528|NCT03069950|Vitamins|vitamins|mesh-ancestor
154542529|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
154542530|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154542531|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154542532|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542533|NCT03577457|Oxytocin|oxytocin|mesh-list
154542534|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
154542535|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154542536|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542537|NCT02455245|Carboplatin|carboplatin|mesh-list
154542538|NCT02455245|Vincristine|vincristine|mesh-list
154542539|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542540|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154542541|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
154542542|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
154542543|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
154542544|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542545|NCT03537599|Daratumumab|daratumumab|mesh-list
154542546|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542547|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154542548|NCT04986254|Meropenem|meropenem|mesh-list
154542549|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
154542550|NCT04986254|Tazobactam|tazobactam|mesh-list
154542551|NCT04986254|Piperacillin|piperacillin|mesh-list
154542552|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154542553|NCT04986254|Penicillin G|penicillin g|mesh-list
154542554|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154542555|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
154542556|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542557|NCT04986254|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154542558|NCT04986254|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154542559|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154542560|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542561|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542562|NCT03257943|Ivermectin|ivermectin|mesh-list
154542563|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154542564|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542565|NCT04986098|Paclitaxel|paclitaxel|mesh-list
154542566|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154542567|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542568|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
154542569|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
154542570|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
154542571|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542572|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
154542573|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
154542574|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154542575|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542576|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542577|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154542578|NCT02239445|Analgesics|analgesics|mesh-ancestor
154542579|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
154542580|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542581|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154542582|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154542583|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154542584|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
154542585|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542586|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542587|NCT03071042|Docetaxel|docetaxel|mesh-list
154542588|NCT03071042|Apatinib|apatinib|mesh-list
154542589|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542590|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
154542591|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
154542592|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
154542593|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542594|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154542595|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542597|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154542598|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542599|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
154542600|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
154542601|NCT04989140|Dexamethasone|dexamethasone|mesh-list
154542602|NCT04989140|Pomalidomide|pomalidomide|mesh-list
154542603|NCT04989140|Ixazomib|ixazomib|mesh-list
154311623|NCT06255626|Vaccines|vaccines|mesh-list
154542604|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542605|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
154542606|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
154542607|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542608|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542609|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154542610|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
154542611|NCT04989140|Hormones|hormones|mesh-ancestor
154542612|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154542613|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154542614|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542615|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
154542616|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154542617|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154542618|NCT04989140|Growth Substances|growth substances|mesh-ancestor
154542619|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
154542620|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
154542621|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542622|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542623|NCT03246009|Lenograstim|lenograstim|mesh-list
154542624|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154542625|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
154542626|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542627|NCT03246399|Lorecivivint|lorecivivint|mesh-list
154542628|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542629|NCT02134249|Cabergoline|cabergoline|mesh-list
154542630|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154542631|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154542632|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
154542633|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
154542634|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542635|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542636|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542637|NCT03245853|Riboflavin|riboflavin|mesh-list
154542638|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
154542639|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
154542640|NCT03245853|Vitamins|vitamins|mesh-ancestor
154542641|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
154542642|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542643|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154542644|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
154542645|NCT03574649|Paclitaxel|paclitaxel|mesh-list
154542646|NCT03574649|Docetaxel|docetaxel|mesh-list
154542647|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
154542648|NCT03574649|Carboplatin|carboplatin|mesh-list
154542649|NCT03574649|Fluorouracil|fluorouracil|mesh-list
154542650|NCT03574649|Avelumab|avelumab|mesh-list
154542651|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154542652|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542653|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
154542654|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
154542655|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
154542656|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542657|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542658|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
154542659|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542660|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154542661|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154542662|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
154542663|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154542664|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
154542665|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542666|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154542668|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542669|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154542670|NCT03073928|Ropivacaine|ropivacaine|mesh-list
154542671|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
154542672|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
154542673|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542674|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542675|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
154542676|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542677|NCT02134405|Esomeprazole|esomeprazole|mesh-list
154542678|NCT02134405|Rebamipide|rebamipide|mesh-list
154542679|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154542680|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154542681|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154542682|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542683|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542684|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
154542685|NCT02134405|Protective Agents|protective agents|mesh-ancestor
154542686|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542687|NCT03574415|Fexuprazan|fexuprazan|mesh-list
154542688|NCT03574415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154542689|NCT02456025|Tacrolimus|tacrolimus|mesh-list
154542690|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542691|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
154542692|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542693|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154542694|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542695|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542696|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
154542697|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154542698|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542699|NCT02136511|Rituximab|rituximab|mesh-list
154542700|NCT02136511|Idelalisib|idelalisib|mesh-list
154542701|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154542702|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542703|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
154542704|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542705|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154542706|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542707|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542708|NCT02136589|Diclofenac|diclofenac|mesh-list
154542709|NCT02136589|Travoprost|travoprost|mesh-list
154542710|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154542711|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154542712|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154542713|NCT02136589|Analgesics|analgesics|mesh-ancestor
154542714|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
154542715|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542716|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542717|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542718|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154542719|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154542720|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542721|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542722|NCT02134639|Edotreotide|edotreotide|mesh-list
154542723|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154542724|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542725|NCT02129101|Azacitidine|azacitidine|mesh-list
154542726|NCT02129101|Decitabine|decitabine|mesh-list
154542727|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542728|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
154542729|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542730|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542731|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542732|NCT02134717|Maraviroc|maraviroc|mesh-list
154542733|NCT02134717|Dimercaprol|dimercaprol|mesh-list
154542734|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154542735|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154542736|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542737|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154542738|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154542739|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
154542740|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542741|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154542742|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
154542743|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
154542744|NCT03245385|Halobetasol|halobetasol|mesh-list
154542745|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154542746|NCT02136823|Isradipine|isradipine|mesh-list
154542747|NCT02136823|Riluzole|riluzole|mesh-list
154542748|NCT02136823|Memantine|memantine|mesh-list
154542749|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154542750|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154542751|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
154542752|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542753|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542754|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542755|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154542756|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154542757|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
154542758|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154542759|NCT02136823|Protective Agents|protective agents|mesh-ancestor
154542760|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154542761|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154542762|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154542763|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154542764|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
154542765|NCT03250143|Cyclosporine|cyclosporine|mesh-list
154542766|NCT03250143|Azathioprine|azathioprine|mesh-list
154542767|NCT03250143|Cyclosporins|cyclosporins|mesh-list
154542768|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542769|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542770|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542771|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
154542772|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542773|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
154542774|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542775|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
154542776|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154542777|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154542778|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
154542779|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542780|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542781|NCT03073850|Anticoagulants|anticoagulants|mesh-list
154542782|NCT03073850|Edoxaban|edoxaban|mesh-list
154542783|NCT03073850|Clopidogrel|clopidogrel|mesh-list
154542784|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542785|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542786|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154542787|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542788|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154542789|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154542790|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154542791|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
154542792|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542793|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154542794|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
154542795|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154542796|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
154542797|NCT03257319|Morphine|morphine|mesh-list
154542798|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154542799|NCT03257319|Narcotics|narcotics|mesh-ancestor
154542800|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542801|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542803|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
154542804|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542805|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154542806|NCT03070574|Mesalamine|mesalamine|mesh-list
154542807|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154542808|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154542809|NCT03070574|Analgesics|analgesics|mesh-ancestor
154542810|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
154542811|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542812|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542813|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154542814|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154542815|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
154542816|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154542817|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542818|NCT03257241|Cytarabine|cytarabine|mesh-list
154542819|NCT03257241|Fludarabine|fludarabine|mesh-list
154542820|NCT03257241|Daunorubicin|daunorubicin|mesh-list
154542821|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
154542822|NCT03257241|Idarubicin|idarubicin|mesh-list
154542823|NCT03257241|Cladribine|cladribine|mesh-list
154542824|NCT03257241|Lenograstim|lenograstim|mesh-list
154542825|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542826|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542827|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
154542828|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542829|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542830|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
154542831|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542832|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
154542833|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542834|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154542835|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154542836|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154542837|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154542838|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542839|NCT03257241|Analgesics|analgesics|mesh-ancestor
154542840|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
154542841|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542842|NCT02129179|Glucagon|glucagon|mesh-list
154542843|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154542844|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154542845|NCT02129179|Hormones|hormones|mesh-ancestor
154542846|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154542847|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542848|NCT02129179|Incretins|incretins|mesh-ancestor
154542849|NCT02129257|Leucovorin|leucovorin|mesh-list
154542850|NCT02129257|Folic Acid|folic acid|mesh-list
154542851|NCT02129257|Fluorouracil|fluorouracil|mesh-list
154542852|NCT02129257|Irinotecan|irinotecan|mesh-list
154542853|NCT02129257|Aflibercept|aflibercept|mesh-list
154542854|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
154542855|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
154542856|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542857|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542858|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542859|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154542860|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
154542861|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542862|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154542863|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154542864|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542865|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154542866|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154542867|NCT02129257|Growth Substances|growth substances|mesh-ancestor
154542868|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
154542869|NCT02129257|Antidotes|antidotes|mesh-ancestor
154542870|NCT02129257|Protective Agents|protective agents|mesh-ancestor
154542871|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
154542872|NCT02129257|Vitamins|vitamins|mesh-ancestor
154542873|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
154266677|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154542874|NCT02129257|Hematinics|hematinics|mesh-ancestor
154542875|NCT03245307|Apatinib|apatinib|mesh-list
154542876|NCT03245307|Nifedipine|nifedipine|mesh-list
154542877|NCT03245307|Warfarin|warfarin|mesh-list
154542878|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
154542879|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542880|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154542881|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542882|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542883|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154542884|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154542885|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154542886|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542887|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
154542888|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
154542889|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154542890|NCT02136979|Propofol|propofol|mesh-list
154542891|NCT02136979|Sevoflurane|sevoflurane|mesh-list
154542892|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154542893|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542894|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542895|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154542897|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
154542898|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154542899|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154542900|NCT02455011|Volagidemab|volagidemab|mesh-list
154542901|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154542902|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542903|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154542904|NCT03249285|Perindopril|perindopril|mesh-list
154542905|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154542906|NCT03249285|Diuretics|diuretics|mesh-ancestor
154542907|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
154542908|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542909|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154542910|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154542911|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542912|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154542913|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
154542914|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542915|NCT03249519|Cisplatin|cisplatin|mesh-list
154542916|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542917|NCT04983524|Propolis|propolis|mesh-list
154542918|NCT04983524|Calcium|calcium|mesh-list
154542919|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154542920|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542921|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542922|NCT03576911|Ubiquinone|ubiquinone|mesh-list
154542923|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
154542924|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
154542925|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542926|NCT03576911|Vitamins|vitamins|mesh-ancestor
154542927|NCT02634320|Aripiprazole|aripiprazole|mesh-list
154542928|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
154542929|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
154542930|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154542931|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154542932|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154542933|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542934|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542935|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
154542936|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
154542937|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542938|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542939|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154542940|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154542941|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
154542942|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154542943|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154542944|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154542945|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154542946|NCT02435680|Carboplatin|carboplatin|mesh-list
154542947|NCT02435680|Gemcitabine|gemcitabine|mesh-list
154542948|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542949|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542950|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
154542951|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266752|NCT03789032|Rabeprazole|rabeprazole|mesh-list
154542952|NCT04988048|Vaccines|vaccines|mesh-list
154542953|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
154542954|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542955|NCT04982900|Aflutinib|aflutinib|mesh-list
154542956|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154542957|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542958|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542959|NCT03256071|Decitabine|decitabine|mesh-list
154542960|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154542961|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
154542962|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542963|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154542964|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154542965|NCT03248817|Phenylephrine|phenylephrine|mesh-list
154542966|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
154542967|NCT03248817|Bupivacaine|bupivacaine|mesh-list
154542968|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
154542969|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
154542970|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154542971|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542972|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
154542973|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542974|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154542975|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
154542976|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
154542977|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
154542978|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154542979|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
154542980|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154542981|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154542982|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154542983|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154542984|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
154542985|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154542986|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154542987|NCT03248817|Protective Agents|protective agents|mesh-ancestor
154542988|NCT03647774|Naltrexone|naltrexone|mesh-list
154542989|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154542990|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154542991|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154542992|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
154542993|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154542994|NCT03248973|Ampicillin|ampicillin|mesh-list
154542995|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154542996|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154542997|NCT02832531|Aspirin|aspirin|mesh-list
154542998|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
154542999|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154543000|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543001|NCT02832531|Analgesics|analgesics|mesh-ancestor
154543002|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
154543003|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543004|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543005|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543006|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543007|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154543008|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154543009|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543010|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154543011|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154543012|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543013|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
154543014|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154543015|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
154543016|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154543017|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
154543018|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
154543019|NCT03248427|Paclitaxel|paclitaxel|mesh-list
154543020|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
154543021|NCT03248427|Doxorubicin|doxorubicin|mesh-list
154543022|NCT03248427|Letrozole|letrozole|mesh-list
154543023|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154543024|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543025|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
154543026|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
154543027|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
154543028|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543029|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154543030|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
154543031|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543032|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543033|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154543034|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
154543035|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154543036|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154543037|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154543038|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154543039|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543040|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154543041|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154543042|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154543043|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
154543044|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543045|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154543046|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543048|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154543049|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154543050|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543051|NCT03576677|Simendan|simendan|mesh-list
154543052|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154543053|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
154543054|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154543055|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154543056|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543057|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543058|NCT03576677|Protective Agents|protective agents|mesh-ancestor
154543059|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543060|NCT03247257|Lidocaine|lidocaine|mesh-list
154543061|NCT03247257|Anesthetics|anesthetics|mesh-list
154543062|NCT03247257|Propofol|propofol|mesh-list
154543063|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
154543064|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543065|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543066|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
154543067|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543068|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154543069|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154543070|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154543071|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543072|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543073|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154543074|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154543075|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
154543076|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
154543077|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154543078|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543079|NCT02239835|Ritonavir|ritonavir|mesh-list
154543080|NCT02239835|Saquinavir|saquinavir|mesh-list
154543081|NCT02239835|Tipranavir|tipranavir|mesh-list
154543082|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154543083|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154543084|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
154543085|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543086|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543087|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154543088|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154543089|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
154543090|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543091|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154543092|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154543093|NCT02239913|Topiramate|topiramate|mesh-list
154543094|NCT02239913|Phentermine|phentermine|mesh-list
154543095|NCT02239913|Cocaine|cocaine|mesh-list
154543096|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
154543097|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154543098|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543099|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
154543100|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
154543101|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543102|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
154543103|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543104|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154543105|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154543106|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154543107|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543108|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543109|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
154543110|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543111|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154543112|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
154543113|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154543114|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
154543115|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
154543116|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
154543117|NCT03576287|Apremilast|apremilast|mesh-list
154543118|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154543119|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543120|NCT03576287|Analgesics|analgesics|mesh-ancestor
154543121|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
154543122|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312137|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
154543123|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543124|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543125|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543126|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154543127|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154543128|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543129|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543130|NCT02455869|Alendronate|alendronate|mesh-list
154543131|NCT02455869|Atorvastatin|atorvastatin|mesh-list
154543132|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154543133|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154543134|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
154543135|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543136|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154543137|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154543138|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543139|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154543140|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543141|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154543142|NCT03246555|Perindopril|perindopril|mesh-list
154543143|NCT03246555|Indapamide|indapamide|mesh-list
154543144|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154543145|NCT03246555|Diuretics|diuretics|mesh-ancestor
154543146|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
154543147|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543148|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154543149|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543150|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543151|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154543152|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
154543153|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543154|NCT03576053|Lidocaine|lidocaine|mesh-list
154543155|NCT03576053|Serotonin|serotonin|mesh-list
154543156|NCT03576053|Histamine|histamine|mesh-list
154543157|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
154543158|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
154543159|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543160|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543161|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
154543162|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543163|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154543164|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154543165|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154543166|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543167|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543168|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154543169|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
154543170|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543171|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
154543172|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
154543173|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
154543174|NCT03242967|Hematinics|hematinics|mesh-ancestor
154543175|NCT03239457|Mitogens|mitogens|mesh-list
154543176|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
154543177|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543179|NCT00075803|Voriconazole|voriconazole|mesh-list
154543180|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
154543181|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543182|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154543183|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154543184|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543185|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543186|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154543187|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
154543188|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543189|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543190|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154543191|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154543192|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154543193|NCT03242499|Lovastatin|lovastatin|mesh-list
154543194|NCT03242499|L 647318|l 647318|mesh-list
154543195|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
154543196|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154543197|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154543198|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
154543199|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543200|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154543201|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154543202|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543203|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
154543205|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
154543206|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154543207|NCT02523911|Analgesics|analgesics|mesh-ancestor
154543208|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
154543209|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543210|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543211|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
154543212|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543213|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154543214|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
154543215|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154543216|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543217|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543218|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154543219|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
154543220|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154543221|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
154543222|NCT02523911|Emollients|emollients|mesh-ancestor
154543223|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
154543224|NCT02523911|Cathartics|cathartics|mesh-ancestor
154543225|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543226|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
154543227|NCT03572231|Mirabegron|mirabegron|mesh-list
154543228|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154543229|NCT03572231|Fesoterodine|fesoterodine|mesh-list
154543230|NCT03572231|Oxybutynin|oxybutynin|mesh-list
154543231|NCT03572231|Darifenacin|darifenacin|mesh-list
154543232|NCT03572231|Propiverine|propiverine|mesh-list
154543233|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154543234|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154543235|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
154543236|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543237|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543238|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543239|NCT03572231|Urological Agents|urological agents|mesh-ancestor
154543240|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154543241|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154543242|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154543243|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
154543244|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
154543245|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
154059066|NCT00700154|Insulin|insulin|mesh-list
154543246|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543247|NCT02135029|Atorvastatin|atorvastatin|mesh-list
154543248|NCT02135029|Bococizumab|bococizumab|mesh-list
154543249|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154543250|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154543251|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
154543252|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543253|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154543254|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154543255|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543256|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
154543257|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154543258|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154543259|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543260|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
154543261|NCT03573245|Coagulants|coagulants|mesh-ancestor
154543262|NCT02241161|Bacteriocins|bacteriocins|mesh-list
154543263|NCT02241161|Antioxidants|antioxidants|mesh-list
154543264|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543265|NCT02241161|Protective Agents|protective agents|mesh-ancestor
154543266|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543267|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154543268|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543269|NCT02135263|Enalapril|enalapril|mesh-list
154543270|NCT02135263|Methylphenidate|methylphenidate|mesh-list
154543271|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154378145|NCT04296396|Oxycodone|oxycodone|mesh-list
154543272|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543273|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154543274|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154543275|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543276|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543277|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
154543278|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543279|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154543280|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
154543281|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543282|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154543283|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
154543284|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154543285|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154543286|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154543287|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154543288|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543289|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543290|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
154543291|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543292|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543293|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154543294|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543295|NCT02239523|Denosumab|denosumab|mesh-list
154543296|NCT02239523|Teriparatide|teriparatide|mesh-list
154543297|NCT02239523|Diphosphonates|diphosphonates|mesh-list
154543298|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154543299|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543300|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154543301|NCT02137213|Naloxone|naloxone|mesh-list
154543302|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154543303|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543304|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
154312331|NCT03967288|Procaine|procaine|mesh-list
154543305|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543306|NCT03571919|Lidocaine|lidocaine|mesh-list
154543307|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
154543308|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
154543309|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543310|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543311|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
154543312|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543313|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154543314|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154543315|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154543316|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543317|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543318|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
154543319|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154543320|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154543321|NCT02252809|Prednisolone|prednisolone|mesh-list
154543322|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
154543323|NCT02252809|Adalimumab|adalimumab|mesh-list
154543324|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154543325|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
154543326|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543327|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
154543328|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
154543329|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543330|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543331|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543332|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
154543333|NCT02252809|Hormones|hormones|mesh-ancestor
154543334|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543335|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154543336|NCT02252809|Protective Agents|protective agents|mesh-ancestor
154543337|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154543338|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543339|NCT02252809|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154543340|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543341|NCT02137525|Fentanyl|fentanyl|mesh-list
154543342|NCT02137525|Morphine|morphine|mesh-list
154543343|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154543344|NCT02137525|Narcotics|narcotics|mesh-ancestor
154543345|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543346|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543348|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
154543349|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543350|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154543351|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154543352|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
154543353|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
154543354|NCT02137681|Rituximab|rituximab|mesh-list
154543355|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154543356|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543357|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
154543358|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543359|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543360|NCT02842073|Naltrexone|naltrexone|mesh-list
154543361|NCT02842073|Bupropion|bupropion|mesh-list
154543362|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154543363|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154543364|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543365|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
154543366|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543367|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154543368|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
154543369|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154543370|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154543371|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154543372|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543373|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543374|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
154543375|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543376|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154543377|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154543378|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543379|NCT02135887|Leucovorin|leucovorin|mesh-list
154543380|NCT02135887|Folic Acid|folic acid|mesh-list
154543381|NCT02135887|Fluorouracil|fluorouracil|mesh-list
154543382|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
154543383|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
154543384|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
154543385|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543386|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154543387|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543388|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154543389|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
154543390|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543391|NCT02135887|Antidotes|antidotes|mesh-ancestor
154543392|NCT02135887|Protective Agents|protective agents|mesh-ancestor
154543393|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
154543394|NCT02135887|Vitamins|vitamins|mesh-ancestor
154543395|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
154543396|NCT02135887|Hematinics|hematinics|mesh-ancestor
154543397|NCT02253277|Nilotinib|nilotinib|mesh-list
154543398|NCT02253277|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154543399|NCT02253277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154543400|NCT02253277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543401|NCT02253277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543402|NCT02137993|Olanzapine|olanzapine|mesh-list
154543403|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
154543404|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
154543405|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543406|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543407|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543408|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154543409|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154543410|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543411|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154543412|NCT02137993|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154543413|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154543414|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543415|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543416|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543417|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
154543418|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154543419|NCT02245841|Hormones|hormones|mesh-ancestor
154558143|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154543420|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543422|NCT05709041|Anesthetics|anesthetics|mesh-list
154543423|NCT05709041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543424|NCT05709041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543425|NCT03570281|Enoxaparin|enoxaparin|mesh-list
154543426|NCT03570281|Edoxaban|edoxaban|mesh-list
154543427|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
154543428|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154543429|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154543430|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543431|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154543432|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
154543433|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154543434|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
154543435|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543436|NCT02242799|Artesunate|artesunate|mesh-list
154543437|NCT02242799|Lumefantrine|lumefantrine|mesh-list
154543438|NCT02242799|Artemether|artemether|mesh-list
154543439|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154543440|NCT02242799|Amodiaquine|amodiaquine|mesh-list
154543441|NCT02242799|Dolutegravir|dolutegravir|mesh-list
154543442|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
154543443|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154543444|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154543445|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543446|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543447|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
154543448|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
154543449|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154543450|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
154543451|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154543452|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154543453|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543454|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543455|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154543456|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154543457|NCT02138383|Paclitaxel|paclitaxel|mesh-list
154543458|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154543459|NCT02138383|Gemcitabine|gemcitabine|mesh-list
154543460|NCT02138383|Androgens|androgens|mesh-list
154543461|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154543462|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543463|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
154543464|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
154543465|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
154543466|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543467|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154543468|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
154543469|NCT02138383|Hormones|hormones|mesh-ancestor
154543470|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543471|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543472|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
154543473|NCT02243735|Trace Elements|trace elements|mesh-ancestor
154543474|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
154543475|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543476|NCT02138539|Hydroquinone|hydroquinone|mesh-list
154543477|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
154543478|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543479|NCT02138539|Protective Agents|protective agents|mesh-ancestor
154543480|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543481|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154543482|NCT02252419|Acetaminophen|acetaminophen|mesh-list
154543483|NCT02252419|Dexamethasone|dexamethasone|mesh-list
154543484|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543485|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
154543486|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
154543487|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543488|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543489|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543490|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
154543491|NCT02252419|Hormones|hormones|mesh-ancestor
154543492|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543493|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154543494|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543495|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543496|NCT02252419|Analgesics|analgesics|mesh-ancestor
154543497|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
154543498|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
154543499|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
154543500|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154543501|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154543502|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543503|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
154543504|NCT02252497|Coagulants|coagulants|mesh-ancestor
154543505|NCT02138773|Tamsulosin|tamsulosin|mesh-list
154543506|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154543507|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154543508|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154543509|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
154543510|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543511|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543512|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543513|NCT02138773|Urological Agents|urological agents|mesh-ancestor
154543514|NCT01367275|Irinotecan|irinotecan|mesh-list
154543515|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154543516|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154543517|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543518|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543519|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543520|NCT02138929|Everolimus|everolimus|mesh-list
154543521|NCT02138929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154543522|NCT02138929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154543523|NCT02138929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543524|NCT02138929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543525|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154543526|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
154543527|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543528|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543529|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
154543530|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154543531|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543532|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543533|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543534|NCT02253199|Analgesics|analgesics|mesh-ancestor
154543535|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
154543536|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543537|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154543538|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154543539|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154543540|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
154543541|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543542|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543543|NCT02842853|Vaccines|vaccines|mesh-list
154543544|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
154543545|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543546|NCT02139241|Ramosetron|ramosetron|mesh-list
154543547|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
154543548|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
154543549|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543550|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543551|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543552|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154543553|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
154543554|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543555|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543556|NCT03569579|Memantine|memantine|mesh-list
154543557|NCT03569579|Donepezil|donepezil|mesh-list
154543558|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154543559|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543560|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543561|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
154543562|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543563|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543564|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
154543565|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154543566|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154543567|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
154543568|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154543569|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154543570|NCT02130661|Itraconazole|itraconazole|mesh-list
154543571|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
154543572|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543573|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154543574|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154543575|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543576|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543577|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154543578|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
154543579|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543580|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543581|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154543582|NCT02130739|Fentanyl|fentanyl|mesh-list
154543583|NCT02130739|Propofol|propofol|mesh-list
154543584|NCT02130739|Ropivacaine|ropivacaine|mesh-list
154543585|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
154543586|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543587|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543588|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154543589|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154543590|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
154543591|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
154543592|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
154543593|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543594|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154543595|NCT02130739|Narcotics|narcotics|mesh-ancestor
154543596|NCT02130739|Analgesics|analgesics|mesh-ancestor
154543597|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154543598|NCT02248493|Acetaminophen|acetaminophen|mesh-list
154543599|NCT02248493|Ketoprofen|ketoprofen|mesh-list
154543600|NCT02248493|Morphine|morphine|mesh-list
154543601|NCT02248493|Tramadol|tramadol|mesh-list
154543602|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154543603|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154543604|NCT02248493|Narcotics|narcotics|mesh-ancestor
154543605|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543606|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543607|NCT02248493|Analgesics|analgesics|mesh-ancestor
154543608|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
154543609|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543610|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543611|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
154543612|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154543613|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543614|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543615|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154543616|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543617|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543618|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
154543619|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154543620|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543621|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543622|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543623|NCT05577871|Analgesics|analgesics|mesh-ancestor
154543624|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
154543625|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543626|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154543627|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154543628|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154543629|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
154543630|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543631|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543632|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
154543633|NCT02130817|Dexamethasone|dexamethasone|mesh-list
154543634|NCT02130817|Prednisone|prednisone|mesh-list
154543635|NCT02130817|Abatacept|abatacept|mesh-list
154543636|NCT02130817|Tacrolimus|tacrolimus|mesh-list
154543637|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
154543638|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154543639|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
154543640|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154543641|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
154543642|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
154543643|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154543644|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543645|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
154543646|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
154543647|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543648|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543649|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543650|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
154543651|NCT02130817|Hormones|hormones|mesh-ancestor
154543652|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543653|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154543654|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543655|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543656|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543657|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154543658|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
154543659|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154543660|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154543661|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154543662|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
154543663|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154543664|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543665|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154543666|NCT02130817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154543667|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543668|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
154543669|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
154543670|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543671|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543672|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543673|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
154543674|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
154543675|NCT02130973|Denosumab|denosumab|mesh-list
154543676|NCT02130973|Teriparatide|teriparatide|mesh-list
154543677|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154543678|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543679|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154543680|NCT02456662|Ondansetron|ondansetron|mesh-list
154543681|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
154543682|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
154543683|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543684|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543685|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543686|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
154543687|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
154543688|NCT02456662|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154543689|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154543690|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
154543691|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543692|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543693|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
154543694|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
154543695|NCT03548311|Vitamins|vitamins|mesh-ancestor
154543696|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
154543697|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543698|NCT01653262|Brivaracetam|brivaracetam|mesh-list
154543699|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
154543700|NCT02455336|Fenofibrate|fenofibrate|mesh-list
154543701|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154543702|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
154543703|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543704|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154543705|NCT02253121|Insulin|insulin|mesh-list
154543706|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154543707|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
154543708|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154543709|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543710|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154543711|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543712|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
154543713|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154543714|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
154543715|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543716|NCT03568721|Acetaminophen|acetaminophen|mesh-list
154543717|NCT03568721|Ibuprofen|ibuprofen|mesh-list
154543718|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543719|NCT03568721|Analgesics|analgesics|mesh-ancestor
154543720|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
154543721|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543722|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543723|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
154543724|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154543725|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543726|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543727|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154543728|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543729|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543730|NCT05354375|Immunomodulating Agents|immunomodulating agents|mesh-list
154543731|NCT05354375|Immunologic Factors|immunologic factors|mesh-ancestor
154543732|NCT05354375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543734|NCT03566303|Warfarin|warfarin|mesh-list
154543735|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
154543736|NCT03566303|Vitamins|vitamins|mesh-ancestor
154543737|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
154543738|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543739|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
154543740|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154543741|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
154543742|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154543743|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
154543744|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543745|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543746|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154543747|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154543748|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
154543749|NCT03566303|Coagulants|coagulants|mesh-ancestor
154543750|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154543751|NCT02140333|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154543752|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154543753|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543754|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543755|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543756|NCT05936216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154543757|NCT05936216|Immunologic Factors|immunologic factors|mesh-ancestor
154543758|NCT05936216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543759|NCT05936060|Plasma-lyte 148|plasma-lyte 148|mesh-list
154543760|NCT05936060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154543761|NCT05936060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154543762|NCT05935449|Lidocaine|lidocaine|mesh-list
154543763|NCT05935449|Anesthetics, Local|anesthetics, local|mesh-ancestor
154543764|NCT05935449|Anesthetics|anesthetics|mesh-ancestor
154543765|NCT05935449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543766|NCT05935449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543767|NCT05935449|Sensory System Agents|sensory system agents|mesh-ancestor
154543768|NCT05935449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543769|NCT05935449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154543770|NCT05935449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154543771|NCT05935449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154543772|NCT05935449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543773|NCT05935449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543774|NCT05935293|Dexmedetomidine|dexmedetomidine|mesh-list
154543775|NCT05935293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154543776|NCT05935293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543777|NCT05935293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543778|NCT05935293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543779|NCT05935293|Analgesics|analgesics|mesh-ancestor
154543780|NCT05935293|Sensory System Agents|sensory system agents|mesh-ancestor
154543781|NCT05935293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543782|NCT05935293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154543783|NCT05935293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154543784|NCT05935293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154543785|NCT05935293|Adrenergic Agents|adrenergic agents|mesh-ancestor
154543786|NCT05935293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543787|NCT05935293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543788|NCT05934812|Oxytocin|oxytocin|mesh-list
154543789|NCT05934812|Oxytocics|oxytocics|mesh-ancestor
154543790|NCT05934812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154543791|NCT05934812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543792|NCT05934799|Clopidogrel|clopidogrel|mesh-list
154543793|NCT05934799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154543794|NCT05934799|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154543795|NCT05934799|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154543796|NCT05934799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154378674|NCT03302182|Ritonavir|ritonavir|mesh-list
154543797|NCT05934799|Purinergic Agents|purinergic agents|mesh-ancestor
154543798|NCT05934799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543799|NCT05934799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543800|NCT05934799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543801|NCT05934552|Lactulose|lactulose|mesh-list
154543802|NCT05934552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154543803|NCT05933538|Cariprazine|cariprazine|mesh-list
154543804|NCT05933538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154543805|NCT05933538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154543806|NCT05933538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543807|NCT05933538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543808|NCT05933538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154543809|NCT05916053|Vitamin D|vitamin d|mesh-list
154543810|NCT05916053|Vitamins|vitamins|mesh-ancestor
154543811|NCT05916053|Micronutrients|micronutrients|mesh-ancestor
154543812|NCT05916053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543813|NCT05916053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154543814|NCT05892393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154543815|NCT05892393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154543816|NCT05892393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543817|NCT05879419|Benzocaine|benzocaine|mesh-list
154543818|NCT05879419|Anesthetics, Local|anesthetics, local|mesh-ancestor
154543819|NCT05879419|Anesthetics|anesthetics|mesh-ancestor
154543820|NCT05879419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543821|NCT05879419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543822|NCT05879419|Sensory System Agents|sensory system agents|mesh-ancestor
154543823|NCT05879419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543824|NCT05820594|BCG Vaccine|bcg vaccine|mesh-list
154543825|NCT05820594|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154543826|NCT05820594|Immunologic Factors|immunologic factors|mesh-ancestor
154543827|NCT05820594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543828|NCT05790499|Atorvastatin|atorvastatin|mesh-list
154543829|NCT05790499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154543830|NCT05790499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154543831|NCT05790499|Antimetabolites|antimetabolites|mesh-ancestor
154543832|NCT05790499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543833|NCT05790499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154543834|NCT05790499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154543835|NCT05790499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543836|NCT05643170|Xanomeline|xanomeline|mesh-list
154543837|NCT05643170|Trospium chloride|trospium chloride|mesh-list
154543838|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
154543839|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
154543840|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543841|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543842|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154543843|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154543844|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
154543845|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543846|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543847|NCT05643170|Urological Agents|urological agents|mesh-ancestor
154543848|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154543849|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154543850|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154543851|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154543852|NCT05635916|Bupivacaine|bupivacaine|mesh-list
154543853|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
154543854|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
154543855|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154543856|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543857|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
154543858|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543859|NCT05633771|Adalimumab|adalimumab|mesh-list
154543860|NCT05633771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154543861|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543862|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543863|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
154543864|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154543865|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543866|NCT05613062|Analgesics|analgesics|mesh-ancestor
154543867|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
154543868|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543869|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543870|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154543871|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154543872|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154543874|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154543875|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543876|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543877|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
154543878|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543879|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543880|NCT05258747|Olaparib|olaparib|mesh-list
154543881|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154543882|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543883|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543884|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543885|NCT05127395|Acyclovir|acyclovir|mesh-list
154543886|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
154543887|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543888|NCT05022342|Fulvestrant|fulvestrant|mesh-list
154543889|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154543890|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543891|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154543892|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154543893|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
154543894|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154543895|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543896|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
154543897|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
154543898|NCT04950270|Coagulants|coagulants|mesh-ancestor
154543899|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154543900|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154543901|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
154543902|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543903|NCT04802876|Tislelizumab|tislelizumab|mesh-list
154543904|NCT04802876|Spartalizumab|spartalizumab|mesh-list
154543905|NCT04802876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154543906|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543907|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154543908|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543909|NCT04789928|Gentamicins|gentamicins|mesh-list
154543910|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154543911|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154543912|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154543913|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543914|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543915|NCT04762992|Enoxaparin|enoxaparin|mesh-list
154543916|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
154543917|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154543918|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154543919|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543920|NCT04738123|Xanomeline|xanomeline|mesh-list
154543921|NCT04738123|Trospium chloride|trospium chloride|mesh-list
154543922|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
154543923|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
154543924|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543925|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543926|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154543927|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154543928|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
154543929|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543930|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543931|NCT04738123|Urological Agents|urological agents|mesh-ancestor
154543932|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154543933|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154543934|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154543935|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154543936|NCT04704453|Amitriptyline|amitriptyline|mesh-list
154543937|NCT04704453|Capsaicin|capsaicin|mesh-list
154543938|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
154543939|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
154543940|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
154543941|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543942|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543943|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154543944|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
154543945|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154558144|NCT05697692|Heparin|heparin|mesh-list
154543946|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543947|NCT04704453|Analgesics|analgesics|mesh-ancestor
154543948|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154543949|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154543950|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154543951|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543952|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
154543953|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154543954|NCT04695847|Antibodies|antibodies|mesh-list
154543955|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
154543956|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154543957|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
154543958|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
154543959|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543960|NCT04665050|Vaccines|vaccines|mesh-list
154543961|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154543962|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
154543963|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543964|NCT04581395|Rocuronium|rocuronium|mesh-list
154543965|NCT04581395|Succinylcholine|succinylcholine|mesh-list
154543966|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154543967|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154543968|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154543969|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154543970|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543971|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154543972|NCT04572100|Paclitaxel|paclitaxel|mesh-list
154543973|NCT04572100|Carboplatin|carboplatin|mesh-list
154543974|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154543975|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543976|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
154543977|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
154543978|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
154543979|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543980|NCT04564625|Vitamin D|vitamin d|mesh-list
154543981|NCT04564625|Vitamins|vitamins|mesh-ancestor
154543982|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
154543983|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154543984|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154543985|NCT04560322|Venetoclax|venetoclax|mesh-list
154543986|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
154543987|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
154543988|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154543989|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154543990|NCT04560322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154543991|NCT04560322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154543992|NCT04560322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154543993|NCT04560322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154543994|NCT04504734|Bucillamine|bucillamine|mesh-list
154543995|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154543996|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154543997|NCT04504734|Analgesics|analgesics|mesh-ancestor
154543998|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
154543999|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544000|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544001|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154544002|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544003|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
154544004|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544005|NCT04504734|Protective Agents|protective agents|mesh-ancestor
154544006|NCT04388774|Ketamine|ketamine|mesh-list
154544007|NCT04388774|Analgesics|analgesics|mesh-ancestor
154544008|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
154544009|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544010|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544011|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154544012|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154544013|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
154544014|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
154544015|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544016|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154544017|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154544018|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154544019|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544020|NCT04267614|Etanercept|etanercept|mesh-list
154544021|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154544022|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154544024|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
154544025|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544026|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544027|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154544028|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544029|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154544030|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544031|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
154544032|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
154544033|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154544034|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154544035|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544036|NCT04164212|Vaccines|vaccines|mesh-list
154544037|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
154544038|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544039|NCT04112199|Terlipressin|terlipressin|mesh-list
154544040|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154544041|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154544042|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
154544043|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544044|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544045|NCT04089904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154544046|NCT04089904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544047|NCT04055428|Valsartan|valsartan|mesh-list
154544048|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154544049|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154544050|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154544051|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154544052|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544053|NCT03998488|Psyllium|psyllium|mesh-list
154544054|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
154544055|NCT03998488|Cathartics|cathartics|mesh-ancestor
154544056|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154544057|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
154544058|NCT03653338|Rituximab|rituximab|mesh-list
154544059|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
154544060|NCT03653338|Fludarabine|fludarabine|mesh-list
154544061|NCT03653338|Thiotepa|thiotepa|mesh-list
154544062|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
154544063|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544064|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544065|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
154544066|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544067|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544068|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544069|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544070|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154544071|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
154544072|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154544073|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
154544074|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544075|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154544076|NCT03576755|Spironolactone|spironolactone|mesh-list
154544077|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154544078|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154544079|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544080|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544081|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154544083|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
154544084|NCT03572049|Itraconazole|itraconazole|mesh-list
154544085|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154544086|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
154544087|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544088|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154313095|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154544089|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154544090|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544091|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544092|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154544093|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
154544094|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544095|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544096|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154544097|NCT03555877|Letrozole|letrozole|mesh-list
154544098|NCT03555877|Fulvestrant|fulvestrant|mesh-list
154544099|NCT03555877|Anastrozole|anastrozole|mesh-list
154544100|NCT03555877|Exemestane|exemestane|mesh-list
154544101|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544102|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154544103|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154544104|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544105|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544106|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154544107|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
154544108|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544109|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544110|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154544111|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154544112|NCT03481972|Doxycycline|doxycycline|mesh-list
154544113|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154544114|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154544115|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544116|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
154544117|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154544118|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154544119|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
154544120|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154544121|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154544122|NCT03472560|Avelumab|avelumab|mesh-list
154544123|NCT03472560|Axitinib|axitinib|mesh-list
154544124|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544125|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544126|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154544127|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544128|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544129|NCT03336216|Leucovorin|leucovorin|mesh-list
154544130|NCT03336216|Paclitaxel|paclitaxel|mesh-list
154544131|NCT03336216|Gemcitabine|gemcitabine|mesh-list
154544132|NCT03336216|Nivolumab|nivolumab|mesh-list
154544133|NCT03336216|Fluorouracil|fluorouracil|mesh-list
154544134|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
154544135|NCT03336216|Irinotecan|irinotecan|mesh-list
154544136|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154544137|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544138|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
154544139|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
154544140|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
154544141|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544142|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154544143|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
154544144|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544145|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154544146|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544147|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
154544148|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544149|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154544150|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154544151|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544152|NCT03336216|Antidotes|antidotes|mesh-ancestor
154544153|NCT03336216|Protective Agents|protective agents|mesh-ancestor
154544154|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
154544155|NCT03336216|Vitamins|vitamins|mesh-ancestor
154544156|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
154544157|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154544158|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154544160|NCT03269994|Piperacillin|piperacillin|mesh-list
154544161|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154544162|NCT03269994|Cefoxitin|cefoxitin|mesh-list
154544163|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154544164|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544165|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154544166|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544167|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544168|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
154544169|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544170|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544171|NCT03062358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154558145|NCT05697692|Calcium heparin|calcium heparin|mesh-list
154544172|NCT03062358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544174|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
154544175|NCT02903537|Interferons|interferons|mesh-list
154544176|NCT02903537|Interferon-beta|interferon-beta|mesh-list
154544177|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544178|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
154544179|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544180|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
154544181|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544182|NCT02903537|Vitamins|vitamins|mesh-ancestor
154544183|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
154544184|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154544185|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154544186|NCT02706873|Methotrexate|methotrexate|mesh-list
154544187|NCT02706873|Upadacitinib|upadacitinib|mesh-list
154544188|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154544189|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
154544190|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154544191|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544192|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154544193|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
154544194|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544195|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544196|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
154544197|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544198|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154544199|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544200|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
154544201|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544202|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154544203|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154544204|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154544205|NCT02677038|Olaparib|olaparib|mesh-list
154544206|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154544207|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544208|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544209|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544210|NCT02584634|Avelumab|avelumab|mesh-list
154544211|NCT02584634|Crizotinib|crizotinib|mesh-list
154544212|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544213|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544214|NCT02584634|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154544215|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154544216|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544217|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544218|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
154544219|NCT02365441|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154544220|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154544221|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544222|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544223|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544224|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
154544225|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154544226|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
154544227|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544228|NCT02124941|Expectorants|expectorants|mesh-ancestor
154544229|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
154544230|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154544231|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
154544232|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544233|NCT02124941|Protective Agents|protective agents|mesh-ancestor
154544234|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544235|NCT02124941|Antidotes|antidotes|mesh-ancestor
154544236|NCT01868451|Doxorubicin|doxorubicin|mesh-list
154544237|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154544238|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154544239|NCT01868451|Dacarbazine|dacarbazine|mesh-list
154544240|NCT01868451|Vinblastine|vinblastine|mesh-list
154544241|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154544242|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544243|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154544244|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154544245|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544246|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544247|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544248|NCT01868451|Immunotoxins|immunotoxins|mesh-ancestor
154544249|NCT01868451|Immunoconjugates|immunoconjugates|mesh-ancestor
154544250|NCT01868451|Immunologic Factors|immunologic factors|mesh-ancestor
154544251|NCT01868451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544252|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154544253|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
154544254|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154544255|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
154544256|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
154544257|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
154544258|NCT01275729|Furosemide|furosemide|mesh-list
154544259|NCT01275729|Diuretics|diuretics|mesh-ancestor
154544260|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
154544261|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544262|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154544263|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154544264|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544265|NCT01107626|Paclitaxel|paclitaxel|mesh-list
154544266|NCT01107626|Bevacizumab|bevacizumab|mesh-list
154544267|NCT01107626|Carboplatin|carboplatin|mesh-list
154544268|NCT01107626|Pemetrexed|pemetrexed|mesh-list
154544269|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154544270|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544271|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
154544272|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
154544273|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
154544274|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544275|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544276|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154544277|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154544278|NCT01107626|Growth Substances|growth substances|mesh-ancestor
154544279|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544280|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
154544281|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544282|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154544283|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154544284|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
154544285|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544286|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154544287|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
154544288|NCT00828009|Paclitaxel|paclitaxel|mesh-list
154544289|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
154544290|NCT00828009|Bevacizumab|bevacizumab|mesh-list
154544291|NCT00828009|Carboplatin|carboplatin|mesh-list
154544292|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154544293|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544294|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
154544295|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
154544296|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
154544297|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544298|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544299|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
154544300|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544301|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544302|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154544303|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
154544304|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154544305|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154268098|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544306|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154544307|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154544308|NCT00828009|Growth Substances|growth substances|mesh-ancestor
154544309|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
154544310|NCT00578721|Aspirin|aspirin|mesh-list
154544311|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154544312|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154544313|NCT00578721|Analgesics|analgesics|mesh-ancestor
154544314|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
154544315|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544316|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544317|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154544318|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544319|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154544320|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154544321|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544322|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154544323|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154544324|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544325|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
154544326|NCT00357890|Insulin|insulin|mesh-list
154544327|NCT00357890|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154544328|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
154544329|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154544330|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544331|NCT00068393|Gemcitabine|gemcitabine|mesh-list
154544332|NCT00068393|Doxorubicin|doxorubicin|mesh-list
154544333|NCT00068393|Lenograstim|lenograstim|mesh-list
154544334|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154544335|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
154544336|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544337|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544338|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154544339|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154544340|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154544341|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544342|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154544343|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
154544344|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544345|NCT00062010|Interferons|interferons|mesh-list
154544346|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
154544347|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
154544348|NCT00062010|Paclitaxel|paclitaxel|mesh-list
154544349|NCT00062010|Tretinoin|tretinoin|mesh-list
154544350|NCT00062010|Isotretinoin|isotretinoin|mesh-list
154544351|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154544352|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544353|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
154544354|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154544355|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154544356|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544357|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
154544358|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544359|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
154544360|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544361|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
154544362|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
154544363|NCT00061568|Sirolimus|sirolimus|mesh-list
154544364|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
154544365|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154544366|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544367|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154544368|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544369|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
154544370|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544371|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
154544372|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544373|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544374|NCT00047008|Cisplatin|cisplatin|mesh-list
154544375|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544376|NCT03567941|Acetaminophen|acetaminophen|mesh-list
154544377|NCT03567941|Hydrocodone|hydrocodone|mesh-list
154544378|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154544379|NCT03567941|Analgesics|analgesics|mesh-ancestor
154544380|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
154544381|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544382|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544383|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
154544385|NCT03567941|Narcotics|narcotics|mesh-ancestor
154544386|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544387|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
154544388|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
154544389|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154544390|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154544391|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154544392|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
154544393|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544394|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154544395|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154544396|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544397|NCT03566225|Metformin|metformin|mesh-list
154544398|NCT03566225|Pioglitazone|pioglitazone|mesh-list
154544399|NCT03566225|Clomiphene|clomiphene|mesh-list
154544400|NCT03566225|Enclomiphene|enclomiphene|mesh-list
154544401|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
154544402|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154544403|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544404|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154544405|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
154544406|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544407|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154544408|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
154544409|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154544410|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154544411|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154544412|NCT02397694|Dolutegravir|dolutegravir|mesh-list
154544413|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154544414|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154544415|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544416|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544417|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154544418|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154544419|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
154544420|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544421|NCT03566069|Oxytocin|oxytocin|mesh-list
154544422|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
154544423|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154544424|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544425|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
154544426|NCT03567629|Leucovorin|leucovorin|mesh-list
154544427|NCT03567629|Bevacizumab|bevacizumab|mesh-list
154544428|NCT03567629|Cetuximab|cetuximab|mesh-list
154544429|NCT03567629|Capecitabine|capecitabine|mesh-list
154544430|NCT03567629|Fluorouracil|fluorouracil|mesh-list
154544431|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
154544432|NCT03567629|Irinotecan|irinotecan|mesh-list
154544433|NCT03567629|Calcium|calcium|mesh-list
154544434|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
154544435|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544436|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544437|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154544438|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154544439|NCT03567629|Growth Substances|growth substances|mesh-ancestor
154544440|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544441|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
154544442|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154544443|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154544444|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154544445|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
154544446|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544447|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544448|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
154544449|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154544450|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154544451|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544452|NCT03567629|Antidotes|antidotes|mesh-ancestor
154544453|NCT03567629|Protective Agents|protective agents|mesh-ancestor
154544454|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
154544455|NCT03567629|Vitamins|vitamins|mesh-ancestor
154544456|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
154544457|NCT02783599|Doxorubicin|doxorubicin|mesh-list
154544458|NCT02783599|Olaratumab|olaratumab|mesh-list
154544459|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154268286|NCT04737278|Niacin|niacin|mesh-list
154544460|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313464|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154544461|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154544462|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154544463|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544464|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544465|NCT03567395|Melatonin|melatonin|mesh-list
154544466|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
154544467|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544468|NCT03567395|Protective Agents|protective agents|mesh-ancestor
154544469|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544470|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544471|NCT03565133|Quinine|quinine|mesh-list
154544472|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
154544473|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154544474|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154544475|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544476|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154544477|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544478|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154544479|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544480|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154544481|NCT03565133|Analgesics|analgesics|mesh-ancestor
154544482|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
154544483|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154544484|NCT05353673|Danazol|danazol|mesh-list
154544485|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154544486|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544487|NCT05353673|Incretins|incretins|mesh-ancestor
154544488|NCT05353673|Hormones|hormones|mesh-ancestor
154544489|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544490|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154544491|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
154544492|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544493|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544494|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154544495|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
154544496|NCT05353205|Flumatinib|flumatinib|mesh-list
154544497|NCT05353205|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154544498|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154544499|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544500|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544501|NCT03068234|Pirfenidone|pirfenidone|mesh-list
154544502|NCT03068234|Analgesics|analgesics|mesh-ancestor
154544503|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
154544504|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544505|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544506|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154544507|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154544508|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154544509|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544510|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544511|NCT05339399|Oxytocin|oxytocin|mesh-list
154544512|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
154544513|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154544514|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544515|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
154544516|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154544517|NCT05634824|Antibodies|antibodies|mesh-list
154544518|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
154544519|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154544520|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
154544521|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544522|NCT02454478|Everolimus|everolimus|mesh-list
154544523|NCT02454478|Lenvatinib|lenvatinib|mesh-list
154544524|NCT02454478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154544525|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154544526|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544527|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544528|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544529|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
154544530|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544531|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544532|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154544533|NCT02359097|Hematinics|hematinics|mesh-ancestor
154544534|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154544535|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154544536|NCT03563963|Lidocaine|lidocaine|mesh-list
154544537|NCT03563963|Ropivacaine|ropivacaine|mesh-list
154544538|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154544539|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
154544540|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
154544541|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544542|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544543|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
154544544|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544545|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154544546|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154544547|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154544548|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154544549|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544550|NCT03066518|Melatonin|melatonin|mesh-list
154544551|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
154558146|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
154544552|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544553|NCT03066518|Protective Agents|protective agents|mesh-ancestor
154544554|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544555|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544556|NCT03069248|Interferons|interferons|mesh-list
154544557|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
154544558|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154544559|NCT03069248|Rituximab|rituximab|mesh-list
154544560|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544561|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544562|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
154544563|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544564|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544565|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
154544566|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544567|NCT05730062|Oxycodone|oxycodone|mesh-list
154544568|NCT05730062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154544569|NCT05730062|Narcotics|narcotics|mesh-ancestor
154544570|NCT05730062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544571|NCT05730062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544572|NCT05730062|Analgesics|analgesics|mesh-ancestor
154544573|NCT05730062|Sensory System Agents|sensory system agents|mesh-ancestor
154544574|NCT05730062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544575|NCT03068936|Cisplatin|cisplatin|mesh-list
154544576|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544577|NCT05017610|Lomustine|lomustine|mesh-list
154544578|NCT05017610|Methimazole|methimazole|mesh-list
154544579|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154544580|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
154544581|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544582|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544583|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
154544584|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
154544585|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544586|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544587|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
154544588|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154544589|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
154544590|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544591|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544592|NCT02452762|Vitamin D|vitamin d|mesh-list
154544593|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
154544594|NCT02452762|Vitamins|vitamins|mesh-ancestor
154544595|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
154544596|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544597|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154544598|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154544599|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
154544600|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154544601|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544602|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
154544603|NCT05633420|Artesunate|artesunate|mesh-list
154544604|NCT05633420|Pyronaridine|pyronaridine|mesh-list
154544605|NCT05633420|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154544606|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
154544607|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154544608|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154544609|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544610|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544611|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
154544612|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
154544613|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154544614|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
154544616|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
154544617|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544618|NCT05487092|Letrozole|letrozole|mesh-list
154544619|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544620|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154544621|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154544622|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544623|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544624|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154544625|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
154544626|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544627|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544628|NCT03067688|Amlodipine|amlodipine|mesh-list
154544629|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154544630|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154544631|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154544632|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154544633|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154544634|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544635|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154544636|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544637|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
154544638|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154544639|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154544640|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
154544641|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154544642|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154544643|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544644|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154544645|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154544646|NCT02396758|Plasminogen|plasminogen|mesh-list
154544647|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154544648|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154544649|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154544650|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544651|NCT05728424|Amoxicillin|amoxicillin|mesh-list
154544652|NCT05728424|Levofloxacin|levofloxacin|mesh-list
154544653|NCT05728424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154544654|NCT05728424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544655|NCT05728424|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154544656|NCT05728424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154544657|NCT05728424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154544658|NCT05728424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544659|NCT05728424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544660|NCT05728424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544661|NCT05728424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154544662|NCT05728424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154544664|NCT05728268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154544665|NCT05728268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544666|NCT05728268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154544667|NCT05728268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154544668|NCT05728268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154544669|NCT05728268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544670|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
154544671|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154544672|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544673|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154544674|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544675|NCT04926844|Midazolam|midazolam|mesh-list
154544676|NCT04926844|Levetiracetam|levetiracetam|mesh-list
154544677|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154544678|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154544679|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544680|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544681|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154544682|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154544683|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154544684|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154544685|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
154544686|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
154544687|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
154544688|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
154544689|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154544690|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544691|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
154544692|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
154544693|NCT05482256|Listerine|listerine|mesh-list
154544694|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
154544695|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
154544696|NCT05482256|Protective Agents|protective agents|mesh-ancestor
154544697|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544698|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154544699|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544700|NCT01651936|Methotrexate|methotrexate|mesh-list
154544701|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154544702|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
154544703|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154544704|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544705|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154544706|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
154544707|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544708|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544709|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
154544710|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544711|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154544712|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544713|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
154544714|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544715|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154544716|NCT03065504|Turmeric extract|turmeric extract|mesh-list
154544717|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
154544718|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544719|NCT03065504|Protective Agents|protective agents|mesh-ancestor
154544720|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544721|NCT02630966|Vedolizumab|vedolizumab|mesh-list
154544722|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154544723|NCT05724212|Interferons|interferons|mesh-list
154544724|NCT05724212|Interferon-gamma|interferon-gamma|mesh-list
154544725|NCT05724212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544726|NCT05724212|Antiviral Agents|antiviral agents|mesh-ancestor
154544727|NCT05724212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544729|NCT01651780|Calcium heparin|calcium heparin|mesh-list
154544730|NCT01651780|Bivalirudin|bivalirudin|mesh-list
154544731|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
154544732|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154544733|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154544734|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544735|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
154544736|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154544737|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
154544738|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544739|NCT02394730|Vorapaxar|vorapaxar|mesh-list
154544740|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154544741|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154544742|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
154544743|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544744|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
154544745|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544746|NCT02394340|Luliconazole|luliconazole|mesh-list
154544747|NCT02394340|Omeprazole|omeprazole|mesh-list
154544748|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154544749|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154544750|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154544751|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544752|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544753|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
154544754|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544755|NCT01672736|Dexamethasone|dexamethasone|mesh-list
154544756|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
154544757|NCT01672736|Bortezomib|bortezomib|mesh-list
154544758|NCT01672736|BB 1101|bb 1101|mesh-list
154268552|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544759|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154544760|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
154544761|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
154544762|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544763|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544764|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154544765|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
154544766|NCT01672736|Hormones|hormones|mesh-ancestor
154544767|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544768|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154544769|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544770|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
154544771|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544772|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544773|NCT03065660|Mifepristone|mifepristone|mesh-list
154544774|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154544775|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
154544776|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154379649|NCT00005780|Hormones|hormones|mesh-ancestor
154544777|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544778|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154544779|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154544780|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154544781|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
154544782|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154544783|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154544784|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
154544785|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544786|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
154544787|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154544788|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154544789|NCT03893630|Aspirin|aspirin|mesh-list
154544790|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154544791|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154544792|NCT03893630|Analgesics|analgesics|mesh-ancestor
154544793|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
154544794|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544795|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544796|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154544797|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544798|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154544799|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154544800|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544801|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154544802|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154544803|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544804|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
154544805|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
154544806|NCT03065816|Antacids|antacids|mesh-ancestor
154544807|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544808|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154544809|NCT05619848|Midazolam|midazolam|mesh-list
154544810|NCT05619848|Remifentanil|remifentanil|mesh-list
154544811|NCT05619848|Bromides|bromides|mesh-list
154544812|NCT05619848|Propofol|propofol|mesh-list
154544813|NCT05619848|Etomidate|etomidate|mesh-list
154544814|NCT05619848|Rocuronium|rocuronium|mesh-list
154544815|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154544816|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544817|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544818|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154544819|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
154544820|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
154544821|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154544822|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154544823|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154544824|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154544825|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
154544826|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
154544827|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154544828|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544829|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154544830|NCT05619848|Narcotics|narcotics|mesh-ancestor
154544831|NCT05619848|Analgesics|analgesics|mesh-ancestor
154544832|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
154544833|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544834|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
154544835|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154544836|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154544837|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154544838|NCT01560637|Treprostinil|treprostinil|mesh-list
154544839|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154544840|NCT04157036|Ibuprofen|ibuprofen|mesh-list
154544841|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
154544842|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154544843|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154544844|NCT04157036|Prednisolone|prednisolone|mesh-list
154544845|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
154544846|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154544847|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
154544848|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154544849|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154544850|NCT04157036|Analgesics|analgesics|mesh-ancestor
154544851|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
154544852|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544853|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544854|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154544855|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544856|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154544857|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544858|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544859|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
154544860|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
154544861|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154544862|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
154544863|NCT04157036|Hormones|hormones|mesh-ancestor
154544864|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154544865|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154544866|NCT04157036|Protective Agents|protective agents|mesh-ancestor
154544867|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154544868|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544869|NCT03547375|Apatinib|apatinib|mesh-list
154544870|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544871|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154544872|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544873|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544874|NCT01353911|Interferons|interferons|mesh-list
154544875|NCT01353911|Ribavirin|ribavirin|mesh-list
154544876|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
154544877|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
154544878|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154544879|NCT01353911|Grazoprevir|grazoprevir|mesh-list
154544880|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544881|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
154544882|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544883|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
154544884|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544885|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
154544886|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544887|NCT05575297|Rifampin|rifampin|mesh-list
154544888|NCT05575297|Methotrexate|methotrexate|mesh-list
154544889|NCT05575297|Febuxostat|febuxostat|mesh-list
154544890|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154544891|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
154544892|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154544893|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544894|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154544895|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
154544896|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544897|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544898|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
154544899|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544900|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154544901|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154544902|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
154544903|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154544904|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154544905|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154544906|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
154544907|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154544908|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544909|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
154544910|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154544911|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154544912|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154544913|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154544914|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154544915|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154544916|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
154544917|NCT01671488|Mitomycins|mitomycins|mesh-list
154544918|NCT01671488|Mitomycin|mitomycin|mesh-list
154544919|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154544920|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544921|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
154544922|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544923|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154544924|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544925|NCT05400889|Tofacitinib|tofacitinib|mesh-list
154860284|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
154544926|NCT05400889|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154544927|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154544928|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544929|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544930|NCT05325229|Bevacizumab|bevacizumab|mesh-list
154544931|NCT05325229|Docetaxel|docetaxel|mesh-list
154544932|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154544933|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154544934|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154544935|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154544936|NCT05325229|Growth Substances|growth substances|mesh-ancestor
154544937|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544938|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
154544939|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
154544940|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
154544941|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
154544942|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544943|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
154544944|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154544945|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154544946|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154544947|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154544948|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544949|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
154544950|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154544951|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544952|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154544953|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154544954|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154544955|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154544956|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154544957|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154544958|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154544959|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154544960|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154544961|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154544962|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154544963|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
154544964|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154544965|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544966|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154544967|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154544968|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
154544969|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154544970|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154544971|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
154544972|NCT05573425|Tazarotene|tazarotene|mesh-list
154544973|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
154544974|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
154544975|NCT02253901|Ritonavir|ritonavir|mesh-list
154544976|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154544977|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154544978|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154544979|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
154544980|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544981|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544982|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154544983|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154544984|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
154544985|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154544986|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154544987|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154544988|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154544989|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154544990|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
154544991|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154544992|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154544993|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154544994|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154544995|NCT03546283|Protective Agents|protective agents|mesh-ancestor
154544996|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860285|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
154544997|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154544998|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154544999|NCT03547219|Escitalopram|escitalopram|mesh-list
154545000|NCT03547219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154545001|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154545002|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545003|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545004|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545005|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
154545006|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545007|NCT04069819|Cilostazol|cilostazol|mesh-list
154545008|NCT04069819|Escitalopram|escitalopram|mesh-list
154545009|NCT04069819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154545010|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154545011|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545012|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545013|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545014|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
154545015|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545016|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
154545017|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545018|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154545019|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154545020|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
154545021|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154545022|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154545023|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154545024|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
154545025|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154545026|NCT04069819|Protective Agents|protective agents|mesh-ancestor
154545027|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154545028|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154545029|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545030|NCT02831855|Methotrexate|methotrexate|mesh-list
154545031|NCT02831855|Tofacitinib|tofacitinib|mesh-list
154545032|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154545033|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
154545034|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154545035|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545036|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154545037|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
154545038|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545039|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545040|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
154545041|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545042|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154545043|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545044|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
154545045|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545046|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154545047|NCT02831855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154545048|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154545049|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
154545050|NCT01356407|Cathartics|cathartics|mesh-ancestor
154545051|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545052|NCT00109837|Leucovorin|leucovorin|mesh-list
154545053|NCT00109837|Cytarabine|cytarabine|mesh-list
154545054|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154545055|NCT00109837|Dexamethasone|dexamethasone|mesh-list
154545056|NCT00109837|Prednisone|prednisone|mesh-list
154545057|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
154545058|NCT00109837|Doxorubicin|doxorubicin|mesh-list
154545059|NCT00109837|Methotrexate|methotrexate|mesh-list
154545060|NCT00109837|Vincristine|vincristine|mesh-list
154545061|NCT00109837|Daunorubicin|daunorubicin|mesh-list
154545062|NCT00109837|Asparaginase|asparaginase|mesh-list
154545063|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
154545064|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
154545065|NCT00109837|Thioguanine|thioguanine|mesh-list
154545066|NCT00109837|Allopurinol|allopurinol|mesh-list
154545067|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545068|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
154545069|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545070|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545071|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154860286|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545072|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
154545073|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545074|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545075|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154545076|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154545077|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
154545078|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
154545079|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545080|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545081|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
154545082|NCT00109837|Hormones|hormones|mesh-ancestor
154545083|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545084|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154545085|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154545086|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154545087|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154545088|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545089|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154545090|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
154545091|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154545092|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154545093|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
154545094|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
154545095|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154545096|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154545097|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
154545098|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545099|NCT00109837|Antidotes|antidotes|mesh-ancestor
154545100|NCT00109837|Protective Agents|protective agents|mesh-ancestor
154545101|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
154545102|NCT00109837|Vitamins|vitamins|mesh-ancestor
154545103|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
154545104|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154545105|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
154545106|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
154545107|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
154545108|NCT00109837|Analgesics|analgesics|mesh-ancestor
154545109|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
154545110|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
154545111|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154545112|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
154545113|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154545114|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154545115|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
154545116|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154545117|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154545118|NCT05229445|Insulin|insulin|mesh-list
154545119|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154545120|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545121|NCT01671332|Suramin|suramin|mesh-list
154545122|NCT01671332|Docetaxel|docetaxel|mesh-list
154545123|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545124|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
154545125|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
154545126|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
154545127|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545128|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
154545129|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
154545130|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154545131|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545132|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154545133|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154545134|NCT03063242|Sargramostim|sargramostim|mesh-list
154268924|NCT04234906|Analgesics|analgesics|mesh-ancestor
154545135|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
154545136|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545137|NCT03897062|Suvorexant|suvorexant|mesh-list
154545138|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154545139|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154545140|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545141|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545142|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154545143|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545144|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545145|NCT00100802|Temozolomide|temozolomide|mesh-list
154545146|NCT00100802|Lomustine|lomustine|mesh-list
154545147|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154545148|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
154545149|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545150|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545152|NCT01355159|Hematinics|hematinics|mesh-ancestor
154545153|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
154545154|NCT01355159|Vitamins|vitamins|mesh-ancestor
154545155|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
154545156|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545157|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
154545158|NCT04661852|Topotecan|topotecan|mesh-list
154545159|NCT04661852|Mitogens|mitogens|mesh-list
154545160|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545161|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
154545162|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545163|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545164|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154545165|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
154545166|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545167|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545168|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154545169|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154545170|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154545171|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545172|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
154545173|NCT02630186|Atezolizumab|atezolizumab|mesh-list
154545174|NCT02630186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154545175|NCT02630186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545176|NCT02630186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545177|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545178|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
154545179|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
154545180|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
154545181|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154545182|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154545183|NCT01669928|Renin Inhibitors|renin inhibitors|mesh-list
154545184|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154545185|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545186|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545187|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
154545188|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545189|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154545190|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545191|NCT01355081|Vortioxetine|vortioxetine|mesh-list
154545192|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
154545193|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154545194|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154545195|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154545196|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545197|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545198|NCT01355081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154545199|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154545200|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545201|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545202|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545203|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
154545204|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154545205|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154545206|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154545207|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154545208|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154545209|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
154268998|NCT00002766|Analgesics|analgesics|mesh-ancestor
154545211|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154545212|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
154545213|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545214|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545215|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154545216|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
154545217|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
154545218|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154545219|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
154545220|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545221|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860287|NCT00376792|Docetaxel|docetaxel|mesh-list
154545222|NCT03062462|Clopidogrel|clopidogrel|mesh-list
154545223|NCT03062462|Ticagrelor|ticagrelor|mesh-list
154545224|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154545225|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154545226|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154545227|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154545228|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
154545229|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545230|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545231|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545232|NCT04433078|Doxycycline|doxycycline|mesh-list
154545233|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154545234|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545235|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
154545236|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154545237|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154545238|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
154545239|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545240|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154545241|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545242|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545243|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
154545244|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545245|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545246|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154545247|NCT04368533|Fluorides|fluorides|mesh-list
154545248|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
154545249|NCT04368533|Protective Agents|protective agents|mesh-ancestor
154545250|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545251|NCT02627144|Interferons|interferons|mesh-list
154545252|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
154545253|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
154545254|NCT02627144|Bevacizumab|bevacizumab|mesh-list
154545255|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545256|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545257|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154545258|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154545259|NCT02627144|Growth Substances|growth substances|mesh-ancestor
154545260|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545261|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
154545262|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
154545263|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545264|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
154545265|NCT04981886|Bimatoprost|bimatoprost|mesh-list
154545266|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154545267|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154545268|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
154545269|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545270|NCT04548440|Paclitaxel|paclitaxel|mesh-list
154545271|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154545272|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154545273|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545274|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
154545275|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
154545276|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
154545277|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545278|NCT02626520|Paclitaxel|paclitaxel|mesh-list
154545279|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154545280|NCT02626520|Gemcitabine|gemcitabine|mesh-list
154545281|NCT02626520|Fluorouracil|fluorouracil|mesh-list
154545282|NCT02626520|Irinotecan|irinotecan|mesh-list
154545283|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154269076|NCT01327326|Naltrexone|naltrexone|mesh-list
154545284|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545285|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
154545286|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
154545287|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
154545288|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545289|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154545290|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
154545291|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545292|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
154545293|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545295|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154545296|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545297|NCT03063710|Olaparib|olaparib|mesh-list
154545298|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154545299|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545300|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545301|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545302|NCT05084521|Famotidine|famotidine|mesh-list
154545303|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154545304|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545305|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154545306|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
154545307|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
154545308|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545309|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545310|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545311|NCT05063851|Memantine|memantine|mesh-list
154545312|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154545313|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154545314|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
154545315|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545316|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545317|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545318|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154545319|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154545320|NCT03359161|Furosemide|furosemide|mesh-list
154545321|NCT03359161|Diuretics|diuretics|mesh-ancestor
154545322|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
154545323|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545324|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154545325|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545326|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545327|NCT03277339|Paroxetine|paroxetine|mesh-list
154545328|NCT03277339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154545329|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154545330|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545331|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545332|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545333|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
154545334|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545335|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154545336|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
154545337|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154545338|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154545339|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154545340|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545341|NCT03145675|Enoxaparin|enoxaparin|mesh-list
154545342|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
154545343|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
154545344|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154545345|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154545346|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545347|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
154545348|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154545349|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545350|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545351|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154545352|NCT04042727|Analgesics|analgesics|mesh-ancestor
154545353|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
154545354|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545355|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154545375|NCT03063788|Copper|copper|mesh-list
154545376|NCT03063788|Trace Elements|trace elements|mesh-ancestor
154545377|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
154545378|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545379|NCT02821715|Flecainide|flecainide|mesh-list
154545380|NCT02821715|Modafinil|modafinil|mesh-list
154545381|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154545382|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545383|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154545384|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154545385|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154545386|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545387|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154545388|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154545389|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154545390|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545391|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
154545392|NCT03545347|Nandrolone|nandrolone|mesh-list
154545393|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
154545394|NCT03545347|Androgens|androgens|mesh-ancestor
154545395|NCT03545347|Hormones|hormones|mesh-ancestor
154545396|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545397|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545398|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
154545399|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154545400|NCT02815397|Metformin|metformin|mesh-list
154545401|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154545402|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545403|NCT02427958|Leuprolide|leuprolide|mesh-list
154545404|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154545405|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
154545406|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154545407|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545408|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154545409|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545410|NCT03715127|Psilocybin|psilocybin|mesh-list
154545411|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
154545412|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545413|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154545414|NCT02260037|Epinastine|epinastine|mesh-list
154545415|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154545416|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
154545417|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
154545418|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545419|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545420|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545421|NCT02036489|Prednisone|prednisone|mesh-list
154545422|NCT02036489|Vincristine|vincristine|mesh-list
154545423|NCT02036489|Daunorubicin|daunorubicin|mesh-list
154545424|NCT02036489|Asparaginase|asparaginase|mesh-list
154545425|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
154545426|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154545427|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
154545428|NCT02036489|Hormones|hormones|mesh-ancestor
154545429|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545430|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545431|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154545432|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545433|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154545434|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154545435|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154545436|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154545437|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545438|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154545439|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154545440|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154545441|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545442|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
154545443|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154545444|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545445|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
154545446|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154545447|NCT02392624|Omalizumab|omalizumab|mesh-list
154545448|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154545449|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154545450|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
154545452|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154545453|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
154545454|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154545455|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
154545456|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545457|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545458|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
154545459|NCT03063866|Midazolam|midazolam|mesh-list
154545460|NCT03063866|Fentanyl|fentanyl|mesh-list
154545461|NCT03063866|Propofol|propofol|mesh-list
154545462|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154545463|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545464|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545465|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154545466|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
154545467|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
154545468|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154545469|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154545470|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154545471|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154545472|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
154545473|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
154545474|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545475|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545476|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154545477|NCT03063866|Narcotics|narcotics|mesh-ancestor
154545478|NCT03063866|Analgesics|analgesics|mesh-ancestor
154545479|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
154545480|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545481|NCT02037191|Methotrexate|methotrexate|mesh-list
154545482|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154545483|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
154545484|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154545485|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545486|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154545487|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
154545488|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545489|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545490|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
154545491|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545492|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154545493|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545494|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
154545495|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545496|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154545497|NCT04980170|Amoxicillin|amoxicillin|mesh-list
154545498|NCT04980170|Clindamycin|clindamycin|mesh-list
154545499|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
154545500|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
154545501|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154545502|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
154545503|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
154545504|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154545505|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545506|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154545507|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545508|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545509|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154545510|NCT02387164|Vitamin D|vitamin d|mesh-list
154545511|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
154545512|NCT02387164|Vitamins|vitamins|mesh-ancestor
154545513|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
154545514|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545515|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154545516|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154545517|NCT02047799|Calcitriol|calcitriol|mesh-list
154545518|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154545519|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545520|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154545521|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545522|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545523|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154545524|NCT02047799|Vitamins|vitamins|mesh-ancestor
154545525|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
154269377|NCT06159322|Olanzapine|olanzapine|mesh-list
154545526|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154545527|NCT02392234|Ivacaftor|ivacaftor|mesh-list
154545528|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154545529|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545530|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545531|NCT02036723|Bevacizumab|bevacizumab|mesh-list
154545532|NCT02036723|Ranibizumab|ranibizumab|mesh-list
154545533|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545534|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545535|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154545537|NCT02036723|Growth Substances|growth substances|mesh-ancestor
154545538|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545539|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
154545540|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154545541|NCT02036879|Norethindrone|norethindrone|mesh-list
154545542|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
154545543|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154545544|NCT02036879|Estradiol|estradiol|mesh-list
154545545|NCT02036879|Estrogens|estrogens|mesh-ancestor
154545546|NCT02036879|Hormones|hormones|mesh-ancestor
154545547|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545548|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545549|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154545550|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
154545551|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154545552|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154545553|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154545554|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154545555|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154545556|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154545557|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154545558|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154545559|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
154545560|NCT02963090|Topotecan|topotecan|mesh-list
154545561|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545562|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545563|NCT02963090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154545564|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545565|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154545566|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154545567|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545568|NCT02048423|Ketamine|ketamine|mesh-list
154545569|NCT02048423|Analgesics|analgesics|mesh-ancestor
154545570|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
154545571|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545572|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545573|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154545574|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154545575|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
154545576|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
154545577|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545578|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154545579|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154545580|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545581|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545582|NCT02037035|Ketamine|ketamine|mesh-list
154545583|NCT02037035|Analgesics|analgesics|mesh-ancestor
154545584|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
154545585|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545586|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545587|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154545588|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154545589|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
154545590|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
154545591|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545592|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154545593|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154545594|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545595|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545596|NCT04979468|Lamivudine|lamivudine|mesh-list
154545597|NCT04979468|Dolutegravir|dolutegravir|mesh-list
154545598|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154545599|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154545600|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545601|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545602|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
154545603|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545604|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154545605|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154545606|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154545607|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154545608|NCT03562169|Thalidomide|thalidomide|mesh-list
154545609|NCT03562169|Dexamethasone|dexamethasone|mesh-list
154545611|NCT03562169|Glycine|glycine|mesh-list
154545612|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154545613|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
154545614|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
154545615|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545616|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545617|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545618|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
154545619|NCT03562169|Hormones|hormones|mesh-ancestor
154545620|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545621|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154545622|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545623|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545624|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
154545625|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
154545626|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154545627|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545628|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154545629|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154545630|NCT03562169|Growth Substances|growth substances|mesh-ancestor
154545631|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
154545632|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
154545633|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545634|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545635|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
154545636|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545637|NCT02427802|Gentamicins|gentamicins|mesh-list
154545638|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154545639|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545640|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154545641|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545642|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545643|NCT02050529|Labetalol|labetalol|mesh-list
154545644|NCT02050529|Hydralazine|hydralazine|mesh-list
154545645|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154545646|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154545647|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154545648|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545649|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545650|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545651|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154545652|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
154545653|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
154545654|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545655|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154545656|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154545657|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
154545658|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154545659|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154545660|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
154545661|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154545662|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154545663|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545664|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545665|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154545666|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545667|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545668|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
154545669|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545670|NCT02048969|Flumazenil|flumazenil|mesh-list
154545671|NCT02048969|Antidotes|antidotes|mesh-ancestor
154545672|NCT02048969|Protective Agents|protective agents|mesh-ancestor
154269527|NCT06158035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154545673|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545674|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
154545675|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
154545676|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545677|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545678|NCT03561935|Propafenone|propafenone|mesh-list
154545679|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154545680|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154545681|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154545682|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545683|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545685|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154545686|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
154545687|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545688|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545689|NCT02808143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154545690|NCT02808143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545691|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154545692|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
154545693|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545694|NCT02806973|Glucagon|glucagon|mesh-list
154545695|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545696|NCT02806973|Hormones|hormones|mesh-ancestor
154545697|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545698|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545699|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
154545700|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
154545701|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545702|NCT02037737|Abatacept|abatacept|mesh-list
154545703|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154545704|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545705|NCT02037737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545706|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545707|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545708|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
154545709|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545710|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545711|NCT02037503|Ketamine|ketamine|mesh-list
154545712|NCT02037503|Analgesics|analgesics|mesh-ancestor
154545713|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
154545714|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545715|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545716|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154545717|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154545718|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
154545719|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
154545720|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545721|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154545722|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154545723|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545724|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545725|NCT02049671|Hormones|hormones|mesh-list
154545726|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545727|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545728|NCT02037815|Mannitol|mannitol|mesh-list
154545729|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154545730|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154545731|NCT02037815|Diuretics|diuretics|mesh-ancestor
154545732|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
154545733|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545734|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154545735|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154545736|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
154545737|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545738|NCT02053727|Abatacept|abatacept|mesh-list
154545739|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154545740|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545741|NCT02053727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545742|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269611|NCT06132880|Kallikreins|kallikreins|mesh-list
154545743|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545744|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
154545745|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545746|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545747|NCT02051153|Modafinil|modafinil|mesh-list
154545748|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154545749|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545750|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154545751|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154545752|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154545753|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545754|NCT02807363|Leuprolide|leuprolide|mesh-list
154545755|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154545756|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
154545757|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154545758|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545759|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154545760|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545761|NCT02051231|Oxytocin|oxytocin|mesh-list
154545762|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
154545763|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154545764|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545765|NCT02051387|Cannabidiol|cannabidiol|mesh-list
154545766|NCT02051387|Olanzapine|olanzapine|mesh-list
154545767|NCT02051387|Risperidone|risperidone|mesh-list
154545768|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154545769|NCT02051387|Amisulpride|amisulpride|mesh-list
154545770|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154545771|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
154545772|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545773|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545774|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545775|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154545776|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154545777|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545778|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154545779|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154545780|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
154545781|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
154545782|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
154545783|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545784|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545785|NCT02051387|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154545786|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154545787|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545788|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
154545789|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
154545790|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154545791|NCT02052167|Methotrexate|methotrexate|mesh-list
154545792|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154545793|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
154545794|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154545795|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545796|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154545797|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
154545798|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545799|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545800|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154545801|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545802|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154545803|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545804|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
154545805|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545806|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154545807|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
154545808|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154545809|NCT03524417|Antibodies|antibodies|mesh-list
154545810|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
154545811|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545812|NCT03806543|Vancomycin|vancomycin|mesh-list
154545813|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154545814|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545815|NCT02052323|Artesunate|artesunate|mesh-list
154545816|NCT02052323|Mefloquine|mefloquine|mesh-list
154545817|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
154545818|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154545820|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545821|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545822|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
154545823|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
154545824|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154545825|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
154545826|NCT02056223|Acetaminophen|acetaminophen|mesh-list
154545827|NCT02056223|Ibuprofen|ibuprofen|mesh-list
154545828|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154545829|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154545830|NCT02056223|Analgesics|analgesics|mesh-ancestor
154545831|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
154545832|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545833|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545834|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154545835|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545836|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154545837|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545838|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545839|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
154545840|NCT02056379|Dexamethasone|dexamethasone|mesh-list
154545841|NCT02056379|Budesonide|budesonide|mesh-list
154545842|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154545843|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
154545844|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
154545845|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545846|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545847|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545848|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
154545849|NCT02056379|Hormones|hormones|mesh-ancestor
154545850|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545851|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154545852|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545853|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154545854|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154545855|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
154545856|NCT02383966|Carboplatin|carboplatin|mesh-list
154545857|NCT02383966|Fluorouracil|fluorouracil|mesh-list
154545858|NCT02383966|Cetuximab|cetuximab|mesh-list
154545859|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545860|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
154545861|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545862|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154545863|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154545864|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
154545865|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545866|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545867|NCT02054663|Clopidogrel|clopidogrel|mesh-list
154545868|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154545869|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154545870|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154545871|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154545872|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
154545873|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545874|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545875|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545876|NCT02054975|Vitamin D|vitamin d|mesh-list
154545877|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
154545878|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
154545879|NCT02054975|Vitamins|vitamins|mesh-list
154545880|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
154545881|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545882|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154545883|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154545884|NCT02055131|Aspirin|aspirin|mesh-list
154545885|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154545886|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154545887|NCT02055131|Analgesics|analgesics|mesh-ancestor
154545888|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
154545889|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154545890|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545891|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154545892|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545893|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154545894|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154545895|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545896|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154545897|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154545898|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545900|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
154545901|NCT02056847|Pitavastatin|pitavastatin|mesh-list
154545902|NCT02056847|Calcium|calcium|mesh-list
154545903|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154545904|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545905|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154545906|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154545907|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154545908|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154545909|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
154545910|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545911|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545912|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154545913|NCT02052713|Tamsulosin|tamsulosin|mesh-list
154545914|NCT02052713|Dutasteride|dutasteride|mesh-list
154545915|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154545916|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154545917|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154545918|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154545919|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545920|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545921|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545922|NCT02052713|Urological Agents|urological agents|mesh-ancestor
154545923|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154545924|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154545925|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545926|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
154545927|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154545928|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
154545929|NCT02057003|Grazoprevir|grazoprevir|mesh-list
154545930|NCT02057003|Ledipasvir|ledipasvir|mesh-list
154545931|NCT02057003|Velpatasvir|velpatasvir|mesh-list
154545932|NCT02057003|Simeprevir|simeprevir|mesh-list
154545933|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
154545934|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154545935|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
154545936|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545937|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545938|NCT02426086|Niacinamide|niacinamide|mesh-list
154545939|NCT02426086|Imetelstat|imetelstat|mesh-list
154545940|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
154545941|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545942|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545943|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154545944|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
154545945|NCT02426086|Vitamins|vitamins|mesh-ancestor
154545946|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
154545947|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545948|NCT02055911|Ranibizumab|ranibizumab|mesh-list
154545949|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154545950|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154545951|NCT02055911|Growth Substances|growth substances|mesh-ancestor
154545952|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545953|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
154545954|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545955|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154545956|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
154545957|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545958|NCT02390362|Rituximab|rituximab|mesh-list
154545959|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154545960|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154545961|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
154545962|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545963|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545964|NCT02389816|Vortioxetine|vortioxetine|mesh-list
154545965|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
154545966|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154545967|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154545968|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154545969|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154545970|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154545971|NCT02389816|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154545972|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154545973|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154545974|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545975|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154545977|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154545978|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154545979|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154545980|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154545982|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
154545983|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154545984|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154545985|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154545986|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545987|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545988|NCT02382796|Dacomitinib|dacomitinib|mesh-list
154545989|NCT02382796|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154545990|NCT02382796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154545991|NCT02382796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154545992|NCT02382796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154545993|NCT02382640|Febuxostat|febuxostat|mesh-list
154545994|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
154545995|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154545996|NCT02801669|Edoxaban|edoxaban|mesh-list
154545997|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154545998|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
154545999|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154546000|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
154546001|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546002|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546003|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
154546004|NCT02804399|Rifampin|rifampin|mesh-list
154546005|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154546006|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
154546007|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154546008|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546009|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
154546010|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154546011|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546012|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546013|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154546014|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154546015|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154546016|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154546017|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154546018|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154546019|NCT05614037|Felodipine|felodipine|mesh-list
154546020|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154546021|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154546022|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154546023|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546024|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546025|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154546026|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546027|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
154546028|NCT02058875|Cyclosporine|cyclosporine|mesh-list
154546029|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
154546030|NCT02058875|Prednisone|prednisone|mesh-list
154546031|NCT02058875|Cyclosporins|cyclosporins|mesh-list
154546032|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154546033|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
154546034|NCT02058875|Hormones|hormones|mesh-ancestor
154546035|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154546036|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546037|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154546038|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546039|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269902|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
154546040|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546041|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546042|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
154546043|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
154546044|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546045|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154546046|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546047|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154546048|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154546049|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154546050|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
154546051|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154546052|NCT02059031|Cabotegravir|cabotegravir|mesh-list
154546053|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154546054|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154546055|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546056|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546057|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154546058|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154546059|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
154546060|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546062|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154546063|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154546064|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
154546065|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546066|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546067|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546068|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154546069|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154546070|NCT04978688|Relugolix|relugolix|mesh-list
154546071|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
154546072|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
154546073|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154546074|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546075|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
154546076|NCT04434326|Vorolanib|vorolanib|mesh-list
154546077|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154546078|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546079|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546080|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
154546081|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154546082|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154546083|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154546084|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546085|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546086|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
154546087|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546088|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546089|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154546090|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546091|NCT02172872|Decitabine|decitabine|mesh-list
154546092|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154546093|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
154546094|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546095|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546096|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546097|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154546098|NCT02059655|Bimatoprost|bimatoprost|mesh-list
154546099|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154546100|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154546101|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154546102|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154546103|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546104|NCT05636501|Prednisolone|prednisolone|mesh-list
154546105|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154546106|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
154546107|NCT05636501|Hormones|hormones|mesh-ancestor
154546108|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154546109|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546110|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154546111|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546112|NCT02058173|Chloroquine|chloroquine|mesh-list
154546113|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154546114|NCT02058173|Amebicides|amebicides|mesh-ancestor
154546115|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154546116|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154546117|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546118|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
154546119|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546120|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154546121|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546122|NCT02058173|Analgesics|analgesics|mesh-ancestor
154546123|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
154546124|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546125|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546126|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860288|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546127|NCT02058173|Filaricides|filaricides|mesh-ancestor
154546128|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
154546129|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
154546130|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
154546131|NCT02060201|Saxagliptin|saxagliptin|mesh-list
154546132|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154546133|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546134|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154546135|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546136|NCT02060201|Incretins|incretins|mesh-ancestor
154546137|NCT02060201|Hormones|hormones|mesh-ancestor
154546138|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154546139|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154546140|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
154546141|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546142|NCT03561233|Omeprazole|omeprazole|mesh-list
154546143|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154546144|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154546145|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154546146|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546147|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546148|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154546149|NCT02058485|Midazolam|midazolam|mesh-list
154546150|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
154546151|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154546152|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546153|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546154|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546155|NCT02058485|Analgesics|analgesics|mesh-ancestor
154546156|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
154546157|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546158|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154546159|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154546160|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154546161|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
154546162|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546163|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546164|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154546165|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154546166|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154546167|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154546168|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154546169|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
154546170|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
154546171|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
154546172|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
154546173|NCT02060279|Carotenoids|carotenoids|mesh-list
154546174|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
154546175|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546176|NCT02060279|Protective Agents|protective agents|mesh-ancestor
154546177|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546178|NCT02058641|Darapladib|darapladib|mesh-list
154546179|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154546180|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546181|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546182|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
154546183|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154546184|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154546185|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546186|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
154546187|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
154546188|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546189|NCT02059967|Paclitaxel|paclitaxel|mesh-list
154546191|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154546192|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546193|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
154546194|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
154546195|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
154546196|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546197|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154546198|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154546199|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546200|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546201|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
154860289|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
154546202|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546203|NCT02061449|Romidepsin|romidepsin|mesh-list
154546204|NCT02061449|Poly ICLC|poly iclc|mesh-list
154546205|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
154546206|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
154546207|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546208|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154546209|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546210|NCT02061449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154546211|NCT02061449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546212|NCT02061449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546213|NCT02060591|Bupivacaine|bupivacaine|mesh-list
154546214|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
154546215|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
154546216|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546217|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546218|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
154546219|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546220|NCT02060669|Capecitabine|capecitabine|mesh-list
154546221|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154546222|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
154546223|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546224|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546225|NCT04428008|Thymalfasin|thymalfasin|mesh-list
154546226|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154546227|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
154546228|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546229|NCT02046590|Propofol|propofol|mesh-list
154546230|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
154546231|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546232|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546233|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154546234|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154546235|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
154546236|NCT02796755|Riluzole|riluzole|mesh-list
154546237|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
154546238|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154315235|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546239|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154546240|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546241|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546242|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546243|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154546244|NCT02796755|Protective Agents|protective agents|mesh-ancestor
154546245|NCT02061917|Lobeline|lobeline|mesh-list
154546246|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154546247|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
154546248|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546249|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546250|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154546251|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154546252|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
154546253|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546254|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546255|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
154546256|NCT03560375|Empagliflozin|empagliflozin|mesh-list
154546257|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154546258|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546259|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154546260|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546261|NCT02382016|Macitentan|macitentan|mesh-list
154270131|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
154546262|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154546263|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154546264|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546265|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154546266|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154546267|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154546268|NCT02422186|Sertraline|sertraline|mesh-list
154546269|NCT02422186|Esketamine|esketamine|mesh-list
154546270|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
154546271|NCT02422186|Escitalopram|escitalopram|mesh-list
154546272|NCT02422186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154546273|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154546274|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546275|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546276|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546277|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
154546278|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546279|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546280|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154546281|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154546282|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154546283|NCT02422186|Analgesics|analgesics|mesh-ancestor
154546284|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
154546285|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
154546286|NCT02796677|Bromides|bromides|mesh-list
154546287|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
154546288|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
154546289|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154546290|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
154546291|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546292|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546293|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154546294|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
154546295|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154546296|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154546297|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154546298|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
154546299|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546300|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546301|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
154546302|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154546303|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
154546304|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
154546305|NCT04973462|Oseltamivir|oseltamivir|mesh-list
154546306|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
154546307|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546308|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546309|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546310|NCT02378506|Etanercept|etanercept|mesh-list
154546311|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154546312|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546313|NCT02378506|Analgesics|analgesics|mesh-ancestor
154546314|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
154546315|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546316|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546317|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154546318|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546319|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154546320|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546321|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
154546322|NCT02794883|Durvalumab|durvalumab|mesh-list
154546323|NCT02794883|Ipilimumab|ipilimumab|mesh-list
154546324|NCT02794883|Tremelimumab|tremelimumab|mesh-list
154546325|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
154546326|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154546327|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
154546328|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154546329|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546330|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
154546331|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546332|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154546333|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546334|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
154546335|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154546336|NCT02063789|Antibodies|antibodies|mesh-list
154546337|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
154546338|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546339|NCT02063945|Risperidone|risperidone|mesh-list
154546340|NCT02063945|Methylphenidate|methylphenidate|mesh-list
154546341|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154546342|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
154546343|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546344|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546345|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546346|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154546347|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154546348|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546349|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154546350|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154546351|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
154546352|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154546353|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154546354|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154546355|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546357|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154546358|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154546359|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546360|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
154546361|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
154546362|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
154546363|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546364|NCT01370603|Atorvastatin|atorvastatin|mesh-list
154546365|NCT01370603|Ezetimibe|ezetimibe|mesh-list
154546366|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154546367|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154546368|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
154546369|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546370|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154546371|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154546372|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546373|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154546374|NCT02659397|Atorvastatin|atorvastatin|mesh-list
154546375|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154546376|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154546377|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
154546378|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546379|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154546380|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154546381|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546382|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154546383|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546384|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
154546385|NCT02347072|Bromides|bromides|mesh-list
154546386|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
154546387|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
154546388|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154546389|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
154546390|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546391|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546392|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154546393|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
154546394|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154546395|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154546396|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154546397|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
154546398|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546399|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546400|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
154546401|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154546402|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
154546403|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
154546404|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154546405|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154546406|NCT02064491|Paclitaxel|paclitaxel|mesh-list
154546407|NCT02064491|Docetaxel|docetaxel|mesh-list
154546408|NCT02064491|Cisplatin|cisplatin|mesh-list
154546409|NCT02064491|Carboplatin|carboplatin|mesh-list
154546410|NCT02064491|Pemetrexed|pemetrexed|mesh-list
154546411|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154546412|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154546413|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546414|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
154546415|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
154546416|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
154546417|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546418|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546419|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154546420|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154546421|NCT02064491|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154546422|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154860290|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
154546423|NCT02064881|Metformin|metformin|mesh-list
154546424|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154546425|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546426|NCT02346370|Docetaxel|docetaxel|mesh-list
154546427|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546428|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
154546429|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
154546430|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
154546431|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546432|NCT02065739|Itraconazole|itraconazole|mesh-list
154546433|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
154546434|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
154546435|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546436|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154546437|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154546438|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546439|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546440|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154546441|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
154546442|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154546443|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546444|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154546445|NCT02068079|Vemurafenib|vemurafenib|mesh-list
154546446|NCT02068079|Trientine|trientine|mesh-list
154546447|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546448|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154546449|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546450|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546451|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
154546452|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
154546453|NCT02793947|Epinephrine|epinephrine|mesh-list
154546454|NCT02793947|Morphine|morphine|mesh-list
154546455|NCT02793947|Ropivacaine|ropivacaine|mesh-list
154546456|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154546457|NCT02793947|Narcotics|narcotics|mesh-ancestor
154546458|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546459|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546460|NCT02793947|Analgesics|analgesics|mesh-ancestor
154546461|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
154546462|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546463|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
154546464|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
154546465|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154546466|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154546467|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
154546468|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546469|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546470|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154546471|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154546472|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
154546473|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154546474|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
154546475|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
154546476|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
154546477|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154546478|NCT02068235|Ponesimod|ponesimod|mesh-list
154546479|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154546480|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546481|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546482|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
154546483|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546484|NCT01370213|Interleukin-2|interleukin-2|mesh-list
154270357|NCT03582033|Dexamethasone|dexamethasone|mesh-list
154546485|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154546486|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546487|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546488|NCT01370213|Analgesics|analgesics|mesh-ancestor
154546489|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
154546490|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546491|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546492|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
154546493|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546494|NCT02066207|Atorvastatin|atorvastatin|mesh-list
154546495|NCT02066207|Fenofibrate|fenofibrate|mesh-list
154546496|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154546497|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154546498|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
154546499|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546500|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154546501|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154546502|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546503|NCT01370525|Esomeprazole|esomeprazole|mesh-list
154546504|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154546505|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154546506|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154546507|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546508|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546509|NCT02065349|ASP8477|asp8477|mesh-list
154546510|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546511|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546512|NCT02068625|Rasagiline|rasagiline|mesh-list
154546513|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154546514|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546515|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546516|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154546517|NCT02068625|Protective Agents|protective agents|mesh-ancestor
154546518|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546519|NCT02068859|Diclofenac|diclofenac|mesh-list
154546520|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154546521|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546522|NCT02068859|Analgesics|analgesics|mesh-ancestor
154546523|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
154546524|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546525|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546526|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154546527|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546528|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154546529|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546530|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546531|NCT02068937|Furosemide|furosemide|mesh-list
154546532|NCT02068937|Diuretics|diuretics|mesh-ancestor
154546533|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
154546534|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546535|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154546536|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546537|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546538|NCT02066675|Trabectedin|trabectedin|mesh-list
154546539|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154546540|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
154546541|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546542|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546543|NCT02072135|Bupivacaine|bupivacaine|mesh-list
154546544|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
154546545|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
154546546|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546547|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546548|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
154546549|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546550|NCT02067065|Propofol|propofol|mesh-list
154546551|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154546552|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546553|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546554|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154546555|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
154546556|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
154546557|NCT02067143|Cytarabine|cytarabine|mesh-list
154546558|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154546559|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
154546560|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546561|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546562|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
154546563|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546564|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546565|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
154546566|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546567|NCT02072213|Tamsulosin|tamsulosin|mesh-list
154546568|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154546569|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154546570|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154546571|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
154546572|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546573|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546574|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546575|NCT02072213|Urological Agents|urological agents|mesh-ancestor
154546576|NCT02072291|Nifedipine|nifedipine|mesh-list
154546577|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154546578|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546579|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546580|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154546581|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546582|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
154546583|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
154546584|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154546585|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154546586|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
154546587|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546588|NCT03059888|Abatacept|abatacept|mesh-list
154546589|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154546590|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546591|NCT03059888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154546592|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546593|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546594|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
154546595|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546596|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546597|NCT03061838|Rituximab|rituximab|mesh-list
154546598|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154546599|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546600|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
154546601|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546602|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546603|NCT04964180|Indomethacin|indomethacin|mesh-list
154546604|NCT04964180|Lidocaine|lidocaine|mesh-list
154546605|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
154546606|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
154546607|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546608|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546609|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
154546610|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546611|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154546612|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154546613|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154546614|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546615|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546616|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154546617|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546618|NCT04964180|Analgesics|analgesics|mesh-ancestor
154546619|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154546620|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546621|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
154546622|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
154546623|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154546624|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154546625|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546626|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
154546627|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154546628|NCT02067377|Antibodies|antibodies|mesh-list
154546629|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
154546630|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546631|NCT02073149|Iron|iron|mesh-list
154546632|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
154546633|NCT02073149|Trace Elements|trace elements|mesh-ancestor
154546634|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
154546635|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546636|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154546637|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
154546638|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
154546639|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546640|NCT02625974|Nifurtimox|nifurtimox|mesh-list
154546641|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154546642|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154546643|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154546644|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546645|NCT02067767|Lamivudine|lamivudine|mesh-list
154546646|NCT02067767|Abacavir|abacavir|mesh-list
154546647|NCT02067767|Dolutegravir|dolutegravir|mesh-list
154860291|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
154546648|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154546649|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154546650|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546651|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546652|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
154546653|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546654|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154546655|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154546656|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154546657|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154546658|NCT02073227|Metformin|metformin|mesh-list
154546659|NCT02073227|Canagliflozin|canagliflozin|mesh-list
154546660|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154546661|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546662|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154546663|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546664|NCT03060044|Fluticasone|fluticasone|mesh-list
154546665|NCT03060044|Xhance|xhance|mesh-list
154546666|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154546667|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154546668|NCT03060044|Charcoal|charcoal|mesh-list
154546669|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154546670|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154546671|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
154546672|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546673|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546674|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154546675|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
154546676|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
154546677|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154546678|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154546679|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154546680|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154546681|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
154546682|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546683|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546684|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
154546685|NCT03060044|Hormones|hormones|mesh-ancestor
154546686|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154546687|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
154546688|NCT03060044|Antidotes|antidotes|mesh-ancestor
154546689|NCT03060044|Protective Agents|protective agents|mesh-ancestor
154546690|NCT02070653|Ticagrelor|ticagrelor|mesh-list
154546691|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154546692|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154546693|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154546694|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154546695|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
154546696|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546697|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546698|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546699|NCT04831892|Isosorbide|isosorbide|mesh-list
154546700|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154546701|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154546702|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154546703|NCT04831892|Diuretics|diuretics|mesh-ancestor
154546704|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
154546705|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546706|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
154546707|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154546708|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546709|NCT02073773|Levodopa|levodopa|mesh-list
154546710|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154546711|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154546712|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
154546713|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546714|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546715|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546716|NCT03062150|Cycloserine|cycloserine|mesh-list
154546717|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
154546718|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154546719|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546720|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154546721|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
154546722|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154546723|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
154546724|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546725|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154546726|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
154546727|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154546728|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154546729|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546730|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
154546731|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
154546732|NCT02076659|Methotrexate|methotrexate|mesh-list
154546733|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154546734|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
154546735|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154546736|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546737|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154546738|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
154546739|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546740|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546741|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
154546742|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546743|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154546744|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546745|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
154546746|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546747|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154546748|NCT02076815|Anagrelide|anagrelide|mesh-list
154546749|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154546750|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154546751|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546752|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154546753|NCT02071043|Capecitabine|capecitabine|mesh-list
154546754|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
154546755|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154546756|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
154546757|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546758|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546759|NCT02076893|Ibuprofen|ibuprofen|mesh-list
154546760|NCT02076893|Gabapentin|gabapentin|mesh-list
154546761|NCT02076893|Tramadol|tramadol|mesh-list
154546762|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154546763|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546764|NCT02076893|Analgesics|analgesics|mesh-ancestor
154546765|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
154546766|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546767|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546768|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154546769|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546770|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154546771|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546772|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546773|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
154546774|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154546775|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154546776|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546777|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154546778|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154546779|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154546780|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546781|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
154546782|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154546783|NCT02076893|Narcotics|narcotics|mesh-ancestor
154270651|NCT00274599|Ramipril|ramipril|mesh-list
154546784|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154546786|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154546787|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546788|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546789|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154546790|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546791|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546792|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
154546793|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860292|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546794|NCT04963088|Capecitabine|capecitabine|mesh-list
154546795|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
154546796|NCT04963088|Tislelizumab|tislelizumab|mesh-list
154546797|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154546798|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
154546799|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546800|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546801|NCT04963088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154546802|NCT02074319|Methotrexate|methotrexate|mesh-list
154546803|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154546804|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
154546805|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154546806|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546807|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154546808|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
154546809|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546810|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546811|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
154546812|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546813|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154546814|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154546815|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
154546816|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546817|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154546818|NCT04975022|Insulin|insulin|mesh-list
154546819|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154546820|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546821|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154546822|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
154546823|NCT03061604|Octreotide|octreotide|mesh-list
154546824|NCT03061604|Hemostatics|hemostatics|mesh-list
154546825|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546826|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154546827|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154546828|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546829|NCT03061604|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154546830|NCT03061604|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154546831|NCT03061604|Coagulants|coagulants|mesh-ancestor
154546832|NCT04974944|Paclitaxel|paclitaxel|mesh-list
154546833|NCT04974944|Bevacizumab|bevacizumab|mesh-list
154546834|NCT04974944|Carboplatin|carboplatin|mesh-list
154546835|NCT04974944|Apatinib|apatinib|mesh-list
154546836|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154546837|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546838|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
154546839|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
154546840|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
154546841|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546842|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154546843|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154546844|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154546845|NCT04974944|Growth Substances|growth substances|mesh-ancestor
154546846|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546847|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
154546848|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154546849|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546850|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154546851|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154546852|NCT04962386|Hormones|hormones|mesh-list
154546853|NCT04962386|Estradiol|estradiol|mesh-list
154546854|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154546855|NCT04962386|Progesterone|progesterone|mesh-list
154546856|NCT04962386|Estrogens|estrogens|mesh-list
154546857|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154546858|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546859|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154546861|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154546862|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154546863|NCT04962386|Progestins|progestins|mesh-ancestor
154546864|NCT02071355|Simeprevir|simeprevir|mesh-list
154546865|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
154546866|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546867|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
154546868|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546869|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546870|NCT02071433|Iodine|iodine|mesh-list
154546871|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154546872|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546873|NCT02071433|Trace Elements|trace elements|mesh-ancestor
154546874|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
154546875|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546876|NCT04962308|Vaccines|vaccines|mesh-list
154546877|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
154546878|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546879|NCT02071589|Nifedipine|nifedipine|mesh-list
154546880|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154546881|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154546882|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546883|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154546884|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546885|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
154546886|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
154546887|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154546888|NCT02077751|Biotin|biotin|mesh-list
154546889|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
154546890|NCT02077751|Vitamins|vitamins|mesh-ancestor
154546891|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
154546892|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546893|NCT04961684|Amorolfine|amorolfine|mesh-list
154546894|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
154546895|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546896|NCT03061058|Docetaxel|docetaxel|mesh-list
154546897|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
154546898|NCT03061058|Irinotecan|irinotecan|mesh-list
154546899|NCT03061058|Pemetrexed|pemetrexed|mesh-list
154546900|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546901|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
154546902|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
154546903|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
154546904|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546905|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154546906|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154546907|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546908|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154546909|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154546910|NCT04961918|Durvalumab|durvalumab|mesh-list
154546911|NCT04961918|Lenvatinib|lenvatinib|mesh-list
154546912|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154546913|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546914|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154546915|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546916|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546917|NCT04954040|Azithromycin|azithromycin|mesh-list
154546918|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
154546919|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154546920|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154546921|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
154546922|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154546923|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154546924|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546925|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546926|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546927|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
154546928|NCT04424654|Testosterone|testosterone|mesh-list
154546929|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
154546930|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
154546931|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154546932|NCT04424654|Androgens|androgens|mesh-ancestor
154546933|NCT04424654|Hormones|hormones|mesh-ancestor
154315947|NCT06119490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546934|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154546935|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546936|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154546937|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546938|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
154546939|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
154546940|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
154546941|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154546942|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546943|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546944|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546945|NCT04968392|Analgesics|analgesics|mesh-ancestor
154546946|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
154546947|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546948|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154546949|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154546950|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154546951|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
154546952|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546953|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546954|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
154546955|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
154546956|NCT02792699|Rituximab|rituximab|mesh-list
154546957|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154546958|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546959|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
154546960|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546961|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154546962|NCT04968002|Apatinib|apatinib|mesh-list
154546963|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546964|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154546965|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546966|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546967|NCT04961138|Lenvatinib|lenvatinib|mesh-list
154546968|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154546969|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154546970|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154546971|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546972|NCT03061136|Clonazepam|clonazepam|mesh-list
154546973|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
154546974|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
154546975|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
154546976|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546977|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546978|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546979|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154546980|NCT02080169|Midazolam|midazolam|mesh-list
154546981|NCT02080169|Fentanyl|fentanyl|mesh-list
154546982|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
154546983|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154546984|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154546985|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154546986|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154546987|NCT02080169|Analgesics|analgesics|mesh-ancestor
154546988|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
154546989|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154546990|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154546991|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154546992|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154546993|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
154546994|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154546995|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154546996|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154546997|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154546998|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154546999|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154547000|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154547001|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
154547002|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
154547003|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
154547004|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
154547005|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154547006|NCT02080169|Narcotics|narcotics|mesh-ancestor
154547007|NCT02078063|Mepivacaine|mepivacaine|mesh-list
154547008|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
154547009|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
154547010|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547011|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547012|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
154547013|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547015|NCT04951856|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154547016|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154547017|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154547018|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
154547019|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547020|NCT04951856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154547021|NCT04951856|Protease Inhibitors|protease inhibitors|mesh-ancestor
154547022|NCT04951856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547023|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154547024|NCT04951232|Cinepazide|cinepazide|mesh-list
154547025|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
154547026|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
154547027|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
154547028|NCT04959578|Hematinics|hematinics|mesh-ancestor
154547029|NCT04959500|Temozolomide|temozolomide|mesh-list
154547030|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154547031|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
154547032|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547033|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547034|NCT02076191|Decitabine|decitabine|mesh-list
154547035|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154547036|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
154547037|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547038|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547039|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547040|NCT02080715|Tolcapone|tolcapone|mesh-list
154547041|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154547042|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154547043|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154547044|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547045|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547046|NCT04965662|Tenofovir|tenofovir|mesh-list
154547047|NCT04965662|Emtricitabine|emtricitabine|mesh-list
154547048|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154547049|NCT04965662|Maraviroc|maraviroc|mesh-list
154547050|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
154547051|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547052|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154547053|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154547054|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547055|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547056|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154547057|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154547058|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154547059|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154547060|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154547061|NCT02078609|Midostaurin|midostaurin|mesh-list
154547062|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547063|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154547064|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547065|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547066|NCT04957940|SMOFlipid|smoflipid|mesh-list
154547067|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154547068|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154547069|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154547070|NCT03060278|Nicotine|nicotine|mesh-list
154547071|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154547072|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
154547073|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547074|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547075|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154547076|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154547077|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
154547078|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547079|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547080|NCT02083991|Prednisolone|prednisolone|mesh-list
154547081|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
154547082|NCT02083991|Basiliximab|basiliximab|mesh-list
154547083|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547084|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
154547085|NCT02083991|Hormones|hormones|mesh-ancestor
154547086|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547087|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547088|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154547089|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547090|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
154547091|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154547093|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
154547094|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154547095|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154547096|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547097|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547098|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547099|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154547100|NCT02081027|Protective Agents|protective agents|mesh-ancestor
154547101|NCT04948034|Tislelizumab|tislelizumab|mesh-list
154547102|NCT04948034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547103|NCT04948034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547104|NCT04947956|Apatinib|apatinib|mesh-list
154547105|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547106|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154547107|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547108|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547109|NCT03254511|Enoxaparin|enoxaparin|mesh-list
154547110|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
154547111|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
154547112|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154547113|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154547114|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547115|NCT04947566|Ibuprofen|ibuprofen|mesh-list
154547116|NCT04947566|Naproxen|naproxen|mesh-list
154547117|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154547118|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154547119|NCT04947566|Analgesics|analgesics|mesh-ancestor
154547120|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
154547121|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547122|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547123|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547124|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547125|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154547126|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547127|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547128|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
154547129|NCT03241875|Pregabalin|pregabalin|mesh-list
154547130|NCT03241875|Gabapentin|gabapentin|mesh-list
154547131|NCT03241875|Analgesics|analgesics|mesh-ancestor
154547132|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
154547133|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547134|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547135|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
154547136|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154547137|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547138|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547139|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154547140|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154547141|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154547142|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547143|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154547144|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154547145|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154547146|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547147|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
154547148|NCT03058094|Pemetrexed|pemetrexed|mesh-list
154547149|NCT03058094|Abivertinib|abivertinib|mesh-list
154547150|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547151|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547152|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547153|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154547154|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154547155|NCT03058094|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154547156|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154547157|NCT04944524|Methotrexate|methotrexate|mesh-list
154547158|NCT04944524|Tofacitinib|tofacitinib|mesh-list
154547159|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154547160|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
154547161|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154547162|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547163|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154547164|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
154547165|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547166|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547167|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
154547168|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547169|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154547170|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154547171|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
154547172|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547173|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154547174|NCT04944524|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154547175|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154547176|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154547177|NCT04412876|Imipramine|imipramine|mesh-list
154547178|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154547179|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154547180|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547181|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547182|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547183|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547184|NCT04412876|Analgesics|analgesics|mesh-ancestor
154547185|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
154547186|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547187|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
154547188|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154547189|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
154547190|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154547191|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154547192|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
154547193|NCT03241563|Triamcinolone|triamcinolone|mesh-list
154547194|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
154547195|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547196|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
154547197|NCT03241563|Hormones|hormones|mesh-ancestor
154547198|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547199|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547200|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154547201|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154547202|NCT03241641|Tenofovir|tenofovir|mesh-list
154547203|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
154316216|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
154547204|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547205|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154547206|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154547207|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547208|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547209|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154547210|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154547211|NCT04486521|Siltuximab|siltuximab|mesh-list
154547212|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547213|NCT04955834|Insulin|insulin|mesh-list
154547214|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154547215|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547216|NCT03241407|Triclosan|triclosan|mesh-list
154547217|NCT03241407|Fluorides|fluorides|mesh-list
154547218|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
154547219|NCT03241407|Protective Agents|protective agents|mesh-ancestor
154547220|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547221|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154547222|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547223|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154547224|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154547225|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
154547226|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547227|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154547228|NCT03238131|Ivermectin|ivermectin|mesh-list
154547229|NCT03238131|Albendazole|albendazole|mesh-list
154547230|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154547231|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547232|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
154547233|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
154547234|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154547235|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154547236|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
154547237|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
154547238|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
154547239|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547240|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547241|NCT01369433|Sirolimus|sirolimus|mesh-list
154547242|NCT01369433|Paclitaxel|paclitaxel|mesh-list
154547243|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154547244|NCT01369433|Capecitabine|capecitabine|mesh-list
154547245|NCT01369433|Temsirolimus|temsirolimus|mesh-list
154547246|NCT01369433|MTOR Inhibitors|mtor inhibitors|mesh-list
154547247|NCT01369433|Tivozanib|tivozanib|mesh-list
154316279|NCT05418556|Aspirin|aspirin|mesh-list
154547248|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154547249|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547250|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
154547251|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
154860293|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
154547252|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
154547253|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547254|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154547255|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
154547256|NCT01369433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154547257|NCT01369433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547258|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154547259|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
154547260|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547261|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154547262|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547263|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154547264|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
154547265|NCT04946162|Tadalafil|tadalafil|mesh-list
154547266|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
154547267|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154547268|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154547269|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547270|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547271|NCT04946162|Urological Agents|urological agents|mesh-ancestor
154547272|NCT02084225|Lidocaine|lidocaine|mesh-list
154547273|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
154547274|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
154547275|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547276|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547277|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
154547278|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547279|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154547280|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154547281|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154547282|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547283|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547284|NCT04945694|Fentanyl|fentanyl|mesh-list
154547285|NCT04945694|Propofol|propofol|mesh-list
154547286|NCT04945694|Sevoflurane|sevoflurane|mesh-list
154547287|NCT04945694|Atracurium|atracurium|mesh-list
154547288|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154547289|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547290|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547291|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154547292|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
154547293|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
154547294|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154547295|NCT04945694|Narcotics|narcotics|mesh-ancestor
154547296|NCT04945694|Analgesics|analgesics|mesh-ancestor
154547297|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
154547298|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547299|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154547300|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154547301|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154547302|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154547303|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154547304|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154547305|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154547306|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154547307|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
154547308|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547309|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547310|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154547311|NCT02084303|Hematinics|hematinics|mesh-ancestor
154547312|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154547313|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154547314|NCT03253887|Ethanol|ethanol|mesh-list
154547315|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154547316|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547317|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547318|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547319|NCT02453607|Infliximab|infliximab|mesh-list
154547320|NCT02453607|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154547321|NCT02453607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547322|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
154547323|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154547324|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547325|NCT02453529|Nafithromycin|nafithromycin|mesh-list
154547326|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154547327|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547328|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154547329|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547330|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547331|NCT03241017|Durvalumab|durvalumab|mesh-list
154547332|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547333|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547334|NCT03240939|Tadalafil|tadalafil|mesh-list
154547335|NCT03240939|Dutasteride|dutasteride|mesh-list
154547336|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
154547337|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154547338|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154547339|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547340|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547341|NCT03240939|Urological Agents|urological agents|mesh-ancestor
154547342|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154547343|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154547344|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
154547345|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547346|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547347|NCT02624492|Rituximab|rituximab|mesh-list
154547348|NCT02624492|BI 836826|bi 836826|mesh-list
154547349|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547350|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547351|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
154547352|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547353|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547354|NCT03240783|Dexamethasone|dexamethasone|mesh-list
154547355|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
154547356|NCT03240783|Betamethasone|betamethasone|mesh-list
154547357|NCT03240783|BB 1101|bb 1101|mesh-list
154547358|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547359|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
154547360|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
154547361|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547362|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547363|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154547364|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
154547365|NCT03240783|Hormones|hormones|mesh-ancestor
154547366|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547367|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154547368|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547369|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
154547370|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547371|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547372|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154547373|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
154547374|NCT03237507|Paclitaxel|paclitaxel|mesh-list
154547375|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
154547376|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154547377|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547378|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
154547379|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
154547380|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
154547381|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547382|NCT04945226|Finasteride|finasteride|mesh-list
154547383|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154547384|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154547385|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547386|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547387|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
154547388|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547389|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547390|NCT04945226|Urological Agents|urological agents|mesh-ancestor
154547391|NCT01975831|Durvalumab|durvalumab|mesh-list
154547392|NCT01975831|Tremelimumab|tremelimumab|mesh-list
154547393|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547394|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547395|NCT04945070|Insulin|insulin|mesh-list
154547396|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154547397|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547398|NCT03240471|Calpastatin|calpastatin|mesh-list
154547399|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154547400|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
154860294|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
154547401|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547402|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547404|NCT04942652|Esomeprazole|esomeprazole|mesh-list
154547405|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154547406|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154547407|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154547408|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547409|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547410|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
154547411|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547412|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154547413|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154547414|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154547415|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
154547416|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547417|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547418|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154547419|NCT03240549|Bevacizumab|bevacizumab|mesh-list
154547420|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547421|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547422|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154547423|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154547424|NCT03240549|Growth Substances|growth substances|mesh-ancestor
154547425|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547426|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
154547427|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
154547428|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
154547429|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154547430|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154547431|NCT04933292|Prednisolone|prednisolone|mesh-list
154547432|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
154547433|NCT04933292|Azathioprine|azathioprine|mesh-list
154547434|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154547435|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
154547436|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154547437|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547438|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154547439|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
154547440|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154547441|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547442|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547443|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547444|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547445|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
154547446|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
154547447|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547448|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547449|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154547450|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
154547451|NCT04933292|Hormones|hormones|mesh-ancestor
154547452|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547453|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154547454|NCT04933292|Protective Agents|protective agents|mesh-ancestor
154547455|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154547456|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
154547457|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154547458|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154547459|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
154547460|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547461|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
154547462|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154547463|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154547464|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547465|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
154547466|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
154547467|NCT03237117|Hormones|hormones|mesh-list
154547468|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547469|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547470|NCT03239691|ACT-709478|act-709478|mesh-list
154547471|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154547472|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547473|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547474|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154547475|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547476|NCT04944602|Omalizumab|omalizumab|mesh-list
154547477|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154547478|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154547479|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
154547480|NCT03253107|Trastuzumab|trastuzumab|mesh-list
154547481|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547482|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547483|NCT03236883|Gemcitabine|gemcitabine|mesh-list
154547484|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154547485|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
154547486|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547487|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547488|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
154547489|NCT03236961|Metronidazole|metronidazole|mesh-list
154547490|NCT03236961|Levofloxacin|levofloxacin|mesh-list
154547491|NCT03236961|Ertapenem|ertapenem|mesh-list
154547492|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154547493|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547494|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154547495|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154547496|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547497|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547498|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547499|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154547500|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154547501|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154547502|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154547503|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154547504|NCT05234619|Ketorolac|ketorolac|mesh-list
154547505|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154547506|NCT05234619|Lidocaine|lidocaine|mesh-list
154547507|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
154547508|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
154547509|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547510|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547511|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
154547512|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547513|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154547514|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154547515|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154547516|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547517|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547518|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154547519|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154547520|NCT05234619|Analgesics|analgesics|mesh-ancestor
154547521|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154316535|NCT04685616|Bleomycin|bleomycin|mesh-list
154547522|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547523|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154547524|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547525|NCT04921904|Ramucirumab|ramucirumab|mesh-list
154547526|NCT04921904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154547527|NCT04921904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154547528|NCT04921904|Growth Substances|growth substances|mesh-ancestor
154547529|NCT04921904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547530|NCT04921904|Growth Inhibitors|growth inhibitors|mesh-ancestor
154547531|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547532|NCT02622386|Riboflavin|riboflavin|mesh-list
154547533|NCT02622386|Vitamins|vitamins|mesh-ancestor
154547534|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
154547535|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547536|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
154547537|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154547538|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
154547539|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
154547540|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154547541|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154547542|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547543|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
154547544|NCT04427618|Coagulants|coagulants|mesh-ancestor
154547545|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
154547546|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154547547|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547548|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547549|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154547550|NCT03236727|Analgesics|analgesics|mesh-ancestor
154547551|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
154547552|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547553|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154547554|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154547555|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154547556|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154547557|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547558|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547559|NCT03236493|PF-06700841|pf-06700841|mesh-list
154547560|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154547561|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547562|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547563|NCT04921124|Teriparatide|teriparatide|mesh-list
154547564|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154547565|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547566|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154547567|NCT04921046|Lidocaine|lidocaine|mesh-list
154547568|NCT04921046|Midazolam|midazolam|mesh-list
154547569|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154547570|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154547571|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547572|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547573|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154547574|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154547575|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154547576|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154547577|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
154547578|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
154547579|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
154547580|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
154547581|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547582|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547583|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
154547584|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
154547585|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547586|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154547587|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154547588|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154547589|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547590|NCT02792231|Teriflunomide|teriflunomide|mesh-list
154547591|NCT02792231|Ofatumumab|ofatumumab|mesh-list
154547592|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154547593|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547594|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
154547595|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547596|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154547597|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154547598|NCT02792231|Analgesics|analgesics|mesh-ancestor
154547599|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
154547600|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547601|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547602|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547603|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154547604|NCT04930952|Ethanol|ethanol|mesh-list
154547605|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154547606|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547607|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271480|NCT03615664|Hormones|hormones|mesh-ancestor
154547608|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547609|NCT04920968|Rituximab|rituximab|mesh-list
154547610|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
154547611|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547612|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547613|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
154547614|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547615|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547616|NCT00700401|Ribavirin|ribavirin|mesh-list
154547617|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154547618|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
154547619|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547620|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
154547621|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547622|NCT04931108|Atenolol|atenolol|mesh-list
154547623|NCT04931108|Nitrendipine|nitrendipine|mesh-list
154547624|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154547625|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154547626|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
154547627|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
154547628|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547629|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547630|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154547631|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154547632|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154547633|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
154547634|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547635|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547636|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154547637|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547638|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154547639|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
154547640|NCT04920500|Cytarabine|cytarabine|mesh-list
154547641|NCT04920500|Daunorubicin|daunorubicin|mesh-list
154547642|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154547643|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
154547644|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547645|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547646|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
154547647|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547648|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154547649|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
154547650|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547651|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154547652|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154547653|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154547654|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547655|NCT02084615|Aspirin|aspirin|mesh-list
154547656|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154547657|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154547658|NCT02084615|Analgesics|analgesics|mesh-ancestor
154547659|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
154547660|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547661|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547662|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547663|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154547664|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154547665|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154547666|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547667|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154547668|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154547669|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547670|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
154547671|NCT03559751|Nicotine|nicotine|mesh-list
154547672|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154547673|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
154547674|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547675|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547676|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154547677|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154547678|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
154547679|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547680|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547681|NCT03234699|Midazolam|midazolam|mesh-list
154547682|NCT03234699|Cenobamate|cenobamate|mesh-list
154547683|NCT03234699|Bupropion|bupropion|mesh-list
154547684|NCT03234699|Omeprazole|omeprazole|mesh-list
154547685|NCT03234699|Warfarin|warfarin|mesh-list
154547686|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154547687|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154547688|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547689|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547690|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154547691|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154547692|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154547693|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154547694|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
154547696|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
154547697|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
154547698|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547699|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547700|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
154547701|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154547702|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154547703|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154547704|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547705|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154547706|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
154547707|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154547708|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154547709|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547710|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
154547711|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154547712|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154547713|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
154547714|NCT03228771|Atorvastatin|atorvastatin|mesh-list
154547715|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154547716|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154547717|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
154547718|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547719|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154547720|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154547721|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547722|NCT02081339|Ranibizumab|ranibizumab|mesh-list
154547723|NCT02081339|Aflibercept|aflibercept|mesh-list
154547724|NCT02081339|Verteporfin|verteporfin|mesh-list
154547725|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154547726|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154547727|NCT02081339|Growth Substances|growth substances|mesh-ancestor
154547728|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547729|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
154547730|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547731|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154547732|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
154547733|NCT04939766|Insulin|insulin|mesh-list
154547734|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154547735|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547736|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154547737|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
154547738|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547739|NCT03559673|Lacosamide|lacosamide|mesh-list
154547740|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
154547741|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154547742|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154547743|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547744|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547745|NCT03234387|Acetylcholine|acetylcholine|mesh-list
154547746|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547747|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
154547748|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154547749|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
154547750|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547751|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547752|NCT03235947|Trimethoprim|trimethoprim|mesh-list
154547753|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
154547754|NCT03235947|Fosfomycin|fosfomycin|mesh-list
154547755|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154547756|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547757|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
154547758|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154547759|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154547760|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154547761|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547762|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547763|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154547764|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154547765|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154547766|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154547767|NCT03057470|Insulin|insulin|mesh-list
154547768|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154547769|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154547770|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547771|NCT02871401|Valganciclovir|valganciclovir|mesh-list
154547772|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
154547773|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547774|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
154547775|NCT03228303|Nilotinib|nilotinib|mesh-list
154547777|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154547778|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547779|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547780|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547781|NCT02085005|Capecitabine|capecitabine|mesh-list
154547782|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
154547783|NCT02085005|Aflibercept|aflibercept|mesh-list
154547784|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154547785|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
154547786|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547787|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547788|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154547789|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154547790|NCT02085005|Growth Substances|growth substances|mesh-ancestor
154547791|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547792|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
154547793|NCT03235869|Durvalumab|durvalumab|mesh-list
154547794|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547795|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547796|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154547797|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
154547798|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547799|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154547800|NCT02081495|Doxorubicin|doxorubicin|mesh-list
154547801|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154547802|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547803|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154547804|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154547805|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547806|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547807|NCT03056846|Sulfalene|sulfalene|mesh-list
154547808|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547809|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154547810|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
154547811|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154547812|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154547813|NCT03227679|Bupropion|bupropion|mesh-list
154547814|NCT03227679|Nicotine|nicotine|mesh-list
154547815|NCT03227679|Varenicline|varenicline|mesh-list
154547816|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154547817|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
154547818|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547819|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547820|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154547821|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154547822|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
154547823|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547824|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547825|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154547826|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
154547827|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154547828|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154547829|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154547830|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547831|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
154547832|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154547833|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154547834|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547835|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154547837|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154547838|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547839|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547840|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
154547841|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547842|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547843|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154547844|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547845|NCT04937894|Tigecycline|tigecycline|mesh-list
154547846|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154547847|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547848|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154547849|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547850|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547851|NCT04919252|Vedolizumab|vedolizumab|mesh-list
154547852|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154547853|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
154547854|NCT04919174|Remifentanil|remifentanil|mesh-list
154547855|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154547856|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547857|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547858|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154547859|NCT04919174|Analgesics|analgesics|mesh-ancestor
154547860|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
154547861|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547862|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154547863|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154547864|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154547865|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
154547866|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547867|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547868|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154547869|NCT04919174|Narcotics|narcotics|mesh-ancestor
154547870|NCT02085239|Lidocaine|lidocaine|mesh-list
154547871|NCT02085239|Ropivacaine|ropivacaine|mesh-list
154547872|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
154547873|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
154547874|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154547875|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547876|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
154547877|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547878|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154547879|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154547880|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154547881|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154547882|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547883|NCT02085317|Nitroprusside|nitroprusside|mesh-list
154547884|NCT02085317|Acetylcholine|acetylcholine|mesh-list
154547885|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154547886|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
154547887|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154547888|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547889|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154547890|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
154547891|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547892|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547893|NCT03234153|Durvalumab|durvalumab|mesh-list
154547894|NCT03234153|Tremelimumab|tremelimumab|mesh-list
154547895|NCT03234153|Immunomodulating Agents|immunomodulating agents|mesh-list
154547896|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
154547897|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547898|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547899|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547900|NCT03056924|Vaccines|vaccines|mesh-list
154547901|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
154547902|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547903|NCT04918862|Granisetron|granisetron|mesh-list
154547904|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
154547905|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
154547906|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547907|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547908|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271797|NCT05193214|Antibodies|antibodies|mesh-list
154547909|NCT04918862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154547910|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154547911|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
154547912|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547913|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547914|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
154547915|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154547916|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154547917|NCT02452281|Ipilimumab|ipilimumab|mesh-list
154547918|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154547919|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547920|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154547921|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547922|NCT02452125|Nicotine|nicotine|mesh-list
154547923|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154547924|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
154547925|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154547926|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547927|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154547928|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154547929|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
154547930|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547931|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547932|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154547933|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
154547934|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154547935|NCT02619812|Antibodies|antibodies|mesh-list
154547936|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
154547937|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547938|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154547939|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154547940|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
154547941|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547942|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154547943|NCT03222765|Metformin|metformin|mesh-list
154547944|NCT03222765|Linagliptin|linagliptin|mesh-list
154547945|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154547946|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547947|NCT03222765|Incretins|incretins|mesh-ancestor
154547948|NCT03222765|Hormones|hormones|mesh-ancestor
154547949|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547950|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154547951|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
154547952|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547953|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547954|NCT04485585|Tamsulosin|tamsulosin|mesh-list
154547955|NCT04485585|Mirabegron|mirabegron|mesh-list
154547956|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154547957|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154547958|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154547959|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
154547960|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154547961|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547962|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547963|NCT04485585|Urological Agents|urological agents|mesh-ancestor
154547964|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154547965|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154547966|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154547967|NCT03222687|Prednisone|prednisone|mesh-list
154547968|NCT03222687|Tacrolimus|tacrolimus|mesh-list
154547969|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154547970|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
154547971|NCT03222687|Hormones|hormones|mesh-ancestor
154547972|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154547973|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547974|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154547975|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154547976|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154547977|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
154547978|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154547979|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154547980|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547981|NCT03055442|Inositol|inositol|mesh-list
154547982|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
154547983|NCT03055442|Vitamins|vitamins|mesh-ancestor
154547984|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
154547985|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547986|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
154547987|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
154547988|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154547989|NCT03226431|Protective Agents|protective agents|mesh-ancestor
154547990|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154547991|NCT03226431|Vitamins|vitamins|mesh-ancestor
154547992|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
154547993|NCT02451579|Cetirizine|cetirizine|mesh-list
154547994|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
154547995|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154547996|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154547997|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154547998|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
154547999|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548000|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548001|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548002|NCT04935788|Caseins|caseins|mesh-list
154548003|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
154548004|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
154548005|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548006|NCT03233295|Vitamin D|vitamin d|mesh-list
154548007|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
154548008|NCT03233295|Vitamins|vitamins|mesh-ancestor
154548009|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
154548010|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548011|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154548012|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154548013|NCT04917458|Vitamin D|vitamin d|mesh-list
154548014|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
154548015|NCT04917458|Vitamins|vitamins|mesh-ancestor
154548016|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
154548017|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548018|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154548019|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154548020|NCT03225963|Temozolomide|temozolomide|mesh-list
154548021|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154548022|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
154548023|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548024|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548025|NCT03221907|Pregabalin|pregabalin|mesh-list
154548026|NCT03221907|Analgesics|analgesics|mesh-ancestor
154548027|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
154548028|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548029|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548030|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
154548031|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154548032|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154548033|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548034|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154548035|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154548036|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154548037|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548038|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548039|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154548040|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
154548041|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154548042|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
154548043|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548044|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548045|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154548046|NCT03107481|Acetaminophen|acetaminophen|mesh-list
154548047|NCT03107481|Hydromorphone|hydromorphone|mesh-list
154548048|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154548049|NCT03107481|Analgesics|analgesics|mesh-ancestor
154548050|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
154548051|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548052|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548053|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
154548054|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548055|NCT03107481|Narcotics|narcotics|mesh-ancestor
154548056|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548057|NCT04934852|Ephedrine|ephedrine|mesh-list
154548058|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
154548059|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154548060|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548061|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
154548062|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
154548063|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548064|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154548065|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
154548066|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548067|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548068|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154548069|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154548070|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
154548071|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
154548073|NCT04934618|Apatinib|apatinib|mesh-list
154548074|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154558147|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154548075|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154548076|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548077|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548078|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548079|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154548080|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154548081|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154548082|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548083|NCT04916522|Colchicine|colchicine|mesh-list
154548084|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
154548085|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154548086|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
154548087|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
154548088|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
154548089|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548090|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548091|NCT04407650|Metformin|metformin|mesh-list
154548092|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154548093|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154548094|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548095|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154548096|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548097|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
154548098|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154548099|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154548100|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
154548101|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548102|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154548103|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154548104|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548105|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548106|NCT03220815|Methamphetamine|methamphetamine|mesh-list
154548107|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154548108|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548109|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
154548110|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
154548111|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548112|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
154548113|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548114|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548115|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
154548116|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154548117|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154548118|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154548119|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154548120|NCT04913402|Sufentanil|sufentanil|mesh-list
154548121|NCT04913402|Dsuvia|dsuvia|mesh-list
154548122|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548123|NCT04913402|Narcotics|narcotics|mesh-ancestor
154548124|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548125|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548126|NCT04913402|Analgesics|analgesics|mesh-ancestor
154548127|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
154548128|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548129|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154548130|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548131|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
154548132|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
154548133|NCT04912934|Insulin|insulin|mesh-list
154548135|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548136|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154548137|NCT04915586|Plasminogen|plasminogen|mesh-list
154548138|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154548139|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154548140|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548141|NCT03232125|Ramosetron|ramosetron|mesh-list
154548142|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
154548143|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
154548144|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548145|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548146|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548147|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154548148|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
154548149|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548150|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548151|NCT03224637|Acetaminophen|acetaminophen|mesh-list
154548152|NCT03224637|Ketorolac|ketorolac|mesh-list
154548153|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154548154|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154548155|NCT03224637|Analgesics|analgesics|mesh-ancestor
154548156|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
154548157|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548158|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548159|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
154548160|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154548161|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154548162|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154548163|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154548164|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548165|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548166|NCT04912700|Vaccines|vaccines|mesh-list
154548167|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
154548168|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548169|NCT03224871|Aldesleukin|aldesleukin|mesh-list
154548170|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
154548171|NCT03224871|Nivolumab|nivolumab|mesh-list
154548172|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154548173|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548174|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154548175|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548176|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154548177|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154548178|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
154548179|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548180|NCT03220425|Insulin|insulin|mesh-list
154548181|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154548182|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
154548183|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
154548184|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
154548185|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
154548186|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154548187|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548188|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154548189|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154548190|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548191|NCT03220191|Palbociclib|palbociclib|mesh-list
154548192|NCT03220191|Rabeprazole|rabeprazole|mesh-list
154548193|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548194|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154548195|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548196|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548197|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154548198|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548199|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154548200|NCT03220113|Thiamine|thiamine|mesh-list
154548201|NCT03220113|Dexamethasone|dexamethasone|mesh-list
154548202|NCT03220113|Lidocaine|lidocaine|mesh-list
154548203|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154548204|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
154548205|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
154548206|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548207|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548208|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548209|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
154548210|NCT03220113|Hormones|hormones|mesh-ancestor
154548211|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154548212|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154548213|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548214|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
154548215|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
154548216|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548217|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
154548218|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154548219|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154548220|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154548221|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154548222|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548223|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
154548224|NCT03220113|Vitamins|vitamins|mesh-ancestor
154548225|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
154548226|NCT02254525|Ibuprofen|ibuprofen|mesh-list
154548227|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154548228|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154548229|NCT02254525|Analgesics|analgesics|mesh-ancestor
154548230|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
154548231|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548232|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548233|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154548234|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154548235|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154548236|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548237|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548239|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
154548240|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
154548241|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
154548242|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548243|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548244|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548245|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
154548246|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154548247|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548248|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548249|NCT02143531|Haloperidol|haloperidol|mesh-list
154548250|NCT02143531|Ondansetron|ondansetron|mesh-list
154548251|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
154548252|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
154548253|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
154548254|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548255|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548256|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548257|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
154548258|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
154548259|NCT02143531|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154548260|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154548261|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
154548262|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548263|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548264|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154548265|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154548266|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548267|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548268|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154548269|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
154548270|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154548271|NCT04485117|Anesthetics|anesthetics|mesh-list
154548272|NCT04485117|Propofol|propofol|mesh-list
154548273|NCT04485117|Sevoflurane|sevoflurane|mesh-list
154548274|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548275|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548276|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154548277|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548278|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
154548279|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154548280|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154548281|NCT00803569|Sargramostim|sargramostim|mesh-list
154548282|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
154548283|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548284|NCT02143687|Sevoflurane|sevoflurane|mesh-list
154548285|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154548286|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154548287|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
154548288|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
154548289|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548290|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548291|NCT02143765|Acarbose|acarbose|mesh-list
154548292|NCT02143765|Mitiglinide|mitiglinide|mesh-list
154548293|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154548294|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548295|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548296|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154548297|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548298|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
154548299|NCT02148367|Hematinics|hematinics|mesh-ancestor
154548300|NCT00482833|Methotrexate|methotrexate|mesh-list
154548301|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
154548302|NCT00482833|Idarubicin|idarubicin|mesh-list
154548303|NCT00482833|Tretinoin|tretinoin|mesh-list
154548304|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
154548305|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154548306|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
154548307|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154548308|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548309|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154548310|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
154548311|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548312|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548313|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
154548314|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548315|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154548316|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154548317|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
154548318|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154548319|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154548320|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154548321|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154548322|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154548323|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
154548325|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154548326|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548327|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
154548328|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154548329|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154548330|NCT04485429|Prednisolone|prednisolone|mesh-list
154548331|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
154548332|NCT04485429|Heparin|heparin|mesh-list
154548333|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154548334|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
154548335|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154548336|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
154548337|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
154548338|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548339|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548340|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548341|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
154548342|NCT04485429|Hormones|hormones|mesh-ancestor
154548343|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154548344|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154548345|NCT04485429|Protective Agents|protective agents|mesh-ancestor
154548346|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154548347|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548348|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
154548349|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154548350|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154548351|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548352|NCT00112957|Vaccines|vaccines|mesh-list
154548353|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
154548354|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548355|NCT02140801|Clopidogrel|clopidogrel|mesh-list
154548356|NCT02140801|Ticagrelor|ticagrelor|mesh-list
154548357|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154548358|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154548359|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154272230|NCT01117662|Rituximab|rituximab|mesh-list
154548360|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154548361|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
154548362|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548363|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548364|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548365|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154548366|NCT02148601|Vancomycin|vancomycin|mesh-list
154548367|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548368|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
154548369|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
154548370|NCT02141035|Vitamins|vitamins|mesh-ancestor
154548371|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
154548372|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548373|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
154548374|NCT03214653|Propofol|propofol|mesh-list
154548375|NCT03214653|Sevoflurane|sevoflurane|mesh-list
154548376|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154548377|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548378|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548380|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
154548381|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
154548382|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154548383|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154548384|NCT02450877|Azacitidine|azacitidine|mesh-list
154548385|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154548386|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
154548387|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548388|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548389|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548390|NCT02141113|Guanfacine|guanfacine|mesh-list
154548391|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154548392|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154548393|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154548394|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154548395|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
154548396|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548397|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548398|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548399|NCT03213639|Esomeprazole|esomeprazole|mesh-list
154548400|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154548401|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548402|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154548403|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548404|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548405|NCT03231033|Pioglitazone|pioglitazone|mesh-list
154548406|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154548407|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548408|NCT02141347|Durvalumab|durvalumab|mesh-list
154548409|NCT02141347|Tremelimumab|tremelimumab|mesh-list
154548410|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154548411|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548412|NCT02254759|Midazolam|midazolam|mesh-list
154548413|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154548414|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154548415|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548416|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548417|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154548418|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154548419|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548420|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548421|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
154548422|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
154548423|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
154548424|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
154548425|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548426|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548427|NCT03208257|Esmolol|esmolol|mesh-list
154548428|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154548429|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154548430|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154548431|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
154548432|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548433|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548434|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548435|NCT02141425|Peficitinib|peficitinib|mesh-list
154548436|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548437|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548438|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154548439|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
154548440|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548442|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154548443|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154548444|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
154548445|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548446|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548447|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154548448|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154548449|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
154548450|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548451|NCT03208101|Vaccines|vaccines|mesh-list
154548452|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
154383336|NCT03239314|Hormones|hormones|mesh-ancestor
154548453|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548454|NCT02149225|Poly I-C|poly i-c|mesh-list
154548455|NCT02149225|Molgramostim|molgramostim|mesh-list
154548456|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154548457|NCT02149225|Vaccines|vaccines|mesh-list
154548458|NCT02149225|Sargramostim|sargramostim|mesh-list
154548459|NCT02149225|Poly ICLC|poly iclc|mesh-list
154548460|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
154548461|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548462|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548463|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
154548464|NCT02149225|Laxatives|laxatives|mesh-ancestor
154548465|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548466|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
154548467|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548468|NCT03208335|Endostatins|endostatins|mesh-list
154548469|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548470|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154548471|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154548472|NCT03208335|Growth Substances|growth substances|mesh-ancestor
154548473|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548474|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
154548475|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
154548476|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154548477|NCT03211065|Antibodies|antibodies|mesh-list
154548478|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
154548479|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548480|NCT02149459|Metformin|metformin|mesh-list
154548481|NCT02149459|Biguanides|biguanides|mesh-list
154548482|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154548483|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548484|NCT02376790|Etanercept|etanercept|mesh-list
154548485|NCT02376790|Methotrexate|methotrexate|mesh-list
154548486|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154548487|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
154548488|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154548489|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548490|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154548491|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
154548492|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548493|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548494|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
154548495|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548496|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154548497|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154548498|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
154548499|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154548500|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154548501|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154548502|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154548503|NCT02376790|Analgesics|analgesics|mesh-ancestor
154548504|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
154548505|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548506|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154548507|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548508|NCT02141737|Lidocaine|lidocaine|mesh-list
154548509|NCT02141737|Midazolam|midazolam|mesh-list
154548510|NCT02141737|Fentanyl|fentanyl|mesh-list
154548511|NCT02141737|Etomidate|etomidate|mesh-list
154548512|NCT02141737|Rocuronium|rocuronium|mesh-list
154548513|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
154548514|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
154548515|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548516|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548517|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
154548518|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548519|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154548520|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154548521|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154548522|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154548523|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548524|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154548525|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154548526|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154548527|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154548528|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548529|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548530|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
154548531|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
154548532|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
154548533|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548534|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548535|NCT02141737|Narcotics|narcotics|mesh-ancestor
154548536|NCT02141737|Analgesics|analgesics|mesh-ancestor
154548537|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154548538|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154548539|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154548540|NCT02254447|Candesartan|candesartan|mesh-list
154548541|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
154548542|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154548543|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154548544|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154548545|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548546|NCT02376166|Metformin|metformin|mesh-list
154548547|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154548548|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548549|NCT03207165|Dobutamine|dobutamine|mesh-list
154548550|NCT03207165|Milrinone|milrinone|mesh-list
154548551|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
154548552|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154548553|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
154548554|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
154548555|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548556|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548557|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154548558|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154548559|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154548560|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
154548561|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548562|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548563|NCT03207165|Protective Agents|protective agents|mesh-ancestor
154548564|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154548565|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
154548566|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154548567|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548568|NCT02142205|Natalizumab|natalizumab|mesh-list
154548569|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
154548570|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548571|NCT03209427|Morphine|morphine|mesh-list
154548572|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548573|NCT03209427|Narcotics|narcotics|mesh-ancestor
154548574|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548575|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548576|NCT03209427|Analgesics|analgesics|mesh-ancestor
154548577|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
154548578|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548579|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
154548580|NCT03544723|Nivolumab|nivolumab|mesh-list
154548581|NCT03544723|Atezolizumab|atezolizumab|mesh-list
154548582|NCT03544723|Durvalumab|durvalumab|mesh-list
154548583|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154548584|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548585|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154548586|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548587|NCT03209661|Menthol|menthol|mesh-list
154548588|NCT03209661|Nicotine|nicotine|mesh-list
154548589|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154548590|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
154548591|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548592|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548594|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154548595|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
154548596|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548597|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548598|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
154548599|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
154548600|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154548601|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
154548602|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548603|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
154548604|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
154548605|NCT03209115|Calcium|calcium|mesh-list
154548606|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154548607|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548608|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154548609|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154548610|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548611|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
154548612|NCT03209193|Sevoflurane|sevoflurane|mesh-list
154548613|NCT03209193|Desflurane|desflurane|mesh-list
154548614|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154548615|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154548616|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
154548617|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
154548618|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548619|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548620|NCT02142595|Midazolam|midazolam|mesh-list
154548621|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
154548622|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154548623|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548624|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548625|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154548626|NCT02142595|Analgesics|analgesics|mesh-ancestor
154548627|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
154548628|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548629|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154548630|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154548631|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154548632|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
154548633|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548634|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548635|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154548636|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154548637|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154548638|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548639|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548640|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
154548641|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
154548642|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
154548643|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
154548644|NCT04898374|Cisplatin|cisplatin|mesh-list
154548645|NCT04898374|Gemcitabine|gemcitabine|mesh-list
154548646|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548647|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154548648|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
154548649|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548650|NCT03207477|Mydriatics|mydriatics|mesh-list
154548651|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
154548652|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548653|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548654|NCT02452515|Fulacimstat|fulacimstat|mesh-list
154548655|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548656|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548657|NCT03206931|Selitrectinib|selitrectinib|mesh-list
154548658|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548659|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548660|NCT02344342|Diuretics|diuretics|mesh-list
154548661|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
154548662|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548663|NCT02452437|Oxycodone|oxycodone|mesh-list
154548664|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548665|NCT02452437|Narcotics|narcotics|mesh-ancestor
154548666|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548667|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548668|NCT02452437|Analgesics|analgesics|mesh-ancestor
154548669|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
154548670|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548671|NCT03208413|Thalidomide|thalidomide|mesh-list
154548672|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154548673|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
154548674|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548675|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
154548676|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154548677|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548678|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154548679|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154548680|NCT03208413|Growth Substances|growth substances|mesh-ancestor
154548681|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
154548682|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548683|NCT03201159|Pentamidine|pentamidine|mesh-list
154548684|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
154548685|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548686|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154548687|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154548688|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154548689|NCT02149927|Sevoflurane|sevoflurane|mesh-list
154548690|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154548691|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154548692|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
154548693|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
154548694|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548695|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548697|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
154548698|NCT02142751|Fosfomycin|fosfomycin|mesh-list
154548699|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154548700|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154548701|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548702|NCT02142751|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154548703|NCT02142751|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154548704|NCT02142829|Bupivacaine|bupivacaine|mesh-list
154548705|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
154548706|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
154548707|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548708|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548709|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
154548710|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548711|NCT03200691|Antibodies|antibodies|mesh-list
154548712|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
154548713|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548714|NCT02150161|Lidocaine|lidocaine|mesh-list
154548715|NCT02150161|Fentanyl|fentanyl|mesh-list
154548716|NCT02150161|Ketamine|ketamine|mesh-list
154548717|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
154548718|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
154548719|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548720|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548721|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
154548722|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548723|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154548724|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154548725|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154548726|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154548727|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548728|NCT02150161|Analgesics|analgesics|mesh-ancestor
154548729|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154548730|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548731|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
154548732|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154548733|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154548734|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548735|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548736|NCT02150161|Narcotics|narcotics|mesh-ancestor
154548737|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154548738|NCT03200613|Heparin|heparin|mesh-list
154548739|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154548740|NCT03200613|Tinzaparin|tinzaparin|mesh-list
154548741|NCT03200613|Dalteparin|dalteparin|mesh-list
154548742|NCT03200613|Apixaban|apixaban|mesh-list
154548743|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
154548744|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154548745|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154548746|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548747|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154548748|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
154548749|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154548750|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
154548751|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548752|NCT02150317|Sorafenib|sorafenib|mesh-list
154548753|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
154548754|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548755|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154548756|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548757|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548758|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154548759|NCT02150317|Estrogens|estrogens|mesh-ancestor
154548760|NCT02150317|Hormones|hormones|mesh-ancestor
154548761|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154548762|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548763|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154548764|NCT02310568|PF-06372865|pf-06372865|mesh-list
154548765|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
154548766|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
154548767|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548768|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548769|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548770|NCT02448069|Argatroban|argatroban|mesh-list
154548771|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
154548772|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154548773|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
154548774|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548775|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548776|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
154548777|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154548778|NCT02449941|Rabeprazole|rabeprazole|mesh-list
154548779|NCT02449941|Pantoprazole|pantoprazole|mesh-list
154548780|NCT02449941|Lansoprazole|lansoprazole|mesh-list
154548781|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
154548782|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154548783|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154548784|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548785|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548786|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548787|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
154548788|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154548789|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
154548790|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154548791|NCT03199989|Capecitabine|capecitabine|mesh-list
154548792|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
154548793|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154548794|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
154548795|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548796|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548797|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
154548798|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154548799|NCT03195543|Thrombin|thrombin|mesh-list
154548800|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
154548801|NCT03195543|Coagulants|coagulants|mesh-ancestor
154548802|NCT03204669|Trace Elements|trace elements|mesh-list
154548803|NCT03204669|Micronutrients|micronutrients|mesh-list
154548804|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548805|NCT03199677|Apatinib|apatinib|mesh-list
154548806|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548807|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154548808|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548809|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548810|NCT02780167|Abrocitinib|abrocitinib|mesh-list
154548811|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154548812|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548813|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548814|NCT02447757|Remifentanil|remifentanil|mesh-list
154548815|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548816|NCT02447757|Narcotics|narcotics|mesh-ancestor
154548817|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548818|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548819|NCT02447757|Analgesics|analgesics|mesh-ancestor
154548820|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
154548821|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548822|NCT02447835|Olanzapine|olanzapine|mesh-list
154548823|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
154548824|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
154548825|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548826|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548827|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154548828|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154548829|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154548830|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548831|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548832|NCT02447835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154548833|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154548834|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154548835|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548836|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548837|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
154548838|NCT02447679|Tegafur|tegafur|mesh-list
154548839|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154548841|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548842|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548843|NCT03203967|Morphine|morphine|mesh-list
154548844|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548845|NCT03203967|Narcotics|narcotics|mesh-ancestor
154548846|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548847|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548848|NCT03203967|Analgesics|analgesics|mesh-ancestor
154548849|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
154548850|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548851|NCT03204045|Fentanyl|fentanyl|mesh-list
154548852|NCT03204045|Oxycodone|oxycodone|mesh-list
154548853|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548854|NCT03204045|Narcotics|narcotics|mesh-ancestor
154548855|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548856|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548857|NCT03204045|Analgesics|analgesics|mesh-ancestor
154548858|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
154548859|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548860|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154548861|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548862|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
154548863|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
154548864|NCT03199521|Thrombin|thrombin|mesh-list
154548865|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
154548866|NCT03199521|Coagulants|coagulants|mesh-ancestor
154548867|NCT03195153|Allopurinol|allopurinol|mesh-list
154548868|NCT03195153|Atorvastatin|atorvastatin|mesh-list
154548869|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154548870|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154548871|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
154548872|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548873|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154548874|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154548875|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548876|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
154548877|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154548878|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154548879|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
154548880|NCT03195153|Protective Agents|protective agents|mesh-ancestor
154548881|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548882|NCT03195309|Fentanyl|fentanyl|mesh-list
154548883|NCT03195309|Ropivacaine|ropivacaine|mesh-list
154548884|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
154548885|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
154548886|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548887|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548888|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
154548889|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548890|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154548891|NCT03195309|Narcotics|narcotics|mesh-ancestor
154548892|NCT03195309|Analgesics|analgesics|mesh-ancestor
154548893|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154548894|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548895|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
154272747|NCT01373710|Trastuzumab|trastuzumab|mesh-list
154548896|NCT03198819|Cefotaxime|cefotaxime|mesh-list
154548897|NCT03198819|Cefoxitin|cefoxitin|mesh-list
154548898|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154548899|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548900|NCT02447601|Simvastatin|simvastatin|mesh-list
154548901|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154548902|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154548903|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
154548904|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548905|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154548906|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154548907|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548908|NCT03118713|Metformin|metformin|mesh-list
154548909|NCT03118713|Glimepiride|glimepiride|mesh-list
154548910|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
154548911|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154548912|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548913|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154548914|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154548915|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
154548916|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154548917|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548918|NCT03198585|Empagliflozin|empagliflozin|mesh-list
154548919|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154548920|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548921|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154548922|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548923|NCT02447289|Midazolam|midazolam|mesh-list
154548924|NCT02447289|Ketamine|ketamine|mesh-list
154548925|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154548926|NCT02447289|Analgesics|analgesics|mesh-ancestor
154548927|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
154548928|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154548929|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548930|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154548931|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154548932|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
154548933|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
154548934|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548935|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154548936|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154548937|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548938|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548939|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154548940|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154548941|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154548942|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154548943|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548944|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
154548945|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
154548946|NCT02447211|Doxepin|doxepin|mesh-list
154548947|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154548948|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154548949|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548950|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548951|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154548952|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
154548953|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154548954|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
154548955|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
154548956|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154548957|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548958|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
154548959|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154548960|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
154548961|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548962|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154548963|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154548964|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
154548965|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548966|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548967|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154548968|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
154548969|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
154548970|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154548971|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
154272851|NCT03936426|Copper|copper|mesh-list
154548972|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154548973|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548974|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
154548975|NCT03203031|Anesthetics|anesthetics|mesh-list
154548976|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154548977|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548978|NCT03118479|Anastrozole|anastrozole|mesh-list
154548979|NCT03118479|Testosterone|testosterone|mesh-list
154548980|NCT03118479|Androgens|androgens|mesh-ancestor
154548981|NCT03118479|Hormones|hormones|mesh-ancestor
154548982|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154548983|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154548984|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154548985|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154548986|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154548987|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154548988|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860295|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154548989|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154548990|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154548991|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
154548993|NCT03197961|Emtricitabine|emtricitabine|mesh-list
154548994|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154548995|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
154548996|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
154548997|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154548998|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154548999|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154549000|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549001|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549002|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154549003|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154549004|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154549005|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154549006|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154549007|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
154549008|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154549009|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549010|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154549011|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154549012|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154549013|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154549014|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549015|NCT03202875|Insulin|insulin|mesh-list
154549016|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154549017|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
154549018|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
154549019|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154549020|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154549021|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549022|NCT03197571|Leucovorin|leucovorin|mesh-list
154549023|NCT03197571|Paclitaxel|paclitaxel|mesh-list
154549024|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
154549025|NCT03197571|Bevacizumab|bevacizumab|mesh-list
154549026|NCT03197571|Capecitabine|capecitabine|mesh-list
154549027|NCT03197571|Fluorouracil|fluorouracil|mesh-list
154549028|NCT03197571|Fulvestrant|fulvestrant|mesh-list
154549029|NCT03197571|Avelumab|avelumab|mesh-list
154549030|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154549031|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549032|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
154549033|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
154549034|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
154549035|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549036|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549037|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
154549038|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549039|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549040|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154549041|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
154549042|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154549043|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154549044|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154549045|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154272898|NCT01123278|Androgens|androgens|mesh-ancestor
154549046|NCT03197571|Growth Substances|growth substances|mesh-ancestor
154549047|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
154549048|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154549049|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
154549050|NCT03197571|Antidotes|antidotes|mesh-ancestor
154549051|NCT03197571|Protective Agents|protective agents|mesh-ancestor
154549052|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
154549053|NCT03197571|Vitamins|vitamins|mesh-ancestor
154549054|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
154549055|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154549056|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154549057|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154549058|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
154549059|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154549060|NCT02446977|Riboflavin|riboflavin|mesh-list
154549061|NCT02446977|Vitamins|vitamins|mesh-ancestor
154549062|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
154549063|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549064|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
154549065|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154549066|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
154549067|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
154549068|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
154549069|NCT02447055|Melphalan|melphalan|mesh-list
154549070|NCT02447055|Fludarabine|fludarabine|mesh-list
154549071|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
154549072|NCT02447055|Tacrolimus|tacrolimus|mesh-list
154549073|NCT02447055|Lenograstim|lenograstim|mesh-list
154549074|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549075|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
154549076|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549077|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549078|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154549079|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
154549080|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549081|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549082|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154549083|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154549084|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
154549085|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154549086|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154549087|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549088|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154549089|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154549090|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
154549091|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154549092|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549093|NCT03202563|Metformin|metformin|mesh-list
154549094|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
154549095|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154549096|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549097|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154549098|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549099|NCT03197493|Levodopa|levodopa|mesh-list
154549100|NCT03197493|Carbidopa|carbidopa|mesh-list
154549101|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154549102|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154549103|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154549104|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
154549105|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549106|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549107|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549108|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154549109|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549110|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154549111|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
154549112|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
154549113|NCT02450175|Everolimus|everolimus|mesh-list
154549114|NCT02450175|Letrozole|letrozole|mesh-list
154549115|NCT02450175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154549116|NCT02450175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154549117|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549118|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549119|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154272976|NCT01126086|Otamixaban|otamixaban|mesh-list
154549120|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
154549121|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549122|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549123|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154549124|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154549125|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154549126|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
154549127|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154549129|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
154549130|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549131|NCT03202407|Calcium|calcium|mesh-list
154549132|NCT03202407|Sevelamer|sevelamer|mesh-list
154549133|NCT03202407|Calcium acetate|calcium acetate|mesh-list
154549134|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154549135|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549136|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
154860296|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
154549137|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
154549138|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549139|NCT02261077|Scopolamine|scopolamine|mesh-list
154549140|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154549141|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154549142|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
154549143|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
154549144|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549145|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549146|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154549147|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
154549148|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154549149|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
154549150|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549151|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549152|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154549153|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
154549154|NCT03196869|Cisplatin|cisplatin|mesh-list
154549155|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549156|NCT02150473|Adalimumab|adalimumab|mesh-list
154549157|NCT02150473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154549158|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549159|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549160|NCT02446431|Sirolimus|sirolimus|mesh-list
154549161|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
154549162|NCT02446431|Bevacizumab|bevacizumab|mesh-list
154549163|NCT02446431|Temsirolimus|temsirolimus|mesh-list
154549164|NCT02446431|MTOR Inhibitors|mtor inhibitors|mesh-list
154549165|NCT02446431|Valproic Acid|valproic acid|mesh-list
154549166|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549167|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
154549168|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549169|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549170|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154549171|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
154549172|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549173|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549174|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154549175|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154549176|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154549177|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154549178|NCT02446431|Growth Substances|growth substances|mesh-ancestor
154549179|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
154549180|NCT02446431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154549181|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549182|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154549183|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549184|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154549185|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
154549186|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
154549187|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
154549188|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549189|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
154549190|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154549191|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154549192|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154549193|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
154273051|NCT01222026|Vitamin D|vitamin d|mesh-list
154549194|NCT02446353|Megestrol|megestrol|mesh-list
154549195|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154549196|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549197|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
154549198|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154549199|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549200|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154549201|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154549202|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154549203|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
154549204|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154549205|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154549206|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154549207|NCT02144389|Praziquantel|praziquantel|mesh-list
154549208|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
154549209|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154549210|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549211|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
154549212|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154549213|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
154549214|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549215|NCT03197103|Expectorants|expectorants|mesh-ancestor
154549216|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
154549217|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154549218|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
154549219|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549220|NCT03197103|Protective Agents|protective agents|mesh-ancestor
154549221|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549222|NCT03197103|Antidotes|antidotes|mesh-ancestor
154549223|NCT02144623|Valproic Acid|valproic acid|mesh-list
154549224|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
154549225|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549226|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549227|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
154549228|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549229|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549230|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
154549231|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154549232|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154549233|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154549235|NCT03201861|Docetaxel|docetaxel|mesh-list
154549236|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154549237|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154549238|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549239|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
154549240|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
154549241|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
154549242|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549243|NCT03194685|FF-10101|ff-10101|mesh-list
154549244|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154549245|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549246|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549247|NCT00105079|Ritonavir|ritonavir|mesh-list
154549248|NCT00105079|Lopinavir|lopinavir|mesh-list
154549249|NCT00105079|Saquinavir|saquinavir|mesh-list
154549250|NCT00105079|Tenofovir|tenofovir|mesh-list
154549251|NCT00105079|Emtricitabine|emtricitabine|mesh-list
154549252|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154549253|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154549254|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154549255|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
154549256|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549257|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549258|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154549259|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154549260|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
154549261|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549262|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154549263|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154549264|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154549265|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154549266|NCT03196401|Durvalumab|durvalumab|mesh-list
154549267|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154549268|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549269|NCT02150707|Liraglutide|liraglutide|mesh-list
154549270|NCT02150707|Exenatide|exenatide|mesh-list
154549271|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154549272|NCT02150707|Glucagon|glucagon|mesh-list
154549273|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154549274|NCT02150707|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154549275|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154549276|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549278|NCT02150707|Hormones|hormones|mesh-ancestor
154549279|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154549280|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154549281|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154549282|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
154549283|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549284|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549285|NCT03196479|Ketamine|ketamine|mesh-list
154549286|NCT03196479|Propofol|propofol|mesh-list
154549287|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154549288|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154549289|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549290|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154384148|NCT02452606|Entacapone|entacapone|mesh-list
154549291|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
154549293|NCT03196479|Analgesics|analgesics|mesh-ancestor
154549294|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
154549295|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549296|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154549297|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154549298|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154549299|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549300|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549301|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
154549302|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
154549303|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154549304|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549305|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549306|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
154549307|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154549308|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154549309|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549310|NCT02151721|Gefitinib|gefitinib|mesh-list
154549311|NCT02151721|Vorinostat|vorinostat|mesh-list
154549312|NCT02151721|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154549313|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154549314|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549315|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549316|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549317|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154549318|NCT03201393|Acetaminophen|acetaminophen|mesh-list
154549319|NCT03201393|Naltrexone|naltrexone|mesh-list
154549320|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549321|NCT03201393|Analgesics|analgesics|mesh-ancestor
154549322|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
154549323|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549324|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549325|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
154549326|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154549327|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154549328|NCT03192969|Abatacept|abatacept|mesh-list
154549329|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
154549330|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154318345|NCT02254018|Maytansine|maytansine|mesh-list
154549331|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549332|NCT03192969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154549333|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549334|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549335|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
154549336|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549337|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549338|NCT03192969|Hormones|hormones|mesh-ancestor
154549339|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154549340|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
154549341|NCT03194139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154549342|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
154549343|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549344|NCT03194139|Protective Agents|protective agents|mesh-ancestor
154549345|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549346|NCT03118167|Antioxidants|antioxidants|mesh-list
154273205|NCT05760430|Apatinib|apatinib|mesh-list
154549347|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549348|NCT03118167|Protective Agents|protective agents|mesh-ancestor
154549349|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549350|NCT00189267|Imiquimod|imiquimod|mesh-list
154549351|NCT00189267|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154549352|NCT00189267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549353|NCT00189267|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154549354|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
154549355|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549356|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154549357|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549358|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
154549359|NCT02444949|Cisplatin|cisplatin|mesh-list
154549360|NCT02444949|Endostar protein|endostar protein|mesh-list
154549361|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549362|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154549363|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154549364|NCT02444949|Growth Substances|growth substances|mesh-ancestor
154549365|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549366|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
154549367|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154549368|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154549369|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154549370|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
154549371|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549372|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154549373|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154549374|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549375|NCT03192657|Basiliximab|basiliximab|mesh-list
154549376|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154549377|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549378|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
154549379|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549380|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549381|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549382|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
154549383|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154549384|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
154549385|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549386|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
154549387|NCT02444169|Protective Agents|protective agents|mesh-ancestor
154549388|NCT03194061|Cisplatin|cisplatin|mesh-list
154549389|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549390|NCT02343406|Temozolomide|temozolomide|mesh-list
154549391|NCT02343406|Lomustine|lomustine|mesh-list
154549392|NCT02343406|ABT-414|abt-414|mesh-list
154549393|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154549394|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
154549395|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549396|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549397|NCT02343406|Immunoconjugates|immunoconjugates|mesh-ancestor
154549398|NCT02343406|Immunologic Factors|immunologic factors|mesh-ancestor
154549399|NCT02343406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549400|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
154549401|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549402|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
154549403|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549404|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549405|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154549406|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
154549407|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549408|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549409|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154549410|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
154549411|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154549412|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
154549413|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549414|NCT03193749|Amiodarone|amiodarone|mesh-list
154549415|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154549416|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
154549417|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154549418|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154549419|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549420|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154549421|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154549422|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154549423|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549424|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154549425|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154549426|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154549427|NCT02444013|Folic Acid|folic acid|mesh-list
154549428|NCT02444013|Uric Acid|uric acid|mesh-list
154549429|NCT02444013|Hematinics|hematinics|mesh-ancestor
154549430|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
154549431|NCT02444013|Vitamins|vitamins|mesh-ancestor
154549432|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
154549433|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549434|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
154549435|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549436|NCT02444013|Protective Agents|protective agents|mesh-ancestor
154549437|NCT02444637|Rivastigmine|rivastigmine|mesh-list
154549438|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154549439|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549440|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549441|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
154549442|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549443|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549444|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154549445|NCT02444637|Protective Agents|protective agents|mesh-ancestor
154549446|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154549448|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154549449|NCT02710071|Diuretics|diuretics|mesh-ancestor
154549450|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
154549451|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549452|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154549453|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154549454|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549455|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
154549456|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154549457|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154549458|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154549459|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
154549460|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549461|NCT02439489|Carboplatin|carboplatin|mesh-list
154549462|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549463|NCT02444481|Polymyxins|polymyxins|mesh-list
154549464|NCT02444481|Neomycin|neomycin|mesh-list
154549465|NCT02444481|Nystatin|nystatin|mesh-list
154549466|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154549467|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549468|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154549469|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549470|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549471|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
154549472|NCT02444481|Ionophores|ionophores|mesh-ancestor
154549473|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154549474|NCT02444559|Clonidine|clonidine|mesh-list
154549475|NCT02444559|Ropivacaine|ropivacaine|mesh-list
154549476|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
154549477|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
154549478|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154549479|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549480|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
154549481|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549482|NCT02444559|Analgesics|analgesics|mesh-ancestor
154549483|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154549484|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
154549485|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
154549486|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154549487|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154549488|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154549489|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
154549490|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549491|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549492|NCT02439411|Trametinib|trametinib|mesh-list
154549493|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549494|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154549495|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549496|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549498|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549499|NCT02443311|Betamethasone|betamethasone|mesh-list
154549500|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
154549501|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154549502|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
154549503|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
154549504|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154549505|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549506|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
154549507|NCT02443311|Hormones|hormones|mesh-ancestor
154549508|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154549509|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549510|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154549511|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
154549512|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154549513|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549514|NCT02443311|Analgesics|analgesics|mesh-ancestor
154549515|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
154549516|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549517|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549518|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
154549519|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549520|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
154549521|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154549522|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549523|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549524|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
154549525|NCT02373202|Mizoribine|mizoribine|mesh-list
154549526|NCT02373202|Bucillamine|bucillamine|mesh-list
154549527|NCT02373202|Tacrolimus|tacrolimus|mesh-list
154549528|NCT02373202|Leflunomide|leflunomide|mesh-list
154549529|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549530|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
154549531|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549532|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154549533|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549534|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549535|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549536|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154549537|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549538|NCT02373202|Analgesics|analgesics|mesh-ancestor
154549539|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
154549540|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549541|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549542|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549543|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154549544|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154549545|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154549546|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549547|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
154549548|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154549549|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154549550|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
154549551|NCT02373202|Protective Agents|protective agents|mesh-ancestor
154549552|NCT03192111|Entinostat|entinostat|mesh-list
154549553|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549554|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154549555|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549556|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549557|NCT02622074|Paclitaxel|paclitaxel|mesh-list
154549558|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154549559|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
154549560|NCT02622074|Carboplatin|carboplatin|mesh-list
154549561|NCT02622074|Doxorubicin|doxorubicin|mesh-list
154549562|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
154549563|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154549564|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549565|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
154549566|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
154549567|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
154549568|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549569|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549570|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
154549571|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549572|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549573|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154549574|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
154549575|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154549576|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154549577|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154549578|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154549579|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549580|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154549581|NCT02622074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154549582|NCT02438709|Etoricoxib|etoricoxib|mesh-list
154549583|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154549584|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154549585|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549586|NCT02438709|Analgesics|analgesics|mesh-ancestor
154549587|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
154549588|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549589|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549590|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549591|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549592|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154549593|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549594|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549595|NCT05438758|Ketamine|ketamine|mesh-list
154549596|NCT05438758|Esketamine|esketamine|mesh-list
154549597|NCT05438758|Analgesics|analgesics|mesh-ancestor
154549598|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
154549599|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549600|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549601|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154549602|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154549603|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
154549604|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
154549605|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154549606|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154549607|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154549608|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549609|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549610|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
154549611|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154549612|NCT02442921|Colchicine|colchicine|mesh-list
154549613|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
154549614|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549615|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
154549616|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
154549617|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
154549618|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549619|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549620|NCT02438865|Epirubicin|epirubicin|mesh-list
154549621|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154549622|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549623|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154549624|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154549625|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549626|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549627|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
154549628|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
154549629|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549630|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
154549631|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
154549632|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
154549633|NCT02342704|Natalizumab|natalizumab|mesh-list
154549634|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154549635|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
154549636|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549637|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154549638|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549639|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549640|NCT02442453|Turmeric extract|turmeric extract|mesh-list
154549641|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
154549642|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549643|NCT02442453|Protective Agents|protective agents|mesh-ancestor
154549644|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549645|NCT02438397|Insulin|insulin|mesh-list
154549646|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154549648|NCT02438397|Acarbose|acarbose|mesh-list
154549649|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154549650|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549651|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154549652|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549653|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549654|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
154549655|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154549656|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154549657|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154549658|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154549659|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549660|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
154549661|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549662|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549663|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154549664|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549665|NCT02442531|Docetaxel|docetaxel|mesh-list
154549666|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549667|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
154549668|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
154549669|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
154549670|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549671|NCT03193203|Etanercept|etanercept|mesh-list
154549672|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154549673|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549674|NCT03193203|Analgesics|analgesics|mesh-ancestor
154549675|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
154549676|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549677|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549678|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549679|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549680|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154549681|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549682|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
154549683|NCT02442063|Paclitaxel|paclitaxel|mesh-list
154549684|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154549685|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154549686|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549687|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
154549688|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
154549689|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
154549690|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549691|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154549692|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154549693|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154549694|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
154549695|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549696|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549697|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154549698|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
154549699|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154549700|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
154549701|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154549702|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549703|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549704|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154549705|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549706|NCT03054662|Hemostatics|hemostatics|mesh-list
154549707|NCT03054662|Coagulants|coagulants|mesh-ancestor
154549708|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
154549709|NCT04922996|Calcium|calcium|mesh-list
154549710|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154549711|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549712|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
154549713|NCT04922996|Coagulants|coagulants|mesh-ancestor
154549714|NCT04913480|Durvalumab|durvalumab|mesh-list
154549715|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154549716|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549717|NCT02441907|Aflibercept|aflibercept|mesh-list
154549718|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154549719|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154549720|NCT02441907|Growth Substances|growth substances|mesh-ancestor
154549721|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549722|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
154549723|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549724|NCT02437461|Triamcinolone|triamcinolone|mesh-list
154549725|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154549726|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154549727|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154549728|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549729|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
154549730|NCT02437461|Hormones|hormones|mesh-ancestor
154549731|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154549732|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549733|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154549734|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
154549735|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549736|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549737|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
154549738|NCT04910594|Hematinics|hematinics|mesh-ancestor
154549739|NCT02441673|Ephedrine|ephedrine|mesh-list
154549740|NCT02441673|Meperidine|meperidine|mesh-list
154549741|NCT02441673|Tramadol|tramadol|mesh-list
154549743|NCT02441673|Metoclopramide|metoclopramide|mesh-list
154549744|NCT02441673|Ranitidine|ranitidine|mesh-list
154549745|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154549746|NCT02441673|Oxytocin|oxytocin|mesh-list
154549747|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
154549748|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154549749|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549750|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154549751|NCT02441673|Narcotics|narcotics|mesh-ancestor
154549752|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154549753|NCT02441673|Analgesics|analgesics|mesh-ancestor
154549754|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
154549755|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549756|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
154549757|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
154549758|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154549759|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154549760|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154549761|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
154549762|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549763|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549764|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154549765|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
154549766|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154549767|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
154549768|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154549769|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154549770|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
154549771|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
154549772|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154549773|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549774|NCT04910126|Doxorubicin|doxorubicin|mesh-list
154549775|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154549776|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154549777|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549778|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154549779|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154549780|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549781|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549782|NCT04922450|Paclitaxel|paclitaxel|mesh-list
154549783|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154549784|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154549785|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549786|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
154549787|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
154549788|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
154549789|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549790|NCT04922450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154549791|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
154549792|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
154549793|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549794|NCT04903808|Protective Agents|protective agents|mesh-ancestor
154549795|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549796|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154549797|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549798|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154549799|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549800|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
154549801|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
154549802|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549803|NCT04893980|Aldesleukin|aldesleukin|mesh-list
154549804|NCT04893980|Interleukin-2|interleukin-2|mesh-list
154549805|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549806|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549807|NCT04893980|Analgesics|analgesics|mesh-ancestor
154549808|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
154549809|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549810|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549811|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154549812|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154549813|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
154549814|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549815|NCT04149470|Omeprazole|omeprazole|mesh-list
154549816|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154549817|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154549818|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154549819|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549820|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549821|NCT04902638|Dexamethasone|dexamethasone|mesh-list
154549822|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549823|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
154549824|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
154549825|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549826|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549827|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154549828|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
154549829|NCT04902638|Hormones|hormones|mesh-ancestor
154549830|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154549831|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154549832|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549833|NCT02617628|Naltrexone|naltrexone|mesh-list
154549834|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154549835|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154549836|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549837|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
154549838|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549839|NCT03053414|Vitamin D|vitamin d|mesh-list
154549840|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
154549841|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
154549842|NCT03053414|Vitamins|vitamins|mesh-ancestor
154549843|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
154549844|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549845|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154549846|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154549847|NCT02308540|Vaccines|vaccines|mesh-list
154549848|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154549849|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
154549850|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549851|NCT02308228|Metformin|metformin|mesh-list
154549852|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154549853|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549854|NCT03051932|Acetaminophen|acetaminophen|mesh-list
154549855|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549856|NCT03051932|Analgesics|analgesics|mesh-ancestor
154549857|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
154549858|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549859|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549860|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
154549861|NCT04908566|Folfirinox|folfirinox|mesh-list
154549862|NCT04908566|Antibodies|antibodies|mesh-list
154549863|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
154549864|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
154549865|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549866|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549867|NCT04892654|Dolutegravir|dolutegravir|mesh-list
154549868|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154549869|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154549870|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549871|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549872|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154549873|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154549874|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
154549875|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549876|NCT04899674|Bupropion|bupropion|mesh-list
154549877|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154549878|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
154549879|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154549880|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154549881|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154549882|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154549883|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549884|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
154549885|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549886|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549887|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154549888|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154549889|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549890|NCT04907708|Metformin|metformin|mesh-list
154549891|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154549892|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549893|NCT04890626|Tenofovir|tenofovir|mesh-list
154549894|NCT04890626|Emtricitabine|emtricitabine|mesh-list
154549895|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154549896|NCT04890626|Dexamethasone|dexamethasone|mesh-list
154549897|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
154549898|NCT04890626|BB 1101|bb 1101|mesh-list
154549899|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549900|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
154549901|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
154549902|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549903|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549904|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154549905|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
154549906|NCT04890626|Hormones|hormones|mesh-ancestor
154549907|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154549908|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154549909|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549910|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
154549911|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549912|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549913|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
154549914|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549915|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154549916|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154549917|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154549918|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154549919|NCT04907864|Ibuprofen|ibuprofen|mesh-list
154549920|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154318926|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
154549921|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154549922|NCT04907864|Analgesics|analgesics|mesh-ancestor
154549923|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
154549924|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549925|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549926|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154549927|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154549928|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154549929|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549930|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549931|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154549932|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154549933|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549934|NCT04907474|Phenylephrine|phenylephrine|mesh-list
154549935|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
154549936|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154549937|NCT04907474|Tropicamide|tropicamide|mesh-list
154549938|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154549939|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154549940|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
154549941|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
154549942|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154549943|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549944|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
154549945|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154549946|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
154549947|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
154549948|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154549949|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154549950|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154549951|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
154549952|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549953|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549954|NCT04907474|Protective Agents|protective agents|mesh-ancestor
154549955|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154549956|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154549957|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
154549958|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
154549959|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154549960|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549961|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
154549962|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
154549963|NCT04890392|Tislelizumab|tislelizumab|mesh-list
154549964|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154549965|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154549966|NCT04890392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154549967|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549968|NCT02616614|Clindamycin|clindamycin|mesh-list
154549970|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
154549971|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154549972|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154549973|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154549974|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154549975|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549976|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549977|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
154549978|NCT04889768|Antibodies|antibodies|mesh-list
154549979|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
154549980|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549981|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
154549982|NCT04898270|Flupenthixol|flupenthixol|mesh-list
154549983|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154549984|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154549985|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154549986|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154549987|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154549988|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154549989|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
154549990|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154549991|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549992|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
154549993|NCT04906304|Cyclosporine|cyclosporine|mesh-list
154549994|NCT04906304|Everolimus|everolimus|mesh-list
154549995|NCT04906304|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154549996|NCT04906304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154549997|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154549998|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154549999|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550000|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
154550001|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550002|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550003|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154550004|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154550005|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
154550006|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154550007|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550008|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
154550009|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
154550010|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550011|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154550012|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154550013|NCT03051698|Metronidazole|metronidazole|mesh-list
154550014|NCT03051698|Vancomycin|vancomycin|mesh-list
154550015|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
154550016|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154550017|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550018|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154550019|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154550020|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154550021|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154550022|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550023|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550024|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550025|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154550026|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154550027|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154550028|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550029|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
154550030|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550031|NCT04887818|Lidocaine|lidocaine|mesh-list
154550032|NCT04887818|Diltiazem|diltiazem|mesh-list
154550033|NCT04887818|Nifedipine|nifedipine|mesh-list
154550034|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
154550035|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
154550036|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550037|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550038|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
154550039|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550040|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154550041|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154550042|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154550043|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154550044|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550045|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154550046|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154550047|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
154550048|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
154550049|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154550050|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154550051|NCT04883996|Pilocarpine|pilocarpine|mesh-list
154550052|NCT04883996|Miotics|miotics|mesh-ancestor
154550053|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
154550054|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550055|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550056|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154550057|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154550058|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
154550059|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550060|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550061|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
154550062|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154550063|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
154550064|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154550065|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550066|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
154550067|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
154550068|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154550069|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
154550070|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550071|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
154550072|NCT04884464|Protective Agents|protective agents|mesh-ancestor
154550073|NCT05028608|Carbamazepine|carbamazepine|mesh-list
154550074|NCT05028608|Midazolam|midazolam|mesh-list
154550075|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154550076|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154550077|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550078|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550079|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154550080|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154550081|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154550082|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154550083|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
154550084|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
154550085|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
154550086|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
154550087|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550088|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550089|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
154550090|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
154550091|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154550092|NCT05028608|Analgesics|analgesics|mesh-ancestor
154550093|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
154550094|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550095|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154550096|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154550097|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154550098|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154550099|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
154550100|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
154550101|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154550102|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154550103|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550104|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550105|NCT04882826|Urological Agents|urological agents|mesh-ancestor
154550106|NCT04309916|Esomeprazole|esomeprazole|mesh-list
154550107|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154550108|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154550109|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154550110|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550111|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550112|NCT01596062|Cyclosporine|cyclosporine|mesh-list
154550113|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
154550115|NCT01596062|Cyclosporins|cyclosporins|mesh-list
154550116|NCT01596062|Basiliximab|basiliximab|mesh-list
154550117|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550118|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550119|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550120|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
154550121|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550123|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319150|NCT02255266|Hormones|hormones|mesh-ancestor
154550124|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
154550125|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550126|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154550127|NCT01596062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154550128|NCT01596062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154550129|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550130|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154550131|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154550132|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
154550133|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154550134|NCT02614898|Eculizumab|eculizumab|mesh-list
154550135|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154550136|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550137|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
154550138|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550139|NCT02145091|Psilocybin|psilocybin|mesh-list
154550140|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154550141|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
154550142|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550143|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154550144|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154550145|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
154550146|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550147|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550148|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154550149|NCT03352934|Avelumab|avelumab|mesh-list
154550150|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154550151|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550152|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
154550153|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
154550154|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550155|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550156|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154550157|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
154550158|NCT04881110|Liraglutide|liraglutide|mesh-list
154550159|NCT04881110|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154550160|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154550161|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550162|NCT04881110|Incretins|incretins|mesh-ancestor
154550163|NCT04881110|Hormones|hormones|mesh-ancestor
154550164|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550165|NCT02152423|Enoxaparin|enoxaparin|mesh-list
154550166|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
154550167|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154550168|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154550169|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550170|NCT02145559|Metformin|metformin|mesh-list
154550171|NCT02145559|Sirolimus|sirolimus|mesh-list
154550172|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154550173|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550174|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154550175|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550176|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154550177|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550178|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
154550179|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550180|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
154550181|NCT02145637|Afatinib|afatinib|mesh-list
154550182|NCT02145637|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154550183|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154550184|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550185|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550186|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550187|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
154550188|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154550189|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
154550190|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550191|NCT03154580|Expectorants|expectorants|mesh-ancestor
154550192|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
154550193|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154550194|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
154385050|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550195|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550196|NCT03154580|Protective Agents|protective agents|mesh-ancestor
154550197|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550198|NCT03154580|Antidotes|antidotes|mesh-ancestor
154550199|NCT02145715|Thalidomide|thalidomide|mesh-list
154550200|NCT02145715|Dexamethasone|dexamethasone|mesh-list
154550202|NCT02145715|Panobinostat|panobinostat|mesh-list
154550203|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154550204|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
154550205|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
154550206|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550207|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550208|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154550209|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
154550210|NCT02145715|Hormones|hormones|mesh-ancestor
154550211|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550212|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154550213|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550214|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550215|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
154550216|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
154550217|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154550218|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550219|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154550220|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154550221|NCT02145715|Growth Substances|growth substances|mesh-ancestor
154550222|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
154550223|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154550224|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550225|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550226|NCT04871750|Caseins|caseins|mesh-list
154550227|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
154550228|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
154550229|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550230|NCT02152579|Isosorbide|isosorbide|mesh-list
154550231|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154550232|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154550233|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154550234|NCT02152579|Diuretics|diuretics|mesh-ancestor
154550235|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
154550236|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550237|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
154550238|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154550239|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550240|NCT02155777|Norinyl|norinyl|mesh-list
154550241|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154550242|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154550243|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154550244|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
154550245|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154550246|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550247|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154550248|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154550249|NCT02145949|Tryptophan|tryptophan|mesh-list
154550250|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154550251|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
154550252|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154550253|NCT00806390|Metoprolol|metoprolol|mesh-list
154550254|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154550255|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154550256|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
154550257|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
154550258|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550259|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550260|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154550261|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154550262|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154550263|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
154550264|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550265|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550266|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
154550267|NCT00566618|Dasatinib|dasatinib|mesh-list
154550268|NCT00566618|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154550269|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154550270|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550271|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550272|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550273|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154550274|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550275|NCT02769481|Glimepiride|glimepiride|mesh-list
154550276|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
154550277|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154550278|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154550279|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550280|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550281|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
154550283|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154550284|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154550285|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550286|NCT02152969|Amlodipine|amlodipine|mesh-list
154550287|NCT02152969|Telmisartan|telmisartan|mesh-list
154550288|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
154550289|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154550290|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154550291|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154550292|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550293|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154550294|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550295|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
154550296|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154550297|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154550298|NCT02152969|Diuretics|diuretics|mesh-ancestor
154550299|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
154550300|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154550301|NCT04879004|Ropivacaine|ropivacaine|mesh-list
154550302|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
154550303|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
154550304|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550305|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550306|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
154550307|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550308|NCT02153125|Eplerenone|eplerenone|mesh-list
154550309|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154550310|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
154550311|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550312|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550313|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154550314|NCT02153125|Diuretics|diuretics|mesh-ancestor
154550315|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
154550316|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154550317|NCT04878926|Midazolam|midazolam|mesh-list
154550318|NCT04878926|Propofol|propofol|mesh-list
154550319|NCT04878926|Anesthetics|anesthetics|mesh-list
154550320|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
154550321|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154550322|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550323|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550324|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154550325|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
154550326|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154550327|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154550328|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154550329|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154550330|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
154550331|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
154550332|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550333|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550334|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
154550335|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550336|NCT02146261|Quetmolimab|quetmolimab|mesh-list
154550337|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550338|NCT02153281|Phenelzine|phenelzine|mesh-list
154550339|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
154550340|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154550341|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154550342|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550343|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550344|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
154860297|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550345|NCT03542851|Convulsants|convulsants|mesh-ancestor
154550346|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154550347|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550348|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
154550349|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
154550350|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550351|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550352|NCT02769247|Naproxen|naproxen|mesh-list
154550353|NCT02769247|Lidocaine|lidocaine|mesh-list
154550354|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
154550355|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
154550356|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550357|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550358|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
154550359|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550360|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154550361|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154550362|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154550363|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154550364|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550365|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154550366|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154550367|NCT02769247|Analgesics|analgesics|mesh-ancestor
154550368|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154550369|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550370|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
154550371|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154550372|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550373|NCT02146651|Insulin|insulin|mesh-list
154550374|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154550375|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
154550376|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154550377|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550378|NCT03542149|Tocopherols|tocopherols|mesh-list
154550379|NCT03542149|Vitamin E|vitamin e|mesh-list
154550380|NCT03542149|Tocotrienols|tocotrienols|mesh-list
154550381|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
154550382|NCT03542149|Piperaquine|piperaquine|mesh-list
154550383|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
154550384|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154550385|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154550386|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550387|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
154550388|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550389|NCT03542149|Protective Agents|protective agents|mesh-ancestor
154550390|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550391|NCT03542149|Vitamins|vitamins|mesh-ancestor
154550392|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
154550393|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
154550394|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154550395|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154550396|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154550397|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550398|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
154550399|NCT02153593|Coagulants|coagulants|mesh-ancestor
154550400|NCT02154217|Timolol|timolol|mesh-list
154550401|NCT02154217|Bimatoprost|bimatoprost|mesh-list
154550402|NCT02154217|Latanoprost|latanoprost|mesh-list
154550403|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154550404|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154274244|NCT05594472|Gentamicins|gentamicins|mesh-list
154550406|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550407|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550408|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550409|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154550410|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154550411|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154550412|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154550413|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154550414|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
154550415|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550416|NCT02147041|Protective Agents|protective agents|mesh-ancestor
154550417|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550418|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154550419|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154550420|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550421|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154550423|NCT02767765|Hematinics|hematinics|mesh-ancestor
154550424|NCT02147431|Semaglutide|semaglutide|mesh-list
154550425|NCT02147431|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154550426|NCT02147431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154550427|NCT02147431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550428|NCT00103207|Cetuximab|cetuximab|mesh-list
154550429|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154550430|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550431|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
154550432|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154550433|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
154550434|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550435|NCT02157181|Rituximab|rituximab|mesh-list
154550436|NCT02157181|Cladribine|cladribine|mesh-list
154550437|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154550438|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550439|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
154550440|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550441|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550442|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550443|NCT02159287|Heparin|heparin|mesh-list
154550444|NCT02159287|Calcium heparin|calcium heparin|mesh-list
154550445|NCT02159287|Enoxaparin|enoxaparin|mesh-list
154550446|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
154550447|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
154550448|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154550449|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154550450|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550451|NCT02157337|Atorvastatin|atorvastatin|mesh-list
154550452|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154550453|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154550454|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
154550455|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550456|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154550457|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154550458|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550459|NCT02159599|Ritonavir|ritonavir|mesh-list
154550460|NCT02159599|Darunavir|darunavir|mesh-list
154550461|NCT02159599|Tenofovir|tenofovir|mesh-list
154550462|NCT02159599|Lamivudine|lamivudine|mesh-list
154550463|NCT02159599|Emtricitabine|emtricitabine|mesh-list
154550464|NCT02159599|Abacavir|abacavir|mesh-list
154550465|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154550466|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154550467|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
154550468|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550469|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550470|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154550471|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154550472|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
154550473|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550474|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154550475|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154550476|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154550477|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154550478|NCT03541681|Anesthetics|anesthetics|mesh-list
154550479|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
154550480|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550481|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550482|NCT03541681|Hormones|hormones|mesh-ancestor
154550483|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550484|NCT02157415|Polihexanide|polihexanide|mesh-list
154550485|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
154550486|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550487|NCT02157571|Levofloxacin|levofloxacin|mesh-list
154550488|NCT02157571|Ofloxacin|ofloxacin|mesh-list
154550489|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
154550490|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
154550491|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154550492|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550493|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154550494|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154550495|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154550496|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550497|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550498|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550499|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154550500|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154550501|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154550502|NCT01369355|Ustekinumab|ustekinumab|mesh-list
154550503|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
154550504|NCT03541993|Resveratrol|resveratrol|mesh-list
154550505|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
154550506|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550507|NCT03541993|Protective Agents|protective agents|mesh-ancestor
154550508|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550509|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550510|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154550511|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
154550512|NCT02157649|Codeine|codeine|mesh-list
154550513|NCT02157649|Guaifenesin|guaifenesin|mesh-list
154550514|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154550515|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154550516|NCT02157649|Narcotics|narcotics|mesh-ancestor
154550517|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550518|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550519|NCT02157649|Analgesics|analgesics|mesh-ancestor
154550520|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
154550521|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550522|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
154550523|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
154550524|NCT02157649|Expectorants|expectorants|mesh-ancestor
154550525|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154550526|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154550527|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
154550528|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550529|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550530|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
154550531|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154550532|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
154550533|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
154550534|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
154550535|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154550536|NCT02159911|Misoprostol|misoprostol|mesh-list
154550537|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154550538|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
154550539|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154550540|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550541|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154550542|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154550543|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
154550544|NCT03542617|Dexamethasone|dexamethasone|mesh-list
154550545|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154550546|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
154550547|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
154550548|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550549|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550550|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154550551|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
154550552|NCT03542617|Hormones|hormones|mesh-ancestor
154550553|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550554|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154550555|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550556|NCT04878770|Cyclosporine|cyclosporine|mesh-list
154550557|NCT04878770|Cyclosporins|cyclosporins|mesh-list
154550558|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550559|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550560|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154550561|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
154550562|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550563|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
154550564|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550565|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
154550566|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550567|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154550568|NCT02086019|Ramipril|ramipril|mesh-list
154550569|NCT02086019|Bisoprolol|bisoprolol|mesh-list
154550570|NCT02086019|Heparin|heparin|mesh-list
154550571|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154550572|NCT02086019|Tinzaparin|tinzaparin|mesh-list
154550573|NCT02086019|Dalteparin|dalteparin|mesh-list
154550574|NCT02086019|Clopidogrel|clopidogrel|mesh-list
154550575|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154550576|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550577|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550578|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154550579|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154550580|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550581|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154550582|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550583|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154550584|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154550585|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154550586|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
154550587|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550588|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
154550589|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
154550590|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154550591|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154550592|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154550593|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
154550594|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
154550595|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
154550596|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154550597|NCT02086097|Ibuprofen|ibuprofen|mesh-list
154550598|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154550599|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154550600|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154550601|NCT02086097|Analgesics|analgesics|mesh-ancestor
154550602|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
154550603|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550604|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550605|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154550606|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550607|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154550608|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550609|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550610|NCT02307682|Aflibercept|aflibercept|mesh-list
154550611|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154550612|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154550613|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154550614|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154550615|NCT02307682|Growth Substances|growth substances|mesh-ancestor
154550616|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550617|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
154550618|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550619|NCT02088515|Docetaxel|docetaxel|mesh-list
154550620|NCT02088515|Nedaplatin|nedaplatin|mesh-list
154550621|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550622|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
154550623|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
154550624|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
154550625|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550626|NCT02086253|BQ 788|bq 788|mesh-list
154550627|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154550628|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154550629|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550630|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154550631|NCT04870502|Clomiphene|clomiphene|mesh-list
154550632|NCT04870502|Enclomiphene|enclomiphene|mesh-list
154550634|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154550635|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
154550636|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550637|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550638|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154550639|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
154550640|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154550641|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154550642|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154550643|NCT02088671|Propofol|propofol|mesh-list
154550644|NCT02088671|Desflurane|desflurane|mesh-list
154550645|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154550646|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550647|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550648|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154550649|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
154550651|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154550652|NCT04870190|Osimertinib|osimertinib|mesh-list
154550653|NCT04870190|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154550654|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154550655|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550656|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550657|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550658|NCT03049046|Caffeic acid|caffeic acid|mesh-list
154550659|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
154550660|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550661|NCT03049046|Protective Agents|protective agents|mesh-ancestor
154550662|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550663|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
154550664|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
154550665|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
154550666|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550667|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550668|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
154550669|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550670|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154550671|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550672|NCT03048110|Itraconazole|itraconazole|mesh-list
154550673|NCT03048110|Rifampin|rifampin|mesh-list
154550674|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
154550675|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550676|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154550677|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154550678|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550679|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550680|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154550681|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
154550682|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550683|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550684|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154550685|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154550686|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
154550687|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154550688|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
154550689|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154550690|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154550691|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154550692|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154550693|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154550694|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154550695|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154550696|NCT05256758|Fenofibrate|fenofibrate|mesh-list
154550697|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154550698|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
154550699|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550700|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154550701|NCT02791763|Glycine|glycine|mesh-list
154550702|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
154550703|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550704|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550705|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550706|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
154550707|NCT02086409|Vitamin D|vitamin d|mesh-list
154550708|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
154550709|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
154550710|NCT02086409|Vitamins|vitamins|mesh-list
154550711|NCT02086409|Calcium|calcium|mesh-list
154550712|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
154550713|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550714|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154550715|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154550716|NCT02086487|Nilotinib|nilotinib|mesh-list
154550717|NCT02086487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154550718|NCT02086487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154550719|NCT02086487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550720|NCT02086487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550721|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
154550722|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
154550723|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550724|NCT02613572|Protective Agents|protective agents|mesh-ancestor
154550725|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550726|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
154550728|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
154550729|NCT02088983|Choline|choline|mesh-list
154550730|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154550731|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
154550732|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154550733|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
154550734|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550735|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154550736|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154550737|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
154550738|NCT02089061|Atorvastatin|atorvastatin|mesh-list
154550739|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154550740|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154550741|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154550742|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
154550743|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550744|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154550745|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154550746|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550747|NCT02082665|Dabrafenib|dabrafenib|mesh-list
154550748|NCT02082665|Midazolam|midazolam|mesh-list
154550749|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154550750|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154550751|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154550752|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550753|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550754|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154550755|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154550756|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154550757|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154550758|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
154550759|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
154550760|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
154550761|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
154550762|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550763|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550764|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154550765|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154550766|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
154550767|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154550768|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154550769|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550770|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550771|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154550772|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
154550773|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154550774|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
154550775|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550776|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
154550777|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154550778|NCT02341456|Paclitaxel|paclitaxel|mesh-list
154274616|NCT05796362|Azithromycin|azithromycin|mesh-list
154550779|NCT02341456|Carboplatin|carboplatin|mesh-list
154550780|NCT02341456|Adavosertib|adavosertib|mesh-list
154550781|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154550783|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
154550784|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
154550785|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
154550786|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550787|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550788|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
154550789|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
154550790|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154550791|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550792|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550793|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154550794|NCT02083055|Analgesics|analgesics|mesh-ancestor
154550795|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
154550796|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550797|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154550798|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154550799|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154550800|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
154550801|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550802|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550803|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
154550805|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154550806|NCT02089295|Narcotics|narcotics|mesh-ancestor
154550807|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550808|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550809|NCT02089295|Analgesics|analgesics|mesh-ancestor
154550810|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
154550811|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550812|NCT02370784|Atorvastatin|atorvastatin|mesh-list
154550813|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154550814|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154550815|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
154550816|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550817|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154550818|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154550819|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550820|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
154550821|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154550822|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550823|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
154550824|NCT01595438|Ceftazidime|ceftazidime|mesh-list
154550825|NCT01595438|Avibactam|avibactam|mesh-list
154550826|NCT01595438|Doripenem|doripenem|mesh-list
154550827|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154550828|NCT01595438|Trimethoprim|trimethoprim|mesh-list
154550829|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
154550830|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154550831|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550832|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154550833|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154550834|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550835|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550836|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550837|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154550838|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154550839|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154550840|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
154550841|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154550842|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154550843|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154550844|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154550845|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154550846|NCT01595438|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154550847|NCT01595438|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154550848|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154550849|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
154550850|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154550851|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550852|NCT02340520|Theophylline|theophylline|mesh-list
154550853|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154550854|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
154550855|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550856|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550857|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154550858|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
154550859|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154550860|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550861|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550862|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
154550863|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154550864|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154550865|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
154550866|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550867|NCT02087579|Olanzapine|olanzapine|mesh-list
154550868|NCT02087579|Risperidone|risperidone|mesh-list
154550869|NCT02087579|Aripiprazole|aripiprazole|mesh-list
154550870|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154550871|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154550872|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154550873|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
154550875|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550876|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550877|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154550878|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154550879|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550880|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154550881|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154550882|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
154550883|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
154550884|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
154550885|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550886|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154550887|NCT02087579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154550888|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154550889|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154550890|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
154550891|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
154550892|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154550893|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154550894|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154550895|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154550896|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154550897|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154550898|NCT02339584|Brinzolamide|brinzolamide|mesh-list
154550899|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154550900|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154550901|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154550902|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154550903|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154550904|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
154550905|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550906|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550907|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550908|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154550909|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550910|NCT02339506|Cosyntropin|cosyntropin|mesh-list
154550911|NCT02339506|Hormones|hormones|mesh-ancestor
154550912|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550913|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550914|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
154550915|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154550916|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
154550917|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154550918|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
154550919|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154550920|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
154550921|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
154550922|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550923|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550924|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154550925|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
154550926|NCT02087813|Hormones|hormones|mesh-ancestor
154550927|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154550928|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154550929|NCT02087813|Protective Agents|protective agents|mesh-ancestor
154550930|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154550931|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550932|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550933|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550934|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154550935|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154550936|NCT02089529|Ibuprofen|ibuprofen|mesh-list
154550937|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154550938|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154550939|NCT02089529|Analgesics|analgesics|mesh-ancestor
154550940|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
154550941|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550942|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550943|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154550944|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550945|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154550946|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550947|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550948|NCT02090933|Celecoxib|celecoxib|mesh-list
154550949|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154550950|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154550951|NCT02090933|Analgesics|analgesics|mesh-ancestor
154550952|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
154550953|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550954|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550955|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154550956|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154550957|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154550958|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154550959|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154550960|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550961|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
154550962|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154550963|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154550964|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550965|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154550966|NCT03046238|Analgesics|analgesics|mesh-ancestor
154550967|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
154550968|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154550969|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154550970|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154550971|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154550972|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
154550973|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154550974|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550975|NCT02089763|BCT-100|bct-100|mesh-list
154550976|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550977|NCT02089841|Lumefantrine|lumefantrine|mesh-list
154550978|NCT02089841|Artemether|artemether|mesh-list
154550979|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154550980|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
154550981|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154550982|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154550983|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154550984|NCT03045770|Leucovorin|leucovorin|mesh-list
154550985|NCT03045770|Paclitaxel|paclitaxel|mesh-list
154550986|NCT03045770|Fluorouracil|fluorouracil|mesh-list
154550987|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
154550988|NCT03045770|Irinotecan|irinotecan|mesh-list
154550989|NCT03045770|Calcium|calcium|mesh-list
154550990|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
154550991|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154550992|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154550993|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
154550994|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
154550995|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
154550996|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154550997|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154550998|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154550999|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
154551000|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154551001|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154551002|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
154551003|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154551004|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154551005|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551006|NCT03045770|Antidotes|antidotes|mesh-ancestor
154551007|NCT03045770|Protective Agents|protective agents|mesh-ancestor
154551008|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
154551009|NCT03045770|Vitamins|vitamins|mesh-ancestor
154551010|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
154551011|NCT02095847|Proflavine|proflavine|mesh-list
154551012|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154551013|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551014|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
154551015|NCT02091401|Analgesics|analgesics|mesh-ancestor
154551016|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
154551017|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551018|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551019|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
154551020|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551021|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154551022|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
154551023|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154551024|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154551025|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551026|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154551027|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
154551028|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154551029|NCT01594970|Bimatoprost|bimatoprost|mesh-list
154551030|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154551031|NCT04869176|Caffeine|caffeine|mesh-list
154551032|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
154551033|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551034|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154551035|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551036|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154551037|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551038|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154551039|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154551040|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
154551041|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551042|NCT03557255|Simendan|simendan|mesh-list
154551043|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154551044|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
154551045|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154551046|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154551047|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551048|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551049|NCT03557255|Protective Agents|protective agents|mesh-ancestor
154551050|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551051|NCT04868552|Naloxone|naloxone|mesh-list
154551052|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154551053|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551054|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
154551055|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551056|NCT02090153|Leucovorin|leucovorin|mesh-list
154551057|NCT02090153|Tegafur|tegafur|mesh-list
154551058|NCT02090153|Antidotes|antidotes|mesh-ancestor
154551059|NCT02090153|Protective Agents|protective agents|mesh-ancestor
154551060|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551061|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
154551062|NCT02090153|Vitamins|vitamins|mesh-ancestor
154551063|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
154551064|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154551065|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
154551066|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551067|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551068|NCT00358163|Paclitaxel|paclitaxel|mesh-list
154551069|NCT00358163|Vatalanib|vatalanib|mesh-list
154551070|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154551071|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551072|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154551073|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154551074|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154551075|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551076|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154551077|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551078|NCT02096315|Murepavadin|murepavadin|mesh-list
154551079|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274916|NCT05840835|Tislelizumab|tislelizumab|mesh-list
154551080|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551081|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
154551082|NCT02337946|Leucovorin|leucovorin|mesh-list
154551083|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
154551084|NCT02337946|Fluorouracil|fluorouracil|mesh-list
154551085|NCT02337946|Panitumumab|panitumumab|mesh-list
154551086|NCT02337946|Calcium|calcium|mesh-list
154551087|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
154551088|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154551089|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551090|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154551091|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551092|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
154551093|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551094|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154551095|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154551096|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
154551097|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154551099|NCT02337946|Protective Agents|protective agents|mesh-ancestor
154551100|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
154551101|NCT02337946|Vitamins|vitamins|mesh-ancestor
154551102|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
154551103|NCT04865510|Heparin|heparin|mesh-list
154551104|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
154551105|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551106|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154551107|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154551108|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
154551109|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154551110|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
154551111|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154551112|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
154551113|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551114|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
154551115|NCT03047096|Protective Agents|protective agents|mesh-ancestor
154551116|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
154551117|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
154551118|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154551119|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
154551120|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154551121|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
154551122|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551123|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551124|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
154551125|NCT02093195|Bosentan|bosentan|mesh-list
154551126|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154551127|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154551128|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
154551129|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154551130|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154551131|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551132|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
154551133|NCT03555617|Itraconazole|itraconazole|mesh-list
154551134|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
154551135|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551136|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154551137|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154551138|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551139|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551140|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154551141|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
154551142|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154551143|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551144|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154551145|NCT02098889|Scopolamine|scopolamine|mesh-list
154551146|NCT02098889|Bromides|bromides|mesh-list
154551147|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154551148|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
154551149|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154551150|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
154551151|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
154551152|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551153|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551154|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154551155|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
154551156|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154551157|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
154551158|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551159|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551160|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154551161|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
154551162|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154551163|NCT01369199|Entecavir|entecavir|mesh-list
154551164|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
154551165|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551166|NCT02097173|Methotrexate|methotrexate|mesh-list
154551167|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154551168|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
154551169|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154551170|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551171|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154551172|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
154551173|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551174|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551175|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
154551176|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551177|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154551178|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154551179|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
154551180|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154551181|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154551182|NCT02097329|Palbociclib|palbociclib|mesh-list
154551183|NCT02097329|Rabeprazole|rabeprazole|mesh-list
154551184|NCT02097329|Famotidine|famotidine|mesh-list
154551185|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
154551186|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
154551187|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154551188|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154551189|NCT02097329|Antacids|antacids|mesh-list
154551190|NCT02097329|TEMPO|tempo|mesh-list
154551191|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551192|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154551193|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551194|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551195|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154551196|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154551197|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154551198|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
154551199|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
154551200|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551201|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551202|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
154551203|NCT02097329|Protective Agents|protective agents|mesh-ancestor
154551204|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154551205|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
154551206|NCT02093585|Tenofovir|tenofovir|mesh-list
154551207|NCT02093585|Abacavir|abacavir|mesh-list
154551208|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
154551209|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551210|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154551211|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154551212|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551213|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551214|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154551215|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154551216|NCT02099357|Vitamin D|vitamin d|mesh-list
154551217|NCT02099357|Vitamins|vitamins|mesh-ancestor
154551218|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
154551219|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551220|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154551221|NCT02093741|Factor VIII|factor viii|mesh-list
154551222|NCT02093741|Coagulants|coagulants|mesh-ancestor
154551223|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
154551224|NCT02097407|Propofol|propofol|mesh-list
154551225|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154551226|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551227|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551228|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154551229|NCT02097407|Analgesics|analgesics|mesh-ancestor
154551230|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
154551231|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551232|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154275070|NCT05702671|Antibodies|antibodies|mesh-list
154551233|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154551234|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154551235|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
154551236|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551237|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551238|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154551239|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
154551241|NCT02250599|Paclitaxel|paclitaxel|mesh-list
154551242|NCT02250599|Bevacizumab|bevacizumab|mesh-list
154551243|NCT02250599|Carboplatin|carboplatin|mesh-list
154551244|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154551245|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551246|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
154551247|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
154551248|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
154551249|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551250|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154551251|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154551252|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154551253|NCT02250599|Growth Substances|growth substances|mesh-ancestor
154551254|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551255|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
154551256|NCT02094053|Donepezil|donepezil|mesh-list
154551257|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154551258|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551259|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551260|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
154551261|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551262|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551263|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
154551264|NCT03555929|Dexamethasone|dexamethasone|mesh-list
154551265|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154551266|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
154551267|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
154551268|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551269|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551270|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154551271|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
154551272|NCT03555929|Hormones|hormones|mesh-ancestor
154551273|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154551274|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154551275|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551276|NCT02099981|Pimagedine|pimagedine|mesh-list
154551277|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551278|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551279|NCT02250209|Capecitabine|capecitabine|mesh-list
154551280|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
154551281|NCT02250209|Trastuzumab|trastuzumab|mesh-list
154551282|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154551283|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
154551284|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551285|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551286|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154551287|NCT02097953|Rifampin|rifampin|mesh-list
154551288|NCT02097953|Daptomycin|daptomycin|mesh-list
154551289|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154551290|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
154551291|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154551292|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551293|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
154551294|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154551295|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551296|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551297|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154551298|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154551299|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154551300|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154551301|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154551302|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154551303|NCT02094287|Dimethindene|dimethindene|mesh-list
154551304|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
154551305|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
154551306|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154551307|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
154551308|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
154551309|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551310|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551311|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551312|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154551313|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
154551314|NCT02100293|Analgesics|analgesics|mesh-ancestor
154551315|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
154551316|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551317|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551318|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
154551319|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551320|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154551321|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
154551322|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154860298|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551323|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154551324|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551325|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154551326|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
154551327|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154551328|NCT02094599|Dronabinol|dronabinol|mesh-list
154551329|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
154551330|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551331|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154551332|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154551333|NCT02094599|Analgesics|analgesics|mesh-ancestor
154551334|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
154551335|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551336|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154551337|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154551338|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551339|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551340|NCT02094599|Hormones|hormones|mesh-ancestor
154551341|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154551342|NCT02094833|Vaccines|vaccines|mesh-list
154551343|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
154551344|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551345|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
154551346|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
154551347|NCT02100605|Ephedrine|ephedrine|mesh-list
154551348|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154551349|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
154551350|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154551351|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551352|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
154551353|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
154551354|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551355|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
154551356|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551357|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551358|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154551359|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154551360|NCT02100761|Voriconazole|voriconazole|mesh-list
154551361|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
154551362|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551363|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154551364|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154551365|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551366|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551367|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154551368|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
154551369|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154551370|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551371|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154551372|NCT02100917|Trastuzumab|trastuzumab|mesh-list
154551373|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154551374|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551375|NCT02098421|Oxytocin|oxytocin|mesh-list
154551376|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
154551377|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154551378|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551379|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
154551381|NCT02098499|Haloperidol|haloperidol|mesh-list
154551382|NCT02098499|Metoclopramide|metoclopramide|mesh-list
154551383|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
154551384|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154551385|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154551386|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551387|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551388|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
154551389|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
154551390|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
154551391|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551392|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
154551393|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
154551394|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154551395|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154551396|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
154551397|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
154551398|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551399|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551400|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154551401|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
154320434|NCT02171416|Rilonacept|rilonacept|mesh-list
154551402|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
154551403|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154551404|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154551405|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154551406|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154551407|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
154551408|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154551409|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154551411|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
154551412|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
154551413|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551414|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551415|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
154551416|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551417|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154551418|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154551419|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154551420|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154551421|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551422|NCT03555383|Hemostatics|hemostatics|mesh-list
154551423|NCT03555383|Coagulants|coagulants|mesh-ancestor
154551424|NCT02101151|Vitamin D|vitamin d|mesh-list
154551425|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
154551426|NCT02101151|Vitamins|vitamins|mesh-ancestor
154551427|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
154551428|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551429|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154551430|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154551431|NCT02101229|Insulin|insulin|mesh-list
154551432|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154551433|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154551434|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551435|NCT02102555|Acetaminophen|acetaminophen|mesh-list
154551436|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154551437|NCT02102555|Analgesics|analgesics|mesh-ancestor
154551438|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
154551439|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551440|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551441|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
154551442|NCT02102633|Dabigatran|dabigatran|mesh-list
154551443|NCT02102633|Bosutinib|bosutinib|mesh-list
154551444|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
154551445|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154551446|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
154551447|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551448|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551449|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
154551450|NCT02102633|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154551451|NCT02102633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154551452|NCT02102711|Vitamin A|vitamin a|mesh-list
154551453|NCT02102711|Vitamins|vitamins|mesh-ancestor
154275295|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
154551454|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
154551455|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551456|NCT02106767|Rifampin|rifampin|mesh-list
154551457|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154551458|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154551459|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154551460|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
154551461|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551462|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154551463|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154551464|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551465|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154551466|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
154551467|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154551468|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551469|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
154551470|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154551471|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154551472|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154551473|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154551474|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154551475|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154551476|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154551479|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
154551480|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551481|NCT02103023|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154320518|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320519|NCT02171728|Afatinib|afatinib|mesh-list
154320520|NCT02171728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154320521|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154551482|NCT02103023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551483|NCT02103023|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154551484|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154551485|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551486|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
154551487|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154551488|NCT02101931|Levulinic acid|levulinic acid|mesh-list
154551489|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154551490|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
154551491|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551492|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551493|NCT02106845|Digoxin|digoxin|mesh-list
154551494|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154551495|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154551496|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154551497|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
154551498|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551499|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154551500|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154551501|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551502|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154551503|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154551504|NCT02106845|Protective Agents|protective agents|mesh-ancestor
154551505|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551506|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
154551507|NCT03554447|Dexetimide|dexetimide|mesh-list
154551508|NCT03554447|Citalopram|citalopram|mesh-list
154551509|NCT03554447|Escitalopram|escitalopram|mesh-list
154551510|NCT03554447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154551511|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154551512|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154551513|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551514|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551515|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
154551516|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551517|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154551518|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154551519|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
154551520|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
154551521|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551522|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154551523|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154551524|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
154551525|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154551526|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
154551527|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154551528|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154551529|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551530|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154551531|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154551533|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
154551534|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154551535|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
154551536|NCT02103335|Dexamethasone|dexamethasone|mesh-list
154551537|NCT02103335|Pomalidomide|pomalidomide|mesh-list
154551538|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154551539|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
154551540|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
154551541|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551542|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551543|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154551544|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
154551545|NCT02103335|Hormones|hormones|mesh-ancestor
154551546|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154551547|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154551548|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551549|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
154551550|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154551551|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154551552|NCT02103335|Growth Substances|growth substances|mesh-ancestor
154551553|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
154551554|NCT02610140|Vinorelbine|vinorelbine|mesh-list
154551555|NCT02610140|Maytansine|maytansine|mesh-list
154551556|NCT02610140|Anetumab ravtansine|anetumab ravtansine|mesh-list
154551557|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154551558|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551559|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
154551560|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
154551561|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
154551562|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551563|NCT02610140|Immunoconjugates|immunoconjugates|mesh-ancestor
154551564|NCT02610140|Immunologic Factors|immunologic factors|mesh-ancestor
154551565|NCT02610140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551566|NCT02102321|Albendazole|albendazole|mesh-list
154551567|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
154551568|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154551569|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551570|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
154551571|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154551572|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154551573|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
154551574|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
154551575|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
154551576|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551577|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551578|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154551579|NCT02103569|Norethindrone|norethindrone|mesh-list
154551580|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
154551581|NCT02103569|Estradiol|estradiol|mesh-list
154551582|NCT02103569|Asunaprevir|asunaprevir|mesh-list
154551583|NCT02103569|Estrogens|estrogens|mesh-ancestor
154551584|NCT02103569|Hormones|hormones|mesh-ancestor
154551585|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154551586|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551587|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154551588|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
154551589|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154551590|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154551591|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154551592|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154551593|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154551594|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
154551595|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551596|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551597|NCT02103647|Pregabalin|pregabalin|mesh-list
154551598|NCT02103647|Analgesics|analgesics|mesh-ancestor
154551599|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
154551600|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551601|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551602|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
154551603|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154551604|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154275441|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
154551605|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551606|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154551607|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154551608|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154551609|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551610|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154551611|NCT02109965|Midazolam|midazolam|mesh-list
154551612|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
154551613|NCT02109965|Propofol|propofol|mesh-list
154551614|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154551615|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551616|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551617|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154551618|NCT02109965|Analgesics|analgesics|mesh-ancestor
154551619|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
154551620|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551621|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154551622|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154551623|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154551624|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
154551625|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551626|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551627|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154551628|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
154551629|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
154551630|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154551631|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154551632|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154551633|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154551634|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
154551635|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
154551636|NCT02789657|Paclitaxel|paclitaxel|mesh-list
154551637|NCT02789657|Carboplatin|carboplatin|mesh-list
154551638|NCT02789657|Trastuzumab|trastuzumab|mesh-list
154551639|NCT02789657|Pertuzumab|pertuzumab|mesh-list
154551640|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154551641|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551642|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
154551643|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
154551644|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
154551645|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551646|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154551647|NCT03555071|Vaccines|vaccines|mesh-list
154551648|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
154551649|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551650|NCT02609984|Atezolizumab|atezolizumab|mesh-list
154551651|NCT02609984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154551652|NCT02609984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551653|NCT02609984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154551654|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551655|NCT02107079|Melatonin|melatonin|mesh-list
154551656|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
154551657|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551658|NCT02107079|Protective Agents|protective agents|mesh-ancestor
154551659|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551660|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551661|NCT02107235|ON 01910|on 01910|mesh-list
154551662|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551663|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154551664|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551665|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551666|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
154551667|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154551668|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154551669|NCT02103725|Analgesics|analgesics|mesh-ancestor
154551670|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
154551671|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551672|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551673|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154551674|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154551675|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
154551676|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154551677|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
154551678|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154551679|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551680|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551681|NCT03042260|Trimethoprim|trimethoprim|mesh-list
154551682|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154551683|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
154551684|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154551685|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551686|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
154551687|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154551688|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154551689|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154551690|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551691|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551692|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154551693|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154551694|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154551695|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154551696|NCT02110355|Trametinib|trametinib|mesh-list
154551697|NCT02110355|Dabrafenib|dabrafenib|mesh-list
154551698|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551700|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551701|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551702|NCT02107391|Leuprolide|leuprolide|mesh-list
154551703|NCT02107391|Goserelin|goserelin|mesh-list
154551704|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154551705|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
154320730|NCT02173288|Tolvaptan|tolvaptan|mesh-list
154551706|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154551707|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551708|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154551709|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551710|NCT02103881|Ketamine|ketamine|mesh-list
154551711|NCT02103881|Haloperidol|haloperidol|mesh-list
154551712|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
154551713|NCT02103881|Analgesics|analgesics|mesh-ancestor
154551714|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
154551715|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551716|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551717|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154551718|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154551719|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
154551720|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
154551721|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551722|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154551723|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154551724|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551725|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551726|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
154551727|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
154551728|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154551729|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154551730|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154551731|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154551732|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154551733|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
154551734|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154551735|NCT03554915|Midazolam|midazolam|mesh-list
154551736|NCT03554915|Ketamine|ketamine|mesh-list
154551737|NCT03554915|Analgesics|analgesics|mesh-ancestor
154551738|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
154551739|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551740|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551741|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154551742|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154551743|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
154551744|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
154551745|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551746|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154551747|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154551748|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551749|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551750|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154551751|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154551752|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154551753|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154551754|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154551755|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
154551756|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
154551757|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
154551758|NCT03044522|Narcotics|narcotics|mesh-ancestor
154551759|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551760|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551761|NCT03044522|Analgesics|analgesics|mesh-ancestor
154551762|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
154551763|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551764|NCT03044366|Anesthetics|anesthetics|mesh-list
154551765|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551766|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551767|NCT02250833|Amlodipine|amlodipine|mesh-list
154551768|NCT02250833|Telmisartan|telmisartan|mesh-list
154551769|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154551770|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154551771|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154551772|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551773|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154551774|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551775|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
154551776|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154551777|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154551778|NCT02110745|Propofol|propofol|mesh-list
154551779|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154551780|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551781|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551782|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154551783|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
154551784|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
154551785|NCT03041948|Acetaminophen|acetaminophen|mesh-list
154551786|NCT03041948|Dexamethasone|dexamethasone|mesh-list
154551787|NCT03041948|Ketorolac|ketorolac|mesh-list
154551788|NCT03041948|Morphine|morphine|mesh-list
154551789|NCT03041948|Remifentanil|remifentanil|mesh-list
154551790|NCT03041948|Ondansetron|ondansetron|mesh-list
154551791|NCT03041948|Propofol|propofol|mesh-list
154551792|NCT03041948|Sevoflurane|sevoflurane|mesh-list
154551793|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154551794|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
154551795|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
154551796|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551797|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551798|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154551799|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
154551800|NCT03041948|Hormones|hormones|mesh-ancestor
154551801|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154320829|NCT02255812|Quinine|quinine|mesh-list
154551802|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154551803|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551804|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154551805|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551806|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154551807|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
154551808|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
154551809|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154551810|NCT03041948|Narcotics|narcotics|mesh-ancestor
154551811|NCT03041948|Analgesics|analgesics|mesh-ancestor
154551812|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
154551813|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154551814|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
154551815|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154551816|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154551817|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
154551818|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
154551819|NCT03041948|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154551820|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154551821|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
154551822|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154551823|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551824|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154551825|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154551826|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154551827|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551828|NCT02104193|Simvastatin|simvastatin|mesh-list
154551829|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154551830|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154551831|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
154551832|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551833|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154551834|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154551835|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551836|NCT03042182|Vaccines|vaccines|mesh-list
154551837|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
154551838|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551839|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
154551840|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
154551841|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154551842|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154551843|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154551844|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551845|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154551846|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154860299|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154551847|NCT02611778|Ranibizumab|ranibizumab|mesh-list
154551848|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154551849|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154551851|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551852|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
154551853|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551854|NCT04867226|Colchicine|colchicine|mesh-list
154551855|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
154551856|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154551857|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
154551858|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
154551859|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
154551860|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551861|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551862|NCT04856852|Iodine|iodine|mesh-list
154551863|NCT04856852|Temozolomide|temozolomide|mesh-list
154551864|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154551865|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
154551866|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551867|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551868|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154551869|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154551870|NCT04856852|Trace Elements|trace elements|mesh-ancestor
154551871|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
154551872|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551873|NCT01453179|Diclofenac|diclofenac|mesh-list
154551874|NCT01453179|Imiquimod|imiquimod|mesh-list
154551875|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154551876|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154551877|NCT01453179|Analgesics|analgesics|mesh-ancestor
154551878|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
154551879|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551880|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551881|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154551882|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154551883|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154551884|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551885|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551886|NCT01453179|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154551887|NCT01453179|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154551888|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
154551889|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154551890|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551891|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
154551892|NCT03192033|Hemostatics|hemostatics|mesh-list
154551893|NCT03192033|Coagulants|coagulants|mesh-ancestor
154551894|NCT06100796|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154551895|NCT06100796|Pembrolizumab|pembrolizumab|mesh-list
154551896|NCT06100796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154551897|NCT06100796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551898|NCT06100796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154551899|NCT06100796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551900|NCT06100796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551901|NCT06100783|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154551902|NCT06100783|Contraceptive Agents|contraceptive agents|mesh-list
154551903|NCT06100783|Medroxyprogesterone|medroxyprogesterone|mesh-list
154551904|NCT06100783|Progesterone|progesterone|mesh-list
154551905|NCT06100783|Progestins|progestins|mesh-ancestor
154551906|NCT06100783|Hormones|hormones|mesh-ancestor
154551907|NCT06100783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154551908|NCT06100783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551909|NCT06100783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154551910|NCT06100783|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154551911|NCT06100783|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154551912|NCT06100783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154551913|NCT06100783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154551914|NCT06100783|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154551915|NCT06100783|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154551916|NCT06100783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154551917|NCT06100783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551918|NCT06100510|Aspirin|aspirin|mesh-list
154551919|NCT06100510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154551920|NCT06100510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154551921|NCT06100510|Analgesics|analgesics|mesh-ancestor
154551922|NCT06100510|Sensory System Agents|sensory system agents|mesh-ancestor
154551923|NCT06100510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551924|NCT06100510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551925|NCT06100510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154551926|NCT06100510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154551927|NCT06100510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154551928|NCT06100510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154551929|NCT06100510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551930|NCT06100510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154551931|NCT06100510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154551932|NCT06100510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551933|NCT06100510|Antipyretics|antipyretics|mesh-ancestor
154551934|NCT06100315|Nalbuphine|nalbuphine|mesh-list
154551935|NCT06100315|Bupivacaine|bupivacaine|mesh-list
154551936|NCT06100315|Anesthetics, Local|anesthetics, local|mesh-ancestor
154551937|NCT06100315|Anesthetics|anesthetics|mesh-ancestor
154551938|NCT06100315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551939|NCT06100315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551940|NCT06100315|Sensory System Agents|sensory system agents|mesh-ancestor
154551941|NCT06100315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551942|NCT06100315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154551943|NCT06100315|Narcotics|narcotics|mesh-ancestor
154551944|NCT06100315|Analgesics|analgesics|mesh-ancestor
154551945|NCT06099990|Prednisone|prednisone|mesh-list
154551946|NCT06099990|Abiraterone Acetate|abiraterone acetate|mesh-list
154551947|NCT06099990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154551948|NCT06099990|Glucocorticoids|glucocorticoids|mesh-ancestor
154551949|NCT06099990|Hormones|hormones|mesh-ancestor
154551950|NCT06099990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154551951|NCT06099990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551952|NCT06099990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154551953|NCT06099990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551954|NCT06099990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154551955|NCT06099990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154551956|NCT06099990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551957|NCT06099990|Hormone Antagonists|hormone antagonists|mesh-ancestor
154551958|NCT06099990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154551959|NCT06099938|Sufentanil|sufentanil|mesh-list
154551960|NCT06099938|Ropivacaine|ropivacaine|mesh-list
154551961|NCT06099938|Anesthetics, Local|anesthetics, local|mesh-ancestor
154551962|NCT06099938|Anesthetics|anesthetics|mesh-ancestor
154551963|NCT06099938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154551964|NCT06099938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551965|NCT06099938|Sensory System Agents|sensory system agents|mesh-ancestor
154551966|NCT06099938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154551967|NCT06099938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154551968|NCT06099938|Narcotics|narcotics|mesh-ancestor
154551969|NCT06099938|Analgesics|analgesics|mesh-ancestor
154551970|NCT06099938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154551971|NCT06099938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154551972|NCT06099938|Anesthetics, General|anesthetics, general|mesh-ancestor
154551973|NCT06099418|Atezolizumab|atezolizumab|mesh-list
154551974|NCT06099418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154551975|NCT06099418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551976|NCT06099418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154551977|NCT06099418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551978|NCT06099366|Cytarabine|cytarabine|mesh-list
154551979|NCT06099366|Dexamethasone|dexamethasone|mesh-list
154551980|NCT06099366|Dexamethasone acetate|dexamethasone acetate|mesh-list
154551981|NCT06099366|Cyclophosphamide|cyclophosphamide|mesh-list
154551982|NCT06099366|Doxorubicin|doxorubicin|mesh-list
154551983|NCT06099366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154551984|NCT06099366|Methotrexate|methotrexate|mesh-list
154551985|NCT06099366|Vincristine|vincristine|mesh-list
154551986|NCT06099366|Asparaginase|asparaginase|mesh-list
154551987|NCT06099366|Mercaptopurine|mercaptopurine|mesh-list
154551988|NCT06099366|BB 1101|bb 1101|mesh-list
154551989|NCT06099366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154551990|NCT06099366|Immunologic Factors|immunologic factors|mesh-ancestor
154551991|NCT06099366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154551992|NCT06099366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154551993|NCT06099366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154551994|NCT06099366|Alkylating Agents|alkylating agents|mesh-ancestor
154551995|NCT06099366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154551996|NCT06099366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154551997|NCT06099366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154551998|NCT06099366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154386878|NCT03688958|Iodine|iodine|mesh-list
154551999|NCT06099366|Antiemetics|antiemetics|mesh-ancestor
154552000|NCT06099366|Autonomic Agents|autonomic agents|mesh-ancestor
154552001|NCT06099366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552002|NCT06099366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552003|NCT06099366|Glucocorticoids|glucocorticoids|mesh-ancestor
154552004|NCT06099366|Hormones|hormones|mesh-ancestor
154552005|NCT06099366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552006|NCT06099366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154552007|NCT06099366|Protease Inhibitors|protease inhibitors|mesh-ancestor
154552008|NCT06099366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552009|NCT06099366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552010|NCT06099366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154552011|NCT06099366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154552012|NCT06099366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154552013|NCT06099366|Abortifacient Agents|abortifacient agents|mesh-ancestor
154552014|NCT06099366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154552015|NCT06099366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154552016|NCT06099366|Antimetabolites|antimetabolites|mesh-ancestor
154552017|NCT06099366|Dermatologic Agents|dermatologic agents|mesh-ancestor
154552018|NCT06099366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154552019|NCT06099366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154552020|NCT06099366|Antiviral Agents|antiviral agents|mesh-ancestor
154552021|NCT06099366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552022|NCT06099366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154552023|NCT06099366|Tubulin Modulators|tubulin modulators|mesh-ancestor
154552024|NCT06099366|Antimitotic Agents|antimitotic agents|mesh-ancestor
154552025|NCT06099366|Mitosis Modulators|mitosis modulators|mesh-ancestor
154552026|NCT06099314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154552027|NCT06099314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552028|NCT06099314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552029|NCT06099314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552030|NCT06099119|Pancrelipase|pancrelipase|mesh-list
154552031|NCT06099119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552032|NCT06099067|Liraglutide|liraglutide|mesh-list
154552033|NCT06099067|Canagliflozin|canagliflozin|mesh-list
154552034|NCT06099067|Saxagliptin|saxagliptin|mesh-list
154552035|NCT06099067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154552036|NCT06099067|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154552037|NCT06099067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154552038|NCT06099067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552039|NCT06099067|Incretins|incretins|mesh-ancestor
154552040|NCT06099067|Hormones|hormones|mesh-ancestor
154552041|NCT06099067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552042|NCT06099067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154552043|NCT06099067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552044|NCT06099067|Protease Inhibitors|protease inhibitors|mesh-ancestor
154552045|NCT06099067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552046|NCT06098898|Trastuzumab|trastuzumab|mesh-list
154552047|NCT06098898|Atezolizumab|atezolizumab|mesh-list
154552048|NCT06098898|Tislelizumab|tislelizumab|mesh-list
154552049|NCT06098898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552050|NCT06098898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552051|NCT06098898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154552052|NCT06098898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552053|NCT06098833|Sildenafil Citrate|sildenafil citrate|mesh-list
154552054|NCT06098833|Vasodilator Agents|vasodilator agents|mesh-ancestor
154552055|NCT06098833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154275894|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
154552056|NCT06098833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154552058|NCT06098833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552059|NCT06098833|Urological Agents|urological agents|mesh-ancestor
154552060|NCT06098820|Vitamin D|vitamin d|mesh-list
154552061|NCT06098820|Vitamins|vitamins|mesh-ancestor
154552062|NCT06098820|Micronutrients|micronutrients|mesh-ancestor
154552063|NCT06098820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552064|NCT06098820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154552065|NCT06098209|Dexmedetomidine|dexmedetomidine|mesh-list
154552066|NCT06098209|Propofol|propofol|mesh-list
154552067|NCT06098209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154552068|NCT06098209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552069|NCT06098209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552070|NCT06098209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154552071|NCT06098209|Analgesics|analgesics|mesh-ancestor
154860300|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
154552072|NCT06098209|Sensory System Agents|sensory system agents|mesh-ancestor
154552073|NCT06098209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552074|NCT06098209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154552075|NCT06098209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154552076|NCT06098209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154552077|NCT06098209|Adrenergic Agents|adrenergic agents|mesh-ancestor
154552078|NCT06098209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552079|NCT06098209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552080|NCT06098209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154552081|NCT06098209|Anesthetics, General|anesthetics, general|mesh-ancestor
154552082|NCT06098209|Anesthetics|anesthetics|mesh-ancestor
154552083|NCT06098105|Bupivacaine|bupivacaine|mesh-list
154552084|NCT06098105|Anesthetics, Local|anesthetics, local|mesh-ancestor
154552085|NCT06098105|Anesthetics|anesthetics|mesh-ancestor
154552086|NCT06098105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552087|NCT06098105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552088|NCT06098105|Sensory System Agents|sensory system agents|mesh-ancestor
154552089|NCT06098105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552090|NCT06097962|Atezolizumab|atezolizumab|mesh-list
154552091|NCT06097962|Tislelizumab|tislelizumab|mesh-list
154552092|NCT06097962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154552093|NCT06097962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552094|NCT06097962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552095|NCT06097962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552096|NCT06096298|Vitamin B 12|vitamin b 12|mesh-list
154552097|NCT06096298|Hydroxocobalamin|hydroxocobalamin|mesh-list
154552098|NCT06096298|Vitamins|vitamins|mesh-ancestor
154552099|NCT06096298|Micronutrients|micronutrients|mesh-ancestor
154552100|NCT06096298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552101|NCT06096298|Vitamin B Complex|vitamin b complex|mesh-ancestor
154552102|NCT06096298|Hematinics|hematinics|mesh-ancestor
154552103|NCT06096103|Iron|iron|mesh-list
154552104|NCT06096103|Micronutrients|micronutrients|mesh-ancestor
154552105|NCT06096103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552106|NCT06096103|Trace Elements|trace elements|mesh-ancestor
154552107|NCT06093841|Cyclophosphamide|cyclophosphamide|mesh-list
154552108|NCT06093841|Fludarabine|fludarabine|mesh-list
154552109|NCT06093841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552110|NCT06093841|Immunologic Factors|immunologic factors|mesh-ancestor
154552111|NCT06093841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552112|NCT06093841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154552113|NCT06093841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154552114|NCT06093841|Alkylating Agents|alkylating agents|mesh-ancestor
154552115|NCT06093841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552116|NCT06093841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552117|NCT06093841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154552118|NCT06091917|Betaine|betaine|mesh-list
154552119|NCT06091917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552120|NCT06091917|Lipotropic Agents|lipotropic agents|mesh-ancestor
154552121|NCT06091917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154552122|NCT06091917|Antimetabolites|antimetabolites|mesh-ancestor
154552123|NCT06091917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552124|NCT06091917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154552125|NCT06077344|Anesthetics|anesthetics|mesh-list
154552126|NCT06077344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321158|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321160|NCT02183506|Hormones|hormones|mesh-ancestor
154552127|NCT06077344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552128|NCT06073600|Metformin|metformin|mesh-list
154552129|NCT06073600|Vildagliptin|vildagliptin|mesh-list
154552130|NCT06073600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154552131|NCT06073600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552132|NCT06073600|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154552133|NCT06073600|Protease Inhibitors|protease inhibitors|mesh-ancestor
154552134|NCT06073600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552135|NCT06073600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552136|NCT06069843|Ketamine|ketamine|mesh-list
154552137|NCT06069843|Analgesics|analgesics|mesh-ancestor
154552138|NCT06069843|Sensory System Agents|sensory system agents|mesh-ancestor
154552139|NCT06069843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552140|NCT06069843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552141|NCT06069843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154552142|NCT06069843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154552143|NCT06069843|Anesthetics, General|anesthetics, general|mesh-ancestor
154552144|NCT06069843|Anesthetics|anesthetics|mesh-ancestor
154552145|NCT06069843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552146|NCT06069843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154552147|NCT06069843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154552148|NCT06069843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552149|NCT06069843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552150|NCT06059222|Zoledronic Acid|zoledronic acid|mesh-list
154552151|NCT06059222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154552152|NCT06059222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154552153|NCT06059222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552154|NCT06059222|Immunologic Factors|immunologic factors|mesh-ancestor
154552155|NCT05994378|Ganirelix|ganirelix|mesh-list
154552156|NCT05994378|Hormone Antagonists|hormone antagonists|mesh-ancestor
154552157|NCT05994378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552158|NCT05994378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552159|NCT05929768|Paclitaxel|paclitaxel|mesh-list
154552160|NCT05929768|Docetaxel|docetaxel|mesh-list
154552161|NCT05929768|Cyclophosphamide|cyclophosphamide|mesh-list
154552162|NCT05929768|Carboplatin|carboplatin|mesh-list
154552163|NCT05929768|Doxorubicin|doxorubicin|mesh-list
154552164|NCT05929768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154552165|NCT05929768|Pembrolizumab|pembrolizumab|mesh-list
154552166|NCT05929768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154552167|NCT05929768|Daunorubicin|daunorubicin|mesh-list
154321194|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154552168|NCT05929768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154552169|NCT05929768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552170|NCT05929768|Tubulin Modulators|tubulin modulators|mesh-ancestor
154552171|NCT05929768|Antimitotic Agents|antimitotic agents|mesh-ancestor
154552172|NCT05929768|Mitosis Modulators|mitosis modulators|mesh-ancestor
154552173|NCT05929768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552174|NCT05929768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552175|NCT05929768|Immunologic Factors|immunologic factors|mesh-ancestor
154552176|NCT05929768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552177|NCT05929768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154552178|NCT05929768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154552179|NCT05929768|Alkylating Agents|alkylating agents|mesh-ancestor
154552180|NCT05929768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154552181|NCT05929768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552182|NCT05929768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154552183|NCT05929768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154552184|NCT05929768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552185|NCT05929768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552186|NCT05929768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154552187|NCT05928741|Vitamin D|vitamin d|mesh-list
154552188|NCT05928741|Cholecalciferol|cholecalciferol|mesh-list
154552189|NCT05928741|Vitamins|vitamins|mesh-ancestor
154552190|NCT05928741|Micronutrients|micronutrients|mesh-ancestor
154552191|NCT05928741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552192|NCT05928741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154552193|NCT05928741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154552194|NCT05881135|Choline|choline|mesh-list
154552195|NCT05881135|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154552196|NCT05881135|Lipotropic Agents|lipotropic agents|mesh-ancestor
154552197|NCT05881135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154552198|NCT05881135|Antimetabolites|antimetabolites|mesh-ancestor
154552199|NCT05881135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552200|NCT05881135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552201|NCT05881135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154552202|NCT05881135|Nootropic Agents|nootropic agents|mesh-ancestor
154552203|NCT05786716|Trastuzumab|trastuzumab|mesh-list
154552204|NCT05786716|Pertuzumab|pertuzumab|mesh-list
154552205|NCT05786716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552206|NCT05786716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276116|NCT03510884|Niacin|niacin|mesh-list
154552208|NCT05781035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552209|NCT05781035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552210|NCT05781035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154552211|NCT05781035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154552212|NCT05781035|Analgesics|analgesics|mesh-ancestor
154552213|NCT05781035|Sensory System Agents|sensory system agents|mesh-ancestor
154552214|NCT05781035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552215|NCT05781035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154552216|NCT05781035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154552217|NCT05781035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154552218|NCT05781035|Adrenergic Agents|adrenergic agents|mesh-ancestor
154552219|NCT05781035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552220|NCT05781035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552221|NCT05768178|Vemurafenib|vemurafenib|mesh-list
154552222|NCT05768178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552223|NCT05768178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154552224|NCT05768178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552225|NCT05768178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552226|NCT05618912|Petrolatum|petrolatum|mesh-list
154552227|NCT05618912|Emollients|emollients|mesh-ancestor
154552228|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
154552229|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
154552230|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
154552231|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154552232|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552233|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552234|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
154552235|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154552236|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552237|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552238|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
154552239|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154552240|NCT05565625|Protective Agents|protective agents|mesh-ancestor
154552241|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552242|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
154552243|NCT05561387|Dexamethasone|dexamethasone|mesh-list
154552244|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
154552245|NCT05561387|Lenalidomide|lenalidomide|mesh-list
154552246|NCT05561387|Bortezomib|bortezomib|mesh-list
154552247|NCT05561387|Daratumumab|daratumumab|mesh-list
154552248|NCT05561387|Ichthammol|ichthammol|mesh-list
154552249|NCT05561387|BB 1101|bb 1101|mesh-list
154552250|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154552251|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154552252|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
154552253|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
154321278|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552254|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552255|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552256|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552257|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
154552258|NCT05561387|Hormones|hormones|mesh-ancestor
154552259|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552260|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154552261|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552262|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
154552263|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552264|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552265|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
154552266|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154552267|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154552268|NCT05561387|Growth Substances|growth substances|mesh-ancestor
154552269|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
154552270|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
154552271|NCT05511948|Hydroquinone|hydroquinone|mesh-list
154552272|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
154552273|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552274|NCT05511948|Protective Agents|protective agents|mesh-ancestor
154552275|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552276|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154552277|NCT05461092|Morphine|morphine|mesh-list
154552278|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
154552279|NCT05461092|Bupivacaine|bupivacaine|mesh-list
154552280|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
154552281|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
154552282|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552283|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552284|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
154552285|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552286|NCT05461092|Narcotics|narcotics|mesh-ancestor
154552287|NCT05461092|Analgesics|analgesics|mesh-ancestor
154552288|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
154552289|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
154552290|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
154552291|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552292|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
154552293|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
154552294|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154552295|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
154552296|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552297|NCT05371288|Protective Agents|protective agents|mesh-ancestor
154552298|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552299|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
154552300|NCT05371288|Vitamins|vitamins|mesh-ancestor
154552301|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
154552302|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
154552303|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552305|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154552306|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154552307|NCT05371288|Antidotes|antidotes|mesh-ancestor
154552308|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
154552309|NCT05325853|Propoxycaine|propoxycaine|mesh-list
154552310|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
154552311|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
154552312|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552313|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552314|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
154552315|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552316|NCT05312255|Propranolol|propranolol|mesh-list
154552317|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154552318|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
154552319|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
154552320|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552321|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552322|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552323|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154552324|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154552325|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
154552326|NCT05276219|Furosemide|furosemide|mesh-list
154552327|NCT05276219|Isosorbide|isosorbide|mesh-list
154552328|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154552329|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154552330|NCT05276219|Diuretics|diuretics|mesh-ancestor
154552331|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
154552332|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552333|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154552334|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154552335|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552336|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154552337|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
154552338|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154552339|NCT05265052|Oxycodone|oxycodone|mesh-list
154552340|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154552341|NCT05265052|Narcotics|narcotics|mesh-ancestor
154552342|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552343|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552344|NCT05265052|Analgesics|analgesics|mesh-ancestor
154552345|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
154321377|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
154552346|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552347|NCT05255484|Antibodies|antibodies|mesh-list
154552348|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
154552349|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552350|NCT05199714|Pramlintide|pramlintide|mesh-list
154552351|NCT05199714|Pancrelipase|pancrelipase|mesh-list
154552352|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552353|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154552354|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552355|NCT05121974|Azithromycin|azithromycin|mesh-list
154552356|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
154552357|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154552358|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552359|NCT05121974|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154552360|NCT05121974|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154552361|NCT05041257|Maytansine|maytansine|mesh-list
154552362|NCT05041257|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154552363|NCT05041257|Immunoconjugates|immunoconjugates|mesh-ancestor
154552364|NCT05041257|Immunologic Factors|immunologic factors|mesh-ancestor
154552365|NCT05041257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552366|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154552367|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552368|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
154552369|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
154552370|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
154552371|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552372|NCT04942067|Dexamethasone|dexamethasone|mesh-list
154552373|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
154552374|NCT04942067|Lenalidomide|lenalidomide|mesh-list
154552375|NCT04942067|Daratumumab|daratumumab|mesh-list
154552376|NCT04942067|Pomalidomide|pomalidomide|mesh-list
154552377|NCT04942067|BB 1101|bb 1101|mesh-list
154552378|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154552379|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
154552380|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
154552381|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552382|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552383|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552384|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
154552386|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552387|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154552388|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552389|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
154552390|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552391|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552392|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
154552393|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154552394|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154552395|NCT04942067|Growth Substances|growth substances|mesh-ancestor
154552396|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
154552397|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154552398|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
154552399|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552400|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
154552401|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552402|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154552403|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
154552404|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552405|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
154552406|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552407|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154552408|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
154552409|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552410|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
154552411|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552412|NCT04887298|Annamycin|annamycin|mesh-list
154552413|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552414|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552415|NCT04843579|Clarithromycin|clarithromycin|mesh-list
154552416|NCT04843579|Dexamethasone|dexamethasone|mesh-list
154552417|NCT04843579|Pomalidomide|pomalidomide|mesh-list
154552418|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154552419|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
154552420|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
154552421|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552422|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552423|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552424|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
154552425|NCT04843579|Hormones|hormones|mesh-ancestor
154552426|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552427|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154552428|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552429|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154552430|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552431|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154552432|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552433|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552434|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154552435|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154552436|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
154552438|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154552439|NCT04843579|Growth Substances|growth substances|mesh-ancestor
154552440|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
154552441|NCT04827446|Methamphetamine|methamphetamine|mesh-list
154552442|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154552443|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552444|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
154552445|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
154552446|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552447|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
154552448|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552449|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552450|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
154552451|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154552452|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154552453|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387310|NCT00702520|Hormones|hormones|mesh-list
154552454|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154552455|NCT04723147|Levodopa|levodopa|mesh-list
154552456|NCT04723147|Carbidopa|carbidopa|mesh-list
154552457|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154552458|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154552459|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154552460|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
154552461|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552462|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552463|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552464|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154552465|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552466|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154552467|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
154552468|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
154552469|NCT04669158|Idebenone|idebenone|mesh-list
154552470|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
154552471|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552472|NCT04669158|Protective Agents|protective agents|mesh-ancestor
154552473|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552474|NCT04484740|Gepotidacin|gepotidacin|mesh-list
154552475|NCT04484740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154552476|NCT04484740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552477|NCT04484740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552478|NCT04484740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552479|NCT04469530|Sirolimus|sirolimus|mesh-list
154552480|NCT04469530|Celecoxib|celecoxib|mesh-list
154552481|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
154552482|NCT04469530|Etoposide|etoposide|mesh-list
154552483|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552484|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
154552485|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552486|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154552487|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154552488|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
154552489|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552490|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552491|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154552492|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154552493|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154552494|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154552495|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552496|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154552497|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552498|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552499|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
154552500|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154552501|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154552502|NCT04469530|Analgesics|analgesics|mesh-ancestor
154552503|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
154552504|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552505|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154552506|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154552507|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154552508|NCT04401761|Aspirin|aspirin|mesh-list
154276365|NCT02782663|Upadacitinib|upadacitinib|mesh-list
154552509|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
154552510|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154552511|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154552512|NCT04401761|Analgesics|analgesics|mesh-ancestor
154552513|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
154552514|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552515|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552516|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154552517|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154552518|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154552519|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154552520|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552521|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154552522|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154552523|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552524|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
154552525|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154552526|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
154552527|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154552528|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
154552529|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
154552530|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154552531|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
154552532|NCT04329975|Coagulants|coagulants|mesh-ancestor
154552533|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154552534|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
154552535|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552536|NCT04248569|Nivolumab|nivolumab|mesh-list
154552537|NCT04248569|Ipilimumab|ipilimumab|mesh-list
154552538|NCT04248569|Poly ICLC|poly iclc|mesh-list
154552539|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552540|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552541|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154552542|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552543|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
154552544|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
154552545|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552546|NCT04238663|Bevacizumab|bevacizumab|mesh-list
154552547|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552548|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552549|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154552550|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154552551|NCT04238663|Growth Substances|growth substances|mesh-ancestor
154552552|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552553|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
154552554|NCT04102020|Azacitidine|azacitidine|mesh-list
154552555|NCT04102020|Venetoclax|venetoclax|mesh-list
154552557|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154552558|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
154552559|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552560|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552561|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552562|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
154552563|NCT04060017|Leucovorin|leucovorin|mesh-list
154552564|NCT04060017|Calcium|calcium|mesh-list
154552565|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
154552566|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154552567|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552568|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154552569|NCT04060017|Antidotes|antidotes|mesh-ancestor
154552570|NCT04060017|Protective Agents|protective agents|mesh-ancestor
154552571|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
154552572|NCT04060017|Vitamins|vitamins|mesh-ancestor
154552573|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
154552574|NCT04052698|Factor VIII|factor viii|mesh-list
154552575|NCT04052698|Coagulants|coagulants|mesh-ancestor
154552576|NCT03862716|Insulin|insulin|mesh-list
154552577|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154552578|NCT03862716|Metformin|metformin|mesh-list
154552579|NCT03862716|Liraglutide|liraglutide|mesh-list
154552580|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
154552581|NCT03862716|Xultophy|xultophy|mesh-list
154552582|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154552583|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552584|NCT03862716|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154552585|NCT03862716|Incretins|incretins|mesh-ancestor
154552586|NCT03862716|Hormones|hormones|mesh-ancestor
154552587|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552588|NCT03840239|Capecitabine|capecitabine|mesh-list
154552589|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
154552590|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154552591|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
154552592|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552593|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552594|NCT03824808|Lidocaine|lidocaine|mesh-list
154552595|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
154552596|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
154552597|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552598|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552599|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
154552600|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552601|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154552602|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154552603|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154552604|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154552605|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552606|NCT03798691|Vaccines|vaccines|mesh-list
154552607|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
154552608|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552609|NCT03768492|Caffeine|caffeine|mesh-list
154552610|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154552611|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552612|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154321620|NCT02186782|Enclomiphene|enclomiphene|mesh-list
154552613|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552614|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552615|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154552616|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154552617|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
154552618|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552619|NCT03733691|Lenalidomide|lenalidomide|mesh-list
154552620|NCT03733691|Ixazomib|ixazomib|mesh-list
154552621|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
154552622|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552623|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154552624|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154552625|NCT03733691|Growth Substances|growth substances|mesh-ancestor
154552626|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
154552627|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552628|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
154552629|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552630|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552631|NCT03686124|Nivolumab|nivolumab|mesh-list
154552632|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552633|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552634|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154552635|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552636|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154552637|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
154552638|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552639|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552640|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552641|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154552642|NCT03510468|Pyridoxine|pyridoxine|mesh-list
154552643|NCT03510468|Vitamin B 6|vitamin b 6|mesh-list
154552644|NCT03510468|Tenofovir|tenofovir|mesh-list
154552645|NCT03510468|Isoniazid|isoniazid|mesh-list
154552646|NCT03510468|Rifapentine|rifapentine|mesh-list
154552647|NCT03510468|Vitamins|vitamins|mesh-ancestor
154552648|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
154552649|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552650|NCT03510468|Antiviral Agents|antiviral agents|mesh-ancestor
154552651|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552652|NCT03510468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154552653|NCT03510468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154552654|NCT03510468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552655|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552656|NCT03510468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154552657|NCT03510468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154552658|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
154552659|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
154552660|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154552661|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154276496|NCT02312245|Paclitaxel|paclitaxel|mesh-list
154552662|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154552663|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
154552664|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154552665|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154552666|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
154552667|NCT03218826|Docetaxel|docetaxel|mesh-list
154552668|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552669|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
154552670|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
154552671|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
154552672|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552673|NCT03192501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154552674|NCT03192501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154552675|NCT03192501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154552676|NCT03192501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552677|NCT03192501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552678|NCT03192501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552679|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
154860301|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154552680|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154552681|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154552682|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
154552683|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552684|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552685|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552686|NCT03149809|Urological Agents|urological agents|mesh-ancestor
154552688|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
154552689|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
154552690|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552691|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552692|NCT03063632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154552693|NCT03063632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552694|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
154552695|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552696|NCT02955082|Carboplatin|carboplatin|mesh-list
154552697|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552698|NCT02947750|Folic Acid|folic acid|mesh-list
154552699|NCT02947750|Hematinics|hematinics|mesh-ancestor
154552700|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
154552701|NCT02947750|Vitamins|vitamins|mesh-ancestor
154552702|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
154552703|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552704|NCT02848560|Xenon|xenon|mesh-list
154552705|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154552706|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
154552707|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
154552708|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552709|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552710|NCT02839915|Leucovorin|leucovorin|mesh-list
154552711|NCT02839915|Folic Acid|folic acid|mesh-list
154552712|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
154552713|NCT02839915|Antidotes|antidotes|mesh-ancestor
154552714|NCT02839915|Protective Agents|protective agents|mesh-ancestor
154552715|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552716|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
154552717|NCT02839915|Vitamins|vitamins|mesh-ancestor
154552718|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
154552719|NCT02839915|Hematinics|hematinics|mesh-ancestor
154552720|NCT02792257|Dronabinol|dronabinol|mesh-list
154552721|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
154552722|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552723|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154552724|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154552725|NCT02792257|Analgesics|analgesics|mesh-ancestor
154552726|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
154552727|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552728|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154552729|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154552730|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552731|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552732|NCT02792257|Hormones|hormones|mesh-ancestor
154552733|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552734|NCT02756962|Cytarabine|cytarabine|mesh-list
154552735|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154552736|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
154552737|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552738|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552739|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
154552740|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552741|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552742|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
154552743|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552744|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
154552745|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
154552746|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552747|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154552748|NCT02665117|Diuretics|diuretics|mesh-ancestor
154552749|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
154552750|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552751|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154321770|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
154552752|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154552753|NCT02665117|Cathartics|cathartics|mesh-ancestor
154552754|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552755|NCT02659254|Sirolimus|sirolimus|mesh-list
154552756|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154552757|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552758|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552759|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552760|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
154552761|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552762|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
154552763|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552764|NCT02617485|Prednisone|prednisone|mesh-list
154552765|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
154552766|NCT02617485|Rituximab|rituximab|mesh-list
154552767|NCT02617485|Doxorubicin|doxorubicin|mesh-list
154552768|NCT02617485|Vincristine|vincristine|mesh-list
154552769|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552770|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
154552771|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552772|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154552773|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154552774|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
154552775|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552776|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552777|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154552778|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154552779|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552780|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154552781|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154552782|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552783|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154552784|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
154552785|NCT02617485|Hormones|hormones|mesh-ancestor
154552786|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552787|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154552788|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154552789|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
154552790|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
154321809|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
154552791|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
154552792|NCT02138357|Buprenorphine|buprenorphine|mesh-list
154552793|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154552794|NCT02138357|Narcotics|narcotics|mesh-ancestor
154552795|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552796|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552797|NCT02138357|Analgesics|analgesics|mesh-ancestor
154552798|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
154552799|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552800|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154552801|NCT02115295|Cytarabine|cytarabine|mesh-list
154552802|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154552803|NCT02115295|Venetoclax|venetoclax|mesh-list
154552804|NCT02115295|Idarubicin|idarubicin|mesh-list
154552805|NCT02115295|Cladribine|cladribine|mesh-list
154552806|NCT02115295|Midostaurin|midostaurin|mesh-list
154552807|NCT02115295|Gilteritinib|gilteritinib|mesh-list
154552808|NCT02115295|Staurosporine|staurosporine|mesh-list
154552809|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154552810|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
154552811|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552812|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552813|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
154552814|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276649|NCT01489813|Genistein|genistein|mesh-list
154552815|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552816|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
154552817|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552818|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552819|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154552820|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154552821|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552822|NCT02115295|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154552823|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154552824|NCT02109614|Niacin|niacin|mesh-list
154552825|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154552826|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
154552827|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552828|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154552829|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
154552830|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
154552831|NCT02109614|Vitamins|vitamins|mesh-ancestor
154552832|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
154552833|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552834|NCT00113360|Everolimus|everolimus|mesh-list
154552835|NCT00113360|Octreotide|octreotide|mesh-list
154321857|NCT02256826|Ritonavir|ritonavir|mesh-list
154552836|NCT00113360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154552837|NCT00113360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154552838|NCT00113360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552839|NCT00113360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552840|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552841|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
154552842|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552843|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552844|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154552845|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154552846|NCT00087685|Everolimus|everolimus|mesh-list
154552847|NCT00087685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154552848|NCT00087685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154552849|NCT00087685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552850|NCT00087685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552851|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552852|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
154552853|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552854|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552855|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
154552856|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
154552857|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154552858|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
154552859|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552860|NCT03188445|Protective Agents|protective agents|mesh-ancestor
154552861|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552862|NCT03188445|Vitamins|vitamins|mesh-ancestor
154552863|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
154552864|NCT03188445|Trace Elements|trace elements|mesh-ancestor
154552865|NCT03188445|Hematinics|hematinics|mesh-ancestor
154552866|NCT04483635|Vitamin D|vitamin d|mesh-list
154552867|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
154552868|NCT04483635|Vitamins|vitamins|mesh-ancestor
154552869|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
154552870|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552871|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154552872|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154552873|NCT04865900|Antibodies|antibodies|mesh-list
154552874|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
154552875|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552876|NCT03191721|Triclosan|triclosan|mesh-list
154552877|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
154552878|NCT03191721|Fluorides|fluorides|mesh-list
154552879|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
154552880|NCT03191721|Protective Agents|protective agents|mesh-ancestor
154552881|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552882|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154552883|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154552884|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154552885|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
154552886|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552887|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154552888|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
154552889|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154552890|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
154552891|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552892|NCT04864496|Expectorants|expectorants|mesh-ancestor
154552893|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
154552894|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154552895|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
154552896|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552897|NCT04864496|Protective Agents|protective agents|mesh-ancestor
154552898|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552899|NCT04864496|Antidotes|antidotes|mesh-ancestor
154552900|NCT03188289|Chitosan|chitosan|mesh-list
154552901|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
154552902|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154552903|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
154552904|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552905|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
154552906|NCT03188289|Protective Agents|protective agents|mesh-ancestor
154552907|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154552908|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154552909|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
154552910|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552911|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154552912|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
154552913|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
154552914|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
154552915|NCT03188289|Coagulants|coagulants|mesh-ancestor
154552916|NCT03044912|Mirabegron|mirabegron|mesh-list
154552917|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154552918|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154552919|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154552920|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
154552921|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154552922|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552923|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552924|NCT03044912|Urological Agents|urological agents|mesh-ancestor
154552925|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154552926|NCT03041012|Romidepsin|romidepsin|mesh-list
154552927|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
154552928|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
154552929|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552930|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552931|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552932|NCT03041012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154552933|NCT03041012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552934|NCT03041012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552935|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
154552936|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552937|NCT03187899|Ropivacaine|ropivacaine|mesh-list
154552938|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
154552939|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
154552940|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552941|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552942|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
154552943|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154552944|NCT01648582|Metformin|metformin|mesh-list
154552945|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
154552946|NCT01648582|Dulaglutide|dulaglutide|mesh-list
154552947|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154552948|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552949|NCT01648582|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154552950|NCT02440347|Anesthetics|anesthetics|mesh-list
154552951|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154552952|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552953|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154552954|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154552955|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
154552956|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154552957|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552958|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154552959|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154552960|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154321976|NCT04308694|Methadone|methadone|mesh-list
154552961|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
154552962|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
154552963|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552964|NCT03189069|Warfarin|warfarin|mesh-list
154552965|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
154552966|NCT03189069|Dabigatran|dabigatran|mesh-list
154552967|NCT03189069|Apixaban|apixaban|mesh-list
154552968|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
154276804|NCT00254670|Naltrexone|naltrexone|mesh-list
154552969|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154552970|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
154552971|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154552972|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
154552973|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552974|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552975|NCT03040934|Sirolimus|sirolimus|mesh-list
154552976|NCT03040934|Everolimus|everolimus|mesh-list
154552977|NCT03040934|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154552978|NCT03040934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154552979|NCT03040934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154552980|NCT03040934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552981|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154552982|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
154552983|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552984|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552985|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154552986|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154552987|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154552988|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
154552989|NCT04861142|Denosumab|denosumab|mesh-list
154552990|NCT04861142|Alendronate|alendronate|mesh-list
154552991|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154552992|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154552993|NCT03117855|Capecitabine|capecitabine|mesh-list
154552994|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154552995|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
154552996|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154552997|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154552998|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
154552999|NCT02607800|Velpatasvir|velpatasvir|mesh-list
154553000|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
154553001|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553002|NCT02304484|Evolocumab|evolocumab|mesh-list
154553003|NCT02304484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154553004|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154553005|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154553006|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
154553007|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553008|NCT02304484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154553009|NCT02304484|Protease Inhibitors|protease inhibitors|mesh-ancestor
154553010|NCT02304484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553011|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154553012|NCT02434029|Budesonide|budesonide|mesh-list
154322022|NCT00095147|Infliximab|infliximab|mesh-list
154553013|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553014|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154553015|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
154553016|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553017|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553018|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154553019|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
154553020|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
154553021|NCT02434029|Hormones|hormones|mesh-ancestor
154553022|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553023|NCT02708355|Esomeprazole|esomeprazole|mesh-list
154553024|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154553025|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553026|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154553027|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553028|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553029|NCT04854044|TIC10 compound|tic10 compound|mesh-list
154553030|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553031|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
154553032|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154553033|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553034|NCT02337478|Vincristine|vincristine|mesh-list
154553035|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154553036|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553037|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
154553038|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
154553039|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
154553040|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553041|NCT02434653|Chrysarobin|chrysarobin|mesh-list
154553042|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154553043|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154276873|NCT05712343|Valacyclovir|valacyclovir|mesh-list
154553044|NCT02434653|Analgesics|analgesics|mesh-ancestor
154553045|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
154553046|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553047|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553048|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553049|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553050|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154553051|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154553052|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154553053|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
154553054|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553055|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154553056|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154553057|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553058|NCT03188835|Glycerol|glycerol|mesh-list
154553059|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154553060|NCT03188835|Protective Agents|protective agents|mesh-ancestor
154553061|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553062|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154553063|NCT04847024|Parecoxib|parecoxib|mesh-list
154553064|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154553065|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553066|NCT04847024|Analgesics|analgesics|mesh-ancestor
154553067|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
154553068|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553069|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553070|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553071|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553072|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154553073|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154553074|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553075|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553076|NCT04860674|Carboplatin|carboplatin|mesh-list
154553077|NCT04860674|Etoposide|etoposide|mesh-list
154553078|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154553079|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553080|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154553081|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154553082|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154553083|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553084|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553085|NCT04860674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154553086|NCT04853342|Aflutinib|aflutinib|mesh-list
154553087|NCT04853342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154553088|NCT04853342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553089|NCT04853342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553090|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
154553091|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154553092|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553093|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
154553094|NCT02430363|Ipatasertib|ipatasertib|mesh-list
154553095|NCT02430363|Dactolisib|dactolisib|mesh-list
154553096|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154553097|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553098|NCT02430363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154553099|NCT02430363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553100|NCT02430363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154553101|NCT02430363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553102|NCT02429973|Sirolimus|sirolimus|mesh-list
154553103|NCT02429973|Gemcitabine|gemcitabine|mesh-list
154553104|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154553105|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
154553106|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553107|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553108|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154553109|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553110|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154553111|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
154553112|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154553113|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
154553114|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553115|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
154553116|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
154553117|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154276950|NCT05318248|Clonidine|clonidine|mesh-list
154553118|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154553119|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553120|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553121|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553122|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553123|NCT04846634|Paclitaxel|paclitaxel|mesh-list
154553124|NCT04846634|Docetaxel|docetaxel|mesh-list
154553125|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154553126|NCT04846634|Cisplatin|cisplatin|mesh-list
154553127|NCT04846634|Carboplatin|carboplatin|mesh-list
154553128|NCT04846634|Gemcitabine|gemcitabine|mesh-list
154553129|NCT04846634|Pemetrexed|pemetrexed|mesh-list
154553130|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154553131|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553132|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
154553133|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
154553134|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
154553135|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860302|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154553136|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154553137|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
154553138|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553139|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154553140|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154553141|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154553142|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154553143|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154322161|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
154553144|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553145|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553146|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154553147|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154553148|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154553149|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
154553150|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553151|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553152|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154553153|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154553154|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
154553155|NCT02429817|Edetic Acid|edetic acid|mesh-list
154553156|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
154553157|NCT02429817|Antidotes|antidotes|mesh-ancestor
154553158|NCT02429817|Protective Agents|protective agents|mesh-ancestor
154553159|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553160|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
154553161|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
154553162|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553163|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154553164|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
154553165|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154553166|NCT04851860|Immunomodulating Agents|immunomodulating agents|mesh-list
154553167|NCT04851860|Immunologic Factors|immunologic factors|mesh-ancestor
154553168|NCT04851860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553169|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
154553170|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154553171|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
154553172|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553173|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
154553174|NCT04851548|Protective Agents|protective agents|mesh-ancestor
154553175|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154553176|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553177|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553179|NCT04851392|Cannabidiol|cannabidiol|mesh-list
154553180|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
154553181|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
154553182|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553183|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154553184|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553185|NCT04851392|Analgesics|analgesics|mesh-ancestor
154553186|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
154553187|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322205|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
154553188|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154553189|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154553190|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553191|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553192|NCT04851392|Hormones|hormones|mesh-ancestor
154553193|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553195|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
154553196|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553197|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
154553198|NCT02429193|Hormones|hormones|mesh-ancestor
154553199|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553200|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553201|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154553202|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553203|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154553204|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553205|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553206|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
154553207|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154553208|NCT04859738|Lidocaine|lidocaine|mesh-list
154553209|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
154553210|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
154553211|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553212|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553213|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
154553214|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553215|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154553216|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154553217|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154553218|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154553219|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553220|NCT02429271|Clopidogrel|clopidogrel|mesh-list
154553221|NCT02429271|Ticagrelor|ticagrelor|mesh-list
154553222|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154553223|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154553224|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154553225|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154553226|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
154553227|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553228|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553229|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553230|NCT02429505|Miltefosine|miltefosine|mesh-list
154553231|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
154553232|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553233|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553234|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154553235|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154553236|NCT04851002|Mitogens|mitogens|mesh-list
154553237|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
154322250|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154553238|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553239|NCT04844996|Ezetimibe|ezetimibe|mesh-list
154553240|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154553241|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154553242|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
154553243|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553244|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154553245|NCT02425137|Gemcitabine|gemcitabine|mesh-list
154553246|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154553247|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
154553248|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553249|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553250|NCT03182595|Acetaminophen|acetaminophen|mesh-list
154553251|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553252|NCT03182595|Analgesics|analgesics|mesh-ancestor
154553253|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
154553254|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553255|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553256|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
154553257|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
154553258|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
154553259|NCT02429037|Cisplatin|cisplatin|mesh-list
154553260|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553261|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
154553262|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154553263|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553264|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154553265|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154553266|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154553267|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553268|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553269|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154553270|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154553271|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553272|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
154553273|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553274|NCT04833218|Propranolol|propranolol|mesh-list
154553275|NCT04833218|Clonidine|clonidine|mesh-list
154553276|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154553277|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154553278|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
154553279|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553280|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553281|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553282|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154553283|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154860303|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154553284|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
154553285|NCT04833218|Analgesics|analgesics|mesh-ancestor
154553286|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
154553287|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553288|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
154553289|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
154553290|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154553291|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154553292|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154553293|NCT04833374|Prednisone|prednisone|mesh-list
154553294|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
154553295|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154553296|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154553297|NCT04833374|Prednisolone|prednisolone|mesh-list
154553298|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
154553299|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154553300|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
154553301|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553302|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
154553303|NCT04833374|Hormones|hormones|mesh-ancestor
154553304|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553305|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553306|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154553307|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553308|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
154553309|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
154553310|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553311|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553312|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154553313|NCT04833374|Protective Agents|protective agents|mesh-ancestor
154553314|NCT02707965|Topiramate|topiramate|mesh-list
154553315|NCT02707965|Lamotrigine|lamotrigine|mesh-list
154553316|NCT02707965|Zonisamide|zonisamide|mesh-list
154553317|NCT02707965|Carbamazepine|carbamazepine|mesh-list
154553318|NCT02707965|Phenytoin|phenytoin|mesh-list
154553319|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
154553320|NCT02707965|Levetiracetam|levetiracetam|mesh-list
154553321|NCT02707965|Valproic Acid|valproic acid|mesh-list
154553322|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
154553323|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154553324|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553325|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
154553326|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154553327|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154553328|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553329|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154553330|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154553331|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154553332|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553333|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154553334|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154553335|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
154553336|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553337|NCT02707965|Analgesics|analgesics|mesh-ancestor
154553338|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
154553339|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553340|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154553341|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154553342|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553343|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
154553344|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553345|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154553346|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154553347|NCT04839536|Sevoflurane|sevoflurane|mesh-list
154553348|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154553349|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154553350|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
154553351|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
154553352|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553353|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553354|NCT02428257|Ephedrine|ephedrine|mesh-list
154553355|NCT02428257|Bupivacaine|bupivacaine|mesh-list
154553356|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
154553357|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
154553358|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553359|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860304|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
154860305|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553360|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
154553361|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553362|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154553363|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
154553364|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
154553365|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154553366|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
154553367|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553368|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553369|NCT04839224|Phenylephrine|phenylephrine|mesh-list
154553370|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
154553371|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154553372|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
154553373|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
154553374|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553375|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553376|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
154553377|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154553378|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
154553379|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
154553380|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154553381|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154553382|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154553383|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
154553384|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553385|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553386|NCT04839224|Protective Agents|protective agents|mesh-ancestor
154553387|NCT03036644|Nicotine|nicotine|mesh-list
154553388|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154553389|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
154553390|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553391|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553392|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154553393|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154553394|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
154553395|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553396|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553397|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
154553398|NCT02424201|Misoprostol|misoprostol|mesh-list
154553399|NCT02424201|Vitamins|vitamins|mesh-ancestor
154553400|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
154553401|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553402|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154553403|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
154553404|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154553405|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154553406|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553407|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
154553408|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
154553409|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553410|NCT02424201|Protective Agents|protective agents|mesh-ancestor
154553411|NCT02432781|Insulin|insulin|mesh-list
154553412|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154553413|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553414|NCT01667900|Dulaglutide|dulaglutide|mesh-list
154553415|NCT01667900|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154553416|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154553417|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553418|NCT04843280|Coal Tar|coal tar|mesh-list
154553419|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
154553420|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
154553421|NCT04833296|Ropivacaine|ropivacaine|mesh-list
154553422|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
154553423|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
154553424|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553425|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553426|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
154553427|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553428|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
154553429|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154553430|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
154553431|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154553432|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553433|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154553434|NCT00702273|Progesterone|progesterone|mesh-list
154322449|NCT02219698|Acetaminophen|acetaminophen|mesh-list
154553435|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154553437|NCT00702273|Progestins|progestins|mesh-ancestor
154553438|NCT00702273|Hormones|hormones|mesh-ancestor
154553439|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553440|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553441|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
154553442|NCT02433795|Rituximab|rituximab|mesh-list
154553443|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154553444|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154553445|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553446|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
154553447|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553448|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553449|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154553450|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
154553451|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553452|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
154553453|NCT03038516|Vitamin D|vitamin d|mesh-list
154553454|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154553455|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553456|NCT03038516|Vitamins|vitamins|mesh-ancestor
154553457|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
154553458|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154553459|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
154553460|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154553461|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154553462|NCT02424435|Prednisolone|prednisolone|mesh-list
154553463|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
154553464|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154553465|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
154553466|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553467|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
154553468|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
154553469|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553470|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553471|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553472|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
154553473|NCT02424435|Hormones|hormones|mesh-ancestor
154553474|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553475|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154553476|NCT02424435|Protective Agents|protective agents|mesh-ancestor
154553477|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154553478|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553479|NCT04842968|Methylene Blue|methylene blue|mesh-list
154553480|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553481|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553482|NCT04832204|Apatinib|apatinib|mesh-list
154553483|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553484|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154553485|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553486|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553487|NCT03038282|Chromium|chromium|mesh-list
154553488|NCT03038282|Chromous chloride|chromous chloride|mesh-list
154553489|NCT03038282|Trace Elements|trace elements|mesh-ancestor
154553490|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
154553491|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553492|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
154553493|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553494|NCT03038282|Protective Agents|protective agents|mesh-ancestor
154553495|NCT02424045|Dexamethasone|dexamethasone|mesh-list
154553496|NCT02424045|Carboplatin|carboplatin|mesh-list
154553497|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154553498|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553499|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
154553500|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
154553501|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553502|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553503|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553504|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
154553505|NCT02424045|Hormones|hormones|mesh-ancestor
154553506|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553507|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154553508|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553509|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154553510|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
154553511|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553512|NCT03037970|Becaplermin|becaplermin|mesh-list
154553513|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
154553514|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154553515|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154322550|NCT02222350|Firuglipel|firuglipel|mesh-list
154553516|NCT03037970|Growth Substances|growth substances|mesh-ancestor
154553517|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553518|NCT04841720|Metformin|metformin|mesh-list
154553519|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154553520|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553521|NCT03039842|Levomethorphan|levomethorphan|mesh-list
154553522|NCT03039842|Valproic Acid|valproic acid|mesh-list
154553523|NCT03039842|Memantine|memantine|mesh-list
154553524|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
154553525|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154553526|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154553527|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
154553528|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553529|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553530|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553531|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154553532|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154553533|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
154553534|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553535|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
154553536|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
154553537|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154553538|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553539|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154553540|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
154553541|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
154553542|NCT03039842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154553543|NCT03039842|Narcotics|narcotics|mesh-ancestor
154553544|NCT03039842|Analgesics|analgesics|mesh-ancestor
154553545|NCT03039842|Sensory System Agents|sensory system agents|mesh-ancestor
154553546|NCT03039842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553547|NCT03181815|Cytarabine|cytarabine|mesh-list
154553548|NCT03181815|Cladribine|cladribine|mesh-list
154553549|NCT03181815|Aclarubicin|aclarubicin|mesh-list
154553550|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
154553551|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154553552|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
154553553|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553554|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553555|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
154553556|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553557|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154553558|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
154553559|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553560|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154553561|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154553562|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154553563|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553564|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154553565|NCT03038048|Ranibizumab|ranibizumab|mesh-list
154553566|NCT03038048|Aflibercept|aflibercept|mesh-list
154553567|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154553568|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154553569|NCT03038048|Growth Substances|growth substances|mesh-ancestor
154553570|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553571|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
154553572|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553573|NCT03185871|Celecoxib|celecoxib|mesh-list
154553574|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154553575|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553576|NCT03185871|Analgesics|analgesics|mesh-ancestor
154553577|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
154553578|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553579|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553580|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553581|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553582|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154553583|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154553584|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553585|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553586|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154553587|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154553589|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553590|NCT03180957|Adalimumab|adalimumab|mesh-list
154553591|NCT03180957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154553592|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553593|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553594|NCT02427165|Albuterol|albuterol|mesh-list
154553595|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154553596|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
154553597|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553598|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553599|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154553600|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
154553601|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
154553602|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154553603|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154553604|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154553605|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154553606|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
154553607|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553608|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553609|NCT03037736|Bevacizumab|bevacizumab|mesh-list
154553610|NCT03037736|Fluorouracil|fluorouracil|mesh-list
154553611|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154553612|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553613|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154553614|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154553615|NCT03037736|Growth Substances|growth substances|mesh-ancestor
154553616|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553617|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
154553618|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
154553619|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553620|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154553621|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154553622|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
154553623|NCT04838132|Ropivacaine|ropivacaine|mesh-list
154553624|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
154553625|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
154553626|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553627|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553628|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
154553629|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553630|NCT03037892|Midazolam|midazolam|mesh-list
154553631|NCT03037892|Fentanyl|fentanyl|mesh-list
154553632|NCT03037892|Remifentanil|remifentanil|mesh-list
154553633|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154553634|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154553635|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553636|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553637|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154553638|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154553639|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154553640|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154553641|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
154553642|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
154553643|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
154553644|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
154553645|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553646|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553647|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154553648|NCT03037892|Narcotics|narcotics|mesh-ancestor
154553649|NCT03037892|Analgesics|analgesics|mesh-ancestor
154553650|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
154553651|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553652|NCT03183843|Warfarin|warfarin|mesh-list
154553653|NCT03183843|Dabigatran|dabigatran|mesh-list
154553654|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
154553655|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
154553656|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154553657|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
154553658|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553659|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553660|NCT03180879|Ibuprofen|ibuprofen|mesh-list
154553661|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154553662|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553663|NCT03180879|Analgesics|analgesics|mesh-ancestor
154553664|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
154553665|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553666|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553667|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553668|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553669|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154553670|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553671|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553672|NCT03180723|Cyclosporine|cyclosporine|mesh-list
154553673|NCT03180723|Rituximab|rituximab|mesh-list
154553674|NCT03180723|Cyclosporins|cyclosporins|mesh-list
154553675|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154553676|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553677|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
154553678|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553679|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553680|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553681|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553682|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154553683|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
154553684|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553685|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
154553686|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154553687|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154553688|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
154553689|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553690|NCT02426697|Fentanyl|fentanyl|mesh-list
154553691|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154553692|NCT02426697|Narcotics|narcotics|mesh-ancestor
154553693|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553694|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553695|NCT02426697|Analgesics|analgesics|mesh-ancestor
154553696|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
154553697|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553698|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154553699|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154553700|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
154553701|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
154553702|NCT03039608|Prednisone|prednisone|mesh-list
154553703|NCT03039608|Triamcinolone|triamcinolone|mesh-list
154553704|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553705|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
154553706|NCT03039608|Hormones|hormones|mesh-ancestor
154553707|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553708|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553709|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154553710|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553711|NCT02423811|Fursultiamin|fursultiamin|mesh-list
154553712|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
154553713|NCT02423811|Vitamins|vitamins|mesh-ancestor
154553714|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
154553715|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553716|NCT04837664|Nystatin|nystatin|mesh-list
154553717|NCT04837664|Curcumin|curcumin|mesh-list
154553718|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154553719|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553720|NCT04837664|Analgesics|analgesics|mesh-ancestor
154553721|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
154553722|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553723|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553724|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553725|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553726|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553727|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553728|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553729|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154553730|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553731|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
154553732|NCT04837664|Ionophores|ionophores|mesh-ancestor
154553733|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154553734|NCT01331837|Etanercept|etanercept|mesh-list
154553735|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154553736|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553737|NCT01331837|Analgesics|analgesics|mesh-ancestor
154553738|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
154553739|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553740|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553741|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553742|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553743|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553744|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154553745|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
154553747|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154553748|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
154553749|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553750|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553751|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
154553752|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553753|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
154553754|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553755|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553756|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154553757|NCT03183297|Fexofenadine|fexofenadine|mesh-list
154553758|NCT03183297|Naproxen|naproxen|mesh-list
154553759|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154553760|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154553761|NCT03183297|Analgesics|analgesics|mesh-ancestor
154553762|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
154553763|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553764|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553765|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553766|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553767|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
154553768|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154553769|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553770|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553771|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154553772|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154553773|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154553774|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
154553775|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
154553776|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553777|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154553778|NCT02426619|Fluorides|fluorides|mesh-list
154553779|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
154553780|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
154553781|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
154553782|NCT02426619|Protective Agents|protective agents|mesh-ancestor
154553783|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553784|NCT02108483|Dapsone|dapsone|mesh-list
154553785|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553786|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
154553787|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154553788|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154553789|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154553790|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553791|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553792|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
154553793|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154553794|NCT01648348|Bevacizumab|bevacizumab|mesh-list
154553795|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154553796|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
154553797|NCT01648348|Antibodies|antibodies|mesh-list
154553798|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
154553799|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154553800|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
154553801|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553802|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154553803|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154553804|NCT01648348|Growth Substances|growth substances|mesh-ancestor
154553805|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553806|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
154553807|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
154553808|NCT03180255|Dexamethasone|dexamethasone|mesh-list
154553809|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
154553810|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154553811|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553812|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
154553813|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
154553814|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553815|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553816|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553818|NCT03180255|Hormones|hormones|mesh-ancestor
154553819|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154553820|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154553821|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553822|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
154553823|NCT02431221|Perhexiline|perhexiline|mesh-list
154553824|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154553825|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154553826|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553827|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154553828|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553829|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
154553830|NCT02108639|Asunaprevir|asunaprevir|mesh-list
154553831|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
154553832|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553833|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553834|NCT03180099|Bupivacaine|bupivacaine|mesh-list
154553835|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
154553836|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
154553837|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553838|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553839|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
154553840|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553841|NCT02251145|Ritonavir|ritonavir|mesh-list
154553842|NCT02251145|Tenofovir|tenofovir|mesh-list
154553843|NCT02251145|Tipranavir|tipranavir|mesh-list
154553844|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154553845|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154553846|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
154553847|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553848|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553849|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154322860|NCT00091949|Pioglitazone|pioglitazone|mesh-list
154553850|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154553851|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
154553852|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553853|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154553854|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154553855|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154553856|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154553857|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154553858|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154553859|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553860|NCT00709371|Zonisamide|zonisamide|mesh-list
154553861|NCT00709371|Bupropion|bupropion|mesh-list
154553862|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154553863|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
154553864|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154553865|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154553866|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154553867|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154553868|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553869|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
154553870|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553871|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553872|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154553873|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154553874|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553875|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
154277698|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
154553876|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154553877|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154553878|NCT02426463|Oxycodone|oxycodone|mesh-list
154553879|NCT02426463|Propofol|propofol|mesh-list
154553880|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154553881|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553882|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553883|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154553884|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
154553885|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
154553886|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154553887|NCT02426463|Narcotics|narcotics|mesh-ancestor
154553888|NCT02426463|Analgesics|analgesics|mesh-ancestor
154553889|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
154553890|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553892|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
154553893|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154553894|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
154553895|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553896|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553897|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
154553898|NCT01648270|Buprenorphine|buprenorphine|mesh-list
154553899|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154553900|NCT01648270|Narcotics|narcotics|mesh-ancestor
154553901|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553902|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553903|NCT01648270|Analgesics|analgesics|mesh-ancestor
154553904|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
154553905|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553906|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154553907|NCT02108795|Remifentanil|remifentanil|mesh-list
154553908|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154553909|NCT02108795|Narcotics|narcotics|mesh-ancestor
154553910|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553911|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553912|NCT02108795|Analgesics|analgesics|mesh-ancestor
154553913|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
154553914|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553915|NCT02431143|Miltefosine|miltefosine|mesh-list
154553916|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
154553917|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553918|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553919|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154553920|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154553921|NCT02302846|Ixazomib|ixazomib|mesh-list
154553922|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553923|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
154553924|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553925|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553926|NCT02431065|Ropivacaine|ropivacaine|mesh-list
154553927|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
154553928|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
154553929|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553930|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553931|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
154553932|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553933|NCT04836806|Cetirizine|cetirizine|mesh-list
154553934|NCT04836806|Famotidine|famotidine|mesh-list
154553935|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154553936|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154553937|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154553938|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
154553939|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
154553940|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154553941|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322946|NCT00090779|Ritonavir|ritonavir|mesh-list
154553942|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553943|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154553944|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154553945|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154553946|NCT04836728|Paclitaxel|paclitaxel|mesh-list
154553947|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154553948|NCT04836728|Carboplatin|carboplatin|mesh-list
154553949|NCT04836728|Pemetrexed|pemetrexed|mesh-list
154553950|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154553951|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154553952|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553953|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
154553954|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
154553955|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
154553956|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553957|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154553958|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154553959|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154553960|NCT04836728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154553961|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
154553962|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553963|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
154553964|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154553965|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
154553966|NCT02430909|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154553967|NCT02430909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553968|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154553969|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
154553970|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553971|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154553972|NCT02105675|Docetaxel|docetaxel|mesh-list
154553973|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553974|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
154553975|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
154553976|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
154553977|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154553978|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
154553979|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154553980|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
154553981|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154553982|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154553983|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
154553984|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553985|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154553986|NCT04824404|Buprenorphine|buprenorphine|mesh-list
154553987|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154553988|NCT04824404|Narcotics|narcotics|mesh-ancestor
154322995|NCT04174612|Cytarabine|cytarabine|mesh-list
154553989|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154553990|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154553991|NCT04824404|Analgesics|analgesics|mesh-ancestor
154553992|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
154553993|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154553994|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154553995|NCT02109341|Paclitaxel|paclitaxel|mesh-list
154553996|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154553997|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154553998|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154553999|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
154554000|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
154554001|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
154554002|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554003|NCT04367168|Colchicine|colchicine|mesh-list
154554004|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
154554005|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154554006|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
154554007|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
154554008|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
154554009|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554010|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554011|NCT02113943|Citalopram|citalopram|mesh-list
154554012|NCT02113943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154554013|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154554014|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154554015|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554016|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554017|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
154554018|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554019|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154554020|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
154554021|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154554022|NCT02114021|Betamethasone|betamethasone|mesh-list
154554023|NCT02114021|Lidocaine|lidocaine|mesh-list
154554024|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
154554025|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
154554026|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554027|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554028|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
154554029|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554030|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154554031|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154554032|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154554033|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154554034|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554035|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554037|NCT02114021|Hormones|hormones|mesh-ancestor
154554038|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554039|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154554041|NCT04826822|Dexamethasone|dexamethasone|mesh-list
154554042|NCT04826822|Spironolactone|spironolactone|mesh-list
154554043|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554044|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
154554045|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
154554046|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554047|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554048|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154554049|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
154554050|NCT04826822|Hormones|hormones|mesh-ancestor
154554051|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554052|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154554053|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554054|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154554055|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
154554056|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154554057|NCT04826822|Diuretics|diuretics|mesh-ancestor
154554058|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
154554059|NCT02251457|Ranolazine|ranolazine|mesh-list
154554060|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154554061|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154554062|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554063|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
154554064|NCT02112305|Analgesics|analgesics|mesh-ancestor
154554065|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
154554066|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554067|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554068|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
154554069|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554070|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154554071|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
154554072|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154554073|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154554074|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554075|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154554076|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
154554077|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154554078|NCT02114099|Atorvastatin|atorvastatin|mesh-list
154554079|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154554080|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154554081|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
154554082|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554083|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154554084|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154554085|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554086|NCT02251223|Ritonavir|ritonavir|mesh-list
154554087|NCT02251223|Tipranavir|tipranavir|mesh-list
154554088|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154554089|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154554090|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
154554091|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554092|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554093|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154554094|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154554095|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
154554096|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554097|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154554098|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154554099|NCT02114333|Vaccines|vaccines|mesh-list
154554100|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
154277934|NCT01375816|Vitamins|vitamins|mesh-ancestor
154554101|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554102|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
154554103|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154554104|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554106|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154554107|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154554108|NCT02114645|Estradiol|estradiol|mesh-list
154554109|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154554110|NCT02114645|Progesterone|progesterone|mesh-list
154554111|NCT02114645|Estrogens|estrogens|mesh-ancestor
154554112|NCT02114645|Hormones|hormones|mesh-ancestor
154554113|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554114|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554115|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154554116|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
154554117|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154554118|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154554120|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154554121|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
154554122|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154554123|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554124|NCT02112695|Diprenorphine|diprenorphine|mesh-list
154554125|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154554126|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554127|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
154554128|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554129|NCT04361162|Nivolumab|nivolumab|mesh-list
154554130|NCT04361162|Ipilimumab|ipilimumab|mesh-list
154554131|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154554132|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554133|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154554134|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554135|NCT04823390|Midazolam|midazolam|mesh-list
154554136|NCT04823390|Fentanyl|fentanyl|mesh-list
154554137|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154554138|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154554139|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554140|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554141|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154554142|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154554143|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154323136|NCT03515044|Rifaximin|rifaximin|mesh-list
154554144|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154554145|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
154554146|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
154554147|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
154554148|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
154554149|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554150|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554151|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154554152|NCT04823390|Narcotics|narcotics|mesh-ancestor
154554153|NCT04823390|Analgesics|analgesics|mesh-ancestor
154554154|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
154554155|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554156|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
154554157|NCT04826510|Perospirone|perospirone|mesh-list
154554158|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
154554159|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154554160|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554161|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554162|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
154554163|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154554164|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554165|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554166|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154554167|NCT03036800|Liraglutide|liraglutide|mesh-list
154554168|NCT03036800|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154554169|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154554170|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554171|NCT03036800|Incretins|incretins|mesh-ancestor
154554172|NCT03036800|Hormones|hormones|mesh-ancestor
154554173|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554174|NCT02301988|Paclitaxel|paclitaxel|mesh-list
154554175|NCT02301988|Ipatasertib|ipatasertib|mesh-list
154554176|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154554177|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554178|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
154554179|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
154554180|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
154554181|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554182|NCT02301988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154554183|NCT02301988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554184|NCT04326920|Sargramostim|sargramostim|mesh-list
154554185|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
154554186|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554187|NCT02112929|Xenon|xenon|mesh-list
154554188|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154389029|NCT03169738|Bevacizumab|bevacizumab|mesh-list
154554189|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
154554190|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
154554191|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554192|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554193|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
154554194|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154554195|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554196|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154554197|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154554198|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554199|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554200|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554201|NCT02115035|Vemurafenib|vemurafenib|mesh-list
154554202|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554203|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154554204|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554205|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554206|NCT02113319|Dasatinib|dasatinib|mesh-list
154554207|NCT02113319|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154554208|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154554209|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554210|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554211|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554212|NCT02113397|Tobramycin|tobramycin|mesh-list
154554213|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154554214|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554215|NCT03553433|Apremilast|apremilast|mesh-list
154554216|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154554217|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154554218|NCT03553433|Analgesics|analgesics|mesh-ancestor
154554219|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
154554220|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323240|NCT02750800|Adalimumab|adalimumab|mesh-list
154554221|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554222|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554223|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154554224|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154554225|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154554226|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554227|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554228|NCT02604212|Tenofovir|tenofovir|mesh-list
154554229|NCT02604212|Entecavir|entecavir|mesh-list
154554230|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
154554231|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154554232|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
154554233|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554234|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154554235|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154554236|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554237|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554238|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154554239|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154554240|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
154554241|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554242|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554243|NCT02115659|Triptolide|triptolide|mesh-list
154554244|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154554245|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554246|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154554247|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
154554248|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154554249|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154554250|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
154554251|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154554253|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554254|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554255|NCT02113631|Interferons|interferons|mesh-list
154554256|NCT02113631|Ribavirin|ribavirin|mesh-list
154554257|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
154554258|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
154554259|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154554260|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554261|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
154554262|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554263|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
154554264|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554266|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554267|NCT02123069|Nitroprusside|nitroprusside|mesh-list
154554268|NCT02123069|Phenylephrine|phenylephrine|mesh-list
154554269|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
154554270|NCT02123069|Norepinephrine|norepinephrine|mesh-list
154554271|NCT02123069|Acetylcholine|acetylcholine|mesh-list
154554272|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154554273|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
154554274|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
154554275|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554276|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554277|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
154554278|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154554279|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
154554280|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
154554281|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154554282|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154554283|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154554284|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
154554285|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554286|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554287|NCT02123069|Protective Agents|protective agents|mesh-ancestor
154554288|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154554289|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
154554290|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154554291|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154554292|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
154554293|NCT04428632|Berotralstat|berotralstat|mesh-list
154554294|NCT04428632|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154554295|NCT04428632|Protease Inhibitors|protease inhibitors|mesh-ancestor
154554296|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554297|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554298|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154323311|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
154554299|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
154554300|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154554301|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154554302|NCT02789111|Alvimopan|alvimopan|mesh-list
154554303|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154554304|NCT04807166|Paclitaxel|paclitaxel|mesh-list
154554305|NCT04807166|Carboplatin|carboplatin|mesh-list
154554306|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154554307|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554308|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
154554309|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
154554310|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
154554311|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554312|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154554313|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154554314|NCT02251925|Estradiol|estradiol|mesh-list
154554315|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154554316|NCT02251925|Estrogens|estrogens|mesh-ancestor
154554317|NCT02251925|Hormones|hormones|mesh-ancestor
154554318|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554319|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554320|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154554321|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
154554322|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154554323|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154554324|NCT03552653|Vitamin D|vitamin d|mesh-list
154554325|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
154554326|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
154554327|NCT03552653|Vitamins|vitamins|mesh-list
154554328|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
154554329|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554330|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154554331|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154554333|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
154554334|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
154554335|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554336|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
154554337|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554338|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
154554339|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154554340|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154554341|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554342|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554343|NCT04806230|Mirtazapine|mirtazapine|mesh-list
154554345|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154554346|NCT04806230|Sertraline|sertraline|mesh-list
154554347|NCT04806230|Escitalopram|escitalopram|mesh-list
154554348|NCT04806230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154554349|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154554350|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154554351|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554352|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554353|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
154554354|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554355|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154554356|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
154554357|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154554358|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154554359|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154554360|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
154554361|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
154554362|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154554363|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154554364|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554365|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154554366|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154554367|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154554368|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
154554369|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154554370|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154554371|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154554372|NCT02603120|Tenofovir|tenofovir|mesh-list
154554373|NCT02603120|Emtricitabine|emtricitabine|mesh-list
154554374|NCT02603120|Lamivudine|lamivudine|mesh-list
154554375|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154554376|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
154554377|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554378|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154554379|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154554380|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554381|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554382|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154554383|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154554384|NCT04815200|Copper|copper|mesh-list
154554385|NCT04815200|Nickel|nickel|mesh-list
154554386|NCT04815200|Trace Elements|trace elements|mesh-ancestor
154554387|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
154554388|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554389|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154554390|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554391|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554392|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154554393|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554394|NCT04814030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154554395|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554396|NCT04412252|Tofacitinib|tofacitinib|mesh-list
154554397|NCT04412252|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154554398|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154554399|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554400|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554401|NCT04813952|Sevoflurane|sevoflurane|mesh-list
154554402|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154554403|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154554404|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
154554405|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
154554406|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554407|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554408|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
154554409|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154554410|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
154554411|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
154554412|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554413|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554414|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154554416|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
154554417|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554418|NCT04803500|Simvastatin|simvastatin|mesh-list
154554419|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154554420|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154554421|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
154554422|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554423|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154554424|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154554425|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554426|NCT01331291|Bosutinib|bosutinib|mesh-list
154554427|NCT01331291|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154554428|NCT01331291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154554429|NCT01331291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554430|NCT01331291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554431|NCT02120339|Carvedilol|carvedilol|mesh-list
154554432|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154554433|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154554434|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
154554435|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554436|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554437|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554438|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154554439|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
154554440|NCT02120339|Protective Agents|protective agents|mesh-ancestor
154554441|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154554442|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154554443|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154554444|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
154554445|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154554446|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154554447|NCT02123381|Cetuximab|cetuximab|mesh-list
154554448|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154554449|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554450|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
154554451|NCT02123615|Antibodies|antibodies|mesh-list
154554452|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
154554453|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154554454|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154554455|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
154554456|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
154554457|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554458|NCT02120651|Hemostatics|hemostatics|mesh-list
154554459|NCT02120651|Coagulants|coagulants|mesh-ancestor
154554460|NCT02117219|Azacitidine|azacitidine|mesh-list
154554461|NCT02117219|Durvalumab|durvalumab|mesh-list
154554462|NCT02117219|Tremelimumab|tremelimumab|mesh-list
154554463|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154554464|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
154554465|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554466|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554467|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554468|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154554469|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154554470|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154554471|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154554472|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
154554473|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554474|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154554475|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154278301|NCT01148472|Analgesics|analgesics|mesh-ancestor
154554476|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554477|NCT02124005|Bupivacaine|bupivacaine|mesh-list
154554478|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
154554479|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
154554480|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554481|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554482|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
154554483|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554484|NCT03551873|Plecanatide|plecanatide|mesh-list
154554485|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154554486|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
154554487|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554488|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154554489|NCT02117765|Ustekinumab|ustekinumab|mesh-list
154554490|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
154554491|NCT02121119|Lidocaine|lidocaine|mesh-list
154554492|NCT02121119|Bupivacaine|bupivacaine|mesh-list
154554493|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
154554494|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
154554495|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554496|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554497|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
154554498|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554499|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154554500|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154554501|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154554502|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154554503|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554504|NCT02121197|Dexamethasone|dexamethasone|mesh-list
154554505|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554506|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
154554507|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
154554508|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554509|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554510|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154554511|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
154554512|NCT02121197|Hormones|hormones|mesh-ancestor
154554513|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323526|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554514|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154554515|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554516|NCT02124317|Paclitaxel|paclitaxel|mesh-list
154554517|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154554518|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154554519|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554520|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
154554521|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
154554522|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
154554523|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554524|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
154554525|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554526|NCT02121353|Ranibizumab|ranibizumab|mesh-list
154554527|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154554528|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154554529|NCT02121353|Growth Substances|growth substances|mesh-ancestor
154554530|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554531|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
154554532|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554533|NCT05617430|Leucovorin|leucovorin|mesh-list
154554534|NCT05617430|Bevacizumab|bevacizumab|mesh-list
154554535|NCT05617430|Fluorouracil|fluorouracil|mesh-list
154554536|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
154554537|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154554538|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554539|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154554540|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154554541|NCT05617430|Growth Substances|growth substances|mesh-ancestor
154554542|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554543|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
154554544|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
154554545|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554546|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154554547|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154554548|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
154554549|NCT05617430|Antidotes|antidotes|mesh-ancestor
154278376|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154554550|NCT05617430|Protective Agents|protective agents|mesh-ancestor
154323569|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
154554551|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
154554552|NCT05617430|Vitamins|vitamins|mesh-ancestor
154554553|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
154554554|NCT02251691|Tacrolimus|tacrolimus|mesh-list
154554555|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154554556|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
154554557|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554558|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154554559|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554560|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554561|NCT02595398|Triamcinolone|triamcinolone|mesh-list
154860306|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554562|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154554563|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154554564|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154554565|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554566|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
154554567|NCT02595398|Hormones|hormones|mesh-ancestor
154554568|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554569|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554570|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154554571|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
154554572|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554573|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554574|NCT02251769|Ritonavir|ritonavir|mesh-list
154554575|NCT02251769|Tipranavir|tipranavir|mesh-list
154554576|NCT02251769|Clarithromycin|clarithromycin|mesh-list
154554577|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154554578|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154554579|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
154554580|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554581|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554582|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154554583|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154554584|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
154554585|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554586|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154554587|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154554588|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154554589|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154554590|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
154554591|NCT02118311|Fludarabine|fludarabine|mesh-list
154554592|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154554593|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
154554594|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554595|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154554596|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154323600|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
154554597|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
154554598|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554599|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554600|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154554601|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154554602|NCT01368497|Entecavir|entecavir|mesh-list
154554603|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
154554604|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554605|NCT04812860|Tramadol|tramadol|mesh-list
154554606|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154554607|NCT04812860|Narcotics|narcotics|mesh-ancestor
154554608|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554609|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554610|NCT04812860|Analgesics|analgesics|mesh-ancestor
154554611|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
154554612|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554613|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
154554614|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154554615|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154554616|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554617|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
154554618|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
154554619|NCT04427540|Oxytocin|oxytocin|mesh-list
154554620|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
154554621|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278452|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554622|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554623|NCT04801940|Apixaban|apixaban|mesh-list
154554624|NCT04801940|Atorvastatin|atorvastatin|mesh-list
154554625|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154554626|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154554627|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
154554628|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554629|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154554630|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154554631|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554632|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154554633|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
154554634|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154554635|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
154554636|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
154554637|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154554639|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154554640|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154554641|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
154323654|NCT01095185|Simvastatin|simvastatin|mesh-list
154554642|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554643|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154554644|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154554645|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554646|NCT06173362|Prednisone|prednisone|mesh-list
154554647|NCT06173362|Cortisone|cortisone|mesh-list
154554648|NCT06173362|Androgen Antagonists|androgen antagonists|mesh-list
154554649|NCT06173362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554650|NCT06173362|Glucocorticoids|glucocorticoids|mesh-ancestor
154554651|NCT06173362|Hormones|hormones|mesh-ancestor
154554652|NCT06173362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554653|NCT06173362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554654|NCT06173362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154554655|NCT06173362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554656|NCT06173362|Hormone Antagonists|hormone antagonists|mesh-ancestor
154554657|NCT06173349|Paclitaxel|paclitaxel|mesh-list
154554658|NCT06173349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154554659|NCT06173349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154554660|NCT06173349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554661|NCT06173349|Tubulin Modulators|tubulin modulators|mesh-ancestor
154554662|NCT06173349|Antimitotic Agents|antimitotic agents|mesh-ancestor
154554663|NCT06173349|Mitosis Modulators|mitosis modulators|mesh-ancestor
154554664|NCT06173349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554665|NCT06173245|Ranibizumab|ranibizumab|mesh-list
154554666|NCT06173245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154554667|NCT06173245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154554668|NCT06173245|Growth Substances|growth substances|mesh-ancestor
154554669|NCT06173245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554670|NCT06173245|Growth Inhibitors|growth inhibitors|mesh-ancestor
154554671|NCT06173245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554672|NCT06173011|Pembrolizumab|pembrolizumab|mesh-list
154554673|NCT06173011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154554674|NCT06173011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554675|NCT06173011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154554676|NCT06173011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554677|NCT06172998|Phentolamine|phentolamine|mesh-list
154554678|NCT06172998|Nitroglycerin|nitroglycerin|mesh-list
154554679|NCT06172998|Vasodilator Agents|vasodilator agents|mesh-ancestor
154554680|NCT06172998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154554681|NCT06172998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154554682|NCT06172998|Adrenergic Agents|adrenergic agents|mesh-ancestor
154554683|NCT06172998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554684|NCT06172998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554685|NCT06172998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554686|NCT06172998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154554687|NCT06172920|Morphine|morphine|mesh-list
154554688|NCT06172920|Tramadol|tramadol|mesh-list
154554689|NCT06172920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154554690|NCT06172920|Narcotics|narcotics|mesh-ancestor
154554691|NCT06172920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554692|NCT06172920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554693|NCT06172920|Analgesics|analgesics|mesh-ancestor
154554694|NCT06172920|Sensory System Agents|sensory system agents|mesh-ancestor
154554695|NCT06172920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554696|NCT06172686|Doxycycline|doxycycline|mesh-list
154554697|NCT06172686|Piperaquine|piperaquine|mesh-list
154554698|NCT06172686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154554699|NCT06172686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554700|NCT06172686|Antimalarials|antimalarials|mesh-ancestor
154554701|NCT06172686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154554702|NCT06172686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154554703|NCT06172660|Vaccines|vaccines|mesh-list
154554704|NCT06172660|Immunologic Factors|immunologic factors|mesh-ancestor
154554705|NCT06172660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554706|NCT06172361|Prednisone|prednisone|mesh-list
154554707|NCT06172361|Tofacitinib|tofacitinib|mesh-list
154554708|NCT06172361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554709|NCT06172361|Glucocorticoids|glucocorticoids|mesh-ancestor
154554710|NCT06172361|Hormones|hormones|mesh-ancestor
154554711|NCT06172361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554712|NCT06172361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554713|NCT06172361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154554714|NCT06172361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554715|NCT06172361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154554716|NCT06172361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154554717|NCT06172361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554718|NCT06172361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554719|NCT06172322|Fulvestrant|fulvestrant|mesh-list
154554720|NCT06172322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154554721|NCT06172322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554722|NCT06172322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154554723|NCT06172322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154554724|NCT06172322|Hormone Antagonists|hormone antagonists|mesh-ancestor
154554725|NCT06172322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554726|NCT06172322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554727|NCT06172205|Leucovorin|leucovorin|mesh-list
154554728|NCT06172205|Apatinib|apatinib|mesh-list
154554729|NCT06172205|Fluorouracil|fluorouracil|mesh-list
154554730|NCT06172205|Oxaliplatin|oxaliplatin|mesh-list
154554731|NCT06172205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554732|NCT06172205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154554733|NCT06172205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554734|NCT06172205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554735|NCT06172205|Antimetabolites|antimetabolites|mesh-ancestor
154554736|NCT06172205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154554737|NCT06172205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154554738|NCT06172205|Immunologic Factors|immunologic factors|mesh-ancestor
154554739|NCT06172205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554740|NCT06172205|Antidotes|antidotes|mesh-ancestor
154554741|NCT06172205|Protective Agents|protective agents|mesh-ancestor
154554742|NCT06172205|Vitamin B Complex|vitamin b complex|mesh-ancestor
154554743|NCT06172205|Vitamins|vitamins|mesh-ancestor
154554744|NCT06172205|Micronutrients|micronutrients|mesh-ancestor
154554745|NCT06172140|Propofol|propofol|mesh-list
154554746|NCT06172140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154554747|NCT06172140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554748|NCT06172140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554749|NCT06172140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154554750|NCT06172140|Anesthetics, General|anesthetics, general|mesh-ancestor
154554751|NCT06172140|Anesthetics|anesthetics|mesh-ancestor
154554752|NCT06172127|Trastuzumab|trastuzumab|mesh-list
154554753|NCT06172127|Pertuzumab|pertuzumab|mesh-list
154554754|NCT06172127|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154554755|NCT06172127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154554756|NCT06172127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554757|NCT06172127|Immunoconjugates|immunoconjugates|mesh-ancestor
154554758|NCT06172127|Immunologic Factors|immunologic factors|mesh-ancestor
154554759|NCT06172127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554760|NCT06172036|Oxaliplatin|oxaliplatin|mesh-list
154554761|NCT06172036|Irinotecan|irinotecan|mesh-list
154554762|NCT06172036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554763|NCT06172036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154554764|NCT06172036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154554765|NCT06172036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554766|NCT06172036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554767|NCT06172023|Chitosan|chitosan|mesh-list
154554768|NCT06172023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154554769|NCT06172023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154554770|NCT06172023|Antimetabolites|antimetabolites|mesh-ancestor
154554771|NCT06172023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554772|NCT06172023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154554773|NCT06172023|Chelating Agents|chelating agents|mesh-ancestor
154554774|NCT06172023|Sequestering Agents|sequestering agents|mesh-ancestor
154554775|NCT06172023|Hemostatics|hemostatics|mesh-ancestor
154554776|NCT06172023|Coagulants|coagulants|mesh-ancestor
154554777|NCT06172010|Levofloxacin|levofloxacin|mesh-list
154554778|NCT06172010|Rifampin|rifampin|mesh-list
154554779|NCT06172010|Clindamycin|clindamycin|mesh-list
154554780|NCT06172010|Clindamycin palmitate|clindamycin palmitate|mesh-list
154554781|NCT06172010|Clindamycin phosphate|clindamycin phosphate|mesh-list
154554782|NCT06172010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154554783|NCT06172010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554784|NCT06172010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154554785|NCT06172010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154554786|NCT06172010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154554787|NCT06172010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554788|NCT06172010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554789|NCT06172010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554790|NCT06172010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154554791|NCT06172010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154554792|NCT06172010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154554793|NCT06172010|Antitubercular Agents|antitubercular agents|mesh-ancestor
154554794|NCT06172010|Leprostatic Agents|leprostatic agents|mesh-ancestor
154554795|NCT06172010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154554796|NCT06172010|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154554797|NCT06172010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154554798|NCT06172010|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154554799|NCT06172010|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154554800|NCT06172010|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154554801|NCT06172010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154554802|NCT06172010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154554803|NCT06171932|Methylprednisolone|methylprednisolone|mesh-list
154554804|NCT06171932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154554805|NCT06171932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154554806|NCT06171932|Prednisolone|prednisolone|mesh-list
154554807|NCT06171932|Prednisolone acetate|prednisolone acetate|mesh-list
154554808|NCT06171932|Hydrocortisone|hydrocortisone|mesh-list
154554809|NCT06171932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154554810|NCT06171932|Prednisolone phosphate|prednisolone phosphate|mesh-list
154554811|NCT06171932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554812|NCT06171932|Antiemetics|antiemetics|mesh-ancestor
154554813|NCT06171932|Autonomic Agents|autonomic agents|mesh-ancestor
154554814|NCT06171932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554815|NCT06171932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554816|NCT06171932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154554817|NCT06171932|Glucocorticoids|glucocorticoids|mesh-ancestor
154554818|NCT06171932|Hormones|hormones|mesh-ancestor
154554819|NCT06171932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154554820|NCT06171932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154554821|NCT06171932|Protective Agents|protective agents|mesh-ancestor
154554822|NCT06171932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154554823|NCT06171932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554824|NCT06171880|Tenofovir|tenofovir|mesh-list
154554825|NCT06171880|Antiviral Agents|antiviral agents|mesh-ancestor
154554826|NCT06171880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554827|NCT06171880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154554828|NCT06171880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154554829|NCT06171880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554830|NCT06171880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554831|NCT06171880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154554832|NCT06171880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154554833|NCT06171776|Calcium|calcium|mesh-list
154554834|NCT06171776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154554835|NCT06171776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554836|NCT06166745|Listerine|listerine|mesh-list
154554837|NCT06166745|Fluorides|fluorides|mesh-list
154323848|NCT01095809|Hormones|hormones|mesh-ancestor
154554838|NCT06166745|Sodium Fluoride|sodium fluoride|mesh-list
154554839|NCT06166745|Cariostatic Agents|cariostatic agents|mesh-ancestor
154554840|NCT06166745|Protective Agents|protective agents|mesh-ancestor
154554841|NCT06166745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554842|NCT06166745|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154554843|NCT06166745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554844|NCT06166602|Bupivacaine|bupivacaine|mesh-list
154554845|NCT06166602|Anesthetics, Local|anesthetics, local|mesh-ancestor
154554846|NCT06166602|Anesthetics|anesthetics|mesh-ancestor
154554847|NCT06166602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554848|NCT06166602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554849|NCT06166602|Sensory System Agents|sensory system agents|mesh-ancestor
154554850|NCT06166602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278677|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554851|NCT06165458|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154554852|NCT06165458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154554853|NCT06165458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154554854|NCT06165068|Aspirin|aspirin|mesh-list
154554855|NCT06165068|Acetylcysteine|acetylcysteine|mesh-list
154554856|NCT06165068|Clopidogrel|clopidogrel|mesh-list
154554857|NCT06165068|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154554858|NCT06165068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154554859|NCT06165068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154554860|NCT06165068|Analgesics|analgesics|mesh-ancestor
154554861|NCT06165068|Sensory System Agents|sensory system agents|mesh-ancestor
154554862|NCT06165068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554863|NCT06165068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554864|NCT06165068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554865|NCT06165068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154554866|NCT06165068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154554867|NCT06165068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154554868|NCT06165068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554869|NCT06165068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154554870|NCT06165068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154554871|NCT06165068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554872|NCT06165068|Antipyretics|antipyretics|mesh-ancestor
154554873|NCT06165068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154554874|NCT06165068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154554875|NCT06165068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154554876|NCT06165068|Purinergic Agents|purinergic agents|mesh-ancestor
154554877|NCT06165068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554878|NCT06165068|Antiviral Agents|antiviral agents|mesh-ancestor
154554879|NCT06165068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323902|NCT00064337|Hormones|hormones|mesh-ancestor
154554880|NCT06165068|Expectorants|expectorants|mesh-ancestor
154554881|NCT06165068|Respiratory System Agents|respiratory system agents|mesh-ancestor
154554882|NCT06165068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154554883|NCT06165068|Antioxidants|antioxidants|mesh-ancestor
154554884|NCT06165068|Protective Agents|protective agents|mesh-ancestor
154554885|NCT06165068|Antidotes|antidotes|mesh-ancestor
154554886|NCT06164795|Zoledronic Acid|zoledronic acid|mesh-list
154554887|NCT06164795|Denosumab|denosumab|mesh-list
154554888|NCT06164795|Teriparatide|teriparatide|mesh-list
154554889|NCT06164795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154554890|NCT06164795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554891|NCT06164795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154554892|NCT06163443|Vitamins|vitamins|mesh-list
154554893|NCT06163443|Vitamin B Complex|vitamin b complex|mesh-list
154554894|NCT06163443|Micronutrients|micronutrients|mesh-ancestor
154554895|NCT06163443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554896|NCT06162013|Niacinamide|niacinamide|mesh-list
154554897|NCT06162013|Niacin|niacin|mesh-list
154554898|NCT06162013|Nicotinic Acids|nicotinic acids|mesh-list
154554899|NCT06162013|Vitamin B Complex|vitamin b complex|mesh-ancestor
154554900|NCT06162013|Vitamins|vitamins|mesh-ancestor
154554901|NCT06162013|Micronutrients|micronutrients|mesh-ancestor
154554902|NCT06162013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554903|NCT06162013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154554904|NCT06162013|Antimetabolites|antimetabolites|mesh-ancestor
154554905|NCT06162013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554906|NCT06162013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154554907|NCT06162013|Vasodilator Agents|vasodilator agents|mesh-ancestor
154554908|NCT06161844|Semaglutide|semaglutide|mesh-list
154554909|NCT06161844|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154554910|NCT06161844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154554911|NCT06161844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554912|NCT06161675|Nicotine|nicotine|mesh-list
154554913|NCT06161675|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154554914|NCT06161675|Autonomic Agents|autonomic agents|mesh-ancestor
154554915|NCT06161675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554916|NCT06161675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554917|NCT06161675|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154554918|NCT06161675|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154554919|NCT06161675|Cholinergic Agents|cholinergic agents|mesh-ancestor
154554920|NCT06161675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554921|NCT06161675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554922|NCT06151431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154554923|NCT06151431|Adrenergic Agents|adrenergic agents|mesh-list
154554924|NCT06151431|Adrenergic Agonists|adrenergic agonists|mesh-list
154554925|NCT06151431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554926|NCT06151431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554927|NCT06151431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554928|NCT06145893|Hemay005|hemay005|mesh-list
154554929|NCT06145893|Dermatologic Agents|dermatologic agents|mesh-ancestor
154554930|NCT06145893|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154554931|NCT06145893|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154554932|NCT06145893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554933|NCT06145893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554934|NCT06135298|Zoledronic Acid|zoledronic acid|mesh-list
154554935|NCT06135298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154554936|NCT06135298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554937|NCT06103721|Dexmedetomidine|dexmedetomidine|mesh-list
154554938|NCT06103721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154554939|NCT06103721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154554940|NCT06103721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554941|NCT06103721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154554943|NCT06103721|Sensory System Agents|sensory system agents|mesh-ancestor
154554944|NCT06103721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554945|NCT06103721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154554946|NCT06103721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154554947|NCT06103721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154554948|NCT06103721|Adrenergic Agents|adrenergic agents|mesh-ancestor
154554949|NCT06103721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554950|NCT06103721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554951|NCT06092957|Cisplatin|cisplatin|mesh-list
154554952|NCT06092957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554953|NCT06066216|Paclitaxel|paclitaxel|mesh-list
154554954|NCT06066216|Carboplatin|carboplatin|mesh-list
154554955|NCT06066216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154554956|NCT06066216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554957|NCT06066216|Tubulin Modulators|tubulin modulators|mesh-ancestor
154554958|NCT06066216|Antimitotic Agents|antimitotic agents|mesh-ancestor
154554959|NCT06066216|Mitosis Modulators|mitosis modulators|mesh-ancestor
154554960|NCT06066216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554961|NCT06026319|Cyclophosphamide|cyclophosphamide|mesh-list
154554962|NCT06026319|Fludarabine|fludarabine|mesh-list
154554963|NCT06026319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154554964|NCT06026319|Immunologic Factors|immunologic factors|mesh-ancestor
154554965|NCT06026319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554966|NCT06026319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154554967|NCT06026319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154554968|NCT06026319|Alkylating Agents|alkylating agents|mesh-ancestor
154554969|NCT06026319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554970|NCT06026319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154554971|NCT06026319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154554972|NCT06001047|Betahistine|betahistine|mesh-list
154554973|NCT06001047|Vasodilator Agents|vasodilator agents|mesh-ancestor
154554974|NCT06001047|Histamine Agonists|histamine agonists|mesh-ancestor
154554975|NCT06001047|Histamine Agents|histamine agents|mesh-ancestor
154554976|NCT06001047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154554977|NCT06001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554978|NCT06001047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554979|NCT05999708|Indomethacin|indomethacin|mesh-list
154554980|NCT05999708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154554981|NCT05999708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154554982|NCT05999708|Analgesics|analgesics|mesh-ancestor
154554983|NCT05999708|Sensory System Agents|sensory system agents|mesh-ancestor
154554984|NCT05999708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154554985|NCT05999708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154554986|NCT05999708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154554987|NCT05999708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154554988|NCT05999708|Gout Suppressants|gout suppressants|mesh-ancestor
154554989|NCT05999708|Tocolytic Agents|tocolytic agents|mesh-ancestor
154554990|NCT05999708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154554991|NCT05999708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154554992|NCT05999708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154554993|NCT05999708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154554994|NCT05990387|Mirabegron|mirabegron|mesh-list
154554995|NCT05990387|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154554996|NCT05990387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154554997|NCT05990387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154554998|NCT05990387|Adrenergic Agents|adrenergic agents|mesh-ancestor
154554999|NCT05990387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555000|NCT05990387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555001|NCT05990387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555002|NCT05990387|Urological Agents|urological agents|mesh-ancestor
154555003|NCT05967403|Propofol|propofol|mesh-list
154555004|NCT05967403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154555005|NCT05967403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154555006|NCT05967403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555007|NCT05967403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154555008|NCT05967403|Anesthetics, General|anesthetics, general|mesh-ancestor
154555009|NCT05967403|Anesthetics|anesthetics|mesh-ancestor
154555010|NCT05833126|Bevacizumab|bevacizumab|mesh-list
154555011|NCT05833126|Atezolizumab|atezolizumab|mesh-list
154555012|NCT05833126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389863|NCT03167164|Antidotes|antidotes|mesh-ancestor
154860307|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555013|NCT05833126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555014|NCT05833126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154555015|NCT05833126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154555016|NCT05833126|Growth Substances|growth substances|mesh-ancestor
154555017|NCT05833126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555018|NCT05833126|Growth Inhibitors|growth inhibitors|mesh-ancestor
154555019|NCT05833126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154555020|NCT05833126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555021|NCT05818735|Escitalopram|escitalopram|mesh-list
154555022|NCT05818735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154555023|NCT05818735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154555024|NCT05818735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154555025|NCT05818735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555026|NCT05818735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555027|NCT05818735|Serotonin Agents|serotonin agents|mesh-ancestor
154555028|NCT05818735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555030|NCT05817240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555031|NCT05817240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154555032|NCT05817240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555033|NCT05817240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555034|NCT05801237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154555035|NCT05801237|Antibodies|antibodies|mesh-list
154555036|NCT05801237|Immunoglobulins|immunoglobulins|mesh-list
154555037|NCT05801237|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154555038|NCT05801237|Immunologic Factors|immunologic factors|mesh-ancestor
154555039|NCT05801237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555040|NCT05801237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555041|NCT05796661|Citric Acid|citric acid|mesh-list
154555042|NCT05796661|Sodium Citrate|sodium citrate|mesh-list
154555043|NCT05796661|Anticoagulants|anticoagulants|mesh-ancestor
154555044|NCT05796661|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154555045|NCT05796661|Chelating Agents|chelating agents|mesh-ancestor
154555046|NCT05796661|Sequestering Agents|sequestering agents|mesh-ancestor
154555047|NCT05796661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555048|NCT05782881|Glucagon|glucagon|mesh-list
154555049|NCT05782881|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154555050|NCT05782881|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154555051|NCT05782881|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154555052|NCT05782881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154555053|NCT05782881|Hormones|hormones|mesh-ancestor
154555054|NCT05782881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555055|NCT05782881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555056|NCT05782881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555057|NCT05782881|Incretins|incretins|mesh-ancestor
154555058|NCT05782881|Protease Inhibitors|protease inhibitors|mesh-ancestor
154555059|NCT05780073|Dasatinib|dasatinib|mesh-list
154555060|NCT05780073|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154555061|NCT05780073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154555062|NCT05780073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555063|NCT05780073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555064|NCT05780073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555065|NCT05755789|Cefoxitin|cefoxitin|mesh-list
154555066|NCT05755789|Cefotaxime|cefotaxime|mesh-list
154555067|NCT05755789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555068|NCT05755789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555069|NCT05702970|Vitamin D|vitamin d|mesh-list
154555070|NCT05702970|Vitamins|vitamins|mesh-ancestor
154555071|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
154324074|NCT01092533|Prednisolone|prednisolone|mesh-list
154555072|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555073|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154555074|NCT05689619|Silybin|silybin|mesh-list
154555075|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154555076|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555077|NCT05689619|Protective Agents|protective agents|mesh-ancestor
154555078|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555079|NCT05674994|Prednisone|prednisone|mesh-list
154555080|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555081|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
154555082|NCT05674994|Hormones|hormones|mesh-ancestor
154555083|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555084|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555085|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154555086|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555088|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154555089|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555090|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555091|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154555092|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154555093|NCT05611268|Protective Agents|protective agents|mesh-ancestor
154555094|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555095|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
154555096|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154555097|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
154555098|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
154555099|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555100|NCT05567562|Clopidogrel|clopidogrel|mesh-list
154555101|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555102|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555103|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154555104|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154555105|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154555106|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154555107|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
154555108|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555109|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154555110|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154555111|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154555112|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154555113|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555114|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555115|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555116|NCT05560516|Analgesics|analgesics|mesh-ancestor
154555117|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
154555118|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555119|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
154555120|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154555121|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
154555122|NCT05554419|Cytarabine|cytarabine|mesh-list
154555123|NCT05554419|Azacitidine|azacitidine|mesh-list
154555124|NCT05554419|Daunorubicin|daunorubicin|mesh-list
154555125|NCT05554419|Venetoclax|venetoclax|mesh-list
154555126|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154555127|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
154555128|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555129|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555130|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
154555131|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555132|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154555133|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
154555134|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555135|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555136|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154555137|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154555138|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154555139|NCT05542264|Olanzapine|olanzapine|mesh-list
154555140|NCT05542264|Risperidone|risperidone|mesh-list
154555141|NCT05542264|Aripiprazole|aripiprazole|mesh-list
154555142|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154555143|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
154555144|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154555145|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
154555146|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555147|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555148|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555149|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154555150|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278975|NCT05922982|Sympathomimetics|sympathomimetics|mesh-ancestor
154324181|NCT01399684|Leucovorin|leucovorin|mesh-list
154555151|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154555152|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154555153|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
154555154|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
154555155|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
154555156|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555157|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154555158|NCT05542264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154555159|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154555160|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154555161|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
154555162|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
154555163|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154555164|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154555165|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154555166|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154555168|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555169|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555170|NCT05360537|Insulin|insulin|mesh-list
154555171|NCT05360537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154555172|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
154555173|NCT05360537|Liraglutide|liraglutide|mesh-list
154555174|NCT05360537|Insulin, Long-Acting|insulin, long-acting|mesh-list
154555175|NCT05360537|Xultophy|xultophy|mesh-list
154555176|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154555177|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555178|NCT05360537|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154555179|NCT05360537|Incretins|incretins|mesh-ancestor
154555180|NCT05360537|Hormones|hormones|mesh-ancestor
154555181|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555182|NCT05268744|Micronutrients|micronutrients|mesh-list
154555183|NCT05268744|Trace Elements|trace elements|mesh-list
154555184|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555185|NCT05251129|Atorvastatin|atorvastatin|mesh-list
154555186|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154555187|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154555188|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
154555189|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555190|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154555191|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154555192|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555193|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
154555194|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154555195|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555196|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154555197|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555198|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
154555199|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154555200|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
154555201|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555202|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555203|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154555204|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
154555205|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555206|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555207|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154555208|NCT05150236|Nivolumab|nivolumab|mesh-list
154555209|NCT05150236|Ipilimumab|ipilimumab|mesh-list
154555210|NCT05150236|Pluvicto|pluvicto|mesh-list
154555211|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555212|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555213|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154555214|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555215|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154555216|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
154555217|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555218|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154555219|NCT05070156|Vaccines|vaccines|mesh-list
154555220|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
154555221|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555222|NCT05050188|Lansoprazole|lansoprazole|mesh-list
154555223|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
154555224|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154555225|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154555226|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154555227|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555228|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555229|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154555230|NCT05017103|Antibodies|antibodies|mesh-list
154555231|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
154555232|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154555233|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
154555234|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555235|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555236|NCT04951063|Immunomodulating Agents|immunomodulating agents|mesh-list
154555237|NCT04951063|Immunologic Factors|immunologic factors|mesh-ancestor
154324253|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
154555238|NCT04951063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555239|NCT04939272|Venetoclax|venetoclax|mesh-list
154555240|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555241|NCT04882085|Ceftazidime|ceftazidime|mesh-list
154555242|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154555243|NCT04882085|Avibactam|avibactam|mesh-list
154555244|NCT04882085|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154555245|NCT04882085|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154555246|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555247|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555248|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154555249|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555250|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555251|NCT04798027|Vaccines|vaccines|mesh-list
154555252|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
154555253|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555254|NCT04788667|Erenumab|erenumab|mesh-list
154555255|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
154555256|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154555257|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154555258|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555259|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
154555260|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555261|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555262|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154555263|NCT04788667|Analgesics|analgesics|mesh-ancestor
154555264|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
154555265|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555266|NCT04778397|Cytarabine|cytarabine|mesh-list
154555267|NCT04778397|Azacitidine|azacitidine|mesh-list
154555268|NCT04778397|Daunorubicin|daunorubicin|mesh-list
154555269|NCT04778397|Venetoclax|venetoclax|mesh-list
154555270|NCT04778397|Idarubicin|idarubicin|mesh-list
154555271|NCT04778397|Magrolimab|magrolimab|mesh-list
154555272|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154555273|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154555274|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
154555275|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555276|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555277|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
154555278|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324293|NCT01517776|Temozolomide|temozolomide|mesh-list
154555279|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154555280|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
154555281|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555282|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555283|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154555284|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154555285|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154555286|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154555287|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555288|NCT04682405|Melphalan|melphalan|mesh-list
154555289|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154555290|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
154555291|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555292|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555293|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154555294|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154555295|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
154555296|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555297|NCT04607980|Ustekinumab|ustekinumab|mesh-list
154555298|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
154555299|NCT04540133|Dexamethasone|dexamethasone|mesh-list
154279130|NCT05262764|Empagliflozin|empagliflozin|mesh-list
154555300|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
154555301|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154555302|NCT04540133|BB 1101|bb 1101|mesh-list
154555303|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555304|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
154555305|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
154555306|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555307|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555308|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154555309|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
154555310|NCT04540133|Hormones|hormones|mesh-ancestor
154555311|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555312|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154555313|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555314|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
154555315|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555316|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555317|NCT04521647|Nicotine|nicotine|mesh-list
154555318|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154555319|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
154555320|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555321|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555322|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154555323|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154324335|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
154555324|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
154555325|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555326|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555327|NCT04494880|Bupivacaine|bupivacaine|mesh-list
154555328|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
154555329|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
154555330|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154555331|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555332|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
154555333|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555334|NCT04456608|Aspirin|aspirin|mesh-list
154555335|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154555336|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555337|NCT04456608|Analgesics|analgesics|mesh-ancestor
154555338|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
154555339|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555340|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555341|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555342|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555343|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154555344|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154555345|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555346|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154555347|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154555348|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555349|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
154555350|NCT04405349|Atezolizumab|atezolizumab|mesh-list
154555351|NCT04405349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154555352|NCT04405349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555353|NCT04405349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555354|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555355|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154555356|NCT04401553|Vancomycin|vancomycin|mesh-list
154555357|NCT04401553|Cephalosporins|cephalosporins|mesh-list
154555358|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555359|NCT04393298|Leucovorin|leucovorin|mesh-list
154555360|NCT04393298|Trifluridine|trifluridine|mesh-list
154555361|NCT04393298|Fluorouracil|fluorouracil|mesh-list
154555362|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555363|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
154324379|NCT01337752|Dexamethasone|dexamethasone|mesh-list
154555364|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555365|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154555366|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555367|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154555368|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
154555369|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
154555370|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555371|NCT04393298|Antidotes|antidotes|mesh-ancestor
154555372|NCT04393298|Protective Agents|protective agents|mesh-ancestor
154555373|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
154555374|NCT04393298|Vitamins|vitamins|mesh-ancestor
154555375|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
154555376|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
154555377|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154555378|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
154555379|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555380|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154555381|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
154555382|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154860308|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
154555383|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154555384|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555385|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555386|NCT04289142|Analgesics|analgesics|mesh-ancestor
154555387|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
154555388|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555389|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154555390|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154555391|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154555392|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
154555393|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555394|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555395|NCT04284852|Niraparib|niraparib|mesh-list
154555396|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154555397|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555398|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555399|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555400|NCT04233801|Empagliflozin|empagliflozin|mesh-list
154555401|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154555402|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555403|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154555404|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555405|NCT04130659|Omeprazole|omeprazole|mesh-list
154555406|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154555407|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154555408|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154555409|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555410|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555411|NCT04097730|Riboflavin|riboflavin|mesh-list
154555412|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
154555413|NCT04097730|Difluprednate|difluprednate|mesh-list
154555414|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555415|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555416|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154555417|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154555418|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555419|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555420|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555421|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555422|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
154555423|NCT04097730|Vitamins|vitamins|mesh-ancestor
154555424|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
154555425|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154555426|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
154555427|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
154555428|NCT04097730|Hormones|hormones|mesh-ancestor
154555429|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555430|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
154555431|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154555432|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154555433|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154555434|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154555435|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555436|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
154555437|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555438|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555439|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154555440|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555441|NCT04069156|Aspirin|aspirin|mesh-list
154555442|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154555443|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555444|NCT04069156|Analgesics|analgesics|mesh-ancestor
154555445|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
154555446|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555447|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555448|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555449|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555450|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154555451|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154555452|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555453|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154555454|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154860309|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154555455|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555457|NCT04019015|Thrombin|thrombin|mesh-list
154555458|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
154555459|NCT04019015|Coagulants|coagulants|mesh-ancestor
154555460|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
154555461|NCT04013555|Tryptophan|tryptophan|mesh-list
154555462|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154555463|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
154555464|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555465|NCT04013555|Expectorants|expectorants|mesh-ancestor
154555466|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
154555467|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154555468|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
154555469|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555470|NCT04013555|Protective Agents|protective agents|mesh-ancestor
154555471|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555472|NCT04013555|Antidotes|antidotes|mesh-ancestor
154555473|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154555474|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
154555475|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154555476|NCT03980314|Nivolumab|nivolumab|mesh-list
154555477|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555478|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555479|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154555480|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555481|NCT03956680|Nivolumab|nivolumab|mesh-list
154555482|NCT03956680|Ipilimumab|ipilimumab|mesh-list
154555483|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555484|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555485|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154555486|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555487|NCT03928314|Paclitaxel|paclitaxel|mesh-list
154555488|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154555489|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555490|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
154555491|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
154555492|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
154555493|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555494|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
154555495|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555496|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555497|NCT03924869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154555498|NCT03924869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555499|NCT03719924|Paclitaxel|paclitaxel|mesh-list
154555500|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154555501|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555502|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
154555503|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
154555504|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
154324519|NCT00039377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154555505|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555506|NCT03713879|Indomethacin|indomethacin|mesh-list
154555507|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154555508|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555509|NCT03713879|Analgesics|analgesics|mesh-ancestor
154555510|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
154555511|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555512|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555513|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555514|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555515|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
154555516|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
154555517|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154555518|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154555519|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555520|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555521|NCT03635788|Rilpivirine|rilpivirine|mesh-list
154555522|NCT03635788|Cabotegravir|cabotegravir|mesh-list
154555523|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154555524|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154555526|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555527|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
154555528|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555529|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154555530|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154860310|NCT03316378|Ropivacaine|ropivacaine|mesh-list
154555531|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154555532|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154555533|NCT03415854|Paclitaxel|paclitaxel|mesh-list
154555534|NCT03415854|Cisplatin|cisplatin|mesh-list
154555535|NCT03415854|Gemcitabine|gemcitabine|mesh-list
154555536|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154555537|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154555538|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555539|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
154555540|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
154555541|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
154555542|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555543|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154555544|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
154555545|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154555546|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
154555547|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555548|NCT03260920|Oxytocin|oxytocin|mesh-list
154555549|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
154555550|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154555551|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555552|NCT03248063|Cefazolin|cefazolin|mesh-list
154555553|NCT03248063|Cloxacillin|cloxacillin|mesh-list
154555554|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555555|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555556|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
154555557|NCT03221257|Pirfenidone|pirfenidone|mesh-list
154555558|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154555559|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555560|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154555561|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
154555562|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555563|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555564|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555565|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555566|NCT03221257|Analgesics|analgesics|mesh-ancestor
154555567|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
154555568|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555569|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555570|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154555571|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555572|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555573|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555574|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
154555575|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154555576|NCT02981173|Psilocybin|psilocybin|mesh-list
154555577|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
154555578|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555579|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154555580|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154555581|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555582|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555583|NCT02978326|Zuranolone|zuranolone|mesh-list
154555584|NCT02978326|Antidepressive Agents|antidepressive agents|mesh-ancestor
154555585|NCT02978326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154555586|NCT02967172|Epinephrine|epinephrine|mesh-list
154555587|NCT02967172|Morphine|morphine|mesh-list
154555588|NCT02967172|Ropivacaine|ropivacaine|mesh-list
154555589|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154555590|NCT02967172|Narcotics|narcotics|mesh-ancestor
154555591|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154555592|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555593|NCT02967172|Analgesics|analgesics|mesh-ancestor
154555594|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
154555595|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555596|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
154555597|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
154555598|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154555599|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154555600|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
154555601|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555602|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555604|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154555605|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
154555606|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154555607|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
154555608|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
154555609|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
154555610|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154555611|NCT02916316|Doxorubicin|doxorubicin|mesh-list
154555612|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154555613|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154555614|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555615|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154555616|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154555617|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555618|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555620|NCT02834403|Docetaxel|docetaxel|mesh-list
154555621|NCT02834403|Amlodipine|amlodipine|mesh-list
154555622|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154555623|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555624|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
154555625|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
154555626|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
154555627|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555628|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154555629|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555630|NCT02834403|Analgesics|analgesics|mesh-ancestor
154555631|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
154555632|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555633|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555634|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555635|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555636|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154555637|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154555638|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154555639|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154555640|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555641|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
154555642|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154555643|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154555644|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154555645|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154555646|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
154555647|NCT02682511|Ifetroban|ifetroban|mesh-list
154555648|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154555649|NCT02456974|Amoxicillin|amoxicillin|mesh-list
154555650|NCT02456974|Vancomycin|vancomycin|mesh-list
154555651|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
154555652|NCT02456974|Meropenem|meropenem|mesh-list
154555653|NCT02456974|Tazobactam|tazobactam|mesh-list
154555654|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
154555655|NCT02456974|Amikacin|amikacin|mesh-list
154555656|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154555657|NCT02456974|Teicoplanin|teicoplanin|mesh-list
154555658|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555659|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555660|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154555661|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154555662|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555663|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555664|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555665|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154555666|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154555667|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154555668|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
154555669|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555670|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555671|NCT02411656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154555672|NCT02411656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555673|NCT02060188|Nivolumab|nivolumab|mesh-list
154555674|NCT02060188|Ipilimumab|ipilimumab|mesh-list
154555675|NCT02060188|Relatlimab|relatlimab|mesh-list
154279503|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
154555676|NCT02060188|Daratumumab|daratumumab|mesh-list
154555677|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555678|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555679|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154555680|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555681|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
154555682|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555683|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
154555684|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555685|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555686|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154555687|NCT01946074|Paclitaxel|paclitaxel|mesh-list
154555688|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154555689|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555690|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
154555691|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
154555692|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
154555693|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555694|NCT01254864|Prednisone|prednisone|mesh-list
154555695|NCT01254864|Sunitinib|sunitinib|mesh-list
154555696|NCT01254864|Dasatinib|dasatinib|mesh-list
154555697|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
154555698|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555699|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
154555700|NCT01254864|Hormones|hormones|mesh-ancestor
154555701|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555702|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555703|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154555704|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555705|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154555706|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154555707|NCT01254864|Growth Substances|growth substances|mesh-ancestor
154555708|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
154555709|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154555710|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555711|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555712|NCT01254864|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154555713|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154555714|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
154555715|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154555716|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
154555717|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154555718|NCT00868283|Protective Agents|protective agents|mesh-ancestor
154555719|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555720|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
154555721|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154555722|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154555723|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555724|NCT02127047|Incretins|incretins|mesh-ancestor
154555725|NCT02127047|Hormones|hormones|mesh-ancestor
154555726|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555727|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154555728|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154555729|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555730|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555731|NCT02122055|Midazolam|midazolam|mesh-list
154555732|NCT02122055|Fentanyl|fentanyl|mesh-list
154555733|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
154555734|NCT02122055|Propofol|propofol|mesh-list
154555735|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154555736|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154555737|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555738|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555739|NCT02122055|Analgesics|analgesics|mesh-ancestor
154555740|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
154555741|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555742|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154555743|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154555744|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154555745|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
154555746|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555747|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555748|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154555749|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
154279576|NCT00786019|Protective Agents|protective agents|mesh-ancestor
154555750|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
154555751|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154555752|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154555753|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154555754|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154555755|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
154555756|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
154555757|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154555758|NCT02122055|Narcotics|narcotics|mesh-ancestor
154555759|NCT02125409|Aspirin|aspirin|mesh-list
154555760|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154555761|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555762|NCT02125409|Analgesics|analgesics|mesh-ancestor
154555763|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
154555764|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555765|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555766|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555767|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555768|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154555769|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154555770|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555771|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154555772|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154555773|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555774|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
154555775|NCT04816838|Osimertinib|osimertinib|mesh-list
154555776|NCT04816838|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154555777|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154555778|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555779|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555780|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555781|NCT02788175|Vedolizumab|vedolizumab|mesh-list
154555782|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154555783|NCT03551171|Niraparib|niraparib|mesh-list
154555784|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154555785|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555786|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555787|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555788|NCT02787083|Mirabegron|mirabegron|mesh-list
154555789|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154555790|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154555791|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154555792|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154555793|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555794|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555795|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555796|NCT02787083|Urological Agents|urological agents|mesh-ancestor
154555797|NCT02122211|Betaine|betaine|mesh-list
154555798|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154555799|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
154555800|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154555801|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
154555802|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555803|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154555804|NCT02125565|Lidocaine|lidocaine|mesh-list
154555805|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
154555806|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
154324824|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
154555807|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154555808|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555809|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
154555810|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555811|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154555812|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154555813|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154555814|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154555815|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555816|NCT02125643|Caffeine|caffeine|mesh-list
154555817|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154555818|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555819|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154555820|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555821|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555822|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154555823|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154555824|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
154555825|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555826|NCT02127437|Lanreotide|lanreotide|mesh-list
154555827|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555828|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
154555829|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154555830|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
154555831|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555832|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
154555833|NCT02122601|Protective Agents|protective agents|mesh-ancestor
154555834|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
154555835|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154555836|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154555837|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154555838|NCT02127593|Norgestimate|norgestimate|mesh-list
154555839|NCT02127593|Norgestrel|norgestrel|mesh-list
154555840|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154555841|NCT02127593|Estradiol|estradiol|mesh-list
154555842|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154555843|NCT02127593|Estrogens|estrogens|mesh-ancestor
154555844|NCT02127593|Hormones|hormones|mesh-ancestor
154555845|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555846|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555847|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154555848|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
154555849|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154555850|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154555851|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154555852|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154555853|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154324866|NCT01093235|Bevacizumab|bevacizumab|mesh-list
154555854|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555855|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555856|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154555857|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154555858|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555859|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555860|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555861|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154555862|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
154555863|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154555864|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154555865|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555866|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
154555867|NCT02122679|Coagulants|coagulants|mesh-ancestor
154555868|NCT04810754|Daratumumab|daratumumab|mesh-list
154555869|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555870|NCT02127749|Metronidazole|metronidazole|mesh-list
154555871|NCT02127749|Vancomycin|vancomycin|mesh-list
154555872|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
154555873|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555874|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555875|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154555876|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154555877|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154555878|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154555879|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555880|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555881|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555882|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154555883|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154555884|NCT04797338|Nafarelin|nafarelin|mesh-list
154555885|NCT04797338|Progesterone|progesterone|mesh-list
154555886|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154555887|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154555888|NCT04797338|Estradiol|estradiol|mesh-list
154555889|NCT04797338|Progestins|progestins|mesh-ancestor
154555890|NCT04797338|Hormones|hormones|mesh-ancestor
154555891|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555892|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555893|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154555894|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
154555895|NCT04797338|Estrogens|estrogens|mesh-ancestor
154324920|NCT04475614|Vitamins|vitamins|mesh-ancestor
154555896|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154555897|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154555898|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
154555899|NCT05272865|Dronabinol|dronabinol|mesh-list
154555900|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
154555901|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555902|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154555903|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555904|NCT05272865|Analgesics|analgesics|mesh-ancestor
154555905|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
154555906|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555907|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154555908|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154860311|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
154555909|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555910|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555911|NCT05272865|Hormones|hormones|mesh-ancestor
154555912|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555913|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154555914|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
154555915|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555916|NCT04809818|Aspirin|aspirin|mesh-list
154555917|NCT04809818|Dabigatran|dabigatran|mesh-list
154555918|NCT04809818|Apixaban|apixaban|mesh-list
154555919|NCT04809818|Clopidogrel|clopidogrel|mesh-list
154555920|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154555921|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154555922|NCT04809818|Analgesics|analgesics|mesh-ancestor
154555923|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
154555924|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154555925|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555926|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154555927|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555928|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154555929|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154555930|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555931|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154555932|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154555933|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555934|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
154555935|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154555936|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154555937|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154555938|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
154555939|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154555940|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
154555941|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154555942|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
154555943|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
154555944|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154555945|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
154555946|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
154555947|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555948|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
154555949|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555950|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154555951|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
154555952|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
154555953|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154555954|NCT02126267|Azithromycin|azithromycin|mesh-list
154555955|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154555956|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555957|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
154555958|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154555959|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555960|NCT02128061|Rituximab|rituximab|mesh-list
154555961|NCT02128061|Lenalidomide|lenalidomide|mesh-list
154555962|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555963|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555964|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
154555965|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555966|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154555967|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154555968|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154555969|NCT02128061|Growth Substances|growth substances|mesh-ancestor
154555970|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
154555971|NCT02596958|Bevacizumab|bevacizumab|mesh-list
154555972|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154555973|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154555974|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154555975|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154279798|NCT01255956|Sirolimus|sirolimus|mesh-list
154555976|NCT02596958|Growth Substances|growth substances|mesh-ancestor
154555977|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555978|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
154555979|NCT04808648|Itraconazole|itraconazole|mesh-list
154555980|NCT04808648|Rifampin|rifampin|mesh-list
154555981|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
154555982|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154555983|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154555984|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154555985|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154555986|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154555987|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154555988|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
154555989|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154555990|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154555991|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154555992|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154555993|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
154555994|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154555995|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
154555996|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154555997|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154555998|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154555999|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154556000|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154556001|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154556002|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154556003|NCT02126657|Glycolic acid|glycolic acid|mesh-list
154556004|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
154556005|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
154556006|NCT02128451|Fentanyl|fentanyl|mesh-list
154556007|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154556008|NCT02128451|Narcotics|narcotics|mesh-ancestor
154556009|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556010|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556011|NCT02128451|Analgesics|analgesics|mesh-ancestor
154556012|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
154556013|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556014|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154556015|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154556016|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
154556017|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
154556018|NCT04785716|Niraparib|niraparib|mesh-list
154556019|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154556020|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325040|NCT00906334|ON 01910|on 01910|mesh-list
154556021|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556022|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556023|NCT01367249|Bromfenac|bromfenac|mesh-list
154556024|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154556025|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154556026|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154556027|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154556028|NCT01367249|Analgesics|analgesics|mesh-ancestor
154556029|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
154556030|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556031|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556032|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556033|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154556034|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
154556035|NCT02128685|Progestins|progestins|mesh-ancestor
154556036|NCT02128685|Hormones|hormones|mesh-ancestor
154556037|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556038|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556039|NCT02252627|Phenylephrine|phenylephrine|mesh-list
154556040|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
154556041|NCT02252627|Ephedrine|ephedrine|mesh-list
154556042|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154556043|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
154556044|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
154556045|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556046|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556047|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
154556048|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154253740|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556050|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556051|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154556052|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154556053|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154556054|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154556055|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556056|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556057|NCT02252627|Protective Agents|protective agents|mesh-ancestor
154556058|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154556059|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
154556060|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154556061|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
154556062|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154556063|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
154556064|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556065|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556066|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
154556067|NCT03550859|Telmisartan|telmisartan|mesh-list
154556068|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154556069|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154556070|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154556071|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
154556072|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556073|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154556074|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154556075|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556076|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154556077|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154556078|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154556080|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
154556081|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154556082|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
154556083|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556084|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154556085|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154556086|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
154556087|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556088|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556089|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154556090|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556091|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
154556092|NCT03550781|Hormones|hormones|mesh-ancestor
154556093|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556094|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154556095|NCT02260661|Fulvestrant|fulvestrant|mesh-list
154556096|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154556097|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556098|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154556099|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154556100|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
154556101|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556102|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556103|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
154556104|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
154556105|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154556106|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154556107|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556108|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556109|NCT02136329|Urological Agents|urological agents|mesh-ancestor
154556110|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
154556111|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154556112|NCT02129231|Simvastatin|simvastatin|mesh-list
154556113|NCT02129231|Ezetimibe|ezetimibe|mesh-list
154556114|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154556115|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154556116|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154556117|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
154556118|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556119|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154253741|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154556120|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154556121|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556122|NCT02129231|Antacids|antacids|mesh-ancestor
154556123|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154556124|NCT02136641|Midazolam|midazolam|mesh-list
154556125|NCT02136641|Fentanyl|fentanyl|mesh-list
154556126|NCT02136641|Ketamine|ketamine|mesh-list
154556127|NCT02136641|Analgesics|analgesics|mesh-ancestor
154556128|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
154556129|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556130|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556131|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154556132|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154556133|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
154556135|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556136|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154556137|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154556138|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556139|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556140|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154556141|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154556142|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154556143|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154556144|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154556145|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
154556146|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
154556147|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154556148|NCT02136641|Narcotics|narcotics|mesh-ancestor
154556149|NCT03549689|Tenofovir|tenofovir|mesh-list
154556150|NCT03549689|Lamivudine|lamivudine|mesh-list
154556151|NCT03549689|Dolutegravir|dolutegravir|mesh-list
154556152|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
154556153|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556154|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154556155|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154556156|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556157|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556158|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154556159|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154556160|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154556161|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154556162|NCT02129621|Spironolactone|spironolactone|mesh-list
154556163|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154556164|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
154556165|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556166|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556167|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154556168|NCT02129621|Diuretics|diuretics|mesh-ancestor
154556169|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
154556170|NCT02129699|Denosumab|denosumab|mesh-list
154325176|NCT01088477|Estradiol|estradiol|mesh-list
154556171|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154556172|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556173|NCT03549923|Esmolol|esmolol|mesh-list
154556174|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154556175|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154556176|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154556177|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154556178|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556179|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556180|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556181|NCT02136875|Fluticasone|fluticasone|mesh-list
154556182|NCT02136875|Xhance|xhance|mesh-list
154556183|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154556184|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556185|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154556186|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
154556187|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556188|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556189|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154556190|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556191|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154556192|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154556193|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154556194|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154556195|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154556197|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556198|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556199|NCT02129933|Bevacizumab|bevacizumab|mesh-list
154556200|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154556201|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556202|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154556203|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154556204|NCT02129933|Growth Substances|growth substances|mesh-ancestor
154556205|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556206|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
154556207|NCT02132897|Carbamazepine|carbamazepine|mesh-list
154556208|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
154556209|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
154556210|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154556211|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556212|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556213|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154556214|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154556215|NCT02132897|Analgesics|analgesics|mesh-ancestor
154556216|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
154556217|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556218|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154556219|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154556220|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556221|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154556222|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154556223|NCT02133053|Beclomethasone|beclomethasone|mesh-list
154556224|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556225|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
154556226|NCT02133053|Hormones|hormones|mesh-ancestor
154556227|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556228|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556229|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154556230|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556231|NCT02137109|Natalizumab|natalizumab|mesh-list
154556232|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
154556233|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556234|NCT02130167|Atropine|atropine|mesh-list
154556235|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154556236|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154556237|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154556238|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
154556239|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556240|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556241|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154556242|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556243|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
154556244|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
154556245|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154556246|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154556247|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
154556248|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556249|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556250|NCT02130323|Imiquimod|imiquimod|mesh-list
154556251|NCT02130323|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154556252|NCT02130323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556253|NCT02130323|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154556254|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
154556255|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556256|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154556257|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556258|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
154556259|NCT03549611|Acetaminophen|acetaminophen|mesh-list
154556260|NCT03549611|Celecoxib|celecoxib|mesh-list
154556261|NCT03549611|Oxycodone|oxycodone|mesh-list
154556262|NCT03549611|Gabapentin|gabapentin|mesh-list
154556263|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154556264|NCT03549611|Analgesics|analgesics|mesh-ancestor
154556265|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
154556266|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556267|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556268|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
154556269|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154556270|NCT03549611|Narcotics|narcotics|mesh-ancestor
154556271|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556272|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154556273|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556274|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154556275|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154556276|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154556277|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556278|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556279|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
154556280|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154556281|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154556282|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154556283|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154556284|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154556285|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556286|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
154556287|NCT02133287|Sirolimus|sirolimus|mesh-list
154556288|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
154556289|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154556290|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556291|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154556292|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556293|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
154556294|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154556295|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
154325321|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154556296|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556297|NCT02137265|Clomiphene|clomiphene|mesh-list
154556298|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154556299|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
154556300|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556301|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556302|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154556303|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
154556304|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154556305|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154556306|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154556307|NCT02592434|Tofacitinib|tofacitinib|mesh-list
154556308|NCT02592434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154556309|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154556310|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556311|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556312|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
154556313|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154556314|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556315|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154556316|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556317|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556318|NCT02137421|Resveratrol|resveratrol|mesh-list
154556319|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
154556320|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556321|NCT02137421|Protective Agents|protective agents|mesh-ancestor
154556322|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556323|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556324|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154556325|NCT02133677|Temozolomide|temozolomide|mesh-list
154556326|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154556327|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
154556328|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556329|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556330|NCT02137733|Carvedilol|carvedilol|mesh-list
154556331|NCT02137733|Bisoprolol|bisoprolol|mesh-list
154556332|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154556333|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154556334|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
154556335|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556336|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556337|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556338|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154556339|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
154556340|NCT02137733|Protective Agents|protective agents|mesh-ancestor
154556341|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154556342|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154556343|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154556344|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
154556345|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154556346|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154556347|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
154556348|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
154556349|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556350|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154556351|NCT02133755|Bromocriptine|bromocriptine|mesh-list
154556352|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154556353|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154556354|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154556355|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556356|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556357|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
154556358|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
154556359|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556360|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556361|NCT02130869|Cytarabine|cytarabine|mesh-list
154556362|NCT02130869|Aldesleukin|aldesleukin|mesh-list
154556363|NCT02130869|Carboplatin|carboplatin|mesh-list
154556364|NCT02130869|Etoposide|etoposide|mesh-list
154556365|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
154556366|NCT02130869|Melphalan|melphalan|mesh-list
154556367|NCT02130869|Busulfan|busulfan|mesh-list
154556368|NCT02130869|Interleukin-2|interleukin-2|mesh-list
154556369|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154556370|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
154556371|NCT02130869|Sargramostim|sargramostim|mesh-list
154556372|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556373|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154556374|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154556375|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154556376|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556377|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556378|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154556379|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
154556380|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
154556381|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556382|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154556383|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
154556384|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556385|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154556386|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
154556387|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154556388|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154556389|NCT02130869|Analgesics|analgesics|mesh-ancestor
154556390|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
154325412|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556391|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556392|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154556393|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154556394|NCT02133911|Ranolazine|ranolazine|mesh-list
154556395|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154556396|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154556397|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556398|NCT02133989|Ticlopidine|ticlopidine|mesh-list
154556399|NCT02133989|Clopidogrel|clopidogrel|mesh-list
154556400|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154556401|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154556402|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154556403|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154556404|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
154556405|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556406|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556407|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556408|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154556409|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154556410|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154556411|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154556412|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556413|NCT02138045|Liraglutide|liraglutide|mesh-list
154556414|NCT02138045|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154556415|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154556416|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556417|NCT02138045|Incretins|incretins|mesh-ancestor
154556418|NCT02138045|Hormones|hormones|mesh-ancestor
154556419|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556421|NCT02134067|TAS-119|tas-119|mesh-list
154556422|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154556423|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556424|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
154556425|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
154556426|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
154556427|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556428|NCT02134067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154556429|NCT02134067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556431|NCT04091126|Lenalidomide|lenalidomide|mesh-list
154556432|NCT04091126|Bortezomib|bortezomib|mesh-list
154556433|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556434|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
154556435|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
154556436|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556437|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556438|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154556439|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
154556440|NCT04091126|Hormones|hormones|mesh-ancestor
154556441|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556442|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154556443|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556444|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
154325456|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154556445|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154556446|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154556447|NCT04091126|Growth Substances|growth substances|mesh-ancestor
154556448|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
154556449|NCT03962114|Niacinamide|niacinamide|mesh-list
154556450|NCT03962114|Niacin|niacin|mesh-list
154556451|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
154556452|NCT03962114|Vitamins|vitamins|mesh-ancestor
154556453|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
154556454|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556455|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
154556456|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154556457|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
154556458|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556459|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154556460|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
154556461|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
154556462|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
154556463|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
154556464|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556465|NCT05472896|Epirubicin|epirubicin|mesh-list
154556466|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154556467|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556468|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154556469|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154556470|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556471|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556472|NCT03596918|Vincristine|vincristine|mesh-list
154556473|NCT03596918|Bleomycin|bleomycin|mesh-list
154556474|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154556475|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556476|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
154556477|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
154556478|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
154556479|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556480|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154556481|NCT02134379|Clotrimazole|clotrimazole|mesh-list
154556482|NCT02134379|Miconazole|miconazole|mesh-list
154556483|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154556484|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556485|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
154556486|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154556487|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154556488|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556489|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556490|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154556491|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
154556492|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556493|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556494|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154556495|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154556496|NCT02134457|Ranibizumab|ranibizumab|mesh-list
154556497|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154325507|NCT01093781|Aliskiren|aliskiren|mesh-list
154556498|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154556499|NCT02134457|Growth Substances|growth substances|mesh-ancestor
154556500|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556501|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
154556502|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556503|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
154556504|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154556505|NCT04090190|Fesoterodine|fesoterodine|mesh-list
154556507|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154556508|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154556509|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
154556510|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556511|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556512|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556513|NCT04090190|Urological Agents|urological agents|mesh-ancestor
154556514|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
154556515|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
154556516|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556517|NCT04792034|Cocaine|cocaine|mesh-list
154556518|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
154556519|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
154556520|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556521|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556522|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
154556523|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556524|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154556525|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154556526|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154556527|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154556528|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556529|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
154556530|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556531|NCT02253095|Micronutrients|micronutrients|mesh-list
154556532|NCT02253095|Trace Elements|trace elements|mesh-list
154556533|NCT02253095|Albendazole|albendazole|mesh-list
154556534|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
154556535|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154556536|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556537|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
154556538|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154556539|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154556540|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
154556541|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
154556542|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
154556543|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556544|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556545|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556546|NCT04791332|Aticaprant|aticaprant|mesh-list
154556547|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154556548|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556549|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
154556550|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556551|NCT04791020|Lidocaine|lidocaine|mesh-list
154556552|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
154556553|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
154556554|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556555|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556556|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
154556557|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556558|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154556559|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154556560|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154556561|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154556562|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556563|NCT02531906|Oxycodone|oxycodone|mesh-list
154556564|NCT02531906|Methadone|methadone|mesh-list
154556565|NCT02531906|Gabapentin|gabapentin|mesh-list
154556566|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154556567|NCT02531906|Narcotics|narcotics|mesh-ancestor
154556568|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556569|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556570|NCT02531906|Analgesics|analgesics|mesh-ancestor
154556571|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
154556572|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556573|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
154556574|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154556575|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154556576|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154556577|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154860313|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556578|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154556579|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556580|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556581|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
154556582|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
154556583|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556584|NCT02783729|Zolpidem|zolpidem|mesh-list
154556585|NCT02783729|Lemborexant|lemborexant|mesh-list
154556586|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154556587|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154556588|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556589|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556590|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154556591|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
154556592|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
154556593|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556594|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325614|NCT02998736|Tadalafil|tadalafil|mesh-list
154556595|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154556596|NCT02227940|Paclitaxel|paclitaxel|mesh-list
154556597|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154556598|NCT02227940|Cisplatin|cisplatin|mesh-list
154556599|NCT02227940|Gemcitabine|gemcitabine|mesh-list
154556600|NCT02227940|Ceritinib|ceritinib|mesh-list
154556601|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154556602|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556603|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
154556604|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
154556605|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
154556606|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556607|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154556608|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
154556609|NCT02227940|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154556610|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154556611|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556612|NCT02072486|Sorafenib|sorafenib|mesh-list
154556613|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556614|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154556615|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556616|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556617|NCT00988364|Simvastatin|simvastatin|mesh-list
154556618|NCT00988364|Ezetimibe|ezetimibe|mesh-list
154556619|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154556620|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154556621|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154556622|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
154556623|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556624|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154556625|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154556626|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556627|NCT05578001|Pilocarpine|pilocarpine|mesh-list
154556628|NCT05578001|Miotics|miotics|mesh-ancestor
154556629|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
154556630|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556631|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556632|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154556633|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154556634|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
154556635|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556636|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556637|NCT05577923|Trastuzumab|trastuzumab|mesh-list
154556638|NCT05577923|Fulvestrant|fulvestrant|mesh-list
154556639|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154556640|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325661|NCT00814372|Metformin|metformin|mesh-list
154556641|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154556642|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154556643|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154556644|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
154556645|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556646|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556647|NCT04790708|Octreotide|octreotide|mesh-list
154556648|NCT04790708|Edotreotide|edotreotide|mesh-list
154556649|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
154556650|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154558148|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154860314|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612250|NCT04186247|Azithromycin|azithromycin|mesh-list
154556651|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556652|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154556653|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154556654|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556655|NCT05614934|Clarithromycin|clarithromycin|mesh-list
154556656|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154556657|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556658|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154556659|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556660|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556661|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154556662|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154556663|NCT02135393|Folic Acid|folic acid|mesh-list
154556664|NCT02135393|Hematinics|hematinics|mesh-ancestor
154556665|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
154556666|NCT02135393|Vitamins|vitamins|mesh-ancestor
154556667|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
154556668|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556669|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
154556670|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154556671|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154556672|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154556673|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154556674|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556675|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154556676|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556677|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154556678|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154556679|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556680|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154556681|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154556682|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
154556683|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556684|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
154556685|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154556686|NCT02139761|Analgesics|analgesics|mesh-ancestor
154556687|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
154556688|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556689|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
154556690|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154556691|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556692|NCT05474924|Prednisolone|prednisolone|mesh-list
154556693|NCT05474924|Budesonide|budesonide|mesh-list
154556694|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556695|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
154556696|NCT05474924|Hormones|hormones|mesh-ancestor
154556697|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556698|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556699|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154556700|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556701|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
154556702|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556703|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154556704|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154556705|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556706|NCT02135627|Epinephrine|epinephrine|mesh-list
154556707|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154556708|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154556709|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154556710|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556711|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556712|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556713|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154556714|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154556715|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
154253742|NCT01233362|Vaccines|vaccines|mesh-list
154556716|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556717|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154556718|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556719|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
154556720|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
154556721|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154556722|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154556723|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
154556724|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154556725|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
154556726|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
154556727|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556728|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556729|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
154556730|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154556731|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154556732|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
154556733|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556734|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556735|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154556737|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
154556738|NCT02140073|Domperidone|domperidone|mesh-list
154556739|NCT02140073|Omeprazole|omeprazole|mesh-list
154556740|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154556741|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154556742|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154556743|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556744|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556745|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
154556746|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
154556747|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556748|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556749|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154556750|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
154556751|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556752|NCT05575973|Rituximab|rituximab|mesh-list
154556753|NCT05575973|Lenalidomide|lenalidomide|mesh-list
154556754|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
154556755|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154556756|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556757|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
154556758|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556759|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154556760|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154556761|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154556762|NCT05575973|Growth Substances|growth substances|mesh-ancestor
154556763|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
154556764|NCT05575973|Analgesics|analgesics|mesh-ancestor
154556765|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
154556766|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556767|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154556768|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154556769|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556770|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556771|NCT03547895|Vitamin K|vitamin k|mesh-list
154556772|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
154556773|NCT03547895|Ribavirin|ribavirin|mesh-list
154556774|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
154556775|NCT03547895|Furosemide|furosemide|mesh-list
154556776|NCT03547895|Spironolactone|spironolactone|mesh-list
154556777|NCT03547895|Silymarin|silymarin|mesh-list
154556778|NCT03547895|Vitamins|vitamins|mesh-ancestor
154556779|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
154556780|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556781|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
154556782|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556783|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
154556784|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556785|NCT03547895|Diuretics|diuretics|mesh-ancestor
154556786|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
154556787|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154556788|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154556789|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154556790|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
154556791|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556792|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154556793|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154556794|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154556795|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
154556796|NCT03547895|Coagulants|coagulants|mesh-ancestor
154556797|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
154556798|NCT03547895|Protective Agents|protective agents|mesh-ancestor
154556799|NCT01359254|Fludarabine|fludarabine|mesh-list
154556800|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
154556801|NCT01359254|Melphalan|melphalan|mesh-list
154556802|NCT01359254|Busulfan|busulfan|mesh-list
154556803|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154556804|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556805|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154556806|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
154556807|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556808|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154556809|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
154556810|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556811|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154556812|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
154556813|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154556814|NCT05575739|Antioxidants|antioxidants|mesh-list
154556815|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
154556816|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556817|NCT05575739|Protective Agents|protective agents|mesh-ancestor
154556818|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556819|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154556820|NCT05035862|Interferons|interferons|mesh-list
154556821|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
154556822|NCT05035862|Prednisone|prednisone|mesh-list
154556823|NCT05035862|Albuterol|albuterol|mesh-list
154556824|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556825|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
154556826|NCT05035862|Hormones|hormones|mesh-ancestor
154556827|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556828|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556829|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154556830|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556831|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
154556832|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556833|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154556834|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
154556835|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556836|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154556837|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556838|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
154556839|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154556840|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154556841|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154556842|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154556843|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
154556844|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556845|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556846|NCT03549221|Ketorolac|ketorolac|mesh-list
154556847|NCT03549221|Epinephrine|epinephrine|mesh-list
154556848|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
154556849|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154556850|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154556851|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
154556852|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556853|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556854|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556855|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154556856|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154556857|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
154556858|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556859|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154556860|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556861|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
154556862|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
154556863|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154325864|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
154556864|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154556865|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154556866|NCT03549221|Analgesics|analgesics|mesh-ancestor
154556867|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
154556868|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556869|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154556870|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154556871|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556872|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
154556873|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
154556874|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556875|NCT05185505|Bevacizumab|bevacizumab|mesh-list
154556876|NCT05185505|Atezolizumab|atezolizumab|mesh-list
154556877|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612251|NCT04186247|Metronidazole|metronidazole|mesh-list
154556878|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556879|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154556880|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154556881|NCT05185505|Growth Substances|growth substances|mesh-ancestor
154556882|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556883|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
154556884|NCT05185505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154556885|NCT05185505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556886|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154556887|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
154556888|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556889|NCT05575271|Norepinephrine|norepinephrine|mesh-list
154556890|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154556891|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154556892|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
154556893|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556894|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556895|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556896|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
154556897|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
154556898|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556899|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154556900|NCT04750460|Teriparatide|teriparatide|mesh-list
154556901|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154556902|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556903|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154556904|NCT04787510|Heparin|heparin|mesh-list
154556905|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154556906|NCT04787510|Tinzaparin|tinzaparin|mesh-list
154556907|NCT04787510|Dalteparin|dalteparin|mesh-list
154556908|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
154556909|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154556910|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154556911|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556912|NCT04787276|Rifaximin|rifaximin|mesh-list
154556913|NCT04787276|Lactulose|lactulose|mesh-list
154556914|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154556915|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556916|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154556917|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
154556918|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154556919|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154556920|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154556921|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154556922|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556923|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
154556924|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154556925|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556926|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154556927|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556928|NCT05613140|Valsartan|valsartan|mesh-list
154556929|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154556930|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154556931|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154556932|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154556933|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556934|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154556935|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
154556936|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154556937|NCT03547505|Protective Agents|protective agents|mesh-ancestor
154556938|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556939|NCT05279183|Erythritol|erythritol|mesh-list
154556940|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
154556941|NCT04462952|Adavosertib|adavosertib|mesh-list
154556942|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556943|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556944|NCT02253485|Telbivudine|telbivudine|mesh-list
154556945|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
154556946|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556947|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154556948|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556949|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556950|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154556952|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154556953|NCT02589626|Empagliflozin|empagliflozin|mesh-list
154556954|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154556955|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556956|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154556957|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556958|NCT04976036|Nintedanib|nintedanib|mesh-list
154556959|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556960|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154556961|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556962|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556963|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154556964|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154556965|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556966|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154556967|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154556968|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
154556969|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154556970|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
154556971|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154556972|NCT05556122|Betamethasone|betamethasone|mesh-list
154556973|NCT05556122|Ropivacaine|ropivacaine|mesh-list
154556974|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
154556975|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
154556976|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154556977|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556978|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
154556979|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154556980|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154556981|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
154556982|NCT05556122|Hormones|hormones|mesh-ancestor
154556983|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556984|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154556985|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
154556986|NCT05549570|Metformin|metformin|mesh-list
154556987|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154556988|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154556989|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154556990|NCT05549570|Incretins|incretins|mesh-ancestor
154556991|NCT05549570|Hormones|hormones|mesh-ancestor
154556992|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154556993|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154556994|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
154556995|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154556996|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154556997|NCT05549492|Buprenorphine|buprenorphine|mesh-list
154556998|NCT05549492|Ropivacaine|ropivacaine|mesh-list
154556999|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
154557000|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
154557001|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557002|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557003|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
154557004|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557005|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154557006|NCT05549492|Narcotics|narcotics|mesh-ancestor
154557007|NCT05549492|Analgesics|analgesics|mesh-ancestor
154557008|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154557009|NCT04331132|Tolvaptan|tolvaptan|mesh-list
154557010|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154557011|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557012|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
154557013|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557014|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154557015|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557016|NCT05549336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557017|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557018|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154557019|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154557020|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557021|NCT01666730|Leucovorin|leucovorin|mesh-list
154557022|NCT01666730|Metformin|metformin|mesh-list
154557023|NCT01666730|Fluorouracil|fluorouracil|mesh-list
154557025|NCT01666730|Calcium|calcium|mesh-list
154557026|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
154557027|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154557028|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557029|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154557030|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
154557031|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557032|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154557033|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557034|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557035|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
154557036|NCT01666730|Antidotes|antidotes|mesh-ancestor
154557037|NCT01666730|Protective Agents|protective agents|mesh-ancestor
154557038|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
154557039|NCT01666730|Vitamins|vitamins|mesh-ancestor
154557040|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
154557041|NCT04434560|Nivolumab|nivolumab|mesh-list
154557042|NCT04434560|Ipilimumab|ipilimumab|mesh-list
154557043|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557044|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557045|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154557046|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557047|NCT05700656|Capecitabine|capecitabine|mesh-list
154557048|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154557049|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
154557050|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557051|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557052|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
154557053|NCT00103285|Leucovorin|leucovorin|mesh-list
154557054|NCT00103285|Folic Acid|folic acid|mesh-list
154557055|NCT00103285|Cytarabine|cytarabine|mesh-list
154557056|NCT00103285|Dexamethasone|dexamethasone|mesh-list
154557057|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
154557058|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
154557059|NCT00103285|Doxorubicin|doxorubicin|mesh-list
154557060|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154557061|NCT00103285|Methotrexate|methotrexate|mesh-list
154557062|NCT00103285|Vincristine|vincristine|mesh-list
154557063|NCT00103285|Asparaginase|asparaginase|mesh-list
154557064|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
154557065|NCT00103285|Pegaspargase|pegaspargase|mesh-list
154557066|NCT00103285|Thioguanine|thioguanine|mesh-list
154557067|NCT00103285|BB 1101|bb 1101|mesh-list
154557068|NCT00103285|Calcium|calcium|mesh-list
154557069|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
154557070|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
154557071|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557072|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
154557073|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557074|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557075|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154557076|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
154557077|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557078|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557079|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154557080|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557081|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
154557082|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
154557083|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557084|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154557085|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
154557086|NCT00103285|Hormones|hormones|mesh-ancestor
154557087|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154557088|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154557089|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
154557090|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557091|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154557092|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154557093|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154557094|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154557095|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154557096|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154557097|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
154557098|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154557100|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
154557101|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
154557102|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154557103|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154557104|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
154557105|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557106|NCT00103285|Antidotes|antidotes|mesh-ancestor
154557107|NCT00103285|Protective Agents|protective agents|mesh-ancestor
154557108|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
154557110|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
154557111|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154557112|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
154557113|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
154557114|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
154557115|NCT00103285|Hematinics|hematinics|mesh-ancestor
154557116|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
154557117|NCT03541915|Analgesics|analgesics|mesh-ancestor
154557118|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
154557119|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557120|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557121|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
154557122|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557123|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154557124|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
154557125|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154557126|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154557127|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557128|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154557129|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
154557130|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154557131|NCT03541837|Ropivacaine|ropivacaine|mesh-list
154557132|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
154557133|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
154557134|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557135|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557136|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
154557137|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557138|NCT02158117|Naloxone|naloxone|mesh-list
154557139|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154557140|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557141|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
154557142|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557143|NCT03541603|Simendan|simendan|mesh-list
154557144|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154557145|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
154557146|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154557147|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154557148|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557149|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557150|NCT03541603|Protective Agents|protective agents|mesh-ancestor
154557151|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557152|NCT02160223|Neostigmine|neostigmine|mesh-list
154557153|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154557154|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557155|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557156|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
154557157|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557158|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557159|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154557160|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
154557161|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557162|NCT02160301|Acetaminophen|acetaminophen|mesh-list
154557163|NCT02160301|Dexamethasone|dexamethasone|mesh-list
154557164|NCT02160301|Celecoxib|celecoxib|mesh-list
154557165|NCT02160301|Oxycodone|oxycodone|mesh-list
154557166|NCT02160301|Gabapentin|gabapentin|mesh-list
154557167|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557168|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
154557169|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
154557170|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557171|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557172|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154557173|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
154557174|NCT02160301|Hormones|hormones|mesh-ancestor
154557175|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154557176|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154557177|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557178|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154557179|NCT02160301|Analgesics|analgesics|mesh-ancestor
154557180|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
154557181|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
154557182|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154557183|NCT02160301|Narcotics|narcotics|mesh-ancestor
154557184|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557185|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154557186|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557187|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154557188|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154557189|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557190|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557191|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
154557192|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154557193|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154557194|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154557195|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154557196|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154557197|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557198|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
154557199|NCT03541759|Hydromorphone|hydromorphone|mesh-list
154557200|NCT03541759|Pirinitramide|pirinitramide|mesh-list
154557201|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154557202|NCT03541759|Narcotics|narcotics|mesh-ancestor
154557203|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557204|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557205|NCT03541759|Analgesics|analgesics|mesh-ancestor
154557206|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
154557207|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557208|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154557209|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
154557210|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154557211|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
154557212|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557213|NCT01666652|Antacids|antacids|mesh-ancestor
154557214|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557215|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154557216|NCT04428086|Metformin|metformin|mesh-list
154557217|NCT04428086|Apatinib|apatinib|mesh-list
154557218|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154557219|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154557220|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557221|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154557222|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154557223|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
154557224|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557225|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154557226|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154557227|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557228|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557229|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154557230|NCT04355858|Paclitaxel|paclitaxel|mesh-list
154557231|NCT04355858|Capecitabine|capecitabine|mesh-list
154557232|NCT04355858|Everolimus|everolimus|mesh-list
154557233|NCT04355858|Fluzoparib|fluzoparib|mesh-list
154557234|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154557235|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557236|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
154557237|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
154557238|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
154557239|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557240|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154557241|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
154557242|NCT04355858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154557243|NCT04355858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154557244|NCT04355858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557245|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557246|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
154557247|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557248|NCT04355858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154557249|NCT05610956|Empagliflozin|empagliflozin|mesh-list
154281065|NCT05835713|Propofol|propofol|mesh-list
154557250|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154557251|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557252|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154557253|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557254|NCT00109733|Hormones|hormones|mesh-list
154557255|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154557256|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557257|NCT05699876|Gabapentin|gabapentin|mesh-list
154557258|NCT05699876|Melatonin|melatonin|mesh-list
154557259|NCT05699876|Analgesics|analgesics|mesh-ancestor
154557260|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
154557261|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557262|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557263|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
154557264|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154557265|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154557266|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557267|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154557268|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154557269|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154557270|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557271|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557272|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
154557273|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
154557274|NCT05699876|Protective Agents|protective agents|mesh-ancestor
154557275|NCT05610878|Curcumin|curcumin|mesh-list
154557276|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154557277|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154557278|NCT05610878|Analgesics|analgesics|mesh-ancestor
154557279|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
154557280|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557281|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557282|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557283|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557284|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557285|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557286|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557287|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
154557288|NCT02706405|Fludarabine|fludarabine|mesh-list
154557289|NCT02706405|Durvalumab|durvalumab|mesh-list
154557290|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
154557291|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154557292|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
154557293|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557294|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
154557295|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557296|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557297|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154557298|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
154557299|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557300|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557301|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154557302|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557303|NCT03545711|Irinotecan|irinotecan|mesh-list
154557304|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154557305|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154557306|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557307|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557308|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557309|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
154557310|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154557311|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154557312|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326329|NCT01100203|Eplerenone|eplerenone|mesh-list
154557313|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
154557314|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557315|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557316|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154557317|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154557318|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154557319|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557320|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557321|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154281144|NCT05834517|Hyaluronic Acid|hyaluronic acid|mesh-list
154557322|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154557323|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154557324|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154557325|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
154612252|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154557326|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557327|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557328|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154557329|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154557330|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
154557331|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154557332|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154557333|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
154557335|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154557336|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154557337|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
154557338|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557339|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557340|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154557341|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154557342|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
154557343|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557344|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154557345|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154557346|NCT03546803|Protective Agents|protective agents|mesh-list
154557347|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557348|NCT02422953|Micronutrients|micronutrients|mesh-list
154557349|NCT02422953|Trace Elements|trace elements|mesh-list
154557350|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557352|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154557353|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557354|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
154557355|NCT02425605|Sorafenib|sorafenib|mesh-list
154557356|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557357|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154557358|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557359|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557360|NCT02422563|Paclitaxel|paclitaxel|mesh-list
154557361|NCT02422563|Carboplatin|carboplatin|mesh-list
154557362|NCT02422563|Ifosfamide|ifosfamide|mesh-list
154557363|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154557364|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557365|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
154557366|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
154557367|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
154557368|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557369|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154557370|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
154557371|NCT03185403|Sufentanil|sufentanil|mesh-list
154557372|NCT03185403|Ropivacaine|ropivacaine|mesh-list
154557373|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
154557374|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
154557375|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557376|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557377|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
154557378|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557379|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154557380|NCT03185403|Narcotics|narcotics|mesh-ancestor
154557381|NCT03185403|Analgesics|analgesics|mesh-ancestor
154557382|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154557383|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154557384|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
154557385|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154557386|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154557387|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154557388|NCT02422485|Analgesics|analgesics|mesh-ancestor
154557389|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
154557390|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557391|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557392|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557393|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557394|NCT05551910|Remifentanil|remifentanil|mesh-list
154557395|NCT05551910|Propofol|propofol|mesh-list
154557396|NCT05551910|Esketamine|esketamine|mesh-list
154557397|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154557398|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557399|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557400|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154557401|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
154557402|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
154557403|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154557404|NCT05551910|Narcotics|narcotics|mesh-ancestor
154557405|NCT05551910|Analgesics|analgesics|mesh-ancestor
154557406|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
154557407|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557408|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
154557409|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154557410|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
154557411|NCT05699720|Analgesics|analgesics|mesh-ancestor
154557412|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
154557413|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557414|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557415|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
154557416|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557417|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154557418|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
154557419|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154557420|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154557421|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557422|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154557423|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
154557424|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154557425|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
154557426|NCT05546762|Povidone|povidone|mesh-list
154557427|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
154557428|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
154557429|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154557430|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557431|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
154557432|NCT05551598|Analgesics|analgesics|mesh-ancestor
154557433|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
154557434|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557435|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557436|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557437|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154557438|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154557439|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557440|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557441|NCT03185793|Benzbromarone|benzbromarone|mesh-list
154557442|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
154557443|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
154557444|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557445|NCT03660488|Penicillins|penicillins|mesh-list
154557446|NCT03660488|Cefixime|cefixime|mesh-list
154557447|NCT03660488|Penicillin G|penicillin g|mesh-list
154557448|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154557449|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
154557450|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154557451|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557452|NCT03660488|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154557453|NCT03660488|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154557454|NCT02422017|Timolol|timolol|mesh-list
154557455|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154557456|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154557457|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
154557458|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557459|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557460|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557461|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154557462|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154557463|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
154557464|NCT02761915|Fludarabine|fludarabine|mesh-list
154557465|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557466|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
154557467|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557468|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557469|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154557470|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
154557471|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557472|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557473|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154557474|NCT03464084|Melatonin|melatonin|mesh-list
154557475|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
154557476|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557477|NCT03464084|Protective Agents|protective agents|mesh-ancestor
154557478|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557479|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557480|NCT05551208|Bevacizumab|bevacizumab|mesh-list
154557481|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557482|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557483|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154557484|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154557485|NCT05551208|Growth Substances|growth substances|mesh-ancestor
154557486|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557487|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
154557488|NCT02764333|Durvalumab|durvalumab|mesh-list
154557489|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557490|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557491|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
154557492|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154557493|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154557494|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154557495|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154557496|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557497|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
154557498|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557499|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557500|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154557501|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557502|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154557503|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154557504|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557505|NCT02161237|Tacrolimus|tacrolimus|mesh-list
154557506|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557507|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
154557508|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557509|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154557510|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557511|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557512|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154557513|NCT03173066|Hematinics|hematinics|mesh-ancestor
154557514|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154557515|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154557516|NCT05546060|Dexamethasone|dexamethasone|mesh-list
154557517|NCT05546060|Etoposide|etoposide|mesh-list
154557518|NCT05546060|Venetoclax|venetoclax|mesh-list
154557519|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557520|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
154557521|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
154557522|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557523|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557524|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154557525|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
154557526|NCT05546060|Hormones|hormones|mesh-ancestor
154557527|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154557528|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154557529|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557530|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154557531|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154557532|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154557533|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557534|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557535|NCT02416869|Dexamethasone|dexamethasone|mesh-list
154557536|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
154557537|NCT02416869|BB 1101|bb 1101|mesh-list
154557538|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557539|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
154557540|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
154557541|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557542|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557543|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154557544|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
154557545|NCT02416869|Hormones|hormones|mesh-ancestor
154557546|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154557547|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154557549|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
154557550|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557551|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557552|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
154557553|NCT02588612|Fludarabine|fludarabine|mesh-list
154557554|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557555|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
154557556|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557557|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557558|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154557559|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
154557560|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557561|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557562|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154557563|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
154557564|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
154557565|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557566|NCT03540979|Letrozole|letrozole|mesh-list
154557567|NCT03540979|Progesterone|progesterone|mesh-list
154557568|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557569|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154557570|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154557571|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557572|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557573|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154557574|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
154557575|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154557576|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557577|NCT03540979|Progestins|progestins|mesh-ancestor
154557578|NCT03540979|Hormones|hormones|mesh-ancestor
154557579|NCT02946788|Minocycline|minocycline|mesh-list
154557580|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154557581|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557582|NCT02159131|Cabotegravir|cabotegravir|mesh-list
154557583|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
154557584|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154557585|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
154557586|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154557587|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557588|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154557589|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154557590|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154557591|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154557592|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154557593|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557594|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557595|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154557596|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154557597|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
154557598|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557599|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154557600|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154557601|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154557602|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154557603|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557604|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557605|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557606|NCT05550506|Analgesics|analgesics|mesh-ancestor
154557607|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
154557608|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557609|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
154557610|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154557611|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
154557612|NCT03174795|Meropenem|meropenem|mesh-list
154557613|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154557614|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557615|NCT02163655|Furosemide|furosemide|mesh-list
154557616|NCT02163655|Diuretics|diuretics|mesh-ancestor
154557617|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
154557618|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557619|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154557620|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154281441|NCT04348006|Bortezomib|bortezomib|mesh-list
154557621|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557622|NCT02410083|Aspirin|aspirin|mesh-list
154557623|NCT02410083|Clopidogrel|clopidogrel|mesh-list
154557624|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154557625|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154557626|NCT02410083|Analgesics|analgesics|mesh-ancestor
154557627|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
154612253|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557628|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557629|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557630|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557631|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557632|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154557633|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154557634|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557635|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154557636|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154557637|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557638|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
154557639|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154557640|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154557641|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154557642|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
154557643|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557644|NCT02416245|Micronutrients|micronutrients|mesh-list
154557645|NCT02416245|Trace Elements|trace elements|mesh-list
154557646|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557647|NCT02416167|Dotinurad|dotinurad|mesh-list
154557648|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
154557649|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
154557650|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557651|NCT02166853|Midazolam|midazolam|mesh-list
154557652|NCT02166853|Sevoflurane|sevoflurane|mesh-list
154557653|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154557654|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154557655|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557656|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557657|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154557658|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154557659|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154557660|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154557661|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
154557662|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
154557663|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
154557664|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
154557665|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557666|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557667|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154557668|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154557669|NCT02162251|Donepezil|donepezil|mesh-list
154557670|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154557671|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557672|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557673|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
154557674|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557675|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557676|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
154557677|NCT02164045|Fostemsavir|fostemsavir|mesh-list
154557678|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154557679|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154557680|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
154557681|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557682|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154557683|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154557684|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557685|NCT02410005|Calcitriol|calcitriol|mesh-list
154557686|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154557687|NCT02410005|Losartan|losartan|mesh-list
154557688|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154557689|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154557690|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154557691|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154557692|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557693|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154557694|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557695|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154557696|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154557697|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154557698|NCT02410005|Vitamins|vitamins|mesh-ancestor
154557699|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
154557700|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154557701|NCT05543330|Cisplatin|cisplatin|mesh-list
154557702|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557703|NCT03174561|Choline|choline|mesh-list
154557704|NCT03174561|Silymarin|silymarin|mesh-list
154557705|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
154557706|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154557707|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
154557708|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557709|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154557710|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154557711|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
154557712|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
154557713|NCT03174561|Protective Agents|protective agents|mesh-ancestor
154557714|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557715|NCT05545592|Estrogens|estrogens|mesh-list
154557716|NCT05545592|Hormones|hormones|mesh-ancestor
154557717|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154557718|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557719|NCT05545436|Capecitabine|capecitabine|mesh-list
154557720|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
154557721|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154557722|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
154557723|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557724|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557725|NCT02167165|Digoxin|digoxin|mesh-list
154557726|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154557727|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154557728|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557729|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557730|NCT02167165|Protective Agents|protective agents|mesh-ancestor
154557731|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557732|NCT05545124|Tislelizumab|tislelizumab|mesh-list
154557733|NCT05545124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557734|NCT05545124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557735|NCT02409849|Octreotide|octreotide|mesh-list
154557736|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154557737|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154557738|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557739|NCT00664040|Aspirin|aspirin|mesh-list
154557740|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154557741|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154557742|NCT00664040|Analgesics|analgesics|mesh-ancestor
154557743|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
154557744|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557745|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557746|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557747|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557748|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154557749|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154557750|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557751|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154557752|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154557753|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557754|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
154557755|NCT02162407|Insulin|insulin|mesh-list
154557756|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154557757|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
154557758|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154326760|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557759|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557760|NCT02162485|Fluticasone|fluticasone|mesh-list
154557761|NCT02162485|Xhance|xhance|mesh-list
154557762|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154557763|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154557764|NCT02162485|Charcoal|charcoal|mesh-list
154557765|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557766|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154557767|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
154557768|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557769|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557770|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154557771|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
154557772|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
154557773|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154557774|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154557775|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154557776|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154557777|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
154612254|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154557778|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557779|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557780|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
154557781|NCT02162485|Hormones|hormones|mesh-ancestor
154557782|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154557783|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
154557784|NCT02162485|Antidotes|antidotes|mesh-ancestor
154557785|NCT02162485|Protective Agents|protective agents|mesh-ancestor
154557786|NCT02415777|Riboflavin|riboflavin|mesh-list
154557787|NCT02415777|Thiamine|thiamine|mesh-list
154557788|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154557789|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
154557790|NCT02415777|Vitamins|vitamins|mesh-ancestor
154557791|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
154557792|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557793|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154557794|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
154557795|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154557796|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154557797|NCT03178539|Diclofenac|diclofenac|mesh-list
154557798|NCT03178539|Ketorolac|ketorolac|mesh-list
154557799|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154557800|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154557801|NCT03178539|Analgesics|analgesics|mesh-ancestor
154557802|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
154557803|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557804|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557805|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557806|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557807|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154557808|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557809|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557810|NCT03174483|Fluticasone|fluticasone|mesh-list
154557811|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557812|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154557813|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
154557814|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557815|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557816|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154557817|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
154557818|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
154557819|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154557820|NCT04320914|Ibuprofen|ibuprofen|mesh-list
154557821|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154557822|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154557823|NCT04320914|Analgesics|analgesics|mesh-ancestor
154557824|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
154557825|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557826|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557827|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557828|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557829|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154557830|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557831|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557832|NCT05544812|Cetuximab|cetuximab|mesh-list
154557833|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557834|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557835|NCT02415699|Leucovorin|leucovorin|mesh-list
154557836|NCT02415699|Fluorouracil|fluorouracil|mesh-list
154557837|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
154557838|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
154557839|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557840|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154557841|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557842|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557843|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
154557844|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557845|NCT02415699|Antidotes|antidotes|mesh-ancestor
154557846|NCT02415699|Protective Agents|protective agents|mesh-ancestor
154557847|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
154281701|NCT02389517|Ixazomib|ixazomib|mesh-list
154557848|NCT02415699|Vitamins|vitamins|mesh-ancestor
154557849|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
154557850|NCT05544656|Tolperisone|tolperisone|mesh-list
154557851|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154557852|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557853|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154557854|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557855|NCT02409537|Resveratrol|resveratrol|mesh-list
154557856|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
154557857|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557858|NCT02409537|Protective Agents|protective agents|mesh-ancestor
154557859|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557860|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557861|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154557862|NCT03177993|Ivermectin|ivermectin|mesh-list
154557863|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154557864|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557865|NCT04425590|Aspirin|aspirin|mesh-list
154557866|NCT04425590|Atorvastatin|atorvastatin|mesh-list
154557867|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154557868|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154326873|NCT03799627|Glycine|glycine|mesh-list
154557869|NCT04425590|Analgesics|analgesics|mesh-ancestor
154557870|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
154557871|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154557872|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557873|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154557874|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557875|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154557876|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154557877|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557878|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154557879|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154557880|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557881|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
154557882|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154557883|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154557884|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
154557885|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154557886|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154557887|NCT00707889|Leucovorin|leucovorin|mesh-list
154557888|NCT00707889|Folic Acid|folic acid|mesh-list
154557889|NCT00707889|Bevacizumab|bevacizumab|mesh-list
154557890|NCT00707889|Fluorouracil|fluorouracil|mesh-list
154557891|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
154557892|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
154557893|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557894|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557895|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154557896|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154557897|NCT00707889|Growth Substances|growth substances|mesh-ancestor
154557898|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557899|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154557900|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
154557901|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557902|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154557903|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557904|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
154557905|NCT00707889|Antidotes|antidotes|mesh-ancestor
154557906|NCT00707889|Protective Agents|protective agents|mesh-ancestor
154557907|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
154557908|NCT00707889|Vitamins|vitamins|mesh-ancestor
154557909|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
154557910|NCT00707889|Hematinics|hematinics|mesh-ancestor
154557911|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
154557912|NCT00109031|Etoposide|etoposide|mesh-list
154557913|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557914|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
154557915|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557916|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154557917|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154557918|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
154557919|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557920|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557921|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154557922|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154557923|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154557924|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154557925|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557926|NCT02419443|Gabapentin|gabapentin|mesh-list
154557927|NCT02419443|Analgesics|analgesics|mesh-ancestor
154557928|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
154557929|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612255|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154557930|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557931|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
154557932|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154557933|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154557934|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154557935|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154557936|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154557937|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154557938|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154557939|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557940|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
154557941|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
154557942|NCT02414919|Etonogestrel|etonogestrel|mesh-list
154557943|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154557944|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
154557945|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154557946|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557947|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154557948|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154557949|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154557950|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
154557951|NCT05005559|Paraproteins|paraproteins|mesh-list
154557952|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
154557953|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557954|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154557955|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154326971|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557956|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557957|NCT02408679|Vitamin D|vitamin d|mesh-list
154557958|NCT02408679|Vitamins|vitamins|mesh-ancestor
154557959|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
154557960|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557961|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154557962|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
154557963|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154557964|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557965|NCT04486781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154557966|NCT04486781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557967|NCT05089565|Interferons|interferons|mesh-list
154557968|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
154557969|NCT05089565|Antibodies|antibodies|mesh-list
154557970|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
154557971|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
154557972|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557973|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557974|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
154557975|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154557976|NCT03174171|Everolimus|everolimus|mesh-list
154557977|NCT03174171|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154557978|NCT03174171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154557979|NCT03174171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154557980|NCT03174171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154557981|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154557982|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
154557983|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557984|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154557985|NCT02414529|Vitamin D|vitamin d|mesh-list
154557986|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
154557987|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
154557988|NCT02414529|Vitamins|vitamins|mesh-list
154557989|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
154557990|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557991|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154557992|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154557993|NCT02418273|Denosumab|denosumab|mesh-list
154557994|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154557995|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154557996|NCT02414685|Paclitaxel|paclitaxel|mesh-list
154557997|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154557998|NCT02414685|Cisplatin|cisplatin|mesh-list
154557999|NCT02414685|Ifosfamide|ifosfamide|mesh-list
154558000|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
154281821|NCT01369212|Tenofovir|tenofovir|mesh-list
154558001|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154558002|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558004|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
154558005|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612256|NCT04098393|Fludarabine|fludarabine|mesh-list
154558006|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558007|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154558009|NCT04425824|Rituximab|rituximab|mesh-list
154558010|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154558011|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327018|NCT00658372|Paroxetine|paroxetine|mesh-list
154558012|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
154558013|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558014|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558015|NCT02414451|Propranolol|propranolol|mesh-list
154558016|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154558017|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154558018|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558019|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558020|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558021|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558022|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154558023|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154558024|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
154558025|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
154558026|NCT02408289|Procyanidin|procyanidin|mesh-list
154612257|NCT04098393|Melphalan|melphalan|mesh-list
154612258|NCT04098393|Busulfan|busulfan|mesh-list
154612259|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154612260|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612261|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612262|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612263|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
154612264|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612265|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154612266|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
154612267|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154612268|NCT04095221|Irinotecan|irinotecan|mesh-list
154612269|NCT04095221|Prexasertib|prexasertib|mesh-list
154612270|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154612271|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154612272|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612273|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612274|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612275|NCT04095221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154612276|NCT04011163|Morphine|morphine|mesh-list
154612277|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154612278|NCT04011163|Narcotics|narcotics|mesh-ancestor
154612279|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612280|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612281|NCT04011163|Analgesics|analgesics|mesh-ancestor
154612282|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
154612283|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612284|NCT04007991|Ecopipam|ecopipam|mesh-list
154612285|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154612286|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154612287|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612288|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612289|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154612290|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154612291|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
154327079|NCT00612742|Testosterone|testosterone|mesh-list
154612292|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612293|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612294|NCT03998670|Methamphetamine|methamphetamine|mesh-list
154612295|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154612296|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612297|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
154612298|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
154612299|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612300|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
154612301|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612302|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612303|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
154612304|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154612305|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154612306|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154612307|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154612308|NCT03998176|Tenofovir|tenofovir|mesh-list
154612309|NCT03998176|Emtricitabine|emtricitabine|mesh-list
154612310|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154612311|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
154612312|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612313|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154612314|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154612315|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612316|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612317|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154612318|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154612319|NCT03950830|Disulfiram|disulfiram|mesh-list
154612320|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154612321|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154612322|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612323|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612324|NCT03935217|Secnidazole|secnidazole|mesh-list
154612325|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154612326|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154612327|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612328|NCT03916341|Nicotine|nicotine|mesh-list
154612329|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154612330|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
154612331|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612332|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612333|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154612334|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154612335|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
154612336|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612337|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612338|NCT03916068|Vitamin E|vitamin e|mesh-list
154612339|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
154612340|NCT03916068|Vitamins|vitamins|mesh-ancestor
154612341|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
154612342|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612343|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
154612344|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612345|NCT03916068|Protective Agents|protective agents|mesh-ancestor
154612346|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154612347|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612348|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154612349|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154612350|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
154612351|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154612352|NCT03895502|Edoxaban|edoxaban|mesh-list
154612353|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154612354|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
154612355|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154612356|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
154612357|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612358|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612359|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
154612360|NCT03884556|Paclitaxel|paclitaxel|mesh-list
154612361|NCT03884556|Gemcitabine|gemcitabine|mesh-list
154612362|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
154612363|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154612364|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612365|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612366|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612367|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612368|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612369|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154612370|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
154612371|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612372|NCT03884556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612373|NCT03861871|Fenfluramine|fenfluramine|mesh-list
154612374|NCT03861871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154612375|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154612376|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154612377|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612378|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612379|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
154612380|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612381|NCT03851835|Ondansetron|ondansetron|mesh-list
154612382|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
154612383|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
154612384|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558027|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
154612385|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612386|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154612387|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
154612388|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
154612389|NCT03851835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154612390|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154612391|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
154612392|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612393|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612394|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
154612395|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612396|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
154612397|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
154612398|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
154612399|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
154612400|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154612401|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154612402|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154612403|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154612404|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154612405|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612406|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
154612407|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612408|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612409|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154612410|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612411|NCT03758989|Prednisone|prednisone|mesh-list
154612412|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
154612413|NCT03758989|Rituximab|rituximab|mesh-list
154612414|NCT03758989|Doxorubicin|doxorubicin|mesh-list
154612415|NCT03758989|Vincristine|vincristine|mesh-list
154612416|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612417|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
154612418|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612419|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612420|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154612421|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
154612422|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612423|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612424|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154612425|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612426|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154612427|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154612428|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154612429|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612430|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154612431|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
154612432|NCT03758989|Hormones|hormones|mesh-ancestor
154612433|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612434|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154612435|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154612436|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612437|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612438|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612439|NCT03730337|Nivolumab|nivolumab|mesh-list
154612440|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612441|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612442|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612443|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612444|NCT03693807|Gemcitabine|gemcitabine|mesh-list
154612445|NCT03693807|Fluorouracil|fluorouracil|mesh-list
154612446|NCT03693807|Floxuridine|floxuridine|mesh-list
154612447|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
154612448|NCT03693807|Irinotecan|irinotecan|mesh-list
154612449|NCT03693807|Cetuximab|cetuximab|mesh-list
154612450|NCT03693807|Panitumumab|panitumumab|mesh-list
154612451|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154612452|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
154612453|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612454|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612455|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612456|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
154612457|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612458|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154612459|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154612460|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612461|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612462|NCT03680521|Nivolumab|nivolumab|mesh-list
154612463|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612464|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612465|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612466|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612467|NCT03568968|Niacinamide|niacinamide|mesh-list
154612468|NCT03568968|Niacin|niacin|mesh-list
154612469|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
154612470|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
154612471|NCT03568968|Vitamins|vitamins|mesh-ancestor
154612472|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
154612473|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612474|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154612475|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
154612476|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612477|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154612478|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
154612479|NCT03374085|Dexamethasone|dexamethasone|mesh-list
154612480|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154612481|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
154612482|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
154612483|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612484|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612485|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154612486|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
154612487|NCT03374085|Hormones|hormones|mesh-ancestor
154612488|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612489|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154612490|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612491|NCT03369223|Nivolumab|nivolumab|mesh-list
154612492|NCT03369223|Ipilimumab|ipilimumab|mesh-list
154612493|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612494|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612495|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612496|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612497|NCT03246906|Cyclosporine|cyclosporine|mesh-list
154612498|NCT03246906|Sirolimus|sirolimus|mesh-list
154612499|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
154612500|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
154612501|NCT03246906|Cyclosporins|cyclosporins|mesh-list
154612502|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612503|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
154612504|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612505|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612506|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154612507|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
154612508|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612509|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612510|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154612511|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612512|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
154612513|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612514|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
154612515|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154612516|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154612517|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154612518|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
154612519|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154612520|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154612521|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154612522|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612523|NCT03162627|Olaparib|olaparib|mesh-list
154612524|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154612525|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612526|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612527|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612528|NCT03072628|Nicotine|nicotine|mesh-list
154612529|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154612530|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
154612531|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612532|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612533|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154612534|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154612535|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
154612536|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612537|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612538|NCT03017833|Metformin|metformin|mesh-list
154612539|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154612540|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612541|NCT02979977|Cetuximab|cetuximab|mesh-list
154612542|NCT02979977|Afatinib|afatinib|mesh-list
154612543|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612544|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612545|NCT02979977|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154612546|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154612547|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612548|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612549|NCT02754856|Durvalumab|durvalumab|mesh-list
154612550|NCT02754856|Ipilimumab|ipilimumab|mesh-list
154612551|NCT02754856|Tremelimumab|tremelimumab|mesh-list
154612552|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
154612553|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612554|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
154612555|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612556|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612557|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
154612558|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612559|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612560|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612561|NCT02710097|Ethanol|ethanol|mesh-list
154612562|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154612563|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612564|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612565|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612566|NCT02709954|Ethanol|ethanol|mesh-list
154612567|NCT02709954|Dronabinol|dronabinol|mesh-list
154612568|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154612569|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612570|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612571|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612572|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
154612573|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154612574|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154612575|NCT02709954|Analgesics|analgesics|mesh-ancestor
154612576|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
154612577|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612578|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154612579|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154612580|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612581|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612582|NCT02709954|Hormones|hormones|mesh-ancestor
154612583|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612584|NCT02689258|Bupivacaine|bupivacaine|mesh-list
154612585|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
154612586|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
154612587|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327362|NCT02282098|Colchicine|colchicine|mesh-list
154612588|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612589|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
154612590|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612591|NCT02685735|Gabapentin|gabapentin|mesh-list
154612592|NCT02685735|Analgesics|analgesics|mesh-ancestor
154612593|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
154612594|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612595|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612596|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
154612597|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154612598|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154612599|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612600|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154612601|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154612602|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154612603|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612604|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612605|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
154612606|NCT02649764|Cytarabine|cytarabine|mesh-list
154612607|NCT02649764|Fludarabine|fludarabine|mesh-list
154612608|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
154612609|NCT02649764|Prexasertib|prexasertib|mesh-list
154612610|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612611|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154612612|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
154612613|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612614|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612615|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
154612616|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612617|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
154612618|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612619|NCT02649764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154612620|NCT02649764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612621|NCT02606136|Mitogens|mitogens|mesh-list
154612622|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612623|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612624|NCT02546232|Paclitaxel|paclitaxel|mesh-list
154612625|NCT02546232|Carboplatin|carboplatin|mesh-list
154612626|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154612627|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612628|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612629|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
154327416|NCT01107145|Lumefantrine|lumefantrine|mesh-list
154612630|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612631|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612632|NCT02520154|Paclitaxel|paclitaxel|mesh-list
154612633|NCT02520154|Carboplatin|carboplatin|mesh-list
154612634|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
154612635|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154612636|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154612637|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612638|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612639|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612640|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612641|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612642|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612643|NCT02520154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612644|NCT02404688|Ethanol|ethanol|mesh-list
154612645|NCT02404688|Dronabinol|dronabinol|mesh-list
154612646|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154612647|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612648|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612649|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612650|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
154612651|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154612652|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154612653|NCT02404688|Analgesics|analgesics|mesh-ancestor
154612654|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
154612655|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612656|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154612657|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154612658|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612659|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612660|NCT02404688|Hormones|hormones|mesh-ancestor
154612661|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612662|NCT02392572|TIC10 compound|tic10 compound|mesh-list
154612663|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612664|NCT02292706|Ribavirin|ribavirin|mesh-list
154612665|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
154612666|NCT02292706|Antimetabolites|antimetabolites|mesh-ancestor
154612667|NCT02292706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612668|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
154612669|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612670|NCT02278601|Fentanyl|fentanyl|mesh-list
154612671|NCT02278601|Ropivacaine|ropivacaine|mesh-list
154612672|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
154612673|NCT02278601|Anesthetics|anesthetics|mesh-list
154612674|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612675|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612676|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
154612677|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612678|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154612679|NCT02278601|Narcotics|narcotics|mesh-ancestor
154612680|NCT02278601|Analgesics|analgesics|mesh-ancestor
154612681|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154612682|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154612683|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
154612684|NCT01931033|Oxytocin|oxytocin|mesh-list
154612685|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
154225355|NCT03953716|Hormones|hormones|mesh-ancestor
154612686|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154612687|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612689|NCT01459484|Doxorubicin|doxorubicin|mesh-list
154612690|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154612691|NCT01459484|Methotrexate|methotrexate|mesh-list
154612692|NCT01459484|Ifosfamide|ifosfamide|mesh-list
154612693|NCT01459484|Mifamurtide|mifamurtide|mesh-list
154612694|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
154612695|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612696|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154612697|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154612698|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154612699|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612700|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612701|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154612702|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
154612703|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154612704|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612705|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154612706|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
154612707|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
154612708|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154612709|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612710|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
154612711|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612712|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154612713|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154612714|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
154612715|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154612716|NCT01060384|Lenalidomide|lenalidomide|mesh-list
154612717|NCT01060384|Ofatumumab|ofatumumab|mesh-list
154612718|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
154612719|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612720|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154612721|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154612722|NCT01060384|Growth Substances|growth substances|mesh-ancestor
154612723|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
154612724|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612725|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
154612726|NCT00580047|Vitamin D|vitamin d|mesh-list
154612727|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
154612728|NCT00580047|Alendronate|alendronate|mesh-list
154612729|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
154612730|NCT00580047|Calcium|calcium|mesh-list
154612731|NCT00580047|Vitamins|vitamins|mesh-ancestor
154612732|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
154327515|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154612733|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612734|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154612735|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154612736|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612737|NCT00580047|Antacids|antacids|mesh-ancestor
154612738|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154612739|NCT00242944|Atorvastatin|atorvastatin|mesh-list
154612740|NCT00242944|Pitavastatin|pitavastatin|mesh-list
154612741|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154612742|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154612743|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
154612744|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612745|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154612746|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154612747|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612748|NCT00204919|Vitamin D|vitamin d|mesh-list
154612749|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
154612750|NCT00204919|Vitamins|vitamins|mesh-ancestor
154612751|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
154612752|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612753|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154612754|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154612755|NCT00084799|Antibodies|antibodies|mesh-list
154612756|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612757|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
154612758|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612759|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154612760|NCT00072410|Antibodies|antibodies|mesh-list
154612761|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
154612762|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612763|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
154612764|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612765|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612766|NCT00006099|Antibodies|antibodies|mesh-list
154612767|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612768|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
154612769|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612770|NCT00006046|Antibodies|antibodies|mesh-list
154612771|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612772|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
154612773|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612774|NCT00003102|Antibodies|antibodies|mesh-list
154612775|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612776|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
154612777|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612778|NCT03331211|Dasatinib|dasatinib|mesh-list
154612779|NCT03331211|Ponatinib|ponatinib|mesh-list
154612780|NCT03331211|Nilotinib|nilotinib|mesh-list
154612781|NCT03331211|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154612782|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154612783|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612784|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612785|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612786|NCT01929915|Fentanyl|fentanyl|mesh-list
154612787|NCT01929915|Morphine|morphine|mesh-list
154612788|NCT01929915|Bupivacaine|bupivacaine|mesh-list
154612789|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
154612790|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
154612791|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612792|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612793|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
154612794|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612795|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154612796|NCT01929915|Narcotics|narcotics|mesh-ancestor
154612797|NCT01929915|Analgesics|analgesics|mesh-ancestor
154612798|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154612799|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154612800|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
154612801|NCT05464745|Perindopril|perindopril|mesh-list
154612802|NCT05464745|Indapamide|indapamide|mesh-list
154612803|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154612804|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
154612805|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612806|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612807|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154612808|NCT05464745|Diuretics|diuretics|mesh-ancestor
154612809|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
154612810|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612811|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154612812|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154612813|NCT03094533|Propofol|propofol|mesh-list
154612814|NCT03094533|Sevoflurane|sevoflurane|mesh-list
154612815|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154612816|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612817|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612818|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154612819|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
154612820|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
154612821|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154612822|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154612823|NCT05028231|Immunomodulating Agents|immunomodulating agents|mesh-list
154612824|NCT05028231|Immunologic Factors|immunologic factors|mesh-ancestor
154612825|NCT05028231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612826|NCT03335579|Sufentanil|sufentanil|mesh-list
154612827|NCT03335579|Remifentanil|remifentanil|mesh-list
154612828|NCT03335579|Propofol|propofol|mesh-list
154612829|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
154612830|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612831|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612832|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154612833|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154612834|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
154612835|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154612836|NCT03335579|Narcotics|narcotics|mesh-ancestor
154612837|NCT03335579|Analgesics|analgesics|mesh-ancestor
154612838|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
154612839|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612840|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154612841|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
154612842|NCT05050071|Calcium|calcium|mesh-list
154612843|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154612844|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612845|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154612846|NCT03335501|Pancrelipase|pancrelipase|mesh-list
154612847|NCT03335501|Hormones|hormones|mesh-list
154612848|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612849|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612850|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154612851|NCT02492945|Lidocaine|lidocaine|mesh-list
154612852|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154612853|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
154612854|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
154612855|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612856|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612857|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
154612858|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612859|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154612860|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154612861|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154612862|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154612863|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612864|NCT03335423|Metformin|metformin|mesh-list
154612865|NCT03335423|Codeine|codeine|mesh-list
154612866|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154612867|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612868|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154612869|NCT03335423|Narcotics|narcotics|mesh-ancestor
154612870|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154612871|NCT03335423|Analgesics|analgesics|mesh-ancestor
154612872|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
154612873|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612874|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
154612875|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
154612876|NCT05038605|Metronidazole|metronidazole|mesh-list
154612877|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612878|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154612879|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154612880|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154612881|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154612882|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154612883|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154612884|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
154612885|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612886|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154612887|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154612888|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612889|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154612890|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154612891|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154612892|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612893|NCT03095547|Cyclosporine|cyclosporine|mesh-list
154612894|NCT03095547|Posaconazole|posaconazole|mesh-list
154612895|NCT03095547|Olorofim|olorofim|mesh-list
154612896|NCT03095547|Pantoprazole|pantoprazole|mesh-list
154612897|NCT03095547|Tacrolimus|tacrolimus|mesh-list
154612898|NCT03095547|Cyclosporins|cyclosporins|mesh-list
154612899|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612900|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
154612901|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612902|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154612903|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612904|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612905|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
154612906|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612907|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
154612908|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612909|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154612910|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154612911|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154612912|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154612913|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154612914|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154612915|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154612916|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154612917|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154612918|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
154612919|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612921|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154612922|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612923|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154612924|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154612925|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612926|NCT05049681|Apatinib|apatinib|mesh-list
154612927|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612928|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154612929|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612930|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612931|NCT03334487|Dexamethasone|dexamethasone|mesh-list
154612932|NCT03334487|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154612933|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154612934|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
154612935|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
154612936|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612937|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612938|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154612939|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
154612940|NCT03334487|Hormones|hormones|mesh-ancestor
154612941|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612942|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154612943|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612944|NCT03334487|Immunoconjugates|immunoconjugates|mesh-ancestor
154612945|NCT03334487|Immunologic Factors|immunologic factors|mesh-ancestor
154612946|NCT05038449|Colchicine|colchicine|mesh-list
154612947|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
154612948|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612949|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612950|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612951|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612952|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612953|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612954|NCT05038059|Acetic Acid|acetic acid|mesh-list
154612955|NCT05038059|Retinol acetate|retinol acetate|mesh-list
154612956|NCT05038059|Ethylene|ethylene|mesh-list
154612957|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154612958|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612959|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154612960|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
154612961|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612962|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154612963|NCT05038059|Protective Agents|protective agents|mesh-ancestor
154612964|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612965|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154612966|NCT05038059|Growth Substances|growth substances|mesh-ancestor
154612967|NCT01236547|Paclitaxel|paclitaxel|mesh-list
154612968|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154612969|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154612970|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612971|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612972|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612973|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612974|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612975|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
154612976|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
154612977|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612978|NCT03329339|Protective Agents|protective agents|mesh-ancestor
154612979|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612980|NCT03329339|Vitamins|vitamins|mesh-ancestor
154612981|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
154612982|NCT03329261|Clopidogrel|clopidogrel|mesh-list
154612983|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154612984|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154612985|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154612986|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154612987|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
154612988|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154612989|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612990|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612991|NCT03329183|Irinotecan|irinotecan|mesh-list
154612992|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154612994|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612995|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612996|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612997|NCT05048511|Vitamin D|vitamin d|mesh-list
154612998|NCT05048511|Vitamins|vitamins|mesh-ancestor
154612999|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
154613000|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613001|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154613002|NCT02167945|Ritonavir|ritonavir|mesh-list
154613003|NCT02167945|Ribavirin|ribavirin|mesh-list
154613004|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154613005|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154613006|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
154613007|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613008|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613009|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154613010|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154613011|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
154613012|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613013|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154613014|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154613015|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
154613016|NCT03328481|Anesthetics|anesthetics|mesh-list
154613017|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613018|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613019|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
154613020|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154613021|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154613022|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
154613023|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613024|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613025|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613026|NCT02452879|Urological Agents|urological agents|mesh-ancestor
154613027|NCT05024799|Fentanyl|fentanyl|mesh-list
154613028|NCT05024799|Butorphanol|butorphanol|mesh-list
154613029|NCT05024799|Propofol|propofol|mesh-list
154613030|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154613031|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613032|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613033|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154613034|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
154613035|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
154613036|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154613037|NCT05024799|Narcotics|narcotics|mesh-ancestor
154613038|NCT05024799|Analgesics|analgesics|mesh-ancestor
154613039|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
154613040|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613041|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154613042|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
154613043|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613044|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154613045|NCT05018637|Teriparatide|teriparatide|mesh-list
154613046|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154613047|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613048|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154613049|NCT03327701|Benralizumab|benralizumab|mesh-list
154613050|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154613051|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613052|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
154327818|NCT00361582|Tapentadol|tapentadol|mesh-list
154613053|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154613054|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613055|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613056|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154613057|NCT03327389|Analgesics|analgesics|mesh-ancestor
154613058|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
154613059|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613060|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154613061|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154613062|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154613063|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
154613064|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613065|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613066|NCT03333083|Lamivudine|lamivudine|mesh-list
154613067|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
154225791|NCT03969758|Liver Extracts|liver extracts|mesh-list
154613068|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154613069|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154613070|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613071|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613072|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
154613073|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613074|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154613075|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154613076|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154613077|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154613078|NCT03093597|Petrolatum|petrolatum|mesh-list
154613079|NCT03093597|Emollients|emollients|mesh-ancestor
154613080|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
154613081|NCT03327155|Tenofovir|tenofovir|mesh-list
154613082|NCT03327155|Emtricitabine|emtricitabine|mesh-list
154613083|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
154613084|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613085|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154613086|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154613087|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613088|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613089|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154613090|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154613091|NCT05024877|Stanozolol|stanozolol|mesh-list
154613092|NCT05024877|Androgens|androgens|mesh-ancestor
154613093|NCT05024877|Hormones|hormones|mesh-ancestor
154613094|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613095|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613096|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
154613097|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
154613098|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154613099|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154613100|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154613101|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327872|NCT02284282|Analgesics|analgesics|mesh-ancestor
154613102|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613103|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
154613104|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613105|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613106|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154613107|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613108|NCT03230851|Aspirin|aspirin|mesh-list
154613109|NCT03230851|Indobufen|indobufen|mesh-list
154613110|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154613111|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154613112|NCT03230851|Analgesics|analgesics|mesh-ancestor
154613113|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
154613114|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613115|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613116|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613117|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154613118|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154613119|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154613120|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613121|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154613122|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154613123|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613124|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
154613125|NCT05464433|Tislelizumab|tislelizumab|mesh-list
154613126|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
154613127|NCT05464433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154613128|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613129|NCT05464433|Analgesics|analgesics|mesh-ancestor
154613130|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
154613131|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613132|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613133|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154613134|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154613135|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613136|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327920|NCT04470076|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154613137|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154613138|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613139|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154613140|NCT05024565|Lactams|lactams|mesh-list
154613141|NCT05024565|beta-Lactams|beta-lactams|mesh-list
154613142|NCT05024565|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
154613143|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613144|NCT03228901|Oxytocin|oxytocin|mesh-list
154613145|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
154613146|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154613147|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613148|NCT03228823|Amiodarone|amiodarone|mesh-list
154613149|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154613150|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
154613151|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154613152|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154613153|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613154|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154613155|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154613156|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154613157|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613158|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154613159|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154613160|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154613161|NCT03332225|Interferons|interferons|mesh-list
154613162|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
154613163|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154613164|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613165|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
154613166|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613167|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154613168|NCT05023941|Acetazolamide|acetazolamide|mesh-list
154613169|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
154613170|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154613171|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613172|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613173|NCT05023941|Diuretics|diuretics|mesh-ancestor
154613174|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
154613175|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613176|NCT03332069|Cisplatin|cisplatin|mesh-list
154613177|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613178|NCT03090087|Regadenoson|regadenoson|mesh-list
154613179|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154613180|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154613181|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
154613182|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
154613183|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613184|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613185|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613186|NCT03326609|Ropivacaine|ropivacaine|mesh-list
154613187|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
154613188|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
154613189|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613190|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613191|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
154613192|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613193|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
154613194|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154613195|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154613196|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154613197|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154613198|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613199|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
154613200|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613201|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613202|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154613203|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613204|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
154613205|NCT03090009|Analgesics|analgesics|mesh-ancestor
154613206|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
154613207|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613208|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613209|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154613210|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154613211|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613212|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154613213|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154613214|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558028|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613215|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613216|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
154613217|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154613218|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154613219|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328006|NCT05982522|Antimitotic Agents|antimitotic agents|mesh-ancestor
154613220|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
154613221|NCT02492087|Coagulants|coagulants|mesh-ancestor
154613222|NCT03093129|Artesunate|artesunate|mesh-list
154613223|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
154613224|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154613225|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154613226|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613227|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613228|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
154613229|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
154613230|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154613231|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
154613232|NCT02491697|Capecitabine|capecitabine|mesh-list
154613233|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154613234|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
154613235|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613236|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613237|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
154613238|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154613239|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613240|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
154613241|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154613242|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154613243|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613244|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
154613245|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613246|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613247|NCT03331523|Betamethasone|betamethasone|mesh-list
154613248|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
154613249|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154613250|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
154613251|NCT03331523|Calcipotriene|calcipotriene|mesh-list
154613252|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154613253|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613254|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
154613255|NCT03331523|Hormones|hormones|mesh-ancestor
154613256|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613257|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613258|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154613259|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613260|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
154613261|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
154613262|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
154613263|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613264|NCT05023863|Protective Agents|protective agents|mesh-ancestor
154613265|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613266|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
154613267|NCT05023863|Vitamins|vitamins|mesh-ancestor
154613268|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
154613269|NCT05463809|Oxycodone|oxycodone|mesh-list
154613270|NCT05463809|Analgesics|analgesics|mesh-list
154613271|NCT05463809|Ropivacaine|ropivacaine|mesh-list
154613272|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
154613273|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
154328042|NCT05982197|Curcumin|curcumin|mesh-list
154613274|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613275|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613276|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
154613277|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613278|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154613279|NCT05463809|Narcotics|narcotics|mesh-ancestor
154613280|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
154613281|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154613282|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
154613283|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613284|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613285|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154613286|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613287|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154613288|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
154613289|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613290|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613291|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154613292|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
154613293|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
154613294|NCT03331445|Protective Agents|protective agents|mesh-ancestor
154613295|NCT05008029|Anesthetics|anesthetics|mesh-list
154613296|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613297|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613298|NCT05008263|Liver Extracts|liver extracts|mesh-list
154613299|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
154613300|NCT05008263|Hematinics|hematinics|mesh-ancestor
154613301|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154613302|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613303|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154613304|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613305|NCT05016063|Fludarabine|fludarabine|mesh-list
154613306|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
154613307|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613308|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613309|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154613310|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
154613311|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613312|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154613313|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154613314|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
154613315|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154613316|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
154613317|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154613318|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
154613319|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613320|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613321|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154613322|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613323|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154613324|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
154613325|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613326|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613327|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154613328|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
154613329|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
154613330|NCT03078933|Protective Agents|protective agents|mesh-ancestor
154613331|NCT03092193|Naproxen|naproxen|mesh-list
154613332|NCT03092193|Esomeprazole|esomeprazole|mesh-list
154613333|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154613334|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154613335|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154613336|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613337|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613338|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154613339|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154613340|NCT03092193|Analgesics|analgesics|mesh-ancestor
154613341|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
154613342|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613343|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613344|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613345|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154613346|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
154613347|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154613348|NCT05015907|Ropivacaine|ropivacaine|mesh-list
154613349|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
154613350|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
154613351|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613352|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613353|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
154613354|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613355|NCT05015595|Memantine|memantine|mesh-list
154613356|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154613357|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154613358|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
154613359|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613360|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613361|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613362|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154226082|NCT01028261|CKD732|ckd732|mesh-list
154613363|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154613364|NCT05015829|Dobutamine|dobutamine|mesh-list
154613365|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154613366|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
154613367|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
154613368|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613369|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613370|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154613371|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154613372|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154613373|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
154613374|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613375|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613376|NCT05015829|Protective Agents|protective agents|mesh-ancestor
154613377|NCT05015361|Propofol|propofol|mesh-list
154613378|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154613379|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613380|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613381|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154613382|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
154613383|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
154613384|NCT01375075|Atorvastatin|atorvastatin|mesh-list
154613385|NCT01375075|Evacetrapib|evacetrapib|mesh-list
154613386|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154613387|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154613388|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
154613389|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613390|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154613391|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154613392|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613393|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154613394|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154613395|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
154613396|NCT03240055|Etomidate|etomidate|mesh-list
154613397|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
154613398|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613399|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613400|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154613401|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154613402|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
154613403|NCT03087201|Nabiximols|nabiximols|mesh-list
154613404|NCT03087201|Analgesics|analgesics|mesh-ancestor
154613405|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
154613406|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613407|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613408|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
154613409|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154613410|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
154613411|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154613412|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613413|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154613414|NCT03239743|Midazolam|midazolam|mesh-list
154613415|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154613416|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154613417|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613418|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613419|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154613420|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154613421|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154613422|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154613423|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
154613424|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
154613425|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
154613426|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
154613427|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613428|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613429|NCT03239821|Codeine|codeine|mesh-list
154613430|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154613431|NCT03239821|Narcotics|narcotics|mesh-ancestor
154613432|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613433|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613434|NCT03239821|Analgesics|analgesics|mesh-ancestor
154613435|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
154613436|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613437|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
154613438|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613439|NCT03230227|Bupivacaine|bupivacaine|mesh-list
154613440|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
154613441|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
154613442|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613443|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613444|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
154613445|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613446|NCT03078465|Clopidogrel|clopidogrel|mesh-list
154613447|NCT03078465|Ticagrelor|ticagrelor|mesh-list
154613448|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154613449|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154613450|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154613451|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154613452|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
154613453|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613454|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613455|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613456|NCT03324815|Morphine|morphine|mesh-list
154613457|NCT03324815|Methadone|methadone|mesh-list
154613458|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154613459|NCT03324815|Narcotics|narcotics|mesh-ancestor
154613460|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613461|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613462|NCT03324815|Analgesics|analgesics|mesh-ancestor
154613463|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
154613464|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613465|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
154613466|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613467|NCT05006469|Dexamethasone|dexamethasone|mesh-list
154613468|NCT05006469|Doxorubicin|doxorubicin|mesh-list
154613469|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154613470|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154613471|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613472|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
154613473|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
154613474|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613475|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613476|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154613477|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
154613478|NCT05006469|Hormones|hormones|mesh-ancestor
154613479|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613480|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154613481|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613482|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613483|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613484|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154613485|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154613486|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154613487|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154613488|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
154613489|NCT03084783|Dexamethasone|dexamethasone|mesh-list
154613490|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613491|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
154613492|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
154613493|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613494|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613495|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154613496|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
154613497|NCT03084783|Hormones|hormones|mesh-ancestor
154613498|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613499|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154613500|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613501|NCT03228355|Cromakalim|cromakalim|mesh-list
154613502|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154613503|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154613504|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
154613505|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613506|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613507|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154613508|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613509|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
154613510|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
154613511|NCT03324503|Prednisone|prednisone|mesh-list
154613512|NCT03324503|Prednisolone|prednisolone|mesh-list
154613513|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154613514|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
154558030|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613515|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154613517|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154613518|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
154613519|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
154328285|NCT05758818|Moxifloxacin|moxifloxacin|mesh-list
154613520|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613521|NCT03324503|Hormones|hormones|mesh-ancestor
154613522|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613523|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613524|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154613525|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613526|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
154613527|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
154613528|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613529|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154613530|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154613531|NCT03324503|Protective Agents|protective agents|mesh-ancestor
154613532|NCT05006001|Colchicine|colchicine|mesh-list
154613533|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
154613534|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154613535|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
154613536|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
154613537|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
154613538|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613539|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613540|NCT04493489|Propranolol|propranolol|mesh-list
154613541|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154613542|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154613543|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
154613544|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613545|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613546|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613547|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154613548|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154613549|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
154613550|NCT03228043|Apatinib|apatinib|mesh-list
154613551|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613552|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154613553|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613554|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613555|NCT03119857|Docetaxel|docetaxel|mesh-list
154613556|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
154613557|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613558|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
154613559|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
154613560|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
154613561|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613562|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154613563|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613564|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613565|NCT03320603|Thrombin|thrombin|mesh-list
154613566|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
154613567|NCT03320603|Coagulants|coagulants|mesh-ancestor
154613568|NCT03227653|Ritonavir|ritonavir|mesh-list
154613569|NCT03227653|Lopinavir|lopinavir|mesh-list
154613570|NCT03227653|Nevirapine|nevirapine|mesh-list
154613571|NCT03227653|Efavirenz|efavirenz|mesh-list
154613572|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154613573|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154328353|NCT06098313|Cyclophosphamide|cyclophosphamide|mesh-list
154613574|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
154613575|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613576|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613577|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154613578|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154613579|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
154613580|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613581|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154613582|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154613583|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154613584|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154613585|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154613586|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154613587|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154613588|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154613589|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154613591|NCT03320447|Prilocaine|prilocaine|mesh-list
154613592|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154613593|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154613594|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154613595|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
154613596|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
154613597|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613598|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613599|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
154613600|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613601|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154613602|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154613603|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154613604|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154613605|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613606|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154613607|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
154613608|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154613609|NCT04434105|Triamcinolone|triamcinolone|mesh-list
154613610|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154613611|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154613612|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154613613|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613614|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
154613615|NCT04434105|Hormones|hormones|mesh-ancestor
154613616|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613617|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613618|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154613619|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
154613620|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613621|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613622|NCT03078777|Fexofenadine|fexofenadine|mesh-list
154613623|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154613624|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154613625|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154613626|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
154613627|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
154613628|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613629|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613630|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613631|NCT03078309|Cannabidiol|cannabidiol|mesh-list
154613632|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
154613633|NCT03208309|Diacerein|diacerein|mesh-list
154613634|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613635|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154613636|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
154613637|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
154613638|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613639|NCT03323567|Lidocaine|lidocaine|mesh-list
154613640|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154613641|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
154613642|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
154613643|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613644|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613645|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
154613646|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613647|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154613648|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154613649|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154613650|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154613651|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613652|NCT04492709|Midazolam|midazolam|mesh-list
154613653|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154613654|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154613655|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613656|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613657|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154613658|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154226339|NCT01029821|Tinzaparin|tinzaparin|mesh-list
154613660|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154613661|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
154613662|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
154613663|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
154613664|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
154613665|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613666|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613667|NCT05006235|Epinephrine|epinephrine|mesh-list
154613668|NCT05006235|Albuterol|albuterol|mesh-list
154613669|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154613670|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154613671|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
154613672|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613673|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613674|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613675|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154613676|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154613677|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
154613678|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613679|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154613680|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613681|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
154613682|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
154613683|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154613684|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
154613685|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154613686|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154613687|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
154613688|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154613689|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613690|NCT03319823|Diuretics|diuretics|mesh-ancestor
154613691|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
154613692|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613693|NCT02487953|Nicotine|nicotine|mesh-list
154613694|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154613695|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
154613696|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613697|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613698|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154613699|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154613700|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
154613701|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613702|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613703|NCT03091569|Vitamin K|vitamin k|mesh-list
154613704|NCT03091569|Vitamins|vitamins|mesh-ancestor
154613705|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
154613706|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613707|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154613708|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154613709|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613710|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
154613711|NCT03091569|Coagulants|coagulants|mesh-ancestor
154613712|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
154613713|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613714|NCT02487719|Teferrol|teferrol|mesh-list
154613715|NCT02487719|Hematinics|hematinics|mesh-ancestor
154613716|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154613717|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
154613718|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613719|NCT04940871|Favipiravir|favipiravir|mesh-list
154613720|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
154613721|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613722|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154613723|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154613724|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613725|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
154613726|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
154613727|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613728|NCT03221881|Docetaxel|docetaxel|mesh-list
154613729|NCT03221881|Doxorubicin|doxorubicin|mesh-list
154613730|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154613731|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613732|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
154613733|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
154558031|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154613734|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
154613735|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613736|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154613737|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154613738|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154613739|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613741|NCT03091257|Dabrafenib|dabrafenib|mesh-list
154613742|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613743|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154613744|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613745|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613746|NCT03078231|Mydriatics|mydriatics|mesh-list
154613747|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
154613748|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613749|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613750|NCT03319121|Theophylline|theophylline|mesh-list
154613751|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
154613752|NCT03319121|Lansoprazole|lansoprazole|mesh-list
154613753|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154613754|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
154613755|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613756|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613757|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154613758|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613759|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154613760|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613761|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613762|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
154613763|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154613764|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154613765|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
154613766|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613767|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154613768|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154613769|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154613770|NCT02487407|Simendan|simendan|mesh-list
154613771|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154613772|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
154613773|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154613774|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154613775|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328563|NCT06091267|Antimetabolites|antimetabolites|mesh-ancestor
154613776|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613777|NCT02487407|Protective Agents|protective agents|mesh-ancestor
154613778|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613779|NCT03221569|Ketorolac|ketorolac|mesh-list
154613780|NCT03221569|Ketamine|ketamine|mesh-list
154613781|NCT03221569|Analgesics|analgesics|mesh-ancestor
154613782|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
154613783|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613784|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613785|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154613786|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154613787|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
154613788|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
154613789|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154613790|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154613791|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154613792|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613793|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613794|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154613795|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154613796|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613797|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154613798|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154613799|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613800|NCT03319043|Budesonide|budesonide|mesh-list
154613801|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
154613802|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613803|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154613804|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
154613805|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613806|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613807|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154613808|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613809|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
154613810|NCT03319043|Hormones|hormones|mesh-ancestor
154613811|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613812|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154613813|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154613814|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154613815|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
154613816|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613817|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613818|NCT02451475|Amitriptyline|amitriptyline|mesh-list
154613819|NCT02451475|Paroxetine|paroxetine|mesh-list
154613820|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154613821|NCT02451475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154613822|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154613823|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154613824|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613825|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613826|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
154613827|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613828|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154613829|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
154613830|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154613831|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154613832|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154613833|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613834|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154613835|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154613836|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154613837|NCT02451475|Analgesics|analgesics|mesh-ancestor
154613838|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
154613839|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613840|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154613841|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
154613842|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154613843|NCT05019417|Glycerol|glycerol|mesh-list
154613844|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154613845|NCT05019417|Protective Agents|protective agents|mesh-ancestor
154613846|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613847|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613848|NCT03225937|Trastuzumab|trastuzumab|mesh-list
154613849|NCT03225937|Pertuzumab|pertuzumab|mesh-list
154613850|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154613851|NCT03225937|Lapatinib|lapatinib|mesh-list
154613852|NCT03225937|Maytansine|maytansine|mesh-list
154613853|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154613854|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613855|NCT03225937|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154613856|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154613857|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613858|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613859|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154613860|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
154613861|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
154613862|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
154613863|NCT03225937|Immunotoxins|immunotoxins|mesh-ancestor
154613864|NCT03225937|Immunoconjugates|immunoconjugates|mesh-ancestor
154613865|NCT03225937|Immunologic Factors|immunologic factors|mesh-ancestor
154613866|NCT03225937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613867|NCT03318887|Ribavirin|ribavirin|mesh-list
154613868|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
154613869|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
154613870|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613871|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
154613872|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613873|NCT03119077|Itraconazole|itraconazole|mesh-list
154613874|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
154613875|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613876|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154613877|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154613878|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613879|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613880|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154613881|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
154860315|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
154613882|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154613883|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613884|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154613885|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
154613886|NCT02487329|Calcium|calcium|mesh-list
154613887|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154613888|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613889|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154613890|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
154613891|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154613892|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613893|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154613894|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613895|NCT04493099|Venetoclax|venetoclax|mesh-list
154613896|NCT04493099|Decitabine|decitabine|mesh-list
154613897|NCT04493099|Alvocidib|alvocidib|mesh-list
154613898|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613899|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154613900|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
154613901|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613902|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613903|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
154613904|NCT04493099|Growth Substances|growth substances|mesh-ancestor
154613905|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613906|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154613907|NCT05004909|Tretinoin|tretinoin|mesh-list
154613908|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613909|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
154613910|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
154613911|NCT03119623|Valsartan|valsartan|mesh-list
154613912|NCT03119623|Enalapril|enalapril|mesh-list
154613913|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154613914|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154613915|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154613916|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154613917|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613918|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154613919|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
154613920|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613921|NCT03318419|Cytarabine|cytarabine|mesh-list
154613922|NCT03318419|Pegaspargase|pegaspargase|mesh-list
154613923|NCT03318419|Asparaginase|asparaginase|mesh-list
154613924|NCT03318419|Cladribine|cladribine|mesh-list
154613925|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154613926|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
154613927|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613928|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613929|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
154613930|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613931|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154613932|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
154613933|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613934|NCT03321773|Amoxicillin|amoxicillin|mesh-list
154613935|NCT03321773|Metronidazole|metronidazole|mesh-list
154613936|NCT03321773|Clarithromycin|clarithromycin|mesh-list
154613937|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154613938|NCT03321773|Pantoprazole|pantoprazole|mesh-list
154613939|NCT03321773|Bismuth|bismuth|mesh-list
154613940|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154613941|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613942|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154613943|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154613944|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154613945|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154613946|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613947|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154613948|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154613949|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154613950|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154613951|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154613952|NCT03321773|Antacids|antacids|mesh-ancestor
154613953|NCT03077217|Rifaximin|rifaximin|mesh-list
154613954|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154613955|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154613956|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154226640|NCT03967665|Antidotes|antidotes|mesh-ancestor
154613957|NCT05001243|Bromfenac|bromfenac|mesh-list
154613958|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154613959|NCT05001243|Phenylephrine|phenylephrine|mesh-list
154613960|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
154613961|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
154613962|NCT05001243|Pilocarpine|pilocarpine|mesh-list
154613963|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154613964|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
154613965|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154613966|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
154613967|NCT05001243|Protective Agents|protective agents|mesh-ancestor
154613968|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154613969|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154613970|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154613971|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154613972|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154613973|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154613974|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154613975|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
154613976|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
154613977|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154613978|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
154613979|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154613980|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
154613981|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154613982|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
154613983|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154613984|NCT05001243|Miotics|miotics|mesh-ancestor
154613985|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154613986|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154613987|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
154613988|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154613989|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154613990|NCT05001243|Analgesics|analgesics|mesh-ancestor
154613991|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
154613992|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154613993|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154613994|NCT03225781|Bleomycin|bleomycin|mesh-list
154613995|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154613996|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154613997|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154613998|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154613999|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614000|NCT03205891|Immunotoxins|immunotoxins|mesh-ancestor
154614001|NCT03205891|Immunoconjugates|immunoconjugates|mesh-ancestor
154614002|NCT03205891|Immunologic Factors|immunologic factors|mesh-ancestor
154614003|NCT03205891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614004|NCT03221023|Vancomycin|vancomycin|mesh-list
154614005|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154614006|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614007|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154614008|NCT02490839|Amoxicillin|amoxicillin|mesh-list
154614009|NCT02490839|Metronidazole|metronidazole|mesh-list
154614010|NCT02490839|Tetracycline|tetracycline|mesh-list
154614011|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154614012|NCT02490839|Rabeprazole|rabeprazole|mesh-list
154614013|NCT02490839|Bismuth|bismuth|mesh-list
154614014|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154614015|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614016|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
154614017|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154614018|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154614019|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154614020|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154614021|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614022|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614023|NCT02490839|Antacids|antacids|mesh-ancestor
154614024|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154614025|NCT02490527|Simvastatin|simvastatin|mesh-list
154614026|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154614027|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154614028|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
154614029|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614030|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154614031|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154614032|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614033|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
154614034|NCT02490449|Lansoprazole|lansoprazole|mesh-list
154614035|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154614036|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154614037|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154614038|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614039|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614040|NCT02452177|Vitamin D|vitamin d|mesh-list
154614041|NCT02452177|Vitamins|vitamins|mesh-ancestor
154614042|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
154614043|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614044|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154614045|NCT03224923|Aspirin|aspirin|mesh-list
154614046|NCT03224923|Clopidogrel|clopidogrel|mesh-list
154614047|NCT03224923|Ticagrelor|ticagrelor|mesh-list
154614048|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154614049|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154614050|NCT03224923|Analgesics|analgesics|mesh-ancestor
154614051|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
154614052|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614053|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614054|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614055|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154614056|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154614057|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154614058|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614059|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154614060|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154614061|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614062|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
154614063|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154614064|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154614065|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154614066|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
154614067|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614068|NCT05004753|Artemisinins|artemisinins|mesh-list
154614069|NCT05004753|Artemisinin|artemisinin|mesh-list
154614070|NCT05004753|Dexamethasone|dexamethasone|mesh-list
154614071|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614072|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
154614073|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
154614074|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614075|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614076|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154614077|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
154614078|NCT05004753|Hormones|hormones|mesh-ancestor
154614079|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614080|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154614081|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614082|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
154614083|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154614084|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154614085|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614086|NCT02486549|Bupivacaine|bupivacaine|mesh-list
154614087|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614088|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
154614089|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614090|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614091|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
154614092|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614093|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
154614094|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614095|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
154614096|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
154614097|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
154614098|NCT04485403|Ibuprofen|ibuprofen|mesh-list
154614099|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154614100|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154614101|NCT04485403|Analgesics|analgesics|mesh-ancestor
154614102|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
154328874|NCT06215768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154614103|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614104|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614105|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614106|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154614107|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154614108|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614109|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614110|NCT03220867|Risperidone|risperidone|mesh-list
154614111|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154614113|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614114|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614115|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614116|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154614117|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154614118|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614119|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154614120|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154614121|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
154614122|NCT03318029|Vitamin D|vitamin d|mesh-list
154614123|NCT03318029|Vitamins|vitamins|mesh-ancestor
154614124|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
154614125|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614126|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154614127|NCT03076281|Metformin|metformin|mesh-list
154614128|NCT03076281|Doxycycline|doxycycline|mesh-list
154614129|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154614130|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614131|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154614132|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614133|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
154614134|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154614135|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154614136|NCT02452255|Propranolol|propranolol|mesh-list
154614137|NCT02452255|Metoprolol|metoprolol|mesh-list
154614138|NCT02452255|Fenofibrate|fenofibrate|mesh-list
154614139|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154614140|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154614141|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
154614142|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614143|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614144|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614145|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154614146|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154614147|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
154614148|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
154614149|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
154614150|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614151|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154614152|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154614153|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
154614154|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154614155|NCT03205033|Melatonin|melatonin|mesh-list
154614156|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
154614157|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614158|NCT03205033|Protective Agents|protective agents|mesh-ancestor
154614159|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614160|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614161|NCT03205267|Bosutinib|bosutinib|mesh-list
154614162|NCT03205267|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154614163|NCT03205267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154614164|NCT03205267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614165|NCT03205267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614166|NCT03076905|Olorofim|olorofim|mesh-list
154614167|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
154614168|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614169|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154614170|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154614171|NCT02452099|Protective Agents|protective agents|mesh-ancestor
154614172|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614173|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154614174|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
154614175|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614176|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154614177|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154614178|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614179|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614180|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154614181|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614182|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614183|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
154614184|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614185|NCT03220789|Methamphetamine|methamphetamine|mesh-list
154558032|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154614186|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154614187|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614188|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
154614189|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
154614190|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614191|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
154614192|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614193|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614194|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154614195|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154614196|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154614197|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614198|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154614199|NCT03220555|Lidocaine|lidocaine|mesh-list
154614200|NCT03220555|Prilocaine|prilocaine|mesh-list
154614201|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614202|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
154614203|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614204|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614205|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
154614206|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614207|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154614208|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154614209|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154614210|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614211|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614212|NCT03204877|Melatonin|melatonin|mesh-list
154614213|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
154614214|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614215|NCT03204877|Protective Agents|protective agents|mesh-ancestor
154614216|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614217|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614218|NCT03204799|Metformin|metformin|mesh-list
154614219|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154614220|NCT03204799|Ezetimibe|ezetimibe|mesh-list
154614221|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154614222|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614223|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154614224|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154614225|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
154614226|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614227|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154614228|NCT03317327|Nivolumab|nivolumab|mesh-list
154614229|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154614230|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614231|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154614232|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614233|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154614234|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154614235|NCT03204331|Norethindrone|norethindrone|mesh-list
154614236|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
154614237|NCT03204331|Estradiol|estradiol|mesh-list
154614238|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154614239|NCT03204331|Relugolix|relugolix|mesh-list
154614240|NCT03204331|Estrogens|estrogens|mesh-ancestor
154614241|NCT03204331|Hormones|hormones|mesh-ancestor
154614242|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614243|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614244|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154614245|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
154614246|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154614247|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154614248|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154614249|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154614250|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154614251|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
154614252|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
154614253|NCT03072849|Fluticasone|fluticasone|mesh-list
154614254|NCT03072849|Azithromycin|azithromycin|mesh-list
154614255|NCT03072849|Montelukast|montelukast|mesh-list
154614256|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614257|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154614258|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
154614259|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614260|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614261|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154614262|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
154614263|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154614264|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154614265|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154614266|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614267|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154614268|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
154614269|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614270|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154614271|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154614272|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614273|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
154614274|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
154614275|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154614276|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614277|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614278|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
154614279|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154614280|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614281|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614282|NCT03075657|Haloperidol|haloperidol|mesh-list
154614283|NCT03075657|Risperidone|risperidone|mesh-list
154614284|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
154614285|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154614286|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
154614287|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614288|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614289|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614290|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154614291|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154614292|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614293|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154614294|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154614295|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
154614296|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
154614297|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
154614298|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614299|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154614300|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154614302|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614303|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
154614304|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
154614305|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
154614306|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614307|NCT05004207|Lactulose|lactulose|mesh-list
154614308|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154614309|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
154614310|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154614311|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154614312|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614313|NCT02489513|Ivosidenib|ivosidenib|mesh-list
154614314|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614315|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614316|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614317|NCT03317015|Fluticasone|fluticasone|mesh-list
154614318|NCT03317015|Triamcinolone|triamcinolone|mesh-list
154614319|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614320|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154614321|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
154614322|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614323|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614324|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154614325|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
154614326|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
154614327|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154614328|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
154614329|NCT03317015|Hormones|hormones|mesh-ancestor
154614330|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614331|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
154614332|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154614333|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
154227026|NCT01102114|Vaccines|vaccines|mesh-list
154614334|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614336|NCT03204565|Protective Agents|protective agents|mesh-ancestor
154614337|NCT03224377|Antibodies|antibodies|mesh-list
154614338|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
154614339|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
154614340|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614341|NCT02451787|Vitamin D|vitamin d|mesh-list
154614342|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
154614343|NCT02451787|Vitamins|vitamins|mesh-ancestor
154614344|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
154614345|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614346|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154614347|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154614348|NCT03224221|Fluorouracil|fluorouracil|mesh-list
154614349|NCT03224221|Apatinib|apatinib|mesh-list
154614350|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
154614351|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614352|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154614353|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614354|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154614355|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
154614356|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614357|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154614358|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614359|NCT03204097|Alendronate|alendronate|mesh-list
154614360|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154614361|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614362|NCT03223519|Ibuprofen|ibuprofen|mesh-list
154614363|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614364|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154614365|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154614366|NCT03223519|Analgesics|analgesics|mesh-ancestor
154329167|NCT05302817|Xenon|xenon|mesh-list
154614367|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
154614368|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614369|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614370|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154614371|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154614372|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614373|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614374|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
154614375|NCT03320915|Vitamin D|vitamin d|mesh-list
154614376|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154614377|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614378|NCT03320915|Vitamins|vitamins|mesh-ancestor
154614379|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
154614380|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154614381|NCT02488889|Ethanol|ethanol|mesh-list
154614382|NCT02488889|Varenicline|varenicline|mesh-list
154614383|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154614384|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614385|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614386|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614387|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154614388|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154614389|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
154614390|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614391|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614392|NCT03220009|Nivolumab|nivolumab|mesh-list
154614393|NCT03220009|Ipilimumab|ipilimumab|mesh-list
154614394|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154614395|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614396|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154614397|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614398|NCT02485613|Dexamethasone|dexamethasone|mesh-list
154614399|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614400|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
154614401|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
154614402|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614403|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614404|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154614405|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
154614406|NCT02485613|Hormones|hormones|mesh-ancestor
154614407|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614408|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154614409|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614410|NCT02484833|Cetuximab|cetuximab|mesh-list
154614411|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154614412|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614413|NCT03204019|Thalidomide|thalidomide|mesh-list
154614414|NCT03204019|Temozolomide|temozolomide|mesh-list
154614415|NCT03204019|Tegafur|tegafur|mesh-list
154614416|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154614417|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
154614418|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614419|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614420|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154614421|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
154614422|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614423|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
154614424|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154614425|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614426|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154614427|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154614428|NCT03204019|Growth Substances|growth substances|mesh-ancestor
154614429|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
154614430|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154614431|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
154614432|NCT02485145|Diclofenac|diclofenac|mesh-list
154614433|NCT02485145|Orphenadrine|orphenadrine|mesh-list
154614434|NCT02485145|Bupivacaine|bupivacaine|mesh-list
154614435|NCT02485145|Baclofen|baclofen|mesh-list
154614436|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614437|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
154614438|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614439|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614440|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
154614441|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614442|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154614443|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154614444|NCT02485145|Analgesics|analgesics|mesh-ancestor
154614445|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614446|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154614447|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154614448|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614449|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614450|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154614451|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154614452|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154614453|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
154614454|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
154614455|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614456|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154614457|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154614458|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
154614459|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
154614460|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154614461|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154614462|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
154614463|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154614464|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154614465|NCT02484755|Gefitinib|gefitinib|mesh-list
154614466|NCT02484755|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154614467|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154614468|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329246|NCT05071183|Trametinib|trametinib|mesh-list
154614469|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614470|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614471|NCT03316469|Clomiphene|clomiphene|mesh-list
154614472|NCT03316469|Enclomiphene|enclomiphene|mesh-list
154614473|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
154614474|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154614475|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
154614476|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614477|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614478|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154614479|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
154614480|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154614481|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154614482|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154227180|NCT00124449|Abatacept|abatacept|mesh-list
154614483|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154614484|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154614485|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154614486|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
154614487|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614488|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614489|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614490|NCT02485067|Urological Agents|urological agents|mesh-ancestor
154614491|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154614492|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154614493|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154614494|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614495|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614496|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
154614497|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614498|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614499|NCT03203317|Insulin|insulin|mesh-list
154614500|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154614501|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614502|NCT03316313|Antibodies|antibodies|mesh-list
154614503|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
154614504|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
154614505|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614506|NCT03201601|Inositol|inositol|mesh-list
154614507|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
154614508|NCT03201601|Vitamins|vitamins|mesh-ancestor
154614509|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
154614510|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614511|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
154614512|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154614513|NCT02480387|Ledipasvir|ledipasvir|mesh-list
154614514|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
154614515|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614516|NCT04999293|Clopidogrel|clopidogrel|mesh-list
154614517|NCT04999293|Ticagrelor|ticagrelor|mesh-list
154614518|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154614519|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154614520|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154614521|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154614522|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
154614523|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614524|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614525|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614526|NCT03315923|Rituximab|rituximab|mesh-list
154614527|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
154614528|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
154614529|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154614530|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614531|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
154614532|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614533|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154614534|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154614535|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154614536|NCT03315845|Anesthetics|anesthetics|mesh-list
154614537|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614538|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614539|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
154614540|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154614541|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
154614542|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154614543|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
154614544|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614545|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614546|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
154614547|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
154614548|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
154614549|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154614550|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
154614551|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614552|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154614553|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154614554|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
154614555|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614556|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614557|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154227255|NCT03974360|Erenumab|erenumab|mesh-list
154558033|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614558|NCT02484209|Metformin|metformin|mesh-list
154614559|NCT02484209|Glimepiride|glimepiride|mesh-list
154614560|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154614561|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614562|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154614563|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154614564|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
154614565|NCT04999137|Vitamins|vitamins|mesh-list
154614566|NCT04999137|Thiamine|thiamine|mesh-list
154614567|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
154614568|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614569|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
154614570|NCT02484053|Rituximab|rituximab|mesh-list
154614571|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154614572|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075709|NCT04111328|Dsuvia|dsuvia|mesh-list
154614573|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
154614574|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614575|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154614576|NCT03200821|Gemcitabine|gemcitabine|mesh-list
154614577|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154614578|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
154614579|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614580|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614581|NCT02483897|Tetracaine|tetracaine|mesh-list
154614582|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154614583|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614584|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
154614585|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614586|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614587|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
154614588|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614589|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154614590|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154614591|NCT01374919|Hematinics|hematinics|mesh-ancestor
154614592|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154614593|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154614594|NCT03202615|Lactoferrin|lactoferrin|mesh-list
154614595|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614596|NCT03202459|Pregabalin|pregabalin|mesh-list
154614597|NCT03202459|Gabapentin|gabapentin|mesh-list
154614598|NCT03202459|Analgesics|analgesics|mesh-ancestor
154614599|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
154614600|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614601|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614602|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
154614603|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154614604|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614605|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614606|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154614607|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154614608|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154614609|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614610|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154614611|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154614612|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154614613|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614614|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
154614615|NCT04991181|Zamicastat|zamicastat|mesh-list
154614616|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614617|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614618|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154614619|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154614620|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614621|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154614622|NCT04456959|Immunotoxins|immunotoxins|mesh-ancestor
154614623|NCT04456959|Immunoconjugates|immunoconjugates|mesh-ancestor
154614624|NCT04456959|Immunologic Factors|immunologic factors|mesh-ancestor
154614625|NCT04456959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614626|NCT05713721|Dopamine|dopamine|mesh-list
154614627|NCT05713721|Dopamine Agonists|dopamine agonists|mesh-list
154558034|NCT02417883|Furosemide|furosemide|mesh-list
154614628|NCT05713721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154614629|NCT05713721|Sympathomimetics|sympathomimetics|mesh-ancestor
154614630|NCT05713721|Autonomic Agents|autonomic agents|mesh-ancestor
154614631|NCT05713721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614632|NCT05713721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614633|NCT05713721|Dopamine Agents|dopamine agents|mesh-ancestor
154614634|NCT05713721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614635|NCT05713721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614636|NCT05713721|Protective Agents|protective agents|mesh-ancestor
154614638|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614639|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
154614640|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614641|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614642|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
154614643|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614644|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154614645|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154614646|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154614647|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614648|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614649|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154614650|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154614651|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154614652|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614653|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614654|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614655|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614656|NCT03315533|Analgesics|analgesics|mesh-ancestor
154614657|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
154614658|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614659|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
154614660|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154614661|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
154614662|NCT05437835|Ropivacaine|ropivacaine|mesh-list
154614663|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614664|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
154614665|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614666|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614667|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
154614668|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614669|NCT03200197|Menthol|menthol|mesh-list
154614670|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
154614671|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
154614672|NCT04997967|Ketamine|ketamine|mesh-list
154614673|NCT04997967|Propofol|propofol|mesh-list
154614674|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154614675|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614676|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614677|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154614678|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
154614679|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
154614680|NCT04997967|Analgesics|analgesics|mesh-ancestor
154614681|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
154614682|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614683|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154614684|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154614685|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154614686|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614687|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614688|NCT02483195|Minoxidil|minoxidil|mesh-list
154614689|NCT02483195|Spironolactone|spironolactone|mesh-list
154614690|NCT02483195|Finasteride|finasteride|mesh-list
154614691|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154614692|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
154614693|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614694|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614695|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154614696|NCT02483195|Diuretics|diuretics|mesh-ancestor
154614697|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
154614698|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154614699|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
154614700|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154614701|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154614702|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614703|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614704|NCT02483195|Urological Agents|urological agents|mesh-ancestor
154614705|NCT02450149|Sorafenib|sorafenib|mesh-list
154614706|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614707|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154614708|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614709|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614711|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614712|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
154614713|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
154614714|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
154614715|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614716|NCT02479529|Norepinephrine|norepinephrine|mesh-list
154614717|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154614718|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154614719|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154614720|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614721|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614722|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614723|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
154614724|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
154614725|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614726|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154614727|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
154614728|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154614729|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
154614730|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614731|NCT03202147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154614732|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614733|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154614734|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
154614735|NCT03213769|Ubiquinone|ubiquinone|mesh-list
154614736|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
154614737|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
154614738|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614739|NCT03213769|Vitamins|vitamins|mesh-ancestor
154614740|NCT05002101|Zinc|zinc|mesh-list
154614741|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
154614742|NCT05002101|Trace Elements|trace elements|mesh-ancestor
154614743|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
154614744|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614745|NCT05002101|Astringents|astringents|mesh-ancestor
154614746|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
154614747|NCT03201913|Estrogens|estrogens|mesh-list
154614748|NCT03201913|Hormones|hormones|mesh-ancestor
154614749|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614750|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614751|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154614752|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
154614753|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154614754|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
154614755|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154614756|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614757|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154614758|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154614759|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614760|NCT03212677|Iron|iron|mesh-list
154614761|NCT03212677|Trace Elements|trace elements|mesh-ancestor
154614762|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
154614763|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614764|NCT03199339|Midazolam|midazolam|mesh-list
154614765|NCT03199339|Bupropion|bupropion|mesh-list
154614766|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154614767|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154614768|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614769|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614770|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154614771|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154614772|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154614773|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154614774|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
154614775|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
154614776|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
154614777|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
154614778|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614779|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614780|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154227471|NCT00261846|Bosutinib|bosutinib|mesh-list
154614781|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
154614782|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154614783|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154614784|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614786|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154614787|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154614788|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614789|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
154614790|NCT03071679|Imiquimod|imiquimod|mesh-list
154614791|NCT03071679|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154614792|NCT03071679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614793|NCT03071679|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154614794|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
154614795|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614796|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154614797|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614798|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
154614799|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614800|NCT03199261|Exenatide|exenatide|mesh-list
154614801|NCT03199261|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154614802|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154614803|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614804|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154614805|NCT03199261|Incretins|incretins|mesh-ancestor
154614806|NCT03199261|Hormones|hormones|mesh-ancestor
154614807|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614808|NCT02482961|Colistin|colistin|mesh-list
154614809|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154614810|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154614811|NCT03201835|Nabiximols|nabiximols|mesh-list
154614812|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614813|NCT03201835|Analgesics|analgesics|mesh-ancestor
154614814|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
154614815|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614816|NCT02478515|Ranibizumab|ranibizumab|mesh-list
154614817|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154614818|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154614819|NCT02478515|Growth Substances|growth substances|mesh-ancestor
154614820|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614821|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
154614822|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614823|NCT02448199|Meloxicam|meloxicam|mesh-list
154614824|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
154614825|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154614826|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154614827|NCT02448199|Analgesics|analgesics|mesh-ancestor
154614828|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
154614829|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614830|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614831|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614832|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154614833|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154614834|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614835|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614836|NCT03071289|Cisplatin|cisplatin|mesh-list
154614837|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614838|NCT03199105|Tetracaine|tetracaine|mesh-list
154614839|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614840|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
154614841|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614842|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614843|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
154614844|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614845|NCT02482649|Methylphenidate|methylphenidate|mesh-list
154614846|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154614847|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154614848|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614849|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154614850|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154614851|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154614852|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614853|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
154614854|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614855|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154614856|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
154614857|NCT03198637|Cisatracurium|cisatracurium|mesh-list
154614858|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154614859|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154614860|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614861|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614862|NCT02478281|Methylene Blue|methylene blue|mesh-list
154614863|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614864|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614865|NCT02478125|Docetaxel|docetaxel|mesh-list
154614866|NCT02478125|Lenograstim|lenograstim|mesh-list
154614867|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614868|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
154614869|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154614870|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154614871|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614872|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154614873|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
154614874|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614875|NCT02478047|Dexamethasone|dexamethasone|mesh-list
154614876|NCT02478047|Ramosetron|ramosetron|mesh-list
154614877|NCT02478047|Antiemetics|antiemetics|mesh-list
154614878|NCT02478047|Tropisetron|tropisetron|mesh-list
154614879|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614880|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
154614881|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614882|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614883|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154614884|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
154614885|NCT02478047|Hormones|hormones|mesh-ancestor
154614886|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154614887|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154614888|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614889|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154614890|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
154614891|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614892|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614893|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154614894|NCT04996485|Ustekinumab|ustekinumab|mesh-list
154614895|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
154614896|NCT02447965|Bupivacaine|bupivacaine|mesh-list
154614897|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614898|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
154614899|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614900|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614901|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
154614902|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614903|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154614904|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
154614905|NCT03070275|Coagulants|coagulants|mesh-ancestor
154614906|NCT05713019|Adenosine|adenosine|mesh-list
154614907|NCT05713019|Capsaicin|capsaicin|mesh-list
154614908|NCT05713019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154614909|NCT05713019|Antipruritics|antipruritics|mesh-ancestor
154614910|NCT05713019|Dermatologic Agents|dermatologic agents|mesh-ancestor
154614911|NCT05713019|Sensory System Agents|sensory system agents|mesh-ancestor
154614912|NCT05713019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614913|NCT05713019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614914|NCT05713019|Analgesics|analgesics|mesh-ancestor
154614915|NCT05713019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154614916|NCT05713019|Vasodilator Agents|vasodilator agents|mesh-ancestor
154614917|NCT05713019|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154614918|NCT05713019|Purinergic Agonists|purinergic agonists|mesh-ancestor
154614919|NCT05713019|Purinergic Agents|purinergic agents|mesh-ancestor
154614920|NCT05713019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614921|NCT05713019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614922|NCT03198403|Epinephrine|epinephrine|mesh-list
154614923|NCT03198403|Bupivacaine|bupivacaine|mesh-list
154614924|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
154614925|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
154614926|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154614927|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614928|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
154614929|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227630|NCT00073528|Letrozole|letrozole|mesh-list
154614930|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154614931|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154614932|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
154614933|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614934|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614935|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154614936|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154614937|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
154614938|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154614939|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
154614940|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
154614941|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
154614942|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154614943|NCT03198949|Everolimus|everolimus|mesh-list
154614944|NCT03198949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154614945|NCT03198949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154614946|NCT03198949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614947|NCT03198949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614948|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154614949|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
154614950|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614951|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614952|NCT02447809|Aspirin|aspirin|mesh-list
154614953|NCT02447809|Clopidogrel|clopidogrel|mesh-list
154614954|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154614955|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154614956|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154614957|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154614958|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
154614959|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614960|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614961|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614962|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154614963|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154614964|NCT02447809|Analgesics|analgesics|mesh-ancestor
154614965|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
154614966|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614967|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154614968|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154614969|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154614970|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154614971|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154614972|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614973|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
154614974|NCT04989855|Tislelizumab|tislelizumab|mesh-list
154614975|NCT04989855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154614976|NCT04989855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154614977|NCT04915287|Maleic acid|maleic acid|mesh-list
154614978|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154614979|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614980|NCT05709353|Niacin|niacin|mesh-list
154614981|NCT05709353|Methamphetamine|methamphetamine|mesh-list
154614982|NCT05709353|Vitamins|vitamins|mesh-ancestor
154614983|NCT05709353|Micronutrients|micronutrients|mesh-ancestor
154614984|NCT05709353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154614985|NCT05709353|Vitamin B Complex|vitamin b complex|mesh-ancestor
154614986|NCT05709353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154614987|NCT05709353|Antimetabolites|antimetabolites|mesh-ancestor
154614988|NCT05709353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154614989|NCT05709353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154614990|NCT05709353|Vasodilator Agents|vasodilator agents|mesh-ancestor
154614991|NCT05709353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154614992|NCT05709353|Sympathomimetics|sympathomimetics|mesh-ancestor
154614993|NCT05709353|Autonomic Agents|autonomic agents|mesh-ancestor
154614994|NCT05709353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154614995|NCT05709353|Dopamine Agents|dopamine agents|mesh-ancestor
154329767|NCT05857059|Misoprostol|misoprostol|mesh-list
154614996|NCT05709353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154614997|NCT05709353|Adrenergic Agents|adrenergic agents|mesh-ancestor
154614998|NCT05709353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154614999|NCT05709353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154615000|NCT05709353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154615001|NCT05709353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154615002|NCT03195673|Terazosin|terazosin|mesh-list
154615003|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154615004|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154615005|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154615006|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
154615007|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615008|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615009|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615010|NCT03195673|Urological Agents|urological agents|mesh-ancestor
154615011|NCT02481791|Remifentanil|remifentanil|mesh-list
154615012|NCT02481791|Propofol|propofol|mesh-list
154615013|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154615014|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615015|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615016|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154615017|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
154615018|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
154615019|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154615020|NCT02481791|Narcotics|narcotics|mesh-ancestor
154615021|NCT02481791|Analgesics|analgesics|mesh-ancestor
154615022|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
154615023|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615024|NCT04484467|Menthol|menthol|mesh-list
154615025|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
154615026|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615027|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
154615028|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154615029|NCT02726399|Capecitabine|capecitabine|mesh-list
154615030|NCT02726399|Trastuzumab|trastuzumab|mesh-list
154615031|NCT02726399|Ramucirumab|ramucirumab|mesh-list
154615032|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615033|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154615034|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
154615035|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615036|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154615037|NCT02726399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154615038|NCT02726399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154615039|NCT02726399|Growth Substances|growth substances|mesh-ancestor
154615040|NCT02726399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615041|NCT02726399|Growth Inhibitors|growth inhibitors|mesh-ancestor
154615042|NCT02477969|Metformin|metformin|mesh-list
154615043|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615044|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615045|NCT03195205|Antibodies|antibodies|mesh-list
154615046|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
154615047|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615048|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154615049|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
154615050|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615051|NCT02481323|Cilostazol|cilostazol|mesh-list
154615052|NCT02481323|Isosorbide|isosorbide|mesh-list
154615053|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154615054|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154615055|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154615056|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
154615057|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615058|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615059|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154615060|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
154615061|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154615062|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154615063|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615064|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154615065|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
154615066|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154615067|NCT02481323|Protective Agents|protective agents|mesh-ancestor
154615068|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154615069|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154615070|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615071|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154615072|NCT02481323|Diuretics|diuretics|mesh-ancestor
154615073|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
154615074|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154615075|NCT03197779|Aspirin|aspirin|mesh-list
154615076|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154615077|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154615078|NCT03197779|Analgesics|analgesics|mesh-ancestor
154615079|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
154615080|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615081|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615082|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615083|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154615084|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154615085|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154615086|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615087|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154615088|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154615089|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615091|NCT03197623|Alendronate|alendronate|mesh-list
154615092|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154615093|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615094|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
154615095|NCT02449603|Exenatide|exenatide|mesh-list
154615096|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
154615097|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154615098|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615099|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615100|NCT02449603|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154615101|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154615102|NCT02449603|Incretins|incretins|mesh-ancestor
154615103|NCT02449603|Hormones|hormones|mesh-ancestor
154615104|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615105|NCT02481479|Saxagliptin|saxagliptin|mesh-list
154615106|NCT02481479|Incretins|incretins|mesh-ancestor
154615107|NCT02481479|Hormones|hormones|mesh-ancestor
154615108|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615109|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615110|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154615111|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
154615112|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615113|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615114|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615115|NCT03195049|Bilirubin|bilirubin|mesh-list
154615116|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
154615117|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615118|NCT03195049|Protective Agents|protective agents|mesh-ancestor
154615119|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615120|NCT03198013|Prednisolone|prednisolone|mesh-list
154615121|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615122|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
154615123|NCT03198013|Hormones|hormones|mesh-ancestor
154615124|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615125|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615126|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154615127|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615128|NCT05651399|Propofol|propofol|mesh-list
154615129|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154615130|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615131|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615132|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154615133|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
154615134|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
154615135|NCT02477891|Daratumumab|daratumumab|mesh-list
154615136|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615137|NCT02477813|Temozolomide|temozolomide|mesh-list
154615138|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154615139|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
154615140|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615141|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615142|NCT02480543|Misoprostol|misoprostol|mesh-list
154615143|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154615144|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
154615145|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154615146|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615147|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154615148|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154615149|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
154615150|NCT03197233|Vitamin D|vitamin d|mesh-list
154615151|NCT03197233|Vitamins|vitamins|mesh-list
154615152|NCT03197233|Vitamin A|vitamin a|mesh-list
154615153|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
154615154|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
154615155|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615156|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
154227847|NCT01104532|Incretins|incretins|mesh-ancestor
154615157|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615158|NCT03197233|Protective Agents|protective agents|mesh-ancestor
154615159|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154615160|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615161|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154615162|NCT02447185|Triamcinolone|triamcinolone|mesh-list
154615163|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154615164|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154615165|NCT02447185|Ranibizumab|ranibizumab|mesh-list
154615166|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154615167|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154615168|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154615169|NCT02447185|Growth Substances|growth substances|mesh-ancestor
154615170|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615171|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
154615172|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615173|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615174|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
154615175|NCT02447185|Hormones|hormones|mesh-ancestor
154615176|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615177|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154615178|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
154615179|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615180|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615181|NCT03196921|Amphotericin B|amphotericin b|mesh-list
154615182|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154615183|NCT03196921|Amebicides|amebicides|mesh-ancestor
154615184|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154615185|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154615186|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615187|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154615188|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
154615189|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154615190|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615191|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615192|NCT02480465|Incretins|incretins|mesh-ancestor
154615193|NCT02480465|Hormones|hormones|mesh-ancestor
154615194|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615195|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154615196|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
154615197|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615198|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615199|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154615200|NCT03208465|Empagliflozin|empagliflozin|mesh-list
154615201|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615202|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615203|NCT03208465|Incretins|incretins|mesh-ancestor
154615204|NCT03208465|Hormones|hormones|mesh-ancestor
154615205|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615206|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154615207|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
154615208|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615209|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615210|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154615211|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
154615212|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615213|NCT04484779|Insulin|insulin|mesh-list
154615214|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
154615215|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
154615216|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615217|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615218|NCT02477501|Norepinephrine|norepinephrine|mesh-list
154615219|NCT02477501|Ephedrine|ephedrine|mesh-list
154615220|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154615221|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154615222|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
154615223|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615224|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615225|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615226|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
154615227|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
154615228|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615229|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154615230|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154615231|NCT02446795|Sunitinib|sunitinib|mesh-list
154615232|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615233|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154615234|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154615235|NCT02446795|Growth Substances|growth substances|mesh-ancestor
154615236|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615237|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
154615238|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154615239|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615240|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615241|NCT02477267|Buprenorphine|buprenorphine|mesh-list
154615242|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154615243|NCT02477267|Naloxone|naloxone|mesh-list
154615244|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154615245|NCT02477267|Narcotics|narcotics|mesh-ancestor
154615246|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615247|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615248|NCT02477267|Analgesics|analgesics|mesh-ancestor
154615249|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
154615250|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615251|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154615252|NCT03196843|Raltitrexed|raltitrexed|mesh-list
154615253|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154615254|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
154615255|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615256|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615257|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154615258|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615259|NCT02476955|Paclitaxel|paclitaxel|mesh-list
154615260|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154615261|NCT02476955|Carboplatin|carboplatin|mesh-list
154615262|NCT02476955|Anastrozole|anastrozole|mesh-list
154615263|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154615264|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615265|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
154615266|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
154615267|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
154615268|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615269|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154615270|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154615271|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154615272|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615273|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154615274|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
154615275|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615276|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615277|NCT02634801|Methotrexate|methotrexate|mesh-list
154615278|NCT02634801|Ixekizumab|ixekizumab|mesh-list
154615279|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154615280|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
154615281|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154615282|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615283|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154615284|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
154615285|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615286|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615287|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615288|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615289|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154615290|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154615291|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
154615292|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154330049|NCT05403086|Ketamine|ketamine|mesh-list
154615293|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154615294|NCT03196531|Loratadine|loratadine|mesh-list
154615295|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
154615296|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615297|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154615298|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154615299|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154615300|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
154615301|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
154615302|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615303|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615304|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392960|NCT02693002|Norethindrone|norethindrone|mesh-list
154615305|NCT02476799|Ketorolac|ketorolac|mesh-list
154615306|NCT02476799|Fentanyl|fentanyl|mesh-list
154615307|NCT02476799|Ropivacaine|ropivacaine|mesh-list
154615308|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
154615309|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
154615310|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615311|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615312|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
154615313|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615314|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154615315|NCT02476799|Narcotics|narcotics|mesh-ancestor
154615316|NCT02476799|Analgesics|analgesics|mesh-ancestor
154615317|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154615318|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154615319|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
154615320|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154615321|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154615322|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615323|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154615324|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154615325|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615326|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615327|NCT02449369|Acetaminophen|acetaminophen|mesh-list
154615328|NCT02449369|Oxycodone|oxycodone|mesh-list
154615329|NCT02449369|Hydromorphone|hydromorphone|mesh-list
154615330|NCT02449369|Orphenadrine|orphenadrine|mesh-list
154615331|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154615332|NCT02449369|Analgesics|analgesics|mesh-ancestor
154615333|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
154615334|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615335|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615336|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
154615337|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154615338|NCT02449369|Narcotics|narcotics|mesh-ancestor
154615339|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615340|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154615341|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154330111|NCT05299125|Pemetrexed|pemetrexed|mesh-list
154615342|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154615343|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154615344|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
154615345|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
154615346|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154615347|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154615348|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
154615349|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615350|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615351|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154615352|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154615353|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615354|NCT03192943|Nivolumab|nivolumab|mesh-list
154615355|NCT03192943|Linrodostat|linrodostat|mesh-list
154615356|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154615357|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615358|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154615359|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615360|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615361|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
154615362|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154615363|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154615364|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615365|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
154615366|NCT04986813|Coagulants|coagulants|mesh-ancestor
154615367|NCT04986735|Empagliflozin|empagliflozin|mesh-list
154615368|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154615369|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615370|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615371|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615372|NCT02475863|Warfarin|warfarin|mesh-list
154615373|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
154615374|NCT03071055|Ranibizumab|ranibizumab|mesh-list
154615375|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154615376|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154615377|NCT03071055|Growth Substances|growth substances|mesh-ancestor
154615378|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615379|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
154615380|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615381|NCT04433559|Tadalafil|tadalafil|mesh-list
154615382|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
154615383|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154615384|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154615385|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615386|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615387|NCT04433559|Urological Agents|urological agents|mesh-ancestor
154615388|NCT04911959|Lenvatinib|lenvatinib|mesh-list
154615389|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330150|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
154615390|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154615391|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615392|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615393|NCT03070665|Norepinephrine|norepinephrine|mesh-list
154615394|NCT03070665|Ephedrine|ephedrine|mesh-list
154615395|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154615396|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154615397|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
154615398|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615399|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615400|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615401|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
154615402|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
154615403|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615404|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154615405|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154615406|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154615407|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154615408|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154615409|NCT02475161|Rabeprazole|rabeprazole|mesh-list
154615410|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154615411|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154615412|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154615413|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615414|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615415|NCT03074097|Bupivacaine|bupivacaine|mesh-list
154615416|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
154615417|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
154615418|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615419|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615420|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
154615421|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615422|NCT04433481|Dabigatran|dabigatran|mesh-list
154615423|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
154615424|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154615425|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
154615426|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615427|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615428|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
154615429|NCT04988607|Bevacizumab|bevacizumab|mesh-list
154615430|NCT04988607|Osimertinib|osimertinib|mesh-list
154615431|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154615432|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615433|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154615434|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154615435|NCT04988607|Growth Substances|growth substances|mesh-ancestor
154615436|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615437|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
154615438|NCT04988607|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154615439|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154615440|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615441|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615442|NCT02475317|Volixibat|volixibat|mesh-list
154615443|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154615444|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154615445|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154615446|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615447|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154615448|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154615449|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154615450|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615451|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
154615452|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615453|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
154615454|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
154615455|NCT02472275|Hormones|hormones|mesh-list
154615456|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154615458|NCT02472275|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154615459|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
154615460|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615461|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615462|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
154615463|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615464|NCT02472275|Protective Agents|protective agents|mesh-ancestor
154615465|NCT02472275|Vitamins|vitamins|mesh-ancestor
154615466|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
154615467|NCT02472275|Estrogens|estrogens|mesh-ancestor
154615468|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154615469|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615470|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
154615471|NCT02472275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154615472|NCT02472275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615473|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
154615474|NCT04491773|Tadalafil|tadalafil|mesh-list
154615475|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
154615476|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154615477|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154615478|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615479|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615480|NCT04491773|Urological Agents|urological agents|mesh-ancestor
154615481|NCT03070353|Dextrans|dextrans|mesh-list
154615482|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
154615483|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
154615484|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
154615485|NCT03073863|Atorvastatin|atorvastatin|mesh-list
154615486|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154615487|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154615488|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
154615489|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615490|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154615491|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154615492|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615493|NCT02471963|Empagliflozin|empagliflozin|mesh-list
154615494|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154615495|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615496|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615497|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615498|NCT01375751|Evolocumab|evolocumab|mesh-list
154615499|NCT01375751|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154615500|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154615501|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154615502|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
154615503|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615504|NCT01375751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154615505|NCT01375751|Protease Inhibitors|protease inhibitors|mesh-ancestor
154615506|NCT01375751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615507|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154615508|NCT05249621|Mannitol|mannitol|mesh-list
154615509|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154615510|NCT05249621|Diuretics|diuretics|mesh-ancestor
154615511|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
154615512|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615513|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154615514|NCT00705575|Aliskiren|aliskiren|mesh-list
154615515|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154615516|NCT00705575|Diuretics|diuretics|mesh-ancestor
154615517|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
154615518|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615519|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154615520|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154615521|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330280|NCT04801303|Calcitriol|calcitriol|mesh-list
154615522|NCT00705575|Renin Inhibitors|renin inhibitors|mesh-ancestor
154615523|NCT00705575|Protease Inhibitors|protease inhibitors|mesh-ancestor
154615524|NCT00705575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615525|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154615526|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154615527|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154615528|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154615529|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615530|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615531|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615532|NCT03068247|Analgesics|analgesics|mesh-ancestor
154615533|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
154615534|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615535|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
154615536|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154615537|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
154615538|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154615540|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154615541|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154615542|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615543|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
154615544|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615545|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615546|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154615547|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154615548|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615549|NCT04450953|Eplerenone|eplerenone|mesh-list
154615550|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154615551|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
154615552|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615553|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615554|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154615555|NCT04450953|Diuretics|diuretics|mesh-ancestor
154615556|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
154615557|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154615558|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154615559|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154615560|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154615561|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615562|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615563|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
154615564|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615565|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154615566|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154615567|NCT02474225|Bevacizumab|bevacizumab|mesh-list
154615568|NCT02474225|Ranibizumab|ranibizumab|mesh-list
154615569|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
154615570|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154615571|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615572|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154615573|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154615574|NCT02474225|Growth Substances|growth substances|mesh-ancestor
154615575|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615576|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
154615577|NCT04430855|Upadacitinib|upadacitinib|mesh-list
154615578|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154615579|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154615580|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615581|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615582|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154615583|NCT02471105|Bimatoprost|bimatoprost|mesh-list
154615584|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154615585|NCT03108989|Neostigmine|neostigmine|mesh-list
154615586|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154615587|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615588|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615589|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
154615590|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615591|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615592|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154615593|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
154615594|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615595|NCT02473601|Mivacurium|mivacurium|mesh-list
154615596|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154615597|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154615598|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154615599|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615600|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228299|NCT01328236|Dexamethasone|dexamethasone|mesh-list
154615601|NCT02470559|Aldesleukin|aldesleukin|mesh-list
154615602|NCT02470559|Interleukin-2|interleukin-2|mesh-list
154615603|NCT02470559|Sargramostim|sargramostim|mesh-list
154615604|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154615605|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615606|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154615607|NCT02470559|Analgesics|analgesics|mesh-ancestor
154615608|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
154615609|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615610|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615611|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
154615612|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154615613|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154615614|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
154615615|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615616|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
154615617|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
154615618|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615619|NCT02470637|Insulin|insulin|mesh-list
154615620|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154615621|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
154615622|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615623|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615624|NCT03948347|Liraglutide|liraglutide|mesh-list
154615625|NCT03948347|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154615626|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615627|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615628|NCT03948347|Incretins|incretins|mesh-ancestor
154615629|NCT03948347|Hormones|hormones|mesh-ancestor
154615630|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615631|NCT02723591|Tacrolimus|tacrolimus|mesh-list
154615632|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154615633|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
154615634|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615635|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154615636|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615637|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615638|NCT00705341|Fluticasone|fluticasone|mesh-list
154615639|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615640|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154615641|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
154615642|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615643|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615644|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154615645|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
154615646|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615647|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154615648|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
154615649|NCT03193931|Methotrexate|methotrexate|mesh-list
154615650|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154615651|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615652|NCT03193931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154615653|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615654|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154615655|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
154615656|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154615657|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615658|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154615659|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
154615660|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615661|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615662|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154615663|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154615664|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
154615665|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154615666|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154615667|NCT00705263|Ribavirin|ribavirin|mesh-list
154615668|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154615669|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
154615670|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615671|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
154615672|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615673|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
154615674|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154615675|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154615676|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615677|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
154615678|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615679|NCT03310463|Durlobactam|durlobactam|mesh-list
154615680|NCT03310463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154615681|NCT03310463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615682|NCT03310463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615683|NCT03310463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154615684|NCT03310463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615685|NCT00704405|Interferons|interferons|mesh-list
154615686|NCT00704405|Ribavirin|ribavirin|mesh-list
154615687|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615688|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
154615689|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615690|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
154615691|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615692|NCT01470755|Albuterol|albuterol|mesh-list
154615693|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154615694|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
154615695|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615696|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615697|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154615698|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
154615699|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
154615700|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154615701|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154615702|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154615703|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154615704|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
154615705|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615706|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615707|NCT03310073|Vaccines|vaccines|mesh-list
154615708|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
154615709|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615710|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
154615711|NCT03309527|Promethazine|promethazine|mesh-list
154615712|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154615713|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154615714|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615715|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615716|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
154615717|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
154615718|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
154615719|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615720|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
154615721|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
154615722|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154615723|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154615724|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
154615725|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
154615726|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615727|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615728|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154615729|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
154615730|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615731|NCT03313661|Gliclazide|gliclazide|mesh-list
154615732|NCT03313661|Cabergoline|cabergoline|mesh-list
154615733|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154615734|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154615735|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
154615736|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
154615737|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615738|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615739|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615740|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615741|NCT00703781|Bromfenac|bromfenac|mesh-list
154615742|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154615743|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154615744|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154615745|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154615746|NCT00703781|Analgesics|analgesics|mesh-ancestor
154615747|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
154615748|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615749|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228449|NCT01110304|Analgesics|analgesics|mesh-list
154615750|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615751|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154615752|NCT03309215|Nickel|nickel|mesh-list
154615753|NCT03309215|Trace Elements|trace elements|mesh-ancestor
154615754|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
154615755|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615756|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
154615757|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615758|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
154615759|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154615760|NCT03309059|Protective Agents|protective agents|mesh-ancestor
154615761|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615762|NCT02469545|Sertraline|sertraline|mesh-list
154615763|NCT02469545|Escitalopram|escitalopram|mesh-list
154615764|NCT02469545|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154615765|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154615766|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154615767|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615768|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615769|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
154615770|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615771|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
154615772|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154615773|NCT03308357|Infliximab|infliximab|mesh-list
154615774|NCT03308357|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154615775|NCT03308357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615776|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
154615777|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154615778|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154615779|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
154615780|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154615781|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154615782|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615783|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
154615784|NCT03308201|Letrozole|letrozole|mesh-list
154615785|NCT03308201|Fulvestrant|fulvestrant|mesh-list
154615786|NCT03308201|Exemestane|exemestane|mesh-list
154615787|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615788|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154615789|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154615790|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615791|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615792|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154615793|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
154615794|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615795|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615796|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154615797|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154615798|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
154615799|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154615800|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615801|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615802|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154615803|NCT03312413|Analgesics|analgesics|mesh-ancestor
154615804|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
154615805|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615806|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154615807|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154615808|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154615809|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
154615810|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615811|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615812|NCT02722967|Aripiprazole|aripiprazole|mesh-list
154615813|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
154615814|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154615815|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154615816|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154615817|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615818|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615819|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
154615820|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
154615821|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615822|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615823|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154615824|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154615825|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
154615826|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154615827|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154615828|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154615829|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154615831|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
154615832|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615833|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154615834|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154615835|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615836|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615837|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154615838|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
154615839|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615840|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615841|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154615842|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154615843|NCT03312335|Aldesleukin|aldesleukin|mesh-list
154615844|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615845|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154615846|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154615847|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
154615848|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615849|NCT03312179|Incretins|incretins|mesh-list
154615850|NCT03312179|Hormones|hormones|mesh-ancestor
154615851|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615852|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615853|NCT02468531|Xenon|xenon|mesh-list
154615854|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154615855|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
154615856|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
154615857|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615858|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615859|NCT03311945|Lamivudine|lamivudine|mesh-list
154615860|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
154615861|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154615862|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154615863|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615864|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615865|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
154615866|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615867|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154615868|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154615869|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154615870|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154615871|NCT03311789|Gemcitabine|gemcitabine|mesh-list
154615872|NCT03311789|Nivolumab|nivolumab|mesh-list
154615873|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154615874|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615875|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154615876|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
154615877|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615878|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154615879|NCT02468999|Insulin|insulin|mesh-list
154615880|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154615881|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615882|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615883|NCT03311321|Vitamin K|vitamin k|mesh-list
154615884|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
154615885|NCT03311321|Menaquinone 7|menaquinone 7|mesh-list
154615886|NCT03311321|Vitamins|vitamins|mesh-ancestor
154615887|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
154615888|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615889|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154615890|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154615891|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615892|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
154615893|NCT03311321|Coagulants|coagulants|mesh-ancestor
154615894|NCT02468297|Ibuprofen|ibuprofen|mesh-list
154615895|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154615896|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154615897|NCT02468297|Analgesics|analgesics|mesh-ancestor
154615898|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
154615899|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615900|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615901|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615902|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154615903|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154615904|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615905|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615906|NCT02468375|Mirabegron|mirabegron|mesh-list
154615907|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154615908|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154615909|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154615910|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
154615911|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615912|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615913|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615914|NCT02468375|Urological Agents|urological agents|mesh-ancestor
154615915|NCT03304457|Olanzapine|olanzapine|mesh-list
154615916|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154615917|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
154615918|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
154615919|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615920|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615921|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154615922|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154330703|NCT03689712|Micronutrients|micronutrients|mesh-ancestor
154330706|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
154615923|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154615924|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154615925|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154615926|NCT03304457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154615927|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154615928|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154615929|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615930|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615931|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
154615932|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154615933|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154615934|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154615935|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
154615936|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154615937|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154615938|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154615939|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154615940|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
154615941|NCT04490837|Antibodies|antibodies|mesh-list
154615942|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
154615943|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615944|NCT03305471|Sevelamer|sevelamer|mesh-list
154615945|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
154615946|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
154615947|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615948|NCT03303677|Vancomycin|vancomycin|mesh-list
154615949|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
154615950|NCT03303677|Gentamicins|gentamicins|mesh-list
154615951|NCT03303677|Mupirocin|mupirocin|mesh-list
154615952|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154615953|NCT03303677|Trimethoprim|trimethoprim|mesh-list
154615954|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
154615955|NCT03303677|Budesonide|budesonide|mesh-list
154615956|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154615957|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154615958|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
154615959|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615960|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615961|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154615962|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
154615963|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
154615964|NCT03303677|Hormones|hormones|mesh-ancestor
154615965|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154615966|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154615967|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154615968|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154615969|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154615970|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615971|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154615972|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154615973|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154615974|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154615975|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154615976|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
154615977|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154615978|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154615979|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154615980|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154615981|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154615982|NCT02468063|Terlipressin|terlipressin|mesh-list
154615983|NCT02468063|Norepinephrine|norepinephrine|mesh-list
154615984|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154615985|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154615986|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154615987|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154615988|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
154615989|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154615990|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615991|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154615992|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
154615993|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
154615994|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154615995|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
154615996|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154615997|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154615998|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154615999|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616000|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
154616001|NCT03303209|Narcotics|narcotics|mesh-ancestor
154616002|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616003|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616004|NCT03303209|Analgesics|analgesics|mesh-ancestor
154616005|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
154616006|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616007|NCT03303053|Prednisolone|prednisolone|mesh-list
154616008|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
154616009|NCT03303053|Carbimazole|carbimazole|mesh-list
154616010|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154616011|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
154616012|NCT03303053|Hormones|hormones|mesh-ancestor
154330781|NCT03138603|Metoprolol|metoprolol|mesh-list
154616013|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616014|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616015|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154616016|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616017|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154616018|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154616019|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
154616020|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616021|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154616022|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
154616023|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
154616024|NCT02467907|Paclitaxel|paclitaxel|mesh-list
154616025|NCT02467907|Bevacizumab|bevacizumab|mesh-list
154616026|NCT02467907|Carboplatin|carboplatin|mesh-list
154616027|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154616028|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616029|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
154616030|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
154616031|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
154616032|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616033|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616034|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154616035|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154616036|NCT02467907|Growth Substances|growth substances|mesh-ancestor
154616037|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616038|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
154616039|NCT02467127|Vitamin D|vitamin d|mesh-list
154616040|NCT02467127|Vitamins|vitamins|mesh-ancestor
154616041|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
154616042|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616043|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154616044|NCT03302585|Vitamin D|vitamin d|mesh-list
154616045|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
154616046|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
154616047|NCT03302585|Vitamins|vitamins|mesh-list
154616048|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
154616049|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616050|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154616051|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616052|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
154616054|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154616055|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616056|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616057|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154616058|NCT03302351|Analgesics|analgesics|mesh-ancestor
154616059|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
154616060|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616061|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154616062|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154616063|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154616064|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
154616065|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616066|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616067|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154616068|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154616069|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
154616070|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
154616071|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154616072|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154616073|NCT05727683|Cyclophosphamide|cyclophosphamide|mesh-list
154616074|NCT05727683|Fludarabine|fludarabine|mesh-list
154616075|NCT05727683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154616076|NCT05727683|Immunologic Factors|immunologic factors|mesh-ancestor
154616077|NCT05727683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616078|NCT05727683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154616079|NCT05727683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154616080|NCT05727683|Alkylating Agents|alkylating agents|mesh-ancestor
154616081|NCT05727683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616082|NCT05727683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616083|NCT05727683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154616084|NCT03302039|Phenylephrine|phenylephrine|mesh-list
154616085|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
154616086|NCT03302039|Bupivacaine|bupivacaine|mesh-list
154616087|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
154616088|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
154616089|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616090|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616091|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
154616092|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616093|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154616094|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
154616095|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
154616096|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
154616097|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154616098|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
154616099|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154616100|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154616101|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154616102|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154616103|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
154616104|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616105|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616106|NCT03302039|Protective Agents|protective agents|mesh-ancestor
154616107|NCT02721875|Azacitidine|azacitidine|mesh-list
154616108|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154616109|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
154616110|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616111|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616112|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616113|NCT02466503|Fluticasone|fluticasone|mesh-list
154616114|NCT02466503|Xhance|xhance|mesh-list
154616115|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154616116|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154616117|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154616118|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
154616119|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616120|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616121|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154616122|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
154616123|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
154616124|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154616125|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154392964|NCT02693002|Hormones|hormones|mesh-ancestor
154616126|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154616127|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154616128|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
154616129|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616130|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616131|NCT03301181|Itraconazole|itraconazole|mesh-list
154616132|NCT03301181|Rifampin|rifampin|mesh-list
154616133|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
154616134|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
154616135|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616136|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154616137|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154616138|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616139|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616140|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154616141|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
154616142|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616143|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616144|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154616145|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154616146|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
154616147|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154616148|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
154616149|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154616150|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154616151|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154616152|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154616153|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154616154|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154616155|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154616156|NCT03301181|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154616157|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154616158|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616159|NCT00702221|Vaccines|vaccines|mesh-list
154616160|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
154616161|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616162|NCT03301025|Pregabalin|pregabalin|mesh-list
154616163|NCT03301025|Analgesics|analgesics|mesh-ancestor
154616164|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
154616165|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616166|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616167|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
154616168|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154616169|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616170|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616171|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616172|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154616173|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154616174|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616175|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154616176|NCT05726903|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154616177|NCT05726903|Medroxyprogesterone|medroxyprogesterone|mesh-list
154616178|NCT05726903|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154616179|NCT05726903|Contraceptive Agents|contraceptive agents|mesh-ancestor
154616180|NCT05726903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154616181|NCT05726903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616182|NCT05726903|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154616183|NCT05726903|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154616184|NCT05726903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154616185|NCT05726903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616186|NCT05726903|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154616187|NCT05726903|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154616188|NCT05726903|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154616189|NCT02467595|Fentanyl|fentanyl|mesh-list
154616190|NCT02467595|Bromides|bromides|mesh-list
154616191|NCT02467595|Propofol|propofol|mesh-list
154616192|NCT02467595|Sevoflurane|sevoflurane|mesh-list
154616193|NCT02467595|Rocuronium|rocuronium|mesh-list
154616194|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154616195|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616196|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616197|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154616198|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
154616199|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
154616200|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154616202|NCT02467595|Analgesics|analgesics|mesh-ancestor
154616203|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
154616204|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616205|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154616206|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154616207|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154616208|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
154616209|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154616210|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154616211|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154616212|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
154616213|NCT02467517|Ketamine|ketamine|mesh-list
154616214|NCT02467517|Analgesics|analgesics|mesh-ancestor
154616215|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
154616216|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616217|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616218|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154616219|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154616220|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
154616221|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
154616222|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616223|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154616224|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154616225|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331008|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616226|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616227|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154616228|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
154616229|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154616230|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616231|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616232|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
154616233|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154616234|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154616235|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154616236|NCT02467673|Estradiol|estradiol|mesh-list
154616237|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154616238|NCT02467673|Progesterone|progesterone|mesh-list
154616239|NCT02467673|Estrogens|estrogens|mesh-ancestor
154616240|NCT02467673|Hormones|hormones|mesh-ancestor
154616241|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616242|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616243|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154616244|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
154616245|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154616246|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154616247|NCT02467673|Progestins|progestins|mesh-ancestor
154616248|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154616249|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
154616250|NCT02953145|Coagulants|coagulants|mesh-ancestor
154616251|NCT03300089|Anesthetics|anesthetics|mesh-list
154616252|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616253|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616254|NCT00702923|Tremelimumab|tremelimumab|mesh-list
154616255|NCT00702923|Bicalutamide|bicalutamide|mesh-list
154616256|NCT00702923|Ipilimumab|ipilimumab|mesh-list
154616257|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154616258|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616259|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
154616260|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616261|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
154616262|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
154616263|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616264|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616265|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154616266|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616267|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
154616268|NCT05294055|Etoposide|etoposide|mesh-list
154616269|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154616270|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
154616271|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616272|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154616273|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154228971|NCT01222312|Docetaxel|docetaxel|mesh-list
154616274|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
154616275|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616276|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616277|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154616278|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154331053|NCT01920737|Leucovorin|leucovorin|mesh-list
154616279|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154616280|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154616281|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616283|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154616284|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154616285|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154616286|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616287|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616288|NCT05718167|Tislelizumab|tislelizumab|mesh-list
154616289|NCT05718167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616290|NCT05718167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616291|NCT03299387|Gentamicins|gentamicins|mesh-list
154616292|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
154616293|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154616294|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616295|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154616296|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616297|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616298|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154616299|NCT04794699|Paclitaxel|paclitaxel|mesh-list
154616300|NCT04794699|Docetaxel|docetaxel|mesh-list
154616301|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154616302|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616303|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
154616304|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
154616305|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
154616306|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616307|NCT02466347|Fluticasone|fluticasone|mesh-list
154616308|NCT02466347|Xhance|xhance|mesh-list
154616309|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154616310|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154616311|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154616312|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
154616313|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616314|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616315|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154616316|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
154616317|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
154616318|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154616319|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154331106|NCT01852890|Gemcitabine|gemcitabine|mesh-list
154616320|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154616321|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154616322|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
154616323|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616324|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616325|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154616326|NCT03067935|Immunoconjugates|immunoconjugates|mesh-ancestor
154616327|NCT03067935|Immunologic Factors|immunologic factors|mesh-ancestor
154616328|NCT03067935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616329|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616330|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616331|NCT02466191|Gabapentin|gabapentin|mesh-list
154616332|NCT02466191|Memantine|memantine|mesh-list
154616333|NCT02466191|Analgesics|analgesics|mesh-ancestor
154616334|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
154616335|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616336|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616337|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
154616338|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154616339|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154616340|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616341|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154616342|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154616343|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154616344|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616345|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616346|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
154616347|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154616348|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154616349|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
154616350|NCT05555069|Menthol|menthol|mesh-list
154616351|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
154616352|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154616353|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
154616354|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
154616355|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616356|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
154616357|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616358|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616359|NCT03069339|Carvedilol|carvedilol|mesh-list
154616360|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154616361|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154616362|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
154331152|NCT01750281|Docetaxel|docetaxel|mesh-list
154616363|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616364|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616365|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616366|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154616367|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
154616368|NCT03069339|Protective Agents|protective agents|mesh-ancestor
154616369|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154616370|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616371|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616372|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
154616373|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154616374|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154616375|NCT05542589|Phenytoin|phenytoin|mesh-list
154616376|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
154616377|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154616378|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154616379|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616380|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616381|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154616382|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154616383|NCT03069027|Lidocaine|lidocaine|mesh-list
154616384|NCT03069027|Epinephrine|epinephrine|mesh-list
154616385|NCT03069027|Racepinephrine|racepinephrine|mesh-list
154616386|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
154616387|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
154616388|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
154616389|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616390|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616391|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
154616392|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616393|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154616394|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154616395|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154616396|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616397|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616398|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154616399|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154616400|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
154616401|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616402|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154616403|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154616404|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
154616405|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154616406|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
154616407|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
154616408|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
154616409|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154616410|NCT05635071|Nintedanib|nintedanib|mesh-list
154616411|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616412|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154616413|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616414|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616415|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154616416|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616417|NCT02720081|Albuterol|albuterol|mesh-list
154616418|NCT02720081|Montelukast|montelukast|mesh-list
154616419|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154616420|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
154616421|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154616422|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
154616423|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616424|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616425|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154616426|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154616427|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616428|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154616429|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
154616430|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616431|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
154616432|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154616433|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154616434|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154616435|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154616436|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154616437|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616438|NCT04552197|Tofacitinib|tofacitinib|mesh-list
154616439|NCT04552197|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154616440|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154616441|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616442|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616443|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154616444|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616445|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616446|NCT05244473|Immunotoxins|immunotoxins|mesh-ancestor
154616447|NCT05244473|Immunoconjugates|immunoconjugates|mesh-ancestor
154331233|NCT00611351|Busulfan|busulfan|mesh-list
154616448|NCT05244473|Immunologic Factors|immunologic factors|mesh-ancestor
154616449|NCT05244473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616450|NCT02310269|Pasireotide|pasireotide|mesh-list
154616451|NCT02310269|Hormones|hormones|mesh-ancestor
154616452|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616453|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616454|NCT04489745|Androgens|androgens|mesh-list
154616455|NCT04489745|Hormones|hormones|mesh-ancestor
154616456|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616457|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616458|NCT02464865|Thiamine|thiamine|mesh-list
154616459|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
154616460|NCT02464865|Vitamins|vitamins|mesh-ancestor
154616461|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
154616462|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616463|NCT02466035|Caseins|caseins|mesh-list
154616464|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
154616465|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
154616466|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616467|NCT05173337|Nefopam|nefopam|mesh-list
154616468|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154616469|NCT05173337|Analgesics|analgesics|mesh-ancestor
154616470|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
154616471|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616472|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616473|NCT02464631|Ribavirin|ribavirin|mesh-list
154616474|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
154616475|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
154616476|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616477|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
154616478|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616479|NCT04880577|Tenofovir|tenofovir|mesh-list
154616480|NCT04880577|Rituximab|rituximab|mesh-list
154616481|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
154616482|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616483|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616484|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
154616485|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331287|NCT00436254|Molgramostim|molgramostim|mesh-list
154616486|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154616487|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
154616488|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616489|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154616490|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154616491|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616492|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616493|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154616494|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154616495|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154616496|NCT04490213|Laxatives|laxatives|mesh-ancestor
154558035|NCT02417883|Diuretics|diuretics|mesh-ancestor
154616497|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154616498|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
154616499|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154616500|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616501|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
154616502|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616503|NCT04562597|Expectorants|expectorants|mesh-ancestor
154616504|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
154616505|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154616506|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
154616507|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616508|NCT04562597|Protective Agents|protective agents|mesh-ancestor
154616509|NCT04562597|Antidotes|antidotes|mesh-ancestor
154616510|NCT04504175|Ketamine|ketamine|mesh-list
154616511|NCT04504175|Analgesics|analgesics|mesh-ancestor
154616512|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
154616513|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616514|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616515|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154616516|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154616517|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
154616518|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
154616519|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616520|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154616521|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154616522|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616523|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616524|NCT05723367|Anesthetics|anesthetics|mesh-list
154616525|NCT05723367|Anesthetics, Local|anesthetics, local|mesh-list
154616526|NCT05723367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616527|NCT05723367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331329|NCT00071708|Analgesics|analgesics|mesh-ancestor
154616528|NCT05723367|Sensory System Agents|sensory system agents|mesh-ancestor
154616529|NCT05723367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616530|NCT04433169|Tretinoin|tretinoin|mesh-list
154616531|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616532|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
154616533|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
154616534|NCT02717195|Olanzapine|olanzapine|mesh-list
154616535|NCT02717195|Risperidone|risperidone|mesh-list
154616536|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154616537|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
154616538|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616539|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616540|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616541|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154616542|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154616543|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616544|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154616545|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154616546|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
154616547|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
154616548|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
154616549|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616550|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154616551|NCT02717195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154616552|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154616553|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616554|NCT05582031|Tislelizumab|tislelizumab|mesh-list
154616555|NCT05582031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616556|NCT05582031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616557|NCT05581719|Nivolumab|nivolumab|mesh-list
154616558|NCT05581719|Tislelizumab|tislelizumab|mesh-list
154616559|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616560|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616561|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154616562|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616563|NCT02465801|Lenograstim|lenograstim|mesh-list
154616564|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154616565|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
154616566|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616567|NCT02465645|Carvedilol|carvedilol|mesh-list
154616568|NCT02465645|Simvastatin|simvastatin|mesh-list
154616569|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154616570|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154616571|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
154616572|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616573|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154616574|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154616576|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154616577|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154616578|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
154616579|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616580|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616581|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154616582|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
154616583|NCT02465645|Protective Agents|protective agents|mesh-ancestor
154616584|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154616585|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616586|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616587|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
154616588|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154616589|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154616590|NCT04872257|Vitamin D|vitamin d|mesh-list
154616591|NCT04872257|Vitamins|vitamins|mesh-ancestor
154616592|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
154616593|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616594|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154616595|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154616596|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154616597|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154616598|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616599|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616600|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616601|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616602|NCT04970121|Analgesics|analgesics|mesh-ancestor
154616603|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
154616604|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616605|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
154616606|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154616607|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
154616608|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
154616609|NCT02463929|Promethazine|promethazine|mesh-list
154616610|NCT02463929|Ketamine|ketamine|mesh-list
154616611|NCT02463929|Bupivacaine|bupivacaine|mesh-list
154616612|NCT02463929|Sevoflurane|sevoflurane|mesh-list
154616613|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
154616614|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
154616615|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616616|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616617|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
154616618|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616619|NCT02463929|Analgesics|analgesics|mesh-ancestor
154616620|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154616621|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154616622|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
154616623|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154616624|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154616625|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616626|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616627|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154616628|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154616629|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154616630|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154616631|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
154616632|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
154616633|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154616634|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154616635|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
154616636|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
154616637|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154616638|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
154616639|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
154616640|NCT02465255|Acetaminophen|acetaminophen|mesh-list
154616641|NCT02465255|Ketorolac|ketorolac|mesh-list
154616642|NCT02465255|Tramadol|tramadol|mesh-list
154616643|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154616644|NCT02465255|Analgesics|analgesics|mesh-ancestor
154616645|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
154558036|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
154616646|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616647|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616648|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
154616649|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154616650|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154616651|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154616652|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154616653|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616654|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616655|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154616656|NCT02465255|Narcotics|narcotics|mesh-ancestor
154616657|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616658|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154616659|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154616660|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154616661|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
154616662|NCT02462915|Lidocaine|lidocaine|mesh-list
154616663|NCT02462915|Fentanyl|fentanyl|mesh-list
154616664|NCT02462915|Propofol|propofol|mesh-list
154616665|NCT02462915|Cisatracurium|cisatracurium|mesh-list
154616666|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
154616667|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
154616668|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616669|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616670|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
154616671|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616672|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154616673|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154616674|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154616675|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616676|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616677|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154616678|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154616679|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
154616680|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154616681|NCT02462915|Narcotics|narcotics|mesh-ancestor
154616682|NCT02462915|Analgesics|analgesics|mesh-ancestor
154616683|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154616684|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154616685|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154616686|NCT05505123|Propofol|propofol|mesh-list
154616687|NCT05505123|Sevoflurane|sevoflurane|mesh-list
154616688|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154616689|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616690|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616691|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154616692|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
154616693|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
154616694|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154616695|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154616696|NCT02462525|Dexamethasone|dexamethasone|mesh-list
154616697|NCT02462525|Pomalidomide|pomalidomide|mesh-list
154616698|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154616699|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
154616700|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
154616701|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616702|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616703|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154616704|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
154616705|NCT02462525|Hormones|hormones|mesh-ancestor
154616706|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616707|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154616708|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616709|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
154616710|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154616711|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154616712|NCT02462525|Growth Substances|growth substances|mesh-ancestor
154616713|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
154616714|NCT04111419|Amlodipine|amlodipine|mesh-list
154616715|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
154616716|NCT04111419|Atorvastatin|atorvastatin|mesh-list
154616717|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154616718|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154229430|NCT01226602|Ticagrelor|ticagrelor|mesh-list
154616719|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
154616720|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616721|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154616722|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154616724|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154616725|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154616726|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331515|NCT04781998|Incretins|incretins|mesh-ancestor
154616727|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616728|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616729|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
154616730|NCT02462447|Choline|choline|mesh-list
154616731|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
154616732|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154616733|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
154616734|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616735|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154616736|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154616737|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
154616738|NCT02462681|Ketamine|ketamine|mesh-list
154616739|NCT02462681|Analgesics|analgesics|mesh-ancestor
154616740|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
154616741|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616742|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616743|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154616744|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154616745|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
154616746|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
154616747|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616748|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154616749|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154616750|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616751|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616752|NCT04129151|Palbociclib|palbociclib|mesh-list
154616753|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616754|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154616755|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616756|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616757|NCT02462369|Glimepiride|glimepiride|mesh-list
154616758|NCT02462369|Saxagliptin|saxagliptin|mesh-list
154616759|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154616760|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154616761|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616762|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154616763|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
154616764|NCT02462369|Incretins|incretins|mesh-ancestor
154616765|NCT02462369|Hormones|hormones|mesh-ancestor
154616766|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616767|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154616768|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
154616769|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616770|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616771|NCT04072835|Etripamil|etripamil|mesh-list
154616772|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154616773|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331557|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154616774|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616775|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616776|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616777|NCT02463383|Ibuprofen|ibuprofen|mesh-list
154616778|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154616779|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154616780|NCT02463383|Analgesics|analgesics|mesh-ancestor
154616781|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
154616782|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616783|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616784|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154616785|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154616786|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154616787|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616788|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616789|NCT03108365|Hemostatics|hemostatics|mesh-list
154616790|NCT03108365|Chitosan|chitosan|mesh-list
154616791|NCT03108365|Coagulants|coagulants|mesh-ancestor
154616792|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154616793|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154616794|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
154616795|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616796|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154616798|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
154616799|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154616800|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154616801|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154616802|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616803|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616804|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154616805|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616806|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616807|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
154616808|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616809|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
154616810|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
154616811|NCT03064191|Calcium|calcium|mesh-list
154616812|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616813|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616814|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154616815|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154616816|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616817|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
154616818|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
154616819|NCT02629965|Olodaterol|olodaterol|mesh-list
154616820|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154616821|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
154616822|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616823|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616824|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154616825|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
154616826|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
154616827|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154616828|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
154616829|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154616830|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616831|NCT03062787|Triamcinolone|triamcinolone|mesh-list
154616832|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154616833|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154616834|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
154616835|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154616836|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154616837|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
154616838|NCT03062787|Hormones|hormones|mesh-ancestor
154616839|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154616840|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616841|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154616842|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
154616843|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616844|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616845|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154616846|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
154616847|NCT03062787|Protective Agents|protective agents|mesh-ancestor
154616848|NCT04601883|Colchicine|colchicine|mesh-list
154616849|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
154616850|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154616851|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
154616852|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
154616853|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
154616854|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616855|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616856|NCT05223075|Lidocaine|lidocaine|mesh-list
154616857|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154616858|NCT05223075|Carticaine|carticaine|mesh-list
154616859|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
154616860|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
154616861|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616862|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616863|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
154616864|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616865|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154331662|NCT03952403|Growth Substances|growth substances|mesh-ancestor
154616866|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154616867|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154616868|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616869|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616870|NCT03719313|Interferons|interferons|mesh-list
154616871|NCT03719313|Ritonavir|ritonavir|mesh-list
154616872|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
154616873|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154616874|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
154616875|NCT03719313|Lonafarnib|lonafarnib|mesh-list
154616876|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616877|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
154616878|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616879|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154616880|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154616881|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
154616882|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616883|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616884|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154616885|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154616886|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154616887|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154616888|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
154616889|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616890|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
154616891|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
154616892|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616893|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
154616894|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154616895|NCT03063723|Ledipasvir|ledipasvir|mesh-list
154616896|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
154616897|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616898|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154616899|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154616900|NCT03305445|Nivolumab|nivolumab|mesh-list
154616901|NCT03305445|Ipilimumab|ipilimumab|mesh-list
154616902|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154616903|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616904|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154616905|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616906|NCT04436913|Fluorides|fluorides|mesh-list
154616907|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
154616908|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
154616909|NCT04436913|Protective Agents|protective agents|mesh-ancestor
154616910|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616911|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154616912|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154616913|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616914|NCT03742193|Apatinib|apatinib|mesh-list
154616915|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616916|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154616917|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616918|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616919|NCT03108287|Amoxicillin|amoxicillin|mesh-list
154616920|NCT03108287|Clarithromycin|clarithromycin|mesh-list
154616921|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154616922|NCT03108287|Rabeprazole|rabeprazole|mesh-list
154616923|NCT03108287|Bismuth|bismuth|mesh-list
154616924|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154616925|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616926|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154616927|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616928|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616929|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154616930|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154616931|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154616932|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154616933|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154616934|NCT03108287|Antacids|antacids|mesh-ancestor
154616935|NCT02461121|Cyclosporine|cyclosporine|mesh-list
154616936|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
154616937|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
154616938|NCT02461121|Fludarabine|fludarabine|mesh-list
154616939|NCT02461121|Cyclosporins|cyclosporins|mesh-list
154616940|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154616941|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154616942|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
154616943|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616944|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154616945|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154616946|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
154616947|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616948|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616949|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154616950|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154616951|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
154616952|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154616953|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
154616954|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154616955|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154616956|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154616957|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
154616958|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154616959|NCT00701363|Lanreotide|lanreotide|mesh-list
154616960|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616961|NCT02461043|Paclitaxel|paclitaxel|mesh-list
154616962|NCT02461043|Cisplatin|cisplatin|mesh-list
154616963|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154616964|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154616965|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
154616966|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
154616967|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
154616968|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616969|NCT03296657|Fluorides|fluorides|mesh-list
154616970|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
154616971|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
154616972|NCT03296657|Protective Agents|protective agents|mesh-ancestor
154616973|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616974|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
154616975|NCT03296579|Aminophylline|aminophylline|mesh-list
154616976|NCT03296579|Albuterol|albuterol|mesh-list
154616977|NCT03296579|Ipratropium|ipratropium|mesh-list
154616978|NCT03296579|Analgesics|analgesics|mesh-ancestor
154616979|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
154616980|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154616981|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154616982|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
154616983|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154616984|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154616985|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
154616986|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154616987|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154616988|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154616989|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154616990|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
154616991|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154616992|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154616993|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
154616994|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154616995|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
154616996|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154616997|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154616998|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154616999|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
154617000|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617001|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154617002|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
154617003|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154617004|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154617005|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617006|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154617007|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154617008|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
154617009|NCT03296579|Protective Agents|protective agents|mesh-ancestor
154617010|NCT02461667|Alendronate|alendronate|mesh-list
154617011|NCT02461667|Metformin|metformin|mesh-list
154617012|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154617013|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617014|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154617015|NCT01670877|Trastuzumab|trastuzumab|mesh-list
154617016|NCT01670877|Fulvestrant|fulvestrant|mesh-list
154617017|NCT01670877|Neratinib|neratinib|mesh-list
154617018|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154617019|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229719|NCT03926182|Aflutinib|aflutinib|mesh-list
154617020|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154617021|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154617022|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154617023|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
154617024|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617025|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617026|NCT01670877|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154617027|NCT01670877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154617028|NCT01670877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617029|NCT01670877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617030|NCT00701129|Rituximab|rituximab|mesh-list
154617031|NCT00701129|Methotrexate|methotrexate|mesh-list
154617032|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154617033|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617034|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
154617035|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617036|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154617037|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154617038|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
154617039|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154617040|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154617041|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
154617042|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617043|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
154617044|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617045|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154617046|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154617047|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154617048|NCT03296189|Dexamethasone|dexamethasone|mesh-list
154617049|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
154617050|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
154617051|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154617052|NCT03296189|BB 1101|bb 1101|mesh-list
154617053|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617054|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
154617055|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
154617056|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331841|NCT01342016|Leflunomide|leflunomide|mesh-list
154617057|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617058|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617059|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
154617060|NCT03296189|Hormones|hormones|mesh-ancestor
154617061|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617062|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154617063|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617064|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
154617065|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
154617066|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617067|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
154617068|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
154617069|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617070|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617071|NCT03295955|Amoxicillin|amoxicillin|mesh-list
154617072|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
154617073|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
154617074|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154617075|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154617076|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617077|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154617078|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617079|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617080|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
154617081|NCT03298373|Nandrolone|nandrolone|mesh-list
154617082|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
154617083|NCT03298373|Androgens|androgens|mesh-ancestor
154617084|NCT03298373|Hormones|hormones|mesh-ancestor
154617085|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617086|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617087|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
154617088|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154617089|NCT01670721|Leucovorin|leucovorin|mesh-list
154617090|NCT01670721|Fluorouracil|fluorouracil|mesh-list
154617091|NCT01670721|Irinotecan|irinotecan|mesh-list
154617092|NCT01670721|Aflibercept|aflibercept|mesh-list
154617093|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
154617094|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617095|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154558037|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617096|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617097|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154617098|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
154617099|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331888|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154617100|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154617101|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154617102|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617103|NCT01670721|Antidotes|antidotes|mesh-ancestor
154617104|NCT01670721|Protective Agents|protective agents|mesh-ancestor
154617105|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
154617106|NCT01670721|Vitamins|vitamins|mesh-ancestor
154617107|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
154617108|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154617109|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154617110|NCT01670721|Growth Substances|growth substances|mesh-ancestor
154617111|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
154617112|NCT03287427|Tislelizumab|tislelizumab|mesh-list
154617113|NCT03287427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154617114|NCT03287427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617115|NCT04491695|Tirofiban|tirofiban|mesh-list
154617116|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154617117|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154617118|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617119|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154617120|NCT04982055|Nadroparin|nadroparin|mesh-list
154617121|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
154617122|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154617123|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154617124|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617125|NCT04981743|Vitamin D|vitamin d|mesh-list
154617126|NCT04981743|Vitamins|vitamins|mesh-ancestor
154617127|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
154617128|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617129|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154617130|NCT04489121|Omalizumab|omalizumab|mesh-list
154617131|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154617132|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154617133|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
154617134|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
154617135|NCT04982211|Propranolol|propranolol|mesh-list
154617136|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154617137|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154617138|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
154617139|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617140|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617141|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617142|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154617143|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154617144|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
154617145|NCT03290963|Ketamine|ketamine|mesh-list
154617146|NCT03290963|Analgesics|analgesics|mesh-ancestor
154617147|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
154617148|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617149|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617150|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154617151|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154617152|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
154617153|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
154617154|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617155|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154617156|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154617157|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617158|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617159|NCT03294707|Coal Tar|coal tar|mesh-list
154617160|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
154617161|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
154617162|NCT03062319|Anticoagulants|anticoagulants|mesh-list
154617163|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154617164|NCT03290495|Ketamine|ketamine|mesh-list
154617165|NCT03290495|Analgesics|analgesics|mesh-ancestor
154617166|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
154617167|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617168|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617169|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154229869|NCT01133080|Minocycline|minocycline|mesh-list
154617170|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154617171|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
154617172|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
154617173|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617174|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154617175|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154617176|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617177|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617178|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
154617179|NCT04429893|Bupivacaine|bupivacaine|mesh-list
154617180|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
154617181|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
154617182|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617183|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617184|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
154617185|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617186|NCT04429893|Analgesics|analgesics|mesh-ancestor
154617187|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154617188|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
154617189|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154617190|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154617191|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617192|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154617193|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
154617194|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154617195|NCT03290417|Vitamin D|vitamin d|mesh-list
154617196|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
154617197|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
154617198|NCT03290417|Vitamins|vitamins|mesh-list
154617199|NCT03290417|Curcumin|curcumin|mesh-list
154617200|NCT03290417|Turmeric extract|turmeric extract|mesh-list
154617201|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
154617202|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617203|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154617204|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154617205|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154617206|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154617207|NCT03290417|Analgesics|analgesics|mesh-ancestor
154617208|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
154617209|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617210|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617211|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154617212|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617213|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617214|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617215|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
154617216|NCT03290417|Protective Agents|protective agents|mesh-ancestor
154617217|NCT04429347|Gabapentin|gabapentin|mesh-list
154617218|NCT04429347|Tizanidine|tizanidine|mesh-list
154617219|NCT04429347|Analgesics|analgesics|mesh-ancestor
154617220|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
154617221|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617222|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617223|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
154617224|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154617225|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154617226|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617227|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154617228|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154617229|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154617230|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617231|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617232|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
154617233|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154617234|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154617235|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
154617236|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
154617237|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154617238|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154617239|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154617240|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
154617241|NCT03294551|Vaccines|vaccines|mesh-list
154332032|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
154617242|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
154617243|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617244|NCT04156581|Dexamethasone|dexamethasone|mesh-list
154617245|NCT04156581|Bupivacaine|bupivacaine|mesh-list
154617246|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617247|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
154617248|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
154617249|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617250|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617251|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617252|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
154617253|NCT04156581|Hormones|hormones|mesh-ancestor
154617254|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617255|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154617256|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617257|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
154617258|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
154617259|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617260|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
154617261|NCT02983071|Fulvestrant|fulvestrant|mesh-list
154617262|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154617263|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617264|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154617265|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154617266|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
154617267|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617268|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617269|NCT03294395|Gentamicins|gentamicins|mesh-list
154617270|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
154617271|NCT03294395|Ertapenem|ertapenem|mesh-list
154617272|NCT03294395|Fosfomycin|fosfomycin|mesh-list
154617273|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154617274|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617275|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154617276|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617277|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617278|NCT03294395|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154617279|NCT03294395|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154617280|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
154617281|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154617282|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154617283|NCT04980105|Prednisolone|prednisolone|mesh-list
154617284|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
154617285|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154617286|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
154617287|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
154617288|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617289|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
154617290|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
154617291|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617292|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617293|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617294|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
154617295|NCT04980105|Hormones|hormones|mesh-ancestor
154617296|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617297|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154617298|NCT04980105|Protective Agents|protective agents|mesh-ancestor
154617299|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154617300|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617301|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154617302|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
154617303|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
154617304|NCT04973319|Trastuzumab|trastuzumab|mesh-list
154617305|NCT04973319|Pertuzumab|pertuzumab|mesh-list
154617306|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154617307|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617308|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154617309|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154617310|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154617311|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617312|NCT03289871|Amorolfine|amorolfine|mesh-list
154617313|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
154617314|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617315|NCT03289637|Vitamin D|vitamin d|mesh-list
154617316|NCT03289637|Vitamins|vitamins|mesh-ancestor
154617317|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
154617318|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617319|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154617320|NCT04854837|Remdesivir|remdesivir|mesh-list
154617321|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
154617322|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617323|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
154617324|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617326|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154617327|NCT03289559|Androgens|androgens|mesh-ancestor
154617328|NCT03289559|Hormones|hormones|mesh-ancestor
154617329|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617330|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617331|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154617332|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617333|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617334|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154617335|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
154617336|NCT03293927|Fentanyl|fentanyl|mesh-list
154617337|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
154617338|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154617339|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617340|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617341|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154617342|NCT03293927|Analgesics|analgesics|mesh-ancestor
154617343|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
154617344|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617345|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154617346|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154617347|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154617348|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
154617349|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617350|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617351|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154617352|NCT03293927|Narcotics|narcotics|mesh-ancestor
154617353|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154617354|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154617355|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
154617356|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
154617357|NCT02730429|Letrozole|letrozole|mesh-list
154617358|NCT02730429|Palbociclib|palbociclib|mesh-list
154617359|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617360|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154617361|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154617362|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617363|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617364|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154617365|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
154617366|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617367|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617368|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154617369|NCT04971759|Fentanyl|fentanyl|mesh-list
154617370|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
154617371|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
154617372|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154332154|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
154617373|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617374|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617375|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154617376|NCT04971759|Analgesics|analgesics|mesh-ancestor
154617377|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
154617378|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617379|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154617380|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154617381|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154617382|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
154617383|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617384|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617385|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154617386|NCT04971759|Narcotics|narcotics|mesh-ancestor
154617387|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154617388|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154617389|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
154617390|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
154617391|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
154617392|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154617393|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154617394|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617395|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617396|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154617397|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154230097|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
154617398|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617399|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
154617400|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617402|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617403|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617404|NCT04971291|Bupropion|bupropion|mesh-list
154617405|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154617406|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
154617407|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154617408|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154617409|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154617410|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154617411|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617412|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
154617413|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617414|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617415|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154617416|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154617417|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617418|NCT03107507|Levetiracetam|levetiracetam|mesh-list
154617419|NCT03107507|Phenobarbital|phenobarbital|mesh-list
154617420|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
154617421|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
154617422|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154617423|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617424|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617425|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154617426|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154617427|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617428|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617429|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
154617430|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
154617431|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154617432|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154617433|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154617434|NCT02711137|Paclitaxel|paclitaxel|mesh-list
154617435|NCT02711137|Gemcitabine|gemcitabine|mesh-list
154617436|NCT02711137|Azacitidine|azacitidine|mesh-list
154617437|NCT02711137|Rucaparib|rucaparib|mesh-list
154617438|NCT02711137|INCB057643|incb057643|mesh-list
154617439|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154617440|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617441|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
154617442|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
154617443|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
154617444|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617445|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154617446|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
154617447|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617448|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154617449|NCT04155411|Dasatinib|dasatinib|mesh-list
154617450|NCT04155411|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154617451|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154617452|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617453|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617454|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617455|NCT04970667|Flupenthixol|flupenthixol|mesh-list
154617456|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154617457|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154617458|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154617459|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617460|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617461|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154617462|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154617463|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
154617464|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617465|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617466|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
154617467|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
154617468|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617469|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
154230169|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
154617470|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617471|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617472|NCT03288077|Tryptophan|tryptophan|mesh-list
154617473|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154617474|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
154617475|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154617476|NCT00777127|Diclofenac|diclofenac|mesh-list
154617477|NCT00777127|Imiquimod|imiquimod|mesh-list
154617478|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154617479|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154617480|NCT00777127|Analgesics|analgesics|mesh-ancestor
154617481|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
154617482|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617483|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617484|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617485|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154617486|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154617487|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617488|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617489|NCT00777127|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154617490|NCT00777127|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154617491|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
154617492|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154617493|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617494|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
154617495|NCT00761371|Imiquimod|imiquimod|mesh-list
154617496|NCT00761371|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154617497|NCT00761371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617498|NCT00761371|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154617499|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
154617500|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617501|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154617502|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617503|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
154617504|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
154617505|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
154617506|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617507|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617508|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154617509|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
154617510|NCT03287609|Evolocumab|evolocumab|mesh-list
154617511|NCT03287609|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154617512|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154617513|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154617514|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
154617515|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617516|NCT03287609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154617517|NCT03287609|Protease Inhibitors|protease inhibitors|mesh-ancestor
154617518|NCT03287609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617519|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154617520|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154617521|NCT03291821|Cetrorelix|cetrorelix|mesh-list
154617522|NCT03291821|Menotropins|menotropins|mesh-list
154617523|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154617524|NCT03291821|Ganirelix|ganirelix|mesh-list
154617525|NCT03291821|Hormones|hormones|mesh-ancestor
154617526|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617527|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617528|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
154617529|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154617530|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
154617531|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154617532|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154617533|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154617534|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617535|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154617536|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
154617537|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
154617538|NCT02448901|Edoxaban|edoxaban|mesh-list
154617539|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154617540|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
154617541|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154617542|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
154617543|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860316|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230248|NCT01234792|Nicotine|nicotine|mesh-list
154617544|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617545|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
154617546|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
154617547|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154617548|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617549|NCT03291353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154617550|NCT03291353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617551|NCT02460341|Ondansetron|ondansetron|mesh-list
154617552|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
154617553|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
154617554|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617555|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617556|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617557|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
154617558|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
154617559|NCT02460341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154617560|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154617561|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
154617562|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617563|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617564|NCT00189319|Flecainide|flecainide|mesh-list
154617565|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154617566|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154617567|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154617568|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154617569|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617570|NCT00189241|Imiquimod|imiquimod|mesh-list
154617571|NCT00189241|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154617572|NCT00189241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617573|NCT00189241|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154617574|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
154617575|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617576|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154617577|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617578|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
154617579|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
154617580|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154617581|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154617582|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154617583|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154617584|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617585|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
154617586|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617587|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617588|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154617589|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617590|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
154617591|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
154617592|NCT03286673|Calcium|calcium|mesh-list
154617593|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154617594|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617595|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154617596|NCT03286673|Antacids|antacids|mesh-ancestor
154617597|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617598|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617599|NCT02448589|TAS-119|tas-119|mesh-list
154617600|NCT02448589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617601|NCT02448589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154617602|NCT02448589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332386|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154617603|NCT02448589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617604|NCT02445703|Vaccines|vaccines|mesh-list
154617605|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
154617606|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617607|NCT03194659|Choline|choline|mesh-list
154617608|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
154617609|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154617610|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
154617611|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617612|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617613|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154617614|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
154617615|NCT02445547|Hormones|hormones|mesh-list
154617616|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230402|NCT00114777|Cyclosporine|cyclosporine|mesh-list
154617617|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617618|NCT03190603|Celecoxib|celecoxib|mesh-list
154617619|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154617620|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154617621|NCT03190603|Analgesics|analgesics|mesh-ancestor
154617622|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
154617623|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617624|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617625|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617626|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154617627|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154617628|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154617629|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617630|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617631|NCT03285503|Aripiprazole|aripiprazole|mesh-list
154617632|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
154617633|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154617634|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154617635|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154617636|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617637|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617638|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
154617639|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
154617640|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617641|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617642|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154617643|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154617644|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
154617645|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154332440|NCT03530488|Lidocaine|lidocaine|mesh-list
154617646|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154617647|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154617648|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154617649|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
154617650|NCT02439697|Hematinics|hematinics|mesh-ancestor
154617651|NCT03284645|Tenofovir|tenofovir|mesh-list
154617652|NCT03284645|Lamivudine|lamivudine|mesh-list
154617653|NCT03284645|Zidovudine|zidovudine|mesh-list
154617654|NCT03284645|Efavirenz|efavirenz|mesh-list
154617655|NCT03284645|Abacavir|abacavir|mesh-list
154617656|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
154617657|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617658|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154617659|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154617660|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617661|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617662|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154617663|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154617664|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
154617665|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154617666|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154617667|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154617668|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154617669|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154617670|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154617671|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154617672|NCT03190447|Laxatives|laxatives|mesh-ancestor
154617673|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617674|NCT03284177|Calcium|calcium|mesh-list
154617675|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154617676|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617677|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
154617678|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
154617679|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154617680|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154617681|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617682|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617683|NCT03192709|Urological Agents|urological agents|mesh-ancestor
154617684|NCT03283943|Durvalumab|durvalumab|mesh-list
154617685|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154617686|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617687|NCT02710045|Vaccines|vaccines|mesh-list
154617688|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
154617689|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617690|NCT02444767|Bimatoprost|bimatoprost|mesh-list
154617691|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154617692|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
154617693|NCT02443285|Cefotaxime|cefotaxime|mesh-list
154617694|NCT02443285|Cefoxitin|cefoxitin|mesh-list
154617695|NCT02443285|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154617696|NCT02443285|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154617697|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154617698|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617699|NCT03193957|Etanercept|etanercept|mesh-list
154617700|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154617701|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154617702|NCT03193957|Analgesics|analgesics|mesh-ancestor
154617703|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
154617704|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617705|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617706|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617707|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154617708|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617709|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154617710|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
154617711|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
154617712|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154617713|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
154617714|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617715|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617716|NCT02444611|Vaccines|vaccines|mesh-list
154617717|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
154617718|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
154617719|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617720|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154617721|NCT02438761|Gedatolisib|gedatolisib|mesh-list
154617722|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154617723|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617724|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617725|NCT03536429|Acetazolamide|acetazolamide|mesh-list
154617726|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
154617727|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154617728|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617729|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617730|NCT03536429|Diuretics|diuretics|mesh-ancestor
154617731|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
154617732|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617733|NCT02438683|BI 409306|bi 409306|mesh-list
154617734|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154617735|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617736|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617737|NCT03270839|Meclizine|meclizine|mesh-list
154617738|NCT03270839|Scopolamine|scopolamine|mesh-list
154617739|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154617740|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
154617741|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
154617742|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617743|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617744|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617745|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
154617746|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154617747|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
154617748|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617749|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617750|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154617751|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154617752|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
154617753|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
154617754|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154617755|NCT02458547|Bupivacaine|bupivacaine|mesh-list
154617756|NCT02458547|Propofol|propofol|mesh-list
154617757|NCT02458547|Desflurane|desflurane|mesh-list
154617758|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
154617759|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
154617760|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617761|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617762|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
154617763|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617764|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154230488|NCT00113919|Busulfan|busulfan|mesh-list
154617765|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154617766|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
154617767|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154617769|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154617770|NCT02458625|Trace Elements|trace elements|mesh-ancestor
154617771|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
154617772|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617773|NCT02458625|Hematinics|hematinics|mesh-ancestor
154617774|NCT04978155|Anesthetics|anesthetics|mesh-list
154617775|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617776|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617777|NCT04970043|Pemetrexed|pemetrexed|mesh-list
154617778|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617779|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617780|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617781|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154617782|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154617783|NCT04977843|Dimercaprol|dimercaprol|mesh-list
154617784|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
154617785|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
154617786|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617787|NCT04432233|Metronidazole|metronidazole|mesh-list
154617788|NCT04432233|Levofloxacin|levofloxacin|mesh-list
154617789|NCT04432233|Esomeprazole|esomeprazole|mesh-list
154617790|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617791|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154617792|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154617793|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154617794|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154617795|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617796|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154617797|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617798|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332593|NCT00135382|Efavirenz|efavirenz|mesh-list
154617799|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154617800|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154617801|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154617802|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617803|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154617804|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154617805|NCT03269747|Prednisone|prednisone|mesh-list
154617806|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617807|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
154617808|NCT03269747|Hormones|hormones|mesh-ancestor
154617809|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617810|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617811|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154617812|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617813|NCT04369469|Ravulizumab|ravulizumab|mesh-list
154617814|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154617815|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154617816|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
154617817|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617818|NCT03269591|Diclofenac|diclofenac|mesh-list
154617819|NCT03269591|Progesterone|progesterone|mesh-list
154617820|NCT03269591|Progestins|progestins|mesh-ancestor
154617821|NCT03269591|Hormones|hormones|mesh-ancestor
154617822|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617823|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617824|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154617825|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154617826|NCT03269591|Analgesics|analgesics|mesh-ancestor
154617827|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
154617828|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617829|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154617830|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154617831|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154617832|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617833|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617834|NCT03989609|Midazolam|midazolam|mesh-list
154617835|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
154617836|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154617837|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617838|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617839|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154617840|NCT03989609|Analgesics|analgesics|mesh-ancestor
154617841|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
154617842|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617843|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154617844|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154617845|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154617846|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154617847|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617848|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617849|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154617850|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154617851|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154617852|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154617853|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154617854|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
154617855|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
154617856|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
154617857|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
154617858|NCT03988205|Cytarabine|cytarabine|mesh-list
154617859|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154617860|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
154617861|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617862|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154617863|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
154617864|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617865|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154617866|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
154617867|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617868|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154617869|NCT03280277|Hematinics|hematinics|mesh-ancestor
154617870|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154617871|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154617872|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
154617873|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154617874|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617875|NCT03269279|Misoprostol|misoprostol|mesh-list
154617876|NCT03269279|Mifepristone|mifepristone|mesh-list
154617877|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154617878|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
154617879|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154617880|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617881|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154617882|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617883|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
154617884|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154617885|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154617886|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154617887|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154617888|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
154617889|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154617890|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154617891|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
154617892|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617893|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
154617894|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154617895|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154617896|NCT03278483|Rifampin|rifampin|mesh-list
154617897|NCT03278483|Isoniazid|isoniazid|mesh-list
154617898|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154617899|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
154617900|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154617901|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617902|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
154617903|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154617904|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617905|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617906|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154617907|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154617908|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154617909|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154617910|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154617911|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154617912|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154617913|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154617914|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
154860317|NCT00637130|Travoprost|travoprost|mesh-list
154617915|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154617916|NCT03268733|Folic Acid|folic acid|mesh-list
154617917|NCT03268733|Hematinics|hematinics|mesh-ancestor
154617918|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
154617919|NCT03268733|Vitamins|vitamins|mesh-ancestor
154617920|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
154617921|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617922|NCT03277391|Droperidol|droperidol|mesh-list
154617923|NCT03277391|Morphine|morphine|mesh-list
154617924|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154617925|NCT03277391|Narcotics|narcotics|mesh-ancestor
154617926|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617927|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617928|NCT03277391|Analgesics|analgesics|mesh-ancestor
154617929|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
154617930|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154617931|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154617932|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
154617933|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
154617934|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154617935|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154617936|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154617937|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154617938|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154617939|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154617940|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
154617941|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617942|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617943|NCT03277001|Enoxaparin|enoxaparin|mesh-list
154332733|NCT01213381|Iniparib|iniparib|mesh-list
154617944|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
154617945|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154617946|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
154617947|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154617948|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
154617949|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617950|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617951|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
154617952|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154617953|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154617954|NCT03272711|Vortioxetine|vortioxetine|mesh-list
154617955|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
154617956|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154617957|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154617958|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154617959|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154617960|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617961|NCT03272711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154617962|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154617963|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154617964|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617965|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154617966|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
154617967|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154617968|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154617969|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154617970|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154617971|NCT03267407|Fluconazole|fluconazole|mesh-list
154617972|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
154617973|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617974|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154617975|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154617976|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154617977|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617978|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154617979|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
154617980|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154617981|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617982|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154617983|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154617984|NCT03267329|Telmisartan|telmisartan|mesh-list
154617985|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154617986|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154617987|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154332774|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
154617988|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154617989|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
154617990|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154617991|NCT05073965|Vitamin D|vitamin d|mesh-list
154617992|NCT05073965|Vitamins|vitamins|mesh-ancestor
154617993|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
154617994|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154617995|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154617996|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
154617997|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154617998|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154617999|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618000|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
154618001|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618002|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618003|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
154618004|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154618005|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618006|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618007|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154618008|NCT05065775|Analgesics|analgesics|mesh-ancestor
154618009|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
154618010|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618011|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154618012|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154618013|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154618014|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
154618015|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618016|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618017|NCT03266159|Trametinib|trametinib|mesh-list
154618018|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618019|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618020|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618021|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618022|NCT02458781|Metronidazole|metronidazole|mesh-list
154618023|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
154618024|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
154618025|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618026|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618027|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154618028|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154618029|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154618030|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154618031|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618032|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618033|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618034|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154618035|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154618036|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154618037|NCT04647383|Lemborexant|lemborexant|mesh-list
154618038|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154618039|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618040|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618041|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154618042|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154618043|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618044|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618045|NCT02458157|Furosemide|furosemide|mesh-list
154618046|NCT02458157|Diuretics|diuretics|mesh-ancestor
154618047|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
154618048|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618049|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154618050|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154618051|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618052|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
154618053|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154618054|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618055|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618056|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154618057|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154618058|NCT02458079|Protective Agents|protective agents|mesh-ancestor
154618059|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618060|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
154230846|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618061|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154618062|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
154618063|NCT03264911|Amoxicillin|amoxicillin|mesh-list
154618064|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618065|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618066|NCT03265223|Ropivacaine|ropivacaine|mesh-list
154618067|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
154618068|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
154618069|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618070|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618071|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
154618072|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618073|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
154618074|NCT02456363|Adalimumab|adalimumab|mesh-list
154618075|NCT02456363|Golimumab|golimumab|mesh-list
154618076|NCT02456363|Etanercept|etanercept|mesh-list
154618077|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154618078|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154618079|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154618080|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154618081|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154618082|NCT02456363|Analgesics|analgesics|mesh-ancestor
154618083|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
154618084|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618085|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618086|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154618087|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154618088|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
154618089|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618090|NCT03259607|Nicotine|nicotine|mesh-list
154618091|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154618092|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
154618093|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618094|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618095|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154618096|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154618097|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
154618098|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618099|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618100|NCT02456129|Itraconazole|itraconazole|mesh-list
154618101|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
154618102|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618103|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154618104|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154618105|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618106|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618107|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154618108|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
154618109|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618110|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618111|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154618112|NCT03263741|Paclitaxel|paclitaxel|mesh-list
154618113|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154618114|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
154618115|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154618116|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618117|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
154618118|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
154618119|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
154618120|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618121|NCT02456207|Rituximab|rituximab|mesh-list
154618122|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618123|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618124|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
154618125|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618126|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154618127|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
154618128|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
154618129|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154618130|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
154618131|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618132|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618133|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154618134|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
154618135|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154618136|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154618138|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
154618139|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618140|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618141|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
154618142|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154618143|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
154618144|NCT03258671|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154618145|NCT03258671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618146|NCT03258671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618147|NCT03258671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618148|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
154618149|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618150|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618151|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154618152|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154618153|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618154|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618155|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618156|NCT04976673|Triamcinolone|triamcinolone|mesh-list
154618157|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154618158|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154618159|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154618160|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154618161|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
154618162|NCT04976673|Hormones|hormones|mesh-ancestor
154618163|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618164|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618165|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154618166|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
154618167|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618168|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618169|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
154618170|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154618171|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154618172|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
154618173|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618174|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618175|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618176|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154618177|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618178|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
154618179|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618180|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618181|NCT03263039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154618182|NCT03263039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618183|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
154618184|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618185|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
154618186|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154618187|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154618188|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618189|NCT03262961|Urological Agents|urological agents|mesh-ancestor
154618190|NCT01670097|Dexamethasone|dexamethasone|mesh-list
154618191|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154618192|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
154618193|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
154618194|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618195|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618196|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154618197|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
154618198|NCT01670097|Hormones|hormones|mesh-ancestor
154618199|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618200|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154618201|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618202|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
154618203|NCT03257423|Metronidazole|metronidazole|mesh-list
154618204|NCT03257423|Levofloxacin|levofloxacin|mesh-list
154618205|NCT03257423|Ertapenem|ertapenem|mesh-list
154618206|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618207|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618208|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154618209|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154618210|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618211|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618212|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618213|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154618214|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154618215|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154618216|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154618217|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154618219|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154618220|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154618221|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618222|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618223|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154618224|NCT03262727|Deucravacitinib|deucravacitinib|mesh-list
154333013|NCT05110144|Amitriptyline|amitriptyline|mesh-list
154618225|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154618226|NCT03262727|Norethindrone|norethindrone|mesh-list
154618227|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
154618228|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154618229|NCT03262727|Estradiol|estradiol|mesh-list
154618230|NCT03262727|Estrogens|estrogens|mesh-ancestor
154618231|NCT03262727|Hormones|hormones|mesh-ancestor
154618232|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618233|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618234|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154618235|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
154618236|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154618237|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154618238|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154618239|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154618240|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154618241|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
154618242|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618243|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618244|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618245|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154618246|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154618247|NCT04975971|Dexamethasone|dexamethasone|mesh-list
154618248|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154618249|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
154618250|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
154618251|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618252|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618253|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154618254|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
154618255|NCT04975971|Hormones|hormones|mesh-ancestor
154618256|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618257|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154618258|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618259|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
154618260|NCT03062163|Resveratrol|resveratrol|mesh-list
154618261|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
154618262|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618263|NCT03062163|Protective Agents|protective agents|mesh-ancestor
154618264|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618265|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618266|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154618267|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
154618268|NCT03062163|Vitamins|vitamins|mesh-ancestor
154618269|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
154618270|NCT02456597|Lidocaine|lidocaine|mesh-list
154618271|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
154618272|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
154618273|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618274|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618275|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
154618276|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618277|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154618278|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154618279|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154618280|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154618281|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618282|NCT03261635|Indomethacin|indomethacin|mesh-list
154618283|NCT03261635|Ranibizumab|ranibizumab|mesh-list
154618284|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154618285|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154618286|NCT03261635|Growth Substances|growth substances|mesh-ancestor
154618287|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618288|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
154618289|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618290|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154618291|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154618292|NCT03261635|Analgesics|analgesics|mesh-ancestor
154618293|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
154618294|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618295|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154618296|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154618297|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
154618298|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
154618299|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154618300|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154618301|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618302|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618303|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
154618304|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154618305|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154618306|NCT03059979|Prednisolone|prednisolone|mesh-list
154618307|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
154618308|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154618309|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
154618310|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154618311|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
154618312|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
154618313|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618314|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618315|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154333118|NCT01118923|Antacids|antacids|mesh-ancestor
154618316|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
154618317|NCT03059979|Hormones|hormones|mesh-ancestor
154618318|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618319|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154618320|NCT03059979|Protective Agents|protective agents|mesh-ancestor
154618321|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154618322|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618323|NCT03256721|Docetaxel|docetaxel|mesh-list
154618324|NCT03256721|Pemetrexed|pemetrexed|mesh-list
154618325|NCT03256721|Apatinib|apatinib|mesh-list
154618326|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618327|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
154618328|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
154618329|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
154618330|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618331|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618332|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154618333|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154618334|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618335|NCT04967859|Gentamicins|gentamicins|mesh-list
154618336|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618337|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618338|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154618339|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618340|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618341|NCT03256487|Morphine|morphine|mesh-list
154618342|NCT03256487|Buprenorphine|buprenorphine|mesh-list
154618343|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154618344|NCT03256487|Narcotics|narcotics|mesh-ancestor
154618345|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618346|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618347|NCT03256487|Analgesics|analgesics|mesh-ancestor
154618348|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
154618349|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618350|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154618351|NCT03061227|Glucagon|glucagon|mesh-list
154618352|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154618353|NCT03061227|Hormones|hormones|mesh-ancestor
154618354|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618355|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618356|NCT03261791|Apatinib|apatinib|mesh-list
154618357|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618358|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618359|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618360|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618362|NCT03060603|Hematinics|hematinics|mesh-ancestor
154618363|NCT04488107|Letrozole|letrozole|mesh-list
154618364|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618365|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154618366|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154618367|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618368|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618369|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154618370|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
154618371|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618372|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618373|NCT04974723|Teriparatide|teriparatide|mesh-list
154618374|NCT04974723|Abaloparatide|abaloparatide|mesh-list
154618375|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154618376|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618377|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154618378|NCT03060681|Bupivacaine|bupivacaine|mesh-list
154618379|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
154618380|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
154618381|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618382|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618383|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
154618384|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618385|NCT03254849|Empagliflozin|empagliflozin|mesh-list
154618386|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154618387|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154618388|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618389|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154618390|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618391|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154618392|NCT03254849|Diuretics|diuretics|mesh-ancestor
154618393|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
154618394|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154618395|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154618396|NCT04963881|Antibodies|antibodies|mesh-list
154618397|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
154618398|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618399|NCT04432155|Xenon|xenon|mesh-list
154618400|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154618401|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
154618402|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
154618403|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618404|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618405|NCT04487951|Vitamin D|vitamin d|mesh-list
154618406|NCT04487951|Vitamins|vitamins|mesh-ancestor
154618407|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
154618408|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618409|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154618410|NCT04963257|Aripiprazole|aripiprazole|mesh-list
154618411|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
154618412|NCT04963257|Sertraline|sertraline|mesh-list
154618413|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
154618414|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154618415|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154618416|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154618417|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618418|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618419|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
154618420|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
154618421|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618422|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333205|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
154618423|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154618424|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154618425|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
154618426|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154618427|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154618428|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154618429|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154618430|NCT04963257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154618431|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154618432|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154618433|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154618434|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154618435|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154618436|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154618437|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618438|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154618439|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
154618440|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
154618441|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618442|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
154618443|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618444|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618445|NCT04953741|Fluticasone|fluticasone|mesh-list
154618446|NCT04953741|Xhance|xhance|mesh-list
154618447|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154618448|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154618449|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
154618450|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618451|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618452|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154618453|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
154618454|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
154618455|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154618456|NCT03259919|Metformin|metformin|mesh-list
154618457|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154618458|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618459|NCT04965831|Aflutinib|aflutinib|mesh-list
154618460|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618461|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618462|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618463|NCT04953117|Paclitaxel|paclitaxel|mesh-list
154618464|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154618465|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618466|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
154618467|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
154618468|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
154618469|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618470|NCT03259529|Rituximab|rituximab|mesh-list
154618471|NCT03259529|Nivolumab|nivolumab|mesh-list
154618472|NCT03259529|Gemcitabine|gemcitabine|mesh-list
154618473|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154618474|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618475|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618476|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
154618477|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618478|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154618479|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154618480|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
154618481|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618482|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154618483|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154618484|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
154618485|NCT03252665|Nicorandil|nicorandil|mesh-list
154618486|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
154618487|NCT03252665|Alprostadil|alprostadil|mesh-list
154618488|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
154618489|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154618490|NCT03252665|Urological Agents|urological agents|mesh-ancestor
154618491|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154618492|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154618493|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
154618494|NCT03252665|Vitamins|vitamins|mesh-ancestor
154618495|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
154618496|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618497|NCT03059667|Carboplatin|carboplatin|mesh-list
154618498|NCT03059667|Etoposide|etoposide|mesh-list
154618499|NCT03059667|Atezolizumab|atezolizumab|mesh-list
154618500|NCT03059667|Topotecan|topotecan|mesh-list
154618501|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231224|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154618502|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154618503|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154618504|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154618505|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618506|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618507|NCT03059667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154618508|NCT03059667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618509|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154618510|NCT03058419|Midazolam|midazolam|mesh-list
154618511|NCT03058419|Levomethorphan|levomethorphan|mesh-list
154618512|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
154618513|NCT03058419|Caffeine|caffeine|mesh-list
154618514|NCT03058419|Bupropion|bupropion|mesh-list
154618515|NCT03058419|Omeprazole|omeprazole|mesh-list
154618516|NCT03058419|Warfarin|warfarin|mesh-list
154618517|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154618518|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154618519|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618520|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618521|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154618522|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154618523|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154618524|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154618525|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
154618526|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
154618527|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
154618528|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
154618529|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333311|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
154618530|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618531|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
154618532|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154618533|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154618534|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618535|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154618536|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154618537|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
154618538|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154618539|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154618540|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154618541|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154618542|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
154618543|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154618544|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154618545|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154618546|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
154618547|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154618548|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154618549|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
154618550|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
154618551|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154618552|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154618553|NCT03058419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154618554|NCT03058419|Narcotics|narcotics|mesh-ancestor
154618555|NCT03058419|Analgesics|analgesics|mesh-ancestor
154618556|NCT03058419|Sensory System Agents|sensory system agents|mesh-ancestor
154618557|NCT03058419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618558|NCT04965051|Insulin|insulin|mesh-list
154618559|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154618560|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
154618561|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154618562|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618563|NCT02455271|Eszopiclone|eszopiclone|mesh-list
154618564|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154618565|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618566|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618567|NCT04964583|Azithromycin|azithromycin|mesh-list
154618568|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
154618569|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618570|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618571|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
154618572|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154618573|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154618574|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618575|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618576|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154618577|NCT03251417|Irinotecan|irinotecan|mesh-list
154618578|NCT03251417|Apatinib|apatinib|mesh-list
154231343|NCT00420641|Paroxetine|paroxetine|mesh-list
154618579|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154618580|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154618581|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618582|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618583|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618584|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618585|NCT04961931|Empagliflozin|empagliflozin|mesh-list
154618586|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154618587|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618588|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154618589|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618590|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
154618591|NCT02454881|Oxycodone|oxycodone|mesh-list
154618592|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154618593|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618594|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618595|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154618596|NCT02454881|Analgesics|analgesics|mesh-ancestor
154618597|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
154618598|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618599|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154618600|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154618601|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154618602|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
154618603|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618604|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618605|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154618606|NCT02454881|Narcotics|narcotics|mesh-ancestor
154618607|NCT03058341|Propofol|propofol|mesh-list
154618608|NCT03058341|Sevoflurane|sevoflurane|mesh-list
154618609|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154618610|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618611|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618612|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154618613|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
154618614|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
154618615|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154618616|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154618617|NCT04951791|SMOFlipid|smoflipid|mesh-list
154618618|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154618619|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154618620|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154618621|NCT04951713|Clarithromycin|clarithromycin|mesh-list
154618622|NCT04951713|Rifampin|rifampin|mesh-list
154618623|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618624|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618625|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154618626|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618627|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618628|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154618629|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154618630|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154618631|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
154618632|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
154618633|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154618634|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154618635|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154618636|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154618637|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154618638|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154618639|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154618640|NCT04944069|Bevacizumab|bevacizumab|mesh-list
154618641|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618642|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618643|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154618644|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154618645|NCT04944069|Growth Substances|growth substances|mesh-ancestor
154618646|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618647|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
154618648|NCT04951167|Norepinephrine|norepinephrine|mesh-list
154618649|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154618650|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154618651|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
154618652|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618653|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231368|NCT01250470|Sargramostim|sargramostim|mesh-list
154618654|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618655|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
154618656|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
154618657|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618658|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154618660|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
154618661|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154618662|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154618663|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618664|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618665|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618666|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154618667|NCT04950933|Protective Agents|protective agents|mesh-ancestor
154618668|NCT04961307|Trastuzumab|trastuzumab|mesh-list
154618669|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618670|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618671|NCT03058263|Neostigmine|neostigmine|mesh-list
154618672|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154618673|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618674|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618675|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
154618676|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618677|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618678|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154618679|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
154618680|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618681|NCT04415853|Irinotecan|irinotecan|mesh-list
154618682|NCT04415853|Tegafur|tegafur|mesh-list
154618683|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154618684|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154618685|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618686|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618687|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618688|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154618689|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
154618690|NCT04415151|Tofacitinib|tofacitinib|mesh-list
154618691|NCT04415151|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154618692|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618693|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618694|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618695|NCT03059277|Aflibercept|aflibercept|mesh-list
154618696|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154618697|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154618698|NCT03059277|Growth Substances|growth substances|mesh-ancestor
154618699|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618700|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
154618701|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618702|NCT00700817|Metformin|metformin|mesh-list
154618703|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154618704|NCT00700817|Liraglutide|liraglutide|mesh-list
154618705|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154618706|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618707|NCT00700817|Incretins|incretins|mesh-ancestor
154618708|NCT00700817|Hormones|hormones|mesh-ancestor
154618709|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618710|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154618711|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
154618712|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618713|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231441|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
154231442|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
154231443|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
154231444|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
154231445|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231446|NCT03914404|Protective Agents|protective agents|mesh-ancestor
154231447|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231448|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
154231449|NCT03914404|Vitamins|vitamins|mesh-ancestor
154231450|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
154231451|NCT01251640|Gemcitabine|gemcitabine|mesh-list
154231452|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154231453|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
154231454|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618714|NCT00700817|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154618715|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154618716|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
154618717|NCT04960293|Coagulants|coagulants|mesh-ancestor
154618718|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154618719|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333526|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
154618720|NCT04941417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618721|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618722|NCT04948125|Apatinib|apatinib|mesh-list
154618723|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618724|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618725|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618726|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618727|NCT02455115|Chromium|chromium|mesh-list
154618728|NCT02455115|Norepinephrine|norepinephrine|mesh-list
154618729|NCT02455115|Edetic Acid|edetic acid|mesh-list
154618730|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
154618731|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154618732|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154618733|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
154618734|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618735|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618736|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618737|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
154618738|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
154618739|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618740|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154618741|NCT02455115|Trace Elements|trace elements|mesh-ancestor
154618742|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
154618743|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
154618744|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154618745|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
154618746|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
154618747|NCT02455115|Antidotes|antidotes|mesh-ancestor
154618748|NCT02455115|Protective Agents|protective agents|mesh-ancestor
154618749|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154618750|NCT03094247|Amoxicillin|amoxicillin|mesh-list
154618751|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618752|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618753|NCT04947423|Scopolamine|scopolamine|mesh-list
154618754|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154618755|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
154618756|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
154618757|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618758|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618759|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154618760|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
154618761|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154618762|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
154618763|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618764|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618765|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154618766|NCT03250481|Oxycodone|oxycodone|mesh-list
154618767|NCT03250481|Propofol|propofol|mesh-list
154618768|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154618769|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618770|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618771|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154618772|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
154618773|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
154618774|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154618775|NCT03250481|Narcotics|narcotics|mesh-ancestor
154618776|NCT03250481|Analgesics|analgesics|mesh-ancestor
154618777|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
154618778|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618779|NCT04947267|Epinephrine|epinephrine|mesh-list
154618780|NCT04947267|Mepivacaine|mepivacaine|mesh-list
154618781|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154618782|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154618783|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
154618784|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618785|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618786|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618787|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154231517|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618788|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154618789|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
154618790|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618791|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154618792|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
154618793|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
154618794|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
154618795|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154618796|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
154618797|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
154618798|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618799|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
154618800|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
154618801|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154618802|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
154618803|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618804|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154618805|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154618806|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
154618807|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618808|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618809|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154618810|NCT04423731|Leucovorin|leucovorin|mesh-list
154618811|NCT04423731|Paclitaxel|paclitaxel|mesh-list
154618812|NCT04423731|Gemcitabine|gemcitabine|mesh-list
154618813|NCT04423731|Fluorouracil|fluorouracil|mesh-list
154618814|NCT04423731|Folfirinox|folfirinox|mesh-list
154618815|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154618816|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618817|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
154618818|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
154618819|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
154618820|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618821|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154618822|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
154618823|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154618824|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
154618825|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618826|NCT04423731|Antidotes|antidotes|mesh-ancestor
154618827|NCT04423731|Protective Agents|protective agents|mesh-ancestor
154618828|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
154618829|NCT04423731|Vitamins|vitamins|mesh-ancestor
154618830|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
154618831|NCT04947111|Antibodies|antibodies|mesh-list
154618832|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
154618833|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
154618834|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
154618835|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618836|NCT04947345|Propofol|propofol|mesh-list
154618837|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154618838|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618839|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618840|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154618841|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
154618842|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
154618843|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154618844|NCT03249311|Milnacipran|milnacipran|mesh-list
154618845|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
154618846|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154618847|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154618848|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154618849|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618850|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618851|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618852|NCT03249311|Analgesics|analgesics|mesh-ancestor
154618853|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
154618854|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618855|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
154618856|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154618857|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
154618858|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154618859|NCT02454491|Verapamil|verapamil|mesh-list
154618860|NCT02454491|Heparin|heparin|mesh-list
154618861|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
154333663|NCT03143816|Insulin|insulin|mesh-list
154618862|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154618863|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154618864|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618865|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154618866|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154618867|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154618868|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154618869|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618870|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
154618871|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
154618872|NCT03248765|Narcotics|narcotics|mesh-ancestor
154618873|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618874|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618875|NCT03248765|Analgesics|analgesics|mesh-ancestor
154618876|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
154618877|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618878|NCT04939857|Trimetazidine|trimetazidine|mesh-list
154618879|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
154618880|NCT04939779|Delpazolid|delpazolid|mesh-list
154618881|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
154618882|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154618883|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618884|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154618885|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618886|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618887|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
154618888|NCT03247595|Bisacodyl|bisacodyl|mesh-list
154618889|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154618890|NCT03247595|Cathartics|cathartics|mesh-ancestor
154618891|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154618892|NCT03247595|Laxatives|laxatives|mesh-ancestor
154618893|NCT03247283|Linrodostat|linrodostat|mesh-list
154618894|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618895|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618896|NCT04938297|Rituximab|rituximab|mesh-list
154618897|NCT04938297|Lenalidomide|lenalidomide|mesh-list
154618898|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
154618899|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618900|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618901|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
154618902|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618903|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154618904|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154618905|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154618906|NCT04938297|Growth Substances|growth substances|mesh-ancestor
154618907|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
154618908|NCT04938297|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154618909|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154618910|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618911|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618912|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
154618913|NCT02625909|Velpatasvir|velpatasvir|mesh-list
154618914|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
154618915|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154618916|NCT03246659|Polygeline|polygeline|mesh-list
154618917|NCT03246659|Gastrins|gastrins|mesh-list
154618918|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
154618919|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
154618920|NCT03246659|Hormones|hormones|mesh-ancestor
154618921|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618922|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618923|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
154618924|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154618925|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
154618926|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154618927|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618928|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154618929|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
154618930|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
154618931|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154618932|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
154618933|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618934|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618935|NCT03246113|Temozolomide|temozolomide|mesh-list
154618936|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154618937|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
154618938|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618939|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618940|NCT04937673|Paclitaxel|paclitaxel|mesh-list
154618941|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154231691|NCT01150630|Epirubicin|epirubicin|mesh-list
154618942|NCT04937673|Cisplatin|cisplatin|mesh-list
154618943|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154618944|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618945|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154618946|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154618947|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154618948|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618949|NCT04944381|Vaccines|vaccines|mesh-list
154618950|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
154618951|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618952|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
154618953|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154618954|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618955|NCT03245177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154618956|NCT03245177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618957|NCT03245333|Hormones|hormones|mesh-list
154618958|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154618959|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618960|NCT04958187|Mitogens|mitogens|mesh-list
154618961|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
154618962|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618963|NCT03244319|Warfarin|warfarin|mesh-list
154618964|NCT03244319|Edoxaban|edoxaban|mesh-list
154618965|NCT03244319|Anticoagulants|anticoagulants|mesh-list
154618966|NCT03244319|Coagulants|coagulants|mesh-list
154618967|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154618968|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
154618969|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154618970|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
154618971|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154618972|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618973|NCT03244553|Prucalopride|prucalopride|mesh-list
154618974|NCT03244553|Laxatives|laxatives|mesh-ancestor
154618975|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154618976|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154618977|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154618978|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
154618979|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154618980|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618981|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618982|NCT03244241|Insulin|insulin|mesh-list
154618983|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154618984|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618985|NCT03243851|Metformin|metformin|mesh-list
154618986|NCT03243851|Temozolomide|temozolomide|mesh-list
154618987|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154618988|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618989|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154618990|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
154618991|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154618992|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154618993|NCT02623959|Doxycycline|doxycycline|mesh-list
154618994|NCT02623959|Fentanyl|fentanyl|mesh-list
154618995|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154618996|NCT02623959|Narcotics|narcotics|mesh-ancestor
154618997|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154618998|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154618999|NCT02623959|Analgesics|analgesics|mesh-ancestor
154619000|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
154619001|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619002|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154619003|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154619004|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
154619005|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
154619006|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154619007|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619008|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
154619009|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154619010|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154619011|NCT03242993|Folic Acid|folic acid|mesh-list
154619012|NCT03242993|Hematinics|hematinics|mesh-ancestor
154619013|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
154619014|NCT03242993|Vitamins|vitamins|mesh-ancestor
154619015|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
154619016|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619017|NCT04487093|Vaccines|vaccines|mesh-list
154619018|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
154619019|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619020|NCT04931433|Lidocaine|lidocaine|mesh-list
154619021|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
154619022|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
154619023|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619024|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619025|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
154619026|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619027|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154619028|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154619029|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154619030|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619031|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619032|NCT04931121|Viscosupplements|viscosupplements|mesh-list
154619033|NCT04931121|Protective Agents|protective agents|mesh-ancestor
154619034|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619035|NCT03241901|Lumefantrine|lumefantrine|mesh-list
154619036|NCT03241901|Artemether|artemether|mesh-list
154619037|NCT03241901|Primaquine|primaquine|mesh-list
154619038|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154619039|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
154619040|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154619041|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154619042|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619043|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
154619044|NCT03241199|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154619045|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154619046|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619047|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619048|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619049|NCT03241043|Tacrolimus|tacrolimus|mesh-list
154619050|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154619051|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
154619052|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619053|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154619054|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619055|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619056|NCT02453867|Tacrolimus|tacrolimus|mesh-list
154619057|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154619058|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
154619059|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619060|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154619061|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619062|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619063|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154619064|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
154619065|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
154619066|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619067|NCT03239327|Alprostadil|alprostadil|mesh-list
154619068|NCT03239327|Misoprostol|misoprostol|mesh-list
154619069|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154619070|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
154619071|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154333860|NCT01222819|Lenograstim|lenograstim|mesh-list
154619072|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619073|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154619074|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619075|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
154619076|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154619077|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
154619078|NCT03239327|Urological Agents|urological agents|mesh-ancestor
154619079|NCT04930185|Vaccines|vaccines|mesh-list
154619080|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
154619081|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619082|NCT02314559|Propofol|propofol|mesh-list
154619083|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154619084|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619085|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619086|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154619087|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
154619088|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
154619089|NCT03238703|Tamoxifen|tamoxifen|mesh-list
154619090|NCT03238703|Toremifene|toremifene|mesh-list
154619091|NCT03238703|Letrozole|letrozole|mesh-list
154619092|NCT03238703|Anastrozole|anastrozole|mesh-list
154619093|NCT03238703|Exemestane|exemestane|mesh-list
154619094|NCT03238703|Citric Acid|citric acid|mesh-list
154619095|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
154619097|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154619098|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
154619099|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
154619100|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619101|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619102|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154619103|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154619104|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619105|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154619106|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
154619107|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619108|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619109|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619110|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154619111|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154619112|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154619113|NCT03238625|Lidocaine|lidocaine|mesh-list
154619114|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
154619115|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
154619116|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619117|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619118|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
154619119|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619120|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154619121|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154619122|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154619123|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619124|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619125|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
154619126|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154619127|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
154619128|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619129|NCT05387681|Endostatins|endostatins|mesh-list
154619130|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619131|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154619132|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154619133|NCT05387681|Growth Substances|growth substances|mesh-ancestor
154619134|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619135|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
154619136|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154619137|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619138|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
154619139|NCT03238157|Hormones|hormones|mesh-ancestor
154619140|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619141|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619142|NCT04485845|Metformin|metformin|mesh-list
154619143|NCT04485845|Vildagliptin|vildagliptin|mesh-list
154619144|NCT04485845|Captopril|captopril|mesh-list
154619145|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154619146|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619147|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154619148|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
154619149|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619150|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619151|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154619152|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154619153|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154619154|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154619155|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154619156|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619157|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619158|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
154619159|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619160|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619161|NCT03237533|Promethazine|promethazine|mesh-list
154619162|NCT03237533|Doxycycline|doxycycline|mesh-list
154619163|NCT03237533|Nystatin|nystatin|mesh-list
154619164|NCT03237533|Dexamethasone|dexamethasone|mesh-list
154619165|NCT03237533|Triamcinolone|triamcinolone|mesh-list
154619166|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619167|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
154619168|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
154619169|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619170|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619171|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619172|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
154619173|NCT03237533|Hormones|hormones|mesh-ancestor
154619174|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619175|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619176|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619177|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619178|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154619179|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619180|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
154619181|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154619182|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154619183|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
154619184|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
154619185|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154619186|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
154619187|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
154619188|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619189|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154619190|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
154619191|NCT03237533|Ionophores|ionophores|mesh-ancestor
154619192|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619193|NCT03235973|Fludarabine|fludarabine|mesh-list
154619194|NCT03235973|Busulfan|busulfan|mesh-list
154619195|NCT03235973|Cladribine|cladribine|mesh-list
154619196|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619197|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619198|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154619199|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
154619200|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619201|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
154619202|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154619203|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154619204|NCT02453087|Rituximab|rituximab|mesh-list
154619205|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
154619206|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619207|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619208|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
154619209|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619210|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154619211|NCT02124772|Trametinib|trametinib|mesh-list
154619212|NCT02124772|Dabrafenib|dabrafenib|mesh-list
154619213|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619214|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154619215|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619216|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619217|NCT02159482|Interferons|interferons|mesh-list
154619218|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
154619219|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
154619220|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619221|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
154619222|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619223|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
154619224|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619225|NCT05269030|Ivermectin|ivermectin|mesh-list
154619226|NCT05269030|Budesonide|budesonide|mesh-list
154619227|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619228|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154619229|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
154619230|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619231|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619232|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154619233|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
154619234|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
154619235|NCT05269030|Hormones|hormones|mesh-ancestor
154619236|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619237|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154619238|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619239|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
154619240|NCT02622321|Coagulants|coagulants|mesh-ancestor
154231966|NCT01257958|Vitamins|vitamins|mesh-ancestor
154619241|NCT02187172|Ustekinumab|ustekinumab|mesh-list
154619242|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154619243|NCT03057015|Dexamethasone|dexamethasone|mesh-list
154619244|NCT03057015|Clonidine|clonidine|mesh-list
154619245|NCT03057015|Epinephrine|epinephrine|mesh-list
154619246|NCT03057015|Ropivacaine|ropivacaine|mesh-list
154619247|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619248|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
154619249|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
154619250|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619251|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619252|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619253|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
154619254|NCT03057015|Hormones|hormones|mesh-ancestor
154619255|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619256|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619257|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619258|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
154619259|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
154619260|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619261|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
154619262|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154619263|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154619264|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
154619265|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619266|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619267|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154619268|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154619269|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154619270|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
154619271|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
154619272|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
154619273|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154619274|NCT03057015|Analgesics|analgesics|mesh-ancestor
154619275|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154619276|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
154619277|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154619278|NCT03057483|Vaccines|vaccines|mesh-list
154619279|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
154619280|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619281|NCT04922151|Ranibizumab|ranibizumab|mesh-list
154619282|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154619283|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154619284|NCT04922151|Growth Substances|growth substances|mesh-ancestor
154619285|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619286|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
154619287|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619288|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
154619289|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
154619290|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154619291|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
154619292|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619293|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154619294|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154619295|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
154619296|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154619297|NCT04920747|Taxane|taxane|mesh-list
154619298|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619299|NCT04927299|Losartan|losartan|mesh-list
154619300|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154619301|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
154619302|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154619303|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154619304|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154619305|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154619306|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619307|NCT04927299|Diuretics|diuretics|mesh-ancestor
154619308|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
154619309|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619310|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154619311|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619312|NCT03056625|Vitamin A|vitamin a|mesh-list
154619313|NCT03056625|Vitamins|vitamins|mesh-ancestor
154619314|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
154619315|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619316|NCT04913103|Rituximab|rituximab|mesh-list
154619317|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154619318|NCT04913103|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154619319|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619320|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619321|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
154619322|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619323|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154619324|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154619325|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
154619326|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619327|NCT04913103|Immunoconjugates|immunoconjugates|mesh-ancestor
154619328|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
154619329|NCT04920669|Bupivacaine|bupivacaine|mesh-list
154619330|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
154619331|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
154619332|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619333|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619334|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
154619335|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619336|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154619337|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154619338|NCT04920669|Analgesics|analgesics|mesh-ancestor
154619339|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154619340|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154619341|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154619342|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
154619343|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619344|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619345|NCT04926753|Fluorouracil|fluorouracil|mesh-list
154619346|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619347|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
154619348|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619349|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154619350|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154619351|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
154619352|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619353|NCT02621931|Calcitonin|calcitonin|mesh-list
154619354|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154619355|NCT02621931|Katacalcin|katacalcin|mesh-list
154619356|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154619357|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619358|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154619359|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
154619360|NCT04912167|Valsartan|valsartan|mesh-list
154619361|NCT04912167|Enalapril|enalapril|mesh-list
154619362|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154619363|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154619364|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154619365|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154619366|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619367|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154619368|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
154619369|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619370|NCT03056703|Aspirin|aspirin|mesh-list
154619371|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154619372|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154619373|NCT03056703|Analgesics|analgesics|mesh-ancestor
154619374|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
154619375|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619376|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619377|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619378|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154619379|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154619380|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154619381|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619382|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154619383|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154619384|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619385|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
154619386|NCT02158936|Azacitidine|azacitidine|mesh-list
154619387|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154619388|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
154619389|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619390|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619391|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619392|NCT04924647|Dexamethasone|dexamethasone|mesh-list
154619393|NCT04924647|Lenalidomide|lenalidomide|mesh-list
154619394|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619395|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
154619396|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
154619397|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619398|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619399|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619400|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
154619401|NCT04924647|Hormones|hormones|mesh-ancestor
154334198|NCT06022146|Leprostatic Agents|leprostatic agents|mesh-ancestor
154619402|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619403|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619404|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619405|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
154619406|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154619407|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154619408|NCT04924647|Growth Substances|growth substances|mesh-ancestor
154619409|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
154619410|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
154619411|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154619412|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
154619413|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619414|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619415|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154619416|NCT04912011|Diuretics|diuretics|mesh-ancestor
154619417|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
154619418|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
154619419|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154619420|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
154619421|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619422|NCT04918719|Expectorants|expectorants|mesh-ancestor
154619423|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
154619424|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154619425|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
154619426|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619427|NCT04918719|Protective Agents|protective agents|mesh-ancestor
154619428|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619429|NCT04918719|Antidotes|antidotes|mesh-ancestor
154619430|NCT03056391|Acetaminophen|acetaminophen|mesh-list
154619431|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154619432|NCT03056391|Analgesics|analgesics|mesh-ancestor
154619433|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
154619434|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619435|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619436|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
154619437|NCT04924413|Tislelizumab|tislelizumab|mesh-list
154619438|NCT04924413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619439|NCT04924413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619440|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
154619441|NCT04918563|Acetylcholine|acetylcholine|mesh-list
154619442|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
154619443|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154619444|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
154619445|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619446|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619447|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619448|NCT02123446|Cephalexin|cephalexin|mesh-list
154619449|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154619450|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619451|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
154619452|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154619453|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154619454|NCT04918953|Prednisolone|prednisolone|mesh-list
154619455|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
154619456|NCT04918953|Budesonide|budesonide|mesh-list
154619457|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154619458|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
154619459|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619460|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
154619461|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
154334236|NCT05930561|Aflibercept|aflibercept|mesh-list
154619462|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619463|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619464|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619465|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
154619466|NCT04918953|Hormones|hormones|mesh-ancestor
154619467|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619468|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154619469|NCT04918953|Protective Agents|protective agents|mesh-ancestor
154619470|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619471|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232205|NCT01260610|Tenofovir|tenofovir|mesh-list
154619472|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154619473|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154619474|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
154619476|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154619477|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619478|NCT03054207|Clopidogrel|clopidogrel|mesh-list
154619479|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154619480|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154619481|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154619482|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154619483|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154619484|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
154619485|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619486|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619487|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619488|NCT02185534|Clopidogrel|clopidogrel|mesh-list
154619489|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154619490|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154619491|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154619492|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154619493|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
154619494|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619495|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334296|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154619496|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619497|NCT03056079|Aflibercept|aflibercept|mesh-list
154619498|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154619499|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154619500|NCT03056079|Growth Substances|growth substances|mesh-ancestor
154619501|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619502|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
154619503|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619504|NCT02157376|Esomeprazole|esomeprazole|mesh-list
154619505|NCT02157376|Cimetidine|cimetidine|mesh-list
154619506|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154619507|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619508|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154619509|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619510|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619511|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154619512|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
154619513|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
154619514|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619515|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619516|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154619517|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154619518|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154619519|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619520|NCT04922541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619521|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619522|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
154619523|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154619524|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619525|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154619526|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619527|NCT03054285|Levetiracetam|levetiracetam|mesh-list
154619528|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
154619529|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
154619530|NCT04917627|Vancomycin|vancomycin|mesh-list
154619531|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154619532|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619533|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
154619534|NCT04903743|Bupivacaine|bupivacaine|mesh-list
154619535|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
154619536|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
154619537|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619538|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619539|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
154619540|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619541|NCT04903743|Analgesics|analgesics|mesh-ancestor
154619542|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154619543|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
154232275|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
154619544|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154619545|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619546|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619547|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154619548|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
154619549|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154619550|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
154619551|NCT04903275|Fluorides|fluorides|mesh-list
154619552|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
154619553|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
154619554|NCT04903275|Protective Agents|protective agents|mesh-ancestor
154619555|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619556|NCT02121262|Dexamethasone|dexamethasone|mesh-list
154619557|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619558|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
154619559|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
154619560|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619561|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619562|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619563|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
154619564|NCT02121262|Hormones|hormones|mesh-ancestor
154619565|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619566|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619567|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619568|NCT03053739|Bosentan|bosentan|mesh-list
154619569|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
154619570|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
154619571|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154619572|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154619573|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619574|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619575|NCT03053739|Urological Agents|urological agents|mesh-ancestor
154619576|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154619577|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154619578|NCT04916925|Vitamin D|vitamin d|mesh-list
154619579|NCT04916925|Vitamins|vitamins|mesh-ancestor
154619580|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
154619581|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619582|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154619583|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
154619584|NCT04902105|Valproic Acid|valproic acid|mesh-list
154619585|NCT04902105|Ecopipam|ecopipam|mesh-list
154619586|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
154619587|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619588|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619589|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
154619590|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619591|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619592|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
154619593|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154619594|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619595|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154619596|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154619597|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154619598|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
154619599|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154619600|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154619601|NCT04902105|Analgesics|analgesics|mesh-ancestor
154619602|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
154619603|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619604|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619605|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154619606|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154619607|NCT02120950|Aflibercept|aflibercept|mesh-list
154619608|NCT02120950|Verteporfin|verteporfin|mesh-list
154619609|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154619610|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154619611|NCT02120950|Growth Substances|growth substances|mesh-ancestor
154619612|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619613|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
154619614|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619615|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154619616|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
154619617|NCT02120794|Insulin|insulin|mesh-list
154619618|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154619619|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619620|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
154619621|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
154619622|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
154619623|NCT04900311|Paclitaxel|paclitaxel|mesh-list
154619624|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154619625|NCT04900311|Trastuzumab|trastuzumab|mesh-list
154619626|NCT04900311|Pertuzumab|pertuzumab|mesh-list
154619627|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154619628|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619629|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
154619630|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
154619631|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
154619632|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619633|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619634|NCT02155738|Acetaminophen|acetaminophen|mesh-list
154619635|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154619636|NCT02155738|Analgesics|analgesics|mesh-ancestor
154619637|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
154619638|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619639|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619640|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
154619641|NCT03053505|Vancomycin|vancomycin|mesh-list
154619642|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
154619643|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154334437|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
154619644|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619645|NCT02181790|Acitretin|acitretin|mesh-list
154619646|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
154619647|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
154619648|NCT03051945|Ketamine|ketamine|mesh-list
154619649|NCT03051945|Analgesics|analgesics|mesh-ancestor
154619650|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
154619651|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619652|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619653|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154619654|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154619655|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
154619656|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
154619657|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619658|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154619659|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154619660|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619661|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619662|NCT04899453|Rituximab|rituximab|mesh-list
154619663|NCT04899453|Methotrexate|methotrexate|mesh-list
154619664|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
154619665|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619666|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619667|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
154619668|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619669|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154619670|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154619671|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
154619672|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154619673|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154619674|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
154619675|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619676|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
154619677|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619678|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154619679|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154619680|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154619681|NCT04899453|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154619682|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154619683|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154619684|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154619685|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619686|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
154619687|NCT04898751|Nivolumab|nivolumab|mesh-list
154619688|NCT04898751|Ipilimumab|ipilimumab|mesh-list
154619689|NCT04898751|Atezolizumab|atezolizumab|mesh-list
154619690|NCT04898751|Durvalumab|durvalumab|mesh-list
154619691|NCT04898751|Avelumab|avelumab|mesh-list
154619692|NCT04898751|Cemiplimab|cemiplimab|mesh-list
154619693|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154232414|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
154619694|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619695|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619696|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619697|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
154619698|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154619699|NCT04898907|Mitogens|mitogens|mesh-list
154619700|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154619701|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619702|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154619703|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154619704|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619705|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619706|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619707|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154619708|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
154619709|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154619710|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619711|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154619712|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154619713|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154619714|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
154619715|NCT04908813|Capecitabine|capecitabine|mesh-list
154619716|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
154619717|NCT04908813|Trastuzumab|trastuzumab|mesh-list
154619718|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154619719|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
154619720|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619721|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619722|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619723|NCT04913571|Tislelizumab|tislelizumab|mesh-list
154619724|NCT04913571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154619725|NCT04913571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619726|NCT03051711|Pyrazole|pyrazole|mesh-list
154619727|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619728|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619729|NCT04908345|Fentanyl|fentanyl|mesh-list
154619730|NCT04908345|Methadone|methadone|mesh-list
154619731|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154619732|NCT04908345|Narcotics|narcotics|mesh-ancestor
154619733|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619734|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619735|NCT04908345|Analgesics|analgesics|mesh-ancestor
154619736|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
154619737|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619738|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154619739|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154619740|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
154619741|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
154619742|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
154619743|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
154619744|NCT04893993|Thiamine|thiamine|mesh-list
154619745|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
154619746|NCT04893993|Vitamins|vitamins|mesh-ancestor
154619747|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
154619748|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619749|NCT03051243|Insulin|insulin|mesh-list
154619750|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154619751|NCT03051243|Linagliptin|linagliptin|mesh-list
154619752|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154619753|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619754|NCT03051243|Incretins|incretins|mesh-ancestor
154619755|NCT03051243|Hormones|hormones|mesh-ancestor
154619756|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619757|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154619758|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
154619759|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619760|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619761|NCT04897737|Tenofovir|tenofovir|mesh-list
154619762|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
154619763|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619764|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154619765|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154619766|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619767|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619768|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154619769|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154619770|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
154619771|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154619772|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619773|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619775|NCT04896177|Paclitaxel|paclitaxel|mesh-list
154619776|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154619777|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619778|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154619779|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154619780|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154619781|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619782|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154619783|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619784|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154619785|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
154619786|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154619787|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
154619788|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619789|NCT03052569|Agerafenib|agerafenib|mesh-list
154619790|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154619791|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619792|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619793|NCT04906317|Midazolam|midazolam|mesh-list
154619794|NCT04906317|Dezocine|dezocine|mesh-list
154619795|NCT04906317|Propofol|propofol|mesh-list
154619796|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154619797|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619798|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619799|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154619800|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
154619801|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
154619802|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154619803|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154619804|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154619805|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154619806|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
154619807|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
154619808|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619809|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619810|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154619811|NCT04906317|Narcotics|narcotics|mesh-ancestor
154619812|NCT04906317|Analgesics|analgesics|mesh-ancestor
154619813|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
154619814|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619815|NCT03051087|Ganirelix|ganirelix|mesh-list
154619816|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
154619817|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619818|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619819|NCT04430361|Dexamethasone|dexamethasone|mesh-list
154619820|NCT04430361|Megestrol|megestrol|mesh-list
154619821|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
154619822|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619823|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
154619824|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
154619825|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619826|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619827|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619828|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
154619829|NCT04430361|Hormones|hormones|mesh-ancestor
154619830|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619831|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619832|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619833|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154619834|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154619835|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154619836|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
154619837|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154619838|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154619839|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154619840|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
154619841|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154619842|NCT04906083|Mitogens|mitogens|mesh-list
154619843|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154619844|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619845|NCT02616783|Lamivudine|lamivudine|mesh-list
154619846|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154619847|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154619848|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619849|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619850|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
154619851|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619852|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154619853|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154619854|NCT04895007|Vaccines|vaccines|mesh-list
154619855|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
154334659|NCT03073941|Cimetidine|cimetidine|mesh-list
154619856|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619857|NCT04890561|Lemborexant|lemborexant|mesh-list
154619858|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154619859|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619860|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619861|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154619862|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154619863|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619864|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619865|NCT04894617|Amantadine|amantadine|mesh-list
154619866|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154619867|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154619868|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
154619869|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154619870|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
154619871|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154619872|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619873|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619874|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154619875|NCT04894617|Analgesics|analgesics|mesh-ancestor
154619876|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
154619877|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619878|NCT04397991|Furosemide|furosemide|mesh-list
154619879|NCT04397991|Diuretics|diuretics|mesh-ancestor
154619880|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
154619881|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619882|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154619883|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619884|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619885|NCT04906161|Vitamin D|vitamin d|mesh-list
154619886|NCT04906161|Calcium|calcium|mesh-list
154619887|NCT04906161|Vitamins|vitamins|mesh-ancestor
154619888|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
154619889|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619890|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154619891|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154619892|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154619893|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
154619894|NCT03051009|Coagulants|coagulants|mesh-ancestor
154334691|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
154619895|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154619896|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
154619897|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619898|NCT04889781|Dexamethasone|dexamethasone|mesh-list
154619899|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
154619900|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619901|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
154619902|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
154619903|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619904|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619905|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619906|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
154619907|NCT04889781|Hormones|hormones|mesh-ancestor
154619908|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619909|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619910|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619911|NCT02616393|XL647|xl647|mesh-list
154619912|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619913|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154619914|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619915|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619916|NCT04905147|Mosapride|mosapride|mesh-list
154619917|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154619918|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154619919|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
154619920|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232638|NCT01074372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154619921|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619922|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619923|NCT03050229|Empagliflozin|empagliflozin|mesh-list
154619924|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154619925|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619926|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154619927|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619928|NCT04882683|Prednisone|prednisone|mesh-list
154619929|NCT04882683|Adalimumab|adalimumab|mesh-list
154619930|NCT04882683|Azathioprine|azathioprine|mesh-list
154619931|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154619932|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
154619933|NCT04882683|Hormones|hormones|mesh-ancestor
154619934|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154619935|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619936|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154619937|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619938|NCT04882683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154619939|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154619940|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
154619941|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619942|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154619943|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154619944|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
154619945|NCT02155660|Benralizumab|benralizumab|mesh-list
154619946|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154619947|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
154619948|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154619949|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154619950|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154619951|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
154619952|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619953|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154619954|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154619955|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619956|NCT04880811|Afatinib|afatinib|mesh-list
154619957|NCT04880811|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154619958|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154619959|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154619960|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619961|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619962|NCT02181634|Paclitaxel|paclitaxel|mesh-list
154619963|NCT02181634|Gemcitabine|gemcitabine|mesh-list
154619964|NCT02181634|Antimetabolites|antimetabolites|mesh-list
154619965|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154619966|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619967|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
154619968|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
154619969|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
154619970|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619971|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154619972|NCT04569045|Lidocaine|lidocaine|mesh-list
154619973|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
154619974|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
154619975|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154619976|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619977|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
154334777|NCT03525652|Vaccines|vaccines|mesh-list
154619978|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154619979|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154619980|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154619981|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154619982|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154619983|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619984|NCT04425291|Vaccines|vaccines|mesh-list
154619985|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
154619986|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619987|NCT04886193|Leucovorin|leucovorin|mesh-list
154619988|NCT04886193|Docetaxel|docetaxel|mesh-list
154619989|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
154619990|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154619991|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
154619992|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
154619993|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
154619994|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154619995|NCT04886193|Antidotes|antidotes|mesh-ancestor
154619996|NCT04886193|Protective Agents|protective agents|mesh-ancestor
154619997|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154619998|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
154619999|NCT04886193|Vitamins|vitamins|mesh-ancestor
154620000|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
154620001|NCT04337073|Propofol|propofol|mesh-list
154620002|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154620003|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620004|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620005|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154620006|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
154620007|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
154620008|NCT04885803|Vitamin D|vitamin d|mesh-list
154620009|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
154620010|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
154620011|NCT04885803|Vitamins|vitamins|mesh-list
154620012|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
154620013|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620014|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154620015|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154620016|NCT03049059|Hydroquinone|hydroquinone|mesh-list
154620017|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
154620018|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620019|NCT03049059|Protective Agents|protective agents|mesh-ancestor
154620020|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620021|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154620022|NCT04885413|Niraparib|niraparib|mesh-list
154620023|NCT04885413|Antibodies|antibodies|mesh-list
154620024|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
154620025|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620026|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154620027|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620028|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620029|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620030|NCT03049293|Midazolam|midazolam|mesh-list
154620031|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154620032|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154620033|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620034|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620035|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154620036|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154620037|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154620038|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154620039|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
154620040|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
154620041|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
154620042|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
154620043|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620044|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620045|NCT01595529|Trimethoprim|trimethoprim|mesh-list
154620046|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
154620047|NCT01595529|Cephalexin|cephalexin|mesh-list
154620048|NCT01595529|Cefixime|cefixime|mesh-list
154620049|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154620050|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620051|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
154620052|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154620053|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154620054|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154620055|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620056|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620057|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154620058|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154620059|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154620060|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154620061|NCT01595529|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154620062|NCT01595529|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154620063|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
154620064|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620065|NCT05257395|Letrozole|letrozole|mesh-list
154620066|NCT05257395|Anastrozole|anastrozole|mesh-list
154620067|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334891|NCT03671044|Docetaxel|docetaxel|mesh-list
154620068|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154620069|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154620070|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620071|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620072|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154620073|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
154620074|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620075|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620076|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154620077|NCT05256693|Vancomycin|vancomycin|mesh-list
154620078|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154620079|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620080|NCT03046953|Avelumab|avelumab|mesh-list
154620081|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620082|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620083|NCT03047109|Phenylephrine|phenylephrine|mesh-list
154620084|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
154620085|NCT03047109|Ephedrine|ephedrine|mesh-list
154620086|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154620087|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
154620088|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
154620089|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620090|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620091|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
154620092|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154620093|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
154620094|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
154620095|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154620096|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154620097|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154620098|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
154620099|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620100|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620101|NCT03047109|Protective Agents|protective agents|mesh-ancestor
154620102|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154620103|NCT03047265|Paclitaxel|paclitaxel|mesh-list
154620104|NCT03047265|Cisplatin|cisplatin|mesh-list
154620105|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154620106|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620107|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
154620108|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
154620109|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
154620110|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620111|NCT05256147|Ibuprofen|ibuprofen|mesh-list
154620112|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154620113|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154620114|NCT05256147|Analgesics|analgesics|mesh-ancestor
154620115|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
154620116|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620117|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620118|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154620119|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154620120|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154620121|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620122|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620123|NCT05214417|Ketamine|ketamine|mesh-list
154620124|NCT05214417|Analgesics|analgesics|mesh-ancestor
154620125|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
154620126|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620127|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620128|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154620129|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154620130|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
154620131|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
154620132|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620133|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154620134|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154620135|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620136|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620137|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
154620138|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620139|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620140|NCT04387461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154620141|NCT04387461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620142|NCT03046719|Bupivacaine|bupivacaine|mesh-list
154620143|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
154620144|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
154620145|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232860|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
154620146|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620147|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
154620148|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620149|NCT04876755|TEMPO|tempo|mesh-list
154620150|NCT04876755|TEMPOL-H|tempol-h|mesh-list
154620151|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
154620152|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620153|NCT04876755|Protective Agents|protective agents|mesh-ancestor
154620154|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620155|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154620156|NCT04876521|Olanzapine|olanzapine|mesh-list
154620157|NCT04876521|Amisulpride|amisulpride|mesh-list
154620158|NCT04876521|Fluoxetine|fluoxetine|mesh-list
154620159|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
154620160|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
154620161|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620162|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620163|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154620164|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154620165|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154620166|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620167|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154620168|NCT04876521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154620169|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154620170|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154620171|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620172|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620173|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
154620174|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154620175|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
154620176|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154620177|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154620178|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620179|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154620180|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
154620181|NCT02119156|Belimumab|belimumab|mesh-list
154620182|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154620183|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
154620184|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620185|NCT02181556|Aflibercept|aflibercept|mesh-list
154620186|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154620187|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154620188|NCT02181556|Growth Substances|growth substances|mesh-ancestor
154620189|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620190|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
154620191|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620192|NCT04865991|Propofol|propofol|mesh-list
154620193|NCT04865991|Sevoflurane|sevoflurane|mesh-list
154620194|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154620195|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620196|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620197|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154620198|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
154620199|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
154620200|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154620201|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154620202|NCT04865211|Bupivacaine|bupivacaine|mesh-list
154620203|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
154620204|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
154620205|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620206|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620207|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
154620208|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620209|NCT04865445|Midazolam|midazolam|mesh-list
154620210|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154620211|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154620212|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620213|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620214|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154620215|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154620216|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154620217|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154620218|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
154620219|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
154620220|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
154620221|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
154620222|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620223|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620224|NCT04875819|Vaccines|vaccines|mesh-list
154620225|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154620226|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
154620227|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620228|NCT04864977|Insulin|insulin|mesh-list
154620229|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154620230|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620231|NCT03046173|Mitogens|mitogens|mesh-list
154620232|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
154620233|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620234|NCT04869579|Selenium|selenium|mesh-list
154620235|NCT04869579|Selenious Acid|selenious acid|mesh-list
154620236|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
154620237|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620238|NCT04869579|Protective Agents|protective agents|mesh-ancestor
154620239|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620240|NCT04869579|Trace Elements|trace elements|mesh-ancestor
154620241|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
154620242|NCT06212401|Dexmedetomidine|dexmedetomidine|mesh-list
154620243|NCT06212401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154620244|NCT06212401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620245|NCT06212401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620246|NCT06212401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154620247|NCT06212401|Analgesics|analgesics|mesh-ancestor
154620248|NCT06212401|Sensory System Agents|sensory system agents|mesh-ancestor
154620249|NCT06212401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620250|NCT06212401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154620251|NCT06212401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154620252|NCT06212401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154620253|NCT06212401|Adrenergic Agents|adrenergic agents|mesh-ancestor
154620254|NCT06212401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620255|NCT06212401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620256|NCT06212336|Ribavirin|ribavirin|mesh-list
154620257|NCT06212336|Favipiravir|favipiravir|mesh-list
154620258|NCT06212336|Dexamethasone|dexamethasone|mesh-list
154620259|NCT06212336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154620260|NCT06212336|Antiemetics|antiemetics|mesh-ancestor
154620261|NCT06212336|Autonomic Agents|autonomic agents|mesh-ancestor
154620262|NCT06212336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620263|NCT06212336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620264|NCT06212336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154620265|NCT06212336|Glucocorticoids|glucocorticoids|mesh-ancestor
154620266|NCT06212336|Hormones|hormones|mesh-ancestor
154620267|NCT06212336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620268|NCT06212336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154620269|NCT06212336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620270|NCT06212336|Antimetabolites|antimetabolites|mesh-ancestor
154620271|NCT06212336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620272|NCT06212336|Antiviral Agents|antiviral agents|mesh-ancestor
154620273|NCT06212336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620274|NCT06211985|Arginine Vasopressin|arginine vasopressin|mesh-list
154620275|NCT06211985|Hemostatics|hemostatics|mesh-ancestor
154620276|NCT06211985|Coagulants|coagulants|mesh-ancestor
154620277|NCT06211985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154620278|NCT06211985|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154620279|NCT06211985|Natriuretic Agents|natriuretic agents|mesh-ancestor
154620280|NCT06211985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620281|NCT06211881|Gemcitabine|gemcitabine|mesh-list
154620282|NCT06211881|Vinorelbine|vinorelbine|mesh-list
154620283|NCT06211881|Mitoxantrone|mitoxantrone|mesh-list
154620284|NCT06211881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154620285|NCT06211881|Antimetabolites|antimetabolites|mesh-ancestor
154620286|NCT06211881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620287|NCT06211881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620288|NCT06211881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154620289|NCT06211881|Tubulin Modulators|tubulin modulators|mesh-ancestor
154620290|NCT06211881|Antimitotic Agents|antimitotic agents|mesh-ancestor
154620291|NCT06211881|Mitosis Modulators|mitosis modulators|mesh-ancestor
154620292|NCT06211881|Analgesics|analgesics|mesh-ancestor
154620293|NCT06211881|Sensory System Agents|sensory system agents|mesh-ancestor
154620294|NCT06211881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620295|NCT06211881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620296|NCT06211881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154620297|NCT06211881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154620298|NCT06211881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620299|NCT06211790|Everolimus|everolimus|mesh-list
154620300|NCT06211790|Tislelizumab|tislelizumab|mesh-list
154620301|NCT06211790|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154620302|NCT06211790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154620303|NCT06211790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620304|NCT06211790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620305|NCT06211790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154620306|NCT06211790|Immunologic Factors|immunologic factors|mesh-ancestor
154620307|NCT06211790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620308|NCT06211790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620309|NCT06211790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620310|NCT06211712|Kallikreins|kallikreins|mesh-list
154620311|NCT06211712|Coagulants|coagulants|mesh-ancestor
154620312|NCT06211712|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154620313|NCT06211712|Fertility Agents|fertility agents|mesh-ancestor
154620314|NCT06211712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154620315|NCT06211712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620316|NCT06211478|Vitamin E|vitamin e|mesh-list
154620317|NCT06211478|Vitamins|vitamins|mesh-ancestor
154620318|NCT06211478|Micronutrients|micronutrients|mesh-ancestor
154620319|NCT06211478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620320|NCT06211478|Antioxidants|antioxidants|mesh-ancestor
154620321|NCT06211478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620322|NCT06211478|Protective Agents|protective agents|mesh-ancestor
154620323|NCT06211335|Pembrolizumab|pembrolizumab|mesh-list
154620324|NCT06211335|Losartan|losartan|mesh-list
154620325|NCT06211335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620326|NCT06211335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620327|NCT06211335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154620328|NCT06211335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620329|NCT06211335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154620330|NCT06211335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154620331|NCT06211335|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154620332|NCT06211335|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154620333|NCT06211114|Axitinib|axitinib|mesh-list
154620334|NCT06211114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620335|NCT06211114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154620336|NCT06211114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620337|NCT06211114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620338|NCT06211088|Famotidine|famotidine|mesh-list
154620339|NCT06211088|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154620340|NCT06211088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154620341|NCT06211088|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154620342|NCT06211088|Histamine Antagonists|histamine antagonists|mesh-ancestor
154620343|NCT06211088|Histamine Agents|histamine agents|mesh-ancestor
154620344|NCT06211088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620345|NCT06211088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620346|NCT06211088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620347|NCT06211036|Durvalumab|durvalumab|mesh-list
154620348|NCT06211036|AMG 757|amg 757|mesh-list
154620349|NCT06211036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620350|NCT06211036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620351|NCT06211023|Carboplatin|carboplatin|mesh-list
154620352|NCT06211023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620353|NCT06210984|Caffeine|caffeine|mesh-list
154620354|NCT06210984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154620355|NCT06210984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620356|NCT06210984|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154620357|NCT06210984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620358|NCT06210984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620359|NCT06210984|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154620360|NCT06210984|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154620361|NCT06210984|Purinergic Agents|purinergic agents|mesh-ancestor
154620362|NCT06210984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620363|NCT06210971|Capecitabine|capecitabine|mesh-list
154620364|NCT06210971|Irinotecan|irinotecan|mesh-list
154620365|NCT06210971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154620366|NCT06210971|Antimetabolites|antimetabolites|mesh-ancestor
154620367|NCT06210971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620368|NCT06210971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620369|NCT06210971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154620370|NCT06210971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154620371|NCT06210971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620372|NCT06210945|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
154233166|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154620373|NCT06210945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620374|NCT06210750|Cytarabine|cytarabine|mesh-list
154620375|NCT06210750|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
154620376|NCT06210750|Dexamethasone|dexamethasone|mesh-list
154620377|NCT06210750|Dexamethasone acetate|dexamethasone acetate|mesh-list
154620378|NCT06210750|Cyclophosphamide|cyclophosphamide|mesh-list
154620379|NCT06210750|Doxorubicin|doxorubicin|mesh-list
154620380|NCT06210750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154620381|NCT06210750|Methotrexate|methotrexate|mesh-list
154620382|NCT06210750|Vincristine|vincristine|mesh-list
154620383|NCT06210750|Daunorubicin|daunorubicin|mesh-list
154620384|NCT06210750|Venetoclax|venetoclax|mesh-list
154620385|NCT06210750|Asparaginase|asparaginase|mesh-list
154620386|NCT06210750|Mercaptopurine|mercaptopurine|mesh-list
154620387|NCT06210750|Pegaspargase|pegaspargase|mesh-list
154620388|NCT06210750|Thioguanine|thioguanine|mesh-list
154620389|NCT06210750|Navitoclax|navitoclax|mesh-list
154620390|NCT06210750|BB 1101|bb 1101|mesh-list
154620391|NCT06210750|2-Aminopurine|2-aminopurine|mesh-list
154620392|NCT06210750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154620393|NCT06210750|Immunologic Factors|immunologic factors|mesh-ancestor
154620394|NCT06210750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620395|NCT06210750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154620396|NCT06210750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154620397|NCT06210750|Alkylating Agents|alkylating agents|mesh-ancestor
154620398|NCT06210750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620399|NCT06210750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620400|NCT06210750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154620401|NCT06210750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154620402|NCT06210750|Antiemetics|antiemetics|mesh-ancestor
154620403|NCT06210750|Autonomic Agents|autonomic agents|mesh-ancestor
154335206|NCT04933058|Fentanyl|fentanyl|mesh-list
154620404|NCT06210750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620405|NCT06210750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154620406|NCT06210750|Glucocorticoids|glucocorticoids|mesh-ancestor
154620407|NCT06210750|Hormones|hormones|mesh-ancestor
154620408|NCT06210750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620409|NCT06210750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154620410|NCT06210750|Protease Inhibitors|protease inhibitors|mesh-ancestor
154620411|NCT06210750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620412|NCT06210750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154620413|NCT06210750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154620414|NCT06210750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154620415|NCT06210750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154620416|NCT06210750|Abortifacient Agents|abortifacient agents|mesh-ancestor
154620417|NCT06210750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154620418|NCT06210750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154620419|NCT06210750|Antimetabolites|antimetabolites|mesh-ancestor
154620420|NCT06210750|Dermatologic Agents|dermatologic agents|mesh-ancestor
154620421|NCT06210750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154620422|NCT06210750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154620423|NCT06210750|Antiviral Agents|antiviral agents|mesh-ancestor
154620424|NCT06210750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620425|NCT06210750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154620426|NCT06210750|Tubulin Modulators|tubulin modulators|mesh-ancestor
154620427|NCT06210750|Antimitotic Agents|antimitotic agents|mesh-ancestor
154620428|NCT06210750|Mitosis Modulators|mitosis modulators|mesh-ancestor
154620429|NCT06210724|Chrysarobin|chrysarobin|mesh-list
154620430|NCT06210724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154620431|NCT06210724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154620432|NCT06210724|Analgesics|analgesics|mesh-ancestor
154620433|NCT06210724|Sensory System Agents|sensory system agents|mesh-ancestor
154620434|NCT06210724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620435|NCT06210724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620436|NCT06210724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154620437|NCT06210724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154620438|NCT06210646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154620439|NCT06210646|Nootropic Agents|nootropic agents|mesh-ancestor
154620440|NCT06210542|Ceftazidime|ceftazidime|mesh-list
154620441|NCT06210542|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154620442|NCT06210542|Avibactam|avibactam|mesh-list
154620443|NCT06210542|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154620444|NCT06210542|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154620445|NCT06210542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154620446|NCT06210542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620447|NCT06210542|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154620448|NCT06210542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860318|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154335234|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620449|NCT06210542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620450|NCT06210490|Disitamab vedotin|disitamab vedotin|mesh-list
154620451|NCT06210490|Immunoconjugates|immunoconjugates|mesh-ancestor
154620452|NCT06210490|Immunologic Factors|immunologic factors|mesh-ancestor
154620453|NCT06210490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620454|NCT06210477|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154620455|NCT06210477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154620456|NCT06210477|Cholinergic Agents|cholinergic agents|mesh-ancestor
154620457|NCT06210477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620458|NCT06210477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620459|NCT06210477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620460|NCT06210438|Bevacizumab|bevacizumab|mesh-list
154620461|NCT06210438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620462|NCT06210438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620463|NCT06210438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154620464|NCT06210438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154620465|NCT06210438|Growth Substances|growth substances|mesh-ancestor
154620466|NCT06210438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620467|NCT06210438|Growth Inhibitors|growth inhibitors|mesh-ancestor
154620468|NCT06210373|Pantothenic Acid|pantothenic acid|mesh-list
154620469|NCT06210373|Vitamin B Complex|vitamin b complex|mesh-ancestor
154620470|NCT06210373|Vitamins|vitamins|mesh-ancestor
154620471|NCT06210373|Micronutrients|micronutrients|mesh-ancestor
154620472|NCT06210373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620473|NCT06210360|Leucovorin|leucovorin|mesh-list
154620474|NCT06210360|Fluorouracil|fluorouracil|mesh-list
154620475|NCT06210360|Oxaliplatin|oxaliplatin|mesh-list
154620476|NCT06210360|Irinotecan|irinotecan|mesh-list
154620477|NCT06210360|Antimetabolites|antimetabolites|mesh-ancestor
154620478|NCT06210360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620479|NCT06210360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154620480|NCT06210360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620481|NCT06210360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154620482|NCT06210360|Immunologic Factors|immunologic factors|mesh-ancestor
154620483|NCT06210360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620484|NCT06210360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154620485|NCT06210360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154620486|NCT06210360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620487|NCT06210360|Antidotes|antidotes|mesh-ancestor
154620488|NCT06210360|Protective Agents|protective agents|mesh-ancestor
154620489|NCT06210360|Vitamin B Complex|vitamin b complex|mesh-ancestor
154620490|NCT06210360|Vitamins|vitamins|mesh-ancestor
154620491|NCT06210360|Micronutrients|micronutrients|mesh-ancestor
154620492|NCT06210321|Escitalopram|escitalopram|mesh-list
154620493|NCT06210321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154620494|NCT06210321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154620495|NCT06210321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154620496|NCT06210321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620497|NCT06210321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620498|NCT06210321|Serotonin Agents|serotonin agents|mesh-ancestor
154620499|NCT06210321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620500|NCT06210269|Moxifloxacin|moxifloxacin|mesh-list
154620501|NCT06210269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154620502|NCT06210269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620503|NCT06210269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154620504|NCT06210269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154620505|NCT06210269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620506|NCT06210269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620507|NCT06210269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620508|NCT06210217|Dobutamine|dobutamine|mesh-list
154620509|NCT06210217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154620510|NCT06210217|Sympathomimetics|sympathomimetics|mesh-ancestor
154620511|NCT06210217|Autonomic Agents|autonomic agents|mesh-ancestor
154620512|NCT06210217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620513|NCT06210217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620514|NCT06210217|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154620515|NCT06210217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154620516|NCT06210217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154620517|NCT06210217|Adrenergic Agents|adrenergic agents|mesh-ancestor
154620518|NCT06210217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620519|NCT06210217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620520|NCT06210217|Protective Agents|protective agents|mesh-ancestor
154620521|NCT06210165|Atropine|atropine|mesh-list
154620522|NCT06210165|Neostigmine|neostigmine|mesh-list
154620523|NCT06210165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154620524|NCT06210165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154233315|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154620525|NCT06210165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154620526|NCT06210165|Autonomic Agents|autonomic agents|mesh-ancestor
154620527|NCT06210165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620528|NCT06210165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620529|NCT06210165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154620530|NCT06210165|Respiratory System Agents|respiratory system agents|mesh-ancestor
154620531|NCT06210165|Mydriatics|mydriatics|mesh-ancestor
154620532|NCT06210165|Parasympatholytics|parasympatholytics|mesh-ancestor
154620533|NCT06210165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154620534|NCT06210165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154620535|NCT06210165|Cholinergic Agents|cholinergic agents|mesh-ancestor
154620536|NCT06210165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620537|NCT06210165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620538|NCT06210165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154620539|NCT06210165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620540|NCT06210165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154620541|NCT06210061|Fentanyl|fentanyl|mesh-list
154620542|NCT06210061|Dexmedetomidine|dexmedetomidine|mesh-list
154620543|NCT06210061|Propofol|propofol|mesh-list
154620544|NCT06210061|Sevoflurane|sevoflurane|mesh-list
154620545|NCT06210061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154620546|NCT06210061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620547|NCT06210061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620548|NCT06210061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154620549|NCT06210061|Analgesics|analgesics|mesh-ancestor
154620550|NCT06210061|Sensory System Agents|sensory system agents|mesh-ancestor
154620551|NCT06210061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620552|NCT06210061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154620553|NCT06210061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154620554|NCT06210061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154620555|NCT06210061|Adrenergic Agents|adrenergic agents|mesh-ancestor
154620556|NCT06210061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620557|NCT06210061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620558|NCT06210061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154620559|NCT06210061|Anesthetics, General|anesthetics, general|mesh-ancestor
154620560|NCT06210061|Anesthetics|anesthetics|mesh-ancestor
154620561|NCT06210061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154620562|NCT06210061|Narcotics|narcotics|mesh-ancestor
154620563|NCT06210061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154620564|NCT06210061|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154620565|NCT06210061|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154620566|NCT06207058|Baloxavir|baloxavir|mesh-list
154620567|NCT06207058|Antiviral Agents|antiviral agents|mesh-ancestor
154620568|NCT06207058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620569|NCT06207058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620570|NCT06207058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620571|NCT06206044|Fentanyl|fentanyl|mesh-list
154620572|NCT06206044|Morphine|morphine|mesh-list
154620573|NCT06206044|Bupivacaine|bupivacaine|mesh-list
154620574|NCT06206044|Anesthetics, Local|anesthetics, local|mesh-ancestor
154620575|NCT06206044|Anesthetics|anesthetics|mesh-ancestor
154620576|NCT06206044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620577|NCT06206044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620578|NCT06206044|Sensory System Agents|sensory system agents|mesh-ancestor
154620579|NCT06206044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620580|NCT06206044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154620581|NCT06206044|Narcotics|narcotics|mesh-ancestor
154620582|NCT06206044|Analgesics|analgesics|mesh-ancestor
154620583|NCT06206044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154620584|NCT06206044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154620585|NCT06206044|Anesthetics, General|anesthetics, general|mesh-ancestor
154620586|NCT06205290|Cyclophosphamide|cyclophosphamide|mesh-list
154620587|NCT06205290|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154620588|NCT06205290|Rituximab|rituximab|mesh-list
154620589|NCT06205290|Fludarabine|fludarabine|mesh-list
154620590|NCT06205290|Idelalisib|idelalisib|mesh-list
154620591|NCT06205290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154620592|NCT06205290|Immunologic Factors|immunologic factors|mesh-ancestor
154620593|NCT06205290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620594|NCT06205290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154620595|NCT06205290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154620596|NCT06205290|Alkylating Agents|alkylating agents|mesh-ancestor
154620597|NCT06205290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620598|NCT06205290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620599|NCT06205290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154620600|NCT06205290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620601|NCT06205290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620602|NCT06201819|Liraglutide|liraglutide|mesh-list
154620603|NCT06201819|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154620604|NCT06201819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154620605|NCT06201819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620606|NCT06201819|Incretins|incretins|mesh-ancestor
154620607|NCT06201819|Hormones|hormones|mesh-ancestor
154620608|NCT06201819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620609|NCT06198894|Glucocorticoids|glucocorticoids|mesh-list
154620610|NCT06198894|Hormones|hormones|mesh-ancestor
154620611|NCT06198894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620612|NCT06198894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620613|NCT06197282|Anesthetics|anesthetics|mesh-list
154620614|NCT06197282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620615|NCT06197282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620616|NCT06192680|Bevacizumab|bevacizumab|mesh-list
154620617|NCT06192680|Capecitabine|capecitabine|mesh-list
154620618|NCT06192680|Irinotecan|irinotecan|mesh-list
154620619|NCT06192680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620620|NCT06192680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620621|NCT06192680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154620622|NCT06192680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154620623|NCT06192680|Growth Substances|growth substances|mesh-ancestor
154620624|NCT06192680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620625|NCT06192680|Growth Inhibitors|growth inhibitors|mesh-ancestor
154620626|NCT06192680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154620627|NCT06192680|Antimetabolites|antimetabolites|mesh-ancestor
154620628|NCT06192680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620629|NCT06192680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154620630|NCT06192680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154620631|NCT06192680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620632|NCT06192589|Morphine|morphine|mesh-list
154620633|NCT06192589|Cannabidiol|cannabidiol|mesh-list
154620634|NCT06192589|Citalopram|citalopram|mesh-list
154620635|NCT06192589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154620636|NCT06192589|Narcotics|narcotics|mesh-ancestor
154620637|NCT06192589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620638|NCT06192589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620639|NCT06192589|Analgesics|analgesics|mesh-ancestor
154620640|NCT06192589|Sensory System Agents|sensory system agents|mesh-ancestor
154620641|NCT06192589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620642|NCT06192589|Anticonvulsants|anticonvulsants|mesh-ancestor
154620643|NCT06192589|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154620644|NCT06192589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154620645|NCT06192589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154620646|NCT06192589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620647|NCT06192589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620648|NCT06192589|Serotonin Agents|serotonin agents|mesh-ancestor
154620649|NCT06192589|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154620650|NCT06192589|Antidepressive Agents|antidepressive agents|mesh-ancestor
154620651|NCT06192589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154620652|NCT06116136|Pembrolizumab|pembrolizumab|mesh-list
154620653|NCT06116136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620654|NCT06116136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620655|NCT06116136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154620656|NCT06116136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620657|NCT06112847|Lenalidomide|lenalidomide|mesh-list
154620658|NCT06112847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154620659|NCT06112847|Immunologic Factors|immunologic factors|mesh-ancestor
154620660|NCT06112847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620661|NCT06112847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154620662|NCT06112847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154620663|NCT06112847|Growth Substances|growth substances|mesh-ancestor
154620664|NCT06112847|Growth Inhibitors|growth inhibitors|mesh-ancestor
154620665|NCT06112847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620666|NCT06094179|Antibodies|antibodies|mesh-list
154620667|NCT06094179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154620668|NCT06094179|Immunologic Factors|immunologic factors|mesh-ancestor
154620669|NCT06094179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620670|NCT06083766|Hormones|hormones|mesh-list
154620671|NCT06083766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620672|NCT06083766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620673|NCT06058078|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154620674|NCT06058078|Immunologic Factors|immunologic factors|mesh-ancestor
154620675|NCT06058078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620676|NCT06055452|Empagliflozin|empagliflozin|mesh-list
154620677|NCT06055452|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154620678|NCT06055452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620679|NCT06055452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154620680|NCT06055452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620681|NCT06014489|Cobicistat|cobicistat|mesh-list
154620682|NCT06014489|Azacitidine|azacitidine|mesh-list
154620683|NCT06014489|Venetoclax|venetoclax|mesh-list
154620684|NCT06014489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154620685|NCT06014489|Antimetabolites|antimetabolites|mesh-ancestor
154620686|NCT06014489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620687|NCT06014489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620688|NCT06014489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620689|NCT06014489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154620690|NCT06014489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154620691|NCT06014489|Antiviral Agents|antiviral agents|mesh-ancestor
154620692|NCT06014489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620693|NCT06014489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154620694|NCT06014489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154620695|NCT05983367|Bevacizumab|bevacizumab|mesh-list
154620696|NCT05983367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620697|NCT05983367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620698|NCT05983367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154620699|NCT05983367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154620700|NCT05983367|Growth Substances|growth substances|mesh-ancestor
154620701|NCT05983367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620702|NCT05983367|Growth Inhibitors|growth inhibitors|mesh-ancestor
154620703|NCT05982340|Lithium Carbonate|lithium carbonate|mesh-list
154620704|NCT05982340|Antidepressive Agents|antidepressive agents|mesh-ancestor
154620705|NCT05982340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154620706|NCT05982340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620707|NCT05982340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620708|NCT05982340|Antimanic Agents|antimanic agents|mesh-ancestor
154620709|NCT05982340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154620710|NCT05982340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620711|NCT05982340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620712|NCT05958342|Vasopressins|vasopressins|mesh-list
154620713|NCT05958342|Arginine Vasopressin|arginine vasopressin|mesh-list
154620714|NCT05958342|Calcium|calcium|mesh-list
154620715|NCT05958342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154620716|NCT05958342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620717|NCT05958342|Hemostatics|hemostatics|mesh-ancestor
154620718|NCT05958342|Coagulants|coagulants|mesh-ancestor
154620719|NCT05958342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154620720|NCT05958342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154620721|NCT05958342|Natriuretic Agents|natriuretic agents|mesh-ancestor
154620722|NCT05941715|Aflibercept|aflibercept|mesh-list
154620723|NCT05941715|Faricimab|faricimab|mesh-list
154620724|NCT05941715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154620725|NCT05941715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154620726|NCT05941715|Growth Substances|growth substances|mesh-ancestor
154620727|NCT05941715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620728|NCT05941715|Growth Inhibitors|growth inhibitors|mesh-ancestor
154620729|NCT05941715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620730|NCT05910801|Lenalidomide|lenalidomide|mesh-list
154620731|NCT05910801|Venetoclax|venetoclax|mesh-list
154620732|NCT05910801|Immunoglobulins|immunoglobulins|mesh-list
154620733|NCT05910801|Immunologic Factors|immunologic factors|mesh-ancestor
154620734|NCT05910801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620735|NCT05910801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154620736|NCT05910801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154620737|NCT05910801|Growth Substances|growth substances|mesh-ancestor
154620738|NCT05910801|Growth Inhibitors|growth inhibitors|mesh-ancestor
154620739|NCT05910801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620740|NCT05898022|Furosemide|furosemide|mesh-list
154620741|NCT05898022|Diuretics|diuretics|mesh-ancestor
154620742|NCT05898022|Natriuretic Agents|natriuretic agents|mesh-ancestor
154620743|NCT05898022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620744|NCT05898022|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154620745|NCT05898022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154620746|NCT05898022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620747|NCT05893888|Cisplatin|cisplatin|mesh-list
154620748|NCT05893888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233466|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620749|NCT05884957|Nitric Oxide|nitric oxide|mesh-list
154620750|NCT05884957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154620751|NCT05884957|Autonomic Agents|autonomic agents|mesh-ancestor
154620752|NCT05884957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620753|NCT05884957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620754|NCT05884957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154335546|NCT03289351|Tazobactam|tazobactam|mesh-list
154620755|NCT05884957|Respiratory System Agents|respiratory system agents|mesh-ancestor
154620756|NCT05884957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154620757|NCT05884957|Antioxidants|antioxidants|mesh-ancestor
154620758|NCT05884957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620759|NCT05884957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620760|NCT05884957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154620761|NCT05884957|Vasodilator Agents|vasodilator agents|mesh-ancestor
154620762|NCT05884957|Gasotransmitters|gasotransmitters|mesh-ancestor
154620763|NCT05884957|Protective Agents|protective agents|mesh-ancestor
154620764|NCT05844735|Ciprofloxacin|ciprofloxacin|mesh-list
154620765|NCT05844735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154620766|NCT05844735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620767|NCT05844735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154620768|NCT05844735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154620769|NCT05844735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620770|NCT05844735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620771|NCT05844735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620772|NCT05844735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154620773|NCT05844735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154620774|NCT05844150|Etoposide|etoposide|mesh-list
154620775|NCT05844150|Atezolizumab|atezolizumab|mesh-list
154620776|NCT05844150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154620777|NCT05844150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620778|NCT05844150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154620779|NCT05844150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154620780|NCT05844150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620781|NCT05844150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620782|NCT05844150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154620783|NCT05844150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620784|NCT05838573|Metformin|metformin|mesh-list
154620785|NCT05838573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154620786|NCT05838573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620787|NCT05799079|Venetoclax|venetoclax|mesh-list
154620788|NCT05799079|Decitabine|decitabine|mesh-list
154620789|NCT05799079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620790|NCT05799079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154620791|NCT05799079|Antimetabolites|antimetabolites|mesh-ancestor
154620792|NCT05799079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620793|NCT05799079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620794|NCT05789589|Dexamethasone|dexamethasone|mesh-list
154620795|NCT05789589|Methylprednisolone|methylprednisolone|mesh-list
154620796|NCT05789589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154620797|NCT05789589|Antiemetics|antiemetics|mesh-ancestor
154620798|NCT05789589|Autonomic Agents|autonomic agents|mesh-ancestor
154620799|NCT05789589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620800|NCT05789589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620801|NCT05789589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154620802|NCT05789589|Glucocorticoids|glucocorticoids|mesh-ancestor
154620803|NCT05789589|Hormones|hormones|mesh-ancestor
154620804|NCT05789589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620805|NCT05789589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154620806|NCT05789589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620807|NCT05789589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154620808|NCT05789589|Protective Agents|protective agents|mesh-ancestor
154620809|NCT05756660|Sodium thiosulfate|sodium thiosulfate|mesh-list
154620810|NCT05756660|Cisplatin|cisplatin|mesh-list
154620811|NCT05756660|Vorinostat|vorinostat|mesh-list
154620812|NCT05756660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620813|NCT05756660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154620814|NCT05756660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620815|NCT05756660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620816|NCT05756660|Antidotes|antidotes|mesh-ancestor
154620817|NCT05756660|Protective Agents|protective agents|mesh-ancestor
154620818|NCT05756660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620819|NCT05756660|Antioxidants|antioxidants|mesh-ancestor
154620820|NCT05756660|Antitubercular Agents|antitubercular agents|mesh-ancestor
154620821|NCT05756660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154620822|NCT05756660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620823|NCT05756660|Chelating Agents|chelating agents|mesh-ancestor
154620824|NCT05756660|Sequestering Agents|sequestering agents|mesh-ancestor
154620825|NCT05752279|Plasma-lyte 148|plasma-lyte 148|mesh-list
154620826|NCT05752279|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154620827|NCT05752279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154620828|NCT05724849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154620829|NCT05724849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154620830|NCT05724849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154620831|NCT05724849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154620832|NCT05724849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620833|NCT05724849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620834|NCT05724849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620835|NCT05724849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154620836|NCT05724849|Antidepressive Agents|antidepressive agents|mesh-ancestor
154620837|NCT05724849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154620838|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154620839|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620840|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620841|NCT05653661|Paclitaxel|paclitaxel|mesh-list
154620842|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154335640|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154620843|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154620844|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620845|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
154620846|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
154620847|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
154620848|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620849|NCT05629702|Temozolomide|temozolomide|mesh-list
154620850|NCT05629702|Nabiximols|nabiximols|mesh-list
154620851|NCT05629702|Dronabinol|dronabinol|mesh-list
154620852|NCT05629702|Cannabidiol|cannabidiol|mesh-list
154620853|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154620854|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
154620855|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620856|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620857|NCT05629702|Analgesics|analgesics|mesh-ancestor
154620858|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
154620859|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620860|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620861|NCT05629702|Anticonvulsants|anticonvulsants|mesh-ancestor
154620862|NCT05629702|Hallucinogens|hallucinogens|mesh-ancestor
154620863|NCT05629702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154620864|NCT05629702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154620865|NCT05629702|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154620866|NCT05629702|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154620867|NCT05629702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620868|NCT05629702|Hormones|hormones|mesh-ancestor
154620869|NCT05629702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620870|NCT05591417|Dexamethasone|dexamethasone|mesh-list
154620871|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
154620872|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
154620873|NCT05591417|Morphine|morphine|mesh-list
154620874|NCT05591417|BB 1101|bb 1101|mesh-list
154620875|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154620876|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
154620877|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
154620878|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620879|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335682|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154620880|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154620881|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
154620882|NCT05591417|Hormones|hormones|mesh-ancestor
154620883|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154620884|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154620885|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620886|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
154620887|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620888|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620889|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154620890|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620891|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154620892|NCT05591417|Analgesics|analgesics|mesh-ancestor
154620893|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
154620894|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154620895|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154620896|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154620897|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
154620898|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620899|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154620900|NCT05591417|Narcotics|narcotics|mesh-ancestor
154620901|NCT05589402|Lidocaine|lidocaine|mesh-list
154620902|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
154620903|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
154620904|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620905|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620906|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
154620907|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620908|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154620909|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154620910|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154620911|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154620912|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620913|NCT05550207|Meloxicam|meloxicam|mesh-list
154620914|NCT05550207|Rizatriptan|rizatriptan|mesh-list
154620915|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154620916|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154620917|NCT05550207|Analgesics|analgesics|mesh-ancestor
154620918|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
154620919|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620920|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620921|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154620922|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154620923|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154620924|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154620925|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154620926|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620927|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154620928|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
154620929|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620930|NCT05506982|Psilocybin|psilocybin|mesh-list
154620931|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
154620932|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620933|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154620934|NCT05479045|Nivolumab|nivolumab|mesh-list
154620935|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620936|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620937|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154620938|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620939|NCT05463393|Xanthohumol|xanthohumol|mesh-list
154620940|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620941|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154620942|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154620943|NCT05463393|Growth Substances|growth substances|mesh-ancestor
154620944|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620945|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
154620946|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
154620947|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
154620948|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154620949|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
154620950|NCT05388929|Methocarbamol|methocarbamol|mesh-list
154620951|NCT05388929|Narcotics|narcotics|mesh-ancestor
154620952|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620953|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620954|NCT05388929|Analgesics|analgesics|mesh-ancestor
154620955|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
154620956|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620957|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154620958|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154620959|NCT05363670|Albuterol|albuterol|mesh-list
154620960|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154620961|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
154620962|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620963|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620964|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154620965|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
154620966|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
154620967|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154620968|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154620969|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154620970|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154620971|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
154620972|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620973|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620974|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
154620975|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154620976|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154620977|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620978|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154620979|NCT05361837|Analgesics|analgesics|mesh-ancestor
154620980|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
154620981|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154620982|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154620983|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154620984|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154620985|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
154620986|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154620987|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620988|NCT05313009|Sotorasib|sotorasib|mesh-list
154620989|NCT05313009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154620990|NCT05313009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154620991|NCT05313009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154620992|NCT05313009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620993|NCT05266469|Ofatumumab|ofatumumab|mesh-list
154620994|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
154620995|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154620996|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
154620997|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154620998|NCT05260957|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154620999|NCT05260957|Immunoconjugates|immunoconjugates|mesh-ancestor
154621000|NCT05260957|Immunologic Factors|immunologic factors|mesh-ancestor
154621001|NCT05260957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621002|NCT05243654|Metformin|metformin|mesh-list
154621003|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154621004|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621005|NCT05237492|Tramadol|tramadol|mesh-list
154621006|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154621007|NCT05237492|Narcotics|narcotics|mesh-ancestor
154621008|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154621009|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621010|NCT05237492|Analgesics|analgesics|mesh-ancestor
154621011|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
154621012|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621013|NCT05155033|Aldesleukin|aldesleukin|mesh-list
154621014|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
154621015|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621016|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621017|NCT05155033|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621018|NCT05155033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621019|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154621020|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154621021|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
154621022|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621023|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154621024|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621025|NCT05136677|Carboplatin|carboplatin|mesh-list
154621026|NCT05136677|Nivolumab|nivolumab|mesh-list
154621027|NCT05136677|Pemetrexed|pemetrexed|mesh-list
154621028|NCT05136677|Ipilimumab|ipilimumab|mesh-list
154621029|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621030|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621031|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621032|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621033|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621034|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154621035|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154621036|NCT05126966|Ranibizumab|ranibizumab|mesh-list
154621037|NCT05126966|Aflibercept|aflibercept|mesh-list
154621038|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154621039|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154621040|NCT05126966|Growth Substances|growth substances|mesh-ancestor
154621041|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621042|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
154621043|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621044|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
154621045|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154621046|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
154233793|NCT02526394|Vaccines|vaccines|mesh-list
154621047|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621048|NCT05123365|Expectorants|expectorants|mesh-ancestor
154621049|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
154621050|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154621052|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621053|NCT05123365|Protective Agents|protective agents|mesh-ancestor
154621054|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621055|NCT05123365|Antidotes|antidotes|mesh-ancestor
154621056|NCT05116085|Tislelizumab|tislelizumab|mesh-list
154621057|NCT05116085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621058|NCT05116085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621059|NCT05113745|Reboxetine|reboxetine|mesh-list
154621060|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
154621061|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154621062|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154621063|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154621064|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154621065|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621066|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
154621067|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621068|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621069|NCT05087992|Bevacizumab|bevacizumab|mesh-list
154621070|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621071|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621072|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154621073|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154621074|NCT05087992|Growth Substances|growth substances|mesh-ancestor
154621075|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621076|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
154621077|NCT05082025|Fulvestrant|fulvestrant|mesh-list
154621078|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154621079|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621080|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154621081|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154621082|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
154621083|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621084|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621085|NCT05058612|Midodrine|midodrine|mesh-list
154621086|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
154621087|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
154621088|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621089|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621090|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154621091|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154621092|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154621093|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154621094|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154621095|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335879|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154621096|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621097|NCT05022004|Brinzolamide|brinzolamide|mesh-list
154621098|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154621099|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621100|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621101|NCT05004259|Daratumumab|daratumumab|mesh-list
154621102|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621103|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154621104|NCT04985760|Vaccines|vaccines|mesh-list
154621105|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
154621106|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
154621107|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621108|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154621109|NCT04985760|Antacids|antacids|mesh-ancestor
154621110|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621111|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154621112|NCT04952610|Etripamil|etripamil|mesh-list
154621113|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154621114|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154621115|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621116|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154621117|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621118|NCT04947553|Levomethorphan|levomethorphan|mesh-list
154621119|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
154621120|NCT04947553|Bupropion|bupropion|mesh-list
154621121|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154621122|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
154621123|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154621124|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154621125|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154621126|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154621127|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621128|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
154621129|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621130|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621131|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154621132|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154621133|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621134|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
154621135|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
154621136|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154621137|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154621138|NCT04947553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154621139|NCT04947553|Narcotics|narcotics|mesh-ancestor
154621140|NCT04947553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154621141|NCT04947553|Analgesics|analgesics|mesh-ancestor
154621142|NCT04947553|Sensory System Agents|sensory system agents|mesh-ancestor
154621143|NCT04947553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621144|NCT04866017|Durvalumab|durvalumab|mesh-list
154621145|NCT04866017|Tislelizumab|tislelizumab|mesh-list
154621146|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621147|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621148|NCT04785326|Ustekinumab|ustekinumab|mesh-list
154621149|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
154621150|NCT04759833|Prucalopride|prucalopride|mesh-list
154621151|NCT04759833|Laxatives|laxatives|mesh-ancestor
154621152|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154621153|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154621154|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154621155|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
154621156|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621157|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621158|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621159|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154621160|NCT04747847|Atorvastatin|atorvastatin|mesh-list
154621161|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154621162|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154621163|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
154621164|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621165|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154621166|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154621167|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621168|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154621169|NCT04740931|Aflibercept|aflibercept|mesh-list
154621170|NCT04740931|Faricimab|faricimab|mesh-list
154621171|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154621172|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154621173|NCT04740931|Growth Substances|growth substances|mesh-ancestor
154621174|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621175|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
154621176|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621177|NCT04711889|Urinastatin|urinastatin|mesh-list
154621178|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154621179|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154621180|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
154621181|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621182|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621183|NCT04703101|Leucovorin|leucovorin|mesh-list
154621184|NCT04703101|Capecitabine|capecitabine|mesh-list
154621185|NCT04703101|Fluorouracil|fluorouracil|mesh-list
154621186|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
154621187|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621188|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
154621189|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621190|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621191|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621192|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
154621193|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621194|NCT04703101|Antidotes|antidotes|mesh-ancestor
154621195|NCT04703101|Protective Agents|protective agents|mesh-ancestor
154621196|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
154233916|NCT01174420|Mitomycins|mitomycins|mesh-list
154621198|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
154621199|NCT04598477|Prednisone|prednisone|mesh-list
154621200|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154621201|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
154621202|NCT04598477|Hormones|hormones|mesh-ancestor
154621203|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621204|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621205|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154621206|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621207|NCT04564157|Paclitaxel|paclitaxel|mesh-list
154621208|NCT04564157|Carboplatin|carboplatin|mesh-list
154621209|NCT04564157|Nivolumab|nivolumab|mesh-list
154621210|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621211|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621212|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621213|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621214|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621215|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621216|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621217|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621218|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
154621219|NCT04539366|Fludarabine|fludarabine|mesh-list
154621220|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
154621221|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
154621222|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621223|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621224|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154621225|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154621226|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
154621227|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621228|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621229|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154621230|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621231|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
154621232|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
154621233|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154621234|NCT04471428|Docetaxel|docetaxel|mesh-list
154621235|NCT04471428|Atezolizumab|atezolizumab|mesh-list
154621236|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621237|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621238|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621239|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621240|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621241|NCT04471428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621242|NCT04471428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621243|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
154621244|NCT04418661|Adagrasib|adagrasib|mesh-list
154621245|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621246|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621247|NCT04418661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621248|NCT04418661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621249|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
154621250|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154621251|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154621252|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
154621253|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621254|NCT04390399|Leucovorin|leucovorin|mesh-list
154621255|NCT04390399|Paclitaxel|paclitaxel|mesh-list
154621256|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
154621257|NCT04390399|Gemcitabine|gemcitabine|mesh-list
154621258|NCT04390399|Fluorouracil|fluorouracil|mesh-list
154621259|NCT04390399|Irinotecan|irinotecan|mesh-list
154621260|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621261|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621262|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621263|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621264|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621265|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621266|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621267|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
154621268|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621269|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154621270|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154621271|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
154621272|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154621273|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621274|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
154621275|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154621276|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154621277|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621278|NCT04390399|Antidotes|antidotes|mesh-ancestor
154621279|NCT04390399|Protective Agents|protective agents|mesh-ancestor
154621280|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
154621281|NCT04390399|Vitamins|vitamins|mesh-ancestor
154621282|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
154621283|NCT04364620|Docetaxel|docetaxel|mesh-list
154621284|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621285|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621286|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621287|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621288|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621289|NCT04333706|Capecitabine|capecitabine|mesh-list
154621290|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621291|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
154621292|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621293|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621294|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
154621295|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154621296|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154621297|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
154621298|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621299|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621300|NCT04323202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621301|NCT04323202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621302|NCT04262206|Atorvastatin|atorvastatin|mesh-list
154621303|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154621304|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154621305|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
154621306|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621307|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154621308|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154621309|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621310|NCT04214249|Cytarabine|cytarabine|mesh-list
154621311|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
154621312|NCT04214249|Daunorubicin|daunorubicin|mesh-list
154621313|NCT04214249|Idarubicin|idarubicin|mesh-list
154621314|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621315|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621316|NCT04214249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621317|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621318|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621319|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
154621320|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
154621321|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621322|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621323|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
154621324|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621325|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154621326|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154621327|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154621328|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621329|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154621330|NCT04163952|Panitumumab|panitumumab|mesh-list
154621331|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154621332|NCT04163952|Antibodies|antibodies|mesh-list
154621333|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
154621334|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154621335|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
154621336|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621337|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621338|NCT04143061|Vaccines|vaccines|mesh-list
154621339|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
154621340|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621341|NCT04098250|Erenumab|erenumab|mesh-list
154621342|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154621343|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621344|NCT04098250|Analgesics|analgesics|mesh-ancestor
154621345|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
154621346|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621347|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621348|NCT04097028|Trifluridine|trifluridine|mesh-list
154621350|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621351|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
154621352|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621353|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
154621354|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621355|NCT04039607|Nivolumab|nivolumab|mesh-list
154621356|NCT04039607|Ipilimumab|ipilimumab|mesh-list
154621357|NCT04039607|Sorafenib|sorafenib|mesh-list
154621358|NCT04039607|Lenvatinib|lenvatinib|mesh-list
154621359|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621360|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621361|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621362|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621363|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154621364|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621365|NCT04026412|Nivolumab|nivolumab|mesh-list
154621366|NCT04026412|Ipilimumab|ipilimumab|mesh-list
154621367|NCT04026412|Durvalumab|durvalumab|mesh-list
154621368|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621369|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621370|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621371|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621372|NCT03980561|Varenicline|varenicline|mesh-list
154621373|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154621374|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154621375|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
154621376|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621377|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621378|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621379|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
154621380|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
154621381|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621382|NCT03966807|Nicotine|nicotine|mesh-list
154621383|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154621384|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
154621385|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621386|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621387|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154621388|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154621389|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
154621390|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621391|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621392|NCT03936309|Lidocaine|lidocaine|mesh-list
154621393|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
154621394|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
154621395|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154621396|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621397|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
154621398|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621399|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154621400|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154621401|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154621402|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154621403|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621404|NCT03929029|Nivolumab|nivolumab|mesh-list
154621405|NCT03929029|Ipilimumab|ipilimumab|mesh-list
154621406|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154621407|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621408|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621409|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621410|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621411|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154621412|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
154621413|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621414|NCT03926299|Clobetasol|clobetasol|mesh-list
154621415|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154621416|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
154621417|NCT03926299|Hormones|hormones|mesh-ancestor
154336215|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154621418|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621419|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621420|NCT03917914|Bisoprolol|bisoprolol|mesh-list
154621421|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154621422|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
154621423|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
154621424|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621425|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621426|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154621427|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154621428|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154621429|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
154621430|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621431|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621432|NCT03912363|Insulin|insulin|mesh-list
154621433|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154621434|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621435|NCT03873402|Nivolumab|nivolumab|mesh-list
154621436|NCT03873402|Ipilimumab|ipilimumab|mesh-list
154621437|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621438|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621439|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621440|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621441|NCT03844620|Trifluridine|trifluridine|mesh-list
154621442|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
154621443|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621444|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
154621445|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621446|NCT03841357|Abatacept|abatacept|mesh-list
154621447|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621448|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621449|NCT03841357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621450|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621451|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621452|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
154621453|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621454|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154621455|NCT03838159|Paclitaxel|paclitaxel|mesh-list
154621456|NCT03838159|Carboplatin|carboplatin|mesh-list
154621457|NCT03838159|Nivolumab|nivolumab|mesh-list
154621458|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621459|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621460|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621461|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621462|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621463|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621464|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621465|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621466|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
154621467|NCT03835286|Vitamins|vitamins|mesh-ancestor
154621468|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
154621469|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621470|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
154621471|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621472|NCT03835286|Protective Agents|protective agents|mesh-ancestor
154621473|NCT03834363|Fentanyl|fentanyl|mesh-list
154621474|NCT03834363|Morphine|morphine|mesh-list
154621475|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154621476|NCT03834363|Narcotics|narcotics|mesh-ancestor
154621477|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154621478|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621479|NCT03834363|Analgesics|analgesics|mesh-ancestor
154621480|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
154621481|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621482|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154621483|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154621484|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
154621485|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
154621486|NCT03802799|Cannabidiol|cannabidiol|mesh-list
154621487|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
154621488|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154621489|NCT03740737|Hormones|hormones|mesh-ancestor
154621490|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621491|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621492|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154621493|NCT03738618|Hormones|hormones|mesh-ancestor
154621494|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621495|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621496|NCT03737643|Paclitaxel|paclitaxel|mesh-list
154621497|NCT03737643|Bevacizumab|bevacizumab|mesh-list
154621498|NCT03737643|Carboplatin|carboplatin|mesh-list
154621499|NCT03737643|Durvalumab|durvalumab|mesh-list
154621500|NCT03737643|Olaparib|olaparib|mesh-list
154621501|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154621502|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621503|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621504|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621505|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621506|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621507|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621508|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621509|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154621510|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154621511|NCT03737643|Growth Substances|growth substances|mesh-ancestor
154621512|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621513|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
154621514|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
154621515|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154621516|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621517|NCT03717415|Carboplatin|carboplatin|mesh-list
154621518|NCT03717415|Rebastinib|rebastinib|mesh-list
154621519|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621520|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154621521|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621522|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621523|NCT03708822|Docetaxel|docetaxel|mesh-list
154621524|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
154621525|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621526|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621527|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621528|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621529|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621530|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621531|NCT03694249|Ifetroban|ifetroban|mesh-list
154621532|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154621533|NCT03677154|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154621534|NCT03677154|Immunoconjugates|immunoconjugates|mesh-ancestor
154621535|NCT03677154|Immunologic Factors|immunologic factors|mesh-ancestor
154621536|NCT03677154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621537|NCT03581292|Temozolomide|temozolomide|mesh-list
154621538|NCT03581292|Veliparib|veliparib|mesh-list
154621539|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154621540|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
154621541|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621542|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621543|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154621544|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621545|NCT03535506|Palbociclib|palbociclib|mesh-list
154621546|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621547|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154621548|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621549|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621550|NCT03533283|Atezolizumab|atezolizumab|mesh-list
154621551|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
154621552|NCT03533283|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154621553|NCT03533283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621554|NCT03533283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621555|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621556|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621557|NCT03533283|Immunoconjugates|immunoconjugates|mesh-ancestor
154621558|NCT03533283|Immunologic Factors|immunologic factors|mesh-ancestor
154621559|NCT03533283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621560|NCT03491059|Nicotine|nicotine|mesh-list
154621561|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154621562|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
154621563|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621564|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621565|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154621566|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154621567|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
154621568|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621569|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621570|NCT03484923|Spartalizumab|spartalizumab|mesh-list
154621571|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621572|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234293|NCT03859102|Gabapentin|gabapentin|mesh-list
154621573|NCT03484923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621574|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621575|NCT03479502|Doxycycline|doxycycline|mesh-list
154621576|NCT03479502|Prednisone|prednisone|mesh-list
154621577|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
154621578|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154621579|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154621580|NCT03479502|Prednisolone|prednisolone|mesh-list
154621581|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
154621582|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154621583|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
154621584|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154621585|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
154621586|NCT03479502|Hormones|hormones|mesh-ancestor
154621587|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621588|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621589|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154621590|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621591|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
154621592|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
154621593|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621594|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154621595|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154621596|NCT03479502|Protective Agents|protective agents|mesh-ancestor
154621597|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154621598|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621599|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
154621600|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154621601|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154621602|NCT03471364|Ketoconazole|ketoconazole|mesh-list
154621603|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
154621604|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621605|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154621606|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154621607|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621608|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621609|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154621610|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
154621611|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621612|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621613|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154621614|NCT03433469|Osimertinib|osimertinib|mesh-list
154621615|NCT03433469|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154621616|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154621617|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621618|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621619|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621620|NCT03427736|Ketorolac|ketorolac|mesh-list
154621621|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154621622|NCT03427736|Ketamine|ketamine|mesh-list
154621623|NCT03427736|Morphine|morphine|mesh-list
154621624|NCT03427736|Oxycodone|oxycodone|mesh-list
154621625|NCT03427736|Hydromorphone|hydromorphone|mesh-list
154621626|NCT03427736|Analgesics|analgesics|mesh-ancestor
154621627|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
154621628|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621629|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621630|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154621631|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154621632|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
154621633|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
154621634|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154621635|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154621636|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154621637|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336430|NCT06142474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154621638|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621639|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154621640|NCT03427736|Narcotics|narcotics|mesh-ancestor
154621641|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154621642|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154621643|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154621644|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154621645|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154621646|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621647|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154621648|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154621649|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621650|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
154621651|NCT03367572|Dexamethasone|dexamethasone|mesh-list
154621652|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
154621653|NCT03367572|Olanzapine|olanzapine|mesh-list
154621654|NCT03367572|Palonosetron|palonosetron|mesh-list
154621655|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
154621656|NCT03367572|Ichthammol|ichthammol|mesh-list
154621657|NCT03367572|BB 1101|bb 1101|mesh-list
154621658|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154621659|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
154621660|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
154621661|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621662|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621663|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154621664|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
154621665|NCT03367572|Hormones|hormones|mesh-ancestor
154621666|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621667|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154621668|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621669|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154621670|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154621671|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154621672|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154621673|NCT03367572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154621674|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154621675|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154621676|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621677|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621678|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
154621679|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
154621680|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621681|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154621682|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154621683|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
154336477|NCT06141226|Docetaxel|docetaxel|mesh-list
154621684|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154621685|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
154621686|NCT03323151|Ixazomib|ixazomib|mesh-list
154621687|NCT03323151|Ibrutinib|ibrutinib|mesh-list
154621688|NCT03323151|Glycine|glycine|mesh-list
154621689|NCT03323151|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154621690|NCT03323151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154621691|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621692|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621693|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621694|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
154621695|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
154621696|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621697|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621698|NCT03308578|Atorvastatin|atorvastatin|mesh-list
154621699|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154621700|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154621701|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
154621702|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621703|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154621704|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154621705|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621706|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
154621707|NCT03276832|Imiquimod|imiquimod|mesh-list
154621708|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621709|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621710|NCT03276832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621711|NCT03276832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621712|NCT03276832|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154621713|NCT03276832|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154621714|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
154621715|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621716|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154621717|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
154621718|NCT03274258|Nivolumab|nivolumab|mesh-list
154621719|NCT03274258|Ipilimumab|ipilimumab|mesh-list
154621720|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621721|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621722|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154860319|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154621723|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621724|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
154621725|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621726|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621727|NCT03179917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621728|NCT03179917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621729|NCT03146650|Nivolumab|nivolumab|mesh-list
154621730|NCT03146650|Ipilimumab|ipilimumab|mesh-list
154621731|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621732|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621733|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621734|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621735|NCT03132532|Paclitaxel|paclitaxel|mesh-list
154621736|NCT03132532|Etoposide|etoposide|mesh-list
154621737|NCT03132532|Podophyllotoxin|podophyllotoxin|mesh-list
154621738|NCT03132532|Cisplatin|cisplatin|mesh-list
154621739|NCT03132532|Carboplatin|carboplatin|mesh-list
154621740|NCT03132532|Pemetrexed|pemetrexed|mesh-list
154621741|NCT03132532|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154621742|NCT03132532|Etoposide phosphate|etoposide phosphate|mesh-list
154621743|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621744|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621745|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621746|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621747|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621748|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621749|NCT03132532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154621750|NCT03132532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154621751|NCT03132532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621752|NCT03132532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154621753|NCT03132532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154621754|NCT03132532|Keratolytic Agents|keratolytic agents|mesh-ancestor
154621755|NCT03132532|Dermatologic Agents|dermatologic agents|mesh-ancestor
154621756|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
154621757|NCT03131908|GSK2636771|gsk2636771|mesh-list
154621758|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621759|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621760|NCT03131908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621761|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621762|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154621763|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621764|NCT03128034|Cyclosporine|cyclosporine|mesh-list
154621765|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
154621766|NCT03128034|Fludarabine|fludarabine|mesh-list
154621767|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
154621768|NCT03128034|Cyclosporins|cyclosporins|mesh-list
154621769|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621770|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621771|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
154621772|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621773|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621774|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
154621775|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621776|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621777|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
154621778|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621779|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
154621780|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154621781|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154621782|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154621783|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154621784|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
154621785|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154621786|NCT03091192|Sunitinib|sunitinib|mesh-list
154621787|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621788|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154621789|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154621790|NCT03091192|Growth Substances|growth substances|mesh-ancestor
154621791|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621792|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
154621793|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154621794|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621795|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621796|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
154621797|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621798|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621799|NCT03087760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621800|NCT03087760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621802|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154621803|NCT03081689|Carboplatin|carboplatin|mesh-list
154621804|NCT03081689|Nivolumab|nivolumab|mesh-list
154621805|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621806|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621807|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621808|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621809|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621810|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621811|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621812|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621813|NCT02871219|Lenalidomide|lenalidomide|mesh-list
154621814|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
154621815|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
154621816|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621817|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154621818|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154621819|NCT02871219|Growth Substances|growth substances|mesh-ancestor
154621820|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
154621821|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621822|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621823|NCT02860000|Fulvestrant|fulvestrant|mesh-list
154621824|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154621825|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621826|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154621827|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154621828|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
154621829|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621830|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621831|NCT02829723|Spartalizumab|spartalizumab|mesh-list
154621832|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621833|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621834|NCT02829723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621835|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621836|NCT02735057|Paclitaxel|paclitaxel|mesh-list
154621837|NCT02735057|Carboplatin|carboplatin|mesh-list
154621838|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621839|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621840|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621841|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621842|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621843|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621844|NCT02722616|Pancrelipase|pancrelipase|mesh-list
154621845|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154621846|NCT02658487|Cytarabine|cytarabine|mesh-list
154621847|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621848|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
154621849|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621850|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621851|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
154621852|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621853|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621854|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
154621855|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621856|NCT02604914|Levodopa|levodopa|mesh-list
154621857|NCT02604914|Carbidopa|carbidopa|mesh-list
154621858|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154621859|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154621860|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154621861|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
154336666|NCT05880862|Mirabegron|mirabegron|mesh-list
154621862|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154621863|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621864|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621865|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154621866|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621867|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154621868|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
154621869|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
154621870|NCT02593175|Paclitaxel|paclitaxel|mesh-list
154621871|NCT02593175|Carboplatin|carboplatin|mesh-list
154621872|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154621873|NCT02593175|Panitumumab|panitumumab|mesh-list
154621874|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154621875|NCT02593175|Antibodies|antibodies|mesh-list
154621876|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
154621877|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154621878|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621879|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621880|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621881|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621882|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621883|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621884|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
154621885|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621886|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
154621887|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621888|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
154621889|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621890|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621891|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154621892|NCT02553460|Leucovorin|leucovorin|mesh-list
154621893|NCT02553460|Cytarabine|cytarabine|mesh-list
154621894|NCT02553460|Dexamethasone|dexamethasone|mesh-list
154621895|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
154621896|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
154621897|NCT02553460|Methotrexate|methotrexate|mesh-list
154621898|NCT02553460|Etoposide|etoposide|mesh-list
154621899|NCT02553460|Vincristine|vincristine|mesh-list
154621900|NCT02553460|Bortezomib|bortezomib|mesh-list
154621901|NCT02553460|Asparaginase|asparaginase|mesh-list
154621902|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
154621903|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
154621904|NCT02553460|Vorinostat|vorinostat|mesh-list
154621905|NCT02553460|Pegaspargase|pegaspargase|mesh-list
154621906|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
154621907|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621908|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
154621909|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621910|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154621911|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154621912|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
154621913|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621914|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621915|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154621916|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154621917|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
154621918|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
154621919|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154621920|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154621921|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
154621922|NCT02553460|Hormones|hormones|mesh-ancestor
154621923|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154621924|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154621925|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154621926|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
154621927|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154621928|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621929|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
154621930|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
154621931|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621932|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154621933|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154621934|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621935|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154621936|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154621937|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
154621938|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154621939|NCT02553460|Antidotes|antidotes|mesh-ancestor
154621940|NCT02553460|Protective Agents|protective agents|mesh-ancestor
154621941|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
154621942|NCT02553460|Vitamins|vitamins|mesh-ancestor
154621943|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
154621944|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621945|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621946|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621947|NCT02553460|Analgesics|analgesics|mesh-ancestor
154621948|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
154621949|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154621950|NCT02525757|Paclitaxel|paclitaxel|mesh-list
154234743|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
154621951|NCT02525757|Carboplatin|carboplatin|mesh-list
154621952|NCT02525757|Atezolizumab|atezolizumab|mesh-list
154621953|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621954|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621955|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621956|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621957|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621958|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621959|NCT02525757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154621960|NCT02525757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621961|NCT02453282|Paclitaxel|paclitaxel|mesh-list
154621962|NCT02453282|Cisplatin|cisplatin|mesh-list
154621963|NCT02453282|Carboplatin|carboplatin|mesh-list
154621964|NCT02453282|Gemcitabine|gemcitabine|mesh-list
154621965|NCT02453282|Pemetrexed|pemetrexed|mesh-list
154621966|NCT02453282|Durvalumab|durvalumab|mesh-list
154621967|NCT02453282|Tremelimumab|tremelimumab|mesh-list
154621968|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154621969|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154621970|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621971|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
154621972|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
154621973|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
154621974|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621975|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154621976|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
154621977|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621978|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154621979|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154621980|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154621981|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
154621982|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621983|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154621984|NCT02296125|Gefitinib|gefitinib|mesh-list
154621985|NCT02296125|Osimertinib|osimertinib|mesh-list
154621986|NCT02296125|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154621987|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154621988|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154621989|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154621990|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154621991|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
154621992|NCT02287311|Fludarabine|fludarabine|mesh-list
154621993|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154621994|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
154621995|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154621996|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154621997|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154621998|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
154621999|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622000|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622001|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154622002|NCT02276443|Immunomodulating Agents|immunomodulating agents|mesh-list
154622003|NCT02276443|Immunologic Factors|immunologic factors|mesh-ancestor
154622004|NCT02276443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622005|NCT02096601|Levodopa|levodopa|mesh-list
154622006|NCT02096601|Carbidopa|carbidopa|mesh-list
154622007|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154622008|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154622009|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
154622010|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622011|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622012|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622013|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154622014|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622015|NCT02087423|Durvalumab|durvalumab|mesh-list
154622016|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154622017|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622018|NCT02031419|Rituximab|rituximab|mesh-list
154622019|NCT02031419|Spebrutinib|spebrutinib|mesh-list
154622020|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154622021|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622022|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
154622023|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622024|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622025|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154622027|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622028|NCT01954979|Abatacept|abatacept|mesh-list
154622029|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154622030|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622031|NCT01954979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154622032|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622033|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622034|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
154622035|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622036|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622037|NCT01883505|Levodopa|levodopa|mesh-list
154622038|NCT01883505|Carbidopa|carbidopa|mesh-list
154622039|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154622040|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154622041|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
154622042|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622043|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622044|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622045|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154622046|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622047|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
154622048|NCT01878617|Gemcitabine|gemcitabine|mesh-list
154622049|NCT01878617|Vincristine|vincristine|mesh-list
154622050|NCT01878617|Pemetrexed|pemetrexed|mesh-list
154622051|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622052|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
154622053|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622054|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622055|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154622056|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
154622057|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622058|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622059|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154622060|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154622061|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
154622062|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154622063|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
154622064|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
154622065|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
154622066|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622067|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154622068|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154622069|NCT01874353|Olaparib|olaparib|mesh-list
154622070|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154622071|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622072|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622073|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622074|NCT01802632|Osimertinib|osimertinib|mesh-list
154622075|NCT01802632|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154622076|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154622077|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622078|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622079|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622080|NCT01782131|Voriconazole|voriconazole|mesh-list
154622081|NCT01782131|Posaconazole|posaconazole|mesh-list
154622082|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
154622083|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622084|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154622085|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154622086|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336882|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154622087|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622088|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154622089|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
154622090|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622091|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622092|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154622093|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154622094|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154622095|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154622096|NCT01725802|Levodopa|levodopa|mesh-list
154622097|NCT01725802|Carbidopa|carbidopa|mesh-list
154622098|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154622099|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154622100|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
154622101|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622102|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622103|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622104|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154622105|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622107|NCT01582191|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154622108|NCT01582191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154622109|NCT01582191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622110|NCT01582191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622111|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622112|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
154622113|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622114|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622115|NCT01903733|Bosutinib|bosutinib|mesh-list
154622116|NCT01903733|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154622117|NCT01903733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154622118|NCT01903733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622119|NCT01903733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622120|NCT03235037|Levodopa|levodopa|mesh-list
154622121|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154622122|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154622123|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
154622124|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622125|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622126|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622127|NCT00700271|Amlodipine|amlodipine|mesh-list
154622128|NCT00700271|Valsartan|valsartan|mesh-list
154622129|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154622130|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154622131|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154622132|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622133|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154622134|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622135|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
154622136|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154622137|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154622138|NCT03228797|Ropivacaine|ropivacaine|mesh-list
154622139|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
154622140|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
154622141|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622142|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622143|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
154622144|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622145|NCT03044379|Dapivirine|dapivirine|mesh-list
154622146|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154622147|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154622148|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
154622149|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622150|NCT04864509|Melatonin|melatonin|mesh-list
154622151|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
154622152|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622153|NCT04864509|Protective Agents|protective agents|mesh-ancestor
154622154|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622155|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622156|NCT04875039|Dexamethasone|dexamethasone|mesh-list
154622157|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
154622158|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
154622159|NCT04875039|BB 1101|bb 1101|mesh-list
154622160|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622161|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
154622162|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
154622163|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622164|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622165|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154622166|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
154622167|NCT04875039|Hormones|hormones|mesh-ancestor
154622168|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622169|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154622170|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622171|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
154622172|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234966|NCT03854266|Calcium heparin|calcium heparin|mesh-list
154622173|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622174|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154622175|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622176|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154622177|NCT04875039|Analgesics|analgesics|mesh-ancestor
154622178|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
154622179|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154622180|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154622181|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154622182|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
154622183|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622184|NCT02452385|Vorolanib|vorolanib|mesh-list
154622185|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154622186|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622187|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622188|NCT03045783|Cefotiam|cefotiam|mesh-list
154622189|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154622190|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622191|NCT01375049|Aztreonam|aztreonam|mesh-list
154622192|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154622193|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622194|NCT04863807|Anesthetics|anesthetics|mesh-list
154622195|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622196|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622197|NCT02452307|Imiquimod|imiquimod|mesh-list
154622198|NCT02452307|Molgramostim|molgramostim|mesh-list
154622199|NCT02452307|Protamines|protamines|mesh-list
154622200|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154622201|NCT02452307|Sargramostim|sargramostim|mesh-list
154622202|NCT02452307|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154622203|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622204|NCT02452307|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154622205|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
154622206|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622207|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154622208|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622209|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
154622210|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
154622211|NCT02452307|Coagulants|coagulants|mesh-ancestor
154622212|NCT02452151|Infliximab|infliximab|mesh-list
154622213|NCT02452151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154622214|NCT02452151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622215|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154622216|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154622217|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622218|NCT04485299|Listerine|listerine|mesh-list
154622219|NCT04485299|Fluorides|fluorides|mesh-list
154622220|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
154622221|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
154622222|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
154622223|NCT04485299|Protective Agents|protective agents|mesh-ancestor
154622224|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337014|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
154622225|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154622226|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622227|NCT01594749|Dexamethasone|dexamethasone|mesh-list
154622228|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
154622229|NCT01594749|Ondansetron|ondansetron|mesh-list
154622230|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
154622231|NCT01594749|Aprepitant|aprepitant|mesh-list
154622232|NCT01594749|BB 1101|bb 1101|mesh-list
154622233|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622234|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
154622235|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
154622236|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622237|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622238|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154622239|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
154622240|NCT01594749|Hormones|hormones|mesh-ancestor
154622241|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622242|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154622243|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622244|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
154622245|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622246|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622247|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
154622248|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154622249|NCT01594749|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154622251|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
154622252|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622253|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154622254|NCT03226145|Scopolamine|scopolamine|mesh-list
154622255|NCT03226145|Bisacodyl|bisacodyl|mesh-list
154622256|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154622257|NCT03226145|Cathartics|cathartics|mesh-ancestor
154622258|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154622259|NCT03226145|Laxatives|laxatives|mesh-ancestor
154622260|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154622261|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
154622262|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
154622263|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622264|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622265|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
154622266|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154622267|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
154622268|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622269|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622270|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154622271|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
154622272|NCT04863183|Triamcinolone|triamcinolone|mesh-list
154622273|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154622274|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154622275|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154622276|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622277|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
154622278|NCT04863183|Hormones|hormones|mesh-ancestor
154622279|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622280|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622281|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622282|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
154622283|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622284|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622285|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
154622286|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154622287|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154622288|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154622289|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154622290|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622291|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
154622292|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622293|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622294|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154622295|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622296|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
154622297|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622298|NCT02453009|Prednisone|prednisone|mesh-list
154622299|NCT02453009|Docetaxel|docetaxel|mesh-list
154622300|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622301|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
154622302|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
154622303|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
154622304|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622305|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622306|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
154622307|NCT02453009|Hormones|hormones|mesh-ancestor
154622308|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622309|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622310|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154622311|NCT04868175|Timolol|timolol|mesh-list
154622312|NCT04868175|Travoprost|travoprost|mesh-list
154622313|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154622314|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154622315|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
154622316|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622317|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622318|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622319|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154622320|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154622321|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154622322|NCT02452775|Poly ICLC|poly iclc|mesh-list
154622323|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154622324|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
154622325|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622326|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
154622327|NCT03045627|Cytarabine|cytarabine|mesh-list
154622328|NCT03045627|Aclarubicin|aclarubicin|mesh-list
154622329|NCT03045627|Lenograstim|lenograstim|mesh-list
154622330|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154622331|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
154622332|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622333|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622334|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
154622335|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622336|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622337|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
154622338|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622339|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154622340|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154622341|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154622342|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154622343|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622344|NCT04868019|Fenofibrate|fenofibrate|mesh-list
154622345|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154622346|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
154622347|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622348|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154622349|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
154622350|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622351|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154622352|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622353|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622354|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
154622355|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622356|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622357|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154622358|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
154622359|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154622360|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622361|NCT02179918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154622362|NCT02179918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622363|NCT03233321|Heparin|heparin|mesh-list
154622364|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154622365|NCT03233321|Tinzaparin|tinzaparin|mesh-list
154622366|NCT03233321|Dalteparin|dalteparin|mesh-list
154622367|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
154622368|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154622369|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154622370|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622371|NCT04868253|Oxazepam|oxazepam|mesh-list
154622372|NCT04868253|Metyrapone|metyrapone|mesh-list
154622373|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
154622374|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622375|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622376|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154622377|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622378|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622379|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154622380|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154622381|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154622382|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
154622383|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
154622384|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622385|NCT02153788|Temazepam|temazepam|mesh-list
154622386|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154622387|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622388|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622389|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154622390|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154622391|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154622392|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
154622393|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
154622394|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622395|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622396|NCT03224039|Sufentanil|sufentanil|mesh-list
154622397|NCT03224039|Morphine|morphine|mesh-list
154622398|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154622399|NCT03224039|Narcotics|narcotics|mesh-ancestor
154622400|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622401|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622402|NCT03224039|Analgesics|analgesics|mesh-ancestor
154622403|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
154622404|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622405|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154622406|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154337199|NCT03916003|Primaquine|primaquine|mesh-list
154622407|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
154622408|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
154622409|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
154622410|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622411|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154622412|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622413|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622414|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
154622415|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622416|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622417|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154622418|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
154622419|NCT03223961|Hematinics|hematinics|mesh-ancestor
154622420|NCT03045471|Prednisolone|prednisolone|mesh-list
154622421|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154622422|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
154622423|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154622424|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
154622425|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
154622426|NCT03045471|Rituximab|rituximab|mesh-list
154622427|NCT03045471|Etoposide|etoposide|mesh-list
154622428|NCT03045471|Vincristine|vincristine|mesh-list
154622429|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154622430|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
154622431|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622432|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
154622433|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622434|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622435|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154622436|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
154622437|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622438|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622439|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154622440|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154622441|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154622442|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154622443|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154622444|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622445|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622446|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
154622447|NCT03045471|Hormones|hormones|mesh-ancestor
154622448|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622449|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154622450|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
154622451|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
154622452|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622453|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154622454|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154622455|NCT03045471|Protective Agents|protective agents|mesh-ancestor
154622456|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
154622457|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
154622458|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
154622459|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
154622460|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154622461|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154622462|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154622463|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154622464|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622465|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
154622466|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622467|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622468|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154622469|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622470|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
154622471|NCT04867941|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154622472|NCT04867941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154622473|NCT04867941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622474|NCT04867941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622475|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622476|NCT04873479|Ketamine|ketamine|mesh-list
154622477|NCT04873479|Esketamine|esketamine|mesh-list
154622478|NCT04873479|Analgesics|analgesics|mesh-ancestor
154622479|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
154622480|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622481|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622482|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154622483|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154622484|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
154622485|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
154622486|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622487|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154622488|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154622489|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622490|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622491|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
154622492|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154622493|NCT02451527|Digoxin|digoxin|mesh-list
154622494|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154622495|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154622496|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622497|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622498|NCT02451527|Protective Agents|protective agents|mesh-ancestor
154622499|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622500|NCT04873011|Quinine|quinine|mesh-list
154622501|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
154622502|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154622503|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154622504|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622505|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154622506|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622507|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154622508|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622509|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154622510|NCT04873011|Analgesics|analgesics|mesh-ancestor
154622511|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
154622512|NCT02451605|Analgesics|analgesics|mesh-list
154622513|NCT02451605|Ropivacaine|ropivacaine|mesh-list
154622514|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
154622515|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
154622516|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622517|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622518|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
154622519|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622520|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
154622521|NCT03222323|Ropivacaine|ropivacaine|mesh-list
154622522|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154622523|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622524|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622525|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154622526|NCT03222323|Analgesics|analgesics|mesh-ancestor
154622527|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
154622528|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622529|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154622530|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154622531|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154622532|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
154622533|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622534|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622535|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
154622536|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
154622537|NCT03043677|Adalimumab|adalimumab|mesh-list
154622538|NCT03043677|Infliximab|infliximab|mesh-list
154622539|NCT03043677|Golimumab|golimumab|mesh-list
154622540|NCT03043677|Ustekinumab|ustekinumab|mesh-list
154622541|NCT03043677|Vedolizumab|vedolizumab|mesh-list
154622542|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154622543|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622544|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622545|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
154622546|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154622547|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622548|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
154622549|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622550|NCT03222089|Leucovorin|leucovorin|mesh-list
154622551|NCT03222089|Fluorouracil|fluorouracil|mesh-list
154622552|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
154622553|NCT03222089|Irinotecan|irinotecan|mesh-list
154622554|NCT03222089|Interleukin-2|interleukin-2|mesh-list
154622555|NCT03222089|Molgramostim|molgramostim|mesh-list
154622556|NCT03222089|Sargramostim|sargramostim|mesh-list
154622557|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
154622558|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
154622559|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622560|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154622561|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622562|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622563|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
154622564|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622565|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154337344|NCT02937571|Hormones|hormones|mesh-ancestor
154622566|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154622567|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622568|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154622569|NCT03222089|Analgesics|analgesics|mesh-ancestor
154622570|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
154622571|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622572|NCT03222089|Antidotes|antidotes|mesh-ancestor
154622573|NCT03222089|Protective Agents|protective agents|mesh-ancestor
154622574|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
154622575|NCT03222089|Vitamins|vitamins|mesh-ancestor
154622576|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
154622577|NCT03043989|Clarithromycin|clarithromycin|mesh-list
154622578|NCT03043989|Docetaxel|docetaxel|mesh-list
154622579|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622580|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
154622581|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
154622582|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
154622583|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622584|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154622585|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622586|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154622587|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622588|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154622589|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154622590|NCT03222167|Grazoprevir|grazoprevir|mesh-list
154622591|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154622592|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
154622593|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622594|NCT03221855|Domperidone|domperidone|mesh-list
154622595|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
154622596|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
154622597|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622598|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622599|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154622600|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154622601|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
154622602|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622603|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622604|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
154622605|NCT03043521|Lansoprazole|lansoprazole|mesh-list
154622606|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154622607|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154622608|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154622609|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622610|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622611|NCT03047733|Tacrolimus|tacrolimus|mesh-list
154622612|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622613|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
154622614|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622615|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154622616|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622617|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622618|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
154622619|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154622620|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
154622621|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622622|NCT03221231|Expectorants|expectorants|mesh-ancestor
154622623|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
154622624|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154622625|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
154622626|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622627|NCT03221231|Protective Agents|protective agents|mesh-ancestor
154622628|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622629|NCT03221231|Antidotes|antidotes|mesh-ancestor
154622630|NCT03221621|Adalimumab|adalimumab|mesh-list
154622631|NCT03221621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154622632|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622633|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622634|NCT03220841|Adalimumab|adalimumab|mesh-list
154622635|NCT03220841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154622636|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622637|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622638|NCT03045393|Maytansine|maytansine|mesh-list
154622639|NCT03045393|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154622640|NCT03045393|Immunoconjugates|immunoconjugates|mesh-ancestor
154622641|NCT03045393|Immunologic Factors|immunologic factors|mesh-ancestor
154622642|NCT03045393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622643|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154622644|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622645|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
154622646|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
154622647|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
154622648|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622649|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
154622650|NCT01374971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154622651|NCT01374971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622652|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622653|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
154622654|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622655|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622656|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
154622657|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622658|NCT02505971|Propranolol|propranolol|mesh-list
154622659|NCT02505971|Nadolol|nadolol|mesh-list
154622660|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154622661|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154622662|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
154622663|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622664|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622665|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622666|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154622667|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154622668|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
154622669|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
154622670|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
154622671|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622672|NCT02505581|Metronidazole|metronidazole|mesh-list
154622673|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
154622674|NCT02505581|Cefuroxime|cefuroxime|mesh-list
154622675|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
154622676|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622677|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154622678|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154622679|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154622680|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154622681|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154622682|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622683|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622684|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622685|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154622686|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154622687|NCT02451293|Melatonin|melatonin|mesh-list
154622688|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
154622689|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622690|NCT02451293|Protective Agents|protective agents|mesh-ancestor
154622691|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622692|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622693|NCT02505113|Montelukast|montelukast|mesh-list
154622694|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154622695|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
154622696|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154622697|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
154622698|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622699|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622700|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154622701|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154622702|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622703|NCT02504801|Budesonide|budesonide|mesh-list
154622704|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622705|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154622706|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
154622707|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622708|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622709|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154622710|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
154622711|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
154622712|NCT02504801|Hormones|hormones|mesh-ancestor
154622713|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622714|NCT02504177|Anticoagulants|anticoagulants|mesh-list
154622715|NCT02450981|Bevacizumab|bevacizumab|mesh-list
154622716|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154622717|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622718|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154622719|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154622720|NCT02450981|Growth Substances|growth substances|mesh-ancestor
154622721|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622722|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
154622723|NCT02503943|Metformin|metformin|mesh-list
154622724|NCT02503943|Liraglutide|liraglutide|mesh-list
154622725|NCT02503943|Mitiglinide|mitiglinide|mesh-list
154622726|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154622727|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622728|NCT02503943|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154622729|NCT02503943|Incretins|incretins|mesh-ancestor
154622730|NCT02503943|Hormones|hormones|mesh-ancestor
154622731|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622732|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
154622733|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154622734|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622735|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622736|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154622737|NCT03213743|Analgesics|analgesics|mesh-ancestor
154622738|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
154622739|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622740|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154622741|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154622742|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154622743|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
154622744|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622745|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622746|NCT03212495|Neostigmine|neostigmine|mesh-list
154622747|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622748|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622749|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622750|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622751|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154622752|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622753|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
154622754|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154622755|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
154622756|NCT02610777|Azacitidine|azacitidine|mesh-list
154622757|NCT02610777|Pevonedistat|pevonedistat|mesh-list
154622758|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154622759|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
154622760|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622761|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622762|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622763|NCT01628692|Ribavirin|ribavirin|mesh-list
154622764|NCT01628692|Simeprevir|simeprevir|mesh-list
154622765|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
154622766|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622767|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
154622768|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622769|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
154622770|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622771|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154622772|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154622773|NCT04496921|Vitamins|vitamins|mesh-list
154622774|NCT04496921|Vitamin K|vitamin k|mesh-list
154622775|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
154622776|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622777|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154622778|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154622779|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235512|NCT00146328|Tipranavir|tipranavir|mesh-list
154622780|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
154622781|NCT04496921|Coagulants|coagulants|mesh-ancestor
154622782|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
154622783|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154622784|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154622785|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154622786|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154622787|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622788|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
154622789|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622790|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622791|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154622792|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622793|NCT03043443|Melatonin|melatonin|mesh-list
154622794|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
154622795|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622796|NCT03043443|Protective Agents|protective agents|mesh-ancestor
154622797|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622798|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622799|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
154622800|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
154622801|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622802|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622803|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
154622804|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154622805|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154622806|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
154622807|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337605|NCT03929575|Calcium|calcium|mesh-list
154622808|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
154622809|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
154622810|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
154622811|NCT03209219|Interferons|interferons|mesh-list
154622812|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
154622813|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
154622814|NCT03209219|Cyclosporine|cyclosporine|mesh-list
154622815|NCT03209219|Cyclosporins|cyclosporins|mesh-list
154622816|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622817|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
154622818|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622819|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622820|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622821|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622822|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
154622823|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622824|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
154622825|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
154622826|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622827|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154622828|NCT04872231|Voriconazole|voriconazole|mesh-list
154622829|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
154622830|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622831|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154622832|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154622833|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622834|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622835|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154622836|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
154622837|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622838|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622839|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154622840|NCT04860531|Betamethasone|betamethasone|mesh-list
154622841|NCT04860531|Lidocaine|lidocaine|mesh-list
154622842|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
154622843|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
154622844|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154622845|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622846|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
154622847|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622848|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154622849|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154622850|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154622851|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154622852|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622853|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622854|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
154622855|NCT04860531|Hormones|hormones|mesh-ancestor
154622856|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622857|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154622858|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
154622859|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
154622860|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154622861|NCT01594827|Vancomycin|vancomycin|mesh-list
154622862|NCT01594827|Doxycycline|doxycycline|mesh-list
154622863|NCT01594827|Rifampin|rifampin|mesh-list
154622864|NCT01594827|Trimethoprim|trimethoprim|mesh-list
154622865|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
154622866|NCT01594827|Mupirocin|mupirocin|mesh-list
154622867|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154622868|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622869|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
154622870|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
154622871|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154622872|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
154622873|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154622874|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154622875|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154622876|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
154622877|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
154622878|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154622879|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622880|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622881|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154622882|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154622883|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154622884|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154622885|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154337678|NCT02292550|Ceritinib|ceritinib|mesh-list
154622886|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154622887|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154622888|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154622889|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154622890|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154622891|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154622892|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154622893|NCT04429191|Antibodies|antibodies|mesh-list
154622894|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154622895|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
154622896|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622897|NCT02610231|Istradefylline|istradefylline|mesh-list
154622898|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154622899|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154622900|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154622901|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
154622902|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622903|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622904|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622905|NCT04850157|Tislelizumab|tislelizumab|mesh-list
154622906|NCT04850157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154622907|NCT04850157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622908|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
154622909|NCT04849533|Prednisone|prednisone|mesh-list
154622910|NCT04849533|Everolimus|everolimus|mesh-list
154622911|NCT04849533|Abatacept|abatacept|mesh-list
154622912|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
154622913|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154622914|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154622915|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
154622916|NCT04849533|Hormones|hormones|mesh-ancestor
154622917|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622918|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622919|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154622920|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622921|NCT04849533|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154622922|NCT04849533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154622923|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622924|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622925|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622926|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
154622927|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154622928|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154622929|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
154235737|NCT03843736|Hormones|hormones|mesh-ancestor
154622930|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154622931|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154622932|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154622933|NCT04849533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154622934|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622935|NCT03040635|Risdiplam|risdiplam|mesh-list
154622936|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154622937|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622938|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622939|NCT02178358|Sorafenib|sorafenib|mesh-list
154622940|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622941|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154622942|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622943|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622944|NCT01598896|Clonidine|clonidine|mesh-list
154622945|NCT01598896|Dronabinol|dronabinol|mesh-list
154622946|NCT01598896|Analgesics|analgesics|mesh-ancestor
154622947|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
154622948|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154622949|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622950|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154622951|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
154622952|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
154622953|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154622954|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154622955|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154622956|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
154622957|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154622958|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622959|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
154622960|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154622961|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154622962|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154622963|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154622964|NCT01598896|Hormones|hormones|mesh-ancestor
154622965|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154622966|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
154622967|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154622968|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
154622969|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154622970|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622971|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154622972|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154622973|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154622974|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
154622975|NCT03042429|Ifosfamide|ifosfamide|mesh-list
154622976|NCT03042429|Cisplatin|cisplatin|mesh-list
154622977|NCT03042429|Doxorubicin|doxorubicin|mesh-list
154622978|NCT03042429|Etoposide|etoposide|mesh-list
154622979|NCT03042429|Topotecan|topotecan|mesh-list
154622980|NCT03042429|Vindesine|vindesine|mesh-list
154622981|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154622982|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
154622983|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154622984|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154622985|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154622986|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
154622987|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154622988|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154622989|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154622990|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154622991|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154622992|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154622993|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154622994|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154622995|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154622996|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
154622997|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
154622998|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
154622999|NCT04849299|Cyclosporine|cyclosporine|mesh-list
154623000|NCT04849299|Cyclosporins|cyclosporins|mesh-list
154623001|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623002|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623003|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154623004|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
154623005|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623006|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
154623007|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623008|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
154623009|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623010|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154623011|NCT02117050|Interferons|interferons|mesh-list
154623012|NCT02117050|Interferon-beta|interferon-beta|mesh-list
154623013|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
154623014|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623015|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
154623016|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623017|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
154623018|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623019|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154623020|NCT04860219|Lactoferrin|lactoferrin|mesh-list
154623021|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623022|NCT02728895|Vedolizumab|vedolizumab|mesh-list
154623023|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623024|NCT04847895|Ranibizumab|ranibizumab|mesh-list
154623025|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154623026|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154623027|NCT04847895|Growth Substances|growth substances|mesh-ancestor
154623028|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623029|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
154623030|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623031|NCT02450513|Adalimumab|adalimumab|mesh-list
154623032|NCT02450513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154623033|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154623034|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623035|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
154623036|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154623037|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623038|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623039|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623040|NCT04859283|Analgesics|analgesics|mesh-ancestor
154623041|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
154623042|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623043|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154623044|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154623045|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154623046|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
154623047|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623048|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623049|NCT04857801|Teduglutide|teduglutide|mesh-list
154623050|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623051|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154623052|NCT04857801|Protective Agents|protective agents|mesh-ancestor
154623053|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623054|NCT03208361|Amoxicillin|amoxicillin|mesh-list
154623055|NCT03208361|Penicillins|penicillins|mesh-list
154623056|NCT03208361|Penicillin V|penicillin v|mesh-list
154623057|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154623058|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623059|NCT02501837|Oxytocin|oxytocin|mesh-list
154623060|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
154623061|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154623062|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623063|NCT04859361|Imiquimod|imiquimod|mesh-list
154623064|NCT04859361|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154623065|NCT04859361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623066|NCT04859361|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154623067|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
154623068|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623069|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154623070|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623071|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
154623072|NCT03039075|Metformin|metformin|mesh-list
154623073|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154623074|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623075|NCT04857177|Ranibizumab|ranibizumab|mesh-list
154623076|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154623077|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154623078|NCT04857177|Growth Substances|growth substances|mesh-ancestor
154623079|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623080|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
154623081|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623082|NCT02606877|Pirfenidone|pirfenidone|mesh-list
154623083|NCT02606877|Nintedanib|nintedanib|mesh-list
154623084|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623085|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154623086|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623087|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623088|NCT02606877|Analgesics|analgesics|mesh-ancestor
154623089|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
154623090|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623091|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623092|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154623093|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623094|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154623095|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623096|NCT03206957|Endostatins|endostatins|mesh-list
154623097|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
154623098|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623099|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154623100|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154623101|NCT03206957|Growth Substances|growth substances|mesh-ancestor
154623102|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623103|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
154623104|NCT03206723|Hydrocodone|hydrocodone|mesh-list
154623105|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154623106|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154623107|NCT03206723|Narcotics|narcotics|mesh-ancestor
154623108|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623109|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623110|NCT03206723|Analgesics|analgesics|mesh-ancestor
154623111|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
154623112|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623113|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
154623114|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
154623115|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154623116|NCT03201185|Ramipril|ramipril|mesh-list
154623117|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154623118|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
154623119|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623120|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623121|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154623122|NCT04856787|Fluorouracil|fluorouracil|mesh-list
154623123|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
154623124|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623125|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154623126|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623127|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154623128|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
154623129|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623130|NCT03206177|Paclitaxel|paclitaxel|mesh-list
154623131|NCT03206177|Carboplatin|carboplatin|mesh-list
154623132|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154623133|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623134|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154623135|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154623136|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154623137|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623138|NCT04839471|Afatinib|afatinib|mesh-list
154623139|NCT04839471|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154623140|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154623141|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623142|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623143|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623144|NCT04839237|Metformin|metformin|mesh-list
154623145|NCT04839237|Liraglutide|liraglutide|mesh-list
154623146|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154623147|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623148|NCT04839237|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154623149|NCT04839237|Incretins|incretins|mesh-ancestor
154623150|NCT04839237|Hormones|hormones|mesh-ancestor
154623151|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154623152|NCT03038607|Aspirin|aspirin|mesh-list
154623153|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154623154|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623155|NCT03038607|Analgesics|analgesics|mesh-ancestor
154623156|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
154623157|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623158|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623159|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154623160|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623161|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154623162|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154623163|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623164|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154623165|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154623166|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623167|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
154623168|NCT03038451|Amlodipine|amlodipine|mesh-list
154623169|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154623170|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154623171|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154623172|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623173|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154623174|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623175|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
154623176|NCT03040401|Aldesleukin|aldesleukin|mesh-list
154623177|NCT03040401|Interleukin-2|interleukin-2|mesh-list
154623178|NCT03040401|Histamine|histamine|mesh-list
154623179|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
154623180|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623181|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154623182|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154623183|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
154623184|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623185|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623186|NCT03040401|Analgesics|analgesics|mesh-ancestor
154623187|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
154623188|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623189|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623190|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
154623191|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
154623192|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623193|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623194|NCT03038295|Propranolol|propranolol|mesh-list
154623195|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154623196|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154623197|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
154623198|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623199|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623200|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623201|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154623202|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154623203|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
154623204|NCT03038217|Capecitabine|capecitabine|mesh-list
154623205|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
154623206|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154623207|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
154623208|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623209|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623210|NCT02609607|Bisacodyl|bisacodyl|mesh-list
154623211|NCT02609607|Cathartics|cathartics|mesh-ancestor
154623212|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623213|NCT02609607|Laxatives|laxatives|mesh-ancestor
154623214|NCT03040167|Epinephrine|epinephrine|mesh-list
154623215|NCT03040167|Bupivacaine|bupivacaine|mesh-list
154623216|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
154623217|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
154623218|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623219|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623220|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
154623221|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623222|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154623223|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154623224|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
154623225|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623226|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623227|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154623228|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154623229|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
154623230|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154623231|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
154623232|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
154623233|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
154623234|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154623235|NCT04843839|Nepafenac|nepafenac|mesh-list
154623236|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154623237|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154623238|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
154623239|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154623240|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154623241|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623242|NCT04843839|Analgesics|analgesics|mesh-ancestor
154623243|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
154623244|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623245|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623246|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154623247|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623248|NCT04843839|Laxatives|laxatives|mesh-ancestor
154623249|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623250|NCT04838145|Ribavirin|ribavirin|mesh-list
154623251|NCT04838145|Pleconaril|pleconaril|mesh-list
154623252|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
154623253|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623254|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
154623255|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623256|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
154623257|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154623258|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
154623259|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623260|NCT03041259|Protective Agents|protective agents|mesh-ancestor
154623261|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623262|NCT04429035|Vitamin K|vitamin k|mesh-list
154623263|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
154623264|NCT04429035|Vitamins|vitamins|mesh-ancestor
154623265|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
154623266|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623267|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154623268|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154623269|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623270|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
154623271|NCT04429035|Coagulants|coagulants|mesh-ancestor
154623272|NCT04843449|Itraconazole|itraconazole|mesh-list
154623273|NCT04843449|Rifampin|rifampin|mesh-list
154623274|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
154623275|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623276|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154623277|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154623278|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623279|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623280|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154623281|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
154623282|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154623283|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623284|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154623285|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154623286|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
154623287|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154623288|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
154623289|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154623290|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154623291|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154623292|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154623293|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154623294|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154623295|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154623296|NCT03037593|Vitamin D|vitamin d|mesh-list
154623297|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
154623298|NCT03037593|Vitamins|vitamins|mesh-ancestor
154623299|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
154623300|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623301|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154623302|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154236017|NCT03829930|Entinostat|entinostat|mesh-list
154623304|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154623305|NCT04842825|Hormones|hormones|mesh-ancestor
154623306|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154623307|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623308|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154623309|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
154623310|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154623311|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
154623312|NCT02606253|Metolazone|metolazone|mesh-list
154623313|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
154623314|NCT02606253|Tolvaptan|tolvaptan|mesh-list
154623315|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154623316|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623317|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
154623318|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623319|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154623320|NCT02606253|Diuretics|diuretics|mesh-ancestor
154623321|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154623322|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154623323|NCT04854759|Amantadine|amantadine|mesh-list
154623324|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154623325|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154623326|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
154623327|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623328|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
154623329|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623330|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623331|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623332|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623333|NCT04854759|Analgesics|analgesics|mesh-ancestor
154623334|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
154623335|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623336|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
154623337|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154623338|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
154623339|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623340|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
154623341|NCT02607735|Velpatasvir|velpatasvir|mesh-list
154623342|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
154623343|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623344|NCT04772313|Methotrexate|methotrexate|mesh-list
154623345|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154623346|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
154623347|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154623348|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623349|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154623350|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
154623351|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623352|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623353|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
154623354|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623355|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154623356|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154623357|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
154623358|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623359|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154623360|NCT03040791|Nivolumab|nivolumab|mesh-list
154623361|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154623362|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623363|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154623364|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623365|NCT04428879|Topotecan|topotecan|mesh-list
154623366|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154623367|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154623368|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623369|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623370|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623371|NCT04836819|Lidocaine|lidocaine|mesh-list
154623372|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
154623373|NCT04836819|Ketamine|ketamine|mesh-list
154623374|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
154623375|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
154623376|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623377|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623378|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
154623379|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623380|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154623381|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154623382|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154623383|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154623384|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623385|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154623386|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623387|NCT04836819|Analgesics|analgesics|mesh-ancestor
154623388|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154623389|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154623390|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154623391|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
154623392|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623393|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154623394|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154623395|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
154623396|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154623397|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154623398|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
154623399|NCT04836507|Fludarabine|fludarabine|mesh-list
154623400|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154623401|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
154623402|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623403|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623404|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154623405|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
154623406|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623407|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623408|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154623409|NCT04835259|Selenium|selenium|mesh-list
154623410|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
154623411|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623412|NCT04835259|Protective Agents|protective agents|mesh-ancestor
154623413|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623414|NCT04835259|Trace Elements|trace elements|mesh-ancestor
154623415|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
154623416|NCT04853901|Remdesivir|remdesivir|mesh-list
154623417|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623418|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623419|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
154623420|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
154623421|NCT01668537|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154623422|NCT01668537|Antiviral Agents|antiviral agents|mesh-ancestor
154623423|NCT01668537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623424|NCT04834791|Letrozole|letrozole|mesh-list
154623425|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623426|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154623427|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154623428|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623429|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623430|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154623431|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
154623432|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154623433|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623434|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154623435|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623436|NCT04835025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154623437|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623438|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
154623439|NCT03038919|Testosterone|testosterone|mesh-list
154623440|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
154623441|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
154623442|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154623443|NCT03038919|Androgens|androgens|mesh-ancestor
154623444|NCT03038919|Hormones|hormones|mesh-ancestor
154623445|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154623446|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623447|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154623448|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623449|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
154623450|NCT03036891|Naloxegol|naloxegol|mesh-list
154623451|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154623452|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623453|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
154623454|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623455|NCT01668147|Ritonavir|ritonavir|mesh-list
154623456|NCT01668147|Efavirenz|efavirenz|mesh-list
154623457|NCT01668147|Loperamide|loperamide|mesh-list
154623458|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
154623459|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154623460|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154623461|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
154623462|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623463|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623464|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154623465|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154623466|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
154623467|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623468|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154623469|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154623470|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154623471|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154623472|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154623473|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154623474|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154623475|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154623476|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154623477|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623478|NCT04833777|Lidocaine|lidocaine|mesh-list
154623479|NCT04833777|Bupivacaine|bupivacaine|mesh-list
154623480|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
154623481|NCT04833777|Anesthetics|anesthetics|mesh-list
154623482|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623483|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623484|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
154623485|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623486|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154623487|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154623488|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154623489|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154623490|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623491|NCT03036501|Risdiplam|risdiplam|mesh-list
154623492|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154623493|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623494|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623495|NCT04851015|Trimethoprim|trimethoprim|mesh-list
154623496|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154623497|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
154623498|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154623499|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623500|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
154623501|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154623502|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154623503|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154623504|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623505|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623506|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154623507|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154623508|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154623509|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154623510|NCT04365933|Interferons|interferons|mesh-list
154623511|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
154623512|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
154623513|NCT04365933|Entecavir|entecavir|mesh-list
154623514|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154623515|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623516|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
154623517|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623518|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
154623519|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623520|NCT04824261|Clotrimazole|clotrimazole|mesh-list
154623521|NCT04824261|Miconazole|miconazole|mesh-list
154623522|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154623523|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623524|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
154623525|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154623526|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154623527|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623528|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623529|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154623530|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
154623531|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154623532|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623533|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154623534|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154623535|NCT04850235|Paclitaxel|paclitaxel|mesh-list
154623536|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154623537|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623538|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
154623539|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
154623540|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
154623541|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623542|NCT04850001|Aspirin|aspirin|mesh-list
154623543|NCT04850001|Clopidogrel|clopidogrel|mesh-list
154623544|NCT04850001|Atorvastatin|atorvastatin|mesh-list
154623545|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154623546|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623547|NCT04850001|Analgesics|analgesics|mesh-ancestor
154623548|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
154623549|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623550|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623551|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154623552|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623553|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154623554|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154623555|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623556|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154623557|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154623558|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623559|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
154623560|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154623561|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154623562|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
154623563|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154623564|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154623565|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154623566|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154623567|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154623568|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
154623569|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623570|NCT03036111|Trimebutine|trimebutine|mesh-list
154623571|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623572|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
154623573|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
154623574|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623575|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623576|NCT04830579|Etoricoxib|etoricoxib|mesh-list
154623577|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154623578|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623579|NCT04830579|Analgesics|analgesics|mesh-ancestor
154623580|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
154623581|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623582|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623583|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338371|NCT03515200|Bortezomib|bortezomib|mesh-list
154623584|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623585|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154623586|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154623587|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623588|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623589|NCT04816461|Piperaquine|piperaquine|mesh-list
154623590|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
154623591|NCT04816461|Amodiaquine|amodiaquine|mesh-list
154623592|NCT04816461|Artenimol|artenimol|mesh-list
154623593|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
154623594|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154623595|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154623596|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623597|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154623598|NCT04427865|Lactoferrin|lactoferrin|mesh-list
154623599|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623600|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
154623601|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154623602|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623603|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154623604|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154623605|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623606|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623607|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623608|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154623609|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154623610|NCT04427787|Lanreotide|lanreotide|mesh-list
154623611|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623612|NCT04829487|Vitamin D|vitamin d|mesh-list
154623613|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
154623614|NCT04829487|Vitamins|vitamins|mesh-ancestor
154623615|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
154623616|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623617|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154623618|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154623619|NCT04821765|Paclitaxel|paclitaxel|mesh-list
154623620|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154623621|NCT04821765|Antibodies|antibodies|mesh-list
154623622|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154623623|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623624|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
154623625|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
154623626|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
154623627|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623628|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
154623629|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623630|NCT04829097|Temozolomide|temozolomide|mesh-list
154623631|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154623632|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
154623633|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623634|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623635|NCT04829019|Osimertinib|osimertinib|mesh-list
154623636|NCT04829019|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154623637|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154623638|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623639|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623640|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623641|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
154623642|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
154623643|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
154623644|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623645|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154623646|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
154623647|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
154623648|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623649|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623650|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623651|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154623652|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
154623653|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154623654|NCT04828395|Paclitaxel|paclitaxel|mesh-list
154623655|NCT04828395|Etoposide|etoposide|mesh-list
154623656|NCT04828395|Cisplatin|cisplatin|mesh-list
154623657|NCT04828395|Carboplatin|carboplatin|mesh-list
154623658|NCT04828395|Pemetrexed|pemetrexed|mesh-list
154623659|NCT04828395|Fluzoparib|fluzoparib|mesh-list
154623660|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154623661|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623662|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
154623663|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
154623664|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
154623665|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623666|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154623667|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154623668|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623669|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154623670|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154623671|NCT04828395|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154623672|NCT04820439|Pertuzumab|pertuzumab|mesh-list
154623673|NCT04820439|Antibodies|antibodies|mesh-list
154623674|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154623676|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
154623677|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623678|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
154623679|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623680|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154623681|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623682|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
154623683|NCT05619315|Calcium|calcium|mesh-list
154623684|NCT05619315|Charcoal|charcoal|mesh-list
154623685|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154623686|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623687|NCT05619315|Antacids|antacids|mesh-ancestor
154338466|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
154623688|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623689|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623690|NCT05619315|Antidotes|antidotes|mesh-ancestor
154623691|NCT05619315|Protective Agents|protective agents|mesh-ancestor
154623692|NCT04814511|Permethrin|permethrin|mesh-list
154623693|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623694|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623695|NCT04814043|Lenvatinib|lenvatinib|mesh-list
154623696|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154623697|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623698|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154623699|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623700|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623701|NCT04814043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154623702|NCT04814589|Ezetimibe|ezetimibe|mesh-list
154623703|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154623704|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154623705|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
154623706|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623707|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154623708|NCT04826679|Paclitaxel|paclitaxel|mesh-list
154623709|NCT04826679|Cisplatin|cisplatin|mesh-list
154623710|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154623711|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623712|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
154623713|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
154623714|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
154623715|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623716|NCT02601573|Ribavirin|ribavirin|mesh-list
154623717|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
154623718|NCT02601573|Grazoprevir|grazoprevir|mesh-list
154623719|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
154623720|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623721|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
154623722|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623723|NCT04818723|Montelukast|montelukast|mesh-list
154623724|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154623725|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
154623726|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154623727|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
154623728|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154623729|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623730|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154623731|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154623732|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623733|NCT02601027|Acetaminophen|acetaminophen|mesh-list
154623734|NCT02601027|Oxycodone|oxycodone|mesh-list
154623735|NCT02601027|Hydromorphone|hydromorphone|mesh-list
154623736|NCT02601027|Ondansetron|ondansetron|mesh-list
154623737|NCT02601027|Bupivacaine|bupivacaine|mesh-list
154623738|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
154623739|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
154338527|NCT01135615|Calcium|calcium|mesh-list
154623740|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623741|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623742|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
154623743|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623744|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154623745|NCT02601027|Narcotics|narcotics|mesh-ancestor
154623746|NCT02601027|Analgesics|analgesics|mesh-ancestor
154623747|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
154623748|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
154623749|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623750|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
154623751|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
154623752|NCT02601027|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154623753|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154623754|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
154623755|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623756|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623757|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623758|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
154623759|NCT04411875|Amlodipine|amlodipine|mesh-list
154623760|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154623761|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154623762|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154623763|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623764|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154623765|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623766|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
154623767|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
154623768|NCT02600871|Povidone|povidone|mesh-list
154623769|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
154623770|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
154623771|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154623772|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623773|NCT04818099|Vortioxetine|vortioxetine|mesh-list
154623774|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
154623775|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154623776|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154623777|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154623778|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623779|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623780|NCT04818099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154623781|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154623782|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154623783|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623784|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623785|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
154623786|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154623787|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154623788|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154623789|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154623790|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154623791|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623792|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
154623793|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154623794|NCT04807569|Tamsulosin|tamsulosin|mesh-list
154623795|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154623796|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154623797|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154623798|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
154623799|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623800|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623801|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623802|NCT04807569|Urological Agents|urological agents|mesh-ancestor
154623803|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
154623804|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154623805|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
154623806|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623807|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623808|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154623809|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
154623810|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154623811|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
154623812|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623813|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623814|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154623815|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
154623816|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
154623817|NCT04807413|Protective Agents|protective agents|mesh-ancestor
154623818|NCT04807335|Sufentanil|sufentanil|mesh-list
154623819|NCT04807335|Ketamine|ketamine|mesh-list
154623820|NCT04807335|Analgesics|analgesics|mesh-ancestor
154623821|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
154623822|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623823|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623824|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154623825|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154623826|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
154623827|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
154623828|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623829|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154623830|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154623831|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623832|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623833|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154623834|NCT04807335|Narcotics|narcotics|mesh-ancestor
154623835|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154623836|NCT05616507|Fucoidan|fucoidan|mesh-list
154623837|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154623838|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154623839|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
154623840|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623841|NCT04806945|Paclitaxel|paclitaxel|mesh-list
154623842|NCT04806945|Carboplatin|carboplatin|mesh-list
154623843|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154623844|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623845|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
154623846|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
154623847|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
154623848|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623849|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
154623850|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154623851|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623852|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154623853|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623854|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
154623855|NCT04805229|Narcotics|narcotics|mesh-ancestor
154623856|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623857|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623858|NCT04805229|Analgesics|analgesics|mesh-ancestor
154623859|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
154623860|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623861|NCT04811313|Bupivacaine|bupivacaine|mesh-list
154623862|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
154623863|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
154623864|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
154623865|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623866|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623867|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
154623868|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623869|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154623870|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154338653|NCT01135927|Insulin|insulin|mesh-list
154623871|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623872|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
154623873|NCT04811313|Coagulants|coagulants|mesh-ancestor
154623874|NCT04352439|Aspirin|aspirin|mesh-list
154623875|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154623876|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623877|NCT04352439|Analgesics|analgesics|mesh-ancestor
154623878|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
154623879|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623880|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623881|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154623882|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623883|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154623884|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154623885|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623886|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154623887|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154623888|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623889|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
154623890|NCT04796025|Bevacizumab|bevacizumab|mesh-list
154623891|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154623892|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623893|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154623894|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154623895|NCT04796025|Growth Substances|growth substances|mesh-ancestor
154623896|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623897|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
154623898|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
154623899|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154623900|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623901|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154623902|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154623904|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623905|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623906|NCT02595723|Megestrol|megestrol|mesh-list
154623907|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
154623908|NCT02595723|Phenytoin|phenytoin|mesh-list
154623909|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154623910|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154623911|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154623912|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
154623913|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154623914|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623915|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154623916|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154623917|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154623918|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623919|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
154623920|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154623921|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
154623922|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154623923|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154623924|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154623925|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623926|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154623927|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154623928|NCT01667679|Sumatriptan|sumatriptan|mesh-list
154623929|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154623930|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154623931|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154623932|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
154623933|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623934|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623935|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623936|NCT02597049|Metformin|metformin|mesh-list
154623937|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
154623938|NCT02597049|Empagliflozin|empagliflozin|mesh-list
154623939|NCT02597049|Canagliflozin|canagliflozin|mesh-list
154623940|NCT02597049|Dulaglutide|dulaglutide|mesh-list
154623941|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154623942|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154623943|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623944|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623945|NCT02597049|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154623946|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
154623947|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154623948|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
154623949|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
154623950|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
154623951|NCT04802967|Ketoprofen|ketoprofen|mesh-list
154623952|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
154623953|NCT04802967|Gabapentin|gabapentin|mesh-list
154623954|NCT04802967|Analgesics|analgesics|mesh-ancestor
154623955|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
154338739|NCT03507556|Minocycline|minocycline|mesh-list
154623956|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154623957|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623958|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
154623959|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154623960|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154623961|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154623962|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154623963|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154623964|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154623965|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154623966|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623967|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
154623968|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154623969|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154623970|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154623971|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623972|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154623973|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154623974|NCT05616117|Vitamin D|vitamin d|mesh-list
154623975|NCT05616117|Vitamins|vitamins|mesh-list
154623976|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
154623977|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623978|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154623979|NCT02594163|Rituximab|rituximab|mesh-list
154623980|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154623981|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154623982|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154623983|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154623984|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
154623985|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623986|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154623987|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154623988|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
154623989|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623990|NCT02594163|Immunotoxins|immunotoxins|mesh-ancestor
154623991|NCT02594163|Immunoconjugates|immunoconjugates|mesh-ancestor
154623992|NCT03206255|Vaccines|vaccines|mesh-list
154623993|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
154623994|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623995|NCT03206411|Hormones|hormones|mesh-list
154659731|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154623996|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154623997|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154623998|NCT03206021|Carboplatin|carboplatin|mesh-list
154623999|NCT03206021|Azacitidine|azacitidine|mesh-list
154624000|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624001|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154624002|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
154624003|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624004|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624005|NCT03200561|Prednisolone|prednisolone|mesh-list
154624006|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
154624007|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154624008|NCT03200561|Antibodies|antibodies|mesh-list
154624009|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624010|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
154624011|NCT03200561|Hormones|hormones|mesh-ancestor
154624012|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624013|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624014|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154624015|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624016|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
154624017|NCT02449811|Amlodipine|amlodipine|mesh-list
154624018|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154624019|NCT02449811|Olmesartan|olmesartan|mesh-list
154624020|NCT02449811|Perindopril|perindopril|mesh-list
154624021|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154624022|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154624023|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624024|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624025|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154624026|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624027|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
154624028|NCT02449811|Diuretics|diuretics|mesh-ancestor
154624029|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
154624030|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154624031|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154624032|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154624033|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154624034|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
154624035|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624036|NCT03200093|Vancomycin|vancomycin|mesh-list
154624037|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154624038|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624039|NCT03204929|Copper|copper|mesh-list
154624040|NCT03204929|Trace Elements|trace elements|mesh-ancestor
154624041|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
154624042|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624043|NCT02596971|Prednisone|prednisone|mesh-list
154624044|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
154624045|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154624046|NCT02596971|Rituximab|rituximab|mesh-list
154624047|NCT02596971|Doxorubicin|doxorubicin|mesh-list
154624048|NCT02596971|Vincristine|vincristine|mesh-list
154624049|NCT02596971|Atezolizumab|atezolizumab|mesh-list
154624050|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
154624051|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154624052|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
154624053|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624054|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624055|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154624056|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
154624057|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624058|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624059|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154624060|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154624061|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154624062|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154624063|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154624064|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624065|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624066|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
154624067|NCT02596971|Hormones|hormones|mesh-ancestor
154624068|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624069|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154624070|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154624071|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
154624072|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
154624073|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
154624074|NCT02596971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154624075|NCT04808739|Adalimumab|adalimumab|mesh-list
154624076|NCT04808739|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154624077|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624078|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624079|NCT04808895|Aspirin|aspirin|mesh-list
154624080|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154624081|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154624082|NCT04808895|Analgesics|analgesics|mesh-ancestor
154624083|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
154624084|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624085|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338878|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
154624086|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624087|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624088|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154624089|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154624090|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624091|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154624092|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154624093|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624094|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
154624095|NCT04485689|Capsaicin|capsaicin|mesh-list
154624096|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
154624097|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
154624098|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
154624099|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624100|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624101|NCT03204071|Metformin|metformin|mesh-list
154624102|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154624103|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624104|NCT04801017|Artemisinins|artemisinins|mesh-list
154624105|NCT04801017|Artemisinin|artemisinin|mesh-list
154624106|NCT04801017|Trabedersen|trabedersen|mesh-list
154624107|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
154624108|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154624109|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154624110|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624111|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624112|NCT03107429|Acetazolamide|acetazolamide|mesh-list
154624113|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
154624114|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154624115|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624116|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624117|NCT03107429|Diuretics|diuretics|mesh-ancestor
154624118|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
154624119|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624120|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
154624121|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154624122|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154236839|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154624123|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624124|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
154624125|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
154624127|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154624128|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154624129|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154624130|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154624131|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624132|NCT03202979|Trazodone|trazodone|mesh-list
154624133|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154624134|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154624135|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624136|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624137|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154624138|NCT03202979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154624139|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154624140|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624141|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624142|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624143|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
154624144|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154624145|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
154624146|NCT04799925|Febuxostat|febuxostat|mesh-list
154624147|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
154624148|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624149|NCT03232307|Dexamethasone|dexamethasone|mesh-list
154624150|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
154624151|NCT03232307|Rituximab|rituximab|mesh-list
154624152|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154624153|NCT03232307|Lenalidomide|lenalidomide|mesh-list
154624154|NCT03232307|Antibodies|antibodies|mesh-list
154624155|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
154624156|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154624157|NCT03232307|BB 1101|bb 1101|mesh-list
154624158|NCT03232307|Ibrutinib|ibrutinib|mesh-list
154624159|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
154624160|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624161|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624162|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624163|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624164|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
154624165|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
154624166|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624167|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154624168|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
154624169|NCT03232307|Hormones|hormones|mesh-ancestor
154624170|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624171|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154624172|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154624173|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154624174|NCT03232307|Growth Substances|growth substances|mesh-ancestor
154624175|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
154624176|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
154624177|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624178|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624179|NCT03232307|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154624180|NCT03232307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154624181|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
154624182|NCT05615727|Zolpidem|zolpidem|mesh-list
154624183|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154624184|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624185|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624186|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154624187|NCT05615727|Analgesics|analgesics|mesh-ancestor
154624188|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
154624189|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624190|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154624191|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154624192|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154624193|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154624194|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624195|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624196|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154236916|NCT03819556|Caseins|caseins|mesh-list
154624197|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154624198|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
154624199|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
154624200|NCT02450279|Edetic Acid|edetic acid|mesh-list
154624201|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
154624202|NCT02450279|Antidotes|antidotes|mesh-ancestor
154624203|NCT02450279|Protective Agents|protective agents|mesh-ancestor
154624204|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624205|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
154624206|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
154624207|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624208|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154624209|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
154624210|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154624211|NCT03231683|Ketamine|ketamine|mesh-list
154624212|NCT03231683|Remifentanil|remifentanil|mesh-list
154624213|NCT03231683|Propofol|propofol|mesh-list
154624214|NCT03231683|Esketamine|esketamine|mesh-list
154624215|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154624216|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624217|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624218|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154624219|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
154624220|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
154624221|NCT03231683|Analgesics|analgesics|mesh-ancestor
154624222|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
154624223|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624224|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154624225|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154624226|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154624227|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624228|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624229|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154624230|NCT03231683|Narcotics|narcotics|mesh-ancestor
154624231|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
154624232|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154624233|NCT02593773|Interferons|interferons|mesh-list
154624234|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
154624235|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624236|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
154624237|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624238|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
154624239|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154624240|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
154624241|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624242|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
154624243|NCT04798443|Protective Agents|protective agents|mesh-ancestor
154624244|NCT02450045|Bupivacaine|bupivacaine|mesh-list
154624245|NCT02450045|Ropivacaine|ropivacaine|mesh-list
154624246|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
154624247|NCT02450045|Anesthetics|anesthetics|mesh-list
154624248|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624249|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624250|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
154624251|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624252|NCT02593539|Nemiralisib|nemiralisib|mesh-list
154624253|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154624254|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339027|NCT01138423|Renin Inhibitors|renin inhibitors|mesh-ancestor
154624255|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624256|NCT02593305|Methamphetamine|methamphetamine|mesh-list
154624257|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154624258|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624259|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
154624260|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
154624261|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624262|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
154624263|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624264|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624265|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
154624266|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154624267|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154624268|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624269|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154624270|NCT04389411|Montelukast|montelukast|mesh-list
154624271|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154624272|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
154624273|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154624274|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
154624275|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624276|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624277|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154624278|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154624279|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624280|NCT02448251|Abivertinib|abivertinib|mesh-list
154624281|NCT02448251|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154624282|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154624283|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624284|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624285|NCT03195569|Paclitaxel|paclitaxel|mesh-list
154624286|NCT03195569|Bevacizumab|bevacizumab|mesh-list
154624287|NCT03195569|Carboplatin|carboplatin|mesh-list
154624288|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154624289|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624290|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
154624291|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
154624292|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
154624293|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624294|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154624295|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154624296|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154624297|NCT03195569|Growth Substances|growth substances|mesh-ancestor
154624298|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624299|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
154624300|NCT02447939|Trametinib|trametinib|mesh-list
154624301|NCT02447939|Dabrafenib|dabrafenib|mesh-list
154624302|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624303|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154624304|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624305|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624306|NCT04785183|Melatonin|melatonin|mesh-list
154624307|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
154624308|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624309|NCT04785183|Protective Agents|protective agents|mesh-ancestor
154624310|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624311|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624312|NCT03195491|Nivolumab|nivolumab|mesh-list
154624313|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154624314|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624315|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154624316|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624317|NCT03195413|Lidocaine|lidocaine|mesh-list
154624318|NCT03195413|Epinephrine|epinephrine|mesh-list
154624319|NCT03195413|Racepinephrine|racepinephrine|mesh-list
154624320|NCT03195413|Bupivacaine|bupivacaine|mesh-list
154624321|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
154624322|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
154624323|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
154624324|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624325|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624326|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
154624327|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624328|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154624329|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154624330|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154624331|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624332|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624333|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154624334|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154624335|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
154624336|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624337|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154624338|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154624339|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
154624340|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154624341|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
154624342|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
154624343|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
154624344|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154624345|NCT02447705|Telbivudine|telbivudine|mesh-list
154624346|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
154624347|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624348|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154624349|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624350|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624351|NCT03195257|Glucagon|glucagon|mesh-list
154624352|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154624353|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154624354|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154624355|NCT03195257|Hormones|hormones|mesh-ancestor
154624356|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624357|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624358|NCT03195257|Incretins|incretins|mesh-ancestor
154624359|NCT02447393|Cetirizine|cetirizine|mesh-list
154624360|NCT02447393|Levocetirizine|levocetirizine|mesh-list
154624361|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154624362|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154624363|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154624364|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
154624365|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
154624366|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624367|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624368|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624369|NCT02447315|Pilocarpine|pilocarpine|mesh-list
154624370|NCT02447315|Miotics|miotics|mesh-ancestor
154624371|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
154624372|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624373|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624374|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154624375|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154624376|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
154624377|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624378|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624379|NCT04792515|Apatinib|apatinib|mesh-list
154624380|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624381|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154624382|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624383|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624384|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154624385|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154624386|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624387|NCT03195023|Amlodipine|amlodipine|mesh-list
154624388|NCT03195023|Lisinopril|lisinopril|mesh-list
154624389|NCT03195023|Lercanidipine|lercanidipine|mesh-list
154624390|NCT03195023|Furosemide|furosemide|mesh-list
154624391|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154624392|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154624393|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154624394|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154624395|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624396|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624397|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154624398|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624399|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
154624400|NCT03195023|Diuretics|diuretics|mesh-ancestor
154624401|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
154624402|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154624403|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
154624404|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154624405|NCT03195023|Protective Agents|protective agents|mesh-ancestor
154624406|NCT02446301|Nalbuphine|nalbuphine|mesh-list
154624407|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154624408|NCT02446301|Narcotics|narcotics|mesh-ancestor
154624409|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624410|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624411|NCT02446301|Analgesics|analgesics|mesh-ancestor
154624412|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
154624413|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624414|NCT04791345|Dexamethasone|dexamethasone|mesh-list
154624415|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
154624416|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
154624417|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154624418|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154624419|NCT04791345|Prednisolone|prednisolone|mesh-list
154624420|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
154624421|NCT04791345|Deflazacort|deflazacort|mesh-list
154237162|NCT00143390|Exemestane|exemestane|mesh-list
154624422|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154624423|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
154624424|NCT04791345|BB 1101|bb 1101|mesh-list
154624425|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624426|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
154624427|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
154624428|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624429|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624430|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154624431|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
154624432|NCT04791345|Hormones|hormones|mesh-ancestor
154624433|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624434|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154624435|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624436|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
154624437|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624438|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624439|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154624440|NCT04791345|Protective Agents|protective agents|mesh-ancestor
154624441|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154624442|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
154624443|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
154624444|NCT02445989|NuvaRing|nuvaring|mesh-list
154624445|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154624446|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624447|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154624448|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
154624449|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154624450|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154624451|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154624452|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
154624453|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624454|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154624455|NCT03231215|Dexamethasone|dexamethasone|mesh-list
154624456|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624457|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
154624458|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
154624459|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624460|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624461|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154624462|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
154624463|NCT03231215|Hormones|hormones|mesh-ancestor
154624464|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624465|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154624466|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624467|NCT04784481|Ivermectin|ivermectin|mesh-list
154624468|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154624469|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624470|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
154624471|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
154624472|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154624473|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624474|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154624475|NCT03526185|Nivolumab|nivolumab|mesh-list
154624476|NCT03526185|Ipilimumab|ipilimumab|mesh-list
154624477|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154624478|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624479|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154624480|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624481|NCT02445599|Dipyrone|dipyrone|mesh-list
154624482|NCT02445599|Diclofenac|diclofenac|mesh-list
154624483|NCT02445599|Atropine|atropine|mesh-list
154624484|NCT02445599|Midazolam|midazolam|mesh-list
154624485|NCT02445599|Fentanyl|fentanyl|mesh-list
154624486|NCT02445599|Tramadol|tramadol|mesh-list
154624487|NCT02445599|Nalbuphine|nalbuphine|mesh-list
154624488|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154624489|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154624490|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624491|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624492|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154339269|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
154624493|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154624494|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154624495|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154624496|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
154624497|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
154624498|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
154624499|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
154624500|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624501|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624502|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154624503|NCT02445599|Narcotics|narcotics|mesh-ancestor
154624504|NCT02445599|Analgesics|analgesics|mesh-ancestor
154624505|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
154624506|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624507|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154624508|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154624509|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624510|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624511|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154624512|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624513|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154624514|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154624515|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
154624516|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154624517|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
154624518|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
154624519|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
154624520|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154624521|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154624522|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
154624523|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
154624524|NCT03194633|Nifedipine|nifedipine|mesh-list
154624525|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154624526|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624527|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624528|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154624529|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624530|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
154624531|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
154624532|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154624533|NCT03194555|Acetaminophen|acetaminophen|mesh-list
154624534|NCT03194555|Naltrexone|naltrexone|mesh-list
154624535|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154624536|NCT03194555|Analgesics|analgesics|mesh-ancestor
154624537|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
154624538|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624539|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624540|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
154624541|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154624542|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154624543|NCT04790331|Verapamil|verapamil|mesh-list
154624544|NCT04790331|Diltiazem|diltiazem|mesh-list
154624545|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154624546|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154624547|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624548|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624549|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154624550|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624551|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
154624552|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154624553|NCT04789941|Irinotecan|irinotecan|mesh-list
154624554|NCT04789941|Cisplatin|cisplatin|mesh-list
154624555|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154624556|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154624557|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624558|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624559|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624560|NCT02445053|Ivacaftor|ivacaftor|mesh-list
154624561|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154624562|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624563|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624564|NCT02444897|Fentanyl|fentanyl|mesh-list
154624565|NCT02444897|Nefopam|nefopam|mesh-list
154624566|NCT02444897|Ramosetron|ramosetron|mesh-list
154624567|NCT02444897|Ropivacaine|ropivacaine|mesh-list
154624568|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
154624569|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
154624570|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624571|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624572|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
154624573|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624574|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154624575|NCT02444897|Narcotics|narcotics|mesh-ancestor
154624576|NCT02444897|Analgesics|analgesics|mesh-ancestor
154624577|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154624578|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154624579|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
154624580|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
154624581|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
154624582|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154624583|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154624584|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
154624585|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624586|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624587|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154624588|NCT03229889|Tadalafil|tadalafil|mesh-list
154624589|NCT03229889|Tamsulosin|tamsulosin|mesh-list
154624590|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
154624591|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154624592|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154624593|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624594|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624595|NCT03229889|Urological Agents|urological agents|mesh-ancestor
154624596|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154624597|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154624598|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154624599|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
154624600|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624601|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624602|NCT02444585|Denosumab|denosumab|mesh-list
154624603|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154624604|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624605|NCT03120221|Iodine|iodine|mesh-list
154624606|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154624607|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624608|NCT03120221|Trace Elements|trace elements|mesh-ancestor
154624609|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
154624610|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624611|NCT03193073|Mitogens|mitogens|mesh-list
154624612|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
154624613|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624614|NCT02444507|Esomeprazole|esomeprazole|mesh-list
154624615|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154624616|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154624617|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154624618|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624619|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624620|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154624621|NCT01626352|Ofatumumab|ofatumumab|mesh-list
154624622|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154624623|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
154624624|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339394|NCT02313922|Analgesics|analgesics|mesh-ancestor
154624625|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624626|NCT02080767|Tecovirimat|tecovirimat|mesh-list
154624627|NCT02080767|Antiviral Agents|antiviral agents|mesh-ancestor
154624628|NCT02080767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624629|NCT01626118|Indomethacin|indomethacin|mesh-list
154624630|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154624631|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154624632|NCT01626118|Analgesics|analgesics|mesh-ancestor
154624633|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
154624634|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624635|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624636|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624637|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624638|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
154624639|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
154624640|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154624641|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154624642|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624643|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624644|NCT04789005|Phenylephrine|phenylephrine|mesh-list
154624645|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
154624646|NCT04789005|Norepinephrine|norepinephrine|mesh-list
154624647|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154624648|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
154624649|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
154624650|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624651|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624652|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
154624653|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154624654|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
154624655|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
154624656|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154624657|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154624658|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154624659|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
154624660|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624661|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624662|NCT04789005|Protective Agents|protective agents|mesh-ancestor
154624663|NCT02152384|Insulin|insulin|mesh-list
154624664|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154624665|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
154624666|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
154624667|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154624668|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624669|NCT05469243|Hallucinogens|hallucinogens|mesh-list
154624670|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624671|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154624672|NCT02177266|Colchicine|colchicine|mesh-list
154624673|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
154624674|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624675|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
154624676|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
154624677|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
154624678|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624679|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624680|NCT04788381|Bevacizumab|bevacizumab|mesh-list
154624681|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154624682|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624683|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154624684|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154624685|NCT04788381|Growth Substances|growth substances|mesh-ancestor
154624686|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624687|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
154624688|NCT05474937|Midazolam|midazolam|mesh-list
154624689|NCT05474937|Ketamine|ketamine|mesh-list
154624690|NCT05474937|Propofol|propofol|mesh-list
154624691|NCT05474937|Sevoflurane|sevoflurane|mesh-list
154624692|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154624693|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624694|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624695|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154624696|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
154624697|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
154624698|NCT05474937|Analgesics|analgesics|mesh-ancestor
154624699|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
154624700|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624701|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154624702|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154624703|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154624704|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624705|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624706|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154624707|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154624708|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154624709|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154624710|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
154624711|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
154624712|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154624713|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154624714|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154624715|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
154624716|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624717|NCT02177032|Vaccines|vaccines|mesh-list
154624718|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
154624719|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154624720|NCT02177032|Antibodies|antibodies|mesh-list
154624721|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
154624722|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624723|NCT02176642|Oxybutynin|oxybutynin|mesh-list
154624724|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
154624725|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
154624726|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624727|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624728|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154624729|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154624730|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
154624731|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624732|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624733|NCT02176642|Urological Agents|urological agents|mesh-ancestor
154624734|NCT02116660|Ritonavir|ritonavir|mesh-list
154624735|NCT02116660|Lopinavir|lopinavir|mesh-list
154624736|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154624737|NCT02116660|Darunavir|darunavir|mesh-list
154624738|NCT02116660|Tenofovir|tenofovir|mesh-list
154624739|NCT02116660|Lamivudine|lamivudine|mesh-list
154624740|NCT02116660|Emtricitabine|emtricitabine|mesh-list
154624741|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
154624742|NCT02116660|Nevirapine|nevirapine|mesh-list
154624743|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154624744|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154624745|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
154624746|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624747|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624748|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154624749|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154624750|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
154624751|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624752|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154624753|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154624754|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154624755|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154624756|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154624757|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154624758|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154624759|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154624760|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154624761|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
154624762|NCT02176018|Quinidine|quinidine|mesh-list
154624763|NCT02176018|Levomethorphan|levomethorphan|mesh-list
154624764|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
154624765|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
154624766|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
154624767|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154624768|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154624769|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624770|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624771|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624772|NCT02176018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154624773|NCT02176018|Narcotics|narcotics|mesh-ancestor
154624774|NCT02176018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624775|NCT02176018|Analgesics|analgesics|mesh-ancestor
154624776|NCT02176018|Sensory System Agents|sensory system agents|mesh-ancestor
154624777|NCT02176018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624778|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154624779|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154624780|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
154624781|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154624782|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
154624783|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154624784|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154624785|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624786|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624787|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154624788|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154624789|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
154624790|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154624791|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154624792|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624793|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154624794|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154624795|NCT05611827|Quercetin|quercetin|mesh-list
154624796|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
154624797|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624798|NCT05611827|Protective Agents|protective agents|mesh-ancestor
154624799|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624800|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
154624801|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154624802|NCT05612607|Antibodies|antibodies|mesh-list
154624803|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
154624804|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624805|NCT02589639|Empagliflozin|empagliflozin|mesh-list
154624806|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154624807|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624808|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154624809|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624810|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154624811|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154624812|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154624813|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624814|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624815|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624816|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624817|NCT05611749|Analgesics|analgesics|mesh-ancestor
154624818|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
154624819|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624820|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
154624821|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154624822|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
154624823|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154624824|NCT05612451|Calcium|calcium|mesh-list
154624825|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154624826|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624827|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624828|NCT02151682|Morphine|morphine|mesh-list
154624829|NCT02151682|Tapentadol|tapentadol|mesh-list
154624830|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154624831|NCT02151682|Narcotics|narcotics|mesh-ancestor
154624832|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624833|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624834|NCT02151682|Analgesics|analgesics|mesh-ancestor
154624835|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
154624836|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624837|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154624838|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154624839|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624840|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624841|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
154624842|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624843|NCT04331691|Amiloride|amiloride|mesh-list
154624844|NCT04331691|Spironolactone|spironolactone|mesh-list
154624845|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154624846|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
154624847|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624848|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624849|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154624850|NCT04331691|Diuretics|diuretics|mesh-ancestor
154624851|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
154624852|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154624853|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154624854|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624855|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624856|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154624857|NCT02174848|Deferiprone|deferiprone|mesh-list
154624858|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154624859|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
154624860|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
154624861|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624862|NCT02151058|Listerine|listerine|mesh-list
154624863|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
154624864|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
154624865|NCT02151058|Protective Agents|protective agents|mesh-ancestor
154624866|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624867|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154624868|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624869|NCT05205759|Sotrovimab|sotrovimab|mesh-list
154624870|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
154624871|NCT05205759|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154624872|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
154624873|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154624874|NCT02149264|Testosterone|testosterone|mesh-list
154624875|NCT02149264|Androgens|androgens|mesh-ancestor
154624876|NCT02149264|Hormones|hormones|mesh-ancestor
154624877|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624878|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624879|NCT05557149|Cocaine|cocaine|mesh-list
154624880|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
154624882|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154624883|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624884|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
154624885|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624886|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154624887|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154624888|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154624889|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154624890|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624891|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
154624892|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624893|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
154624894|NCT02115256|Terbutaline|terbutaline|mesh-list
154624895|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
154624896|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154624897|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
154624898|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624899|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624900|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154624901|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
154624902|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
154624903|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
154624904|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154624905|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154624906|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154624907|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154624908|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154624909|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154624910|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624911|NCT02173054|Adapalene|adapalene|mesh-list
154624912|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154624913|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154624914|NCT02173054|Analgesics|analgesics|mesh-ancestor
154624915|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
154624916|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624917|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624918|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624919|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624920|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
154624921|NCT04225221|Leuprolide|leuprolide|mesh-list
154624922|NCT04225221|Estradiol|estradiol|mesh-list
154624923|NCT04225221|Progesterone|progesterone|mesh-list
154624924|NCT04225221|Estrogens|estrogens|mesh-ancestor
154624925|NCT04225221|Hormones|hormones|mesh-ancestor
154624926|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624927|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624928|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154624929|NCT04225221|Progestins|progestins|mesh-ancestor
154624930|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154624931|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
154624932|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154624933|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624934|NCT04425993|Indomethacin|indomethacin|mesh-list
154624935|NCT04425993|Isosorbide|isosorbide|mesh-list
154624936|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154339712|NCT04463056|Eculizumab|eculizumab|mesh-list
154624937|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154624938|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154624939|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154624940|NCT04425993|Analgesics|analgesics|mesh-ancestor
154624941|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
154624942|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624943|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624944|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624945|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624946|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
154624947|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
154624948|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154624949|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154624950|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624951|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624952|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154624953|NCT04425993|Diuretics|diuretics|mesh-ancestor
154624954|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
154624955|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
154624956|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154624957|NCT03971643|Vilobelimab|vilobelimab|mesh-list
154624958|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154624959|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154624960|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
154624961|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624962|NCT02149108|Nintedanib|nintedanib|mesh-list
154624963|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624964|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154624965|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154624966|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624967|NCT02148718|Adalimumab|adalimumab|mesh-list
154624968|NCT02148718|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154624969|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624970|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154624971|NCT03397953|Vinorelbine|vinorelbine|mesh-list
154624972|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154624973|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624974|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154624975|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154624976|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154624977|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154624978|NCT05549973|Dexamethasone|dexamethasone|mesh-list
154624979|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624980|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
154624981|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
154624982|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154624983|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624984|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154624985|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
154624986|NCT05549973|Hormones|hormones|mesh-ancestor
154624987|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154624988|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154624989|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154624990|NCT02148250|Insulin|insulin|mesh-list
154624991|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154624992|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154624993|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154624994|NCT04870359|Prednisolone|prednisolone|mesh-list
154624995|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154624996|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154624997|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
154624998|NCT04870359|Hormones|hormones|mesh-ancestor
154624999|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625000|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625001|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625002|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625003|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
154625004|NCT05549583|Metformin|metformin|mesh-list
154625005|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154625006|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625007|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625008|NCT05549583|Incretins|incretins|mesh-ancestor
154625009|NCT05549583|Hormones|hormones|mesh-ancestor
154625010|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625011|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154625012|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
154625013|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625014|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625015|NCT05554731|Hemostatics|hemostatics|mesh-list
154625016|NCT05554731|Coagulants|coagulants|mesh-ancestor
154625017|NCT02172040|Celecoxib|celecoxib|mesh-list
154625018|NCT02172040|Amlodipine|amlodipine|mesh-list
154625019|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154625020|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154625021|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625022|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625023|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154625024|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625025|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
154625026|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154625027|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625028|NCT02172040|Analgesics|analgesics|mesh-ancestor
154625029|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
154625030|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625031|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625032|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154625033|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154625034|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154625035|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625036|NCT02367105|Testosterone|testosterone|mesh-list
154625037|NCT02367105|Androgens|androgens|mesh-ancestor
154625038|NCT02367105|Hormones|hormones|mesh-ancestor
154625039|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625040|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625041|NCT05554185|Aspirin|aspirin|mesh-list
154625042|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154625043|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625044|NCT05554185|Analgesics|analgesics|mesh-ancestor
154625045|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
154625046|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625047|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625048|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625049|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154625050|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154625051|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154625052|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625053|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154625054|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154625055|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625056|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
154625057|NCT05558397|Morphine|morphine|mesh-list
154625058|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154625059|NCT05558397|Narcotics|narcotics|mesh-ancestor
154625060|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625061|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625062|NCT05558397|Analgesics|analgesics|mesh-ancestor
154625063|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
154625064|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625065|NCT05558319|Dexamethasone|dexamethasone|mesh-list
154625066|NCT05558319|Lenalidomide|lenalidomide|mesh-list
154625067|NCT05558319|Bortezomib|bortezomib|mesh-list
154625068|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625069|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
154625070|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
154625071|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625072|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625073|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154625074|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
154625075|NCT05558319|Hormones|hormones|mesh-ancestor
154625076|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625077|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625078|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625079|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
154625080|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154625081|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154625082|NCT05558319|Growth Substances|growth substances|mesh-ancestor
154625083|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
154625084|NCT05553717|Carvedilol|carvedilol|mesh-list
154625085|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154625086|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154625087|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
154625088|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625089|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625090|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625091|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154625092|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
154625093|NCT05553717|Protective Agents|protective agents|mesh-ancestor
154625094|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154625095|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625096|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154625097|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
154625098|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154625099|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154625100|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
154625101|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154625102|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
154625103|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154625104|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625105|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154625106|NCT05553093|Insulin|insulin|mesh-list
154625107|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154625108|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
154625109|NCT05553093|Tirzepatide|tirzepatide|mesh-list
154625110|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625111|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625112|NCT05553093|Incretins|incretins|mesh-ancestor
154625113|NCT05553093|Hormones|hormones|mesh-ancestor
154625114|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625115|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
154625116|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154625117|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154625118|NCT04757740|Prednisolone|prednisolone|mesh-list
154625119|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
154625120|NCT04757740|Lidocaine|lidocaine|mesh-list
154625121|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154625122|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
154625123|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
154625124|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
154625125|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625126|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625127|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
154625128|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625129|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154625130|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154625131|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154625132|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625133|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625134|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625135|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
154625136|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
154625137|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154625138|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
154625139|NCT04757740|Hormones|hormones|mesh-ancestor
154625140|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625141|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154625142|NCT04757740|Protective Agents|protective agents|mesh-ancestor
154625143|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625144|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625145|NCT05552937|Lenalidomide|lenalidomide|mesh-list
154625146|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
154625147|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625148|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154625149|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154625150|NCT05552937|Growth Substances|growth substances|mesh-ancestor
154625151|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
154625152|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625153|NCT02112448|Acetaminophen|acetaminophen|mesh-list
154625154|NCT02112448|Ketorolac|ketorolac|mesh-list
154625155|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154625156|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625157|NCT02112448|Analgesics|analgesics|mesh-ancestor
154625158|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
154625159|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625160|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625161|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
154625162|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154625163|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625164|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154625165|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154625166|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625167|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625168|NCT02109562|Risperidone|risperidone|mesh-list
154625169|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154625170|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
154625171|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625172|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625173|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625174|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154625175|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154625176|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237914|NCT02043587|Hormones|hormones|mesh-ancestor
154625177|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154625178|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154625179|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
154625180|NCT02109484|Vaccines|vaccines|mesh-list
154625181|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
154625182|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625183|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
154625184|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154625185|NCT05134792|Antibodies|antibodies|mesh-list
154625186|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
154625187|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154625188|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
154625189|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625190|NCT02105974|Fluticasone|fluticasone|mesh-list
154625191|NCT02105974|Xhance|xhance|mesh-list
154625192|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625193|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154625194|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
154625195|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625196|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625197|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154625198|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
154625199|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
154625200|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154625201|NCT02105662|Grazoprevir|grazoprevir|mesh-list
154625202|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
154625203|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625204|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
154625205|NCT02142712|Promethazine|promethazine|mesh-list
154625206|NCT02142712|Levomethorphan|levomethorphan|mesh-list
154625207|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
154625208|NCT02142712|Pantoprazole|pantoprazole|mesh-list
154625209|NCT02142712|Famotidine|famotidine|mesh-list
154625210|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154625211|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154625212|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154625213|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625214|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625215|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154625216|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154625217|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625218|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625219|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
154625220|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
154625221|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
154625222|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625223|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
154625224|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
154625225|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154625226|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
154625227|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
154625228|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625229|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154625230|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
154625231|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
154625232|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
154625233|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
154625234|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154625235|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154625236|NCT02142712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154625237|NCT02142712|Narcotics|narcotics|mesh-ancestor
154625238|NCT02142712|Analgesics|analgesics|mesh-ancestor
154625239|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154625240|NCT02105272|Carteolol|carteolol|mesh-list
154625241|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154625242|NCT02105272|Latanoprost|latanoprost|mesh-list
154625243|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154625244|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154625245|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154625246|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
154625247|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625248|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625249|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625250|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154625251|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154625252|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
154625253|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
154625254|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237974|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625255|NCT02141854|Fluticasone|fluticasone|mesh-list
154625256|NCT02141854|Xhance|xhance|mesh-list
154625257|NCT02141854|Albuterol|albuterol|mesh-list
154625258|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154625259|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
154625260|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625261|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154625262|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
154625263|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625264|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625265|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154625266|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
154625267|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
154625268|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154625269|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154625270|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154625271|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
154625272|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625273|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625274|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
154625275|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154625277|NCT02141620|Cocaine|cocaine|mesh-list
154625278|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154625279|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
154625280|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625281|NCT02141620|Expectorants|expectorants|mesh-ancestor
154625282|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
154625283|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154625284|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
154625285|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625286|NCT02141620|Protective Agents|protective agents|mesh-ancestor
154625287|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625288|NCT02141620|Antidotes|antidotes|mesh-ancestor
154625289|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154625290|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
154625291|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625292|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
154625293|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625294|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154625295|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154625296|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154625297|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625298|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
154625299|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625300|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154625301|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154625302|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
154625303|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154625304|NCT01664949|Laxatives|laxatives|mesh-ancestor
154625305|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154625306|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
154625307|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
154625308|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
154625309|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625310|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625311|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
154625312|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625313|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
154625314|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154625315|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625316|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154625317|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154625318|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625319|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625320|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625321|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154625322|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154625323|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
154625324|NCT05552391|Ketamine|ketamine|mesh-list
154625325|NCT05552391|Bupivacaine|bupivacaine|mesh-list
154625326|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
154625327|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
154625328|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625329|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625330|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
154625331|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625332|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154238078|NCT03775876|Propofol|propofol|mesh-list
154625333|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625335|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154625336|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154625337|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154625338|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
154625339|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625340|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625341|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154625342|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154625343|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
154625344|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154625345|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154625346|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
154625347|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154625348|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625349|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625350|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154625351|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625352|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154625353|NCT02105116|Cytarabine|cytarabine|mesh-list
154625354|NCT02105116|Fludarabine|fludarabine|mesh-list
154625355|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
154625356|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625357|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154625358|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
154625359|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625360|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154625361|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
154625362|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625363|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
154625364|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625365|NCT05551767|Cisplatin|cisplatin|mesh-list
154625366|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
154625367|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625368|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154625369|NCT05551767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154625370|NCT05551767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625371|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154625372|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154625373|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625374|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154625375|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154625376|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625377|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625378|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
154625379|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625380|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154625381|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154625382|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625383|NCT05547789|Analgesics|analgesics|mesh-ancestor
154625384|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
154625385|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625386|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625387|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154625388|NCT05542095|Simvastatin|simvastatin|mesh-list
154625389|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154625390|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154625391|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
154625392|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625393|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154625394|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154625395|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625396|NCT05551221|Tamsulosin|tamsulosin|mesh-list
154625397|NCT05551221|Silodosin|silodosin|mesh-list
154625398|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154625399|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154625400|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154625401|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
154625402|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625403|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238165|NCT01321138|Analgesics|analgesics|mesh-ancestor
154625404|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625405|NCT05551221|Urological Agents|urological agents|mesh-ancestor
154625406|NCT02104804|Insulin|insulin|mesh-list
154625407|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154625408|NCT02104804|Metformin|metformin|mesh-list
154625409|NCT02104804|Saxagliptin|saxagliptin|mesh-list
154625410|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
154625411|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625412|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625413|NCT02104804|Incretins|incretins|mesh-ancestor
154625414|NCT02104804|Hormones|hormones|mesh-ancestor
154625415|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625416|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154625417|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
154625418|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625419|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625420|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
154625421|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154625422|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625423|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625424|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625425|NCT05546619|Tislelizumab|tislelizumab|mesh-list
154625426|NCT05546619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154625427|NCT05546619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625428|NCT05592327|Citric Acid|citric acid|mesh-list
154625429|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
154625430|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
154625431|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154625432|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
154625433|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
154340201|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
154625434|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625435|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
154625436|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154625437|NCT05592171|Estrogens|estrogens|mesh-ancestor
154625438|NCT05592171|Hormones|hormones|mesh-ancestor
154625439|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625440|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625441|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625442|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625443|NCT05539521|Propofol|propofol|mesh-list
154625444|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154625445|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625446|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625447|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154625448|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
154625449|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
154625450|NCT05538507|Memantine|memantine|mesh-list
154625451|NCT05538507|Donepezil|donepezil|mesh-list
154625452|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154625453|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625454|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625455|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
154625456|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625457|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625458|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
154625459|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154625460|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154625461|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
154625462|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154625463|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154625464|NCT05591235|Metformin|metformin|mesh-list
154625465|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
154625466|NCT05591235|Pioglitazone|pioglitazone|mesh-list
154625467|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625468|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625469|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154625470|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625471|NCT01666119|Buprenorphine|buprenorphine|mesh-list
154625472|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154625473|NCT01666119|Narcotics|narcotics|mesh-ancestor
154625474|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625475|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625476|NCT01666119|Analgesics|analgesics|mesh-ancestor
154625477|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
154625478|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625479|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154625480|NCT04425681|Bevacizumab|bevacizumab|mesh-list
154625481|NCT04425681|Osimertinib|osimertinib|mesh-list
154625482|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154625483|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625484|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154625485|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154625486|NCT04425681|Growth Substances|growth substances|mesh-ancestor
154625487|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625488|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
154625489|NCT04425681|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154625490|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154625491|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625492|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625493|NCT05545059|Amlodipine|amlodipine|mesh-list
154625494|NCT05545059|Valsartan|valsartan|mesh-list
154625495|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154625496|NCT05545059|Spironolactone|spironolactone|mesh-list
154625497|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154340261|NCT05158309|Capsaicin|capsaicin|mesh-list
154625498|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154625499|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154625500|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625501|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625502|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154625503|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625504|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
154625505|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154625506|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154625507|NCT05545059|Diuretics|diuretics|mesh-ancestor
154625508|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
154625509|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154625510|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154625511|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
154625512|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625513|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154625514|NCT05128773|Tamoxifen|tamoxifen|mesh-list
154625515|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154625516|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
154625517|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625518|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625519|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625520|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625521|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154625522|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154625523|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154625524|NCT04677855|Prednisone|prednisone|mesh-list
154625525|NCT04677855|Dutasteride|dutasteride|mesh-list
154625526|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625527|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
154625528|NCT04677855|Hormones|hormones|mesh-ancestor
154625529|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625530|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625531|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625532|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625533|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154625534|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154625535|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625536|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625537|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
154625538|NCT02584959|Complement C1s|complement c1s|mesh-list
154625539|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154625540|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154625541|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
154625542|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625543|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154625544|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154625545|NCT02584257|Albuterol|albuterol|mesh-list
154625546|NCT02584257|Procaterol|procaterol|mesh-list
154625547|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
154625548|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154625549|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
154625550|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625551|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625552|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154625553|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
154625554|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
154625555|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154625556|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154625557|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154625558|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154625559|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
154625560|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625561|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625562|NCT02584257|Miotics|miotics|mesh-ancestor
154625563|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154625564|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154625565|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154625566|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154625567|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
154625568|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
154625569|NCT04090203|Immunomodulating Agents|immunomodulating agents|mesh-list
154625570|NCT04090203|Immunologic Factors|immunologic factors|mesh-ancestor
154625571|NCT04090203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625572|NCT04062201|Levofloxacin|levofloxacin|mesh-list
154625573|NCT04062201|Ofloxacin|ofloxacin|mesh-list
154625574|NCT04062201|Isoniazid|isoniazid|mesh-list
154625575|NCT04062201|Linezolid|linezolid|mesh-list
154625576|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
154625577|NCT04062201|Ethambutol|ethambutol|mesh-list
154625578|NCT04062201|Bedaquiline|bedaquiline|mesh-list
154625579|NCT04062201|Clofazimine|clofazimine|mesh-list
154625580|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154625581|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625582|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154625583|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154625584|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154625585|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625586|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625587|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625588|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154625589|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154625590|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
154625591|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154625592|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154625593|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
154625594|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154625595|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154625596|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625597|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
154625598|NCT02583477|Paclitaxel|paclitaxel|mesh-list
154625599|NCT02583477|Gemcitabine|gemcitabine|mesh-list
154625600|NCT02583477|Durvalumab|durvalumab|mesh-list
154625601|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154625602|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154625603|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625604|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
154625605|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
154625606|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
154625607|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625608|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154625609|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
154625610|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154625611|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
154625612|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625613|NCT02583399|Ibuprofen|ibuprofen|mesh-list
154625614|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154625615|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625616|NCT02583399|Analgesics|analgesics|mesh-ancestor
154625617|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
154625618|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625619|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625620|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625621|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154625622|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154625623|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625624|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625625|NCT02580591|Empagliflozin|empagliflozin|mesh-list
154238313|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
154625626|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154625627|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625629|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625630|NCT05319249|Talazoparib|talazoparib|mesh-list
154625631|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154625632|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625633|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625634|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625635|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154625636|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
154625637|NCT02577315|Metformin|metformin|mesh-list
154625638|NCT02577315|Empagliflozin|empagliflozin|mesh-list
154625639|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625640|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625641|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154625642|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625643|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
154625644|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154625645|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625646|NCT03526887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154625647|NCT03526887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625648|NCT03496779|Gemcitabine|gemcitabine|mesh-list
154625649|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154625650|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154625651|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154625652|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
154625653|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625654|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625655|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154625656|NCT03496779|Immunotoxins|immunotoxins|mesh-ancestor
154625657|NCT03496779|Immunoconjugates|immunoconjugates|mesh-ancestor
154625658|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
154625659|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625660|NCT03398655|Paclitaxel|paclitaxel|mesh-list
154625661|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154625662|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154625663|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625664|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
154625665|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
154625666|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
154625667|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625668|NCT05695287|Propofol|propofol|mesh-list
154625669|NCT05695287|Sevoflurane|sevoflurane|mesh-list
154625670|NCT05695287|Isoflurane|isoflurane|mesh-list
154625671|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154625672|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625673|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625674|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154625675|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
154625676|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
154625677|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154625678|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154625679|NCT00591227|Insulin|insulin|mesh-list
154625680|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154625681|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
154625682|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
154625683|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625684|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625685|NCT00408473|Flecainide|flecainide|mesh-list
154625686|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154625687|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154625688|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154625689|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625690|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625691|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
154625692|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
154625693|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625694|NCT00328601|Protective Agents|protective agents|mesh-ancestor
154625695|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625696|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
154625697|NCT00328601|Vitamins|vitamins|mesh-ancestor
154625698|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
154625699|NCT00189293|Imiquimod|imiquimod|mesh-list
154625700|NCT00189293|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154625701|NCT00189293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625702|NCT00189293|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154625703|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
154625704|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625705|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154625706|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625707|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
154625708|NCT03194009|Metformin|metformin|mesh-list
154625709|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625710|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625711|NCT02581995|Aflibercept|aflibercept|mesh-list
154625712|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154625713|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154625714|NCT02581995|Growth Substances|growth substances|mesh-ancestor
154625715|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625716|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
154625717|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625718|NCT02910843|Capecitabine|capecitabine|mesh-list
154625719|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154625720|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
154625721|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625722|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625723|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154625724|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
154625725|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154625726|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
154625727|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154625728|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625729|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154625730|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625731|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625732|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
154625733|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154625734|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154625735|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154625736|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625737|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625738|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
154625739|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625740|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625741|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154625742|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625743|NCT03193463|Topotecan|topotecan|mesh-list
154625744|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154625745|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154625746|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625747|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625748|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625749|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154625750|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
154625751|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625752|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625753|NCT02577003|Incretins|incretins|mesh-ancestor
154625754|NCT02577003|Hormones|hormones|mesh-ancestor
154625755|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340524|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
154625756|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154625757|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
154625758|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625759|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625760|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154625761|NCT05487417|Minocycline|minocycline|mesh-list
154625762|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154625763|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625764|NCT03471611|Lenograstim|lenograstim|mesh-list
154625765|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154625766|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
154625767|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625768|NCT05674305|Cisplatin|cisplatin|mesh-list
154625769|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625770|NCT03192449|Albendazole|albendazole|mesh-list
154625771|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
154625772|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154625773|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625774|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
154625775|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154625776|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154625777|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
154625778|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
154625779|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
154625780|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625781|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625782|NCT05691933|Morphine|morphine|mesh-list
154625783|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154625784|NCT05691933|Narcotics|narcotics|mesh-ancestor
154625785|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625786|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625787|NCT05691933|Analgesics|analgesics|mesh-ancestor
154625788|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
154625789|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625790|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
154625791|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
154625792|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625793|NCT00977483|Protective Agents|protective agents|mesh-ancestor
154625794|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625795|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
154625796|NCT00977483|Vitamins|vitamins|mesh-ancestor
154625797|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
154625798|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
154625799|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154625800|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625801|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625802|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625803|NCT02439905|Analgesics|analgesics|mesh-ancestor
154625804|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
154625805|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625806|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154625807|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154625808|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154625809|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
154625810|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625811|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625812|NCT03192371|Vaccines|vaccines|mesh-list
154625813|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
154625814|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625815|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
154625816|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154625817|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625818|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
154625819|NCT02442791|Exenatide|exenatide|mesh-list
154625820|NCT02442791|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154625821|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625822|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625823|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154625824|NCT02442791|Incretins|incretins|mesh-ancestor
154625825|NCT02442791|Hormones|hormones|mesh-ancestor
154625826|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625827|NCT04756557|Fluorides|fluorides|mesh-list
154625828|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
154625829|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
154625830|NCT04756557|Protective Agents|protective agents|mesh-ancestor
154625831|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625832|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
154625833|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154625834|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154625835|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625836|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625837|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154625838|NCT02442713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154625839|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154625840|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625841|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625842|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625843|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
154625844|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154625845|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
154625846|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154625847|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154238615|NCT03767920|Bupivacaine|bupivacaine|mesh-list
154625848|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625849|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154625850|NCT03189953|Exenatide|exenatide|mesh-list
154625851|NCT03189953|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154625852|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625853|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625854|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154625855|NCT03189953|Incretins|incretins|mesh-ancestor
154625856|NCT03189953|Hormones|hormones|mesh-ancestor
154625857|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625858|NCT02204085|Decitabine|decitabine|mesh-list
154625859|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154625860|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
154625861|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625862|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625863|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625864|NCT03192293|Metformin|metformin|mesh-list
154625865|NCT03192293|Fulvestrant|fulvestrant|mesh-list
154625866|NCT03192293|Simvastatin|simvastatin|mesh-list
154625867|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625868|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625869|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154625870|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154625871|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
154625872|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625873|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154625874|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154625875|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625876|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625877|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625878|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154625879|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154625880|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
154625881|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625882|NCT02439125|Eltoprazine|eltoprazine|mesh-list
154625883|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154625884|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
154625885|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625886|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625887|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625888|NCT02441933|Carboplatin|carboplatin|mesh-list
154625889|NCT02441933|Taxane|taxane|mesh-list
154625890|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625891|NCT01604265|Nabiximols|nabiximols|mesh-list
154625892|NCT01604265|Analgesics|analgesics|mesh-ancestor
154625893|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
154625894|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625895|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625896|NCT04483427|Ketorolac|ketorolac|mesh-list
154625897|NCT04483427|Nalbuphine|nalbuphine|mesh-list
154625898|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154625899|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625900|NCT04483427|Analgesics|analgesics|mesh-ancestor
154625901|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
154625902|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625903|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625904|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625905|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154625906|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154625907|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625908|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625909|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154625910|NCT04483427|Narcotics|narcotics|mesh-ancestor
154625911|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625912|NCT01664247|Liraglutide|liraglutide|mesh-list
154625913|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154625914|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625915|NCT01664247|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154625916|NCT01664247|Incretins|incretins|mesh-ancestor
154625917|NCT01664247|Hormones|hormones|mesh-ancestor
154625918|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625919|NCT02441465|Vemurafenib|vemurafenib|mesh-list
154625920|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625921|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154625923|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625924|NCT02438657|Lidocaine|lidocaine|mesh-list
154625925|NCT02438657|Epinephrine|epinephrine|mesh-list
154625926|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
154625927|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
154625928|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625929|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625930|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
154625931|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625932|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154625933|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154625934|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154625935|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154625936|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625937|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154625938|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154625939|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
154625940|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154625941|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154625942|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154625943|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
154625944|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154625945|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
154625946|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
154625947|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
154625948|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154625949|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
154625950|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154625951|NCT01441947|Fulvestrant|fulvestrant|mesh-list
154625952|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154625953|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625954|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154625955|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154625956|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
154340729|NCT02322502|Propofol|propofol|mesh-list
154625957|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154625958|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625959|NCT03192059|Aspirin|aspirin|mesh-list
154625960|NCT03192059|Vitamin D|vitamin d|mesh-list
154625961|NCT03192059|Curcumin|curcumin|mesh-list
154625962|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
154625963|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
154625964|NCT03192059|Lansoprazole|lansoprazole|mesh-list
154625965|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
154625966|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154625967|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
154625968|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154625969|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154625970|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154625971|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
154625972|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154625973|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154625974|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154625975|NCT03192059|Vitamins|vitamins|mesh-ancestor
154625976|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
154625977|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154625978|NCT03192059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154625979|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154625980|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154625981|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154625982|NCT03192059|Analgesics|analgesics|mesh-ancestor
154625983|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
154625984|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154625985|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154625986|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154625987|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154625988|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154625989|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154625990|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154625991|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
154625992|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154625993|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154625994|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154625995|NCT02441075|Ethanol|ethanol|mesh-list
154625996|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154625997|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154625998|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154625999|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626001|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154626002|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154626003|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626004|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154626005|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154626006|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
154626007|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626008|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
154626009|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
154626010|NCT03191981|Lenalidomide|lenalidomide|mesh-list
154626011|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626012|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
154626013|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626014|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626015|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154626016|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
154626017|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626018|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626019|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154626020|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154626021|NCT03191981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154626022|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154626023|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154626024|NCT03191981|Growth Substances|growth substances|mesh-ancestor
154626025|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
154626026|NCT05530785|Bevacizumab|bevacizumab|mesh-list
154626027|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154626028|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626029|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154626030|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154626031|NCT05530785|Growth Substances|growth substances|mesh-ancestor
154626032|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626033|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
154626034|NCT05530395|Testosterone|testosterone|mesh-list
154626035|NCT05530395|Androgens|androgens|mesh-ancestor
154626036|NCT05530395|Hormones|hormones|mesh-ancestor
154626037|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626038|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626039|NCT03191903|Triamcinolone|triamcinolone|mesh-list
154626040|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154626041|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154626042|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154626043|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626044|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
154626045|NCT03191903|Hormones|hormones|mesh-ancestor
154626046|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626047|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626048|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626049|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
154626050|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626051|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626052|NCT05534685|Budesonide|budesonide|mesh-list
154626053|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154626054|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626055|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154626056|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
154626057|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626058|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626059|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154626060|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
154626061|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
154626062|NCT05534685|Hormones|hormones|mesh-ancestor
154626063|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626064|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
154626065|NCT02437955|Trace Elements|trace elements|mesh-ancestor
154626066|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
154626067|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626068|NCT02437721|Folic Acid|folic acid|mesh-list
154626069|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
154626070|NCT02437721|Hematinics|hematinics|mesh-ancestor
154626071|NCT02437721|Vitamins|vitamins|mesh-ancestor
154626072|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
154626073|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626074|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
154626075|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626076|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
154626077|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
154626078|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
154626079|NCT05533983|Nivolumab|nivolumab|mesh-list
154626080|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154626081|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626082|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154626083|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626084|NCT02437019|Ibrutinib|ibrutinib|mesh-list
154626085|NCT02437019|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154626086|NCT02437019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154626087|NCT02437019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626088|NCT02437019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626089|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
154626090|NCT02436395|Povidone|povidone|mesh-list
154626091|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
154626092|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
154626093|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154626094|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626095|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154626096|NCT02436083|Cefuroxime|cefuroxime|mesh-list
154626097|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
154626098|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626099|NCT03117335|Endostatins|endostatins|mesh-list
154626100|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626101|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154626102|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154626103|NCT03117335|Growth Substances|growth substances|mesh-ancestor
154626104|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626105|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
154626106|NCT02435927|Leucovorin|leucovorin|mesh-list
154626107|NCT02435927|Capecitabine|capecitabine|mesh-list
154626108|NCT02435927|Fluorouracil|fluorouracil|mesh-list
154626109|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
154626110|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154626111|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
154626112|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626113|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626114|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626115|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
154626116|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626117|NCT02435927|Antidotes|antidotes|mesh-ancestor
154626118|NCT02435927|Protective Agents|protective agents|mesh-ancestor
154626119|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
154626120|NCT02435927|Vitamins|vitamins|mesh-ancestor
154626121|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
154626122|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
154626123|NCT02435771|Vitamin D|vitamin d|mesh-list
154626124|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154626125|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626126|NCT02435771|Vitamins|vitamins|mesh-ancestor
154626127|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
154626128|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154626129|NCT02440841|Itraconazole|itraconazole|mesh-list
154626130|NCT02440841|Rifampin|rifampin|mesh-list
154626131|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
154626132|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626133|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154626134|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154626135|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626136|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626137|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154626138|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
154626139|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626140|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626141|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154626142|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154626143|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
154626144|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154626145|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
154626146|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154626147|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154626148|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154626149|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154626150|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154626151|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154626152|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154626154|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626155|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
154626156|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626157|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
154626158|NCT02435537|Morphine|morphine|mesh-list
154626159|NCT02435537|Bupivacaine|bupivacaine|mesh-list
154626160|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
154626161|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
154626162|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626163|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626164|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
154626165|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626166|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154626167|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154626168|NCT02435537|Analgesics|analgesics|mesh-ancestor
154626169|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154626170|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154626171|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154626172|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
154626173|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626174|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626175|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154626176|NCT02435537|Narcotics|narcotics|mesh-ancestor
154626177|NCT02576067|Methotrexate|methotrexate|mesh-list
154626178|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154626179|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
154626180|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154626181|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626182|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154626183|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
154626184|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626185|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626186|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
154626187|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626188|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154626189|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626190|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
154626191|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626192|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154626193|NCT02435459|Calcium|calcium|mesh-list
154626194|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154626195|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626196|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
154626197|NCT05199909|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154626198|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154626199|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626200|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626201|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626202|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
154626203|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
154626204|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154626205|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154626206|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626207|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626208|NCT02435303|Urological Agents|urological agents|mesh-ancestor
154626209|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154626210|NCT02434757|Hormones|hormones|mesh-ancestor
154626211|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626212|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626213|NCT03189329|Lidocaine|lidocaine|mesh-list
154626214|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
154626215|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154626216|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
154626217|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626218|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626219|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
154626220|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626221|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154626222|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154626223|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154626224|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154626225|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626227|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154626228|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626229|NCT02575833|Analgesics|analgesics|mesh-ancestor
154626230|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
154626231|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626232|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626233|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
154626234|NCT02709083|Dasatinib|dasatinib|mesh-list
154626235|NCT02709083|Nilotinib|nilotinib|mesh-list
154626236|NCT02709083|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154626237|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154626238|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626239|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626240|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626241|NCT02709005|Monolaurin|monolaurin|mesh-list
154626242|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
154626243|NCT02709005|Protective Agents|protective agents|mesh-ancestor
154626244|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626245|NCT03188471|Aspirin|aspirin|mesh-list
154626246|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626247|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154626248|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154626249|NCT03188471|Analgesics|analgesics|mesh-ancestor
154626250|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
154626251|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626252|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626253|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626254|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154626255|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154626256|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626257|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154626258|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154626259|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626260|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
154626261|NCT04650087|Apixaban|apixaban|mesh-list
154626262|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154626263|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
154626264|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154626265|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
154626266|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626267|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626268|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
154626269|NCT03188159|Vinorelbine|vinorelbine|mesh-list
154626270|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154626271|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626272|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
154626273|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
154626274|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
154626275|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626276|NCT05532501|Oxytocin|oxytocin|mesh-list
154626277|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
154626278|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154626279|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626280|NCT05524857|Decitabine|decitabine|mesh-list
154626281|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154626282|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
154626283|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626284|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626285|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626286|NCT05327439|Nicotine|nicotine|mesh-list
154626287|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154626288|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
154626289|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626290|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626291|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154626292|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154626293|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
154626294|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626295|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626297|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154626298|NCT03187691|Amebicides|amebicides|mesh-ancestor
154626299|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154626300|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154626301|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626302|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154626303|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
154626304|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
154626305|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154626306|NCT02433899|Dexamethasone|dexamethasone|mesh-list
154626307|NCT02433899|Epinephrine|epinephrine|mesh-list
154626308|NCT02433899|Mepivacaine|mepivacaine|mesh-list
154626309|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626310|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
154626311|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
154626312|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626313|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626314|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154626315|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
154626316|NCT02433899|Hormones|hormones|mesh-ancestor
154626317|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626318|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154626319|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626320|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154626321|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626322|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
154626323|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
154626324|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154626325|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154626326|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
154626327|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626328|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626329|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154626330|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154626331|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154626332|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
154626333|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
154626334|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
154626335|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154626336|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
154626337|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
154626338|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626339|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
154626340|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
154626341|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154626342|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626343|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154626344|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154626345|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626346|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626347|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626348|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154626349|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154626350|NCT03187457|Metronidazole|metronidazole|mesh-list
154626351|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626352|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154626353|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154626354|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154626355|NCT03187223|Melphalan|melphalan|mesh-list
154626356|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154626357|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154626358|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
154626359|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626360|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626361|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154626362|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626363|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
154626364|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626365|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
154626366|NCT05532111|Rituximab|rituximab|mesh-list
154626367|NCT05532111|Tacrolimus|tacrolimus|mesh-list
154626368|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
154341129|NCT02323516|Aspirin|aspirin|mesh-list
154626369|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626370|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
154626371|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626372|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626373|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154626374|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
154626375|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626376|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626377|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154626378|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154626379|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154626380|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626381|NCT05532111|Hormones|hormones|mesh-ancestor
154626382|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626383|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154626384|NCT04299867|Metronidazole|metronidazole|mesh-list
154626385|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626386|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154626387|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154626388|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154626389|NCT02433587|Aspirin|aspirin|mesh-list
154626390|NCT02433587|Clopidogrel|clopidogrel|mesh-list
154626391|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154626392|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154626393|NCT02433587|Analgesics|analgesics|mesh-ancestor
154626394|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
154626395|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626396|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626397|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626398|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626399|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154626400|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154626401|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626402|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154626403|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154626404|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626405|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
154626406|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154626407|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154626408|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154626409|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
154626410|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626411|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154626412|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154626413|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154626414|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154626415|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626416|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626417|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626418|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154626419|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
154626420|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154626421|NCT03190733|Fludarabine|fludarabine|mesh-list
154626422|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626423|NCT04425135|Carboplatin|carboplatin|mesh-list
154626424|NCT04425135|Apatinib|apatinib|mesh-list
154626425|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626426|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154626427|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626428|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626429|NCT02573883|Clobetasol|clobetasol|mesh-list
154626430|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626431|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
154626432|NCT02573883|Hormones|hormones|mesh-ancestor
154626433|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341195|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
154626434|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626435|NCT02432885|Enalapril|enalapril|mesh-list
154626436|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154626437|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
154626438|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626439|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626440|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154626441|NCT02433041|Ketamine|ketamine|mesh-list
154626442|NCT02433041|Haloperidol|haloperidol|mesh-list
154626443|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
154626444|NCT02433041|Analgesics|analgesics|mesh-ancestor
154626445|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
154626446|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626447|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626448|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154626449|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154626450|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
154626451|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
154626452|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626453|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154626454|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154626455|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626456|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626457|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
154626458|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
154626459|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154626460|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154626461|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154626462|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154626463|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154626464|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
154626465|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154626466|NCT02429921|Selenium|selenium|mesh-list
154626467|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
154626468|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626469|NCT02429921|Protective Agents|protective agents|mesh-ancestor
154626470|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626471|NCT02429921|Trace Elements|trace elements|mesh-ancestor
154626472|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
154626473|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154626474|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154626475|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626476|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626477|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
154626478|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626479|NCT02432807|Vancomycin|vancomycin|mesh-list
154626480|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154626481|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626482|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
154626483|NCT05527275|Analgesics|analgesics|mesh-ancestor
154626484|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
154626485|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626486|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626487|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626488|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154626489|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154626490|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626491|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626492|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
154626493|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154626494|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
154626495|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626496|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626497|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154626498|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
154626499|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154626500|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154626501|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154626502|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
154626503|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626504|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626505|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
154626506|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154626507|NCT03186053|Protective Agents|protective agents|mesh-ancestor
154626508|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626509|NCT02429219|Ethanol|ethanol|mesh-list
154626510|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154626511|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626512|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626513|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626514|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154626515|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
154626516|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626517|NCT02429453|Thrombin|thrombin|mesh-list
154626518|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
154626519|NCT02429453|Coagulants|coagulants|mesh-ancestor
154626520|NCT02428751|Prednisone|prednisone|mesh-list
154626521|NCT02428751|Rituximab|rituximab|mesh-list
154626522|NCT02428751|Doxorubicin|doxorubicin|mesh-list
154626523|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154626524|NCT02428751|Vincristine|vincristine|mesh-list
154626525|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154626526|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626527|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
154626528|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626529|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626530|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154626531|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154626532|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154626533|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626534|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626535|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626536|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
154626537|NCT02428751|Hormones|hormones|mesh-ancestor
154626538|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626539|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154626540|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154626541|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
154626542|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
154626543|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
154626544|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154626545|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154626546|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154626547|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154626548|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154626549|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
154626550|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626551|NCT02432651|Xanthohumol|xanthohumol|mesh-list
154626552|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626553|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154626554|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154626555|NCT02432651|Growth Substances|growth substances|mesh-ancestor
154626556|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626557|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
154626558|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154626559|NCT02707757|Hematinics|hematinics|mesh-ancestor
154626560|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
154626561|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154626562|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626563|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154626564|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
154626565|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154626566|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626567|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626568|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626569|NCT03184805|Aspirin|aspirin|mesh-list
154626570|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154626571|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154626572|NCT03184805|Analgesics|analgesics|mesh-ancestor
154626573|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
154626574|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626575|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626576|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626577|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626578|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154626579|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154626580|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626581|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154626582|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154626583|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626584|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
154626585|NCT05518383|Cytarabine|cytarabine|mesh-list
154626586|NCT05518383|Dexamethasone|dexamethasone|mesh-list
154626587|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
154626588|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
154626589|NCT05518383|Melphalan|melphalan|mesh-list
154626590|NCT05518383|Ifosfamide|ifosfamide|mesh-list
154626591|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
154626592|NCT05518383|Doxorubicin|doxorubicin|mesh-list
154626593|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154626594|NCT05518383|Methotrexate|methotrexate|mesh-list
154626595|NCT05518383|Etoposide|etoposide|mesh-list
154626596|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
154626597|NCT05518383|Vincristine|vincristine|mesh-list
154626598|NCT05518383|Idarubicin|idarubicin|mesh-list
154626599|NCT05518383|Carboplatin|carboplatin|mesh-list
154626600|NCT05518383|BB 1101|bb 1101|mesh-list
154626601|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626602|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
154626603|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626604|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626605|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154626606|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
154626607|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626608|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626609|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154626610|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626611|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
154626612|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
154626613|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626614|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154626615|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
154626616|NCT05518383|Hormones|hormones|mesh-ancestor
154626617|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626618|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154626619|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
154626620|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626621|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154626622|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154626623|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154626624|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154626625|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
154626626|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154626627|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154626628|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
154626629|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
154626630|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154626631|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154626632|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154626633|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
154626634|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626635|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
154626636|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
154626637|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
154626638|NCT02432027|Betamethasone|betamethasone|mesh-list
154626639|NCT02432027|Calcipotriene|calcipotriene|mesh-list
154626640|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626641|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
154626642|NCT02432027|Hormones|hormones|mesh-ancestor
154626643|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626644|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626645|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154626646|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
154626647|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
154626648|NCT02428439|Lamotrigine|lamotrigine|mesh-list
154626649|NCT02428439|Bupropion|bupropion|mesh-list
154626650|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154626651|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
154626652|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154626653|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154626654|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154626655|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154626656|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626657|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
154626658|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626659|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626660|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154626661|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154626662|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626663|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
154626664|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154626665|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154626666|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154626667|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154239368|NCT03756220|Thiamine|thiamine|mesh-list
154626668|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626670|NCT03186443|Pregabalin|pregabalin|mesh-list
154626671|NCT03186443|Gabapentin|gabapentin|mesh-list
154626672|NCT03186443|Analgesics|analgesics|mesh-ancestor
154626673|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
154626674|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626675|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626676|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
154626677|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154341450|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
154626678|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154626679|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626680|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154626681|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154626682|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154626683|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626684|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154626685|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154626686|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154626687|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626688|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
154626689|NCT03186131|Vitamin D|vitamin d|mesh-list
154626690|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
154626691|NCT03186131|Vitamins|vitamins|mesh-ancestor
154626692|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
154626693|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626694|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154626695|NCT03184649|Acetaminophen|acetaminophen|mesh-list
154626696|NCT03184649|Ibuprofen|ibuprofen|mesh-list
154626697|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154626698|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154626699|NCT03184649|Analgesics|analgesics|mesh-ancestor
154626700|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
154626701|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626702|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626703|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626704|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626705|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154626706|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626707|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626708|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
154626709|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
154626710|NCT02432261|ST 1435|st 1435|mesh-list
154626711|NCT02432261|Testosterone|testosterone|mesh-list
154626712|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
154626713|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
154626714|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154626715|NCT02432261|Androgens|androgens|mesh-ancestor
154626716|NCT02432261|Hormones|hormones|mesh-ancestor
154626717|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626718|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626719|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154626720|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626721|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
154626722|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154626723|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
154626724|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154626725|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154626726|NCT02428283|Remifentanil|remifentanil|mesh-list
154626727|NCT02428283|Ropivacaine|ropivacaine|mesh-list
154626728|NCT02428283|Sevoflurane|sevoflurane|mesh-list
154626729|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
154626730|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
154626731|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626732|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626733|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
154626734|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626735|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154626736|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154626737|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
154626738|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154626739|NCT02428283|Narcotics|narcotics|mesh-ancestor
154626740|NCT02428283|Analgesics|analgesics|mesh-ancestor
154626741|NCT02427893|Vemurafenib|vemurafenib|mesh-list
154626742|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626743|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154626744|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626745|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626747|NCT03184493|Celecoxib|celecoxib|mesh-list
154626748|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154626749|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626750|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154626751|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154626752|NCT03184493|Analgesics|analgesics|mesh-ancestor
154626753|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
154626754|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626755|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626756|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626757|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154626758|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154626759|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659732|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626760|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626761|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
154626762|NCT02431403|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154626763|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154626764|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626765|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626766|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626767|NCT02431325|Teduglutide|teduglutide|mesh-list
154626768|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154626769|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154626770|NCT02431325|Protective Agents|protective agents|mesh-ancestor
154626771|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626772|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
154626773|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
154626774|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
154626775|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626776|NCT02103478|Decitabine|decitabine|mesh-list
154626777|NCT02103478|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154626778|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154626779|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
154626780|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626781|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626782|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626783|NCT02431013|Cilostazol|cilostazol|mesh-list
154626784|NCT02431013|Simvastatin|simvastatin|mesh-list
154626785|NCT02431013|Pravastatin|pravastatin|mesh-list
154626786|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154626787|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154626788|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
154626789|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626790|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154626791|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154626792|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626793|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154626794|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
154626795|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626796|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626797|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154626798|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
154626799|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154626800|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154626801|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154626802|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
154626803|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154626804|NCT02431013|Protective Agents|protective agents|mesh-ancestor
154626805|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154626806|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154626807|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
154626808|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
154626809|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626810|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154626811|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626812|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154626813|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
154626814|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626815|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626816|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154626817|NCT02430545|Rifampin|rifampin|mesh-list
154626818|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154626819|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
154626820|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154626821|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626822|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
154626823|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154626824|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626825|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626826|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154626827|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154626828|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154626829|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154626830|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154626831|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154626832|NCT03117725|Melatonin|melatonin|mesh-list
154626833|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
154626834|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626835|NCT03117725|Protective Agents|protective agents|mesh-ancestor
154626836|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626837|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626838|NCT03185351|Midazolam|midazolam|mesh-list
154626839|NCT03185351|Bupivacaine|bupivacaine|mesh-list
154626840|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
154626841|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
154626842|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626843|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626844|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
154626845|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626846|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154626847|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154626848|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154626849|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154626850|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154626851|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154626852|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
154626853|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
154626854|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
154626855|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626856|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626857|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
154626858|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154626859|NCT02707601|Ledipasvir|ledipasvir|mesh-list
154626860|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154626861|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
154626862|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626863|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154626864|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154626865|NCT03183557|Vitamin D|vitamin d|mesh-list
154626866|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
154626867|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
154626868|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154626869|NCT03183557|Vitamins|vitamins|mesh-ancestor
154626870|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
154626871|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626872|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154626873|NCT02426723|Dexamethasone|dexamethasone|mesh-list
154626874|NCT02426723|Lenalidomide|lenalidomide|mesh-list
154626875|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626876|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
154626877|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
154626878|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626879|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626880|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154626881|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
154626882|NCT02426723|Hormones|hormones|mesh-ancestor
154626883|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626884|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154626885|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626886|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
154626887|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154626888|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154626889|NCT02426723|Growth Substances|growth substances|mesh-ancestor
154626890|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
154626891|NCT02425241|Vaccines|vaccines|mesh-list
154626892|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
154626893|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626895|NCT03182855|Cangrelor|cangrelor|mesh-list
154626896|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154626897|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154626898|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154626899|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154626900|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
154626901|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626902|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626903|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626904|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
154626905|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626906|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154626907|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626908|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626909|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
154626910|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626911|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626912|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154626913|NCT02426177|Labetalol|labetalol|mesh-list
154626914|NCT02426177|Nifedipine|nifedipine|mesh-list
154626915|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154626916|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154626917|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626918|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154626919|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626920|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
154626921|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
154626922|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154626923|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154626924|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154626925|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
154626926|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154626927|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154626928|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
154626929|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
154626930|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626931|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154626932|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154626933|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
154626934|NCT02426099|Spironolactone|spironolactone|mesh-list
154626935|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154626936|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
154626937|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626938|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626939|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154626940|NCT02426099|Diuretics|diuretics|mesh-ancestor
154626941|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
154626942|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154626943|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
154626944|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626945|NCT02425709|Diclofenac|diclofenac|mesh-list
154626946|NCT02425709|Tramadol|tramadol|mesh-list
154626947|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154626948|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154626949|NCT02425709|Analgesics|analgesics|mesh-ancestor
154626950|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
154626951|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154626952|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626953|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154626954|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626955|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154626956|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626957|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626958|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154626959|NCT02425709|Narcotics|narcotics|mesh-ancestor
154626960|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154626961|NCT02073682|Heparin|heparin|mesh-list
154626962|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154626963|NCT02073682|Tinzaparin|tinzaparin|mesh-list
154626964|NCT02073682|Dalteparin|dalteparin|mesh-list
154626965|NCT02073682|Edoxaban|edoxaban|mesh-list
154626966|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
154626967|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154626968|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154626969|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626970|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154626971|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
154626972|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154626973|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
154626974|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626975|NCT03181919|Letrozole|letrozole|mesh-list
154626976|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626977|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154626978|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154626979|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626980|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626981|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154626982|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
154626983|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154626984|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154626985|NCT02706899|Azacitidine|azacitidine|mesh-list
154626986|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154626987|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
154626988|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626989|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154626990|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626991|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
154626992|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
154626993|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154626994|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154626995|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154626996|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154626997|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154626998|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154626999|NCT02424695|Gabapentin|gabapentin|mesh-list
154627000|NCT02424695|Analgesics|analgesics|mesh-ancestor
154627001|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
154627002|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627003|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627004|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
154627005|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154627006|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154627007|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627008|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154627009|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154627010|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154627011|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627012|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627013|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
154627014|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
154627015|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
154627016|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
154627017|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154627018|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627019|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627020|NCT02422277|Urological Agents|urological agents|mesh-ancestor
154627021|NCT02422121|RNS60|rns60|mesh-list
154627022|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154627023|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154627024|NCT02422121|Analgesics|analgesics|mesh-ancestor
154627025|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
154627026|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627027|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627028|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627029|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627030|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154627031|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
154627032|NCT02424461|Ofloxacin|ofloxacin|mesh-list
154627033|NCT02424461|Levofloxacin|levofloxacin|mesh-list
154627034|NCT02424461|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154627035|NCT02424461|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154627036|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154627037|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627038|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154627039|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154239745|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627040|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154627041|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627042|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627043|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627044|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154627045|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154627046|NCT02072824|Pregabalin|pregabalin|mesh-list
154627047|NCT02072824|Analgesics|analgesics|mesh-ancestor
154627048|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
154627049|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627050|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627051|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
154627052|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154627053|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154627054|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627055|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154627056|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154627057|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154627058|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627059|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154627060|NCT03117257|Cisplatin|cisplatin|mesh-list
154627061|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627062|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
154627063|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154627064|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
154627065|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154627066|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
154627067|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627068|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627069|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
154627070|NCT03181685|Cetrorelix|cetrorelix|mesh-list
154627071|NCT03181685|Progesterone|progesterone|mesh-list
154627072|NCT03181685|Progestins|progestins|mesh-ancestor
154627073|NCT03181685|Hormones|hormones|mesh-ancestor
154627074|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627075|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627076|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154627077|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
154627078|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154627079|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
154627080|NCT02424071|Melatonin|melatonin|mesh-list
154627081|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
154627082|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627083|NCT02424071|Protective Agents|protective agents|mesh-ancestor
154627084|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627085|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627086|NCT03178955|Etanercept|etanercept|mesh-list
154627087|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154627088|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154627089|NCT03178955|Analgesics|analgesics|mesh-ancestor
154627090|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
154627091|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627092|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627093|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627094|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627095|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154627096|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627097|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
154627098|NCT01598506|Hydromorphone|hydromorphone|mesh-list
154627099|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154627100|NCT01598506|Narcotics|narcotics|mesh-ancestor
154627101|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627102|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627103|NCT01598506|Analgesics|analgesics|mesh-ancestor
154627104|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
154627105|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627106|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
154627107|NCT02423915|Sirolimus|sirolimus|mesh-list
154627108|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
154627109|NCT02423915|Rituximab|rituximab|mesh-list
154627110|NCT02423915|Fludarabine|fludarabine|mesh-list
154627111|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
154627112|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627113|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
154627114|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627115|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627116|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154627117|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
154627118|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627119|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627120|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154627121|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154627122|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154627123|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
154627124|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627125|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154627126|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154627127|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
154627128|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154627129|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627130|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
154627131|NCT02423837|Rituximab|rituximab|mesh-list
154627132|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154341921|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154341922|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341924|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154341925|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154341926|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341927|NCT05152264|Analgesics|analgesics|mesh-list
154341928|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
154341929|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627133|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154627134|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627135|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
154627136|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627137|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627138|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154627139|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
154627140|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627141|NCT02140060|Travoprost|travoprost|mesh-list
154627142|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154627143|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154627144|NCT02140060|Brinzolamide|brinzolamide|mesh-list
154627145|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154627146|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154627147|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627148|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627149|NCT03178721|Calcium|calcium|mesh-list
154627150|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154627151|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627152|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
154627153|NCT02421029|Edetic Acid|edetic acid|mesh-list
154627154|NCT02421029|Calcium|calcium|mesh-list
154627155|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
154627156|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154627157|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627158|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154627159|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
154627160|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154627161|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
154627162|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
154627163|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627164|NCT02421029|Antidotes|antidotes|mesh-ancestor
154627165|NCT02421029|Protective Agents|protective agents|mesh-ancestor
154627166|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154627167|NCT02139982|Ropivacaine|ropivacaine|mesh-list
154627168|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
154627169|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
154627170|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627171|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627172|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
154627173|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627174|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154627175|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154627176|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627177|NCT02139592|Immunotoxins|immunotoxins|mesh-ancestor
154627178|NCT02139592|Immunoconjugates|immunoconjugates|mesh-ancestor
154627179|NCT02139592|Immunologic Factors|immunologic factors|mesh-ancestor
154627180|NCT02139592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627181|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
154627182|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627183|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
154627184|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627185|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627186|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154627187|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
154627188|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239901|NCT03750916|Docetaxel|docetaxel|mesh-list
154627189|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627190|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154627192|NCT02072434|Warfarin|warfarin|mesh-list
154627193|NCT02072434|Edoxaban|edoxaban|mesh-list
154627194|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
154627195|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154627196|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154627197|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627198|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154627199|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
154627200|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154627201|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
154627202|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627203|NCT04725994|Irinotecan|irinotecan|mesh-list
154627204|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154627205|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154627206|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627207|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627208|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627209|NCT02139046|Naproxen|naproxen|mesh-list
154627210|NCT02139046|Colchicine|colchicine|mesh-list
154627211|NCT02139046|Febuxostat|febuxostat|mesh-list
154627212|NCT02139046|Lansoprazole|lansoprazole|mesh-list
154627213|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
154627214|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154627215|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154627216|NCT02139046|Analgesics|analgesics|mesh-ancestor
154627217|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
154627218|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627219|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627220|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627221|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627222|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
154627223|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154627224|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627225|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627226|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
154627227|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
154627228|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
154659733|NCT02452047|Imipenem|imipenem|mesh-list
154627229|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627230|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154627231|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154627232|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154627233|NCT02100670|Diclofenac|diclofenac|mesh-list
154627234|NCT02100670|Menthol|menthol|mesh-list
154627235|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154627236|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154627237|NCT02100670|Analgesics|analgesics|mesh-ancestor
154627238|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
154627239|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627240|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627241|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627242|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627243|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154627244|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627245|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627246|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
154627247|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627248|NCT02100514|Bococizumab|bococizumab|mesh-list
154627249|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154627250|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154627251|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
154627252|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627253|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154627254|NCT02069392|Nicotine|nicotine|mesh-list
154627255|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154627256|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
154627257|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627258|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627259|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154627260|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154627261|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
154627262|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627263|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239973|NCT03965858|Esketamine|esketamine|mesh-list
154627264|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
154627265|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154627266|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627267|NCT02046616|Methotrexate|methotrexate|mesh-list
154627268|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154627269|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
154627270|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154627271|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627272|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154627273|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
154627274|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627275|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627276|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627277|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627278|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154627279|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627280|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
154627281|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627282|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154627283|NCT05525481|Tamoxifen|tamoxifen|mesh-list
154627284|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154627285|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
154627286|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627287|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627288|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154627289|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627290|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154627291|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154627292|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154627293|NCT02068222|Ritonavir|ritonavir|mesh-list
154627294|NCT02068222|Ribavirin|ribavirin|mesh-list
154627295|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154627296|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154627297|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
154627298|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627299|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627300|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154627301|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154627302|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
154627303|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627304|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154627305|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154627306|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
154627307|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
154627308|NCT05517213|Etoposide|etoposide|mesh-list
154627309|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627310|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
154627311|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627312|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627313|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154627314|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
154627315|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627316|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627317|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154627318|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154627319|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154627320|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154627321|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627322|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
154627323|NCT02099110|Metformin|metformin|mesh-list
154627324|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
154627325|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154627326|NCT02099110|Glimepiride|glimepiride|mesh-list
154627327|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
154627328|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154627329|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627330|NCT02099110|Incretins|incretins|mesh-ancestor
154627331|NCT02099110|Hormones|hormones|mesh-ancestor
154627332|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627333|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154627334|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
154627335|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627336|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627337|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154627338|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627339|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
154627340|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154627342|NCT02098876|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154627343|NCT02098876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154627344|NCT02098876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627345|NCT02098876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627346|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627347|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
154627348|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627349|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627350|NCT01624090|Plicamycin|plicamycin|mesh-list
154627351|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154627352|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627353|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154627354|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627355|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154342147|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
154627356|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627357|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627358|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154627359|NCT02571777|Fluticasone|fluticasone|mesh-list
154627360|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154627361|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627362|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154627363|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
154627364|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627365|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627366|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154627367|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
154627368|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627369|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154627370|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154627371|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154627372|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154627373|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
154627374|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627375|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627376|NCT05511831|Ketotifen|ketotifen|mesh-list
154627377|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
154627378|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627379|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154627380|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
154627381|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
154627382|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627383|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627384|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627385|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154627386|NCT02705105|Nivolumab|nivolumab|mesh-list
154627387|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
154627388|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154627389|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627390|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154627391|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627392|NCT05521347|Caffeine|caffeine|mesh-list
154627393|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154627394|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627395|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154627396|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627397|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627398|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154627399|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154627400|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
154627401|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627402|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154627403|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
154627404|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627405|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
154627406|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627407|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
154627408|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
154627409|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627410|NCT02420171|Insulin|insulin|mesh-list
154240125|NCT00114218|Gemcitabine|gemcitabine|mesh-list
154627411|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154627412|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627413|NCT03180593|Valsartan|valsartan|mesh-list
154627414|NCT03180593|Nebivolol|nebivolol|mesh-list
154627415|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154627416|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154627417|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154627418|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627419|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
154627420|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154627421|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154627422|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154627423|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
154627424|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627425|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627426|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
154627427|NCT02423759|Gentamicins|gentamicins|mesh-list
154627428|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154627429|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627430|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154627431|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154627432|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627433|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627434|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627435|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154627436|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154627437|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154627438|NCT01623310|Fluticasone|fluticasone|mesh-list
154627439|NCT01623310|Xhance|xhance|mesh-list
154627440|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627441|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154627442|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
154627443|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627444|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627445|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154627446|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
154627447|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627448|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154627449|NCT03180125|Lidocaine|lidocaine|mesh-list
154627450|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
154627451|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
154627452|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
154627453|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627454|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627455|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
154627456|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627457|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154627458|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154627459|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154627460|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154627461|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627462|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154627463|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
154627464|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
154627465|NCT03180125|Protective Agents|protective agents|mesh-ancestor
154627466|NCT02423603|Paclitaxel|paclitaxel|mesh-list
154627467|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154627468|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627469|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
154627470|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
154627471|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
154627472|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627473|NCT03178409|Liver Extracts|liver extracts|mesh-list
154627474|NCT03178409|Hematinics|hematinics|mesh-ancestor
154627475|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154627476|NCT03180281|Glimepiride|glimepiride|mesh-list
154627477|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154627478|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627479|NCT03180281|Incretins|incretins|mesh-ancestor
154627480|NCT03180281|Hormones|hormones|mesh-ancestor
154627481|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627482|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154627483|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
154627484|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240275|NCT00127166|Xhance|xhance|mesh-list
154627485|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627486|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154627487|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627488|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
154627489|NCT03116945|Gallium citrate|gallium citrate|mesh-list
154627490|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627491|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154627492|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
154627493|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154627494|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627495|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627496|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154627497|NCT03117023|Analgesics|analgesics|mesh-ancestor
154627498|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
154627499|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627500|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154627501|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154627502|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154627503|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
154627504|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627505|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627506|NCT02097238|Halichondrin B|halichondrin b|mesh-list
154627507|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
154627508|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
154627509|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
154627510|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627511|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627512|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
154627513|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627514|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
154627515|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154627516|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627517|NCT02419859|Insulin|insulin|mesh-list
154627518|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154627519|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154627520|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627521|NCT02419391|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154627522|NCT02419391|Antiviral Agents|antiviral agents|mesh-ancestor
154627523|NCT02419391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627524|NCT02419235|Ethanol|ethanol|mesh-list
154627525|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154627526|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627527|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627528|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627529|NCT02422823|Epinephrine|epinephrine|mesh-list
154627530|NCT02422823|Carticaine|carticaine|mesh-list
154627531|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154627532|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154627533|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
154627534|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627535|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627536|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627537|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154627538|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154627539|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
154627540|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627541|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154627542|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
154627543|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
154627544|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
154627545|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154627546|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
154627547|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
154627548|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627549|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
154627550|NCT02422589|Ceritinib|ceritinib|mesh-list
154627551|NCT02422589|Midazolam|midazolam|mesh-list
154627552|NCT02422589|Warfarin|warfarin|mesh-list
154627553|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154627554|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154627555|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627556|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627557|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154627558|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154627559|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154627560|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154627561|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
154627563|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
154627564|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
154627565|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627566|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627567|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
154627568|NCT02422589|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154627569|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154627570|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627571|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627572|NCT02422199|Capecitabine|capecitabine|mesh-list
154627573|NCT02422199|Lapatinib|lapatinib|mesh-list
154627574|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154627575|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
154627576|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627577|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627578|NCT02422199|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154627579|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154627580|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627581|NCT02416739|Niacinamide|niacinamide|mesh-list
154627582|NCT02416739|Niacin|niacin|mesh-list
154627583|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
154627584|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
154627585|NCT02416739|Vitamins|vitamins|mesh-ancestor
154627586|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
154627587|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627588|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154627589|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
154627590|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627591|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154627592|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
154627593|NCT02416583|Oxytocin|oxytocin|mesh-list
154627594|NCT02416583|Dinoprostone|dinoprostone|mesh-list
154627595|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
154627596|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154627597|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627598|NCT02416427|Atorvastatin|atorvastatin|mesh-list
154627599|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154627600|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154627601|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
154627602|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627603|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154627604|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154627605|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627606|NCT02416271|Vitamin D|vitamin d|mesh-list
154627607|NCT02416271|Alendronate|alendronate|mesh-list
154627608|NCT02416271|Teriparatide|teriparatide|mesh-list
154627609|NCT02416271|Calcium|calcium|mesh-list
154627610|NCT02416271|Vitamins|vitamins|mesh-ancestor
154627611|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
154627612|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627613|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154627614|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154627615|NCT02416115|Morphine|morphine|mesh-list
154627616|NCT02416115|Ramosetron|ramosetron|mesh-list
154627617|NCT02416115|Naloxone|naloxone|mesh-list
154627618|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154627619|NCT02416115|Narcotics|narcotics|mesh-ancestor
154627620|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627621|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627622|NCT02416115|Analgesics|analgesics|mesh-ancestor
154627623|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
154627624|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627625|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154627626|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
154627627|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
154627628|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154627629|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154627630|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
154627631|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627632|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627633|NCT02415881|Panitumumab|panitumumab|mesh-list
154627634|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154240355|NCT03747094|Fentanyl|fentanyl|mesh-list
154627635|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627636|NCT02415803|Clopidogrel|clopidogrel|mesh-list
154627637|NCT02415803|Ticagrelor|ticagrelor|mesh-list
154627638|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154627639|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154627640|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154627641|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154627642|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
154627643|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627644|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627645|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627646|NCT04482881|Isosorbide|isosorbide|mesh-list
154627647|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154627648|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154627649|NCT04482881|Misoprostol|misoprostol|mesh-list
154627650|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154627651|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
154627652|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154627653|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627654|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154627655|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154627656|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
154627657|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154627658|NCT04482881|Diuretics|diuretics|mesh-ancestor
154627659|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
154627660|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
154627661|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154627662|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627663|NCT02415569|Bisacodyl|bisacodyl|mesh-list
154627664|NCT02415569|Cathartics|cathartics|mesh-ancestor
154627665|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154627666|NCT02415569|Laxatives|laxatives|mesh-ancestor
154627667|NCT02415335|Dexamethasone|dexamethasone|mesh-list
154627668|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
154627669|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154627670|NCT02415335|BB 1101|bb 1101|mesh-list
154627671|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627672|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
154627673|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
154627674|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627675|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627676|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342459|NCT01883804|Methyldopa|methyldopa|mesh-list
154627677|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
154627678|NCT02415335|Hormones|hormones|mesh-ancestor
154627679|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627680|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154627681|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627682|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
154627683|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627684|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627685|NCT02415257|Gentamicins|gentamicins|mesh-list
154627686|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154627687|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627688|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154627689|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627690|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627691|NCT02415179|Fluticasone|fluticasone|mesh-list
154627692|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
154627693|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
154627694|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154627695|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154627696|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627697|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154627698|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
154627699|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627700|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627701|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154627702|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
154627703|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627704|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154627705|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154627706|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154627707|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154627708|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
154627709|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627710|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627711|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
154240425|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627712|NCT02415179|Hormones|hormones|mesh-ancestor
154627713|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627714|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
154627715|NCT02415023|Paclitaxel|paclitaxel|mesh-list
154627716|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154627717|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154627718|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627719|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
154627720|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
154627721|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
154627722|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627723|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
154627724|NCT02414945|Fludarabine|fludarabine|mesh-list
154627725|NCT02414945|Interleukin-2|interleukin-2|mesh-list
154627726|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627727|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
154627728|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627729|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627730|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154627731|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
154627732|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627733|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627734|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154627735|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154627736|NCT02414945|Analgesics|analgesics|mesh-ancestor
154627737|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
154627738|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627739|NCT02414555|Phenylephrine|phenylephrine|mesh-list
154627740|NCT02414555|Norepinephrine|norepinephrine|mesh-list
154627741|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154627742|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154627743|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
154627744|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
154627745|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627746|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627747|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
154627748|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
154627749|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
154627750|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154627751|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154627752|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154627753|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
154627754|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627755|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627756|NCT02414555|Protective Agents|protective agents|mesh-ancestor
154627757|NCT02046070|Dexamethasone|dexamethasone|mesh-list
154627758|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
154627759|NCT02046070|Ixazomib|ixazomib|mesh-list
154627760|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627761|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
154627762|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627763|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627764|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154627765|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
154627766|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627767|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627768|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154627769|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627770|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
154627771|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
154627772|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627773|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154627774|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
154627775|NCT02046070|Hormones|hormones|mesh-ancestor
154627776|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627777|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154627778|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
154627779|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627780|NCT01663857|Carboplatin|carboplatin|mesh-list
154627781|NCT01663857|Gemcitabine|gemcitabine|mesh-list
154627782|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627783|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154627784|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
154627785|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627786|NCT02414165|Flucytosine|flucytosine|mesh-list
154627787|NCT02414165|Bevacizumab|bevacizumab|mesh-list
154627788|NCT02414165|Temozolomide|temozolomide|mesh-list
154627789|NCT02414165|Lomustine|lomustine|mesh-list
154627790|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154627791|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627792|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154627793|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154627794|NCT02414165|Growth Substances|growth substances|mesh-ancestor
154627795|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627796|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
154627797|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154627798|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
154627799|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627800|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
154627801|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627802|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
154627803|NCT02094898|Ketamine|ketamine|mesh-list
154627804|NCT02094898|Analgesics|analgesics|mesh-ancestor
154627805|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
154627806|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627807|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627808|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154627809|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154627810|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
154627811|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
154627812|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627813|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154627814|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154627815|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659734|NCT02452047|Relebactam|relebactam|mesh-list
154627816|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627817|NCT02414009|Leucovorin|leucovorin|mesh-list
154627818|NCT02414009|Capecitabine|capecitabine|mesh-list
154627819|NCT02414009|Fluorouracil|fluorouracil|mesh-list
154627820|NCT02414009|Irinotecan|irinotecan|mesh-list
154627821|NCT02414009|Temozolomide|temozolomide|mesh-list
154627822|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154627823|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
154627824|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627825|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627826|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627827|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
154627828|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627829|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154627830|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154627831|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627832|NCT02414009|Antidotes|antidotes|mesh-ancestor
154627833|NCT02414009|Protective Agents|protective agents|mesh-ancestor
154627834|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
154627835|NCT02414009|Vitamins|vitamins|mesh-ancestor
154627836|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
154627837|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154627838|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
154627839|NCT02413853|Leucovorin|leucovorin|mesh-list
154627840|NCT02413853|Bevacizumab|bevacizumab|mesh-list
154627841|NCT02413853|Fluorouracil|fluorouracil|mesh-list
154627842|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
154627843|NCT02413853|Calcium|calcium|mesh-list
154627844|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
154627845|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154627846|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627847|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154627848|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154627849|NCT02413853|Growth Substances|growth substances|mesh-ancestor
154627850|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627851|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
154627852|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154627853|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
154627854|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627855|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154627856|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627857|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
154627858|NCT02413853|Antidotes|antidotes|mesh-ancestor
154627859|NCT02413853|Protective Agents|protective agents|mesh-ancestor
154627860|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
154627861|NCT02413853|Vitamins|vitamins|mesh-ancestor
154627862|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
154627863|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
154627864|NCT00704483|Sevelamer|sevelamer|mesh-list
154627865|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
154627866|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
154627867|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627868|NCT00704483|Hematinics|hematinics|mesh-ancestor
154627869|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
154627870|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627871|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627872|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154627873|NCT03176537|Testosterone|testosterone|mesh-list
154627874|NCT03176537|Androgens|androgens|mesh-ancestor
154627875|NCT03176537|Hormones|hormones|mesh-ancestor
154627876|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627877|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627878|NCT05511441|Aspirin|aspirin|mesh-list
154627879|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154627880|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154627881|NCT05511441|Analgesics|analgesics|mesh-ancestor
154627882|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
154627883|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627884|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627885|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627886|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627887|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154627888|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154627889|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627890|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154627891|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154627892|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627893|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
154627894|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154627895|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154627896|NCT02413541|Polymyxins|polymyxins|mesh-list
154627897|NCT02413541|Polymyxin B|polymyxin b|mesh-list
154627898|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154627899|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627900|NCT02045836|Vaccines|vaccines|mesh-list
154627901|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154627902|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
154627903|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627904|NCT02412917|Valacyclovir|valacyclovir|mesh-list
154627905|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
154627906|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627907|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
154627908|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627909|NCT02569437|Fluticasone|fluticasone|mesh-list
154627910|NCT02569437|Doxycycline|doxycycline|mesh-list
154627911|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
154627912|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154627913|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154627914|NCT02569437|Prednisolone|prednisolone|mesh-list
154627915|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
154627916|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154627917|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
154627918|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627919|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
154627920|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
154627921|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627922|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627923|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154627924|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
154627925|NCT02569437|Hormones|hormones|mesh-ancestor
154627926|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627927|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154627928|NCT02569437|Protective Agents|protective agents|mesh-ancestor
154627929|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154627930|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627931|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154627932|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154627933|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
154627934|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154627935|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154627936|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154627937|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154627938|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
154627939|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
154627940|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154240650|NCT05069896|Analgesics|analgesics|mesh-ancestor
154627941|NCT02412449|Glycine|glycine|mesh-list
154627942|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
154627943|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154627944|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627945|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627946|NCT02412059|Prednisolone|prednisolone|mesh-list
154627947|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154627948|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
154342732|NCT00925652|Bevacizumab|bevacizumab|mesh-list
154627949|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154627950|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
154627951|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154627952|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
154627953|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154627954|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
154627955|NCT02412059|Hormones|hormones|mesh-ancestor
154627956|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154627957|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627958|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154627959|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627960|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
154627961|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
154627962|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627963|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154627964|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154627965|NCT02412059|Protective Agents|protective agents|mesh-ancestor
154627966|NCT03175679|Interleukin-2|interleukin-2|mesh-list
154627967|NCT03175679|Tegafur|tegafur|mesh-list
154627968|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154627969|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154627970|NCT03175679|Analgesics|analgesics|mesh-ancestor
154627971|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
154627972|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154627973|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627974|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154627975|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
154627976|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154627977|NCT05520645|Propofol|propofol|mesh-list
154627978|NCT05520645|Etomidate|etomidate|mesh-list
154627979|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154627980|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154627981|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627982|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154627983|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
154627984|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
154627985|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154627986|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154627987|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154627988|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
154627989|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342770|NCT03525444|Ivacaftor|ivacaftor|mesh-list
154627990|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154627991|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154627992|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154627993|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
154627994|NCT05515185|Fludarabine|fludarabine|mesh-list
154627995|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154627996|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
154627997|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154627998|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154627999|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154628000|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
154628001|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628002|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628003|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154628004|NCT02044822|Rituximab|rituximab|mesh-list
154628005|NCT02044822|Idelalisib|idelalisib|mesh-list
154628006|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154628007|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628008|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
154628009|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628010|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628011|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628012|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628013|NCT03116555|Irinotecan|irinotecan|mesh-list
154628014|NCT03116555|Apatinib|apatinib|mesh-list
154628015|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154628016|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154628017|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628018|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628019|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628020|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154628021|NCT02044510|Mirabegron|mirabegron|mesh-list
154628022|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154628023|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154628024|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154628025|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154628026|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628027|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628028|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628029|NCT02044510|Urological Agents|urological agents|mesh-ancestor
154628030|NCT02411903|Clopidogrel|clopidogrel|mesh-list
154628031|NCT02411903|Atorvastatin|atorvastatin|mesh-list
154628032|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154628033|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154628034|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154628035|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
154628036|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628037|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154628038|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154628039|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628040|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154628041|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154628042|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154628043|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154628044|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
154628045|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628046|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628047|NCT02411825|Metformin|metformin|mesh-list
154628048|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628049|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628050|NCT02410655|Oxytocin|oxytocin|mesh-list
154628051|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
154628052|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154628053|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628054|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154628055|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
154628056|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628057|NCT05510505|Antibodies|antibodies|mesh-list
154628058|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154628059|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
154628060|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628061|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
154628062|NCT05514015|Rituximab|rituximab|mesh-list
154628063|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154628064|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
154628065|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628066|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628067|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154628068|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
154628069|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628070|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628071|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154628072|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154628073|NCT03174821|Insulin|insulin|mesh-list
154628074|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154628075|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628076|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628077|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
154628078|NCT05520021|Nifedipine|nifedipine|mesh-list
154628079|NCT05520021|Analgesics|analgesics|mesh-ancestor
154628080|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
154628081|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628082|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628083|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
154628084|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628085|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154628086|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
154628087|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154628088|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154628089|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628090|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154628091|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
154628092|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154628093|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
154628094|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
154628095|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154628096|NCT02410031|Cyproterone|cyproterone|mesh-list
154628097|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
154628098|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154628099|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154628100|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154628101|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
154628102|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154628103|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628104|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154628105|NCT02410031|Estrogens|estrogens|mesh-ancestor
154628107|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628108|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
154628109|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
154628110|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628111|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154628112|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154628113|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154628114|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154628115|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154628116|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
154628117|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628118|NCT02067676|Antacids|antacids|mesh-ancestor
154628119|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628120|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154628121|NCT02409407|Alprostadil|alprostadil|mesh-list
154628122|NCT02409407|Misoprostol|misoprostol|mesh-list
154628123|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154628124|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
154628125|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154628126|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628127|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154628128|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154628129|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
154628130|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154628131|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
154628132|NCT02409407|Urological Agents|urological agents|mesh-ancestor
154628133|NCT02409563|Budesonide|budesonide|mesh-list
154342918|NCT01250743|Vitamins|vitamins|mesh-list
154628134|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628135|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154628136|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
154628137|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628138|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628139|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154628140|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
154628141|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
154628142|NCT02409563|Hormones|hormones|mesh-ancestor
154628143|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628144|NCT02409017|Insulin|insulin|mesh-list
154628145|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628146|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628147|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
154628148|NCT00702689|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154628149|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154628150|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628151|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628152|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628153|NCT02065570|Adalimumab|adalimumab|mesh-list
154628154|NCT02065570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154628155|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628156|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628157|NCT02408705|Acetaminophen|acetaminophen|mesh-list
154628158|NCT02408705|Liraglutide|liraglutide|mesh-list
154628159|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154628160|NCT02408705|Analgesics|analgesics|mesh-ancestor
154628161|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
154628162|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628163|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628164|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
154628165|NCT02408705|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154628166|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628167|NCT02408705|Incretins|incretins|mesh-ancestor
154628168|NCT02408705|Hormones|hormones|mesh-ancestor
154628169|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628170|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
154628171|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
154628172|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628173|NCT05507697|Protective Agents|protective agents|mesh-ancestor
154628174|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628175|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
154628176|NCT05507697|Vitamins|vitamins|mesh-ancestor
154628177|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
154628178|NCT04292223|Pimavanserin|pimavanserin|mesh-list
154628179|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154628180|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154628181|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154628182|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154628183|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628184|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628185|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154628186|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154628187|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154628188|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
154628189|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628190|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628191|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154628192|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
154628193|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154628194|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154628195|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154628196|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628197|NCT03174041|Itraconazole|itraconazole|mesh-list
154628198|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154628199|NCT03174041|Midazolam|midazolam|mesh-list
154628200|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154628201|NCT03174041|Simvastatin|simvastatin|mesh-list
154628202|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154628203|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154628204|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628205|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628206|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154628207|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154628208|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154628209|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154628210|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
154628211|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
154628212|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
154628213|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
154628214|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628215|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628216|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154628217|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154628218|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
154628219|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154628220|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154628221|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628222|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
154628223|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628224|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154628225|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154628226|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154628227|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
154628228|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628229|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154628230|NCT02566005|Misoprostol|misoprostol|mesh-list
154628231|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154628232|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
154628233|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154628234|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628235|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154628236|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154628237|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
154628238|NCT02408393|Ropivacaine|ropivacaine|mesh-list
154628239|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
154628240|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
154628241|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628242|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628243|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
154628244|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628245|NCT03173963|Empagliflozin|empagliflozin|mesh-list
154628246|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154628247|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628248|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628249|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628250|NCT05507229|Vaccines|vaccines|mesh-list
154628251|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
154628252|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628253|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
154628254|NCT03173417|Fludarabine|fludarabine|mesh-list
154628255|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154628256|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
154628257|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628258|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628259|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154628260|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
154628261|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628262|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628263|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154628264|NCT03173339|Remifentanil|remifentanil|mesh-list
154628265|NCT03173339|Sevoflurane|sevoflurane|mesh-list
154628266|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154628267|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154628268|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
154628269|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
154628270|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628271|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628272|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154628273|NCT03173339|Narcotics|narcotics|mesh-ancestor
154628274|NCT03173339|Analgesics|analgesics|mesh-ancestor
154628275|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
154628276|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628277|NCT03172871|Aripiprazole|aripiprazole|mesh-list
154628278|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
154628279|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154628280|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154628281|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154628282|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628283|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628284|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
154628285|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
154628286|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628287|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628288|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154628289|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154628290|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
154628291|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154628292|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154628293|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154628294|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154628295|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
154628296|NCT02065336|Entecavir|entecavir|mesh-list
154628297|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
154628298|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628299|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
154628300|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
154628301|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154628302|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
154628303|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
154628304|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628305|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628306|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628307|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154628308|NCT02408003|Simendan|simendan|mesh-list
154628309|NCT02408003|Milrinone|milrinone|mesh-list
154628310|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154628311|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
154628312|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154628313|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154628314|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628315|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241025|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
154628316|NCT02408003|Protective Agents|protective agents|mesh-ancestor
154628317|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628318|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154628319|NCT02406911|Ticagrelor|ticagrelor|mesh-list
154628320|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154628321|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154628322|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154628323|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154628324|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
154628325|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628326|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628327|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628328|NCT03172793|Telavancin|telavancin|mesh-list
154628329|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154628330|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628331|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
154628332|NCT03116087|Testosterone|testosterone|mesh-list
154628333|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
154628334|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
154628335|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154628336|NCT03116087|Androgens|androgens|mesh-ancestor
154628337|NCT03116087|Hormones|hormones|mesh-ancestor
154628338|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628339|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628340|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154628341|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628342|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
154628343|NCT02701985|Petesicatib|petesicatib|mesh-list
154628344|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628345|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628346|NCT02406521|Sorafenib|sorafenib|mesh-list
154628347|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154628348|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628349|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154628350|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628351|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628352|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154628353|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154628354|NCT02406053|Antioxidants|antioxidants|mesh-list
154628355|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628356|NCT02406053|Protective Agents|protective agents|mesh-ancestor
154628357|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628358|NCT02064166|Insulin|insulin|mesh-list
154628359|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628360|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628361|NCT03171623|Globalagliatin|globalagliatin|mesh-list
154628362|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
154628363|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628364|NCT03171389|Ponatinib|ponatinib|mesh-list
154628365|NCT03171389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154628366|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154628367|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628368|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628369|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628370|NCT05508633|Mebeverine|mebeverine|mesh-list
154628371|NCT05508633|Alverine|alverine|mesh-list
154628372|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
154628373|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
154628374|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628375|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628376|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
154628377|NCT04482257|Irinotecan|irinotecan|mesh-list
154628378|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154628379|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154628380|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628381|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628382|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628383|NCT05502705|Lidocaine|lidocaine|mesh-list
154628384|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
154628385|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
154628386|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628387|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628388|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
154628389|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241106|NCT00407537|Amlodipine|amlodipine|mesh-list
154628390|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154628391|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154628392|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154628393|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154628394|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628395|NCT05506137|Pilocarpine|pilocarpine|mesh-list
154628397|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
154628398|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628399|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628400|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154628401|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154628402|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
154628403|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628404|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628405|NCT04742283|Timolol|timolol|mesh-list
154628406|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154628407|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154628408|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628409|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154628410|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154628411|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
154628412|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628413|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628414|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154628415|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154628416|NCT04289805|Letrozole|letrozole|mesh-list
154628417|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628418|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154628419|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154628420|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628421|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628422|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154628423|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
154628424|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628425|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628426|NCT05505591|Cangrelor|cangrelor|mesh-list
154628427|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154628428|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154628429|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154628430|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154628431|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
154628432|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628433|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628434|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628435|NCT05448807|Phentolamine|phentolamine|mesh-list
154628436|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154628437|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154628438|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
154628439|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628440|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628441|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628442|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154628443|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
154628444|NCT01662999|Saxagliptin|saxagliptin|mesh-list
154628445|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154628446|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628447|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628448|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628449|NCT01662999|Incretins|incretins|mesh-ancestor
154628450|NCT01662999|Hormones|hormones|mesh-ancestor
154628451|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628452|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154628453|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
154628454|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628455|NCT05366283|Sargramostim|sargramostim|mesh-list
154628456|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
154628457|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628458|NCT02565381|Nicotine|nicotine|mesh-list
154628459|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154628460|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
154628461|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628462|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628463|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154628464|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154628465|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
154628466|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628467|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628468|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
154628470|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154628471|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154628472|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628473|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154628474|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628475|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154628476|NCT02063698|Auranofin|auranofin|mesh-list
154628477|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628478|NCT04701034|Prednisolone|prednisolone|mesh-list
154628479|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
154628480|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154628481|NCT04701034|Antibodies|antibodies|mesh-list
154628482|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
154628483|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154628484|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628485|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
154628486|NCT04701034|Hormones|hormones|mesh-ancestor
154628487|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628488|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628489|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154628490|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628491|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
154628492|NCT01663623|Azathioprine|azathioprine|mesh-list
154628493|NCT01663623|Belimumab|belimumab|mesh-list
154628494|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
154628495|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628496|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154628497|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628498|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154628499|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
154628500|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628501|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628502|NCT04582305|Bleomycin|bleomycin|mesh-list
154628503|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154628504|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628505|NCT05504967|Dexamethasone|dexamethasone|mesh-list
154628506|NCT05504967|Ropivacaine|ropivacaine|mesh-list
154628507|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628508|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
154628509|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
154628510|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628511|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628512|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154628513|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
154628514|NCT05504967|Hormones|hormones|mesh-ancestor
154628515|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628516|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154628517|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628518|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
154628519|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
154628520|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628521|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
154628522|NCT02565147|Heparin|heparin|mesh-list
154628523|NCT02565147|Bivalirudin|bivalirudin|mesh-list
154628524|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
154628525|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154628526|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154628527|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628528|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
154628529|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154628530|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
154628531|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628532|NCT02061280|Fluticasone|fluticasone|mesh-list
154628533|NCT02061280|Xhance|xhance|mesh-list
154628534|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154241246|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628535|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154628536|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628537|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154628538|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
154628539|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628540|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628541|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154628542|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
154628543|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
154628544|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154628545|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154628546|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154628547|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154628548|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
154628549|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628550|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628551|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
154628552|NCT02061280|Hormones|hormones|mesh-ancestor
154628553|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628554|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
154628555|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
154628556|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628557|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
154628558|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154628559|NCT04698850|Ranibizumab|ranibizumab|mesh-list
154628560|NCT04698850|Aflibercept|aflibercept|mesh-list
154628561|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154628562|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154628563|NCT04698850|Growth Substances|growth substances|mesh-ancestor
154628564|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628565|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
154628566|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628567|NCT04698226|Temazepam|temazepam|mesh-list
154628568|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154628569|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628570|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628571|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154628572|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154628573|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154628574|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
154628575|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
154628576|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628577|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628578|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
154628579|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
154628580|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154628581|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154628582|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628583|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
154628584|NCT05504577|Coagulants|coagulants|mesh-ancestor
154628585|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
154628586|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154628587|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154628588|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628589|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154628590|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154343376|NCT01255579|Hormones|hormones|mesh-ancestor
154628591|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628592|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628593|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
154628594|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
154628595|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154628596|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154628597|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628598|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628599|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628600|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628601|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
154628602|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154628603|NCT05504265|Analgesics|analgesics|mesh-ancestor
154628604|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
154628605|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628606|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628607|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154628608|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154628609|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628610|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241323|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
154628611|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154628612|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628613|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628614|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
154628615|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
154628616|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628617|NCT04740099|Naloxone|naloxone|mesh-list
154628618|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154628619|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628620|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
154628621|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628622|NCT02560389|Levodopa|levodopa|mesh-list
154628623|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154628624|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154628625|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
154628626|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628627|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628628|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628629|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154628630|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
154628631|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628632|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628633|NCT02564211|Incretins|incretins|mesh-ancestor
154628634|NCT02564211|Hormones|hormones|mesh-ancestor
154628635|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628636|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154628637|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
154628638|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628639|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628640|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154628641|NCT04596579|Antibodies|antibodies|mesh-list
154628642|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
154628643|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628644|NCT04465383|Propofol|propofol|mesh-list
154628645|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154628646|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628647|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628648|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154628649|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
154628650|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
154628651|NCT05500677|Lidocaine|lidocaine|mesh-list
154628652|NCT05500677|Fentanyl|fentanyl|mesh-list
154628653|NCT05500677|Tramadol|tramadol|mesh-list
154628654|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
154628655|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
154628656|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628657|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628658|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
154628659|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628660|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154628661|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154628662|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154628663|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154628664|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628665|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154628666|NCT05500677|Narcotics|narcotics|mesh-ancestor
154628667|NCT05500677|Analgesics|analgesics|mesh-ancestor
154628668|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154628669|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154628670|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
154628671|NCT02093026|Folic Acid|folic acid|mesh-list
154628672|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
154628673|NCT02093026|Rituximab|rituximab|mesh-list
154628674|NCT02093026|Methotrexate|methotrexate|mesh-list
154628675|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154628676|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628677|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
154628678|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628679|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628680|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154628681|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
154628682|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154628683|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154628684|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
154628685|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628686|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
154241402|NCT01044329|Hormones|hormones|mesh-ancestor
154628687|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628688|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154628689|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154628690|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154628691|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628692|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
154628693|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
154628694|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628695|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154628696|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
154628697|NCT02093026|Hormones|hormones|mesh-ancestor
154628698|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628699|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154628700|NCT02093026|Protective Agents|protective agents|mesh-ancestor
154628701|NCT02093026|Hematinics|hematinics|mesh-ancestor
154628702|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
154628703|NCT02093026|Vitamins|vitamins|mesh-ancestor
154628704|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
154628705|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
154628706|NCT02059174|MK-1293|mk-1293|mesh-list
154628707|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628708|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628709|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154628710|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
154628711|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628712|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154628713|NCT04417582|Liraglutide|liraglutide|mesh-list
154628714|NCT04417582|Orlistat|orlistat|mesh-list
154628715|NCT04417582|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154628716|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628717|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628718|NCT04417582|Incretins|incretins|mesh-ancestor
154628719|NCT04417582|Hormones|hormones|mesh-ancestor
154628720|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628721|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628722|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628723|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154343493|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
154628724|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154628725|NCT02040766|Beclomethasone|beclomethasone|mesh-list
154628726|NCT02040766|Albuterol|albuterol|mesh-list
154628727|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
154628728|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
154628729|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628730|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628731|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154628732|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
154628733|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
154628734|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154628735|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154628736|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154628737|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154628738|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
154628739|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628740|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628741|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628742|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
154628743|NCT02040766|Hormones|hormones|mesh-ancestor
154628744|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628745|NCT02040532|Gabapentin|gabapentin|mesh-list
154628746|NCT02040532|Analgesics|analgesics|mesh-ancestor
154628747|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
154628748|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628749|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628750|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
154628751|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154628752|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154628753|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628754|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154628755|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154628756|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154628757|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628758|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628759|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
154628760|NCT02039908|Methylphenidate|methylphenidate|mesh-list
154628761|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154241481|NCT00119678|Prednisone|prednisone|mesh-list
154628762|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628763|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154628764|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154628765|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154628766|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628767|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
154628768|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628769|NCT04417348|Tretinoin|tretinoin|mesh-list
154628770|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628771|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
154628772|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
154628773|NCT02058940|Exenatide|exenatide|mesh-list
154628774|NCT02058940|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154628775|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628776|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628777|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154628778|NCT02058940|Incretins|incretins|mesh-ancestor
154628779|NCT02058940|Hormones|hormones|mesh-ancestor
154628780|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154628781|NCT02058628|Clindamycin|clindamycin|mesh-list
154628782|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
154628783|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
154628784|NCT02058628|Azelaic acid|azelaic acid|mesh-list
154628785|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154628786|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628787|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154628788|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628789|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628790|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628791|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
154628792|NCT02058160|Insulin|insulin|mesh-list
154628793|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154628794|NCT02058160|Metformin|metformin|mesh-list
154628795|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
154628796|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628797|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628798|NCT02090764|Ozenoxacin|ozenoxacin|mesh-list
154628799|NCT02090764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154628800|NCT02090764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628801|NCT02090764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154628802|NCT02090764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628803|NCT02090764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628804|NCT02090764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628805|NCT02088034|Metformin|metformin|mesh-list
154628806|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154628807|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628808|NCT02037256|Bortezomib|bortezomib|mesh-list
154628809|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628810|NCT02035696|Vaccines|vaccines|mesh-list
154628811|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
154628812|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628813|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
154628814|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
154628815|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154628816|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154628817|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628818|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628819|NCT02057458|Urological Agents|urological agents|mesh-ancestor
154628820|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
154628821|NCT02087176|Adavosertib|adavosertib|mesh-list
154628822|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628823|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628824|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
154628825|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154628826|NCT02056288|Fentanyl|fentanyl|mesh-list
154628827|NCT02056288|Ropivacaine|ropivacaine|mesh-list
154628828|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
154628829|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
154628830|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628831|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628832|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
154628833|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628834|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154628835|NCT02056288|Narcotics|narcotics|mesh-ancestor
154628836|NCT02056288|Analgesics|analgesics|mesh-ancestor
154628837|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154628838|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154628839|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
154628840|NCT03115697|Rifaximin|rifaximin|mesh-list
154628841|NCT03115697|Lactulose|lactulose|mesh-list
154628842|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154628843|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628844|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154628845|NCT03115775|Vitamin D|vitamin d|mesh-list
154628846|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
154628847|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
154628848|NCT03115775|Vitamins|vitamins|mesh-list
154628849|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
154628850|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628851|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154628852|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154628853|NCT02404259|Ritonavir|ritonavir|mesh-list
154628854|NCT02404259|Lopinavir|lopinavir|mesh-list
154628855|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154628856|NCT02404259|Tenofovir|tenofovir|mesh-list
154628857|NCT02404259|Efavirenz|efavirenz|mesh-list
154628858|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154628859|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154628860|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
154628861|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628862|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628863|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154628864|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154628865|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
154628866|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154628867|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154628868|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154628869|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154628870|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154628871|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154628872|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154628873|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154628874|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154628875|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154628876|NCT03170687|Calpastatin|calpastatin|mesh-list
154628877|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154628878|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
154628879|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628880|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628881|NCT03169751|Caffeine|caffeine|mesh-list
154628882|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154343649|NCT02527603|Analgesics|analgesics|mesh-ancestor
154628883|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628884|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154628885|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628886|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628887|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154628888|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154628889|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
154628890|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628891|NCT02403713|Fluticasone|fluticasone|mesh-list
154628892|NCT02403713|Xhance|xhance|mesh-list
154628893|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
154628894|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628895|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154628896|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
154628897|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628898|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628899|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154628900|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
154628901|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
154628902|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154628903|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154628904|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154628905|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154628906|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154628907|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154628908|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628909|NCT02700815|Diclofenac|diclofenac|mesh-list
154628910|NCT02700815|Capsaicin|capsaicin|mesh-list
154628911|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154628912|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154241622|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
154628913|NCT02700815|Analgesics|analgesics|mesh-ancestor
154628914|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
154628915|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628916|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628917|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628918|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154628919|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154628920|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628921|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628922|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
154343688|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154628923|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154628924|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
154628925|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154628926|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
154628927|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154628928|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628929|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154628930|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154628931|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154628932|NCT02402621|Fentanyl|fentanyl|mesh-list
154628933|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154628934|NCT02402621|Narcotics|narcotics|mesh-ancestor
154628935|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154628936|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628937|NCT02402621|Analgesics|analgesics|mesh-ancestor
154628938|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
154628939|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628940|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154628941|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154628942|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
154628943|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
154628944|NCT04481789|Furosemide|furosemide|mesh-list
154628945|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
154628946|NCT04481789|Edaravone|edaravone|mesh-list
154628947|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154628948|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154628949|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154628950|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
154628951|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628952|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154628953|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154628954|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628955|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
154628956|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154628957|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154628958|NCT04481789|Urological Agents|urological agents|mesh-ancestor
154628959|NCT04481789|Diuretics|diuretics|mesh-ancestor
154628960|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
154628961|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628962|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154628963|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154628964|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154628965|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
154628966|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154628967|NCT04481789|Protective Agents|protective agents|mesh-ancestor
154628968|NCT02402465|Fluticasone|fluticasone|mesh-list
154628969|NCT02402465|Xhance|xhance|mesh-list
154628970|NCT02402465|Azelastine|azelastine|mesh-list
154628971|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628972|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154628973|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
154628974|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154628975|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154628976|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154628977|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
154628978|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154628979|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154628980|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154628981|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154628982|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154628983|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154628984|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154628985|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
154628986|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
154628987|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241696|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154628988|NCT02402231|Omalizumab|omalizumab|mesh-list
154628989|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154628990|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154628991|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
154628992|NCT02402543|Acetaminophen|acetaminophen|mesh-list
154628993|NCT02402543|Dexamethasone|dexamethasone|mesh-list
154628994|NCT02402543|Ketamine|ketamine|mesh-list
154628995|NCT02402543|Gabapentin|gabapentin|mesh-list
154628996|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154628997|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
154628998|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
154628999|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629000|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629001|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154629002|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
154629003|NCT02402543|Hormones|hormones|mesh-ancestor
154629004|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629005|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154629006|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629007|NCT02402543|Analgesics|analgesics|mesh-ancestor
154629008|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
154629009|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154629010|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154629011|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
154629012|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
154629013|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629014|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154629015|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154629016|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629017|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629018|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629019|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
154629020|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
154629021|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154629022|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154629023|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154629024|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
154629025|NCT02401295|Itraconazole|itraconazole|mesh-list
154629026|NCT02401295|Celecoxib|celecoxib|mesh-list
154629027|NCT02401295|Tretinoin|tretinoin|mesh-list
154629028|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154629029|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629030|NCT02401295|Analgesics|analgesics|mesh-ancestor
154629031|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
154629032|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629033|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629034|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629035|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629036|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154629037|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154629038|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629039|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629040|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
154629041|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629042|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154629043|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154629044|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154629045|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
154629046|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629047|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154629048|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629049|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
154629050|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
154629051|NCT00708305|Listerine|listerine|mesh-list
154629052|NCT00708305|Fluorides|fluorides|mesh-list
154629053|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
154629054|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
154629055|NCT00708305|Protective Agents|protective agents|mesh-ancestor
154629056|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629057|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154629058|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629059|NCT03169127|Ibuprofen|ibuprofen|mesh-list
154629060|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154629061|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629062|NCT03169127|Analgesics|analgesics|mesh-ancestor
154629063|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
154629064|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629065|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629066|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629067|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629068|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154629069|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629070|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629071|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154629072|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
154629073|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154629074|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
154629075|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629076|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629077|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154629078|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154629079|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629080|NCT02418533|Menotropins|menotropins|mesh-list
154629081|NCT02418533|Hormones|hormones|mesh-list
154629082|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154629083|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629084|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629085|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154629086|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
154629087|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629088|NCT02418065|Testosterone|testosterone|mesh-list
154629089|NCT02418065|Androgens|androgens|mesh-ancestor
154629090|NCT02418065|Hormones|hormones|mesh-ancestor
154629091|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629092|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629093|NCT05058443|Denosumab|denosumab|mesh-list
154629094|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154629095|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629096|NCT02055976|Ezetimibe|ezetimibe|mesh-list
154629097|NCT02055976|Bococizumab|bococizumab|mesh-list
154629098|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154629099|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154629100|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
154629101|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629102|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154629103|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
154629104|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154629105|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154629106|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
154629107|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
154629108|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629109|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629110|NCT04406259|Verapamil|verapamil|mesh-list
154629111|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154629112|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154629113|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154629114|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629115|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154629116|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629117|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
154629118|NCT03972111|Tecovirimat|tecovirimat|mesh-list
154629119|NCT03972111|Antiviral Agents|antiviral agents|mesh-ancestor
154629120|NCT03972111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629121|NCT02699099|Vitamin A|vitamin a|mesh-list
154629122|NCT02699099|Vaccines|vaccines|mesh-list
154629123|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
154629124|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629125|NCT02699099|Vitamins|vitamins|mesh-ancestor
154629126|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
154629127|NCT02400047|Dexamethasone|dexamethasone|mesh-list
154629128|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
154629129|NCT02400047|Ketoprofen|ketoprofen|mesh-list
154629130|NCT02400047|BB 1101|bb 1101|mesh-list
154629131|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629132|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
154629133|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
154629134|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629135|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629136|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154629137|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
154629138|NCT02400047|Hormones|hormones|mesh-ancestor
154343901|NCT03430986|Lidocaine|lidocaine|mesh-list
154629139|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629140|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154629141|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629142|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154629143|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629144|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629145|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154629146|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629147|NCT02400047|Analgesics|analgesics|mesh-ancestor
154629148|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
154629149|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629150|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154629151|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
154629152|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154629153|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
154629154|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629155|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
154629156|NCT02698865|Protective Agents|protective agents|mesh-ancestor
154629157|NCT05499897|Anesthetics|anesthetics|mesh-list
154629158|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629159|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629160|NCT02417207|Entecavir|entecavir|mesh-list
154629161|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
154629162|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629163|NCT02698475|Ustekinumab|ustekinumab|mesh-list
154629164|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154629165|NCT02399657|Dexamethasone|dexamethasone|mesh-list
154629166|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629167|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
154629168|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
154629169|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629170|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629171|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154629172|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
154629173|NCT02399657|Hormones|hormones|mesh-ancestor
154629174|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154343939|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154629175|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154629176|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629177|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
154629178|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629179|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629180|NCT02559687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154629181|NCT02559687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629182|NCT03177317|Dexamethasone|dexamethasone|mesh-list
154629183|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629184|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
154629185|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
154629186|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629187|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629188|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154629189|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
154629190|NCT03177317|Hormones|hormones|mesh-ancestor
154629191|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629192|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154629193|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629194|NCT03177239|Nivolumab|nivolumab|mesh-list
154629195|NCT03177239|Ipilimumab|ipilimumab|mesh-list
154629196|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629197|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629198|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154629199|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629200|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
154629201|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154629202|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154629203|NCT04480775|Prednisolone|prednisolone|mesh-list
154629204|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
154629205|NCT04480775|Triamcinolone|triamcinolone|mesh-list
154629206|NCT04480775|Bupivacaine|bupivacaine|mesh-list
154629207|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154629208|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
154629209|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
154629210|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
154629211|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629212|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629213|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
154343979|NCT01154959|Rifampin|rifampin|mesh-list
154629214|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629215|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629216|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
154629217|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
154629218|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154629219|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
154629220|NCT04480775|Hormones|hormones|mesh-ancestor
154629221|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629222|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154629223|NCT04480775|Protective Agents|protective agents|mesh-ancestor
154629224|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154629225|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629226|NCT02416817|Thrombin|thrombin|mesh-list
154629227|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
154629228|NCT02416817|Coagulants|coagulants|mesh-ancestor
154629229|NCT02399189|Methotrexate|methotrexate|mesh-list
154629230|NCT02399189|Temozolomide|temozolomide|mesh-list
154629231|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629232|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
154629233|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629234|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629235|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154629236|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
154629237|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629238|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154629239|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
154629240|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629241|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
154629242|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629243|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154629244|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154629245|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154629246|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154629247|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
154629248|NCT03176849|Vitamin D|vitamin d|mesh-list
154629249|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
154629250|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
154629251|NCT03176849|Vitamins|vitamins|mesh-list
154629252|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
154629253|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629254|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154629255|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154629256|NCT03106571|Methamphetamine|methamphetamine|mesh-list
154629257|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154629258|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629259|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
154629260|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
154629261|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629262|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
154629263|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629264|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629265|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
154629266|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154629267|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154629268|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154629269|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154629270|NCT03177083|Interferons|interferons|mesh-list
154629271|NCT03177083|Interferon-beta|interferon-beta|mesh-list
154629272|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
154629273|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
154629274|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629275|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
154629276|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629277|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
154629278|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629279|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154629280|NCT03629925|Carboplatin|carboplatin|mesh-list
154629281|NCT03629925|Gemcitabine|gemcitabine|mesh-list
154629282|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629283|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154629284|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
154629285|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629286|NCT02398487|Nicotine|nicotine|mesh-list
154629287|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154629288|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
154629289|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629290|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629291|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154629292|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154629293|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
154629294|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629295|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629296|NCT03250299|Lisavanbulin|lisavanbulin|mesh-list
154629297|NCT03250299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154629298|NCT03250299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629299|NCT03250299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629300|NCT03250299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629301|NCT02697617|Pioglitazone|pioglitazone|mesh-list
154629302|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154629303|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629304|NCT02396225|Voriconazole|voriconazole|mesh-list
154629305|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
154629306|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629307|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154629308|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154629309|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629310|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629311|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154629312|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
154629313|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629314|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629315|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154629316|NCT02396303|Carbetocin|carbetocin|mesh-list
154629317|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
154629318|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629319|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629320|NCT02397863|Cannabidiol|cannabidiol|mesh-list
154629321|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
154629322|NCT03168035|NC-4016|nc-4016|mesh-list
154629323|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629324|NCT02397395|Simeprevir|simeprevir|mesh-list
154629325|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
154629326|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629327|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154629328|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629329|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629330|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154629331|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629332|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629333|NCT03168191|Menthol|menthol|mesh-list
154629334|NCT03168191|Nicotine|nicotine|mesh-list
154629335|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154629336|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
154629337|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629338|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629339|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154629340|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154629341|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
154629342|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629343|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629344|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
154629345|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
154629346|NCT04280055|Psilocybin|psilocybin|mesh-list
154629347|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
154629348|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629349|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154629350|NCT05499117|Fluoxetine|fluoxetine|mesh-list
154629351|NCT05499117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154629352|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154629353|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154629354|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629355|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629356|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
154344117|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629357|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629358|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154629359|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
154629360|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154629361|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154629362|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154629363|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629364|NCT05498337|Calcium|calcium|mesh-list
154629365|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153988975|NCT00772681|Docetaxel|docetaxel|mesh-list
154629366|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629367|NCT01663233|Amlodipine|amlodipine|mesh-list
154629368|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154629369|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154629370|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154629371|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154629372|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629373|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154629374|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629375|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
154629376|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154629377|NCT05494281|Anesthetics|anesthetics|mesh-list
154629378|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
154629379|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629380|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629381|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
154629382|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629383|NCT05494047|Vaccines|vaccines|mesh-list
154629384|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
154629385|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629386|NCT05493969|Lamivudine|lamivudine|mesh-list
154629387|NCT05493969|Dolutegravir|dolutegravir|mesh-list
154629388|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154629389|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154629390|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629391|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629392|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
154629393|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629394|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154629395|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154344165|NCT01589809|Niacin|niacin|mesh-list
154629396|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154629397|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154629398|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
154629399|NCT05493267|Interleukin-2|interleukin-2|mesh-list
154629400|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629401|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629402|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629403|NCT05493267|Analgesics|analgesics|mesh-ancestor
154629404|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
154629405|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629406|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154629407|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
154629408|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
154629409|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154629410|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
154629411|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629412|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629413|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154629414|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154629415|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154629416|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154629417|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629418|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
154629419|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154629420|NCT05492019|Doxycycline|doxycycline|mesh-list
154629421|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154629422|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629423|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
154629424|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154629425|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154629426|NCT05491785|Oxycodone|oxycodone|mesh-list
154629427|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154629428|NCT05491785|Narcotics|narcotics|mesh-ancestor
154629429|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629430|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629431|NCT05491785|Analgesics|analgesics|mesh-ancestor
154629432|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
154629433|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629434|NCT05484375|Capecitabine|capecitabine|mesh-list
154629435|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154629436|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
154344201|NCT03880357|Betamethasone|betamethasone|mesh-list
154629437|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629438|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629439|NCT05480007|Metformin|metformin|mesh-list
154629440|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154629442|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629443|NCT05480007|Incretins|incretins|mesh-ancestor
154629444|NCT05480007|Hormones|hormones|mesh-ancestor
154629445|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629446|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154629447|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
154629448|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629449|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629450|NCT05489601|Oxycodone|oxycodone|mesh-list
154629451|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154629452|NCT05489601|Narcotics|narcotics|mesh-ancestor
154629453|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629454|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629455|NCT05489601|Analgesics|analgesics|mesh-ancestor
154629456|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
154629457|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629458|NCT05488899|Iodine|iodine|mesh-list
154629459|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
154629460|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154629461|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629462|NCT05488899|Trace Elements|trace elements|mesh-ancestor
154629463|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
154629464|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629465|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
154629466|NCT05483439|Carboplatin|carboplatin|mesh-list
154629467|NCT05483439|Docetaxel|docetaxel|mesh-list
154629468|NCT05483439|Trastuzumab|trastuzumab|mesh-list
154629469|NCT05483439|Epirubicin|epirubicin|mesh-list
154629470|NCT05483439|Pertuzumab|pertuzumab|mesh-list
154629471|NCT05483439|Antibodies|antibodies|mesh-list
154629472|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154629473|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154629474|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
154629475|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629476|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629477|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154629478|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
154629479|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629480|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629481|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154629482|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
154629483|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
154629484|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
154629485|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629486|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154629487|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154629488|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154629489|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629490|NCT03748095|Tazobactam|tazobactam|mesh-list
154629491|NCT03748095|Piperacillin|piperacillin|mesh-list
154629492|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154629493|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629494|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154629495|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629496|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629497|NCT04275375|Anesthetics|anesthetics|mesh-list
154344245|NCT01266187|Leucovorin|leucovorin|mesh-list
154629498|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629499|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629500|NCT05488353|Disitamab vedotin|disitamab vedotin|mesh-list
154629501|NCT05488353|Immunoconjugates|immunoconjugates|mesh-ancestor
154629502|NCT05488353|Immunologic Factors|immunologic factors|mesh-ancestor
154629503|NCT05488353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629504|NCT05487963|Tofacitinib|tofacitinib|mesh-list
154629505|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629506|NCT05487963|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154629507|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154629508|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629509|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154629510|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
154629511|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629512|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
154629513|NCT05476731|Clotrimazole|clotrimazole|mesh-list
154242217|NCT04116398|Hormones|hormones|mesh-ancestor
154629514|NCT05476731|Miconazole|miconazole|mesh-list
154629515|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629516|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154629517|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154629518|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154629519|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629520|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629521|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154629522|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
154629523|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629524|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629525|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154629526|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154629527|NCT05482113|Bupivacaine|bupivacaine|mesh-list
154629528|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
154629529|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
154629530|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629531|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629532|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
154629533|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629534|NCT05481957|Vortioxetine|vortioxetine|mesh-list
154629535|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
154629536|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154629537|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154344300|NCT00075725|Pegaspargase|pegaspargase|mesh-list
154629538|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154629539|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629540|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629541|NCT05481957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154629542|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154629543|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154629544|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629545|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629546|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
154629547|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154629548|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154629549|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154629550|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154629551|NCT05475561|Bupivacaine|bupivacaine|mesh-list
154629552|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
154629553|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
154629554|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629555|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629556|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
154629557|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629558|NCT05476341|Bevacizumab|bevacizumab|mesh-list
154629559|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629560|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629561|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154629562|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154629563|NCT05476341|Growth Substances|growth substances|mesh-ancestor
154629564|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629565|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
154629566|NCT05481723|Norepinephrine|norepinephrine|mesh-list
154629567|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154629568|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154629569|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
154629570|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629571|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629572|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629573|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
154629574|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
154629575|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344355|NCT01264783|RNS60|rns60|mesh-list
154629576|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154629577|NCT04272021|Methylphenidate|methylphenidate|mesh-list
154629578|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154629579|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629580|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154629581|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154629582|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154629583|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629584|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
154629585|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629586|NCT02697773|Tanezumab|tanezumab|mesh-list
154629587|NCT02697773|Analgesics|analgesics|mesh-ancestor
154629588|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
154629589|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629590|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629592|NCT02394821|Polihexanide|polihexanide|mesh-list
154629593|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629594|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154629595|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154629596|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154629597|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
154629598|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154629599|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154629600|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629601|NCT05745857|Bevacizumab|bevacizumab|mesh-list
154629602|NCT05745857|Cetuximab|cetuximab|mesh-list
154629603|NCT05745857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629604|NCT05745857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629605|NCT05745857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154629606|NCT05745857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154629607|NCT05745857|Growth Substances|growth substances|mesh-ancestor
154629608|NCT05745857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629609|NCT05745857|Growth Inhibitors|growth inhibitors|mesh-ancestor
154629610|NCT05745779|Vitamin D|vitamin d|mesh-list
154629611|NCT05745779|Vitamins|vitamins|mesh-list
154629612|NCT05745779|Vitamin B 12|vitamin b 12|mesh-list
154629613|NCT05745779|Hydroxocobalamin|hydroxocobalamin|mesh-list
154629614|NCT05745779|Micronutrients|micronutrients|mesh-ancestor
154629615|NCT05745779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629616|NCT05745779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154629617|NCT05745779|Vitamin B Complex|vitamin b complex|mesh-ancestor
154629618|NCT05745779|Hematinics|hematinics|mesh-ancestor
154629619|NCT02394197|Chloroquine|chloroquine|mesh-list
154629620|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154629621|NCT02394197|Primaquine|primaquine|mesh-list
154629622|NCT02394197|Amebicides|amebicides|mesh-ancestor
154629623|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154629624|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154629625|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629626|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
154629627|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629628|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154629629|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629630|NCT02394197|Analgesics|analgesics|mesh-ancestor
154629631|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
154629632|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629633|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629634|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629635|NCT02394197|Filaricides|filaricides|mesh-ancestor
154629636|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
154629637|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
154629638|NCT02394119|Rituximab|rituximab|mesh-list
154629639|NCT02394119|Ofatumumab|ofatumumab|mesh-list
154629640|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629641|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629642|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
154629643|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629644|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629645|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
154629646|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154629647|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
154629648|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629649|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
154629650|NCT03167333|Protective Agents|protective agents|mesh-ancestor
154629651|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
154629652|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154629653|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154629654|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629655|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
154629656|NCT02393963|Coagulants|coagulants|mesh-ancestor
154629657|NCT03115619|Pirfenidone|pirfenidone|mesh-list
154629658|NCT03115619|Analgesics|analgesics|mesh-ancestor
154629659|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
154629660|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629661|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629662|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154629663|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629664|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629665|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629666|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629667|NCT02393573|Metformin|metformin|mesh-list
154629668|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154629669|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629670|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
154629671|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154629672|NCT02693171|Dinutuximab|dinutuximab|mesh-list
154629673|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629674|NCT02392793|Irinotecan|irinotecan|mesh-list
154629675|NCT02392793|Temozolomide|temozolomide|mesh-list
154629676|NCT02392793|Talazoparib|talazoparib|mesh-list
154629677|NCT02392793|Lenograstim|lenograstim|mesh-list
154629678|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154629679|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154629680|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629681|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629682|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629683|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154629684|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
154629685|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629686|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154629687|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
154629688|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154629689|NCT03167177|Leucovorin|leucovorin|mesh-list
154629690|NCT03167177|Paclitaxel|paclitaxel|mesh-list
154629691|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
154629692|NCT03167177|Bevacizumab|bevacizumab|mesh-list
154629693|NCT03167177|Capecitabine|capecitabine|mesh-list
154629694|NCT03167177|Nivolumab|nivolumab|mesh-list
154629695|NCT03167177|Fluorouracil|fluorouracil|mesh-list
154629696|NCT03167177|Avelumab|avelumab|mesh-list
154629697|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154629698|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629699|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154629700|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154629701|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154629702|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629703|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154629704|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
154629705|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629706|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629707|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154629708|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
154629709|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154629710|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629711|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154629712|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154629713|NCT03167177|Growth Substances|growth substances|mesh-ancestor
154629714|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
154629715|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154629716|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
154629717|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154629718|NCT03167177|Antidotes|antidotes|mesh-ancestor
154629719|NCT03167177|Protective Agents|protective agents|mesh-ancestor
154629720|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
154629721|NCT03167177|Vitamins|vitamins|mesh-ancestor
154629722|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
154629723|NCT02392169|Methylphenidate|methylphenidate|mesh-list
154629724|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154629725|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629726|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154629727|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154629728|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154629729|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629730|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
154629731|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629732|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
154629733|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154629734|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
154629735|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629736|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
154629737|NCT03166865|Protective Agents|protective agents|mesh-ancestor
154629738|NCT03166787|Tadalafil|tadalafil|mesh-list
154629739|NCT03166787|Charcoal|charcoal|mesh-list
154629740|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
154629741|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629742|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629743|NCT03166787|Protective Agents|protective agents|mesh-ancestor
154629744|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
154629745|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154629746|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154629747|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629748|NCT03166787|Urological Agents|urological agents|mesh-ancestor
154629749|NCT03166787|Antidotes|antidotes|mesh-ancestor
154629750|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
154629751|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
154629752|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629753|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
154629754|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629755|NCT03167957|Amphotericin B|amphotericin b|mesh-list
154629756|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154629757|NCT03167957|Amebicides|amebicides|mesh-ancestor
154629758|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154629759|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154629760|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629761|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154629762|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
154629763|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
154629764|NCT03166397|Nivolumab|nivolumab|mesh-list
154629765|NCT03166397|Fludarabine|fludarabine|mesh-list
154629766|NCT03166397|Ipilimumab|ipilimumab|mesh-list
154629767|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154629768|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
154629769|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629770|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629771|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154629772|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
154629773|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629774|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629775|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154629776|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629777|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154629778|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
154629779|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629780|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629781|NCT02552355|Metformin|metformin|mesh-list
154629782|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154629783|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629784|NCT02551731|Cannabidiol|cannabidiol|mesh-list
154629785|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
154629786|NCT04479657|Cefuroxime|cefuroxime|mesh-list
154629787|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
154629788|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154629789|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629790|NCT05471661|PENTA|penta|mesh-list
154629791|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
154629792|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154629793|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154629794|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629795|NCT05480631|Mitogens|mitogens|mesh-list
154629796|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
154629797|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629798|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154629799|NCT02542605|Erenumab|erenumab|mesh-list
154629800|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154629801|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629802|NCT02542605|Analgesics|analgesics|mesh-ancestor
154629803|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
154629804|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629805|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629806|NCT02542605|Growth Substances|growth substances|mesh-ancestor
154629807|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
154629808|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629809|NCT02550795|Dexamethasone|dexamethasone|mesh-list
154629810|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
154629811|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629812|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
154629813|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
154629814|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629815|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629816|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154629817|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
154629818|NCT02550795|Hormones|hormones|mesh-ancestor
154629819|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629820|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154629822|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154629823|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629824|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629825|NCT02550795|Analgesics|analgesics|mesh-ancestor
154629826|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
154629827|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154629828|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154629829|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154629830|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
154629831|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629832|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629833|NCT02541903|Afatinib|afatinib|mesh-list
154629834|NCT02541903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154629835|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154629836|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629837|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629838|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629839|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154629840|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154629841|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154629842|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629843|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154629844|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154629845|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629846|NCT02688647|Belumosudil|belumosudil|mesh-list
154629847|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154629848|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629849|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629850|NCT05453799|Antibodies|antibodies|mesh-list
154629851|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
154629852|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154629853|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
154629854|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629855|NCT05453487|Vaccines|vaccines|mesh-list
154629856|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
154629857|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629858|NCT05431725|Vaccines|vaccines|mesh-list
154629859|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
154629860|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629861|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154344614|NCT01160341|Androgens|androgens|mesh-ancestor
154629862|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154629863|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
154629864|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629865|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629866|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154629867|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154629868|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154629869|NCT05451615|Abatacept|abatacept|mesh-list
154629870|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154629871|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154629872|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629873|NCT05451615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629874|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629875|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154629876|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
154629877|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629878|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629879|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154629880|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629881|NCT02534883|Misoprostol|misoprostol|mesh-list
154629882|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154629883|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
154629884|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629885|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629886|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154629887|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154629888|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
154629889|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
154629890|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629891|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629892|NCT05430009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154629893|NCT05430009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629894|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
154629895|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154629896|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154629897|NCT05429697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154659735|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
154629898|NCT05429697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629899|NCT02540265|Meloxicam|meloxicam|mesh-list
154629900|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154629901|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629902|NCT02540265|Analgesics|analgesics|mesh-ancestor
154629903|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
154629904|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629905|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629906|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629907|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629908|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154629909|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154629910|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629911|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629912|NCT02684357|Ustekinumab|ustekinumab|mesh-list
154629913|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154629914|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
154629915|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
154629916|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629917|NCT03115073|Clotrimazole|clotrimazole|mesh-list
154629918|NCT03115073|Miconazole|miconazole|mesh-list
154629919|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154629920|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629921|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
154629922|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154629923|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154629924|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629925|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629926|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154629927|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
154629928|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154629929|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629930|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154629931|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154629932|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
154629933|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154629934|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629935|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
154629936|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
154629937|NCT03165929|Analgesics|analgesics|mesh-ancestor
154629938|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
154629939|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629940|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629941|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154629942|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154629943|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154629944|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154629945|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154629946|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629947|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629948|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154629949|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154629950|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154629951|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
154629952|NCT02546193|Misoprostol|misoprostol|mesh-list
154629953|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154629954|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
154629955|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154629956|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629957|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154629958|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154629959|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
154629960|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
154629961|NCT01661595|Tadalafil|tadalafil|mesh-list
154629962|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
154629963|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154629964|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154629965|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154629966|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629967|NCT01661595|Urological Agents|urological agents|mesh-ancestor
154629968|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
154629969|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154629970|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629971|NCT02957097|Gabapentin|gabapentin|mesh-list
154629972|NCT02957097|Analgesics|analgesics|mesh-ancestor
154629973|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
154629974|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629975|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629976|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
154629977|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154629978|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154629979|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629980|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154629981|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154629982|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154629983|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154629984|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154629985|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
154629986|NCT03165383|Morphine|morphine|mesh-list
154629987|NCT03165383|Bupivacaine|bupivacaine|mesh-list
154629988|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
154629989|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
154629990|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154629991|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154629992|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
154629993|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154629994|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154629995|NCT03165383|Narcotics|narcotics|mesh-ancestor
154629996|NCT03165383|Analgesics|analgesics|mesh-ancestor
154629997|NCT03162185|Escitalopram|escitalopram|mesh-list
154629998|NCT03162185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154629999|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154630000|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154630001|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630002|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630003|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
154630004|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630005|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154630006|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154630007|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630008|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154630009|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154630010|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630011|NCT02683187|Incretins|incretins|mesh-ancestor
154630012|NCT02683187|Hormones|hormones|mesh-ancestor
154630013|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630014|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154630015|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
154630016|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630017|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630018|NCT05515601|Mirikizumab|mirikizumab|mesh-list
154630019|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154630020|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154630021|NCT05515601|Analgesics|analgesics|mesh-ancestor
154630022|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
154630023|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630024|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630025|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630026|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630027|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154630028|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154630029|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
154630030|NCT02683109|Olodaterol|olodaterol|mesh-list
154630031|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154630032|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
154630033|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630034|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630035|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154630036|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
154630037|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
154630038|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154630039|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
154630040|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630041|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630042|NCT02544321|Bromocriptine|bromocriptine|mesh-list
154630043|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154630044|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154630045|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
154630046|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630047|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630048|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
154630049|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
154630050|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630051|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630052|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
154630053|NCT02533401|Rituximab|rituximab|mesh-list
154630054|NCT02533401|Fludarabine|fludarabine|mesh-list
154630055|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630056|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
154630057|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630058|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630059|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154630060|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
154630061|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630062|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630063|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154630064|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630065|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
154630066|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154630067|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630068|NCT02536833|Lorecivivint|lorecivivint|mesh-list
154630069|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630070|NCT02680847|Naltrexone|naltrexone|mesh-list
154630071|NCT02680847|Oxycodone|oxycodone|mesh-list
154630072|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154630073|NCT02680847|Narcotics|narcotics|mesh-ancestor
154630074|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630075|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630076|NCT02680847|Analgesics|analgesics|mesh-ancestor
154630077|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
154630078|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630079|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154630080|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154630081|NCT02532855|Metformin|metformin|mesh-list
154630082|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
154630083|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154630084|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154630085|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630086|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154630087|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630088|NCT02532855|Incretins|incretins|mesh-ancestor
154630089|NCT02532855|Hormones|hormones|mesh-ancestor
154630090|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630091|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154630092|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
154630093|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630094|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
154630095|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
154630096|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630097|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
154630098|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630099|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630100|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154630101|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
154630102|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630103|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630104|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154630105|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630106|NCT04262427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154630107|NCT02530125|Pidilizumab|pidilizumab|mesh-list
154630108|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630109|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630110|NCT02055820|Prednisone|prednisone|mesh-list
154630111|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
154630112|NCT02055820|Rituximab|rituximab|mesh-list
153989709|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
154630114|NCT02055820|Vincristine|vincristine|mesh-list
154630115|NCT02055820|Venetoclax|venetoclax|mesh-list
154630116|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
154630117|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630118|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
154630119|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630120|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630121|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154630122|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
154630123|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630124|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630125|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154630126|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630127|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154630128|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154630129|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154630130|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630131|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630132|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
154630133|NCT02055820|Hormones|hormones|mesh-ancestor
154630134|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630135|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154630136|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154630137|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
154630138|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
154630139|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
154630140|NCT02055352|Fluticasone|fluticasone|mesh-list
154630141|NCT02055352|Budesonide|budesonide|mesh-list
154630142|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154630143|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630144|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154630145|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
154630146|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630147|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630148|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154630149|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
154630150|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
154630151|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154630152|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
154630153|NCT02055352|Hormones|hormones|mesh-ancestor
154630154|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630155|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154630156|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154630157|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154630158|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
154630159|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630160|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630161|NCT02034916|Talazoparib|talazoparib|mesh-list
154630162|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154630163|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630164|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630165|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630166|NCT01374425|Leucovorin|leucovorin|mesh-list
154630167|NCT01374425|Bevacizumab|bevacizumab|mesh-list
154630168|NCT01374425|Capecitabine|capecitabine|mesh-list
154630169|NCT01374425|Fluorouracil|fluorouracil|mesh-list
154630170|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
154630171|NCT01374425|Irinotecan|irinotecan|mesh-list
154630172|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630173|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630174|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154630175|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154630176|NCT01374425|Growth Substances|growth substances|mesh-ancestor
154630177|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630178|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
154659736|NCT02452047|Cilastatin|cilastatin|mesh-list
154630179|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154630180|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
154630181|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630182|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630183|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
154630184|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154630185|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154630186|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630187|NCT01374425|Antidotes|antidotes|mesh-ancestor
154630188|NCT01374425|Protective Agents|protective agents|mesh-ancestor
154630189|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
154630190|NCT01374425|Vitamins|vitamins|mesh-ancestor
154630191|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
154630192|NCT02085460|Rebamipide|rebamipide|mesh-list
154630193|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154630194|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154630195|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
154630196|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630197|NCT02085460|Protective Agents|protective agents|mesh-ancestor
154630198|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630199|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630200|NCT03164291|Rifabutin|rifabutin|mesh-list
154630201|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630202|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630203|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154630204|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
154630205|NCT02084134|Dexamethasone|dexamethasone|mesh-list
154630206|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
154630207|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
154630208|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154630209|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154630210|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154630211|NCT02084134|BB 1101|bb 1101|mesh-list
154630212|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630213|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
154630214|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
154630215|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630216|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630217|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154630218|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
154630219|NCT02084134|Hormones|hormones|mesh-ancestor
154630220|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630221|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154630222|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630223|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
154630224|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630225|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630226|NCT01374269|Acetaminophen|acetaminophen|mesh-list
154630227|NCT01374269|Celecoxib|celecoxib|mesh-list
154630228|NCT01374269|Naproxen|naproxen|mesh-list
154630229|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154630230|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154630231|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154630232|NCT01374269|Analgesics|analgesics|mesh-ancestor
154630233|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
154630234|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630235|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630236|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
154630237|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630238|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154630239|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154630240|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630241|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630242|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
154630243|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154630244|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154630245|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630246|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
154630247|NCT03163589|Hematinics|hematinics|mesh-ancestor
154630248|NCT03163277|Emtricitabine|emtricitabine|mesh-list
154630249|NCT03163277|Maraviroc|maraviroc|mesh-list
154630250|NCT03163277|Darunavir|darunavir|mesh-list
154630251|NCT03163277|Cobicistat|cobicistat|mesh-list
154630252|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154630253|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
154630254|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630255|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154630256|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154630257|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630258|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630259|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154630260|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154630261|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154630262|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154630263|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154630264|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154630265|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154630266|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
154630267|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154630268|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154630269|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
154630270|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630271|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630272|NCT05419817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154630273|NCT05419817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630274|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154630275|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154630276|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630277|NCT02679755|Letrozole|letrozole|mesh-list
154630278|NCT02679755|Palbociclib|palbociclib|mesh-list
154630279|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630280|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154630281|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154630282|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630283|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630284|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154630285|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154630286|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630287|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630288|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154630289|NCT03163121|Vaccines|vaccines|mesh-list
154630290|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
154630291|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630292|NCT03114371|Oxytocin|oxytocin|mesh-list
154630293|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
154630294|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154630295|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630296|NCT03114215|Biotin|biotin|mesh-list
154630297|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
154630298|NCT03114215|Vitamins|vitamins|mesh-ancestor
154630299|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
154630300|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630301|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154630302|NCT04205903|Paclitaxel|paclitaxel|mesh-list
154630303|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154630304|NCT04205903|Nilotinib|nilotinib|mesh-list
154630305|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154630306|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630307|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
154630308|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
154630309|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
154630310|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630311|NCT04205903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154630312|NCT04205903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154630313|NCT04205903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630314|NCT02670551|Cariprazine|cariprazine|mesh-list
154630315|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154630316|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154630317|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630318|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630319|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154630320|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
154630321|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630322|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630323|NCT00893399|Immunotoxins|immunotoxins|mesh-ancestor
154630324|NCT00893399|Immunoconjugates|immunoconjugates|mesh-ancestor
154630325|NCT00893399|Immunologic Factors|immunologic factors|mesh-ancestor
154630326|NCT00893399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630327|NCT05675033|Bevacizumab|bevacizumab|mesh-list
154630328|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630329|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630330|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154630331|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154630332|NCT05675033|Growth Substances|growth substances|mesh-ancestor
154630333|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630334|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
154630335|NCT04479527|Apatinib|apatinib|mesh-list
154630336|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630337|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154630338|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630339|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630340|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154630341|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
154630342|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
154630343|NCT02391077|Povidone|povidone|mesh-list
154630344|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630345|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154630346|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
154630347|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
154630348|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
154630349|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154630350|NCT02390921|Hematinics|hematinics|mesh-ancestor
154630351|NCT02390609|Ibrutinib|ibrutinib|mesh-list
154630352|NCT02390609|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154630353|NCT02390609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154630354|NCT02390609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630355|NCT02390609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630356|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
154630357|NCT02390843|Topotecan|topotecan|mesh-list
154630358|NCT02390843|Simvastatin|simvastatin|mesh-list
154630359|NCT02390843|Lenograstim|lenograstim|mesh-list
154630360|NCT02390843|Mitogens|mitogens|mesh-list
154630361|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630362|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
154630363|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630364|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630365|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154630366|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
154630367|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630368|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630369|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154630370|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154630371|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154630372|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
154630373|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154630374|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154630375|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630376|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154630377|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154630378|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
154630379|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154630380|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154630381|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154630382|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154630383|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
154630384|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630385|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154630386|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154630387|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630388|NCT03806309|Leucovorin|leucovorin|mesh-list
154630389|NCT03806309|Fluorouracil|fluorouracil|mesh-list
154630390|NCT03806309|Irinotecan|irinotecan|mesh-list
154630391|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
154630392|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630393|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154630394|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630395|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630396|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
154630397|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630398|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154630399|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154630400|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630401|NCT03806309|Antidotes|antidotes|mesh-ancestor
154630402|NCT03806309|Protective Agents|protective agents|mesh-ancestor
154630403|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
154630404|NCT03806309|Vitamins|vitamins|mesh-ancestor
154630405|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
154630406|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
154630407|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154630408|NCT03489629|Minocycline|minocycline|mesh-list
154630409|NCT03489629|Trimethoprim|trimethoprim|mesh-list
154630410|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
154630411|NCT03489629|Mupirocin|mupirocin|mesh-list
154630412|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154630413|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154630414|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630415|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
154630416|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
154630417|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630418|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154630419|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
154630420|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154630421|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154630422|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154630423|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630424|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630425|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154630426|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154630427|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154630428|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154630429|NCT02389751|Paclitaxel|paclitaxel|mesh-list
154630430|NCT02389751|Carboplatin|carboplatin|mesh-list
154630431|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154630432|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154630433|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630434|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
154630435|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
154630436|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
154630437|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630438|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
154630439|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630440|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
154345210|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630441|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630442|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630443|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154630444|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
154630445|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630446|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630447|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154630448|NCT02388035|Cefotaxime|cefotaxime|mesh-list
154630449|NCT02388035|Cefoxitin|cefoxitin|mesh-list
154630450|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630451|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630452|NCT02389439|Artesunate|artesunate|mesh-list
154630453|NCT02389439|Pyronaridine|pyronaridine|mesh-list
154630454|NCT02389439|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154630455|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
154630456|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154630457|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154630458|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630459|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630460|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
154630461|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
154630462|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154630463|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
154630464|NCT02663687|Complement C1s|complement c1s|mesh-list
154630465|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154630466|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154630467|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
154630468|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630469|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154630470|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630471|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154630472|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154630473|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154630474|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154630475|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
154630476|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154630477|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154630478|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630479|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
154630480|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630481|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630482|NCT02388581|Amoxicillin|amoxicillin|mesh-list
154630483|NCT02388581|Metronidazole|metronidazole|mesh-list
154630484|NCT02388581|Clarithromycin|clarithromycin|mesh-list
154630485|NCT02388581|Lansoprazole|lansoprazole|mesh-list
154630486|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
154630487|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630488|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630489|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154630490|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154630491|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154243208|NCT00079040|Etoposide|etoposide|mesh-list
154630492|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630493|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630494|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154630495|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154630496|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154630497|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154630498|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154630499|NCT02387567|Lidocaine|lidocaine|mesh-list
154630500|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
154630501|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
154630502|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630503|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630504|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
154630505|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630506|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154630507|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154630508|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154630509|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154630510|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630511|NCT02383121|Midodrine|midodrine|mesh-list
154630512|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
154630513|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
154630514|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630515|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630516|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154630517|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154630518|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154630519|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154630520|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154630521|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630522|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630523|NCT02387021|Ropivacaine|ropivacaine|mesh-list
154630524|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
154630525|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
154630526|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630527|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630528|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
154630529|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630530|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154630531|NCT02386943|Saxagliptin|saxagliptin|mesh-list
154630532|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154630533|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630534|NCT02386943|Incretins|incretins|mesh-ancestor
154630535|NCT02386943|Hormones|hormones|mesh-ancestor
154630536|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630537|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154630538|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
154630539|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630540|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630541|NCT02084056|Metformin|metformin|mesh-list
154630542|NCT02084056|Linagliptin|linagliptin|mesh-list
154630543|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154630544|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630545|NCT02084056|Incretins|incretins|mesh-ancestor
154630546|NCT02084056|Hormones|hormones|mesh-ancestor
154630547|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630548|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154630549|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
154630550|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630551|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630552|NCT02386397|Gemcitabine|gemcitabine|mesh-list
154630553|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
154630554|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154630555|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
154630556|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630557|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630558|NCT02386475|Dexetimide|dexetimide|mesh-list
154630559|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154630560|NCT02386475|Citalopram|citalopram|mesh-list
154630561|NCT02386475|Escitalopram|escitalopram|mesh-list
154630562|NCT02386475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154630563|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154630564|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154345316|NCT00028769|Bicalutamide|bicalutamide|mesh-list
154630565|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630566|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630567|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
154630568|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630569|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154630570|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
154630571|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154630572|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154630573|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154630574|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
154630575|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
154630576|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630577|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154630578|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154630579|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
154630580|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154630581|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
154630582|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
154630583|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
154630584|NCT02382653|Piroxicam|piroxicam|mesh-list
154630585|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154630586|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154630587|NCT02382653|Analgesics|analgesics|mesh-ancestor
154630588|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
154630589|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630590|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630591|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630592|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630593|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154630594|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630595|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630596|NCT02382263|Paclitaxel|paclitaxel|mesh-list
154630597|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154630598|NCT02382263|Gemcitabine|gemcitabine|mesh-list
154630599|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154630600|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630601|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
154630602|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
154630603|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
154630604|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630605|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154630606|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
154630607|NCT02382029|Clonazepam|clonazepam|mesh-list
154630608|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
154630609|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
154630610|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
154630611|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630612|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630613|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630614|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
154630615|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
154630616|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
154630617|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630618|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630619|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
154630620|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630621|NCT02385461|Heparin|heparin|mesh-list
154630622|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154630623|NCT02385461|Tinzaparin|tinzaparin|mesh-list
154630624|NCT02385461|Dalteparin|dalteparin|mesh-list
154630625|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
154630626|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154630627|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154345381|NCT01169935|Dextrans|dextrans|mesh-list
154630628|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630629|NCT02381717|Morphine|morphine|mesh-list
154630630|NCT02381717|Bupivacaine|bupivacaine|mesh-list
154630631|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
154630632|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
154630633|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630634|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630635|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
154630636|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630637|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154630638|NCT02381717|Narcotics|narcotics|mesh-ancestor
154243342|NCT00095199|Cetuximab|cetuximab|mesh-list
154630639|NCT02381717|Analgesics|analgesics|mesh-ancestor
154630640|NCT02385305|Anesthetics|anesthetics|mesh-list
154630641|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630642|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630643|NCT02385227|Nicotine|nicotine|mesh-list
154630644|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154630645|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
154630646|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630647|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630648|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154630649|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154630650|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
154630651|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630652|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630653|NCT02385071|Simeprevir|simeprevir|mesh-list
154630654|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
154630655|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630656|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
154630657|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630658|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630659|NCT02384915|Prilocaine|prilocaine|mesh-list
154630660|NCT02384915|Mepivacaine|mepivacaine|mesh-list
154630661|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
154630662|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630663|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630664|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
154630665|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
154630666|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630667|NCT02384837|Sirolimus|sirolimus|mesh-list
154630668|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630669|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630670|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154630671|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630672|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
154630673|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630674|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
154630675|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630676|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
154630677|NCT03105791|Narcotics|narcotics|mesh-ancestor
154630678|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630679|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630680|NCT03105791|Analgesics|analgesics|mesh-ancestor
154630681|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
154630682|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630683|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
154630684|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154630685|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154630686|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630687|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
154630688|NCT02384135|Coagulants|coagulants|mesh-ancestor
154630689|NCT02380625|Azithromycin|azithromycin|mesh-list
154630690|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154630691|NCT02380625|Sunitinib|sunitinib|mesh-list
154630692|NCT02380625|Irbesartan|irbesartan|mesh-list
154630693|NCT02380625|Atorvastatin|atorvastatin|mesh-list
154630694|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154630695|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154630696|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
154630697|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630698|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154630699|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154630700|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630701|NCT02380625|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154630702|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154630703|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630704|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630705|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630706|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154630707|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154630708|NCT02380625|Growth Substances|growth substances|mesh-ancestor
154630709|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630710|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
154630711|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154630712|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154630713|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154630714|NCT02380313|Prednisone|prednisone|mesh-list
154243417|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
154630715|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630716|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
154630717|NCT02380313|Hormones|hormones|mesh-ancestor
154630718|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630719|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630720|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154630721|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630722|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154630723|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154630724|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630725|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630726|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
154630727|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630728|NCT02383901|Methotrexate|methotrexate|mesh-list
154630729|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154630730|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
154630731|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154630732|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630733|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154630734|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
154630735|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630736|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630737|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
154630738|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630739|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154630740|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630741|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
154630742|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630743|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154630744|NCT02383823|Estradiol|estradiol|mesh-list
154630745|NCT02383823|Estrogens|estrogens|mesh-list
154630746|NCT02383823|Hormones|hormones|mesh-ancestor
154630747|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630748|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630749|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154630750|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154630751|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154630752|NCT02380001|Analgesics|analgesics|mesh-ancestor
154630753|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
154630754|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630755|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630756|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630757|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630758|NCT02379767|Harmine|harmine|mesh-list
154630759|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
154630760|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630761|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154630762|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154630763|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630764|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630765|NCT02661815|Paclitaxel|paclitaxel|mesh-list
154630766|NCT02661815|Bevacizumab|bevacizumab|mesh-list
154630767|NCT02661815|Ricolinostat|ricolinostat|mesh-list
154630768|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154630769|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630770|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
154630771|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
154630772|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
154630773|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630774|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630775|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154630776|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154630777|NCT02661815|Growth Substances|growth substances|mesh-ancestor
154630778|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630779|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
154630780|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154630781|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630782|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
154630783|NCT02377193|Tacrolimus|tacrolimus|mesh-list
154630784|NCT02377193|Basiliximab|basiliximab|mesh-list
154630785|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630786|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
154630787|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630788|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154630789|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630790|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630791|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154630792|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630793|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154630794|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
154630795|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630796|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630797|NCT04688021|Cytarabine|cytarabine|mesh-list
154630798|NCT04688021|Cyclosporine|cyclosporine|mesh-list
154630799|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
154630800|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
154630801|NCT04688021|Busulfan|busulfan|mesh-list
154630802|NCT04688021|Cyclosporins|cyclosporins|mesh-list
154630803|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154630804|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
154630805|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154630806|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
154630807|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630808|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630809|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154630810|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
154630811|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630812|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630813|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154630814|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154630815|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
154630816|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
154630817|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630818|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630819|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
154630820|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
154630821|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154630822|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154630823|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154630824|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
154630825|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630826|NCT02053246|Nebivolol|nebivolol|mesh-list
154630827|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154630828|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
154630829|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154630830|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154630831|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154630832|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
154630833|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630834|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630835|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630836|NCT02379299|Hormones|hormones|mesh-list
154630837|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630838|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630839|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
154630840|NCT02376881|Hematinics|hematinics|mesh-ancestor
154630841|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
154630842|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
154630843|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630844|NCT02376803|Warfarin|warfarin|mesh-list
154630845|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
154630846|NCT04132427|Vancomycin|vancomycin|mesh-list
154630847|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
154630848|NCT04132427|Citric Acid|citric acid|mesh-list
154630849|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
154630850|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
154630851|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154630852|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
154630853|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
154630854|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630855|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154630856|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630857|NCT04132427|Cathartics|cathartics|mesh-ancestor
154630858|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154630859|NCT02031640|Beclomethasone|beclomethasone|mesh-list
154630860|NCT02031640|Albuterol|albuterol|mesh-list
154630861|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
154630862|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
154630863|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630864|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630865|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154243574|NCT05665348|Ipilimumab|ipilimumab|mesh-list
154630866|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
154630867|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
154630868|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154630869|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154630870|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154630871|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154630872|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
154630873|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630874|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630875|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630876|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
154630877|NCT02031640|Hormones|hormones|mesh-ancestor
154630878|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630879|NCT02376413|Trastuzumab|trastuzumab|mesh-list
154630880|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630881|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630882|NCT02378441|Metformin|metformin|mesh-list
154630883|NCT02378441|Atorvastatin|atorvastatin|mesh-list
154630884|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154630885|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630886|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154630887|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154630888|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
154630889|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630890|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154630891|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154630892|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630893|NCT04600427|Anesthetics|anesthetics|mesh-list
154630894|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630895|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630896|NCT02378129|Methamphetamine|methamphetamine|mesh-list
154630897|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154630898|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630899|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
154630900|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
154630901|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630902|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
154630903|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630904|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630905|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
154091989|NCT01034683|Leucovorin|leucovorin|mesh-list
154630906|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154630907|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154630908|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154630909|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154630910|NCT02376335|Rituximab|rituximab|mesh-list
154630911|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154630912|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630913|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
154630914|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630915|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154630916|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
154630917|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154630918|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154630919|NCT02375867|Prednisolone|prednisolone|mesh-list
154630920|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
154630921|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154630922|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
154630923|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154630924|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
154630925|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
154630926|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630927|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630928|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154630929|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
154630930|NCT02375867|Hormones|hormones|mesh-ancestor
154630931|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630932|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154630933|NCT02375867|Protective Agents|protective agents|mesh-ancestor
154630934|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154630935|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630936|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
154630937|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154630938|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154630939|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630940|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154630941|NCT02375243|Analgesics|analgesics|mesh-ancestor
154630942|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
154630943|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630944|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154630945|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154630946|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154630947|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154630948|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154630949|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630950|NCT02374931|Estradiol|estradiol|mesh-list
154630951|NCT02374931|Estrogens|estrogens|mesh-ancestor
154630952|NCT02374931|Hormones|hormones|mesh-ancestor
154630953|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630954|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630955|NCT02377661|Amlodipine|amlodipine|mesh-list
154630956|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154630957|NCT02377661|Olmesartan|olmesartan|mesh-list
154630958|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154630959|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154630960|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154630961|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154630962|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630963|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154630964|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630965|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
154630966|NCT02377661|Diuretics|diuretics|mesh-ancestor
154630967|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
154630968|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154630969|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154630970|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154630971|NCT02372357|Posaconazole|posaconazole|mesh-list
154630972|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
154630973|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154630974|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154630975|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154630976|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154630977|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154630978|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154630979|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154630980|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154630981|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154630982|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
154630983|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154630984|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630985|NCT02371577|Lenalidomide|lenalidomide|mesh-list
154630986|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
154630987|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630988|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154630989|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154630990|NCT02371577|Growth Substances|growth substances|mesh-ancestor
154630991|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
154630992|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154630993|NCT02373449|Ketamine|ketamine|mesh-list
154630994|NCT02373449|Analgesics|analgesics|mesh-ancestor
154630995|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
154630996|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154630997|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154630998|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154630999|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154631000|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
154631001|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
154631002|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631003|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154631004|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154631005|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631006|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631007|NCT02371421|Allopurinol|allopurinol|mesh-list
154631008|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
154631009|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631010|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631011|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
154631012|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631013|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154631014|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
154631015|NCT02371421|Protective Agents|protective agents|mesh-ancestor
154631016|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631017|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154631018|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
154345783|NCT01175161|Copper|copper|mesh-list
154631019|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631020|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631021|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631022|NCT03959891|Letrozole|letrozole|mesh-list
154631023|NCT03959891|Fulvestrant|fulvestrant|mesh-list
154631024|NCT03959891|Palbociclib|palbociclib|mesh-list
154631025|NCT03959891|Ipatasertib|ipatasertib|mesh-list
154631026|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154631027|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631028|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154631029|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631030|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631031|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154631032|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
154631033|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631034|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631035|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154631036|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154631037|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154631038|NCT02373215|Nalbuphine|nalbuphine|mesh-list
154631039|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154631040|NCT02373215|Narcotics|narcotics|mesh-ancestor
154631041|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631042|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631043|NCT02373215|Analgesics|analgesics|mesh-ancestor
154631044|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
154631045|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631046|NCT02372903|Palmidrol|palmidrol|mesh-list
154631047|NCT02372903|Analgesics|analgesics|mesh-ancestor
154631048|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
154631049|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631050|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631051|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631052|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631053|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631054|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631055|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
154631056|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631057|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154631058|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154631059|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631060|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631061|NCT02372903|Hormones|hormones|mesh-ancestor
154631062|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631063|NCT02372591|Buprenorphine|buprenorphine|mesh-list
154631064|NCT02372591|Hydromorphone|hydromorphone|mesh-list
154631065|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154631066|NCT02372591|Narcotics|narcotics|mesh-ancestor
154631067|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631068|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631069|NCT02372591|Analgesics|analgesics|mesh-ancestor
154631070|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
154631071|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631072|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154631073|NCT02372669|Chitosan|chitosan|mesh-list
154631074|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154631075|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154631076|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
154631077|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631078|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154631079|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
154631080|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
154631081|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
154631082|NCT02372669|Coagulants|coagulants|mesh-ancestor
154631083|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154631084|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
154631085|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154631086|NCT02369939|Fluorouracil|fluorouracil|mesh-list
153990672|NCT00662857|Insulin|insulin|mesh-list
154631087|NCT02369939|Mitomycins|mitomycins|mesh-list
154631088|NCT02369939|Mitomycin|mitomycin|mesh-list
154631089|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
154631090|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631091|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154631092|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631093|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631094|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
154631095|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631096|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154631097|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
154631098|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154631099|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631100|NCT02369549|Curcumin|curcumin|mesh-list
154631101|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631102|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631103|NCT02369549|Analgesics|analgesics|mesh-ancestor
154631104|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
154631105|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631106|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631107|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631108|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631109|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631110|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631111|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631112|NCT02365415|Sirolimus|sirolimus|mesh-list
154631113|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631114|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631115|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154631116|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631117|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
154631118|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631119|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
154631120|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631121|NCT02369081|Bisoprolol|bisoprolol|mesh-list
154631122|NCT02369081|Doxazosin|doxazosin|mesh-list
154631123|NCT02369081|Spironolactone|spironolactone|mesh-list
154631124|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154631125|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
154631126|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631127|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631128|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154631129|NCT02369081|Diuretics|diuretics|mesh-ancestor
154631130|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
154631131|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154631132|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
154631133|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
154631134|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631135|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154631136|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154631137|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154631138|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154631139|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631140|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631141|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154631142|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154631143|NCT02365493|Cefazolin|cefazolin|mesh-list
154631144|NCT02365493|Lactams|lactams|mesh-list
154631145|NCT02365493|beta-Lactams|beta-lactams|mesh-list
154631146|NCT02365493|Floxacillin|floxacillin|mesh-list
154631147|NCT02365493|Cloxacillin|cloxacillin|mesh-list
154631148|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631149|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631150|NCT02365181|Ropivacaine|ropivacaine|mesh-list
154631151|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
154631152|NCT02365181|Anesthetics|anesthetics|mesh-list
154631153|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631154|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631155|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
154631156|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631157|NCT05653895|Metformin|metformin|mesh-list
154631158|NCT05653895|Resveratrol|resveratrol|mesh-list
154631159|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154631160|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631161|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
154631162|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631163|NCT05653895|Protective Agents|protective agents|mesh-ancestor
154631164|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631165|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154631166|NCT02364479|Etanercept|etanercept|mesh-list
154631167|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631168|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631169|NCT02364479|Analgesics|analgesics|mesh-ancestor
154631170|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
154631171|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631172|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631173|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631174|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631175|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631176|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631177|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
154631178|NCT05653817|Paclitaxel|paclitaxel|mesh-list
154631179|NCT05653817|Apatinib|apatinib|mesh-list
154631180|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154631181|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154631182|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631183|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
154631184|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
154631185|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
154631186|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631187|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154631188|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631189|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
154631190|NCT02052310|Hematinics|hematinics|mesh-ancestor
154631191|NCT02368379|Metyrapone|metyrapone|mesh-list
154631192|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
154631193|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345964|NCT01288339|Vitamins|vitamins|mesh-ancestor
154631194|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631195|NCT02051296|Minocycline|minocycline|mesh-list
154631196|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631197|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631198|NCT02367755|Lorazepam|lorazepam|mesh-list
154631199|NCT02367755|Propofol|propofol|mesh-list
154631200|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154631201|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631202|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631203|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154631204|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
154631205|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
154631206|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
154631207|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
154631208|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
154631209|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631210|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631211|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154631212|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154631213|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154631214|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
154631215|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
154631216|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631217|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631218|NCT02363699|Lidocaine|lidocaine|mesh-list
154631219|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
154631220|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
154631221|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631222|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631223|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
154631224|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631225|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154631226|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154631227|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154631228|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154631229|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631230|NCT02049814|Metformin|metformin|mesh-list
154631231|NCT02049814|Acarbose|acarbose|mesh-list
154631232|NCT02049814|Voglibose|voglibose|mesh-list
154631233|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154631234|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631235|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154631236|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631237|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631238|NCT03344159|Spironolactone|spironolactone|mesh-list
154631239|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154631240|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
154243938|NCT05642572|Ramucirumab|ramucirumab|mesh-list
154631241|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631242|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631243|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154631244|NCT03344159|Diuretics|diuretics|mesh-ancestor
154631245|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
154631246|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
154631247|NCT03324113|Promethazine|promethazine|mesh-list
154631248|NCT03324113|Dexamethasone|dexamethasone|mesh-list
154631249|NCT03324113|Naphazoline|naphazoline|mesh-list
154631250|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154631251|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631252|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
154631253|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
154631254|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631255|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631256|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631257|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
154631258|NCT03324113|Hormones|hormones|mesh-ancestor
154631259|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631260|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154631261|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631262|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154631263|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154631264|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154631265|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631266|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
154631267|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
154631268|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
154631269|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154631270|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
154631271|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
154631272|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631273|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631274|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154631275|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
154631276|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
154631277|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154631278|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154631279|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
154631280|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
154631281|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154631282|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
154631283|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
154631284|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154631285|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631286|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631287|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154631288|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
154631289|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154346068|NCT03864913|Testosterone|testosterone|mesh-list
154631290|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631291|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154631292|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154631293|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154631294|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631295|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
154631296|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631297|NCT02367053|Glucagon|glucagon|mesh-list
154631298|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631299|NCT02367053|Hormones|hormones|mesh-ancestor
154631300|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631301|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631302|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154631303|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154631304|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154631305|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
154631306|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631307|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154631308|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154631309|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631310|NCT02366975|Testosterone|testosterone|mesh-list
154631311|NCT02366975|Androgens|androgens|mesh-ancestor
154631312|NCT02366975|Hormones|hormones|mesh-ancestor
154631313|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244018|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
154631314|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631315|NCT04479371|Bupivacaine|bupivacaine|mesh-list
154631316|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
154631317|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
154631318|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631319|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631320|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
154631321|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631322|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
154631323|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154631324|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
154631325|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154631326|NCT02366585|Cyclosporine|cyclosporine|mesh-list
154631327|NCT02366585|Cyclosporins|cyclosporins|mesh-list
154631328|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631329|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631330|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631331|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
154631332|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631333|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
154631334|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631335|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
154631336|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631337|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154631339|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154631340|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631341|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
154631342|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631343|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631344|NCT02958917|Pirfenidone|pirfenidone|mesh-list
154631345|NCT02958917|Analgesics|analgesics|mesh-ancestor
154631346|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
154631347|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631348|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631349|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631350|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631351|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631352|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631353|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631354|NCT02362529|Minocycline|minocycline|mesh-list
154631355|NCT02362529|Celecoxib|celecoxib|mesh-list
154631356|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631357|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631358|NCT02362529|Analgesics|analgesics|mesh-ancestor
154631359|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
154631360|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631361|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631362|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631363|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631364|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154631365|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154631366|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631367|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631368|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631369|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631370|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
154631371|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154631372|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154631373|NCT02769689|Prednisolone|prednisolone|mesh-list
154631374|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
154631375|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154631376|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
154631377|NCT02769689|Natalizumab|natalizumab|mesh-list
154631378|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631379|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
154631380|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
154631381|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631382|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631383|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631384|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
154631385|NCT02769689|Hormones|hormones|mesh-ancestor
154631386|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631387|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154244088|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631388|NCT02769689|Protective Agents|protective agents|mesh-ancestor
154631389|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154631390|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631391|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
154631392|NCT02365571|Itraconazole|itraconazole|mesh-list
154631393|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
154631394|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631395|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154631396|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154631397|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631398|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631399|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154631400|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
154631401|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631402|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631403|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154631404|NCT02365727|Clonidine|clonidine|mesh-list
154631405|NCT02365727|Epinephrine|epinephrine|mesh-list
154631406|NCT02365727|Bupivacaine|bupivacaine|mesh-list
154631407|NCT02365727|Ropivacaine|ropivacaine|mesh-list
154631408|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
154631409|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
154631410|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631411|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346174|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
154631412|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
154631413|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631414|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154631415|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154631416|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154631417|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631418|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631419|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154631420|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154631421|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
154631422|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154631423|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
154631424|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
154631425|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
154631426|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154631427|NCT02365727|Analgesics|analgesics|mesh-ancestor
154631428|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154631429|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
154631430|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154631431|NCT02365805|Paclitaxel|paclitaxel|mesh-list
154631432|NCT02365805|Docetaxel|docetaxel|mesh-list
154631433|NCT02365805|Fluorouracil|fluorouracil|mesh-list
154631434|NCT02365805|Epirubicin|epirubicin|mesh-list
154631435|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
154631436|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154631437|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631438|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
154631439|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
154631440|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
154631441|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631442|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
154631443|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154631444|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631445|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
154631446|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631447|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154631448|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154631449|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154631450|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631451|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631452|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154631453|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
154631454|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154631455|NCT03112889|Valproic Acid|valproic acid|mesh-list
154631456|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
154631457|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244162|NCT04175470|Protective Agents|protective agents|mesh-ancestor
154631458|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631459|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
154631460|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631461|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631462|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
154631463|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154631464|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631465|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154631466|NCT03112577|Fluticasone|fluticasone|mesh-list
154631467|NCT03112577|Xhance|xhance|mesh-list
154631468|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631469|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154631470|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
154631471|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631472|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631473|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154631474|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
154631475|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
154631476|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154631477|NCT02361905|Leuprolide|leuprolide|mesh-list
154631478|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
154631479|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154631480|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
154631481|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154631482|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631483|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154631484|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631485|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154631486|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
154631487|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154631488|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
154631489|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154631490|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154631491|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631492|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
154631493|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631494|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631495|NCT02358707|Ibuprofen|ibuprofen|mesh-list
154631496|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631497|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631498|NCT02358707|Analgesics|analgesics|mesh-ancestor
154631499|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
154631500|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631501|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631502|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631503|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631504|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154631505|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631506|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631507|NCT02360501|Docetaxel|docetaxel|mesh-list
154631508|NCT02360501|Capecitabine|capecitabine|mesh-list
154631509|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631510|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
154631511|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
154631512|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
154631513|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631514|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154631515|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
154631516|NCT02360423|Sirolimus|sirolimus|mesh-list
154631517|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631518|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631519|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154631520|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631521|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
154631522|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631523|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
154631524|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631525|NCT02358161|Paclitaxel|paclitaxel|mesh-list
154631526|NCT02358161|Gemcitabine|gemcitabine|mesh-list
154631527|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154631528|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631529|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
154631530|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
154631531|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
154631532|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631533|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154631534|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
154631535|NCT02357849|Aripiprazole|aripiprazole|mesh-list
154631536|NCT02357849|Fluoxetine|fluoxetine|mesh-list
154631537|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
154631538|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154631539|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154631540|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154631541|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631542|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631543|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
154631544|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
154631545|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631546|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631547|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154631548|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154631549|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
154631550|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154631551|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154631552|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154631553|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154631554|NCT02357849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154631555|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154631556|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154631557|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154631558|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154631559|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154631560|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631561|NCT02357693|Aprepitant|aprepitant|mesh-list
154631562|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
154631563|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
154631564|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631565|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631566|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631567|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154631568|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631569|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631570|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154631571|NCT02357615|Nifedipine|nifedipine|mesh-list
154631572|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154631573|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154631574|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631575|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154631576|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631577|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
154631578|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
154631579|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154631580|NCT03160001|Niclosamide|niclosamide|mesh-list
154631581|NCT03160001|Etanercept|etanercept|mesh-list
154631582|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631583|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631584|NCT03160001|Analgesics|analgesics|mesh-ancestor
154631585|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
154631586|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631587|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631588|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631589|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631590|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631591|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631592|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
154631593|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
154631594|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154631595|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
154631596|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154631597|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631598|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
154631599|NCT02359643|Aspirin|aspirin|mesh-list
154631600|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631601|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631602|NCT02359643|Analgesics|analgesics|mesh-ancestor
154631603|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
154631604|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631605|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631606|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631607|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631608|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154631609|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154860320|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154244320|NCT03003520|Hormones|hormones|mesh-ancestor
154631610|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631611|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154631612|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154631613|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631614|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
154631615|NCT02359721|Clarithromycin|clarithromycin|mesh-list
154346387|NCT00004859|Growth Substances|growth substances|mesh-ancestor
154631616|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631617|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631618|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154631619|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631620|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631621|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154631622|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154631623|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
154631624|NCT02357303|Simethicone|simethicone|mesh-list
154631625|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154631626|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
154631627|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631628|NCT02357303|Expectorants|expectorants|mesh-ancestor
154631629|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
154631630|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154631631|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
154631632|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631633|NCT02357303|Protective Agents|protective agents|mesh-ancestor
154631634|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631635|NCT02357303|Antidotes|antidotes|mesh-ancestor
154631636|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
154631637|NCT02357303|Emollients|emollients|mesh-ancestor
154631638|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
154631639|NCT02357225|Bromides|bromides|mesh-list
154631640|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154631641|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
154631642|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154631643|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631644|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631645|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
154631646|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631647|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631648|NCT02357069|Etanercept|etanercept|mesh-list
154631649|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154631650|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154631651|NCT02357069|Analgesics|analgesics|mesh-ancestor
154631652|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
154631653|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631654|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631655|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631656|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631657|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631658|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631659|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
154631660|NCT02356913|Nicotine|nicotine|mesh-list
154631661|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154631662|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
154631663|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631664|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631665|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154631666|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154631667|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
154631668|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631669|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631670|NCT02352545|Montelukast|montelukast|mesh-list
154631671|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154631672|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
154631673|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154631674|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
154631675|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631676|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631677|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154631678|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154631679|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631680|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
154631681|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154631682|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
154631683|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631684|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631685|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154631686|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
154631687|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154631688|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
154631689|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631690|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631691|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154631692|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
154631693|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
154631694|NCT02356835|Protective Agents|protective agents|mesh-ancestor
154631695|NCT02352701|Amoxicillin|amoxicillin|mesh-list
154631696|NCT02352701|Levofloxacin|levofloxacin|mesh-list
154346496|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346497|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154346498|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631697|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631698|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631699|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154631700|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154631701|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154631702|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631703|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631704|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631705|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154631706|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154631707|NCT02356445|Infliximab|infliximab|mesh-list
154631708|NCT02356445|Methotrexate|methotrexate|mesh-list
154631709|NCT02356445|Azathioprine|azathioprine|mesh-list
154631710|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154631711|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
154631712|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154631713|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631714|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154631715|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
154631716|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631717|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631718|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
154631719|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631720|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154631721|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631722|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
154631723|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631724|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154631725|NCT02356445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154631726|NCT02356445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154631727|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631728|NCT02356679|Ethanol|ethanol|mesh-list
154631729|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154631730|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631731|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631732|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631733|NCT02352155|Epinephrine|epinephrine|mesh-list
154631734|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154631735|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154631736|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
154631737|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631738|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631739|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631740|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154631741|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154631742|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
154631743|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631744|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154631745|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
154631746|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
154631747|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
154631748|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154631749|NCT02352311|Tadalafil|tadalafil|mesh-list
154631750|NCT02352311|Dutasteride|dutasteride|mesh-list
154631751|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
154631752|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154631753|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154631754|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631755|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631756|NCT02352311|Urological Agents|urological agents|mesh-ancestor
154631757|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154631758|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154631759|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
154631760|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631761|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631762|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154631763|NCT02355431|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154631764|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154631765|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631766|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631767|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631768|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
154631769|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
154631770|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154631771|NCT02351687|Albendazole|albendazole|mesh-list
154631772|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
154631773|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154631774|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154631775|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631776|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154631777|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631778|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631779|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154631780|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
154631781|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
154631782|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154631783|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
154631784|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
154631785|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
154631786|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631787|NCT02355509|Acarbose|acarbose|mesh-list
154631788|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154631789|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659737|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631790|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631791|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154631792|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631793|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
154631794|NCT02355197|Vitamins|vitamins|mesh-ancestor
154631795|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
154631796|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631797|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
154631798|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631799|NCT02355197|Protective Agents|protective agents|mesh-ancestor
154631800|NCT02351297|Caseins|caseins|mesh-list
154631801|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
154631802|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
154631803|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631804|NCT02355119|Gemcitabine|gemcitabine|mesh-list
154631805|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154631806|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
154631807|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631808|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631809|NCT03149939|Febuxostat|febuxostat|mesh-list
154631810|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
154631811|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631812|NCT03149783|Ropivacaine|ropivacaine|mesh-list
154631813|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
154631814|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
154631815|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631816|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631817|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
154631818|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631819|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
154631820|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154631821|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154631822|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631823|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
154631824|NCT02354885|Coagulants|coagulants|mesh-ancestor
154631825|NCT02354807|Mirabegron|mirabegron|mesh-list
154631826|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154631827|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154631828|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154631829|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
154631830|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631831|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631832|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631833|NCT02354807|Urological Agents|urological agents|mesh-ancestor
154631834|NCT03159845|Levofloxacin|levofloxacin|mesh-list
154631835|NCT03159845|Fluconazole|fluconazole|mesh-list
154631836|NCT03159845|Acyclovir|acyclovir|mesh-list
154631837|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
154631838|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154631839|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631840|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154631841|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154631842|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154631843|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631844|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631845|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631846|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154631847|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154631848|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
154631849|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154631850|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154631851|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
154631852|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631853|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631854|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154631855|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154631856|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
154631857|NCT03159845|Astringents|astringents|mesh-ancestor
154631858|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
154631859|NCT02350751|MEDI8852|medi8852|mesh-list
154631860|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
154631861|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631862|NCT02350985|Propranolol|propranolol|mesh-list
154631863|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154631864|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154631865|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154631866|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
154631867|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631868|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631869|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631870|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154631871|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154631872|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
154631873|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154631874|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154631875|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154631876|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154631877|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
154631878|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154631879|NCT02354261|Itraconazole|itraconazole|mesh-list
154631880|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
154631881|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154631882|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154631883|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154631884|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631885|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631886|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154631887|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
154631888|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631889|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631890|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154631891|NCT02350439|Adenosine|adenosine|mesh-list
154631892|NCT02350439|Analgesics|analgesics|mesh-ancestor
154631893|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
154631894|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631895|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631896|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154631897|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
154631898|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154631899|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
154631900|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
154631901|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631902|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631903|NCT02350673|Atezolizumab|atezolizumab|mesh-list
154631904|NCT02350673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154631905|NCT02350673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631906|NCT02350673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154631907|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631908|NCT02350361|Endostatins|endostatins|mesh-list
154631909|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154631910|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154631911|NCT02350361|Growth Substances|growth substances|mesh-ancestor
154631912|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631913|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
154631914|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631915|NCT02353949|Flutemetamol|flutemetamol|mesh-list
154631916|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154631917|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631918|NCT02354027|Metformin|metformin|mesh-list
154631919|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154346697|NCT03477994|Analgesics|analgesics|mesh-ancestor
154631920|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631921|NCT03149393|Mosapride|mosapride|mesh-list
154631922|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631923|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154631924|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154631925|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
154631926|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631927|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631928|NCT03149315|Ibrutinib|ibrutinib|mesh-list
154631929|NCT03149315|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154631930|NCT03149315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154631931|NCT03149315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631932|NCT03149315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631933|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
154631934|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631935|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154631936|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154631937|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631938|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
154631939|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154631940|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631941|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154631942|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
154631943|NCT02353325|Fesoterodine|fesoterodine|mesh-list
154631944|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
154631945|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631946|NCT02353325|Protective Agents|protective agents|mesh-ancestor
154631947|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631948|NCT02353325|Vitamins|vitamins|mesh-ancestor
154631949|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
154631950|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154631951|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154631952|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
154631953|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154631954|NCT02353325|Urological Agents|urological agents|mesh-ancestor
154631955|NCT03157505|Immunomodulating Agents|immunomodulating agents|mesh-list
154631956|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
154631957|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631958|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
154631959|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154631960|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
154631961|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631962|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
154631963|NCT03157193|Protective Agents|protective agents|mesh-ancestor
154631964|NCT03149159|Nivolumab|nivolumab|mesh-list
154631965|NCT03149159|Ipilimumab|ipilimumab|mesh-list
154631966|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154631967|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631968|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154631969|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154631970|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
154631971|NCT03155477|Vitamin D|vitamin d|mesh-list
154631972|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154631973|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631974|NCT03155477|Vitamins|vitamins|mesh-ancestor
154631975|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
154631976|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154631977|NCT02349581|Bupivacaine|bupivacaine|mesh-list
154631978|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
154244717|NCT04652245|Xhance|xhance|mesh-list
154631979|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
154631980|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154631981|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631982|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
154631983|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154631984|NCT03154385|Rituximab|rituximab|mesh-list
154631985|NCT03154385|Belimumab|belimumab|mesh-list
154631986|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154631987|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154631988|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
154093171|NCT06018467|Niacin|niacin|mesh-list
154631989|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631990|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154631991|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154631992|NCT03112187|Iron|iron|mesh-list
154631993|NCT03112187|Trace Elements|trace elements|mesh-ancestor
154631994|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
154631995|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154631996|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
154631997|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154631998|NCT03147677|Irbesartan|irbesartan|mesh-list
154631999|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154632000|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154632001|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154632002|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632003|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154632004|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632005|NCT03147677|Vitamins|vitamins|mesh-ancestor
154632006|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
154632007|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
154632008|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
154632009|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632010|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632011|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632012|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
154632013|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632014|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632015|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632016|NCT03147599|Mebeverine|mebeverine|mesh-list
154632017|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
154632018|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
154632019|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
154632020|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632021|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632022|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154632023|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154632024|NCT02349113|Estrogens|estrogens|mesh-list
154632025|NCT02349113|Estradiol|estradiol|mesh-list
154632026|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154632027|NCT02349113|Hormones|hormones|mesh-ancestor
154632028|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632029|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632030|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154632031|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
154632032|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154632033|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154632034|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154632035|NCT04151849|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154632036|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632037|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154632038|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632039|NCT02348177|Ritonavir|ritonavir|mesh-list
154632040|NCT02348177|Lopinavir|lopinavir|mesh-list
154632041|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154632042|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154632043|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
154632044|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632045|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632046|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154632047|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154632048|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
154632049|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632050|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154632051|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154632052|NCT02348255|Bevacizumab|bevacizumab|mesh-list
154632053|NCT02348255|Carmustine|carmustine|mesh-list
154632054|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154632055|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632056|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154632057|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154632058|NCT02348255|Growth Substances|growth substances|mesh-ancestor
154632059|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632060|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
154632061|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154632062|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
154632063|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632064|NCT02348333|Dotinurad|dotinurad|mesh-list
154632065|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
154632066|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
154632067|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154632068|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
154632069|NCT02343419|Miotics|miotics|mesh-ancestor
154632070|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
154632071|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632072|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632073|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154632074|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154632075|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
154632076|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154632077|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154632078|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632079|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632080|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632081|NCT02342717|Itraconazole|itraconazole|mesh-list
154632082|NCT02342717|BI 425809|bi 425809|mesh-list
154632083|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
154632084|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632085|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154632086|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154632087|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632088|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632089|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154632090|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
154632091|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632092|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632093|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154632094|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
154632095|NCT04478357|Fesoterodine|fesoterodine|mesh-list
154632096|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154632097|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154632098|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632099|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632100|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632101|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632102|NCT04478357|Urological Agents|urological agents|mesh-ancestor
154632103|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
154632104|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154632105|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632106|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632107|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632108|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632109|NCT04478513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154632110|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154632111|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632112|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632113|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632114|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
154632115|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154632116|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
154632117|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154632118|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154632119|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632120|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154632121|NCT02342093|Drospirenone|drospirenone|mesh-list
154632122|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154632123|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
154860321|NCT02847559|Bevacizumab|bevacizumab|mesh-list
154244844|NCT05933759|Insulin|insulin|mesh-list
154632124|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632125|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632126|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154632127|NCT02342093|Diuretics|diuretics|mesh-ancestor
154632128|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
154632129|NCT02347319|Silymarin|silymarin|mesh-list
154632130|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
154632131|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632132|NCT02347319|Protective Agents|protective agents|mesh-ancestor
154632133|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632134|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
154632135|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154632136|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632137|NCT02341703|Metformin|metformin|mesh-list
154632138|NCT02341703|Pioglitazone|pioglitazone|mesh-list
154632139|NCT02341703|Letrozole|letrozole|mesh-list
154632140|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154632141|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632142|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632143|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154632144|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154632145|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632146|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632147|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154632148|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
154632149|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632150|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
154632151|NCT02341547|Hematinics|hematinics|mesh-ancestor
154632152|NCT02341079|Bupivacaine|bupivacaine|mesh-list
154632153|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
154632154|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
154632155|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632156|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632157|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
154632158|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632159|NCT02346539|Nicotine|nicotine|mesh-list
154632160|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154632161|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
154632162|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632163|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632164|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154632165|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154632166|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632167|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632168|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632169|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154632170|NCT02340455|Pregabalin|pregabalin|mesh-list
154632171|NCT02340455|Analgesics|analgesics|mesh-ancestor
154632172|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
154632173|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632174|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632175|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
154632176|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154632177|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632178|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632179|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154632180|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154632181|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632182|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632183|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632184|NCT02345837|Clomiphene|clomiphene|mesh-list
154632185|NCT02345837|Enclomiphene|enclomiphene|mesh-list
154632186|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
154632187|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154632188|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
154632189|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632190|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632191|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154632192|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
154632193|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154632194|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154632195|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154632196|NCT02345993|Beclomethasone|beclomethasone|mesh-list
154244915|NCT05932524|Hormones|hormones|mesh-ancestor
154632197|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
154632198|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154632199|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
154632200|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632201|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632202|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154632203|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
154632204|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154632205|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154632206|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154632207|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
154632208|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632209|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632210|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154632211|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
154632213|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632214|NCT02345681|Furosemide|furosemide|mesh-list
154632215|NCT02345681|Diuretics|diuretics|mesh-ancestor
154632216|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
154632217|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632218|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154632219|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154347012|NCT01185223|Valganciclovir|valganciclovir|mesh-list
154632220|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632221|NCT02340611|Olaparib|olaparib|mesh-list
154632222|NCT02340611|Cediranib|cediranib|mesh-list
154632223|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154632224|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632225|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632226|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632227|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154632228|NCT03145649|Insulin|insulin|mesh-list
154632229|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154632230|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632231|NCT02345213|Donepezil|donepezil|mesh-list
154632232|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154632233|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632234|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632235|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632236|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632237|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632238|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
154632239|NCT02339753|Carboplatin|carboplatin|mesh-list
154632240|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632241|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
154632242|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
154632243|NCT02339441|Methotrexate|methotrexate|mesh-list
154632244|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154632245|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
154632246|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632247|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154632248|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154632249|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
154632250|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632251|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632252|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154632253|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154632254|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
154632255|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154632256|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154632257|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
154632258|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
154632259|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632260|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154632261|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154632262|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154632263|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154632264|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
154632265|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632266|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632267|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154632268|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
154632269|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154632270|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154632271|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632272|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632273|NCT02344823|Urological Agents|urological agents|mesh-ancestor
154632274|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
154632275|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154632276|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632277|NCT03145961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154632278|NCT03145961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632279|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
154632280|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
154632281|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632282|NCT02344511|Vancomycin|vancomycin|mesh-list
154632283|NCT02344511|Cefazolin|cefazolin|mesh-list
154632284|NCT02344511|Dalbavancin|dalbavancin|mesh-list
154632285|NCT02344511|Oxacillin|oxacillin|mesh-list
154632286|NCT02344511|Nafcillin|nafcillin|mesh-list
154632287|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632288|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632289|NCT02344589|Lidocaine|lidocaine|mesh-list
154632290|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
154632291|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
154632292|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632293|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632294|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
154632295|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632296|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154632297|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154632298|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154632299|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632300|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632301|NCT02338115|Paclitaxel|paclitaxel|mesh-list
154632302|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154632303|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632304|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
154632305|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
154632306|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
154632307|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632308|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
154632309|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
154632310|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154632311|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154632312|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632313|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632314|NCT02337881|Urological Agents|urological agents|mesh-ancestor
154632315|NCT02337257|Vitamin D|vitamin d|mesh-list
154632316|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
154632317|NCT02337257|Vitamins|vitamins|mesh-ancestor
154632318|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
154632319|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632320|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154632321|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154632322|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154632323|NCT02337413|Laxatives|laxatives|mesh-ancestor
154632324|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154632325|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
154632326|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154632327|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632328|NCT04477811|Vitamins|vitamins|mesh-list
154632329|NCT04477811|Vitamin K|vitamin k|mesh-list
154632330|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
154632331|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
154632332|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
154632333|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632334|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154632335|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154632336|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632337|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
154632338|NCT04477811|Coagulants|coagulants|mesh-ancestor
154632339|NCT02332031|Sorafenib|sorafenib|mesh-list
154632340|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632341|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154632342|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632343|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245063|NCT05931263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632344|NCT03112031|Tamoxifen|tamoxifen|mesh-list
154632345|NCT03112031|Fluconazole|fluconazole|mesh-list
154632346|NCT03112031|Amphotericin B|amphotericin b|mesh-list
154632347|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154632348|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154632349|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
154632350|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632351|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632352|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154632353|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632354|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154632355|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154632356|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154632357|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
154632358|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632359|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154632360|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154632361|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632362|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632363|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154632364|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154632365|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154632366|NCT03112031|Amebicides|amebicides|mesh-ancestor
154632367|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154632368|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154632369|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632370|NCT03111797|Morphine|morphine|mesh-list
154632371|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154632372|NCT03111797|Narcotics|narcotics|mesh-ancestor
154632373|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632374|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632375|NCT03111797|Analgesics|analgesics|mesh-ancestor
154632376|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
154632377|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632378|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
154632379|NCT02938013|Velpatasvir|velpatasvir|mesh-list
154632380|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154632381|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
154632382|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632383|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
154632384|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632385|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632386|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154632387|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154632388|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632389|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632390|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632391|NCT02336633|Resveratrol|resveratrol|mesh-list
154632392|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
154632393|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632394|NCT02336633|Protective Agents|protective agents|mesh-ancestor
154632395|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632396|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632397|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154632398|NCT02336477|Mexiletine|mexiletine|mesh-list
154632399|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154632400|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154632401|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154632402|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632403|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632404|NCT04624451|Dalbavancin|dalbavancin|mesh-list
154632405|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632406|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632407|NCT02642315|Gabapentin|gabapentin|mesh-list
154632408|NCT02642315|Analgesics|analgesics|mesh-ancestor
154632409|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
154632410|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632411|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632412|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
154632413|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154632414|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632415|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632416|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632417|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154632418|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154245137|NCT05930080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154632419|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632420|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632421|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
154632422|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
154632423|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154632424|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
154632425|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632426|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632427|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154632428|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
154632429|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
154632430|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154632431|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632432|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632433|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632434|NCT02709889|Dexamethasone|dexamethasone|mesh-list
154632435|NCT02709889|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154632436|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154632437|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
154632438|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
154632439|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632440|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632441|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154632442|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
154632443|NCT02709889|Hormones|hormones|mesh-ancestor
154632444|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632445|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154632446|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632447|NCT02709889|Immunoconjugates|immunoconjugates|mesh-ancestor
154632448|NCT02709889|Immunologic Factors|immunologic factors|mesh-ancestor
154632449|NCT03189901|Simendan|simendan|mesh-list
154632450|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154632451|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
154632452|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154632453|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154632454|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632455|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632456|NCT03189901|Protective Agents|protective agents|mesh-ancestor
154632457|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632458|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154632459|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
154632460|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154632461|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632462|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632463|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632464|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632465|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632466|NCT02711995|Laxatives|laxatives|mesh-ancestor
154632467|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154632468|NCT03193723|Anesthetics|anesthetics|mesh-list
154632469|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632470|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632471|NCT02437825|Octreotide|octreotide|mesh-list
154632472|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154632473|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154632474|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632475|NCT02442817|Linagliptin|linagliptin|mesh-list
154632476|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154632477|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632478|NCT02442817|Incretins|incretins|mesh-ancestor
154632479|NCT02442817|Hormones|hormones|mesh-ancestor
154632480|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632481|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154632482|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
154632483|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632484|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632485|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
154632486|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632487|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632488|NCT02442739|Ketamine|ketamine|mesh-list
154632489|NCT02442739|Analgesics|analgesics|mesh-ancestor
154632490|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
154632491|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632492|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632493|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154632494|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154632495|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
154632496|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
154632497|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632498|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154632499|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154632500|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632501|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632502|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154632503|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154632504|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154632505|NCT02442427|Palivizumab|palivizumab|mesh-list
154632506|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
154632507|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632508|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
154632509|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154632510|NCT05233735|Betamethasone|betamethasone|mesh-list
154632511|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154632512|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
154632513|NCT05233735|Hormones|hormones|mesh-ancestor
154632514|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632515|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632516|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154632517|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
154632518|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
154632519|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154632520|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154632521|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154632522|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632523|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632524|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632525|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632526|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632527|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154632528|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632529|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
154632530|NCT02331563|Bupivacaine|bupivacaine|mesh-list
154632531|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
154632532|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
154632533|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632534|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632535|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
154632536|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632537|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154632538|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154632539|NCT02331563|Analgesics|analgesics|mesh-ancestor
154632540|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154632541|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154632542|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154632543|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
154632544|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632545|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632546|NCT02331173|Dorzolamide|dorzolamide|mesh-list
154632547|NCT02331173|Brinzolamide|brinzolamide|mesh-list
154632548|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154632549|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154632550|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632551|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632552|NCT02709109|Ivacaftor|ivacaftor|mesh-list
154632553|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154632554|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632555|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632556|NCT03117595|Fentanyl|fentanyl|mesh-list
154632557|NCT03117595|Morphine|morphine|mesh-list
154632558|NCT03117595|Bupivacaine|bupivacaine|mesh-list
154632559|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
154632560|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
154632561|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632562|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632563|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
154632564|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632565|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154632566|NCT03117595|Narcotics|narcotics|mesh-ancestor
154632567|NCT03117595|Analgesics|analgesics|mesh-ancestor
154632568|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154632569|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154632570|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
154632572|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
154632573|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
154632574|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632575|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154632576|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
154632577|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632578|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
154632579|NCT02039531|Protective Agents|protective agents|mesh-ancestor
154632580|NCT02331251|Paclitaxel|paclitaxel|mesh-list
154632581|NCT02331251|Vinorelbine|vinorelbine|mesh-list
154632582|NCT02331251|Docetaxel|docetaxel|mesh-list
154632583|NCT02331251|Gemcitabine|gemcitabine|mesh-list
154632584|NCT02331251|Doxorubicin|doxorubicin|mesh-list
154632585|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154632586|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
154632587|NCT02331251|Irinotecan|irinotecan|mesh-list
154632588|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154632589|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632590|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154632591|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154632592|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154632593|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632594|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154632595|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
154632596|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154632597|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154632598|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154632599|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632600|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154632601|NCT02331251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154632602|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154632603|NCT02435797|Nicorandil|nicorandil|mesh-list
154632604|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154632605|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154632606|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
154632607|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
154632608|NCT02435797|Vitamins|vitamins|mesh-ancestor
154632609|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
154632610|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632611|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154632612|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154632613|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632614|NCT02330783|Bevacizumab|bevacizumab|mesh-list
154632615|NCT02330783|Sorafenib|sorafenib|mesh-list
154632616|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154632617|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632618|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154632619|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154632620|NCT02330783|Growth Substances|growth substances|mesh-ancestor
154632621|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632622|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
154632623|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154632624|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632625|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632626|NCT02335151|Desflurane|desflurane|mesh-list
154632627|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154632628|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
154632629|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
154632630|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632631|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632632|NCT02709655|Vortioxetine|vortioxetine|mesh-list
154632633|NCT02709655|Fluoxetine|fluoxetine|mesh-list
154632634|NCT02709655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154632635|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154632636|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632637|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632638|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632639|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
154632640|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632641|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154632642|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
154245365|NCT05332561|Pertuzumab|pertuzumab|mesh-list
154632643|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632644|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154632645|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154632646|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632647|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154632648|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632649|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632650|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154632651|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154632652|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154632653|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154632654|NCT02334605|Capsaicin|capsaicin|mesh-list
154632655|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
154632656|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
154632657|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
154632658|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632659|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632660|NCT02329535|Progesterone|progesterone|mesh-list
154632661|NCT02329535|Progestins|progestins|mesh-ancestor
154632662|NCT02329535|Hormones|hormones|mesh-ancestor
154632663|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632664|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632665|NCT03187795|Mirabegron|mirabegron|mesh-list
154632666|NCT03187795|Oxybutynin|oxybutynin|mesh-list
154632667|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154632668|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154632669|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154632670|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
154632671|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632672|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632673|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632674|NCT03187795|Urological Agents|urological agents|mesh-ancestor
154632675|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
154632676|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
154632677|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632678|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154632679|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154632680|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632681|NCT02435563|Ritonavir|ritonavir|mesh-list
154632682|NCT02435563|Ticagrelor|ticagrelor|mesh-list
154632683|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154632684|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154632685|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
154632686|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632687|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632688|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154632689|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154632690|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
154632691|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632692|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154632693|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154632694|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154632695|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154632696|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154632697|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154632698|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
154632699|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632700|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632701|NCT02433847|Mosapride|mosapride|mesh-list
154632702|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154632703|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154632704|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
154632705|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632706|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632707|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632708|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
154632709|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632710|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632711|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632712|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632713|NCT02328521|Nicorandil|nicorandil|mesh-list
154632714|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154632715|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154632716|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
154632718|NCT02328521|Vitamins|vitamins|mesh-ancestor
154632719|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
154632720|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632721|NCT03187093|Vortioxetine|vortioxetine|mesh-list
154632722|NCT03187093|Escitalopram|escitalopram|mesh-list
154632723|NCT03187093|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154632724|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154632725|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632726|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632727|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632728|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
154632729|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632730|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
154632731|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632732|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154632733|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632734|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632735|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154632736|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154632737|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154632738|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154632739|NCT02039999|Citric Acid|citric acid|mesh-list
154632740|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
154632741|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154632742|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
154632743|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154632744|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
154632745|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
154632746|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632747|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
154632748|NCT02434861|Digoxin|digoxin|mesh-list
154632749|NCT02434861|Rolapitant|rolapitant|mesh-list
154632750|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154632751|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154632752|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632753|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632754|NCT02434861|Protective Agents|protective agents|mesh-ancestor
154632755|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632756|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632757|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154632758|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154632759|NCT02434861|Analgesics|analgesics|mesh-ancestor
154632760|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
154632761|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632762|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154632763|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154632764|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154632765|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154632766|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632767|NCT03187015|Entinostat|entinostat|mesh-list
154632768|NCT03187015|Midazolam|midazolam|mesh-list
154632769|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154632770|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154632771|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632772|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632773|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154632774|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632775|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632776|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154632777|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
154632778|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
154632779|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
154632780|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
154632781|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632782|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632783|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632784|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154632785|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632786|NCT02328053|Voriconazole|voriconazole|mesh-list
154632787|NCT02328053|Natamycin|natamycin|mesh-list
154632788|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
154632789|NCT02328053|Clotrimazole|clotrimazole|mesh-list
154632790|NCT02328053|Miconazole|miconazole|mesh-list
154632791|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245512|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
154632792|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154632793|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154632794|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632795|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632796|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154632797|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
154632798|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632799|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632800|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154632801|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154632802|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632803|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154632804|NCT02022748|Ticagrelor|ticagrelor|mesh-list
154632805|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154632806|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154632807|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154632808|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154632809|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
154632810|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632811|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632812|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632813|NCT02333513|Vincristine|vincristine|mesh-list
154632814|NCT02333513|Lomustine|lomustine|mesh-list
154632815|NCT02333513|Procarbazine|procarbazine|mesh-list
154632816|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154632817|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632818|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
154632819|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
154632820|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
154632821|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632822|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154632823|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
154632824|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154632825|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154632826|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154632827|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632828|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
154632829|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632830|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632831|NCT02328209|Ranibizumab|ranibizumab|mesh-list
154632832|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154632833|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154632834|NCT02328209|Growth Substances|growth substances|mesh-ancestor
154632835|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632836|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
154632837|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632838|NCT02328443|Itraconazole|itraconazole|mesh-list
154632839|NCT02328443|Rifampin|rifampin|mesh-list
154632840|NCT02328443|Midazolam|midazolam|mesh-list
154632841|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154632842|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154632843|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154632844|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632845|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154632846|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154632847|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154632848|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154632849|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
154632850|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
154632851|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
154632852|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
154632853|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632854|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632855|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
154632856|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632857|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154632858|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154632859|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632860|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154632861|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
154632862|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632863|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154632864|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154632865|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
154632866|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632867|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
154632868|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154632869|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154632870|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154632871|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154632872|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154632873|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154632874|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154632875|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154632876|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154632877|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154632878|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154632879|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154632880|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
154632881|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632882|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632883|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632884|NCT03191539|Apremilast|apremilast|mesh-list
154632885|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154632886|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154632887|NCT03191539|Analgesics|analgesics|mesh-ancestor
154632888|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
154632889|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632890|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632891|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154632892|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154632893|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154632894|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154632895|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632896|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632897|NCT02433925|Resveratrol|resveratrol|mesh-list
154632898|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
154632899|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632900|NCT02433925|Protective Agents|protective agents|mesh-ancestor
154632901|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632902|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632903|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154632904|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
154632905|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632906|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632907|NCT02327663|Emtricitabine|emtricitabine|mesh-list
154632908|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
154632909|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632910|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154632911|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154632912|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632913|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632914|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154632915|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154632916|NCT02333123|Aspirin|aspirin|mesh-list
154632917|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154632918|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154632919|NCT02333123|Analgesics|analgesics|mesh-ancestor
154632920|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
154632921|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632922|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632923|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154632924|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154632925|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154632926|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154632927|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632928|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154632929|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154632930|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632931|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
154632932|NCT02332811|Sevelamer|sevelamer|mesh-list
154632933|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
154632934|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
154632935|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632936|NCT02433457|Omeprazole|omeprazole|mesh-list
154632937|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154632938|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154632939|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154632940|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632941|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632942|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
154632943|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154632944|NCT02021656|Ledipasvir|ledipasvir|mesh-list
154632945|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
154632946|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632947|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154632948|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154632949|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
154632950|NCT03145025|Hormones|hormones|mesh-ancestor
154632951|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632952|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632953|NCT03144947|Docetaxel|docetaxel|mesh-list
154632954|NCT03144947|Trastuzumab|trastuzumab|mesh-list
154632955|NCT03144947|Pertuzumab|pertuzumab|mesh-list
154632956|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154632957|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
154632958|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
154632959|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
154632960|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632961|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154632962|NCT02433535|Simvastatin|simvastatin|mesh-list
154632963|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154632964|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154632965|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
154632966|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632967|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154632968|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154632969|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154632970|NCT03144713|Terlipressin|terlipressin|mesh-list
154632971|NCT03144713|Midodrine|midodrine|mesh-list
154632972|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
154632973|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
154632974|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154632975|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632976|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154632977|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154632978|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154632979|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154632980|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154632981|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154632982|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154632983|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154632984|NCT03191383|Vaccines|vaccines|mesh-list
154632985|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
154632986|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632987|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
154632988|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154632989|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
154632990|NCT02075632|Hormones|hormones|mesh-ancestor
154632991|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154632992|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154632993|NCT02430259|Isoniazid|isoniazid|mesh-list
154632994|NCT02430259|Rifapentine|rifapentine|mesh-list
154632995|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
154632996|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154632997|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154632998|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154632999|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154633000|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
154633001|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633002|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154633003|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154633004|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
154633005|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
154633006|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154633007|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245734|NCT04590508|Growth Substances|growth substances|mesh-ancestor
154633008|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154633009|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633010|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
154633011|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154633012|NCT03142607|Metronidazole|metronidazole|mesh-list
154633013|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154633014|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633015|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
154633016|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
154633017|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154633018|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154633019|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154633020|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
154633021|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154633022|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154633023|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154633024|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154633025|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633026|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
154633027|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633028|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633029|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154633030|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633031|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
154633032|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
154633033|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
154633034|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633035|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633036|NCT02326727|Fentanyl|fentanyl|mesh-list
154633037|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
154633038|NCT02326727|Propofol|propofol|mesh-list
154633039|NCT02326727|Ropivacaine|ropivacaine|mesh-list
154633040|NCT02326727|Isoflurane|isoflurane|mesh-list
154633041|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154633042|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633043|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633044|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154633045|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
154633046|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
154633047|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
154633048|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
154633049|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633050|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154633051|NCT02326727|Narcotics|narcotics|mesh-ancestor
154633052|NCT02326727|Analgesics|analgesics|mesh-ancestor
154633053|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154633054|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154633055|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154633056|NCT02432911|Cytarabine|cytarabine|mesh-list
154633057|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
154633058|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154633059|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
154633060|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633061|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633062|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
154633063|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633064|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154633065|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
154633066|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633067|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154633068|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154633069|NCT03588767|Vitamin D|vitamin d|mesh-list
154633070|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
154633071|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
154633072|NCT03588767|Vitamins|vitamins|mesh-list
154633073|NCT03588767|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
154633074|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
154633075|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
154633076|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633077|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154633078|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154633079|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
154633080|NCT03588767|Hormones|hormones|mesh-ancestor
154633081|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633082|NCT03588767|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
154633083|NCT02440399|Acetaminophen|acetaminophen|mesh-list
154633084|NCT02440399|Diclofenac|diclofenac|mesh-list
154245809|NCT04310995|Isosorbide|isosorbide|mesh-list
154633085|NCT02440399|Morphine|morphine|mesh-list
154633086|NCT02440399|Oxycodone|oxycodone|mesh-list
154633087|NCT02440399|Tramadol|tramadol|mesh-list
154633088|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154633090|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633091|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633092|NCT02440399|Analgesics|analgesics|mesh-ancestor
154633093|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
154633094|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633095|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154633096|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
154633097|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154633098|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154633099|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154633100|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154633101|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633102|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633103|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
154633104|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154633105|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154633106|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154633107|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633108|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633109|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633110|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
154633111|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
154633112|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633113|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
154633114|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154633115|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
154633116|NCT03191305|Warfarin|warfarin|mesh-list
154633117|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
154633118|NCT03144401|Misoprostol|misoprostol|mesh-list
154633119|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154633120|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
154633121|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154633122|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633123|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154633124|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154633125|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
154633126|NCT04483765|Anesthetics|anesthetics|mesh-list
154633127|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633128|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633129|NCT03186313|Ribavirin|ribavirin|mesh-list
154633130|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
154633131|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
154633132|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633133|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
154633134|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633135|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
154347927|NCT04285684|Ketamine|ketamine|mesh-list
154633136|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154633137|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633138|NCT03144245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154633139|NCT03144245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633140|NCT04996199|Zileuton|zileuton|mesh-list
154633141|NCT04996199|Carbamazepine|carbamazepine|mesh-list
154633142|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
154633143|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
154633144|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
154633145|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154633146|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633147|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633148|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154633149|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154633150|NCT04996199|Analgesics|analgesics|mesh-ancestor
154633151|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
154633152|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633153|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154633154|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154633155|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633156|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154633157|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154633158|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154633159|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154633160|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154633161|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154633162|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154633163|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633164|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154633165|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633166|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633167|NCT02432833|Tacrolimus|tacrolimus|mesh-list
154633168|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154633169|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
154633170|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633171|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154633172|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633173|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633174|NCT02429323|Sevoflurane|sevoflurane|mesh-list
154633175|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154633176|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154633177|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
154633178|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
154633179|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633180|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633181|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
154633182|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154633183|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633184|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154633185|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154633186|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633187|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633188|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633189|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154347992|NCT01147822|Growth Substances|growth substances|mesh-ancestor
154633190|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633191|NCT02707861|Ibalizumab|ibalizumab|mesh-list
154633192|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154633193|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
154633194|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633195|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154633196|NCT02432599|Choline|choline|mesh-list
154633197|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
154633198|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154633199|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
154633200|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633201|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154633202|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154633203|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
154633204|NCT03185143|Acetaminophen|acetaminophen|mesh-list
154633205|NCT03185143|Sumatriptan|sumatriptan|mesh-list
154633206|NCT03185143|Naltrexone|naltrexone|mesh-list
154633207|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154633208|NCT03185143|Analgesics|analgesics|mesh-ancestor
154633209|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
154633210|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633211|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633212|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
154633213|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154633214|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154633215|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154633216|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154633217|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154633218|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
154633219|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633220|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633221|NCT05076773|Morphine|morphine|mesh-list
154633222|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154633223|NCT05076773|Narcotics|narcotics|mesh-ancestor
154633224|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633225|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633226|NCT05076773|Analgesics|analgesics|mesh-ancestor
154633227|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
154633228|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633229|NCT02432677|Remifentanil|remifentanil|mesh-list
154633230|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154633231|NCT02432677|Narcotics|narcotics|mesh-ancestor
154633232|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633233|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633234|NCT02432677|Analgesics|analgesics|mesh-ancestor
154633235|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
154633236|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245963|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154633237|NCT03442673|Gemcitabine|gemcitabine|mesh-list
154633238|NCT03442673|Vinorelbine|vinorelbine|mesh-list
154633239|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154633240|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
154633241|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633242|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633243|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154633244|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154633245|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154633246|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154633247|NCT02432365|Paclitaxel|paclitaxel|mesh-list
154633248|NCT02432365|Cisplatin|cisplatin|mesh-list
154633249|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154633250|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633251|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
154633252|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
154633253|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
154633254|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633255|NCT05076695|Trastuzumab|trastuzumab|mesh-list
154633256|NCT05076695|Fulvestrant|fulvestrant|mesh-list
154633257|NCT05076695|Palbociclib|palbociclib|mesh-list
154633258|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154633259|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633260|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154633261|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154633262|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154633263|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633264|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633265|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633266|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154633267|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633268|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633269|NCT03143933|Fentanyl|fentanyl|mesh-list
154633270|NCT03143933|Propofol|propofol|mesh-list
154633271|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154633272|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633273|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633274|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154633275|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
154633276|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
154633277|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154633278|NCT03143933|Narcotics|narcotics|mesh-ancestor
154633279|NCT03143933|Analgesics|analgesics|mesh-ancestor
154633280|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
154633281|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633282|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154633283|NCT02440243|Vaccines|vaccines|mesh-list
154633284|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
154633285|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633286|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
154633287|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154633288|NCT05076461|Ondansetron|ondansetron|mesh-list
154633289|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
154633290|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
154633291|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633292|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633293|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154633294|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
154633295|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
154633296|NCT05076461|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154633297|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154633298|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
154633299|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633300|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633301|NCT02428933|Bromocriptine|bromocriptine|mesh-list
154633302|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154633303|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154633304|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633305|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633306|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633307|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
154633308|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
154633309|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633310|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633311|NCT02428777|Diclofenac|diclofenac|mesh-list
154633312|NCT02428777|Tramadol|tramadol|mesh-list
154633313|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154633314|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154633315|NCT02428777|Analgesics|analgesics|mesh-ancestor
154633316|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
154633317|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633318|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633319|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154633320|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154633321|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154633322|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633323|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633324|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154633325|NCT02428777|Narcotics|narcotics|mesh-ancestor
154633326|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633327|NCT02432053|Tacrolimus|tacrolimus|mesh-list
154633328|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154633329|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
154633330|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633331|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154633332|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633333|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633334|NCT03141827|Insulin|insulin|mesh-list
154633335|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154633336|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633337|NCT03190681|Methylphenidate|methylphenidate|mesh-list
154633338|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154633339|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633340|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154633341|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154633342|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154633343|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633344|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
154633345|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633346|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154633347|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154633348|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154633349|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154633350|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633351|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
154633352|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633353|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633354|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154633355|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633356|NCT04593563|Psilocybin|psilocybin|mesh-list
154633357|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
154633358|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633359|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154633360|NCT04551911|Calcifediol|calcifediol|mesh-list
154633361|NCT04551911|Vitamins|vitamins|mesh-ancestor
154633362|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
154633363|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633364|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154633365|NCT02431975|Ritonavir|ritonavir|mesh-list
154633366|NCT02431975|Lopinavir|lopinavir|mesh-list
154633367|NCT02431975|Lamivudine|lamivudine|mesh-list
154633368|NCT02431975|Zidovudine|zidovudine|mesh-list
154633369|NCT02431975|Nevirapine|nevirapine|mesh-list
154633370|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154633371|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154633372|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
154633373|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633374|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633375|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154633376|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154633377|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
154633378|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633379|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154633380|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633381|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154633382|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154633383|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
154633384|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154633385|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154246111|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
154633386|NCT03143465|Calcitonin|calcitonin|mesh-list
154633387|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
154633388|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
154633389|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154633390|NCT03143465|Katacalcin|katacalcin|mesh-list
154633391|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
154633392|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154633393|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154633394|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633395|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633396|NCT03143465|Urological Agents|urological agents|mesh-ancestor
154633397|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154633398|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633399|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154633400|NCT05034809|Melatonin|melatonin|mesh-list
154633401|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
154633402|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633403|NCT05034809|Protective Agents|protective agents|mesh-ancestor
154633404|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633405|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633406|NCT02428543|Cytarabine|cytarabine|mesh-list
154633407|NCT02428543|Ponatinib|ponatinib|mesh-list
154633408|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154633409|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
154633410|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633411|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633412|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
154633413|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633414|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154633415|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
154633416|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633417|NCT02428543|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154633418|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154633419|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633420|NCT04428203|Cannabidiol|cannabidiol|mesh-list
154633421|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
154633422|NCT02431663|Ketamine|ketamine|mesh-list
154633423|NCT02431663|Analgesics|analgesics|mesh-ancestor
154633424|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
154633425|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633426|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633427|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154633428|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154633429|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
154633430|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
154633431|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633432|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154633433|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154633434|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633435|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633436|NCT03185845|Warfarin|warfarin|mesh-list
154633437|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
154633438|NCT03182803|Antibodies|antibodies|mesh-list
154633439|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
154633440|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633441|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154633442|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633443|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633444|NCT03185611|Rifaximin|rifaximin|mesh-list
154633445|NCT03185611|Azathioprine|azathioprine|mesh-list
154633446|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154633447|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633448|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154633449|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
154633450|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633451|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154633452|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633453|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154633454|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
154633455|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633456|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154633457|NCT02431429|Miltefosine|miltefosine|mesh-list
154633458|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
154633459|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633460|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633461|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154633462|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154633463|NCT02027428|Paclitaxel|paclitaxel|mesh-list
154633464|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154633465|NCT02027428|Carboplatin|carboplatin|mesh-list
154633466|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154633467|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633468|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
154633469|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
154633470|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
154633471|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633472|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154633473|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154633474|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154633475|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633476|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633477|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154633478|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154633479|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633480|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
154633481|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633482|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154633483|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633484|NCT01995136|Travoprost|travoprost|mesh-list
154633485|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154633486|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154633487|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154633488|NCT03141593|Vitamin D|vitamin d|mesh-list
154633489|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
154633490|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
154633491|NCT03141593|Vitamins|vitamins|mesh-list
154633492|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
154633493|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633494|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154633495|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154633496|NCT04102241|Hemay005|hemay005|mesh-list
154633497|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
154633498|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154633499|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154633500|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633501|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633502|NCT03576443|Idelalisib|idelalisib|mesh-list
154633503|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633504|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633505|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633506|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154633507|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154633508|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633509|NCT04438733|Anastrozole|anastrozole|mesh-list
154633510|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154633511|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633512|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154633513|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154633514|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633515|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633516|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154633517|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633518|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633519|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633520|NCT04438811|Anesthetics|anesthetics|mesh-list
154633521|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633522|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633523|NCT02427295|Octreotide|octreotide|mesh-list
154633524|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154633525|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154633526|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633527|NCT01994590|Prednisone|prednisone|mesh-list
154633528|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
154633529|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154633530|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
154633531|NCT01994590|Hormones|hormones|mesh-ancestor
154633532|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633533|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633534|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154633535|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633536|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154633538|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633539|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633540|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633541|NCT03182413|Modafinil|modafinil|mesh-list
154633542|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154633543|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633544|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154633545|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154633546|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154633547|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633548|NCT03182257|ONO-7579|ono-7579|mesh-list
154633549|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154633550|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633551|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633552|NCT03183739|ASP8062|asp8062|mesh-list
154633553|NCT03183739|Analgesics|analgesics|mesh-ancestor
154633554|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
154633555|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633556|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633557|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
154633558|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
154633559|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633560|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633561|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
154633562|NCT03117439|Clotrimazole|clotrimazole|mesh-list
154633563|NCT03117439|Miconazole|miconazole|mesh-list
154633564|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633565|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154633566|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154633567|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633568|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633569|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633570|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154633571|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633572|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633573|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633574|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154633575|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154633576|NCT02426905|Trientine|trientine|mesh-list
154633577|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
154633578|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
154633579|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633580|NCT02421289|Efavirenz|efavirenz|mesh-list
154633581|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154633582|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154633583|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633584|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633585|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
154633586|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633587|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154633588|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633589|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154633590|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154633591|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154633592|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154633593|NCT03141125|Ethanol|ethanol|mesh-list
154633594|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154633595|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633596|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633597|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633598|NCT02426983|Levomethorphan|levomethorphan|mesh-list
154633599|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
154633600|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
154633601|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
154633602|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154633603|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154633604|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633605|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633606|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633607|NCT02426983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154633608|NCT02426983|Narcotics|narcotics|mesh-ancestor
154633609|NCT02426983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633610|NCT02426983|Analgesics|analgesics|mesh-ancestor
154633611|NCT02426983|Sensory System Agents|sensory system agents|mesh-ancestor
154633612|NCT02426983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633613|NCT03142763|Choline|choline|mesh-list
154633614|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
154633615|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154633616|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
154633617|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633618|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154633619|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154633620|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
154633621|NCT05081765|Olaparib|olaparib|mesh-list
154633622|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154633623|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633624|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633625|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633626|NCT05078177|Rituximab|rituximab|mesh-list
154633627|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154633628|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633629|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
154633630|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633631|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154633632|NCT05387369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154633633|NCT05387369|Antiviral Agents|antiviral agents|mesh-ancestor
154633634|NCT05387369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633635|NCT05080985|Bupivacaine|bupivacaine|mesh-list
154633636|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
154633637|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
154633638|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633639|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633640|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
154633641|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633642|NCT03139487|Dalteparin|dalteparin|mesh-list
154633643|NCT03139487|Tinzaparin|tinzaparin|mesh-list
154633644|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154633645|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
154633646|NCT03139487|Apixaban|apixaban|mesh-list
154633647|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154633648|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
154633649|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154633650|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
154633651|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633652|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633653|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
154633654|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154633655|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154633656|NCT03139253|Amoxicillin|amoxicillin|mesh-list
154633657|NCT03139253|Clarithromycin|clarithromycin|mesh-list
154633658|NCT03139253|Levofloxacin|levofloxacin|mesh-list
154633659|NCT03139253|Tetracycline|tetracycline|mesh-list
154633660|NCT03139253|Tinidazole|tinidazole|mesh-list
154633661|NCT03139253|Furazolidone|furazolidone|mesh-list
154633662|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154633663|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633664|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154633665|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633666|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633667|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154633668|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633669|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154633670|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154633671|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154633672|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633673|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154633674|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154633675|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154633676|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154633677|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154633678|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154633679|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
154633680|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
154246431|NCT02244125|Hormones|hormones|mesh-ancestor
154633681|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154633682|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633683|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
154633684|NCT02019472|Adalimumab|adalimumab|mesh-list
154633685|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154633686|NCT02019472|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154633687|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154633688|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154633689|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
154633690|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633691|NCT00157937|Theophylline|theophylline|mesh-list
154633692|NCT00157937|Montelukast|montelukast|mesh-list
154633693|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633694|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633695|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633696|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
154633697|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633698|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
154633699|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154633700|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154633701|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633702|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633703|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154633704|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154633705|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154633706|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154633707|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633708|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
154633709|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154633710|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154633711|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
154633712|NCT03139565|Vaccines|vaccines|mesh-list
154633713|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
154633714|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633715|NCT03139331|Irinotecan|irinotecan|mesh-list
154633716|NCT03139331|Temozolomide|temozolomide|mesh-list
154633717|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154633718|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154633719|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633720|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633721|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633722|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154633723|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
154633724|NCT04423601|Itraconazole|itraconazole|mesh-list
154633725|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
154633726|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633727|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154633728|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633729|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633730|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633731|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154633732|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633733|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633734|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633735|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154633736|NCT02936687|Ambrisentan|ambrisentan|mesh-list
154633737|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154633738|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
154633739|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154633740|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154633741|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633742|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
154633743|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633744|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633745|NCT05083793|Pregabalin|pregabalin|mesh-list
154633746|NCT05083793|Analgesics|analgesics|mesh-ancestor
154633747|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
154633748|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633749|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633750|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
154633751|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154633752|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154633753|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246490|NCT01334944|Ibuprofen|ibuprofen|mesh-list
154633754|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154633755|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154633756|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154633757|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633758|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154633759|NCT05083013|Chrysarobin|chrysarobin|mesh-list
154633760|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154633761|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154633762|NCT05083013|Analgesics|analgesics|mesh-ancestor
154633763|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
154633764|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633765|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633766|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154633767|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154633768|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154633769|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154633770|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633771|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154633772|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154633773|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154633774|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
154633775|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633776|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154633777|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154633778|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633779|NCT03194165|Ritonavir|ritonavir|mesh-list
154633780|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154633781|NCT03194165|Darunavir|darunavir|mesh-list
154633782|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
154633783|NCT03194165|Nevirapine|nevirapine|mesh-list
154633784|NCT03194165|Dolutegravir|dolutegravir|mesh-list
154633785|NCT03194165|Rilpivirine|rilpivirine|mesh-list
154633786|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154633787|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154633788|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
154633789|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633790|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633791|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154633792|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154633793|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
154633794|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633795|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154633796|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633797|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154633798|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154633799|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154633800|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154633801|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154633802|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154633803|NCT04065113|Ethanol|ethanol|mesh-list
154633804|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154633805|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633806|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633807|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633808|NCT03116737|Benzocaine|benzocaine|mesh-list
154633809|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154633810|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
154633811|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
154633812|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633813|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633814|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
154633815|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633816|NCT03116659|Doxycycline|doxycycline|mesh-list
154633817|NCT03116659|Imiquimod|imiquimod|mesh-list
154633818|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154633819|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633820|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
154633821|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154633822|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154633823|NCT03116659|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154633824|NCT03116659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633825|NCT03116659|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154633826|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
154633827|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633828|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154633829|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633830|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
154633831|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154633832|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
154633833|NCT01993888|Coagulants|coagulants|mesh-ancestor
154633834|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
154633835|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154633836|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154633837|NCT02425813|Prednisolone|prednisolone|mesh-list
154633838|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
154633839|NCT02425813|Budesonide|budesonide|mesh-list
154633840|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154633841|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
154633842|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154633843|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
154633844|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
154633845|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633846|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633847|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154633848|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
154633849|NCT02425813|Hormones|hormones|mesh-ancestor
154633850|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633851|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154633852|NCT02425813|Protective Agents|protective agents|mesh-ancestor
154633853|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154633854|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633855|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154633856|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154633857|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
154633858|NCT03106831|Norepinephrine|norepinephrine|mesh-list
154633859|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154633860|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154633861|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
154633862|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633863|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633864|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633865|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
154633866|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
154633867|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154633868|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154633869|NCT03138785|Itraconazole|itraconazole|mesh-list
154633870|NCT03138785|Voriconazole|voriconazole|mesh-list
154633871|NCT03138785|Levofloxacin|levofloxacin|mesh-list
154633872|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
154633873|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633874|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154633875|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154633876|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633877|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633878|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154633879|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
154633880|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633881|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633882|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154633883|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154633884|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154633885|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154633886|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154633887|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633888|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154633889|NCT03106597|Amlodipine|amlodipine|mesh-list
154633890|NCT03106597|Manidipine|manidipine|mesh-list
154633891|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154633892|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154633893|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154633894|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633895|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154633896|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633897|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
154633898|NCT02018458|Paclitaxel|paclitaxel|mesh-list
154633899|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154633900|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
154633901|NCT02018458|Carboplatin|carboplatin|mesh-list
154633902|NCT02018458|Doxorubicin|doxorubicin|mesh-list
154633903|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154633904|NCT02018458|Vaccines|vaccines|mesh-list
154633905|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
154633906|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633907|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154633908|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633909|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
154633910|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
154633911|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
154633912|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633913|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154633914|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154633915|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154633916|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
154633917|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154633918|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154633919|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154633920|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154633921|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633922|NCT02423083|Guanabenz|guanabenz|mesh-list
154633923|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154633924|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154633925|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154633926|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154633927|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154633928|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633929|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633930|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633931|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
154633932|NCT02423863|Nivolumab|nivolumab|mesh-list
154633933|NCT02423863|Atezolizumab|atezolizumab|mesh-list
154633934|NCT02423863|Durvalumab|durvalumab|mesh-list
154633935|NCT02423863|Cemiplimab|cemiplimab|mesh-list
154633936|NCT02423863|Poly ICLC|poly iclc|mesh-list
154633937|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154633938|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633939|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154633940|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633941|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
154633942|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
154633943|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633944|NCT03178747|Methylene Blue|methylene blue|mesh-list
154633945|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659738|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154633946|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633947|NCT05392673|Bilirubin|bilirubin|mesh-list
154633948|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
154633949|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633950|NCT05392673|Protective Agents|protective agents|mesh-ancestor
154633951|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633952|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
154633953|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
154633954|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633955|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
154633956|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154633957|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633958|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
154633959|NCT03178591|Vildagliptin|vildagliptin|mesh-list
154633960|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154633961|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633962|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154633963|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633964|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154633965|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
154633966|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633967|NCT01993186|Glycerol|glycerol|mesh-list
154633968|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154633969|NCT01993186|Protective Agents|protective agents|mesh-ancestor
154633970|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633971|NCT03181243|Anesthetics|anesthetics|mesh-list
154633972|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154633973|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633974|NCT02420665|Acetic Acid|acetic acid|mesh-list
154633975|NCT02420665|Proflavine|proflavine|mesh-list
154633976|NCT02420665|Retinol acetate|retinol acetate|mesh-list
154633977|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154633978|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246722|NCT00042939|Docetaxel|docetaxel|mesh-list
154633979|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154633981|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633982|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154633983|NCT02420665|Protective Agents|protective agents|mesh-ancestor
154633984|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633985|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154633986|NCT02016898|Mitomycins|mitomycins|mesh-list
154633987|NCT02016898|Mitomycin|mitomycin|mesh-list
154633988|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154633989|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154633990|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
154633991|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154633992|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154633993|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154633994|NCT04482907|Hormones|hormones|mesh-list
154633995|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154633996|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154633997|NCT02420509|Leucovorin|leucovorin|mesh-list
154633998|NCT02420509|Capecitabine|capecitabine|mesh-list
154633999|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634000|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634001|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154634002|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
154659739|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154634003|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634004|NCT02420509|Antidotes|antidotes|mesh-ancestor
154634005|NCT02420509|Protective Agents|protective agents|mesh-ancestor
154634006|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
154634007|NCT02420509|Vitamins|vitamins|mesh-ancestor
154634008|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
154634009|NCT02416531|Clobetasol|clobetasol|mesh-list
154634010|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154634011|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
154634012|NCT02416531|Hormones|hormones|mesh-ancestor
154634013|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634014|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634015|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
154634016|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154634017|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154634018|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634019|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
154634020|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
154634021|NCT02416141|Tramadol|tramadol|mesh-list
154634022|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154634023|NCT02416141|Narcotics|narcotics|mesh-ancestor
154634024|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634025|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634026|NCT02416141|Analgesics|analgesics|mesh-ancestor
154634027|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
154634028|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634029|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154634030|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154634031|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634032|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
154634033|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154634034|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634035|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634036|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154634037|NCT02416063|Analgesics|analgesics|mesh-ancestor
154634038|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
154634039|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634040|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154634041|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154634042|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154634043|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
154634044|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634045|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634046|NCT01828697|Enoxaparin|enoxaparin|mesh-list
154634047|NCT01828697|Dalteparin|dalteparin|mesh-list
154634048|NCT01828697|Tinzaparin|tinzaparin|mesh-list
154634049|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154634050|NCT01828697|Nadroparin|nadroparin|mesh-list
154634051|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
154634052|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
154634053|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154634054|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154634055|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634056|NCT02415985|Lopinavir|lopinavir|mesh-list
154634057|NCT02415985|Rifabutin|rifabutin|mesh-list
154634058|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154634059|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154634060|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
154634061|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634062|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634063|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154634064|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154634065|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
154634066|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634067|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154634068|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154634069|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154634070|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154634071|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
154634072|NCT02415907|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154634073|NCT02415907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154634074|NCT02415907|Serotonin Agents|serotonin agents|mesh-ancestor
154634075|NCT02415907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634076|NCT02415907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634077|NCT02415907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634078|NCT02415829|Capecitabine|capecitabine|mesh-list
154634079|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
154634080|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154634081|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
154634082|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634083|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634084|NCT04631393|Alfentanil|alfentanil|mesh-list
154634085|NCT04631393|Propofol|propofol|mesh-list
154634086|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154634087|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634088|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634089|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154634090|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
154634091|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
154634092|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154634093|NCT04631393|Narcotics|narcotics|mesh-ancestor
154634094|NCT04631393|Analgesics|analgesics|mesh-ancestor
154634095|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
154634096|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634097|NCT03180775|Glycine|glycine|mesh-list
154634098|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
154634099|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634100|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634101|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634102|NCT03137927|Vaccines|vaccines|mesh-list
154634103|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
154634104|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634105|NCT04482985|Meclizine|meclizine|mesh-list
154634106|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
154634107|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
154634108|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634109|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634110|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634111|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154634112|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
154634113|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
154634114|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634115|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634116|NCT04482985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154634117|NCT04482985|Cholinergic Agents|cholinergic agents|mesh-ancestor
154634118|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154634119|NCT05385263|Nivolumab|nivolumab|mesh-list
154634120|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154634121|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634122|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246869|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246871|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154246872|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154246873|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154348950|NCT06105671|Diuretics|diuretics|mesh-ancestor
154246874|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154634123|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634125|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
154634126|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
154634127|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634128|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634129|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634130|NCT03180229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154634131|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154634132|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
154634133|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634134|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634135|NCT03178123|Interferons|interferons|mesh-list
154634136|NCT03178123|Antibodies|antibodies|mesh-list
154634137|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154634138|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
154634139|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634140|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634141|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
154634142|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634143|NCT05111197|Immunomodulating Agents|immunomodulating agents|mesh-list
154634144|NCT05111197|Immunologic Factors|immunologic factors|mesh-ancestor
154634145|NCT05111197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634146|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
154634147|NCT05106517|Denosumab|denosumab|mesh-list
154634148|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154634149|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634150|NCT03140033|Misoprostol|misoprostol|mesh-list
154634151|NCT03140033|Ranitidine|ranitidine|mesh-list
154634152|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154634153|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154634154|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
154634155|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154634156|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634157|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154634158|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634159|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
154634160|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154634161|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
154634162|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
154634163|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634164|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634165|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
154634166|NCT05338931|Gossypol|gossypol|mesh-list
154634167|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154634168|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348999|NCT06102395|Antimetabolites|antimetabolites|mesh-ancestor
154634169|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154634170|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
154634171|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154634172|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634173|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154634174|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154634175|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154634176|NCT02706691|Infigratinib|infigratinib|mesh-list
154634177|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634178|NCT02419729|Estrogens|estrogens|mesh-list
154634179|NCT02419729|Hormones|hormones|mesh-ancestor
154634180|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634181|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634182|NCT02419651|Diclofenac|diclofenac|mesh-list
154634183|NCT02419651|Tramadol|tramadol|mesh-list
154634184|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154634185|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154634186|NCT02419651|Analgesics|analgesics|mesh-ancestor
154634187|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
154634188|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634189|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634190|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154634191|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154634192|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154634193|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634194|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634195|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154634196|NCT02419651|Narcotics|narcotics|mesh-ancestor
154634197|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634198|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154634199|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634200|NCT02419261|Analgesics|analgesics|mesh-list
154634201|NCT02419261|Ropivacaine|ropivacaine|mesh-list
154634202|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
154634203|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
154634204|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634205|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634206|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
154634207|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634208|NCT02414503|Oxytocin|oxytocin|mesh-list
154634209|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
154634210|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154634211|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634212|NCT03137615|Anesthetics|anesthetics|mesh-list
154634213|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
154634214|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634215|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634216|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
154634217|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634218|NCT03415061|Insulin|insulin|mesh-list
154634219|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154634220|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154634221|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634222|NCT05088083|Paclitaxel|paclitaxel|mesh-list
154634223|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154634224|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634225|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
154634226|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
154634227|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154634228|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634229|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
154634230|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154634231|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154634232|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634233|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
154634234|NCT01990768|Coagulants|coagulants|mesh-ancestor
154634235|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
154634236|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634237|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
154634238|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
154634239|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
154634240|NCT05085587|Fluticasone|fluticasone|mesh-list
154634241|NCT05085587|Xhance|xhance|mesh-list
154634242|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154634243|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154634244|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154634245|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154634246|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
154634247|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634248|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634249|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154634250|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
154634251|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154634252|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154634253|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154634254|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154634255|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154634256|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
154634257|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634258|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634259|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
154634260|NCT05085587|Hormones|hormones|mesh-ancestor
154634261|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634262|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
154634263|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154634264|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154634265|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634266|NCT01990534|Immunotoxins|immunotoxins|mesh-ancestor
154247016|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247017|NCT02537509|Vitamins|vitamins|mesh-ancestor
154247018|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
154247019|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154247020|NCT02490878|Bevacizumab|bevacizumab|mesh-list
154247021|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154247022|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634267|NCT01990534|Immunoconjugates|immunoconjugates|mesh-ancestor
154634268|NCT01990534|Immunologic Factors|immunologic factors|mesh-ancestor
154634269|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634270|NCT05084573|Bupivacaine|bupivacaine|mesh-list
154634271|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
154634272|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
154634273|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634274|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634275|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
154634276|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634277|NCT05088707|Misoprostol|misoprostol|mesh-list
154634278|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154634279|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
154634280|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154634281|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634282|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154634283|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634284|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
154634285|NCT05028257|Vaccines|vaccines|mesh-list
154634286|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
154634287|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634288|NCT03135977|Etoposide|etoposide|mesh-list
154634289|NCT03135977|Apatinib|apatinib|mesh-list
154634290|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154634291|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634292|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154634293|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154634294|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634295|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634296|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154634297|NCT04850651|Fluconazole|fluconazole|mesh-list
154634298|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
154634299|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634300|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154634301|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154634302|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634303|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634304|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154634305|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
154634306|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634307|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634308|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154634309|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154634310|NCT04837235|Hemay005|hemay005|mesh-list
154634311|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
154634312|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154634313|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154634314|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634315|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634316|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
154634317|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154634318|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634319|NCT02702401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154634320|NCT02702401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634321|NCT03116971|Etoposide|etoposide|mesh-list
154634322|NCT03116971|Peposertib|peposertib|mesh-list
154634323|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634324|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154634325|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154247107|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
154247108|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154247109|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
154247110|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247111|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
154247112|NCT01934218|Protective Agents|protective agents|mesh-ancestor
154247134|NCT01233635|Losartan|losartan|mesh-list
154247135|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154247136|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154247137|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154247138|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154247139|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247140|NCT00385606|Rofecoxib|rofecoxib|mesh-list
154247157|NCT03721744|Paclitaxel|paclitaxel|mesh-list
154634326|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154634327|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634328|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634329|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154634330|NCT02414581|Ethanol|ethanol|mesh-list
154634331|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
154634332|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154634333|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154634334|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634335|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634336|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634337|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
154634338|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
154634339|NCT02419105|Vitamin D|vitamin d|mesh-list
154634340|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
154634341|NCT02419105|Testosterone|testosterone|mesh-list
154634342|NCT02419105|Vitamins|vitamins|mesh-ancestor
154634343|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
154634344|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634345|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154634346|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154634347|NCT02419105|Androgens|androgens|mesh-ancestor
154634348|NCT02419105|Hormones|hormones|mesh-ancestor
154634349|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634350|NCT04643249|Repaglinide|repaglinide|mesh-list
154634351|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
154634352|NCT04643249|Midazolam|midazolam|mesh-list
154634353|NCT04643249|Levomethorphan|levomethorphan|mesh-list
154634354|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
154634355|NCT04643249|Caffeine|caffeine|mesh-list
154634356|NCT04643249|Bupropion|bupropion|mesh-list
154634357|NCT04643249|Omeprazole|omeprazole|mesh-list
154634358|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154634359|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154634360|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634361|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634362|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154634363|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154634364|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154634365|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154634366|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
154634367|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
154634368|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
154634369|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
154634370|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634371|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634372|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154634373|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154349192|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
154634374|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634375|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154634376|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154634377|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
154634378|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154634379|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634380|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154634381|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154634382|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
154634383|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154634384|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154634385|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154634386|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
154634387|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154634388|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154634389|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
154634390|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
154634391|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154634392|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154634393|NCT04643249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154634394|NCT04643249|Narcotics|narcotics|mesh-ancestor
154634395|NCT04643249|Analgesics|analgesics|mesh-ancestor
154634396|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
154634397|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634398|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154634399|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154634400|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154634401|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154634402|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154634403|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154634404|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
154634405|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154634406|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154634407|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154634408|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154634409|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634410|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
154634411|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634412|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634413|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154634414|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634415|NCT03116893|Itraconazole|itraconazole|mesh-list
154634416|NCT03116893|Rifampin|rifampin|mesh-list
154634417|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
154634418|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634419|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154634420|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154634421|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634422|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634423|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154634424|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
154634425|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634426|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634427|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154659740|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634428|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154634429|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
154634430|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154634431|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
154634432|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154634433|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154634434|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154634435|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154634436|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154634437|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154634438|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154634439|NCT05737511|Diazepam|diazepam|mesh-list
154634440|NCT05737511|Gabapentin|gabapentin|mesh-list
154634441|NCT05737511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154634442|NCT05737511|Milnacipran|milnacipran|mesh-list
154634443|NCT05737511|Levetiracetam|levetiracetam|mesh-list
154634444|NCT05737511|Lorazepam|lorazepam|mesh-list
154634445|NCT05737511|Clonazepam|clonazepam|mesh-list
154634446|NCT05737511|Dexetimide|dexetimide|mesh-list
154634447|NCT05737511|Olanzapine|olanzapine|mesh-list
154634448|NCT05737511|Alprazolam|alprazolam|mesh-list
154634449|NCT05737511|Mirtazapine|mirtazapine|mesh-list
154634450|NCT05737511|Fluvoxamine|fluvoxamine|mesh-list
154634451|NCT05737511|Tranylcypromine|tranylcypromine|mesh-list
154634452|NCT05737511|Risperidone|risperidone|mesh-list
154634453|NCT05737511|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154634454|NCT05737511|Citalopram|citalopram|mesh-list
154634455|NCT05737511|Bupropion|bupropion|mesh-list
154634456|NCT05737511|Sertraline|sertraline|mesh-list
154634457|NCT05737511|Fluoxetine|fluoxetine|mesh-list
154634458|NCT05737511|Paroxetine|paroxetine|mesh-list
154634459|NCT05737511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154634460|NCT05737511|Reboxetine|reboxetine|mesh-list
154634461|NCT05737511|Imipramine|imipramine|mesh-list
154634462|NCT05737511|Clomipramine|clomipramine|mesh-list
154634463|NCT05737511|Phenelzine|phenelzine|mesh-list
154634464|NCT05737511|Moclobemide|moclobemide|mesh-list
154634465|NCT05737511|Hydroxyzine|hydroxyzine|mesh-list
154634466|NCT05737511|Escitalopram|escitalopram|mesh-list
154634467|NCT05737511|Analgesics|analgesics|mesh-ancestor
154634468|NCT05737511|Sensory System Agents|sensory system agents|mesh-ancestor
154634469|NCT05737511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634470|NCT05737511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634471|NCT05737511|Anticonvulsants|anticonvulsants|mesh-ancestor
154634472|NCT05737511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154634473|NCT05737511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154634474|NCT05737511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634475|NCT05737511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154634476|NCT05737511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154634477|NCT05737511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154247247|NCT01583036|Digoxin|digoxin|mesh-list
154634478|NCT05737511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634479|NCT05737511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634480|NCT05737511|Antimanic Agents|antimanic agents|mesh-ancestor
154634481|NCT05737511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154634482|NCT05737511|Serotonin Agents|serotonin agents|mesh-ancestor
154634483|NCT05737511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154634484|NCT05737511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154634485|NCT05737511|Dopamine Agents|dopamine agents|mesh-ancestor
154634486|NCT05737511|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154634487|NCT05737511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154634488|NCT05737511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154634489|NCT05737511|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154634490|NCT05737511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154634491|NCT05737511|Parasympatholytics|parasympatholytics|mesh-ancestor
154634492|NCT05737511|Autonomic Agents|autonomic agents|mesh-ancestor
154634493|NCT05737511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154634494|NCT05737511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154634495|NCT05737511|Cholinergic Agents|cholinergic agents|mesh-ancestor
154634496|NCT05737511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154634497|NCT05737511|Antidepressive Agents|antidepressive agents|mesh-ancestor
154634498|NCT05737511|Antiemetics|antiemetics|mesh-ancestor
154634499|NCT05737511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634500|NCT05737511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154634501|NCT05737511|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154349317|NCT05051436|Tadalafil|tadalafil|mesh-list
154634502|NCT05737511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154634503|NCT05737511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634504|NCT05737511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154634505|NCT05737511|Nootropic Agents|nootropic agents|mesh-ancestor
154634506|NCT05737511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154634507|NCT05737511|GABA Modulators|gaba modulators|mesh-ancestor
154634508|NCT05737511|GABA Agents|gaba agents|mesh-ancestor
154634509|NCT05737511|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154634510|NCT05737511|Histamine Antagonists|histamine antagonists|mesh-ancestor
154634511|NCT05737511|Histamine Agents|histamine agents|mesh-ancestor
154634512|NCT05737511|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154634513|NCT05737511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154634514|NCT05737511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154634515|NCT05737511|Adrenergic Agents|adrenergic agents|mesh-ancestor
154634516|NCT05737511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154634517|NCT05737511|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154634518|NCT05737511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154634519|NCT05737511|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154634520|NCT05737511|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154634521|NCT05737511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154634522|NCT05737511|Anesthetics, General|anesthetics, general|mesh-ancestor
154634523|NCT05737511|Anesthetics|anesthetics|mesh-ancestor
154634524|NCT05737511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154634525|NCT05737511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154634526|NCT05737511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154634527|NCT05737511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154634528|NCT05737511|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154634529|NCT05737511|Antipruritics|antipruritics|mesh-ancestor
154634530|NCT05737511|Dermatologic Agents|dermatologic agents|mesh-ancestor
154634531|NCT05737511|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154634532|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
154634533|NCT03179839|Sertraline|sertraline|mesh-list
154634534|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
154634535|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154634536|NCT03179839|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154634537|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154634538|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154634539|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634540|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634541|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
154634542|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634543|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154634544|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154634545|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634546|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154634547|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154634548|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154634549|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634550|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154634551|NCT05736887|Acetylcysteine|acetylcysteine|mesh-list
154634552|NCT05736887|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154634553|NCT05736887|Antiviral Agents|antiviral agents|mesh-ancestor
154634554|NCT05736887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634555|NCT05736887|Expectorants|expectorants|mesh-ancestor
154634556|NCT05736887|Respiratory System Agents|respiratory system agents|mesh-ancestor
154634557|NCT05736887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154634558|NCT05736887|Antioxidants|antioxidants|mesh-ancestor
154634559|NCT05736887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634560|NCT05736887|Protective Agents|protective agents|mesh-ancestor
154634561|NCT05736887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634562|NCT05736887|Antidotes|antidotes|mesh-ancestor
154634563|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
154634564|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154634565|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634566|NCT04483219|Antibodies|antibodies|mesh-list
154634567|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
154634568|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634569|NCT03176563|Fosfomycin|fosfomycin|mesh-list
154634570|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154634571|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634572|NCT03827447|Vancomycin|vancomycin|mesh-list
154634573|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154634574|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634575|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
154634576|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154634577|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
154634578|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634579|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
154634580|NCT01680497|Protective Agents|protective agents|mesh-ancestor
154634581|NCT02423395|Orphenadrine|orphenadrine|mesh-list
154634582|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634583|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154634584|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154634585|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154634586|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154634587|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634588|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
154634589|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
154634590|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154634591|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154634592|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
154634593|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634594|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634595|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154634596|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154634597|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634598|NCT05694689|Vitamin D|vitamin d|mesh-list
154634599|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
154634600|NCT05694689|Vitamins|vitamins|mesh-ancestor
154634601|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
154634602|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634603|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154634604|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154634605|NCT02423239|Paclitaxel|paclitaxel|mesh-list
154634606|NCT02423239|Gemcitabine|gemcitabine|mesh-list
154634607|NCT02423239|Sorafenib|sorafenib|mesh-list
154634608|NCT02423239|HU 211|hu 211|mesh-list
154634609|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154634610|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634611|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
154634612|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
154634613|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
154634614|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634615|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154634616|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
154634617|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154634618|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634619|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154634620|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
154634621|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
154634622|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634623|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634624|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634625|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154634626|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154634627|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634628|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154634629|NCT02423239|Protective Agents|protective agents|mesh-ancestor
154634630|NCT02449733|Tenofovir|tenofovir|mesh-list
154634631|NCT02449733|Emtricitabine|emtricitabine|mesh-list
154634632|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154634633|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
154634634|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634635|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154634636|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154634637|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634638|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634639|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154634640|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154634641|NCT02417467|Nicotine|nicotine|mesh-list
154634642|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154634643|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
154634644|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634645|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634646|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154634647|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154634648|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
154634649|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634650|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634651|NCT02417389|Alendronate|alendronate|mesh-list
154634652|NCT02417389|Cinacalcet|cinacalcet|mesh-list
154634653|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154634654|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634655|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154634656|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154634657|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
154634658|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634659|NCT02413021|Cytarabine|cytarabine|mesh-list
154634660|NCT02413021|Deferasirox|deferasirox|mesh-list
154634661|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154634662|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
154634663|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634664|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634665|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
154634666|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634667|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154634668|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
154634669|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634670|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154634671|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
154349497|NCT04323956|Prednisone|prednisone|mesh-list
154634672|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
154634673|NCT01680341|Insulin|insulin|mesh-list
154634674|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154634675|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
154634676|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
154634677|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154634678|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154634679|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634680|NCT03177811|Acetazolamide|acetazolamide|mesh-list
154634681|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
154634682|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154634683|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634684|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634685|NCT03177811|Diuretics|diuretics|mesh-ancestor
154634686|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
154634687|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634688|NCT03175939|Fluorouracil|fluorouracil|mesh-list
154634689|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634690|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
154634691|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634692|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154634693|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154634694|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
154634695|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634696|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
154634697|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154634698|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154634699|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154634700|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154634701|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634702|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634703|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154634704|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154634705|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634707|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634708|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
154634709|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154634710|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
154634711|NCT02412475|Cytarabine|cytarabine|mesh-list
154634712|NCT02412475|Fludarabine|fludarabine|mesh-list
154634713|NCT02412475|Sorafenib|sorafenib|mesh-list
154634714|NCT02412475|Decitabine|decitabine|mesh-list
154634715|NCT02412475|Vorinostat|vorinostat|mesh-list
154634716|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634717|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154634718|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
154634719|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634720|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154634721|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
154634722|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634723|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
154634724|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634725|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154634726|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634727|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154634728|NCT04543643|Carvedilol|carvedilol|mesh-list
154634729|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154634730|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154634731|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
154634732|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634733|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634734|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634735|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154634736|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
154634737|NCT04543643|Protective Agents|protective agents|mesh-ancestor
154349565|NCT04172220|Midazolam|midazolam|mesh-list
154634738|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154634739|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154634740|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154634741|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
154634742|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154634743|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154634744|NCT05377619|Buspirone|buspirone|mesh-list
154634745|NCT05377619|Prucalopride|prucalopride|mesh-list
154634746|NCT05377619|Laxatives|laxatives|mesh-ancestor
154634747|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634748|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154634749|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154634750|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
154634751|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634752|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634753|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634754|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154634755|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154634756|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634757|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154634758|NCT03199157|Fentanyl|fentanyl|mesh-list
154634759|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154634760|NCT03199157|Narcotics|narcotics|mesh-ancestor
154634761|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634762|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634763|NCT03199157|Analgesics|analgesics|mesh-ancestor
154634764|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
154634765|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634766|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154634767|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154634768|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
154634769|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
154634770|NCT02416999|Bevacizumab|bevacizumab|mesh-list
154634771|NCT02416999|Temozolomide|temozolomide|mesh-list
154634772|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154634773|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634774|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154634775|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154634776|NCT02416999|Growth Substances|growth substances|mesh-ancestor
154634777|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634778|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
154634779|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154634780|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
154634781|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634782|NCT02412085|Golimumab|golimumab|mesh-list
154634783|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154634784|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154634785|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154634786|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
154634787|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634788|NCT01679405|Cisplatin|cisplatin|mesh-list
154634789|NCT01679405|Gemcitabine|gemcitabine|mesh-list
154634790|NCT01679405|Afatinib|afatinib|mesh-list
154634791|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634792|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154634793|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
154634794|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634795|NCT01679405|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154634796|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154634797|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634798|NCT03175705|Interleukin-2|interleukin-2|mesh-list
154634799|NCT03175705|Tegafur|tegafur|mesh-list
154634800|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634801|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154634802|NCT03175705|Analgesics|analgesics|mesh-ancestor
154634803|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
154349626|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634804|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634805|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634806|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154634807|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
154634808|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634809|NCT00301457|Anastrozole|anastrozole|mesh-list
154634810|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154634811|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634812|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154634813|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154634814|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634815|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634816|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154634817|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
154634818|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634819|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634820|NCT03177109|Fluorides|fluorides|mesh-list
154634821|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
154634822|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
154634823|NCT03177109|Protective Agents|protective agents|mesh-ancestor
154634824|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634825|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154634826|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154634827|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
154634828|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634829|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634830|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634831|NCT02421913|Ketamine|ketamine|mesh-list
154634832|NCT02421913|Analgesics|analgesics|mesh-ancestor
154634833|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
154634834|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634835|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634836|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154634837|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154634838|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
154634839|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
154634840|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634841|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154634842|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154634843|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634844|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634845|NCT03179293|Propofol|propofol|mesh-list
154634846|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154634847|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634848|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634849|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154634850|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
154634851|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
154634852|NCT02416765|Glucagon|glucagon|mesh-list
154634853|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634854|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154634855|NCT02416765|Hormones|hormones|mesh-ancestor
154634856|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154634857|NCT02703259|Acetaminophen|acetaminophen|mesh-list
154634858|NCT02703259|Celecoxib|celecoxib|mesh-list
154634859|NCT02703259|Gabapentin|gabapentin|mesh-list
154634860|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154634861|NCT02703259|Analgesics|analgesics|mesh-ancestor
154634862|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
154634863|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634864|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634865|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
154634866|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154634867|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154634868|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349693|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
154634869|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154634870|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154634871|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634872|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634873|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
154634874|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154634875|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154634876|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634877|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154634878|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154634879|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154634880|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634881|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
154634882|NCT02416687|Etonogestrel|etonogestrel|mesh-list
154634883|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154634884|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
154634885|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154634886|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634887|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154634888|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
154634889|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
154634890|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634891|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634892|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634893|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
154634894|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
154634895|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
154634896|NCT05093231|Olaparib|olaparib|mesh-list
154634897|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154634898|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634899|NCT05093231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154634900|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634901|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154634902|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154634903|NCT02411149|Epinephrine|epinephrine|mesh-list
154634904|NCT02411149|Racepinephrine|racepinephrine|mesh-list
154634905|NCT02411149|Morphine|morphine|mesh-list
154634906|NCT02411149|Ropivacaine|ropivacaine|mesh-list
154634907|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
154634908|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154634909|NCT02411149|Narcotics|narcotics|mesh-ancestor
154634910|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634911|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634912|NCT02411149|Analgesics|analgesics|mesh-ancestor
154634913|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
154634914|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634915|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
154634916|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
154634917|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154634918|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154634919|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
154634920|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634921|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634922|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154634923|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154634924|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
154634925|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154634926|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
154634927|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
154247697|NCT03802994|Vaccines|vaccines|mesh-list
154247770|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154634928|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
154634929|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154634930|NCT04413227|Docetaxel|docetaxel|mesh-list
154634931|NCT04413227|Endostatins|endostatins|mesh-list
154634932|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154634933|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
154634934|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154634935|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154634936|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634937|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154634938|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154634939|NCT04413227|Growth Substances|growth substances|mesh-ancestor
154634940|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634941|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
154634942|NCT02410135|Mirabegron|mirabegron|mesh-list
154634943|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154634944|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154634945|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154634946|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
154634947|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154634948|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634949|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634950|NCT02410135|Urological Agents|urological agents|mesh-ancestor
154634951|NCT02410759|Carbetocin|carbetocin|mesh-list
154634952|NCT02410759|Ergonovine|ergonovine|mesh-list
154634953|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
154634954|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154634955|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634956|NCT03175081|Ropivacaine|ropivacaine|mesh-list
154634957|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
154634958|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
154634959|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634960|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634961|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
154634962|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154634963|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
154634964|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154634965|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154634966|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634967|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154634968|NCT02401477|Amoxicillin|amoxicillin|mesh-list
154634969|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154634970|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634971|NCT03174457|Micafungin|micafungin|mesh-list
154634972|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
154634973|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634974|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
154634975|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154634976|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634977|NCT02409433|Lacosamide|lacosamide|mesh-list
154634978|NCT02409433|Phenytoin|phenytoin|mesh-list
154634979|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
154634980|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154634981|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154634982|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154634983|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634984|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154634985|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154634986|NCT01989754|Canagliflozin|canagliflozin|mesh-list
154634987|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154634988|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154634989|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154634990|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154634991|NCT01619878|Lumefantrine|lumefantrine|mesh-list
154634992|NCT01619878|Artemether|artemether|mesh-list
154634993|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154634994|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
154634995|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154634996|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154634997|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154634998|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
154634999|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154635000|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
154635001|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635002|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
154635003|NCT01989208|Cathartics|cathartics|mesh-ancestor
154635004|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154635005|NCT01619410|Clindamycin|clindamycin|mesh-list
154635006|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
154635007|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
154635008|NCT01619410|Linezolid|linezolid|mesh-list
154635009|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154635010|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635011|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154635012|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635013|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635014|NCT01261247|Panobinostat|panobinostat|mesh-list
154635015|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154635016|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635017|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635018|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635019|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154635020|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154635021|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154635022|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
154635023|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635024|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154635025|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154635026|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635027|NCT02449655|Paclitaxel|paclitaxel|mesh-list
154635028|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154635029|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154635030|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635031|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
154635032|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
154635033|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
154635034|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635035|NCT04254731|Methadone|methadone|mesh-list
154635036|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154635037|NCT04254731|Narcotics|narcotics|mesh-ancestor
154635038|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635039|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635040|NCT04254731|Analgesics|analgesics|mesh-ancestor
154635041|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
154635042|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635043|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
154635044|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
154635045|NCT01603277|Antibodies|antibodies|mesh-list
154635046|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154635047|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
154635048|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635049|NCT01678313|Celecoxib|celecoxib|mesh-list
154635050|NCT01678313|Doxazosin|doxazosin|mesh-list
154635051|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154635052|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154635053|NCT01678313|Analgesics|analgesics|mesh-ancestor
154635054|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
154635055|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635056|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635057|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635058|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635059|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154635060|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154635061|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635062|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635063|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154635064|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154635065|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154635066|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154635067|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
154635068|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635069|NCT03197207|Camphor|camphor|mesh-list
154635070|NCT03197207|Salicylates|salicylates|mesh-list
154635071|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
154635072|NCT03197207|Menthol|menthol|mesh-list
154635073|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154349910|NCT03848533|Metformin|metformin|mesh-list
154635074|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635075|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
154247849|NCT00060944|Hormones|hormones|mesh-ancestor
154635076|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
154635077|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154635078|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154635079|NCT03197207|Analgesics|analgesics|mesh-ancestor
154635080|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
154635081|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635082|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635083|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635084|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635085|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154635086|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635087|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635088|NCT01603121|Lisofylline|lisofylline|mesh-list
154635089|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154635090|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
154635091|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635092|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154635093|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154635094|NCT01603121|Analgesics|analgesics|mesh-ancestor
154635095|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
154635096|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635097|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635098|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635099|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635100|NCT02449265|Prednisone|prednisone|mesh-list
154635101|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
154635102|NCT02449265|Doxorubicin|doxorubicin|mesh-list
154635103|NCT02449265|Vincristine|vincristine|mesh-list
154635104|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635105|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
154635106|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635107|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635108|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154635109|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
154635110|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635111|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635112|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154635113|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154635114|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154635115|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154635116|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635117|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635118|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
154635119|NCT02449265|Hormones|hormones|mesh-ancestor
154635120|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154635121|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154635122|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154635123|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
154635124|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
154635125|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
154635126|NCT03196817|Betamethasone|betamethasone|mesh-list
154635127|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
154635128|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154635129|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
154635130|NCT03196817|Lidocaine|lidocaine|mesh-list
154635131|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154635132|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
154635133|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
154635134|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635135|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635136|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
154635137|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635138|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154635139|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154635140|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154635141|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154635142|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635143|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635144|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
154635145|NCT03196817|Hormones|hormones|mesh-ancestor
154635146|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154635147|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154635148|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154635149|NCT05091359|Calcium|calcium|mesh-list
154635150|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154635151|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635152|NCT02014402|Thrombin|thrombin|mesh-list
154635153|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
154635154|NCT02014402|Coagulants|coagulants|mesh-ancestor
154635155|NCT01988662|Ranibizumab|ranibizumab|mesh-list
154635156|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154635157|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154635158|NCT01988662|Growth Substances|growth substances|mesh-ancestor
154635159|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635160|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
154635161|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635162|NCT00127673|Sertraline|sertraline|mesh-list
154635163|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
154635164|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154635165|NCT00127673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154635166|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154635167|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154635168|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635169|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635170|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
154635171|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635172|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
154635173|NCT02449187|Metformin|metformin|mesh-list
154635174|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154635175|NCT02449187|Calcium|calcium|mesh-list
154635176|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154635177|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635178|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154635179|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154635180|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154635181|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154635182|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
154635183|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635184|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154635185|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154635186|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635187|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
154635188|NCT02677181|Methotrexate|methotrexate|mesh-list
154635189|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
154635190|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154635191|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
154635192|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154635193|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635194|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154635195|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
154635196|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635197|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635198|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
154635199|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635200|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154350032|NCT03844243|Mitogens|mitogens|mesh-list
154635201|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635202|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
154635203|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635204|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154635205|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154635206|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154635207|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
154635208|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154635209|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635210|NCT05095025|Bupivacaine|bupivacaine|mesh-list
154635211|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
154635212|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
154635213|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635214|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635215|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
154635216|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635217|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154635218|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154635219|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635220|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
154635221|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
154635222|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635223|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635224|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635225|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
154635226|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
154635227|NCT05084027|Fludarabine|fludarabine|mesh-list
154635228|NCT05084027|Melphalan|melphalan|mesh-list
154635229|NCT05084027|Venetoclax|venetoclax|mesh-list
154635230|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635231|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635232|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635233|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
154635234|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635235|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154635236|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
154635237|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154635238|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
154635239|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
154635240|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635241|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635242|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635243|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
154635244|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
154635245|NCT02448797|Vinorelbine|vinorelbine|mesh-list
154635246|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154635247|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635248|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
154635249|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
154635250|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
154635251|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635252|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
154635253|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154635254|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154635255|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
154635256|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154635257|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635258|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
154635259|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
154635260|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154635261|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
154635262|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635263|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
154635264|NCT04438421|Protective Agents|protective agents|mesh-ancestor
154635265|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
154635266|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154635267|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154635268|NCT04438577|Lidocaine|lidocaine|mesh-list
154635269|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
154635270|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
154635271|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635272|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635273|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
154635274|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635275|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154635276|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154635277|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154635278|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154635279|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635280|NCT05087615|Ondansetron|ondansetron|mesh-list
154635281|NCT05087615|Metoclopramide|metoclopramide|mesh-list
154635282|NCT05087615|Granisetron|granisetron|mesh-list
154635283|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
154635284|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
154635285|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635286|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635287|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154635288|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
154635289|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
154635290|NCT05087615|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154635291|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154635292|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
154635293|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635294|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635295|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154635296|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154635297|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
154635298|NCT01987102|Leucovorin|leucovorin|mesh-list
154635299|NCT01987102|Calcium|calcium|mesh-list
154248073|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
154635300|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
154635301|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154635302|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635304|NCT01987102|Protective Agents|protective agents|mesh-ancestor
154635305|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
154635306|NCT01987102|Vitamins|vitamins|mesh-ancestor
154635307|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
154635308|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154635309|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154635310|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
154635311|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635312|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
154635313|NCT03968939|Promethazine|promethazine|mesh-list
154635314|NCT03968939|Melatonin|melatonin|mesh-list
154635315|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
154635316|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635317|NCT03968939|Protective Agents|protective agents|mesh-ancestor
154635318|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635319|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635320|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154635321|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154635322|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
154635323|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
154635324|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
154635325|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635326|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
154635327|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
154635328|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154635329|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154635330|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
154635331|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
154635332|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635333|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154635334|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
154635335|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
154635336|NCT03856619|Teriflunomide|teriflunomide|mesh-list
154635337|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154635338|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154635339|NCT03856619|Analgesics|analgesics|mesh-ancestor
154635340|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
154635341|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635342|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635343|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635344|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635345|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635346|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
154635347|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
154635348|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154635349|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
154635350|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635351|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
154635352|NCT02448407|Protective Agents|protective agents|mesh-ancestor
154635353|NCT05098847|Lenvatinib|lenvatinib|mesh-list
154635354|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635355|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154635356|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635357|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635358|NCT04517357|Apatinib|apatinib|mesh-list
154635359|NCT04517357|Fluzoparib|fluzoparib|mesh-list
154635360|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635361|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154635362|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635363|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635364|NCT04517357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154635365|NCT02012296|Mifepristone|mifepristone|mesh-list
154635366|NCT02012296|Androgens|androgens|mesh-list
154635367|NCT02012296|Hormones|hormones|mesh-ancestor
154635368|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154635369|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635370|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154635371|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
154635372|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154635373|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154635374|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154635375|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154635376|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
154635377|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154635378|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154635379|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
154635380|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
154635381|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154635382|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154635383|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
154635384|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
154635385|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635386|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635387|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635388|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
154635389|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
154635390|NCT04658836|Triamcinolone|triamcinolone|mesh-list
154635391|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154635392|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154350228|NCT01198639|Propofol|propofol|mesh-list
154635393|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154635394|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635395|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
154635396|NCT04658836|Hormones|hormones|mesh-ancestor
154635397|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154635398|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635399|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635400|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
154635401|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635402|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635403|NCT01677377|Risperidone|risperidone|mesh-list
154635404|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154635405|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
154635406|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635407|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635408|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635409|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154635410|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154635411|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635412|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154635413|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154635414|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
154635415|NCT05097911|Bevacizumab|bevacizumab|mesh-list
154635416|NCT05097911|Atezolizumab|atezolizumab|mesh-list
154635417|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154635418|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635419|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154635420|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154635421|NCT05097911|Growth Substances|growth substances|mesh-ancestor
154635422|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635423|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
154635424|NCT05097911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154635425|NCT05097911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635426|NCT05097365|Folic Acid|folic acid|mesh-list
154635427|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
154635428|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
154635429|NCT05097365|Vitamins|vitamins|mesh-ancestor
154635430|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
154635431|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635432|NCT05097365|Hematinics|hematinics|mesh-ancestor
154635433|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
154635434|NCT01964716|Vaccines|vaccines|mesh-list
154635435|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154635436|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
154635437|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635438|NCT01964560|Lacosamide|lacosamide|mesh-list
154635439|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
154635440|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154635441|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154635442|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154635443|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635444|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
154635445|NCT02659943|Fludarabine|fludarabine|mesh-list
154635446|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635447|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
154635448|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635449|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635450|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154635451|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
154635452|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635453|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635454|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154635455|NCT05083325|Oseltamivir|oseltamivir|mesh-list
154635456|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
154635457|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635458|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635459|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635460|NCT01677299|Metformin|metformin|mesh-list
154635461|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154635462|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635463|NCT04999631|Ethanol|ethanol|mesh-list
154635464|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
154635465|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154635466|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635467|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635468|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635469|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154635470|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
154635471|NCT02718833|Dexamethasone|dexamethasone|mesh-list
154635472|NCT02718833|Bortezomib|bortezomib|mesh-list
154635473|NCT02718833|Pomalidomide|pomalidomide|mesh-list
154635474|NCT02718833|Elotuzumab|elotuzumab|mesh-list
154635475|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635476|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
154635477|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
154635478|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635479|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635480|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154635481|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
154635482|NCT02718833|Hormones|hormones|mesh-ancestor
154635483|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154635484|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154635485|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635486|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
154635487|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154635488|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154635489|NCT02718833|Growth Substances|growth substances|mesh-ancestor
154635490|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
154635491|NCT04908293|Listerine|listerine|mesh-list
154635492|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
154635493|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
154635494|NCT04908293|Protective Agents|protective agents|mesh-ancestor
154635495|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635496|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154635497|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635498|NCT01964326|Atorvastatin|atorvastatin|mesh-list
154635499|NCT01964326|Calcium|calcium|mesh-list
154635500|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154635501|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635502|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154635503|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154635504|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
154635505|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635506|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154635507|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154635508|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635509|NCT05102045|Memantine|memantine|mesh-list
154635510|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154635511|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154635512|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154635513|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
154635514|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635515|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635516|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635517|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154635518|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154635519|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635520|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
154635521|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
154635522|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
154635523|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154635524|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154635525|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635526|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635527|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635528|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635530|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
154635531|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
154635532|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635533|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635534|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
154635535|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635536|NCT05101811|Vitamin D|vitamin d|mesh-list
154635537|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
154635538|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
154635539|NCT05101811|Vitamins|vitamins|mesh-list
154635540|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
154635541|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635542|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154635543|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154635544|NCT04088123|Ticagrelor|ticagrelor|mesh-list
154635545|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154635546|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154635547|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154635548|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154635549|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
154635550|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635551|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635552|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635553|NCT03847181|Vitamin K|vitamin k|mesh-list
154635554|NCT03847181|Warfarin|warfarin|mesh-list
154635555|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
154635556|NCT03847181|Apixaban|apixaban|mesh-list
154635557|NCT03847181|Anticoagulants|anticoagulants|mesh-list
154635558|NCT03847181|Vitamins|vitamins|mesh-ancestor
154635559|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
154635560|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635561|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154635562|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
154635563|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154635564|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
154635565|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635566|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635567|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154635568|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154635569|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
154635570|NCT03847181|Coagulants|coagulants|mesh-ancestor
154635571|NCT03477851|Tramadol|tramadol|mesh-list
154635572|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154635573|NCT03477851|Narcotics|narcotics|mesh-ancestor
154635574|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635575|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635576|NCT03477851|Analgesics|analgesics|mesh-ancestor
154635577|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
154635578|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635579|NCT02409199|Docetaxel|docetaxel|mesh-list
154635580|NCT02409199|Apatinib|apatinib|mesh-list
154635581|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635582|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
154635583|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
154635584|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
154635585|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635586|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154635587|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635588|NCT03115489|Ketamine|ketamine|mesh-list
154635589|NCT03115489|Propofol|propofol|mesh-list
154635590|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154635591|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635592|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635593|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154635594|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
154635595|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
154635596|NCT03115489|Analgesics|analgesics|mesh-ancestor
154635597|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
154635598|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635599|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154635600|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154635601|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154635602|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635603|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635604|NCT03168997|Memantine|memantine|mesh-list
154635605|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154635606|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154635607|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
154635608|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635609|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635610|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635611|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154635612|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154635613|NCT03171727|Heparin|heparin|mesh-list
154635614|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154635615|NCT03171727|Tinzaparin|tinzaparin|mesh-list
154635616|NCT03171727|Dalteparin|dalteparin|mesh-list
154635617|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
154635618|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154635619|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154635620|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635621|NCT02400931|Rocuronium|rocuronium|mesh-list
154635622|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154635623|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154635624|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154635625|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635626|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635627|NCT03116269|Aspirin|aspirin|mesh-list
154635628|NCT03116269|Cilostazol|cilostazol|mesh-list
154635629|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154635630|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154635631|NCT03116269|Analgesics|analgesics|mesh-ancestor
154635632|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
154635633|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635634|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635635|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154635636|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635637|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154635638|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154635639|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635640|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154635641|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154635642|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635643|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
154635644|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154635645|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
154635646|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154635647|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
154635648|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
154635649|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154635650|NCT03116269|Protective Agents|protective agents|mesh-ancestor
154635651|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154635652|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154635653|NCT03174067|Clonidine|clonidine|mesh-list
154635654|NCT03174067|Buprenorphine|buprenorphine|mesh-list
154635655|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154635656|NCT03174067|Narcotics|narcotics|mesh-ancestor
154635657|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635658|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635659|NCT03174067|Analgesics|analgesics|mesh-ancestor
154635660|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
154635661|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635662|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154635663|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154635664|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
154635665|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
154635666|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154635667|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154635668|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154635669|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
154635670|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635671|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635672|NCT02408185|Colistin|colistin|mesh-list
154635673|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154635674|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635675|NCT02408419|Bupivacaine|bupivacaine|mesh-list
154635676|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
154635677|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
154635678|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635679|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635680|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
154248459|NCT00377819|Denosumab|denosumab|mesh-list
154635681|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635683|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
154635684|NCT00708097|Protective Agents|protective agents|mesh-ancestor
154635685|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635686|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154635687|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154635688|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154635689|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635690|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
154635691|NCT02405689|Remifentanil|remifentanil|mesh-list
154635692|NCT02405689|Sevoflurane|sevoflurane|mesh-list
154635693|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154635694|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635695|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635696|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154635697|NCT02405689|Analgesics|analgesics|mesh-ancestor
154635698|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
154635699|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635700|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154635701|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154635702|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154635703|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
154635704|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635705|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635706|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154635707|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154635708|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
154635709|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
154635710|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154635711|NCT02405689|Narcotics|narcotics|mesh-ancestor
154635712|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
154635713|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154635714|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154350531|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635715|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154635716|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154635717|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635718|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
154635719|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635720|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635721|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154635722|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635723|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154635724|NCT02699125|Guanfacine|guanfacine|mesh-list
154635725|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154635726|NCT02699125|Diuretics|diuretics|mesh-ancestor
154635727|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
154635728|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635729|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154635730|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154635731|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635732|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154635733|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154635734|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154635735|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
154635736|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635737|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
154635738|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
154635739|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635740|NCT04279535|Protective Agents|protective agents|mesh-ancestor
154635741|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635742|NCT04279535|Vitamins|vitamins|mesh-ancestor
154635743|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
154635744|NCT02400151|Vitamin D|vitamin d|mesh-list
154635745|NCT02400151|Vitamins|vitamins|mesh-ancestor
154635746|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
154635747|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635748|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154635749|NCT02400385|Nivolumab|nivolumab|mesh-list
154635750|NCT02400385|Sunitinib|sunitinib|mesh-list
154635751|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154635752|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635753|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154635754|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635755|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154635756|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154635757|NCT02400385|Growth Substances|growth substances|mesh-ancestor
154635758|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635759|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
154635760|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154635761|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635762|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154635763|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154635764|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154635765|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154635766|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154635767|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
154635768|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635769|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635770|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635771|NCT05100719|Mebeverine|mebeverine|mesh-list
154635772|NCT05100719|Simethicone|simethicone|mesh-list
154635773|NCT05100719|Citric Acid|citric acid|mesh-list
154635774|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
154635775|NCT05100719|Alverine|alverine|mesh-list
154635776|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
154635777|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154635778|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
154635779|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
154350600|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154635780|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635781|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
154635782|NCT05100719|Emollients|emollients|mesh-ancestor
154635783|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154635784|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
154635785|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
154635786|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635787|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635788|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
154635789|NCT05100563|Naltrexone|naltrexone|mesh-list
154635790|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154635791|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154635792|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635793|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
154635794|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635795|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
154635796|NCT05100329|Analgesics|analgesics|mesh-ancestor
154635797|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
154635798|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635799|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635800|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635801|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154635802|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154635803|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635804|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635805|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
154635806|NCT04530539|Melatonin|melatonin|mesh-list
154635807|NCT04530539|Vitamins|vitamins|mesh-ancestor
154635808|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
154635809|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635810|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
154635811|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635812|NCT04530539|Protective Agents|protective agents|mesh-ancestor
154635813|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635814|NCT02698891|Paclitaxel|paclitaxel|mesh-list
154635815|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154635816|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635817|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
154635818|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
154635819|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
154635820|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635821|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
154635822|NCT04719065|Analgesics|analgesics|mesh-ancestor
154635823|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
154635824|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635825|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635826|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635827|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154635828|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154635829|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635830|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635831|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154635832|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635833|NCT05108051|Oseltamivir|oseltamivir|mesh-list
154635834|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
154635835|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635836|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635837|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635838|NCT03765359|Metformin|metformin|mesh-list
154635839|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154635840|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635841|NCT04351295|Chloroquine|chloroquine|mesh-list
154635842|NCT04351295|Favipiravir|favipiravir|mesh-list
154635843|NCT04351295|Amebicides|amebicides|mesh-ancestor
154635844|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154635845|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154635846|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635847|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
154635848|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635849|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
154635850|NCT02399137|Paclitaxel|paclitaxel|mesh-list
154635851|NCT02399137|Gemcitabine|gemcitabine|mesh-list
154635852|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154635853|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635854|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
154635855|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
154635856|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
154635857|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635858|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154635859|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
154635860|NCT05093387|Carboplatin|carboplatin|mesh-list
154635861|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
154635862|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635863|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154635864|NCT05093387|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154635865|NCT05093387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635866|NCT02850263|Aflibercept|aflibercept|mesh-list
154635867|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154635868|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154635869|NCT02850263|Growth Substances|growth substances|mesh-ancestor
154635870|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635871|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
154635872|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635873|NCT04481815|Rituximab|rituximab|mesh-list
154635874|NCT04481815|Methotrexate|methotrexate|mesh-list
154635875|NCT04481815|Lenalidomide|lenalidomide|mesh-list
154635876|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154635877|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635878|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
154635879|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635880|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635881|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154635882|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
154635883|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154635884|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154635885|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
154635886|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635887|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154635888|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635889|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154635890|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635891|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154635892|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154635893|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154635894|NCT04481815|Growth Substances|growth substances|mesh-ancestor
154635895|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
154635896|NCT05106803|Amoxicillin|amoxicillin|mesh-list
154635897|NCT05106803|Vancomycin|vancomycin|mesh-list
154635898|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
154635899|NCT05106803|Clindamycin|clindamycin|mesh-list
154635900|NCT05106803|Gentamicins|gentamicins|mesh-list
154635901|NCT05106803|Tetracycline|tetracycline|mesh-list
154635902|NCT05106803|Penicillins|penicillins|mesh-list
154635903|NCT05106803|Erythromycin|erythromycin|mesh-list
154635904|NCT05106803|Ampicillin|ampicillin|mesh-list
154248684|NCT03409276|Vaccines|vaccines|mesh-list
154635905|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
154635906|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
154635907|NCT05106803|Cefepime|cefepime|mesh-list
154635908|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154635909|NCT05106803|Norfloxacin|norfloxacin|mesh-list
154635910|NCT05106803|Oxacillin|oxacillin|mesh-list
154635911|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
154635912|NCT05106803|Trimethoprim|trimethoprim|mesh-list
154635913|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
154635914|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154635915|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154635916|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154635917|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154635918|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154635919|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635920|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635921|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154635922|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154635923|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154635924|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154635925|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
154635926|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154635927|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154635928|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154635929|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154635930|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154635931|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154635932|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154635933|NCT02398357|Nadroparin|nadroparin|mesh-list
154635934|NCT02398357|Warfarin|warfarin|mesh-list
154635935|NCT02398357|Calcium|calcium|mesh-list
154635936|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154635937|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635938|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
154635939|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154635940|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154635941|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635942|NCT02398201|Bezafibrate|bezafibrate|mesh-list
154635943|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154635944|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
154635945|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635946|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154635947|NCT05106179|Propranolol|propranolol|mesh-list
154635948|NCT05106179|Atenolol|atenolol|mesh-list
154635949|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154635950|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154635951|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
154635952|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635953|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635954|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635955|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154635956|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154635957|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
154635958|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
154635959|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
154635960|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635961|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154635962|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
154635963|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
154635964|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154635965|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635966|NCT02406781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154635967|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635968|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154635969|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
154635970|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635971|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154635972|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154635973|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
154635974|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154635975|NCT05106023|Temozolomide|temozolomide|mesh-list
154635976|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154635977|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
154635978|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635979|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154635980|NCT02398123|Bupivacaine|bupivacaine|mesh-list
154635981|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
154635982|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
154635983|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154635984|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635985|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
154635986|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154635987|NCT02404363|Clopidogrel|clopidogrel|mesh-list
154635988|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154635989|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154635990|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154635991|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154635992|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
154635993|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154635994|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154635995|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154635996|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
154635997|NCT02404519|Vitamin K|vitamin k|mesh-list
154635998|NCT02404519|Menaquinone 7|menaquinone 7|mesh-list
154635999|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154636000|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154636001|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636002|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
154636003|NCT02404519|Coagulants|coagulants|mesh-ancestor
154636004|NCT02404519|Vitamins|vitamins|mesh-ancestor
154636005|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
154636006|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636007|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
154636008|NCT03173131|Narcotics|narcotics|mesh-ancestor
154636009|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636010|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636011|NCT03173131|Analgesics|analgesics|mesh-ancestor
154636012|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
154636013|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636014|NCT02658149|Ketorolac|ketorolac|mesh-list
154636015|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154636016|NCT02658149|Epinephrine|epinephrine|mesh-list
154636017|NCT02658149|Morphine|morphine|mesh-list
154636018|NCT02658149|Ropivacaine|ropivacaine|mesh-list
154636019|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154636020|NCT02658149|Narcotics|narcotics|mesh-ancestor
154636021|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636022|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636023|NCT02658149|Analgesics|analgesics|mesh-ancestor
154636024|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
154636025|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636026|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
154636027|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
154636028|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154350862|NCT01567111|Metomidate|metomidate|mesh-list
154636029|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154636030|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
154636031|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636032|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636033|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154636034|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154636035|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
154636036|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154636037|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
154636038|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
154636039|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
154636040|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154636041|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154636042|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636043|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636044|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636045|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154636046|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636047|NCT04481971|Prednisolone|prednisolone|mesh-list
154636048|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636049|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
154636050|NCT04481971|Hormones|hormones|mesh-ancestor
154636051|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636052|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636053|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154636054|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636055|NCT03172741|Dronabinol|dronabinol|mesh-list
154636056|NCT03172741|Cannabidiol|cannabidiol|mesh-list
154636057|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
154636058|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
154636059|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636060|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154636061|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636062|NCT03172741|Analgesics|analgesics|mesh-ancestor
154636063|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
154636064|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636065|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154636066|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154636067|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636068|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636069|NCT03172741|Hormones|hormones|mesh-ancestor
154636070|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636071|NCT02702011|Empagliflozin|empagliflozin|mesh-list
154636072|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154636073|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636074|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154636075|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636076|NCT03170713|Ibuprofen|ibuprofen|mesh-list
154636077|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154636078|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154636079|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636080|NCT03170713|Analgesics|analgesics|mesh-ancestor
154636081|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
154636082|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636083|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636084|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636085|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636086|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154636087|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636088|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636089|NCT02657369|Lenvatinib|lenvatinib|mesh-list
154636090|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636091|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154350919|NCT01125449|Vitamins|vitamins|mesh-ancestor
154636092|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636093|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636094|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
154636095|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154636096|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636097|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154636098|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636099|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
154636100|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154636101|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
154636102|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636103|NCT04832009|Protective Agents|protective agents|mesh-ancestor
154636104|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636105|NCT04832009|Vitamins|vitamins|mesh-ancestor
154636106|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
154636107|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154636108|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154636109|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154636110|NCT03129113|Metformin|metformin|mesh-list
154636111|NCT03129113|Maraviroc|maraviroc|mesh-list
154636112|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154636113|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636114|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154636115|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154636116|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636117|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154636118|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154636119|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
154636120|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636121|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154636122|NCT05105009|Furosemide|furosemide|mesh-list
154636123|NCT05105009|Diuretics|diuretics|mesh-ancestor
154636124|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
154636125|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636126|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154636127|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154636128|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636129|NCT05104931|Piroxicam|piroxicam|mesh-list
154636130|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154350979|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
154636131|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636132|NCT05104931|Analgesics|analgesics|mesh-ancestor
154636133|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
154636134|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636135|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636136|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636137|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636138|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154636139|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636140|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636141|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154636142|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154636143|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
154636144|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636145|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636146|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154636147|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
154636148|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154636149|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154636150|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154636151|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
154636152|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636153|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636154|NCT02406703|Mepivacaine|mepivacaine|mesh-list
154636155|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
154636156|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
154636157|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
154636158|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636159|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636160|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
154636161|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636162|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
154636163|NCT05110469|Meperidine|meperidine|mesh-list
154636164|NCT05110469|Analgesics|analgesics|mesh-ancestor
154636165|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
154636166|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636167|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636168|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
154636169|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636170|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154636171|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
154636172|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154636173|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154636174|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636175|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154636176|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
154636177|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154636178|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154636179|NCT05110469|Narcotics|narcotics|mesh-ancestor
154636180|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154636181|NCT02404051|Everolimus|everolimus|mesh-list
154636182|NCT02404051|Fulvestrant|fulvestrant|mesh-list
154636183|NCT02404051|Exemestane|exemestane|mesh-list
154636184|NCT02404051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154636185|NCT02404051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154636186|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636187|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636188|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154636189|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
154636190|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636191|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636192|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154636193|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154636194|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154636195|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
154636196|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636197|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154636198|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154636199|NCT05094323|Bupivacaine|bupivacaine|mesh-list
154636200|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
154636201|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
154636202|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636203|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636204|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
154636205|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636206|NCT03170323|Cyclosporine|cyclosporine|mesh-list
154636207|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
154636208|NCT03170323|Cyclosporins|cyclosporins|mesh-list
154636209|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636210|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636211|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154636212|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
154636213|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636214|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
154636215|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636216|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
154636217|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636218|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154636219|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154636220|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636221|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154636222|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
154636223|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154636224|NCT02396563|Ropivacaine|ropivacaine|mesh-list
154636225|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
154636226|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
154636227|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636228|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636229|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
154636230|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636231|NCT05109377|Tadalafil|tadalafil|mesh-list
154636232|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
154636233|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154636234|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154636235|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636236|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636237|NCT05109377|Urological Agents|urological agents|mesh-ancestor
154636238|NCT05109299|Fluorides|fluorides|mesh-list
154636239|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
154636240|NCT05109299|Protective Agents|protective agents|mesh-ancestor
154636241|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636242|NCT05108597|Misoprostol|misoprostol|mesh-list
154636243|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154636244|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
154636245|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154636246|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636247|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154636248|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154636249|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
154636250|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
154636251|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
154636252|NCT02396329|Povidone|povidone|mesh-list
154636253|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154636254|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636255|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
154636256|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
154636257|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
154636258|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
154636259|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154636260|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636261|NCT03168139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154636262|NCT03168139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636263|NCT02395783|Melatonin|melatonin|mesh-list
154636264|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
154636265|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636266|NCT02395783|Protective Agents|protective agents|mesh-ancestor
154636267|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636268|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636269|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
154636270|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154636271|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154636272|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636273|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
154636274|NCT04555343|Coagulants|coagulants|mesh-ancestor
154636275|NCT04528667|Abivertinib|abivertinib|mesh-list
154636276|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636277|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636278|NCT04528667|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154636279|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154249072|NCT00398567|Trastuzumab|trastuzumab|mesh-list
154636280|NCT04309877|Theophylline|theophylline|mesh-list
154636281|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154636283|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636284|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636285|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154636286|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
154636287|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154636288|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636289|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636290|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
154636291|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154636292|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154636293|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
154636294|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636295|NCT04367909|Carboplatin|carboplatin|mesh-list
154636296|NCT04367909|Docetaxel|docetaxel|mesh-list
154636297|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
154636298|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636299|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
154636300|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
154636301|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
154636302|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636303|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154636304|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
154636305|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154636306|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
154351135|NCT05665075|Cytarabine|cytarabine|mesh-list
154636307|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154636308|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636309|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154636310|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154636311|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154636312|NCT04196075|Andrographolide|andrographolide|mesh-list
154636313|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636314|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154636315|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636316|NCT04196075|Analgesics|analgesics|mesh-ancestor
154636317|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
154636318|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636319|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636320|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636321|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154636322|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154636323|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636324|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
154636325|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154636326|NCT03863483|Docetaxel|docetaxel|mesh-list
154636327|NCT03863483|Pemetrexed|pemetrexed|mesh-list
154636328|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636329|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
154636330|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
154636331|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
154636332|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636333|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636334|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154636335|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154636336|NCT03830411|Docetaxel|docetaxel|mesh-list
154636337|NCT03830411|Pemetrexed|pemetrexed|mesh-list
154636338|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636339|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
154636340|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
154636341|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
154636342|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636343|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636344|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154636345|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154636346|NCT03300479|Urapidil|urapidil|mesh-list
154636347|NCT03300479|Clevidipine|clevidipine|mesh-list
154636348|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154636349|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154636350|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636351|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154636352|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636353|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154636354|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
154636355|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154636356|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
154636357|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636358|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154636359|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154636360|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154636361|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
154636362|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
154636363|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636364|NCT03540875|Remifentanil|remifentanil|mesh-list
154636365|NCT03540875|Propofol|propofol|mesh-list
154636366|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
154636367|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636368|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636369|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154636370|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154636371|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
154636372|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154636373|NCT03540875|Narcotics|narcotics|mesh-ancestor
154636374|NCT03540875|Analgesics|analgesics|mesh-ancestor
154636375|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
154636376|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636377|NCT03536507|Acetazolamide|acetazolamide|mesh-list
154636378|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
154636379|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154636380|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636381|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636382|NCT03536507|Diuretics|diuretics|mesh-ancestor
154636383|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
154636384|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636385|NCT04765787|Acetaminophen|acetaminophen|mesh-list
154636386|NCT04765787|Orphenadrine|orphenadrine|mesh-list
154636387|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636388|NCT04765787|Analgesics|analgesics|mesh-ancestor
154636389|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
154636390|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636391|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636392|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
154636393|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154636394|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154636395|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154636396|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154636397|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
154636398|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
154636399|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154636400|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154636401|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
154636402|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636403|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636404|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154636405|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154636406|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636407|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
154636408|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
154636409|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636410|NCT05115149|Protective Agents|protective agents|mesh-ancestor
154636411|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636412|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154636413|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636414|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154636415|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636416|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
154636417|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
154636418|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154636419|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154636420|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636421|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
154636422|NCT04521881|Coagulants|coagulants|mesh-ancestor
154636423|NCT04305899|Deucravacitinib|deucravacitinib|mesh-list
154636424|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
154636425|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154636426|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636427|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636428|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
154249216|NCT05840822|Anticonvulsants|anticonvulsants|mesh-ancestor
154636429|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154636431|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636432|NCT01675661|Expectorants|expectorants|mesh-ancestor
154636433|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
154636434|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154636435|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
154636436|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636437|NCT01675661|Protective Agents|protective agents|mesh-ancestor
154636438|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636439|NCT01675661|Antidotes|antidotes|mesh-ancestor
154636440|NCT05113511|Bevacizumab|bevacizumab|mesh-list
154636441|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154636442|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636443|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154636444|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154636445|NCT05113511|Growth Substances|growth substances|mesh-ancestor
154636446|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636447|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
154636448|NCT04161989|Progesterone|progesterone|mesh-list
154636449|NCT04161989|Progestins|progestins|mesh-ancestor
154636450|NCT04161989|Hormones|hormones|mesh-ancestor
154636451|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636452|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636453|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
154636454|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154636455|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
154636456|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636457|NCT01986010|Antacids|antacids|mesh-ancestor
154636458|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636459|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154636460|NCT04160117|Colchicine|colchicine|mesh-list
154636461|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
154636462|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636463|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
154636464|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
154636465|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
154636466|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636467|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636468|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154636469|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154636470|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154636471|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
154636472|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636473|NCT03115255|Ranibizumab|ranibizumab|mesh-list
154636474|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154636475|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154636476|NCT03115255|Growth Substances|growth substances|mesh-ancestor
154636477|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636478|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
154636479|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636480|NCT02009878|Tolvaptan|tolvaptan|mesh-list
154636481|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154636482|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636483|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
154636484|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636485|NCT02009722|Morphine|morphine|mesh-list
154636486|NCT02009722|Hydromorphone|hydromorphone|mesh-list
154636487|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154636488|NCT02009722|Narcotics|narcotics|mesh-ancestor
154636489|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636490|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636491|NCT02009722|Analgesics|analgesics|mesh-ancestor
154636492|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
154636493|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636494|NCT02655419|Metronidazole|metronidazole|mesh-list
154636495|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636496|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154636497|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154636498|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154636499|NCT01962922|Tacrolimus|tacrolimus|mesh-list
154636500|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154636501|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
154636502|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636503|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154636504|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636505|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636506|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
154636507|NCT04198961|Narcotics|narcotics|mesh-ancestor
154636508|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636509|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636510|NCT04198961|Analgesics|analgesics|mesh-ancestor
154636511|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
154636512|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636513|NCT01984684|Vancomycin|vancomycin|mesh-list
154636514|NCT01984684|Aztreonam|aztreonam|mesh-list
154636515|NCT01984684|Delafloxacin|delafloxacin|mesh-list
154636516|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154636517|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636518|NCT02694523|Adalimumab|adalimumab|mesh-list
154636519|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154636520|NCT02694523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154636521|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636522|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636523|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
154636524|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636525|NCT05038475|Antibodies|antibodies|mesh-list
154636526|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
154636527|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636528|NCT02009332|Sirolimus|sirolimus|mesh-list
154636529|NCT02009332|Gemcitabine|gemcitabine|mesh-list
154636530|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154636531|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
154636532|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636533|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636534|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154636535|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636536|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154636537|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
154636538|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154636539|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
154636540|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636541|NCT01984294|Ribavirin|ribavirin|mesh-list
154636542|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
154636543|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636544|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
154636545|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636546|NCT03170479|Vitamin D|vitamin d|mesh-list
154636547|NCT03170479|Vitamins|vitamins|mesh-ancestor
154636548|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
154636549|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636550|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154636551|NCT01962298|Rocuronium|rocuronium|mesh-list
154636552|NCT01962298|Neostigmine|neostigmine|mesh-list
154636553|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154636554|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154636555|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154636556|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636557|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636558|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154636559|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636560|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636561|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
154636562|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636563|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154636564|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
154636565|NCT03169933|Androgens|androgens|mesh-list
154636566|NCT03169933|Hormones|hormones|mesh-ancestor
154636567|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636568|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636569|NCT02403349|Atenolol|atenolol|mesh-list
154636570|NCT02403349|Valsartan|valsartan|mesh-list
154636571|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154636572|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154636573|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154636574|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636575|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154636576|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
154636577|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
154636578|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249368|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
154636579|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636580|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154636581|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154636582|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154636583|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
154636584|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636585|NCT04735822|Belumosudil|belumosudil|mesh-list
154636586|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154636587|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636588|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636589|NCT01982812|Levetiracetam|levetiracetam|mesh-list
154636590|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
154636591|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
154636592|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
154636593|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154636594|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636595|NCT02007070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154636596|NCT02007070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636597|NCT03906617|Dexamethasone|dexamethasone|mesh-list
154636598|NCT03906617|Epinephrine|epinephrine|mesh-list
154636599|NCT03906617|Bupivacaine|bupivacaine|mesh-list
154636600|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636601|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
154636602|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
154636603|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636604|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636605|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154636606|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
154636607|NCT03906617|Hormones|hormones|mesh-ancestor
154636608|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636609|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154636610|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636611|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
154636612|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
154636613|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636614|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
154636615|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154636616|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154636617|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
154636618|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636619|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636620|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154636621|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154636622|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154636623|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
154636624|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
154636625|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
154636626|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154636627|NCT04655482|Aflibercept|aflibercept|mesh-list
154636628|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154636629|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154636630|NCT04655482|Growth Substances|growth substances|mesh-ancestor
154636631|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636632|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
154636633|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636634|NCT02184767|Loxapine|loxapine|mesh-list
154636635|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154636636|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154636637|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636638|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636639|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154636640|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154636641|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
154636642|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636643|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636644|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
154636645|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154636646|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154636647|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
154636648|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636649|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636650|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636651|NCT01981954|Urological Agents|urological agents|mesh-ancestor
154636652|NCT05120687|Cyclosporine|cyclosporine|mesh-list
154636653|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
154636654|NCT05120687|Adalimumab|adalimumab|mesh-list
154636655|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
154636656|NCT05120687|Methotrexate|methotrexate|mesh-list
154636657|NCT05120687|Cyclosporins|cyclosporins|mesh-list
154636658|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154636659|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
154636660|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636661|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636662|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154636663|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
154636664|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636665|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636666|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154636667|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154636668|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
154636669|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154636670|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154636671|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
154636672|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
154636673|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636674|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154636675|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154636676|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
154636677|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636678|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154636679|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154636680|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154636681|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
154636682|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154636683|NCT05120687|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154636684|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636685|NCT03416855|Insulin|insulin|mesh-list
154636686|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
154636687|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154636688|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636689|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154636690|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154636691|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636692|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154636693|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154636694|NCT05121233|Diclofenac|diclofenac|mesh-list
154636695|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154636696|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636697|NCT05121233|Analgesics|analgesics|mesh-ancestor
154636698|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
154636699|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636700|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636701|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636702|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636703|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154636704|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636705|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636706|NCT06121401|Bevacizumab|bevacizumab|mesh-list
154636707|NCT06121401|Olaparib|olaparib|mesh-list
154636708|NCT06121401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154636709|NCT06121401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636710|NCT06121401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154636711|NCT06121401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154636712|NCT06121401|Growth Substances|growth substances|mesh-ancestor
154636713|NCT06121401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636714|NCT06121401|Growth Inhibitors|growth inhibitors|mesh-ancestor
154636715|NCT06121401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154636716|NCT06121401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636717|NCT06121401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636718|NCT06121284|Cycloserine|cycloserine|mesh-list
154636719|NCT06121284|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154636720|NCT06121284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636721|NCT06121284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154636722|NCT06121284|Antitubercular Agents|antitubercular agents|mesh-ancestor
154636723|NCT06121284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154636724|NCT06121284|Antimetabolites|antimetabolites|mesh-ancestor
154636725|NCT06121284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636726|NCT06121245|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154636727|NCT06121245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860322|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154249522|NCT03252756|Cannabidiol|cannabidiol|mesh-list
154636728|NCT06121245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636730|NCT06121180|Cemiplimab|cemiplimab|mesh-list
154636731|NCT06121180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154636732|NCT06121180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154636733|NCT06121180|Growth Substances|growth substances|mesh-ancestor
154636734|NCT06121180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636735|NCT06121180|Growth Inhibitors|growth inhibitors|mesh-ancestor
154636736|NCT06121180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636737|NCT06121180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154636738|NCT06121141|Lidocaine|lidocaine|mesh-list
154636739|NCT06121141|Epinephrine|epinephrine|mesh-list
154636740|NCT06121141|Racepinephrine|racepinephrine|mesh-list
154636741|NCT06121141|Epinephryl borate|epinephryl borate|mesh-list
154636742|NCT06121141|Anesthetics, Local|anesthetics, local|mesh-ancestor
154636743|NCT06121141|Anesthetics|anesthetics|mesh-ancestor
154636744|NCT06121141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636745|NCT06121141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636746|NCT06121141|Sensory System Agents|sensory system agents|mesh-ancestor
154636747|NCT06121141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636748|NCT06121141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154636749|NCT06121141|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154636750|NCT06121141|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154636751|NCT06121141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154636752|NCT06121141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636753|NCT06121141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154636754|NCT06121141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154636755|NCT06121141|Adrenergic Agents|adrenergic agents|mesh-ancestor
154636756|NCT06121141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636757|NCT06121141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154636758|NCT06121141|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154636759|NCT06121141|Autonomic Agents|autonomic agents|mesh-ancestor
154636760|NCT06121141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154636761|NCT06121141|Respiratory System Agents|respiratory system agents|mesh-ancestor
154636762|NCT06121141|Mydriatics|mydriatics|mesh-ancestor
154636763|NCT06121141|Sympathomimetics|sympathomimetics|mesh-ancestor
154636764|NCT06121141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154636765|NCT06121115|Norepinephrine|norepinephrine|mesh-list
154636766|NCT06121115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154636767|NCT06121115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154636768|NCT06121115|Adrenergic Agents|adrenergic agents|mesh-ancestor
154636769|NCT06121115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154636770|NCT06121115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636771|NCT06121115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636772|NCT06121115|Sympathomimetics|sympathomimetics|mesh-ancestor
154636773|NCT06121115|Autonomic Agents|autonomic agents|mesh-ancestor
154636774|NCT06121115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636775|NCT06121115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154636776|NCT06120673|Prednisolone|prednisolone|mesh-list
154636777|NCT06120673|Cyclophosphamide|cyclophosphamide|mesh-list
154636778|NCT06120673|Obinutuzumab|obinutuzumab|mesh-list
154636779|NCT06120673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154636780|NCT06120673|Immunologic Factors|immunologic factors|mesh-ancestor
154636781|NCT06120673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636782|NCT06120673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636783|NCT06120673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154636784|NCT06120673|Alkylating Agents|alkylating agents|mesh-ancestor
154636785|NCT06120673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636786|NCT06120673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636787|NCT06120673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154636788|NCT06120673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636789|NCT06120673|Glucocorticoids|glucocorticoids|mesh-ancestor
154636790|NCT06120673|Hormones|hormones|mesh-ancestor
154636791|NCT06120673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636792|NCT06120673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154636793|NCT06120673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154636794|NCT06120530|Bupivacaine|bupivacaine|mesh-list
154636795|NCT06120530|Anesthetics, Local|anesthetics, local|mesh-ancestor
154636796|NCT06120530|Anesthetics|anesthetics|mesh-ancestor
154636797|NCT06120530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636798|NCT06120530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636799|NCT06120530|Sensory System Agents|sensory system agents|mesh-ancestor
154636800|NCT06120530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636801|NCT06120439|Anesthetics|anesthetics|mesh-list
154636802|NCT06120439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636803|NCT06120439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636804|NCT06120374|Immunomodulating Agents|immunomodulating agents|mesh-list
154636805|NCT06120374|Immunologic Factors|immunologic factors|mesh-ancestor
154636806|NCT06120374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636807|NCT06120127|Antibodies|antibodies|mesh-list
154636808|NCT06120127|Immunologic Factors|immunologic factors|mesh-ancestor
154636809|NCT06120127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636810|NCT06120088|Dexamethasone|dexamethasone|mesh-list
154636811|NCT06120088|Fentanyl|fentanyl|mesh-list
154636812|NCT06120088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636813|NCT06120088|Antiemetics|antiemetics|mesh-ancestor
154636814|NCT06120088|Autonomic Agents|autonomic agents|mesh-ancestor
154636815|NCT06120088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636816|NCT06120088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636817|NCT06120088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154636818|NCT06120088|Glucocorticoids|glucocorticoids|mesh-ancestor
154636819|NCT06120088|Hormones|hormones|mesh-ancestor
154351636|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154636820|NCT06120088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636821|NCT06120088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154636822|NCT06120088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636823|NCT06120088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154636824|NCT06120088|Narcotics|narcotics|mesh-ancestor
154636825|NCT06120088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636826|NCT06120088|Analgesics|analgesics|mesh-ancestor
154636827|NCT06120088|Sensory System Agents|sensory system agents|mesh-ancestor
154636828|NCT06120088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154636829|NCT06120088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154636830|NCT06120088|Anesthetics, General|anesthetics, general|mesh-ancestor
154636831|NCT06120088|Anesthetics|anesthetics|mesh-ancestor
154636832|NCT06120036|Deoxycholic Acid|deoxycholic acid|mesh-list
154636833|NCT06120036|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154636834|NCT06120036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154636835|NCT06119880|Pancreatin|pancreatin|mesh-list
154636836|NCT06119880|Pancrelipase|pancrelipase|mesh-list
154636837|NCT06119880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154636838|NCT06119789|Imatinib Mesylate|imatinib mesylate|mesh-list
154636839|NCT06119789|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154636840|NCT06119789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154636841|NCT06119789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636842|NCT06119789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636843|NCT06119789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636844|NCT06119763|Antibodies|antibodies|mesh-list
154636845|NCT06119763|Immunologic Factors|immunologic factors|mesh-ancestor
154636846|NCT06119763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636847|NCT06119750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154636848|NCT06119672|Clobetasol|clobetasol|mesh-list
154636849|NCT06119672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636850|NCT06119672|Glucocorticoids|glucocorticoids|mesh-ancestor
154636851|NCT06119672|Hormones|hormones|mesh-ancestor
154636852|NCT06119672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636853|NCT06119672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636854|NCT06119126|Fluorides|fluorides|mesh-list
154636855|NCT06119126|Cariostatic Agents|cariostatic agents|mesh-ancestor
154636856|NCT06119126|Protective Agents|protective agents|mesh-ancestor
154636857|NCT06119126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636858|NCT06115356|Vitamin D|vitamin d|mesh-list
154636859|NCT06115356|Vitamins|vitamins|mesh-ancestor
154636860|NCT06115356|Micronutrients|micronutrients|mesh-ancestor
154636861|NCT06115356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636862|NCT06115356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154636863|NCT06114719|Silymarin|silymarin|mesh-list
154636864|NCT06114719|Antioxidants|antioxidants|mesh-ancestor
154636865|NCT06114719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636866|NCT06114719|Protective Agents|protective agents|mesh-ancestor
154636867|NCT06114719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636868|NCT06077916|Azithromycin|azithromycin|mesh-list
154636869|NCT06077916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154636870|NCT06077916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636871|NCT06076707|Tramadol|tramadol|mesh-list
154636872|NCT06076707|Bupivacaine|bupivacaine|mesh-list
154636873|NCT06076707|Anesthetics, Local|anesthetics, local|mesh-ancestor
154636874|NCT06076707|Anesthetics|anesthetics|mesh-ancestor
154636875|NCT06076707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636876|NCT06076707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636877|NCT06076707|Sensory System Agents|sensory system agents|mesh-ancestor
154351706|NCT03817411|Capecitabine|capecitabine|mesh-list
154636878|NCT06076707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636879|NCT06076707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154636880|NCT06076707|Narcotics|narcotics|mesh-ancestor
154636881|NCT06076707|Analgesics|analgesics|mesh-ancestor
154636882|NCT06054529|Niacinamide|niacinamide|mesh-list
154636883|NCT06054529|Vitamin B Complex|vitamin b complex|mesh-ancestor
154636885|NCT06054529|Micronutrients|micronutrients|mesh-ancestor
154636886|NCT06054529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636887|NCT06050512|Dexamethasone|dexamethasone|mesh-list
154636888|NCT06050512|Ixazomib|ixazomib|mesh-list
154636889|NCT06050512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636890|NCT06050512|Antiemetics|antiemetics|mesh-ancestor
154636891|NCT06050512|Autonomic Agents|autonomic agents|mesh-ancestor
154636892|NCT06050512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636893|NCT06050512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636894|NCT06050512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154636895|NCT06050512|Glucocorticoids|glucocorticoids|mesh-ancestor
154636896|NCT06050512|Hormones|hormones|mesh-ancestor
154636897|NCT06050512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154636898|NCT06050512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154636899|NCT06050512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636900|NCT06050512|Protease Inhibitors|protease inhibitors|mesh-ancestor
154636901|NCT06050512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636902|NCT06050512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636903|NCT05891587|Semaglutide|semaglutide|mesh-list
154636904|NCT05891587|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154636905|NCT05891587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154636906|NCT05891587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636907|NCT05842044|Acetaminophen|acetaminophen|mesh-list
154636908|NCT05842044|Ibuprofen|ibuprofen|mesh-list
154636909|NCT05842044|Ketorolac|ketorolac|mesh-list
154636910|NCT05842044|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154636911|NCT05842044|Oxycodone|oxycodone|mesh-list
154636912|NCT05842044|Hydromorphone|hydromorphone|mesh-list
154636913|NCT05842044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636914|NCT05842044|Analgesics|analgesics|mesh-ancestor
154636915|NCT05842044|Sensory System Agents|sensory system agents|mesh-ancestor
154636916|NCT05842044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636917|NCT05842044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636918|NCT05842044|Antipyretics|antipyretics|mesh-ancestor
154636919|NCT05842044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154636920|NCT05842044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636921|NCT05842044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636922|NCT05842044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154636923|NCT05842044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636924|NCT05842044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636925|NCT05842044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154636926|NCT05842044|Narcotics|narcotics|mesh-ancestor
154636927|NCT05842044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636928|NCT05785585|Vitamin B 12|vitamin b 12|mesh-list
154636929|NCT05785585|Hydroxocobalamin|hydroxocobalamin|mesh-list
154636930|NCT05785585|Vitamin B Complex|vitamin b complex|mesh-ancestor
154636931|NCT05785585|Vitamins|vitamins|mesh-ancestor
154636932|NCT05785585|Micronutrients|micronutrients|mesh-ancestor
154636933|NCT05785585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636934|NCT05785585|Hematinics|hematinics|mesh-ancestor
154636935|NCT05778760|Vitamin A|vitamin a|mesh-list
154636936|NCT05778760|Vitamins|vitamins|mesh-ancestor
154636937|NCT05778760|Micronutrients|micronutrients|mesh-ancestor
154636938|NCT05778760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636939|NCT05667116|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154636940|NCT05667116|Antiviral Agents|antiviral agents|mesh-ancestor
154636941|NCT05667116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636942|NCT05634525|Adagrasib|adagrasib|mesh-list
154636943|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636944|NCT05594147|Sorafenib|sorafenib|mesh-list
154636945|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636946|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154636947|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636948|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636949|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154636950|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154636951|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154636952|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154636953|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636954|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636955|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
154636956|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636957|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154636958|NCT05591105|Acetaminophen|acetaminophen|mesh-list
154636959|NCT05591105|Dipyrone|dipyrone|mesh-list
154636960|NCT05591105|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154636961|NCT05591105|Morphine|morphine|mesh-list
154636962|NCT05591105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154636963|NCT05591105|Narcotics|narcotics|mesh-ancestor
154636964|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154636965|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154636966|NCT05591105|Analgesics|analgesics|mesh-ancestor
154636967|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
154636968|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154636969|NCT05591105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154636970|NCT05591105|Antipyretics|antipyretics|mesh-ancestor
154636971|NCT05591105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154636972|NCT05591105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154636973|NCT05591105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154636974|NCT05583006|Tenofovir|tenofovir|mesh-list
154636975|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
154636976|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154636977|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154636978|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154636979|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636980|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636981|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154636982|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154636983|NCT05567601|Doxorubicin|doxorubicin|mesh-list
154636984|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154636985|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154636986|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154636987|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154636988|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154636989|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636990|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636991|NCT05558007|Tadalafil|tadalafil|mesh-list
154636992|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
154636993|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154636994|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154636995|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154636996|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154636997|NCT05558007|Urological Agents|urological agents|mesh-ancestor
154636998|NCT05497726|Bevacizumab|bevacizumab|mesh-list
154636999|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637000|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637001|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154637002|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154637003|NCT05497726|Growth Substances|growth substances|mesh-ancestor
154637004|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637005|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
154637006|NCT05494060|Capecitabine|capecitabine|mesh-list
154637007|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
154637008|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154637009|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
154351822|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154637010|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637011|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637012|NCT05478707|Dulaglutide|dulaglutide|mesh-list
154637013|NCT05478707|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154637014|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154637015|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637016|NCT05469347|Alirocumab|alirocumab|mesh-list
154637017|NCT05469347|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154637018|NCT05469347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154637019|NCT05469347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154637020|NCT05469347|Antimetabolites|antimetabolites|mesh-ancestor
154637021|NCT05469347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637022|NCT05469347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154637023|NCT05469347|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637024|NCT05469347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637025|NCT05469347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154637026|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
154637027|NCT05462938|Propofol|propofol|mesh-list
154637028|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154637029|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637030|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637031|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637032|NCT05462938|Analgesics|analgesics|mesh-ancestor
154637033|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
154637034|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637035|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154637036|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154637037|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154637038|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
154637039|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637040|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637041|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154637042|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
154637044|NCT05456542|Dexamethasone|dexamethasone|mesh-list
154637045|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637046|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
154637047|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
154637048|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637049|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637050|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154637051|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
154637052|NCT05456542|Hormones|hormones|mesh-ancestor
154637053|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637054|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637055|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637056|NCT05445921|Mepivacaine|mepivacaine|mesh-list
154637057|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
154637058|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
154637059|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637060|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637061|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
154351892|NCT00741988|Bevacizumab|bevacizumab|mesh-list
154637062|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637063|NCT05444478|Lenvatinib|lenvatinib|mesh-list
154637064|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637065|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154637066|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637067|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637068|NCT05384665|Sufentanil|sufentanil|mesh-list
154637069|NCT05384665|Remifentanil|remifentanil|mesh-list
154637070|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154637071|NCT05384665|Narcotics|narcotics|mesh-ancestor
154637072|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637073|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637074|NCT05384665|Analgesics|analgesics|mesh-ancestor
154637075|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
154637076|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637077|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154637078|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154637079|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
154637080|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
154637081|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154637082|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637083|NCT05350696|Morphine|morphine|mesh-list
154637084|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154637085|NCT05350696|Narcotics|narcotics|mesh-ancestor
154637086|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637087|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637088|NCT05350696|Analgesics|analgesics|mesh-ancestor
154637089|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
154637090|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637091|NCT05336266|Ketorolac|ketorolac|mesh-list
154637092|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154637093|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154637094|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637095|NCT05336266|Analgesics|analgesics|mesh-ancestor
154637096|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
154637097|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637098|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637099|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637100|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154637101|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154637102|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637103|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637104|NCT05321394|Ritonavir|ritonavir|mesh-list
154637105|NCT05321394|Nirmatrelvir|nirmatrelvir|mesh-list
154637106|NCT05321394|Sotrovimab|sotrovimab|mesh-list
154637107|NCT05321394|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154637109|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154637110|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637111|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637112|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637113|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154637114|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154637115|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
154637116|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154637117|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154637118|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154637119|NCT05157698|Naltrexone|naltrexone|mesh-list
154637120|NCT05157698|Bupropion|bupropion|mesh-list
154637121|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154637122|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154637123|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637124|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
154637125|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637126|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154637127|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
154637128|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154637129|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154637130|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154637131|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154637132|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637133|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
154637134|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637135|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154637136|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154637137|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637138|NCT05111314|Edetic Acid|edetic acid|mesh-list
154637139|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154637140|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
154637141|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
154637142|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637143|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
154637144|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154637145|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154637146|NCT05073835|Semaglutide|semaglutide|mesh-list
154637147|NCT05073835|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154637148|NCT05073835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154637149|NCT05073835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637150|NCT05067933|Vaccines|vaccines|mesh-list
154637151|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
154637152|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637153|NCT05058677|Lidocaine|lidocaine|mesh-list
154637154|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
154637155|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
154637156|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637157|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637158|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
154637159|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637160|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154637161|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154637162|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154637163|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154637164|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637165|NCT05052307|Vaccines|vaccines|mesh-list
154637166|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
154637167|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637168|NCT05040971|Semaglutide|semaglutide|mesh-list
154637169|NCT05040971|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154637170|NCT05040971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154637171|NCT05040971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637172|NCT05004662|Nicotine|nicotine|mesh-list
154637173|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154637174|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
154637175|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637176|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637177|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154637178|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154637179|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
154637180|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637181|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637182|NCT04979780|Heparin|heparin|mesh-list
154637183|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154637184|NCT04979780|Tinzaparin|tinzaparin|mesh-list
154637185|NCT04979780|Dalteparin|dalteparin|mesh-list
154637186|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
154637187|NCT04979780|Anticoagulants|anticoagulants|mesh-list
154637188|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154637189|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154637190|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637191|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154637192|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
154637193|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154637194|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637195|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637196|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
154637197|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154637198|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
154637199|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637200|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637201|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154637202|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
154637203|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154637204|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
154637205|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637206|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637207|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154637208|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
154637209|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
154637210|NCT04972513|Protective Agents|protective agents|mesh-ancestor
154637211|NCT04972110|Olaparib|olaparib|mesh-list
154637212|NCT04972110|Niraparib|niraparib|mesh-list
154637213|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154637214|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637215|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637216|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637217|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
154637218|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154637219|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637220|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637221|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637222|NCT04824144|Analgesics|analgesics|mesh-ancestor
154637223|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
154352061|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154637224|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637225|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154637226|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154637227|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154637228|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
154637229|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637230|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637231|NCT04817410|Naltrexone|naltrexone|mesh-list
154637232|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154637233|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154637234|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637235|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
154637236|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637237|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
154637238|NCT04816877|Narcotics|narcotics|mesh-ancestor
154637239|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637240|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637241|NCT04816877|Analgesics|analgesics|mesh-ancestor
154637242|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
154637243|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637244|NCT04795531|Insulin|insulin|mesh-list
154637245|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154637246|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
154637247|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154637248|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637249|NCT04765267|Vitamin D|vitamin d|mesh-list
154637250|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
154637251|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
154637252|NCT04765267|Vitamins|vitamins|mesh-ancestor
154637253|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
154637254|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637255|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154637256|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154637257|NCT04765267|Astringents|astringents|mesh-ancestor
154637258|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154637259|NCT04725383|Amitriptyline|amitriptyline|mesh-list
154637260|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154637261|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
154637262|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154637263|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637264|NCT04725383|Analgesics|analgesics|mesh-ancestor
154637265|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
154637266|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637267|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637268|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154637269|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154637270|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154637271|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637272|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
154637273|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637274|NCT04718389|Benralizumab|benralizumab|mesh-list
154637275|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154637276|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
154637277|NCT04677816|Vitamin D|vitamin d|mesh-list
154637278|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
154637279|NCT04677816|Vitamins|vitamins|mesh-ancestor
154637280|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
154637281|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637282|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154637283|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154637284|NCT04597697|Insulin|insulin|mesh-list
154637285|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154637286|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637287|NCT04566653|Calcium|calcium|mesh-list
154637288|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
154637289|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154637290|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637291|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
154637292|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
154637293|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637294|NCT04484350|Enalapril|enalapril|mesh-list
154637295|NCT04484350|Labetalol|labetalol|mesh-list
154637296|NCT04484350|Hydralazine|hydralazine|mesh-list
154637297|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154637298|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637299|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637300|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637301|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154637302|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154637303|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154637304|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
154637305|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637306|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637307|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
154637308|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
154637309|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637310|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154637311|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154637312|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
154637313|NCT04481113|Niraparib|niraparib|mesh-list
154637314|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154637315|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637316|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637317|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637318|NCT04271202|Erenumab|erenumab|mesh-list
154637319|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154637320|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637321|NCT04271202|Analgesics|analgesics|mesh-ancestor
154637322|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
154637323|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637324|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637325|NCT04253964|Paclitaxel|paclitaxel|mesh-list
154637326|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154637327|NCT04253964|Carboplatin|carboplatin|mesh-list
154637328|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
154637329|NCT04253964|Pemetrexed|pemetrexed|mesh-list
154637330|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154637331|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637332|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
154637333|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
154637334|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
154637335|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637336|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637337|NCT04253964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154637338|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637339|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154637340|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154637341|NCT04221451|Venglustat|venglustat|mesh-list
154637342|NCT04221451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637343|NCT04221451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637344|NCT04200313|Pancrelipase|pancrelipase|mesh-list
154637345|NCT04200313|Pancreatin|pancreatin|mesh-list
154637346|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154637347|NCT04184609|Albuterol|albuterol|mesh-list
154637348|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154637349|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
154637350|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637351|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637352|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154637353|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
154637354|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
154637355|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154637356|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154637357|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154637358|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154637359|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154637360|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637361|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637362|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
154637363|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154637364|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
154637365|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154637366|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637367|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637368|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637369|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
154637370|NCT04055844|Decitabine|decitabine|mesh-list
154637371|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154637372|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
154637373|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637374|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637375|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637376|NCT04053322|Durvalumab|durvalumab|mesh-list
154637377|NCT04053322|Fulvestrant|fulvestrant|mesh-list
154637378|NCT04053322|Olaparib|olaparib|mesh-list
154637379|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637380|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637381|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637382|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154637383|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154637384|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
154637385|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637386|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637387|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154637388|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637389|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637390|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154637391|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637392|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637393|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
154637394|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154637395|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154637396|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154637397|NCT03751800|Dienogest|dienogest|mesh-list
154637398|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
154637399|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
154637400|NCT03751800|Estradiol|estradiol|mesh-list
154637401|NCT03751800|Estrogens|estrogens|mesh-ancestor
154637402|NCT03751800|Hormones|hormones|mesh-ancestor
154637403|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637404|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637405|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154637406|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
154637407|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154637408|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154637409|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154637410|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154637411|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154637412|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154637413|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637414|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637415|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
154637416|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
154637417|NCT03613727|Vitamins|vitamins|mesh-ancestor
154637418|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
154637419|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637420|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
154637421|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637422|NCT03613727|Protective Agents|protective agents|mesh-ancestor
154637423|NCT03582930|Calfactant|calfactant|mesh-list
154637424|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154637425|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154637426|NCT03555149|Bevacizumab|bevacizumab|mesh-list
154637427|NCT03555149|Atezolizumab|atezolizumab|mesh-list
154637428|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637429|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637430|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154637431|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154637432|NCT03555149|Growth Substances|growth substances|mesh-ancestor
154637433|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637434|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
154637435|NCT03555149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154637436|NCT03555149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637437|NCT03530267|Aflibercept|aflibercept|mesh-list
154637438|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154637439|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154637440|NCT03530267|Growth Substances|growth substances|mesh-ancestor
154637441|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637442|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
154637443|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637444|NCT03463265|Sirolimus|sirolimus|mesh-list
154637445|NCT03463265|Bevacizumab|bevacizumab|mesh-list
154637446|NCT03463265|Temozolomide|temozolomide|mesh-list
154637447|NCT03463265|Temsirolimus|temsirolimus|mesh-list
154637448|NCT03463265|Lomustine|lomustine|mesh-list
154637449|NCT03463265|MTOR Inhibitors|mtor inhibitors|mesh-list
154637450|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637451|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637452|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154637453|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154637454|NCT03463265|Growth Substances|growth substances|mesh-ancestor
154637455|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637456|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
154637457|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154637458|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
154637459|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637460|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154637461|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154637462|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154637463|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
154637464|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154637465|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
154637466|NCT03463265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154637467|NCT03463265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637468|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
154637469|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154637470|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154637471|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154637472|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154637473|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637474|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
154637475|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637476|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637477|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154637478|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637479|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154637480|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637481|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
154637482|NCT03453931|Hormones|hormones|mesh-ancestor
154637483|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637484|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637485|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154637486|NCT03453931|Protective Agents|protective agents|mesh-ancestor
154637487|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637488|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637489|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154637490|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637491|NCT03289741|Octreotide|octreotide|mesh-list
154637492|NCT03289741|Lanreotide|lanreotide|mesh-list
154637493|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154637494|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637495|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637496|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
154637497|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154637498|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
154637499|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154637500|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637501|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637502|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637503|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
154637504|NCT02911142|Prednisone|prednisone|mesh-list
154637505|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
154637506|NCT02911142|Rituximab|rituximab|mesh-list
154637507|NCT02911142|Doxorubicin|doxorubicin|mesh-list
154637508|NCT02911142|Vincristine|vincristine|mesh-list
154637509|NCT02911142|Lenalidomide|lenalidomide|mesh-list
154637510|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154637511|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
154637512|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637513|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154637514|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154637515|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
154637516|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637517|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637518|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154637519|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637520|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154637521|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154637522|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154637523|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637524|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637525|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
154637526|NCT02911142|Hormones|hormones|mesh-ancestor
154637527|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637528|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637529|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154637530|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
154637531|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
154637532|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
154637533|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154637534|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154637535|NCT02911142|Growth Substances|growth substances|mesh-ancestor
154637536|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
154637537|NCT02864758|Vitamin K|vitamin k|mesh-list
154637538|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
154637539|NCT02864758|Dabigatran|dabigatran|mesh-list
154637540|NCT02864758|Vitamins|vitamins|mesh-ancestor
154637541|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
154637542|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637543|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154637544|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
154637545|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154637546|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637547|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637548|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637549|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
154637550|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154637551|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154637552|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
154637553|NCT02864758|Coagulants|coagulants|mesh-ancestor
154637554|NCT02834975|Paclitaxel|paclitaxel|mesh-list
154637555|NCT02834975|Carboplatin|carboplatin|mesh-list
154637556|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
154637557|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154637558|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637559|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
154637560|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
154637561|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
154637562|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637563|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637564|NCT02834975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154637565|NCT02822508|Laxatives|laxatives|mesh-list
154637566|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154637567|NCT02755272|Carboplatin|carboplatin|mesh-list
154637568|NCT02755272|Gemcitabine|gemcitabine|mesh-list
154637569|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
154637570|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637571|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154637572|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
154637573|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637574|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637575|NCT02755272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154637576|NCT02684123|Apremilast|apremilast|mesh-list
154637577|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154637578|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637579|NCT02684123|Analgesics|analgesics|mesh-ancestor
154637580|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
154637581|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637582|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637583|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637584|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154637585|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154637586|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154637587|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352401|NCT01132235|Analgesics|analgesics|mesh-ancestor
154637588|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637589|NCT02606448|Bupivacaine|bupivacaine|mesh-list
154637590|NCT02606448|Ropivacaine|ropivacaine|mesh-list
154637591|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
154637592|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
154637593|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637594|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637595|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
154637596|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637597|NCT02584309|Doxorubicin|doxorubicin|mesh-list
154637598|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154637599|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
154637600|NCT02584309|Razoxane|razoxane|mesh-list
154637601|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154637602|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637603|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154637604|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154637605|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637606|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637607|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154637608|NCT02584309|Protective Agents|protective agents|mesh-ancestor
154637609|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637610|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
154637611|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
154637612|NCT02229656|Olaparib|olaparib|mesh-list
154637613|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154637614|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637615|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637616|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637617|NCT02207465|Paclitaxel|paclitaxel|mesh-list
154637618|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154637619|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154637620|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637621|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
154637622|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
154637623|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
154637624|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637625|NCT02203331|Anastrozole|anastrozole|mesh-list
154637626|NCT02203331|Leuprolide|leuprolide|mesh-list
154637627|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
154637628|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637629|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637630|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154637631|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154637632|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637633|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637634|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154637635|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
154637636|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637637|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637638|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154637639|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
154637640|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154637641|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154637642|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
154637643|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154637644|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154637645|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154637646|NCT02178436|Paclitaxel|paclitaxel|mesh-list
154637647|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154637648|NCT02178436|Gemcitabine|gemcitabine|mesh-list
154637649|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154637650|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637651|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154637652|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154637653|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154352463|NCT03919565|Tenofovir|tenofovir|mesh-list
154637654|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637655|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154637656|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
154637657|NCT02170025|Riociguat|riociguat|mesh-list
154637658|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
154637659|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637660|NCT02164578|Aspirin|aspirin|mesh-list
154637661|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
154637662|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154637663|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637664|NCT02164578|Analgesics|analgesics|mesh-ancestor
154637665|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
154637666|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637667|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637668|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637669|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154637670|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154637671|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154637672|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637673|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154637674|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154637675|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637676|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
154637677|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154637678|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
154637679|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154637680|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637681|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
154637682|NCT01823198|Aldesleukin|aldesleukin|mesh-list
154637683|NCT01823198|Fludarabine|fludarabine|mesh-list
154637684|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
154637685|NCT01823198|Busulfan|busulfan|mesh-list
154637686|NCT01823198|Interleukin-2|interleukin-2|mesh-list
154637687|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637688|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154637689|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
154637690|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637691|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154637692|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
154637693|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637694|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
154637695|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154637696|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154637697|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637698|NCT01823198|Analgesics|analgesics|mesh-ancestor
154637699|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
154637700|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637701|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154637702|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154637703|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
154637704|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154637705|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154637706|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154637707|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637708|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637710|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154637711|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637712|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154637713|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154637714|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637715|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154637716|NCT01725113|Vitamins|vitamins|mesh-ancestor
154637717|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
154637718|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154637719|NCT01580293|Factor VIII|factor viii|mesh-list
154637720|NCT01580293|Coagulants|coagulants|mesh-ancestor
154637721|NCT01089933|Anesthetics|anesthetics|mesh-list
154637722|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
154637723|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637724|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637725|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
154637726|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637727|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
154637728|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154637729|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154637730|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
154637731|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637732|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637733|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154637734|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
154637735|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
154637736|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154637737|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
154637738|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637739|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637740|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154637741|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154637742|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154637743|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
154637744|NCT05745259|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154637745|NCT05745259|Tenecteplase|tenecteplase|mesh-list
154637746|NCT05745259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154637747|NCT05745259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154637748|NCT05745259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637749|NCT02893241|Cafedrine|cafedrine|mesh-list
154637750|NCT02893241|Theodrenaline|theodrenaline|mesh-list
154637751|NCT02893241|Ephedrine|ephedrine|mesh-list
154637752|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154637753|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637754|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
154637755|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
154637756|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637757|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154637758|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
154637759|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637760|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637761|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154637762|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
154637763|NCT02395237|Glimepiride|glimepiride|mesh-list
154637764|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154637765|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154637766|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637767|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154637768|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
154637769|NCT02394847|Propofol|propofol|mesh-list
154637770|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154637771|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154637772|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637773|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154637774|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
154637775|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
154637776|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
154637777|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154637778|NCT05021861|Estradiol|estradiol|mesh-list
154352590|NCT03918551|Febuxostat|febuxostat|mesh-list
154637779|NCT05021861|Cyproterone|cyproterone|mesh-list
154637780|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
154637781|NCT05021861|Estrogens|estrogens|mesh-ancestor
154637782|NCT05021861|Hormones|hormones|mesh-ancestor
154637783|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637784|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637785|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154637786|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
154637787|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154637788|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154637789|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154637790|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154637791|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
154637792|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
154637793|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637794|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154637795|NCT02403037|Dexamethasone|dexamethasone|mesh-list
154637796|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
154637797|NCT02403037|Antiemetics|antiemetics|mesh-list
154637798|NCT02403037|Emetics|emetics|mesh-list
154637799|NCT02403037|BB 1101|bb 1101|mesh-list
154637800|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637801|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
154637802|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637803|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637804|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154637805|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
154637806|NCT02403037|Hormones|hormones|mesh-ancestor
154637807|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637808|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637809|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637810|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637811|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637812|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637813|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
154637814|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154637815|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637816|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154637817|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154637818|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
154637819|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154637820|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
154637821|NCT04480333|Remdesivir|remdesivir|mesh-list
154637822|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
154637823|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154637824|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
154637825|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637826|NCT04480333|Protective Agents|protective agents|mesh-ancestor
154637827|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637828|NCT03166891|Chiauranib|chiauranib|mesh-list
154637829|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637830|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154637831|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637832|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637833|NCT01980940|Etoricoxib|etoricoxib|mesh-list
154637834|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154637835|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154637836|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637837|NCT01980940|Analgesics|analgesics|mesh-ancestor
154637838|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
154637839|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637840|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637841|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637842|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154637843|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154637844|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154637845|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637846|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637847|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154637848|NCT01980940|Protective Agents|protective agents|mesh-ancestor
154637849|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154637850|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
154637851|NCT01960114|Acetaminophen|acetaminophen|mesh-list
154637852|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154637853|NCT01960114|Analgesics|analgesics|mesh-ancestor
154637854|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
154637855|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637856|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637857|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
154637858|NCT04752527|Sorafenib|sorafenib|mesh-list
154637859|NCT04752527|Venetoclax|venetoclax|mesh-list
154637860|NCT04752527|Decitabine|decitabine|mesh-list
154637861|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637862|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154637863|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637864|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637865|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154637866|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
154637867|NCT05229497|Carboplatin|carboplatin|mesh-list
154637868|NCT05229497|Fluorouracil|fluorouracil|mesh-list
154637869|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637870|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
154637871|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637872|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154637873|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154637874|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
154637875|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637876|NCT03169777|Leucovorin|leucovorin|mesh-list
154637877|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
154637878|NCT03169777|Bevacizumab|bevacizumab|mesh-list
154637879|NCT03169777|Capecitabine|capecitabine|mesh-list
154637880|NCT03169777|Nivolumab|nivolumab|mesh-list
154637881|NCT03169777|Fluorouracil|fluorouracil|mesh-list
154637882|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
154637883|NCT03169777|Cetuximab|cetuximab|mesh-list
154637884|NCT03169777|Fulvestrant|fulvestrant|mesh-list
154637885|NCT03169777|Avelumab|avelumab|mesh-list
154637886|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637887|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637888|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154637889|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
154637890|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637891|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154637892|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154637893|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
154637894|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154637895|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154637896|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154637897|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154637898|NCT03169777|Growth Substances|growth substances|mesh-ancestor
154637899|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
154637900|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154637901|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
154637902|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154637903|NCT03169777|Antidotes|antidotes|mesh-ancestor
154352729|NCT05402189|Fentanyl|fentanyl|mesh-list
154637904|NCT03169777|Protective Agents|protective agents|mesh-ancestor
154637905|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
154637906|NCT03169777|Vitamins|vitamins|mesh-ancestor
154637907|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
154637908|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637909|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154637910|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154637911|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
154637912|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637913|NCT01980706|Baclofen|baclofen|mesh-list
154637914|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154637915|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637916|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154637917|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637918|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154637919|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
154637920|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
154637921|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637922|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637923|NCT02092571|Progesterone|progesterone|mesh-list
154637924|NCT02092571|Progestins|progestins|mesh-ancestor
154637925|NCT02092571|Hormones|hormones|mesh-ancestor
154637926|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637927|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637928|NCT02402725|Dexamethasone|dexamethasone|mesh-list
154637929|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
154637930|NCT02402725|BB 1101|bb 1101|mesh-list
154637931|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637932|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
154637933|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
154637934|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154637935|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637936|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154637937|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
154637938|NCT02402725|Hormones|hormones|mesh-ancestor
154637939|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637940|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154637941|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637942|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
154637943|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637944|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637945|NCT02394145|Clopidogrel|clopidogrel|mesh-list
154637946|NCT02394145|Ticagrelor|ticagrelor|mesh-list
154637947|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154637948|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154637949|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154637950|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154637951|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
154637952|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154637953|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637954|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637955|NCT02004886|Metformin|metformin|mesh-list
154637956|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154637957|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637958|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
154637959|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154637960|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154637961|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
154637962|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154637963|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154637964|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
154637965|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
154637966|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154637967|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154637968|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
154637969|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
154637970|NCT04255277|Charcoal|charcoal|mesh-list
154637971|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154637972|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154637973|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154637974|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154637975|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637976|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637977|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154637978|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154637979|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154637980|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154637981|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154637982|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154637983|NCT04255277|Antidotes|antidotes|mesh-ancestor
154637984|NCT04255277|Protective Agents|protective agents|mesh-ancestor
154637985|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154637986|NCT04255277|Estrogens|estrogens|mesh-ancestor
154637987|NCT04255277|Hormones|hormones|mesh-ancestor
154637988|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154637989|NCT01980628|Ibrutinib|ibrutinib|mesh-list
154637990|NCT01980628|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154637991|NCT01980628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154637992|NCT01980628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154637993|NCT01980628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154637994|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154637995|NCT04435925|Fentanyl|fentanyl|mesh-list
154637996|NCT04435925|Remifentanil|remifentanil|mesh-list
154637997|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154637998|NCT04435925|Narcotics|narcotics|mesh-ancestor
154637999|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638000|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638001|NCT04435925|Analgesics|analgesics|mesh-ancestor
154638002|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
154638003|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638004|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154638005|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154638006|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
154638007|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
154638008|NCT03648281|Semaglutide|semaglutide|mesh-list
154638009|NCT03648281|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154638010|NCT03648281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638011|NCT03648281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638012|NCT04649476|Cisplatin|cisplatin|mesh-list
154638013|NCT04649476|Docetaxel|docetaxel|mesh-list
154638014|NCT04649476|Fluorouracil|fluorouracil|mesh-list
154638015|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638016|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
154638017|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
154638018|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
154638019|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638020|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
154638021|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154638022|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154638023|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
154638024|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638025|NCT05117957|Sorafenib|sorafenib|mesh-list
154638026|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638027|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154638028|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352838|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154638029|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638030|NCT03251729|Progesterone|progesterone|mesh-list
154638031|NCT03251729|Progestins|progestins|mesh-ancestor
154638032|NCT03251729|Hormones|hormones|mesh-ancestor
154638033|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638034|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638035|NCT02696785|Adalimumab|adalimumab|mesh-list
154638036|NCT02696785|Ixekizumab|ixekizumab|mesh-list
154638037|NCT02696785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154638038|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638039|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638040|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154638041|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
154638042|NCT02004262|Pancrelipase|pancrelipase|mesh-list
154638043|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154638044|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
154638045|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638046|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638047|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154638048|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
154638049|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638050|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638051|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154638052|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154638053|NCT02393599|Cocaine|cocaine|mesh-list
154638054|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
154638055|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
154638056|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638057|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638058|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
154638059|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638060|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154638061|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154638062|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154638063|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154638064|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638065|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
154638066|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638067|NCT02402491|Aspirin|aspirin|mesh-list
154638068|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
154638069|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154638070|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638071|NCT02402491|Analgesics|analgesics|mesh-ancestor
154638072|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
154638073|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638074|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638075|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638076|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638077|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154638078|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154638079|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638080|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154638081|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154638082|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638083|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
154638084|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154638085|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154250870|NCT01112540|Morphine|morphine|mesh-list
154638086|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
154638087|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638088|NCT02402413|Androgens|androgens|mesh-list
154638089|NCT02402413|Hormones|hormones|mesh-ancestor
154638090|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638091|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638092|NCT02393443|Oxytocin|oxytocin|mesh-list
154638093|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
154638094|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154638095|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638096|NCT01977898|Morphine|morphine|mesh-list
154638097|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154638098|NCT01977898|Narcotics|narcotics|mesh-ancestor
154638099|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638100|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638101|NCT01977898|Analgesics|analgesics|mesh-ancestor
154638102|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
154638103|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638104|NCT02003638|Niacin|niacin|mesh-list
154638105|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154638106|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
154638107|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638108|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154638109|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
154638110|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
154638111|NCT02003638|Vitamins|vitamins|mesh-ancestor
154638112|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
154638113|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638114|NCT02402179|Tryptophan|tryptophan|mesh-list
154638115|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154638116|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
154638117|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154638118|NCT02401945|Aflibercept|aflibercept|mesh-list
154638119|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154638120|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154638121|NCT02401945|Growth Substances|growth substances|mesh-ancestor
154638122|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638123|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
154638124|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638125|NCT02003014|Pioglitazone|pioglitazone|mesh-list
154638126|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638127|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638128|NCT01977352|Bupivacaine|bupivacaine|mesh-list
154638129|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
154638130|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
154638131|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638132|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638133|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
154638134|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638135|NCT03166111|Lidocaine|lidocaine|mesh-list
154638136|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154638137|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
154638138|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638139|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638140|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
154638141|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638142|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154638143|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154638144|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154638145|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154638146|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638147|NCT05117021|Bupivacaine|bupivacaine|mesh-list
154638148|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
154638149|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
154638150|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638151|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638152|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
154352966|NCT01232075|Letrozole|letrozole|mesh-list
154638153|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638154|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154638155|NCT02392117|Insulin|insulin|mesh-list
154638156|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638157|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638158|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
154638159|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
154638160|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154638161|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154638163|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638164|NCT02812433|Urological Agents|urological agents|mesh-ancestor
154638165|NCT02392039|Loratadine|loratadine|mesh-list
154638166|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
154638167|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
154638168|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154638169|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154638170|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154638171|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
154638172|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
154638173|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638174|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638175|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638176|NCT03106363|Ethanol|ethanol|mesh-list
154638177|NCT03106363|Dronabinol|dronabinol|mesh-list
154638178|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154638179|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638180|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638181|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638182|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
154638183|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154638184|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638185|NCT03106363|Analgesics|analgesics|mesh-ancestor
154638186|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
154638187|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638188|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154638189|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154638190|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638191|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638192|NCT03106363|Hormones|hormones|mesh-ancestor
154638193|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638194|NCT03106519|Bupivacaine|bupivacaine|mesh-list
154638195|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
154638196|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
154638197|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638198|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638199|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
154638200|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638201|NCT02687815|Vitamin D|vitamin d|mesh-list
154638202|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
154638203|NCT02687815|Vitamins|vitamins|mesh-ancestor
154638204|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
154638205|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638206|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154638207|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154638208|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
154638209|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154638210|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638211|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
154638212|NCT01959334|Glucagon|glucagon|mesh-list
154638213|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154638214|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154638215|NCT01959334|Hormones|hormones|mesh-ancestor
154638216|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638217|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638218|NCT01959334|Incretins|incretins|mesh-ancestor
154638219|NCT01958476|Morphine|morphine|mesh-list
154638220|NCT01958476|Methadone|methadone|mesh-list
154638221|NCT01958476|Phenobarbital|phenobarbital|mesh-list
154638222|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154638223|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154638224|NCT01958476|Narcotics|narcotics|mesh-ancestor
154638225|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638226|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638227|NCT01958476|Analgesics|analgesics|mesh-ancestor
154638228|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
154638229|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638230|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
154638231|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
154638232|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
154638233|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154638234|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154638235|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154638236|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638237|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638239|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
154638240|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154638241|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154638242|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154638243|NCT04809181|Azacitidine|azacitidine|mesh-list
154638244|NCT04809181|Venetoclax|venetoclax|mesh-list
154638245|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154638246|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
154638247|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638248|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638249|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638250|NCT01057121|Lenalidomide|lenalidomide|mesh-list
154638251|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
154638252|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638253|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154638254|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154638255|NCT01057121|Growth Substances|growth substances|mesh-ancestor
154638256|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
154638257|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638258|NCT02695537|Cannabidiol|cannabidiol|mesh-list
154638259|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
154638260|NCT04620941|Chrysarobin|chrysarobin|mesh-list
154638261|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154638262|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638263|NCT04620941|Analgesics|analgesics|mesh-ancestor
154638264|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
154638265|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353100|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154638266|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638267|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638268|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638269|NCT04615871|Semaglutide|semaglutide|mesh-list
154638270|NCT04615871|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154638271|NCT04615871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638272|NCT04615871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638273|NCT04746989|Allopurinol|allopurinol|mesh-list
154638274|NCT04746989|Probenecid|probenecid|mesh-list
154638275|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
154638276|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638277|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638278|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
154638279|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638280|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154638281|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
154638282|NCT04746989|Protective Agents|protective agents|mesh-ancestor
154638283|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638284|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
154638285|NCT04671953|Metformin|metformin|mesh-list
154638286|NCT04671953|Deucravacitinib|deucravacitinib|mesh-list
154638287|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638288|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638289|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
154638290|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154638291|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638292|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638293|NCT04585061|Lidocaine|lidocaine|mesh-list
154638294|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
154638295|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
154638296|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638297|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638298|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
154638299|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638300|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154638301|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154638302|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154638303|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154638304|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638305|NCT03874091|Epinephrine|epinephrine|mesh-list
154638306|NCT03874091|Racepinephrine|racepinephrine|mesh-list
154638307|NCT03874091|Morphine|morphine|mesh-list
154638308|NCT03874091|Bupivacaine|bupivacaine|mesh-list
154251097|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
154638309|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
154638310|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
154638311|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
154638312|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638313|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638314|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
154638315|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638316|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154638317|NCT03874091|Narcotics|narcotics|mesh-ancestor
154638318|NCT03874091|Analgesics|analgesics|mesh-ancestor
154638319|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154638320|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154638321|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
154638322|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638323|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638324|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154638325|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154638326|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
154638327|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154638328|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
154638329|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
154638330|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
154638331|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154638332|NCT01362491|Ibuprofen|ibuprofen|mesh-list
154638333|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154638334|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638335|NCT01362491|Analgesics|analgesics|mesh-ancestor
154638336|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
154638337|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638338|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638339|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638340|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638341|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154638342|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638343|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638344|NCT03560297|Nitrazepam|nitrazepam|mesh-list
154638345|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
154638346|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154638347|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638348|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638349|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154638350|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154638351|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154638352|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
154638353|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
154638354|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638355|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638356|NCT04122287|Levofloxacin|levofloxacin|mesh-list
154638357|NCT04122287|Tinidazole|tinidazole|mesh-list
154638358|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154638359|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638360|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154638361|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154638362|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154638363|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638364|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638365|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638366|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154638367|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154638368|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
154638369|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154638370|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154638371|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154638372|NCT05746351|Fentanyl|fentanyl|mesh-list
154638373|NCT05746351|Dexmedetomidine|dexmedetomidine|mesh-list
154638374|NCT05746351|Nalbuphine|nalbuphine|mesh-list
154638375|NCT05746351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154638376|NCT05746351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638377|NCT05746351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638378|NCT05746351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638379|NCT05746351|Analgesics|analgesics|mesh-ancestor
154638380|NCT05746351|Sensory System Agents|sensory system agents|mesh-ancestor
154638381|NCT05746351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638382|NCT05746351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154638383|NCT05746351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154638384|NCT05746351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154251172|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
154638385|NCT05746351|Adrenergic Agents|adrenergic agents|mesh-ancestor
154638386|NCT05746351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638387|NCT05746351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638388|NCT05746351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154638390|NCT05746351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154638391|NCT05746351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154638392|NCT05746351|Anesthetics, General|anesthetics, general|mesh-ancestor
154638393|NCT05746351|Anesthetics|anesthetics|mesh-ancestor
154638394|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
154638395|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154638396|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154638397|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638398|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638399|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638400|NCT05403281|Incretins|incretins|mesh-ancestor
154638401|NCT05403281|Hormones|hormones|mesh-ancestor
154638402|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638403|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154638404|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
154638405|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638406|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154638407|NCT03115099|Liraglutide|liraglutide|mesh-list
154638408|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638409|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638410|NCT03115099|Incretins|incretins|mesh-ancestor
154638411|NCT03115099|Hormones|hormones|mesh-ancestor
154638412|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638413|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154638414|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
154638415|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638416|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638417|NCT03115099|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154638418|NCT03165097|ACT-709478|act-709478|mesh-list
154638419|NCT03165097|Midazolam|midazolam|mesh-list
154638420|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154638421|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154638422|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638423|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638424|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154638425|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154638426|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154638427|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154638428|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
154638429|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
154638430|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
154638431|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
154638432|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638433|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638434|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154638435|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154638436|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154638437|NCT03165409|Nivolumab|nivolumab|mesh-list
154638438|NCT03165409|Ipilimumab|ipilimumab|mesh-list
154638439|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154638440|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638441|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154638442|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638443|NCT05403125|Listerine|listerine|mesh-list
154638444|NCT05403125|Fluorides|fluorides|mesh-list
154638445|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
154638446|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
154638447|NCT05403125|Protective Agents|protective agents|mesh-ancestor
154638448|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638449|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154638450|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638451|NCT05701423|Natalizumab|natalizumab|mesh-list
154638452|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
154638453|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638454|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
154638455|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
154638456|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154638457|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154638458|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638459|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638460|NCT02795351|Urological Agents|urological agents|mesh-ancestor
154638461|NCT05403047|Tenofovir|tenofovir|mesh-list
154638462|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
154638463|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638464|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154638465|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154638466|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638467|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638468|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154638469|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154638470|NCT03927443|Bimatoprost|bimatoprost|mesh-list
154638471|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154638472|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
154638473|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154638474|NCT05124353|Protective Agents|protective agents|mesh-ancestor
154638475|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638476|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
154638477|NCT03805841|Bromides|bromides|mesh-list
154638478|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
154638479|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
154638480|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154638481|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638482|NCT02684617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154638483|NCT02684617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638484|NCT01999972|Axitinib|axitinib|mesh-list
154638485|NCT01999972|Crizotinib|crizotinib|mesh-list
154638486|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638487|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154638488|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638489|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638490|NCT01999972|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154638491|NCT04055389|Antithrombins|antithrombins|mesh-list
154638492|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
154638493|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154638494|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
154638495|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638496|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638497|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
154638498|NCT05697055|Ritonavir|ritonavir|mesh-list
154638499|NCT05697055|Nirmatrelvir|nirmatrelvir|mesh-list
154638500|NCT05697055|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154638501|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154638502|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154638503|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
154353328|NCT05332821|Bevacizumab|bevacizumab|mesh-list
154638504|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638505|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638506|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154638507|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154638508|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
154638509|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638510|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154638511|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154638512|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
154638513|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154638514|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154638515|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638516|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154638517|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154638518|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
154638519|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154638520|NCT01999894|Memantine|memantine|mesh-list
154638521|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154638522|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154638523|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
154638524|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638525|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638526|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638527|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154638528|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154638529|NCT01976806|Aspirin|aspirin|mesh-list
154638530|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154638531|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638532|NCT01976806|Analgesics|analgesics|mesh-ancestor
154251323|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
154638533|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
154638534|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638535|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638536|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638537|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638538|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154638539|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154638540|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638541|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154638542|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154638543|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638544|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
154638545|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154638546|NCT01976728|Hormones|hormones|mesh-ancestor
154638547|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638548|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638549|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154638550|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154638551|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638552|NCT02689219|Immunotoxins|immunotoxins|mesh-ancestor
154638553|NCT02689219|Immunoconjugates|immunoconjugates|mesh-ancestor
154638554|NCT02689219|Immunologic Factors|immunologic factors|mesh-ancestor
154638555|NCT02689219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638556|NCT03165253|Amoxicillin|amoxicillin|mesh-list
154638557|NCT03165253|Clarithromycin|clarithromycin|mesh-list
154638558|NCT03165253|Omeprazole|omeprazole|mesh-list
154638559|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154638560|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638561|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154638562|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154638563|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154638564|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638565|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638566|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154353387|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154638567|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154638568|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154638569|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154638570|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154638571|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638572|NCT03161977|Mannitol|mannitol|mesh-list
154638573|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154638574|NCT03161977|Diuretics|diuretics|mesh-ancestor
154638575|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
154638576|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638577|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154638578|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638579|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638580|NCT02683525|Incretins|incretins|mesh-ancestor
154638581|NCT02683525|Hormones|hormones|mesh-ancestor
154638582|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638583|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154638584|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
154638585|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638586|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638587|NCT01976338|Ranibizumab|ranibizumab|mesh-list
154638588|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154638589|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154638590|NCT01976338|Growth Substances|growth substances|mesh-ancestor
154638591|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638592|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
154638593|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638594|NCT02651987|Lanreotide|lanreotide|mesh-list
154638595|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638596|NCT05115773|Anesthetics|anesthetics|mesh-list
154638597|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638598|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638599|NCT04657939|Pioglitazone|pioglitazone|mesh-list
154638600|NCT04657939|Liraglutide|liraglutide|mesh-list
154638601|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154638602|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638603|NCT04657939|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154638604|NCT04657939|Incretins|incretins|mesh-ancestor
154638605|NCT04657939|Hormones|hormones|mesh-ancestor
154638606|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638607|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
154638608|NCT01999114|Naltrexone|naltrexone|mesh-list
154638609|NCT01999114|Buprenorphine|buprenorphine|mesh-list
154638610|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154638611|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154638612|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638613|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154353447|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638614|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154638615|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638616|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638617|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638618|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154638619|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
154638620|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154638621|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638622|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154638623|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154638624|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154638625|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154638627|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638628|NCT01999114|Analgesics|analgesics|mesh-ancestor
154638629|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
154638630|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638631|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154638632|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154638633|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154638634|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154638635|NCT04503161|Estradiol|estradiol|mesh-list
154638636|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154638637|NCT04503161|Estrogens|estrogens|mesh-ancestor
154638638|NCT04503161|Hormones|hormones|mesh-ancestor
154638639|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638640|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638641|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154638642|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
154638643|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154638644|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154638645|NCT02214407|Decitabine|decitabine|mesh-list
154638646|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
154638647|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154638648|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
154638649|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638650|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638651|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638652|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
154638653|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154638654|NCT02261285|Nivolumab|nivolumab|mesh-list
154638655|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154638656|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638657|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154638658|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638659|NCT01288625|Amifostine|amifostine|mesh-list
154638660|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154638661|NCT01288625|Protective Agents|protective agents|mesh-ancestor
154638662|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638663|NCT01374451|Everolimus|everolimus|mesh-list
154638664|NCT01374451|Pasireotide|pasireotide|mesh-list
154638665|NCT01374451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154638666|NCT01374451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154638667|NCT01374451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638668|NCT01374451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638669|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154638670|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
154638671|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638672|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638673|NCT01374451|Hormones|hormones|mesh-ancestor
154638674|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638675|NCT02674399|Hylan|hylan|mesh-list
154638676|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
154638677|NCT02674399|Protective Agents|protective agents|mesh-ancestor
154638678|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638679|NCT03161509|Acetaminophen|acetaminophen|mesh-list
154638680|NCT03161509|Lamotrigine|lamotrigine|mesh-list
154638681|NCT03161509|Carbamazepine|carbamazepine|mesh-list
154638682|NCT03161509|Phenytoin|phenytoin|mesh-list
154638683|NCT03161509|Valproic Acid|valproic acid|mesh-list
154638684|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
154638685|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638686|NCT03161509|Analgesics|analgesics|mesh-ancestor
154638687|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
154638688|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638689|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638690|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
154638691|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154638692|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154638693|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638694|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154638695|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154638696|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154638697|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638698|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154638699|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154638700|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638701|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
154638702|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638703|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
154638704|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154638705|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154638706|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154638707|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154638708|NCT02676895|Vaccines|vaccines|mesh-list
154638709|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
154638710|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638711|NCT04440085|Midodrine|midodrine|mesh-list
154638712|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
154638713|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
154638714|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638715|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638716|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154638717|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154638718|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154638719|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154638720|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
154638721|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638722|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638723|NCT05129033|Omalizumab|omalizumab|mesh-list
154638724|NCT05129033|Itraconazole|itraconazole|mesh-list
154638725|NCT05129033|Prednisone|prednisone|mesh-list
154638726|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638727|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
154638728|NCT05129033|Hormones|hormones|mesh-ancestor
154638729|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638730|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638731|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154638732|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638733|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
154638734|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638735|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154638736|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154638737|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638738|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638739|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154638740|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
154638741|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154638742|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154638743|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154638744|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
154638745|NCT05128721|Vaccines|vaccines|mesh-list
154638746|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
154638747|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638748|NCT05128175|Levodopa|levodopa|mesh-list
154638749|NCT05128175|Carbidopa|carbidopa|mesh-list
154638750|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154638751|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154638752|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154638753|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
154638754|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638755|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638756|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860323|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
154251540|NCT03985865|Analgesics|analgesics|mesh-ancestor
154251617|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638757|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154638758|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638759|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154638760|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
154638761|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
154638762|NCT04184453|Deferiprone|deferiprone|mesh-list
154638763|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154638764|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
154638765|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
154638766|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638767|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
154638768|NCT05127707|Narcotics|narcotics|mesh-ancestor
154638769|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638770|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638771|NCT05127707|Analgesics|analgesics|mesh-ancestor
154638772|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
154638773|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638774|NCT00719225|Abatacept|abatacept|mesh-list
154638775|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154638776|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638777|NCT00719225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154638778|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638779|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154638780|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
154638781|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638782|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638783|NCT05134337|Itraconazole|itraconazole|mesh-list
154638784|NCT05134337|Rifampin|rifampin|mesh-list
154638785|NCT05134337|Pirtobrutinib|pirtobrutinib|mesh-list
154638786|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
154638787|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638788|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154638789|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154638790|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638791|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638792|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154638793|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
154638794|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638795|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638796|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154638797|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154638798|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
154638799|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154638800|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
154638801|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154638802|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154638803|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154638804|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154638805|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154638806|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154638807|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154638808|NCT05134337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154638809|NCT05134337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154638810|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154638811|NCT04499495|Mesalamine|mesalamine|mesh-list
154638812|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154638813|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638814|NCT04499495|Analgesics|analgesics|mesh-ancestor
154638815|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
154638816|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638817|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638818|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638819|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638820|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
154638821|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154638822|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638823|NCT05323175|Ropivacaine|ropivacaine|mesh-list
154638824|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
154638825|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
154638826|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638827|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638828|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
154638829|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638830|NCT05279963|Amitriptyline|amitriptyline|mesh-list
154638831|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154638832|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
154638833|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154638834|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638835|NCT05279963|Analgesics|analgesics|mesh-ancestor
154638836|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
154638837|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638838|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638839|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154638840|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154638841|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154638842|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638843|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
154638844|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638845|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
154638846|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154638847|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154638848|NCT05133635|Prednisolone|prednisolone|mesh-list
154638849|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
154638850|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154638851|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
154638852|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638853|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
154638854|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
154638855|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638856|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638857|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154638858|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
154638859|NCT05133635|Hormones|hormones|mesh-ancestor
154638860|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638861|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154638862|NCT05133635|Protective Agents|protective agents|mesh-ancestor
154638863|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154638864|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638865|NCT05132777|Osimertinib|osimertinib|mesh-list
154638866|NCT05132777|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154638867|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154638868|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638869|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638870|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638871|NCT05422027|Dexamethasone|dexamethasone|mesh-list
154638872|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
154638873|NCT05422027|Lenalidomide|lenalidomide|mesh-list
154638874|NCT05422027|Bortezomib|bortezomib|mesh-list
154638875|NCT05422027|BB 1101|bb 1101|mesh-list
154638876|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638877|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
154638878|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
154638879|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638880|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638881|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154638882|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
154638883|NCT05422027|Hormones|hormones|mesh-ancestor
154638884|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638885|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154638886|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638887|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
154638888|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638889|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638890|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
154638891|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154638892|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154638893|NCT05422027|Growth Substances|growth substances|mesh-ancestor
154638894|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
154638895|NCT01674725|Ribavirin|ribavirin|mesh-list
154638896|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
154638897|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638898|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
154638899|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638900|NCT05404061|Hormones|hormones|mesh-list
154251690|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154638901|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860324|NCT02847559|Antibodies|antibodies|mesh-list
154638902|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638903|NCT03161041|Bevacizumab|bevacizumab|mesh-list
154638904|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
154638905|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154638906|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638907|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154638908|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154638909|NCT03161041|Growth Substances|growth substances|mesh-ancestor
154638910|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638911|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
154638912|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
154638913|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154638914|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154638915|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638916|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154638917|NCT03163693|Analgesics|analgesics|mesh-ancestor
154638918|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
154638919|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638920|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154638921|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154638922|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154353773|NCT03708861|Ritonavir|ritonavir|mesh-list
154638923|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154638924|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638925|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638927|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154638928|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
154638929|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
154638930|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638931|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638932|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154638933|NCT05030545|Diuretics|diuretics|mesh-ancestor
154638934|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
154638935|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154638936|NCT05030545|Hormones|hormones|mesh-ancestor
154638937|NCT03164161|Endorphins|endorphins|mesh-list
154638938|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154638939|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638940|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638941|NCT00754949|Azithromycin|azithromycin|mesh-list
154638942|NCT00754949|Dexamethasone|dexamethasone|mesh-list
154638943|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
154638944|NCT00754949|BB 1101|bb 1101|mesh-list
154638945|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638946|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
154638947|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
154638948|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638949|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638950|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154638951|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
154638952|NCT00754949|Hormones|hormones|mesh-ancestor
154638953|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638954|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154638955|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638956|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
154638957|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638958|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638959|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154638960|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638961|NCT03160807|Levofloxacin|levofloxacin|mesh-list
154638962|NCT03160807|Ofloxacin|ofloxacin|mesh-list
154638963|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154638964|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154638965|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154638966|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154638967|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154638968|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154638969|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154638970|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638971|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154638972|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154638973|NCT01674569|Ranibizumab|ranibizumab|mesh-list
154638974|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154251765|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
154638975|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154638976|NCT01674569|Growth Substances|growth substances|mesh-ancestor
154638977|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638978|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
154638979|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638980|NCT03160729|Dexamethasone|dexamethasone|mesh-list
154638981|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638982|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
154638983|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
154638984|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154638985|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154638986|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154638987|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
154638988|NCT03160729|Hormones|hormones|mesh-ancestor
154638989|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154638990|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154638991|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638992|NCT04439929|Adalimumab|adalimumab|mesh-list
154638993|NCT04439929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154638994|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154638995|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154638996|NCT05131841|Vinorelbine|vinorelbine|mesh-list
154638997|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154638998|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154638999|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
154639000|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
154639001|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
154639002|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639003|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
154639004|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
154639005|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639006|NCT03163381|Apatinib|apatinib|mesh-list
154639007|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639008|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154639009|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639010|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639011|NCT05131295|Dapsone|dapsone|mesh-list
154639012|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154639013|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639014|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
154639015|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154639016|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154639017|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154639018|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639019|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639020|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
154639021|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154639022|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154639023|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
154639024|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639025|NCT05131295|Antacids|antacids|mesh-ancestor
154639026|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154639027|NCT01374217|Clarithromycin|clarithromycin|mesh-list
154639028|NCT01374217|Dexamethasone|dexamethasone|mesh-list
154639029|NCT01374217|Lenalidomide|lenalidomide|mesh-list
154639030|NCT01374217|Tadalafil|tadalafil|mesh-list
154639031|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639032|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
154639033|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
154639034|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639035|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639036|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154639037|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
154639038|NCT01374217|Hormones|hormones|mesh-ancestor
154639039|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639040|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639041|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639042|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
154639043|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154639044|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154639045|NCT01374217|Growth Substances|growth substances|mesh-ancestor
154639046|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
154639047|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154639048|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639049|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154639050|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860325|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
154353884|NCT04595591|Narcotics|narcotics|mesh-ancestor
154639051|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639052|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154639053|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154639054|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
154639055|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154639056|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154639057|NCT01374217|Urological Agents|urological agents|mesh-ancestor
154639059|NCT04941937|Dexamethasone|dexamethasone|mesh-list
154639060|NCT04941937|Lenalidomide|lenalidomide|mesh-list
154639061|NCT04941937|Pomalidomide|pomalidomide|mesh-list
154639062|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639063|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
154639064|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
154639065|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639066|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639067|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154639068|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
154639069|NCT04941937|Hormones|hormones|mesh-ancestor
154639070|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639071|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639072|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639073|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
154639074|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154639075|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154639076|NCT04941937|Growth Substances|growth substances|mesh-ancestor
154639077|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
154639078|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154639079|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
154639080|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154639081|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639082|NCT05124431|Everolimus|everolimus|mesh-list
154639083|NCT05124431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154639084|NCT05124431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154639085|NCT05124431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639086|NCT05124431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639087|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154639088|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
154639089|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639090|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639091|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
154639092|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154639093|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639094|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639095|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154639096|NCT04955249|Analgesics|analgesics|mesh-ancestor
154639097|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
154639098|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639099|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154639100|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154639101|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154639102|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
154639103|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639104|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639105|NCT03114085|Capecitabine|capecitabine|mesh-list
154639106|NCT03114085|Apatinib|apatinib|mesh-list
154639107|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154639108|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
154639109|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639110|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639111|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154639112|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639113|NCT05136521|Trazodone|trazodone|mesh-list
154639114|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154639115|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154639116|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639117|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639118|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154639119|NCT05136521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154639120|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154639121|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154639122|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251910|NCT01119638|Escitalopram|escitalopram|mesh-list
154639123|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639124|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
154639125|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154639126|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
154639127|NCT02388373|Fluticasone|fluticasone|mesh-list
154639128|NCT02388373|Xhance|xhance|mesh-list
154639129|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
154639130|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154639131|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639132|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154639133|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
154639134|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639135|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639136|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154639137|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
154639138|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
154639139|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154639140|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154639141|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154639142|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154639143|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
154639144|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639145|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639146|NCT01674647|Vitamin K|vitamin k|mesh-list
154639147|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
154639148|NCT01674647|Vitamins|vitamins|mesh-ancestor
154639149|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
154639150|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639151|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154639152|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
154639153|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154639154|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
154639155|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639156|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639157|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
154639158|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154639159|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154639160|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
154639161|NCT01674647|Coagulants|coagulants|mesh-ancestor
154639162|NCT02669407|Lidocaine|lidocaine|mesh-list
154639163|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
154639164|NCT02669407|Anesthetics|anesthetics|mesh-list
154639165|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639166|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639167|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
154639168|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639169|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154639170|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154639171|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154639172|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154639173|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639174|NCT04637555|Valsartan|valsartan|mesh-list
154639175|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154639176|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154639177|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154639178|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154639179|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639180|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154639181|NCT02388061|Plasminogen|plasminogen|mesh-list
154639182|NCT02388061|Tenecteplase|tenecteplase|mesh-list
154639183|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154639184|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154639185|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639186|NCT04556357|Phenylephrine|phenylephrine|mesh-list
154639187|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
154639188|NCT04556357|Norepinephrine|norepinephrine|mesh-list
154639189|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154639190|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154639191|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
154639192|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
154639193|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639194|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639195|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
154639196|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
154639197|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
154860326|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154639198|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154639199|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154639200|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154639201|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
154639202|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639203|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639204|NCT04556357|Protective Agents|protective agents|mesh-ancestor
154639205|NCT04553939|Gemcitabine|gemcitabine|mesh-list
154639206|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154639207|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
154639208|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639209|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639210|NCT03113773|Aldesleukin|aldesleukin|mesh-list
154639211|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639212|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154639213|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154639214|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
154639215|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639216|NCT04874831|Avelumab|avelumab|mesh-list
154639217|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639218|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639219|NCT05122169|Iodine|iodine|mesh-list
154639220|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
154639221|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154639222|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
154639223|NCT05122169|Povidone|povidone|mesh-list
154639224|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154639225|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639226|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
154639227|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
154639228|NCT05122169|Trace Elements|trace elements|mesh-ancestor
154639229|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
154639230|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639231|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
154639232|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
154639233|NCT04359329|Estradiol|estradiol|mesh-list
154639234|NCT04359329|Estrogens|estrogens|mesh-ancestor
154639235|NCT04359329|Hormones|hormones|mesh-ancestor
154639236|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639237|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639238|NCT04203875|Abatacept|abatacept|mesh-list
154639239|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154639240|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639241|NCT04203875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639242|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639243|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154639244|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
154639245|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639246|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154639247|NCT05900674|Reteplase|reteplase|mesh-list
154639248|NCT05900674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154639249|NCT05900674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154639250|NCT05900674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639251|NCT05900661|Inositol|inositol|mesh-list
154639252|NCT05900661|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154639253|NCT05900661|Vitamin B Complex|vitamin b complex|mesh-ancestor
154639254|NCT05900661|Vitamins|vitamins|mesh-ancestor
154639255|NCT05900661|Micronutrients|micronutrients|mesh-ancestor
154639256|NCT05900661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639257|NCT05900661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154639258|NCT05900661|Immunologic Factors|immunologic factors|mesh-ancestor
154639259|NCT05900635|Lactoferrin|lactoferrin|mesh-list
154639260|NCT05900635|Glycine|glycine|mesh-list
154639261|NCT05900635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639262|NCT05900635|Glycine Agents|glycine agents|mesh-ancestor
154639263|NCT05900635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639264|NCT05900635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639265|NCT05900635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639266|NCT05900531|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154639267|NCT05900531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154639268|NCT05900531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639269|NCT05900531|Incretins|incretins|mesh-ancestor
154639270|NCT05900531|Hormones|hormones|mesh-ancestor
154639271|NCT05900531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639272|NCT05900531|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154639273|NCT05900531|Protease Inhibitors|protease inhibitors|mesh-ancestor
154639274|NCT05900531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639275|NCT05900531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639276|NCT05900349|Caffeine|caffeine|mesh-list
154639277|NCT05900349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154639278|NCT05900349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639279|NCT05900349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154639280|NCT05900349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639281|NCT05900349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639282|NCT05900349|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154639283|NCT05900349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154639284|NCT05900349|Purinergic Agents|purinergic agents|mesh-ancestor
154639285|NCT05900349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639286|NCT05900232|Antibodies|antibodies|mesh-list
154639287|NCT05900232|Immunologic Factors|immunologic factors|mesh-ancestor
154639288|NCT05900232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639289|NCT05900219|Vemurafenib|vemurafenib|mesh-list
154639290|NCT05900219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639291|NCT05900219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154639292|NCT05900219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639293|NCT05900219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639294|NCT05899764|Brivaracetam|brivaracetam|mesh-list
154639295|NCT05899764|Anticonvulsants|anticonvulsants|mesh-ancestor
154639296|NCT05899751|Methotrexate|methotrexate|mesh-list
154639297|NCT05899751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154639298|NCT05899751|Abortifacient Agents|abortifacient agents|mesh-ancestor
154639299|NCT05899751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154639300|NCT05899751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639301|NCT05899751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154639302|NCT05899751|Antimetabolites|antimetabolites|mesh-ancestor
154639303|NCT05899751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639304|NCT05899751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639305|NCT05899751|Dermatologic Agents|dermatologic agents|mesh-ancestor
154639306|NCT05899751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639307|NCT05899751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154639308|NCT05899751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154639309|NCT05899751|Immunologic Factors|immunologic factors|mesh-ancestor
154639310|NCT05899751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154639311|NCT05899751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154639312|NCT05899621|Prednisone|prednisone|mesh-list
154639313|NCT05899621|Cyclophosphamide|cyclophosphamide|mesh-list
154639314|NCT05899621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154639315|NCT05899621|Doxorubicin|doxorubicin|mesh-list
154639316|NCT05899621|Vincristine|vincristine|mesh-list
154639317|NCT05899621|Lenalidomide|lenalidomide|mesh-list
154639318|NCT05899621|Obinutuzumab|obinutuzumab|mesh-list
154639319|NCT05899621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154639320|NCT05899621|Immunologic Factors|immunologic factors|mesh-ancestor
154639321|NCT05899621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639322|NCT05899621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154639323|NCT05899621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154639324|NCT05899621|Alkylating Agents|alkylating agents|mesh-ancestor
154639325|NCT05899621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639326|NCT05899621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639327|NCT05899621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154639328|NCT05899621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154639329|NCT05899621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154639330|NCT05899621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154639331|NCT05899621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639332|NCT05899621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639333|NCT05899621|Glucocorticoids|glucocorticoids|mesh-ancestor
154639334|NCT05899621|Hormones|hormones|mesh-ancestor
154639335|NCT05899621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639336|NCT05899621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639337|NCT05899621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154639338|NCT05899621|Tubulin Modulators|tubulin modulators|mesh-ancestor
154639339|NCT05899621|Antimitotic Agents|antimitotic agents|mesh-ancestor
154639340|NCT05899621|Mitosis Modulators|mitosis modulators|mesh-ancestor
154639341|NCT05899621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154639342|NCT05899621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154639343|NCT05899621|Growth Substances|growth substances|mesh-ancestor
154639344|NCT05899621|Growth Inhibitors|growth inhibitors|mesh-ancestor
154639345|NCT05899621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639346|NCT05899517|Oxytocin|oxytocin|mesh-list
154639347|NCT05899517|Oxytocics|oxytocics|mesh-ancestor
154252143|NCT01121276|Insulin|insulin|mesh-list
154639348|NCT05899517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154639349|NCT05899517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639350|NCT05898984|Beclomethasone|beclomethasone|mesh-list
154639351|NCT05898984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639352|NCT05898984|Glucocorticoids|glucocorticoids|mesh-ancestor
154639354|NCT05898984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639355|NCT05898984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639356|NCT05898984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154639357|NCT05898984|Respiratory System Agents|respiratory system agents|mesh-ancestor
154639358|NCT05898451|Cisplatin|cisplatin|mesh-list
154639359|NCT05898451|Dacarbazine|dacarbazine|mesh-list
154639360|NCT05898451|Lomustine|lomustine|mesh-list
154639361|NCT05898451|Thymalfasin|thymalfasin|mesh-list
154639362|NCT05898451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639363|NCT05898451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154639364|NCT05898451|Alkylating Agents|alkylating agents|mesh-ancestor
154639365|NCT05898451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639366|NCT05898451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154639367|NCT05898451|Immunologic Factors|immunologic factors|mesh-ancestor
154639368|NCT05898451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639369|NCT05898373|Antineoplastic Agents|antineoplastic agents|mesh-list
154639370|NCT05898321|Goserelin|goserelin|mesh-list
154639371|NCT05898321|Mifepristone|mifepristone|mesh-list
154639372|NCT05898321|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154639373|NCT05898321|Abortifacient Agents|abortifacient agents|mesh-ancestor
154639374|NCT05898321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154639375|NCT05898321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639376|NCT05898321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154639377|NCT05898321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154639378|NCT05898321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154639379|NCT05898321|Contraceptive Agents|contraceptive agents|mesh-ancestor
154639380|NCT05898321|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154639381|NCT05898321|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154639382|NCT05898321|Hormone Antagonists|hormone antagonists|mesh-ancestor
154639383|NCT05898321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639384|NCT05898321|Luteolytic Agents|luteolytic agents|mesh-ancestor
154639385|NCT05898321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154639386|NCT05898321|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154639387|NCT05898321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639388|NCT05898321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639389|NCT05898308|Rituximab|rituximab|mesh-list
154639390|NCT05898308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639391|NCT05898308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639392|NCT05898308|Immunologic Factors|immunologic factors|mesh-ancestor
154639393|NCT05898308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639394|NCT05898308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154639395|NCT05898256|Gemcitabine|gemcitabine|mesh-list
154639396|NCT05898256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639397|NCT05898256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154639398|NCT05898256|Antimetabolites|antimetabolites|mesh-ancestor
154639399|NCT05898256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639400|NCT05898087|Bupivacaine|bupivacaine|mesh-list
154639401|NCT05898087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154639402|NCT05898087|Anesthetics, Local|anesthetics, local|mesh-ancestor
154639403|NCT05898087|Anesthetics|anesthetics|mesh-ancestor
154639404|NCT05898087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639405|NCT05898087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639406|NCT05898087|Sensory System Agents|sensory system agents|mesh-ancestor
154639407|NCT05898087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639408|NCT05897918|Tranexamic Acid|tranexamic acid|mesh-list
154639409|NCT05897918|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154639410|NCT05897918|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154639411|NCT05897918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639412|NCT05897918|Hemostatics|hemostatics|mesh-ancestor
154639413|NCT05897918|Coagulants|coagulants|mesh-ancestor
154639414|NCT05897034|Doxycycline|doxycycline|mesh-list
154639415|NCT05897034|Nitazoxanide|nitazoxanide|mesh-list
154639416|NCT05897034|Pentoxifylline|pentoxifylline|mesh-list
154639417|NCT05897034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154639418|NCT05897034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639419|NCT05897034|Antimalarials|antimalarials|mesh-ancestor
154639420|NCT05897034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154639421|NCT05897034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154639422|NCT05897034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154639423|NCT05897034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639424|NCT05897034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639425|NCT05897034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154639426|NCT05897034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154639427|NCT05897034|Protective Agents|protective agents|mesh-ancestor
154639428|NCT05897034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639429|NCT05897034|Vasodilator Agents|vasodilator agents|mesh-ancestor
154639430|NCT05897034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154639431|NCT05897034|Antioxidants|antioxidants|mesh-ancestor
154639432|NCT05897008|Omalizumab|omalizumab|mesh-list
154639433|NCT05897008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154639434|NCT05897008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154639435|NCT05897008|Respiratory System Agents|respiratory system agents|mesh-ancestor
154639436|NCT05892939|Oxytocin|oxytocin|mesh-list
154639437|NCT05892939|Oxytocics|oxytocics|mesh-ancestor
154639438|NCT05892939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154639439|NCT05892939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639440|NCT05890534|Pycnogenols|pycnogenols|mesh-list
154639441|NCT05890534|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154639442|NCT05890534|Immunologic Factors|immunologic factors|mesh-ancestor
154639443|NCT05890534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639444|NCT05890534|Antioxidants|antioxidants|mesh-ancestor
154639445|NCT05890534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639446|NCT05890534|Protective Agents|protective agents|mesh-ancestor
154639447|NCT05890534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154639448|NCT05861765|Papaverine|papaverine|mesh-list
154639449|NCT05861765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154639450|NCT05861765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639451|NCT05861765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639452|NCT05861765|Vasodilator Agents|vasodilator agents|mesh-ancestor
154639453|NCT05861765|Urological Agents|urological agents|mesh-ancestor
154639454|NCT05818618|Clobetasol|clobetasol|mesh-list
154639455|NCT05818618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639456|NCT05818618|Glucocorticoids|glucocorticoids|mesh-ancestor
154639457|NCT05818618|Hormones|hormones|mesh-ancestor
154639458|NCT05818618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639459|NCT05818618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639460|NCT05783219|Lidocaine|lidocaine|mesh-list
154639461|NCT05783219|Anesthetics, Local|anesthetics, local|mesh-ancestor
154639462|NCT05783219|Anesthetics|anesthetics|mesh-ancestor
154639463|NCT05783219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639464|NCT05783219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639465|NCT05783219|Sensory System Agents|sensory system agents|mesh-ancestor
154639466|NCT05783219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639467|NCT05783219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154639468|NCT05783219|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154639469|NCT05783219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154639470|NCT05783219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154639471|NCT05783219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639472|NCT05709444|Angiotensin II|angiotensin ii|mesh-list
154639473|NCT05709444|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154639474|NCT05709444|alpha-MSH|alpha-msh|mesh-list
154639475|NCT05709444|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154639476|NCT05709444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154639477|NCT05709444|Protease Inhibitors|protease inhibitors|mesh-ancestor
154639478|NCT05709444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639479|NCT05709444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639480|NCT05709444|Hormones|hormones|mesh-ancestor
154639481|NCT05709444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639482|NCT05709444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639483|NCT05583110|Trastuzumab|trastuzumab|mesh-list
154639484|NCT05583110|Vinorelbine|vinorelbine|mesh-list
154639485|NCT05583110|Tucatinib|tucatinib|mesh-list
154639486|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639487|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639488|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154639489|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154639490|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154639491|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154639492|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639493|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154639494|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639495|NCT05537935|Naltrexone|naltrexone|mesh-list
154639496|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154639497|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154639498|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639499|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
154639500|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639501|NCT05411679|Olaparib|olaparib|mesh-list
154639502|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154639503|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639504|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639505|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639506|NCT05406479|Bedaquiline|bedaquiline|mesh-list
154639507|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
154639508|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154639509|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639510|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
154639511|NCT05325281|Gemcitabine|gemcitabine|mesh-list
154639512|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154639513|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
154639514|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639515|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639516|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
154639517|NCT05325281|Protective Agents|protective agents|mesh-ancestor
154639518|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639519|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
154639520|NCT05325281|Vitamins|vitamins|mesh-ancestor
154639521|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
154639522|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
154639523|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154639524|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639525|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
154639526|NCT05193994|Lamivudine|lamivudine|mesh-list
154639527|NCT05193994|Abacavir|abacavir|mesh-list
154639528|NCT05193994|Dolutegravir|dolutegravir|mesh-list
154639529|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154639530|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154639531|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639532|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639533|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
154639534|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639535|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154639536|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154639537|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154639538|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154639539|NCT05191784|Bevacizumab|bevacizumab|mesh-list
154639540|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639541|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639542|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154639543|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154639544|NCT05191784|Growth Substances|growth substances|mesh-ancestor
154639545|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639546|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
154639547|NCT05137717|Maribavir|maribavir|mesh-list
154639548|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
154639549|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639550|NCT05119179|Semaglutide|semaglutide|mesh-list
154639551|NCT05119179|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154639552|NCT05119179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154639553|NCT05119179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639554|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
154639555|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639556|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639557|NCT05077709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154639558|NCT05077709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639559|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
154639560|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154639561|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639562|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639563|NCT04911062|Epinephrine|epinephrine|mesh-list
154639564|NCT04911062|Bupivacaine|bupivacaine|mesh-list
154639565|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
154639566|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
154639567|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639568|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639569|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
154639570|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639571|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154639572|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154639573|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154639574|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639575|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639576|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154639577|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154639578|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
154639579|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154639580|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
154639581|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
154639582|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
154639583|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154639584|NCT04818749|Dexamethasone|dexamethasone|mesh-list
154639585|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
154639586|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
154639587|NCT04818749|BB 1101|bb 1101|mesh-list
154639588|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639589|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
154639590|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
154639591|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639592|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639593|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354454|NCT01306123|Vitamins|vitamins|mesh-ancestor
154639594|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
154639595|NCT04818749|Hormones|hormones|mesh-ancestor
154639596|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639597|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639598|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639599|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
154639600|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639601|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639602|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154639603|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639604|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154639605|NCT04818749|Analgesics|analgesics|mesh-ancestor
154639606|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
154639607|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154639608|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154639609|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154639610|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
154639611|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639612|NCT04776395|Dexamethasone|dexamethasone|mesh-list
154639613|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
154639614|NCT04776395|Ichthammol|ichthammol|mesh-list
154639615|NCT04776395|BB 1101|bb 1101|mesh-list
154639616|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639617|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
154639618|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
154639619|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639620|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639621|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154639622|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
154639623|NCT04776395|Hormones|hormones|mesh-ancestor
154639624|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639625|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639626|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639627|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154639628|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639629|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639630|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
154639631|NCT04588688|Mifepristone|mifepristone|mesh-list
154639632|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154639633|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
154639634|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154639635|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639636|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154639637|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154639638|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154639639|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
154639640|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154639641|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154639642|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
154639643|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639644|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
154639645|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154639646|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154639647|NCT04587830|Temozolomide|temozolomide|mesh-list
154860327|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
154639648|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154639649|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
154639650|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639651|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639652|NCT04558281|Ropivacaine|ropivacaine|mesh-list
154639653|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
154639654|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
154639655|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639656|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639657|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
154639658|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639659|NCT04343222|Bromfenac|bromfenac|mesh-list
154354500|NCT03130348|Hormones|hormones|mesh-ancestor
154639660|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
154639661|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154639662|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154639663|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154639664|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154639665|NCT04343222|Analgesics|analgesics|mesh-ancestor
154639666|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
154639667|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639668|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639669|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639670|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154639671|NCT04342039|Budesonide|budesonide|mesh-list
154639672|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639673|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154639674|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
154639675|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639676|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639677|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154639678|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154639679|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
154639680|NCT04342039|Hormones|hormones|mesh-ancestor
154639681|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639682|NCT04281108|Fluticasone|fluticasone|mesh-list
154639683|NCT04281108|Xhance|xhance|mesh-list
154639684|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639685|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154639686|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
154639687|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639688|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639689|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154639690|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
154639691|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
154639692|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154639693|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154639694|NCT04268849|Hematinics|hematinics|mesh-ancestor
154639695|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154639696|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154639697|NCT04258046|Trametinib|trametinib|mesh-list
154639698|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639699|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154639700|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639701|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639702|NCT04189055|Irinotecan|irinotecan|mesh-list
154639703|NCT04189055|Cetuximab|cetuximab|mesh-list
154639704|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154639705|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154639706|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639707|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639708|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639709|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639710|NCT04147806|Dexamethasone|dexamethasone|mesh-list
154639711|NCT04147806|Tamsulosin|tamsulosin|mesh-list
154639712|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639713|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
154354572|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
154639714|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
154639715|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639716|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639717|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154639718|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
154639719|NCT04147806|Hormones|hormones|mesh-ancestor
154639720|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639721|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639722|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999431|NCT04622904|Lidocaine|lidocaine|mesh-list
154639723|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154639724|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154639725|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154639726|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
154639727|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639728|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639729|NCT04147806|Urological Agents|urological agents|mesh-ancestor
154639730|NCT04122625|Nivolumab|nivolumab|mesh-list
154639731|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639732|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639733|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154639734|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639735|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
154639736|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154639737|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
154639738|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639739|NCT04044313|Lenvatinib|lenvatinib|mesh-list
154639740|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639741|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154639742|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639743|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639744|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
154639745|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154639746|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
154639747|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639748|NCT03824704|Nivolumab|nivolumab|mesh-list
154639749|NCT03824704|Rucaparib|rucaparib|mesh-list
154639750|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639751|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639752|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154639753|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639754|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154639755|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639756|NCT03798106|Durvalumab|durvalumab|mesh-list
154639757|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639758|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639759|NCT03767075|Atezolizumab|atezolizumab|mesh-list
154639760|NCT03767075|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154639761|NCT03767075|Futibatinib|futibatinib|mesh-list
154639762|NCT03767075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154639763|NCT03767075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639764|NCT03767075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639765|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639766|NCT03766581|Aspirin|aspirin|mesh-list
154639767|NCT03766581|Clopidogrel|clopidogrel|mesh-list
154639768|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154639769|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154639770|NCT03766581|Analgesics|analgesics|mesh-ancestor
154639771|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
154639772|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639773|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639774|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639775|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154639776|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154639777|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154639778|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639779|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154639780|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154639781|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639782|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
154639783|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154639784|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154639785|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154639786|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
154639787|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639788|NCT03527745|Albendazole|albendazole|mesh-list
154639789|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
154639790|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154639791|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639792|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
154639793|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154639794|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154639795|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
154639796|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
154639797|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
154639798|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639799|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639800|NCT03522584|Durvalumab|durvalumab|mesh-list
154639801|NCT03522584|Ipilimumab|ipilimumab|mesh-list
154639802|NCT03522584|Tremelimumab|tremelimumab|mesh-list
154639803|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
154639804|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154639805|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
154639806|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639807|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639808|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
154639809|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639810|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154639811|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639812|NCT03284463|Glyburide|glyburide|mesh-list
154639813|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154639814|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639815|NCT03223103|Poly ICLC|poly iclc|mesh-list
154639816|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
154639817|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
154639818|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639819|NCT03174782|Bupivacaine|bupivacaine|mesh-list
154639820|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
154639821|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
154639822|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639823|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639824|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
154639825|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639826|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
154639827|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639828|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639829|NCT02919969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154639830|NCT02919969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639831|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
154639832|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154639833|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354678|NCT04370847|Narcotics|narcotics|mesh-ancestor
154639834|NCT02837263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154639835|NCT02837263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639836|NCT02352883|Hormones|hormones|mesh-list
154639837|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639838|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639839|NCT02270632|Methotrexate|methotrexate|mesh-list
154639840|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154639841|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
154639842|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154639843|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639844|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154639845|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
154639846|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639847|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639848|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154639849|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639850|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154639851|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154639852|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
154639853|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154639854|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154639855|NCT01891344|Rucaparib|rucaparib|mesh-list
154639856|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154639857|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639858|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639859|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639860|NCT01188096|Poly ICLC|poly iclc|mesh-list
154639861|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
154639862|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
154639863|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639864|NCT00632853|Carboplatin|carboplatin|mesh-list
154639865|NCT00632853|Etoposide|etoposide|mesh-list
154639866|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639867|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154639868|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154639869|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154639870|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639871|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639872|NCT00579826|Letrozole|letrozole|mesh-list
154639873|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639874|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154639875|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154639876|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639877|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639878|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154639879|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
154639880|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639881|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639882|NCT00106691|Toremifene|toremifene|mesh-list
154639883|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639884|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639885|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154639886|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154639887|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
154639888|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639889|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639890|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154639891|NCT04576325|Voriconazole|voriconazole|mesh-list
154639892|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
154639893|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154639894|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154639895|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154639896|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639897|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639898|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154639899|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
154639900|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154639901|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639902|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154639903|NCT03126617|Elotuzumab|elotuzumab|mesh-list
154639904|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639905|NCT04422743|Tramiprosate|tramiprosate|mesh-list
154639906|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154639907|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
154639908|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
154639909|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
154639910|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
154639911|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639912|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639913|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639914|NCT02535221|Epirubicin|epirubicin|mesh-list
154639915|NCT02535221|Goserelin|goserelin|mesh-list
154639916|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154639917|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639918|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154639919|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154639920|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639921|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639922|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154639923|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
154639924|NCT00000587|Hematinics|hematinics|mesh-ancestor
154639925|NCT04592159|Nabiximols|nabiximols|mesh-list
154639926|NCT04592159|Analgesics|analgesics|mesh-ancestor
154639927|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
154639928|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639929|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639930|NCT05137145|Linaclotide|linaclotide|mesh-list
154639931|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154639932|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
154639933|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639934|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154639935|NCT05304845|Aspirin|aspirin|mesh-list
154639936|NCT05304845|Fexuprazan|fexuprazan|mesh-list
154639937|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154639938|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154639939|NCT05304845|Analgesics|analgesics|mesh-ancestor
154639940|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
154639941|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639942|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639943|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154639945|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154639946|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154639947|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639948|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154639949|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154639950|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154639951|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
154639952|NCT05304845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154639953|NCT04892459|Vaccines|vaccines|mesh-list
154639954|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
154639955|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639956|NCT04881539|Cannabidiol|cannabidiol|mesh-list
154639957|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
154639958|NCT04854083|Semaglutide|semaglutide|mesh-list
154639959|NCT04854083|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154639960|NCT04854083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154639961|NCT04854083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639962|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154639963|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
154639964|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639965|NCT04280939|Anesthetics|anesthetics|mesh-list
154639966|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154639967|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639968|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
154639969|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154639970|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
154639971|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639972|NCT04314713|Scopolamine|scopolamine|mesh-list
154639973|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154639974|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154639975|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
154639976|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
154639977|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154639978|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639979|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154639980|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
154639981|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154639982|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
154639983|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154639984|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639985|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154639986|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
154639987|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
154639988|NCT04121507|Thiotepa|thiotepa|mesh-list
154639989|NCT04121507|Fludarabine|fludarabine|mesh-list
154639990|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154639991|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
154639992|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154639993|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154639994|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154639995|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
154639996|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154639997|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154639998|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154639999|NCT03790397|Osimertinib|osimertinib|mesh-list
154640000|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640001|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640002|NCT03790397|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154640003|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154640004|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640005|NCT01171937|Risperidone|risperidone|mesh-list
154640006|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154640007|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
154640008|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640009|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640010|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640011|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154640012|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154640013|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640014|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154640015|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154640016|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
154640017|NCT00887783|Vinorelbine|vinorelbine|mesh-list
154640018|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154640019|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640020|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
154640021|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
154640022|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
154640023|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640024|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154640025|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640026|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154640027|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
154640028|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640029|NCT01125371|Ethanol|ethanol|mesh-list
154640030|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154640031|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640032|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640033|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640034|NCT03199547|Azithromycin|azithromycin|mesh-list
154640035|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154640036|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640037|NCT00416351|Clofarabine|clofarabine|mesh-list
154640038|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154640039|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
154640040|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640041|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640042|NCT03938831|Fentanyl|fentanyl|mesh-list
154640043|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
154640044|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154640045|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640046|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640047|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640048|NCT03938831|Analgesics|analgesics|mesh-ancestor
154640049|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
154640050|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640051|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154640052|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154640053|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154640054|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
154640055|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640056|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640057|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154640058|NCT03938831|Narcotics|narcotics|mesh-ancestor
154640059|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154640060|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154640061|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
154640062|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
154640063|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154640064|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154640065|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640066|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
154640067|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154640068|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640069|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640070|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640071|NCT03102359|Analgesics|analgesics|mesh-ancestor
154640072|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
154640073|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640074|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154640075|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154640076|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154640077|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
154640078|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640079|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640080|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
154640081|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154640082|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
154640083|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154640084|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640085|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154640086|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154640087|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154640088|NCT03832049|Vaccines|vaccines|mesh-list
154640089|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
154252871|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640090|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640091|NCT02102477|Androgens|androgens|mesh-list
154640092|NCT02102477|Hormones|hormones|mesh-ancestor
154640093|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640094|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640095|NCT03103685|Clopidogrel|clopidogrel|mesh-list
154640096|NCT03103685|Ticagrelor|ticagrelor|mesh-list
154640097|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154640098|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154640099|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154640100|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154640101|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154640102|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
154640103|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640104|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640105|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640106|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154640107|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
154640108|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640109|NCT05001815|Insulin|insulin|mesh-list
154640110|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154640111|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154640112|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640113|NCT02644967|Ipilimumab|ipilimumab|mesh-list
154640114|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154640115|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640116|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154640117|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640118|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
154640119|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154640120|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640121|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640122|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640123|NCT04771637|Analgesics|analgesics|mesh-ancestor
154640124|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
154640125|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640126|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154640127|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154640128|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154640129|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
154640130|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640131|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640132|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154640133|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640134|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154640135|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
154640136|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640137|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154640138|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154640139|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640140|NCT05243693|Immunotoxins|immunotoxins|mesh-ancestor
154640141|NCT05243693|Immunoconjugates|immunoconjugates|mesh-ancestor
154640142|NCT05243693|Immunologic Factors|immunologic factors|mesh-ancestor
154640143|NCT05243693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640144|NCT04552847|Octreotide|octreotide|mesh-list
154640145|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
154640146|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154640147|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154640148|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640149|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154640150|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640151|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
154640152|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154640153|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
154640154|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
154640155|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640156|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640157|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640158|NCT05167331|Analgesics|analgesics|mesh-ancestor
154640159|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
154640160|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640161|NCT04509401|Vitamins|vitamins|mesh-list
154640162|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
154640163|NCT04509401|Pyridoxal|pyridoxal|mesh-list
154640164|NCT04509401|Pyridoxine|pyridoxine|mesh-list
154252941|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
154640165|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
154640166|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
154640167|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640168|NCT05155007|Cyclosporine|cyclosporine|mesh-list
154640169|NCT05155007|Cyclosporins|cyclosporins|mesh-list
154640170|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640171|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640172|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154640173|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
154640174|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640175|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
154640176|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355066|NCT03466216|Octreotide|octreotide|mesh-list
154640177|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640178|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640179|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154640180|NCT01641107|Ponatinib|ponatinib|mesh-list
154640181|NCT01641107|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154640182|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154640183|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640184|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640185|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640186|NCT03101423|Interleukin-2|interleukin-2|mesh-list
154640187|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640188|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640189|NCT03101423|Analgesics|analgesics|mesh-ancestor
154640190|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
154640191|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640192|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640193|NCT05073029|Vitamin D|vitamin d|mesh-list
154640194|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
154640195|NCT05073029|Vitamins|vitamins|mesh-ancestor
154640196|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
154640197|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640198|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154640199|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154640200|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
154640201|NCT02642159|Niacin|niacin|mesh-list
154640202|NCT02642159|Niacinamide|niacinamide|mesh-list
154640203|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154640204|NCT02642159|Ezetimibe|ezetimibe|mesh-list
154640205|NCT02642159|Alirocumab|alirocumab|mesh-list
154640206|NCT02642159|Fenofibrate|fenofibrate|mesh-list
154640207|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154640208|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154640209|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
154640210|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640211|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154640212|NCT02642159|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154640213|NCT02642159|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154640214|NCT02642159|Protease Inhibitors|protease inhibitors|mesh-ancestor
154640215|NCT02642159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640216|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
154640217|NCT02642159|Vitamins|vitamins|mesh-ancestor
154640218|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
154640219|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640220|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
154640221|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
154640222|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154640223|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154640224|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640225|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
154640226|NCT05072873|Coagulants|coagulants|mesh-ancestor
154640227|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154640228|NCT05072405|Simvastatin|simvastatin|mesh-list
154640229|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154640230|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154640231|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
154640232|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640233|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154640234|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154640235|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640236|NCT03101579|Folic Acid|folic acid|mesh-list
154640237|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
154640238|NCT03101579|Dexamethasone|dexamethasone|mesh-list
154640239|NCT03101579|Pemetrexed|pemetrexed|mesh-list
154640240|NCT03101579|Vitamins|vitamins|mesh-ancestor
154640241|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
154640242|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640243|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154640244|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
154640245|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
154640246|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355093|NCT03780361|Aflibercept|aflibercept|mesh-list
154640247|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154640248|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
154640249|NCT03101579|Hormones|hormones|mesh-ancestor
154640250|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640251|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154640252|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640253|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640254|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640255|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154640256|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154640257|NCT03101579|Hematinics|hematinics|mesh-ancestor
154640258|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
154640259|NCT05071781|Hormones|hormones|mesh-list
154640260|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154640261|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640262|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640263|NCT03882905|Ezetimibe|ezetimibe|mesh-list
154640264|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154640265|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154640266|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
154640267|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640268|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154640269|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154640270|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154640271|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640272|NCT04479865|Donepezil|donepezil|mesh-list
154640273|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154640274|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640275|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640276|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
154640277|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640278|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640279|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
154640280|NCT02668393|Docetaxel|docetaxel|mesh-list
154640281|NCT02668393|Nintedanib|nintedanib|mesh-list
154640282|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640283|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
154640284|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
154640285|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
154640286|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640287|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154640288|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640289|NCT01226563|Calcium|calcium|mesh-list
154640290|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154640291|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640292|NCT02382757|Insulin|insulin|mesh-list
154640293|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154640294|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154640295|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640296|NCT02382679|Vitamins|vitamins|mesh-list
154640297|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
154640298|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640299|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
154640300|NCT00916747|Pravastatin|pravastatin|mesh-list
154640301|NCT00916747|Lonafarnib|lonafarnib|mesh-list
154640302|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154640303|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640304|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154640305|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154640306|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
154640307|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640308|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154640309|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154355160|NCT04195958|Omalizumab|omalizumab|mesh-list
154640310|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640311|NCT02391883|Clopidogrel|clopidogrel|mesh-list
154640312|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154640313|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154640314|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154640315|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154640316|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
154640317|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253102|NCT01228682|Tolvaptan|tolvaptan|mesh-list
154640318|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640319|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640320|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154640321|NCT02382523|Hormones|hormones|mesh-ancestor
154640322|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640323|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640324|NCT02391805|Tenofovir|tenofovir|mesh-list
154640325|NCT02391805|Entecavir|entecavir|mesh-list
154640326|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
154640327|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640328|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154640329|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154640330|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640331|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640332|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154640333|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154640334|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154640335|NCT02391181|Hematinics|hematinics|mesh-ancestor
154640336|NCT02381899|Rituximab|rituximab|mesh-list
154640337|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154640338|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154640339|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640340|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
154640341|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640342|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640343|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154640344|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
154640345|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640346|NCT01998958|Esketamine|esketamine|mesh-list
154640347|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
154640348|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154640349|NCT02386111|Sunitinib|sunitinib|mesh-list
154640350|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640351|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154640352|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154640353|NCT02386111|Growth Substances|growth substances|mesh-ancestor
154640354|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640355|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
154640356|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154640357|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640358|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640359|NCT02386033|Atorvastatin|atorvastatin|mesh-list
154640360|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154640361|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154640362|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
154640363|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640364|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154640365|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154640366|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640367|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154640368|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154640369|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154640370|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640371|NCT02381275|Tenofovir|tenofovir|mesh-list
154640372|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
154640373|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640374|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154640375|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154640376|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640377|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640378|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154640379|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154640380|NCT04693507|Antarelix|antarelix|mesh-list
154640381|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
154640382|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640383|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640384|NCT03105661|Atenolol|atenolol|mesh-list
154640385|NCT03105661|Labetalol|labetalol|mesh-list
154640386|NCT03105661|Nifedipine|nifedipine|mesh-list
154640387|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154640388|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154640389|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253163|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
154640390|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154640391|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640392|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
154640393|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
154640394|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154640395|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154640396|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154640397|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
154640398|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
154640399|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640400|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154640401|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154640402|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154640403|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
154640404|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640405|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
154640406|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154640407|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154640408|NCT01998880|Rituximab|rituximab|mesh-list
154640409|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
154640410|NCT01998880|Chlorambucil|chlorambucil|mesh-list
154640411|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154640412|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640413|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
154640414|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640415|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640416|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154640417|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
154640418|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640419|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154640420|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154640421|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640422|NCT02385019|Immunomodulating Agents|immunomodulating agents|mesh-list
154640423|NCT02385019|Immunologic Factors|immunologic factors|mesh-ancestor
154640424|NCT02385019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640425|NCT02380417|Ropivacaine|ropivacaine|mesh-list
154640426|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
154640427|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
154640428|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640429|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640430|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
154640431|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640432|NCT02390089|Capsaicin|capsaicin|mesh-list
154640433|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
154640434|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640435|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
154640436|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640437|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640438|NCT02379793|Mineral Oil|mineral oil|mesh-list
154640439|NCT02379793|Emollients|emollients|mesh-ancestor
154640440|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640441|NCT01975246|Amlodipine|amlodipine|mesh-list
154640442|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154640443|NCT01975246|Telmisartan|telmisartan|mesh-list
154640444|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154640445|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154640446|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154640447|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154640448|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640449|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154640450|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640451|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
154640452|NCT01975246|Diuretics|diuretics|mesh-ancestor
154640453|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
154640454|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154640455|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154640456|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154640457|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154640458|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154640459|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640460|NCT02379715|Remifentanil|remifentanil|mesh-list
154640461|NCT02379715|Desflurane|desflurane|mesh-list
154640462|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154640463|NCT02379715|Narcotics|narcotics|mesh-ancestor
154640464|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640465|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640466|NCT02379715|Analgesics|analgesics|mesh-ancestor
154640467|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
154640468|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640469|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154640470|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
154640471|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
154640472|NCT04439773|Lidocaine|lidocaine|mesh-list
154640473|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
154640474|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
154640475|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640476|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640477|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
154640478|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640479|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154640480|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154640481|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154640482|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154640483|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640484|NCT02389231|Interleukin-2|interleukin-2|mesh-list
154640485|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640486|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640487|NCT02389231|Analgesics|analgesics|mesh-ancestor
154640488|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
154640489|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640490|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640491|NCT02383927|Tipifarnib|tipifarnib|mesh-list
154640492|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640493|NCT02383771|Aspirin|aspirin|mesh-list
154640494|NCT02383771|Ticagrelor|ticagrelor|mesh-list
154640495|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154640496|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640497|NCT02383771|Analgesics|analgesics|mesh-ancestor
154640498|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
154640499|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640500|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640501|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154640502|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640503|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154640504|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154640505|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640506|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154640507|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154640508|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640509|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
154640510|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154640511|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154640512|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154640513|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
154640514|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640515|NCT02378623|Apixaban|apixaban|mesh-list
154640516|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154640517|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
154640518|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154640519|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
154640520|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640521|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640522|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
154640523|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
154640524|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154640525|NCT02372149|Antibodies|antibodies|mesh-list
154640526|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
154640527|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154640528|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
154640529|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640530|NCT02661061|Midazolam|midazolam|mesh-list
154640531|NCT02661061|Ketamine|ketamine|mesh-list
154640532|NCT02661061|Analgesics|analgesics|mesh-ancestor
154640533|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
154640534|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640535|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640536|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154253315|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154640537|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154640538|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
154640540|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640541|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154640542|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154640543|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640544|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640545|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154640546|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154640547|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154640548|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154640549|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154640550|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
154640551|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
154640552|NCT02376985|Everolimus|everolimus|mesh-list
154640553|NCT02376985|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154640554|NCT02376985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154640555|NCT02376985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640556|NCT02376985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640557|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154640558|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
154640559|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640560|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640561|NCT02371993|Choline|choline|mesh-list
154640562|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
154640563|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154640564|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
154640565|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640566|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154640567|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154640568|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
154640569|NCT02371603|Pioglitazone|pioglitazone|mesh-list
154640570|NCT02371603|Trimethoprim|trimethoprim|mesh-list
154640571|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154640572|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154640573|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154640574|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
154640575|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640576|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154640577|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154640578|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640579|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154640580|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640581|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154640582|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640583|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
154640584|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154640585|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154640586|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154640587|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154640588|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154640589|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154640590|NCT04149145|Niraparib|niraparib|mesh-list
154640591|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154640592|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640593|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640594|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640595|NCT02378389|Docetaxel|docetaxel|mesh-list
154640596|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640597|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
154640598|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
154640599|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
154640600|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640601|NCT02376595|Bromides|bromides|mesh-list
154640602|NCT02376595|Rocuronium|rocuronium|mesh-list
154640603|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
154640604|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154640605|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154640606|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154640607|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640608|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640609|NCT02370745|Insulin|insulin|mesh-list
154640610|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154640611|NCT02370745|Incretins|incretins|mesh-list
154640612|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253389|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
154640613|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640614|NCT02370745|Hormones|hormones|mesh-ancestor
154640615|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640616|NCT02376049|Betamethasone|betamethasone|mesh-list
154640617|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
154640618|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154640619|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
154640620|NCT02376049|Clobetasol|clobetasol|mesh-list
154640621|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
154640622|NCT02376049|Emollients|emollients|mesh-list
154640623|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154640624|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154640625|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
154640626|NCT02376049|Hormones|hormones|mesh-ancestor
154640627|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640628|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640629|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154640630|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
154640631|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154640632|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640633|NCT02376049|Analgesics|analgesics|mesh-ancestor
154640634|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
154640635|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640636|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640637|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640638|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154640639|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
154640640|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154640641|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640642|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640643|NCT02376205|Bupivacaine|bupivacaine|mesh-list
154640644|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154640645|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
154640646|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
154640647|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640648|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640649|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
154640650|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640651|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
154640652|NCT02370433|Neostigmine|neostigmine|mesh-list
154640653|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154640654|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640655|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640656|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
154640657|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640658|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640659|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154640660|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
154640661|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640662|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154640663|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154640664|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154640665|NCT01957150|Fluticasone|fluticasone|mesh-list
154640666|NCT01957150|Xhance|xhance|mesh-list
154640667|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154640668|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154640669|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
154640670|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640671|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640672|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154640673|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
154640674|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640675|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154640676|NCT01995526|Insulin|insulin|mesh-list
154640677|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154640678|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640679|NCT01973218|Vaccines|vaccines|mesh-list
154640680|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
154640681|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640682|NCT01946152|Dexamethasone|dexamethasone|mesh-list
154640683|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
154640684|NCT01946152|Pomalidomide|pomalidomide|mesh-list
154640685|NCT01946152|Ichthammol|ichthammol|mesh-list
154640686|NCT01946152|Lenograstim|lenograstim|mesh-list
154640687|NCT01946152|BB 1101|bb 1101|mesh-list
154640688|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154640689|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
154640690|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
154640691|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640692|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640693|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154640695|NCT01946152|Hormones|hormones|mesh-ancestor
154640696|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640697|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154640698|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640699|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154640700|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
154640701|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
154640702|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640703|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640704|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154640705|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154640706|NCT01946152|Growth Substances|growth substances|mesh-ancestor
154640707|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
154640708|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640709|NCT01971346|Etanercept|etanercept|mesh-list
154640710|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154640711|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640712|NCT01971346|Analgesics|analgesics|mesh-ancestor
154640713|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
154640714|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640715|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640716|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154640717|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640718|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154640719|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154640720|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
154640721|NCT01945216|Alogliptin|alogliptin|mesh-list
154640722|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154640723|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640724|NCT01945216|Incretins|incretins|mesh-ancestor
154640725|NCT01945216|Hormones|hormones|mesh-ancestor
154640726|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154640727|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154640728|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
154355592|NCT03449524|CXA-10|cxa-10|mesh-list
154640729|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640730|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640731|NCT02641379|Ribavirin|ribavirin|mesh-list
154640732|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154640733|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
154640734|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640735|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
154640736|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640737|NCT02660983|Donepezil|donepezil|mesh-list
154640738|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154640739|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640740|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640741|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
154640742|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640743|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640744|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
154640745|NCT05070221|Axitinib|axitinib|mesh-list
154640746|NCT05070221|Antibodies|antibodies|mesh-list
154640747|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154640748|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
154640749|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640750|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640751|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154640752|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640753|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640754|NCT04404439|Topiramate|topiramate|mesh-list
154640755|NCT04404439|Verapamil|verapamil|mesh-list
154640756|NCT04404439|Paroxetine|paroxetine|mesh-list
154640757|NCT04404439|Nortriptyline|nortriptyline|mesh-list
154640758|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
154640759|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154640760|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640761|NCT04404439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154640762|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154640763|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154640764|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640765|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640766|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
154640767|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154640768|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
154640769|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154640770|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154640771|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154640772|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640773|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154640774|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154640775|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154640776|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
154640777|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154640778|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154640779|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
154640780|NCT01953328|Atorvastatin|atorvastatin|mesh-list
154640781|NCT01953328|Evolocumab|evolocumab|mesh-list
154640782|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154640783|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154640784|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154640785|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
154640786|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640787|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154640788|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154640789|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640790|NCT01953328|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154640791|NCT01953328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154640792|NCT01953328|Protease Inhibitors|protease inhibitors|mesh-ancestor
154640793|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
154640794|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640795|NCT03100955|Cisplatin|cisplatin|mesh-list
154640796|NCT03100955|Etoposide|etoposide|mesh-list
154640797|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
154640798|NCT03100955|Apatinib|apatinib|mesh-list
154640799|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640800|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154640801|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154640802|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154640803|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640804|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640805|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154640806|NCT02377609|Tacrolimus|tacrolimus|mesh-list
154640807|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154640808|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
154640809|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640810|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154640811|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640812|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640813|NCT02369965|Ritonavir|ritonavir|mesh-list
154640814|NCT02369965|Lopinavir|lopinavir|mesh-list
154640815|NCT02369965|Tenofovir|tenofovir|mesh-list
154640816|NCT02369965|Lamivudine|lamivudine|mesh-list
154640817|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154640818|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154640819|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
154640820|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640821|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640822|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154640823|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154640824|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
154640825|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640826|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154640827|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154640828|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154640829|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154640830|NCT02640755|Paclitaxel|paclitaxel|mesh-list
154640831|NCT02640755|Fulvestrant|fulvestrant|mesh-list
154640832|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154640833|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640834|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
154640835|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
154640836|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
154640837|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640838|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154253618|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
154640839|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154640840|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154640841|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154640842|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355706|NCT01235819|Incretins|incretins|mesh-ancestor
154640843|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640844|NCT04400539|Nivolumab|nivolumab|mesh-list
154640845|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154640846|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640847|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154640848|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640849|NCT03099785|Rifamycins|rifamycins|mesh-list
154640850|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
154640851|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154640852|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640853|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640854|NCT02375503|Vitamin D|vitamin d|mesh-list
154640855|NCT02375503|Calcium|calcium|mesh-list
154640856|NCT02375503|Vitamins|vitamins|mesh-ancestor
154640857|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
154640858|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640859|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154640860|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154640861|NCT00867191|Desloratadine|desloratadine|mesh-list
154640862|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154640863|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
154640864|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640865|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640866|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640867|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154640868|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154640869|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
154640870|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
154640871|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
154640872|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154640873|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640874|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154640875|NCT02643251|Clonidine|clonidine|mesh-list
154640876|NCT02643251|Analgesics|analgesics|mesh-ancestor
154640877|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
154640878|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640879|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640880|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154640881|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
154640882|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
154640883|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154640884|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154640885|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154640886|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
154640887|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640888|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640889|NCT02375191|Fentanyl|fentanyl|mesh-list
154640890|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
154640891|NCT02375191|Ropivacaine|ropivacaine|mesh-list
154640892|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154640893|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640894|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640895|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154640896|NCT02375191|Analgesics|analgesics|mesh-ancestor
154640897|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
154640898|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640899|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154640900|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154640901|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154640902|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
154640903|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640904|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355766|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
154640905|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
154640906|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
154640907|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154640908|NCT02375191|Narcotics|narcotics|mesh-ancestor
154640909|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154640910|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154640911|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
154640912|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
154640913|NCT03100877|Melphalan|melphalan|mesh-list
154640914|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
154640915|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154640916|NCT03100877|Lenalidomide|lenalidomide|mesh-list
154640917|NCT03100877|Lenograstim|lenograstim|mesh-list
154640918|NCT03100877|Mitogens|mitogens|mesh-list
154640919|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154640920|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
154640921|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640922|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154640923|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154640924|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
154640925|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640926|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154640927|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154640928|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154640929|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154640930|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154640931|NCT03100877|Growth Substances|growth substances|mesh-ancestor
154640932|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
154640933|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
154640934|NCT00794495|Cetirizine|cetirizine|mesh-list
154640935|NCT00794495|Desloratadine|desloratadine|mesh-list
154640936|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154640937|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154640938|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154640939|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
154640940|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
154640941|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640942|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640943|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640944|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154640945|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
154640946|NCT04157075|Bupivacaine|bupivacaine|mesh-list
154640947|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
154640948|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
154640949|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154640950|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640951|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
154640952|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640953|NCT00763529|Fluticasone|fluticasone|mesh-list
154640954|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
154640955|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154640956|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154640957|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
154640958|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640959|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640960|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154640961|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
154640962|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
154640963|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154640964|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
154640965|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154640966|NCT03105505|Permethrin|permethrin|mesh-list
154640967|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154640968|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154640969|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640970|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154640971|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154640972|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154640973|NCT03105193|Lidocaine|lidocaine|mesh-list
154640974|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
154640975|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
154640976|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355844|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
154640977|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640978|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
154640979|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640980|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154640981|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154640982|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154640983|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154640984|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640985|NCT05066633|Metoprolol|metoprolol|mesh-list
154640986|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154640987|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154640988|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
154640989|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
154393122|NCT03710317|Misoprostol|misoprostol|mesh-list
154640990|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154640991|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154640992|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154640993|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154640994|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154640995|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
154640996|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154640997|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154640998|NCT04439305|Dasatinib|dasatinib|mesh-list
154640999|NCT04439305|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154641000|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154641001|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641002|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641003|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641004|NCT02368951|Aprutumab ixadotin|aprutumab ixadotin|mesh-list
154641005|NCT02368951|Immunoconjugates|immunoconjugates|mesh-ancestor
154641006|NCT02368951|Immunologic Factors|immunologic factors|mesh-ancestor
154641007|NCT02368951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641008|NCT02368795|Indomethacin|indomethacin|mesh-list
154641009|NCT02368795|Isosorbide|isosorbide|mesh-list
154641010|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154641011|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154641012|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154641013|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154641014|NCT02368795|Analgesics|analgesics|mesh-ancestor
154641015|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
154641016|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641017|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641018|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154641019|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154641020|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
154641021|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
154641022|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641023|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154641024|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641025|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641026|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154641027|NCT02368795|Diuretics|diuretics|mesh-ancestor
154641028|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
154641029|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
154641030|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154641031|NCT00650663|Simvastatin|simvastatin|mesh-list
154641032|NCT00650663|Ezetimibe|ezetimibe|mesh-list
154641033|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154641034|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154641035|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
154641036|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641037|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154641038|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154641039|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641040|NCT02368717|Mesalamine|mesalamine|mesh-list
154641041|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154641042|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154641043|NCT02368717|Analgesics|analgesics|mesh-ancestor
154641044|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
154641045|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641046|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641047|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154641048|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154641049|NCT03100565|Lidocaine|lidocaine|mesh-list
154641050|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
154641051|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
154641052|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641053|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641054|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
154641055|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641056|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154641057|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154641058|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154641059|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154641060|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641061|NCT05035277|Aspirin|aspirin|mesh-list
154641062|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
154641063|NCT05035277|Apixaban|apixaban|mesh-list
154641064|NCT05035277|Edoxaban|edoxaban|mesh-list
154641065|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154641066|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
154641067|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154641068|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
154641069|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641070|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641071|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
154641072|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154641073|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154641074|NCT05035277|Analgesics|analgesics|mesh-ancestor
154641075|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
154641076|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641077|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641078|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154641079|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154641080|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154641081|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154641082|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154641083|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154641084|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
154641085|NCT02374645|Gefitinib|gefitinib|mesh-list
154355979|NCT03432442|Ivermectin|ivermectin|mesh-list
154641086|NCT02374645|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154641087|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154641088|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641089|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641090|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641091|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
154641092|NCT02368561|Hylan|hylan|mesh-list
154641093|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154641094|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
154641095|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641096|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
154641097|NCT02368561|Protective Agents|protective agents|mesh-ancestor
154641098|NCT04095845|Tacrine|tacrine|mesh-list
154641099|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154641100|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641101|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641102|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
154641103|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641104|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641105|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154641106|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
154641107|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641108|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
154641109|NCT02374489|Ceritinib|ceritinib|mesh-list
154641110|NCT02374489|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154641111|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154641112|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641113|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641114|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641115|NCT02374567|Topiramate|topiramate|mesh-list
154641116|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
154641117|NCT02374567|Promethazine|promethazine|mesh-list
154641118|NCT02374567|Pregabalin|pregabalin|mesh-list
154641119|NCT02374567|Lamotrigine|lamotrigine|mesh-list
154641120|NCT02374567|Lacosamide|lacosamide|mesh-list
154641121|NCT02374567|Carbamazepine|carbamazepine|mesh-list
154641122|NCT02374567|Phenytoin|phenytoin|mesh-list
154641123|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
154641124|NCT02374567|Nicergoline|nicergoline|mesh-list
154641125|NCT02374567|Midazolam|midazolam|mesh-list
154641126|NCT02374567|Diazepam|diazepam|mesh-list
154641127|NCT02374567|Triazolam|triazolam|mesh-list
154641128|NCT02374567|Acamprosate|acamprosate|mesh-list
154641129|NCT02374567|Gabapentin|gabapentin|mesh-list
154641130|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154641131|NCT02374567|Amitriptyline|amitriptyline|mesh-list
154641132|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
154641133|NCT02374567|Levetiracetam|levetiracetam|mesh-list
154641134|NCT02374567|Valproic Acid|valproic acid|mesh-list
154641135|NCT02374567|Lorazepam|lorazepam|mesh-list
154641136|NCT02374567|Clonazepam|clonazepam|mesh-list
154641137|NCT02374567|Phenobarbital|phenobarbital|mesh-list
154641138|NCT02374567|Clobazam|clobazam|mesh-list
154641139|NCT02374567|Zaleplon|zaleplon|mesh-list
154393288|NCT04762680|Vaccines|vaccines|mesh-list
154641140|NCT02374567|Nitrazepam|nitrazepam|mesh-list
154641141|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
154641142|NCT02374567|Memantine|memantine|mesh-list
154641143|NCT02374567|Biperiden|biperiden|mesh-list
154641144|NCT02374567|Haloperidol|haloperidol|mesh-list
154641145|NCT02374567|Pimozide|pimozide|mesh-list
154641146|NCT02374567|Olanzapine|olanzapine|mesh-list
154641147|NCT02374567|Zolpidem|zolpidem|mesh-list
154641148|NCT02374567|Alprazolam|alprazolam|mesh-list
154641149|NCT02374567|Zopiclone|zopiclone|mesh-list
154641150|NCT02374567|Agomelatine|agomelatine|mesh-list
154641151|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
154641152|NCT02374567|Doxepin|doxepin|mesh-list
154641153|NCT02374567|Oxazepam|oxazepam|mesh-list
154641154|NCT02374567|Temazepam|temazepam|mesh-list
154641155|NCT02374567|Brotizolam|brotizolam|mesh-list
154641156|NCT02374567|Lormetazepam|lormetazepam|mesh-list
154641157|NCT02374567|Flurazepam|flurazepam|mesh-list
154641158|NCT02374567|Mirtazapine|mirtazapine|mesh-list
154641159|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
154641160|NCT02374567|Buspirone|buspirone|mesh-list
154641161|NCT02374567|Trazodone|trazodone|mesh-list
154641162|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
154641163|NCT02374567|Bromazepam|bromazepam|mesh-list
154641164|NCT02374567|Risperidone|risperidone|mesh-list
154641165|NCT02374567|Melatonin|melatonin|mesh-list
154641166|NCT02374567|Aripiprazole|aripiprazole|mesh-list
154641167|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154641168|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154641169|NCT02374567|Ziprasidone|ziprasidone|mesh-list
154641170|NCT02374567|Clozapine|clozapine|mesh-list
154641171|NCT02374567|Amisulpride|amisulpride|mesh-list
154641172|NCT02374567|Flupenthixol|flupenthixol|mesh-list
154641173|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154641174|NCT02374567|Perphenazine|perphenazine|mesh-list
154641175|NCT02374567|Sertindole|sertindole|mesh-list
154641176|NCT02374567|Fluphenazine|fluphenazine|mesh-list
154641177|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
154641178|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
154641179|NCT02374567|Sulpiride|sulpiride|mesh-list
154641180|NCT02374567|Thioridazine|thioridazine|mesh-list
154641181|NCT02374567|Pipamperone|pipamperone|mesh-list
154641182|NCT02374567|Clopenthixol|clopenthixol|mesh-list
154641183|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
154641184|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
154641185|NCT02374567|Fluspirilene|fluspirilene|mesh-list
154641186|NCT02374567|Benperidol|benperidol|mesh-list
154641187|NCT02374567|Bromperidol|bromperidol|mesh-list
154641188|NCT02374567|Perazine|perazine|mesh-list
154641189|NCT02374567|Rivastigmine|rivastigmine|mesh-list
154641190|NCT02374567|Piracetam|piracetam|mesh-list
154641191|NCT02374567|Donepezil|donepezil|mesh-list
154641192|NCT02374567|Galantamine|galantamine|mesh-list
154641193|NCT02374567|Citalopram|citalopram|mesh-list
154641194|NCT02374567|Bupropion|bupropion|mesh-list
154641195|NCT02374567|Sertraline|sertraline|mesh-list
154641196|NCT02374567|Fluoxetine|fluoxetine|mesh-list
154641197|NCT02374567|Paroxetine|paroxetine|mesh-list
154641198|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154641199|NCT02374567|Nortriptyline|nortriptyline|mesh-list
154641200|NCT02374567|Reboxetine|reboxetine|mesh-list
154641201|NCT02374567|Imipramine|imipramine|mesh-list
154641202|NCT02374567|Clomipramine|clomipramine|mesh-list
154641203|NCT02374567|Mianserin|mianserin|mesh-list
154641204|NCT02374567|Moclobemide|moclobemide|mesh-list
154641205|NCT02374567|Opipramol|opipramol|mesh-list
154641206|NCT02374567|Maprotiline|maprotiline|mesh-list
154641207|NCT02374567|Trimipramine|trimipramine|mesh-list
154641208|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
154641209|NCT02374567|Escitalopram|escitalopram|mesh-list
154641210|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154641211|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154641212|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641213|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641214|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154641215|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154641216|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154641217|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154641218|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
154641219|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
154641220|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
154641221|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
154641222|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641223|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641224|NCT02374567|Analgesics|analgesics|mesh-ancestor
154641225|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
154641226|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641227|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
154641228|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154641229|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154641230|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154641231|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154641232|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154641233|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
154641234|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154641235|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
154641236|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154641237|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154641238|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
154641239|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
154641240|NCT02374567|Protective Agents|protective agents|mesh-ancestor
154641241|NCT02374567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154641242|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154641243|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154641244|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154641245|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
154641246|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
154641247|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154641248|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154641249|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
154641250|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154641251|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
154641252|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
154641253|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641254|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154641255|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154641256|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154641257|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641258|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
154641259|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154641260|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154356114|NCT01243697|Hormones|hormones|mesh-ancestor
154641261|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154641262|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154641263|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154641264|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154641265|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
154641266|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154641267|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154641268|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154641269|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
154641270|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154641271|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
154641272|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
154641273|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154641274|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
154641275|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
154641276|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154641277|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
154641278|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154641279|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154641280|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154641281|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154641282|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
154641283|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154641284|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154641285|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154641286|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154641287|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154641288|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154641289|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154641290|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154641291|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154641292|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154641293|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
154641294|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154641295|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154641296|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154641297|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154641298|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154641299|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154641300|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
154641301|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
154641302|NCT03965741|Apixaban|apixaban|mesh-list
154641303|NCT03965741|Dabigatran|dabigatran|mesh-list
154641304|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154641305|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
154641306|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154641307|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
154641308|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641309|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641310|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
154641311|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
154641312|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
154641313|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154641314|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
154641315|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641316|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641317|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154641318|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
154641319|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154641320|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
154641321|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641322|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641323|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154641324|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
154641325|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
154641326|NCT02368171|Protective Agents|protective agents|mesh-ancestor
154641327|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
154641329|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
154641330|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154641331|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154641332|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154641333|NCT02368015|Cefazolin|cefazolin|mesh-list
154641334|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154641335|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154641336|NCT02373943|Carotenoids|carotenoids|mesh-list
154641337|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
154641338|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641339|NCT02373943|Protective Agents|protective agents|mesh-ancestor
154641340|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641341|NCT02368249|Terlipressin|terlipressin|mesh-list
154641342|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154641343|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154641344|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
154641345|NCT02367937|Midazolam|midazolam|mesh-list
154641346|NCT02367937|Omeprazole|omeprazole|mesh-list
154641347|NCT02367937|Simvastatin|simvastatin|mesh-list
154641348|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154641349|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154641350|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641351|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641352|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154641353|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154641354|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154641355|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154641356|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
154641357|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
154641358|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
154641359|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
154641360|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641361|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641362|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154641363|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154641364|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
154641365|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154641366|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154641367|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641368|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154641369|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641370|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154641371|NCT02367937|Analgesics|analgesics|mesh-ancestor
154641372|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
154641373|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641374|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154641375|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154641376|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154641377|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154641378|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154641379|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154641380|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154641381|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154641382|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
154641383|NCT05061641|Progesterone|progesterone|mesh-list
154641384|NCT05061641|Progestins|progestins|mesh-ancestor
154641385|NCT05061641|Hormones|hormones|mesh-ancestor
154641386|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641387|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641388|NCT03100019|Resveratrol|resveratrol|mesh-list
154641390|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641391|NCT03100019|Protective Agents|protective agents|mesh-ancestor
154641392|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641393|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641394|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154641395|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154641396|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641397|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641398|NCT05046041|Misoprostol|misoprostol|mesh-list
154641399|NCT05046041|Mifepristone|mifepristone|mesh-list
154641400|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154641401|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
154641402|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641403|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641404|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154641405|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641406|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
154641407|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154641408|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154641409|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154641410|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154641411|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
154641412|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154641413|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154641414|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
154641415|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641416|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
154641417|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154641418|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154641419|NCT01970878|Bromides|bromides|mesh-list
154641420|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
154641421|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154641422|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
154641423|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641424|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641425|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154641426|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
154641427|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
154641428|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154641429|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
154641430|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641431|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641432|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
154641433|NCT05045651|Cimetidine|cimetidine|mesh-list
154641434|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154641435|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641436|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154356288|NCT01143545|Analgesics|analgesics|mesh-ancestor
154641437|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
154641438|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
154641439|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641440|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641441|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641442|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154641443|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154641444|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641445|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
154641446|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154641447|NCT05059145|Fluconazole|fluconazole|mesh-list
154641448|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154641449|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154641450|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
154641451|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154641452|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
154641453|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154641454|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154641455|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641456|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641457|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154641458|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
154641459|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641460|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641461|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154641462|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154641464|NCT01970488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154641465|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154641466|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154641467|NCT03097835|Anesthetics|anesthetics|mesh-list
154641468|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641469|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641470|NCT03097601|Sunitinib|sunitinib|mesh-list
154641471|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641472|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154641473|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154641474|NCT03097601|Growth Substances|growth substances|mesh-ancestor
154641475|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641476|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
154641477|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154641478|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641479|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641480|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
154641481|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154641482|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
154641483|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641484|NCT05058209|Triamcinolone|triamcinolone|mesh-list
154641485|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154641486|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154641487|NCT05058209|Betamethasone|betamethasone|mesh-list
154641488|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
154641489|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154641490|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
154641491|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
154641492|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154641493|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154641494|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154641495|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
154641496|NCT05058209|Hormones|hormones|mesh-ancestor
154641497|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641498|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641499|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154641500|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
154641501|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641502|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641503|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154641504|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
154641505|NCT05057663|Fluorouracil|fluorouracil|mesh-list
154641506|NCT05057663|Bleomycin|bleomycin|mesh-list
154641507|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
154641508|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641509|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154641510|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641511|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154641512|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
154641513|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641514|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154641515|NCT03097445|Nicotine|nicotine|mesh-list
154641516|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154641517|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
154641518|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641519|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641520|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154641521|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154641522|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
154641523|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641524|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641525|NCT05057351|Glycerol|glycerol|mesh-list
154641526|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154641527|NCT05057351|Protective Agents|protective agents|mesh-ancestor
154641528|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641529|NCT03097211|Levodopa|levodopa|mesh-list
154641530|NCT03097211|Benserazide|benserazide|mesh-list
154641531|NCT03097211|Resveratrol|resveratrol|mesh-list
154641532|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
154641533|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154641534|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154641535|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
154641536|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641537|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641538|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641539|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
154641540|NCT03097211|Protective Agents|protective agents|mesh-ancestor
154641541|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641542|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154641543|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
154641544|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154641545|NCT05056337|Lenvatinib|lenvatinib|mesh-list
154641546|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641547|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154641548|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641549|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641550|NCT05056025|Vitamins|vitamins|mesh-list
154641551|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
154641552|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641553|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154641554|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154641555|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641556|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154641557|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641558|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641559|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641560|NCT01952080|Teduglutide|teduglutide|mesh-list
154641561|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641562|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154641563|NCT01952080|Protective Agents|protective agents|mesh-ancestor
154641564|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641565|NCT01951378|Albuterol|albuterol|mesh-list
154641566|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154641567|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
154641568|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641569|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641570|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154641571|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
154641572|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
154641573|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641574|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154641575|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154641576|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154641577|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
154641578|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641579|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641580|NCT05043233|Methimazole|methimazole|mesh-list
154641581|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
154641582|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
154641583|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641584|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641585|NCT05054465|Venetoclax|venetoclax|mesh-list
154641586|NCT05054465|Navitoclax|navitoclax|mesh-list
154641587|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641588|NCT03860233|Oxytocin|oxytocin|mesh-list
154641589|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
154641590|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641591|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641592|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154641593|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
154641594|NCT01361009|Pramipexole|pramipexole|mesh-list
154641595|NCT01361009|Dexpramipexole|dexpramipexole|mesh-list
154641596|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
154641597|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641598|NCT01361009|Protective Agents|protective agents|mesh-ancestor
154641599|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641600|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154641601|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154641602|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
154641603|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
154641604|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641605|NCT02373163|Amlodipine|amlodipine|mesh-list
154641606|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154641607|NCT02373163|Telmisartan|telmisartan|mesh-list
154641608|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154641609|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154641610|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154641611|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641612|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154641613|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641614|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
154641616|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
154641617|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154641618|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154641619|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154641620|NCT02366377|Metformin|metformin|mesh-list
154641621|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154641622|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641623|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
154641624|NCT02366299|Propofol|propofol|mesh-list
154641625|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154641626|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641627|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641628|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154641629|NCT02366299|Analgesics|analgesics|mesh-ancestor
154641630|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
154641631|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641632|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154641633|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154641634|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154641635|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
154641636|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641637|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641638|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154641639|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
154641640|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
154641641|NCT05041985|Diazepam|diazepam|mesh-list
154641642|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154641643|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
154641644|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
154641645|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
154641646|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641647|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641648|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641649|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154641650|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641651|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154641652|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154641653|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154641654|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154641655|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154641656|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154641657|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
154641658|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
154641659|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
154641660|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
154641661|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641662|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641663|NCT05053841|Metformin|metformin|mesh-list
154641664|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154641665|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641666|NCT02372461|Amoxicillin|amoxicillin|mesh-list
154641667|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154641668|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154641669|NCT04499131|Progesterone|progesterone|mesh-list
154641670|NCT04499131|Progestins|progestins|mesh-ancestor
154641671|NCT04499131|Hormones|hormones|mesh-ancestor
154641672|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641673|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641674|NCT02366065|Acetaminophen|acetaminophen|mesh-list
154641675|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154641676|NCT02366065|Analgesics|analgesics|mesh-ancestor
154641677|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
154641678|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641679|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641680|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
154641681|NCT02362945|Oxytocin|oxytocin|mesh-list
154641682|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
154641683|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641684|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393809|NCT04911361|Dexamethasone|dexamethasone|mesh-list
154641685|NCT02365909|Bupivacaine|bupivacaine|mesh-list
154641686|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
154641687|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
154641688|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641689|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641690|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
154641691|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641693|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641694|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
154641695|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154641696|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
154641697|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641698|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154641699|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
154641700|NCT02365675|Petrolatum|petrolatum|mesh-list
154641701|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154641702|NCT02365675|Laxatives|laxatives|mesh-ancestor
154641703|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641704|NCT02365675|Emollients|emollients|mesh-ancestor
154641705|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
154641706|NCT05052437|Capecitabine|capecitabine|mesh-list
154641707|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154641708|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
154641709|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641710|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641711|NCT05052359|Lectins|lectins|mesh-list
154641712|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
154641713|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
154641714|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641715|NCT05052359|Coagulants|coagulants|mesh-ancestor
154641716|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
154641717|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154641718|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154641719|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
154641720|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641721|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641722|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154641723|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154641724|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154641725|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154641726|NCT02362711|Estrogens|estrogens|mesh-ancestor
154641727|NCT02362711|Hormones|hormones|mesh-ancestor
154641728|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641729|NCT01944046|Oxytocin|oxytocin|mesh-list
154641730|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
154641731|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641732|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641733|NCT00773695|Paclitaxel|paclitaxel|mesh-list
154641734|NCT00773695|Docetaxel|docetaxel|mesh-list
154641735|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
154641736|NCT00773695|Bevacizumab|bevacizumab|mesh-list
154641737|NCT00773695|Fluorouracil|fluorouracil|mesh-list
154641738|NCT00773695|Epirubicin|epirubicin|mesh-list
154641739|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154641740|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154641741|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641742|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
154641743|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
154641744|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
154641745|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641746|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154641747|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
154641748|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641749|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154641750|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154641751|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
154641752|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154641753|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154641754|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154641755|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154641756|NCT00773695|Growth Substances|growth substances|mesh-ancestor
154641757|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
154641758|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
154641759|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154641760|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154641761|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393877|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154641762|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154641763|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
154641764|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641765|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154641766|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154641767|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154641768|NCT01969084|Linagliptin|linagliptin|mesh-list
154641769|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154641770|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641771|NCT01969084|Incretins|incretins|mesh-ancestor
154641772|NCT01969084|Hormones|hormones|mesh-ancestor
154641773|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641774|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154641775|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
154641776|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641777|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641778|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
154641779|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641780|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
154641781|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154641782|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154641783|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641784|NCT02362399|Urological Agents|urological agents|mesh-ancestor
154641785|NCT04410887|Olaparib|olaparib|mesh-list
154641786|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154641787|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641788|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641789|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641790|NCT02358499|Posaconazole|posaconazole|mesh-list
154641791|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
154641792|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154641793|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154641794|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154641795|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154641796|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154641797|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154641798|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641799|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641800|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154641801|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
154641802|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641803|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641804|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
154641805|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
154641806|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
154641807|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641808|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154641809|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
154641810|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
154641811|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641812|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641813|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641814|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154641815|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
154641816|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154641817|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
154641818|NCT01968694|Promethazine|promethazine|mesh-list
154641819|NCT01968694|Lidocaine|lidocaine|mesh-list
154641820|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
154641821|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
154641822|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641823|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641824|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
154641825|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641826|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154641827|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154641828|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154641829|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154641830|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641831|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154641832|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154641833|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
154641834|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
154641835|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641836|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154641837|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
154641839|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641840|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154641841|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
154641842|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
154641843|NCT05038007|Bupivacaine|bupivacaine|mesh-list
154641844|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
154641845|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
154641846|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641847|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641848|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
154641849|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641850|NCT02362165|Dexamethasone|dexamethasone|mesh-list
154641851|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
154641852|NCT02362165|Doxorubicin|doxorubicin|mesh-list
154641853|NCT02362165|Bortezomib|bortezomib|mesh-list
154641854|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154641855|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
154641856|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641857|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154641858|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154641859|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
154641860|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641861|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641862|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154641863|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154641864|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
154641865|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
154641866|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641867|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641868|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
154641869|NCT02362165|Hormones|hormones|mesh-ancestor
154641870|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641871|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154641872|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154641873|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154641874|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154641875|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641876|NCT05049473|Cytarabine|cytarabine|mesh-list
154641877|NCT05049473|Dexamethasone|dexamethasone|mesh-list
154641878|NCT05049473|Prednisone|prednisone|mesh-list
154641879|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
154641880|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
154641881|NCT05049473|Rituximab|rituximab|mesh-list
154641882|NCT05049473|Doxorubicin|doxorubicin|mesh-list
154641883|NCT05049473|Methotrexate|methotrexate|mesh-list
154641884|NCT05049473|Etoposide|etoposide|mesh-list
154641885|NCT05049473|Vincristine|vincristine|mesh-list
154641886|NCT05049473|Vindesine|vindesine|mesh-list
154641887|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154641888|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
154641889|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641890|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154641891|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154641892|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
154641893|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641894|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641895|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154641896|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154641897|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154641898|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
154641899|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
154641900|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641901|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641902|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
154641903|NCT05049473|Hormones|hormones|mesh-ancestor
154641904|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641905|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154641906|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154641907|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154641908|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154641909|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641910|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154641911|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
154641912|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641913|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154641915|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
154641916|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154641917|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154641918|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154641919|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
154641920|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154641921|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
154641922|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
154641923|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
154641924|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
154641925|NCT02361931|Hematinics|hematinics|mesh-ancestor
154641926|NCT05037695|Empagliflozin|empagliflozin|mesh-list
154641927|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154641928|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641929|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154641930|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641931|NCT02357563|Leuprolide|leuprolide|mesh-list
154641932|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
154641933|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154641934|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
154641935|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154641936|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641937|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154641938|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641939|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154641940|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
154641941|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154641942|NCT02640053|Paclitaxel|paclitaxel|mesh-list
154641943|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154641944|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154641945|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154641946|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
154641947|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
154641948|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
154641949|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641950|NCT03160261|Exenatide|exenatide|mesh-list
154641951|NCT03160261|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154641952|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154641953|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641954|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154641955|NCT03160261|Incretins|incretins|mesh-ancestor
154641956|NCT03160261|Hormones|hormones|mesh-ancestor
154641957|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154641958|NCT02361775|Ropivacaine|ropivacaine|mesh-list
154641959|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
154641960|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
154641961|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641962|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641963|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
154641964|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154641965|NCT02361619|Clarithromycin|clarithromycin|mesh-list
154641966|NCT02361619|Diclofenac|diclofenac|mesh-list
154641967|NCT02361619|Metoprolol|metoprolol|mesh-list
154641968|NCT02361619|Midazolam|midazolam|mesh-list
154641969|NCT02361619|Caffeine|caffeine|mesh-list
154641970|NCT02361619|Esomeprazole|esomeprazole|mesh-list
154641971|NCT02361619|Dabigatran|dabigatran|mesh-list
154641972|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154641973|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154641974|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154641975|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154641976|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154641977|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154641978|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154641979|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154641980|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
154641981|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
154641982|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
154641983|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
154641984|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154641985|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154641986|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154641987|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154641988|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154641989|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154641990|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154641991|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
154641992|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154641993|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154641994|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154641995|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154641996|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154641997|NCT02361619|Analgesics|analgesics|mesh-ancestor
154641998|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
154641999|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642000|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642001|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642002|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154642003|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154642004|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642005|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154642006|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154642007|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154642008|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
154642009|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154642010|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
154642011|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
154642012|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154642013|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154642014|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
154642015|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
154642016|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154642017|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154642018|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154642019|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
154642020|NCT02352025|Equol|equol|mesh-list
154642021|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
154642022|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154642023|NCT02352025|Estrogens|estrogens|mesh-ancestor
154642024|NCT02352025|Hormones|hormones|mesh-ancestor
154642025|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642026|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642027|NCT01950364|Rifampin|rifampin|mesh-list
154642028|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154642029|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154642030|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154642031|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
154642032|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154642033|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642034|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
154642035|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154642036|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642037|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642038|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154642039|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154642040|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154642041|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154642042|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154642043|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154642044|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154642045|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642046|NCT01950364|Immunotoxins|immunotoxins|mesh-ancestor
154642047|NCT01950364|Immunoconjugates|immunoconjugates|mesh-ancestor
154642048|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
154642049|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642050|NCT05047991|Leucovorin|leucovorin|mesh-list
154642051|NCT05047991|Paclitaxel|paclitaxel|mesh-list
154642052|NCT05047991|Gemcitabine|gemcitabine|mesh-list
154642053|NCT05047991|Fluorouracil|fluorouracil|mesh-list
154642054|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
154642055|NCT05047991|Irinotecan|irinotecan|mesh-list
154642056|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154642057|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642058|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154642059|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154642060|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154642061|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642062|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154642063|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
154642064|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642065|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
154642066|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642067|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154642068|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154642069|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642070|NCT05047991|Antidotes|antidotes|mesh-ancestor
154642071|NCT05047991|Protective Agents|protective agents|mesh-ancestor
154642072|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
154642074|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
154642075|NCT00014443|Thalidomide|thalidomide|mesh-list
154642076|NCT00014443|Topotecan|topotecan|mesh-list
154642077|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154642078|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154642079|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642080|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642081|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642082|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642083|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
154642084|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642085|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
154642086|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154642087|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642088|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154642089|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154642090|NCT00014443|Growth Substances|growth substances|mesh-ancestor
154642091|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
154642092|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
154642093|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154642094|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154642095|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642096|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
154642097|NCT05047133|Coagulants|coagulants|mesh-ancestor
154642098|NCT04334863|Tyrphostins|tyrphostins|mesh-list
154642099|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642100|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642101|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642102|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
154642103|NCT02357407|Ofloxacin|ofloxacin|mesh-list
154642104|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154642105|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642106|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154642107|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154642108|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642109|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642110|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642111|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154642112|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154642113|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154642114|NCT02038699|TIC10 compound|tic10 compound|mesh-list
154642115|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642116|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
154642117|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154642118|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154642119|NCT03160651|Prednisolone|prednisolone|mesh-list
154642120|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
154642121|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154642122|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
154642123|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642124|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
154642125|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
154642126|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642127|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642128|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154642129|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
154642130|NCT03160651|Hormones|hormones|mesh-ancestor
154642131|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642132|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154642133|NCT03160651|Protective Agents|protective agents|mesh-ancestor
154642134|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154642135|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642136|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
154642137|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154642138|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
154642139|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642140|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
154642141|NCT05034965|Protective Agents|protective agents|mesh-ancestor
154642142|NCT05034887|Trastuzumab|trastuzumab|mesh-list
154642143|NCT05034887|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154642144|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154642145|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642146|NCT05034887|Immunoconjugates|immunoconjugates|mesh-ancestor
154642147|NCT05034887|Immunologic Factors|immunologic factors|mesh-ancestor
154642148|NCT05034887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642149|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
154642150|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154642151|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
154642152|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642153|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642154|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154642155|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
154642156|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
154642157|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154642158|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
154642159|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642160|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642161|NCT05024825|Acetaminophen|acetaminophen|mesh-list
154642162|NCT05024825|Ibuprofen|ibuprofen|mesh-list
154642163|NCT05024825|Gabapentin|gabapentin|mesh-list
154642164|NCT05024825|Hydrocodone|hydrocodone|mesh-list
154642165|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154642166|NCT05024825|Analgesics|analgesics|mesh-ancestor
154642167|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
154642168|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642169|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642170|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
154642171|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154642172|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642173|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642174|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154642175|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642176|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642177|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
154642178|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154642179|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154642180|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642181|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154642182|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154642183|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154642184|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642185|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
154642186|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154642187|NCT05024825|Narcotics|narcotics|mesh-ancestor
154642188|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
154642189|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
154642190|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154642191|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
154642192|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
154642193|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
154642194|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
154642195|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154642196|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154642197|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642198|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642199|NCT03149653|SMOFlipid|smoflipid|mesh-list
154642200|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154642201|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154642202|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154642203|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
154642204|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154642205|NCT03093545|Antibodies|antibodies|mesh-list
154642206|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
154642207|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642208|NCT05024357|Dasatinib|dasatinib|mesh-list
154642209|NCT05024357|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154642210|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642211|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642212|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642213|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642214|NCT03095105|Resveratrol|resveratrol|mesh-list
154642215|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
154642216|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642217|NCT03095105|Protective Agents|protective agents|mesh-ancestor
154642218|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642219|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642220|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154642221|NCT01968070|Celecoxib|celecoxib|mesh-list
154642222|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154642223|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154642224|NCT01968070|Analgesics|analgesics|mesh-ancestor
154642225|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
154642226|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642227|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642228|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642229|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642230|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154642231|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154642232|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642233|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642234|NCT03093389|Resveratrol|resveratrol|mesh-list
154642235|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
154642236|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642237|NCT03093389|Protective Agents|protective agents|mesh-ancestor
154642238|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642239|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642240|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154642241|NCT01949116|Folic Acid|folic acid|mesh-list
154642242|NCT01949116|Methotrexate|methotrexate|mesh-list
154642243|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154642244|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
154642245|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154642246|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642247|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154642248|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
154642249|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642250|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642251|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
154642252|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642253|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154642254|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642255|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
154642256|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642257|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154642258|NCT01949116|Hematinics|hematinics|mesh-ancestor
154642259|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
154642260|NCT01949116|Vitamins|vitamins|mesh-ancestor
154642261|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
154642262|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
154642263|NCT01673009|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154642264|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642265|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642266|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642267|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642268|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
154642269|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154642270|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154642271|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
154642272|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642273|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642274|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642275|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
154642276|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
154642277|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642278|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
154642279|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154642280|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
154642281|NCT02350543|Aspirin|aspirin|mesh-list
154642282|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154642283|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154642284|NCT02350543|Analgesics|analgesics|mesh-ancestor
154642285|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
154642286|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642287|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394402|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
154642288|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642289|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642290|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154642291|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154642292|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642293|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154642294|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154642295|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642296|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
154642297|NCT05023577|Metronidazole|metronidazole|mesh-list
154642298|NCT05023577|Clarithromycin|clarithromycin|mesh-list
154642299|NCT05023577|Levofloxacin|levofloxacin|mesh-list
154642300|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
154642301|NCT05023577|Rabeprazole|rabeprazole|mesh-list
154642302|NCT05023577|Bismuth|bismuth|mesh-list
154642303|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642304|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642305|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154642306|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154642307|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154642308|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154642309|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642310|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154642311|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154642312|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154642313|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154642314|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154642315|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642316|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154642317|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154642318|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154642319|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154642320|NCT05023577|Antacids|antacids|mesh-ancestor
154642321|NCT05023577|Diuretics|diuretics|mesh-ancestor
154357166|NCT01239719|Clemastine|clemastine|mesh-list
154642322|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
154642323|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642324|NCT05023577|Expectorants|expectorants|mesh-ancestor
154642325|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
154642326|NCT03149419|Paroxetine|paroxetine|mesh-list
154642327|NCT03149419|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154642328|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154642329|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154642330|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642331|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642332|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
154642333|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642334|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154642335|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
154642336|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154642337|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154642338|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154642339|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642340|NCT03092765|Quetmolimab|quetmolimab|mesh-list
154642341|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642342|NCT01939366|Pregabalin|pregabalin|mesh-list
154642343|NCT01939366|Analgesics|analgesics|mesh-ancestor
154642344|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
154642345|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642346|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642347|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
154642348|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154642349|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154642350|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642351|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154642352|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154642353|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154642354|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642355|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154642356|NCT04434365|Aspirin|aspirin|mesh-list
154642357|NCT04434365|Clopidogrel|clopidogrel|mesh-list
154642358|NCT04434365|Atorvastatin|atorvastatin|mesh-list
154642359|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154642360|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154642361|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154394481|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
154642363|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
154642364|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642365|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642366|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642367|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642368|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154642369|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154642370|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642371|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154642372|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154642373|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642374|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
154642375|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154642376|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154642377|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
154642378|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154642379|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154642380|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154642381|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154642382|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154642383|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
154642384|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642385|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
154642386|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154642387|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154642388|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154642389|NCT05032001|Biguanides|biguanides|mesh-list
154642390|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642391|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154642392|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642393|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
154642394|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642395|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
154642396|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154642397|NCT05031689|Protective Agents|protective agents|mesh-ancestor
154642398|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642399|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
154642400|NCT02350231|Progesterone|progesterone|mesh-list
154642401|NCT02350231|Progestins|progestins|mesh-ancestor
154642402|NCT02350231|Hormones|hormones|mesh-ancestor
154642403|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642404|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642405|NCT01918306|Cisplatin|cisplatin|mesh-list
154642406|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642407|NCT05031143|Triamcinolone|triamcinolone|mesh-list
154642408|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154642409|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154642410|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154642411|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642412|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
154642413|NCT05031143|Hormones|hormones|mesh-ancestor
154642414|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642415|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642416|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642417|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
154642418|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642419|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642420|NCT01916980|Desloratadine|desloratadine|mesh-list
154642421|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154642422|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
154642423|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642424|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642425|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642426|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154642427|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154642428|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
154642429|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
154642430|NCT02348281|Bicalutamide|bicalutamide|mesh-list
154642431|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
154642432|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
154642433|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394555|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
154642434|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642435|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642436|NCT02349919|Procaterol|procaterol|mesh-list
154642437|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154642438|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
154642439|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642440|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642441|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154642442|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
154642443|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
154642444|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154642445|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154642446|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154642447|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
154642448|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642449|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642450|NCT02349763|Dexamethasone|dexamethasone|mesh-list
154642451|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
154642452|NCT02349763|BB 1101|bb 1101|mesh-list
154642453|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642454|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
154642455|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
154642456|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642457|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642458|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154642459|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
154642460|NCT02349763|Hormones|hormones|mesh-ancestor
154642461|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642462|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154642463|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642464|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
154642465|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642466|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642467|NCT02349841|Amoxicillin|amoxicillin|mesh-list
154642468|NCT02349841|Meropenem|meropenem|mesh-list
154642469|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
154642470|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
154642471|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154642472|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642473|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642474|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642475|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154642476|NCT02354053|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
154642477|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154642478|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154642479|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
154642480|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642481|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154642482|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642483|NCT03094481|Epinephrine|epinephrine|mesh-list
154642484|NCT03094481|Bupivacaine|bupivacaine|mesh-list
154642485|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154642486|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
154642487|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642488|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642489|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
154642490|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642491|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154642492|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154642493|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
154642494|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642495|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642496|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154642497|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154642498|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
154642499|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154642500|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
154642501|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
154642502|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
154642503|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154642504|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
154642505|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
154642506|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154642507|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154642508|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642509|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642510|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642511|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642512|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
154642513|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
154642514|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642515|NCT02348125|Protective Agents|protective agents|mesh-ancestor
154642516|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642517|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
154642518|NCT02348125|Vitamins|vitamins|mesh-ancestor
154642519|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
154642520|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
154642521|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154642522|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642523|NCT03094403|Azelaic acid|azelaic acid|mesh-list
154642524|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642525|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154642526|NCT03147157|Tacrolimus|tacrolimus|mesh-list
154642527|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642528|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
154642529|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642530|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154642531|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642532|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642533|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154642534|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154642535|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642536|NCT02347501|Incretins|incretins|mesh-ancestor
154642537|NCT02347501|Hormones|hormones|mesh-ancestor
154642538|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642539|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154642540|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
154642541|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642542|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642543|NCT03148717|Misoprostol|misoprostol|mesh-list
154642544|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154642545|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
154642546|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154642547|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642548|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154642549|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154642550|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
154642551|NCT02349607|Ibuprofen|ibuprofen|mesh-list
154642552|NCT02349607|Pregabalin|pregabalin|mesh-list
154642553|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154642554|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154642555|NCT02349607|Analgesics|analgesics|mesh-ancestor
154642556|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
154642557|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642558|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642559|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642560|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642561|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154642562|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642563|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642564|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
154642565|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154642566|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154642567|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154642568|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154642569|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154642570|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642571|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154642572|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
154642573|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154642574|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642575|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642576|NCT04478461|Antibodies|antibodies|mesh-list
154642577|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154642578|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
154642579|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642580|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154642581|NCT02353507|Laxatives|laxatives|mesh-ancestor
154642582|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154642583|NCT03148561|Misoprostol|misoprostol|mesh-list
154642584|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154642585|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
154642586|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154642587|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642588|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154642589|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154642590|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
154642591|NCT02353429|Toremifene|toremifene|mesh-list
154642592|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154642593|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642594|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154642595|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154642596|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
154642597|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642598|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642599|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154642600|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154642601|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154642602|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642603|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642604|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154642605|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154642606|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642607|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
154642608|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642609|NCT03112135|Epinephrine|epinephrine|mesh-list
154642610|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
154642611|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154642612|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154642613|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642614|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
154642615|NCT03112135|Coagulants|coagulants|mesh-ancestor
154642616|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154642617|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154642618|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
154642619|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642620|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642621|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154642622|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154642623|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
154642624|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642625|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154642626|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
154642627|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
154642628|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
154642629|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154642630|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154642631|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642632|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642633|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642634|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
154642635|NCT03146533|Fludarabine|fludarabine|mesh-list
154642636|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642637|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
154642638|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642639|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642640|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154642641|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
154642642|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642643|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642644|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154642645|NCT03090971|Diclofenac|diclofenac|mesh-list
154642646|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154642647|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154642648|NCT03090971|Analgesics|analgesics|mesh-ancestor
154642649|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
154642650|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642651|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642652|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642653|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642654|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154642655|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642656|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642657|NCT03146689|Ibuprofen|ibuprofen|mesh-list
154642658|NCT03146689|Capsaicin|capsaicin|mesh-list
154642659|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154642660|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154642661|NCT03146689|Analgesics|analgesics|mesh-ancestor
154642662|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
154642663|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642664|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642665|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642666|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642667|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154642668|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642669|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642670|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
154642671|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
154642673|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154642674|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642675|NCT05026229|Cytarabine|cytarabine|mesh-list
154642676|NCT05026229|Prednisone|prednisone|mesh-list
154642677|NCT05026229|Methotrexate|methotrexate|mesh-list
154642678|NCT05026229|Vincristine|vincristine|mesh-list
154642679|NCT05026229|Dasatinib|dasatinib|mesh-list
154642680|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642681|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
154642682|NCT05026229|Hormones|hormones|mesh-ancestor
154642683|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642684|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642685|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154642686|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642687|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154642688|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
154642689|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154642690|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154642691|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
154642692|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642693|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
154642694|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642695|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154642696|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642697|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
154642698|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642699|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154642700|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
154642701|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642702|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154642703|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
154642704|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
154642705|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
154642706|NCT05026229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154642707|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642708|NCT02343679|Ceritinib|ceritinib|mesh-list
154642709|NCT02343679|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154642710|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642711|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642712|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642713|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642714|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154642715|NCT02348905|Hormones|hormones|mesh-ancestor
154642716|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642717|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642718|NCT02347033|Sertraline|sertraline|mesh-list
154642719|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
154642720|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154642721|NCT02347033|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154642722|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154642723|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154642724|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642725|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642726|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
154357566|NCT03425656|Docetaxel|docetaxel|mesh-list
154642727|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642728|NCT04949633|Oxytocin|oxytocin|mesh-list
154642729|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
154642730|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154642731|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642732|NCT03146377|Capecitabine|capecitabine|mesh-list
154642733|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
154642734|NCT03146377|Irinotecan|irinotecan|mesh-list
154642735|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154642736|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
154642737|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642738|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642739|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154642740|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154642741|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642742|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
154642743|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154642744|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642745|NCT02346955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154642746|NCT02346955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642747|NCT03079505|Dasatinib|dasatinib|mesh-list
154642748|NCT03079505|Nilotinib|nilotinib|mesh-list
154642749|NCT03079505|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154642750|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642751|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642752|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642753|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642754|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
154642755|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154642756|NCT02343211|Antibodies|antibodies|mesh-list
154642757|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
154642758|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642759|NCT03090503|Risperidone|risperidone|mesh-list
154642760|NCT03090503|Aripiprazole|aripiprazole|mesh-list
154642761|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154642762|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
154642763|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642764|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642765|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642766|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154642767|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154642768|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642769|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154642770|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154642771|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
154642772|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
154642773|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
154642774|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154642775|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154642776|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154642777|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154642778|NCT02343289|Clarithromycin|clarithromycin|mesh-list
154642779|NCT02343289|Esketamine|esketamine|mesh-list
154642780|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154642781|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642782|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154642783|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642784|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642785|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154642786|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154642787|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
154642788|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154642789|NCT03090269|Methylphenidate|methylphenidate|mesh-list
154642790|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154642791|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642792|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154642793|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154642794|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154642795|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642796|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
154642797|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642798|NCT05008679|Oseltamivir|oseltamivir|mesh-list
154642799|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
154642800|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642801|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642802|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642803|NCT03090035|Interferons|interferons|mesh-list
154642804|NCT03090035|Ribavirin|ribavirin|mesh-list
154642805|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642806|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
154642807|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642808|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
154642809|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642811|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642812|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
154642813|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
154642814|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642815|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642816|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154642817|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
154642818|NCT05008367|Hormones|hormones|mesh-ancestor
154642819|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642820|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154642821|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642822|NCT02342587|Lapatinib|lapatinib|mesh-list
154642823|NCT02342587|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154642824|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642825|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642826|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642827|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357708|NCT03413020|Antacids|antacids|mesh-ancestor
154642828|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154642829|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642830|NCT02342509|Sevoflurane|sevoflurane|mesh-list
154642831|NCT02342509|Desflurane|desflurane|mesh-list
154642832|NCT02342509|Isoflurane|isoflurane|mesh-list
154642833|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154642834|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154642835|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
154642836|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
154642837|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642838|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642839|NCT03079271|Benzocaine|benzocaine|mesh-list
154642840|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
154642841|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
154642842|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642843|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642844|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
154642845|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642846|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154642847|NCT02342353|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154642848|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642849|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642850|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642851|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642852|NCT02337127|Lamivudine|lamivudine|mesh-list
154642853|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154642854|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154642855|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642856|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642857|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
154642858|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642859|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154642860|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154642861|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
154642862|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642863|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642864|NCT05007587|Leucovorin|leucovorin|mesh-list
154642865|NCT05007587|Fluorouracil|fluorouracil|mesh-list
154642866|NCT05007587|Raltitrexed|raltitrexed|mesh-list
154642867|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
154642868|NCT05007587|Lenvatinib|lenvatinib|mesh-list
154642869|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
154642870|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642871|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154642872|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642873|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642874|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
154642875|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642876|NCT05007587|Antidotes|antidotes|mesh-ancestor
154642877|NCT05007587|Protective Agents|protective agents|mesh-ancestor
154642878|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
154642879|NCT05007587|Vitamins|vitamins|mesh-ancestor
154394998|NCT06169891|Hormones|hormones|mesh-ancestor
154642880|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
154642881|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154642882|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642883|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154642884|NCT02039323|Tenofovir|tenofovir|mesh-list
154642885|NCT02039323|Maraviroc|maraviroc|mesh-list
154642886|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
154642887|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642888|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154642889|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154642890|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642891|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642892|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154642893|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154642894|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154642895|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154357737|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154642896|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154642897|NCT03079115|Atorvastatin|atorvastatin|mesh-list
154642898|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154642899|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154642900|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
154642901|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642902|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154642903|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154642904|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642905|NCT05917431|Tislelizumab|tislelizumab|mesh-list
154642906|NCT05917431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154642907|NCT05917431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642908|NCT05917405|Fludarabine|fludarabine|mesh-list
154642909|NCT05917405|Busulfan|busulfan|mesh-list
154642910|NCT05917405|Clofarabine|clofarabine|mesh-list
154642911|NCT05917405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642912|NCT05917405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154642913|NCT05917405|Antimetabolites|antimetabolites|mesh-ancestor
154642914|NCT05917405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642915|NCT05917405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642916|NCT05917405|Immunologic Factors|immunologic factors|mesh-ancestor
154642917|NCT05917405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642918|NCT05917405|Alkylating Agents|alkylating agents|mesh-ancestor
154642919|NCT05917405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154642920|NCT05917405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154642921|NCT05917288|Belimumab|belimumab|mesh-list
154642922|NCT05917288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154642923|NCT05917288|Immunologic Factors|immunologic factors|mesh-ancestor
154642924|NCT05917288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642925|NCT05991622|Rilpivirine|rilpivirine|mesh-list
154642926|NCT05991622|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
154642927|NCT05991622|Buprenorphine|buprenorphine|mesh-list
154642928|NCT05991622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154642929|NCT05991622|Narcotics|narcotics|mesh-ancestor
154642930|NCT05991622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642931|NCT05991622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642932|NCT05991622|Analgesics|analgesics|mesh-ancestor
154642933|NCT05991622|Sensory System Agents|sensory system agents|mesh-ancestor
154642934|NCT05991622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642935|NCT05991622|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154642936|NCT05991622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154642937|NCT05991622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154642938|NCT05991622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642939|NCT05991622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642940|NCT05991622|Antiviral Agents|antiviral agents|mesh-ancestor
154642941|NCT05991622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154642942|NCT05991622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154642943|NCT05991622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154642944|NCT05991466|Dexmedetomidine|dexmedetomidine|mesh-list
154642945|NCT05991466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154642946|NCT05991466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642947|NCT05991466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642948|NCT05991466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154642949|NCT05991466|Analgesics|analgesics|mesh-ancestor
154642950|NCT05991466|Sensory System Agents|sensory system agents|mesh-ancestor
154642951|NCT05991466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642952|NCT05991466|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154642953|NCT05991466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154642954|NCT05991466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154642955|NCT05991466|Adrenergic Agents|adrenergic agents|mesh-ancestor
154395073|NCT05950113|Deoxyglucose|deoxyglucose|mesh-list
154642957|NCT05991466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642958|NCT05991388|Dexamethasone|dexamethasone|mesh-list
154642959|NCT05991388|Rituximab|rituximab|mesh-list
154642960|NCT05991388|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154642961|NCT05991388|Carboplatin|carboplatin|mesh-list
154642962|NCT05991388|Etoposide|etoposide|mesh-list
154642963|NCT05991388|Etoposide phosphate|etoposide phosphate|mesh-list
154642964|NCT05991388|Ifosfamide|ifosfamide|mesh-list
154642965|NCT05991388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154642966|NCT05991388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154642967|NCT05991388|Immunologic Factors|immunologic factors|mesh-ancestor
154642968|NCT05991388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642969|NCT05991388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154642970|NCT05991388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154642971|NCT05991388|Antiemetics|antiemetics|mesh-ancestor
154642972|NCT05991388|Autonomic Agents|autonomic agents|mesh-ancestor
154642973|NCT05991388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642974|NCT05991388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154642975|NCT05991388|Glucocorticoids|glucocorticoids|mesh-ancestor
154642976|NCT05991388|Hormones|hormones|mesh-ancestor
154642977|NCT05991388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154642978|NCT05991388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154642979|NCT05991388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154642980|NCT05991388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154642981|NCT05991388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154642982|NCT05991388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154642983|NCT05991388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154642984|NCT05991388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154642985|NCT05991388|Alkylating Agents|alkylating agents|mesh-ancestor
154642986|NCT05991375|Dexmedetomidine|dexmedetomidine|mesh-list
154642987|NCT05991375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154642988|NCT05991375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154642989|NCT05991375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154642990|NCT05991375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154642991|NCT05991375|Analgesics|analgesics|mesh-ancestor
154642992|NCT05991375|Sensory System Agents|sensory system agents|mesh-ancestor
154642993|NCT05991375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154642994|NCT05991375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154642995|NCT05991375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154642996|NCT05991375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154642997|NCT05991375|Adrenergic Agents|adrenergic agents|mesh-ancestor
154642998|NCT05991375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154642999|NCT05991375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643000|NCT05991037|Psychotropic Drugs|psychotropic drugs|mesh-list
154643001|NCT05990933|Epinephrine|epinephrine|mesh-list
154643002|NCT05990933|Racepinephrine|racepinephrine|mesh-list
154643003|NCT05990933|Epinephryl borate|epinephryl borate|mesh-list
154643004|NCT05990933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154643005|NCT05990933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154643006|NCT05990933|Adrenergic Agents|adrenergic agents|mesh-ancestor
154643007|NCT05990933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643008|NCT05990933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643009|NCT05990933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643010|NCT05990933|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154643011|NCT05990933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154643012|NCT05990933|Autonomic Agents|autonomic agents|mesh-ancestor
154643013|NCT05990933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643014|NCT05990933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154643015|NCT05990933|Respiratory System Agents|respiratory system agents|mesh-ancestor
154643016|NCT05990933|Mydriatics|mydriatics|mesh-ancestor
154643017|NCT05990933|Sympathomimetics|sympathomimetics|mesh-ancestor
154643018|NCT05990933|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154643019|NCT05990881|Botulinum Toxins|botulinum toxins|mesh-list
154643020|NCT05990881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154643021|NCT05990881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643022|NCT05990881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643023|NCT05990881|Cholinergic Agents|cholinergic agents|mesh-ancestor
154643024|NCT05990881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643025|NCT05990881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643026|NCT05990868|Acetaminophen|acetaminophen|mesh-list
154643027|NCT05990868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154643028|NCT05990868|Analgesics|analgesics|mesh-ancestor
154643029|NCT05990868|Sensory System Agents|sensory system agents|mesh-ancestor
154643030|NCT05990868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643031|NCT05990868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643032|NCT05990868|Antipyretics|antipyretics|mesh-ancestor
154643033|NCT05990842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154643034|NCT05990842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643035|NCT05990829|Aflibercept|aflibercept|mesh-list
154643036|NCT05990829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154643037|NCT05990829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154643038|NCT05990829|Growth Substances|growth substances|mesh-ancestor
154643039|NCT05990829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643040|NCT05990829|Growth Inhibitors|growth inhibitors|mesh-ancestor
154643041|NCT05990829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643042|NCT05990543|Capecitabine|capecitabine|mesh-list
154643043|NCT05990543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154643044|NCT05990543|Antimetabolites|antimetabolites|mesh-ancestor
154643045|NCT05990543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643046|NCT05990543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643047|NCT05990374|Semaglutide|semaglutide|mesh-list
154643048|NCT05990374|Tirzepatide|tirzepatide|mesh-list
154643049|NCT05990374|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154643050|NCT05990374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643051|NCT05990374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643052|NCT05990374|Incretins|incretins|mesh-ancestor
154643053|NCT05990374|Hormones|hormones|mesh-ancestor
154643054|NCT05990374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154643055|NCT05990205|Metformin|metformin|mesh-list
154643056|NCT05990205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643057|NCT05990205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643058|NCT05990127|Paclitaxel|paclitaxel|mesh-list
154643059|NCT05990127|Carboplatin|carboplatin|mesh-list
154643060|NCT05990127|Pemetrexed|pemetrexed|mesh-list
154643061|NCT05990127|Tislelizumab|tislelizumab|mesh-list
154643062|NCT05990127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154643063|NCT05990127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643064|NCT05990127|Tubulin Modulators|tubulin modulators|mesh-ancestor
154643065|NCT05990127|Antimitotic Agents|antimitotic agents|mesh-ancestor
154643066|NCT05990127|Mitosis Modulators|mitosis modulators|mesh-ancestor
154643067|NCT05990127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643068|NCT05990127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643069|NCT05990127|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154643070|NCT05990127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154643071|NCT05990127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643072|NCT05989984|Iron|iron|mesh-list
154643073|NCT05989984|Trace Elements|trace elements|mesh-ancestor
154643074|NCT05989984|Micronutrients|micronutrients|mesh-ancestor
154643075|NCT05989984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643076|NCT05989633|Selenium|selenium|mesh-list
154643077|NCT05989633|Antioxidants|antioxidants|mesh-ancestor
154643078|NCT05989633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643079|NCT05989633|Protective Agents|protective agents|mesh-ancestor
154643080|NCT05989633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643081|NCT05989633|Trace Elements|trace elements|mesh-ancestor
154643082|NCT05989633|Micronutrients|micronutrients|mesh-ancestor
154643083|NCT05988879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154643084|NCT05988879|Antiviral Agents|antiviral agents|mesh-ancestor
154643085|NCT05988879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643086|NCT05987826|Aflutinib|aflutinib|mesh-list
154643087|NCT05987826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154643088|NCT05987826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643089|NCT05987826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643090|NCT05915949|Dapagliflozin|dapagliflozin|mesh-list
154643091|NCT05915949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154643092|NCT05915949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643093|NCT05915949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643094|NCT05915949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643095|NCT05874037|Fluvoxamine|fluvoxamine|mesh-list
154643096|NCT05874037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154643097|NCT05874037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154643098|NCT05874037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154643099|NCT05874037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643100|NCT05874037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154643101|NCT05874037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154643102|NCT05874037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154643103|NCT05874037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643104|NCT05874037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643105|NCT05874037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643107|NCT05874037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154643108|NCT05874037|Antidepressive Agents|antidepressive agents|mesh-ancestor
154643109|NCT05874037|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154643110|NCT05874037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154643111|NCT05874037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643112|NCT05874037|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154643113|NCT05814939|Tofacitinib|tofacitinib|mesh-list
154357972|NCT03393364|Ketorolac|ketorolac|mesh-list
154643114|NCT05814939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643115|NCT05814939|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154643116|NCT05814939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154643117|NCT05814939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643118|NCT05732389|Nivolumab|nivolumab|mesh-list
154643119|NCT05732389|Ipilimumab|ipilimumab|mesh-list
154643120|NCT05732389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643121|NCT05732389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643122|NCT05732389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643123|NCT05732389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643124|NCT05698511|Psilocybin|psilocybin|mesh-list
154643125|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
154643126|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643127|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154643128|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
154643129|NCT05671029|Pritelivir|pritelivir|mesh-list
154643130|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154643131|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643132|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643133|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154643134|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154643135|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643136|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643137|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643138|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154643139|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
154643140|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154643141|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643142|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154643143|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154643144|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154643145|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
154643146|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
154643147|NCT05633615|Fludarabine|fludarabine|mesh-list
154643148|NCT05633615|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154643149|NCT05633615|Tisagenlecleucel|tisagenlecleucel|mesh-list
154643150|NCT05633615|Antibodies|antibodies|mesh-list
154643151|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
154643152|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154643153|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154643154|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
154643155|NCT05633615|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154643156|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643157|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
154643158|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643159|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643160|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154643161|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
154643162|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643163|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643164|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154643165|NCT05633615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643166|NCT05608070|Oxytocin|oxytocin|mesh-list
154643167|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
154643168|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154643169|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643170|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154643171|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
154643172|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643173|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154643174|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154643175|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
154643176|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643177|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395295|NCT05443178|Amebicides|amebicides|mesh-ancestor
154643178|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154643179|NCT05374564|Flutemetamol|flutemetamol|mesh-list
154643180|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154643181|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643182|NCT05370599|Losartan|losartan|mesh-list
154643183|NCT05370599|Amlodipine|amlodipine|mesh-list
154643184|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
154643185|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
154643186|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154643187|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643188|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643189|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154643190|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643191|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
154643192|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154643193|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154643194|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154643195|NCT05370599|Diuretics|diuretics|mesh-ancestor
154643196|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
154643197|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154643198|NCT05301712|Naloxone|naloxone|mesh-list
154643199|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154643200|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643201|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
154643202|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643203|NCT05266612|Nivolumab|nivolumab|mesh-list
154643204|NCT05266612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643205|NCT05266612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643206|NCT05266612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643207|NCT05266612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643208|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
154643209|NCT05222191|Spironolactone|spironolactone|mesh-list
154643210|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154643211|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
154643212|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154643213|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643214|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154643215|NCT05222191|Diuretics|diuretics|mesh-ancestor
154643216|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
154643217|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154643218|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154643219|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643220|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643221|NCT05189015|Olmesartan|olmesartan|mesh-list
154643222|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154643223|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154643224|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154643225|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154643226|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643227|NCT05153070|Cyclosporine|cyclosporine|mesh-list
154643228|NCT05153070|Cyclosporins|cyclosporins|mesh-list
154643229|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643230|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643231|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643232|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
154643233|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643234|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
154643235|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643236|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
154643237|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643238|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154643239|NCT05045638|Sotorasib|sotorasib|mesh-list
154643240|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154643241|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154643242|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154643243|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
154643244|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643245|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154643246|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154643247|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643248|NCT05045638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643249|NCT05045638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643251|NCT05040360|Capecitabine|capecitabine|mesh-list
154643252|NCT05040360|Temozolomide|temozolomide|mesh-list
154643253|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154643254|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
154643255|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643256|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643257|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154643258|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
154643259|NCT05011513|Ritonavir|ritonavir|mesh-list
154643260|NCT05011513|Nirmatrelvir|nirmatrelvir|mesh-list
154643261|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154643262|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154643263|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
154643264|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643265|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643266|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154643267|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154643268|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
154643269|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643270|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154643271|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154643272|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
154643273|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154643274|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643275|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643276|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643277|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
154643278|NCT04812028|Analgesics|analgesics|mesh-ancestor
154643279|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
154643280|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643281|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643282|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
154643283|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154643284|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154643285|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
154643286|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154643287|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643288|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643289|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154643290|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
154643291|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154643292|NCT04807972|Folfirinox|folfirinox|mesh-list
154643293|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643294|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
154643295|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154643296|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643297|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643298|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643299|NCT04770012|Aspirin|aspirin|mesh-list
154643300|NCT04770012|Clopidogrel|clopidogrel|mesh-list
154643301|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154643302|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154643303|NCT04770012|Analgesics|analgesics|mesh-ancestor
154643304|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
154643305|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643306|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643307|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154643308|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643309|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154643310|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154643311|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643312|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154643313|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154643314|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643315|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
154643316|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154643317|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154643318|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154643319|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
154643320|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643321|NCT04755244|Azacitidine|azacitidine|mesh-list
154643322|NCT04755244|Venetoclax|venetoclax|mesh-list
154643323|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154643324|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
154643325|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643326|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643327|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643328|NCT04718740|Vitamin K|vitamin k|mesh-list
154643329|NCT04718740|Repaglinide|repaglinide|mesh-list
154643330|NCT04718740|Fluzoparib|fluzoparib|mesh-list
154643331|NCT04718740|Midazolam|midazolam|mesh-list
154643332|NCT04718740|Caffeine|caffeine|mesh-list
154643333|NCT04718740|Bupropion|bupropion|mesh-list
154643334|NCT04718740|Omeprazole|omeprazole|mesh-list
154643335|NCT04718740|Warfarin|warfarin|mesh-list
154643336|NCT04718740|Vitamins|vitamins|mesh-ancestor
154643337|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
154643338|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643339|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154643340|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154643341|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154643342|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154643343|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154643344|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154643345|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154643346|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
154643347|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
154643348|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
154643349|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
154643350|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643351|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643352|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
154643353|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154643354|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154643355|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643356|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154643357|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154643358|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
154643359|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154643360|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154643361|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154643362|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154643363|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
154643364|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154643365|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154643366|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643367|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
154643368|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154643369|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154643370|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154643371|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154643372|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
154643373|NCT04718740|Coagulants|coagulants|mesh-ancestor
154643374|NCT04718740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154643375|NCT04718740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643376|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643377|NCT04647916|Camptothecin|camptothecin|mesh-list
154643378|NCT04647916|Irinotecan|irinotecan|mesh-list
154643379|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
154643380|NCT04647916|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154643381|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
154643382|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643383|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154643384|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643385|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154643386|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154643387|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643388|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643389|NCT04590248|Adavosertib|adavosertib|mesh-list
154643390|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643391|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643392|NCT04586231|Lenvatinib|lenvatinib|mesh-list
154643393|NCT04586231|Belzutifan|belzutifan|mesh-list
154643394|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643395|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154643396|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643397|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643398|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
154643399|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154643400|NCT04560816|Choline|choline|mesh-list
154643401|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643402|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643403|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154643404|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154643405|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643406|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643407|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643408|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643409|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
154643410|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154643411|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
154643412|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154643413|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154643414|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
154643415|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
154643416|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
154643417|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154643418|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154643419|NCT04560816|Growth Substances|growth substances|mesh-ancestor
154643420|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
154643421|NCT04511013|Nivolumab|nivolumab|mesh-list
154643422|NCT04511013|Ipilimumab|ipilimumab|mesh-list
154643423|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643424|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643425|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643426|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643427|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
154643428|NCT04468061|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154643429|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643430|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643431|NCT04468061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643432|NCT04468061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643433|NCT04468061|Immunoconjugates|immunoconjugates|mesh-ancestor
154643434|NCT04468061|Immunologic Factors|immunologic factors|mesh-ancestor
154643435|NCT04468061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643436|NCT04417517|Azacitidine|azacitidine|mesh-list
154643437|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154643438|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
154643439|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643440|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643441|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643442|NCT04337177|Temozolomide|temozolomide|mesh-list
154643443|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154643444|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
154643445|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643446|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643447|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
154643448|NCT04205968|Leucovorin|leucovorin|mesh-list
154643449|NCT04205968|Folic Acid|folic acid|mesh-list
154643450|NCT04205968|Paclitaxel|paclitaxel|mesh-list
154643451|NCT04205968|Camptothecin|camptothecin|mesh-list
154643452|NCT04205968|Fluorouracil|fluorouracil|mesh-list
154643453|NCT04205968|Irinotecan|irinotecan|mesh-list
154643454|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154643455|NCT04205968|Ramucirumab|ramucirumab|mesh-list
154643456|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154643457|NCT04205968|Antibodies|antibodies|mesh-list
154643458|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
154643459|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154643460|NCT04205968|Lexatumumab|lexatumumab|mesh-list
154643461|NCT04205968|Calcium|calcium|mesh-list
154643462|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
154643463|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154643464|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643465|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
154643466|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
154643467|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
154643468|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643469|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
154643470|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643471|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154643472|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154643473|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
154643474|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154643475|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395621|NCT04631484|Niacin|niacin|mesh-list
154643476|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154643477|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154643478|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643479|NCT04205968|Antidotes|antidotes|mesh-ancestor
154643480|NCT04205968|Protective Agents|protective agents|mesh-ancestor
154643481|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
154643482|NCT04205968|Vitamins|vitamins|mesh-ancestor
154643483|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
154643484|NCT04205968|Hematinics|hematinics|mesh-ancestor
154643485|NCT04205968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154643486|NCT04205968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154643487|NCT04205968|Growth Substances|growth substances|mesh-ancestor
154643488|NCT04205968|Growth Inhibitors|growth inhibitors|mesh-ancestor
154643489|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
154643490|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154643491|NCT04141020|Sirolimus|sirolimus|mesh-list
154643492|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643493|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643494|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154643495|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643496|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
154643497|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643498|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
154643499|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643500|NCT04071457|Lenalidomide|lenalidomide|mesh-list
154643501|NCT04071457|Daratumumab|daratumumab|mesh-list
154643502|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
154643503|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643504|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154643505|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154643506|NCT04071457|Growth Substances|growth substances|mesh-ancestor
154643507|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
154643508|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643509|NCT04060719|Rifampin|rifampin|mesh-list
154643510|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154643511|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
154643512|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643513|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643514|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
154643515|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154643516|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643517|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643518|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154643519|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154643520|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154643521|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154643522|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154643523|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154643524|NCT03877406|Empagliflozin|empagliflozin|mesh-list
154643525|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154643526|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154643527|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643528|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643529|NCT03746106|Thiamine|thiamine|mesh-list
154643530|NCT03746106|Metformin|metformin|mesh-list
154643531|NCT03746106|Trimethoprim|trimethoprim|mesh-list
154643532|NCT03746106|Vitamins|vitamins|mesh-ancestor
154643533|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
154643534|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643535|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643536|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
154643537|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154643538|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643539|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
154643540|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154643541|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154643542|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154643543|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358389|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154643544|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643545|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154643546|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154643547|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154643548|NCT03737461|Lidocaine|lidocaine|mesh-list
154643549|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
154643550|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
154643551|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154643552|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643553|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
154643554|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643555|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154643556|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154643557|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154643558|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643559|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643560|NCT03722173|Itraconazole|itraconazole|mesh-list
154643561|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
154643562|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643563|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154643564|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154643565|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643566|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643567|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154643568|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
154643569|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154643570|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643571|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154643572|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
154643573|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154643574|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643575|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643576|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643577|NCT03695380|Atezolizumab|atezolizumab|mesh-list
154643578|NCT03695380|Niraparib|niraparib|mesh-list
154643579|NCT03695380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643580|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643581|NCT03695380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643582|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643583|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154643584|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643585|NCT03678025|Prednisone|prednisone|mesh-list
154643586|NCT03678025|Cortisone|cortisone|mesh-list
154643587|NCT03678025|Docetaxel|docetaxel|mesh-list
154643588|NCT03678025|Leuprolide|leuprolide|mesh-list
154643589|NCT03678025|Goserelin|goserelin|mesh-list
154643590|NCT03678025|Bicalutamide|bicalutamide|mesh-list
154643591|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154643592|NCT03678025|Flutamide|flutamide|mesh-list
154643593|NCT03678025|Nilutamide|nilutamide|mesh-list
154643594|NCT03678025|Tryptophan|tryptophan|mesh-list
154643595|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643596|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
154643597|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
154643598|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
154643599|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643600|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154643601|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
154643602|NCT03678025|Hormones|hormones|mesh-ancestor
154643603|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154643604|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643605|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154643606|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154643607|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
154643608|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154643609|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
154643610|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
154643611|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
154643612|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154643613|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
154643614|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154643615|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154643616|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
154643617|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154643618|NCT03636256|Docetaxel|docetaxel|mesh-list
154643619|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643620|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
154643621|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
154643622|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
154643623|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643624|NCT03451331|Carboplatin|carboplatin|mesh-list
154395746|NCT04227288|Hormones|hormones|mesh-ancestor
154643625|NCT03451331|Gemcitabine|gemcitabine|mesh-list
154643626|NCT03451331|Nivolumab|nivolumab|mesh-list
154643627|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
154643628|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643629|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154643630|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
154643631|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643632|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643633|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643634|NCT03418961|Carvedilol|carvedilol|mesh-list
154643635|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154643636|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154643637|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
154643638|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643639|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643640|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643641|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154643642|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
154643643|NCT03418961|Protective Agents|protective agents|mesh-ancestor
154643644|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154643645|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643646|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154643647|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
154643648|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154643649|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154643650|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
154643651|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643652|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643653|NCT03386357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643654|NCT03386357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643655|NCT03293784|Infliximab|infliximab|mesh-list
154643656|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
154643657|NCT03293784|Nivolumab|nivolumab|mesh-list
154643658|NCT03293784|Ipilimumab|ipilimumab|mesh-list
154643659|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643660|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643661|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643662|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643663|NCT03293784|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154358510|NCT02774265|Analgesics|analgesics|mesh-ancestor
154643664|NCT03293784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154643665|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
154643666|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154643667|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643668|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643669|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
154643670|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643671|NCT02996487|Vancomycin|vancomycin|mesh-list
154643672|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643673|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643674|NCT02980276|Metformin|metformin|mesh-list
154643675|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154643676|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643677|NCT02614794|Capecitabine|capecitabine|mesh-list
154643678|NCT02614794|Trastuzumab|trastuzumab|mesh-list
154643679|NCT02614794|Tucatinib|tucatinib|mesh-list
154643680|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154643681|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
154643682|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643683|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643684|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643685|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154643686|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643687|NCT02495896|Paclitaxel|paclitaxel|mesh-list
154643688|NCT02495896|Docetaxel|docetaxel|mesh-list
154643689|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154643690|NCT02495896|Cisplatin|cisplatin|mesh-list
154643691|NCT02495896|Gemcitabine|gemcitabine|mesh-list
154643692|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154643693|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643694|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
154643695|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
154643696|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
154643697|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643698|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154643699|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
154643700|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
154643701|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154643703|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
154643704|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643705|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643706|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643707|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
154643708|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
154643709|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643710|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
154643711|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154643712|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
154643713|NCT01782443|Aflibercept|aflibercept|mesh-list
154643714|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154643715|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154643716|NCT01782443|Growth Substances|growth substances|mesh-ancestor
154643717|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643718|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
154643719|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643720|NCT01712815|Clevudine|clevudine|mesh-list
154643721|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
154643722|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643723|NCT01555632|Atorvastatin|atorvastatin|mesh-list
154643724|NCT01555632|Calcium|calcium|mesh-list
154643725|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154643726|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643727|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154643728|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154643729|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
154643730|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643731|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154643732|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154643733|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643734|NCT01274026|Verapamil|verapamil|mesh-list
154643735|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154643736|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154643737|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643738|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643739|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154643740|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643741|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
154643742|NCT01186029|Aprepitant|aprepitant|mesh-list
154643743|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
154643744|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
154643745|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643746|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643747|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154643748|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154643749|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643750|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643751|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154643752|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
154643753|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643754|NCT00896012|Sirolimus|sirolimus|mesh-list
154643755|NCT00896012|Tacrolimus|tacrolimus|mesh-list
154643756|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643757|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
154643758|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643759|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154643760|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643761|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643762|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643763|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643764|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154643765|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643766|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
154643767|NCT00876226|Citalopram|citalopram|mesh-list
154643768|NCT00876226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154643769|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154643770|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643771|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643772|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643773|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
154643774|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643775|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154643776|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
154643778|NCT00816413|Cyclosporine|cyclosporine|mesh-list
154643779|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
154643780|NCT00816413|Pentostatin|pentostatin|mesh-list
154643781|NCT00816413|Cyclosporins|cyclosporins|mesh-list
154643782|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643783|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643784|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643785|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
154643786|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643787|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
154643788|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643789|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
154643790|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643791|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154643792|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154643793|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643794|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154643795|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
154643796|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643797|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154643798|NCT02342977|Lacosamide|lacosamide|mesh-list
154643799|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
154643800|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154643801|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154643802|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154643803|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643804|NCT05916781|Mycophenolic Acid|mycophenolic acid|mesh-list
154643805|NCT05916781|Tacrolimus|tacrolimus|mesh-list
154643806|NCT05916781|Glucocorticoids|glucocorticoids|mesh-list
154643807|NCT05916781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643808|NCT05916781|Immunologic Factors|immunologic factors|mesh-ancestor
154643809|NCT05916781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643810|NCT05916781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154643811|NCT05916781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643812|NCT05916781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643813|NCT05916781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154643814|NCT05916781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643815|NCT05916781|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154643816|NCT05916781|Antitubercular Agents|antitubercular agents|mesh-ancestor
154643817|NCT05916781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643818|NCT05916781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643819|NCT05916781|Hormones|hormones|mesh-ancestor
154643820|NCT05916781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154643821|NCT05916755|Cyclophosphamide|cyclophosphamide|mesh-list
154643822|NCT05916755|Carboplatin|carboplatin|mesh-list
154643823|NCT05916755|Pembrolizumab|pembrolizumab|mesh-list
154643824|NCT05916755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643825|NCT05916755|Immunologic Factors|immunologic factors|mesh-ancestor
154643826|NCT05916755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643827|NCT05916755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643828|NCT05916755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154643829|NCT05916755|Alkylating Agents|alkylating agents|mesh-ancestor
154643830|NCT05916755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643831|NCT05916755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643832|NCT05916755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154643833|NCT05916755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643834|NCT05916755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154643835|NCT05916742|Dipyrone|dipyrone|mesh-list
154643836|NCT05916742|Amoxicillin|amoxicillin|mesh-list
154643837|NCT05916742|Chlorhexidine|chlorhexidine|mesh-list
154643838|NCT05916742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643839|NCT05916742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643840|NCT05916742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154643841|NCT05916742|Disinfectants|disinfectants|mesh-ancestor
154643842|NCT05916742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154643843|NCT05916742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154643844|NCT05916742|Analgesics|analgesics|mesh-ancestor
154358698|NCT03697993|Levofloxacin|levofloxacin|mesh-list
154643845|NCT05916742|Sensory System Agents|sensory system agents|mesh-ancestor
154643846|NCT05916742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643847|NCT05916742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643848|NCT05916742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154643849|NCT05916742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643851|NCT05916729|Miconazole|miconazole|mesh-list
154643852|NCT05916729|Antifungal Agents|antifungal agents|mesh-ancestor
154643853|NCT05916729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643854|NCT05916729|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154643855|NCT05916729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154643856|NCT05916729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643857|NCT05916729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643858|NCT05916729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154643859|NCT05916729|Hormone Antagonists|hormone antagonists|mesh-ancestor
154643860|NCT05916729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154643861|NCT05916729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643862|NCT05916729|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154643863|NCT05916729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154643864|NCT05916716|Dipyrone|dipyrone|mesh-list
154643865|NCT05916716|Amoxicillin|amoxicillin|mesh-list
154643866|NCT05916716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643867|NCT05916716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643868|NCT05916716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154643869|NCT05916716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154643870|NCT05916716|Analgesics|analgesics|mesh-ancestor
154643871|NCT05916716|Sensory System Agents|sensory system agents|mesh-ancestor
154643872|NCT05916716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643873|NCT05916716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643874|NCT05916716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154643875|NCT05916716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643876|NCT05916716|Antipyretics|antipyretics|mesh-ancestor
154643877|NCT05916521|Fluorides|fluorides|mesh-list
154643878|NCT05916521|Tin Fluorides|tin fluorides|mesh-list
154643879|NCT05916521|Fluorophosphate|fluorophosphate|mesh-list
154643880|NCT05916521|Cariostatic Agents|cariostatic agents|mesh-ancestor
154643881|NCT05916521|Protective Agents|protective agents|mesh-ancestor
154643882|NCT05916521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643883|NCT05916508|Fluorides|fluorides|mesh-list
154643884|NCT05916508|Tin Fluorides|tin fluorides|mesh-list
154643885|NCT05916508|Fluorophosphate|fluorophosphate|mesh-list
154643886|NCT05916508|Cariostatic Agents|cariostatic agents|mesh-ancestor
154643887|NCT05916508|Protective Agents|protective agents|mesh-ancestor
154643888|NCT05916508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643889|NCT05916469|Levonorgestrel|levonorgestrel|mesh-list
154643890|NCT05916469|Norethindrone|norethindrone|mesh-list
154643891|NCT05916469|Norethindrone Acetate|norethindrone acetate|mesh-list
154643892|NCT05916469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154643893|NCT05916469|Contraceptive Agents|contraceptive agents|mesh-ancestor
154643894|NCT05916469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154643895|NCT05916469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643896|NCT05916469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154643897|NCT05916469|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154643898|NCT05916469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154643899|NCT05916469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154643900|NCT05916105|Ciprofloxacin|ciprofloxacin|mesh-list
154643901|NCT05916105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643902|NCT05916105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643903|NCT05916105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154643904|NCT05916105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154643905|NCT05916105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643906|NCT05916105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643907|NCT05916105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643908|NCT05916105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154643909|NCT05916105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154643910|NCT05916066|Niacinamide|niacinamide|mesh-list
154643911|NCT05916066|Niacin|niacin|mesh-list
154643912|NCT05916066|Nicotinic Acids|nicotinic acids|mesh-list
154643913|NCT05916066|Vitamin B Complex|vitamin b complex|mesh-ancestor
154643914|NCT05916066|Vitamins|vitamins|mesh-ancestor
154643915|NCT05916066|Micronutrients|micronutrients|mesh-ancestor
154643916|NCT05916066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643917|NCT05916066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154643918|NCT05916066|Antimetabolites|antimetabolites|mesh-ancestor
154643919|NCT05916066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643920|NCT05916066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154643921|NCT05916066|Vasodilator Agents|vasodilator agents|mesh-ancestor
154643922|NCT05915871|Clarithromycin|clarithromycin|mesh-list
154643923|NCT05915871|Bismuth|bismuth|mesh-list
154643924|NCT05915871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154643925|NCT05915871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154643926|NCT05915871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154643927|NCT05915871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643928|NCT05915871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643929|NCT05915871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154643930|NCT05915871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154643931|NCT05915871|Antacids|antacids|mesh-ancestor
154643932|NCT05915871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154643933|NCT05915676|Immunoglobulins|immunoglobulins|mesh-list
154643934|NCT05915676|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154643935|NCT05915676|Antibodies|antibodies|mesh-list
154643936|NCT05915676|Immunologic Factors|immunologic factors|mesh-ancestor
154643937|NCT05915676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643938|NCT05915520|Pantoprazole|pantoprazole|mesh-list
154643939|NCT05915520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154643940|NCT05915520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154643941|NCT05915520|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154643942|NCT05915520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643943|NCT05915520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643944|NCT05915481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154643945|NCT05915481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643946|NCT05915481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154643947|NCT05915481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643948|NCT05915260|Adenosine|adenosine|mesh-list
154643949|NCT05915260|Analgesics|analgesics|mesh-ancestor
154643950|NCT05915260|Sensory System Agents|sensory system agents|mesh-ancestor
154643951|NCT05915260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643952|NCT05915260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643953|NCT05915260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154643954|NCT05915260|Vasodilator Agents|vasodilator agents|mesh-ancestor
154643955|NCT05915260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154643956|NCT05915260|Purinergic Agonists|purinergic agonists|mesh-ancestor
154643957|NCT05915260|Purinergic Agents|purinergic agents|mesh-ancestor
154643958|NCT05915260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643959|NCT05915260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643960|NCT05915013|Ketamine|ketamine|mesh-list
154643961|NCT05915013|Analgesics|analgesics|mesh-ancestor
154643962|NCT05915013|Sensory System Agents|sensory system agents|mesh-ancestor
154643963|NCT05915013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154643964|NCT05915013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643965|NCT05915013|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154643966|NCT05915013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154643967|NCT05915013|Anesthetics, General|anesthetics, general|mesh-ancestor
154643968|NCT05915013|Anesthetics|anesthetics|mesh-ancestor
154643969|NCT05915013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154643970|NCT05915013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154643971|NCT05915013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154643972|NCT05915013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154643973|NCT05915013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643974|NCT05914753|Cyclophosphamide|cyclophosphamide|mesh-list
154643975|NCT05914753|Docetaxel|docetaxel|mesh-list
154643976|NCT05914753|Epirubicin|epirubicin|mesh-list
154643977|NCT05914753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154643978|NCT05914753|Immunologic Factors|immunologic factors|mesh-ancestor
154643979|NCT05914753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154643980|NCT05914753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154643981|NCT05914753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154643982|NCT05914753|Alkylating Agents|alkylating agents|mesh-ancestor
154643983|NCT05914753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154643984|NCT05914753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643985|NCT05914753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154643986|NCT05914753|Tubulin Modulators|tubulin modulators|mesh-ancestor
154643987|NCT05914753|Antimitotic Agents|antimitotic agents|mesh-ancestor
154643988|NCT05914753|Mitosis Modulators|mitosis modulators|mesh-ancestor
154643989|NCT05914753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154643990|NCT05914753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154643991|NCT05914753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154643992|NCT05914753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643993|NCT05914701|Letermovir|letermovir|mesh-list
154643994|NCT05914701|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154643995|NCT05914701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154643996|NCT05914701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396119|NCT01658878|Sorafenib|sorafenib|mesh-list
154643997|NCT05914701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154643999|NCT05914701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644000|NCT05914675|Letermovir|letermovir|mesh-list
154644001|NCT05914675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154644002|NCT05914675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644003|NCT05914675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644004|NCT05914675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644005|NCT05914675|Antiviral Agents|antiviral agents|mesh-ancestor
154644006|NCT05914675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644007|NCT05914662|Rituximab|rituximab|mesh-list
154644008|NCT05914662|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154644009|NCT05914662|Zanubrutinib|zanubrutinib|mesh-list
154644010|NCT05914662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644011|NCT05914662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644012|NCT05914662|Immunologic Factors|immunologic factors|mesh-ancestor
154644013|NCT05914662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644014|NCT05914662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644015|NCT05914662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154644016|NCT05914662|Alkylating Agents|alkylating agents|mesh-ancestor
154644017|NCT05914662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644018|NCT05914662|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154644019|NCT05914662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154644020|NCT05914662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644021|NCT05914610|Oxaliplatin|oxaliplatin|mesh-list
154644022|NCT05914610|Tegafur|tegafur|mesh-list
154644023|NCT05914610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644024|NCT05914610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154644025|NCT05914610|Antimetabolites|antimetabolites|mesh-ancestor
154644026|NCT05914610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644027|NCT05914545|Immunoconjugates|immunoconjugates|mesh-list
154644028|NCT05914545|Immunologic Factors|immunologic factors|mesh-ancestor
154644029|NCT05914545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644030|NCT05914454|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154644031|NCT05914454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644032|NCT05914350|Methylprednisolone|methylprednisolone|mesh-list
154644033|NCT05914350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154644034|NCT05914350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154644035|NCT05914350|Prednisolone|prednisolone|mesh-list
154644036|NCT05914350|Prednisolone acetate|prednisolone acetate|mesh-list
154644037|NCT05914350|Lidocaine|lidocaine|mesh-list
154644038|NCT05914350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154644039|NCT05914350|Prednisolone phosphate|prednisolone phosphate|mesh-list
154644040|NCT05914350|Anesthetics, Local|anesthetics, local|mesh-ancestor
154644041|NCT05914350|Anesthetics|anesthetics|mesh-ancestor
154644042|NCT05914350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644043|NCT05914350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644044|NCT05914350|Sensory System Agents|sensory system agents|mesh-ancestor
154644045|NCT05914350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644046|NCT05914350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154644047|NCT05914350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154644048|NCT05914350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154644049|NCT05914350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154644050|NCT05914350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644051|NCT05914350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154644052|NCT05914350|Antiemetics|antiemetics|mesh-ancestor
154644053|NCT05914350|Autonomic Agents|autonomic agents|mesh-ancestor
154644054|NCT05914350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154644055|NCT05914350|Glucocorticoids|glucocorticoids|mesh-ancestor
154644056|NCT05914350|Hormones|hormones|mesh-ancestor
154644057|NCT05914350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154644058|NCT05914350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154644059|NCT05914350|Protective Agents|protective agents|mesh-ancestor
154644060|NCT05914350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154644061|NCT05914350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644062|NCT05914285|Albuterol|albuterol|mesh-list
154644063|NCT05914285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154644064|NCT05914285|Autonomic Agents|autonomic agents|mesh-ancestor
154644065|NCT05914285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644066|NCT05914285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644067|NCT05914285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154644068|NCT05914285|Respiratory System Agents|respiratory system agents|mesh-ancestor
154644069|NCT05914285|Tocolytic Agents|tocolytic agents|mesh-ancestor
154644070|NCT05914285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154644071|NCT05914285|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154644072|NCT05914285|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154644073|NCT05914285|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154644074|NCT05914285|Adrenergic Agents|adrenergic agents|mesh-ancestor
154644075|NCT05914285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644076|NCT05914285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644078|NCT05914129|Hematinics|hematinics|mesh-ancestor
154644079|NCT05913947|Cariprazine|cariprazine|mesh-list
154644080|NCT05913947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154644081|NCT05913947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154644082|NCT05913947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644083|NCT05913947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644084|NCT05913947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154644085|NCT05913856|Chlorhexidine|chlorhexidine|mesh-list
154644086|NCT05913856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154644087|NCT05913856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644088|NCT05913856|Disinfectants|disinfectants|mesh-ancestor
154644089|NCT05913661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154644090|NCT05913661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644091|NCT05913661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644092|NCT05913661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644093|NCT05913596|Daratumumab|daratumumab|mesh-list
154644094|NCT05913596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644095|NCT05913583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154644096|NCT05913583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644097|NCT05913583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644098|NCT05913583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644099|NCT05913570|Antibodies|antibodies|mesh-list
154644100|NCT05913570|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154644101|NCT05913570|Immunologic Factors|immunologic factors|mesh-ancestor
154644102|NCT05913570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644103|NCT05913466|Tranexamic Acid|tranexamic acid|mesh-list
154644104|NCT05913466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154644105|NCT05913466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154644106|NCT05913466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644107|NCT05913466|Hemostatics|hemostatics|mesh-ancestor
154644108|NCT05913466|Coagulants|coagulants|mesh-ancestor
154644109|NCT05913427|Cisplatin|cisplatin|mesh-list
154644110|NCT05913427|Doxorubicin|doxorubicin|mesh-list
154644111|NCT05913427|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154644112|NCT05913427|Etoposide|etoposide|mesh-list
154644113|NCT05913427|Etoposide phosphate|etoposide phosphate|mesh-list
154644114|NCT05913427|Megestrol|megestrol|mesh-list
154644115|NCT05913427|Megestrol Acetate|megestrol acetate|mesh-list
154644116|NCT05913427|Mitotane|mitotane|mesh-list
154644117|NCT05913427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644118|NCT05913427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154644119|NCT05913427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154644120|NCT05913427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154644121|NCT05913427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644122|NCT05913427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644123|NCT05913427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644124|NCT05913427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154644125|NCT05913427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154644126|NCT05913427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154644127|NCT05913427|Contraceptive Agents|contraceptive agents|mesh-ancestor
154644128|NCT05913427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154644129|NCT05913427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644130|NCT05913427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154644131|NCT05913427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154644132|NCT05913427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154644133|NCT05913427|Appetite Stimulants|appetite stimulants|mesh-ancestor
154644134|NCT05913427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154644135|NCT05913414|Iron|iron|mesh-list
154644136|NCT05913414|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154644137|NCT05913414|Ferric Compounds|ferric compounds|mesh-list
154644138|NCT05913414|Trace Elements|trace elements|mesh-ancestor
154644139|NCT05913414|Micronutrients|micronutrients|mesh-ancestor
154644140|NCT05913414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644141|NCT05913414|Hematinics|hematinics|mesh-ancestor
154644142|NCT05913180|Ascorbic Acid|ascorbic acid|mesh-list
154644143|NCT05913180|Vitamins|vitamins|mesh-ancestor
154644144|NCT05913180|Micronutrients|micronutrients|mesh-ancestor
154644145|NCT05913180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644146|NCT05913180|Antioxidants|antioxidants|mesh-ancestor
154644147|NCT05913180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644148|NCT05913180|Protective Agents|protective agents|mesh-ancestor
154644149|NCT05913115|Bemarituzumab|bemarituzumab|mesh-list
154644150|NCT05913115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644151|NCT05913115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644152|NCT05912816|Tislelizumab|tislelizumab|mesh-list
154644153|NCT05912816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644154|NCT05912816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644155|NCT05912712|Infliximab|infliximab|mesh-list
154644156|NCT05912712|Mesalamine|mesalamine|mesh-list
154644157|NCT05912712|Thrombin|thrombin|mesh-list
154644158|NCT05912712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154644159|NCT05912712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154644160|NCT05912712|Dermatologic Agents|dermatologic agents|mesh-ancestor
154644161|NCT05912712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154644162|NCT05912712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644163|NCT05912712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154644164|NCT05912712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154644165|NCT05912712|Analgesics|analgesics|mesh-ancestor
154644166|NCT05912712|Sensory System Agents|sensory system agents|mesh-ancestor
154644167|NCT05912712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644168|NCT05912712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644169|NCT05912712|Hemostatics|hemostatics|mesh-ancestor
154644170|NCT05912712|Coagulants|coagulants|mesh-ancestor
154644171|NCT05912686|Atorvastatin|atorvastatin|mesh-list
154644172|NCT05912686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154644173|NCT05912686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154644174|NCT05912686|Antimetabolites|antimetabolites|mesh-ancestor
154644175|NCT05912686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644176|NCT05912686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154644177|NCT05912686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154644178|NCT05912686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644179|NCT05912621|Tirzepatide|tirzepatide|mesh-list
154644180|NCT05912621|Incretins|incretins|mesh-ancestor
154644181|NCT05912621|Hormones|hormones|mesh-ancestor
154644182|NCT05912621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154644183|NCT05912621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644184|NCT05912335|Anesthetics|anesthetics|mesh-list
154644185|NCT05912335|Anesthetics, Local|anesthetics, local|mesh-list
154644186|NCT05912335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644187|NCT05912335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644188|NCT05912335|Sensory System Agents|sensory system agents|mesh-ancestor
154644189|NCT05912335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644190|NCT05912205|Disitamab vedotin|disitamab vedotin|mesh-list
154644191|NCT05912205|Immunoconjugates|immunoconjugates|mesh-ancestor
154644192|NCT05912205|Immunologic Factors|immunologic factors|mesh-ancestor
154644193|NCT05912205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644194|NCT05912192|Mometasone Furoate|mometasone furoate|mesh-list
154644195|NCT05912192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154644196|NCT05912192|Dermatologic Agents|dermatologic agents|mesh-ancestor
154644197|NCT05912192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154644198|NCT05912179|Liver Extracts|liver extracts|mesh-list
154644199|NCT05912179|Hematinics|hematinics|mesh-ancestor
154644200|NCT05912114|Mannitol|mannitol|mesh-list
154644201|NCT05912114|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154644202|NCT05912114|Diuretics|diuretics|mesh-ancestor
154644203|NCT05912114|Natriuretic Agents|natriuretic agents|mesh-ancestor
154644204|NCT05912114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644205|NCT05911659|Ticagrelor|ticagrelor|mesh-list
154644206|NCT05911659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154644207|NCT05911659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154644208|NCT05911659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154644209|NCT05911659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154644210|NCT05911659|Purinergic Agents|purinergic agents|mesh-ancestor
154644211|NCT05911659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644212|NCT05911659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644213|NCT05911659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644214|NCT05911503|Ganciclovir|ganciclovir|mesh-list
154644215|NCT05911503|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154644216|NCT05911503|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154644217|NCT05911503|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154644218|NCT05911503|Antiviral Agents|antiviral agents|mesh-ancestor
154644219|NCT05911503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644220|NCT05911503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154644221|NCT05911503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644222|NCT05911503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644223|NCT05911438|Epoetin Alfa|epoetin alfa|mesh-list
154644224|NCT05911438|Hematinics|hematinics|mesh-ancestor
154644225|NCT05911347|Psyllium|psyllium|mesh-list
154644226|NCT05911347|Cathartics|cathartics|mesh-ancestor
154644227|NCT05911347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154644228|NCT05911282|Acetylcysteine|acetylcysteine|mesh-list
154644229|NCT05911282|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154644230|NCT05911282|Antiviral Agents|antiviral agents|mesh-ancestor
154644231|NCT05911282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644232|NCT05911282|Expectorants|expectorants|mesh-ancestor
154644233|NCT05911282|Respiratory System Agents|respiratory system agents|mesh-ancestor
154644234|NCT05911282|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154644235|NCT05911282|Antioxidants|antioxidants|mesh-ancestor
154644236|NCT05911282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644237|NCT05911282|Protective Agents|protective agents|mesh-ancestor
154644238|NCT05911282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644239|NCT05911282|Antidotes|antidotes|mesh-ancestor
154644240|NCT05911022|Colchicine|colchicine|mesh-list
154644241|NCT05911022|Gout Suppressants|gout suppressants|mesh-ancestor
154644242|NCT05911022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644243|NCT05911022|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644244|NCT05911022|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644245|NCT05911022|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644246|NCT05911022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644247|NCT05911022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644248|NCT05907655|Nitroglycerin|nitroglycerin|mesh-list
154644249|NCT05907655|Vasodilator Agents|vasodilator agents|mesh-ancestor
154644250|NCT05907512|Endostar protein|endostar protein|mesh-list
154644251|NCT05907512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154644252|NCT05907512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154644253|NCT05907512|Growth Substances|growth substances|mesh-ancestor
154644254|NCT05907512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644255|NCT05907512|Growth Inhibitors|growth inhibitors|mesh-ancestor
154644256|NCT05907512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644257|NCT05906056|Zoledronic Acid|zoledronic acid|mesh-list
154644258|NCT05906056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154644259|NCT05906056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644260|NCT05905770|Alemtuzumab|alemtuzumab|mesh-list
154644261|NCT05905770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644262|NCT05905770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644263|NCT05905510|Anesthetics|anesthetics|mesh-list
154644264|NCT05905510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644265|NCT05905510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644266|NCT05904964|Disitamab vedotin|disitamab vedotin|mesh-list
154644267|NCT05904964|Immunoconjugates|immunoconjugates|mesh-ancestor
154644268|NCT05904964|Immunologic Factors|immunologic factors|mesh-ancestor
154644269|NCT05904964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644270|NCT05904353|Zoledronic Acid|zoledronic acid|mesh-list
154644271|NCT05904353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154644272|NCT05904353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644273|NCT05903014|Acetylcysteine|acetylcysteine|mesh-list
154644274|NCT05903014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154644275|NCT05903014|Antiviral Agents|antiviral agents|mesh-ancestor
154644276|NCT05903014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644277|NCT05903014|Expectorants|expectorants|mesh-ancestor
154644278|NCT05903014|Respiratory System Agents|respiratory system agents|mesh-ancestor
154644279|NCT05903014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154644280|NCT05903014|Antioxidants|antioxidants|mesh-ancestor
154644281|NCT05903014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644282|NCT05903014|Protective Agents|protective agents|mesh-ancestor
154644283|NCT05903014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644284|NCT05903014|Antidotes|antidotes|mesh-ancestor
154644285|NCT05874492|Dermatologic Agents|dermatologic agents|mesh-list
154644286|NCT05823896|Ritonavir|ritonavir|mesh-list
154644287|NCT05823896|Nirmatrelvir|nirmatrelvir|mesh-list
154644288|NCT05823896|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154644289|NCT05823896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154644290|NCT05823896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154644291|NCT05823896|Protease Inhibitors|protease inhibitors|mesh-ancestor
154644292|NCT05823896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644293|NCT05823896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644294|NCT05823896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154644295|NCT05823896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154644296|NCT05823896|Antiviral Agents|antiviral agents|mesh-ancestor
154644297|NCT05823896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644298|NCT05823896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154644299|NCT05823896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154644300|NCT05821088|Carboplatin|carboplatin|mesh-list
154644301|NCT05821088|Etoposide|etoposide|mesh-list
154644302|NCT05821088|Lenalidomide|lenalidomide|mesh-list
154644303|NCT05821088|Etoposide phosphate|etoposide phosphate|mesh-list
154644304|NCT05821088|Ifosfamide|ifosfamide|mesh-list
154644305|NCT05821088|Isophosphamide mustard|isophosphamide mustard|mesh-list
154644306|NCT05821088|Podophyllotoxin|podophyllotoxin|mesh-list
154644307|NCT05821088|Immunoglobulins|immunoglobulins|mesh-list
154644308|NCT05821088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644309|NCT05821088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644310|NCT05821088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154644311|NCT05821088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154644312|NCT05821088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644313|NCT05821088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644314|NCT05821088|Immunologic Factors|immunologic factors|mesh-ancestor
154644315|NCT05821088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644316|NCT05821088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154644317|NCT05821088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154644318|NCT05821088|Growth Substances|growth substances|mesh-ancestor
154644319|NCT05821088|Growth Inhibitors|growth inhibitors|mesh-ancestor
154644320|NCT05821088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154644321|NCT05821088|Alkylating Agents|alkylating agents|mesh-ancestor
154644322|NCT05821088|Keratolytic Agents|keratolytic agents|mesh-ancestor
154644323|NCT05821088|Dermatologic Agents|dermatologic agents|mesh-ancestor
154644324|NCT05821088|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644325|NCT05821088|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644326|NCT05821088|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644327|NCT05794581|Liraglutide|liraglutide|mesh-list
154644328|NCT05794581|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154644329|NCT05794581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154644330|NCT05794581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644331|NCT05794581|Incretins|incretins|mesh-ancestor
154644332|NCT05794581|Hormones|hormones|mesh-ancestor
154644333|NCT05794581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154644334|NCT05767944|Anesthetics|anesthetics|mesh-list
154644335|NCT05767944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644336|NCT05767944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644337|NCT05751265|Paclitaxel|paclitaxel|mesh-list
154644338|NCT05751265|Tislelizumab|tislelizumab|mesh-list
154644339|NCT05751265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644340|NCT05751265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644341|NCT05751265|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644342|NCT05751265|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644343|NCT05751265|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644344|NCT05751265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644345|NCT05751265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644346|NCT05716854|Moxifloxacin|moxifloxacin|mesh-list
154644347|NCT05716854|Clarithromycin|clarithromycin|mesh-list
154644348|NCT05716854|Cobicistat|cobicistat|mesh-list
154644349|NCT05716854|Pimozide|pimozide|mesh-list
154644350|NCT05716854|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154644351|NCT05716854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154644352|NCT05716854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644353|NCT05716854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154644354|NCT05716854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154644355|NCT05716854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644356|NCT05716854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644357|NCT05716854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644358|NCT05716854|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154644359|NCT05716854|Contraceptive Agents|contraceptive agents|mesh-ancestor
154644360|NCT05716854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154644361|NCT05716854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644362|NCT05716854|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154644363|NCT05716854|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154644364|NCT05716854|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154644365|NCT05716854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154644366|NCT05716854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154644367|NCT05716854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154644368|NCT05716854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154644369|NCT05716854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154644370|NCT05716854|Antiviral Agents|antiviral agents|mesh-ancestor
154644371|NCT05716854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154644372|NCT05716854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154644373|NCT05716854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644374|NCT05716854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154644375|NCT05716854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154644376|NCT05716854|Dopamine Agents|dopamine agents|mesh-ancestor
154644377|NCT05716854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644378|NCT05716854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154644379|NCT05714553|Leucovorin|leucovorin|mesh-list
154644380|NCT05714553|Docetaxel|docetaxel|mesh-list
154644381|NCT05714553|Pembrolizumab|pembrolizumab|mesh-list
154644382|NCT05714553|Levoleucovorin|levoleucovorin|mesh-list
154644383|NCT05714553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644384|NCT05714553|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644385|NCT05714553|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644386|NCT05714553|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644387|NCT05714553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644388|NCT05714553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644389|NCT05714553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644390|NCT05714553|Antidotes|antidotes|mesh-ancestor
154644391|NCT05714553|Protective Agents|protective agents|mesh-ancestor
154644392|NCT05714553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644393|NCT05714553|Vitamin B Complex|vitamin b complex|mesh-ancestor
154644394|NCT05714553|Vitamins|vitamins|mesh-ancestor
154644395|NCT05714553|Micronutrients|micronutrients|mesh-ancestor
154644396|NCT05713760|Tirbanibulin|tirbanibulin|mesh-list
154644397|NCT05713760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644398|NCT05713760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644399|NCT05701488|Durvalumab|durvalumab|mesh-list
154644400|NCT05701488|Tremelimumab|tremelimumab|mesh-list
154644401|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644402|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644403|NCT05685407|Caffeine|caffeine|mesh-list
154644404|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154644405|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644406|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154644407|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644408|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644409|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154644410|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154644411|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
154644412|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644413|NCT05684276|Paclitaxel|paclitaxel|mesh-list
154644414|NCT05684276|Carboplatin|carboplatin|mesh-list
154644415|NCT05684276|Nivolumab|nivolumab|mesh-list
154359270|NCT05274672|Cephalexin|cephalexin|mesh-list
154644416|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644417|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644418|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644419|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644420|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644421|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644422|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644423|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644424|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
154644425|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
154644426|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154644427|NCT05641051|Metoclopramide|metoclopramide|mesh-list
154644428|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
154644429|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
154644430|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644431|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644432|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154644433|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154644434|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154644435|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
154644436|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644437|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644438|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154644439|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154644440|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644441|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154644442|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154644443|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154644444|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644445|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
154644446|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644447|NCT05618366|Venetoclax|venetoclax|mesh-list
154644448|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644449|NCT05587998|Morphine|morphine|mesh-list
154644450|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154644451|NCT05587998|Narcotics|narcotics|mesh-ancestor
154644452|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644453|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644454|NCT05587998|Analgesics|analgesics|mesh-ancestor
154644455|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
154644456|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644457|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
154644458|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154644459|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154644460|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154644461|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154644462|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154644463|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644464|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
154644465|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644466|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644467|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154644468|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644469|NCT05571735|Vaccines|vaccines|mesh-list
154644470|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
154644471|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644472|NCT05554237|Ceftibuten|ceftibuten|mesh-list
154644473|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154644474|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644475|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
154644476|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154644477|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644478|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
154644479|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154644480|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
154644481|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644482|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
154644483|NCT05544695|Protective Agents|protective agents|mesh-ancestor
154644484|NCT05538312|Itraconazole|itraconazole|mesh-list
154644485|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
154644486|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644487|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154644488|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154644489|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644490|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644491|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154644492|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
154644493|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154644494|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644495|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154644496|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154644497|NCT05507476|Epinephrine|epinephrine|mesh-list
154644498|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154644499|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154644500|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
154644501|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644502|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644503|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644504|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154644505|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154644506|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
154644507|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644508|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154644509|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
154644510|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
154644511|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
154644512|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154644513|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
154644514|NCT05507476|Coagulants|coagulants|mesh-ancestor
154644515|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154644516|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
154644517|NCT05494125|Ropivacaine|ropivacaine|mesh-list
154644518|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
154644519|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
154644520|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644521|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644522|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
154644523|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644524|NCT05484401|Ibuprofen|ibuprofen|mesh-list
154860328|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644525|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154644526|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154644527|NCT05484401|Analgesics|analgesics|mesh-ancestor
154644528|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
154644529|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644530|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644531|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154644532|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644533|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154644534|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644535|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644536|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
154644537|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154644538|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154644539|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644540|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
154644541|NCT05442580|Fludarabine|fludarabine|mesh-list
154644542|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154644543|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
154644544|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644545|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644546|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154644547|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
154644548|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644549|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644550|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154644552|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154644553|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
154644554|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644555|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644556|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154644557|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154644558|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
154644559|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644560|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644561|NCT05418582|Carbamazepine|carbamazepine|mesh-list
154644562|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
154644563|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
154644564|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154644565|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644566|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644567|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154644568|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154644569|NCT05418582|Analgesics|analgesics|mesh-ancestor
154644570|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
154644571|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644572|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154644573|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154644574|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644575|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154644576|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154644577|NCT05417425|Lidocaine|lidocaine|mesh-list
154644578|NCT05417425|Protective Agents|protective agents|mesh-list
154644579|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
154644580|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
154644581|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644582|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644583|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
154644584|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644585|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154644586|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154644587|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154644588|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154644589|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644590|NCT05394103|Pembrolizumab|pembrolizumab|mesh-list
154644591|NCT05394103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644592|NCT05394103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644593|NCT05394103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644594|NCT05394103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644595|NCT05388474|Ibalizumab|ibalizumab|mesh-list
154644596|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154644597|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154644598|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154644599|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
154644600|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644601|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
154644602|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644603|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
154644604|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154644605|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154644606|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
154644607|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644608|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
154644609|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154644610|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644611|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644612|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154644613|NCT05342844|Analgesics|analgesics|mesh-ancestor
154644614|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
154644615|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644616|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154644617|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154644618|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154644619|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
154644620|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644621|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644622|NCT05323617|Cyclosporine|cyclosporine|mesh-list
154644623|NCT05323617|Cyclosporins|cyclosporins|mesh-list
154644624|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154644625|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644626|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644627|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154644628|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
154644629|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644630|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
154644631|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644632|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
154644633|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644634|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154644635|NCT05229965|Acetaminophen|acetaminophen|mesh-list
154644636|NCT05229965|Codeine|codeine|mesh-list
154644637|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154644638|NCT05229965|Analgesics|analgesics|mesh-ancestor
154644639|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
154644640|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644641|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644642|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
154644643|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154644644|NCT05229965|Narcotics|narcotics|mesh-ancestor
154644645|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644646|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
154644647|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
154644648|NCT05227391|Letrozole|letrozole|mesh-list
154644649|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154644650|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154644651|NCT05227391|Estradiol|estradiol|mesh-list
154644652|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154644653|NCT05227391|Estrogens|estrogens|mesh-ancestor
154644654|NCT05227391|Hormones|hormones|mesh-ancestor
154644655|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154644656|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644657|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154644658|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
154644659|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154644660|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154644661|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644662|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154644663|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154644664|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644665|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644666|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154644667|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
154644668|NCT05207709|Paclitaxel|paclitaxel|mesh-list
154644669|NCT05207709|Letrozole|letrozole|mesh-list
154644670|NCT05207709|Fulvestrant|fulvestrant|mesh-list
154644671|NCT05207709|Tislelizumab|tislelizumab|mesh-list
154644672|NCT05207709|Palbociclib|palbociclib|mesh-list
154644673|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644674|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644675|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644676|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644677|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644678|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644679|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154644680|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154644681|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644682|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154644683|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
154644684|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154644685|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644686|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154644687|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154644688|NCT05207709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644689|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154644690|NCT05203276|Endostar protein|endostar protein|mesh-list
154644691|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154644692|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154644693|NCT05203276|Growth Substances|growth substances|mesh-ancestor
154644694|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644695|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
154644696|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644697|NCT05167487|Cisplatin|cisplatin|mesh-list
154644698|NCT05167487|Carboplatin|carboplatin|mesh-list
154644699|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644700|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
154644701|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644702|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644703|NCT05159778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644704|NCT05159778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644705|NCT05152888|Evolocumab|evolocumab|mesh-list
154644706|NCT05152888|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154644707|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154644708|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154644709|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
154644710|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644711|NCT05152888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154644712|NCT05152888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154644713|NCT05152888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644714|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154644715|NCT05151484|Alendronate|alendronate|mesh-list
154644716|NCT05151484|Teriparatide|teriparatide|mesh-list
154644717|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154644718|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644719|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154644720|NCT05113537|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154644721|NCT05113537|Chelating Agents|chelating agents|mesh-ancestor
154644722|NCT05113537|Sequestering Agents|sequestering agents|mesh-ancestor
154644723|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644724|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154644725|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
154644726|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154644727|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
154644728|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154644729|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644730|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154644731|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154644732|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644733|NCT05088252|Propofol|propofol|mesh-list
154644734|NCT05088252|Desflurane|desflurane|mesh-list
154644735|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154644736|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644737|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644738|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154644739|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
154644740|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
154644741|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154644742|NCT05069298|Silybin|silybin|mesh-list
154644743|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644744|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644745|NCT05069298|Protective Agents|protective agents|mesh-ancestor
154644746|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644747|NCT05047640|Vaccines|vaccines|mesh-list
154644748|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
154644749|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644750|NCT05043714|Nivolumab|nivolumab|mesh-list
154644751|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644752|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644753|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644754|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644755|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154644756|NCT05039073|Nivolumab|nivolumab|mesh-list
154644757|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154644758|NCT05039073|Antibodies|antibodies|mesh-list
154644759|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
154644760|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154644761|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
154644762|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
154644763|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644764|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644765|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644766|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644767|NCT05039073|Immunotoxins|immunotoxins|mesh-ancestor
154644768|NCT05029999|Doxorubicin|doxorubicin|mesh-list
154644769|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154644770|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154644771|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644772|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154644773|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154644774|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644775|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644776|NCT05023967|Metformin|metformin|mesh-list
154644777|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154644778|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644779|NCT05012254|Paclitaxel|paclitaxel|mesh-list
154644780|NCT05012254|Cisplatin|cisplatin|mesh-list
154644781|NCT05012254|Carboplatin|carboplatin|mesh-list
154644782|NCT05012254|Nivolumab|nivolumab|mesh-list
154644783|NCT05012254|Pemetrexed|pemetrexed|mesh-list
154644784|NCT05012254|Ipilimumab|ipilimumab|mesh-list
154644785|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644786|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644787|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644788|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644789|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644790|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644791|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644792|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644793|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644794|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154644795|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154644796|NCT04995978|Pioglitazone|pioglitazone|mesh-list
154644797|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154644798|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644799|NCT04987294|Rasburicase|rasburicase|mesh-list
154644800|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
154644801|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644802|NCT04987242|Rasburicase|rasburicase|mesh-list
154644803|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
154644804|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644805|NCT04958486|Trastuzumab|trastuzumab|mesh-list
154644806|NCT04958486|Azacitidine|azacitidine|mesh-list
154644807|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644808|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644809|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154644810|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
154644811|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644812|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644813|NCT04942210|Vaccines|vaccines|mesh-list
154644814|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
154644815|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644816|NCT04940767|Minocycline|minocycline|mesh-list
154644817|NCT04940767|Isotretinoin|isotretinoin|mesh-list
154644818|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154644819|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644820|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
154644821|NCT04913805|Niacinamide|niacinamide|mesh-list
154644822|NCT04913805|Niacin|niacin|mesh-list
154396942|NCT02387086|Aspirin|aspirin|mesh-list
154644823|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
154644824|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
154644825|NCT04913805|Vitamins|vitamins|mesh-ancestor
154644826|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
154644827|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644828|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154644829|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
154644830|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644831|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154644832|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
154644834|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644835|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
154644836|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154644837|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154644838|NCT04900220|Prednisolone|prednisolone|mesh-list
154644839|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
154644840|NCT04900220|Betamethasone|betamethasone|mesh-list
154644841|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154359707|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
154644842|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
154644843|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154644844|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
154644845|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
154644846|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644847|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644848|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154644849|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
154644850|NCT04900220|Hormones|hormones|mesh-ancestor
154644851|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154644852|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154644853|NCT04900220|Protective Agents|protective agents|mesh-ancestor
154644854|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154644855|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644856|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154644857|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
154644858|NCT04896320|Tucatinib|tucatinib|mesh-list
154644859|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644860|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154644861|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644862|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644863|NCT04887259|Interleukin-2|interleukin-2|mesh-list
154644864|NCT04887259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644865|NCT04887259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154644866|NCT04887259|Analgesics|analgesics|mesh-ancestor
154644867|NCT04887259|Sensory System Agents|sensory system agents|mesh-ancestor
154644868|NCT04887259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644869|NCT04887259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644870|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
154644871|NCT04877613|Fludarabine|fludarabine|mesh-list
154644872|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154644873|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
154644874|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644875|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154644876|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154644877|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
154644878|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644879|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359752|NCT01237535|Progesterone|progesterone|mesh-list
154644880|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154644881|NCT04871607|Cytarabine|cytarabine|mesh-list
154644882|NCT04871607|Etoposide|etoposide|mesh-list
154644883|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
154644884|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
154644885|NCT04871607|Carmustine|carmustine|mesh-list
154644886|NCT04871607|Basiliximab|basiliximab|mesh-list
154644887|NCT04871607|Lenograstim|lenograstim|mesh-list
154644888|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644889|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644890|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154644891|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154644892|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644893|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644894|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154644895|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
154644896|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
154644897|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644898|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154644899|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
154644900|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644901|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154644902|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154644903|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
154644904|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
154644905|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
154644906|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644907|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644908|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644909|NCT04865042|Gabapentin|gabapentin|mesh-list
154644910|NCT04865042|Analgesics|analgesics|mesh-ancestor
154644911|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
154644912|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644913|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644914|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
154644915|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154644916|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154644917|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644918|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154644919|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154644920|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154644921|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154644922|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644923|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
154644924|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154644925|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644926|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
154644927|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644928|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644929|NCT04830592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644930|NCT04830592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644931|NCT04824131|Tenofovir|tenofovir|mesh-list
154644932|NCT04824131|Emtricitabine|emtricitabine|mesh-list
154644933|NCT04824131|Cabotegravir|cabotegravir|mesh-list
154644934|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
154644935|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154644936|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154644937|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154644938|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644939|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644940|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154644941|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154644942|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154644943|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154644944|NCT04776447|Carboplatin|carboplatin|mesh-list
154644945|NCT04776447|Atezolizumab|atezolizumab|mesh-list
154644946|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644947|NCT04776447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154644948|NCT04776447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644949|NCT04776447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154644950|NCT04768504|Tofacitinib|tofacitinib|mesh-list
154644951|NCT04768504|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154644952|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154644953|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644954|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644955|NCT04748172|Antibodies|antibodies|mesh-list
154644956|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
154644957|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644958|NCT04736823|Paclitaxel|paclitaxel|mesh-list
154644959|NCT04736823|Docetaxel|docetaxel|mesh-list
154644960|NCT04736823|Carboplatin|carboplatin|mesh-list
154644961|NCT04736823|Pemetrexed|pemetrexed|mesh-list
154644962|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154644963|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154644964|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
154644965|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
154644966|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
154644967|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644968|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154644969|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154644970|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154644971|NCT04729621|Denosumab|denosumab|mesh-list
154644972|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154644973|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644974|NCT04664023|Vaccines|vaccines|mesh-list
154644975|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
154644976|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644977|NCT04633889|Deferoxamine|deferoxamine|mesh-list
154644978|NCT04633889|Siderophores|siderophores|mesh-ancestor
154644979|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154644980|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
154644981|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
154644982|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644983|NCT04630886|Lidocaine|lidocaine|mesh-list
154644984|NCT04630886|Epinephrine|epinephrine|mesh-list
154644985|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
154359830|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
154644986|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
154644987|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
154644988|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154644989|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154644990|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
154644991|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154644992|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154644993|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154644994|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154644995|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154644996|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154644997|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154644998|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154644999|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
154645000|NCT04630886|Coagulants|coagulants|mesh-ancestor
154645001|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154645002|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154645003|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
154645004|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154645005|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154645006|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154645007|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
154645008|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154645009|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
154645010|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
154645011|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
154645012|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154645013|NCT04619316|Trametinib|trametinib|mesh-list
154645014|NCT04619316|Dabrafenib|dabrafenib|mesh-list
154645015|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645016|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154645017|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645018|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645019|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154645020|NCT04610528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154645021|NCT04610528|Immunologic Factors|immunologic factors|mesh-ancestor
154645022|NCT04610528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645023|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645024|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645025|NCT04609111|Aspirin|aspirin|mesh-list
154645026|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154645027|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154645028|NCT04609111|Analgesics|analgesics|mesh-ancestor
154645029|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
154645030|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645031|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645032|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645033|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645034|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154645035|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154645036|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645037|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154645038|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154645039|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645040|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
154645041|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154359890|NCT01147523|Vitamins|vitamins|mesh-ancestor
154645042|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645043|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645044|NCT04590196|Curcumin|curcumin|mesh-list
154645045|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154645046|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154645047|NCT04590196|Analgesics|analgesics|mesh-ancestor
154645048|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
154645049|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645050|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645051|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645052|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645053|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645054|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645055|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645057|NCT04589208|Analgesics|analgesics|mesh-ancestor
154645058|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
154645059|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645060|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645061|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154645062|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154645063|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
154645064|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
154645065|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154645066|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154645067|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154645068|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154645069|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645070|NCT04566328|Dexamethasone|dexamethasone|mesh-list
154645071|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
154645072|NCT04566328|Lenalidomide|lenalidomide|mesh-list
154645073|NCT04566328|Bortezomib|bortezomib|mesh-list
154645074|NCT04566328|Daratumumab|daratumumab|mesh-list
154645075|NCT04566328|Ichthammol|ichthammol|mesh-list
154645076|NCT04566328|BB 1101|bb 1101|mesh-list
154645077|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154645078|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645079|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
154645080|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
154645081|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645082|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645083|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645084|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
154645085|NCT04566328|Hormones|hormones|mesh-ancestor
154645086|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645087|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645088|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645089|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
154645090|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645091|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645092|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
154645093|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645094|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645095|NCT04566328|Growth Substances|growth substances|mesh-ancestor
154645096|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645097|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
154645098|NCT04559139|Cisplatin|cisplatin|mesh-list
154645099|NCT04559139|Gemcitabine|gemcitabine|mesh-list
154645100|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645101|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645102|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
154645103|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645104|NCT04551222|Probenecid|probenecid|mesh-list
154645105|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
154645106|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
154645107|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645108|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
154645109|NCT04527549|Trametinib|trametinib|mesh-list
154645110|NCT04527549|Dabrafenib|dabrafenib|mesh-list
154645111|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154645112|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
154645113|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154645114|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154645115|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645116|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645117|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645118|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645119|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645120|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154645121|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154645122|NCT04527549|Protective Agents|protective agents|mesh-ancestor
154645123|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645124|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154645125|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
154645126|NCT04512430|Bevacizumab|bevacizumab|mesh-list
154645127|NCT04512430|Atezolizumab|atezolizumab|mesh-list
154645128|NCT04512430|Carboplatin|carboplatin|mesh-list
154645129|NCT04512430|Pemetrexed|pemetrexed|mesh-list
154397236|NCT02385058|Mebendazole|mebendazole|mesh-list
154645130|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645131|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645132|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645133|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645134|NCT04512430|Growth Substances|growth substances|mesh-ancestor
154645135|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645136|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645137|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645138|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645139|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154645140|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154645141|NCT04512430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154360007|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360008|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154360009|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
154360010|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154360011|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154360012|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154645143|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154645144|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
154645145|NCT04484818|Leuprolide|leuprolide|mesh-list
154645146|NCT04484818|Goserelin|goserelin|mesh-list
154645147|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154645148|NCT04484818|Tryptophan|tryptophan|mesh-list
154645149|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
154645150|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645151|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645152|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154645153|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
154645154|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154645155|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645156|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645157|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
154645158|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154645159|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
154645160|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154645161|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154645162|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
154645163|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154645164|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
154645165|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
154645166|NCT04484012|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154645167|NCT04484012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154645168|NCT04484012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645169|NCT04484012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645170|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645171|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
154645172|NCT04477200|Temozolomide|temozolomide|mesh-list
154645173|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154645174|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
154645175|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645176|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645177|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154645178|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154645179|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
154645180|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154645181|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645182|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645183|NCT04455802|Morphine|morphine|mesh-list
154645184|NCT04455802|Buprenorphine|buprenorphine|mesh-list
154645185|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154645186|NCT04455802|Narcotics|narcotics|mesh-ancestor
154645187|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154645188|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645189|NCT04455802|Analgesics|analgesics|mesh-ancestor
154645190|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
154645191|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645192|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154645193|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
154645194|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645195|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645196|NCT04443088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154645197|NCT04443088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645198|NCT04426890|Omalizumab|omalizumab|mesh-list
154645199|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154645200|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154645201|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154645202|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
154397314|NCT03331315|Analgesics|analgesics|mesh-ancestor
154645203|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
154645204|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645205|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
154645206|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
154645207|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154645208|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645209|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645210|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645211|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154645212|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154645213|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
154645214|NCT04364048|Cisplatin|cisplatin|mesh-list
154645215|NCT04364048|Carboplatin|carboplatin|mesh-list
154645216|NCT04364048|Etoposide|etoposide|mesh-list
154645217|NCT04364048|Pemetrexed|pemetrexed|mesh-list
154645218|NCT04364048|Durvalumab|durvalumab|mesh-list
154645219|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154645220|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645221|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154645222|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154645223|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154645224|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645225|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645226|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154645227|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154645228|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645229|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
154645230|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645231|NCT04311580|Mitomycins|mitomycins|mesh-list
154645232|NCT04311580|Mitomycin|mitomycin|mesh-list
154645233|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154645234|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645235|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
154645236|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645237|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154645238|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645239|NCT04301492|Vortioxetine|vortioxetine|mesh-list
154645240|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
154645241|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154645242|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154645243|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154645244|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154645245|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645246|NCT04301492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154645247|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154645248|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154645249|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645250|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154645251|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
154645252|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154645253|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154645254|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154645255|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154645256|NCT04290039|Atropine|atropine|mesh-list
154645257|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154645258|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154645259|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154645260|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154645261|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154645262|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
154645263|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645264|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645265|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154645266|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154645267|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
154645268|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
154645269|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154645270|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154645271|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
154645272|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154645273|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645274|NCT04266249|Paclitaxel|paclitaxel|mesh-list
154645275|NCT04266249|Maytansine|maytansine|mesh-list
154645276|NCT04266249|Docetaxel|docetaxel|mesh-list
154645277|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154645278|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154645279|NCT04266249|Trastuzumab|trastuzumab|mesh-list
154645280|NCT04266249|Pertuzumab|pertuzumab|mesh-list
154645281|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154645282|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154645283|NCT04266249|Antibodies|antibodies|mesh-list
154645284|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
154645285|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154645286|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
154645287|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154645288|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645289|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
154645290|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
154645291|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
154645292|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645293|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
154645294|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645295|NCT04266249|Immunotoxins|immunotoxins|mesh-ancestor
154645296|NCT04233112|Melatonin|melatonin|mesh-list
154645297|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
154645298|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645299|NCT04233112|Protective Agents|protective agents|mesh-ancestor
154645300|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645301|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154645302|NCT04217954|Bevacizumab|bevacizumab|mesh-list
154645303|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645304|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645305|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645306|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645307|NCT04217954|Growth Substances|growth substances|mesh-ancestor
154645308|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645309|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645310|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154645311|NCT04210427|Laxatives|laxatives|mesh-ancestor
154645312|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645313|NCT04194034|Flucytosine|flucytosine|mesh-list
154645314|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
154645315|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645316|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
154645317|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645318|NCT04166318|Capecitabine|capecitabine|mesh-list
154645319|NCT04166318|Fluorouracil|fluorouracil|mesh-list
154645320|NCT04166318|Mitomycins|mitomycins|mesh-list
154645321|NCT04166318|Mitomycin|mitomycin|mesh-list
154645322|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645323|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
154645324|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645325|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645326|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645327|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
154645328|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645329|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154645330|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
154645331|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154645332|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645333|NCT04150614|Dexamethasone|dexamethasone|mesh-list
154645334|NCT04150614|Ondansetron|ondansetron|mesh-list
154645335|NCT04150614|Granisetron|granisetron|mesh-list
154645336|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645337|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
154645338|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
154645339|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645340|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645341|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645342|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
154645343|NCT04150614|Hormones|hormones|mesh-ancestor
154645344|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645345|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645346|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645347|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
154645348|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
154645349|NCT04150614|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154645350|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154645351|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
154645352|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154645353|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645354|NCT04126096|Lactams|lactams|mesh-list
154645355|NCT04126096|beta-Lactams|beta-lactams|mesh-list
154645356|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154645357|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645358|NCT04121455|Bevacizumab|bevacizumab|mesh-list
154645359|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
154645360|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645361|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645362|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645363|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645364|NCT04121455|Growth Substances|growth substances|mesh-ancestor
154645365|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645366|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645367|NCT04121455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154645368|NCT04121455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645369|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
154645370|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
154645371|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645372|NCT04115631|Cytarabine|cytarabine|mesh-list
154645373|NCT04115631|Rituximab|rituximab|mesh-list
154645374|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154645375|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154645376|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
154645377|NCT04115631|Antibodies|antibodies|mesh-list
154645378|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
154645379|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154645380|NCT04115631|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154645381|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
154645382|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645383|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645384|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645385|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645386|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
154645387|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645388|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
154645389|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360242|NCT01148303|Etoricoxib|etoricoxib|mesh-list
154645390|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645391|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154645392|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
154645393|NCT04115631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154645394|NCT04115631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645395|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
154645396|NCT04109482|Fludarabine|fludarabine|mesh-list
154645397|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645398|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
154645399|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645400|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645401|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154645402|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
154645403|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645404|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645405|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154645406|NCT04094584|Naltrexone|naltrexone|mesh-list
154645407|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154645408|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154645409|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645410|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
154645411|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645412|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
154645413|NCT04020341|Gepotidacin|gepotidacin|mesh-list
154645414|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154645415|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645416|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154645417|NCT04020341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154645418|NCT04020341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645419|NCT04020341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645420|NCT04020341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645421|NCT04011280|Varenicline|varenicline|mesh-list
154645422|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154645423|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154645424|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
154645425|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154645426|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645427|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558038|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154645428|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
154645429|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154645430|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154645431|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
154645432|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645433|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645434|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154645435|NCT03987711|Warfarin|warfarin|mesh-list
154645436|NCT03987711|Apixaban|apixaban|mesh-list
154645437|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
154645438|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154645439|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
154645440|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154645441|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
154645442|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645443|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645444|NCT03937635|Dexamethasone|dexamethasone|mesh-list
154645445|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
154645446|NCT03937635|Lenalidomide|lenalidomide|mesh-list
154645447|NCT03937635|Daratumumab|daratumumab|mesh-list
154645448|NCT03937635|Ichthammol|ichthammol|mesh-list
154645449|NCT03937635|BB 1101|bb 1101|mesh-list
154645450|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645451|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
154645452|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
154645453|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645454|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645455|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645456|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
154645457|NCT03937635|Hormones|hormones|mesh-ancestor
154645458|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645459|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645460|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645461|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
154645462|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645463|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645464|NCT03937635|Growth Substances|growth substances|mesh-ancestor
154645465|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645466|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
154645467|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645468|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645469|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
154645470|NCT03892044|Nivolumab|nivolumab|mesh-list
154645471|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645472|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645473|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154645474|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645475|NCT03867851|Heparin|heparin|mesh-list
154645476|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
154645477|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154645478|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154645479|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645480|NCT03809780|Dexamethasone|dexamethasone|mesh-list
154645481|NCT03809780|Lenalidomide|lenalidomide|mesh-list
154645482|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645483|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
154645484|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
154645485|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645486|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645487|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645488|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
154645489|NCT03809780|Hormones|hormones|mesh-ancestor
154645490|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645491|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645492|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645493|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
154645494|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645495|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645496|NCT03809780|Growth Substances|growth substances|mesh-ancestor
154645497|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645498|NCT03802604|Atezolizumab|atezolizumab|mesh-list
154645499|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154645500|NCT03802604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154645501|NCT03802604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645502|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645503|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645504|NCT03785873|Leucovorin|leucovorin|mesh-list
154645505|NCT03785873|Nivolumab|nivolumab|mesh-list
154645506|NCT03785873|Fluorouracil|fluorouracil|mesh-list
154645507|NCT03785873|Irinotecan|irinotecan|mesh-list
154645508|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645509|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645510|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154645511|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645512|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
154645513|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645514|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645515|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
154645516|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645517|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154645518|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154645519|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645520|NCT03785873|Antidotes|antidotes|mesh-ancestor
154645521|NCT03785873|Protective Agents|protective agents|mesh-ancestor
154645522|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
154645523|NCT03785873|Vitamins|vitamins|mesh-ancestor
154645524|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
154645525|NCT03782064|Nivolumab|nivolumab|mesh-list
154645526|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645527|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645528|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154645529|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645530|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
154645531|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154645532|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645533|NCT03739112|Vaccines|vaccines|mesh-list
154645534|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
154645535|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645536|NCT03724071|Flucytosine|flucytosine|mesh-list
154645537|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
154645538|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645539|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
154360402|NCT01255475|Amlodipine|amlodipine|mesh-list
154645540|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645541|NCT03709446|Leflunomide|leflunomide|mesh-list
154645542|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645543|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645544|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645545|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
154645546|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645547|NCT03671525|Nimodipine|nimodipine|mesh-list
154645548|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154645549|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154645550|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154645551|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645552|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154645553|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645554|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
154645555|NCT03648437|Acetaminophen|acetaminophen|mesh-list
154645556|NCT03648437|Ibuprofen|ibuprofen|mesh-list
154645557|NCT03648437|Indomethacin|indomethacin|mesh-list
154645558|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154645559|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154645560|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154645561|NCT03648437|Analgesics|analgesics|mesh-ancestor
154645562|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
154645563|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645564|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645565|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645566|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645567|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154645568|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645569|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645570|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
154645571|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
154645572|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
154645573|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154645574|NCT03622593|Aflibercept|aflibercept|mesh-list
154645575|NCT03622593|Faricimab|faricimab|mesh-list
154645576|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645577|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645578|NCT03622593|Growth Substances|growth substances|mesh-ancestor
154397683|NCT02370550|Prednisone|prednisone|mesh-list
154645579|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645580|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645581|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645582|NCT03593655|Tenofovir|tenofovir|mesh-list
154645583|NCT03593655|Emtricitabine|emtricitabine|mesh-list
154645584|NCT03593655|Dapivirine|dapivirine|mesh-list
154645585|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
154645586|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645587|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154645588|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154645589|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645590|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645591|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154645592|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154645593|NCT03572530|Azacitidine|azacitidine|mesh-list
154645594|NCT03572530|Decitabine|decitabine|mesh-list
154645595|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645596|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
154645597|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645598|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645599|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645600|NCT03558087|Gemcitabine|gemcitabine|mesh-list
154645601|NCT03558087|Nivolumab|nivolumab|mesh-list
154645602|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645603|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645604|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
154645605|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645606|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645607|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154645608|NCT03542695|Alendronate|alendronate|mesh-list
154645609|NCT03542695|Copper|copper|mesh-list
154645610|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154645611|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645612|NCT03542695|Trace Elements|trace elements|mesh-ancestor
154645613|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
154645614|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154645615|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
154645616|NCT03512405|Blinatumomab|blinatumomab|mesh-list
154645617|NCT03512405|Antibodies|antibodies|mesh-list
154645618|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
154645619|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154645620|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
154645621|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154645622|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
154645623|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645624|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645625|NCT03512405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154645626|NCT03512405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645627|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645628|NCT03458416|Cannabidiol|cannabidiol|mesh-list
154645629|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
154645630|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154645631|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154645632|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645633|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645634|NCT03430219|Calcium|calcium|mesh-list
154645635|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154645636|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645637|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
154645638|NCT03419234|Prednisone|prednisone|mesh-list
154645639|NCT03419234|Cortisone|cortisone|mesh-list
154645640|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
154645641|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
154645642|NCT03419234|Hormones|hormones|mesh-list
154645643|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154645644|NCT03419234|Androgens|androgens|mesh-list
154645645|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
154645646|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645647|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
154645648|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645649|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645650|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645651|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645652|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154645653|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645654|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645655|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
154645656|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154645657|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
154645658|NCT03419234|Protective Agents|protective agents|mesh-ancestor
154645659|NCT03419234|Vitamins|vitamins|mesh-ancestor
154645660|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
154645661|NCT03419234|Estrogens|estrogens|mesh-ancestor
154645662|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
154645663|NCT03267433|Rituximab|rituximab|mesh-list
154645664|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645665|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645666|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
154645667|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645668|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645669|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
154645670|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154645671|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
154645672|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645673|NCT03238300|Expectorants|expectorants|mesh-ancestor
154645674|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
154645675|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154645676|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
154645677|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645678|NCT03238300|Protective Agents|protective agents|mesh-ancestor
154645679|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645680|NCT03238300|Antidotes|antidotes|mesh-ancestor
154645681|NCT03214003|Cisplatin|cisplatin|mesh-list
154645682|NCT03214003|Etoposide|etoposide|mesh-list
154645683|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
154645684|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645685|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154645686|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154645687|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154645688|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645689|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645690|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
154645691|NCT03139370|Fludarabine|fludarabine|mesh-list
154645692|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645693|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
154645694|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645695|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645696|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154645697|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
154645698|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645699|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645700|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154645701|NCT03133221|Idelalisib|idelalisib|mesh-list
154645702|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645703|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645704|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645705|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
154645706|NCT03089203|Fludarabine|fludarabine|mesh-list
154645707|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645708|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
154645709|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645710|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645711|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154645712|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
154645713|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645714|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645715|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154645716|NCT03049540|Tadalafil|tadalafil|mesh-list
154645717|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
154645718|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154645719|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154645720|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645721|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645722|NCT03049540|Urological Agents|urological agents|mesh-ancestor
154645723|NCT03012880|Dexamethasone|dexamethasone|mesh-list
154645724|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
154645725|NCT03012880|Lenalidomide|lenalidomide|mesh-list
154645726|NCT03012880|Daratumumab|daratumumab|mesh-list
154645727|NCT03012880|Ixazomib|ixazomib|mesh-list
154645728|NCT03012880|Ichthammol|ichthammol|mesh-list
154645729|NCT03012880|BB 1101|bb 1101|mesh-list
154645730|NCT03012880|Glycine|glycine|mesh-list
154645731|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645732|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
154645733|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
154645734|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645735|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645736|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645737|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
154645738|NCT03012880|Hormones|hormones|mesh-ancestor
154645739|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645740|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645741|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645742|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
154645743|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645744|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645745|NCT03012880|Growth Substances|growth substances|mesh-ancestor
154645746|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645747|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645748|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
154645749|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645750|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
154645751|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
154645752|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154645753|NCT02999087|Cetuximab|cetuximab|mesh-list
154645754|NCT02999087|Avelumab|avelumab|mesh-list
154645755|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645756|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645757|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
154645758|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
154645759|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154645760|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154645761|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645762|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645763|NCT02983461|Urological Agents|urological agents|mesh-ancestor
154645764|NCT02924727|Valsartan|valsartan|mesh-list
154645765|NCT02924727|Ramipril|ramipril|mesh-list
154645766|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154645767|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154645768|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154645769|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154645770|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645771|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154645772|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
154645773|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645774|NCT02905110|Methotrexate|methotrexate|mesh-list
154645775|NCT02905110|Etoposide|etoposide|mesh-list
154645776|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154645777|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
154645778|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154645779|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645780|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645781|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
154645782|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645783|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645784|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
154645785|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645786|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154645787|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645788|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
154645789|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645790|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154645791|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154645792|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154645793|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154645794|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
154645795|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154645796|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154645797|NCT02798523|Prednisolone|prednisolone|mesh-list
154645798|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
154645799|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
154645800|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154645801|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
154645802|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645803|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
154645804|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
154645805|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397916|NCT02359162|Prednisone|prednisone|mesh-list
154645806|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645807|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645808|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
154645810|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645811|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154645812|NCT02798523|Protective Agents|protective agents|mesh-ancestor
154645813|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645814|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645815|NCT02797977|Gemcitabine|gemcitabine|mesh-list
154645816|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645817|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645818|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
154645819|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645820|NCT02720692|Meloxicam|meloxicam|mesh-list
154645821|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154645822|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154645823|NCT02720692|Analgesics|analgesics|mesh-ancestor
154645824|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
154645825|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645826|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645827|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154645828|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154645829|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154645830|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154645831|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645832|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645833|NCT02712151|Ropivacaine|ropivacaine|mesh-list
154645834|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
154645835|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
154645836|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154645837|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645838|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
154645839|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645840|NCT02707484|Thalidomide|thalidomide|mesh-list
154645841|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154645842|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
154645843|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645844|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
154645845|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154645846|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645847|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154645848|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154645849|NCT02707484|Growth Substances|growth substances|mesh-ancestor
154645850|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
154645851|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645852|NCT02646683|Vedolizumab|vedolizumab|mesh-list
154645853|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645854|NCT02628626|Clonidine|clonidine|mesh-list
154645855|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154645856|NCT02628626|Analgesics|analgesics|mesh-ancestor
154645857|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
154645858|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645859|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645860|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154645861|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
154645862|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
154645863|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154645864|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154645865|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154645866|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
154645867|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154645868|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645869|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154645870|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154645871|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
154645872|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154645873|NCT02554812|Avelumab|avelumab|mesh-list
154360711|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
154645874|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645875|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645876|NCT02527707|Ritonavir|ritonavir|mesh-list
154645877|NCT02527707|Lonafarnib|lonafarnib|mesh-list
154645878|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154645879|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154645880|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
154645881|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645882|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645883|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154645884|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154645885|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
154645886|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645887|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154645888|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154645889|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154645890|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154645891|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645892|NCT02367924|Trabectedin|trabectedin|mesh-list
154645893|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154645894|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
154645895|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645896|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645897|NCT02352090|Dienogest|dienogest|mesh-list
154645898|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154645899|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154645900|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154645901|NCT02352090|Estradiol|estradiol|mesh-list
154645902|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154645903|NCT02352090|Nandrolone|nandrolone|mesh-list
154645904|NCT02352090|Estrogens|estrogens|mesh-ancestor
154645905|NCT02352090|Hormones|hormones|mesh-ancestor
154645906|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154645907|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645908|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154645909|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
154645910|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154645911|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154645912|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154645913|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154645914|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154645915|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
154645916|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154645917|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645918|NCT02352090|Androgens|androgens|mesh-ancestor
154645919|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
154645920|NCT02135107|Rabeprazole|rabeprazole|mesh-list
154645921|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154645922|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154645923|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154645924|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645925|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645926|NCT01982448|Paclitaxel|paclitaxel|mesh-list
154645927|NCT01982448|Cisplatin|cisplatin|mesh-list
154645928|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154645929|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645930|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
154645931|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
154645932|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
154645933|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645934|NCT01809041|Remifentanil|remifentanil|mesh-list
154645935|NCT01809041|Propofol|propofol|mesh-list
154645936|NCT01809041|Sevoflurane|sevoflurane|mesh-list
154645937|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154645938|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154645939|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154645940|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154645941|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
154645942|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
154645943|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154645944|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154645945|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154645946|NCT01809041|Narcotics|narcotics|mesh-ancestor
154645947|NCT01809041|Analgesics|analgesics|mesh-ancestor
154645948|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
154645949|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154645950|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
154645951|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154645952|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645953|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
154645954|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154645955|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645956|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
154645957|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154645958|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645959|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
154645960|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154645961|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645962|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
154645963|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154645964|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645965|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
154645966|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154645967|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645969|NCT01593254|Dasatinib|dasatinib|mesh-list
154645970|NCT01593254|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154645971|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154645972|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645973|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645974|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645975|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154645976|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645977|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
154645978|NCT01525394|Lenvatinib|lenvatinib|mesh-list
154645979|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154645980|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154645981|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154645982|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154645983|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645984|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645985|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645986|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154645987|NCT01454934|Gemcitabine|gemcitabine|mesh-list
154645988|NCT01454934|Docetaxel|docetaxel|mesh-list
154645989|NCT01454934|Pemetrexed|pemetrexed|mesh-list
154645990|NCT01454934|Vinorelbine|vinorelbine|mesh-list
154645991|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154645992|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
154645993|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154645994|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154645995|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
154645996|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
154645997|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
154645998|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154645999|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154646000|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154646001|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646002|NCT01442246|Leuprolide|leuprolide|mesh-list
154646003|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154646004|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
154646005|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646006|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646007|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646008|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646009|NCT01439282|Capecitabine|capecitabine|mesh-list
154646010|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646011|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
154646012|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646013|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646014|NCT01326312|Leuprolide|leuprolide|mesh-list
154646015|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154646016|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
154646017|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646018|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646019|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646020|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646021|NCT01321554|Lenvatinib|lenvatinib|mesh-list
154646022|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646023|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646024|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646025|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646026|NCT01308437|Insulin|insulin|mesh-list
154646027|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154646028|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
154360897|NCT05210192|Lidocaine|lidocaine|mesh-list
154646029|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154646030|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646031|NCT01268293|Lenvatinib|lenvatinib|mesh-list
154646032|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646033|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646034|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646035|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646036|NCT01267175|Insulin|insulin|mesh-list
154646037|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154646038|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646039|NCT01231841|Cyclosporine|cyclosporine|mesh-list
154646040|NCT01231841|Cyclosporins|cyclosporins|mesh-list
154646041|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
154646042|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154646043|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
154646044|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646045|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646046|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646047|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
154646048|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646049|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
154646050|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646051|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646052|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646053|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154646054|NCT01133756|Carboplatin|carboplatin|mesh-list
154646055|NCT01133756|Gemcitabine|gemcitabine|mesh-list
154646056|NCT01133756|Lenvatinib|lenvatinib|mesh-list
154646057|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646058|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646059|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
154646060|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646061|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646062|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646063|NCT01126736|Pemetrexed|pemetrexed|mesh-list
154646064|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646065|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646066|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646067|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154646068|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154646069|NCT01111461|Lenvatinib|lenvatinib|mesh-list
154646070|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646071|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646072|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646073|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646074|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154646075|NCT01104155|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154646076|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646077|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646078|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646079|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646080|NCT01067287|Pidilizumab|pidilizumab|mesh-list
154646081|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154646082|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646083|NCT00796263|Dolutegravir|dolutegravir|mesh-list
154646084|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154646085|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154646086|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646087|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646088|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154646089|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154646090|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
154646091|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646092|NCT00715442|Sunitinib|sunitinib|mesh-list
154646093|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646094|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154646095|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154646096|NCT00715442|Growth Substances|growth substances|mesh-ancestor
154646097|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646098|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
154646099|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646100|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646101|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646102|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
154646103|NCT00675922|Mafenide|mafenide|mesh-list
154646104|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154646105|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646106|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154646107|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154646108|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646109|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646110|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
154646111|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646112|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
154646113|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646114|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646115|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646116|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
154646117|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646118|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646119|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154646120|NCT00244933|Gemcitabine|gemcitabine|mesh-list
154646121|NCT00244933|Genistein|genistein|mesh-list
154646122|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646123|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
154646124|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646125|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646126|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154646127|NCT00244933|Protective Agents|protective agents|mesh-ancestor
154646128|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646129|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646130|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646131|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
154646132|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154646133|NCT00244933|Estrogens|estrogens|mesh-ancestor
154646134|NCT00244933|Hormones|hormones|mesh-ancestor
154646135|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646136|NCT00121719|Lenvatinib|lenvatinib|mesh-list
154646137|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646138|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646139|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646140|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646141|NCT00053209|Gemcitabine|gemcitabine|mesh-list
154646142|NCT00053209|Pemetrexed|pemetrexed|mesh-list
154646143|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646144|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
154646145|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646146|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646147|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646148|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154646149|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154646150|NCT00039429|Atrasentan|atrasentan|mesh-list
154646151|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646152|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154646153|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154646154|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646155|NCT00014508|Cyclosporine|cyclosporine|mesh-list
154646156|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
154646157|NCT00014508|Melphalan|melphalan|mesh-list
154646158|NCT00014508|Fludarabine|fludarabine|mesh-list
154646159|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
154646160|NCT00014508|Cyclosporins|cyclosporins|mesh-list
154646161|NCT00014508|Sargramostim|sargramostim|mesh-list
154646162|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646163|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
154646164|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646165|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646166|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646167|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
154646168|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646169|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646170|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154646171|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646172|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
154646173|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646174|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
154646175|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646176|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646177|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154646178|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
154646179|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
154646180|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646181|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
154646182|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646183|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646184|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646185|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
154646186|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646187|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646188|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154646189|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154646190|NCT00005962|Cytarabine|cytarabine|mesh-list
154646191|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
154646192|NCT00005962|Daunorubicin|daunorubicin|mesh-list
154646193|NCT00005962|Topotecan|topotecan|mesh-list
154646194|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
154646195|NCT00005962|Sargramostim|sargramostim|mesh-list
154646196|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646197|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
154646198|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646199|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646200|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646201|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
154646202|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646203|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646204|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154646205|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646206|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
154646207|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
154646208|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646209|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154646210|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646211|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646212|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646213|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154646214|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154646215|NCT00005962|Immunotoxins|immunotoxins|mesh-ancestor
154646216|NCT00005962|Immunoconjugates|immunoconjugates|mesh-ancestor
154646217|NCT00005847|Interferons|interferons|mesh-list
154646218|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
154646219|NCT00005847|Paclitaxel|paclitaxel|mesh-list
154646220|NCT00005847|Vinorelbine|vinorelbine|mesh-list
154646221|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
154646222|NCT00005847|Estramustine|estramustine|mesh-list
154646223|NCT00005847|Isotretinoin|isotretinoin|mesh-list
154646224|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646225|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646226|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646227|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646228|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646229|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646230|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
154646231|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646232|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
154646233|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646234|NCT00005847|Analgesics|analgesics|mesh-ancestor
154646235|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
154646236|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646237|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646238|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646239|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646240|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646241|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646242|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
154646243|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646244|NCT00005644|Paclitaxel|paclitaxel|mesh-list
154646245|NCT00005644|Gemcitabine|gemcitabine|mesh-list
154646246|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646247|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646248|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646249|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646250|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646251|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646252|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646253|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
154646254|NCT00003871|Vaccines|vaccines|mesh-list
154646255|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
154646256|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646257|NCT00003809|Cetuximab|cetuximab|mesh-list
154646258|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646259|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154646260|NCT00003808|Theophylline|theophylline|mesh-list
154646261|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154646262|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
154646263|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646264|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646265|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154646266|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
154646267|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154646268|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646269|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646270|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
154646271|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154646272|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154646273|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
154646274|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154646275|NCT00003592|Paclitaxel|paclitaxel|mesh-list
154646276|NCT00003592|Methotrexate|methotrexate|mesh-list
154646277|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646278|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646279|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646280|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646281|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646282|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646283|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154646284|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
154646285|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646286|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646287|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646288|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
154646289|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646290|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646291|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154646292|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646293|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
154646294|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646295|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154646296|NCT00003518|Paclitaxel|paclitaxel|mesh-list
154646297|NCT00003518|Gemcitabine|gemcitabine|mesh-list
154646298|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646299|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646300|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646301|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646302|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646303|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646304|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646305|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
154646306|NCT00003444|Interferons|interferons|mesh-list
154646307|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
154646308|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646309|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
154646310|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646311|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
154646312|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646313|NCT00003388|Cytarabine|cytarabine|mesh-list
154646314|NCT00003388|Prednisone|prednisone|mesh-list
154646315|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
154646316|NCT00003388|Doxorubicin|doxorubicin|mesh-list
154646317|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154646318|NCT00003388|Methotrexate|methotrexate|mesh-list
154646319|NCT00003388|Vincristine|vincristine|mesh-list
154646320|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646321|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
154646322|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646323|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646324|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646325|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
154646326|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646327|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646328|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154646329|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154646330|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646331|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646332|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646333|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646334|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
154646335|NCT00003388|Hormones|hormones|mesh-ancestor
154646336|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646337|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646338|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154646339|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
154646340|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646341|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646342|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
154646343|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646344|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154646345|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154646346|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
154646347|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646348|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646349|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646350|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646351|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646352|NCT00003376|Paclitaxel|paclitaxel|mesh-list
154646353|NCT00003376|Vinblastine|vinblastine|mesh-list
154646354|NCT00003376|Carboplatin|carboplatin|mesh-list
154646355|NCT00003376|Doxorubicin|doxorubicin|mesh-list
154646356|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154646357|NCT00003376|Methotrexate|methotrexate|mesh-list
154646358|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646359|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646360|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646361|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646362|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646363|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646364|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154646365|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646366|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646367|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646368|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154646369|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
154646370|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646371|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646372|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646373|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
154646374|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646375|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154646376|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646377|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
154646378|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646379|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154646380|NCT00003353|Melphalan|melphalan|mesh-list
154646381|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
154646382|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646383|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646384|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
154646385|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646386|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646387|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154646388|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646389|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
154646390|NCT00003309|Etoposide|etoposide|mesh-list
154646391|NCT00003309|Vincristine|vincristine|mesh-list
154646392|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646393|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
154646394|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646395|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646396|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646397|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
154646398|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646399|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646400|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154646401|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646402|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646403|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646404|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646405|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646406|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646407|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646409|NCT00003237|Cisplatin|cisplatin|mesh-list
154646410|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646411|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646412|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646413|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646414|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646415|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646416|NCT00003129|Valrubicin|valrubicin|mesh-list
154646417|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646418|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646419|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646420|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646421|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646422|NCT00003027|Interferons|interferons|mesh-list
154646423|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
154646424|NCT00003027|Aldesleukin|aldesleukin|mesh-list
154646425|NCT00003027|Dacarbazine|dacarbazine|mesh-list
154646426|NCT00003027|Vinblastine|vinblastine|mesh-list
154646427|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646428|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
154646429|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646430|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
154646431|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646432|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154646433|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154646434|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646435|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
154646436|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646437|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646438|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
154646439|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
154646440|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
154646441|NCT00002914|Piritrexim|piritrexim|mesh-list
154646442|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646443|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154646444|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646445|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646446|NCT00002872|Doxycycline|doxycycline|mesh-list
154646447|NCT00002872|Bleomycin|bleomycin|mesh-list
154646448|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154646449|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646450|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
154646451|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154646452|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154646453|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154646454|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646455|NCT00002868|Interferons|interferons|mesh-list
154646456|NCT00002868|Cytarabine|cytarabine|mesh-list
154646457|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
154646458|NCT00002868|Etoposide|etoposide|mesh-list
154646459|NCT00002868|Idarubicin|idarubicin|mesh-list
154646460|NCT00002868|Busulfan|busulfan|mesh-list
154361332|NCT01155791|Prednisone|prednisone|mesh-list
154646461|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
154646462|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154646463|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646464|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646465|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646466|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646467|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646468|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
154646469|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646470|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154646471|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
154646472|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646473|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
154646474|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646475|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
154646476|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646477|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154646478|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154646479|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
154646480|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154646481|NCT00002650|Folic Acid|folic acid|mesh-list
154646482|NCT00002650|Hematinics|hematinics|mesh-ancestor
154646483|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
154646484|NCT00002650|Vitamins|vitamins|mesh-ancestor
154646485|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
154646486|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646488|NCT03078725|Glyburide|glyburide|mesh-list
154646489|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154646490|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646491|NCT02341963|Ketamine|ketamine|mesh-list
154646492|NCT02341963|Analgesics|analgesics|mesh-ancestor
154646493|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
154646494|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646495|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646496|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154646497|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154646498|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
154646499|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
154646500|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154646501|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154646502|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154646503|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154646504|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646505|NCT05014685|Amoxicillin|amoxicillin|mesh-list
154646506|NCT05014685|Metronidazole|metronidazole|mesh-list
154646507|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
154646508|NCT05014685|Rabeprazole|rabeprazole|mesh-list
154646509|NCT05014685|Bismuth|bismuth|mesh-list
154646510|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646511|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154646512|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646513|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154646514|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154646515|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154646516|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154646517|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154646518|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646519|NCT05014685|Antacids|antacids|mesh-ancestor
154646520|NCT05014685|Diuretics|diuretics|mesh-ancestor
154646521|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
154646522|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646523|NCT05014685|Expectorants|expectorants|mesh-ancestor
154646524|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
154646525|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
154646526|NCT03111901|Interleukin-2|interleukin-2|mesh-list
154646527|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154646528|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361355|NCT03881423|Bromides|bromides|mesh-list
154646529|NCT03111901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154646530|NCT03111901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646531|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154646532|NCT03111901|Analgesics|analgesics|mesh-ancestor
154646533|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
154646534|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646535|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646536|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154646537|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154646538|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
154646539|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646540|NCT02341729|Ticagrelor|ticagrelor|mesh-list
154646541|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154646542|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154646543|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154646544|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154646545|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
154646546|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154646547|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646548|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646549|NCT05014373|Favipiravir|favipiravir|mesh-list
154646550|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
154646551|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646552|NCT04762459|Pemetrexed|pemetrexed|mesh-list
154646553|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646554|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646555|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646556|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154646557|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154646558|NCT03078569|Testosterone|testosterone|mesh-list
154646559|NCT03078569|Androgens|androgens|mesh-ancestor
154646560|NCT03078569|Hormones|hormones|mesh-ancestor
154398657|NCT03509675|Ibuprofen|ibuprofen|mesh-list
154646561|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646562|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646563|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154646564|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
154646565|NCT02345863|Ibrutinib|ibrutinib|mesh-list
154646566|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154646567|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
154646568|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646569|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646570|NCT02345863|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154646571|NCT02345863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154646572|NCT02345863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646573|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154646574|NCT03078257|Aspirin|aspirin|mesh-list
154646575|NCT03078257|Tirofiban|tirofiban|mesh-list
154646576|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
154646577|NCT03078257|Clopidogrel|clopidogrel|mesh-list
154646578|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154646579|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154646580|NCT03078257|Analgesics|analgesics|mesh-ancestor
154646581|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
154646582|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646583|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646584|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646585|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646586|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154646587|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154646588|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646589|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154646590|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154646591|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646592|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
154646593|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154646594|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154646595|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154646596|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
154646597|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154646598|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
154646599|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154646600|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
154646601|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
154646602|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646603|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646604|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
154646605|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154646606|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154646607|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646608|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154646609|NCT05005715|Analgesics|analgesics|mesh-ancestor
154646610|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
154646611|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646612|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154646613|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154646614|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154646615|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
154646616|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154646617|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646618|NCT02345707|Cabotegravir|cabotegravir|mesh-list
154646619|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154646620|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154646621|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646622|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646623|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154646624|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154646625|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
154646626|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646627|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
154646628|NCT05005637|Prednisone|prednisone|mesh-list
154646629|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646630|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
154646631|NCT05005637|Hormones|hormones|mesh-ancestor
154646632|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646633|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646634|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646635|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646636|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154646637|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646638|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154646639|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154646640|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646641|NCT02336659|Incretins|incretins|mesh-ancestor
154646642|NCT02336659|Hormones|hormones|mesh-ancestor
154646643|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646644|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154646645|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
154646646|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646647|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646648|NCT03081923|Durvalumab|durvalumab|mesh-list
154646649|NCT03081923|Tremelimumab|tremelimumab|mesh-list
154646650|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154646651|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646652|NCT02341105|Amiodarone|amiodarone|mesh-list
154646653|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154646654|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
154646655|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154646656|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154646657|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646658|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154646659|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154646660|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154646661|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646662|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154646663|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154646664|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154646665|NCT03078101|Empagliflozin|empagliflozin|mesh-list
154646666|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154646667|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646668|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154646669|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646670|NCT02345239|Pantoprazole|pantoprazole|mesh-list
154646671|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154646672|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154646673|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154646674|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646675|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646676|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
154646677|NCT04688203|Labetalol|labetalol|mesh-list
154646678|NCT04688203|Analgesics|analgesics|mesh-ancestor
154646679|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
154646680|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646681|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646682|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
154646683|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154646684|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154646685|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
154646686|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154646687|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154646688|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646689|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154646690|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
154646691|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646692|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154646693|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154646694|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
154646695|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154646696|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154646697|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
154646698|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
154646699|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154646700|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154646701|NCT05254561|Immunomodulating Agents|immunomodulating agents|mesh-list
154646702|NCT05254561|Immunologic Factors|immunologic factors|mesh-ancestor
154646703|NCT05254561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646704|NCT04509973|Dexamethasone|dexamethasone|mesh-list
154646705|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646706|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
154361544|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
154646707|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
154646708|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646709|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646710|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154646711|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
154646712|NCT04509973|Hormones|hormones|mesh-ancestor
154646713|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646714|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646715|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646716|NCT02336347|Quinidine|quinidine|mesh-list
154646717|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
154646718|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
154646719|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
154646720|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154646721|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154646722|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154646723|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646724|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646725|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154646726|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154646727|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
154646728|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154646729|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
154646730|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154646731|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154646732|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646733|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646734|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154646735|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154646736|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
154646737|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154646738|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154646739|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154646740|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154646741|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154646742|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
154646743|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
154646744|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646745|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646746|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154646747|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154646748|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154646749|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154646750|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
154646751|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
154646752|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154646753|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646754|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646755|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
154646756|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154646757|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154646758|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646759|NCT02340481|Simethicone|simethicone|mesh-list
154646760|NCT02340481|Loperamide|loperamide|mesh-list
154646761|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
154646762|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154646763|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
154646764|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646765|NCT02340481|Emollients|emollients|mesh-ancestor
154646766|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646767|NCT03077633|Progesterone|progesterone|mesh-list
154646768|NCT03077633|Progestins|progestins|mesh-ancestor
154646769|NCT03077633|Hormones|hormones|mesh-ancestor
154646770|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646771|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646772|NCT05253781|Aspirin|aspirin|mesh-list
154646773|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154646774|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154646775|NCT05253781|Analgesics|analgesics|mesh-ancestor
154646776|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
154646777|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646778|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646779|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646780|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646782|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154646783|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646784|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154646785|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154646786|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646787|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
154646788|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
154646789|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154646790|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154646791|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154646792|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646793|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646794|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154646795|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154646796|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154646797|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154646798|NCT02340247|Cathartics|cathartics|mesh-ancestor
154646799|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154646800|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
154646801|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154646802|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154646803|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154646804|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
154646805|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646806|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646807|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154646808|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154646809|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154646810|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646811|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646812|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
154646813|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
154646814|NCT05178823|Fluorides|fluorides|mesh-list
154646815|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
154646816|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
154646817|NCT05178823|Protective Agents|protective agents|mesh-ancestor
154646818|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646819|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154646820|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646821|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
154646822|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
154646823|NCT03105583|Vitamins|vitamins|mesh-list
154646824|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
154646825|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646826|NCT03105115|Fentanyl|fentanyl|mesh-list
154646827|NCT03105115|Bupivacaine|bupivacaine|mesh-list
154646828|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
154646829|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
154646830|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154646831|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646832|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
154646833|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646834|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154646835|NCT03105115|Narcotics|narcotics|mesh-ancestor
154646836|NCT03105115|Analgesics|analgesics|mesh-ancestor
154646837|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154646838|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154646839|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
154646840|NCT03105349|Ribavirin|ribavirin|mesh-list
154646841|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
154646842|NCT03105349|Grazoprevir|grazoprevir|mesh-list
154646843|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154646844|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
154646845|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646846|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
154646847|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646848|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154646849|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154646850|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154646851|NCT03077555|Estradiol|estradiol|mesh-list
154646852|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154646853|NCT03077555|Estrogens|estrogens|mesh-ancestor
154646854|NCT03077555|Hormones|hormones|mesh-ancestor
154646855|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646856|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646857|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154646858|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
154646859|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154646860|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154646861|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154646862|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154646864|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
154646865|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646866|NCT05012033|Prednisolone|prednisolone|mesh-list
154646867|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646868|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
154646869|NCT05012033|Hormones|hormones|mesh-ancestor
154646870|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646871|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646872|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646873|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646874|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
154646875|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154646876|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646877|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646878|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646879|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646880|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646881|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646882|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
154646883|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154646884|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154646885|NCT02334475|Prednisolone|prednisolone|mesh-list
154646886|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
154646887|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154646888|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
154646889|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646890|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
154646891|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
154646892|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646893|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646894|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154646895|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
154646896|NCT02334475|Hormones|hormones|mesh-ancestor
154646897|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646898|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154646899|NCT02334475|Protective Agents|protective agents|mesh-ancestor
154646900|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154646901|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646902|NCT02334631|Simethicone|simethicone|mesh-list
154646903|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
154646904|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646905|NCT02334631|Emollients|emollients|mesh-ancestor
154646906|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646907|NCT02338531|Nirogacestat|nirogacestat|mesh-list
154646908|NCT02338531|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154646909|NCT02338531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646910|NCT02338531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646911|NCT02332135|Vitamin D|vitamin d|mesh-list
154646912|NCT02332135|Vitamins|vitamins|mesh-ancestor
154646913|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
154646914|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646915|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154646916|NCT02334163|Metronidazole|metronidazole|mesh-list
154646917|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
154646918|NCT02334163|Lactulose|lactulose|mesh-list
154646919|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646920|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154646921|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154646922|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154646923|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154646924|NCT02332057|Diclofenac|diclofenac|mesh-list
154646925|NCT02332057|Lidocaine|lidocaine|mesh-list
154646926|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
154646927|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
154646928|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154646929|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646930|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
154646931|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154646932|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154646933|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154646934|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154646935|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154646936|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646937|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154646938|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154646939|NCT02332057|Analgesics|analgesics|mesh-ancestor
154646940|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646941|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154646942|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154646943|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646944|NCT02331745|Lenograstim|lenograstim|mesh-list
154646945|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154646946|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
154646947|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646948|NCT02638259|GP2015|gp2015|mesh-list
154646949|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
154646950|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
154646951|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154646952|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
154646953|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154646954|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
154646955|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646956|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646957|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
154646958|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
154646959|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154646960|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646961|NCT02334007|Dalteparin|dalteparin|mesh-list
154646962|NCT02334007|Tinzaparin|tinzaparin|mesh-list
154646963|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154646964|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
154646965|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154646966|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154646967|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646968|NCT02637323|Triamcinolone|triamcinolone|mesh-list
154646969|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154646970|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154646971|NCT02637323|FX006|fx006|mesh-list
154646972|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154646973|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154646974|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
154646975|NCT02637323|Hormones|hormones|mesh-ancestor
154646976|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154646977|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154646978|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154646979|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
154646980|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646981|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646982|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
154646983|NCT02331823|Isoniazid|isoniazid|mesh-list
154646984|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
154646985|NCT02331823|Ethambutol|ethambutol|mesh-list
154646986|NCT02331823|Rifabutin|rifabutin|mesh-list
154646987|NCT02331823|Streptomycin|streptomycin|mesh-list
154646988|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154646989|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154646990|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154646991|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154646992|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154646993|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154646994|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154646995|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154646996|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
154646997|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154646998|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154646999|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
154647000|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154647001|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154647002|NCT02890459|Denatonium|denatonium|mesh-list
154647003|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
154647004|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647005|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
154647006|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647007|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
154399102|NCT02344888|Folic Acid|folic acid|mesh-list
154647008|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647009|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
154647010|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154647011|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
154647012|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647013|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
154647014|NCT03077009|Protective Agents|protective agents|mesh-ancestor
154647015|NCT04477525|Bupivacaine|bupivacaine|mesh-list
154647016|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
154647017|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
154647018|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647019|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647020|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
154647021|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647022|NCT03079973|Calcipotriene|calcipotriene|mesh-list
154647023|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
154647024|NCT05004545|Propofol|propofol|mesh-list
154647025|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154647026|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647027|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647028|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154647029|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
154647030|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
154647031|NCT03079895|Nicotine|nicotine|mesh-list
154647032|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154647033|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
154647034|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647035|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647036|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154647037|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154647038|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
154647039|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647040|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647041|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
154647042|NCT05003765|Buprenorphine|buprenorphine|mesh-list
154647043|NCT05003765|Bupivacaine|bupivacaine|mesh-list
154647044|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154647045|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
154647046|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
154647047|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647048|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647049|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
154647050|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647051|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154647052|NCT05003765|Narcotics|narcotics|mesh-ancestor
154647053|NCT05003765|Analgesics|analgesics|mesh-ancestor
154647054|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154647055|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154647056|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
154647057|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154647058|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154647059|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647060|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154647061|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
154647062|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154647063|NCT02337283|BI 425809|bi 425809|mesh-list
154647064|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
154647065|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
154647066|NCT02333305|Vitamins|vitamins|mesh-ancestor
154647067|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
154647068|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647069|NCT02326987|Pregabalin|pregabalin|mesh-list
154647070|NCT02326987|Analgesics|analgesics|mesh-ancestor
154647071|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
154647072|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647073|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647074|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
154647075|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154647076|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154647077|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647078|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154647079|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154647080|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154647081|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647082|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154647083|NCT02331511|Aspirin|aspirin|mesh-list
154647084|NCT02331511|Clopidogrel|clopidogrel|mesh-list
154647085|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154647086|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647087|NCT02331511|Analgesics|analgesics|mesh-ancestor
154647088|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
154647089|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647090|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647091|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154647092|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647093|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154647094|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154647095|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647096|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154647097|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154647098|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647099|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
154647100|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154647101|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154647102|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154647103|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
154647104|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647105|NCT02326441|KX2-361|kx2-361|mesh-list
154647106|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154647107|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647108|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647109|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154647110|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154647111|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154647112|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647113|NCT03144271|Semaglutide|semaglutide|mesh-list
154647114|NCT03144271|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154647115|NCT03144271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154647116|NCT03144271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647117|NCT02039791|Paclitaxel|paclitaxel|mesh-list
154647118|NCT02039791|Carboplatin|carboplatin|mesh-list
154647119|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
154647120|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154647121|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647122|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
154647123|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
154647124|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
154647125|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647126|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647127|NCT06276283|Bevacizumab|bevacizumab|mesh-list
154647128|NCT06276283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647129|NCT06276283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647130|NCT06276283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154647131|NCT06276283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154647132|NCT06276283|Growth Substances|growth substances|mesh-ancestor
154647133|NCT06276283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647134|NCT06276283|Growth Inhibitors|growth inhibitors|mesh-ancestor
154647135|NCT06276205|Vitamin D|vitamin d|mesh-list
154647136|NCT06276205|Vitamins|vitamins|mesh-ancestor
154647137|NCT06276205|Micronutrients|micronutrients|mesh-ancestor
154647138|NCT06276205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647139|NCT06276205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154647140|NCT06275763|Eplerenone|eplerenone|mesh-list
154647141|NCT06275763|Torsemide|torsemide|mesh-list
154647142|NCT06275763|Spironolactone|spironolactone|mesh-list
154647143|NCT06275763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154647144|NCT06275763|Hormone Antagonists|hormone antagonists|mesh-ancestor
154647145|NCT06275763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154647146|NCT06275763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647147|NCT06275763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154647148|NCT06275763|Diuretics|diuretics|mesh-ancestor
154647149|NCT06275763|Natriuretic Agents|natriuretic agents|mesh-ancestor
154647150|NCT06275763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154647151|NCT06275763|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154647152|NCT06275763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154647153|NCT06275763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647154|NCT06275633|Levodopa|levodopa|mesh-list
154647155|NCT06275633|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154647156|NCT06275633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154647157|NCT06275633|Dopamine Agents|dopamine agents|mesh-ancestor
154647158|NCT06275633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647159|NCT06275633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647160|NCT06275633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647161|NCT06275594|Midazolam|midazolam|mesh-list
154647162|NCT06275594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154647163|NCT06275594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154647164|NCT06275594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647165|NCT06275594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647166|NCT06275594|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154647167|NCT06275594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154647168|NCT06275594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154647169|NCT06275594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154647170|NCT06275594|Anesthetics, General|anesthetics, general|mesh-ancestor
154647171|NCT06275594|Anesthetics|anesthetics|mesh-ancestor
154647172|NCT06275594|GABA Modulators|gaba modulators|mesh-ancestor
154647173|NCT06275594|GABA Agents|gaba agents|mesh-ancestor
154647174|NCT06275594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647175|NCT06275594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647176|NCT06275581|Methamphetamine|methamphetamine|mesh-list
154647177|NCT06275581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154647178|NCT06275581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647179|NCT06275581|Sympathomimetics|sympathomimetics|mesh-ancestor
154647180|NCT06275581|Autonomic Agents|autonomic agents|mesh-ancestor
154647181|NCT06275581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647182|NCT06275581|Dopamine Agents|dopamine agents|mesh-ancestor
154647183|NCT06275581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647184|NCT06275581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647185|NCT06275581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154647186|NCT06275581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154647187|NCT06275581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154647188|NCT06275581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154647189|NCT06275581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154647190|NCT06275542|Neostigmine|neostigmine|mesh-list
154647191|NCT06275542|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154647192|NCT06275542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647193|NCT06275542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647194|NCT06275542|Cholinergic Agents|cholinergic agents|mesh-ancestor
154647195|NCT06275542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647196|NCT06275542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647197|NCT06275542|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154647198|NCT06275542|Autonomic Agents|autonomic agents|mesh-ancestor
154647199|NCT06275542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647200|NCT06275477|FAPI-46|fapi-46|mesh-list
154647201|NCT06275477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154647202|NCT06275477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647203|NCT06275425|Anesthetics|anesthetics|mesh-list
154647204|NCT06275425|Sevoflurane|sevoflurane|mesh-list
154647205|NCT06275425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647206|NCT06275425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647207|NCT06275425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154647208|NCT06275425|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154647209|NCT06275425|Anesthetics, General|anesthetics, general|mesh-ancestor
154647210|NCT06275386|Paclitaxel|paclitaxel|mesh-list
154647211|NCT06275386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154647212|NCT06275386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647213|NCT06275386|Tubulin Modulators|tubulin modulators|mesh-ancestor
154647214|NCT06275386|Antimitotic Agents|antimitotic agents|mesh-ancestor
154647215|NCT06275386|Mitosis Modulators|mitosis modulators|mesh-ancestor
154647216|NCT06275386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647217|NCT06275360|Nivolumab|nivolumab|mesh-list
154647218|NCT06275360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647219|NCT06275360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647220|NCT06275360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154647221|NCT06275360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647222|NCT06274996|Upadacitinib|upadacitinib|mesh-list
154647223|NCT06274996|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154647224|NCT06274996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154647225|NCT06274996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647226|NCT06274996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647227|NCT06274996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647228|NCT06274905|Ethyl Chloride|ethyl chloride|mesh-list
154647229|NCT06274905|Anesthetics, Local|anesthetics, local|mesh-ancestor
154647230|NCT06274905|Anesthetics|anesthetics|mesh-ancestor
154647231|NCT06274905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399334|NCT03148444|Cephalexin|cephalexin|mesh-list
154647232|NCT06274905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647233|NCT06274905|Sensory System Agents|sensory system agents|mesh-ancestor
154647234|NCT06274905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647236|NCT06274879|Gemcitabine|gemcitabine|mesh-list
154647237|NCT06274879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647238|NCT06274879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647239|NCT06274879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154647240|NCT06274879|Antimetabolites|antimetabolites|mesh-ancestor
154647241|NCT06274879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647242|NCT06274853|Silicon|silicon|mesh-list
154647243|NCT06274853|GS-441524|gs-441524|mesh-list
154647244|NCT06274853|Trace Elements|trace elements|mesh-ancestor
154647245|NCT06274853|Micronutrients|micronutrients|mesh-ancestor
154647246|NCT06274853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647247|NCT06274853|Antiviral Agents|antiviral agents|mesh-ancestor
154647248|NCT06274853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647249|NCT06274554|Fluconazole|fluconazole|mesh-list
154647250|NCT06274554|Ustekinumab|ustekinumab|mesh-list
154647251|NCT06274554|Antifungal Agents|antifungal agents|mesh-ancestor
154647252|NCT06274554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647253|NCT06274554|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154647254|NCT06274554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154647255|NCT06274554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647256|NCT06274554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647257|NCT06274554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154647258|NCT06274554|Hormone Antagonists|hormone antagonists|mesh-ancestor
154647259|NCT06274554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154647260|NCT06274554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362094|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154647261|NCT06274554|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154647262|NCT06274554|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154647263|NCT06274554|Dermatologic Agents|dermatologic agents|mesh-ancestor
154647264|NCT06274437|Nivolumab|nivolumab|mesh-list
154647265|NCT06274437|Cetuximab|cetuximab|mesh-list
154647266|NCT06274437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647267|NCT06274437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647268|NCT06274437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154647269|NCT06274437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647270|NCT06274216|Vitamin D|vitamin d|mesh-list
154647271|NCT06274216|Cholecalciferol|cholecalciferol|mesh-list
154647272|NCT06274216|Vitamins|vitamins|mesh-list
154647273|NCT06274216|Vitamin E|vitamin e|mesh-list
154647274|NCT06274216|Micronutrients|micronutrients|mesh-ancestor
154647275|NCT06274216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647276|NCT06274216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154647277|NCT06274216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154647278|NCT06274216|Antioxidants|antioxidants|mesh-ancestor
154647279|NCT06274216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647280|NCT06274216|Protective Agents|protective agents|mesh-ancestor
154647281|NCT06274203|Vitamin D|vitamin d|mesh-list
154647282|NCT06274203|Cholecalciferol|cholecalciferol|mesh-list
154647283|NCT06274203|Vitamins|vitamins|mesh-ancestor
154647284|NCT06274203|Micronutrients|micronutrients|mesh-ancestor
154647285|NCT06274203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647286|NCT06274203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154647287|NCT06274203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154647288|NCT06274151|Naproxen|naproxen|mesh-list
154647289|NCT06274151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154647290|NCT06274151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154647291|NCT06274151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647292|NCT06274151|Analgesics|analgesics|mesh-ancestor
154647293|NCT06274151|Sensory System Agents|sensory system agents|mesh-ancestor
154647294|NCT06274151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647295|NCT06274151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647296|NCT06274151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647297|NCT06274151|Gout Suppressants|gout suppressants|mesh-ancestor
154647298|NCT06274151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154647299|NCT06274151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647300|NCT06274151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647301|NCT06273943|Tenofovir|tenofovir|mesh-list
154647302|NCT06273943|Emtricitabine|emtricitabine|mesh-list
154647303|NCT06273943|Cabotegravir|cabotegravir|mesh-list
154647304|NCT06273943|Antiviral Agents|antiviral agents|mesh-ancestor
154647305|NCT06273943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647306|NCT06273943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154647307|NCT06273943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154647308|NCT06273943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647309|NCT06273943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647310|NCT06273943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154647311|NCT06273943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154647312|NCT06273943|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154647313|NCT06273943|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154647314|NCT06273930|Calcium|calcium|mesh-list
154647315|NCT06273930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154647316|NCT06273930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647317|NCT06273813|Ketorolac|ketorolac|mesh-list
154647318|NCT06273813|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154647319|NCT06273813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154647320|NCT06273813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647321|NCT06273813|Analgesics|analgesics|mesh-ancestor
154647322|NCT06273813|Sensory System Agents|sensory system agents|mesh-ancestor
154647323|NCT06273813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647324|NCT06273813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647325|NCT06273813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154647326|NCT06273813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647327|NCT06273813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154647328|NCT06273813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647329|NCT06273813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647330|NCT06271096|Midazolam|midazolam|mesh-list
154647331|NCT06271096|Diazepam|diazepam|mesh-list
154647332|NCT06271096|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154647333|NCT06271096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154647334|NCT06271096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647335|NCT06271096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647336|NCT06271096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154647337|NCT06271096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154647338|NCT06271096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154647339|NCT06271096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154647340|NCT06271096|Anesthetics, General|anesthetics, general|mesh-ancestor
154647341|NCT06271096|Anesthetics|anesthetics|mesh-ancestor
154647342|NCT06271096|GABA Modulators|gaba modulators|mesh-ancestor
154647343|NCT06271096|GABA Agents|gaba agents|mesh-ancestor
154647344|NCT06271096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647345|NCT06271096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647346|NCT06271096|Anticonvulsants|anticonvulsants|mesh-ancestor
154647347|NCT06271096|Antiemetics|antiemetics|mesh-ancestor
154647348|NCT06271096|Autonomic Agents|autonomic agents|mesh-ancestor
154647349|NCT06271096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647350|NCT06271096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154647351|NCT06271096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154647352|NCT06271096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154647353|NCT06256549|Semaglutide|semaglutide|mesh-list
154647354|NCT06256549|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154647355|NCT06256549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154647356|NCT06256549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647357|NCT06254001|Bupropion|bupropion|mesh-list
154647358|NCT06254001|Nicotine|nicotine|mesh-list
154647359|NCT06254001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154647360|NCT06254001|Autonomic Agents|autonomic agents|mesh-ancestor
154647361|NCT06254001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647362|NCT06254001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647363|NCT06254001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154647364|NCT06254001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154647365|NCT06254001|Cholinergic Agents|cholinergic agents|mesh-ancestor
154647366|NCT06254001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647367|NCT06254001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647368|NCT06254001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154647369|NCT06254001|Antidepressive Agents|antidepressive agents|mesh-ancestor
154647370|NCT06254001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154647371|NCT06254001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154647372|NCT06254001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154647373|NCT06254001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154647374|NCT06254001|Dopamine Agents|dopamine agents|mesh-ancestor
154647375|NCT06254001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154647376|NCT06254001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154647377|NCT06254001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647378|NCT06253923|Amantadine|amantadine|mesh-list
154647379|NCT06253923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154647380|NCT06253923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154647381|NCT06253923|Antiviral Agents|antiviral agents|mesh-ancestor
154647382|NCT06253923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647383|NCT06253923|Dopamine Agents|dopamine agents|mesh-ancestor
154647384|NCT06253923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647385|NCT06253923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647386|NCT06253923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647387|NCT06253923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647388|NCT06253923|Analgesics|analgesics|mesh-ancestor
154647389|NCT06253923|Sensory System Agents|sensory system agents|mesh-ancestor
154647390|NCT06253923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647391|NCT06241677|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154647392|NCT06241677|Tenecteplase|tenecteplase|mesh-list
154647393|NCT06241677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154647394|NCT06241677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154647395|NCT06241677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647396|NCT06238115|Aspirin|aspirin|mesh-list
154647397|NCT06238115|Tirofiban|tirofiban|mesh-list
154647398|NCT06238115|Clopidogrel|clopidogrel|mesh-list
154647399|NCT06238115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154647400|NCT06238115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647401|NCT06238115|Analgesics|analgesics|mesh-ancestor
154647402|NCT06238115|Sensory System Agents|sensory system agents|mesh-ancestor
154647403|NCT06238115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647404|NCT06238115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647405|NCT06238115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154647406|NCT06238115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647407|NCT06238115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154647408|NCT06238115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154647409|NCT06238115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647410|NCT06238115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154647411|NCT06238115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154647412|NCT06238115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647413|NCT06238115|Antipyretics|antipyretics|mesh-ancestor
154647414|NCT06238115|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154647415|NCT06238115|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154647416|NCT06238115|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154647417|NCT06238115|Purinergic Agents|purinergic agents|mesh-ancestor
154647418|NCT06238115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647419|NCT06236451|Risperidone|risperidone|mesh-list
154647420|NCT06236451|Aripiprazole|aripiprazole|mesh-list
154647421|NCT06236451|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154647422|NCT06236451|Serotonin Agents|serotonin agents|mesh-ancestor
154647423|NCT06236451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647424|NCT06236451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647425|NCT06236451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647426|NCT06236451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154647427|NCT06236451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154647428|NCT06236451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647429|NCT06236451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154647430|NCT06236451|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154647431|NCT06236451|Dopamine Agents|dopamine agents|mesh-ancestor
154647432|NCT06236451|Antidepressive Agents|antidepressive agents|mesh-ancestor
154647433|NCT06236451|Dopamine Agonists|dopamine agonists|mesh-ancestor
154647434|NCT06236451|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154647435|NCT06236451|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154647436|NCT06236451|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154647437|NCT06236451|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154647438|NCT06184750|Tamoxifen|tamoxifen|mesh-list
154647439|NCT06184750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154647440|NCT06184750|Hormone Antagonists|hormone antagonists|mesh-ancestor
154647441|NCT06184750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154647442|NCT06184750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647443|NCT06184750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154647444|NCT06184750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647445|NCT06184750|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154647446|NCT06184750|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154647447|NCT06184750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154647448|NCT06181760|Fenretinide|fenretinide|mesh-list
154647449|NCT06181760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647450|NCT06181760|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154647451|NCT06181760|Protective Agents|protective agents|mesh-ancestor
154647452|NCT06181760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647453|NCT06167265|Cilostazol|cilostazol|mesh-list
154647454|NCT06167265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154399549|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
154647455|NCT06167265|Autonomic Agents|autonomic agents|mesh-ancestor
154647456|NCT06167265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647457|NCT06167265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647458|NCT06167265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154647459|NCT06167265|Respiratory System Agents|respiratory system agents|mesh-ancestor
154647460|NCT06167265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154647461|NCT06167265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154647462|NCT06167265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647463|NCT06167265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154647464|NCT06167265|Vasodilator Agents|vasodilator agents|mesh-ancestor
154647465|NCT06167265|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154647466|NCT06167265|Protective Agents|protective agents|mesh-ancestor
154647467|NCT06167265|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154647468|NCT06167265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154647469|NCT06167265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647470|NCT06162221|Carboplatin|carboplatin|mesh-list
154647471|NCT06162221|Pembrolizumab|pembrolizumab|mesh-list
154647472|NCT06162221|Pemetrexed|pemetrexed|mesh-list
154647473|NCT06162221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647474|NCT06162221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362309|NCT00462748|Ezetimibe|ezetimibe|mesh-list
154647475|NCT06162221|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154647476|NCT06162221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647477|NCT06162221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647478|NCT06162221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154647479|NCT06162221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154647480|NCT06158100|Azacitidine|azacitidine|mesh-list
154647481|NCT06158100|Venetoclax|venetoclax|mesh-list
154647482|NCT06158100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154647483|NCT06158100|Antimetabolites|antimetabolites|mesh-ancestor
154647484|NCT06158100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647485|NCT06158100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647486|NCT06158100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647487|NCT06153537|Insulin|insulin|mesh-list
154647488|NCT06153537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154647489|NCT06153537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647490|NCT06148311|Dexmedetomidine|dexmedetomidine|mesh-list
154647491|NCT06148311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154647492|NCT06148311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647493|NCT06148311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647494|NCT06148311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647495|NCT06148311|Analgesics|analgesics|mesh-ancestor
154647496|NCT06148311|Sensory System Agents|sensory system agents|mesh-ancestor
154647497|NCT06148311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647498|NCT06148311|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154647499|NCT06148311|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154647500|NCT06148311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154647501|NCT06148311|Adrenergic Agents|adrenergic agents|mesh-ancestor
154647502|NCT06148311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647503|NCT06148311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647504|NCT06118034|Colchicine|colchicine|mesh-list
154647505|NCT06118034|Gout Suppressants|gout suppressants|mesh-ancestor
154647506|NCT06118034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647507|NCT06118034|Tubulin Modulators|tubulin modulators|mesh-ancestor
154647508|NCT06118034|Antimitotic Agents|antimitotic agents|mesh-ancestor
154647509|NCT06118034|Mitosis Modulators|mitosis modulators|mesh-ancestor
154647510|NCT06118034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647511|NCT06118034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647512|NCT06040346|Meplazumab|meplazumab|mesh-list
154647513|NCT06040346|Antiviral Agents|antiviral agents|mesh-ancestor
154647514|NCT06040346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647515|NCT06014515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154647516|NCT06014515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154647517|NCT06014515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647518|NCT05949684|Epoetin Alfa|epoetin alfa|mesh-list
154647519|NCT05949684|Luspatercept|luspatercept|mesh-list
154647520|NCT05949684|Hematinics|hematinics|mesh-ancestor
154647521|NCT05929222|Obinutuzumab|obinutuzumab|mesh-list
154647522|NCT05929222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647523|NCT05929222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647524|NCT05922124|Meropenem|meropenem|mesh-list
154647525|NCT05922124|Colistin|colistin|mesh-list
154647526|NCT05922124|Ampicillin|ampicillin|mesh-list
154647527|NCT05922124|Sulbactam|sulbactam|mesh-list
154399626|NCT04344444|Azithromycin|azithromycin|mesh-list
154647528|NCT05922124|Cefiderocol|cefiderocol|mesh-list
154647529|NCT05922124|Sultamicillin|sultamicillin|mesh-list
154647530|NCT05922124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154647531|NCT05922124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362374|NCT00418834|Ezetimibe|ezetimibe|mesh-list
154647532|NCT05922124|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154647533|NCT05922124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647534|NCT05922124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647535|NCT05922124|Siderophores|siderophores|mesh-ancestor
154647536|NCT05922124|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154647537|NCT05922124|Chelating Agents|chelating agents|mesh-ancestor
154647538|NCT05922124|Sequestering Agents|sequestering agents|mesh-ancestor
154647539|NCT05922124|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154647540|NCT05918211|Udenafil|udenafil|mesh-list
154647541|NCT05918211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154647542|NCT05918211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154647543|NCT05918211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647544|NCT05918211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647545|NCT05902533|Capecitabine|capecitabine|mesh-list
154647546|NCT05902533|Mitomycins|mitomycins|mesh-list
154647547|NCT05902533|Mitomycin|mitomycin|mesh-list
154647548|NCT05902533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154647549|NCT05902533|Antimetabolites|antimetabolites|mesh-ancestor
154647550|NCT05902533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647551|NCT05902533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647552|NCT05902533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154647553|NCT05902533|Alkylating Agents|alkylating agents|mesh-ancestor
154647554|NCT05902533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154647555|NCT05902533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647556|NCT05878184|Cyclophosphamide|cyclophosphamide|mesh-list
154647557|NCT05878184|Fludarabine|fludarabine|mesh-list
154647558|NCT05878184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154647559|NCT05878184|Immunologic Factors|immunologic factors|mesh-ancestor
154647560|NCT05878184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647561|NCT05878184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647562|NCT05878184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154647563|NCT05878184|Alkylating Agents|alkylating agents|mesh-ancestor
154647564|NCT05878184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647565|NCT05878184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647566|NCT05878184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154647567|NCT05864209|Bisphenol A|bisphenol a|mesh-list
154647568|NCT05864209|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154647569|NCT05864209|Estrogens|estrogens|mesh-ancestor
154647570|NCT05864209|Hormones|hormones|mesh-ancestor
154647571|NCT05864209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154647572|NCT05864209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647573|NCT05864209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154647574|NCT05864209|Antioxidants|antioxidants|mesh-ancestor
154647575|NCT05864209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647576|NCT05864209|Protective Agents|protective agents|mesh-ancestor
154647577|NCT05830864|Isoflurane|isoflurane|mesh-list
154647578|NCT05830864|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154647579|NCT05830864|Anesthetics, General|anesthetics, general|mesh-ancestor
154647580|NCT05830864|Anesthetics|anesthetics|mesh-ancestor
154647581|NCT05830864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647582|NCT05830864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647583|NCT05813587|Meplazumab|meplazumab|mesh-list
154647584|NCT05813587|Antiviral Agents|antiviral agents|mesh-ancestor
154647585|NCT05813587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647586|NCT05810363|Propofol|propofol|mesh-list
154647587|NCT05810363|Etomidate|etomidate|mesh-list
154647588|NCT05810363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154647589|NCT05810363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647590|NCT05810363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647591|NCT05810363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154647592|NCT05810363|Anesthetics, General|anesthetics, general|mesh-ancestor
154647593|NCT05810363|Anesthetics|anesthetics|mesh-ancestor
154647594|NCT05807204|Acetylcysteine|acetylcysteine|mesh-list
154647595|NCT05807204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154647596|NCT05807204|Antiviral Agents|antiviral agents|mesh-ancestor
154647597|NCT05807204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647598|NCT05807204|Expectorants|expectorants|mesh-ancestor
154647599|NCT05807204|Respiratory System Agents|respiratory system agents|mesh-ancestor
154647600|NCT05807204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154647601|NCT05807204|Antioxidants|antioxidants|mesh-ancestor
154647602|NCT05807204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647603|NCT05807204|Protective Agents|protective agents|mesh-ancestor
154647604|NCT05807204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647605|NCT05807204|Antidotes|antidotes|mesh-ancestor
154399696|NCT03105310|Ezetimibe|ezetimibe|mesh-list
154647606|NCT05804903|Fexofenadine|fexofenadine|mesh-list
154647607|NCT05804903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154647608|NCT05804903|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154647609|NCT05804903|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154647610|NCT05804903|Histamine Antagonists|histamine antagonists|mesh-ancestor
154647611|NCT05804903|Histamine Agents|histamine agents|mesh-ancestor
154647612|NCT05804903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647613|NCT05804903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647614|NCT05804903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647616|NCT05800366|Methylprednisolone|methylprednisolone|mesh-list
154647617|NCT05800366|Prednisolone|prednisolone|mesh-list
154647618|NCT05800366|Cyclophosphamide|cyclophosphamide|mesh-list
154647619|NCT05800366|Rituximab|rituximab|mesh-list
154647620|NCT05800366|Doxorubicin|doxorubicin|mesh-list
154647621|NCT05800366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154647622|NCT05800366|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154647623|NCT05800366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154647624|NCT05800366|Immunologic Factors|immunologic factors|mesh-ancestor
154647625|NCT05800366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647626|NCT05800366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647627|NCT05800366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154647628|NCT05800366|Alkylating Agents|alkylating agents|mesh-ancestor
154647629|NCT05800366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647630|NCT05800366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647631|NCT05800366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154647632|NCT05800366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647633|NCT05800366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154647634|NCT05800366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154647635|NCT05800366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154647636|NCT05800366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647637|NCT05800366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154647638|NCT05800366|Glucocorticoids|glucocorticoids|mesh-ancestor
154647639|NCT05800366|Hormones|hormones|mesh-ancestor
154647640|NCT05800366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154647641|NCT05800366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154647642|NCT05800366|Antiemetics|antiemetics|mesh-ancestor
154647643|NCT05800366|Autonomic Agents|autonomic agents|mesh-ancestor
154647644|NCT05800366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647645|NCT05800366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154647646|NCT05800366|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154647647|NCT05800366|Protective Agents|protective agents|mesh-ancestor
154647648|NCT05800366|Immunoconjugates|immunoconjugates|mesh-ancestor
154647649|NCT05750758|Rivaroxaban|rivaroxaban|mesh-list
154647650|NCT05750758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154647651|NCT05750758|Antithrombins|antithrombins|mesh-ancestor
154647652|NCT05750758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154647653|NCT05750758|Protease Inhibitors|protease inhibitors|mesh-ancestor
154647654|NCT05750758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647655|NCT05750758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647656|NCT05750758|Anticoagulants|anticoagulants|mesh-ancestor
154647657|NCT05739981|Paclitaxel|paclitaxel|mesh-list
154647658|NCT05739981|Bevacizumab|bevacizumab|mesh-list
154647659|NCT05739981|Carboplatin|carboplatin|mesh-list
154647660|NCT05739981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154647661|NCT05739981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647662|NCT05739981|Tubulin Modulators|tubulin modulators|mesh-ancestor
154647663|NCT05739981|Antimitotic Agents|antimitotic agents|mesh-ancestor
154647664|NCT05739981|Mitosis Modulators|mitosis modulators|mesh-ancestor
154647665|NCT05739981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647666|NCT05739981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647667|NCT05739981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154647668|NCT05739981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154647669|NCT05739981|Growth Substances|growth substances|mesh-ancestor
154647670|NCT05739981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647671|NCT05739981|Growth Inhibitors|growth inhibitors|mesh-ancestor
154647672|NCT05728814|Dostarlimab|dostarlimab|mesh-list
154647673|NCT05728814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647674|NCT05725213|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154647675|NCT05725213|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154647676|NCT05725213|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154647677|NCT05725213|Dermatologic Agents|dermatologic agents|mesh-ancestor
154647678|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
154647679|NCT05688371|Morphine|morphine|mesh-list
154647680|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154647681|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399768|NCT03720041|Ixazomib|ixazomib|mesh-list
154647682|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647683|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647684|NCT05688371|Analgesics|analgesics|mesh-ancestor
154647685|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
154647686|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647687|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154647688|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154647689|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154647690|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
154647691|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647692|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647693|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154647694|NCT05688371|Narcotics|narcotics|mesh-ancestor
154647695|NCT05679479|Meplazumab|meplazumab|mesh-list
154647696|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
154647697|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647698|NCT05678257|Leucovorin|leucovorin|mesh-list
154647699|NCT05678257|Bevacizumab|bevacizumab|mesh-list
154647700|NCT05678257|Fluorouracil|fluorouracil|mesh-list
154647701|NCT05678257|Irinotecan|irinotecan|mesh-list
154647702|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647703|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647704|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154647705|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154647706|NCT05678257|Growth Substances|growth substances|mesh-ancestor
154647707|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647708|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
154647709|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
154647710|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647711|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154647712|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154647713|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
154647714|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154647715|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154647716|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647717|NCT05678257|Antidotes|antidotes|mesh-ancestor
154647718|NCT05678257|Protective Agents|protective agents|mesh-ancestor
154647719|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
154647720|NCT05678257|Vitamins|vitamins|mesh-ancestor
154647721|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
154647722|NCT05673187|Adagrasib|adagrasib|mesh-list
154647723|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647724|NCT05664074|Ketorolac|ketorolac|mesh-list
154647725|NCT05664074|Indomethacin|indomethacin|mesh-list
154647726|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154647727|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647728|NCT05664074|Analgesics|analgesics|mesh-ancestor
154647729|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
154647730|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647731|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647732|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154647733|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647734|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154647735|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647736|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647737|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
154647738|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
154647739|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154647740|NCT05659927|Antibodies|antibodies|mesh-list
154647741|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154647742|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
154647743|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647744|NCT05625932|Tinzaparin|tinzaparin|mesh-list
154647745|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154647746|NCT05625932|Dalteparin|dalteparin|mesh-list
154647747|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
154647748|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154647749|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154647750|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647751|NCT05603754|Lorecivivint|lorecivivint|mesh-list
154647752|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154647753|NCT05596955|Naltrexone|naltrexone|mesh-list
154647754|NCT05596955|Buprenorphine|buprenorphine|mesh-list
154647755|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154647756|NCT05596955|Narcotics|narcotics|mesh-ancestor
154647757|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647758|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647759|NCT05596955|Analgesics|analgesics|mesh-ancestor
154647760|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
154647761|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647762|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154647763|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154647765|NCT05595447|Nivolumab|nivolumab|mesh-list
154647766|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154647767|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647768|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647769|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154647770|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647771|NCT05595447|Immunotoxins|immunotoxins|mesh-ancestor
154647772|NCT05595447|Immunoconjugates|immunoconjugates|mesh-ancestor
154647773|NCT05595447|Immunologic Factors|immunologic factors|mesh-ancestor
154647774|NCT05595447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647775|NCT05571267|Bevacizumab|bevacizumab|mesh-list
154647776|NCT05571267|Ranibizumab|ranibizumab|mesh-list
154647777|NCT05571267|Aflibercept|aflibercept|mesh-list
154647778|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647779|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647780|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154647781|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154647782|NCT05571267|Growth Substances|growth substances|mesh-ancestor
154647783|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362617|NCT04084626|Lenalidomide|lenalidomide|mesh-list
154647784|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
154647785|NCT05556473|Tryptophan|tryptophan|mesh-list
154647786|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154647787|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
154647788|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154647789|NCT05540262|Edaravone|edaravone|mesh-list
154647790|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154647791|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
154647792|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647793|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154647794|NCT05540262|Protective Agents|protective agents|mesh-ancestor
154647795|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647796|NCT05521997|Cisplatin|cisplatin|mesh-list
154647797|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647798|NCT05494866|Cobicistat|cobicistat|mesh-list
154647799|NCT05494866|Paclitaxel|paclitaxel|mesh-list
154647800|NCT05494866|Gemcitabine|gemcitabine|mesh-list
154647801|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154647802|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647803|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
154647804|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
154647805|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
154647806|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647807|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154647808|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154647809|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
154647810|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647811|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154647812|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154647813|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647814|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154647815|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
154647816|NCT05487001|Dexamethasone|dexamethasone|mesh-list
154647817|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154647818|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
154647819|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
154647820|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647821|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647822|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154647823|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
154647824|NCT05487001|Hormones|hormones|mesh-ancestor
154647825|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154647826|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154647827|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647828|NCT05478252|Semaglutide|semaglutide|mesh-list
154647829|NCT05478252|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154647830|NCT05478252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154647831|NCT05478252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647832|NCT05446142|Rabeprazole|rabeprazole|mesh-list
154647833|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154647834|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154647835|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154647836|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647837|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647838|NCT05436418|Sirolimus|sirolimus|mesh-list
154647839|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
154647840|NCT05436418|Melphalan|melphalan|mesh-list
154647841|NCT05436418|Fludarabine|fludarabine|mesh-list
154647842|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154647843|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
154647844|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647845|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647846|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154647847|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
154647848|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647849|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647850|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154647851|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154647852|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154647853|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154647854|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
154647855|NCT05384496|Nivolumab|nivolumab|mesh-list
154647856|NCT05384496|Ipilimumab|ipilimumab|mesh-list
154647857|NCT05384496|Axitinib|axitinib|mesh-list
154647858|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647859|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647860|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154647861|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647862|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154647863|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647864|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
154647865|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647866|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647867|NCT05357898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154647868|NCT05357898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647869|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
154647870|NCT05345938|Analgesics|analgesics|mesh-ancestor
154647871|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
154647872|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647873|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647874|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647875|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154647876|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154647877|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647878|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647879|NCT05293808|Aspirin|aspirin|mesh-list
154647880|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154647881|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154647882|NCT05293808|Analgesics|analgesics|mesh-ancestor
154647883|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
154647884|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647885|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647886|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154647887|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647888|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154647889|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154647890|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647891|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154647892|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154647893|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647894|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
154647895|NCT05290129|Oxytocin|oxytocin|mesh-list
154647896|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
154647897|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154647898|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647899|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
154647900|NCT05289167|Bortezomib|bortezomib|mesh-list
154647901|NCT05289167|Abatacept|abatacept|mesh-list
154647902|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154647903|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
154647904|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647905|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154647906|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154647907|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
154647908|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647909|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647910|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154647911|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154647912|NCT05289167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154647913|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154647914|NCT05263388|Hormones|hormones|mesh-ancestor
154647915|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154647916|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647917|NCT05232071|Empagliflozin|empagliflozin|mesh-list
154647918|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154647919|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647920|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154647921|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647922|NCT05213208|Propofol|propofol|mesh-list
154647923|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154647924|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647925|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647926|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154647927|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
154647928|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
154647929|NCT05156060|Ketamine|ketamine|mesh-list
154647930|NCT05156060|Gabapentin|gabapentin|mesh-list
154647931|NCT05156060|Analgesics|analgesics|mesh-ancestor
154647932|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
154647933|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154647934|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647935|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154647936|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154647937|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
154647938|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
154647939|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154647940|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154647941|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154647942|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154647943|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647944|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
154647945|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154647946|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154647947|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154647948|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
154647949|NCT05155189|Lenvatinib|lenvatinib|mesh-list
154647950|NCT05155189|Antibodies|antibodies|mesh-list
154647951|NCT05155189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154647952|NCT05155189|Immunologic Factors|immunologic factors|mesh-ancestor
154647953|NCT05155189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647954|NCT05155189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647955|NCT05155189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154647956|NCT05155189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647957|NCT05155189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647958|NCT05153395|Insulin|insulin|mesh-list
154647959|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154647960|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154647961|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647962|NCT05116774|Eculizumab|eculizumab|mesh-list
154647963|NCT05116774|Ravulizumab|ravulizumab|mesh-list
154647964|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154647965|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154647966|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
154647967|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647968|NCT05101551|Gemcitabine|gemcitabine|mesh-list
154647969|NCT05101551|Topotecan|topotecan|mesh-list
154647970|NCT05101551|Talazoparib|talazoparib|mesh-list
154647971|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154647972|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
154647973|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647974|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154647975|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154647976|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154647977|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647978|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154647979|NCT05090085|Z 350|z 350|mesh-list
154647980|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154647981|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154647982|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154647983|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154647984|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
154558039|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154647985|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154647986|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647987|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
154647988|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154647989|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
154647990|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647991|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
154647992|NCT05085067|Protective Agents|protective agents|mesh-ancestor
154647993|NCT05013229|Insulin|insulin|mesh-list
154647994|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154647995|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
154647996|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
154647997|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154647998|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154647999|NCT04982848|Talazoparib|talazoparib|mesh-list
154648000|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154648001|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648002|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648003|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648004|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
154648005|NCT04927481|Analgesics|analgesics|mesh-ancestor
154648006|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
154648007|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648008|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648009|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648010|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154648011|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154648012|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648013|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648014|NCT04894435|Vaccines|vaccines|mesh-list
154648015|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
154648016|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648017|NCT04892043|Nivolumab|nivolumab|mesh-list
154648018|NCT04892043|Ipilimumab|ipilimumab|mesh-list
154648019|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648020|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648021|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648022|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648023|NCT04837716|Bevacizumab|bevacizumab|mesh-list
154648024|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154648025|NCT04837716|Carboplatin|carboplatin|mesh-list
154648026|NCT04837716|Pemetrexed|pemetrexed|mesh-list
154648027|NCT04837716|Ensartinib|ensartinib|mesh-list
154648028|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
154648029|NCT04837716|Antibodies|antibodies|mesh-list
154648030|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
154648031|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154648032|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
154648033|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648034|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648035|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648036|NCT04837716|Growth Substances|growth substances|mesh-ancestor
154648037|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648038|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648039|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
154648040|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648041|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648042|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154648043|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154648044|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648045|NCT04809311|Insulin|insulin|mesh-list
154648046|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154648047|NCT04809311|Glucagon|glucagon|mesh-list
154648048|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154648049|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154648050|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648051|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154648052|NCT04809311|Hormones|hormones|mesh-ancestor
154648053|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648054|NCT04809311|Incretins|incretins|mesh-ancestor
154648055|NCT04803994|Bevacizumab|bevacizumab|mesh-list
154648056|NCT04803994|Atezolizumab|atezolizumab|mesh-list
154648057|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648058|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648059|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648060|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648061|NCT04803994|Growth Substances|growth substances|mesh-ancestor
154648062|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648063|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648064|NCT04803994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648065|NCT04803994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648066|NCT04781192|Durvalumab|durvalumab|mesh-list
154648067|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648068|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648069|NCT04742777|Sirolimus|sirolimus|mesh-list
154648070|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154648071|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648072|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154648073|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648074|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
154648075|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648076|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
154648077|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648078|NCT04721977|Capecitabine|capecitabine|mesh-list
154648079|NCT04721977|Trastuzumab|trastuzumab|mesh-list
154648080|NCT04721977|Tucatinib|tucatinib|mesh-list
154648081|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154648082|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
154648083|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648084|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648085|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648086|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648087|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648088|NCT04720781|Esomeprazole|esomeprazole|mesh-list
154648089|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154648090|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154648091|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154648092|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648093|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648094|NCT04716881|Naltrexone|naltrexone|mesh-list
154648095|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154648096|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154648097|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648098|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
154648099|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648100|NCT04707872|Antibodies|antibodies|mesh-list
154648101|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
154648102|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648103|NCT04706026|Anesthetics|anesthetics|mesh-list
154648104|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154648105|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648106|NCT04698187|Nivolumab|nivolumab|mesh-list
154648107|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648108|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648109|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648110|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648111|NCT04695197|Artesunate|artesunate|mesh-list
154648112|NCT04695197|Lumefantrine|lumefantrine|mesh-list
154648113|NCT04695197|Artemether|artemether|mesh-list
154648114|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154648115|NCT04695197|Pyronaridine|pyronaridine|mesh-list
154648116|NCT04695197|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154648117|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
154648118|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154648119|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154648120|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648121|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648122|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
154648123|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
154648124|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154648125|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
154648126|NCT04625257|Antibodies|antibodies|mesh-list
154648127|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
154648128|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648129|NCT04606537|Itraconazole|itraconazole|mesh-list
154648130|NCT04606537|Rifampin|rifampin|mesh-list
154648131|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
154648132|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648133|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154648134|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154648135|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648136|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648138|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
154648139|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648140|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648141|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154648142|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154648143|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
154648144|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154648145|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
154648146|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154648147|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154648148|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154648149|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154648150|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154648151|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154648152|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154648153|NCT04576156|Imetelstat|imetelstat|mesh-list
154648154|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
154648155|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648156|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648157|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648158|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
154648159|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648160|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
154648161|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154648162|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
154648163|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648164|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154648165|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648166|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
154648167|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648168|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
154648169|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154648170|NCT04535882|Protective Agents|protective agents|mesh-ancestor
154648171|NCT04533451|Carboplatin|carboplatin|mesh-list
154648172|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
154648173|NCT04533451|Pemetrexed|pemetrexed|mesh-list
154648174|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648175|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648176|NCT04533451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648177|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648178|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648179|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154648180|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154648181|NCT04530006|Amantadine|amantadine|mesh-list
154648182|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154648183|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154648184|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
154648185|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648186|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
154648187|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154648188|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648189|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648190|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154648191|NCT04530006|Analgesics|analgesics|mesh-ancestor
154648192|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
154648193|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648194|NCT04507503|Futibatinib|futibatinib|mesh-list
154648195|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648196|NCT04489732|Interferons|interferons|mesh-list
154648197|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
154648198|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648199|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
154648200|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648201|NCT04462276|Atezolizumab|atezolizumab|mesh-list
154648202|NCT04462276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648203|NCT04462276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648204|NCT04462276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648205|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648206|NCT04408313|Naltrexone|naltrexone|mesh-list
154648207|NCT04408313|Buprenorphine|buprenorphine|mesh-list
154648208|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154648209|NCT04408313|Narcotics|narcotics|mesh-ancestor
154400282|NCT03070002|Denosumab|denosumab|mesh-list
154648210|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154648211|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648213|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
154648214|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648215|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154648216|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154648217|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
154648218|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648219|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648220|NCT04373265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648221|NCT04373265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648222|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
154648223|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154648224|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154648225|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648226|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
154648227|NCT04344860|Coagulants|coagulants|mesh-ancestor
154648228|NCT04344717|Apixaban|apixaban|mesh-list
154648229|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154648230|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
154648231|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154648232|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
154648233|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648234|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648235|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
154648236|NCT04332744|Talazoparib|talazoparib|mesh-list
154648237|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154648238|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648239|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648240|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648241|NCT04310397|Trametinib|trametinib|mesh-list
154648242|NCT04310397|Dabrafenib|dabrafenib|mesh-list
154648243|NCT04310397|Spartalizumab|spartalizumab|mesh-list
154648244|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648245|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648246|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648247|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648248|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648249|NCT04310397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648250|NCT04294641|Ibrutinib|ibrutinib|mesh-list
154648251|NCT04294641|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154648252|NCT04294641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648253|NCT04294641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648254|NCT04294641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648255|NCT04257032|Dabigatran|dabigatran|mesh-list
154648256|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154648257|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154648258|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154648259|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
154648260|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648261|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154648262|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154648263|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648264|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
154648265|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154648266|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
154648267|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
154648268|NCT04177810|Plerixafor|plerixafor|mesh-list
154648269|NCT04177810|Cemiplimab|cemiplimab|mesh-list
154648270|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154648271|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154648272|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
154648273|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648274|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648275|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648276|NCT04168879|Bupivacaine|bupivacaine|mesh-list
154648277|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
154648278|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
154648279|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154648280|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648281|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
154648282|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648283|NCT04135989|Everolimus|everolimus|mesh-list
154648284|NCT04135989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154648285|NCT04135989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648286|NCT04135989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648287|NCT04135989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648288|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648289|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
154648290|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648291|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648292|NCT04024436|Fulvestrant|fulvestrant|mesh-list
154648293|NCT04024436|Futibatinib|futibatinib|mesh-list
154648294|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154648295|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648296|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154648297|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154648298|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
154648299|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648300|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648301|NCT03971669|Vaccines|vaccines|mesh-list
154648302|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
154648303|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648304|NCT03933202|Cladribine|cladribine|mesh-list
154648305|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648306|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648307|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
154648308|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648309|NCT03900624|Dexamethasone|dexamethasone|mesh-list
154648310|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648311|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
154648312|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
154648313|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648314|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648315|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154648316|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
154648317|NCT03900624|Hormones|hormones|mesh-ancestor
154648318|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648319|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154648320|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648321|NCT03871036|Paclitaxel|paclitaxel|mesh-list
154648322|NCT03871036|Durvalumab|durvalumab|mesh-list
154648323|NCT03871036|Tremelimumab|tremelimumab|mesh-list
154648324|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154648325|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648326|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
154648327|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
154648328|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
154648329|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648330|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648331|NCT03796364|Endostar protein|endostar protein|mesh-list
154648332|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648333|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648334|NCT03796364|Growth Substances|growth substances|mesh-ancestor
154648335|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648336|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648337|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648338|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
154648339|NCT03753555|Atorvastatin|atorvastatin|mesh-list
154648340|NCT03753555|Probucol|probucol|mesh-list
154648341|NCT03753555|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154648342|NCT03753555|Calcium|calcium|mesh-list
154648343|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154648344|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648345|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154648346|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154648347|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154648348|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
154648349|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648350|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154648351|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154648352|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648353|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
154648354|NCT03753555|Protective Agents|protective agents|mesh-ancestor
154648355|NCT03753555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154648356|NCT03753555|Protease Inhibitors|protease inhibitors|mesh-ancestor
154648357|NCT03749187|Temozolomide|temozolomide|mesh-list
154400423|NCT03122145|Capsaicin|capsaicin|mesh-list
154648358|NCT03749187|Pamiparib|pamiparib|mesh-list
154648359|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154648360|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154648361|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
154648362|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648363|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648364|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648365|NCT03725202|Upadacitinib|upadacitinib|mesh-list
154648366|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154648367|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648368|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648369|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648370|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648371|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
154648372|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648373|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648374|NCT03709706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648375|NCT03709706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648376|NCT03671967|Meropenem|meropenem|mesh-list
154648377|NCT03671967|Tazobactam|tazobactam|mesh-list
154648378|NCT03671967|Piperacillin|piperacillin|mesh-list
154648379|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154648380|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154648381|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648382|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154648383|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648384|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648385|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
154648386|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648387|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648388|NCT03598608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648389|NCT03598608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648390|NCT03558867|Metformin|metformin|mesh-list
154648391|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154648392|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648393|NCT03528694|Durvalumab|durvalumab|mesh-list
154648394|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
154648395|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648396|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648397|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154648398|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
154648399|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648400|NCT03523390|Avelumab|avelumab|mesh-list
154648401|NCT03523390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154648402|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648403|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648404|NCT03523390|Immunologic Factors|immunologic factors|mesh-ancestor
154648405|NCT03523390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648406|NCT03501576|Vaccines|vaccines|mesh-list
154648407|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
154648408|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648409|NCT03439046|Letrozole|letrozole|mesh-list
154648410|NCT03439046|Fulvestrant|fulvestrant|mesh-list
154648411|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648412|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154648413|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154648414|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648415|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648416|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154648417|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
154648418|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648419|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648420|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154648421|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154648422|NCT03429543|Metformin|metformin|mesh-list
154648423|NCT03429543|Empagliflozin|empagliflozin|mesh-list
154648424|NCT03429543|Linagliptin|linagliptin|mesh-list
154648425|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154648426|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648427|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154648428|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648429|NCT03429543|Incretins|incretins|mesh-ancestor
154648430|NCT03429543|Hormones|hormones|mesh-ancestor
154648431|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648432|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154648433|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
154648434|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648435|NCT03427463|Morphine|morphine|mesh-list
154648436|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154648437|NCT03427463|Narcotics|narcotics|mesh-ancestor
154648438|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154648439|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648440|NCT03427463|Analgesics|analgesics|mesh-ancestor
154648441|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
154648442|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648443|NCT03393884|Paclitaxel|paclitaxel|mesh-list
154648444|NCT03393884|Carboplatin|carboplatin|mesh-list
154648445|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154648446|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648447|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
154648448|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
154648449|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
154648450|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648451|NCT03362190|Ranibizumab|ranibizumab|mesh-list
154648452|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648453|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648454|NCT03362190|Growth Substances|growth substances|mesh-ancestor
154648455|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648456|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648457|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648458|NCT03356860|Paclitaxel|paclitaxel|mesh-list
154648459|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
154648460|NCT03356860|Durvalumab|durvalumab|mesh-list
154648461|NCT03356860|Epirubicin|epirubicin|mesh-list
154648462|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154648463|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648464|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
154648465|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
154648466|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
154648467|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648468|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648469|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
154648470|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648471|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648472|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154648473|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
154648474|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154648475|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648476|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154648477|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154648478|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154648479|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648480|NCT03312400|Danazol|danazol|mesh-list
154648481|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154648482|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
154648483|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648484|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648485|NCT03269136|Thalidomide|thalidomide|mesh-list
154648486|NCT03269136|Dexamethasone|dexamethasone|mesh-list
154648487|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
154648488|NCT03269136|Lenalidomide|lenalidomide|mesh-list
154648489|NCT03269136|Pomalidomide|pomalidomide|mesh-list
154648490|NCT03269136|Antibodies|antibodies|mesh-list
154648491|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
154648492|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154648493|NCT03269136|BB 1101|bb 1101|mesh-list
154648494|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
154648495|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648496|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648497|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
154648498|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
154648499|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648500|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154648501|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
154648502|NCT03269136|Hormones|hormones|mesh-ancestor
154648503|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648504|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154648505|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648506|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
154648507|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648508|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648509|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648510|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648511|NCT03269136|Growth Substances|growth substances|mesh-ancestor
154648512|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648513|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648514|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
154648515|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154648516|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648517|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
154648518|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154648519|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648520|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154648521|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648522|NCT03254667|Brodalumab|brodalumab|mesh-list
154648523|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
154648524|NCT03182244|Cytarabine|cytarabine|mesh-list
154648525|NCT03182244|Fludarabine|fludarabine|mesh-list
154648526|NCT03182244|Etoposide|etoposide|mesh-list
154648527|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
154648528|NCT03182244|Lenograstim|lenograstim|mesh-list
154648529|NCT03182244|Gilteritinib|gilteritinib|mesh-list
154648530|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648531|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154648532|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
154648533|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648534|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648535|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
154648536|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648537|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154648538|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154648539|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154648540|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648541|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
154648542|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648543|NCT03182244|Analgesics|analgesics|mesh-ancestor
154648544|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
154648545|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648546|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154648547|NCT03182244|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154648548|NCT03182244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648549|NCT03137160|Ixekizumab|ixekizumab|mesh-list
154648550|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
154648551|NCT03136705|Niacinamide|niacinamide|mesh-list
154648552|NCT03136705|Niacin|niacin|mesh-list
154648553|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
154648554|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
154648555|NCT03136705|Vitamins|vitamins|mesh-ancestor
154648556|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
154648557|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648558|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154648559|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
154648560|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648561|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154363413|NCT01279811|Dopamine|dopamine|mesh-list
154648562|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
154648563|NCT03134196|Valacyclovir|valacyclovir|mesh-list
154648564|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
154648565|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648566|NCT03130127|Terlipressin|terlipressin|mesh-list
154648567|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154648568|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154648569|NCT03127007|Atezolizumab|atezolizumab|mesh-list
154648570|NCT03127007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648571|NCT03127007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648572|NCT03127007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648573|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648574|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
154648575|NCT03110432|Niacin|niacin|mesh-list
154648576|NCT03110432|Ezetimibe|ezetimibe|mesh-list
154648577|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154648578|NCT03110432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154648579|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154648580|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154648581|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
154648582|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648583|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154648584|NCT03110432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154648585|NCT03110432|Protease Inhibitors|protease inhibitors|mesh-ancestor
154648586|NCT03110432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648587|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
154648588|NCT03110432|Vitamins|vitamins|mesh-ancestor
154648589|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
154648590|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648591|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
154648592|NCT03046251|Natalizumab|natalizumab|mesh-list
154648593|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
154648594|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648595|NCT02989662|Mifepristone|mifepristone|mesh-list
154648596|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154648597|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
154648598|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154648599|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648600|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154648601|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154648602|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154648603|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
154648604|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154648605|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154648606|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
154648607|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648608|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
154648609|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154648610|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154648611|NCT02944617|Micronutrients|micronutrients|mesh-list
154648612|NCT02944617|Trace Elements|trace elements|mesh-list
154648613|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648614|NCT02940301|Nivolumab|nivolumab|mesh-list
154648615|NCT02940301|Ibrutinib|ibrutinib|mesh-list
154648616|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648617|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648618|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154648619|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648620|NCT02940301|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154648621|NCT02940301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648622|NCT02940301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648623|NCT02867124|Naltrexone|naltrexone|mesh-list
154648624|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648625|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
154648626|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648627|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154648628|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154648629|NCT02837965|Doxycycline|doxycycline|mesh-list
154648630|NCT02837965|Prednisone|prednisone|mesh-list
154648631|NCT02837965|Methotrexate|methotrexate|mesh-list
154648632|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648633|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
154648634|NCT02837965|Hormones|hormones|mesh-ancestor
154648635|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648636|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648637|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154648638|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648639|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154648640|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
154648641|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154648642|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154648643|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
154648644|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648645|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
154648646|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648647|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154648648|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648649|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
154648650|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648651|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154648652|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154648653|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648654|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
154648655|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154648656|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154648657|NCT02813369|Naloxegol|naloxegol|mesh-list
154648658|NCT02813369|Laxatives|laxatives|mesh-list
154648659|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154648660|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648661|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
154648662|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648663|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154648664|NCT02806440|Naltrexone|naltrexone|mesh-list
154648665|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154648666|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154648667|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648668|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
154648669|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648670|NCT02684669|Naloxone|naloxone|mesh-list
154648671|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154648672|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648673|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
154648674|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648675|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154363518|NCT02527798|Furosemide|furosemide|mesh-list
154648676|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
154648677|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
154648678|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648679|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648680|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154648681|NCT02653014|Diuretics|diuretics|mesh-ancestor
154648682|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
154648683|NCT02653014|Hormones|hormones|mesh-ancestor
154648684|NCT02639026|Durvalumab|durvalumab|mesh-list
154648685|NCT02639026|Tremelimumab|tremelimumab|mesh-list
154648686|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648687|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648688|NCT02616640|Dexamethasone|dexamethasone|mesh-list
154648689|NCT02616640|Durvalumab|durvalumab|mesh-list
154648690|NCT02616640|Pomalidomide|pomalidomide|mesh-list
154648691|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648692|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
154648693|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
154648694|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648695|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648696|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154648697|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
154648698|NCT02616640|Hormones|hormones|mesh-ancestor
154648699|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648700|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154648701|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648702|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648703|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
154648704|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648705|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648706|NCT02616640|Growth Substances|growth substances|mesh-ancestor
154648707|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648708|NCT02598349|Capecitabine|capecitabine|mesh-list
154648709|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154648710|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
154648711|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648712|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648713|NCT02574728|Sirolimus|sirolimus|mesh-list
154648714|NCT02574728|Celecoxib|celecoxib|mesh-list
154648715|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
154648716|NCT02574728|Etoposide|etoposide|mesh-list
154648717|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648718|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
154648719|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648720|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648721|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154648722|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
154648723|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648724|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648725|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154648726|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154648727|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154648728|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154648729|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648730|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154648731|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648732|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154648733|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
154648734|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154648735|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154648736|NCT02574728|Analgesics|analgesics|mesh-ancestor
154648737|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
154648738|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648739|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648740|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154648741|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154648742|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
154648743|NCT02527746|Epirubicin|epirubicin|mesh-list
154648744|NCT02527746|Lenograstim|lenograstim|mesh-list
154648745|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648746|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
154648747|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648748|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648749|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154648750|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
154648751|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648752|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648753|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154648754|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154648755|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154648756|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154648757|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648758|NCT02527746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154648759|NCT02397954|Ranibizumab|ranibizumab|mesh-list
154648760|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648761|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648762|NCT02397954|Growth Substances|growth substances|mesh-ancestor
154648763|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648764|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648765|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648766|NCT02387957|Bevacizumab|bevacizumab|mesh-list
154648767|NCT02387957|Ranibizumab|ranibizumab|mesh-list
154648768|NCT02387957|Aflibercept|aflibercept|mesh-list
154648769|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648770|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648771|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648772|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648773|NCT02387957|Growth Substances|growth substances|mesh-ancestor
154648774|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648775|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648776|NCT02214628|Becaplermin|becaplermin|mesh-list
154648777|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
154648778|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154648779|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648780|NCT02214628|Growth Substances|growth substances|mesh-ancestor
154648781|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648782|NCT02163694|Paclitaxel|paclitaxel|mesh-list
154648783|NCT02163694|Carboplatin|carboplatin|mesh-list
154648784|NCT02163694|Veliparib|veliparib|mesh-list
154648785|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154648786|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648787|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
154648788|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
154648789|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
154648790|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648791|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154648792|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648793|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154648794|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
154648795|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154648796|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648797|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648798|NCT02013648|Cytarabine|cytarabine|mesh-list
154648799|NCT02013648|Daunorubicin|daunorubicin|mesh-list
154648800|NCT02013648|Dasatinib|dasatinib|mesh-list
154648801|NCT02013648|Idarubicin|idarubicin|mesh-list
154648802|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154648803|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
154648804|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648805|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648806|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
154648807|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648808|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648809|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
154648810|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648811|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154648812|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154648813|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154648814|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648815|NCT02013648|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154648816|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648817|NCT01944839|Ranibizumab|ranibizumab|mesh-list
154648818|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648819|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648820|NCT01944839|Growth Substances|growth substances|mesh-ancestor
154648821|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648822|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648823|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648824|NCT01940900|Ranibizumab|ranibizumab|mesh-list
154648825|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648826|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648827|NCT01940900|Growth Substances|growth substances|mesh-ancestor
154648828|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648829|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648830|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648831|NCT01940887|Bevacizumab|bevacizumab|mesh-list
154648832|NCT01940887|Aflibercept|aflibercept|mesh-list
154648833|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648834|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648835|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648836|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648837|NCT01940887|Growth Substances|growth substances|mesh-ancestor
154648838|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648839|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648840|NCT01905046|Metformin|metformin|mesh-list
154648841|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154648842|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648843|NCT01081431|Lenalidomide|lenalidomide|mesh-list
154648844|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
154648845|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648846|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154648847|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154648848|NCT01081431|Growth Substances|growth substances|mesh-ancestor
154648849|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
154648850|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648851|NCT00783510|Adalimumab|adalimumab|mesh-list
154648852|NCT00783510|Methotrexate|methotrexate|mesh-list
154648853|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154648854|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
154648855|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154648856|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648857|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154648858|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
154648859|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648860|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648861|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
154648862|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648863|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154648864|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648865|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
154648866|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648867|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154648868|NCT00783510|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154648869|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648870|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
154648871|NCT00712881|Docetaxel|docetaxel|mesh-list
154648872|NCT00712881|Doxorubicin|doxorubicin|mesh-list
154648873|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154648874|NCT00712881|Trastuzumab|trastuzumab|mesh-list
154648875|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648876|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
154648877|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648878|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648879|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154648880|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
154648881|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648882|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648883|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154648884|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
154648885|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
154648886|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
154648887|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154648888|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154648889|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154648890|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648891|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648892|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
154648893|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154648894|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154648895|NCT00568997|Analgesics|analgesics|mesh-ancestor
154648896|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
154648897|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648898|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648899|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648900|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648901|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
154648902|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154648903|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
154648904|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154648905|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648906|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648907|NCT00216294|Secretin|secretin|mesh-list
154648908|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154648909|NCT00216294|Hormones|hormones|mesh-ancestor
154648910|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648911|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648912|NCT00001337|Rituximab|rituximab|mesh-list
154648913|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154648914|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648915|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
154648916|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648917|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154648918|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
154648919|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154648920|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
154648921|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648922|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648923|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154648924|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154648925|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154648926|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154648927|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154648928|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
154648929|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154648930|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648931|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
154648932|NCT03111511|Drospirenone|drospirenone|mesh-list
154648933|NCT03111511|Midazolam|midazolam|mesh-list
154648934|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154648935|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154648936|NCT03111511|Betadex|betadex|mesh-list
154648937|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154648938|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154648939|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154648940|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648941|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154648942|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154648943|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154648944|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154648945|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
154648946|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
154648947|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
154648948|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
154648949|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154648950|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648951|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154648952|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
154648953|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648954|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154648955|NCT03111511|Diuretics|diuretics|mesh-ancestor
154648956|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
154648957|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154648958|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154648959|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154648960|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
154648961|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154648962|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154648963|NCT03111511|Estrogens|estrogens|mesh-ancestor
154648964|NCT03111511|Hormones|hormones|mesh-ancestor
154401029|NCT01373697|Ibuprofen|ibuprofen|mesh-list
154648965|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
154648966|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154648967|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
154648968|NCT03144115|Oxytocin|oxytocin|mesh-list
154648969|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
154648970|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154648971|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648972|NCT02326285|Docetaxel|docetaxel|mesh-list
154648973|NCT02326285|Gefitinib|gefitinib|mesh-list
154648974|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154648975|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
154648976|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
154648977|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
154648978|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154648979|NCT02326285|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154648980|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154648981|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154648982|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
154648983|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154648984|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154648985|NCT02332603|Prednisolone|prednisolone|mesh-list
154648986|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
154648987|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154648988|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
154648989|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154648990|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
154648991|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
154648992|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154648993|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154648994|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154648995|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
154648996|NCT02332603|Hormones|hormones|mesh-ancestor
154648997|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154648998|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154648999|NCT02332603|Protective Agents|protective agents|mesh-ancestor
154649000|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154649001|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649002|NCT02332447|Naloxone|naloxone|mesh-list
154649003|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154649004|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649005|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
154649006|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649007|NCT05077813|Vitamin D|vitamin d|mesh-list
154649008|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
154649009|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
154649010|NCT05077813|Vitamins|vitamins|mesh-list
154649011|NCT05077813|Minocycline|minocycline|mesh-list
154649012|NCT05077813|Tretinoin|tretinoin|mesh-list
154649013|NCT05077813|Alitretinoin|alitretinoin|mesh-list
154649014|NCT05077813|Isotretinoin|isotretinoin|mesh-list
154649015|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
154649016|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649017|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154649018|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154649019|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649020|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649021|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649022|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
154649023|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
154649024|NCT02326051|Enoxaparin|enoxaparin|mesh-list
154363854|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
154649025|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
154649026|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
154649027|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154649028|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154649029|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649030|NCT05076955|Vancomycin|vancomycin|mesh-list
154649031|NCT05076955|Tobramycin|tobramycin|mesh-list
154649032|NCT05076955|Itraconazole|itraconazole|mesh-list
154649033|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649034|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649035|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
154649036|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154649037|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154649038|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649039|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649040|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154649041|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
154649042|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649043|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649044|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154649046|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649047|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649048|NCT05075863|Letrozole|letrozole|mesh-list
154649049|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649050|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154649051|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154649052|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649053|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649054|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154649055|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
154649056|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649057|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649058|NCT02330419|Naltrexone|naltrexone|mesh-list
154649059|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154649060|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154649061|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649062|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
154649063|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649064|NCT05068141|Paclitaxel|paclitaxel|mesh-list
154649065|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154649066|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649067|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
154649068|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
154649069|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
154649070|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649071|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
154649072|NCT03142165|Promethazine|promethazine|mesh-list
154649073|NCT03142165|Famotidine|famotidine|mesh-list
154649074|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154649075|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154649076|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649077|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649078|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649079|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
154649080|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
154649081|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649082|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
154649083|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
154649084|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649085|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154649086|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
154649087|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
154649088|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649089|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649090|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154649091|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
154649092|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
154649093|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154649094|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154649095|NCT02330029|Pinaverium|pinaverium|mesh-list
154649096|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154649097|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649098|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649099|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154649100|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649101|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
154649102|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
154649103|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649104|NCT04988971|Corticosterone|corticosterone|mesh-list
154649105|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
154649106|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649107|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154649108|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
154649109|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
154649110|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649111|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649112|NCT02329795|Temozolomide|temozolomide|mesh-list
154649113|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154649114|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
153975835|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
154649115|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649116|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649117|NCT02329561|Tramadol|tramadol|mesh-list
154649118|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154649119|NCT02329561|Narcotics|narcotics|mesh-ancestor
154649120|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649121|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649122|NCT02329561|Analgesics|analgesics|mesh-ancestor
154649123|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
154363984|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
154649124|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649125|NCT03143491|Paclitaxel|paclitaxel|mesh-list
154649126|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154649127|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649128|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
154649129|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
154649130|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
154649131|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649132|NCT05002673|Anesthetics|anesthetics|mesh-list
154649133|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649134|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649135|NCT03076151|Tacrolimus|tacrolimus|mesh-list
154649136|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154649137|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
154649138|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649139|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154649140|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649141|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649142|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
154649143|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154649144|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154649145|NCT05002517|Prednisolone|prednisolone|mesh-list
154649146|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
154649147|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154649148|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
154649149|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649150|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
154649151|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
154649152|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649153|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649154|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649155|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
154649156|NCT05002517|Hormones|hormones|mesh-ancestor
154649157|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649158|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154649159|NCT05002517|Protective Agents|protective agents|mesh-ancestor
154649160|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154649161|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649162|NCT05002361|Dexamethasone|dexamethasone|mesh-list
154649163|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649164|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
154649165|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
154364025|NCT03374722|Analgesics|analgesics|mesh-ancestor
154649166|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649167|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649168|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649169|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
154649170|NCT05002361|Hormones|hormones|mesh-ancestor
154649171|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649172|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154649173|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649174|NCT02329405|Rifampin|rifampin|mesh-list
154649175|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154649176|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
154649177|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649178|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649179|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
154649180|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154649181|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649182|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649183|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154649184|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154649185|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154649186|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154649187|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154649188|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154649189|NCT02329171|Imiquimod|imiquimod|mesh-list
154649190|NCT02329171|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154649191|NCT02329171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649192|NCT02329171|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154649193|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
154649194|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649195|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154649196|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649197|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
154649198|NCT04498741|Midazolam|midazolam|mesh-list
154649199|NCT04498741|Dabigatran|dabigatran|mesh-list
154649200|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154649201|NCT04498741|Tacrolimus|tacrolimus|mesh-list
154649202|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154649203|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
154649204|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649205|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154649206|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649207|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649208|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154649209|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154649210|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649211|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154649212|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154649213|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154649214|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154649215|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
154649216|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
154649217|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
154649218|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
154649219|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649220|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154649221|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154649222|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
154649223|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154649224|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154649225|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
154649226|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154364068|NCT03628417|Bleomycin|bleomycin|mesh-list
154649227|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
154649228|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
154649229|NCT03551743|Edoxaban|edoxaban|mesh-list
154649230|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154649231|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
154649232|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154649233|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
154649234|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649235|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649236|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
154649237|NCT04654429|Ondansetron|ondansetron|mesh-list
154649238|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
154649239|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
154649240|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649241|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649242|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649243|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
154649244|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
154649245|NCT04654429|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154649246|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154649247|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
154649248|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649249|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649250|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
154649251|NCT03111121|Neostigmine|neostigmine|mesh-list
154649252|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154649253|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649254|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649255|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
154649256|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649257|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649258|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154649259|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
154649260|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649261|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154649262|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154649263|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154649264|NCT02328469|Doxycycline|doxycycline|mesh-list
154649265|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
154649266|NCT02328469|Acyclovir|acyclovir|mesh-list
154649267|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649268|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649269|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
154649270|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154649271|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154649272|NCT02328469|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154649273|NCT02328469|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154649274|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
154649275|NCT04998071|Bupivacaine|bupivacaine|mesh-list
154649276|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649277|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
154649278|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649279|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649280|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
154649281|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649282|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154649283|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649284|NCT03073343|Betaine|betaine|mesh-list
154649285|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649286|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
154649287|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154649288|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
154649289|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649290|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154649291|NCT03073265|Apixaban|apixaban|mesh-list
154649292|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154649293|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
154649294|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154649295|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
154649296|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649297|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649298|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
154649299|NCT04997837|Capecitabine|capecitabine|mesh-list
154649300|NCT04997837|Tegafur|tegafur|mesh-list
154649301|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
154649302|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154649303|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154649304|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
154649305|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649306|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649307|NCT04997837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154649308|NCT04202263|Minocycline|minocycline|mesh-list
154649309|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649310|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649311|NCT04996979|Ropivacaine|ropivacaine|mesh-list
154649312|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649313|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
154649314|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649315|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649316|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
154649317|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649318|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
154649319|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649320|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154649321|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649322|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649323|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
154649324|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649325|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649326|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154649327|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
154649328|NCT04997291|Razoxane|razoxane|mesh-list
154649329|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649330|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154649331|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154649332|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154649333|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649334|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649335|NCT04997291|Protective Agents|protective agents|mesh-ancestor
154649336|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649337|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
154649338|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
154649339|NCT02328079|Acyclovir|acyclovir|mesh-list
154649340|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
154649341|NCT02328079|Prednisolone|prednisolone|mesh-list
154649342|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154649344|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154649345|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
154649346|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154649347|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
154649348|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649349|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
154649350|NCT02328079|Hormones|hormones|mesh-ancestor
154649351|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649352|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649353|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154649354|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649355|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
154649356|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
154649357|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649358|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649359|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154649360|NCT02328079|Protective Agents|protective agents|mesh-ancestor
154649361|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649362|NCT04992377|Ibrutinib|ibrutinib|mesh-list
154649363|NCT04992377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154649364|NCT04992377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154649365|NCT04992377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649366|NCT04992377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649367|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
154649368|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154649369|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154649370|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154649371|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649372|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649373|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649374|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
154649375|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
154649376|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649377|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
154649378|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154649379|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
154649380|NCT02578069|Sirolimus|sirolimus|mesh-list
154649381|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649382|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649383|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154649384|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649385|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
154649386|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154649387|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
154649388|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649389|NCT03074825|Chiauranib|chiauranib|mesh-list
154649390|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649391|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154649392|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649393|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649394|NCT03072485|Metformin|metformin|mesh-list
154649395|NCT03072485|Sirolimus|sirolimus|mesh-list
154649396|NCT03072485|Diclofenac|diclofenac|mesh-list
154649397|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154649398|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649399|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649400|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649401|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154649402|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649403|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
154649404|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154649405|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
154649406|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649407|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649408|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154649409|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154649410|NCT03072485|Analgesics|analgesics|mesh-ancestor
154649411|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
154649412|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649413|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649414|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154649415|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154649416|NCT05080543|Terlipressin|terlipressin|mesh-list
154649417|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154649418|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154649419|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
154649420|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154649421|NCT03074591|Hematinics|hematinics|mesh-ancestor
154649422|NCT03111433|Ubiquinone|ubiquinone|mesh-list
154649423|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
154649424|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649425|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
154649426|NCT03111433|Vitamins|vitamins|mesh-ancestor
154649427|NCT03143023|Fluorides|fluorides|mesh-list
154649428|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
154649429|NCT03143023|Protective Agents|protective agents|mesh-ancestor
154649430|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649431|NCT03074435|Ivermectin|ivermectin|mesh-list
154649432|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154649433|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649434|NCT03142789|Cerivastatin|cerivastatin|mesh-list
154649435|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154649436|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154649437|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154649438|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
154649439|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649440|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649441|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154649442|NCT03072329|Bupivacaine|bupivacaine|mesh-list
154649443|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649444|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
154649445|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649446|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649447|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
154649448|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649449|NCT02327689|Emtricitabine|emtricitabine|mesh-list
154649450|NCT02327689|Adefovir|adefovir|mesh-list
154649451|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154649452|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
154649453|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649454|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154649455|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154649456|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649457|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649458|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154649459|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154649460|NCT02327923|Ketorolac|ketorolac|mesh-list
154649461|NCT02327923|Lidocaine|lidocaine|mesh-list
154649462|NCT02327923|Atropine|atropine|mesh-list
154649463|NCT02327923|Ephedrine|ephedrine|mesh-list
154649464|NCT02327923|Fentanyl|fentanyl|mesh-list
154649465|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
154649466|NCT02327923|Morphine|morphine|mesh-list
154649467|NCT02327923|Tramadol|tramadol|mesh-list
154649468|NCT02327923|Ondansetron|ondansetron|mesh-list
154649469|NCT02327923|Bupivacaine|bupivacaine|mesh-list
154649470|NCT02327923|Propofol|propofol|mesh-list
154649471|NCT02327923|Neostigmine|neostigmine|mesh-list
154649472|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
154649473|NCT02327923|Esmolol|esmolol|mesh-list
154649474|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649475|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
154649476|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649477|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649478|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
154649479|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649480|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154649481|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154649482|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154649483|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649484|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649485|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154649486|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154649487|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
154649488|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154649489|NCT02327923|Narcotics|narcotics|mesh-ancestor
154649490|NCT02327923|Analgesics|analgesics|mesh-ancestor
154649491|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154649492|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154649493|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
154649494|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
154649495|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649496|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
154649497|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
154649498|NCT02327923|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154649499|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154649500|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
154649501|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649502|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154649503|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649504|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154649505|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154649506|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649507|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154649508|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154649509|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
154649510|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
154649511|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
154649512|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154649513|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154649514|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
154649515|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154649516|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154649517|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154649518|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154649519|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154649520|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154649521|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154649522|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
154649523|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154649524|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154649525|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154649526|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154649527|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154649528|NCT04991207|Bosentan|bosentan|mesh-list
154649529|NCT04991207|Zamicastat|zamicastat|mesh-list
154649530|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154649531|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154649532|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649533|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649534|NCT03072173|Xylometazoline|xylometazoline|mesh-list
154649535|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
154649536|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154649537|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
154649538|NCT03074123|Cosyntropin|cosyntropin|mesh-list
154649539|NCT03074123|Hormones|hormones|mesh-ancestor
154649540|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649541|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649542|NCT02327299|Fesoterodine|fesoterodine|mesh-list
154649543|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154649544|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154649545|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
154649546|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649547|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649548|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649549|NCT02327299|Urological Agents|urological agents|mesh-ancestor
154649550|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
154649551|NCT03071549|Salicylates|salicylates|mesh-list
154649552|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649553|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
154649554|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
154649555|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
154649556|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154649557|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154649558|NCT03071549|Analgesics|analgesics|mesh-ancestor
154649559|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
154649560|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649561|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649562|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649563|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154649564|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154649565|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649566|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649567|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
154649568|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154649569|NCT04994951|Triamcinolone|triamcinolone|mesh-list
154649570|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154649571|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154649572|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154649573|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649574|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
154649575|NCT04994951|Hormones|hormones|mesh-ancestor
154649576|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649577|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649578|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154649579|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
154649580|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649581|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649582|NCT03073889|Ropivacaine|ropivacaine|mesh-list
154649583|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649584|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
154649585|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649586|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649587|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
154649588|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649589|NCT03071705|Metformin|metformin|mesh-list
154649590|NCT03071705|Gefitinib|gefitinib|mesh-list
154649591|NCT03071705|Afatinib|afatinib|mesh-list
154649592|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154649593|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649594|NCT03071705|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154649595|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154649596|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649597|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649598|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649599|NCT03351439|Celecoxib|celecoxib|mesh-list
154649600|NCT03351439|Naproxen|naproxen|mesh-list
154649601|NCT03351439|Gabapentin|gabapentin|mesh-list
154649602|NCT03351439|Zopiclone|zopiclone|mesh-list
154649603|NCT03351439|Analgesics|analgesics|mesh-ancestor
154649604|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
154649605|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649606|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649607|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
154649608|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154649609|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154649610|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649611|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154649612|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154649613|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154649614|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649615|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649616|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
154649617|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154649618|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154649619|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649620|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154649621|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154649622|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154649623|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649624|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
154649625|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154649626|NCT03139747|Everolimus|everolimus|mesh-list
154649627|NCT03139747|Lenvatinib|lenvatinib|mesh-list
154649628|NCT03139747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154649629|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154649630|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649631|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649632|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154649633|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
154649634|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649635|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649636|NCT03139591|Dexamethasone|dexamethasone|mesh-list
154649637|NCT03139591|Lidocaine|lidocaine|mesh-list
154649638|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649639|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
154649640|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
154649641|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649642|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649643|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649644|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
154649645|NCT03139591|Hormones|hormones|mesh-ancestor
154401677|NCT03055338|Risperidone|risperidone|mesh-list
154649646|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649647|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154649648|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649649|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649650|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
154649651|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649652|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
154649653|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154649654|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154649655|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154649656|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649657|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649658|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154649659|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154649660|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649661|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154649662|NCT03139513|Vemurafenib|vemurafenib|mesh-list
154649663|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649664|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154649665|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649666|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649667|NCT04986995|Opicapone|opicapone|mesh-list
154649668|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154649669|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649670|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649671|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154649672|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154649673|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154649674|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154649675|NCT03971929|Diuretics|diuretics|mesh-ancestor
154649676|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
154649677|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649678|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154649679|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649680|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649681|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
154649682|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154649683|NCT04986371|Niraparib|niraparib|mesh-list
154649684|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154649685|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649686|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649687|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649688|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
154649689|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154649690|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154649691|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649692|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
154649693|NCT03070847|Coagulants|coagulants|mesh-ancestor
154649694|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
154649695|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154649696|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154649697|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154649698|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649699|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649700|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
154649701|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649702|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649703|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154649704|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649705|NCT04989257|Clopidogrel|clopidogrel|mesh-list
154649706|NCT04989257|Ticagrelor|ticagrelor|mesh-list
154649707|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154649708|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154649709|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154649710|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154649711|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
154649712|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649713|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649714|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649715|NCT04892069|Insulin|insulin|mesh-list
154649716|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
154649717|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154649718|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649719|NCT03140449|Calcitriol|calcitriol|mesh-list
154649720|NCT03140449|Sirolimus|sirolimus|mesh-list
154649722|NCT03140449|MTOR Inhibitors|mtor inhibitors|mesh-list
154649723|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649724|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649725|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154649726|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649727|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
154649728|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154649729|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
154649730|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649731|NCT03140449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154649732|NCT03140449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649733|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649734|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154649735|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154649736|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649737|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154649738|NCT03140449|Vitamins|vitamins|mesh-ancestor
154649739|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
154649740|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154649741|NCT02659813|Copper|copper|mesh-list
154649742|NCT02659813|Nickel|nickel|mesh-list
154649743|NCT02659813|Trace Elements|trace elements|mesh-ancestor
154364571|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
154649744|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
154649745|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649746|NCT04985435|Adalimumab|adalimumab|mesh-list
154649747|NCT04985435|Etanercept|etanercept|mesh-list
154649748|NCT04985435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154649749|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154649750|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154649751|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154649752|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154649753|NCT04985435|Analgesics|analgesics|mesh-ancestor
154649754|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
154649755|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649756|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649757|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649758|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154649759|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
154649760|NCT03070613|Lectins|lectins|mesh-list
154649761|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
154649762|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
154649763|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649764|NCT03070613|Coagulants|coagulants|mesh-ancestor
154649765|NCT03441139|Analgesics|analgesics|mesh-list
154649766|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
154649767|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649768|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649769|NCT04988789|Paclitaxel|paclitaxel|mesh-list
154649770|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154649771|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649772|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
154649773|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
154649774|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
154649775|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649776|NCT04985669|Prucalopride|prucalopride|mesh-list
154649777|NCT04985669|Laxatives|laxatives|mesh-ancestor
154649778|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649779|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154649780|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154649781|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
154649782|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649783|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649784|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649785|NCT04753957|Progesterone|progesterone|mesh-list
154649786|NCT04753957|Progestins|progestins|mesh-ancestor
154649787|NCT04753957|Hormones|hormones|mesh-ancestor
154649788|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154649789|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649790|NCT03070379|Lidocaine|lidocaine|mesh-list
154649791|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649792|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
154649793|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364637|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
154649794|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649795|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
154401830|NCT03418727|Laxatives|laxatives|mesh-ancestor
154649796|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649797|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154649798|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154649799|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154649800|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649801|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649802|NCT03227263|Bevacizumab|bevacizumab|mesh-list
154649803|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154649804|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649805|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154649806|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154649807|NCT03227263|Growth Substances|growth substances|mesh-ancestor
154649808|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649809|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
154649811|NCT04985201|Simvastatin|simvastatin|mesh-list
154649812|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154649813|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154649814|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649815|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649816|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649817|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154649818|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154649819|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
154649820|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154649821|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154649822|NCT02031601|Carboplatin|carboplatin|mesh-list
154649823|NCT02031601|Docetaxel|docetaxel|mesh-list
154649824|NCT02031601|Pemetrexed|pemetrexed|mesh-list
154649825|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154649826|NCT02031601|Gefitinib|gefitinib|mesh-list
154649827|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649828|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
154649829|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
154649830|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
154649831|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649832|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649833|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154649834|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154649835|NCT02031601|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154649836|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154649837|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154649838|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154649839|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154649840|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
154649841|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649842|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154649843|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154649844|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154649845|NCT03068429|Sertraline|sertraline|mesh-list
154649846|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
154649847|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154649848|NCT03068429|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154649849|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154649850|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649851|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649852|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649853|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
154649854|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649855|NCT03068351|Daratumumab|daratumumab|mesh-list
154649856|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649857|NCT03140293|Lidocaine|lidocaine|mesh-list
154649858|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
154649859|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649860|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
154649861|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649862|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649863|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
154649864|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649865|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154649866|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154649867|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154649868|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649869|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649871|NCT04982861|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154649872|NCT04982861|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154649873|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154649874|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649875|NCT04572217|Topiramate|topiramate|mesh-list
154649876|NCT04572217|Phentermine|phentermine|mesh-list
154649877|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
154649878|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154649879|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649880|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154649881|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
154649882|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154649883|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
154649884|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
154649885|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649886|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
154649887|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649888|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649889|NCT05635955|Propofol|propofol|mesh-list
154649890|NCT05635955|Esketamine|esketamine|mesh-list
154649891|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154649892|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649893|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649894|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154649895|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
154649896|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
154649897|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
154649898|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154649899|NCT03137017|Acetaminophen|acetaminophen|mesh-list
154649900|NCT03137017|Hydrocodone|hydrocodone|mesh-list
154649901|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154649902|NCT03137017|Analgesics|analgesics|mesh-ancestor
154649903|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
154649904|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649905|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649906|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
154649907|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154649908|NCT03137017|Narcotics|narcotics|mesh-ancestor
154649909|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649910|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
154649911|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
154649912|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154649913|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154649914|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154649915|NCT04262479|Vitamin D|vitamin d|mesh-list
154649916|NCT04262479|Vitamins|vitamins|mesh-ancestor
154649917|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
154649918|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649919|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154649920|NCT04133311|Latanoprost|latanoprost|mesh-list
154649921|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154649922|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154649923|NCT03217825|Losartan|losartan|mesh-list
154649924|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154649925|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154649926|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154649927|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154649928|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649929|NCT00157963|Losartan|losartan|mesh-list
154649930|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154649931|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154649932|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154649933|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154649934|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154649935|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649936|NCT00157963|Diuretics|diuretics|mesh-ancestor
154649937|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
154649938|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649939|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154649940|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649941|NCT05087797|Nicorandil|nicorandil|mesh-list
154649942|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154649943|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154649944|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
154649945|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
154649946|NCT05087797|Vitamins|vitamins|mesh-ancestor
154649947|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
154649948|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649949|NCT03867799|Nivolumab|nivolumab|mesh-list
154649950|NCT03867799|Relatlimab|relatlimab|mesh-list
154649951|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154649952|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154649953|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154649954|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649955|NCT04873297|Metoclopramide|metoclopramide|mesh-list
154649956|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
154649957|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
154649958|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649959|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649960|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154649961|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154649962|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154649963|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
154649964|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649965|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649966|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
154649967|NCT05634473|Miotics|miotics|mesh-ancestor
154649968|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
154649969|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649970|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649971|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154649972|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154649973|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
154649974|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154649975|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154649976|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
154649977|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154649978|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649979|NCT04858711|Lidocaine|lidocaine|mesh-list
154649980|NCT04858711|Fentanyl|fentanyl|mesh-list
154649981|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
154649982|NCT04858711|Ketamine|ketamine|mesh-list
154649983|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
154649984|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
154649985|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154649986|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154649987|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
154649988|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154649989|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154649990|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154649991|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154649992|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154649993|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154649994|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154649995|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154649996|NCT04858711|Analgesics|analgesics|mesh-ancestor
154649997|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154649998|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154649999|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154650000|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
154650001|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650002|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154650003|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154650004|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
154650005|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154650006|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154650007|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154650008|NCT04858711|Narcotics|narcotics|mesh-ancestor
154650009|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154650010|NCT03068975|Alvimopan|alvimopan|mesh-list
154650011|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154650012|NCT02034331|Acetylcholine|acetylcholine|mesh-list
154650013|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650014|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
154650015|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154650016|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
154650017|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402050|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
154650018|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650019|NCT03067883|Ritonavir|ritonavir|mesh-list
154650020|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154650021|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154650022|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
154650023|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364874|NCT04523272|Sunitinib|sunitinib|mesh-list
154650024|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650025|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154650026|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154650027|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
154650028|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650029|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154650030|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154650031|NCT03285763|Atezolizumab|atezolizumab|mesh-list
154650032|NCT03285763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154650033|NCT03285763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650034|NCT03285763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650035|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650036|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154650037|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154650038|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650039|NCT03085771|Deferoxamine|deferoxamine|mesh-list
154650040|NCT03085771|Siderophores|siderophores|mesh-ancestor
154650041|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154650042|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
154650043|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
154650044|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650045|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154650046|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650047|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650048|NCT02985619|Triamcinolone|triamcinolone|mesh-list
154650049|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154650050|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154650051|NCT02985619|Bevacizumab|bevacizumab|mesh-list
154650052|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154650053|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650054|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650055|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154650056|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154650057|NCT02985619|Growth Substances|growth substances|mesh-ancestor
154650058|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650059|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
154364922|NCT03677401|Serlopitant|serlopitant|mesh-list
154650060|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154650061|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
154650062|NCT02985619|Hormones|hormones|mesh-ancestor
154650063|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154650064|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154650065|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
154650066|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650067|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650068|NCT03110653|Remifentanil|remifentanil|mesh-list
154650069|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154650070|NCT03110653|Narcotics|narcotics|mesh-ancestor
154650071|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650072|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650073|NCT03110653|Analgesics|analgesics|mesh-ancestor
154650074|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
154650075|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650076|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
154650077|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650078|NCT04450199|Vitamin D|vitamin d|mesh-list
154650079|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
154650080|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
154650081|NCT04450199|Vitamins|vitamins|mesh-list
154650082|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
154650083|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650084|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154650085|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154650086|NCT01884259|Docetaxel|docetaxel|mesh-list
154650087|NCT01884259|Fluorouracil|fluorouracil|mesh-list
154650088|NCT01884259|Cetuximab|cetuximab|mesh-list
154650089|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650090|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650091|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650092|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650093|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650094|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
154650095|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154650096|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154650097|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
154650098|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650099|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650100|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
154650101|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154650102|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650103|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154650104|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650105|NCT03067727|Dinoprostone|dinoprostone|mesh-list
154650106|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
154650107|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154650108|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650109|NCT01794793|Cabergoline|cabergoline|mesh-list
154650110|NCT01794793|Pasireotide|pasireotide|mesh-list
154650111|NCT01794793|Somatostatin|somatostatin|mesh-list
154650113|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154650114|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650115|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154650116|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154650117|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
154650118|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
154650119|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650120|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650121|NCT03067103|Ketamine|ketamine|mesh-list
154650122|NCT03067103|Tramadol|tramadol|mesh-list
154650123|NCT03067103|Analgesics|analgesics|mesh-ancestor
154650124|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
154650125|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650126|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650127|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154650128|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154650129|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
154650130|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
154650131|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650132|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154650133|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154650134|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650135|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650136|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154650137|NCT03067103|Narcotics|narcotics|mesh-ancestor
154650138|NCT01398319|Ethanol|ethanol|mesh-list
154650139|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154650140|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650141|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650142|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650143|NCT01305889|Sertraline|sertraline|mesh-list
154650144|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
154650145|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154650146|NCT01305889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154650147|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154650148|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650149|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650150|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650151|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
154650152|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650153|NCT00223171|Androgens|androgens|mesh-list
154650154|NCT00223171|Hormones|hormones|mesh-ancestor
154650155|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154650156|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650157|NCT03138031|Ethanol|ethanol|mesh-list
154650158|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154650159|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650160|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650161|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650162|NCT05431283|Tofacitinib|tofacitinib|mesh-list
154650163|NCT05431283|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154650164|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154650165|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650166|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650167|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
154650168|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154650169|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
154650170|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154650171|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650172|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154650173|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
154650174|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650175|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
154650176|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650177|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650178|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154650179|NCT03630835|Annexin A5|annexin a5|mesh-list
154650180|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650181|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650182|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
154650183|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154650184|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650185|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154650186|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650187|NCT05391451|Anesthetics|anesthetics|mesh-list
154650188|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650189|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650190|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
154650191|NCT03110341|Hematinics|hematinics|mesh-ancestor
154650192|NCT04405063|Paclitaxel|paclitaxel|mesh-list
154650193|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650194|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650195|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650196|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650197|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650198|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650199|NCT05090449|Losartan|losartan|mesh-list
154650200|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
154650201|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154650202|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154650203|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154650204|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154650205|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650206|NCT05090449|Diuretics|diuretics|mesh-ancestor
154650207|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
154365063|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
154650208|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650209|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154650210|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650211|NCT05090137|Diuretics|diuretics|mesh-list
154650212|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
154650213|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650214|NCT03067415|Latanoprost|latanoprost|mesh-list
154650215|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154650216|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154650217|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
154650218|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154650219|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
154650220|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650221|NCT05089981|Expectorants|expectorants|mesh-ancestor
154650222|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
154650223|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154650224|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
154650225|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650226|NCT05089981|Protective Agents|protective agents|mesh-ancestor
154650227|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650228|NCT05089981|Antidotes|antidotes|mesh-ancestor
154650229|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
154650230|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154650231|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650232|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650233|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154650234|NCT04206059|Analgesics|analgesics|mesh-ancestor
154650235|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
154650236|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650237|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154650238|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154650239|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154402273|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
154650240|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
154650241|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650242|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365105|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650243|NCT05431049|Anesthetics|anesthetics|mesh-list
154650244|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650245|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650246|NCT04132817|Paclitaxel|paclitaxel|mesh-list
154650247|NCT04132817|Nivolumab|nivolumab|mesh-list
154650248|NCT04132817|Ipilimumab|ipilimumab|mesh-list
154650249|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650250|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650251|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650252|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650253|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650254|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650255|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650256|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154650257|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
154650258|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154650259|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154650260|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154650261|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650262|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650263|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
154650264|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650265|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650266|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154650267|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650268|NCT03136237|Cyclosporine|cyclosporine|mesh-list
154650269|NCT03136237|Digoxin|digoxin|mesh-list
154650270|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154650271|NCT03136237|Cyclosporins|cyclosporins|mesh-list
154650272|NCT03136237|Berotralstat|berotralstat|mesh-list
154650273|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650274|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650275|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154650276|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
154650277|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650278|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
154650279|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650280|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
154650281|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650282|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154650283|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154650284|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154650285|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
154650286|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154650287|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154650288|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154650289|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154650290|NCT03136237|Protective Agents|protective agents|mesh-ancestor
154650291|NCT03136237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154365154|NCT04445194|Vaccines|vaccines|mesh-list
154650292|NCT03136237|Protease Inhibitors|protease inhibitors|mesh-ancestor
154650293|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
154650294|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154650295|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
154650296|NCT04021381|Cathartics|cathartics|mesh-ancestor
154650297|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154650298|NCT03066791|Curcumin|curcumin|mesh-list
154650299|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154650300|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154650301|NCT03066791|Analgesics|analgesics|mesh-ancestor
154650302|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
154650303|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650304|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650305|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154650306|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650307|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650308|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650309|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650310|NCT05729555|Diphenhydramine|diphenhydramine|mesh-list
154650311|NCT05729555|Promethazine|promethazine|mesh-list
154650312|NCT05729555|Ibuprofen|ibuprofen|mesh-list
154650313|NCT05729555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154650314|NCT05729555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154650315|NCT05729555|Analgesics|analgesics|mesh-ancestor
154650316|NCT05729555|Sensory System Agents|sensory system agents|mesh-ancestor
154650317|NCT05729555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650318|NCT05729555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650319|NCT05729555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154650320|NCT05729555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650321|NCT05729555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154650322|NCT05729555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650323|NCT05729555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650324|NCT05729555|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154650325|NCT05729555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154650326|NCT05729555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650327|NCT05729555|Anesthetics, Local|anesthetics, local|mesh-ancestor
154650328|NCT05729555|Anesthetics|anesthetics|mesh-ancestor
154650329|NCT05729555|Antiemetics|antiemetics|mesh-ancestor
154650330|NCT05729555|Autonomic Agents|autonomic agents|mesh-ancestor
154650331|NCT05729555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154650332|NCT05729555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154650333|NCT05729555|Histamine Antagonists|histamine antagonists|mesh-ancestor
154650334|NCT05729555|Histamine Agents|histamine agents|mesh-ancestor
154650335|NCT05729555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650336|NCT05729555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154650337|NCT05729555|Antipruritics|antipruritics|mesh-ancestor
154650338|NCT05729555|Dermatologic Agents|dermatologic agents|mesh-ancestor
154650339|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154650340|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154650341|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650342|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650343|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154650344|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650345|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650346|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
154650347|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650348|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154650349|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154650350|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154650351|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154650352|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
154650353|NCT03136003|Coagulants|coagulants|mesh-ancestor
154650354|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154650355|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
154650356|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650357|NCT05410847|Paclitaxel|paclitaxel|mesh-list
154650358|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650359|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650360|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650361|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650362|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650363|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650364|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
154650365|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154650366|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154650367|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154650368|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650369|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650370|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
154650371|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650372|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650373|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154650374|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650375|NCT03726749|Prednisone|prednisone|mesh-list
154650376|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
154650377|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154650378|NCT03726749|Hormones|hormones|mesh-ancestor
154650379|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154650380|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650381|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154650382|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650383|NCT03821077|Immunomodulating Agents|immunomodulating agents|mesh-list
154650384|NCT03821077|Immunologic Factors|immunologic factors|mesh-ancestor
154650385|NCT03821077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650386|NCT03066557|Apatinib|apatinib|mesh-list
154650387|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
154650388|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650389|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154650390|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650391|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650392|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154650393|NCT03066557|Estrogens|estrogens|mesh-ancestor
154650394|NCT03066557|Hormones|hormones|mesh-ancestor
154650395|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154650396|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650397|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154650398|NCT05737303|Paclitaxel|paclitaxel|mesh-list
154650399|NCT05737303|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154650400|NCT05737303|Carboplatin|carboplatin|mesh-list
154650401|NCT05737303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650402|NCT05737303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650403|NCT05737303|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650404|NCT05737303|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650405|NCT05737303|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650406|NCT05737303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650407|NCT03066089|Fenugreek seed meal|fenugreek seed meal|mesh-list
154650408|NCT03066089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154650409|NCT03066089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650410|NCT05188313|Paclitaxel|paclitaxel|mesh-list
154650411|NCT05188313|Carboplatin|carboplatin|mesh-list
154650412|NCT05188313|Trastuzumab|trastuzumab|mesh-list
154650413|NCT05188313|Pertuzumab|pertuzumab|mesh-list
154650414|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650415|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650416|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650417|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650418|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650419|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650420|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650421|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154650422|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650423|NCT03066011|Voriconazole|voriconazole|mesh-list
154650424|NCT03066011|Posaconazole|posaconazole|mesh-list
154650425|NCT03066011|Isavuconazole|isavuconazole|mesh-list
154650426|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
154650427|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650428|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154650429|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154650430|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650431|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650432|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154650433|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
154650434|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154650435|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650436|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154650437|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154650438|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154650439|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154650440|NCT03135769|Avelumab|avelumab|mesh-list
154650441|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650442|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650443|NCT03123211|Veliparib|veliparib|mesh-list
154650444|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154650445|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650446|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650447|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650448|NCT05520749|Luspatercept|luspatercept|mesh-list
154650449|NCT05520749|Hematinics|hematinics|mesh-ancestor
154650450|NCT03073525|Atezolizumab|atezolizumab|mesh-list
154650451|NCT03073525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154650452|NCT03073525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650453|NCT03073525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650454|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650455|NCT02563015|Vitamin D|vitamin d|mesh-list
154650456|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
154650457|NCT02563015|Vitamins|vitamins|mesh-ancestor
154650458|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
154650459|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650460|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154650461|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154650462|NCT02382445|Anesthetics|anesthetics|mesh-list
154650463|NCT02382445|Propofol|propofol|mesh-list
154650464|NCT02382445|Sevoflurane|sevoflurane|mesh-list
154650465|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650466|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650467|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154650468|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154650469|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
154650470|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154650471|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154650472|NCT05736757|Plasminogen|plasminogen|mesh-list
154650473|NCT05736757|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154650474|NCT05736757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154650475|NCT05736757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154650476|NCT05736757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650477|NCT05091775|Mesalamine|mesalamine|mesh-list
154650478|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154650479|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154650480|NCT05091775|Analgesics|analgesics|mesh-ancestor
154650481|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
154650482|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650483|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650484|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154650485|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650486|NCT04821869|Albuterol|albuterol|mesh-list
154650487|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154650488|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
154650489|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650490|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650491|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154650492|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
154650493|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154650494|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154650495|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154650496|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
154650497|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650498|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650499|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
154650500|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154650501|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
154650502|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154650503|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
154650504|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650505|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
154650506|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154650507|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154650508|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
154650509|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154650510|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154650511|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154650512|NCT02631551|Analgesics|analgesics|mesh-ancestor
154650513|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
154650514|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650515|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650516|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650517|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154650518|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154650519|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
154650520|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
154650521|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650522|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650523|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
154650524|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154650525|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650526|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650527|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154650528|NCT05091151|Analgesics|analgesics|mesh-ancestor
154650529|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
154650530|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650531|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154650532|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154650533|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154650534|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
154650535|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650536|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650537|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
154650538|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650540|NCT04447235|Losartan|losartan|mesh-list
154650541|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154650542|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154650543|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154650544|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154650545|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650546|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154650547|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650548|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
154650549|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650550|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650551|NCT01700569|Leucovorin|leucovorin|mesh-list
154650552|NCT01700569|Folic Acid|folic acid|mesh-list
154650553|NCT01700569|Temozolomide|temozolomide|mesh-list
154650554|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
154650555|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650556|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154650557|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
154650558|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650559|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650560|NCT01700569|Antidotes|antidotes|mesh-ancestor
154650561|NCT01700569|Protective Agents|protective agents|mesh-ancestor
154650562|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
154650563|NCT01700569|Vitamins|vitamins|mesh-ancestor
154650564|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
154650565|NCT01700569|Hematinics|hematinics|mesh-ancestor
154650566|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
154650567|NCT05090761|Buprenorphine|buprenorphine|mesh-list
154650568|NCT05090761|Bupivacaine|bupivacaine|mesh-list
154650569|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154650570|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
154650571|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
154650572|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650573|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650574|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
154650575|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650576|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154650577|NCT05090761|Narcotics|narcotics|mesh-ancestor
154650578|NCT05090761|Analgesics|analgesics|mesh-ancestor
154650579|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154650580|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154650581|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
154650582|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154650583|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650584|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650585|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154650586|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
154650587|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154650588|NCT03065309|Remifentanil|remifentanil|mesh-list
154650589|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154650590|NCT03065309|Narcotics|narcotics|mesh-ancestor
154650591|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650592|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650593|NCT03065309|Analgesics|analgesics|mesh-ancestor
154650594|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
154650595|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650596|NCT02819479|Bevacizumab|bevacizumab|mesh-list
154650597|NCT02819479|Mannitol|mannitol|mesh-list
154650598|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650599|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650600|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154650601|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154650602|NCT02819479|Growth Substances|growth substances|mesh-ancestor
154650603|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650604|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
154650605|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154650606|NCT02819479|Diuretics|diuretics|mesh-ancestor
154650607|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
154650608|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
154650609|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650610|NCT04074785|Bevacizumab|bevacizumab|mesh-list
154650611|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650612|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650613|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154650614|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154650615|NCT04074785|Growth Substances|growth substances|mesh-ancestor
154650616|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650617|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
154650618|NCT04533841|Propranolol|propranolol|mesh-list
154650619|NCT04533841|Misoprostol|misoprostol|mesh-list
154650620|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154650621|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
154650622|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154650623|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650624|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154650625|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154650626|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
154650627|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154650628|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154650629|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
154650630|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650631|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650632|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154650633|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154650634|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
154650635|NCT05376865|Vitamin D|vitamin d|mesh-list
154650636|NCT05376865|Vitamins|vitamins|mesh-ancestor
154650637|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
154650638|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650639|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154650640|NCT04064411|Abaloparatide|abaloparatide|mesh-list
154650641|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
154650642|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154650643|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650644|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154650645|NCT04012931|Rilpivirine|rilpivirine|mesh-list
154650646|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154650647|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154650648|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650649|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650650|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
154650651|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650652|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154650653|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154650654|NCT03063359|Fentanyl|fentanyl|mesh-list
154650655|NCT03063359|Morphine|morphine|mesh-list
154650656|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154650657|NCT03063359|Narcotics|narcotics|mesh-ancestor
154650658|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650659|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650660|NCT03063359|Analgesics|analgesics|mesh-ancestor
154650661|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
154650662|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650663|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154650664|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154650665|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
154650666|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
154650667|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
154650668|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
154650669|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154650670|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154650671|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154650672|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650673|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650674|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
154650675|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650676|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650677|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154650678|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650679|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
154650680|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
154650681|NCT02660359|Coagulants|coagulants|mesh-ancestor
154650682|NCT05067985|Anesthetics|anesthetics|mesh-list
154650683|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650684|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650685|NCT04262869|Paclitaxel|paclitaxel|mesh-list
154650686|NCT04262869|Carboplatin|carboplatin|mesh-list
154650687|NCT04262869|Pemetrexed|pemetrexed|mesh-list
154650688|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154650689|NCT04262869|Durvalumab|durvalumab|mesh-list
154650690|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
154650691|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154650692|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
154650693|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650694|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650695|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650696|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650697|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
154365535|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650698|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650699|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650700|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154650701|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154650702|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650703|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
154650704|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650705|NCT03062813|Entecavir|entecavir|mesh-list
154650706|NCT03062813|Tacrolimus|tacrolimus|mesh-list
154650707|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154650708|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
154650709|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650710|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154650711|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650712|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650713|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
154650714|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650715|NCT04582981|Raltitrexed|raltitrexed|mesh-list
154650716|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154650717|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
154650718|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650719|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650720|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154650721|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650722|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
154650723|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154650724|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
154650725|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650726|NCT04531579|Valproic Acid|valproic acid|mesh-list
154650727|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154650728|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
154650729|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650730|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650731|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
154650732|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650733|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650734|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
154650735|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154650736|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650737|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154650738|NCT05097781|Antibodies|antibodies|mesh-list
154650739|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
154650740|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
154650741|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650742|NCT01117441|Cytarabine|cytarabine|mesh-list
154650743|NCT01117441|Dexamethasone|dexamethasone|mesh-list
154650744|NCT01117441|Prednisone|prednisone|mesh-list
154650745|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
154650746|NCT01117441|Ifosfamide|ifosfamide|mesh-list
154650747|NCT01117441|Doxorubicin|doxorubicin|mesh-list
154650748|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154650749|NCT01117441|Methotrexate|methotrexate|mesh-list
154650750|NCT01117441|Fludarabine|fludarabine|mesh-list
154650751|NCT01117441|Etoposide|etoposide|mesh-list
154650752|NCT01117441|Vincristine|vincristine|mesh-list
154650753|NCT01117441|Daunorubicin|daunorubicin|mesh-list
154650754|NCT01117441|Asparaginase|asparaginase|mesh-list
154650755|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
154650756|NCT01117441|Thioguanine|thioguanine|mesh-list
154650757|NCT01117441|Pegaspargase|pegaspargase|mesh-list
154650758|NCT01117441|Vindesine|vindesine|mesh-list
154650759|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154650760|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
154650761|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650762|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650763|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154650764|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
154650765|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650766|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650767|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154650768|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154650769|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
154650770|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
154650771|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650772|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154650773|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
154650774|NCT01117441|Hormones|hormones|mesh-ancestor
154650775|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154650776|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154650777|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154650778|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154650779|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154650780|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650781|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154650782|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
154650783|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154650784|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154650785|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
154650786|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
154650787|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154650788|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154650789|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650790|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
154650791|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650792|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650793|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650794|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650795|NCT01101451|Cisplatin|cisplatin|mesh-list
154650796|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650797|NCT03656627|Nivolumab|nivolumab|mesh-list
154650798|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650799|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650800|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154650801|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650802|NCT04759703|Pramipexole|pramipexole|mesh-list
154650803|NCT04759703|Dexpramipexole|dexpramipexole|mesh-list
154650804|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
154650805|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650806|NCT04759703|Protective Agents|protective agents|mesh-ancestor
154650807|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650808|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154650809|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154650810|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
154650811|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
154650812|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650813|NCT05026801|Azithromycin|azithromycin|mesh-list
154650814|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
154650815|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154650816|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650817|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
154650818|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154650819|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154650820|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650821|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650822|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650823|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
154650824|NCT03493061|Irinotecan|irinotecan|mesh-list
154650825|NCT03493061|Floxuridine|floxuridine|mesh-list
154650826|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650827|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154650828|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154650829|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650830|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650831|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154650832|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
154650833|NCT04523935|Topiramate|topiramate|mesh-list
154650834|NCT04523935|Lamotrigine|lamotrigine|mesh-list
154650835|NCT04523935|Diazepam|diazepam|mesh-list
154650836|NCT04523935|Gabapentin|gabapentin|mesh-list
154650837|NCT04523935|Amitriptyline|amitriptyline|mesh-list
154650838|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
154650839|NCT04523935|Clonazepam|clonazepam|mesh-list
154650840|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
154650841|NCT04523935|Baclofen|baclofen|mesh-list
154650842|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
154650843|NCT04523935|Analgesics|analgesics|mesh-ancestor
154650844|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
154402867|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154650845|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650846|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650847|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154650848|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154650849|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650850|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154650851|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154650852|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154650853|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650854|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650855|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
154650856|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154650857|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154650858|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650859|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154650860|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154650861|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154650862|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154650863|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154650864|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154650865|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
154650866|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
154650867|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154650868|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
154650869|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154650870|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154650871|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154650872|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
154650873|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154650874|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
154650875|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
154650876|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154650877|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154650878|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154650879|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
154650880|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
154650881|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
154650882|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154650883|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154650884|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154650885|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154650886|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
154650887|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
154650888|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154650889|NCT01938430|Ledipasvir|ledipasvir|mesh-list
154650890|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
154650891|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650892|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154650893|NCT01916824|Mirtazapine|mirtazapine|mesh-list
154650894|NCT01916824|Citalopram|citalopram|mesh-list
154650895|NCT01916824|Bupropion|bupropion|mesh-list
154650896|NCT01916824|Fluoxetine|fluoxetine|mesh-list
154650897|NCT01916824|Paroxetine|paroxetine|mesh-list
154650898|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154650899|NCT01916824|Sertraline|sertraline|mesh-list
154650900|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
154650901|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154650902|NCT01916824|Escitalopram|escitalopram|mesh-list
154650903|NCT01916824|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154650904|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154650905|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154650906|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650907|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650908|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
154650909|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650910|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154650911|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154650912|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154650913|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154650914|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
154650915|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154650916|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154650917|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650918|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154650919|NCT01916824|Analgesics|analgesics|mesh-ancestor
154650920|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
154650921|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154650922|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
154650923|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
154650924|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154650925|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154650926|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154650927|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154650928|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154650929|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154650930|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
154650931|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154650932|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154650933|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154650934|NCT01915732|Clindamycin|clindamycin|mesh-list
154650935|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
154650936|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
154650937|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154650938|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154650939|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154650940|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650941|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650942|NCT01936870|Fesoterodine|fesoterodine|mesh-list
154650943|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154650944|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154650945|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
154650946|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154650947|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650948|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650949|NCT01936870|Urological Agents|urological agents|mesh-ancestor
154650951|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
154650952|NCT01618708|Protective Agents|protective agents|mesh-ancestor
154650953|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650954|NCT02229149|Paclitaxel|paclitaxel|mesh-list
154650955|NCT02229149|Vinorelbine|vinorelbine|mesh-list
154650956|NCT02229149|Docetaxel|docetaxel|mesh-list
154650957|NCT02229149|Capecitabine|capecitabine|mesh-list
154650958|NCT02229149|Trastuzumab|trastuzumab|mesh-list
154650959|NCT02229149|Pertuzumab|pertuzumab|mesh-list
154650960|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650961|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650962|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650963|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650964|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650965|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650966|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154650967|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
154650968|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154650969|NCT04440371|Betamethasone|betamethasone|mesh-list
154650970|NCT04440371|Calcipotriene|calcipotriene|mesh-list
154650971|NCT04440371|Tacrolimus|tacrolimus|mesh-list
154650972|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154650973|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
154650974|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154650975|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154650976|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650977|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650978|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154650979|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
154650980|NCT04440371|Hormones|hormones|mesh-ancestor
154650981|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154650982|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154650983|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
154650984|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
154650985|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
154650986|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650987|NCT04982549|Paclitaxel|paclitaxel|mesh-list
154650988|NCT04982549|Carboplatin|carboplatin|mesh-list
154650989|NCT04982549|Pemetrexed|pemetrexed|mesh-list
154650990|NCT04982549|Durvalumab|durvalumab|mesh-list
154650991|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154650992|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154650993|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
154650994|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
154650995|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
154650996|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154650997|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154650998|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154650999|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154651000|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651002|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
154651003|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651004|NCT00790933|Vedolizumab|vedolizumab|mesh-list
154651005|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651006|NCT04981457|Misoprostol|misoprostol|mesh-list
154651007|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154651008|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
154651009|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154651010|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651011|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154651012|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651013|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
154651014|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154651015|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
154651016|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651017|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
154651018|NCT04981379|Favipiravir|favipiravir|mesh-list
154651019|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
154651020|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154651021|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154651022|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651023|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651024|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651025|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651026|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
154651027|NCT04389775|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154651028|NCT04389775|Glucagon|glucagon|mesh-list
154651029|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154651030|NCT04389775|Incretins|incretins|mesh-ancestor
154651031|NCT04389775|Hormones|hormones|mesh-ancestor
154651032|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154651033|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651034|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651035|NCT04389775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154651036|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
154651037|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651038|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
154651039|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651040|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651041|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154651042|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
154651043|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154651044|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154651045|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651046|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
154651047|NCT02926651|Coagulants|coagulants|mesh-ancestor
154651048|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
154651049|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
154651050|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651051|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651052|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651053|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
154651054|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
154651055|NCT04188145|Bevacizumab|bevacizumab|mesh-list
154651056|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651057|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651058|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154651059|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154651060|NCT04188145|Growth Substances|growth substances|mesh-ancestor
154651061|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651062|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
154651063|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
154651064|NCT03063983|Methotrexate|methotrexate|mesh-list
154651065|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154651066|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
154651067|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651068|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651069|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154651070|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
154651071|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651072|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651073|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154651074|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154651075|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
154651076|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154651077|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154651078|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
154651079|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
154651080|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651081|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154651082|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154651083|NCT03945721|Niraparib|niraparib|mesh-list
154651084|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154651085|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651086|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651087|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651088|NCT01876355|Clonidine|clonidine|mesh-list
154651089|NCT01876355|Analgesics|analgesics|mesh-ancestor
154651090|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
154651091|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651092|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651093|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154651094|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
154651095|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
154651096|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154651097|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154651098|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154651099|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
154651100|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651101|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651102|NCT02747407|Vaccines|vaccines|mesh-list
154651103|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
154651104|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651105|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
154651106|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154651107|NCT01870193|Glycine|glycine|mesh-list
154651108|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
154651109|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651110|NCT01870193|Expectorants|expectorants|mesh-ancestor
154651111|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
154651112|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154651113|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
154651114|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651115|NCT01870193|Protective Agents|protective agents|mesh-ancestor
154651116|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651117|NCT01870193|Antidotes|antidotes|mesh-ancestor
154651118|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
154651119|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651120|NCT03063905|Buprenorphine|buprenorphine|mesh-list
154651121|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154651122|NCT03063905|Narcotics|narcotics|mesh-ancestor
154651123|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651124|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651125|NCT03063905|Analgesics|analgesics|mesh-ancestor
154651126|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
154651127|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651128|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154651129|NCT04432415|Fluorides|fluorides|mesh-list
154651130|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
154651131|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
154651132|NCT04432415|Protective Agents|protective agents|mesh-ancestor
154651133|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651134|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
154651135|NCT03063671|Ketamine|ketamine|mesh-list
154651136|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154651137|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651138|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651139|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154651140|NCT03063671|Analgesics|analgesics|mesh-ancestor
154651141|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
154651142|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651143|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154651144|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154651145|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154651146|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
154651147|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651148|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651149|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154651150|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154651151|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
154651152|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
154651153|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154651154|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154651155|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154651156|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154651157|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154651158|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651159|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651160|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154651161|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154651162|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651163|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
154651164|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651165|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
154651166|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154651167|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
154651168|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651169|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651170|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154651171|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154651172|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154651173|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
154651174|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154651175|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
154651176|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154651177|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651178|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154651179|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154651180|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651181|NCT02958709|Rifampin|rifampin|mesh-list
154651182|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154651183|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
154651184|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154651185|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651186|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
154651187|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154651188|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651189|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651190|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154651191|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154651192|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154651193|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154651194|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154651195|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154651196|NCT04979663|Gemcitabine|gemcitabine|mesh-list
154651197|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
154651198|NCT04979663|Tislelizumab|tislelizumab|mesh-list
154651199|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154651200|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
154651201|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651202|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651203|NCT04979663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651204|NCT04979585|Paclitaxel|paclitaxel|mesh-list
154651205|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154651206|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651207|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
154651208|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
154651209|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
154651210|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651211|NCT05103397|Prednisolone|prednisolone|mesh-list
154651212|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154651213|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
154651214|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154651215|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
154651216|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154651217|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
154651218|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154651219|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
154651220|NCT05103397|Hormones|hormones|mesh-ancestor
154651221|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154651222|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403243|NCT03706157|Doxorubicin|doxorubicin|mesh-list
154651223|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154651224|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651225|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
154651226|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
154651227|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651228|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651229|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154651230|NCT05103397|Protective Agents|protective agents|mesh-ancestor
154651231|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
154651232|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154651233|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651234|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154651235|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
154651236|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154651237|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651238|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651239|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651240|NCT05101291|Bupivacaine|bupivacaine|mesh-list
154651241|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
154651242|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
154651243|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651244|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651245|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
154651246|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651247|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
154651248|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
154651249|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154651250|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154651251|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651252|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651253|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651254|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651255|NCT04979273|Epinephrine|epinephrine|mesh-list
154651256|NCT04979273|Racepinephrine|racepinephrine|mesh-list
154651257|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
154651258|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154651259|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154651260|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
154651261|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651262|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651263|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651264|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154651265|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154651266|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
154651267|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651268|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154651269|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
154651270|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
154651271|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
154651272|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154651273|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
154651274|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154651275|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154651276|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651277|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
154651278|NCT05092555|Coagulants|coagulants|mesh-ancestor
154651279|NCT05036473|Levodopa|levodopa|mesh-list
154651280|NCT05036473|Carbidopa|carbidopa|mesh-list
154651281|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154651282|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154651283|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154651284|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
154651285|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651286|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651287|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651288|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154651289|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651290|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154651291|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
154651292|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
154651293|NCT04985851|Durvalumab|durvalumab|mesh-list
154651294|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154651295|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651296|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651297|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
154651298|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651299|NCT05099575|Oxytocin|oxytocin|mesh-list
154651300|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
154651301|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154651302|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651303|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154651304|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154651305|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651306|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651307|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
154651308|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651309|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651310|NCT04973579|Anesthetics|anesthetics|mesh-list
154651311|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651312|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651313|NCT04834063|Selenium|selenium|mesh-list
154651314|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
154651315|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651316|NCT04834063|Protective Agents|protective agents|mesh-ancestor
154651317|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651318|NCT04834063|Trace Elements|trace elements|mesh-ancestor
154651319|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
154651320|NCT04794205|Caryophyllene|caryophyllene|mesh-list
154651321|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154651322|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154651323|NCT04794205|Analgesics|analgesics|mesh-ancestor
154651324|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
154651325|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651326|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651327|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154651328|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651329|NCT04973033|Tofacitinib|tofacitinib|mesh-list
154651330|NCT04973033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154651331|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154651332|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651333|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651334|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
154651335|NCT02660281|Melphalan|melphalan|mesh-list
154651336|NCT02660281|Busulfan|busulfan|mesh-list
154651337|NCT02660281|Thiotepa|thiotepa|mesh-list
154651338|NCT02660281|Fludarabine|fludarabine|mesh-list
154651339|NCT02660281|Mesna|mesna|mesh-list
154651340|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154651341|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
154651342|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651343|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651344|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154651345|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
154651346|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651347|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651348|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154651349|NCT02660281|Protective Agents|protective agents|mesh-ancestor
154651350|NCT02438995|Cetuximab|cetuximab|mesh-list
154651351|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651352|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651353|NCT01669811|Esomeprazole|esomeprazole|mesh-list
154651354|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154651355|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651356|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154651357|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651358|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651359|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154651360|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154651361|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154651362|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651363|NCT04437017|Dexamethasone|dexamethasone|mesh-list
154651364|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
154651365|NCT04437017|Olanzapine|olanzapine|mesh-list
154651366|NCT04437017|Serotonin|serotonin|mesh-list
154651367|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154651368|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
154651369|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
154651370|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651371|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651372|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651373|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
154651374|NCT04437017|Hormones|hormones|mesh-ancestor
154860329|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154651375|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154651376|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154651377|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651378|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154651379|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154651380|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651381|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154651382|NCT04437017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154651383|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154651384|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154651385|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651386|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651387|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
154651388|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154651389|NCT03061253|Nicotine|nicotine|mesh-list
154651390|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154651391|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
154651392|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651393|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651394|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154651395|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154651396|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
154651397|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651398|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651399|NCT05107063|Pravastatin|pravastatin|mesh-list
154651400|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154651401|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154651402|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
154651403|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651404|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154651405|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154651406|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651407|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
154651408|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154651409|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
154651410|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651411|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
154366257|NCT03235050|Hormones|hormones|mesh-ancestor
154651412|NCT05106751|Protective Agents|protective agents|mesh-ancestor
154651413|NCT04977557|Thiamine|thiamine|mesh-list
154651414|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
154651415|NCT04977557|Vitamins|vitamins|mesh-ancestor
154651416|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
154651417|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651418|NCT04316143|Zamicastat|zamicastat|mesh-list
154651419|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651420|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651421|NCT05104801|Tislelizumab|tislelizumab|mesh-list
154651422|NCT05104801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651423|NCT05104801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651424|NCT04530877|Infliximab|infliximab|mesh-list
154651425|NCT04530877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154651426|NCT04530877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154651427|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
154651428|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651429|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651430|NCT04971239|Methotrexate|methotrexate|mesh-list
154651431|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154651432|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
154651433|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154651434|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651435|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154651436|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
154651437|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651438|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651439|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
154651440|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651441|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154651442|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154651443|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
154651444|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651445|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154651446|NCT04903093|Famotidine|famotidine|mesh-list
154651447|NCT04903093|Abrocitinib|abrocitinib|mesh-list
154651448|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154651449|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651450|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154651451|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
154651452|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
154651453|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651454|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651455|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651456|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154651457|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651458|NCT04529785|Ethanol|ethanol|mesh-list
154651459|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154651460|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651461|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651462|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651463|NCT04271293|Edoxaban|edoxaban|mesh-list
154651464|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154651465|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
154651466|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154651467|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
154651468|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366314|NCT01292993|Metformin|metformin|mesh-list
154651469|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651470|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
154651471|NCT03059849|Adalimumab|adalimumab|mesh-list
154651472|NCT03059849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154651473|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154651474|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651475|NCT04970693|Aflutinib|aflutinib|mesh-list
154651476|NCT04970693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154651477|NCT04970693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651478|NCT04970693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651479|NCT04970303|Methylphenidate|methylphenidate|mesh-list
154651480|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154651481|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651482|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154651483|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154651484|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154651485|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651486|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
154651487|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651488|NCT04432259|Dexamethasone|dexamethasone|mesh-list
154651489|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154651490|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
154651491|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
154651492|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651493|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651494|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651495|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
154651496|NCT04432259|Hormones|hormones|mesh-ancestor
154651497|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154651498|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154651499|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651500|NCT04964219|Ketamine|ketamine|mesh-list
154651501|NCT04964219|Esketamine|esketamine|mesh-list
154651502|NCT04964219|Analgesics|analgesics|mesh-ancestor
154651503|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
154651504|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651505|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651506|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154651507|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154651508|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
154651509|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
154651510|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651511|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154651512|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154651513|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651514|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651515|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
154651516|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154651517|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
154651518|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154651519|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
154651520|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651521|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
154651522|NCT04975373|Protective Agents|protective agents|mesh-ancestor
154651523|NCT04974827|Carboplatin|carboplatin|mesh-list
154651524|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651525|NCT04963595|Vinorelbine|vinorelbine|mesh-list
154651526|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154651527|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651528|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
154651529|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
154651530|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
154366367|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
154651531|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651532|NCT04962425|Trastuzumab|trastuzumab|mesh-list
154651533|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651534|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651536|NCT03060707|Rocuronium|rocuronium|mesh-list
154651537|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
154651538|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154651539|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154651540|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154651541|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651542|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651543|NCT03060005|Dextrans|dextrans|mesh-list
154651544|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
154651545|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
154651546|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
154651547|NCT04210141|Antivenins|antivenins|mesh-list
154651548|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
154651549|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651550|NCT04418531|Antibodies|antibodies|mesh-list
154651551|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
154651552|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154651553|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
154651554|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651555|NCT02555293|Rifaximin|rifaximin|mesh-list
154651556|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154651557|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651558|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651559|NCT03293017|Diazepam|diazepam|mesh-list
154651560|NCT03293017|Baclofen|baclofen|mesh-list
154651561|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154651562|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651563|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154651564|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651565|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154651566|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
154651567|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
154651568|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651569|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651570|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154651571|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
154651572|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
154651573|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
154651574|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651575|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154651576|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651577|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154651578|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154651579|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154651580|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154651581|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
154651582|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
154651583|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
154651584|NCT02625623|Paclitaxel|paclitaxel|mesh-list
154651585|NCT02625623|Irinotecan|irinotecan|mesh-list
154651586|NCT02625623|Avelumab|avelumab|mesh-list
154651587|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154651588|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651589|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
154651590|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
154651591|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
154651592|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651593|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154651594|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154651595|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651596|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651597|NCT02749513|Itraconazole|itraconazole|mesh-list
154651598|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
154651599|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651600|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154651601|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154651602|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651603|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651604|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154651605|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
154651606|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154651607|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651608|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154651609|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
154651610|NCT05110339|Ropivacaine|ropivacaine|mesh-list
154651611|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154651612|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651613|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651614|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154651615|NCT05110339|Analgesics|analgesics|mesh-ancestor
154651616|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
154651617|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651618|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154651619|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154651620|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154651621|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
154651622|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651623|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651624|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
154651625|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
154651626|NCT04965545|Copper|copper|mesh-list
154651627|NCT04965545|Trace Elements|trace elements|mesh-ancestor
154651628|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
154651629|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651630|NCT05105347|Prednisone|prednisone|mesh-list
154651631|NCT05105347|Adalimumab|adalimumab|mesh-list
154651632|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154651633|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
154651634|NCT05105347|Hormones|hormones|mesh-ancestor
154651635|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154651636|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651637|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154651638|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651639|NCT05105347|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154651640|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651641|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
154651642|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
154651643|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154651644|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154651645|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651646|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651647|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651648|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651649|NCT03060785|Tenofovir|tenofovir|mesh-list
154651650|NCT03060785|Emtricitabine|emtricitabine|mesh-list
154651651|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
154651652|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651653|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154651654|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154651655|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651656|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651657|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154651658|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154651659|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
154651660|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
154651661|NCT04952207|Grazoprevir|grazoprevir|mesh-list
154651662|NCT04952207|Ledipasvir|ledipasvir|mesh-list
154651663|NCT04952207|Velpatasvir|velpatasvir|mesh-list
154651664|NCT04952207|Asunaprevir|asunaprevir|mesh-list
154651665|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651666|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
154651667|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651668|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651669|NCT04632589|Losartan|losartan|mesh-list
154651670|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154651671|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154651672|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154651673|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154651674|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403704|NCT04853147|Aprepitant|aprepitant|mesh-list
154651675|NCT05108545|Amphotericin B|amphotericin b|mesh-list
154651676|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154651677|NCT05108545|Amebicides|amebicides|mesh-ancestor
154651678|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154651679|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154651680|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651681|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154651682|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
154651683|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
154651684|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154651685|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154651686|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651687|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
154651688|NCT05102695|Coagulants|coagulants|mesh-ancestor
154651689|NCT05007769|Atezolizumab|atezolizumab|mesh-list
154651690|NCT05007769|Ramucirumab|ramucirumab|mesh-list
154651691|NCT05007769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154651692|NCT05007769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651693|NCT05007769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651694|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651695|NCT05007769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154651696|NCT05007769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154651697|NCT05007769|Growth Substances|growth substances|mesh-ancestor
154651698|NCT05007769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651699|NCT05007769|Growth Inhibitors|growth inhibitors|mesh-ancestor
154651700|NCT04952051|Folic Acid|folic acid|mesh-list
154651701|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
154651702|NCT04952051|Amlodipine|amlodipine|mesh-list
154651703|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154651704|NCT04952051|Enalapril|enalapril|mesh-list
154651705|NCT04952051|Enalaprilat|enalaprilat|mesh-list
154651706|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154651707|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154651708|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154651709|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651710|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154651711|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651712|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
154651713|NCT04952051|Hematinics|hematinics|mesh-ancestor
154651714|NCT04952051|Vitamins|vitamins|mesh-ancestor
154651715|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
154651716|NCT04952051|Diuretics|diuretics|mesh-ancestor
154651717|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
154651718|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154651719|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154651720|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
154651721|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651722|NCT04960943|Trastuzumab|trastuzumab|mesh-list
154651723|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651724|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651725|NCT04431713|Exenatide|exenatide|mesh-list
154651726|NCT04431713|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154651727|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154651728|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651729|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154651730|NCT04431713|Incretins|incretins|mesh-ancestor
154651731|NCT04431713|Hormones|hormones|mesh-ancestor
154651732|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154651733|NCT05104333|Vaccines|vaccines|mesh-list
154651734|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
154651735|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651736|NCT03059615|Doxorubicin|doxorubicin|mesh-list
154651737|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154651738|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651739|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154651740|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154651741|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651742|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651743|NCT04951505|Cefepime|cefepime|mesh-list
154651744|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154651745|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651746|NCT04951349|Petrolatum|petrolatum|mesh-list
154651747|NCT04951349|Emollients|emollients|mesh-ancestor
154651748|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
154651749|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
154651750|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154651751|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651752|NCT02658019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154651753|NCT02658019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651754|NCT03059303|Simeprevir|simeprevir|mesh-list
154651755|NCT03059303|Odalasvir|odalasvir|mesh-list
154651756|NCT03059303|Omeprazole|omeprazole|mesh-list
154651757|NCT03059303|Lansoprazole|lansoprazole|mesh-list
154651758|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
154651759|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154651760|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651761|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154651762|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651763|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651764|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
154651765|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651766|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
154651767|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154651768|NCT03059537|Cathartics|cathartics|mesh-ancestor
154651769|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651770|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
154651771|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154651772|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
154651773|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651774|NCT04428775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154651775|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154651776|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154651777|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
154651778|NCT04950569|Simendan|simendan|mesh-list
154651779|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154651780|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
154651781|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154651782|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154651783|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651784|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651785|NCT04950569|Protective Agents|protective agents|mesh-ancestor
154651786|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651787|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
154651788|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
154651789|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
154651790|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651791|NCT04436419|Protective Agents|protective agents|mesh-ancestor
154651792|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651793|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
154651794|NCT04436419|Vitamins|vitamins|mesh-ancestor
154651795|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
154651796|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
154651797|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651798|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
154651799|NCT01675765|Cisplatin|cisplatin|mesh-list
154651800|NCT01675765|Pemetrexed|pemetrexed|mesh-list
154651801|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
154651802|NCT01675765|Immunomodulating Agents|immunomodulating agents|mesh-list
154651803|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154651804|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651805|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651806|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154651807|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
154651808|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651809|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651810|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154651811|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651812|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154651813|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154651814|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
154651815|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154651816|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651817|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154651818|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154651819|NCT04943237|Analgesics|analgesics|mesh-ancestor
154651820|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
154651821|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651822|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651823|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154651824|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651825|NCT04285255|Lidocaine|lidocaine|mesh-list
154651826|NCT04285255|Fentanyl|fentanyl|mesh-list
154403839|NCT01702571|Immunotoxins|immunotoxins|mesh-ancestor
154651827|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
154651828|NCT04285255|Ketamine|ketamine|mesh-list
154651830|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
154651831|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651832|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651833|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
154651834|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651835|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154651836|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154651837|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154651838|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154651839|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651840|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154651841|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154651842|NCT04285255|Analgesics|analgesics|mesh-ancestor
154651843|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154651844|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154651845|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154651846|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
154651847|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651848|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154651849|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154651850|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
154651851|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154651852|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154651853|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154366679|NCT01296971|Ribavirin|ribavirin|mesh-list
154651854|NCT04285255|Narcotics|narcotics|mesh-ancestor
154651855|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154651856|NCT04121299|Amlodipine|amlodipine|mesh-list
154651857|NCT04121299|Carvedilol|carvedilol|mesh-list
154651858|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154651859|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154651860|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154651861|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651862|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154651863|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651864|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
154651865|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154651866|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154651867|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
154651868|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651869|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
154651870|NCT04121299|Protective Agents|protective agents|mesh-ancestor
154651871|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154651872|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154651873|NCT04942769|Selenium|selenium|mesh-list
154651874|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
154651875|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651876|NCT04942769|Protective Agents|protective agents|mesh-ancestor
154651877|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651878|NCT04942769|Trace Elements|trace elements|mesh-ancestor
154651879|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
154651880|NCT04942301|Endostar protein|endostar protein|mesh-list
154651881|NCT04942301|Endostatins|endostatins|mesh-list
154651882|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154651883|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154651884|NCT04942301|Growth Substances|growth substances|mesh-ancestor
154651885|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651886|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
154651887|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651888|NCT03057899|Fenugreek seed meal|fenugreek seed meal|mesh-list
154651889|NCT03057899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154651890|NCT03057899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651891|NCT04434001|Thrombin|thrombin|mesh-list
154651892|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
154651893|NCT04434001|Coagulants|coagulants|mesh-ancestor
154651894|NCT03540901|Acetazolamide|acetazolamide|mesh-list
154651895|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
154651896|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154651897|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651898|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651899|NCT03540901|Diuretics|diuretics|mesh-ancestor
154651900|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
154651901|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651902|NCT03517735|Remifentanil|remifentanil|mesh-list
154651903|NCT03517735|Propofol|propofol|mesh-list
154651904|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154651905|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651906|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651907|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154651909|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
154651910|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154651911|NCT03517735|Narcotics|narcotics|mesh-ancestor
154651912|NCT03517735|Analgesics|analgesics|mesh-ancestor
154651913|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
154651914|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651915|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
154651916|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154651917|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
154651918|NCT04941131|Povidone|povidone|mesh-list
154651919|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154651920|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651921|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
154651922|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
154651923|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
154651924|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
154651925|NCT03400501|Insulin|insulin|mesh-list
154651926|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154651927|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
154651928|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154651929|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651930|NCT04940273|Remifentanil|remifentanil|mesh-list
154651931|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154651932|NCT04940273|Narcotics|narcotics|mesh-ancestor
154651933|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651934|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651935|NCT04940273|Analgesics|analgesics|mesh-ancestor
154651936|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
154651937|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651938|NCT04948385|Propofol|propofol|mesh-list
154651939|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154651940|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651941|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651942|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154651943|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
154651944|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
154651945|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154651946|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154651947|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651948|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
154651949|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
154651950|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154651951|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154651952|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651953|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651954|NCT04948151|Urological Agents|urological agents|mesh-ancestor
154651955|NCT02633293|Treprostinil|treprostinil|mesh-list
154651956|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154651957|NCT04938713|Ketamine|ketamine|mesh-list
154651958|NCT04938713|Esketamine|esketamine|mesh-list
154651959|NCT04938713|Analgesics|analgesics|mesh-ancestor
154651960|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
154651961|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651962|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651963|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154651964|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154651965|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
154651966|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
154651967|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154651968|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154651969|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154651970|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154651971|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651972|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
154651973|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154651974|NCT04938011|Progesterone|progesterone|mesh-list
154651975|NCT04938011|Progestins|progestins|mesh-ancestor
154651976|NCT04938011|Hormones|hormones|mesh-ancestor
154651977|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154651978|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651979|NCT03057509|Octreotide|octreotide|mesh-list
154651980|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154651981|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154651982|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154651983|NCT03572413|Bromides|bromides|mesh-list
154651984|NCT03572413|Rocuronium|rocuronium|mesh-list
154651985|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
154651986|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154651987|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154651988|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154651989|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154651990|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154651991|NCT04956419|Fluconazole|fluconazole|mesh-list
154651992|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
154651993|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154651994|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154651995|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154651996|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154651997|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154651998|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154651999|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
154652000|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652001|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652002|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154652003|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154652004|NCT04946669|Abatacept|abatacept|mesh-list
154652005|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154652006|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652007|NCT04946669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652008|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652009|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154652010|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
154652011|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652012|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154652013|NCT03219775|Nivolumab|nivolumab|mesh-list
154652014|NCT03219775|Ipilimumab|ipilimumab|mesh-list
154652015|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652016|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652017|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154652018|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652019|NCT03100045|Artesunate|artesunate|mesh-list
154652020|NCT03100045|Artemisinins|artemisinins|mesh-list
154652021|NCT03100045|Artemisinin|artemisinin|mesh-list
154652022|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
154652023|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154652024|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154652025|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652026|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652027|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
154652028|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
154652029|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154652030|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
154652031|NCT04946123|Selenium|selenium|mesh-list
154652032|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
154652033|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652034|NCT04946123|Protective Agents|protective agents|mesh-ancestor
154652035|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652036|NCT04946123|Trace Elements|trace elements|mesh-ancestor
154652037|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
154652038|NCT04945577|Vitamin D|vitamin d|mesh-list
154652039|NCT04945577|Vitamins|vitamins|mesh-ancestor
154652040|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
154652041|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652042|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154652043|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
154652044|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154652045|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154652046|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154652047|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652048|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154652049|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652050|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652051|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154652052|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652053|NCT02655679|Ether|ether|mesh-list
154652054|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154652055|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
154652057|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652058|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652059|NCT04936295|Fulvestrant|fulvestrant|mesh-list
154652060|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652061|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652062|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154652063|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154652064|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
154652065|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652066|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652067|NCT05114239|Timolol|timolol|mesh-list
154652068|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154652069|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154652070|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154652071|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154652072|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652073|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652074|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652075|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652076|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154652077|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154652078|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154652079|NCT04418999|Dexamethasone|dexamethasone|mesh-list
154652080|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652081|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
154652082|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
154652083|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652084|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652085|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652086|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
154652087|NCT04418999|Hormones|hormones|mesh-ancestor
154652088|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652089|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652090|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652091|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154652092|NCT05113459|Disitamab vedotin|disitamab vedotin|mesh-list
154652093|NCT05113459|Immunoconjugates|immunoconjugates|mesh-ancestor
154652094|NCT05113459|Immunologic Factors|immunologic factors|mesh-ancestor
154652095|NCT05113459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652096|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154652097|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652098|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154652099|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154652100|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154652101|NCT04935515|Anticoagulants|anticoagulants|mesh-list
154652102|NCT04935515|Coagulants|coagulants|mesh-list
154652103|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
154652104|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154652105|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652106|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
154652107|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
154652108|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652109|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652110|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652111|NCT04376281|Norepinephrine|norepinephrine|mesh-list
154652112|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154652113|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154652114|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652115|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652116|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652117|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652118|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
154652119|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
154652120|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652121|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154652122|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
154652123|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154652124|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
154652125|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652126|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
154652127|NCT04332445|Protective Agents|protective agents|mesh-ancestor
154404134|NCT03452839|Meropenem|meropenem|mesh-list
154652128|NCT03890887|Itraconazole|itraconazole|mesh-list
154652129|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
154652130|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652131|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154652132|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154652133|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652134|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652135|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154652136|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
154652137|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652138|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652139|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154652140|NCT05015335|Adalimumab|adalimumab|mesh-list
154652141|NCT05015335|Methotrexate|methotrexate|mesh-list
154652142|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154652143|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
154652144|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154652145|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652146|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154652147|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
154652148|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652149|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652150|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
154652151|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652152|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154652153|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154652154|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
154652155|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154652156|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154652157|NCT05015335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154652158|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652159|NCT03056261|Anesthetics|anesthetics|mesh-list
154652160|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652161|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652162|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154652163|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154652164|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652165|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
154652166|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652167|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154652168|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652169|NCT04574479|Morphine|morphine|mesh-list
154652170|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154652171|NCT04574479|Narcotics|narcotics|mesh-ancestor
154652172|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652173|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652174|NCT04574479|Analgesics|analgesics|mesh-ancestor
154652175|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
154652176|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652177|NCT02195947|Hormones|hormones|mesh-list
154652178|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652179|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652180|NCT01698307|Adalimumab|adalimumab|mesh-list
154652181|NCT01698307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154652182|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652183|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154652184|NCT04954339|Bevacizumab|bevacizumab|mesh-list
154652185|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652186|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652187|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154652188|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154652189|NCT04954339|Growth Substances|growth substances|mesh-ancestor
154652190|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652191|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
154652192|NCT01966263|Epinephrine|epinephrine|mesh-list
154652193|NCT01966263|Racepinephrine|racepinephrine|mesh-list
154652194|NCT01966263|Ropivacaine|ropivacaine|mesh-list
154652195|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
154652196|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
154652197|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
154652198|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652199|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652200|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
154652201|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652202|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154652203|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154652204|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652205|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652206|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652207|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154652208|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154652209|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
154652210|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154652211|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
154652212|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
154652213|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
154652214|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154652215|NCT04400201|Propofol|propofol|mesh-list
154652216|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154652217|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652218|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652219|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154652220|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
154652221|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
154367056|NCT00708916|Apremilast|apremilast|mesh-list
154652222|NCT04423107|Acetaminophen|acetaminophen|mesh-list
154652223|NCT04423107|Ibuprofen|ibuprofen|mesh-list
154652224|NCT04423107|Oxycodone|oxycodone|mesh-list
154652225|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154652226|NCT04423107|Analgesics|analgesics|mesh-ancestor
154652227|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
154652228|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652229|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652230|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
154652231|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154652232|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652233|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154652234|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154652235|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652236|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652237|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154652238|NCT04423107|Narcotics|narcotics|mesh-ancestor
154652239|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652240|NCT01675531|Oxycodone|oxycodone|mesh-list
154652241|NCT01675531|Naloxone|naloxone|mesh-list
154652242|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154652243|NCT01675531|Narcotics|narcotics|mesh-ancestor
154652244|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652245|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652246|NCT01675531|Analgesics|analgesics|mesh-ancestor
154652247|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
154652248|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652249|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154652250|NCT05406999|Prednisolone|prednisolone|mesh-list
154652251|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
154652252|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154652253|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652254|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
154652255|NCT05406999|Hormones|hormones|mesh-ancestor
154652256|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652257|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652258|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652259|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652260|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154652261|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652262|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652263|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
154652264|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154652265|NCT04930211|Dexamethasone|dexamethasone|mesh-list
154652266|NCT04930211|Lidocaine|lidocaine|mesh-list
154652267|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652268|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
154652269|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
154652270|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652271|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652272|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652273|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
154404288|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652274|NCT04930211|Hormones|hormones|mesh-ancestor
154652275|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652276|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652277|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652278|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
154652279|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
154652280|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652281|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
154652282|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154652283|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154367107|NCT03637556|Deferasirox|deferasirox|mesh-list
154652284|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154652285|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154652286|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652287|NCT04912271|Dexamethasone|dexamethasone|mesh-list
154652288|NCT04912271|Aprepitant|aprepitant|mesh-list
154652289|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
154652290|NCT04912271|Palonosetron|palonosetron|mesh-list
154652291|NCT04912271|Granisetron|granisetron|mesh-list
154652292|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652293|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
154652294|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
154652295|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652296|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652297|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652298|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
154652299|NCT04912271|Hormones|hormones|mesh-ancestor
154652300|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652301|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652302|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652303|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154652304|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652305|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652306|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154652307|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154652308|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
154652309|NCT02807779|Dexamethasone|dexamethasone|mesh-list
154652310|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652311|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
154652312|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
154652313|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652314|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652315|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652316|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
154652317|NCT02807779|Hormones|hormones|mesh-ancestor
154652318|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652319|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652320|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652321|NCT04912193|Antithrombins|antithrombins|mesh-list
154652322|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
154652323|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154652324|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
154652325|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652326|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652327|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
154652328|NCT02680561|Fluticasone|fluticasone|mesh-list
154652329|NCT02680561|Xhance|xhance|mesh-list
154652330|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154652331|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154652332|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652333|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154652334|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
154652335|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652336|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652337|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154652338|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
154652339|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
154652340|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154652341|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154652342|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154652343|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154652344|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652345|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367170|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
154652346|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652347|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
154652348|NCT02680561|Hormones|hormones|mesh-ancestor
154652349|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652350|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
154652351|NCT05025163|Fluorides|fluorides|mesh-list
154652352|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
154652353|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
154652354|NCT05025163|Protective Agents|protective agents|mesh-ancestor
154652355|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652356|NCT02592031|Goserelin|goserelin|mesh-list
154652357|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652358|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652359|NCT04784299|Lidocaine|lidocaine|mesh-list
154652360|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
154652361|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
154652362|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652363|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652364|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
154652365|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652366|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154652367|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154652368|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154652369|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154652370|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652371|NCT02333149|Melatonin|melatonin|mesh-list
154652372|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
154652373|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652374|NCT02333149|Protective Agents|protective agents|mesh-ancestor
154652375|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652376|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652377|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
154652378|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154652379|NCT05122117|Methylene Blue|methylene blue|mesh-list
154652380|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652381|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652382|NCT05116345|Dexamethasone|dexamethasone|mesh-list
154652383|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
154652384|NCT05116345|BB 1101|bb 1101|mesh-list
154652385|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652386|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
154652387|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
154652388|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652389|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652390|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652391|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
154652392|NCT05116345|Hormones|hormones|mesh-ancestor
154652393|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652394|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652395|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652396|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
154652397|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652398|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652399|NCT05076097|Rituximab|rituximab|mesh-list
154652400|NCT05076097|Lenalidomide|lenalidomide|mesh-list
154652401|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652402|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652403|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
154652404|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652405|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367234|NCT01198379|Aspirin|aspirin|mesh-list
154652406|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154652407|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154652408|NCT05076097|Growth Substances|growth substances|mesh-ancestor
154652409|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
154652410|NCT04513639|Dexamethasone|dexamethasone|mesh-list
154652411|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
154652412|NCT04513639|Daratumumab|daratumumab|mesh-list
154652413|NCT04513639|BB 1101|bb 1101|mesh-list
154652414|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154652415|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652416|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
154652417|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
154652418|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652419|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652420|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652421|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
154652422|NCT04513639|Hormones|hormones|mesh-ancestor
154652423|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652424|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652425|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652426|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
154652427|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652428|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652429|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
154652430|NCT05229913|Esketamine|esketamine|mesh-list
154652431|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
154652432|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154652433|NCT05108155|Tacrine|tacrine|mesh-list
154652434|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154652435|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652436|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652437|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
154652438|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652439|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652440|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154652441|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
154652442|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652443|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
154652444|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154652445|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
154652446|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154652447|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154652448|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154652449|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652450|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652451|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154652452|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154652453|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154652454|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
154652455|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652456|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652457|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154652458|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154652459|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
154652460|NCT05228743|Paclitaxel|paclitaxel|mesh-list
154652461|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154367295|NCT01198535|Cetuximab|cetuximab|mesh-list
154652462|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652463|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
154652464|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
154652465|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
154652466|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652467|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
154652468|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652469|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652470|NCT04990921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154652471|NCT04990921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652472|NCT04507477|Rituximab|rituximab|mesh-list
154652473|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652474|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652475|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
154652476|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652477|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154652478|NCT01675141|Lenalidomide|lenalidomide|mesh-list
154652479|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
154652480|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652481|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154652482|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154652483|NCT01675141|Growth Substances|growth substances|mesh-ancestor
154652484|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
154652485|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652486|NCT05102149|Vildagliptin|vildagliptin|mesh-list
154652487|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154652488|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652489|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154652490|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
154652491|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652492|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652493|NCT04412395|Lactoferrin|lactoferrin|mesh-list
154652494|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652495|NCT04987099|Choline|choline|mesh-list
154652496|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
154652497|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154652498|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
154652499|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652500|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652501|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154652502|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
154652503|NCT03906721|Oxycodone|oxycodone|mesh-list
154652504|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154652505|NCT03906721|Narcotics|narcotics|mesh-ancestor
154652506|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652507|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652508|NCT03906721|Analgesics|analgesics|mesh-ancestor
154652509|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
154652510|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652511|NCT04663711|Anesthetics|anesthetics|mesh-list
154652512|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652513|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652514|NCT04529863|Abatacept|abatacept|mesh-list
154652515|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154652516|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652517|NCT04529863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652518|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652519|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154652520|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
154652521|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652522|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154652523|NCT04582591|Cannabidiol|cannabidiol|mesh-list
154652524|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
154652525|NCT04497883|Maribavir|maribavir|mesh-list
154652526|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
154652527|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652528|NCT03688633|Candesartan|candesartan|mesh-list
154652529|NCT03688633|Candesartan cilexetil|candesartan cilexetil|mesh-list
154652530|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154652531|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154652532|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154652533|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652534|NCT03662815|Molgramostim|molgramostim|mesh-list
154652535|NCT03662815|Sargramostim|sargramostim|mesh-list
154652536|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
154652537|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652538|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652539|NCT03490903|Midazolam|midazolam|mesh-list
154652540|NCT03490903|Fentanyl|fentanyl|mesh-list
154652541|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154652542|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154652543|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652544|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652545|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154652546|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154652547|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154652548|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154652549|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
154652550|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
154652551|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
154652552|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
154652553|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652554|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652555|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154652556|NCT03490903|Narcotics|narcotics|mesh-ancestor
154652557|NCT03490903|Analgesics|analgesics|mesh-ancestor
154652558|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
154652559|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652560|NCT03954613|Memantine|memantine|mesh-list
154652561|NCT03954613|Donepezil|donepezil|mesh-list
154652562|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154652563|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652564|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652565|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
154652566|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652567|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652568|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
154652569|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154652570|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154652571|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
154652572|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154652573|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154652574|NCT03367819|Cemiplimab|cemiplimab|mesh-list
154652575|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652576|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652577|NCT04781725|Cisplatin|cisplatin|mesh-list
154404582|NCT02117700|Antidotes|antidotes|mesh-ancestor
154652578|NCT04781725|Vinblastine|vinblastine|mesh-list
154652579|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652580|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154652581|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
154652582|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
154652583|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
154652584|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652585|NCT03554707|Bevacizumab|bevacizumab|mesh-list
154652586|NCT03554707|Irinotecan|irinotecan|mesh-list
154652587|NCT03554707|Temozolomide|temozolomide|mesh-list
154652588|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652589|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652590|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154652591|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154652592|NCT03554707|Growth Substances|growth substances|mesh-ancestor
154652593|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652594|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
154652595|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154652596|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154652597|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652598|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652599|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154652600|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
154652601|NCT04264663|Furazolidone|furazolidone|mesh-list
154652602|NCT04264663|Tinidazole|tinidazole|mesh-list
154652603|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154652604|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652605|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154652606|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154652607|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154652608|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154652609|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154652610|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652611|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652612|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
154652613|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154652614|NCT04563559|Prednisolone|prednisolone|mesh-list
154652615|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154652616|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
154652617|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154652618|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
154652619|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154652620|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
154652621|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652622|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
154652623|NCT04563559|Hormones|hormones|mesh-ancestor
154652624|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652625|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652626|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652627|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652628|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
154652629|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
154652630|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652631|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652632|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154652633|NCT04563559|Protective Agents|protective agents|mesh-ancestor
154652634|NCT02124187|Nicotine|nicotine|mesh-list
154652635|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154652636|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
154652637|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652638|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652639|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154652640|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154652641|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
154652642|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652643|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652644|NCT02002819|Levetiracetam|levetiracetam|mesh-list
154652645|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
154652646|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
154652647|NCT01597193|Fulvestrant|fulvestrant|mesh-list
154652648|NCT01597193|Anastrozole|anastrozole|mesh-list
154652649|NCT01597193|Exemestane|exemestane|mesh-list
154652650|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154652651|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652652|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154652653|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154652654|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
154860330|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154652655|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652656|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652657|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154652658|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154652659|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652660|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652661|NCT04930133|Afatinib|afatinib|mesh-list
154652662|NCT04930133|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154652663|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154652664|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652665|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652666|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652667|NCT03057041|Fentanyl|fentanyl|mesh-list
154652668|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154652669|NCT03057041|Narcotics|narcotics|mesh-ancestor
154652670|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652671|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652672|NCT03057041|Analgesics|analgesics|mesh-ancestor
154652673|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
154652674|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652675|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154652676|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154652677|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
154652678|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
154652679|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154652680|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652681|NCT05123287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652682|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652683|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
154652684|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154652685|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154652686|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652687|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
154652688|NCT04911413|Coagulants|coagulants|mesh-ancestor
154652689|NCT02622113|Canagliflozin|canagliflozin|mesh-list
154652690|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154652691|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652692|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154652693|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652694|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
154652695|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154652696|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154652697|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652698|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
154652699|NCT04430777|Coagulants|coagulants|mesh-ancestor
154652700|NCT04910477|Atropine|atropine|mesh-list
154652701|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
154652702|NCT04910477|Neostigmine|neostigmine|mesh-list
154652703|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154652704|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652705|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652706|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154652707|NCT04910477|Analgesics|analgesics|mesh-ancestor
154652708|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
154652709|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652710|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154652711|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154652712|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154652713|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652714|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652715|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652716|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154652717|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154652718|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154652719|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
154652720|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154652721|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
154652722|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
154652723|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
154652724|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154652725|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154652726|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
154652727|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154404734|NCT03094611|Immunotoxins|immunotoxins|mesh-ancestor
154652728|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652729|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154652731|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
154652732|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652733|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154652734|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154652735|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652736|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652737|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154652738|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
154652739|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652740|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652741|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154652742|NCT04929509|Listerine|listerine|mesh-list
154652743|NCT04929509|Fluorides|fluorides|mesh-list
154652744|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
154652745|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
154652746|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
154652747|NCT04929509|Protective Agents|protective agents|mesh-ancestor
154652748|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652749|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154652750|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652751|NCT03054467|Amlodipine|amlodipine|mesh-list
154652752|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154652753|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154652754|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154652755|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652756|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154652757|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652758|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
154652759|NCT04910165|Ropivacaine|ropivacaine|mesh-list
154652760|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
154652761|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
154652762|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652763|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652764|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
154652765|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652766|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
154652767|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154652768|NCT02730325|Antibodies|antibodies|mesh-list
154652769|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
154652770|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367594|NCT03841721|Linezolid|linezolid|mesh-list
154652771|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
154652772|NCT04928495|Bromhexine|bromhexine|mesh-list
154652773|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154652774|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652775|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
154652776|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652777|NCT04928495|Protective Agents|protective agents|mesh-ancestor
154652778|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
154652779|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652780|NCT04928495|Expectorants|expectorants|mesh-ancestor
154652781|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
154652782|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154652783|NCT04928495|Antidotes|antidotes|mesh-ancestor
154652784|NCT01573429|Bisphenol A|bisphenol a|mesh-list
154652785|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154652786|NCT01573429|Estrogens|estrogens|mesh-ancestor
154652787|NCT01573429|Hormones|hormones|mesh-ancestor
154652788|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652789|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652790|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154652791|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
154652792|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652793|NCT01573429|Protective Agents|protective agents|mesh-ancestor
154652794|NCT04909931|Vitamin D|vitamin d|mesh-list
154652795|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
154652796|NCT04909931|Vitamins|vitamins|mesh-ancestor
154652797|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
154652798|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652799|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154652800|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154652801|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
154404805|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
154652802|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154652803|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154652804|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652805|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
154652806|NCT04918589|Coagulants|coagulants|mesh-ancestor
154652807|NCT04101643|Evolocumab|evolocumab|mesh-list
154652808|NCT04101643|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154652809|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154652810|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154652811|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
154652812|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652813|NCT04101643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154652814|NCT04101643|Protease Inhibitors|protease inhibitors|mesh-ancestor
154652815|NCT04101643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652816|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154652817|NCT02620787|Tedizolid|tedizolid|mesh-list
154652818|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154652819|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652820|NCT04909619|Anesthetics|anesthetics|mesh-list
154652821|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
154652822|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652823|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652824|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
154652825|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652826|NCT03520231|Vitamin D|vitamin d|mesh-list
154652827|NCT03520231|Denosumab|denosumab|mesh-list
154652828|NCT03520231|Carboplatin|carboplatin|mesh-list
154652829|NCT03520231|Gemcitabine|gemcitabine|mesh-list
154652830|NCT03520231|Calcium|calcium|mesh-list
154652831|NCT03520231|Vitamins|vitamins|mesh-ancestor
154652832|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
154652833|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652834|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652835|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154652836|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
154652837|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652838|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154652839|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154652840|NCT03056495|Vorinostat|vorinostat|mesh-list
154652841|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652842|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154652843|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652844|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652845|NCT03171805|Propranolol|propranolol|mesh-list
154652846|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154652847|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154652848|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652849|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652850|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652851|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652852|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154652853|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154652854|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
154652855|NCT04918433|Anesthetics|anesthetics|mesh-list
154652856|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652857|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652858|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154652859|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154652860|NCT03053219|Abivertinib|abivertinib|mesh-list
154652861|NCT03053219|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154652862|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154652863|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652864|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652865|NCT03055793|Budesonide|budesonide|mesh-list
154652866|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
154652867|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154652868|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154652869|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
154652870|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652871|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652872|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154652873|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
154652874|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
154652875|NCT03055793|Hormones|hormones|mesh-ancestor
154652876|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154652877|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154652878|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154652879|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154652880|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652881|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652882|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652884|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154652885|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652886|NCT04909775|Gemcitabine|gemcitabine|mesh-list
154652887|NCT04909775|Tislelizumab|tislelizumab|mesh-list
154652888|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652889|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154652890|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
154652891|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652892|NCT04909775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652893|NCT04925141|Dasatinib|dasatinib|mesh-list
154652894|NCT04925141|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154652895|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154652896|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652897|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652898|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652899|NCT02651155|Lubiprostone|lubiprostone|mesh-list
154652900|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154652901|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154652902|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652903|NCT04925063|Metformin|metformin|mesh-list
154652904|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154652905|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652906|NCT04909151|Methamphetamine|methamphetamine|mesh-list
154652907|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154652908|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652909|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
154652910|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
154652911|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652912|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
154652913|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652914|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652915|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
154652916|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154652917|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154652918|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154652919|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154652920|NCT05132413|Bevacizumab|bevacizumab|mesh-list
154652921|NCT05132413|Cisplatin|cisplatin|mesh-list
154652922|NCT05132413|Carboplatin|carboplatin|mesh-list
154652923|NCT05132413|Pemetrexed|pemetrexed|mesh-list
154652924|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154652925|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652926|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154652927|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154652928|NCT05132413|Growth Substances|growth substances|mesh-ancestor
154652929|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652930|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
154652931|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652932|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652933|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154652934|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154652935|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154652936|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
154652937|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154652938|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154652939|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154652940|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154652941|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154652942|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652943|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
154652944|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652945|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652946|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154652947|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154652948|NCT04917497|Simendan|simendan|mesh-list
154652949|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154652950|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
154652951|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154652952|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154652953|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652954|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652955|NCT04917497|Protective Agents|protective agents|mesh-ancestor
154652956|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652957|NCT03933007|Fexofenadine|fexofenadine|mesh-list
154652958|NCT03933007|Colchicine|colchicine|mesh-list
154652959|NCT03933007|Midazolam|midazolam|mesh-list
154652960|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154652961|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154652962|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154652963|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154652964|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154652965|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154652966|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154652967|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154652968|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
154652969|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
154652970|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
154652971|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
154652972|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154652973|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652974|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
154652975|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154652976|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
154652977|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
154652978|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
154652979|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154652980|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154652981|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154652982|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154652983|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
154652984|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
154652985|NCT04907747|Amoxicillin|amoxicillin|mesh-list
154652986|NCT04907747|Furazolidone|furazolidone|mesh-list
154652987|NCT04907747|Esomeprazole|esomeprazole|mesh-list
154652988|NCT04907747|Bismuth|bismuth|mesh-list
154652989|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154652990|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154652991|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154652992|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154652993|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154652994|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154652995|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154652996|NCT04907747|Antacids|antacids|mesh-ancestor
154652997|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154652998|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154652999|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154653000|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154653001|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154653002|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154653003|NCT03052673|Fentanyl|fentanyl|mesh-list
154653004|NCT03052673|Ketamine|ketamine|mesh-list
154653005|NCT03052673|Analgesics|analgesics|mesh-ancestor
154653006|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
154653007|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653008|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653009|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154653010|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154653011|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
154653012|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
154653013|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653014|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154653015|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154653016|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653017|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653018|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154653019|NCT03052673|Narcotics|narcotics|mesh-ancestor
154653020|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154653021|NCT04907123|Diuretics|diuretics|mesh-list
154653022|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
154653023|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653024|NCT05030857|Midazolam|midazolam|mesh-list
154653025|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154653026|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154653027|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653028|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653029|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154653030|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154653031|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154653032|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154653033|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
154653034|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
154653035|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
154653036|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
154653037|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653038|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653039|NCT03319459|Trastuzumab|trastuzumab|mesh-list
154653040|NCT03319459|Cetuximab|cetuximab|mesh-list
154653041|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653042|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653043|NCT04430933|Paclitaxel|paclitaxel|mesh-list
154653044|NCT04430933|Docetaxel|docetaxel|mesh-list
154653045|NCT04430933|Carboplatin|carboplatin|mesh-list
154653046|NCT04430933|Pemetrexed|pemetrexed|mesh-list
154653047|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154653048|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653049|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
154653050|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
154653051|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
154653052|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653053|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653054|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154653055|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154653056|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
154653057|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154653058|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154653059|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154653060|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
154653061|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653062|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653063|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653064|NCT03055091|Sorbitol|sorbitol|mesh-list
154653065|NCT03055091|Cathartics|cathartics|mesh-ancestor
154653066|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653067|NCT02648581|Ustekinumab|ustekinumab|mesh-list
154653068|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
154653069|NCT02609815|Metformin|metformin|mesh-list
154653070|NCT02609815|Glimepiride|glimepiride|mesh-list
154653071|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154653072|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653073|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154653074|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154653075|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
154653076|NCT05132023|Metformin|metformin|mesh-list
154653077|NCT05132023|Empagliflozin|empagliflozin|mesh-list
154653078|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154653079|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653080|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154653081|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653082|NCT05131711|Immunomodulating Agents|immunomodulating agents|mesh-list
154653083|NCT05131711|Immunologic Factors|immunologic factors|mesh-ancestor
154653084|NCT05131711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653085|NCT02619617|Pasireotide|pasireotide|mesh-list
154653086|NCT02619617|Hormones|hormones|mesh-ancestor
154653087|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653088|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653089|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
154653090|NCT04012957|Hematinics|hematinics|mesh-ancestor
154653091|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154653092|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154653093|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154653094|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653095|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
154653096|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154653097|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
154653098|NCT05125627|Progesterone|progesterone|mesh-list
154653099|NCT05125627|Progestins|progestins|mesh-ancestor
154653100|NCT05125627|Hormones|hormones|mesh-ancestor
154653101|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653102|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653103|NCT05125549|Clopidogrel|clopidogrel|mesh-list
154860331|NCT02847559|Growth Substances|growth substances|mesh-ancestor
154653104|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154653105|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154653106|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154653107|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154653108|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
154653109|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653110|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653111|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653112|NCT04903847|Tenofovir|tenofovir|mesh-list
154653113|NCT04903847|Lamivudine|lamivudine|mesh-list
154653114|NCT04903847|Dolutegravir|dolutegravir|mesh-list
154653115|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
154653116|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653117|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154653118|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154653119|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653120|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653121|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154653122|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154653123|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154653124|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154653125|NCT04905953|Neostigmine|neostigmine|mesh-list
154653126|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154653127|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653128|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653129|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
154653130|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653131|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653132|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154653133|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
154653134|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653135|NCT04916093|Metformin|metformin|mesh-list
154653136|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154653137|NCT04916093|Vildagliptin|vildagliptin|mesh-list
154653138|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154653139|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653140|NCT04916093|Incretins|incretins|mesh-ancestor
154653141|NCT04916093|Hormones|hormones|mesh-ancestor
154653142|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653143|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154653144|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
154653145|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653146|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653147|NCT03512119|Ivacaftor|ivacaftor|mesh-list
154653148|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154653149|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154653150|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653151|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
154653152|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653153|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653154|NCT02642809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154653155|NCT02642809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653156|NCT03052361|Ondansetron|ondansetron|mesh-list
154653157|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
154653158|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
154653159|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653160|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653161|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653162|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
154653163|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
154653164|NCT03052361|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154653165|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154653166|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
154653167|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653168|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653169|NCT02370589|Vaccines|vaccines|mesh-list
154653170|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
154653171|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653172|NCT05057845|Lenvatinib|lenvatinib|mesh-list
154653173|NCT05057845|Tislelizumab|tislelizumab|mesh-list
154653174|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653175|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154653176|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653177|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653178|NCT05057845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653179|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
154653180|NCT05109949|Empagliflozin|empagliflozin|mesh-list
154653181|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154653182|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653183|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154653184|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653185|NCT04901663|Amoxicillin|amoxicillin|mesh-list
154653186|NCT04901663|Clarithromycin|clarithromycin|mesh-list
154653188|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653189|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653190|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154653191|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653192|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154653193|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653194|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653195|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154653196|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154653197|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154653198|NCT05134519|Trastuzumab|trastuzumab|mesh-list
154653199|NCT05134519|Antibodies|antibodies|mesh-list
154653200|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154653201|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
154653202|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653203|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653204|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653205|NCT04394663|Omeprazole|omeprazole|mesh-list
154653206|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154653207|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653208|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154653209|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653210|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653211|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154653212|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154653213|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653214|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
154653215|NCT04901117|Amoxicillin|amoxicillin|mesh-list
154653216|NCT04901117|Metronidazole|metronidazole|mesh-list
154653217|NCT04901117|Clarithromycin|clarithromycin|mesh-list
154653218|NCT04901117|Tetracycline|tetracycline|mesh-list
154653219|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
154653220|NCT04901117|Bismuth|bismuth|mesh-list
154653221|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653222|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653223|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653224|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154653225|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154653226|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154653227|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653228|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154653229|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154653230|NCT04901117|Antacids|antacids|mesh-ancestor
154653231|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653232|NCT04901117|Diuretics|diuretics|mesh-ancestor
154653233|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
154653234|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653235|NCT04901117|Expectorants|expectorants|mesh-ancestor
154653236|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
154653237|NCT05121571|Sorafenib|sorafenib|mesh-list
154653238|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653239|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154653240|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653241|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653242|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
154653243|NCT03051269|Calcium|calcium|mesh-list
154653244|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154653245|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653246|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154653247|NCT04576663|Phenylephrine|phenylephrine|mesh-list
154653248|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
154653249|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154653250|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
154653251|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
154653252|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653253|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653254|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
154653255|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154653256|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
154653257|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
154653258|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154653259|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154653260|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154653261|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
154653262|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653263|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653264|NCT04576663|Protective Agents|protective agents|mesh-ancestor
154653265|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154653266|NCT05281549|Tenecteplase|tenecteplase|mesh-list
154653267|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154653268|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154653269|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653270|NCT05191225|Rituximab|rituximab|mesh-list
154653271|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653272|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653273|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
154653274|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653275|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154653276|NCT03909217|Dexetimide|dexetimide|mesh-list
154653277|NCT03909217|Citalopram|citalopram|mesh-list
154653278|NCT03909217|Escitalopram|escitalopram|mesh-list
154653279|NCT03909217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154653280|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154653281|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154653282|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653283|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653284|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
154653285|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653286|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154653287|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154653288|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
154653289|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
154653290|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653291|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154653292|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154653293|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
154653294|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154653295|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
154653296|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154653297|NCT02650921|Lidocaine|lidocaine|mesh-list
154653298|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
154653299|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
154653300|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653301|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653302|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
154653303|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653304|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154653305|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154653306|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154653307|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154653308|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653309|NCT04913987|Cimetidine|cimetidine|mesh-list
154653310|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154653311|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653312|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154653313|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
154653314|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
154653315|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653316|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653317|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653318|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154653319|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154653320|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653321|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
154653322|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154653323|NCT01596335|Antibodies|antibodies|mesh-list
154653324|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
154653325|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653326|NCT04891679|Misoprostol|misoprostol|mesh-list
154405332|NCT03681990|Ethanol|ethanol|mesh-list
154653327|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154653328|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
154653329|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154653330|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653331|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154653332|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653333|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
154653334|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
154653335|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154653336|NCT04913831|Protective Agents|protective agents|mesh-ancestor
154653337|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653338|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
154653339|NCT04900415|Vitamin A|vitamin a|mesh-list
154653340|NCT04900415|Vitamins|vitamins|mesh-ancestor
154653341|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
154653342|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653343|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
154653344|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154653345|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653346|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653347|NCT04891211|Vitamin D|vitamin d|mesh-list
154653348|NCT04891211|Vitamins|vitamins|mesh-ancestor
154653349|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
154653350|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653351|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154653352|NCT03050957|Menthol|menthol|mesh-list
154653353|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
154653354|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
154653355|NCT04885049|Racecadotril|racecadotril|mesh-list
154653356|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
154653357|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653358|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
154653359|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653360|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653361|NCT04430621|Hormones|hormones|mesh-list
154653362|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154653363|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653364|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653365|NCT04884503|Clonazepam|clonazepam|mesh-list
154653366|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
154653367|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
154653368|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
154653369|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653370|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653371|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653372|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
154653373|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653374|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154653375|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653376|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653377|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
154653378|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653379|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653380|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154653381|NCT04898699|Tenofovir|tenofovir|mesh-list
154653382|NCT04898699|Emtricitabine|emtricitabine|mesh-list
154653383|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154653384|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
154653385|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653386|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154653387|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154653388|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653389|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653390|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154653391|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154653392|NCT04888715|Pirfenidone|pirfenidone|mesh-list
154653393|NCT04888715|Nintedanib|nintedanib|mesh-list
154653394|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653395|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154653396|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653397|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653398|NCT04888715|Analgesics|analgesics|mesh-ancestor
154653399|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
154653400|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653401|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653402|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154368223|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
154653403|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154653404|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154653405|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154653406|NCT04888403|Paclitaxel|paclitaxel|mesh-list
154653407|NCT04888403|Nedaplatin|nedaplatin|mesh-list
154653408|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154653409|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653410|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
154653411|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
154653412|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
154653413|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653414|NCT03050177|Gefitinib|gefitinib|mesh-list
154653415|NCT03050177|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154653416|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154653417|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653418|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653419|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653420|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154653421|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154653422|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653423|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154653424|NCT03050411|Apatinib|apatinib|mesh-list
154653425|NCT03050411|Gefitinib|gefitinib|mesh-list
154653426|NCT03050411|Osimertinib|osimertinib|mesh-list
154653427|NCT03050411|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154653428|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154653429|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653430|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653431|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653432|NCT04887311|Tempol|tempol|mesh-list
154653433|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
154653434|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653435|NCT04887311|Protective Agents|protective agents|mesh-ancestor
154653436|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653437|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154653438|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653439|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154653440|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154653441|NCT03051503|Fentanyl|fentanyl|mesh-list
154653442|NCT03051503|Morphine|morphine|mesh-list
154653443|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154653444|NCT03051503|Narcotics|narcotics|mesh-ancestor
154653445|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653446|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653447|NCT03051503|Analgesics|analgesics|mesh-ancestor
154653448|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
154653449|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653450|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154653451|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154653452|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
154653453|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
154653454|NCT04896125|Bimatoprost|bimatoprost|mesh-list
154653455|NCT04896125|Latanoprost|latanoprost|mesh-list
154653456|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154653457|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154653458|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154653459|NCT04895657|Tazobactam|tazobactam|mesh-list
154653460|NCT04895657|Piperacillin|piperacillin|mesh-list
154653461|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154653462|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653463|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653464|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154653465|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653466|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653467|NCT04895423|Cyclosporine|cyclosporine|mesh-list
154653468|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
154653469|NCT04895423|Methotrexate|methotrexate|mesh-list
154653470|NCT04895423|Cyclosporins|cyclosporins|mesh-list
154653471|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154653472|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
154653473|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154653474|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653475|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154653476|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
154860332|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405493|NCT03026166|Nivolumab|nivolumab|mesh-list
154653477|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653478|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653479|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
154653480|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653481|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154653482|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154653483|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
154653484|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154653485|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154653486|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
154653487|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653488|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154653489|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154653490|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154653491|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
154653492|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653493|NCT04882163|Dexamethasone|dexamethasone|mesh-list
154653494|NCT04882163|Rituximab|rituximab|mesh-list
154653495|NCT04882163|Gemcitabine|gemcitabine|mesh-list
154653496|NCT04882163|Lenalidomide|lenalidomide|mesh-list
154653497|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154653498|NCT04882163|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154653499|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653500|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653501|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
154653502|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653503|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154653504|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154653505|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
154653506|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
154653507|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653508|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653509|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
154653510|NCT04882163|Hormones|hormones|mesh-ancestor
154653511|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653512|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154653513|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154653514|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
154653515|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653516|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154653517|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154653518|NCT04882163|Growth Substances|growth substances|mesh-ancestor
154653519|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
154653520|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154653521|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
154653522|NCT04882163|Immunoconjugates|immunoconjugates|mesh-ancestor
154653523|NCT04885751|Rebamipide|rebamipide|mesh-list
154653524|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154653525|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653526|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
154653527|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653528|NCT04885751|Protective Agents|protective agents|mesh-ancestor
154653529|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653530|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653531|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
154653532|NCT03049163|Propoxycaine|propoxycaine|mesh-list
154653533|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
154653534|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653535|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653536|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
154653537|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
154653538|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653539|NCT04881851|Folic Acid|folic acid|mesh-list
154653540|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
154653541|NCT04881851|Inositol|inositol|mesh-list
154653542|NCT04881851|Hematinics|hematinics|mesh-ancestor
154653543|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
154653544|NCT04881851|Vitamins|vitamins|mesh-ancestor
154653545|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
154653546|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653547|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
154653548|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653549|NCT04881851|Protective Agents|protective agents|mesh-ancestor
154653550|NCT04871633|Azithromycin|azithromycin|mesh-list
154653551|NCT04871633|Remdesivir|remdesivir|mesh-list
154405561|NCT03676140|Filaricides|filaricides|mesh-ancestor
154653552|NCT04871633|Dexamethasone|dexamethasone|mesh-list
154653553|NCT04871633|Prednisolone|prednisolone|mesh-list
154653554|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154653555|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154653556|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
154653557|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
154653558|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653559|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653560|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653561|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
154653562|NCT04871633|Hormones|hormones|mesh-ancestor
154653563|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653564|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154653565|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653566|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653567|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154653568|NCT04871633|Protective Agents|protective agents|mesh-ancestor
154653569|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653570|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653571|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
154653572|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
154653573|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
154653574|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154653575|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653576|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154653577|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653578|NCT03046979|Apatinib|apatinib|mesh-list
154653579|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653580|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154653581|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653582|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653583|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154653584|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154368416|NCT03829943|Vitamin D|vitamin d|mesh-list
154653585|NCT04676399|Diuretics|diuretics|mesh-ancestor
154653586|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
154653587|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653588|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154653589|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154653590|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653591|NCT03047057|Lidocaine|lidocaine|mesh-list
154653592|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
154653593|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
154653594|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653595|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653596|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
154653597|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653598|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154653599|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154653600|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154653601|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154653602|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653603|NCT04550195|Famotidine|famotidine|mesh-list
154653604|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154653605|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653606|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154653607|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
154653608|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
154653609|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653610|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653611|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653612|NCT04525391|Durvalumab|durvalumab|mesh-list
154653613|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653614|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653615|NCT04879511|Metformin|metformin|mesh-list
154653616|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154653617|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653618|NCT03046901|Vancomycin|vancomycin|mesh-list
154653619|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653620|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653621|NCT03871049|Dexamethasone|dexamethasone|mesh-list
154653622|NCT03871049|Bupivacaine|bupivacaine|mesh-list
154653623|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154653624|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
154653625|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
154653626|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405632|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154653627|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653628|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653629|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
154653630|NCT03871049|Hormones|hormones|mesh-ancestor
154653631|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653632|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154653633|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653634|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
154653635|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
154653636|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653637|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
154653638|NCT04870541|Nefopam|nefopam|mesh-list
154653639|NCT04870541|Ondansetron|ondansetron|mesh-list
154653640|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
154653641|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
154653642|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653643|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653644|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653645|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
154653646|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
154653647|NCT04870541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154653648|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154653649|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
154653650|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368470|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653651|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653652|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154653653|NCT04870541|Analgesics|analgesics|mesh-ancestor
154653654|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
154653655|NCT04870073|Mannitol|mannitol|mesh-list
154653656|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154653657|NCT04870073|Diuretics|diuretics|mesh-ancestor
154653658|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
154653659|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653660|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154653661|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154653662|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154653663|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
154653664|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653665|NCT04878497|Warfarin|warfarin|mesh-list
154653666|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
154653667|NCT04878497|Dabigatran|dabigatran|mesh-list
154653668|NCT04878497|Apixaban|apixaban|mesh-list
154653669|NCT04878497|Edoxaban|edoxaban|mesh-list
154653670|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
154653671|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154653672|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
154653673|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154653674|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
154653675|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653676|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653677|NCT03257033|Paclitaxel|paclitaxel|mesh-list
154653678|NCT03257033|Gemcitabine|gemcitabine|mesh-list
154653679|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154653680|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653681|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
154653682|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
154653683|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
154653684|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653685|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154653686|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
154653687|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
154653688|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653689|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653690|NCT02614859|Metformin|metformin|mesh-list
154653691|NCT02614859|Bicalutamide|bicalutamide|mesh-list
154653692|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154653693|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653694|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
154653695|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
154653696|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653697|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653698|NCT04876859|Anesthetics|anesthetics|mesh-list
154653699|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405708|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154653700|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653701|NCT04876313|Paclitaxel|paclitaxel|mesh-list
154653702|NCT04876313|Nivolumab|nivolumab|mesh-list
154653703|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154653704|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653705|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
154653706|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
154653707|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
154653708|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653709|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653710|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154653712|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653713|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154653714|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154653715|NCT03049085|Analgesics|analgesics|mesh-ancestor
154653716|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
154653717|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653718|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154653719|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154653720|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154653721|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154653722|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653723|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154653724|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154653725|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653726|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
154653727|NCT04875611|Nivolumab|nivolumab|mesh-list
154653728|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653729|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653730|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154653731|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653732|NCT05256953|Anesthetics|anesthetics|mesh-list
154653733|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653734|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653735|NCT04874675|Acetaminophen|acetaminophen|mesh-list
154653736|NCT04874675|Ibuprofen|ibuprofen|mesh-list
154653737|NCT04874675|Diclofenac|diclofenac|mesh-list
154653738|NCT04874675|Codeine|codeine|mesh-list
154653739|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154653740|NCT04874675|Analgesics|analgesics|mesh-ancestor
154653741|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
154653742|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653743|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653744|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
154653745|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154653746|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154653747|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154653748|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154653749|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653750|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653751|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154653752|NCT04874675|Narcotics|narcotics|mesh-ancestor
154653753|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653754|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
154653755|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
154653756|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
154653757|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154653758|NCT04868513|Fluorides|fluorides|mesh-list
154653759|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
154653760|NCT04868513|Protective Agents|protective agents|mesh-ancestor
154653761|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653762|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154653763|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653764|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
154653765|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
154653766|NCT05256173|Melatonin|melatonin|mesh-list
154653767|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
154653768|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653769|NCT05256173|Protective Agents|protective agents|mesh-ancestor
154653770|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653771|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653772|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
154653773|NCT02648347|Hematinics|hematinics|mesh-ancestor
154653774|NCT02614703|Acetic Acid|acetic acid|mesh-list
154653775|NCT02614703|Retinol acetate|retinol acetate|mesh-list
154653776|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653777|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653778|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154653779|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
154653780|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653781|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154653782|NCT02614703|Protective Agents|protective agents|mesh-ancestor
154653783|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653784|NCT01669343|Letrozole|letrozole|mesh-list
154653785|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653786|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154653787|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154653788|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653789|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653790|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154653791|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
154653792|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653793|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653794|NCT03126643|Nivolumab|nivolumab|mesh-list
154653795|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653796|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653797|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154653798|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653799|NCT04617067|Paclitaxel|paclitaxel|mesh-list
154653800|NCT04617067|Gemcitabine|gemcitabine|mesh-list
154653801|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154653802|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653803|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
154653804|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
154653805|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
154653806|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653807|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154653808|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
154653809|NCT01594931|Artesunate|artesunate|mesh-list
154653810|NCT01594931|Pyronaridine|pyronaridine|mesh-list
154653811|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
154653812|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154653813|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154653814|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653815|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653816|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
154653817|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
154653818|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154653819|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
154653820|NCT03045185|Metronidazole|metronidazole|mesh-list
154653821|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
154653822|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154653823|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154653824|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154653825|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154653826|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154653827|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154653828|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653829|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653830|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653831|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154653832|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154653833|NCT04969237|Vitamin D|vitamin d|mesh-list
154653834|NCT04969237|Vitamins|vitamins|mesh-ancestor
154653835|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
154653836|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653837|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154653838|NCT04341467|Olanzapine|olanzapine|mesh-list
154653839|NCT04341467|Amisulpride|amisulpride|mesh-list
154653840|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
154653841|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
154368665|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
154653842|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653843|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653844|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653845|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154653846|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154653847|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653848|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154653849|NCT04341467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154653850|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154653851|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154653852|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653853|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653854|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
154653855|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154653856|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
154653857|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154653858|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
154653859|NCT04872881|Fentanyl|fentanyl|mesh-list
154653860|NCT04872881|Propofol|propofol|mesh-list
154653861|NCT04872881|Rocuronium|rocuronium|mesh-list
154653862|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154653863|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653864|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653865|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154653866|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
154653867|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
154653868|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154653869|NCT04872881|Narcotics|narcotics|mesh-ancestor
154653870|NCT04872881|Analgesics|analgesics|mesh-ancestor
154653871|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
154653872|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653873|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154653874|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154653875|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154653876|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154653877|NCT03044873|Deucravacitinib|deucravacitinib|mesh-list
154653878|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154653879|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154653880|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154653881|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
154653882|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653883|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154653884|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154653885|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653886|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
154653887|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154653888|NCT03044795|Veliparib|veliparib|mesh-list
154653889|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154653890|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653891|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653892|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653893|NCT04865705|Paclitaxel|paclitaxel|mesh-list
154653894|NCT04865705|Cisplatin|cisplatin|mesh-list
154653895|NCT04865705|Carboplatin|carboplatin|mesh-list
154653896|NCT04865705|Tislelizumab|tislelizumab|mesh-list
154653897|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154653898|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653899|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
154653900|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
154653901|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
154368727|NCT03335956|Pioglitazone|pioglitazone|mesh-list
154653902|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653903|NCT04865705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653904|NCT04858997|Palbociclib|palbociclib|mesh-list
154653905|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653906|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154653907|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154653908|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653909|NCT05135143|Antioxidants|antioxidants|mesh-list
154653910|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653911|NCT05135143|Protective Agents|protective agents|mesh-ancestor
154653912|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653913|NCT05305183|Alendronate|alendronate|mesh-list
154653914|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154653915|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653916|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
154653917|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
154653918|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653919|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653920|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653921|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
154653922|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
154653923|NCT05304559|Ketamine|ketamine|mesh-list
154653924|NCT05304559|Esketamine|esketamine|mesh-list
154653925|NCT05304559|Analgesics|analgesics|mesh-ancestor
154653926|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
154653927|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405933|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154653928|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653929|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154653930|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154653931|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
154653932|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
154653933|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154653934|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154653935|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154653936|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653937|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653938|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
154653939|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154653940|NCT02613221|Panitumumab|panitumumab|mesh-list
154653941|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653942|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653943|NCT05304169|Leuprolide|leuprolide|mesh-list
154653944|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154653945|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
154653946|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154653947|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653948|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154653949|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653950|NCT04858841|Levetiracetam|levetiracetam|mesh-list
154653951|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
154653952|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
154653953|NCT04682743|Acetaminophen|acetaminophen|mesh-list
154653954|NCT04682743|Ondansetron|ondansetron|mesh-list
154653955|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154653956|NCT04682743|Analgesics|analgesics|mesh-ancestor
154653957|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
154653958|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653959|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653960|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
154653961|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
154653962|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
154653963|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154653964|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
154653965|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
154653966|NCT04682743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154653967|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154653968|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
154653969|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653970|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653971|NCT04636333|Vaccines|vaccines|mesh-list
154653972|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
154653973|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653974|NCT03103009|Pasireotide|pasireotide|mesh-list
154653975|NCT03103009|Hormones|hormones|mesh-ancestor
154653976|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154653977|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653978|NCT03020875|Acetaminophen|acetaminophen|mesh-list
154653979|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154653980|NCT03020875|Analgesics|analgesics|mesh-ancestor
154653981|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
154653982|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653983|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653984|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
154653985|NCT02996305|Gaboxadol|gaboxadol|mesh-list
154653986|NCT02996305|Analgesics|analgesics|mesh-ancestor
154653987|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
154653988|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154653989|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154653990|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
154653991|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
154653992|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
154653993|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154653994|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154653995|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
154653996|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154653997|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154653998|NCT04866485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154653999|NCT04866485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654000|NCT02888041|Dinoprostone|dinoprostone|mesh-list
154654001|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
154654002|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154654003|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654004|NCT02838745|Pemetrexed|pemetrexed|mesh-list
154654005|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654006|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654007|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654008|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154654009|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154654010|NCT00136435|Leucovorin|leucovorin|mesh-list
154654011|NCT00136435|Cytarabine|cytarabine|mesh-list
154654012|NCT00136435|Dexamethasone|dexamethasone|mesh-list
154654013|NCT00136435|Prednisone|prednisone|mesh-list
154654014|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
154654015|NCT00136435|Doxorubicin|doxorubicin|mesh-list
154654016|NCT00136435|Methotrexate|methotrexate|mesh-list
154654017|NCT00136435|Vincristine|vincristine|mesh-list
154654018|NCT00136435|Asparaginase|asparaginase|mesh-list
154654019|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
154654020|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654021|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
154654022|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
154654023|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654024|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654025|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654026|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
154654027|NCT00136435|Hormones|hormones|mesh-ancestor
154654028|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654029|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154654030|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654031|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154654032|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154654033|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154654034|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654035|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654036|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154654037|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
154654038|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154654039|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154654040|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
154654041|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
154654042|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154654043|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154654044|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
154654045|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654046|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154654047|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
154654048|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654049|NCT00136435|Antidotes|antidotes|mesh-ancestor
154654050|NCT00136435|Protective Agents|protective agents|mesh-ancestor
154654051|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
154654052|NCT00136435|Vitamins|vitamins|mesh-ancestor
154654053|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
154654054|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154654055|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
154654056|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
154654057|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
154654058|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154654059|NCT04864379|Molgramostim|molgramostim|mesh-list
154654060|NCT04864379|Sargramostim|sargramostim|mesh-list
154654061|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654062|NCT04864379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154654063|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654064|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
154654065|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654066|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
154654067|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654068|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
154654069|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154654070|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154654071|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654072|NCT03044561|Urological Agents|urological agents|mesh-ancestor
154654073|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
154654074|NCT02455141|Carboplatin|carboplatin|mesh-list
154654075|NCT02455141|Epirubicin|epirubicin|mesh-list
154654076|NCT02455141|Taxane|taxane|mesh-list
154654077|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154654078|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
154654079|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654080|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860333|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
154654081|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154654082|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
154654083|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654084|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654085|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154654086|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154654087|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154654088|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154654089|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654090|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
154654091|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154654092|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154654093|NCT02439385|Curcumin|curcumin|mesh-list
154654094|NCT02439385|Bevacizumab|bevacizumab|mesh-list
154654095|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154654096|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654097|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154654098|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154654099|NCT02439385|Growth Substances|growth substances|mesh-ancestor
154654100|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654101|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
154654102|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154654103|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154654104|NCT02439385|Analgesics|analgesics|mesh-ancestor
154654105|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
154654106|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654107|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654108|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654109|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654110|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654111|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
154654112|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154654113|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
154654114|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654115|NCT03104959|Expectorants|expectorants|mesh-ancestor
154654116|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
154654117|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154654118|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
154654119|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654120|NCT03104959|Protective Agents|protective agents|mesh-ancestor
154654121|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654122|NCT03104959|Antidotes|antidotes|mesh-ancestor
154654123|NCT03044171|Listerine|listerine|mesh-list
154654124|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154654125|NCT03044171|Fluorides|fluorides|mesh-list
154654126|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
154654127|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
154654128|NCT03044171|Protective Agents|protective agents|mesh-ancestor
154654129|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654130|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154654131|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654132|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
154654133|NCT04856969|Olmesartan|olmesartan|mesh-list
154654134|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154654135|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654136|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154654137|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654138|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154654139|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154654140|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154654141|NCT04856111|Pirfenidone|pirfenidone|mesh-list
154654142|NCT04856111|Nintedanib|nintedanib|mesh-list
154654143|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654144|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154654145|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654146|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654147|NCT04856111|Analgesics|analgesics|mesh-ancestor
154654148|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
154654149|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654150|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654151|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154654152|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154654153|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406162|NCT03622073|Misoprostol|misoprostol|mesh-list
154654154|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654155|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
154654156|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154654157|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654158|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154654159|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
154654160|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154654161|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154654162|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154654163|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654164|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654165|NCT01799629|Glycerol|glycerol|mesh-list
154654166|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154654167|NCT01799629|Protective Agents|protective agents|mesh-ancestor
154654168|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654169|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154654170|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154654171|NCT03044093|Misoprostol|misoprostol|mesh-list
154654172|NCT03044093|Mifepristone|mifepristone|mesh-list
154654173|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154654174|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
154654175|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154654176|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654177|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154654178|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654179|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
154654180|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154654181|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154654182|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154654183|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154654184|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
154654185|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154654186|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154654187|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
154654188|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654189|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
154654190|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154654191|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154654192|NCT01553071|Fenretinide|fenretinide|mesh-list
154654193|NCT01553071|Safingol|safingol|mesh-list
154654194|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654195|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154654196|NCT01553071|Protective Agents|protective agents|mesh-ancestor
154654197|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654198|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654199|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654200|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
154654201|NCT01506973|Gemcitabine|gemcitabine|mesh-list
154654202|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154654203|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154654204|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
154654205|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654206|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654207|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
154654208|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154654209|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154654210|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654211|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654212|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654213|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154654214|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654215|NCT04848467|Vaccines|vaccines|mesh-list
154654216|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
154654217|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654218|NCT03104335|Apatinib|apatinib|mesh-list
154654219|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654220|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154654221|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654222|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654223|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154654224|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154654225|NCT00484471|Valproic Acid|valproic acid|mesh-list
154654226|NCT00484471|Aripiprazole|aripiprazole|mesh-list
154654227|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
154654228|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154654229|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154654230|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154654231|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654232|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654233|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
154654234|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
154654235|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654236|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654237|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154654238|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154654239|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
154654240|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154654241|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154654242|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154654243|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154654244|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
154654245|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654246|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
154654247|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
154654248|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154654249|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154654250|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654251|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
154654252|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154654253|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154654254|NCT04847687|Prednisolone|prednisolone|mesh-list
154654255|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
154654256|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154654257|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
154654258|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654259|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
154654260|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
154654261|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654262|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654263|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654264|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
154654265|NCT04847687|Hormones|hormones|mesh-ancestor
154654266|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654267|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154654268|NCT04847687|Protective Agents|protective agents|mesh-ancestor
154654269|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154654270|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654271|NCT01729455|Belimumab|belimumab|mesh-list
154654272|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154654273|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
154654274|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654275|NCT03103867|Insulin|insulin|mesh-list
154654276|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154654277|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654278|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154654279|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
154654280|NCT04737343|Azathioprine|azathioprine|mesh-list
154654281|NCT04737343|Leflunomide|leflunomide|mesh-list
154654282|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
154654283|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654284|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154654285|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654286|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154654287|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
154654288|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654289|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654290|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654291|NCT02609399|Oseltamivir|oseltamivir|mesh-list
154654292|NCT02609399|Peramivir|peramivir|mesh-list
154654293|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
154654294|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654295|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654296|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654297|NCT05430217|Buspirone|buspirone|mesh-list
154654298|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154654299|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154654300|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654301|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654302|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154654303|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154654304|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
154406309|NCT03616808|Hemostatics|hemostatics|mesh-list
154654305|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654306|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654307|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
154654308|NCT03103555|Bortezomib|bortezomib|mesh-list
154654309|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154654310|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
154654311|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654312|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654313|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154654314|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
154654315|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654316|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654317|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154654318|NCT02720185|Dasatinib|dasatinib|mesh-list
154654319|NCT02720185|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154654320|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154654321|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654322|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654323|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654324|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
154654325|NCT04846673|Pregabalin|pregabalin|mesh-list
154654326|NCT04846673|Analgesics|analgesics|mesh-ancestor
154654327|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
154654328|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654329|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654330|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
154654331|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154654332|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154654333|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654334|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154654335|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154654336|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154654337|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654338|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154654339|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
154654340|NCT04846673|Protective Agents|protective agents|mesh-ancestor
154654341|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
154654342|NCT04846673|Vitamins|vitamins|mesh-ancestor
154654343|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
154654344|NCT04498273|Aspirin|aspirin|mesh-list
154654345|NCT04498273|Apixaban|apixaban|mesh-list
154654346|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154654347|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154654348|NCT04498273|Analgesics|analgesics|mesh-ancestor
154654349|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
154654350|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654351|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654352|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654353|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654354|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154654355|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154654356|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654357|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154654358|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154654359|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654360|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
154654361|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154654362|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
154654363|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154654364|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
154654365|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
154654366|NCT04853615|Empagliflozin|empagliflozin|mesh-list
154654367|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154654368|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654369|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154654370|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654371|NCT05573607|Chromium|chromium|mesh-list
154654372|NCT05573607|Trace Elements|trace elements|mesh-ancestor
154654373|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
154654374|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654375|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
154654376|NCT04435483|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154654377|NCT04435483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154654378|NCT04435483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654379|NCT04435483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654380|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654381|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154654382|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
154654383|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654384|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654385|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654387|NCT03040817|Mosapride|mosapride|mesh-list
154654388|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654389|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154654390|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654391|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154654392|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654393|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154654394|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
154654395|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654396|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654397|NCT04853069|Estradiol|estradiol|mesh-list
154654398|NCT04853069|Estrogens|estrogens|mesh-ancestor
154654399|NCT04853069|Hormones|hormones|mesh-ancestor
154654400|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654401|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654402|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
154654403|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
154654404|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154654405|NCT05244811|Progestins|progestins|mesh-list
154654406|NCT05244811|Estradiol|estradiol|mesh-list
154654407|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154654408|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654409|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154654410|NCT05244811|Hormones|hormones|mesh-ancestor
154654411|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654412|NCT05244811|Estrogens|estrogens|mesh-ancestor
154654413|NCT02710669|Propafenone|propafenone|mesh-list
154654414|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154654415|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154654416|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154654417|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154654418|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654419|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
154369245|NCT05863455|Anesthetics, General|anesthetics, general|mesh-ancestor
154654420|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154654421|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654422|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154654423|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654424|NCT04851977|Vaccines|vaccines|mesh-list
154654425|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
154654426|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654427|NCT05370417|Fluorides|fluorides|mesh-list
154654428|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
154654429|NCT05370417|Protective Agents|protective agents|mesh-ancestor
154654430|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654431|NCT04423185|Atezolizumab|atezolizumab|mesh-list
154654432|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
154654433|NCT04423185|Palbociclib|palbociclib|mesh-list
154654434|NCT04423185|Niraparib|niraparib|mesh-list
154654435|NCT04423185|Vemurafenib|vemurafenib|mesh-list
154654436|NCT04423185|Crizotinib|crizotinib|mesh-list
154654437|NCT04423185|Alectinib|alectinib|mesh-list
154654438|NCT04423185|Dacomitinib|dacomitinib|mesh-list
154654439|NCT04423185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154654440|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654441|NCT04423185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154654442|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654443|NCT04423185|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154654444|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154654445|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654446|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154654447|NCT04850885|Dexamethasone|dexamethasone|mesh-list
154654448|NCT04850885|Lidocaine|lidocaine|mesh-list
154654449|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654450|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
154654451|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
154654452|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654453|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654454|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654455|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
154654456|NCT04850885|Hormones|hormones|mesh-ancestor
154654457|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654458|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154654459|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654460|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
154654461|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
154654462|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654463|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
154654464|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154654465|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154654466|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154654467|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154654468|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654469|NCT04850417|Aspirin|aspirin|mesh-list
154654470|NCT04850417|Clopidogrel|clopidogrel|mesh-list
154654471|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154654472|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154654473|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154654474|NCT04850417|Analgesics|analgesics|mesh-ancestor
154654475|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
154654476|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654477|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654478|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654479|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654480|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154654481|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154654482|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654483|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154654484|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154654485|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654486|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
154654487|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154654488|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154654489|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154654490|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
154654491|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654492|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154654493|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
154654494|NCT04843943|Bevacizumab|bevacizumab|mesh-list
154654495|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154654496|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654497|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154654498|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154654499|NCT04843943|Growth Substances|growth substances|mesh-ancestor
154654500|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654501|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
154654502|NCT04850261|Nafarelin|nafarelin|mesh-list
154654503|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154654504|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
154654505|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154654506|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654507|NCT04843553|Niacinamide|niacinamide|mesh-list
154654508|NCT04843553|Niacin|niacin|mesh-list
154654509|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
154654510|NCT04843553|Vitamins|vitamins|mesh-ancestor
154654511|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
154654512|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654513|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
154654514|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154654515|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
154654516|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654517|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154654518|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
154654519|NCT02684461|Paclitaxel|paclitaxel|mesh-list
154654520|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
154654521|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154654522|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654523|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
154654524|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
154654525|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
154654526|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654527|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154654528|NCT02684461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154654529|NCT03040193|Lidocaine|lidocaine|mesh-list
154654530|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
154654531|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
154654532|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654533|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654534|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
154654535|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654536|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154654537|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154654538|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154654539|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154654540|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654542|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154654543|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
154654544|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154654545|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
154654546|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654547|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654548|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154654549|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154654550|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654551|NCT03103399|Levodopa|levodopa|mesh-list
154654552|NCT03103399|Carbidopa|carbidopa|mesh-list
154654553|NCT03103399|Entacapone|entacapone|mesh-list
154654554|NCT03103399|Benserazide|benserazide|mesh-list
154654555|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
154654556|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
154654557|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154654558|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154654559|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
154654560|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654561|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654562|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654563|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654564|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154654565|NCT03043157|Rocuronium|rocuronium|mesh-list
154654566|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154654567|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154654568|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154654569|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654570|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654571|NCT05339113|FAPI-46|fapi-46|mesh-list
154654572|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154654573|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654574|NCT03042923|Mannitol|mannitol|mesh-list
154654575|NCT03042923|Lactulose|lactulose|mesh-list
154654576|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154654577|NCT03042923|Diuretics|diuretics|mesh-ancestor
154654578|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
154654579|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654580|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654581|NCT04429295|Vaccines|vaccines|mesh-list
154654582|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
154654583|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654584|NCT05258851|Colistin|colistin|mesh-list
154654585|NCT05258851|Ceftazidime|ceftazidime|mesh-list
154654586|NCT05258851|Avibactam|avibactam|mesh-list
154654587|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154654588|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154654589|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654590|NCT05258851|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154654591|NCT05258851|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154654592|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154654593|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654594|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654595|NCT03043001|Memantine|memantine|mesh-list
154654596|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154654597|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154654598|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
154654599|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654600|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654601|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654602|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154654603|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154654604|NCT04843007|Pemetrexed|pemetrexed|mesh-list
154654605|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654606|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654607|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654608|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154654609|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154654610|NCT04840745|Leuprolide|leuprolide|mesh-list
154654611|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154654612|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
154654613|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154654614|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654615|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154654616|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654617|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
154654618|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154654619|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
154654620|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654621|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
154654622|NCT05072899|Protective Agents|protective agents|mesh-ancestor
154654623|NCT04839653|Vancomycin|vancomycin|mesh-list
154654624|NCT04839653|Gentamicins|gentamicins|mesh-list
154654625|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
154654626|NCT04839653|Polymyxins|polymyxins|mesh-list
154654627|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154654628|NCT04839653|Cefotaxime|cefotaxime|mesh-list
154654629|NCT04839653|Cefoxitin|cefoxitin|mesh-list
154654630|NCT04839653|Polymyxin B|polymyxin b|mesh-list
154654631|NCT04839653|Amphotericin B|amphotericin b|mesh-list
154654632|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154654633|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654634|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154654635|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654636|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654637|NCT04839653|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154654638|NCT04839653|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154654639|NCT04839653|Amebicides|amebicides|mesh-ancestor
154654640|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154654641|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154654642|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
154654643|NCT04842383|Peppermint oil|peppermint oil|mesh-list
154654644|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
154654645|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
154654646|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654647|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654648|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654649|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
154654650|NCT04884139|Tenofovir|tenofovir|mesh-list
154654651|NCT04884139|Lamivudine|lamivudine|mesh-list
154654652|NCT04884139|Emtricitabine|emtricitabine|mesh-list
154654653|NCT04884139|Dolutegravir|dolutegravir|mesh-list
154654654|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
154654655|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654656|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154654657|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154654658|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654659|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654660|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154654661|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154654662|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154654663|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154654664|NCT04860167|Diclofenac|diclofenac|mesh-list
154654665|NCT04860167|Lidocaine|lidocaine|mesh-list
154654666|NCT04860167|Propofol|propofol|mesh-list
154654667|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154654668|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654669|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654670|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154654671|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
154654672|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
154654673|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154654674|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154654675|NCT04860167|Analgesics|analgesics|mesh-ancestor
154654676|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
154654677|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654678|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654679|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654680|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154654681|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654682|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654683|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
154654684|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154654685|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154654686|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154654687|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154654688|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
154654689|NCT02514031|Paclitaxel|paclitaxel|mesh-list
154654690|NCT02514031|Gemcitabine|gemcitabine|mesh-list
154654691|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154654692|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654693|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
154654694|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
154654695|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
154654696|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654697|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154654698|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
154654699|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654700|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154654701|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154654702|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654703|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
154654704|NCT03038477|Durvalumab|durvalumab|mesh-list
154654705|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154654706|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654707|NCT03038243|Vaccines|vaccines|mesh-list
154654708|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
154654709|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654710|NCT03038321|Levofloxacin|levofloxacin|mesh-list
154654711|NCT03038321|Lornoxicam|lornoxicam|mesh-list
154654712|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154654713|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654714|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154654715|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154654716|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154654717|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654718|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654719|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654720|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154654721|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154654722|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154654723|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154654724|NCT03038321|Analgesics|analgesics|mesh-ancestor
154654725|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
154654726|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654727|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654728|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654729|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154654730|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154654731|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
154654732|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654733|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
154654734|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154654735|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154654736|NCT03042377|Calcium|calcium|mesh-list
154654737|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154654738|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654739|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154654740|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654741|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
154654742|NCT05071417|Semaglutide|semaglutide|mesh-list
154654743|NCT05071417|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154654744|NCT05071417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154654745|NCT05071417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654746|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
154654747|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154654748|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654749|NCT04859777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154654750|NCT04859777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654751|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
154654752|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154654753|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154654754|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654755|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
154654756|NCT05562609|Coagulants|coagulants|mesh-ancestor
154654757|NCT05071339|Ganirelix|ganirelix|mesh-list
154654758|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
154654759|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654760|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654761|NCT02606279|Valsartan|valsartan|mesh-list
154654762|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154654763|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154654764|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154654765|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654766|NCT03039491|Vaccines|vaccines|mesh-list
154654767|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154654768|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
154654769|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654770|NCT03037775|Nicotine|nicotine|mesh-list
154654771|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154654772|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
154654773|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654774|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654775|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154654776|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154654777|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
154654778|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654779|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654780|NCT03039257|Vitamin A|vitamin a|mesh-list
154654781|NCT03039257|Vitamins|vitamins|mesh-ancestor
154654782|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
154654783|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654784|NCT03038009|Pantoprazole|pantoprazole|mesh-list
154654785|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154654786|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654787|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154654788|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654789|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654790|NCT03466801|Prednisone|prednisone|mesh-list
154654791|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
154369628|NCT03596866|Alectinib|alectinib|mesh-list
154654792|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154654793|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654794|NCT03466801|Hormones|hormones|mesh-ancestor
154654795|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654796|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654797|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154654798|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654799|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
154654800|NCT05069779|Diazepam|diazepam|mesh-list
154654801|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154654802|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
154654803|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
154654804|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
154654805|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654806|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654807|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654808|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154654809|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654810|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154654811|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154654812|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154654813|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154654814|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154654815|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154654816|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
154654817|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
154654818|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
154654819|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
154654820|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654821|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654822|NCT03251911|Ivacaftor|ivacaftor|mesh-list
154654823|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154654824|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154654825|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654826|NCT02643355|Clonidine|clonidine|mesh-list
154654827|NCT02643355|Olanzapine|olanzapine|mesh-list
154654828|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
154654829|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
154654830|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654831|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654832|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654833|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154654834|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154654835|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654836|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154654837|NCT02643355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154654838|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154654839|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154654840|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654841|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654842|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
154654843|NCT02643355|Analgesics|analgesics|mesh-ancestor
154654844|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
154654845|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154654846|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
154654847|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154654848|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154654849|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154654850|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
154654851|NCT03036605|Dexamethasone|dexamethasone|mesh-list
154654852|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
154654853|NCT03036605|Bupivacaine|bupivacaine|mesh-list
154654854|NCT03036605|BB 1101|bb 1101|mesh-list
154654855|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654856|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
154654857|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
154654858|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654859|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654860|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654861|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
154654862|NCT03036605|Hormones|hormones|mesh-ancestor
154654863|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154654864|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154654865|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654866|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
154654867|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654868|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654869|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
154654870|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
154654871|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654872|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
154654873|NCT03098875|Remifentanil|remifentanil|mesh-list
154654874|NCT03098875|Propofol|propofol|mesh-list
154654875|NCT03098875|Sevoflurane|sevoflurane|mesh-list
154654876|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154654877|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654878|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654879|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154654880|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
154654881|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
154654882|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154654883|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154654884|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154654885|NCT03098875|Narcotics|narcotics|mesh-ancestor
154654886|NCT03098875|Analgesics|analgesics|mesh-ancestor
154654887|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
154654888|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654889|NCT03099031|Tinzaparin|tinzaparin|mesh-list
154654890|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154654891|NCT03099031|Dalteparin|dalteparin|mesh-list
154654892|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
154654893|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154654894|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154654895|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654896|NCT03101137|Dexamethasone|dexamethasone|mesh-list
154654897|NCT03101137|Bupivacaine|bupivacaine|mesh-list
154654898|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654899|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
154654900|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
154654901|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654902|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654903|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154654904|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
154654905|NCT03101137|Hormones|hormones|mesh-ancestor
154654906|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860334|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
154406909|NCT03203447|Triamcinolone|triamcinolone|mesh-list
154654907|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154654908|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654909|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
154654910|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
154654911|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654912|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
154654913|NCT04833257|Tislelizumab|tislelizumab|mesh-list
154654914|NCT04833257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154654915|NCT04833257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154654916|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154654917|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154654918|NCT04833101|Vaccines|vaccines|mesh-list
154654919|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
154654920|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654921|NCT00794599|Cetirizine|cetirizine|mesh-list
154654922|NCT00794599|Desloratadine|desloratadine|mesh-list
154654923|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154654924|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154654925|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154654926|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
154654927|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
154654928|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654929|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654930|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654931|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154654932|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
154654933|NCT00783133|Fexofenadine|fexofenadine|mesh-list
154654934|NCT00783133|Desloratadine|desloratadine|mesh-list
154654935|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154654936|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
154654937|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154654938|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654939|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654940|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154654941|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154654942|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
154654943|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
154654944|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154654945|NCT03098407|Buprenorphine|buprenorphine|mesh-list
154654946|NCT03098407|Methadone|methadone|mesh-list
154654947|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154654948|NCT03098407|Narcotics|narcotics|mesh-ancestor
154654949|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154654950|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654951|NCT03098407|Analgesics|analgesics|mesh-ancestor
154654952|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
154654953|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154654954|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154654955|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
154654956|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
154654957|NCT04836143|Mitogens|mitogens|mesh-list
154654958|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
154654959|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
154654960|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654961|NCT04836143|Growth Substances|growth substances|mesh-ancestor
154654962|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654963|NCT05068453|Antibodies|antibodies|mesh-list
154654964|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154654965|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
154654966|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154654967|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
154654968|NCT00751075|Amoxicillin|amoxicillin|mesh-list
154654969|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154654970|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654971|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654972|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
154654973|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154654974|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
154654975|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154654976|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
154654977|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154654978|NCT04836299|Ivermectin|ivermectin|mesh-list
154654979|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154654980|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154654981|NCT00651391|Simvastatin|simvastatin|mesh-list
154654982|NCT00651391|Ezetimibe|ezetimibe|mesh-list
154654983|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154654984|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154654985|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
154654986|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654987|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154654988|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154654989|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654990|NCT00650689|Atorvastatin|atorvastatin|mesh-list
154654991|NCT00650689|Ezetimibe|ezetimibe|mesh-list
154654992|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154654993|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154654994|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
154654995|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154654996|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154654997|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154654998|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154654999|NCT05067517|Nintedanib|nintedanib|mesh-list
154655000|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655001|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154655002|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655003|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655004|NCT03100513|Lactulose|lactulose|mesh-list
154655005|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655006|NCT00552097|Simvastatin|simvastatin|mesh-list
154655007|NCT00552097|Ezetimibe|ezetimibe|mesh-list
154655008|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154655009|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154655010|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
154655011|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655012|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154655013|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154655014|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655015|NCT00396175|Finasteride|finasteride|mesh-list
154655016|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655017|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655018|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154655019|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154655020|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655021|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
154655022|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655023|NCT00396175|Urological Agents|urological agents|mesh-ancestor
154655024|NCT02603393|Fluticasone|fluticasone|mesh-list
154655025|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
154655026|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154655027|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655028|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154655029|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
154655030|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655031|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655032|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154655033|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
154655034|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655035|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154655036|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
154655037|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154655038|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
154655039|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655040|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655041|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154655042|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154655043|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154655044|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
154655045|NCT04832945|Ivermectin|ivermectin|mesh-list
154655046|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154655047|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655048|NCT02642653|Lovastatin|lovastatin|mesh-list
154655049|NCT02642653|L 647318|l 647318|mesh-list
154655050|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
154655051|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154655052|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154655053|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
154655054|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655055|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154655056|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154655057|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655058|NCT01659567|Interferons|interferons|mesh-list
154655059|NCT01659567|Ribavirin|ribavirin|mesh-list
154655060|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
154655061|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
154655062|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154655063|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655064|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
154655065|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655066|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
154655067|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655068|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
154655069|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655070|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
154655071|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154655072|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655073|NCT03036995|Apremilast|apremilast|mesh-list
154655074|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154655075|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154655076|NCT03036995|Analgesics|analgesics|mesh-ancestor
154655077|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
154655078|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655079|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655080|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655081|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154655082|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154655083|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154655084|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655085|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655086|NCT05066035|Neostigmine|neostigmine|mesh-list
154655087|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154655088|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655089|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655090|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
154655091|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655092|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655093|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154655094|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
154655095|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655096|NCT04822415|Mepivacaine|mepivacaine|mesh-list
154655097|NCT04822415|Carticaine|carticaine|mesh-list
154655098|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
154655099|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
154655100|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655101|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655102|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
154655103|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655104|NCT05065177|Vaccines|vaccines|mesh-list
154655105|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
154655106|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655107|NCT04821947|Bupivacaine|bupivacaine|mesh-list
154655108|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
154655109|NCT04821947|Anesthetics|anesthetics|mesh-list
154655110|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655111|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655112|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
154655113|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655114|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154655115|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154655116|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154655117|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154655118|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655119|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655120|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655121|NCT03037073|Analgesics|analgesics|mesh-ancestor
154655122|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
154655123|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655124|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
154655125|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154655126|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
154655127|NCT04470973|Amikacin|amikacin|mesh-list
154655128|NCT04470973|Cefuroxime|cefuroxime|mesh-list
154655129|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
154655130|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154655131|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655132|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
154655133|NCT05046457|Provitamins|provitamins|mesh-ancestor
154655134|NCT05046457|Vitamins|vitamins|mesh-ancestor
154655135|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
154655136|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655137|NCT05063071|Tenofovir|tenofovir|mesh-list
154655138|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
154655139|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655140|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154655141|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154655142|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655143|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655144|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154655145|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154655146|NCT05062681|Dexamethasone|dexamethasone|mesh-list
154655147|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
154655148|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154655149|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154655150|NCT05062681|Prednisolone|prednisolone|mesh-list
154655151|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
154655152|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154655153|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
154655154|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655155|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
154655156|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
154655157|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655158|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655159|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655160|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
154655161|NCT05062681|Hormones|hormones|mesh-ancestor
154655162|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655163|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655164|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655165|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154655166|NCT05062681|Protective Agents|protective agents|mesh-ancestor
154655167|NCT05056519|Vaccines|vaccines|mesh-list
154655168|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
154655169|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655170|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154655171|NCT05045053|Lifitegrast|lifitegrast|mesh-list
154655172|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154655173|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154655174|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
154655175|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655176|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655177|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655178|NCT05060809|Vitamin K|vitamin k|mesh-list
154655179|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
154655180|NCT05060809|Vitamins|vitamins|mesh-ancestor
154655181|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
154655182|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655183|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154655184|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154655185|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655186|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
154655187|NCT05060809|Coagulants|coagulants|mesh-ancestor
154655188|NCT05060419|Meropenem|meropenem|mesh-list
154655189|NCT05060419|Tazobactam|tazobactam|mesh-list
154655190|NCT05060419|Piperacillin|piperacillin|mesh-list
154655191|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154655192|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154655193|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655194|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154655195|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655196|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655197|NCT03097003|Apremilast|apremilast|mesh-list
154655198|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154655199|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154655200|NCT03097003|Analgesics|analgesics|mesh-ancestor
154655201|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
154655202|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655203|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655204|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655205|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154655206|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154655207|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154655208|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655209|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655210|NCT02605967|Spartalizumab|spartalizumab|mesh-list
154655211|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154655212|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655213|NCT02605967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655214|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655215|NCT03036059|Ivermectin|ivermectin|mesh-list
154655216|NCT03036059|Albendazole|albendazole|mesh-list
154655217|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154655218|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655219|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
154655220|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
154655221|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154655222|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154655223|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
154655224|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
154655225|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
154655226|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655227|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655228|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154655229|NCT05035849|Acarbose|acarbose|mesh-list
154655230|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154655231|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655232|NCT05035849|Incretins|incretins|mesh-ancestor
154655233|NCT05035849|Hormones|hormones|mesh-ancestor
154655234|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655235|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154655236|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
154655237|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655238|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655239|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154655240|NCT05035381|Leucovorin|leucovorin|mesh-list
154655241|NCT05035381|Bevacizumab|bevacizumab|mesh-list
154655242|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
154655243|NCT05035381|Fluorouracil|fluorouracil|mesh-list
154655244|NCT05035381|Irinotecan|irinotecan|mesh-list
154655245|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154655246|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655247|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655248|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154655249|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154655250|NCT05035381|Growth Substances|growth substances|mesh-ancestor
154655251|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655252|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
154655253|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655254|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
154655255|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154655256|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154655257|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
154655258|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154655259|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154655260|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655261|NCT05035381|Antidotes|antidotes|mesh-ancestor
154655262|NCT05035381|Protective Agents|protective agents|mesh-ancestor
154655263|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
154655264|NCT05035381|Vitamins|vitamins|mesh-ancestor
154655265|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
154655266|NCT04821323|Indomethacin|indomethacin|mesh-list
154655267|NCT04821323|Mannitol|mannitol|mesh-list
154655268|NCT04821323|Lactulose|lactulose|mesh-list
154655269|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154655270|NCT04821323|Diuretics|diuretics|mesh-ancestor
154655271|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
154655272|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655273|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154655274|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154655275|NCT04821323|Analgesics|analgesics|mesh-ancestor
154655276|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
154655277|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655278|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655279|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154655280|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
154655281|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
154655282|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154655283|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154655284|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655285|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655286|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407289|NCT03636659|Amphotericin B|amphotericin b|mesh-list
154655287|NCT05035069|Propofol|propofol|mesh-list
154655288|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154655289|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655290|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655291|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154655292|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
154655293|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
154655294|NCT05035147|Paclitaxel|paclitaxel|mesh-list
154655295|NCT05035147|Gemcitabine|gemcitabine|mesh-list
154655296|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154655297|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154655298|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655299|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
154655300|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
154655301|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
154370134|NCT03722875|Apatinib|apatinib|mesh-list
154655302|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655303|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154655304|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
154655305|NCT04834115|Ivermectin|ivermectin|mesh-list
154655306|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154655307|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655308|NCT01505465|Melatonin|melatonin|mesh-list
154655309|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
154655310|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655311|NCT01505465|Protective Agents|protective agents|mesh-ancestor
154655312|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655313|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655314|NCT04831229|Menthol|menthol|mesh-list
154655315|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
154655316|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655317|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
154655318|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154655319|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154655320|NCT04816253|Prednisolone|prednisolone|mesh-list
154655321|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
154655322|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154655323|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
154655324|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
154655325|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655326|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
154655327|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
154655328|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655329|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655330|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655331|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
154655332|NCT04816253|Hormones|hormones|mesh-ancestor
154655333|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655334|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154655335|NCT04816253|Protective Agents|protective agents|mesh-ancestor
154655336|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655337|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655338|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154655339|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
154655340|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
154655341|NCT04816097|Dexamethasone|dexamethasone|mesh-list
154655342|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154655343|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655344|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
154655345|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
154655346|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655347|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655348|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655349|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
154655350|NCT04816097|Hormones|hormones|mesh-ancestor
154655351|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655352|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655353|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655354|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
154655355|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154655356|NCT02600351|Ledipasvir|ledipasvir|mesh-list
154655357|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
154655358|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655359|NCT04829435|Rasburicase|rasburicase|mesh-list
154655360|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
154655361|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154655362|NCT05042635|Ixekizumab|ixekizumab|mesh-list
154655363|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655364|NCT04815395|Oxytocin|oxytocin|mesh-list
154655365|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
154655366|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154655367|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655368|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
154655369|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655370|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
154655371|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
154655372|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655373|NCT05034055|Atezolizumab|atezolizumab|mesh-list
154655374|NCT05034055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154655375|NCT05034055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655376|NCT05034055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655377|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655378|NCT05042245|Silymarin|silymarin|mesh-list
154655379|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
154655380|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
154655381|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655382|NCT05042245|Protective Agents|protective agents|mesh-ancestor
154655383|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655384|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154655385|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154655386|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655387|NCT03095209|Paclitaxel|paclitaxel|mesh-list
154655388|NCT03095209|Carboplatin|carboplatin|mesh-list
154655389|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154655390|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655391|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
154655392|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
154655393|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
154655394|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655395|NCT05034133|Cisplatin|cisplatin|mesh-list
154655396|NCT05034133|Etoposide|etoposide|mesh-list
154655397|NCT05034133|Durvalumab|durvalumab|mesh-list
154655398|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655399|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154655400|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154655401|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154655402|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655403|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655404|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655405|NCT03096457|Paromomycin|paromomycin|mesh-list
154655406|NCT03096457|Pentamidine|pentamidine|mesh-list
154655407|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154655408|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655409|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154655410|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154655411|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
154655412|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154655413|NCT03096223|KHK4083|khk4083|mesh-list
154655414|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655415|NCT04814303|Morphine|morphine|mesh-list
154655416|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154655417|NCT04814303|Narcotics|narcotics|mesh-ancestor
154655418|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655419|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655420|NCT04814303|Analgesics|analgesics|mesh-ancestor
154655421|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
154655422|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655423|NCT05053009|Ibuprofen|ibuprofen|mesh-list
154655424|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154655425|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154655426|NCT05053009|Analgesics|analgesics|mesh-ancestor
154655427|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
154655428|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655429|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655430|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655431|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154655432|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154655433|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655434|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655435|NCT04813913|Bevacizumab|bevacizumab|mesh-list
154655436|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655437|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655438|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154655439|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154655440|NCT04813913|Growth Substances|growth substances|mesh-ancestor
154655441|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655442|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
154655443|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
154655445|NCT04814381|Analgesics|analgesics|mesh-ancestor
154655446|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
154655447|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655448|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655449|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154655450|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154655451|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
154655452|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
154655453|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655454|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154655455|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154655456|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655457|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655458|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154655459|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
154655460|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154655461|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154655462|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154655463|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
154655464|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154655465|NCT04819217|Charcoal|charcoal|mesh-list
154655466|NCT04819217|Antidotes|antidotes|mesh-ancestor
154655467|NCT04819217|Protective Agents|protective agents|mesh-ancestor
154655468|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655469|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154655470|NCT05052619|Cefmetazole|cefmetazole|mesh-list
154655471|NCT05052619|Sulperazone|sulperazone|mesh-list
154655472|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655473|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154655474|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
154655475|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154655476|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655477|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
154655478|NCT04813523|Cisplatin|cisplatin|mesh-list
154655479|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
154655480|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655481|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655482|NCT04813523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154655483|NCT04813523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655484|NCT05032261|Norepinephrine|norepinephrine|mesh-list
154655485|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154655486|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154655487|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
154655488|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655489|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655490|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655491|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
154655492|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
154655493|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655494|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154655495|NCT05619341|Psyllium|psyllium|mesh-list
154655496|NCT05619341|Cathartics|cathartics|mesh-ancestor
154655497|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655498|NCT04814069|Tislelizumab|tislelizumab|mesh-list
154655499|NCT04814069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655500|NCT04814069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655501|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
154655502|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
154655503|NCT05051137|Infliximab|infliximab|mesh-list
154655504|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
154655505|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154655506|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154655507|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655508|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370358|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
154655509|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655510|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154655511|NCT05051137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154655512|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655513|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655514|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407517|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655515|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154655516|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154655518|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
154655519|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655520|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655521|NCT05038969|Esomeprazole|esomeprazole|mesh-list
154655522|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154655523|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655524|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154655525|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655526|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655527|NCT05038657|Atezolizumab|atezolizumab|mesh-list
154655528|NCT05038657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154655529|NCT05038657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655530|NCT05038657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655531|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655532|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
154655533|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154655534|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655535|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655536|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154655537|NCT05038111|Analgesics|analgesics|mesh-ancestor
154655538|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
154655539|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655540|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154655541|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154655542|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154655543|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
154655544|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655545|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655546|NCT05030077|Carboplatin|carboplatin|mesh-list
154655547|NCT05030077|Gemcitabine|gemcitabine|mesh-list
154655548|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655549|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154655550|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
154655551|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655552|NCT05029531|Immunomodulating Agents|immunomodulating agents|mesh-list
154655553|NCT05029531|Immunologic Factors|immunologic factors|mesh-ancestor
154655554|NCT05029531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655555|NCT05029453|Apatinib|apatinib|mesh-list
154655556|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655557|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154655558|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655559|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655560|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
154655561|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
154655562|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655563|NCT05037253|Vitamin D|vitamin d|mesh-list
154655564|NCT05037253|Vitamins|vitamins|mesh-ancestor
154655565|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
154370392|NCT05014334|Bismuth|bismuth|mesh-list
154655566|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655567|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154655568|NCT05029297|Capsaicin|capsaicin|mesh-list
154655569|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
154655570|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655571|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
154655572|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655573|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655574|NCT05028907|Tocopherols|tocopherols|mesh-list
154655575|NCT05028907|Vitamin E|vitamin e|mesh-list
154655576|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
154655577|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
154655578|NCT05028907|Dexamethasone|dexamethasone|mesh-list
154655579|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
154655580|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
154655581|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154655582|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
154655583|NCT05028907|BB 1101|bb 1101|mesh-list
154655584|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655585|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
154655586|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
154655587|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655588|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655589|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655590|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
154655591|NCT05028907|Hormones|hormones|mesh-ancestor
154407597|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
154860335|NCT00637052|Filanesib|filanesib|mesh-list
154655592|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655593|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655594|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655595|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154655596|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
154655597|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
154655598|NCT05028907|Protective Agents|protective agents|mesh-ancestor
154655599|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
154655600|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655601|NCT05028907|Vitamins|vitamins|mesh-ancestor
154655602|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
154655603|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
154655604|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655605|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154655606|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655607|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154655608|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154655609|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154655610|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
154655611|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
154655612|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154655613|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
154655614|NCT05028049|Sufentanil|sufentanil|mesh-list
154655615|NCT05028049|Remifentanil|remifentanil|mesh-list
154655616|NCT05028049|Dsuvia|dsuvia|mesh-list
154655617|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154655618|NCT05028049|Narcotics|narcotics|mesh-ancestor
154655619|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655620|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655621|NCT05028049|Analgesics|analgesics|mesh-ancestor
154655622|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
154655623|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655624|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154655625|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154655626|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
154655627|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
154655628|NCT05023915|Dexamethasone|dexamethasone|mesh-list
154655629|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154655630|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655631|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
154655632|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
154655633|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655634|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655635|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655636|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
154655637|NCT05023915|Hormones|hormones|mesh-ancestor
154655638|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655639|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655640|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655641|NCT05027191|Sevoflurane|sevoflurane|mesh-list
154655642|NCT05027191|Desflurane|desflurane|mesh-list
154655643|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154655644|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154655645|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
154655646|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
154655647|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655648|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655649|NCT03094507|Dolutegravir|dolutegravir|mesh-list
154655650|NCT03094507|Darunavir|darunavir|mesh-list
154655651|NCT03094507|Cobicistat|cobicistat|mesh-list
154655652|NCT03094507|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154655653|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154655654|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154655655|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655656|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655657|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154655658|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154655659|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
154655660|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655661|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154655662|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154655663|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
154655664|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154655665|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154655666|NCT02528253|Tramadol|tramadol|mesh-list
154407663|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154655667|NCT02528253|Tanezumab|tanezumab|mesh-list
154655668|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154655669|NCT02528253|Narcotics|narcotics|mesh-ancestor
154655670|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655671|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655672|NCT02528253|Analgesics|analgesics|mesh-ancestor
154655673|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
154655674|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655675|NCT03093103|Empagliflozin|empagliflozin|mesh-list
154655676|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154655677|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655678|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154655679|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655680|NCT03093805|Calcipotriene|calcipotriene|mesh-list
154655681|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655682|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154655683|NCT03093883|Hematinics|hematinics|mesh-ancestor
154655684|NCT05023759|Cannabidiol|cannabidiol|mesh-list
154655685|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
154655686|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
154655687|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154655688|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154655689|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655690|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154655691|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
154655692|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154655693|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655694|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655695|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655696|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
154655697|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655698|NCT05047393|Vitamin D|vitamin d|mesh-list
154655699|NCT05047393|Vitamins|vitamins|mesh-ancestor
154655700|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
154655701|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655702|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154655703|NCT05021887|Fluticasone|fluticasone|mesh-list
154655704|NCT05021887|Xhance|xhance|mesh-list
154655705|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655706|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154655707|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
154655708|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655709|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655710|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154655711|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
154655712|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655713|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154655714|NCT05009953|Leucovorin|leucovorin|mesh-list
154655715|NCT05009953|Fluorouracil|fluorouracil|mesh-list
154655716|NCT05009953|Irinotecan|irinotecan|mesh-list
154655717|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
154655718|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655719|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154655720|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655721|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154655722|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
154655723|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655724|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154655725|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154655726|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655727|NCT05009953|Antidotes|antidotes|mesh-ancestor
154655728|NCT05009953|Protective Agents|protective agents|mesh-ancestor
154655729|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
154655730|NCT05009953|Vitamins|vitamins|mesh-ancestor
154655731|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
154655732|NCT03079453|Dexamethasone|dexamethasone|mesh-list
154655733|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655734|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
154655735|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
154655736|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655737|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655738|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655739|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
154655740|NCT03079453|Hormones|hormones|mesh-ancestor
154655741|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655742|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655743|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655744|NCT05009017|Bevacizumab|bevacizumab|mesh-list
154655745|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655746|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655747|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154655748|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154655749|NCT05009017|Growth Substances|growth substances|mesh-ancestor
154655750|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655751|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
154655752|NCT05008939|Sevoflurane|sevoflurane|mesh-list
154655753|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154655754|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154655755|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
154655756|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
154655757|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655758|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655759|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
154655760|NCT05008861|Nivolumab|nivolumab|mesh-list
154655761|NCT05008861|Durvalumab|durvalumab|mesh-list
154655762|NCT05008861|Tislelizumab|tislelizumab|mesh-list
154655763|NCT05008861|Antibodies|antibodies|mesh-list
154655764|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154655765|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
154655766|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655767|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655768|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655769|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154655770|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655771|NCT05016973|Disitamab vedotin|disitamab vedotin|mesh-list
154655772|NCT05016973|Immunoconjugates|immunoconjugates|mesh-ancestor
154655773|NCT05016973|Immunologic Factors|immunologic factors|mesh-ancestor
154655774|NCT05016973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655775|NCT03091699|Nicotine|nicotine|mesh-list
154655776|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154655777|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
154655778|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655779|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655780|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154655781|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154655782|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
154655783|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655784|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655785|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
154655786|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655787|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655788|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
154655789|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655790|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655791|NCT04253457|Triamcinolone|triamcinolone|mesh-list
154655792|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655793|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
154655794|NCT04253457|Hormones|hormones|mesh-ancestor
154655795|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655796|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655797|NCT05380947|Rabeprazole|rabeprazole|mesh-list
154655798|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154655799|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655800|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154655801|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655802|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655803|NCT02525133|Bupivacaine|bupivacaine|mesh-list
154655804|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
154655805|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
154370616|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154655806|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655807|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655808|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
154655809|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655810|NCT05602311|Anesthetics|anesthetics|mesh-list
154655811|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
154655812|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655813|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655814|NCT05016349|Tamoxifen|tamoxifen|mesh-list
154655815|NCT05016349|Tocopherols|tocopherols|mesh-list
154655816|NCT05016349|Tretinoin|tretinoin|mesh-list
154655817|NCT05016349|Alitretinoin|alitretinoin|mesh-list
154655818|NCT05016349|Cannabidiol|cannabidiol|mesh-list
154655819|NCT05016349|Isotretinoin|isotretinoin|mesh-list
154655820|NCT05016349|Mifepristone|mifepristone|mesh-list
154655821|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154407814|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
154655822|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
154655823|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655824|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655825|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655826|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655827|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154655828|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154655829|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154655830|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
154655831|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
154655832|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655833|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154655834|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
154655835|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154655836|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154655837|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154655838|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154655839|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
154655840|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154655841|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154655842|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
154655843|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154655844|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154655845|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
154655846|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655847|NCT05016349|Protective Agents|protective agents|mesh-ancestor
154655848|NCT05016349|Vitamins|vitamins|mesh-ancestor
154655849|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
154655850|NCT05380635|Hypericin|hypericin|mesh-list
154655851|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
154655852|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154655853|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655854|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
154655855|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655856|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655857|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655858|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154655859|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
154655860|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655861|NCT05538819|Glimepiride|glimepiride|mesh-list
154655862|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154655863|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154655864|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655865|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154655866|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
154655867|NCT03079219|Dexamethasone|dexamethasone|mesh-list
154655868|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
154655869|NCT03079219|Ondansetron|ondansetron|mesh-list
154655870|NCT03079219|Olanzapine|olanzapine|mesh-list
154655871|NCT03079219|Aprepitant|aprepitant|mesh-list
154655872|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
154655873|NCT03079219|BB 1101|bb 1101|mesh-list
154655874|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655875|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
154655876|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
154655877|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655878|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655879|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655880|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
154655881|NCT03079219|Hormones|hormones|mesh-ancestor
154655882|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655883|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655884|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655885|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
154655886|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655887|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655888|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
154655889|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
154655890|NCT03079219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154655891|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154655892|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
154655893|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655894|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154655895|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154655896|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655897|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154655898|NCT03079219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154655899|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154655900|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154655901|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154655903|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154655904|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
154655905|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154655906|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655907|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154655908|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655909|NCT05008237|Docetaxel|docetaxel|mesh-list
154370754|NCT03328312|Atropine|atropine|mesh-list
154655910|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655911|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
154655912|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
154655913|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
154655914|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655915|NCT05014711|Fentanyl|fentanyl|mesh-list
154655916|NCT05014711|Remifentanil|remifentanil|mesh-list
154655917|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154655918|NCT05014711|Narcotics|narcotics|mesh-ancestor
154655919|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154655920|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655921|NCT05014711|Analgesics|analgesics|mesh-ancestor
154655922|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
154655923|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655924|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154655925|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154655926|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
154655927|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
154655928|NCT05018923|Metronidazole|metronidazole|mesh-list
154655929|NCT05018923|Doxycycline|doxycycline|mesh-list
154655930|NCT05018923|Tetracycline|tetracycline|mesh-list
154655931|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
154655932|NCT05018923|Rabeprazole|rabeprazole|mesh-list
154655933|NCT05018923|Bismuth|bismuth|mesh-list
154655934|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655935|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154655936|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154655937|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154655938|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154655939|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
154655940|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154655941|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655942|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154655943|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655944|NCT05018923|Antacids|antacids|mesh-ancestor
154655945|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154655946|NCT05018923|Diuretics|diuretics|mesh-ancestor
154655947|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
154655948|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655949|NCT05018923|Expectorants|expectorants|mesh-ancestor
154655950|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
154655951|NCT03086473|Caffeine|caffeine|mesh-list
154655952|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
154655953|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154655954|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154655955|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655956|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154655957|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154655958|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154655959|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154655960|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
154655961|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154655962|NCT03086005|Metformin|metformin|mesh-list
154655963|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154655964|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655965|NCT03079141|Eplerenone|eplerenone|mesh-list
154655966|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154655967|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
154655968|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154655969|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655970|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154655971|NCT03079141|Diuretics|diuretics|mesh-ancestor
154655972|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
154655973|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154655974|NCT03085849|Durvalumab|durvalumab|mesh-list
154655975|NCT03085849|Tremelimumab|tremelimumab|mesh-list
154655976|NCT03085849|Guadecitabine|guadecitabine|mesh-list
154655977|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154655978|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154655979|NCT05001529|Antibodies|antibodies|mesh-list
154655980|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
154655981|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655982|NCT05001061|Misoprostol|misoprostol|mesh-list
154655983|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154655984|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
154655985|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154655986|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655987|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154655988|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154655989|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
154655990|NCT05531955|Pirfenidone|pirfenidone|mesh-list
154655991|NCT05531955|Analgesics|analgesics|mesh-ancestor
154655992|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
154655993|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154655994|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154655995|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154655996|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154655997|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154655998|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154655999|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656000|NCT05006911|Bromfenac|bromfenac|mesh-list
154656001|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154656002|NCT05006911|Phenylephrine|phenylephrine|mesh-list
154656003|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
154656004|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
154656005|NCT05006911|Pilocarpine|pilocarpine|mesh-list
154656006|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154656007|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
154656008|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656009|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
154656010|NCT05006911|Protective Agents|protective agents|mesh-ancestor
154656011|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154656012|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154656013|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154656014|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154656015|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
154656016|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656017|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656018|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
154656019|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
154656020|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656021|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
154656022|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154656023|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
154656024|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154656025|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
154656026|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154656027|NCT05006911|Miotics|miotics|mesh-ancestor
154656028|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154656029|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154656030|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
154656031|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154656032|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154656033|NCT05006911|Analgesics|analgesics|mesh-ancestor
154656034|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
154656035|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656036|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656037|NCT05339295|Levofloxacin|levofloxacin|mesh-list
154656038|NCT05339295|Ofloxacin|ofloxacin|mesh-list
154656039|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154656040|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656041|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154656042|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154656043|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154656044|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656045|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656046|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656047|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154408036|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
154656048|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154656049|NCT02637037|Metformin|metformin|mesh-list
154656050|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
154656051|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154656052|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656053|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154656054|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656055|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
154656056|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154656057|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154656058|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
154656059|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656060|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
154656061|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
154656062|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
154656063|NCT02637895|Vortioxetine|vortioxetine|mesh-list
154656064|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
154656065|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154656066|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154656067|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154656068|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656069|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656070|NCT02637895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154656071|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154656072|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154656073|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656074|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656075|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
154656076|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154656077|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154656078|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154656079|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154656080|NCT05013697|Paclitaxel|paclitaxel|mesh-list
154656081|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154656082|NCT05013697|Cisplatin|cisplatin|mesh-list
154656083|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154656084|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656085|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
154656086|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
154656087|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
154656088|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656089|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
154656090|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154656091|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656092|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154656093|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656094|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154656095|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656096|NCT05007223|Doxycycline|doxycycline|mesh-list
154656097|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154656098|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656099|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
154656100|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154656101|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154656102|NCT05000281|Ibuprofen|ibuprofen|mesh-list
154656103|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154656104|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154656105|NCT05000281|Analgesics|analgesics|mesh-ancestor
154656106|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
154656107|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656108|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656109|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656110|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656111|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154656112|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656113|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656114|NCT03081949|Selenium|selenium|mesh-list
154656115|NCT03081949|Selenious Acid|selenious acid|mesh-list
154656116|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
154656117|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
154656118|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656119|NCT03081949|Protective Agents|protective agents|mesh-ancestor
154656120|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656121|NCT03081949|Trace Elements|trace elements|mesh-ancestor
154656122|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
154656123|NCT05006287|Warfarin|warfarin|mesh-list
154656124|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
154656125|NCT05006287|Dabigatran|dabigatran|mesh-list
154656126|NCT05006287|Apixaban|apixaban|mesh-list
154656127|NCT05006287|Anticoagulants|anticoagulants|mesh-list
154656128|NCT05006287|Edoxaban|edoxaban|mesh-list
154656129|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154656130|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
154656131|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154656132|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
154656133|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656134|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656135|NCT05013151|Castor Oil|castor oil|mesh-list
154656136|NCT05013151|Cathartics|cathartics|mesh-ancestor
154656137|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154656138|NCT05006209|Calcium|calcium|mesh-list
154656139|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154656140|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656141|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
154656142|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154656143|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656144|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656145|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154656146|NCT03076099|Analgesics|analgesics|mesh-ancestor
154656147|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
154656148|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656149|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154656150|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154656151|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154656152|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
154656153|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656154|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656155|NCT05554965|Propofol|propofol|mesh-list
154656156|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154656157|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656158|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656159|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154656160|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
154656161|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
154656162|NCT05331573|Apomorphine|apomorphine|mesh-list
154656163|NCT05331573|Emetics|emetics|mesh-ancestor
154656164|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656165|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
154656166|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656167|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154656168|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
154656169|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
154656170|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656171|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656172|NCT05260359|Ethanol|ethanol|mesh-list
154656173|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
154656174|NCT05260359|Petrolatum|petrolatum|mesh-list
154656175|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154656176|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656177|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656178|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656179|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154656180|NCT05260359|Protective Agents|protective agents|mesh-ancestor
154656181|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
154656182|NCT05260359|Emollients|emollients|mesh-ancestor
154656183|NCT05294835|Ketamine|ketamine|mesh-list
154656184|NCT05294835|Analgesics|analgesics|mesh-ancestor
154656185|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
154656186|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656187|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656188|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154656189|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154656190|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
154656191|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
154656192|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656193|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154656194|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154656195|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656196|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656197|NCT02522325|Cocaine|cocaine|mesh-list
154656198|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
154408200|NCT03217175|Glucagon|glucagon|mesh-list
154656199|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
154656200|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
154656201|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656202|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656203|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
154656204|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656205|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154656206|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154656207|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154656208|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154656209|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656210|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
154656211|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656212|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154656213|NCT01659021|Ofatumumab|ofatumumab|mesh-list
154656214|NCT01659021|Idelalisib|idelalisib|mesh-list
154656215|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656216|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656217|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656218|NCT05012137|Ropivacaine|ropivacaine|mesh-list
154656219|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
154656220|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
154656221|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656222|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656223|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
154656224|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656225|NCT06163170|Nivolumab|nivolumab|mesh-list
154656226|NCT06163170|Ipilimumab|ipilimumab|mesh-list
154656227|NCT06163170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154656228|NCT06163170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656229|NCT06163170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154656230|NCT06163170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656231|NCT06163053|Immunomodulating Agents|immunomodulating agents|mesh-list
154656232|NCT06163053|Immunologic Factors|immunologic factors|mesh-ancestor
154656233|NCT06163053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656234|NCT06163040|Dexamethasone|dexamethasone|mesh-list
154656235|NCT06163040|Dexamethasone acetate|dexamethasone acetate|mesh-list
154656236|NCT06163040|Lenalidomide|lenalidomide|mesh-list
154656237|NCT06163040|Pomalidomide|pomalidomide|mesh-list
154656238|NCT06163040|Elotuzumab|elotuzumab|mesh-list
154656239|NCT06163040|BB 1101|bb 1101|mesh-list
154656240|NCT06163040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656241|NCT06163040|Antiemetics|antiemetics|mesh-ancestor
154656242|NCT06163040|Autonomic Agents|autonomic agents|mesh-ancestor
154656243|NCT06163040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656244|NCT06163040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656245|NCT06163040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154656246|NCT06163040|Glucocorticoids|glucocorticoids|mesh-ancestor
154656247|NCT06163040|Hormones|hormones|mesh-ancestor
154656248|NCT06163040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656249|NCT06163040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154656250|NCT06163040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656251|NCT06163040|Protease Inhibitors|protease inhibitors|mesh-ancestor
154656252|NCT06163040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656253|NCT06163040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656254|NCT06163040|Immunologic Factors|immunologic factors|mesh-ancestor
154656255|NCT06163040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154371080|NCT03920657|Deferasirox|deferasirox|mesh-list
154656256|NCT06163040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154656257|NCT06163040|Growth Substances|growth substances|mesh-ancestor
154656258|NCT06163040|Growth Inhibitors|growth inhibitors|mesh-ancestor
154656259|NCT06162832|Becaplermin|becaplermin|mesh-list
154656260|NCT06162832|Anticoagulants|anticoagulants|mesh-ancestor
154656261|NCT06162832|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154656262|NCT06162832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154656263|NCT06162832|Growth Substances|growth substances|mesh-ancestor
154656264|NCT06162832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656265|NCT06162468|Paclitaxel|paclitaxel|mesh-list
154656266|NCT06162468|Gemcitabine|gemcitabine|mesh-list
154656267|NCT06162468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154656268|NCT06162468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656269|NCT06162468|Tubulin Modulators|tubulin modulators|mesh-ancestor
154656270|NCT06162468|Antimitotic Agents|antimitotic agents|mesh-ancestor
154656271|NCT06162468|Mitosis Modulators|mitosis modulators|mesh-ancestor
154656272|NCT06162468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656273|NCT06162468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408260|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
154656274|NCT06162468|Antimetabolites|antimetabolites|mesh-ancestor
154656275|NCT06162442|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154656276|NCT06162442|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154656277|NCT06162390|Remifentanil|remifentanil|mesh-list
154656278|NCT06162390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154656279|NCT06162390|Narcotics|narcotics|mesh-ancestor
154656280|NCT06162390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656281|NCT06162390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656282|NCT06162390|Analgesics|analgesics|mesh-ancestor
154656283|NCT06162390|Sensory System Agents|sensory system agents|mesh-ancestor
154656284|NCT06162390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656285|NCT06162286|Moxifloxacin|moxifloxacin|mesh-list
154656286|NCT06162286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154656287|NCT06162286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656288|NCT06162286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154656289|NCT06162286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154656290|NCT06162286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656291|NCT06162286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656292|NCT06162286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656293|NCT06162169|Itraconazole|itraconazole|mesh-list
154656294|NCT06162169|Rifampin|rifampin|mesh-list
154656295|NCT06162169|Digoxin|digoxin|mesh-list
154656296|NCT06162169|Midazolam|midazolam|mesh-list
154656297|NCT06162169|Omeprazole|omeprazole|mesh-list
154656298|NCT06162169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154656299|NCT06162169|Calcium|calcium|mesh-list
154656300|NCT06162169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154656301|NCT06162169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656302|NCT06162169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154656303|NCT06162169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154656304|NCT06162169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656305|NCT06162169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154656306|NCT06162169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154656307|NCT06162169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154656308|NCT06162169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154656309|NCT06162169|Anesthetics, General|anesthetics, general|mesh-ancestor
154656310|NCT06162169|Anesthetics|anesthetics|mesh-ancestor
154656311|NCT06162169|GABA Modulators|gaba modulators|mesh-ancestor
154656312|NCT06162169|GABA Agents|gaba agents|mesh-ancestor
154656313|NCT06162169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656314|NCT06162169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656315|NCT06162169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154656316|NCT06162169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154656317|NCT06162169|Antimetabolites|antimetabolites|mesh-ancestor
154656318|NCT06162169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154371132|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656319|NCT06162169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154656320|NCT06162169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656321|NCT06162169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154656322|NCT06162169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154656323|NCT06162169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154656324|NCT06162169|Antifungal Agents|antifungal agents|mesh-ancestor
154656325|NCT06162169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656326|NCT06162169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154656327|NCT06162169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154656328|NCT06162169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154656329|NCT06162169|Hormone Antagonists|hormone antagonists|mesh-ancestor
154656330|NCT06162169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656331|NCT06162169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154656332|NCT06162169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154656333|NCT06162169|Antitubercular Agents|antitubercular agents|mesh-ancestor
154656334|NCT06162169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154656335|NCT06162169|Leprostatic Agents|leprostatic agents|mesh-ancestor
154656336|NCT06162169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154656337|NCT06162169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154656338|NCT06162169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154656339|NCT06162169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154656340|NCT06162169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154656341|NCT06162169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154656342|NCT06162169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154656343|NCT06162169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154656344|NCT06162169|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154656345|NCT06162169|Protective Agents|protective agents|mesh-ancestor
154656346|NCT06162065|Oxybutynin|oxybutynin|mesh-list
154656347|NCT06162065|Parasympatholytics|parasympatholytics|mesh-ancestor
154408338|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
154656348|NCT06162065|Autonomic Agents|autonomic agents|mesh-ancestor
154656349|NCT06162065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656350|NCT06162065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656351|NCT06162065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154656352|NCT06162065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154656353|NCT06162065|Cholinergic Agents|cholinergic agents|mesh-ancestor
154656354|NCT06162065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656355|NCT06162065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656356|NCT06162065|Urological Agents|urological agents|mesh-ancestor
154656358|NCT06161870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154656359|NCT06161870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656360|NCT06161766|Terlipressin|terlipressin|mesh-list
154656361|NCT06161766|Norepinephrine|norepinephrine|mesh-list
154656362|NCT06161766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154656363|NCT06161766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154656364|NCT06161766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154656365|NCT06161766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154656366|NCT06161766|Adrenergic Agents|adrenergic agents|mesh-ancestor
154656367|NCT06161766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656368|NCT06161766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656369|NCT06161766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656370|NCT06161766|Sympathomimetics|sympathomimetics|mesh-ancestor
154656371|NCT06161766|Autonomic Agents|autonomic agents|mesh-ancestor
154656372|NCT06161766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656373|NCT06161714|Lidocaine|lidocaine|mesh-list
154656374|NCT06161714|Carticaine|carticaine|mesh-list
154656375|NCT06161714|Anesthetics, Local|anesthetics, local|mesh-ancestor
154656376|NCT06161714|Anesthetics|anesthetics|mesh-ancestor
154656377|NCT06161714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656378|NCT06161714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656379|NCT06161714|Sensory System Agents|sensory system agents|mesh-ancestor
154656380|NCT06161714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656381|NCT06161714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154656382|NCT06161714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154656383|NCT06161714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154656384|NCT06161714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154656385|NCT06161714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656386|NCT06160492|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154656387|NCT06160492|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154656388|NCT06160492|Dermatologic Agents|dermatologic agents|mesh-ancestor
154656389|NCT06155773|Methamphetamine|methamphetamine|mesh-list
154656390|NCT06155773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154656391|NCT06155773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656392|NCT06155773|Sympathomimetics|sympathomimetics|mesh-ancestor
154656393|NCT06155773|Autonomic Agents|autonomic agents|mesh-ancestor
154656394|NCT06155773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656395|NCT06155773|Dopamine Agents|dopamine agents|mesh-ancestor
154656396|NCT06155773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656397|NCT06155773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656398|NCT06155773|Adrenergic Agents|adrenergic agents|mesh-ancestor
154656399|NCT06155773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154656400|NCT06155773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154656401|NCT06155773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154656402|NCT06155773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154656403|NCT06154720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154656404|NCT06154720|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154656405|NCT06154720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656406|NCT06154720|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154656407|NCT06154720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656408|NCT06154720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656409|NCT06154434|Chlorpromazine|chlorpromazine|mesh-list
154656410|NCT06154434|Antiemetics|antiemetics|mesh-ancestor
154656411|NCT06154434|Autonomic Agents|autonomic agents|mesh-ancestor
154656412|NCT06154434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656413|NCT06154434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656414|NCT06154434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154656415|NCT06154434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154656416|NCT06154434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154656417|NCT06154434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656418|NCT06154434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154656419|NCT06154434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154408413|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154656420|NCT06154434|Dopamine Agents|dopamine agents|mesh-ancestor
154656421|NCT06154434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656422|NCT06154434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656423|NCT06147518|Metformin|metformin|mesh-list
154656424|NCT06147518|Dapagliflozin|dapagliflozin|mesh-list
154656425|NCT06147518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154656426|NCT06147518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154656427|NCT06147518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656428|NCT06147518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154656429|NCT06147518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656430|NCT06147518|Incretins|incretins|mesh-ancestor
154656431|NCT06147518|Hormones|hormones|mesh-ancestor
154371261|NCT03722329|Eculizumab|eculizumab|mesh-list
154371266|NCT03467971|Metformin|metformin|mesh-list
154656432|NCT06147518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656433|NCT06147518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154656434|NCT06147518|Protease Inhibitors|protease inhibitors|mesh-ancestor
154656435|NCT06147518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656436|NCT06140108|Metformin|metformin|mesh-list
154656437|NCT06140108|Empagliflozin|empagliflozin|mesh-list
154656438|NCT06140108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154656439|NCT06140108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656440|NCT06140108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154656441|NCT06140108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656442|NCT06106009|Midazolam|midazolam|mesh-list
154656443|NCT06106009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154656444|NCT06106009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154656445|NCT06106009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656446|NCT06106009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656447|NCT06106009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154656448|NCT06106009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154656449|NCT06106009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154656450|NCT06106009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154656451|NCT06106009|Anesthetics, General|anesthetics, general|mesh-ancestor
154656452|NCT06106009|Anesthetics|anesthetics|mesh-ancestor
154656453|NCT06106009|GABA Modulators|gaba modulators|mesh-ancestor
154656454|NCT06106009|GABA Agents|gaba agents|mesh-ancestor
154656455|NCT06106009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656456|NCT06106009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656457|NCT06087237|Pentoxifylline|pentoxifylline|mesh-list
154656458|NCT06087237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154656459|NCT06087237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656460|NCT06087237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656461|NCT06087237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154656462|NCT06087237|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154656463|NCT06087237|Protective Agents|protective agents|mesh-ancestor
154656464|NCT06087237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656465|NCT06087237|Vasodilator Agents|vasodilator agents|mesh-ancestor
154656466|NCT06087237|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154656467|NCT06087237|Antioxidants|antioxidants|mesh-ancestor
154656468|NCT06074315|Triamcinolone|triamcinolone|mesh-list
154656469|NCT06074315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656470|NCT06074315|Glucocorticoids|glucocorticoids|mesh-ancestor
154656471|NCT06074315|Hormones|hormones|mesh-ancestor
154656472|NCT06074315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656473|NCT06074315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656474|NCT06067958|Dexmedetomidine|dexmedetomidine|mesh-list
154656475|NCT06067958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154656476|NCT06067958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656477|NCT06067958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656478|NCT06067958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154656479|NCT06067958|Analgesics|analgesics|mesh-ancestor
154656480|NCT06067958|Sensory System Agents|sensory system agents|mesh-ancestor
154656481|NCT06067958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656482|NCT06067958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154656483|NCT06067958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154656484|NCT06067958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154656485|NCT06067958|Adrenergic Agents|adrenergic agents|mesh-ancestor
154656486|NCT06067958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656487|NCT06067958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656488|NCT06004752|Cyclosporine|cyclosporine|mesh-list
154656489|NCT06004752|Cyclosporins|cyclosporins|mesh-list
154656490|NCT06004752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656491|NCT06004752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656492|NCT06004752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154656493|NCT06004752|Immunologic Factors|immunologic factors|mesh-ancestor
154656494|NCT06004752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656495|NCT06004752|Antifungal Agents|antifungal agents|mesh-ancestor
154656496|NCT06004752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656497|NCT06004752|Dermatologic Agents|dermatologic agents|mesh-ancestor
154656498|NCT06004752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656499|NCT06004752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154656500|NCT05998239|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
154656501|NCT05998239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656502|NCT05998239|Immunologic Factors|immunologic factors|mesh-ancestor
154656503|NCT05998239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656505|NCT05971602|Isoniazid|isoniazid|mesh-list
154656506|NCT05971602|Pyrazinamide|pyrazinamide|mesh-list
154656507|NCT05971602|Ethambutol|ethambutol|mesh-list
154656508|NCT05971602|Bedaquiline|bedaquiline|mesh-list
154656509|NCT05971602|Diarylquinolines|diarylquinolines|mesh-list
154656510|NCT05971602|Oxazolidinones|oxazolidinones|mesh-list
154656511|NCT05971602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154656512|NCT05971602|Antitubercular Agents|antitubercular agents|mesh-ancestor
154656513|NCT05971602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154656514|NCT05971602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656515|NCT05971602|Leprostatic Agents|leprostatic agents|mesh-ancestor
154656516|NCT05971602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154656517|NCT05971602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656518|NCT05971602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656519|NCT05971602|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154656520|NCT05971602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154656521|NCT05971602|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154656522|NCT05971602|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154656523|NCT05971602|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154656524|NCT05971602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154656525|NCT05971602|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154656526|NCT05971602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154656527|NCT05971602|Antimetabolites|antimetabolites|mesh-ancestor
154656528|NCT05971602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154656529|NCT05971602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154656530|NCT05971485|Melatonin|melatonin|mesh-list
154656531|NCT05971485|Antioxidants|antioxidants|mesh-ancestor
154656532|NCT05971485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656533|NCT05971485|Protective Agents|protective agents|mesh-ancestor
154656534|NCT05971485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656535|NCT05971485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656536|NCT05946603|Fluorophosphate|fluorophosphate|mesh-list
154656537|NCT05946603|Cariostatic Agents|cariostatic agents|mesh-ancestor
154656538|NCT05946603|Protective Agents|protective agents|mesh-ancestor
154656539|NCT05946603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656540|NCT05928039|Adalimumab|adalimumab|mesh-list
154656541|NCT05928039|Infliximab|infliximab|mesh-list
154656542|NCT05928039|Interleukin-12|interleukin-12|mesh-list
154656543|NCT05928039|Interleukin-23|interleukin-23|mesh-list
154656544|NCT05928039|Ustekinumab|ustekinumab|mesh-list
154656545|NCT05928039|Vedolizumab|vedolizumab|mesh-list
154656546|NCT05928039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154656547|NCT05928039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656548|NCT05928039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656549|NCT05928039|Dermatologic Agents|dermatologic agents|mesh-ancestor
154656550|NCT05928039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154656551|NCT05928039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154656552|NCT05928039|Immunologic Factors|immunologic factors|mesh-ancestor
154656553|NCT05928039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656554|NCT05928039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154656555|NCT05928039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154656556|NCT05928039|Growth Substances|growth substances|mesh-ancestor
154656557|NCT05928039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154656558|NCT05928039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656559|NCT05903040|Lasmiditan|lasmiditan|mesh-list
154656560|NCT05903040|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154656561|NCT05903040|Serotonin Agents|serotonin agents|mesh-ancestor
154656562|NCT05903040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371387|NCT03498313|Progestins|progestins|mesh-ancestor
154656563|NCT05903040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656564|NCT05903040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656565|NCT05878249|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154656566|NCT05878249|Eusol|eusol|mesh-list
154656567|NCT05878249|Edetic Acid|edetic acid|mesh-list
154408564|NCT01378143|Pentamidine|pentamidine|mesh-list
154656568|NCT05878249|Pentetic Acid|pentetic acid|mesh-list
154656569|NCT05878249|Disinfectants|disinfectants|mesh-ancestor
154656570|NCT05878249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656571|NCT05878249|Anticoagulants|anticoagulants|mesh-ancestor
154656572|NCT05878249|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154656573|NCT05878249|Chelating Agents|chelating agents|mesh-ancestor
154656574|NCT05878249|Sequestering Agents|sequestering agents|mesh-ancestor
154656575|NCT05878249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656576|NCT05878249|Antidotes|antidotes|mesh-ancestor
154656577|NCT05878249|Protective Agents|protective agents|mesh-ancestor
154656578|NCT05878249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656579|NCT05878249|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154656580|NCT05820256|Caseins|caseins|mesh-list
154656581|NCT05820256|Chelating Agents|chelating agents|mesh-ancestor
154656582|NCT05820256|Sequestering Agents|sequestering agents|mesh-ancestor
154656583|NCT05820256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656584|NCT05655507|Zuranolone|zuranolone|mesh-list
154656585|NCT05655507|Antidepressive Agents|antidepressive agents|mesh-ancestor
154656586|NCT05655507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154656587|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
154656588|NCT05610072|Hydromorphone|hydromorphone|mesh-list
154656589|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154656590|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
154656591|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656592|NCT05610072|Expectorants|expectorants|mesh-ancestor
154656593|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
154656594|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154656595|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
154656596|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656597|NCT05610072|Protective Agents|protective agents|mesh-ancestor
154656598|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656599|NCT05610072|Antidotes|antidotes|mesh-ancestor
154656600|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154656601|NCT05610072|Narcotics|narcotics|mesh-ancestor
154656602|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656603|NCT05610072|Analgesics|analgesics|mesh-ancestor
154656604|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
154656605|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656606|NCT05604300|Vitamin E|vitamin e|mesh-list
154656607|NCT05604300|Vitamins|vitamins|mesh-ancestor
154656608|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
154656609|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656610|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
154656611|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656612|NCT05604300|Protective Agents|protective agents|mesh-ancestor
154656613|NCT05603884|Cytarabine|cytarabine|mesh-list
154656614|NCT05603884|Azacitidine|azacitidine|mesh-list
154656615|NCT05603884|Venetoclax|venetoclax|mesh-list
154656616|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
154656617|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154656618|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
154656619|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656620|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656621|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
154656622|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656623|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154656624|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
154656625|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656626|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656627|NCT05603884|Analgesics|analgesics|mesh-ancestor
154656628|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
154656629|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656630|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154656631|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154656632|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
154656633|NCT05597150|Cathartics|cathartics|mesh-ancestor
154656634|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154656635|NCT05596214|Curcumin|curcumin|mesh-list
154656636|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154656637|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154656638|NCT05596214|Analgesics|analgesics|mesh-ancestor
154656639|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
154656640|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656641|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656642|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656643|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656644|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408641|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154656645|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656646|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656647|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
154656648|NCT05565105|Melphalan|melphalan|mesh-list
154656649|NCT05565105|Busulfan|busulfan|mesh-list
154656650|NCT05565105|Thiotepa|thiotepa|mesh-list
154656651|NCT05565105|Fludarabine|fludarabine|mesh-list
154656652|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154656653|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
154656654|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656655|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656656|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154656657|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
154656658|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656659|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656660|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154656661|NCT05418907|Exenatide|exenatide|mesh-list
154656662|NCT05418907|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154656663|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154656664|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656665|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154656666|NCT05418907|Incretins|incretins|mesh-ancestor
154656667|NCT05418907|Hormones|hormones|mesh-ancestor
154656668|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656669|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
154656670|NCT05345132|Nifedipine|nifedipine|mesh-list
154656671|NCT05345132|Analgesics|analgesics|mesh-ancestor
154656672|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
154656673|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656674|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656675|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
154656676|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656677|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154656678|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
154656679|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154656680|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154656681|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656682|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154656683|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
154656684|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154656685|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
154656686|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
154656687|NCT05343806|Nifedipine|nifedipine|mesh-list
154656688|NCT05343806|Analgesics|analgesics|mesh-ancestor
154656689|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
154656690|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656691|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656692|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
154656693|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656694|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154656695|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
154656696|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154656697|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154656698|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656699|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154656700|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
154656701|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154656702|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
154656703|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154656704|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
154656705|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154656706|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154656707|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656708|NCT05326308|Obinutuzumab|obinutuzumab|mesh-list
154656709|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
154656710|NCT05326308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154656711|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656712|NCT05326308|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154656713|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154656714|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656715|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656716|NCT05315700|Carboplatin|carboplatin|mesh-list
154656717|NCT05315700|Pemetrexed|pemetrexed|mesh-list
154656718|NCT05315700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656719|NCT05315700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656720|NCT05315700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656721|NCT05315700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154656722|NCT05315700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154656723|NCT05313256|Lidocaine|lidocaine|mesh-list
154656724|NCT05313256|Epinephrine|epinephrine|mesh-list
154656725|NCT05313256|Racepinephrine|racepinephrine|mesh-list
154656726|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
154656727|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
154656728|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
154656729|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656730|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656731|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
154656732|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656733|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154656734|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154656735|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154656736|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154656737|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656738|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154656739|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154656740|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154656741|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656742|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154656743|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154656744|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
154656745|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154656746|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
154656747|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
154656748|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
154656749|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154656750|NCT05305859|Azacitidine|azacitidine|mesh-list
154656751|NCT05305859|Venetoclax|venetoclax|mesh-list
154656752|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154656753|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
154656754|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656755|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656756|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656757|NCT05302271|Prednisone|prednisone|mesh-list
154656758|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656759|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
154656760|NCT05302271|Hormones|hormones|mesh-ancestor
154656761|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656762|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656763|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154656764|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656765|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
154656766|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
154656767|NCT05269381|Sargramostim|sargramostim|mesh-list
154656768|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154656769|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
154656770|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656771|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656772|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154656773|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
154656774|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656775|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656776|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154656777|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154656778|NCT05269381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154656779|NCT05223582|Prednisone|prednisone|mesh-list
154656780|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
154656781|NCT05223582|Fluzoparib|fluzoparib|mesh-list
154656782|NCT05223582|Androgens|androgens|mesh-list
154656783|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656784|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
154656785|NCT05223582|Hormones|hormones|mesh-ancestor
154656786|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656787|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656788|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154656789|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656790|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154656791|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371629|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
154656792|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656793|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
154656794|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154656795|NCT05223582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154408798|NCT05462535|Losartan|losartan|mesh-list
154656796|NCT05206448|Letrozole|letrozole|mesh-list
154656797|NCT05206448|Clomiphene|clomiphene|mesh-list
154656798|NCT05206448|Enclomiphene|enclomiphene|mesh-list
154656799|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
154656800|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656801|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656802|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154656803|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154656804|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656805|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154656806|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
154656807|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656808|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656809|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154656810|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
154656811|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154656812|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154656813|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154656814|NCT05193604|Paclitaxel|paclitaxel|mesh-list
154656815|NCT05193604|Gemcitabine|gemcitabine|mesh-list
154656816|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154656817|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656818|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
154656819|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
154656820|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
154656821|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656822|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154656823|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
154656824|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
154656825|NCT05146245|Risperidone|risperidone|mesh-list
154656826|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154656827|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
154656828|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656829|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656830|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656831|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154656832|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154656833|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656834|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154656835|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154656836|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
154656837|NCT05040217|Mitogens|mitogens|mesh-list
154656838|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
154656839|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656840|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
154656841|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154656842|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
154656843|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656844|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
154656845|NCT05025865|Protective Agents|protective agents|mesh-ancestor
154656846|NCT05012618|Cetuximab|cetuximab|mesh-list
154656847|NCT05012618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154656848|NCT05012618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656849|NCT04978675|Fluorides|fluorides|mesh-list
154656850|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
154656851|NCT04978675|Protective Agents|protective agents|mesh-ancestor
154656852|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656853|NCT04976855|Buprenorphine|buprenorphine|mesh-list
154656854|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154656855|NCT04976855|Naloxone|naloxone|mesh-list
154656856|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154656857|NCT04976855|Narcotics|narcotics|mesh-ancestor
154656858|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154656859|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656860|NCT04976855|Analgesics|analgesics|mesh-ancestor
154656861|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
154656862|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656863|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154656864|NCT04904692|Dimercaprol|dimercaprol|mesh-list
154656865|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
154656866|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
154656867|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656868|NCT04865978|Warfarin|warfarin|mesh-list
154656869|NCT04865978|Apixaban|apixaban|mesh-list
154656870|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
154656871|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154656872|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
154656873|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154656874|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
154656875|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656876|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656877|NCT04861558|Fluorouracil|fluorouracil|mesh-list
154656878|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
154656879|NCT04861558|Irinotecan|irinotecan|mesh-list
154656880|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
154656881|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656882|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154656883|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656884|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154656885|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
154656886|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656887|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154656888|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154656889|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656890|NCT04772521|Nicotine|nicotine|mesh-list
154656891|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154656892|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
154656893|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656894|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656895|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154656896|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154656897|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
154656898|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154656899|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656900|NCT04755322|Aspirin|aspirin|mesh-list
154656901|NCT04755322|Folic Acid|folic acid|mesh-list
154656902|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
154656903|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154656904|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154656905|NCT04755322|Analgesics|analgesics|mesh-ancestor
154656906|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
154656907|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656908|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656909|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656910|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656911|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154656912|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154656913|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656914|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154656915|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154656916|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656917|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
154656918|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
154656919|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154656920|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154656921|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656922|NCT04755322|Hematinics|hematinics|mesh-ancestor
154656923|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
154656924|NCT04755322|Vitamins|vitamins|mesh-ancestor
154656925|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
154656926|NCT04721795|Pyrazinamide|pyrazinamide|mesh-list
154656927|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
154656928|NCT04721795|Atorvastatin|atorvastatin|mesh-list
154656929|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154656930|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154656931|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
154656932|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656933|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154656934|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154656935|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656936|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154656937|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656938|NCT04705415|Niclosamide|niclosamide|mesh-list
154656939|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
154656940|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154656941|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
154656942|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154656943|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656944|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
154656945|NCT04644016|Cyclosporine|cyclosporine|mesh-list
154656946|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
154656947|NCT04644016|Fludarabine|fludarabine|mesh-list
154656948|NCT04644016|Busulfan|busulfan|mesh-list
154656949|NCT04644016|Clofarabine|clofarabine|mesh-list
154656950|NCT04644016|Cyclosporins|cyclosporins|mesh-list
154656951|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154656952|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154656953|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
154656954|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154656955|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154656956|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
154656957|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656958|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154656959|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
154656960|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656961|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
154656962|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154656963|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154656964|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154656965|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154656966|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
154656967|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154656968|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
154656969|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154656970|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154656971|NCT04615910|Exenatide|exenatide|mesh-list
154656972|NCT04615910|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154656973|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154656974|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656975|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154656976|NCT04615910|Incretins|incretins|mesh-ancestor
154656977|NCT04615910|Hormones|hormones|mesh-ancestor
154656978|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154656979|NCT04603924|Niclosamide|niclosamide|mesh-list
154656980|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
154656981|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154656982|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
154656983|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154656984|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154656985|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
154656986|NCT04596657|Vitamin D|vitamin d|mesh-list
154656987|NCT04596657|Vitamins|vitamins|mesh-ancestor
154656988|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
154656989|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656990|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154656991|NCT04528082|Apremilast|apremilast|mesh-list
154656992|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154656993|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154656994|NCT04528082|Analgesics|analgesics|mesh-ancestor
154656995|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
154656996|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154656997|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154656998|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154656999|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657000|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154657001|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154657002|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657003|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657004|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
154657005|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657006|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657007|NCT04513067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657008|NCT04513067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657009|NCT04505410|Infliximab|infliximab|mesh-list
154657010|NCT04505410|Ustekinumab|ustekinumab|mesh-list
154657011|NCT04505410|Tofacitinib|tofacitinib|mesh-list
154657012|NCT04505410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154657013|NCT04505410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657014|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
154657015|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154657016|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657017|NCT04505410|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154657018|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154657019|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657020|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657021|NCT04478266|Letrozole|letrozole|mesh-list
154657022|NCT04478266|Palbociclib|palbociclib|mesh-list
154657023|NCT04478266|Goserelin|goserelin|mesh-list
154657024|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657025|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154409014|NCT02849678|Lidocaine|lidocaine|mesh-list
154657026|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154657027|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657028|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657029|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154657030|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
154657031|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657032|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657033|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154657034|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154657035|NCT04426968|Interferons|interferons|mesh-list
154657036|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657037|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
154657038|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657039|NCT04286295|Nicotine|nicotine|mesh-list
154657040|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154657041|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
154657042|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657043|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657044|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154657045|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154657046|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
154657047|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657048|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657049|NCT04286087|Anesthetics|anesthetics|mesh-list
154657050|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657051|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657052|NCT04233216|Islatravir|islatravir|mesh-list
154657053|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
154657054|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657055|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657056|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657057|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154657058|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154657059|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154657060|NCT04218409|Oxycodone|oxycodone|mesh-list
154657061|NCT04218409|Oxytocin|oxytocin|mesh-list
154657062|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
154657063|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154657064|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657065|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154657066|NCT04218409|Narcotics|narcotics|mesh-ancestor
154657067|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657068|NCT04218409|Analgesics|analgesics|mesh-ancestor
154657069|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
154657070|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657071|NCT04173507|Avelumab|avelumab|mesh-list
154657072|NCT04173507|Talazoparib|talazoparib|mesh-list
154657073|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154657074|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657075|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657076|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154657077|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657078|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657079|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
154657080|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657081|NCT04121260|Daratumumab|daratumumab|mesh-list
154657082|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657083|NCT04074330|Rituximab|rituximab|mesh-list
154657084|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657085|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657086|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
154657087|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657088|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657089|NCT04007874|Vitamin E|vitamin e|mesh-list
154657090|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
154657091|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154657092|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154657093|NCT04007874|Vitamins|vitamins|mesh-ancestor
154657094|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
154657095|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657096|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
154657097|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657098|NCT04007874|Protective Agents|protective agents|mesh-ancestor
154657099|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154657100|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
154657101|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154657102|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154657103|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154657104|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154657105|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154657106|NCT04007874|Estrogens|estrogens|mesh-ancestor
154657107|NCT04007874|Hormones|hormones|mesh-ancestor
154657108|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657109|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154657110|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
154657111|NCT03978624|Entinostat|entinostat|mesh-list
154657112|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154371932|NCT02486458|Fluorides|fluorides|mesh-list
154657113|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657114|NCT03978624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657115|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657116|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154657117|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657118|NCT03971474|Gemcitabine|gemcitabine|mesh-list
154657119|NCT03971474|Docetaxel|docetaxel|mesh-list
154657120|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
154657121|NCT03971474|Pemetrexed|pemetrexed|mesh-list
154657122|NCT03971474|Ramucirumab|ramucirumab|mesh-list
154657123|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154657124|NCT03971474|Antibodies|antibodies|mesh-list
154657125|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
154657126|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154657127|NCT03971474|Lexatumumab|lexatumumab|mesh-list
154657128|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
154657129|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657130|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154657131|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
154657132|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657133|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657134|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
154657135|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
154657136|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
154657137|NCT03971474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657138|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657139|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154657140|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154657141|NCT03971474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154657142|NCT03971474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154657143|NCT03971474|Growth Substances|growth substances|mesh-ancestor
154657144|NCT03971474|Growth Inhibitors|growth inhibitors|mesh-ancestor
154657145|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
154657146|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154657147|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154657148|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657149|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
154657150|NCT03954314|Coagulants|coagulants|mesh-ancestor
154657151|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
154657152|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154657153|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657154|NCT03926130|Mirikizumab|mirikizumab|mesh-list
154657155|NCT03926130|Ustekinumab|ustekinumab|mesh-list
154657156|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
154657157|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154657158|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154657159|NCT03926130|Analgesics|analgesics|mesh-ancestor
154657160|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
154657161|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657162|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657163|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657164|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657165|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154657166|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154657167|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
154657168|NCT03919526|Fludarabine|fludarabine|mesh-list
154657169|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154657170|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
154657171|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657172|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657173|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154657174|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
154657175|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409171|NCT03367715|Nivolumab|nivolumab|mesh-list
154657176|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657177|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154657178|NCT03905798|Lorazepam|lorazepam|mesh-list
154657179|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
154657180|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
154657181|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
154657182|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657183|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657184|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154657185|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154657186|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657187|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154657188|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154657189|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154657190|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
154657191|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
154657192|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657193|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657194|NCT03881696|Omalizumab|omalizumab|mesh-list
154657195|NCT03881696|Immunomodulating Agents|immunomodulating agents|mesh-list
154657196|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
154657197|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154657198|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657199|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154657200|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154657201|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
154657202|NCT03845296|Rucaparib|rucaparib|mesh-list
154657203|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154657204|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657205|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657206|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657207|NCT03819296|Prednisone|prednisone|mesh-list
154657208|NCT03819296|Infliximab|infliximab|mesh-list
154657209|NCT03819296|Cortisone|cortisone|mesh-list
154657210|NCT03819296|Vedolizumab|vedolizumab|mesh-list
154657211|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
154657212|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
154657213|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657214|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
154657215|NCT03819296|Hormones|hormones|mesh-ancestor
154657216|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657217|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657218|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154657219|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657220|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
154657221|NCT03819296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154657222|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
154657223|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154657224|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657225|NCT03805581|Defibrotide|defibrotide|mesh-list
154657226|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154657227|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154657228|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657229|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154657230|NCT03769766|Curcumin|curcumin|mesh-list
154657231|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154657232|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154657233|NCT03769766|Analgesics|analgesics|mesh-ancestor
154657234|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
154657235|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657236|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657237|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657238|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657239|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657240|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657241|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657242|NCT03713580|Venetoclax|venetoclax|mesh-list
154657243|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657244|NCT03703856|Memantine|memantine|mesh-list
154657245|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154657246|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154657247|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
154657248|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657249|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657250|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657251|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154657252|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154657253|NCT03699540|Ethanol|ethanol|mesh-list
154657254|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154657255|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657256|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657257|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657258|NCT03691714|Cetuximab|cetuximab|mesh-list
154657259|NCT03691714|Durvalumab|durvalumab|mesh-list
154657260|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657261|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657262|NCT03656718|Nivolumab|nivolumab|mesh-list
154657263|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657264|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657265|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657266|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657267|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
154657268|NCT03645928|Nivolumab|nivolumab|mesh-list
154657269|NCT03645928|Ipilimumab|ipilimumab|mesh-list
154657270|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657271|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657272|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657273|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657274|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
154657275|NCT03577431|Everolimus|everolimus|mesh-list
154657276|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154657277|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
154657278|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657279|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657280|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154657281|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
154657282|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657283|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657284|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154657285|NCT03577431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154657286|NCT03577431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154657287|NCT03577431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657288|NCT03528642|Temozolomide|temozolomide|mesh-list
154657289|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154657290|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
154657291|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657292|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657293|NCT03407144|Prednisone|prednisone|mesh-list
154657294|NCT03407144|Prednisolone|prednisolone|mesh-list
154657295|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
154657296|NCT03407144|Dacarbazine|dacarbazine|mesh-list
154657297|NCT03407144|Doxorubicin|doxorubicin|mesh-list
154657298|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
154657299|NCT03407144|Etoposide|etoposide|mesh-list
154657300|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
154657301|NCT03407144|Vincristine|vincristine|mesh-list
154657302|NCT03407144|Bleomycin|bleomycin|mesh-list
154657303|NCT03407144|Vinblastine|vinblastine|mesh-list
154657304|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154657305|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
154657306|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657307|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657308|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154657309|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
154657310|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657311|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657312|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154657313|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154657314|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154657315|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154657316|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657317|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657318|NCT03407144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657319|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657320|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
154657321|NCT03407144|Hormones|hormones|mesh-ancestor
154657322|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657323|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154657324|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154657325|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
154657326|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
154657327|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
154657328|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154657329|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154657330|NCT03396276|Narcotics|narcotics|mesh-ancestor
154657331|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657332|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657333|NCT03396276|Analgesics|analgesics|mesh-ancestor
154657334|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
154657335|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657336|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154657337|NCT03360916|Atorvastatin|atorvastatin|mesh-list
154657338|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154657339|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154657340|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
154657341|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657342|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154657343|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154657344|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657345|NCT03351998|Atorvastatin|atorvastatin|mesh-list
154657346|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154657347|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154657348|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
154657349|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657350|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154657351|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154657352|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657353|NCT03211741|Bevacizumab|bevacizumab|mesh-list
154657354|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657355|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657356|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154657357|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154657358|NCT03211741|Growth Substances|growth substances|mesh-ancestor
154657359|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657360|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
154657361|NCT03203525|Leucovorin|leucovorin|mesh-list
154657362|NCT03203525|Sirolimus|sirolimus|mesh-list
154657363|NCT03203525|Bevacizumab|bevacizumab|mesh-list
154657364|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154657365|NCT03203525|Doxorubicin|doxorubicin|mesh-list
154657366|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154657367|NCT03203525|Fluorouracil|fluorouracil|mesh-list
154657368|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
154657369|NCT03203525|Temsirolimus|temsirolimus|mesh-list
154657370|NCT03203525|MTOR Inhibitors|mtor inhibitors|mesh-list
154657371|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
154657372|NCT03203525|Antibodies|antibodies|mesh-list
154657373|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
154657374|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154657375|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
154657376|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657377|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154657378|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154657379|NCT03203525|Growth Substances|growth substances|mesh-ancestor
154657380|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657381|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
154657382|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
154657383|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154657384|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154657385|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154657386|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657387|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657388|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
154657389|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154657390|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154657391|NCT03203525|Antidotes|antidotes|mesh-ancestor
154657392|NCT03203525|Protective Agents|protective agents|mesh-ancestor
154657393|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
154657394|NCT03203525|Vitamins|vitamins|mesh-ancestor
154657395|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
154657396|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154657397|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657398|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
154657399|NCT03203525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154409392|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
154657400|NCT03182192|Exenatide|exenatide|mesh-list
154657401|NCT03182192|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154657402|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154657403|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657404|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154657405|NCT03182192|Incretins|incretins|mesh-ancestor
154657406|NCT03182192|Hormones|hormones|mesh-ancestor
154657407|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657408|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154657409|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154657410|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657411|NCT03137771|Gemcitabine|gemcitabine|mesh-list
154657412|NCT03137771|Docetaxel|docetaxel|mesh-list
154657413|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
154657414|NCT03137771|Pemetrexed|pemetrexed|mesh-list
154657415|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154657416|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154657417|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
154657418|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657419|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657420|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
154657421|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
154657422|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
154657423|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657424|NCT03137771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657425|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657426|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154657427|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154657428|NCT03137771|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154657429|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154657430|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
154657431|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657432|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
154657433|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154657434|NCT03083184|Ethanol|ethanol|mesh-list
154657435|NCT03083184|Enoxaparin|enoxaparin|mesh-list
154657436|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
154657437|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154657438|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154657439|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657440|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154657441|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657442|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657443|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657444|NCT03023631|Vaccines|vaccines|mesh-list
154657445|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
154657446|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657447|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
154657448|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154657449|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657450|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657451|NCT02965716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657452|NCT02965716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372296|NCT03315520|Etoposide|etoposide|mesh-list
154372314|NCT02483182|Acyclovir|acyclovir|mesh-list
154657453|NCT02876328|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154657454|NCT02876328|Antiviral Agents|antiviral agents|mesh-ancestor
154657455|NCT02876328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657456|NCT02875223|Itraconazole|itraconazole|mesh-list
154657457|NCT02875223|Rifampin|rifampin|mesh-list
154657458|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
154657459|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
154657460|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657461|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154657462|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154657463|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657464|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657465|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154657466|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
154657467|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657468|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657469|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154657470|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154657471|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
154657472|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154657473|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
154657474|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154657475|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154409466|NCT03161405|Itraconazole|itraconazole|mesh-list
154657476|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154657477|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154657478|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154657479|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154657480|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154657481|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657482|NCT02870920|Durvalumab|durvalumab|mesh-list
154657483|NCT02870920|Tremelimumab|tremelimumab|mesh-list
154657484|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657485|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657486|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
154657487|NCT02869217|Fludarabine|fludarabine|mesh-list
154657488|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154657489|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
154657490|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657491|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657492|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154657493|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
154657494|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657495|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657496|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154657497|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
154657498|NCT02697630|Entinostat|entinostat|mesh-list
154657499|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657500|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657501|NCT02697630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657502|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657503|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154657504|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657505|NCT02639806|Lidocaine|lidocaine|mesh-list
154657506|NCT02639806|Sevoflurane|sevoflurane|mesh-list
154657507|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
154657508|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
154657509|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657510|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657511|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
154657512|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657513|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154657514|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154657515|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154657516|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154657517|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657518|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154372335|NCT01313585|Beclomethasone|beclomethasone|mesh-list
154657519|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154657520|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
154657521|NCT02468232|Enalapril|enalapril|mesh-list
154657522|NCT02468232|Enalaprilat|enalaprilat|mesh-list
154657523|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154657524|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154657525|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
154657526|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657527|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657528|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154657529|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154657530|NCT02262780|Telmisartan|telmisartan|mesh-list
154657531|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154657532|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154657533|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154657534|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657535|NCT02210117|Bevacizumab|bevacizumab|mesh-list
154657536|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154657537|NCT02210117|Nivolumab|nivolumab|mesh-list
154657538|NCT02210117|Ipilimumab|ipilimumab|mesh-list
154657539|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
154657540|NCT02210117|Antibodies|antibodies|mesh-list
154657541|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
154657542|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154657543|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
154657544|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657545|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154657546|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154657547|NCT02210117|Growth Substances|growth substances|mesh-ancestor
154657548|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657549|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
154657550|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
154657551|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154657552|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657553|NCT01803555|Budesonide|budesonide|mesh-list
154657554|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
154657555|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154657556|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657557|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154657558|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
154657559|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657560|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657561|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154657562|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
154657563|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
154657564|NCT01803555|Hormones|hormones|mesh-ancestor
154657565|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657566|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154657567|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154657568|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154657569|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
154657570|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657571|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657572|NCT01297764|Dexamethasone|dexamethasone|mesh-list
154657573|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
154657574|NCT01297764|Lenalidomide|lenalidomide|mesh-list
154657575|NCT01297764|Vorinostat|vorinostat|mesh-list
154657576|NCT01297764|BB 1101|bb 1101|mesh-list
154657577|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657578|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
154657579|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
154657580|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657581|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657582|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154657583|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
154657584|NCT01297764|Hormones|hormones|mesh-ancestor
154657585|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657586|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154657587|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657588|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
154657589|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657590|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657591|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
154657592|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154657593|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154657594|NCT01297764|Growth Substances|growth substances|mesh-ancestor
154657595|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
154657596|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154657597|NCT01245179|Panobinostat|panobinostat|mesh-list
154657598|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657599|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154657600|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657601|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657602|NCT01112306|Selexipag|selexipag|mesh-list
154657603|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154657604|NCT00242814|Amlodipine|amlodipine|mesh-list
154657605|NCT00242814|Telmisartan|telmisartan|mesh-list
154657606|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154657607|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154657608|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154657609|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657610|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154657611|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657612|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
154657613|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154657614|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154657615|NCT00168857|Losartan|losartan|mesh-list
154657616|NCT00168857|Telmisartan|telmisartan|mesh-list
154657617|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154657618|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154657619|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154657620|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154372457|NCT02483104|Veliparib|veliparib|mesh-list
154657621|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657622|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154657623|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154657624|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154657625|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657626|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657627|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154657628|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154657629|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154657630|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154657631|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
154657632|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657633|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657634|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154657635|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154657636|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
154657637|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154657638|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154657639|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
154657640|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
154657641|NCT02524665|Salicylates|salicylates|mesh-list
154657642|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154657643|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657644|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
154657645|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
154657646|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
154657647|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154657648|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154657649|NCT02524665|Analgesics|analgesics|mesh-ancestor
154657650|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
154657651|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657652|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657653|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657654|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657655|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154657656|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657657|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657658|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154657659|NCT04998253|Propofol|propofol|mesh-list
154657660|NCT04998253|Sevoflurane|sevoflurane|mesh-list
154657661|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154657662|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657663|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657664|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154657665|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
154657666|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
154657667|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154657668|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154657669|NCT02638129|Naltrexone|naltrexone|mesh-list
154657670|NCT02638129|Bupropion|bupropion|mesh-list
154657671|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154657672|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154657673|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657674|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
154657675|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657676|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154657677|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
154657678|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154657679|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154657680|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154657681|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154657682|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657683|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
154657684|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657685|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154657686|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154657687|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657688|NCT03079687|Olaparib|olaparib|mesh-list
154657689|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154657690|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657691|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657692|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657693|NCT04997707|Propofol|propofol|mesh-list
154657694|NCT04997707|Sevoflurane|sevoflurane|mesh-list
154409710|NCT02239952|Sunitinib|sunitinib|mesh-list
154657695|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154657696|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657697|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657698|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154657699|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
154657700|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
154657701|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154657702|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154657703|NCT05010499|Bupivacaine|bupivacaine|mesh-list
154657704|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
154657705|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
154657706|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
154657707|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657708|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657709|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
154657710|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657712|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154657713|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154657714|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657715|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657716|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154657717|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
154657718|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
154657719|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657720|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657721|NCT04994119|Warfarin|warfarin|mesh-list
154657722|NCT04994119|Zamicastat|zamicastat|mesh-list
154657723|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
154657724|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657725|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657726|NCT01658943|Fluorouracil|fluorouracil|mesh-list
154657727|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
154657728|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
154657729|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657730|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154657731|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657732|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154657733|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
154657734|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657735|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154657736|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154657737|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154657738|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
154657739|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657740|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154657741|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154657742|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154657743|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
154657744|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657745|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154657746|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154657747|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657748|NCT04996459|Tislelizumab|tislelizumab|mesh-list
154657749|NCT04996459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657750|NCT04996459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657751|NCT03074773|Dexamethasone|dexamethasone|mesh-list
154657752|NCT03074773|Bupivacaine|bupivacaine|mesh-list
154657753|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657754|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
154657755|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
154657756|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657757|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657758|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154657759|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
154657760|NCT03074773|Hormones|hormones|mesh-ancestor
154657761|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657762|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154657763|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657764|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
154657765|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
154657766|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657767|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
154657768|NCT03077581|Anesthetics|anesthetics|mesh-list
154657769|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657770|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657771|NCT03077503|Fentanyl|fentanyl|mesh-list
154657772|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
154657773|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154657774|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657775|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657776|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154657777|NCT03077503|Analgesics|analgesics|mesh-ancestor
154657778|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
154657779|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657780|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154657781|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154657782|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154657783|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
154657784|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657785|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657786|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154657787|NCT03077503|Narcotics|narcotics|mesh-ancestor
154657788|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154657789|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154657790|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
154657791|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
154657792|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
154657793|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
154657794|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657795|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
154657796|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154657797|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657798|NCT03073057|Budesonide|budesonide|mesh-list
154657799|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
154657800|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154657801|NCT03073057|Charcoal|charcoal|mesh-list
154657802|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657803|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154657804|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
154657805|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657806|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657807|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154657808|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
154657809|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
154657810|NCT03073057|Hormones|hormones|mesh-ancestor
154657811|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154657812|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154657813|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154657814|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154657815|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
154657816|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657817|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657818|NCT03073057|Antidotes|antidotes|mesh-ancestor
154657819|NCT03073057|Protective Agents|protective agents|mesh-ancestor
154657820|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
154657821|NCT03073369|Vitamin D|vitamin d|mesh-list
154657822|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154657823|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657824|NCT03073369|Vitamins|vitamins|mesh-ancestor
154657825|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
154657826|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154657827|NCT04433611|Lidocaine|lidocaine|mesh-list
154657828|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
154657829|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
154657830|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657831|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657832|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
154657833|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657834|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154657835|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154657836|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154657837|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154657838|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657839|NCT04992481|Fluorides|fluorides|mesh-list
154657840|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
154657841|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
154657842|NCT04992481|Protective Agents|protective agents|mesh-ancestor
154657843|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657844|NCT02597933|Nintedanib|nintedanib|mesh-list
154657845|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657846|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154657847|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657848|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657849|NCT04995133|Colistin|colistin|mesh-list
154657850|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154657851|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154657852|NCT04360889|Tocopherols|tocopherols|mesh-list
154657853|NCT04360889|Vitamin E|vitamin e|mesh-list
154657854|NCT04360889|Tocotrienols|tocotrienols|mesh-list
154657855|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
154657856|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
154657857|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657858|NCT04360889|Protective Agents|protective agents|mesh-ancestor
154657859|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657860|NCT04360889|Vitamins|vitamins|mesh-ancestor
154657861|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
154657862|NCT03072589|Regadenoson|regadenoson|mesh-list
154657863|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154657864|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154657865|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
154657866|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
154657867|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657868|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657869|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657870|NCT04994743|Cortisone|cortisone|mesh-list
154657871|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657872|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154657873|NCT04807829|Nabilone|nabilone|mesh-list
154657874|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
154657875|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
154657876|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657877|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657878|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154657879|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154657880|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154657881|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154657882|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154657883|NCT03072511|Nicotine|nicotine|mesh-list
154657884|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154657885|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
154657886|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657887|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657888|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154657889|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154657890|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
154657891|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657892|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657893|NCT03072121|Aspirin|aspirin|mesh-list
154657894|NCT03072121|Metoprolol|metoprolol|mesh-list
154657895|NCT03072121|Isosorbide|isosorbide|mesh-list
154657896|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154657897|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154657898|NCT03072121|Trimetazidine|trimetazidine|mesh-list
154657899|NCT03072121|Clopidogrel|clopidogrel|mesh-list
154657900|NCT03072121|Atorvastatin|atorvastatin|mesh-list
154657901|NCT03072121|Calcium|calcium|mesh-list
154657902|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154657903|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657904|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154657905|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154657906|NCT03072121|Analgesics|analgesics|mesh-ancestor
154657907|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
154657908|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657909|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657910|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657911|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154657912|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154657913|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657914|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154657915|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154657916|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657917|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
154657918|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154657919|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154657920|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
154409969|NCT02889133|Iron|iron|mesh-list
154657921|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154657922|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154657923|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154657924|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154657925|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154657926|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
154657927|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154657928|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154657929|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154657930|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
154657931|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
154657932|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154657933|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154657934|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154657935|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154657936|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154657937|NCT03072121|Diuretics|diuretics|mesh-ancestor
154657938|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
154657939|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
154657940|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154657941|NCT02597855|Aflibercept|aflibercept|mesh-list
154657942|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154657943|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154657944|NCT02597855|Growth Substances|growth substances|mesh-ancestor
154657945|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657946|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
154657947|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657948|NCT04987567|Antioxidants|antioxidants|mesh-list
154657949|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657950|NCT04987567|Protective Agents|protective agents|mesh-ancestor
154657951|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657952|NCT03072199|Rituximab|rituximab|mesh-list
154657953|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154657954|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657955|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
154657956|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657957|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657958|NCT03070093|Gilteritinib|gilteritinib|mesh-list
154657959|NCT03070093|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154657960|NCT03070093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154657961|NCT03070093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657962|NCT03070093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657963|NCT04806737|Teriflunomide|teriflunomide|mesh-list
154657964|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154657965|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154657966|NCT04806737|Analgesics|analgesics|mesh-ancestor
154657967|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
154657968|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154657969|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657970|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154657971|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154657972|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154657973|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
154657974|NCT04991155|Zamicastat|zamicastat|mesh-list
154657975|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657976|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657977|NCT04462315|Cobalt|cobalt|mesh-list
154657978|NCT04462315|Chromium|chromium|mesh-list
154657979|NCT04462315|Everolimus|everolimus|mesh-list
154657980|NCT04462315|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154657981|NCT04462315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154657982|NCT04462315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154657983|NCT04462315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154657984|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154657985|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
154657986|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154657987|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154657988|NCT04462315|Trace Elements|trace elements|mesh-ancestor
154657989|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
154657990|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154657991|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154657992|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154657993|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154657994|NCT03071731|Bromides|bromides|mesh-list
154657995|NCT03071731|Ipratropium|ipratropium|mesh-list
154409991|NCT00092209|Losartan|losartan|mesh-list
154657996|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
154657997|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
154657998|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
154657999|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658000|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658001|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154658002|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
154658003|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658004|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658005|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154658006|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
154658007|NCT04809935|Ethanol|ethanol|mesh-list
154658008|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154658009|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658010|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658011|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658012|NCT04255927|Triclosan|triclosan|mesh-list
154658013|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154658014|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658015|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154658016|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154658017|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
154658018|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658019|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154658020|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154658021|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154658022|NCT03069781|Estradiol|estradiol|mesh-list
154658023|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154658024|NCT03069781|Estrogens|estrogens|mesh-ancestor
154658025|NCT03069781|Hormones|hormones|mesh-ancestor
154658026|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658027|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658028|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154658029|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
154658030|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154658031|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154658032|NCT03071575|Vaccines|vaccines|mesh-list
154658033|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
154658034|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658035|NCT04798391|Dexamethasone|dexamethasone|mesh-list
154658036|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154658037|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
154658038|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
154658039|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658040|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658041|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658042|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
154658043|NCT04798391|Hormones|hormones|mesh-ancestor
154658044|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658045|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154658046|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658047|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
154658048|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
154658049|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154658050|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
154658051|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658052|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658053|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
154658054|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
154658055|NCT04986319|Vitamin D|vitamin d|mesh-list
154658056|NCT04986319|Vitamins|vitamins|mesh-ancestor
154658057|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
154658058|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658059|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154658060|NCT02593097|Metformin|metformin|mesh-list
154658061|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154658062|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658063|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154658064|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
154658065|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658066|NCT01657461|Plasminogen|plasminogen|mesh-list
154658067|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154658068|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154658069|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154658070|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658071|NCT05001919|Mitogens|mitogens|mesh-list
154658072|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
154658073|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658074|NCT05001763|Prucalopride|prucalopride|mesh-list
154658075|NCT05001763|Laxatives|laxatives|mesh-ancestor
154658076|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658077|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154658078|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154658079|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
154658080|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658081|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658082|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658083|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
154658084|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658085|NCT02592551|Durvalumab|durvalumab|mesh-list
154658086|NCT02592551|Tremelimumab|tremelimumab|mesh-list
154658087|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154658088|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658089|NCT04982809|Dexamethasone|dexamethasone|mesh-list
154658090|NCT04982809|Prednisolone|prednisolone|mesh-list
154658091|NCT04982809|Betamethasone|betamethasone|mesh-list
154658092|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154658093|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
154658094|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
154658095|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658096|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658097|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658098|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
154658099|NCT04982809|Hormones|hormones|mesh-ancestor
154658100|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658101|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154658102|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658103|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154658104|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
154658105|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
154658106|NCT03068533|Calcium|calcium|mesh-list
154658107|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154658108|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658109|NCT03068533|Antacids|antacids|mesh-ancestor
154658110|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658111|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658112|NCT05281341|Hormones|hormones|mesh-list
154658113|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658114|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658115|NCT04808687|Paclitaxel|paclitaxel|mesh-list
154658116|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154658117|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658118|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
154658119|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
154658120|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
154658121|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658122|NCT05279703|Epinephrine|epinephrine|mesh-list
154658123|NCT05279703|Racepinephrine|racepinephrine|mesh-list
154658124|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
154658125|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154658126|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154658127|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
154658128|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658129|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658130|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658131|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154658132|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154658133|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
154658134|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658135|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154658136|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
154658137|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
154658138|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
154658139|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154658140|NCT05392933|Lidocaine|lidocaine|mesh-list
154658141|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
154658142|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
154658143|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658144|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658145|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
154658146|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658147|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154658148|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154658149|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154658150|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658151|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658152|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
154658153|NCT04796675|Fludarabine|fludarabine|mesh-list
154658154|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154658155|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
154658156|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658157|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154658158|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154658159|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
154658160|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658161|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658162|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154658163|NCT04785755|Etilefrine|etilefrine|mesh-list
154658164|NCT04785755|Furosemide|furosemide|mesh-list
154658165|NCT04785755|Spironolactone|spironolactone|mesh-list
154658166|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154658167|NCT04785755|Diuretics|diuretics|mesh-list
154658168|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
154658169|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658170|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154658171|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658172|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658173|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154658174|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154658175|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658176|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154658177|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154658178|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154658179|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
154658180|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658181|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154658182|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
154658183|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
154658184|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658185|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154658186|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154658187|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154658188|NCT04785755|Protective Agents|protective agents|mesh-ancestor
154658189|NCT04785911|Antiemetics|antiemetics|mesh-list
154658190|NCT04785911|Histamine|histamine|mesh-list
154658191|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
154658192|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
154658193|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658194|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658195|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658196|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
154658197|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658198|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658199|NCT05314101|Bevacizumab|bevacizumab|mesh-list
154658200|NCT05314101|Tislelizumab|tislelizumab|mesh-list
154658201|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154658202|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658203|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154658204|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154658205|NCT05314101|Growth Substances|growth substances|mesh-ancestor
154658206|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658207|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
154658208|NCT02595749|Oxytocin|oxytocin|mesh-list
154658209|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
154658210|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154658211|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658212|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
154658213|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154658214|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
154658215|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658216|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
154658217|NCT04426721|Protective Agents|protective agents|mesh-ancestor
154658218|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
154658219|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154860336|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
154410225|NCT02847494|Hormones|hormones|mesh-ancestor
154658220|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658221|NCT04794413|Pimavanserin|pimavanserin|mesh-list
154658222|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154658223|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154658224|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154658225|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154658226|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658227|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658228|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154658229|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154658230|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154658231|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
154658232|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658233|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658234|NCT04988191|Bevacizumab|bevacizumab|mesh-list
154658235|NCT04988191|Irinotecan|irinotecan|mesh-list
154658236|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154658237|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658238|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154658239|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154658240|NCT04988191|Growth Substances|growth substances|mesh-ancestor
154658241|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658242|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
154658243|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154658244|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154658245|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658246|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658247|NCT03069001|Ribavirin|ribavirin|mesh-list
154658248|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
154658249|NCT03069001|Simeprevir|simeprevir|mesh-list
154658250|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
154658251|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658252|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
154658253|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658254|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
154658255|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658256|NCT03070405|Tenofovir|tenofovir|mesh-list
154658257|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154658258|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
154658259|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658260|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154658261|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154658262|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658263|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658264|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154658265|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154658266|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
154658267|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154658268|NCT03068065|Metformin|metformin|mesh-list
154658269|NCT03068065|Liraglutide|liraglutide|mesh-list
154658270|NCT03068065|Gliclazide|gliclazide|mesh-list
154658271|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154658272|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658273|NCT03068065|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154658274|NCT03068065|Incretins|incretins|mesh-ancestor
154658275|NCT03068065|Hormones|hormones|mesh-ancestor
154658276|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658277|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
154658278|NCT05161611|Astringents|astringents|mesh-ancestor
154658279|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658280|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
154658281|NCT03660475|Naltrexone|naltrexone|mesh-list
154658282|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154658283|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154658284|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658285|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
154658286|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658287|NCT05211609|Methyldopa|methyldopa|mesh-list
154658288|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154658289|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
154658290|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
154658291|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658292|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658293|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154658294|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154658295|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154658296|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154658297|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658298|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658299|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154658300|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154658301|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154658302|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658303|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658304|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154658305|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658306|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658307|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
154658308|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658309|NCT02594735|Abatacept|abatacept|mesh-list
154658310|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154658311|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658312|NCT02594735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154658313|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658314|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154658315|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
154658316|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658317|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154658318|NCT04793243|Vitamin D|vitamin d|mesh-list
154658319|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
154658320|NCT04793243|Vitamins|vitamins|mesh-ancestor
154658321|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
154658322|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658323|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154658324|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154658325|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
154658326|NCT05157711|Phenylephrine|phenylephrine|mesh-list
154658327|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
154658328|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
154658329|NCT05157711|Bismuth|bismuth|mesh-list
154658330|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154658331|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
154658332|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
154658333|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658334|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658335|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
154658336|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154658337|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
154658338|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
154658339|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154658340|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154658341|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154658342|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
154658343|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658344|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658345|NCT05157711|Protective Agents|protective agents|mesh-ancestor
154658346|NCT05157711|Antacids|antacids|mesh-ancestor
154658347|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658348|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
154658349|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
154658350|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154658351|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658352|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
154658353|NCT05157711|Coagulants|coagulants|mesh-ancestor
154658354|NCT05105997|Dexamethasone|dexamethasone|mesh-list
154658355|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154658356|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
154658357|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
154658358|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658359|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658360|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658361|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
154658362|NCT05105997|Hormones|hormones|mesh-ancestor
154658363|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658364|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154658365|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658366|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
154658367|NCT04801511|Vitamins|vitamins|mesh-ancestor
154658368|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
154658369|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658370|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
154658371|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658372|NCT04801511|Protective Agents|protective agents|mesh-ancestor
154658373|NCT05471687|Adenosine|adenosine|mesh-list
154658374|NCT05471687|Analgesics|analgesics|mesh-ancestor
154658375|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
154658376|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658377|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658378|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154658379|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
154658380|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154658381|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
154658382|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
154658383|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658384|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658385|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
154658386|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154658387|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
154658388|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658389|NCT05370729|Expectorants|expectorants|mesh-ancestor
154658390|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
154658391|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154658392|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
154658393|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658394|NCT05370729|Protective Agents|protective agents|mesh-ancestor
154658395|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658396|NCT05370729|Antidotes|antidotes|mesh-ancestor
154658397|NCT05471531|Vaccines|vaccines|mesh-list
154658398|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154658399|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
154658400|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658401|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154658402|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154658403|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658404|NCT04801199|Incretins|incretins|mesh-ancestor
154658405|NCT04801199|Hormones|hormones|mesh-ancestor
154658406|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658407|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154658408|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
154658409|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658410|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658411|NCT05445791|Metformin|metformin|mesh-list
154658412|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154658413|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658414|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154658415|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
154658416|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154658417|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154658418|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
154658419|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373259|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
154658420|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658421|NCT04799639|Paclitaxel|paclitaxel|mesh-list
154658422|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154658423|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658424|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
154658425|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
154658426|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
154658427|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658428|NCT04798703|Paclitaxel|paclitaxel|mesh-list
154658429|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
154658430|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154658431|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658432|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
154658433|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
154658434|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
154658435|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658436|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154658437|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
154658438|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658439|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
154658440|NCT04798703|Protective Agents|protective agents|mesh-ancestor
154658441|NCT04798313|Denosumab|denosumab|mesh-list
154658442|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154658443|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658444|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
154658445|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
154658446|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
154860337|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
154658447|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658448|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658449|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
154658450|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658451|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154658452|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658453|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658454|NCT05092581|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154658455|NCT05092581|Antiviral Agents|antiviral agents|mesh-ancestor
154658456|NCT05092581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658458|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154658459|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
154658460|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658461|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
154658462|NCT05089461|Analgesics|analgesics|mesh-ancestor
154658463|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
154658464|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658465|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658466|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658467|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154658468|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154658469|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658470|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658471|NCT05730439|Lobeline|lobeline|mesh-list
154658472|NCT05730439|Nicotine|nicotine|mesh-list
154658473|NCT05730439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154658474|NCT05730439|Autonomic Agents|autonomic agents|mesh-ancestor
154658475|NCT05730439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658476|NCT05730439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658477|NCT05730439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154658478|NCT05730439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154658479|NCT05730439|Cholinergic Agents|cholinergic agents|mesh-ancestor
154658480|NCT05730439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658481|NCT05730439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658482|NCT05730439|Respiratory System Agents|respiratory system agents|mesh-ancestor
154658483|NCT04805515|Nicotine|nicotine|mesh-list
154658484|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154658485|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
154658486|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658487|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658488|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154658489|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154658490|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
154658491|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658492|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658493|NCT05170919|Olanzapine|olanzapine|mesh-list
154658494|NCT05170919|Mirtazapine|mirtazapine|mesh-list
154658495|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
154658496|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
154658497|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658498|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658499|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658500|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154658501|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154658502|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658503|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154658504|NCT05170919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154658505|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154658506|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658507|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658508|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658509|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
154658510|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
154658511|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154658512|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
154658513|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
154658514|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154658515|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154658516|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154658517|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154658518|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
154658519|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154658520|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154658521|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154658523|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154658524|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154658525|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658526|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
154658527|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154658528|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658529|NCT03066427|Sunitinib|sunitinib|mesh-list
154658530|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658531|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154658532|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154658533|NCT03066427|Growth Substances|growth substances|mesh-ancestor
154658534|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658535|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
154658536|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154658537|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658538|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658539|NCT05177133|Capecitabine|capecitabine|mesh-list
154658540|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
154658541|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154658542|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
154658543|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658544|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658545|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
154658546|NCT02866643|Etonogestrel|etonogestrel|mesh-list
154658547|NCT02866643|Desogestrel|desogestrel|mesh-list
154658548|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154658549|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658550|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154658551|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154658552|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154658553|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154658554|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154658555|NCT02866643|Progestins|progestins|mesh-ancestor
154658556|NCT02866643|Hormones|hormones|mesh-ancestor
154658557|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658558|NCT05176821|Amoxicillin|amoxicillin|mesh-list
154658559|NCT05176821|Furazolidone|furazolidone|mesh-list
154658560|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
154658561|NCT05176821|Esomeprazole|esomeprazole|mesh-list
154658562|NCT05176821|Bismuth|bismuth|mesh-list
154658563|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658564|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154658565|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658566|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154658567|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658568|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154658569|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658570|NCT05176821|Antacids|antacids|mesh-ancestor
154658571|NCT05176821|Diuretics|diuretics|mesh-ancestor
154658572|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
154658573|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658574|NCT05176821|Expectorants|expectorants|mesh-ancestor
154658575|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
154658576|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154658577|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154658578|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154658579|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154658580|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154658581|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154658582|NCT05555641|Nafamostat|nafamostat|mesh-list
154658583|NCT05555641|Heparin|heparin|mesh-list
154658584|NCT05555641|Calcium heparin|calcium heparin|mesh-list
154658585|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
154658586|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154658587|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154658588|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658589|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154658590|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154658591|NCT05555641|Analgesics|analgesics|mesh-ancestor
154658592|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
154658593|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658594|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658595|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154658596|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154658597|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
154658598|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658599|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154658600|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154658601|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154658602|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154658603|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
154658605|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154658606|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154658607|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658608|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658609|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154658610|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658611|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
154658612|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154658613|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
154658614|NCT05613335|Coagulants|coagulants|mesh-ancestor
154658615|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154658616|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
154658617|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
154658618|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
154658619|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658620|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658621|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
154658622|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658623|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154658624|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154658625|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
154658626|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658627|NCT05078463|Protective Agents|protective agents|mesh-ancestor
154658628|NCT05170113|Caffeine|caffeine|mesh-list
154658629|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154658630|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658631|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154658632|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658633|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658634|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154658635|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154658636|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
154658637|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658638|NCT05611463|Docetaxel|docetaxel|mesh-list
154658639|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658640|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
154658641|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
154658642|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
154658643|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658644|NCT05611385|Amphetamine|amphetamine|mesh-list
154658645|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154658646|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658647|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
154658648|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
154658649|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658650|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
154658651|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658652|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658653|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
154658654|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154658655|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154658656|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658657|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154658658|NCT05475041|Liver Extracts|liver extracts|mesh-list
154658659|NCT05475041|Hematinics|hematinics|mesh-ancestor
154658660|NCT02631577|Lenalidomide|lenalidomide|mesh-list
154658661|NCT02631577|Atezolizumab|atezolizumab|mesh-list
154658662|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
154658663|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
154658664|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658665|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154658666|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154658667|NCT02631577|Growth Substances|growth substances|mesh-ancestor
154658668|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
154658669|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658670|NCT02631577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154658671|NCT02631577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658672|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154658673|NCT01667081|Grazoprevir|grazoprevir|mesh-list
154658674|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
154658675|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658676|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
154658677|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154658678|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154658679|NCT03067753|Prednisolone|prednisolone|mesh-list
154658680|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
154658681|NCT03067753|Hormones|hormones|mesh-list
154658682|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154658683|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
154658684|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658685|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658686|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154658687|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
154658688|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
154658689|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658690|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658691|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
154658692|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154658693|NCT03067753|Protective Agents|protective agents|mesh-ancestor
154658694|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154658695|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658696|NCT04331639|Vitamin D|vitamin d|mesh-list
154658697|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
154658698|NCT04331639|Vitamins|vitamins|mesh-ancestor
154658699|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
154658700|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658701|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154658702|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154658703|NCT03067597|Dinoprostone|dinoprostone|mesh-list
154658704|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
154658705|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154658706|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658707|NCT02518971|Tamsulosin|tamsulosin|mesh-list
154658708|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154658709|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154658710|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154658711|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
154658712|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658713|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658714|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658715|NCT02518971|Urological Agents|urological agents|mesh-ancestor
154658716|NCT04733963|Bevacizumab|bevacizumab|mesh-list
154658717|NCT04733963|Capecitabine|capecitabine|mesh-list
154658718|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154658719|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658720|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154658721|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154658722|NCT04733963|Growth Substances|growth substances|mesh-ancestor
154658723|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658724|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
154658725|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154658726|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
154658727|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658728|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
154658729|NCT03066115|Ketorolac|ketorolac|mesh-list
154658730|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154658731|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154658732|NCT03066115|Analgesics|analgesics|mesh-ancestor
154658733|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
154658734|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658735|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658736|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154658737|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154658738|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154658739|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658740|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658741|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
154658742|NCT03066115|Protective Agents|protective agents|mesh-ancestor
154658743|NCT03066115|Vitamins|vitamins|mesh-ancestor
154658744|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
154658745|NCT04212039|Bupivacaine|bupivacaine|mesh-list
154658746|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
154658747|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
154658748|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658749|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658750|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
154658751|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658752|NCT05048589|Vaccines|vaccines|mesh-list
154658753|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
154658754|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658755|NCT04447651|Immunomodulating Agents|immunomodulating agents|mesh-list
154658756|NCT04447651|Immunologic Factors|immunologic factors|mesh-ancestor
154658757|NCT04447651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658758|NCT01364727|Amrubicin|amrubicin|mesh-list
154658759|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658760|NCT01364649|Vortioxetine|vortioxetine|mesh-list
154658761|NCT01364649|Escitalopram|escitalopram|mesh-list
154658762|NCT01364649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154658763|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154658764|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658765|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658766|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658767|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
154658768|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658769|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
154658770|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154658771|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154658772|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154658773|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658774|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154658775|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154658776|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154658777|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154658778|NCT03065569|Bupivacaine|bupivacaine|mesh-list
154658779|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
154658780|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
154658781|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658782|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658783|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
154658784|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658785|NCT05723419|Anesthetics|anesthetics|mesh-list
154658786|NCT05723419|Anesthetics, Local|anesthetics, local|mesh-list
154658787|NCT05723419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658788|NCT05723419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658789|NCT05723419|Sensory System Agents|sensory system agents|mesh-ancestor
154658790|NCT05723419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658791|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154658792|NCT02588261|Gefitinib|gefitinib|mesh-list
154658793|NCT02588261|Naquotinib|naquotinib|mesh-list
154658794|NCT02588261|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154658795|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154658796|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658797|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658798|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658799|NCT04426487|Progesterone|progesterone|mesh-list
154658800|NCT04426487|Progestins|progestins|mesh-ancestor
154658801|NCT04426487|Hormones|hormones|mesh-ancestor
154658802|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658803|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658804|NCT04988217|Interferons|interferons|mesh-list
154658805|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
154658806|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
154658807|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658808|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
154658809|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154658810|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
154658811|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658812|NCT01672723|Naltrexone|naltrexone|mesh-list
154658813|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154658814|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154658815|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658816|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
154658817|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658818|NCT04443673|Glycine|glycine|mesh-list
154658819|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
154410812|NCT02247986|Methylphenidate|methylphenidate|mesh-list
154658820|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658821|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658822|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658823|NCT05031975|Irinotecan|irinotecan|mesh-list
154658824|NCT05031975|Temozolomide|temozolomide|mesh-list
154658825|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154373656|NCT02473198|Narcotics|narcotics|mesh-ancestor
154658826|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154658827|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658828|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658829|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658830|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154658831|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
154658832|NCT02632747|Empagliflozin|empagliflozin|mesh-list
154658833|NCT02632747|Ramipril|ramipril|mesh-list
154658834|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154658835|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658836|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154658837|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658838|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154658839|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
154658840|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658841|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154658842|NCT04216797|Diazepam|diazepam|mesh-list
154658843|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154658844|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
154658845|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
154658846|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
154658847|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658848|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658849|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658850|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154658851|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658852|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154658853|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154658854|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154658855|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154658856|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154658857|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154658858|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
154658859|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
154658860|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
154658861|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
154658862|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658863|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658864|NCT05029401|Ibogaine|ibogaine|mesh-list
154658865|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
154658866|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658867|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154658868|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154658869|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154658870|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154658871|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658872|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
154658873|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154658874|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658875|NCT05025813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154658876|NCT05025813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658877|NCT04421547|Letrozole|letrozole|mesh-list
154658878|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658879|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154373711|NCT01341834|Everolimus|everolimus|mesh-list
154658880|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154658881|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658882|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658883|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154658884|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
154658885|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658886|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658887|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
154658888|NCT03066817|Vitamin D|vitamin d|mesh-list
154658889|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154658890|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658891|NCT03066817|Vitamins|vitamins|mesh-ancestor
154658892|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
154658893|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154658894|NCT05060913|Lidocaine|lidocaine|mesh-list
154658895|NCT05060913|Prilocaine|prilocaine|mesh-list
154658896|NCT05060913|Benzocaine|benzocaine|mesh-list
154658897|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154658898|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
154658899|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
154658900|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658901|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658902|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
154658903|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658904|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154658905|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154658906|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154658907|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658908|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658909|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154658910|NCT05165251|Amlodipine|amlodipine|mesh-list
154658911|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
154658912|NCT05165251|Atorvastatin|atorvastatin|mesh-list
154658913|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154658914|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154658915|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
154658916|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658917|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154658918|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154658919|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658920|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154658921|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154658922|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154658923|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154658924|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658925|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
154658926|NCT04209075|Metformin|metformin|mesh-list
154658927|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154658928|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658929|NCT05023473|Morphine|morphine|mesh-list
154658930|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154658931|NCT05023473|Narcotics|narcotics|mesh-ancestor
154658932|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658933|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658934|NCT05023473|Analgesics|analgesics|mesh-ancestor
154658935|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
154658936|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658937|NCT03066661|Entrectinib|entrectinib|mesh-list
154658938|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154658939|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154658940|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658941|NCT03775629|Tramadol|tramadol|mesh-list
154658942|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154658943|NCT03775629|Narcotics|narcotics|mesh-ancestor
154658944|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658945|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658946|NCT03775629|Analgesics|analgesics|mesh-ancestor
154658947|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
154658948|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658949|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
154658950|NCT01671319|Docetaxel|docetaxel|mesh-list
154658951|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154658952|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
154658953|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658954|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154658955|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154658956|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
154658957|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154658958|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154658959|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154658960|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
154658961|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
154658962|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
154658963|NCT03763305|Fentanyl|fentanyl|mesh-list
154658964|NCT03763305|Remifentanil|remifentanil|mesh-list
154658965|NCT03763305|Propofol|propofol|mesh-list
154658966|NCT03763305|Sevoflurane|sevoflurane|mesh-list
154658967|NCT03763305|Desflurane|desflurane|mesh-list
154658968|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154658969|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154658970|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154658971|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658972|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154658973|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
154658974|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
154658975|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154658976|NCT03763305|Narcotics|narcotics|mesh-ancestor
154658977|NCT03763305|Analgesics|analgesics|mesh-ancestor
154658978|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
154658979|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154658980|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154658981|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154373807|NCT03155178|Ethanol|ethanol|mesh-list
154658982|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154658983|NCT05054361|Mannitol|mannitol|mesh-list
154658984|NCT05054361|Lactulose|lactulose|mesh-list
154658985|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154658986|NCT05054361|Diuretics|diuretics|mesh-ancestor
154658987|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
154658988|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658989|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154658990|NCT01670539|Triamcinolone|triamcinolone|mesh-list
154658991|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154658992|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
154658993|NCT01670539|Hormones|hormones|mesh-ancestor
154658994|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154658995|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154658996|NCT04431895|Tofacitinib|tofacitinib|mesh-list
154658997|NCT04431895|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154658998|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154658999|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659000|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659001|NCT03064633|Dexamethasone|dexamethasone|mesh-list
154659002|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
154659003|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
154659004|NCT03064633|Bupivacaine|bupivacaine|mesh-list
154659005|NCT03064633|BB 1101|bb 1101|mesh-list
154659006|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659007|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
154659008|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
154659009|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659010|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659011|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659012|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
154659013|NCT03064633|Hormones|hormones|mesh-ancestor
154659014|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659015|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154659016|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659017|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
154659018|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659019|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659020|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
154659021|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
154659022|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659023|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
154659024|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154659025|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659026|NCT03064633|Analgesics|analgesics|mesh-ancestor
154659027|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154659028|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154659029|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154659030|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
154659031|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659032|NCT02589665|Mirikizumab|mirikizumab|mesh-list
154659033|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154659034|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659035|NCT02589665|Analgesics|analgesics|mesh-ancestor
154659036|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
154659037|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659038|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659039|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659040|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659041|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154659042|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659043|NCT04426409|Ofloxacin|ofloxacin|mesh-list
154659044|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154659045|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659046|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154659047|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154659048|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154659049|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659050|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659051|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659052|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154659053|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154659054|NCT04426097|Iodine|iodine|mesh-list
154659055|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154659056|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659057|NCT04426097|Trace Elements|trace elements|mesh-ancestor
154659058|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
154659059|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659060|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
154659061|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
154659062|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154659063|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154659064|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659065|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659066|NCT05556083|Urological Agents|urological agents|mesh-ancestor
154659067|NCT05556005|Trimetazidine|trimetazidine|mesh-list
154659068|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
154659069|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
154659070|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
154659071|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154659072|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154659073|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659074|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
154659075|NCT04373603|Coagulants|coagulants|mesh-ancestor
154659076|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154659077|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
154659078|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659079|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
154659080|NCT04373603|Protective Agents|protective agents|mesh-ancestor
154659081|NCT02519595|Ketamine|ketamine|mesh-list
154659082|NCT02519595|Analgesics|analgesics|mesh-ancestor
154659083|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
154659084|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659085|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659086|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154659087|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154659088|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
154659089|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
154659090|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659091|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154659092|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154659093|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659094|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659095|NCT04278755|Drospirenone|drospirenone|mesh-list
154659096|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154659097|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154659098|NCT04278755|Estradiol|estradiol|mesh-list
154659099|NCT04278755|Estrogens|estrogens|mesh-ancestor
154659100|NCT04278755|Hormones|hormones|mesh-ancestor
154659101|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659102|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659103|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154659104|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
154659105|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154659106|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154659107|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154659108|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154659109|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154659110|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154659111|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154659112|NCT04278755|Diuretics|diuretics|mesh-ancestor
154659113|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
154659114|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
154659115|NCT04277975|Narcotics|narcotics|mesh-ancestor
154659116|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659117|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659118|NCT04277975|Analgesics|analgesics|mesh-ancestor
154659119|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
154411113|NCT01345357|Gemcitabine|gemcitabine|mesh-list
154659120|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659122|NCT04062695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154659123|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154659124|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659125|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659126|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
154659127|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154659128|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659129|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154659130|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659131|NCT00660673|Levodopa|levodopa|mesh-list
154659132|NCT00660673|Carbidopa|carbidopa|mesh-list
154659133|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154659134|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154659135|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154659136|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
154659137|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659138|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659139|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659140|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154659141|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659142|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154659143|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
154659144|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
154659145|NCT03644381|Immunomodulating Agents|immunomodulating agents|mesh-list
154659146|NCT03644381|Immunologic Factors|immunologic factors|mesh-ancestor
154659147|NCT03644381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659148|NCT05612711|Dronabinol|dronabinol|mesh-list
154659149|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
154659150|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659151|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154659152|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659153|NCT05612711|Analgesics|analgesics|mesh-ancestor
154659154|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
154659155|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659156|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154659157|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154659158|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659159|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659160|NCT05612711|Hormones|hormones|mesh-ancestor
154659161|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659162|NCT04807309|Danazol|danazol|mesh-list
154659163|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154659164|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
154659165|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659166|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659167|NCT04744649|Fluorouracil|fluorouracil|mesh-list
154659168|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
154659169|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659170|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154659171|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659172|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154659173|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
154659174|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659175|NCT04426955|Paclitaxel|paclitaxel|mesh-list
154659176|NCT04426955|Cisplatin|cisplatin|mesh-list
154659177|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154659178|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659179|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
154659180|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
154659181|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
154659182|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659183|NCT02630563|Cyclosporine|cyclosporine|mesh-list
154659184|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
154659185|NCT02630563|Cyclosporins|cyclosporins|mesh-list
154659186|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659187|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659188|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154659189|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
154659190|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659191|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
154659192|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659193|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
154659194|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659195|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154659196|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154659197|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659198|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154659199|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
154659200|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154659201|NCT05555147|Ropivacaine|ropivacaine|mesh-list
154659202|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
154659203|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
154659204|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659205|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659206|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
154659207|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659208|NCT02587247|Antibodies|antibodies|mesh-list
154659209|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
154659210|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659211|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
154659212|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154659213|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
154659214|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154659215|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
154659216|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659217|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659218|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
154659219|NCT02521415|Acetaminophen|acetaminophen|mesh-list
154659220|NCT02521415|Ibuprofen|ibuprofen|mesh-list
154659221|NCT02521415|Fentanyl|fentanyl|mesh-list
154659222|NCT02521415|Ketamine|ketamine|mesh-list
154659223|NCT02521415|Analgesics|analgesics|mesh-list
154659224|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
154659225|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659226|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659227|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154659228|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154659229|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
154659230|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
154659231|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659232|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154659233|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154659234|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659235|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659236|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154659237|NCT02521415|Narcotics|narcotics|mesh-ancestor
154659238|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154659239|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659240|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
154659241|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154659242|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659243|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659244|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154659245|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659246|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
154659247|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
154659248|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374088|NCT06208540|Cerebrolysin|cerebrolysin|mesh-list
154659249|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
154659250|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659251|NCT02588339|Sirolimus|sirolimus|mesh-list
154659252|NCT02588339|Panobinostat|panobinostat|mesh-list
154659253|NCT02588339|Tacrolimus|tacrolimus|mesh-list
154659254|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154659255|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
154659256|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659257|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154659258|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659259|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659260|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154659261|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659262|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154659263|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659264|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
154659265|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154659266|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154659267|NCT05554055|Dalteparin|dalteparin|mesh-list
154411271|NCT01317433|Doxycycline|doxycycline|mesh-list
154659268|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
154659269|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154659270|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154659271|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659273|NCT05700617|Milrinone|milrinone|mesh-list
154659274|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154659275|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
154659276|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
154659277|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659278|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659279|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154659280|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154659281|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154659282|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
154659283|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659284|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659285|NCT05700617|Protective Agents|protective agents|mesh-ancestor
154659286|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154659287|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
154659288|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154659289|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154659290|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659291|NCT02629159|Adalimumab|adalimumab|mesh-list
154659292|NCT02629159|Upadacitinib|upadacitinib|mesh-list
154659293|NCT02629159|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154659294|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659295|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659296|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154659297|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154659298|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659299|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659300|NCT02628769|Solithromycin|solithromycin|mesh-list
154659301|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154659302|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659303|NCT05552807|Paclitaxel|paclitaxel|mesh-list
154659304|NCT05552807|Docetaxel|docetaxel|mesh-list
154659305|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154659306|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659307|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
154659308|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
154659309|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
154659310|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659311|NCT05552729|Vitamin D|vitamin d|mesh-list
154659312|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
154659313|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
154659314|NCT05552729|Vitamins|vitamins|mesh-list
154659315|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
154659316|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659317|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154659318|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154659319|NCT05552651|Paclitaxel|paclitaxel|mesh-list
154659320|NCT05552651|Carboplatin|carboplatin|mesh-list
154659321|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154659322|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154659323|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659324|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
154659325|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
154659326|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
154659327|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659328|NCT04981327|Apixaban|apixaban|mesh-list
154659329|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154659330|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
154659331|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154659332|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
154659333|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659334|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659335|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
154659336|NCT05547659|Acetaminophen|acetaminophen|mesh-list
154659337|NCT05547659|Celecoxib|celecoxib|mesh-list
154659338|NCT05547659|Pregabalin|pregabalin|mesh-list
154659339|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659340|NCT05547659|Analgesics|analgesics|mesh-ancestor
154659341|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
154659342|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659343|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659344|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
154411335|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
154659345|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
154659346|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154659347|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154659348|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659349|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154659350|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154659351|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154659352|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659353|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154659354|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154659355|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659356|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659357|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154659358|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154659359|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659360|NCT05541419|Budesonide|budesonide|mesh-list
154659361|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659362|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154659363|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
154659364|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659365|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659366|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154659367|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
154659368|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
154659369|NCT05541419|Hormones|hormones|mesh-ancestor
154659370|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659371|NCT05541185|Naproxen|naproxen|mesh-list
154659372|NCT05541185|Lidocaine|lidocaine|mesh-list
154659373|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
154659374|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
154659375|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659376|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659377|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
154659378|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659379|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154659380|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154659381|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154659382|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154659383|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659384|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154659385|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659386|NCT05541185|Analgesics|analgesics|mesh-ancestor
154659387|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659388|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659389|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
154659390|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154659391|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659392|NCT02518113|Dexamethasone|dexamethasone|mesh-list
154659393|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659394|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
154659395|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
154659396|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659397|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659398|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659399|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
154659400|NCT02518113|Hormones|hormones|mesh-ancestor
154659401|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659402|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154659403|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659404|NCT05541107|Amphotericin B|amphotericin b|mesh-list
154659405|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154659406|NCT05541107|Amebicides|amebicides|mesh-ancestor
154659407|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154659408|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154659409|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659410|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154659411|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
154659412|NCT03062839|Melatonin|melatonin|mesh-list
154659413|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
154659414|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659415|NCT03062839|Protective Agents|protective agents|mesh-ancestor
154659416|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659417|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659418|NCT05540951|Bevacizumab|bevacizumab|mesh-list
154659419|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154659420|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659421|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154659422|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154659423|NCT05540951|Growth Substances|growth substances|mesh-ancestor
154659424|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659425|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
154659426|NCT04981093|Dexamethasone|dexamethasone|mesh-list
154659427|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
154659428|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659429|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
154659430|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
154659431|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659432|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659433|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659434|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
154659435|NCT04981093|Hormones|hormones|mesh-ancestor
154659436|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659437|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154659438|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659439|NCT05551247|Endostatins|endostatins|mesh-list
154659440|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659441|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154659442|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154659443|NCT05551247|Growth Substances|growth substances|mesh-ancestor
154659444|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659445|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
154659446|NCT05540483|Disitamab vedotin|disitamab vedotin|mesh-list
154659447|NCT05540483|Immunoconjugates|immunoconjugates|mesh-ancestor
154374311|NCT06205719|Remifentanil|remifentanil|mesh-list
154659448|NCT05540483|Immunologic Factors|immunologic factors|mesh-ancestor
154659449|NCT05540483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659450|NCT02629861|Calcitonin|calcitonin|mesh-list
154659451|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154659452|NCT02629861|Katacalcin|katacalcin|mesh-list
154659453|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154659454|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659455|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154659456|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
154659457|NCT02513823|Vitamin D|vitamin d|mesh-list
154659458|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
154659459|NCT02513823|Vitamins|vitamins|mesh-ancestor
154659460|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
154374340|NCT06205589|Immunologic Factors|immunologic factors|mesh-ancestor
154374341|NCT06205589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374342|NCT06205550|Flecainide|flecainide|mesh-list
154374343|NCT06205550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154374344|NCT06205550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154374345|NCT06205550|Adrenergic Agents|adrenergic agents|mesh-ancestor
154374346|NCT06205550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374347|NCT06205550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374348|NCT06205550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374349|NCT06205550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154374350|NCT06205550|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154374351|NCT06205550|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153813437|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813438|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
153359900|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813439|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659461|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659462|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154659463|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154659464|NCT05545475|Heparin|heparin|mesh-list
154659465|NCT05545475|Enoxaparin|enoxaparin|mesh-list
154659466|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154659467|NCT05545475|Tinzaparin|tinzaparin|mesh-list
154659468|NCT05545475|Dalteparin|dalteparin|mesh-list
154659469|NCT05545475|Nadroparin|nadroparin|mesh-list
154659470|NCT05545475|Warfarin|warfarin|mesh-list
154659471|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
154659472|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154659473|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154659474|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659475|NCT05545397|Propofol|propofol|mesh-list
154659476|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154659477|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659478|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659479|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154659480|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
154374352|NCT06205550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374353|NCT06205498|Acalabrutinib|acalabrutinib|mesh-list
154374354|NCT06205498|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154374355|NCT06205498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154374356|NCT06205498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374357|NCT06205498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374358|NCT06205498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374359|NCT06205329|Ritonavir|ritonavir|mesh-list
154374360|NCT06205329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154374361|NCT06205329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154374362|NCT06205329|Protease Inhibitors|protease inhibitors|mesh-ancestor
154374363|NCT06205329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374364|NCT06205329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374365|NCT06205329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154374366|NCT06205329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154374367|NCT06205329|Antiviral Agents|antiviral agents|mesh-ancestor
154374368|NCT06205329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626611|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153626613|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
154659481|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
154659482|NCT04952727|Vaccines|vaccines|mesh-list
154659483|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
154659484|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659485|NCT04433143|Minocycline|minocycline|mesh-list
154659486|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154659487|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659488|NCT01665911|Listerine|listerine|mesh-list
154659489|NCT01665911|Fluorides|fluorides|mesh-list
154659490|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
154374369|NCT06205329|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153910854|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
153813440|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153359902|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153813441|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153813442|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
154659491|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
154659492|NCT01665911|Protective Agents|protective agents|mesh-ancestor
154659493|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659494|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154411485|NCT01371656|Levofloxacin|levofloxacin|mesh-list
154659495|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659496|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
154659497|NCT03063073|Bupivacaine|bupivacaine|mesh-list
154659498|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
154659499|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
154659500|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659501|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659502|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
154659503|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659504|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154659505|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659506|NCT03063073|Analgesics|analgesics|mesh-ancestor
154374370|NCT06205329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154374371|NCT06205030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154374372|NCT06205030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374373|NCT06201715|Tofacitinib|tofacitinib|mesh-list
153443279|NCT02034006|Ranibizumab|ranibizumab|mesh-list
153626634|NCT02018094|Clindamycin|clindamycin|mesh-list
153901886|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659507|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154659508|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154659509|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154659510|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
154659511|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659512|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659513|NCT04620733|Seladelpar|seladelpar|mesh-list
154659514|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154659515|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
154659516|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659517|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154374374|NCT06201715|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154374375|NCT06201715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154374376|NCT06201715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626635|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154659518|NCT02476617|Ritonavir|ritonavir|mesh-list
154659519|NCT02476617|Ribavirin|ribavirin|mesh-list
154659520|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154659521|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154659522|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
154659523|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659524|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659525|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154659526|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154374377|NCT06201715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443430|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
153359908|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
153359909|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659527|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
154659528|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659529|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154659530|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154659531|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
154659532|NCT05535725|Vancomycin|vancomycin|mesh-list
154659533|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154659534|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659535|NCT05535569|Paclitaxel|paclitaxel|mesh-list
154374378|NCT06200155|Niacin|niacin|mesh-list
153813445|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154659536|NCT05535569|Nivolumab|nivolumab|mesh-list
154659537|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154659538|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659539|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
154659540|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
154659541|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
154659542|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659543|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154659544|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154659545|NCT03064165|Epinephrine|epinephrine|mesh-list
154659546|NCT03064165|Bupivacaine|bupivacaine|mesh-list
154659547|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
154659548|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
154659549|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659550|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659551|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
154659552|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659553|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154659554|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154659555|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
154659556|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374379|NCT06200155|Psilocybin|psilocybin|mesh-list
154374380|NCT06200155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154374381|NCT06200155|Antimetabolites|antimetabolites|mesh-ancestor
154374382|NCT06200155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374383|NCT06200155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154374384|NCT06200155|Vasodilator Agents|vasodilator agents|mesh-ancestor
154374385|NCT06200155|Vitamin B Complex|vitamin b complex|mesh-ancestor
154374386|NCT06200155|Vitamins|vitamins|mesh-ancestor
154374387|NCT06200155|Micronutrients|micronutrients|mesh-ancestor
154374388|NCT06200155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374389|NCT06200155|Hallucinogens|hallucinogens|mesh-ancestor
154374390|NCT06200155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154374391|NCT06196320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154374392|NCT06196320|Tenecteplase|tenecteplase|mesh-list
154374393|NCT06196320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154374394|NCT06196320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154374395|NCT06196320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374396|NCT06195228|Lenvatinib|lenvatinib|mesh-list
154374397|NCT06195228|Trametinib|trametinib|mesh-list
154374398|NCT06195228|Dabrafenib|dabrafenib|mesh-list
154374399|NCT06195228|Pralsetinib|pralsetinib|mesh-list
154374400|NCT06195228|Antibodies|antibodies|mesh-list
154374401|NCT06195228|Immunoglobulins|immunoglobulins|mesh-list
154374402|NCT06195228|Entrectinib|entrectinib|mesh-list
153813448|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154659557|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659558|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154659559|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154659560|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
154659561|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154659562|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
154659563|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
154659564|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
154659565|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154659566|NCT05535413|Capecitabine|capecitabine|mesh-list
154659567|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154659568|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
153915316|NCT04215835|Letrozole|letrozole|mesh-list
153453023|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
153813450|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154659569|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659570|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659571|NCT03813199|Methotrexate|methotrexate|mesh-list
154659572|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154659574|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154659575|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659576|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154659577|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
154659578|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659579|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659580|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
154659581|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659582|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154659583|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154659584|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
154659585|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659586|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154659587|NCT05699135|Avelumab|avelumab|mesh-list
154659588|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154659589|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659590|NCT03791593|Evolocumab|evolocumab|mesh-list
154659591|NCT03791593|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154659592|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154659593|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154659594|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
154659595|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374403|NCT06195228|Immunologic Factors|immunologic factors|mesh-ancestor
154374404|NCT06195228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374405|NCT06195228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374406|NCT06195228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154374407|NCT06195228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374408|NCT06195228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374409|NCT06191848|Tirzepatide|tirzepatide|mesh-list
154374410|NCT06191848|Incretins|incretins|mesh-ancestor
154374411|NCT06191848|Hormones|hormones|mesh-ancestor
154374412|NCT06191848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374413|NCT06191848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374414|NCT06185452|Rilpivirine|rilpivirine|mesh-list
154374415|NCT06185452|Cabotegravir|cabotegravir|mesh-list
154374416|NCT06185452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154374417|NCT06185452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154374418|NCT06185452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374419|NCT06185452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374420|NCT06185452|Antiviral Agents|antiviral agents|mesh-ancestor
154374426|NCT06179446|Vaccines|vaccines|mesh-list
153359914|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153813451|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154659596|NCT03791593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154659597|NCT03791593|Protease Inhibitors|protease inhibitors|mesh-ancestor
154659598|NCT03791593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659599|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154659600|NCT03064243|Apatinib|apatinib|mesh-list
154659601|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659602|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154659603|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659604|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374430|NCT06177457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154659605|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
154659606|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154659607|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154659608|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659609|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
154659610|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154659611|NCT04979923|Lidocaine|lidocaine|mesh-list
154659612|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
154659613|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
154659614|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659615|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659616|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
154659617|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659618|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154659619|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154659620|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154659621|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154659622|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659623|NCT03706885|Efavirenz|efavirenz|mesh-list
154659624|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154659625|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154659626|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374431|NCT06177457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154374432|NCT06177457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374433|NCT06177457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374434|NCT06177457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154374435|NCT06177457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154374436|NCT06177457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154374437|NCT06177457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154374438|NCT06177457|Anesthetics, General|anesthetics, general|mesh-ancestor
154374439|NCT06177457|Anesthetics|anesthetics|mesh-ancestor
154374440|NCT06177457|GABA Modulators|gaba modulators|mesh-ancestor
154374441|NCT06177457|GABA Agents|gaba agents|mesh-ancestor
154374442|NCT06177457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374443|NCT06177457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374444|NCT06177301|Tislelizumab|tislelizumab|mesh-list
154120688|NCT00808314|Dipyridamole|dipyridamole|mesh-list
154374445|NCT06177301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374446|NCT06177301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374448|NCT06175832|Ganirelix|ganirelix|mesh-list
154374449|NCT06175832|Hormone Antagonists|hormone antagonists|mesh-ancestor
154374450|NCT06175832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374451|NCT06175832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374452|NCT06175832|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153453248|NCT01762800|Hormones|hormones|mesh-ancestor
153902347|NCT01359592|Hormones|hormones|mesh-ancestor
153902375|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
154374453|NCT06175832|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153813454|NCT00432315|Docetaxel|docetaxel|mesh-list
153911613|NCT02757391|Analgesics|analgesics|mesh-ancestor
153813458|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813459|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813460|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659627|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659628|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
154659629|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659630|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154659631|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154659632|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154659633|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154374454|NCT06175832|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153813461|NCT00333671|Glycerol|glycerol|mesh-list
153359923|NCT02861573|Dexamethasone|dexamethasone|mesh-list
153359925|NCT02861573|Carboplatin|carboplatin|mesh-list
153911736|NCT02855632|Hormones|hormones|mesh-list
153813462|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153813463|NCT00333671|Protective Agents|protective agents|mesh-ancestor
153359926|NCT02861573|Docetaxel|docetaxel|mesh-list
153359927|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
153359928|NCT02861573|Etoposide|etoposide|mesh-list
153813464|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813465|NCT00432354|Atorvastatin|atorvastatin|mesh-list
153359929|NCT02861573|Lenvatinib|lenvatinib|mesh-list
153813466|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153902598|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
153646474|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154659634|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154659635|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154659636|NCT01665599|Testosterone|testosterone|mesh-list
154659637|NCT01665599|Androgens|androgens|mesh-ancestor
154659638|NCT01665599|Hormones|hormones|mesh-ancestor
154659639|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659640|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659641|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
153911816|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153359936|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813471|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154659642|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
154659643|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
154659644|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659645|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154659646|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
154659648|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659649|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374455|NCT06175832|Contraceptive Agents|contraceptive agents|mesh-ancestor
153813472|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813473|NCT00333944|Pralidoxime|pralidoxime|mesh-list
153359937|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646475|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154659650|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659651|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154659652|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
154659653|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154659654|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
154659655|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
154659656|NCT03063775|Coagulants|coagulants|mesh-ancestor
154659657|NCT03063541|Aspirin|aspirin|mesh-list
154659658|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154659659|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659660|NCT03063541|Analgesics|analgesics|mesh-ancestor
154659661|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
154659662|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659663|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374456|NCT06175832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153813474|NCT00333944|Antidotes|antidotes|mesh-ancestor
153813475|NCT00333944|Protective Agents|protective agents|mesh-ancestor
153813476|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659664|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659665|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659666|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154659667|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154659668|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659669|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154659670|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154374457|NCT06175832|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153813479|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813480|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
153452123|NCT01898442|Ticagrelor|ticagrelor|mesh-list
153646476|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153452170|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
153813481|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736410|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736411|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736412|NCT02768792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153736413|NCT02768792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659671|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659672|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
154659673|NCT04978597|Opicapone|opicapone|mesh-list
154659674|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154659675|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659676|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659677|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154659678|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154659679|NCT04977661|Vitamin E|vitamin e|mesh-list
154659680|NCT04977661|Tocopherols|tocopherols|mesh-list
154659681|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
154659682|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
154659683|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154659684|NCT04977661|Vitamins|vitamins|mesh-ancestor
154374458|NCT06175832|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154659685|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
154659686|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659687|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
154659688|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659689|NCT04977661|Protective Agents|protective agents|mesh-ancestor
154659690|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154659691|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659692|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154659693|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154659694|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
154659695|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154659696|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154374459|NCT06175832|Progestins|progestins|mesh-ancestor
154374460|NCT06175832|Hormones|hormones|mesh-ancestor
153646477|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
154659697|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659698|NCT04977427|Prednisolone|prednisolone|mesh-list
154659699|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154659700|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
154659701|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154659702|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
154659703|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154659704|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
154659705|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659706|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
154659707|NCT04977427|Hormones|hormones|mesh-ancestor
154659708|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659709|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659710|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154659711|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659712|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
154659713|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
154659714|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659715|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659716|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154659717|NCT04977427|Protective Agents|protective agents|mesh-ancestor
154659718|NCT04224415|Irinotecan|irinotecan|mesh-list
154659719|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154659720|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154659721|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659722|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659723|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659724|NCT03061981|Metformin|metformin|mesh-list
154659725|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154659726|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659727|NCT02510001|Crizotinib|crizotinib|mesh-list
154659728|NCT02510001|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154659729|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154659730|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374461|NCT06173505|Carboplatin|carboplatin|mesh-list
153359945|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
153359946|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813486|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153813487|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153813488|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
153813489|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813490|NCT04701528|Tacrolimus|tacrolimus|mesh-list
153813491|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813492|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
153813493|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813494|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153813495|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359949|NCT02861573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153452401|NCT01832766|Dronabinol|dronabinol|mesh-list
153454010|NCT01693068|Dacarbazine|dacarbazine|mesh-list
153444502|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
153813498|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154374462|NCT06173505|Pembrolizumab|pembrolizumab|mesh-list
153444603|NCT00957827|Cephalexin|cephalexin|mesh-list
153359951|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153359952|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153359953|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359954|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153359955|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153359956|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153359957|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
153452581|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
154769512|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769513|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154769514|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
154769515|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769516|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769517|NCT01581307|Leucovorin|leucovorin|mesh-list
154769518|NCT01581307|Folic Acid|folic acid|mesh-list
154769519|NCT01581307|Fluorouracil|fluorouracil|mesh-list
154769520|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
154769521|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
154769522|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
154769523|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769524|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154374463|NCT06173505|Pemetrexed|pemetrexed|mesh-list
154374464|NCT06173505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813501|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153813502|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153813503|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813509|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
153359960|NCT02807558|Daratumumab|daratumumab|mesh-list
153452681|NCT01838616|Oxycodone|oxycodone|mesh-list
154769525|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769526|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769527|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
154769528|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769529|NCT01581307|Antidotes|antidotes|mesh-ancestor
154769530|NCT01581307|Protective Agents|protective agents|mesh-ancestor
154769531|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
154769532|NCT01581307|Vitamins|vitamins|mesh-ancestor
153454228|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
154769533|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
154769534|NCT01581307|Hematinics|hematinics|mesh-ancestor
154769535|NCT01580995|Valacyclovir|valacyclovir|mesh-list
154769536|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
154769537|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769538|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154769539|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
154769540|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769541|NCT01562743|Rotigotine|rotigotine|mesh-list
154769542|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
154769543|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
154769544|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769545|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769546|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769547|NCT03028571|Trimethaphan|trimethaphan|mesh-list
154769548|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
154769549|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153454292|NCT04410354|Remdesivir|remdesivir|mesh-list
153813513|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454308|NCT01563354|Everolimus|everolimus|mesh-list
153359961|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153359962|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
154769550|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154769551|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154769552|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
154769553|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769554|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769555|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154769556|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154769557|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
154769558|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769559|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769560|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
154769561|NCT01535443|Bromfenac|bromfenac|mesh-list
153454355|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153813514|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359963|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359964|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454379|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153813515|NCT00438048|Pilocarpine|pilocarpine|mesh-list
153813516|NCT00438048|Miotics|miotics|mesh-ancestor
153813517|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
154374465|NCT06173505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769562|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154769563|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769564|NCT01535443|Analgesics|analgesics|mesh-ancestor
154769565|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
154769566|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769567|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769568|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769569|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769570|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
154769571|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154374466|NCT06173505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153813518|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359967|NCT02296229|Hormones|hormones|mesh-ancestor
154769572|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769573|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769574|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769575|NCT01535287|Analgesics|analgesics|mesh-ancestor
154769576|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
154769577|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769578|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153466089|NCT00151320|Rituximab|rituximab|mesh-list
153912748|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153912749|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153912750|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
153912751|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912752|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813519|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453028|NCT01810302|Nicardipine|nicardipine|mesh-list
153813520|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153813521|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153466212|NCT00350142|Gemcitabine|gemcitabine|mesh-list
153813522|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
154769579|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154769580|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154769581|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
154769582|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769583|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769584|NCT01549613|Vancomycin|vancomycin|mesh-list
154769585|NCT01549613|Daptomycin|daptomycin|mesh-list
154769586|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153466260|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153454673|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
154769587|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769588|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
154769589|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769590|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769591|NCT01546883|Dabigatran|dabigatran|mesh-list
154769592|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
154769593|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154769594|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
154769595|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813525|NCT00334256|Tenofovir|tenofovir|mesh-list
153813526|NCT00334256|Emtricitabine|emtricitabine|mesh-list
154769596|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769597|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
154769598|NCT01546649|Leuprolide|leuprolide|mesh-list
154769599|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154769600|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
154769601|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154769602|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769603|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154374467|NCT06173505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769604|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769605|NCT02985983|Brodalumab|brodalumab|mesh-list
154769606|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
154769607|NCT01544309|Atorvastatin|atorvastatin|mesh-list
154769608|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154769609|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154769610|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154769611|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
154769612|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769613|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154769614|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154769615|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769616|NCT01544153|Nicotine|nicotine|mesh-list
154769617|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154769618|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
154769619|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769620|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374468|NCT06173505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813528|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813529|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153359969|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769621|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154769622|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154769623|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
154769624|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769625|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769626|NCT01543685|Celecoxib|celecoxib|mesh-list
154769627|NCT01543685|Indomethacin|indomethacin|mesh-list
154769628|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154769629|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769630|NCT01543685|Analgesics|analgesics|mesh-ancestor
154769631|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
154769632|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769633|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769634|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769635|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769636|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154769637|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153454869|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153813530|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153813531|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769638|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769639|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769640|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
154769641|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
154769642|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154769643|NCT01540565|Veliparib|veliparib|mesh-list
154769644|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154769645|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769646|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769647|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769648|NCT01540487|Metformin|metformin|mesh-list
154769649|NCT01540487|Linagliptin|linagliptin|mesh-list
154769650|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154769651|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769652|NCT01540487|Incretins|incretins|mesh-ancestor
154769653|NCT01540487|Hormones|hormones|mesh-ancestor
154769654|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769655|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154769656|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
154769657|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769658|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769659|NCT01539317|Lidocaine|lidocaine|mesh-list
154769660|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
154769661|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
154769662|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769663|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769664|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
154769665|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769666|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154769667|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154769668|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154769669|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374469|NCT06173505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153813533|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153359970|NCT02203799|Immunomodulating Agents|immunomodulating agents|mesh-list
153453501|NCT01706328|Albuterol|albuterol|mesh-list
153813534|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153359975|NCT02180724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153359976|NCT02180724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359977|NCT02180724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359978|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359979|NCT02135419|Fluorouracil|fluorouracil|mesh-list
153359980|NCT02135419|Imiquimod|imiquimod|mesh-list
153359981|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
153359982|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359984|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359997|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359998|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
153359999|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813536|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153813537|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153813538|NCT00438087|Prednisolone|prednisolone|mesh-list
153813539|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
153813540|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153813541|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
153813542|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813543|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
153813544|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
153813545|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813546|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813547|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813548|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
153813549|NCT00438087|Hormones|hormones|mesh-ancestor
153813550|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813561|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153455026|NCT01518972|Prazosin|prazosin|mesh-list
153813564|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
154769670|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769671|NCT01539083|Thalidomide|thalidomide|mesh-list
154769672|NCT01539083|Dexamethasone|dexamethasone|mesh-list
154769673|NCT01539083|Prednisolone|prednisolone|mesh-list
154769674|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
154769675|NCT01539083|Bortezomib|bortezomib|mesh-list
154769676|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769677|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
154769678|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374470|NCT06173505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154769679|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769680|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154769681|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
154769682|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769683|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769684|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154769685|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769686|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
154374471|NCT06166381|Vancomycin|vancomycin|mesh-list
154374472|NCT06166381|Ceftriaxone|ceftriaxone|mesh-list
153813565|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153813566|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153903945|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
153813567|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769687|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
154769688|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769689|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769690|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
154769691|NCT01539083|Hormones|hormones|mesh-ancestor
154769692|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769693|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154769694|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
154769695|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154769696|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769697|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154769698|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154769699|NCT01539083|Growth Substances|growth substances|mesh-ancestor
154769700|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
154769701|NCT01537133|Fluticasone|fluticasone|mesh-list
154769702|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769703|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154769704|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
154769705|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455160|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
153813568|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813569|NCT00334490|Urological Agents|urological agents|mesh-ancestor
153813570|NCT00334529|Oseltamivir|oseltamivir|mesh-list
153360001|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813571|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
153813572|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360002|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153813573|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769706|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769707|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154769708|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
154769709|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
154769710|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154769712|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154769713|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
154769714|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769715|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374473|NCT06166381|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153467304|NCT00531882|Ibuprofen|ibuprofen|mesh-list
153813574|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374474|NCT06166381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360005|NCT01853748|Immunologic Factors|immunologic factors|mesh-ancestor
153813575|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
153813576|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153813577|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454006|NCT01712178|Adalimumab|adalimumab|mesh-list
154769716|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154769717|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
154769718|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154769719|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154769720|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154769721|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
154769722|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913577|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360006|NCT01853748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360007|NCT01843374|Tremelimumab|tremelimumab|mesh-list
154769723|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769724|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
154769725|NCT02985905|Astringents|astringents|mesh-ancestor
154769726|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769727|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
154769728|NCT01535261|Ranibizumab|ranibizumab|mesh-list
154769729|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154769730|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154769731|NCT01535261|Growth Substances|growth substances|mesh-ancestor
154769732|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374475|NCT06166381|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154374476|NCT06166381|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153913622|NCT02265367|Analgesics|analgesics|mesh-ancestor
153813581|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360010|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153813582|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
153813583|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
154769733|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
154769734|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769735|NCT01534637|Gemcitabine|gemcitabine|mesh-list
154769736|NCT01534637|Capecitabine|capecitabine|mesh-list
154769737|NCT01534637|Fluorouracil|fluorouracil|mesh-list
154769738|NCT01534637|Aprepitant|aprepitant|mesh-list
154769739|NCT01534637|Antiemetics|antiemetics|mesh-list
154769740|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154769741|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
154769742|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769743|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769744|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769745|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
154769746|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769747|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
154769748|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374477|NCT06164314|Dexmedetomidine|dexmedetomidine|mesh-list
153919009|NCT05746442|Nicotine|nicotine|mesh-list
153360011|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
153813584|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
153360012|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360014|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360015|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153360016|NCT00840801|Vaccines|vaccines|mesh-list
153360017|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
153360018|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360019|NCT00515359|Propofol|propofol|mesh-list
153360020|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153360021|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360022|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360023|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153360024|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
153360025|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
153360026|NCT00494234|Olaparib|olaparib|mesh-list
153813605|NCT04701606|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
153813606|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
153813607|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153813608|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153813609|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813610|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813611|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
153813612|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
154769749|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769750|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154769751|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769752|NCT02655016|Niraparib|niraparib|mesh-list
154769753|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154769754|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769755|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913790|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153360043|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153360044|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153813613|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153813614|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
153360045|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
154769756|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769757|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
154769758|NCT01533935|Olodaterol|olodaterol|mesh-list
154769759|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154769760|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
154769761|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769762|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769763|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154769764|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
154374478|NCT06164314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153455583|NCT05757063|Propofol|propofol|mesh-list
153813615|NCT00334685|Pregabalin|pregabalin|mesh-list
153813616|NCT00334685|Reboxetine|reboxetine|mesh-list
153360046|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
153904388|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154769765|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
154769766|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154769767|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
154769768|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769769|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769770|NCT01532687|Gemcitabine|gemcitabine|mesh-list
154769771|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154769772|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
154769773|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913820|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454400|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154769774|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769775|NCT02677116|Doxorubicin|doxorubicin|mesh-list
154769776|NCT02677116|Irinotecan|irinotecan|mesh-list
154769777|NCT02677116|Vincristine|vincristine|mesh-list
154769778|NCT02677116|Ifosfamide|ifosfamide|mesh-list
154769779|NCT02677116|Olaratumab|olaratumab|mesh-list
154769780|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154769781|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769782|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154769783|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154769784|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374479|NCT06164314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360047|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913859|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
153461786|NCT03163992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153461787|NCT03163992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461788|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
153461789|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
153461790|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154769785|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769786|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154769787|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154769788|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
154769789|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
154769790|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374483|NCT06164314|Sensory System Agents|sensory system agents|mesh-ancestor
154769791|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154769792|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
154769793|NCT02689518|Aflibercept|aflibercept|mesh-list
154769794|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153462676|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
154769795|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153462893|NCT04758936|Clonidine|clonidine|mesh-list
153462997|NCT04393584|Vitamins|vitamins|mesh-ancestor
154769796|NCT02689518|Growth Substances|growth substances|mesh-ancestor
154769797|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468762|NCT06058299|Linezolid|linezolid|mesh-list
153463537|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
154769798|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
154769799|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769800|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
154769801|NCT02681094|Saxagliptin|saxagliptin|mesh-list
153464176|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
153464177|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464180|NCT01331148|Vitamin D|vitamin d|mesh-list
153455940|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
153464401|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769802|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154769803|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769804|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154769805|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769806|NCT02681094|Incretins|incretins|mesh-ancestor
154769807|NCT02681094|Hormones|hormones|mesh-ancestor
153456134|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
154374487|NCT06164314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153465418|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769808|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769809|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154769810|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
154769811|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469634|NCT04671667|Cisplatin|cisplatin|mesh-list
154769812|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
154769813|NCT03164304|Analgesics|analgesics|mesh-ancestor
154769814|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
154769815|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769816|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769817|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
154769818|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769819|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154769820|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
154769821|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154374492|NCT06156982|Antiviral Agents|antiviral agents|mesh-ancestor
154769822|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153466067|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
154769823|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769824|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154769825|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
154769826|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154769827|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
154769828|NCT02689284|Margetuximab|margetuximab|mesh-list
154769829|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154769830|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769831|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466619|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154769832|NCT02689284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154769833|NCT02689284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769834|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
154769835|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769836|NCT03165396|Propofol|propofol|mesh-list
154769837|NCT03165396|Sevoflurane|sevoflurane|mesh-list
154769838|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153466952|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467164|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467165|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769839|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769840|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769841|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154769842|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
154769843|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
154769844|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154769845|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154769846|NCT03164382|Sorafenib|sorafenib|mesh-list
154769847|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769848|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154769849|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769850|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769851|NCT03161340|Sirolimus|sirolimus|mesh-list
154769852|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154769853|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769854|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154769855|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769856|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
154769857|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769858|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
154769859|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769860|NCT03161574|Fluorouracil|fluorouracil|mesh-list
153467504|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
153813709|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154769861|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
154769862|NCT03161574|Irinotecan|irinotecan|mesh-list
153467984|NCT00525798|Calcitonin|calcitonin|mesh-list
154769863|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
154769864|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374528|NCT06107543|Sensory System Agents|sensory system agents|mesh-ancestor
154769865|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154769866|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468331|NCT06298071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154769867|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769868|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
154769869|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813733|NCT00335075|Temozolomide|temozolomide|mesh-list
153468577|NCT06277609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468727|NCT06170788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815576|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769870|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153457002|NCT01436370|Vaccines|vaccines|mesh-list
153815689|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769871|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154769872|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769873|NCT03163914|Phenylephrine|phenylephrine|mesh-list
154769874|NCT03163914|Epinephrine|epinephrine|mesh-list
154769875|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
154769876|NCT03163914|Norepinephrine|norepinephrine|mesh-list
154769877|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154769878|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153627572|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154769879|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
154769880|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769881|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769882|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769883|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154769884|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154769885|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
154769886|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769887|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154769888|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
154769889|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
154769890|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
154769891|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154769892|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154769893|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
154769894|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154769895|NCT03163914|Protective Agents|protective agents|mesh-ancestor
154769896|NCT03160872|Hormones|hormones|mesh-list
153627975|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374540|NCT06107153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628081|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
154769897|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769898|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769899|NCT03163680|Omeprazole|omeprazole|mesh-list
154769900|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154769901|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769902|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153923144|NCT03709680|Irinotecan|irinotecan|mesh-list
153628440|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153628608|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628610|NCT02031692|Vitamin D|vitamin d|mesh-list
153628611|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
154769903|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769904|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769905|NCT04574232|Triamcinolone|triamcinolone|mesh-list
154769906|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154769907|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153628946|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
154769908|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154769909|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154769910|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
154769911|NCT04574232|Hormones|hormones|mesh-ancestor
154769912|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769913|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769914|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769915|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
154769916|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769917|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769918|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154769919|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154769920|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
154769921|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769922|NCT04557384|Ramucirumab|ramucirumab|mesh-list
154769923|NCT04557384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154769924|NCT04557384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154374543|NCT06107153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769925|NCT04557384|Growth Substances|growth substances|mesh-ancestor
154769926|NCT04557384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769927|NCT04557384|Growth Inhibitors|growth inhibitors|mesh-ancestor
154769928|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769929|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
154769930|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769931|NCT05231850|Tislelizumab|tislelizumab|mesh-list
154769932|NCT05231850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769933|NCT05231850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769934|NCT03163212|Lactoferrin|lactoferrin|mesh-list
154769935|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769936|NCT05007678|Leflunomide|leflunomide|mesh-list
154769937|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154769938|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769939|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154769940|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
154769941|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769942|NCT03161106|Lactulose|lactulose|mesh-list
154769943|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154769944|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
154769945|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154769946|NCT02671500|Velpatasvir|velpatasvir|mesh-list
154769947|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
154769948|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154769949|NCT02671266|Oxytocin|oxytocin|mesh-list
154769950|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
154769951|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154769952|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769953|NCT03160404|Zolpidem|zolpidem|mesh-list
154769954|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154769955|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154769956|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154769957|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769958|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154769959|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
154769960|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
154769961|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154769962|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769963|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
154769964|NCT03162588|Hematinics|hematinics|mesh-ancestor
154769965|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154769966|NCT03320070|Hormones|hormones|mesh-ancestor
154769967|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154769968|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769969|NCT04977336|Acetaminophen|acetaminophen|mesh-list
154769970|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154769971|NCT04977336|Analgesics|analgesics|mesh-ancestor
154769972|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
154769973|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154769974|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769975|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
154769976|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
154769977|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154769978|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154769979|NCT03284424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154769980|NCT03284424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769981|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154769982|NCT02674854|Latanoprost|latanoprost|mesh-list
154769983|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154769984|NCT02388516|Vitamin D|vitamin d|mesh-list
154769985|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
154769986|NCT02388516|Vitamins|vitamins|mesh-ancestor
154769987|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
154769988|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154769989|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154769990|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154769991|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154769992|NCT01531673|Ivacaftor|ivacaftor|mesh-list
154769993|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154769994|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154769995|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154769996|NCT01531205|Leuprolide|leuprolide|mesh-list
154769997|NCT01531205|Goserelin|goserelin|mesh-list
154769998|NCT01531205|Bicalutamide|bicalutamide|mesh-list
154769999|NCT01531205|Androgens|androgens|mesh-list
154770000|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154770001|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
154770002|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154770003|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770004|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154770005|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770006|NCT01531205|Hormones|hormones|mesh-ancestor
154770007|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154770008|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
154522002|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154770009|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
154770010|NCT02985671|Acetaminophen|acetaminophen|mesh-list
154770011|NCT02985671|Diclofenac|diclofenac|mesh-list
154770012|NCT02985671|Orphenadrine|orphenadrine|mesh-list
154770013|NCT02985671|Caffeine|caffeine|mesh-list
154770014|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154770015|NCT02985671|Analgesics|analgesics|mesh-ancestor
154770016|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
154770017|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770018|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770019|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
154770020|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154770021|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154770022|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770023|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770024|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154770025|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154770026|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
154770027|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770028|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154770029|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770030|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770031|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154770032|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154770033|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154770034|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154770035|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154770036|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
154770037|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
154770038|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154770039|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154770040|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
154770041|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154770042|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154770043|NCT01529645|Vaccines|vaccines|mesh-list
154770044|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
154770045|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770046|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154770047|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154770048|NCT01528709|Atorvastatin|atorvastatin|mesh-list
154770049|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154770050|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154770051|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
154770052|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770053|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154770054|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154770055|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770056|NCT01527383|Vaccines|vaccines|mesh-list
154770057|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
154770058|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770059|NCT01526057|Rituximab|rituximab|mesh-list
154770060|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154770061|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770062|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
154770063|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770064|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770065|NCT01525901|Mitogens|mitogens|mesh-list
154770066|NCT01525901|Mecasermin|mecasermin|mesh-list
154770067|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770068|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
154770069|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770070|NCT01525901|Growth Substances|growth substances|mesh-ancestor
154770071|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
154770072|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154770073|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154770074|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770075|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
154770076|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
154770077|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
154770078|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154770079|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770080|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770081|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154770082|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154770083|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
154770084|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154770085|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770086|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154522078|NCT03612323|Piroxicam|piroxicam|mesh-list
154770087|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154770088|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154770089|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
154770090|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770091|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154770092|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154770093|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770095|NCT00264381|Tinzaparin|tinzaparin|mesh-list
154770096|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154770097|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
154770098|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154770099|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154770100|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770101|NCT00246441|Paroxetine|paroxetine|mesh-list
154770102|NCT00246441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154770103|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154770104|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154770105|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770106|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770107|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
154770108|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770109|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154770110|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
154770111|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154770112|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154770113|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154770114|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770115|NCT00246519|Atenolol|atenolol|mesh-list
154770116|NCT00246519|Metoprolol|metoprolol|mesh-list
154770117|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154770118|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
154770119|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154770120|NCT00246519|Diuretics|diuretics|mesh-ancestor
154770121|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
154770122|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770123|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154770124|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154770125|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770126|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154770127|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
154770128|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
154770129|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770130|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154770131|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154770132|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154770133|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
154770134|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770135|NCT00248547|Dexamethasone|dexamethasone|mesh-list
154770136|NCT00248547|Ondansetron|ondansetron|mesh-list
154770137|NCT00248547|Aprepitant|aprepitant|mesh-list
154770138|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770139|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
154770140|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
154770141|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770142|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770143|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154770144|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
154770145|NCT00248547|Hormones|hormones|mesh-ancestor
154770146|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154770147|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154770148|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770149|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
154770150|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
154770151|NCT00248547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154770152|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154770153|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
154770154|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770155|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770156|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154770157|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
154770158|NCT01524887|Antibodies|antibodies|mesh-list
154770159|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
154522154|NCT03067844|Alirocumab|alirocumab|mesh-list
154770161|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154770162|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
154770163|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770164|NCT00266799|Doxorubicin|doxorubicin|mesh-list
154770165|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154770166|NCT00266799|Capecitabine|capecitabine|mesh-list
154770167|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154770168|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770169|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154770170|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154770171|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374739|NCT05972681|Epinephrine|epinephrine|mesh-list
154770172|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770173|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154770174|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
154770175|NCT00249249|Atorvastatin|atorvastatin|mesh-list
154770176|NCT00249249|Pitavastatin|pitavastatin|mesh-list
154770177|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154770178|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154770179|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
154770180|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770181|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154770182|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154770183|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770184|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154770185|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
154770186|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154770187|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
154770188|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770189|NCT00125931|Pentazocine|pentazocine|mesh-list
154770190|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154770191|NCT00125931|Narcotics|narcotics|mesh-ancestor
154770192|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770193|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770194|NCT00125931|Analgesics|analgesics|mesh-ancestor
154770195|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
154770196|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770197|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154770198|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154770199|NCT00267111|Tetracaine|tetracaine|mesh-list
154770200|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154770201|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
154770202|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770203|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770204|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
154770205|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770206|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
154770207|NCT01521923|Methotrexate|methotrexate|mesh-list
154770208|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154770209|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
154770210|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154770211|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770212|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154770213|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
154770214|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770215|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770216|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
154770217|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770218|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154770219|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770220|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
154770221|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770222|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154770223|NCT01521923|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154770224|NCT01521923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770225|NCT05240781|Sirolimus|sirolimus|mesh-list
154770226|NCT05240781|Temsirolimus|temsirolimus|mesh-list
154770227|NCT05240781|MTOR Inhibitors|mtor inhibitors|mesh-list
154770228|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154770229|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770230|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154770231|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770232|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
154770233|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770234|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
154770235|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770236|NCT05240781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154770237|NCT05240781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770238|NCT05240781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770239|NCT01520987|Opicapone|opicapone|mesh-list
154374805|NCT05905367|Narcotics|narcotics|mesh-ancestor
154770240|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154770241|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770242|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770243|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154770244|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154770245|NCT00130923|Risperidone|risperidone|mesh-list
154770246|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154770247|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
154770248|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770249|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770250|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770251|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154770252|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154770253|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770254|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154770255|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154770256|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
154770257|NCT04117581|Vitamin D|vitamin d|mesh-list
154770258|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
154770259|NCT04117581|Vitamins|vitamins|mesh-ancestor
154770260|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
154770261|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770262|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154770263|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154770264|NCT00272337|Aspirin|aspirin|mesh-list
154770265|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154770266|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154770267|NCT00272337|Analgesics|analgesics|mesh-ancestor
154770268|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
154770269|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770270|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770271|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770272|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770273|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154770274|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154770275|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770276|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154770277|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154770278|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770279|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
154770280|NCT01562275|Ipatasertib|ipatasertib|mesh-list
154770281|NCT01562275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770282|NCT01562275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154770283|NCT01562275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770284|NCT01562275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770285|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
154770286|NCT01535053|Leucovorin|leucovorin|mesh-list
154770287|NCT01535053|Folic Acid|folic acid|mesh-list
154770288|NCT01535053|Dactinomycin|dactinomycin|mesh-list
154770289|NCT01535053|Methotrexate|methotrexate|mesh-list
154770290|NCT01535053|Calcium|calcium|mesh-list
154770291|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
154770292|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154770293|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770294|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154770295|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154770296|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
154770297|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154770298|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154770299|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
154770300|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770301|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770302|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
154770303|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770304|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154770305|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770306|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
154770307|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770308|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154770309|NCT01535053|Antidotes|antidotes|mesh-ancestor
154770310|NCT01535053|Protective Agents|protective agents|mesh-ancestor
154770311|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
154770312|NCT01535053|Vitamins|vitamins|mesh-ancestor
154770313|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
154770314|NCT01535053|Hematinics|hematinics|mesh-ancestor
154770315|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154770316|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770317|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154770318|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154770319|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
154770320|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154770321|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770322|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154770323|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154770324|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770325|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770326|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770327|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154770328|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154770329|NCT01520363|Levomethorphan|levomethorphan|mesh-list
154770330|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
154770331|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
154770332|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
154770333|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154770334|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154770335|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770336|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770337|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770338|NCT01520363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154770339|NCT01520363|Narcotics|narcotics|mesh-ancestor
154770340|NCT01520363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770341|NCT01520363|Analgesics|analgesics|mesh-ancestor
154770342|NCT01520363|Sensory System Agents|sensory system agents|mesh-ancestor
154770343|NCT01520363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770344|NCT01578499|Methotrexate|methotrexate|mesh-list
154770345|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154770346|NCT01578499|Bexarotene|bexarotene|mesh-list
154770347|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154770348|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
154770349|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154770350|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770351|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154770352|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
154770353|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374938|NCT05775939|Antimetabolites|antimetabolites|mesh-ancestor
154770354|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770355|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
154770356|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770357|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154770358|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770359|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
154770360|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770361|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154770362|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154770363|NCT01578499|Immunotoxins|immunotoxins|mesh-ancestor
154770364|NCT01578499|Immunoconjugates|immunoconjugates|mesh-ancestor
154770365|NCT01561963|Rifampin|rifampin|mesh-list
154770366|NCT01561963|Apremilast|apremilast|mesh-list
154770367|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154770368|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
154770369|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154770370|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770371|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
154770372|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154770373|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770374|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770375|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154770376|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154770377|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154770378|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154770379|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154770380|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154770381|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154770382|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154770383|NCT01561963|Analgesics|analgesics|mesh-ancestor
154770384|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
154770385|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770386|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770387|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770389|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154770390|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154770391|NCT04852003|Morphine|morphine|mesh-list
154770392|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154770393|NCT04852003|Narcotics|narcotics|mesh-ancestor
154770394|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770395|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770396|NCT04852003|Analgesics|analgesics|mesh-ancestor
154770397|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
154770398|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770399|NCT01534351|Tamsulosin|tamsulosin|mesh-list
154770400|NCT01534351|Finasteride|finasteride|mesh-list
154770401|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154770402|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154770403|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154770404|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
154770405|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770406|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770407|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770408|NCT01534351|Urological Agents|urological agents|mesh-ancestor
154770409|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154770410|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154770411|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770412|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
154770413|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374998|NCT05666336|Prednisone|prednisone|mesh-list
154770414|NCT01534195|Prednisolone|prednisolone|mesh-list
154770415|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154770416|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
154770417|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154770418|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
154770419|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154770420|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154770421|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154770422|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
154770423|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770424|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
154770425|NCT01534195|Hormones|hormones|mesh-ancestor
154770426|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154770427|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770428|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154770429|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770430|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
154770431|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
154770432|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770433|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154770434|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154770435|NCT01534195|Protective Agents|protective agents|mesh-ancestor
154770436|NCT01560949|Gemcitabine|gemcitabine|mesh-list
154770437|NCT01560949|Fluorouracil|fluorouracil|mesh-list
154770438|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
154770439|NCT01560949|Irinotecan|irinotecan|mesh-list
154770440|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154770441|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
154770442|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770443|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770444|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770445|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
154770446|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770447|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154770448|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154770449|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770450|NCT03113448|Capsaicin|capsaicin|mesh-list
154770451|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
154770452|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
154770453|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
154770454|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770455|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770456|NCT01533493|Memantine|memantine|mesh-list
154770457|NCT01533493|Methylphenidate|methylphenidate|mesh-list
154522455|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154770458|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154770459|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770460|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154770461|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154770462|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154770463|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770464|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
154770465|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770466|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154770467|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154770468|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154770469|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154770471|NCT02388048|Ibrutinib|ibrutinib|mesh-list
154770472|NCT02388048|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154770473|NCT02388048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154770474|NCT02388048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770475|NCT02388048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770476|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770477|NCT02387892|Vitamin D|vitamin d|mesh-list
154770478|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
154770479|NCT02387892|Vitamins|vitamins|mesh-ancestor
154770480|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
154770481|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770482|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154770483|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154770484|NCT00133575|Vaccines|vaccines|mesh-list
154770485|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
154770486|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770487|NCT00134043|Vorinostat|vorinostat|mesh-list
154770488|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770489|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154770490|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770491|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770492|NCT03715998|Ramipril|ramipril|mesh-list
154770493|NCT03715998|Firibastat|firibastat|mesh-list
154770494|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154770495|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
154770496|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770497|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770498|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154770499|NCT01790529|Metronidazole|metronidazole|mesh-list
154770500|NCT01790529|Cefuroxime|cefuroxime|mesh-list
154770501|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
154770502|NCT01790529|Anesthetics|anesthetics|mesh-list
154770503|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770504|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770505|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770506|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154770507|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154770508|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154770509|NCT01533181|Topotecan|topotecan|mesh-list
154770510|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154770511|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154770512|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770513|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770514|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770515|NCT04641507|Tadalafil|tadalafil|mesh-list
154770516|NCT04641507|Tamsulosin|tamsulosin|mesh-list
154770517|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
154770518|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154770519|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154770520|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770521|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770522|NCT04641507|Urological Agents|urological agents|mesh-ancestor
154375120|NCT05638087|Dexamethasone|dexamethasone|mesh-list
154770523|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154770524|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154770525|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154770526|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
154770527|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770528|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770529|NCT04489173|Trifluridine|trifluridine|mesh-list
154770530|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
154770531|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770532|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
154770533|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770535|NCT00512070|Melatonin|melatonin|mesh-list
154770536|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
154770537|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770538|NCT00512070|Protective Agents|protective agents|mesh-ancestor
154770539|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770540|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770541|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
154770542|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
154770543|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770544|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154770545|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154770546|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154770547|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154770548|NCT00512070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154770549|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154770550|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154770551|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770552|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
154770553|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
154770554|NCT03534102|Narcotics|narcotics|mesh-ancestor
154770555|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770556|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770557|NCT03534102|Analgesics|analgesics|mesh-ancestor
154770558|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
154770559|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770560|NCT00144963|Dexamethasone|dexamethasone|mesh-list
154770561|NCT00144963|Vincristine|vincristine|mesh-list
154770562|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770563|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
154770564|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
154770565|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770566|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770567|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154770568|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
154770569|NCT00144963|Hormones|hormones|mesh-ancestor
154770570|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154770571|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154770572|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770573|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154770574|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
154770575|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
154770576|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
154770577|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770578|NCT02662764|Sufentanil|sufentanil|mesh-list
154770579|NCT02662764|Dsuvia|dsuvia|mesh-list
154770580|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154770581|NCT02662764|Narcotics|narcotics|mesh-ancestor
154770582|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770583|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770584|NCT02662764|Analgesics|analgesics|mesh-ancestor
154770585|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
154770586|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375183|NCT05560399|Elotuzumab|elotuzumab|mesh-list
154770587|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154770588|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154770589|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
154770590|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
154770591|NCT01519817|Vaccines|vaccines|mesh-list
154770592|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
154770593|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770594|NCT05549154|Vitamin D|vitamin d|mesh-list
154770595|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
154770596|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
154770597|NCT05549154|Vitamins|vitamins|mesh-list
154770598|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
154770599|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770600|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154770601|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154770602|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
154770603|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154770604|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154770605|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154770606|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154770607|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770608|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
154770609|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770610|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770611|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154770612|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770613|NCT02391636|Oxytocin|oxytocin|mesh-list
154770614|NCT02391636|Carbetocin|carbetocin|mesh-list
154770615|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
154770616|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154770617|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770618|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154770619|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
154770620|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770621|NCT02383212|Paclitaxel|paclitaxel|mesh-list
154770622|NCT02383212|Docetaxel|docetaxel|mesh-list
154770623|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
154770624|NCT02383212|Carboplatin|carboplatin|mesh-list
154770625|NCT02383212|Pemetrexed|pemetrexed|mesh-list
154770626|NCT02383212|Cemiplimab|cemiplimab|mesh-list
154770627|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154770628|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770629|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
154770630|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
154770631|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
154770632|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770633|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770634|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
154770635|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770636|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770637|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154770638|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
154770639|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154770640|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770641|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154770642|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154770643|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154770644|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
154770645|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770646|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
154770647|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770648|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770649|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154770650|NCT01531153|Galantamine|galantamine|mesh-list
154770651|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154770652|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770653|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770654|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
154770655|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770656|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770657|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154770658|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
154770659|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770660|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
154770661|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
154770662|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
154770663|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154770664|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154770665|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770666|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
154770667|NCT03027973|Coagulants|coagulants|mesh-ancestor
154770668|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154770669|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
154770670|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154770671|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770672|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154770673|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
154770674|NCT01529749|Losartan|losartan|mesh-list
154770675|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154770676|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154770677|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154770678|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154770679|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770680|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154522670|NCT03385161|Ethanol|ethanol|mesh-list
154770681|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154770682|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
154770683|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770684|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154770685|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154770686|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770687|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154770688|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154770689|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154770690|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154770692|NCT01528969|Cathartics|cathartics|mesh-ancestor
154770693|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154770694|NCT01514201|Temozolomide|temozolomide|mesh-list
154770695|NCT01514201|Veliparib|veliparib|mesh-list
154770696|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154770697|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
154770698|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770699|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770700|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154770701|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770702|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154770703|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154770704|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
154770705|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770706|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154770707|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770708|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154770709|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770710|NCT01528735|Ribavirin|ribavirin|mesh-list
154770711|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
154770712|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770713|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
154770714|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770715|NCT02386488|Vortioxetine|vortioxetine|mesh-list
154770716|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
154770717|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154770718|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154770719|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154770720|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770721|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770722|NCT02386488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154770723|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154770724|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154770725|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770726|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770727|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
154770728|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154770729|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154770730|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154770731|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154770732|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
154770733|NCT02661594|Amisulpride|amisulpride|mesh-list
154770734|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154770735|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770736|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154770737|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154770738|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770739|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770740|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770741|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770742|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154770743|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154770744|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770745|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154770746|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154770747|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
154770748|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770749|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154770750|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
154770751|NCT02386566|Natalizumab|natalizumab|mesh-list
154770752|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
154770753|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770754|NCT01528345|Fulvestrant|fulvestrant|mesh-list
154522744|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
154770755|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154770756|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770757|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154770758|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154770759|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
154770760|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154770761|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770762|NCT01511939|Diclofenac|diclofenac|mesh-list
154375371|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
154770763|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154770764|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154770765|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154770766|NCT01511939|Analgesics|analgesics|mesh-ancestor
154770767|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
154770768|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770769|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770770|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770771|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154770772|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770773|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770774|NCT02391480|Venetoclax|venetoclax|mesh-list
154770775|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770776|NCT01576705|Leucovorin|leucovorin|mesh-list
154770777|NCT01576705|Folic Acid|folic acid|mesh-list
154770778|NCT01576705|Hormones|hormones|mesh-list
154770779|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
154770780|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154770781|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770782|NCT01576705|Antidotes|antidotes|mesh-ancestor
154770783|NCT01576705|Protective Agents|protective agents|mesh-ancestor
154770784|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
154770785|NCT01576705|Vitamins|vitamins|mesh-ancestor
154770786|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
154770787|NCT01576705|Hematinics|hematinics|mesh-ancestor
154770788|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
154770789|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154770790|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770791|NCT02382666|Rolapitant|rolapitant|mesh-list
154770792|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154770793|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770794|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770795|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770796|NCT00145041|Vincristine|vincristine|mesh-list
154770797|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154770798|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770799|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
154770800|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
154770801|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
154770802|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770803|NCT04123561|Dexamethasone|dexamethasone|mesh-list
154770804|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
154770805|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154770806|NCT04123561|BB 1101|bb 1101|mesh-list
154770807|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770808|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
154770809|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
154770810|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770811|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770812|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154770813|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
154770814|NCT04123561|Hormones|hormones|mesh-ancestor
154770815|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154770816|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154770817|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770818|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
154770819|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770820|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770821|NCT01510769|Febuxostat|febuxostat|mesh-list
154770822|NCT01510769|Lesinurad|lesinurad|mesh-list
154770823|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
154770824|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770825|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
154770826|NCT02382354|Remifentanil|remifentanil|mesh-list
154770827|NCT02382354|Propofol|propofol|mesh-list
154770828|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154770829|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770830|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770831|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154770832|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
154770833|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
154770834|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154770835|NCT02382354|Narcotics|narcotics|mesh-ancestor
154770836|NCT02382354|Analgesics|analgesics|mesh-ancestor
154770837|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
154770838|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770839|NCT01510145|Travoprost|travoprost|mesh-list
154770840|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154770841|NCT03027167|Aspirin|aspirin|mesh-list
154770842|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154770843|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154770844|NCT03027167|Analgesics|analgesics|mesh-ancestor
154770845|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
154770846|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770847|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770848|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770849|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770850|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154770851|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154770852|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770853|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154770854|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154770855|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770856|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
154770857|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
154770858|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154770859|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154770860|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154770861|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
154770862|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770863|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770864|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770865|NCT02382432|Meperidine|meperidine|mesh-list
154770866|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
154770867|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154770868|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770869|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770870|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154770871|NCT02382432|Analgesics|analgesics|mesh-ancestor
154770872|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
154770873|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770874|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154770875|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154770876|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154770877|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
154770878|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770879|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770880|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154770881|NCT02382432|Narcotics|narcotics|mesh-ancestor
154770882|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154770883|NCT00145587|Antibodies|antibodies|mesh-list
154770884|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
154770885|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770886|NCT04298463|Vancomycin|vancomycin|mesh-list
154770887|NCT04298463|Daptomycin|daptomycin|mesh-list
154770888|NCT04298463|Teicoplanin|teicoplanin|mesh-list
154770889|NCT04298463|Dalbavancin|dalbavancin|mesh-list
154770890|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154770891|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154770892|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
154770893|NCT02381964|Vitamins|vitamins|mesh-ancestor
154770894|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
154770895|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770896|NCT01509053|Aripiprazole|aripiprazole|mesh-list
154770897|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
154770898|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154770899|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154770900|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154770901|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770902|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770903|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
154770904|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
154770905|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770906|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770907|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154770908|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154770909|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
154770910|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154770911|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154770912|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154770913|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154770914|NCT01560403|Teduglutide|teduglutide|mesh-list
154770915|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154770916|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154770917|NCT01560403|Protective Agents|protective agents|mesh-ancestor
154770918|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770919|NCT02100579|Bupivacaine|bupivacaine|mesh-list
154770920|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
154770921|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
154770922|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154770923|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770924|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
154770925|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770926|NCT04251351|Acetaminophen|acetaminophen|mesh-list
154770927|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154770928|NCT04251351|Analgesics|analgesics|mesh-ancestor
154770929|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
154770930|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154770931|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770932|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
154770933|NCT02390700|Golimumab|golimumab|mesh-list
154770934|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154770935|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154770936|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770937|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
154770938|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770939|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154770940|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154770941|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154770942|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770943|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
154770944|NCT01527487|Docetaxel|docetaxel|mesh-list
154770945|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770946|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
154770947|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770948|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154770949|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154770950|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
154770951|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770952|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770953|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154770954|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
154770955|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
154770956|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
154770957|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
154770958|NCT01506947|Hematinics|hematinics|mesh-ancestor
154770959|NCT00149643|Fluoxetine|fluoxetine|mesh-list
154770960|NCT00149643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154770961|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154770962|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154770963|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770964|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770965|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
154770966|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770967|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154770968|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
154770969|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154770970|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154770971|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154770972|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154770973|NCT02381730|Aflibercept|aflibercept|mesh-list
154770974|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154770975|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154770976|NCT02381730|Growth Substances|growth substances|mesh-ancestor
154770977|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770978|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
154770979|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770980|NCT00149799|Escitalopram|escitalopram|mesh-list
154770981|NCT00149799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154770982|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154770983|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154770984|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770985|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154770986|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
154770987|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770988|NCT02390544|Melphalan|melphalan|mesh-list
154770989|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154770990|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
154770991|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154770992|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154770993|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154770994|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154770995|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
154770996|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154770997|NCT01790997|Aspirin|aspirin|mesh-list
154770998|NCT01790997|Clopidogrel|clopidogrel|mesh-list
154375594|NCT05064735|Semaglutide|semaglutide|mesh-list
154770999|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154771000|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154771001|NCT01790997|Analgesics|analgesics|mesh-ancestor
154771002|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
154771003|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771004|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771005|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771006|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771007|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154771008|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154771009|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771010|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154771011|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154771012|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771013|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
154771014|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154771015|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154771016|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154771017|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
154771018|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771019|NCT02385474|Fluorides|fluorides|mesh-list
154771020|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
154771021|NCT02385474|Protective Agents|protective agents|mesh-ancestor
154771022|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771023|NCT02390310|Lidocaine|lidocaine|mesh-list
154771024|NCT02390310|Prilocaine|prilocaine|mesh-list
154771025|NCT02390310|Anesthetics|anesthetics|mesh-list
154771026|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
154771027|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771028|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771029|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
154771030|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771031|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154771032|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154771033|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154771034|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154771035|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771036|NCT02381184|Clomiphene|clomiphene|mesh-list
154771037|NCT02381184|Enclomiphene|enclomiphene|mesh-list
154771038|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
154771039|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154771040|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
154771041|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771042|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771043|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154771044|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
154771045|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154375656|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771046|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154771047|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154771048|NCT02381028|Emollients|emollients|mesh-list
154771049|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
154771050|NCT00326781|Nicotine|nicotine|mesh-list
154771051|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154771052|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
154771053|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771054|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154523040|NCT03609775|Ethanol|ethanol|mesh-list
154771055|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154771056|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154771057|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
154771058|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771059|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771060|NCT02385396|Folic Acid|folic acid|mesh-list
154771061|NCT02385396|Inositol|inositol|mesh-list
154771062|NCT02385396|Hematinics|hematinics|mesh-ancestor
154771063|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
154771064|NCT02385396|Vitamins|vitamins|mesh-ancestor
154771065|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
154771066|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771067|NCT02979405|Phenylephrine|phenylephrine|mesh-list
154771068|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
154771069|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154771070|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
154771071|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
154771072|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771073|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771074|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
154771075|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154771076|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
154771077|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
154771078|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154771079|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154771080|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154771081|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
154771082|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771083|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771084|NCT02979405|Protective Agents|protective agents|mesh-ancestor
154771085|NCT01791231|Canagliflozin|canagliflozin|mesh-list
154771086|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154771087|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771088|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154771089|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771090|NCT01791309|Panitumumab|panitumumab|mesh-list
154771091|NCT01791309|Vemurafenib|vemurafenib|mesh-list
154771092|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771093|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771094|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154771095|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771096|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771097|NCT02389920|Nilotinib|nilotinib|mesh-list
154771098|NCT02389920|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154771099|NCT02389920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154771100|NCT02389920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771101|NCT02389920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771102|NCT00329433|Heparin|heparin|mesh-list
154771103|NCT00329433|Desirudin|desirudin|mesh-list
154771104|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
154771105|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154771106|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154771107|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771108|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
154771109|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154771110|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771111|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
154771112|NCT02389842|Palbociclib|palbociclib|mesh-list
154771113|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771114|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154771115|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771116|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771117|NCT00289653|Nicotine|nicotine|mesh-list
154771118|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154771119|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
154771120|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771121|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771122|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154771123|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154771124|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
154771125|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771126|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771127|NCT00291135|Letrozole|letrozole|mesh-list
154771128|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771129|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154771130|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154771131|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771132|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771133|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154771134|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
154771135|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771136|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771137|NCT02103855|Abatacept|abatacept|mesh-list
154771138|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154771139|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771140|NCT02103855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771141|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771142|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771143|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
154771144|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771145|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771146|NCT03706053|Midodrine|midodrine|mesh-list
154771147|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
154771148|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
154771149|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771150|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771151|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154771152|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154771153|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154771154|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154771155|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
154771156|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771157|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771158|NCT01504841|Etravirine|etravirine|mesh-list
154771159|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154771160|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154771161|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771162|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771163|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
154771164|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771165|NCT00330915|Pemetrexed|pemetrexed|mesh-list
154771166|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771167|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771168|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771169|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154771170|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154771171|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154771172|NCT03026933|Calcium|calcium|mesh-list
154771173|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154771174|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771175|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154771176|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154771177|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
154771178|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771179|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154771180|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154771181|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771182|NCT01502423|Adalimumab|adalimumab|mesh-list
154771183|NCT01502423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154771184|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771185|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771186|NCT04861584|Gemcitabine|gemcitabine|mesh-list
154771187|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771188|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154771189|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
154771190|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771191|NCT02388750|Palonosetron|palonosetron|mesh-list
154771192|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
154771193|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
154771194|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771195|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771196|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154771197|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154771198|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154771199|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
154771200|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771201|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154523186|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
154771202|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
154771203|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771204|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
154771205|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771206|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771207|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154771208|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
154771209|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771210|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771211|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154771212|NCT01500317|Oxycodone|oxycodone|mesh-list
154771213|NCT01500317|Tapentadol|tapentadol|mesh-list
154771214|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154771215|NCT01500317|Narcotics|narcotics|mesh-ancestor
154771216|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771217|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771218|NCT01500317|Analgesics|analgesics|mesh-ancestor
154771219|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
154771220|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771221|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154771222|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154771223|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154771224|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771225|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
154771226|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771227|NCT02379546|Desflurane|desflurane|mesh-list
154771228|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154771229|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
154771230|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
154771231|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771232|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771233|NCT00332163|Irinotecan|irinotecan|mesh-list
154771234|NCT00332163|Panitumumab|panitumumab|mesh-list
154771235|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154771236|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154771237|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771238|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771239|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771240|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771241|NCT02379000|Triamcinolone|triamcinolone|mesh-list
154771242|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154771243|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154771244|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154771245|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771246|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
154771247|NCT02379000|Hormones|hormones|mesh-ancestor
154771248|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771249|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771250|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771251|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
154771252|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771253|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771254|NCT00333177|Risperidone|risperidone|mesh-list
154771255|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154771256|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
154771257|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771258|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771259|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771260|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154771261|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154771262|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771263|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154771264|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154771265|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
154771266|NCT02379156|Midodrine|midodrine|mesh-list
154771267|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
154771268|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
154771269|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771270|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771271|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154771272|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154771273|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154523267|NCT03386643|Clobetasol|clobetasol|mesh-list
154771274|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154771275|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
154771276|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771277|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771278|NCT00335283|Lansoprazole|lansoprazole|mesh-list
154771279|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
154771280|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154771281|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154771282|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154771283|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771284|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771285|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154771286|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154771287|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
154771288|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771289|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771290|NCT02779257|Diazoxide|diazoxide|mesh-list
154771291|NCT02779257|Pasireotide|pasireotide|mesh-list
154771292|NCT02779257|Hormones|hormones|mesh-ancestor
154771293|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771294|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771295|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154771296|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
154771297|NCT00295503|Bevacizumab|bevacizumab|mesh-list
154771298|NCT00295503|Pemetrexed|pemetrexed|mesh-list
154771299|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771300|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771301|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154771302|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154771303|NCT00295503|Growth Substances|growth substances|mesh-ancestor
154771304|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771305|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
154771306|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771307|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771308|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154771309|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154771310|NCT02371590|Lenalidomide|lenalidomide|mesh-list
154771311|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
154771312|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
154771313|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771314|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154771315|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154771316|NCT02371590|Growth Substances|growth substances|mesh-ancestor
154771317|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
154771318|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771319|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771320|NCT00298155|Ketoconazole|ketoconazole|mesh-list
154771321|NCT00298155|Goserelin|goserelin|mesh-list
154771322|NCT00298155|Bicalutamide|bicalutamide|mesh-list
154771323|NCT00298155|Dutasteride|dutasteride|mesh-list
154771324|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154771325|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771326|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
154771327|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771328|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154771329|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154771330|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771331|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771332|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154771333|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
154771334|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771335|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771336|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154771337|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
154771338|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154771339|NCT01499849|Dexamethasone|dexamethasone|mesh-list
154771340|NCT01499849|Granisetron|granisetron|mesh-list
154771341|NCT01499849|Rolapitant|rolapitant|mesh-list
154771342|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771343|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
154771344|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
154771345|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771346|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771347|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154771348|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
154523335|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
154771349|NCT01499849|Hormones|hormones|mesh-ancestor
154771350|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771351|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154771352|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771353|NCT01499849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154771354|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154771355|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
154771356|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771357|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771358|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154771359|NCT00298233|Oseltamivir|oseltamivir|mesh-list
154771360|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
154771361|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771362|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771363|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771364|NCT02376972|Rifaximin|rifaximin|mesh-list
154771365|NCT02376972|Metronidazole|metronidazole|mesh-list
154771366|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154771367|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771368|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154771369|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154771370|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154771371|NCT02378532|Chloroquine|chloroquine|mesh-list
154771372|NCT02378532|Temozolomide|temozolomide|mesh-list
154771373|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154771374|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
154771375|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771376|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771377|NCT02378532|Amebicides|amebicides|mesh-ancestor
154771378|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154771379|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154771380|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771381|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
154771382|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771383|NCT01498679|Fluticasone|fluticasone|mesh-list
154771384|NCT01498679|Xhance|xhance|mesh-list
154771385|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771386|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154771387|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
154771388|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771389|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771390|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154771391|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
154771392|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
154771393|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154771394|NCT01000467|Probucol|probucol|mesh-list
154771395|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154771396|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154771397|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
154771398|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771399|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154771400|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
154771401|NCT01000467|Protective Agents|protective agents|mesh-ancestor
154771402|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771403|NCT00198315|Bleomycin|bleomycin|mesh-list
154771404|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154771405|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771406|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
154771407|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154771408|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154771409|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
154771410|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771411|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771412|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771413|NCT01559389|Urological Agents|urological agents|mesh-ancestor
154771414|NCT01526551|Vaccines|vaccines|mesh-list
154771415|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
154771416|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771417|NCT00343083|Paclitaxel|paclitaxel|mesh-list
154771418|NCT00343083|Carboplatin|carboplatin|mesh-list
154771419|NCT00343083|Cetuximab|cetuximab|mesh-list
154771420|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154771421|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771422|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
154771423|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
154771424|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154523415|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771425|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771426|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771427|NCT02376426|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154771429|NCT02376426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771430|NCT00343785|Cyclosporine|cyclosporine|mesh-list
154771431|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
154771432|NCT00343785|Methotrexate|methotrexate|mesh-list
154771433|NCT00343785|Cyclosporins|cyclosporins|mesh-list
154771434|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
154771435|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154771436|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
154771437|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771438|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
154771439|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771440|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771441|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154771442|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
154771443|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771444|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771445|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154771446|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154771447|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
154771448|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154771449|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154771450|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
154771451|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154771452|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771453|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154771454|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154771455|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
154771456|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771457|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154771458|NCT00343863|Dexamethasone|dexamethasone|mesh-list
154771459|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
154771460|NCT00343863|Doxorubicin|doxorubicin|mesh-list
154771461|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154771462|NCT00343863|Ondansetron|ondansetron|mesh-list
154771463|NCT00343863|Palonosetron|palonosetron|mesh-list
154771464|NCT00343863|Antiemetics|antiemetics|mesh-list
154771465|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771466|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
154771467|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771468|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771469|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154771470|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
154771471|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771472|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771473|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154771474|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771475|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
154771476|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771477|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154771478|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
154771479|NCT00343863|Hormones|hormones|mesh-ancestor
154771480|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771481|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154771482|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154771483|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154771484|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154771485|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771486|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
154771487|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
154771488|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154771489|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154771490|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
154771491|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771492|NCT06307301|Aldesleukin|aldesleukin|mesh-list
154771493|NCT06307301|Abatacept|abatacept|mesh-list
154771494|NCT06307301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771495|NCT06307301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154771496|NCT06307301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154771497|NCT06307301|Antiviral Agents|antiviral agents|mesh-ancestor
154771498|NCT06307301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771499|NCT06307301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154771500|NCT06307301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771501|NCT06307301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771502|NCT06307301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771503|NCT06307301|Immunologic Factors|immunologic factors|mesh-ancestor
154771504|NCT06307301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771505|NCT06307301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771506|NCT06307288|Tranilast|tranilast|mesh-list
154771507|NCT06307288|Minocycline|minocycline|mesh-list
154771508|NCT06307288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154771509|NCT06307288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771510|NCT06307288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154771511|NCT06307288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154771512|NCT06307288|Analgesics|analgesics|mesh-ancestor
154771513|NCT06307288|Sensory System Agents|sensory system agents|mesh-ancestor
154771514|NCT06307288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771515|NCT06307288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771516|NCT06307288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771517|NCT06307288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771518|NCT06307288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154771519|NCT06307288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154771520|NCT06307288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771521|NCT06307288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154771522|NCT06307288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154771523|NCT06307288|Histamine Antagonists|histamine antagonists|mesh-ancestor
154771524|NCT06307288|Histamine Agents|histamine agents|mesh-ancestor
154771525|NCT06307288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771526|NCT06307288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154771527|NCT06307288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154771528|NCT06307249|Bevacizumab|bevacizumab|mesh-list
154771529|NCT06307249|Palbociclib|palbociclib|mesh-list
154771530|NCT06307249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771531|NCT06307249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771532|NCT06307249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154771533|NCT06307249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154771534|NCT06307249|Growth Substances|growth substances|mesh-ancestor
154771535|NCT06307249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771536|NCT06307249|Growth Inhibitors|growth inhibitors|mesh-ancestor
154771537|NCT06307249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154771538|NCT06307249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771539|NCT06307249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771540|NCT06307223|Salicylic Acid|salicylic acid|mesh-list
154771541|NCT06307223|Salicylates|salicylates|mesh-list
154771542|NCT06307223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771543|NCT06307223|Antifungal Agents|antifungal agents|mesh-ancestor
154771544|NCT06307223|Keratolytic Agents|keratolytic agents|mesh-ancestor
154771545|NCT06307223|Dermatologic Agents|dermatologic agents|mesh-ancestor
154771546|NCT06307223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154771547|NCT06307223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154771548|NCT06307223|Analgesics|analgesics|mesh-ancestor
154771549|NCT06307223|Sensory System Agents|sensory system agents|mesh-ancestor
154771550|NCT06307223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771551|NCT06307223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771552|NCT06307223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771553|NCT06307223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771554|NCT06307223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154771555|NCT06307223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771556|NCT06307223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771557|NCT06307106|Diclofenac|diclofenac|mesh-list
154771558|NCT06307106|Ketorolac|ketorolac|mesh-list
154771559|NCT06307106|Bupivacaine|bupivacaine|mesh-list
154771560|NCT06307106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154771561|NCT06307106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154771562|NCT06307106|Analgesics|analgesics|mesh-ancestor
154771563|NCT06307106|Sensory System Agents|sensory system agents|mesh-ancestor
154771564|NCT06307106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771565|NCT06307106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771566|NCT06307106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771567|NCT06307106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771568|NCT06307106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154771569|NCT06307106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771570|NCT06307106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771571|NCT06307106|Anesthetics, Local|anesthetics, local|mesh-ancestor
154771572|NCT06307106|Anesthetics|anesthetics|mesh-ancestor
154771573|NCT06307106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771574|NCT06307093|Pembrolizumab|pembrolizumab|mesh-list
154771575|NCT06307093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771576|NCT06307093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771577|NCT06307093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154771578|NCT06307093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771579|NCT06306989|Letermovir|letermovir|mesh-list
154771580|NCT06306989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154771581|NCT06306989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771582|NCT06306989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771583|NCT06306989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771584|NCT06306989|Antiviral Agents|antiviral agents|mesh-ancestor
154771585|NCT06306989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771586|NCT06306937|Vitamin D|vitamin d|mesh-list
154771587|NCT06306937|Vitamins|vitamins|mesh-ancestor
154771588|NCT06306937|Micronutrients|micronutrients|mesh-ancestor
154771589|NCT06306937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771590|NCT06306937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154771591|NCT06306846|Cetuximab|cetuximab|mesh-list
154771592|NCT06306846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771593|NCT06306846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771594|NCT06306638|Verteporfin|verteporfin|mesh-list
154771595|NCT06306638|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154771596|NCT06306638|Dermatologic Agents|dermatologic agents|mesh-ancestor
154771597|NCT06306560|Cisplatin|cisplatin|mesh-list
154771598|NCT06306560|Carboplatin|carboplatin|mesh-list
154771599|NCT06306560|Etoposide|etoposide|mesh-list
154771600|NCT06306560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771601|NCT06306560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154771602|NCT06306560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154771603|NCT06306560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154771604|NCT06306560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771605|NCT06306560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771606|NCT06306456|Osimertinib|osimertinib|mesh-list
154771607|NCT06306456|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154771608|NCT06306456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154771609|NCT06306456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771610|NCT06306456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771611|NCT06306456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771612|NCT06306443|Buprenorphine|buprenorphine|mesh-list
154771613|NCT06306443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154771614|NCT06306443|Narcotics|narcotics|mesh-ancestor
154771615|NCT06306443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771616|NCT06306443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771617|NCT06306443|Analgesics|analgesics|mesh-ancestor
154771618|NCT06306443|Sensory System Agents|sensory system agents|mesh-ancestor
154771619|NCT06306443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771620|NCT06306443|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154771621|NCT06306404|Estrogens|estrogens|mesh-list
154771622|NCT06306404|Progestins|progestins|mesh-list
154771623|NCT06306404|Hormones|hormones|mesh-ancestor
154771624|NCT06306404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771625|NCT06306404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771626|NCT06306274|Tacrolimus|tacrolimus|mesh-list
154771627|NCT06306274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771628|NCT06306274|Immunologic Factors|immunologic factors|mesh-ancestor
154771629|NCT06306274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771630|NCT06306274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154771631|NCT06306274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771632|NCT06306274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771633|NCT06306183|Acetaminophen|acetaminophen|mesh-list
154771634|NCT06306183|Naproxen|naproxen|mesh-list
154771635|NCT06306183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771636|NCT06306183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154771637|NCT06306183|Analgesics|analgesics|mesh-ancestor
154771638|NCT06306183|Sensory System Agents|sensory system agents|mesh-ancestor
154771639|NCT06306183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771640|NCT06306183|Antipyretics|antipyretics|mesh-ancestor
154771641|NCT06306183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771642|NCT06306183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154771643|NCT06306183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771644|NCT06306183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771645|NCT06306183|Gout Suppressants|gout suppressants|mesh-ancestor
154771646|NCT06306183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154771647|NCT06306183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771648|NCT06306157|Naltrexone|naltrexone|mesh-list
154771649|NCT06306157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154771650|NCT06306157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154771651|NCT06306157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771652|NCT06306157|Sensory System Agents|sensory system agents|mesh-ancestor
154771653|NCT06306157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771655|NCT06306131|Calcium Carbonate|calcium carbonate|mesh-list
154771656|NCT06306131|Levonorgestrel|levonorgestrel|mesh-list
154771657|NCT06306131|Calcium|calcium|mesh-list
154771658|NCT06306131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154771659|NCT06306131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771660|NCT06306131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154771661|NCT06306131|Contraceptive Agents|contraceptive agents|mesh-ancestor
154771662|NCT06306131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154771663|NCT06306131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154771664|NCT06306131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154771665|NCT06306131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154771666|NCT06306131|Antacids|antacids|mesh-ancestor
154771667|NCT06306131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771668|NCT06306131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154771669|NCT06306131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154771670|NCT06306131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154771671|NCT06306131|Analgesics|analgesics|mesh-ancestor
154771672|NCT06306131|Sensory System Agents|sensory system agents|mesh-ancestor
154771673|NCT06306131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771674|NCT06306131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771675|NCT06306131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771676|NCT06306131|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154771677|NCT06306131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154771678|NCT06306131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771679|NCT06306040|Magnesium Sulfate|magnesium sulfate|mesh-list
154771680|NCT06306040|Analgesics|analgesics|mesh-list
154771681|NCT06306040|Nalbuphine|nalbuphine|mesh-list
154771682|NCT06306040|Sensory System Agents|sensory system agents|mesh-ancestor
154771683|NCT06306040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771684|NCT06306040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771685|NCT06306040|Anesthetics|anesthetics|mesh-ancestor
154771686|NCT06306040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771687|NCT06306040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154771688|NCT06306040|Anticonvulsants|anticonvulsants|mesh-ancestor
154771689|NCT06306040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154771690|NCT06306040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154771691|NCT06306040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771692|NCT06306040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154771693|NCT06306040|Tocolytic Agents|tocolytic agents|mesh-ancestor
154771694|NCT06306040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154771695|NCT06306040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154771696|NCT06306040|Narcotics|narcotics|mesh-ancestor
154771697|NCT06306001|Methylene Blue|methylene blue|mesh-list
154771698|NCT06306001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376287|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771699|NCT06306001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771700|NCT06305910|Imiquimod|imiquimod|mesh-list
154771701|NCT06305910|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154771702|NCT06305910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771703|NCT06305910|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154771704|NCT06305910|Immunologic Factors|immunologic factors|mesh-ancestor
154771705|NCT06305910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771706|NCT06305910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154771707|NCT06305910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771708|NCT06305910|Interferon Inducers|interferon inducers|mesh-ancestor
154771709|NCT06305832|Androgens|androgens|mesh-list
154771710|NCT06305832|Hormones|hormones|mesh-ancestor
154771711|NCT06305832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771712|NCT06305832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771713|NCT06305637|Ketoconazole|ketoconazole|mesh-list
154771714|NCT06305637|Antifungal Agents|antifungal agents|mesh-ancestor
154771715|NCT06305637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771716|NCT06305637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154771717|NCT06305637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154771718|NCT06305637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771719|NCT06305637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771720|NCT06305637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154771721|NCT06305637|Hormone Antagonists|hormone antagonists|mesh-ancestor
154771722|NCT06305637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771723|NCT06305637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771724|NCT06305637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154771725|NCT06305598|Methyltestosterone|methyltestosterone|mesh-list
154771726|NCT06305598|Leuprolide|leuprolide|mesh-list
154771727|NCT06305598|Testosterone|testosterone|mesh-list
154771728|NCT06305598|Testosterone undecanoate|testosterone undecanoate|mesh-list
154771729|NCT06305598|Testosterone enanthate|testosterone enanthate|mesh-list
154771730|NCT06305598|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154771731|NCT06305598|Androgens|androgens|mesh-ancestor
154771732|NCT06305598|Hormones|hormones|mesh-ancestor
154771733|NCT06305598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771734|NCT06305598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771735|NCT06305598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154771736|NCT06305598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771737|NCT06305598|Anabolic Agents|anabolic agents|mesh-ancestor
154771738|NCT06305598|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154771739|NCT06305598|Fertility Agents|fertility agents|mesh-ancestor
154771740|NCT06305598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154771741|NCT06305559|Ezetimibe|ezetimibe|mesh-list
154771742|NCT06305559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154771743|NCT06305559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154771744|NCT06305559|Antimetabolites|antimetabolites|mesh-ancestor
154771745|NCT06305559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771746|NCT06305559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154771747|NCT06304545|Capecitabine|capecitabine|mesh-list
154771748|NCT06304545|Oxaliplatin|oxaliplatin|mesh-list
154771749|NCT06304545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154771750|NCT06304545|Antimetabolites|antimetabolites|mesh-ancestor
154771751|NCT06304545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771752|NCT06304545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771753|NCT06302257|Lidocaine|lidocaine|mesh-list
154771754|NCT06302257|Chloroprocaine|chloroprocaine|mesh-list
154771755|NCT06302257|Procaine|procaine|mesh-list
154771756|NCT06302257|Anesthetics, Local|anesthetics, local|mesh-ancestor
154771757|NCT06302257|Anesthetics|anesthetics|mesh-ancestor
154771758|NCT06302257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771759|NCT06302257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771760|NCT06302257|Sensory System Agents|sensory system agents|mesh-ancestor
154771761|NCT06302257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771762|NCT06302257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154771763|NCT06302257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154771764|NCT06302257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154771765|NCT06302257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154771766|NCT06302257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771767|NCT06288685|Triamcinolone|triamcinolone|mesh-list
154771768|NCT06288685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771769|NCT06288685|Glucocorticoids|glucocorticoids|mesh-ancestor
154771770|NCT06288685|Hormones|hormones|mesh-ancestor
154771771|NCT06288685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771772|NCT06288685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771773|NCT06267638|Ketamine|ketamine|mesh-list
154771774|NCT06267638|Analgesics|analgesics|mesh-ancestor
154771775|NCT06267638|Sensory System Agents|sensory system agents|mesh-ancestor
154771776|NCT06267638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771777|NCT06267638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771778|NCT06267638|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154771779|NCT06267638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154771780|NCT06267638|Anesthetics, General|anesthetics, general|mesh-ancestor
154771781|NCT06267638|Anesthetics|anesthetics|mesh-ancestor
154771782|NCT06267638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771783|NCT06267638|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154771784|NCT06267638|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154771785|NCT06267638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771786|NCT06267638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771787|NCT06261125|Lenvatinib|lenvatinib|mesh-list
154771788|NCT06261125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771789|NCT06261125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154771790|NCT06261125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771791|NCT06261125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771792|NCT06238635|Dostarlimab|dostarlimab|mesh-list
154771793|NCT06238635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771794|NCT06232616|Dexamethasone|dexamethasone|mesh-list
154771795|NCT06232616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154771796|NCT06232616|Antiemetics|antiemetics|mesh-ancestor
154523788|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
154771797|NCT06232616|Autonomic Agents|autonomic agents|mesh-ancestor
154771798|NCT06232616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771799|NCT06232616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771800|NCT06232616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154771801|NCT06232616|Glucocorticoids|glucocorticoids|mesh-ancestor
154771802|NCT06232616|Hormones|hormones|mesh-ancestor
154771803|NCT06232616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771804|NCT06232616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154771805|NCT06232616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771806|NCT06230614|Colistin|colistin|mesh-list
154771807|NCT06230614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154771808|NCT06230614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771809|NCT06222697|Factor VIII|factor viii|mesh-list
154771810|NCT06222697|Coagulants|coagulants|mesh-ancestor
154771811|NCT06219941|Leucovorin|leucovorin|mesh-list
154771812|NCT06219941|Gemcitabine|gemcitabine|mesh-list
154771813|NCT06219941|Fluorouracil|fluorouracil|mesh-list
154771814|NCT06219941|Irinotecan|irinotecan|mesh-list
154771815|NCT06219941|Levoleucovorin|levoleucovorin|mesh-list
154771816|NCT06219941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154771817|NCT06219941|Antimetabolites|antimetabolites|mesh-ancestor
154771818|NCT06219941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771819|NCT06219941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771820|NCT06219941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771821|NCT06219941|Immunologic Factors|immunologic factors|mesh-ancestor
154771822|NCT06219941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771823|NCT06219941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154771824|NCT06219941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154771825|NCT06219941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771826|NCT06219941|Antidotes|antidotes|mesh-ancestor
154771827|NCT06219941|Protective Agents|protective agents|mesh-ancestor
154771828|NCT06219941|Vitamin B Complex|vitamin b complex|mesh-ancestor
154771829|NCT06219941|Vitamins|vitamins|mesh-ancestor
154771830|NCT06219941|Micronutrients|micronutrients|mesh-ancestor
154771831|NCT06218251|Botulinum Toxins|botulinum toxins|mesh-list
154771832|NCT06218251|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154771833|NCT06218251|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154771834|NCT06218251|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154771835|NCT06218251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154771836|NCT06218251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771837|NCT06218251|Cholinergic Agents|cholinergic agents|mesh-ancestor
154771838|NCT06218251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771839|NCT06218251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771840|NCT06218251|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154771841|NCT06218251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771842|NCT06207786|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154771843|NCT06207786|Amoxicillin|amoxicillin|mesh-list
154771844|NCT06207786|Azithromycin|azithromycin|mesh-list
154771845|NCT06207786|Clarithromycin|clarithromycin|mesh-list
154771846|NCT06207786|Clindamycin|clindamycin|mesh-list
154771847|NCT06207786|Cephalexin|cephalexin|mesh-list
154771848|NCT06207786|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154771849|NCT06207786|Povidone-Iodine|povidone-iodine|mesh-list
154771850|NCT06207786|Trimethoprim|trimethoprim|mesh-list
154771851|NCT06207786|Sulfamethoxazole|sulfamethoxazole|mesh-list
154771852|NCT06207786|Povidone|povidone|mesh-list
154771853|NCT06207786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771854|NCT06207786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154771855|NCT06207786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771856|NCT06207786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771857|NCT06207786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154771858|NCT06207786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154771859|NCT06207786|Plasma Substitutes|plasma substitutes|mesh-ancestor
154771860|NCT06207786|Blood Substitutes|blood substitutes|mesh-ancestor
154771861|NCT06207786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154771862|NCT06207786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154771863|NCT06207786|Antimalarials|antimalarials|mesh-ancestor
154771864|NCT06207786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154771865|NCT06207786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154771866|NCT06207786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154771867|NCT06207786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154771868|NCT06207786|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154771869|NCT06205875|Morphine|morphine|mesh-list
154771870|NCT06205875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154771871|NCT06205875|Narcotics|narcotics|mesh-ancestor
154771872|NCT06205875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771873|NCT06205875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771874|NCT06205875|Analgesics|analgesics|mesh-ancestor
154771875|NCT06205875|Sensory System Agents|sensory system agents|mesh-ancestor
154771876|NCT06205875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771877|NCT06202261|Paclitaxel|paclitaxel|mesh-list
154771878|NCT06202261|Vinorelbine|vinorelbine|mesh-list
154771879|NCT06202261|Gemcitabine|gemcitabine|mesh-list
154771880|NCT06202261|Capecitabine|capecitabine|mesh-list
154771881|NCT06202261|Fulvestrant|fulvestrant|mesh-list
154771882|NCT06202261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154771883|NCT06202261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771884|NCT06202261|Tubulin Modulators|tubulin modulators|mesh-ancestor
154771885|NCT06202261|Antimitotic Agents|antimitotic agents|mesh-ancestor
154771886|NCT06202261|Mitosis Modulators|mitosis modulators|mesh-ancestor
154771887|NCT06202261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771888|NCT06202261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154771889|NCT06202261|Antimetabolites|antimetabolites|mesh-ancestor
154771890|NCT06202261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154771891|NCT06202261|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154771892|NCT06202261|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154771893|NCT06202261|Hormone Antagonists|hormone antagonists|mesh-ancestor
154771894|NCT06202261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154771895|NCT06202261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771896|NCT06194396|Chlorhexidine|chlorhexidine|mesh-list
154771897|NCT06194396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154771898|NCT06194396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771899|NCT06194396|Disinfectants|disinfectants|mesh-ancestor
154771900|NCT06187597|Tegafur|tegafur|mesh-list
154771901|NCT06187597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154771902|NCT06187597|Antimetabolites|antimetabolites|mesh-ancestor
154771903|NCT06187597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771904|NCT06187597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771905|NCT06167785|Tislelizumab|tislelizumab|mesh-list
154771906|NCT06167785|Zanubrutinib|zanubrutinib|mesh-list
154771907|NCT06167785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154771908|NCT06167785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771909|NCT06167785|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154771910|NCT06167785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154771911|NCT06167785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771912|NCT06167785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771913|NCT06165679|Bupivacaine|bupivacaine|mesh-list
154771914|NCT06165679|Prilocaine|prilocaine|mesh-list
154771915|NCT06165679|Anesthetics, Local|anesthetics, local|mesh-ancestor
154771916|NCT06165679|Anesthetics|anesthetics|mesh-ancestor
154771917|NCT06165679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154771918|NCT06165679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771919|NCT06165679|Sensory System Agents|sensory system agents|mesh-ancestor
154771920|NCT06165679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771921|NCT06157177|Oxazolidinones|oxazolidinones|mesh-list
154771922|NCT06157177|Metaxalone|metaxalone|mesh-list
154771923|NCT06157177|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154771924|NCT06157177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771925|NCT06157177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771926|NCT06157177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771927|NCT06157177|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154771928|NCT06157177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771929|NCT06157177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771930|NCT06143748|Paclitaxel|paclitaxel|mesh-list
154771931|NCT06143748|Cisplatin|cisplatin|mesh-list
154771932|NCT06143748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154771933|NCT06143748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771934|NCT06143748|Tubulin Modulators|tubulin modulators|mesh-ancestor
154771935|NCT06143748|Antimitotic Agents|antimitotic agents|mesh-ancestor
154771936|NCT06143748|Mitosis Modulators|mitosis modulators|mesh-ancestor
154771937|NCT06143748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771938|NCT06143241|Anticonvulsants|anticonvulsants|mesh-list
154771939|NCT06122480|Folfirinox|folfirinox|mesh-list
154771940|NCT06122480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771941|NCT06116916|Aflibercept|aflibercept|mesh-list
154771942|NCT06116916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154771943|NCT06116916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154771944|NCT06116916|Growth Substances|growth substances|mesh-ancestor
154771945|NCT06116916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771946|NCT06116916|Growth Inhibitors|growth inhibitors|mesh-ancestor
154771947|NCT06116916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771948|NCT06116890|Aflibercept|aflibercept|mesh-list
154771949|NCT06116890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154771950|NCT06116890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154771951|NCT06116890|Growth Substances|growth substances|mesh-ancestor
154771952|NCT06116890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771953|NCT06116890|Growth Inhibitors|growth inhibitors|mesh-ancestor
154771954|NCT06116890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771955|NCT06098079|Naltrexone|naltrexone|mesh-list
154771956|NCT06098079|Bupropion|bupropion|mesh-list
154771957|NCT06098079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154771958|NCT06098079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154771959|NCT06098079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771960|NCT06098079|Sensory System Agents|sensory system agents|mesh-ancestor
154771961|NCT06098079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154771962|NCT06098079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154771963|NCT06098079|Antidepressive Agents|antidepressive agents|mesh-ancestor
154771964|NCT06098079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154771965|NCT06098079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154771966|NCT06098079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154771967|NCT06098079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154771968|NCT06098079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771969|NCT06098079|Dopamine Agents|dopamine agents|mesh-ancestor
154771970|NCT06098079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154771971|NCT06098079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154771972|NCT06098079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154771973|NCT06098079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771974|NCT06093191|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154771975|NCT06093191|Ciprofloxacin|ciprofloxacin|mesh-list
154771976|NCT06093191|Tobramycin|tobramycin|mesh-list
154771977|NCT06093191|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154771978|NCT06093191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154771979|NCT06093191|Antitubercular Agents|antitubercular agents|mesh-ancestor
154771980|NCT06093191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154771981|NCT06093191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154771982|NCT06093191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154771983|NCT06093191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771984|NCT06093191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771985|NCT06093191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154771986|NCT06093191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154771987|NCT06072612|Interferons|interferons|mesh-list
154771988|NCT06072612|Cyclophosphamide|cyclophosphamide|mesh-list
154771989|NCT06072612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154771990|NCT06072612|Immunologic Factors|immunologic factors|mesh-ancestor
154771991|NCT06072612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154771992|NCT06072612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154771993|NCT06072612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154771994|NCT06072612|Alkylating Agents|alkylating agents|mesh-ancestor
154771995|NCT06072612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154771996|NCT06072612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154771997|NCT06072612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154771998|NCT06072612|Antiviral Agents|antiviral agents|mesh-ancestor
154771999|NCT06072612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772000|NCT06054464|Rabeprazole|rabeprazole|mesh-list
154772001|NCT06054464|Famotidine|famotidine|mesh-list
154772002|NCT06054464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154772003|NCT06054464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154772004|NCT06054464|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154772005|NCT06054464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772006|NCT06054464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772007|NCT06054464|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154772008|NCT06054464|Histamine Antagonists|histamine antagonists|mesh-ancestor
154772009|NCT06054464|Histamine Agents|histamine agents|mesh-ancestor
154772010|NCT06054464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772011|NCT06054464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772012|NCT06051513|Colistin|colistin|mesh-list
154772013|NCT06051513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154772014|NCT06051513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772015|NCT06048614|Glycerol|glycerol|mesh-list
154772016|NCT06048614|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154772017|NCT06048614|Protective Agents|protective agents|mesh-ancestor
154772018|NCT06048614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772019|NCT06044857|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154772020|NCT06044857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154772021|NCT06044857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772022|NCT06036511|Ketamine|ketamine|mesh-list
154772023|NCT06036511|Analgesics|analgesics|mesh-ancestor
154772024|NCT06036511|Sensory System Agents|sensory system agents|mesh-ancestor
154524028|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
154772025|NCT06036511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772026|NCT06036511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772027|NCT06036511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154772028|NCT06036511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154772029|NCT06036511|Anesthetics, General|anesthetics, general|mesh-ancestor
154772031|NCT06036511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772032|NCT06036511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154772033|NCT06036511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154772034|NCT06036511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772035|NCT06036511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772036|NCT06030895|Sorafenib|sorafenib|mesh-list
154772037|NCT06030895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772038|NCT06030895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772039|NCT06030895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772040|NCT06030895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772041|NCT06012929|TIC10 compound|tic10 compound|mesh-list
154772042|NCT06012929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772043|NCT06005597|Ezetimibe|ezetimibe|mesh-list
154772044|NCT06005597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154772045|NCT06005597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154772046|NCT06005597|Antimetabolites|antimetabolites|mesh-ancestor
154772047|NCT06005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772048|NCT06005597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154772049|NCT05979415|Apomorphine|apomorphine|mesh-list
154772050|NCT05979415|Emetics|emetics|mesh-ancestor
154772051|NCT05979415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772052|NCT05979415|Autonomic Agents|autonomic agents|mesh-ancestor
154772053|NCT05979415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772054|NCT05979415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154772055|NCT05979415|Dopamine Agonists|dopamine agonists|mesh-ancestor
154772056|NCT05979415|Dopamine Agents|dopamine agents|mesh-ancestor
154772057|NCT05979415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772058|NCT05979415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772059|NCT05965726|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154772060|NCT05965726|Antiviral Agents|antiviral agents|mesh-ancestor
154772061|NCT05965726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772062|NCT05944926|Fluoxetine|fluoxetine|mesh-list
154772063|NCT05944926|Antidepressive Agents|antidepressive agents|mesh-list
154772064|NCT05944926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154772065|NCT05944926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154772066|NCT05944926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154772067|NCT05944926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772068|NCT05944926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772069|NCT05944926|Serotonin Agents|serotonin agents|mesh-ancestor
154772070|NCT05944926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772071|NCT05944926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154772072|NCT05944926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772073|NCT05944926|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154772074|NCT05944926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154772075|NCT05944926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772076|NCT05943535|Treprostinil|treprostinil|mesh-list
154772077|NCT05943535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154772078|NCT05911776|Dexmedetomidine|dexmedetomidine|mesh-list
154772079|NCT05911776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154772080|NCT05911776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772081|NCT05911776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772082|NCT05911776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154772083|NCT05911776|Analgesics|analgesics|mesh-ancestor
154772084|NCT05911776|Sensory System Agents|sensory system agents|mesh-ancestor
154772085|NCT05911776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772086|NCT05911776|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154772087|NCT05911776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154772088|NCT05911776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154772089|NCT05911776|Adrenergic Agents|adrenergic agents|mesh-ancestor
154772090|NCT05911776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772091|NCT05911776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772092|NCT05845671|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154772093|NCT05845671|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154772094|NCT05845671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772095|NCT05845671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772096|NCT05845671|Immunologic Factors|immunologic factors|mesh-ancestor
154772097|NCT05845671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772099|NCT05838768|Tislelizumab|tislelizumab|mesh-list
154772100|NCT05838768|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154772101|NCT05838768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772102|NCT05838768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772103|NCT05838768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772104|NCT05838768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772105|NCT05838768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772106|NCT05801029|Osimertinib|osimertinib|mesh-list
154772107|NCT05801029|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154772108|NCT05801029|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154772109|NCT05801029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772110|NCT05801029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772111|NCT05801029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772112|NCT05801029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772113|NCT05801029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772114|NCT05795647|Tocopherols|tocopherols|mesh-list
154772115|NCT05795647|Vitamin E|vitamin e|mesh-list
154772116|NCT05795647|Tocotrienols|tocotrienols|mesh-list
154772117|NCT05795647|alpha-Tocopherol|alpha-tocopherol|mesh-list
154772118|NCT05795647|Pentoxifylline|pentoxifylline|mesh-list
154772119|NCT05795647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154772120|NCT05795647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772121|NCT05795647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772122|NCT05795647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154772123|NCT05795647|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154772124|NCT05795647|Protective Agents|protective agents|mesh-ancestor
154772125|NCT05795647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772126|NCT05795647|Vasodilator Agents|vasodilator agents|mesh-ancestor
154772127|NCT05795647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154772128|NCT05795647|Antioxidants|antioxidants|mesh-ancestor
154772129|NCT05795647|Vitamins|vitamins|mesh-ancestor
154772130|NCT05795647|Micronutrients|micronutrients|mesh-ancestor
154772131|NCT05780489|Estradiol|estradiol|mesh-list
154772132|NCT05780489|Progesterone|progesterone|mesh-list
154772133|NCT05780489|Estrogens|estrogens|mesh-ancestor
154772134|NCT05780489|Hormones|hormones|mesh-ancestor
154772135|NCT05780489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772136|NCT05780489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772137|NCT05780489|Progestins|progestins|mesh-ancestor
154772138|NCT05737030|N-Methylaspartate|n-methylaspartate|mesh-list
154772139|NCT05737030|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154772140|NCT05737030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154772141|NCT05737030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772142|NCT05737030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772143|NCT05737030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772144|NCT05730712|Trastuzumab|trastuzumab|mesh-list
154772145|NCT05730712|Pertuzumab|pertuzumab|mesh-list
154772146|NCT05730712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772147|NCT05730712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772148|NCT05723341|Morphine|morphine|mesh-list
154772149|NCT05723341|Bupivacaine|bupivacaine|mesh-list
154772150|NCT05723341|Anesthetics, Local|anesthetics, local|mesh-ancestor
154772151|NCT05723341|Anesthetics|anesthetics|mesh-ancestor
154772152|NCT05723341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772153|NCT05723341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772154|NCT05723341|Sensory System Agents|sensory system agents|mesh-ancestor
154772155|NCT05723341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772156|NCT05723341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154772157|NCT05723341|Narcotics|narcotics|mesh-ancestor
154772158|NCT05723341|Analgesics|analgesics|mesh-ancestor
154772159|NCT05698524|Temozolomide|temozolomide|mesh-list
154772160|NCT05698524|Abexinostat|abexinostat|mesh-list
154772161|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154772162|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
154772163|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772164|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772165|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154772166|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772167|NCT05695352|Meloxicam|meloxicam|mesh-list
154772168|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
154772169|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154772170|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
154772171|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154772172|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772173|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154772174|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154772175|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154772176|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154772177|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154772178|NCT05695352|Analgesics|analgesics|mesh-ancestor
154772179|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
154772180|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772181|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154772182|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154772183|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154772184|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154772185|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772186|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772187|NCT05662306|Aripiprazole|aripiprazole|mesh-list
154772188|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
154772189|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
154772190|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772191|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154772192|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154772193|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772194|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772195|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
154772196|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
154772197|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772198|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772199|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154772200|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154772201|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
154772202|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154772203|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154772204|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154772205|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154772206|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
154772207|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154772208|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
154772209|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772210|NCT05598905|Pregabalin|pregabalin|mesh-list
154772211|NCT05598905|Lacosamide|lacosamide|mesh-list
154772212|NCT05598905|Oxycodone|oxycodone|mesh-list
154772213|NCT05598905|Analgesics|analgesics|mesh-ancestor
154772214|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
154772215|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772216|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772217|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
154772218|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154772219|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154772220|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772221|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154772222|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154772223|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154772224|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772225|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772226|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154772227|NCT05598905|Narcotics|narcotics|mesh-ancestor
154772228|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154772229|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154772230|NCT05595369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154772231|NCT05595369|Antiviral Agents|antiviral agents|mesh-ancestor
154772232|NCT05595369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772233|NCT05570708|Psilocybin|psilocybin|mesh-list
154772234|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
154772235|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772236|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772237|NCT05568940|Tibolone|tibolone|mesh-list
154772238|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
154772239|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
154772240|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772241|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772242|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154772243|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154772244|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772245|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154524230|NCT05850377|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154772246|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
154772247|NCT05568940|Hormones|hormones|mesh-ancestor
154772248|NCT05557838|Durvalumab|durvalumab|mesh-list
154772249|NCT05557838|Tremelimumab|tremelimumab|mesh-list
154772250|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772251|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772252|NCT05547542|Carfentanil|carfentanil|mesh-list
154772253|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154772254|NCT05547542|Narcotics|narcotics|mesh-ancestor
154772255|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772256|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772257|NCT05547542|Analgesics|analgesics|mesh-ancestor
154772258|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
154772259|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772260|NCT05542342|Tislelizumab|tislelizumab|mesh-list
154772261|NCT05542342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772262|NCT05542342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772263|NCT05526755|Osimertinib|osimertinib|mesh-list
154772264|NCT05526755|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154772265|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772266|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772267|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772268|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772269|NCT05517928|Omeprazole|omeprazole|mesh-list
154772270|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154772271|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154772272|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154772273|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772274|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772275|NCT05500443|Vitamin K|vitamin k|mesh-list
154772276|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
154772277|NCT05500443|Menaquinone 7|menaquinone 7|mesh-list
154772278|NCT05500443|Vitamins|vitamins|mesh-ancestor
154772279|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
154772280|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772281|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154772282|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154772283|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772284|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
154772285|NCT05500443|Coagulants|coagulants|mesh-ancestor
154772286|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
154772287|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772288|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772289|NCT05470985|Ozanimod|ozanimod|mesh-list
154772290|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154772291|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772292|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154772293|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
154772294|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772295|NCT05463744|Insulin|insulin|mesh-list
154772296|NCT05463744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154772297|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154772298|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772299|NCT05459571|Dexamethasone|dexamethasone|mesh-list
154772300|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
154772301|NCT05459571|Fludarabine|fludarabine|mesh-list
154772302|NCT05459571|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154772303|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154772304|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
154772305|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772306|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154772307|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154772308|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
154772309|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772310|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772311|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154772312|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154772313|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
154772314|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
154772315|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772316|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154772317|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
154772318|NCT05459571|Hormones|hormones|mesh-ancestor
154772319|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772320|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154772321|NCT05459571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772322|NCT05373108|Macitentan|macitentan|mesh-list
154772323|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154772324|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154772325|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772326|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154772327|NCT05363553|Caseins|caseins|mesh-list
154772328|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
154772329|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
154772330|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772331|NCT05362058|Insulin|insulin|mesh-list
154772332|NCT05362058|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154772333|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154772334|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772335|NCT05355701|Cetuximab|cetuximab|mesh-list
154772336|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772337|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772338|NCT05326087|Cetrorelix|cetrorelix|mesh-list
154772339|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154772340|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
154772341|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154772342|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772343|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
154772344|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772345|NCT05275400|Insulin|insulin|mesh-list
154772346|NCT05275400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154772347|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154772348|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772349|NCT05170204|Durvalumab|durvalumab|mesh-list
154772350|NCT05170204|Alectinib|alectinib|mesh-list
154772351|NCT05170204|Entrectinib|entrectinib|mesh-list
154772352|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772353|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772354|NCT05170204|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154772355|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772356|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772357|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772358|NCT05112536|Paclitaxel|paclitaxel|mesh-list
154772359|NCT05112536|Carboplatin|carboplatin|mesh-list
154772360|NCT05112536|Doxorubicin|doxorubicin|mesh-list
154772361|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
154772362|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154772363|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772364|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
154772365|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
154772366|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
154772367|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772368|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154772369|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154772370|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772371|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772372|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772373|NCT05112536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772374|NCT05091567|Carboplatin|carboplatin|mesh-list
154772375|NCT05091567|Etoposide|etoposide|mesh-list
154772376|NCT05091567|Atezolizumab|atezolizumab|mesh-list
154772377|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772378|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154772379|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154772380|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772381|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772382|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772383|NCT05091567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772384|NCT05091567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772385|NCT05033808|Epirubicin|epirubicin|mesh-list
154772386|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154772387|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772388|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154772389|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772390|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772391|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772392|NCT05004116|Irinotecan|irinotecan|mesh-list
154772393|NCT05004116|Temozolomide|temozolomide|mesh-list
154772394|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154524383|NCT06040944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772395|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772396|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772397|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772398|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772399|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154772400|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
154772402|NCT04983901|Meropenem|meropenem|mesh-list
154772403|NCT04983901|Tazobactam|tazobactam|mesh-list
154772404|NCT04983901|Linezolid|linezolid|mesh-list
154772405|NCT04983901|Piperacillin|piperacillin|mesh-list
154772406|NCT04983901|Daptomycin|daptomycin|mesh-list
154772407|NCT04983901|Imipenem|imipenem|mesh-list
154772408|NCT04983901|Cefepime|cefepime|mesh-list
154772409|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154772410|NCT04983901|Relebactam|relebactam|mesh-list
154772411|NCT04983901|Cilastatin|cilastatin|mesh-list
154772412|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154772413|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772414|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154772415|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772416|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772417|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154772418|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
154772419|NCT04978428|Cannabidiol|cannabidiol|mesh-list
154772420|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
154772421|NCT04952389|Budesonide|budesonide|mesh-list
154772422|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154772423|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154772424|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
154772425|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772426|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772427|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154772428|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
154772429|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
154772430|NCT04952389|Hormones|hormones|mesh-ancestor
154772431|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772432|NCT04931368|Rituximab|rituximab|mesh-list
154772433|NCT04931368|Methotrexate|methotrexate|mesh-list
154772434|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772435|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772436|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
154772437|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772438|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154772439|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154772440|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
154772441|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154772442|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154772443|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
154772444|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772445|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
154772446|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772447|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154772448|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154772449|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154772450|NCT04930744|Metformin|metformin|mesh-list
154772451|NCT04930744|Rifampin|rifampin|mesh-list
154772452|NCT04930744|Isoniazid|isoniazid|mesh-list
154772453|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
154772454|NCT04930744|Ethambutol|ethambutol|mesh-list
154772455|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154772456|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772457|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154772458|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
154772459|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154772460|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772461|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
154772462|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154772463|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772464|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772465|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154772466|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154772467|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154772468|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154772469|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154772470|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154524456|NCT05896761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772471|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154772472|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154772474|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154772475|NCT04926324|Niraparib|niraparib|mesh-list
154772476|NCT04926324|Dostarlimab|dostarlimab|mesh-list
154772477|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154772478|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772479|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772480|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772481|NCT04899492|Nicotine|nicotine|mesh-list
154772482|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154772483|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
154772484|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772485|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772486|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154772487|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154772488|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
154772489|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772490|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772491|NCT04895436|Venetoclax|venetoclax|mesh-list
154772492|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
154772493|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772494|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772495|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
154772496|NCT04841148|Palbociclib|palbociclib|mesh-list
154772497|NCT04841148|Avelumab|avelumab|mesh-list
154772498|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
154772499|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154772500|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154772501|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772502|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772503|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772504|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154772505|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772506|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772507|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772508|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
154772509|NCT04736706|Lenvatinib|lenvatinib|mesh-list
154772510|NCT04736706|Belzutifan|belzutifan|mesh-list
154772511|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772512|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772513|NCT04736706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772514|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772515|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772516|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772517|NCT04697628|Gemcitabine|gemcitabine|mesh-list
154772518|NCT04697628|Irinotecan|irinotecan|mesh-list
154772519|NCT04697628|Pemetrexed|pemetrexed|mesh-list
154772520|NCT04697628|Topotecan|topotecan|mesh-list
154772521|NCT04697628|Vinorelbine|vinorelbine|mesh-list
154772522|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
154772523|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154772524|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
154772525|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772526|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772527|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154772528|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772529|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772530|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154772531|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154772532|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154772533|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
154772534|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
154772535|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
154772536|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772537|NCT04662632|Vancomycin|vancomycin|mesh-list
154772538|NCT04662632|Tobramycin|tobramycin|mesh-list
154772539|NCT04662632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154772540|NCT04662632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772541|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
154772542|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154772543|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154772544|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772545|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
154772546|NCT04650698|Coagulants|coagulants|mesh-ancestor
154772547|NCT04645160|Tivozanib|tivozanib|mesh-list
154772548|NCT04645160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772549|NCT04645160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772550|NCT04645160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772551|NCT04630730|Gemcitabine|gemcitabine|mesh-list
154772552|NCT04630730|Atezolizumab|atezolizumab|mesh-list
154772553|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
154772554|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772555|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154772556|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
154772557|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772558|NCT04630730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772559|NCT04630730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772560|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154772561|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
154772562|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772563|NCT04599855|Esketamine|esketamine|mesh-list
154772564|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
154772565|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772566|NCT04576104|Metformin|metformin|mesh-list
154772567|NCT04576104|Megestrol|megestrol|mesh-list
154772568|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
154772569|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154772570|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772571|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154772572|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154772573|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154772574|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
154772575|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154772576|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154772577|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154772578|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154772579|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772580|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
154772581|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154772582|NCT04574960|Carboplatin|carboplatin|mesh-list
154772583|NCT04574960|Gemcitabine|gemcitabine|mesh-list
154772584|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772585|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154772586|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
154772587|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772588|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
154772589|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772590|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
154772591|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154772592|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154772593|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772594|NCT04565925|Urological Agents|urological agents|mesh-ancestor
154772595|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
154772596|NCT04558866|Testosterone|testosterone|mesh-list
154772597|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
154772598|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
154772599|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154772600|NCT04558866|Androgens|androgens|mesh-ancestor
154772601|NCT04558866|Hormones|hormones|mesh-ancestor
154772602|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377218|NCT00557193|Daunorubicin|daunorubicin|mesh-list
154772603|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772604|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154772605|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772606|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
154772607|NCT04550377|Cannabidiol|cannabidiol|mesh-list
154772608|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
154772609|NCT04529772|Prednisone|prednisone|mesh-list
154772610|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
154772611|NCT04529772|Rituximab|rituximab|mesh-list
154772612|NCT04529772|Doxorubicin|doxorubicin|mesh-list
154772613|NCT04529772|Vincristine|vincristine|mesh-list
154772614|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
154772615|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154772616|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
154772617|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772618|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154772619|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154772620|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
154772621|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772622|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772623|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154772624|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772625|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154772626|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154772627|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772628|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772629|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154772630|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
154772631|NCT04529772|Hormones|hormones|mesh-ancestor
154772632|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772633|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154772634|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154772635|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
154772636|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
154772637|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
154772638|NCT04529772|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154772639|NCT04529772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772640|NCT04497168|Citalopram|citalopram|mesh-list
154772641|NCT04497168|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154772642|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154772643|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154772644|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772645|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772646|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
154772647|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772648|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154772649|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
154772650|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772651|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
154772652|NCT04477837|Apixaban|apixaban|mesh-list
154772653|NCT04477837|Edoxaban|edoxaban|mesh-list
154772654|NCT04477837|Dabigatran|dabigatran|mesh-list
154772655|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154772656|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
154772657|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154772658|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
154772659|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772660|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772661|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
154772662|NCT04468984|Navitoclax|navitoclax|mesh-list
154772663|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772664|NCT04454437|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154772665|NCT04454437|Immunoconjugates|immunoconjugates|mesh-ancestor
154772666|NCT04454437|Immunologic Factors|immunologic factors|mesh-ancestor
154772667|NCT04454437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772668|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
154772669|NCT04441034|Convulsants|convulsants|mesh-list
154772670|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
154772671|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772672|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154772673|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772674|NCT04426500|Bupivacaine|bupivacaine|mesh-list
154772675|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
154772676|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
154772677|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772678|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772679|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
154772680|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772681|NCT04417257|Fenretinide|fenretinide|mesh-list
154772682|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772683|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154772684|NCT04417257|Protective Agents|protective agents|mesh-ancestor
154772685|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772686|NCT04414748|Cetrorelix|cetrorelix|mesh-list
154772687|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
154772688|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154772689|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
154772690|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154772691|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772692|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
154772693|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772694|NCT04414748|Progestins|progestins|mesh-ancestor
154772695|NCT04414748|Hormones|hormones|mesh-ancestor
154772696|NCT04266912|Avelumab|avelumab|mesh-list
154772697|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154772698|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772699|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772700|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
154772701|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772702|NCT04250155|Atezolizumab|atezolizumab|mesh-list
154772703|NCT04250155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772704|NCT04250155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772705|NCT04250155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772706|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772707|NCT04245644|Aspirin|aspirin|mesh-list
154772708|NCT04245644|Metformin|metformin|mesh-list
154772709|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154772710|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154772711|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772712|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154772713|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154772714|NCT04245644|Analgesics|analgesics|mesh-ancestor
154772715|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
154772716|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772717|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154772718|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154772719|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154772720|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154772721|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772722|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154772723|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154772724|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772725|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
154772726|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
154772727|NCT04152200|Lumasiran|lumasiran|mesh-list
154772728|NCT04152200|Renal Agents|renal agents|mesh-ancestor
154772729|NCT04109066|Paclitaxel|paclitaxel|mesh-list
154772730|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
154772731|NCT04109066|Nivolumab|nivolumab|mesh-list
154772732|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154772733|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772734|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
154772735|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
154772736|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
154772737|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772738|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154772739|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
154772740|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772741|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154772742|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154772743|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
154772744|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154772745|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772746|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772747|NCT04092270|Doxorubicin|doxorubicin|mesh-list
154772748|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154772749|NCT04092270|Peposertib|peposertib|mesh-list
154772750|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154772751|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772752|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154772753|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772754|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772755|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772756|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772757|NCT04063267|Nicotine|nicotine|mesh-list
154772758|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154772759|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
154772760|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772761|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772762|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154772763|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154772764|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
154772765|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772766|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772767|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
154772768|NCT03993353|Tadalafil|tadalafil|mesh-list
154772769|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772770|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772771|NCT03993353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772772|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772773|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
154524772|NCT04421820|Vitamins|vitamins|mesh-ancestor
154772774|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154772775|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154772777|NCT03993353|Urological Agents|urological agents|mesh-ancestor
154772778|NCT03993262|Bortezomib|bortezomib|mesh-list
154772779|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772780|NCT03943875|Vaccines|vaccines|mesh-list
154772781|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
154772782|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772783|NCT03905694|Lumasiran|lumasiran|mesh-list
154772784|NCT03905694|Renal Agents|renal agents|mesh-ancestor
154772785|NCT03774641|Lamotrigine|lamotrigine|mesh-list
154772786|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
154772787|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154772788|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154772789|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772790|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154772791|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772792|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154772793|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154772794|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772795|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772796|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154772797|NCT03748966|Calcitriol|calcitriol|mesh-list
154772798|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154772799|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154772800|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772801|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154772802|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154772803|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772804|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154772805|NCT03748966|Vitamins|vitamins|mesh-ancestor
154772806|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
154772807|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154772808|NCT03697408|Everolimus|everolimus|mesh-list
154772809|NCT03697408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154772810|NCT03697408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772811|NCT03697408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772812|NCT03697408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772813|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154772814|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
154772815|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772816|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772817|NCT03689114|Topiramate|topiramate|mesh-list
154772818|NCT03689114|Lamotrigine|lamotrigine|mesh-list
154772819|NCT03689114|Zonisamide|zonisamide|mesh-list
154772820|NCT03689114|Carbamazepine|carbamazepine|mesh-list
154772821|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
154772822|NCT03689114|Gabapentin|gabapentin|mesh-list
154772823|NCT03689114|Levetiracetam|levetiracetam|mesh-list
154772824|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
154772825|NCT03689114|Valproic Acid|valproic acid|mesh-list
154772826|NCT03689114|Analgesics|analgesics|mesh-ancestor
154772827|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
154772828|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772829|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772830|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154772831|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154772832|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772833|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772834|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154772835|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154772836|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772837|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772838|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
154772839|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154772840|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
154772841|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154772842|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154772843|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154772844|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154772845|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154772846|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154524840|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772847|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
154772848|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154772849|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154772850|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154772851|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154772852|NCT03646188|Doxorubicin|doxorubicin|mesh-list
154772853|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154772854|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154772855|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772856|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154772857|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154772858|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772859|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772860|NCT03582488|Corticosterone|corticosterone|mesh-list
154772861|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154772863|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154772864|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
154772865|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154772866|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772867|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154772868|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154772869|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
154772870|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772871|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772872|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154772873|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
154772874|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772875|NCT03478865|Vitamin A|vitamin a|mesh-list
154772876|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
154772877|NCT03478865|Vitamins|vitamins|mesh-ancestor
154772878|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
154377485|NCT06064162|Ketamine|ketamine|mesh-list
154772879|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772880|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
154772881|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772882|NCT03478865|Protective Agents|protective agents|mesh-ancestor
154772883|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154772884|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772885|NCT03399110|Capecitabine|capecitabine|mesh-list
154772886|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
154772887|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154772888|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
154772889|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772890|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772891|NCT03388632|Nivolumab|nivolumab|mesh-list
154772892|NCT03388632|Ipilimumab|ipilimumab|mesh-list
154772893|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772894|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772895|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772896|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772897|NCT03337724|Paclitaxel|paclitaxel|mesh-list
154772898|NCT03337724|Ipatasertib|ipatasertib|mesh-list
154772899|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154772900|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772901|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
154772902|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
154772903|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
154772904|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772905|NCT03337724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772906|NCT03337724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772907|NCT03298061|Prednisolone|prednisolone|mesh-list
154772908|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154772909|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
154772910|NCT03298061|Hormones|hormones|mesh-ancestor
154772911|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772912|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772913|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154772914|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772915|NCT03178552|Bevacizumab|bevacizumab|mesh-list
154772916|NCT03178552|Atezolizumab|atezolizumab|mesh-list
154772917|NCT03178552|Carboplatin|carboplatin|mesh-list
154772918|NCT03178552|Gemcitabine|gemcitabine|mesh-list
154772919|NCT03178552|Docetaxel|docetaxel|mesh-list
154772920|NCT03178552|Pemetrexed|pemetrexed|mesh-list
154772921|NCT03178552|Vemurafenib|vemurafenib|mesh-list
154772922|NCT03178552|Alectinib|alectinib|mesh-list
154772923|NCT03178552|Entrectinib|entrectinib|mesh-list
154248820|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772924|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154772925|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772926|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154772927|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154772928|NCT03178552|Growth Substances|growth substances|mesh-ancestor
154772929|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772930|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
154772931|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154772932|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
154377554|NCT06040424|Albuterol|albuterol|mesh-list
154772933|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772934|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
154772935|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
154772936|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
154772937|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772938|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154772939|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154772940|NCT03178552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154772941|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772942|NCT03178552|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154772943|NCT03115424|Liraglutide|liraglutide|mesh-list
154772944|NCT03115424|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154772945|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154772946|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772947|NCT03115424|Incretins|incretins|mesh-ancestor
154772948|NCT03115424|Hormones|hormones|mesh-ancestor
154772949|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154772950|NCT03089866|Midazolam|midazolam|mesh-list
154772951|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154772952|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154772953|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154772954|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772955|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154772956|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154772957|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154772958|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154772959|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
154772960|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
154772961|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
154772962|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
154772963|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772964|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772965|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
154772966|NCT03032406|Everolimus|everolimus|mesh-list
154772967|NCT03032406|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154772968|NCT03032406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154772969|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772970|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772971|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154772972|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
154772973|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772974|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772975|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
154772976|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154772977|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154772978|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154772979|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154772980|NCT02966756|Venetoclax|venetoclax|mesh-list
154772981|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154772982|NCT02913612|Timolol|timolol|mesh-list
154772983|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154772984|NCT02913612|Maleic acid|maleic acid|mesh-list
154772985|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154772986|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154772987|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154772988|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154772989|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154772990|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154772991|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154772992|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154772993|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154772994|NCT02899052|Dexamethasone|dexamethasone|mesh-list
154772995|NCT02899052|Venetoclax|venetoclax|mesh-list
154772996|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154772997|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
154772998|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
154772999|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773000|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773001|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154773002|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
154773003|NCT02899052|Hormones|hormones|mesh-ancestor
154773004|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773005|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154773006|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773007|NCT02893371|Lamotrigine|lamotrigine|mesh-list
154773008|NCT02893371|Carbamazepine|carbamazepine|mesh-list
154773009|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
154773010|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154773011|NCT02893371|Valproic Acid|valproic acid|mesh-list
154773012|NCT02893371|Haloperidol|haloperidol|mesh-list
154773013|NCT02893371|Olanzapine|olanzapine|mesh-list
154773014|NCT02893371|Risperidone|risperidone|mesh-list
154773015|NCT02893371|Aripiprazole|aripiprazole|mesh-list
154773016|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154773017|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154773018|NCT02893371|Ziprasidone|ziprasidone|mesh-list
154773019|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154773020|NCT02893371|Clozapine|clozapine|mesh-list
154773021|NCT02893371|Asenapine|asenapine|mesh-list
154773022|NCT02893371|Perphenazine|perphenazine|mesh-list
154773023|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
154773024|NCT02893371|Mirtazapine|mirtazapine|mesh-list
154773025|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
154773026|NCT02893371|Doxepin|doxepin|mesh-list
154773027|NCT02893371|Citalopram|citalopram|mesh-list
154773028|NCT02893371|Bupropion|bupropion|mesh-list
154773029|NCT02893371|Sertraline|sertraline|mesh-list
154773030|NCT02893371|Fluoxetine|fluoxetine|mesh-list
154773031|NCT02893371|Paroxetine|paroxetine|mesh-list
154773032|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154377641|NCT05875948|Terlipressin|terlipressin|mesh-list
154773033|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154773034|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154773035|NCT02893371|Escitalopram|escitalopram|mesh-list
154773036|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154773037|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
154773038|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773039|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773040|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773041|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154773042|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154773043|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773044|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154773045|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154773046|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
154773047|NCT02893371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154773048|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154773049|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154773050|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154773051|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
154773052|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773053|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154773054|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
154773055|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
154773056|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154773057|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154773058|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154773059|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154773060|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773061|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
154773062|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154773063|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154773064|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154773065|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154773066|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154773067|NCT02893371|Analgesics|analgesics|mesh-ancestor
154773068|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
154773069|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
154773070|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
154773071|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154773072|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154773073|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154773074|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
154773075|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154525009|NCT02064673|Analgesics|analgesics|mesh-ancestor
154773076|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
154773077|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
154773078|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154773079|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154773080|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154773081|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154773082|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
154773083|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154773084|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154773085|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154773086|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154773087|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
154773088|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154773089|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154773090|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154773091|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154773092|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154773093|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154773094|NCT02795988|Capecitabine|capecitabine|mesh-list
154773095|NCT02795988|Fluorouracil|fluorouracil|mesh-list
154773096|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
154773097|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773098|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154773099|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
154773100|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773101|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154773102|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
154773103|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773104|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
154773105|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773106|NCT02737306|Leronlimab|leronlimab|mesh-list
154773107|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154773108|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154773109|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773110|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154773111|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154773112|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
154773113|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154773114|NCT02711553|Gemcitabine|gemcitabine|mesh-list
154773115|NCT02711553|Ramucirumab|ramucirumab|mesh-list
154773116|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773117|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154773118|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
154773119|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773120|NCT02711553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154773121|NCT02711553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154773122|NCT02711553|Growth Substances|growth substances|mesh-ancestor
154773123|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773124|NCT02711553|Growth Inhibitors|growth inhibitors|mesh-ancestor
154773125|NCT02700841|Melphalan|melphalan|mesh-list
154773126|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
154773127|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154773128|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
154773129|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773130|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773131|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154773132|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154773133|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
154773134|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773135|NCT02546661|Durvalumab|durvalumab|mesh-list
154773136|NCT02546661|Olaparib|olaparib|mesh-list
154773137|NCT02546661|Adavosertib|adavosertib|mesh-list
154773138|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773139|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773140|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154773141|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773142|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773143|NCT02367040|Rituximab|rituximab|mesh-list
154773144|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773145|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773146|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
154773147|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773148|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154773149|NCT02278120|Tamoxifen|tamoxifen|mesh-list
154773150|NCT02278120|Letrozole|letrozole|mesh-list
154773151|NCT02278120|Anastrozole|anastrozole|mesh-list
154773152|NCT02278120|Goserelin|goserelin|mesh-list
154773153|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773154|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154773155|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154773156|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377777|NCT05449392|Petrolatum|petrolatum|mesh-list
154773157|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773158|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154773159|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
154773160|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773161|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773162|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154773163|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154773164|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154773165|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154773166|NCT02242942|Venetoclax|venetoclax|mesh-list
154773167|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
154773168|NCT02242942|Chlorambucil|chlorambucil|mesh-list
154773169|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773170|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773171|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154773172|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
154773173|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773174|NCT02242097|Ibrutinib|ibrutinib|mesh-list
154773175|NCT02242097|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154773176|NCT02242097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154773177|NCT02242097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773178|NCT02242097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773179|NCT02100891|Immunomodulating Agents|immunomodulating agents|mesh-list
154773180|NCT02100891|Immunologic Factors|immunologic factors|mesh-ancestor
154773181|NCT02100891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773182|NCT01953926|Paclitaxel|paclitaxel|mesh-list
154773183|NCT01953926|Trastuzumab|trastuzumab|mesh-list
154773184|NCT01953926|Fulvestrant|fulvestrant|mesh-list
154773185|NCT01953926|Neratinib|neratinib|mesh-list
154773186|NCT01953926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154773187|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773188|NCT01953926|Tubulin Modulators|tubulin modulators|mesh-ancestor
154773189|NCT01953926|Antimitotic Agents|antimitotic agents|mesh-ancestor
154773190|NCT01953926|Mitosis Modulators|mitosis modulators|mesh-ancestor
154773191|NCT01953926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773192|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773193|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154773194|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154773195|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154773196|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
154773197|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773198|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773199|NCT01953926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154773200|NCT01953926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154773201|NCT01953926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773202|NCT01886794|Estrogens|estrogens|mesh-list
154773203|NCT01886794|Hormones|hormones|mesh-ancestor
154773204|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773205|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773206|NCT01858168|Irinotecan|irinotecan|mesh-list
154773207|NCT01858168|Temozolomide|temozolomide|mesh-list
154773208|NCT01858168|Olaparib|olaparib|mesh-list
154773209|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154773210|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154773211|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773212|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773213|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773214|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154773215|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
154773216|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154773217|NCT01829958|Prednisone|prednisone|mesh-list
154773218|NCT01829958|Rituximab|rituximab|mesh-list
154773219|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773220|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773221|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
154773222|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773223|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154773224|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154773225|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
154773226|NCT01829958|Hormones|hormones|mesh-ancestor
154773227|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773228|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154773229|NCT01764451|Simvastatin|simvastatin|mesh-list
154773230|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154773231|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154773232|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
154773233|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773234|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154773235|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154773236|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773237|NCT01746238|Bevacizumab|bevacizumab|mesh-list
154773238|NCT01746238|Doxorubicin|doxorubicin|mesh-list
154773239|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773240|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773241|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154773242|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154773243|NCT01746238|Growth Substances|growth substances|mesh-ancestor
154773244|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773245|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
154773246|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154773247|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154773248|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154773249|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773250|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773251|NCT01593241|Carboplatin|carboplatin|mesh-list
154773252|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773253|NCT01407198|Nilotinib|nilotinib|mesh-list
154773254|NCT01407198|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154773255|NCT01407198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154773256|NCT01407198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773257|NCT01407198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773258|NCT01168739|Quercetin|quercetin|mesh-list
154773259|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
154773260|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773261|NCT01168739|Protective Agents|protective agents|mesh-ancestor
154773262|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773263|NCT01027910|Doxorubicin|doxorubicin|mesh-list
154773264|NCT01027910|Abexinostat|abexinostat|mesh-list
154773265|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154773266|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773267|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154773268|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154773269|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773270|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773271|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154773272|NCT00942877|Cediranib|cediranib|mesh-list
154773273|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773274|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154773275|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773276|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773277|NCT00344175|Simvastatin|simvastatin|mesh-list
154773278|NCT00344175|Pitavastatin|pitavastatin|mesh-list
154773279|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154773280|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154773281|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
154773282|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773283|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154773284|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154773285|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773286|NCT00345033|Aripiprazole|aripiprazole|mesh-list
154773287|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
154773288|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154773289|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154773290|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154773291|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773292|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773293|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
154773294|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
154773295|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773296|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773297|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154773298|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154773299|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
154773300|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154773301|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154773302|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154773303|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154773304|NCT00345969|Testosterone|testosterone|mesh-list
154773305|NCT00345969|Androgens|androgens|mesh-ancestor
154773306|NCT00345969|Hormones|hormones|mesh-ancestor
154773307|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773308|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773309|NCT01498445|Decitabine|decitabine|mesh-list
154773310|NCT01498445|Dasatinib|dasatinib|mesh-list
154773311|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154773312|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
154773313|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773314|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773315|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773316|NCT01498445|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154773317|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154773318|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
154773319|NCT01525615|Olodaterol|olodaterol|mesh-list
154773320|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154773321|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
154773322|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773323|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773324|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154773325|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
154773326|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
154773327|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154773328|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
154773329|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773330|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773331|NCT00309465|Insulin|insulin|mesh-list
154773332|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154773333|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
154773334|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154773335|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773336|NCT01791699|Moxonidine|moxonidine|mesh-list
154773337|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154773338|NCT00302133|Naltrexone|naltrexone|mesh-list
154773339|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154773340|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154773341|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773342|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
154773343|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773344|NCT01525225|Metformin|metformin|mesh-list
154773345|NCT01525225|Saxagliptin|saxagliptin|mesh-list
154773346|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154773347|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773348|NCT01525225|Incretins|incretins|mesh-ancestor
154773349|NCT01525225|Hormones|hormones|mesh-ancestor
154773350|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773351|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154773352|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
154773353|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773354|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773355|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154773356|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154773357|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154773358|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154773359|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773360|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
154773361|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773362|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773363|NCT01524991|Gemcitabine|gemcitabine|mesh-list
154773364|NCT01524991|Ipilimumab|ipilimumab|mesh-list
154773365|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773366|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154773367|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
154773368|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773369|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773370|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154773371|NCT04039230|Talazoparib|talazoparib|mesh-list
154773372|NCT04039230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154773373|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154773374|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773375|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773376|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773377|NCT04039230|Immunoconjugates|immunoconjugates|mesh-ancestor
154773378|NCT04039230|Immunologic Factors|immunologic factors|mesh-ancestor
154773379|NCT04039230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773380|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
154773381|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154773382|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
154773383|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773384|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
154773385|NCT01524913|Protective Agents|protective agents|mesh-ancestor
154773386|NCT02376192|Phenylephrine|phenylephrine|mesh-list
154773387|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
154773388|NCT02376192|Ephedrine|ephedrine|mesh-list
154773389|NCT02376192|Bupivacaine|bupivacaine|mesh-list
154773390|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
154773391|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
154773392|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773393|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773394|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
154773395|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773396|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154773397|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
154773398|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
154773399|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
154773400|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154773401|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
154773402|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
154773403|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154773404|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154773405|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154773406|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
154773407|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773408|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773409|NCT02376192|Protective Agents|protective agents|mesh-ancestor
154773410|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154773411|NCT02375880|Gemcitabine|gemcitabine|mesh-list
154773412|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773413|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154773414|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
154773415|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773416|NCT01524679|Interferons|interferons|mesh-list
154773417|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
154773418|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
154773419|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154773420|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773421|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
154773422|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154773423|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
154773424|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773425|NCT02365272|Amikacin|amikacin|mesh-list
154773426|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154773427|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154773428|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154773429|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154773430|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154773431|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
154773432|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773433|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154773434|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154773435|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773436|NCT01880541|Anesthetics|anesthetics|mesh-list
154773437|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773438|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773439|NCT02368860|Capecitabine|capecitabine|mesh-list
154773440|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
154773441|NCT02368860|Irinotecan|irinotecan|mesh-list
154773442|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154773443|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
154773444|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773445|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773446|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154773447|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154773448|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773449|NCT02375646|Heparin|heparin|mesh-list
154773450|NCT02375646|Enoxaparin|enoxaparin|mesh-list
154773451|NCT02375646|Warfarin|warfarin|mesh-list
154773452|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
154773453|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154773454|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154773455|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378092|NCT04498832|Vaccines|vaccines|mesh-list
154773456|NCT01524289|Anacetrapib|anacetrapib|mesh-list
154773457|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154773458|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154773459|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
154773460|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773461|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154773462|NCT01498289|Leucovorin|leucovorin|mesh-list
154773463|NCT01498289|Docetaxel|docetaxel|mesh-list
154773464|NCT01498289|Fluorouracil|fluorouracil|mesh-list
154773465|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
154773466|NCT01498289|Irinotecan|irinotecan|mesh-list
154773467|NCT01498289|Calcium|calcium|mesh-list
154773468|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
154773469|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773470|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
154773471|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
154773472|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
154773473|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773474|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154773475|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773476|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
154773477|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154773478|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154773479|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
154773480|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154773481|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154773482|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773483|NCT01498289|Antidotes|antidotes|mesh-ancestor
154773484|NCT01498289|Protective Agents|protective agents|mesh-ancestor
154773485|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
154773486|NCT01498289|Vitamins|vitamins|mesh-ancestor
154773487|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
154773488|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
154773489|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
154773490|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154773491|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154773492|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773493|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773494|NCT02364882|Urological Agents|urological agents|mesh-ancestor
154773495|NCT02364804|Aprepitant|aprepitant|mesh-list
154773496|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
154773497|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
154773498|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773499|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773500|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154773501|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154773502|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773503|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773504|NCT01524133|Sertraline|sertraline|mesh-list
154773505|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
154773506|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154773507|NCT01524133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154773508|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154773509|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154773510|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773511|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773512|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
154773513|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773514|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
154773515|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154773516|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154773517|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773518|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773519|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154773520|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154773521|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773522|NCT05800418|Ramucirumab|ramucirumab|mesh-list
154773523|NCT05800418|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154773524|NCT05800418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154773525|NCT05800418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154773526|NCT05800418|Growth Substances|growth substances|mesh-ancestor
154773527|NCT05800418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773528|NCT05800418|Growth Inhibitors|growth inhibitors|mesh-ancestor
154773529|NCT05800418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773530|NCT05800418|Immunologic Factors|immunologic factors|mesh-ancestor
154773531|NCT05800340|Paclitaxel|paclitaxel|mesh-list
154773532|NCT05800340|Carboplatin|carboplatin|mesh-list
154773533|NCT05800340|Pemetrexed|pemetrexed|mesh-list
154773534|NCT05800340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154773535|NCT05800340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773536|NCT05800340|Tubulin Modulators|tubulin modulators|mesh-ancestor
154773537|NCT05800340|Antimitotic Agents|antimitotic agents|mesh-ancestor
154773538|NCT05800340|Mitosis Modulators|mitosis modulators|mesh-ancestor
154773539|NCT05800340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773540|NCT05800340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773541|NCT05800340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154773542|NCT05800340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154773543|NCT05800301|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154773544|NCT05800301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773545|NCT05800301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773546|NCT05800106|Sunitinib|sunitinib|mesh-list
154773547|NCT05800106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773548|NCT05800106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154773549|NCT05800106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154773550|NCT05800106|Growth Substances|growth substances|mesh-ancestor
154773551|NCT05800106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773552|NCT05800106|Growth Inhibitors|growth inhibitors|mesh-ancestor
154773553|NCT05800106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154773554|NCT05800106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773555|NCT05800106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773556|NCT05800080|Oxaliplatin|oxaliplatin|mesh-list
154773557|NCT05800080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773558|NCT05800054|Docetaxel|docetaxel|mesh-list
154773559|NCT05800054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773560|NCT05800054|Tubulin Modulators|tubulin modulators|mesh-ancestor
154773561|NCT05800054|Antimitotic Agents|antimitotic agents|mesh-ancestor
154773562|NCT05800054|Mitosis Modulators|mitosis modulators|mesh-ancestor
154773563|NCT05800054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773564|NCT05800041|Cyclophosphamide|cyclophosphamide|mesh-list
154773565|NCT05800041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154773566|NCT05800041|Immunologic Factors|immunologic factors|mesh-ancestor
154773567|NCT05800041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773568|NCT05800041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154773569|NCT05800041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154773570|NCT05800041|Alkylating Agents|alkylating agents|mesh-ancestor
154773571|NCT05800041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773572|NCT05800041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773573|NCT05800041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154773574|NCT05799924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154773575|NCT05799924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154773576|NCT05799924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154773577|NCT05799924|Analgesics|analgesics|mesh-ancestor
154773578|NCT05799924|Sensory System Agents|sensory system agents|mesh-ancestor
154773579|NCT05799924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773580|NCT05799924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773581|NCT05799924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154773582|NCT05799469|Cisplatin|cisplatin|mesh-list
154773583|NCT05799469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773584|NCT05799443|Irinotecan|irinotecan|mesh-list
154773585|NCT05799443|Cetuximab|cetuximab|mesh-list
154773586|NCT05799443|Tislelizumab|tislelizumab|mesh-list
154773587|NCT05799443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154773588|NCT05799443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154773589|NCT05799443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773590|NCT05799443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773591|NCT05799443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773592|NCT05799443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773593|NCT05799300|Anesthetics|anesthetics|mesh-list
154773594|NCT05799300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773595|NCT05799300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773596|NCT05799053|Peppermint oil|peppermint oil|mesh-list
154773597|NCT05799053|Antiemetics|antiemetics|mesh-ancestor
154773598|NCT05799053|Autonomic Agents|autonomic agents|mesh-ancestor
154773599|NCT05799053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773600|NCT05799053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773601|NCT05799053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154773602|NCT05799053|Parasympatholytics|parasympatholytics|mesh-ancestor
154773603|NCT05798936|Ethanol|ethanol|mesh-list
154773604|NCT05798936|Polidocanol|polidocanol|mesh-list
154773605|NCT05798936|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154773606|NCT05798936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154773607|NCT05798936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773608|NCT05798936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773609|NCT05798936|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154773610|NCT05798936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154773611|NCT05798871|Erythritol|erythritol|mesh-list
154773612|NCT05798871|Vasodilator Agents|vasodilator agents|mesh-ancestor
154773613|NCT05798819|Paclitaxel|paclitaxel|mesh-list
154773614|NCT05798819|Bevacizumab|bevacizumab|mesh-list
154773615|NCT05798819|Carboplatin|carboplatin|mesh-list
154773616|NCT05798819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154773617|NCT05798819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773618|NCT05798819|Tubulin Modulators|tubulin modulators|mesh-ancestor
154773619|NCT05798819|Antimitotic Agents|antimitotic agents|mesh-ancestor
154773620|NCT05798819|Mitosis Modulators|mitosis modulators|mesh-ancestor
154773621|NCT05798819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773622|NCT05798819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773623|NCT05798819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154773624|NCT05798819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154773625|NCT05798819|Growth Substances|growth substances|mesh-ancestor
154773626|NCT05798819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773627|NCT05798819|Growth Inhibitors|growth inhibitors|mesh-ancestor
154773628|NCT05798728|Misoprostol|misoprostol|mesh-list
154773629|NCT05798728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154773630|NCT05798728|Abortifacient Agents|abortifacient agents|mesh-ancestor
154773631|NCT05798728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154773632|NCT05798728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773633|NCT05798728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154773634|NCT05798728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154773635|NCT05798728|Oxytocics|oxytocics|mesh-ancestor
154773636|NCT05798715|Metformin|metformin|mesh-list
154773637|NCT05798715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154773638|NCT05798715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154773639|NCT05798715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773640|NCT05798715|Incretins|incretins|mesh-ancestor
154773641|NCT05798715|Hormones|hormones|mesh-ancestor
154773642|NCT05798715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773643|NCT05798715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154773644|NCT05798715|Protease Inhibitors|protease inhibitors|mesh-ancestor
154773645|NCT05798715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773646|NCT05798715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773647|NCT05795491|Fluconazole|fluconazole|mesh-list
154773648|NCT05795491|Antifungal Agents|antifungal agents|mesh-list
154773649|NCT05795491|Clotrimazole|clotrimazole|mesh-list
154773650|NCT05795491|Miconazole|miconazole|mesh-list
154773651|NCT05795491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154773652|NCT05795491|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154773653|NCT05795491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154773654|NCT05795491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773655|NCT05795491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773656|NCT05795491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154773657|NCT05795491|Hormone Antagonists|hormone antagonists|mesh-ancestor
154773658|NCT05795491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773659|NCT05795491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773660|NCT05795491|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154773661|NCT05795491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154773662|NCT05795491|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154773663|NCT05795491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154773664|NCT05788627|Lactulose|lactulose|mesh-list
154773665|NCT05788627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154773666|NCT05777135|Propofol|propofol|mesh-list
154773667|NCT05777135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154773668|NCT05777135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378283|NCT03426761|Vancomycin|vancomycin|mesh-list
154773669|NCT05777135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773670|NCT05777135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154773671|NCT05777135|Anesthetics, General|anesthetics, general|mesh-ancestor
154773672|NCT05777135|Anesthetics|anesthetics|mesh-ancestor
154773673|NCT05771883|Lenalidomide|lenalidomide|mesh-list
154773674|NCT05771883|Immunologic Factors|immunologic factors|mesh-ancestor
154773675|NCT05771883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773676|NCT05771883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154773677|NCT05771883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154773678|NCT05771883|Growth Substances|growth substances|mesh-ancestor
154773679|NCT05771883|Growth Inhibitors|growth inhibitors|mesh-ancestor
154773680|NCT05771883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773681|NCT05767892|Carboplatin|carboplatin|mesh-list
154773682|NCT05767892|Pemetrexed|pemetrexed|mesh-list
154773683|NCT05767892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773684|NCT05767892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773685|NCT05767892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773686|NCT05767892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154773687|NCT05767892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154773688|NCT05730816|Magnesium Sulfate|magnesium sulfate|mesh-list
154773689|NCT05730816|Analgesics|analgesics|mesh-ancestor
154773690|NCT05730816|Sensory System Agents|sensory system agents|mesh-ancestor
154773691|NCT05730816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773692|NCT05730816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773693|NCT05730816|Anesthetics|anesthetics|mesh-ancestor
154773694|NCT05730816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773695|NCT05730816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154773696|NCT05730816|Anticonvulsants|anticonvulsants|mesh-ancestor
154773697|NCT05730816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154773698|NCT05730816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154773699|NCT05730816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773700|NCT05730816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154773701|NCT05730816|Tocolytic Agents|tocolytic agents|mesh-ancestor
154773702|NCT05730816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154773703|NCT05702333|Simendan|simendan|mesh-list
154773704|NCT05702333|Dobutamine|dobutamine|mesh-list
154773705|NCT05702333|Dopamine|dopamine|mesh-list
154773706|NCT05702333|Epinephrine|epinephrine|mesh-list
154773707|NCT05702333|Norepinephrine|norepinephrine|mesh-list
154773708|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154773709|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154773710|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
154773711|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773712|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773713|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773714|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154773715|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154773716|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
154773717|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773718|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154773719|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
154773720|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
154773721|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
154773722|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154773723|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154773724|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
154773725|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154773726|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154773727|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773728|NCT05702333|Protective Agents|protective agents|mesh-ancestor
154773729|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154773730|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
154773731|NCT05671913|Ketamine|ketamine|mesh-list
154773732|NCT05671913|Analgesics|analgesics|mesh-ancestor
154773733|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
154773734|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773735|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773736|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154773737|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154773738|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
154773739|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
154773740|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773741|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154773742|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154773743|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773744|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773745|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
154773746|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154773747|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154773748|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154773749|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154773750|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154773751|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773752|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773753|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773754|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154773755|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
154773756|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154773757|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773758|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154773759|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154773760|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154773761|NCT05657990|Tamsulosin|tamsulosin|mesh-list
154773762|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154773763|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154773764|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154773765|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
154773766|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773767|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773768|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773769|NCT05657990|Urological Agents|urological agents|mesh-ancestor
154773770|NCT05559814|Peppermint oil|peppermint oil|mesh-list
154773771|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
154773772|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
154773773|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773774|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773775|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154773776|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
154773777|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154773778|NCT05382481|Dalteparin|dalteparin|mesh-list
154773779|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
154773780|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154773781|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154773782|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773783|NCT05323786|Anesthetics|anesthetics|mesh-list
154773784|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773785|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773786|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
154773787|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154773788|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773789|NCT05221554|Tacrine|tacrine|mesh-list
154773790|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154773791|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773792|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773793|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
154773794|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773795|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773796|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154773797|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
154773798|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773799|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
154773800|NCT05162937|Antibodies|antibodies|mesh-list
154773801|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
154773802|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773803|NCT04985500|Bupivacaine|bupivacaine|mesh-list
154773804|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
154773805|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
154773806|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773807|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773808|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
154773809|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773810|NCT04973670|Sivelestat|sivelestat|mesh-list
154773811|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154773812|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
154773813|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773814|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773815|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
154773816|NCT04929626|Albuterol|albuterol|mesh-list
154773817|NCT04929626|Analgesics|analgesics|mesh-ancestor
154773818|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
154773819|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773820|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773821|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
154773822|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773823|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154773824|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
154773825|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154773826|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154773827|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773828|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154773829|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
154773830|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154773831|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154773832|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
154773833|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154773834|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
154773835|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154773836|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154773837|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154773838|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
154773839|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773840|NCT04826198|Olaparib|olaparib|mesh-list
154773841|NCT04826198|Niraparib|niraparib|mesh-list
154773842|NCT04826198|Rucaparib|rucaparib|mesh-list
154773843|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154773844|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773845|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773846|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773847|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
154773848|NCT04808934|Apixaban|apixaban|mesh-list
154773849|NCT04808934|Dabigatran|dabigatran|mesh-list
154773850|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154773851|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
154773852|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154773853|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
154773854|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773855|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773856|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
154773857|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
154773858|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154773859|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154773860|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773861|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
154773862|NCT04754230|Coagulants|coagulants|mesh-ancestor
154773863|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154773864|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154773865|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154773866|NCT04653337|Norepinephrine|norepinephrine|mesh-list
154773867|NCT04653337|Serotonin|serotonin|mesh-list
154773868|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
154773869|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154773870|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154773871|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
154773872|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773873|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773874|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773875|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
154773876|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
154773877|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773878|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154773879|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154773880|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
154773881|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154773882|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154773883|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154773884|NCT04539626|Estradiol|estradiol|mesh-list
154773885|NCT04539626|Estrogens|estrogens|mesh-list
154773886|NCT04539626|Hormones|hormones|mesh-ancestor
154773887|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154773888|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773889|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154773890|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
154773891|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154773892|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154773893|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154773894|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154773895|NCT04512534|Antibodies|antibodies|mesh-list
154773896|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154773897|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
154773898|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773899|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773900|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773901|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
154773902|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154773903|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773904|NCT04442581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154773905|NCT04442581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773906|NCT04436731|Phentolamine|phentolamine|mesh-list
154773907|NCT04436731|Phenylephrine|phenylephrine|mesh-list
154773908|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
154773909|NCT04436731|Norepinephrine|norepinephrine|mesh-list
154773910|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
154773911|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154773912|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773913|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773914|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154773915|NCT04436731|Analgesics|analgesics|mesh-ancestor
154773916|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
154773917|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773918|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154773919|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154773920|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154773921|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
154773922|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773923|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773924|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154773925|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
154773926|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
154773927|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
154773928|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154773929|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
154773930|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
154773931|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154773932|NCT04436731|Protective Agents|protective agents|mesh-ancestor
154773933|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154773934|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154773935|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154773936|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
154773937|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154773938|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773939|NCT04268706|Fludarabine|fludarabine|mesh-list
154773940|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154773941|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773942|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773943|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154773944|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
154773945|NCT04223609|Oxycodone|oxycodone|mesh-list
154773946|NCT04223609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154773947|NCT04223609|Narcotics|narcotics|mesh-ancestor
154773948|NCT04223609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154773949|NCT04223609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773950|NCT04223609|Analgesics|analgesics|mesh-ancestor
154773951|NCT04223609|Sensory System Agents|sensory system agents|mesh-ancestor
154773952|NCT04223609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154773953|NCT04118920|Insulin|insulin|mesh-list
154773954|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154773955|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
154773956|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154773957|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773958|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154773959|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154773960|NCT04083144|Varenicline|varenicline|mesh-list
154773961|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154773962|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154773963|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
154773964|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154773965|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773966|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773967|NCT04055818|Niacinamide|niacinamide|mesh-list
154773968|NCT04055818|Niacin|niacin|mesh-list
154773969|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
154773970|NCT04055818|Decitabine|decitabine|mesh-list
154773971|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
154773972|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154773973|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
154773974|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773975|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773976|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773977|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
154773978|NCT04055818|Vitamins|vitamins|mesh-ancestor
154773979|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
154773980|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154773981|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154773982|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154773983|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
154773984|NCT04047953|Paclitaxel|paclitaxel|mesh-list
154773985|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154773986|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
154773987|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154773988|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154773989|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154773990|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154773991|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154773992|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773993|NCT03981900|Tofacitinib|tofacitinib|mesh-list
154773994|NCT03981900|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154773995|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154773996|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154773997|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154773998|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154773999|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154774000|NCT03856671|Metronidazole|metronidazole|mesh-list
154774001|NCT03856671|Neomycin|neomycin|mesh-list
154774002|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774003|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154774004|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154774005|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154774006|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154774007|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774008|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774009|NCT03662685|Coal Tar|coal tar|mesh-list
154774010|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
154774011|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
154774012|NCT03391934|Leucovorin|leucovorin|mesh-list
154774013|NCT03391934|Fluorouracil|fluorouracil|mesh-list
154774014|NCT03391934|Irinotecan|irinotecan|mesh-list
154774015|NCT03391934|Cetuximab|cetuximab|mesh-list
154774016|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774017|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
154774018|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774019|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154774020|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774021|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154774022|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
154774023|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154774024|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154774025|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774026|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774027|NCT03391934|Antidotes|antidotes|mesh-ancestor
154774028|NCT03391934|Protective Agents|protective agents|mesh-ancestor
154774029|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
154774030|NCT03391934|Vitamins|vitamins|mesh-ancestor
154774031|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
154774032|NCT03289234|Edaravone|edaravone|mesh-list
154774033|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154774034|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
154774035|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774036|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154774037|NCT03289234|Protective Agents|protective agents|mesh-ancestor
154774038|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774039|NCT03289208|Edaravone|edaravone|mesh-list
154774040|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154774041|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
154774042|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774043|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154774044|NCT03289208|Protective Agents|protective agents|mesh-ancestor
154774045|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774046|NCT03244059|Belimumab|belimumab|mesh-list
154774047|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154774048|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
154774049|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774050|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
154774051|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
154774052|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154525985|NCT02311998|Bosutinib|bosutinib|mesh-list
154774053|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774054|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774055|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
154774056|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154774057|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774058|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774059|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
154774060|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154774061|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
154774062|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774063|NCT02927249|Aspirin|aspirin|mesh-list
154774064|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154774065|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774066|NCT02927249|Analgesics|analgesics|mesh-ancestor
154774067|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
154774068|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774069|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774070|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774071|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774072|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154774073|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154774074|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774075|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154774076|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154774077|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774078|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
154774079|NCT02890368|Interferons|interferons|mesh-list
154774080|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154774081|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154774082|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
154774083|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774084|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
154774085|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774086|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774087|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
154774088|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774089|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774090|NCT02754141|Nivolumab|nivolumab|mesh-list
154774091|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774092|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774093|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154774094|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774095|NCT02659059|Paclitaxel|paclitaxel|mesh-list
154774096|NCT02659059|Cisplatin|cisplatin|mesh-list
154774097|NCT02659059|Carboplatin|carboplatin|mesh-list
154774098|NCT02659059|Nivolumab|nivolumab|mesh-list
154774099|NCT02659059|Pemetrexed|pemetrexed|mesh-list
154774100|NCT02659059|Ipilimumab|ipilimumab|mesh-list
154774101|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154774102|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774103|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
154774104|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
154774105|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
154774106|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774107|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774108|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154774109|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774110|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154774111|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154774112|NCT02375178|Biguanides|biguanides|mesh-list
154774113|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
154774114|NCT02375178|Polihexanide|polihexanide|mesh-list
154774115|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154774116|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774117|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
154774118|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154774119|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774120|NCT02375100|Acetaminophen|acetaminophen|mesh-list
154774121|NCT02375100|Tramadol|tramadol|mesh-list
154774122|NCT02375100|Analgesics|analgesics|mesh-list
154774123|NCT02375100|Bupivacaine|bupivacaine|mesh-list
154774124|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
154774125|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
154774126|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774127|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774128|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
154774129|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774130|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774131|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
154774132|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154774133|NCT02375100|Narcotics|narcotics|mesh-ancestor
154774134|NCT02364258|Atorvastatin|atorvastatin|mesh-list
154774135|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154774136|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154774137|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154774138|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
154774139|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774140|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154774141|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154774142|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774143|NCT02375022|Endostar protein|endostar protein|mesh-list
154774144|NCT02375022|Endostatins|endostatins|mesh-list
154774145|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154774146|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154774147|NCT02375022|Growth Substances|growth substances|mesh-ancestor
154774148|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774149|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
154774150|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774151|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154774152|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154774153|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154774154|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
154774155|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774156|NCT01497275|Rituximab|rituximab|mesh-list
154774157|NCT01497275|Bortezomib|bortezomib|mesh-list
154774158|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774159|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774160|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
154774161|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774162|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774163|NCT01557517|Clobetasol|clobetasol|mesh-list
154774164|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774165|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
154774166|NCT01557517|Hormones|hormones|mesh-ancestor
154774167|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774168|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774169|NCT02363556|Misoprostol|misoprostol|mesh-list
154774170|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154774171|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
154774172|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154774173|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774174|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154774175|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154774176|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
154774177|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154774178|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154774179|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774180|NCT01557283|Etanercept|etanercept|mesh-list
154774181|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154774182|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774183|NCT01557283|Analgesics|analgesics|mesh-ancestor
154774184|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
154774185|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774186|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774187|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774188|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774189|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154774190|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154774191|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
154774192|NCT02374632|Octreotide|octreotide|mesh-list
154774193|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154774194|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154774195|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774196|NCT02363400|Cisplatin|cisplatin|mesh-list
154774197|NCT02363400|Epirubicin|epirubicin|mesh-list
154774198|NCT02363400|Mitomycins|mitomycins|mesh-list
154774199|NCT02363400|Mitomycin|mitomycin|mesh-list
154774200|NCT02363400|Tegafur|tegafur|mesh-list
154774201|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774202|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154774203|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154774204|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154774205|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774206|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774207|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
154774208|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154774209|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154774211|NCT00350025|Paclitaxel|paclitaxel|mesh-list
154774212|NCT00350025|Cetuximab|cetuximab|mesh-list
154774213|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154774214|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774215|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
154774216|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
154774217|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
154774218|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774219|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774220|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154774221|NCT01496807|Ipilimumab|ipilimumab|mesh-list
154774222|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774223|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774224|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154774225|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774226|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
154774227|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774228|NCT02374320|Bupivacaine|bupivacaine|mesh-list
154774229|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
154774230|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
154774231|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774232|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774233|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
154774234|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774235|NCT01496183|Olanzapine|olanzapine|mesh-list
154774236|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
154774237|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
154774238|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774239|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774240|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154774241|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154774242|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154774243|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774244|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154774245|NCT01496183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154774246|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154774247|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154774248|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774249|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774250|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
154774251|NCT01495793|Rotigotine|rotigotine|mesh-list
154774252|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
154774253|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
154774254|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774255|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774256|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774257|NCT02374008|Dexamethasone|dexamethasone|mesh-list
154774258|NCT02374008|Ketorolac|ketorolac|mesh-list
154774259|NCT02374008|Ropivacaine|ropivacaine|mesh-list
154774260|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774261|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
154774262|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
154774263|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774264|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774265|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154774266|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
154774267|NCT02374008|Hormones|hormones|mesh-ancestor
154774268|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774269|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154774270|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774271|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774272|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774273|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
154774274|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
154774275|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774276|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
154774277|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154774278|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774279|NCT02374008|Analgesics|analgesics|mesh-ancestor
154774280|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154526211|NCT05413863|Insulin|insulin|mesh-list
154774281|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154774282|NCT04505280|Lidocaine|lidocaine|mesh-list
154774283|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154774284|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
154774285|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774286|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774287|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
154774288|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774289|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154774290|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154774291|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154774292|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154774293|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774294|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
154774295|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154774296|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
154774297|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774298|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
154774299|NCT02366676|Protective Agents|protective agents|mesh-ancestor
154774300|NCT02373384|Allopurinol|allopurinol|mesh-list
154774301|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
154774302|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774303|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
154774304|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774305|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
154774306|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774307|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154774308|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
154774309|NCT02373384|Protective Agents|protective agents|mesh-ancestor
154774310|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774311|NCT02373384|Diuretics|diuretics|mesh-ancestor
154774312|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
154774313|NCT02373384|Expectorants|expectorants|mesh-ancestor
154774314|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
154774315|NCT01494467|Azelaic acid|azelaic acid|mesh-list
154774316|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774317|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
154774318|NCT02881086|Cytarabine|cytarabine|mesh-list
154774319|NCT02881086|Dexamethasone|dexamethasone|mesh-list
154774320|NCT02881086|Prednisolone|prednisolone|mesh-list
154774321|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
154774322|NCT02881086|Rituximab|rituximab|mesh-list
154774323|NCT02881086|Methotrexate|methotrexate|mesh-list
154774324|NCT02881086|Fludarabine|fludarabine|mesh-list
154774325|NCT02881086|Vincristine|vincristine|mesh-list
154774326|NCT02881086|Doxorubicin|doxorubicin|mesh-list
154774327|NCT02881086|Daunorubicin|daunorubicin|mesh-list
154774328|NCT02881086|Asparaginase|asparaginase|mesh-list
154774329|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
154774330|NCT02881086|Idarubicin|idarubicin|mesh-list
154774331|NCT02881086|Pegaspargase|pegaspargase|mesh-list
154774332|NCT02881086|Vindesine|vindesine|mesh-list
154774333|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154774334|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
154774335|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774336|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774337|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154774338|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
154774339|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774340|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774341|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154774342|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774343|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774344|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
154774345|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
154774346|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774347|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154774348|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
154774349|NCT02881086|Hormones|hormones|mesh-ancestor
154774350|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774351|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154774352|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154774353|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
154774354|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154526293|NCT05317676|Hormones|hormones|mesh-ancestor
154774355|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154774356|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
154774357|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
154774358|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774359|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154774360|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154774361|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
154774362|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774363|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154774364|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
154774365|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
154774366|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
154774367|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154774368|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154378999|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
154774369|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154774370|NCT01493687|Azelaic acid|azelaic acid|mesh-list
154774371|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774372|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
154774373|NCT02362308|Eplerenone|eplerenone|mesh-list
154774374|NCT02362308|Spironolactone|spironolactone|mesh-list
154774375|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154774376|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
154774377|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
154774378|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774379|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774380|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154774381|NCT02362308|Diuretics|diuretics|mesh-ancestor
154774382|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
154774383|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154774384|NCT02362308|Hormones|hormones|mesh-ancestor
154774385|NCT02366208|Adefovir|adefovir|mesh-list
154774386|NCT02366208|Thymalfasin|thymalfasin|mesh-list
154774387|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
154774388|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774389|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154774390|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154774391|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774392|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774393|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154774394|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
154774395|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774396|NCT02373462|Olmesartan|olmesartan|mesh-list
154774397|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
154774398|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154774399|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154774400|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774401|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154774402|NCT01523587|Afatinib|afatinib|mesh-list
154774403|NCT01523587|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154774404|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154774405|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774406|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774407|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774408|NCT00310401|Albuterol|albuterol|mesh-list
154774409|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154774410|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
154774411|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774412|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774413|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154774414|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
154774415|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
154774416|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154774417|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154774418|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154774419|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154774420|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
154774421|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774422|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774423|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
154774424|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154774425|NCT00310791|Hormones|hormones|mesh-list
154774426|NCT00310791|Estradiol|estradiol|mesh-list
154774427|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154774428|NCT00310791|Estrogens|estrogens|mesh-list
154774429|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154774430|NCT00310791|Progestins|progestins|mesh-list
154774431|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774432|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774433|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154774435|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154774436|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154774437|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154774438|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154774439|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154774440|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154774441|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
154774442|NCT02362152|Diclofenac|diclofenac|mesh-list
154774443|NCT02362152|Fluorouracil|fluorouracil|mesh-list
154774444|NCT02362152|Imiquimod|imiquimod|mesh-list
154774445|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
154774446|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774447|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154774448|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774449|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154774450|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
154774451|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774452|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154774453|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774454|NCT02362152|Analgesics|analgesics|mesh-ancestor
154774455|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
154774456|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774457|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774458|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774459|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154774460|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774461|NCT02362152|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154774462|NCT02362152|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154774463|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154774464|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
154774465|NCT01493531|Allopurinol|allopurinol|mesh-list
154774466|NCT01493531|Lesinurad|lesinurad|mesh-list
154774467|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
154774468|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774469|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774470|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
154774471|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774472|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154774473|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
154774474|NCT01493531|Protective Agents|protective agents|mesh-ancestor
154774475|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774476|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
154774477|NCT02105415|Ketamine|ketamine|mesh-list
154774478|NCT02105415|Propofol|propofol|mesh-list
154774479|NCT02105415|Etomidate|etomidate|mesh-list
154774480|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154774481|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774482|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774483|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154774484|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
154774485|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
154774486|NCT02105415|Analgesics|analgesics|mesh-ancestor
154774487|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
154774488|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774489|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154774490|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154774491|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154774492|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774493|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774494|NCT01523275|Mitomycins|mitomycins|mesh-list
154774495|NCT01523275|Mitomycin|mitomycin|mesh-list
154774496|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154774497|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774498|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
154774499|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774500|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154774501|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774502|NCT00304707|Bupropion|bupropion|mesh-list
154774503|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154774504|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
154774505|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154774506|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154774507|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154774508|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154774509|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774510|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
154774511|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774512|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774513|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154774514|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154774515|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774516|NCT04409483|Ritonavir|ritonavir|mesh-list
154774517|NCT04409483|Lopinavir|lopinavir|mesh-list
154774518|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154774519|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154774520|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
154774521|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774522|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774523|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154774524|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154774525|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
154774526|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774527|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154774528|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154774529|NCT02365740|Insulin|insulin|mesh-list
154774530|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154774531|NCT02365740|Hormones|hormones|mesh-list
154774532|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154774533|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774534|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774535|NCT05267847|Anesthetics|anesthetics|mesh-list
154774536|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774537|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774538|NCT05267457|Vanadium|vanadium|mesh-list
154774539|NCT05267457|Trace Elements|trace elements|mesh-ancestor
154774540|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
154774541|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774542|NCT00351039|Bevacizumab|bevacizumab|mesh-list
154774543|NCT00351039|Pemetrexed|pemetrexed|mesh-list
154774544|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154774545|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774546|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774547|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154774548|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154774549|NCT00351039|Growth Substances|growth substances|mesh-ancestor
154774550|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774551|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154774552|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774553|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774554|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154774555|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154774556|NCT00351039|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154774557|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154774558|NCT02372916|Ranibizumab|ranibizumab|mesh-list
154774559|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154774560|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154774561|NCT02372916|Growth Substances|growth substances|mesh-ancestor
154774562|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774563|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
154774564|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774565|NCT02361528|Sargramostim|sargramostim|mesh-list
154774566|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
154774567|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774568|NCT01572727|Paclitaxel|paclitaxel|mesh-list
154774569|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154774570|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774571|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
154774572|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
154774573|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
154774574|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774575|NCT02359266|Vitamin D|vitamin d|mesh-list
154774576|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
154774577|NCT02359266|Vitamins|vitamins|mesh-ancestor
154774578|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
154774579|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774580|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154774581|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154774582|NCT02359500|Octreotide|octreotide|mesh-list
154774583|NCT02359500|Edotreotide|edotreotide|mesh-list
154774584|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154774585|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154774586|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774587|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154774588|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774589|NCT02372526|Orlistat|orlistat|mesh-list
154774590|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774591|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774592|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154774593|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154774594|NCT02985697|Midazolam|midazolam|mesh-list
154774595|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
154774596|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
154774597|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154774598|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774599|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774600|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774601|NCT02985697|Analgesics|analgesics|mesh-ancestor
154774602|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
154774603|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774604|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154774605|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154774606|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154774607|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
154774608|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774609|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774610|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154774611|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154774612|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154774613|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154774614|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154774615|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
154774616|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
154774617|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
154774618|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
154774619|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154774620|NCT02372760|Lidocaine|lidocaine|mesh-list
154774621|NCT02372760|Anesthetics|anesthetics|mesh-list
154774622|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
154774623|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774624|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774625|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
154774626|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774627|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154774628|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154774629|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154774630|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154774631|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774632|NCT00352911|Mifepristone|mifepristone|mesh-list
154774633|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154774634|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
154774635|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154774636|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774637|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154774638|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154774639|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154774640|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
154774641|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154774642|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154774643|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
154774644|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774645|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
154774646|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154774647|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154774648|NCT00353301|Sirolimus|sirolimus|mesh-list
154774649|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154774650|NCT00353301|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154774651|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154774652|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774653|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774654|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774655|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154774656|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774657|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154774658|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
154774659|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154774660|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
154774661|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774662|NCT02372604|Cetirizine|cetirizine|mesh-list
154774663|NCT02372604|Levocetirizine|levocetirizine|mesh-list
154774664|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154774665|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154774666|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
154774667|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
154774668|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774669|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774670|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774671|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154774672|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
154774673|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154774674|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774675|NCT02358642|Lisinopril|lisinopril|mesh-list
154774676|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154774677|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154774678|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
154774679|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774680|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154774681|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154774682|NCT02358642|Protective Agents|protective agents|mesh-ancestor
154774683|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774684|NCT03160248|Apremilast|apremilast|mesh-list
154774685|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154774686|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774687|NCT03160248|Analgesics|analgesics|mesh-ancestor
154774688|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
154774689|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774690|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774691|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774692|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774693|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154774694|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154774695|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774696|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774697|NCT01522651|Dronedarone|dronedarone|mesh-list
154774698|NCT01522651|Ranolazine|ranolazine|mesh-list
154774699|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154774700|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154774701|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774702|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154774703|NCT02372292|Furosemide|furosemide|mesh-list
154774704|NCT02372292|Diuretics|diuretics|mesh-ancestor
154774705|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
154774706|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774707|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154774708|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154774709|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774710|NCT01554241|Vitamin D|vitamin d|mesh-list
154774711|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
154774712|NCT01554241|Vitamins|vitamins|mesh-ancestor
154774713|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
154774714|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774715|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154774716|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154774717|NCT02353026|Artesunate|artesunate|mesh-list
154774718|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
154774719|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154774720|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154774721|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774722|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774723|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
154774724|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
154774725|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154774726|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
154774727|NCT01521559|Aflibercept|aflibercept|mesh-list
154774728|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154774729|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154774730|NCT01521559|Growth Substances|growth substances|mesh-ancestor
154774731|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774732|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
154774733|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774734|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
154774735|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154774736|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154774737|NCT04438980|Prednisolone|prednisolone|mesh-list
154774738|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
154774739|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154774740|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
154774741|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774742|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
154774743|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
154774744|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774745|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774746|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154774747|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
154774748|NCT04438980|Hormones|hormones|mesh-ancestor
154774749|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774750|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154774751|NCT04438980|Protective Agents|protective agents|mesh-ancestor
154774752|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154774753|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774754|NCT03824847|Clarithromycin|clarithromycin|mesh-list
154774755|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154774756|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774757|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154774758|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774759|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774760|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154774761|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154774762|NCT01554163|Celecoxib|celecoxib|mesh-list
154774763|NCT01554163|Etoricoxib|etoricoxib|mesh-list
154774764|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154774765|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774766|NCT01554163|Analgesics|analgesics|mesh-ancestor
154774767|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
154774768|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774769|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774770|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774771|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774772|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154774773|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154774774|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774775|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774776|NCT02360826|Simvastatin|simvastatin|mesh-list
154774777|NCT02360826|Pravastatin|pravastatin|mesh-list
154774778|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154774779|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154774780|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
154774781|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774782|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154774783|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154774784|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774785|NCT02361060|Atropine|atropine|mesh-list
154774786|NCT02361060|Neostigmine|neostigmine|mesh-list
154774787|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154774788|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154774789|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154774790|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
154774791|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774792|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774793|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154774794|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
154774795|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
154774796|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
154774797|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154774798|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154774799|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
154774800|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774801|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774802|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154774803|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774804|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154526730|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
154774805|NCT02360982|Fentanyl|fentanyl|mesh-list
154774806|NCT02360982|Propofol|propofol|mesh-list
154774807|NCT02360982|Bupivacaine|bupivacaine|mesh-list
154774808|NCT02360982|Rocuronium|rocuronium|mesh-list
154774809|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154774810|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774811|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774812|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154774813|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
154774814|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
154774815|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154774816|NCT02360982|Narcotics|narcotics|mesh-ancestor
154774817|NCT02360982|Analgesics|analgesics|mesh-ancestor
154774818|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
154774819|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774820|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154774821|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
154774822|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154774823|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154774824|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154774825|NCT01553851|Trametinib|trametinib|mesh-list
154774826|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774827|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154774828|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774829|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774830|NCT02358018|Edotreotide|edotreotide|mesh-list
154774831|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154774832|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774833|NCT01552915|Methylphenidate|methylphenidate|mesh-list
154774834|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154774835|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154774836|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774837|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154774838|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154774839|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154774840|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774841|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
154774842|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774843|NCT02352714|Lidocaine|lidocaine|mesh-list
154774844|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
154774845|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
154774846|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154774847|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774848|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
154774849|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774850|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154774851|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154774852|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154774853|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154774854|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774855|NCT03911557|Durvalumab|durvalumab|mesh-list
154774856|NCT03911557|Tremelimumab|tremelimumab|mesh-list
154379465|NCT01355952|Vitamins|vitamins|mesh-ancestor
154774857|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774858|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774859|NCT00356031|Bevacizumab|bevacizumab|mesh-list
154774860|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154774861|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774862|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154774863|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154774864|NCT00356031|Growth Substances|growth substances|mesh-ancestor
154774865|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774866|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
154774867|NCT02038842|Vaccines|vaccines|mesh-list
154774868|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
154774869|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774870|NCT01790139|Simethicone|simethicone|mesh-list
154774871|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
154774872|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774873|NCT01790139|Emollients|emollients|mesh-ancestor
154774874|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
154774875|NCT02360592|Interferons|interferons|mesh-list
154774876|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
154774877|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
154774878|NCT02360592|Entecavir|entecavir|mesh-list
154526811|NCT03664544|Edaravone|edaravone|mesh-list
154774879|NCT02360592|Interleukin-2|interleukin-2|mesh-list
154774880|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774882|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774883|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
154774884|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774885|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154774886|NCT02360592|Analgesics|analgesics|mesh-ancestor
154774887|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
154774888|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774889|NCT02360202|Clobetasol|clobetasol|mesh-list
154774890|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774891|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
154774892|NCT02360202|Hormones|hormones|mesh-ancestor
154774893|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774894|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774895|NCT00322101|Cyclosporine|cyclosporine|mesh-list
154774896|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
154774897|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
154774898|NCT00322101|Busulfan|busulfan|mesh-list
154774899|NCT00322101|Methotrexate|methotrexate|mesh-list
154774900|NCT00322101|Fludarabine|fludarabine|mesh-list
154774901|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
154774902|NCT00322101|Tacrolimus|tacrolimus|mesh-list
154774903|NCT00322101|Cyclosporins|cyclosporins|mesh-list
154774904|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154774905|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
154774906|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774907|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154774908|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154774909|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
154774910|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774911|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154774912|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154774913|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154774914|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
154774915|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154774916|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154774917|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
154774918|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
154774919|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154774920|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154774921|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154379548|NCT01351428|Nifedipine|nifedipine|mesh-list
154774922|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154774923|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
154774924|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774925|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154774926|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154774927|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
154774928|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154774929|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
154774930|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774931|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
154774932|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
154774933|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774934|NCT02352402|Ticagrelor|ticagrelor|mesh-list
154774935|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154774936|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154774937|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154774938|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154774939|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
154774940|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774941|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774942|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774943|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154774944|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154774945|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
154774946|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774947|NCT00322335|PENTA|penta|mesh-list
154774948|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
154774949|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154774950|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154774951|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774952|NCT03153852|Glycolic acid|glycolic acid|mesh-list
154774953|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
154774954|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154774955|NCT01792557|Phenol|phenol|mesh-list
154774956|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154774957|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774958|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
154774959|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154774960|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154774961|NCT01792713|Sertaconazole|sertaconazole|mesh-list
154774962|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
154774963|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154774965|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154774966|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154774967|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
154774968|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154774969|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774970|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154774971|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
154774972|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
154774973|NCT02352168|Hormones|hormones|mesh-ancestor
154774974|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154774975|NCT02357004|Carvedilol|carvedilol|mesh-list
154774976|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
154774977|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154774978|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154774979|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
154774980|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154774981|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154774982|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154774983|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154774984|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
154774985|NCT02357004|Protective Agents|protective agents|mesh-ancestor
154774986|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154774987|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154379602|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154774988|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154774989|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
154774990|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154774991|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154774992|NCT02357004|Diuretics|diuretics|mesh-ancestor
154774993|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
154774994|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154774995|NCT01570387|Dexamethasone|dexamethasone|mesh-list
154774996|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
154774997|NCT01570387|Pomalidomide|pomalidomide|mesh-list
154774998|NCT01570387|BB 1101|bb 1101|mesh-list
154774999|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775000|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
154775001|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
154775002|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775003|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775004|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775005|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
154775006|NCT01570387|Hormones|hormones|mesh-ancestor
154775007|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775008|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154775009|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775010|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
154775011|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775012|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775013|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
154775014|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154775015|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775016|NCT01570387|Growth Substances|growth substances|mesh-ancestor
154775017|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775018|NCT02348424|Solithromycin|solithromycin|mesh-list
154775019|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154775020|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775021|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
154775022|NCT01570309|Vitamin D|vitamin d|mesh-list
154775023|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154775024|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775025|NCT01570309|Vitamins|vitamins|mesh-ancestor
154775026|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
154775027|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154775028|NCT02356146|Tacrolimus|tacrolimus|mesh-list
154775029|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154775030|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
154775031|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775032|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154775033|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775034|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775035|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154775036|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
154775037|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775038|NCT01519765|Misoprostol|misoprostol|mesh-list
154775039|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154775040|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
154775041|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154775042|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775043|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154775044|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775045|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
154775046|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
154775047|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154775048|NCT03147066|Dezocine|dezocine|mesh-list
154775049|NCT03147066|Analgesics|analgesics|mesh-ancestor
154775050|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
154775051|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379666|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
154775052|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775053|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154775054|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154775055|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775056|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775057|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154775058|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775059|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775060|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154775061|NCT03147066|Narcotics|narcotics|mesh-ancestor
154775062|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775063|NCT02351622|Dexamethasone|dexamethasone|mesh-list
154775064|NCT02351622|Caffeic acid|caffeic acid|mesh-list
154775065|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775066|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
154775067|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
154775068|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775069|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775070|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775071|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
154775072|NCT02351622|Hormones|hormones|mesh-ancestor
154775073|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775074|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154775075|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775076|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
154775077|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775078|NCT02351622|Protective Agents|protective agents|mesh-ancestor
154775079|NCT01552603|Pancrelipase|pancrelipase|mesh-list
154775080|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775081|NCT02348190|Heparin|heparin|mesh-list
154775082|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
154775083|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154775084|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154775085|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775086|NCT01552369|Valganciclovir|valganciclovir|mesh-list
154775087|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
154775088|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775089|NCT02351232|Liraglutide|liraglutide|mesh-list
154775090|NCT02351232|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154775091|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154775092|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775093|NCT02351232|Incretins|incretins|mesh-ancestor
154775094|NCT02351232|Hormones|hormones|mesh-ancestor
154775095|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775096|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
154775097|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
154775098|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154775099|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775100|NCT02355678|Acetaminophen|acetaminophen|mesh-list
154775101|NCT02355678|Dexamethasone|dexamethasone|mesh-list
154775102|NCT02355678|Propacetamol|propacetamol|mesh-list
154775103|NCT02355678|Tramadol|tramadol|mesh-list
154775104|NCT02355678|Anesthetics|anesthetics|mesh-list
154775105|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
154775106|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775107|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
154775108|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
154775109|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775110|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775111|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775112|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
154775113|NCT02355678|Hormones|hormones|mesh-ancestor
154775114|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775115|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154775116|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775117|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775118|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154775119|NCT02355678|Analgesics|analgesics|mesh-ancestor
154775120|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
154775121|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
154775122|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154775123|NCT02355678|Narcotics|narcotics|mesh-ancestor
154775124|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154775125|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775126|NCT02351310|Betamethasone|betamethasone|mesh-list
154775127|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775128|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
154775129|NCT02351310|Hormones|hormones|mesh-ancestor
154775130|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775131|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775132|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154775133|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
154775134|NCT02347878|Aprepitant|aprepitant|mesh-list
154775135|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
154775136|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
154775137|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775138|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775139|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775140|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154775141|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775142|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775143|NCT02355522|Lidocaine|lidocaine|mesh-list
154775144|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
154775145|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
154775146|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775147|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775148|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
154775149|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775150|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154775151|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154775152|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154775153|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154775154|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775155|NCT02355054|Choline|choline|mesh-list
154775156|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
154775157|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154775158|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
154775159|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775160|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775161|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154775162|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
154775163|NCT04478448|Favipiravir|favipiravir|mesh-list
154775164|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
154775165|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775166|NCT04478526|Norepinephrine|norepinephrine|mesh-list
154775167|NCT04478526|Serotonin|serotonin|mesh-list
154775168|NCT04478526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154775169|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
154775170|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154775171|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154775172|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
154775173|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775174|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775175|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775176|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
154775177|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
154775178|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775179|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154775180|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154775181|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
154775182|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154527105|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
154775183|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154775184|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154775185|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154775186|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154775187|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154775188|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775189|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775190|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775191|NCT01552057|Analgesics|analgesics|mesh-ancestor
154775192|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
154775193|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775194|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
154775195|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154775196|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
154775197|NCT02350686|Capecitabine|capecitabine|mesh-list
154775198|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
154775199|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154775200|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
154775201|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775202|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775203|NCT03159078|Imipenem|imipenem|mesh-list
154775204|NCT03159078|Polymyxins|polymyxins|mesh-list
154775205|NCT03159078|Polymyxin B|polymyxin b|mesh-list
154775206|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154775207|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775208|NCT01551745|Bevacizumab|bevacizumab|mesh-list
154775209|NCT01551745|Vaccines|vaccines|mesh-list
154775210|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
154775211|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775212|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154775213|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775214|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154775215|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775216|NCT01551745|Growth Substances|growth substances|mesh-ancestor
154775217|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775218|NCT02350530|Bevacizumab|bevacizumab|mesh-list
154775219|NCT02350530|Fluorouracil|fluorouracil|mesh-list
154775220|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
154775221|NCT02350530|Irinotecan|irinotecan|mesh-list
154775222|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154775223|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775224|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154775225|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775226|NCT02350530|Growth Substances|growth substances|mesh-ancestor
154775227|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775228|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775229|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
154775230|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775231|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154775232|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154775233|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
154775234|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154775235|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154775236|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775237|NCT01569841|Insulin|insulin|mesh-list
154775238|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154775239|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
154775240|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154775241|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775242|NCT01550965|Adalimumab|adalimumab|mesh-list
154775243|NCT01550965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154775244|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775245|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775246|NCT05265819|Hormones|hormones|mesh-list
154775247|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775248|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775249|NCT02353494|Piperaquine|piperaquine|mesh-list
154775250|NCT02353494|Artenimol|artenimol|mesh-list
154775251|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
154775252|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154775253|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154775254|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775255|NCT02353260|Docetaxel|docetaxel|mesh-list
154775256|NCT02353260|Fluorouracil|fluorouracil|mesh-list
154775257|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775258|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
154775259|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
154775260|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
154775261|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775262|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
154775263|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154775264|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154775265|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
154775266|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775267|NCT03158610|Capecitabine|capecitabine|mesh-list
154775268|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154775269|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
154775270|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775271|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775272|NCT00323739|Bevacizumab|bevacizumab|mesh-list
154775273|NCT00323739|Everolimus|everolimus|mesh-list
154775274|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154775275|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775276|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154775277|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775278|NCT00323739|Growth Substances|growth substances|mesh-ancestor
154775279|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379894|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
154775280|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775281|NCT00323739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154775282|NCT00323739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154775283|NCT00323739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775284|NCT00323739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775285|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154775286|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
154775287|NCT02350218|Alprostadil|alprostadil|mesh-list
154775288|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154775289|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
154775290|NCT02350218|Urological Agents|urological agents|mesh-ancestor
154775291|NCT00390429|Docetaxel|docetaxel|mesh-list
154775292|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154775293|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775294|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
154775295|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
154775296|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
154775297|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775298|NCT00390429|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154775299|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154775300|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775301|NCT02349828|Acyclovir|acyclovir|mesh-list
154775302|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
154775303|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775304|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
154775305|NCT02353182|Remifentanil|remifentanil|mesh-list
154775306|NCT02353182|Bupivacaine|bupivacaine|mesh-list
154775307|NCT02353182|Ropivacaine|ropivacaine|mesh-list
154775308|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
154775309|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
154775310|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775311|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775312|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
154775313|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775314|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154775315|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154775316|NCT02353182|Analgesics|analgesics|mesh-ancestor
154775317|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154775318|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154775319|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154775320|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
154775321|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775322|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775323|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154775324|NCT02353182|Narcotics|narcotics|mesh-ancestor
154775325|NCT02349516|Squalamine|squalamine|mesh-list
154775326|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154775327|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154775328|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154775329|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775330|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154775331|NCT02349516|Protective Agents|protective agents|mesh-ancestor
154775332|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775333|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775334|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154527260|NCT02237755|Citric Acid|citric acid|mesh-list
154775335|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775336|NCT02349516|Growth Substances|growth substances|mesh-ancestor
154775337|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775338|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154775339|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154775340|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154775341|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154775342|NCT02346084|Maraviroc|maraviroc|mesh-list
154775343|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154775344|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154775345|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775346|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154775347|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154775348|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
154775349|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775350|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154775351|NCT03149250|Hemostatics|hemostatics|mesh-list
154775352|NCT03149250|Coagulants|coagulants|mesh-ancestor
154775353|NCT00391443|Bosentan|bosentan|mesh-list
154775354|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154775355|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154775356|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775357|NCT02343432|Triamcinolone|triamcinolone|mesh-list
154775358|NCT02343432|Bupivacaine|bupivacaine|mesh-list
154775359|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
154775360|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
154775361|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775362|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775363|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
154775364|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775365|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775366|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
154775367|NCT02343432|Hormones|hormones|mesh-ancestor
154775368|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775369|NCT02349282|Vitamin D|vitamin d|mesh-list
154775370|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
154775371|NCT02349282|Calcifediol|calcifediol|mesh-list
154775372|NCT02349282|Vitamins|vitamins|mesh-ancestor
154775373|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
154775374|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775375|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154775376|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154775377|NCT02349204|Zaleplon|zaleplon|mesh-list
154775378|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
154775379|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154775380|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775381|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775382|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
154775383|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
154775384|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775385|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775386|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
154775387|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154775388|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
154775389|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775390|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775391|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154775392|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
154775393|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154775394|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
154775395|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775396|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775397|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154775398|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
154775399|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
154775400|NCT02345616|Protective Agents|protective agents|mesh-ancestor
154775401|NCT00391989|Dasatinib|dasatinib|mesh-list
154775402|NCT00391989|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154775403|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154775404|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775405|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775406|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775407|NCT03148704|Palonosetron|palonosetron|mesh-list
154775408|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
154775409|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
154527339|NCT02849743|Oxytocin|oxytocin|mesh-list
154775410|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775411|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775412|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775413|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154775414|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154775416|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775417|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775418|NCT01795287|Anesthetics|anesthetics|mesh-list
154775419|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775420|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775421|NCT04976283|Pioglitazone|pioglitazone|mesh-list
154775422|NCT04976283|Empagliflozin|empagliflozin|mesh-list
154775423|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154775424|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775425|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154775426|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775427|NCT02345304|Digoxin|digoxin|mesh-list
154775428|NCT02345304|Midazolam|midazolam|mesh-list
154775429|NCT02345304|Omeprazole|omeprazole|mesh-list
154775430|NCT02345304|Warfarin|warfarin|mesh-list
154775431|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154775432|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154775433|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775434|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775435|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154775436|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154775437|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154775438|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154775439|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
154775440|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
154775441|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
154775442|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
154775443|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775444|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775445|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
154775446|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154775447|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775448|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154775449|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775450|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154775451|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154775452|NCT02345304|Protective Agents|protective agents|mesh-ancestor
154775453|NCT01569295|Rituximab|rituximab|mesh-list
154775454|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154775455|NCT01569295|Idelalisib|idelalisib|mesh-list
154775456|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154775457|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775458|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
154775459|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775460|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775461|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154775462|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
154775463|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775464|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775465|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
154775466|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775467|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
154775468|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
154775469|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
154775470|NCT02345148|Esketamine|esketamine|mesh-list
154775471|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
154775472|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154775473|NCT00394329|Beclomethasone|beclomethasone|mesh-list
154775474|NCT00394329|Albuterol|albuterol|mesh-list
154775475|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154775476|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
154775477|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775478|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775479|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154775480|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
154775481|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
154775482|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154775483|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154775484|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154775485|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154775486|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
154775487|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775488|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775489|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775490|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
154775491|NCT00394329|Hormones|hormones|mesh-ancestor
154775492|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775493|NCT03146052|Simethicone|simethicone|mesh-list
154775494|NCT03146052|Bisacodyl|bisacodyl|mesh-list
154775495|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775496|NCT03146052|Cathartics|cathartics|mesh-ancestor
154775497|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775498|NCT03146052|Laxatives|laxatives|mesh-ancestor
154775499|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
154775500|NCT03146052|Emollients|emollients|mesh-ancestor
154775501|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
154775502|NCT01549951|Prednisone|prednisone|mesh-list
154775503|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775504|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
154775505|NCT01549951|Hormones|hormones|mesh-ancestor
154775506|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775507|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775508|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154775509|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775510|NCT03148314|Misoprostol|misoprostol|mesh-list
154775511|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154775512|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
154775513|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154775514|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775515|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154775516|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775517|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
154775518|NCT01517893|Simvastatin|simvastatin|mesh-list
154775519|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154775520|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154775521|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
154775522|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775523|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154775524|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154775525|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775526|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
154775527|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154775528|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775529|NCT01489891|Lidocaine|lidocaine|mesh-list
154775530|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
154775531|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
154775532|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775533|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380149|NCT03108274|Fexofenadine|fexofenadine|mesh-list
154775534|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
154775535|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775536|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154775537|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154775538|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154775539|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154775540|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775541|NCT02342574|Olorofim|olorofim|mesh-list
154775542|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
154775543|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775544|NCT03148002|Lactulose|lactulose|mesh-list
154775545|NCT03148002|Sennosides|sennosides|mesh-list
154775546|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775547|NCT03148002|Laxatives|laxatives|mesh-ancestor
154775548|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154775549|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
154775550|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775551|NCT00396201|Plerixafor|plerixafor|mesh-list
154775552|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154775553|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154775554|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
154775555|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775556|NCT03145896|Vitamin D|vitamin d|mesh-list
154775557|NCT03145896|Vitamins|vitamins|mesh-ancestor
154775558|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
154775559|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775560|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154775561|NCT02341872|Calcium|calcium|mesh-list
154775562|NCT02341872|Fluorides|fluorides|mesh-list
154775563|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154775564|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775566|NCT02341872|Protective Agents|protective agents|mesh-ancestor
154775567|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154775568|NCT00360399|Escitalopram|escitalopram|mesh-list
154775569|NCT00360399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154775570|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154775571|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154775572|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775573|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775574|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
154775575|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775576|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775577|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
154775578|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154775579|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154775580|NCT00360399|Analgesics|analgesics|mesh-ancestor
154775581|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
154775582|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
154775583|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154775584|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154775585|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154775586|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
154775587|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775588|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154775589|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154775590|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775591|NCT02344602|Febuxostat|febuxostat|mesh-list
154775592|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
154775593|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775594|NCT02348268|Analgesics|analgesics|mesh-list
154775595|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
154775596|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775597|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775598|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
154775599|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
154775600|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154775601|NCT02348346|Protective Agents|protective agents|mesh-ancestor
154775602|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775603|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
154775604|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154775605|NCT00361257|Minocycline|minocycline|mesh-list
154775606|NCT00361257|Tetracycline|tetracycline|mesh-list
154775607|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154775608|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775609|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154775610|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775611|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775612|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
154775613|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
154775614|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
154775615|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775616|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775617|NCT02341638|Aspirin|aspirin|mesh-list
154775618|NCT02341638|Itraconazole|itraconazole|mesh-list
154775619|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154775620|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154775621|NCT02341638|Analgesics|analgesics|mesh-ancestor
154775622|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
154775623|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775624|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775625|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775626|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775627|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154775628|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154775629|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775630|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154775631|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154775632|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775633|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
154775634|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
154775635|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775636|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154775637|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154775638|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154775639|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
154775640|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775641|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154775642|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
154775643|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154775644|NCT02337192|Curcumin|curcumin|mesh-list
154775645|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154775646|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154775647|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775648|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
154775649|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
154775650|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154775651|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154775652|NCT02337192|Analgesics|analgesics|mesh-ancestor
154775653|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
154775654|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775655|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775656|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775657|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775658|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775659|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775660|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775661|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
154775662|NCT03111966|Grazoprevir|grazoprevir|mesh-list
154775663|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154775664|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
154775665|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775666|NCT02343666|Plerixafor|plerixafor|mesh-list
154775667|NCT02343666|Carmustine|carmustine|mesh-list
154775668|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
154775669|NCT02343666|Lenograstim|lenograstim|mesh-list
154775670|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154775671|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
154775672|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775673|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154775674|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
154775675|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775676|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775677|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154775678|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154775679|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
154775680|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775681|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775682|NCT02340936|Lenalidomide|lenalidomide|mesh-list
154775683|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
154775684|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775685|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154775686|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775687|NCT02340936|Growth Substances|growth substances|mesh-ancestor
154775688|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775689|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775690|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
154775691|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154775692|NCT02337036|Tacrolimus|tacrolimus|mesh-list
154775693|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154775694|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
154775695|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775696|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154775697|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775698|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775699|NCT02336568|Oxytocin|oxytocin|mesh-list
154775700|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
154775701|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154775702|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775703|NCT04630938|Lidocaine|lidocaine|mesh-list
154775704|NCT04630938|Morphine|morphine|mesh-list
154775705|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
154775706|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
154775707|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775708|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775709|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
154775710|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775711|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154775712|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154775714|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154775715|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775716|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154775717|NCT04630938|Narcotics|narcotics|mesh-ancestor
154775718|NCT04630938|Analgesics|analgesics|mesh-ancestor
154775719|NCT04594746|Amiodarone|amiodarone|mesh-list
154775720|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154775721|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
154775722|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154775723|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154775724|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775725|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154775726|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154775727|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154775728|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775729|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154775730|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154775731|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154775732|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
154775733|NCT02790138|Vedolizumab|vedolizumab|mesh-list
154775734|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154775735|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775736|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154775737|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154775738|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775739|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775740|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775741|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154775742|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154775743|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775744|NCT02339844|Aripiprazole|aripiprazole|mesh-list
154775745|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
154775746|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154775747|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154775748|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154775749|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775750|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775751|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
154775752|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
154775753|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775754|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775755|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154775756|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154775757|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
154775758|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154775759|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154775760|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154775761|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154775762|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
154775763|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154775764|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775765|NCT02331576|Fentanyl|fentanyl|mesh-list
154775766|NCT02331576|Ropivacaine|ropivacaine|mesh-list
154775767|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
154775768|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
154775769|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775770|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775771|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
154775772|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775773|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154775774|NCT02331576|Narcotics|narcotics|mesh-ancestor
154775775|NCT02331576|Analgesics|analgesics|mesh-ancestor
154775776|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154775777|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154775778|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
154775779|NCT00400803|Bevacizumab|bevacizumab|mesh-list
154775780|NCT00400803|Carboplatin|carboplatin|mesh-list
154775781|NCT00400803|Gemcitabine|gemcitabine|mesh-list
154775782|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154775783|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775784|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154775785|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775786|NCT00400803|Growth Substances|growth substances|mesh-ancestor
154775787|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775788|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775789|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154775790|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
154775791|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775792|NCT04681443|Phenol|phenol|mesh-list
154775793|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154775794|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775795|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
154775796|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154775797|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154775798|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
154775799|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154775800|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154775801|NCT02339142|Prednisolone|prednisolone|mesh-list
154775802|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
154775803|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154775804|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
154775805|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775806|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
154775807|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
154775808|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775809|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775810|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775811|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
154775812|NCT02339142|Hormones|hormones|mesh-ancestor
154775813|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775814|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154775815|NCT02339142|Protective Agents|protective agents|mesh-ancestor
154775816|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154775817|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775818|NCT00362817|Carboplatin|carboplatin|mesh-list
154775819|NCT00362817|Temozolomide|temozolomide|mesh-list
154775820|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775821|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154775822|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
154775823|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775824|NCT02338830|Progesterone|progesterone|mesh-list
154775825|NCT02338830|Progestins|progestins|mesh-ancestor
154775826|NCT02338830|Hormones|hormones|mesh-ancestor
154775827|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775828|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775829|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154775830|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154775831|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775832|NCT00364377|Incretins|incretins|mesh-ancestor
154775833|NCT00364377|Hormones|hormones|mesh-ancestor
154775834|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775835|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154775836|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
154775837|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775838|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775839|NCT02338674|Tenofovir|tenofovir|mesh-list
154775840|NCT02338674|Telbivudine|telbivudine|mesh-list
154775841|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
154775842|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775843|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154775844|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154775845|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775846|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775847|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154775848|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154775849|NCT01826838|Dasatinib|dasatinib|mesh-list
154775850|NCT01826838|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154775851|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154775852|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775853|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775854|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126677|NCT03861052|Hormones|hormones|mesh-ancestor
154775855|NCT00365391|Bevacizumab|bevacizumab|mesh-list
154775856|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154775857|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154775858|NCT00365391|Antibodies|antibodies|mesh-list
154775859|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
154775860|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154775861|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775862|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154775863|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775864|NCT00365391|Growth Substances|growth substances|mesh-ancestor
154775865|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775866|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775867|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
154775868|NCT00365391|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154775869|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154775870|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775871|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775873|NCT03105180|Sorbitol|sorbitol|mesh-list
154775874|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154775875|NCT03105180|Diuretics|diuretics|mesh-ancestor
154775876|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
154775877|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775878|NCT03105180|Cathartics|cathartics|mesh-ancestor
154775879|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154775880|NCT02331030|Ropivacaine|ropivacaine|mesh-list
154775881|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
154775882|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
154775883|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775884|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775885|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
154775886|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775887|NCT04270929|Folfirinox|folfirinox|mesh-list
154775888|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775889|NCT00401817|Bevacizumab|bevacizumab|mesh-list
154775890|NCT00401817|Rituximab|rituximab|mesh-list
154775891|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154775892|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775893|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154775894|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154775895|NCT00401817|Growth Substances|growth substances|mesh-ancestor
154775896|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775897|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
154775898|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
154775899|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775900|NCT04417179|Bupivacaine|bupivacaine|mesh-list
154775901|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
154775902|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
154775903|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775904|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775905|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
154775906|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775907|NCT02330796|Bucillamine|bucillamine|mesh-list
154775908|NCT02330796|Colchicine|colchicine|mesh-list
154775909|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
154380539|NCT05821517|Methoxyflurane|methoxyflurane|mesh-list
154775910|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154775911|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
154775912|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
154775913|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
154775914|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775915|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775916|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154775917|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154775918|NCT02330796|Analgesics|analgesics|mesh-ancestor
154775919|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
154775920|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775921|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775922|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154775923|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
154775924|NCT02330796|Protective Agents|protective agents|mesh-ancestor
154775925|NCT02330640|Clopidogrel|clopidogrel|mesh-list
154775926|NCT02330640|Ticagrelor|ticagrelor|mesh-list
154775927|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154775928|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154775929|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154775930|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154775931|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
154775932|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775933|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775934|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775935|NCT02335398|Methadone|methadone|mesh-list
154775936|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154775937|NCT02335398|Narcotics|narcotics|mesh-ancestor
154775938|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775939|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775940|NCT02335398|Analgesics|analgesics|mesh-ancestor
154775941|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
154775942|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154775943|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
154775944|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
154775946|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775947|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775948|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
154775949|NCT02338050|Immunotoxins|immunotoxins|mesh-ancestor
154775950|NCT02338050|Immunoconjugates|immunoconjugates|mesh-ancestor
154775951|NCT02338050|Immunologic Factors|immunologic factors|mesh-ancestor
154775952|NCT02338050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775953|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154775954|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154775955|NCT02330406|Anagliptin|anagliptin|mesh-list
154775956|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154775957|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775958|NCT02330406|Incretins|incretins|mesh-ancestor
154775959|NCT02330406|Hormones|hormones|mesh-ancestor
154775960|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154775961|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154775962|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
154775963|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154775964|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775965|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
154775966|NCT02337972|Povidone|povidone|mesh-list
154775967|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
154775968|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
154775969|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154775970|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154775971|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
154775972|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
154775973|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
154775974|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775975|NCT02335164|Coagulants|coagulants|mesh-ancestor
154775976|NCT00365859|Aripiprazole|aripiprazole|mesh-list
154775977|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
154775978|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154775979|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154775980|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154775981|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154775982|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154775983|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
154775984|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
154775985|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154775986|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775987|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154775988|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154775989|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
154775990|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154775991|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154775992|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154775993|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154775994|NCT02337426|Temozolomide|temozolomide|mesh-list
154775995|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154775996|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154775997|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
154775998|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154775999|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776000|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776001|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776002|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
154776003|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776004|NCT00407355|Ranibizumab|ranibizumab|mesh-list
154776005|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154776006|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154776007|NCT00407355|Growth Substances|growth substances|mesh-ancestor
154776008|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776009|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
154776010|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776011|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154776012|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154776013|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
154776014|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776015|NCT02334462|Antacids|antacids|mesh-ancestor
154776016|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776017|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776018|NCT03144882|Curcumin|curcumin|mesh-list
154776019|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154776020|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154776021|NCT03144882|Analgesics|analgesics|mesh-ancestor
154776022|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
154776023|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776024|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776025|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776026|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776027|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776028|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776029|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776030|NCT01793259|Methotrexate|methotrexate|mesh-list
154776031|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154776032|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
154776033|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154776034|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776035|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154776036|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
154776037|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776038|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776039|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776040|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776041|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154776042|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776043|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
154776044|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776045|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154776046|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154776047|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154776048|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776049|NCT03111810|Prednisolone|prednisolone|mesh-list
154776050|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154776051|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
154776052|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154776053|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
154776054|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154776055|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
154776056|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776057|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
154776058|NCT03111810|Hormones|hormones|mesh-ancestor
154776059|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154776060|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776061|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154776062|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776063|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
154776064|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
154776065|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776066|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776067|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154776068|NCT03111810|Protective Agents|protective agents|mesh-ancestor
154776069|NCT02334150|Sufentanil|sufentanil|mesh-list
154776070|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154776071|NCT02334150|Narcotics|narcotics|mesh-ancestor
154776072|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776073|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776074|NCT02334150|Analgesics|analgesics|mesh-ancestor
154776075|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
154776076|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776077|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154776078|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154776079|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
154776080|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
154776081|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154776082|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154776083|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154776084|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776085|NCT04477590|Metformin|metformin|mesh-list
154776086|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154776087|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776088|NCT02333838|Fludarabine|fludarabine|mesh-list
154776089|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
154776090|NCT02333838|Busulfan|busulfan|mesh-list
154776091|NCT02333838|Thiotepa|thiotepa|mesh-list
154776092|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776093|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154776094|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
154776095|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776096|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776097|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
154776098|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776099|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
154776100|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154776101|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154776102|NCT02326584|Cytarabine|cytarabine|mesh-list
154776103|NCT02326584|Daunorubicin|daunorubicin|mesh-list
154776104|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154776105|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
154776106|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776107|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776108|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
154776109|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776110|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776111|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
154776112|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776113|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154776114|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154776115|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154776116|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776117|NCT03111342|Lidocaine|lidocaine|mesh-list
154776118|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
154776119|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
154776120|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776121|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776122|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
154776123|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776124|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154776125|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154776126|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154776127|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154776128|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776129|NCT03111420|Clopidogrel|clopidogrel|mesh-list
154776130|NCT03111420|Ticagrelor|ticagrelor|mesh-list
154776131|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154776132|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154776133|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154776134|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154776135|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154776136|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
154776137|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776138|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776139|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776140|NCT02333682|Vitamin D|vitamin d|mesh-list
154776141|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
154776142|NCT02333682|Calcifediol|calcifediol|mesh-list
154776143|NCT02333682|Vitamins|vitamins|mesh-ancestor
154776144|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
154776145|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776146|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154776147|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154776148|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154776149|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154776150|NCT02326350|Aspirin|aspirin|mesh-list
154776151|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154776152|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154776153|NCT02326350|Analgesics|analgesics|mesh-ancestor
154776154|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
154126998|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
154776155|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776156|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776157|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776158|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776159|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154776160|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154776161|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776162|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154776163|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154776164|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776165|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
154776166|NCT02326194|Vaccines|vaccines|mesh-list
154776167|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
154776168|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776169|NCT02326038|Methylphenidate|methylphenidate|mesh-list
154776170|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154776171|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776172|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154776173|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154776174|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154776175|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776176|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
154776177|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776178|NCT00970866|Folic Acid|folic acid|mesh-list
154776179|NCT00970866|Micronutrients|micronutrients|mesh-list
154776180|NCT00970866|Trace Elements|trace elements|mesh-list
154776181|NCT00970866|Hematinics|hematinics|mesh-ancestor
154776182|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
154776183|NCT00970866|Vitamins|vitamins|mesh-ancestor
154776184|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776185|NCT03145584|Bupivacaine|bupivacaine|mesh-list
154776186|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
154776187|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
154776188|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776189|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776190|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
154776191|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776192|NCT03145194|Ticagrelor|ticagrelor|mesh-list
154776193|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154776194|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154776195|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154776196|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154776197|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
154776198|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776199|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776200|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776201|NCT03143946|Vitamins|vitamins|mesh-list
154776202|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
154776203|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776204|NCT02039700|Lesinurad|lesinurad|mesh-list
154776205|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
154776206|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776207|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
154776208|NCT05076474|Orlistat|orlistat|mesh-list
154776209|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776210|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776211|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154776212|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154776213|NCT02328144|Metronidazole|metronidazole|mesh-list
154776214|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776215|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154776216|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154776217|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154776218|NCT02327676|Emtricitabine|emtricitabine|mesh-list
154776219|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
154776220|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776221|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154776222|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154776223|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776224|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776225|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154776226|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154776227|NCT02333058|Treosulfan|treosulfan|mesh-list
154776228|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154776229|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
154776230|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776231|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776232|NCT03111186|Acetaminophen|acetaminophen|mesh-list
154776233|NCT03111186|Ibuprofen|ibuprofen|mesh-list
154776234|NCT03111186|Oxycodone|oxycodone|mesh-list
154776235|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154776236|NCT03111186|Analgesics|analgesics|mesh-ancestor
154776237|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
154776238|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776239|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776240|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
154776241|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154776242|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776243|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776244|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154776245|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776246|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776247|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154776248|NCT03111186|Narcotics|narcotics|mesh-ancestor
154776249|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776250|NCT02332512|Apatinib|apatinib|mesh-list
154776251|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776252|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154776253|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776254|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776255|NCT02327754|FYX-051|fyx-051|mesh-list
154776256|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776257|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776258|NCT06103500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154776259|NCT06103500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776260|NCT06103292|Calcium|calcium|mesh-list
154776261|NCT06103292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154776262|NCT06103292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776263|NCT06103279|Empagliflozin|empagliflozin|mesh-list
154776264|NCT06103279|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154776265|NCT06103279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776266|NCT06103279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154776267|NCT06103279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776268|NCT06103266|Rivaroxaban|rivaroxaban|mesh-list
154776269|NCT06103266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154776270|NCT06103266|Antithrombins|antithrombins|mesh-ancestor
154776271|NCT06103266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154776272|NCT06103266|Protease Inhibitors|protease inhibitors|mesh-ancestor
154776273|NCT06103266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776274|NCT06103266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776275|NCT06103266|Anticoagulants|anticoagulants|mesh-ancestor
154776276|NCT06102863|Atorvastatin|atorvastatin|mesh-list
154776277|NCT06102863|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154776278|NCT06102863|Calcium|calcium|mesh-list
154776279|NCT06102863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154776280|NCT06102863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776281|NCT06102863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154776282|NCT06102863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154776283|NCT06102863|Antimetabolites|antimetabolites|mesh-ancestor
154776284|NCT06102863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776285|NCT06102863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154776286|NCT06102863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154776287|NCT06102863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776288|NCT06102707|Apatinib|apatinib|mesh-list
154776289|NCT06102707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776290|NCT06102707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154776291|NCT06102707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776292|NCT06102707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776293|NCT06102525|Valganciclovir|valganciclovir|mesh-list
154776294|NCT06102525|Antiviral Agents|antiviral agents|mesh-ancestor
154776295|NCT06102525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776296|NCT06102460|Caseins|caseins|mesh-list
154776297|NCT06102460|Chelating Agents|chelating agents|mesh-ancestor
154776298|NCT06102460|Sequestering Agents|sequestering agents|mesh-ancestor
154776299|NCT06102460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776300|NCT06102447|Dexamethasone|dexamethasone|mesh-list
154776301|NCT06102447|Palonosetron|palonosetron|mesh-list
154776302|NCT06102447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776303|NCT06102447|Antiemetics|antiemetics|mesh-ancestor
154776304|NCT06102447|Autonomic Agents|autonomic agents|mesh-ancestor
154776305|NCT06102447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776306|NCT06102447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776307|NCT06102447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776308|NCT06102447|Glucocorticoids|glucocorticoids|mesh-ancestor
154776309|NCT06102447|Hormones|hormones|mesh-ancestor
154860420|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154528252|NCT03898154|Dexamethasone|dexamethasone|mesh-list
154776310|NCT06102447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154776311|NCT06102447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154776312|NCT06102447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776313|NCT06102447|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154776314|NCT06102447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154776315|NCT06102447|Serotonin Agents|serotonin agents|mesh-ancestor
154776316|NCT06102447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776317|NCT06102447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776318|NCT06102434|Psilocybin|psilocybin|mesh-list
154776319|NCT06102434|Hallucinogens|hallucinogens|mesh-ancestor
154776320|NCT06102434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776321|NCT06102434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154776322|NCT06102252|Paclitaxel|paclitaxel|mesh-list
154776323|NCT06102252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154776324|NCT06102252|Carboplatin|carboplatin|mesh-list
154776325|NCT06102252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154380961|NCT04246437|Entacapone|entacapone|mesh-list
154776326|NCT06102252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776327|NCT06102252|Tubulin Modulators|tubulin modulators|mesh-ancestor
154776328|NCT06102252|Antimitotic Agents|antimitotic agents|mesh-ancestor
154776329|NCT06102252|Mitosis Modulators|mitosis modulators|mesh-ancestor
154776330|NCT06102252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776331|NCT06102239|Bilirubin|bilirubin|mesh-list
154776332|NCT06102239|Antioxidants|antioxidants|mesh-ancestor
154776333|NCT06102239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776334|NCT06102239|Protective Agents|protective agents|mesh-ancestor
154776335|NCT06102239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776336|NCT06102200|Buprenorphine|buprenorphine|mesh-list
154776337|NCT06102200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154776338|NCT06102200|Narcotics|narcotics|mesh-ancestor
154776339|NCT06102200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776340|NCT06102200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776341|NCT06102200|Analgesics|analgesics|mesh-ancestor
154776342|NCT06102200|Sensory System Agents|sensory system agents|mesh-ancestor
154776343|NCT06102200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776344|NCT06102200|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154776345|NCT06101420|Amoxicillin|amoxicillin|mesh-list
154776346|NCT06101420|Clarithromycin|clarithromycin|mesh-list
154776347|NCT06101420|Levofloxacin|levofloxacin|mesh-list
154776348|NCT06101420|Nitazoxanide|nitazoxanide|mesh-list
154776349|NCT06101420|Esomeprazole|esomeprazole|mesh-list
154776350|NCT06101420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154776351|NCT06101420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776352|NCT06101420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154776353|NCT06101420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776354|NCT06101420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154776355|NCT06101420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776356|NCT06101420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776357|NCT06101420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154776358|NCT06101420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154776359|NCT06101420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154776360|NCT06101420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154776361|NCT06101420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154776362|NCT06101420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154776363|NCT06101420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776364|NCT06101420|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154776365|NCT06101420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154776366|NCT06099821|Apatinib|apatinib|mesh-list
154776367|NCT06099821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776368|NCT06099821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154776369|NCT06099821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776370|NCT06099821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776371|NCT06045299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154776372|NCT06045299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154776373|NCT06045299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154776374|NCT06045299|Aceclidine|aceclidine|mesh-list
154776375|NCT06045299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154776376|NCT06045299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154776377|NCT06045299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154776378|NCT06045299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154776379|NCT06045299|Adrenergic Agents|adrenergic agents|mesh-ancestor
154776380|NCT06045299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776381|NCT06045299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776382|NCT06045299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776383|NCT06045299|Miotics|miotics|mesh-ancestor
154776384|NCT06045299|Autonomic Agents|autonomic agents|mesh-ancestor
154776385|NCT06045299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776386|NCT06045299|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154776387|NCT06044493|Mycophenolic Acid|mycophenolic acid|mesh-list
154776388|NCT06044493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154776389|NCT06044493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776390|NCT06044493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154776391|NCT06044493|Antitubercular Agents|antitubercular agents|mesh-ancestor
154776392|NCT06044493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154776393|NCT06044493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776394|NCT06044493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776395|NCT06044493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776396|NCT05987293|Salicylic Acid|salicylic acid|mesh-list
154776397|NCT05987293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776398|NCT05987293|Antifungal Agents|antifungal agents|mesh-ancestor
154776399|NCT05987293|Keratolytic Agents|keratolytic agents|mesh-ancestor
154776400|NCT05987293|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776401|NCT05941520|Tamoxifen|tamoxifen|mesh-list
154776402|NCT05941520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154776403|NCT05941520|Hormone Antagonists|hormone antagonists|mesh-ancestor
154776404|NCT05941520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154776405|NCT05941520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776406|NCT05941520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154776407|NCT05941520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776408|NCT05941520|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154776409|NCT05941520|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154776410|NCT05941520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154776411|NCT05933395|Everolimus|everolimus|mesh-list
154776412|NCT05933395|Fulvestrant|fulvestrant|mesh-list
154776413|NCT05933395|Neratinib|neratinib|mesh-list
154776414|NCT05933395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154776415|NCT05933395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154776416|NCT05933395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776417|NCT05933395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776418|NCT05933395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776419|NCT05933395|Immunologic Factors|immunologic factors|mesh-ancestor
154776420|NCT05933395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776421|NCT05933395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776422|NCT05933395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154776423|NCT05933395|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154776424|NCT05933395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154776425|NCT05933395|Hormone Antagonists|hormone antagonists|mesh-ancestor
154776426|NCT05933395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154776427|NCT05933395|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154776428|NCT05909800|Fenofibrate|fenofibrate|mesh-list
154776429|NCT05909800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154776430|NCT05909800|Antimetabolites|antimetabolites|mesh-ancestor
154776431|NCT05909800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776432|NCT05909800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154776433|NCT05905055|Cefepime|cefepime|mesh-list
154776434|NCT05905055|Aztreonam|aztreonam|mesh-list
154776435|NCT05905055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154776436|NCT05905055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776437|NCT05782127|Venetoclax|venetoclax|mesh-list
154776438|NCT05782127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776439|NCT05778227|Etidronic Acid|etidronic acid|mesh-list
154776440|NCT05778227|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154776441|NCT05778227|Eusol|eusol|mesh-list
154776442|NCT05778227|Acetic Acid|acetic acid|mesh-list
154776443|NCT05778227|Retinol acetate|retinol acetate|mesh-list
154776444|NCT05778227|Ethylene|ethylene|mesh-list
154776445|NCT05778227|Maleic acid|maleic acid|mesh-list
154776446|NCT05778227|Disinfectants|disinfectants|mesh-ancestor
154776447|NCT05778227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776448|NCT05778227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154776449|NCT05778227|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154776450|NCT05778227|Immunologic Factors|immunologic factors|mesh-ancestor
154776451|NCT05778227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776452|NCT05778227|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154776453|NCT05778227|Protective Agents|protective agents|mesh-ancestor
154776454|NCT05778227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776455|NCT05778227|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154776456|NCT05778227|Growth Substances|growth substances|mesh-ancestor
154776457|NCT05778227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154528395|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776458|NCT05778227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776459|NCT05778227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154776460|NCT05753150|Primaquine|primaquine|mesh-list
154776461|NCT05753150|Tafenoquine|tafenoquine|mesh-list
154776462|NCT05753150|Antimalarials|antimalarials|mesh-ancestor
154776463|NCT05753150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154776464|NCT05753150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154776465|NCT05753150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776466|NCT05636904|Minoxidil|minoxidil|mesh-list
154776467|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154776468|NCT05636904|Dinoprost|dinoprost|mesh-list
154776469|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
154776470|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154776471|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
154776472|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154776473|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
154776474|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154776475|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776476|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
154776477|NCT05630794|TIC10 compound|tic10 compound|mesh-list
154776478|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776479|NCT05590637|Pimavanserin|pimavanserin|mesh-list
154776480|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154776481|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
154776482|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154776483|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154776484|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154776485|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776486|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776487|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154776488|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154776489|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154776490|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154776491|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
154776492|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776493|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776494|NCT05583721|Regadenoson|regadenoson|mesh-list
154776495|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154776496|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154776497|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
154776498|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
154776499|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776500|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776501|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776502|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154776503|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154776504|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776505|NCT05363319|Cemiplimab|cemiplimab|mesh-list
154776506|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154776507|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776508|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154776509|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154776510|NCT05339022|Coal Tar|coal tar|mesh-list
154776511|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
154776512|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776513|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
154776514|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
154776515|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776516|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154776517|NCT05312762|Chitosan|chitosan|mesh-list
154776518|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154776519|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154776520|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
154776521|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776522|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154776523|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
154776524|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
154776525|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
154776526|NCT05312762|Coagulants|coagulants|mesh-ancestor
154776527|NCT05312762|Laxatives|laxatives|mesh-ancestor
154776528|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776529|NCT05275205|Aflibercept|aflibercept|mesh-list
154776530|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154776531|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154776532|NCT05275205|Growth Substances|growth substances|mesh-ancestor
154776533|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154528469|NCT00709059|Ribavirin|ribavirin|mesh-list
154776534|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
154776535|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776536|NCT05253495|Cytarabine|cytarabine|mesh-list
154776537|NCT05253495|Etoposide|etoposide|mesh-list
154776538|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154776539|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776540|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154776541|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154776542|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776543|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776544|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154776545|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
154776546|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
154776547|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776548|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776549|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
154776550|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776551|NCT05224050|Nicotine|nicotine|mesh-list
154776552|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154776553|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
154776554|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776555|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776556|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154776557|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154776558|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
154776559|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776560|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776561|NCT05183646|Propagermanium|propagermanium|mesh-list
154776562|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776563|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
154776564|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
154776565|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776566|NCT05182658|Empagliflozin|empagliflozin|mesh-list
154776567|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154776568|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776569|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154776570|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776571|NCT05154669|Nicotine|nicotine|mesh-list
154776572|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154776573|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
154776574|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776575|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776576|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154776577|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154776578|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
154776579|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776580|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776581|NCT05148234|Decitabine|decitabine|mesh-list
154776582|NCT05148234|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154776583|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154776584|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
154776585|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776586|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776587|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776588|NCT05109312|Acetaminophen|acetaminophen|mesh-list
154776589|NCT05109312|Ibuprofen|ibuprofen|mesh-list
154776590|NCT05109312|Bupivacaine|bupivacaine|mesh-list
154776591|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
154776592|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
154776593|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776594|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776595|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
154776596|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776597|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154776598|NCT05109312|Analgesics|analgesics|mesh-ancestor
154776599|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
154776600|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154776601|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776602|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776603|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154776604|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776605|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776606|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
154776607|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154776608|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154776609|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776610|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
154776611|NCT05075200|Coagulants|coagulants|mesh-ancestor
154776612|NCT05053854|Talazoparib|talazoparib|mesh-list
154776613|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154776614|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776615|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776616|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776617|NCT05030194|Nicotine|nicotine|mesh-list
154776618|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154776619|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
154776620|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381258|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
154776621|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776622|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154776623|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154776624|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
154776625|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776626|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776627|NCT04937413|Evolocumab|evolocumab|mesh-list
154776628|NCT04937413|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154776629|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154776630|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154776631|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
154776632|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776633|NCT04937413|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154776634|NCT04937413|Protease Inhibitors|protease inhibitors|mesh-ancestor
154776635|NCT04937413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776636|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154776637|NCT04880655|Bacitracin|bacitracin|mesh-list
154776638|NCT04880655|Petrolatum|petrolatum|mesh-list
154776639|NCT04880655|Emollients|emollients|mesh-ancestor
154776640|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776641|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154776642|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776643|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154776644|NCT04861987|Capecitabine|capecitabine|mesh-list
154776645|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154776646|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
154776647|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776648|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776649|NCT04827056|Ethanol|ethanol|mesh-list
154776650|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
154776651|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154776652|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776653|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776654|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154776655|NCT04827056|Analgesics|analgesics|mesh-ancestor
154776656|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
154776657|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776658|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154776659|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154776660|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154776661|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
154776662|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776663|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776664|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154776665|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776666|NCT04777422|Defibrotide|defibrotide|mesh-list
154776667|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154776668|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154776669|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776670|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154776671|NCT04691986|Niacinamide|niacinamide|mesh-list
154776672|NCT04691986|Niacin|niacin|mesh-list
154776673|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
154776674|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
154776675|NCT04691986|Vitamins|vitamins|mesh-ancestor
154776676|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
154776677|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776678|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154776679|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
154776680|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776681|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154776682|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
154776683|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154776684|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154528622|NCT03345303|Bortezomib|bortezomib|mesh-list
154776685|NCT04641338|Dipyrone|dipyrone|mesh-list
154776686|NCT04641338|Codeine|codeine|mesh-list
154776687|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154776688|NCT04641338|Narcotics|narcotics|mesh-ancestor
154776689|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776690|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776691|NCT04641338|Analgesics|analgesics|mesh-ancestor
154776692|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
154776693|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776694|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
154776695|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
154776696|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154776697|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154776698|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776699|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776700|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
154776701|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154776702|NCT04491370|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154776703|NCT04491370|Immunoconjugates|immunoconjugates|mesh-ancestor
154776704|NCT04491370|Immunologic Factors|immunologic factors|mesh-ancestor
154776705|NCT04491370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776706|NCT04478474|Ganciclovir|ganciclovir|mesh-list
154776707|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154776708|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
154776709|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776710|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154776711|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776712|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776713|NCT04470817|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154776714|NCT04470817|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154776715|NCT04470817|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154776716|NCT04470817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776717|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
154776718|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154776719|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154776720|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776721|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154776722|NCT04470050|Analgesics|analgesics|mesh-ancestor
154776723|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
154776724|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776725|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154776726|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154776727|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154776728|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
154776729|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776730|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776731|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154776732|NCT04457258|FAPI-46|fapi-46|mesh-list
154776733|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154776734|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776735|NCT04456660|Immunologic Factors|immunologic factors|mesh-list
154776736|NCT04456660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776737|NCT04430894|Dexamethasone|dexamethasone|mesh-list
154776738|NCT04430894|Lenalidomide|lenalidomide|mesh-list
154776739|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776740|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
154776741|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
154776742|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776743|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776744|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776745|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
154776746|NCT04430894|Hormones|hormones|mesh-ancestor
154776747|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154776748|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154776749|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776750|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
154776751|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154776752|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154776753|NCT04430894|Growth Substances|growth substances|mesh-ancestor
154776754|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
154776755|NCT04375384|Cetuximab|cetuximab|mesh-list
154776756|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154776757|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776758|NCT04369664|Atorvastatin|atorvastatin|mesh-list
154776759|NCT04369664|Ezetimibe|ezetimibe|mesh-list
154776760|NCT04369664|Evolocumab|evolocumab|mesh-list
154528696|NCT01603394|Pregabalin|pregabalin|mesh-list
154776761|NCT04369664|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154776762|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154776763|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154776764|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
154776765|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776766|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154776767|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154776768|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776769|NCT04369664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154776770|NCT04369664|Protease Inhibitors|protease inhibitors|mesh-ancestor
154776771|NCT04337580|Omeprazole|omeprazole|mesh-list
154776772|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154776773|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776774|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154776775|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776776|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776777|NCT04308330|Vorinostat|vorinostat|mesh-list
154776778|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776779|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154776780|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776781|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776782|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
154776783|NCT04245722|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154776784|NCT04245722|Rituximab|rituximab|mesh-list
154776785|NCT04245722|Fludarabine|fludarabine|mesh-list
154776786|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
154776787|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776788|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
154776789|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776790|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776791|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154776792|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
154776793|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776794|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776795|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154776796|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154776797|NCT04204772|Charcoal|charcoal|mesh-list
154776798|NCT04204772|Antidotes|antidotes|mesh-ancestor
154776799|NCT04204772|Protective Agents|protective agents|mesh-ancestor
154776800|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776801|NCT04188873|Varenicline|varenicline|mesh-list
154776802|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776803|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776804|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776805|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154776806|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154776807|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
154776808|NCT04126603|Semaglutide|semaglutide|mesh-list
154776809|NCT04126603|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154776810|NCT04126603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154776811|NCT04126603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776812|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
154776813|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154776814|NCT04023071|Rituximab|rituximab|mesh-list
154776815|NCT04023071|Fludarabine|fludarabine|mesh-list
154776816|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
154776817|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776818|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
154776819|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776820|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776821|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154776822|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
154776823|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776824|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776825|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154776826|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154776827|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
154776828|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154776829|NCT03910738|Testosterone|testosterone|mesh-list
154776830|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
154776831|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
154776832|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154776833|NCT03910738|Androgens|androgens|mesh-ancestor
154776834|NCT03910738|Hormones|hormones|mesh-ancestor
154776835|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154776836|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776837|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154776838|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776839|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
154776840|NCT03869996|Cytarabine|cytarabine|mesh-list
154776841|NCT03869996|Methotrexate|methotrexate|mesh-list
154776842|NCT03869996|Etoposide|etoposide|mesh-list
154776843|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154776844|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
154776845|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776846|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776847|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
154776848|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776849|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776850|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
154776851|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776852|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154776853|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154776854|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154776855|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776856|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154776857|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
154776858|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154776859|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776860|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154776861|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776862|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154776863|NCT03785223|Methylphenidate|methylphenidate|mesh-list
154776864|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154776865|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776866|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154776867|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154776868|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154776869|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776870|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
154776871|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776872|NCT03779087|Amoxicillin|amoxicillin|mesh-list
154776873|NCT03779087|Levofloxacin|levofloxacin|mesh-list
154776874|NCT03779087|Ofloxacin|ofloxacin|mesh-list
154776875|NCT03779087|Tetracycline|tetracycline|mesh-list
154776876|NCT03779087|Esomeprazole|esomeprazole|mesh-list
154776877|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154776878|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776879|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154776880|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776881|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154776882|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776883|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776884|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154776885|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154776886|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154776887|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776888|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154776889|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154776890|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154776891|NCT03779074|Amoxicillin|amoxicillin|mesh-list
154776892|NCT03779074|Metronidazole|metronidazole|mesh-list
154776893|NCT03779074|Clarithromycin|clarithromycin|mesh-list
154776894|NCT03779074|Tetracycline|tetracycline|mesh-list
154776895|NCT03779074|Rabeprazole|rabeprazole|mesh-list
154776896|NCT03779074|Bismuth|bismuth|mesh-list
154776897|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154776898|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154776899|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154776900|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154776901|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154776902|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776903|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776904|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154776905|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154776906|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154776907|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776908|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154776909|NCT03779074|Antacids|antacids|mesh-ancestor
154776910|NCT03750786|Leucovorin|leucovorin|mesh-list
154776911|NCT03750786|Antidotes|antidotes|mesh-ancestor
154776912|NCT03750786|Protective Agents|protective agents|mesh-ancestor
154776913|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776914|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
154776915|NCT03750786|Vitamins|vitamins|mesh-ancestor
154776916|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
154776917|NCT03742414|Fluticasone|fluticasone|mesh-list
154776918|NCT03742414|Xhance|xhance|mesh-list
154776919|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776920|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154776921|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
154776922|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776923|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776924|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154776925|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
154776926|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776927|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154776928|NCT03728933|Rotigotine|rotigotine|mesh-list
154776929|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
154776930|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
154776931|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154776932|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776933|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776934|NCT03719105|Dexamethasone|dexamethasone|mesh-list
154776935|NCT03719105|Prednisone|prednisone|mesh-list
154776936|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
154776937|NCT03719105|Ifosfamide|ifosfamide|mesh-list
154776938|NCT03719105|Doxorubicin|doxorubicin|mesh-list
154776939|NCT03719105|Methotrexate|methotrexate|mesh-list
154776940|NCT03719105|Etoposide|etoposide|mesh-list
154776941|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154776942|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154776943|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
154776944|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776945|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154776946|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154776947|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
154776948|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776949|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776950|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154776951|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776952|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
154776953|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
154776954|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154776955|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154776956|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
154776957|NCT03719105|Hormones|hormones|mesh-ancestor
154776958|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154776959|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154776960|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154776961|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154776962|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154776963|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776964|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154776965|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
154776966|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154776967|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154776968|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
154776969|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
154776970|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154776971|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154776972|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154776973|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154776974|NCT03719105|Immunotoxins|immunotoxins|mesh-ancestor
154776975|NCT03719105|Immunoconjugates|immunoconjugates|mesh-ancestor
154776976|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
154776977|NCT03649841|Prednisone|prednisone|mesh-list
154776978|NCT03649841|Cortisone|cortisone|mesh-list
154776979|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
154776980|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
154776981|NCT03649841|Hormones|hormones|mesh-list
154776982|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154776983|NCT03649841|Androgens|androgens|mesh-list
154776984|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
154776985|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154776986|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
154776987|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154776988|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154776989|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154776990|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154776991|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154776992|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154776993|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154776994|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
154776995|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154776996|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
154776997|NCT03649841|Protective Agents|protective agents|mesh-ancestor
154776998|NCT03649841|Vitamins|vitamins|mesh-ancestor
154776999|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
154777000|NCT03649841|Estrogens|estrogens|mesh-ancestor
154777001|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
154777002|NCT03557281|GSK656|gsk656|mesh-list
154777003|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154777004|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777005|NCT03537196|Ribavirin|ribavirin|mesh-list
154777006|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
154777007|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
154777008|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777009|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
154777010|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777011|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
154777012|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154777013|NCT03515304|Evolocumab|evolocumab|mesh-list
154777014|NCT03515304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154777015|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154777016|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154777017|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
154777018|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777019|NCT03515304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154777020|NCT03515304|Protease Inhibitors|protease inhibitors|mesh-ancestor
154777021|NCT03515304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777022|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154777023|NCT03502746|Nivolumab|nivolumab|mesh-list
154777024|NCT03502746|Ramucirumab|ramucirumab|mesh-list
154777025|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777026|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777027|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154777028|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777029|NCT03502746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154777030|NCT03502746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154777031|NCT03502746|Growth Substances|growth substances|mesh-ancestor
154777032|NCT03502746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777033|NCT03502746|Growth Inhibitors|growth inhibitors|mesh-ancestor
154777034|NCT03345797|Testosterone|testosterone|mesh-list
154777035|NCT03345797|Androgens|androgens|mesh-ancestor
154777036|NCT03345797|Hormones|hormones|mesh-ancestor
154777037|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777038|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777039|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
154777040|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154777041|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154777042|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
154777043|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
154777044|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777045|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777046|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
154777047|NCT03260894|Sunitinib|sunitinib|mesh-list
154777048|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777049|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777050|NCT03260894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154777051|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777052|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154777053|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154777054|NCT03260894|Growth Substances|growth substances|mesh-ancestor
154777055|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777056|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
154777057|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777058|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777059|NCT03197935|Paclitaxel|paclitaxel|mesh-list
154777060|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
154777061|NCT03197935|Doxorubicin|doxorubicin|mesh-list
154777062|NCT03197935|Atezolizumab|atezolizumab|mesh-list
154777063|NCT03197935|Antibodies|antibodies|mesh-list
154777064|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154528991|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
154777065|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777066|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
154777067|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
154777068|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
154777069|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777070|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154777071|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
154777072|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777073|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154777074|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154777075|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
154777076|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154777077|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154777078|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154777079|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154777080|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777081|NCT03197935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154777082|NCT03197935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777083|NCT03115151|Fentanyl|fentanyl|mesh-list
154777084|NCT03115151|Hydromorphone|hydromorphone|mesh-list
154777085|NCT03115151|Bupivacaine|bupivacaine|mesh-list
154777086|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
154777087|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
154777088|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777089|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777090|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
154777091|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777092|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154777093|NCT03115151|Narcotics|narcotics|mesh-ancestor
154777094|NCT03115151|Analgesics|analgesics|mesh-ancestor
154777095|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154777096|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154777097|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
154777098|NCT02908685|Risdiplam|risdiplam|mesh-list
154777099|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154777100|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777101|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777102|NCT02845596|Cyclosporine|cyclosporine|mesh-list
154777103|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
154777104|NCT02845596|Methotrexate|methotrexate|mesh-list
154777105|NCT02845596|Fludarabine|fludarabine|mesh-list
154777106|NCT02845596|Cyclosporins|cyclosporins|mesh-list
154777107|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
154777108|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154777109|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154777110|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
154777111|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777112|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154777113|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154777114|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
154777115|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777116|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777117|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154777118|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154777119|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
154777120|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154777121|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154777122|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
154777123|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
154777124|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777125|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154777126|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154777127|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
154777128|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777129|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154777130|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
154777131|NCT02778685|Letrozole|letrozole|mesh-list
154777132|NCT02778685|Fulvestrant|fulvestrant|mesh-list
154777133|NCT02778685|Palbociclib|palbociclib|mesh-list
154777134|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777135|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777136|NCT02778685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154777137|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777138|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154777139|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154777140|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777141|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154777142|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
154860421|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
154777143|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777144|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777145|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154777146|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154777147|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777148|NCT02676739|Adderall|adderall|mesh-list
154777149|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154777150|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777151|NCT02675959|Defibrotide|defibrotide|mesh-list
154777152|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154777153|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154777154|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777155|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154777156|NCT02668562|Ticagrelor|ticagrelor|mesh-list
154777157|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154777158|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154777159|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154777160|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154777161|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
154777162|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777163|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777164|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777166|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
154777167|NCT02646839|Vitamins|vitamins|mesh-ancestor
154777168|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
154777169|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777170|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
154777171|NCT02601313|Fludarabine|fludarabine|mesh-list
154777172|NCT02601313|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154777173|NCT02601313|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154777174|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154777175|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
154777176|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777177|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154777178|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154777179|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
154777180|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777181|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777182|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154777183|NCT02601313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777184|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
154777185|NCT02550652|Prednisone|prednisone|mesh-list
154777186|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
154777187|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
154777188|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154777189|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
154777190|NCT02550652|Hormones|hormones|mesh-ancestor
154381818|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
154777191|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777192|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777193|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154777194|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777195|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154777196|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154777197|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
154777198|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154777199|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777200|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777201|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777202|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
154777203|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
154777204|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777205|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154777206|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154777207|NCT02550652|Protective Agents|protective agents|mesh-ancestor
154777208|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777209|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154777210|NCT02547025|Amoxicillin|amoxicillin|mesh-list
154777211|NCT02547025|Clarithromycin|clarithromycin|mesh-list
154777212|NCT02547025|Levofloxacin|levofloxacin|mesh-list
154777213|NCT02547025|Ofloxacin|ofloxacin|mesh-list
154777214|NCT02547025|Tetracycline|tetracycline|mesh-list
154777215|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154777216|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154777218|NCT02547025|Bismuth|bismuth|mesh-list
154777219|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777220|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
154777221|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154777222|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777223|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777224|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154777225|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154777226|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154777227|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154777228|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154777229|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777230|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154777231|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154777232|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154777233|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154777234|NCT02547025|Antacids|antacids|mesh-ancestor
154777235|NCT02491099|Afatinib|afatinib|mesh-list
154777236|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777237|NCT02491099|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154777238|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777239|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777240|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777241|NCT02484443|Dinutuximab|dinutuximab|mesh-list
154777242|NCT02484443|Sargramostim|sargramostim|mesh-list
154777243|NCT02484443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154777244|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
154777245|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777246|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777247|NCT02422381|Gemcitabine|gemcitabine|mesh-list
154777248|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
154777249|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154777250|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
154777251|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777252|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777253|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777254|NCT02422381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154777255|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
154777256|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154777257|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
154777258|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777259|NCT02371941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154777260|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154777261|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154777262|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
154777263|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
154777264|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777265|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777266|NCT02221310|Immunotoxins|immunotoxins|mesh-ancestor
154777267|NCT02221310|Immunoconjugates|immunoconjugates|mesh-ancestor
154777268|NCT02221310|Immunologic Factors|immunologic factors|mesh-ancestor
154777269|NCT02221310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777270|NCT02140788|Metformin|metformin|mesh-list
154777271|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154777272|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777273|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
154777274|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777275|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777276|NCT02117297|Immunotoxins|immunotoxins|mesh-ancestor
154777277|NCT02117297|Immunoconjugates|immunoconjugates|mesh-ancestor
154777278|NCT02117297|Immunologic Factors|immunologic factors|mesh-ancestor
154777279|NCT02117297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777280|NCT01863745|Nilotinib|nilotinib|mesh-list
154777281|NCT01863745|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154777282|NCT01863745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777283|NCT01863745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777284|NCT01863745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777285|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154777286|NCT01703949|Nivolumab|nivolumab|mesh-list
154777287|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154777288|NCT01703949|Antibodies|antibodies|mesh-list
154777289|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
154777290|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154777291|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
154777292|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
154777293|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777294|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777295|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154777296|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777297|NCT01703949|Immunotoxins|immunotoxins|mesh-ancestor
154777298|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
154777299|NCT01307956|Leucovorin|leucovorin|mesh-list
154777300|NCT01307956|Folic Acid|folic acid|mesh-list
154777301|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154777302|NCT01307956|Panitumumab|panitumumab|mesh-list
154777303|NCT01307956|Fluorouracil|fluorouracil|mesh-list
154777304|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
154777305|NCT01307956|Antibodies|antibodies|mesh-list
154777306|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
154777307|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154777308|NCT01307956|Calcium|calcium|mesh-list
154777309|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
154777310|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
154777311|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777312|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777313|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154777314|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154777315|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
154777316|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777317|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154777318|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154777319|NCT01307956|Antidotes|antidotes|mesh-ancestor
154777320|NCT01307956|Protective Agents|protective agents|mesh-ancestor
154777321|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
154777322|NCT01307956|Vitamins|vitamins|mesh-ancestor
154777323|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
154777324|NCT01307956|Hematinics|hematinics|mesh-ancestor
154777325|NCT01280669|Sirolimus|sirolimus|mesh-list
154777326|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154777327|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777328|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154777329|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777330|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
154777331|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154777332|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
154777333|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777334|NCT01225913|Fluticasone|fluticasone|mesh-list
154777335|NCT01225913|Xhance|xhance|mesh-list
154777336|NCT01225913|Budesonide|budesonide|mesh-list
154777337|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
154777338|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154777339|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154777340|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154777341|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154777342|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154777343|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
154777344|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777345|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777346|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154777347|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
154777348|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
154777349|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154777350|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
154777351|NCT01225913|Hormones|hormones|mesh-ancestor
154777352|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777353|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154777354|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154777355|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154777356|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777357|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777358|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777359|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
154777360|NCT01041027|Paclitaxel|paclitaxel|mesh-list
154777361|NCT01041027|Carboplatin|carboplatin|mesh-list
154777362|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154777363|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381990|NCT05183997|Verapamil|verapamil|mesh-list
154777364|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
154777365|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
154777366|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
154777367|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777368|NCT00669734|Metronidazole|metronidazole|mesh-list
154777369|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
154777370|NCT00669734|Vaccines|vaccines|mesh-list
154777371|NCT00669734|Sargramostim|sargramostim|mesh-list
154777372|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
154777373|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777374|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777375|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777376|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154777377|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154777378|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154777379|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
154777380|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777381|NCT00669734|Protective Agents|protective agents|mesh-ancestor
154777382|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
154777383|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
154777384|NCT00669734|Growth Substances|growth substances|mesh-ancestor
154777385|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154777386|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777387|NCT00576069|Fluticasone|fluticasone|mesh-list
154777388|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
154777389|NCT00576069|Prednisone|prednisone|mesh-list
154777390|NCT00576069|Budesonide|budesonide|mesh-list
154777391|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
154777392|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154777393|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154777394|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154777395|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154777396|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
154777397|NCT00576069|Hormones|hormones|mesh-ancestor
154777398|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777399|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777400|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154777401|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777402|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154777403|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
154777404|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777405|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154777406|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
154777407|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154777408|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154777409|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154777410|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154777411|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154777412|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777413|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777414|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777415|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
154777416|NCT00501150|Linezolid|linezolid|mesh-list
154777417|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154777418|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777419|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154777420|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777421|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777422|NCT00389610|Pancrelipase|pancrelipase|mesh-list
154777423|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154777424|NCT03142620|Vitamin D|vitamin d|mesh-list
154777425|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
154777426|NCT03142620|Amoxicillin|amoxicillin|mesh-list
154777427|NCT03142620|Clarithromycin|clarithromycin|mesh-list
154777428|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
154777429|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154777430|NCT03142620|Esomeprazole|esomeprazole|mesh-list
154777431|NCT03142620|Vitamins|vitamins|mesh-ancestor
154777432|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
154777433|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777434|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154777435|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154777436|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777437|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154777438|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154777439|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154777440|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154777441|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777442|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777443|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154777444|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154529373|NCT05060666|Ivermectin|ivermectin|mesh-list
154777445|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154777446|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154777447|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
154777448|NCT03110952|Vaccines|vaccines|mesh-list
154777449|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
154777450|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777451|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
154777452|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777453|NCT03110952|Protective Agents|protective agents|mesh-ancestor
154777454|NCT03110952|Vitamins|vitamins|mesh-ancestor
154777455|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
154777456|NCT03143244|Ketorolac|ketorolac|mesh-list
154777457|NCT03143244|Midazolam|midazolam|mesh-list
154777458|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
154777459|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154777460|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777461|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777462|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154777463|NCT03143244|Analgesics|analgesics|mesh-ancestor
154777464|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
154777465|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777466|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154777467|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154777468|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154777469|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777470|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777471|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777472|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154777473|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154777474|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154777475|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154777476|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154777477|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
154777478|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
154777479|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
154777480|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
154777481|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154777482|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154777483|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154777484|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154777485|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777486|NCT03838692|Ponatinib|ponatinib|mesh-list
154777487|NCT03838692|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154777488|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777489|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777490|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777491|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777492|NCT03505944|Venetoclax|venetoclax|mesh-list
154777493|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777494|NCT01489189|Ranibizumab|ranibizumab|mesh-list
154777495|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154777496|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154777497|NCT01489189|Growth Substances|growth substances|mesh-ancestor
154777498|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777499|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
154777500|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777501|NCT01549873|Propofol|propofol|mesh-list
154777502|NCT01549873|Desflurane|desflurane|mesh-list
154777503|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154777504|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777505|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777506|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154777507|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
154777508|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
154777509|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154777510|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
154777511|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
154777512|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777513|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
154777514|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777515|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777516|NCT01488487|Everolimus|everolimus|mesh-list
154777517|NCT01488487|Pasireotide|pasireotide|mesh-list
154777518|NCT01488487|Somatostatin|somatostatin|mesh-list
154777519|NCT01488487|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154529451|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
154777520|NCT01488487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777521|NCT01488487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777522|NCT01488487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777523|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154777524|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
154777525|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777526|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777527|NCT01488487|Hormones|hormones|mesh-ancestor
154777528|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777529|NCT03027115|Tamsulosin|tamsulosin|mesh-list
154777530|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154777531|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154777532|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154777533|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777534|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777535|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777536|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777537|NCT03027115|Urological Agents|urological agents|mesh-ancestor
154777538|NCT03026881|Paclitaxel|paclitaxel|mesh-list
154777539|NCT03026881|Apatinib|apatinib|mesh-list
154777540|NCT03026881|Fluzoparib|fluzoparib|mesh-list
154777541|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154777542|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777543|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
154777544|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
154777545|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
154777546|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777547|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777548|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777549|NCT03026881|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154777550|NCT01516879|Atorvastatin|atorvastatin|mesh-list
154777551|NCT01516879|Ezetimibe|ezetimibe|mesh-list
154777552|NCT01516879|Evolocumab|evolocumab|mesh-list
154777553|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154777554|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154777555|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
154777556|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777557|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154777558|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154777559|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777560|NCT01516879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154777561|NCT01516879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154777562|NCT01516879|Protease Inhibitors|protease inhibitors|mesh-ancestor
154777563|NCT01515865|Midodrine|midodrine|mesh-list
154777564|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
154777565|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
154777566|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777567|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777568|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154777569|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154777570|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154777571|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154777572|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777573|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777574|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777575|NCT01547299|Leuprolide|leuprolide|mesh-list
154777576|NCT01547299|Dutasteride|dutasteride|mesh-list
154777577|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154777578|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
154777579|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154777580|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777581|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154777582|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777583|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154777584|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154777585|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777586|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777587|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
154777588|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777589|NCT04072107|Capecitabine|capecitabine|mesh-list
154777590|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154777591|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
154777592|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777593|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154529523|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
154777594|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154777595|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154777596|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777597|NCT00411411|Incretins|incretins|mesh-ancestor
154777598|NCT00411411|Hormones|hormones|mesh-ancestor
154777599|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777600|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154777601|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
154777602|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777603|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777604|NCT01794273|Phenylephrine|phenylephrine|mesh-list
154777605|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
154777606|NCT01794273|Ephedrine|ephedrine|mesh-list
154777607|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154777608|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
154777609|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
154777610|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777611|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777612|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
154777613|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154777614|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
154777615|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
154777616|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154777617|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154777618|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154777619|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777620|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777621|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777622|NCT01794273|Protective Agents|protective agents|mesh-ancestor
154777623|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154777624|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
154777625|NCT01795599|Mifepristone|mifepristone|mesh-list
154777626|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154777627|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
154777628|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154777629|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777630|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154777631|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154777632|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154777633|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
154777634|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154777635|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154777636|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
154777637|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777638|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
154777639|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154777640|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154777641|NCT01794351|Resveratrol|resveratrol|mesh-list
154777642|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
154777643|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777644|NCT01794351|Protective Agents|protective agents|mesh-ancestor
154777645|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777646|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777647|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154777648|NCT04409431|Epinephrine|epinephrine|mesh-list
154777649|NCT04409431|Racepinephrine|racepinephrine|mesh-list
154777650|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
154777651|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154777652|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154777653|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777654|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777655|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777656|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777657|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154777658|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154777659|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
154777660|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777661|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154777662|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
154777663|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
154777664|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
154777665|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154777666|NCT01794507|Dexamethasone|dexamethasone|mesh-list
154777667|NCT01794507|Bortezomib|bortezomib|mesh-list
154529598|NCT02500017|Protective Agents|protective agents|mesh-ancestor
154777668|NCT01794507|Venetoclax|venetoclax|mesh-list
154777669|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154777670|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
154777671|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
154777672|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777673|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777674|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154777675|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
154777676|NCT01794507|Hormones|hormones|mesh-ancestor
154777677|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777678|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154777679|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777680|NCT00412425|Palonosetron|palonosetron|mesh-list
154777681|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
154777682|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
154777683|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777684|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777685|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154777686|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154777687|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154777688|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
154777689|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777690|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777691|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154777692|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154777693|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154777694|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154777695|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
154777696|NCT00415857|Vaccines|vaccines|mesh-list
154777697|NCT00415857|Sargramostim|sargramostim|mesh-list
154777698|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
154777699|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777700|NCT00415857|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154777701|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777702|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777703|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777704|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777705|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
154777706|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777707|NCT03491631|Apatinib|apatinib|mesh-list
154777708|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777709|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154382348|NCT01367652|Letrozole|letrozole|mesh-list
154777710|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777711|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777712|NCT00416793|Carboplatin|carboplatin|mesh-list
154777713|NCT00416793|Bortezomib|bortezomib|mesh-list
154777714|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777715|NCT00417417|Rilonacept|rilonacept|mesh-list
154777716|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154777717|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
154777718|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154777719|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154777720|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
154777721|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777722|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777723|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777724|NCT00420459|Aripiprazole|aripiprazole|mesh-list
154777725|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
154777726|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154777727|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154777728|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154777729|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777730|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777731|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
154777732|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
154777733|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777734|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777735|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154777736|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154777737|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
154777738|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154777739|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154777740|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154777741|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154529686|NCT02238431|Leuprolide|leuprolide|mesh-list
154777742|NCT00420771|Gabapentin|gabapentin|mesh-list
154777743|NCT00420771|Analgesics|analgesics|mesh-ancestor
154777744|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
154777745|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777746|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777747|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
154777748|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154777749|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154777750|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777751|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154777752|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154777753|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154777754|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777755|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777756|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
154777757|NCT00426153|Octreotide|octreotide|mesh-list
154777758|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154777759|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154777760|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777761|NCT04750317|Tofacitinib|tofacitinib|mesh-list
154777762|NCT04750317|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154777763|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777764|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777765|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777766|NCT01996449|Amlodipine|amlodipine|mesh-list
154777767|NCT01996449|Eplerenone|eplerenone|mesh-list
154777768|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154777769|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154777770|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154777771|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777772|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154777773|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777774|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
154777775|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154777776|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
154777777|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777778|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154777779|NCT01996449|Diuretics|diuretics|mesh-ancestor
154777780|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
154777781|NCT00426855|Bortezomib|bortezomib|mesh-list
154777782|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154777783|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777784|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154777785|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
154777786|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777787|NCT01491737|Trastuzumab|trastuzumab|mesh-list
154777788|NCT01491737|Pertuzumab|pertuzumab|mesh-list
154777789|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154777790|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777791|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777792|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154777793|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777794|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777795|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154777796|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
154777797|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777798|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777799|NCT00427557|Rituximab|rituximab|mesh-list
154777800|NCT00427557|Fludarabine|fludarabine|mesh-list
154777801|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
154777802|NCT00427557|Melphalan|melphalan|mesh-list
154777803|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777804|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777805|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
154777806|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777807|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154777808|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154777809|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
154777810|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777811|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154777812|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154777813|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
154777814|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154777815|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
154777816|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777817|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154777818|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777819|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777820|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
154777821|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777822|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777823|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154777825|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154777826|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777827|NCT00427791|Rituximab|rituximab|mesh-list
154777828|NCT00427791|Etoposide|etoposide|mesh-list
154777829|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154777830|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777831|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
154777832|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777833|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154777834|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154777835|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154777836|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154777837|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777838|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777839|NCT01487161|Triamcinolone|triamcinolone|mesh-list
154777840|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154777841|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154777842|NCT01487161|FX006|fx006|mesh-list
154777843|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154777844|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154777845|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
154777846|NCT01487161|Hormones|hormones|mesh-ancestor
154777847|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777848|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777849|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154777850|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
154777851|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777852|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777853|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
154777854|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154777855|NCT00429507|Analgesics|analgesics|mesh-ancestor
154777856|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
154777857|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777858|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777859|NCT01794897|Valacyclovir|valacyclovir|mesh-list
154777860|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
154777861|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777862|NCT01794975|Ketamine|ketamine|mesh-list
154777863|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154777864|NCT01794975|Analgesics|analgesics|mesh-ancestor
154777865|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
154777866|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777867|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777868|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154777869|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154777870|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
154777871|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
154777872|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777873|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154777874|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154777875|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777876|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777877|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154382518|NCT04735965|Narcotics|narcotics|mesh-ancestor
154777878|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154777879|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154777880|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777881|NCT05285787|Menaquinone 7|menaquinone 7|mesh-list
154777882|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
154777883|NCT05285787|Coagulants|coagulants|mesh-ancestor
154777884|NCT01491035|Vortioxetine|vortioxetine|mesh-list
154777885|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
154777886|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154777887|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154777888|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154777889|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777890|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777891|NCT01491035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154777892|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154777893|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154777894|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777895|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777896|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
154777897|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154777898|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154777899|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154777900|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154777901|NCT00375999|Docetaxel|docetaxel|mesh-list
154777902|NCT00375999|Epirubicin|epirubicin|mesh-list
154777903|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777904|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
154777905|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
154777906|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
154777907|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777908|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154777909|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154777910|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154777911|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777912|NCT04409327|Dactolisib|dactolisib|mesh-list
154777913|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154777914|NCT01488071|Vortioxetine|vortioxetine|mesh-list
154777915|NCT01488071|Agomelatine|agomelatine|mesh-list
154777916|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
154777917|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154777918|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154777919|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154777920|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154777921|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777922|NCT01488071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154777923|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154777924|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154777925|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777926|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777927|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
154777928|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154777929|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154777930|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154777931|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154777932|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154777933|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154777934|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154777935|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154777936|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154777937|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777938|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777939|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777940|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154777941|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
154777942|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154777943|NCT01484951|Timolol|timolol|mesh-list
154777944|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154777945|NCT01484951|Brinzolamide|brinzolamide|mesh-list
154777946|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154777947|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154777948|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154777949|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
154777950|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777951|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777952|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777953|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154777954|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154777955|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154777956|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777957|NCT01484873|Exenatide|exenatide|mesh-list
154777958|NCT01484873|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154777959|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154777960|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777961|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154777962|NCT01484873|Incretins|incretins|mesh-ancestor
154777963|NCT01484873|Hormones|hormones|mesh-ancestor
154777964|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154777965|NCT01486927|Factor VIII|factor viii|mesh-list
154777966|NCT01486927|Coagulants|coagulants|mesh-ancestor
154777967|NCT00379197|Naltrexone|naltrexone|mesh-list
154777968|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154777969|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154777970|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777971|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
154777972|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777973|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154777974|NCT01513759|Plasminogen|plasminogen|mesh-list
154777975|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154777976|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154777977|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777978|NCT01484561|Tofacitinib|tofacitinib|mesh-list
154777979|NCT01484561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154777980|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154777981|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154777982|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777983|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
154777984|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154777985|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
154777986|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154777987|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154777988|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154777989|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
154777990|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
154777991|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154777992|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
154777993|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154777994|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154777995|NCT01485991|Simeprevir|simeprevir|mesh-list
154777996|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
154777997|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154777998|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154777999|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778000|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778001|NCT00379821|Azithromycin|azithromycin|mesh-list
154778002|NCT00379821|Artesunate|artesunate|mesh-list
154778003|NCT00379821|Chloroquine|chloroquine|mesh-list
154778004|NCT00379821|Atovaquone|atovaquone|mesh-list
154778005|NCT00379821|Proguanil|proguanil|mesh-list
154778006|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154778007|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154382648|NCT01319370|Minoxidil|minoxidil|mesh-list
154778008|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778009|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
154778010|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154778011|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154778012|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778013|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
154778014|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
154778015|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154778016|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
154778017|NCT00379821|Amebicides|amebicides|mesh-ancestor
154778018|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154778019|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778020|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778021|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
154778022|NCT01482767|Interferons|interferons|mesh-list
154778023|NCT01482767|Ribavirin|ribavirin|mesh-list
154778024|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
154778025|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
154778026|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154778027|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778028|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
154778029|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778030|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
154778031|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778032|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
154778033|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778034|NCT00435591|Conivaptan|conivaptan|mesh-list
154778035|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154778036|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778037|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
154778038|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778039|NCT00439335|Vaccines|vaccines|mesh-list
154778040|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
154778041|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778042|NCT01545817|Everolimus|everolimus|mesh-list
154778043|NCT01545817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154778044|NCT01545817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154778045|NCT01545817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778046|NCT01545817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778047|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778048|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
154778049|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778050|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778051|NCT01512979|Metformin|metformin|mesh-list
154778052|NCT01512979|Linagliptin|linagliptin|mesh-list
154778053|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778054|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778055|NCT01512979|Incretins|incretins|mesh-ancestor
154778056|NCT01512979|Hormones|hormones|mesh-ancestor
154778057|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778058|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154778059|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778060|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778061|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778062|NCT00383565|Romidepsin|romidepsin|mesh-list
154778063|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154778064|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778065|NCT00383565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154778066|NCT00383565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778067|NCT00383565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778068|NCT01512745|Apatinib|apatinib|mesh-list
154778069|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778070|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154778071|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778072|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778073|NCT01478321|Bevacizumab|bevacizumab|mesh-list
154778074|NCT01478321|Temozolomide|temozolomide|mesh-list
154778075|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778076|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778077|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154778078|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154778079|NCT01478321|Growth Substances|growth substances|mesh-ancestor
154778080|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778081|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
154778082|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154778083|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
154778084|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778085|NCT01544491|Everolimus|everolimus|mesh-list
154778086|NCT01544491|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154778087|NCT01544491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154778088|NCT01544491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778089|NCT01544491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778090|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778091|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
154778092|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778093|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778094|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
154778095|NCT00383643|Zolpidem|zolpidem|mesh-list
154778096|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154778097|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154778098|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154778099|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778100|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154778101|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
154778102|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
154778103|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778104|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778105|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154778106|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154778107|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
154778108|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
154778109|NCT00439413|Selegiline|selegiline|mesh-list
154778110|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
154530053|NCT03340701|Progesterone|progesterone|mesh-list
154778111|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154778112|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154778113|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154778114|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154778115|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778116|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778117|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154778118|NCT00439413|Protective Agents|protective agents|mesh-ancestor
154778119|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778121|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154778122|NCT01477853|Glimepiride|glimepiride|mesh-list
154778123|NCT01477853|Atorvastatin|atorvastatin|mesh-list
154778124|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778125|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778126|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154778127|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154778128|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
154778129|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778130|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154778131|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154778132|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778133|NCT01477853|Incretins|incretins|mesh-ancestor
154778134|NCT01477853|Hormones|hormones|mesh-ancestor
154778135|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778136|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154778137|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778138|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154778139|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778140|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
154778141|NCT00440505|Nicotine|nicotine|mesh-list
154778142|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154778143|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
154778144|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778145|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778146|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154778147|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154778148|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
154778149|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778150|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778151|NCT00441285|Albendazole|albendazole|mesh-list
154778152|NCT00441285|Praziquantel|praziquantel|mesh-list
154778153|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
154778154|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154778155|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778156|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
154778157|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154778158|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154778159|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
154778160|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
154778161|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
154778162|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778163|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778164|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154778165|NCT01796613|Desogestrel|desogestrel|mesh-list
154778166|NCT01796613|Etonogestrel|etonogestrel|mesh-list
154778167|NCT01796613|NuvaRing|nuvaring|mesh-list
154778168|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154778169|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154778170|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154778171|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
154778172|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154778173|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778174|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154778175|NCT01796613|Estrogens|estrogens|mesh-ancestor
154778176|NCT01796613|Hormones|hormones|mesh-ancestor
154778177|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778178|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154778179|NCT01796613|Progestins|progestins|mesh-ancestor
154778180|NCT00442611|Abatacept|abatacept|mesh-list
154778181|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154778182|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778183|NCT00442611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778184|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778185|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778186|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
154778187|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778188|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154778189|NCT01511107|Amoxicillin|amoxicillin|mesh-list
154778190|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
154778191|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
154778192|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154778193|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154778194|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778195|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154778196|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382832|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154778197|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778198|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154778199|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
154778200|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778201|NCT00442689|Flutamide|flutamide|mesh-list
154778202|NCT00442689|Drospirenone|drospirenone|mesh-list
154778203|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154778204|NCT00442689|Estradiol|estradiol|mesh-list
154778205|NCT00442689|Estrogens|estrogens|mesh-ancestor
154778206|NCT00442689|Hormones|hormones|mesh-ancestor
154778207|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778208|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778209|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154778210|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
154778211|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154778212|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154778213|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154778214|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154778215|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154778216|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
154778217|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154778218|NCT00442689|Diuretics|diuretics|mesh-ancestor
154778219|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
154778220|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
154778221|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154778222|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778223|NCT01484977|Lacosamide|lacosamide|mesh-list
154778224|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
154778225|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154778226|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154778227|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154778228|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778229|NCT00442767|Insulin|insulin|mesh-list
154778230|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154778231|NCT00442767|Pramlintide|pramlintide|mesh-list
154778232|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
154778233|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778234|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778235|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
154778236|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154778237|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
154778238|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778239|NCT00445263|Tirofiban|tirofiban|mesh-list
154778240|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154778241|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154778242|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778243|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154778244|NCT00389493|Risperidone|risperidone|mesh-list
154778245|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154778246|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
154778247|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778248|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778249|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778250|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154382906|NCT03966339|Hormones|hormones|mesh-list
154778251|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154778252|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154778253|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154778254|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154778255|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
154778256|NCT04388709|Interferons|interferons|mesh-list
154778257|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778258|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
154778259|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778260|NCT00389805|Pemetrexed|pemetrexed|mesh-list
154530204|NCT02497833|Tretinoin|tretinoin|mesh-list
154778261|NCT00389805|Bortezomib|bortezomib|mesh-list
154778262|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778263|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778264|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778265|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154778266|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154778267|NCT00456807|Vaccines|vaccines|mesh-list
154778268|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
154778269|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778270|NCT00456885|Exenatide|exenatide|mesh-list
154778271|NCT00456885|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154778272|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778273|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778274|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154778275|NCT00456885|Incretins|incretins|mesh-ancestor
154778276|NCT00456885|Hormones|hormones|mesh-ancestor
154778277|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778278|NCT01475825|Mipomersen|mipomersen|mesh-list
154778279|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154778280|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154778281|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
154778282|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778283|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154778284|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154778285|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
154778286|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154778287|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154778288|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154778289|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154778290|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778291|NCT01484431|Tadalafil|tadalafil|mesh-list
154778292|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
154778293|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154778294|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154778295|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778296|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778297|NCT01484431|Urological Agents|urological agents|mesh-ancestor
154778298|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
154778299|NCT00445887|Norgestrel|norgestrel|mesh-list
154778300|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154778301|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
154778302|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154778303|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778304|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154778305|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154778306|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154778307|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154778308|NCT01473953|Liraglutide|liraglutide|mesh-list
154129135|NCT00981903|Tinzaparin|tinzaparin|mesh-list
154778309|NCT01473953|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154778310|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778311|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778312|NCT01473953|Incretins|incretins|mesh-ancestor
154778313|NCT01473953|Hormones|hormones|mesh-ancestor
154778314|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778315|NCT00457977|Vaccines|vaccines|mesh-list
154778316|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154778317|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
154778318|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778319|NCT01473563|Pemetrexed|pemetrexed|mesh-list
154778320|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778321|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778322|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778323|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154778324|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154778325|NCT01795209|Ranibizumab|ranibizumab|mesh-list
154778326|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154778327|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154778328|NCT01795209|Growth Substances|growth substances|mesh-ancestor
154778329|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778330|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
154778331|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778332|NCT01484275|Siltuximab|siltuximab|mesh-list
154778333|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778334|NCT01484197|Maleic acid|maleic acid|mesh-list
154778335|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778336|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778337|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
154778338|NCT01473407|Hematinics|hematinics|mesh-ancestor
154778339|NCT04082897|Atezolizumab|atezolizumab|mesh-list
154778340|NCT04082897|Venetoclax|venetoclax|mesh-list
154778341|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
154778342|NCT04082897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154778343|NCT04082897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778344|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778345|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778346|NCT01544179|Pemetrexed|pemetrexed|mesh-list
154778347|NCT01544179|Gefitinib|gefitinib|mesh-list
154778348|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778349|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778350|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778351|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154778352|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154778353|NCT01544179|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154778354|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154778355|NCT01483651|Insulin|insulin|mesh-list
154778356|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154778357|NCT01483651|Glucagon|glucagon|mesh-list
154778358|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778359|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778360|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154778361|NCT01483651|Hormones|hormones|mesh-ancestor
154778362|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778363|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154778364|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154778365|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778366|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778367|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154778368|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154778369|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778370|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
154778371|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778372|NCT01482169|Adenosine|adenosine|mesh-list
154778373|NCT01482169|Regadenoson|regadenoson|mesh-list
154778374|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154778375|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154778376|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
154778377|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
154778378|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778379|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778380|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778381|NCT01482169|Analgesics|analgesics|mesh-ancestor
154778382|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
154778383|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778384|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154778385|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
154778386|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
154778387|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778388|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778389|NCT01509547|Varenicline|varenicline|mesh-list
154778390|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154778391|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154778392|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
154778393|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778394|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778395|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778396|NCT01509079|Vitamin D|vitamin d|mesh-list
154778397|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
154778398|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
154778399|NCT01509079|Vitamins|vitamins|mesh-list
154778400|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
154778401|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778402|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154778403|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154778404|NCT04650217|Levodopa|levodopa|mesh-list
154778405|NCT04650217|Carbidopa|carbidopa|mesh-list
154778406|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154778407|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154778408|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154778409|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
154778410|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860422|NCT01924286|Hormones|hormones|mesh-ancestor
154778411|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778412|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778413|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154778414|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778415|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154778416|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
154778417|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
154778418|NCT01462435|Celecoxib|celecoxib|mesh-list
154778419|NCT01462435|Diclofenac|diclofenac|mesh-list
154778420|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154778421|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154778422|NCT01462435|Analgesics|analgesics|mesh-ancestor
154778423|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
154778424|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778425|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778426|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778427|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154778428|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154778429|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154778430|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778431|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778432|NCT01472081|Nivolumab|nivolumab|mesh-list
154778433|NCT01472081|Ipilimumab|ipilimumab|mesh-list
154778434|NCT01472081|Sunitinib|sunitinib|mesh-list
154778435|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778436|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778437|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154778438|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778439|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154778440|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154778441|NCT01472081|Growth Substances|growth substances|mesh-ancestor
154778442|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778443|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
154778444|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154778445|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778446|NCT01471691|Ranibizumab|ranibizumab|mesh-list
154778447|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154778448|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154778449|NCT01471691|Growth Substances|growth substances|mesh-ancestor
154778450|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778451|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
154778452|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778453|NCT01471379|Milnacipran|milnacipran|mesh-list
154778454|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
154778455|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154778456|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154778457|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154778458|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778459|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778460|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778461|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154778462|NCT01471379|Analgesics|analgesics|mesh-ancestor
154778463|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
154778464|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778465|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
154778466|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154778467|NCT01470989|Triamcinolone|triamcinolone|mesh-list
154778468|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154778469|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154778470|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154778471|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778472|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
154778473|NCT01470989|Hormones|hormones|mesh-ancestor
154778474|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778475|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778476|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778477|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
154778478|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778479|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778480|NCT01470599|Tofacitinib|tofacitinib|mesh-list
154778481|NCT01470599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154778482|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154530421|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154778483|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383125|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154778484|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778485|NCT01469819|Lubiprostone|lubiprostone|mesh-list
154778486|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154778487|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154778488|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778489|NCT04618523|Artesunate|artesunate|mesh-list
154778490|NCT04618523|Lumefantrine|lumefantrine|mesh-list
154778491|NCT04618523|Artemether|artemether|mesh-list
154778492|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154778493|NCT04618523|Amodiaquine|amodiaquine|mesh-list
154778494|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
154778495|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154778496|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154778497|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778498|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778499|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
154778500|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
154778501|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154778502|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
154778503|NCT01507831|Alirocumab|alirocumab|mesh-list
154778504|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154778505|NCT01507831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154778506|NCT01507831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154778507|NCT01507831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154778508|NCT01507831|Antimetabolites|antimetabolites|mesh-ancestor
154778509|NCT01507831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778510|NCT01507831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154778511|NCT01507831|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778512|NCT01507831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778513|NCT01507831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154778514|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
154778515|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778516|NCT01479439|Losartan|losartan|mesh-list
154778517|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154778518|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154778519|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154778520|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154778521|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778522|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
154778523|NCT01478971|Hematinics|hematinics|mesh-ancestor
154778524|NCT01507051|Vitamin K|vitamin k|mesh-list
154778525|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
154778526|NCT01507051|Warfarin|warfarin|mesh-list
154778527|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
154778528|NCT01507051|Vitamins|vitamins|mesh-ancestor
154778529|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
154778530|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778531|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
154778532|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154778533|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
154778534|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154778535|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778536|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778537|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778538|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154778539|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154778540|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
154778541|NCT01507051|Coagulants|coagulants|mesh-ancestor
154778542|NCT04079257|Eculizumab|eculizumab|mesh-list
154778543|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154778544|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778545|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
154778546|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778547|NCT01478113|Amphetamine|amphetamine|mesh-list
154778548|NCT01478113|Adderall|adderall|mesh-list
154778549|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
154778550|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154778551|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778552|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
154778553|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
154778554|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778555|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
154778556|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778557|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778558|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
154778559|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154778560|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154778561|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154778562|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154778563|NCT01506271|Imipenem|imipenem|mesh-list
154778564|NCT01506271|Relebactam|relebactam|mesh-list
154778565|NCT01506271|Cilastatin|cilastatin|mesh-list
154778566|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154778567|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778568|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778569|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778570|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778571|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154778572|NCT01506193|Vaccines|vaccines|mesh-list
154778573|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
154778574|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778575|NCT01505881|Warfarin|warfarin|mesh-list
154778576|NCT01505881|Dabigatran|dabigatran|mesh-list
154778577|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
154778578|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
154778579|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154778580|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778581|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778582|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778583|NCT01505647|Vaccines|vaccines|mesh-list
154778584|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
154778585|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778586|NCT01505491|Adalimumab|adalimumab|mesh-list
154778587|NCT01505491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154778588|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778589|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154778590|NCT01504867|Aspirin|aspirin|mesh-list
154383231|NCT01352559|Milnacipran|milnacipran|mesh-list
154778591|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154778592|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154778593|NCT01504867|Analgesics|analgesics|mesh-ancestor
154778594|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
154778595|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778596|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778597|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778598|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154778599|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154778600|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154778601|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778602|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154778603|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154778604|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778605|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
154778606|NCT01476475|Insulin|insulin|mesh-list
154778607|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154778608|NCT01476475|Metformin|metformin|mesh-list
154778609|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
154778610|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778611|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778612|NCT01460719|Vaccines|vaccines|mesh-list
154778613|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
154778614|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778615|NCT00527943|Vorapaxar|vorapaxar|mesh-list
154778616|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154778617|NCT00448227|Famciclovir|famciclovir|mesh-list
154778618|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
154778619|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778620|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154778621|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778622|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778623|NCT00529191|Atorvastatin|atorvastatin|mesh-list
154778624|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154778625|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154778626|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
154778627|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778628|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154778629|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154778630|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778631|NCT00449007|Bupropion|bupropion|mesh-list
154778632|NCT00449007|Fluoxetine|fluoxetine|mesh-list
154778633|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154778634|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
154778635|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154778636|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154778637|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154383289|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154778638|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154778639|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778640|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
154778641|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778642|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778643|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154778644|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154778645|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778646|NCT00449007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154778647|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
154778648|NCT00460551|Zalutumumab|zalutumumab|mesh-list
154778649|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778650|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778651|NCT01468181|Dulaglutide|dulaglutide|mesh-list
154778652|NCT01468181|Biguanides|biguanides|mesh-list
154778653|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154778654|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
154778655|NCT01468181|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154778656|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778657|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778658|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778659|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778660|NCT01693562|Durvalumab|durvalumab|mesh-list
154778661|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778662|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778663|NCT00461097|Immunomodulating Agents|immunomodulating agents|mesh-list
154778664|NCT00461097|Immunologic Factors|immunologic factors|mesh-ancestor
154778665|NCT00461097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778666|NCT00531453|Thalidomide|thalidomide|mesh-list
154778667|NCT00531453|Dexamethasone|dexamethasone|mesh-list
154778668|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
154778669|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
154778670|NCT00531453|Bortezomib|bortezomib|mesh-list
154778671|NCT00531453|BB 1101|bb 1101|mesh-list
154778672|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778673|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
154778674|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778675|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154778676|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154778677|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
154778678|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778679|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778680|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154778681|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778682|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
154778683|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
154778684|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778685|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154778686|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
154778687|NCT00531453|Hormones|hormones|mesh-ancestor
154778688|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778689|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154778690|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778691|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778692|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
154778693|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154383340|NCT03241888|Megestrol|megestrol|mesh-list
154778694|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778695|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154778696|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154778697|NCT00531453|Growth Substances|growth substances|mesh-ancestor
154778698|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
154778699|NCT00531843|PENTA|penta|mesh-list
154778700|NCT00531843|Fondaparinux|fondaparinux|mesh-list
154778701|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154778702|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
154778703|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154778704|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778705|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778706|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778707|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
154778708|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154778709|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154778710|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154778711|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
154778712|NCT01590758|Pexiganan|pexiganan|mesh-list
154778713|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154778714|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778715|NCT00534417|Capecitabine|capecitabine|mesh-list
154778716|NCT00534417|Fulvestrant|fulvestrant|mesh-list
154778717|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154778718|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
154778719|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778720|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778721|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154778722|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154778723|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154778724|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
154778725|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778726|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778727|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
154778728|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154778729|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154778730|NCT01692626|Analgesics|analgesics|mesh-ancestor
154778731|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
154778732|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778733|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778734|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778735|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154778736|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
154778737|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778738|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
154778739|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154778740|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778741|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778742|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154778743|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154778744|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778745|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778746|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
154778747|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778748|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778749|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154778750|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778751|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778752|NCT01475461|Incretins|incretins|mesh-ancestor
154778753|NCT01475461|Hormones|hormones|mesh-ancestor
154778754|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778755|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154383396|NCT01353339|Ofloxacin|ofloxacin|mesh-list
154778756|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778757|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778758|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778759|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154778760|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
154778761|NCT01589822|Coagulants|coagulants|mesh-ancestor
154778762|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154778763|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154778764|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154778765|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
154778766|NCT01474993|Sulforaphane|sulforaphane|mesh-list
154778767|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154778768|NCT01474993|Protective Agents|protective agents|mesh-ancestor
154778769|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778770|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778771|NCT01691768|Tenofovir|tenofovir|mesh-list
154778772|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
154778773|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778774|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154778775|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154778776|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778777|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778778|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154778779|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154778780|NCT01503229|Prednisone|prednisone|mesh-list
154778781|NCT01503229|Cortisone|cortisone|mesh-list
154778782|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
154778783|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778784|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
154778785|NCT01503229|Hormones|hormones|mesh-ancestor
154778786|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778787|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778788|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154778789|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778790|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154778791|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778792|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778793|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
154778794|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154778795|NCT01460407|Clarithromycin|clarithromycin|mesh-list
154778796|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154778797|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778798|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154778799|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778800|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778801|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154778802|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154778803|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
154778804|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778805|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
154778806|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154778807|NCT01588496|Evolocumab|evolocumab|mesh-list
154778808|NCT01588496|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154778809|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154778810|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154778811|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
154778812|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778813|NCT01588496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154778814|NCT01588496|Protease Inhibitors|protease inhibitors|mesh-ancestor
154778815|NCT01588496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778816|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154778817|NCT01502293|Interleukin-12|interleukin-12|mesh-list
154778818|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154778819|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
154778820|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778821|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154778822|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154778823|NCT01502293|Growth Substances|growth substances|mesh-ancestor
154778824|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
154778825|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778826|NCT01588184|Bevacizumab|bevacizumab|mesh-list
154778827|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154383454|NCT03238612|Oseltamivir|oseltamivir|mesh-list
154778828|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778829|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154778830|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154778831|NCT01588184|Growth Substances|growth substances|mesh-ancestor
154778832|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778833|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
154778834|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154778835|NCT01564862|Vortioxetine|vortioxetine|mesh-list
154778836|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154778837|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154778838|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154778839|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778840|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778841|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778842|NCT01564862|Analgesics|analgesics|mesh-ancestor
154778843|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
154778844|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778845|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
154778846|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154778847|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
154778848|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154778849|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154778850|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154778851|NCT01564862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154778852|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
154778853|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154778854|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154778855|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154778856|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154778857|NCT01467479|Interferons|interferons|mesh-list
154778858|NCT01467479|Ribavirin|ribavirin|mesh-list
154778859|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
154778860|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
154778861|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154778862|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154778863|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778864|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
154778865|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778866|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
154778867|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778868|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
154778869|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778870|NCT01466387|Vaccines|vaccines|mesh-list
154778871|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
154778872|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778873|NCT00535743|Bromides|bromides|mesh-list
154778874|NCT00535743|Rocuronium|rocuronium|mesh-list
154778875|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
154778876|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154778877|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154778878|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154778879|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778880|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778881|NCT01564784|Cytarabine|cytarabine|mesh-list
154778882|NCT01564784|Fludarabine|fludarabine|mesh-list
154778883|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
154778884|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154778885|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778886|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154778887|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
154778888|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778889|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778890|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
154778891|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778892|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
154778893|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154778894|NCT01564784|Analgesics|analgesics|mesh-ancestor
154778895|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
154778896|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778897|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154778898|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154778899|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778900|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778901|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154778902|NCT01564784|Immunotoxins|immunotoxins|mesh-ancestor
154778903|NCT01564784|Immunoconjugates|immunoconjugates|mesh-ancestor
154778904|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
154778905|NCT00536601|Melphalan|melphalan|mesh-list
154778906|NCT00536601|Busulfan|busulfan|mesh-list
154778907|NCT00536601|Thiotepa|thiotepa|mesh-list
154778908|NCT00536601|Carmustine|carmustine|mesh-list
154778909|NCT00536601|Carboplatin|carboplatin|mesh-list
154778910|NCT00536601|Etoposide|etoposide|mesh-list
154778911|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
154778912|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778913|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
154778914|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778915|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154778916|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154778917|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
154778918|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778919|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778920|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154778921|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154778922|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154778923|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154778924|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778925|NCT00536913|Budesonide|budesonide|mesh-list
154778926|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
154778927|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154778928|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154778929|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154778930|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
154778931|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778932|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778933|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154778934|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
154778935|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
154778936|NCT00536913|Hormones|hormones|mesh-ancestor
154530893|NCT03073070|Biotin|biotin|mesh-list
154778937|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154778938|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154778939|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154778940|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154778941|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
154778942|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778943|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778944|NCT00462423|Bevacizumab|bevacizumab|mesh-list
154778945|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154778946|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778947|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778948|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154778949|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154778950|NCT00462423|Growth Substances|growth substances|mesh-ancestor
154778951|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778952|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
154778953|NCT00461331|Insulin|insulin|mesh-list
154778954|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154778955|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
154778956|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
154778957|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154778958|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
154778959|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154778960|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778961|NCT00462735|Fluorouracil|fluorouracil|mesh-list
154778962|NCT00462735|Cetuximab|cetuximab|mesh-list
154778963|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
154778964|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
154778965|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778966|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154778967|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778968|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154778969|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
154778970|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778971|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778972|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
154778973|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154778974|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154778975|NCT01690988|Ketamine|ketamine|mesh-list
154778976|NCT01690988|Analgesics|analgesics|mesh-ancestor
154778977|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
154778978|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154778979|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778980|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154778981|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154778982|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
154778983|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
154778984|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154778985|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154778986|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154778987|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154778988|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154778989|NCT00463437|Vaccines|vaccines|mesh-list
154778990|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154778991|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
154778992|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778993|NCT01466153|Rituximab|rituximab|mesh-list
154778994|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154778995|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154778996|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154778997|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
154778998|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154778999|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154779000|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154779001|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
154779002|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779003|NCT00464685|Dexamethasone|dexamethasone|mesh-list
154779004|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154779005|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
154779006|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
154779007|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779008|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779009|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154779010|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
154779011|NCT00464685|Hormones|hormones|mesh-ancestor
154530955|NCT03325335|Midazolam|midazolam|mesh-list
154779012|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779013|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154779014|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779015|NCT01465997|Lacosamide|lacosamide|mesh-list
154779016|NCT01465997|Carbamazepine|carbamazepine|mesh-list
154779017|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
154779018|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154779019|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154779020|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779021|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779022|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
154779023|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154779024|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779025|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779026|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154779027|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154779028|NCT01465997|Analgesics|analgesics|mesh-ancestor
154779029|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
154779030|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779031|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154779032|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154779033|NCT00538863|Fentanyl|fentanyl|mesh-list
154779034|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154779035|NCT00538863|Narcotics|narcotics|mesh-ancestor
154779036|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779037|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779038|NCT00538863|Analgesics|analgesics|mesh-ancestor
154779039|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
154779040|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779041|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154779042|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154779043|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
154779044|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
154779045|NCT01465763|Tofacitinib|tofacitinib|mesh-list
154779046|NCT01465763|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154779047|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154779048|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779049|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779050|NCT00540579|Gemcitabine|gemcitabine|mesh-list
154779051|NCT00540579|Pomalidomide|pomalidomide|mesh-list
154779052|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154779053|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
154779054|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779055|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779056|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
154779057|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779058|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154779059|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154779060|NCT00540579|Growth Substances|growth substances|mesh-ancestor
154779061|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
154779062|NCT01690520|Cyclosporine|cyclosporine|mesh-list
154779063|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
154779064|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
154779065|NCT01690520|Thiotepa|thiotepa|mesh-list
154779066|NCT01690520|Fludarabine|fludarabine|mesh-list
154779067|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
154779068|NCT01690520|Cyclosporins|cyclosporins|mesh-list
154779069|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154779070|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
154779071|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779072|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154779073|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154779074|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
154779075|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779076|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779077|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154779078|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154779079|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
154779080|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779081|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
154779082|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779083|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
154779084|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154779085|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154779086|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154779087|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
154779088|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154779089|NCT00541671|Promethazine|promethazine|mesh-list
154779090|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
154779091|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
154383731|NCT03234400|Dapivirine|dapivirine|mesh-list
154779092|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154779093|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
154779094|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
154779095|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779096|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779097|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779098|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154779099|NCT01563536|Ritonavir|ritonavir|mesh-list
154779100|NCT01563536|Ribavirin|ribavirin|mesh-list
154779101|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154779102|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154779103|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
154779104|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779105|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779106|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154779107|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154779108|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
154779109|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779110|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154779111|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154779112|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
154779113|NCT01690052|Pilocarpine|pilocarpine|mesh-list
154779114|NCT01690052|Cevimeline|cevimeline|mesh-list
154779115|NCT01690052|Miotics|miotics|mesh-ancestor
154779116|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
154779117|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779118|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779119|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154779120|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154779121|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
154779122|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779123|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779124|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154779125|NCT01689974|Ipilimumab|ipilimumab|mesh-list
154779126|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154779127|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779128|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154779129|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779130|NCT04750083|Carboplatin|carboplatin|mesh-list
154779131|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
154779132|NCT04750083|Pemetrexed|pemetrexed|mesh-list
154779133|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779134|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154779135|NCT04750083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154779136|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779137|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779138|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154779139|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154779140|NCT02954991|Nivolumab|nivolumab|mesh-list
154779141|NCT02954991|Mocetinostat|mocetinostat|mesh-list
154779142|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154779143|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779144|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154779145|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779146|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154779147|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779148|NCT00470301|Paclitaxel|paclitaxel|mesh-list
154779149|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
154779150|NCT00470301|Doxorubicin|doxorubicin|mesh-list
154779151|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154779152|NCT00470301|Tipifarnib|tipifarnib|mesh-list
154779153|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154779154|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779155|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
154779156|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
154779157|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
154531105|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779158|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779159|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154779160|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
154779161|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779162|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154779163|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154779164|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
154779165|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154779166|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154779167|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154779168|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154779169|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779170|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154779171|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
154779172|NCT00544713|Glycerol|glycerol|mesh-list
154779173|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154779174|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154779175|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154779176|NCT00544713|Protective Agents|protective agents|mesh-ancestor
154779177|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779178|NCT00544713|Laxatives|laxatives|mesh-ancestor
154779179|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154779180|NCT00545181|Metronidazole|metronidazole|mesh-list
154779181|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779182|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154779183|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154779184|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154779185|NCT01797315|Sirolimus|sirolimus|mesh-list
154779186|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154779187|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779188|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154779189|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779190|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
154779191|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154779192|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
154779193|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779194|NCT00471705|Miltefosine|miltefosine|mesh-list
154779195|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154779196|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
154779197|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779198|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779199|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154779200|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154779201|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
154779202|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154779203|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
154779204|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779205|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779206|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
154779207|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779208|NCT01458535|Ritonavir|ritonavir|mesh-list
154779209|NCT01458535|Ribavirin|ribavirin|mesh-list
154779210|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154779211|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154779212|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
154779213|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779214|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779215|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154779216|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154779217|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
154779218|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779219|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154779220|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154779221|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
154779222|NCT01464827|Ritonavir|ritonavir|mesh-list
154779223|NCT01464827|Ribavirin|ribavirin|mesh-list
154779224|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154779225|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154779226|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
154779227|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779228|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779229|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154779230|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154779231|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
154779232|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779233|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154779234|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154779235|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
154779236|NCT01463111|Lamotrigine|lamotrigine|mesh-list
154779237|NCT01463111|Valproic Acid|valproic acid|mesh-list
154531178|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
154779238|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154779239|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779240|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779241|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
154779242|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154779243|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779244|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779245|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
154779246|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154779247|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779248|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779249|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154779250|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154779251|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
154779252|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779253|NCT01463033|Levetiracetam|levetiracetam|mesh-list
154779254|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
154779255|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
154779256|NCT01461551|Propofol|propofol|mesh-list
154779257|NCT01461551|Sevoflurane|sevoflurane|mesh-list
154779258|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154779259|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779260|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779261|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154779262|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
154779263|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
154779264|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154779265|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154779266|NCT01460381|Quinidine|quinidine|mesh-list
154779267|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
154779268|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154779269|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154779270|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
154779271|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779272|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779273|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779274|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154779275|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
154779276|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154779277|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154779278|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779279|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779280|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154779281|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154779282|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
154779283|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154779284|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154779285|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779286|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154779287|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154779288|NCT00546897|Lenalidomide|lenalidomide|mesh-list
154779289|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
154779290|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779291|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154779292|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154779293|NCT00546897|Growth Substances|growth substances|mesh-ancestor
154779294|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
154779295|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779296|NCT00474123|Simvastatin|simvastatin|mesh-list
154779297|NCT00474123|Ezetimibe|ezetimibe|mesh-list
154779298|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154779299|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154779300|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
154779301|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779302|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154779303|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154779304|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779305|NCT00474201|Ritonavir|ritonavir|mesh-list
154779306|NCT00474201|Lopinavir|lopinavir|mesh-list
154779307|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
154779308|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154779309|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154779310|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
154779311|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779312|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779313|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154531256|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
154779314|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154779315|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
154779316|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779317|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154779318|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154779319|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154779320|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
154779321|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154779322|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154779324|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154779325|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154779326|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383964|NCT03228862|Vitamins|vitamins|mesh-ancestor
154779327|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
154779328|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
154779329|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
154779330|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154779331|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154779332|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154779333|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779334|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779335|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
154779336|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779337|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779338|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154779339|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779340|NCT00475215|Rocuronium|rocuronium|mesh-list
154779341|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154779342|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154779343|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154779344|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779345|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779346|NCT00477087|Molgramostim|molgramostim|mesh-list
154779347|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
154779348|NCT00477087|Sargramostim|sargramostim|mesh-list
154779349|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
154779350|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779351|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779352|NCT00477087|Analgesics|analgesics|mesh-ancestor
154779353|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
154779354|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779355|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154779356|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154779357|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779358|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779359|NCT04409912|Sirolimus|sirolimus|mesh-list
154779360|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154779361|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779362|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154779363|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779364|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
154779365|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154779366|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
154779367|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779368|NCT01473589|Vitamin D|vitamin d|mesh-list
154779369|NCT01473589|Teriparatide|teriparatide|mesh-list
154779370|NCT01473589|Calcium|calcium|mesh-list
154779371|NCT01473589|Vitamins|vitamins|mesh-ancestor
154779372|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
154779373|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779374|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779375|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154779376|NCT00478335|Calcitonin|calcitonin|mesh-list
154779377|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
154779378|NCT00478335|Indomethacin|indomethacin|mesh-list
154779379|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154779380|NCT00478335|Amiloride|amiloride|mesh-list
154779381|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
154779382|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154779383|NCT00478335|Katacalcin|katacalcin|mesh-list
154779384|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
154779385|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154779386|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154779387|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779388|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779389|NCT00478335|Urological Agents|urological agents|mesh-ancestor
154779390|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154779391|NCT00478335|Diuretics|diuretics|mesh-ancestor
154779392|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
154779393|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779394|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154779395|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779396|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154779397|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154779398|NCT00478335|Analgesics|analgesics|mesh-ancestor
154779399|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
154779400|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779401|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154779402|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154779403|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
154779404|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
154779405|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154779406|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154779407|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154779408|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154779409|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154779410|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154779411|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779412|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154779413|NCT00478569|Hormones|hormones|mesh-list
154779414|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
154779415|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779416|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779417|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779418|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
154779419|NCT00479037|Hormones|hormones|mesh-list
154779420|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
154779421|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779422|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779423|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779424|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154779425|NCT02985229|Misoprostol|misoprostol|mesh-list
154779426|NCT02985229|Mifepristone|mifepristone|mesh-list
154779427|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154779428|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
154779429|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154779430|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779431|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154779432|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154779433|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
154779434|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154779435|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154779436|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154779437|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154779438|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
154779439|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154779440|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154779441|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
154779442|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779443|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
154779444|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154779445|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154779446|NCT00479115|Plerixafor|plerixafor|mesh-list
154779447|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154779448|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154779449|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
154779450|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779451|NCT01472965|Ethanol|ethanol|mesh-list
154779452|NCT01472965|Heparin|heparin|mesh-list
154779453|NCT01472965|Calcium heparin|calcium heparin|mesh-list
154779454|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
154779455|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154779456|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154779457|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779458|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154779459|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779460|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779461|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779462|NCT00480987|Cytarabine|cytarabine|mesh-list
154779463|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
154779464|NCT00480987|Fludarabine|fludarabine|mesh-list
154779465|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
154779466|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779467|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154779468|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
154779469|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779470|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154779471|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
154779472|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779473|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
154779474|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779475|NCT01457053|Torsemide|torsemide|mesh-list
154779476|NCT01457053|Furosemide|furosemide|mesh-list
154779477|NCT01457053|Bumetanide|bumetanide|mesh-list
154779478|NCT01457053|Diuretics|diuretics|mesh-list
154779479|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154779480|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
154779481|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779482|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779483|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779484|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154779485|NCT00481845|Anastrozole|anastrozole|mesh-list
154779486|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154779487|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779488|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154779489|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154779490|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779491|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779492|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154779493|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
154779494|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779495|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779496|NCT01472185|Ranolazine|ranolazine|mesh-list
154779497|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154779498|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779499|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779500|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154779501|NCT00482625|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154779502|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154779503|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779504|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779505|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779506|NCT00553839|Ketamine|ketamine|mesh-list
154779507|NCT00553839|Analgesics|analgesics|mesh-ancestor
154779508|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
154779509|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779510|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779511|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154779512|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154779513|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
154779514|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
154779515|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779516|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154779517|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154779518|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779519|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779520|NCT00554463|Etoposide|etoposide|mesh-list
154779521|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779522|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154779523|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154779524|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154779525|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779526|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779527|NCT00554853|Pioglitazone|pioglitazone|mesh-list
154779528|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
154779529|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154779530|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779531|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
154779532|NCT00556491|Minocycline|minocycline|mesh-list
154779533|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154779534|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779535|NCT00485433|Epinephrine|epinephrine|mesh-list
154531477|NCT02483325|Busulfan|busulfan|mesh-list
154779536|NCT00485433|Bupivacaine|bupivacaine|mesh-list
154779537|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
154779538|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
154779539|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779540|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779541|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
154779542|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779543|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154779544|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154779545|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
154779546|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779547|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779548|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154779549|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154779550|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
154779551|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154779552|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
154779553|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
154779554|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
154779555|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154779556|NCT02850081|Atorvastatin|atorvastatin|mesh-list
154779557|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154779558|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154779559|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154779560|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
154779561|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779562|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154779563|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779564|NCT01456039|Romidepsin|romidepsin|mesh-list
154779565|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154779566|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779567|NCT01456039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154779568|NCT01456039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779569|NCT01456039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779570|NCT01455415|Pregabalin|pregabalin|mesh-list
154779571|NCT01455415|Analgesics|analgesics|mesh-ancestor
154779572|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
154779573|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779574|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779575|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
154779576|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154779577|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779578|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779579|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779580|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154779581|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154779582|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779583|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154779584|NCT01471171|Bromides|bromides|mesh-list
154779585|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
154779586|NCT01471093|Rebamipide|rebamipide|mesh-list
154779587|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154779588|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154779589|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154779590|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154779591|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
154779592|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779593|NCT01471093|Protective Agents|protective agents|mesh-ancestor
154779594|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779595|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779596|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
154779597|NCT01471015|Hematinics|hematinics|mesh-ancestor
154779598|NCT01470469|Guanfacine|guanfacine|mesh-list
154779599|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154779600|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154779601|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154779602|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154779603|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
154779604|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384263|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779605|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779606|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779607|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
154779608|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154779609|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154531577|NCT03317847|Bromfenac|bromfenac|mesh-list
154779610|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
154779611|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779612|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779613|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779614|NCT01470001|Urological Agents|urological agents|mesh-ancestor
154779615|NCT01469377|Cariprazine|cariprazine|mesh-list
154779616|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154779617|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154779618|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779619|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779620|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154779621|NCT01469221|Apaziquone|apaziquone|mesh-list
154779622|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779623|NCT01453855|Travoprost|travoprost|mesh-list
154779624|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154779625|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154779626|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154779627|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
154779628|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
154779629|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779630|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779631|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
154779632|NCT01469065|Vitamins|vitamins|mesh-ancestor
154779633|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
154779634|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779635|NCT01586156|Carvedilol|carvedilol|mesh-list
154779636|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154779637|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154779638|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
154779639|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779640|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779641|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779642|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154779643|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
154779644|NCT01586156|Protective Agents|protective agents|mesh-ancestor
154779645|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154779646|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779647|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779648|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
154779649|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154384313|NCT03747341|Analgesics|analgesics|mesh-ancestor
154779650|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154779651|NCT01459913|Interferons|interferons|mesh-list
154779652|NCT01459913|Ribavirin|ribavirin|mesh-list
154779653|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
154779654|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
154779655|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154779656|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779657|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
154779658|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779659|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
154779660|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779661|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
154779662|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779663|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154779664|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154779665|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154779666|NCT01458275|Ciclesonide|ciclesonide|mesh-list
154779667|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
154779668|NCT01458275|Hormones|hormones|mesh-ancestor
154779669|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779670|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779671|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154779672|NCT02334527|Palbociclib|palbociclib|mesh-list
154779673|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779674|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154779675|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779676|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779677|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154779678|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154779679|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154779680|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154779681|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779682|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154779683|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154779684|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384361|NCT04318535|Griseofulvin|griseofulvin|mesh-list
154779685|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779686|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
154779687|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779688|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
154779689|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154779690|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154779691|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154779692|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779693|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154779694|NCT01456169|Diuretics|diuretics|mesh-ancestor
154779695|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
154779696|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779697|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154779698|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779699|NCT01453595|Dactolisib|dactolisib|mesh-list
154779700|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779701|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154779702|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154779703|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779704|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154779705|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
154779706|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779707|NCT04124198|Nimorazole|nimorazole|mesh-list
154779708|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154779709|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154779710|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154779711|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779712|NCT01453205|Rituximab|rituximab|mesh-list
154779713|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154779714|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779715|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
154779716|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779717|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154779718|NCT01453049|Glimepiride|glimepiride|mesh-list
154779719|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
154779720|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154779721|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154779722|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779723|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154779724|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
154779725|NCT01452347|Warfarin|warfarin|mesh-list
154779726|NCT01452347|Dabigatran|dabigatran|mesh-list
154779727|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
154779728|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
154779729|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154779730|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
154779731|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779732|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779733|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154779734|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
154779735|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779736|NCT01451723|Protective Agents|protective agents|mesh-ancestor
154779737|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779738|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154779739|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154779740|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779741|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154779742|NCT01451645|Colchicine|colchicine|mesh-list
154779743|NCT01451645|Allopurinol|allopurinol|mesh-list
154779744|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
154779745|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154779746|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
154779747|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
154779748|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
154779749|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779750|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779751|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
154779752|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779753|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154779754|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
154779755|NCT01451645|Protective Agents|protective agents|mesh-ancestor
154779756|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779757|NCT01450007|Dexamethasone|dexamethasone|mesh-list
154779758|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
154779759|NCT01450007|Ropivacaine|ropivacaine|mesh-list
154779760|NCT01450007|BB 1101|bb 1101|mesh-list
154779761|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154779762|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
154779763|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
154779764|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779765|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779766|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154779767|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
154779768|NCT01450007|Hormones|hormones|mesh-ancestor
154779769|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779770|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154779771|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779772|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
154779773|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779774|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779775|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
154779776|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
154779777|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779778|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
154779779|NCT01496365|Pregabalin|pregabalin|mesh-list
154779780|NCT01496365|Analgesics|analgesics|mesh-ancestor
154779781|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
154779782|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779783|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779784|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
154779785|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154779786|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779787|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779788|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779789|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154779790|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154779791|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779792|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154779793|NCT01468987|Insulin|insulin|mesh-list
154779794|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154779795|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
154779796|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
154779797|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154779798|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779799|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154779800|NCT01687712|Hormones|hormones|mesh-ancestor
154779801|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779802|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779803|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
154779804|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154779805|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154779806|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154779807|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779808|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779809|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
154779810|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779811|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779812|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154779813|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779814|NCT01453153|Gemcitabine|gemcitabine|mesh-list
154779815|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154779816|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
154779817|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779818|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779819|NCT01584440|Quinidine|quinidine|mesh-list
154779820|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
154779821|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
154779822|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
154779823|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154779824|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154779825|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779826|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779827|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779828|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154779829|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154779830|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
154779831|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154779832|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
154779833|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154779834|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154779835|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154779836|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779837|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154779838|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154779839|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
154779840|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154779841|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154779842|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779843|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154384502|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154779844|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154779846|NCT01687478|Fluoxetine|fluoxetine|mesh-list
154779847|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
154779848|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
154779849|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779850|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779851|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154779852|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154779853|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154779854|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779855|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154779856|NCT01687478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154779857|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154779858|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154779859|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779860|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779861|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
154779862|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154779863|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
154779864|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154779865|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154779866|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779867|NCT01468909|Paclitaxel|paclitaxel|mesh-list
154779868|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154779869|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154779870|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779871|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
154779872|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
154779873|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
154779874|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779875|NCT01687166|Acifluorfen|acifluorfen|mesh-list
154779876|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779877|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779878|NCT01561976|Metformin|metformin|mesh-list
154779879|NCT01561976|Glimepiride|glimepiride|mesh-list
154779880|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154779881|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779882|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154779883|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154779884|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
154779885|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154779886|NCT01686932|Vildagliptin|vildagliptin|mesh-list
154779887|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154779888|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779889|NCT01686932|Incretins|incretins|mesh-ancestor
154779890|NCT01686932|Hormones|hormones|mesh-ancestor
154779891|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154779892|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154779893|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
154779894|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779895|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779896|NCT01468207|Adalimumab|adalimumab|mesh-list
154779897|NCT01468207|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154779898|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154779899|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154779900|NCT03026725|Calcium|calcium|mesh-list
154779901|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154779902|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779903|NCT01686152|Imiquimod|imiquimod|mesh-list
154779904|NCT01686152|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154779905|NCT01686152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154531853|NCT02482155|Analgesics|analgesics|mesh-ancestor
154779906|NCT01686152|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154779907|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
154779908|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779909|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154779910|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779911|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
154779912|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154779913|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154779914|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154779915|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779916|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779917|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154779918|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154779919|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154779920|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
154779921|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779922|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779923|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154779924|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154779925|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
154779926|NCT01452529|Hydrocodone|hydrocodone|mesh-list
154779927|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154779928|NCT01452529|Narcotics|narcotics|mesh-ancestor
154779929|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779930|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779931|NCT01452529|Analgesics|analgesics|mesh-ancestor
154384605|NCT04393493|Diuretics|diuretics|mesh-ancestor
154779932|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
154779933|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779934|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
154779935|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
154779936|NCT01685606|Immunomodulating Agents|immunomodulating agents|mesh-list
154779937|NCT01685606|Immunologic Factors|immunologic factors|mesh-ancestor
154779938|NCT01685606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779939|NCT01685372|Vaccines|vaccines|mesh-list
154779940|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
154779941|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779942|NCT01685138|Ceritinib|ceritinib|mesh-list
154779943|NCT01685138|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154779944|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154779945|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779946|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779947|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779948|NCT01685060|Ceritinib|ceritinib|mesh-list
154779949|NCT01685060|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154779950|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154779951|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154779952|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779953|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154779954|NCT01684202|Tolvaptan|tolvaptan|mesh-list
154779955|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154779956|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779957|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
154779958|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779959|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154779960|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
154779961|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779962|NCT01683266|Insulin|insulin|mesh-list
154779963|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154779964|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
154779965|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154779966|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779967|NCT01467661|Anagrelide|anagrelide|mesh-list
154779968|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154779969|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154779970|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779971|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154779972|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154779973|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154779974|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154779975|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154779976|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779977|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154779978|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154779979|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154779980|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
154779981|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384645|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
154779982|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154779983|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154779984|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154779985|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
154779987|NCT01559012|Analgesics|analgesics|mesh-ancestor
154779988|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
154779989|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154779990|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154779991|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154779992|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
154779993|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
154779994|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154779995|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154779996|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154779997|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
154779998|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154779999|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780000|NCT01451827|Tolvaptan|tolvaptan|mesh-list
154780001|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154780002|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780003|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
154780004|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780005|NCT01557920|Propofol|propofol|mesh-list
154780006|NCT01557920|Sevoflurane|sevoflurane|mesh-list
154780007|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154780008|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154780009|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780010|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154780011|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
154780012|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
154780013|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154780014|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154780015|NCT01467583|PENTA|penta|mesh-list
154780016|NCT01467583|Fondaparinux|fondaparinux|mesh-list
154780017|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154780018|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
154780019|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154780020|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
154780021|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780022|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780023|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
154780024|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154780025|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154780026|NCT01576718|Fluticasone|fluticasone|mesh-list
154780027|NCT01576718|Xhance|xhance|mesh-list
154780028|NCT01576718|Albuterol|albuterol|mesh-list
154780029|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
154780030|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154780031|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154780032|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
154780033|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780034|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780035|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154780036|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
154780037|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
154780038|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154780039|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
154780040|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154780041|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154780042|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154780043|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
154780044|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780045|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780046|NCT01493557|Pantoprazole|pantoprazole|mesh-list
154780047|NCT01493557|Dabigatran|dabigatran|mesh-list
154780048|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
154780049|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154780050|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
154780051|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780052|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780053|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
154780054|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154532005|NCT02481609|Antidotes|antidotes|mesh-ancestor
154780055|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780056|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154780057|NCT01451749|Donepezil|donepezil|mesh-list
154780058|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154780059|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780060|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780061|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
154780062|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780063|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780064|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
154780065|NCT01576484|Alirocumab|alirocumab|mesh-list
154780066|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154780067|NCT01576484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154780068|NCT01576484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154780069|NCT01576484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154780070|NCT01576484|Antimetabolites|antimetabolites|mesh-ancestor
154780071|NCT01576484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780072|NCT01576484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154780073|NCT01576484|Protease Inhibitors|protease inhibitors|mesh-ancestor
154780074|NCT01576484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780075|NCT01576484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154780076|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
154780077|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780078|NCT01467505|Interferons|interferons|mesh-list
154780079|NCT01467505|Ribavirin|ribavirin|mesh-list
154780080|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
154780081|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
154780082|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154780083|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154780084|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780085|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
154780086|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780087|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
154780088|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780089|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
154780090|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780091|NCT01449929|Ritonavir|ritonavir|mesh-list
154780092|NCT01449929|Darunavir|darunavir|mesh-list
154780093|NCT01449929|Dolutegravir|dolutegravir|mesh-list
154384774|NCT03203356|Hormones|hormones|mesh-list
154780094|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154780095|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154780096|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
154780097|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780098|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780099|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154780100|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154780101|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
154780102|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780103|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154780104|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154780105|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154780106|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154780107|NCT01451515|Cytarabine|cytarabine|mesh-list
154780108|NCT01451515|Dexamethasone|dexamethasone|mesh-list
154780109|NCT01451515|Prednisone|prednisone|mesh-list
154780110|NCT01451515|Prednisolone|prednisolone|mesh-list
154780111|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
154780112|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
154780113|NCT01451515|Doxorubicin|doxorubicin|mesh-list
154780114|NCT01451515|Methotrexate|methotrexate|mesh-list
154780115|NCT01451515|Etoposide|etoposide|mesh-list
154780116|NCT01451515|Vincristine|vincristine|mesh-list
154780117|NCT01451515|Daunorubicin|daunorubicin|mesh-list
154780118|NCT01451515|Asparaginase|asparaginase|mesh-list
154780119|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
154780120|NCT01451515|Clofarabine|clofarabine|mesh-list
154780121|NCT01451515|Pegaspargase|pegaspargase|mesh-list
154780122|NCT01451515|Thioguanine|thioguanine|mesh-list
154780123|NCT01451515|Antimetabolites|antimetabolites|mesh-list
154780124|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154780125|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
154780126|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780127|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154780128|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154780129|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
154780130|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780131|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780132|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154780133|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154780134|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
154780135|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
154780136|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780137|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780138|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
154780139|NCT01451515|Hormones|hormones|mesh-ancestor
154780140|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780141|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154780142|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154780143|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154780144|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154780145|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780146|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154780147|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
154780148|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154780149|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154780150|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
154780151|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154780152|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154780153|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154780154|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
154780155|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780156|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
154780157|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
154780158|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
154780159|NCT01576406|Crizotinib|crizotinib|mesh-list
154780160|NCT01576406|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154780161|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154780162|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780163|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780164|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780165|NCT01576172|Prednisone|prednisone|mesh-list
154780166|NCT01576172|Cortisone|cortisone|mesh-list
154780167|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
154780168|NCT01576172|Veliparib|veliparib|mesh-list
154780169|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154780170|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
154780171|NCT01576172|Hormones|hormones|mesh-ancestor
154780172|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780173|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780174|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154780175|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780176|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154780177|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780178|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780179|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
154780180|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154780181|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154780182|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
154780183|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
154780184|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780185|NCT01541930|Metronidazole|metronidazole|mesh-list
154780186|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780187|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154780188|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154780189|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154780190|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
154780191|NCT03028298|Citric Acid|citric acid|mesh-list
154780192|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
154780193|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
154780194|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154780195|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
154780196|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
154780197|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780198|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
154780199|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154780200|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154780201|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780202|NCT03028298|Urological Agents|urological agents|mesh-ancestor
154780203|NCT01540838|Acetaminophen|acetaminophen|mesh-list
154780204|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154780205|NCT01540838|Analgesics|analgesics|mesh-ancestor
154780206|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
154780207|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780208|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780209|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
154780210|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
154780212|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154780213|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
154780214|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154780215|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780216|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154780217|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
154780218|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780219|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780220|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
154780221|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780222|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154780223|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154780224|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
154780225|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154780226|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154780227|NCT01451203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154780228|NCT01451203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154780229|NCT01556438|Dexamethasone|dexamethasone|mesh-list
154780230|NCT01556438|Bortezomib|bortezomib|mesh-list
154780231|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154780232|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
154780233|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
154780234|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780235|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780236|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780237|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
154780238|NCT01556438|Hormones|hormones|mesh-ancestor
154780239|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780240|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154780241|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780242|NCT02073487|Paclitaxel|paclitaxel|mesh-list
154780243|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154780244|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154780245|NCT02073487|Trastuzumab|trastuzumab|mesh-list
154780246|NCT02073487|Pertuzumab|pertuzumab|mesh-list
154780247|NCT02073487|Lapatinib|lapatinib|mesh-list
154780248|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154780249|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780250|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
154780251|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
154780252|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
154780253|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780254|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780255|NCT02073487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154780256|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154780257|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780258|NCT02073487|Immunotoxins|immunotoxins|mesh-ancestor
154780259|NCT02073487|Immunoconjugates|immunoconjugates|mesh-ancestor
154780260|NCT02073487|Immunologic Factors|immunologic factors|mesh-ancestor
154780261|NCT02073487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780262|NCT01466491|Lidocaine|lidocaine|mesh-list
154780263|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
154780264|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
154780265|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154780266|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780267|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
154780268|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780269|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154780270|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154780271|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154780272|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154780273|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780274|NCT01466179|Blinatumomab|blinatumomab|mesh-list
154780275|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780276|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
154780277|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154780278|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780279|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780280|NCT01450813|Bromides|bromides|mesh-list
154780281|NCT01450813|Rocuronium|rocuronium|mesh-list
154780282|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
154780283|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154780284|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154780285|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154780286|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780287|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780288|NCT01539512|Rituximab|rituximab|mesh-list
154780289|NCT01539512|Idelalisib|idelalisib|mesh-list
154780290|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780291|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780292|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
154780293|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780294|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154780295|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780296|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780297|NCT01449955|Sirolimus|sirolimus|mesh-list
154780298|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154780299|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780300|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154780301|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780302|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
154780303|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154780304|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
154780305|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780306|NCT01574612|Acyclovir|acyclovir|mesh-list
154780307|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
154780308|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154780309|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
154780310|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780311|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
154780312|NCT01573910|Ofloxacin|ofloxacin|mesh-list
154780313|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154780314|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154780315|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154780316|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780317|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154780318|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154780319|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780320|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780321|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780322|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154780323|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154780324|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154780325|NCT01491919|Lisinopril|lisinopril|mesh-list
154780326|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154780327|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
154780328|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780329|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780330|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154780331|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154780332|NCT01491919|Protective Agents|protective agents|mesh-ancestor
154780333|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780334|NCT01573442|Testosterone|testosterone|mesh-list
154780335|NCT01573442|Androgens|androgens|mesh-ancestor
154780336|NCT01573442|Hormones|hormones|mesh-ancestor
154780337|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780338|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780339|NCT02319369|Azacitidine|azacitidine|mesh-list
154780340|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154780341|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
154780342|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780343|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780344|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780345|NCT01491841|Rituximab|rituximab|mesh-list
154780346|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154780347|NCT01491841|Pixantrone|pixantrone|mesh-list
154780348|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780349|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780350|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
154780351|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780352|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154780353|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154780354|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
154780355|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780356|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154780357|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154780358|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780359|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
154780360|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154780361|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780362|NCT01553318|Ketotifen|ketotifen|mesh-list
154780363|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
154780364|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
154780365|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154780366|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
154780367|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
154780368|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780369|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780370|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780371|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154780372|NCT01572740|Liraglutide|liraglutide|mesh-list
154780373|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154780374|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780375|NCT01572740|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154780376|NCT01572740|Incretins|incretins|mesh-ancestor
154780377|NCT01572740|Hormones|hormones|mesh-ancestor
154780378|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780379|NCT01491607|Vaccines|vaccines|mesh-list
154780380|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
154780381|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780382|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
154780383|NCT02338713|Antacids|antacids|mesh-ancestor
154780384|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780385|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780386|NCT00557349|Omeprazole|omeprazole|mesh-list
154780387|NCT00557349|Famotidine|famotidine|mesh-list
154780388|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154780389|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780390|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154780391|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780392|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780393|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154780394|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
154780395|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
154780396|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780397|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780398|NCT01553084|Nicotine|nicotine|mesh-list
154780399|NCT01553084|Varenicline|varenicline|mesh-list
154780400|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154780401|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
154780402|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780403|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780404|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154780405|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154780406|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
154780407|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780408|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780409|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
154780410|NCT01552928|Anagrelide|anagrelide|mesh-list
154780411|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154780412|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780413|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154780414|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154780415|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780416|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780417|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780418|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154780419|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154780420|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154780421|NCT01448707|Ritonavir|ritonavir|mesh-list
154780422|NCT01448707|Darunavir|darunavir|mesh-list
154780423|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154780424|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154780425|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
154780426|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780427|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780428|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154780429|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154780430|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
154780431|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780432|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154780433|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154780434|NCT01536704|Nicotine|nicotine|mesh-list
154780435|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154780436|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
154780437|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780438|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780439|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154780440|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154780441|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
154780442|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780443|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780445|NCT04108676|Omeprazole|omeprazole|mesh-list
154780446|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154780447|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780448|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154780449|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780450|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780451|NCT04108676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154780452|NCT04108676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780453|NCT01552772|Aripiprazole|aripiprazole|mesh-list
154780454|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
154780455|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154780456|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154780457|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154385119|NCT03416348|Ethanol|ethanol|mesh-list
154780458|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154780459|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780460|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
154780461|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
154780462|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780463|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780464|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154780465|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154780466|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
154780467|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154780468|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154780469|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154780470|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154780471|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154780472|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154780473|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780474|NCT01552694|Incretins|incretins|mesh-ancestor
154780475|NCT01552694|Hormones|hormones|mesh-ancestor
154780476|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780477|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154780478|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
154780479|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780480|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780481|NCT01464931|Denosumab|denosumab|mesh-list
154780482|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154780483|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780484|NCT01536392|Ondansetron|ondansetron|mesh-list
154780485|NCT01536392|Granisetron|granisetron|mesh-list
154780486|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
154780487|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
154780488|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780489|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780490|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780491|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
154780492|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
154780493|NCT01536392|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154780494|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154780495|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
154780496|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780497|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780498|NCT04767295|Paclitaxel|paclitaxel|mesh-list
154780499|NCT04767295|Carboplatin|carboplatin|mesh-list
154780500|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154780501|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780502|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
154780503|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
154780504|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
154780505|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780506|NCT02118831|Bevacizumab|bevacizumab|mesh-list
154780507|NCT02118831|Ranibizumab|ranibizumab|mesh-list
154780508|NCT02118831|Aflibercept|aflibercept|mesh-list
154780509|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780510|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780511|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154780512|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154780513|NCT02118831|Growth Substances|growth substances|mesh-ancestor
154780514|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780515|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
154780516|NCT00490269|Dronabinol|dronabinol|mesh-list
154780517|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
154780518|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780519|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154780520|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154780521|NCT00490269|Analgesics|analgesics|mesh-ancestor
154780522|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
154780523|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780524|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154780525|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154780526|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780527|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780528|NCT00490269|Hormones|hormones|mesh-ancestor
154780529|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780530|NCT05621499|Lenvatinib|lenvatinib|mesh-list
154780531|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780532|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154780533|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780534|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780535|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
154780536|NCT01490125|Albuterol|albuterol|mesh-list
154780537|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
154780538|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154780539|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
154780540|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780541|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780542|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154780543|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
154780544|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
154780545|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154780546|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
154780547|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780548|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780549|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
154780550|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154780551|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154780552|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154780553|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154780554|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
154780555|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154780556|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154780557|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
154780558|NCT00491751|Atorvastatin|atorvastatin|mesh-list
154780559|NCT00491751|Vitamins|vitamins|mesh-ancestor
154780560|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
154780561|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780562|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154780563|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154780564|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
154780565|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780566|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154780567|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154780568|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780569|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
154780570|NCT00491751|Protective Agents|protective agents|mesh-ancestor
154780571|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154780572|NCT01420549|Simvastatin|simvastatin|mesh-list
154780573|NCT01420549|Ezetimibe|ezetimibe|mesh-list
154780574|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154780575|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154780576|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
154780577|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780578|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154780579|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154780580|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154532534|NCT04177355|Antacids|antacids|mesh-ancestor
154780581|NCT01440595|Ribavirin|ribavirin|mesh-list
154780582|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154780583|NCT01440595|Grazoprevir|grazoprevir|mesh-list
154780584|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
154780585|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780586|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
154780587|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780588|NCT05560035|Lidocaine|lidocaine|mesh-list
154780589|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
154780590|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
154780591|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154780592|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780593|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
154780594|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780595|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154780596|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154780597|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154780598|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154780599|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780600|NCT00497055|Aripiprazole|aripiprazole|mesh-list
154780601|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
154780602|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154780603|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154780604|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154780605|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154780606|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780607|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
154780608|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
154780609|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780610|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780611|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154780612|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154780613|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
154780614|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154780615|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154780616|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154780617|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154780618|NCT00498615|Fasudil|fasudil|mesh-list
154780619|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154780620|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385291|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154780621|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780622|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154780623|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780624|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
154780625|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154780626|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780627|NCT00498927|Temozolomide|temozolomide|mesh-list
154780628|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154780629|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
154780630|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780631|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780632|NCT00499473|Sunitinib|sunitinib|mesh-list
154780633|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780634|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154780635|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154780636|NCT00499473|Growth Substances|growth substances|mesh-ancestor
154780637|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780638|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
154780639|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154780640|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780641|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780642|NCT00501891|Bevacizumab|bevacizumab|mesh-list
154780643|NCT00501891|Temozolomide|temozolomide|mesh-list
154780644|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780645|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780646|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154780647|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154780648|NCT00501891|Growth Substances|growth substances|mesh-ancestor
154780649|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780650|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
154780651|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154780652|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
154780653|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780654|NCT01798017|Misoprostol|misoprostol|mesh-list
154780655|NCT01798017|Mifepristone|mifepristone|mesh-list
154532613|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
154780656|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154780657|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
154780658|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154780659|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780660|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154780661|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780663|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154780664|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154780665|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154780666|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154780667|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
154780668|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154780669|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154780670|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
154780671|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780672|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
154780673|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154780674|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154780675|NCT00502905|Fludarabine|fludarabine|mesh-list
154780676|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
154780677|NCT00502905|Busulfan|busulfan|mesh-list
154780678|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780679|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154780680|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
154780681|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780682|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154780683|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
154780684|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780685|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
154780686|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154780687|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154780688|NCT00505635|Interferons|interferons|mesh-list
154780689|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
154780690|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
154780691|NCT00505635|Thalidomide|thalidomide|mesh-list
154780692|NCT00505635|Cisplatin|cisplatin|mesh-list
154780693|NCT00505635|Temozolomide|temozolomide|mesh-list
154780694|NCT00505635|Interleukin-2|interleukin-2|mesh-list
154780695|NCT00505635|Vinblastine|vinblastine|mesh-list
154780696|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780697|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
154780698|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780699|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154780700|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
154780701|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780702|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
154780703|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780704|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154780705|NCT00505635|Analgesics|analgesics|mesh-ancestor
154780706|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
154780707|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780708|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154780709|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
154780710|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154780711|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154780712|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154780713|NCT00505635|Growth Substances|growth substances|mesh-ancestor
154780714|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
154780715|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154780716|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
154780717|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
154780718|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
154780719|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154780720|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154780721|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780722|NCT04479813|Moxonidine|moxonidine|mesh-list
154780723|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154780724|NCT04474899|Amlodipine|amlodipine|mesh-list
154780725|NCT04474899|Moxonidine|moxonidine|mesh-list
154780726|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154780727|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154780728|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154780729|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154532685|NCT03029390|Metformin|metformin|mesh-list
154780730|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154780731|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780732|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
154780733|NCT00511173|Warfarin|warfarin|mesh-list
154780734|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
154780735|NCT01447927|Metformin|metformin|mesh-list
154780736|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154780737|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780738|NCT00513747|Rituximab|rituximab|mesh-list
154780739|NCT00513747|Fludarabine|fludarabine|mesh-list
154780740|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
154780741|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780742|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780743|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
154780744|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780745|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154780746|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154780747|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
154780748|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780749|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154780750|NCT00514137|Sunitinib|sunitinib|mesh-list
154780751|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780752|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154780753|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154780754|NCT00514137|Growth Substances|growth substances|mesh-ancestor
154780755|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780756|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
154780757|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154780758|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780759|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780760|NCT00514215|Molgramostim|molgramostim|mesh-list
154780761|NCT00514215|Sargramostim|sargramostim|mesh-list
154780762|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
154780763|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780764|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780765|NCT03912909|Empagliflozin|empagliflozin|mesh-list
154780766|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154780767|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780768|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154780769|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780770|NCT02130063|Iron|iron|mesh-list
154780771|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154780772|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154780773|NCT02130063|Trace Elements|trace elements|mesh-ancestor
154780774|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
154780775|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780776|NCT02130063|Hematinics|hematinics|mesh-ancestor
154780777|NCT00515697|Ramucirumab|ramucirumab|mesh-list
154780778|NCT00515697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154780779|NCT00515697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154780780|NCT00515697|Growth Substances|growth substances|mesh-ancestor
154780781|NCT00515697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780782|NCT00515697|Growth Inhibitors|growth inhibitors|mesh-ancestor
154780783|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780784|NCT00516165|Everolimus|everolimus|mesh-list
154780785|NCT00516165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154780786|NCT00516165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154780787|NCT00516165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385435|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
154780788|NCT00516165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780789|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154780790|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
154780791|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780792|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780793|NCT02132169|Cetirizine|cetirizine|mesh-list
154780794|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154780795|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154780796|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154780797|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
154780798|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
154780799|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780800|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780801|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780802|NCT03174405|Avelumab|avelumab|mesh-list
154780803|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780804|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780805|NCT00522795|Paclitaxel|paclitaxel|mesh-list
154780806|NCT00522795|Cisplatin|cisplatin|mesh-list
154780807|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
154780808|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154780809|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780810|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
154780811|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
154780812|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
154780813|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780814|NCT02871687|Simvastatin|simvastatin|mesh-list
154780815|NCT02871687|Pravastatin|pravastatin|mesh-list
154780816|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154780817|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154780818|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
154780819|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780820|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154780821|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154780822|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780823|NCT00525057|Dalteparin|dalteparin|mesh-list
154780824|NCT00525057|Tinzaparin|tinzaparin|mesh-list
154780825|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154780826|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
154780827|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154780828|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154780829|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780830|NCT00525135|Valproic Acid|valproic acid|mesh-list
154780831|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
154780832|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385512|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
154780833|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780834|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
154780835|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780836|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780837|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
154780838|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154780839|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154780840|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154780841|NCT00525525|Bevacizumab|bevacizumab|mesh-list
154780842|NCT00525525|Temozolomide|temozolomide|mesh-list
154780843|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154780844|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780845|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780846|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154780847|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154780848|NCT00525525|Growth Substances|growth substances|mesh-ancestor
154780849|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780850|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
154780851|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154780852|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
154780853|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780854|NCT00525525|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154780855|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154780856|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780857|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
154780858|NCT00525603|Rituximab|rituximab|mesh-list
154780859|NCT00525603|Fludarabine|fludarabine|mesh-list
154780860|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
154780861|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
154780862|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154780863|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
154780864|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780865|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154780866|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154780867|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
154780868|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780869|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780870|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154780871|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780872|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154780873|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
154780874|NCT00398307|Cisplatin|cisplatin|mesh-list
154780875|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780876|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
154780877|NCT00564447|Azithromycin|azithromycin|mesh-list
154780878|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154780879|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154780880|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154780881|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154780882|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154780883|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780884|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780885|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
154780886|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154780887|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154780888|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154780889|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154780890|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780891|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
154780892|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780893|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780894|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154780895|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780896|NCT00525837|Varenicline|varenicline|mesh-list
154780897|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154780898|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154780899|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
154780900|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780901|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780902|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780903|NCT00527475|Ranibizumab|ranibizumab|mesh-list
154780904|NCT00527475|Verteporfin|verteporfin|mesh-list
154780905|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154780906|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154780907|NCT00527475|Growth Substances|growth substances|mesh-ancestor
154780908|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780909|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
154780910|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780911|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154780912|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154780913|NCT01798251|Capecitabine|capecitabine|mesh-list
154780914|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
154780915|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154780916|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
154780917|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780918|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780919|NCT02121483|Empagliflozin|empagliflozin|mesh-list
154780920|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154780921|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780922|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154780923|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780924|NCT01572038|Paclitaxel|paclitaxel|mesh-list
154780925|NCT01572038|Docetaxel|docetaxel|mesh-list
154780926|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154780927|NCT01572038|Trastuzumab|trastuzumab|mesh-list
154780928|NCT01572038|Pertuzumab|pertuzumab|mesh-list
154780929|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154780930|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780931|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
154780932|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
154780933|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
154780934|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780935|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154780936|NCT01448213|Fluorometholone|fluorometholone|mesh-list
154780937|NCT01448213|Prednisolone|prednisolone|mesh-list
154780938|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154780939|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
154780940|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154780941|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
154780942|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154780943|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
154780944|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154780945|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
154780946|NCT01448213|Hormones|hormones|mesh-ancestor
154780947|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154780948|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780949|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154780950|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154780951|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
154780952|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
154780953|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780954|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780955|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154532910|NCT04263350|Cobicistat|cobicistat|mesh-list
154780956|NCT01448213|Protective Agents|protective agents|mesh-ancestor
154780957|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154780958|NCT01448057|Acetaminophen|acetaminophen|mesh-list
154780959|NCT01448057|Dimethindene|dimethindene|mesh-list
154780960|NCT01448057|Phenylephrine|phenylephrine|mesh-list
154780961|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
154780962|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154780963|NCT01448057|Analgesics|analgesics|mesh-ancestor
154780964|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
154780965|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780966|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780967|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
154780968|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154780969|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154780970|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
154780971|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
154780972|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
154780973|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154780974|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
154780975|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
154780976|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154780977|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154780978|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154780979|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
154780980|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154780981|NCT01448057|Protective Agents|protective agents|mesh-ancestor
154780982|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
154780983|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
154780984|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154780985|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
154780986|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
154780987|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154780988|NCT05246631|Dexamethasone|dexamethasone|mesh-list
154780989|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
154780990|NCT05246631|Haloperidol|haloperidol|mesh-list
154780991|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
154780992|NCT05246631|BB 1101|bb 1101|mesh-list
154780993|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154780994|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
154780995|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
154780996|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154780997|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154780998|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154780999|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
154781000|NCT05246631|Hormones|hormones|mesh-ancestor
154781001|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781002|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154781003|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781004|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
154781005|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781006|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781007|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154781008|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154781009|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781010|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154781011|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154781012|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
154781013|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781014|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154781015|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
154781016|NCT01447433|Calcium|calcium|mesh-list
154781017|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154781018|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781019|NCT01447433|Antacids|antacids|mesh-ancestor
154781020|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781021|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154781022|NCT01798875|Metformin|metformin|mesh-list
154781023|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
154781024|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
154781025|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154781026|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781027|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154781028|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154781029|NCT05362851|Celecoxib|celecoxib|mesh-list
154781030|NCT05362851|Tramadol|tramadol|mesh-list
154781031|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154781032|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154781033|NCT05362851|Analgesics|analgesics|mesh-ancestor
154781034|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
154781035|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781036|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781037|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781038|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781039|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154781040|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154781041|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781042|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781043|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154781044|NCT05362851|Narcotics|narcotics|mesh-ancestor
154781045|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781046|NCT04408235|Enoxaparin|enoxaparin|mesh-list
154781047|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
154781048|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154781049|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154781050|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781051|NCT01446809|Doxorubicin|doxorubicin|mesh-list
154781052|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154781053|NCT01446809|Ifosfamide|ifosfamide|mesh-list
154781054|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
154781055|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154781056|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781057|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154781058|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154781059|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781060|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781061|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154781062|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
154781063|NCT04387929|Antibodies|antibodies|mesh-list
154781064|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
154781065|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781066|NCT05361291|Dexamethasone|dexamethasone|mesh-list
154781067|NCT05361291|Lidocaine|lidocaine|mesh-list
154781068|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781069|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
154781070|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
154781071|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781072|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781073|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154781074|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
154781075|NCT05361291|Hormones|hormones|mesh-ancestor
154781076|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781077|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154781078|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781079|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781080|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
154781081|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
154781082|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781083|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
154781084|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154781085|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154781086|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154781087|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781088|NCT01445951|Insulin|insulin|mesh-list
154781089|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154781090|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
154781091|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154781092|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781093|NCT03169101|Nicotine|nicotine|mesh-list
154781094|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154781095|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
154781096|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781097|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781098|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154781099|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154781100|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
154781101|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781102|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781103|NCT00513435|Saracatinib|saracatinib|mesh-list
154781104|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781105|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781106|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533059|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
154781107|NCT05214339|Bevacizumab|bevacizumab|mesh-list
154781108|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781109|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781110|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154781111|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154781112|NCT05214339|Growth Substances|growth substances|mesh-ancestor
154781113|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781114|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
154781116|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154781117|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
154781118|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781119|NCT02431845|Fluoxetine|fluoxetine|mesh-list
154781120|NCT02431845|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154781121|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154781122|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781123|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781124|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781125|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
154781126|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781127|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154781128|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
154781129|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154781130|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154781131|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154781132|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781133|NCT01443923|Interferons|interferons|mesh-list
154781134|NCT01443923|Ribavirin|ribavirin|mesh-list
154781135|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
154781136|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
154781137|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154781138|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781139|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
154781140|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781141|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
154781142|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781143|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
154781144|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781145|NCT00569673|Docetaxel|docetaxel|mesh-list
154781146|NCT00569673|Trabectedin|trabectedin|mesh-list
154781147|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781148|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154781149|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154781150|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154781151|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781152|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154781153|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
154781154|NCT01551212|Everolimus|everolimus|mesh-list
154781155|NCT01551212|Tacrolimus|tacrolimus|mesh-list
154781156|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781157|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
154781158|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781159|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154781160|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781161|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781162|NCT01551212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154781163|NCT01551212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154781164|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781165|NCT00573261|Pregabalin|pregabalin|mesh-list
154781166|NCT00573261|Analgesics|analgesics|mesh-ancestor
154781167|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
154781168|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781169|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781170|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
154781171|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154781172|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781173|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781174|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154781175|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154781176|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154781177|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781178|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154781179|NCT04514211|Propofol|propofol|mesh-list
154781180|NCT04514211|Sevoflurane|sevoflurane|mesh-list
154781181|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154781182|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781183|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781185|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
154781186|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
154781187|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154781188|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154781189|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
154781190|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154781191|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781192|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154781193|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
154781194|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154781195|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781196|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781197|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781198|NCT00574587|Paclitaxel|paclitaxel|mesh-list
154781199|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
154781200|NCT00574587|Doxorubicin|doxorubicin|mesh-list
154781201|NCT00574587|Trastuzumab|trastuzumab|mesh-list
154781202|NCT00574587|Vorinostat|vorinostat|mesh-list
154781203|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154781204|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781205|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
154781206|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
154781207|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
154781208|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781209|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781210|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
154781211|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781212|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781213|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154781214|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
154781215|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154781216|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154781217|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154781218|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154781219|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781220|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781221|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154781222|NCT00603993|Adalimumab|adalimumab|mesh-list
154781223|NCT00603993|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154781224|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781225|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781226|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
154781227|NCT00575367|Azithromycin|azithromycin|mesh-list
154781228|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154781229|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154781230|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154781231|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154781232|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781233|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154781234|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154781235|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781236|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781237|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781238|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154781239|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
154781240|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154781241|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781242|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154781243|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154781244|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154781245|NCT00604461|Bevacizumab|bevacizumab|mesh-list
154781246|NCT00604461|Carboplatin|carboplatin|mesh-list
154781247|NCT00604461|Pemetrexed|pemetrexed|mesh-list
154781248|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781249|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781250|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154781251|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154781252|NCT00604461|Growth Substances|growth substances|mesh-ancestor
154781253|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781254|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
154781255|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781256|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781257|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154781258|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154781259|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154781260|NCT04417569|Estradiol|estradiol|mesh-list
154781261|NCT04417569|Progesterone|progesterone|mesh-list
154781262|NCT04417569|Hormones|hormones|mesh-ancestor
154781263|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781264|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781265|NCT04417569|Estrogens|estrogens|mesh-ancestor
154781266|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154781267|NCT04417569|Progestins|progestins|mesh-ancestor
154781268|NCT01550744|Ustekinumab|ustekinumab|mesh-list
154781269|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
154781270|NCT00606489|Ibuprofen|ibuprofen|mesh-list
154781271|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154781272|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154781273|NCT00606489|Analgesics|analgesics|mesh-ancestor
154781274|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
154781275|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781276|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781277|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781278|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781279|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154781280|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781281|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781282|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154781283|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154781284|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154781285|NCT00578331|Analgesics|analgesics|mesh-ancestor
154781286|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
154781287|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781288|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781289|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781290|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781291|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154781292|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154781293|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154781294|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
154781295|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
154781296|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781297|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781298|NCT00607113|Bevacizumab|bevacizumab|mesh-list
154781299|NCT00607113|Everolimus|everolimus|mesh-list
154781300|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781301|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781302|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154781303|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154781304|NCT00607113|Growth Substances|growth substances|mesh-ancestor
154781305|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781306|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
154781307|NCT00607113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154781308|NCT00607113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154781309|NCT00607113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781310|NCT00607113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781311|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781312|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
154781313|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154781314|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154781315|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781316|NCT01549964|Incretins|incretins|mesh-ancestor
154781317|NCT01549964|Hormones|hormones|mesh-ancestor
154781318|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781319|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154781320|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
154781321|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781322|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781323|NCT00579111|Fludarabine|fludarabine|mesh-list
154781324|NCT00579111|Busulfan|busulfan|mesh-list
154781325|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
154781326|NCT00579111|Tacrolimus|tacrolimus|mesh-list
154781327|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781328|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533285|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154781329|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781330|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
154781331|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781332|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154781333|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781334|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
154781335|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154781336|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154781337|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781338|NCT04363437|Colchicine|colchicine|mesh-list
154781339|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
154781340|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781341|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
154781342|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
154781343|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
154781344|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781345|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781346|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
154781347|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154781348|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154781349|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
154781350|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154781351|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781352|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154781353|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154781354|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154781355|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154781356|NCT01570244|Estrogens|estrogens|mesh-ancestor
154781357|NCT01570244|Hormones|hormones|mesh-ancestor
154781358|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781359|NCT00579813|Pioglitazone|pioglitazone|mesh-list
154781360|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154781361|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781362|NCT01549886|Rituximab|rituximab|mesh-list
154781363|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781364|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781365|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
154781366|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781367|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781368|NCT00610311|Aldesleukin|aldesleukin|mesh-list
154781369|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
154781370|NCT00610311|Fludarabine|fludarabine|mesh-list
154781371|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
154781372|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781373|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
154781374|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781375|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781376|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154781377|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
154781378|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781379|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781380|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154781381|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154781382|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
154781383|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154781384|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154781385|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
154781386|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781387|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
154781388|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154781389|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154781390|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
154781391|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781392|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781393|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781394|NCT00581061|Urological Agents|urological agents|mesh-ancestor
154781395|NCT01549652|Morphine|morphine|mesh-list
154781396|NCT01549652|Ondansetron|ondansetron|mesh-list
154781397|NCT01549652|Naloxone|naloxone|mesh-list
154781398|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154781399|NCT01549652|Narcotics|narcotics|mesh-ancestor
154781400|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781401|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781402|NCT01549652|Analgesics|analgesics|mesh-ancestor
154781403|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
154781404|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781405|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
154781406|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
154781407|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154781408|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
154781409|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
154781410|NCT01549652|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154781411|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154781412|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
154781413|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781414|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781415|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154781416|NCT01569464|Rotigotine|rotigotine|mesh-list
154781417|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
154781418|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
154781419|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781420|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781421|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781422|NCT01534520|Lidocaine|lidocaine|mesh-list
154781423|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
154781424|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
154781425|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781426|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781427|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
154781428|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781429|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154781430|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154781431|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154781432|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781433|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781434|NCT00611325|Bevacizumab|bevacizumab|mesh-list
154781435|NCT00611325|Bortezomib|bortezomib|mesh-list
154781436|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781437|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781438|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154781439|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154781440|NCT00611325|Growth Substances|growth substances|mesh-ancestor
154781441|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781442|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
154781443|NCT00611403|Cyclosporine|cyclosporine|mesh-list
154781444|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
154781445|NCT00611403|Cyclosporins|cyclosporins|mesh-list
154781446|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781447|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781448|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781449|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
154781450|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781451|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
154781452|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781453|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154781454|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781455|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154781456|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154781457|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154781458|NCT01534208|Enclomiphene|enclomiphene|mesh-list
154781459|NCT01534208|Clomiphene|clomiphene|mesh-list
154781460|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
154781461|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154781462|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
154781463|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781464|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781465|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154781466|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
154781467|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154781468|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154781469|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154781470|NCT01548638|Galantamine|galantamine|mesh-list
154781471|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154781472|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781473|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781474|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
154781475|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781476|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781477|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154781478|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
154533432|NCT04812002|Growth Substances|growth substances|mesh-ancestor
154781479|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781480|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
154781481|NCT00612339|Bevacizumab|bevacizumab|mesh-list
154781482|NCT00612339|Temozolomide|temozolomide|mesh-list
154781483|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781484|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781485|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154781486|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154781487|NCT00612339|Growth Substances|growth substances|mesh-ancestor
154781488|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781489|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
154781490|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154781491|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
154781492|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781493|NCT01533428|Capsaicin|capsaicin|mesh-list
154781494|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
154781495|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
154781496|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
154781497|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781498|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781499|NCT04066725|Aspirin|aspirin|mesh-list
154781500|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154781501|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154781502|NCT04066725|Analgesics|analgesics|mesh-ancestor
154781503|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
154781504|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781505|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781506|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781507|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781508|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154781509|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154781510|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781511|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154781512|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154781513|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781514|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
154781515|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
154781516|NCT01517984|Prednisone|prednisone|mesh-list
154781517|NCT01517984|Tacrolimus|tacrolimus|mesh-list
154781518|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
154781519|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154781520|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154781521|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154781522|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781523|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
154781524|NCT01517984|Hormones|hormones|mesh-ancestor
154781525|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781526|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781527|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154781528|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781529|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
154781530|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781531|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781532|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154781533|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154781534|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
154781535|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154781536|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781537|NCT00612573|Doxycycline|doxycycline|mesh-list
154781538|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154781539|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781540|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
154781541|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154781542|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154781543|NCT00614445|Pyridoxine|pyridoxine|mesh-list
154781544|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
154781545|NCT00614445|Doxylamine|doxylamine|mesh-list
154781546|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
154781547|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
154781548|NCT00614445|Vitamins|vitamins|mesh-ancestor
154781549|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
154781550|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781551|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
154781552|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
154781553|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781554|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154781555|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154781556|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
154781557|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
154781558|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781559|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781560|NCT00583011|Anesthetics|anesthetics|mesh-list
154781561|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781562|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781563|NCT01547390|Aspirin|aspirin|mesh-list
154781564|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154781565|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154781566|NCT01547390|Analgesics|analgesics|mesh-ancestor
154781567|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
154781568|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781569|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781570|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781571|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781572|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154781573|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154781574|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781575|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154781576|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154781577|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781578|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
154781579|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
154781580|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781581|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
154781582|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
154781583|NCT00615927|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154781584|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154781585|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781586|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781587|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781588|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
154781589|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154781590|NCT01532648|Budesonide|budesonide|mesh-list
154781591|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781592|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154781593|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
154781594|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781595|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781596|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154781597|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
154781598|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
154781599|NCT01532648|Hormones|hormones|mesh-ancestor
154781600|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781601|NCT00617097|Ketorolac|ketorolac|mesh-list
154781602|NCT00617097|Lidocaine|lidocaine|mesh-list
154781603|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
154781604|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
154781605|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781606|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781607|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
154781608|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781609|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154781610|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154781611|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154781612|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781613|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781614|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154781615|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154781616|NCT00617097|Analgesics|analgesics|mesh-ancestor
154781617|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781618|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781619|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154781620|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781621|NCT01532414|Enclomiphene|enclomiphene|mesh-list
154781622|NCT01532414|Clomiphene|clomiphene|mesh-list
154781623|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
154781624|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154781625|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
154781626|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781627|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781628|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154781629|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
154781630|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154781631|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154781632|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154781633|NCT01441973|Elotuzumab|elotuzumab|mesh-list
154781634|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781635|NCT02074709|Bupivacaine|bupivacaine|mesh-list
154781636|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
154781637|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
154781638|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781639|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781640|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
154781641|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781642|NCT03571191|Denosumab|denosumab|mesh-list
154781643|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154781644|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781645|NCT01575899|Amoxicillin|amoxicillin|mesh-list
154781646|NCT01575899|Clarithromycin|clarithromycin|mesh-list
154781647|NCT01575899|Levofloxacin|levofloxacin|mesh-list
154781648|NCT01575899|Ofloxacin|ofloxacin|mesh-list
154781649|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
154781650|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154781651|NCT01575899|Rabeprazole|rabeprazole|mesh-list
154781652|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154781653|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781654|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154781655|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781656|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781657|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154781658|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154781659|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154781660|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154781661|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154781662|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781663|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154781664|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154781665|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154781666|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154781667|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154781668|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154781669|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
154781670|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781671|NCT00620061|Lubiprostone|lubiprostone|mesh-list
154781672|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154781673|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781674|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781675|NCT00587769|Bupropion|bupropion|mesh-list
154781676|NCT00587769|Varenicline|varenicline|mesh-list
154781677|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154781678|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
154781679|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154781680|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154781681|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154781682|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781683|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781684|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
154781685|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781686|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781687|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154781688|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154781689|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781690|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154781691|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154781692|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
154781693|NCT00623181|Vaccines|vaccines|mesh-list
154781694|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
154781695|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781696|NCT03433833|Digoxin|digoxin|mesh-list
154781697|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154781698|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154781699|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781700|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154533656|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
154781701|NCT03433833|Protective Agents|protective agents|mesh-ancestor
154781702|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781704|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
154781705|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
154781706|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154781707|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
154781708|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781709|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781710|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154781711|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
154781712|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154781713|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154781714|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154781715|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
154781716|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781717|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781718|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
154781719|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154386402|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
154781720|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
154781721|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154781722|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154781723|NCT01440803|Teriparatide|teriparatide|mesh-list
154781724|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154781725|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781726|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154781727|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
154781728|NCT05247177|Ketamine|ketamine|mesh-list
154781729|NCT05247177|Anesthetics|anesthetics|mesh-list
154781730|NCT05247177|Sevoflurane|sevoflurane|mesh-list
154781731|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781732|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781733|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154781734|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154781735|NCT05247177|Analgesics|analgesics|mesh-ancestor
154781736|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
154781737|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781738|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154781739|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154781740|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154781741|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
154781742|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781743|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781744|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154781745|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154781746|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
154781747|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154781748|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154781749|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154781750|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154781751|NCT00624195|Etravirine|etravirine|mesh-list
154781752|NCT00624195|Maraviroc|maraviroc|mesh-list
154781753|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154781754|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154781755|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154781756|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781757|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781758|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
154781759|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781760|NCT00624195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154781761|NCT00624195|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154781762|NCT00624195|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154781763|NCT00624195|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154781764|NCT01516970|Ritonavir|ritonavir|mesh-list
154781765|NCT01516970|Lopinavir|lopinavir|mesh-list
154781766|NCT01516970|Darunavir|darunavir|mesh-list
154781767|NCT01516970|Zidovudine|zidovudine|mesh-list
154781768|NCT01516970|Efavirenz|efavirenz|mesh-list
154781769|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154781770|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154781771|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
154781772|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781773|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781774|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154781775|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154781776|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
154781777|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781778|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154781779|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154781780|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
154781781|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154781782|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154781783|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154781784|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154781785|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154781786|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154781787|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154781788|NCT02140593|Rocuronium|rocuronium|mesh-list
154781789|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154781790|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154781791|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154781792|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781793|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781794|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
154781795|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154781796|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154781797|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154781798|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781799|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781800|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
154781801|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781802|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781803|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154781804|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781805|NCT00668811|Sunitinib|sunitinib|mesh-list
154781806|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781807|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154781808|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154781809|NCT00668811|Growth Substances|growth substances|mesh-ancestor
154781810|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386475|NCT03715309|Lenalidomide|lenalidomide|mesh-list
154781811|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
154781812|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154781813|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781814|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781815|NCT02776605|Prednisone|prednisone|mesh-list
154781816|NCT02776605|Methotrexate|methotrexate|mesh-list
154781817|NCT02776605|Vincristine|vincristine|mesh-list
154781818|NCT02776605|Daunorubicin|daunorubicin|mesh-list
154781819|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
154781820|NCT02776605|Ponatinib|ponatinib|mesh-list
154781821|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154781822|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
154781823|NCT02776605|Hormones|hormones|mesh-ancestor
154781824|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154781825|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781826|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154781827|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781828|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154781829|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
154781830|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154781831|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154781832|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
154781833|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781834|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
154781835|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781836|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154781837|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781838|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
154781839|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781840|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154781841|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154781842|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
154781843|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
154781844|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
154781845|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154781846|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154781847|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154781848|NCT02776605|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154781849|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154781850|NCT00627861|Metoprolol|metoprolol|mesh-list
154781851|NCT00627861|Aliskiren|aliskiren|mesh-list
154781852|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154781853|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154781854|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
154781855|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
154386531|NCT03712735|Fentanyl|fentanyl|mesh-list
154781856|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781857|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781858|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154781859|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154781860|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154781861|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
154781862|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781863|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781864|NCT00627861|Renin Inhibitors|renin inhibitors|mesh-ancestor
154781865|NCT00627861|Protease Inhibitors|protease inhibitors|mesh-ancestor
154781866|NCT00627861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781867|NCT00669279|Atenolol|atenolol|mesh-list
154781868|NCT00669279|Carvedilol|carvedilol|mesh-list
154781869|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154781870|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154781871|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
154781872|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781873|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781874|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781875|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154781876|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
154781877|NCT00669279|Protective Agents|protective agents|mesh-ancestor
154781878|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154781879|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781880|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154781881|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
154781882|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154781883|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154781884|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154781885|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
154781886|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
154781887|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781888|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154781889|NCT01546688|Zonisamide|zonisamide|mesh-list
154781890|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
154781891|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154781892|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154781893|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781894|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154781895|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781896|NCT04409522|Melatonin|melatonin|mesh-list
154781897|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
154781898|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781899|NCT04409522|Protective Agents|protective agents|mesh-ancestor
154781900|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781901|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781902|NCT00672243|Sirolimus|sirolimus|mesh-list
154781903|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154781904|NCT00672243|Temsirolimus|temsirolimus|mesh-list
154781905|NCT00672243|MTOR Inhibitors|mtor inhibitors|mesh-list
154781906|NCT00672243|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154781907|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154781908|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781909|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781910|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781911|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154781912|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781913|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154781914|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
154781915|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781916|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
154781917|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781918|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
154781919|NCT04105946|Remifentanil|remifentanil|mesh-list
154781920|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154781921|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154781922|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781923|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154533875|NCT02477397|Fluticasone|fluticasone|mesh-list
154781924|NCT04105946|Analgesics|analgesics|mesh-ancestor
154781925|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
154781926|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781927|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154781928|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154781929|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154781930|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
154781931|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154781932|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781933|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154781934|NCT04105946|Narcotics|narcotics|mesh-ancestor
154781935|NCT01440569|Darunavir|darunavir|mesh-list
154781936|NCT01440569|Cobicistat|cobicistat|mesh-list
154781937|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154781938|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154781939|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
154781940|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781941|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781942|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154781943|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154781944|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
154781945|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781946|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154781947|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154781948|NCT00629499|Paclitaxel|paclitaxel|mesh-list
154781949|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
154781950|NCT00629499|Trastuzumab|trastuzumab|mesh-list
154781951|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154781952|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154781953|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
154781954|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
154781955|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
154781956|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781957|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154781958|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
154781959|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386619|NCT04620252|Antacids|antacids|mesh-ancestor
154781960|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154781961|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154781962|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
154781963|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154781964|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154781965|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
154781966|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154781967|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154781968|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
154781969|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154781970|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154781971|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154781972|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781973|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781974|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
154781975|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154781976|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154781977|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154781978|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781979|NCT01440101|Natalizumab|natalizumab|mesh-list
154781980|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
154781981|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781982|NCT01530464|Ambrisentan|ambrisentan|mesh-list
154781983|NCT01530464|Aminophylline|aminophylline|mesh-list
154781984|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154781985|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154781986|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
154781987|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154781988|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154781989|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154781990|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
154781991|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154781992|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154781993|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154781994|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154781995|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154781996|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154781997|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
154781998|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782000|NCT00633399|Ziprasidone|ziprasidone|mesh-list
154782001|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154782002|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
154782003|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782004|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782005|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782006|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154782007|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154782008|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782009|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154782010|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154782011|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
154782012|NCT01077843|Etoricoxib|etoricoxib|mesh-list
154782013|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154782014|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154782015|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154782016|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154782017|NCT01077843|Analgesics|analgesics|mesh-ancestor
154782018|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
154782019|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782020|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782021|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782022|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154782023|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782024|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782025|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154782026|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
154782027|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154782028|NCT00635817|Leuprolide|leuprolide|mesh-list
154386685|NCT02429050|Narcotics|narcotics|mesh-ancestor
154782029|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154782030|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
154782031|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154782032|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782033|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154782034|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782035|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
154782036|NCT01439945|Antacids|antacids|mesh-ancestor
154782037|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782038|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782039|NCT00651963|Ezetimibe|ezetimibe|mesh-list
154782040|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154782041|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154782042|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
154782043|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782044|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154782045|NCT00674115|Omeprazole|omeprazole|mesh-list
154782046|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
154782047|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154782048|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782049|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154782050|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782051|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782052|NCT02142153|Olorofim|olorofim|mesh-list
154782053|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
154782054|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782055|NCT00674583|Vaccines|vaccines|mesh-list
154782056|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
154782057|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782058|NCT01420081|Gedatolisib|gedatolisib|mesh-list
154782059|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154782060|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782061|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782062|NCT01439867|Cinacalcet|cinacalcet|mesh-list
154782063|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154782064|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782065|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154782066|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
154782067|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782068|NCT00637923|Ribavirin|ribavirin|mesh-list
154782069|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154782070|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
154782071|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
154534022|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782072|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782073|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
154782074|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782075|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154782076|NCT01439711|Letrozole|letrozole|mesh-list
154782077|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782078|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154782079|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154782080|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782081|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782082|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154782083|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
154782084|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782085|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782086|NCT01439555|Simvastatin|simvastatin|mesh-list
154782087|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154782088|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154782089|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
154782090|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782091|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154386755|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
154782092|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154782093|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782094|NCT00674739|Imiquimod|imiquimod|mesh-list
154782095|NCT00674739|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154782096|NCT00674739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782097|NCT00674739|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154782098|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
154782099|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782100|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154782101|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782102|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
154782103|NCT00675909|Midazolam|midazolam|mesh-list
154782104|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154782105|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154782106|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782107|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782108|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154782109|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154782110|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154782111|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154782112|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
154782113|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
154782114|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
154782115|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
154782116|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782117|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782118|NCT03027908|Fluorides|fluorides|mesh-list
154782119|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
154782120|NCT03027908|Protective Agents|protective agents|mesh-ancestor
154782121|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782122|NCT00638937|Saracatinib|saracatinib|mesh-list
154782123|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782124|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782125|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782126|NCT01439009|Tolvaptan|tolvaptan|mesh-list
154782127|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154782128|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782129|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
154782130|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782131|NCT00675987|Losartan|losartan|mesh-list
154782132|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154782133|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154782134|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154782135|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154782136|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782137|NCT00639717|Etanercept|etanercept|mesh-list
154782138|NCT00639717|Methoxsalen|methoxsalen|mesh-list
154782139|NCT00639717|Tacrolimus|tacrolimus|mesh-list
154782140|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154782141|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
154782142|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782143|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154782144|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154534101|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
154782145|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782146|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154782147|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154782148|NCT00639717|Analgesics|analgesics|mesh-ancestor
154782149|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
154782150|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782151|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782152|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782153|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782154|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154782155|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
154782156|NCT01571453|Vortioxetine|vortioxetine|mesh-list
154782157|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154782158|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154782159|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154782160|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154782161|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782162|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782163|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782164|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154782165|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
154782166|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154782167|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154782168|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154782169|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782170|NCT01571453|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154782171|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
154782172|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154782173|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154782174|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154782175|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154782176|NCT04120961|Hirudins|hirudins|mesh-list
154782177|NCT04120961|Bivalirudin|bivalirudin|mesh-list
154782178|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
154782179|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154782180|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
154782181|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782182|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782183|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
154782184|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154782185|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154782186|NCT04410263|Dimercaprol|dimercaprol|mesh-list
154782187|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
154782188|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
154782189|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782190|NCT01444651|Tadalafil|tadalafil|mesh-list
154782191|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
154782192|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154782193|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154782194|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782195|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782196|NCT01444651|Urological Agents|urological agents|mesh-ancestor
154782197|NCT01570751|Insulin|insulin|mesh-list
154782198|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154386885|NCT04117607|Rezafungin|rezafungin|mesh-list
154782199|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
154782200|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154782201|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782202|NCT01419535|Mifepristone|mifepristone|mesh-list
154782203|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154782204|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
154782205|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154782206|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782207|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154782208|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154782209|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154782210|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
154782211|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154782212|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154782213|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
154782214|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782215|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
154534173|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782216|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154782217|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154782218|NCT01438151|Infliximab|infliximab|mesh-list
154782219|NCT01438151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154782220|NCT01438151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782221|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154782222|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782223|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782224|NCT02141451|Rituximab|rituximab|mesh-list
154782225|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154782226|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782227|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
154782228|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782229|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782230|NCT01418365|Metronidazole|metronidazole|mesh-list
154782231|NCT01418365|Mesalamine|mesalamine|mesh-list
154782232|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782233|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154782234|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154782235|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154782236|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154782237|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154782238|NCT01418365|Analgesics|analgesics|mesh-ancestor
154782239|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
154782240|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782241|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782242|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782243|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782244|NCT02075125|Ticagrelor|ticagrelor|mesh-list
154782245|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154782246|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154782247|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154782248|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154782249|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154782250|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
154782251|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782252|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782253|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782254|NCT00678015|Masoprocol|masoprocol|mesh-list
154782255|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
154782256|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782257|NCT00678015|Protective Agents|protective agents|mesh-ancestor
154782258|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782259|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154782260|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782261|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154782262|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154782263|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154782264|NCT00678015|Analgesics|analgesics|mesh-ancestor
154782265|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
154782266|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782267|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782268|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782269|NCT01437995|Fluticasone|fluticasone|mesh-list
154782270|NCT01437995|Xhance|xhance|mesh-list
154782271|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154782272|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154782273|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782274|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154782275|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
154782276|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782277|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782278|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154782279|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
154782280|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
154782281|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154782282|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154782283|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154782284|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154782285|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782286|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782287|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782288|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
154782289|NCT01437995|Hormones|hormones|mesh-ancestor
154534249|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154782290|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782291|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
154782292|NCT00641745|Risperidone|risperidone|mesh-list
154782293|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154782294|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154782295|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
154782296|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782297|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782298|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782299|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154782300|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154782301|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782302|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154782303|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154782304|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
154782305|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154782306|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154782307|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154782308|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782309|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154782310|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154782311|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
154782312|NCT01799109|Albuterol|albuterol|mesh-list
154782313|NCT01799109|Analgesics|analgesics|mesh-ancestor
154782314|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
154782315|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782316|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782317|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
154782318|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782319|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154782320|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
154782321|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154782322|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154782323|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782324|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154782325|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
154782326|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154782327|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154782328|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
154782329|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154782330|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
154782331|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154782332|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154782333|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154782334|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782335|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782336|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
154782337|NCT00588159|Promethazine|promethazine|mesh-list
154782338|NCT00588159|Gabapentin|gabapentin|mesh-list
154782339|NCT00588159|Analgesics|analgesics|mesh-ancestor
154782340|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
154782341|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782342|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782343|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
154782344|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154782345|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154782346|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782347|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154782348|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154782349|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154782350|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782351|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782352|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
154782353|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154782354|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154782355|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
154782356|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
154782357|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
154782358|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
154782359|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782360|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154782361|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
154782362|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
154782363|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154782364|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
154782365|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
154782367|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154782368|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782369|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
154782370|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
154782371|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
154782372|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782373|NCT00680823|Ropivacaine|ropivacaine|mesh-list
154782374|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
154782375|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
154782376|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782377|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782378|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
154782379|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782380|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154782381|NCT00589329|Metronidazole|metronidazole|mesh-list
154782382|NCT00589329|Erythromycin|erythromycin|mesh-list
154782383|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
154782384|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154782385|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
154782386|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782387|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154782388|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154782389|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782390|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154782391|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782392|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782393|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
154782394|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154782395|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782396|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782397|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154782398|NCT01438957|Analgesics|analgesics|mesh-ancestor
154782399|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
154782400|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782401|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154782402|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154782403|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154782404|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782405|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782406|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782407|NCT00589563|Sirolimus|sirolimus|mesh-list
154782408|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
154782409|NCT00589563|Melphalan|melphalan|mesh-list
154782410|NCT00589563|Methotrexate|methotrexate|mesh-list
154782411|NCT00589563|Fludarabine|fludarabine|mesh-list
154782412|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
154782413|NCT00589563|Etoposide|etoposide|mesh-list
154782414|NCT00589563|Tacrolimus|tacrolimus|mesh-list
154782415|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154782416|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154782417|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
154782418|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782419|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782420|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154782421|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
154782422|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782423|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782424|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154782425|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154782426|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
154782427|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154782428|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154782429|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
154782430|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
154782431|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782432|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154782433|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154782434|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154782435|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154782436|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154782437|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154782438|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154782439|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782440|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154782442|NCT00645333|Docetaxel|docetaxel|mesh-list
154782443|NCT00645333|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
154782444|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782445|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
154782446|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
154782447|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
154782448|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782449|NCT00645333|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154782450|NCT00645333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782451|NCT00646581|Insulin|insulin|mesh-list
154782452|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154782453|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154782454|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782455|NCT00648375|Propranolol|propranolol|mesh-list
154782456|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154782457|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154782458|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782459|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782460|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782461|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782462|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154782463|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154782464|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
154782465|NCT00654069|Niacin|niacin|mesh-list
154782466|NCT00654069|Niacinamide|niacinamide|mesh-list
154782467|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
154782468|NCT00654069|Oxycodone|oxycodone|mesh-list
154782469|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154782470|NCT00654069|Narcotics|narcotics|mesh-ancestor
154782471|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782472|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782473|NCT00654069|Analgesics|analgesics|mesh-ancestor
154782474|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
154782475|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782476|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154782477|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
154782478|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782479|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154782480|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
154782481|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
154782482|NCT00654069|Vitamins|vitamins|mesh-ancestor
154782483|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
154782484|NCT00654147|Ritonavir|ritonavir|mesh-list
154782485|NCT00654147|Lopinavir|lopinavir|mesh-list
154782486|NCT00654147|Tenofovir|tenofovir|mesh-list
154782487|NCT00654147|Emtricitabine|emtricitabine|mesh-list
154782488|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
154782489|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154782490|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154782491|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
154782492|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782493|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782494|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154782495|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154782496|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
154782497|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782498|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154782499|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154782500|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154782501|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154782502|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154782503|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154782504|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154782505|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
154782506|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782507|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
154782508|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154782509|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154782510|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782511|NCT00655083|MEN 11420|men 11420|mesh-list
154782512|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154782513|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
154782514|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782515|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782516|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154782517|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
154782518|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154782519|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154782520|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154782521|NCT01418209|Estradiol|estradiol|mesh-list
154782522|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154782523|NCT01418209|Progesterone|progesterone|mesh-list
154782524|NCT01418209|Estrogens|estrogens|mesh-ancestor
154782525|NCT01418209|Hormones|hormones|mesh-ancestor
154782526|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782527|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782528|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154782529|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
154782530|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154782531|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154782532|NCT01418209|Progestins|progestins|mesh-ancestor
154782533|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154782534|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154782535|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154782536|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387228|NCT01442649|Leucovorin|leucovorin|mesh-list
154782537|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782538|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154782539|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
154782540|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154782541|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
154782542|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154782543|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154782544|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
154782545|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782546|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154782547|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154782548|NCT01417195|Menotropins|menotropins|mesh-list
154782549|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154782550|NCT01417195|Hormones|hormones|mesh-ancestor
154782551|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782552|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782553|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154782554|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
154782555|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154782556|NCT00656487|Rimonabant|rimonabant|mesh-list
154782557|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154782558|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154782559|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154782560|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782561|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782562|NCT00656487|Hormones|hormones|mesh-ancestor
154782563|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782564|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782565|NCT01438177|Chloroquine|chloroquine|mesh-list
154782566|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
154782567|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154782568|NCT01438177|Bortezomib|bortezomib|mesh-list
154782569|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154782570|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
154782571|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782572|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782573|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154782574|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
154782575|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782576|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782577|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154782578|NCT01438177|Amebicides|amebicides|mesh-ancestor
154782579|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154782580|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154782581|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782582|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
154782583|NCT01442779|Interferons|interferons|mesh-list
154782584|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
154782585|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782586|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
154782587|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782588|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
154387277|NCT01354665|Interferons|interferons|mesh-list
154782589|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782590|NCT01437943|Aliskiren|aliskiren|mesh-list
154782591|NCT01437943|Renin Inhibitors|renin inhibitors|mesh-ancestor
154782592|NCT01437943|Protease Inhibitors|protease inhibitors|mesh-ancestor
154782593|NCT01437943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782594|NCT01437943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782595|NCT01436201|Dulaglutide|dulaglutide|mesh-list
154782596|NCT01436201|Digoxin|digoxin|mesh-list
154782597|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154782598|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154782599|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782600|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782601|NCT01436201|Protective Agents|protective agents|mesh-ancestor
154782602|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782603|NCT01436201|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154782604|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154782605|NCT01437397|Bromides|bromides|mesh-list
154782606|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
154782607|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154782608|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
154782609|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782610|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782611|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154782612|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
154782613|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154782614|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154782615|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154782616|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782617|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782618|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782619|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
154782620|NCT04070833|Vitamin D|vitamin d|mesh-list
154782621|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
154782622|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
154782623|NCT04070833|Vitamins|vitamins|mesh-list
154782624|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
154782625|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782626|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154782627|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154782628|NCT01442155|Capecitabine|capecitabine|mesh-list
154782629|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
154782630|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154782631|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
154782632|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782633|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782634|NCT01416181|Natalizumab|natalizumab|mesh-list
154782635|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
154782636|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782637|NCT03026023|Ribavirin|ribavirin|mesh-list
154782638|NCT03026023|Grazoprevir|grazoprevir|mesh-list
154782639|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
154782640|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782641|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
154782642|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782643|NCT01441765|Pidilizumab|pidilizumab|mesh-list
154782644|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154782645|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782646|NCT01419665|Rituximab|rituximab|mesh-list
154782647|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154782648|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782649|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
154782650|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782651|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782652|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
154782653|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
154782654|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
154782655|NCT01436305|Abatacept|abatacept|mesh-list
154782656|NCT01436305|Tacrolimus|tacrolimus|mesh-list
154782657|NCT01436305|Basiliximab|basiliximab|mesh-list
154782658|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154782659|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
154782660|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782661|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154782662|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782663|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782664|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154782665|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782666|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154782667|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
154782668|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154782669|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782670|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782671|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
154782672|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
154782673|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782674|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782675|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
154782676|NCT01436305|Hormones|hormones|mesh-ancestor
154782677|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782678|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154782679|NCT01436305|Protective Agents|protective agents|mesh-ancestor
154782680|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154782681|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154782682|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782683|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154782684|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154782685|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782686|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154782687|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154782688|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387360|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782689|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782690|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
154782691|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782692|NCT01415401|Timolol|timolol|mesh-list
154782693|NCT01415401|Brinzolamide|brinzolamide|mesh-list
154782694|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782695|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782696|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154782697|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154782698|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782699|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782700|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782701|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154782702|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154782703|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154782704|NCT01414855|Prednisone|prednisone|mesh-list
154782705|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
154782706|NCT01414855|Doxorubicin|doxorubicin|mesh-list
154782707|NCT01414855|Vincristine|vincristine|mesh-list
154782708|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
154782709|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154782710|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
154782711|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782712|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782713|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154782714|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
154782715|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782716|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782717|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154782718|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154782719|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154782720|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154782721|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782722|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782723|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
154782724|NCT01414855|Hormones|hormones|mesh-ancestor
154782725|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782726|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154782727|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154782728|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
154782729|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
154782730|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
154782731|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154782732|NCT02074735|Choline|choline|mesh-list
154782733|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154782734|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
154782735|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154782736|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
154782737|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782738|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782739|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154782740|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
154782741|NCT01527110|Zanamivir|zanamivir|mesh-list
154782742|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
154782743|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782744|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782745|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782746|NCT01441063|Zidovudine|zidovudine|mesh-list
154782747|NCT01441063|Valganciclovir|valganciclovir|mesh-list
154782748|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
154782749|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782750|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154782751|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154782752|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782753|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
154782754|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782755|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154782756|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154782757|NCT01436071|Fluticasone|fluticasone|mesh-list
154782758|NCT01436071|Xhance|xhance|mesh-list
154782759|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782760|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154782761|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
154782762|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782763|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782764|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154782765|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
154782766|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
154782767|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154782768|NCT01514240|Mesalamine|mesalamine|mesh-list
154782769|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154782770|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154782771|NCT01514240|Analgesics|analgesics|mesh-ancestor
154782772|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
154782773|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782774|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782775|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782776|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782777|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154782778|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
154782779|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154782780|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154782781|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782782|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154782783|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154782784|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154782785|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782786|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
154782787|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782788|NCT01393405|Methotrexate|methotrexate|mesh-list
154782789|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154782790|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
154782791|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154782792|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782793|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154782794|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
154782795|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782796|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782797|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
154782798|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782799|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154782800|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154782801|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
154782802|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782803|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154782804|NCT01419197|Trastuzumab|trastuzumab|mesh-list
154782805|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154782806|NCT01419197|Maytansine|maytansine|mesh-list
154782807|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154782808|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782809|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154782810|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
154782811|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
154782812|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
154782813|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782814|NCT01419197|Immunotoxins|immunotoxins|mesh-ancestor
154782815|NCT01419197|Immunoconjugates|immunoconjugates|mesh-ancestor
154782816|NCT01419197|Immunologic Factors|immunologic factors|mesh-ancestor
154782817|NCT01419197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782819|NCT01414075|Trace Elements|trace elements|mesh-ancestor
154782820|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
154782821|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782822|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
154782823|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
154782824|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154782825|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
154782826|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782827|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782828|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154782829|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
154782830|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
154782831|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154782832|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
154782833|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782834|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782835|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154782836|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154782837|NCT01418339|Aripiprazole|aripiprazole|mesh-list
154782838|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
154782839|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154782840|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154782841|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154782842|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782843|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782844|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
154782845|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
154782846|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782847|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782848|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154782849|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154782850|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
154782851|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154782852|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154782853|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154782854|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154782855|NCT01417481|Glycine|glycine|mesh-list
154782856|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
154782857|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782858|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782859|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782860|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
154782861|NCT01392469|Bosentan|bosentan|mesh-list
154782862|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
154782863|NCT01392469|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154782864|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154782865|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782866|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782867|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782868|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
154782869|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154782870|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154782871|NCT01392469|Urological Agents|urological agents|mesh-ancestor
154782872|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154782873|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154782874|NCT01435577|Tapentadol|tapentadol|mesh-list
154782875|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154782876|NCT01435577|Narcotics|narcotics|mesh-ancestor
154782877|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154782878|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782879|NCT01435577|Analgesics|analgesics|mesh-ancestor
154782880|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
154782881|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782882|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154782883|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154782884|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154782885|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782886|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782887|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782888|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
154782889|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
154782890|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154782891|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154782892|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782893|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782894|NCT04039087|Urological Agents|urological agents|mesh-ancestor
154782895|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
154782896|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154782897|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782898|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
154782899|NCT01416389|Lenograstim|lenograstim|mesh-list
154782900|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154782901|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
154782902|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782903|NCT04497155|Norepinephrine|norepinephrine|mesh-list
154782904|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154782905|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154782906|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782907|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782908|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782909|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782910|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
154782911|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
154782912|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782913|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154782914|NCT01544348|Omalizumab|omalizumab|mesh-list
154782915|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154782916|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154782917|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
154782918|NCT01416155|Natalizumab|natalizumab|mesh-list
154782919|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
154782920|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782921|NCT01415921|Bromides|bromides|mesh-list
154782922|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154782923|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
154782924|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154782925|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782926|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782927|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
154782928|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782929|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782930|NCT01415531|Nebivolol|nebivolol|mesh-list
154782931|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154782932|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
154782933|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154782934|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154782935|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154782936|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
154782937|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154782938|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782939|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782940|NCT01544114|Naproxen|naproxen|mesh-list
154782941|NCT01544114|Esomeprazole|esomeprazole|mesh-list
154782942|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154782943|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154782944|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154782945|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782946|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782947|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154782948|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154782949|NCT01544114|Analgesics|analgesics|mesh-ancestor
154782950|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
154782951|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154782952|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782953|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154782954|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154782955|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
154782956|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154782957|NCT01410799|Hormones|hormones|mesh-list
154782958|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154782959|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154782960|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782961|NCT01432171|Lacosamide|lacosamide|mesh-list
154534924|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782962|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
154782963|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154782964|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154782965|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154782966|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782968|NCT04046263|Hematinics|hematinics|mesh-ancestor
154782969|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
154782970|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154782971|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782972|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154782973|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782974|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782975|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782976|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154782977|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154782978|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
154782979|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154782980|NCT01412957|Panitumumab|panitumumab|mesh-list
154782981|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154782982|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154782983|NCT04973826|Aztreonam|aztreonam|mesh-list
154782984|NCT04973826|Avibactam|avibactam|mesh-list
154782985|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154782986|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782987|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154782988|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154782989|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782990|NCT03025841|Ceftaroline|ceftaroline|mesh-list
154782991|NCT03025841|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154782992|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154782993|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154782994|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154782995|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154782996|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154782997|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154782998|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154782999|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783000|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783001|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
154783002|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154783003|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
154783004|NCT05062278|Vinblastine|vinblastine|mesh-list
154783005|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783006|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
154783007|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783008|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783009|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154783010|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154783011|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
154783012|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
154783013|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
154783014|NCT02823990|Nivolumab|nivolumab|mesh-list
154783015|NCT02823990|Interleukin-2|interleukin-2|mesh-list
154783016|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783017|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783018|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783019|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154783020|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783021|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154783022|NCT02823990|Analgesics|analgesics|mesh-ancestor
154783023|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
154783024|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783025|NCT02427126|Aspirin|aspirin|mesh-list
154783026|NCT02427126|Apixaban|apixaban|mesh-list
154783027|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154783028|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154783029|NCT02427126|Analgesics|analgesics|mesh-ancestor
154783030|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
154783031|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783032|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783033|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154783034|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783035|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154783036|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154783037|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783038|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154783039|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154783040|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783041|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
154783042|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154783043|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
154783044|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154783045|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
154783046|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
154783047|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154783048|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154783049|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154783050|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783051|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783052|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154783053|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154783054|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783055|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
154783056|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783057|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
154783058|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154783059|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154783060|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
154783061|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783062|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154783064|NCT04797312|Remifentanil|remifentanil|mesh-list
154783065|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
154783066|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
154783067|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387745|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
154783068|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783069|NCT04797312|Narcotics|narcotics|mesh-ancestor
154783070|NCT04797312|Analgesics|analgesics|mesh-ancestor
154783071|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
154783072|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783073|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154783074|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154783075|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
154783076|NCT05080140|Ezetimibe|ezetimibe|mesh-list
154783077|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154783078|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154783079|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
154783080|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783081|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154783082|NCT01390441|Acetaminophen|acetaminophen|mesh-list
154783083|NCT01390441|Loratadine|loratadine|mesh-list
154783084|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
154783085|NCT01390441|Rituximab|rituximab|mesh-list
154783086|NCT01390441|Methotrexate|methotrexate|mesh-list
154783087|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783088|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783089|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
154783090|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783091|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783092|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154783093|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
154783094|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154783095|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154783096|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
154783097|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783098|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
154783099|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783100|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154783101|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154783102|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154783103|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154783104|NCT01390441|Analgesics|analgesics|mesh-ancestor
154783105|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
154783106|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783107|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
154783108|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154783109|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
154783110|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
154783111|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154783112|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
154783114|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154783115|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154783116|NCT01390441|Protective Agents|protective agents|mesh-ancestor
154783117|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
154783118|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154783119|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154783120|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154783121|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
154783122|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
154783123|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783124|NCT03142542|Udenafil|udenafil|mesh-list
154783125|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154783126|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154783127|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783128|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783129|NCT03025867|Niraparib|niraparib|mesh-list
154783130|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154783131|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783132|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783133|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783134|NCT01412879|Leucovorin|leucovorin|mesh-list
154783135|NCT01412879|Cytarabine|cytarabine|mesh-list
154783136|NCT01412879|Dexamethasone|dexamethasone|mesh-list
154783137|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
154783138|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154783139|NCT01412879|Rituximab|rituximab|mesh-list
154783140|NCT01412879|Doxorubicin|doxorubicin|mesh-list
154783141|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154783142|NCT01412879|Methotrexate|methotrexate|mesh-list
154783143|NCT01412879|Vincristine|vincristine|mesh-list
154783144|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
154783145|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154783146|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
154783147|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783148|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783149|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154783150|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
154783151|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783152|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783153|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154783154|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783155|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154783156|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
154783157|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
154783158|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783159|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154783160|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
154783161|NCT01412879|Hormones|hormones|mesh-ancestor
154783162|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154783163|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154783164|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154783165|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154783166|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154783167|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783168|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154783169|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
154783170|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154783171|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154783172|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
154783173|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
154783174|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154783175|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154783176|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
154783177|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783178|NCT01412879|Antidotes|antidotes|mesh-ancestor
154783179|NCT01412879|Protective Agents|protective agents|mesh-ancestor
154783180|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
154783181|NCT01412879|Vitamins|vitamins|mesh-ancestor
154783182|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
154783183|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154783184|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
154783185|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
154535148|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154783186|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
154783188|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154783189|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783190|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783191|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154783192|NCT03143010|Analgesics|analgesics|mesh-ancestor
154783193|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
154783194|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783195|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154783196|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154783197|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154783198|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
154387866|NCT01356615|Tinzaparin|tinzaparin|mesh-list
154783199|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783200|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783201|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154783202|NCT03142776|Clarithromycin|clarithromycin|mesh-list
154783203|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783204|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154783205|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783206|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783207|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154783208|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154783209|NCT01430611|Vaccines|vaccines|mesh-list
154783210|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
154783211|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783212|NCT03140826|Meropenem|meropenem|mesh-list
154783213|NCT03140826|Tazobactam|tazobactam|mesh-list
154783214|NCT03140826|Piperacillin|piperacillin|mesh-list
154783215|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154783216|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154783217|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783218|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154783219|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783220|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783221|NCT01389973|Ustekinumab|ustekinumab|mesh-list
154783222|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
154783223|NCT04529460|Antibodies|antibodies|mesh-list
154783224|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
154783225|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783226|NCT04032067|Finasteride|finasteride|mesh-list
154783227|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154783228|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154783229|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783230|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783231|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
154783232|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154783233|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783234|NCT04032067|Urological Agents|urological agents|mesh-ancestor
154783235|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
154783236|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154783237|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783238|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
154783239|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
154783240|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154783241|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154783242|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783243|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783244|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154783245|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154783246|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783247|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783248|NCT04051957|Isosorbide|isosorbide|mesh-list
154783249|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154783250|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154783251|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154783252|NCT04051957|Diuretics|diuretics|mesh-ancestor
154783253|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
154783254|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783255|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
154783256|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154783257|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783258|NCT00591123|Leucovorin|leucovorin|mesh-list
154783259|NCT00591123|Fluorouracil|fluorouracil|mesh-list
154783260|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
154783261|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154783262|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
154783263|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783264|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
154783265|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783266|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154783267|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783268|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154783269|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
154783270|NCT00591123|Antidotes|antidotes|mesh-ancestor
154783271|NCT00591123|Protective Agents|protective agents|mesh-ancestor
154783272|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
154783273|NCT00591123|Vitamins|vitamins|mesh-ancestor
154783274|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
154783275|NCT00591123|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154783276|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154783277|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783278|NCT04149990|Valsartan|valsartan|mesh-list
154783279|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154783280|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154783281|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154783282|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154783283|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783284|NCT00591825|Cycloserine|cycloserine|mesh-list
154783285|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154783286|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783287|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154783288|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
154783289|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154783290|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
154783291|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783292|NCT01429285|Hydromorphone|hydromorphone|mesh-list
154783293|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154783294|NCT01429285|Narcotics|narcotics|mesh-ancestor
154783295|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783296|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783297|NCT01429285|Analgesics|analgesics|mesh-ancestor
154783298|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
154783299|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783300|NCT00594945|Clonazepam|clonazepam|mesh-list
154783301|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
154783302|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
154783303|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
154783304|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783305|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783306|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783307|NCT00595101|Latanoprost|latanoprost|mesh-list
154783308|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154783309|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154783310|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154783311|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154783312|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783313|NCT00660075|Incretins|incretins|mesh-ancestor
154783314|NCT00660075|Hormones|hormones|mesh-ancestor
154783315|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154783316|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154783317|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
154783318|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783319|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783320|NCT01429051|Fentanyl|fentanyl|mesh-list
154783321|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154783322|NCT01429051|Narcotics|narcotics|mesh-ancestor
154783323|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783324|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783325|NCT01429051|Analgesics|analgesics|mesh-ancestor
154783326|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
154783327|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783328|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154783329|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154783330|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
154783331|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
154783332|NCT03968562|Doxycycline|doxycycline|mesh-list
154783333|NCT03968562|Petrolatum|petrolatum|mesh-list
154783334|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154783335|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783336|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
154783338|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154783339|NCT03968562|Emollients|emollients|mesh-ancestor
154783340|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
154783341|NCT03425292|Bevacizumab|bevacizumab|mesh-list
154783342|NCT03425292|Nivolumab|nivolumab|mesh-list
154783343|NCT03425292|Ipilimumab|ipilimumab|mesh-list
154783344|NCT03425292|Temozolomide|temozolomide|mesh-list
154783345|NCT03425292|Lomustine|lomustine|mesh-list
154783346|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783347|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783348|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154783349|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154783350|NCT03425292|Growth Substances|growth substances|mesh-ancestor
154783351|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783352|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
154783353|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154783354|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783355|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154783356|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
154783357|NCT00596271|Vaccines|vaccines|mesh-list
154783358|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
154783359|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783360|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
154783361|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
154783362|NCT03139422|Calcium|calcium|mesh-list
154783363|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154783364|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783365|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154783366|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154783367|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783368|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
154783369|NCT03139422|Coagulants|coagulants|mesh-ancestor
154783370|NCT01428583|Naltrexone|naltrexone|mesh-list
154783371|NCT01428583|Oxycodone|oxycodone|mesh-list
154783372|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154783373|NCT01428583|Narcotics|narcotics|mesh-ancestor
154783374|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783375|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783376|NCT01428583|Analgesics|analgesics|mesh-ancestor
154783377|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
154783378|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783379|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154783380|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154783381|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154783382|NCT00660543|Hematinics|hematinics|mesh-ancestor
154783383|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154783384|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154783385|NCT01428193|Flutamide|flutamide|mesh-list
154783386|NCT01428193|Estradiol|estradiol|mesh-list
154783387|NCT01428193|Progesterone|progesterone|mesh-list
154783388|NCT01428193|Estrogens|estrogens|mesh-ancestor
154783389|NCT01428193|Hormones|hormones|mesh-ancestor
154783390|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154783391|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783392|NCT01428193|Progestins|progestins|mesh-ancestor
154783393|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
154783394|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
154783395|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154783396|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783397|NCT03864276|Propofol|propofol|mesh-list
154783398|NCT03864276|Desflurane|desflurane|mesh-list
154783399|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
154783400|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783401|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783402|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154783403|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154783404|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
154783405|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154783406|NCT03141918|Curcumin|curcumin|mesh-list
154783407|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154783408|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154783409|NCT03141918|Analgesics|analgesics|mesh-ancestor
154783410|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
154783411|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783412|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783413|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154783414|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783415|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783416|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783417|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783418|NCT01427803|Naproxen|naproxen|mesh-list
154783419|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154783420|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154783421|NCT01427803|Analgesics|analgesics|mesh-ancestor
154783422|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
154783423|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783424|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783425|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154783426|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783427|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
154783428|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154783429|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783430|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783431|NCT03139500|Midazolam|midazolam|mesh-list
154783432|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154783433|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154783434|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783435|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783436|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154783437|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154783438|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154783439|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154783440|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
154783441|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
154783442|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
154783443|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
154783444|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783445|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783446|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154783447|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154783448|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154783449|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154783450|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154783451|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
154783452|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783453|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783454|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783455|NCT04476966|Mirabegron|mirabegron|mesh-list
154783456|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154783457|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154783458|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154783459|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
154783460|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783461|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783462|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783463|NCT04476966|Urological Agents|urological agents|mesh-ancestor
154783464|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
154783465|NCT03821610|Melphalan|melphalan|mesh-list
154783466|NCT03821610|Fludarabine|fludarabine|mesh-list
154783467|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
154783468|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154783469|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
154783470|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783471|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783472|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154783473|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
154783474|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783475|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783476|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154783477|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783478|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
154783479|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
154783480|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154783481|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783482|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154783483|NCT04044001|Isoniazid|isoniazid|mesh-list
154783484|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
154783485|NCT04044001|Ethambutol|ethambutol|mesh-list
154783486|NCT04044001|Dolutegravir|dolutegravir|mesh-list
154783487|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
154535446|NCT00779636|Desloratadine|desloratadine|mesh-list
154783488|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154783489|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783490|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783491|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783492|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154783493|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154783494|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
154783495|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154783496|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154783497|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154783498|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154783499|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154783500|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
154783502|NCT00684723|L 647318|l 647318|mesh-list
154783503|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
154783504|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154783505|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154783506|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
154783507|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783508|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154783509|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154783510|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783511|NCT01405027|Interferons|interferons|mesh-list
154783512|NCT01405027|Ribavirin|ribavirin|mesh-list
154783513|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
154783514|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
154783515|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154783516|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154783517|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783518|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
154783519|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783520|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
154783521|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783522|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
154783523|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783524|NCT00663039|Oxytocin|oxytocin|mesh-list
154783525|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
154783526|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154783527|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783528|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
154783529|NCT04387539|Simeprevir|simeprevir|mesh-list
154783530|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
154783531|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783532|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
154783533|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783534|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783535|NCT00664755|Nicotine|nicotine|mesh-list
154783536|NCT00664755|Varenicline|varenicline|mesh-list
154783537|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154783538|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
154783539|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783540|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783541|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154783542|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154783543|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
154783544|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783545|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783546|NCT01525628|Tolbutamide|tolbutamide|mesh-list
154783547|NCT01525628|Interferons|interferons|mesh-list
154783548|NCT01525628|Tenofovir|tenofovir|mesh-list
154783549|NCT01525628|Ribavirin|ribavirin|mesh-list
154783550|NCT01525628|Midazolam|midazolam|mesh-list
154783551|NCT01525628|Caffeine|caffeine|mesh-list
154783552|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783553|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
154783554|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783555|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154783556|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154783557|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783558|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783559|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154783560|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154783561|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154783562|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154783563|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
154783564|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
154783565|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
154783566|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
154783567|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783568|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783569|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154783570|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154783571|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783572|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154783573|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154783574|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
154783575|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154783576|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154783577|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154783578|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154783579|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
154783580|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154783581|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154783582|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
154783583|NCT02320695|Bacitracin|bacitracin|mesh-list
154783584|NCT02320695|Neomycin|neomycin|mesh-list
154783585|NCT02320695|Polymyxin B|polymyxin b|mesh-list
154783586|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154783587|NCT02320695|Ethanol|ethanol|mesh-list
154783588|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783589|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
154783590|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154783591|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783592|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783593|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154783594|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783595|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783596|NCT01426009|Bromides|bromides|mesh-list
154783597|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
154783598|NCT01426009|Ipratropium|ipratropium|mesh-list
154783599|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154783600|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
154783601|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783602|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783603|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154783604|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
154783605|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
154783606|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154783607|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
154783608|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783609|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783610|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
154783611|NCT01543958|Sevelamer|sevelamer|mesh-list
154783612|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
154783613|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
154783614|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783615|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154783616|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154783617|NCT01411085|Risperidone|risperidone|mesh-list
154783618|NCT01411085|Desipramine|desipramine|mesh-list
154783619|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154783620|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
154783621|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783622|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783623|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783624|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154783625|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154783626|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783627|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154783628|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154783629|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
154783630|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154783631|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
154783632|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783633|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154783634|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154783635|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154783636|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
154783637|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
154783638|NCT01404949|Tretinoin|tretinoin|mesh-list
154783639|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783640|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
154783641|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
154783642|NCT01431521|Pioglitazone|pioglitazone|mesh-list
154783643|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154783644|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783645|NCT00601965|Escitalopram|escitalopram|mesh-list
154783646|NCT00601965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154783647|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154783648|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154783649|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783650|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783651|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
154783652|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783653|NCT04751994|Sorbitol|sorbitol|mesh-list
154783654|NCT04751994|Cathartics|cathartics|mesh-ancestor
154783655|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154783656|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154783657|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154783658|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783659|NCT02998437|Amoxicillin|amoxicillin|mesh-list
154783660|NCT02998437|Clarithromycin|clarithromycin|mesh-list
154783661|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154783662|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388354|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
154783663|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154783664|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783665|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783666|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154783667|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154783668|NCT02618148|Estrogens|estrogens|mesh-list
154783669|NCT02618148|Hormones|hormones|mesh-ancestor
154783670|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154783671|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783672|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154783673|NCT01404325|Everolimus|everolimus|mesh-list
154783674|NCT01404325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154783675|NCT01404325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154783676|NCT01404325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783677|NCT01404325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783678|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154783679|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
154783680|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783681|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783682|NCT00602355|Sertraline|sertraline|mesh-list
154783683|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
154783684|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154783685|NCT00602355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154783686|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154783687|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154783688|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783689|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783690|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
154783691|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783692|NCT01425463|Glycine|glycine|mesh-list
154783693|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
154783694|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783695|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783696|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783697|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154783698|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
154783699|NCT02144259|Etonogestrel|etonogestrel|mesh-list
154783700|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154783701|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154783702|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154783703|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
154783704|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154783705|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783706|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154783707|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154388398|NCT03177538|Menotropins|menotropins|mesh-list
154783708|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154783709|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154783710|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783711|NCT04655586|Heparin|heparin|mesh-list
154783712|NCT04655586|Protein C|protein c|mesh-list
154783713|NCT04655586|Anticoagulants|anticoagulants|mesh-list
154783714|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154783715|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154783716|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783717|NCT01388647|Carboplatin|carboplatin|mesh-list
154783718|NCT01388647|Trastuzumab|trastuzumab|mesh-list
154783719|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783720|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783721|NCT03140982|Propofol|propofol|mesh-list
154783722|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154783723|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783724|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783725|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154783726|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
154783727|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
154783728|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154783729|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154783730|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783731|NCT05392686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783732|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783733|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783734|NCT00705003|Melatonin|melatonin|mesh-list
154783735|NCT00705003|Buspirone|buspirone|mesh-list
154783736|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
154783737|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783738|NCT00705003|Protective Agents|protective agents|mesh-ancestor
154783739|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783740|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783741|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154783742|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154783743|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154783744|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154783745|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
154783746|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783747|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
154783748|NCT03110640|Fludarabine|fludarabine|mesh-list
154783749|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154783750|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
154783751|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783752|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783753|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154783754|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
154783755|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783756|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783757|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154783758|NCT00690495|Propofol|propofol|mesh-list
154783759|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154783760|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783761|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783762|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154783763|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
154783764|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
154783765|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154783766|NCT00691197|Glycerol|glycerol|mesh-list
154783767|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154783768|NCT00691197|Protective Agents|protective agents|mesh-ancestor
154783769|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783770|NCT00691197|Laxatives|laxatives|mesh-ancestor
154783771|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154783772|NCT02997969|Vaccines|vaccines|mesh-list
154783773|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154783774|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
154388445|NCT01346475|Valacyclovir|valacyclovir|mesh-list
154783775|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783776|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154783777|NCT04351230|Trastuzumab|trastuzumab|mesh-list
154783778|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154783779|NCT04351230|Maytansine|maytansine|mesh-list
154783780|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
154783781|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783782|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783783|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154783784|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
154783785|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
154783786|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
154783787|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783788|NCT04351230|Immunotoxins|immunotoxins|mesh-ancestor
154535750|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
154783789|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
154783790|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783791|NCT05392374|TIC10 compound|tic10 compound|mesh-list
154783792|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783793|NCT04028388|Docetaxel|docetaxel|mesh-list
154783794|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783795|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
154783796|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
154783797|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
154783798|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783799|NCT01402063|Temozolomide|temozolomide|mesh-list
154783800|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
154783801|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154783802|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
154783803|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783804|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783805|NCT01796301|Teriparatide|teriparatide|mesh-list
154783806|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154783807|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783808|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154783809|NCT00868179|Dabigatran|dabigatran|mesh-list
154783810|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
154783811|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154783812|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
154783813|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783814|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783815|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
154783816|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
154783817|NCT01204905|Maraviroc|maraviroc|mesh-list
154783818|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154783819|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154783820|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
154783821|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783822|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154783823|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154783824|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783825|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783826|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154783827|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154783828|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154783829|NCT00691665|Fluticasone|fluticasone|mesh-list
154783831|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154783832|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154783833|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154783834|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
154783835|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783836|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388514|NCT02416804|Tramadol|tramadol|mesh-list
154783837|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154783838|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
154783839|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
154783840|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154783841|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154783842|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154783843|NCT00691665|Analgesics|analgesics|mesh-ancestor
154783844|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
154783845|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783846|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154783847|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154783848|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
154783849|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
154783850|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783851|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783852|NCT01388335|Warfarin|warfarin|mesh-list
154783853|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
154783854|NCT00713583|Levodopa|levodopa|mesh-list
154783855|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154783856|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154783857|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
154783858|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783859|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783860|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783861|NCT03359460|Lenalidomide|lenalidomide|mesh-list
154783862|NCT03359460|Ibrutinib|ibrutinib|mesh-list
154783863|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
154783864|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783865|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154535855|NCT02796391|Nicotine|nicotine|mesh-list
154783866|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154783868|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
154783869|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783870|NCT03359460|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154783871|NCT03359460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154783872|NCT03359460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783873|NCT03359460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783874|NCT03025477|Paclitaxel|paclitaxel|mesh-list
154783875|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154783876|NCT03025477|Cisplatin|cisplatin|mesh-list
154783877|NCT03025477|Carboplatin|carboplatin|mesh-list
154783878|NCT03025477|Epirubicin|epirubicin|mesh-list
154783879|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154783880|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783881|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
154783882|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
154783883|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
154783884|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783885|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154783886|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154783887|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154783888|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783889|NCT03147378|Docetaxel|docetaxel|mesh-list
154783890|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783891|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
154783892|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
154783893|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
154783894|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783895|NCT00159744|Olanzapine|olanzapine|mesh-list
154783896|NCT00159744|Asenapine|asenapine|mesh-list
154783897|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
154783898|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
154783899|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154783900|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783901|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154783902|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154783903|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154783904|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154783905|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154783906|NCT00159744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154783907|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154783908|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154783909|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783910|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783911|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
154783912|NCT02914470|Atezolizumab|atezolizumab|mesh-list
154783913|NCT02914470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154783914|NCT02914470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783915|NCT02914470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783916|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783917|NCT05088330|Daratumumab|daratumumab|mesh-list
154783918|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783919|NCT00695097|Rituximab|rituximab|mesh-list
154783920|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783921|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783922|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
154783923|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783924|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783925|NCT01795911|Interferons|interferons|mesh-list
154783926|NCT01795911|Ribavirin|ribavirin|mesh-list
154783927|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783928|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
154783929|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783930|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
154783931|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783932|NCT03137316|Hormones|hormones|mesh-list
154783933|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
154783934|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154783935|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388631|NCT04039503|Hormones|hormones|mesh-ancestor
154783936|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154783937|NCT03137082|Guanfacine|guanfacine|mesh-list
154783938|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154783939|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154783940|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154783941|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154783942|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
154783943|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154783944|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783945|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783946|NCT05088174|Cyclosporine|cyclosporine|mesh-list
154783947|NCT05088174|Cyclosporins|cyclosporins|mesh-list
154783948|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783949|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783950|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154783951|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
154783952|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783953|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
154783954|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783955|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
154783956|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783957|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154783958|NCT00695409|Cytarabine|cytarabine|mesh-list
154783959|NCT00695409|Rituximab|rituximab|mesh-list
154783960|NCT00695409|Etoposide|etoposide|mesh-list
154783961|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
154783962|NCT00695409|Melphalan|melphalan|mesh-list
154783963|NCT00695409|Carmustine|carmustine|mesh-list
154783964|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154783965|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154783966|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783967|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
154783968|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783969|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154783970|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154783971|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154783972|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154783973|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154783974|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154783975|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154783976|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
154783977|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
154783978|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783979|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154783980|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154783981|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
154783982|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154783983|NCT03469050|Rifaximin|rifaximin|mesh-list
154783984|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154783985|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154783986|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154783987|NCT05087706|Bicalutamide|bicalutamide|mesh-list
154783988|NCT05087706|Leuprolide|leuprolide|mesh-list
154783989|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
154783990|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
154783991|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154783992|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154783993|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154783994|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154783995|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
154783996|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154783997|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154783998|NCT02990403|Aspirin|aspirin|mesh-list
154783999|NCT02990403|Prednisone|prednisone|mesh-list
154784000|NCT02990403|Heparin|heparin|mesh-list
154784001|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
154784002|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
154784003|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154784004|NCT02990403|Antibodies|antibodies|mesh-list
154784005|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784006|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
154784007|NCT02990403|Hormones|hormones|mesh-ancestor
154784008|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784009|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784010|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154784011|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784012|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154784013|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154784014|NCT02990403|Analgesics|analgesics|mesh-ancestor
154784015|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
154784016|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784017|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154784018|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154784019|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154784020|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784021|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154784022|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154784023|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784024|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
154784025|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
154784026|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
154784027|NCT02990403|Progestins|progestins|mesh-ancestor
154784028|NCT00697203|Pravastatin|pravastatin|mesh-list
154784029|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
154784030|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154784031|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154784032|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
154784033|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784034|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154784035|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154784036|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784037|NCT05086848|Leucovorin|leucovorin|mesh-list
154784038|NCT05086848|Fluorouracil|fluorouracil|mesh-list
154784039|NCT05086848|Irinotecan|irinotecan|mesh-list
154784040|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
154784041|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784042|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154784043|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784044|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784045|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
154784046|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784047|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154784048|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154784049|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784050|NCT05086848|Antidotes|antidotes|mesh-ancestor
154784051|NCT05086848|Protective Agents|protective agents|mesh-ancestor
154784052|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
154784053|NCT05086848|Vitamins|vitamins|mesh-ancestor
154784054|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
154784055|NCT00830895|Everolimus|everolimus|mesh-list
154784056|NCT00830895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154784057|NCT00830895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154784058|NCT00830895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784059|NCT00830895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784060|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784061|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
154784062|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784063|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784064|NCT01158417|Resveratrol|resveratrol|mesh-list
154784065|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
154784066|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784067|NCT01158417|Protective Agents|protective agents|mesh-ancestor
154784068|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784069|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784070|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154784071|NCT05086614|Thymalfasin|thymalfasin|mesh-list
154784072|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154784073|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
154784074|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784075|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
154784076|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
154784077|NCT01795131|Vitamins|vitamins|mesh-ancestor
154784078|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
154784079|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784080|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
154784081|NCT01795131|Hematinics|hematinics|mesh-ancestor
154784082|NCT03137004|Docetaxel|docetaxel|mesh-list
154784083|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784084|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
154784085|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
154784086|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154784087|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784088|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
154784089|NCT03113994|Vitamin D|vitamin d|mesh-list
154784090|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
154784091|NCT03113994|Ubiquinone|ubiquinone|mesh-list
154784092|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
154784093|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154784094|NCT03113994|Calcium|calcium|mesh-list
154784095|NCT03113994|Vitamins|vitamins|mesh-ancestor
154784096|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
154784097|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784098|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154784099|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154784100|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154784101|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154784102|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
154784103|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784104|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154784105|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154784106|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784107|NCT03113994|Antacids|antacids|mesh-ancestor
154784108|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784109|NCT02003742|Tamsulosin|tamsulosin|mesh-list
154784110|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154784111|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154784112|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154784113|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
154784114|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784115|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784116|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784117|NCT02003742|Urological Agents|urological agents|mesh-ancestor
154784118|NCT03134118|Nivolumab|nivolumab|mesh-list
154784119|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784120|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784121|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154784122|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784123|NCT05085912|Ethanol|ethanol|mesh-list
154784124|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154784125|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784126|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784127|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784128|NCT02339415|Edoxaban|edoxaban|mesh-list
154784129|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154784130|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
154784131|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154784132|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
154784133|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784134|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784135|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
154784136|NCT02998047|Lintuzumab|lintuzumab|mesh-list
154784137|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784138|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784139|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154784140|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154784141|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154784142|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154784143|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784144|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784145|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784146|NCT03110172|Analgesics|analgesics|mesh-ancestor
154784147|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
154784148|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784149|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
154784150|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154784151|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
154784152|NCT01400503|Siltuximab|siltuximab|mesh-list
154784153|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784154|NCT00706719|Enclomiphene|enclomiphene|mesh-list
154784155|NCT00706719|Clomiphene|clomiphene|mesh-list
154784156|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
154784157|NCT00706719|Testosterone|testosterone|mesh-list
154784158|NCT00706719|Androgens|androgens|mesh-ancestor
154784159|NCT00706719|Hormones|hormones|mesh-ancestor
154784160|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784161|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784162|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154784163|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
154784164|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154784165|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
154784166|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154784167|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154784168|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154784169|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
154784170|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154784171|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784172|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784173|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154784174|NCT05079672|Analgesics|analgesics|mesh-ancestor
154784175|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
154784176|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784177|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154784178|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154784179|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154784180|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
154784181|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784182|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784183|NCT04766827|Paclitaxel|paclitaxel|mesh-list
154784184|NCT04766827|Docetaxel|docetaxel|mesh-list
154784185|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154784186|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154784187|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784188|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
154784189|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
154784190|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
154784191|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784192|NCT02960568|Primaquine|primaquine|mesh-list
154784193|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
154784194|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154784195|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154784196|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784197|NCT02996409|Lidocaine|lidocaine|mesh-list
154784198|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
154784199|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
154784200|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784201|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784202|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
154784203|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784204|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154784205|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154784206|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154784207|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154784208|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784209|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154784210|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154784211|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784212|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784213|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154784214|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154784215|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784216|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
154784217|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784218|NCT01421641|Lidocaine|lidocaine|mesh-list
154784219|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
154784220|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
154784221|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784222|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784223|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
154784224|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784225|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154784226|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154784227|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154784228|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154784229|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784230|NCT05068206|Bevacizumab|bevacizumab|mesh-list
154784231|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784232|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784233|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784234|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784235|NCT05068206|Growth Substances|growth substances|mesh-ancestor
154784236|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784237|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784238|NCT05063370|Simendan|simendan|mesh-list
154784239|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154784240|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
154784241|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154784242|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154784243|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784244|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784245|NCT05063370|Protective Agents|protective agents|mesh-ancestor
154784246|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784247|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
154784248|NCT01421017|Imiquimod|imiquimod|mesh-list
154784249|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784250|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
154784251|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784252|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154784253|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154784254|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
154784255|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784256|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784257|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154784258|NCT01421017|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154784259|NCT01421017|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154784260|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154784261|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
154784262|NCT05089344|Clomiphene|clomiphene|mesh-list
154784263|NCT05089344|Enclomiphene|enclomiphene|mesh-list
154784264|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
154784265|NCT05089344|Hormones|hormones|mesh-list
154784266|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784267|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784268|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154784269|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
154784270|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154784271|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
154784272|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154784273|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154784274|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154784275|NCT01400113|Asenapine|asenapine|mesh-list
154784276|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154784277|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154784278|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784279|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784280|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154784281|NCT01399723|Amoxicillin|amoxicillin|mesh-list
154784282|NCT01399723|Penicillins|penicillins|mesh-list
154784283|NCT01399723|Penicillin G|penicillin g|mesh-list
154784284|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154784285|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
154784286|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154784287|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784288|NCT04726098|Dexamethasone|dexamethasone|mesh-list
154784289|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
154784290|NCT04726098|BB 1101|bb 1101|mesh-list
154784291|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784292|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
154784293|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
154784294|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784295|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784296|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784297|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
154784298|NCT04726098|Hormones|hormones|mesh-ancestor
154784299|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784300|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154784301|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784302|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
154784303|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784304|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784305|NCT05088720|Misoprostol|misoprostol|mesh-list
154784306|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154784307|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
154784308|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154784309|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784310|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154784311|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784312|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
154784313|NCT01383499|Bromides|bromides|mesh-list
154784314|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
154784315|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154784316|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
154784317|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784318|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784319|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154784320|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
154784321|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
154784322|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154784323|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
154784324|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784325|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784326|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
154784327|NCT05084118|Landiolol|landiolol|mesh-list
154784328|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154784329|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154784330|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
154784331|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784332|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784333|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784334|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154784335|NCT03025009|Insulin|insulin|mesh-list
154784336|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154784337|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
154784338|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154784339|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784340|NCT03135912|Terbinafine|terbinafine|mesh-list
154784341|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
154784342|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784343|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784344|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784345|NCT01397461|Retapamulin|retapamulin|mesh-list
154784346|NCT01397461|Ozenoxacin|ozenoxacin|mesh-list
154784347|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154784348|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784349|NCT01397461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154784350|NCT01397461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784351|NCT01397461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784352|NCT01397461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784353|NCT04335084|Vitamin D|vitamin d|mesh-list
154784354|NCT04335084|Vitamins|vitamins|mesh-list
154784355|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
154784356|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
154784357|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784358|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154784359|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
154784360|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154784361|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154784362|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784363|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784364|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784365|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154784366|NCT02996019|Etrolizumab|etrolizumab|mesh-list
154784367|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784368|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
154784369|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784370|NCT02998827|Thalidomide|thalidomide|mesh-list
154784371|NCT02998827|Infliximab|infliximab|mesh-list
154784372|NCT02998827|Azathioprine|azathioprine|mesh-list
154784373|NCT02998827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154784374|NCT02998827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784375|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
154784376|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784377|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154784378|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784379|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
154784380|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784381|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
154784382|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154784383|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784384|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784385|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784386|NCT02998827|Growth Substances|growth substances|mesh-ancestor
154784387|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784388|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784389|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
154784390|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784391|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154784392|NCT02995707|Thalidomide|thalidomide|mesh-list
154536345|NCT02077309|Hormones|hormones|mesh-ancestor
154784393|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784394|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
154784395|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784396|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
154784397|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154784398|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784399|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784400|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784401|NCT02995707|Growth Substances|growth substances|mesh-ancestor
154784402|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784403|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784404|NCT01270035|Adalimumab|adalimumab|mesh-list
154784405|NCT01270035|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154784406|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784407|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154784408|NCT01396447|Cariprazine|cariprazine|mesh-list
154784409|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154784410|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154784411|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784412|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784413|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154784414|NCT00704379|Sertraline|sertraline|mesh-list
154784415|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
154784416|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154784417|NCT00704379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154784418|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154784419|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154784420|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784421|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784422|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
154784423|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784424|NCT02991495|Vaccines|vaccines|mesh-list
154784425|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
154784426|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784427|NCT04449042|Anesthetics|anesthetics|mesh-list
154784428|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784429|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784430|NCT04341090|Apatinib|apatinib|mesh-list
154784431|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784432|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154784433|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784434|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784435|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154784436|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784437|NCT04089150|Leucovorin|leucovorin|mesh-list
154784438|NCT04089150|Paclitaxel|paclitaxel|mesh-list
154784439|NCT04089150|Gemcitabine|gemcitabine|mesh-list
154784440|NCT04089150|Capecitabine|capecitabine|mesh-list
154784441|NCT04089150|Fluorouracil|fluorouracil|mesh-list
154784442|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
154784443|NCT04089150|Irinotecan|irinotecan|mesh-list
154784444|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154784445|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784446|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
154784447|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
154784448|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
154784449|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784450|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154784451|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
154784452|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784453|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
154784454|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784455|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154784456|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154784457|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784458|NCT04089150|Antidotes|antidotes|mesh-ancestor
154784459|NCT04089150|Protective Agents|protective agents|mesh-ancestor
154784460|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
154784461|NCT04089150|Vitamins|vitamins|mesh-ancestor
154784462|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
154784463|NCT02076919|Acrizanib|acrizanib|mesh-list
154784464|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154784465|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154784466|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154784467|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784468|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784469|NCT02076997|Methotrexate|methotrexate|mesh-list
154784470|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154784471|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
154784472|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154784473|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784474|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154784475|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
154784476|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784477|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784478|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
154784479|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784480|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154784481|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784482|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
154784483|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154784484|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154784485|NCT05365165|Sevoflurane|sevoflurane|mesh-list
154784486|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154784487|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154784488|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
154784489|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
154784490|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784491|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784493|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154784494|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784495|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784496|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784497|NCT00707967|Vaccines|vaccines|mesh-list
154784498|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
154784499|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784500|NCT02994381|Ozanimod|ozanimod|mesh-list
154784501|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154784502|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784503|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784504|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
154784505|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784506|NCT00716079|Metoprolol|metoprolol|mesh-list
154784507|NCT00716079|Clonidine|clonidine|mesh-list
154784508|NCT00716079|Labetalol|labetalol|mesh-list
154784509|NCT00716079|Hydralazine|hydralazine|mesh-list
154784510|NCT00716079|Nicardipine|nicardipine|mesh-list
154784511|NCT00716079|Phentolamine|phentolamine|mesh-list
154784512|NCT00716079|Urapidil|urapidil|mesh-list
154784513|NCT00716079|Enalaprilat|enalaprilat|mesh-list
154784514|NCT00716079|Esmolol|esmolol|mesh-list
154784515|NCT00716079|Glycerol|glycerol|mesh-list
154784516|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154784517|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154784518|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
154784519|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
154784520|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784521|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784522|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154784523|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154784524|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154784525|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
154784526|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784527|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784528|NCT00716079|Analgesics|analgesics|mesh-ancestor
154784529|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
154784530|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154784531|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154784532|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154784533|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154784534|NCT00716079|Protective Agents|protective agents|mesh-ancestor
154784535|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
154784536|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154784537|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154784538|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
154784539|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154784540|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154784541|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154784542|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154784543|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
154784544|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154536492|NCT02078323|Linaclotide|linaclotide|mesh-list
154784545|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
154784546|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784547|NCT01270191|Exenatide|exenatide|mesh-list
154784548|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
154784549|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154784550|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784551|NCT01270191|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154784552|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154784553|NCT01270191|Incretins|incretins|mesh-ancestor
154784554|NCT01270191|Hormones|hormones|mesh-ancestor
154784555|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784556|NCT02999919|Bupivacaine|bupivacaine|mesh-list
154784557|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
154784558|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
154784559|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784560|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784561|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
154784562|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784563|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
154784564|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154784565|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784566|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784567|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154784568|NCT04526652|Analgesics|analgesics|mesh-ancestor
154784569|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
154784570|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784571|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154784572|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154784573|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154784574|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
154784575|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784576|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784577|NCT01381549|Imipenem|imipenem|mesh-list
154784578|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
154784579|NCT01381549|Cilastatin|cilastatin|mesh-list
154784580|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154784581|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784582|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
154784583|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784584|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784585|NCT00159432|Bevacizumab|bevacizumab|mesh-list
154784586|NCT00159432|Capecitabine|capecitabine|mesh-list
154784587|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
154784588|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784589|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784590|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784591|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784592|NCT00159432|Growth Substances|growth substances|mesh-ancestor
154784593|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784594|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784595|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154784596|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
154784597|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784598|NCT02969850|Vitamin D|vitamin d|mesh-list
154784599|NCT02969850|Calcium|calcium|mesh-list
154784600|NCT02969850|Vitamins|vitamins|mesh-ancestor
154784601|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
154784602|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784603|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154784604|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154784605|NCT02339766|Morphine|morphine|mesh-list
154784606|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154784607|NCT02339766|Narcotics|narcotics|mesh-ancestor
154784608|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784609|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784610|NCT02339766|Analgesics|analgesics|mesh-ancestor
154784611|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
154784612|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784613|NCT04287660|Clarithromycin|clarithromycin|mesh-list
154784614|NCT04287660|Dexamethasone|dexamethasone|mesh-list
154784615|NCT04287660|Lenalidomide|lenalidomide|mesh-list
154784616|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784617|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
154784618|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
154784619|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784620|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784621|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784622|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
154784623|NCT04287660|Hormones|hormones|mesh-ancestor
154784624|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784625|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154784626|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784627|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
154784628|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784629|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784630|NCT04287660|Growth Substances|growth substances|mesh-ancestor
154784631|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784632|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154784633|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784634|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154784635|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784636|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784637|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154784638|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154784639|NCT01396057|Dexamethasone|dexamethasone|mesh-list
154784640|NCT01396057|Ranibizumab|ranibizumab|mesh-list
154784641|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784642|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
154784643|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
154784644|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784645|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784646|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784647|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
154784648|NCT01396057|Hormones|hormones|mesh-ancestor
154784649|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784650|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154784651|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784652|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784653|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784654|NCT01396057|Growth Substances|growth substances|mesh-ancestor
154784655|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784656|NCT02419560|Venetoclax|venetoclax|mesh-list
154784657|NCT02419560|Ibrutinib|ibrutinib|mesh-list
154784658|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784659|NCT02419560|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154784660|NCT02419560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154784661|NCT02419560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784662|NCT02419560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784663|NCT00704847|Calcitonin|calcitonin|mesh-list
154784664|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
154784665|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154784666|NCT00704847|Katacalcin|katacalcin|mesh-list
154784667|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154784668|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784669|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154784670|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
154784671|NCT03393468|Dapivirine|dapivirine|mesh-list
154784672|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154784673|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154784674|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
154784675|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784676|NCT05091606|Anesthetics|anesthetics|mesh-list
154784677|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784678|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784679|NCT01395901|Ondansetron|ondansetron|mesh-list
154784680|NCT01395901|Palonosetron|palonosetron|mesh-list
154784681|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
154784682|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
154784683|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784684|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784685|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784686|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
154784687|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
154784688|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154784689|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154784690|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
154784691|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784692|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784693|NCT01395823|Vitamin D|vitamin d|mesh-list
154784694|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
154784695|NCT01395823|Vitamins|vitamins|mesh-ancestor
154784696|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
154784697|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784698|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154784699|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154784700|NCT02993991|Durvalumab|durvalumab|mesh-list
154784701|NCT02993991|Mocetinostat|mocetinostat|mesh-list
154784702|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784703|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784704|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154784705|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784706|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784707|NCT00158184|Oxycodone|oxycodone|mesh-list
154784708|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154784709|NCT00158184|Narcotics|narcotics|mesh-ancestor
154784710|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784711|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784712|NCT00158184|Analgesics|analgesics|mesh-ancestor
154784713|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
154784714|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784715|NCT02405520|Vaccines|vaccines|mesh-list
154784716|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
154784717|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784718|NCT02993835|Iron|iron|mesh-list
154784719|NCT02993835|Trace Elements|trace elements|mesh-ancestor
154784720|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
154784721|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784722|NCT05091138|Buprenorphine|buprenorphine|mesh-list
154784723|NCT05091138|Bupivacaine|bupivacaine|mesh-list
154784724|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
154784725|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
154784726|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784727|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784728|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
154784729|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784730|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154784731|NCT05091138|Narcotics|narcotics|mesh-ancestor
154784732|NCT05091138|Analgesics|analgesics|mesh-ancestor
154784733|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154784734|NCT02999295|Nivolumab|nivolumab|mesh-list
154784735|NCT02999295|Ramucirumab|ramucirumab|mesh-list
154784736|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784737|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784738|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154784739|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784740|NCT02999295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784741|NCT02999295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784742|NCT02999295|Growth Substances|growth substances|mesh-ancestor
154784743|NCT02999295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784744|NCT02999295|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784745|NCT02998905|Aspirin|aspirin|mesh-list
154784746|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154784747|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154784748|NCT02998905|Analgesics|analgesics|mesh-ancestor
154784749|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
154784750|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784751|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784752|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784753|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154784754|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154784755|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154784756|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784757|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154784758|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154784759|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784760|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
154784761|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154784762|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154784763|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154784764|NCT02993367|Protective Agents|protective agents|mesh-ancestor
154784765|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784766|NCT05094492|Fluorides|fluorides|mesh-list
154784767|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
154784768|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
154784769|NCT05094492|Protective Agents|protective agents|mesh-ancestor
154784770|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784771|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
154784772|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154784773|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784774|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
154784775|NCT01270893|Nilotinib|nilotinib|mesh-list
154784776|NCT01270893|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154784777|NCT01270893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154784778|NCT01270893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784779|NCT01270893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784780|NCT05094414|Valacyclovir|valacyclovir|mesh-list
154784781|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
154784782|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784783|NCT04386447|Oxytocin|oxytocin|mesh-list
154784784|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
154784785|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154784786|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784787|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
154784788|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154784789|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784790|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154784791|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
154784792|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154784793|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784794|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784795|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784796|NCT01380535|Methoxsalen|methoxsalen|mesh-list
154784797|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154784798|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
154784799|NCT00725361|Ambrisentan|ambrisentan|mesh-list
154784800|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154784801|NCT02816424|TEMPO|tempo|mesh-list
154784802|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
154784803|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784804|NCT02816424|Protective Agents|protective agents|mesh-ancestor
154784805|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784806|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
154784807|NCT01275885|Vitamin D|vitamin d|mesh-list
154784808|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154784809|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784810|NCT01275885|Vitamins|vitamins|mesh-ancestor
154784811|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
154784812|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154784813|NCT02794896|Fentanyl|fentanyl|mesh-list
154784814|NCT02794896|Propofol|propofol|mesh-list
154784815|NCT02794896|Sevoflurane|sevoflurane|mesh-list
154784816|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154784817|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784818|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784819|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154784820|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
154784821|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
154784822|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154784823|NCT02794896|Narcotics|narcotics|mesh-ancestor
154784824|NCT02794896|Analgesics|analgesics|mesh-ancestor
154784825|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
154784826|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784827|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154784828|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154784829|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154784830|NCT01271283|Lenalidomide|lenalidomide|mesh-list
154784831|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
154784832|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784833|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784834|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784835|NCT01271283|Growth Substances|growth substances|mesh-ancestor
154784836|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784837|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784838|NCT01271439|Cetuximab|cetuximab|mesh-list
154784839|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784840|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784841|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
154784842|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
154784843|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
154784844|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154784845|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784846|NCT05090592|Atropine|atropine|mesh-list
154784847|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154784848|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154784849|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154784850|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
154784851|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784852|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784853|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154784854|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
154784855|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
154784856|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
154784857|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154784858|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154784859|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
154784860|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784861|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784862|NCT02992665|Calcimycin|calcimycin|mesh-list
154784863|NCT02992665|Ionophores|ionophores|mesh-list
154784864|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154784865|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784866|NCT02992665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154784867|NCT02992665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784868|NCT02992665|Calcium Ionophores|calcium ionophores|mesh-ancestor
154784869|NCT05093478|Lidocaine|lidocaine|mesh-list
154784870|NCT05093478|Capsaicin|capsaicin|mesh-list
154784871|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
154784872|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
154784873|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784874|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784875|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
154784876|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784877|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154784878|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154784879|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154784880|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154784881|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784882|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
154784883|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
154784884|NCT00725751|Interferons|interferons|mesh-list
154784885|NCT00725751|Ribavirin|ribavirin|mesh-list
154784886|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
154784887|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
154784888|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154784889|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784890|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
154784891|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154784892|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
154784893|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784894|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
154784895|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784896|NCT05364385|Budesonide|budesonide|mesh-list
154784897|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154389561|NCT03731741|Protective Agents|protective agents|mesh-ancestor
154784898|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784899|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154784900|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
154784901|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784902|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784903|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154784904|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
154784905|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
154784906|NCT05364385|Hormones|hormones|mesh-ancestor
154784907|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784908|NCT00726375|Etanercept|etanercept|mesh-list
154784909|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154784910|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154784911|NCT00726375|Analgesics|analgesics|mesh-ancestor
154784912|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
154784913|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784914|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784915|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154784916|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154784917|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154784918|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154784919|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
154784920|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154784921|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
154784922|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784923|NCT01394185|Dronabinol|dronabinol|mesh-list
154784924|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
154784925|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784926|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154784927|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154784928|NCT01394185|Analgesics|analgesics|mesh-ancestor
154784929|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
154784930|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784931|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154784932|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154784933|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154784934|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784935|NCT01394185|Hormones|hormones|mesh-ancestor
154784936|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154784937|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
154784938|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784939|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784940|NCT04361851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154784941|NCT04361851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784942|NCT04407715|Anesthetics|anesthetics|mesh-list
154784943|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784944|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784945|NCT00727857|Metformin|metformin|mesh-list
154784946|NCT00727857|Pioglitazone|pioglitazone|mesh-list
154784947|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154784948|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784949|NCT05092152|Propofol|propofol|mesh-list
154784950|NCT05092152|Esketamine|esketamine|mesh-list
154784951|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154784952|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784953|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784954|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154784955|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
154784956|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
154784957|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
154784958|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154784959|NCT05001360|Nivolumab|nivolumab|mesh-list
154784960|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154784961|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784962|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784963|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784964|NCT01525550|Sunitinib|sunitinib|mesh-list
154784965|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784966|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154784967|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154784968|NCT01525550|Growth Substances|growth substances|mesh-ancestor
154784969|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784970|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
154784971|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154784972|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154784973|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784974|NCT04730232|Paclitaxel|paclitaxel|mesh-list
154784975|NCT04730232|Tislelizumab|tislelizumab|mesh-list
154784976|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154784977|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154784978|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
154784979|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
154784980|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
154784981|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154784982|NCT04730232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154784983|NCT04540848|Bupivacaine|bupivacaine|mesh-list
154784984|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
154784985|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
154784986|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784987|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784988|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
154784989|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154784990|NCT04760028|Anesthetics|anesthetics|mesh-list
154784991|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154784992|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154784993|NCT05366101|Valsartan|valsartan|mesh-list
154784994|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154784995|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154784996|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154784997|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154784998|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154536941|NCT06088147|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154784999|NCT04993560|Vaccines|vaccines|mesh-list
154785000|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
154785001|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785002|NCT05365555|Anesthetics|anesthetics|mesh-list
154785003|NCT05365555|Ropivacaine|ropivacaine|mesh-list
154785004|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
154785005|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785006|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785007|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
154785008|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785009|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
154785010|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154785011|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785012|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154785013|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785014|NCT05374356|Morphine|morphine|mesh-list
154785015|NCT05374356|Bupivacaine|bupivacaine|mesh-list
154785016|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
154785017|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
154785018|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785019|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785020|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
154785021|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785022|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154785023|NCT05374356|Narcotics|narcotics|mesh-ancestor
154785024|NCT05374356|Analgesics|analgesics|mesh-ancestor
154785025|NCT00717405|Bevacizumab|bevacizumab|mesh-list
154389692|NCT03168412|Vaccines|vaccines|mesh-list
154785026|NCT00717405|Trastuzumab|trastuzumab|mesh-list
154785027|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154785028|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785029|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154785030|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154785031|NCT00717405|Growth Substances|growth substances|mesh-ancestor
154785032|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785033|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
154785034|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
154785035|NCT01276977|Eletriptan|eletriptan|mesh-list
154785036|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154785037|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154785038|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
154785039|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785040|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785041|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785042|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
154785043|NCT03832699|Progesterone|progesterone|mesh-list
154785044|NCT03832699|Progestins|progestins|mesh-ancestor
154785045|NCT03832699|Hormones|hormones|mesh-ancestor
154785046|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785047|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785048|NCT01277289|Dexamethasone|dexamethasone|mesh-list
154785049|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785050|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
154785051|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
154785052|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785053|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785054|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785055|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
154785056|NCT01277289|Hormones|hormones|mesh-ancestor
154785057|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785058|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785059|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785060|NCT03599791|Fluticasone|fluticasone|mesh-list
154785062|NCT03599791|Azelastine|azelastine|mesh-list
154785063|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785064|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154785065|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
154785066|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785067|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785068|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154785069|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
154785070|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
154785071|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154785072|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154785073|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785074|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785075|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154785076|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154785077|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
154785078|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
154785079|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785080|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154785081|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154785082|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154785083|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
154785084|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785085|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785086|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785087|NCT01488578|Urological Agents|urological agents|mesh-ancestor
154785088|NCT00720369|Ubiquinone|ubiquinone|mesh-list
154785089|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
154785090|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
154785091|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785092|NCT00720369|Vitamins|vitamins|mesh-ancestor
154785093|NCT01524770|Dulaglutide|dulaglutide|mesh-list
154785094|NCT01524770|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154785095|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154785096|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785097|NCT02991339|Dexamethasone|dexamethasone|mesh-list
154785098|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
154785099|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154785100|NCT02991339|BB 1101|bb 1101|mesh-list
154785101|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785102|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
154785103|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
154785104|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785105|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785106|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785107|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
154785108|NCT02991339|Hormones|hormones|mesh-ancestor
154785109|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785110|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785111|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785112|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
154785113|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785114|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785115|NCT06123520|Paclitaxel|paclitaxel|mesh-list
154785116|NCT06123520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154785117|NCT06123520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154785118|NCT06123520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785119|NCT06123520|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785120|NCT06123520|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785121|NCT06123520|Mitosis Modulators|mitosis modulators|mesh-ancestor
154785122|NCT06123520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785123|NCT06123403|Methotrexate|methotrexate|mesh-list
154785124|NCT06123403|Cystatins|cystatins|mesh-list
154785125|NCT06123403|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154785126|NCT06123403|Abortifacient Agents|abortifacient agents|mesh-ancestor
154785127|NCT06123403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154785128|NCT06123403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785129|NCT06123403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154785130|NCT06123403|Antimetabolites|antimetabolites|mesh-ancestor
154785131|NCT06123403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785132|NCT06123403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785133|NCT06123403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154785134|NCT06123403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785135|NCT06123403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154785136|NCT06123403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154785137|NCT06123403|Immunologic Factors|immunologic factors|mesh-ancestor
154785138|NCT06123403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154785139|NCT06123403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154785140|NCT06123403|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154785141|NCT06123403|Protease Inhibitors|protease inhibitors|mesh-ancestor
154785142|NCT06123377|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
154389807|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154785143|NCT06123377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154785144|NCT06123377|Growth Substances|growth substances|mesh-ancestor
154785145|NCT06123377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785146|NCT06123169|Tazobactam|tazobactam|mesh-list
154785147|NCT06123169|Piperacillin|piperacillin|mesh-list
154785148|NCT06123169|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154785149|NCT06123169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154785150|NCT06123169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154785151|NCT06123169|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154785153|NCT06123169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785154|NCT06123156|Sildenafil Citrate|sildenafil citrate|mesh-list
154785155|NCT06123156|Vasodilator Agents|vasodilator agents|mesh-ancestor
154785156|NCT06123156|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154785157|NCT06123156|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154785158|NCT06123156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785159|NCT06123156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785160|NCT06123156|Urological Agents|urological agents|mesh-ancestor
154785161|NCT06122987|Hydrocortisone|hydrocortisone|mesh-list
154785162|NCT06122987|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154785163|NCT06122987|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154785164|NCT06122987|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154785165|NCT06122987|Angiotensin II|angiotensin ii|mesh-list
154785166|NCT06122987|Giapreza|giapreza|mesh-list
154785167|NCT06122987|Angiotensinogen|angiotensinogen|mesh-list
154785168|NCT06122987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785169|NCT06122987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154785170|NCT06122987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154785171|NCT06122987|Protease Inhibitors|protease inhibitors|mesh-ancestor
154785172|NCT06122987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785173|NCT06122987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785174|NCT06122701|Thiamine|thiamine|mesh-list
154785175|NCT06122701|Vitamin B Complex|vitamin b complex|mesh-ancestor
154785176|NCT06122701|Vitamins|vitamins|mesh-ancestor
154785177|NCT06122701|Micronutrients|micronutrients|mesh-ancestor
154785178|NCT06122701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785179|NCT06122545|Bupivacaine|bupivacaine|mesh-list
154785180|NCT06122545|Anesthetics, Local|anesthetics, local|mesh-ancestor
154785181|NCT06122545|Anesthetics|anesthetics|mesh-ancestor
154785182|NCT06122545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785183|NCT06122545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785184|NCT06122545|Sensory System Agents|sensory system agents|mesh-ancestor
154785185|NCT06122545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785186|NCT06122493|Paclitaxel|paclitaxel|mesh-list
154785187|NCT06122493|Carboplatin|carboplatin|mesh-list
154785188|NCT06122493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154785189|NCT06122493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785190|NCT06122493|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785191|NCT06122493|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785192|NCT06122493|Mitosis Modulators|mitosis modulators|mesh-ancestor
154785193|NCT06122493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785194|NCT06122454|Tenofovir|tenofovir|mesh-list
154785195|NCT06122454|Antiviral Agents|antiviral agents|mesh-ancestor
154785196|NCT06122454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154785197|NCT06122454|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154785198|NCT06122454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154785199|NCT06122454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785200|NCT06122454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785201|NCT06122454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154785202|NCT06122454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154785203|NCT06122428|Riboflavin|riboflavin|mesh-list
154785204|NCT06122428|Hyaluronic Acid|hyaluronic acid|mesh-list
154785205|NCT06122428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154785206|NCT06122428|Immunologic Factors|immunologic factors|mesh-ancestor
154785207|NCT06122428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785208|NCT06122428|Viscosupplements|viscosupplements|mesh-ancestor
154785209|NCT06122428|Protective Agents|protective agents|mesh-ancestor
154785210|NCT06122428|Vitamin B Complex|vitamin b complex|mesh-ancestor
154785211|NCT06122428|Vitamins|vitamins|mesh-ancestor
154785212|NCT06122428|Micronutrients|micronutrients|mesh-ancestor
154785213|NCT06122428|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154785214|NCT06122428|Dermatologic Agents|dermatologic agents|mesh-ancestor
154785215|NCT06122324|Lidocaine|lidocaine|mesh-list
154785216|NCT06122324|Anesthetics, Local|anesthetics, local|mesh-ancestor
154785217|NCT06122324|Anesthetics|anesthetics|mesh-ancestor
154785218|NCT06122324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785219|NCT06122324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785220|NCT06122324|Sensory System Agents|sensory system agents|mesh-ancestor
154785221|NCT06122324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785222|NCT06122324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154785223|NCT06122324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154785224|NCT06122324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154537190|NCT05789342|Digoxin|digoxin|mesh-list
154785225|NCT06122324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785226|NCT06122324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785228|NCT06122090|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154785229|NCT06121830|Fexuprazan|fexuprazan|mesh-list
154785230|NCT06121830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785231|NCT06121804|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154785232|NCT06121804|Immunologic Factors|immunologic factors|mesh-ancestor
154785233|NCT06121804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785234|NCT06121765|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154785235|NCT06121765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154785236|NCT06121765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785237|NCT06121765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785238|NCT06121726|Anesthetics|anesthetics|mesh-list
154785239|NCT06121726|Anesthetics, Local|anesthetics, local|mesh-list
154785240|NCT06121726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785241|NCT06121726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785242|NCT06121726|Sensory System Agents|sensory system agents|mesh-ancestor
154785243|NCT06121726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785244|NCT06121700|Trastuzumab|trastuzumab|mesh-list
154785245|NCT06121700|Antibodies|antibodies|mesh-list
154785246|NCT06121700|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154785247|NCT06121700|Immunologic Factors|immunologic factors|mesh-ancestor
154785248|NCT06121700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785249|NCT06121700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154785250|NCT06121700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785251|NCT06121570|Paclitaxel|paclitaxel|mesh-list
154785252|NCT06121570|Cyclophosphamide|cyclophosphamide|mesh-list
154785253|NCT06121570|Doxorubicin|doxorubicin|mesh-list
154785254|NCT06121570|Fludarabine|fludarabine|mesh-list
154785255|NCT06121570|Interleukin-2|interleukin-2|mesh-list
154785256|NCT06121570|Epirubicin|epirubicin|mesh-list
154785257|NCT06121570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154785258|NCT06121570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785259|NCT06121570|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785260|NCT06121570|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785261|NCT06121570|Mitosis Modulators|mitosis modulators|mesh-ancestor
154785262|NCT06121570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785263|NCT06121570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154785264|NCT06121570|Immunologic Factors|immunologic factors|mesh-ancestor
154785265|NCT06121570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785266|NCT06121570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154785267|NCT06121570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154785268|NCT06121570|Alkylating Agents|alkylating agents|mesh-ancestor
154785269|NCT06121570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154785270|NCT06121570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154785271|NCT06121570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154785272|NCT06121570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154785273|NCT06121570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785274|NCT06121570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154785275|NCT06121570|Analgesics|analgesics|mesh-ancestor
154785276|NCT06121570|Sensory System Agents|sensory system agents|mesh-ancestor
154785277|NCT06121570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785278|NCT06121557|Cyclophosphamide|cyclophosphamide|mesh-list
154785279|NCT06121557|Fludarabine|fludarabine|mesh-list
154785280|NCT06121557|Interleukin-2|interleukin-2|mesh-list
154785281|NCT06121557|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154785282|NCT06121557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154785283|NCT06121557|Immunologic Factors|immunologic factors|mesh-ancestor
154785284|NCT06121557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785285|NCT06121557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154785286|NCT06121557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154785287|NCT06121557|Alkylating Agents|alkylating agents|mesh-ancestor
154785288|NCT06121557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785289|NCT06121557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785290|NCT06121557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154785291|NCT06121557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154785292|NCT06121557|Analgesics|analgesics|mesh-ancestor
154785293|NCT06121557|Sensory System Agents|sensory system agents|mesh-ancestor
154785294|NCT06121557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785295|NCT06121557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785296|NCT06121518|Verapamil|verapamil|mesh-list
154785297|NCT06121518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154785298|NCT06121518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154785299|NCT06121518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785300|NCT06121518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785301|NCT06121518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154785302|NCT06121518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785304|NCT06120803|Esomeprazole|esomeprazole|mesh-list
154785305|NCT06120803|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154785306|NCT06120803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785307|NCT06120803|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154785308|NCT06120803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785309|NCT06120803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785310|NCT06119373|Icodextrin|icodextrin|mesh-list
154785311|NCT06119373|Dialysis Solutions|dialysis solutions|mesh-ancestor
154785312|NCT06119373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154785313|NCT06119217|Paclitaxel|paclitaxel|mesh-list
154785314|NCT06119217|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154785315|NCT06119217|Gemcitabine|gemcitabine|mesh-list
154785316|NCT06119217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154785317|NCT06119217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785318|NCT06119217|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785319|NCT06119217|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785320|NCT06119217|Mitosis Modulators|mitosis modulators|mesh-ancestor
154389983|NCT06336174|Aspirin|aspirin|mesh-list
154785321|NCT06119217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785322|NCT06119217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154785323|NCT06119217|Antimetabolites|antimetabolites|mesh-ancestor
154785324|NCT06119139|Carticaine|carticaine|mesh-list
154785325|NCT06119139|Anesthetics, Local|anesthetics, local|mesh-ancestor
154785326|NCT06119139|Anesthetics|anesthetics|mesh-ancestor
154785327|NCT06119139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785328|NCT06119139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785329|NCT06119139|Sensory System Agents|sensory system agents|mesh-ancestor
154785330|NCT06119139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785331|NCT06118762|Raltitrexed|raltitrexed|mesh-list
154785332|NCT06118762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154785333|NCT06118762|Antimetabolites|antimetabolites|mesh-ancestor
154785334|NCT06118762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785335|NCT06118762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785336|NCT06118762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154785337|NCT06118762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785338|NCT06118710|Dexamethasone|dexamethasone|mesh-list
154785339|NCT06118710|Histamine Antagonists|histamine antagonists|mesh-list
154785340|NCT06118710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154785341|NCT06118710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785342|NCT06118710|Antiemetics|antiemetics|mesh-ancestor
154785343|NCT06118710|Autonomic Agents|autonomic agents|mesh-ancestor
154785344|NCT06118710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785345|NCT06118710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785346|NCT06118710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785347|NCT06118710|Glucocorticoids|glucocorticoids|mesh-ancestor
154785348|NCT06118710|Hormones|hormones|mesh-ancestor
154785349|NCT06118710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785350|NCT06118710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785351|NCT06118710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785352|NCT06118710|Histamine Agents|histamine agents|mesh-ancestor
154785353|NCT06118710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785354|NCT06118710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785355|NCT06118658|Tislelizumab|tislelizumab|mesh-list
154785356|NCT06118658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154785357|NCT06118658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785358|NCT06118645|Paclitaxel|paclitaxel|mesh-list
154785359|NCT06118645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154785360|NCT06118645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785361|NCT06118645|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785362|NCT06118645|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785363|NCT06118645|Mitosis Modulators|mitosis modulators|mesh-ancestor
154785364|NCT06118645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785365|NCT06118580|Ethanol|ethanol|mesh-list
154785366|NCT06118580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154785367|NCT06118580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154785368|NCT06118580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785369|NCT06118580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785370|NCT06118567|Nitrous Oxide|nitrous oxide|mesh-list
154785371|NCT06118567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154785372|NCT06118567|Anesthetics, General|anesthetics, general|mesh-ancestor
154785373|NCT06118567|Anesthetics|anesthetics|mesh-ancestor
154785374|NCT06118567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785375|NCT06118567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785376|NCT06118567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154785377|NCT06118567|Analgesics|analgesics|mesh-ancestor
154785378|NCT06118567|Sensory System Agents|sensory system agents|mesh-ancestor
154785379|NCT06118567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785380|NCT06118515|Letermovir|letermovir|mesh-list
154785381|NCT06118515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154785382|NCT06118515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785383|NCT06118515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785384|NCT06118515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785385|NCT06118515|Antiviral Agents|antiviral agents|mesh-ancestor
154785386|NCT06118515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154785387|NCT06118398|Methylprednisolone|methylprednisolone|mesh-list
154785388|NCT06118398|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154785389|NCT06118398|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154785390|NCT06118398|Prednisolone|prednisolone|mesh-list
154785391|NCT06118398|Prednisolone acetate|prednisolone acetate|mesh-list
154785392|NCT06118398|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154785393|NCT06118398|Prednisolone phosphate|prednisolone phosphate|mesh-list
154785394|NCT06118398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785395|NCT06118398|Antiemetics|antiemetics|mesh-ancestor
154785396|NCT06118398|Autonomic Agents|autonomic agents|mesh-ancestor
154785397|NCT06118398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785398|NCT06118398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785399|NCT06118398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785400|NCT06118398|Glucocorticoids|glucocorticoids|mesh-ancestor
154785401|NCT06118398|Hormones|hormones|mesh-ancestor
154785402|NCT06118398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785403|NCT06118398|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154785404|NCT06118398|Protective Agents|protective agents|mesh-ancestor
154785405|NCT06118398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785406|NCT06118398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785407|NCT06118216|Anesthetics|anesthetics|mesh-list
154785408|NCT06118216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785409|NCT06118216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785410|NCT06118203|Semaglutide|semaglutide|mesh-list
154785411|NCT06118203|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154785412|NCT06118203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154785413|NCT06118203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785414|NCT06118190|Lidocaine|lidocaine|mesh-list
154785415|NCT06118190|Anesthetics, Local|anesthetics, local|mesh-ancestor
154785416|NCT06118190|Anesthetics|anesthetics|mesh-ancestor
154785417|NCT06118190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785418|NCT06118190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785419|NCT06118190|Sensory System Agents|sensory system agents|mesh-ancestor
154785420|NCT06118190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785421|NCT06118190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154785422|NCT06118190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154785423|NCT06118190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154785424|NCT06118190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785425|NCT06118190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785426|NCT06118151|Hemagglutinins|hemagglutinins|mesh-list
154785427|NCT06118151|Vaccines|vaccines|mesh-list
154785428|NCT06118151|Immunologic Factors|immunologic factors|mesh-ancestor
154785429|NCT06118151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785430|NCT06118151|Agglutinins|agglutinins|mesh-ancestor
154785431|NCT06118151|Coagulants|coagulants|mesh-ancestor
154785432|NCT06118047|Cetuximab|cetuximab|mesh-list
154785433|NCT06118047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154785434|NCT06118047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785435|NCT06117917|Pregabalin|pregabalin|mesh-list
154785436|NCT06117917|Ketamine|ketamine|mesh-list
154785437|NCT06117917|Esketamine|esketamine|mesh-list
154785438|NCT06117917|Analgesics|analgesics|mesh-ancestor
154785439|NCT06117917|Sensory System Agents|sensory system agents|mesh-ancestor
154785440|NCT06117917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785441|NCT06117917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785442|NCT06117917|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154785443|NCT06117917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154785444|NCT06117917|Anesthetics, General|anesthetics, general|mesh-ancestor
154785445|NCT06117917|Anesthetics|anesthetics|mesh-ancestor
154785446|NCT06117917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785447|NCT06117917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154785448|NCT06117917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154785449|NCT06117917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785450|NCT06117917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785451|NCT06117917|Anticonvulsants|anticonvulsants|mesh-ancestor
154390114|NCT06334965|Choline|choline|mesh-list
154785452|NCT06117917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154785453|NCT06117917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785454|NCT06117917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154785455|NCT06117917|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154785456|NCT06117917|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154785457|NCT06117917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154785458|NCT06117917|Antidepressive Agents|antidepressive agents|mesh-ancestor
154785459|NCT06117644|Aflutinib|aflutinib|mesh-list
154785460|NCT06117644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154785461|NCT06117644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785462|NCT06117644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785463|NCT06117436|Selenium|selenium|mesh-list
154785464|NCT06117436|Cilostazol|cilostazol|mesh-list
154785465|NCT06117436|Antioxidants|antioxidants|mesh-ancestor
154785466|NCT06117436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785467|NCT06117436|Protective Agents|protective agents|mesh-ancestor
154785468|NCT06117436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785469|NCT06117436|Trace Elements|trace elements|mesh-ancestor
154785470|NCT06117436|Micronutrients|micronutrients|mesh-ancestor
154785471|NCT06117436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154785472|NCT06117436|Autonomic Agents|autonomic agents|mesh-ancestor
154785473|NCT06117436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785474|NCT06117436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154785475|NCT06117436|Respiratory System Agents|respiratory system agents|mesh-ancestor
154785476|NCT06117436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154785477|NCT06117436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154785478|NCT06117436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154785479|NCT06117436|Vasodilator Agents|vasodilator agents|mesh-ancestor
154785480|NCT06117436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154785481|NCT06117436|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154785482|NCT06117436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154785483|NCT06117436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785484|NCT06117306|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154785485|NCT06117306|Hallucinogens|hallucinogens|mesh-ancestor
154785486|NCT06117306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785487|NCT06117306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154785488|NCT06117306|Serotonin Agents|serotonin agents|mesh-ancestor
154785489|NCT06117306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785490|NCT06117306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785491|NCT06117306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154785492|NCT06117306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154785493|NCT06117306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785494|NCT06117306|Adrenergic Agents|adrenergic agents|mesh-ancestor
154785495|NCT06117280|Theophylline|theophylline|mesh-list
154785496|NCT06117280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154785497|NCT06117280|Autonomic Agents|autonomic agents|mesh-ancestor
154785498|NCT06117280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785499|NCT06117280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785500|NCT06117280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154785501|NCT06117280|Respiratory System Agents|respiratory system agents|mesh-ancestor
154785502|NCT06117280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154785503|NCT06117280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785504|NCT06117280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785505|NCT06117280|Vasodilator Agents|vasodilator agents|mesh-ancestor
154785506|NCT06117280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154785507|NCT06117280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154785508|NCT06117280|Purinergic Agents|purinergic agents|mesh-ancestor
154785509|NCT06117280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785510|NCT06117267|Titanium dioxide|titanium dioxide|mesh-list
154785511|NCT06117267|Sunscreening Agents|sunscreening agents|mesh-ancestor
154785512|NCT06117267|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154785513|NCT06117267|Protective Agents|protective agents|mesh-ancestor
154785514|NCT06117267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785515|NCT06117267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154785516|NCT06117267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154785517|NCT06115473|Epinephrine|epinephrine|mesh-list
154785518|NCT06115473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154785519|NCT06115473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154785520|NCT06115473|Adrenergic Agents|adrenergic agents|mesh-ancestor
154785521|NCT06115473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785522|NCT06115473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785523|NCT06115473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785524|NCT06115473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154785525|NCT06115473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154785527|NCT06115473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785528|NCT06115473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154785529|NCT06115473|Respiratory System Agents|respiratory system agents|mesh-ancestor
154785530|NCT06115473|Mydriatics|mydriatics|mesh-ancestor
154785531|NCT06115473|Sympathomimetics|sympathomimetics|mesh-ancestor
154785532|NCT06115473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154785533|NCT06115460|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154785534|NCT06115460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154785535|NCT06115460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785536|NCT06115460|Incretins|incretins|mesh-ancestor
154785537|NCT06115460|Hormones|hormones|mesh-ancestor
154785538|NCT06115460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785539|NCT06115460|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154785540|NCT06115460|Protease Inhibitors|protease inhibitors|mesh-ancestor
154785541|NCT06115460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785542|NCT06115460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785543|NCT06114836|Omeprazole|omeprazole|mesh-list
154785544|NCT06114836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154785545|NCT06114836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785546|NCT06114836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154785547|NCT06114836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785548|NCT06114836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785549|NCT06113744|Vaccines|vaccines|mesh-list
154785550|NCT06113744|Immunologic Factors|immunologic factors|mesh-ancestor
154785551|NCT06113744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785552|NCT06113731|Vaccines|vaccines|mesh-list
154785553|NCT06113731|Immunologic Factors|immunologic factors|mesh-ancestor
154785554|NCT06113731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785555|NCT06102720|Colchicine|colchicine|mesh-list
154785556|NCT06102720|Clopidogrel|clopidogrel|mesh-list
154785557|NCT06102720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154785558|NCT06102720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154785559|NCT06102720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154785560|NCT06102720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154785561|NCT06102720|Purinergic Agents|purinergic agents|mesh-ancestor
154785562|NCT06102720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785563|NCT06102720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785564|NCT06102720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785565|NCT06102720|Gout Suppressants|gout suppressants|mesh-ancestor
154785566|NCT06102720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154785567|NCT06102720|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785568|NCT06102720|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785569|NCT06102720|Mitosis Modulators|mitosis modulators|mesh-ancestor
154785570|NCT06102720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785571|NCT06100692|Vitamin D|vitamin d|mesh-list
154785572|NCT06100692|Vitamins|vitamins|mesh-ancestor
154785573|NCT06100692|Micronutrients|micronutrients|mesh-ancestor
154785574|NCT06100692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785575|NCT06100692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154785576|NCT06098872|Trametinib|trametinib|mesh-list
154785577|NCT06098872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785578|NCT06098872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154785579|NCT06098872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785580|NCT06098872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785581|NCT06095908|Bupivacaine|bupivacaine|mesh-list
154785582|NCT06095908|Anesthetics, Local|anesthetics, local|mesh-ancestor
154785583|NCT06095908|Anesthetics|anesthetics|mesh-ancestor
154785584|NCT06095908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785585|NCT06095908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785586|NCT06095908|Sensory System Agents|sensory system agents|mesh-ancestor
154785587|NCT06095908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785588|NCT06028347|Vaccines|vaccines|mesh-list
154785589|NCT06028347|Immunologic Factors|immunologic factors|mesh-ancestor
154785590|NCT06028347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785591|NCT06003075|Nivolumab|nivolumab|mesh-list
154785592|NCT06003075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154785593|NCT06003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785594|NCT06003075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154785595|NCT06003075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785596|NCT05986942|Fentanyl|fentanyl|mesh-list
154785597|NCT05986942|Dexmedetomidine|dexmedetomidine|mesh-list
154785598|NCT05986942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154785599|NCT05986942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785600|NCT05986942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785601|NCT05986942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154785602|NCT05986942|Analgesics|analgesics|mesh-ancestor
154785603|NCT05986942|Sensory System Agents|sensory system agents|mesh-ancestor
154785604|NCT05986942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785605|NCT05986942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154785606|NCT05986942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154785607|NCT05986942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154785608|NCT05986942|Adrenergic Agents|adrenergic agents|mesh-ancestor
154785609|NCT05986942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785610|NCT05986942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785611|NCT05986942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154785612|NCT05986942|Narcotics|narcotics|mesh-ancestor
154785613|NCT05986942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154785614|NCT05986942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154785615|NCT05986942|Anesthetics, General|anesthetics, general|mesh-ancestor
154785616|NCT05986942|Anesthetics|anesthetics|mesh-ancestor
154785617|NCT05945797|Dexamethasone|dexamethasone|mesh-list
154785618|NCT05945797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785619|NCT05945797|Antiemetics|antiemetics|mesh-ancestor
154785620|NCT05945797|Autonomic Agents|autonomic agents|mesh-ancestor
154785621|NCT05945797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785622|NCT05945797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785623|NCT05945797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785624|NCT05945797|Glucocorticoids|glucocorticoids|mesh-ancestor
154785625|NCT05945797|Hormones|hormones|mesh-ancestor
154785626|NCT05945797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785627|NCT05945797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785628|NCT05945797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785629|NCT05940285|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
154785630|NCT05940285|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154785631|NCT05940285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785632|NCT05909059|Cyclophosphamide|cyclophosphamide|mesh-list
154785633|NCT05909059|Fludarabine|fludarabine|mesh-list
154785634|NCT05909059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154390316|NCT06327256|Midazolam|midazolam|mesh-list
154785635|NCT05909059|Immunologic Factors|immunologic factors|mesh-ancestor
154785636|NCT05909059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785637|NCT05909059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154785638|NCT05909059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154785639|NCT05909059|Alkylating Agents|alkylating agents|mesh-ancestor
154785640|NCT05909059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785641|NCT05909059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785642|NCT05909059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154785643|NCT05905341|Fulvestrant|fulvestrant|mesh-list
154785644|NCT05905341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785645|NCT05905341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785646|NCT05905341|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154785647|NCT05905341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154785648|NCT05905341|Hormone Antagonists|hormone antagonists|mesh-ancestor
154785649|NCT05905341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785650|NCT05905341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785651|NCT05882734|Cemiplimab|cemiplimab|mesh-list
154785652|NCT05882734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154785653|NCT05882734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785654|NCT05874401|Topotecan|topotecan|mesh-list
154785655|NCT05874401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154785656|NCT05874401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154785657|NCT05874401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785658|NCT05874401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785659|NCT05874401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785660|NCT05867472|Sevoflurane|sevoflurane|mesh-list
154785661|NCT05867472|Isoflurane|isoflurane|mesh-list
154785662|NCT05867472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154785663|NCT05867472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154785664|NCT05867472|Anesthetics, General|anesthetics, general|mesh-ancestor
154785665|NCT05867472|Anesthetics|anesthetics|mesh-ancestor
154785666|NCT05867472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785667|NCT05867472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785668|NCT05863325|Docetaxel|docetaxel|mesh-list
154785669|NCT05863325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785670|NCT05863325|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785671|NCT05863325|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785672|NCT05863325|Mitosis Modulators|mitosis modulators|mesh-ancestor
154785673|NCT05863325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785674|NCT05819138|Semaglutide|semaglutide|mesh-list
154785675|NCT05819138|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154785676|NCT05819138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154785677|NCT05819138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785678|NCT05809921|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154785679|NCT05809921|Tenecteplase|tenecteplase|mesh-list
154785680|NCT05809921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154785681|NCT05809921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154785682|NCT05809921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785683|NCT05805826|Vaccines|vaccines|mesh-list
154785684|NCT05805826|Immunologic Factors|immunologic factors|mesh-ancestor
154785685|NCT05805826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785686|NCT05805800|Dexamethasone|dexamethasone|mesh-list
154785687|NCT05805800|Olanzapine|olanzapine|mesh-list
154785688|NCT05805800|Serotonin|serotonin|mesh-list
154785689|NCT05805800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785690|NCT05805800|Antiemetics|antiemetics|mesh-ancestor
154785691|NCT05805800|Autonomic Agents|autonomic agents|mesh-ancestor
154785692|NCT05805800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785693|NCT05805800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785694|NCT05805800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785695|NCT05805800|Glucocorticoids|glucocorticoids|mesh-ancestor
154785696|NCT05805800|Hormones|hormones|mesh-ancestor
154785697|NCT05805800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785698|NCT05805800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785699|NCT05805800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785700|NCT05805800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154785701|NCT05805800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154785702|NCT05805800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785703|NCT05805800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154785704|NCT05805800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154785705|NCT05805800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154785706|NCT05805800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785707|NCT05805800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785708|NCT05805800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785709|NCT05805800|Serotonin Agents|serotonin agents|mesh-ancestor
154785710|NCT05805800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154785711|NCT05794503|Neostigmine|neostigmine|mesh-list
154785712|NCT05794503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154785713|NCT05794503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785714|NCT05794503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785715|NCT05794503|Cholinergic Agents|cholinergic agents|mesh-ancestor
154785716|NCT05794503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785717|NCT05794503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785718|NCT05794503|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154785719|NCT05794503|Autonomic Agents|autonomic agents|mesh-ancestor
154785720|NCT05794503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785721|NCT05763550|Pregabalin|pregabalin|mesh-list
154785722|NCT05763550|Analgesics|analgesics|mesh-ancestor
154785723|NCT05763550|Sensory System Agents|sensory system agents|mesh-ancestor
154785724|NCT05763550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785725|NCT05763550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785726|NCT05763550|Anticonvulsants|anticonvulsants|mesh-ancestor
154785727|NCT05763550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154785728|NCT05763550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785729|NCT05763550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785730|NCT05763550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154785731|NCT05763550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154785732|NCT05763550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154785733|NCT05763550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785734|NCT05763550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154785735|NCT05756777|Ivosidenib|ivosidenib|mesh-list
154785736|NCT05756777|Gilteritinib|gilteritinib|mesh-list
154785737|NCT05756777|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154785738|NCT05756777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154785739|NCT05756777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785740|NCT05756777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785741|NCT05756777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785742|NCT05755204|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154785743|NCT05755204|Cabotegravir|cabotegravir|mesh-list
154785744|NCT05755204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154785745|NCT05755204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154785746|NCT05755204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785747|NCT05755204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785748|NCT05755204|Antiviral Agents|antiviral agents|mesh-ancestor
154785749|NCT05755204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154785750|NCT05755204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154785751|NCT05755204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154785752|NCT05755204|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154785753|NCT05755204|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154785755|NCT05747352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154785756|NCT05747352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785757|NCT05746819|Antipyretics|antipyretics|mesh-list
154785758|NCT05746819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785759|NCT05733507|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154785760|NCT05733507|Tenecteplase|tenecteplase|mesh-list
154785761|NCT05733507|Tirofiban|tirofiban|mesh-list
154785762|NCT05733507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154785763|NCT05733507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154785764|NCT05733507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785765|NCT05733507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154785766|NCT05728736|Lemborexant|lemborexant|mesh-list
154785767|NCT05728736|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154785768|NCT05728736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785769|NCT05728736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785770|NCT05728736|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154785771|NCT05728736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154785772|NCT05728736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785773|NCT05728736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785774|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
154785775|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154785776|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785777|NCT05689021|Prednisone|prednisone|mesh-list
154785778|NCT05689021|Cortisone|cortisone|mesh-list
154785779|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
154785780|NCT05689021|Niraparib|niraparib|mesh-list
154785781|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785782|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
154785783|NCT05689021|Hormones|hormones|mesh-ancestor
154785784|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785785|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785786|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785787|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785788|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154785789|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785790|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785791|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
154785792|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154785793|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154785794|NCT05673629|Docetaxel|docetaxel|mesh-list
154785795|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785796|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785797|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785798|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
154785799|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785800|NCT05673590|Docetaxel|docetaxel|mesh-list
154785801|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785802|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
154785803|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
154785804|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
154785805|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785806|NCT05650736|Abrocitinib|abrocitinib|mesh-list
154785807|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154785808|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785809|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785810|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154785811|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154785812|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154390498|NCT06188520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785813|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785814|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785815|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154785816|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785817|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785819|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785820|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
154785821|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785822|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154785823|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785824|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785825|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
154785826|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785827|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785828|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154785829|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154785830|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154785831|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785832|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785833|NCT05580523|Aspirin|aspirin|mesh-list
154785834|NCT05580523|Metformin|metformin|mesh-list
154785835|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154785836|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785837|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154785838|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154785839|NCT05580523|Analgesics|analgesics|mesh-ancestor
154785840|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
154785841|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785842|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154785843|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154785844|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154785845|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154785846|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785847|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154785848|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154785849|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785850|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
154785851|NCT05558137|Mivacurium|mivacurium|mesh-list
154785852|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154785853|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154785854|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154785855|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785856|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785857|NCT05554393|Cytarabine|cytarabine|mesh-list
154785858|NCT05554393|Azacitidine|azacitidine|mesh-list
154785859|NCT05554393|Daunorubicin|daunorubicin|mesh-list
154785860|NCT05554393|Venetoclax|venetoclax|mesh-list
154785861|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154785862|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
154785863|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785864|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785865|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
154785866|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154785867|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154785868|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
154785869|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785870|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785871|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154785872|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154785873|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154785874|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154785875|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154785876|NCT05553314|Carvedilol|carvedilol|mesh-list
154785877|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154785878|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154785879|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
154785880|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785881|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785882|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785883|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154785884|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
154785885|NCT05553314|Protective Agents|protective agents|mesh-ancestor
154785886|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154785887|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785888|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154785889|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
154785890|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154785891|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154785892|NCT05544071|Sertraline|sertraline|mesh-list
154785893|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
154785894|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154785895|NCT05544071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154785896|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154785897|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785898|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785899|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785900|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
154785901|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785902|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
154785903|NCT05544045|Antacids|antacids|mesh-ancestor
154785904|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785905|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154785906|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
154785907|NCT05523323|Lenvatinib|lenvatinib|mesh-list
154785908|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154785909|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785910|NCT05523323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154785911|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785912|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154785913|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785914|NCT05518812|Carboprost|carboprost|mesh-list
154785915|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
154785916|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154785917|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
154785918|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154785919|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785920|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
154785921|NCT05512364|Tamoxifen|tamoxifen|mesh-list
154785922|NCT05512364|Letrozole|letrozole|mesh-list
154785923|NCT05512364|Anastrozole|anastrozole|mesh-list
154785924|NCT05512364|Exemestane|exemestane|mesh-list
154785925|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785926|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154785927|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154785928|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785929|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785930|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154785931|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
154785932|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154785933|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785934|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154785935|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154785936|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154785937|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154785938|NCT05491720|Risperidone|risperidone|mesh-list
154785939|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154785940|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
154785941|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785942|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785943|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785944|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154785945|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154785946|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154785947|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154785948|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154785949|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
154785950|NCT05490485|Cisplatin|cisplatin|mesh-list
154785951|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785952|NCT05482334|Molgramostim|molgramostim|mesh-list
154785953|NCT05482334|Sargramostim|sargramostim|mesh-list
154785954|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
154785955|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785956|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785957|NCT05478863|Caffeine|caffeine|mesh-list
154785958|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154785959|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785960|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154785961|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154785962|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154537916|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
154785963|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154785964|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154785965|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
154785966|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785968|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154785969|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154785970|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154785971|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785972|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
154785973|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785974|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785975|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154785976|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154785977|NCT05419193|Propranolol|propranolol|mesh-list
154785978|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154785979|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154785980|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
154785981|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154785982|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154785983|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785984|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154785985|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154785986|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
154785987|NCT05417971|Fludarabine|fludarabine|mesh-list
154785988|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154785989|NCT05403307|Vaccines|vaccines|mesh-list
154785990|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
154785991|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154785992|NCT05375760|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154785993|NCT05375760|Antiviral Agents|antiviral agents|mesh-ancestor
154785994|NCT05375760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154785995|NCT05366933|Folic Acid|folic acid|mesh-list
154785996|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
154785997|NCT05366933|Vitamins|vitamins|mesh-ancestor
154785998|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
154785999|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786000|NCT05366933|Hematinics|hematinics|mesh-ancestor
154786001|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154786002|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154786003|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154786004|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154786005|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154786006|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154786007|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154786008|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
154786009|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786010|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786011|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786012|NCT05333250|Modafinil|modafinil|mesh-list
154786013|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154786014|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786015|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154786016|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154786017|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154786018|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786019|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
154786020|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154786021|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786022|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154786023|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786024|NCT05272826|Dexamethasone|dexamethasone|mesh-list
154786025|NCT05272826|Bortezomib|bortezomib|mesh-list
154786026|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786027|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
154786028|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
154786029|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786030|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786031|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154786032|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
154786033|NCT05272826|Hormones|hormones|mesh-ancestor
154786034|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786035|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154786036|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786037|NCT05246514|Trastuzumab|trastuzumab|mesh-list
154786038|NCT05246514|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154786039|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786040|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786041|NCT05246514|Immunoconjugates|immunoconjugates|mesh-ancestor
154786042|NCT05246514|Immunologic Factors|immunologic factors|mesh-ancestor
154786043|NCT05246514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786044|NCT05206877|Insulin|insulin|mesh-list
154786045|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154786046|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154390745|NCT05965492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786047|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786048|NCT05166876|Brequinar|brequinar|mesh-list
154786049|NCT05166876|Dipyridamole|dipyridamole|mesh-list
154786050|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154786051|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786052|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786053|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154786054|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
154786055|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786056|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786057|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
154786058|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786059|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154786060|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154786061|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154786062|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786063|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786064|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154786065|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154786066|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786067|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
154786068|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786069|NCT05080218|Adalimumab|adalimumab|mesh-list
154786070|NCT05080218|Golimumab|golimumab|mesh-list
154786071|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154786072|NCT05080218|Etanercept|etanercept|mesh-list
154786073|NCT05080218|Abatacept|abatacept|mesh-list
154786074|NCT05080218|Upadacitinib|upadacitinib|mesh-list
154786075|NCT05080218|Ixekizumab|ixekizumab|mesh-list
154786076|NCT05080218|Tofacitinib|tofacitinib|mesh-list
154786077|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786078|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786079|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154786080|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154786081|NCT05080218|Analgesics|analgesics|mesh-ancestor
154786082|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
154786083|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786084|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786085|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154786086|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786087|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
154786088|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154786089|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786090|NCT05080218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786091|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786092|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154786093|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154786094|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786095|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
154786096|NCT05042102|Donepezil|donepezil|mesh-list
154786097|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154786098|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786099|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786100|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
154786101|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786102|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786103|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
154786104|NCT05041101|Halichondrin B|halichondrin b|mesh-list
154786105|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
154538065|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154786106|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786107|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
154390803|NCT05900336|Naproxen|naproxen|mesh-list
154786108|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786109|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786110|NCT05005689|Fluorides|fluorides|mesh-list
154786111|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
154786112|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786113|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
154786114|NCT05005689|Protective Agents|protective agents|mesh-ancestor
154786116|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
154786117|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786118|NCT04996498|Oxytocin|oxytocin|mesh-list
154786119|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
154786120|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154786121|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786122|NCT04987372|Lidocaine|lidocaine|mesh-list
154786123|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
154786124|NCT04987372|Pregabalin|pregabalin|mesh-list
154786125|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
154786126|NCT04987372|Ketamine|ketamine|mesh-list
154786127|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
154786128|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
154786129|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154786130|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786131|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
154786132|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786133|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154786134|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154786135|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154786136|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154786137|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786138|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154786139|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154786140|NCT04987372|Analgesics|analgesics|mesh-ancestor
154786141|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154786142|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154786143|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154786144|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
154786145|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786146|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154786147|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154786148|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
154786149|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154786150|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154786151|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
154786152|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154786153|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154786154|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154786155|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154786156|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154786157|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
154786158|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154786159|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
154786160|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786161|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786162|NCT04977375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154786163|NCT04977375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786164|NCT04977024|Vaccines|vaccines|mesh-list
154786165|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
154786166|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786167|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
154786168|NCT04947254|Prednisone|prednisone|mesh-list
154786169|NCT04947254|Cortisone|cortisone|mesh-list
154786170|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
154786171|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
154786172|NCT04947254|Niraparib|niraparib|mesh-list
154786173|NCT04947254|Hormones|hormones|mesh-list
154786174|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154786175|NCT04947254|Androgens|androgens|mesh-list
154786176|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
154786177|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786178|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
154786179|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786180|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786181|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154786182|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786183|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154786184|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786185|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786186|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
154786187|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154786188|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154786189|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
154786190|NCT04947254|Protective Agents|protective agents|mesh-ancestor
154786191|NCT04947254|Vitamins|vitamins|mesh-ancestor
154786192|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
154786193|NCT04947254|Estrogens|estrogens|mesh-ancestor
154786194|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
154786195|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
154786196|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786197|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786198|NCT04939701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154786199|NCT04939701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786200|NCT04917055|Dexamethasone|dexamethasone|mesh-list
154786201|NCT04917055|Epinephrine|epinephrine|mesh-list
154786202|NCT04917055|Ropivacaine|ropivacaine|mesh-list
154786203|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786204|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
154786205|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
154786206|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786207|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786208|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154786209|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
154786210|NCT04917055|Hormones|hormones|mesh-ancestor
154786211|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786212|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154786213|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786214|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
154786215|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
154786216|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154786217|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
154786218|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154786219|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154786220|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
154786221|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786222|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786223|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154786224|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154786225|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154786226|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
154786227|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
154786228|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
154786229|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154786230|NCT04909801|Adalimumab|adalimumab|mesh-list
154786231|NCT04909801|Methotrexate|methotrexate|mesh-list
154786232|NCT04909801|Abatacept|abatacept|mesh-list
154786233|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154786234|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
154786235|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154786236|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786237|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154786238|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
154786239|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786240|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786241|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
154786242|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786243|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154786244|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786245|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
154786246|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786247|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154786248|NCT04909801|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154786249|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786250|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154786251|NCT04909801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786252|NCT04877821|Paclitaxel|paclitaxel|mesh-list
154786253|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
154786254|NCT04877821|Carboplatin|carboplatin|mesh-list
154786255|NCT04877821|Epirubicin|epirubicin|mesh-list
154786256|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786257|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786258|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786259|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786260|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786261|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786262|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786263|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
154786264|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786265|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786266|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154786267|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
154786268|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154786269|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154786270|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154786271|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154786272|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786273|NCT04858529|Carboplatin|carboplatin|mesh-list
154786274|NCT04858529|Trastuzumab|trastuzumab|mesh-list
154786275|NCT04858529|Pertuzumab|pertuzumab|mesh-list
154786276|NCT04858529|Taxane|taxane|mesh-list
154786277|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786278|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786279|NCT04855136|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154786280|NCT04855136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786281|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786282|NCT04821830|Levodopa|levodopa|mesh-list
154786283|NCT04821830|Carbidopa|carbidopa|mesh-list
154786284|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154786285|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154786286|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154786287|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
154786288|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786289|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786290|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786291|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154786292|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786293|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154786294|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
154786295|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
154786296|NCT04787848|Bromides|bromides|mesh-list
154786297|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
154786298|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
154786299|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154786300|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786301|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
154786302|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786303|NCT04787731|Lidocaine|lidocaine|mesh-list
154786304|NCT04787731|Bupivacaine|bupivacaine|mesh-list
154786305|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
154786306|NCT04787731|Anesthetics|anesthetics|mesh-list
154786307|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154786308|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786309|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
154786310|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786311|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154786312|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154786313|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154786314|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154786315|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786316|NCT04745910|Rasburicase|rasburicase|mesh-list
154786317|NCT04745910|Uric Acid|uric acid|mesh-list
154786318|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
154786319|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786320|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
154786321|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786322|NCT04745910|Protective Agents|protective agents|mesh-ancestor
154786323|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786324|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154786325|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
154786326|NCT04728087|Coagulants|coagulants|mesh-ancestor
154786327|NCT04663750|Aflibercept|aflibercept|mesh-list
154786328|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154786329|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154786330|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154786331|NCT04663750|Growth Substances|growth substances|mesh-ancestor
154786332|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786333|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
154786334|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786335|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154786336|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154786337|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786338|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154786339|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
154786340|NCT04639466|Vaccines|vaccines|mesh-list
154786341|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
154786342|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786343|NCT04634604|Bevacizumab|bevacizumab|mesh-list
154786344|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786345|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786346|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154786347|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154786348|NCT04634604|Growth Substances|growth substances|mesh-ancestor
154786349|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786350|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
154786351|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154786352|NCT04631601|Androgens|androgens|mesh-list
154786353|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
154786354|NCT04631601|Hormones|hormones|mesh-ancestor
154786355|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786356|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786357|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786358|NCT04631601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786359|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786360|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
154786361|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
154786362|NCT04628429|Erenumab|erenumab|mesh-list
154786363|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154786364|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786365|NCT04628429|Analgesics|analgesics|mesh-ancestor
154786366|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
154786367|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786368|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786369|NCT04603066|Ondansetron|ondansetron|mesh-list
154786370|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
154786371|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
154786372|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786373|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786374|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154786375|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
154786376|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
154786377|NCT04603066|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154786378|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154786379|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
154786380|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786381|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786382|NCT04602026|Coal Tar|coal tar|mesh-list
154786383|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
154786384|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
154786385|NCT04553770|Trastuzumab|trastuzumab|mesh-list
154786386|NCT04553770|Anastrozole|anastrozole|mesh-list
154786387|NCT04553770|Camptothecin|camptothecin|mesh-list
154786388|NCT04553770|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154786389|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
154786390|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786391|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786392|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154786393|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154786394|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154786395|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786396|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786397|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154786398|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
154786399|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786400|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786401|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
154786402|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786403|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154786404|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154786405|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
154786406|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
154786407|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154786408|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154786409|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154786410|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786411|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786412|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786413|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154786414|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
154786415|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786416|NCT04468230|Nicotine|nicotine|mesh-list
154786417|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154786418|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
154786419|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786420|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786421|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154786422|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154786423|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
154786424|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786425|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786426|NCT04467801|Ipatasertib|ipatasertib|mesh-list
154786427|NCT04467801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786428|NCT04467801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154786429|NCT04467801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786430|NCT04467801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786431|NCT04460937|Adavosertib|adavosertib|mesh-list
154786432|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786433|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786434|NCT04456517|Ranolazine|ranolazine|mesh-list
154786435|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154786436|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154786437|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786438|NCT04439227|Adavosertib|adavosertib|mesh-list
154786439|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786440|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786441|NCT04439136|Afatinib|afatinib|mesh-list
154786442|NCT04439136|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154786443|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154786444|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786445|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786446|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786447|NCT04416334|Acetaminophen|acetaminophen|mesh-list
154786448|NCT04416334|Colchicine|colchicine|mesh-list
154786449|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154786450|NCT04416334|Analgesics|analgesics|mesh-ancestor
154786451|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
154786452|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786453|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786454|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
154786455|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
154786456|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786457|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786458|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786459|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786460|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786461|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786462|NCT04383639|Locust bean gum|locust bean gum|mesh-list
154786463|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
154786464|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154786465|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154786466|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154786467|NCT04305691|Ixazomib|ixazomib|mesh-list
154786468|NCT04305691|Glycine|glycine|mesh-list
154786469|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786470|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786471|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
154786472|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786473|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
154391184|NCT05516914|Cisplatin|cisplatin|mesh-list
154786474|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786475|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786476|NCT04299880|Leucovorin|leucovorin|mesh-list
154786477|NCT04299880|Paclitaxel|paclitaxel|mesh-list
154786478|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154786479|NCT04299880|Bevacizumab|bevacizumab|mesh-list
154786480|NCT04299880|Gemcitabine|gemcitabine|mesh-list
154786481|NCT04299880|Nivolumab|nivolumab|mesh-list
154786482|NCT04299880|Fluorouracil|fluorouracil|mesh-list
154786483|NCT04299880|Irinotecan|irinotecan|mesh-list
154786484|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154538437|NCT03503786|Paclitaxel|paclitaxel|mesh-list
154786485|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786486|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786487|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786488|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786489|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786490|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786491|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154786492|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154786493|NCT04299880|Growth Substances|growth substances|mesh-ancestor
154786494|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786495|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
154786496|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154786497|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
154786498|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154786499|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786500|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
154786501|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154786502|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154786503|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786504|NCT04299880|Antidotes|antidotes|mesh-ancestor
154786505|NCT04299880|Protective Agents|protective agents|mesh-ancestor
154786506|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
154786507|NCT04299880|Vitamins|vitamins|mesh-ancestor
154786508|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
154786509|NCT04280848|Temozolomide|temozolomide|mesh-list
154786510|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154786511|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
154786512|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786513|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786514|NCT04256421|Carboplatin|carboplatin|mesh-list
154786515|NCT04256421|Etoposide|etoposide|mesh-list
154786516|NCT04256421|Atezolizumab|atezolizumab|mesh-list
154786517|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786518|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786519|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154786520|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154786521|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391230|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
154786522|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786523|NCT04256421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154786524|NCT04256421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786525|NCT04252742|Erenumab|erenumab|mesh-list
154786526|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154786527|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786528|NCT04252742|Analgesics|analgesics|mesh-ancestor
154786529|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
154786530|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786531|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786532|NCT04237623|Sargramostim|sargramostim|mesh-list
154786533|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
154786534|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786535|NCT04204902|Tepotinib|tepotinib|mesh-list
154786536|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786537|NCT04197713|Olaparib|olaparib|mesh-list
154786538|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154786539|NCT04197713|Adavosertib|adavosertib|mesh-list
154786540|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786541|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786542|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786543|NCT04176705|Triamcinolone|triamcinolone|mesh-list
154786544|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154786545|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154786546|NCT04176705|Lidocaine|lidocaine|mesh-list
154786547|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154786548|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
154786549|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
154786550|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154786551|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786552|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
154786553|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786554|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154786555|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154786556|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154786557|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154786558|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786559|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786560|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
154786561|NCT04176705|Hormones|hormones|mesh-ancestor
154860502|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786562|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786563|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786564|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
154786565|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786566|NCT04166383|Nivolumab|nivolumab|mesh-list
154786567|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786568|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786569|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154786570|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786571|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154786572|NCT04163458|Menotropins|menotropins|mesh-list
154786573|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154786574|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
154391280|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154786575|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154786576|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786577|NCT04130464|Ketorolac|ketorolac|mesh-list
154786578|NCT04130464|Ropivacaine|ropivacaine|mesh-list
154786579|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
154786580|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
154786581|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154786582|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786583|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
154786584|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786585|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154786586|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154786587|NCT04130464|Analgesics|analgesics|mesh-ancestor
154786588|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786589|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786590|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154786591|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786592|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786593|NCT04108858|Trastuzumab|trastuzumab|mesh-list
154786594|NCT04108858|Pertuzumab|pertuzumab|mesh-list
154786595|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154786596|NCT04108858|Antibodies|antibodies|mesh-list
154786597|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
154786598|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154786599|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
154786600|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786601|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786602|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786603|NCT04098237|Pancrelipase|pancrelipase|mesh-list
154786604|NCT04098237|Pancreatin|pancreatin|mesh-list
154786605|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154786606|NCT04084860|Ketamine|ketamine|mesh-list
154786607|NCT04084860|Analgesics|analgesics|mesh-ancestor
154786608|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
154786609|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786610|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786611|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154786612|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154786613|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
154786614|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
154786615|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154786616|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154786617|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154786618|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786619|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786620|NCT04060628|Docetaxel|docetaxel|mesh-list
154786621|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786622|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786623|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786624|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786625|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786626|NCT04037605|Ketoconazole|ketoconazole|mesh-list
154786627|NCT04037605|Dexamethasone|dexamethasone|mesh-list
154786628|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
154786629|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
154786630|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154786631|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154786632|NCT04037605|Hormones|hormones|mesh-list
154786633|NCT04037605|Cosyntropin|cosyntropin|mesh-list
154391343|NCT05383352|Leucovorin|leucovorin|mesh-list
154786634|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154786635|NCT04037605|BB 1101|bb 1101|mesh-list
154786636|NCT04037605|Ganirelix|ganirelix|mesh-list
154786637|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786638|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
154786639|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
154786640|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786641|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786642|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154786643|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
154786644|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786645|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154786646|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786647|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
154786648|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786649|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786650|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
154786651|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154786652|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154786653|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154786654|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154786655|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
154786656|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154786657|NCT04018937|Fludarabine|fludarabine|mesh-list
154786658|NCT04018937|Melphalan|melphalan|mesh-list
154786659|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
154786660|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786661|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786662|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786663|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
154786664|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786665|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154786666|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
154786667|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154786668|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786669|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154786670|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786671|NCT04016389|Paclitaxel|paclitaxel|mesh-list
154786672|NCT04016389|Carboplatin|carboplatin|mesh-list
154786673|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786674|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786675|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786676|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786677|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786678|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786679|NCT04009668|Adalimumab|adalimumab|mesh-list
154786680|NCT04009668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154786681|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786682|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786683|NCT03943667|Paclitaxel|paclitaxel|mesh-list
154786684|NCT03943667|Gemcitabine|gemcitabine|mesh-list
154786685|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786686|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786687|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786688|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786689|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786690|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786691|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154786692|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
154786693|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
154786694|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154786695|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154786696|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786697|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
154786698|NCT03923959|Coagulants|coagulants|mesh-ancestor
154786699|NCT03923374|Buprenorphine|buprenorphine|mesh-list
154786700|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154786701|NCT03923374|Narcotics|narcotics|mesh-ancestor
154786702|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154786703|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786704|NCT03923374|Analgesics|analgesics|mesh-ancestor
154786705|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
154786706|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786707|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154786708|NCT03923270|Durvalumab|durvalumab|mesh-list
154786709|NCT03923270|Olaparib|olaparib|mesh-list
154786710|NCT03923270|Tremelimumab|tremelimumab|mesh-list
154786711|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154786712|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786713|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786714|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154786715|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786716|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786717|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
154786718|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786719|NCT03911466|Buprenorphine|buprenorphine|mesh-list
154786720|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154786721|NCT03911466|Narcotics|narcotics|mesh-ancestor
154786722|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154786723|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786724|NCT03911466|Analgesics|analgesics|mesh-ancestor
154786725|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
154786726|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786727|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154786728|NCT03910244|Pomalidomide|pomalidomide|mesh-list
154786729|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
154786730|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786731|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154786732|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154786733|NCT03910244|Growth Substances|growth substances|mesh-ancestor
154786734|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
154786735|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786736|NCT03904550|Rocuronium|rocuronium|mesh-list
154786737|NCT03904550|Cisatracurium|cisatracurium|mesh-list
154786738|NCT03904550|Neostigmine|neostigmine|mesh-list
154786739|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154786740|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154786741|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154786742|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786743|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786744|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154786745|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786746|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786747|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
154786748|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786749|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154786750|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
154786751|NCT03895099|Desogestrel|desogestrel|mesh-list
154786752|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154786753|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154786754|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154786755|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
154786756|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154786757|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786758|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154786759|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154786760|NCT03895099|Progestins|progestins|mesh-ancestor
154786761|NCT03895099|Hormones|hormones|mesh-ancestor
154786762|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786763|NCT03808610|Cytarabine|cytarabine|mesh-list
154786764|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
154786765|NCT03808610|Dexamethasone|dexamethasone|mesh-list
154786766|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
154786767|NCT03808610|Prednisone|prednisone|mesh-list
154786768|NCT03808610|Cortisone|cortisone|mesh-list
154786769|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
154786770|NCT03808610|Rituximab|rituximab|mesh-list
154786771|NCT03808610|Methotrexate|methotrexate|mesh-list
154786772|NCT03808610|Vincristine|vincristine|mesh-list
154786773|NCT03808610|Venetoclax|venetoclax|mesh-list
154786774|NCT03808610|Asparaginase|asparaginase|mesh-list
154786775|NCT03808610|Pegaspargase|pegaspargase|mesh-list
154786776|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154786777|NCT03808610|Antibodies|antibodies|mesh-list
154786778|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
154786779|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154786780|NCT03808610|BB 1101|bb 1101|mesh-list
154786781|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786782|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
154786783|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786784|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154786785|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154786786|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
154786787|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786788|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786789|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154786790|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786791|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
154786792|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
154786793|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786794|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154786795|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
154786796|NCT03808610|Hormones|hormones|mesh-ancestor
154786797|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154786798|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154786799|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
154786800|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786801|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154786802|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
154786803|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154786804|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154786805|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
154786806|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
154786807|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154786808|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154786809|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
154786810|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154786811|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786812|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786813|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786814|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786815|NCT03792516|Artesunate|artesunate|mesh-list
154786816|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
154786817|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154786818|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154786819|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154786820|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786821|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
154786822|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
154786823|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154786824|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
154786825|NCT03783442|Paclitaxel|paclitaxel|mesh-list
154786826|NCT03783442|Capecitabine|capecitabine|mesh-list
154786827|NCT03783442|Fluorouracil|fluorouracil|mesh-list
154786828|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
154786829|NCT03783442|Tislelizumab|tislelizumab|mesh-list
154786830|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786831|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786832|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786833|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786834|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786835|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786836|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154786837|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
154786838|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154786839|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
154786840|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786841|NCT03783442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786842|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
154786843|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154786844|NCT03756311|Paclitaxel|paclitaxel|mesh-list
154786845|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154786846|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786847|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786848|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786849|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786850|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786851|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786852|NCT03745950|Olaparib|olaparib|mesh-list
154786853|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154786854|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786855|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786856|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786857|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
154786858|NCT03734016|Ibrutinib|ibrutinib|mesh-list
154786859|NCT03734016|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154786860|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154786861|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786862|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786863|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786864|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
154786865|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786866|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786867|NCT03728972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154786868|NCT03728972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786869|NCT03722680|Riluzole|riluzole|mesh-list
154786870|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
154786871|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154786872|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154786873|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786874|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786875|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786876|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154786877|NCT03722680|Protective Agents|protective agents|mesh-ancestor
154786878|NCT03693300|Durvalumab|durvalumab|mesh-list
154786879|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154786880|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786881|NCT03632720|Vaccines|vaccines|mesh-list
154786882|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
154786883|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786884|NCT03624062|Insulin|insulin|mesh-list
154786885|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154786886|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786887|NCT03587311|Paclitaxel|paclitaxel|mesh-list
154786888|NCT03587311|Maytansine|maytansine|mesh-list
154786889|NCT03587311|Bevacizumab|bevacizumab|mesh-list
154786890|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154786891|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154786892|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
154786893|NCT03587311|Antibodies|antibodies|mesh-list
154786894|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
154786895|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154786896|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
154786897|NCT03587311|Anetumab ravtansine|anetumab ravtansine|mesh-list
154786898|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154786899|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786900|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786901|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786902|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786903|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786904|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154786905|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154786906|NCT03587311|Growth Substances|growth substances|mesh-ancestor
154786907|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786908|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
154786909|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
154786910|NCT03587311|Immunoconjugates|immunoconjugates|mesh-ancestor
154786911|NCT03539302|Flecainide|flecainide|mesh-list
154786912|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154786913|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154786914|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154786915|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154786916|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786917|NCT03513562|Venetoclax|venetoclax|mesh-list
154786918|NCT03513562|Ibrutinib|ibrutinib|mesh-list
154786919|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786920|NCT03513562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154786921|NCT03513562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154786922|NCT03513562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786923|NCT03513562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786924|NCT03490344|Lenalidomide|lenalidomide|mesh-list
154786925|NCT03490344|Daratumumab|daratumumab|mesh-list
154786926|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
154786927|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786928|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154786929|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154786930|NCT03490344|Growth Substances|growth substances|mesh-ancestor
154786931|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
154786932|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786933|NCT03489018|Vaccines|vaccines|mesh-list
154786934|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154786935|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
154786936|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786937|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
154786938|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154786939|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
154786940|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154538894|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
154786941|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
154786942|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154786943|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786944|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
154786945|NCT03450018|Gemcitabine|gemcitabine|mesh-list
154786946|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154786947|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
154786948|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786949|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786950|NCT03435718|Albendazole|albendazole|mesh-list
154786951|NCT03435718|Oxfendazole|oxfendazole|mesh-list
154786952|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
154786953|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154786954|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154786955|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
154786956|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154786957|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154786958|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
154786959|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
154786960|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
154786961|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786962|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786963|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
154786964|NCT03323034|Irinotecan|irinotecan|mesh-list
154786965|NCT03323034|Temozolomide|temozolomide|mesh-list
154786966|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154786967|NCT03323034|Pevonedistat|pevonedistat|mesh-list
154786968|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154786969|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154786970|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786971|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154786972|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154786973|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
154786974|NCT03315910|Nicotine|nicotine|mesh-list
154786975|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154786976|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
154786977|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154786978|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786979|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154786980|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154786981|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
154786982|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154786983|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786984|NCT03307252|Metformin|metformin|mesh-list
154786985|NCT03307252|Rifampin|rifampin|mesh-list
154786986|NCT03307252|Probenecid|probenecid|mesh-list
154786987|NCT03307252|Digoxin|digoxin|mesh-list
154786988|NCT03307252|Verapamil|verapamil|mesh-list
154786989|NCT03307252|Furosemide|furosemide|mesh-list
154786990|NCT03307252|Cimetidine|cimetidine|mesh-list
154786991|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154786992|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154786993|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154786994|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154786995|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154786996|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
154786997|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154786998|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154786999|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154787000|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787001|NCT03307252|Diuretics|diuretics|mesh-ancestor
154787002|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
154787003|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154787004|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154787005|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154787006|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
154787007|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154787008|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787009|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
154787010|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154787011|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154787012|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154787013|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154787014|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154787015|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154787016|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154538971|NCT00657878|Paclitaxel|paclitaxel|mesh-list
154787017|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154787018|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154787019|NCT03307252|Protective Agents|protective agents|mesh-ancestor
154787020|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154787021|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154787022|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
154787023|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
154787024|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
154787025|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154787026|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154787027|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154787028|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154787029|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
154391737|NCT04971473|Hormones|hormones|mesh-list
154787030|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
154787031|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154787032|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154787033|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154787034|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
154787035|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
154787037|NCT03247088|Fludarabine|fludarabine|mesh-list
154787038|NCT03247088|Sorafenib|sorafenib|mesh-list
154787039|NCT03247088|Tacrolimus|tacrolimus|mesh-list
154787040|NCT03247088|Lenograstim|lenograstim|mesh-list
154787041|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787042|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
154787043|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787044|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154787045|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154787046|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
154787047|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787048|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787049|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154787050|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154787051|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154787052|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787053|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154787054|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154787055|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
154787056|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154787057|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787058|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154787059|NCT03233139|Paclitaxel|paclitaxel|mesh-list
154787060|NCT03233139|Gemcitabine|gemcitabine|mesh-list
154787061|NCT03233139|Pemetrexed|pemetrexed|mesh-list
154787062|NCT03233139|Ipilimumab|ipilimumab|mesh-list
154787063|NCT03233139|Cemiplimab|cemiplimab|mesh-list
154787064|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154787065|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787066|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787067|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787068|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787069|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787070|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154787071|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
154787072|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787073|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154787074|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154787075|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787076|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154787077|NCT03213002|Capecitabine|capecitabine|mesh-list
154787078|NCT03213002|Temozolomide|temozolomide|mesh-list
154787079|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154787080|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
154787081|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787082|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787083|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154787084|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
154787085|NCT03191786|Gemcitabine|gemcitabine|mesh-list
154787086|NCT03191786|Atezolizumab|atezolizumab|mesh-list
154787087|NCT03191786|Vinorelbine|vinorelbine|mesh-list
154787088|NCT03191786|Antibodies|antibodies|mesh-list
154787089|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154787090|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
154787091|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787092|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154539044|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
154787093|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
154787094|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787095|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787096|NCT03191786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154787097|NCT03191786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787098|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154787099|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787100|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787101|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787102|NCT03174938|Flutemetamol|flutemetamol|mesh-list
154787103|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154787104|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787105|NCT03170518|Canagliflozin|canagliflozin|mesh-list
154787106|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154787107|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787108|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154787109|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787110|NCT03153462|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154787111|NCT03153462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154787112|NCT03153462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787113|NCT03138733|Daptomycin|daptomycin|mesh-list
154787114|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
154787115|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154787116|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154787117|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787118|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
154787119|NCT03121001|Sirolimus|sirolimus|mesh-list
154787120|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
154787121|NCT03121001|Fludarabine|fludarabine|mesh-list
154787122|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
154787123|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154787124|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
154787125|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154787126|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154787127|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154787128|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
154787129|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787130|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787131|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154787132|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154787133|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154787134|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
154787135|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154787136|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154787137|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154787138|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
154787139|NCT03077685|Paclitaxel|paclitaxel|mesh-list
154787140|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154787141|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154787142|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
154787143|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
154787144|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
154787145|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154787146|NCT03020030|Leucovorin|leucovorin|mesh-list
154787147|NCT03020030|Cytarabine|cytarabine|mesh-list
154787148|NCT03020030|Dexamethasone|dexamethasone|mesh-list
154787149|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
154787150|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
154787151|NCT03020030|Doxorubicin|doxorubicin|mesh-list
154787152|NCT03020030|Methotrexate|methotrexate|mesh-list
154787153|NCT03020030|Etoposide|etoposide|mesh-list
154787154|NCT03020030|Vincristine|vincristine|mesh-list
154787155|NCT03020030|Asparaginase|asparaginase|mesh-list
154787156|NCT03020030|Dasatinib|dasatinib|mesh-list
154670825|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
154670826|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154670827|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154670828|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154670829|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154670830|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154670831|NCT02208843|Afatinib|afatinib|mesh-list
154670832|NCT02208843|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154670833|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154670834|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670835|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670836|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670837|NCT02208063|Vancomycin|vancomycin|mesh-list
154670838|NCT02208063|Cefazolin|cefazolin|mesh-list
154670839|NCT02208063|Penicillins|penicillins|mesh-list
154670840|NCT02208063|Daptomycin|daptomycin|mesh-list
154670841|NCT02208063|Cloxacillin|cloxacillin|mesh-list
154670842|NCT02208063|Oxacillin|oxacillin|mesh-list
154670843|NCT02208063|Telavancin|telavancin|mesh-list
154670844|NCT02208063|Nafcillin|nafcillin|mesh-list
154670845|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154670846|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670847|NCT02207907|Listerine|listerine|mesh-list
154670848|NCT02207907|Fluorides|fluorides|mesh-list
154670849|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
154670850|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
154670851|NCT02207907|Protective Agents|protective agents|mesh-ancestor
154670852|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670853|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154670854|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670855|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
154670856|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154670857|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
154670858|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670859|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670860|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154670861|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
154670862|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
154670863|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154670864|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154670865|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670866|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670867|NCT02237157|Gemcitabine|gemcitabine|mesh-list
154670868|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154670869|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
154670870|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670871|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670872|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
154670873|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154670874|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154670875|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154670876|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
154670877|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670878|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670879|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670880|NCT02233803|Budesonide|budesonide|mesh-list
154670881|NCT02233803|Albuterol|albuterol|mesh-list
154670882|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154670883|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670884|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154670885|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
154582945|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
154670886|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670887|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670888|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154670889|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
154670890|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
154670891|NCT02233803|Hormones|hormones|mesh-ancestor
154670892|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670893|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
154670894|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154670895|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154670896|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154670897|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154670898|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
154670899|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670900|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670901|NCT02233647|Cocaine|cocaine|mesh-list
154670902|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
154670903|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
154670904|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670905|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670906|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
154670907|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670908|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154670909|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154670910|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154670911|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670912|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670913|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
154670914|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670915|NCT01632579|Celecoxib|celecoxib|mesh-list
154670916|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154670917|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154670918|NCT01632579|Analgesics|analgesics|mesh-ancestor
154670919|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
154670920|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670921|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670922|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670923|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670924|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154670925|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154670926|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670927|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670928|NCT01632345|Efavirenz|efavirenz|mesh-list
154670929|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154670930|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154670931|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154670932|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670933|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670934|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
154670935|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670936|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154670937|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154670938|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154670939|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154670940|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154670941|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154670942|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154670943|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154670944|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
154670945|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
154670946|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154670947|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154670948|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670949|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670950|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670951|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670952|NCT02205333|Rituximab|rituximab|mesh-list
154670953|NCT02205333|Durvalumab|durvalumab|mesh-list
154670954|NCT02205333|Tremelimumab|tremelimumab|mesh-list
154670955|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154670956|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670957|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
154670958|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670959|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670960|NCT04776369|Lidocaine|lidocaine|mesh-list
154670961|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
154670962|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
154670963|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
154670964|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670965|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670966|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
154670967|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670968|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154670969|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154670970|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154670971|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670972|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670973|NCT04776369|Analgesics|analgesics|mesh-ancestor
154670974|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
154670975|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154670976|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154670977|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
154670978|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154670979|NCT02230527|Clopidogrel|clopidogrel|mesh-list
154670980|NCT02230527|Ticagrelor|ticagrelor|mesh-list
154670981|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154670982|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154670983|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154670984|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154670985|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
154670986|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670987|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670988|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670989|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
154670990|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154670991|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670992|NCT02203149|Grazoprevir|grazoprevir|mesh-list
154670993|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
154670994|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670995|NCT02202837|Etanercept|etanercept|mesh-list
154670996|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154670997|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154670998|NCT02202837|Analgesics|analgesics|mesh-ancestor
154670999|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
154671000|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671001|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671002|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671003|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671004|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671005|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671006|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
154671007|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
154671008|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154671009|NCT02226549|Ledipasvir|ledipasvir|mesh-list
154671010|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
154671011|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671012|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154671013|NCT02226003|Glimepiride|glimepiride|mesh-list
154671014|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
154671015|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154671016|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671017|NCT02226003|Incretins|incretins|mesh-ancestor
154671018|NCT02226003|Hormones|hormones|mesh-ancestor
154671019|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671020|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154671021|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
154671022|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671023|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671024|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154671025|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671026|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
154671027|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154671028|NCT02469519|Dexamethasone|dexamethasone|mesh-list
154671030|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671031|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
154671032|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
154671033|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671034|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671035|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671036|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
154671037|NCT02469519|Hormones|hormones|mesh-ancestor
154671038|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671039|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154671040|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671041|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154671042|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
154671043|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
154671044|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154671045|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
154671046|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671047|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671048|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154671049|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
154671050|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
154671051|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154671052|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
154671053|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671054|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671055|NCT02404441|Spartalizumab|spartalizumab|mesh-list
153925738|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
154671056|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154671057|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671058|NCT02404441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154671059|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671060|NCT02101281|Mitogens|mitogens|mesh-list
154671061|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
154671062|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671063|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
154671064|NCT02224599|Imiquimod|imiquimod|mesh-list
154671065|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671066|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
154671067|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671068|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671069|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154671070|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
154671071|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671072|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671073|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154671074|NCT02224599|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154671075|NCT02224599|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154671076|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154671077|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
154671078|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
154671079|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154671080|NCT02201901|Velpatasvir|velpatasvir|mesh-list
154671081|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
154671082|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671083|NCT02224053|Osimertinib|osimertinib|mesh-list
154671084|NCT02224053|Omeprazole|omeprazole|mesh-list
154671085|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154671086|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671087|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154671088|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671089|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671090|NCT02224053|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154671091|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154671092|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671093|NCT04774107|Ribavirin|ribavirin|mesh-list
154671094|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
154671095|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671096|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
154671097|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671098|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
154671099|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671100|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154671101|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423129|NCT03571230|Metronidazole|metronidazole|mesh-list
154671102|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671103|NCT02434939|Ketamine|ketamine|mesh-list
154671104|NCT02434939|Morphine|morphine|mesh-list
154671105|NCT02434939|Analgesics|analgesics|mesh-ancestor
154671106|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
154671107|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671108|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671109|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154671110|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154671111|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
154671112|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
154671113|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671114|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154671115|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154671116|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671117|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671118|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154671119|NCT02434939|Narcotics|narcotics|mesh-ancestor
154671120|NCT02457325|Carticaine|carticaine|mesh-list
154671121|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
154671122|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
154671123|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671124|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671125|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
154671126|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671127|NCT02434081|Nivolumab|nivolumab|mesh-list
154671128|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154671129|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671130|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154671131|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671132|NCT02222493|Infliximab|infliximab|mesh-list
154671133|NCT02222493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154671134|NCT02222493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671135|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
154671136|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671137|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671138|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154671139|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
154671140|NCT01439997|Coagulants|coagulants|mesh-ancestor
154671141|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154671142|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
154671143|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671144|NCT02403271|Durvalumab|durvalumab|mesh-list
154671145|NCT02403271|Ibrutinib|ibrutinib|mesh-list
154671146|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154671147|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671148|NCT02403271|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154671149|NCT02403271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154671150|NCT02403271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671151|NCT02403271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671152|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
154671153|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154671154|NCT02219685|Ledipasvir|ledipasvir|mesh-list
154671155|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
154671156|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671157|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
154671158|NCT02457247|Antacids|antacids|mesh-ancestor
154671159|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671160|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671161|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154671162|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154671163|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671164|NCT02198235|Dexamethasone|dexamethasone|mesh-list
154671165|NCT02198235|Buprenorphine|buprenorphine|mesh-list
154671166|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671167|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
154671168|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
154671169|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671170|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671171|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671172|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
154671173|NCT02198235|Hormones|hormones|mesh-ancestor
154671174|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671175|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154671176|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423207|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154671177|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154671179|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671180|NCT02198235|Analgesics|analgesics|mesh-ancestor
154671181|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
154671182|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154671183|NCT00346125|Doxorubicin|doxorubicin|mesh-list
154671184|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154671185|NCT00346125|Ifosfamide|ifosfamide|mesh-list
154671186|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154671187|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154671188|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671189|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154671190|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154671191|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671192|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671193|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154671194|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
154671195|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154671196|NCT02217501|Aspirin|aspirin|mesh-list
154671197|NCT02217501|Clopidogrel|clopidogrel|mesh-list
154671198|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154671199|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154671200|NCT02217501|Analgesics|analgesics|mesh-ancestor
154671201|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
154671202|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671203|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671204|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671205|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671206|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154671207|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154671208|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671209|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154671210|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154671211|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671212|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
154671213|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154671214|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154671215|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154671216|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
154671217|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671218|NCT01649869|Valganciclovir|valganciclovir|mesh-list
154671219|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
154671220|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671221|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
154671222|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154671223|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671224|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
154671225|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
154671226|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
154671227|NCT02399449|Hematinics|hematinics|mesh-ancestor
154671228|NCT02217345|Hormones|hormones|mesh-list
154671229|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671230|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671231|NCT02428855|Dasatinib|dasatinib|mesh-list
154671232|NCT02428855|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154671233|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154671234|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582947|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671235|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671236|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671237|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
154671238|NCT02428699|Liver Extracts|liver extracts|mesh-list
154671239|NCT02428699|Hematinics|hematinics|mesh-ancestor
154671240|NCT02428699|Vitamins|vitamins|mesh-ancestor
154671241|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
154671242|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671243|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154671244|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
154671245|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671246|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
154671247|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671248|NCT02397889|Midazolam|midazolam|mesh-list
154671249|NCT02397889|Ketamine|ketamine|mesh-list
154671250|NCT02397889|Analgesics|analgesics|mesh-ancestor
154671251|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
154671252|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671253|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671254|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154671255|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154671256|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
154671257|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
154671258|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671259|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154671260|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154671261|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671262|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671263|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154671264|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154671265|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154671266|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154671267|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154671268|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
154671269|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
154671270|NCT02396953|Lanreotide|lanreotide|mesh-list
154671271|NCT02396953|Somatostatin|somatostatin|mesh-list
154671272|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671273|NCT02396953|Hormones|hormones|mesh-ancestor
154671274|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671275|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671276|NCT02387983|Posaconazole|posaconazole|mesh-list
154671277|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
154671278|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671279|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154671280|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154671281|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154671282|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154671283|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154671284|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671285|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671286|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154671287|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
154671288|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671289|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671290|NCT02395627|Tamoxifen|tamoxifen|mesh-list
154671291|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
154671292|NCT02395627|Vorinostat|vorinostat|mesh-list
154671293|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154671294|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671295|NCT02395627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154671296|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671297|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154671298|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
154671299|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671300|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671301|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154671302|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154671303|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154671304|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154671305|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154671306|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671307|NCT02395081|Vitamin D|vitamin d|mesh-list
154671308|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
154671309|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
154671310|NCT02395081|Vitamins|vitamins|mesh-list
154671311|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
154671312|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671313|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154671314|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154671315|NCT02425111|Vedolizumab|vedolizumab|mesh-list
154671316|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671317|NCT02393755|Capecitabine|capecitabine|mesh-list
154671318|NCT02393755|Nintedanib|nintedanib|mesh-list
154671319|NCT02393755|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154671320|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154671321|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
154671322|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671323|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671324|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154671325|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671326|NCT02393209|Docetaxel|docetaxel|mesh-list
154423358|NCT01373021|Narcotics|narcotics|mesh-ancestor
154671327|NCT02393209|Serabelisib|serabelisib|mesh-list
154671328|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671329|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683580|NCT00047099|Fluorouracil|fluorouracil|mesh-list
154671330|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
154671331|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
154671332|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671333|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671334|NCT02424097|Listerine|listerine|mesh-list
154671335|NCT02424097|Fluorides|fluorides|mesh-list
154671336|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
154671337|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
154671338|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
154671339|NCT02424097|Protective Agents|protective agents|mesh-ancestor
154671340|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671341|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154671342|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671343|NCT02392507|Paclitaxel|paclitaxel|mesh-list
154671344|NCT02392507|Carboplatin|carboplatin|mesh-list
154671345|NCT02392507|Necitumumab|necitumumab|mesh-list
154671346|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154671347|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671348|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
154671349|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
154671350|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
154671351|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671352|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154671353|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
154671354|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154671355|NCT04904341|Protective Agents|protective agents|mesh-ancestor
154671356|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671357|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
154671358|NCT02385799|Sertraline|sertraline|mesh-list
154671359|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
154671360|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154671361|NCT02385799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154671362|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154671363|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154671364|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671365|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671366|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
154671367|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671368|NCT02422303|Ketamine|ketamine|mesh-list
154671369|NCT02422303|Analgesics|analgesics|mesh-ancestor
154671370|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
154671371|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671372|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671373|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154671374|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154671375|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
154671376|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
154671377|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671378|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154671379|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154671380|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671381|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671382|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
154671383|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154671384|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154671385|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671386|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154671387|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154671388|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671389|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154671390|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671391|NCT02384395|Lamivudine|lamivudine|mesh-list
154671392|NCT02384395|Abacavir|abacavir|mesh-list
154671393|NCT02384395|Dolutegravir|dolutegravir|mesh-list
154671394|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154671395|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154671396|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671397|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671398|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
154671399|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671400|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154671401|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154671402|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154671403|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154671405|NCT02391337|Bisoprolol|bisoprolol|mesh-list
154671406|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154671407|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154671408|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671409|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671410|NCT02391337|Protective Agents|protective agents|mesh-ancestor
154671411|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671412|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154671413|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
154671414|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
154671415|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671416|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154671417|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154671418|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154671419|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
154671420|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671421|NCT01649791|Lenalidomide|lenalidomide|mesh-list
154671422|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
154671423|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671424|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154671425|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154671426|NCT01649791|Growth Substances|growth substances|mesh-ancestor
154671427|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
154671428|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671429|NCT02347657|Ivacaftor|ivacaftor|mesh-list
154671430|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154671431|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154671432|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671433|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
154671434|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154671435|NCT02346721|Velpatasvir|velpatasvir|mesh-list
154671436|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
154671437|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671438|NCT02388997|Omalizumab|omalizumab|mesh-list
154671439|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154671440|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154671441|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
154671442|NCT02345161|Budesonide|budesonide|mesh-list
154671443|NCT02345161|Albuterol|albuterol|mesh-list
154671444|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
154671445|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154671446|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671447|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154671448|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
154671449|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671450|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671451|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154671452|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
154671453|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
154671454|NCT02345161|Hormones|hormones|mesh-ancestor
154671455|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671456|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154671457|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154671458|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154671459|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
154671460|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671461|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671462|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
154671463|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154671464|NCT02251275|Tolvaptan|tolvaptan|mesh-list
154671465|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154671466|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671467|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
154671468|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671469|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
154671470|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154671471|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
154671472|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671473|NCT02379637|Expectorants|expectorants|mesh-ancestor
154671474|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
154671475|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154671476|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
154671477|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671478|NCT02379637|Protective Agents|protective agents|mesh-ancestor
154671479|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671480|NCT02379637|Antidotes|antidotes|mesh-ancestor
154671482|NCT02195583|Listerine|listerine|mesh-list
154671483|NCT02195583|Fluorides|fluorides|mesh-list
154671484|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
154671485|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
154671486|NCT02195583|Protective Agents|protective agents|mesh-ancestor
154671487|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671488|NCT02195583|Trace Elements|trace elements|mesh-ancestor
154671489|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
154671490|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154671491|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671492|NCT02379091|Leucovorin|leucovorin|mesh-list
154671493|NCT02379091|Folic Acid|folic acid|mesh-list
154671494|NCT02379091|Methotrexate|methotrexate|mesh-list
154671495|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
154671496|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154671497|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
154671498|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154671499|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671500|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154671501|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
154671502|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671503|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671504|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
154671505|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671506|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154671507|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671508|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
154671509|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671510|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154671511|NCT02379091|Antidotes|antidotes|mesh-ancestor
154671512|NCT02379091|Protective Agents|protective agents|mesh-ancestor
154671513|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
154671514|NCT02379091|Vitamins|vitamins|mesh-ancestor
154671515|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
154671516|NCT02379091|Hematinics|hematinics|mesh-ancestor
154671517|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
154671518|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154671519|NCT02378935|Velpatasvir|velpatasvir|mesh-list
154671520|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
154671521|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671522|NCT02250651|Timolol|timolol|mesh-list
154671523|NCT02250651|Bimatoprost|bimatoprost|mesh-list
154671524|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154671525|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154671526|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
154671527|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671528|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671529|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671530|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154671531|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154671532|NCT02214225|Vaccines|vaccines|mesh-list
154671533|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
154671534|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671535|NCT02249949|Efatutazone|efatutazone|mesh-list
154671536|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671537|NCT02249091|Cytarabine|cytarabine|mesh-list
154671538|NCT02249091|Idarubicin|idarubicin|mesh-list
154671539|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154671540|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
154671541|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671542|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671543|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
154671544|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671545|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671546|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
154671547|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671548|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154671549|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154671550|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154671551|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671552|NCT02213055|Permethrin|permethrin|mesh-list
154671553|NCT02213055|Malathion|malathion|mesh-list
154671554|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671555|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671556|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154671557|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
154671558|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671559|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671560|NCT02309515|Lenalidomide|lenalidomide|mesh-list
154671561|NCT02309515|Vaccines|vaccines|mesh-list
154671562|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
154671563|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671564|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154671565|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154671566|NCT02309515|Growth Substances|growth substances|mesh-ancestor
154671567|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
154671568|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671569|NCT02309359|Methotrexate|methotrexate|mesh-list
154671570|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154671571|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
154671572|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154671573|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671574|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154671575|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
154671576|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671577|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671578|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
154671579|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671580|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154671581|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671582|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
154671583|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671584|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154671585|NCT02375971|Ranibizumab|ranibizumab|mesh-list
154671586|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154671587|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154671588|NCT02375971|Growth Substances|growth substances|mesh-ancestor
154671589|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671590|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
154671591|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671592|NCT02212197|Leuprolide|leuprolide|mesh-list
154671593|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154671594|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
154671595|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154671596|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671597|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154671598|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671599|NCT02193165|Triclosan|triclosan|mesh-list
154671600|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
154671601|NCT02193165|Fluorides|fluorides|mesh-list
154671602|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
154671603|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
154671604|NCT02193165|Protective Agents|protective agents|mesh-ancestor
154671605|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671606|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154671607|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671608|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154671609|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154671610|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
154671611|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671612|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154671613|NCT01617460|Aripiprazole|aripiprazole|mesh-list
154671614|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
154671615|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154671616|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154671617|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154671618|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671619|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671620|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
154671621|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
154671622|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671623|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671624|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154671625|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154671626|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
154671627|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154671628|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154671629|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154671630|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154671632|NCT01889602|Lorazepam|lorazepam|mesh-list
154671633|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
154671634|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154671635|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671636|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
154671637|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
154671638|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671639|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671640|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154671641|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671642|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154671643|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154671644|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154671645|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
154671646|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
154671647|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671648|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671649|NCT01935700|Colchicine|colchicine|mesh-list
154671650|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
154671651|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671652|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
154671653|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
154671654|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
154671655|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671656|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671657|NCT01618162|Liraglutide|liraglutide|mesh-list
154671658|NCT01618162|Xultophy|xultophy|mesh-list
154671659|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154671660|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671661|NCT01618162|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154671662|NCT01618162|Incretins|incretins|mesh-ancestor
154671663|NCT01618162|Hormones|hormones|mesh-ancestor
154671664|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671665|NCT04771767|Ketamine|ketamine|mesh-list
154671666|NCT04771767|Analgesics|analgesics|mesh-ancestor
154671667|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
154671668|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671669|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926334|NCT00653965|Atorvastatin|atorvastatin|mesh-list
154671670|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154671671|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154671672|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
154671673|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
154671674|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671675|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154671676|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154671677|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671678|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671679|NCT02341417|Cinacalcet|cinacalcet|mesh-list
154671680|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154671681|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671682|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154671683|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
154671684|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671685|NCT02340949|Leucovorin|leucovorin|mesh-list
154671686|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
154671687|NCT02340949|Aflibercept|aflibercept|mesh-list
154671688|NCT02340949|Fluorouracil|fluorouracil|mesh-list
154671689|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671690|NCT02340949|Antidotes|antidotes|mesh-ancestor
154671691|NCT02340949|Protective Agents|protective agents|mesh-ancestor
154671692|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671693|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
154671694|NCT02340949|Vitamins|vitamins|mesh-ancestor
154671695|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
154671696|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154671697|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154423727|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
154671698|NCT02340949|Growth Substances|growth substances|mesh-ancestor
154671699|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
154671700|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
154671701|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671702|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154671703|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671704|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
154671705|NCT02374957|Cilostazol|cilostazol|mesh-list
154671706|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154671707|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
154671708|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671709|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671710|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154671711|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
154671712|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154671713|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154671714|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671715|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154671716|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
154671717|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154671718|NCT02374957|Protective Agents|protective agents|mesh-ancestor
154671719|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154671720|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154671721|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671722|NCT02308033|Metronidazole|metronidazole|mesh-list
154671723|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671724|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154671725|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154671726|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154671727|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154671728|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
154671729|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154671730|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154671731|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154671732|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671733|NCT02210091|Factor VIII|factor viii|mesh-list
154671734|NCT02210091|BAX 855|bax 855|mesh-list
154671735|NCT02210091|Coagulants|coagulants|mesh-ancestor
154671736|NCT02338999|Pioglitazone|pioglitazone|mesh-list
154671737|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154671738|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671739|NCT02169219|Prednisone|prednisone|mesh-list
154671740|NCT02169219|Rituximab|rituximab|mesh-list
154671741|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
154671742|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154671743|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671744|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
154671745|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671746|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671747|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671748|NCT02169219|Hormones|hormones|mesh-ancestor
154671749|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671750|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154671751|NCT02191137|Riociguat|riociguat|mesh-list
154671752|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
154671753|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671754|NCT02168439|Midazolam|midazolam|mesh-list
154671755|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
154671756|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154671757|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671758|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671759|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154671760|NCT02168439|Analgesics|analgesics|mesh-ancestor
154671761|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
154671762|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671763|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154671764|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154671765|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154671766|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
154671767|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671768|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671769|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154671770|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154671771|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154671772|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154671773|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154671774|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
154671775|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
154671776|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
154671777|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
154671778|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
154671779|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154671780|NCT02135445|Relugolix|relugolix|mesh-list
154671781|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
154671782|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
154671783|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671784|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671785|NCT02374099|Azacitidine|azacitidine|mesh-list
154671786|NCT02374099|Fulvestrant|fulvestrant|mesh-list
154671787|NCT02374099|Cc-486|cc-486|mesh-list
154671788|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154671789|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
154671790|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671791|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671792|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671793|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154671794|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154671795|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154671796|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
154671797|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154671798|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671799|NCT02134977|Leuprolide|leuprolide|mesh-list
154671800|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154671801|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
154671802|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154671803|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671804|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154671805|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671806|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
154671807|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
154671808|NCT02374021|Adalimumab|adalimumab|mesh-list
154671809|NCT02374021|Etanercept|etanercept|mesh-list
154671810|NCT02374021|Methotrexate|methotrexate|mesh-list
154671811|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154671812|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
154671813|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154671814|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671815|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154671816|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
154671817|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671818|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671819|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
154671820|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671821|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154671822|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671823|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
154671824|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671825|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154671826|NCT02374021|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154671827|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671828|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
154671829|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154671830|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154671831|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671832|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154671833|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154671834|NCT02374021|Analgesics|analgesics|mesh-ancestor
154671835|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
154671836|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671837|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671838|NCT02372383|Azithromycin|azithromycin|mesh-list
154671839|NCT02372383|Rifampin|rifampin|mesh-list
154671840|NCT02372383|Ethambutol|ethambutol|mesh-list
154671841|NCT02372383|Pancrelipase|pancrelipase|mesh-list
154671842|NCT02372383|Pancreatin|pancreatin|mesh-list
154671843|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154671844|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154671845|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154671846|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
154671847|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
154671848|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154671849|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671850|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671851|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154671852|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154671853|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154671854|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154582948|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
154671855|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154671856|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154671857|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154671858|NCT01648699|Hydromorphone|hydromorphone|mesh-list
154671859|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154671860|NCT01648699|Narcotics|narcotics|mesh-ancestor
154671861|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154671862|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671863|NCT01648699|Analgesics|analgesics|mesh-ancestor
154671864|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
154671865|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671866|NCT02134353|Mannitol|mannitol|mesh-list
154671867|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154671868|NCT02134353|Diuretics|diuretics|mesh-ancestor
154671869|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
154671870|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671871|NCT01646125|Docetaxel|docetaxel|mesh-list
154671872|NCT01646125|Pemetrexed|pemetrexed|mesh-list
154671873|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671874|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
154671875|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154671876|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154671877|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671878|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671879|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154671880|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154671881|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
154671882|NCT01362790|Pentostatin|pentostatin|mesh-list
154671883|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154671884|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671885|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
154671886|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671887|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671888|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154671889|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
154671890|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671891|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671892|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154671893|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154671894|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671895|NCT02167893|Leuprolide|leuprolide|mesh-list
154671896|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154671897|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
154671898|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154671899|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671900|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154671901|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671902|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
154671903|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154671904|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154671905|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
154671906|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671907|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671908|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671909|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154671910|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154671911|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154671912|NCT01615198|Olmesartan|olmesartan|mesh-list
154671913|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154671914|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154671915|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154671916|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154671917|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671918|NCT02337907|Donepezil|donepezil|mesh-list
154671919|NCT02337907|BI 409306|bi 409306|mesh-list
154671920|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154671921|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671922|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671923|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
154671924|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154671925|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671926|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
154423950|NCT02681237|Olaparib|olaparib|mesh-list
154671927|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154671928|NCT01913470|Losartan|losartan|mesh-list
154671929|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154671930|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154671931|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154671932|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154671933|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671934|NCT02166333|Vitamin D|vitamin d|mesh-list
154671935|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
154671936|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
154671937|NCT02166333|Vitamins|vitamins|mesh-list
154671938|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
154671939|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671940|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154671941|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154671942|NCT02132949|Paclitaxel|paclitaxel|mesh-list
154671943|NCT02132949|Docetaxel|docetaxel|mesh-list
154671944|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
154671945|NCT02132949|Doxorubicin|doxorubicin|mesh-list
154671946|NCT02132949|Fluorouracil|fluorouracil|mesh-list
154671947|NCT02132949|Trastuzumab|trastuzumab|mesh-list
154671948|NCT02132949|Epirubicin|epirubicin|mesh-list
154671949|NCT02132949|Pertuzumab|pertuzumab|mesh-list
154671950|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154671951|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671952|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
154671953|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
154671954|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
154671955|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671956|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154671957|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
154671958|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671959|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671960|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154671961|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
154671962|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154671963|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154671964|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154671965|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154671966|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671967|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
154671968|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154671969|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154671970|NCT02165397|Rituximab|rituximab|mesh-list
154671971|NCT02165397|Ibrutinib|ibrutinib|mesh-list
154671972|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154671973|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154671974|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
154671975|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671976|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154671977|NCT02165397|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154671978|NCT02165397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154671979|NCT02165397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154671980|NCT02165397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154671981|NCT02132637|Insulin|insulin|mesh-list
154671982|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154671983|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
154671984|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154671985|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154671986|NCT02164929|Acetaminophen|acetaminophen|mesh-list
154671987|NCT02164929|Dexamethasone|dexamethasone|mesh-list
154671988|NCT02164929|Lidocaine|lidocaine|mesh-list
154671989|NCT02164929|Epinephrine|epinephrine|mesh-list
154671990|NCT02164929|Midazolam|midazolam|mesh-list
154671991|NCT02164929|Hydromorphone|hydromorphone|mesh-list
154671992|NCT02164929|Ropivacaine|ropivacaine|mesh-list
154671993|NCT02164929|Propofol|propofol|mesh-list
154671994|NCT02164929|Sevoflurane|sevoflurane|mesh-list
154671995|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154671996|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
154671997|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
154671998|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154671999|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424020|NCT05041673|Liraglutide|liraglutide|mesh-list
154672000|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154672001|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
154672002|NCT02164929|Hormones|hormones|mesh-ancestor
154672003|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672004|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672005|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672006|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
154672007|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
154672008|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672009|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
154672010|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154672011|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154672012|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154672013|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672014|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672015|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154672016|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154672017|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
154672018|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154672019|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154672020|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154672021|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154672022|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
154672023|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
154672024|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672025|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154672026|NCT02164929|Analgesics|analgesics|mesh-ancestor
154672027|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
154672028|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154672029|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154672030|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154672031|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154672032|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
154672033|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154672034|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154672035|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154672036|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
154672037|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
154672038|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
154672039|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154672040|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154672041|NCT02164929|Narcotics|narcotics|mesh-ancestor
154672043|NCT01888432|Tacrolimus|tacrolimus|mesh-list
154672044|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672045|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
154672046|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672047|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154672048|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672049|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672050|NCT01888432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154672051|NCT01888432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154672052|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672053|NCT02188719|Acetaminophen|acetaminophen|mesh-list
154672054|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
154672055|NCT02188719|Promethazine|promethazine|mesh-list
154672056|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
154672057|NCT02188719|Valganciclovir|valganciclovir|mesh-list
154672058|NCT02188719|Ganciclovir|ganciclovir|mesh-list
154672059|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
154672060|NCT02188719|Prednisone|prednisone|mesh-list
154672061|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154672062|NCT02188719|Everolimus|everolimus|mesh-list
154672063|NCT02188719|Liver Extracts|liver extracts|mesh-list
154672064|NCT02188719|Tacrolimus|tacrolimus|mesh-list
154672065|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
154672066|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154672067|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672068|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
154672069|NCT02188719|Hormones|hormones|mesh-ancestor
154672070|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672071|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672072|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672073|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672074|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672075|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
154672076|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154672077|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672078|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672079|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154672080|NCT02188719|Analgesics|analgesics|mesh-ancestor
154672081|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
154672082|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672083|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
154672085|NCT02188719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154672086|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154672087|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154672088|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
154672089|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154672090|NCT02188719|Hematinics|hematinics|mesh-ancestor
154672091|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154672092|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154672093|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672094|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
154672095|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
154672096|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
154672097|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
154672098|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154672099|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154672100|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
154672101|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
154672102|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672103|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154672104|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
154672105|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154672106|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
154672107|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154672108|NCT02188719|Protective Agents|protective agents|mesh-ancestor
154672109|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154672110|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154672111|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672112|NCT01933672|Incretins|incretins|mesh-ancestor
154672113|NCT01933672|Hormones|hormones|mesh-ancestor
154672114|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672115|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154672116|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
154672117|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672118|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672119|NCT02132247|Diclofenac|diclofenac|mesh-list
154672120|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154672121|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154672122|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154672123|NCT02132247|Analgesics|analgesics|mesh-ancestor
154672124|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
154672125|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672126|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672127|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672128|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154672129|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154672130|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672131|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672132|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
154672133|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154672134|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
154672135|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154672136|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
154672137|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672138|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672139|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
154672140|NCT05269017|Vitamin D|vitamin d|mesh-list
154672141|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
154672142|NCT05269017|Budesonide|budesonide|mesh-list
154672143|NCT05269017|Vitamins|vitamins|mesh-ancestor
154672144|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
154672145|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672146|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154672147|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154672148|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672149|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154672150|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
154672151|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672152|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154672153|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
154672154|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
154672155|NCT05269017|Hormones|hormones|mesh-ancestor
154672156|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672157|NCT01628913|Everolimus|everolimus|mesh-list
154672158|NCT01628913|Dactolisib|dactolisib|mesh-list
154672159|NCT01628913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154672160|NCT01628913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154672161|NCT01628913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672162|NCT01628913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672163|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672164|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
154672165|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672166|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672167|NCT02164383|Nicotine|nicotine|mesh-list
154672168|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154672169|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
154672170|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672171|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672172|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154672173|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154672174|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
154672175|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672176|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672177|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154672178|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
154672179|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154672180|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154672181|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672182|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672183|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
154672184|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672185|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154672186|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154672187|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154672188|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154672189|NCT02131155|Afatinib|afatinib|mesh-list
154672190|NCT02131155|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154672191|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154672192|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672193|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672194|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672195|NCT01933594|Romidepsin|romidepsin|mesh-list
154672196|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154672197|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672198|NCT01933594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154672199|NCT01933594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672200|NCT01933594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672201|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154672202|NCT02305849|Methotrexate|methotrexate|mesh-list
154672203|NCT02305849|Peficitinib|peficitinib|mesh-list
154672204|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154672205|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
154672206|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154672207|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672208|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154672209|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
154672210|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672211|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672212|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154672213|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672214|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154672215|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672216|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
154672217|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154672218|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154672219|NCT02371759|Anesthetics|anesthetics|mesh-list
154672220|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672221|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672222|NCT02531633|Prednisone|prednisone|mesh-list
154672223|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154672224|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672225|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
154672226|NCT02531633|Hormones|hormones|mesh-ancestor
154672227|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672228|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672229|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672230|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672231|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
154672232|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
154672233|NCT02536313|Velpatasvir|velpatasvir|mesh-list
154672234|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
154672235|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672236|NCT02187861|Rituximab|rituximab|mesh-list
154672237|NCT02187861|Venetoclax|venetoclax|mesh-list
154672238|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154672239|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672240|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672241|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
154672242|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672243|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154672244|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154672245|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
154582949|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
154672246|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672247|NCT05383001|Durvalumab|durvalumab|mesh-list
154672248|NCT05383001|Tremelimumab|tremelimumab|mesh-list
154672249|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672250|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672251|NCT05610371|Lidocaine|lidocaine|mesh-list
154672252|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
154672253|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
154672254|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672255|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672256|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
154672257|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672258|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154672259|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154672260|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154672261|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672262|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672263|NCT02163759|Adalimumab|adalimumab|mesh-list
154672264|NCT02163759|Etrolizumab|etrolizumab|mesh-list
154672265|NCT02163759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154672266|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672267|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154672268|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154672269|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
154672270|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672271|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154672272|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154672273|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672274|NCT02305381|Semaglutide|semaglutide|mesh-list
154672275|NCT02305381|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154672276|NCT02305381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154672277|NCT02305381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672278|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
154672279|NCT02163447|Piperaquine|piperaquine|mesh-list
154672280|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
154672281|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154672282|NCT02163447|Artenimol|artenimol|mesh-list
154672283|NCT02163447|Artemisinins|artemisinins|mesh-list
154672284|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
154672285|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154672286|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154672287|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672288|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154672289|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672290|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672291|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154672292|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
154672293|NCT01887418|Testosterone|testosterone|mesh-list
154672294|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
154672295|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
154672296|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154672297|NCT01887418|Androgens|androgens|mesh-ancestor
154672298|NCT01887418|Hormones|hormones|mesh-ancestor
154672299|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672300|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672301|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672302|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672303|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
154672304|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154424337|NCT03327844|Metronidazole|metronidazole|mesh-list
154672305|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154672306|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154672307|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672308|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672309|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672310|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672312|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
154672313|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672314|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
154672315|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154672316|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
154672317|NCT02302807|Paclitaxel|paclitaxel|mesh-list
154672318|NCT02302807|Docetaxel|docetaxel|mesh-list
154672319|NCT02302807|Atezolizumab|atezolizumab|mesh-list
154672320|NCT02302807|Antibodies|antibodies|mesh-list
154672321|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154672322|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672323|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
154672324|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
154672325|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
154672326|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672327|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
154672328|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672329|NCT02302807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154672330|NCT02302807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672331|NCT01931566|Pioglitazone|pioglitazone|mesh-list
154672332|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154672333|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672334|NCT05372939|Adalimumab|adalimumab|mesh-list
154672335|NCT05372939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154672336|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672337|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154672338|NCT01912456|Complement C1s|complement c1s|mesh-list
154672339|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154672340|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154672341|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
154672342|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672343|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154672344|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672345|NCT04251065|Daratumumab|daratumumab|mesh-list
154672346|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672347|NCT01885936|Albuterol|albuterol|mesh-list
154672348|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154672349|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
154672350|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672351|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672352|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154672353|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
154672354|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
154672355|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154672356|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154672357|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154672358|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154672359|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
154672360|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672361|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672362|NCT05368415|Norepinephrine|norepinephrine|mesh-list
154672363|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154672364|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154672365|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
154672366|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672367|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672368|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672369|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
154672370|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
154672371|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672372|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154672373|NCT05335109|Xenon|xenon|mesh-list
154672374|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154672375|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
154672376|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
154672377|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672378|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672379|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154672380|NCT01912222|Ixazomib|ixazomib|mesh-list
154672381|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672382|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
154672383|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672384|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672385|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154672386|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
154672387|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154672388|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672389|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672390|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154672391|NCT05500703|Analgesics|analgesics|mesh-ancestor
154672392|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
154672393|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672394|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154672395|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154672396|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154672397|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
154672398|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672399|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672400|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
154672401|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154672402|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672403|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672404|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154672405|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154672406|NCT02524847|Methoxsalen|methoxsalen|mesh-list
154672407|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154672408|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
154672409|NCT04422275|Budesonide|budesonide|mesh-list
154672410|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672411|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154672412|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
154672413|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672414|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672415|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154672416|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
154672417|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
154672418|NCT04422275|Hormones|hormones|mesh-ancestor
154672419|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672420|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
154672421|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154672422|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672423|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672424|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154672425|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154672426|NCT05324735|Protective Agents|protective agents|mesh-ancestor
154672427|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672428|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
154672429|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154672430|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
154672431|NCT05359055|Itraconazole|itraconazole|mesh-list
154672432|NCT05359055|Rifampin|rifampin|mesh-list
154672433|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
154672434|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672435|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154672436|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154672437|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672438|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672439|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154672440|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
154672441|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672442|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672443|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154672444|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154672445|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
154672446|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154672447|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
154672448|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154672449|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154672450|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154672451|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154672452|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154424468|NCT05530707|Niacin|niacin|mesh-list
154672453|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154672454|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154672455|NCT02524379|Glyburide|glyburide|mesh-list
154672456|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154672457|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672458|NCT02524145|Isoproterenol|isoproterenol|mesh-list
154672459|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
154672460|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
154672461|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154672462|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672463|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672464|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154672465|NCT02524145|Analgesics|analgesics|mesh-ancestor
154672466|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
154672467|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672468|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154672469|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154672470|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154672471|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
154672472|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672473|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672474|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154672475|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154672476|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154672477|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
154672478|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154672479|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154672480|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
154672481|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154672482|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
154672483|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154672484|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
154672485|NCT02524145|Protective Agents|protective agents|mesh-ancestor
154672486|NCT05357417|Bevacizumab|bevacizumab|mesh-list
154672487|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672488|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672489|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154672490|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154672491|NCT05357417|Growth Substances|growth substances|mesh-ancestor
154672492|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672493|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
154672494|NCT01658813|Interferons|interferons|mesh-list
154672495|NCT01658813|Fluorouracil|fluorouracil|mesh-list
154672496|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
154672497|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672498|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154672499|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672500|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672501|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
154672502|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672503|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
154672504|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672505|NCT02187471|Pregabalin|pregabalin|mesh-list
154672506|NCT02187471|Analgesics|analgesics|mesh-ancestor
154672507|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
154672508|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672509|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672510|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
154672511|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154672512|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672513|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672514|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154672515|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154672516|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154672517|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672518|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154672519|NCT02525471|RNS60|rns60|mesh-list
154672520|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154672521|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154672522|NCT02525471|Analgesics|analgesics|mesh-ancestor
154672523|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
154672524|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672525|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672526|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672527|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154672528|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154672529|NCT05284409|Acetaminophen|acetaminophen|mesh-list
154672530|NCT05284409|Dexamethasone|dexamethasone|mesh-list
154672531|NCT05284409|Meperidine|meperidine|mesh-list
154672532|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672533|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
154672534|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
154672535|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672536|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672537|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154672538|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
154672539|NCT05284409|Hormones|hormones|mesh-ancestor
154672540|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672541|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672542|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672543|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154672544|NCT05284409|Analgesics|analgesics|mesh-ancestor
154672545|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
154672546|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
154672547|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154672548|NCT05284409|Narcotics|narcotics|mesh-ancestor
154672549|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672550|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154672551|NCT02523599|Bupivacaine|bupivacaine|mesh-list
154672552|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
154672553|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
154672554|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672555|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672556|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
154672557|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672558|NCT05354999|Caffeine|caffeine|mesh-list
154672559|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154672560|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672561|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154672562|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672563|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672564|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154672565|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154672566|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
154672567|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672568|NCT02187159|Pregabalin|pregabalin|mesh-list
154672569|NCT02187159|Analgesics|analgesics|mesh-ancestor
154672570|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
154672571|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672572|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672573|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
154672574|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154672575|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672576|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672577|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154672578|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154672579|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154672580|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672581|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154672582|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
154672583|NCT02335411|Capecitabine|capecitabine|mesh-list
154672584|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672585|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672586|NCT02335411|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154672587|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672588|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154672589|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
154672590|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154672591|NCT02186301|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154672592|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154672593|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672594|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672595|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672596|NCT02161731|Warfarin|warfarin|mesh-list
154672597|NCT02161731|Evacetrapib|evacetrapib|mesh-list
154672598|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
154672599|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154672600|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154672601|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
154672602|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672603|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154672604|NCT02124759|Sevelamer|sevelamer|mesh-list
154672605|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
154672606|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
154672607|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672608|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
154672609|NCT02302339|Nivolumab|nivolumab|mesh-list
154672610|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154672611|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154672612|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672613|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672614|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154672615|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672616|NCT02302339|Immunoconjugates|immunoconjugates|mesh-ancestor
154672617|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
154672618|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672619|NCT04895917|Daratumumab|daratumumab|mesh-list
154672620|NCT04895917|Pomalidomide|pomalidomide|mesh-list
154672621|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672622|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
154672623|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672624|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154672625|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154672626|NCT04895917|Growth Substances|growth substances|mesh-ancestor
154672627|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
154672628|NCT02161575|Ranibizumab|ranibizumab|mesh-list
154672629|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154672630|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154672631|NCT02161575|Growth Substances|growth substances|mesh-ancestor
154672632|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672633|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
154672634|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672635|NCT02161185|Midazolam|midazolam|mesh-list
154672636|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154672637|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154672638|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672639|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672640|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154672641|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154672642|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154672643|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154672644|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
154672645|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
154672646|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
154672647|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
154672648|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672649|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672650|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
154672651|NCT02159469|Testosterone|testosterone|mesh-list
154672652|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
154672653|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
154672654|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154672655|NCT02159469|Androgens|androgens|mesh-ancestor
154672656|NCT02159469|Hormones|hormones|mesh-ancestor
154672657|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672658|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672659|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672660|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672661|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
154672662|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
154672663|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154672664|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
154672665|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672666|NCT02123511|Expectorants|expectorants|mesh-ancestor
154672667|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
154672668|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154672669|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
154672670|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672671|NCT02123511|Protective Agents|protective agents|mesh-ancestor
154672672|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672673|NCT02123511|Antidotes|antidotes|mesh-ancestor
154672674|NCT04746339|Apixaban|apixaban|mesh-list
154672675|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154672676|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
154672677|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154424691|NCT04509336|Orphenadrine|orphenadrine|mesh-list
154672678|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
154672679|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672680|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672681|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
154672682|NCT02301403|Nicotine|nicotine|mesh-list
154672683|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154672684|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
154672685|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672686|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672687|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154672688|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154672689|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
154672690|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672691|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672692|NCT02333383|Adalimumab|adalimumab|mesh-list
154672693|NCT02333383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154672694|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672695|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154672696|NCT02369341|Vaccines|vaccines|mesh-list
154672697|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
154672698|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672699|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154672700|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
154672701|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672702|NCT02158533|Naltrexone|naltrexone|mesh-list
154672703|NCT02158533|Buprenorphine|buprenorphine|mesh-list
154672704|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154672705|NCT02158533|Narcotics|narcotics|mesh-ancestor
154672706|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672707|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672708|NCT02158533|Analgesics|analgesics|mesh-ancestor
154672709|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
154672710|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672711|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154672712|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154672713|NCT02120469|Everolimus|everolimus|mesh-list
154672714|NCT02120469|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154672715|NCT02120469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154672716|NCT02120469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672717|NCT02120469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672718|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672719|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
154672720|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672721|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672722|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
154672723|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672724|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672725|NCT02180061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154672726|NCT02180061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672727|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
154672728|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
154672729|NCT02120157|Busulfan|busulfan|mesh-list
154672730|NCT02120157|Tacrolimus|tacrolimus|mesh-list
154672731|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672732|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
154672733|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672734|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154672735|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154672736|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
154672737|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672738|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672739|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154672740|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154672741|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672742|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154672743|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154672744|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
154672745|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154672746|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672747|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154672748|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
154672749|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672750|NCT02155881|Ciclesonide|ciclesonide|mesh-list
154672751|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
154672752|NCT02155881|Hormones|hormones|mesh-ancestor
154672753|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672754|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672755|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154672756|NCT05279807|Amlodipine|amlodipine|mesh-list
154672757|NCT05279807|Zofenopril|zofenopril|mesh-list
154672758|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154672759|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154672760|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672761|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672762|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154672763|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672764|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
154672765|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154672766|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
154672767|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672768|NCT05319431|Lenvatinib|lenvatinib|mesh-list
154672769|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672770|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154672771|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672772|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672773|NCT05276531|Progesterone|progesterone|mesh-list
154672774|NCT05276531|Progestins|progestins|mesh-ancestor
154672775|NCT05276531|Hormones|hormones|mesh-ancestor
154672776|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672777|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672778|NCT01658579|Insulin|insulin|mesh-list
154672779|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154672780|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
154672781|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154672782|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672783|NCT05268497|Esketamine|esketamine|mesh-list
154672784|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
154672785|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154672786|NCT05266859|Calcium|calcium|mesh-list
154672787|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154672788|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672789|NCT05346731|Dexamethasone|dexamethasone|mesh-list
154672790|NCT05346731|Ondansetron|ondansetron|mesh-list
154672791|NCT05346731|Olanzapine|olanzapine|mesh-list
154672792|NCT05346731|Aprepitant|aprepitant|mesh-list
154672793|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672794|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
154672795|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
154672796|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672797|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672798|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153927494|NCT04202380|Ampicillin|ampicillin|mesh-list
154672799|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
154672800|NCT05346731|Hormones|hormones|mesh-ancestor
154672801|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672802|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672803|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672804|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
154672805|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
154672806|NCT05346731|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154672807|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154672808|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
154672809|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672810|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672811|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154672812|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154672813|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672814|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154672815|NCT05346731|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154672816|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154672817|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672818|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154672819|NCT02118597|Interferons|interferons|mesh-list
154672820|NCT02118597|Ribavirin|ribavirin|mesh-list
154672821|NCT02118597|Simeprevir|simeprevir|mesh-list
154672822|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672823|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
154672824|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672825|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
154672826|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672827|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
154672828|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672829|NCT05218889|Paclitaxel|paclitaxel|mesh-list
154672830|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154672831|NCT05218889|Gemcitabine|gemcitabine|mesh-list
154672832|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154672833|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672834|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
154672835|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
154672836|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
154672837|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672838|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154672839|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
154672840|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154672841|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154672842|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
154672843|NCT02117349|Coagulants|coagulants|mesh-ancestor
154672844|NCT02177175|Carvedilol|carvedilol|mesh-list
154672845|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154672846|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154672847|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
154672848|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672849|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672850|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672851|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154672852|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
154672853|NCT02177175|Protective Agents|protective agents|mesh-ancestor
154672854|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154672855|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672856|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154672857|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
154672858|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154672859|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154672860|NCT01657877|Calcium|calcium|mesh-list
154672861|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154672862|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672863|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
154672864|NCT05254925|Petrolatum|petrolatum|mesh-list
154672865|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154672866|NCT05254925|Protective Agents|protective agents|mesh-ancestor
154672867|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672868|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
154672869|NCT05254925|Emollients|emollients|mesh-ancestor
154672870|NCT05205473|Lidocaine|lidocaine|mesh-list
154672871|NCT05205473|Anesthetics|anesthetics|mesh-list
154672872|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
154672873|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154672874|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672875|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
154672876|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672877|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154672878|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154672879|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154672880|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672881|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672882|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154672883|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154672884|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154672885|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672886|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672887|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154672888|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154672889|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672890|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
154672891|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672892|NCT02175771|Fluticasone|fluticasone|mesh-list
154672893|NCT02175771|Xhance|xhance|mesh-list
154672894|NCT02175771|Albuterol|albuterol|mesh-list
154672895|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154672896|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154672897|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
154672898|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672899|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154672900|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
154672901|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672902|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672903|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154672904|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
154424915|NCT05392361|Baclofen|baclofen|mesh-list
154672905|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
154672906|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154672907|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154672908|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154672909|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
154672910|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154672911|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672912|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
154672913|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154672914|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
154672915|NCT02175771|Hormones|hormones|mesh-ancestor
153685170|NCT00151060|Paclitaxel|paclitaxel|mesh-list
154672916|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672917|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
154672918|NCT01657799|Veliparib|veliparib|mesh-list
154672919|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154672920|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672921|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672922|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672923|NCT02116803|Fulvestrant|fulvestrant|mesh-list
154672924|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672925|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672926|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154672927|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154672928|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
154672929|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672930|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672931|NCT02115321|Grazoprevir|grazoprevir|mesh-list
154672932|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
154672933|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154672934|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
154672935|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154672936|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672937|NCT05248139|Prednisolone|prednisolone|mesh-list
154672938|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154672939|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
154672940|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154672941|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
154672942|NCT05248139|Triamcinolone|triamcinolone|mesh-list
154672943|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154672944|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154672945|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154672946|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
154672947|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154672948|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
154672949|NCT05248139|Hormones|hormones|mesh-ancestor
154672950|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154672951|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672952|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154672953|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672954|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
154672955|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
154672956|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154672957|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154672958|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154672959|NCT05248139|Protective Agents|protective agents|mesh-ancestor
154672960|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154672961|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
154672962|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154672963|NCT05154383|Vaccines|vaccines|mesh-list
154672964|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
154672965|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672966|NCT05245877|Enoxaparin|enoxaparin|mesh-list
154672967|NCT05245877|Dalteparin|dalteparin|mesh-list
154672968|NCT05245877|Tinzaparin|tinzaparin|mesh-list
154672969|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154672970|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
154672971|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154672972|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154672973|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672974|NCT02367781|Paclitaxel|paclitaxel|mesh-list
154672975|NCT02367781|Carboplatin|carboplatin|mesh-list
154672976|NCT02367781|Pemetrexed|pemetrexed|mesh-list
154672977|NCT02367781|Atezolizumab|atezolizumab|mesh-list
154672978|NCT02367781|Antibodies|antibodies|mesh-list
154672979|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154672980|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154672981|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672982|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
154672983|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
154672984|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
154672985|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154672986|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
154672987|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154672988|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154672989|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154672990|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154672991|NCT02367781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154672992|NCT02367781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672993|NCT04242173|Cemiplimab|cemiplimab|mesh-list
154672994|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154672995|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154672996|NCT02152371|Metformin|metformin|mesh-list
154672997|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
154672998|NCT02152371|Dulaglutide|dulaglutide|mesh-list
154672999|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673000|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673001|NCT02152371|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154673002|NCT02332291|Bupropion|bupropion|mesh-list
154673003|NCT02332291|Escitalopram|escitalopram|mesh-list
154673004|NCT02332291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154673005|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154673006|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673007|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673008|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673009|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
154673010|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673011|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154673012|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
154673013|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154673014|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154673015|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
154673016|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154673017|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154673018|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673019|NCT01656395|Montelukast|montelukast|mesh-list
154673020|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154673021|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
154673022|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154673023|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
154673024|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673025|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673026|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154673027|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154673028|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673029|NCT02114931|Adalimumab|adalimumab|mesh-list
154673030|NCT02114931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154673031|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673032|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673033|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
154673034|NCT05185739|Lenvatinib|lenvatinib|mesh-list
154673035|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154673036|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673037|NCT05185739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154673038|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673039|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154673040|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673041|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154673042|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154673043|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673044|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154673045|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154673046|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673047|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673048|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
154673049|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673050|NCT05181605|Folfirinox|folfirinox|mesh-list
154673051|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673052|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
154673053|NCT02300311|Capsaicin|capsaicin|mesh-list
154673054|NCT02300311|Nonivamide|nonivamide|mesh-list
154673055|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
154673056|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673057|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673058|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
154673059|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
154673060|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
154673061|NCT02300311|Vitamins|vitamins|mesh-ancestor
154673062|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
154673063|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154673064|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673065|NCT04229381|Coal Tar|coal tar|mesh-list
154673066|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
154673067|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
154673068|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154673069|NCT05178485|Bupivacaine|bupivacaine|mesh-list
154673070|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
154673071|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
154673072|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673073|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673074|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
154673075|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673076|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673077|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
154673078|NCT05178485|Hormones|hormones|mesh-ancestor
154673079|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673080|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154673081|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
154673082|NCT05228951|Trastuzumab|trastuzumab|mesh-list
154673083|NCT05228951|Letrozole|letrozole|mesh-list
154673084|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154673085|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673086|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154673087|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154673088|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673089|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673090|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154673091|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
154673092|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673093|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673094|NCT05174039|Miglustat|miglustat|mesh-list
154673095|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673096|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673097|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154673098|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154673099|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
154673100|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673101|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154673102|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673103|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673104|NCT02175225|Deferoxamine|deferoxamine|mesh-list
154673105|NCT02175225|Siderophores|siderophores|mesh-ancestor
154673106|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154673107|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
154673108|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
154673109|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673110|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154673111|NCT05170841|Tramadol|tramadol|mesh-list
154673112|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154673113|NCT05170841|Narcotics|narcotics|mesh-ancestor
154673114|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673115|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673116|NCT05170841|Analgesics|analgesics|mesh-ancestor
154673117|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
154673118|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673119|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154673120|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154673121|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673122|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673123|NCT05135273|Vaccines|vaccines|mesh-list
154673124|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
154673125|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673126|NCT02299375|Albuterol|albuterol|mesh-list
154673127|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154425137|NCT03663335|Tacrolimus|tacrolimus|mesh-list
154673128|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
154673129|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673130|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673131|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154673132|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
154673133|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
154673134|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154673135|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154673136|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154673137|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154673138|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
154673139|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673140|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673141|NCT02151591|Varenicline|varenicline|mesh-list
154673142|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154673143|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154673144|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673145|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673146|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673147|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673148|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154673149|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154673150|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154673151|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673152|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673153|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154673154|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154673155|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154673156|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154673157|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
154673158|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673159|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673160|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154673161|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154673162|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
154673163|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154673164|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154673165|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
154673166|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154673167|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154673168|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673169|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
154673170|NCT02114385|Vaccines|vaccines|mesh-list
154673171|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
154673172|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673173|NCT05098457|Lidocaine|lidocaine|mesh-list
154673174|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
154673175|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
154673176|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673177|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673178|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
154673179|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673180|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154673181|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154673182|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154673183|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673184|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673185|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
154673186|NCT02114151|Simeprevir|simeprevir|mesh-list
154673187|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
154673188|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927868|NCT00885703|Amebicides|amebicides|mesh-ancestor
154673189|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
154673190|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673191|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673192|NCT05220293|Betamethasone|betamethasone|mesh-list
154673193|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
154673194|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154673195|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
154673196|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154673197|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673198|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
154673199|NCT05220293|Hormones|hormones|mesh-ancestor
154673200|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673201|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673202|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154673203|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
154673204|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
154673205|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154673206|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
154673207|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154673208|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673209|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673210|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673211|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673212|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673213|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154673214|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
154673215|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
154673216|NCT02297503|Protective Agents|protective agents|mesh-ancestor
154673217|NCT02366767|Insulin|insulin|mesh-list
154673218|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673219|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673220|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
154673221|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154673222|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154673223|NCT02149875|Protective Agents|protective agents|mesh-ancestor
154673224|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673225|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
154673226|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154673227|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
154673228|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154673229|NCT05124899|Protective Agents|protective agents|mesh-ancestor
154673230|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673231|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
154673232|NCT02112045|Melphalan|melphalan|mesh-list
154673233|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154673234|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
154673235|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673236|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673237|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154673238|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154673239|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
154673240|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673241|NCT02147691|Azelaic acid|azelaic acid|mesh-list
154673242|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154673243|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154673244|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154673245|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154673246|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154673247|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
154673248|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673249|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673250|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673251|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673252|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
154673253|NCT01655693|Doxorubicin|doxorubicin|mesh-list
154673254|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154673255|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154673256|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673257|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154673258|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154673259|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673260|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673261|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
154673262|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154673263|NCT05090657|Methylene Blue|methylene blue|mesh-list
154673264|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154673265|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673266|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
154673267|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
154673268|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673269|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673270|NCT05048849|Somatomedin B|somatomedin b|mesh-list
154673271|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154673272|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154673273|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
154673274|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673275|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673276|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154673277|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
154673278|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154673279|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
154673280|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154673281|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673282|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154673283|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154673284|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673285|NCT04751877|Dexamethasone|dexamethasone|mesh-list
154673286|NCT04751877|Lenalidomide|lenalidomide|mesh-list
154673287|NCT04751877|Bortezomib|bortezomib|mesh-list
154673288|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673289|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
154673290|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
154673291|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673292|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673293|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154673294|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
154673295|NCT04751877|Hormones|hormones|mesh-ancestor
154582950|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673296|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673297|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154673298|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673299|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
154673300|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154673301|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154673302|NCT04751877|Growth Substances|growth substances|mesh-ancestor
154673303|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
154673304|NCT02147067|Ranolazine|ranolazine|mesh-list
154673305|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154673306|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673307|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673308|NCT02107131|Ranibizumab|ranibizumab|mesh-list
154673309|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154673310|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154673311|NCT02107131|Growth Substances|growth substances|mesh-ancestor
154673312|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673313|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
154673314|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673315|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
154673316|NCT02106975|Vitamins|vitamins|mesh-ancestor
154673317|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
154673318|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673319|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
154673320|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673321|NCT02106975|Protective Agents|protective agents|mesh-ancestor
154673322|NCT05133765|Insulin|insulin|mesh-list
154673323|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673324|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673325|NCT02520011|Cytarabine|cytarabine|mesh-list
154673326|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
154673327|NCT02520011|Alvocidib|alvocidib|mesh-list
154673328|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154673329|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
154673330|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673331|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673332|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
154673333|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673334|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154673335|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
154673336|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673337|NCT02520011|Analgesics|analgesics|mesh-ancestor
154673338|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
154673339|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673340|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154673341|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154673342|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673343|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
154673344|NCT02520011|Growth Substances|growth substances|mesh-ancestor
154673345|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154673346|NCT05037539|Fentanyl|fentanyl|mesh-list
154673347|NCT05037539|Morphine|morphine|mesh-list
154673348|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154673349|NCT05037539|Narcotics|narcotics|mesh-ancestor
154425364|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
154673350|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673351|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673352|NCT05037539|Analgesics|analgesics|mesh-ancestor
154673353|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
154673354|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673355|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154673356|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154673357|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
154673359|NCT02519231|Naproxen|naproxen|mesh-list
154673360|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154673361|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154673362|NCT02519231|Analgesics|analgesics|mesh-ancestor
154673363|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
154673364|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673365|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673366|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673367|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673368|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
154673369|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154673370|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673371|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673372|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
154673373|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154673374|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154673375|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154673376|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673377|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673378|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673379|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673380|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673381|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154673382|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673383|NCT02075073|Trastuzumab|trastuzumab|mesh-list
154673384|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154673385|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673386|NCT04738149|Bimatoprost|bimatoprost|mesh-list
154673387|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154673388|NCT05060627|Dexamethasone|dexamethasone|mesh-list
154673389|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673390|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
154673391|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
154673392|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673393|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673394|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154673395|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
154673396|NCT05060627|Hormones|hormones|mesh-ancestor
154673397|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673398|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154673399|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673400|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154673401|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
154673402|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673403|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154673404|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154673405|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
154673406|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673407|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673408|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154673409|NCT05056883|Ivermectin|ivermectin|mesh-list
154673410|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154673411|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673412|NCT04991597|Lidocaine|lidocaine|mesh-list
154673413|NCT04991597|Epinephrine|epinephrine|mesh-list
154673414|NCT04991597|Racepinephrine|racepinephrine|mesh-list
154673415|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
154673416|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
154673417|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
154673418|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673419|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673420|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
154673421|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673422|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154673423|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154673424|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154673425|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673426|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673427|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154673428|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154673429|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
154673430|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673431|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154673432|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154673433|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
154673434|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154673435|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
154673436|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
154673437|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
154673438|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154673439|NCT04949867|Glucagon|glucagon|mesh-list
154673440|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154673441|NCT04949867|Hormones|hormones|mesh-ancestor
154673442|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673443|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673444|NCT05018117|Nicotine|nicotine|mesh-list
154673445|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154673446|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
154673447|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673448|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673449|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154673450|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154673451|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673452|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673453|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673454|NCT05016869|Capecitabine|capecitabine|mesh-list
154673455|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154673456|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
154673457|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673458|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673459|NCT02141997|Adalimumab|adalimumab|mesh-list
154673460|NCT02141997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154673461|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673462|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673463|NCT04411433|Azithromycin|azithromycin|mesh-list
154673464|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
154673465|NCT04411433|Favipiravir|favipiravir|mesh-list
154673466|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154673467|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673468|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
154673469|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154673470|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154673471|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673472|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673473|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673474|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
154673475|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
154673476|NCT05012735|Provitamins|provitamins|mesh-list
154673477|NCT05012735|Vitamins|vitamins|mesh-ancestor
154673478|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
154673479|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673480|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
154673481|NCT02519777|Dolutegravir|dolutegravir|mesh-list
154673482|NCT02519777|Maraviroc|maraviroc|mesh-list
154673483|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154673484|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154673485|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673486|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673487|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154673488|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154673489|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
154673490|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673491|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154673492|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154673493|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154673494|NCT05008913|Adavosertib|adavosertib|mesh-list
154673495|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673496|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673497|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154673498|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673499|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673500|NCT04982705|Incretins|incretins|mesh-ancestor
154673501|NCT04982705|Hormones|hormones|mesh-ancestor
154673502|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673503|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154673504|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
154673506|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673507|NCT04944095|Antibodies|antibodies|mesh-list
154673508|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
154673509|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673510|NCT02141295|Leucovorin|leucovorin|mesh-list
154673511|NCT02141295|Folic Acid|folic acid|mesh-list
154673512|NCT02141295|Bevacizumab|bevacizumab|mesh-list
154673513|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
154673514|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
154673515|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154673516|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673517|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154673518|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154673519|NCT02141295|Growth Substances|growth substances|mesh-ancestor
154673520|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673521|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
154673522|NCT02141295|Antidotes|antidotes|mesh-ancestor
154673523|NCT02141295|Protective Agents|protective agents|mesh-ancestor
154673524|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
154673525|NCT02141295|Vitamins|vitamins|mesh-ancestor
154673526|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
154673527|NCT02141295|Hematinics|hematinics|mesh-ancestor
154673528|NCT02514551|Paclitaxel|paclitaxel|mesh-list
154673529|NCT02514551|Ramucirumab|ramucirumab|mesh-list
154673530|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154673531|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673532|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
154673533|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
154673534|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
154673535|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673536|NCT02514551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154673537|NCT02514551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154673538|NCT02514551|Growth Substances|growth substances|mesh-ancestor
154673539|NCT02514551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673540|NCT02514551|Growth Inhibitors|growth inhibitors|mesh-ancestor
154673541|NCT02141217|Amoxicillin|amoxicillin|mesh-list
154673542|NCT02141217|Clindamycin|clindamycin|mesh-list
154673543|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
154673544|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
154673545|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
154673546|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
154673547|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154673548|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154673549|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673550|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154673551|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673552|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673553|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154673554|NCT02514473|Ivacaftor|ivacaftor|mesh-list
154673555|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154673556|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673557|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673558|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154673559|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673560|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673561|NCT02513771|Incretins|incretins|mesh-ancestor
154673562|NCT02513771|Hormones|hormones|mesh-ancestor
154582951|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673563|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673564|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154673565|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
154673566|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673567|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673568|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154673569|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
154673570|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673571|NCT02069379|Metformin|metformin|mesh-list
154673572|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673573|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673574|NCT02511431|Ritonavir|ritonavir|mesh-list
154673575|NCT02511431|Lonafarnib|lonafarnib|mesh-list
154673576|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154673577|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154425585|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
154673578|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
154673579|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673580|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673581|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154673582|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154673583|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
154673584|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673585|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154673586|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154673587|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154673588|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154673589|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154673590|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
154673591|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154673592|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154673593|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673594|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673595|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673596|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673597|NCT01655069|Urological Agents|urological agents|mesh-ancestor
154673598|NCT01654601|Clozapine|clozapine|mesh-list
154673599|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154673600|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
154673601|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673602|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673603|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673604|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154673605|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154673606|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673607|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154673608|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
154673609|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
154673610|NCT04978649|Amlodipine|amlodipine|mesh-list
154673611|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154673612|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154673613|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673614|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673615|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154673616|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673617|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
154673618|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154673619|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153928299|NCT01822288|Tibolone|tibolone|mesh-list
154673620|NCT02508935|Narcotics|narcotics|mesh-ancestor
154673621|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673622|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673623|NCT02508935|Analgesics|analgesics|mesh-ancestor
154673624|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
154673625|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673626|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154673627|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154673628|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673629|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673630|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154673631|NCT02507375|Pertuzumab|pertuzumab|mesh-list
154673632|NCT02507375|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154673633|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154673634|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673635|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673636|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673637|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154673638|NCT02507219|Ibuprofen|ibuprofen|mesh-list
154673639|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154673640|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154673641|NCT02507219|Analgesics|analgesics|mesh-ancestor
154673642|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
154673643|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673644|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673645|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673646|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673647|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154673648|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673649|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673650|NCT02483975|Albuterol|albuterol|mesh-list
154673651|NCT02483975|Montelukast|montelukast|mesh-list
154673652|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154673653|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
154673654|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154673655|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
154673656|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673657|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673658|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154673659|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154673660|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673661|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154673662|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
154673663|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673664|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
154673665|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154673666|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154673667|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154673668|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154673669|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
154673670|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673671|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154673672|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154673673|NCT02047227|Hormones|hormones|mesh-ancestor
154673674|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673675|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673676|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154673677|NCT02483585|Erenumab|erenumab|mesh-list
154673678|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154673679|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673680|NCT02483585|Analgesics|analgesics|mesh-ancestor
154673681|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
154673682|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673683|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673684|NCT02101983|Cytarabine|cytarabine|mesh-list
154673685|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154673686|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
154673687|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673688|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673689|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
154673690|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673691|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154673692|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
154673693|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673694|NCT04974281|Lenvatinib|lenvatinib|mesh-list
154673695|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673696|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154673697|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673698|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673699|NCT02503865|Orlistat|orlistat|mesh-list
154673700|NCT02503865|Diltiazem|diltiazem|mesh-list
154673701|NCT02503865|Atorvastatin|atorvastatin|mesh-list
154673702|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154673703|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154673704|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
154673705|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673706|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154673707|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154673708|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673709|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154673710|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154673711|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673712|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154673713|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673714|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
154673715|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154673716|NCT02481947|Laxatives|laxatives|mesh-list
154673717|NCT02481947|Lubiprostone|lubiprostone|mesh-list
154673718|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154673719|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673720|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673721|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154673722|NCT02503085|Ibuprofen|ibuprofen|mesh-list
154673723|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154425733|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673724|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154673726|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
154673727|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673728|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673729|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673730|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673731|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154673732|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673733|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673734|NCT02502149|Factor VIII|factor viii|mesh-list
154673735|NCT02502149|Coagulants|coagulants|mesh-ancestor
154673736|NCT02480621|Bupivacaine|bupivacaine|mesh-list
154673737|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
154673738|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
154673739|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673740|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673741|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
154673742|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673743|NCT02046603|Methotrexate|methotrexate|mesh-list
154673744|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154673745|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
154673746|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154673747|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673748|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154673749|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
154673750|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673751|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673752|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154673753|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673754|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154673755|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154673756|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
154673757|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673758|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154673759|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154673760|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154673761|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154673762|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673763|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673764|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154673765|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154673766|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154673767|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154673768|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
154673769|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673770|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673771|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154673772|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154673773|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
154673774|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154673775|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154673776|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
154673777|NCT02101359|Tetracaine|tetracaine|mesh-list
154673778|NCT02101359|Tropicamide|tropicamide|mesh-list
154673779|NCT02101359|Mydriatics|mydriatics|mesh-list
154673780|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
154673781|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
154673782|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673783|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673784|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
154673785|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673786|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
154673787|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154673788|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154673789|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673790|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673791|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673792|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
154673793|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
154673794|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154673795|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154673796|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
154673797|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673799|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154673800|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154673801|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154673802|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154673803|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
154673804|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673805|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673806|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673807|NCT01883362|Midostaurin|midostaurin|mesh-list
154673808|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673809|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154673810|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673811|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673812|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
154673813|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
154673814|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
154673815|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673816|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673817|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154673818|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154673819|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
154673820|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
154673821|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673822|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673823|NCT02045979|Adalimumab|adalimumab|mesh-list
154673824|NCT02045979|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154673825|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673826|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673827|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
154673828|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
154673829|NCT04734405|Fluconazole|fluconazole|mesh-list
154673830|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
154673831|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673832|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154673833|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154673834|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673835|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673836|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154673837|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
154673838|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673839|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673840|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154673841|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154673842|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154673843|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154673844|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154673845|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154673846|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673847|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154673848|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154673849|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154673850|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154673851|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
154673852|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673853|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673854|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154673855|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154673856|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
154673857|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154673858|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154673859|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
154673860|NCT01928758|Nicotine|nicotine|mesh-list
154673861|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154673862|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
154673863|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673864|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673865|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154673866|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154673867|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673868|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425890|NCT05958810|Artemether|artemether|mesh-list
154673869|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673871|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154673872|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673873|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673874|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673875|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673876|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673877|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154673878|NCT01614886|Protective Agents|protective agents|mesh-ancestor
154673879|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
154673880|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154673881|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154673882|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154673883|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154673884|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582952|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154673885|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673886|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
154673887|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673888|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673889|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154673890|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673891|NCT04171726|Edoxaban|edoxaban|mesh-list
154673892|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154673893|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
154673894|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154673895|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
154673896|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673897|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673898|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
154673899|NCT02100657|Dexamethasone|dexamethasone|mesh-list
154673900|NCT02100657|Bortezomib|bortezomib|mesh-list
154673901|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673902|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
154673903|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
154673904|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154673905|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673906|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154673907|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
154673908|NCT02100657|Hormones|hormones|mesh-ancestor
154673909|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673910|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154673911|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673912|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
154673913|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154673914|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
154673915|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154673916|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673917|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154673918|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154673919|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154673920|NCT01909804|Ribavirin|ribavirin|mesh-list
154673921|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
154673922|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154673923|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
154673924|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673925|NCT01880086|Clomiphene|clomiphene|mesh-list
154673926|NCT01880086|Enclomiphene|enclomiphene|mesh-list
154673927|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
154673928|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154673929|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
154673930|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673931|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673932|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154673933|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
154673934|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154673935|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154673936|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154673937|NCT01879618|Dalteparin|dalteparin|mesh-list
154673938|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
154673939|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154673940|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154673941|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673942|NCT01926886|Trastuzumab|trastuzumab|mesh-list
154673943|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154673944|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673945|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154673947|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673948|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
154673949|NCT01925950|Hormones|hormones|mesh-ancestor
154673950|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673951|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673952|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154673953|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
154673954|NCT04415320|Ensartinib|ensartinib|mesh-list
154673955|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673956|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154673957|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673958|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673959|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154673960|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
154673961|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154673962|NCT01878292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154673963|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154673964|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154673965|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673966|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154673967|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
154673968|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673969|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154673970|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154673971|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154673972|NCT01907854|Liraglutide|liraglutide|mesh-list
154673973|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673974|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673975|NCT01907854|Incretins|incretins|mesh-ancestor
154673976|NCT01907854|Hormones|hormones|mesh-ancestor
154673977|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154673978|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154673979|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
154673980|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154673981|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154673982|NCT01907854|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154673983|NCT02480153|Adalimumab|adalimumab|mesh-list
154673984|NCT02480153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154673985|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154673986|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154673987|NCT04972253|Infigratinib|infigratinib|mesh-list
154673988|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154673989|NCT02500979|Insulin|insulin|mesh-list
154673990|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154673991|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
154673992|NCT02500979|Pramlintide|pramlintide|mesh-list
154673993|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
154673994|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154673995|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154673996|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
154673997|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154673998|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
154673999|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674000|NCT02500901|Niraparib|niraparib|mesh-list
154674001|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154674002|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674003|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674004|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674005|NCT01877668|Adalimumab|adalimumab|mesh-list
154674006|NCT01877668|Tofacitinib|tofacitinib|mesh-list
154674007|NCT01877668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154674008|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674009|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674010|NCT01877668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154674011|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154674012|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674013|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674014|NCT01906372|Hormones|hormones|mesh-list
154674015|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154674016|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154674017|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
154674018|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674019|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674020|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674021|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674022|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154674023|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154674024|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674025|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
154674026|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154674027|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
154674028|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674029|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154674030|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154674031|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154674032|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674033|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
154674034|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
154674035|NCT01876732|Vitamins|vitamins|mesh-ancestor
154674036|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
154674037|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674038|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
154674039|NCT01876732|Hematinics|hematinics|mesh-ancestor
154674040|NCT01905592|Niraparib|niraparib|mesh-list
154582953|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
154674041|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154674042|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674043|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674044|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674045|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
154674046|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674047|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674048|NCT02500121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154674049|NCT02500121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674050|NCT01875250|Metronidazole|metronidazole|mesh-list
154674051|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674052|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154674053|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154674054|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154674055|NCT01904032|Vitamin D|vitamin d|mesh-list
154674056|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
154674057|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
154674058|NCT01904032|Vitamins|vitamins|mesh-list
154674059|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
154674060|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674061|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154674062|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154674063|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154674064|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154674065|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154674066|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154674067|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674068|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
154674069|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674070|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674071|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154674072|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674073|NCT02325739|Spartalizumab|spartalizumab|mesh-list
154674074|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154674075|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674076|NCT02325739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674077|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674078|NCT01903720|Dexamethasone|dexamethasone|mesh-list
154674079|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674080|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
154674081|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
154674082|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674083|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674084|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674085|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
154674086|NCT01903720|Hormones|hormones|mesh-ancestor
154674087|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674088|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154674089|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674090|NCT02366689|Triclosan|triclosan|mesh-list
154674091|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
154674092|NCT02366689|Fluorides|fluorides|mesh-list
154674093|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
154674094|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
154674095|NCT02366689|Protective Agents|protective agents|mesh-ancestor
154674096|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674097|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154674098|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674099|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154674100|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154674101|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
154674102|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674103|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154674104|NCT01903252|Mesalamine|mesalamine|mesh-list
154674105|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154674106|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154674107|NCT01903252|Analgesics|analgesics|mesh-ancestor
154674108|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
154674109|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674110|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674111|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674112|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674113|NCT01613716|Dexamethasone|dexamethasone|mesh-list
154674114|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674115|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
154674116|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
154674117|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674118|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674119|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674120|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
154674121|NCT01613716|Hormones|hormones|mesh-ancestor
154674122|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674123|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154674124|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674125|NCT01872910|Celecoxib|celecoxib|mesh-list
154674126|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154674127|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154674128|NCT01872910|Analgesics|analgesics|mesh-ancestor
154674129|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
154674130|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674131|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674132|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674133|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674134|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154674135|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154674136|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674137|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674138|NCT01920568|Vitamin D|vitamin d|mesh-list
154674139|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
154674140|NCT01920568|Denosumab|denosumab|mesh-list
154674141|NCT01920568|Calcium|calcium|mesh-list
154674142|NCT01920568|Vitamins|vitamins|mesh-ancestor
154674143|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
154674144|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674145|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154674146|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154674147|NCT01901848|Bupropion|bupropion|mesh-list
154674148|NCT01901848|Nicotine|nicotine|mesh-list
154674149|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154674150|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
154674151|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674152|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674153|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154674154|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154674155|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
154674156|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674157|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674158|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154674159|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
154674160|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154674161|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154674162|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154674163|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154674164|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
154674165|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154674166|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154674167|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674168|NCT01901614|Anesthetics|anesthetics|mesh-list
154674169|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154674170|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674171|NCT02499575|Bupivacaine|bupivacaine|mesh-list
154674172|NCT02499575|Ropivacaine|ropivacaine|mesh-list
154674173|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
154674174|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
154674175|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154674176|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674177|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
154674178|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674179|NCT02065791|Canagliflozin|canagliflozin|mesh-list
154674180|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154674181|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674182|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674183|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674184|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
154674185|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154674186|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
154674187|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674188|NCT02499029|Expectorants|expectorants|mesh-ancestor
154674189|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
154674190|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154674191|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
154674192|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674193|NCT02499029|Protective Agents|protective agents|mesh-ancestor
154674194|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674195|NCT02499029|Antidotes|antidotes|mesh-ancestor
154674196|NCT02065713|Golimumab|golimumab|mesh-list
154674197|NCT02065713|Methotrexate|methotrexate|mesh-list
154674198|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154674199|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
154674200|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154674201|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674202|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154674203|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
154674204|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674205|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674206|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
154674207|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674208|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154674209|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154674210|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
154674211|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674212|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154674213|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154674214|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674215|NCT02497781|Ceftazidime|ceftazidime|mesh-list
154674216|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154674217|NCT02497781|Cefepime|cefepime|mesh-list
154674218|NCT02497781|Avibactam|avibactam|mesh-list
154674219|NCT02497781|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154674220|NCT02497781|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154674221|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154674222|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674223|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154674224|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674225|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674226|NCT02497469|Adalimumab|adalimumab|mesh-list
154674227|NCT02497469|Vedolizumab|vedolizumab|mesh-list
154674228|NCT02497469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154674229|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674230|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674231|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674232|NCT02497391|Evacetrapib|evacetrapib|mesh-list
154674233|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154674234|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154674235|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
154674236|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674237|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154674238|NCT02476175|Mirabegron|mirabegron|mesh-list
154674239|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154674240|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154674241|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154674242|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
154674243|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674244|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674245|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674246|NCT02476175|Urological Agents|urological agents|mesh-ancestor
154674247|NCT02065557|Adalimumab|adalimumab|mesh-list
154674248|NCT02065557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154674249|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674250|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674251|NCT02065245|Penicillins|penicillins|mesh-list
154674252|NCT02065245|Streptomycin|streptomycin|mesh-list
154674253|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154674254|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674255|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154674256|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674257|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674258|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
154674259|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154674260|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154674261|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
154674262|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
154674263|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928967|NCT02835664|Niacin|niacin|mesh-list
154674264|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674265|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154674266|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154674267|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
154674268|NCT04182555|Bilirubin|bilirubin|mesh-list
154674269|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
154674270|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674271|NCT04182555|Protective Agents|protective agents|mesh-ancestor
154674272|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674273|NCT02366143|Paclitaxel|paclitaxel|mesh-list
154674274|NCT02366143|Bevacizumab|bevacizumab|mesh-list
154674275|NCT02366143|Carboplatin|carboplatin|mesh-list
154674276|NCT02366143|Atezolizumab|atezolizumab|mesh-list
154674277|NCT02366143|Antibodies|antibodies|mesh-list
154674278|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154674279|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154674280|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674281|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
154674282|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
154674283|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
154674284|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674285|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674286|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154674287|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154674288|NCT02366143|Growth Substances|growth substances|mesh-ancestor
154674289|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674290|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
154674291|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
154674292|NCT02366143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154674293|NCT02098395|Liraglutide|liraglutide|mesh-list
154674294|NCT02098395|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154674295|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674296|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674297|NCT02098395|Incretins|incretins|mesh-ancestor
154674298|NCT02098395|Hormones|hormones|mesh-ancestor
154674299|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674300|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154674301|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154674302|NCT02096835|Dexamethasone|dexamethasone|mesh-list
154674303|NCT02096835|Tropisetron|tropisetron|mesh-list
154674304|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674305|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
154674306|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
154674307|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674308|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674309|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674310|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
154674311|NCT02096835|Hormones|hormones|mesh-ancestor
154674312|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674313|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154674314|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674315|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154674316|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154674317|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
154674318|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674319|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674320|NCT02294773|Letrozole|letrozole|mesh-list
154674321|NCT02294773|Clomiphene|clomiphene|mesh-list
154674322|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674323|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154674324|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154674325|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674326|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674327|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154674328|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
154674329|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674330|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674331|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154674332|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
154674333|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154674334|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154674335|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154674336|NCT02365285|Heparin|heparin|mesh-list
154674337|NCT02365285|Galantamine|galantamine|mesh-list
154674338|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154674339|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
154674340|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154674341|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154674342|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674343|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154674344|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154674345|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154674346|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154674347|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674348|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
154674349|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674350|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674351|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154674352|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
154674353|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674354|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
154674355|NCT02041299|Deferiprone|deferiprone|mesh-list
154674356|NCT02041299|Deferoxamine|deferoxamine|mesh-list
154674357|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154674358|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
154674359|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
154674360|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674361|NCT02041299|Siderophores|siderophores|mesh-ancestor
154674362|NCT01645735|Vancomycin|vancomycin|mesh-list
154674363|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
154674364|NCT01645735|Ceftaroline|ceftaroline|mesh-list
154674365|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154674366|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674367|NCT01645735|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153929064|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
154674368|NCT01645735|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154674369|NCT01645111|Clevidipine|clevidipine|mesh-list
154674370|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154674371|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154674372|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674373|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154674374|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674375|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
154674376|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154674377|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674378|NCT01919164|Mitogens|mitogens|mesh-list
154674379|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
154674380|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674381|NCT01901224|Metformin|metformin|mesh-list
154674382|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674383|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674384|NCT01901146|Paclitaxel|paclitaxel|mesh-list
154674385|NCT01901146|Trastuzumab|trastuzumab|mesh-list
154674386|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154674387|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674388|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
154426408|NCT03182426|Plerixafor|plerixafor|mesh-list
154674389|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
154674390|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
154674391|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674392|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674393|NCT01644643|Metronidazole|metronidazole|mesh-list
154674394|NCT01644643|Ceftazidime|ceftazidime|mesh-list
154674395|NCT01644643|Avibactam|avibactam|mesh-list
154674396|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674397|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154674398|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154674399|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154674400|NCT01644643|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154674401|NCT01644643|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154674402|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154674403|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674404|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674405|NCT01864174|Metformin|metformin|mesh-list
154674406|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674407|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674408|NCT01900444|Vaccines|vaccines|mesh-list
154674409|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
154674410|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674411|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
154674412|NCT02496221|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154674413|NCT02496221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674414|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674415|NCT02475629|Ibalizumab|ibalizumab|mesh-list
154674416|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154674417|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154674418|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
154674419|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674420|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154674421|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154674422|NCT01653743|Hormones|hormones|mesh-ancestor
154674423|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674424|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674425|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154674426|NCT02293993|Guadecitabine|guadecitabine|mesh-list
154674427|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674428|NCT02322775|Benralizumab|benralizumab|mesh-list
154674429|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154674430|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
154674431|NCT01646827|Aripiprazole|aripiprazole|mesh-list
154674432|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
154674433|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154674434|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154674435|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154674436|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154674437|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674438|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
154674439|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
154674440|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674441|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674442|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154674443|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154674444|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
154674445|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154674446|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154674447|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154674448|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154674449|NCT02360995|Triclosan|triclosan|mesh-list
154674450|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
154674451|NCT02360995|Fluorides|fluorides|mesh-list
154674452|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
154674453|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
154674454|NCT02360995|Protective Agents|protective agents|mesh-ancestor
154674455|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674456|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154674457|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674458|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154674459|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154674460|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
154674461|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426490|NCT02454933|Durvalumab|durvalumab|mesh-list
154674462|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154674463|NCT02359903|Infliximab|infliximab|mesh-list
154674464|NCT02359903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154674465|NCT02359903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674466|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154674467|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674468|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674469|NCT02291419|Aspirin|aspirin|mesh-list
154674470|NCT02291419|Ticagrelor|ticagrelor|mesh-list
154674471|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154674472|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154674473|NCT02291419|Analgesics|analgesics|mesh-ancestor
154674474|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
154674475|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674476|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674477|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674478|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674479|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154674480|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154674481|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674482|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154674483|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154674484|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674485|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
154674486|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154674487|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154674488|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154674489|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
154674490|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674491|NCT02319031|Ribavirin|ribavirin|mesh-list
154674492|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
154674493|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
154674494|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674495|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
154674496|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674497|NCT02359435|Amoxicillin|amoxicillin|mesh-list
154674498|NCT02359435|Metronidazole|metronidazole|mesh-list
154674499|NCT02359435|Clarithromycin|clarithromycin|mesh-list
154674500|NCT02359435|Pantoprazole|pantoprazole|mesh-list
154674501|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154674502|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674503|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154674504|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154674505|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154674506|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674507|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674508|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154674509|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154674510|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154674511|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674512|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154674513|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
154674514|NCT04599868|Analgesics|analgesics|mesh-ancestor
154674515|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
154674516|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674517|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674518|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
154674519|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154674520|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154674521|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
154674522|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154674523|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154674524|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674525|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154674526|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
154674527|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154674528|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
154674529|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154674530|NCT01612156|Lidocaine|lidocaine|mesh-list
154674531|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
154674532|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
154674533|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154674534|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674535|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
154674536|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674537|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154674538|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154674539|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154674540|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154674541|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674542|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
154674543|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154674544|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
154674545|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674546|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674547|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154674548|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
154674549|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
154674550|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154674551|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
154674552|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674553|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674554|NCT01615822|Artefenomel|artefenomel|mesh-list
154674555|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
154674556|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154674557|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154674558|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674559|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
154674561|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
154674562|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154674563|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
154674564|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674565|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674566|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154674567|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
154674568|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
154674569|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154674570|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
154674571|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674572|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674573|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
154674574|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154674575|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154674576|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154674577|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154674578|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
154674579|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154674580|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154674581|NCT01898806|Triamcinolone|triamcinolone|mesh-list
154674582|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154674583|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154674584|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154674585|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674586|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
154674587|NCT01898806|Hormones|hormones|mesh-ancestor
154582954|NCT05668455|Hormones|hormones|mesh-ancestor
154674588|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674589|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674590|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154674591|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
154674592|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674593|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674594|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154674595|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
154674596|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674597|NCT02290873|Midazolam|midazolam|mesh-list
154674598|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154674599|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154674600|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154674601|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674602|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154674603|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154674604|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154674605|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154674606|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
154674607|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
154674608|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
154674609|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
154674610|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674611|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674612|NCT02358343|Sertraline|sertraline|mesh-list
154674613|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
154674614|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154674615|NCT02358343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154674616|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154674617|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154674618|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674619|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674620|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
154674621|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674622|NCT02318095|Paclitaxel|paclitaxel|mesh-list
154674623|NCT02318095|Gemcitabine|gemcitabine|mesh-list
154674624|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154674625|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674626|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
154674627|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
154674628|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
154674629|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674630|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154674631|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
154674632|NCT02317627|Belumosudil|belumosudil|mesh-list
154674633|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154674634|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674635|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674636|NCT02517905|Bupivacaine|bupivacaine|mesh-list
154674637|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
154674638|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
154674639|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929334|NCT02887313|Vitamins|vitamins|mesh-ancestor
154674640|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674641|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
154674642|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674643|NCT02473913|Silymarin|silymarin|mesh-list
154674644|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
154674645|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674646|NCT02473913|Protective Agents|protective agents|mesh-ancestor
154674647|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674648|NCT02316847|Diazepam|diazepam|mesh-list
154674649|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154674650|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
154674651|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
154674652|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
154674653|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674654|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674655|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674656|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154674657|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154674658|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154674659|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154674660|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154674661|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154674662|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154674663|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154674664|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
154674665|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
154674666|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
154674667|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
154674668|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674669|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674670|NCT02473445|Cysteamine|cysteamine|mesh-list
154674671|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154674672|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674673|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
154674674|NCT02473367|Antacids|antacids|mesh-list
154674675|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154674676|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154674677|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
154674678|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674679|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154674680|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154674681|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929397|NCT01188551|Midazolam|midazolam|mesh-list
154674682|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674683|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674684|NCT02316613|Rituximab|rituximab|mesh-list
154674685|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674686|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674687|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
154674688|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674689|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674690|NCT02492165|Vaccines|vaccines|mesh-list
154674691|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
154674692|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674693|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154674694|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
154674695|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674696|NCT02286895|Vaccines|vaccines|mesh-list
154674697|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
154674698|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674699|NCT02472977|Nivolumab|nivolumab|mesh-list
154674700|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674701|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674702|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154674703|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674704|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
154674705|NCT02060487|Citric Acid|citric acid|mesh-list
154674706|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
154674707|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
154674708|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154674709|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
154674710|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
154674711|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674712|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
154674713|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154674714|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154674715|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674716|NCT02060487|Urological Agents|urological agents|mesh-ancestor
154674717|NCT02059239|Cytarabine|cytarabine|mesh-list
154674718|NCT02059239|Rituximab|rituximab|mesh-list
154674719|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
154674720|NCT02059239|Etoposide|etoposide|mesh-list
154674721|NCT02059239|Melphalan|melphalan|mesh-list
154674722|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154674723|NCT02059239|Carmustine|carmustine|mesh-list
154674724|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674725|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674726|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
154674727|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674728|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674729|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154674730|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154674731|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154674732|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674733|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674734|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154674735|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
154674736|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
154674737|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674738|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154674739|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154674740|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
154674741|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154674742|NCT02059161|Insulin|insulin|mesh-list
154674743|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154674744|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
154674745|NCT02059161|MK-1293|mk-1293|mesh-list
154674746|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674747|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674748|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154674749|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
153929418|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
154674750|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674751|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154674752|NCT01897714|Dexamethasone|dexamethasone|mesh-list
154674753|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674754|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
154674755|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
154674756|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674757|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674758|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674759|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
154674760|NCT01897714|Hormones|hormones|mesh-ancestor
154674761|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674762|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154674763|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674764|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
154674765|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154674766|NCT01860976|Abatacept|abatacept|mesh-list
154674767|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154674768|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674769|NCT01860976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674770|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674771|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154674772|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
154674773|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674774|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674775|NCT01860040|Gemcitabine|gemcitabine|mesh-list
154674777|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674778|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154674779|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
154674780|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674781|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674782|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154674783|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154674784|NCT04618744|Insulin|insulin|mesh-list
154674785|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154674786|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674787|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674788|NCT01896934|Sertraline|sertraline|mesh-list
154674789|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
154674790|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154674791|NCT01896934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154674792|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154674793|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154674794|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674795|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674796|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
154674797|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674798|NCT02039505|Vedolizumab|vedolizumab|mesh-list
154674799|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674800|NCT02095197|Triamcinolone|triamcinolone|mesh-list
154674801|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674802|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
154674803|NCT02095197|Hormones|hormones|mesh-ancestor
154674804|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674805|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674806|NCT02039427|Dexamethasone|dexamethasone|mesh-list
154674807|NCT02039427|Ketorolac|ketorolac|mesh-list
154674808|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674809|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
154674810|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
154674811|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674812|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674813|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154674814|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
154674815|NCT02039427|Hormones|hormones|mesh-ancestor
154674816|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674817|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154674818|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674819|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154674820|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154674821|NCT02039427|Analgesics|analgesics|mesh-ancestor
154674822|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
154674823|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674824|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154674825|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674826|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674827|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154674828|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
154674829|NCT02094885|Coagulants|coagulants|mesh-ancestor
154674830|NCT01896856|Trifluridine|trifluridine|mesh-list
154674831|NCT01896856|Irinotecan|irinotecan|mesh-list
154674832|NCT01896856|Guadecitabine|guadecitabine|mesh-list
154674833|NCT01896856|Azacitidine|azacitidine|mesh-list
154674834|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154674835|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154674836|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674837|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674838|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674839|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
154674840|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
154674841|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674842|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154674843|NCT01896700|Methylphenidate|methylphenidate|mesh-list
154674844|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154674845|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674846|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154674847|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154674848|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153929530|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674849|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674850|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
154674851|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674852|NCT01896232|Cinacalcet|cinacalcet|mesh-list
154674853|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154674854|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674855|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154674856|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
154674857|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154674858|NCT02460224|Spartalizumab|spartalizumab|mesh-list
154674859|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154674860|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674861|NCT02460224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674862|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674863|NCT02058537|Bethanechol|bethanechol|mesh-list
154674864|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154674865|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
154674866|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674867|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674868|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154674869|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154674870|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
154674871|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674872|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674873|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
154674874|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
154674875|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
154674876|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674877|NCT01612000|Coagulants|coagulants|mesh-ancestor
154674878|NCT02409680|Aspirin|aspirin|mesh-list
154674879|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154674880|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154674881|NCT02409680|Analgesics|analgesics|mesh-ancestor
154674882|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
154674883|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674884|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674885|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154674886|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674887|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154674888|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154674889|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674890|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154674891|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154674892|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674893|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
154674894|NCT01894984|Risperidone|risperidone|mesh-list
154674895|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
154674896|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154674897|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
154674898|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674899|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674900|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674901|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154674902|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154674903|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154674904|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154674905|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
154674906|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
154674907|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674908|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674909|NCT02375672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154674910|NCT02375672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674911|NCT02491463|Vaccines|vaccines|mesh-list
154674912|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
154674913|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426933|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674914|NCT02038881|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154674916|NCT02038881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154674917|NCT01857622|Edoxaban|edoxaban|mesh-list
154674918|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154674919|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
154674920|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154674921|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
154674922|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674923|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674924|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
154674925|NCT01857310|Folic Acid|folic acid|mesh-list
154674926|NCT01857310|Hematinics|hematinics|mesh-ancestor
154674927|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
154674928|NCT01857310|Vitamins|vitamins|mesh-ancestor
154674929|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
154674930|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674931|NCT02472353|Metformin|metformin|mesh-list
154674932|NCT02472353|Doxorubicin|doxorubicin|mesh-list
154674933|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674934|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674935|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154674936|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674937|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154674938|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154674939|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154674940|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674941|NCT02314117|Capecitabine|capecitabine|mesh-list
154674942|NCT02314117|Fluorouracil|fluorouracil|mesh-list
154674943|NCT02314117|Ramucirumab|ramucirumab|mesh-list
154674944|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674945|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154674946|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
154674947|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674948|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154674949|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
154674950|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674951|NCT02314117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154674952|NCT02314117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154674953|NCT02314117|Growth Substances|growth substances|mesh-ancestor
154674954|NCT02314117|Growth Inhibitors|growth inhibitors|mesh-ancestor
154674955|NCT02058147|Insulin|insulin|mesh-list
154674956|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154674957|NCT02058147|Metformin|metformin|mesh-list
154674958|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
154674959|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154674960|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674961|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
154674962|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154674963|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
154674964|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154674965|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674966|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154674967|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
154674968|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
154674969|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154674970|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
154674971|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154674972|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674973|NCT02471183|Selexipag|selexipag|mesh-list
154674974|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154674975|NCT01855828|Paclitaxel|paclitaxel|mesh-list
154674976|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
154674977|NCT01855828|Fluorouracil|fluorouracil|mesh-list
154674978|NCT01855828|Trastuzumab|trastuzumab|mesh-list
154674979|NCT01855828|Epirubicin|epirubicin|mesh-list
154674980|NCT01855828|Pertuzumab|pertuzumab|mesh-list
154674981|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154674982|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154674983|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
154674984|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
154674985|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
154674986|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154674987|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154674988|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
154674989|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154674990|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154674991|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154674992|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
154674993|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154674994|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
154674995|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154674996|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154674997|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154674998|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154674999|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154675000|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929690|NCT04245046|Amlodipine|amlodipine|mesh-list
154675001|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
154675002|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154675003|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
154675004|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675005|NCT02351167|Nicotine|nicotine|mesh-list
154675006|NCT02351167|Varenicline|varenicline|mesh-list
154675007|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154675008|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
154675009|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675010|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675011|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154675012|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154675013|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
154675014|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675015|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675016|NCT02350309|Lemborexant|lemborexant|mesh-list
154675017|NCT02350309|Flurazepam|flurazepam|mesh-list
154675018|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154675019|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675020|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675021|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154675022|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154675023|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675024|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675025|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154675026|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154675027|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154675028|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
154675029|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
154675030|NCT02038647|Paclitaxel|paclitaxel|mesh-list
154675031|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154675032|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675033|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
154675034|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
154675035|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
154675036|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675037|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
154675038|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154675039|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675040|NCT02037477|Esomeprazole|esomeprazole|mesh-list
154675041|NCT02037477|Rabeprazole|rabeprazole|mesh-list
154675042|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154675043|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675044|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154675045|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675046|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675047|NCT02057523|Hormones|hormones|mesh-list
154675048|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154675049|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154675050|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
154675051|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675052|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675053|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675054|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675055|NCT02037165|Celecoxib|celecoxib|mesh-list
154675056|NCT02037165|Pregabalin|pregabalin|mesh-list
154675057|NCT02037165|Analgesics|analgesics|mesh-ancestor
154675058|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
154675059|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675060|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675061|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
154675062|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154675063|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154675064|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427081|NCT01381835|Simeprevir|simeprevir|mesh-list
154675065|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154675066|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154675067|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154675068|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675069|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154675070|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154675071|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154675072|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675073|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675074|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154675075|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154675076|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675077|NCT02470403|Licogliflozin|licogliflozin|mesh-list
154675078|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154675079|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675080|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675081|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675082|NCT01855750|Prednisone|prednisone|mesh-list
154675083|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
154675084|NCT01855750|Rituximab|rituximab|mesh-list
154675085|NCT01855750|Doxorubicin|doxorubicin|mesh-list
154675086|NCT01855750|Vincristine|vincristine|mesh-list
154675087|NCT01855750|Ibrutinib|ibrutinib|mesh-list
154675088|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675089|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
154675090|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675091|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675092|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154675093|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
154675094|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675095|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675096|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154675097|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154675098|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154675099|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154675100|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154675101|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675102|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675103|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
154675104|NCT01855750|Hormones|hormones|mesh-ancestor
154675105|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675106|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154675107|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154675108|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
154675109|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
154675110|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
154675111|NCT01855750|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154675112|NCT01855750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675113|NCT04963439|Macitentan|macitentan|mesh-list
154675114|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154675115|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154675116|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675117|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154675118|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
154675119|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
154675120|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154675121|NCT01622673|Antacids|antacids|mesh-list
154675122|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
154675123|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
154675124|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
154675125|NCT01622673|TEMPO|tempo|mesh-list
154675126|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675127|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154675128|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154675129|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
154675130|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675131|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154675132|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154675133|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675134|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675135|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675136|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154427155|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154675137|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
154675138|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
154675139|NCT01622673|Protective Agents|protective agents|mesh-ancestor
154675140|NCT02469077|Morphine|morphine|mesh-list
154675141|NCT02469077|Naloxone|naloxone|mesh-list
154675142|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154675143|NCT02469077|Narcotics|narcotics|mesh-ancestor
154675144|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675145|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675146|NCT02469077|Analgesics|analgesics|mesh-ancestor
154675147|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
154675148|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675149|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154675150|NCT02486627|Levofloxacin|levofloxacin|mesh-list
154675151|NCT02486627|Meropenem|meropenem|mesh-list
154675152|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154675153|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675154|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154675155|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154675156|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154675157|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675158|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675159|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675160|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154675161|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675162|NCT02282293|Piperaquine|piperaquine|mesh-list
154675163|NCT02282293|Trimethoprim|trimethoprim|mesh-list
154675164|NCT02282293|Artenimol|artenimol|mesh-list
154675165|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
154675166|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
154675167|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154675168|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153929853|NCT00596947|Protective Agents|protective agents|mesh-ancestor
154675169|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675170|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154675171|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154675172|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675173|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675174|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154675175|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154675176|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675177|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
154675178|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
154675179|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154675180|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
154675181|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675182|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675183|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154675184|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
154675185|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154675186|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154675187|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154675188|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
154675189|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675190|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675191|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154675192|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154675193|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154675194|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
154675195|NCT01892020|Insulin|insulin|mesh-list
154675196|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154675197|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
154675198|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
154675199|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675200|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675201|NCT02485691|Prednisone|prednisone|mesh-list
154675202|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
154675203|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675204|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
154675205|NCT02485691|Hormones|hormones|mesh-ancestor
154675206|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675207|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675208|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154427230|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154675209|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675210|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154675211|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675212|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675213|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
154675214|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675215|NCT02517515|Ritonavir|ritonavir|mesh-list
154675216|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154675217|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154675218|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
154675219|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675220|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675221|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154675222|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154675223|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
154675224|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675225|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154675226|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675227|NCT01891864|Etanercept|etanercept|mesh-list
154675228|NCT01891864|GP2015|gp2015|mesh-list
154675229|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154675230|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154675231|NCT01891864|Analgesics|analgesics|mesh-ancestor
154675232|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
154675233|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675234|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675235|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675236|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675237|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675238|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675239|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
154675240|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
154675241|NCT02484911|Dexamethasone|dexamethasone|mesh-list
154675242|NCT02484911|Olanzapine|olanzapine|mesh-list
154675243|NCT02484911|Aprepitant|aprepitant|mesh-list
154675244|NCT02484911|Palonosetron|palonosetron|mesh-list
154675245|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675246|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
154675247|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
154675248|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675249|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675250|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675251|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
154675252|NCT02484911|Hormones|hormones|mesh-ancestor
154675253|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675254|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154675255|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675256|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154675257|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154675258|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675259|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154675260|NCT02484911|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154675261|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154675262|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154675263|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675264|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675265|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
154675266|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154675267|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154675268|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154675269|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
154675270|NCT04306367|Olaparib|olaparib|mesh-list
154675271|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154675272|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675273|NCT04306367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154675274|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675275|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154675276|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675277|NCT02451917|Insulin|insulin|mesh-list
154675278|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154675279|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
154675280|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
154675281|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
154675282|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
154675283|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675284|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675285|NCT02349451|Adalimumab|adalimumab|mesh-list
154675286|NCT02349451|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153929967|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
154675287|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675288|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675289|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
154675290|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154675291|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675292|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675293|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675294|NCT02409368|Nivolumab|nivolumab|mesh-list
154675295|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154675296|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675297|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154675298|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675299|NCT04891484|Ondansetron|ondansetron|mesh-list
154675300|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
154675301|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
154675302|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675303|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675304|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675305|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
154675306|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
154675307|NCT04891484|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154675308|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154675309|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
154675310|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675311|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675312|NCT01853644|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154675313|NCT01853644|Tivozanib|tivozanib|mesh-list
154675314|NCT01853644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675315|NCT01853644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675316|NCT01853644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675317|NCT01853254|Ribavirin|ribavirin|mesh-list
154675318|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154675319|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
154675320|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675321|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
154675322|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675323|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154675324|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154675325|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675326|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675327|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
154675328|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675329|NCT01853176|Bupivacaine|bupivacaine|mesh-list
154675330|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
154675331|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
154675332|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675333|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675334|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
154675335|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675336|NCT01852942|Losartan|losartan|mesh-list
154675337|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154675338|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154675339|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154675340|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154675341|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675342|NCT01852162|Dabigatran|dabigatran|mesh-list
154675343|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
154675344|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154675345|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
154675346|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675347|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675348|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
154675349|NCT01835470|Abatacept|abatacept|mesh-list
154675350|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154675351|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675352|NCT01835470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154675353|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675354|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675355|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
154675356|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675357|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675358|NCT02451137|Insulin|insulin|mesh-list
154675359|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154675360|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
154675361|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
154675362|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675363|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675365|NCT02372006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154675366|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675367|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675368|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675369|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675370|NCT02406248|Ticagrelor|ticagrelor|mesh-list
154675371|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154675372|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154675373|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154675374|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154675375|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
154675376|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675377|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675378|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675379|NCT02450903|Ceritinib|ceritinib|mesh-list
154675380|NCT02450903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154675381|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675382|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675383|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675384|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675385|NCT02371616|Listerine|listerine|mesh-list
154675386|NCT02371616|Calcium|calcium|mesh-list
154675387|NCT02371616|Fluorides|fluorides|mesh-list
154675388|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
154675389|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
154675390|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154675391|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675392|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
154675393|NCT02371616|Protective Agents|protective agents|mesh-ancestor
154675394|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154675395|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675396|NCT01835158|Sunitinib|sunitinib|mesh-list
154675397|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675398|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154675399|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154675400|NCT01835158|Growth Substances|growth substances|mesh-ancestor
154675401|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675402|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
154675403|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675404|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675405|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675406|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
154675407|NCT01833832|Antidotes|antidotes|mesh-ancestor
154675408|NCT01833832|Protective Agents|protective agents|mesh-ancestor
154675409|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675410|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
154675411|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675412|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
154675413|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154675414|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675415|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
154675416|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
154675417|NCT01850602|Sevelamer|sevelamer|mesh-list
154675418|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
154675419|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
154675420|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675421|NCT02405780|Adalimumab|adalimumab|mesh-list
154675422|NCT02405780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154675423|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675424|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675425|NCT02369510|Epinephrine|epinephrine|mesh-list
154675426|NCT02369510|Racepinephrine|racepinephrine|mesh-list
154675427|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
154675428|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154675429|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154675430|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154675431|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675432|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675433|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675434|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154675435|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154675436|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
154675437|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675438|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154675439|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
154675440|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
154675441|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
154675442|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154675443|NCT01650194|Prednisone|prednisone|mesh-list
154675444|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
154675445|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675446|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
154675447|NCT01650194|Hormones|hormones|mesh-ancestor
154675448|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675449|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675450|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154675451|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675452|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154675453|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675454|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675455|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
154675456|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675457|NCT02404220|Dexamethasone|dexamethasone|mesh-list
154675458|NCT02404220|Vincristine|vincristine|mesh-list
154675459|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675460|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
154675461|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
154675462|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675463|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675464|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675465|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
154675466|NCT02404220|Hormones|hormones|mesh-ancestor
154675467|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675468|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154675469|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675470|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154675471|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
154675472|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
154675473|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
154675474|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675475|NCT02366468|Ranibizumab|ranibizumab|mesh-list
154675476|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154675477|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154675478|NCT02366468|Growth Substances|growth substances|mesh-ancestor
154675479|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675480|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
154675481|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675482|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154675483|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154675484|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154675485|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154675486|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675487|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675488|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675489|NCT02335346|Analgesics|analgesics|mesh-ancestor
154675490|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
154675491|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675492|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
154675493|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154675494|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
154675495|NCT02401256|Efavirenz|efavirenz|mesh-list
154675496|NCT02401256|Bupropion|bupropion|mesh-list
154675497|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154675498|NCT02401256|Montelukast|montelukast|mesh-list
154675499|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154675500|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154675501|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
154675502|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675503|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154675504|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154675505|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675506|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154675507|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
154675508|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154675509|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154675510|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154675511|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154675512|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
154675513|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675514|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675515|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154675516|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675517|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154675518|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
154675519|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154675520|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
154675521|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675522|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154675523|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154675524|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154675525|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154675526|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
154675527|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675528|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154675529|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154675530|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154675531|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154675532|NCT02349295|Ixekizumab|ixekizumab|mesh-list
154675533|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
154675534|NCT04877587|Gemcitabine|gemcitabine|mesh-list
154675535|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154675536|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
154675537|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675538|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675539|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
154675540|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154675541|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675542|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675543|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154675544|NCT02284243|Analgesics|analgesics|mesh-ancestor
154675545|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
154675546|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675547|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154675548|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154675549|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154675550|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154675551|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675552|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675553|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
154675554|NCT02284009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675555|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675556|NCT02284009|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154675557|NCT02400476|Budesonide|budesonide|mesh-list
154675558|NCT02400476|Loperamide|loperamide|mesh-list
154675559|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
154675560|NCT02400476|Colestipol|colestipol|mesh-list
154675561|NCT02400476|Neratinib|neratinib|mesh-list
154675562|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675563|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154675564|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
154675565|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675566|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675567|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154675568|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
154675569|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
154675570|NCT02400476|Hormones|hormones|mesh-ancestor
154675571|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675572|NCT02400476|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154675573|NCT02400476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675574|NCT02400476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675575|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675576|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675577|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154675578|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
154675579|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154675580|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
154675581|NCT02363738|Infliximab|infliximab|mesh-list
154675583|NCT02363738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675584|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
154675585|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675586|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675587|NCT02331680|Tolvaptan|tolvaptan|mesh-list
154675588|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154675589|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675590|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
154675591|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675592|NCT02349061|Ustekinumab|ustekinumab|mesh-list
154675593|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
154675594|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
154675595|NCT02331368|Lenalidomide|lenalidomide|mesh-list
154675596|NCT02331368|Melphalan|melphalan|mesh-list
154675597|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154675598|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675599|NCT02331368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154675600|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675601|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
154675602|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675603|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154675604|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154675605|NCT02331368|Growth Substances|growth substances|mesh-ancestor
154675606|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
154675607|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154675608|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
154675609|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154675610|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675611|NCT02280421|Cyclosporine|cyclosporine|mesh-list
154675612|NCT02280421|Cyclosporins|cyclosporins|mesh-list
154675613|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675614|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675615|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675616|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
154675617|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675618|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
154675619|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675620|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
154675621|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675622|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154675623|NCT04906382|Paclitaxel|paclitaxel|mesh-list
154675624|NCT04906382|Carboplatin|carboplatin|mesh-list
154675625|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154675626|NCT04906382|Tislelizumab|tislelizumab|mesh-list
154675627|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154675628|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675629|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
154675630|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
154675631|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
154675632|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675633|NCT04906382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154675634|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154675635|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
154675636|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154675637|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154675638|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154675639|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675640|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675641|NCT02347813|Pioglitazone|pioglitazone|mesh-list
154675642|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675643|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675644|NCT02359994|Hemostatics|hemostatics|mesh-list
154675645|NCT02359994|Coagulants|coagulants|mesh-ancestor
154675646|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
154675647|NCT02326298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154675648|NCT02326298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675649|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675650|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
153930358|NCT01104246|Testosterone|testosterone|mesh-list
154675651|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675652|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675653|NCT02279719|Sorafenib|sorafenib|mesh-list
154675654|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675655|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675656|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675657|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675658|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
154675659|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154675660|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675661|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675662|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675663|NCT02326220|Alirocumab|alirocumab|mesh-list
154675664|NCT02326220|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154675665|NCT02326220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154675666|NCT02326220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154675667|NCT02326220|Antimetabolites|antimetabolites|mesh-ancestor
154675668|NCT02326220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675669|NCT02326220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154675670|NCT02326220|Protease Inhibitors|protease inhibitors|mesh-ancestor
154675671|NCT02326220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675672|NCT02326220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154675673|NCT02358668|PAZ320|paz320|mesh-list
154675674|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675675|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675676|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
154675677|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154675678|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154675679|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675680|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
154675681|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
154675682|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154675683|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154675684|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154675685|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
154675686|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675687|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675688|NCT05650099|Cimetidine|cimetidine|mesh-list
154675689|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154675690|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675691|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154675692|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
154675693|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
154675694|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675695|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675696|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675697|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154675698|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675699|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675700|NCT02278471|Losartan|losartan|mesh-list
154675701|NCT02278471|Amlodipine|amlodipine|mesh-list
154675702|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154675703|NCT02278471|Atorvastatin|atorvastatin|mesh-list
154675704|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154675705|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154675706|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
154675707|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675708|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154675709|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154675710|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675711|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154675712|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154675713|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154675714|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154675715|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675716|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
154675717|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154675718|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154675719|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154675720|NCT02278471|Diuretics|diuretics|mesh-ancestor
154675721|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
154675722|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154675723|NCT05565235|Nalbuphine|nalbuphine|mesh-list
154675724|NCT05565235|Bupivacaine|bupivacaine|mesh-list
154675725|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
154675726|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
154675727|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675728|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675729|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
154675730|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675731|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154675732|NCT05565235|Narcotics|narcotics|mesh-ancestor
154675733|NCT05565235|Analgesics|analgesics|mesh-ancestor
154675734|NCT02278003|Propofol|propofol|mesh-list
154675735|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154675736|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675737|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675738|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154675739|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
154675740|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
154675741|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154675742|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
154675743|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675744|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154675745|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154675746|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154675747|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675748|NCT02395172|Docetaxel|docetaxel|mesh-list
154675749|NCT02395172|Avelumab|avelumab|mesh-list
154675750|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675751|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
154675752|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930439|NCT00676819|Insulin|insulin|mesh-list
154675753|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
154675754|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675755|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154675756|NCT04876027|Dulaglutide|dulaglutide|mesh-list
154675757|NCT04876027|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154675758|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675759|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675760|NCT02358044|Ribavirin|ribavirin|mesh-list
154675761|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
154675762|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154675763|NCT02358044|Grazoprevir|grazoprevir|mesh-list
154675764|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154675765|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
154675766|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675767|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
154675768|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675769|NCT05649241|Nicotine|nicotine|mesh-list
154675770|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154675771|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
154675772|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675773|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675774|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154675775|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154675776|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
154675777|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675778|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675779|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
154675780|NCT02272777|Nilotinib|nilotinib|mesh-list
154675781|NCT02272777|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154675782|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675783|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675784|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675785|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675786|NCT02357810|Topotecan|topotecan|mesh-list
154675787|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154675788|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154675789|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675790|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675791|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675792|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154675793|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154675794|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154675795|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154675796|NCT01850446|Oseltamivir|oseltamivir|mesh-list
154675797|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
154675798|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675799|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675800|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675801|NCT01644175|Alirocumab|alirocumab|mesh-list
154675802|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154675803|NCT01644175|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154675804|NCT01644175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154675805|NCT01644175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154675806|NCT01644175|Antimetabolites|antimetabolites|mesh-ancestor
154675807|NCT01644175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675808|NCT01644175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154675810|NCT01644175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675811|NCT01644175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153930494|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
154675812|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
154675813|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675814|NCT04856761|Capecitabine|capecitabine|mesh-list
154675815|NCT04856761|Tegafur|tegafur|mesh-list
154675816|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154675817|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
154675818|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675819|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675820|NCT01832038|Lacosamide|lacosamide|mesh-list
154675821|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
154675822|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154675823|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154675824|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154675825|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675826|NCT01849588|Sorafenib|sorafenib|mesh-list
154675827|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675828|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675829|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675830|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675831|NCT02357342|Sirolimus|sirolimus|mesh-list
154675832|NCT02357342|Aflibercept|aflibercept|mesh-list
154675833|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675834|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154675835|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154675836|NCT02357342|Growth Substances|growth substances|mesh-ancestor
154675837|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675838|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
154675839|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154675840|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675841|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154675842|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
154675843|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675844|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
154675845|NCT02325518|Timolol|timolol|mesh-list
154675846|NCT02325518|Dorzolamide|dorzolamide|mesh-list
154675847|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154675848|NCT02325518|Maleic acid|maleic acid|mesh-list
154675849|NCT02325518|Brinzolamide|brinzolamide|mesh-list
154675850|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154675851|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675852|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675853|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154675854|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154675855|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
154675856|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675857|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675858|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154675859|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154675860|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154675861|NCT02270983|Linaclotide|linaclotide|mesh-list
154675862|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154675863|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
154675864|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675865|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154675866|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154675867|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154675868|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675869|NCT02324270|Diclofenac|diclofenac|mesh-list
154675870|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
153930552|NCT00674089|Vitamin A|vitamin a|mesh-list
154675871|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154675872|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154675873|NCT02324270|Analgesics|analgesics|mesh-ancestor
154675874|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
154675875|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675876|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675877|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154675878|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154675879|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154675880|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675881|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675882|NCT05648071|Pemetrexed|pemetrexed|mesh-list
154675883|NCT05648071|Nedaplatin|nedaplatin|mesh-list
154675884|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675885|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675886|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675887|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154675888|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154675889|NCT01849276|Metformin|metformin|mesh-list
154675890|NCT01849276|Cytarabine|cytarabine|mesh-list
154675891|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154675892|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675893|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154675894|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
154675895|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675896|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675897|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
154675898|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675899|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675900|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
154675901|NCT02465489|Deferiprone|deferiprone|mesh-list
154675902|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154675903|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
154675904|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
154675905|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675906|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
154675907|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154675908|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675909|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154675910|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154675911|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675912|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675913|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675914|NCT01601821|Sirolimus|sirolimus|mesh-list
154675915|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154675916|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675917|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154675918|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675919|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
154675920|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154675921|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
154675922|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675923|NCT01846624|Decitabine|decitabine|mesh-list
154675924|NCT01846624|Azacitidine|azacitidine|mesh-list
154675925|NCT01846624|Midostaurin|midostaurin|mesh-list
154675926|NCT01846624|Staurosporine|staurosporine|mesh-list
154675927|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154675928|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
154675929|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675930|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154675931|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675932|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154675933|NCT01827670|Fluorides|fluorides|mesh-list
154675934|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
154675935|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
154675936|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
154675937|NCT01827670|Protective Agents|protective agents|mesh-ancestor
154675938|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675939|NCT01844830|Phenylephrine|phenylephrine|mesh-list
154675940|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
154675941|NCT01844830|Tetracaine|tetracaine|mesh-list
154675942|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
154675943|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
154675944|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154675945|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675946|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
154675947|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154675948|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154675949|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154675950|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
154675951|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154675952|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675953|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
154675954|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
154675955|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
154675956|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154427978|NCT02052180|Bupivacaine|bupivacaine|mesh-list
154675957|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
154675958|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154675959|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
154675960|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154675961|NCT01844830|Protective Agents|protective agents|mesh-ancestor
154675962|NCT02323334|Itraconazole|itraconazole|mesh-list
154675963|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
154675964|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675965|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154675966|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675967|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675968|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675969|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154675970|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
154675971|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154675972|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154675973|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154675974|NCT02322866|Sarecycline|sarecycline|mesh-list
154675975|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154675976|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675977|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
154675978|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154675979|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154675980|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154675981|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675982|NCT02356562|Ritonavir|ritonavir|mesh-list
154675983|NCT02356562|Ribavirin|ribavirin|mesh-list
154675984|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
154675985|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154675986|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154675987|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
154675988|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154675989|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154675990|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154675991|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154675992|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
154675993|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154675994|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154675995|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154675996|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
154675997|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
154675998|NCT02354690|Fludarabine|fludarabine|mesh-list
154675999|NCT02354690|Interleukin-2|interleukin-2|mesh-list
154676000|NCT02354690|Vemurafenib|vemurafenib|mesh-list
154676001|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676002|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
154676003|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676004|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676005|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154676006|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
154676007|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676008|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676009|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154676010|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154676011|NCT02354690|Analgesics|analgesics|mesh-ancestor
154676012|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
154676013|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676014|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154676015|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676016|NCT02354222|Canagliflozin|canagliflozin|mesh-list
154676017|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154676018|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676019|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676020|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676021|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
154676022|NCT02351960|Lansoprazole|lansoprazole|mesh-list
154676023|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154676024|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676025|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154676026|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676027|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676028|NCT02351180|Beclomethasone|beclomethasone|mesh-list
154676029|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676030|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
154428058|NCT00101582|Cisplatin|cisplatin|mesh-list
154676031|NCT02351180|Hormones|hormones|mesh-ancestor
154676032|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676033|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676034|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154676035|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
154676036|NCT02350478|Linagliptin|linagliptin|mesh-list
154676037|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676038|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676039|NCT02350478|Incretins|incretins|mesh-ancestor
154676040|NCT02350478|Hormones|hormones|mesh-ancestor
154676041|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676042|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154676043|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
154676044|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676045|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676046|NCT02349542|Bupivacaine|bupivacaine|mesh-list
154676047|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154676048|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
154676049|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676050|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676051|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
154676052|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676053|NCT02321930|Tofacitinib|tofacitinib|mesh-list
154676054|NCT02321930|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154676055|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154676056|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676057|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676058|NCT02264821|Morphine|morphine|mesh-list
154676059|NCT02264821|Ropivacaine|ropivacaine|mesh-list
154676060|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
154676061|NCT02264821|Anesthetics|anesthetics|mesh-list
154676062|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154676063|NCT02264821|Narcotics|narcotics|mesh-ancestor
154676064|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676065|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676066|NCT02264821|Analgesics|analgesics|mesh-ancestor
154676067|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
154676068|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676069|NCT04854889|Decitabine|decitabine|mesh-list
154676070|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154676071|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
154676072|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676073|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676074|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676075|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
154676076|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154676077|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154676078|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154676079|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676080|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676081|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
154676082|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676083|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676084|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154676085|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676086|NCT05341843|Sertraline|sertraline|mesh-list
154676087|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
154676088|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154676089|NCT05341843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154676090|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154676091|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676092|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676093|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676094|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
154676095|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676096|NCT02320058|Nivolumab|nivolumab|mesh-list
154676097|NCT02320058|Ipilimumab|ipilimumab|mesh-list
154676098|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154676099|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676100|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154676101|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676102|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
154676103|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154676104|NCT02319668|Listerine|listerine|mesh-list
154676105|NCT02319668|Fluorides|fluorides|mesh-list
154676106|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
154676107|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
154676108|NCT02319668|Protective Agents|protective agents|mesh-ancestor
154676109|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676110|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154676111|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676112|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
154676113|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
154676114|NCT02092467|Adalimumab|adalimumab|mesh-list
154676115|NCT02092467|Etanercept|etanercept|mesh-list
154676116|NCT02092467|Tofacitinib|tofacitinib|mesh-list
154676117|NCT02092467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154676118|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676119|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676120|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154676121|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154676122|NCT02092467|Analgesics|analgesics|mesh-ancestor
154676123|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
154676124|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676125|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676126|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676127|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676128|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
154676129|NCT02092467|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154676130|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154676131|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676132|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676133|NCT04420871|Capecitabine|capecitabine|mesh-list
154676134|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154676135|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
154676136|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676137|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676138|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154676139|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154676140|NCT02349386|Estradiol|estradiol|mesh-list
154676141|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154676142|NCT02349386|Estrogens|estrogens|mesh-ancestor
154676143|NCT02349386|Hormones|hormones|mesh-ancestor
154676144|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676145|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676146|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154676147|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
154676148|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154676149|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154676150|NCT04892888|Vaccines|vaccines|mesh-list
154676151|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
154676152|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676153|NCT02036775|Ambroxol|ambroxol|mesh-list
154676154|NCT02036775|Expectorants|expectorants|mesh-ancestor
154676155|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
154676156|NCT02034591|Apixaban|apixaban|mesh-list
154676157|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154676158|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
154676159|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154676160|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
154676161|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676162|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676163|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
154676164|NCT02091921|Ticagrelor|ticagrelor|mesh-list
154676165|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154676166|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154676167|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154676168|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154676169|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
154676170|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676171|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676172|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676173|NCT02034513|Insulin|insulin|mesh-list
154676174|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154676175|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
154676176|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
154676177|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676178|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676179|NCT02461745|Ribavirin|ribavirin|mesh-list
154676180|NCT02461745|Ritonavir|ritonavir|mesh-list
154676181|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
154676182|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676183|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
154676184|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676185|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154676186|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154676187|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
154676188|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676189|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154676190|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154676191|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154676192|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154676193|NCT02034435|Amlodipine|amlodipine|mesh-list
154676194|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154676195|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154676196|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676197|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676198|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154676199|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676200|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
154676201|NCT02033889|Insulin|insulin|mesh-list
154676202|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154676203|NCT02033889|Metformin|metformin|mesh-list
154676204|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
154676205|NCT02033889|Glimepiride|glimepiride|mesh-list
154676206|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
154676207|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
154676208|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676209|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676210|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154676211|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676212|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
154676213|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154676214|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676215|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
154676216|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154676217|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676218|NCT02447003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154676219|NCT02447003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676220|NCT02054481|Ustekinumab|ustekinumab|mesh-list
154676221|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154676222|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
154676223|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
154676224|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676225|NCT02054325|Polidocanol|polidocanol|mesh-list
154676226|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154676227|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154676228|NCT02091375|Cannabidiol|cannabidiol|mesh-list
154676229|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
154676230|NCT02032875|Ribavirin|ribavirin|mesh-list
154676231|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
154676232|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
154676233|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676234|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
154676235|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676236|NCT02032407|Dapsone|dapsone|mesh-list
154676237|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676238|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
154676239|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154676240|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154676241|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154676242|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676243|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676244|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
154676245|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154676246|NCT01843660|Acetaminophen|acetaminophen|mesh-list
154676247|NCT01843660|Tramadol|tramadol|mesh-list
154676248|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154676249|NCT01843660|Analgesics|analgesics|mesh-ancestor
154676250|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
154676251|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676252|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676253|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
154676254|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154676255|NCT01843660|Narcotics|narcotics|mesh-ancestor
154428283|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676256|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676257|NCT02032173|Ranibizumab|ranibizumab|mesh-list
154676258|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154676259|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154676260|NCT02032173|Growth Substances|growth substances|mesh-ancestor
154676261|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676262|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
154676263|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676264|NCT02461589|Liraglutide|liraglutide|mesh-list
154676265|NCT02461589|Semaglutide|semaglutide|mesh-list
154676266|NCT02461589|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154676267|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676268|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676269|NCT02461589|Incretins|incretins|mesh-ancestor
154676270|NCT02461589|Hormones|hormones|mesh-ancestor
154676271|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676272|NCT02089737|Panitumumab|panitumumab|mesh-list
154676273|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154676274|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676275|NCT02089347|Vaccines|vaccines|mesh-list
154676276|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
154676277|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676278|NCT02419469|Cytarabine|cytarabine|mesh-list
154676279|NCT02419469|Dexamethasone|dexamethasone|mesh-list
154676280|NCT02419469|Prednisone|prednisone|mesh-list
154676281|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
154676282|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
154676283|NCT02419469|Rituximab|rituximab|mesh-list
154676284|NCT02419469|Doxorubicin|doxorubicin|mesh-list
154676285|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154676286|NCT02419469|Methotrexate|methotrexate|mesh-list
154676287|NCT02419469|Vincristine|vincristine|mesh-list
154676288|NCT02419469|Daunorubicin|daunorubicin|mesh-list
154676289|NCT02419469|Asparaginase|asparaginase|mesh-list
154676290|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
154676291|NCT02419469|Ofatumumab|ofatumumab|mesh-list
154676292|NCT02419469|Pegaspargase|pegaspargase|mesh-list
154676293|NCT02419469|Thioguanine|thioguanine|mesh-list
154676294|NCT02419469|BB 1101|bb 1101|mesh-list
154676295|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676296|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
154676297|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676298|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676299|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154676300|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
154676301|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676302|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676303|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154676304|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153930976|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676305|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676306|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
154676307|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
154676308|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676309|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676310|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
154676311|NCT02419469|Hormones|hormones|mesh-ancestor
154676312|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676313|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154676314|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154676315|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154676316|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154676317|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676318|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154676319|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
154676320|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154676321|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154676322|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
154676323|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
154676324|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154676325|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154676326|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
154676327|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676328|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154676329|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
154676330|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
154676331|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
154676332|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
154676333|NCT04687761|Cytarabine|cytarabine|mesh-list
154676334|NCT04687761|Azacitidine|azacitidine|mesh-list
154676335|NCT04687761|Venetoclax|venetoclax|mesh-list
154676336|NCT04687761|Quizartinib|quizartinib|mesh-list
154676337|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154676338|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
154676339|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676340|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676341|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
154676342|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676343|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676344|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
154676345|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676346|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676347|NCT04687761|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154676348|NCT04687761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154676349|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154676350|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154676351|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676352|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676353|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154676354|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676355|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676356|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
154676357|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676358|NCT04730193|Caffeine|caffeine|mesh-list
154676359|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154676360|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676361|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154676362|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676363|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676364|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154676365|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154676366|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
154676367|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676368|NCT02088957|Phenytoin|phenytoin|mesh-list
154676369|NCT02088957|Brivaracetam|brivaracetam|mesh-list
154676370|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154676371|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
154676372|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154676373|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154676374|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676375|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676376|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154676377|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154676378|NCT02088177|Naltrexone|naltrexone|mesh-list
154676379|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154676380|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154676381|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676382|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
154676383|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676384|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
154676385|NCT02030535|Olodaterol|olodaterol|mesh-list
154676386|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154676387|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
154676388|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676389|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676390|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154676391|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
154676392|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
154676393|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154676394|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
154676395|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676396|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676397|NCT02029989|Chrysarobin|chrysarobin|mesh-list
154676398|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154676399|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154676400|NCT02029989|Analgesics|analgesics|mesh-ancestor
154676401|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
154676402|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676403|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676404|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676405|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676406|NCT02048241|Guanfacine|guanfacine|mesh-list
154676407|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153931104|NCT04238806|Desflurane|desflurane|mesh-list
154676408|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154428424|NCT03699033|Paclitaxel|paclitaxel|mesh-list
154676409|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154676410|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154676411|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
154676412|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676413|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676414|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676415|NCT02087943|Thalidomide|thalidomide|mesh-list
154676416|NCT02087943|Apremilast|apremilast|mesh-list
154676417|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154676418|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154676419|NCT02087943|Analgesics|analgesics|mesh-ancestor
154676420|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
154676421|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676422|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676423|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676424|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676425|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154676426|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154676427|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676428|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676429|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676430|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
154676431|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
154676432|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154676433|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676434|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154676435|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154676436|NCT02087943|Growth Substances|growth substances|mesh-ancestor
154676437|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
154676438|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676439|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154676440|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154676441|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676442|NCT04709211|Bupivacaine|bupivacaine|mesh-list
154676443|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
154676444|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
154676445|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676446|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676447|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
154676448|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676449|NCT02443883|Ramucirumab|ramucirumab|mesh-list
154676450|NCT02443883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154676451|NCT02443883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154676452|NCT02443883|Growth Substances|growth substances|mesh-ancestor
154676453|NCT02443883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676454|NCT02443883|Growth Inhibitors|growth inhibitors|mesh-ancestor
154676455|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676456|NCT02087241|Carboplatin|carboplatin|mesh-list
154676457|NCT02087241|Pemetrexed|pemetrexed|mesh-list
154676458|NCT02087241|Adavosertib|adavosertib|mesh-list
154676459|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676460|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676461|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676462|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154676463|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154676464|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154676465|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154676466|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154676467|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153931144|NCT05658640|Cytarabine|cytarabine|mesh-list
154676468|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154676469|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
154676470|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676471|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676472|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676473|NCT02443337|Necitumumab|necitumumab|mesh-list
154676474|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154676475|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676476|NCT02443103|Guanabenz|guanabenz|mesh-list
154676477|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154676478|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154676479|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154676480|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154676481|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
154428508|NCT02171390|Hormones|hormones|mesh-ancestor
154676482|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676483|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676484|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676486|NCT02022657|Emtricitabine|emtricitabine|mesh-list
154676487|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154676488|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
154676489|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676490|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154676491|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154676492|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676493|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676494|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154676495|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154676496|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
154676497|NCT02021643|Ribavirin|ribavirin|mesh-list
154676498|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
154676499|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676500|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
154676501|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676502|NCT02415959|Pancrelipase|pancrelipase|mesh-list
154676503|NCT02415959|Pancreatin|pancreatin|mesh-list
154676504|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676505|NCT02021331|Cimetidine|cimetidine|mesh-list
154676506|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154676507|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676508|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154676509|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
154676510|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
154676511|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676512|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676513|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676514|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154676515|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154676516|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676517|NCT02441309|Ifosfamide|ifosfamide|mesh-list
154676518|NCT02441309|Mifamurtide|mifamurtide|mesh-list
154676519|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154676520|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
154676521|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676522|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676523|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154676524|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
154676525|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676526|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154676527|NCT01652729|Exenatide|exenatide|mesh-list
154676528|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676529|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676530|NCT01652729|Incretins|incretins|mesh-ancestor
154676531|NCT01652729|Hormones|hormones|mesh-ancestor
154676532|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676533|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154676534|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
154676535|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676536|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676537|NCT01652729|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154676538|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154676539|NCT02083965|Factor VIII|factor viii|mesh-list
154676540|NCT02083965|Coagulants|coagulants|mesh-ancestor
154676541|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
154676542|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154676543|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676544|NCT02458469|Buspirone|buspirone|mesh-list
154676545|NCT02458469|Trazodone|trazodone|mesh-list
154676546|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154676547|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154676548|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676549|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676550|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154676551|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154676552|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
154676553|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676554|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428573|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154676555|NCT02458469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154676556|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154676557|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676558|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154676559|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
154676560|NCT01843348|Cyclosporine|cyclosporine|mesh-list
154676561|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
154676562|NCT01843348|Everolimus|everolimus|mesh-list
154676563|NCT01843348|Tacrolimus|tacrolimus|mesh-list
154676564|NCT01843348|Cyclosporins|cyclosporins|mesh-list
154676565|NCT01843348|Basiliximab|basiliximab|mesh-list
154676566|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676567|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
154676568|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676569|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154676570|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676571|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676572|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
154676573|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676574|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
154676575|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676576|NCT01843348|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154676577|NCT01843348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154676578|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676579|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154676580|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154676581|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
154676582|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154676583|NCT01825876|Warfarin|warfarin|mesh-list
154676584|NCT01825876|Evacetrapib|evacetrapib|mesh-list
154676585|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
154676586|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154676587|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154676588|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
154676589|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676590|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154676591|NCT01825798|Metformin|metformin|mesh-list
154676592|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676593|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676594|NCT02412761|Amlodipine|amlodipine|mesh-list
154676595|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154676596|NCT02412761|Lisinopril|lisinopril|mesh-list
154676597|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
154676598|NCT02412761|Diuretics|diuretics|mesh-list
154676599|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
154676600|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154676601|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154676602|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154676603|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676604|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154676605|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676606|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676607|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
154676608|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
154676609|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
154676610|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154676611|NCT02412761|Protective Agents|protective agents|mesh-ancestor
154676612|NCT01842334|Nicotine|nicotine|mesh-list
154676613|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154676614|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
154676615|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676616|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676617|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154676618|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154676619|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
154676620|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676621|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676622|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
154676623|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154676624|NCT02457611|Ledipasvir|ledipasvir|mesh-list
154676625|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
154676626|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676627|NCT02083653|Capecitabine|capecitabine|mesh-list
154676628|NCT02083653|Fluorouracil|fluorouracil|mesh-list
154676629|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154676630|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154676631|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
154676632|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676633|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676634|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676635|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
154676636|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676637|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154676638|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
154676639|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154676640|NCT02436239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154676641|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154676642|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676643|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676644|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676645|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
154676646|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676647|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154676648|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154676649|NCT02026011|Naltrexone|naltrexone|mesh-list
154676650|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154676651|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154676652|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676653|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
154676654|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676655|NCT02456909|Morphine|morphine|mesh-list
154676656|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154676657|NCT02456909|Narcotics|narcotics|mesh-ancestor
154676658|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676659|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676660|NCT02456909|Analgesics|analgesics|mesh-ancestor
154676661|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
154676662|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676663|NCT02025621|Simendan|simendan|mesh-list
154676664|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154676665|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
154676666|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154676667|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154676668|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676669|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676670|NCT02025621|Protective Agents|protective agents|mesh-ancestor
154676671|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676672|NCT04729023|Temazepam|temazepam|mesh-list
154676673|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154676674|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676675|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676676|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154676677|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154676678|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154676679|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
154676680|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
154676681|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676682|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676683|NCT02020941|Dexamethasone|dexamethasone|mesh-list
154676684|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676685|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
154676686|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
154676687|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676688|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676689|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676690|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
154676691|NCT02020941|Hormones|hormones|mesh-ancestor
154676692|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676693|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154676694|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676695|NCT01823224|Acetaminophen|acetaminophen|mesh-list
154676696|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154676697|NCT01823224|Analgesics|analgesics|mesh-ancestor
154676698|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
154676699|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676700|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676701|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
154676702|NCT01840228|Progesterone|progesterone|mesh-list
154676703|NCT01840228|Progestins|progestins|mesh-ancestor
154676704|NCT01840228|Hormones|hormones|mesh-ancestor
154676705|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676706|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676707|NCT01823146|Oxytocin|oxytocin|mesh-list
154676708|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
154676709|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154676710|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676711|NCT02083185|Leuprolide|leuprolide|mesh-list
154676712|NCT02083185|Relugolix|relugolix|mesh-list
154676713|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154676714|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
154676715|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154676716|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676717|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154676718|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676719|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
154676720|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
154676721|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676722|NCT02412371|Paclitaxel|paclitaxel|mesh-list
154676723|NCT02412371|Carboplatin|carboplatin|mesh-list
154676724|NCT02412371|Veliparib|veliparib|mesh-list
154676725|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154676726|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676727|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
154676728|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
154676729|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
154676730|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676731|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154676732|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676733|NCT01822756|Paclitaxel|paclitaxel|mesh-list
154676734|NCT01822756|Gemcitabine|gemcitabine|mesh-list
154676735|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154676736|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676737|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
154676738|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
154676739|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
154676740|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676741|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154676742|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
154676743|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154676744|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
154676745|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154676746|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154676747|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676748|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676749|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
154676750|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
153931432|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
154676751|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676752|NCT01611298|Vaccines|vaccines|mesh-list
154676753|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
154676754|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676755|NCT01822132|Naltrexone|naltrexone|mesh-list
154676756|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154676757|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154676758|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676759|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
154676760|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676761|NCT01821898|Budesonide|budesonide|mesh-list
154676762|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676763|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154676764|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
154676765|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676766|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676767|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154676768|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
154676769|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
154676770|NCT01821898|Hormones|hormones|mesh-ancestor
154676771|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676772|NCT02411591|Necitumumab|necitumumab|mesh-list
154676773|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154676774|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676775|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154676776|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
154676777|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
154676778|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676779|NCT01838044|Celecoxib|celecoxib|mesh-list
154676780|NCT01838044|Pregabalin|pregabalin|mesh-list
154676782|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
154676783|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676784|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676785|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
154676786|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154676787|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676788|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676789|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154676790|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154676791|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154676792|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676793|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154676794|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154676795|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154676796|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676797|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676798|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154676799|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154676800|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676801|NCT02435147|Denosumab|denosumab|mesh-list
154676802|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154676803|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676804|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154676805|NCT02435069|Glycerol|glycerol|mesh-list
154676806|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154676807|NCT02435069|Protective Agents|protective agents|mesh-ancestor
154676808|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676809|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
154676810|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154676811|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154676812|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153931490|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676813|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154676814|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676815|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
154676816|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676817|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676818|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154676819|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676820|NCT01820572|Cyclosporine|cyclosporine|mesh-list
154676821|NCT01820572|Abatacept|abatacept|mesh-list
154676822|NCT01820572|Tacrolimus|tacrolimus|mesh-list
154676823|NCT01820572|Cyclosporins|cyclosporins|mesh-list
154676824|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154676825|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
154676826|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676827|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154676828|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676829|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676830|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
154676831|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676832|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
154676833|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154676834|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154676835|NCT01820572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154676836|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676837|NCT01610596|Halobetasol|halobetasol|mesh-list
154676838|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154676839|NCT01818700|Buprenorphine|buprenorphine|mesh-list
154676840|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154676841|NCT01818700|Narcotics|narcotics|mesh-ancestor
154676842|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676843|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676844|NCT01818700|Analgesics|analgesics|mesh-ancestor
154676845|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
154676846|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676847|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154676848|NCT01817764|Fluticasone|fluticasone|mesh-list
154676849|NCT01817764|Xhance|xhance|mesh-list
154676850|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154676851|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676852|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154676853|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
154676854|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428875|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
154676855|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676856|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154676857|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
154676858|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
154676859|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154676860|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154676861|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154676862|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154676863|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
154676864|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676865|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676867|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154676868|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
154676869|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
154676870|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676871|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676872|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154676873|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154676874|NCT01817530|Norethindrone|norethindrone|mesh-list
154676875|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
154676876|NCT01817530|Estradiol|estradiol|mesh-list
154676877|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154676878|NCT01817530|Estrogens|estrogens|mesh-ancestor
154676879|NCT01817530|Hormones|hormones|mesh-ancestor
154676880|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676881|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676882|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154676883|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
154676884|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154676885|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154676886|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154676887|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154676888|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154676889|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154676890|NCT01816984|Cetuximab|cetuximab|mesh-list
154676891|NCT01816984|Antibodies|antibodies|mesh-list
154676892|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
154676893|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154676894|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
154676895|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676896|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676897|NCT01816594|Paclitaxel|paclitaxel|mesh-list
154676898|NCT01816594|Trastuzumab|trastuzumab|mesh-list
154676899|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154676900|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676901|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
154676902|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
154676903|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
154676904|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676905|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154676906|NCT02453711|Liraglutide|liraglutide|mesh-list
154676907|NCT02453711|Semaglutide|semaglutide|mesh-list
154676908|NCT02453711|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154676909|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676910|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676911|NCT02453711|Incretins|incretins|mesh-ancestor
154676912|NCT02453711|Hormones|hormones|mesh-ancestor
154676913|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676914|NCT02453555|Empagliflozin|empagliflozin|mesh-list
154676915|NCT02453555|Linagliptin|linagliptin|mesh-list
154676916|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154676917|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676918|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676919|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676920|NCT02453555|Incretins|incretins|mesh-ancestor
154676921|NCT02453555|Hormones|hormones|mesh-ancestor
154676922|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676923|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154676924|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
154676925|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676926|NCT02453321|Bupivacaine|bupivacaine|mesh-list
154676927|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
154676928|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
154428951|NCT02170766|Pantoprazole|pantoprazole|mesh-list
154676929|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676930|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676931|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
154676932|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676933|NCT01610284|Fulvestrant|fulvestrant|mesh-list
154676934|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154676935|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676936|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154676937|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154676938|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
154676939|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676940|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676941|NCT02452463|Durvalumab|durvalumab|mesh-list
154676942|NCT02452463|Nintedanib|nintedanib|mesh-list
154676943|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
154676944|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154676945|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
154676946|NCT02452463|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154676947|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154676948|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676949|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
154676950|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676951|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154676952|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154676953|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676954|NCT03628391|Haloperidol|haloperidol|mesh-list
154676955|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
154676956|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
154676957|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
154676958|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676959|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676960|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676961|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154676962|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154676963|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154676964|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154676965|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154676966|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
154676967|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154676968|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676969|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154676970|NCT01610206|Gemcitabine|gemcitabine|mesh-list
154676971|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154676972|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
154676973|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154676974|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676975|NCT01816048|Listerine|listerine|mesh-list
154676976|NCT01816048|Fluorides|fluorides|mesh-list
154676977|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
154676978|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
154676979|NCT01816048|Protective Agents|protective agents|mesh-ancestor
154676980|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676981|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154676982|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154676983|NCT01612858|Metformin|metformin|mesh-list
154676984|NCT01612858|Pioglitazone|pioglitazone|mesh-list
154676985|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154676986|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676987|NCT01612702|Dexamethasone|dexamethasone|mesh-list
154676988|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154676989|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
154676990|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
154676991|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154676992|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154676993|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154676994|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
154676995|NCT01612702|Hormones|hormones|mesh-ancestor
154676996|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154676997|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154676998|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154676999|NCT02431559|Doxorubicin|doxorubicin|mesh-list
154677000|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154677001|NCT02431559|Durvalumab|durvalumab|mesh-list
154677002|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154677003|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677004|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154677005|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154677006|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677007|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677008|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677010|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
154677011|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154677012|NCT01652573|Katacalcin|katacalcin|mesh-list
154677013|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154677014|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677015|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154677016|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
154677017|NCT02388191|Naproxen|naproxen|mesh-list
154677018|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154677019|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154677020|NCT02388191|Analgesics|analgesics|mesh-ancestor
154677021|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
154677022|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677023|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677024|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677025|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677026|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
154677027|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154677028|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677029|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677030|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154677031|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
154677032|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677033|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154677034|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154677035|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154677036|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154677037|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154677038|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154677039|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677040|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677041|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
154677042|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677043|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154677044|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154677045|NCT01799590|Topiramate|topiramate|mesh-list
154677046|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
154677047|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154677048|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677049|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154677050|NCT04902131|Menotropins|menotropins|mesh-list
154677051|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154677052|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
154677053|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154677054|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677055|NCT01815424|Tofacitinib|tofacitinib|mesh-list
154677056|NCT01815424|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154677057|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154677058|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677059|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677060|NCT02431247|Tenofovir|tenofovir|mesh-list
154677061|NCT02431247|Emtricitabine|emtricitabine|mesh-list
154677062|NCT02431247|Darunavir|darunavir|mesh-list
154677063|NCT02431247|Cobicistat|cobicistat|mesh-list
154677064|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154677065|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154677066|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
154677067|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677068|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154677069|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154677070|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677071|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677072|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154677073|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154677074|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154429100|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677075|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154677076|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
154677077|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154677078|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154677079|NCT01814878|Acetaminophen|acetaminophen|mesh-list
154677080|NCT01814878|Tramadol|tramadol|mesh-list
154677081|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154677082|NCT01814878|Analgesics|analgesics|mesh-ancestor
154677083|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
154677084|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677085|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677086|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
154677087|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154677088|NCT01814878|Narcotics|narcotics|mesh-ancestor
154677089|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677090|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
154677091|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
154677092|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677093|NCT02407223|Ustekinumab|ustekinumab|mesh-list
154677094|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
154677095|NCT01813474|Olaparib|olaparib|mesh-list
154677096|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154677097|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677098|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677099|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677100|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
154677101|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154677102|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677103|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
154677104|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154677105|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154677106|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154677107|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154677108|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677109|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
154677110|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677111|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677112|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154677113|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677114|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
154677115|NCT02383589|Rituximab|rituximab|mesh-list
154677116|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677117|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677118|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
154677119|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677120|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677121|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154677122|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154677123|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
154677124|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677125|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677126|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677127|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677128|NCT01810432|Evacetrapib|evacetrapib|mesh-list
154677129|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154677130|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154677131|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
154677132|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677133|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154677134|NCT02404805|Dolutegravir|dolutegravir|mesh-list
154677135|NCT02404805|Simeprevir|simeprevir|mesh-list
154677136|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154677137|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154677138|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677139|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677140|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154677141|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154677142|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
154677143|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677144|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
154677145|NCT02430311|Paclitaxel|paclitaxel|mesh-list
154677146|NCT02430311|Olaparib|olaparib|mesh-list
154677147|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154677148|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677149|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
154677150|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
154677151|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
154677152|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677153|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154677154|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677155|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
154677156|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154677157|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154677158|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
154677159|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677160|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153931843|NCT02880462|Sulforaphane|sulforaphane|mesh-list
154677161|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154677162|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677163|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677165|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
154677166|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677167|NCT02379221|Lidocaine|lidocaine|mesh-list
154677168|NCT02379221|Epinephrine|epinephrine|mesh-list
154677169|NCT02379221|Benzocaine|benzocaine|mesh-list
154677170|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
154677171|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
154677172|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677173|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677174|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
154677175|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677176|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154677177|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154677178|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154677179|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154677180|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677181|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154677182|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154677183|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
154677184|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677185|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154677186|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154677187|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
154677188|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154677189|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
154677190|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
154677191|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
154677192|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154677193|NCT02404103|Flunisolide|flunisolide|mesh-list
154677194|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677195|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154677196|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
154677197|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
154677198|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
154677199|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677200|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154677201|NCT02403635|Midazolam|midazolam|mesh-list
154677202|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154677203|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154677204|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677205|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677206|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154677207|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154677208|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154677209|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154677210|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
154677211|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
154677212|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
154677213|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
154677214|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677215|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677216|NCT02402933|Glucagon|glucagon|mesh-list
154677217|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154677218|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677219|NCT02402933|Hormones|hormones|mesh-ancestor
154677220|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677221|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677222|NCT02402933|Incretins|incretins|mesh-ancestor
154677223|NCT01796470|Idelalisib|idelalisib|mesh-list
154677224|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429244|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
154677225|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677226|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677228|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677229|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154677230|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677231|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677232|NCT01810042|Ranibizumab|ranibizumab|mesh-list
154677233|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154677234|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154677235|NCT01810042|Growth Substances|growth substances|mesh-ancestor
154677236|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677237|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
154677238|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677239|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
154677240|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
154677241|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677242|NCT01867294|Doxycycline|doxycycline|mesh-list
154677243|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
154677244|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154677245|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154677246|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154677247|NCT01867294|Spironolactone|spironolactone|mesh-list
154677248|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
154677249|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677250|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677251|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677252|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
154677253|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154677254|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154677255|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154677256|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
154677257|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677258|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677259|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154677260|NCT01867294|Diuretics|diuretics|mesh-ancestor
154677261|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
154677262|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154677263|NCT01867294|Protective Agents|protective agents|mesh-ancestor
154677264|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
154677265|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154677266|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677267|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677268|NCT02423291|Immunotoxins|immunotoxins|mesh-ancestor
154677269|NCT02423291|Immunoconjugates|immunoconjugates|mesh-ancestor
154677270|NCT02423291|Immunologic Factors|immunologic factors|mesh-ancestor
154677271|NCT02423291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677272|NCT02401529|Acetaminophen|acetaminophen|mesh-list
154677273|NCT02401529|Dexamethasone|dexamethasone|mesh-list
154677274|NCT02401529|Prednisolone|prednisolone|mesh-list
154677275|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677276|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
154677277|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
154677278|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677279|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677280|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677281|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
154677282|NCT02401529|Hormones|hormones|mesh-ancestor
154677283|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677284|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154677285|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677286|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154677287|NCT02401529|Analgesics|analgesics|mesh-ancestor
154677288|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
154677289|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
154677290|NCT01866826|Rifaximin|rifaximin|mesh-list
154677291|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677292|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677293|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677294|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154677295|NCT01865812|Cathartics|cathartics|mesh-ancestor
154677296|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677297|NCT01808092|Meropenem|meropenem|mesh-list
154677298|NCT01808092|Ceftazidime|ceftazidime|mesh-list
154677299|NCT01808092|Avibactam|avibactam|mesh-list
154677300|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154677301|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677302|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677303|NCT01808092|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154677304|NCT01808092|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154677305|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154677306|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677307|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677308|NCT01807234|Ketorolac|ketorolac|mesh-list
154677309|NCT01807234|Sumatriptan|sumatriptan|mesh-list
154677310|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154677311|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154677312|NCT01807234|Analgesics|analgesics|mesh-ancestor
154677313|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
154677314|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677315|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677316|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677317|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677318|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154677319|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677320|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677321|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154677322|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154677323|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154677324|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
154677325|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677326|NCT02421887|Antioxidants|antioxidants|mesh-list
154677327|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677328|NCT02421887|Protective Agents|protective agents|mesh-ancestor
154677329|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677330|NCT01789606|Ibuprofen|ibuprofen|mesh-list
154677331|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154677332|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154677333|NCT01789606|Analgesics|analgesics|mesh-ancestor
154677334|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
154677335|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677336|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677337|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677338|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677339|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154677340|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677341|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677342|NCT01788358|Candesartan|candesartan|mesh-list
154677343|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
154677344|NCT01788358|Nifedipine|nifedipine|mesh-list
154677345|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154677346|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154677347|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154677348|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677349|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154677350|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154677351|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154677352|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677353|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
154677354|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
154677355|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154677356|NCT01773070|Ritonavir|ritonavir|mesh-list
154677357|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154677358|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154677359|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
154677360|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677361|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677362|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154677363|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154677364|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
154677365|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677366|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154677367|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154677368|NCT01772368|Fluticasone|fluticasone|mesh-list
154677369|NCT01772368|Xhance|xhance|mesh-list
154677370|NCT01772368|Albuterol|albuterol|mesh-list
154677371|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154677372|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154677373|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
154677374|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429393|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154677375|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154677377|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677378|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677379|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154677380|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
154677381|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
154677382|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154677383|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154677384|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154677385|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
154677386|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677387|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677388|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
154677389|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154677390|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
154677391|NCT01772368|Hormones|hormones|mesh-ancestor
154677392|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677393|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
154677394|NCT01806298|Hormones|hormones|mesh-list
154677395|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677396|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677397|NCT01772134|Fluticasone|fluticasone|mesh-list
154677398|NCT01772134|Xhance|xhance|mesh-list
154677399|NCT01772134|Bromides|bromides|mesh-list
154677400|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154677401|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677402|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154677403|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
154677404|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677405|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677406|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154677407|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
154677408|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
154677409|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154677410|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154677411|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154677412|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154677413|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154677414|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677415|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677416|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
154677417|NCT02017899|Vaccines|vaccines|mesh-list
154677418|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
154677419|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677420|NCT01993329|Mitomycin|mitomycin|mesh-list
154677421|NCT01993329|Cisplatin|cisplatin|mesh-list
154677422|NCT01993329|Ifosfamide|ifosfamide|mesh-list
154677423|NCT01993329|Mesna|mesna|mesh-list
154677424|NCT01993329|Protective Agents|protective agents|mesh-ancestor
154677425|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677426|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
154677427|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677428|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154677429|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677430|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154677431|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677432|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154677433|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154677434|NCT02016183|Candesartan|candesartan|mesh-list
154677435|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
154677436|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154677437|NCT02016183|Diuretics|diuretics|mesh-ancestor
154677438|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
154677439|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677440|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154677441|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154677442|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677443|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154677444|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154677445|NCT02421419|Dexamethasone|dexamethasone|mesh-list
154677446|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
154677447|NCT02421419|Lidocaine|lidocaine|mesh-list
154677448|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154677449|NCT02421419|BB 1101|bb 1101|mesh-list
154677450|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677451|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
154677452|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
154677453|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677454|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677455|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677456|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
154677458|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677459|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154677460|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677461|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
154677462|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
154677463|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677464|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
154677465|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154677466|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154677467|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154677468|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154677469|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677470|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
154677471|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677472|NCT02016105|Adalimumab|adalimumab|mesh-list
154677473|NCT02016105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154677474|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677475|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677476|NCT02400749|Apremilast|apremilast|mesh-list
154677477|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154677478|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154677479|NCT02400749|Analgesics|analgesics|mesh-ancestor
154677480|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
154677481|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677482|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677483|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677484|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677485|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154677486|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154677487|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677488|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677489|NCT02420327|Galantamine|galantamine|mesh-list
154677490|NCT02420327|Nicotine|nicotine|mesh-list
154677491|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154677492|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
154677493|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677494|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677495|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154677496|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154677497|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
154677498|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677499|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677500|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154677501|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677502|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154677503|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
154677504|NCT02374853|Vancomycin|vancomycin|mesh-list
154677505|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677506|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677507|NCT02015793|Adalimumab|adalimumab|mesh-list
154677508|NCT02015793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154677509|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677510|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677511|NCT02347631|Dipivefrin|dipivefrin|mesh-list
154677512|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154677513|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
154677514|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677515|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677516|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677517|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
154677518|NCT02015637|Delafloxacin|delafloxacin|mesh-list
154677519|NCT02015637|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154677520|NCT02015637|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154677521|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677522|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677523|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
154677524|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
154677525|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154677527|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677528|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677529|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154677530|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
154677531|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153932216|NCT00694291|Sorafenib|sorafenib|mesh-list
154677532|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154677533|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154677534|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
154677535|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677536|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677537|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154677538|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154677539|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154677540|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
154677541|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154677542|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154677543|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154677544|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154677545|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677546|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677547|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677548|NCT01621191|Analgesics|analgesics|mesh-ancestor
154677549|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
154677550|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677551|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
154677552|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154677553|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
154677554|NCT02343263|Bupivacaine|bupivacaine|mesh-list
154677555|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154677556|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
154677557|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
154677558|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677559|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677560|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
154677561|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677562|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
154677563|NCT02343263|Coagulants|coagulants|mesh-ancestor
154677564|NCT02342639|Rifaximin|rifaximin|mesh-list
154677565|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677566|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677567|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677568|NCT01625091|Naltrexone|naltrexone|mesh-list
154677569|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154677570|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154677571|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677572|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
154677573|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677574|NCT02396537|Lidocaine|lidocaine|mesh-list
154677575|NCT02396537|Midazolam|midazolam|mesh-list
154677576|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
154677577|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
154677578|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677579|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677580|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
154677581|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677582|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154677583|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154677584|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154677585|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154677586|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677587|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154677588|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154677589|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154677590|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154677591|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154677592|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154677593|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
154677594|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
154677595|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
154677596|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677597|NCT01624467|Necitumumab|necitumumab|mesh-list
154677598|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677599|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677601|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
154677602|NCT01993017|Bupropion|bupropion|mesh-list
154677603|NCT01993017|Sertraline|sertraline|mesh-list
154677604|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
154677605|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154677606|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154677607|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154677608|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154677609|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154677610|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677611|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
154677612|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677613|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677614|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154677615|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154677616|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677617|NCT01993017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154677618|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
154677619|NCT01988493|Sorafenib|sorafenib|mesh-list
154677620|NCT01988493|Tepotinib|tepotinib|mesh-list
154677621|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677622|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154677623|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677624|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677625|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
154677626|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154677627|NCT02081079|Ledipasvir|ledipasvir|mesh-list
154677628|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
154677629|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677630|NCT02081001|Glucagon|glucagon|mesh-list
154677631|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677632|NCT02081001|Hormones|hormones|mesh-ancestor
154677633|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677634|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677635|NCT02080221|Leucovorin|leucovorin|mesh-list
154677636|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
154677637|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677638|NCT02080221|Antidotes|antidotes|mesh-ancestor
154677639|NCT02080221|Protective Agents|protective agents|mesh-ancestor
154677640|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677641|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
154677642|NCT02080221|Vitamins|vitamins|mesh-ancestor
154677643|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
154677644|NCT02014467|Vitamin D|vitamin d|mesh-list
154677645|NCT02014467|Denosumab|denosumab|mesh-list
154677646|NCT02014467|Calcium|calcium|mesh-list
154677647|NCT02014467|Vitamins|vitamins|mesh-ancestor
154677648|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
154677649|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677650|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154677651|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154677652|NCT02013765|Trastuzumab|trastuzumab|mesh-list
154677653|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677654|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677655|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
154677656|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
154677657|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677658|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677659|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677660|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
154677661|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
154677662|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
154677663|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
154677664|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677665|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677666|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677667|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
154677668|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
154677669|NCT01988103|Thalidomide|thalidomide|mesh-list
154677670|NCT01988103|Apremilast|apremilast|mesh-list
154677671|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154677672|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154677673|NCT01988103|Analgesics|analgesics|mesh-ancestor
154677674|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
154677675|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677676|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677677|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677678|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677679|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154677680|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154677681|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677682|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677683|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154677684|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
154677685|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
154677686|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677687|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677688|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154677689|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154677690|NCT01988103|Growth Substances|growth substances|mesh-ancestor
154677691|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
154677692|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677693|NCT02013375|Sirolimus|sirolimus|mesh-list
154677694|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
154677695|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
154677696|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154677697|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
154677698|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677699|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677700|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154677701|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
154677702|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677703|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677704|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154677705|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154677706|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677707|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154677708|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
154677709|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677710|NCT02079519|Bevacizumab|bevacizumab|mesh-list
154677711|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677712|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677713|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154677714|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154677715|NCT02079519|Growth Substances|growth substances|mesh-ancestor
154677716|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677717|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
154677718|NCT02078817|Ketamine|ketamine|mesh-list
154677719|NCT02078817|Analgesics|analgesics|mesh-ancestor
154677720|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
154677721|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677722|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677723|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154677724|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154677725|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
154677726|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
154677727|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677728|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154677729|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154677730|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677731|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677732|NCT02011113|Dexamethasone|dexamethasone|mesh-list
154677733|NCT02011113|Pomalidomide|pomalidomide|mesh-list
154677734|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677735|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
154677736|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
154677737|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677738|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677739|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677740|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
154677741|NCT02011113|Hormones|hormones|mesh-ancestor
154677742|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677743|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154677744|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677745|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
154677746|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154677747|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154677748|NCT02011113|Growth Substances|growth substances|mesh-ancestor
154677749|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
154677751|NCT01807156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154677752|NCT01807156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677753|NCT01807156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677754|NCT01987479|Methotrexate|methotrexate|mesh-list
154677755|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154677756|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
154677757|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154677758|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677759|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154677760|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
154677761|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677762|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677763|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
154677764|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677765|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154677766|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154677767|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
154677768|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677769|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154677770|NCT01620489|Liraglutide|liraglutide|mesh-list
154677771|NCT01620489|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154677772|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154677773|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677774|NCT01620489|Incretins|incretins|mesh-ancestor
154677775|NCT01620489|Hormones|hormones|mesh-ancestor
154677776|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677777|NCT02010567|Capecitabine|capecitabine|mesh-list
154677778|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154677779|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
154677780|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677781|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677782|NCT01806064|Axitinib|axitinib|mesh-list
154677783|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677784|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154677785|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677786|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677787|NCT01787188|Meloxicam|meloxicam|mesh-list
154677788|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154677789|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154677790|NCT01787188|Analgesics|analgesics|mesh-ancestor
154677791|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
154677792|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677793|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677794|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677795|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677796|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154677797|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154677798|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677799|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677800|NCT01787032|Ketoconazole|ketoconazole|mesh-list
154677801|NCT01787032|Voriconazole|voriconazole|mesh-list
154677802|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
154677803|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677804|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154677805|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154677806|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677807|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677808|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154677809|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
154677810|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677811|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677812|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154677813|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154677814|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
154677815|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154677816|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154677817|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154677818|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677819|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677820|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
154677821|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154677822|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677823|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154677824|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154677825|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677826|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154677827|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
154677828|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677829|NCT01768858|Adalimumab|adalimumab|mesh-list
154677830|NCT01768858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154677831|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677832|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677833|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
154677834|NCT01736254|Evacetrapib|evacetrapib|mesh-list
154677835|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154677836|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
154677837|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677838|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154677839|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154677840|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154677841|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677842|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154677843|NCT01785472|Olmesartan|olmesartan|mesh-list
154677844|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154677845|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154677846|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154677847|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153932529|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677848|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154677849|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677850|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
154677851|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154677852|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154677853|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
154677854|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677855|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154677856|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154677857|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677858|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677859|NCT01736176|Levodopa|levodopa|mesh-list
154677860|NCT01736176|Carbidopa|carbidopa|mesh-list
154677861|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154677862|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154677863|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154677864|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
154677865|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677866|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677867|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677868|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154677869|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677870|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154677871|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
154677872|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
154677873|NCT01735630|Inositol|inositol|mesh-list
154677874|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
154677875|NCT01735630|Vitamins|vitamins|mesh-ancestor
154677876|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
154677877|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677878|NCT04575922|Nivolumab|nivolumab|mesh-list
154677879|NCT04575922|Ipilimumab|ipilimumab|mesh-list
154677880|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677881|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677882|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154677883|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677884|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
154677885|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677886|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154677887|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677888|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677889|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
154677890|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677891|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677892|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154677893|NCT01734850|Busulfan|busulfan|mesh-list
154429918|NCT02187536|Telmisartan|telmisartan|mesh-list
154677894|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
154677895|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677896|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154677897|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
154677898|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677899|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154677900|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677901|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154677902|NCT01766050|Abatacept|abatacept|mesh-list
154677903|NCT01766050|Losartan|losartan|mesh-list
154677904|NCT01766050|Midazolam|midazolam|mesh-list
154677905|NCT01766050|Levomethorphan|levomethorphan|mesh-list
154677906|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
154677907|NCT01766050|Caffeine|caffeine|mesh-list
154677908|NCT01766050|Omeprazole|omeprazole|mesh-list
154677909|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154677910|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154677911|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154677912|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677913|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154677914|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154677915|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154677916|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154677917|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
154677918|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
154677919|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
154677920|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
154677921|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677922|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677923|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154677924|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154677925|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154677926|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154677927|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154677928|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154677929|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677930|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154677931|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154677932|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
154677933|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154677934|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154677935|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154677936|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
154677937|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
154677938|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154677939|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154677940|NCT01766050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154677941|NCT01766050|Narcotics|narcotics|mesh-ancestor
154677942|NCT01766050|Analgesics|analgesics|mesh-ancestor
154677943|NCT01766050|Sensory System Agents|sensory system agents|mesh-ancestor
154677944|NCT01766050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154677945|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154677946|NCT01766050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677947|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677948|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154677949|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
154677950|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677951|NCT02341625|Nivolumab|nivolumab|mesh-list
154677952|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154677953|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677954|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154677955|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677956|NCT02370095|Treprostinil|treprostinil|mesh-list
154677957|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154677958|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154677959|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
154677960|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
154677961|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677962|NCT01734772|Dabigatran|dabigatran|mesh-list
154677963|NCT01734772|Ticagrelor|ticagrelor|mesh-list
154677964|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154677965|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154677966|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154677967|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154677968|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
154677969|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154677970|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677971|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677973|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154677974|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
154677975|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677976|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
154677977|NCT02340221|Fulvestrant|fulvestrant|mesh-list
154677978|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154677979|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154677980|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154677981|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154677982|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
154677983|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154677984|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154677985|NCT02395055|Adalimumab|adalimumab|mesh-list
154677986|NCT02395055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154677987|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154677988|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154677989|NCT02369159|Oseltamivir|oseltamivir|mesh-list
154677990|NCT02369159|Peramivir|peramivir|mesh-list
154677991|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
154677992|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154677993|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154677994|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677995|NCT02394665|Temozolomide|temozolomide|mesh-list
154677996|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154677997|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
154677998|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154677999|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678000|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
154678001|NCT02367833|NuvaRing|nuvaring|mesh-list
154678002|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
154678003|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154678004|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154678005|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678006|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154678007|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154678008|NCT02338193|Metformin|metformin|mesh-list
154678009|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
154678010|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678011|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678012|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154678013|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678014|NCT01783444|Capecitabine|capecitabine|mesh-list
154678015|NCT01783444|Everolimus|everolimus|mesh-list
154678016|NCT01783444|Exemestane|exemestane|mesh-list
154678017|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678018|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
153932718|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678019|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678020|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678021|NCT01783444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154678022|NCT01783444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154678023|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678024|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678025|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
154678026|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678027|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154678028|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154678029|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154678030|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
154678031|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678032|NCT01608724|Saxagliptin|saxagliptin|mesh-list
154678033|NCT01608724|Incretins|incretins|mesh-ancestor
154678034|NCT01608724|Hormones|hormones|mesh-ancestor
154678035|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678036|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678037|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154678038|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
154678039|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678040|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678041|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678042|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154678043|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678044|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678045|NCT04905251|Misoprostol|misoprostol|mesh-list
154678046|NCT04905251|Mifepristone|mifepristone|mesh-list
154678047|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154678048|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
154678049|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154678050|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678051|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154678052|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678053|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
154678054|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154678055|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154678056|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154678057|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154678058|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
154678059|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154678060|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154678061|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
154678062|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678063|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
154678064|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154678065|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154678066|NCT02364947|Nalmefene|nalmefene|mesh-list
154678067|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154678068|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678069|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
154678070|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678071|NCT02337491|Bevacizumab|bevacizumab|mesh-list
154678072|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
154678073|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678074|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678075|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154678076|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154678077|NCT02337491|Growth Substances|growth substances|mesh-ancestor
154678078|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678079|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
154678080|NCT02337491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154678081|NCT02337491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678082|NCT01765582|Leucovorin|leucovorin|mesh-list
154678083|NCT01765582|Folic Acid|folic acid|mesh-list
154678084|NCT01765582|Bevacizumab|bevacizumab|mesh-list
154678085|NCT01765582|Capecitabine|capecitabine|mesh-list
154678086|NCT01765582|Fluorouracil|fluorouracil|mesh-list
154678087|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
154678088|NCT01765582|Irinotecan|irinotecan|mesh-list
154678089|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
154678090|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678091|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678092|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154678093|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154678094|NCT01765582|Growth Substances|growth substances|mesh-ancestor
154678095|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678096|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
154678097|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678098|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
154678099|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678100|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678101|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
154678102|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154678103|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154678104|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678105|NCT01765582|Antidotes|antidotes|mesh-ancestor
154678106|NCT01765582|Protective Agents|protective agents|mesh-ancestor
154678107|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
154678108|NCT01765582|Vitamins|vitamins|mesh-ancestor
154678109|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
154678110|NCT01765582|Hematinics|hematinics|mesh-ancestor
154678111|NCT04413838|Nivolumab|nivolumab|mesh-list
154678112|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678113|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678114|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154678115|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678116|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154678117|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
154678118|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678120|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154678121|NCT01648283|Narcotics|narcotics|mesh-ancestor
154678122|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678123|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678124|NCT01648283|Analgesics|analgesics|mesh-ancestor
154678125|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
154678126|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678127|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
154678128|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
154678129|NCT01649297|Empagliflozin|empagliflozin|mesh-list
154678130|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154678131|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678132|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678133|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678134|NCT01648205|Ranolazine|ranolazine|mesh-list
154678135|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154678136|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154678137|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678138|NCT02362451|Vaccines|vaccines|mesh-list
154678139|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
154678140|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678141|NCT01765270|Saxagliptin|saxagliptin|mesh-list
154678142|NCT01765270|Incretins|incretins|mesh-ancestor
154678143|NCT01765270|Hormones|hormones|mesh-ancestor
154678144|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678145|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678146|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154678147|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
154678148|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678149|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678150|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678151|NCT01733758|Liraglutide|liraglutide|mesh-list
154678152|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
154678153|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154678154|NCT01733758|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154678155|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678156|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678157|NCT01733758|Incretins|incretins|mesh-ancestor
154678158|NCT01733758|Hormones|hormones|mesh-ancestor
154678159|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678160|NCT01607554|Irinotecan|irinotecan|mesh-list
154678161|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154678162|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154678163|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678164|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678165|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678166|NCT01607476|Corticosterone|corticosterone|mesh-list
154678167|NCT01607476|Flutemetamol|flutemetamol|mesh-list
154678168|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154678169|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154678170|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678171|NCT01765192|Montelukast|montelukast|mesh-list
154678172|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154678173|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
154678174|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154678175|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
154678176|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678177|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678178|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154678179|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154678180|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678181|NCT01733680|Amiloride|amiloride|mesh-list
154678182|NCT01733680|Diuretics|diuretics|mesh-ancestor
154678183|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
154678184|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678185|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154678186|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154678187|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154678188|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678189|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154430206|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
154678190|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154678191|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154678192|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678193|NCT04892498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678195|NCT02336165|Bevacizumab|bevacizumab|mesh-list
154678196|NCT02336165|Durvalumab|durvalumab|mesh-list
154678197|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678198|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678199|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154678200|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154678201|NCT02336165|Growth Substances|growth substances|mesh-ancestor
154678202|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678203|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
154678204|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
154678205|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678206|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
154678207|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678208|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154678209|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154678210|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
154678211|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678212|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678213|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154678214|NCT02319044|Durvalumab|durvalumab|mesh-list
154678215|NCT02319044|Tremelimumab|tremelimumab|mesh-list
154678216|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154678217|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678218|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678219|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
154678220|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678221|NCT01649765|Belimumab|belimumab|mesh-list
154678222|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678223|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
154678224|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678225|NCT02317016|Osimertinib|osimertinib|mesh-list
154678226|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154678227|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154678228|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154678229|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
154678230|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678231|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154678232|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154678233|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678234|NCT02317016|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154678235|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154678236|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678237|NCT02311478|Copper|copper|mesh-list
154678238|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
154678239|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154678240|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678241|NCT02311478|Trace Elements|trace elements|mesh-ancestor
154678242|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
154678243|NCT02281760|Trametinib|trametinib|mesh-list
154678244|NCT02281760|Dabrafenib|dabrafenib|mesh-list
154678245|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154678246|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678247|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154678248|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678249|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678250|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154678251|NCT02281760|Protective Agents|protective agents|mesh-ancestor
154678252|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678253|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154678254|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
154678255|NCT02390531|Bevacizumab|bevacizumab|mesh-list
154678256|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678257|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678258|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154678259|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154678260|NCT02390531|Growth Substances|growth substances|mesh-ancestor
154678261|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430296|NCT02192450|Insulin|insulin|mesh-list
154678262|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
154678263|NCT02390219|Ivacaftor|ivacaftor|mesh-list
154678264|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154678265|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154678266|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678267|NCT02334215|Methadone|methadone|mesh-list
154678268|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154678269|NCT02334215|Narcotics|narcotics|mesh-ancestor
154678270|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678271|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678272|NCT02334215|Analgesics|analgesics|mesh-ancestor
154678273|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
154678274|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678275|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
154678276|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
154678277|NCT02359877|Interferons|interferons|mesh-list
154678278|NCT02359877|Interferon-beta|interferon-beta|mesh-list
154678279|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
154678280|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678281|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
154678282|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678283|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
154678284|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678285|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154678286|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
154678287|NCT02389829|Promethazine|promethazine|mesh-list
154678288|NCT02389829|Hydromorphone|hydromorphone|mesh-list
154678289|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
154678290|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154678291|NCT02389829|Narcotics|narcotics|mesh-ancestor
154678292|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678293|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678294|NCT02389829|Analgesics|analgesics|mesh-ancestor
154678295|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
154678296|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678297|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154678298|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154678299|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
154678300|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
154678301|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
154678302|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
154678303|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678304|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154678305|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
154678306|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
154678307|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678308|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678309|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154678310|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
154678311|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
154678312|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154678313|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154678314|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154678315|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154678316|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
154678317|NCT02358863|Leucovorin|leucovorin|mesh-list
154678318|NCT02358863|Cisplatin|cisplatin|mesh-list
154678319|NCT02358863|Docetaxel|docetaxel|mesh-list
154678320|NCT02358863|Capecitabine|capecitabine|mesh-list
154678321|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
154678322|NCT02358863|Irinotecan|irinotecan|mesh-list
154678323|NCT02358863|Epirubicin|epirubicin|mesh-list
154678324|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678325|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
154678326|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
154678327|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
154678328|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678329|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678330|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
154678331|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154678332|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154678333|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678334|NCT02358863|Antidotes|antidotes|mesh-ancestor
154678335|NCT02358863|Protective Agents|protective agents|mesh-ancestor
154678336|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678337|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
154678338|NCT02358863|Vitamins|vitamins|mesh-ancestor
154678339|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
154678340|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154678341|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154678342|NCT02358473|Docetaxel|docetaxel|mesh-list
154678343|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
154678344|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678345|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
154678346|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
154678347|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
154678348|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678349|NCT02357459|Triamcinolone|triamcinolone|mesh-list
154678350|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154678351|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154678352|NCT02357459|FX006|fx006|mesh-list
154678353|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154678354|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154678355|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
154678356|NCT02357459|Hormones|hormones|mesh-ancestor
154678357|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678358|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678359|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678360|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
154678361|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678362|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678363|NCT02332889|Decitabine|decitabine|mesh-list
154678364|NCT02332889|Poly ICLC|poly iclc|mesh-list
154678365|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678366|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
153933053|NCT02790580|Sunitinib|sunitinib|mesh-list
154678367|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678368|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678369|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678370|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
154678371|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
154678372|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678373|NCT02357147|Pemetrexed|pemetrexed|mesh-list
154678374|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678375|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678376|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678377|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154678378|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154678379|NCT02332655|Cannabidiol|cannabidiol|mesh-list
154678380|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
154678381|NCT02388737|Lansoprazole|lansoprazole|mesh-list
154678382|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
154678383|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154678384|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678385|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154678386|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678387|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678388|NCT02355665|Nicotine|nicotine|mesh-list
154678389|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154678390|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
154678391|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678392|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678393|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154678394|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154678395|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
154678396|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678397|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678398|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
154678399|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154678400|NCT02010255|Ledipasvir|ledipasvir|mesh-list
154678401|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
154678402|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678403|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
154678404|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154678405|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678406|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154678407|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154678408|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
154678409|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678410|NCT01620177|Ethanol|ethanol|mesh-list
154678411|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154678412|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678413|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678414|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678415|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
154678416|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154678417|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678418|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678419|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678421|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154678422|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154678423|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154678424|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154678425|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678426|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
154678427|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933116|NCT02884115|Penicillins|penicillins|mesh-list
154678428|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678429|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154678430|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678431|NCT02009397|Ipilimumab|ipilimumab|mesh-list
154678432|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678433|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678434|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154678435|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678436|NCT02312219|Folic Acid|folic acid|mesh-list
154678437|NCT02312219|Methotrexate|methotrexate|mesh-list
154678438|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154678439|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
154678440|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154678441|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678442|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678443|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
154678444|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678445|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678446|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
154678447|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678448|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154678449|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678450|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
154678451|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154678452|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154678453|NCT02312219|Hematinics|hematinics|mesh-ancestor
154678454|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
154678455|NCT02312219|Vitamins|vitamins|mesh-ancestor
154678456|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
154678457|NCT01986231|Glucagon|glucagon|mesh-list
154678458|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678459|NCT01986231|Hormones|hormones|mesh-ancestor
154678460|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678461|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678462|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154678463|NCT02312063|Glimepiride|glimepiride|mesh-list
154678464|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678465|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678466|NCT02312063|Incretins|incretins|mesh-ancestor
154678467|NCT02312063|Hormones|hormones|mesh-ancestor
154678468|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678469|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154678470|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
154678471|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678472|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678473|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154678474|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678475|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
154678476|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
154678477|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154678478|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678479|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678480|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154678481|NCT02353169|Analgesics|analgesics|mesh-ancestor
154678482|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
154678483|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678484|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154678485|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154678486|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154678487|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
154678488|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933174|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678489|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678490|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154430516|NCT02060916|PAZ320|paz320|mesh-list
154678491|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154678492|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678493|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154678494|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154678495|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154678496|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678497|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
154678498|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678499|NCT01983969|Pyridoxine|pyridoxine|mesh-list
154678500|NCT01983969|Dexamethasone|dexamethasone|mesh-list
154678501|NCT01983969|Rituximab|rituximab|mesh-list
154678502|NCT01983969|Gemcitabine|gemcitabine|mesh-list
154678503|NCT01983969|Azacitidine|azacitidine|mesh-list
154678504|NCT01983969|Melphalan|melphalan|mesh-list
154678505|NCT01983969|Busulfan|busulfan|mesh-list
154678506|NCT01983969|Vorinostat|vorinostat|mesh-list
154678507|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678508|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678509|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
154678510|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678511|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154678512|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154678513|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
154678514|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
154678515|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678516|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678517|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
154678518|NCT01983969|Hormones|hormones|mesh-ancestor
154678519|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678520|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154678521|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678522|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
154678523|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678524|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678525|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154678526|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
154678527|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154678528|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678529|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154678530|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
154678531|NCT01983969|Vitamins|vitamins|mesh-ancestor
154678532|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
154678533|NCT02008773|Valacyclovir|valacyclovir|mesh-list
154678534|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
154678535|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678536|NCT02257567|Rituximab|rituximab|mesh-list
154678537|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
154678538|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154678539|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154678540|NCT02257567|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154678541|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
154678542|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678543|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678544|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
154678545|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678546|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154678547|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154678548|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
154678549|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678550|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
154678551|NCT01642615|Lansoprazole|lansoprazole|mesh-list
154678552|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154678553|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678554|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154678555|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678556|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678557|NCT02311361|Durvalumab|durvalumab|mesh-list
154678558|NCT02311361|Tremelimumab|tremelimumab|mesh-list
154678559|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678560|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678561|NCT02329223|Omalizumab|omalizumab|mesh-list
154678562|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154678563|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154678564|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
154678565|NCT05302297|Cemiplimab|cemiplimab|mesh-list
154678566|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678567|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678568|NCT02310581|Buprenorphine|buprenorphine|mesh-list
154678569|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154678570|NCT02310581|Narcotics|narcotics|mesh-ancestor
154678571|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678572|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678573|NCT02310581|Analgesics|analgesics|mesh-ancestor
154678574|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
154678575|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678576|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154678577|NCT04892693|Talazoparib|talazoparib|mesh-list
154678578|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154678579|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678580|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678581|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678582|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
154678583|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154678584|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
154678585|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154678586|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
154678587|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678588|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678589|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
154678590|NCT02008227|Docetaxel|docetaxel|mesh-list
154678591|NCT02008227|Atezolizumab|atezolizumab|mesh-list
154678592|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678593|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
154678594|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154678595|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154678596|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678597|NCT02008227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154678598|NCT02008227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678599|NCT02348723|Warfarin|warfarin|mesh-list
154678600|NCT02348723|Dabigatran|dabigatran|mesh-list
154678601|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
154678602|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
154678603|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154678604|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
154678605|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678606|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678607|NCT02006667|Gemcitabine|gemcitabine|mesh-list
154678608|NCT02006667|Trastuzumab|trastuzumab|mesh-list
154678609|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678610|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678611|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
154678612|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678613|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678614|NCT01983111|Acetaminophen|acetaminophen|mesh-list
154678615|NCT01983111|Buprenorphine|buprenorphine|mesh-list
154678616|NCT01983111|Tramadol|tramadol|mesh-list
154678617|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154678618|NCT01983111|Analgesics|analgesics|mesh-ancestor
154678619|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
154678620|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678621|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678622|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
154678623|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154678624|NCT01983111|Narcotics|narcotics|mesh-ancestor
154678625|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678626|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154678627|NCT02348489|Guadecitabine|guadecitabine|mesh-list
154678628|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678629|NCT01966107|Bromides|bromides|mesh-list
154678630|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
154678631|NCT01982331|Vaccines|vaccines|mesh-list
154678632|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
154678633|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678634|NCT02326025|Doxorubicin|doxorubicin|mesh-list
154678635|NCT02326025|Olaratumab|olaratumab|mesh-list
154678636|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154678637|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678638|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154678639|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154678640|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678641|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678642|NCT01619865|Edotreotide|edotreotide|mesh-list
154678643|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154430707|NCT02195492|Hylan|hylan|mesh-list
154678644|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678646|NCT02006121|Emetics|emetics|mesh-ancestor
154678647|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678648|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
154678649|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678650|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678651|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
154678652|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
154678653|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678654|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678655|NCT02005887|Letrozole|letrozole|mesh-list
154678656|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154678657|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678658|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154678659|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154678660|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678661|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678662|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154678663|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
154678664|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678665|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678666|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
154678667|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154678668|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
154678669|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154678670|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154678671|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154678672|NCT01981473|Infliximab|infliximab|mesh-list
154678673|NCT01981473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154678674|NCT01981473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154678675|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
154678676|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678677|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154678678|NCT02005029|Erythromycin|erythromycin|mesh-list
154678679|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
154678680|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154678681|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
154678682|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154678683|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678684|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678685|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154678686|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678687|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678688|NCT04416399|Budesonide|budesonide|mesh-list
154678689|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154678690|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154678691|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
154678692|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678693|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678694|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154678695|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
154678696|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
154678697|NCT04416399|Hormones|hormones|mesh-ancestor
154678698|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678699|NCT02282345|Talazoparib|talazoparib|mesh-list
154678700|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154678701|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678702|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678703|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678704|NCT01732822|Clopidogrel|clopidogrel|mesh-list
154678705|NCT01732822|Ticagrelor|ticagrelor|mesh-list
154678706|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154678707|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154678708|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154678709|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154678710|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
154678711|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678712|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678713|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678714|NCT02004093|Paclitaxel|paclitaxel|mesh-list
154678715|NCT02004093|Carboplatin|carboplatin|mesh-list
154678716|NCT02004093|Gemcitabine|gemcitabine|mesh-list
154678717|NCT02004093|Pertuzumab|pertuzumab|mesh-list
154430726|NCT02195804|Ranitidine|ranitidine|mesh-list
154678718|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154678719|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678720|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
154678721|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
154678722|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
154678723|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678724|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678725|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
154678726|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678727|NCT01641367|Tenofovir|tenofovir|mesh-list
154678728|NCT01641367|Emtricitabine|emtricitabine|mesh-list
154678729|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154678730|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
154678731|NCT01641367|Darunavir|darunavir|mesh-list
154678732|NCT01641367|Etravirine|etravirine|mesh-list
154678733|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154678734|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
154678735|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
154678736|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678737|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154678738|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154678739|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678740|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678741|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154678742|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154678743|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154678744|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154678745|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154678746|NCT02325713|Praziquantel|praziquantel|mesh-list
154678747|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
154678748|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154678749|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678750|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
154678751|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154678752|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678753|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678754|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154678755|NCT04877639|Analgesics|analgesics|mesh-ancestor
154678756|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
154678757|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678758|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154678759|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154678760|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154678761|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
154678762|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678763|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678764|NCT02325401|Metformin|metformin|mesh-list
154678765|NCT02325401|Cisplatin|cisplatin|mesh-list
154678766|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678767|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678768|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678769|NCT02324699|Prednisone|prednisone|mesh-list
154678770|NCT02324699|Vedolizumab|vedolizumab|mesh-list
154678771|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154678772|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
154678773|NCT02324699|Hormones|hormones|mesh-ancestor
154678774|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678775|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678776|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154678777|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678778|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678779|NCT01979523|Trametinib|trametinib|mesh-list
154678780|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678781|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154678782|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678783|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678784|NCT02255461|Palbociclib|palbociclib|mesh-list
154678785|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678786|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154678787|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678788|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678789|NCT01764022|Paclitaxel|paclitaxel|mesh-list
154678790|NCT01764022|Trastuzumab|trastuzumab|mesh-list
154678791|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154678792|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678793|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
154678794|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
154678795|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
154678796|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678797|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678799|NCT02003391|Travoprost|travoprost|mesh-list
154678800|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154678801|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154678802|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154678803|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154678804|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
154678805|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678806|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678807|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678808|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154678809|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154678810|NCT02254681|Gemcitabine|gemcitabine|mesh-list
154678811|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678812|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678813|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
154678814|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678815|NCT01965327|Interferons|interferons|mesh-list
154678816|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
154678817|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678818|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
154678819|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678820|NCT01639729|Sufentanil|sufentanil|mesh-list
154678821|NCT01639729|Dsuvia|dsuvia|mesh-list
154678822|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154678823|NCT01639729|Narcotics|narcotics|mesh-ancestor
154678824|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678825|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678826|NCT01639729|Analgesics|analgesics|mesh-ancestor
154678827|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
154678828|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678829|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154678830|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154678831|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
154678832|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
154678833|NCT02002221|Metformin|metformin|mesh-list
154678834|NCT02002221|Vildagliptin|vildagliptin|mesh-list
154678835|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154678836|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678837|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154678838|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
154678839|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678840|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678841|NCT05650723|Venetoclax|venetoclax|mesh-list
154678842|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
154678843|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
154678844|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678845|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678846|NCT05650723|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154678847|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154678848|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678849|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678850|NCT05247697|Mirtazapine|mirtazapine|mesh-list
154678851|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
154678852|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154678853|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154678854|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
154678855|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
154678856|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691158|NCT00189748|Tacrolimus|tacrolimus|mesh-list
154678857|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678858|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678859|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154678860|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154678861|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678862|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154678863|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154678864|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154678865|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
154678866|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154678867|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154678868|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
154678869|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154678870|NCT02001987|Methotrexate|methotrexate|mesh-list
154678871|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154678872|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
154678873|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154678874|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678875|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154678876|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
154678877|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678878|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678879|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
154678880|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678881|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154678882|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678883|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
154678884|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154678885|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154678886|NCT01763164|Dacarbazine|dacarbazine|mesh-list
154678887|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154678888|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
154678889|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678890|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678891|NCT01782742|Bexarotene|bexarotene|mesh-list
154678892|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678893|NCT01732588|Artefenomel|artefenomel|mesh-list
154678894|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
154678895|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154678896|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154678897|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154678898|NCT01639339|Belimumab|belimumab|mesh-list
154678899|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678900|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
154678901|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678902|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154678903|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
154678904|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678905|NCT04419259|Erenumab|erenumab|mesh-list
154678906|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154678907|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678908|NCT04419259|Analgesics|analgesics|mesh-ancestor
154678909|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
154678910|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678911|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678912|NCT04845217|Peppermint oil|peppermint oil|mesh-list
154678913|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
154678914|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
154678915|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678916|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678917|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678918|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
154678919|NCT05359393|Tislelizumab|tislelizumab|mesh-list
154678920|NCT05359393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154678921|NCT05359393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678922|NCT01600885|Guanfacine|guanfacine|mesh-list
154678923|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154678924|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154678925|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154678926|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154678927|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
154678928|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678929|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678930|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678931|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
154678932|NCT05369377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154678933|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154678934|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678935|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678936|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678937|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
154678938|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154678939|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154678940|NCT04832269|Prednisolone|prednisolone|mesh-list
154430953|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678941|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
154678942|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154678943|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
154678944|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154678945|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
154678946|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
154678947|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678948|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678949|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678950|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
154678951|NCT04832269|Hormones|hormones|mesh-ancestor
154678952|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154678953|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154678954|NCT04832269|Protective Agents|protective agents|mesh-ancestor
154678955|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154678956|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154678957|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
154678958|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154678959|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678960|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678961|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154678962|NCT04608331|Analgesics|analgesics|mesh-ancestor
154678963|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
154678964|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678965|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154678966|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154678967|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154678968|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
154678969|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933666|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154678970|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678971|NCT01637077|Pregabalin|pregabalin|mesh-list
154678972|NCT01637077|Analgesics|analgesics|mesh-ancestor
154678973|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
154678974|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678975|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678976|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
154678977|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154678978|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154678979|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154678980|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154678981|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154678982|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154678983|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154678984|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154678985|NCT02308163|Etanercept|etanercept|mesh-list
154678986|NCT02308163|Peficitinib|peficitinib|mesh-list
154678987|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154678988|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154678989|NCT02308163|Analgesics|analgesics|mesh-ancestor
154678990|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
154678991|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154678992|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154678993|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154678994|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154678995|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154678996|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154678997|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
154678998|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154678999|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679000|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
154679001|NCT04001647|Nitroprusside|nitroprusside|mesh-list
154679002|NCT04001647|Acetylcholine|acetylcholine|mesh-list
154679003|NCT04001647|Vitamins|vitamins|mesh-ancestor
154679004|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
154679005|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679006|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
154679007|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679008|NCT04001647|Protective Agents|protective agents|mesh-ancestor
154679009|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154679010|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
154679011|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154679012|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154679013|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
154679014|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431036|NCT02206490|Narcotics|narcotics|mesh-ancestor
154679015|NCT01999335|Dexamethasone|dexamethasone|mesh-list
154679016|NCT01999335|Pomalidomide|pomalidomide|mesh-list
154679017|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154679018|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
154679019|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
154679020|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933724|NCT02784340|Hormones|hormones|mesh-ancestor
154679021|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679022|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154679023|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
154679024|NCT01999335|Hormones|hormones|mesh-ancestor
154679025|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679026|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154679027|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679028|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
154679029|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154679030|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154679031|NCT01999335|Growth Substances|growth substances|mesh-ancestor
154679032|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
154679033|NCT01999179|Heparin|heparin|mesh-list
154679034|NCT01999179|Enoxaparin|enoxaparin|mesh-list
154679035|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154679036|NCT01999179|Tinzaparin|tinzaparin|mesh-list
154679037|NCT01999179|Dalteparin|dalteparin|mesh-list
154679038|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
154679039|NCT01999179|Dabigatran|dabigatran|mesh-list
154679040|NCT01999179|Apixaban|apixaban|mesh-list
154679041|NCT01999179|Anticoagulants|anticoagulants|mesh-list
154679042|NCT01999179|Edoxaban|edoxaban|mesh-list
154679043|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154679044|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154679045|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679046|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154679047|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
154679048|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154679049|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
154679050|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679051|NCT01977729|Sertraline|sertraline|mesh-list
154679052|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
154679053|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154679054|NCT01977729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154679055|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154679056|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154679057|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679058|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679059|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
154679060|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679061|NCT01998399|Ticagrelor|ticagrelor|mesh-list
154679062|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154679063|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154679064|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154679065|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154679066|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
154679067|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679068|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679069|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679070|NCT01731886|Dexamethasone|dexamethasone|mesh-list
154679071|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
154679072|NCT01731886|Melphalan|melphalan|mesh-list
154679073|NCT01731886|Lenalidomide|lenalidomide|mesh-list
154679074|NCT01731886|Lenograstim|lenograstim|mesh-list
154679075|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679076|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
154679077|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679078|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679079|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154679080|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
154679081|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679082|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679083|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154679084|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154679085|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
154679086|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
154679087|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679088|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154679089|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
154679090|NCT01731886|Hormones|hormones|mesh-ancestor
154679091|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679092|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154679093|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154679094|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154679095|NCT01731886|Growth Substances|growth substances|mesh-ancestor
154679096|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
154679097|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154679098|NCT01759420|Ondansetron|ondansetron|mesh-list
154679099|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
154679100|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
154679101|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679102|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679103|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154679104|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
154679105|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
154679106|NCT01759420|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154679107|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154679108|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
154679109|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679110|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679111|NCT01781026|Vemurafenib|vemurafenib|mesh-list
154679112|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679113|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154679114|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679115|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679117|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154679118|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679119|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154679120|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154679121|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679122|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679123|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
154679124|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679125|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
154679126|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154679127|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
154679128|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679129|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679130|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679131|NCT01975701|Infigratinib|infigratinib|mesh-list
154679132|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679133|NCT01962987|Diclofenac|diclofenac|mesh-list
154679134|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154679135|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154679136|NCT01962987|Analgesics|analgesics|mesh-ancestor
154679137|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
154679138|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679139|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679140|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154679141|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679142|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154679143|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679144|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679145|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
154679146|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
154679147|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679148|NCT01638013|Peficitinib|peficitinib|mesh-list
154679149|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679150|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679151|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679152|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
154679153|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679154|NCT01637623|Allopurinol|allopurinol|mesh-list
154679155|NCT01637623|Losartan|losartan|mesh-list
154679156|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154679157|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154679158|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154679159|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154679160|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679161|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
154679162|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679163|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
154679164|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679165|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154679166|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
154679167|NCT01637623|Protective Agents|protective agents|mesh-ancestor
154679168|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679169|NCT01995825|Lamotrigine|lamotrigine|mesh-list
154679170|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
154679171|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154679172|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154679173|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679174|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154679175|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679176|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154679177|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154679178|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679179|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154679180|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154679181|NCT04267081|Venetoclax|venetoclax|mesh-list
154679182|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679183|NCT04792567|Siponimod|siponimod|mesh-list
154679184|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154679185|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679186|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679187|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
154679188|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679189|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
154679190|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154679191|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
154679192|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679193|NCT04419025|Expectorants|expectorants|mesh-ancestor
154679194|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
154679195|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154679196|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
154679197|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679198|NCT04419025|Protective Agents|protective agents|mesh-ancestor
154679199|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679200|NCT04419025|Antidotes|antidotes|mesh-ancestor
154679201|NCT05259787|Propofol|propofol|mesh-list
154679202|NCT05259787|Etomidate|etomidate|mesh-list
154679203|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154679204|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679205|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679206|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154679207|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
154679208|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
154679209|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
154679210|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154679211|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679212|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679213|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154679214|NCT05226325|Analgesics|analgesics|mesh-ancestor
154679215|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
154679216|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679217|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154679218|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154679219|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154679220|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
154679221|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679222|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679223|NCT05221021|Mirabegron|mirabegron|mesh-list
154679224|NCT05221021|Estradiol|estradiol|mesh-list
154679225|NCT05221021|Estrogens|estrogens|mesh-list
154679226|NCT05221021|Hormones|hormones|mesh-ancestor
154679227|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679228|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679229|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154679230|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154679231|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154679232|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
154679233|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679234|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679235|NCT05221021|Urological Agents|urological agents|mesh-ancestor
154679236|NCT03164473|Rituximab|rituximab|mesh-list
154679237|NCT03164473|Azathioprine|azathioprine|mesh-list
154679238|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679239|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679240|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
154679241|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679242|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679243|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
154679244|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679245|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154679246|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679247|NCT05218915|Dulaglutide|dulaglutide|mesh-list
154679248|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154679249|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679250|NCT05218915|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154679251|NCT01995201|Methotrexate|methotrexate|mesh-list
154679252|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154679253|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
154679254|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154679255|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679256|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154679257|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
154679258|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679259|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679260|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
154679261|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679262|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154679263|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679264|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
154679265|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679266|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154679267|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154679268|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
154679269|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679270|NCT05165641|Anesthetics|anesthetics|mesh-list
154679271|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679272|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679273|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154679274|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154679275|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679276|NCT05814302|Acetaminophen|acetaminophen|mesh-list
154679277|NCT05814302|Ibuprofen|ibuprofen|mesh-list
154679278|NCT05814302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154679279|NCT05814302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154679280|NCT05814302|Analgesics|analgesics|mesh-ancestor
154679281|NCT05814302|Sensory System Agents|sensory system agents|mesh-ancestor
154679282|NCT05814302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679283|NCT05814302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679284|NCT05814302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154679285|NCT05814302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679286|NCT05814302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154679287|NCT05814302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679288|NCT05814302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679289|NCT05814302|Antipyretics|antipyretics|mesh-ancestor
154679290|NCT05814068|Antihypertensive Agents|antihypertensive agents|mesh-list
154679291|NCT05813951|Linezolid|linezolid|mesh-list
154679292|NCT05813951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154679293|NCT05813951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679294|NCT05813951|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154679295|NCT05813951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679296|NCT05813951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679297|NCT05813821|Anti-Infective Agents|anti-infective agents|mesh-list
154679298|NCT05813821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154679299|NCT05813691|Antibodies|antibodies|mesh-list
154679300|NCT05813691|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
154679301|NCT05813691|Immunologic Factors|immunologic factors|mesh-ancestor
154679302|NCT05813691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679303|NCT05813665|Denosumab|denosumab|mesh-list
154679304|NCT05813665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154679305|NCT05813665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679306|NCT05813600|Ritonavir|ritonavir|mesh-list
154679307|NCT05813600|Nirmatrelvir|nirmatrelvir|mesh-list
154679308|NCT05813600|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154679309|NCT05813600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154679310|NCT05813600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154679311|NCT05813600|Protease Inhibitors|protease inhibitors|mesh-ancestor
154679312|NCT05813600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679313|NCT05813600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679314|NCT05813600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154679315|NCT05813600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154679316|NCT05813600|Antiviral Agents|antiviral agents|mesh-ancestor
154679317|NCT05813600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679318|NCT05813600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154679319|NCT05813600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154679320|NCT05813561|Fexuprazan|fexuprazan|mesh-list
154679321|NCT05813561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154679322|NCT05813522|Aflutinib|aflutinib|mesh-list
154679323|NCT05813522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154679324|NCT05813522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679325|NCT05813522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679326|NCT05813496|Thioctic Acid|thioctic acid|mesh-list
154679327|NCT05813496|Antioxidants|antioxidants|mesh-ancestor
154679328|NCT05813496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679329|NCT05813496|Protective Agents|protective agents|mesh-ancestor
153934021|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679330|NCT05813496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679331|NCT05813496|Vitamin B Complex|vitamin b complex|mesh-ancestor
154679332|NCT05813496|Vitamins|vitamins|mesh-ancestor
154679333|NCT05813496|Micronutrients|micronutrients|mesh-ancestor
154679334|NCT05813470|Omalizumab|omalizumab|mesh-list
154679335|NCT05813470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154679336|NCT05813470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154679337|NCT05813470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154679338|NCT05813470|Respiratory System Agents|respiratory system agents|mesh-ancestor
154679339|NCT05813470|Immunologic Factors|immunologic factors|mesh-ancestor
154679340|NCT05813470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679341|NCT05813405|Antihypertensive Agents|antihypertensive agents|mesh-list
154679342|NCT05813366|Vitamin B 6|vitamin b 6|mesh-list
154679343|NCT05813366|Pyridoxal|pyridoxal|mesh-list
154679344|NCT05813366|Pyridoxine|pyridoxine|mesh-list
154679345|NCT05813366|Tryptophan|tryptophan|mesh-list
154679346|NCT05813366|Vitamins|vitamins|mesh-ancestor
154679347|NCT05813366|Micronutrients|micronutrients|mesh-ancestor
154679348|NCT05813366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679349|NCT05813366|Vitamin B Complex|vitamin b complex|mesh-ancestor
154679350|NCT05813366|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154679351|NCT05813366|Antidepressive Agents|antidepressive agents|mesh-ancestor
154679352|NCT05813366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154679353|NCT05813249|Tocopherols|tocopherols|mesh-list
154679354|NCT05813249|Vitamin E|vitamin e|mesh-list
154679355|NCT05813249|Tocotrienols|tocotrienols|mesh-list
154679356|NCT05813249|alpha-Tocopherol|alpha-tocopherol|mesh-list
154679357|NCT05813249|Semaglutide|semaglutide|mesh-list
154679358|NCT05813249|Antioxidants|antioxidants|mesh-ancestor
154679359|NCT05813249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679360|NCT05813249|Protective Agents|protective agents|mesh-ancestor
154679361|NCT05813249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679362|NCT05813249|Vitamins|vitamins|mesh-ancestor
154679363|NCT05813249|Micronutrients|micronutrients|mesh-ancestor
154679364|NCT05813249|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154679365|NCT05813249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154679366|NCT05813184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154679367|NCT05813184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679368|NCT05813145|Fenofibrate|fenofibrate|mesh-list
154679369|NCT05813145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154679370|NCT05813145|Antimetabolites|antimetabolites|mesh-ancestor
154679371|NCT05813145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679372|NCT05813145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154679373|NCT05813106|Dexmedetomidine|dexmedetomidine|mesh-list
154679374|NCT05813106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154679375|NCT05813106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679376|NCT05813106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679377|NCT05813106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154679378|NCT05813106|Analgesics|analgesics|mesh-ancestor
154679379|NCT05813106|Sensory System Agents|sensory system agents|mesh-ancestor
154679380|NCT05813106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679381|NCT05813106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154679382|NCT05813106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154679383|NCT05813106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154679384|NCT05813106|Adrenergic Agents|adrenergic agents|mesh-ancestor
154679385|NCT05813106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679386|NCT05813106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679387|NCT05813015|Docetaxel|docetaxel|mesh-list
154679388|NCT05813015|Tegafur|tegafur|mesh-list
154679389|NCT05813015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679390|NCT05813015|Tubulin Modulators|tubulin modulators|mesh-ancestor
154679391|NCT05813015|Antimitotic Agents|antimitotic agents|mesh-ancestor
154679392|NCT05813015|Mitosis Modulators|mitosis modulators|mesh-ancestor
154679393|NCT05813015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679394|NCT05813015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154679395|NCT05813015|Antimetabolites|antimetabolites|mesh-ancestor
154679396|NCT05808582|Fulvestrant|fulvestrant|mesh-list
154679397|NCT05808582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154679398|NCT05808582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679399|NCT05808582|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154679400|NCT05808582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154679401|NCT05808582|Hormone Antagonists|hormone antagonists|mesh-ancestor
154679402|NCT05808582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679403|NCT05808582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679404|NCT05796804|Anesthetics|anesthetics|mesh-list
154679405|NCT05796804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679406|NCT05796804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679407|NCT05788874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154679408|NCT05788874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154679409|NCT05788874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679410|NCT05775887|Vaccines|vaccines|mesh-list
154679411|NCT05775887|Immunologic Factors|immunologic factors|mesh-ancestor
154679412|NCT05775887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679413|NCT05757388|Acetaminophen|acetaminophen|mesh-list
154679414|NCT05757388|Parecoxib|parecoxib|mesh-list
154679415|NCT05757388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154679416|NCT05757388|Analgesics|analgesics|mesh-ancestor
154679417|NCT05757388|Sensory System Agents|sensory system agents|mesh-ancestor
154679418|NCT05757388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679419|NCT05757388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679420|NCT05757388|Antipyretics|antipyretics|mesh-ancestor
154679421|NCT05757388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154679422|NCT05757388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154679423|NCT05757388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679424|NCT05757388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679425|NCT05757388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154679426|NCT05757388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154679427|NCT05757388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679428|NCT05755334|Ropivacaine|ropivacaine|mesh-list
154679429|NCT05755334|Anesthetics, Local|anesthetics, local|mesh-ancestor
154679430|NCT05755334|Anesthetics|anesthetics|mesh-ancestor
154679431|NCT05755334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679432|NCT05755334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679433|NCT05755334|Sensory System Agents|sensory system agents|mesh-ancestor
154679434|NCT05755334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679435|NCT05688735|Isosorbide|isosorbide|mesh-list
154679436|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154679437|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154679438|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154679439|NCT05688735|Diuretics|diuretics|mesh-ancestor
154679440|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
154679441|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679442|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
154679443|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154679444|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679445|NCT05627596|Nicotine|nicotine|mesh-list
154679446|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154679447|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
154679448|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679449|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679450|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154679451|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154679452|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
154679453|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679454|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679455|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
154679456|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154679457|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679458|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679459|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154679460|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154679461|NCT05496192|Nivolumab|nivolumab|mesh-list
154679462|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679463|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679464|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154679465|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679466|NCT05472623|Nivolumab|nivolumab|mesh-list
154679467|NCT05472623|Adagrasib|adagrasib|mesh-list
154679468|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679469|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679470|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154679471|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679472|NCT05438394|Melphalan|melphalan|mesh-list
154679473|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154679474|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
154679475|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679476|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679477|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154679478|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679479|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
154679480|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679481|NCT05386030|Lidocaine|lidocaine|mesh-list
154679482|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
154679483|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
154679484|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679485|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679486|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
154679487|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679488|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154679489|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154679490|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154679491|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153934180|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679492|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679493|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
154679494|NCT05287191|Digoxin|digoxin|mesh-list
154679495|NCT05287191|Amiodarone|amiodarone|mesh-list
154679496|NCT05287191|Analgesics|analgesics|mesh-ancestor
154679497|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
154679498|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679499|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679500|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
154679501|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679502|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154679503|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
154679504|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154679505|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154679506|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679507|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154679508|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
154679509|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154679510|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154679511|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679512|NCT05287191|Protective Agents|protective agents|mesh-ancestor
154679513|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
154679514|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154679515|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154679516|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154679517|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154679518|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154679519|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154679520|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154679521|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
154679522|NCT05259046|Vitamin K|vitamin k|mesh-list
154679523|NCT05259046|Menaquinone 7|menaquinone 7|mesh-list
154679524|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154679525|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154679526|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679527|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
154679528|NCT05259046|Coagulants|coagulants|mesh-ancestor
154679529|NCT05259046|Vitamins|vitamins|mesh-ancestor
154679530|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
154679531|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679532|NCT05206682|Leuprolide|leuprolide|mesh-list
154679533|NCT05206682|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154679534|NCT05206682|Fertility Agents|fertility agents|mesh-ancestor
154679535|NCT05206682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154679536|NCT05206682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679537|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154679538|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679539|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
154679540|NCT05129748|Mannitol|mannitol|mesh-list
154679541|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154679542|NCT05129748|Diuretics|diuretics|mesh-ancestor
154679543|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
154679544|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679545|NCT05129748|Antidotes|antidotes|mesh-ancestor
154679546|NCT05129748|Protective Agents|protective agents|mesh-ancestor
154679547|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
154679548|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679549|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
154679550|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154679551|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679552|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
154679553|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
154679554|NCT05127746|Donepezil|donepezil|mesh-list
154679555|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154679556|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679557|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679558|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
154679559|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679560|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679561|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
154679562|NCT04930887|Bupivacaine|bupivacaine|mesh-list
154679563|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
154679564|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
154679565|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679566|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679567|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
154679568|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679569|NCT04863248|Docetaxel|docetaxel|mesh-list
154679570|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679571|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
154679572|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
154679573|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
154679574|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679575|NCT04815902|Losartan|losartan|mesh-list
154679576|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154679577|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154679578|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154679579|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154679580|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679581|NCT04807140|Paclitaxel|paclitaxel|mesh-list
154679582|NCT04807140|Carboplatin|carboplatin|mesh-list
154679583|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154679584|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679585|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
154679586|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
154679587|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
154679588|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679589|NCT04759248|Trastuzumab|trastuzumab|mesh-list
154679590|NCT04759248|Atezolizumab|atezolizumab|mesh-list
154679591|NCT04759248|Vinorelbine|vinorelbine|mesh-list
154679592|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679593|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679594|NCT04759248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154679595|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679596|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154679597|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
154679598|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
154679599|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
154679600|NCT04756726|Dexamethasone|dexamethasone|mesh-list
154679601|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154679602|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
154679603|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
154679604|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679605|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679606|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154679607|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
154679608|NCT04756726|Hormones|hormones|mesh-ancestor
154679609|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679610|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154679611|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679612|NCT04704505|Androgens|androgens|mesh-list
154679613|NCT04704505|Hormones|hormones|mesh-ancestor
154679614|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679615|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679616|NCT04529278|Liraglutide|liraglutide|mesh-list
154679617|NCT04529278|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154679618|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154679619|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679620|NCT04529278|Incretins|incretins|mesh-ancestor
154679621|NCT04529278|Hormones|hormones|mesh-ancestor
154679622|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679623|NCT04503148|Propofol|propofol|mesh-list
154679624|NCT04503148|Anesthetics|anesthetics|mesh-list
154679625|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
154679626|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
154679627|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154679628|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679629|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679630|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154679631|NCT04429516|Morphine|morphine|mesh-list
154679632|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154679633|NCT04429516|Narcotics|narcotics|mesh-ancestor
154679634|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679635|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679636|NCT04429516|Analgesics|analgesics|mesh-ancestor
154679637|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
154679638|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679639|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
154679640|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679641|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679642|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679643|NCT04357951|Cycloserine|cycloserine|mesh-list
154679644|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154679645|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679646|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154679647|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
154679648|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154679649|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
154679650|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679651|NCT04285229|Ixekizumab|ixekizumab|mesh-list
154679652|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
154679653|NCT04282668|Tretinoin|tretinoin|mesh-list
154679654|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679655|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
154679656|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
154679657|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
154679658|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
154679659|NCT04259060|Hematinics|hematinics|mesh-ancestor
154679660|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
154679661|NCT04259060|Vitamins|vitamins|mesh-ancestor
154679662|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
154679663|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679664|NCT04218240|Lofexidine|lofexidine|mesh-list
154679665|NCT04218240|Pregabalin|pregabalin|mesh-list
154679666|NCT04218240|Analgesics|analgesics|mesh-ancestor
154679667|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
154679668|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679669|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679670|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
154679671|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154679672|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154679673|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679674|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154679675|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154679676|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154679677|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679678|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154679679|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154679680|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154679681|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154679682|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154679683|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154679684|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
154679685|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679686|NCT04212793|Bevacizumab|bevacizumab|mesh-list
154679687|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679688|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679689|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154679690|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154679691|NCT04212793|Growth Substances|growth substances|mesh-ancestor
154679692|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679693|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
154679694|NCT04084951|Nivolumab|nivolumab|mesh-list
154679695|NCT04084951|Ipilimumab|ipilimumab|mesh-list
154679696|NCT04084951|Atezolizumab|atezolizumab|mesh-list
154679697|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679698|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679699|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154679700|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679701|NCT04035837|Interferons|interferons|mesh-list
154679702|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
154679703|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679704|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
154679705|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679706|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
154679707|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679708|NCT04022135|Folic Acid|folic acid|mesh-list
154679709|NCT04022135|Hematinics|hematinics|mesh-ancestor
154679710|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
154679711|NCT04022135|Vitamins|vitamins|mesh-ancestor
154679712|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
154679713|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679714|NCT04001777|Osimertinib|osimertinib|mesh-list
154679715|NCT04001777|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154679716|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154679717|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679718|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679719|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679720|NCT03977012|Buprenorphine|buprenorphine|mesh-list
154679721|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154679722|NCT03977012|Narcotics|narcotics|mesh-ancestor
154679723|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934410|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679724|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679725|NCT03977012|Analgesics|analgesics|mesh-ancestor
154679726|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
154679727|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679728|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154679729|NCT03907423|Metformin|metformin|mesh-list
154679730|NCT03907423|Glimepiride|glimepiride|mesh-list
154679731|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154679732|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154679733|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679734|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154679735|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154679736|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
154679737|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679738|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154679739|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154679740|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679741|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154679742|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679743|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
154679744|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
154679745|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154679746|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154679747|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679748|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
154679749|NCT03897621|Coagulants|coagulants|mesh-ancestor
154679750|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
154679751|NCT03809884|Diuretics|diuretics|mesh-ancestor
154679752|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
154679753|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679754|NCT03809884|Expectorants|expectorants|mesh-ancestor
154679755|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
154679756|NCT03768427|Atorvastatin|atorvastatin|mesh-list
154679757|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154679758|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154679759|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
154679760|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679761|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154679762|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154679763|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679764|NCT03758781|Nivolumab|nivolumab|mesh-list
154679765|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679766|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431770|NCT02220608|Lenograstim|lenograstim|mesh-list
154679767|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154679768|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679770|NCT03746080|Temozolomide|temozolomide|mesh-list
154679771|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154679772|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
154679773|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679774|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679775|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154679776|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154679777|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
154679778|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679779|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154679780|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154679781|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
154679782|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679783|NCT03572933|Pregnanolone|pregnanolone|mesh-list
153934528|NCT02876796|Firsocostat|firsocostat|mesh-list
154679784|NCT03572933|Ganaxolone|ganaxolone|mesh-list
154679785|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
154679786|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679787|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679788|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679789|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
154679790|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
154679791|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
154679792|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679793|NCT03558152|Vedolizumab|vedolizumab|mesh-list
154679794|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154679795|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154679796|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
154679797|NCT03461406|Coagulants|coagulants|mesh-ancestor
154679798|NCT03431974|Aminopterin|aminopterin|mesh-list
154679799|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154679800|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679801|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679802|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
154679803|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679804|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679805|NCT03416335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154679806|NCT03416335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679807|NCT03311308|Metformin|metformin|mesh-list
154679808|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
154679809|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154679810|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679811|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154679812|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679813|NCT03311308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154679814|NCT03311308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679815|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154679816|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154679817|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679818|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154679819|NCT03179449|Hematinics|hematinics|mesh-ancestor
154679820|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154679821|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154679822|NCT02915744|Paclitaxel|paclitaxel|mesh-list
154679823|NCT02915744|Vinorelbine|vinorelbine|mesh-list
154679824|NCT02915744|Docetaxel|docetaxel|mesh-list
154679825|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154679826|NCT02915744|Gemcitabine|gemcitabine|mesh-list
154679827|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
154679828|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154679829|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679830|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154679831|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154679832|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154679833|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679834|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154679835|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
154679836|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154679837|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154679838|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679839|NCT02736656|Viloxazine|viloxazine|mesh-list
154679840|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154679841|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
154679842|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154679843|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154679844|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154679845|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154679846|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679847|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
154679848|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679849|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679850|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
154679851|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154679852|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154679853|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679854|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154679855|NCT02409810|Analgesics|analgesics|mesh-ancestor
154679856|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
154679857|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679858|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154679859|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154679860|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154679861|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
154679862|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679863|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679864|NCT02206815|Aspirin|aspirin|mesh-list
154679865|NCT02206815|Warfarin|warfarin|mesh-list
154679866|NCT02206815|Clopidogrel|clopidogrel|mesh-list
154679867|NCT02206815|Ticagrelor|ticagrelor|mesh-list
154679868|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154679869|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154679870|NCT02206815|Analgesics|analgesics|mesh-ancestor
154679871|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
154679872|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679873|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679874|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154679875|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679876|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154679877|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154679878|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679879|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154679880|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154679881|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679882|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
154679883|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154679884|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154679885|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154679886|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
154679887|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154679888|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
154679889|NCT02175680|Leronlimab|leronlimab|mesh-list
154679890|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154679891|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154679892|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679893|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154679894|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154679895|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
154679896|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679897|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154679898|NCT01983462|Clonidine|clonidine|mesh-list
154679899|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154679900|NCT01983462|Diuretics|diuretics|mesh-ancestor
154679901|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
154679902|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934599|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154679903|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154679904|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154679905|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679906|NCT01983462|Analgesics|analgesics|mesh-ancestor
154679907|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
154679908|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154679909|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
154679910|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
154679911|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154679912|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154679913|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154679914|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
154679915|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431925|NCT02206022|Analgesics|analgesics|mesh-ancestor
154679916|NCT01779375|Metformin|metformin|mesh-list
154679917|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
154679918|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154679919|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679920|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154679921|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
154679922|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154679923|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
154679924|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154679925|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679926|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154679927|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154679928|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679929|NCT00565851|Paclitaxel|paclitaxel|mesh-list
154679930|NCT00565851|Docetaxel|docetaxel|mesh-list
154679931|NCT00565851|Bevacizumab|bevacizumab|mesh-list
154679932|NCT00565851|Carboplatin|carboplatin|mesh-list
154679933|NCT00565851|Gemcitabine|gemcitabine|mesh-list
154679934|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154679935|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154679936|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
154679937|NCT00565851|Antibodies|antibodies|mesh-list
154679938|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
154679939|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154679940|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
154679941|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154679942|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679943|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
154679944|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
154679945|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
154679946|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679947|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154679948|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154679949|NCT00565851|Growth Substances|growth substances|mesh-ancestor
154679950|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679951|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
154679952|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
154679953|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154679954|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
154679955|NCT00238563|Triamcinolone|triamcinolone|mesh-list
154679956|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154679957|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
154679958|NCT00238563|Hormones|hormones|mesh-ancestor
154679959|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679960|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679961|NCT04499677|Ritonavir|ritonavir|mesh-list
154679962|NCT04499677|Lopinavir|lopinavir|mesh-list
154679963|NCT04499677|Favipiravir|favipiravir|mesh-list
154679964|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154679965|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154679966|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
154679967|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154679968|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679969|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154679970|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154679971|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
154679972|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154679973|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154679974|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154679975|NCT05652751|Mitogens|mitogens|mesh-list
154679976|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
154679977|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154679978|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
154679979|NCT02909335|Prednisone|prednisone|mesh-list
154679980|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
154679981|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154679982|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154679983|NCT02909335|Prednisolone|prednisolone|mesh-list
154679984|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
154679985|NCT02909335|Everolimus|everolimus|mesh-list
154679986|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154679987|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
154679988|NCT02909335|Tacrolimus|tacrolimus|mesh-list
154679989|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154432002|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679990|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
154679991|NCT02909335|Hormones|hormones|mesh-ancestor
154679992|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154679993|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154679994|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154679995|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154679996|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154679997|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
154679998|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154679999|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680000|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680001|NCT02909335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154680002|NCT02909335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154680003|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154680004|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154680005|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
154680006|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680007|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680008|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
154680009|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
154680010|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680011|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680012|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154680013|NCT02909335|Protective Agents|protective agents|mesh-ancestor
154680014|NCT05652517|Ethanol|ethanol|mesh-list
154680015|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154680016|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680017|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680018|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680019|NCT03998293|Somatostatin|somatostatin|mesh-list
154680020|NCT03998293|Hormones|hormones|mesh-ancestor
154680021|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680022|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680023|NCT01606306|Fluticasone|fluticasone|mesh-list
154680024|NCT01606306|Xhance|xhance|mesh-list
154680025|NCT01606306|Montelukast|montelukast|mesh-list
154680026|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154680027|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154680028|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
154680029|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680030|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680031|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154680032|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
154680033|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
154680034|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154680035|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154680036|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
154680037|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680038|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154680039|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154680040|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680041|NCT01753570|Interferon-beta|interferon-beta|mesh-list
154680042|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680043|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
154680044|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680045|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
154680046|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680047|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
154680048|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154680049|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154680050|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154680051|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680052|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680053|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
154680054|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680055|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680056|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154680057|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680058|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
154680059|NCT01777282|Biguanides|biguanides|mesh-list
154680060|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154680061|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
154680062|NCT01777282|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154680063|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154680064|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680065|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432078|NCT02225054|Analgesics|analgesics|mesh-ancestor
154680066|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680067|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
154680068|NCT04571632|Ipilimumab|ipilimumab|mesh-list
154680069|NCT04571632|Avelumab|avelumab|mesh-list
154680070|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154680071|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680072|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154680073|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680074|NCT01975389|Bococizumab|bococizumab|mesh-list
154680075|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154680076|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154680077|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
154680078|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680079|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154680080|NCT01974141|Dapsone|dapsone|mesh-list
154680081|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680082|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
154680083|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154680084|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154680085|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154680086|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680087|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680088|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
154680089|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680090|NCT01945593|Factor VIII|factor viii|mesh-list
154680091|NCT01945593|BAX 855|bax 855|mesh-list
154680092|NCT01945593|Coagulants|coagulants|mesh-ancestor
154680093|NCT01945281|Amphotericin B|amphotericin b|mesh-list
154680094|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154680095|NCT01945281|Caspofungin|caspofungin|mesh-list
154680096|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
154680097|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
154680098|NCT01945281|Amebicides|amebicides|mesh-ancestor
154680099|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154680100|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154680101|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680102|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680103|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
154680104|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680105|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680106|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154680107|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680108|NCT01961349|Propofol|propofol|mesh-list
154680109|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154680110|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154680111|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680112|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680113|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154680114|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
154680115|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
154680116|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154680117|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154680118|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154680119|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
154680120|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
154680121|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680122|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680123|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680124|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
154680125|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
154680126|NCT04661397|Tenofovir|tenofovir|mesh-list
154680127|NCT04661397|Emtricitabine|emtricitabine|mesh-list
154680128|NCT04661397|Darunavir|darunavir|mesh-list
154680129|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154680130|NCT04661397|Cobicistat|cobicistat|mesh-list
154680131|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154680132|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154680133|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
154680134|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680135|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154680136|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154680137|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680138|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680139|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154680140|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154680141|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154680142|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154680143|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
154680144|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154680145|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154680146|NCT01973439|Abacavir|abacavir|mesh-list
154680147|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
154680148|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154680149|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154680150|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680151|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680152|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
154680153|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680154|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154680155|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154680156|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
154680157|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154680158|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
154680159|NCT01973283|Escitalopram|escitalopram|mesh-list
154680160|NCT01973283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154680161|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154680162|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680163|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680164|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680165|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
154680166|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680167|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680168|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154680169|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154680170|NCT01973283|Analgesics|analgesics|mesh-ancestor
154680171|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
154680172|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
154680173|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
154680174|NCT01972659|Analgesics|analgesics|mesh-ancestor
154680175|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
154680176|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680177|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680178|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
154680179|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680180|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154680181|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
154680182|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154680183|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680184|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680185|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154680186|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
154680187|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154680188|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
154680189|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
154680190|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680191|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680192|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680193|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
154680194|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
154680195|NCT01774786|Capecitabine|capecitabine|mesh-list
154680196|NCT01774786|Fluorouracil|fluorouracil|mesh-list
154680197|NCT01774786|Trastuzumab|trastuzumab|mesh-list
154680198|NCT01774786|Pertuzumab|pertuzumab|mesh-list
154680199|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680200|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154680201|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
154680202|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680203|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154680204|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
154680205|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680206|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154680207|NCT01942161|Aripiprazole|aripiprazole|mesh-list
154680208|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
154680209|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154680210|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154680211|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154680212|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680213|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680214|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
154432228|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154680215|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
154680216|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680217|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680218|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154680219|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154680220|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
154680221|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154680222|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154680223|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154680224|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154680225|NCT01971645|Dexamethasone|dexamethasone|mesh-list
154680226|NCT01971645|Ropivacaine|ropivacaine|mesh-list
154680227|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154680228|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
154680229|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
154680230|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680231|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680232|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680233|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
154680234|NCT01971645|Hormones|hormones|mesh-ancestor
154680235|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680236|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154680237|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680238|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
154680239|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
154680240|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680241|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
154680242|NCT01941537|Fezakinumab|fezakinumab|mesh-list
154680243|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
154680244|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
154680245|NCT01960413|Montelukast|montelukast|mesh-list
154680246|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154680247|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
154680248|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154680249|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
154680250|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680251|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680252|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154680253|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154680254|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680255|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680256|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
154680257|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680258|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154680259|NCT01970475|Adalimumab|adalimumab|mesh-list
154680260|NCT01970475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154680261|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154680262|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154680263|NCT01939977|Calcifediol|calcifediol|mesh-list
154680264|NCT01939977|Vitamins|vitamins|mesh-ancestor
154680265|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
154680266|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680267|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154680268|NCT01939899|Ixazomib|ixazomib|mesh-list
154680269|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680270|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
154680271|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680272|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680273|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
154680274|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154680275|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
154680276|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680277|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
154680278|NCT01970397|Protective Agents|protective agents|mesh-ancestor
154680279|NCT01970241|Insulin|insulin|mesh-list
154680280|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154680281|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154680282|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680283|NCT01728376|Daptomycin|daptomycin|mesh-list
154680284|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680285|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680286|NCT02217709|Phenelzine|phenelzine|mesh-list
154680287|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
154680288|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153934992|NCT02770378|Analgesics|analgesics|mesh-ancestor
154680289|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154680290|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680291|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680292|NCT05651347|Melatonin|melatonin|mesh-list
154680293|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
154680294|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680295|NCT05651347|Protective Agents|protective agents|mesh-ancestor
154680296|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680297|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680298|NCT05651269|Gemcitabine|gemcitabine|mesh-list
154680299|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154680300|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
154680301|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680302|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680303|NCT01707004|Vidarabine|vidarabine|mesh-list
154680304|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
154680305|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
154680306|NCT01707004|Busulfan|busulfan|mesh-list
154680307|NCT01707004|Fludarabine|fludarabine|mesh-list
154680308|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
154680309|NCT01707004|Azacitidine|azacitidine|mesh-list
154680310|NCT01707004|Decitabine|decitabine|mesh-list
154680311|NCT01707004|Tacrolimus|tacrolimus|mesh-list
154680312|NCT01707004|Lenograstim|lenograstim|mesh-list
154680313|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154680314|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
154680315|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680316|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154680317|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154680318|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
154680319|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680320|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680321|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154680322|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154680323|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
154680324|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
154680325|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680326|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154680327|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154680328|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680329|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154680330|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154680331|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
154680332|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680333|NCT01939197|Ritonavir|ritonavir|mesh-list
154680334|NCT01939197|Ribavirin|ribavirin|mesh-list
154680335|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154680336|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154680337|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
154680338|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680339|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680340|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154680341|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154680342|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
154680343|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680344|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153935044|NCT00943917|Exenatide|exenatide|mesh-list
154680345|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154680346|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
154680347|NCT01969851|Lacosamide|lacosamide|mesh-list
154680348|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
154680349|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154680350|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154680351|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680352|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680353|NCT01938573|Sirolimus|sirolimus|mesh-list
154680354|NCT01938573|Cisplatin|cisplatin|mesh-list
154680355|NCT01938573|Gemcitabine|gemcitabine|mesh-list
154680356|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680357|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154680358|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
154680359|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680360|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680361|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680362|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154680363|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
154680364|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154680365|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
154680366|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680367|NCT01937871|Tadalafil|tadalafil|mesh-list
154680368|NCT01937871|Tamsulosin|tamsulosin|mesh-list
154680369|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
154680370|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154680371|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154680372|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680373|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680374|NCT01937871|Urological Agents|urological agents|mesh-ancestor
154680375|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154680376|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154680377|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154680378|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680379|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680380|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680381|NCT01287091|Rabeprazole|rabeprazole|mesh-list
154680382|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154680383|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680384|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154680385|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680386|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680387|NCT01269463|Methylphenidate|methylphenidate|mesh-list
154680388|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154680389|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680390|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154680391|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154680392|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680393|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680394|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
154680395|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680396|NCT02539459|Everolimus|everolimus|mesh-list
154680397|NCT02539459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154680398|NCT02539459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154680399|NCT02539459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680400|NCT02539459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680401|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154680402|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
154680403|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680404|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680405|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
154680406|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154680407|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154680408|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
154680409|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680410|NCT01634113|Bromides|bromides|mesh-list
154680411|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
154680412|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154680413|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
154680414|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680415|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680416|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154680417|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
154680418|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
154680419|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154680420|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
154680421|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680422|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680423|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
154680424|NCT01937715|Bevacizumab|bevacizumab|mesh-list
154680425|NCT01937715|Gedatolisib|gedatolisib|mesh-list
154680426|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154680427|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680428|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154680429|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154680430|NCT01937715|Growth Substances|growth substances|mesh-ancestor
154680431|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680432|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
154680433|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154680434|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680435|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680436|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
154680437|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154680438|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154680439|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432449|NCT02477384|Propranolol|propranolol|mesh-list
154680441|NCT01937559|Coagulants|coagulants|mesh-ancestor
154680442|NCT01918371|Ranibizumab|ranibizumab|mesh-list
154680443|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154680444|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154680445|NCT01918371|Growth Substances|growth substances|mesh-ancestor
154680446|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680447|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
154680448|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680449|NCT01916967|Desloratadine|desloratadine|mesh-list
154680450|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154680451|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
154680452|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935136|NCT02768116|Temsirolimus|temsirolimus|mesh-list
154680453|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680454|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680455|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154680456|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154680457|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
154680458|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
154680459|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154680460|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154680461|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154680462|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154680463|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154680464|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154680465|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154680466|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680467|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680468|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680469|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680470|NCT01916109|Carboplatin|carboplatin|mesh-list
154680471|NCT01916109|Gemcitabine|gemcitabine|mesh-list
154680472|NCT01916109|Panitumumab|panitumumab|mesh-list
154680473|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680474|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154680475|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
154680476|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680477|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154680478|NCT01958619|Artefenomel|artefenomel|mesh-list
154680479|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
154680480|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154680481|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154680482|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680483|NCT01726270|Tamsulosin|tamsulosin|mesh-list
154680484|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154680485|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154680486|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154680487|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680488|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680489|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680490|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680491|NCT01726270|Urological Agents|urological agents|mesh-ancestor
154680492|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154680493|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154680494|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154680495|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680496|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680497|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154680498|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154680499|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154680500|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154680501|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680502|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680503|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680504|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154680505|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154680506|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
154680507|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154680508|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154680509|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
154680510|NCT01545271|Xenon|xenon|mesh-list
154680511|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154680512|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
154680513|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
154680514|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680515|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680516|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154680517|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154680518|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680519|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680520|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154680521|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680522|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680523|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
154680524|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680525|NCT01617447|Aripiprazole|aripiprazole|mesh-list
154680526|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
154680527|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154680528|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154680529|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154680530|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680531|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680532|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
154680533|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
154680534|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680535|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680536|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154680537|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154680538|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
154680539|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154680540|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154680541|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154680542|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154680543|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
154680544|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154680545|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680546|NCT04797325|Prednisolone|prednisolone|mesh-list
154680547|NCT04797325|Infliximab|infliximab|mesh-list
154680548|NCT04797325|Vedolizumab|vedolizumab|mesh-list
154680549|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154680550|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
154680551|NCT04797325|Hormones|hormones|mesh-ancestor
154680552|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680553|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680554|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154680555|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680556|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680557|NCT04797325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154680558|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
154680559|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154680560|NCT02246647|Mannitol|mannitol|mesh-list
154680561|NCT02246647|Lactulose|lactulose|mesh-list
154680562|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154680563|NCT02246647|Diuretics|diuretics|mesh-ancestor
154680564|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
154680565|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680566|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680567|NCT02244619|Acetaminophen|acetaminophen|mesh-list
154680568|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154680569|NCT02244619|Analgesics|analgesics|mesh-ancestor
154680570|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
154680571|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680572|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680573|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
154680574|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
154680575|NCT02243371|Nivolumab|nivolumab|mesh-list
154680576|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
154680577|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680578|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154680579|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154680580|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154680581|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
154680582|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680583|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680584|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154680585|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154680586|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154680587|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154432597|NCT01377961|Lycopene|lycopene|mesh-list
154680588|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154680589|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154680590|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680591|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680592|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680593|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680594|NCT01931475|Analgesics|analgesics|mesh-ancestor
154680595|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
154680596|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680597|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
154680598|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154680599|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
154680600|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154680601|NCT04630821|Eusol|eusol|mesh-list
154680602|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
154680603|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680604|NCT01646177|Etanercept|etanercept|mesh-list
154680605|NCT01646177|Ixekizumab|ixekizumab|mesh-list
154680606|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154680607|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154680608|NCT01646177|Analgesics|analgesics|mesh-ancestor
154680609|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
154680610|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680611|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680612|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154680613|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154680614|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680615|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154680616|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
154680617|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
154680618|NCT01929135|Atorvastatin|atorvastatin|mesh-list
154680619|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154680620|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154680621|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
154680622|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680623|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154680624|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154680625|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680626|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154680627|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154680628|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154680629|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680630|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680631|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154680632|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154680633|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154680634|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154680635|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680636|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680637|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680638|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154680639|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154680640|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
154680641|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154680642|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154680643|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
154680644|NCT02324153|Riboflavin|riboflavin|mesh-list
154680645|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
154680646|NCT02324153|Vitamins|vitamins|mesh-ancestor
154680647|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
154680648|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680649|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154680650|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
154680651|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154680652|NCT02280473|Laxatives|laxatives|mesh-ancestor
154680653|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680654|NCT02308007|Metronidazole|metronidazole|mesh-list
154680655|NCT02308007|Terconazole|terconazole|mesh-list
154680656|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680657|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680658|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154680659|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154680660|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
154680661|NCT01910181|Vemurafenib|vemurafenib|mesh-list
154680662|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680663|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154680664|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680665|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680666|NCT04885907|Vaccines|vaccines|mesh-list
154680667|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
154680668|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680669|NCT01957215|Indomethacin|indomethacin|mesh-list
154680670|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154680671|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154680672|NCT01957215|Analgesics|analgesics|mesh-ancestor
154680673|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
154680674|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680675|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680676|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154680677|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154680678|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
154680679|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
154680680|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154680681|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154680682|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680683|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680684|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
154680685|NCT01928433|Finafloxacin|finafloxacin|mesh-list
154680686|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
154680687|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680688|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680689|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154680690|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154680691|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680692|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680693|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680694|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154680695|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154680696|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154680697|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154680698|NCT02322281|Paclitaxel|paclitaxel|mesh-list
154680699|NCT02322281|Docetaxel|docetaxel|mesh-list
154680700|NCT02322281|Gemcitabine|gemcitabine|mesh-list
154680701|NCT02322281|Pemetrexed|pemetrexed|mesh-list
154680702|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154680703|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680704|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
154680705|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
154680706|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
154680707|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680708|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154680709|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
154680710|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680711|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154680712|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154680713|NCT02243293|Ribavirin|ribavirin|mesh-list
154680714|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
154680715|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680716|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
154680717|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680718|NCT02322047|Prazosin|prazosin|mesh-list
154680719|NCT02322047|Naltrexone|naltrexone|mesh-list
154680720|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154680721|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154680722|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680723|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
154680724|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680725|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154680726|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154680727|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154680728|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154680729|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680730|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680731|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680732|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154680733|NCT02254291|Semaglutide|semaglutide|mesh-list
154680734|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154680735|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680736|NCT02254291|Incretins|incretins|mesh-ancestor
154680737|NCT02254291|Hormones|hormones|mesh-ancestor
154860338|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680738|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680739|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154680740|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
154680741|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935437|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680742|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680743|NCT02254291|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154680744|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154680745|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
154680746|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680747|NCT02320721|Insulin|insulin|mesh-list
154680748|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154680749|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
154680750|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154680751|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680752|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154680753|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
154680754|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154680755|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
154680756|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680757|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680758|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154680759|NCT04197089|Vitamin D|vitamin d|mesh-list
154680760|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
154680761|NCT04197089|Vitamins|vitamins|mesh-ancestor
154680762|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
154680763|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680764|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154680765|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154680766|NCT02252965|Metformin|metformin|mesh-list
154680767|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154680768|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680769|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
154680770|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154680771|NCT02251717|Ledipasvir|ledipasvir|mesh-list
154680772|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
154680773|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680774|NCT02242201|Ketorolac|ketorolac|mesh-list
154680775|NCT02242201|Epinephrine|epinephrine|mesh-list
154680776|NCT02242201|Bupivacaine|bupivacaine|mesh-list
154680777|NCT02242201|Ropivacaine|ropivacaine|mesh-list
154680778|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
154680779|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
154680780|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680781|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680782|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
154680783|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680784|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154680785|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154680786|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680787|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680788|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680789|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154680790|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154680791|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
154680792|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154680793|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
154680794|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
154680795|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
154680796|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154680797|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154680798|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154680799|NCT02242201|Analgesics|analgesics|mesh-ancestor
154680800|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154680801|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154680802|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154680803|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680804|NCT02242045|Idelalisib|idelalisib|mesh-list
154680805|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680806|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935501|NCT02762656|Lidocaine|lidocaine|mesh-list
154680807|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680808|NCT02241889|Pancrelipase|pancrelipase|mesh-list
154680809|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154432824|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680810|NCT02241187|Cetuximab|cetuximab|mesh-list
154680811|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154680812|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680813|NCT02249767|Tretinoin|tretinoin|mesh-list
154680814|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680815|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
154680816|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
154680817|NCT02238379|Oxytocin|oxytocin|mesh-list
154680818|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
154680819|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154680820|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680821|NCT02207491|Timolol|timolol|mesh-list
154680822|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154680823|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154680824|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680825|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154680826|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154680827|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680828|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680829|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680830|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154680831|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154680832|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154680833|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
154680834|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
154680835|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680836|NCT02207413|Vaccines|vaccines|mesh-list
154680837|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
154680838|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680839|NCT02276027|Ceritinib|ceritinib|mesh-list
154680840|NCT02276027|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154680841|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154680842|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680843|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680844|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680845|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
154680846|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154680847|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154680848|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154680849|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
154680850|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680851|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680852|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680853|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
154680854|NCT04761133|Povidone|povidone|mesh-list
154680855|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
154680856|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
154680857|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154680858|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680859|NCT02233309|Anesthetics|anesthetics|mesh-list
154680860|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680861|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680862|NCT02280044|Rifaximin|rifaximin|mesh-list
154680863|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680864|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680865|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154680866|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
154680867|NCT02308748|Lidocaine|lidocaine|mesh-list
154680868|NCT02308748|Mexiletine|mexiletine|mesh-list
154680869|NCT02308748|Dofetilide|dofetilide|mesh-list
154680870|NCT02308748|Diltiazem|diltiazem|mesh-list
154680871|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
154680872|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
154680873|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154680874|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680875|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
154680876|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680877|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154680878|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154680879|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154680880|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680881|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680882|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154680883|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680884|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154680885|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154680886|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680887|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432957|NCT04333160|Hylan|hylan|mesh-list
154680888|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154680889|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154680890|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154680891|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
154680892|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154680893|NCT04745689|Carboplatin|carboplatin|mesh-list
154680894|NCT04745689|Etoposide|etoposide|mesh-list
154680895|NCT04745689|Durvalumab|durvalumab|mesh-list
154680896|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154680897|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154680898|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154680899|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154680900|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680901|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680902|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154680903|NCT02308124|Midodrine|midodrine|mesh-list
154680904|NCT02308124|Bromides|bromides|mesh-list
154680905|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154680906|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
154680907|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
154680908|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
154680909|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680910|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680911|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154680912|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154680913|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154680914|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154680915|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680916|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680917|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680918|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154680919|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680920|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
154680921|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154680922|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154680923|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680924|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154680925|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
154680926|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680927|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
154680928|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
154680929|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154680930|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
154680931|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680932|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680933|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154680934|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
154680935|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
154680936|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154680937|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
154680938|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680939|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680940|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154680941|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154680942|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154680943|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680944|NCT02308046|Terconazole|terconazole|mesh-list
154680945|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
154680946|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154680947|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154680948|NCT02318693|Glyburide|glyburide|mesh-list
154680949|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154680950|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680951|NCT02318693|Incretins|incretins|mesh-ancestor
154680952|NCT02318693|Hormones|hormones|mesh-ancestor
154680953|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680954|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154680955|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
154680956|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154680957|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680958|NCT02230891|Carvedilol|carvedilol|mesh-list
154680959|NCT02230891|Spironolactone|spironolactone|mesh-list
154680960|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154680961|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
154680962|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680963|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680964|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154680966|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
154680967|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154680968|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154680969|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
154680970|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680971|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680972|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154680973|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
154680974|NCT02230891|Protective Agents|protective agents|mesh-ancestor
154680975|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154680976|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154680977|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154680978|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
154680979|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154680980|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154680981|NCT02302859|Nicotine|nicotine|mesh-list
154680982|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154680983|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
154680984|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154680985|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680986|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154680987|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154680988|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
154680989|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154680990|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154680991|NCT02274311|Clomiphene|clomiphene|mesh-list
154680992|NCT02274311|Enclomiphene|enclomiphene|mesh-list
154680993|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
154680994|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154680995|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
154680996|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154680997|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154680998|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154680999|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
154681000|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154681001|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154681002|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154681003|NCT02316353|Complement C1s|complement c1s|mesh-list
154681004|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154681005|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154681006|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
154681007|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681008|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154681009|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681010|NCT02279732|Paclitaxel|paclitaxel|mesh-list
154681011|NCT02279732|Carboplatin|carboplatin|mesh-list
154681012|NCT02279732|Ipilimumab|ipilimumab|mesh-list
154681013|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154681014|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681015|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
154681016|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
154681017|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
154681018|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681019|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153935750|NCT00848497|Testosterone|testosterone|mesh-list
154681020|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154681021|NCT04876430|Meropenem|meropenem|mesh-list
154681022|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154681023|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681024|NCT02304926|Simvastatin|simvastatin|mesh-list
154681025|NCT02304926|Ezetimibe|ezetimibe|mesh-list
154681026|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154681027|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154681028|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154681029|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
154681030|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681031|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154681032|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154681033|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681034|NCT01646255|Levodopa|levodopa|mesh-list
154681035|NCT01646255|Rotigotine|rotigotine|mesh-list
154681036|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154681037|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154681038|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
154681039|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681040|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681041|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681042|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
154681043|NCT02203591|Ethanol|ethanol|mesh-list
154681044|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
154681045|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154681046|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154681047|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681048|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154681049|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681050|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
154681051|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
154681052|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
154681053|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154681054|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154681055|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
154681056|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681057|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681058|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681059|NCT01642277|Urological Agents|urological agents|mesh-ancestor
154681060|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
154681061|NCT02230189|Miotics|miotics|mesh-ancestor
154681062|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
154681063|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681064|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681065|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154681066|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154681067|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
154681068|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154681069|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154681070|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
154681071|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681072|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681073|NCT02304302|Memantine|memantine|mesh-list
154681074|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154681075|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154681076|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
154681077|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681078|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681079|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681080|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154681081|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154681082|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154681083|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154681084|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154681085|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
154681086|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681087|NCT02301143|Paclitaxel|paclitaxel|mesh-list
154681088|NCT02301143|Gemcitabine|gemcitabine|mesh-list
154681089|NCT02301143|Capecitabine|capecitabine|mesh-list
154681090|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154681091|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681092|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
154681093|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
154681094|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
154681095|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681096|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154681097|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
154681098|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
154681099|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
154681100|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154681101|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
154681102|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681103|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681104|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154681105|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
154681106|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
154681107|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154681108|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
154681109|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433122|NCT02234882|Fostemsavir|fostemsavir|mesh-list
154681110|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681111|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154681112|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154681113|NCT02275052|Albuterol|albuterol|mesh-list
154681114|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154681115|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
154681116|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681117|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681118|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154681119|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
154681120|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
154681121|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154681122|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154681123|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154681124|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154681125|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
154681126|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681127|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681128|NCT05649020|Prilocaine|prilocaine|mesh-list
154681129|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
154681130|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
154681131|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154681132|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681133|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
154681134|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681135|NCT04869488|Prednisone|prednisone|mesh-list
154681136|NCT04869488|Apatinib|apatinib|mesh-list
154681137|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
154681138|NCT04869488|Fluzoparib|fluzoparib|mesh-list
154681139|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154681140|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
154681141|NCT04869488|Hormones|hormones|mesh-ancestor
154681142|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681143|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681144|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154681145|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681146|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154681147|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681148|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681149|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154681150|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
154681151|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154681152|NCT04869488|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154681153|NCT02274038|Pemetrexed|pemetrexed|mesh-list
154681154|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681155|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681156|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681157|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154681158|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154681159|NCT01646021|Sirolimus|sirolimus|mesh-list
154681160|NCT01646021|Temsirolimus|temsirolimus|mesh-list
154681161|NCT01646021|MTOR Inhibitors|mtor inhibitors|mesh-list
154681162|NCT01646021|Ibrutinib|ibrutinib|mesh-list
154681163|NCT01646021|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154681164|NCT01646021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154681165|NCT01646021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681166|NCT01646021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681167|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681168|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
154681169|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681170|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681171|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154681172|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681173|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154681174|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
154681175|NCT01750918|Fluorouracil|fluorouracil|mesh-list
154681176|NCT01750918|Panitumumab|panitumumab|mesh-list
154681177|NCT01750918|Trametinib|trametinib|mesh-list
154681178|NCT01750918|Dabrafenib|dabrafenib|mesh-list
154681179|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
154681180|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681181|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154681182|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681183|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681184|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
154681185|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681186|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154681187|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154681188|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681189|NCT01750840|Cimetidine|cimetidine|mesh-list
154681190|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154681191|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154681192|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154681193|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
154681194|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
154681195|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681196|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681197|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681198|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154681199|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154681200|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681201|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154681202|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154681203|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154681204|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154681205|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681206|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154681207|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154681208|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154681209|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
154681210|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681211|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681212|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154681213|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154681214|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
154681215|NCT02269943|Azacitidine|azacitidine|mesh-list
154681216|NCT02269943|Cc-486|cc-486|mesh-list
154681217|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154681218|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
154681219|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681220|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681221|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681222|NCT01605370|Metoprolol|metoprolol|mesh-list
154681223|NCT01605370|Nebivolol|nebivolol|mesh-list
154681224|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154681225|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154681226|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
154681227|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
154681228|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681229|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681230|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154681231|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154681232|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154681233|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
154681234|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681235|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681236|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
154681237|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154681238|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154681239|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154681240|NCT01605136|Afamelanotide|afamelanotide|mesh-list
154681241|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
154681242|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
154681243|NCT01706146|Apixaban|apixaban|mesh-list
154681244|NCT01706146|Dabigatran|dabigatran|mesh-list
154681245|NCT01706146|Anticoagulants|anticoagulants|mesh-list
154681246|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154681247|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
154681248|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154681249|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
154681250|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681251|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681252|NCT02269241|Drospirenone|drospirenone|mesh-list
154681253|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154681254|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
154681255|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681256|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681257|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154433267|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
154681258|NCT02269241|Diuretics|diuretics|mesh-ancestor
154681259|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
154681260|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
154681261|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154681262|NCT01750294|Diuretics|diuretics|mesh-ancestor
154681263|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
154681264|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681265|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154681266|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154681267|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681268|NCT01749982|Choline|choline|mesh-list
154681269|NCT01749982|Betaine|betaine|mesh-list
154681270|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
154681271|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154681272|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
154681273|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681274|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154681275|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154681276|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
154681277|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
154681278|NCT02269163|Antibodies|antibodies|mesh-list
154681279|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
154681280|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154681281|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154681282|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
154681283|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
154681284|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681285|NCT01749826|Morphine|morphine|mesh-list
154681286|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154681287|NCT01749826|Narcotics|narcotics|mesh-ancestor
154681288|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154681289|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681290|NCT01749826|Analgesics|analgesics|mesh-ancestor
154681291|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
154681292|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681293|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
154681294|NCT01724866|Docetaxel|docetaxel|mesh-list
154681295|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681296|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
154681297|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681298|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154681299|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154681300|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
154681301|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681302|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681303|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154681304|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
154681305|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
154681306|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
154681307|NCT02266433|Dexamethasone|dexamethasone|mesh-list
154681308|NCT02266433|Ketorolac|ketorolac|mesh-list
154681309|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154681310|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
154681311|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
154681312|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681313|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681314|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154681315|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
154681316|NCT02266433|Hormones|hormones|mesh-ancestor
154681317|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681318|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154681319|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681320|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154681321|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154681322|NCT02266433|Analgesics|analgesics|mesh-ancestor
154681323|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
154681324|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154681325|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154681326|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681327|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681328|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
154681329|NCT02273726|Hematinics|hematinics|mesh-ancestor
154681330|NCT01723228|Rasagiline|rasagiline|mesh-list
153936048|NCT00838201|Denosumab|denosumab|mesh-list
154681331|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154681332|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681333|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681334|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154681335|NCT01723228|Protective Agents|protective agents|mesh-ancestor
154681336|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681337|NCT02273180|Insulin|insulin|mesh-list
154681338|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154681339|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
154681340|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
154681341|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154681342|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681343|NCT01745380|Phenylephrine|phenylephrine|mesh-list
154681344|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
154681345|NCT01745380|Tetracaine|tetracaine|mesh-list
154681346|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
154681347|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
154681348|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154681349|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681350|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
154681351|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681352|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154681353|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154681354|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
154681355|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681356|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681357|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
154681358|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
154681359|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
154681360|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154681361|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
154681362|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154681363|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
154681364|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154681365|NCT01745380|Protective Agents|protective agents|mesh-ancestor
154681366|NCT05648318|Lactulose|lactulose|mesh-list
154681367|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154681368|NCT02203513|Prexasertib|prexasertib|mesh-list
154681369|NCT02203513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154681370|NCT02203513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681371|NCT02203513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681372|NCT01703260|Pioglitazone|pioglitazone|mesh-list
154681373|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154681374|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681375|NCT02299388|Liraglutide|liraglutide|mesh-list
154681376|NCT02299388|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154681377|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154681378|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681379|NCT02299388|Incretins|incretins|mesh-ancestor
154681380|NCT02299388|Hormones|hormones|mesh-ancestor
154681381|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681382|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
154681383|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
154681384|NCT02202577|Povidone|povidone|mesh-list
153936082|NCT02757040|Ibrutinib|ibrutinib|mesh-list
154681385|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154681386|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681387|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
154681388|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
154681389|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
154681390|NCT01723072|Omalizumab|omalizumab|mesh-list
154681391|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154681392|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154681393|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154681394|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
154681395|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
154681396|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681397|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154681398|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154681399|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681400|NCT02169505|Immunotoxins|immunotoxins|mesh-ancestor
154681401|NCT02169505|Immunoconjugates|immunoconjugates|mesh-ancestor
154681402|NCT02169505|Immunologic Factors|immunologic factors|mesh-ancestor
154681403|NCT02169505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681404|NCT01909791|Aflibercept|aflibercept|mesh-list
154681405|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154681406|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154681407|NCT01909791|Growth Substances|growth substances|mesh-ancestor
154681408|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681409|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
154681410|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433415|NCT02547818|Ibuprofen|ibuprofen|mesh-list
154681411|NCT02202499|Varenicline|varenicline|mesh-list
154681412|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154681413|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154681414|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
154681415|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681416|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681417|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681418|NCT02227849|Canagliflozin|canagliflozin|mesh-list
154681419|NCT02227849|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154681420|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154681421|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681422|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154681423|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681424|NCT02169271|Aspirin|aspirin|mesh-list
154681425|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154681426|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154681427|NCT02169271|Analgesics|analgesics|mesh-ancestor
154681428|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
154681429|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681430|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681431|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154681432|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154681433|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154681434|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154681435|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681436|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154681437|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154681438|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681439|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
153936144|NCT02758990|Niacin|niacin|mesh-list
154681440|NCT01644188|Ezetimibe|ezetimibe|mesh-list
154681441|NCT01644188|Alirocumab|alirocumab|mesh-list
154681442|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154681443|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154681444|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154681445|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
154681446|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681447|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154681448|NCT01644188|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154681449|NCT01644188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154681450|NCT01644188|Protease Inhibitors|protease inhibitors|mesh-ancestor
154681451|NCT01644188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681452|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
154681453|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681454|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
154681455|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
154681456|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681457|NCT02271854|Diclofenac|diclofenac|mesh-list
154681458|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154681459|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154681460|NCT02271854|Analgesics|analgesics|mesh-ancestor
154681461|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
154681462|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681463|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681464|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154681465|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154681466|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154681467|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681468|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681469|NCT02296892|Midazolam|midazolam|mesh-list
154681470|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154681471|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154681472|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154681473|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681474|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154681475|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154681476|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154681477|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154681478|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
154681479|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
154681480|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
154681481|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
154681482|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681483|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681484|NCT02168803|Evacetrapib|evacetrapib|mesh-list
154681485|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154681486|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154433492|NCT02490488|Gemcitabine|gemcitabine|mesh-list
154681488|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681489|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154681490|NCT02201329|Azacitidine|azacitidine|mesh-list
154681491|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154681492|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
154681493|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681494|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681495|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681496|NCT01927419|Nivolumab|nivolumab|mesh-list
154681497|NCT01927419|Ipilimumab|ipilimumab|mesh-list
154681498|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154681499|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681500|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154681501|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681502|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
154681503|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154681504|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681505|NCT01721746|Paclitaxel|paclitaxel|mesh-list
154681506|NCT01721746|Carboplatin|carboplatin|mesh-list
154681507|NCT01721746|Nivolumab|nivolumab|mesh-list
154681508|NCT01721746|Dacarbazine|dacarbazine|mesh-list
154681509|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154681510|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681511|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
154681512|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
154681513|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
154681514|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681515|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154681516|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154681517|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154681518|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
154681519|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
154681520|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681521|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
154681522|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681523|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154681524|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154681525|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
154681526|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681527|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681528|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154681529|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154681530|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
154681531|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681532|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154681533|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
154681534|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681535|NCT02296190|Etripamil|etripamil|mesh-list
154681536|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154681537|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154681538|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681539|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154681540|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681541|NCT04875026|Fluorouracil|fluorouracil|mesh-list
154681542|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
154681543|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681544|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154681545|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681546|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681547|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
154681548|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681549|NCT02296112|Trametinib|trametinib|mesh-list
154681550|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681551|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154681552|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936250|NCT00939627|Cetuximab|cetuximab|mesh-list
154681553|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681554|NCT02269670|Tamoxifen|tamoxifen|mesh-list
154681555|NCT02269670|Everolimus|everolimus|mesh-list
154681556|NCT02269670|Letrozole|letrozole|mesh-list
154681557|NCT02269670|Fulvestrant|fulvestrant|mesh-list
154681558|NCT02269670|Anastrozole|anastrozole|mesh-list
154681559|NCT02269670|Megestrol|megestrol|mesh-list
154681560|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
154681561|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681562|NCT02269670|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154681563|NCT02269670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154681564|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681565|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681566|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
154681567|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681568|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681569|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154681570|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154681571|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154681572|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
154681573|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681574|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154681575|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154681576|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154681577|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154681578|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154681579|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154681580|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154681581|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154681582|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
154681583|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154681584|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154681585|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154681586|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
154681587|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154681588|NCT02225353|Progesterone|progesterone|mesh-list
154681589|NCT02225353|Progestins|progestins|mesh-ancestor
154681590|NCT02225353|Hormones|hormones|mesh-ancestor
154681591|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681592|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681593|NCT01641926|Interferons|interferons|mesh-list
154681594|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
154681595|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
154681596|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154681597|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154681598|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681599|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
154681600|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681601|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
154681602|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681603|NCT02294786|Capecitabine|capecitabine|mesh-list
154681604|NCT02294786|Lapatinib|lapatinib|mesh-list
154681605|NCT02294786|Octreotide|octreotide|mesh-list
154681606|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154681607|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
154681608|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681609|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681610|NCT02294786|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154681611|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154681612|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681613|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154681614|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154681615|NCT04880876|Eluxadoline|eluxadoline|mesh-list
154681616|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154681617|NCT01927341|Panitumumab|panitumumab|mesh-list
154681618|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154681619|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681620|NCT02294474|Insulin|insulin|mesh-list
154681621|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154681622|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
154681623|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
154681624|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154681625|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681626|NCT02168101|Ixazomib|ixazomib|mesh-list
154681627|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681628|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
154681629|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681630|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681631|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154681632|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154681633|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154681634|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
154681635|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681637|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681638|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154681639|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154681640|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
154681641|NCT02298023|Coagulants|coagulants|mesh-ancestor
154681642|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
154681643|NCT02296931|Analgesics|analgesics|mesh-ancestor
154681644|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
154681645|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681646|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681647|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
154681648|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154681649|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154681650|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
154681651|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154681652|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154681653|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681654|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154681655|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
154681656|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154681657|NCT02166697|Candesartan|candesartan|mesh-list
154681658|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
154681659|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154681660|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154681661|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154681662|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681663|NCT02197897|Tamoxifen|tamoxifen|mesh-list
154681664|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154681665|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
154681666|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681667|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681668|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154681669|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681670|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154681671|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154681672|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154681673|NCT02196259|Ketamine|ketamine|mesh-list
154681674|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
154681675|NCT02196259|Anesthetics|anesthetics|mesh-list
154681676|NCT02196259|Analgesics|analgesics|mesh-ancestor
154681677|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
154681678|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681679|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681680|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154681681|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
154681682|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154681683|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154681684|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154681685|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681686|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681687|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
154681688|NCT02294396|Mirabegron|mirabegron|mesh-list
154681689|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154681690|NCT02294396|Propiverine|propiverine|mesh-list
154681691|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154681692|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154681693|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
154681694|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681695|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681696|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681697|NCT02294396|Urological Agents|urological agents|mesh-ancestor
154681698|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154681699|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154681700|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154681701|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
154681702|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
154681703|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
154681704|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681705|NCT02164981|Nitroprusside|nitroprusside|mesh-list
154681706|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154681707|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
154681708|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154681709|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681710|NCT02195869|Ibrutinib|ibrutinib|mesh-list
154681711|NCT02195869|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154681712|NCT02195869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154681713|NCT02195869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681714|NCT02195869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681715|NCT01908699|Beraprost|beraprost|mesh-list
154681716|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154681717|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
154681718|NCT01363011|Darunavir|darunavir|mesh-list
154681719|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154681720|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154681721|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154681722|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
154681723|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681724|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681725|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154681726|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154681727|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
154681728|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681729|NCT02263547|Teriflunomide|teriflunomide|mesh-list
154681730|NCT02263547|Colestipol|colestipol|mesh-list
154681731|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154681732|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154681733|NCT02263547|Analgesics|analgesics|mesh-ancestor
154681734|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
154681735|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681736|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681737|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154681738|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154681739|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681740|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
154681741|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154681742|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
154681743|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681744|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154681745|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
154681746|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
154681747|NCT01925703|Hematinics|hematinics|mesh-ancestor
154681748|NCT01617681|Valsartan|valsartan|mesh-list
154681749|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154681750|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154681751|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154681752|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681753|NCT02263079|Interferons|interferons|mesh-list
154681754|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
154681755|NCT02263079|Lamivudine|lamivudine|mesh-list
154681756|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
154681757|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154681758|NCT02263079|Entecavir|entecavir|mesh-list
154681759|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681760|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
154681761|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681762|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
154681763|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681764|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154681765|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154681766|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681767|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681768|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154681769|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154681770|NCT02260817|Choline|choline|mesh-list
154681771|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
154681772|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154681773|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
154681774|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681775|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154681776|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154681777|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
154681778|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154681779|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681780|NCT01642589|Vaccines|vaccines|mesh-list
154681781|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
154681782|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433796|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
154681784|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
154681785|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681786|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154681787|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154681788|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681789|NCT02257385|Albuterol|albuterol|mesh-list
154681790|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
154681791|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154681792|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
154681793|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681794|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681795|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154681796|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
154681797|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
154681798|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154681799|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
154681800|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681801|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681802|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
154681803|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154681804|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154681805|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154681806|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154681807|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
154681808|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154681809|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
154681810|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681811|NCT01645280|Methotrexate|methotrexate|mesh-list
154681812|NCT01645280|Ustekinumab|ustekinumab|mesh-list
154681813|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154681814|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
154681815|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154681816|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681817|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154681818|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
154681819|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681820|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681821|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
154681822|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681823|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154681824|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154681825|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
154681826|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154681827|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154681828|NCT01629589|Vaccines|vaccines|mesh-list
154681829|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
154681830|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681831|NCT04188223|Vaccines|vaccines|mesh-list
154681832|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
154681833|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681834|NCT02220907|Canagliflozin|canagliflozin|mesh-list
154681835|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154681836|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681837|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154681838|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681839|NCT01601873|Heparin|heparin|mesh-list
154681840|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
154681841|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154681842|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154681843|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681844|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
154681845|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
154681846|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681847|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681848|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681849|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
154681850|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
154681851|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
154681852|NCT04420247|Chloroquine|chloroquine|mesh-list
154681853|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
154681854|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154681855|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154681856|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681857|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681858|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681859|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154681860|NCT04420247|Amebicides|amebicides|mesh-ancestor
154681861|NCT01644890|Paclitaxel|paclitaxel|mesh-list
154681862|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154681863|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936574|NCT04267653|Lactoferrin|lactoferrin|mesh-list
154681864|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
154681865|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
154681866|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
154681867|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681868|NCT04865237|Remdesivir|remdesivir|mesh-list
154681869|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
154681870|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681871|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
154681872|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681873|NCT01628965|Rotigotine|rotigotine|mesh-list
154681874|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
154681875|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
154681876|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681877|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681878|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681879|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
154681880|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154681881|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
154681882|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154681883|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681884|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154681885|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154681886|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
154681887|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154681888|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
154681889|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154681890|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681891|NCT02255279|Vaccines|vaccines|mesh-list
154681892|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
154681893|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681894|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154681895|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154681896|NCT02266706|Tazobactam|tazobactam|mesh-list
154681897|NCT02266706|Ceftolozane|ceftolozane|mesh-list
154681898|NCT02266706|Cephalosporins|cephalosporins|mesh-list
154681899|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154681900|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
154681901|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154681902|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681903|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154681904|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681905|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681906|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154681907|NCT02292719|Ritonavir|ritonavir|mesh-list
154681908|NCT02292719|Ribavirin|ribavirin|mesh-list
154681909|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
154681910|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154681911|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154681912|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
154681913|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681914|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681915|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154681916|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154681917|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
154681918|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154681919|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154681920|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154681921|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
154681922|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
154681923|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154681924|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
154681925|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154681926|NCT02264990|Paclitaxel|paclitaxel|mesh-list
154681927|NCT02264990|Carboplatin|carboplatin|mesh-list
154681928|NCT02264990|Pemetrexed|pemetrexed|mesh-list
154681929|NCT02264990|Veliparib|veliparib|mesh-list
154681930|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154681931|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681932|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
154681933|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
154681934|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
154681935|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681936|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681937|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154681938|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154681939|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154681940|NCT02289833|Trastuzumab|trastuzumab|mesh-list
154681941|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154681942|NCT02289833|Maytansine|maytansine|mesh-list
154681943|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154681944|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681945|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154681946|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
154681947|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
154681948|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
154681949|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681950|NCT02289833|Immunotoxins|immunotoxins|mesh-ancestor
154681951|NCT02289833|Immunoconjugates|immunoconjugates|mesh-ancestor
154681952|NCT02289833|Immunologic Factors|immunologic factors|mesh-ancestor
154681953|NCT02289833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681954|NCT01702558|Capecitabine|capecitabine|mesh-list
154681955|NCT01702558|Trastuzumab|trastuzumab|mesh-list
154681956|NCT01702558|Maytansine|maytansine|mesh-list
154681957|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154681958|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154681959|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
154681960|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681961|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154681962|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154681963|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154681964|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
154681965|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
154681966|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
154681967|NCT01702558|Immunotoxins|immunotoxins|mesh-ancestor
154681968|NCT01702558|Immunoconjugates|immunoconjugates|mesh-ancestor
154681969|NCT01702558|Immunologic Factors|immunologic factors|mesh-ancestor
154681970|NCT01702558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681971|NCT02194465|Spironolactone|spironolactone|mesh-list
154681972|NCT02194465|Tadalafil|tadalafil|mesh-list
154681973|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154681974|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
154681975|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
154681976|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154681977|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154681978|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681979|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681980|NCT02194465|Urological Agents|urological agents|mesh-ancestor
154681981|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
154681982|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681983|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681984|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154681985|NCT02194465|Diuretics|diuretics|mesh-ancestor
154681986|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
154681987|NCT02194465|Hormones|hormones|mesh-ancestor
154681988|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154681989|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154681990|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154681991|NCT01720264|Incretins|incretins|mesh-ancestor
154681992|NCT01720264|Hormones|hormones|mesh-ancestor
154681993|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154681994|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154681995|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
154681996|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154681997|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154681998|NCT04564846|Insulin|insulin|mesh-list
154681999|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154682000|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682001|NCT01702246|Simvastatin|simvastatin|mesh-list
154682002|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154682003|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154682004|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
154682005|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682006|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154682007|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154434016|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
154682008|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682009|NCT01631227|Eprosartan|eprosartan|mesh-list
154682010|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154682011|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
154682012|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154682013|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682014|NCT01719172|Hemostatics|hemostatics|mesh-list
154682015|NCT01719172|Coagulants|coagulants|mesh-ancestor
154682016|NCT02285855|Metformin|metformin|mesh-list
154682017|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154682018|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682019|NCT02285153|Aspirin|aspirin|mesh-list
154682020|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
154682021|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154682022|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154682023|NCT02285153|Analgesics|analgesics|mesh-ancestor
154682024|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
154682025|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682026|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682027|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682028|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682029|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154682030|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154682031|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682032|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154682033|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154682034|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682035|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
154682036|NCT01632241|Belimumab|belimumab|mesh-list
154682037|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154682038|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
154682039|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682040|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
154682041|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154682042|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682043|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682044|NCT02263508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154682045|NCT02263508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682046|NCT01741792|Blinatumomab|blinatumomab|mesh-list
154682047|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682048|NCT02289950|Farletuzumab|farletuzumab|mesh-list
154682049|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682050|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154682051|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
154682052|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154682053|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154682054|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154682055|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682056|NCT01740388|Besifloxacin|besifloxacin|mesh-list
154682057|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154682058|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682059|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154682060|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154682061|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682062|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682063|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682064|NCT01740154|Sunitinib|sunitinib|mesh-list
154682065|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682066|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154682067|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154682068|NCT01740154|Growth Substances|growth substances|mesh-ancestor
154682069|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682070|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
154682071|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154682072|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682073|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682074|NCT02287610|Prednisone|prednisone|mesh-list
154682075|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682076|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
154682077|NCT02287610|Hormones|hormones|mesh-ancestor
154682078|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682079|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682080|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682081|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682082|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
154682083|NCT02262728|Simeprevir|simeprevir|mesh-list
154682084|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
154682085|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682086|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
154682087|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682088|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682089|NCT01717768|Testosterone|testosterone|mesh-list
154682090|NCT01717768|Androgens|androgens|mesh-ancestor
154682091|NCT01717768|Hormones|hormones|mesh-ancestor
154682092|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682093|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682094|NCT02260934|Acetaminophen|acetaminophen|mesh-list
154682095|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
154682096|NCT02260934|Promethazine|promethazine|mesh-list
154682097|NCT02260934|Prednisone|prednisone|mesh-list
154682098|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
154682099|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154682100|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154682101|NCT02260934|Prednisolone|prednisolone|mesh-list
154682102|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
154682103|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
154682104|NCT02260934|Rituximab|rituximab|mesh-list
154682105|NCT02260934|Belimumab|belimumab|mesh-list
154682106|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154682107|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
154682108|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154682109|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
154682110|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682111|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682112|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154682113|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
154682114|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682115|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682116|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154682117|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682118|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682119|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
154682120|NCT02260934|Hormones|hormones|mesh-ancestor
154682121|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682122|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682123|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154682124|NCT02260934|Analgesics|analgesics|mesh-ancestor
154682125|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
154682126|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682127|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
154682128|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
154682129|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
154682130|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682131|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154682132|NCT02260934|Protective Agents|protective agents|mesh-ancestor
154682133|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154682134|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154682135|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154682136|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
154682137|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
154682138|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154682139|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
154682140|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
154682141|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682142|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154682143|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
154682144|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154682145|NCT02260388|Mexiletine|mexiletine|mesh-list
154682146|NCT02260388|Pregabalin|pregabalin|mesh-list
154682147|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154682148|NCT02260388|Nortriptyline|nortriptyline|mesh-list
154682149|NCT02260388|Analgesics|analgesics|mesh-ancestor
154682150|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
154682151|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682152|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682153|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
154682154|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154682155|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154682156|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434164|NCT06091475|Eplerenone|eplerenone|mesh-list
154682157|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154682158|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154682159|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154682160|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154682161|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154682162|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154682163|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154682164|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682165|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
154682166|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
154682167|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154682168|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154682169|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
154682170|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154682171|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154682172|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154682173|NCT02260154|Mebeverine|mebeverine|mesh-list
154682174|NCT02260154|Alverine|alverine|mesh-list
154682175|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
154682176|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
154682177|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
154682178|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682179|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682180|NCT01643408|Asparaginase|asparaginase|mesh-list
154682181|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682182|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
154682183|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154682184|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154682185|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682186|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154682187|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154682188|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682189|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682190|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682191|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
154682192|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154682193|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154682194|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154682195|NCT01739764|Vemurafenib|vemurafenib|mesh-list
154682196|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682197|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154682198|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936908|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682199|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682200|NCT01700530|Simvastatin|simvastatin|mesh-list
154682201|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154682202|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154682203|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154682204|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
154682205|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682206|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154682207|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682208|NCT01717456|Loperamide|loperamide|mesh-list
154682209|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
154682210|NCT01717456|Laxatives|laxatives|mesh-list
154682211|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682212|NCT01716754|Omalizumab|omalizumab|mesh-list
154682213|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154682214|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682215|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682216|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154682217|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154682218|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154682219|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154682220|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154682221|NCT01698814|Analgesics|analgesics|mesh-ancestor
154682222|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
154682223|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682224|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682225|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682226|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682227|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154682228|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154682229|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154682230|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
154682231|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
154682232|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860339|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682233|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682234|NCT01738594|Romidepsin|romidepsin|mesh-list
154682235|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154682236|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682237|NCT01738594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154682238|NCT01738594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682239|NCT01738594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682240|NCT01697956|Beclomethasone|beclomethasone|mesh-list
154682241|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682242|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
154682243|NCT01697956|Hormones|hormones|mesh-ancestor
154682244|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682245|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682246|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682247|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682248|NCT01697800|Tadalafil|tadalafil|mesh-list
154682249|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
154682250|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154682251|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154682252|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682253|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682254|NCT01697800|Urological Agents|urological agents|mesh-ancestor
154682255|NCT01644500|Glimepiride|glimepiride|mesh-list
154682256|NCT01644500|Dulaglutide|dulaglutide|mesh-list
154682257|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154682258|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154682259|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682260|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154682261|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
154682262|NCT01644500|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154682263|NCT01604824|Alirocumab|alirocumab|mesh-list
154682264|NCT01604824|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154682265|NCT01604824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154682266|NCT01604824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154682267|NCT01604824|Antimetabolites|antimetabolites|mesh-ancestor
154682268|NCT01604824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682269|NCT01604824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154682270|NCT01604824|Protease Inhibitors|protease inhibitors|mesh-ancestor
154682271|NCT01604824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682272|NCT01604824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154682273|NCT01716052|Ibuprofen|ibuprofen|mesh-list
154682274|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154682275|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154682276|NCT01716052|Analgesics|analgesics|mesh-ancestor
154682277|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
154682278|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682279|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682280|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682281|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682282|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154682283|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682284|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682285|NCT01641692|Albuterol|albuterol|mesh-list
154682286|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154682287|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
154682288|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682289|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682290|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682291|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682292|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
154682293|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154682294|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154682295|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154682296|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154682297|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
154682298|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682299|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682300|NCT01682512|Rituximab|rituximab|mesh-list
154682301|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682302|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682303|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
154682304|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682305|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682306|NCT04863716|Fentanyl|fentanyl|mesh-list
154682307|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154682308|NCT04863716|Narcotics|narcotics|mesh-ancestor
154682309|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154682310|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682311|NCT04863716|Analgesics|analgesics|mesh-ancestor
154682312|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
154682313|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682314|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154682315|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154682316|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
154682317|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
154682318|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
153937023|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
154682319|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682320|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682321|NCT04135352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154682322|NCT04135352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682323|NCT01715896|Golimumab|golimumab|mesh-list
154682324|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
154682325|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154682326|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682327|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154682328|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
154682329|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682330|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682331|NCT05642702|Vitamins|vitamins|mesh-list
154682332|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
154682333|NCT05642702|Niacinamide|niacinamide|mesh-list
154682334|NCT05642702|Niacin|niacin|mesh-list
154682335|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
154682336|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154682337|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
154682338|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682339|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
154682340|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682341|NCT05642702|Protective Agents|protective agents|mesh-ancestor
154682342|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
154682343|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154682344|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
154682345|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154682346|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
154682347|NCT02254772|Ipilimumab|ipilimumab|mesh-list
154682348|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682349|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682350|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154682351|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682352|NCT01682044|Rituximab|rituximab|mesh-list
154682353|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682354|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682355|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
154682356|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682357|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682358|NCT05640596|Betamethasone|betamethasone|mesh-list
154682359|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682360|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
154682361|NCT05640596|Hormones|hormones|mesh-ancestor
154682362|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682363|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682364|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682365|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682366|NCT01696942|Mesalamine|mesalamine|mesh-list
154682367|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682368|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682369|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682370|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154682371|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154682372|NCT01696942|Analgesics|analgesics|mesh-ancestor
153937082|NCT02613013|Pilocarpine|pilocarpine|mesh-list
154682373|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
154682374|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682375|NCT04871204|Octreotide|octreotide|mesh-list
154682376|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682377|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682378|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682379|NCT05650268|Vitamin D|vitamin d|mesh-list
154682380|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
154682381|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
154682382|NCT05650268|Vitamins|vitamins|mesh-list
154682383|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
154860340|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
154682384|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682385|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154682386|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154682388|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
154682389|NCT04835870|Rituximab|rituximab|mesh-list
154682390|NCT04835870|Doxorubicin|doxorubicin|mesh-list
154682391|NCT04835870|Vincristine|vincristine|mesh-list
154682392|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
154682393|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154682394|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
154682395|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682396|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682397|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154682398|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
154682399|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682400|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682401|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154682402|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682403|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154682404|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154682405|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154682406|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682407|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682408|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
154682409|NCT04835870|Hormones|hormones|mesh-ancestor
154682410|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682411|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682412|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154682413|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
154682414|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
154682415|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
154682416|NCT04835870|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154682417|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154682418|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154682419|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
154682420|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682421|NCT04834310|Clindamycin|clindamycin|mesh-list
154682422|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
154682423|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
154682424|NCT04834310|Cefazolin|cefazolin|mesh-list
154682425|NCT04834310|Cephalexin|cephalexin|mesh-list
154682426|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154682427|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682428|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154682429|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682430|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682431|NCT05372198|Immunomodulating Agents|immunomodulating agents|mesh-list
154682432|NCT05372198|Immunologic Factors|immunologic factors|mesh-ancestor
154682433|NCT05372198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682434|NCT05359406|Tislelizumab|tislelizumab|mesh-list
154682435|NCT05359406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682436|NCT05359406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682437|NCT04654208|Palbociclib|palbociclib|mesh-list
154682438|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682439|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154682440|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682441|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682442|NCT04844216|Lidocaine|lidocaine|mesh-list
154682443|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
154682444|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
154682445|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
154682446|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154682447|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682448|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
154682449|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682450|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154682451|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154682452|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154682453|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154682454|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682455|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154682456|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
154682457|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
154682458|NCT04844216|Protective Agents|protective agents|mesh-ancestor
154682459|NCT05345678|Durvalumab|durvalumab|mesh-list
154682460|NCT05345678|Tremelimumab|tremelimumab|mesh-list
154682461|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682462|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682463|NCT05327738|Atezolizumab|atezolizumab|mesh-list
154682464|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154682465|NCT05327738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154682466|NCT05327738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682467|NCT05327738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682468|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682469|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
154682470|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682471|NCT04419662|Phenylephrine|phenylephrine|mesh-list
154682472|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
154682473|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154682474|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
154682475|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
154682476|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682477|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682478|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
154682479|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154682480|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
154682481|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682482|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154682483|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154682484|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154682485|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
154682486|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682487|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682488|NCT04419662|Protective Agents|protective agents|mesh-ancestor
154682489|NCT04589546|Niacinamide|niacinamide|mesh-list
154682490|NCT04589546|Niacin|niacin|mesh-list
154682491|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
154682492|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
154682493|NCT04589546|Vitamins|vitamins|mesh-ancestor
154682494|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
154682495|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682496|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154682497|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
154682498|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682499|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154682500|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
154682501|NCT02164513|Fluticasone|fluticasone|mesh-list
154682502|NCT02164513|Xhance|xhance|mesh-list
154682503|NCT02164513|Bromides|bromides|mesh-list
154682504|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682505|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154682506|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
154682507|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682508|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682509|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682510|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682511|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
154682512|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154682513|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
154682514|NCT04513184|Dexamethasone|dexamethasone|mesh-list
154682515|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
154682516|NCT04513184|BB 1101|bb 1101|mesh-list
154682517|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682518|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
154682519|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
154682520|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682521|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682522|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682523|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
154682524|NCT04513184|Hormones|hormones|mesh-ancestor
154682525|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682526|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682527|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682528|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
154682529|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682530|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682531|NCT04756531|Nirmatrelvir|nirmatrelvir|mesh-list
154682532|NCT04756531|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154682533|NCT04756531|Protease Inhibitors|protease inhibitors|mesh-ancestor
154682534|NCT04756531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860341|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
154682535|NCT04756531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682536|NCT04756531|Antiviral Agents|antiviral agents|mesh-ancestor
154682537|NCT04756531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682538|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154682539|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154682540|NCT01713946|Everolimus|everolimus|mesh-list
154682541|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
154682542|NCT01713946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154682543|NCT01713946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154682544|NCT01713946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682545|NCT01713946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682546|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154682547|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
154682548|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682549|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682550|NCT04464512|Sufentanil|sufentanil|mesh-list
154682551|NCT04464512|Buprenorphine|buprenorphine|mesh-list
153937272|NCT02737696|Analgesics|analgesics|mesh-ancestor
154682552|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154682553|NCT04464512|Narcotics|narcotics|mesh-ancestor
154682554|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154682555|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682556|NCT04464512|Analgesics|analgesics|mesh-ancestor
154682557|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
154682558|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682559|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154682560|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154682561|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154682562|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
154682563|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
154682564|NCT02191579|Topiramate|topiramate|mesh-list
154682565|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
154682566|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154682567|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154682568|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154682569|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154682570|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682571|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
154682572|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682573|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682574|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154682575|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682576|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
154682577|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154682578|NCT05324462|Xultophy|xultophy|mesh-list
154682579|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154682580|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682581|NCT05324462|Incretins|incretins|mesh-ancestor
154682582|NCT05324462|Hormones|hormones|mesh-ancestor
154682583|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682584|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154682585|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154682586|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154682587|NCT01363700|Epinastine|epinastine|mesh-list
154682588|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154682589|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154682590|NCT01363700|Analgesics|analgesics|mesh-ancestor
154682591|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
154682592|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682593|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682594|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682595|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682596|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154682597|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154682598|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154682599|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
154682600|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
154682601|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682602|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682603|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
154682604|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682605|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682606|NCT04372706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154682607|NCT04372706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682608|NCT04178642|Idarubicin|idarubicin|mesh-list
154682609|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
154682610|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154682611|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682612|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154682613|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154682614|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682615|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682616|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
154682617|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
154682618|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154682619|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682620|NCT04791566|Dexamethasone|dexamethasone|mesh-list
154682621|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682622|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
154682623|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
154682624|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682625|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682626|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682627|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
154682628|NCT04791566|Hormones|hormones|mesh-ancestor
154682629|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682630|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682631|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682632|NCT04129736|Teriflunomide|teriflunomide|mesh-list
154682633|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154682634|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154682635|NCT04129736|Analgesics|analgesics|mesh-ancestor
154682636|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
154682637|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682638|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682639|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682640|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682641|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154682642|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
154682643|NCT01637402|Prednisone|prednisone|mesh-list
154682644|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
154682645|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682646|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
154682647|NCT01637402|Hormones|hormones|mesh-ancestor
154682648|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682649|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682650|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682651|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682652|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154682653|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682654|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682655|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
154682656|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154682657|NCT04419038|Mitomycins|mitomycins|mesh-list
154682658|NCT04419038|Mitomycin|mitomycin|mesh-list
154682659|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154682660|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682661|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
154682662|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937397|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154682663|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154682664|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682665|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
154682666|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154682667|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682668|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154682669|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154682670|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
154682671|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682672|NCT04818944|Tirofiban|tirofiban|mesh-list
154682673|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154682674|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154682675|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682676|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154682677|NCT02189941|Deferiprone|deferiprone|mesh-list
154682678|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154682679|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
154682680|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
154682681|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682682|NCT01601132|Colchicine|colchicine|mesh-list
154682683|NCT01601132|Theophylline|theophylline|mesh-list
154682684|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
154682685|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682686|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
154682687|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
154682688|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
154682689|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682690|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682691|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154682692|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
154682693|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682694|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682695|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682696|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682697|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154682698|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682699|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
154682700|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154682701|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154682702|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
154682703|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682704|NCT04836962|Dexamethasone|dexamethasone|mesh-list
154682705|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682706|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
154682707|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
154682708|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682709|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682710|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682711|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
154682713|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682714|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682715|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682716|NCT05289440|Esketamine|esketamine|mesh-list
154682717|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
154682718|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154682719|NCT04691960|Metformin|metformin|mesh-list
154682720|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154682721|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682722|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
154682723|NCT04809038|Analgesics|analgesics|mesh-ancestor
154682724|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
154682725|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682726|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682727|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
154682728|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154682729|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154682730|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
154682731|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154682732|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154682733|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682734|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154682735|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
154682736|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154682737|NCT05221190|Lidocaine|lidocaine|mesh-list
154682738|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
154682739|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
154682740|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154682741|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682742|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
154682743|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682744|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154682745|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154682746|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154682747|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154682748|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682749|NCT04816682|Silymarin|silymarin|mesh-list
154682750|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
154682751|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682752|NCT04816682|Protective Agents|protective agents|mesh-ancestor
154682753|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682754|NCT02162719|Paclitaxel|paclitaxel|mesh-list
154682755|NCT02162719|Ipatasertib|ipatasertib|mesh-list
154682756|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154682757|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682758|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
154682759|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
154682760|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
154682761|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682762|NCT02162719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154682763|NCT02162719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682765|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154682766|NCT04808882|Dalteparin|dalteparin|mesh-list
154682767|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
154682768|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154682769|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154682770|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682771|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
154682772|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154682773|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682774|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154682775|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154682776|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154682777|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
154682778|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682779|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682780|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682781|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682782|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154682783|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154682784|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154682785|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
154682786|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682787|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682788|NCT03029000|Lenograstim|lenograstim|mesh-list
154682789|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154682790|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
154682791|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682792|NCT03783182|Betamethasone|betamethasone|mesh-list
154682793|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
154682794|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154682795|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
154682796|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154682797|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
154682798|NCT03783182|Hormones|hormones|mesh-ancestor
154682799|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682800|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682801|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682802|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682803|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682804|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
154682805|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154682806|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682807|NCT05651750|Fluticasone|fluticasone|mesh-list
154682808|NCT05651750|Xhance|xhance|mesh-list
154682809|NCT05651750|Montelukast|montelukast|mesh-list
154682810|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682811|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154682812|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
154682813|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682814|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682815|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682816|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682817|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
154682818|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154682819|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154682820|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
154682821|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682822|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154682823|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154682824|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682825|NCT02160145|Tolvaptan|tolvaptan|mesh-list
154682826|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154682827|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682828|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
154682829|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682830|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
154682831|NCT02216071|Dexamethasone|dexamethasone|mesh-list
154682832|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
154682833|NCT02216071|BB 1101|bb 1101|mesh-list
154682834|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682835|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
154682836|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
154682837|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682838|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682839|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682840|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
154682841|NCT02216071|Hormones|hormones|mesh-ancestor
154682842|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682843|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682844|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937594|NCT02730364|Phenylephrine|phenylephrine|mesh-list
154682845|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
154682846|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682847|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682848|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154682849|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682850|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154682851|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154682852|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154682853|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154682854|NCT01681576|Valsartan|valsartan|mesh-list
154682855|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154682856|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154682857|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154682858|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154682859|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682860|NCT02188459|Bupropion|bupropion|mesh-list
154682861|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154682862|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
154682863|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154682864|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154682865|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154682866|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154682867|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682868|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
154682869|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682870|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682871|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154682872|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154682873|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682874|NCT02743364|Simvastatin|simvastatin|mesh-list
154682875|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154682876|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154682877|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
154682878|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682879|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154682880|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154682881|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682882|NCT02214121|Ticagrelor|ticagrelor|mesh-list
154682883|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154682884|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154682885|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154682886|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154682887|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
154682888|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154682889|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682890|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682891|NCT01681186|Lansoprazole|lansoprazole|mesh-list
154682892|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
154682893|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154682894|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682895|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154682896|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682897|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682898|NCT01695772|Bevacizumab|bevacizumab|mesh-list
154682899|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154682900|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682901|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154682902|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154682903|NCT01695772|Growth Substances|growth substances|mesh-ancestor
154860342|NCT01921868|Vitamins|vitamins|mesh-ancestor
154682904|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682905|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
154682906|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154682907|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154682908|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154682909|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682910|NCT01636934|Minocycline|minocycline|mesh-list
154682911|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154682912|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682913|NCT01712854|Budesonide|budesonide|mesh-list
154682914|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154682915|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682916|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154682917|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
154682918|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682919|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682920|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154682921|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
154682922|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
154682923|NCT01712854|Hormones|hormones|mesh-ancestor
154682924|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682925|NCT02986594|Aspirin|aspirin|mesh-list
154682926|NCT02986594|Heparin|heparin|mesh-list
154682927|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154682928|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154682929|NCT02986594|Analgesics|analgesics|mesh-ancestor
154682930|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
154682931|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682932|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682933|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682934|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154682935|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154682936|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154682937|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682938|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154682939|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154682940|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682941|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
154682942|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
154682943|NCT02159365|Dexamethasone|dexamethasone|mesh-list
154682944|NCT02159365|Lenalidomide|lenalidomide|mesh-list
154682945|NCT02159365|Elotuzumab|elotuzumab|mesh-list
154682946|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682947|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
154682948|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
154682949|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682950|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682951|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154682952|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
154682953|NCT02159365|Hormones|hormones|mesh-ancestor
154682954|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682955|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682956|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682957|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
154682958|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154682959|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154682960|NCT02159365|Growth Substances|growth substances|mesh-ancestor
154682961|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
154682962|NCT02072200|Prednisone|prednisone|mesh-list
154682963|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154682964|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
154682965|NCT02072200|Hormones|hormones|mesh-ancestor
154682966|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154682967|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682968|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154682969|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682970|NCT01691794|Ritonavir|ritonavir|mesh-list
154682971|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154682972|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154682973|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154682974|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
154682975|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682976|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682977|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154682978|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154682979|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
154682980|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154682981|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154682982|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154682983|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154682984|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
154682985|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682986|NCT02158975|Ixazomib|ixazomib|mesh-list
154682987|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154682988|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
154682989|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154682990|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154682991|NCT02158039|Ethanol|ethanol|mesh-list
154682992|NCT02158039|Lidocaine|lidocaine|mesh-list
154682993|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
154682994|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
154682995|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154682996|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154682997|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
154682998|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154682999|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154683000|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154683001|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154683002|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683003|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683004|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154683005|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683006|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154683007|NCT03563222|SMOFlipid|smoflipid|mesh-list
154683008|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154683009|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154683010|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154683011|NCT02490800|Lisavanbulin|lisavanbulin|mesh-list
153937764|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
154683012|NCT02490800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154683013|NCT02490800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683014|NCT02490800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154683015|NCT02490800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683016|NCT01635764|Adalimumab|adalimumab|mesh-list
154683017|NCT01635764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154683018|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683019|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683020|NCT04810598|Venetoclax|venetoclax|mesh-list
154683021|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683022|NCT02158052|Tacrolimus|tacrolimus|mesh-list
154683023|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154683024|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683025|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
154683026|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683027|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154683028|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683029|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683030|NCT01635218|Fluoxetine|fluoxetine|mesh-list
154683031|NCT01635218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154683032|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154683033|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683034|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683035|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683036|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
154683037|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683038|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154683039|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
154683040|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154683041|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154683042|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154683043|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683044|NCT05351684|Dolutegravir|dolutegravir|mesh-list
154683045|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154683046|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154683047|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683048|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683049|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154683050|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154683051|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
154683052|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683054|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154683055|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683056|NCT04274894|Testosterone|testosterone|mesh-list
154683057|NCT04274894|Androgens|androgens|mesh-ancestor
154683058|NCT04274894|Hormones|hormones|mesh-ancestor
154683059|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154683060|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683061|NCT04786964|Folic Acid|folic acid|mesh-list
154683062|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
154683063|NCT04786964|Dexamethasone|dexamethasone|mesh-list
154683064|NCT04786964|Carboplatin|carboplatin|mesh-list
154683065|NCT04786964|Pemetrexed|pemetrexed|mesh-list
154683066|NCT04786964|Vitamins|vitamins|mesh-ancestor
154683067|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
154683068|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683069|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683070|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683071|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
154683072|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
154683073|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683074|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154683075|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
154683076|NCT04786964|Hormones|hormones|mesh-ancestor
154683077|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154683078|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154683079|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683080|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683081|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154683082|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154683083|NCT04786964|Hematinics|hematinics|mesh-ancestor
154683084|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
154683085|NCT02213263|Rituximab|rituximab|mesh-list
154683086|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154683087|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683088|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
154683089|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683090|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683091|NCT04216784|Furosemide|furosemide|mesh-list
154683092|NCT04216784|Diuretics|diuretics|mesh-ancestor
154683093|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
154683094|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683095|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154683096|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683097|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683098|NCT01975064|Propofol|propofol|mesh-list
154683099|NCT01975064|Sevoflurane|sevoflurane|mesh-list
154683100|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154683101|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683102|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683103|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154683104|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
154683105|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
154683106|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154683107|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154683108|NCT02210689|Clindamycin|clindamycin|mesh-list
154683109|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
154683110|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
154683111|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683112|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683113|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154683114|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683115|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683116|NCT02209597|Bupropion|bupropion|mesh-list
154683117|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154683118|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
154683119|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154683120|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154683121|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154683122|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683123|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683124|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
154683125|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683126|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683127|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154683128|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154683129|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683130|NCT01469156|Ranibizumab|ranibizumab|mesh-list
154683131|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154683132|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154683133|NCT01469156|Growth Substances|growth substances|mesh-ancestor
154683134|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683135|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
154683136|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683137|NCT04191434|Budesonide|budesonide|mesh-list
154683138|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
154683139|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154683140|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683141|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154683142|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
154683143|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683144|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937914|NCT01121393|Gemcitabine|gemcitabine|mesh-list
154683145|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154683146|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
154683147|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
154683148|NCT04191434|Hormones|hormones|mesh-ancestor
154683149|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154683150|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154683151|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154683152|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154683153|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
154683154|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683155|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683156|NCT03835676|Treprostinil|treprostinil|mesh-list
154683157|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154683158|NCT03651128|Dexamethasone|dexamethasone|mesh-list
154683159|NCT03651128|Lenalidomide|lenalidomide|mesh-list
154683160|NCT03651128|Bortezomib|bortezomib|mesh-list
154683161|NCT03651128|Daratumumab|daratumumab|mesh-list
154683162|NCT03651128|Pomalidomide|pomalidomide|mesh-list
154683163|NCT03651128|Ixazomib|ixazomib|mesh-list
154683164|NCT03651128|Elotuzumab|elotuzumab|mesh-list
154683165|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683166|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
154683167|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
154683168|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683169|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683170|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154683171|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
154683172|NCT03651128|Hormones|hormones|mesh-ancestor
154683173|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154683174|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154683175|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683176|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
154683177|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154683178|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154683179|NCT03651128|Growth Substances|growth substances|mesh-ancestor
154683180|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
154683181|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
154683182|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683183|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683184|NCT00664898|Bortezomib|bortezomib|mesh-list
154683185|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683186|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154683187|NCT04776980|Hematinics|hematinics|mesh-ancestor
154683188|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154683189|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154683190|NCT02187055|Adalimumab|adalimumab|mesh-list
154683191|NCT02187055|Methotrexate|methotrexate|mesh-list
154683192|NCT02187055|Tofacitinib|tofacitinib|mesh-list
154683193|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154683194|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
154683195|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154683196|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683197|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154683198|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
154683199|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683200|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683201|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
154683202|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683203|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154683204|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683205|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
154683206|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683207|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154683208|NCT02187055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154683209|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683210|NCT02187055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154683211|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154683212|NCT00119366|Iodine|iodine|mesh-list
154683213|NCT00119366|Cyclosporine|cyclosporine|mesh-list
154683214|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
154683215|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154683216|NCT00119366|Fludarabine|fludarabine|mesh-list
154683217|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
154683218|NCT00119366|Antibodies|antibodies|mesh-list
154683219|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
154683220|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154683221|NCT00119366|Cyclosporins|cyclosporins|mesh-list
154683222|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
154683223|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683224|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683225|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154683226|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
154683227|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683228|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683229|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683230|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
154683231|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683232|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
154683233|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683234|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154683235|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154683236|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154683237|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
154683238|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683239|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154683240|NCT00119366|Trace Elements|trace elements|mesh-ancestor
154683241|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
154683242|NCT02246660|Resveratrol|resveratrol|mesh-list
154683243|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
154683244|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683245|NCT02246660|Protective Agents|protective agents|mesh-ancestor
154683246|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683247|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683248|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154683249|NCT02246582|Insulin|insulin|mesh-list
154683250|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154683251|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683252|NCT02137369|Dexetimide|dexetimide|mesh-list
154683253|NCT02137369|Citalopram|citalopram|mesh-list
154683254|NCT02137369|Sertraline|sertraline|mesh-list
154683255|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
154683256|NCT02137369|Escitalopram|escitalopram|mesh-list
154683257|NCT02137369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154683258|NCT02137369|Serotonin|serotonin|mesh-list
154683259|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154683260|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683261|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683262|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683263|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
154683264|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683265|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154683266|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154683267|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
154683268|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
154683269|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683270|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154683271|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154683272|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
154683273|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154683274|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154683275|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154683276|NCT02155309|Scopolamine|scopolamine|mesh-list
154683277|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154683278|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154683279|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
154683280|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
154683281|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683282|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683283|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154683284|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
154683285|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154683286|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
154683287|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683288|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683289|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154683290|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
154683291|NCT02186821|Ceritinib|ceritinib|mesh-list
154683292|NCT02186821|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154683293|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154683294|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683295|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683296|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683297|NCT01710358|Adalimumab|adalimumab|mesh-list
154683298|NCT01710358|Methotrexate|methotrexate|mesh-list
154683299|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154683300|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
154683301|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154683302|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683303|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154683304|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
154683305|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683306|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683307|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
154683308|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683309|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154683310|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683311|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
154683312|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683313|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154683314|NCT01710358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154683315|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683316|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
154683317|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154683318|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
154683319|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154683320|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683321|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683322|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
154683323|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683324|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154683325|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683326|NCT03455270|Palbociclib|palbociclib|mesh-list
154683327|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683328|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154683329|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683330|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683331|NCT01691482|Albuterol|albuterol|mesh-list
154683332|NCT01691482|Ipratropium|ipratropium|mesh-list
154683333|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154683334|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
154683335|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683336|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683337|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154683338|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
154683339|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
154683340|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154683341|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154683342|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154683343|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154683344|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
154683345|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683346|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683347|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154683348|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
154683349|NCT01710046|Tofacitinib|tofacitinib|mesh-list
154683350|NCT01710046|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154683351|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154683352|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860343|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
154683353|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683354|NCT02154529|Trastuzumab|trastuzumab|mesh-list
154683355|NCT02154529|XL647|xl647|mesh-list
154683356|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154683357|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683358|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154683359|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683360|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683361|NCT02154139|Leuprolide|leuprolide|mesh-list
154683362|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154683363|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
154683364|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154683365|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683366|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154683367|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683368|NCT02154061|Metronidazole|metronidazole|mesh-list
154683369|NCT02154061|Vancomycin|vancomycin|mesh-list
154683370|NCT02154061|Neomycin|neomycin|mesh-list
154683371|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683372|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683373|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154683374|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154683375|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154683376|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683377|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683378|NCT01907217|Methohexital|methohexital|mesh-list
154683379|NCT01907217|Succinylcholine|succinylcholine|mesh-list
154683380|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154683381|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154683382|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154683383|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683384|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683385|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154683386|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
154683387|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
154683388|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683389|NCT01953783|Ixazomib|ixazomib|mesh-list
154683390|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683391|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
154683392|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683393|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683394|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154683395|NCT02134015|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154683396|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154683397|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683398|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683399|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683400|NCT04619979|Anesthetics|anesthetics|mesh-list
154683401|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683402|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683403|NCT01630135|Fluticasone|fluticasone|mesh-list
154683404|NCT01630135|Xhance|xhance|mesh-list
154683405|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683406|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154683407|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
154683408|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683409|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683410|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154683411|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
154683412|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
154683413|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154683414|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
154683415|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683416|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683417|NCT01924767|Empagliflozin|empagliflozin|mesh-list
154683418|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154683419|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683420|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154683421|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683422|NCT01691092|Ketamine|ketamine|mesh-list
154683423|NCT01691092|Analgesics|analgesics|mesh-ancestor
154683424|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
154683425|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683426|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683427|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154683428|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154683429|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
154683430|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
154683431|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683432|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154683433|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154683434|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683435|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683436|NCT02133001|Esketamine|esketamine|mesh-list
154683437|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
154683438|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154683439|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
154683440|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
154683441|NCT01709578|Methotrexate|methotrexate|mesh-list
154683442|NCT01709578|Leflunomide|leflunomide|mesh-list
154683443|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154683444|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
154683445|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154683446|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683447|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154683448|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
154683449|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683450|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683451|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
154683452|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683453|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154683454|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683455|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
154683456|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683457|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154683458|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
154683459|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154683460|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154683461|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683462|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154683463|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154683464|NCT01709578|Analgesics|analgesics|mesh-ancestor
154683465|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
154683466|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683467|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683468|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154683469|NCT02132767|Digoxin|digoxin|mesh-list
154683470|NCT02132767|Amiodarone|amiodarone|mesh-list
154683471|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
154683472|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154683473|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683474|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154683475|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154683476|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683477|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683478|NCT02132767|Protective Agents|protective agents|mesh-ancestor
154683479|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
154683480|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154683481|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683482|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154683483|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154683484|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154683485|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154683486|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154683487|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154683488|NCT02153905|Aldesleukin|aldesleukin|mesh-list
154683489|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
154683490|NCT02153905|Fludarabine|fludarabine|mesh-list
154683491|NCT02153905|Interleukin-2|interleukin-2|mesh-list
154683492|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683493|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
154683494|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683495|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683496|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154683497|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
154683498|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683499|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683500|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154683501|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154683502|NCT02153905|Analgesics|analgesics|mesh-ancestor
154683503|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
154683504|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683505|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154683506|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154683507|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
154683508|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683509|NCT04752631|Tenecteplase|tenecteplase|mesh-list
154683510|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154683511|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154683512|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683513|NCT02244944|Ezetimibe|ezetimibe|mesh-list
154683514|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154683515|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154683516|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
154683517|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683518|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154683519|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154683520|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
154683521|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683522|NCT01591096|Plasminogen|plasminogen|mesh-list
154683523|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154683524|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154683525|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154683526|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683527|NCT01953003|Capecitabine|capecitabine|mesh-list
154683528|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154683529|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
154683530|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683531|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683532|NCT01709500|Atorvastatin|atorvastatin|mesh-list
154683533|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154683534|NCT01709500|Simvastatin|simvastatin|mesh-list
154683535|NCT01709500|Alirocumab|alirocumab|mesh-list
154683536|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154683537|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154683538|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
154683539|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683540|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154683541|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154683542|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683543|NCT01709500|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154683544|NCT01709500|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154683545|NCT01709500|Protease Inhibitors|protease inhibitors|mesh-ancestor
154683546|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
154683547|NCT01599806|Ceftazidime|ceftazidime|mesh-list
154683548|NCT01599806|Avibactam|avibactam|mesh-list
154683549|NCT01599806|Doripenem|doripenem|mesh-list
154683550|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154683551|NCT01599806|Trimethoprim|trimethoprim|mesh-list
154683552|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
154683553|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683554|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938315|NCT02708446|Misoprostol|misoprostol|mesh-list
154683555|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154683556|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154683557|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683558|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683559|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683560|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154683561|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154683562|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154683563|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
154683564|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154683565|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154683566|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154683567|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154683568|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154683569|NCT01599806|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154683570|NCT01599806|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154683571|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154683572|NCT01599325|Azacitidine|azacitidine|mesh-list
154683573|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154683574|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
154683575|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435586|NCT02084472|Petrolatum|petrolatum|mesh-list
154683576|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683577|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683578|NCT01924299|Fluconazole|fluconazole|mesh-list
154683579|NCT01924299|Ketoconazole|ketoconazole|mesh-list
154683580|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
154683581|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683582|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154683583|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154683584|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683585|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683586|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154683587|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
154683588|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154683589|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683590|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154683591|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154683592|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154683593|NCT02182999|Ropivacaine|ropivacaine|mesh-list
154683594|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
154683595|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
154683596|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683597|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683598|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
154683599|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683600|NCT01598311|Vancomycin|vancomycin|mesh-list
154683601|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683602|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683603|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
154683604|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154683605|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683606|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683607|NCT02978222|Molgramostim|molgramostim|mesh-list
154683608|NCT02978222|Sargramostim|sargramostim|mesh-list
154683609|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
154683610|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683611|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683612|NCT02181673|Golimumab|golimumab|mesh-list
154683613|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154683614|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683615|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683616|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
154683617|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683618|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
154683619|NCT02152345|Abatacept|abatacept|mesh-list
154683620|NCT02152345|Tacrolimus|tacrolimus|mesh-list
154683621|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154683622|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
154683623|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154683624|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
154683625|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683626|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153938418|NCT00936975|Fluorides|fluorides|mesh-list
154683627|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683628|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683629|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683630|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683631|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
154683632|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
154683633|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683634|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154683635|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
154683636|NCT02152345|Hormones|hormones|mesh-ancestor
154683637|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154683638|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154683639|NCT02152345|Protective Agents|protective agents|mesh-ancestor
154683640|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154683641|NCT02152345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154683642|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683643|NCT02180659|Buprenorphine|buprenorphine|mesh-list
154683644|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154683645|NCT02180659|Narcotics|narcotics|mesh-ancestor
154683646|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683647|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683648|NCT02180659|Analgesics|analgesics|mesh-ancestor
154683649|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
154435661|NCT01300208|CC-11050|cc-11050|mesh-list
154683650|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683651|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154683652|NCT02207816|Vaccines|vaccines|mesh-list
154683653|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
154683654|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683655|NCT02241512|Ibuprofen|ibuprofen|mesh-list
154683656|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154683657|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154683658|NCT02241512|Analgesics|analgesics|mesh-ancestor
154683659|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
154683660|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683661|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683662|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683663|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683664|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154683665|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683666|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683667|NCT01709110|Vitamin D|vitamin d|mesh-list
154683668|NCT01709110|Teriparatide|teriparatide|mesh-list
154683669|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
154683670|NCT01709110|Calcium|calcium|mesh-list
154683671|NCT01709110|Vitamins|vitamins|mesh-ancestor
154683672|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
153938430|NCT00936897|Denosumab|denosumab|mesh-list
154683673|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683674|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154683675|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154683676|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154683677|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683678|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683679|NCT02240108|Rifaximin|rifaximin|mesh-list
154683680|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683681|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683682|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154683683|NCT01590082|Doxycycline|doxycycline|mesh-list
154683684|NCT01590082|Temozolomide|temozolomide|mesh-list
154683685|NCT01590082|Ipilimumab|ipilimumab|mesh-list
154683686|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154683687|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
154683688|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683689|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683690|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154683691|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154683692|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683693|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683694|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
154683695|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154683696|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154683697|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154683698|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154683699|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154683700|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683701|NCT02179177|Apixaban|apixaban|mesh-list
154683702|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154683703|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
154683704|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154683705|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
154683706|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683707|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683708|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
154683709|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154683710|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154683711|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154683712|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683713|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683714|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154683715|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154683716|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154683717|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154683718|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
154683719|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938480|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154683720|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683721|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154683722|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154683723|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
154683724|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154683725|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154683726|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
154683727|NCT02129647|Axitinib|axitinib|mesh-list
154683728|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683729|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154683730|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683731|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683732|NCT02238626|Ibudilast|ibudilast|mesh-list
154683733|NCT02238626|Riluzole|riluzole|mesh-list
154683734|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
154683735|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154683736|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154683737|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683738|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683739|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683740|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154683741|NCT02238626|Protective Agents|protective agents|mesh-ancestor
154683742|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154683743|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
154683744|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683745|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154683746|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
154683747|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154683748|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683749|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154683750|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
154683751|NCT02151643|Iron|iron|mesh-list
154683752|NCT02151643|Trace Elements|trace elements|mesh-ancestor
154683753|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
154683754|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683755|NCT02203838|Risperidone|risperidone|mesh-list
154683756|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154683757|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
154683758|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683759|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683760|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683761|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154683762|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154683763|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683764|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154683765|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154683766|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
154683767|NCT02178709|Leucovorin|leucovorin|mesh-list
154683768|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
154683769|NCT02178709|Irinotecan|irinotecan|mesh-list
154683770|NCT02178709|Folfirinox|folfirinox|mesh-list
154683771|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683772|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154683773|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154683774|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683775|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683776|NCT02178709|Antidotes|antidotes|mesh-ancestor
154683777|NCT02178709|Protective Agents|protective agents|mesh-ancestor
154683778|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683779|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
154683780|NCT02178709|Vitamins|vitamins|mesh-ancestor
154683781|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
154683782|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
154683783|NCT02238080|Hematinics|hematinics|mesh-ancestor
154683784|NCT02178553|Bupivacaine|bupivacaine|mesh-list
154683785|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
154683786|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
154683787|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683788|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683789|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
154683790|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683791|NCT01627327|Fluticasone|fluticasone|mesh-list
154683792|NCT01627327|Xhance|xhance|mesh-list
154683793|NCT01627327|Bromides|bromides|mesh-list
154683794|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
154683795|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683796|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154683797|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
154683798|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683799|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683800|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154683801|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
154683802|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
154683803|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154683804|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
154683805|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154683806|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
154683807|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683808|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683809|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
154683810|NCT01627249|Bevacizumab|bevacizumab|mesh-list
154683811|NCT01627249|Ranibizumab|ranibizumab|mesh-list
154683812|NCT01627249|Aflibercept|aflibercept|mesh-list
154683813|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154683814|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683815|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154683816|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154683817|NCT01627249|Growth Substances|growth substances|mesh-ancestor
154683818|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683819|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
154683820|NCT01688830|Dabigatran|dabigatran|mesh-list
154683821|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
154683822|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154683823|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
154683824|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683825|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683826|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
154683827|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
154683828|NCT01604278|Bromides|bromides|mesh-list
154683829|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
154683830|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154683831|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154683832|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154683833|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
154683834|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683835|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683836|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683837|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
154683838|NCT01687270|Ribavirin|ribavirin|mesh-list
154683839|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
154683840|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683841|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
154683842|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683843|NCT01588990|Leucovorin|leucovorin|mesh-list
154683844|NCT01588990|Bevacizumab|bevacizumab|mesh-list
154683845|NCT01588990|Capecitabine|capecitabine|mesh-list
154683846|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
154683847|NCT01588990|Irinotecan|irinotecan|mesh-list
154683848|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154683849|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683850|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154683851|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154683852|NCT01588990|Growth Substances|growth substances|mesh-ancestor
154683853|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683854|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
154683855|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154683856|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
154683857|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683858|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154683859|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154683860|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683861|NCT01588990|Antidotes|antidotes|mesh-ancestor
154683862|NCT01588990|Protective Agents|protective agents|mesh-ancestor
154683863|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
154683864|NCT01588990|Vitamins|vitamins|mesh-ancestor
154683865|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
154683866|NCT02126839|Albuterol|albuterol|mesh-list
154683867|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154683868|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
154683869|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683870|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683871|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154683872|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
154683873|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
154683874|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154683875|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154683876|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154683877|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154683878|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
154683879|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683880|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683881|NCT02125279|Calcitriol|calcitriol|mesh-list
154683882|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154683883|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683884|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154683885|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154683886|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683887|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154683888|NCT02125279|Vitamins|vitamins|mesh-ancestor
154683889|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
154683890|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154683891|NCT02124811|Minocycline|minocycline|mesh-list
154683892|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154683893|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154683894|NCT02148445|Nicotine|nicotine|mesh-list
154683895|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154683896|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
154683897|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683898|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683899|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154683900|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154683901|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
154683902|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683903|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683904|NCT02147587|Tofacitinib|tofacitinib|mesh-list
154683905|NCT02147587|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154683906|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154683907|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683908|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683909|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
154683910|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154683911|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
154683912|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154683913|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683914|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154683915|NCT02176291|Buprenorphine|buprenorphine|mesh-list
154683916|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154683917|NCT02176291|Narcotics|narcotics|mesh-ancestor
154683918|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683919|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683920|NCT02176291|Analgesics|analgesics|mesh-ancestor
154683921|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
154683922|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683923|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154683924|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154683925|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
154683926|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683927|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683928|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683929|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
154683930|NCT02175277|Hematinics|hematinics|mesh-ancestor
154683931|NCT01568866|Dexamethasone|dexamethasone|mesh-list
154683932|NCT01568866|Bortezomib|bortezomib|mesh-list
154683933|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683934|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
154683935|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
154683936|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683937|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683938|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154683939|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
154683940|NCT01568866|Hormones|hormones|mesh-ancestor
154683941|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154683942|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154683943|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683944|NCT01567852|Ketamine|ketamine|mesh-list
154683945|NCT01567852|Methohexital|methohexital|mesh-list
154683946|NCT01567852|Analgesics|analgesics|mesh-ancestor
154683947|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
154683948|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683949|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683950|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154683951|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154435954|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154683952|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
154683953|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
154683954|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683955|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154683956|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154683957|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154683958|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683959|NCT01587274|Acetaminophen|acetaminophen|mesh-list
154683960|NCT01587274|Naproxen|naproxen|mesh-list
154683961|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154683962|NCT01587274|Oxycodone|oxycodone|mesh-list
154683963|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
154683964|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154683965|NCT01587274|Analgesics|analgesics|mesh-ancestor
154683966|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
154683967|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154683968|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683969|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
154683970|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154683971|NCT01587274|Narcotics|narcotics|mesh-ancestor
154683972|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683973|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154683974|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154683975|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154683976|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
154683977|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154683978|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154683979|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683980|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154683981|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
154683982|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154683983|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154683984|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154683985|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154683986|NCT01587118|Asenapine|asenapine|mesh-list
154683987|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154683988|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154683989|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154683990|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154683991|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154683992|NCT01905657|Docetaxel|docetaxel|mesh-list
154683993|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
154683994|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154683995|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
154683996|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
154683997|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
154683998|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154683999|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154684000|NCT01905657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154684001|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
154684002|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
154684003|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684004|NCT01952145|Insulin|insulin|mesh-list
154684005|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154684006|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
154684007|NCT01952145|Liraglutide|liraglutide|mesh-list
154684008|NCT01952145|Xultophy|xultophy|mesh-list
154684009|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154684010|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684011|NCT01952145|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154684012|NCT01952145|Incretins|incretins|mesh-ancestor
154684013|NCT01952145|Hormones|hormones|mesh-ancestor
154684014|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684015|NCT01923363|Tazobactam|tazobactam|mesh-list
154684016|NCT01923363|Piperacillin|piperacillin|mesh-list
154684017|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154684018|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154684019|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684020|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154684021|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684022|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684023|NCT01904721|Bimatoprost|bimatoprost|mesh-list
154684024|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154684025|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154684026|NCT01922739|Hydrocodone|hydrocodone|mesh-list
154684027|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154684028|NCT01922739|Narcotics|narcotics|mesh-ancestor
154684029|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684030|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684031|NCT01922739|Analgesics|analgesics|mesh-ancestor
154684032|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
154684033|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684034|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
154684035|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
154684036|NCT02236988|Thalidomide|thalidomide|mesh-list
154684037|NCT02236988|Apremilast|apremilast|mesh-list
154684038|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154684039|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154684040|NCT02236988|Analgesics|analgesics|mesh-ancestor
154684041|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
154684042|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684043|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684044|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154684045|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154684046|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154684047|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154684048|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684049|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684050|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154684051|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
153938787|NCT02883400|Diuretics|diuretics|mesh-ancestor
154684052|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
154684053|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154684054|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684055|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154684056|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154684057|NCT02236988|Growth Substances|growth substances|mesh-ancestor
154684058|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
154684059|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684060|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
154684061|NCT02236520|Spironolactone|spironolactone|mesh-list
154684062|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154684063|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
154684064|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684065|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684066|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154684067|NCT02236520|Diuretics|diuretics|mesh-ancestor
154684068|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
154684069|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154684070|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154684071|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684072|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684073|NCT04769414|Gemcitabine|gemcitabine|mesh-list
154684074|NCT04769414|Fluorouracil|fluorouracil|mesh-list
154684075|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154684076|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
154684077|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684078|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684079|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154684080|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
154684081|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684082|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
154684083|NCT01922271|Albuterol|albuterol|mesh-list
154684084|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
154684085|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154684086|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
154684087|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684088|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684089|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154684090|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
154684091|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
154684092|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154684093|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
154684094|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684095|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684096|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
154684097|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154684098|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154684099|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154684100|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154684101|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
154684102|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154684103|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154684104|NCT02236130|Acetaminophen|acetaminophen|mesh-list
154684106|NCT02236130|Hydrocodone|hydrocodone|mesh-list
154684107|NCT02236130|Analgesics|analgesics|mesh-list
154684108|NCT02236130|Anesthetics|anesthetics|mesh-list
154684109|NCT02236130|Ropivacaine|ropivacaine|mesh-list
154684110|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
154684111|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684112|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684113|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154684114|NCT02236130|Narcotics|narcotics|mesh-ancestor
154684115|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
154684116|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684117|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154684118|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
154684119|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
154684120|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
154684121|NCT01641809|Tenofovir|tenofovir|mesh-list
154684122|NCT01641809|Lamivudine|lamivudine|mesh-list
154684123|NCT01641809|Emtricitabine|emtricitabine|mesh-list
154684124|NCT01641809|Efavirenz|efavirenz|mesh-list
154684125|NCT01641809|Abacavir|abacavir|mesh-list
154684126|NCT01641809|Rilpivirine|rilpivirine|mesh-list
154684127|NCT01641809|Cabotegravir|cabotegravir|mesh-list
154684128|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
154684129|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684130|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154684131|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154684132|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684133|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684134|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154684135|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154684136|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154684137|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154684138|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154684139|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154684140|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154684141|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154684142|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154684143|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154684144|NCT01632566|Celecoxib|celecoxib|mesh-list
154684145|NCT01632566|Simvastatin|simvastatin|mesh-list
154684146|NCT01632566|LY3031207|ly3031207|mesh-list
154684147|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154684148|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154684149|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
154684150|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684151|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154684152|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154684153|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684154|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154684155|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154684156|NCT01632566|Analgesics|analgesics|mesh-ancestor
154684157|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
154684158|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684159|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684160|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154684161|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154684162|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154684163|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154684164|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
154684165|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
154684166|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684167|NCT02254304|Interferons|interferons|mesh-list
154684168|NCT02254304|Interferon-beta|interferon-beta|mesh-list
154684169|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
154684170|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684171|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
154684172|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684173|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
154684174|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684175|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154684176|NCT05650151|Vitamin D|vitamin d|mesh-list
154684177|NCT05650151|Vitamins|vitamins|mesh-ancestor
154684178|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
154684179|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436174|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154684180|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154684181|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
154684182|NCT02174731|Hematinics|hematinics|mesh-ancestor
154684183|NCT01922037|Omalizumab|omalizumab|mesh-list
154684184|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154684185|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154684186|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
154684187|NCT02282813|Calcitriol|calcitriol|mesh-list
154684188|NCT02282813|Calcifediol|calcifediol|mesh-list
154684189|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
154684190|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154684191|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684192|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154684193|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684194|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684195|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154684196|NCT02282813|Vitamins|vitamins|mesh-ancestor
154684197|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
154684198|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154684199|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154684200|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154684201|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684202|NCT02121847|Cyclosporine|cyclosporine|mesh-list
154684203|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154684204|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154684205|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
154684206|NCT02121847|Cyclosporins|cyclosporins|mesh-list
154684207|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684208|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684209|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154684210|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
154684211|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684212|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
154684213|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684214|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
154684215|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154684216|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154684217|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154684218|NCT02121847|Laxatives|laxatives|mesh-ancestor
154684219|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154684220|NCT01586806|Dexamethasone|dexamethasone|mesh-list
154684221|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
154684222|NCT01586806|Bupivacaine|bupivacaine|mesh-list
154684223|NCT01586806|BB 1101|bb 1101|mesh-list
154684224|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154684225|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
154684226|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
154684227|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684228|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684229|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154684230|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
154684231|NCT01586806|Hormones|hormones|mesh-ancestor
154684232|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684233|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154684234|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684235|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
154684236|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684237|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684238|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
154684239|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
154684240|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684241|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
154684242|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154684243|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154684244|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154684245|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
154684246|NCT02143843|Bimatoprost|bimatoprost|mesh-list
154684247|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154684248|NCT01586338|Hylan|hylan|mesh-list
154684249|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
154684250|NCT01586338|Protective Agents|protective agents|mesh-ancestor
154684251|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684252|NCT02143141|Morphine|morphine|mesh-list
154436252|NCT03019965|Meropenem|meropenem|mesh-list
154684253|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154684254|NCT02143141|Narcotics|narcotics|mesh-ancestor
154684255|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684256|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684257|NCT02143141|Analgesics|analgesics|mesh-ancestor
154684258|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
154684259|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684260|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
154684261|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154684262|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154684263|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154684264|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
154684265|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684266|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939010|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154684267|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684268|NCT05497583|Factor VIII|factor viii|mesh-list
154684269|NCT05497583|Coagulants|coagulants|mesh-ancestor
154684270|NCT02253992|Nivolumab|nivolumab|mesh-list
154684271|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154684272|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684273|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154684274|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684275|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
154684276|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154684277|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684278|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
154684279|NCT01585558|Tamoxifen|tamoxifen|mesh-list
154684280|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154684281|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
154684282|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684283|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684284|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154684285|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684286|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154684287|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154684288|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154684289|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
154684290|NCT01585246|Urological Agents|urological agents|mesh-ancestor
154684291|NCT01585168|Memantine|memantine|mesh-list
154684292|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154684293|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154684294|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
154684295|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684296|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684297|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684298|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154684299|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154684300|NCT02231918|Pramipexole|pramipexole|mesh-list
154684301|NCT02231918|Dexpramipexole|dexpramipexole|mesh-list
154684302|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
154684303|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684304|NCT02231918|Protective Agents|protective agents|mesh-ancestor
154684305|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684306|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154684307|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154684308|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
154684309|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
154684310|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684311|NCT02199314|Desflurane|desflurane|mesh-list
154684312|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154684313|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
154684314|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
154684315|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684316|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684317|NCT02197520|Insulin|insulin|mesh-list
154684318|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154684319|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
154684320|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
154684321|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154684322|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684323|NCT02230904|Rotigotine|rotigotine|mesh-list
154684324|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
154684325|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
154684326|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684327|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684328|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684329|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
154684330|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
154684331|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436324|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
154684332|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684333|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684334|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
154684335|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
154684336|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
154684337|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154684338|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
154684339|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154684340|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154684341|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
154684342|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684343|NCT02228096|Tisagenlecleucel|tisagenlecleucel|mesh-list
154684344|NCT02228096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154684345|NCT02228096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684346|NCT01683994|Prednisone|prednisone|mesh-list
154684347|NCT01683994|Docetaxel|docetaxel|mesh-list
154684348|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684349|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
154684350|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
154684351|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
154684352|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684353|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154684354|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
154684355|NCT01683994|Hormones|hormones|mesh-ancestor
154684356|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684357|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684358|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154684359|NCT02247440|Interferons|interferons|mesh-list
154684360|NCT02247440|Ribavirin|ribavirin|mesh-list
154684361|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684362|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
154684363|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684364|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
154684365|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684366|NCT04857203|Vitamin D|vitamin d|mesh-list
154684367|NCT04857203|Vitamins|vitamins|mesh-ancestor
154684368|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
153939115|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
153939158|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154684369|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684370|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154684371|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
154684372|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154684373|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684374|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684375|NCT04660643|Tirzepatide|tirzepatide|mesh-list
154684376|NCT04660643|Incretins|incretins|mesh-ancestor
154684377|NCT04660643|Hormones|hormones|mesh-ancestor
154684378|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684379|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684380|NCT04659317|Oxycodone|oxycodone|mesh-list
154684381|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154684382|NCT04659317|Narcotics|narcotics|mesh-ancestor
154684383|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684384|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684385|NCT04659317|Analgesics|analgesics|mesh-ancestor
154684386|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
154684387|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684388|NCT03602261|Calcifediol|calcifediol|mesh-list
154684389|NCT03602261|Vitamins|vitamins|mesh-ancestor
154684390|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
154684391|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684392|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154684393|NCT02141659|Relugolix|relugolix|mesh-list
154684394|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
154684395|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
154684396|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684397|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684398|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154684399|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154684400|NCT05422703|Analgesics|analgesics|mesh-list
154684401|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
154684402|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684403|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684404|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
154684405|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436401|NCT01002248|Hormones|hormones|mesh-ancestor
154684406|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684407|NCT02120833|Decanoic acid|decanoic acid|mesh-list
154684408|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
154684409|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684410|NCT04615949|Cannabidiol|cannabidiol|mesh-list
154684411|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
154684412|NCT02170207|Lansoprazole|lansoprazole|mesh-list
154684413|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
154684414|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154684415|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154684416|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154684417|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684418|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684419|NCT02227784|Atorvastatin|atorvastatin|mesh-list
154684420|NCT02227784|Ezetimibe|ezetimibe|mesh-list
154684421|NCT02227784|Evacetrapib|evacetrapib|mesh-list
154684422|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154684423|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154684424|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
154684425|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684426|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154684427|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154684428|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684429|NCT01565668|Quizartinib|quizartinib|mesh-list
154684430|NCT01565668|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154684431|NCT01565668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154684432|NCT01565668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684433|NCT01565668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684434|NCT04577417|Methylphenidate|methylphenidate|mesh-list
154684435|NCT04577417|Amphetamine|amphetamine|mesh-list
154684436|NCT04577417|Adderall|adderall|mesh-list
154684437|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154684438|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
154684439|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154684440|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684441|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154684442|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154684443|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684444|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684445|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
154684446|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684447|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
154684448|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
154684449|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684450|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
154684451|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154684452|NCT01683058|Aripiprazole|aripiprazole|mesh-list
154684453|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
154684454|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154684455|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154684456|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154684457|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684458|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684459|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
154684460|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
154684461|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684462|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684463|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154684464|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154684465|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
154684466|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154684467|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154684468|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154684469|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154684470|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
154684471|NCT02193776|Rifampin|rifampin|mesh-list
154684472|NCT02193776|Isoniazid|isoniazid|mesh-list
154684473|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
154684474|NCT02193776|Ethambutol|ethambutol|mesh-list
154684475|NCT02193776|Bedaquiline|bedaquiline|mesh-list
154684476|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154684477|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684478|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154684479|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154684480|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684481|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684482|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684483|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154684484|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
154684485|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
153939209|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
154684486|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154684487|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154684488|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154684489|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154684490|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154684491|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154684492|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154684493|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154684494|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154684495|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
154684496|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154684497|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154684498|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
154684499|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154684500|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154684501|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684502|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684503|NCT02169830|Topiramate|topiramate|mesh-list
154684504|NCT02169830|Nortriptyline|nortriptyline|mesh-list
154684505|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
154684506|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154684507|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684508|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154684509|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
154684510|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154684511|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154684512|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154684513|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684514|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684515|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
154684516|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684517|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
154684518|NCT05341349|Nivolumab|nivolumab|mesh-list
154684519|NCT05341349|Ipilimumab|ipilimumab|mesh-list
154684520|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154684521|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684522|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154684523|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684524|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154684525|NCT02169284|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154684526|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154684527|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684528|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684529|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684530|NCT02119819|Metformin|metformin|mesh-list
154684531|NCT02119819|Exenatide|exenatide|mesh-list
154684532|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154684533|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684534|NCT02119819|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154684535|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154684536|NCT02119819|Incretins|incretins|mesh-ancestor
154684537|NCT02119819|Hormones|hormones|mesh-ancestor
154684538|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684539|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
154684540|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154684541|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
154684542|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684543|NCT04766450|Expectorants|expectorants|mesh-ancestor
154684544|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
154684545|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154684546|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
154684547|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684548|NCT04766450|Protective Agents|protective agents|mesh-ancestor
154684549|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684550|NCT04766450|Antidotes|antidotes|mesh-ancestor
154684551|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
154684552|NCT02168816|Metronidazole|metronidazole|mesh-list
154684553|NCT02168816|Vancomycin|vancomycin|mesh-list
154684554|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
154684555|NCT02168816|Clindamycin|clindamycin|mesh-list
154684556|NCT02168816|Meropenem|meropenem|mesh-list
154436576|NCT04059003|Taxane|taxane|mesh-list
154684558|NCT02168816|Linezolid|linezolid|mesh-list
154684559|NCT02168816|Piperacillin|piperacillin|mesh-list
154684560|NCT02168816|Daptomycin|daptomycin|mesh-list
154684561|NCT02168816|Cefepime|cefepime|mesh-list
154684562|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154684563|NCT02168816|Aztreonam|aztreonam|mesh-list
154684564|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154684565|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154684566|NCT02168816|Trimethoprim|trimethoprim|mesh-list
154684567|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
154684568|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684569|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154684570|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154684571|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684572|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684573|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684574|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154684575|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154684576|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154684577|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154684578|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154684579|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154684580|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154684581|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
154684582|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154684583|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154684584|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154684585|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
154684586|NCT01584232|Dulaglutide|dulaglutide|mesh-list
154684587|NCT01584232|Biguanides|biguanides|mesh-list
154684588|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154684589|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684590|NCT01584232|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154684591|NCT02119663|Capecitabine|capecitabine|mesh-list
154684592|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154684593|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
154684594|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684595|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684596|NCT04481009|Paclitaxel|paclitaxel|mesh-list
154684597|NCT04481009|Gemcitabine|gemcitabine|mesh-list
154684598|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154684599|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684600|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
154684601|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
154684602|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
154684603|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684604|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154684605|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
154684606|NCT05327231|Docetaxel|docetaxel|mesh-list
154684607|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684608|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
154684609|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
154684610|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
154684611|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684612|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
154684613|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684614|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684615|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
154684616|NCT01628107|Hematinics|hematinics|mesh-ancestor
154684617|NCT04745377|Antibodies|antibodies|mesh-list
154684618|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
154684619|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684620|NCT01583530|Belimumab|belimumab|mesh-list
154684621|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154684622|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
154684623|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684624|NCT01639001|Carboplatin|carboplatin|mesh-list
154684625|NCT01639001|Pemetrexed|pemetrexed|mesh-list
154684626|NCT01639001|Crizotinib|crizotinib|mesh-list
154684627|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684628|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684629|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684630|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154684631|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154684632|NCT01639001|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154684633|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154684634|NCT02167256|Saracatinib|saracatinib|mesh-list
154684635|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684636|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684637|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684638|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154684639|NCT02166476|Levofloxacin|levofloxacin|mesh-list
154684640|NCT02166476|Meropenem|meropenem|mesh-list
154684641|NCT02166476|Tazobactam|tazobactam|mesh-list
154684642|NCT02166476|Piperacillin|piperacillin|mesh-list
154684643|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154684644|NCT02166476|Vaborbactam|vaborbactam|mesh-list
154684645|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
154684646|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684647|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154684648|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154684649|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154684650|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684651|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684652|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684653|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154684654|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154684655|NCT02224274|Clopidogrel|clopidogrel|mesh-list
154684656|NCT02224274|Ticagrelor|ticagrelor|mesh-list
154684657|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154684658|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154684659|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154684660|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154684661|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
154684662|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684663|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684664|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684665|NCT05219669|Nalmefene|nalmefene|mesh-list
154684666|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154684667|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684668|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
154684669|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684670|NCT04763252|Coal Tar|coal tar|mesh-list
154684671|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
154684672|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
154684673|NCT05369039|Prednisolone|prednisolone|mesh-list
154684674|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939460|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
154684675|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
154684676|NCT05369039|Hormones|hormones|mesh-ancestor
154684677|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684678|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684679|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154684680|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684681|NCT04373369|Atezolizumab|atezolizumab|mesh-list
154684682|NCT04373369|Vorolanib|vorolanib|mesh-list
154684683|NCT04373369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154684684|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684685|NCT04373369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154684686|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684687|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154684688|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684689|NCT04791059|Sufentanil|sufentanil|mesh-list
154684690|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
154684691|NCT04791059|Ketamine|ketamine|mesh-list
154684692|NCT04791059|Esketamine|esketamine|mesh-list
154684693|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154684694|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684695|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684696|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154684697|NCT04791059|Analgesics|analgesics|mesh-ancestor
154684698|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
154684699|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684700|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154684701|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154684702|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154684703|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
154684704|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684705|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684706|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154436706|NCT05102422|Propofol|propofol|mesh-list
154684707|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154684708|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
154684709|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
154684710|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154684711|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154684712|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154684713|NCT04791059|Narcotics|narcotics|mesh-ancestor
154684714|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154684715|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
154684716|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154684717|NCT05398913|Rimonabant|rimonabant|mesh-list
154684718|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154684719|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154684720|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154684721|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684722|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684723|NCT05398913|Hormones|hormones|mesh-ancestor
154684724|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684725|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684726|NCT01583374|Thalidomide|thalidomide|mesh-list
154684727|NCT01583374|Apremilast|apremilast|mesh-list
154684728|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154684729|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154684730|NCT01583374|Analgesics|analgesics|mesh-ancestor
154684731|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
154684732|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684733|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684734|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154684735|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154684736|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154684737|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154684738|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684739|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684740|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154684741|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
154684742|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
154684743|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154684744|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684745|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154684746|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154684747|NCT01583374|Growth Substances|growth substances|mesh-ancestor
154684748|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
154684749|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684750|NCT02222714|Protein C|protein c|mesh-list
154684751|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
154684752|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154684753|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154684754|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684755|NCT04145219|Immunomodulating Agents|immunomodulating agents|mesh-list
154684756|NCT04145219|Immunologic Factors|immunologic factors|mesh-ancestor
154684757|NCT04145219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684758|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154684759|NCT02164916|Cetuximab|cetuximab|mesh-list
154684760|NCT02164916|Irinotecan|irinotecan|mesh-list
154684761|NCT02164916|Camptothecin|camptothecin|mesh-list
154684762|NCT02164916|Vemurafenib|vemurafenib|mesh-list
154684763|NCT02164916|Antibodies|antibodies|mesh-list
154684764|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
154684765|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154684766|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
154684767|NCT02164916|Mitogens|mitogens|mesh-list
154684768|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
154684769|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684770|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684771|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154684772|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154684773|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684774|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684775|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
154684776|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154684777|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154684778|NCT04091867|Cetuximab|cetuximab|mesh-list
154684779|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154684780|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684781|NCT05651789|Propranolol|propranolol|mesh-list
154684782|NCT05651789|Carvedilol|carvedilol|mesh-list
154684783|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154684784|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154684785|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154684786|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684787|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684788|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684789|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154684790|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154684791|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
154684792|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
154684793|NCT05651789|Protective Agents|protective agents|mesh-ancestor
154684794|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154684795|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684796|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154684797|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154684798|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154684799|NCT02999477|Paclitaxel|paclitaxel|mesh-list
154684800|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
154684801|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154684802|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684803|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
154684804|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
154684805|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
154684806|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684807|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154684808|NCT02999477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154684809|NCT02222558|Testosterone|testosterone|mesh-list
154684810|NCT02222558|Androgens|androgens|mesh-ancestor
154684811|NCT02222558|Hormones|hormones|mesh-ancestor
154684812|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154684813|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684814|NCT02975999|Vasopressins|vasopressins|mesh-list
154684815|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
154684816|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
154684817|NCT02975999|Coagulants|coagulants|mesh-ancestor
154684818|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154684819|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154684820|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
154684821|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684823|NCT02188784|Trace Elements|trace elements|mesh-ancestor
154684824|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
154684825|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684826|NCT02222246|Morphine|morphine|mesh-list
154684827|NCT02222246|Hydromorphone|hydromorphone|mesh-list
154684828|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154684829|NCT02222246|Narcotics|narcotics|mesh-ancestor
154684830|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684831|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684832|NCT02222246|Analgesics|analgesics|mesh-ancestor
154684833|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
154684834|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684835|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154684836|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154684837|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
154684838|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
154684839|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684840|NCT02220920|Canagliflozin|canagliflozin|mesh-list
154684841|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154684842|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684843|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154684844|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684845|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
154684846|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
154684847|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
154684848|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684849|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684850|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154684851|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154684852|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154684853|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684854|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154436848|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
154684855|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154684856|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
154684857|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684858|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684859|NCT04790279|Amlodipine|amlodipine|mesh-list
154684860|NCT04790279|Nifedipine|nifedipine|mesh-list
154684861|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153939594|NCT00927069|Adalimumab|adalimumab|mesh-list
154684862|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154684863|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684864|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684865|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154684866|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684867|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
154684868|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
154684869|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154684870|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154684871|NCT03877289|Oxybutynin|oxybutynin|mesh-list
154684872|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684873|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
154684874|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
154684875|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684876|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684877|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154684878|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154684879|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
154684880|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684881|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684882|NCT03877289|Urological Agents|urological agents|mesh-ancestor
154684883|NCT03877055|Ibrutinib|ibrutinib|mesh-list
154684884|NCT03877055|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154684885|NCT03877055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154684886|NCT03877055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684887|NCT03877055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684888|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
154684889|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154684890|NCT05494619|Antibodies|antibodies|mesh-list
154684891|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
154684892|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154684893|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
154684894|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684895|NCT01634555|Leucovorin|leucovorin|mesh-list
154684896|NCT01634555|Folic Acid|folic acid|mesh-list
154684897|NCT01634555|Fluorouracil|fluorouracil|mesh-list
154684898|NCT01634555|Irinotecan|irinotecan|mesh-list
154684899|NCT01634555|Ramucirumab|ramucirumab|mesh-list
154684900|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
154684901|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
154684902|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684903|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154684904|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684905|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154684906|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
154684907|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684908|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154684909|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154684910|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684911|NCT01634555|Antidotes|antidotes|mesh-ancestor
154684912|NCT01634555|Protective Agents|protective agents|mesh-ancestor
154684913|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
154684914|NCT01634555|Vitamins|vitamins|mesh-ancestor
154684915|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
154684916|NCT01634555|Hematinics|hematinics|mesh-ancestor
154684917|NCT01634555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154684918|NCT01634555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154684919|NCT01634555|Growth Substances|growth substances|mesh-ancestor
154684920|NCT01634555|Growth Inhibitors|growth inhibitors|mesh-ancestor
154684921|NCT05355155|Bevacizumab|bevacizumab|mesh-list
154684922|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154684923|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684924|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154684925|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154684926|NCT05355155|Growth Substances|growth substances|mesh-ancestor
154684927|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684928|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
154684929|NCT01634243|Rotigotine|rotigotine|mesh-list
154684930|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
154684931|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
154436923|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
154684932|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684933|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684934|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684935|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
154684936|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154684937|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154684938|NCT04814615|Daratumumab|daratumumab|mesh-list
154684939|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684940|NCT04814537|Bupivacaine|bupivacaine|mesh-list
154684941|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
154684942|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
154684943|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684944|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684945|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
154684946|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684947|NCT01582282|Psyllium|psyllium|mesh-list
154684948|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
154684949|NCT01582282|Cathartics|cathartics|mesh-ancestor
154684950|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154684951|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
154684952|NCT01599650|Ranibizumab|ranibizumab|mesh-list
154684953|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154684954|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154684955|NCT01599650|Growth Substances|growth substances|mesh-ancestor
154684956|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684957|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
154684958|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154684959|NCT03774875|Apremilast|apremilast|mesh-list
154684960|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154684961|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154684962|NCT03774875|Analgesics|analgesics|mesh-ancestor
154684963|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
154684964|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684965|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684966|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154684967|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154684968|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154684969|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154684970|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154684971|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684972|NCT01563172|Listerine|listerine|mesh-list
154684973|NCT01563172|Fluorides|fluorides|mesh-list
154684974|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
154684975|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
154684976|NCT01563172|Protective Agents|protective agents|mesh-ancestor
154684977|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684978|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154684979|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154684980|NCT02161718|Olanzapine|olanzapine|mesh-list
154684981|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
154684982|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
154684983|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154684984|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154684985|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154684986|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154684987|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154684988|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154684989|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154684990|NCT02161718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154684991|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154684992|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154684993|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154684994|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154684995|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
154684996|NCT04813991|Ibuprofen|ibuprofen|mesh-list
154684997|NCT04813991|Oxycodone|oxycodone|mesh-list
154684998|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154684999|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154685000|NCT04813991|Analgesics|analgesics|mesh-ancestor
154685001|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
154685002|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685003|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685004|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685005|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685006|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154685007|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436996|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154860344|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685008|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685009|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154685010|NCT04813991|Narcotics|narcotics|mesh-ancestor
154685011|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685012|NCT02218736|Aticaprant|aticaprant|mesh-list
154685013|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
154685014|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685015|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
154685016|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685017|NCT01580488|Calcitriol|calcitriol|mesh-list
154685018|NCT01580488|Calcipotriene|calcipotriene|mesh-list
154685019|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154685020|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
154685021|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154685022|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685023|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154685024|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154685025|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685026|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154685027|NCT01580488|Vitamins|vitamins|mesh-ancestor
154685028|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
154685029|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154685030|NCT01580020|Dexamethasone|dexamethasone|mesh-list
154685031|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685032|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
154685033|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
154685034|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685035|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685036|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154685037|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
154685038|NCT01580020|Hormones|hormones|mesh-ancestor
154685039|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685040|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154685041|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685042|NCT01579318|Interleukin-12|interleukin-12|mesh-list
153939759|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
154685043|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154685044|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
154685045|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685046|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154685047|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154685048|NCT01579318|Growth Substances|growth substances|mesh-ancestor
154685049|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
154685050|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685051|NCT01578850|Etanercept|etanercept|mesh-list
154685052|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154685053|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154685054|NCT01578850|Analgesics|analgesics|mesh-ancestor
154685055|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
154685056|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685057|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685058|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685059|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685060|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154685061|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154685062|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
154685063|NCT01539538|Sufentanil|sufentanil|mesh-list
154685064|NCT01539538|Morphine|morphine|mesh-list
154685065|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154685066|NCT01539538|Narcotics|narcotics|mesh-ancestor
154685067|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685068|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685069|NCT01539538|Analgesics|analgesics|mesh-ancestor
154685070|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
154685071|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685072|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154685073|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154685074|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
154685075|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
154685076|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
154685077|NCT01562548|Guaifenesin|guaifenesin|mesh-list
154685078|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154685079|NCT01562548|Expectorants|expectorants|mesh-ancestor
154685080|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
154685081|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154685082|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154685083|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
154685084|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685085|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685086|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685087|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
154685088|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154685089|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
154685090|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
154685091|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685092|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
154685093|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154685094|NCT03027934|Ticagrelor|ticagrelor|mesh-list
154685095|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154685096|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154685097|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154685098|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154685099|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154685100|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
154685101|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685102|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685103|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685104|NCT01562314|Cannabidiol|cannabidiol|mesh-list
154685105|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
154685106|NCT01539226|Dapivirine|dapivirine|mesh-list
154685107|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154685108|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154685109|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
154685110|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685111|NCT01537120|Vildagliptin|vildagliptin|mesh-list
154685112|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154685113|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685114|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154685115|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
154685116|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685117|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685118|NCT01537042|Rotigotine|rotigotine|mesh-list
154685119|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
154685120|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
154685121|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685122|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685123|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685124|NCT01536574|Ropinirole|ropinirole|mesh-list
154685125|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154685126|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154685127|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
154685128|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
154685129|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685130|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685131|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685132|NCT04410094|Itraconazole|itraconazole|mesh-list
154685133|NCT04410094|Rifampin|rifampin|mesh-list
154685134|NCT04410094|Lazertinib|lazertinib|mesh-list
154685135|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
154685136|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685137|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154685138|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154685139|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685140|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685141|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154685142|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
154685143|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685144|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685145|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154685146|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154685147|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
154685148|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154685149|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
154685150|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154685151|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154685152|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154685153|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154685154|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154685155|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154685156|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154685157|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154685159|NCT01576042|Sotalol|sotalol|mesh-list
154685160|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154685161|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
154685162|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154685163|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154685164|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685165|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154685166|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154685167|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154685168|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685169|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154685170|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154685171|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154685172|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154685173|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154685174|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
154685175|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685176|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685177|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
154685178|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
154685179|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685180|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
154685181|NCT01536262|Olodaterol|olodaterol|mesh-list
154685182|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154685183|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
154685184|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685185|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685186|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154685187|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
154685188|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
154685189|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154685190|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
154685191|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685192|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685193|NCT04102618|Trastuzumab|trastuzumab|mesh-list
154685194|NCT04102618|Atezolizumab|atezolizumab|mesh-list
154685195|NCT04102618|Letrozole|letrozole|mesh-list
154685196|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685197|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685198|NCT04102618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154685199|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685200|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154685201|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154685202|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685203|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154685204|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
154685205|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685206|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685207|NCT01575028|Bupivacaine|bupivacaine|mesh-list
154685208|NCT01575028|Ropivacaine|ropivacaine|mesh-list
154685209|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
154685210|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
154685211|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685212|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685213|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
154685214|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685215|NCT04443569|Lidocaine|lidocaine|mesh-list
154685216|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
154685217|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
154685218|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685219|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685220|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
154685221|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685222|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154685223|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154685224|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154685225|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154685226|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685227|NCT03508895|Caseins|caseins|mesh-list
154685228|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
154685229|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
154685230|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685231|NCT01574716|Gemcitabine|gemcitabine|mesh-list
154685232|NCT01574716|Docetaxel|docetaxel|mesh-list
154685233|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154685234|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
154685235|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685236|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685237|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
154685238|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
154685239|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
154685240|NCT02161562|Omalizumab|omalizumab|mesh-list
154685241|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154685242|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154685243|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154685244|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
154685245|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
154685246|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685247|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
154685248|NCT01559116|Olodaterol|olodaterol|mesh-list
154685249|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154685250|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
154685251|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685252|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685253|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154685254|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
154685255|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
154685256|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154685257|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
154685258|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685259|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685260|NCT01574326|Sevelamer|sevelamer|mesh-list
154685261|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
154685262|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
154685263|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685264|NCT01574248|Icatibant|icatibant|mesh-list
154685265|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154685266|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154685267|NCT01574248|Analgesics|analgesics|mesh-ancestor
154685268|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
154685269|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685270|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685271|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685272|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685273|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154685274|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154685275|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685276|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154685277|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154685278|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
154685279|NCT04761094|Insulin|insulin|mesh-list
154685280|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154685281|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685282|NCT01557946|Citalopram|citalopram|mesh-list
154685283|NCT01557946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154685284|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154685285|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154685286|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685287|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685288|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
154685289|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685290|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154685291|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
154685292|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154685293|NCT01534078|Doxorubicin|doxorubicin|mesh-list
154685294|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154685295|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154685296|NCT01534078|Dacarbazine|dacarbazine|mesh-list
154685297|NCT01534078|Vinblastine|vinblastine|mesh-list
154685298|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154685299|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685300|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154685301|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154685302|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437263|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
154860345|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
154685303|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685304|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685305|NCT01534078|Immunotoxins|immunotoxins|mesh-ancestor
154685306|NCT01534078|Immunoconjugates|immunoconjugates|mesh-ancestor
154685307|NCT01534078|Immunologic Factors|immunologic factors|mesh-ancestor
154685308|NCT01534078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685309|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154685310|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
154685311|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154685312|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
154685313|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
154685314|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
154685315|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
154685316|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154685317|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685318|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
154685319|NCT02161406|Abatacept|abatacept|mesh-list
154685320|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154685321|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685322|NCT02161406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685323|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685324|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154685325|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
154685326|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940057|NCT02698306|Diclofenac|diclofenac|mesh-list
154685327|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685328|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
154685329|NCT01573000|Antibodies|antibodies|mesh-list
154685330|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
154685331|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
154685332|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685333|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685334|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
154685335|NCT01572844|Antidotes|antidotes|mesh-ancestor
154685336|NCT01572844|Protective Agents|protective agents|mesh-ancestor
154685337|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685338|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
154685339|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685340|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
154685341|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154685342|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685343|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
154685344|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
154685345|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
154685346|NCT01533922|Olodaterol|olodaterol|mesh-list
154685347|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154685348|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
154685349|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685350|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685351|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154685352|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
154685353|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
154685354|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154685355|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
154685356|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685357|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685358|NCT01533688|Bisacodyl|bisacodyl|mesh-list
154685359|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154685360|NCT01533688|Cathartics|cathartics|mesh-ancestor
154685361|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154685362|NCT01533688|Laxatives|laxatives|mesh-ancestor
154685363|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
154685364|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
154685365|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685366|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154685367|NCT02217878|Morphine|morphine|mesh-list
154685368|NCT02217878|Ticagrelor|ticagrelor|mesh-list
154685369|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154685370|NCT02217878|Narcotics|narcotics|mesh-ancestor
154685371|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685372|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685373|NCT02217878|Analgesics|analgesics|mesh-ancestor
154685374|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
154685375|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685376|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154685377|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154685378|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154437343|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
154685379|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154685380|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
154685381|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685382|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685383|NCT02217566|Prednisone|prednisone|mesh-list
154685384|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
154685385|NCT02217566|Androgens|androgens|mesh-list
154685386|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685387|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
154685388|NCT02217566|Hormones|hormones|mesh-ancestor
154685389|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685390|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685391|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154685392|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685393|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154685394|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685395|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685396|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
154685397|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154685398|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
154685399|NCT02217410|Tacrolimus|tacrolimus|mesh-list
154685400|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154685401|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
154685402|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685403|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154685404|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685405|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685406|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154685407|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685408|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154685409|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
154685410|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154685411|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685412|NCT02217332|Pramipexole|pramipexole|mesh-list
154685413|NCT02217332|Dexpramipexole|dexpramipexole|mesh-list
154685414|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
154685415|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685416|NCT02217332|Protective Agents|protective agents|mesh-ancestor
154685417|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685418|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
154685419|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685420|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154685421|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154685422|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
154685423|NCT02184572|Vaccines|vaccines|mesh-list
154685424|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
153940162|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154685425|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685426|NCT02181842|Pioglitazone|pioglitazone|mesh-list
154685427|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154685428|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685429|NCT01632020|Metformin|metformin|mesh-list
154685430|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154685431|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685432|NCT02181296|Ropivacaine|ropivacaine|mesh-list
154685433|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
154685434|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
154685435|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685436|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685437|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
154685438|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685439|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
154685440|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
154685441|NCT02158442|Ticarcillin|ticarcillin|mesh-list
154685442|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154685443|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685444|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685445|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154685446|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685447|NCT02158364|Vaccines|vaccines|mesh-list
154685448|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
154685449|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685450|NCT02180672|Fluticasone|fluticasone|mesh-list
154685451|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685452|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154685453|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
154685454|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685455|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685456|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154685457|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
154685458|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
154685459|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154685460|NCT01920711|Valsartan|valsartan|mesh-list
154685461|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154685462|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154685463|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154685464|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154685465|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685466|NCT02180438|Tenofovir|tenofovir|mesh-list
154685467|NCT02180438|Emtricitabine|emtricitabine|mesh-list
154685468|NCT02180438|Cobicistat|cobicistat|mesh-list
154685469|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154685470|NCT02180438|Elvitegravir|elvitegravir|mesh-list
154685471|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
154685472|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685473|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154685474|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154685475|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685476|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685477|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154685478|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154685479|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154685480|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154685481|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154685482|NCT02157116|Docetaxel|docetaxel|mesh-list
154685483|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685484|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
154685485|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
154685486|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
154685487|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685488|NCT01920555|Midazolam|midazolam|mesh-list
154685489|NCT01920555|Ketamine|ketamine|mesh-list
154685490|NCT01920555|Analgesics|analgesics|mesh-ancestor
154685491|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
154685492|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685493|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685494|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154685495|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154685496|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
154685497|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
154685498|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685499|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154685500|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154685501|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685502|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685503|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154685504|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154685505|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154685506|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154685507|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154685508|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
154685509|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
154685510|NCT02156804|Nivolumab|nivolumab|mesh-list
154685511|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685512|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685513|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154685514|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685515|NCT02156492|Atorvastatin|atorvastatin|mesh-list
154685516|NCT02156492|Simvastatin|simvastatin|mesh-list
154685517|NCT02156492|Evacetrapib|evacetrapib|mesh-list
154685518|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154685519|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154685520|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
154685521|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685522|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154685523|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154685524|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685525|NCT01920477|Ofatumumab|ofatumumab|mesh-list
154685526|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685527|NCT04641195|Vitamin D|vitamin d|mesh-list
154685528|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
154685529|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
154685531|NCT04641195|Zinc|zinc|mesh-list
154685532|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
154685533|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685534|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154685535|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154685536|NCT04641195|Trace Elements|trace elements|mesh-ancestor
154685537|NCT02213042|Trastuzumab|trastuzumab|mesh-list
154685538|NCT02213042|Lapatinib|lapatinib|mesh-list
154685539|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154685540|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685541|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685542|NCT02213042|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154685543|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154685544|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685545|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685546|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154685547|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154685548|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
154685549|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685550|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685551|NCT04418180|Fenofibrate|fenofibrate|mesh-list
154685552|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154685553|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
154685554|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685555|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154685556|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
154685557|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685558|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685559|NCT02212730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154685560|NCT02212730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685561|NCT02178956|Paclitaxel|paclitaxel|mesh-list
154685562|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154685563|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685564|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
154685565|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
154685566|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
154685567|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685568|NCT02211638|Candesartan|candesartan|mesh-list
154685569|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
154685570|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154685571|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154685572|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154685573|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685574|NCT02178566|Treprostinil|treprostinil|mesh-list
154685575|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154685576|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
154685577|NCT02211014|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154685578|NCT02211014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154685579|NCT02211014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685580|NCT02211014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685581|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685582|NCT01631864|Amlodipine|amlodipine|mesh-list
154685583|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154685584|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154685585|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154685586|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154685587|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685588|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154685589|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685590|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
154685591|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154685592|NCT01557244|Fesoterodine|fesoterodine|mesh-list
154685593|NCT01557244|Oxybutynin|oxybutynin|mesh-list
154685594|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154685595|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154685596|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
154685597|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685598|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685599|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437578|NCT03134612|Lidocaine|lidocaine|mesh-list
154685600|NCT01557244|Urological Agents|urological agents|mesh-ancestor
154685601|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
154685602|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
154685603|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685605|NCT02177942|Trace Elements|trace elements|mesh-list
154685606|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685607|NCT02155322|Interferons|interferons|mesh-list
154685608|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
154685609|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
154685610|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154685611|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685612|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
154685613|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685614|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
154685615|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685616|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154685617|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154685618|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154685619|NCT02209454|Analgesics|analgesics|mesh-ancestor
154685620|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
154685621|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685622|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685623|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685624|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685625|NCT01557166|Liraglutide|liraglutide|mesh-list
154685626|NCT01557166|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154685627|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154685628|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685629|NCT01557166|Incretins|incretins|mesh-ancestor
154685630|NCT01557166|Hormones|hormones|mesh-ancestor
154685631|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685632|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
154685633|NCT01556932|Promethazine|promethazine|mesh-list
154685634|NCT01556932|Lorazepam|lorazepam|mesh-list
154685635|NCT01556932|Haloperidol|haloperidol|mesh-list
154685636|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154685637|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154685638|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685639|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685640|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
154685641|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
154685642|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
154685643|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685644|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
154685645|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
154685646|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154685647|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154685648|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
154685649|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
154685650|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685651|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685652|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154685653|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
154685654|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
154685655|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154685656|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154685657|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154685658|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154685659|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
154685660|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154685661|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
154685662|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154685663|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
154685664|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
154685665|NCT02985736|Desoximetasone|desoximetasone|mesh-list
154685666|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685667|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
154685668|NCT02985736|Hormones|hormones|mesh-ancestor
154685669|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685670|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685671|NCT02985658|Cisplatin|cisplatin|mesh-list
154685672|NCT02985658|Vinorelbine|vinorelbine|mesh-list
154685673|NCT02985658|Veliparib|veliparib|mesh-list
154685674|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685675|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154685676|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
154685677|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
154685678|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
154685679|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685680|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154685681|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685683|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154685684|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685685|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685686|NCT02153918|Metronidazole|metronidazole|mesh-list
154685687|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685688|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154685689|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154685690|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154685691|NCT01571362|Naltrexone|naltrexone|mesh-list
154685692|NCT01571362|Oxycodone|oxycodone|mesh-list
154685693|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154685694|NCT01571362|Narcotics|narcotics|mesh-ancestor
154685695|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685696|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685697|NCT01571362|Analgesics|analgesics|mesh-ancestor
154685698|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
154685699|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685700|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154685701|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154685702|NCT01571284|Aflibercept|aflibercept|mesh-list
154685703|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154685704|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154685705|NCT01571284|Growth Substances|growth substances|mesh-ancestor
154685706|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685707|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
154685708|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685709|NCT02137772|Letermovir|letermovir|mesh-list
154685710|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154685711|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685712|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685713|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685714|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
154685715|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685716|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154685717|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154685718|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
153940452|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
154685719|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685720|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685721|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154685722|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
154685723|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154685724|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154685725|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154685726|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
154685727|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685728|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685729|NCT02137226|Adalimumab|adalimumab|mesh-list
154685730|NCT02137226|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154685731|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685732|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685733|NCT01530334|Gefitinib|gefitinib|mesh-list
154685734|NCT01530334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154685735|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154685736|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685737|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685738|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685739|NCT01570192|Vancomycin|vancomycin|mesh-list
154685740|NCT01570192|Gentamicins|gentamicins|mesh-list
154685741|NCT01570192|Meropenem|meropenem|mesh-list
154685742|NCT01570192|Linezolid|linezolid|mesh-list
154685743|NCT01570192|Tobramycin|tobramycin|mesh-list
154685744|NCT01570192|Amikacin|amikacin|mesh-list
154685745|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154685746|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685747|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154685748|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685749|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685750|NCT02136914|Amantadine|amantadine|mesh-list
154685751|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154685752|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154685753|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
154685754|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685755|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
154685756|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685757|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685758|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685759|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154685760|NCT02136914|Analgesics|analgesics|mesh-ancestor
154685761|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
154685762|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685763|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
154685764|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154685765|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154685766|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154685767|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
154685768|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685769|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685770|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685771|NCT01554514|Rituximab|rituximab|mesh-list
154685772|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685773|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685774|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
154685775|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685776|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685777|NCT01553188|Prednisone|prednisone|mesh-list
154685778|NCT01553188|Trebananib|trebananib|mesh-list
154685779|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685780|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
154685781|NCT01553188|Hormones|hormones|mesh-ancestor
154685782|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940506|NCT04939467|Nintedanib|nintedanib|mesh-list
154685783|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685784|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154685785|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685786|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154685787|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154685788|NCT01553188|Growth Substances|growth substances|mesh-ancestor
154685789|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
154685790|NCT02175758|Ribavirin|ribavirin|mesh-list
154685791|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
154685792|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
154685793|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685794|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
154685795|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685796|NCT01599104|Olmesartan|olmesartan|mesh-list
154685797|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154685798|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154685799|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154685800|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154685801|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685802|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
154685803|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154685804|NCT01518244|Timolol|timolol|mesh-list
154685805|NCT01518244|Brinzolamide|brinzolamide|mesh-list
154685806|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685807|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685808|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154685809|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154685810|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
154685811|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685812|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685813|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154685814|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154685815|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154685816|NCT01552408|Ranibizumab|ranibizumab|mesh-list
154685817|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154685818|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154685819|NCT01552408|Growth Substances|growth substances|mesh-ancestor
154685820|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685821|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
154685822|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685823|NCT02174276|Tenofovir|tenofovir|mesh-list
154685824|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
154437787|NCT02283476|Endostar protein|endostar protein|mesh-list
154685825|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685826|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154860346|NCT02150785|Streptokinase|streptokinase|mesh-list
154685827|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154685828|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685829|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685830|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154685831|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154685833|NCT01527682|Latanoprost|latanoprost|mesh-list
154685834|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154685835|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154685836|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154685837|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154685838|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685839|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685840|NCT01516216|Vitamin D|vitamin d|mesh-list
154685841|NCT01516216|Leucovorin|leucovorin|mesh-list
154685842|NCT01516216|Bevacizumab|bevacizumab|mesh-list
154685843|NCT01516216|Fluorouracil|fluorouracil|mesh-list
154685844|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
154685845|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685846|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685847|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154685848|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154685849|NCT01516216|Growth Substances|growth substances|mesh-ancestor
154685850|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685851|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
154685852|NCT01516216|Vitamins|vitamins|mesh-ancestor
154685853|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
154685854|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154685855|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
154685856|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685857|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154685858|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154685859|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
154685860|NCT01516216|Antidotes|antidotes|mesh-ancestor
154685861|NCT01516216|Protective Agents|protective agents|mesh-ancestor
154685862|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
154685863|NCT01950819|Cyclosporine|cyclosporine|mesh-list
154685864|NCT01950819|Prednisone|prednisone|mesh-list
154685865|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
154685866|NCT01950819|Tacrolimus|tacrolimus|mesh-list
154685867|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
154685868|NCT01950819|Cyclosporins|cyclosporins|mesh-list
154685869|NCT01950819|Basiliximab|basiliximab|mesh-list
154685870|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685871|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
154685872|NCT01950819|Hormones|hormones|mesh-ancestor
154685873|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685874|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685875|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154685876|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685877|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
154685878|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
154685879|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685880|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154685881|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154685882|NCT01950819|Protective Agents|protective agents|mesh-ancestor
154685883|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154685884|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
154685885|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154685886|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685887|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685888|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685889|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
154685890|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
154685891|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685892|NCT01514422|Minocycline|minocycline|mesh-list
154685893|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154685894|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685895|NCT01524796|Pregabalin|pregabalin|mesh-list
154685896|NCT01524796|Analgesics|analgesics|mesh-ancestor
154685897|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
154685898|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685899|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685900|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
154685901|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154685902|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154685903|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685904|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940630|NCT02612545|Mefloquine|mefloquine|mesh-list
154685905|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154685906|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154685907|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154685908|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154685909|NCT01547728|Antithrombins|antithrombins|mesh-list
154685910|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
154685911|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154685912|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
154685913|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685914|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685915|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
154685916|NCT01523392|Clopidogrel|clopidogrel|mesh-list
154685917|NCT01523392|Ticagrelor|ticagrelor|mesh-list
154685918|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154685919|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154685920|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154685921|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154685922|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
154685923|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154685924|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685925|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685926|NCT01512160|Ibuprofen|ibuprofen|mesh-list
154685927|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154685928|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154685929|NCT01512160|Analgesics|analgesics|mesh-ancestor
154685930|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
154685931|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685932|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685933|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685934|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685935|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154685936|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685937|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685938|NCT01950741|Aflibercept|aflibercept|mesh-list
154685939|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154685940|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154685941|NCT01950741|Growth Substances|growth substances|mesh-ancestor
154685942|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685943|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
154685944|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685945|NCT01950273|Rituximab|rituximab|mesh-list
154685946|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154685947|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685948|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
154685949|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685950|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685951|NCT01919229|Letrozole|letrozole|mesh-list
154685952|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685953|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154685954|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154685955|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685956|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685957|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154685958|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
154685959|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685960|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685961|NCT01511536|Prednisone|prednisone|mesh-list
154685962|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
154685963|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685964|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
154685965|NCT01511536|Hormones|hormones|mesh-ancestor
154685966|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154685967|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940705|NCT01021878|Icodextrin|icodextrin|mesh-list
154685968|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154685969|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685970|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154685971|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685972|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685973|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
154685974|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154685975|NCT01510912|Diclofenac|diclofenac|mesh-list
154437934|NCT02283710|Protective Agents|protective agents|mesh-ancestor
154685976|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154685977|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154685978|NCT01510912|Analgesics|analgesics|mesh-ancestor
154685979|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
154685980|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154685981|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154685982|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154685983|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154685984|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154685985|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685986|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685988|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685989|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154685990|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154685991|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154685992|NCT01522456|Tretinoin|tretinoin|mesh-list
154685993|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
154685994|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154685995|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
154685996|NCT01521364|Clarithromycin|clarithromycin|mesh-list
154685997|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154685998|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154685999|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154686000|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686001|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686002|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154686003|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154686004|NCT01545388|Metformin|metformin|mesh-list
154686005|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154686006|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686007|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686008|NCT01545388|Incretins|incretins|mesh-ancestor
154686009|NCT01545388|Hormones|hormones|mesh-ancestor
154686010|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154686011|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154686012|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
154686013|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686014|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686015|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
154686016|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
154686017|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686018|NCT01544920|Interferons|interferons|mesh-list
154686019|NCT01544920|Ribavirin|ribavirin|mesh-list
154686020|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
154686021|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
154686022|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154686023|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686024|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
154686025|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686026|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
154686027|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686028|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
154686029|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686030|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154686031|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
154686032|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
154686033|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686034|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
154686035|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686036|NCT01543204|Etanercept|etanercept|mesh-list
154686037|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154686038|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154686039|NCT01543204|Analgesics|analgesics|mesh-ancestor
154686040|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
154686041|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686042|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686043|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686044|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686045|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154686046|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686047|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
154686048|NCT01518946|Midodrine|midodrine|mesh-list
154686049|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
154438006|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154686051|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686052|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686053|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154686054|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154686055|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154686056|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154686057|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
154686058|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686059|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686060|NCT01507246|Morphine|morphine|mesh-list
154686061|NCT01507246|Bupivacaine|bupivacaine|mesh-list
154686062|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
154686063|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
154686064|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686065|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686066|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
154686067|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686068|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154686069|NCT01507246|Narcotics|narcotics|mesh-ancestor
154686070|NCT01507246|Analgesics|analgesics|mesh-ancestor
154686071|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
154686072|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
154686073|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686074|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
154686075|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686076|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686077|NCT02073448|Adapalene|adapalene|mesh-list
154686078|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154686079|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
153940821|NCT00923091|Amlodipine|amlodipine|mesh-list
154686080|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154686081|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154686082|NCT02073448|Analgesics|analgesics|mesh-ancestor
154686083|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
154686084|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686085|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686086|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686087|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686088|NCT01487200|Triamcinolone|triamcinolone|mesh-list
154686089|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154686090|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154686091|NCT01487200|FX006|fx006|mesh-list
154686092|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154686093|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686094|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
154686095|NCT01487200|Hormones|hormones|mesh-ancestor
154686096|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154686097|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686098|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686099|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
154686100|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686101|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686102|NCT01486966|Insulin|insulin|mesh-list
154686103|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154686104|NCT01486966|Metformin|metformin|mesh-list
154686105|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
154686106|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
154686107|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
154686108|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
154686109|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
154686110|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686111|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686112|NCT04080076|Tacrolimus|tacrolimus|mesh-list
154686113|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686114|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
154686115|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686116|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154686117|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686118|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686119|NCT01900431|Leucovorin|leucovorin|mesh-list
154686120|NCT01900431|Folic Acid|folic acid|mesh-list
154686121|NCT01900431|Prednisone|prednisone|mesh-list
154686122|NCT01900431|Methotrexate|methotrexate|mesh-list
154686123|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
154438089|NCT02281058|Abatacept|abatacept|mesh-list
154686124|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686125|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
154686126|NCT01900431|Hormones|hormones|mesh-ancestor
154686127|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154686128|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686129|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154686130|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686131|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154686132|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
154686133|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154686134|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154686135|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
154686136|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686137|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686138|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686139|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154686140|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686141|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
154686142|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686143|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154686144|NCT01900431|Antidotes|antidotes|mesh-ancestor
154686145|NCT01900431|Protective Agents|protective agents|mesh-ancestor
154686146|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
154686147|NCT01900431|Vitamins|vitamins|mesh-ancestor
154686148|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
154686149|NCT01900431|Hematinics|hematinics|mesh-ancestor
154686150|NCT01948791|Rivastigmine|rivastigmine|mesh-list
154686151|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154686152|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686153|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686154|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
154686155|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686156|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686157|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154686158|NCT01948791|Protective Agents|protective agents|mesh-ancestor
154686159|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
154686160|NCT01898091|Glycerol|glycerol|mesh-list
154686161|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
154686162|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686163|NCT01898091|Protective Agents|protective agents|mesh-ancestor
154686164|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686165|NCT01898091|Vitamins|vitamins|mesh-ancestor
154686166|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
154686167|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154686168|NCT01947855|Empagliflozin|empagliflozin|mesh-list
154686169|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154686170|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686171|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686172|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686173|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
154686174|NCT01888497|Promethazine|promethazine|mesh-list
154686175|NCT01888497|Triazolam|triazolam|mesh-list
154686176|NCT01888497|Gabapentin|gabapentin|mesh-list
154686177|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686178|NCT01888497|Analgesics|analgesics|mesh-ancestor
154686179|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
154686180|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686181|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686182|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
154686183|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154686184|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686185|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686186|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686187|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154686188|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154686189|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686190|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
154686191|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154686192|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154686193|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
154686194|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
154686195|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
154686196|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
154686197|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154686198|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154686199|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
154686200|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
154686201|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154438160|NCT00680342|Silymarin|silymarin|mesh-list
154686202|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
154686203|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686204|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154686205|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
154686206|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
154686207|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
154686208|NCT01485796|Antibodies|antibodies|mesh-list
154686209|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
154686210|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154686211|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154686212|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
154686213|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686214|NCT01897233|Ivacaftor|ivacaftor|mesh-list
154686215|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154686216|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154686217|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686218|NCT01887717|Sorafenib|sorafenib|mesh-list
154686219|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686220|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154686221|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686222|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686223|NCT01463098|Zolpidem|zolpidem|mesh-list
154686224|NCT01463098|Lemborexant|lemborexant|mesh-list
154686225|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154686226|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154686227|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686228|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686229|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154686230|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
154686231|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
154686232|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686233|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686234|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154686235|NCT01462942|Bromides|bromides|mesh-list
154686236|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
154686237|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154686238|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
154686239|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686240|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686241|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154686242|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
154686243|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154686244|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154686245|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154686246|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
154686247|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686248|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686249|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
154686250|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154686251|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154686252|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686253|NCT01504204|Adapalene|adapalene|mesh-list
154686254|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154686255|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154686256|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686257|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154686258|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154686259|NCT01504204|Analgesics|analgesics|mesh-ancestor
154686260|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
154686261|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686262|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686263|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686264|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686265|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154686266|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154686267|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686268|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686269|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686270|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686271|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154686272|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154686273|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154686274|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
154686275|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438230|NCT00612170|Reboxetine|reboxetine|mesh-list
154686276|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686277|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154686278|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154686279|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
154686280|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154686281|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154686282|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
154686283|NCT02118961|Vaccines|vaccines|mesh-list
154686284|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
154686285|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686286|NCT02140645|Linagliptin|linagliptin|mesh-list
154686287|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686288|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686289|NCT02140645|Incretins|incretins|mesh-ancestor
154686290|NCT02140645|Hormones|hormones|mesh-ancestor
154686291|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154686292|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154686293|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
154686294|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686295|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686296|NCT02140411|Ranibizumab|ranibizumab|mesh-list
154686297|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154686298|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154686299|NCT02140411|Growth Substances|growth substances|mesh-ancestor
154686300|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686301|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
154686302|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686303|NCT02139943|Canagliflozin|canagliflozin|mesh-list
154686304|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154686305|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686306|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686307|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686308|NCT01485172|Ropinirole|ropinirole|mesh-list
154686309|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154686310|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154686311|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
154686312|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
154686313|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686314|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686315|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686316|NCT02105701|Ribavirin|ribavirin|mesh-list
154686317|NCT02105701|Grazoprevir|grazoprevir|mesh-list
154686318|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
154686319|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686320|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
154686321|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686322|NCT04411225|Cannabidiol|cannabidiol|mesh-list
154686323|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
154686324|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154686325|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154686326|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686327|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686328|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154686329|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154686330|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686331|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
154686332|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686333|NCT01502644|Morphine|morphine|mesh-list
154686334|NCT01502644|Oxycodone|oxycodone|mesh-list
154686335|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154686336|NCT01502644|Narcotics|narcotics|mesh-ancestor
154686337|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686338|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686339|NCT01502644|Analgesics|analgesics|mesh-ancestor
154686340|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
154686341|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686342|NCT01462318|Vitamin K|vitamin k|mesh-list
154686343|NCT01462318|Midazolam|midazolam|mesh-list
154686344|NCT01462318|Levomethorphan|levomethorphan|mesh-list
154686345|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
154686346|NCT01462318|Caffeine|caffeine|mesh-list
154686347|NCT01462318|Omeprazole|omeprazole|mesh-list
154686348|NCT01462318|Warfarin|warfarin|mesh-list
154686349|NCT01462318|Daclizumab|daclizumab|mesh-list
154686350|NCT01462318|Vitamins|vitamins|mesh-ancestor
154438306|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
154686351|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
154686352|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686353|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154686354|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154686355|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686356|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154686357|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686358|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686359|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154686360|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
154686361|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
154686362|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
154686363|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
154686364|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686365|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686366|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
154686367|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154686368|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154686369|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686370|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154686371|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154686372|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
154686373|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154686374|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154686375|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154686376|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154686377|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154686378|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
154686379|NCT01462318|Coagulants|coagulants|mesh-ancestor
154686380|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
154686381|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
154686382|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154686383|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154686384|NCT01462318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154686385|NCT01462318|Narcotics|narcotics|mesh-ancestor
154686386|NCT01462318|Analgesics|analgesics|mesh-ancestor
154686387|NCT01462318|Sensory System Agents|sensory system agents|mesh-ancestor
154686388|NCT01462318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686389|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686390|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
154686391|NCT01485094|Pregabalin|pregabalin|mesh-list
154686392|NCT01485094|Analgesics|analgesics|mesh-ancestor
154686393|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
154686394|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686395|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686396|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
154686397|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154686398|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154686399|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686400|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154686401|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154686402|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686403|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686404|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686405|NCT04079686|Cefazolin|cefazolin|mesh-list
154686406|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154686407|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686408|NCT01502410|Sorafenib|sorafenib|mesh-list
154686409|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686410|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154686411|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686412|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686413|NCT02132312|Phenylephrine|phenylephrine|mesh-list
154686414|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
154686415|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154686416|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
154686417|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
154686418|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686419|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686420|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
154686421|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154686422|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
154686423|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
154686424|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154686425|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154686426|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154686427|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
154686428|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686429|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686430|NCT02132312|Protective Agents|protective agents|mesh-ancestor
154686431|NCT02150954|Oxytocin|oxytocin|mesh-list
154686432|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
154686433|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154686434|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686435|NCT04188392|Pimavanserin|pimavanserin|mesh-list
154686436|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154686437|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154686438|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154686439|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686440|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686441|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686442|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686443|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154686444|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154686445|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
154686446|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686447|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686448|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154686449|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154686450|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686451|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154686452|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154686453|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154686454|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686455|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
154686456|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686457|NCT02131064|Carboplatin|carboplatin|mesh-list
154686458|NCT02131064|Docetaxel|docetaxel|mesh-list
154686459|NCT02131064|Trastuzumab|trastuzumab|mesh-list
154686460|NCT02131064|Pertuzumab|pertuzumab|mesh-list
154686461|NCT02131064|Maytansine|maytansine|mesh-list
154686462|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154686463|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686464|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
154686465|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
154686466|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
154686467|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686468|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154686469|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154686470|NCT02131064|Immunotoxins|immunotoxins|mesh-ancestor
154686471|NCT02131064|Immunoconjugates|immunoconjugates|mesh-ancestor
154686472|NCT02131064|Immunologic Factors|immunologic factors|mesh-ancestor
154686473|NCT02131064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686474|NCT02130284|Insulin|insulin|mesh-list
154686475|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154686476|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686477|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686478|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154686479|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
154686480|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686481|NCT04748822|Ethanol|ethanol|mesh-list
154686482|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154686483|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686484|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686485|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686486|NCT04739150|Nintedanib|nintedanib|mesh-list
154686487|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686488|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154686489|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686490|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686491|NCT02147132|Nicotine|nicotine|mesh-list
154686492|NCT02147132|Varenicline|varenicline|mesh-list
154686493|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154686494|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
154686495|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686496|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686497|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154686498|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154686499|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
154686500|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438457|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686501|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686502|NCT02146430|Pregabalin|pregabalin|mesh-list
154686503|NCT02146430|Analgesics|analgesics|mesh-ancestor
154686504|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
154686505|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686506|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686507|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
154686508|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154686509|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154686510|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686511|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154686512|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154686513|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686514|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686515|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686516|NCT02129192|Amlodipine|amlodipine|mesh-list
154686517|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154686518|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154686519|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154686520|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686521|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154686522|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686523|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
154686524|NCT02128490|Naproxen|naproxen|mesh-list
154686525|NCT02128490|Colchicine|colchicine|mesh-list
154686526|NCT02128490|Febuxostat|febuxostat|mesh-list
154686527|NCT02128490|Lansoprazole|lansoprazole|mesh-list
154686528|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
154686529|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154686530|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154686531|NCT02128490|Analgesics|analgesics|mesh-ancestor
154686532|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
154686533|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686534|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686535|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686536|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686537|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
154686538|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154686539|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686540|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686541|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
154686542|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
154686543|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
154686544|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686545|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154686546|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154686547|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154686548|NCT02105636|Docetaxel|docetaxel|mesh-list
154686549|NCT02105636|Nivolumab|nivolumab|mesh-list
154686550|NCT02105636|Methotrexate|methotrexate|mesh-list
154686551|NCT02105636|Cetuximab|cetuximab|mesh-list
154686552|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686553|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
154686554|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
154686555|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
154686556|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686557|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154686558|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154686559|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154686560|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
154686561|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154686562|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686563|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154686564|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
154686565|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686566|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686567|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154686568|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686569|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
154686570|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686571|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154686572|NCT01626872|Risperidone|risperidone|mesh-list
154686573|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154686574|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
154686575|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860347|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154438527|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
154686576|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686577|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686578|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154686579|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686580|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686581|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686582|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154686583|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
154686584|NCT01598090|Ribavirin|ribavirin|mesh-list
154686585|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154686586|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
154686587|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686588|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
154686589|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686590|NCT02145182|Eculizumab|eculizumab|mesh-list
154686591|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154686592|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686593|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
154686594|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686595|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
154686596|NCT02145026|Hematinics|hematinics|mesh-ancestor
154686597|NCT02144012|Docetaxel|docetaxel|mesh-list
154686598|NCT02144012|Trastuzumab|trastuzumab|mesh-list
154686599|NCT02144012|Maytansine|maytansine|mesh-list
154686600|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154686601|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686602|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
154686603|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
154686604|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
154686605|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686606|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154686607|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154686608|NCT02144012|Immunotoxins|immunotoxins|mesh-ancestor
154686609|NCT02144012|Immunoconjugates|immunoconjugates|mesh-ancestor
154686610|NCT02144012|Immunologic Factors|immunologic factors|mesh-ancestor
154686611|NCT02144012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686612|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154686613|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686614|NCT02141672|Cyclosporine|cyclosporine|mesh-list
154686615|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
154686616|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686617|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686618|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686619|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686620|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686621|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
154686622|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686623|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686624|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154686625|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
154686626|NCT01628120|Hematinics|hematinics|mesh-ancestor
154686627|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154686628|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686629|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686630|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
154686631|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686632|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154686633|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154686634|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686635|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686636|NCT02123966|Sirolimus|sirolimus|mesh-list
154686637|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154686638|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686639|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154686640|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686641|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
154686642|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686643|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
154686644|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686645|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
154686646|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154686647|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686648|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686649|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154686650|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154686651|NCT02123576|Protective Agents|protective agents|mesh-ancestor
154686652|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686653|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
154686654|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154686655|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
154686656|NCT05235347|Sotrovimab|sotrovimab|mesh-list
154686657|NCT05235347|Antiviral Agents|antiviral agents|mesh-ancestor
154686658|NCT05235347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686659|NCT02140970|Ibuprofen|ibuprofen|mesh-list
154686660|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154686661|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154686662|NCT02140970|Analgesics|analgesics|mesh-ancestor
154686663|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
154686664|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686665|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686666|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686667|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686668|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154686669|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686670|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686671|NCT02101112|Apixaban|apixaban|mesh-list
154686672|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154686673|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
154686674|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154686675|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
154686676|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686677|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686678|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
154686679|NCT02139644|Fluticasone|fluticasone|mesh-list
154686680|NCT02139644|Xhance|xhance|mesh-list
154686681|NCT02139644|Beclomethasone|beclomethasone|mesh-list
154686682|NCT02139644|Albuterol|albuterol|mesh-list
154686683|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154686684|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
154686685|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686686|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154686687|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
154686688|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686689|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686690|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154686691|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
154686692|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686693|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154686694|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154686695|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154686696|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
154686697|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686698|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686699|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
154686700|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154686701|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
154686702|NCT02139644|Hormones|hormones|mesh-ancestor
154686703|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154686704|NCT02100644|Lamotrigine|lamotrigine|mesh-list
154686705|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
154686706|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154686707|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154686708|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686709|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154686710|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686711|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154686712|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686713|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686714|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686715|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154686716|NCT02074982|Ustekinumab|ustekinumab|mesh-list
154686717|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154686718|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
154686719|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686720|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686721|NCT04798001|Vaccines|vaccines|mesh-list
154686722|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
154686723|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686724|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
154686725|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
154686726|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686727|NCT02099708|Lansoprazole|lansoprazole|mesh-list
154686728|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
154686729|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154686730|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154686731|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154686732|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686733|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686734|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
154686735|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154686736|NCT02073656|Ledipasvir|ledipasvir|mesh-list
154686737|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
154686738|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686739|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
154686740|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154686741|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686742|NCT02209181|Acetaminophen|acetaminophen|mesh-list
154686743|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154686744|NCT02209181|Analgesics|analgesics|mesh-ancestor
154686745|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
154686746|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686747|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686748|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
154686749|NCT02242487|Levodopa|levodopa|mesh-list
154686750|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154686751|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154686752|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
154686753|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686754|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686755|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686756|NCT02241785|Natalizumab|natalizumab|mesh-list
154686757|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
154686758|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686759|NCT02241551|Paclitaxel|paclitaxel|mesh-list
154686760|NCT02241551|Gemcitabine|gemcitabine|mesh-list
154686761|NCT02241551|Fluorouracil|fluorouracil|mesh-list
154686762|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
154686763|NCT02241551|Irinotecan|irinotecan|mesh-list
154686764|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154686765|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686766|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
154686767|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
154686768|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
154686769|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686770|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154686771|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
154686772|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686773|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
154686774|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686775|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154686776|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154686777|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686778|NCT02207621|Timolol|timolol|mesh-list
154686779|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154686780|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154686781|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686782|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154686783|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154686784|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
154686785|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686786|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686787|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154686788|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154686789|NCT02240693|BI 409306|bi 409306|mesh-list
154686790|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154686791|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686792|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686793|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154686794|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154686795|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686796|NCT02072096|Metformin|metformin|mesh-list
154686797|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
154686798|NCT02072096|Pioglitazone|pioglitazone|mesh-list
154686799|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154686800|NCT02072096|Liraglutide|liraglutide|mesh-list
154686801|NCT02072096|Exenatide|exenatide|mesh-list
154438748|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
154686802|NCT02072096|Glimepiride|glimepiride|mesh-list
154686803|NCT02072096|Linagliptin|linagliptin|mesh-list
154686805|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686806|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686807|NCT02072096|Incretins|incretins|mesh-ancestor
154686808|NCT02072096|Hormones|hormones|mesh-ancestor
154686809|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154686810|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154686811|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
154686812|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686813|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686814|NCT02072096|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154686815|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154686816|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154686817|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686818|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
154686819|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154686820|NCT01631825|Rotigotine|rotigotine|mesh-list
154686821|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
154686822|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
154686823|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686824|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686825|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686826|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154686827|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154686828|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154686829|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
154686830|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686831|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
154686832|NCT02123108|Tacrolimus|tacrolimus|mesh-list
154686833|NCT02123108|Basiliximab|basiliximab|mesh-list
154686834|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686835|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
154686836|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686837|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154686838|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686839|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686840|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154686841|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686842|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154686843|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
154686844|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154686845|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686846|NCT02121392|Bupivacaine|bupivacaine|mesh-list
154686847|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
154686848|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
154686849|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686850|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686851|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
154686852|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686853|NCT02097056|Donepezil|donepezil|mesh-list
154686854|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154686855|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686856|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686857|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
154686858|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686859|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686860|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
154686861|NCT02121002|Diclofenac|diclofenac|mesh-list
154686862|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154686863|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154686864|NCT02121002|Analgesics|analgesics|mesh-ancestor
154686865|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
154686866|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686867|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686868|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686869|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686870|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154686871|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686872|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686873|NCT02096900|Midazolam|midazolam|mesh-list
154686874|NCT02096900|Zolpidem|zolpidem|mesh-list
154686875|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154686876|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154686877|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686878|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686879|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154686880|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154686881|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686882|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154686883|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
154686885|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
154686886|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
154686887|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686888|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686889|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154686890|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154686891|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
154686892|NCT02120924|Azelaic acid|azelaic acid|mesh-list
154686893|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686894|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
154686895|NCT02096744|Clonidine|clonidine|mesh-list
154686896|NCT02096744|Analgesics|analgesics|mesh-ancestor
154686897|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
154686898|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686899|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686900|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154686901|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
154686902|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
154686903|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154686904|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154686905|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154686906|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
154686907|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686908|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686909|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
154686910|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
154686911|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154686912|NCT02069366|Dronabinol|dronabinol|mesh-list
154686913|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
154686914|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686915|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154686916|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154686917|NCT02069366|Analgesics|analgesics|mesh-ancestor
154686918|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
154686919|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686920|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154686921|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154686922|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154686923|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686924|NCT02069366|Hormones|hormones|mesh-ancestor
154686925|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154686926|NCT04732208|Mydriatics|mydriatics|mesh-list
154686927|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
154686928|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686929|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686930|NCT02068508|Pioglitazone|pioglitazone|mesh-list
154686931|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686932|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686933|NCT02207231|Adalimumab|adalimumab|mesh-list
154686934|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154686935|NCT02207231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154686936|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154686937|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154686938|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
154686939|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686940|NCT02206685|Methadone|methadone|mesh-list
154686941|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154686942|NCT02206685|Narcotics|narcotics|mesh-ancestor
154686943|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154686944|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686945|NCT02206685|Analgesics|analgesics|mesh-ancestor
154686946|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
154686947|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154686948|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
154686949|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
154686950|NCT02095106|Calpastatin|calpastatin|mesh-list
154686951|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154686952|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
154686953|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686954|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686955|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
154686956|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154686957|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686958|NCT02235311|Pantoprazole|pantoprazole|mesh-list
154686959|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154686960|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154686961|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154686962|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686963|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686964|NCT02235077|Spironolactone|spironolactone|mesh-list
154686965|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154686966|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
154686967|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154686968|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686969|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154686970|NCT02235077|Diuretics|diuretics|mesh-ancestor
154686971|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
154686972|NCT02234141|Selonsertib|selonsertib|mesh-list
154686973|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154686974|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686975|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686976|NCT01896531|Leucovorin|leucovorin|mesh-list
154686977|NCT01896531|Fluorouracil|fluorouracil|mesh-list
154686978|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
154686979|NCT01896531|Ipatasertib|ipatasertib|mesh-list
154686980|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
154686981|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154686982|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154686983|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154686984|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154686985|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
154686986|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154686987|NCT01896531|Antidotes|antidotes|mesh-ancestor
154686988|NCT01896531|Protective Agents|protective agents|mesh-ancestor
154686989|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
154686990|NCT01896531|Vitamins|vitamins|mesh-ancestor
154686991|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
154686992|NCT01896531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154686993|NCT01896531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154686994|NCT01618305|Lamivudine|lamivudine|mesh-list
154686995|NCT01618305|Zidovudine|zidovudine|mesh-list
154686996|NCT01618305|Efavirenz|efavirenz|mesh-list
154686997|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154686998|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
154686999|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154687000|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154687001|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687002|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687003|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
154687004|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687005|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154687006|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154687007|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
154687008|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154687009|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154687010|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154687011|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154687012|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154687013|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154687014|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154687015|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154687016|NCT01896297|Dabigatran|dabigatran|mesh-list
154687017|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
154687018|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154687019|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
154687020|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687021|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687022|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
154687023|NCT01884675|Ambrisentan|ambrisentan|mesh-list
154687024|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154687025|NCT01884597|Ranibizumab|ranibizumab|mesh-list
154687026|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154687027|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154687029|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687030|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
154687031|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687032|NCT01864005|Clopidogrel|clopidogrel|mesh-list
154687033|NCT01864005|Ticagrelor|ticagrelor|mesh-list
154687034|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154687035|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154687036|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154687037|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154687038|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
154687039|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687040|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687041|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687042|NCT01863771|Golimumab|golimumab|mesh-list
154687043|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154687044|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687045|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154687046|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
154687047|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687048|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154687049|NCT01894581|Hormones|hormones|mesh-ancestor
154687050|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687051|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687052|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
154687053|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154687054|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154687055|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154687056|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154687057|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154687058|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687059|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
154687060|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687061|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687062|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154687063|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687064|NCT02202551|Amantadine|amantadine|mesh-list
154687065|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154687066|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154687067|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
154687068|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687069|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
154687070|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687071|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687072|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687073|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687074|NCT02202551|Analgesics|analgesics|mesh-ancestor
154687075|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
154687076|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687077|NCT02118337|Nivolumab|nivolumab|mesh-list
154687078|NCT02118337|Durvalumab|durvalumab|mesh-list
154687079|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687080|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687081|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154687082|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687083|NCT02105467|Grazoprevir|grazoprevir|mesh-list
154687084|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154687085|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
154687086|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687087|NCT02202161|Metformin|metformin|mesh-list
154687088|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154687089|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154687090|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687091|NCT02202161|Incretins|incretins|mesh-ancestor
154687092|NCT02202161|Hormones|hormones|mesh-ancestor
154687093|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687094|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154687095|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
154687096|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687097|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687098|NCT03109847|Metformin|metformin|mesh-list
154687099|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154439046|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687100|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687102|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687103|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687104|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
154687105|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687106|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687107|NCT02623205|Escitalopram|escitalopram|mesh-list
154687108|NCT02623205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154687109|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154687110|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154687111|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687112|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687113|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
154687114|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687115|NCT01500694|Guanfacine|guanfacine|mesh-list
154687116|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154687117|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154687118|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154687119|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154687120|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
154687121|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687122|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687123|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687124|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154687125|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154687126|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687127|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154687128|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154687129|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
154687130|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687131|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687132|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687133|NCT01500382|Urological Agents|urological agents|mesh-ancestor
154687134|NCT02137837|Everolimus|everolimus|mesh-list
154687135|NCT02137837|Fulvestrant|fulvestrant|mesh-list
154687136|NCT02137837|Anastrozole|anastrozole|mesh-list
154687137|NCT02137837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154687138|NCT02137837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154687139|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687140|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687141|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154687142|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
154687143|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687144|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687145|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687146|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154687147|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154687148|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
154687149|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687150|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154687151|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154687152|NCT01483690|Dexamethasone|dexamethasone|mesh-list
154687153|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
154687154|NCT01483690|Methotrexate|methotrexate|mesh-list
154687155|NCT01483690|Vincristine|vincristine|mesh-list
154687156|NCT01483690|Decitabine|decitabine|mesh-list
154687157|NCT01483690|Asparaginase|asparaginase|mesh-list
154687158|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
154687159|NCT01483690|Vorinostat|vorinostat|mesh-list
154687160|NCT01483690|Pegaspargase|pegaspargase|mesh-list
154687161|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154687162|NCT01483690|BB 1101|bb 1101|mesh-list
154687163|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687164|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
154687165|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
154687166|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687167|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687168|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687169|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
154687170|NCT01483690|Hormones|hormones|mesh-ancestor
154687171|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687172|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687173|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687174|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
154687175|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687176|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687177|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154687178|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
154687179|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154687180|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154687181|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
154687182|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
154687183|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154687184|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154687185|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
154687186|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687187|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154687188|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154687189|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
154687190|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
154687191|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
154687192|NCT01483690|Analgesics|analgesics|mesh-ancestor
154687193|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
154687194|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154687195|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154687196|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154687197|NCT01483144|Eflornithine|eflornithine|mesh-list
154687198|NCT01483144|Sulindac|sulindac|mesh-list
154687199|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687200|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154687201|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154687202|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154687203|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687204|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154687205|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687206|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687207|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154687208|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687209|NCT01483144|Analgesics|analgesics|mesh-ancestor
154687210|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
154687211|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687212|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687213|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687214|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687215|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154687216|NCT01881789|Dexamethasone|dexamethasone|mesh-list
154687217|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
154687218|NCT01881789|Lenalidomide|lenalidomide|mesh-list
154687219|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154687220|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
154687221|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687222|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687223|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154687224|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
154687225|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687226|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687227|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154687228|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687229|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
154687230|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
154687231|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687232|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687233|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
154687234|NCT01881789|Hormones|hormones|mesh-ancestor
154687235|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687236|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687237|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154687238|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154687239|NCT01881789|Growth Substances|growth substances|mesh-ancestor
154687240|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
154687241|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
154687242|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154687243|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
154687244|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687245|NCT01892163|Dexamethasone|dexamethasone|mesh-list
154687246|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687247|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
154687248|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
154687249|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687250|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687251|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687252|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
154687253|NCT01892163|Hormones|hormones|mesh-ancestor
154687254|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687255|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687256|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687257|NCT06287151|Clonidine|clonidine|mesh-list
154687258|NCT06287151|Sevoflurane|sevoflurane|mesh-list
154687259|NCT06287151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154687260|NCT06287151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154687261|NCT06287151|Anesthetics, General|anesthetics, general|mesh-ancestor
154687262|NCT06287151|Anesthetics|anesthetics|mesh-ancestor
154687263|NCT06287151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687264|NCT06287151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687265|NCT06287151|Analgesics|analgesics|mesh-ancestor
154687266|NCT06287151|Sensory System Agents|sensory system agents|mesh-ancestor
154687267|NCT06287151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687268|NCT06287151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154687269|NCT06287151|Sympatholytics|sympatholytics|mesh-ancestor
154687270|NCT06287151|Autonomic Agents|autonomic agents|mesh-ancestor
154687271|NCT06287151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154687272|NCT06287151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154687273|NCT06287151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154687274|NCT06287151|Adrenergic Agents|adrenergic agents|mesh-ancestor
154687275|NCT06287151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687276|NCT06287151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687277|NCT06286878|Dapagliflozin|dapagliflozin|mesh-list
154687278|NCT06286878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154687279|NCT06286878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687280|NCT06286878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154687281|NCT06286878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687282|NCT06286839|Cannabidiol|cannabidiol|mesh-list
154687283|NCT06286839|Anticonvulsants|anticonvulsants|mesh-ancestor
154687284|NCT06286657|Xanthohumol|xanthohumol|mesh-list
154687285|NCT06286657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687286|NCT06286657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154687287|NCT06286657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154687288|NCT06286657|Growth Substances|growth substances|mesh-ancestor
154687289|NCT06286657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687290|NCT06286657|Growth Inhibitors|growth inhibitors|mesh-ancestor
154687291|NCT06286644|Xanthohumol|xanthohumol|mesh-list
154687292|NCT06286644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687293|NCT06286644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154687294|NCT06286644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154687295|NCT06286644|Growth Substances|growth substances|mesh-ancestor
154687296|NCT06286644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687297|NCT06286644|Growth Inhibitors|growth inhibitors|mesh-ancestor
154687298|NCT06286254|Acetaminophen|acetaminophen|mesh-list
154687299|NCT06286254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687300|NCT06286254|Analgesics|analgesics|mesh-ancestor
154687301|NCT06286254|Sensory System Agents|sensory system agents|mesh-ancestor
154687302|NCT06286254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687303|NCT06286254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942064|NCT00626015|Daclizumab|daclizumab|mesh-list
154687304|NCT06286254|Antipyretics|antipyretics|mesh-ancestor
154687305|NCT06286189|Trazodone|trazodone|mesh-list
154687306|NCT06286189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154687307|NCT06286189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154687308|NCT06286189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687309|NCT06286189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687310|NCT06286189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154687311|NCT06286189|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154687312|NCT06286189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154687313|NCT06286189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154687314|NCT06286189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687315|NCT06286189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687316|NCT06286189|Serotonin Agents|serotonin agents|mesh-ancestor
154687317|NCT06286189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154687318|NCT06286189|Antidepressive Agents|antidepressive agents|mesh-ancestor
154687319|NCT06285942|Edoxaban|edoxaban|mesh-list
154687320|NCT06285942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154687321|NCT06285942|Antithrombins|antithrombins|mesh-ancestor
154687322|NCT06285942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154687323|NCT06285942|Protease Inhibitors|protease inhibitors|mesh-ancestor
154687324|NCT06285942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687325|NCT06285942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687326|NCT06285942|Anticoagulants|anticoagulants|mesh-ancestor
154687327|NCT06285799|Locust bean gum|locust bean gum|mesh-list
154687328|NCT06285799|Antidiarrheals|antidiarrheals|mesh-ancestor
154687329|NCT06285799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687330|NCT06285617|Celecoxib|celecoxib|mesh-list
154687331|NCT06285617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154687332|NCT06285617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687333|NCT06285617|Analgesics|analgesics|mesh-ancestor
154687334|NCT06285617|Sensory System Agents|sensory system agents|mesh-ancestor
154687335|NCT06285617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687336|NCT06285617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687337|NCT06285617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687338|NCT06285617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687339|NCT06285617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154687340|NCT06285617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154687341|NCT06285617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687342|NCT06285617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687343|NCT06285435|Thrombin|thrombin|mesh-list
154687344|NCT06285435|Hemostatics|hemostatics|mesh-ancestor
154687345|NCT06285435|Coagulants|coagulants|mesh-ancestor
154687346|NCT06285370|Mogamulizumab|mogamulizumab|mesh-list
154687347|NCT06285370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687348|NCT06285019|Bevacizumab|bevacizumab|mesh-list
154687349|NCT06285019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687350|NCT06285019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687351|NCT06285019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154687352|NCT06285019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154687353|NCT06285019|Growth Substances|growth substances|mesh-ancestor
154687354|NCT06285019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687355|NCT06285019|Growth Inhibitors|growth inhibitors|mesh-ancestor
154687356|NCT06285006|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154687357|NCT06285006|Hemostatics|hemostatics|mesh-ancestor
154687358|NCT06285006|Coagulants|coagulants|mesh-ancestor
154687359|NCT06285006|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154687360|NCT06285006|Natriuretic Agents|natriuretic agents|mesh-ancestor
154687361|NCT06285006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687362|NCT06284941|Ropivacaine|ropivacaine|mesh-list
154687363|NCT06284941|Methylene Blue|methylene blue|mesh-list
154687364|NCT06284941|Anesthetics, Local|anesthetics, local|mesh-ancestor
154687365|NCT06284941|Anesthetics|anesthetics|mesh-ancestor
154687366|NCT06284941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687367|NCT06284941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687368|NCT06284941|Sensory System Agents|sensory system agents|mesh-ancestor
154687369|NCT06284941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687370|NCT06284941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687371|NCT06284941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687372|NCT06284915|Vaccines|vaccines|mesh-list
154687373|NCT06284915|Immunologic Factors|immunologic factors|mesh-ancestor
154687374|NCT06284915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687375|NCT06284876|Lansoprazole|lansoprazole|mesh-list
154687376|NCT06284876|Dexlansoprazole|dexlansoprazole|mesh-list
154687377|NCT06284876|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154687378|NCT06284876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687379|NCT06284876|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154687380|NCT06284876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687381|NCT06284876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687382|NCT06284850|Empagliflozin|empagliflozin|mesh-list
154687383|NCT06284850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154687384|NCT06284850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687385|NCT06284850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154687386|NCT06284850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687387|NCT06284746|Fluorouracil|fluorouracil|mesh-list
154687388|NCT06284746|Antimetabolites|antimetabolites|mesh-ancestor
154687389|NCT06284746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687390|NCT06284746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154687391|NCT06284746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687392|NCT06284746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154687393|NCT06284746|Immunologic Factors|immunologic factors|mesh-ancestor
154687394|NCT06284746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687395|NCT06284642|Plasminogen|plasminogen|mesh-list
154687396|NCT06284642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154687397|NCT06284642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154687398|NCT06284642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439347|NCT02283320|Docetaxel|docetaxel|mesh-list
154687399|NCT06284590|Pembrolizumab|pembrolizumab|mesh-list
154687400|NCT06284590|Interleukin-2|interleukin-2|mesh-list
154687401|NCT06284590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687402|NCT06284590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687403|NCT06284590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154687404|NCT06284590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687405|NCT06284590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687406|NCT06284590|Analgesics|analgesics|mesh-ancestor
154687407|NCT06284590|Sensory System Agents|sensory system agents|mesh-ancestor
154687408|NCT06284590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687409|NCT06284590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687410|NCT06284564|Nivolumab|nivolumab|mesh-list
154687411|NCT06284564|Evolocumab|evolocumab|mesh-list
154687412|NCT06284564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687413|NCT06284564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687414|NCT06284564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153942147|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
154687415|NCT06284564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687416|NCT06284564|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154687417|NCT06284564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154687418|NCT06284564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154687419|NCT06284564|Antimetabolites|antimetabolites|mesh-ancestor
154687420|NCT06284564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154687421|NCT06284564|Protease Inhibitors|protease inhibitors|mesh-ancestor
154687422|NCT06284564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687423|NCT06284564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154687424|NCT06284460|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154687425|NCT06284460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154687426|NCT06284460|Antimetabolites|antimetabolites|mesh-ancestor
154687427|NCT06284460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687428|NCT06284460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687429|NCT06283550|Abrocitinib|abrocitinib|mesh-list
154687430|NCT06283550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154687431|NCT06283550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687432|NCT06283550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687433|NCT06281951|Fentanyl|fentanyl|mesh-list
154687434|NCT06281951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154687435|NCT06281951|Narcotics|narcotics|mesh-ancestor
154687436|NCT06281951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687437|NCT06281951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687438|NCT06281951|Analgesics|analgesics|mesh-ancestor
154687439|NCT06281951|Sensory System Agents|sensory system agents|mesh-ancestor
154687440|NCT06281951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687441|NCT06281951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154687442|NCT06281951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154687443|NCT06281951|Anesthetics, General|anesthetics, general|mesh-ancestor
154687444|NCT06281951|Anesthetics|anesthetics|mesh-ancestor
154687445|NCT06279429|Iron|iron|mesh-list
154687446|NCT06279429|Trace Elements|trace elements|mesh-ancestor
154687447|NCT06279429|Micronutrients|micronutrients|mesh-ancestor
154687448|NCT06279429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687449|NCT06278038|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154687450|NCT06278038|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154687451|NCT06278038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154687452|NCT06278038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154687453|NCT06278038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687454|NCT06278038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687455|NCT06278038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687456|NCT06278038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154687457|NCT06278038|Antidepressive Agents|antidepressive agents|mesh-ancestor
154687458|NCT06278038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154687459|NCT06276738|Pancrelipase|pancrelipase|mesh-list
154687460|NCT06276738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687461|NCT06271668|Naloxone|naloxone|mesh-list
154687462|NCT06271668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154687463|NCT06271668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687464|NCT06271668|Sensory System Agents|sensory system agents|mesh-ancestor
154687465|NCT06271668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687466|NCT06260722|Semaglutide|semaglutide|mesh-list
154687467|NCT06260722|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154687468|NCT06260722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154687469|NCT06260722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687470|NCT06257264|Fulvestrant|fulvestrant|mesh-list
154687471|NCT06257264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154439424|NCT02097342|Linagliptin|linagliptin|mesh-list
154687472|NCT06257264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687473|NCT06257264|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154687474|NCT06257264|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154687475|NCT06257264|Hormone Antagonists|hormone antagonists|mesh-ancestor
154687476|NCT06257264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687477|NCT06257264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687478|NCT06247540|Rituximab|rituximab|mesh-list
154687479|NCT06247540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154687480|NCT06247540|Nivolumab|nivolumab|mesh-list
154687481|NCT06247540|Venetoclax|venetoclax|mesh-list
154687482|NCT06247540|Antibodies|antibodies|mesh-list
154687483|NCT06247540|Immunoglobulins|immunoglobulins|mesh-list
154687484|NCT06247540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154687485|NCT06247540|Immunologic Factors|immunologic factors|mesh-ancestor
154687486|NCT06247540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687487|NCT06247540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687488|NCT06247540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687489|NCT06247540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154687490|NCT06247540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687491|NCT06237920|Nivolumab|nivolumab|mesh-list
154687492|NCT06237920|Relatlimab|relatlimab|mesh-list
154687493|NCT06237920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687494|NCT06237920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687495|NCT06237920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154687496|NCT06237920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687497|NCT06230081|Clonidine|clonidine|mesh-list
154687498|NCT06230081|Analgesics|analgesics|mesh-ancestor
154687499|NCT06230081|Sensory System Agents|sensory system agents|mesh-ancestor
154687500|NCT06230081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687501|NCT06230081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687502|NCT06230081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154687503|NCT06230081|Sympatholytics|sympatholytics|mesh-ancestor
154687504|NCT06230081|Autonomic Agents|autonomic agents|mesh-ancestor
154687505|NCT06230081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154687506|NCT06230081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154687507|NCT06230081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154687508|NCT06230081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154687509|NCT06230081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687510|NCT06230081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687511|NCT06208150|Dexamethasone|dexamethasone|mesh-list
154687512|NCT06208150|Bortezomib|bortezomib|mesh-list
154687513|NCT06208150|Pomalidomide|pomalidomide|mesh-list
154687514|NCT06208150|Elotuzumab|elotuzumab|mesh-list
154687515|NCT06208150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687516|NCT06208150|Antiemetics|antiemetics|mesh-ancestor
154687517|NCT06208150|Autonomic Agents|autonomic agents|mesh-ancestor
154687518|NCT06208150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687519|NCT06208150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687520|NCT06208150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687521|NCT06208150|Glucocorticoids|glucocorticoids|mesh-ancestor
154687522|NCT06208150|Hormones|hormones|mesh-ancestor
154687523|NCT06208150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687524|NCT06208150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687525|NCT06208150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687526|NCT06208150|Immunologic Factors|immunologic factors|mesh-ancestor
154687527|NCT06208150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154687528|NCT06208150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154687529|NCT06208150|Growth Substances|growth substances|mesh-ancestor
154687530|NCT06208150|Growth Inhibitors|growth inhibitors|mesh-ancestor
154687531|NCT06206525|Insulin|insulin|mesh-list
154687532|NCT06206525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154687533|NCT06206525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687534|NCT06173648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154687535|NCT06170723|Itraconazole|itraconazole|mesh-list
154687536|NCT06170723|Famotidine|famotidine|mesh-list
154687537|NCT06170723|Antifungal Agents|antifungal agents|mesh-ancestor
153942261|NCT00619996|Docetaxel|docetaxel|mesh-list
154687538|NCT06170723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687539|NCT06170723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154687540|NCT06170723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154687541|NCT06170723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687542|NCT06170723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687543|NCT06170723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154687544|NCT06170723|Hormone Antagonists|hormone antagonists|mesh-ancestor
154687545|NCT06170723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687546|NCT06170723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687547|NCT06170723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154687548|NCT06170723|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154687549|NCT06170723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687550|NCT06170723|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154687551|NCT06170723|Histamine Antagonists|histamine antagonists|mesh-ancestor
154687552|NCT06170723|Histamine Agents|histamine agents|mesh-ancestor
154687553|NCT06170723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687554|NCT06143566|Empagliflozin|empagliflozin|mesh-list
154687555|NCT06143566|Losartan|losartan|mesh-list
154687556|NCT06143566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154687557|NCT06143566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154687558|NCT06143566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154687559|NCT06143566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154687560|NCT06143566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687561|NCT06143566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154687562|NCT06143566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154687563|NCT06143566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687564|NCT06140758|Listerine|listerine|mesh-list
154687565|NCT06140758|Fluorides|fluorides|mesh-list
154687566|NCT06140758|Sodium Fluoride|sodium fluoride|mesh-list
154687567|NCT06140758|Tin Fluorides|tin fluorides|mesh-list
154687568|NCT06140758|Fluorophosphate|fluorophosphate|mesh-list
154687569|NCT06140758|Cariostatic Agents|cariostatic agents|mesh-ancestor
154687570|NCT06140758|Protective Agents|protective agents|mesh-ancestor
154687571|NCT06140758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687572|NCT06140758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154687573|NCT06140758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687574|NCT06120283|Letrozole|letrozole|mesh-list
154687575|NCT06120283|Fulvestrant|fulvestrant|mesh-list
154687576|NCT06120283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687577|NCT06120283|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154687578|NCT06120283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154687579|NCT06120283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687580|NCT06120283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687581|NCT06120283|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154687582|NCT06120283|Hormone Antagonists|hormone antagonists|mesh-ancestor
154687583|NCT06120283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687584|NCT06120283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687585|NCT06120283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687586|NCT06120283|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154687587|NCT06106334|Itraconazole|itraconazole|mesh-list
154687588|NCT06106334|Antifungal Agents|antifungal agents|mesh-ancestor
154687589|NCT06106334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687590|NCT06106334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154687591|NCT06106334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154687592|NCT06106334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687593|NCT06106334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687594|NCT06106334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154687595|NCT06106334|Hormone Antagonists|hormone antagonists|mesh-ancestor
154687596|NCT06106334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687597|NCT06106334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687598|NCT06106334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154687599|NCT06097169|Fentanyl|fentanyl|mesh-list
154687600|NCT06097169|Dexmedetomidine|dexmedetomidine|mesh-list
154687601|NCT06097169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154687602|NCT06097169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687603|NCT06097169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687604|NCT06097169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687605|NCT06097169|Analgesics|analgesics|mesh-ancestor
154687606|NCT06097169|Sensory System Agents|sensory system agents|mesh-ancestor
154687607|NCT06097169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687608|NCT06097169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154687609|NCT06097169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154687610|NCT06097169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154687611|NCT06097169|Adrenergic Agents|adrenergic agents|mesh-ancestor
154687612|NCT06097169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687613|NCT06097169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687614|NCT06097169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154687615|NCT06097169|Narcotics|narcotics|mesh-ancestor
154687616|NCT06097169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154687617|NCT06097169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154687618|NCT06097169|Anesthetics, General|anesthetics, general|mesh-ancestor
154687619|NCT06097169|Anesthetics|anesthetics|mesh-ancestor
154687620|NCT06091943|Tislelizumab|tislelizumab|mesh-list
154687621|NCT06091943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687623|NCT06081244|Pembrolizumab|pembrolizumab|mesh-list
154687624|NCT06081244|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154687625|NCT06081244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687626|NCT06081244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687627|NCT06081244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154687628|NCT06081244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687629|NCT06081244|Immunoconjugates|immunoconjugates|mesh-ancestor
154687630|NCT06081244|Immunologic Factors|immunologic factors|mesh-ancestor
154687631|NCT06081244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687632|NCT06080880|Dexamethasone|dexamethasone|mesh-list
154687633|NCT06080880|Ondansetron|ondansetron|mesh-list
154687634|NCT06080880|Aprepitant|aprepitant|mesh-list
154687635|NCT06080880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687636|NCT06080880|Antiemetics|antiemetics|mesh-ancestor
154687637|NCT06080880|Autonomic Agents|autonomic agents|mesh-ancestor
154687638|NCT06080880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687639|NCT06080880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687640|NCT06080880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687641|NCT06080880|Glucocorticoids|glucocorticoids|mesh-ancestor
154687642|NCT06080880|Hormones|hormones|mesh-ancestor
154687643|NCT06080880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687644|NCT06080880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687645|NCT06080880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687646|NCT06080880|Antipruritics|antipruritics|mesh-ancestor
154687647|NCT06080880|Dermatologic Agents|dermatologic agents|mesh-ancestor
154687648|NCT06080880|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154687649|NCT06080880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154687650|NCT06080880|Serotonin Agents|serotonin agents|mesh-ancestor
154687651|NCT06080880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687652|NCT06080880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687653|NCT06080880|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154687654|NCT06075667|Tirzepatide|tirzepatide|mesh-list
154687655|NCT06075667|Incretins|incretins|mesh-ancestor
154687656|NCT06075667|Hormones|hormones|mesh-ancestor
154687657|NCT06075667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687658|NCT06075667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687659|NCT06074380|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154687660|NCT06074380|Respiratory System Agents|respiratory system agents|mesh-ancestor
154687661|NCT06069791|Bupivacaine|bupivacaine|mesh-list
154687662|NCT06069791|Anesthetics, Local|anesthetics, local|mesh-ancestor
154687663|NCT06069791|Anesthetics|anesthetics|mesh-ancestor
154687664|NCT06069791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687665|NCT06069791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687666|NCT06069791|Sensory System Agents|sensory system agents|mesh-ancestor
154687667|NCT06069791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687668|NCT06066710|Propranolol|propranolol|mesh-list
154687669|NCT06066710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154687670|NCT06066710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154687671|NCT06066710|Adrenergic Agents|adrenergic agents|mesh-ancestor
154687672|NCT06066710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687673|NCT06066710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687674|NCT06066710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687675|NCT06066710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154687676|NCT06066710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154687677|NCT06066710|Vasodilator Agents|vasodilator agents|mesh-ancestor
154687678|NCT06055465|Pembrolizumab|pembrolizumab|mesh-list
154687679|NCT06055465|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154687680|NCT06055465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687681|NCT06055465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687682|NCT06055465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154687683|NCT06055465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687684|NCT06055465|Immunoconjugates|immunoconjugates|mesh-ancestor
154687685|NCT06055465|Immunologic Factors|immunologic factors|mesh-ancestor
154687686|NCT06055465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687687|NCT06047548|Tirzepatide|tirzepatide|mesh-list
154687688|NCT06047548|Incretins|incretins|mesh-ancestor
154687689|NCT06047548|Hormones|hormones|mesh-ancestor
154687690|NCT06047548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687691|NCT06047548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687692|NCT06037252|Tirzepatide|tirzepatide|mesh-list
154687693|NCT06037252|Incretins|incretins|mesh-ancestor
154687694|NCT06037252|Hormones|hormones|mesh-ancestor
154687695|NCT06037252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687696|NCT06037252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687697|NCT06014385|Scopolamine|scopolamine|mesh-list
154687698|NCT06014385|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154687699|NCT06014385|LSN3172176|lsn3172176|mesh-list
154687700|NCT06014385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154687701|NCT06014385|Antiemetics|antiemetics|mesh-ancestor
154687702|NCT06014385|Autonomic Agents|autonomic agents|mesh-ancestor
154687703|NCT06014385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687704|NCT06014385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687705|NCT06014385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687706|NCT06014385|Mydriatics|mydriatics|mesh-ancestor
154687707|NCT06014385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154687708|NCT06014385|Cholinergic Agents|cholinergic agents|mesh-ancestor
154687709|NCT06014385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687710|NCT06014385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687711|NCT06014385|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154687712|NCT06014385|Parasympatholytics|parasympatholytics|mesh-ancestor
154687713|NCT06014385|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154687714|NCT06010303|Tislelizumab|tislelizumab|mesh-list
154687715|NCT06010303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687716|NCT06010303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687717|NCT05986318|Acetylcysteine|acetylcysteine|mesh-list
154687718|NCT05986318|Dexamethasone|dexamethasone|mesh-list
154687719|NCT05986318|Dexamethasone acetate|dexamethasone acetate|mesh-list
154687720|NCT05986318|BB 1101|bb 1101|mesh-list
154687721|NCT05986318|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154687722|NCT05986318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687723|NCT05986318|Antiemetics|antiemetics|mesh-ancestor
154687724|NCT05986318|Autonomic Agents|autonomic agents|mesh-ancestor
154687725|NCT05986318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687726|NCT05986318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687727|NCT05986318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687728|NCT05986318|Glucocorticoids|glucocorticoids|mesh-ancestor
154687729|NCT05986318|Hormones|hormones|mesh-ancestor
154687730|NCT05986318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687731|NCT05986318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687732|NCT05986318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687733|NCT05986318|Protease Inhibitors|protease inhibitors|mesh-ancestor
154687734|NCT05986318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687735|NCT05986318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687736|NCT05986318|Antiviral Agents|antiviral agents|mesh-ancestor
154687737|NCT05986318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687738|NCT05986318|Expectorants|expectorants|mesh-ancestor
154687739|NCT05986318|Respiratory System Agents|respiratory system agents|mesh-ancestor
154687740|NCT05986318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154687741|NCT05986318|Antioxidants|antioxidants|mesh-ancestor
154687742|NCT05986318|Protective Agents|protective agents|mesh-ancestor
154687743|NCT05986318|Antidotes|antidotes|mesh-ancestor
154687744|NCT05977998|Diphenhydramine|diphenhydramine|mesh-list
154687745|NCT05977998|Promethazine|promethazine|mesh-list
154687746|NCT05977998|Dexamethasone|dexamethasone|mesh-list
154687747|NCT05977998|Paclitaxel|paclitaxel|mesh-list
154687748|NCT05977998|Famotidine|famotidine|mesh-list
154687749|NCT05977998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154687750|NCT05977998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687751|NCT05977998|Tubulin Modulators|tubulin modulators|mesh-ancestor
154687752|NCT05977998|Antimitotic Agents|antimitotic agents|mesh-ancestor
154687753|NCT05977998|Mitosis Modulators|mitosis modulators|mesh-ancestor
154687754|NCT05977998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687755|NCT05977998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687756|NCT05977998|Antiemetics|antiemetics|mesh-ancestor
154687757|NCT05977998|Autonomic Agents|autonomic agents|mesh-ancestor
154687758|NCT05977998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687759|NCT05977998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687760|NCT05977998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687761|NCT05977998|Glucocorticoids|glucocorticoids|mesh-ancestor
154687762|NCT05977998|Hormones|hormones|mesh-ancestor
154687763|NCT05977998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687764|NCT05977998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687765|NCT05977998|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154687766|NCT05977998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154687767|NCT05977998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687768|NCT05977998|Anesthetics, Local|anesthetics, local|mesh-ancestor
154687769|NCT05977998|Anesthetics|anesthetics|mesh-ancestor
154687770|NCT05977998|Sensory System Agents|sensory system agents|mesh-ancestor
154687771|NCT05977998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154687772|NCT05977998|Histamine Antagonists|histamine antagonists|mesh-ancestor
154687773|NCT05977998|Histamine Agents|histamine agents|mesh-ancestor
154687774|NCT05977998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687775|NCT05977998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154687776|NCT05977998|Antipruritics|antipruritics|mesh-ancestor
154687777|NCT05977998|Dermatologic Agents|dermatologic agents|mesh-ancestor
154687778|NCT05977998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154687779|NCT05977998|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154687780|NCT05968482|Diclofenac|diclofenac|mesh-list
154687781|NCT05968482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154687782|NCT05968482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687783|NCT05968482|Analgesics|analgesics|mesh-ancestor
154687784|NCT05968482|Sensory System Agents|sensory system agents|mesh-ancestor
154687785|NCT05968482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687786|NCT05968482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687787|NCT05968482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687788|NCT05968482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687789|NCT05968482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154687790|NCT05968482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687791|NCT05968482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687792|NCT05952557|Tamoxifen|tamoxifen|mesh-list
154687793|NCT05952557|Letrozole|letrozole|mesh-list
154687794|NCT05952557|Anastrozole|anastrozole|mesh-list
154687795|NCT05952557|Exemestane|exemestane|mesh-list
154687796|NCT05952557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687797|NCT05952557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154687798|NCT05952557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154687799|NCT05952557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687800|NCT05952557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687801|NCT05952557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154687802|NCT05952557|Hormone Antagonists|hormone antagonists|mesh-ancestor
154687803|NCT05952557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687804|NCT05952557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687805|NCT05952557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154687806|NCT05952557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154687807|NCT05952557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154687808|NCT05952557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154687809|NCT05937776|Deoxyglucose|deoxyglucose|mesh-list
154687810|NCT05937776|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154687811|NCT05937776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154687812|NCT05937776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154687813|NCT05937776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687814|NCT05937776|Antimetabolites|antimetabolites|mesh-ancestor
154687815|NCT05937776|Antiviral Agents|antiviral agents|mesh-ancestor
154687816|NCT05937776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687817|NCT05937776|Chelating Agents|chelating agents|mesh-ancestor
154687818|NCT05937776|Sequestering Agents|sequestering agents|mesh-ancestor
154687819|NCT05920512|Calcitriol|calcitriol|mesh-list
154687820|NCT05920512|Sirolimus|sirolimus|mesh-list
154687821|NCT05920512|Valproic Acid|valproic acid|mesh-list
154687822|NCT05920512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154687823|NCT05920512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687824|NCT05920512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154687825|NCT05920512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687826|NCT05920512|Antifungal Agents|antifungal agents|mesh-ancestor
154687827|NCT05920512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154687828|NCT05920512|Immunologic Factors|immunologic factors|mesh-ancestor
154687829|NCT05920512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687830|NCT05920512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687831|NCT05920512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687832|NCT05920512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154687833|NCT05920512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154687834|NCT05920512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154687835|NCT05920512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154687836|NCT05920512|Vitamins|vitamins|mesh-ancestor
154687837|NCT05920512|Micronutrients|micronutrients|mesh-ancestor
154687838|NCT05920512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154687839|NCT05920512|Anticonvulsants|anticonvulsants|mesh-ancestor
154687840|NCT05920512|GABA Agents|gaba agents|mesh-ancestor
154687841|NCT05920512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687842|NCT05920512|Antimanic Agents|antimanic agents|mesh-ancestor
154687843|NCT05920512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154687844|NCT05920512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687845|NCT05920512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154687846|NCT05909995|Ipilimumab|ipilimumab|mesh-list
154439819|NCT02101476|Oxycodone|oxycodone|mesh-list
154687847|NCT05909995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687848|NCT05909995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687849|NCT05909995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154687850|NCT05909995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687852|NCT05880056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154687853|NCT05880056|Sympatholytics|sympatholytics|mesh-ancestor
154687854|NCT05880056|Autonomic Agents|autonomic agents|mesh-ancestor
154687855|NCT05880056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687856|NCT05880056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687857|NCT05880056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154687858|NCT05880056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154687859|NCT05880056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154687860|NCT05880056|Adrenergic Agents|adrenergic agents|mesh-ancestor
154687861|NCT05880056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687862|NCT05880056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687863|NCT05860296|Pembrolizumab|pembrolizumab|mesh-list
154687864|NCT05860296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687865|NCT05860296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687866|NCT05860296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154687867|NCT05860296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687868|NCT05818826|Hydrocortisone|hydrocortisone|mesh-list
154687869|NCT05818826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154687870|NCT05818826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687871|NCT05784246|Mirikizumab|mirikizumab|mesh-list
154687872|NCT05784246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154687873|NCT05784246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687874|NCT05784246|Analgesics|analgesics|mesh-ancestor
154687875|NCT05784246|Sensory System Agents|sensory system agents|mesh-ancestor
154687876|NCT05784246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687877|NCT05784246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687878|NCT05784246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154687879|NCT05784246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687880|NCT05784246|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154687881|NCT05784246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154687882|NCT05774626|Contraceptive Agents|contraceptive agents|mesh-list
154687883|NCT05774626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154687884|NCT05774626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687885|NCT05772429|Cannabidiol|cannabidiol|mesh-list
154687886|NCT05772429|Anticonvulsants|anticonvulsants|mesh-ancestor
154687887|NCT05766709|Semaglutide|semaglutide|mesh-list
154687888|NCT05766709|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154687889|NCT05766709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154687890|NCT05766709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687891|NCT05750628|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154687892|NCT05750628|Antimalarials|antimalarials|mesh-ancestor
154687893|NCT05750628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154687894|NCT05750628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154687895|NCT05750628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687896|NCT05732272|Bupropion|bupropion|mesh-list
154687897|NCT05732272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154687898|NCT05732272|Antidepressive Agents|antidepressive agents|mesh-ancestor
154687899|NCT05732272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154687900|NCT05732272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154687901|NCT05732272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154687902|NCT05732272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154687903|NCT05732272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687904|NCT05732272|Dopamine Agents|dopamine agents|mesh-ancestor
154687905|NCT05732272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687906|NCT05732272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687907|NCT05732272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154687908|NCT05732272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154687909|NCT05732272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687910|NCT05730218|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154439872|NCT03878368|Protective Agents|protective agents|mesh-ancestor
154439873|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439874|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439875|NCT02910063|Blinatumomab|blinatumomab|mesh-list
154439876|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439877|NCT04441762|Ketorolac|ketorolac|mesh-list
154439878|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154439879|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154687911|NCT05730218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154687912|NCT05718024|Dexmedetomidine|dexmedetomidine|mesh-list
154687913|NCT05718024|Remifentanil|remifentanil|mesh-list
154687914|NCT05718024|Propofol|propofol|mesh-list
154687915|NCT05718024|Esketamine|esketamine|mesh-list
154687916|NCT05718024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154687917|NCT05718024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154687918|NCT05718024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687919|NCT05718024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154687920|NCT05718024|Analgesics|analgesics|mesh-ancestor
154687921|NCT05718024|Sensory System Agents|sensory system agents|mesh-ancestor
154687922|NCT05718024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154687923|NCT05718024|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154687924|NCT05718024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154687925|NCT05718024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154687926|NCT05718024|Adrenergic Agents|adrenergic agents|mesh-ancestor
154687927|NCT05718024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687928|NCT05718024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687929|NCT05718024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154687930|NCT05718024|Anesthetics, General|anesthetics, general|mesh-ancestor
154687931|NCT05718024|Anesthetics|anesthetics|mesh-ancestor
154687932|NCT05718024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154687933|NCT05718024|Narcotics|narcotics|mesh-ancestor
154687934|NCT05718024|Antidepressive Agents|antidepressive agents|mesh-ancestor
154687935|NCT05718024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154687936|NCT05700344|Avelumab|avelumab|mesh-list
154687937|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687938|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687939|NCT05692739|Cyclosporine|cyclosporine|mesh-list
154687940|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
154687941|NCT05692739|Cyclosporins|cyclosporins|mesh-list
154687942|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687943|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687944|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687945|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154687946|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
154687947|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
154687948|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687949|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
154687950|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154687951|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154687952|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154687953|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154687954|NCT05691712|Tirzepatide|tirzepatide|mesh-list
154687955|NCT05691712|Incretins|incretins|mesh-ancestor
154687956|NCT05691712|Hormones|hormones|mesh-ancestor
154687957|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687958|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687959|NCT05676203|Docetaxel|docetaxel|mesh-list
154687960|NCT05676203|Androgens|androgens|mesh-list
154687961|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687962|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
154687963|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
154687964|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
154687965|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687966|NCT05676203|Hormones|hormones|mesh-ancestor
154687967|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154687968|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687969|NCT05673928|Trastuzumab|trastuzumab|mesh-list
154687970|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154687971|NCT05673928|Maytansine|maytansine|mesh-list
154687972|NCT05673928|Tucatinib|tucatinib|mesh-list
154687973|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154687974|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154687975|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154687976|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
154687977|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
154687978|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
154687979|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687980|NCT05673928|Immunotoxins|immunotoxins|mesh-ancestor
154687981|NCT05673928|Immunoconjugates|immunoconjugates|mesh-ancestor
154687982|NCT05673928|Immunologic Factors|immunologic factors|mesh-ancestor
154687983|NCT05673928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439947|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
154687984|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154687985|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154687986|NCT05670678|Lactoferrin|lactoferrin|mesh-list
154687987|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154687988|NCT05669924|Methylphenidate|methylphenidate|mesh-list
154687989|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154687990|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154687991|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154687992|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154687993|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154687994|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154687995|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
154687996|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154687998|NCT05659251|Carboplatin|carboplatin|mesh-list
154687999|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154688000|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688001|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688002|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688003|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688004|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688005|NCT05646706|Semaglutide|semaglutide|mesh-list
154688006|NCT05646706|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154688007|NCT05646706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154688008|NCT05646706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688009|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154688010|NCT05635786|Tenecteplase|tenecteplase|mesh-list
154688011|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154688012|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154688013|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688014|NCT05634759|Azithromycin|azithromycin|mesh-list
154688015|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154688016|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688017|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154688018|NCT05609370|Bevacizumab|bevacizumab|mesh-list
154688019|NCT05609370|Tislelizumab|tislelizumab|mesh-list
154688020|NCT05609370|Capecitabine|capecitabine|mesh-list
154688021|NCT05609370|Fluorouracil|fluorouracil|mesh-list
154688022|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688023|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688024|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154688025|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154688026|NCT05609370|Growth Substances|growth substances|mesh-ancestor
154688027|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688028|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
154688029|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154688030|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
154688031|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688032|NCT05609370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688033|NCT05609370|Immunologic Factors|immunologic factors|mesh-ancestor
154688034|NCT05602194|Asparaginase|asparaginase|mesh-list
154688035|NCT05602194|Pegaspargase|pegaspargase|mesh-list
154688036|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688037|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154688038|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
154688039|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688040|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154688041|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154688042|NCT05569512|Fludarabine|fludarabine|mesh-list
154688043|NCT05569512|Busulfan|busulfan|mesh-list
154688044|NCT05569512|Clofarabine|clofarabine|mesh-list
154688045|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688046|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154688047|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
154688048|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688049|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688050|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
154688051|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688052|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
154688053|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154688054|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154688055|NCT05536804|Tirzepatide|tirzepatide|mesh-list
154688056|NCT05536804|Incretins|incretins|mesh-ancestor
154688057|NCT05536804|Hormones|hormones|mesh-ancestor
154688058|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154688059|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688060|NCT05481112|Buprenorphine|buprenorphine|mesh-list
154688061|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154688063|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688064|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688065|NCT05481112|Analgesics|analgesics|mesh-ancestor
154688066|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
154688067|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688068|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154688069|NCT05468645|Hemay005|hemay005|mesh-list
154688070|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688071|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154688072|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154688073|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688074|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688075|NCT05448365|Vitamin D|vitamin d|mesh-list
154688076|NCT05448365|Vitamins|vitamins|mesh-list
154688077|NCT05448365|Inositol|inositol|mesh-list
154688078|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
154688079|NCT05448365|Pyridoxal|pyridoxal|mesh-list
154688080|NCT05448365|Pyridoxine|pyridoxine|mesh-list
154688081|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154688082|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
154688083|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688084|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154688085|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
154688086|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
154688087|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688088|NCT05448365|Protective Agents|protective agents|mesh-ancestor
154688089|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154688090|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154688091|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688092|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154688093|NCT05427162|Epoprostenol|epoprostenol|mesh-list
154688094|NCT05427162|Tezosentan|tezosentan|mesh-list
154688095|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154688096|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154688097|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
154688098|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
154688099|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154688100|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688101|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688102|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154688103|NCT05413746|Antioxidants|antioxidants|mesh-list
154688104|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688105|NCT05413746|Protective Agents|protective agents|mesh-ancestor
154688106|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688107|NCT05359939|Choline|choline|mesh-list
154688108|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
154688109|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154688110|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
154688111|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688112|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154688113|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154688114|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
154688115|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
154688116|NCT05338801|Menthol|menthol|mesh-list
154688117|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
154688118|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688119|NCT05311176|Paclitaxel|paclitaxel|mesh-list
154688120|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
154688121|NCT05311176|Ramucirumab|ramucirumab|mesh-list
154688122|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154688123|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688124|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688125|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688126|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688127|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688128|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688129|NCT05311176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688130|NCT05311176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154688131|NCT05311176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154688132|NCT05311176|Growth Substances|growth substances|mesh-ancestor
154688133|NCT05311176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688134|NCT05311176|Growth Inhibitors|growth inhibitors|mesh-ancestor
154688135|NCT05310734|Benzyl Alcohol|benzyl alcohol|mesh-list
154688136|NCT05310734|Anesthetics, Local|anesthetics, local|mesh-ancestor
154688137|NCT05310734|Anesthetics|anesthetics|mesh-ancestor
154688138|NCT05310734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688139|NCT05310734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688140|NCT05310734|Sensory System Agents|sensory system agents|mesh-ancestor
154688141|NCT05310734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688142|NCT05304585|Dactinomycin|dactinomycin|mesh-list
154688143|NCT05304585|Cactinomycin|cactinomycin|mesh-list
154688144|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
154688145|NCT05304585|Vincristine|vincristine|mesh-list
154688146|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688147|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
154688148|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688149|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688150|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154688151|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
154688152|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688153|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688154|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154688155|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154688156|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688157|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688158|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688159|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154688160|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688161|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154688162|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154688163|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688164|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154688165|NCT05303311|Dexamethasone|dexamethasone|mesh-list
154688167|NCT05303311|Bupivacaine|bupivacaine|mesh-list
154688168|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154688169|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
154688170|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
154688171|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688172|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688173|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154688174|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
154688175|NCT05303311|Hormones|hormones|mesh-ancestor
154688176|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154688177|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154688178|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688179|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
154688180|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
154688181|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688182|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
154688183|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154688184|NCT05303311|Narcotics|narcotics|mesh-ancestor
154688185|NCT05303311|Analgesics|analgesics|mesh-ancestor
154688186|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154688187|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
154688188|NCT05296317|Epirubicin|epirubicin|mesh-list
154688189|NCT05296317|Lenograstim|lenograstim|mesh-list
154688190|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688191|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
154688192|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688193|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688194|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154688195|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
154688196|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688197|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688198|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154688199|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154688200|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154688201|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154688202|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154688203|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688204|NCT05260021|Tirzepatide|tirzepatide|mesh-list
154688205|NCT05260021|Incretins|incretins|mesh-ancestor
154688206|NCT05260021|Hormones|hormones|mesh-ancestor
154688207|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154688208|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688209|NCT05232929|Risdiplam|risdiplam|mesh-list
154688210|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154688211|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688212|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688213|NCT05214599|Budesonide|budesonide|mesh-list
154688214|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154688215|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154688216|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
154688217|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688218|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688219|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154688220|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
154688221|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
154688222|NCT05214599|Hormones|hormones|mesh-ancestor
154688223|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154688224|NCT05212337|Denosumab|denosumab|mesh-list
154688225|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154688226|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688227|NCT05207514|Ethanol|ethanol|mesh-list
154688228|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
154688229|NCT05207514|Docetaxel|docetaxel|mesh-list
154688230|NCT05207514|Doxorubicin|doxorubicin|mesh-list
154688231|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688232|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
154688233|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688234|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942972|NCT00640432|Analgesics|analgesics|mesh-ancestor
154688235|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154688236|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
154688237|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688238|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688239|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154688240|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688241|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688242|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688243|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154688244|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154688245|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154688246|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688247|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154688248|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688249|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688250|NCT05204927|Prednisone|prednisone|mesh-list
154688251|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154688252|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
154688253|NCT05204927|Hormones|hormones|mesh-ancestor
154688254|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154688255|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688256|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154688257|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688258|NCT05201547|Paclitaxel|paclitaxel|mesh-list
154688259|NCT05201547|Carboplatin|carboplatin|mesh-list
154688260|NCT05201547|Dostarlimab|dostarlimab|mesh-list
154688261|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154688262|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688263|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688264|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688265|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688266|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688267|NCT05195645|Abatacept|abatacept|mesh-list
154688268|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688269|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688270|NCT05195645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688271|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688272|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688273|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
154688274|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688275|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688276|NCT05169593|Adalimumab|adalimumab|mesh-list
154688277|NCT05169593|Infliximab|infliximab|mesh-list
154688278|NCT05169593|Ustekinumab|ustekinumab|mesh-list
154688279|NCT05169593|Vedolizumab|vedolizumab|mesh-list
154688280|NCT05169593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154688281|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154688282|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688283|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688284|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154688285|NCT05141305|Tenecteplase|tenecteplase|mesh-list
154688286|NCT05141305|Clopidogrel|clopidogrel|mesh-list
154688287|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688288|NCT05141305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154688289|NCT05141305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154688290|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688291|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154688292|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154688293|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154688294|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154688295|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
154688296|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154688297|NCT05090358|Canagliflozin|canagliflozin|mesh-list
154688298|NCT05090358|Fulvestrant|fulvestrant|mesh-list
154688299|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154688300|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688301|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154688302|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154688303|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
154688304|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154688305|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688306|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154688307|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688308|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154688309|NCT05084989|Vaccines|vaccines|mesh-list
154688310|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
154688311|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688312|NCT05076760|Nivolumab|nivolumab|mesh-list
154688313|NCT05076760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688314|NCT05076760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688315|NCT05076760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688316|NCT05076760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688317|NCT05068661|Fentanyl|fentanyl|mesh-list
154688318|NCT05068661|Bupivacaine|bupivacaine|mesh-list
154688319|NCT05068661|Ropivacaine|ropivacaine|mesh-list
154688320|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154688321|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
154688322|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
154688323|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688324|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688325|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
154688326|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688327|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154688328|NCT05068661|Narcotics|narcotics|mesh-ancestor
154688329|NCT05068661|Analgesics|analgesics|mesh-ancestor
154688330|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154688331|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154688332|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
154688333|NCT05065216|Kallikreins|kallikreins|mesh-list
154688334|NCT05065216|Coagulants|coagulants|mesh-ancestor
154688335|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154688336|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
154688337|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154688338|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688339|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
154688340|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154688341|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
154688342|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688343|NCT05062980|Docetaxel|docetaxel|mesh-list
154688344|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
154688345|NCT05062980|Ramucirumab|ramucirumab|mesh-list
154688346|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688347|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688348|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688349|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688350|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688351|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688352|NCT05062980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688353|NCT05062980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154688354|NCT05062980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154688355|NCT05062980|Growth Substances|growth substances|mesh-ancestor
154688356|NCT05062980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688357|NCT05062980|Growth Inhibitors|growth inhibitors|mesh-ancestor
154688358|NCT05043090|Durvalumab|durvalumab|mesh-list
154688359|NCT05043090|Sunitinib|sunitinib|mesh-list
154688360|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688361|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688362|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154688363|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154688364|NCT05043090|Growth Substances|growth substances|mesh-ancestor
154688365|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688366|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
154688367|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154688368|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688369|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688370|NCT05027919|Lofexidine|lofexidine|mesh-list
154688371|NCT05027919|Clonidine|clonidine|mesh-list
154688372|NCT05027919|Morphine|morphine|mesh-list
154688373|NCT05027919|Naloxone|naloxone|mesh-list
154688374|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154688375|NCT05027919|Narcotics|narcotics|mesh-ancestor
154688376|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688377|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688378|NCT05027919|Analgesics|analgesics|mesh-ancestor
154688379|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
154688380|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688381|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154688382|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154688383|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154688384|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154688385|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154688386|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
154688387|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154688388|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688389|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
154688390|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
154688391|NCT04998136|Semaglutide|semaglutide|mesh-list
154688392|NCT04998136|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154688393|NCT04998136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154688394|NCT04998136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688395|NCT04995029|Buprenorphine|buprenorphine|mesh-list
154688396|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154688397|NCT04995029|Narcotics|narcotics|mesh-ancestor
154688398|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688399|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688400|NCT04995029|Analgesics|analgesics|mesh-ancestor
154688401|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
154688402|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688403|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154688404|NCT04982224|Cemiplimab|cemiplimab|mesh-list
154688405|NCT04982224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688406|NCT04982224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688407|NCT04977167|Antibodies|antibodies|mesh-list
154688408|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
154688409|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688410|NCT04973748|Analgesics, Opioid|analgesics, opioid|mesh-list
154688411|NCT04973748|Narcotics|narcotics|mesh-ancestor
154688412|NCT04973748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688413|NCT04973748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688414|NCT04973748|Analgesics|analgesics|mesh-ancestor
154688415|NCT04973748|Sensory System Agents|sensory system agents|mesh-ancestor
154688416|NCT04973748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688417|NCT04966702|Ivermectin|ivermectin|mesh-list
154688418|NCT04966702|Albendazole|albendazole|mesh-list
154688419|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154688420|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688421|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
154688422|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
154688423|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154688424|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154688425|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688426|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688427|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688428|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688429|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688430|NCT04948697|Tislelizumab|tislelizumab|mesh-list
154688431|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688432|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688433|NCT04941287|Atezolizumab|atezolizumab|mesh-list
154688434|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
154688435|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154688436|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
154688437|NCT04941287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688438|NCT04941287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688439|NCT04941287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688440|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688441|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
154688442|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688443|NCT04939597|Memantine|memantine|mesh-list
154688444|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154688445|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154688446|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
154688447|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154688448|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688449|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688450|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154688451|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154688452|NCT04893525|Buprenorphine|buprenorphine|mesh-list
154688453|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154688454|NCT04893525|Naloxone|naloxone|mesh-list
154688455|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154688456|NCT04893525|Narcotics|narcotics|mesh-ancestor
154688457|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688458|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688459|NCT04893525|Analgesics|analgesics|mesh-ancestor
154688460|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
154688461|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688462|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154688463|NCT04879368|Trifluridine|trifluridine|mesh-list
154688464|NCT04879368|Paclitaxel|paclitaxel|mesh-list
154688465|NCT04879368|Docetaxel|docetaxel|mesh-list
154688466|NCT04879368|Nivolumab|nivolumab|mesh-list
154688467|NCT04879368|Irinotecan|irinotecan|mesh-list
154688468|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154688469|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688470|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688471|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688472|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688473|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688474|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688475|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688476|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154688477|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154688478|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688479|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
154688480|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
154688481|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688482|NCT04862975|Tenofovir|tenofovir|mesh-list
154688483|NCT04862975|Lamivudine|lamivudine|mesh-list
154688484|NCT04862975|Emtricitabine|emtricitabine|mesh-list
154688485|NCT04862975|Dolutegravir|dolutegravir|mesh-list
154688486|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
154688487|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688488|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154688489|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154688490|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688491|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688492|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154688493|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154688494|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154688495|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154688496|NCT04859660|Tamsulosin|tamsulosin|mesh-list
154688497|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154688498|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154688499|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154688500|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
154688501|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154688502|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688503|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688504|NCT04859660|Urological Agents|urological agents|mesh-ancestor
154688505|NCT04817956|Trastuzumab|trastuzumab|mesh-list
154688506|NCT04817956|Atezolizumab|atezolizumab|mesh-list
154688507|NCT04817956|Pertuzumab|pertuzumab|mesh-list
154688508|NCT04817956|Niraparib|niraparib|mesh-list
154688509|NCT04817956|Vemurafenib|vemurafenib|mesh-list
154688510|NCT04817956|Dostarlimab|dostarlimab|mesh-list
154688511|NCT04817956|Ceritinib|ceritinib|mesh-list
154688512|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154688513|NCT04817956|Alectinib|alectinib|mesh-list
154688514|NCT04817956|Entrectinib|entrectinib|mesh-list
154688515|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688516|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688517|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688518|NCT04817956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688519|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688520|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
154688521|NCT04817956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154688522|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688523|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153943258|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
154688524|NCT04817956|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154688525|NCT04788615|Interferons|interferons|mesh-list
154688526|NCT04788615|Interferon-beta|interferon-beta|mesh-list
154688527|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
154688528|NCT04788615|Teriflunomide|teriflunomide|mesh-list
154688529|NCT04788615|Ofatumumab|ofatumumab|mesh-list
154688530|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
154688531|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154688532|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
154688533|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688534|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
154688535|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688536|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
154688537|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688538|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154688539|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688540|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688541|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688542|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154688543|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154688544|NCT04788615|Analgesics|analgesics|mesh-ancestor
154688545|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
154688546|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688547|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154688548|NCT04731272|Dulaglutide|dulaglutide|mesh-list
154688549|NCT04731272|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154688550|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154688551|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688552|NCT04704154|Nivolumab|nivolumab|mesh-list
154688553|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688554|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688555|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688556|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688557|NCT04684368|Carboplatin|carboplatin|mesh-list
154688558|NCT04684368|Etoposide|etoposide|mesh-list
154688559|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
154688560|NCT04684368|Ifosfamide|ifosfamide|mesh-list
154688561|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
154688562|NCT04684368|Thiotepa|thiotepa|mesh-list
154688563|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
154688564|NCT04684368|Lenograstim|lenograstim|mesh-list
154688565|NCT04684368|Mesna|mesna|mesh-list
154688566|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688567|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154688568|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154688569|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154688570|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688571|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688572|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154688573|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
154688574|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688575|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154688576|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
154688577|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688578|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154688579|NCT04684368|Protective Agents|protective agents|mesh-ancestor
154688580|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
154688581|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688582|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688583|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688584|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
154860348|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154860349|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860350|NCT01926158|Denosumab|denosumab|mesh-list
154860351|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153943319|NCT01160198|Vitamins|vitamins|mesh-ancestor
154860352|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860353|NCT03445390|Acetaminophen|acetaminophen|mesh-list
154860354|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154860355|NCT03445390|Analgesics|analgesics|mesh-ancestor
154860356|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
154860357|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860358|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860359|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
154860360|NCT00981890|Sunitinib|sunitinib|mesh-list
154860361|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688585|NCT04675931|Artesunate|artesunate|mesh-list
154688586|NCT04675931|Lumefantrine|lumefantrine|mesh-list
154688587|NCT04675931|Artemether|artemether|mesh-list
154688588|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154688589|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
154688590|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154688591|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154688592|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688593|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688594|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
154688595|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
154688596|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154688597|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
154688598|NCT04665570|Metformin|metformin|mesh-list
154688599|NCT04665570|Acarbose|acarbose|mesh-list
154688600|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154688601|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688602|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154688603|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688604|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688605|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154688606|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154688607|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
154688608|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688609|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688610|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154688611|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
154688612|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
154688613|NCT04655508|Hormones|hormones|mesh-ancestor
154688614|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154688615|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
154688616|NCT04629196|Ustekinumab|ustekinumab|mesh-list
154688617|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688618|NCT04578756|Cariprazine|cariprazine|mesh-list
154688619|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154688620|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154688621|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688622|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688623|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154688624|NCT04553692|Leucovorin|leucovorin|mesh-list
154688625|NCT04553692|Bevacizumab|bevacizumab|mesh-list
154688626|NCT04553692|Gemcitabine|gemcitabine|mesh-list
154688627|NCT04553692|Docetaxel|docetaxel|mesh-list
154688628|NCT04553692|Fluorouracil|fluorouracil|mesh-list
154688629|NCT04553692|Irinotecan|irinotecan|mesh-list
154688630|NCT04553692|Azacitidine|azacitidine|mesh-list
154688631|NCT04553692|Venetoclax|venetoclax|mesh-list
154688632|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688633|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688634|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154688635|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154688636|NCT04553692|Growth Substances|growth substances|mesh-ancestor
154688637|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688638|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
154688639|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154688640|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
154688641|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688642|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688643|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688644|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688645|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688646|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
154688647|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154688648|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154688649|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688650|NCT04553692|Antidotes|antidotes|mesh-ancestor
154688651|NCT04553692|Protective Agents|protective agents|mesh-ancestor
154688652|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
154688653|NCT04553692|Vitamins|vitamins|mesh-ancestor
154688654|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
154688655|NCT04486833|Cisplatin|cisplatin|mesh-list
154688656|NCT04486833|Carboplatin|carboplatin|mesh-list
154688657|NCT04486833|Osimertinib|osimertinib|mesh-list
154688658|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688659|NCT04486833|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154688660|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154688661|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688662|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688663|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
154688664|NCT04477629|Abatacept|abatacept|mesh-list
154688665|NCT04477629|Tacrolimus|tacrolimus|mesh-list
154688666|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688667|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
154688668|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688669|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154688670|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688671|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688672|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154688673|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688674|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154688675|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
154688676|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154688677|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688678|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688679|NCT04477629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688680|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688681|NCT04445025|Leuprolide|leuprolide|mesh-list
154688682|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154688683|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
154688684|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154688685|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688686|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154688687|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688688|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154688689|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
154688690|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688691|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154688692|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
154688693|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154688694|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688695|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154688696|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154688697|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154688698|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
154688699|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
154688700|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688701|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943442|NCT04178980|Simvastatin|simvastatin|mesh-list
154688702|NCT04432857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688703|NCT04432857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688704|NCT04427956|Riboflavin|riboflavin|mesh-list
154688705|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
154688706|NCT04427956|Vitamins|vitamins|mesh-ancestor
154688707|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
154688708|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688709|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154688710|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688711|NCT04396223|Methotrexate|methotrexate|mesh-list
154688712|NCT04396223|Avelumab|avelumab|mesh-list
154688713|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154688714|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
154688715|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154688716|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688717|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154688718|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
154688719|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688720|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688721|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688722|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688723|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154688724|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688725|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
154688726|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688727|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154688728|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688729|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154688730|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154688731|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154688732|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154688733|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688734|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154688735|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688736|NCT04395001|Analgesics|analgesics|mesh-ancestor
154688737|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
154688738|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688739|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
154688740|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154688741|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
154688742|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154688743|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154688744|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154688745|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154688746|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688747|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154688748|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688749|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
154688750|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154688752|NCT04334512|Vitamins|vitamins|mesh-list
154688753|NCT04334512|Azithromycin|azithromycin|mesh-list
154688754|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
154688755|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
154688756|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688757|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154688758|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153943508|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
154688759|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154688760|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
154688761|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154688762|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154688763|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688764|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688765|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688766|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
154688767|NCT04322318|Ifosfamide|ifosfamide|mesh-list
154688768|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
154688769|NCT04322318|Carboplatin|carboplatin|mesh-list
154688770|NCT04322318|Doxorubicin|doxorubicin|mesh-list
154688771|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154688772|NCT04322318|Irinotecan|irinotecan|mesh-list
154688773|NCT04322318|Etoposide|etoposide|mesh-list
154688774|NCT04322318|Vincristine|vincristine|mesh-list
154688775|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
154688776|NCT04322318|Daunorubicin|daunorubicin|mesh-list
154688777|NCT04322318|Topotecan|topotecan|mesh-list
154688778|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
154688779|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688780|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
154688781|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688782|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688783|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154688784|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
154688785|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688786|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688787|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154688788|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154688789|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154688790|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154688791|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688792|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154688793|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154688794|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688795|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688796|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688797|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
154688798|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
154688799|NCT04315233|Belinostat|belinostat|mesh-list
154688800|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688801|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154688802|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688803|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688804|NCT04278144|Nivolumab|nivolumab|mesh-list
154688805|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688806|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688807|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688808|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688809|NCT04277637|Obinutuzumab|obinutuzumab|mesh-list
154688810|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
154440770|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
154688811|NCT04277637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688813|NCT04277637|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154688814|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154688815|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688816|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688817|NCT04232306|Bupivacaine|bupivacaine|mesh-list
154688818|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
154688819|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
154688820|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688821|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688822|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
154688823|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688824|NCT04185883|Docetaxel|docetaxel|mesh-list
154688825|NCT04185883|Bevacizumab|bevacizumab|mesh-list
154688826|NCT04185883|Carboplatin|carboplatin|mesh-list
154688827|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
154688828|NCT04185883|Pemetrexed|pemetrexed|mesh-list
154688829|NCT04185883|Everolimus|everolimus|mesh-list
154688830|NCT04185883|Atezolizumab|atezolizumab|mesh-list
154688831|NCT04185883|Palbociclib|palbociclib|mesh-list
154688832|NCT04185883|Panitumumab|panitumumab|mesh-list
154688833|NCT04185883|Trametinib|trametinib|mesh-list
154688834|NCT04185883|Afatinib|afatinib|mesh-list
154688835|NCT04185883|Sotorasib|sotorasib|mesh-list
154688836|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688837|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
154688838|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
154688839|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
154688840|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688841|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688842|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154688843|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154688844|NCT04185883|Growth Substances|growth substances|mesh-ancestor
154688845|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688846|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
154688847|NCT04185883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688848|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688849|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154688850|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154688851|NCT04185883|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154688852|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154688853|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688854|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
154688855|NCT04185883|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154688856|NCT04169737|Venetoclax|venetoclax|mesh-list
154688857|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
154688858|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
154688859|NCT04169737|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154688860|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688861|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688862|NCT04169737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154688863|NCT04169737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688864|NCT04169737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688865|NCT04164199|Capecitabine|capecitabine|mesh-list
154688866|NCT04164199|Pemetrexed|pemetrexed|mesh-list
154688867|NCT04164199|Temozolomide|temozolomide|mesh-list
154688868|NCT04164199|Tislelizumab|tislelizumab|mesh-list
154688869|NCT04164199|Pamiparib|pamiparib|mesh-list
154688870|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154688871|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
154688872|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688873|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688874|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688875|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154688876|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154688877|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154688878|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
154688879|NCT04164199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688880|NCT04164199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154688881|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
154688882|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154688883|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688884|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154688885|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154688886|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154440844|NCT01062555|Cyclosporine|cyclosporine|mesh-list
154688887|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688888|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154688889|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688890|NCT04137107|Analgesics|analgesics|mesh-ancestor
154688891|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
154688892|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688893|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
154688894|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154688895|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
154688896|NCT04102098|Bevacizumab|bevacizumab|mesh-list
154688897|NCT04102098|Atezolizumab|atezolizumab|mesh-list
154688898|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688899|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688900|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154688901|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154688902|NCT04102098|Growth Substances|growth substances|mesh-ancestor
154688903|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688904|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
154688905|NCT04102098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154688906|NCT04102098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688907|NCT04096170|Lidocaine|lidocaine|mesh-list
154688908|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
154688909|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
154688910|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688911|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688912|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
154688913|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688914|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154688915|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154688916|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154688917|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154688918|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688919|NCT04086745|Adalimumab|adalimumab|mesh-list
154688920|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154688921|NCT04086745|Etanercept|etanercept|mesh-list
154688922|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154688923|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688924|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154688925|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154688926|NCT04086745|Analgesics|analgesics|mesh-ancestor
154688927|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
154688928|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688929|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688930|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154688931|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154688932|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
154688933|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
154688934|NCT04049331|Testosterone|testosterone|mesh-list
154688935|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
154688936|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
154688937|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154688938|NCT04049331|Androgens|androgens|mesh-ancestor
154688939|NCT04049331|Hormones|hormones|mesh-ancestor
154688940|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154688941|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688942|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154688943|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688944|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
154688945|NCT04030442|Morphine|morphine|mesh-list
154688946|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154688947|NCT04030442|Narcotics|narcotics|mesh-ancestor
154688948|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154688949|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688950|NCT04030442|Analgesics|analgesics|mesh-ancestor
154688951|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
154688952|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688953|NCT03980509|Curcumin|curcumin|mesh-list
154688954|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154688955|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154688956|NCT03980509|Analgesics|analgesics|mesh-ancestor
154688957|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
154688958|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154688959|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688960|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154688961|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688962|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688963|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688964|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688966|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688967|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688968|NCT03950076|Edoxaban|edoxaban|mesh-list
154688969|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154688970|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
154688971|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154688972|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
154688973|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688974|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688975|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
154688976|NCT03942211|Selexipag|selexipag|mesh-list
154688977|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154688978|NCT03917459|Enalapril|enalapril|mesh-list
154688979|NCT03917459|Enalaprilat|enalaprilat|mesh-list
154688980|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154688981|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154688982|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
154688983|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154688984|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154688985|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154688986|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154688987|NCT03863184|Rituximab|rituximab|mesh-list
154688988|NCT03863184|Lenalidomide|lenalidomide|mesh-list
154688989|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
154688990|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154688991|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154688992|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
154688993|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154688994|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154688995|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154688996|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154688997|NCT03863184|Growth Substances|growth substances|mesh-ancestor
154688998|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
154688999|NCT03863184|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154689000|NCT03863184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689001|NCT03863184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689002|NCT03863184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689003|NCT03831334|Minoxidil|minoxidil|mesh-list
154689004|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154689005|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
154689006|NCT03817398|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154689007|NCT03817398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689008|NCT03817398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689009|NCT03817398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689010|NCT03800134|Paclitaxel|paclitaxel|mesh-list
154689011|NCT03800134|Carboplatin|carboplatin|mesh-list
154689012|NCT03800134|Gemcitabine|gemcitabine|mesh-list
154689013|NCT03800134|Pemetrexed|pemetrexed|mesh-list
154689014|NCT03800134|Durvalumab|durvalumab|mesh-list
154689015|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154689016|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689017|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
154689018|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
154689019|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
154689020|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689021|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689022|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
154689023|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689024|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154689025|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154689026|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689027|NCT03760263|Tacrolimus|tacrolimus|mesh-list
154689028|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689029|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
154689030|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689031|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154689032|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440999|NCT02123628|Levofloxacin|levofloxacin|mesh-list
154689033|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689034|NCT03745716|Azacitidine|azacitidine|mesh-list
154689035|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689036|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
154689037|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689038|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689039|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689040|NCT03723772|Insulin|insulin|mesh-list
154689041|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154689042|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154689043|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689044|NCT03711279|Apatinib|apatinib|mesh-list
154689045|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689046|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689047|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689048|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689049|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
154689050|NCT03705559|Narcotics|narcotics|mesh-ancestor
154689051|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154689052|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689053|NCT03705559|Analgesics|analgesics|mesh-ancestor
154689054|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
154689055|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689056|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154689057|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
154689058|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689059|NCT03670095|Memantine|memantine|mesh-list
154689060|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154689061|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154689062|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
154689063|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689064|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689065|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689066|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154689067|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154689068|NCT03666559|Azacitidine|azacitidine|mesh-list
154689069|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689070|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
154689071|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689072|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689073|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689074|NCT03658304|Mitomycins|mitomycins|mesh-list
154689075|NCT03658304|Mitomycin|mitomycin|mesh-list
154689076|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154689077|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689078|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
154689079|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689080|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154689081|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689082|NCT03649048|Cisplatin|cisplatin|mesh-list
154689083|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689084|NCT03643549|Temozolomide|temozolomide|mesh-list
154689085|NCT03643549|Bortezomib|bortezomib|mesh-list
154689086|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689087|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
154689088|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689089|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689090|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
154689091|NCT03585465|Capecitabine|capecitabine|mesh-list
154689092|NCT03585465|Nivolumab|nivolumab|mesh-list
154689093|NCT03585465|Vinblastine|vinblastine|mesh-list
154689094|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689095|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
154689096|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689097|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154689098|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689099|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
154689100|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689101|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689102|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154689103|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689104|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
154689105|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689106|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154689107|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154441078|NCT00289640|Ipilimumab|ipilimumab|mesh-list
154689108|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
154689109|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
154689110|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
154689111|NCT03533582|Cisplatin|cisplatin|mesh-list
154689112|NCT03533582|Carboplatin|carboplatin|mesh-list
154689113|NCT03533582|Gemcitabine|gemcitabine|mesh-list
154689114|NCT03533582|Doxorubicin|doxorubicin|mesh-list
154689115|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154689116|NCT03533582|Fluorouracil|fluorouracil|mesh-list
154689117|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
154689118|NCT03533582|Irinotecan|irinotecan|mesh-list
154689119|NCT03533582|Etoposide|etoposide|mesh-list
154689120|NCT03533582|Vincristine|vincristine|mesh-list
154689121|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
154689122|NCT03533582|Sorafenib|sorafenib|mesh-list
154689123|NCT03533582|Daunorubicin|daunorubicin|mesh-list
154689124|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
154689125|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689126|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689127|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
154689128|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689129|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154689130|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154689131|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154689132|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689133|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689134|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
154689135|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689136|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154689137|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154689138|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
154689139|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
154689140|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
154689141|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689142|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
154689143|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
154689144|NCT03481660|Aflibercept|aflibercept|mesh-list
154689145|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154689146|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154689147|NCT03481660|Growth Substances|growth substances|mesh-ancestor
154689148|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689149|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
154689150|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689151|NCT03471182|Cocaine|cocaine|mesh-list
154689152|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
154689153|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
154689154|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154689155|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689156|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
154689157|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689158|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154689159|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154689160|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154689161|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154689162|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689163|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
154689164|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689165|NCT03465592|Nivolumab|nivolumab|mesh-list
154689166|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689167|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689168|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154689169|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689170|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
154689171|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689172|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689173|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154689174|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
154689175|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154689176|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
154689177|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
154689178|NCT03412565|Dexamethasone|dexamethasone|mesh-list
154689179|NCT03412565|Prednisone|prednisone|mesh-list
154689180|NCT03412565|Lenalidomide|lenalidomide|mesh-list
154689181|NCT03412565|Bortezomib|bortezomib|mesh-list
154689182|NCT03412565|Melphalan|melphalan|mesh-list
154689183|NCT03412565|Daratumumab|daratumumab|mesh-list
154689184|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689185|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
154689186|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
154689187|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689188|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689189|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154689190|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
154689191|NCT03412565|Hormones|hormones|mesh-ancestor
154689192|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689193|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154689194|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689195|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
154689196|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154689197|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154689198|NCT03412565|Growth Substances|growth substances|mesh-ancestor
154689199|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
154689200|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689201|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
154689202|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689203|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154689204|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689205|NCT03385655|Carboplatin|carboplatin|mesh-list
154689206|NCT03385655|Durvalumab|durvalumab|mesh-list
154689207|NCT03385655|Tremelimumab|tremelimumab|mesh-list
154689208|NCT03385655|Ipatasertib|ipatasertib|mesh-list
154689209|NCT03385655|Adavosertib|adavosertib|mesh-list
154689210|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689211|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689212|NCT03385655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689213|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689214|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689215|NCT03379727|Cytarabine|cytarabine|mesh-list
154689216|NCT03379727|Daunorubicin|daunorubicin|mesh-list
154689217|NCT03379727|Idarubicin|idarubicin|mesh-list
154689218|NCT03379727|Midostaurin|midostaurin|mesh-list
154689219|NCT03379727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689220|NCT03379727|Antimetabolites|antimetabolites|mesh-ancestor
154689221|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689222|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689223|NCT03379727|Antiviral Agents|antiviral agents|mesh-ancestor
154689224|NCT03379727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689225|NCT03379727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689226|NCT03379727|Immunologic Factors|immunologic factors|mesh-ancestor
154689227|NCT03379727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689228|NCT03379727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154689229|NCT03379727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154689230|NCT03379727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154689231|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689232|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689233|NCT03268382|Doxorubicin|doxorubicin|mesh-list
154689234|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154689235|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154689236|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689237|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154689238|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154689239|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689240|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689241|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
154689242|NCT03161379|Nivolumab|nivolumab|mesh-list
154689243|NCT03161379|Pancrelipase|pancrelipase|mesh-list
154689244|NCT03161379|Vaccines|vaccines|mesh-list
154689245|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
154689246|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689247|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689248|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154689249|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689250|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
154689251|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689252|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689253|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154689254|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689255|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154689256|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154689257|NCT03129646|Paromomycin|paromomycin|mesh-list
154689258|NCT03129646|Miltefosine|miltefosine|mesh-list
154689259|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154689260|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154689261|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689262|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154689263|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154689264|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
154689265|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689266|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
154689267|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154689268|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
154689269|NCT03126916|Vitamin A|vitamin a|mesh-list
154689270|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
154689271|NCT03126916|Melphalan|melphalan|mesh-list
154689272|NCT03126916|Busulfan|busulfan|mesh-list
154689273|NCT03126916|Thiotepa|thiotepa|mesh-list
154689274|NCT03126916|Cisplatin|cisplatin|mesh-list
154689275|NCT03126916|Carboplatin|carboplatin|mesh-list
154689276|NCT03126916|Doxorubicin|doxorubicin|mesh-list
154689277|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154689278|NCT03126916|Etoposide|etoposide|mesh-list
154689279|NCT03126916|Vincristine|vincristine|mesh-list
154689280|NCT03126916|Topotecan|topotecan|mesh-list
154689281|NCT03126916|Tretinoin|tretinoin|mesh-list
154689282|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
154689283|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154689284|NCT03126916|Dinutuximab|dinutuximab|mesh-list
154689285|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
154689286|NCT03126916|Razoxane|razoxane|mesh-list
154689287|NCT03126916|Isotretinoin|isotretinoin|mesh-list
154689288|NCT03126916|Sargramostim|sargramostim|mesh-list
154689289|NCT03126916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154689290|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689291|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
154689292|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689293|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944037|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154689294|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689295|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
154689296|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689297|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689298|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154689299|NCT03126916|Vitamins|vitamins|mesh-ancestor
154689300|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
154689301|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154689302|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154689303|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154689304|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689305|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154689306|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
154689307|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
154689308|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
154689309|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154689310|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
154689311|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
154689312|NCT03126916|Protective Agents|protective agents|mesh-ancestor
154689313|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154689314|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154689315|NCT03108846|Escitalopram|escitalopram|mesh-list
154689316|NCT03108846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154689317|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154689318|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154689319|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689320|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689321|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
154689322|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689323|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154689324|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689325|NCT03067181|Cisplatin|cisplatin|mesh-list
154689326|NCT03067181|Carboplatin|carboplatin|mesh-list
154689327|NCT03067181|Etoposide|etoposide|mesh-list
154689328|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
154689329|NCT03067181|Bleomycin|bleomycin|mesh-list
154689330|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
154689331|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689332|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154689333|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154689334|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154689335|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689336|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689337|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154689338|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
154689339|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
154689340|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
154689341|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
154689342|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
154689343|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154689344|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154689345|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689346|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
154689348|NCT02989584|Atezolizumab|atezolizumab|mesh-list
154689349|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689350|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689351|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
154689352|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689353|NCT02989584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154689354|NCT02989584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689355|NCT02963064|Antibodies|antibodies|mesh-list
154689356|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154689357|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
154689358|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689359|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
154689360|NCT02962492|Exenatide|exenatide|mesh-list
154689361|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154689362|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689363|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154689364|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689365|NCT02962492|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154689366|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154689367|NCT02962492|Incretins|incretins|mesh-ancestor
154689368|NCT02962492|Hormones|hormones|mesh-ancestor
154689369|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689370|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
154689371|NCT02777073|Liraglutide|liraglutide|mesh-list
154689372|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154689373|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689374|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154689375|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689376|NCT02777073|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154689377|NCT02777073|Incretins|incretins|mesh-ancestor
154689378|NCT02777073|Hormones|hormones|mesh-ancestor
154689379|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689380|NCT02684708|Prednisone|prednisone|mesh-list
154689381|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
154689382|NCT02684708|Dacarbazine|dacarbazine|mesh-list
154689383|NCT02684708|Vincristine|vincristine|mesh-list
154689384|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689385|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
154689386|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689387|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154689388|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689389|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
154689390|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689391|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689392|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154689393|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689394|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
154689395|NCT02684708|Hormones|hormones|mesh-ancestor
154689396|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689397|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154689398|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154689399|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154689400|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154689401|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154689402|NCT02667587|Nivolumab|nivolumab|mesh-list
154689403|NCT02667587|Temozolomide|temozolomide|mesh-list
154689404|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689405|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689406|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154689407|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689408|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689409|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
154689410|NCT02598661|Imetelstat|imetelstat|mesh-list
154689411|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
154689412|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689413|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689414|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689415|NCT02597361|Irbesartan|irbesartan|mesh-list
154441370|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689416|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154689417|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154689418|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154689419|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689420|NCT02338609|Everolimus|everolimus|mesh-list
154689421|NCT02338609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154689422|NCT02338609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689423|NCT02338609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689424|NCT02338609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689425|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689426|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
154689427|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689428|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689429|NCT02252432|Ketamine|ketamine|mesh-list
154689430|NCT02252432|Methadone|methadone|mesh-list
154689431|NCT02252432|Analgesics|analgesics|mesh-ancestor
154689432|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
154689433|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689434|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689435|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154689436|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154689437|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
154689438|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
154689439|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154689440|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154689441|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154689442|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689443|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689444|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154689445|NCT02252432|Narcotics|narcotics|mesh-ancestor
154689446|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
154689447|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
154689448|NCT02195479|Dexamethasone|dexamethasone|mesh-list
154689449|NCT02195479|Prednisone|prednisone|mesh-list
154689450|NCT02195479|Melphalan|melphalan|mesh-list
154689451|NCT02195479|Bortezomib|bortezomib|mesh-list
154689452|NCT02195479|Daratumumab|daratumumab|mesh-list
154689453|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154689454|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689455|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
154689456|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
154689457|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689458|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689459|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154689460|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
154689461|NCT02195479|Hormones|hormones|mesh-ancestor
154689462|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689463|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154689464|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689465|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689466|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
154689467|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689468|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154689469|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689470|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
154689471|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
154689472|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154689473|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689474|NCT01979211|Cetuximab|cetuximab|mesh-list
154689475|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689476|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689477|NCT01844986|Olaparib|olaparib|mesh-list
154689478|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154689479|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689480|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689481|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689482|NCT01784068|Nilotinib|nilotinib|mesh-list
154689483|NCT01784068|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154689484|NCT01784068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689485|NCT01784068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689486|NCT01784068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689487|NCT01698905|Nilotinib|nilotinib|mesh-list
154689488|NCT01698905|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154689489|NCT01698905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154441451|NCT00260078|Ritonavir|ritonavir|mesh-list
154689490|NCT01698905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689491|NCT01698905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689493|NCT01666080|Busulfan|busulfan|mesh-list
154689494|NCT01666080|Levetiracetam|levetiracetam|mesh-list
154689495|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944249|NCT00647686|Fentanyl|fentanyl|mesh-list
154689496|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689497|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689498|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
154689499|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689500|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
154689501|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689502|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154689503|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
154689504|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
154689505|NCT01543763|Abexinostat|abexinostat|mesh-list
154689506|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154689507|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689508|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689509|NCT01542021|Androgens|androgens|mesh-list
154689510|NCT01542021|Hormones|hormones|mesh-ancestor
154689511|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689512|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689513|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
154689514|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154689515|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
154689516|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689517|NCT00775476|Expectorants|expectorants|mesh-ancestor
154689518|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
154689519|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154689520|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
154689521|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689522|NCT00775476|Protective Agents|protective agents|mesh-ancestor
154689523|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689524|NCT00775476|Antidotes|antidotes|mesh-ancestor
154689525|NCT00544414|Leucovorin|leucovorin|mesh-list
154689526|NCT00544414|Gemcitabine|gemcitabine|mesh-list
154689527|NCT00544414|Docetaxel|docetaxel|mesh-list
154689528|NCT00544414|Fluorouracil|fluorouracil|mesh-list
154689529|NCT00544414|Calcium|calcium|mesh-list
154689530|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
154689531|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689532|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689533|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
154689534|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689535|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
154689536|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
154689537|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
153944294|NCT00647842|Narcotics|narcotics|mesh-ancestor
154689538|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154689539|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689540|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689541|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
154689542|NCT00544414|Antidotes|antidotes|mesh-ancestor
154689543|NCT00544414|Protective Agents|protective agents|mesh-ancestor
154689544|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
154689545|NCT00544414|Vitamins|vitamins|mesh-ancestor
154689546|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
154689547|NCT00235560|Sirolimus|sirolimus|mesh-list
154689548|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154689549|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689550|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154689551|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689552|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
154689553|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689554|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
154689555|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689556|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154689557|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
154689558|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689559|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154689560|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
154689561|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689562|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689563|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154689564|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154689565|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154689566|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
154689567|NCT01500226|Dexamethasone|dexamethasone|mesh-list
154689568|NCT01500226|Granisetron|granisetron|mesh-list
154689569|NCT01500226|Rolapitant|rolapitant|mesh-list
154689570|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689571|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
154689572|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
154689573|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689574|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689575|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154689576|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
154689577|NCT01500226|Hormones|hormones|mesh-ancestor
154689578|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689579|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154689580|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689581|NCT01500226|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154689582|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154689583|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
154689584|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689585|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689586|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154689587|NCT02075047|Ziprasidone|ziprasidone|mesh-list
154689588|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154689589|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
154689590|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689591|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689592|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689593|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154689594|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154689595|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154689596|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154689597|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154689598|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
154689599|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154689600|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154689601|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689602|NCT01859793|Incretins|incretins|mesh-ancestor
154689603|NCT01859793|Hormones|hormones|mesh-ancestor
154689604|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689605|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154689606|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
154689607|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689608|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689609|NCT01859715|Oxycodone|oxycodone|mesh-list
154689610|NCT01859715|Hydrocodone|hydrocodone|mesh-list
154689611|NCT01859715|Ondansetron|ondansetron|mesh-list
154689612|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154689613|NCT01859715|Narcotics|narcotics|mesh-ancestor
154689614|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154689615|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689616|NCT01859715|Analgesics|analgesics|mesh-ancestor
154689617|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
154689618|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689619|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
154689620|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
154689621|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154689622|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
154689623|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
154689624|NCT01859715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154689625|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154689626|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
154689627|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689628|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689629|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
154689630|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
154689631|NCT04590495|Cannabidiol|cannabidiol|mesh-list
154689632|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
154689633|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154689634|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154689635|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154689636|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689637|NCT01461538|Immunotoxins|immunotoxins|mesh-ancestor
154689638|NCT01461538|Immunoconjugates|immunoconjugates|mesh-ancestor
154689639|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
154689640|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441593|NCT02121990|Paclitaxel|paclitaxel|mesh-list
154689641|NCT02117479|Capecitabine|capecitabine|mesh-list
154689642|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689643|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
154689644|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689645|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689646|NCT01482910|Aflibercept|aflibercept|mesh-list
154689647|NCT01482910|Verteporfin|verteporfin|mesh-list
154689648|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154689649|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154689650|NCT01482910|Growth Substances|growth substances|mesh-ancestor
154689651|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689652|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
154689653|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689654|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154689655|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
154689656|NCT04077190|Cortisone|cortisone|mesh-list
154689657|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689658|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154689659|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
154689660|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689661|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
154689662|NCT02229539|Promethazine|promethazine|mesh-list
154689663|NCT02229539|Lidocaine|lidocaine|mesh-list
154689664|NCT02229539|Doxepin|doxepin|mesh-list
154689665|NCT02229539|Antacids|antacids|mesh-list
154689666|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
154689667|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
154689668|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154689669|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689670|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
154689671|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689672|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154689673|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154689674|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154689675|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154689676|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689677|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154689678|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154689679|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
154689680|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
154689681|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154689682|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154689683|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
154689684|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
154689685|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689686|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154689687|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
154689688|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
154689689|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154689690|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
154689691|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154689692|NCT01835223|Tivozanib|tivozanib|mesh-list
154689693|NCT01835223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689694|NCT01835223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689695|NCT01835223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689696|NCT02229383|Exenatide|exenatide|mesh-list
154689697|NCT02229383|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154689698|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154689699|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689700|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154689701|NCT02229383|Incretins|incretins|mesh-ancestor
154689702|NCT02229383|Hormones|hormones|mesh-ancestor
154689703|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689704|NCT01499368|Omeprazole|omeprazole|mesh-list
154689705|NCT01499368|Famotidine|famotidine|mesh-list
154689706|NCT01499368|Lafutidine|lafutidine|mesh-list
154689707|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154689708|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154689709|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154689710|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689711|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689712|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154689713|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
154689714|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
154689715|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689716|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689717|NCT01835145|Temozolomide|temozolomide|mesh-list
154689718|NCT01835145|Dacarbazine|dacarbazine|mesh-list
154689719|NCT01835145|Imidazole|imidazole|mesh-list
154689720|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154689721|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
154689722|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689723|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689724|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689725|NCT02229227|Insulin|insulin|mesh-list
154689726|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
154689727|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
154689728|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
154689729|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154689730|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689731|NCT02229227|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154689732|NCT01499290|Metronidazole|metronidazole|mesh-list
154689733|NCT01499290|Meropenem|meropenem|mesh-list
154689734|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689735|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154689736|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154689737|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154689738|NCT01833897|Cycloserine|cycloserine|mesh-list
154689739|NCT01833897|Ketamine|ketamine|mesh-list
154689740|NCT01833897|Olanzapine|olanzapine|mesh-list
154689741|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154689742|NCT01833897|Fluoxetine|fluoxetine|mesh-list
154689743|NCT01833897|Analgesics|analgesics|mesh-ancestor
154689744|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
154689745|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689746|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689747|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154689748|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154689749|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
154689750|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
154689751|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154689752|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154689753|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154689754|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689755|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689756|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
154689757|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
154689758|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154689759|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154689760|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154689761|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154689762|NCT01833897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154689763|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154689764|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154689765|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
154689766|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
154689767|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154689768|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154689769|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154689770|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689771|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154689772|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689773|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154689774|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
154689775|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154689776|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
154689777|NCT02226653|Evacetrapib|evacetrapib|mesh-list
154689778|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154689779|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154689780|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
154689781|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689782|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154689783|NCT02201771|Aspirin|aspirin|mesh-list
154689784|NCT02201771|Ticagrelor|ticagrelor|mesh-list
154689785|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154689786|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154689787|NCT02201771|Analgesics|analgesics|mesh-ancestor
154689788|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
153944535|NCT04169854|Lidocaine|lidocaine|mesh-list
154689789|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689790|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441745|NCT00141284|Lamivudine|lamivudine|mesh-list
154689791|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689792|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154689793|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154689794|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154689795|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689796|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154689797|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154689798|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689799|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
154689800|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154689801|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154689802|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154689803|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
154689804|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689805|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
154689806|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154689807|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689808|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154689809|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154689810|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689811|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689812|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689813|NCT01460290|Asenapine|asenapine|mesh-list
154689814|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154689815|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154689816|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154689817|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689818|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154689819|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
154689820|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154689821|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154689822|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154689823|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154689824|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689825|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
154689826|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689827|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689828|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154689829|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689830|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
154689831|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
154689832|NCT01459666|Coagulants|coagulants|mesh-ancestor
154689833|NCT01858389|Dacomitinib|dacomitinib|mesh-list
154689834|NCT01858389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154689835|NCT01858389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689836|NCT01858389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689837|NCT01858389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689838|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154689839|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
154689840|NCT01645475|Coagulants|coagulants|mesh-ancestor
154689841|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154689842|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
154689843|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689844|NCT04767113|Heparin|heparin|mesh-list
154689845|NCT04767113|Calcium heparin|calcium heparin|mesh-list
154689846|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
154689847|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154689848|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154689849|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689850|NCT02199509|Levetiracetam|levetiracetam|mesh-list
154689851|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
153944654|NCT00913237|Desipramine|desipramine|mesh-list
154689852|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
154689853|NCT01458574|Tofacitinib|tofacitinib|mesh-list
154689854|NCT01458574|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154689855|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689856|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689857|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689858|NCT02224703|Cannabidiol|cannabidiol|mesh-list
154689859|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
154689860|NCT01458106|Factor VIII|factor viii|mesh-list
154689861|NCT01458106|Coagulants|coagulants|mesh-ancestor
154689862|NCT01457950|Denosumab|denosumab|mesh-list
154689863|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154689864|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689865|NCT01499134|Metoprolol|metoprolol|mesh-list
154689866|NCT01499134|Nebivolol|nebivolol|mesh-list
154689867|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154689868|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154689869|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
154689870|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
154689871|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689872|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689873|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154689875|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154689876|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154689877|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689878|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689879|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
154689880|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154689881|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154689882|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154689883|NCT02198651|Adalimumab|adalimumab|mesh-list
154689884|NCT02198651|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154689885|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689886|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154689887|NCT03026842|Cytarabine|cytarabine|mesh-list
154689888|NCT03026842|Decitabine|decitabine|mesh-list
154689889|NCT03026842|Daunorubicin|daunorubicin|mesh-list
154689890|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
154689891|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
154689892|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689893|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
154689894|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689895|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689896|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
154689897|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689898|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689899|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
154689900|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689901|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154689902|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154689903|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154689904|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689905|NCT03026842|Analgesics|analgesics|mesh-ancestor
154689906|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
154689907|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689908|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154689909|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
154689910|NCT01498822|Levetiracetam|levetiracetam|mesh-list
154689911|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
154689912|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
154689913|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154689914|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154689915|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154689916|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689917|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154689918|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154689919|NCT01498120|Rotigotine|rotigotine|mesh-list
154689920|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
154689921|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
154689922|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689923|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689924|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689925|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154689926|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154689927|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689928|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689929|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
154689930|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689931|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
154689932|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154689933|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154689934|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689935|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
154689936|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
154689937|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154689938|NCT02197247|Rifampin|rifampin|mesh-list
154689939|NCT02197247|Osimertinib|osimertinib|mesh-list
154689940|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154689941|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
154689942|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154689943|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154689944|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
154689945|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154689946|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689947|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689948|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154689949|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154689950|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154689951|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154689952|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154689953|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154689954|NCT02197247|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154689955|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154689956|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689957|NCT02224157|Budesonide|budesonide|mesh-list
154689958|NCT02224157|Terbutaline|terbutaline|mesh-list
154689959|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
154689960|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689961|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154689962|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
154689963|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154689964|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689965|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154689966|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
154689967|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
154689968|NCT02224157|Hormones|hormones|mesh-ancestor
154689969|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154689970|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154689971|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154689972|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154689973|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
154689974|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154689975|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689976|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
154689977|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
154689978|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154689979|NCT02196701|Adalimumab|adalimumab|mesh-list
154689980|NCT02196701|Methotrexate|methotrexate|mesh-list
154689981|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154689982|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
154689983|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154689984|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154689985|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154689986|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
154689987|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154689988|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154689989|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
154689990|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154689991|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154689992|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154689993|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
154689994|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154689995|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154689996|NCT02196701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154689997|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154689998|NCT01481116|Glimepiride|glimepiride|mesh-list
154689999|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154690000|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690001|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690002|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690003|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
154690004|NCT02222207|Ranibizumab|ranibizumab|mesh-list
154690005|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154690006|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154690007|NCT02222207|Growth Substances|growth substances|mesh-ancestor
154690008|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944774|NCT00706225|Estrogens|estrogens|mesh-list
154690009|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
154690010|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690011|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
154690012|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154690013|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154690014|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154690015|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154690016|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690017|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
154690018|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690019|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690020|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154690021|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690022|NCT02252081|Metformin|metformin|mesh-list
154690023|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690024|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690025|NCT01623752|Etanercept|etanercept|mesh-list
154690026|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154690027|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154690028|NCT01623752|Analgesics|analgesics|mesh-ancestor
154690029|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
154690030|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690031|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690032|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690033|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690034|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154690035|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690036|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
154690037|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154690038|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154690039|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690040|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690041|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
154690042|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690043|NCT02219477|Ritonavir|ritonavir|mesh-list
154690044|NCT02219477|Ribavirin|ribavirin|mesh-list
154690045|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154690046|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154690047|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
154690048|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690049|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690050|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154690051|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154690052|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
154690053|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690054|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154690055|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154690056|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
154690057|NCT02093390|Fluconazole|fluconazole|mesh-list
154690058|NCT02093390|Atorvastatin|atorvastatin|mesh-list
154690059|NCT02093390|Relugolix|relugolix|mesh-list
154690060|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154690061|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154690062|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
154690063|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690064|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154690065|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154690066|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690067|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
154690068|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690069|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154690070|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154690071|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154690072|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
154690073|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690074|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690075|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154690076|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154690077|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
154690078|NCT02219087|Bupivacaine|bupivacaine|mesh-list
154690079|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
154690080|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
154690081|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690082|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690083|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
154690084|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690085|NCT02248961|Losartan|losartan|mesh-list
154690086|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154690087|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154690088|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154690089|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154690090|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690091|NCT02219009|Aripiprazole|aripiprazole|mesh-list
154690092|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
154690093|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154690094|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154690095|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154690096|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690097|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690098|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
154690099|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
154690100|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690101|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690102|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154690103|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154690104|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
154690105|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154690106|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154690107|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154690108|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154690109|NCT01456936|Bupropion|bupropion|mesh-list
154690110|NCT01456936|Nicotine|nicotine|mesh-list
154690111|NCT01456936|Varenicline|varenicline|mesh-list
154690112|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154690113|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
154690114|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690115|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690116|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154690117|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154690118|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
154690119|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690120|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690121|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154690122|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
154690123|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154690124|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154690125|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154690126|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154690127|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
154690128|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154690129|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154690130|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690131|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154690132|NCT01456780|Tobramycin|tobramycin|mesh-list
154690133|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
154690134|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154690135|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690136|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154690137|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154690138|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154690139|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154690140|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
154690141|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690142|NCT01479868|Interferons|interferons|mesh-list
154690143|NCT01479868|Ribavirin|ribavirin|mesh-list
154690144|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
154690145|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
154690146|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154690147|NCT01479868|Simeprevir|simeprevir|mesh-list
154690148|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690149|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
154690150|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690151|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
154690152|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690153|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
154690154|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690155|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
154690156|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690157|NCT01455220|Natalizumab|natalizumab|mesh-list
154690158|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
154690159|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944914|NCT04116931|Ticagrelor|ticagrelor|mesh-list
154690160|NCT01454596|Aldesleukin|aldesleukin|mesh-list
154690161|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
154690162|NCT01454596|Fludarabine|fludarabine|mesh-list
154690163|NCT01454596|Mitogens|mitogens|mesh-list
154690164|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154442120|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
154690165|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
154690166|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690167|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690168|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154690169|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
154690170|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690171|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690172|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154690173|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
154690174|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154690175|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154690176|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
154690177|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690178|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
154690179|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690180|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690181|NCT04541290|Tacrolimus|tacrolimus|mesh-list
154690182|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690183|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
154690184|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690185|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154690186|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690187|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690188|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154690189|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
154690190|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690191|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154690192|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154690193|NCT01495000|Denosumab|denosumab|mesh-list
154690194|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154690195|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690196|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154690197|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154690198|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
154690199|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690200|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690201|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154690202|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
154690203|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
154690204|NCT01494610|Hormones|hormones|mesh-ancestor
154690205|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690206|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
154690207|NCT02116777|Temozolomide|temozolomide|mesh-list
154690208|NCT02116777|Talazoparib|talazoparib|mesh-list
154690209|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154690210|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
154690211|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690212|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690213|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154690214|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690215|NCT01494532|Ropinirole|ropinirole|mesh-list
154690216|NCT01494532|Levodopa|levodopa|mesh-list
154690217|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154690218|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
154690219|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690220|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690221|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690222|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154690223|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154690224|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
154690225|NCT02191397|Dexetimide|dexetimide|mesh-list
154690226|NCT02191397|Citalopram|citalopram|mesh-list
154690227|NCT02191397|Bupropion|bupropion|mesh-list
154690228|NCT02191397|Escitalopram|escitalopram|mesh-list
154690229|NCT02191397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154690230|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154690231|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154690232|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690233|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690234|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
154690235|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690236|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154690237|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154690238|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
154690239|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
154690240|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690241|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154690242|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154690243|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
154690244|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154690245|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
154690246|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154690247|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154690248|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
154690249|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154690250|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154690251|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690252|NCT01630811|Quinidine|quinidine|mesh-list
154690253|NCT01630811|Levomethorphan|levomethorphan|mesh-list
154690254|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
154690255|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
154690256|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
154690257|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154690258|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154690259|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690260|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690261|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690262|NCT01630811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154690263|NCT01630811|Narcotics|narcotics|mesh-ancestor
154690264|NCT01630811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690265|NCT01630811|Analgesics|analgesics|mesh-ancestor
154690266|NCT01630811|Sensory System Agents|sensory system agents|mesh-ancestor
154690267|NCT01630811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690268|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154690269|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154690270|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
154690271|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154690272|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
154690273|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154690274|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154690275|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690276|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690277|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154690278|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154690279|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
154690280|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154690281|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154690282|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154690283|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154690284|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154690285|NCT02169791|Ixazomib|ixazomib|mesh-list
154690286|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690287|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
154690288|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690289|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690290|NCT02216357|Ifetroban|ifetroban|mesh-list
154690291|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154690292|NCT01492426|Ribavirin|ribavirin|mesh-list
154690293|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154690294|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
154690295|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690296|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
154690297|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690298|NCT01453348|Vaccines|vaccines|mesh-list
154690299|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
154690300|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690301|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
154690302|NCT01475734|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154690303|NCT01475734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690304|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690305|NCT02189837|Atorvastatin|atorvastatin|mesh-list
154690306|NCT02189837|Evolocumab|evolocumab|mesh-list
154690307|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154690308|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154690309|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154690310|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
154690311|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690312|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154690313|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154690314|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442259|NCT02137356|Capecitabine|capecitabine|mesh-list
154690315|NCT02189837|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154690316|NCT02189837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154690317|NCT02189837|Protease Inhibitors|protease inhibitors|mesh-ancestor
154690318|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
154690319|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690321|NCT02216123|Primaquine|primaquine|mesh-list
154690322|NCT02216123|Tafenoquine|tafenoquine|mesh-list
154690323|NCT02216123|Amebicides|amebicides|mesh-ancestor
154690324|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154690325|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154690326|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690327|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
154690328|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690329|NCT01490866|Leucovorin|leucovorin|mesh-list
154690330|NCT01490866|Bevacizumab|bevacizumab|mesh-list
154690331|NCT01490866|Fluorouracil|fluorouracil|mesh-list
154690332|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
154690333|NCT01490866|Axitinib|axitinib|mesh-list
154690334|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154690335|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690336|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154690337|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154690338|NCT01490866|Growth Substances|growth substances|mesh-ancestor
154690339|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690340|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
154690341|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
153945088|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690342|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690343|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154690344|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690345|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
154690346|NCT01490866|Antidotes|antidotes|mesh-ancestor
154690347|NCT01490866|Protective Agents|protective agents|mesh-ancestor
154690348|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
154690349|NCT01490866|Vitamins|vitamins|mesh-ancestor
154690350|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
154690351|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154690352|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690353|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
154690354|NCT02215967|Fludarabine|fludarabine|mesh-list
154690355|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690356|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
154690357|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690358|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690359|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154690360|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
154690361|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690362|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690363|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154690364|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
154690365|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154690366|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
154690367|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690368|NCT02168387|Expectorants|expectorants|mesh-ancestor
154690369|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
154690370|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154690371|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
154690372|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690373|NCT02168387|Protective Agents|protective agents|mesh-ancestor
154690374|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690375|NCT02168387|Antidotes|antidotes|mesh-ancestor
154690376|NCT04418219|Interferons|interferons|mesh-list
154690377|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
154690378|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
154690379|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
154690380|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
154690381|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690382|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
154690383|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690384|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690385|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154690386|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
154690387|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690388|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690389|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154690390|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154690391|NCT04418219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154690392|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
154690393|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690394|NCT02167451|Maraviroc|maraviroc|mesh-list
154690395|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154690396|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153945150|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690397|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690398|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154690399|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154690400|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
154690401|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690402|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154690403|NCT02167139|Adalimumab|adalimumab|mesh-list
154690404|NCT02167139|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154690405|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690406|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690407|NCT02116309|Indomethacin|indomethacin|mesh-list
154690408|NCT02116309|Epinephrine|epinephrine|mesh-list
154690409|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154690410|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154690411|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
154690412|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690413|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690414|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690415|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154690416|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154690417|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
154690418|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690419|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154690420|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
154690421|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
154690422|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
154690423|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154690424|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154690425|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154690426|NCT02116309|Analgesics|analgesics|mesh-ancestor
154690427|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
154690428|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690429|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690430|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
154690431|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
154690432|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154690433|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154690434|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690435|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
154690436|NCT01474486|Thiamine|thiamine|mesh-list
154690437|NCT01474486|Micronutrients|micronutrients|mesh-list
154690438|NCT01474486|Trace Elements|trace elements|mesh-list
154690439|NCT01474486|Vitamins|vitamins|mesh-ancestor
154690440|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690441|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
154690442|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154690443|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154690444|NCT01451398|Insulin|insulin|mesh-list
154690445|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690446|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690447|NCT02073565|Everolimus|everolimus|mesh-list
154690448|NCT02073565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154690449|NCT02073565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154690450|NCT02073565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690451|NCT02073565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690452|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690453|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
154690454|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690455|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690456|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154690457|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
154690458|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154690459|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
154690460|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690461|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690462|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154690463|NCT01450696|Capecitabine|capecitabine|mesh-list
154690464|NCT01450696|Trastuzumab|trastuzumab|mesh-list
154690465|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690466|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154690467|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
154690468|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690469|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154690470|NCT02070991|Macitentan|macitentan|mesh-list
154690471|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154690472|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154690473|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690474|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154690475|NCT01490086|Aripiprazole|aripiprazole|mesh-list
154690476|NCT01490086|RP5063|rp5063|mesh-list
154690477|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
154690478|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154690479|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154690480|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154690481|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690482|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690483|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
154690484|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
154690485|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690486|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690487|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154690488|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154690489|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
154690490|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154690491|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154690492|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154690493|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154690494|NCT02113579|Fluorides|fluorides|mesh-list
154690495|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
154690496|NCT02113579|Protective Agents|protective agents|mesh-ancestor
154690497|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690498|NCT01474018|Bromocriptine|bromocriptine|mesh-list
154690499|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154690500|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154690501|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
153945246|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154690502|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690503|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690504|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
154690505|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
154690506|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690507|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690508|NCT02100475|Insulin|insulin|mesh-list
154690509|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154690510|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
154690511|NCT02100475|Liraglutide|liraglutide|mesh-list
154690512|NCT02100475|Xultophy|xultophy|mesh-list
154690513|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690514|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690515|NCT02100475|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154690516|NCT02100475|Incretins|incretins|mesh-ancestor
154690517|NCT02100475|Hormones|hormones|mesh-ancestor
154690518|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690519|NCT02070757|Meropenem|meropenem|mesh-list
154690520|NCT02070757|Tazobactam|tazobactam|mesh-list
154690521|NCT02070757|Ceftolozane|ceftolozane|mesh-list
154690522|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154690523|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154690524|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690525|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154690526|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690527|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690528|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154690529|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154690530|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154690531|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154690532|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690533|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
154690534|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154690535|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690536|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690537|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154690538|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154690539|NCT01625845|Protective Agents|protective agents|mesh-ancestor
154690540|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690541|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
154690542|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154690543|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
154690544|NCT01473940|Gemcitabine|gemcitabine|mesh-list
154690545|NCT01473940|Ipilimumab|ipilimumab|mesh-list
154690546|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154690547|NCT01473940|Antibodies|antibodies|mesh-list
154690548|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
154690549|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154690550|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
154690551|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690552|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154690553|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
154690554|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690555|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690556|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154690557|NCT01832727|Dexamethasone|dexamethasone|mesh-list
154690558|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690559|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
154690560|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
154690561|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690562|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690563|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154690564|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
154690565|NCT01832727|Hormones|hormones|mesh-ancestor
154690566|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690567|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154690568|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690569|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154690570|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
154690571|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154690572|NCT01473394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154690573|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154690574|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154690575|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690576|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690577|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
154690578|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690579|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154690580|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154690581|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
154690582|NCT04408144|Progestins|progestins|mesh-ancestor
154690583|NCT04408144|Hormones|hormones|mesh-ancestor
154690584|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690585|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690586|NCT01449682|Dexamethasone|dexamethasone|mesh-list
154690587|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
154690588|NCT01449682|BB 1101|bb 1101|mesh-list
154690589|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690590|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
154690591|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
154690592|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690593|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690594|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154690595|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
154690596|NCT01449682|Hormones|hormones|mesh-ancestor
154690597|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690598|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154690599|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690600|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
154690601|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690602|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690603|NCT01831791|Dutasteride|dutasteride|mesh-list
154690604|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154690605|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154690606|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690607|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690608|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
154690609|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690610|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690611|NCT01857531|Nicotine|nicotine|mesh-list
154690612|NCT01857531|Ganaxolone|ganaxolone|mesh-list
154690613|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154690614|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
154690615|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690616|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690617|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154690618|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154690619|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
154690620|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690621|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690622|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
154690623|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
154690624|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
154690625|NCT02166047|Vesatolimod|vesatolimod|mesh-list
154690626|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
154690627|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690628|NCT01831089|Paclitaxel|paclitaxel|mesh-list
154690629|NCT01831089|Bevacizumab|bevacizumab|mesh-list
154690630|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154690631|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690632|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
154690633|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
154690634|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
154690635|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690636|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154690637|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154690638|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154690639|NCT01831089|Growth Substances|growth substances|mesh-ancestor
154690640|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690641|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
154690642|NCT02111785|Dexamethasone|dexamethasone|mesh-list
154690643|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690644|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
154690645|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
154690646|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690647|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690648|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154690649|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
154690650|NCT02111785|Hormones|hormones|mesh-ancestor
154690651|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690652|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154690653|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690654|NCT02068495|Amlodipine|amlodipine|mesh-list
154690655|NCT02068495|Candesartan|candesartan|mesh-list
154690656|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
154690657|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154690658|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154690659|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154690660|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690661|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154690662|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690663|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
154690664|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154690665|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154690666|NCT02097823|Olanzapine|olanzapine|mesh-list
154690667|NCT02097823|Aprepitant|aprepitant|mesh-list
154690668|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
154690669|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
154690670|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690671|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690672|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154690673|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154690674|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154690675|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690676|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154690677|NCT02097823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154690678|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154690679|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154690680|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690681|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690682|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
154690683|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154690684|NCT01857063|Montelukast|montelukast|mesh-list
154690685|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154690686|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
154690687|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154690688|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
154690689|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690690|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690691|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154690692|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154690693|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690694|NCT01856907|Metformin|metformin|mesh-list
154690695|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154690696|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690697|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690698|NCT01856907|Incretins|incretins|mesh-ancestor
154690699|NCT01856907|Hormones|hormones|mesh-ancestor
154690700|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690701|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154690702|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
154690703|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690704|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690705|NCT02097745|Rituximab|rituximab|mesh-list
154690706|NCT02097745|Methotrexate|methotrexate|mesh-list
154690707|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154690708|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690709|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
154690710|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690711|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690712|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154690713|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
153945483|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
154690714|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154690715|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154690716|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
154690717|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690718|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
154690719|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690720|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154690721|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690722|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154690723|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
154690724|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154690725|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690726|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
154690727|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154690728|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
154690729|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154690730|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690731|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154690732|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
154690733|NCT02212379|Etravirine|etravirine|mesh-list
154690734|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154690735|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154690736|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
154690737|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690738|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154690739|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154690740|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690741|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690742|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154690743|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154690744|NCT02187809|Clobazam|clobazam|mesh-list
154690745|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
154690746|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154690747|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154690748|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690749|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690750|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154690751|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154690752|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
154690753|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
154690754|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690755|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690756|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
154690757|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154690758|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690759|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154690760|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154690761|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690762|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442712|NCT02134938|Cathartics|cathartics|mesh-ancestor
153945530|NCT00827359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154690763|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690764|NCT02162771|Prednisone|prednisone|mesh-list
154690765|NCT02162771|Prednisolone|prednisolone|mesh-list
154690766|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
154690767|NCT02162771|Rituximab|rituximab|mesh-list
154690768|NCT02162771|Vincristine|vincristine|mesh-list
154690769|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690770|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
154690771|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690772|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690773|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154690774|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
154690775|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690776|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690777|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154690778|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154690779|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690780|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
154690781|NCT02162771|Hormones|hormones|mesh-ancestor
154690782|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154690783|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154690784|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154690785|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
154690786|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
154690787|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
154690788|NCT02160041|Infigratinib|infigratinib|mesh-list
154690789|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690790|NCT02186873|Golimumab|golimumab|mesh-list
154690791|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154690792|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690793|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154690794|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
154690795|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690796|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154690797|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
154690798|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690799|NCT01830543|Aspirin|aspirin|mesh-list
154690800|NCT01830543|Vitamin K|vitamin k|mesh-list
154690801|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
154690802|NCT01830543|Clopidogrel|clopidogrel|mesh-list
154690803|NCT01830543|Ticagrelor|ticagrelor|mesh-list
154690804|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154690805|NCT01830543|Vitamins|vitamins|mesh-ancestor
154690806|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
154690807|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690808|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154690809|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154690810|NCT01830543|Analgesics|analgesics|mesh-ancestor
154690811|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
154690812|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690813|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690814|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690815|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154690816|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154690817|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690818|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154690819|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154690820|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690821|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
154690822|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154690823|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154690824|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154690825|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
153945585|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
154690826|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690827|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154690828|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
154690829|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154690830|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
154690831|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
154690832|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154690833|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
154690834|NCT01830543|Coagulants|coagulants|mesh-ancestor
154690835|NCT02109445|Paclitaxel|paclitaxel|mesh-list
154690836|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154690837|NCT02109445|Gemcitabine|gemcitabine|mesh-list
154690838|NCT02109445|Nirogacestat|nirogacestat|mesh-list
154558040|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690839|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154690840|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690841|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
154690842|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
154690843|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
154690844|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690845|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154690846|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
154690847|NCT02109445|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154690848|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690849|NCT02109133|Rocuronium|rocuronium|mesh-list
154690850|NCT02109133|Atracurium|atracurium|mesh-list
154690851|NCT02109133|Neostigmine|neostigmine|mesh-list
154690852|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154690853|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154690854|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154690855|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690856|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690857|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154690858|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690859|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690860|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
154690861|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690862|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154690863|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
154690864|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154690865|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154690866|NCT01623271|Gabapentin|gabapentin|mesh-list
154690867|NCT01623271|Analgesics|analgesics|mesh-ancestor
154690868|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
154690869|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690870|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690871|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
154690872|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154690873|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154690874|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690875|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154690876|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154690877|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154690878|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945645|NCT00849901|Analgesics|analgesics|mesh-ancestor
154690879|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690880|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
154690881|NCT02095951|Ethanol|ethanol|mesh-list
154690882|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154690883|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690884|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690885|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690886|NCT02095873|Resveratrol|resveratrol|mesh-list
154690887|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
154690888|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690889|NCT02095873|Protective Agents|protective agents|mesh-ancestor
154690890|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690891|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690892|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154690893|NCT02094937|Fluticasone|fluticasone|mesh-list
154690894|NCT02094937|Xhance|xhance|mesh-list
154690895|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154690896|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154690897|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
154690898|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690899|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690900|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154690901|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
154690902|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
154690903|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154690904|NCT04724629|Aldesleukin|aldesleukin|mesh-list
154690905|NCT04724629|Colchicine|colchicine|mesh-list
154690906|NCT04724629|Ixekizumab|ixekizumab|mesh-list
154690907|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154690908|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154690909|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154690910|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
154690911|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690912|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
154690913|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690914|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
154690915|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
154690916|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
154690917|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690918|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
154690919|NCT02186015|Vitamin D|vitamin d|mesh-list
154690920|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
154690921|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
154690922|NCT02186015|Vitamins|vitamins|mesh-list
154690923|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
154690924|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690925|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154690926|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154690927|NCT02066389|Upadacitinib|upadacitinib|mesh-list
154690928|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154690929|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154690930|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690931|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690932|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154690933|NCT02106403|Disinfectants|disinfectants|mesh-list
154690934|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690935|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
154690936|NCT02133131|Grazoprevir|grazoprevir|mesh-list
154690937|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154690938|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
154690939|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690940|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
154690941|NCT02106325|Promethazine|promethazine|mesh-list
154690942|NCT02106325|Ketamine|ketamine|mesh-list
154690943|NCT02106325|Analgesics|analgesics|mesh-ancestor
154690944|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
154690945|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690946|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690947|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154690948|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154690949|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
154690950|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
154690951|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690952|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154690953|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154690954|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154690955|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690956|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154690957|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154690958|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
154690959|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
154690960|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
154690961|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154690962|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154690963|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
154690964|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
154690965|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154690966|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
154690967|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
154690968|NCT02184611|Bromides|bromides|mesh-list
154690969|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
154690970|NCT02066311|Nelfinavir|nelfinavir|mesh-list
154690971|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154690972|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154690973|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
154690974|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154690975|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154690976|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154690977|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154690978|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
154690979|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154690980|NCT01625611|Naltrexone|naltrexone|mesh-list
154690981|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154690982|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154690983|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690984|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
154690985|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690986|NCT02159807|Fentanyl|fentanyl|mesh-list
154690987|NCT02159807|Bupivacaine|bupivacaine|mesh-list
154690988|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
154690989|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
154690990|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154690991|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154690992|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
154690993|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154690994|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154690995|NCT02159807|Narcotics|narcotics|mesh-ancestor
154690996|NCT02159807|Analgesics|analgesics|mesh-ancestor
154690997|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154690998|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154690999|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
154691000|NCT02183675|Amlodipine|amlodipine|mesh-list
154691001|NCT02183675|Telmisartan|telmisartan|mesh-list
154691002|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154691003|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154691004|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154691005|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154691006|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154691007|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691008|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154691009|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691010|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
154691011|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154691012|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154691013|NCT02183675|Diuretics|diuretics|mesh-ancestor
154691014|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
154691015|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154691016|NCT02183519|Capsaicin|capsaicin|mesh-list
154691017|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
154691018|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691019|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
154691020|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691021|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691022|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154691023|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154691024|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
154691025|NCT02132195|Hormones|hormones|mesh-ancestor
154691026|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691027|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691028|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691029|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691030|NCT02182895|Saxagliptin|saxagliptin|mesh-list
154691031|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154691032|NCT02182895|Incretins|incretins|mesh-ancestor
154691033|NCT02182895|Hormones|hormones|mesh-ancestor
154691034|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691035|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691036|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
154691037|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691038|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691039|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691040|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
154691041|NCT01625377|Everolimus|everolimus|mesh-list
154691042|NCT01625377|Tacrolimus|tacrolimus|mesh-list
154691043|NCT01625377|Basiliximab|basiliximab|mesh-list
154691044|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691045|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
154691046|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691047|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154691048|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691049|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691050|NCT01625377|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154691051|NCT01625377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691052|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691053|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154691054|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154691055|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
154691056|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691057|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691058|NCT02132117|Phenylephrine|phenylephrine|mesh-list
154691059|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
154691060|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154691061|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154691062|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
154691063|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691064|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691065|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691066|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
154691068|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691069|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
154691070|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154691071|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691072|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154691073|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
154691074|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154691075|NCT02132117|Protective Agents|protective agents|mesh-ancestor
154691076|NCT02047045|Prucalopride|prucalopride|mesh-list
154691077|NCT02047045|Serotonin|serotonin|mesh-list
154691078|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154691079|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
154691080|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691081|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691082|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691083|NCT02047045|Laxatives|laxatives|mesh-ancestor
154691084|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154691085|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154691086|NCT02131259|Afatinib|afatinib|mesh-list
154691087|NCT02131259|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154691088|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691089|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691090|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945850|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691091|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691092|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
154691093|NCT01829295|Prednisone|prednisone|mesh-list
154691094|NCT01829295|Methotrexate|methotrexate|mesh-list
154691095|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691096|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
154691097|NCT01829295|Hormones|hormones|mesh-ancestor
154691098|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691099|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691100|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154691101|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691102|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154691103|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
154691104|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154691105|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154691106|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
154691107|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691108|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691109|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691110|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154691111|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691112|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
154691113|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691114|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154691115|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154691116|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154691117|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
154691118|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691119|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691120|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
154691121|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154691122|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691123|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
154691124|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691125|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691126|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691127|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691128|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154691129|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154691130|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154691131|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
154691132|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691133|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691134|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
154691135|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154691136|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
154691137|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691138|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691139|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154691140|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154691142|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154691143|NCT01623115|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154691144|NCT01623115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154691145|NCT01623115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154691146|NCT01623115|Antimetabolites|antimetabolites|mesh-ancestor
154691147|NCT01623115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691148|NCT01623115|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154691149|NCT01623115|Protease Inhibitors|protease inhibitors|mesh-ancestor
153945909|NCT00816595|Rituximab|rituximab|mesh-list
154691150|NCT01623115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691151|NCT01623115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154691152|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
154691153|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691154|NCT02092285|Golimumab|golimumab|mesh-list
154691155|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154691156|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691157|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691158|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
154691159|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691160|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
154691161|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154691162|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154691163|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154691164|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154691165|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154691166|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691167|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
154691168|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691169|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691170|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154691171|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691172|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
154691173|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
154691174|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691175|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
154691176|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691177|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691178|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691179|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691180|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154691181|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154691182|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154691183|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
154691184|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691185|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691186|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691187|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691188|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154691189|NCT01827267|Sirolimus|sirolimus|mesh-list
154691190|NCT01827267|Temsirolimus|temsirolimus|mesh-list
154691191|NCT01827267|MTOR Inhibitors|mtor inhibitors|mesh-list
154691192|NCT01827267|Neratinib|neratinib|mesh-list
154691193|NCT01827267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691194|NCT01827267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691195|NCT01827267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691196|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691197|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
154691198|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691199|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691200|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691201|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691202|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154691203|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
154691204|NCT01827267|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154691205|NCT01827111|Paclitaxel|paclitaxel|mesh-list
154691206|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154691207|NCT01827111|Ipilimumab|ipilimumab|mesh-list
154691208|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154691209|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691210|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
154691211|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
154443154|NCT02854696|Insulin|insulin|mesh-list
154691212|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
154691213|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691214|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154691215|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154691216|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
154691217|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154691218|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
154691219|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154691220|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
154691221|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691222|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691223|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
154691224|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
154691225|NCT02130557|Bosutinib|bosutinib|mesh-list
154691226|NCT02130557|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154691227|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691228|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691229|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691230|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691231|NCT01854645|Bromides|bromides|mesh-list
154691232|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
154691233|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691234|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
154691235|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691236|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691237|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691238|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691239|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
154691240|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154691241|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
154691242|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691243|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691244|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
154691245|NCT04418089|Simvastatin|simvastatin|mesh-list
154691246|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154691247|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154691248|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
154691249|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691250|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154691251|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154691252|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691253|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
154691254|NCT01825941|Promethazine|promethazine|mesh-list
154691255|NCT01825941|Metoclopramide|metoclopramide|mesh-list
154691256|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154691257|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154691258|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154691259|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691260|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
154691261|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
154691262|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
154691263|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691264|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
154691265|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
154691266|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154691267|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154691268|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
154691269|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
154691270|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946036|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
153946087|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691271|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691272|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154691273|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
154691274|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691275|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154691276|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154691277|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
154691278|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
154691279|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154691280|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691281|NCT02180165|Voriconazole|voriconazole|mesh-list
154691282|NCT02180165|Posaconazole|posaconazole|mesh-list
154691283|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
154691284|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691285|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154691286|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154691287|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443227|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154691288|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691289|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154691290|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
154691291|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691292|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691293|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154691294|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154691295|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154691296|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154691298|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154691299|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154691300|NCT02155985|Analgesics|analgesics|mesh-ancestor
154691301|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
154691302|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691303|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691304|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691305|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691306|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154691307|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154691308|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691309|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154691310|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154691311|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691312|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
154691313|NCT02155829|Riluzole|riluzole|mesh-list
154691314|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
154691315|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154691316|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154691317|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691318|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691319|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691320|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154691321|NCT02155829|Protective Agents|protective agents|mesh-ancestor
154691322|NCT02178995|Methylphenidate|methylphenidate|mesh-list
154691323|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154691324|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691325|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154691326|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154691327|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154691328|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691329|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
154691330|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691331|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
154691332|NCT02154425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154691333|NCT02154425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691334|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691335|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
154691336|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691337|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691338|NCT02154347|Mitiglinide|mitiglinide|mesh-list
154691339|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691340|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691341|NCT01627067|Metformin|metformin|mesh-list
154691342|NCT01627067|Everolimus|everolimus|mesh-list
154691343|NCT01627067|Exemestane|exemestane|mesh-list
154691344|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691345|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691346|NCT01627067|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154691347|NCT01627067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691348|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691349|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691350|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691351|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
154691352|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691353|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154691354|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154691355|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154691356|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
154691357|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691358|NCT02178059|Terbutaline|terbutaline|mesh-list
154691359|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691360|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
154691361|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691362|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691363|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691364|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691365|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
154691366|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
154691367|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154691368|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154691369|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154691370|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154691371|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
154691372|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691373|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691374|NCT02128217|Ribavirin|ribavirin|mesh-list
154691375|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
154691376|NCT02128217|Ledipasvir|ledipasvir|mesh-list
154691377|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154691378|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
154691379|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691380|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
154691381|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691382|NCT01628549|Sarecycline|sarecycline|mesh-list
154691383|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691384|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691385|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691386|NCT02127125|Sevelamer|sevelamer|mesh-list
154691387|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
154691388|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
154691389|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691390|NCT02090413|Aspirin|aspirin|mesh-list
154691391|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154691392|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154691393|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154691394|NCT02090413|Analgesics|analgesics|mesh-ancestor
154691395|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
154691396|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691397|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691398|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691399|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691400|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154691401|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154691402|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691403|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154691404|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154691405|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691406|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
154691407|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691408|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691409|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
154691410|NCT02125877|Deferasirox|deferasirox|mesh-list
154691411|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154691412|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
154691413|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
154691414|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691415|NCT01598987|Cyclosporine|cyclosporine|mesh-list
154691416|NCT01598987|Everolimus|everolimus|mesh-list
154691417|NCT01598987|Tacrolimus|tacrolimus|mesh-list
154691418|NCT01598987|Cyclosporins|cyclosporins|mesh-list
154691419|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691420|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
154691421|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691422|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154691423|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946188|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154691424|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691425|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
154691426|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691427|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691428|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691429|NCT01598987|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154691430|NCT01598987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691431|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691432|NCT02062879|Ketamine|ketamine|mesh-list
154691433|NCT02062879|Hydromorphone|hydromorphone|mesh-list
154691434|NCT02062879|Analgesics|analgesics|mesh-ancestor
154691435|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
154691436|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558041|NCT01664624|Exenatide|exenatide|mesh-list
154691437|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691438|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154691439|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154691440|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
154691441|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
154691442|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154691443|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154691444|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154691445|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691446|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691447|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154691448|NCT02062879|Narcotics|narcotics|mesh-ancestor
154691449|NCT02062645|Amlodipine|amlodipine|mesh-list
154691450|NCT02062645|Valsartan|valsartan|mesh-list
154691451|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154691452|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154691453|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154691454|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154691455|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691456|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154691457|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691458|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
154691459|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154691460|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154691461|NCT04700839|Metformin|metformin|mesh-list
154691462|NCT04700839|Canagliflozin|canagliflozin|mesh-list
154691463|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154691464|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691465|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691466|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691467|NCT02043301|Bococizumab|bococizumab|mesh-list
154691468|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154691469|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154691470|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
154691471|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691472|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154691473|NCT01598753|Tramadol|tramadol|mesh-list
154691474|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154691475|NCT01598753|Narcotics|narcotics|mesh-ancestor
154691476|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154691477|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691478|NCT01598753|Analgesics|analgesics|mesh-ancestor
154691479|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
154691480|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691481|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
154691482|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
154691483|NCT01824693|Melphalan|melphalan|mesh-list
154691484|NCT01824693|Busulfan|busulfan|mesh-list
154691485|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
154691486|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154691487|NCT01824693|Fludarabine|fludarabine|mesh-list
154691488|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
154691489|NCT01824693|Tacrolimus|tacrolimus|mesh-list
154691490|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691491|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
154691492|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691493|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691494|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154691495|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
154691496|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691497|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691498|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154691499|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154691500|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
154691501|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154691502|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691503|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154691504|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154691505|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
154691506|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691507|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691508|NCT02176655|Aspirin|aspirin|mesh-list
154691509|NCT02176655|Sumatriptan|sumatriptan|mesh-list
154691510|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154691511|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154691512|NCT02176655|Analgesics|analgesics|mesh-ancestor
154691513|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
154691514|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691515|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691516|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691518|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154691519|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154691520|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691521|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154691522|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154691523|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691524|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
154691525|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154691526|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154691527|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154691528|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
154691529|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691530|NCT01622569|Fluticasone|fluticasone|mesh-list
154691531|NCT01622569|Xhance|xhance|mesh-list
154691532|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691533|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691534|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
154691535|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691536|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691537|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691538|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691539|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691540|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154691541|NCT02152163|Ibuprofen|ibuprofen|mesh-list
154691542|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154691543|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154691544|NCT02152163|Analgesics|analgesics|mesh-ancestor
154691545|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
154691546|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691547|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691548|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691549|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691550|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154691551|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691552|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691553|NCT02152007|Sirolimus|sirolimus|mesh-list
154691554|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691555|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691556|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154691557|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691558|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
154691559|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691560|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
154691561|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691562|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
154691563|NCT02151851|Methotrexate|methotrexate|mesh-list
154691564|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154691565|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
154691566|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154691567|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691568|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154691569|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
154691570|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691571|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691572|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
154691573|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691574|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154691575|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691576|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
154691577|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691578|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154691579|NCT02151851|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154691580|NCT02151851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691581|NCT02176421|Lidocaine|lidocaine|mesh-list
154691582|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
154691583|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
154691584|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154691585|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691586|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
154691587|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691588|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154691589|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154691590|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154691591|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154691592|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691593|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
154691595|NCT02042443|Folic Acid|folic acid|mesh-list
154691596|NCT02042443|Capecitabine|capecitabine|mesh-list
154691597|NCT02042443|Fluorouracil|fluorouracil|mesh-list
154691598|NCT02042443|Trametinib|trametinib|mesh-list
154691599|NCT02042443|Calcium|calcium|mesh-list
154691600|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
154691601|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154691602|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691603|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154691604|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154691605|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
154691606|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691607|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691608|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691609|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
154691610|NCT02042443|Antidotes|antidotes|mesh-ancestor
154691611|NCT02042443|Protective Agents|protective agents|mesh-ancestor
154691612|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
154691613|NCT02042443|Vitamins|vitamins|mesh-ancestor
154691614|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
154691615|NCT02042443|Hematinics|hematinics|mesh-ancestor
154691616|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691617|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691618|NCT02118896|Tacrolimus|tacrolimus|mesh-list
154691619|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691620|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
154691621|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691622|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154691623|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691624|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691625|NCT02124707|Paclitaxel|paclitaxel|mesh-list
154691626|NCT02124707|Carboplatin|carboplatin|mesh-list
154691627|NCT02124707|Cetuximab|cetuximab|mesh-list
154691628|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154691629|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691630|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
154691631|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
154691632|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
154691633|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691634|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154691635|NCT02092220|Pancrelipase|pancrelipase|mesh-list
154691636|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154691637|NCT02066402|Linezolid|linezolid|mesh-list
154691638|NCT02066402|Tedizolid|tedizolid|mesh-list
154691639|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
154691640|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691641|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691642|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154691643|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691644|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691645|NCT02060383|Metformin|metformin|mesh-list
154691646|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154691647|NCT02060383|Liraglutide|liraglutide|mesh-list
154691648|NCT02060383|Pasireotide|pasireotide|mesh-list
154691649|NCT02060383|Somatostatin|somatostatin|mesh-list
154691650|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691651|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691652|NCT02060383|Incretins|incretins|mesh-ancestor
154691653|NCT02060383|Hormones|hormones|mesh-ancestor
154691654|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691655|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154691656|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
154691657|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691658|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691659|NCT02060383|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154691660|NCT02086591|Doxycycline|doxycycline|mesh-list
154443612|NCT03869944|Lamivudine|lamivudine|mesh-list
154691661|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691662|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691663|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
154691664|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154691665|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154691666|NCT02065622|Adalimumab|adalimumab|mesh-list
154691667|NCT02065622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154691668|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691669|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691670|NCT02117648|Clarithromycin|clarithromycin|mesh-list
154691671|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691672|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691673|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154691674|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691675|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691676|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154691677|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154691678|NCT02124161|Vaccines|vaccines|mesh-list
154691679|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154691680|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
154691681|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691682|NCT02117570|Vaccines|vaccines|mesh-list
154691683|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
154691684|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691685|NCT02123459|Cephalexin|cephalexin|mesh-list
154691686|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691687|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691688|NCT01853475|Artefenomel|artefenomel|mesh-list
154691689|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
154691690|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154691691|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154691692|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691693|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
154691694|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691695|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
154691696|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691697|NCT04411160|Protective Agents|protective agents|mesh-ancestor
154691698|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691699|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
154691700|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691701|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691702|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691703|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154691704|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691705|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154691706|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
154691707|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
154691708|NCT02151773|Vaccines|vaccines|mesh-list
154691709|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
154691710|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691711|NCT02151461|Metformin|metformin|mesh-list
154691712|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691713|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691714|NCT02091986|Budesonide|budesonide|mesh-list
154691715|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154691716|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691717|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691718|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
154691719|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946497|NCT01133678|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154691720|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691721|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691722|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691723|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
154691724|NCT02091986|Hormones|hormones|mesh-ancestor
154691725|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691726|NCT02117024|Paclitaxel|paclitaxel|mesh-list
154691727|NCT02117024|Vinorelbine|vinorelbine|mesh-list
154691728|NCT02117024|Docetaxel|docetaxel|mesh-list
154691729|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
154691730|NCT02117024|Gemcitabine|gemcitabine|mesh-list
154691731|NCT02117024|Pemetrexed|pemetrexed|mesh-list
154691732|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154691733|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154691734|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691735|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
154691736|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
154691737|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
154691738|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691739|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154691740|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
154691741|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691742|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691743|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154691744|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
154691745|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154691746|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154691747|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
154691748|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691749|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154691750|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154691751|NCT02117024|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154691752|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691754|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154691755|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691756|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691757|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
154691758|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691759|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691760|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
154691761|NCT02151149|Paclitaxel|paclitaxel|mesh-list
154691762|NCT02151149|Carboplatin|carboplatin|mesh-list
154691763|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154691764|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691765|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
154691766|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
154691767|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
154691768|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691769|NCT02150213|Dexamethasone|dexamethasone|mesh-list
154691770|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691771|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
154691772|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
154691773|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691774|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691775|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154691776|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
154691777|NCT02150213|Hormones|hormones|mesh-ancestor
154691778|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691779|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154691780|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691781|NCT02091362|Metformin|metformin|mesh-list
154691782|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691783|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691784|NCT02115386|Nilotinib|nilotinib|mesh-list
154691785|NCT02115386|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154691786|NCT02115386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154691787|NCT02115386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691788|NCT02115386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691789|NCT02091206|Cannabidiol|cannabidiol|mesh-list
154691790|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
154691791|NCT02062658|Ketamine|ketamine|mesh-list
154691792|NCT02062658|Analgesics|analgesics|mesh-ancestor
154691793|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
154691794|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691795|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691796|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154691797|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154691798|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
154691799|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
154691800|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154691801|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154691802|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154691803|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691804|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691805|NCT02115308|Regadenoson|regadenoson|mesh-list
154691806|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154691807|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154691808|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
154691809|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
154691810|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691811|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691812|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691813|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
154691814|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691815|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691816|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154691817|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154691818|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691819|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691820|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691821|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
154691822|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
154691823|NCT02090114|Testosterone|testosterone|mesh-list
154691824|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
154691825|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
154691826|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154691827|NCT02090114|Androgens|androgens|mesh-ancestor
154691828|NCT02090114|Hormones|hormones|mesh-ancestor
154691829|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691830|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691831|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154691832|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691833|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
154691834|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154691835|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691836|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691837|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
154691838|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154691839|NCT04742036|Paclitaxel|paclitaxel|mesh-list
154691840|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154691841|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691842|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
154691843|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
154691844|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
154691845|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691846|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
154691847|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154691848|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
154691849|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154691850|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
154691851|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691852|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691853|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
154691854|NCT02111096|Metformin|metformin|mesh-list
154691855|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154691856|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691857|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691858|NCT02111096|Incretins|incretins|mesh-ancestor
154691859|NCT02111096|Hormones|hormones|mesh-ancestor
154691860|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691861|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154691862|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
154691863|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691864|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691865|NCT02110706|Rituximab|rituximab|mesh-list
154691866|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154691867|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691868|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
154691869|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691870|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154691871|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
154691872|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154691873|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
154691874|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691875|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
154691876|NCT02110238|Protective Agents|protective agents|mesh-ancestor
154691877|NCT02107898|Alirocumab|alirocumab|mesh-list
154691878|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154691879|NCT02107898|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154691880|NCT02107898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154691881|NCT02107898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154691882|NCT02107898|Antimetabolites|antimetabolites|mesh-ancestor
154691883|NCT02107898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691884|NCT02107898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154691885|NCT02107898|Protease Inhibitors|protease inhibitors|mesh-ancestor
154691886|NCT02107898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691887|NCT02107898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154691888|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
154691889|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691891|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154691892|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154691893|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154691894|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691895|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
154691896|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691897|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691898|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154691899|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691900|NCT02107274|Azithromycin|azithromycin|mesh-list
154691901|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154691902|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154691903|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
154691904|NCT02173769|Olodaterol|olodaterol|mesh-list
154691905|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691906|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
154691907|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691908|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691909|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691910|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691911|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
154691912|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154691913|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
154691914|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691915|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691916|NCT02121509|Metformin|metformin|mesh-list
154691917|NCT02121509|Linagliptin|linagliptin|mesh-list
154691918|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154691919|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691920|NCT02121509|Incretins|incretins|mesh-ancestor
154691921|NCT02121509|Hormones|hormones|mesh-ancestor
154691922|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691923|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154691924|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
154691925|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691926|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691927|NCT02149199|Budesonide|budesonide|mesh-list
154691928|NCT02149199|Terbutaline|terbutaline|mesh-list
154691929|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
154691930|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154691931|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154691932|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
154691933|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691934|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691935|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154691936|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
154691937|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
154691938|NCT02149199|Hormones|hormones|mesh-ancestor
154691939|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691940|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154691941|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154691942|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154691943|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
154691944|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691945|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691946|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
154691947|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
154691948|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154691949|NCT02120417|Capecitabine|capecitabine|mesh-list
154691950|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154691951|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
154691952|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691953|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154691954|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
154691955|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154691956|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154691957|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154691958|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154691959|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691960|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
154691961|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691962|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691963|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154691964|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691965|NCT02058368|Tamsulosin|tamsulosin|mesh-list
154691966|NCT02058368|Dutasteride|dutasteride|mesh-list
154691967|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154691968|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154691969|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154691970|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
154691971|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154691972|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154691973|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691974|NCT02058368|Urological Agents|urological agents|mesh-ancestor
154691975|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154691976|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154691977|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154691978|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
154691979|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154691980|NCT02058290|Morphine|morphine|mesh-list
154691981|NCT02058290|Bupivacaine|bupivacaine|mesh-list
154691982|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
154691983|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
154691984|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154691985|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691986|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
154691987|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154691988|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154691989|NCT02058290|Narcotics|narcotics|mesh-ancestor
154691990|NCT02058290|Analgesics|analgesics|mesh-ancestor
154691991|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
154691992|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154691993|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154691994|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154691995|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154691996|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154691997|NCT04718480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154691998|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154691999|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154692000|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692001|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692002|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
154692003|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154692004|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
154692005|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154692006|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154692007|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692008|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154692009|NCT02106884|Paclitaxel|paclitaxel|mesh-list
154692010|NCT02106884|Gemcitabine|gemcitabine|mesh-list
154692011|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154692012|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692013|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
154692014|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
154692015|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
154692016|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692017|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154692018|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
154692019|NCT02081690|Macitentan|macitentan|mesh-list
154692020|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154692021|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154692022|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692023|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154692024|NCT01625000|Risperidone|risperidone|mesh-list
154692025|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154692026|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
154692027|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692028|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692029|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692030|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154692031|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154692032|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692033|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154692034|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154692035|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
154692036|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154692037|NCT02057198|Metronidazole|metronidazole|mesh-list
154692038|NCT02057198|Vancomycin|vancomycin|mesh-list
154692039|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
154692040|NCT02057198|Amebicides|amebicides|mesh-list
154692041|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692042|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154692043|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154692044|NCT02056340|Atorvastatin|atorvastatin|mesh-list
154692045|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154692046|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154692047|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
154692048|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692049|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154692050|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154692051|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692052|NCT02046122|Cytarabine|cytarabine|mesh-list
154692053|NCT02046122|Idarubicin|idarubicin|mesh-list
154692054|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154692055|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
154692056|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692057|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692058|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
154692059|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692060|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692061|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
154692062|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692063|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154692064|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153946852|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692065|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154692066|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692067|NCT02080832|Dexetimide|dexetimide|mesh-list
154692068|NCT02080832|Citalopram|citalopram|mesh-list
154692069|NCT02080832|Escitalopram|escitalopram|mesh-list
154692070|NCT02080832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154692071|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154692072|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154692073|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692074|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692075|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
154692076|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692077|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154692078|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
154692079|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154692080|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154692081|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154692082|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
154692083|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
154692084|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692085|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154692086|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154692087|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
154692088|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
154692089|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154692090|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692091|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154692092|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692093|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692094|NCT02078102|Meloxicam|meloxicam|mesh-list
154692095|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692096|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154692097|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154692098|NCT02078102|Analgesics|analgesics|mesh-ancestor
154692099|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
154692100|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692101|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154692102|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692103|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154692104|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154692105|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692106|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692107|NCT02054702|Aripiprazole|aripiprazole|mesh-list
154692108|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
154692109|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
154692110|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154692111|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154692112|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154692113|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692114|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692115|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
154692116|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
154692117|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692118|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692119|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154692120|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154692121|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
154692122|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154692123|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154692124|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154692125|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154692126|NCT02044094|Buprenorphine|buprenorphine|mesh-list
154692127|NCT02044094|Hydromorphone|hydromorphone|mesh-list
154692128|NCT02044094|Naloxone|naloxone|mesh-list
154692129|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154692130|NCT02044094|Narcotics|narcotics|mesh-ancestor
154692131|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692132|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692133|NCT02044094|Analgesics|analgesics|mesh-ancestor
154692134|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
154692135|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692136|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154692137|NCT02053610|Rituximab|rituximab|mesh-list
154692138|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
154692139|NCT02053610|Chlorambucil|chlorambucil|mesh-list
154692140|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692141|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692142|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
154692143|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692144|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692145|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154692146|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
154692147|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692148|NCT02075606|Lanreotide|lanreotide|mesh-list
154692149|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692150|NCT04701008|Ketamine|ketamine|mesh-list
154692151|NCT04701008|Analgesics|analgesics|mesh-ancestor
154692152|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
154692153|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692154|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692155|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154692156|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154692157|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
154692158|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
154692159|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692160|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154692161|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154692162|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692163|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692164|NCT02052440|Baclofen|baclofen|mesh-list
154692165|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154692166|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692167|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154692168|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692169|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154692170|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
154692171|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
154692172|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692173|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692174|NCT02049944|Cefazolin|cefazolin|mesh-list
154692175|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154692176|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692177|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
154692178|NCT01621880|Bevacizumab|bevacizumab|mesh-list
154692179|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692180|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692181|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154692182|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154692183|NCT01621880|Growth Substances|growth substances|mesh-ancestor
154692184|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692185|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
154692186|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154692187|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
154692188|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
154692189|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946957|NCT00883558|Insulin|insulin|mesh-list
154692190|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154692191|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
154692192|NCT01621880|Hormones|hormones|mesh-ancestor
154692193|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692194|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154692195|NCT01621880|Protective Agents|protective agents|mesh-ancestor
154692196|NCT02041429|Paclitaxel|paclitaxel|mesh-list
154692197|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154692198|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692199|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
154692200|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
154692201|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
154692202|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692203|NCT02083783|Amphetamine|amphetamine|mesh-list
154692204|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154692205|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692206|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
154692207|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
154692208|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692209|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
154692210|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692211|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692212|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
154692213|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154692214|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154692215|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154692216|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154692217|NCT02059135|Antithrombins|antithrombins|mesh-list
154692218|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
154692219|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154692220|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
154692221|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692222|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692223|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
154692224|NCT04695769|Ribavirin|ribavirin|mesh-list
154692225|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
154692226|NCT04695769|Velpatasvir|velpatasvir|mesh-list
154692227|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154692228|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
154692229|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692230|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
154692231|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692232|NCT02038933|Nivolumab|nivolumab|mesh-list
154692233|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692234|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692235|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692236|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692237|NCT02081599|Insulin|insulin|mesh-list
154692238|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154692239|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692240|NCT02038153|Lenalidomide|lenalidomide|mesh-list
154692241|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
154692242|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692243|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154692244|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154692245|NCT02038153|Growth Substances|growth substances|mesh-ancestor
154692246|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
154692247|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692248|NCT02079805|Telmisartan|telmisartan|mesh-list
154692249|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154692250|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154692251|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154692252|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154692253|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692254|NCT02037295|Vancomycin|vancomycin|mesh-list
154692255|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154692256|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692257|NCT02079649|Dexamethasone|dexamethasone|mesh-list
154692258|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154692259|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154692260|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154692261|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
154692262|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
154692263|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692264|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692265|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154692266|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
154692267|NCT02079649|Hormones|hormones|mesh-ancestor
154692268|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692269|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154692270|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692271|NCT02036515|Metformin|metformin|mesh-list
154692272|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154692273|NCT02036515|Glimepiride|glimepiride|mesh-list
154692274|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
154692275|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154692276|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692277|NCT02036515|Incretins|incretins|mesh-ancestor
154692278|NCT02036515|Hormones|hormones|mesh-ancestor
154692279|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692280|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154692281|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
154692282|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692283|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692284|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154692285|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692286|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
154692287|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154692288|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
154692289|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154692290|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692291|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
154692292|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154692293|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154692294|NCT05887375|Glycopyrrolate|glycopyrrolate|mesh-list
154692295|NCT05887375|Bromides|bromides|mesh-list
154692296|NCT05887375|Rocuronium|rocuronium|mesh-list
154692297|NCT05887375|Neostigmine|neostigmine|mesh-list
154692298|NCT05887375|Anticonvulsants|anticonvulsants|mesh-ancestor
154692299|NCT05887375|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154692300|NCT05887375|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154692301|NCT05887375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154692302|NCT05887375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692303|NCT05887375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692304|NCT05887375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154692305|NCT05887375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692306|NCT05887375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692307|NCT05887375|Cholinergic Agents|cholinergic agents|mesh-ancestor
154692308|NCT05887375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692309|NCT05887375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154692310|NCT05887375|Autonomic Agents|autonomic agents|mesh-ancestor
154692311|NCT05887375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154692312|NCT05887375|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154692313|NCT05887375|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154692314|NCT05887258|Analgesics, Opioid|analgesics, opioid|mesh-list
154692315|NCT05887258|Anesthetics|anesthetics|mesh-list
154692316|NCT05887258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692317|NCT05887258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692318|NCT05887258|Narcotics|narcotics|mesh-ancestor
154692319|NCT05887258|Analgesics|analgesics|mesh-ancestor
154692320|NCT05887258|Sensory System Agents|sensory system agents|mesh-ancestor
154692321|NCT05887258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692322|NCT05887219|Azelaic acid|azelaic acid|mesh-list
154692323|NCT05887219|Tranexamic Acid|tranexamic acid|mesh-list
154692324|NCT05887219|Hydroquinone|hydroquinone|mesh-list
154692325|NCT05887219|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154692326|NCT05887219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154692327|NCT05887219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692328|NCT05887219|Hemostatics|hemostatics|mesh-ancestor
154692329|NCT05887219|Coagulants|coagulants|mesh-ancestor
154692330|NCT05887219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692331|NCT05887219|Dermatologic Agents|dermatologic agents|mesh-ancestor
154692332|NCT05887219|Antioxidants|antioxidants|mesh-ancestor
154692333|NCT05887219|Protective Agents|protective agents|mesh-ancestor
154444275|NCT02291705|Tramadol|tramadol|mesh-list
154692334|NCT05887219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692335|NCT05887219|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154692336|NCT05886998|Heparin|heparin|mesh-list
154692337|NCT05886998|Anticoagulants|anticoagulants|mesh-ancestor
154692338|NCT05886998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154692339|NCT05886998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154692340|NCT05886998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692341|NCT05886933|Fexuprazan|fexuprazan|mesh-list
154692342|NCT05886933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154692343|NCT05886829|Chlorpheniramine|chlorpheniramine|mesh-list
154692344|NCT05886829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692345|NCT05886829|Antipruritics|antipruritics|mesh-ancestor
154692346|NCT05886829|Dermatologic Agents|dermatologic agents|mesh-ancestor
154692347|NCT05886829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154692348|NCT05886829|Histamine Antagonists|histamine antagonists|mesh-ancestor
154692349|NCT05886829|Histamine Agents|histamine agents|mesh-ancestor
154692350|NCT05886829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692351|NCT05886829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692352|NCT05886829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154692353|NCT05886790|Vaccines|vaccines|mesh-list
154692354|NCT05886790|Immunologic Factors|immunologic factors|mesh-ancestor
154692355|NCT05886790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692356|NCT05886660|Scopolamine|scopolamine|mesh-list
154692357|NCT05886660|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154692358|NCT05886660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154692359|NCT05886660|Antiemetics|antiemetics|mesh-ancestor
154692360|NCT05886660|Autonomic Agents|autonomic agents|mesh-ancestor
154692361|NCT05886660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692362|NCT05886660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692363|NCT05886660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154692364|NCT05886660|Mydriatics|mydriatics|mesh-ancestor
154692365|NCT05886660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154692366|NCT05886660|Cholinergic Agents|cholinergic agents|mesh-ancestor
154692367|NCT05886660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692368|NCT05886660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692369|NCT05886660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154692370|NCT05886660|Parasympatholytics|parasympatholytics|mesh-ancestor
154692371|NCT05886465|Bevacizumab|bevacizumab|mesh-list
154692372|NCT05886465|Atezolizumab|atezolizumab|mesh-list
154692373|NCT05886465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692374|NCT05886465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692375|NCT05886465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154692376|NCT05886465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154692377|NCT05886465|Growth Substances|growth substances|mesh-ancestor
154692378|NCT05886465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692379|NCT05886465|Growth Inhibitors|growth inhibitors|mesh-ancestor
154692380|NCT05886465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692381|NCT05886465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692382|NCT05886439|Pembrolizumab|pembrolizumab|mesh-list
154692383|NCT05886439|Durvalumab|durvalumab|mesh-list
154692384|NCT05886439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692385|NCT05886439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692386|NCT05886439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692387|NCT05886439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692388|NCT05886257|Bevacizumab|bevacizumab|mesh-list
154692389|NCT05886257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692390|NCT05886257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692391|NCT05886257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154692392|NCT05886257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154692393|NCT05886257|Growth Substances|growth substances|mesh-ancestor
154692394|NCT05886257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692395|NCT05886257|Growth Inhibitors|growth inhibitors|mesh-ancestor
154692396|NCT05886192|Vasopressins|vasopressins|mesh-list
154692397|NCT05886192|Arginine Vasopressin|arginine vasopressin|mesh-list
154692398|NCT05886192|Norepinephrine|norepinephrine|mesh-list
154692399|NCT05886192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154692400|NCT05886192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154692401|NCT05886192|Adrenergic Agents|adrenergic agents|mesh-ancestor
154692402|NCT05886192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692403|NCT05886192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692404|NCT05886192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692405|NCT05886192|Sympathomimetics|sympathomimetics|mesh-ancestor
154692406|NCT05886192|Autonomic Agents|autonomic agents|mesh-ancestor
154692407|NCT05886192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692408|NCT05886192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154692409|NCT05886192|Hemostatics|hemostatics|mesh-ancestor
154692410|NCT05886192|Coagulants|coagulants|mesh-ancestor
154692411|NCT05886192|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154692412|NCT05886192|Natriuretic Agents|natriuretic agents|mesh-ancestor
154692413|NCT05886127|Hemostatics|hemostatics|mesh-list
154692414|NCT05886127|Coagulants|coagulants|mesh-ancestor
154692415|NCT05886088|Dapagliflozin|dapagliflozin|mesh-list
154692416|NCT05886088|Linagliptin|linagliptin|mesh-list
154692417|NCT05886088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154692418|NCT05886088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692419|NCT05886088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154692420|NCT05886088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692421|NCT05886088|Incretins|incretins|mesh-ancestor
154692422|NCT05886088|Hormones|hormones|mesh-ancestor
154692423|NCT05886088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692424|NCT05886088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154692425|NCT05886088|Protease Inhibitors|protease inhibitors|mesh-ancestor
154692426|NCT05886088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692427|NCT05885919|Edaravone|edaravone|mesh-list
154692428|NCT05885919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154692429|NCT05885919|Antioxidants|antioxidants|mesh-ancestor
154692430|NCT05885919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692431|NCT05885919|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154692432|NCT05885919|Protective Agents|protective agents|mesh-ancestor
154692433|NCT05885919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692434|NCT05885802|Anesthetics|anesthetics|mesh-list
154692435|NCT05885802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692436|NCT05885802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692437|NCT05885776|Trastuzumab|trastuzumab|mesh-list
154692438|NCT05885776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692439|NCT05885776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692440|NCT05794477|Paclitaxel|paclitaxel|mesh-list
154692441|NCT05794477|Carboplatin|carboplatin|mesh-list
154692442|NCT05794477|Pemetrexed|pemetrexed|mesh-list
154692443|NCT05794477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154692444|NCT05794477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692445|NCT05794477|Tubulin Modulators|tubulin modulators|mesh-ancestor
154692446|NCT05794477|Antimitotic Agents|antimitotic agents|mesh-ancestor
154692447|NCT05794477|Mitosis Modulators|mitosis modulators|mesh-ancestor
154692448|NCT05794477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692449|NCT05794477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692450|NCT05794477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154692451|NCT05794477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154692452|NCT05789381|Magnesium Sulfate|magnesium sulfate|mesh-list
154692453|NCT05789381|Analgesics|analgesics|mesh-ancestor
154692454|NCT05789381|Sensory System Agents|sensory system agents|mesh-ancestor
154692455|NCT05789381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692456|NCT05789381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692457|NCT05789381|Anesthetics|anesthetics|mesh-ancestor
154692458|NCT05789381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692459|NCT05789381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154692460|NCT05789381|Anticonvulsants|anticonvulsants|mesh-ancestor
154692461|NCT05789381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154692462|NCT05789381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154692463|NCT05789381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692464|NCT05789381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154692465|NCT05789381|Tocolytic Agents|tocolytic agents|mesh-ancestor
154692466|NCT05789381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154692467|NCT05745701|Cyclosporine|cyclosporine|mesh-list
154692468|NCT05745701|Itraconazole|itraconazole|mesh-list
154692469|NCT05745701|Cyclosporins|cyclosporins|mesh-list
154692470|NCT05745701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692471|NCT05745701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692472|NCT05745701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692473|NCT05745701|Immunologic Factors|immunologic factors|mesh-ancestor
154692474|NCT05745701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692475|NCT05745701|Antifungal Agents|antifungal agents|mesh-ancestor
154692476|NCT05745701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692477|NCT05745701|Dermatologic Agents|dermatologic agents|mesh-ancestor
154692478|NCT05745701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692479|NCT05745701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154692480|NCT05745701|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154692481|NCT05745701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154692482|NCT05745701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154692483|NCT05745701|Hormone Antagonists|hormone antagonists|mesh-ancestor
154692484|NCT05745701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692485|NCT05745701|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154692486|NCT05742594|Lazertinib|lazertinib|mesh-list
154692487|NCT05742594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154692488|NCT05742594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692489|NCT05742594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692490|NCT05741086|Atorvastatin|atorvastatin|mesh-list
154692491|NCT05741086|Evolocumab|evolocumab|mesh-list
154692492|NCT05741086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154692493|NCT05741086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154692494|NCT05741086|Antimetabolites|antimetabolites|mesh-ancestor
154692495|NCT05741086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692496|NCT05741086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154692497|NCT05741086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154692498|NCT05741086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692499|NCT05741086|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154692500|NCT05741086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154692501|NCT05741086|Protease Inhibitors|protease inhibitors|mesh-ancestor
154692502|NCT05722262|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
154692503|NCT05722262|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154692504|NCT05722262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692505|NCT05722262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154692506|NCT05722262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692507|NCT05710887|Nitrous Oxide|nitrous oxide|mesh-list
154692508|NCT05710887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154692509|NCT05710887|Anesthetics, General|anesthetics, general|mesh-ancestor
154692510|NCT05710887|Anesthetics|anesthetics|mesh-ancestor
154692511|NCT05710887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692512|NCT05710887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692513|NCT05710887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154692514|NCT05710887|Analgesics|analgesics|mesh-ancestor
154692515|NCT05710887|Sensory System Agents|sensory system agents|mesh-ancestor
154692516|NCT05710887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692517|NCT05657041|Clopidogrel|clopidogrel|mesh-list
154692518|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154692519|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154692520|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154692521|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154692522|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154692523|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
154692524|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692525|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692526|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692527|NCT05607316|Metformin|metformin|mesh-list
154692528|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154692529|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692530|NCT05605587|Leflunomide|leflunomide|mesh-list
154692531|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692532|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692533|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692534|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
154692535|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692536|NCT05582993|Factor VIII|factor viii|mesh-list
154692537|NCT05582993|Coagulants|coagulants|mesh-ancestor
154692538|NCT05581758|Sotorasib|sotorasib|mesh-list
154692539|NCT05581758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692540|NCT05581758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692541|NCT05581758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692542|NCT05581758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692543|NCT05554146|Dronabinol|dronabinol|mesh-list
154692544|NCT05554146|Hallucinogens|hallucinogens|mesh-ancestor
154692545|NCT05554146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692546|NCT05554146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154692547|NCT05554146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154692548|NCT05554146|Analgesics|analgesics|mesh-ancestor
154692549|NCT05554146|Sensory System Agents|sensory system agents|mesh-ancestor
154692550|NCT05554146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692551|NCT05554146|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154692552|NCT05554146|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154692553|NCT05554146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692554|NCT05554146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692555|NCT05554146|Hormones|hormones|mesh-ancestor
154692556|NCT05554146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692557|NCT05553301|Vaccines|vaccines|mesh-list
154692558|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
154692559|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692560|NCT05535738|Fluticasone|fluticasone|mesh-list
154692562|NCT05535738|Adalimumab|adalimumab|mesh-list
154692563|NCT05535738|Triamcinolone|triamcinolone|mesh-list
154692564|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154692565|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154692566|NCT05535738|Betamethasone|betamethasone|mesh-list
154692567|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
154692568|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154692569|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
154692570|NCT05535738|Ustekinumab|ustekinumab|mesh-list
154692571|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154692572|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
154692573|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154692574|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154692575|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154692576|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
154692577|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692578|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692579|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154692580|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
154692581|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
154692582|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154692583|NCT05535738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154692584|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692585|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
154692586|NCT05535738|Hormones|hormones|mesh-ancestor
154692587|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692588|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692589|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
154692590|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692591|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692592|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154692593|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
154692594|NCT05518110|Trametinib|trametinib|mesh-list
154692595|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
154692596|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154692597|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154692598|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692599|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692600|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692601|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692602|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692603|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154692604|NCT05345717|Abatacept|abatacept|mesh-list
154692605|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
154692606|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692607|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692608|NCT05345717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692609|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692610|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692611|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
154692612|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692613|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692614|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
154692615|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692616|NCT05245968|Sunitinib|sunitinib|mesh-list
154692617|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
154692618|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692619|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154692620|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154692621|NCT05245968|Growth Substances|growth substances|mesh-ancestor
154692622|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692623|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
154692624|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154692625|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692626|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692627|NCT05245968|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154692628|NCT05220514|PK 11195|pk 11195|mesh-list
154692629|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692630|NCT05194969|Petrolatum|petrolatum|mesh-list
154444570|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
154692631|NCT05194969|Emollients|emollients|mesh-ancestor
154692632|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
154692633|NCT05166239|Lenvatinib|lenvatinib|mesh-list
154692634|NCT05166239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154692635|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692636|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154692637|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692638|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692639|NCT05166239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692640|NCT05145296|Daratumumab|daratumumab|mesh-list
154692641|NCT05145296|Abatacept|abatacept|mesh-list
154692642|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692643|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692644|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692645|NCT05145296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692646|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692647|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
154692648|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692649|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692650|NCT05095922|Valsartan|valsartan|mesh-list
154692651|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
154692652|NCT05095922|Calcium|calcium|mesh-list
154692653|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154692654|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692655|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154692656|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154692657|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154692658|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692659|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
154692660|NCT05095922|Coagulants|coagulants|mesh-ancestor
154692661|NCT04875715|Hydroquinone|hydroquinone|mesh-list
154692662|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
154692663|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692664|NCT04875715|Protective Agents|protective agents|mesh-ancestor
154692665|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692666|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154692667|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154692668|NCT04836429|Trioxsalen|trioxsalen|mesh-list
154692669|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692670|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
154692671|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154692672|NCT04822467|Ethanol|ethanol|mesh-list
154692673|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154692674|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692675|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692676|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692677|NCT04769713|Ropivacaine|ropivacaine|mesh-list
154692678|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
154692679|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
154692680|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692681|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692682|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
154692683|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692684|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154692685|NCT04728581|Mirtazapine|mirtazapine|mesh-list
154692686|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
154692687|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154692688|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154692689|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154692690|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692691|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692692|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154692693|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
154692694|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
154692695|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692696|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692697|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154692698|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154692699|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154692700|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154692701|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154692702|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154692703|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154692704|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
154692705|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154692706|NCT04677543|Azithromycin|azithromycin|mesh-list
154692707|NCT04677543|Amikacin|amikacin|mesh-list
154692708|NCT04677543|Ethambutol|ethambutol|mesh-list
154692709|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154692710|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692711|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
154692712|NCT04662840|Anesthetics|anesthetics|mesh-list
154692713|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
154692714|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692715|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692716|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
154692717|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692718|NCT04544293|Molgramostim|molgramostim|mesh-list
154692719|NCT04544293|Sargramostim|sargramostim|mesh-list
154692720|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
154692721|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692722|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692723|NCT04413201|Osimertinib|osimertinib|mesh-list
154692724|NCT04413201|Afatinib|afatinib|mesh-list
154692725|NCT04413201|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154692726|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154692727|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692728|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692729|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692730|NCT04139902|Dostarlimab|dostarlimab|mesh-list
154692731|NCT04139902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692732|NCT04136366|Methotrexate|methotrexate|mesh-list
154692733|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154692734|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
154692735|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154692736|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692737|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154692738|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
154692739|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692740|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692741|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
154692742|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692743|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154692744|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947554|NCT06199505|Insulin|insulin|mesh-list
154692745|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
154692746|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692747|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154692748|NCT03811847|Methylphenidate|methylphenidate|mesh-list
154692749|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154692750|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692751|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154692752|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154692753|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154692754|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692755|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
154692756|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692757|NCT03568097|Avelumab|avelumab|mesh-list
154692758|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692759|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692760|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
154692761|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692762|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692763|NCT03546582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692764|NCT03546582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692765|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
154692766|NCT03226249|Doxorubicin|doxorubicin|mesh-list
154692767|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154692768|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
154692769|NCT03226249|Dacarbazine|dacarbazine|mesh-list
154692770|NCT03226249|Vinblastine|vinblastine|mesh-list
154692771|NCT03226249|Imidazole|imidazole|mesh-list
154692772|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154692773|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154692774|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692775|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154692776|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154692777|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692778|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692779|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692780|NCT03226249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692781|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154558042|NCT01664624|Alogliptin|alogliptin|mesh-list
154692782|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154692783|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
154692784|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154692785|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
154692786|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
154692787|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
154692788|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
154692789|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
154692790|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692792|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154692793|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154692794|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154692795|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692796|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154692797|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692798|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
154692799|NCT03172624|Nivolumab|nivolumab|mesh-list
154692800|NCT03172624|Ipilimumab|ipilimumab|mesh-list
154692801|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692802|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692803|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692804|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692805|NCT03063944|Azacitidine|azacitidine|mesh-list
154692806|NCT03063944|Decitabine|decitabine|mesh-list
154692807|NCT03063944|Venetoclax|venetoclax|mesh-list
154692808|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154692809|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
154692810|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692811|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692812|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692813|NCT03062631|Amifampridine|amifampridine|mesh-list
154692814|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154692815|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692816|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692817|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154692818|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154692819|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692820|NCT02849548|Suvorexant|suvorexant|mesh-list
154692821|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154692822|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154692823|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692824|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692825|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154692826|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692827|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692828|NCT02780310|Lenvatinib|lenvatinib|mesh-list
154692829|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692830|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154692831|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692832|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692833|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
154692834|NCT02758431|Anastrozole|anastrozole|mesh-list
154692835|NCT02758431|Testosterone|testosterone|mesh-list
154692836|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
154692837|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
154692838|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154692839|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154692840|NCT02758431|Acyline|acyline|mesh-list
154692841|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
154692842|NCT02758431|Hormones|hormones|mesh-ancestor
154692843|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692844|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692845|NCT02758431|Androgens|androgens|mesh-ancestor
154692846|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154692847|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692848|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
154692849|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154692850|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692851|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692852|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154692853|NCT02756000|Dobutamine|dobutamine|mesh-list
154692854|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154692855|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
154692857|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692858|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692859|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154692860|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154692861|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154692862|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
154692863|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692864|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692865|NCT02756000|Protective Agents|protective agents|mesh-ancestor
154692866|NCT02601365|Molgramostim|molgramostim|mesh-list
154692867|NCT02601365|Sargramostim|sargramostim|mesh-list
154692868|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
154692869|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692870|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692871|NCT02583893|Cytarabine|cytarabine|mesh-list
154692872|NCT02583893|Sirolimus|sirolimus|mesh-list
154692873|NCT02583893|Etoposide|etoposide|mesh-list
154692874|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
154692875|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
154692876|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154692877|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692878|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154692879|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154692880|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692881|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692882|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154692883|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
154692884|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
154692885|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692886|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692887|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
154692888|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692889|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154692890|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154692891|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
154692892|NCT02583893|Analgesics|analgesics|mesh-ancestor
154692893|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
154692894|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154692895|NCT02107144|Trimetazidine|trimetazidine|mesh-list
154692896|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
154692897|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
154692898|NCT01860170|Bortezomib|bortezomib|mesh-list
154692899|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154692900|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
154692901|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692902|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154692903|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154692904|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
154692905|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692906|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692907|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154692908|NCT01847274|Niraparib|niraparib|mesh-list
154692909|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154692910|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692911|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692912|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692913|NCT00866554|Tamoxifen|tamoxifen|mesh-list
154692914|NCT00866554|Bicalutamide|bicalutamide|mesh-list
154692915|NCT00866554|Dutasteride|dutasteride|mesh-list
154692916|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154692917|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
154692918|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154692919|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692920|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153947728|NCT06011772|Leucovorin|leucovorin|mesh-list
154692921|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692922|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154692923|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154692924|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154692925|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
154692926|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154692927|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154692928|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692929|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692930|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154692931|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154692932|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692933|NCT00452023|Interferons|interferons|mesh-list
154692934|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
154692935|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
154692936|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154692937|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692938|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
154692939|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154692940|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
154692941|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692942|NCT00442104|Ganaxolone|ganaxolone|mesh-list
154692943|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
154692944|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692945|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692946|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692947|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
154692948|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
154692949|NCT00441896|Ganaxolone|ganaxolone|mesh-list
154692950|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
154692951|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154692952|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692953|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692954|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
154692955|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
154692956|NCT00202800|Gemcitabine|gemcitabine|mesh-list
154692957|NCT00202800|Etoposide|etoposide|mesh-list
154692958|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154692959|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
154692960|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692961|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692962|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154692963|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154692964|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154692965|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692966|NCT00194714|Vaccines|vaccines|mesh-list
154692967|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
154692968|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692969|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154692970|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
154692971|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692972|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154692973|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
154692974|NCT02034799|Coagulants|coagulants|mesh-ancestor
154692975|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154692976|NCT02057575|Latanoprost|latanoprost|mesh-list
154692977|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154692978|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154692979|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
154692980|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692981|NCT02034565|Apixaban|apixaban|mesh-list
154692982|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154692983|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
154692984|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154692985|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
154692986|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154692987|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692988|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
154692989|NCT02075515|Vaccines|vaccines|mesh-list
154692990|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
154692991|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154692992|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
154692993|NCT04682587|Avelumab|avelumab|mesh-list
154692994|NCT04682587|Axitinib|axitinib|mesh-list
154692995|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154692996|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154692997|NCT04682587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154692998|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154692999|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154693000|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693001|NCT04417543|Memantine|memantine|mesh-list
154693002|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154693003|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154693004|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
154693005|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693006|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693007|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947819|NCT05804032|Hormones|hormones|mesh-ancestor
154693008|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154693009|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154693010|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
154693011|NCT02021318|Hematinics|hematinics|mesh-ancestor
154693012|NCT02020616|Metformin|metformin|mesh-list
154693013|NCT02020616|Exenatide|exenatide|mesh-list
154693014|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693015|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693016|NCT02020616|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154693017|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154693018|NCT02020616|Incretins|incretins|mesh-ancestor
154693019|NCT02020616|Hormones|hormones|mesh-ancestor
154693020|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693021|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154693022|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154693023|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693024|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693025|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
154693026|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693027|NCT01622660|Gemcitabine|gemcitabine|mesh-list
154693028|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154693029|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
154693030|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693031|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693032|NCT04697498|Anesthetics|anesthetics|mesh-list
154693033|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693034|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693035|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
154693036|NCT02019602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154693037|NCT02019602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693038|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693039|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
154693040|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693041|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693042|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154693043|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
154693044|NCT02040428|Coagulants|coagulants|mesh-ancestor
154693045|NCT02018822|Urethane|urethane|mesh-list
154693046|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693047|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154693048|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
154693049|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
154693050|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693051|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693052|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
153947858|NCT05664386|Propofol|propofol|mesh-list
154693053|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
154693054|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693055|NCT02022007|Metformin|metformin|mesh-list
154693056|NCT02022007|Saxagliptin|saxagliptin|mesh-list
154693057|NCT02022007|Biguanides|biguanides|mesh-list
154693058|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154693059|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693060|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693061|NCT02022007|Incretins|incretins|mesh-ancestor
154693062|NCT02022007|Hormones|hormones|mesh-ancestor
154693063|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693064|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
154693065|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693066|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693067|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
154693068|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154693069|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
154693070|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154693071|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
154693072|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693073|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693074|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
154693075|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154693076|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693077|NCT02053753|Denosumab|denosumab|mesh-list
154693078|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154693079|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693080|NCT02019979|Metformin|metformin|mesh-list
154693081|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693082|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693083|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
154693084|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154693085|NCT02019667|Protective Agents|protective agents|mesh-ancestor
154693086|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693088|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
154693089|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693090|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693091|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
154693092|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
154693093|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154693094|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154693095|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693096|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
154693097|NCT02030821|Coagulants|coagulants|mesh-ancestor
154693098|NCT02052739|Brexanolone|brexanolone|mesh-list
154693099|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
154693100|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693101|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693102|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693103|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
154693104|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
154693105|NCT02019277|Paclitaxel|paclitaxel|mesh-list
154693106|NCT02019277|Docetaxel|docetaxel|mesh-list
154693107|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154693108|NCT02019277|Trastuzumab|trastuzumab|mesh-list
154693109|NCT02019277|Pertuzumab|pertuzumab|mesh-list
154693110|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154693111|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693112|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
154693113|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
154693114|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
154693115|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693116|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154693117|NCT01823835|Palbociclib|palbociclib|mesh-list
154693118|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693119|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154693120|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693121|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693122|NCT01823679|Capecitabine|capecitabine|mesh-list
154693123|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154693124|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
154693125|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693126|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693127|NCT01823289|Itraconazole|itraconazole|mesh-list
154693128|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
154693129|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154693130|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154693131|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154693132|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693133|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693134|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154693135|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
154693136|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693137|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693138|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154693139|NCT01822899|Fluticasone|fluticasone|mesh-list
154693140|NCT01822899|Xhance|xhance|mesh-list
154693141|NCT01822899|Bromides|bromides|mesh-list
154693142|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154693143|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693144|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154693145|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
154693146|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693147|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693148|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154693149|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
154693150|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
154693151|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154693152|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154693153|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154693154|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154693155|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
154693156|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693157|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693158|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
154693159|NCT01822821|Acetaminophen|acetaminophen|mesh-list
154693160|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154693161|NCT01822821|Analgesics|analgesics|mesh-ancestor
154693162|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
154693163|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693164|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693165|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
154693166|NCT01822665|Acetaminophen|acetaminophen|mesh-list
154693167|NCT01822665|Ibuprofen|ibuprofen|mesh-list
154693168|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154693169|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154693170|NCT01822665|Analgesics|analgesics|mesh-ancestor
154693171|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
154693172|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693173|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693174|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693175|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693176|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154693177|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693178|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693179|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
154693180|NCT01822587|Propranolol|propranolol|mesh-list
154693181|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154693182|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154693183|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
154693184|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693185|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693186|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693187|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154693188|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154693189|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
154693190|NCT01821963|Interferons|interferons|mesh-list
154693191|NCT01821963|Ribavirin|ribavirin|mesh-list
154693192|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
154693193|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
154693194|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154693195|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693196|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
154693197|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154693198|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
154693199|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693200|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
154693201|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693202|NCT01821729|Leucovorin|leucovorin|mesh-list
154693203|NCT01821729|Fluorouracil|fluorouracil|mesh-list
154693204|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
154693205|NCT01821729|Folfirinox|folfirinox|mesh-list
154693206|NCT01821729|Losartan|losartan|mesh-list
154693207|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
154693208|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693209|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154693210|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693211|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693212|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
154693213|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693214|NCT01821729|Antidotes|antidotes|mesh-ancestor
154693215|NCT01821729|Protective Agents|protective agents|mesh-ancestor
154693216|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
154693217|NCT01821729|Vitamins|vitamins|mesh-ancestor
154693218|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
154693219|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154693220|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154693221|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154693222|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154693223|NCT01820637|Paclitaxel|paclitaxel|mesh-list
154693224|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154693225|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693226|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
154693227|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
154693228|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
154445168|NCT05005000|Hormones|hormones|mesh-ancestor
154693229|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693230|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
154693231|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693232|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
154693233|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154693234|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154693235|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
154693236|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154693237|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154693238|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154693239|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693240|NCT02171429|Adalimumab|adalimumab|mesh-list
154693241|NCT02171429|Etrolizumab|etrolizumab|mesh-list
154693242|NCT02171429|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153948057|NCT05090566|Hormones|hormones|mesh-ancestor
154693243|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693244|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693245|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693246|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
154693247|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693248|NCT01818141|Vancomycin|vancomycin|mesh-list
154693249|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
154693250|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154693251|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154693252|NCT01849497|Evolocumab|evolocumab|mesh-list
154693253|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154693254|NCT01849497|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154693255|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154693256|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154693257|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
154693258|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693259|NCT01849497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154693260|NCT01849497|Protease Inhibitors|protease inhibitors|mesh-ancestor
154693261|NCT01849497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693262|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154693263|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
154693264|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693265|NCT04170465|Metformin|metformin|mesh-list
154693266|NCT04170465|Paclitaxel|paclitaxel|mesh-list
154693267|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
154693268|NCT04170465|Doxorubicin|doxorubicin|mesh-list
154693269|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154693270|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693271|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
154693272|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
154693273|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
154693274|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693275|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693276|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
154693277|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693278|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693279|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154693280|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
154693281|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154693282|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693283|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154693284|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154693285|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154693286|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693287|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154693288|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693289|NCT01847313|Liraglutide|liraglutide|mesh-list
154693290|NCT01847313|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154693291|NCT01847313|Glucagon|glucagon|mesh-list
154693292|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154693293|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693294|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693295|NCT01847313|Incretins|incretins|mesh-ancestor
154693296|NCT01847313|Hormones|hormones|mesh-ancestor
154693297|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693298|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693299|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154693300|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
154693301|NCT02117687|Glycerol|glycerol|mesh-list
154445239|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
154445240|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154445241|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154693302|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154693303|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
154693304|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693306|NCT02117687|Protective Agents|protective agents|mesh-ancestor
154693307|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154693308|NCT02117687|Laxatives|laxatives|mesh-ancestor
154693309|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693310|NCT02141633|Fluticasone|fluticasone|mesh-list
154693311|NCT02141633|Xhance|xhance|mesh-list
154693312|NCT02141633|Albuterol|albuterol|mesh-list
154693313|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693314|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154693315|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
154693316|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693317|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693318|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154693319|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
154693320|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
154693321|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154693322|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
154693323|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154693324|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154693325|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154693326|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154693327|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
154693328|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693329|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693330|NCT01846611|Dexamethasone|dexamethasone|mesh-list
154693331|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154693332|NCT01846611|Doxorubicin|doxorubicin|mesh-list
154693333|NCT01846611|Trabectedin|trabectedin|mesh-list
154693334|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693335|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
154693336|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
154693337|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693338|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693339|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693340|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
154693341|NCT01846611|Hormones|hormones|mesh-ancestor
154693342|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693343|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154693344|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693345|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154693346|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154693347|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153948174|NCT04592913|Durvalumab|durvalumab|mesh-list
154693348|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693349|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693350|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154693351|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
154693352|NCT01846299|Ranibizumab|ranibizumab|mesh-list
154693353|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154693354|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154693355|NCT01846299|Growth Substances|growth substances|mesh-ancestor
154693356|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693357|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
154693358|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693359|NCT01628393|Ozanimod|ozanimod|mesh-list
154693360|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154693361|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693362|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693363|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
154693364|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693365|NCT01846221|Clonidine|clonidine|mesh-list
154693366|NCT01846221|Fentanyl|fentanyl|mesh-list
154693367|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154693368|NCT01846221|Narcotics|narcotics|mesh-ancestor
154693369|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693370|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693371|NCT01846221|Analgesics|analgesics|mesh-ancestor
154693372|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
154693373|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693374|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154693375|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154693376|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
154693377|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
154693378|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154693379|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
154693380|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
154693381|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154693382|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154693383|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154693384|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
154693385|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693386|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693387|NCT01845831|Metformin|metformin|mesh-list
154693388|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
154693389|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154693390|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693391|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693392|NCT01845831|Incretins|incretins|mesh-ancestor
154693393|NCT01845831|Hormones|hormones|mesh-ancestor
154693394|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693395|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154693396|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
154693397|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693398|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693399|NCT01844895|Abatacept|abatacept|mesh-list
154693400|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154693401|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693402|NCT01844895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154693403|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693404|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693405|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
154693406|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693407|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693408|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
154693409|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154693410|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154693411|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154693412|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154693413|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693414|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
154693415|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693416|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693417|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154693418|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693419|NCT04594239|Lidocaine|lidocaine|mesh-list
154693420|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
154693421|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
154693422|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
154693423|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693424|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693425|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
154693426|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693427|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154693428|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154693429|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154693430|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154693431|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693432|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154693433|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
154693434|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
154693435|NCT04594239|Protective Agents|protective agents|mesh-ancestor
154693436|NCT01814553|Afatinib|afatinib|mesh-list
154693437|NCT01814553|Loperamide|loperamide|mesh-list
154693438|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
154693439|NCT01814553|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154693440|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154693441|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693442|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693443|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693444|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693445|NCT02116205|Vaccines|vaccines|mesh-list
154693446|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
154693447|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693448|NCT01844583|Rifampin|rifampin|mesh-list
154693449|NCT01844583|Esomeprazole|esomeprazole|mesh-list
154693450|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154693451|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693452|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154693453|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693454|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693455|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154693456|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
154693457|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154693458|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154693459|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
154693460|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154693461|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154693462|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154693463|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154693464|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154693465|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154693466|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154693467|NCT02115113|Everolimus|everolimus|mesh-list
154693468|NCT02115113|Tacrolimus|tacrolimus|mesh-list
154693469|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693470|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
154693471|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693472|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154693473|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693474|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693475|NCT02115113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154693476|NCT02115113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154693477|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693478|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
154693479|NCT02114177|Simeprevir|simeprevir|mesh-list
154693480|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
154693481|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154693482|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
154693483|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693484|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693485|NCT02138825|Riociguat|riociguat|mesh-list
154693486|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
154693487|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693488|NCT02138747|Mirabegron|mirabegron|mesh-list
154693489|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154693490|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154693491|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154693492|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154693493|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
154693494|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693495|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948301|NCT04109456|Atezolizumab|atezolizumab|mesh-list
154693496|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693497|NCT02138747|Urological Agents|urological agents|mesh-ancestor
154693498|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154693499|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154693500|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
154693501|NCT02105285|Carteolol|carteolol|mesh-list
154693502|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154693503|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154693504|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154693505|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154693506|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
154693507|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693508|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693509|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693510|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154693511|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154693512|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
154693513|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
154693514|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693515|NCT01621490|Nivolumab|nivolumab|mesh-list
154693516|NCT01621490|Ipilimumab|ipilimumab|mesh-list
154693517|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154693518|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693519|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154693520|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693521|NCT02030041|Vitamin D|vitamin d|mesh-list
154693522|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
154693523|NCT02030041|Simvastatin|simvastatin|mesh-list
154693524|NCT02030041|Vitamins|vitamins|mesh-ancestor
154693525|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
154693526|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693527|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154693528|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154693529|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154693531|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
154693532|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693533|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154693534|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154693535|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693536|NCT01994720|Aspirin|aspirin|mesh-list
154693537|NCT01994720|Ticagrelor|ticagrelor|mesh-list
154693538|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154693539|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154693540|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154693541|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154693542|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
154693543|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693544|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693545|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693546|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154693547|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154693548|NCT01994720|Analgesics|analgesics|mesh-ancestor
154693549|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
154693550|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693551|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693552|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693553|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154693554|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154693555|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154693556|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693557|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
154693558|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154693559|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
154693560|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154693561|NCT01844115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154693562|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154693563|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154693564|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693565|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693566|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
154693567|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693568|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154693569|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154693570|NCT02018042|Abatacept|abatacept|mesh-list
154693571|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154693572|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693573|NCT02018042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154693574|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693575|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693576|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
154693577|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693578|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693579|NCT02017171|Allopurinol|allopurinol|mesh-list
154693580|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
154693581|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693582|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693583|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
154693584|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693585|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154693586|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
154693587|NCT02017171|Protective Agents|protective agents|mesh-ancestor
154693588|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693589|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
154693590|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154693591|NCT02029417|Cytarabine|cytarabine|mesh-list
154693592|NCT02029417|Decitabine|decitabine|mesh-list
154693593|NCT02029417|Azacitidine|azacitidine|mesh-list
154693594|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
154693595|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154693596|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
154693597|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693598|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693599|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
154693600|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154693601|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693602|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
154693603|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693604|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693605|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154693606|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154693607|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154693608|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
154693609|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693610|NCT02050321|Vemurafenib|vemurafenib|mesh-list
154693612|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693613|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154693614|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693615|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693616|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
154693617|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
154693618|NCT02017015|Paclitaxel|paclitaxel|mesh-list
154693619|NCT02017015|Gemcitabine|gemcitabine|mesh-list
154693620|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154693621|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693622|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
154693623|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
154693624|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
154693625|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693626|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154693627|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
154693628|NCT02016625|Cyclosporine|cyclosporine|mesh-list
154693629|NCT02016625|Tacrolimus|tacrolimus|mesh-list
154693630|NCT02016625|Cyclosporins|cyclosporins|mesh-list
154693631|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693632|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
154693633|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693634|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154693635|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693636|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693637|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
154693638|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154693639|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
154693640|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693641|NCT02016482|Adalimumab|adalimumab|mesh-list
154693642|NCT02016482|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154693643|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693644|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693645|NCT02028871|Insulin|insulin|mesh-list
154693646|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693647|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693648|NCT02028715|Acetaminophen|acetaminophen|mesh-list
154693649|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154693650|NCT02028715|Analgesics|analgesics|mesh-ancestor
154693651|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
154693652|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693653|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693654|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
154693655|NCT02016170|Ticagrelor|ticagrelor|mesh-list
154693656|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154693657|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154693658|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154693659|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154693660|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154693661|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
154693662|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693663|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693664|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693665|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154693666|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
154693667|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154693668|NCT02015546|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154693669|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154693670|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154693671|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693672|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693673|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
154693674|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693675|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154693676|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154693677|NCT02038790|Buprenorphine|buprenorphine|mesh-list
154693678|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154693679|NCT02038790|Naloxone|naloxone|mesh-list
154693680|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154693681|NCT02038790|Narcotics|narcotics|mesh-ancestor
154693682|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693683|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693684|NCT02038790|Analgesics|analgesics|mesh-ancestor
154693685|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
154693686|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693687|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154693688|NCT02027311|Midazolam|midazolam|mesh-list
154693689|NCT02027311|Meperidine|meperidine|mesh-list
154693690|NCT02027311|Etomidate|etomidate|mesh-list
154693691|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154693692|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154693693|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693694|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693695|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154693696|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154693697|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154693698|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154693699|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
154693700|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
154693701|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
154693702|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
154693703|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693704|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693705|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154693706|NCT02027311|Narcotics|narcotics|mesh-ancestor
154693707|NCT02027311|Analgesics|analgesics|mesh-ancestor
154693708|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
154693709|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693710|NCT02047903|Afatinib|afatinib|mesh-list
154693711|NCT02047903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948514|NCT03587662|Gemcitabine|gemcitabine|mesh-list
154693712|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154693713|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693714|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693715|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693716|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
154693717|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154693718|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693719|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693720|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154693721|NCT02026141|Analgesics|analgesics|mesh-ancestor
154693722|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
154693723|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693724|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154693725|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154693726|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154693727|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
154693728|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693729|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693730|NCT02025907|Canagliflozin|canagliflozin|mesh-list
154693731|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154693732|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693733|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693734|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693735|NCT02025751|Metoclopramide|metoclopramide|mesh-list
154693736|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
154693737|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
154693738|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693739|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693740|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693741|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154693742|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154693743|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
154693744|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693745|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693746|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154693747|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154693748|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
154693749|NCT02024971|Metformin|metformin|mesh-list
154693750|NCT02024971|Pioglitazone|pioglitazone|mesh-list
154693751|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693752|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693754|NCT01843023|Buprenorphine|buprenorphine|mesh-list
154693755|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154693756|NCT01843023|Narcotics|narcotics|mesh-ancestor
154693757|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693758|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693759|NCT01843023|Analgesics|analgesics|mesh-ancestor
154693760|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
153948579|NCT03158129|Cisplatin|cisplatin|mesh-list
154693761|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693762|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154693763|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154693764|NCT01812759|Fentanyl|fentanyl|mesh-list
154693765|NCT01812759|Hydromorphone|hydromorphone|mesh-list
154693766|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154693767|NCT01812759|Narcotics|narcotics|mesh-ancestor
154693768|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693769|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693770|NCT01812759|Analgesics|analgesics|mesh-ancestor
154693771|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
154693772|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693773|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154693774|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154693775|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
154693776|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
154693777|NCT01812057|Dexamethasone|dexamethasone|mesh-list
154693778|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693779|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
154693780|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
154693781|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693782|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693783|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693784|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
154693785|NCT01812057|Hormones|hormones|mesh-ancestor
154693786|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693787|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154693788|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693789|NCT01842633|Acetaminophen|acetaminophen|mesh-list
154693790|NCT01842633|Ibuprofen|ibuprofen|mesh-list
154693791|NCT01842633|Caffeine|caffeine|mesh-list
154693792|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154693793|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154693794|NCT01842633|Analgesics|analgesics|mesh-ancestor
154693795|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
154693796|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693797|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693798|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693799|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693800|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154693801|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693802|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693803|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
154693804|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154693805|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154693806|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154693807|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154693808|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
154693809|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693810|NCT01841697|Metformin|metformin|mesh-list
154693811|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154693812|NCT01841697|Glimepiride|glimepiride|mesh-list
154693813|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693814|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693815|NCT01841697|Incretins|incretins|mesh-ancestor
154693816|NCT01841697|Hormones|hormones|mesh-ancestor
154693817|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693818|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154693819|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
154693820|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693821|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693822|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154693823|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693824|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
154445791|NCT03581734|Vaccines|vaccines|mesh-list
154693825|NCT01809327|Metformin|metformin|mesh-list
154693826|NCT01809327|Canagliflozin|canagliflozin|mesh-list
154693827|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693828|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693829|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154693830|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693831|NCT03272139|Bupivacaine|bupivacaine|mesh-list
154693832|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
154693833|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
154693834|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154693835|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693836|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
154693837|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693838|NCT01808313|Ambrisentan|ambrisentan|mesh-list
154693839|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154693840|NCT01840605|Ketotifen|ketotifen|mesh-list
154693841|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
154693842|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
154693843|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
154693844|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154693845|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
154693846|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
154693847|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154693848|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693849|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693850|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154693851|NCT02023879|Alirocumab|alirocumab|mesh-list
154693852|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154693853|NCT02023879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154693854|NCT02023879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154693855|NCT02023879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154693856|NCT02023879|Antimetabolites|antimetabolites|mesh-ancestor
154693857|NCT02023879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693858|NCT02023879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154693859|NCT02023879|Protease Inhibitors|protease inhibitors|mesh-ancestor
154693860|NCT02023879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693861|NCT02023879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154693862|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
154693863|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693864|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154693865|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154693866|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693867|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
154693868|NCT02013817|Rituximab|rituximab|mesh-list
154693869|NCT02013817|Fludarabine|fludarabine|mesh-list
154693870|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693871|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
154693872|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693873|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948670|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
154693874|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154693875|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
154693876|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693877|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693878|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154693879|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154693880|NCT02023099|Ritonavir|ritonavir|mesh-list
154693881|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154693882|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154693883|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
154693884|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693885|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693886|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154693887|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154693888|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
154693889|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154693890|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154693891|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154693892|NCT02013037|Eculizumab|eculizumab|mesh-list
154693893|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154693894|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154693895|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
154693896|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693897|NCT04416607|Menotropins|menotropins|mesh-list
154693898|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154693899|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
154693900|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154693901|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693902|NCT01967173|Fluticasone|fluticasone|mesh-list
154693903|NCT01967173|Xhance|xhance|mesh-list
154445913|NCT03506828|Phenol|phenol|mesh-list
154693904|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154693905|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154693906|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
154693907|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154693908|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693909|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154693910|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
154693911|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
154693913|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693914|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
154693915|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154693916|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
154693917|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154693918|NCT01993927|Voglibose|voglibose|mesh-list
154693919|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154693920|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693921|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154693922|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693923|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693924|NCT02012959|Tolvaptan|tolvaptan|mesh-list
154693925|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154693926|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693927|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
154693928|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693929|NCT02012491|Misoprostol|misoprostol|mesh-list
154693930|NCT02012491|Mifepristone|mifepristone|mesh-list
154693931|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154693932|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
154693933|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154693934|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693935|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154693936|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154693937|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
154693938|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154693939|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154693940|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154693941|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154693942|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
154693943|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154693944|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154693945|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
154693946|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154693947|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
154693948|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154693949|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154693950|NCT02038010|Trastuzumab|trastuzumab|mesh-list
154693951|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154693952|NCT02038010|Maytansine|maytansine|mesh-list
154693953|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
154693954|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
154693955|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154693956|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693957|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154693958|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
154693959|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154693960|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154693961|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693962|NCT02038010|Immunotoxins|immunotoxins|mesh-ancestor
154693963|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
154693964|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693965|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693966|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
154693967|NCT04178798|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154693968|NCT04178798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154693969|NCT04178798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693970|NCT04178798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693971|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693972|NCT01989572|Sargramostim|sargramostim|mesh-list
154693973|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
154693974|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693975|NCT01988402|Allopurinol|allopurinol|mesh-list
154693976|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
154693977|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693978|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154693979|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
154693980|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154693981|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154693982|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
154693983|NCT01988402|Protective Agents|protective agents|mesh-ancestor
154693984|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693985|NCT01988090|Vitamin D|vitamin d|mesh-list
154693986|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
154693987|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
154693988|NCT01988090|Vitamins|vitamins|mesh-list
154693989|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
154693990|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154693991|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154693992|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154693993|NCT02011945|Nivolumab|nivolumab|mesh-list
154693994|NCT02011945|Dasatinib|dasatinib|mesh-list
154693995|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154693996|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154693997|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154693998|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154693999|NCT02011945|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154694000|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154694001|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694002|NCT02013830|Bevacizumab|bevacizumab|mesh-list
154694003|NCT02013830|Capecitabine|capecitabine|mesh-list
154694004|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694005|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694006|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154694007|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154694008|NCT02013830|Growth Substances|growth substances|mesh-ancestor
154694009|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694010|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
154694011|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154694012|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
154694013|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694014|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
154694015|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154694016|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154694017|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154694018|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694019|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694020|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
154694021|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694022|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694023|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154694024|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694025|NCT01619059|Metformin|metformin|mesh-list
154694026|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
154694027|NCT01619059|Saxagliptin|saxagliptin|mesh-list
154694028|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694029|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694030|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154694031|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694032|NCT01619059|Incretins|incretins|mesh-ancestor
154694033|NCT01619059|Hormones|hormones|mesh-ancestor
154694034|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694035|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154694036|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
154694037|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694038|NCT04691804|Prednisone|prednisone|mesh-list
154694039|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
154694040|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694041|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
154694042|NCT04691804|Hormones|hormones|mesh-ancestor
154694043|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694044|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694045|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154694046|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948859|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694047|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154694048|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694049|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694050|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
154694051|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154694052|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154694053|NCT02013206|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154694054|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154694055|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694056|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694057|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694058|NCT01807923|Ivacaftor|ivacaftor|mesh-list
154694059|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154694060|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694061|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694062|NCT01966003|Paclitaxel|paclitaxel|mesh-list
154694063|NCT01966003|Bevacizumab|bevacizumab|mesh-list
154694064|NCT01966003|Carboplatin|carboplatin|mesh-list
154694065|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154694066|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694067|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
154694068|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
154694069|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
154694070|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694071|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694072|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154694073|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154694074|NCT01966003|Growth Substances|growth substances|mesh-ancestor
154694075|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694076|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
154694077|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
154694078|NCT01839279|Tizanidine|tizanidine|mesh-list
154694079|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154694080|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694081|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154694082|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154694083|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694084|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694085|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694086|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694087|NCT01839279|Analgesics|analgesics|mesh-ancestor
154694088|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
154694089|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694090|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
154694091|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154694092|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154694093|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
154694094|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
154694095|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154694096|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154694097|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154694098|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
154694099|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694100|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
154694101|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154694102|NCT01965535|Ledipasvir|ledipasvir|mesh-list
154694103|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
154694104|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694105|NCT01964755|Leucovorin|leucovorin|mesh-list
154694106|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
154694107|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
154694108|NCT01964755|Zidovudine|zidovudine|mesh-list
154694109|NCT01964755|Rituximab|rituximab|mesh-list
154694110|NCT01964755|Doxorubicin|doxorubicin|mesh-list
154694111|NCT01964755|Methotrexate|methotrexate|mesh-list
154694112|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
154694113|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
154694114|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694115|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694116|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
154694117|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694118|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694119|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154694120|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154694121|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154694122|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694123|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694124|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154694125|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
154694126|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154694127|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154694128|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
154694129|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694130|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154694131|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154694132|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154694133|NCT01964755|Antidotes|antidotes|mesh-ancestor
154694134|NCT01964755|Protective Agents|protective agents|mesh-ancestor
154694135|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
154694137|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
154694138|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154694139|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
154694140|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694141|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154694142|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154694143|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
154694144|NCT01991743|Bupivacaine|bupivacaine|mesh-list
154694145|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
154694146|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
154694147|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154694148|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694149|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
154694150|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694151|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154694152|NCT01991197|Gliclazide|gliclazide|mesh-list
154694153|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694154|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694155|NCT01991197|Incretins|incretins|mesh-ancestor
154694156|NCT01991197|Hormones|hormones|mesh-ancestor
154694157|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694158|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154694159|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
154694160|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948982|NCT01950390|Ipilimumab|ipilimumab|mesh-list
154694161|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694162|NCT01990573|Methadone|methadone|mesh-list
154694163|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154694164|NCT01990573|Narcotics|narcotics|mesh-ancestor
154694165|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154694166|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694167|NCT01990573|Analgesics|analgesics|mesh-ancestor
154694168|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
154694169|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694170|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
154694171|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
154694172|NCT01990339|Lansoprazole|lansoprazole|mesh-list
154694173|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
154694174|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154694175|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154694176|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154694177|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694178|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694179|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154694180|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154694181|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154694182|NCT02007577|Analgesics|analgesics|mesh-ancestor
154694183|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
154694184|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694185|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694186|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694187|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694188|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154694189|NCT01990261|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154694190|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154694191|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694192|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694193|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694194|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
154694195|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154694196|NCT01962493|Listerine|listerine|mesh-list
154694197|NCT01962493|Fluorides|fluorides|mesh-list
154694198|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
154694199|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
154694200|NCT01962493|Protective Agents|protective agents|mesh-ancestor
154694201|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694202|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154694203|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694204|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
154694205|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694207|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154694208|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154694209|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154694210|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694211|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154694212|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154694213|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154694214|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154694215|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
154694216|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
154694217|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
154694218|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
154694219|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694220|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694221|NCT01988779|Levofloxacin|levofloxacin|mesh-list
154694222|NCT01988779|Ofloxacin|ofloxacin|mesh-list
154694223|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154694224|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694225|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154694226|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154694227|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154694228|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694229|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694230|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694231|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154694232|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154694233|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154694234|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154694235|NCT01987232|Carboplatin|carboplatin|mesh-list
154694236|NCT01987232|Etoposide|etoposide|mesh-list
154694237|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694238|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154694239|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154694240|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154694241|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694242|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694243|NCT04676204|Teriflunomide|teriflunomide|mesh-list
154694244|NCT04676204|Cladribine|cladribine|mesh-list
154694245|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154694246|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154694247|NCT04676204|Ozanimod|ozanimod|mesh-list
154694248|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694249|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154694250|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
154694251|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694252|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154694253|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694254|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694255|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154694256|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154694257|NCT04676204|Analgesics|analgesics|mesh-ancestor
154694258|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
154694259|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694260|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694261|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694262|NCT02010632|Clopidogrel|clopidogrel|mesh-list
154694263|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154694264|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154694265|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154694266|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154694267|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
154694268|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694269|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694270|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694271|NCT01986062|Amphetamine|amphetamine|mesh-list
154694272|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154694273|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694274|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
154694275|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
154694276|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694278|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694279|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949095|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
154694280|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154694281|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154694282|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154694283|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694284|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154694285|NCT01985126|Acetaminophen|acetaminophen|mesh-list
154694286|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
154694287|NCT01985126|Promethazine|promethazine|mesh-list
154694288|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
154694289|NCT01985126|Daratumumab|daratumumab|mesh-list
154694290|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154694291|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154694292|NCT01985126|Analgesics|analgesics|mesh-ancestor
154694293|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
154694294|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694295|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694296|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
154694297|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694298|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
154694299|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
154694300|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154694301|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
154694302|NCT01985126|Hormones|hormones|mesh-ancestor
154694303|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694304|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154694305|NCT01985126|Protective Agents|protective agents|mesh-ancestor
154694306|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694307|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
154694308|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154694309|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154694310|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154694311|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
154694312|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
154694313|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154694314|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
154694315|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
154694316|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694317|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694318|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154694319|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
154694320|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694321|NCT01984892|Poly ICLC|poly iclc|mesh-list
154694322|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
154694323|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
154694324|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694325|NCT01807221|Eplerenone|eplerenone|mesh-list
154694326|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154694327|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
154694328|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694329|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694330|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154694331|NCT01807221|Diuretics|diuretics|mesh-ancestor
154694332|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
154694333|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154694334|NCT02031458|Atezolizumab|atezolizumab|mesh-list
154694335|NCT02031458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153949153|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694336|NCT02031458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694337|NCT02031458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694338|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694339|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154694340|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
154694341|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694342|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
154694343|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154694344|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
154694345|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694346|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694347|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154694348|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
154694349|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
154694350|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154694351|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
154694352|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694353|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694354|NCT04687514|Dulaglutide|dulaglutide|mesh-list
154694355|NCT04687514|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154694356|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694357|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694358|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
154694359|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
154694360|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694361|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694362|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694363|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
154694364|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
154694365|NCT01984424|Atorvastatin|atorvastatin|mesh-list
154694366|NCT01984424|Ezetimibe|ezetimibe|mesh-list
154694367|NCT01984424|Evolocumab|evolocumab|mesh-list
154694368|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154694369|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154694370|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154694371|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
154694372|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694373|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154694374|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154694375|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694376|NCT01984424|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154694377|NCT01984424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154694378|NCT01984424|Protease Inhibitors|protease inhibitors|mesh-ancestor
154694379|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
154694380|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694381|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154694382|NCT01837719|Cobicistat|cobicistat|mesh-list
154694383|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154694384|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154694385|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
154694386|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694387|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694388|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154694389|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154694390|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
154694391|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694392|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154694393|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154694394|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154694395|NCT01984268|Hormones|hormones|mesh-ancestor
154694396|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694397|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694398|NCT02009384|Ipilimumab|ipilimumab|mesh-list
154694399|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694400|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694401|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154694402|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694403|NCT01805037|Rituximab|rituximab|mesh-list
154694404|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154694405|NCT01805037|Antibodies|antibodies|mesh-list
154694406|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
154694407|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154694408|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
154694409|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
154694410|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694411|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694412|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694413|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694414|NCT01805037|Immunotoxins|immunotoxins|mesh-ancestor
154694415|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154694416|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154694417|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154694418|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694419|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694420|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694421|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694422|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
154694423|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154694424|NCT01836549|Imetelstat|imetelstat|mesh-list
154694425|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
154694426|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694427|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694428|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154694429|NCT01836471|Fluticasone|fluticasone|mesh-list
154694431|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
154694432|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694433|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154694434|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
154694435|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694436|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694437|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154694438|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
154694439|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694440|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154694441|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154694442|NCT01836471|Growth Substances|growth substances|mesh-ancestor
154694443|NCT02030600|Insulin|insulin|mesh-list
154694444|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154694445|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
154694446|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694447|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694448|NCT01802775|Aspirin|aspirin|mesh-list
154694449|NCT01802775|Edoxaban|edoxaban|mesh-list
154694450|NCT01802775|Clopidogrel|clopidogrel|mesh-list
154694451|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154694452|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154694453|NCT01802775|Analgesics|analgesics|mesh-ancestor
154694454|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
154694455|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694456|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694457|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694458|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694459|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154694460|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154694461|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694462|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154694463|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154694464|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694465|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
154694466|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154694467|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154694468|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154694469|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
154694470|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694471|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154694472|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
154694473|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154694474|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
154694475|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
154694476|NCT01802385|Sertraline|sertraline|mesh-list
154694477|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
154694478|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154694479|NCT01802385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154694480|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154694481|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694482|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694483|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694484|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
153949305|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
154694485|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694486|NCT01773993|Pregabalin|pregabalin|mesh-list
154694487|NCT01773993|Analgesics|analgesics|mesh-ancestor
154694488|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
154694489|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694490|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694491|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
154694492|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154694493|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694494|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694495|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154694496|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154694497|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154694498|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154694499|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154694500|NCT01802073|Vancomycin|vancomycin|mesh-list
154694501|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154694502|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694503|NCT01607073|Verapamil|verapamil|mesh-list
154694504|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154694505|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154694506|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694507|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694508|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154694509|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694510|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
154694511|NCT01801917|Siponimod|siponimod|mesh-list
154694512|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154694513|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694514|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154694515|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
154694516|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694517|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154694518|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
154694519|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694520|NCT01772823|Tenofovir|tenofovir|mesh-list
154694521|NCT01772823|Emtricitabine|emtricitabine|mesh-list
154694522|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154694523|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
154694524|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694525|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154694526|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154694527|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694528|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694529|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154694530|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154694531|NCT04177082|Riboflavin|riboflavin|mesh-list
154694532|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
154694533|NCT04177082|Vitamins|vitamins|mesh-ancestor
154694534|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
154694535|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694536|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154694537|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694538|NCT01982942|Ibudilast|ibudilast|mesh-list
154694539|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154694540|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
154694541|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694542|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694543|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154694544|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
154694545|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154694546|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949364|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
154694547|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694548|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154694549|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
154694550|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154694551|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154694552|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154694553|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694554|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694555|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
154694556|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694557|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154694558|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154694559|NCT01769391|Paclitaxel|paclitaxel|mesh-list
154694560|NCT01769391|Carboplatin|carboplatin|mesh-list
154694561|NCT01769391|Necitumumab|necitumumab|mesh-list
154694562|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154694563|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694564|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
154694565|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
154694566|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
154694567|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694568|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694569|NCT01767987|Ranolazine|ranolazine|mesh-list
154694570|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154694571|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694572|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694573|NCT01767909|Insulin|insulin|mesh-list
154694574|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154694575|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694576|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694577|NCT02029274|Siponimod|siponimod|mesh-list
154694578|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154694579|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694580|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154694581|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
154694582|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694583|NCT02008370|Bupivacaine|bupivacaine|mesh-list
154694584|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
154694585|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
154694586|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154694587|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694588|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
154694589|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694590|NCT01981616|Vedolizumab|vedolizumab|mesh-list
154694591|NCT01981616|Vaccines|vaccines|mesh-list
154694592|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
154694593|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694594|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154694595|NCT01962103|Paclitaxel|paclitaxel|mesh-list
154694596|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154694597|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949430|NCT02866032|Ciclopirox|ciclopirox|mesh-list
154694598|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694599|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
154694600|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
154694601|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
154694602|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694603|NCT01961323|Nebivolol|nebivolol|mesh-list
154694604|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154694605|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
154694606|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154694607|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154694608|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154694609|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
154694610|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694611|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694612|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694613|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
154694614|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
154694615|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694616|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694617|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694618|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
154694619|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
154694620|NCT01960855|Upadacitinib|upadacitinib|mesh-list
154694621|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154694622|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154694623|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694624|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694625|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694626|NCT02007434|Loratadine|loratadine|mesh-list
154694627|NCT02007434|Ibuprofen|ibuprofen|mesh-list
154694628|NCT02007434|Lidocaine|lidocaine|mesh-list
154694629|NCT02007434|Epinephrine|epinephrine|mesh-list
154694630|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
154694631|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
154694632|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
154694633|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154694634|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694635|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
154694636|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694637|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154694638|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154694639|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154694640|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694641|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694642|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154694643|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154694644|NCT02007434|Analgesics|analgesics|mesh-ancestor
154694645|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154446589|NCT02144922|Pitavastatin|pitavastatin|mesh-list
154694646|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694647|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154694648|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694649|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154694650|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154694651|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
154694652|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694653|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154694654|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154694655|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
154694656|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154694657|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
154694658|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
154694659|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
154694660|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154694661|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
154694662|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694663|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154694664|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154694665|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154694666|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
154694667|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
154694668|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154694669|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154694670|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
154694671|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154694672|NCT01987453|Ledipasvir|ledipasvir|mesh-list
154694673|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
154694674|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694675|NCT02006641|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154694676|NCT02006641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154694677|NCT02006641|Serotonin Agents|serotonin agents|mesh-ancestor
154694678|NCT02006641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694679|NCT02006641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694680|NCT02006641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694681|NCT01959919|Factor VIII|factor viii|mesh-list
154694682|NCT01959919|Coagulants|coagulants|mesh-ancestor
154694683|NCT01986907|Ranibizumab|ranibizumab|mesh-list
154694684|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154694685|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154694686|NCT01986907|Growth Substances|growth substances|mesh-ancestor
154694687|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694688|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
154694689|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694690|NCT01959841|Valacyclovir|valacyclovir|mesh-list
154694691|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
154694692|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694693|NCT02005627|Immunomodulating Agents|immunomodulating agents|mesh-list
154694694|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
154694695|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694696|NCT02073929|Liraglutide|liraglutide|mesh-list
154694697|NCT02073929|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154694698|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694699|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694700|NCT02073929|Incretins|incretins|mesh-ancestor
154694701|NCT02073929|Hormones|hormones|mesh-ancestor
154694702|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694703|NCT02113007|Rituximab|rituximab|mesh-list
154694704|NCT02113007|Temozolomide|temozolomide|mesh-list
154694705|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694706|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694707|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
154694708|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694709|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694710|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154694711|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
154694712|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694713|NCT02104505|Tocopherols|tocopherols|mesh-list
154694714|NCT02104505|Vitamin E|vitamin e|mesh-list
154694715|NCT02104505|Tocotrienols|tocotrienols|mesh-list
153949547|NCT02882828|Tacrolimus|tacrolimus|mesh-list
154694716|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
154694717|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
154694718|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
154694719|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694720|NCT02104505|Protective Agents|protective agents|mesh-ancestor
154694721|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694722|NCT02104505|Vitamins|vitamins|mesh-ancestor
154446672|NCT03500432|Lidocaine|lidocaine|mesh-list
154694723|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
154694724|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154694725|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154694726|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154694727|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
154694728|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694729|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154694730|NCT02111369|Propranolol|propranolol|mesh-list
154694731|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
154694732|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154694733|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694734|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694735|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
154694736|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694737|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694738|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154694739|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154694740|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
154694741|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154694742|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154694743|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
154694744|NCT02069093|Dexamethasone|dexamethasone|mesh-list
154694745|NCT02069093|Everolimus|everolimus|mesh-list
154694746|NCT02069093|Exemestane|exemestane|mesh-list
154694747|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694748|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
154694749|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
154694750|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694751|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694752|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154694753|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
154694754|NCT02069093|Hormones|hormones|mesh-ancestor
154694755|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694756|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154694757|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694758|NCT02069093|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154694759|NCT02069093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154694760|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694761|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694762|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154694763|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
154694764|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154694765|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154694766|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154694767|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
154694768|NCT02109029|Insulin|insulin|mesh-list
154694769|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154694770|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694771|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694772|NCT02108951|Nilotinib|nilotinib|mesh-list
154694773|NCT02108951|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154694774|NCT02108951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154694775|NCT02108951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694776|NCT02108951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694777|NCT02007278|Metformin|metformin|mesh-list
154694778|NCT02007278|Glimepiride|glimepiride|mesh-list
154694779|NCT02007278|Vildagliptin|vildagliptin|mesh-list
154694780|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694781|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694782|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154694783|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154694784|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
154694785|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154694786|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
154694787|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694788|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694789|NCT02028338|Dapivirine|dapivirine|mesh-list
154694790|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154694791|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154694792|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
154694793|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694794|NCT01625897|Risperidone|risperidone|mesh-list
154694795|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154694796|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
154694797|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694798|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694799|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694801|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154694802|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154694803|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154694804|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154694805|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
154694806|NCT02106923|Metformin|metformin|mesh-list
154694807|NCT02106923|Empagliflozin|empagliflozin|mesh-list
154694808|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694809|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694810|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154694811|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694812|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
154694813|NCT02006732|Olodaterol|olodaterol|mesh-list
154694814|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154694815|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
154694816|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694817|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694818|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154694819|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
154694820|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
154694821|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154694822|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
154694823|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694824|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694825|NCT02098733|Pioglitazone|pioglitazone|mesh-list
154694826|NCT02098733|Glimepiride|glimepiride|mesh-list
154694827|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154694828|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694829|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154694830|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154694831|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
154694832|NCT02098109|Plerixafor|plerixafor|mesh-list
154694833|NCT02098109|Lenograstim|lenograstim|mesh-list
154694834|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154694835|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
154694836|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694837|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154694838|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154694839|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
154694840|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694841|NCT02097719|Timolol|timolol|mesh-list
154694842|NCT02097719|Bimatoprost|bimatoprost|mesh-list
154694843|NCT02097719|Travoprost|travoprost|mesh-list
154694844|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694845|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154694846|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154694847|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
154694848|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694849|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694850|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154694851|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154694852|NCT01449370|Serabelisib|serabelisib|mesh-list
154694853|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694854|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694855|NCT02066129|Fluticasone|fluticasone|mesh-list
154694856|NCT02066129|Xhance|xhance|mesh-list
154694857|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694858|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154694859|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
154694860|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694861|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694862|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154694863|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
154694864|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694865|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154694866|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154694867|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154694868|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694869|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
154694870|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154694871|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154694872|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694873|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154694874|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694875|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154694876|NCT02006654|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154694877|NCT02006654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154694878|NCT02006654|Serotonin Agents|serotonin agents|mesh-ancestor
154694879|NCT02006654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154694880|NCT02006654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694881|NCT02006654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694882|NCT01448824|Ketoconazole|ketoconazole|mesh-list
154694883|NCT01448824|Evacetrapib|evacetrapib|mesh-list
154694884|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
154694885|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694886|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154694887|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154694888|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694889|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694890|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154694891|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
154694892|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694893|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694894|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154694895|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154694896|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154694897|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
154694898|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154694899|NCT02005562|Cyclosporine|cyclosporine|mesh-list
154694900|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
154694901|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
154694902|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154694903|NCT02005562|Cyclosporins|cyclosporins|mesh-list
154694904|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694905|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694906|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154694907|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
154694908|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694909|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
154694910|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694911|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
154694912|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154694913|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154694914|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154694915|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694916|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154694917|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
154694918|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154694919|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694920|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
154694921|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
154694922|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694923|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154694924|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
154694925|NCT02005562|Hormones|hormones|mesh-ancestor
154694926|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154694927|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154694928|NCT02005562|Protective Agents|protective agents|mesh-ancestor
154694929|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154694930|NCT01448044|Interferons|interferons|mesh-list
154694931|NCT01448044|Ribavirin|ribavirin|mesh-list
154694932|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
154694933|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
154694934|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154694935|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694936|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
154694937|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694938|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
154694939|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694940|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
154694941|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694942|NCT01472380|Efavirenz|efavirenz|mesh-list
154694943|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
154694944|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154694945|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154694946|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860362|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154446884|NCT02142036|Cetuximab|cetuximab|mesh-list
154694947|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694948|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
154694949|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694950|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154694951|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154694952|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154694953|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154694954|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154694955|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154694956|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154694957|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154694958|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
154694959|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154694960|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
154694961|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154694962|NCT01447420|Ribavirin|ribavirin|mesh-list
154694963|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154694964|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
154694965|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694966|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
154694967|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694968|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
154694969|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154694970|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694971|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
154694972|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
154694973|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154694974|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154694975|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154694976|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154694977|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154694978|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
154694979|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154694980|NCT01438840|Maleic acid|maleic acid|mesh-list
154694981|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154694982|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154694983|NCT01471054|Dexamethasone|dexamethasone|mesh-list
154694984|NCT01471054|Bevacizumab|bevacizumab|mesh-list
154694985|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154694986|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154694987|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949826|NCT05616494|Docetaxel|docetaxel|mesh-list
154694988|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154694989|NCT01471054|Growth Substances|growth substances|mesh-ancestor
154694990|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154694991|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
154694992|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154694993|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
154694994|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
154694995|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154694996|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154694997|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
154694998|NCT01471054|Hormones|hormones|mesh-ancestor
154694999|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154695000|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154695001|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
154695002|NCT01978184|Gemcitabine|gemcitabine|mesh-list
154695003|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154695004|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154695005|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
154695006|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695007|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695008|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
154695009|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154695010|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154695011|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695012|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695013|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154695014|NCT01445548|Sirolimus|sirolimus|mesh-list
154695015|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154695016|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695017|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154695018|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695019|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
154695020|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154695021|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
154695022|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695023|NCT01977794|Amlodipine|amlodipine|mesh-list
154695024|NCT01977794|Bisoprolol|bisoprolol|mesh-list
154695025|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154695026|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154695027|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695028|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695029|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154695030|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695031|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
154695032|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
154695033|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
154695034|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695035|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154695036|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154695037|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154695038|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
154695039|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695040|NCT02005484|Trastuzumab|trastuzumab|mesh-list
154695041|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154695042|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695043|NCT01597973|Meropenem|meropenem|mesh-list
154695044|NCT01597973|Colistin|colistin|mesh-list
154695045|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154695046|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695047|NCT02047253|Acyclovir|acyclovir|mesh-list
154695048|NCT02047253|Dexamethasone|dexamethasone|mesh-list
154695049|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695050|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
154695051|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
154695052|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695053|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695054|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154695055|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
154695056|NCT02047253|Hormones|hormones|mesh-ancestor
154695057|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154695058|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154695059|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695060|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
154695061|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695062|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
154695063|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154695064|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695065|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695066|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695067|NCT02096003|Morphine|morphine|mesh-list
154695068|NCT02096003|Hydromorphone|hydromorphone|mesh-list
154695069|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154695070|NCT02096003|Narcotics|narcotics|mesh-ancestor
154695071|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695072|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695073|NCT02096003|Analgesics|analgesics|mesh-ancestor
154695074|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
154695075|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695076|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
154695077|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154695078|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154695079|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695080|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
154695081|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
154695082|NCT02059187|Insulin|insulin|mesh-list
154695083|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154695084|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
154695085|NCT02059187|MK-1293|mk-1293|mesh-list
154695086|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695087|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695088|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154695089|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
154695090|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695091|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154695092|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154695093|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695094|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695095|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695096|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154447039|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
154695097|NCT01622231|Fluticasone|fluticasone|mesh-list
154695098|NCT01622231|Xhance|xhance|mesh-list
154695099|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695100|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154695101|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
154695102|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695103|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695104|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154695105|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
154695106|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
154695107|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154695108|NCT02042183|Lubiprostone|lubiprostone|mesh-list
154695109|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154695110|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695111|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695112|NCT02058095|Tadalafil|tadalafil|mesh-list
154695113|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
154695114|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154695115|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154695116|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695117|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695118|NCT02058095|Urological Agents|urological agents|mesh-ancestor
154695119|NCT02023112|Ritonavir|ritonavir|mesh-list
154695120|NCT02023112|Ribavirin|ribavirin|mesh-list
154695121|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154695122|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154695123|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
154695124|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695125|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695126|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154695127|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154695128|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
154695129|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695130|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154695131|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154695132|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
154695133|NCT01976624|Timolol|timolol|mesh-list
154695134|NCT01976624|Bimatoprost|bimatoprost|mesh-list
154695135|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154695136|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154695137|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
154695138|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695139|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695140|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695141|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154695142|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154695143|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154695144|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
154695145|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695146|NCT04717973|Vitamin D|vitamin d|mesh-list
154695147|NCT04717973|Vitamins|vitamins|mesh-list
154695148|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
154695149|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
154695150|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
154695151|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695152|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154695153|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
154695154|NCT04717973|Hematinics|hematinics|mesh-ancestor
154695155|NCT02057549|Haloperidol|haloperidol|mesh-list
154695156|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
154695157|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
154695158|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
154695159|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695160|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695161|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154695162|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154695163|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154695164|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695165|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154695166|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154695167|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
154695168|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695169|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695170|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154695171|NCT02057393|Methylene Blue|methylene blue|mesh-list
154695172|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695173|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695174|NCT02040779|Beclomethasone|beclomethasone|mesh-list
154695175|NCT02040779|Albuterol|albuterol|mesh-list
154695176|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
154695177|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
154695178|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695179|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695180|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154695181|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
154695182|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
154695183|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154695184|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154695185|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154695186|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154695187|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154695188|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695189|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695190|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695191|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
154695192|NCT02040779|Hormones|hormones|mesh-ancestor
154695193|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154695194|NCT02056301|Morphine|morphine|mesh-list
154695195|NCT02056301|Hydromorphone|hydromorphone|mesh-list
154695196|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154695197|NCT02056301|Narcotics|narcotics|mesh-ancestor
154695198|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695199|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695200|NCT02056301|Analgesics|analgesics|mesh-ancestor
154695201|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
154695202|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695203|NCT01967576|Axitinib|axitinib|mesh-list
154695204|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695205|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695206|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695207|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695208|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154695209|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154695210|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154695211|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154695212|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154695213|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
154695214|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695215|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695216|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695217|NCT02054897|Semaglutide|semaglutide|mesh-list
154695218|NCT02054897|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154695219|NCT02054897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695220|NCT02054897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695221|NCT01976312|Ranibizumab|ranibizumab|mesh-list
154695222|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154695223|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154695224|NCT01976312|Growth Substances|growth substances|mesh-ancestor
154695225|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695226|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
154695227|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695228|NCT02053493|Isosorbide|isosorbide|mesh-list
154695229|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154695230|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154695231|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154695232|NCT02053493|Diuretics|diuretics|mesh-ancestor
154695233|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
154695234|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695235|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
154695236|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154695237|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695238|NCT02003144|Eculizumab|eculizumab|mesh-list
154695239|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154695240|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154695241|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
154695242|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695243|NCT02038907|Vaccines|vaccines|mesh-list
154695244|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
154695245|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695246|NCT02052011|Ranolazine|ranolazine|mesh-list
154695247|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154695248|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695249|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695250|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
154695251|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154695252|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154695253|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154695254|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695255|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695256|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
154695257|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695258|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695259|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154695260|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695261|NCT02035553|Pimavanserin|pimavanserin|mesh-list
154695262|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154695263|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154695264|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154695265|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154695266|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695267|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695268|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154695269|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154695270|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154695271|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
154695272|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695273|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695274|NCT01445080|Sorafenib|sorafenib|mesh-list
154695275|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695276|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695277|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695278|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695279|NCT04709471|Nicotine|nicotine|mesh-list
154695280|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154695281|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
154695282|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695283|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695284|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154695285|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154695286|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
154695287|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695288|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695289|NCT01959529|Insulin|insulin|mesh-list
154695290|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154695291|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
154695292|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695293|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695294|NCT02033369|Pramipexole|pramipexole|mesh-list
154695295|NCT02033369|Dexpramipexole|dexpramipexole|mesh-list
154695296|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
154695297|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695298|NCT02033369|Protective Agents|protective agents|mesh-ancestor
154695299|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695300|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154695301|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154695302|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
154695303|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
154695304|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695305|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
154695306|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
154695307|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695308|NCT04681469|Niraparib|niraparib|mesh-list
154695309|NCT04681469|Dostarlimab|dostarlimab|mesh-list
154695310|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154695311|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695312|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695313|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695314|NCT01986751|Clonidine|clonidine|mesh-list
154695315|NCT01986751|Ropivacaine|ropivacaine|mesh-list
154695316|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
154695317|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
154695318|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695319|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695320|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
154695321|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695322|NCT01986751|Analgesics|analgesics|mesh-ancestor
154695323|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154695324|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
154695325|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
154695326|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154695327|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154695329|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
154695330|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695331|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695332|NCT01438060|Aripiprazole|aripiprazole|mesh-list
154695333|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
154695334|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154695335|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154695336|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154695337|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695338|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695339|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
154695340|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
154695341|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695342|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695343|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154695344|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154695345|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
154695346|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154695347|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154695348|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154695349|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154695350|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
154695351|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154695352|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695353|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695354|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
154695355|NCT01443364|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154695356|NCT01443364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695357|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154695358|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
154695359|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695360|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154695361|NCT02020577|Cetuximab|cetuximab|mesh-list
154695362|NCT02020577|Afatinib|afatinib|mesh-list
154695363|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154695364|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695365|NCT02020577|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154695366|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695367|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695368|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695369|NCT02020031|Vancomycin|vancomycin|mesh-list
154695370|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154695371|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695372|NCT02030405|Ixazomib|ixazomib|mesh-list
154695373|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
154695374|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695375|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
154695376|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695377|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695378|NCT01975376|Bococizumab|bococizumab|mesh-list
154695379|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154695380|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154695381|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
154695382|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695383|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154695384|NCT01443130|Chloroquine|chloroquine|mesh-list
154695385|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
154695386|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
154695387|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154695388|NCT01443130|Amebicides|amebicides|mesh-ancestor
154695389|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154695390|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154695391|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695392|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
154695393|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154695394|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154695395|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695396|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695397|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154695398|NCT01436500|Ifetroban|ifetroban|mesh-list
154447342|NCT02148432|Analgesics|analgesics|mesh-ancestor
154695399|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154695400|NCT01958827|Adalimumab|adalimumab|mesh-list
154695401|NCT01958827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154695402|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695403|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154695404|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
154695405|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695406|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
154695407|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154695408|NCT01436110|Fluticasone|fluticasone|mesh-list
154695410|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695411|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154695412|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
154695413|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695414|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695415|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154695416|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
154695417|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
154695418|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154695419|NCT01619852|Lidocaine|lidocaine|mesh-list
154695420|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
154695421|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
154695422|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695423|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695424|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
154695425|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695426|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154695427|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154695428|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154695429|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695430|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695431|NCT04069936|Nivolumab|nivolumab|mesh-list
154695432|NCT04069936|Tadalafil|tadalafil|mesh-list
154695433|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154695434|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695435|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154695436|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695437|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
154695438|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154695439|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154695440|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695441|NCT04069936|Urological Agents|urological agents|mesh-ancestor
154695442|NCT02000882|Capecitabine|capecitabine|mesh-list
154695443|NCT02000882|Trastuzumab|trastuzumab|mesh-list
154695444|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154695445|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
154695446|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695447|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695448|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154695449|NCT04666129|Prednisone|prednisone|mesh-list
154695450|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
154695451|NCT04666129|Docetaxel|docetaxel|mesh-list
154695452|NCT04666129|Relugolix|relugolix|mesh-list
154695453|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695454|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
154695455|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
154695456|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
154695457|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695458|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695459|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
154695460|NCT04666129|Hormones|hormones|mesh-ancestor
154695461|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154695462|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950304|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154695463|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154695464|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
154695465|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
154695466|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695467|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154695468|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154695469|NCT04666129|Protective Agents|protective agents|mesh-ancestor
154695470|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
154695471|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
154695472|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154695473|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
154695474|NCT04666051|Coagulants|coagulants|mesh-ancestor
154695476|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
154695477|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
154695478|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695479|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695480|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154695481|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
154695482|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
154695483|NCT01965704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154695484|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154695485|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
154695486|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695487|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695488|NCT02003365|Triamcinolone|triamcinolone|mesh-list
154695489|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154695490|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154695491|NCT02003365|FX006|fx006|mesh-list
154695492|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154695493|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695494|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
154695495|NCT02003365|Hormones|hormones|mesh-ancestor
154695496|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154695497|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695498|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154695499|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
154695500|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695501|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695502|NCT01975220|Metformin|metformin|mesh-list
154695503|NCT01975220|Empagliflozin|empagliflozin|mesh-list
154695504|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695505|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695506|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154695507|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695508|NCT01974752|Dacarbazine|dacarbazine|mesh-list
154695509|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154695510|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
154695511|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695512|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695513|NCT01999946|Naltrexone|naltrexone|mesh-list
154695514|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154695515|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154695516|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695517|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
154695518|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695519|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
154695520|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154695521|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
154695522|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695523|NCT04665115|Ibrutinib|ibrutinib|mesh-list
154695524|NCT04665115|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154695525|NCT04665115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695526|NCT04665115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695527|NCT04665115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695528|NCT02002975|Pioglitazone|pioglitazone|mesh-list
154695529|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695530|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695531|NCT02001181|Tofacitinib|tofacitinib|mesh-list
154695532|NCT02001181|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154695533|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695534|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695535|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695536|NCT04176055|Haloperidol|haloperidol|mesh-list
154695537|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
154695538|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
154695539|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
154695540|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695541|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695542|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154695543|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154695544|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154695545|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695546|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154695547|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154695548|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
154447504|NCT02031861|Nifedipine|nifedipine|mesh-list
154695549|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695550|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695551|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154695552|NCT04659278|Peppermint oil|peppermint oil|mesh-list
154695553|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
154695554|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
154695555|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695556|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695557|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154695558|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
154695559|NCT01999868|Abatacept|abatacept|mesh-list
154695560|NCT01999868|Ustekinumab|ustekinumab|mesh-list
154695561|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
154695562|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
154695563|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695564|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154695565|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695566|NCT01999868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154695567|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695568|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154695569|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154695570|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
154695571|NCT03511963|Bevacizumab|bevacizumab|mesh-list
154695572|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154695573|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695574|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154695575|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154695576|NCT03511963|Growth Substances|growth substances|mesh-ancestor
154695577|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695578|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
154695579|NCT01999322|Insulin|insulin|mesh-list
154695580|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154695581|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
154695582|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
154695583|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154695584|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695585|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695586|NCT01964924|Trametinib|trametinib|mesh-list
154695587|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695588|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695589|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695590|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695591|NCT01964378|Morphine|morphine|mesh-list
154695592|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154695593|NCT01964378|Narcotics|narcotics|mesh-ancestor
154695594|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695595|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695596|NCT01964378|Analgesics|analgesics|mesh-ancestor
154695597|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
154695598|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695599|NCT01442038|Ranolazine|ranolazine|mesh-list
154695600|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154695601|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695602|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695603|NCT01998919|Carboplatin|carboplatin|mesh-list
154695604|NCT01998919|Gemcitabine|gemcitabine|mesh-list
154695605|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154695606|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695607|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154695608|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
154695609|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695610|NCT01998919|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154695611|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695612|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695613|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154695614|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
154695615|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695616|NCT01972724|Metformin|metformin|mesh-list
154695617|NCT01972724|Pioglitazone|pioglitazone|mesh-list
154695618|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695619|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695620|NCT01441960|Rocuronium|rocuronium|mesh-list
154695621|NCT01441960|Succinylcholine|succinylcholine|mesh-list
154695622|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154695623|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154695624|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154695625|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695626|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695627|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154695629|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
154695630|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695631|NCT01435798|Levomethorphan|levomethorphan|mesh-list
154695632|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
154695633|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
154695634|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
154695635|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154695636|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154695637|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950476|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
154695638|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695639|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695640|NCT01435798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154695641|NCT01435798|Narcotics|narcotics|mesh-ancestor
154695642|NCT01435798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695643|NCT01435798|Analgesics|analgesics|mesh-ancestor
154695644|NCT01435798|Sensory System Agents|sensory system agents|mesh-ancestor
154695645|NCT01435798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695646|NCT01955161|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154695647|NCT01955161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154695648|NCT01955161|Serotonin Agents|serotonin agents|mesh-ancestor
154695649|NCT01955161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695650|NCT01955161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695651|NCT01955161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695652|NCT01441414|Axitinib|axitinib|mesh-list
154695653|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695654|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695655|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695656|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695657|NCT01954927|Gabapentin|gabapentin|mesh-list
154695658|NCT01954927|Analgesics|analgesics|mesh-ancestor
154695659|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
154695660|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695661|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695662|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
154695663|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154695664|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154695665|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695666|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154695667|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154695668|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154695669|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695670|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695671|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
154695672|NCT01953913|Afatinib|afatinib|mesh-list
154695673|NCT01953913|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154695674|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695675|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695676|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695677|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695678|NCT01970540|Doxorubicin|doxorubicin|mesh-list
154695679|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154695680|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695681|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154695682|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154695683|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695684|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695685|NCT01996826|Bevacizumab|bevacizumab|mesh-list
154695686|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154695687|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154695688|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695689|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154695690|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154695691|NCT01996826|Growth Substances|growth substances|mesh-ancestor
154695692|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695693|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
154695694|NCT01996826|Laxatives|laxatives|mesh-ancestor
154695695|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154695696|NCT01621178|Insulin|insulin|mesh-list
154695698|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
154695699|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
154695700|NCT01621178|Dulaglutide|dulaglutide|mesh-list
154695701|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695702|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695703|NCT01621178|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154695704|NCT01962974|Golimumab|golimumab|mesh-list
154695705|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154695706|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695707|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154695708|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
154695709|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695710|NCT01962896|Sirolimus|sirolimus|mesh-list
154695711|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154695712|NCT01962896|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154695713|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154695714|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695715|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695716|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695717|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154695718|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695719|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154695720|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
154695721|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154695722|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
154695723|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695724|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154695725|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695726|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695727|NCT01970462|Incretins|incretins|mesh-ancestor
154695728|NCT01970462|Hormones|hormones|mesh-ancestor
154695729|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154695730|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154695731|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
154695732|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695733|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695734|NCT01958671|Metformin|metformin|mesh-list
154695735|NCT01958671|Glimepiride|glimepiride|mesh-list
154695736|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
154695737|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695738|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695739|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154695740|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154695741|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
154695742|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154695743|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695744|NCT01995266|Asunaprevir|asunaprevir|mesh-list
154695745|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
154695746|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695747|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695748|NCT01969058|Isotretinoin|isotretinoin|mesh-list
154695749|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
154695750|NCT01968980|Bococizumab|bococizumab|mesh-list
154695751|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154695752|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154695753|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
154695754|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695755|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154695756|NCT01968434|Carbocysteine|carbocysteine|mesh-list
154695757|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154695758|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695759|NCT01968434|Expectorants|expectorants|mesh-ancestor
154695760|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
154695761|NCT01946438|Vaccines|vaccines|mesh-list
154695762|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
154695763|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695764|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
154695765|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
154695766|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154695767|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695768|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695769|NCT01917656|Metformin|metformin|mesh-list
154695770|NCT01917656|Liraglutide|liraglutide|mesh-list
154695771|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695772|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695773|NCT01917656|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154695774|NCT01917656|Incretins|incretins|mesh-ancestor
154695775|NCT01917656|Hormones|hormones|mesh-ancestor
154695776|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154695777|NCT02017535|Fluoxetine|fluoxetine|mesh-list
154695778|NCT02017535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154695779|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154695780|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695781|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695782|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695783|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
154695784|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695785|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154695786|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
154695787|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154695788|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154695789|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154695790|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695791|NCT01944098|Lidocaine|lidocaine|mesh-list
154695792|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
154695793|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
154695794|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695795|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695796|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
154695797|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695798|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154695799|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154695800|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154695801|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695802|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695803|NCT01943552|Bromides|bromides|mesh-list
154695804|NCT01943552|Ipratropium|ipratropium|mesh-list
154695805|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
154695806|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154695807|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
154695808|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695809|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695810|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154695811|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
154695812|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154695813|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
154695814|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695815|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695816|NCT01915940|Timolol|timolol|mesh-list
154695817|NCT01915940|Bimatoprost|bimatoprost|mesh-list
154695818|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154695819|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154695820|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154695821|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154695822|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
154695823|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695824|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695825|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695826|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154695827|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154695828|NCT01914926|Metoprolol|metoprolol|mesh-list
154695829|NCT01914926|Diltiazem|diltiazem|mesh-list
154695830|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154695831|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154695832|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
154695833|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
154695834|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695835|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695836|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154695837|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154695838|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154695839|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
154695840|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695841|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695842|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154695843|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695844|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154695845|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
154695847|NCT05119166|Niacin|niacin|mesh-list
154695848|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
154695849|NCT05119166|Azithromycin|azithromycin|mesh-list
154695850|NCT05119166|Vitamins|vitamins|mesh-ancestor
154695851|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
154695852|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695853|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154695854|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695855|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
154695856|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154695857|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
154695858|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695859|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154695860|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
154695861|NCT01942148|Aripiprazole|aripiprazole|mesh-list
154695862|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
154695863|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154695864|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154695865|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154695866|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695867|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695868|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
154695869|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
154695870|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695871|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695872|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154695873|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154695874|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
154695875|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154695876|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154695877|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154695878|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154695879|NCT02030015|Miglustat|miglustat|mesh-list
154695880|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695881|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695882|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154695883|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154695884|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
154695885|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695886|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154695887|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695888|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695889|NCT02029235|Acetaminophen|acetaminophen|mesh-list
154695890|NCT02029235|Ibuprofen|ibuprofen|mesh-list
154695891|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154695892|NCT02029235|Hydrocodone|hydrocodone|mesh-list
154695893|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154695894|NCT02029235|Analgesics|analgesics|mesh-ancestor
154695895|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
154695896|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695897|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695898|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
154695899|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154695900|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154695901|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154695902|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154695903|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695904|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695905|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154695906|NCT02029235|Narcotics|narcotics|mesh-ancestor
154695907|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695908|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
154695909|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
154695910|NCT01617434|Liraglutide|liraglutide|mesh-list
154695911|NCT01617434|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154695912|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695913|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695914|NCT01617434|Incretins|incretins|mesh-ancestor
154695915|NCT01617434|Hormones|hormones|mesh-ancestor
154695916|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154695917|NCT01911260|Chelating Agents|chelating agents|mesh-list
154695918|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
154695919|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695921|NCT02015819|Flucytosine|flucytosine|mesh-list
154695922|NCT02015819|Calcium|calcium|mesh-list
154695923|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
154695924|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154695925|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695926|NCT02015819|Antidotes|antidotes|mesh-ancestor
154695927|NCT02015819|Protective Agents|protective agents|mesh-ancestor
154695928|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
154695929|NCT02015819|Vitamins|vitamins|mesh-ancestor
154695930|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
154695931|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
154695932|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695933|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
154695934|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695935|NCT01939496|Canagliflozin|canagliflozin|mesh-list
154695936|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154695937|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695938|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695939|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695940|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154695941|NCT01938716|Gemcitabine|gemcitabine|mesh-list
154695942|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154695943|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
154695944|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695945|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695946|NCT01937390|Bromides|bromides|mesh-list
154695947|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
154695948|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154695949|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
154695950|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695951|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695952|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154695953|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
154695954|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
154695955|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154695956|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
154695957|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154695958|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695959|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
154695960|NCT02028767|Metformin|metformin|mesh-list
154695961|NCT02028767|Empagliflozin|empagliflozin|mesh-list
154695962|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154695963|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695964|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154695965|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695966|NCT04683965|Bevacizumab|bevacizumab|mesh-list
154695967|NCT04683965|Pemetrexed|pemetrexed|mesh-list
154695968|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154695969|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154695970|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154695971|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154695972|NCT04683965|Growth Substances|growth substances|mesh-ancestor
154695973|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695974|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
154695975|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154695976|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695977|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154695978|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154695979|NCT02015195|Ethanol|ethanol|mesh-list
154695980|NCT02015195|Acetic Acid|acetic acid|mesh-list
154695981|NCT02015195|Retinol acetate|retinol acetate|mesh-list
154695982|NCT02015195|Lidocaine|lidocaine|mesh-list
154695983|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
154695984|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
154695985|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154695986|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154695987|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
154695988|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154695989|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154695990|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154695991|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154695992|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154695993|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154695994|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154695995|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154695996|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154695997|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154695998|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
154695999|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154696000|NCT02015195|Protective Agents|protective agents|mesh-ancestor
154696001|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696003|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
154696004|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
154696005|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696006|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696007|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154696008|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154696009|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154696010|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
154696011|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696012|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696013|NCT02025179|Teriparatide|teriparatide|mesh-list
154696014|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154696015|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696016|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154696017|NCT02013791|Cyclosporine|cyclosporine|mesh-list
154696018|NCT02013791|Cyclosporins|cyclosporins|mesh-list
154696019|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696020|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696021|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154696022|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
154696023|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696024|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
154696025|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696026|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
154696027|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696028|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154696029|NCT02024867|Trimethoprim|trimethoprim|mesh-list
154696030|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154696031|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
154696032|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154696033|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696034|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
154696035|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154696036|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154696037|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154696038|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696039|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696040|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154696041|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154696042|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154696043|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154696044|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154696045|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696046|NCT01951417|Adapalene|adapalene|mesh-list
154696047|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154696048|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
154696049|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696050|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696051|NCT01951417|Analgesics|analgesics|mesh-ancestor
154696052|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
154696053|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696054|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696055|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696056|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696057|NCT02023151|Omalizumab|omalizumab|mesh-list
154696058|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154696059|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154696060|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
154696061|NCT01979185|Simvastatin|simvastatin|mesh-list
154696062|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154696063|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154696064|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
154696065|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696066|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154696067|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154696069|NCT01946425|Vaccines|vaccines|mesh-list
154696070|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
154696071|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696072|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154696073|NCT01937312|Travoprost|travoprost|mesh-list
154696074|NCT01937312|Brinzolamide|brinzolamide|mesh-list
154696075|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154696076|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154696077|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154696078|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154696079|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
154696080|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696081|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696082|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696083|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154696084|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696085|NCT01935128|Everolimus|everolimus|mesh-list
154696086|NCT01935128|Tacrolimus|tacrolimus|mesh-list
154696087|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154696088|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
154696089|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696090|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154696091|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696092|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696093|NCT01935128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154696094|NCT01935128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154696095|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696096|NCT01934972|Cycloserine|cycloserine|mesh-list
154696097|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154696098|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696099|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154696100|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
154696101|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154696102|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
154696103|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696104|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154696105|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154696106|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154696107|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154696108|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154696109|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154696110|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154696111|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
154696112|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696113|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696114|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696115|NCT01977937|Gabapentin|gabapentin|mesh-list
154696116|NCT01977937|Analgesics|analgesics|mesh-ancestor
154696117|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
154696118|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696119|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696120|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
154696121|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154696122|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154696123|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696124|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154696125|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154696126|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154696127|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696128|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696129|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
154696130|NCT02015663|Tobramycin|tobramycin|mesh-list
154696131|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154696132|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696133|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154696134|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
154696135|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696136|NCT01951105|Naproxen|naproxen|mesh-list
154696137|NCT01951105|Levodopa|levodopa|mesh-list
154696138|NCT01951105|Carbidopa|carbidopa|mesh-list
154696139|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154448091|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154696140|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696141|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696142|NCT01951105|Analgesics|analgesics|mesh-ancestor
154696143|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
154696144|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696145|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696146|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696147|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696148|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
154696149|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154696150|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696151|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696152|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154696153|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154696154|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
154696155|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696156|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154696157|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154696158|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
154696159|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
154696160|NCT01958918|Ranibizumab|ranibizumab|mesh-list
154696161|NCT01958918|Aflibercept|aflibercept|mesh-list
154696162|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154696163|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154696164|NCT01958918|Growth Substances|growth substances|mesh-ancestor
154696165|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696166|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
154696167|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696168|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
154696169|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154696170|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154696171|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153950991|NCT00961116|Fenofibrate|fenofibrate|mesh-list
154696172|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696173|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696174|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
154696175|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696176|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696177|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154696178|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696179|NCT01934894|Lapatinib|lapatinib|mesh-list
154696180|NCT01934894|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154696181|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154696182|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696183|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696184|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696185|NCT01950169|Vitamin D|vitamin d|mesh-list
154696186|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
154696187|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
154696188|NCT01950169|Diphosphonates|diphosphonates|mesh-list
154696189|NCT01950169|Calcium|calcium|mesh-list
154696190|NCT01950169|Vitamins|vitamins|mesh-ancestor
154696191|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
154696192|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696193|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154696194|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154696195|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154696196|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696197|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696198|NCT01909466|Aripiprazole|aripiprazole|mesh-list
154696199|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
154696200|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154696201|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154696202|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154696203|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696204|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696205|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
154696206|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
154696207|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696208|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696209|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154696210|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154696211|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
154696212|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154696213|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154696214|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154696216|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154696217|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154696218|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696219|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154696220|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154696221|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696222|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696223|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
154696224|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696225|NCT01995071|Ribavirin|ribavirin|mesh-list
154696226|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
153951052|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
154696227|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696228|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
154696229|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696230|NCT01994837|Venetoclax|venetoclax|mesh-list
154696231|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696232|NCT02010593|Dapivirine|dapivirine|mesh-list
154696233|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154696234|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154696235|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
154696236|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696237|NCT01994291|Ranibizumab|ranibizumab|mesh-list
154696238|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154696239|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154696240|NCT01994291|Growth Substances|growth substances|mesh-ancestor
154696241|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696242|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
154696243|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696244|NCT01993823|Clotrimazole|clotrimazole|mesh-list
154696245|NCT01993823|Miconazole|miconazole|mesh-list
154696246|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154696247|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696248|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
154696249|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154696250|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154696251|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696252|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696253|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154696254|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
154696255|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154696256|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696257|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154696258|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154696259|NCT01993667|Acetazolamide|acetazolamide|mesh-list
154696260|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
154696261|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154696262|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696263|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696264|NCT01993667|Diuretics|diuretics|mesh-ancestor
154696265|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
154696266|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696267|NCT01934192|Metoclopramide|metoclopramide|mesh-list
154696268|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
154696269|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
154696270|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696271|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696272|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154696273|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154696274|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154696275|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
154696276|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696277|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696278|NCT01933880|Methylphenidate|methylphenidate|mesh-list
154696279|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154696280|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696281|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154696282|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154696283|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153951108|NCT03773445|Golimumab|golimumab|mesh-list
154558043|NCT01664624|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154448245|NCT05023408|Bleomycin|bleomycin|mesh-list
154696284|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696286|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696287|NCT02008877|Sirolimus|sirolimus|mesh-list
154696288|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154696289|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696290|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154696291|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696292|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
154696293|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154696294|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
154696295|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696296|NCT01933334|Pirfenidone|pirfenidone|mesh-list
154696297|NCT01933334|Analgesics|analgesics|mesh-ancestor
154696298|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
154696299|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696300|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696301|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696302|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696303|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696304|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696305|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696306|NCT01908140|Fluticasone|fluticasone|mesh-list
154696307|NCT01908140|Bromides|bromides|mesh-list
154696308|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
154696309|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154696310|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696311|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154696312|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
154696313|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696314|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696315|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154696316|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
154696317|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
154696318|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154696319|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154696320|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154696321|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154696322|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
154696323|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696324|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696325|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
154696326|NCT02008565|Loperamide|loperamide|mesh-list
154696327|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
154696328|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154696329|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154696330|NCT01931150|Dapsone|dapsone|mesh-list
154696331|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696332|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
154696333|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154696334|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154696335|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154696336|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696337|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696338|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
154696339|NCT01906346|Cocaine|cocaine|mesh-list
154696340|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
154696341|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
154696342|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696343|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696344|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
154696345|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696346|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154696347|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154696348|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154696349|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696350|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696351|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
154696352|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696353|NCT04645004|Aspirin|aspirin|mesh-list
154696354|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696355|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696356|NCT04645004|Analgesics|analgesics|mesh-ancestor
154696357|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
154696358|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696359|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696360|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696361|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696362|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154696363|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154696364|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696365|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154696366|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154696367|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696368|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
154696369|NCT01929980|Bortezomib|bortezomib|mesh-list
154696370|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696371|NCT01363076|Ketorolac|ketorolac|mesh-list
154696372|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154696373|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696374|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696375|NCT01363076|Analgesics|analgesics|mesh-ancestor
154696376|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
154696377|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696378|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696379|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696380|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696381|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154696382|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696383|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696384|NCT01929044|Anisodamine|anisodamine|mesh-list
154696385|NCT01929044|Scopolamine|scopolamine|mesh-list
154696386|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154696387|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154696388|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
154696389|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
154696390|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696391|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696392|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154696393|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
154696394|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154696395|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
154696396|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696397|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696398|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154696399|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
154696400|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154696401|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154696402|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
154696403|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154696404|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696405|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696406|NCT01929044|Analgesics|analgesics|mesh-ancestor
154696407|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
154696408|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696409|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696410|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154696411|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
154696412|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154696413|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
154696414|NCT01929044|Protective Agents|protective agents|mesh-ancestor
154696415|NCT01957202|Levocabastine|levocabastine|mesh-list
154696416|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154696417|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154696418|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
154696419|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
154696420|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696421|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696422|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696423|NCT01616654|Tazarotene|tazarotene|mesh-list
154696424|NCT01616654|Trifarotene|trifarotene|mesh-list
154696425|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
154696426|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
154696427|NCT01902290|Brodalumab|brodalumab|mesh-list
154696428|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
154696429|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
154696430|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154696431|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
154696432|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696433|NCT01467466|Expectorants|expectorants|mesh-ancestor
154696434|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
154696435|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154696436|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
154696437|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696438|NCT01467466|Protective Agents|protective agents|mesh-ancestor
154696439|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696440|NCT01467466|Antidotes|antidotes|mesh-ancestor
154696441|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
154696442|NCT01441180|Ribavirin|ribavirin|mesh-list
154696443|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
154696444|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696445|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
154696446|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696447|NCT01441102|Levomethorphan|levomethorphan|mesh-list
154696448|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
154696449|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
154696450|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
154696451|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154696452|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154696453|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696454|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696455|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696456|NCT01441102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154696457|NCT01441102|Narcotics|narcotics|mesh-ancestor
154696458|NCT01441102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696459|NCT01441102|Analgesics|analgesics|mesh-ancestor
154696460|NCT01441102|Sensory System Agents|sensory system agents|mesh-ancestor
154696461|NCT01441102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696462|NCT04061980|Nivolumab|nivolumab|mesh-list
154696463|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154696464|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696465|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154696466|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696467|NCT01467076|Alprostadil|alprostadil|mesh-list
154696468|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154696469|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
154696470|NCT01467076|Urological Agents|urological agents|mesh-ancestor
154696471|NCT01466062|Palivizumab|palivizumab|mesh-list
154696472|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
154696473|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696474|NCT04504864|Aspirin|aspirin|mesh-list
154696475|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696476|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696477|NCT04504864|Analgesics|analgesics|mesh-ancestor
154696478|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
154696479|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696480|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696481|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696482|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696483|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154696484|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154696485|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696486|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154696487|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154696488|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696489|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
154696490|NCT04060342|Paclitaxel|paclitaxel|mesh-list
154696491|NCT04060342|Gemcitabine|gemcitabine|mesh-list
154696492|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
154696493|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154696494|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696495|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
154696496|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
154696497|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
154696498|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696499|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154696500|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
154696501|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154696502|NCT04060342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154696503|NCT01435018|Tenofovir|tenofovir|mesh-list
154696504|NCT01435018|Emtricitabine|emtricitabine|mesh-list
154696505|NCT01435018|Efavirenz|efavirenz|mesh-list
154696506|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154696507|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154696508|NCT01435018|Paclitaxel|paclitaxel|mesh-list
154696509|NCT01435018|Etoposide|etoposide|mesh-list
154696510|NCT01435018|Vincristine|vincristine|mesh-list
154696512|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154696513|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696514|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154696515|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
154696516|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154696517|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696518|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154696519|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154696520|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696521|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
154696522|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696523|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154696524|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154696525|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154696526|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154696527|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154696528|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154696529|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154696530|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154696531|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154696532|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154696533|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154696534|NCT01419184|Vancomycin|vancomycin|mesh-list
154696535|NCT01419184|Daptomycin|daptomycin|mesh-list
154696536|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154696537|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696538|NCT01417156|Nintedanib|nintedanib|mesh-list
154696539|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696540|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154696541|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696542|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696543|NCT01417078|Diazepam|diazepam|mesh-list
154696544|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154696545|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
154696546|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
154696547|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
154696548|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696549|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696550|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154696551|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154696552|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696553|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154696554|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154696555|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154696556|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154696557|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154696558|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154696559|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
154696560|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
154696561|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
154696562|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
154696563|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696564|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696565|NCT01954394|Alirocumab|alirocumab|mesh-list
154696566|NCT01954394|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154696567|NCT01954394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154696568|NCT01954394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154696569|NCT01954394|Antimetabolites|antimetabolites|mesh-ancestor
154696570|NCT01954394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696571|NCT01954394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154696572|NCT01954394|Protease Inhibitors|protease inhibitors|mesh-ancestor
154696573|NCT01954394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696574|NCT01954394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154696575|NCT01464424|Bimatoprost|bimatoprost|mesh-list
154696576|NCT01464424|Travoprost|travoprost|mesh-list
154696577|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154696578|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154696579|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154696580|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154696581|NCT01902134|Tramadol|tramadol|mesh-list
154696582|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154696583|NCT01902134|Narcotics|narcotics|mesh-ancestor
154696584|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696585|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696586|NCT01902134|Analgesics|analgesics|mesh-ancestor
154696588|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696589|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696590|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696591|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696592|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696593|NCT01954082|Inositol|inositol|mesh-list
154696594|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
154696595|NCT01954082|Vitamins|vitamins|mesh-ancestor
154696596|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
154696597|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696598|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
154696599|NCT01417000|Pancrelipase|pancrelipase|mesh-list
154696600|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154696601|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
154696602|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696603|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696604|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154696605|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
154696606|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696607|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696608|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154696609|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154696610|NCT01415986|Temoporfin|temoporfin|mesh-list
154696611|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696612|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154696613|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
154696614|NCT01415518|Budesonide|budesonide|mesh-list
154696615|NCT01415518|Theophylline|theophylline|mesh-list
154696616|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
154696617|NCT01415518|Ipratropium|ipratropium|mesh-list
154696618|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154696619|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696620|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154696621|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
154696622|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696623|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696624|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154696625|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
154696626|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
154696627|NCT01415518|Hormones|hormones|mesh-ancestor
154696628|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154696629|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154696630|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154696631|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154696632|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
154696633|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696634|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696635|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154696636|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
154696637|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154696638|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696639|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
154696640|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154696641|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154696642|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
154696643|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
154696644|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154696645|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154696646|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696647|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696648|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
154696649|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696650|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696651|NCT04767178|Acetaminophen|acetaminophen|mesh-list
154696652|NCT04767178|Ibuprofen|ibuprofen|mesh-list
154696653|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696654|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696655|NCT04767178|Analgesics|analgesics|mesh-ancestor
154696656|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
154696657|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696658|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696659|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696660|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696661|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154696662|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696663|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696664|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
154696665|NCT01432600|Dexamethasone|dexamethasone|mesh-list
154696666|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
154696667|NCT01432600|Pomalidomide|pomalidomide|mesh-list
154696668|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154696669|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
154696670|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696671|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696672|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154696673|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
154696674|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696675|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696676|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154696677|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696678|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
154696679|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
154696680|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696681|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154696682|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
154696683|NCT01432600|Hormones|hormones|mesh-ancestor
154696684|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154696685|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154696686|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154696687|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154696688|NCT01432600|Growth Substances|growth substances|mesh-ancestor
154696689|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
154696690|NCT01432444|Aripiprazole|aripiprazole|mesh-list
154696691|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
154696692|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154696693|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154696694|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154696695|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696696|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696697|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
154696698|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
154696699|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696700|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696701|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154696702|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154696703|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
154696704|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154696705|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154696706|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154696707|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154696708|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154696709|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154696710|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696711|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154696712|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154696713|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696714|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696715|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
154696716|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696717|NCT01932788|Vitamin D|vitamin d|mesh-list
154696718|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
154696719|NCT01932788|Vitamins|vitamins|mesh-list
154696720|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
154696721|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696722|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154696723|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154696724|NCT01431976|Lamotrigine|lamotrigine|mesh-list
154696725|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
154696726|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154696727|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696728|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696729|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154696730|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696731|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154696732|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154696733|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696734|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154696735|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154696736|NCT01413958|Loratadine|loratadine|mesh-list
154696737|NCT01413958|Phenylephrine|phenylephrine|mesh-list
154696738|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
154696739|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154696740|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
154696741|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
154696742|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696743|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696744|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
154696745|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154696746|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
154696747|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
154696748|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154696749|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154696750|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154696751|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
154696752|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696753|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696754|NCT01413958|Protective Agents|protective agents|mesh-ancestor
154696755|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
154696756|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
154696757|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154696758|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154696759|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154696760|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
154696761|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
154696762|NCT01413178|Melphalan|melphalan|mesh-list
154696763|NCT01413178|Busulfan|busulfan|mesh-list
154696764|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154696765|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
154696766|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696767|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696768|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154696769|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154696770|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
154696771|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696772|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154696773|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
154696774|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696775|NCT03025906|Valproic Acid|valproic acid|mesh-list
154696776|NCT03025906|Phenobarbital|phenobarbital|mesh-list
154696777|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
154696778|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696779|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696780|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
154696781|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696782|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696783|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
154696784|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154696785|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696786|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154696787|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154696788|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154696789|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154696790|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
154696791|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154696792|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154696793|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154696794|NCT04053712|Glucagon|glucagon|mesh-list
154696795|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154696796|NCT04053712|Hormones|hormones|mesh-ancestor
154696797|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154696798|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696799|NCT01798485|Docetaxel|docetaxel|mesh-list
154696800|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696801|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
154696802|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
154696803|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
154696804|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696805|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
154696806|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
154696807|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154696808|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154696809|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154696810|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696811|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696812|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
153951635|NCT00632385|Eletriptan|eletriptan|mesh-list
154696813|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696814|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696815|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154696816|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696817|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154696818|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154696819|NCT01767519|Urological Agents|urological agents|mesh-ancestor
154696821|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154696822|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154696823|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154696824|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154696825|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696826|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
154696827|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696828|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696829|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154696830|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696831|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154696832|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696833|NCT01765569|Vemurafenib|vemurafenib|mesh-list
154696834|NCT01765569|Digoxin|digoxin|mesh-list
154696835|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154696836|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154696837|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696838|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696839|NCT01765569|Protective Agents|protective agents|mesh-ancestor
154696840|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696841|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696842|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154696843|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154696844|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
154696845|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696846|NCT01609023|Rituximab|rituximab|mesh-list
154696847|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154696848|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696849|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
154696850|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696851|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696852|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
154696853|NCT01765179|Testosterone|testosterone|mesh-list
154696854|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
154696855|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
154696856|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154696857|NCT01765179|Androgens|androgens|mesh-ancestor
154696858|NCT01765179|Hormones|hormones|mesh-ancestor
154696859|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154696860|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696861|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154696862|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696863|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
154696864|NCT01793883|Laninamivir|laninamivir|mesh-list
154696865|NCT01793883|Zanamivir|zanamivir|mesh-list
154696866|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
154696867|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696868|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696869|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696870|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
154696871|NCT01953692|Lenalidomide|lenalidomide|mesh-list
154696872|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154696873|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696874|NCT01953692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154696875|NCT01953692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696876|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
154696877|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696878|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153951696|NCT00811135|Bevacizumab|bevacizumab|mesh-list
154696879|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154696880|NCT01953692|Growth Substances|growth substances|mesh-ancestor
154696881|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
154696882|NCT01791153|Prednisone|prednisone|mesh-list
154696883|NCT01791153|Methotrexate|methotrexate|mesh-list
154696884|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696885|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
154696886|NCT01791153|Hormones|hormones|mesh-ancestor
154696887|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154696888|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696889|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154696890|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154696891|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154696892|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
154696893|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154696894|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154696895|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
154696896|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696897|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
154696898|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696899|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154696900|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154696901|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
154696902|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696903|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154696904|NCT01926782|Alirocumab|alirocumab|mesh-list
154696905|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154696906|NCT01926782|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154696907|NCT01926782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154696908|NCT01926782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154696909|NCT01926782|Antimetabolites|antimetabolites|mesh-ancestor
154696910|NCT01926782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696911|NCT01926782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154696912|NCT01926782|Protease Inhibitors|protease inhibitors|mesh-ancestor
154696913|NCT01926782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696914|NCT01926782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154696915|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
154696916|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696917|NCT01926626|Moclobemide|moclobemide|mesh-list
154696918|NCT01926626|Nicotine|nicotine|mesh-list
154696919|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154696920|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
154696921|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696922|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696923|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154696924|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154696925|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
154696926|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696927|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696928|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
154696929|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154696930|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154696931|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696932|NCT01900730|Valproic Acid|valproic acid|mesh-list
154696933|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
154696934|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696935|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696936|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
154696937|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696938|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696939|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
154696940|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154696941|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154696942|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154696943|NCT01952834|Vancomycin|vancomycin|mesh-list
154696944|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154696945|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696946|NCT01952054|Denosumab|denosumab|mesh-list
154696947|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154696948|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696949|NCT01925768|Apremilast|apremilast|mesh-list
154696950|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154696951|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154696952|NCT01925768|Analgesics|analgesics|mesh-ancestor
154696953|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
154696954|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696955|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696956|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154696957|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154696958|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154696959|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154696960|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154696961|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696962|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
154696963|NCT01431274|Olodaterol|olodaterol|mesh-list
154696964|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154696965|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
154696966|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154696967|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696968|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154696969|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
154696970|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
154696971|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154696972|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
154696973|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696974|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696975|NCT01991795|Ticagrelor|ticagrelor|mesh-list
154696976|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154696977|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154696978|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154696979|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154696980|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
154696981|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154696982|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696983|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696984|NCT02076100|Ruzasvir|ruzasvir|mesh-list
154696985|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
154696986|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696987|NCT01411774|Cycloserine|cycloserine|mesh-list
154696988|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154696989|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154696990|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154696991|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
154696992|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154696993|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
154696994|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154696995|NCT01410604|Metformin|metformin|mesh-list
154696996|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154696997|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154696998|NCT01410448|Cyclosporine|cyclosporine|mesh-list
154696999|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
154697000|NCT01410448|Everolimus|everolimus|mesh-list
154697001|NCT01410448|Cyclosporins|cyclosporins|mesh-list
154697002|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697003|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697004|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154697005|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
154697006|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697007|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
154697008|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697009|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
154697010|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697011|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154697012|NCT01410448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154697013|NCT01410448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154697014|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697015|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154697016|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154697017|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
154697018|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154697019|NCT01430104|Teriparatide|teriparatide|mesh-list
154697020|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154697021|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697022|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154697023|NCT01990859|Ipilimumab|ipilimumab|mesh-list
154697024|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697025|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697026|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154697027|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697028|NCT02093897|Factor VIII|factor viii|mesh-list
154697029|NCT02093897|Coagulants|coagulants|mesh-ancestor
154697030|NCT01976845|Midazolam|midazolam|mesh-list
154697031|NCT01976845|Propofol|propofol|mesh-list
154697032|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154697033|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154697034|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697035|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154697036|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
154697037|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
154697038|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154697039|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154697040|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154697041|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154697042|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
154697043|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
154697044|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697045|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697046|NCT01989689|Etanercept|etanercept|mesh-list
154697047|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154697048|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154697049|NCT01989689|Analgesics|analgesics|mesh-ancestor
154697050|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
154697051|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697052|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697053|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697054|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697055|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154697056|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951880|NCT00676702|Coagulants|coagulants|mesh-ancestor
154697057|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
154697058|NCT01942993|Vemurafenib|vemurafenib|mesh-list
154697059|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697060|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154697061|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697062|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697063|NCT01989455|Deferiprone|deferiprone|mesh-list
154697064|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154697065|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
154697066|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
154697067|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697068|NCT01987895|Vancomycin|vancomycin|mesh-list
154697069|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
154697070|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154697071|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697072|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154697073|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697074|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697075|NCT01618669|Regadenoson|regadenoson|mesh-list
154697076|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154697077|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154697078|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
154697079|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
154697080|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697081|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697082|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697083|NCT01390948|Bevacizumab|bevacizumab|mesh-list
154697084|NCT01390948|Temozolomide|temozolomide|mesh-list
154697085|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697086|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697087|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154697088|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154697089|NCT01390948|Growth Substances|growth substances|mesh-ancestor
154697090|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697091|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
154697092|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154697093|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
154697094|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697095|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
154697096|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154697097|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
154697098|NCT01429792|Ribavirin|ribavirin|mesh-list
154697099|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154697100|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
154697101|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697102|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
154697103|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697104|NCT01925612|Prednisone|prednisone|mesh-list
154697105|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
154558044|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154697106|NCT01925612|Rituximab|rituximab|mesh-list
154697107|NCT01925612|Doxorubicin|doxorubicin|mesh-list
154697108|NCT01925612|Vincristine|vincristine|mesh-list
153951945|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
154697109|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154697110|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154697111|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154697112|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
154697113|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697114|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697115|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154697116|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
154697117|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697118|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697119|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154697120|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697121|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154697122|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154697123|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154697124|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697125|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697126|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
154697127|NCT01925612|Hormones|hormones|mesh-ancestor
154697128|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697129|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154697130|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154697131|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
154697132|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
154697133|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
154697134|NCT01925612|Immunotoxins|immunotoxins|mesh-ancestor
154697135|NCT01925612|Immunoconjugates|immunoconjugates|mesh-ancestor
154697136|NCT02093663|Mesalamine|mesalamine|mesh-list
154697137|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154697138|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154697139|NCT02093663|Analgesics|analgesics|mesh-ancestor
154697140|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
154697141|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697142|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697143|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697144|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697145|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154697146|NCT01408888|Dulaglutide|dulaglutide|mesh-list
154697147|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154697148|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697149|NCT01408888|Incretins|incretins|mesh-ancestor
154697150|NCT01408888|Hormones|hormones|mesh-ancestor
154697151|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697152|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154697153|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154697154|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697155|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697156|NCT01408888|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154697157|NCT01918033|Desloratadine|desloratadine|mesh-list
154697158|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154697159|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
154697160|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697161|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697162|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697163|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154697164|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154697165|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
154697166|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
154697167|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
154697168|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154697169|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154697170|NCT01390402|Aldesleukin|aldesleukin|mesh-list
154697171|NCT01390402|Methotrexate|methotrexate|mesh-list
154697172|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
154697173|NCT01390402|Fludarabine|fludarabine|mesh-list
154697174|NCT01390402|Busulfan|busulfan|mesh-list
154697175|NCT01390402|Interleukin-2|interleukin-2|mesh-list
154697176|NCT01390402|Tacrolimus|tacrolimus|mesh-list
154697177|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
154697178|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154697179|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154697180|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
154697181|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154697182|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449138|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
154697183|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154697184|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
154697185|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697186|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697187|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
154697188|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697189|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154697190|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154697191|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
154697192|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697193|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154697194|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
154697195|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697196|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154697197|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
154697198|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154697199|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154697200|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154697201|NCT01390402|Analgesics|analgesics|mesh-ancestor
154697202|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
154697203|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697204|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154697205|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154697206|NCT01428076|Polidocanol|polidocanol|mesh-list
154697207|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154697208|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154697209|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154697210|NCT01900652|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154697211|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154697212|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697213|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697214|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697215|NCT02093351|Tamoxifen|tamoxifen|mesh-list
154697216|NCT02093351|Letrozole|letrozole|mesh-list
154697217|NCT02093351|Olaparib|olaparib|mesh-list
154697218|NCT02093351|Anastrozole|anastrozole|mesh-list
154697219|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697220|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154697221|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154697222|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697223|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697224|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154697225|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
153952053|NCT00680602|Sertraline|sertraline|mesh-list
154697226|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697227|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697228|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154697229|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154697230|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154697231|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154697232|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154697233|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154697234|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154697235|NCT02078284|Protective Agents|protective agents|mesh-ancestor
154697236|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697237|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154697238|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
154697239|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697240|NCT02092961|Adalimumab|adalimumab|mesh-list
154697241|NCT02092961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154697242|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697243|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697244|NCT01940497|Paclitaxel|paclitaxel|mesh-list
154697245|NCT01940497|Docetaxel|docetaxel|mesh-list
154697246|NCT01940497|Doxorubicin|doxorubicin|mesh-list
154697247|NCT01940497|Trastuzumab|trastuzumab|mesh-list
154697248|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154697249|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697250|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
154697251|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
154697252|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
154697253|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697254|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154697255|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154697256|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154697257|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697258|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697259|NCT01987505|Rituximab|rituximab|mesh-list
154697260|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697261|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697262|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
154697263|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697264|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697265|NCT01923896|Cycloserine|cycloserine|mesh-list
154697266|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154697267|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697268|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154697269|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
154697270|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154697271|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
154697272|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697273|NCT01938625|Cyclosporine|cyclosporine|mesh-list
154697274|NCT01938625|Ribavirin|ribavirin|mesh-list
154697275|NCT01938625|Simeprevir|simeprevir|mesh-list
154697276|NCT01938625|Tacrolimus|tacrolimus|mesh-list
154697277|NCT01938625|Cyclosporins|cyclosporins|mesh-list
153952118|NCT00877006|Prednisone|prednisone|mesh-list
154697278|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154697279|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
154697280|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697281|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154697282|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697283|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697284|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
154697285|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697286|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
154697287|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697288|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
154697289|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
154697290|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
154697291|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
154697292|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
154697293|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697294|NCT01975285|Dexamethasone|dexamethasone|mesh-list
154697295|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697296|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
154697297|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
154697298|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697299|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697300|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154697301|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
154697302|NCT01975285|Hormones|hormones|mesh-ancestor
154697303|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697304|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154697305|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697306|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154697307|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
154697308|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697309|NCT04624399|Atezolizumab|atezolizumab|mesh-list
154697310|NCT04624399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154697311|NCT04624399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697312|NCT04624399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697313|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697314|NCT01915849|Licogliflozin|licogliflozin|mesh-list
154697315|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154697316|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697317|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154697318|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697319|NCT01915303|Cabergoline|cabergoline|mesh-list
154697320|NCT01915303|Pasireotide|pasireotide|mesh-list
154697321|NCT01915303|Hormones|hormones|mesh-ancestor
154697322|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697323|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697324|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154697325|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154697326|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
154697327|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
154697328|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697329|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697330|NCT01987427|Phentermine|phentermine|mesh-list
154697331|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154697332|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697333|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
154697334|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154697335|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
154697336|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
154697337|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697338|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
154697339|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697340|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697341|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154697342|NCT01937299|Travoprost|travoprost|mesh-list
154697343|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154697344|NCT01937299|Brinzolamide|brinzolamide|mesh-list
154697345|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154697346|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154697347|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154697348|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154697349|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154697350|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
154697351|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697352|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697353|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697354|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154697355|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697356|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154697357|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
154697358|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697359|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
154697360|NCT01597557|Analgesics|analgesics|mesh-ancestor
154697361|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
154697362|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697363|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697364|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
154697365|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154697366|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154697367|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
154697368|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154697369|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154697370|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697371|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154697372|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
154697373|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154697374|NCT01914757|Benralizumab|benralizumab|mesh-list
154697375|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154697376|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
154697377|NCT02003573|Decitabine|decitabine|mesh-list
154697378|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154697379|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
154697380|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697381|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697382|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697383|NCT01789281|Everolimus|everolimus|mesh-list
154697384|NCT01789281|Octreotide|octreotide|mesh-list
154697385|NCT01789281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154697386|NCT01789281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154697387|NCT01789281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697388|NCT01789281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697389|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154697390|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
154697391|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697392|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697393|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154697394|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154697395|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
154697396|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154697397|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697398|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154697399|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154697400|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697401|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697402|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697403|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154697404|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154697405|NCT01789047|Topiramate|topiramate|mesh-list
154697406|NCT01789047|Amantadine|amantadine|mesh-list
154697407|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
154697408|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154697409|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697410|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154697411|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154697412|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
154697413|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697414|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
154697415|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697416|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697417|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154697418|NCT01789047|Analgesics|analgesics|mesh-ancestor
154697419|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
154697420|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697422|NCT01617187|Asenapine|asenapine|mesh-list
154697423|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
154697424|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
154697425|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697426|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697427|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154697428|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154697429|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154697430|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154697431|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154697432|NCT01617187|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154697433|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154697434|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154697435|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697436|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697437|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
154697438|NCT01759407|Epinephrine|epinephrine|mesh-list
154697439|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154697440|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154697441|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
154697442|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697443|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697444|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697445|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154697446|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154697447|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
154697448|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697449|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154697450|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
154697451|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
154697452|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
154697453|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154697454|NCT01787331|Itraconazole|itraconazole|mesh-list
154697455|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
154697456|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697457|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154697458|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154697459|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697460|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697461|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154697462|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
154697463|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697464|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697465|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154697466|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
154697467|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154697468|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154697469|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
154697470|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697471|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697472|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154697473|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
154697474|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154697475|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154697476|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154697477|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
154697478|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697479|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697480|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154697481|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154697482|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697483|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154697484|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
154697485|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697486|NCT01786707|Metformin|metformin|mesh-list
154697487|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154697488|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697489|NCT01786551|Eplerenone|eplerenone|mesh-list
154697490|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154697491|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
154697492|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697493|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697494|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154697495|NCT01786551|Diuretics|diuretics|mesh-ancestor
154697496|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
154697497|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154697498|NCT01973569|Denosumab|denosumab|mesh-list
154697499|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154697500|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697501|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
154697502|NCT01951586|Denosumab|denosumab|mesh-list
154697503|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154697504|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697505|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154697506|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697507|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
154697508|NCT04641728|Olaparib|olaparib|mesh-list
154697509|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697510|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697511|NCT04641728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154697512|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697513|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154697514|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697515|NCT01756833|Doxycycline|doxycycline|mesh-list
154697516|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154697517|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697518|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
154697519|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154697520|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154697521|NCT01785615|Atorvastatin|atorvastatin|mesh-list
154697522|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154697523|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154697524|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
154697525|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697526|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154697527|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154697528|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697529|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
154697530|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
154697531|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154697532|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154697533|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697534|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697535|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697536|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697537|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
154697538|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154697539|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697540|NCT01783821|Budesonide|budesonide|mesh-list
154697541|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
154697542|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697543|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154697544|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
154697545|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697546|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697547|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154697548|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
154697549|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
154697550|NCT01783821|Hormones|hormones|mesh-ancestor
154697551|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697552|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154697553|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154697554|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154697555|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
154697556|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697557|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697558|NCT01608087|Bevacizumab|bevacizumab|mesh-list
154697559|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697560|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697561|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154697562|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154697563|NCT01608087|Growth Substances|growth substances|mesh-ancestor
154697564|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697565|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
154697566|NCT01912963|Trastuzumab|trastuzumab|mesh-list
154697568|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697569|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697570|NCT01912807|Ondansetron|ondansetron|mesh-list
154697571|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
154697572|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
154697573|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697574|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952402|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
154697575|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154697576|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
154697577|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
154697578|NCT01912807|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154697579|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154697580|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
154697581|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697582|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697583|NCT01782885|Acetaminophen|acetaminophen|mesh-list
154697584|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154697585|NCT01782885|Analgesics|analgesics|mesh-ancestor
154697586|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
154697587|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697588|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697589|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
154697590|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154697591|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154697592|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154697593|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154697594|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697595|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697596|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697597|NCT01754493|Analgesics|analgesics|mesh-ancestor
154697598|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
154697599|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697600|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
154697601|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154697602|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
154697603|NCT01972789|Ranibizumab|ranibizumab|mesh-list
154697604|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154697605|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154697606|NCT01972789|Growth Substances|growth substances|mesh-ancestor
154697607|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697608|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
154697609|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697610|NCT01910389|Tadalafil|tadalafil|mesh-list
154697611|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
154697612|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154697613|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154697614|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697615|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697616|NCT01910389|Urological Agents|urological agents|mesh-ancestor
154697617|NCT01970995|Menthol|menthol|mesh-list
154697618|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
154697619|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
154697620|NCT01970527|Ipilimumab|ipilimumab|mesh-list
154697621|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697622|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697623|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154697624|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697625|NCT01408576|Epratuzumab|epratuzumab|mesh-list
154697626|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697627|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697628|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
154697629|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
154697630|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154697631|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154697632|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697633|NCT01427608|Olanzapine|olanzapine|mesh-list
154697634|NCT01427608|Sertraline|sertraline|mesh-list
154697635|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
154697636|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
154697637|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697638|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697639|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154697640|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154697641|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154697642|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154697643|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154697644|NCT01427608|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154697645|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154697646|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154697647|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697648|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697649|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
154697650|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
154697651|NCT01408030|Bevacizumab|bevacizumab|mesh-list
154697652|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
154697653|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
154697654|NCT01408030|Estrogens|estrogens|mesh-list
154697655|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154697656|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697657|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154697658|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154697659|NCT01408030|Growth Substances|growth substances|mesh-ancestor
154697660|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697661|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
154697662|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154697663|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154697664|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697665|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
154697666|NCT01408030|Coagulants|coagulants|mesh-ancestor
154697667|NCT01408030|Hormones|hormones|mesh-ancestor
154697668|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697669|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154697670|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154697671|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697672|NCT01897532|Linagliptin|linagliptin|mesh-list
154697673|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154697674|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697675|NCT01897532|Incretins|incretins|mesh-ancestor
154697676|NCT01897532|Hormones|hormones|mesh-ancestor
154697677|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697678|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154697679|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
154697680|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697681|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697682|NCT01896128|Modafinil|modafinil|mesh-list
154697683|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154697684|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697685|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154697686|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154697687|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154697688|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697689|NCT01949870|Gemcitabine|gemcitabine|mesh-list
154697690|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697691|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154697692|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
154697693|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697694|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
154697695|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
154697696|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697697|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697698|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697699|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
154697700|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
154697701|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154697702|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
154697703|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697705|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
154697706|NCT01405924|Aprepitant|aprepitant|mesh-list
154697707|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697708|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
154697709|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
154697710|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697711|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697712|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154697713|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
154697714|NCT01405924|Hormones|hormones|mesh-ancestor
154697715|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697716|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154697717|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697718|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154697719|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697720|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697721|NCT01426438|Aspirin|aspirin|mesh-list
154697722|NCT01426438|Niacin|niacin|mesh-list
154697723|NCT01426438|Fenofibrate|fenofibrate|mesh-list
154697724|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154697725|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154697726|NCT01426438|Analgesics|analgesics|mesh-ancestor
154697727|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
154697728|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697729|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697730|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697731|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697732|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154697733|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154697734|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697735|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154697736|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154697737|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697738|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
154697739|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154697740|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
154697741|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154697742|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
154697743|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
154697744|NCT01426438|Vitamins|vitamins|mesh-ancestor
154697745|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
154697746|NCT01782495|Ritonavir|ritonavir|mesh-list
154697747|NCT01782495|Ribavirin|ribavirin|mesh-list
154697748|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154697749|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154697750|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
154697751|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697752|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697753|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154697754|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154697755|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
154697756|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697757|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154697758|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154697759|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
154697760|NCT01922102|Ranibizumab|ranibizumab|mesh-list
154697761|NCT01922102|Verteporfin|verteporfin|mesh-list
154697762|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154697763|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154697764|NCT01922102|Growth Substances|growth substances|mesh-ancestor
154697765|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697766|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
154697767|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697768|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154697769|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
154697770|NCT01405768|Lidocaine|lidocaine|mesh-list
154697771|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
154697772|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
154449742|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449743|NCT05607017|Losartan|losartan|mesh-list
154449744|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154449745|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154449754|NCT05503875|Adalimumab|adalimumab|mesh-list
154697773|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154697774|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697775|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
154697776|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697777|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154697778|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154697779|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154697780|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154697781|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697782|NCT01913353|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154697783|NCT01913353|Antiviral Agents|antiviral agents|mesh-ancestor
154697784|NCT01913353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697786|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154697787|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154697788|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697789|NCT01405456|Eplerenone|eplerenone|mesh-list
154697790|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154697791|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
154697792|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697793|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697794|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154697795|NCT01405456|Diuretics|diuretics|mesh-ancestor
154697796|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
154697797|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154697798|NCT01404208|Cycloserine|cycloserine|mesh-list
154697799|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154697800|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697801|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154697802|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
154697803|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154697804|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
154697805|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697806|NCT01617668|Paclitaxel|paclitaxel|mesh-list
154697807|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154697808|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697809|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
154697810|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
154697811|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
154697812|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697813|NCT01895270|Isradipine|isradipine|mesh-list
154697814|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154697815|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154697816|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154697817|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697818|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154697819|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697820|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
154697821|NCT01424644|Vaccines|vaccines|mesh-list
154697822|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
154697823|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697824|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
154697825|NCT01403116|Testosterone|testosterone|mesh-list
154697826|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
154697827|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
154697828|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154697829|NCT01403116|Androgens|androgens|mesh-ancestor
154697830|NCT01403116|Hormones|hormones|mesh-ancestor
154697831|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697832|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697833|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154697834|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697835|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
154697836|NCT01753401|Prednisone|prednisone|mesh-list
154697837|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154697838|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697839|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
154697840|NCT01753401|Hormones|hormones|mesh-ancestor
154697841|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154697842|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697843|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154697844|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697845|NCT01894568|Insulin|insulin|mesh-list
154697846|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154697847|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
154697848|NCT01894568|Pioglitazone|pioglitazone|mesh-list
154697849|NCT01894568|Biguanides|biguanides|mesh-list
154697850|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154697851|NCT01894568|Meglitinide|meglitinide|mesh-list
154697852|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697853|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
154697854|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154697855|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
154697856|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697857|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
154697858|NCT01920152|Protective Agents|protective agents|mesh-ancestor
154697859|NCT01752933|Guadecitabine|guadecitabine|mesh-list
154697860|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697861|NCT01752855|Adalimumab|adalimumab|mesh-list
154697862|NCT01752855|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154697863|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154697864|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154697865|NCT01402492|Naltrexone|naltrexone|mesh-list
154697866|NCT01402492|Buprenorphine|buprenorphine|mesh-list
154697867|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154697868|NCT01402492|Naloxone|naloxone|mesh-list
154697869|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154697870|NCT01402492|Narcotics|narcotics|mesh-ancestor
154697871|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154697872|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697873|NCT01402492|Analgesics|analgesics|mesh-ancestor
154697874|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
154697875|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697876|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154697877|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154697878|NCT01894256|Olaparib|olaparib|mesh-list
154697879|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154697880|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697881|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697882|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697883|NCT01780935|Ranibizumab|ranibizumab|mesh-list
154697884|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154697885|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154697886|NCT01780935|Growth Substances|growth substances|mesh-ancestor
154697887|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697888|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
154697889|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697890|NCT01422538|Mannitol|mannitol|mesh-list
154697891|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154697892|NCT01422538|Diuretics|diuretics|mesh-ancestor
154697893|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
154697894|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697895|NCT01422382|Diltiazem|diltiazem|mesh-list
154697896|NCT01422382|Pitavastatin|pitavastatin|mesh-list
154697897|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154697898|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154697899|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154697900|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697901|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154697902|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697903|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
154697904|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154697905|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154697906|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154697907|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
154697908|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697909|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154697910|NCT01401322|Lenalidomide|lenalidomide|mesh-list
154697911|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
154697912|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697913|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153952747|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154697914|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154697915|NCT01401322|Growth Substances|growth substances|mesh-ancestor
154697916|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
154697917|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697918|NCT01401010|Doripenem|doripenem|mesh-list
154697919|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154697920|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697921|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154697922|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
154697923|NCT01890746|Cytarabine|cytarabine|mesh-list
154697924|NCT01890746|Daunorubicin|daunorubicin|mesh-list
154697925|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154697926|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
154697927|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697928|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154697929|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
154697930|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697931|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154697932|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
154697933|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697934|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154697935|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154697936|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154697937|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697938|NCT01422304|Atropine|atropine|mesh-list
154697939|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
154697940|NCT01422304|Neostigmine|neostigmine|mesh-list
154697941|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154697942|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154697943|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154697944|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
154697945|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697946|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697947|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154697948|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
154697949|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
154697950|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
154697951|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154697952|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154697953|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
154697954|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697955|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697956|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154697957|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697958|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154697959|NCT01387516|Nicotine|nicotine|mesh-list
154697960|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154697961|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
154697962|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154697963|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697964|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154697965|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154697966|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
154697967|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697968|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697969|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154697970|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154697971|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154697972|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154697973|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154697974|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154697975|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154697976|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154697977|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154697978|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154697979|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154697980|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697981|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154697982|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154697983|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
154697984|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154697985|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154697986|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
154697987|NCT01894022|Ambrisentan|ambrisentan|mesh-list
154697988|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154697989|NCT01386970|Lamivudine|lamivudine|mesh-list
154697990|NCT01386970|Zidovudine|zidovudine|mesh-list
154697991|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154697992|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154697993|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154697994|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154697995|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154697996|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
154697997|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154697998|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154697999|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154698000|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
154698001|NCT01385566|Vaccines|vaccines|mesh-list
154698002|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
154698003|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698004|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
154698005|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
154698006|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698007|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
154698008|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698009|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698010|NCT01780545|Docetaxel|docetaxel|mesh-list
154698011|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698012|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
154698013|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
154698014|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
154698015|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698016|NCT01780389|Milnacipran|milnacipran|mesh-list
154698017|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
154698018|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154698019|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154698020|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154698021|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698022|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698023|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698024|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154698025|NCT01780389|Analgesics|analgesics|mesh-ancestor
154698026|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
154698027|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698028|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
154698029|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154698030|NCT01778985|Estrogens|estrogens|mesh-list
154698031|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154698032|NCT01778985|Hormones|hormones|mesh-ancestor
154698033|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698034|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698035|NCT01865084|Tadalafil|tadalafil|mesh-list
154698036|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
154698037|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154698038|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154698039|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698040|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698041|NCT01865084|Urological Agents|urological agents|mesh-ancestor
154698042|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
154698043|NCT01385098|Vitamin D|vitamin d|mesh-list
154698044|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
154698045|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
154698046|NCT01385098|Vitamins|vitamins|mesh-list
154698047|NCT01385098|Calcium|calcium|mesh-list
154698048|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
154698049|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698050|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154698051|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154698052|NCT01398514|Escitalopram|escitalopram|mesh-list
154698053|NCT01398514|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154698054|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154698055|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154698056|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698057|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698058|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
154698059|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698060|NCT03025282|Betamethasone|betamethasone|mesh-list
154698061|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
154698062|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154698063|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698064|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
154698065|NCT03025282|Hormones|hormones|mesh-ancestor
154698066|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698067|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698068|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154698069|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
154698070|NCT01778049|Empagliflozin|empagliflozin|mesh-list
154698071|NCT01778049|Linagliptin|linagliptin|mesh-list
154698072|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154698073|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698074|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698075|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698077|NCT01778049|Hormones|hormones|mesh-ancestor
154698078|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698079|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154698080|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
154698081|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698082|NCT01777581|Milnacipran|milnacipran|mesh-list
154698083|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
154698084|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153952934|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698085|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154698086|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154698087|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698088|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698089|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698090|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154698091|NCT01777581|Analgesics|analgesics|mesh-ancestor
154698092|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
154698093|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698094|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
154698095|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154698096|NCT01864148|Interferons|interferons|mesh-list
154698097|NCT01864148|Interferon-beta|interferon-beta|mesh-list
154698098|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
154698099|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698100|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
154698101|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698102|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
154698103|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698104|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154698105|NCT01890122|Metformin|metformin|mesh-list
154698106|NCT01890122|Alogliptin|alogliptin|mesh-list
154698107|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698108|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698109|NCT01890122|Incretins|incretins|mesh-ancestor
154698110|NCT01890122|Hormones|hormones|mesh-ancestor
154698111|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698112|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154698113|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
154698114|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698115|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698116|NCT01397890|Budesonide|budesonide|mesh-list
154698117|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
154698118|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
154698119|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154698120|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698121|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154698122|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
154698123|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698124|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698125|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154698126|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
154698127|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
154698128|NCT01397890|Hormones|hormones|mesh-ancestor
154698129|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698130|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154698131|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154698132|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154698133|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698134|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698135|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698136|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
154698137|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154698138|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
154698139|NCT01777269|Tamsulosin|tamsulosin|mesh-list
154698140|NCT01777269|Dutasteride|dutasteride|mesh-list
154698141|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154698142|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154698143|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154698144|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698145|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952980|NCT00681772|Urological Agents|urological agents|mesh-ancestor
154698146|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698147|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698148|NCT01777269|Urological Agents|urological agents|mesh-ancestor
154698149|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154698150|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154698151|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698152|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
154698153|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698154|NCT01777191|Ixekizumab|ixekizumab|mesh-list
154698155|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
154698156|NCT01896050|Tamoxifen|tamoxifen|mesh-list
154698157|NCT01896050|Letrozole|letrozole|mesh-list
154698158|NCT01896050|Anastrozole|anastrozole|mesh-list
154698159|NCT01896050|Exemestane|exemestane|mesh-list
154698160|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698161|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154698162|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154698163|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698164|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698165|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154698166|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
154698167|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698168|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698169|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154698170|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154698171|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154698172|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154698173|NCT01775787|Menthol|menthol|mesh-list
154698174|NCT01775787|Nicotine|nicotine|mesh-list
154698175|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154698176|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
154698177|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698178|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698179|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154698180|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154698181|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
154698182|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698183|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698184|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
154698185|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
154698186|NCT01775475|Prednisone|prednisone|mesh-list
154698187|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
154698188|NCT01775475|Lomustine|lomustine|mesh-list
154698189|NCT01775475|Doxorubicin|doxorubicin|mesh-list
154698190|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154698191|NCT01775475|Etoposide|etoposide|mesh-list
154698192|NCT01775475|Vincristine|vincristine|mesh-list
154698193|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
154698194|NCT01775475|Procarbazine|procarbazine|mesh-list
154698195|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154698196|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
154698197|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698198|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153953044|NCT02855346|Dapivirine|dapivirine|mesh-list
154698199|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154698200|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
154698201|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698202|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698203|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154698204|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154698205|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154698206|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154698207|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698208|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698209|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
154698210|NCT01775475|Hormones|hormones|mesh-ancestor
154698211|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698212|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154698213|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154698214|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
154698215|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
154698216|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
154698217|NCT01774929|Fentanyl|fentanyl|mesh-list
154698218|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154698219|NCT01774929|Narcotics|narcotics|mesh-ancestor
154698220|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698222|NCT01774929|Analgesics|analgesics|mesh-ancestor
154698223|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
154698224|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698225|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154698226|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154698227|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
154698228|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
154698229|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
154698230|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154698231|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698232|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698233|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154698234|NCT01774305|Analgesics|analgesics|mesh-ancestor
154698235|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
154698236|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698237|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154698238|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154698239|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154698240|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698241|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698242|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698243|NCT01397422|Amantadine|amantadine|mesh-list
154698244|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154698245|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154698246|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
154698247|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698248|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
154698249|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698250|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698251|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698252|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154698253|NCT01397422|Analgesics|analgesics|mesh-ancestor
154698254|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
154698255|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698256|NCT01736475|Factor VIII|factor viii|mesh-list
154698257|NCT01736475|BAX 855|bax 855|mesh-list
154698258|NCT01736475|Coagulants|coagulants|mesh-ancestor
154698259|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154698260|NCT01863680|Hormones|hormones|mesh-list
154698261|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154698262|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698263|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698264|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154698265|NCT01747629|Albuterol|albuterol|mesh-list
154698266|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154698267|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
154698268|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698269|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698270|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154698271|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
154698272|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
154698273|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154698274|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154698275|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154698276|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154698277|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698278|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698279|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698280|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154698281|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
154698282|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154698283|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154698284|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154698285|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154698286|NCT01886690|Laxatives|laxatives|mesh-ancestor
154698287|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154698288|NCT01885208|Semaglutide|semaglutide|mesh-list
154698289|NCT01885208|Exenatide|exenatide|mesh-list
154698290|NCT01885208|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154698291|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698292|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698293|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154698294|NCT01885208|Incretins|incretins|mesh-ancestor
154698295|NCT01885208|Hormones|hormones|mesh-ancestor
154698296|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698297|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
154698298|NCT01859702|Dexamethasone|dexamethasone|mesh-list
154698299|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154698300|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698301|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
154698302|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
154698303|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698304|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698305|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154698306|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
154698307|NCT01859702|Hormones|hormones|mesh-ancestor
154698308|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698309|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154698310|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698311|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154698312|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154698313|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698314|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154698315|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154698316|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698317|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698318|NCT01747551|Leucovorin|leucovorin|mesh-list
154698319|NCT01747551|Fluorouracil|fluorouracil|mesh-list
154698320|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
154698321|NCT01747551|Aflibercept|aflibercept|mesh-list
154698322|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
154698323|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698324|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154698325|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698326|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154698327|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
154698328|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698329|NCT01747551|Antidotes|antidotes|mesh-ancestor
154698330|NCT01747551|Protective Agents|protective agents|mesh-ancestor
154698331|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
154698332|NCT01747551|Vitamins|vitamins|mesh-ancestor
154698333|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
154698334|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154698335|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154698336|NCT01747551|Growth Substances|growth substances|mesh-ancestor
154698337|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
154698338|NCT01859390|Antioxidants|antioxidants|mesh-list
154698339|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698340|NCT01859390|Protective Agents|protective agents|mesh-ancestor
154698341|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698342|NCT01858766|Ribavirin|ribavirin|mesh-list
154698343|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
154698344|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698345|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
154698346|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698347|NCT01745367|Paclitaxel|paclitaxel|mesh-list
154698348|NCT01745367|Tivozanib|tivozanib|mesh-list
154698349|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154698350|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698351|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
154698352|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
154698353|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
154698354|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698355|NCT01745367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154698356|NCT01745367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698357|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
154698358|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154698359|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154698360|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558045|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558046|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154558047|NCT01664624|Incretins|incretins|mesh-ancestor
154558048|NCT01664624|Hormones|hormones|mesh-ancestor
154558049|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558050|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154558051|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
154558052|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558053|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558054|NCT03173781|Droxidopa|droxidopa|mesh-list
154698361|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698362|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698363|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698364|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698366|NCT01383928|Lenalidomide|lenalidomide|mesh-list
154698367|NCT01383928|Ixazomib|ixazomib|mesh-list
154698368|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698369|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
154698370|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
154698371|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698372|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698373|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154698374|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
154698375|NCT01383928|Hormones|hormones|mesh-ancestor
154698376|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698377|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154698378|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698379|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
154698380|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154698381|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154698382|NCT01383928|Growth Substances|growth substances|mesh-ancestor
154698383|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
154698384|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
154698385|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698386|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698387|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154698388|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698389|NCT05892705|Dexmedetomidine|dexmedetomidine|mesh-list
154698390|NCT05892705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154698391|NCT05892705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698392|NCT05892705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698393|NCT05892705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154698394|NCT05892705|Analgesics|analgesics|mesh-ancestor
154698395|NCT05892705|Sensory System Agents|sensory system agents|mesh-ancestor
154698396|NCT05892705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698397|NCT05892705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154698398|NCT05892705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154698399|NCT05892705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154698400|NCT05892705|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698401|NCT05892705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698402|NCT05892705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698403|NCT05892471|Propofol|propofol|mesh-list
154698404|NCT05892471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154698405|NCT05892471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698406|NCT05892471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698407|NCT05892471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154698408|NCT05892471|Anesthetics, General|anesthetics, general|mesh-ancestor
154698409|NCT05892471|Anesthetics|anesthetics|mesh-ancestor
154698410|NCT05892068|Tucatinib|tucatinib|mesh-list
154698411|NCT05892068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698412|NCT05892068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154698413|NCT05892068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698414|NCT05892068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698415|NCT05892042|Rivaroxaban|rivaroxaban|mesh-list
154698416|NCT05892042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154698417|NCT05892042|Antithrombins|antithrombins|mesh-ancestor
154698418|NCT05892042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154698419|NCT05892042|Protease Inhibitors|protease inhibitors|mesh-ancestor
154698420|NCT05892042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698421|NCT05892042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698422|NCT05892042|Anticoagulants|anticoagulants|mesh-ancestor
154698423|NCT05889949|Sorafenib|sorafenib|mesh-list
154698424|NCT05889949|Lenvatinib|lenvatinib|mesh-list
154698425|NCT05889949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698426|NCT05889949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154698427|NCT05889949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698428|NCT05889949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698429|NCT05887804|Triamcinolone|triamcinolone|mesh-list
154698430|NCT05887804|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154698431|NCT05887804|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154698432|NCT05887804|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154698433|NCT05887804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698434|NCT05887804|Glucocorticoids|glucocorticoids|mesh-ancestor
154698435|NCT05887804|Hormones|hormones|mesh-ancestor
154698436|NCT05887804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698437|NCT05887804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698438|NCT05887804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154698439|NCT05887804|Immunologic Factors|immunologic factors|mesh-ancestor
154698440|NCT05887804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698441|NCT05887804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698442|NCT05808725|Amlodipine|amlodipine|mesh-list
154698443|NCT05808725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154698444|NCT05808725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154698445|NCT05808725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154698446|NCT05808725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154698447|NCT05808725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698448|NCT05808725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154698449|NCT05808725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698450|NCT05808725|Vasodilator Agents|vasodilator agents|mesh-ancestor
154698451|NCT05792540|Dapagliflozin|dapagliflozin|mesh-list
154698452|NCT05792540|Fluoxetine|fluoxetine|mesh-list
154698453|NCT05792540|Atorvastatin|atorvastatin|mesh-list
154698454|NCT05792540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154698455|NCT05792540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154698456|NCT05792540|Antimetabolites|antimetabolites|mesh-ancestor
154698457|NCT05792540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698458|NCT05792540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154698459|NCT05792540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154698460|NCT05792540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698461|NCT05792540|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154698462|NCT05792540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698463|NCT05792540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698464|NCT05792540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154698465|NCT05792540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154698466|NCT05792540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154698467|NCT05792540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698468|NCT05792540|Serotonin Agents|serotonin agents|mesh-ancestor
154698469|NCT05792540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154698470|NCT05792540|Antidepressive Agents|antidepressive agents|mesh-ancestor
154698471|NCT05792540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154698472|NCT05792540|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154698473|NCT05792540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154698474|NCT05780307|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154698475|NCT05780307|Immunologic Factors|immunologic factors|mesh-ancestor
154698476|NCT05780307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698477|NCT05700214|Lidocaine|lidocaine|mesh-list
154698478|NCT05700214|Ropivacaine|ropivacaine|mesh-list
154698479|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
154698480|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
154698481|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698482|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698483|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
154698484|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698485|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154698486|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154698487|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154698488|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154698489|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698490|NCT05600686|Prednisone|prednisone|mesh-list
154698491|NCT05600686|Cortisone|cortisone|mesh-list
154698492|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
154698493|NCT05600686|Rituximab|rituximab|mesh-list
154698494|NCT05600686|Doxorubicin|doxorubicin|mesh-list
154698495|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154698496|NCT05600686|Etoposide|etoposide|mesh-list
154698497|NCT05600686|Vincristine|vincristine|mesh-list
154698498|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
154698499|NCT05600686|Daunorubicin|daunorubicin|mesh-list
154698500|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
154698501|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154698502|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154698503|NCT05600686|Antibodies|antibodies|mesh-list
154698504|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
154698505|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154698506|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154698507|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
153710955|NCT00315835|Narcotics|narcotics|mesh-ancestor
154698508|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698509|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154698510|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154698511|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
154698512|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698513|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698514|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154698515|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154698516|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154698517|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154698518|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698519|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698520|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
154698521|NCT05600686|Hormones|hormones|mesh-ancestor
154698522|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698523|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154698524|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154698525|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
154698526|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
154698527|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
154698528|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
154698529|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
154698530|NCT05564338|Tislelizumab|tislelizumab|mesh-list
154698531|NCT05564338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154698532|NCT05564338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698533|NCT05536284|Bisoprolol|bisoprolol|mesh-list
154698534|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154698535|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
154698536|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
154698537|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698538|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698539|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154698540|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154698541|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154698542|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698543|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698544|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698545|NCT05409391|Insulin|insulin|mesh-list
154698546|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698547|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698548|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154698549|NCT05367063|Canagliflozin|canagliflozin|mesh-list
154698550|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698551|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698552|NCT05367063|Incretins|incretins|mesh-ancestor
154698553|NCT05367063|Hormones|hormones|mesh-ancestor
154698554|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698555|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154698556|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
154698557|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698558|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698559|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154698560|NCT05358548|Paclitaxel|paclitaxel|mesh-list
154698561|NCT05358548|Carboplatin|carboplatin|mesh-list
154698562|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
154698563|NCT05358548|Fluorouracil|fluorouracil|mesh-list
154698564|NCT05358548|Pemetrexed|pemetrexed|mesh-list
154698565|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154698566|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698567|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
154698568|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
154698569|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
154698570|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698571|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154698572|NCT05358548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154698573|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
154698574|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154698575|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154698576|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
154698577|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698578|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698579|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154698580|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154698581|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
154698582|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154698583|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154698584|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698585|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
154698586|NCT05244070|Fludarabine|fludarabine|mesh-list
154698587|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154698588|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
154698589|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698590|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154698591|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154698592|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
154698593|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698594|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698595|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154698596|NCT05236777|Natalizumab|natalizumab|mesh-list
154698597|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
154698598|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698599|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154698600|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154698601|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698602|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698603|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154698604|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154698605|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698606|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
154698607|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698608|NCT05129891|Semaglutide|semaglutide|mesh-list
154698609|NCT05129891|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154698610|NCT05129891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698611|NCT05129891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698612|NCT05096117|ASP8062|asp8062|mesh-list
154698613|NCT05096117|Analgesics|analgesics|mesh-ancestor
154698614|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
154698615|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698616|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698617|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
154698618|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
154698619|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698620|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698621|NCT05072093|Tenofovir|tenofovir|mesh-list
154698622|NCT05072093|Emtricitabine|emtricitabine|mesh-list
154698623|NCT05072093|Cabotegravir|cabotegravir|mesh-list
154698624|NCT05072093|Doxycycline|doxycycline|mesh-list
154698625|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
154698626|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698627|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154698628|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154698629|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698630|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698631|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154698632|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154698633|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154698634|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
154698635|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154698636|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154698637|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154698638|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154698639|NCT05047718|Vaccines|vaccines|mesh-list
154698640|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
154698641|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698642|NCT05027633|Carboplatin|carboplatin|mesh-list
154698643|NCT05027633|Docetaxel|docetaxel|mesh-list
154698644|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
154698645|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698646|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
154698647|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
154698648|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
154698649|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698650|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154698651|NCT05027633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154698652|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154698653|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154698654|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698655|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154698656|NCT04851613|Fulvestrant|fulvestrant|mesh-list
154698657|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154698658|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698659|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154698660|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154698661|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
154698662|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698663|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698665|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953510|NCT01106690|Metformin|metformin|mesh-list
154698666|NCT04605861|Liraglutide|liraglutide|mesh-list
154698667|NCT04605861|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154698668|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698669|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698670|NCT04605861|Incretins|incretins|mesh-ancestor
154698671|NCT04605861|Hormones|hormones|mesh-ancestor
154698672|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698673|NCT04564443|Calcium|calcium|mesh-list
154698674|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154698675|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698676|NCT04469764|Letrozole|letrozole|mesh-list
154698677|NCT04469764|Anastrozole|anastrozole|mesh-list
154698678|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698679|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154698680|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154698681|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698682|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698683|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154698684|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
154698685|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698686|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698687|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154698688|NCT04416737|Insulin|insulin|mesh-list
154698689|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154698690|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698691|NCT04364607|Neostigmine|neostigmine|mesh-list
154698692|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154698693|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698694|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698695|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
154698696|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698697|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698698|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154698699|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
154698700|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698701|NCT04348383|Defibrotide|defibrotide|mesh-list
154698702|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154698703|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154698704|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698705|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154698706|NCT04230564|Azacitidine|azacitidine|mesh-list
154698707|NCT04230564|Venetoclax|venetoclax|mesh-list
154698708|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154698709|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
154698710|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698711|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698712|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698713|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
154698714|NCT04081545|Analgesics|analgesics|mesh-list
154698715|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
154698716|NCT04081545|Anesthetics|anesthetics|mesh-list
154698717|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698718|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698719|NCT04081545|Narcotics|narcotics|mesh-ancestor
154698720|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
154698721|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698722|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154698723|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154698724|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154698725|NCT04064697|Valganciclovir|valganciclovir|mesh-list
154698726|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
154698727|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698728|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154698729|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
154698730|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698731|NCT03896230|Ketamine|ketamine|mesh-list
154698732|NCT03896230|Analgesics|analgesics|mesh-ancestor
154698733|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
154698734|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698735|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698736|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154698737|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154698738|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
154698739|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
154698740|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698741|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154698742|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154698743|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698744|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698745|NCT03878316|Oxytocin|oxytocin|mesh-list
154698746|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
154698747|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154698748|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698749|NCT03854929|Azithromycin|azithromycin|mesh-list
154698750|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
154698751|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154698752|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698753|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154698754|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154698755|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698756|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698757|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698758|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154698759|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154698760|NCT03852628|Naltrexone|naltrexone|mesh-list
154698761|NCT03852628|Buprenorphine|buprenorphine|mesh-list
154698762|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154698763|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154698764|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698765|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
154698766|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698767|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154698768|NCT03852628|Narcotics|narcotics|mesh-ancestor
154698769|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698770|NCT03852628|Analgesics|analgesics|mesh-ancestor
154698771|NCT03826524|Epinephrine|epinephrine|mesh-list
154698772|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154698773|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154698774|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698775|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698776|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698777|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698778|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154698779|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154698780|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
154698781|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698782|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154698783|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
154698784|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
154698785|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
154698786|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154698787|NCT03741426|Durvalumab|durvalumab|mesh-list
154698788|NCT03741426|Olaparib|olaparib|mesh-list
154698789|NCT03741426|Cediranib|cediranib|mesh-list
154698790|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153953645|NCT04956302|Bortezomib|bortezomib|mesh-list
154698791|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698792|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154698793|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698794|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698795|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154698796|NCT03623633|Denosumab|denosumab|mesh-list
154698797|NCT03623633|Alendronate|alendronate|mesh-list
154698798|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154698799|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154698800|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698801|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154698802|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
154698803|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698804|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154698805|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154698806|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154698807|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154698808|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154698809|NCT03554174|Psilocybin|psilocybin|mesh-list
154698810|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
154698811|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698812|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154698813|NCT03508440|Prednisone|prednisone|mesh-list
154698814|NCT03508440|Prednisolone|prednisolone|mesh-list
154698815|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698816|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
154698817|NCT03508440|Hormones|hormones|mesh-ancestor
154698818|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154698819|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698820|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154698821|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698822|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154698823|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698824|NCT03422861|Nabilone|nabilone|mesh-list
154698825|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
154698826|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
154698827|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698828|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698829|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154698830|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154698831|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154698832|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698833|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154698834|NCT03421496|Cannabidiol|cannabidiol|mesh-list
154698835|NCT03421496|Vigabatrin|vigabatrin|mesh-list
154698836|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
154698837|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698838|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698839|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
154698840|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698841|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698842|NCT03278106|Trifluridine|trifluridine|mesh-list
154698843|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
154698844|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698845|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
154698846|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698847|NCT03255252|Cisplatin|cisplatin|mesh-list
154698848|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698849|NCT03192215|Aspirin|aspirin|mesh-list
154698850|NCT03192215|Apixaban|apixaban|mesh-list
154698851|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154698852|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154698853|NCT03192215|Analgesics|analgesics|mesh-ancestor
154698854|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
154698855|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698856|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698857|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154698858|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154698859|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154698860|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154698861|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698862|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154698863|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154698864|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698865|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
154698866|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154698867|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
154698868|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154698869|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
154698870|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
154698871|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154698872|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154698873|NCT02865018|Cetirizine|cetirizine|mesh-list
154698874|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154698875|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154698876|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154698877|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
154698878|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
154698879|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698880|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698881|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698882|NCT02795143|Isotretinoin|isotretinoin|mesh-list
154698883|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
154698884|NCT02790736|Propranolol|propranolol|mesh-list
154698885|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154698886|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154698887|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
154698888|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698889|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698890|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698891|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154698892|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154698893|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
154698894|NCT02704208|Nicotine|nicotine|mesh-list
154698895|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154698896|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
154698897|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698898|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698899|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154698900|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154698901|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
154698902|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154698903|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698904|NCT02516670|Vitamins|vitamins|mesh-list
154698905|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
154698906|NCT02516670|Docetaxel|docetaxel|mesh-list
154698907|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
154698908|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698909|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698910|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
154698911|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
154698912|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
154698913|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698914|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
154698915|NCT02516670|Protective Agents|protective agents|mesh-ancestor
154698916|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154698917|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154698918|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154698919|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698920|NCT02280525|Cytarabine|cytarabine|mesh-list
154698921|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
154698922|NCT02280525|Rituximab|rituximab|mesh-list
154698923|NCT02280525|Fludarabine|fludarabine|mesh-list
154698924|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
154698925|NCT02280525|Lenalidomide|lenalidomide|mesh-list
154698926|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154698927|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
154698928|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698929|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154698930|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154698931|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
154698932|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698933|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698934|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154698935|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154698936|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154698937|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
154698938|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
154698939|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154698940|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154698941|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154698942|NCT02280525|Growth Substances|growth substances|mesh-ancestor
154698943|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
154698944|NCT02066181|Sorafenib|sorafenib|mesh-list
154698945|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698946|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154698947|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698948|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698949|NCT01970865|Crizotinib|crizotinib|mesh-list
154698950|NCT01970865|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154698951|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154698952|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698953|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698954|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698955|NCT01928576|Nivolumab|nivolumab|mesh-list
154698956|NCT01928576|Azacitidine|azacitidine|mesh-list
154698957|NCT01928576|Entinostat|entinostat|mesh-list
154698958|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154698959|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698960|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154698961|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698962|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154698963|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
154698964|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698965|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154698966|NCT01843751|Buprenorphine|buprenorphine|mesh-list
154698967|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154698969|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154698970|NCT01843751|Narcotics|narcotics|mesh-ancestor
154698971|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154698972|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698973|NCT01843751|Analgesics|analgesics|mesh-ancestor
154698974|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
154698975|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154698976|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154698977|NCT01756248|Aflibercept|aflibercept|mesh-list
154698978|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154698979|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154698980|NCT01756248|Growth Substances|growth substances|mesh-ancestor
154698981|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154698982|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
154698983|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698984|NCT01744652|Dasatinib|dasatinib|mesh-list
154698985|NCT01744652|Crizotinib|crizotinib|mesh-list
154698986|NCT01744652|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154698987|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154698988|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154698989|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154698990|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154698991|NCT01711541|Paclitaxel|paclitaxel|mesh-list
154698992|NCT01711541|Cisplatin|cisplatin|mesh-list
154698993|NCT01711541|Carboplatin|carboplatin|mesh-list
154698994|NCT01711541|Fluorouracil|fluorouracil|mesh-list
154698995|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154698996|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
154698997|NCT01711541|Veliparib|veliparib|mesh-list
154698998|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154698999|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699000|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
154699001|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
154699002|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
154699003|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699004|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
154699005|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699006|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699007|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
154699008|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699009|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
154699010|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699011|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154699012|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154699013|NCT01370512|Droxidopa|droxidopa|mesh-list
154699014|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154699015|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154699016|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699017|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699018|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
154699019|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699020|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699021|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154699022|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154699023|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154699024|NCT00215813|Poly I-C|poly i-c|mesh-list
154699025|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
154699026|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699027|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
154699028|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
154699029|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699030|NCT00179465|Tiagabine|tiagabine|mesh-list
154699031|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
154699032|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154558055|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154699033|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699034|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699035|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154699036|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
154699037|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
154699038|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154699039|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699040|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699042|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699043|NCT00134030|Interferons|interferons|mesh-list
154699044|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
154699045|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
154699046|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154699047|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154699048|NCT00134030|Cisplatin|cisplatin|mesh-list
154699049|NCT00134030|Doxorubicin|doxorubicin|mesh-list
154699050|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154699051|NCT00134030|Methotrexate|methotrexate|mesh-list
154699052|NCT00134030|Etoposide|etoposide|mesh-list
154699053|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
154699054|NCT00134030|Ifosfamide|ifosfamide|mesh-list
154699055|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
154699056|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
154699057|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699058|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154699059|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154699060|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154699061|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699062|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699063|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154699064|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
154699065|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154699066|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699067|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699068|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
154699069|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
154699070|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154699071|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699072|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
154699073|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154699074|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154699075|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154699076|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
154699077|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699078|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154699079|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
154699080|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
154699081|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154699082|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154699083|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154699084|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
154699085|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154699086|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154699087|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699088|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
154699089|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
154699090|NCT01381900|Metformin|metformin|mesh-list
154699091|NCT01381900|Canagliflozin|canagliflozin|mesh-list
154699092|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154699093|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699094|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154699095|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699096|NCT01744665|Nilotinib|nilotinib|mesh-list
154699097|NCT01744665|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154699098|NCT01744665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699099|NCT01744665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699100|NCT01744665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699101|NCT01744197|Lidocaine|lidocaine|mesh-list
154699102|NCT01744197|Tetracaine|tetracaine|mesh-list
154699103|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
154699104|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
154699105|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699106|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699107|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
154699108|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699109|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154699110|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154699111|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154699112|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699113|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699114|NCT04565301|Dexamethasone|dexamethasone|mesh-list
154699115|NCT04565301|Neostigmine|neostigmine|mesh-list
154699116|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154699117|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
154699118|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
154699119|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699120|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699121|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154699122|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
154699123|NCT04565301|Hormones|hormones|mesh-ancestor
154699124|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699125|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154699126|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699127|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154699128|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699129|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699130|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
154699131|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699132|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154699133|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154699134|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154699135|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154699136|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154699137|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154699138|NCT01743027|Analgesics|analgesics|mesh-ancestor
154699139|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
154699140|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699141|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699142|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154699143|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154699144|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154699145|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154699146|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154699147|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
154699148|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
154699149|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699150|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699151|NCT01380730|Evolocumab|evolocumab|mesh-list
154699152|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154699153|NCT01380730|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154699154|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154699155|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154699156|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
154699157|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699158|NCT01380730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154699159|NCT01380730|Protease Inhibitors|protease inhibitors|mesh-ancestor
154699160|NCT01380730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699161|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154699162|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
154699163|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699164|NCT04010968|Venetoclax|venetoclax|mesh-list
154699165|NCT04010968|Ibrutinib|ibrutinib|mesh-list
154699166|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699167|NCT04010968|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154699168|NCT04010968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699169|NCT04010968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699170|NCT04010968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699171|NCT01395784|Pioglitazone|pioglitazone|mesh-list
154699172|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154699173|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699174|NCT01380184|Sirolimus|sirolimus|mesh-list
154699175|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154699176|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699177|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154699178|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699179|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
154699180|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699181|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
154451170|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699182|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699183|NCT00002826|Paclitaxel|paclitaxel|mesh-list
154699184|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154699186|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
154699187|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
154699188|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
154699189|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699190|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
154699191|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154699192|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699193|NCT04331938|Anesthetics|anesthetics|mesh-list
154699194|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699195|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699196|NCT01731951|Imetelstat|imetelstat|mesh-list
154699197|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
154699198|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699199|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699200|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699201|NCT01741545|Interferons|interferons|mesh-list
154699202|NCT01741545|Ribavirin|ribavirin|mesh-list
154699203|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699204|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
154699205|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699206|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
154699207|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699208|NCT01884350|Apixaban|apixaban|mesh-list
154699209|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154699210|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
154699211|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154699212|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
154699213|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699214|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699215|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
154699216|NCT01614795|Sirolimus|sirolimus|mesh-list
154699217|NCT01614795|Temsirolimus|temsirolimus|mesh-list
154699218|NCT01614795|MTOR Inhibitors|mtor inhibitors|mesh-list
154699219|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154699220|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154699221|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699222|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154699223|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699224|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
154699225|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699226|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
154699227|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699228|NCT01614795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699229|NCT01614795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699230|NCT01614795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699231|NCT01834586|Anesthetics|anesthetics|mesh-list
154699232|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699233|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699234|NCT01614093|Oxytocin|oxytocin|mesh-list
154699235|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
154699236|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154699237|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699238|NCT01834274|Metformin|metformin|mesh-list
154699239|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154699240|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154699241|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699242|NCT01834274|Incretins|incretins|mesh-ancestor
154699243|NCT01834274|Hormones|hormones|mesh-ancestor
154699244|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699245|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154699246|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
154699247|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699248|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699249|NCT01739595|Enclomiphene|enclomiphene|mesh-list
154699250|NCT01739595|Clomiphene|clomiphene|mesh-list
154699251|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
154699252|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154699253|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
154699254|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699255|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699256|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154699257|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
154451238|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154451239|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699258|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154699259|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154699260|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154699261|NCT01738971|Progestins|progestins|mesh-list
154699262|NCT01738971|Hormones|hormones|mesh-ancestor
154699263|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699264|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699265|NCT01738503|Buprenorphine|buprenorphine|mesh-list
154699266|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154699267|NCT01738503|Narcotics|narcotics|mesh-ancestor
154699268|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699269|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699270|NCT01738503|Analgesics|analgesics|mesh-ancestor
154699271|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
154699272|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699273|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154699274|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154699275|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154699276|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154699277|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699278|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699279|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
154699280|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699281|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699282|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
154699283|NCT01737879|Hematinics|hematinics|mesh-ancestor
154699284|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
154699285|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154699286|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699287|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699288|NCT01726335|Risperidone|risperidone|mesh-list
154699289|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154699290|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
154699291|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699292|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699293|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699294|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154699295|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154699296|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699297|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154699298|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154699299|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
154699300|NCT01726023|Metronidazole|metronidazole|mesh-list
154699301|NCT01726023|Meropenem|meropenem|mesh-list
154699302|NCT01726023|Ceftazidime|ceftazidime|mesh-list
154699303|NCT01726023|Avibactam|avibactam|mesh-list
154699304|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154699305|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699306|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154699307|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154699308|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154699309|NCT01726023|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154699310|NCT01726023|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154699311|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154699312|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699313|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699314|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
154699315|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699316|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
154699317|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154699318|NCT04609761|Antibodies|antibodies|mesh-list
154699319|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
154699320|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154699321|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
154699322|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699323|NCT01858532|Atrasentan|atrasentan|mesh-list
154699324|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699325|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154699326|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154699327|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699328|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
154699329|NCT04613960|Analgesics|analgesics|mesh-ancestor
154699330|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
154699331|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451323|NCT06160843|Olaparib|olaparib|mesh-list
154699332|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699333|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
154699334|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699335|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154699336|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
154699337|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154699338|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699339|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699340|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154699341|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
154699342|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154699343|NCT01857206|Vaccines|vaccines|mesh-list
154699344|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
154699345|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699346|NCT01882088|Psyllium|psyllium|mesh-list
154699347|NCT01882088|Cathartics|cathartics|mesh-ancestor
154699348|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154699349|NCT01722669|Quercetin|quercetin|mesh-list
154699350|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
154699351|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699352|NCT01722669|Protective Agents|protective agents|mesh-ancestor
154699353|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699354|NCT01707147|Linagliptin|linagliptin|mesh-list
154699355|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154699356|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699357|NCT01707147|Incretins|incretins|mesh-ancestor
154699358|NCT01707147|Hormones|hormones|mesh-ancestor
154699359|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699360|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154699361|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
154699362|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699363|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699364|NCT01876251|Docetaxel|docetaxel|mesh-list
154699365|NCT01876251|Nirogacestat|nirogacestat|mesh-list
154699366|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699367|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154699368|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154699369|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154699370|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699371|NCT01876251|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154699372|NCT01876251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699373|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
154699374|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154699375|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154699376|NCT01875237|Prednisolone|prednisolone|mesh-list
154699377|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
154699378|NCT01875237|Methotrexate|methotrexate|mesh-list
154699379|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
154699380|NCT01875237|Fludarabine|fludarabine|mesh-list
154699381|NCT01875237|Melphalan|melphalan|mesh-list
154699382|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
154699383|NCT01875237|Tacrolimus|tacrolimus|mesh-list
154699384|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154699385|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
154699386|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154699387|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
154699388|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154699389|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699390|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699391|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
154699392|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699393|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699394|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
154699395|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699396|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154699397|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699398|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
154699399|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154699400|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154699401|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154699402|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154699403|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
154699404|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
154699405|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699406|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451388|NCT06160232|Psilocybin|psilocybin|mesh-list
154699408|NCT01875237|Hormones|hormones|mesh-ancestor
154699409|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699410|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154699411|NCT01875237|Protective Agents|protective agents|mesh-ancestor
154699412|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154699413|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154699414|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
154699415|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154699416|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154699417|NCT01874535|Esomeprazole|esomeprazole|mesh-list
154699418|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154699419|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154699420|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154699421|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699422|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699423|NCT01722045|Aflibercept|aflibercept|mesh-list
154699424|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154699425|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154699426|NCT01722045|Growth Substances|growth substances|mesh-ancestor
154699427|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699428|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
154699429|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699430|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154699431|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154699432|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154699433|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
154699434|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699435|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
154699436|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
154699437|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154699438|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
154699439|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699440|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699441|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154699442|NCT04415385|Apatinib|apatinib|mesh-list
154699443|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699444|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699445|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699446|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699447|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
154699448|NCT01720797|Anesthetics|anesthetics|mesh-list
154699449|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
154699450|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699451|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699452|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154699453|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699454|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
154699455|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
154699456|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699457|NCT01831466|Tofacitinib|tofacitinib|mesh-list
154699458|NCT01831466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154699459|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699460|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699461|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699462|NCT01881230|Paclitaxel|paclitaxel|mesh-list
154699463|NCT01881230|Carboplatin|carboplatin|mesh-list
154699464|NCT01881230|Gemcitabine|gemcitabine|mesh-list
154699465|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154699466|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699467|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
154699468|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
154699469|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
154699470|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699471|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699472|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
154699473|NCT01856114|Fentanyl|fentanyl|mesh-list
154699474|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154699475|NCT01856114|Narcotics|narcotics|mesh-ancestor
154699476|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699477|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699478|NCT01856114|Analgesics|analgesics|mesh-ancestor
154699479|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
154451466|NCT06153368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154699480|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699481|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154699482|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154699483|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
154699484|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
154699485|NCT01614470|Ivacaftor|ivacaftor|mesh-list
154699486|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154699487|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699488|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699489|NCT01880528|Lisinopril|lisinopril|mesh-list
154699490|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154699491|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
154699492|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699493|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699494|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154699495|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154699496|NCT01880528|Protective Agents|protective agents|mesh-ancestor
154699497|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699498|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
154699499|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
154699500|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699501|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699502|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699503|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
154699504|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
154699505|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
154699506|NCT01854710|Loxapine|loxapine|mesh-list
154699507|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154699508|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699509|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154699510|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154699511|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699512|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699513|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699514|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699515|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154699516|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154699517|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699518|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154699519|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154699520|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
154699521|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699522|NCT01828034|Gemcitabine|gemcitabine|mesh-list
154699523|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699524|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699525|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
154699526|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699527|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154699528|NCT01853696|Prednisolone|prednisolone|mesh-list
154699529|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154699530|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
154699531|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154699532|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
154699533|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154699534|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
154699535|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154699536|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
154699537|NCT01853696|Hormones|hormones|mesh-ancestor
154699538|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699539|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699540|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154699541|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699542|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
154699543|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
153954391|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
154699544|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699545|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154699546|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154699547|NCT01853696|Protective Agents|protective agents|mesh-ancestor
154699548|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154699549|NCT01871805|Alectinib|alectinib|mesh-list
154699550|NCT01871805|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154699551|NCT01871805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699552|NCT01871805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699553|NCT01871805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699554|NCT01719861|Desipramine|desipramine|mesh-list
154699555|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154699556|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
154699557|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154699558|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699559|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699560|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154699561|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154699562|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699563|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
154699564|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699565|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699566|NCT01853618|Tremelimumab|tremelimumab|mesh-list
154699567|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699568|NCT01719783|Vaccines|vaccines|mesh-list
154699569|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
154699570|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699571|NCT01878890|Efavirenz|efavirenz|mesh-list
154699572|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154699573|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154699574|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699575|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699576|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
154699577|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699578|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154699579|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154699580|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154699581|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154699582|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154699583|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154699584|NCT01827332|Oxytocin|oxytocin|mesh-list
154699585|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
154699586|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154699587|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699588|NCT01719003|Metformin|metformin|mesh-list
154699589|NCT01719003|Empagliflozin|empagliflozin|mesh-list
154699590|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154699591|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699592|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154699593|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699594|NCT01853228|Cytarabine|cytarabine|mesh-list
154699595|NCT01853228|Decitabine|decitabine|mesh-list
154699596|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699597|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
154699598|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699599|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699600|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
154699601|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699602|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699603|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
154699604|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699605|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699606|NCT01705587|Teriparatide|teriparatide|mesh-list
154699607|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154699608|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699609|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154699610|NCT01705509|Ranolazine|ranolazine|mesh-list
154699611|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154699612|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699613|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699614|NCT01853072|Prednisolone|prednisolone|mesh-list
154699615|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154699616|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
154699617|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154699618|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
154699619|NCT01853072|Nepafenac|nepafenac|mesh-list
154699620|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154699621|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
154699622|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154699623|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
154699624|NCT01853072|Hormones|hormones|mesh-ancestor
154699625|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699626|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699627|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154699628|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699629|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
154699630|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
154699631|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699632|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154699633|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154699634|NCT01853072|Protective Agents|protective agents|mesh-ancestor
154699635|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154699636|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154699637|NCT01853072|Analgesics|analgesics|mesh-ancestor
154699638|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
154699639|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154699640|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
154699641|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154699642|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154699643|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
154699644|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699645|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154699646|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154699647|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699648|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699649|NCT01827254|Sunitinib|sunitinib|mesh-list
154699650|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699651|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154699652|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154699653|NCT01827254|Growth Substances|growth substances|mesh-ancestor
154699654|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699655|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
154699656|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699657|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699658|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699659|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154699660|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
154699661|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154699662|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154699663|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699664|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699665|NCT01704651|Alvimopan|alvimopan|mesh-list
154699666|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154699667|NCT01876082|Methotrexate|methotrexate|mesh-list
154699668|NCT01876082|Vinblastine|vinblastine|mesh-list
154699669|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154699670|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
154699671|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154699672|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699673|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699674|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
154699675|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699676|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699677|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
154699678|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699679|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154699680|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699681|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
154699682|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154699683|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154699684|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154699685|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
154699686|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
154699687|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
154699688|NCT01716585|Ribavirin|ribavirin|mesh-list
154699689|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
154699690|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699691|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
154699692|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699693|NCT01852292|Paclitaxel|paclitaxel|mesh-list
154699694|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154699695|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699696|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
154699697|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
154699698|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
154699699|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699700|NCT01715805|Cariprazine|cariprazine|mesh-list
154699701|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
154451710|NCT05590416|Adalimumab|adalimumab|mesh-list
154699702|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154699703|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154699704|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154699705|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699706|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699707|NCT01852214|Ticagrelor|ticagrelor|mesh-list
154699708|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154699709|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154699710|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154699711|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154699712|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154699713|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
154699714|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699715|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699716|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699717|NCT01393990|Tamoxifen|tamoxifen|mesh-list
154699718|NCT01393990|Midazolam|midazolam|mesh-list
154699719|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154699720|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154699721|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699722|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699723|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154699724|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154699725|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154699726|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154699727|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
154699728|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
154699729|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
154699730|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
154699731|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699732|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699733|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154699734|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
154699735|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699736|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153954594|NCT01093586|Hormones|hormones|mesh-ancestor
154699737|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699738|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154699739|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154699740|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154699741|NCT00210184|Leucovorin|leucovorin|mesh-list
154699742|NCT00210184|Fluorouracil|fluorouracil|mesh-list
154699743|NCT00210184|Irinotecan|irinotecan|mesh-list
154699744|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
154699745|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699746|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699747|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699748|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154699749|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
154699750|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699751|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154699752|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154699753|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699754|NCT00210184|Antidotes|antidotes|mesh-ancestor
154699755|NCT00210184|Protective Agents|protective agents|mesh-ancestor
154699756|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
154699757|NCT00210184|Vitamins|vitamins|mesh-ancestor
154699758|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
154699759|NCT00210964|Linezolid|linezolid|mesh-list
154699760|NCT00210964|Ceftazidime|ceftazidime|mesh-list
154699761|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
154699762|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154699763|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154699764|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699765|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154699766|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699767|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699768|NCT00210964|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154699769|NCT00210964|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154699770|NCT03593434|Xenon|xenon|mesh-list
154699771|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154699772|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
154699773|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
154699774|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699775|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699776|NCT03792958|Vorolanib|vorolanib|mesh-list
154451763|NCT05461508|Amoxicillin|amoxicillin|mesh-list
154699777|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699778|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699779|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699780|NCT03989362|Ipilimumab|ipilimumab|mesh-list
154699781|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154699782|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699783|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154699784|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699785|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
154699786|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
154699787|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154699788|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
154699789|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154699790|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154699791|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699792|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154699793|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699794|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699795|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154699796|NCT04407130|Doxycycline|doxycycline|mesh-list
154699797|NCT04407130|Ivermectin|ivermectin|mesh-list
154699798|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154699799|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699800|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
154699801|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154699802|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154699803|NCT03599284|Clopidogrel|clopidogrel|mesh-list
154699804|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154699805|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154699806|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154699807|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154699808|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
154699809|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699810|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699811|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699812|NCT03024814|Acetaminophen|acetaminophen|mesh-list
154699813|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154699814|NCT03024814|Analgesics|analgesics|mesh-ancestor
154699815|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
154699816|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699817|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699818|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
154699819|NCT03024502|Clotrimazole|clotrimazole|mesh-list
154699820|NCT03024502|Miconazole|miconazole|mesh-list
154699821|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154699822|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699823|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
154699824|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154699825|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154699826|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699827|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699828|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154699829|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
154699830|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699831|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699832|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154699833|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154699834|NCT03024580|Tamoxifen|tamoxifen|mesh-list
154699835|NCT03024580|Letrozole|letrozole|mesh-list
154699836|NCT03024580|Fulvestrant|fulvestrant|mesh-list
154699837|NCT03024580|Anastrozole|anastrozole|mesh-list
154699838|NCT03024580|Exemestane|exemestane|mesh-list
154699839|NCT03024580|Megestrol|megestrol|mesh-list
154699840|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
154699841|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699842|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154699843|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154699844|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699845|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699846|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154699847|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
154699848|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699849|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699850|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154699851|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154699852|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154699853|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154699854|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154699855|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154699856|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154699857|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154699858|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
154699859|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153954707|NCT00688948|Alfuzosin|alfuzosin|mesh-list
154699860|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154699861|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154699862|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
154699863|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154699864|NCT01851590|Terbinafine|terbinafine|mesh-list
154699865|NCT01851590|Amorolfine|amorolfine|mesh-list
154699866|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
154699867|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154699868|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699869|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699870|NCT03598816|Durvalumab|durvalumab|mesh-list
154699871|NCT03598816|Tremelimumab|tremelimumab|mesh-list
154699872|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154699873|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699874|NCT05633758|Metolazone|metolazone|mesh-list
154699875|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154699876|NCT05633758|Diuretics|diuretics|mesh-ancestor
154699877|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
154699878|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699879|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154699880|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154699881|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699882|NCT03598738|Esomeprazole|esomeprazole|mesh-list
154699883|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154699884|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154699885|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154699886|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699887|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699888|NCT03594214|Vitamin D|vitamin d|mesh-list
154699889|NCT03594214|Vitamins|vitamins|mesh-ancestor
154699890|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
154699891|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699892|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154699893|NCT04003948|Ibogaine|ibogaine|mesh-list
154699894|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
154699895|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699896|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154699897|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154699898|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154699899|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699900|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699901|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
154699902|NCT03598582|Hematinics|hematinics|mesh-ancestor
154699903|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
154699904|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154699905|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154699906|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154699907|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153954777|NCT00691912|Paclitaxel|paclitaxel|mesh-list
154699908|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699909|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
154699910|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699911|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699912|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154699913|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699914|NCT03593668|Metformin|metformin|mesh-list
154699915|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154699916|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699917|NCT03598348|Capecitabine|capecitabine|mesh-list
154699918|NCT03598348|Apatinib|apatinib|mesh-list
154699919|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699920|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
154699921|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699922|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699923|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154699924|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699925|NCT03598192|Sufentanil|sufentanil|mesh-list
154699926|NCT03598192|Dsuvia|dsuvia|mesh-list
154699927|NCT03598192|Ropivacaine|ropivacaine|mesh-list
154699928|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
154699929|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
154699930|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154699931|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699932|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
154699933|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699934|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154699935|NCT03598192|Narcotics|narcotics|mesh-ancestor
154699936|NCT03598192|Analgesics|analgesics|mesh-ancestor
154699937|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154699938|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154699939|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
154699940|NCT04003246|Durvalumab|durvalumab|mesh-list
154699941|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154699942|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154699943|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699944|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
154699945|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699946|NCT00218296|Lobeline|lobeline|mesh-list
154699947|NCT00218296|Nicotine|nicotine|mesh-list
154699948|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154699949|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
154699950|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699951|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699952|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154699953|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154699954|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
154699955|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154699956|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699957|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
154699958|NCT00217672|Bevacizumab|bevacizumab|mesh-list
154699959|NCT00217672|Docetaxel|docetaxel|mesh-list
154699960|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154699961|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699962|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154699963|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153954839|NCT00694252|Lapatinib|lapatinib|mesh-list
154699964|NCT00217672|Growth Substances|growth substances|mesh-ancestor
154699965|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699966|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
154699967|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
154699968|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
154699969|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
154699970|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699971|NCT00216736|Dexamethasone|dexamethasone|mesh-list
154699972|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154699973|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
154699974|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
154699975|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154699976|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699977|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154699978|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
154699979|NCT00216736|Hormones|hormones|mesh-ancestor
154699980|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699981|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154699982|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699983|NCT01850030|Progesterone|progesterone|mesh-list
154699984|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
154699985|NCT01850030|Progestins|progestins|mesh-ancestor
154699986|NCT01850030|Hormones|hormones|mesh-ancestor
154699987|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154699988|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154699989|NCT00215644|Capecitabine|capecitabine|mesh-list
154699990|NCT00215644|Epirubicin|epirubicin|mesh-list
154699991|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154699992|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154699993|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
154699994|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154699995|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154699996|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154699997|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154699998|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154699999|NCT00213148|Anastrozole|anastrozole|mesh-list
154700000|NCT00213148|Citric Acid|citric acid|mesh-list
154700001|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
154700002|NCT00213148|Clomiphene|clomiphene|mesh-list
154700003|NCT00213148|Enclomiphene|enclomiphene|mesh-list
154700004|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
154700005|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
154700006|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154700007|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
154700008|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
154700009|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700010|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700011|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700012|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154700013|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154700014|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700015|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154700016|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
154700017|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700018|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700019|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154700020|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
154700021|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154700022|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154700023|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154700024|NCT01704261|Metformin|metformin|mesh-list
154700025|NCT01704261|Glimepiride|glimepiride|mesh-list
154700026|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154700027|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700028|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154700029|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154700030|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
154700031|NCT00212758|Hormones|hormones|mesh-list
154700032|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954884|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
154700033|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700034|NCT01824290|Tadalafil|tadalafil|mesh-list
154700035|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
154700036|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154700037|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154700038|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700039|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700040|NCT01824290|Urological Agents|urological agents|mesh-ancestor
154700041|NCT03592342|Clobetasol|clobetasol|mesh-list
154700042|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700043|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
154700044|NCT03592342|Hormones|hormones|mesh-ancestor
154700045|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700046|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700047|NCT01715415|Ribavirin|ribavirin|mesh-list
154700048|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
154700049|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700050|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
154700051|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700052|NCT00211510|Insulin|insulin|mesh-list
154700053|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154700054|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700055|NCT04198636|Denosumab|denosumab|mesh-list
154700056|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154700057|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700058|NCT04414995|Acetaminophen|acetaminophen|mesh-list
154700059|NCT04414995|Ibuprofen|ibuprofen|mesh-list
154700060|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154700061|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154700062|NCT04414995|Analgesics|analgesics|mesh-ancestor
154700063|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
154700064|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700065|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700066|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700067|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154700068|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154700069|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700070|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700071|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
154700072|NCT01869699|Acetaminophen|acetaminophen|mesh-list
154700073|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154700074|NCT01869699|Analgesics|analgesics|mesh-ancestor
154700075|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
154700076|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700077|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700079|NCT01875848|Buprenorphine|buprenorphine|mesh-list
154700080|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154700081|NCT01875848|Naloxone|naloxone|mesh-list
154700082|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154700083|NCT01875848|Narcotics|narcotics|mesh-ancestor
154700084|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700085|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700086|NCT01875848|Analgesics|analgesics|mesh-ancestor
154700087|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
154700088|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700089|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154700090|NCT03591172|Propolis|propolis|mesh-list
154700091|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700092|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154700093|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154700094|NCT04197622|Diuretics|diuretics|mesh-ancestor
154700095|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
154700096|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700097|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154700098|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154700099|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700100|NCT03595930|Fluticasone|fluticasone|mesh-list
154700101|NCT03595930|Xhance|xhance|mesh-list
154700102|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700103|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154700104|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
154700105|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700106|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700107|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154700108|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154700109|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
154700110|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154700111|NCT03595852|Cefazolin|cefazolin|mesh-list
154700112|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154700113|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700114|NCT04191382|Letrozole|letrozole|mesh-list
154700115|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700116|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154700117|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154700118|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700119|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700120|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154700121|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
154700122|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700123|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700124|NCT01703091|Docetaxel|docetaxel|mesh-list
154700125|NCT01703091|Ramucirumab|ramucirumab|mesh-list
154700126|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700127|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
154700128|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
154700129|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
154700130|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700131|NCT01703091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154700132|NCT01703091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154700133|NCT01703091|Growth Substances|growth substances|mesh-ancestor
154700134|NCT01703091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700135|NCT01703091|Growth Inhibitors|growth inhibitors|mesh-ancestor
154700136|NCT04196998|Tenofovir|tenofovir|mesh-list
154700137|NCT04196998|Entecavir|entecavir|mesh-list
154700138|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
154700139|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700140|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154700141|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154700142|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700143|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700144|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154700145|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154700146|NCT04196452|Ipilimumab|ipilimumab|mesh-list
154700147|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700148|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700149|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154700150|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700151|NCT01867671|Immunomodulating Agents|immunomodulating agents|mesh-list
154700152|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
154700153|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700154|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
154700155|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154700156|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700157|NCT04196608|Tazobactam|tazobactam|mesh-list
154700158|NCT04196608|Imipenem|imipenem|mesh-list
154700159|NCT04196608|Ceftolozane|ceftolozane|mesh-list
154700160|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154700161|NCT04196608|Relebactam|relebactam|mesh-list
154700162|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154700163|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700164|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154700165|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700166|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700167|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154700168|NCT04022200|Paclitaxel|paclitaxel|mesh-list
154700169|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154700170|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700171|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
154700172|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
154700173|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
154700174|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700175|NCT04552743|Plerixafor|plerixafor|mesh-list
154700176|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154700177|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154700178|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
154700179|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700180|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
154700181|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154700182|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154700183|NCT03590080|Prednisolone|prednisolone|mesh-list
154700184|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
154700185|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154700186|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
154700187|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700188|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
154700189|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
154700190|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700191|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700192|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700193|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
154700194|NCT03590080|Hormones|hormones|mesh-ancestor
154700195|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700196|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154700197|NCT03590080|Protective Agents|protective agents|mesh-ancestor
154700198|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700199|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700200|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154700201|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154700202|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700203|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700204|NCT03594058|Solabegron|solabegron|mesh-list
154700205|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154700206|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154700207|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154700208|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
154700209|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700210|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700211|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700212|NCT04194658|Letrozole|letrozole|mesh-list
154700213|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700214|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154700215|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154700216|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700217|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700218|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154700219|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
154700220|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700221|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700222|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154700223|NCT04028518|Plasminogen|plasminogen|mesh-list
154700224|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154700225|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154700226|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700227|NCT04747678|Ivermectin|ivermectin|mesh-list
154700228|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154700229|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700230|NCT04191928|Apixaban|apixaban|mesh-list
154700231|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154700232|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
154700233|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154700234|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
154700235|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700236|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700237|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
154700238|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154700239|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700240|NCT04027192|Midazolam|midazolam|mesh-list
154700241|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154700242|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154700243|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700244|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700245|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154700246|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154700247|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154700248|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154700249|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
154700250|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
154700251|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
154700252|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
154700253|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700254|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700255|NCT04406506|Erythromycin|erythromycin|mesh-list
154700256|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
154700257|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154700258|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
154700259|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154700260|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700261|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700262|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154700263|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700264|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700265|NCT04191694|Ondansetron|ondansetron|mesh-list
154700266|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
154700267|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
154700268|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700269|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700270|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700271|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
154700272|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
154700273|NCT04191694|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154700274|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154700275|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
154700276|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700277|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700278|NCT04026022|Fentanyl|fentanyl|mesh-list
154700279|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154700280|NCT04026022|Narcotics|narcotics|mesh-ancestor
154700281|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700282|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700283|NCT04026022|Analgesics|analgesics|mesh-ancestor
154700284|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
154700285|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700286|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154700287|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154700288|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
154700289|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
154700290|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154700291|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700292|NCT04020328|Prednisone|prednisone|mesh-list
154700293|NCT04020328|Leflunomide|leflunomide|mesh-list
154700294|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700295|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
154700296|NCT04020328|Hormones|hormones|mesh-ancestor
154700297|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700298|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700299|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700300|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700301|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700302|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700303|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154700304|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
154700306|NCT04020094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154700307|NCT04020094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700308|NCT04020094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700309|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700310|NCT02080468|Norgestimate|norgestimate|mesh-list
154700311|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154700312|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
154700313|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154700314|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700315|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154700316|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154700317|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154700318|NCT04020016|Nalbuphine|nalbuphine|mesh-list
154700319|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154700320|NCT04020016|Narcotics|narcotics|mesh-ancestor
154700321|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700322|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700323|NCT04020016|Analgesics|analgesics|mesh-ancestor
154700324|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
154700325|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700326|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154700327|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154700328|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154700329|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
154700330|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700331|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700332|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700333|NCT01874054|Immunotoxins|immunotoxins|mesh-ancestor
154700334|NCT01874054|Immunoconjugates|immunoconjugates|mesh-ancestor
154700335|NCT01874054|Immunologic Factors|immunologic factors|mesh-ancestor
154700336|NCT01874054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700337|NCT04029610|Lidocaine|lidocaine|mesh-list
154700338|NCT04029610|Epinephrine|epinephrine|mesh-list
154700339|NCT04029610|Racepinephrine|racepinephrine|mesh-list
154700340|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
154700341|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
154700342|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
154700343|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700344|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700345|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
154700346|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700347|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154700348|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154700349|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154700350|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154700351|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700352|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154700353|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154700354|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
154700355|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700356|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154700357|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154700358|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
154700359|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154700360|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
154700361|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
154700362|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
154700363|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154700364|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
154700365|NCT04026880|Testosterone|testosterone|mesh-list
154700366|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
154700367|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
154700368|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154700369|NCT04026880|Androgens|androgens|mesh-ancestor
154700370|NCT04026880|Hormones|hormones|mesh-ancestor
153955223|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
154700371|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700372|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700373|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700374|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700375|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
154700376|NCT04024384|Daratumumab|daratumumab|mesh-list
154700377|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700378|NCT04023760|Apixaban|apixaban|mesh-list
154700379|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154700380|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
154700381|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154700382|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
154700383|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700384|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700385|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
154700386|NCT04020718|Nicotine|nicotine|mesh-list
154700387|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154700388|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
154700389|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700390|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700391|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154700392|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154700393|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
154700394|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700395|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700396|NCT04027348|Dexamethasone|dexamethasone|mesh-list
154700397|NCT04027348|Octreotide|octreotide|mesh-list
154700398|NCT04027348|Metoclopramide|metoclopramide|mesh-list
154700399|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700400|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
154700401|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
154700402|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700403|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700404|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700405|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
154700406|NCT04027348|Hormones|hormones|mesh-ancestor
154700407|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700408|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700409|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700410|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154700411|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154700412|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
154700413|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700414|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700415|NCT04195204|Tropisetron|tropisetron|mesh-list
154700416|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
154700417|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
154700418|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700419|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700420|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700421|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154700422|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154700423|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
154700424|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700425|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700426|NCT04023292|Tamoxifen|tamoxifen|mesh-list
154700427|NCT04023292|Letrozole|letrozole|mesh-list
154700428|NCT04023292|Exemestane|exemestane|mesh-list
154700429|NCT04023292|Anastrozole|anastrozole|mesh-list
154700430|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700431|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154700432|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154700433|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700434|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700435|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154700436|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
154700437|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700438|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700439|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700440|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154700441|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154700442|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154700443|NCT03022240|Ondansetron|ondansetron|mesh-list
154700444|NCT03022240|Propofol|propofol|mesh-list
154700445|NCT03022240|Sevoflurane|sevoflurane|mesh-list
154700446|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154700447|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700448|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700449|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154700450|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
154700451|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
154700452|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154700453|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154700455|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
154700456|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700457|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700458|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
154700459|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
154700460|NCT03022240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154700461|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154700462|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
154700463|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700464|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700465|NCT02704390|Methylphenidate|methylphenidate|mesh-list
154700466|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154700467|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700468|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154700469|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154700470|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154700471|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700472|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
154700473|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700474|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
154700475|NCT04147390|Tacrolimus|tacrolimus|mesh-list
154700476|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154700477|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
154700478|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700479|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154700480|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700481|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700482|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154700483|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700484|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154700485|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
154700486|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154700487|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700488|NCT02708680|Atezolizumab|atezolizumab|mesh-list
154700489|NCT02708680|Entinostat|entinostat|mesh-list
154700490|NCT02708680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154700491|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700492|NCT02708680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700493|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700494|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154700495|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700496|NCT03931642|Blinatumomab|blinatumomab|mesh-list
154700497|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700498|NCT04021420|Nivolumab|nivolumab|mesh-list
154700499|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700500|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700501|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154700502|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700503|NCT04144582|Docetaxel|docetaxel|mesh-list
154700504|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700505|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
154700506|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
154700507|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
154700508|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700509|NCT01611974|Maribavir|maribavir|mesh-list
154700510|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
154700511|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700512|NCT01871870|Pancrelipase|pancrelipase|mesh-list
154700513|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700514|NCT02080780|Clarithromycin|clarithromycin|mesh-list
154700515|NCT02080780|Diltiazem|diltiazem|mesh-list
154700516|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154700517|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700518|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154700519|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700520|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700521|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154700522|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154700523|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154700524|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153955404|NCT02622802|Acetaminophen|acetaminophen|mesh-list
154700525|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154700526|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154700527|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700528|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
154700529|NCT01871558|Metformin|metformin|mesh-list
154700530|NCT01871558|Vildagliptin|vildagliptin|mesh-list
154700531|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154700532|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700533|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154700534|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
154700535|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700536|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700537|NCT01711359|Folic Acid|folic acid|mesh-list
154700538|NCT01711359|Methotrexate|methotrexate|mesh-list
154700539|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154700540|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
154700541|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154700542|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700543|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154700544|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
154700545|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700546|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700547|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
154700548|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700549|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154700550|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154700551|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
154700552|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154700553|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154700554|NCT01711359|Hematinics|hematinics|mesh-ancestor
154700555|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
154700556|NCT01711359|Vitamins|vitamins|mesh-ancestor
154700557|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
154700558|NCT04140136|Tocotrienols|tocotrienols|mesh-list
154700559|NCT04140136|Vitamin E|vitamin e|mesh-list
154700560|NCT04140136|Tocopherols|tocopherols|mesh-list
154700561|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
154700562|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700563|NCT04140136|Protective Agents|protective agents|mesh-ancestor
154700564|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700565|NCT04140136|Vitamins|vitamins|mesh-ancestor
154700566|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
154700567|NCT04146532|Aspirin|aspirin|mesh-list
154700568|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154700569|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154700570|NCT04146532|Analgesics|analgesics|mesh-ancestor
154700571|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
154700572|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700573|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700574|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700575|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154700576|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154700577|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154700578|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700579|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154700580|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154700581|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700582|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
154700583|NCT03929224|Bacitracin|bacitracin|mesh-list
154700584|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154700585|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700586|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154700587|NCT04146610|Antibodies|antibodies|mesh-list
154700588|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
154700589|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
154700590|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700591|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
154700592|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154700593|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153955444|NCT00675688|Estrogens|estrogens|mesh-list
154700594|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700595|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
154700596|NCT04146376|Coagulants|coagulants|mesh-ancestor
154700597|NCT01710657|Lacosamide|lacosamide|mesh-list
154700598|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
154700599|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154700600|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154700601|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154700602|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700603|NCT03021772|Dexamethasone|dexamethasone|mesh-list
154700604|NCT03021772|Neostigmine|neostigmine|mesh-list
154700605|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700606|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
154700607|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
154700608|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700609|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700610|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700611|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
154700612|NCT03021772|Hormones|hormones|mesh-ancestor
154700613|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700614|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700615|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700616|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154700617|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700618|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700619|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
154700620|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700621|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154700622|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
154700623|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154700624|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700625|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
154700626|NCT05581420|Trace Elements|trace elements|mesh-ancestor
154700627|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
154700628|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700629|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
154700630|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154700631|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154700632|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700633|NCT04405960|Vitamins|vitamins|mesh-ancestor
154700634|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
154700635|NCT03945604|Apatinib|apatinib|mesh-list
154700636|NCT03945604|Fluzoparib|fluzoparib|mesh-list
154700637|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700638|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154700639|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700640|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700641|NCT03945604|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154700642|NCT03944356|Trametinib|trametinib|mesh-list
154700643|NCT03944356|Dabrafenib|dabrafenib|mesh-list
154700644|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700645|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154700646|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700647|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700648|NCT01701063|Ribavirin|ribavirin|mesh-list
154700649|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154700650|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
154700651|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700652|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
154700653|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700654|NCT03920722|Rituximab|rituximab|mesh-list
154700655|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700656|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700657|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
154700658|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700659|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154700660|NCT05580094|Anesthetics|anesthetics|mesh-list
154700661|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700662|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700663|NCT05586100|Cetuximab|cetuximab|mesh-list
154700664|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700665|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700666|NCT05585086|Peppermint oil|peppermint oil|mesh-list
154700667|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
154700668|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
154700669|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700670|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700671|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700672|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
154700673|NCT01710501|Interferons|interferons|mesh-list
154700674|NCT01710501|Ribavirin|ribavirin|mesh-list
154700675|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
154700676|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
154700677|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154700678|NCT01710501|Grazoprevir|grazoprevir|mesh-list
154700679|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700680|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
154700681|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700682|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
154700683|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700684|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
154700685|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700686|NCT05583058|Hormones|hormones|mesh-list
154700687|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700688|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700689|NCT01700829|Midazolam|midazolam|mesh-list
154700690|NCT01700829|Ketamine|ketamine|mesh-list
154700691|NCT01700829|Analgesics|analgesics|mesh-ancestor
154700692|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
154700693|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700694|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700695|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154700696|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154700697|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
154700698|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
154700699|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700700|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154700701|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154700702|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700703|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700704|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153955569|NCT02614456|Nivolumab|nivolumab|mesh-list
154700705|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154700706|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154700707|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154700708|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154700709|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
154700710|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
154700711|NCT04143880|Progesterone|progesterone|mesh-list
154700712|NCT04143880|Progestins|progestins|mesh-ancestor
154700713|NCT04143880|Hormones|hormones|mesh-ancestor
154700714|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700715|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700716|NCT04144192|Lidocaine|lidocaine|mesh-list
154700717|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
154700718|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
154700719|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700720|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700721|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
154700722|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700723|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154700724|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154700725|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154700726|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154700727|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700728|NCT01710345|Sufentanil|sufentanil|mesh-list
154700729|NCT01710345|Dsuvia|dsuvia|mesh-list
154700730|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154700731|NCT01710345|Narcotics|narcotics|mesh-ancestor
154700732|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700733|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700734|NCT01710345|Analgesics|analgesics|mesh-ancestor
154700735|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
154700736|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700737|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154700738|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154700739|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
154700740|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
154700741|NCT03022006|Grazoprevir|grazoprevir|mesh-list
154700742|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
154700743|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700744|NCT04143256|Menthol|menthol|mesh-list
154700745|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
154700746|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
154700747|NCT04143412|Ramipril|ramipril|mesh-list
154700748|NCT04143412|Eplerenone|eplerenone|mesh-list
154700749|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154700750|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
154700751|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700752|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700753|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154700754|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154700755|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
154700756|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700758|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154700759|NCT04143412|Diuretics|diuretics|mesh-ancestor
154700760|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
154700761|NCT05582278|Lenvatinib|lenvatinib|mesh-list
154700762|NCT05582278|Tislelizumab|tislelizumab|mesh-list
154700763|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154700764|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700765|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154700766|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700767|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700768|NCT05582278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700769|NCT01710033|Tofacitinib|tofacitinib|mesh-list
154700770|NCT01710033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154700771|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154700772|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700773|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700774|NCT01822496|Paclitaxel|paclitaxel|mesh-list
154700775|NCT01822496|Etoposide|etoposide|mesh-list
154700776|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
154700777|NCT01822496|Cisplatin|cisplatin|mesh-list
154700778|NCT01822496|Carboplatin|carboplatin|mesh-list
154700779|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154700780|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
154700781|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154700782|NCT01822496|Crizotinib|crizotinib|mesh-list
154700783|NCT01822496|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154700784|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154700785|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700786|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
154700787|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
154700788|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
154700789|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700790|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154700791|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154700792|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700793|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154700794|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
154700795|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
154700796|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154700797|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154700798|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700799|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700800|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
154700801|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154700802|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700803|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700804|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154700805|NCT03588988|Analgesics|analgesics|mesh-ancestor
154700806|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
154700807|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700808|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154700809|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154700810|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154700811|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
154700812|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700813|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700814|NCT04414137|Daptomycin|daptomycin|mesh-list
154700815|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154700816|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154700817|NCT01821560|Baclofen|baclofen|mesh-list
154700818|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154700819|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700820|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154700821|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700822|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154700823|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
154700824|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
154700825|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700826|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700827|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
154700828|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154700829|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
154700830|NCT03588676|Melatonin|melatonin|mesh-list
154700831|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
154700832|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700833|NCT03588676|Protective Agents|protective agents|mesh-ancestor
154700834|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700835|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700836|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154700837|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154700838|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
154700839|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700840|NCT01709721|Hydromorphone|hydromorphone|mesh-list
154700841|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154700842|NCT01709721|Narcotics|narcotics|mesh-ancestor
154700843|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700844|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700845|NCT01709721|Analgesics|analgesics|mesh-ancestor
154700846|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
154700847|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700848|NCT01866657|Phenylephrine|phenylephrine|mesh-list
154700849|NCT01866657|Dopamine|dopamine|mesh-list
154700850|NCT01866657|Ephedrine|ephedrine|mesh-list
154700851|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154700852|NCT01866657|Propofol|propofol|mesh-list
154700853|NCT01866657|Sevoflurane|sevoflurane|mesh-list
154700854|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
154700855|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154700856|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700857|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154700858|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154700859|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
154700860|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154700861|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154700862|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154700863|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
154700864|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
154700865|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700866|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
154700867|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
154700868|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
154700869|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154700870|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154700871|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154700872|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
154700873|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700874|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700875|NCT01866657|Protective Agents|protective agents|mesh-ancestor
154700876|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154700877|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
154700878|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
154700879|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
154700880|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700881|NCT03589690|Protective Agents|protective agents|mesh-ancestor
154700882|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700883|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
154700884|NCT03589690|Vitamins|vitamins|mesh-ancestor
154700885|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
154700886|NCT03587194|Apremilast|apremilast|mesh-list
154700887|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154700888|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154700889|NCT03587194|Analgesics|analgesics|mesh-ancestor
154700890|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
154700891|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700892|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700893|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700894|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154700895|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154700896|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154700897|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700898|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700899|NCT01699815|Acetaminophen|acetaminophen|mesh-list
154700900|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154700901|NCT01699815|Analgesics|analgesics|mesh-ancestor
154700902|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
154700903|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700904|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700905|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
154700906|NCT03589222|Dexamethasone|dexamethasone|mesh-list
154700907|NCT03589222|Bortezomib|bortezomib|mesh-list
154700908|NCT03589222|Daratumumab|daratumumab|mesh-list
154700909|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700910|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
154700911|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
154700912|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700913|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700914|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154700915|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
154700916|NCT03589222|Hormones|hormones|mesh-ancestor
154700917|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700918|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700919|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700920|NCT01846208|Immunomodulating Agents|immunomodulating agents|mesh-list
154700921|NCT01846208|Immunologic Factors|immunologic factors|mesh-ancestor
154700922|NCT01846208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700923|NCT03589066|Rotigotine|rotigotine|mesh-list
154700924|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
154700925|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
154700926|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700927|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700928|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700929|NCT03020368|Diclofenac|diclofenac|mesh-list
154700930|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154700931|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154700932|NCT03020368|Analgesics|analgesics|mesh-ancestor
154700933|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
154700934|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154700935|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700936|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700937|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154700938|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154700939|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154700940|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700941|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154700942|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154700943|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700944|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
154700945|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154700946|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154700947|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
154700948|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154700949|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700950|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700951|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154700952|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
154700953|NCT03580876|Azathioprine|azathioprine|mesh-list
154700954|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
154700955|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700956|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154700957|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700958|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154700959|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
154700960|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700961|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154700962|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
154700963|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700964|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700965|NCT03586024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154700966|NCT03586024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700967|NCT03585556|Prednisolone|prednisolone|mesh-list
154700968|NCT03585556|Ranibizumab|ranibizumab|mesh-list
154700969|NCT03585556|Aflibercept|aflibercept|mesh-list
154700970|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154700971|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154700972|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154700973|NCT03585556|Growth Substances|growth substances|mesh-ancestor
154700974|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700975|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
154700976|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154700977|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
154700978|NCT03585556|Hormones|hormones|mesh-ancestor
154700979|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154700980|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154700981|NCT05702398|Vitamins|vitamins|mesh-list
154700982|NCT05702398|Vitamin A|vitamin a|mesh-list
154700983|NCT05702398|Niacin|niacin|mesh-list
154700984|NCT05702398|Niacinamide|niacinamide|mesh-list
154700985|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
154700986|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
154700987|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154700988|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
154700989|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154700990|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154700991|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
154700992|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154700993|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
154700994|NCT01709409|Poractant alfa|poractant alfa|mesh-list
154700995|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154700996|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
154700997|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
154700998|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154700999|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701000|NCT01698879|Immunotoxins|immunotoxins|mesh-ancestor
154701001|NCT01698879|Immunoconjugates|immunoconjugates|mesh-ancestor
154701002|NCT01698879|Immunologic Factors|immunologic factors|mesh-ancestor
154701003|NCT01698879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701004|NCT02335294|Morphine|morphine|mesh-list
154701005|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154701006|NCT02335294|Narcotics|narcotics|mesh-ancestor
154701007|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701008|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701009|NCT02335294|Analgesics|analgesics|mesh-ancestor
154701010|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
154701011|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701012|NCT01698801|Dexamethasone|dexamethasone|mesh-list
154701013|NCT01698801|Lenalidomide|lenalidomide|mesh-list
154701014|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701015|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
154701016|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
154701017|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701018|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701019|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701020|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
154701021|NCT01698801|Hormones|hormones|mesh-ancestor
154701022|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701023|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154701024|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701025|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
154701026|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154701027|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154701028|NCT01698801|Growth Substances|growth substances|mesh-ancestor
154701029|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
154701030|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154701031|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154701032|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154701033|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
154701034|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154701035|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154701036|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701037|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
154701038|NCT03580018|Coagulants|coagulants|mesh-ancestor
154701039|NCT03584854|Carboprost|carboprost|mesh-list
154701040|NCT03584854|Dinoprost|dinoprost|mesh-list
154701041|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
154701042|NCT03584854|Methylergonovine|methylergonovine|mesh-list
154701043|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154701044|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
154701045|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154701046|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701047|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
154701048|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
154701049|NCT03584698|Misoprostol|misoprostol|mesh-list
154701050|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154701051|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
154701052|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154701053|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701054|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154701055|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701056|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
154701057|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153955916|NCT02615782|Tadalafil|tadalafil|mesh-list
154701058|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154701059|NCT03584698|Analgesics|analgesics|mesh-ancestor
154701060|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
154701061|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701062|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701063|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701064|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154701065|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
154701066|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701067|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154701068|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
154701069|NCT01682031|Selenium|selenium|mesh-list
154701070|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
154701071|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701072|NCT01682031|Protective Agents|protective agents|mesh-ancestor
154701073|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701074|NCT01682031|Trace Elements|trace elements|mesh-ancestor
154701075|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
154701076|NCT03020134|Ritonavir|ritonavir|mesh-list
154701077|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154701078|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154701079|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
154701080|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701081|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701082|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154701083|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154701084|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
154701085|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701086|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154701087|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154701088|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154701089|NCT03020056|Antioxidants|antioxidants|mesh-list
154701090|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154701091|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701092|NCT03020056|Protective Agents|protective agents|mesh-ancestor
154701093|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701094|NCT03584074|Celecoxib|celecoxib|mesh-list
154701095|NCT03584074|Pregabalin|pregabalin|mesh-list
154701096|NCT03584074|Analgesics|analgesics|mesh-ancestor
154701097|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
154701098|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701099|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701100|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
154701101|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154701102|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154701103|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701104|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154701105|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154701106|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154701107|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701108|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154701109|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154701110|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154701111|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701112|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701113|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154701114|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154701115|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701116|NCT03583138|Buprenorphine|buprenorphine|mesh-list
154701117|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154701118|NCT03583138|Narcotics|narcotics|mesh-ancestor
154701119|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701120|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701121|NCT03583138|Analgesics|analgesics|mesh-ancestor
154701122|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
154701123|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701124|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154701125|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
154701126|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701127|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701128|NCT03020602|Ubiquinone|ubiquinone|mesh-list
154701129|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
154701130|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
154701131|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701132|NCT03020602|Vitamins|vitamins|mesh-ancestor
154701133|NCT01567527|Aripiprazole|aripiprazole|mesh-list
154701134|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
154701135|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154701136|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154701138|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701139|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701140|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
154701141|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
154701142|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701143|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701144|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154701145|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154701146|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
154701147|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154701148|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154701149|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154701150|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154701151|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154701152|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154701153|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
154701154|NCT03159598|Urethane|urethane|mesh-list
154701155|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701156|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154701157|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
154701158|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
154701159|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701160|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701161|NCT01818752|Prednisone|prednisone|mesh-list
154701162|NCT01818752|Bortezomib|bortezomib|mesh-list
154701163|NCT01818752|Melphalan|melphalan|mesh-list
154701164|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701165|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
154701166|NCT01818752|Hormones|hormones|mesh-ancestor
154701167|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701168|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701169|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154701170|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701171|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154701172|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
154701173|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701174|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154701175|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154701176|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
154701177|NCT05701384|Lazertinib|lazertinib|mesh-list
154701178|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154701179|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701180|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701181|NCT01362608|Triamcinolone|triamcinolone|mesh-list
154701182|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154701183|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154701184|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154701185|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701186|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
154701187|NCT01362608|Hormones|hormones|mesh-ancestor
154701188|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701189|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701190|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154701191|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
154701192|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701193|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701194|NCT03581968|Pancrelipase|pancrelipase|mesh-list
154701195|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701196|NCT03158584|Morphine|morphine|mesh-list
154701197|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154701198|NCT03158584|Narcotics|narcotics|mesh-ancestor
154701199|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701200|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701201|NCT03158584|Analgesics|analgesics|mesh-ancestor
154701202|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
154701203|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701204|NCT04765228|Doxorubicin|doxorubicin|mesh-list
154701205|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154701206|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154701207|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701208|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154701209|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154701210|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701211|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701212|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154701214|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154701215|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
154701216|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701217|NCT03156322|Fentanyl|fentanyl|mesh-list
154701218|NCT03156322|Bupivacaine|bupivacaine|mesh-list
154701219|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
154701220|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
154701221|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701222|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701223|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
154701224|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701225|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154701226|NCT03156322|Narcotics|narcotics|mesh-ancestor
154701227|NCT03156322|Analgesics|analgesics|mesh-ancestor
154701228|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154701229|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154701230|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
154701231|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154701232|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713616|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154701233|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701234|NCT04140058|Ondansetron|ondansetron|mesh-list
154701235|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
154701236|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
154701237|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701238|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701239|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701240|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
154701241|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
154701242|NCT04140058|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154701243|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154701244|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
154701245|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701246|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701247|NCT02899078|Nivolumab|nivolumab|mesh-list
154701248|NCT02899078|Ibrutinib|ibrutinib|mesh-list
154701249|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701250|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701251|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154701252|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701253|NCT02899078|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154701254|NCT02899078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154701255|NCT02899078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701256|NCT01670734|Alirocumab|alirocumab|mesh-list
154701257|NCT01670734|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154701258|NCT01670734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154701259|NCT01670734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154701260|NCT01670734|Antimetabolites|antimetabolites|mesh-ancestor
154701261|NCT01670734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701262|NCT01670734|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154701263|NCT01670734|Protease Inhibitors|protease inhibitors|mesh-ancestor
154701264|NCT01670734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701265|NCT01670734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154701266|NCT01670890|Cisplatin|cisplatin|mesh-list
154701267|NCT01670890|Temozolomide|temozolomide|mesh-list
154701268|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701269|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154701270|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
154701271|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701272|NCT04551196|Acetaminophen|acetaminophen|mesh-list
154701273|NCT04551196|Ibuprofen|ibuprofen|mesh-list
154701274|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154701275|NCT04551196|Analgesics|analgesics|mesh-ancestor
154701276|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
154701277|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701278|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701279|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
154701280|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154701281|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701282|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701283|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154701284|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701285|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701286|NCT01923298|Estradiol|estradiol|mesh-list
154701287|NCT01923298|Estrogens|estrogens|mesh-ancestor
154701288|NCT01923298|Hormones|hormones|mesh-ancestor
154701289|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701290|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701291|NCT03154918|Dexamethasone|dexamethasone|mesh-list
154701292|NCT03154918|Gemcitabine|gemcitabine|mesh-list
154701293|NCT03154918|Etoposide|etoposide|mesh-list
154701294|NCT03154918|Ifosfamide|ifosfamide|mesh-list
154701295|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701296|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
154701297|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
154701298|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701299|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701300|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701301|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
154701302|NCT03154918|Hormones|hormones|mesh-ancestor
154701303|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701304|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154701305|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701306|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701307|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701308|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154701309|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
154701310|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154701311|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154701312|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154701313|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154701314|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
154701315|NCT01671904|Rituximab|rituximab|mesh-list
154701316|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
154701317|NCT01671904|Venetoclax|venetoclax|mesh-list
154701318|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154701319|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701320|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701321|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
154701322|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701323|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701324|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154701325|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
154701326|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701327|NCT04027894|Rifamycins|rifamycins|mesh-list
154701328|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
154701329|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154701330|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701331|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701332|NCT03154528|Vitamin D|vitamin d|mesh-list
154701333|NCT03154528|Vitamins|vitamins|mesh-ancestor
154701334|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
154701335|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701336|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154701337|NCT03154372|Metronidazole|metronidazole|mesh-list
154701338|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701339|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154701340|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154701341|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154701342|NCT01676506|Ranibizumab|ranibizumab|mesh-list
154701343|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154701344|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154701345|NCT01676506|Growth Substances|growth substances|mesh-ancestor
154701346|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701347|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
154701348|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701349|NCT03154294|Paclitaxel|paclitaxel|mesh-list
154701350|NCT03154294|Serabelisib|serabelisib|mesh-list
154701351|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154701352|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701353|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
154701354|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
154701355|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
154701356|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701357|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453343|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154701358|NCT03154606|Calcium|calcium|mesh-list
154701359|NCT03154606|Caseins|caseins|mesh-list
154701360|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154701361|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701362|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
154701363|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
154701364|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701365|NCT01672450|Ipilimumab|ipilimumab|mesh-list
154701366|NCT01672450|Interleukin-2|interleukin-2|mesh-list
154701367|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701368|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701369|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154701370|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701371|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154701372|NCT01672450|Analgesics|analgesics|mesh-ancestor
154701373|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
154701374|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701375|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701376|NCT01854268|Capsaicin|capsaicin|mesh-list
154701377|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
154701378|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
154701379|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
154701380|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701381|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701382|NCT01672606|Rocuronium|rocuronium|mesh-list
154701383|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154701384|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154701385|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154701386|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701387|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701388|NCT01594281|Ranibizumab|ranibizumab|mesh-list
154701389|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154701390|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154701391|NCT01594281|Growth Substances|growth substances|mesh-ancestor
154701392|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701393|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
154701394|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701395|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
154701396|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154701397|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
154701398|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701399|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701400|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154701401|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154701402|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154701403|NCT04964050|Diuretics|diuretics|mesh-ancestor
154701404|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
154701405|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701406|NCT03526900|Atezolizumab|atezolizumab|mesh-list
154701407|NCT03526900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154701408|NCT03526900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701409|NCT03526900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701410|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701411|NCT03420742|Midazolam|midazolam|mesh-list
154701412|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154701413|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154701414|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701415|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701416|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154701417|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154701418|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154701419|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154701420|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
154701421|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
154701422|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
154701423|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
154701424|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701425|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701426|NCT01818284|Plerixafor|plerixafor|mesh-list
154701427|NCT01818284|Lenograstim|lenograstim|mesh-list
154701428|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154701429|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
154701430|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701431|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154701432|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154701433|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
154453428|NCT03587025|Amitriptyline|amitriptyline|mesh-list
154701434|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701435|NCT02081014|Glucagon|glucagon|mesh-list
154701436|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154701437|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701438|NCT02081014|Hormones|hormones|mesh-ancestor
154701439|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701440|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701441|NCT02081014|Incretins|incretins|mesh-ancestor
154701442|NCT03025594|Ketorolac|ketorolac|mesh-list
154701443|NCT03025594|Epinephrine|epinephrine|mesh-list
154701444|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
154701445|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154701446|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154701447|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
154701448|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701449|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701450|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701451|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154701452|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154701453|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
154701454|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701455|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154701456|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
154701457|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
154701458|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
154701459|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154701460|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154701461|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154701462|NCT03025594|Analgesics|analgesics|mesh-ancestor
154701463|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
154701464|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701465|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701466|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154701467|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701468|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
154701469|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
154701470|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701471|NCT04404946|Phenylephrine|phenylephrine|mesh-list
154701472|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
154701473|NCT04404946|Norepinephrine|norepinephrine|mesh-list
154701474|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154701475|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
154701476|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
154701477|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701478|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701479|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
154701480|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154701481|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
154701482|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
154701483|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154701484|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154701485|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154701486|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
154701487|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701488|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701489|NCT04404946|Protective Agents|protective agents|mesh-ancestor
154701490|NCT01673542|Lidocaine|lidocaine|mesh-list
154701491|NCT01673542|Prilocaine|prilocaine|mesh-list
154701492|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154701493|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154701494|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
154701495|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701496|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701497|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
154701498|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701499|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154701500|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154701501|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154701502|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154701503|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701504|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154701505|NCT01610492|Belimumab|belimumab|mesh-list
154701506|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154701507|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
154701508|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701509|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154701510|NCT01817582|Cyclosporine|cyclosporine|mesh-list
154701511|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154701512|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
154701513|NCT01817582|Cyclosporins|cyclosporins|mesh-list
154701514|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701515|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701516|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154701517|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
154701518|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701519|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
154701520|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701521|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
154701522|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701523|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154701524|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154701525|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154701526|NCT01594125|Nintedanib|nintedanib|mesh-list
154701527|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701528|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154701529|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701530|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701531|NCT01592409|Dronabinol|dronabinol|mesh-list
154701532|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
154701533|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701534|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154701535|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154701536|NCT01592409|Analgesics|analgesics|mesh-ancestor
154701537|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
154701538|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701539|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154701540|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154701541|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701542|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701543|NCT01592409|Hormones|hormones|mesh-ancestor
154701544|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701545|NCT02081638|Aspirin|aspirin|mesh-list
154701546|NCT02081638|Atorvastatin|atorvastatin|mesh-list
154701547|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154701548|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154701549|NCT02081638|Analgesics|analgesics|mesh-ancestor
154701550|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
154701551|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701552|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701553|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701554|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701555|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154701556|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154701557|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701558|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154701559|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154701560|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701561|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
154701562|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154701563|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154701564|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
154701565|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154701566|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154701567|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
154701568|NCT04603508|Empagliflozin|empagliflozin|mesh-list
154701569|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154701570|NCT04603508|Calcium|calcium|mesh-list
154701571|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154701572|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701573|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154701574|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154701575|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154701576|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
154701577|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701578|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154701579|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154701580|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701581|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154701582|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154701583|NCT01674166|Prucalopride|prucalopride|mesh-list
154701584|NCT01674166|Laxatives|laxatives|mesh-ancestor
154701585|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701586|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154701587|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154701588|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
154701589|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701590|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701591|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701592|NCT02235688|Gemcitabine|gemcitabine|mesh-list
154701593|NCT02235688|Doxorubicin|doxorubicin|mesh-list
154701594|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154701595|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
154701596|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701597|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701598|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154701599|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154701600|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154701601|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701602|NCT03152578|Capsaicin|capsaicin|mesh-list
154701603|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
154701604|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
154701605|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
154701606|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701607|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701608|NCT01065532|Paclitaxel|paclitaxel|mesh-list
154701609|NCT01065532|Everolimus|everolimus|mesh-list
154701610|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154701611|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701612|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
154701613|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
154701614|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
154701615|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701616|NCT01065532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154701617|NCT01065532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154701618|NCT01065532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701619|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154701620|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
154701621|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701622|NCT01674322|Ibrutinib|ibrutinib|mesh-list
154701623|NCT01674322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154701624|NCT01674322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154701625|NCT01674322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701626|NCT01674322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701627|NCT04764916|Bupivacaine|bupivacaine|mesh-list
154701628|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
154701629|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
154701630|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701631|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701632|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
154701633|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701634|NCT01674868|Fluoxetine|fluoxetine|mesh-list
154701635|NCT01674868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154701636|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154701637|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154701638|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701639|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701640|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
154701641|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701642|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154701643|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
154701644|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154701645|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154701646|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154701647|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701648|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154701649|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
154701650|NCT01674946|Cathartics|cathartics|mesh-ancestor
154701651|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701652|NCT01675024|Rotigotine|rotigotine|mesh-list
154701653|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
154701654|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
154701655|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701656|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701657|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701658|NCT02081950|Enoxaparin|enoxaparin|mesh-list
154701659|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
154701660|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
154701661|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154701662|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154701663|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701664|NCT01675648|Lofexidine|lofexidine|mesh-list
154701665|NCT01675648|Clonidine|clonidine|mesh-list
154701666|NCT01675648|Diazepam|diazepam|mesh-list
154701667|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154701668|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
154701669|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
154701670|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
154701671|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701672|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701673|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701674|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154701675|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701676|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154701677|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154701678|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154701679|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154701680|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154701681|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154701682|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
154701683|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
154701684|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
154701685|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
154701686|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701687|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701688|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154701689|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154701690|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
154701691|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154701692|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154701693|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154701694|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
154701695|NCT01675648|Analgesics|analgesics|mesh-ancestor
154701696|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
154701697|NCT01566435|Paclitaxel|paclitaxel|mesh-list
154701698|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154701699|NCT01566435|Fluorouracil|fluorouracil|mesh-list
154701700|NCT01566435|Cetuximab|cetuximab|mesh-list
154701701|NCT01566435|Antibodies|antibodies|mesh-list
154701702|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154701703|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154701704|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701705|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
154701706|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
154701707|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
154701708|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701709|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
154701710|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701711|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
154701712|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154701713|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154701714|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701715|NCT01675804|Methylphenidate|methylphenidate|mesh-list
154701716|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154701717|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701718|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154701719|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154701720|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154701721|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701722|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
154701723|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701724|NCT01696695|Capecitabine|capecitabine|mesh-list
154701725|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154701726|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
154701727|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701728|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701729|NCT05261386|Betadex|betadex|mesh-list
154701730|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
154701731|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701732|NCT03861988|Ketamine|ketamine|mesh-list
154701733|NCT03861988|Analgesics|analgesics|mesh-ancestor
154701734|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
154701735|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701736|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701737|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154701738|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154701739|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
154701740|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
154701741|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701742|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154701743|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154701744|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701745|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701746|NCT03755440|Antibodies|antibodies|mesh-list
154701747|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
154701748|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701749|NCT01565889|Ritonavir|ritonavir|mesh-list
154701750|NCT01565889|Ribavirin|ribavirin|mesh-list
154701751|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154701752|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154701753|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
154701754|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701755|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701756|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154701757|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154701758|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
154701759|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701760|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154701761|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154701762|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
154701763|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
154701764|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154701765|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
154701766|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701767|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701768|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154701769|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
154701770|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
154701771|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154701772|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
154701773|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701774|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701775|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
154701776|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154701777|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701778|NCT01591785|Retapamulin|retapamulin|mesh-list
154701779|NCT01591785|Petrolatum|petrolatum|mesh-list
154701780|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154701781|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701782|NCT01591785|Emollients|emollients|mesh-ancestor
154701783|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154701784|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
154701785|NCT03654040|Everolimus|everolimus|mesh-list
154701786|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154701787|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
154701788|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701789|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701790|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154701791|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
154701792|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701793|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701794|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154701795|NCT03654040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154701796|NCT03654040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154701797|NCT03654040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701798|NCT03833440|Docetaxel|docetaxel|mesh-list
154701799|NCT03833440|Durvalumab|durvalumab|mesh-list
154701800|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701801|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
154701802|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
154701803|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
154701804|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701805|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701806|NCT01677442|Anesthetics|anesthetics|mesh-list
153956643|NCT00798889|Sunitinib|sunitinib|mesh-list
154701807|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701808|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701809|NCT01695135|Prednisone|prednisone|mesh-list
154701810|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
154701811|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154701812|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
154701813|NCT01695135|Hormones|hormones|mesh-ancestor
154701814|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701815|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701816|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154701817|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701818|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154701819|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701820|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701821|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
154701822|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154701823|NCT03749902|Misoprostol|misoprostol|mesh-list
154701824|NCT03749902|Oxytocin|oxytocin|mesh-list
154701825|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
154701826|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154701827|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701828|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154701829|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
154701830|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154701831|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154701832|NCT01590771|Metformin|metformin|mesh-list
154701833|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154701834|NCT01590771|Glimepiride|glimepiride|mesh-list
154701835|NCT01590771|Gliclazide|gliclazide|mesh-list
154701836|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154701837|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701838|NCT01590771|Incretins|incretins|mesh-ancestor
154701839|NCT01590771|Hormones|hormones|mesh-ancestor
154701840|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701841|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154701842|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
154701843|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701844|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701845|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154701846|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154701847|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
154701848|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
154701849|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154701850|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701851|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
154701852|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701853|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701854|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
154701855|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
154701856|NCT03735316|Vitamins|vitamins|mesh-ancestor
154701857|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
154701858|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701859|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
154701860|NCT03735316|Hematinics|hematinics|mesh-ancestor
154701861|NCT01694433|Vitamin D|vitamin d|mesh-list
154701862|NCT01694433|Calcitriol|calcitriol|mesh-list
154701863|NCT01694433|Calcipotriene|calcipotriene|mesh-list
154701864|NCT01694433|Vitamins|vitamins|mesh-ancestor
154701865|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
154701866|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701867|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153956708|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
154701868|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
154701869|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154701870|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154701871|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154701872|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701873|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154701874|NCT01693185|Midazolam|midazolam|mesh-list
154701875|NCT01693185|Meperidine|meperidine|mesh-list
154701876|NCT01693185|Remifentanil|remifentanil|mesh-list
154701877|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154701878|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154701879|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701880|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701881|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154701882|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154701883|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154453867|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
154701884|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154701885|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
154701886|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
154701887|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
154701888|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
154701889|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701890|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701891|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154701892|NCT01693185|Narcotics|narcotics|mesh-ancestor
154701893|NCT01693185|Analgesics|analgesics|mesh-ancestor
154701894|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
154701895|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701896|NCT03630640|Nivolumab|nivolumab|mesh-list
154701897|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701898|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701899|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154701900|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701901|NCT03625726|Thrombin|thrombin|mesh-list
154701902|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
154701903|NCT03625726|Coagulants|coagulants|mesh-ancestor
154701904|NCT03814954|Epinephrine|epinephrine|mesh-list
154701905|NCT03814954|Albuterol|albuterol|mesh-list
154701906|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154701907|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154701908|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
154701909|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701910|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701911|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701912|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154701913|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154701914|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
154701915|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701916|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154701917|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
154701918|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
154701919|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
154701920|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154701921|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
154701922|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154701923|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154701924|NCT03813160|Dronabinol|dronabinol|mesh-list
154701925|NCT03813160|Lenabasum|lenabasum|mesh-list
154701926|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154701927|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154701928|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701929|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701930|NCT03813160|Hormones|hormones|mesh-ancestor
154701931|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154701932|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701933|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
154701934|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154701935|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154701936|NCT03813160|Analgesics|analgesics|mesh-ancestor
154701937|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
154701938|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701939|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154701940|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154701941|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
154701942|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701943|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154701944|NCT03807856|Dabigatran|dabigatran|mesh-list
154701945|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
154701946|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154701947|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
154701948|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154701949|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701950|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
154701951|NCT03806530|Gabapentin|gabapentin|mesh-list
154701952|NCT03806530|Ropinirole|ropinirole|mesh-list
154701953|NCT03806530|Analgesics|analgesics|mesh-ancestor
154701954|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
154701955|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154701956|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701957|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
154701958|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154701959|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154701960|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154701961|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154701962|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154701963|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154701964|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154701965|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154701966|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
154701967|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154701968|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154701969|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
154701970|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
154701972|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154701973|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154701974|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
153956826|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
154701975|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701976|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154701977|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
154701978|NCT01693029|Hematinics|hematinics|mesh-ancestor
154701979|NCT01589445|Metformin|metformin|mesh-list
154701980|NCT01589445|Pioglitazone|pioglitazone|mesh-list
154701981|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154701982|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701983|NCT01561989|Vitamin D|vitamin d|mesh-list
154701984|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
154701985|NCT01561989|Vaccines|vaccines|mesh-list
154701986|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
154701987|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154701988|NCT01561989|Vitamins|vitamins|mesh-ancestor
154701989|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
154701990|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154701991|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154701992|NCT00004054|Paclitaxel|paclitaxel|mesh-list
154701993|NCT00004054|Etoposide|etoposide|mesh-list
154701994|NCT00004054|Bicalutamide|bicalutamide|mesh-list
154701995|NCT00004054|Flutamide|flutamide|mesh-list
154701996|NCT00004054|Estramustine|estramustine|mesh-list
154701997|NCT00004054|Warfarin|warfarin|mesh-list
154701998|NCT00004054|Hormones|hormones|mesh-list
154701999|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154702000|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154702001|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702002|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
154702003|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
154702004|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
154702005|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702006|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154702007|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154702008|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702009|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154702010|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702011|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
154702012|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
154702013|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
154702014|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154702015|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154702016|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
154702017|NCT01587885|Omeprazole|omeprazole|mesh-list
154702018|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154702019|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154702020|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154702021|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702022|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702023|NCT01587651|Ticagrelor|ticagrelor|mesh-list
154702024|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154702025|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154702026|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154702027|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154702028|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154702029|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
154702030|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702031|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702032|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702033|NCT04763434|Dexamethasone|dexamethasone|mesh-list
154702034|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
154702035|NCT04763434|Ropivacaine|ropivacaine|mesh-list
154702036|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702037|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
154702038|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
154702039|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702040|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702041|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154702042|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
154702044|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154702045|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154702046|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702047|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154702048|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702049|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154702050|NCT04763434|Analgesics|analgesics|mesh-ancestor
154702051|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
154702052|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154702053|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154702054|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154702055|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
154702056|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702057|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702058|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
154702059|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
154702060|NCT04762966|Metformin|metformin|mesh-list
154702061|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154702062|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702063|NCT03602560|Seladelpar|seladelpar|mesh-list
154702064|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154702065|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
154702066|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702067|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154702068|NCT00779116|Cetirizine|cetirizine|mesh-list
154702069|NCT00779116|Desloratadine|desloratadine|mesh-list
154702070|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154702071|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154702072|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154702073|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
154702074|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
154702075|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702076|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702077|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702078|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154702079|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
154702080|NCT01691781|Lisinopril|lisinopril|mesh-list
154702081|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154702082|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
154702083|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702084|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702085|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154702086|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154702087|NCT01691781|Protective Agents|protective agents|mesh-ancestor
154702088|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702089|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
154702090|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154702091|NCT01561755|Antibodies|antibodies|mesh-list
154702092|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
154702093|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154702094|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
154702095|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702096|NCT03789214|Suvorexant|suvorexant|mesh-list
154702097|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154702098|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956938|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
154702099|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702100|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702101|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154702102|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702103|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702104|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
154702105|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154702106|NCT04124367|Protective Agents|protective agents|mesh-ancestor
154702107|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702108|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
154702109|NCT01560507|Bupropion|bupropion|mesh-list
154702110|NCT01560507|Nicotine|nicotine|mesh-list
154702111|NCT01560507|Varenicline|varenicline|mesh-list
154702112|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154702113|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
154702114|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702115|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702116|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154702117|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154702118|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
154702119|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702120|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702121|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154702122|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
154702123|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154702124|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154702125|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154702126|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154702127|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
154702128|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154702129|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154702130|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702131|NCT03684538|Zinc|zinc|mesh-list
154702132|NCT03684538|Trace Elements|trace elements|mesh-ancestor
154702133|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
154702134|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702135|NCT03682978|Baclofen|baclofen|mesh-list
154702136|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154702137|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702138|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154702139|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702140|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154702141|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
154702142|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
154702143|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702144|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702145|NCT03676192|Bevacizumab|bevacizumab|mesh-list
154702146|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154702147|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702148|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154702149|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154702150|NCT03676192|Growth Substances|growth substances|mesh-ancestor
154702151|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702152|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
154702153|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
154702154|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154702155|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154702156|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154702157|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154702158|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702159|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
154702160|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702161|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702162|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154702163|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702164|NCT03580408|Nivolumab|nivolumab|mesh-list
154702165|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154702166|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702167|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154702168|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702169|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
154702170|NCT03766750|Linagliptin|linagliptin|mesh-list
154702171|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154702172|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702173|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154702174|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702175|NCT03766750|Incretins|incretins|mesh-ancestor
154702176|NCT03766750|Hormones|hormones|mesh-ancestor
154702177|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154702178|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154702179|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
154702180|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702181|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
154702182|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
154702183|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702184|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
154702185|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702186|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702187|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154702188|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
154702189|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702190|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702191|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154702192|NCT04762810|Hormones|hormones|mesh-ancestor
154702193|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154702194|NCT03674242|Carboplatin|carboplatin|mesh-list
154702195|NCT03674242|Gemcitabine|gemcitabine|mesh-list
154702196|NCT03674242|Asparaginase|asparaginase|mesh-list
154702197|NCT03674242|Eryaspase|eryaspase|mesh-list
154702198|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702199|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154702200|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
154702201|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702202|NCT04761952|Infliximab|infliximab|mesh-list
154702203|NCT04761952|Azathioprine|azathioprine|mesh-list
154702204|NCT04761952|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154702205|NCT04761952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702206|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
154702207|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154702208|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702209|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
154702210|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702211|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154702212|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702213|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702214|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
154702215|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702216|NCT03673072|Gemcitabine|gemcitabine|mesh-list
154702217|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702218|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154702219|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
154702220|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702221|NCT01690299|Etanercept|etanercept|mesh-list
154702222|NCT01690299|Apremilast|apremilast|mesh-list
154702223|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154702224|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154702225|NCT01690299|Analgesics|analgesics|mesh-ancestor
154702226|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
154702227|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702228|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702229|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702230|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702231|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154702232|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702233|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
154702234|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154702235|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154702236|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702237|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702238|NCT03570814|Azithromycin|azithromycin|mesh-list
154702239|NCT03570814|Ivermectin|ivermectin|mesh-list
154702240|NCT03570814|Albendazole|albendazole|mesh-list
154702241|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154702242|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702243|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154702244|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
154702245|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
154702246|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154702247|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154702248|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
154702249|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
154702250|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
154702251|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702252|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702253|NCT00723736|Desloratadine|desloratadine|mesh-list
154702254|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154702255|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
154702256|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702257|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702258|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702259|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154702260|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154702261|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
154454237|NCT02172768|Micafungin|micafungin|mesh-list
154702262|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
154702263|NCT00305344|Vaccines|vaccines|mesh-list
154702264|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
154702265|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702266|NCT01690143|Melphalan|melphalan|mesh-list
154702267|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154702268|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
154702269|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702270|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729858|NCT03117309|Nivolumab|nivolumab|mesh-list
154702271|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154702272|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702273|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
154702274|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702275|NCT05347498|Febuxostat|febuxostat|mesh-list
154702276|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
154702277|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702278|NCT01677364|Oxytocin|oxytocin|mesh-list
154702279|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
154702280|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154702281|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702282|NCT03563248|Nivolumab|nivolumab|mesh-list
154702283|NCT03563248|Folfirinox|folfirinox|mesh-list
154702284|NCT03563248|Losartan|losartan|mesh-list
154702285|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154702286|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702287|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154702288|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702289|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154702290|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154702291|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154702292|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154702293|NCT04403776|Tofacitinib|tofacitinib|mesh-list
154702294|NCT04403776|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154702295|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154702296|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702297|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702298|NCT03559348|Leucovorin|leucovorin|mesh-list
154702299|NCT03559348|Gemcitabine|gemcitabine|mesh-list
154702300|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154702301|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
154702302|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702303|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702304|NCT03559348|Antidotes|antidotes|mesh-ancestor
154702305|NCT03559348|Protective Agents|protective agents|mesh-ancestor
154702306|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702307|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
154702308|NCT03559348|Vitamins|vitamins|mesh-ancestor
154702309|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
154702310|NCT04762030|Paclitaxel|paclitaxel|mesh-list
154702311|NCT04762030|Carboplatin|carboplatin|mesh-list
154702312|NCT04762030|Durvalumab|durvalumab|mesh-list
154702313|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154702314|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702315|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154702316|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154702317|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154702318|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702319|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154702320|NCT01559259|Acetaminophen|acetaminophen|mesh-list
154702321|NCT01559259|Ibuprofen|ibuprofen|mesh-list
154702322|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154702323|NCT01559259|Analgesics|analgesics|mesh-ancestor
154702324|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
154702325|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702326|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702327|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
154702328|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154702329|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702330|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702331|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154702332|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702333|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702334|NCT03088306|Acetaminophen|acetaminophen|mesh-list
154702335|NCT03088306|Fentanyl|fentanyl|mesh-list
154702336|NCT03088306|Ketamine|ketamine|mesh-list
154702337|NCT03088306|Gabapentin|gabapentin|mesh-list
154702338|NCT03088306|Hydromorphone|hydromorphone|mesh-list
154702339|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
154702340|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702341|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702342|NCT03088306|Analgesics|analgesics|mesh-ancestor
154702343|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
154702344|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702345|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154702346|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154702347|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
154702348|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154702349|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154702350|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702351|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702352|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154702353|NCT03088306|Narcotics|narcotics|mesh-ancestor
154702354|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154702355|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154702356|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
154702357|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
154702358|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154702359|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154702360|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154702361|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
154702362|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
154702363|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154702364|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702365|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154702366|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702367|NCT03088384|Ketamine|ketamine|mesh-list
154702368|NCT03088384|Analgesics|analgesics|mesh-ancestor
154702369|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
154702370|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702371|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702372|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154702373|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154702374|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
154702375|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
154702376|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702377|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154702378|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154702379|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702380|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702381|NCT01677598|Ustekinumab|ustekinumab|mesh-list
154702382|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
154702383|NCT01677754|Memantine|memantine|mesh-list
154702384|NCT01677754|Rivastigmine|rivastigmine|mesh-list
154702385|NCT01677754|Donepezil|donepezil|mesh-list
154702386|NCT01677754|Galantamine|galantamine|mesh-list
154702387|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154702388|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702389|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702390|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
154702391|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702392|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702393|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
154702394|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154702395|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154702396|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
154702397|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154702398|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154702399|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154702400|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
154702401|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702402|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154702403|NCT01677754|Protective Agents|protective agents|mesh-ancestor
154702404|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
154702405|NCT01670500|Cisplatin|cisplatin|mesh-list
154702406|NCT01670500|Doxorubicin|doxorubicin|mesh-list
154702407|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702408|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
154702409|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702410|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702411|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154702412|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
154702413|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702414|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702415|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154702416|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154702417|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154702418|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154702419|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702420|NCT01678612|Copper|copper|mesh-list
154702421|NCT01678612|Trace Elements|trace elements|mesh-ancestor
154702422|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
154702423|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702424|NCT03525574|Ivacaftor|ivacaftor|mesh-list
154702425|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154702426|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154702427|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702428|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154702429|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154702430|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702431|NCT02405260|Incretins|incretins|mesh-ancestor
154702432|NCT02405260|Hormones|hormones|mesh-ancestor
154702433|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154702434|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154702435|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
154702436|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702437|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702438|NCT03519646|Eliglustat|eliglustat|mesh-list
154702439|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702440|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702441|NCT02984722|Metformin|metformin|mesh-list
154702442|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154702443|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702444|NCT02401750|Naltrexone|naltrexone|mesh-list
154702445|NCT02401750|Oxycodone|oxycodone|mesh-list
154702446|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154702447|NCT02401750|Narcotics|narcotics|mesh-ancestor
154702448|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702449|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702450|NCT02401750|Analgesics|analgesics|mesh-ancestor
154702451|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
154702452|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702453|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154702454|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154702455|NCT01689519|Vemurafenib|vemurafenib|mesh-list
154702456|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702457|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154702458|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702459|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702460|NCT01689363|Histamine|histamine|mesh-list
154702461|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
154702462|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
154702463|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702464|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702465|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702466|NCT03455140|BCT-100|bct-100|mesh-list
154702467|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702468|NCT01689207|Aztreonam|aztreonam|mesh-list
154702469|NCT01689207|Avibactam|avibactam|mesh-list
154702470|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154702471|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702472|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154702473|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702474|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702475|NCT00089284|Rituximab|rituximab|mesh-list
154702476|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
154702477|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154702478|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702479|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
154702480|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702481|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702482|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154702483|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
154702484|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154702485|NCT01688973|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154702486|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154702487|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702488|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702489|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702490|NCT00087646|Ribavirin|ribavirin|mesh-list
154702491|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153957319|NCT02837835|Ceftazidime|ceftazidime|mesh-list
154702492|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
154702493|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
154702494|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702495|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
154702496|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702497|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
154702498|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702499|NCT03492658|Methotrexate|methotrexate|mesh-list
154702500|NCT03492658|Abatacept|abatacept|mesh-list
154702501|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154702502|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
154702503|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154702504|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702505|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154702506|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
154702507|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702508|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702509|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
154702510|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702511|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154702512|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702513|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
154702514|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702515|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154702516|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154702517|NCT03492658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154702518|NCT03085654|Oxytocin|oxytocin|mesh-list
154702519|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
154702520|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154702521|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702522|NCT00087568|Ribavirin|ribavirin|mesh-list
154702523|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154702524|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
154702525|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702526|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
154702527|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702528|NCT04402762|Enoxaparin|enoxaparin|mesh-list
154702529|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
154702530|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
154702531|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154702532|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154702533|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702534|NCT00085540|Romidepsin|romidepsin|mesh-list
154702535|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154702536|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702537|NCT00085540|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154702538|NCT00085540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702539|NCT00085540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702540|NCT01688739|Erenumab|erenumab|mesh-list
154702541|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154702542|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702543|NCT01688739|Analgesics|analgesics|mesh-ancestor
154702544|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
153729878|NCT03095274|Tremelimumab|tremelimumab|mesh-list
154702545|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702546|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702547|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
154702548|NCT00084838|Leucovorin|leucovorin|mesh-list
154702549|NCT00084838|Cytarabine|cytarabine|mesh-list
154702550|NCT00084838|Dactinomycin|dactinomycin|mesh-list
154702551|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
154702552|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154702553|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154702554|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154702555|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
154702556|NCT00084838|Temozolomide|temozolomide|mesh-list
154702557|NCT00084838|Cisplatin|cisplatin|mesh-list
154702558|NCT00084838|Doxorubicin|doxorubicin|mesh-list
154702559|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154702560|NCT00084838|Methotrexate|methotrexate|mesh-list
154702561|NCT00084838|Etoposide|etoposide|mesh-list
154702562|NCT00084838|Vincristine|vincristine|mesh-list
154702563|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
154702564|NCT00084838|Razoxane|razoxane|mesh-list
154702565|NCT00084838|Lenograstim|lenograstim|mesh-list
154702566|NCT00084838|Calcium|calcium|mesh-list
154702567|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
154702568|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702569|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
154702570|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702571|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702572|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154702573|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
154702574|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702575|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702576|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154702577|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154702578|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154702579|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154702580|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702581|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154702582|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154702583|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154702584|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
154702585|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154702586|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154702587|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
154702588|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154702589|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154702590|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154702591|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154702592|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
154702593|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702594|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154702595|NCT00084838|Antidotes|antidotes|mesh-ancestor
154702596|NCT00084838|Protective Agents|protective agents|mesh-ancestor
154702597|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
154702598|NCT00084838|Vitamins|vitamins|mesh-ancestor
154702599|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
154702600|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
154702601|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
154702602|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
154702603|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702604|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154702605|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154702606|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154702607|NCT01558089|Etanercept|etanercept|mesh-list
154702608|NCT01558089|Methotrexate|methotrexate|mesh-list
154702609|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154702610|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
154702611|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154702612|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702613|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154702614|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
154702615|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702616|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702617|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
154702618|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702619|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154702620|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702621|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
154702622|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702623|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154702624|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154702625|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154702626|NCT01558089|Analgesics|analgesics|mesh-ancestor
154702627|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
154702628|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702629|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702630|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154702631|NCT00084682|Romidepsin|romidepsin|mesh-list
154702632|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154702633|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702634|NCT00084682|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154702635|NCT00084682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702636|NCT00084682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702637|NCT01556997|Amlodipine|amlodipine|mesh-list
154702638|NCT01556997|Perindopril|perindopril|mesh-list
154702639|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154702640|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154702641|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154702642|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702643|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154702644|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702645|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
154702646|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154702647|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
154702648|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702649|NCT00082888|Tipifarnib|tipifarnib|mesh-list
154702650|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702651|NCT03085186|Crizotinib|crizotinib|mesh-list
154702652|NCT03085186|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154702653|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154702654|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702655|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702656|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702657|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154702658|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154702659|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154702660|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702661|NCT00082810|Fulvestrant|fulvestrant|mesh-list
154702662|NCT00082810|Tipifarnib|tipifarnib|mesh-list
154702663|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154702664|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702665|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154702666|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154702667|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
154702668|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154702669|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702670|NCT03445000|Alectinib|alectinib|mesh-list
154702671|NCT03445000|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154702672|NCT03445000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154702673|NCT03445000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702674|NCT03445000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702675|NCT03085030|Antioxidants|antioxidants|mesh-list
154702676|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702677|NCT03085030|Protective Agents|protective agents|mesh-ancestor
154702678|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702679|NCT03443128|Vinorelbine|vinorelbine|mesh-list
154702680|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154702681|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702682|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
154702683|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
154702684|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
154702685|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702686|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
154702687|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154702688|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154702689|NCT03437746|Prednisolone|prednisolone|mesh-list
154702690|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
154702691|NCT03437746|Anesthetics|anesthetics|mesh-list
154702692|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154702693|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
154702694|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702695|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
154702696|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
154702697|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702698|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702699|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154702700|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
154702701|NCT03437746|Hormones|hormones|mesh-ancestor
154702702|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154702703|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154702704|NCT03437746|Protective Agents|protective agents|mesh-ancestor
154702705|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154702706|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702707|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702708|NCT03084250|Tenofovir|tenofovir|mesh-list
154702709|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154702710|NCT03084250|Entecavir|entecavir|mesh-list
154702711|NCT03084250|Adefovir|adefovir|mesh-list
154702712|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
154702713|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702714|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154702715|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154702716|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860363|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154702717|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702718|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154702719|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154702720|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
154702721|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154702722|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154702723|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957530|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702724|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702725|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
154702726|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702727|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702728|NCT03084328|Vitamin D|vitamin d|mesh-list
154702729|NCT03084328|Vitamins|vitamins|mesh-ancestor
154702730|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
154702731|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702732|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154702733|NCT01678690|Gemcitabine|gemcitabine|mesh-list
154702734|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154702735|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
154702736|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702737|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702738|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
154702739|NCT01679080|Teriparatide|teriparatide|mesh-list
154702740|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154702741|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702742|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154702743|NCT03083782|Cyclosporine|cyclosporine|mesh-list
154702744|NCT03083782|Apixaban|apixaban|mesh-list
154702745|NCT03083782|Tacrolimus|tacrolimus|mesh-list
154702746|NCT03083782|Cyclosporins|cyclosporins|mesh-list
154702747|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702748|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
154702749|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702750|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154702751|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702752|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702753|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
154702754|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702755|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
154702756|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702757|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154702758|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
154702759|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154702760|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
154702761|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
154702762|NCT03471442|Bupivacaine|bupivacaine|mesh-list
154702763|NCT03471442|Ropivacaine|ropivacaine|mesh-list
154702764|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
154702765|NCT03471442|Anesthetics|anesthetics|mesh-list
154702766|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
154702767|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702768|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702769|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
154702770|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702771|NCT01679392|Ropivacaine|ropivacaine|mesh-list
154702772|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
154702773|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
154702774|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702775|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702776|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
154702777|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702778|NCT03083080|Epinephrine|epinephrine|mesh-list
154702779|NCT03083080|Ropivacaine|ropivacaine|mesh-list
154702780|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
154702781|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
154702782|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702783|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702784|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
154702785|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702786|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154702787|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154702788|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
154702789|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702790|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702791|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154454758|NCT03066700|Coagulants|coagulants|mesh-ancestor
154702792|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154702793|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
154702794|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154702795|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
154702796|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
154702797|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
154702798|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154702799|NCT03082300|Naquotinib|naquotinib|mesh-list
154702800|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702801|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154702802|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702803|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702804|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
154702805|NCT01679860|Immunomodulating Agents|immunomodulating agents|mesh-list
154702806|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
154702807|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702808|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154702809|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702810|NCT05346952|Carboplatin|carboplatin|mesh-list
154702811|NCT05346952|Pemetrexed|pemetrexed|mesh-list
154702812|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702813|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702814|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702815|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154702816|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154702817|NCT03081442|Misoprostol|misoprostol|mesh-list
154702818|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
154702819|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154702820|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
154702821|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154702822|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702823|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154702824|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154702825|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
154702826|NCT03431194|Midodrine|midodrine|mesh-list
154702827|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
153957664|NCT02836743|Melatonin|melatonin|mesh-list
154702828|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
154702829|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702830|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702831|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154702832|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154702833|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154702834|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154702835|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
154702836|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702837|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702838|NCT03080740|Metronidazole|metronidazole|mesh-list
154702839|NCT03080740|Clindamycin|clindamycin|mesh-list
154702840|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
154702841|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
154702842|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702843|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154702844|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154702845|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154702846|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154702847|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702848|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702849|NCT03081832|Oxytocin|oxytocin|mesh-list
154702850|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
154702851|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154702852|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702853|NCT03080350|Fentanyl|fentanyl|mesh-list
154702854|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154702855|NCT03080350|Narcotics|narcotics|mesh-ancestor
154702856|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702857|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702858|NCT03080350|Analgesics|analgesics|mesh-ancestor
154702859|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
154702860|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702861|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154702862|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154702863|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
154702864|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
154702865|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154702866|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154702867|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154860364|NCT00981890|Growth Substances|growth substances|mesh-ancestor
154702868|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702869|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702870|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154702871|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154702872|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154702873|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
154702874|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702875|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702876|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154702877|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154702878|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
154702879|NCT01610336|Gefitinib|gefitinib|mesh-list
154702880|NCT01610336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154702881|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154702882|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702883|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702884|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702885|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
154702886|NCT03323866|Budesonide|budesonide|mesh-list
154702887|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702888|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154702889|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
154702890|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702891|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702892|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154702893|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
154702894|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
154702895|NCT03323866|Hormones|hormones|mesh-ancestor
154702896|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154702897|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
154702898|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154702899|NCT05684848|Resveratrol|resveratrol|mesh-list
154702900|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
154702901|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702902|NCT05684848|Protective Agents|protective agents|mesh-ancestor
154702903|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702904|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702905|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154702906|NCT03366298|Epinephrine|epinephrine|mesh-list
154702907|NCT03366298|Racepinephrine|racepinephrine|mesh-list
154702908|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
154702909|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154702910|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154702911|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154702912|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702913|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702914|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702915|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154702916|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154702917|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
154702918|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702919|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154702920|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
154702921|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
154702922|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
154702923|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154702924|NCT01842620|Metformin|metformin|mesh-list
154702925|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154702926|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702927|NCT04760704|Antibodies|antibodies|mesh-list
154702928|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
154702929|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702930|NCT01931839|Ivacaftor|ivacaftor|mesh-list
154702931|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154702932|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154702933|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702934|NCT01842308|Melphalan|melphalan|mesh-list
154702935|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
154702936|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154702937|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154702938|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
154702939|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702940|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702941|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154702942|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702943|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
154702944|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702945|NCT01931059|Risperidone|risperidone|mesh-list
154702946|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154702947|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
154702948|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702949|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702950|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702951|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154702952|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154702953|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154702954|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154702955|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154702956|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
154702957|NCT01841762|Macitentan|macitentan|mesh-list
153957766|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
154702958|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154702959|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154702960|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702961|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154702962|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
154702963|NCT03301636|Nivolumab|nivolumab|mesh-list
154702964|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154702965|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154702966|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154702967|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702968|NCT04602494|Varenicline|varenicline|mesh-list
154702969|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154702970|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154702971|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
154702972|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154702973|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702974|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702975|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154702976|NCT01970371|Meropenem|meropenem|mesh-list
154702977|NCT01970371|Colistin|colistin|mesh-list
154702978|NCT01970371|Tigecycline|tigecycline|mesh-list
154702979|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154702980|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154702981|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154702982|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154702983|NCT05604742|Belimumab|belimumab|mesh-list
154702984|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154702985|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
154702986|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702987|NCT03350386|Oxaprozin|oxaprozin|mesh-list
154702988|NCT03350386|Dotinurad|dotinurad|mesh-list
154702989|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
154702990|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
154702991|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154702992|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154702993|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154702994|NCT03350386|Analgesics|analgesics|mesh-ancestor
154702995|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
154702996|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154702997|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154702998|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154702999|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154703000|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703001|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703002|NCT03344692|Alirocumab|alirocumab|mesh-list
154703003|NCT03344692|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154703004|NCT03344692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154703005|NCT03344692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154703006|NCT03344692|Antimetabolites|antimetabolites|mesh-ancestor
154703007|NCT03344692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703008|NCT03344692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154703009|NCT03344692|Protease Inhibitors|protease inhibitors|mesh-ancestor
154703010|NCT03344692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703011|NCT03344692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154703012|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154703013|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
154703014|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703015|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
154703016|NCT05223088|Apatinib|apatinib|mesh-list
154703017|NCT05223088|Tislelizumab|tislelizumab|mesh-list
154703018|NCT05223088|Tegafur|tegafur|mesh-list
154703019|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703020|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703021|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703022|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703023|NCT05223088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703024|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154703025|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
154703026|NCT01838876|Cariprazine|cariprazine|mesh-list
154703027|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
154703028|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154703029|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154703030|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154703031|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703032|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703033|NCT03279250|Prednisone|prednisone|mesh-list
154703034|NCT03279250|Cortisone|cortisone|mesh-list
154703035|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
154703036|NCT03279250|Hormones|hormones|mesh-list
154703037|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154703038|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703039|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
154703040|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703041|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703042|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154703043|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703044|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154703045|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703046|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703047|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
154703048|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154703049|NCT01838642|Ponatinib|ponatinib|mesh-list
154703050|NCT01838642|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154703051|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703052|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703053|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703054|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703055|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154703056|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154703057|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
154703058|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154703059|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154703060|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703061|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
154703062|NCT01813058|Coagulants|coagulants|mesh-ancestor
154703063|NCT05491330|Ritonavir|ritonavir|mesh-list
154703064|NCT05491330|Nirmatrelvir|nirmatrelvir|mesh-list
154703065|NCT05491330|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154703066|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154703067|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154703068|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
154703069|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703070|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703071|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154703072|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154703073|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
153957891|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
154703074|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703075|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154703076|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154703077|NCT01811732|Vancomycin|vancomycin|mesh-list
154703078|NCT01811732|Aztreonam|aztreonam|mesh-list
154703079|NCT01811732|Delafloxacin|delafloxacin|mesh-list
154703080|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703081|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703082|NCT05139004|Fludarabine|fludarabine|mesh-list
154703083|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
154703084|NCT05139004|Melphalan|melphalan|mesh-list
154703085|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
154703086|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154703087|NCT05139004|Basiliximab|basiliximab|mesh-list
154703088|NCT05139004|Mitogens|mitogens|mesh-list
154703089|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154703090|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703091|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154703092|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
154703093|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703094|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154703095|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
154703096|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703097|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154703098|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
154703099|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154703100|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154703101|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
154703102|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
154703103|NCT01811186|Oxycodone|oxycodone|mesh-list
154703104|NCT01811186|Naloxone|naloxone|mesh-list
154703105|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154703106|NCT01811186|Narcotics|narcotics|mesh-ancestor
154703107|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703108|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703109|NCT01811186|Analgesics|analgesics|mesh-ancestor
154703110|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
154703111|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703112|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154703113|NCT01866098|Naltrexone|naltrexone|mesh-list
154703114|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154703115|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154703116|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703117|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
154703118|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703119|NCT04885972|Triamcinolone|triamcinolone|mesh-list
154703120|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154703121|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154703122|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154703123|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703124|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
154703125|NCT04885972|Hormones|hormones|mesh-ancestor
154703126|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703127|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703128|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154703129|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
154703130|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703131|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703132|NCT03985540|Methamphetamine|methamphetamine|mesh-list
154703133|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154703134|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703135|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
154703136|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
154703137|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703138|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
154703139|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703140|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703141|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
154703142|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154703143|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154703144|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154703145|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154703146|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154703147|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
154703148|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
154703149|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703150|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703151|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
154703152|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703153|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154703154|NCT01865552|Etanercept|etanercept|mesh-list
154703155|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154703156|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154703157|NCT01865552|Analgesics|analgesics|mesh-ancestor
154703158|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
154703159|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703160|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703161|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703162|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154703163|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703164|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154703165|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
154703166|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
154455137|NCT02183220|Aspirin|aspirin|mesh-list
154703167|NCT01809314|Hematinics|hematinics|mesh-ancestor
154703168|NCT01808690|Metformin|metformin|mesh-list
154703169|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154703170|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703171|NCT04583618|Vaccines|vaccines|mesh-list
154703172|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154703173|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
154703174|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703175|NCT04413734|Cisplatin|cisplatin|mesh-list
154703176|NCT04413734|Gemcitabine|gemcitabine|mesh-list
154703177|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703178|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154703179|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
154703180|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703181|NCT03229798|Sumatriptan|sumatriptan|mesh-list
154703182|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154703183|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154703184|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154703185|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
154703186|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703187|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703188|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703189|NCT04805944|Dolutegravir|dolutegravir|mesh-list
154703190|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154703191|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154703192|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703193|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703194|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154703195|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154703196|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
154703197|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703198|NCT03906292|Niacinamide|niacinamide|mesh-list
154703199|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
154703200|NCT03906292|Dasatinib|dasatinib|mesh-list
154703201|NCT03906292|Nilotinib|nilotinib|mesh-list
154703202|NCT03906292|Asciminib|asciminib|mesh-list
154703203|NCT03906292|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154703204|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703205|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703206|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703207|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703208|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
154703209|NCT03906292|Vitamins|vitamins|mesh-ancestor
154703210|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
154703211|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703212|NCT03229174|Droxidopa|droxidopa|mesh-list
154703213|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154703214|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154703215|NCT03227926|Panitumumab|panitumumab|mesh-list
154703216|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703217|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703218|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154703219|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703220|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703221|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154703222|NCT01363297|Immunotoxins|immunotoxins|mesh-ancestor
154703223|NCT01363297|Immunoconjugates|immunoconjugates|mesh-ancestor
154703224|NCT01363297|Immunologic Factors|immunologic factors|mesh-ancestor
154703225|NCT01363297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703226|NCT03199924|Diclofenac|diclofenac|mesh-list
154703227|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154703228|NCT03199924|Lidocaine|lidocaine|mesh-list
154703229|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
154703230|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
154703231|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
154703232|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703233|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703234|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
154703235|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703236|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154703237|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154703238|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154703239|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154703240|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703241|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154703242|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154703243|NCT03199924|Analgesics|analgesics|mesh-ancestor
154703244|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154703245|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154703246|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703247|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
154703248|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154703249|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154703250|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
154703251|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154703253|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703254|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
154703255|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
154703256|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703257|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703258|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703259|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
154703260|NCT04746430|Hormones|hormones|mesh-ancestor
154703261|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703262|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154703263|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703264|NCT03197662|Oxytocin|oxytocin|mesh-list
154703265|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
154703266|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154703267|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703268|NCT03247582|Edoxaban|edoxaban|mesh-list
154703269|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154703270|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
154703271|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154703272|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
154703273|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703274|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703275|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
154703276|NCT01808612|Fluoxetine|fluoxetine|mesh-list
154703277|NCT01808612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154703278|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154703279|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154703280|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703281|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703282|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
154703283|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703284|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154703285|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
154703286|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154703287|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154703288|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154703289|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703290|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
154703291|NCT01908829|Mirabegron|mirabegron|mesh-list
154703292|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154703293|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154703294|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154703295|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703296|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703297|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703298|NCT01908829|Urological Agents|urological agents|mesh-ancestor
154703299|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154703300|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154703301|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154703302|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
154703303|NCT01773122|Dapsone|dapsone|mesh-list
154703304|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703305|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
154703306|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154703307|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154703308|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154703309|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703310|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703311|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
154703312|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703313|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
154703314|NCT01808534|Ifosfamide|ifosfamide|mesh-list
154703315|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154703316|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
154703317|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455280|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
154703318|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703319|NCT03218800|Ertapenem|ertapenem|mesh-list
154703320|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703321|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703322|NCT01802216|Minocycline|minocycline|mesh-list
154703323|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703324|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703325|NCT03621904|Tamoxifen|tamoxifen|mesh-list
154703326|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
154703327|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
154703328|NCT03621904|Progesterone|progesterone|mesh-list
154703329|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154703330|NCT03621904|Progestins|progestins|mesh-ancestor
154703331|NCT03621904|Hormones|hormones|mesh-ancestor
154703332|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703333|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703334|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154703335|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
154703336|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154703337|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154703338|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154703339|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154703340|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703341|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703342|NCT01808144|Febuxostat|febuxostat|mesh-list
154703343|NCT01808144|Lesinurad|lesinurad|mesh-list
154703344|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
154703345|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154703346|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
154703347|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
154703348|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703349|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703350|NCT02085070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154703351|NCT02085070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703352|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154703353|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
154703354|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703355|NCT01801436|Bortezomib|bortezomib|mesh-list
154703356|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703357|NCT01771250|Insulin|insulin|mesh-list
154703358|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154703359|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
154703360|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154703361|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703362|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154703363|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154703364|NCT03568708|Estradiol|estradiol|mesh-list
154703365|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154703366|NCT03568708|Estrogens|estrogens|mesh-list
154703367|NCT03568708|Hormones|hormones|mesh-ancestor
154703368|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703369|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703370|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154703371|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
154703372|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154703373|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154703374|NCT04305106|Bevacizumab|bevacizumab|mesh-list
154703375|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703376|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703377|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154703378|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154703379|NCT04305106|Growth Substances|growth substances|mesh-ancestor
154703380|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703381|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
154703382|NCT01770392|Rifampin|rifampin|mesh-list
154703383|NCT01770392|Nintedanib|nintedanib|mesh-list
154703384|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154703385|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
154703386|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703387|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703388|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
154703389|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154703390|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703391|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703392|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154703393|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154703394|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154703395|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154703396|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154703397|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154703398|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703399|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703400|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
154703401|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154703402|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154703403|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154703404|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154703405|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703406|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
154703407|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703408|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703409|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154703410|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703411|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
154703412|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154703413|NCT03492112|Velpatasvir|velpatasvir|mesh-list
154703414|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
154703415|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703416|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
154703417|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154703418|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703419|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703420|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154703421|NCT01576575|Rifampin|rifampin|mesh-list
154703422|NCT01576575|Ketoconazole|ketoconazole|mesh-list
154703423|NCT01576575|Buprenorphine|buprenorphine|mesh-list
154703424|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154703425|NCT01576575|Narcotics|narcotics|mesh-ancestor
154703426|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703427|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703428|NCT01576575|Analgesics|analgesics|mesh-ancestor
154703429|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
154703430|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703431|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154703432|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154703433|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
154703434|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703435|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703436|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
154703437|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154703438|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703439|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703440|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154703441|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154703442|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154703443|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154703444|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154703445|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154703446|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
154703447|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154703448|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154703449|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154703450|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
154703451|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703452|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154703453|NCT05051566|Esomeprazole|esomeprazole|mesh-list
154703454|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154703455|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703456|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154703457|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703458|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703459|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
154703460|NCT01576341|Hematinics|hematinics|mesh-ancestor
154703461|NCT04398004|Clarithromycin|clarithromycin|mesh-list
154703462|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703463|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703464|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154703465|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860365|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703466|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703467|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154703468|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154703469|NCT01687413|Cisplatin|cisplatin|mesh-list
154703470|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703471|NCT01555671|Meperidine|meperidine|mesh-list
154703472|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154703473|NCT01555671|Narcotics|narcotics|mesh-ancestor
154703474|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703475|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703476|NCT01555671|Analgesics|analgesics|mesh-ancestor
154703477|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
154703478|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703479|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154703480|NCT03226756|Nivolumab|nivolumab|mesh-list
154703481|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703482|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703483|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154703484|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703485|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154703486|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
154703487|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703488|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703489|NCT01807598|Immunotoxins|immunotoxins|mesh-ancestor
154703490|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
154703491|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703492|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
154703493|NCT01801280|Pantoprazole|pantoprazole|mesh-list
154703494|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154703495|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703496|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154703497|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
154703498|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703499|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703500|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703501|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703502|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154703503|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703504|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154703505|NCT01769456|Tenofovir|tenofovir|mesh-list
154703506|NCT01769456|Emtricitabine|emtricitabine|mesh-list
154703507|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154703508|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
154703509|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703510|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154703511|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154703512|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703513|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703514|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154703515|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154703516|NCT01769378|Glimepiride|glimepiride|mesh-list
154703517|NCT01769378|Dulaglutide|dulaglutide|mesh-list
154703518|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154703519|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154703520|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703521|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154703522|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
154703523|NCT01769378|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154703524|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154703525|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
154703526|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703527|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154703528|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
154703529|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703530|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154703531|NCT01768286|Ledipasvir|ledipasvir|mesh-list
154703532|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
154703533|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703534|NCT01800968|Liraglutide|liraglutide|mesh-list
154703535|NCT01800968|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154703536|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154703537|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703538|NCT01800968|Incretins|incretins|mesh-ancestor
154703539|NCT01800968|Hormones|hormones|mesh-ancestor
154455515|NCT02190708|Midazolam|midazolam|mesh-list
154703540|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703541|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
154703542|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
154703543|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703544|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154703545|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
154703546|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
154703547|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703548|NCT01687101|Menthol|menthol|mesh-list
154703549|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
154703550|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
154703551|NCT01968967|Bococizumab|bococizumab|mesh-list
154703552|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154703553|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154703554|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
154703555|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703556|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154703557|NCT01806662|Ustekinumab|ustekinumab|mesh-list
154703558|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
154703559|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
154703560|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
154703561|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154703562|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154703563|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
154703564|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703565|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154703566|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154703567|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703568|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703569|NCT01930045|Antacids|antacids|mesh-ancestor
154703570|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703571|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
154703572|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154703573|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
154703574|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703575|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
154703576|NCT04631263|Protective Agents|protective agents|mesh-ancestor
154703577|NCT01929343|Lidocaine|lidocaine|mesh-list
154703578|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
154703579|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
154703580|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703581|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703582|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
154703583|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703584|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154703585|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154703586|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154703587|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154703588|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703589|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154703590|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
154703591|NCT01806584|Coagulants|coagulants|mesh-ancestor
154703592|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154703593|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703594|NCT01767194|Sirolimus|sirolimus|mesh-list
154703595|NCT01767194|Irinotecan|irinotecan|mesh-list
154703596|NCT01767194|Camptothecin|camptothecin|mesh-list
154703597|NCT01767194|Temozolomide|temozolomide|mesh-list
154703598|NCT01767194|Temsirolimus|temsirolimus|mesh-list
154703599|NCT01767194|Dinutuximab|dinutuximab|mesh-list
154703600|NCT01767194|MTOR Inhibitors|mtor inhibitors|mesh-list
154703601|NCT01767194|Sargramostim|sargramostim|mesh-list
154703602|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154703603|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154703604|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703605|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703606|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703607|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154703608|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
154703609|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703610|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703611|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154703612|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
154703613|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154703614|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
154703615|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703616|NCT01767194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703617|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154703618|NCT01575873|Denosumab|denosumab|mesh-list
154703619|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154703620|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703621|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
154703622|NCT04276636|Antacids|antacids|mesh-ancestor
154703623|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703624|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703625|NCT00002644|Tamoxifen|tamoxifen|mesh-list
154703626|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154703627|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
154703628|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703629|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703630|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154703631|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703632|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154703633|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154703634|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154703635|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154703636|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154703637|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154703638|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703639|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703640|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154703641|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154703642|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154703643|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154703644|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
154703645|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703646|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703647|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154703648|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154703649|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
154703650|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154703651|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154703652|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
154703653|NCT04397770|Temozolomide|temozolomide|mesh-list
154703654|NCT04397770|Apatinib|apatinib|mesh-list
154703655|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154703656|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
154703657|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703658|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703659|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703660|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703661|NCT03082846|Temozolomide|temozolomide|mesh-list
154703662|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154703663|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
154703664|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703665|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703666|NCT01609790|Bevacizumab|bevacizumab|mesh-list
154703667|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154703668|NCT01609790|Trebananib|trebananib|mesh-list
154703669|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
154703670|NCT01609790|Antibodies|antibodies|mesh-list
154703671|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
154703672|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154703673|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
154703674|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703675|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154703676|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154703677|NCT01609790|Growth Substances|growth substances|mesh-ancestor
154703678|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703679|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
154703680|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
154703681|NCT01767116|Ribavirin|ribavirin|mesh-list
154703682|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
154703683|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703684|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
154703685|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703686|NCT01574703|Bupropion|bupropion|mesh-list
154703687|NCT01574703|Nicotine|nicotine|mesh-list
154455653|NCT03694873|Celecoxib|celecoxib|mesh-list
154703688|NCT01574703|Varenicline|varenicline|mesh-list
154703689|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154703690|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
154703691|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703692|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703693|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154703694|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154703695|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
154703696|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703697|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703698|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154703699|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
154703700|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153958519|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
154703701|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154703702|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154703703|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154703704|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
154703705|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154703706|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154703707|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703708|NCT01686633|Fluticasone|fluticasone|mesh-list
154703709|NCT01686633|Xhance|xhance|mesh-list
154703710|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703711|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154703712|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
154703713|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703714|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703715|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154703716|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
154703717|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
154703718|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154703719|NCT03141424|Fluticasone|fluticasone|mesh-list
154703720|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
154703721|NCT03141424|Ciclesonide|ciclesonide|mesh-list
154703722|NCT03141424|Budesonide|budesonide|mesh-list
154703723|NCT03141424|Beclomethasone|beclomethasone|mesh-list
154703724|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703725|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154703726|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
154703727|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703728|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703729|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154703730|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
154703731|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
154703732|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154703733|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
154703734|NCT03141424|Hormones|hormones|mesh-ancestor
154703735|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703736|NCT03614494|Piroxicam|piroxicam|mesh-list
154703737|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
154703738|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154703739|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
154703740|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154703741|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703742|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154703743|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154703744|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154703745|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154703746|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154703747|NCT03614494|Analgesics|analgesics|mesh-ancestor
154703748|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
154703749|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703750|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703751|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154703752|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154703753|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703754|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703755|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
154703756|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703757|NCT05245708|Oxytocin|oxytocin|mesh-list
154703758|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
154703759|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154703760|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703761|NCT01922596|Ropivacaine|ropivacaine|mesh-list
154703762|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
154703763|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
154703764|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860366|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
154703765|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703766|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
154703767|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703768|NCT01573767|Fluticasone|fluticasone|mesh-list
154703769|NCT01573767|Xhance|xhance|mesh-list
154703770|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703771|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154703772|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
154703773|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703774|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703775|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154703776|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
154703777|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
154703778|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154703779|NCT03133546|Bevacizumab|bevacizumab|mesh-list
154703780|NCT03133546|Osimertinib|osimertinib|mesh-list
154703781|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703782|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703783|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154703784|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154703785|NCT03133546|Growth Substances|growth substances|mesh-ancestor
154703786|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703787|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
154703788|NCT03133546|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154703789|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703790|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703791|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703792|NCT01551303|Oxytocin|oxytocin|mesh-list
154703793|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
154703794|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154703795|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703796|NCT01685073|Zolpidem|zolpidem|mesh-list
154703797|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154703798|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154703799|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703800|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703801|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154703802|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
154703803|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
154703804|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703805|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703806|NCT05241028|Ensartinib|ensartinib|mesh-list
154703807|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703808|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703809|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703810|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703811|NCT01572675|Celecoxib|celecoxib|mesh-list
154703812|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154703813|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154703814|NCT01572675|Analgesics|analgesics|mesh-ancestor
154703815|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
154703816|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703817|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703818|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703819|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154703820|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154703821|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154703822|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703823|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703824|NCT05929937|Analgesics, Opioid|analgesics, opioid|mesh-list
154703825|NCT05929937|Narcotics|narcotics|mesh-ancestor
154703826|NCT05929937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703827|NCT05929937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703828|NCT05929937|Analgesics|analgesics|mesh-ancestor
154703829|NCT05929937|Sensory System Agents|sensory system agents|mesh-ancestor
154703830|NCT05929937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703831|NCT05929755|Methylprednisolone|methylprednisolone|mesh-list
154703832|NCT05929755|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154703833|NCT05929755|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154703834|NCT05929755|Prednisolone|prednisolone|mesh-list
154703835|NCT05929755|Prednisolone acetate|prednisolone acetate|mesh-list
154703836|NCT05929755|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154703837|NCT05929755|Prednisolone phosphate|prednisolone phosphate|mesh-list
154703838|NCT05929755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455799|NCT02257008|Ritonavir|ritonavir|mesh-list
154703840|NCT05929755|Autonomic Agents|autonomic agents|mesh-ancestor
154703841|NCT05929755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703842|NCT05929755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703843|NCT05929755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703844|NCT05929755|Glucocorticoids|glucocorticoids|mesh-ancestor
154703845|NCT05929755|Hormones|hormones|mesh-ancestor
154703846|NCT05929755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703847|NCT05929755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154703848|NCT05929755|Protective Agents|protective agents|mesh-ancestor
154703849|NCT05929755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154703850|NCT05929755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703851|NCT05929456|Cetuximab|cetuximab|mesh-list
154703852|NCT05929456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703853|NCT05929456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703854|NCT05929339|Oxytocin|oxytocin|mesh-list
154703855|NCT05929339|Oxytocics|oxytocics|mesh-ancestor
154703856|NCT05929339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154703857|NCT05929339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703858|NCT05928988|Itraconazole|itraconazole|mesh-list
154703859|NCT05928988|Antifungal Agents|antifungal agents|mesh-ancestor
154703860|NCT05928988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703861|NCT05928988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154703862|NCT05928988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154703863|NCT05928988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703864|NCT05928988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703865|NCT05928988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154703866|NCT05928988|Hormone Antagonists|hormone antagonists|mesh-ancestor
154703867|NCT05928988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703868|NCT05928988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703869|NCT05928988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154703870|NCT05928780|Fluzoparib|fluzoparib|mesh-list
154703871|NCT05928780|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154703872|NCT05928780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703873|NCT05928780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703874|NCT05928780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703875|NCT05928000|Tenofovir|tenofovir|mesh-list
154703876|NCT05928000|Entecavir|entecavir|mesh-list
154703877|NCT05928000|Antiviral Agents|antiviral agents|mesh-ancestor
154703878|NCT05928000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703879|NCT05928000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154703880|NCT05928000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154703881|NCT05928000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958689|NCT05251662|Bevacizumab|bevacizumab|mesh-list
154703882|NCT05928000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703883|NCT05928000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154703884|NCT05928000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154703885|NCT05927233|Methylprednisolone|methylprednisolone|mesh-list
154703886|NCT05927233|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154703887|NCT05927233|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154703888|NCT05927233|Prednisolone|prednisolone|mesh-list
154703889|NCT05927233|Prednisolone acetate|prednisolone acetate|mesh-list
154703890|NCT05927233|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154703891|NCT05927233|Prednisolone phosphate|prednisolone phosphate|mesh-list
154703892|NCT05927233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154703893|NCT05927233|Antiemetics|antiemetics|mesh-ancestor
154703894|NCT05927233|Autonomic Agents|autonomic agents|mesh-ancestor
154703895|NCT05927233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703896|NCT05927233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703897|NCT05927233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703898|NCT05927233|Glucocorticoids|glucocorticoids|mesh-ancestor
154703899|NCT05927233|Hormones|hormones|mesh-ancestor
154703900|NCT05927233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154703901|NCT05927233|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154703902|NCT05927233|Protective Agents|protective agents|mesh-ancestor
154703903|NCT05927233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154703904|NCT05927233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703905|NCT05873218|Ephedrine|ephedrine|mesh-list
154703906|NCT05873218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154703907|NCT05873218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703908|NCT05873218|Sympathomimetics|sympathomimetics|mesh-ancestor
154703909|NCT05873218|Autonomic Agents|autonomic agents|mesh-ancestor
154703910|NCT05873218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703911|NCT05873218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154455884|NCT02194452|Octreotide|octreotide|mesh-list
154703912|NCT05873218|Adrenergic Agents|adrenergic agents|mesh-ancestor
154703913|NCT05873218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703914|NCT05873218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703915|NCT05839158|Mupirocin|mupirocin|mesh-list
154703916|NCT05839158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154703917|NCT05839158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703918|NCT05839158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154703919|NCT05839158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703920|NCT05839158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703921|NCT05441280|Pimavanserin|pimavanserin|mesh-list
154703922|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154703923|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154703924|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154703925|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154703926|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154703927|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703928|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154703929|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154703930|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154703931|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
154703932|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703933|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703934|NCT05413161|Omalizumab|omalizumab|mesh-list
154703935|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154703936|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154703937|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154703938|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
154703939|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
154703940|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703941|NCT05343169|Naloxone|naloxone|mesh-list
154703942|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154703943|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703944|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
154703945|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154703946|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154703947|NCT05228314|Vaccines|vaccines|mesh-list
154703948|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
154703949|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
154703950|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703951|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154703952|NCT05228314|Antacids|antacids|mesh-ancestor
154703953|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703954|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154703955|NCT05167760|Apraclonidine|apraclonidine|mesh-list
154703956|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154703957|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154703958|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154703959|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
154703960|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154703961|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703962|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703963|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
154703964|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154703965|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703966|NCT05127590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154703967|NCT05127590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703968|NCT05116891|Leucovorin|leucovorin|mesh-list
154703969|NCT05116891|Cisplatin|cisplatin|mesh-list
154703970|NCT05116891|Gemcitabine|gemcitabine|mesh-list
154703971|NCT05116891|Docetaxel|docetaxel|mesh-list
154703972|NCT05116891|Fluorouracil|fluorouracil|mesh-list
154703973|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
154703974|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703975|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154703976|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
154703977|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703978|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
154703979|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
154703980|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
154703981|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154703982|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
154703983|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154703984|NCT05116891|Antidotes|antidotes|mesh-ancestor
154703985|NCT05116891|Protective Agents|protective agents|mesh-ancestor
154703986|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
154703987|NCT05116891|Vitamins|vitamins|mesh-ancestor
154703988|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
154703989|NCT05069038|Palbociclib|palbociclib|mesh-list
154703990|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154703991|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154703992|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154703993|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582987|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154703994|NCT04983030|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154703995|NCT04983030|Antiviral Agents|antiviral agents|mesh-ancestor
154703996|NCT04983030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154703997|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
154703998|NCT04973566|Etanercept|etanercept|mesh-list
154703999|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
154704000|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154704001|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154704002|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704003|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704004|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704005|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704006|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154704007|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154704008|NCT04973566|Analgesics|analgesics|mesh-ancestor
154704009|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
154704010|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704011|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704012|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154704013|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704014|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704015|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
154704016|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
154704017|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704018|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704019|NCT04856189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704020|NCT04856189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704021|NCT04855929|Ipilimumab|ipilimumab|mesh-list
154704022|NCT04855929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704023|NCT04855929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704024|NCT04855929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704025|NCT04855929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704026|NCT04760496|Oxytocin|oxytocin|mesh-list
154704027|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
154704028|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154704029|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704030|NCT04722822|Vaccines|vaccines|mesh-list
154704031|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
154704032|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704033|NCT04515641|Islatravir|islatravir|mesh-list
154704034|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
154704035|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704036|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704037|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704038|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154704039|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154704040|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154704041|NCT04474366|Ropivacaine|ropivacaine|mesh-list
154704042|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
154704043|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
154704044|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704045|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704046|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
154704047|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704048|NCT04465643|Nivolumab|nivolumab|mesh-list
154704049|NCT04465643|Ipilimumab|ipilimumab|mesh-list
154704050|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704051|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704052|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704053|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704054|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154704055|NCT04422431|Choline|choline|mesh-list
154704056|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
154704057|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154704058|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
154704059|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704060|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704061|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154704062|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
154704063|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
154704064|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
154704065|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704066|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154704067|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154704068|NCT04422431|Growth Substances|growth substances|mesh-ancestor
154704069|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704070|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
154704071|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704072|NCT04416451|Rituximab|rituximab|mesh-list
154704073|NCT04416451|Venetoclax|venetoclax|mesh-list
154704074|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704075|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704076|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
154704077|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704078|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704079|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
154704080|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154704081|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
154704082|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
154704083|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704084|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704085|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704086|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154704087|NCT04406649|Analgesics|analgesics|mesh-ancestor
154704088|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
154704089|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704090|NCT04316390|Vitamins|vitamins|mesh-list
154704091|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
154704092|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
154704093|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704094|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
154704095|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704096|NCT04316390|Protective Agents|protective agents|mesh-ancestor
154704097|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
154704098|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154704099|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704100|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
154704101|NCT04129554|Tenofovir|tenofovir|mesh-list
154704102|NCT04129554|Entecavir|entecavir|mesh-list
154704103|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
154704104|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
154704105|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582988|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154704106|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154704107|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154704108|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704109|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704110|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154704111|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154704112|NCT04109729|Nivolumab|nivolumab|mesh-list
154704113|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704114|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704115|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704116|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704117|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
154704118|NCT04049513|Fludarabine|fludarabine|mesh-list
154704119|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704120|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
154704121|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704122|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704123|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704124|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
154704125|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704126|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704127|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154704128|NCT04002180|Vedolizumab|vedolizumab|mesh-list
154704129|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704130|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
154704131|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704132|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704133|NCT03968419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704134|NCT03968419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704135|NCT03924986|Tislelizumab|tislelizumab|mesh-list
154704136|NCT03924986|Gemcitabine|gemcitabine|mesh-list
154704137|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704138|NCT03924986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704139|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154704140|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
154704141|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704142|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
154704143|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154704144|NCT03866577|Antibodies|antibodies|mesh-list
154704145|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
154704146|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154704147|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
154704148|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704149|NCT03662022|Rifampin|rifampin|mesh-list
154704150|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154704151|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
154704152|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154704153|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704154|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
154704155|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154704156|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704157|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704158|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154704159|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153958989|NCT00833794|Tramadol|tramadol|mesh-list
154704160|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154704161|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154704162|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154704163|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154704164|NCT03648996|Allopurinol|allopurinol|mesh-list
154704165|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
154704166|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704167|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704168|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
154704169|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704170|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154704171|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
154704172|NCT03648996|Protective Agents|protective agents|mesh-ancestor
154704173|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704174|NCT03523312|Capecitabine|capecitabine|mesh-list
154704175|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154704176|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
154704177|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704178|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704179|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
154704180|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
154704181|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704182|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704183|NCT03449238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704184|NCT03449238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704185|NCT03439293|Dexamethasone|dexamethasone|mesh-list
154704186|NCT03439293|Daratumumab|daratumumab|mesh-list
154704187|NCT03439293|Ixazomib|ixazomib|mesh-list
154704188|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154704189|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
154704190|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
154704191|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704192|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704193|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704194|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
154704195|NCT03439293|Hormones|hormones|mesh-ancestor
154704196|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704197|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154704198|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704199|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
154704200|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704201|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704202|NCT03423979|Paclitaxel|paclitaxel|mesh-list
154704203|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154704204|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704205|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
154704206|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
154704207|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
154704208|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704209|NCT03239210|Ondansetron|ondansetron|mesh-list
154704210|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
154456168|NCT02201082|Amikacin|amikacin|mesh-list
154704211|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
154704212|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704213|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704214|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704215|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
154704216|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
154704217|NCT03239210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154704218|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154704219|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
154704220|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704221|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704222|NCT03196466|Topiramate|topiramate|mesh-list
154704223|NCT03196466|Pregabalin|pregabalin|mesh-list
154704224|NCT03196466|Lamotrigine|lamotrigine|mesh-list
154704225|NCT03196466|Zonisamide|zonisamide|mesh-list
154704226|NCT03196466|Lacosamide|lacosamide|mesh-list
154704227|NCT03196466|Carbamazepine|carbamazepine|mesh-list
154704228|NCT03196466|Phenytoin|phenytoin|mesh-list
154704229|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
154704230|NCT03196466|Rufinamide|rufinamide|mesh-list
154704231|NCT03196466|Cannabidiol|cannabidiol|mesh-list
154704232|NCT03196466|Levetiracetam|levetiracetam|mesh-list
154704233|NCT03196466|Valproic Acid|valproic acid|mesh-list
154704234|NCT03196466|Brivaracetam|brivaracetam|mesh-list
154704235|NCT03196466|Phenobarbital|phenobarbital|mesh-list
154704236|NCT03196466|Clobazam|clobazam|mesh-list
154704237|NCT03196466|Ethosuximide|ethosuximide|mesh-list
154704238|NCT03196466|Stiripentol|stiripentol|mesh-list
154704239|NCT03196466|Tiagabine|tiagabine|mesh-list
154704240|NCT03196466|Primidone|primidone|mesh-list
154704241|NCT03196466|Felbamate|felbamate|mesh-list
154704242|NCT03196466|Analgesics|analgesics|mesh-ancestor
154704243|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
154704244|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704245|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704246|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
154704247|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154704248|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154704249|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704250|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154704251|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154704252|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154704253|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704254|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154704255|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154704256|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
154704257|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154704258|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154704259|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704260|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
154704261|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704262|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
154704263|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154704264|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154704265|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154704266|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154704267|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154704268|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154704269|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154704270|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154704271|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
154704272|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154704273|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154704274|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
154704275|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
154704276|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154704277|NCT03184870|Leucovorin|leucovorin|mesh-list
154704278|NCT03184870|Paclitaxel|paclitaxel|mesh-list
154704279|NCT03184870|Gemcitabine|gemcitabine|mesh-list
154704280|NCT03184870|Nivolumab|nivolumab|mesh-list
154704281|NCT03184870|Fluorouracil|fluorouracil|mesh-list
154704282|NCT03184870|Irinotecan|irinotecan|mesh-list
154704283|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154704284|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704285|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
154704286|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
154704287|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
154704288|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704289|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154704290|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
154704291|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704292|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704293|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704295|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704296|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154704297|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154704298|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704299|NCT03184870|Antidotes|antidotes|mesh-ancestor
154704300|NCT03184870|Protective Agents|protective agents|mesh-ancestor
154704301|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
154704302|NCT03184870|Vitamins|vitamins|mesh-ancestor
154704303|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
154704304|NCT03122522|Nivolumab|nivolumab|mesh-list
154704305|NCT03122522|Ipilimumab|ipilimumab|mesh-list
154704306|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704307|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704308|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704309|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704310|NCT03086343|Abatacept|abatacept|mesh-list
154704311|NCT03086343|Upadacitinib|upadacitinib|mesh-list
154704312|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704313|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704314|NCT03086343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704315|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704316|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704317|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
154704318|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704319|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704320|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154704321|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154704322|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704323|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
154704324|NCT02904226|Nivolumab|nivolumab|mesh-list
154704325|NCT02904226|Ipilimumab|ipilimumab|mesh-list
154704326|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704327|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704328|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704329|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704330|NCT02775695|Doxycycline|doxycycline|mesh-list
154704331|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154704332|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704333|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
154704334|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154704335|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154704336|NCT02679040|Trastuzumab|trastuzumab|mesh-list
154704337|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704338|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704339|NCT02610075|Adavosertib|adavosertib|mesh-list
154704340|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704341|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704342|NCT02599454|Atezolizumab|atezolizumab|mesh-list
154704343|NCT02599454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704344|NCT02599454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704345|NCT02599454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704346|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704347|NCT02482311|Adavosertib|adavosertib|mesh-list
154704348|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704349|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704350|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
154704351|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154704352|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
154704353|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704354|NCT01466686|Temozolomide|temozolomide|mesh-list
154704355|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704356|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
154704357|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704358|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704359|NCT01093196|Dexamethasone|dexamethasone|mesh-list
154704360|NCT01093196|Prednisone|prednisone|mesh-list
154704361|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
154704362|NCT01093196|Melphalan|melphalan|mesh-list
154704363|NCT01093196|Lenalidomide|lenalidomide|mesh-list
154704364|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154456328|NCT03533556|Caffeine|caffeine|mesh-list
154704365|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
154704366|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704367|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704368|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704369|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
154704370|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704371|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704372|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154704373|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154704374|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
154704375|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
154704376|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704377|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704378|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
154704379|NCT01093196|Hormones|hormones|mesh-ancestor
154704380|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704381|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154704382|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154704383|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154704384|NCT01093196|Growth Substances|growth substances|mesh-ancestor
154704385|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
154704386|NCT01091831|Dexamethasone|dexamethasone|mesh-list
154704387|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
154704388|NCT01091831|Melphalan|melphalan|mesh-list
154704389|NCT01091831|Lenalidomide|lenalidomide|mesh-list
154704390|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704391|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
154704392|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704393|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704394|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704395|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
154704396|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704397|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704398|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154704399|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154704400|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
154704401|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
154704402|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704403|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704404|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
154704405|NCT01091831|Hormones|hormones|mesh-ancestor
154704406|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704407|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154704408|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154704409|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154704410|NCT01091831|Growth Substances|growth substances|mesh-ancestor
154704411|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
154704412|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
154704413|NCT00093834|Doxorubicin|doxorubicin|mesh-list
154704414|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154704415|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704416|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
154704417|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704418|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704419|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704420|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
154704421|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704422|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704423|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154704424|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154704425|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154704426|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154704427|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704428|NCT01550289|Vaccines|vaccines|mesh-list
154704429|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
154704430|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704431|NCT01968031|Istradefylline|istradefylline|mesh-list
154704432|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154704433|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154704434|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154704435|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
154704436|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704437|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704438|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456394|NCT02203500|Telmisartan|telmisartan|mesh-list
154704439|NCT01684215|Letrozole|letrozole|mesh-list
154704440|NCT01684215|Palbociclib|palbociclib|mesh-list
154704441|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704442|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154704443|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154704444|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704445|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704446|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154704447|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
154704448|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704449|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704450|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154704451|NCT01908205|Oxytocin|oxytocin|mesh-list
154704452|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
154704453|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154704454|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704455|NCT01549041|Asenapine|asenapine|mesh-list
154704456|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154704457|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154704458|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704459|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704460|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154704461|NCT01907815|Trametinib|trametinib|mesh-list
154704462|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704463|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154704464|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704465|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704466|NCT01548573|Thalidomide|thalidomide|mesh-list
154704467|NCT01548573|Dexamethasone|dexamethasone|mesh-list
154704468|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
154704469|NCT01548573|Melphalan|melphalan|mesh-list
154704470|NCT01548573|Doxorubicin|doxorubicin|mesh-list
154704471|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154704472|NCT01548573|Etoposide|etoposide|mesh-list
154704473|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
154704474|NCT01548573|Bortezomib|bortezomib|mesh-list
154704475|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704476|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
154704477|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704478|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704479|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704480|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
154704481|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704482|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704483|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154704484|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154704485|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
154704486|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
154704487|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704488|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704489|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
154704490|NCT01548573|Hormones|hormones|mesh-ancestor
154704491|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704492|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154704493|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154704494|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154704495|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154704496|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704497|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154704498|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
154704499|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154704500|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704501|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154704502|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154704503|NCT01548573|Growth Substances|growth substances|mesh-ancestor
154704504|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
154704505|NCT01570491|Anesthetics|anesthetics|mesh-list
154704506|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704507|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704508|NCT01518153|Methotrexate|methotrexate|mesh-list
154704509|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
154704510|NCT01518153|Fludarabine|fludarabine|mesh-list
154704511|NCT01518153|Melphalan|melphalan|mesh-list
154704512|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
154704513|NCT01518153|Tacrolimus|tacrolimus|mesh-list
154704514|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154704515|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
154704516|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154704517|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704518|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154704519|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
154704520|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704521|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704522|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
154704523|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704524|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154704525|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704526|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
154704527|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704528|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154704529|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154704530|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704531|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
154704532|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154704533|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704534|NCT04620343|Anesthetics|anesthetics|mesh-list
154704535|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704536|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704537|NCT01517373|Glimepiride|glimepiride|mesh-list
154704538|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154704539|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154704540|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704541|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704542|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
154704543|NCT01517295|Hydrocodone|hydrocodone|mesh-list
154704544|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154704545|NCT01517295|Narcotics|narcotics|mesh-ancestor
154704546|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704547|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704548|NCT01517295|Analgesics|analgesics|mesh-ancestor
154704549|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
154704550|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704551|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
154704552|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
154704553|NCT01548417|Mifepristone|mifepristone|mesh-list
154704554|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154704555|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
154704556|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154704557|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704558|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154704559|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154704560|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154704561|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
154704562|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154704563|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154704564|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
154704565|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704566|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
154704567|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154704568|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154704569|NCT01546857|Gabapentin|gabapentin|mesh-list
154704570|NCT01546857|Analgesics|analgesics|mesh-ancestor
154704571|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
154704572|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704573|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704574|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
154704575|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154704576|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154704577|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704578|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154704579|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154704580|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154704581|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704582|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704583|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
154704584|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154704585|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704586|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154704587|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154456548|NCT02209350|Aspirin|aspirin|mesh-list
154704588|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154704589|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154704590|NCT00637000|Buprenorphine|buprenorphine|mesh-list
154704591|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154704592|NCT00637000|Naloxone|naloxone|mesh-list
154704593|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154704594|NCT00637000|Narcotics|narcotics|mesh-ancestor
154704595|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704596|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704597|NCT00637000|Analgesics|analgesics|mesh-ancestor
154704598|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
154704599|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704600|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154704601|NCT01515189|Ipilimumab|ipilimumab|mesh-list
154704602|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704603|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704604|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154704605|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704606|NCT01546623|Leuprolide|leuprolide|mesh-list
154704607|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154704608|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
154704609|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154704610|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704611|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154704612|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704613|NCT00636610|Bevacizumab|bevacizumab|mesh-list
154704614|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704615|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704616|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154704617|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154704618|NCT00636610|Growth Substances|growth substances|mesh-ancestor
154704619|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704620|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
154704621|NCT00635050|Paclitaxel|paclitaxel|mesh-list
154704622|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
154704623|NCT00635050|Bevacizumab|bevacizumab|mesh-list
154704624|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154704625|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704626|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
154704627|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
154704628|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
154704629|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704630|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704631|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
154704632|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704633|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704634|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704635|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
154704636|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154704637|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704638|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154704639|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154704640|NCT00635050|Growth Substances|growth substances|mesh-ancestor
154704641|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
154704642|NCT05240404|Immunomodulating Agents|immunomodulating agents|mesh-list
154704643|NCT05240404|Immunologic Factors|immunologic factors|mesh-ancestor
154704644|NCT05240404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704645|NCT01923376|Lactulose|lactulose|mesh-list
154704646|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154704647|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704648|NCT01923376|Laxatives|laxatives|mesh-ancestor
154704649|NCT05245786|Copper|copper|mesh-list
154704650|NCT05245786|Antibodies|antibodies|mesh-list
154704651|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154704652|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
154704653|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704654|NCT05245786|Trace Elements|trace elements|mesh-ancestor
154704655|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
154704656|NCT00634504|Leucovorin|leucovorin|mesh-list
154704657|NCT00634504|Methotrexate|methotrexate|mesh-list
154704658|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
154704659|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154704660|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
154704661|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154704662|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704663|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154456616|NCT02220660|Olodaterol|olodaterol|mesh-list
154704664|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
154704665|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704666|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704667|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
154704668|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704669|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154704670|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704671|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
154704672|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704673|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154704674|NCT00634504|Antidotes|antidotes|mesh-ancestor
154704675|NCT00634504|Protective Agents|protective agents|mesh-ancestor
154704676|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
154704677|NCT00634504|Vitamins|vitamins|mesh-ancestor
154704678|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
154704679|NCT03101254|Vemurafenib|vemurafenib|mesh-list
154704680|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704681|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154704682|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704683|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704684|NCT00634114|Esomeprazole|esomeprazole|mesh-list
154704685|NCT00634114|Omeprazole|omeprazole|mesh-list
154704686|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154704687|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704688|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154704689|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704690|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704691|NCT00634036|Pioglitazone|pioglitazone|mesh-list
154704692|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154704693|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704694|NCT05241496|Lidocaine|lidocaine|mesh-list
154704695|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
154704696|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
154704697|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704698|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704699|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
154704700|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704701|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154704702|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154704703|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154704704|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154704705|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704706|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154704707|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
154704708|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704709|NCT01539837|Deferiprone|deferiprone|mesh-list
154704710|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154704711|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
154704712|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
154704713|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704714|NCT04410081|Lazertinib|lazertinib|mesh-list
154704715|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154704716|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704717|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704718|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154704719|NCT01923844|Beractant|beractant|mesh-list
154704720|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
154704721|NCT01924000|Minoxidil|minoxidil|mesh-list
154704722|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154704723|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
154704724|NCT01924078|Capecitabine|capecitabine|mesh-list
154704725|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154704726|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154704727|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
154704728|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704729|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704730|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154704731|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704732|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154704733|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
154704734|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704735|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704736|NCT00630994|Decitabine|decitabine|mesh-list
154704737|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154704738|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
154704739|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704740|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704741|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704743|NCT01924234|Remifentanil|remifentanil|mesh-list
154704744|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154704745|NCT01924234|Narcotics|narcotics|mesh-ancestor
154704746|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704747|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704748|NCT01924234|Analgesics|analgesics|mesh-ancestor
154704749|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
154704750|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704751|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
154704752|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
154704753|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154704754|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154704755|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
154704756|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704757|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
154704758|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704759|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704760|NCT01927198|Verinurad|verinurad|mesh-list
154704761|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
154704762|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704763|NCT01924468|Haloperidol|haloperidol|mesh-list
154704764|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
154704765|NCT01924468|Methylphenidate|methylphenidate|mesh-list
154704766|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154704767|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704768|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154704769|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154704770|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154704771|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704772|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
154704773|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704774|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
154704775|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
154704776|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704777|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154704778|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154704779|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154704780|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704781|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154704782|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154704783|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154704784|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
154704785|NCT01923064|Polidocanol|polidocanol|mesh-list
154704786|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704787|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154704788|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154704789|NCT01924624|Thalidomide|thalidomide|mesh-list
154704790|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704791|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
154704792|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704793|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
154704794|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154704795|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704796|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154704797|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154704798|NCT01924624|Growth Substances|growth substances|mesh-ancestor
154704799|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
154704800|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704801|NCT01929382|Interferons|interferons|mesh-list
154704802|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
154704803|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704804|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
154704805|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704806|NCT00989950|Methylphenidate|methylphenidate|mesh-list
154704807|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154704808|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704809|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154704810|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154704811|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154704812|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704813|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
154704814|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704816|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153959636|NCT02818725|Cisplatin|cisplatin|mesh-list
154704817|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
154704818|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154704819|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704820|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154704821|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154704822|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154704823|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
154704824|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154704825|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154704826|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
154704827|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704828|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
154704829|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154704830|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154704831|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
154704832|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154704833|NCT01905943|Chlorambucil|chlorambucil|mesh-list
154704834|NCT01905943|Fludarabine|fludarabine|mesh-list
154704835|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
154704836|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154704837|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
154704838|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704839|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704840|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154704841|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
154704842|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704843|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704844|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154704845|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154704846|NCT01929031|Ibuprofen|ibuprofen|mesh-list
154704847|NCT01929031|Caffeine|caffeine|mesh-list
154704848|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154704849|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154704850|NCT01929031|Analgesics|analgesics|mesh-ancestor
154704851|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
154704852|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704853|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704854|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154704855|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704856|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154704857|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704858|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704859|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154704860|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154704861|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154704862|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154704863|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
154704864|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704865|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
154704866|NCT00989092|Hematinics|hematinics|mesh-ancestor
154704867|NCT00988858|Pemetrexed|pemetrexed|mesh-list
154704868|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704869|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704870|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704871|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154704872|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154704873|NCT01920334|Zolpidem|zolpidem|mesh-list
154704874|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154704875|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154704876|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704877|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704878|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154704879|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
154704880|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
154704881|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704882|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704883|NCT00986986|Niacin|niacin|mesh-list
154704884|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154704885|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
154704886|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704887|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154704888|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
154704889|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
154704891|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
154704892|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704893|NCT01928719|Nicotine|nicotine|mesh-list
154704894|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154704895|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
154704896|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704897|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704898|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154704899|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154704900|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
154704901|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704902|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704903|NCT00986674|Paclitaxel|paclitaxel|mesh-list
154704904|NCT00986674|Carboplatin|carboplatin|mesh-list
154704905|NCT00986674|Cetuximab|cetuximab|mesh-list
154704906|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154704907|NCT00986674|Antibodies|antibodies|mesh-list
154704908|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
154704909|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154704910|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154704911|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704912|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
154704913|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
154704914|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
154704915|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704916|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
154704917|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704918|NCT00986440|Efatutazone|efatutazone|mesh-list
154704919|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704920|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154704921|NCT01904149|Tramadol|tramadol|mesh-list
154704922|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154704923|NCT01904149|Narcotics|narcotics|mesh-ancestor
154704924|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154704925|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704926|NCT01904149|Analgesics|analgesics|mesh-ancestor
154704927|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
154704928|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704929|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154704930|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154704931|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154704932|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154704933|NCT01925638|Ketoconazole|ketoconazole|mesh-list
154704934|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
154704935|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704936|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154704937|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154704938|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704939|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704940|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154704941|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
154704942|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704943|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704944|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154704945|NCT00985738|Dutasteride|dutasteride|mesh-list
154704946|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154704947|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154704948|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704949|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704950|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
154704951|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154704952|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704953|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154704954|NCT00985504|Escitalopram|escitalopram|mesh-list
154704955|NCT00985504|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154704956|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154704957|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154704958|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704959|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154704960|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
154704961|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704962|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154704963|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
154704964|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154704965|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154704966|NCT00985504|Analgesics|analgesics|mesh-ancestor
154704967|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
154704968|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
154704970|NCT01921192|Hematinics|hematinics|mesh-ancestor
154704971|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
154704972|NCT01921192|Vitamins|vitamins|mesh-ancestor
154704973|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
154704974|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704975|NCT04275388|Interferons|interferons|mesh-list
154704976|NCT04275388|Ritonavir|ritonavir|mesh-list
154704977|NCT04275388|Lopinavir|lopinavir|mesh-list
154704978|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
154704979|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154704980|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154704981|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
154704982|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154704983|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154704984|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154704985|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
154704986|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154704987|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704988|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154704989|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154704990|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154704991|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154704992|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
154704993|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154704994|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
154704995|NCT01921426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154704996|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
154704997|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154704998|NCT01921426|Protective Agents|protective agents|mesh-ancestor
154704999|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705000|NCT01921582|Methylphenidate|methylphenidate|mesh-list
154705001|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154705002|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705003|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154705004|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154705005|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705006|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705007|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
154705008|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705009|NCT00985426|Vaccines|vaccines|mesh-list
154705010|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
154705011|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705012|NCT00985192|Everolimus|everolimus|mesh-list
154705013|NCT00985192|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154705014|NCT00985192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154705015|NCT00985192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705016|NCT00985192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705017|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705018|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
154705019|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705020|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705021|NCT03390010|Misoprostol|misoprostol|mesh-list
154705022|NCT03390010|Carboprost|carboprost|mesh-list
154705023|NCT03390010|Oxytocin|oxytocin|mesh-list
154705024|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
154705025|NCT03390010|Methylergonovine|methylergonovine|mesh-list
154705026|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154705027|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
154705028|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154705029|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705030|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154705031|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705032|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
154705033|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154705034|NCT00984568|Prednisolone|prednisolone|mesh-list
154705035|NCT00984568|Infliximab|infliximab|mesh-list
154705036|NCT00984568|Mesalamine|mesalamine|mesh-list
154705037|NCT00984568|Azathioprine|azathioprine|mesh-list
154705038|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705039|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
154705041|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705042|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705043|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705044|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705045|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705046|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705047|NCT00984568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154705048|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
154705049|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705050|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
154705051|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705052|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154705053|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705054|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
154705055|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705056|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705057|NCT00984568|Analgesics|analgesics|mesh-ancestor
154705058|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
154705059|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
154705060|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705061|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705062|NCT02984176|Simethicone|simethicone|mesh-list
154705063|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
154705064|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705065|NCT02984176|Emollients|emollients|mesh-ancestor
154705066|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
154705067|NCT01921738|Azithromycin|azithromycin|mesh-list
154705068|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705069|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705070|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
154705071|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154705072|NCT00984256|Atovaquone|atovaquone|mesh-list
154705073|NCT00984256|Proguanil|proguanil|mesh-list
154705074|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154705075|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705076|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
154705077|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154705078|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154705079|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705080|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705081|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
154705082|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154705083|NCT00984022|Laxatives|laxatives|mesh-ancestor
154705084|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705085|NCT01890265|Pirfenidone|pirfenidone|mesh-list
154705086|NCT01890265|Nintedanib|nintedanib|mesh-list
154705087|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
154705088|NCT01890265|Antibodies|antibodies|mesh-list
154705089|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
154705090|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154705091|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
154705092|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705093|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705094|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154705095|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705096|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705097|NCT01890265|Analgesics|analgesics|mesh-ancestor
154705098|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
154705099|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705100|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705101|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705102|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705103|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705104|NCT01926652|Amlodipine|amlodipine|mesh-list
154705105|NCT01926652|Candesartan|candesartan|mesh-list
154705106|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
154705107|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154705108|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154705109|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705110|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705111|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154705112|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705113|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
154705114|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154705115|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153959928|NCT06276465|Androgens|androgens|mesh-list
154705117|NCT01928329|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154705118|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154705119|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705120|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154705121|NCT01928329|Incretins|incretins|mesh-ancestor
154705122|NCT01928329|Hormones|hormones|mesh-ancestor
154705123|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705124|NCT01890109|Erenumab|erenumab|mesh-list
154705125|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154705126|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705127|NCT01890109|Analgesics|analgesics|mesh-ancestor
154705128|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
154705129|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705130|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705131|NCT03069976|Metronidazole|metronidazole|mesh-list
154705132|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705133|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705134|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154705135|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154705136|NCT00982930|Tobramycin|tobramycin|mesh-list
154705137|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705138|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705139|NCT01903993|Docetaxel|docetaxel|mesh-list
154705140|NCT01903993|Atezolizumab|atezolizumab|mesh-list
154705141|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705142|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154705143|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154705144|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
154705145|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705146|NCT01903993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154705147|NCT01903993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154705148|NCT00980044|Tramadol|tramadol|mesh-list
154705149|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154705150|NCT00980044|Narcotics|narcotics|mesh-ancestor
154705151|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705152|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705153|NCT00980044|Analgesics|analgesics|mesh-ancestor
154705154|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
154705155|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705156|NCT01927588|Prednisone|prednisone|mesh-list
154705157|NCT01927588|Everolimus|everolimus|mesh-list
154705158|NCT01927588|Tacrolimus|tacrolimus|mesh-list
154705159|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705160|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
154705161|NCT01927588|Hormones|hormones|mesh-ancestor
154705162|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705163|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705164|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705165|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705166|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705167|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
154705168|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154705169|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705170|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705171|NCT01927588|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153959987|NCT06272461|Analgesics|analgesics|mesh-ancestor
154705172|NCT01927588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154705173|NCT05601466|Cytarabine|cytarabine|mesh-list
154705174|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
154705175|NCT05601466|Fludarabine|fludarabine|mesh-list
154705176|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705177|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
154705178|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705179|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705180|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154705181|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
154705182|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705183|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705184|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154705185|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154705186|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
154705187|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
154705188|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705189|NCT01903837|Naltrexone|naltrexone|mesh-list
154705190|NCT01903837|Olanzapine|olanzapine|mesh-list
154705191|NCT01903837|ALKS-33|alks-33|mesh-list
154705192|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
154705193|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
154705194|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705195|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705196|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705197|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154705198|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154705199|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705200|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154705201|NCT01903837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154705202|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154705203|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705204|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705205|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705206|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
154705207|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154705208|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154705209|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
154705210|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
154705211|NCT00982696|Mitogens|mitogens|mesh-list
154705212|NCT00982696|Enkephalins|enkephalins|mesh-list
154705213|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
154705214|NCT00982696|Narcotics|narcotics|mesh-ancestor
154705215|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705216|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705217|NCT00982696|Analgesics|analgesics|mesh-ancestor
154705218|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
154705219|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705220|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
154705221|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705222|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705223|NCT00981526|Telmisartan|telmisartan|mesh-list
154705224|NCT00981526|Olanzapine|olanzapine|mesh-list
154705225|NCT00981526|Clozapine|clozapine|mesh-list
154705226|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
154705227|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
154705228|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705229|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705230|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705231|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154705232|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154705233|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705234|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154705235|NCT00981526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154705236|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154705237|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705238|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705239|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705240|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
154705241|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154705242|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154705243|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154705244|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154705245|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
154705246|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
154705247|NCT04274920|Calcium|calcium|mesh-list
154705248|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154705249|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705250|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
154705251|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154705252|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154705253|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154705254|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705255|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705256|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
154705257|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705258|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705259|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154705260|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705261|NCT05607940|Chrysarobin|chrysarobin|mesh-list
154705262|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705263|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705264|NCT05607940|Analgesics|analgesics|mesh-ancestor
154705265|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
154705266|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705267|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705268|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705269|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705270|NCT04394728|Trabectedin|trabectedin|mesh-list
154705271|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154705272|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
154705273|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705274|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705275|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154705276|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705277|NCT01616173|Dexamethasone|dexamethasone|mesh-list
154705278|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
154705279|NCT01616173|BB 1101|bb 1101|mesh-list
154705280|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705281|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
154705282|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
154705283|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705284|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705285|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705286|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
154705287|NCT01616173|Hormones|hormones|mesh-ancestor
154705288|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705289|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705290|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705291|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
154705292|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705293|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705294|NCT05609500|Warfarin|warfarin|mesh-list
154705295|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
154705296|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
154705297|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154705298|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
154705299|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705300|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705301|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154705302|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
154705303|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154705304|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
154705305|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705306|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705307|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154705308|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
154705309|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
154705310|NCT03044314|Protective Agents|protective agents|mesh-ancestor
154705311|NCT05608642|Prednisolone|prednisolone|mesh-list
154705312|NCT05608642|Lidocaine|lidocaine|mesh-list
154705313|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
154705314|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
154705315|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705316|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705317|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
154705318|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705319|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154705320|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154705321|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154705322|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705323|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705324|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705325|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
154705326|NCT05608642|Hormones|hormones|mesh-ancestor
154705327|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705328|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705329|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705330|NCT03036904|Prednisone|prednisone|mesh-list
154705331|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
154705332|NCT03036904|Rituximab|rituximab|mesh-list
154705333|NCT03036904|Doxorubicin|doxorubicin|mesh-list
154705334|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154705335|NCT03036904|Etoposide|etoposide|mesh-list
154705336|NCT03036904|Vincristine|vincristine|mesh-list
154705337|NCT03036904|Venetoclax|venetoclax|mesh-list
154705338|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705340|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705341|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705342|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154705343|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
154705344|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705345|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705346|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154705347|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154705348|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154705349|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154705350|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154705351|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705352|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705353|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
154705354|NCT03036904|Hormones|hormones|mesh-ancestor
154705355|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705356|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705357|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154705358|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154705359|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
154705360|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
154705361|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154705362|NCT05604898|Antibodies|antibodies|mesh-list
154705363|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
154705364|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154705365|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
154705366|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705367|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705368|NCT04392700|Tenofovir|tenofovir|mesh-list
154705369|NCT04392700|Entecavir|entecavir|mesh-list
154705370|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
154705371|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705372|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154705373|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154705374|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705375|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705376|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154705377|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154705378|NCT03828058|Tacrolimus|tacrolimus|mesh-list
154705379|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705380|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
154705381|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705382|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154705383|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705384|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705385|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154705386|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
154705387|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705388|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154705389|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154705390|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154705391|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705392|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705393|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154705394|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705395|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705396|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
154705397|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705398|NCT03827200|Ambrisentan|ambrisentan|mesh-list
154705399|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154705400|NCT02983630|Penicillins|penicillins|mesh-list
154705401|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705402|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705403|NCT03827278|Itraconazole|itraconazole|mesh-list
154705404|NCT03827278|Voriconazole|voriconazole|mesh-list
154705405|NCT03827278|Amphotericin B|amphotericin b|mesh-list
154705406|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
154705407|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705408|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154705409|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154705410|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705411|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705412|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154705413|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
154705414|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705415|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705416|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154705418|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154705419|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154705420|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705421|NCT01513473|Insulin|insulin|mesh-list
154705422|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154705423|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
154705424|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
154705425|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154705426|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705427|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
154705428|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154705429|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705430|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705431|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705432|NCT03109990|Analgesics|analgesics|mesh-ancestor
154705433|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
154705434|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705435|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154705436|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154705437|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154705438|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
154705439|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705440|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705441|NCT01513317|Siltuximab|siltuximab|mesh-list
154705442|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705443|NCT03825328|Paclitaxel|paclitaxel|mesh-list
154705444|NCT03825328|Gemcitabine|gemcitabine|mesh-list
154705445|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
154705446|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154705447|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154705448|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705449|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
154705450|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
154705451|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
154705452|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705453|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154705454|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
154705455|NCT03825016|Diclofenac|diclofenac|mesh-list
154705456|NCT03825016|Lidocaine|lidocaine|mesh-list
154705457|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
154705458|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
154705459|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705460|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705461|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
154705462|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705463|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154705464|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154705465|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154705466|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705467|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705468|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705469|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705470|NCT03825016|Analgesics|analgesics|mesh-ancestor
154705471|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705472|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705473|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154705474|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705475|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
154705476|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154705477|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154705478|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
154705479|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154705480|NCT03043924|Estradiol|estradiol|mesh-list
154705481|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154705482|NCT03043924|Cyproterone|cyproterone|mesh-list
154705483|NCT03043924|Estrogens|estrogens|mesh-ancestor
154705484|NCT03043924|Hormones|hormones|mesh-ancestor
154705485|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705486|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705487|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154705488|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
154705489|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154705490|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154705491|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154705492|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154705493|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154705494|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
154705495|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
154705496|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705497|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154705498|NCT03824314|Midazolam|midazolam|mesh-list
154705499|NCT03824314|Fentanyl|fentanyl|mesh-list
154705500|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154705501|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154705502|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705503|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705504|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154705505|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154705506|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154705507|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154705508|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
154705509|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
154705510|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
154705511|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
154705512|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705513|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705514|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154705515|NCT03824314|Narcotics|narcotics|mesh-ancestor
154705516|NCT03824314|Analgesics|analgesics|mesh-ancestor
154705517|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
154705518|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705519|NCT03824002|Insulin|insulin|mesh-list
154705520|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154705521|NCT03824002|Metformin|metformin|mesh-list
154705522|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
154705523|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
154705524|NCT03824002|Dulaglutide|dulaglutide|mesh-list
154705525|NCT03824002|Repaglinide|repaglinide|mesh-list
154705526|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
154705527|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154705528|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154705529|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705530|NCT03824002|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154705531|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
154705532|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154705533|NCT03823846|Parecoxib|parecoxib|mesh-list
154705534|NCT03823846|Dezocine|dezocine|mesh-list
154705535|NCT03823846|Analgesics|analgesics|mesh-ancestor
154705536|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
154705537|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705538|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705539|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705540|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705541|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705542|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705543|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154705544|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705545|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705546|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154705547|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154705548|NCT03823846|Narcotics|narcotics|mesh-ancestor
154705549|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705550|NCT02908750|Fexofenadine|fexofenadine|mesh-list
154705551|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154705552|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154705553|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154705554|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
154705555|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
154705556|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705557|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705558|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705559|NCT03823612|Calcium|calcium|mesh-list
154705560|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154705561|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705562|NCT02810704|Aspirin|aspirin|mesh-list
154705563|NCT02810704|Warfarin|warfarin|mesh-list
154705565|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705566|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705567|NCT02810704|Analgesics|analgesics|mesh-ancestor
154705568|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
154705569|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705570|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705571|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705572|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705573|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154705574|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154705575|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705576|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154705577|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154705578|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705579|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
154705580|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
154705581|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154705582|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
154705583|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154705584|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
154705585|NCT02926222|Lomustine|lomustine|mesh-list
154705586|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154705587|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
154705588|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705589|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705590|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
154705591|NCT04273282|Dexamethasone|dexamethasone|mesh-list
154705592|NCT04273282|Prednisolone|prednisolone|mesh-list
154705593|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154705594|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
154705595|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154705596|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
154705597|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154705598|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
154705599|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705600|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
154705601|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
154705602|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705603|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705604|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705605|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
154705606|NCT04273282|Hormones|hormones|mesh-ancestor
154705607|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705608|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705609|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705610|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154705611|NCT04273282|Protective Agents|protective agents|mesh-ancestor
154705612|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705613|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705614|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154705615|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154705616|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705617|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705618|NCT01454440|Eptifibatide|eptifibatide|mesh-list
154705619|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154705620|NCT01454518|Anesthetics|anesthetics|mesh-list
154705621|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
154705622|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705623|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705624|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
154705625|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705626|NCT02983084|Copper|copper|mesh-list
154705627|NCT02983084|Nickel|nickel|mesh-list
154705628|NCT02983084|Trace Elements|trace elements|mesh-ancestor
154705629|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
154705630|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705631|NCT01455142|Insulin|insulin|mesh-list
154705632|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
154705633|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154705634|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705635|NCT01455532|Carboplatin|carboplatin|mesh-list
154705636|NCT01455532|Gemcitabine|gemcitabine|mesh-list
154705637|NCT01455532|Doxorubicin|doxorubicin|mesh-list
154705638|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154705639|NCT01455532|Iniparib|iniparib|mesh-list
154705640|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705641|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154705642|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
154705643|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705644|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154705645|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154705646|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154705647|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705648|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154705649|NCT01455922|Glimepiride|glimepiride|mesh-list
154705651|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154705652|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154705653|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705654|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705655|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
154705656|NCT01455922|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154705657|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154705658|NCT01455922|Incretins|incretins|mesh-ancestor
154705659|NCT01455922|Hormones|hormones|mesh-ancestor
154705660|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705661|NCT01456234|Oseltamivir|oseltamivir|mesh-list
154705662|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
154705663|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705664|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705665|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705666|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154705667|NCT01456312|Entecavir|entecavir|mesh-list
154705668|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
154705669|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705670|NCT01456468|Tretinoin|tretinoin|mesh-list
154705671|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705672|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
154705673|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
154705674|NCT01456546|Proguanil|proguanil|mesh-list
154705675|NCT01456546|Clopidogrel|clopidogrel|mesh-list
154705676|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154705677|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154705678|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154705679|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153960506|NCT05242874|Dexamethasone|dexamethasone|mesh-list
154705680|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
154705681|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705682|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705683|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705684|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
154705685|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154705686|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154705687|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705688|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
154705689|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
154705690|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705691|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705692|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
154705693|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154705694|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705695|NCT01457716|Budesonide|budesonide|mesh-list
154705696|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
154705697|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705698|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154705699|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
154705700|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705701|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705702|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154705703|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
154705704|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
154705705|NCT01457716|Hormones|hormones|mesh-ancestor
154705706|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705707|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154705708|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154705709|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154705710|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
154705711|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705712|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705713|NCT02880982|Vitamin D|vitamin d|mesh-list
154705714|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
154705715|NCT02880982|Vitamins|vitamins|mesh-ancestor
154705716|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
154705717|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705718|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154705719|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154705720|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154705721|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
154705722|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154705723|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154705724|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154705725|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705726|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705727|NCT01459198|Vaccines|vaccines|mesh-list
154705728|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
154705729|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705730|NCT02490904|Eplerenone|eplerenone|mesh-list
154705731|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154705732|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
154705733|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705734|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705735|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154705736|NCT02490904|Diuretics|diuretics|mesh-ancestor
154705737|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
154705738|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154705739|NCT04390984|Apatinib|apatinib|mesh-list
154705740|NCT04390984|Gefitinib|gefitinib|mesh-list
154705741|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705742|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154705743|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705744|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705745|NCT04390984|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154705746|NCT02873806|Tobramycin|tobramycin|mesh-list
154705747|NCT02873806|Dexamethasone|dexamethasone|mesh-list
154705748|NCT02873806|Travoprost|travoprost|mesh-list
154705749|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705750|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
154705751|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
154705752|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705753|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705754|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705755|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
154705756|NCT02873806|Hormones|hormones|mesh-ancestor
154705757|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705758|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705759|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705760|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154705761|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705762|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705763|NCT01890772|Vitamin D|vitamin d|mesh-list
154705764|NCT01890772|Ribavirin|ribavirin|mesh-list
154705765|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154705766|NCT01890772|Vitamins|vitamins|mesh-ancestor
154705767|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
154705768|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705769|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154705770|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
154705771|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705772|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
154705773|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705774|NCT01891084|Acetaminophen|acetaminophen|mesh-list
154705775|NCT01891084|Ibuprofen|ibuprofen|mesh-list
154705776|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705777|NCT01891084|Analgesics|analgesics|mesh-ancestor
154705778|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
154705779|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960602|NCT05063136|Capecitabine|capecitabine|mesh-list
154705780|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705781|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
154705782|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705783|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705784|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705785|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154705786|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705787|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705788|NCT01891708|Bevacizumab|bevacizumab|mesh-list
154705789|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154705790|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457756|NCT04728360|Ustekinumab|ustekinumab|mesh-list
154705791|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154705792|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154705793|NCT01891708|Growth Substances|growth substances|mesh-ancestor
154705794|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705795|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
154705796|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
154705797|NCT01892098|Astringents|astringents|mesh-ancestor
154705798|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705799|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
154705801|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
154705802|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
154705803|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705804|NCT01892176|Vitamins|vitamins|mesh-ancestor
154705805|NCT01892254|Metformin|metformin|mesh-list
154705806|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154705807|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705808|NCT01892332|Lidocaine|lidocaine|mesh-list
154705809|NCT01892332|Fentanyl|fentanyl|mesh-list
154705810|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
154705811|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
154705812|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705813|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705814|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
154705815|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705816|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154705817|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154705818|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154705819|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705820|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705821|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154705822|NCT01892332|Narcotics|narcotics|mesh-ancestor
154705823|NCT01892332|Analgesics|analgesics|mesh-ancestor
154705824|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154705825|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154705826|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
154705827|NCT01892488|Sultamicillin|sultamicillin|mesh-list
154705828|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
154705829|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705830|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705831|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705832|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705833|NCT01892644|Deferasirox|deferasirox|mesh-list
154705834|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154705835|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
154705836|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
154705837|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705838|NCT01901653|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154705839|NCT01901653|Immunoconjugates|immunoconjugates|mesh-ancestor
154705840|NCT01901653|Immunologic Factors|immunologic factors|mesh-ancestor
154705841|NCT01901653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705842|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
154705843|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154705844|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705845|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
154705846|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
154705847|NCT02798536|Paclitaxel|paclitaxel|mesh-list
154705848|NCT02798536|LMB-100|lmb-100|mesh-list
154705849|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154705850|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705851|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
154705852|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
154705853|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
154705854|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705855|NCT02798536|Immunoconjugates|immunoconjugates|mesh-ancestor
154705856|NCT02798536|Immunologic Factors|immunologic factors|mesh-ancestor
154705857|NCT02798536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705858|NCT04758286|Anesthetics|anesthetics|mesh-list
154705859|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705860|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705861|NCT01615939|Bupivacaine|bupivacaine|mesh-list
154705862|NCT01615939|Ropivacaine|ropivacaine|mesh-list
154705863|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
154705864|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
154705865|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154705866|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705867|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
154705868|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705870|NCT02789878|Goserelin|goserelin|mesh-list
154705871|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705872|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
154705873|NCT02789878|Hormones|hormones|mesh-ancestor
154705874|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705875|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705876|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705877|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705878|NCT01901185|Etanercept|etanercept|mesh-list
154705879|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705880|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705881|NCT01901185|Analgesics|analgesics|mesh-ancestor
154705882|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
154705883|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705884|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705885|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705886|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705887|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154705888|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705889|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
154705890|NCT01893424|Dronabinol|dronabinol|mesh-list
154705891|NCT01893424|Nabiximols|nabiximols|mesh-list
154705892|NCT01893424|Cannabidiol|cannabidiol|mesh-list
154705893|NCT01893424|Piperine|piperine|mesh-list
154705894|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
154705895|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
154705896|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705897|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154705898|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705899|NCT01893424|Analgesics|analgesics|mesh-ancestor
154705900|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
154705901|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705902|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154705903|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154705904|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705905|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705906|NCT01893424|Hormones|hormones|mesh-ancestor
154705907|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705908|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154705909|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705910|NCT02788708|Paclitaxel|paclitaxel|mesh-list
154705911|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154705912|NCT02788708|Lenvatinib|lenvatinib|mesh-list
154705913|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154705914|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705915|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154705916|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154705917|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154705918|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705919|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154705920|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705921|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
154705922|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154705923|NCT01888003|Hematinics|hematinics|mesh-ancestor
154705924|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
154705925|NCT02773732|Etoposide|etoposide|mesh-list
154705926|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154705927|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705928|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154705929|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154705930|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705931|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705932|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154705933|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705934|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154705935|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154705936|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
154705937|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154705938|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705939|NCT02769520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154705940|NCT02769520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705941|NCT02735122|Acetaminophen|acetaminophen|mesh-list
154705942|NCT02735122|Ibuprofen|ibuprofen|mesh-list
154705943|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154705944|NCT02735122|Analgesics|analgesics|mesh-ancestor
154705945|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
154705946|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705947|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705948|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
154705949|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154705950|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705951|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705952|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154705953|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705954|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705955|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154705956|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154705957|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154705958|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154705959|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705960|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
154705961|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154705962|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705963|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154705964|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154705965|NCT01893658|Omalizumab|omalizumab|mesh-list
154705966|NCT01893658|Prednisone|prednisone|mesh-list
154705967|NCT01893658|Prednisolone|prednisolone|mesh-list
154705968|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154705969|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
154705970|NCT01893658|Hormones|hormones|mesh-ancestor
154705971|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154705972|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705973|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154705974|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705975|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154705976|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154705977|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
154705978|NCT02688556|Cyclosporine|cyclosporine|mesh-list
154705979|NCT02688556|Cyclosporins|cyclosporins|mesh-list
154705980|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705981|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705982|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154705983|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
154705984|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154705985|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
154705986|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154705987|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154705988|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154705989|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154705990|NCT02684032|Letrozole|letrozole|mesh-list
154705991|NCT02684032|Fulvestrant|fulvestrant|mesh-list
154705992|NCT02684032|Palbociclib|palbociclib|mesh-list
154705993|NCT02684032|Gedatolisib|gedatolisib|mesh-list
154705994|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154705995|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154705996|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154705997|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154705998|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154705999|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154706000|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
154706001|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706002|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706003|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706004|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154706005|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154706006|NCT02388178|Fluorides|fluorides|mesh-list
154706007|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
153960817|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
154706008|NCT02388178|Protective Agents|protective agents|mesh-ancestor
154706009|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706010|NCT02384668|Vitamin D|vitamin d|mesh-list
154706011|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
154706012|NCT02384668|Vitamins|vitamins|mesh-ancestor
154706013|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
154706014|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706015|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154706016|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154457985|NCT02215265|Cisplatin|cisplatin|mesh-list
154706017|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154706018|NCT01898923|Laxatives|laxatives|mesh-ancestor
154706019|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706020|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154706021|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154706022|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706023|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154706024|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154706025|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154706026|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706027|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
154706028|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706029|NCT01886287|Octreotide|octreotide|mesh-list
154706030|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706031|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706032|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706033|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
154706034|NCT02707588|Cetuximab|cetuximab|mesh-list
154706035|NCT02707588|Antibodies|antibodies|mesh-list
154706036|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
154706037|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
154706038|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706039|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154706040|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706041|NCT02707588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154706042|NCT02707588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706043|NCT05602480|Vaccines|vaccines|mesh-list
154706044|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
154706045|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706046|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
154706047|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154706048|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
154706049|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706050|NCT05604586|Expectorants|expectorants|mesh-ancestor
154706051|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
154706052|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154706053|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
154706054|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706055|NCT05604586|Protective Agents|protective agents|mesh-ancestor
154706056|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706057|NCT05604586|Antidotes|antidotes|mesh-ancestor
154706058|NCT05604118|Aspirin|aspirin|mesh-list
154706059|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154706060|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154706061|NCT05604118|Analgesics|analgesics|mesh-ancestor
154706062|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
154706063|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706064|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706065|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706066|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154706067|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154706068|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154706069|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706070|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154706071|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154706072|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706073|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
154706074|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154706075|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
154706076|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
154706077|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706078|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
154706079|NCT04393792|Povidone|povidone|mesh-list
154706080|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
154706081|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
154706082|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154706083|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706084|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
154706085|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154706086|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154706087|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154706088|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154706089|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154706090|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706092|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706093|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706094|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154706095|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706096|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154706097|NCT02315872|Hormones|hormones|mesh-ancestor
154706098|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706099|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706100|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
154706101|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154706102|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154706103|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706104|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154706105|NCT04127500|Analgesics|analgesics|mesh-ancestor
154706106|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
154706107|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706108|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154706109|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154706110|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154706111|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
154706112|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706113|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706114|NCT03017326|Carboplatin|carboplatin|mesh-list
154706115|NCT03017326|Gemcitabine|gemcitabine|mesh-list
154706116|NCT03017326|Doxorubicin|doxorubicin|mesh-list
154706117|NCT03017326|Fluorouracil|fluorouracil|mesh-list
154706118|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
154706119|NCT03017326|Irinotecan|irinotecan|mesh-list
154706120|NCT03017326|Etoposide|etoposide|mesh-list
154706121|NCT03017326|Vincristine|vincristine|mesh-list
154706122|NCT03017326|Sorafenib|sorafenib|mesh-list
154706123|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706124|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154706125|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
154706126|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706127|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154706128|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154706129|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154706130|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706131|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706132|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
154706133|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706134|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154706135|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154706136|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
154706137|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
154706138|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
154706139|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154706140|NCT04126330|Vitamin D|vitamin d|mesh-list
154706141|NCT04126330|Vitamins|vitamins|mesh-ancestor
154706142|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
154706143|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706144|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154706145|NCT04126720|Vitamin E|vitamin e|mesh-list
154706146|NCT04126720|Vitamins|vitamins|mesh-ancestor
154706147|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
154706148|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706149|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
154706150|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706151|NCT04126720|Protective Agents|protective agents|mesh-ancestor
154706152|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
154706153|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706154|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
154706155|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154706156|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154706157|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706158|NCT04126252|Urological Agents|urological agents|mesh-ancestor
154706159|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
154706160|NCT03007732|Prednisone|prednisone|mesh-list
154706161|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
154706162|NCT03007732|Leuprolide|leuprolide|mesh-list
154706163|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
154458122|NCT02228772|Ixazomib|ixazomib|mesh-list
154706164|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
154706165|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154706166|NCT03007732|Androgens|androgens|mesh-list
154706167|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154706168|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706169|NCT03007732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154706170|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706171|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706172|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
154706173|NCT03007732|Hormones|hormones|mesh-ancestor
154706174|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706175|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706176|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706177|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154706178|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
154706179|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154706180|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154706181|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706182|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
154706183|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154706184|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
154706185|NCT03007732|Protective Agents|protective agents|mesh-ancestor
154706186|NCT03007732|Vitamins|vitamins|mesh-ancestor
154706187|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
154706188|NCT03007732|Estrogens|estrogens|mesh-ancestor
154706189|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
154706190|NCT03007420|Lidocaine|lidocaine|mesh-list
154706191|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
154706192|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
154706193|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961008|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706194|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706195|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
154706196|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706197|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154706198|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154706199|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154706200|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154706201|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706202|NCT04125706|Metronidazole|metronidazole|mesh-list
154706203|NCT04125706|Minocycline|minocycline|mesh-list
154706204|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706205|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154706206|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154706207|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154706208|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154706209|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154706210|NCT04125082|Insulin|insulin|mesh-list
154706211|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154706212|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154706213|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706214|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
154706215|NCT04393246|Ambrisentan|ambrisentan|mesh-list
154706216|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154706217|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706218|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154706219|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706220|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154706221|NCT01923181|Semaglutide|semaglutide|mesh-list
154706222|NCT01923181|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154706223|NCT01923181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154706224|NCT01923181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706225|NCT04124302|Insulin|insulin|mesh-list
154706226|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154706227|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
154706228|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
154706229|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
154706230|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154706231|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706232|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153961069|NCT03768414|Paclitaxel|paclitaxel|mesh-list
154706233|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154706234|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706235|NCT04411069|Droperidol|droperidol|mesh-list
154706236|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154706237|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
154706238|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
154706239|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706240|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706241|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154458197|NCT03844074|Growth Substances|growth substances|mesh-ancestor
154706242|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154706243|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154706244|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154706245|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154706246|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154706247|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154706248|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
154706249|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706250|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706251|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
154706252|NCT01884571|Prednisone|prednisone|mesh-list
154706253|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
154706254|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154706255|NCT01884571|Tacrolimus|tacrolimus|mesh-list
154706256|NCT01884571|Basiliximab|basiliximab|mesh-list
154706257|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706258|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
154706259|NCT01884571|Hormones|hormones|mesh-ancestor
154706260|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706261|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706262|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706263|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706264|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706265|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
154706266|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154706267|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706268|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706269|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154706270|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154706271|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
154706272|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154706273|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706274|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
154706275|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
154706276|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706277|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706278|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154706279|NCT01884571|Protective Agents|protective agents|mesh-ancestor
154706280|NCT01884337|Apixaban|apixaban|mesh-list
154706281|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154706282|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
154706283|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154706284|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
154706285|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706286|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706287|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
154706288|NCT04123288|ACT-709478|act-709478|mesh-list
154706289|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154706290|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154706291|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706292|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154706293|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706294|NCT04123210|Vitamin A|vitamin a|mesh-list
154706295|NCT04123210|Vitamins|vitamins|mesh-ancestor
154706296|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
154706297|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706298|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154706299|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154706300|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706301|NCT04121416|Sufentanil|sufentanil|mesh-list
154706302|NCT04121416|Oxycodone|oxycodone|mesh-list
154706303|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154706304|NCT04121416|Narcotics|narcotics|mesh-ancestor
154706305|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154706306|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706307|NCT04121416|Analgesics|analgesics|mesh-ancestor
154706308|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
154706309|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706310|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154706311|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154706312|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
154706313|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
154706314|NCT04121338|Bupivacaine|bupivacaine|mesh-list
154706315|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
154458278|NCT04943146|Analgesics|analgesics|mesh-ancestor
154706316|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
154706317|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154706318|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706319|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
154706320|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706321|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
154706322|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
154706323|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706324|NCT01922011|Vancomycin|vancomycin|mesh-list
154706325|NCT01922011|Daptomycin|daptomycin|mesh-list
154706326|NCT01922011|Nafcillin|nafcillin|mesh-list
154706327|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154706328|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706329|NCT04127968|Vitamin A|vitamin a|mesh-list
154706330|NCT04127968|Vitamins|vitamins|mesh-ancestor
154706331|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
154706332|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706333|NCT01921387|Cytarabine|cytarabine|mesh-list
154706334|NCT01921387|Etoposide|etoposide|mesh-list
154706335|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
154706336|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
154706337|NCT01921387|Melphalan|melphalan|mesh-list
154706338|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
154706339|NCT01921387|Carmustine|carmustine|mesh-list
154706340|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154706341|NCT01921387|Antibodies|antibodies|mesh-list
154706342|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154706343|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
154706344|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706345|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154706346|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718830|NCT04728386|Eusol|eusol|mesh-list
154706347|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154706348|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154706349|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706350|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706351|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154706352|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
154706353|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
154706354|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706355|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706356|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154706357|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
154706358|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154706359|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
154706360|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
154706361|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154706362|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154706363|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154706364|NCT04129996|Paclitaxel|paclitaxel|mesh-list
154706365|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154706366|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706367|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
154706368|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
154706369|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
154706370|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706371|NCT04129216|Tamoxifen|tamoxifen|mesh-list
154706372|NCT04129216|Letrozole|letrozole|mesh-list
154706373|NCT04129216|Exemestane|exemestane|mesh-list
154706374|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706375|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706376|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154706377|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154706378|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706379|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154706380|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
154706381|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706382|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706383|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706384|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154706385|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154706386|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154706387|NCT01895335|Teriflunomide|teriflunomide|mesh-list
154706388|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154706389|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154706390|NCT01895335|Analgesics|analgesics|mesh-ancestor
154706391|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
154706392|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706393|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706394|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706395|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154706396|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706397|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
154706398|NCT03829696|Misoprostol|misoprostol|mesh-list
154706399|NCT03829696|Mifepristone|mifepristone|mesh-list
154706400|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
154706401|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154706402|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
154706403|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154706404|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706405|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154706406|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706407|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
154706408|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154706409|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154706410|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154706411|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154706412|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
154706413|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154706414|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154706415|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
154706416|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706417|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
154706418|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154706419|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154706420|NCT03829774|Acetaminophen|acetaminophen|mesh-list
154706421|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154706422|NCT03829774|Analgesics|analgesics|mesh-ancestor
154706423|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
154706424|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706425|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706426|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
154706427|NCT02974738|Belzutifan|belzutifan|mesh-list
154706428|NCT02974738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706429|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
154706430|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154706431|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
154706432|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706433|NCT02972398|Expectorants|expectorants|mesh-ancestor
154706434|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
154706435|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154706436|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
154706437|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706438|NCT02972398|Protective Agents|protective agents|mesh-ancestor
154706439|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706440|NCT02972398|Antidotes|antidotes|mesh-ancestor
154706441|NCT01617655|Alirocumab|alirocumab|mesh-list
154706442|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154706443|NCT01617655|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154706444|NCT01617655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154706445|NCT01617655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154706446|NCT01617655|Antimetabolites|antimetabolites|mesh-ancestor
154706447|NCT01617655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706448|NCT01617655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154706449|NCT01617655|Protease Inhibitors|protease inhibitors|mesh-ancestor
154706450|NCT01617655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706451|NCT01617655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154706452|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
154706453|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706454|NCT02965768|Naltrexone|naltrexone|mesh-list
154706455|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154706456|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154706457|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706458|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
154706459|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706460|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
154706461|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154706462|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154706463|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706464|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
154706465|NCT01895101|Coagulants|coagulants|mesh-ancestor
154706466|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
154706467|NCT03828682|Prednisone|prednisone|mesh-list
154706468|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
154706469|NCT03828682|Tacrolimus|tacrolimus|mesh-list
154706470|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
154706471|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154706472|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706473|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
154706474|NCT03828682|Hormones|hormones|mesh-ancestor
154706475|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706476|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706477|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706478|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706479|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706480|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
154706481|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154706482|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706483|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706484|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154706485|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154706486|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
154706487|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154706488|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706489|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
154706490|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
154706491|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706492|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706493|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154706494|NCT03828682|Protective Agents|protective agents|mesh-ancestor
154706495|NCT03483649|Bevacizumab|bevacizumab|mesh-list
154706496|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154706497|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706498|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154706499|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154706500|NCT03483649|Growth Substances|growth substances|mesh-ancestor
154706501|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706502|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
154706503|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
154706504|NCT03822520|Celecoxib|celecoxib|mesh-list
154706505|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154706506|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706507|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154706508|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154706509|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706510|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706511|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706512|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706513|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154706514|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154706515|NCT03822520|Analgesics|analgesics|mesh-ancestor
154706516|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
154706517|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706518|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706519|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154706520|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154706521|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154706522|NCT01894477|Fludarabine|fludarabine|mesh-list
154706523|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
154706524|NCT01894477|Treosulfan|treosulfan|mesh-list
154706525|NCT01894477|Busulfan|busulfan|mesh-list
154706526|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706527|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154706528|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
154706529|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706530|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706531|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
154706532|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706533|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154706534|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
154706535|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154706536|NCT04391998|Metronidazole|metronidazole|mesh-list
154706537|NCT04391998|Albendazole|albendazole|mesh-list
154706538|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706539|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154706540|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154706541|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154706542|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
154706543|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
154706544|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154706545|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
154706546|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
154706547|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
154706548|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706549|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706550|NCT03820180|Fluticasone|fluticasone|mesh-list
154706551|NCT03820180|Xhance|xhance|mesh-list
154706552|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154706553|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154706554|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706555|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154706556|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
154706557|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706558|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706559|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154706560|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
154706561|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
154706562|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154706563|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154706564|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154706565|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154706566|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
154706567|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706568|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706569|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
154706570|NCT03820180|Hormones|hormones|mesh-ancestor
154706571|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706572|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
154706573|NCT01894243|Olaparib|olaparib|mesh-list
154706574|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154706575|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706576|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706577|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706578|NCT01450384|Pemetrexed|pemetrexed|mesh-list
154706579|NCT01450384|Sorafenib|sorafenib|mesh-list
154706580|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706581|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706582|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706583|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154706584|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154706585|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154706586|NCT01450462|Vitamin D|vitamin d|mesh-list
154706587|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
154706588|NCT01450462|Vitamins|vitamins|mesh-ancestor
154706589|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
154706590|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706591|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154706592|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154706593|NCT01450774|Beclomethasone|beclomethasone|mesh-list
154706594|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
154706595|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154706596|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
154706597|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706598|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706599|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154706600|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
154706601|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154706602|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154706603|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153961423|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
154706604|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
154706605|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706606|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706607|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706608|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
154706609|NCT01450774|Hormones|hormones|mesh-ancestor
154706610|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706611|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
154706612|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154706613|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154706614|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154706615|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706616|NCT01451086|Vaccines|vaccines|mesh-list
154706617|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
154706618|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706619|NCT01451710|Prednisone|prednisone|mesh-list
154706620|NCT01451710|Prednisolone|prednisolone|mesh-list
154458579|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
154706621|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154706622|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
154706623|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154706624|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
154706625|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154706626|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
154706627|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706628|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
154706629|NCT01451710|Hormones|hormones|mesh-ancestor
154706630|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706631|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706632|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706633|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706634|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
154706635|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
154706636|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706637|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706638|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154706639|NCT01451710|Protective Agents|protective agents|mesh-ancestor
154706640|NCT01451788|Thrombin|thrombin|mesh-list
154706641|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
154706642|NCT01451788|Coagulants|coagulants|mesh-ancestor
154706643|NCT01452100|Prednisone|prednisone|mesh-list
154706644|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706645|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
154706646|NCT01452100|Hormones|hormones|mesh-ancestor
154706647|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706648|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706649|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706650|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706651|NCT01452334|BMS-936559|bms-936559|mesh-list
154706652|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154706653|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706654|NCT01452568|Aspirin|aspirin|mesh-list
154706655|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
154706656|NCT01452568|Salicylates|salicylates|mesh-list
154706657|NCT01452568|Warfarin|warfarin|mesh-list
154706658|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154706659|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154706660|NCT01452568|Analgesics|analgesics|mesh-ancestor
154706661|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
154706662|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706663|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706664|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706665|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154706666|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154706667|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154706668|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706669|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154706670|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154706671|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706672|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
154706673|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
154706674|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706675|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
154706676|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
154706677|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
154706678|NCT01452724|Lansoprazole|lansoprazole|mesh-list
154706679|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
154706680|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154706681|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706682|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154706683|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706684|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706685|NCT01452880|Remifentanil|remifentanil|mesh-list
154706686|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154706687|NCT01452880|Narcotics|narcotics|mesh-ancestor
154706688|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154706689|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706690|NCT01452880|Analgesics|analgesics|mesh-ancestor
154706691|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
154706692|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706693|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
154706694|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154706695|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154706696|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
154458651|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154706697|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706698|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154706699|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154706700|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706701|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706702|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154706703|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
154706704|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706705|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
154706706|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706707|NCT01453504|Everolimus|everolimus|mesh-list
154706708|NCT01453504|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154706709|NCT01453504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154706710|NCT01453504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961529|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154706711|NCT01453504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706712|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706713|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
154706714|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706715|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706716|NCT01453582|Propolis|propolis|mesh-list
154706717|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706718|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
154706719|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154706720|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154706721|NCT04847752|Aspirin|aspirin|mesh-list
154706722|NCT04847752|Warfarin|warfarin|mesh-list
154706723|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
154706724|NCT04847752|Dabigatran|dabigatran|mesh-list
154706725|NCT04847752|Anticoagulants|anticoagulants|mesh-list
154706726|NCT04847752|Clopidogrel|clopidogrel|mesh-list
154706727|NCT04847752|Atorvastatin|atorvastatin|mesh-list
154706728|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154706729|NCT04847752|Evolocumab|evolocumab|mesh-list
154706730|NCT04847752|Alirocumab|alirocumab|mesh-list
154706731|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154706732|NCT04847752|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154706733|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154706734|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154706735|NCT04847752|Analgesics|analgesics|mesh-ancestor
154706736|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
154706737|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706738|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706739|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706740|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154706741|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154706742|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154706743|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706744|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154706745|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154706746|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706747|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
154706748|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154706749|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154706750|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
154706751|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154706752|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154706753|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154706754|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154706755|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
154706756|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706757|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154706758|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
154706759|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154706760|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
154706761|NCT02864914|Empagliflozin|empagliflozin|mesh-list
154706762|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154706763|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154706764|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706765|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154706766|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706767|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
154706768|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706769|NCT02849470|Complement Factor H|complement factor h|mesh-list
154706770|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154706771|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706772|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
154458734|NCT05195450|Tenofovir|tenofovir|mesh-list
154706773|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706775|NCT05024188|Metronidazole|metronidazole|mesh-list
154706776|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
154706777|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706778|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154706779|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154706780|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154706781|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154706782|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706783|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706784|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706785|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154706786|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154706787|NCT04390594|Nafamostat|nafamostat|mesh-list
154706788|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154706789|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154706790|NCT04390594|Analgesics|analgesics|mesh-ancestor
154706791|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
154706792|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706793|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706794|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706795|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154706796|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
154706797|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
154706798|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706799|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706800|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154706801|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154706802|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154706803|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706804|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
154706805|NCT05024422|Pyridoxine|pyridoxine|mesh-list
154706806|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
154706807|NCT05024422|Cabergoline|cabergoline|mesh-list
154706808|NCT05024422|Vitamins|vitamins|mesh-ancestor
154706809|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
153961655|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
154706810|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706811|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
154706812|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154706813|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154706814|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
154706815|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
154706816|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706817|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706818|NCT02819596|Durvalumab|durvalumab|mesh-list
154706819|NCT02819596|Tremelimumab|tremelimumab|mesh-list
154706820|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154706821|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706822|NCT02818894|Lidocaine|lidocaine|mesh-list
154706823|NCT02818894|Bupivacaine|bupivacaine|mesh-list
154706824|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
154706825|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
154706826|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154706827|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706828|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
154706829|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706830|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154706831|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154706832|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154706833|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154706834|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706835|NCT05586568|Itraconazole|itraconazole|mesh-list
154706836|NCT05586568|Rifampin|rifampin|mesh-list
154706837|NCT05586568|Esomeprazole|esomeprazole|mesh-list
154706838|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154706839|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706840|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154706841|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706842|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706843|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
154706844|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706845|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154706846|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154458811|NCT00308516|Antidotes|antidotes|mesh-ancestor
154706847|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154706848|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
154706849|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706850|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706851|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154706852|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154706853|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
154706854|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154706855|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
154706856|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154706857|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154706858|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154706859|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154706860|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154706861|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154706862|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154706863|NCT02624908|Canagliflozin|canagliflozin|mesh-list
154706864|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154706865|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706866|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154706867|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706868|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
154706869|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154706870|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
154706871|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154706872|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706873|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154706874|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
154706875|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154706876|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706877|NCT02556424|Dexamethasone|dexamethasone|mesh-list
154706878|NCT02556424|Triamcinolone|triamcinolone|mesh-list
154706879|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706880|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
154706881|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
154706882|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706883|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706884|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706885|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
154706887|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706888|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706889|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706890|NCT02543944|Clonidine|clonidine|mesh-list
154706891|NCT02543944|Naltrexone|naltrexone|mesh-list
154706892|NCT02543944|Buprenorphine|buprenorphine|mesh-list
154706893|NCT02543944|Gabapentin|gabapentin|mesh-list
154706894|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154706895|NCT02543944|Narcotics|narcotics|mesh-ancestor
154706896|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154706897|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706898|NCT02543944|Analgesics|analgesics|mesh-ancestor
154706899|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
154706900|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706901|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154706902|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
154706903|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154706904|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154706905|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154706906|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154706907|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154706908|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154706909|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706910|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
154706911|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154706912|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154706913|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
154706914|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
154706915|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154706916|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154706917|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154706918|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
154706919|NCT02531308|Metformin|metformin|mesh-list
154706920|NCT02531308|Prednisone|prednisone|mesh-list
154706921|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
154706922|NCT02531308|Rituximab|rituximab|mesh-list
154706923|NCT02531308|Doxorubicin|doxorubicin|mesh-list
154706924|NCT02531308|Vincristine|vincristine|mesh-list
154706925|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706926|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
154706927|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706928|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154706929|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154706930|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
154706931|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706932|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706933|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154706934|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154706935|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154706936|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154706937|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154706938|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154706939|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706940|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706941|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
154706942|NCT02531308|Hormones|hormones|mesh-ancestor
154706943|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706944|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706945|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154706946|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
154706947|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
154706948|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
154706949|NCT02523976|Cytarabine|cytarabine|mesh-list
154706950|NCT02523976|Dexamethasone|dexamethasone|mesh-list
154706951|NCT02523976|Prednisone|prednisone|mesh-list
154706952|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
154706953|NCT02523976|Methotrexate|methotrexate|mesh-list
154706954|NCT02523976|Etoposide|etoposide|mesh-list
154706955|NCT02523976|Vincristine|vincristine|mesh-list
154706956|NCT02523976|Daunorubicin|daunorubicin|mesh-list
154706957|NCT02523976|Dasatinib|dasatinib|mesh-list
154706958|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
154706959|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
154706960|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154706961|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
154706962|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154706963|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154706964|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154706965|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
154706966|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154706967|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154706968|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154706969|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154706970|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
154706971|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
154706972|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154706973|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154706974|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
154706975|NCT02523976|Hormones|hormones|mesh-ancestor
154706976|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154706977|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154706978|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154706979|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
154706980|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154706981|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154706982|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
154706983|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
154706984|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154706985|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154706986|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154706987|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154706988|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154706989|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154706990|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
154706991|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154706992|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
154458966|NCT03057574|Hormones|hormones|mesh-ancestor
154706993|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
154706994|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
154706995|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154706996|NCT02523976|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154706997|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154706998|NCT02523976|Analgesics|analgesics|mesh-ancestor
154706999|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
154707000|NCT04757974|Fostemsavir|fostemsavir|mesh-list
154707001|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154707002|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154707003|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
154707004|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707005|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154707006|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154707007|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707008|NCT04757506|Naltrexone|naltrexone|mesh-list
154707009|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154707010|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154707011|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707012|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
154707013|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707014|NCT02477644|Olaparib|olaparib|mesh-list
154707015|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154707016|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707017|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707018|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707019|NCT02466334|Calcitonin|calcitonin|mesh-list
154707020|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
154707021|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154707022|NCT02466334|Katacalcin|katacalcin|mesh-list
154707023|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154707024|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707025|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154707026|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
154707027|NCT02460874|Glyburide|glyburide|mesh-list
154707028|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154707029|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707030|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
154707031|NCT02443324|Ramucirumab|ramucirumab|mesh-list
154707032|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154707033|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707034|NCT02443324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154707035|NCT02443324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707036|NCT02443324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154707037|NCT02443324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154707038|NCT02443324|Growth Substances|growth substances|mesh-ancestor
154707039|NCT02443324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707040|NCT02443324|Growth Inhibitors|growth inhibitors|mesh-ancestor
154707041|NCT01894048|Beclomethasone|beclomethasone|mesh-list
154707042|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707043|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
154707044|NCT01894048|Hormones|hormones|mesh-ancestor
154707045|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707046|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707047|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153961868|NCT05629923|Antiviral Agents|antiviral agents|mesh-ancestor
154707048|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
154707049|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
154707050|NCT02420314|Paclitaxel|paclitaxel|mesh-list
154707051|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154707052|NCT02420314|Carboplatin|carboplatin|mesh-list
154707053|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154707054|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707055|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
154707056|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
154707057|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
154707058|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707059|NCT02420314|Vitamins|vitamins|mesh-ancestor
154707060|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
154707061|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707062|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
154707063|NCT02420314|Protective Agents|protective agents|mesh-ancestor
154707064|NCT01539291|Idelalisib|idelalisib|mesh-list
154707065|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707066|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707067|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707068|NCT04746040|Fluticasone|fluticasone|mesh-list
154707069|NCT04746040|Xhance|xhance|mesh-list
154707070|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154707071|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154707072|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707073|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154707074|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
154707075|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707076|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707077|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154707078|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
154707079|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707080|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154707081|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154707082|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154707083|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154707084|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707085|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707086|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707087|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
154707088|NCT04746040|Hormones|hormones|mesh-ancestor
154707089|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707090|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
154707091|NCT02400814|Atezolizumab|atezolizumab|mesh-list
154707092|NCT02400814|Antibodies|antibodies|mesh-list
154707093|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154707094|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
154707095|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707096|NCT02400814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154707097|NCT02400814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707098|NCT02400814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154707099|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707100|NCT02398240|Rituximab|rituximab|mesh-list
154707101|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154707102|NCT02398240|Doxorubicin|doxorubicin|mesh-list
154707103|NCT02398240|Vincristine|vincristine|mesh-list
154707104|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154707105|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707106|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
154707107|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707108|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154707109|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154707110|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154707111|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154707112|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707113|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707114|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154707115|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
154707116|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
154707117|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
154707118|NCT02398240|Immunotoxins|immunotoxins|mesh-ancestor
154707119|NCT02398240|Immunoconjugates|immunoconjugates|mesh-ancestor
154707120|NCT02022280|Lansoprazole|lansoprazole|mesh-list
154707121|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
154707122|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154707123|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154707124|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154707125|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707126|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707127|NCT01511445|Silicon|silicon|mesh-list
154707128|NCT01511445|Trace Elements|trace elements|mesh-ancestor
154707129|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
154707130|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707131|NCT02344186|Liraglutide|liraglutide|mesh-list
154707132|NCT02344186|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154707133|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154707134|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707135|NCT02344186|Incretins|incretins|mesh-ancestor
154707136|NCT02344186|Hormones|hormones|mesh-ancestor
154707137|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707138|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
154707139|NCT01537887|Evacetrapib|evacetrapib|mesh-list
154707140|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154707141|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707142|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154707143|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154707144|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707145|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707146|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707147|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154707148|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154707149|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
154707150|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154707151|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154707152|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154707153|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707154|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
154707155|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154707156|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707157|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154707158|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
154707159|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154707160|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707161|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707162|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707163|NCT01928056|Montelukast|montelukast|mesh-list
154707164|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154707165|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
154707166|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154707167|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
154707168|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961992|NCT01057862|Naltrexone|naltrexone|mesh-list
154707169|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707170|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154707171|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154707172|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707173|NCT05585866|Anesthetics|anesthetics|mesh-list
154707174|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707175|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707176|NCT01992952|Fulvestrant|fulvestrant|mesh-list
154707177|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154707178|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707179|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154707180|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154707181|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
154707182|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707183|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707184|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
154707185|NCT01928134|Calcium|calcium|mesh-list
154707186|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154707187|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707188|NCT01928134|Antacids|antacids|mesh-ancestor
154707189|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707190|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154707191|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154707192|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154707193|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154707194|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707195|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707196|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
154707197|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707198|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707199|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154707200|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707201|NCT04756492|Cyclosporine|cyclosporine|mesh-list
154707202|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
154707203|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707204|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707205|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707206|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707207|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154707208|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
154707209|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707210|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154707211|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154707212|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
154707213|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154707214|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707215|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154707216|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154707217|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707218|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707219|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707220|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
154707221|NCT04767633|Analgesics|analgesics|mesh-ancestor
154707222|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
154707223|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707224|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707225|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
154707226|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707227|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154707228|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
154707229|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154707230|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707231|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707232|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154707233|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
154707234|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154707235|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
154707236|NCT01928914|Tafenoquine|tafenoquine|mesh-list
154707237|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154707238|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707239|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154707240|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154707241|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707242|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707243|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707244|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
154707245|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154707246|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154707247|NCT02249104|Adapalene|adapalene|mesh-list
154707248|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154707249|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154707250|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707251|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154707252|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154707253|NCT02249104|Analgesics|analgesics|mesh-ancestor
154707254|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
154707255|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707256|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707257|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707258|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154707259|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154707260|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154707261|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154707262|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
154707263|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707264|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154707265|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154707266|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707267|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
154707268|NCT01536561|Antibodies|antibodies|mesh-list
154707269|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154707270|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
154707271|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
154707272|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707273|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707274|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
154707275|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154707276|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154707277|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154707278|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707279|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707280|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
154707281|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707282|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707283|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154707284|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707285|NCT01916278|Lidocaine|lidocaine|mesh-list
154707286|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
154707287|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
154707288|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707289|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707290|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
154707291|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707292|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154707293|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154707294|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154707295|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707296|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707297|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
154707298|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154707299|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707300|NCT03084640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154707301|NCT03084640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707302|NCT04409691|Sirolimus|sirolimus|mesh-list
154707303|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153962118|NCT02804841|Vitamin D|vitamin d|mesh-list
154707304|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707305|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154707306|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707307|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
154707308|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154707309|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
154707310|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707311|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
154707312|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154707313|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154707314|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154707315|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707316|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
154707317|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707318|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154707319|NCT01487265|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154707320|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154707321|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707322|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707323|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707324|NCT01516606|Clarithromycin|clarithromycin|mesh-list
154707325|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154707326|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707327|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154707328|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707329|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707330|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154707331|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154707332|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
154707333|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
154707334|NCT02209636|Vitamins|vitamins|mesh-ancestor
154707335|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
154707336|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707337|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
154707338|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707339|NCT02209636|Protective Agents|protective agents|mesh-ancestor
154707340|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
154707341|NCT01508325|Metoprolol|metoprolol|mesh-list
154707342|NCT01508325|Bisoprolol|bisoprolol|mesh-list
154707343|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154707344|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154707345|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
154707346|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
154707347|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707348|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707349|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154707350|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154707351|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154707352|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707353|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707354|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707355|NCT01514344|Rituximab|rituximab|mesh-list
154707356|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154707357|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707358|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
154707359|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707360|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962184|NCT04236453|Tenofovir|tenofovir|mesh-list
154707361|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
154707362|NCT02191930|Doxorubicin|doxorubicin|mesh-list
154707363|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154707364|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154707365|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154707366|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
154707367|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707368|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154707369|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154707370|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
154707371|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707372|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707373|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154707374|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154707375|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154707376|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154707377|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707378|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154707379|NCT02191930|Immunotoxins|immunotoxins|mesh-ancestor
154707380|NCT02191930|Immunoconjugates|immunoconjugates|mesh-ancestor
154707381|NCT01536015|Rotigotine|rotigotine|mesh-list
154707382|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
154707383|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
154707384|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707385|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707386|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707387|NCT01484691|Budesonide|budesonide|mesh-list
154707388|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707389|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154707390|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
154707391|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707392|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707393|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154707394|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
154707395|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
154707396|NCT01484691|Hormones|hormones|mesh-ancestor
154707397|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707398|NCT01464034|Dexamethasone|dexamethasone|mesh-list
154707399|NCT01464034|Pomalidomide|pomalidomide|mesh-list
154707400|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707401|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
154707402|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
154707403|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707404|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707405|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153962241|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
154707406|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
154707407|NCT01464034|Hormones|hormones|mesh-ancestor
154707408|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707409|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154707410|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707411|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
154707412|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154707413|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154707414|NCT01464034|Growth Substances|growth substances|mesh-ancestor
154707415|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
154707416|NCT01535235|Lisinopril|lisinopril|mesh-list
154707417|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154707418|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
154707419|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707420|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707421|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154707422|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154707423|NCT01535235|Protective Agents|protective agents|mesh-ancestor
154707424|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707425|NCT02317744|Naltrexone|naltrexone|mesh-list
154707426|NCT02317744|Bupropion|bupropion|mesh-list
154707427|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154707428|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154707429|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707430|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
154707431|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707432|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154707433|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
154707434|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707435|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154707436|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154707437|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707438|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707439|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
154707440|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707441|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154459424|NCT05887843|Azelastine|azelastine|mesh-list
154707442|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154707443|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707444|NCT05577442|Trastuzumab|trastuzumab|mesh-list
154707445|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154707446|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707448|NCT01895764|Methotrexate|methotrexate|mesh-list
154707449|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154707450|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
154707451|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154707452|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707453|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154707454|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
154707455|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707456|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707457|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707458|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707459|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154707460|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154707461|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
154707462|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154707463|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154707464|NCT01895764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154707465|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707466|NCT01894360|Belimumab|belimumab|mesh-list
154707467|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154707468|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
154707469|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707470|NCT01483599|Adalimumab|adalimumab|mesh-list
153962284|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
154707471|NCT01483599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154707472|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707473|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154707474|NCT01407562|Paclitaxel|paclitaxel|mesh-list
154707475|NCT01407562|Carboplatin|carboplatin|mesh-list
154707476|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154707477|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707478|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
154707479|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154707480|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
154707481|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707482|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154707483|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
154707484|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707485|NCT01393522|Milnacipran|milnacipran|mesh-list
154707486|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
154707487|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154707488|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154707489|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707490|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707491|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707492|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707493|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154707494|NCT01393522|Analgesics|analgesics|mesh-ancestor
154707495|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
154707496|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707497|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
154707498|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707499|NCT02086786|Risperidone|risperidone|mesh-list
154707500|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154707501|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
154707502|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707503|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707504|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707505|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154707506|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154707507|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707508|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707509|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154707510|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
154707511|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
154707512|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154707513|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154707514|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154707515|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707516|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707517|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
154707518|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707519|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707520|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154707521|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707522|NCT01774630|Nilotinib|nilotinib|mesh-list
154707523|NCT01774630|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154707524|NCT01774630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154707525|NCT01774630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707526|NCT01774630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707527|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154707528|NCT01895218|Hematinics|hematinics|mesh-ancestor
154707529|NCT01895998|Albuterol|albuterol|mesh-list
154707530|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154707531|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
154707532|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707533|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707534|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154707535|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
154707536|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
154707537|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154707538|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154707539|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154707540|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154707541|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707542|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707543|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707544|NCT01895296|Pasireotide|pasireotide|mesh-list
154707545|NCT01895296|Hormones|hormones|mesh-ancestor
154707546|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707547|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707548|NCT01276600|Tenofovir|tenofovir|mesh-list
154707549|NCT01276600|Emtricitabine|emtricitabine|mesh-list
154707550|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
154707551|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707552|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154707553|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154707554|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707555|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707556|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154707557|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154707558|NCT04755868|Talazoparib|talazoparib|mesh-list
154707559|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154707560|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707561|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707562|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707563|NCT01621906|Alovudine|alovudine|mesh-list
154707564|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
154707565|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707566|NCT01615510|Tapentadol|tapentadol|mesh-list
154707567|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154707568|NCT01615510|Narcotics|narcotics|mesh-ancestor
154707569|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707570|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707571|NCT01615510|Analgesics|analgesics|mesh-ancestor
154707572|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
154707573|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707574|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154707575|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154707576|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962403|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154707577|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707578|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707579|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707580|NCT00530062|Albuterol|albuterol|mesh-list
154707581|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154707582|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
154707583|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707584|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707585|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154707586|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
154707587|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
154707588|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154707589|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154707590|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154707591|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154707592|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707593|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707594|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707595|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
154707596|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154707597|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154707598|NCT01209364|Prednisolone|prednisolone|mesh-list
154707599|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
154707600|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154707601|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
154707602|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707603|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
154707604|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
154707605|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707606|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707607|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154707608|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
154707609|NCT01209364|Hormones|hormones|mesh-ancestor
154707610|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707611|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154707612|NCT01209364|Protective Agents|protective agents|mesh-ancestor
154707613|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154707614|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707615|NCT05080192|Fenofibrate|fenofibrate|mesh-list
154707616|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154707617|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
154707618|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707619|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154707620|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154707621|NCT00472966|Tretinoin|tretinoin|mesh-list
154707622|NCT00472966|Glycolic acid|glycolic acid|mesh-list
154707623|NCT00472966|Hydroquinone|hydroquinone|mesh-list
154707624|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707625|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
154707626|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707627|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707628|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
154707629|NCT00472966|Hormones|hormones|mesh-ancestor
154707630|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707631|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707632|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
154707633|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707634|NCT00472966|Protective Agents|protective agents|mesh-ancestor
154707635|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154707636|NCT01573780|Gemcitabine|gemcitabine|mesh-list
154707637|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154707638|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
154707639|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707640|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707641|NCT01547260|Gemcitabine|gemcitabine|mesh-list
154707642|NCT01547260|Lenalidomide|lenalidomide|mesh-list
154707643|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154707644|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
154707645|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707646|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707647|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
154707648|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707649|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154707650|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154707651|NCT01547260|Growth Substances|growth substances|mesh-ancestor
154707652|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
154707653|NCT01896388|Ifenprodil|ifenprodil|mesh-list
154707654|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154707655|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154707656|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707657|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707658|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707659|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707660|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
154707661|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154707662|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154707663|NCT01125436|Vitamin D|vitamin d|mesh-list
154707664|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
154707665|NCT01125436|Vitamins|vitamins|mesh-ancestor
154707666|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
154707667|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707668|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154707669|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154707670|NCT00436540|Clobetasol|clobetasol|mesh-list
154707671|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707672|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
154707673|NCT00436540|Hormones|hormones|mesh-ancestor
154707674|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707675|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707676|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154707677|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154707678|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154707679|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707680|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707681|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707682|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707683|NCT00425230|Analgesics|analgesics|mesh-ancestor
154707684|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
154707685|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707686|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
154707687|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707688|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
154707689|NCT01066858|Tenofovir|tenofovir|mesh-list
154707690|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
154707691|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707692|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154707693|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154707694|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707695|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707696|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154707697|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154707698|NCT04777552|Diazepam|diazepam|mesh-list
154707699|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154707700|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
154707701|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
154707702|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
154707703|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707704|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707705|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154707706|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154707707|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707708|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154707709|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154707710|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154707711|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154707712|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707713|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154707714|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
154707715|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
154707716|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
154707717|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
154707718|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707719|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707720|NCT01506609|Paclitaxel|paclitaxel|mesh-list
154707721|NCT01506609|Carboplatin|carboplatin|mesh-list
154707722|NCT01506609|Temozolomide|temozolomide|mesh-list
154707723|NCT01506609|Veliparib|veliparib|mesh-list
154707724|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154707725|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707726|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
154707727|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
154707728|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
154707729|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707730|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154707731|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
154707732|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154707733|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707734|NCT04777162|Tislelizumab|tislelizumab|mesh-list
154707735|NCT04777162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154707736|NCT04777162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707737|NCT03027219|Alprostadil|alprostadil|mesh-list
154707738|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154459706|NCT05047211|Hematinics|hematinics|mesh-ancestor
154707739|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
154707740|NCT03027219|Urological Agents|urological agents|mesh-ancestor
154707741|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
154707742|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
154707743|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707744|NCT01506453|Gabapentin|gabapentin|mesh-list
154707745|NCT01506453|Analgesics|analgesics|mesh-ancestor
154707746|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
154707747|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707748|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707749|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
154707750|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154707751|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154707752|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707753|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707754|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154707755|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154707756|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582989|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707757|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707758|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
154707759|NCT04389580|Tamoxifen|tamoxifen|mesh-list
154707760|NCT04389580|Isotretinoin|isotretinoin|mesh-list
154707761|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154707762|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
154707763|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707764|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707765|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154707766|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707767|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154707768|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154707769|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154707770|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707771|NCT00199108|Dexamethasone|dexamethasone|mesh-list
154707772|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707773|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
154707774|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
154707775|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707776|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707777|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154707778|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
154707779|NCT00199108|Hormones|hormones|mesh-ancestor
154707780|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154707781|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154707782|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707783|NCT01504971|Rabeprazole|rabeprazole|mesh-list
154707784|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154707785|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154707786|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154707787|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707788|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707789|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
154707790|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154707791|NCT04753918|Trioxsalen|trioxsalen|mesh-list
154707792|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707793|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707794|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154707795|NCT04161664|Paclitaxel|paclitaxel|mesh-list
154707796|NCT04161664|Carboplatin|carboplatin|mesh-list
154707797|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154707798|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707799|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
154707800|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
154707801|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
154707802|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707803|NCT00936832|Leucovorin|leucovorin|mesh-list
154707804|NCT00936832|Fluorouracil|fluorouracil|mesh-list
154707805|NCT00936832|Irinotecan|irinotecan|mesh-list
154707806|NCT00936832|Sunitinib|sunitinib|mesh-list
154707807|NCT00936832|Calcium|calcium|mesh-list
154707808|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
154707809|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154707810|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707811|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
154707812|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707813|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154707814|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707815|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154707817|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154707818|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154707819|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707820|NCT00936832|Antidotes|antidotes|mesh-ancestor
154707821|NCT00936832|Protective Agents|protective agents|mesh-ancestor
154707822|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
154707823|NCT00936832|Vitamins|vitamins|mesh-ancestor
154707824|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
154707825|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154707826|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154707827|NCT00936832|Growth Substances|growth substances|mesh-ancestor
154707828|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
154707829|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154707830|NCT01479621|Fluticasone|fluticasone|mesh-list
154707831|NCT01479621|Xhance|xhance|mesh-list
154707832|NCT01479621|Albuterol|albuterol|mesh-list
154707833|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
154707834|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154707835|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154707836|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
154707837|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707838|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707839|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154707840|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
154707841|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
154707842|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154707843|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
154707844|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154707845|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154707846|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154707847|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707848|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707849|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707850|NCT04776226|Citalopram|citalopram|mesh-list
154707851|NCT04776226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154707852|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154707853|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707854|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707855|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707856|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
154707857|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707858|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154707859|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
154707860|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707861|NCT02319304|Leucovorin|leucovorin|mesh-list
154707862|NCT02319304|Fluorouracil|fluorouracil|mesh-list
154707863|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
154707864|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
154707865|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707866|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154707867|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707868|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154707869|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
154707870|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707871|NCT02319304|Antidotes|antidotes|mesh-ancestor
154707872|NCT02319304|Protective Agents|protective agents|mesh-ancestor
154707873|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
154707874|NCT02319304|Vitamins|vitamins|mesh-ancestor
154707875|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
154707876|NCT00885664|Ritonavir|ritonavir|mesh-list
154707877|NCT00885664|Lopinavir|lopinavir|mesh-list
154707878|NCT00885664|Tenofovir|tenofovir|mesh-list
154707879|NCT00885664|Emtricitabine|emtricitabine|mesh-list
154707880|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154707881|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154707882|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154707883|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
154707884|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707885|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707886|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154707887|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154707888|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
154707889|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154707890|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154707891|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154707892|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154707893|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154707894|NCT04784104|Epinephrine|epinephrine|mesh-list
154707895|NCT04784104|Racepinephrine|racepinephrine|mesh-list
154707896|NCT04784104|Bupivacaine|bupivacaine|mesh-list
154707897|NCT04784104|Prilocaine|prilocaine|mesh-list
154707898|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154707899|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
154707900|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
154707901|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
154707902|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707903|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707904|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
154707905|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707906|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154707907|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154707908|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707909|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707910|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707911|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154707912|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154707913|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
154707914|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154707915|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
154707916|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
154707917|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
154707918|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154707919|NCT00880594|Desipramine|desipramine|mesh-list
154707920|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154707921|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
154707922|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707923|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707924|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707925|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154707926|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154707927|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154707928|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
154707929|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707930|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707931|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
154707932|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154707933|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707934|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154707935|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707936|NCT04783636|Leuprolide|leuprolide|mesh-list
154707937|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154707938|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
154707939|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154707940|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707941|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154707942|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707943|NCT00820846|Vaccines|vaccines|mesh-list
154707944|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
154707945|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707946|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154707947|NCT03364348|Trastuzumab|trastuzumab|mesh-list
154707948|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154707949|NCT03364348|Maytansine|maytansine|mesh-list
154707950|NCT03364348|Antibodies|antibodies|mesh-list
154707951|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
154707952|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154707953|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
154707954|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
154707955|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
154707956|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707957|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707958|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154707959|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
154707960|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
154707961|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
154707962|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707963|NCT03364348|Immunotoxins|immunotoxins|mesh-ancestor
154707964|NCT04782622|Apatinib|apatinib|mesh-list
154707965|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154707966|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154707967|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707968|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707969|NCT04775212|Sevoflurane|sevoflurane|mesh-list
154707970|NCT04775212|Desflurane|desflurane|mesh-list
154707971|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154707972|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154707973|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
154707974|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
154707975|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707976|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707977|NCT04774822|Mydriatics|mydriatics|mesh-list
154707978|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
154707979|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154707980|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707981|NCT04782388|Alprazolam|alprazolam|mesh-list
154707982|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154707983|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154707984|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154707985|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154707986|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154707987|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154707988|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
154707989|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
154707990|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154707991|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707992|NCT04782076|Dabigatran|dabigatran|mesh-list
154707993|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
154707994|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154707995|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
154707996|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154707997|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154707998|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
154707999|NCT04782310|Pregabalin|pregabalin|mesh-list
154708000|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154708001|NCT04782310|Analgesics|analgesics|mesh-ancestor
154708002|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
154708003|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708004|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708005|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
153962840|NCT05671822|Capecitabine|capecitabine|mesh-list
154708006|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154708007|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708008|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708009|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154708010|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154708011|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154708012|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708013|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154708014|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154708015|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154708016|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708017|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
154708018|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
154708019|NCT03300544|Leucovorin|leucovorin|mesh-list
154708020|NCT03300544|Capecitabine|capecitabine|mesh-list
154708021|NCT03300544|Fluorouracil|fluorouracil|mesh-list
154708022|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
154708023|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154708024|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708025|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
154708026|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708027|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708028|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708029|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
154708030|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708031|NCT03300544|Antidotes|antidotes|mesh-ancestor
154708032|NCT03300544|Protective Agents|protective agents|mesh-ancestor
154708033|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
154708034|NCT03300544|Vitamins|vitamins|mesh-ancestor
154708035|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
154708036|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154708037|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
154708038|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154460008|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
154708039|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154708040|NCT03249844|Prednisolone|prednisolone|mesh-list
154708041|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
154708042|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154708043|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
154708044|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708045|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
154708046|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
154708047|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708048|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708049|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154708050|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
154708051|NCT03249844|Hormones|hormones|mesh-ancestor
154708052|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708053|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154708054|NCT03249844|Protective Agents|protective agents|mesh-ancestor
154708055|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154708056|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708057|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
154708058|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154708059|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
154708060|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708061|NCT00637624|Expectorants|expectorants|mesh-ancestor
154708062|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
154708063|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154708064|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
154708065|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708066|NCT00637624|Protective Agents|protective agents|mesh-ancestor
154708067|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708068|NCT00637624|Antidotes|antidotes|mesh-ancestor
154708069|NCT01479465|Leucovorin|leucovorin|mesh-list
154708070|NCT01479465|Fluorouracil|fluorouracil|mesh-list
154708071|NCT01479465|Irinotecan|irinotecan|mesh-list
154708072|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
154708073|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708074|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708075|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708076|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708077|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
154708078|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708079|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154708080|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154708081|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708082|NCT01479465|Antidotes|antidotes|mesh-ancestor
154708083|NCT01479465|Protective Agents|protective agents|mesh-ancestor
154708084|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
154708085|NCT01479465|Vitamins|vitamins|mesh-ancestor
154708086|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
154708087|NCT04781686|Docetaxel|docetaxel|mesh-list
154708088|NCT04781686|Apatinib|apatinib|mesh-list
154708089|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708090|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
154708091|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
154708092|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
154708093|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708094|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708095|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708096|NCT04780750|Docetaxel|docetaxel|mesh-list
154708097|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708098|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
154708099|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
154708100|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
154708101|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708102|NCT04780984|Bromides|bromides|mesh-list
154708103|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
154708104|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154708105|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
154708106|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708107|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708108|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154708109|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
154708110|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
154708111|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154708112|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
154708113|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708114|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708115|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
154708116|NCT02090374|Vitamin D|vitamin d|mesh-list
154708117|NCT02090374|Poly ICLC|poly iclc|mesh-list
154708118|NCT02090374|Resiquimod|resiquimod|mesh-list
154708119|NCT02090374|Vitamins|vitamins|mesh-ancestor
154708120|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
154708121|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708122|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154708123|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
154708124|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
154708125|NCT02090374|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154708126|NCT02090374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708127|NCT02090374|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154708128|NCT02222740|Hydrocodone|hydrocodone|mesh-list
154708129|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154708130|NCT02222740|Narcotics|narcotics|mesh-ancestor
154708131|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708132|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708133|NCT02222740|Analgesics|analgesics|mesh-ancestor
154708134|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
154708135|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708136|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
154708137|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
154708138|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
154708139|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154708140|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708141|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708142|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708143|NCT04779892|Infliximab|infliximab|mesh-list
154708144|NCT04779892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154708145|NCT04779892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708146|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
154708147|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154708148|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708149|NCT04389424|Tamoxifen|tamoxifen|mesh-list
154708150|NCT04389424|Anastrozole|anastrozole|mesh-list
154708151|NCT04389424|Exemestane|exemestane|mesh-list
154708152|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154708153|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
154708154|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708155|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708156|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154708157|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708158|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154708159|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154708160|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154708161|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154708162|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154708163|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708164|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708165|NCT04771390|Selitrectinib|selitrectinib|mesh-list
154708166|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708167|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708168|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
154708169|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154708170|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154708171|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708172|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
154708173|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
154708174|NCT05411380|Capecitabine|capecitabine|mesh-list
154708175|NCT05411380|Letrozole|letrozole|mesh-list
154708176|NCT05411380|Fulvestrant|fulvestrant|mesh-list
154708177|NCT05411380|Anastrozole|anastrozole|mesh-list
154708178|NCT05411380|Exemestane|exemestane|mesh-list
154708179|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708180|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
154708181|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708182|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708183|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154708184|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154708185|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708186|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154708187|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
154708188|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708189|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708190|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153963013|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154708191|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154708192|NCT04779580|Anesthetics|anesthetics|mesh-list
154708193|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
154708194|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708195|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708196|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
154708197|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708199|NCT04770688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154708200|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708201|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708202|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708203|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708204|NCT05390476|Capecitabine|capecitabine|mesh-list
154708205|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708206|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
154708207|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708208|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708209|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154708210|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154708211|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708212|NCT04769908|Lenvatinib|lenvatinib|mesh-list
154708213|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708214|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708215|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708216|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708217|NCT00054028|Suramin|suramin|mesh-list
154708218|NCT00054028|Paclitaxel|paclitaxel|mesh-list
154708219|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154708220|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708221|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
154708222|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
154708223|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
154708224|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708225|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
154708226|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
154708227|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154708228|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708229|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154708230|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154708231|NCT00058240|Alvocidib|alvocidib|mesh-list
154708232|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708233|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
154708234|NCT00058240|Growth Substances|growth substances|mesh-ancestor
154708235|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708236|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708237|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708238|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708239|NCT03026907|Azathioprine|azathioprine|mesh-list
154708240|NCT03026907|Alitretinoin|alitretinoin|mesh-list
154708241|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708242|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
154708243|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
154708244|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708245|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708246|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708247|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
154708248|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708249|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708250|NCT00060424|Cyclosporine|cyclosporine|mesh-list
154708251|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
154708252|NCT00060424|Fludarabine|fludarabine|mesh-list
154708253|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
154708254|NCT00060424|Cyclosporins|cyclosporins|mesh-list
154708255|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708256|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708257|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
154708258|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708259|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708260|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
154708261|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708262|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708263|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
154708264|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708265|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
154708266|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708267|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154460229|NCT03469544|Hormones|hormones|mesh-list
154708268|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154708269|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154708270|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
154708271|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154708273|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708274|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708275|NCT00063232|Metformin|metformin|mesh-list
154708276|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708277|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708278|NCT00063622|Vitamin E|vitamin e|mesh-list
154708279|NCT00063622|Pioglitazone|pioglitazone|mesh-list
154708280|NCT00063622|Vitamins|vitamins|mesh-ancestor
154708281|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
154708282|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708283|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708284|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
154708285|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708286|NCT00063622|Protective Agents|protective agents|mesh-ancestor
154708287|NCT00153166|Pioglitazone|pioglitazone|mesh-list
154708288|NCT00153166|Atorvastatin|atorvastatin|mesh-list
154708289|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154708290|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154708291|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
154708292|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708293|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154708294|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154708295|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708296|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708297|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708298|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
154708299|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154708300|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154708301|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154708302|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708303|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708304|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
154708305|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708306|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708307|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154708308|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708309|NCT01475721|Fluticasone|fluticasone|mesh-list
154708310|NCT01475721|Xhance|xhance|mesh-list
154708311|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154708312|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154708313|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
154708314|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708315|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708316|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154708317|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
154708318|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
154708319|NCT01475721|Hormones|hormones|mesh-ancestor
154708320|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708321|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
154708322|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708323|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
154708324|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154708325|NCT00065806|Atorvastatin|atorvastatin|mesh-list
154708326|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154708327|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154708328|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
154708329|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708330|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154708331|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154708332|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708333|NCT00068770|Celecoxib|celecoxib|mesh-list
154708334|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154708335|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154708336|NCT00068770|Analgesics|analgesics|mesh-ancestor
154708337|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
154708338|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708339|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708340|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708341|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708342|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154460303|NCT03469310|Acetaminophen|acetaminophen|mesh-list
154708343|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154708344|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708345|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708346|NCT01475331|Ethanol|ethanol|mesh-list
154708347|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154708348|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708349|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708350|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708351|NCT01500213|Dexamethasone|dexamethasone|mesh-list
154708352|NCT01500213|Granisetron|granisetron|mesh-list
154708353|NCT01500213|Rolapitant|rolapitant|mesh-list
154708354|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708355|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
154708356|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
154708357|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708358|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708359|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154708360|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
154708361|NCT01500213|Hormones|hormones|mesh-ancestor
154708362|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708363|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154708364|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708365|NCT01500213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154708366|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154708367|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
154708368|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708369|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708370|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154708371|NCT00069160|Docetaxel|docetaxel|mesh-list
154708372|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154708373|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708374|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
154708375|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
154708376|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
154708377|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708378|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154708379|NCT00071890|Aldesleukin|aldesleukin|mesh-list
154708380|NCT00071890|Interleukin-2|interleukin-2|mesh-list
154708381|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708382|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154708383|NCT00071890|Analgesics|analgesics|mesh-ancestor
154708384|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
154708385|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708386|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708387|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154708388|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154708389|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
154708390|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708391|NCT01475253|Lidocaine|lidocaine|mesh-list
154708392|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
154708393|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
154708394|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708395|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708396|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
154708397|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708398|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154708399|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154708400|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154708401|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708402|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708403|NCT00072514|Dexamethasone|dexamethasone|mesh-list
154708404|NCT00072514|Rituximab|rituximab|mesh-list
154708405|NCT00072514|Carboplatin|carboplatin|mesh-list
154708406|NCT00072514|Gemcitabine|gemcitabine|mesh-list
154708407|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154708408|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708409|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
154708410|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708411|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708412|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708413|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
154708414|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
154708415|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708416|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154708417|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
154708418|NCT00072514|Hormones|hormones|mesh-ancestor
154708419|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708420|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154708421|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708422|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
154708423|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708424|NCT00074308|Bevacizumab|bevacizumab|mesh-list
154708425|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154708426|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
154708427|NCT00074308|Antibodies|antibodies|mesh-list
154708428|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
154708429|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154708430|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708431|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154708432|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154708433|NCT00074308|Growth Substances|growth substances|mesh-ancestor
154708434|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708435|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
154708436|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
154708437|NCT00074308|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154708438|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708439|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708440|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708441|NCT00166036|Atorvastatin|atorvastatin|mesh-list
154708442|NCT00166036|Pravastatin|pravastatin|mesh-list
154708443|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154708444|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154708445|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
154708446|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708447|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154708448|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154708449|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708450|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
154708451|NCT00167206|Fludarabine|fludarabine|mesh-list
154708452|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708453|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
154708454|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708455|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708456|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154708457|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
154708458|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963284|NCT02737787|Nivolumab|nivolumab|mesh-list
154708459|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708460|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154708461|NCT01474551|Vemurafenib|vemurafenib|mesh-list
154708462|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708463|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708464|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708465|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708466|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154708467|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154708468|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708469|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708470|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
154708471|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708472|NCT00168298|Dexamethasone|dexamethasone|mesh-list
154708473|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
154708474|NCT00168298|BB 1101|bb 1101|mesh-list
154708475|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708476|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
154708477|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
154708478|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708479|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708480|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154708481|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
154708482|NCT00168298|Hormones|hormones|mesh-ancestor
154708483|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708484|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154708485|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708486|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
154708487|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708488|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708489|NCT00076258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154708490|NCT00076258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154708491|NCT00076258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708492|NCT00076258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708493|NCT00076258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708495|NCT00076258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708496|NCT00078286|Sertraline|sertraline|mesh-list
154708497|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
154708498|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154708499|NCT00078286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154708500|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154708501|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708502|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708503|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708504|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
154708505|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708506|NCT00078754|Valproic Acid|valproic acid|mesh-list
154708507|NCT00078754|Fluoxetine|fluoxetine|mesh-list
154708508|NCT00078754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154708509|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154708510|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708511|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708512|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708513|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
154708514|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708515|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154708516|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
154708517|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154708518|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153963343|NCT01439802|Copper|copper|mesh-list
154708519|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154708520|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708521|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
154708522|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
154708523|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
154708524|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154708525|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708526|NCT00081328|Metformin|metformin|mesh-list
154708527|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
154708528|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708529|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708530|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
154708531|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154708532|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708533|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154708534|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
154708535|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154708536|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708537|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708538|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708539|NCT00083122|Cisplatin|cisplatin|mesh-list
154708540|NCT00083122|Alvocidib|alvocidib|mesh-list
154708541|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708542|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
154708543|NCT00083122|Growth Substances|growth substances|mesh-ancestor
154708544|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708545|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708546|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708547|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708548|NCT01474239|Bevacizumab|bevacizumab|mesh-list
154708549|NCT01474239|Fotemustine|fotemustine|mesh-list
154708550|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154708551|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708552|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154708553|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154708554|NCT01474239|Growth Substances|growth substances|mesh-ancestor
154708555|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708556|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
154708557|NCT01473381|Dexetimide|dexetimide|mesh-list
154708558|NCT01473381|Citalopram|citalopram|mesh-list
154708559|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154708560|NCT01473381|Escitalopram|escitalopram|mesh-list
154708561|NCT01473381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154708562|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154708563|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708564|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708565|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708566|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
154708567|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708568|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154708569|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
154708570|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154708571|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154708572|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153963408|NCT02796105|Ganirelix|ganirelix|mesh-list
154708573|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
154708574|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
154708575|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708576|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154708577|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154708578|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
154708579|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154708580|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154708581|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
154708582|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154708583|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154708584|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154708585|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708586|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708587|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
154708588|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708589|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708590|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154708591|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708592|NCT01499277|Vancomycin|vancomycin|mesh-list
154708593|NCT01499277|Ceftaroline|ceftaroline|mesh-list
154708594|NCT01499277|Aztreonam|aztreonam|mesh-list
154708595|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154708596|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708597|NCT01499277|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154708598|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154708599|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
154708600|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
154708601|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708602|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708603|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154708604|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154708605|NCT00176800|Growth Substances|growth substances|mesh-ancestor
154708606|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708607|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
154708608|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708609|NCT00176878|Fludarabine|fludarabine|mesh-list
154708610|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
154708611|NCT00176878|Busulfan|busulfan|mesh-list
154708612|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154708613|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708614|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708615|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
154708616|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708617|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708618|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
154708619|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708620|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
154708621|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154708622|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154708623|NCT01898182|Kinetin|kinetin|mesh-list
154708624|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154708625|NCT01898182|Growth Substances|growth substances|mesh-ancestor
154708626|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708627|NCT01499199|Dolutegravir|dolutegravir|mesh-list
154708628|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154708629|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154708630|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708631|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708632|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154708633|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154708634|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
154708635|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708636|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154708637|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
154708638|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154708639|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
154708640|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154708641|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708642|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154708643|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154708644|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708645|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154708646|NCT01897012|Romidepsin|romidepsin|mesh-list
154708647|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708648|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154708649|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708650|NCT01897012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154708651|NCT01897012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708652|NCT01897012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708653|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154708654|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154708655|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708656|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708657|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
154708658|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708659|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
154708660|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154708661|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708662|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708663|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708664|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154708665|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
154708666|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
154708667|NCT01527357|Coagulants|coagulants|mesh-ancestor
154708668|NCT00181714|Methylphenidate|methylphenidate|mesh-list
154708669|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154708670|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708671|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154708672|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154708673|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708674|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708675|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
154708676|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708677|NCT01472835|Midazolam|midazolam|mesh-list
154708678|NCT01472835|Fentanyl|fentanyl|mesh-list
154708679|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154708680|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154708681|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708682|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708683|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154708684|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154708685|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154708686|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154708687|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
154708688|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
154708689|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
154708690|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
154708691|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708692|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708693|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154708694|NCT01472835|Narcotics|narcotics|mesh-ancestor
154708695|NCT01472835|Analgesics|analgesics|mesh-ancestor
154708696|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
154708697|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708698|NCT00185692|Acetaminophen|acetaminophen|mesh-list
153963529|NCT02794155|Insulin|insulin|mesh-list
154708699|NCT00185692|Cyclosporine|cyclosporine|mesh-list
154708700|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
154708701|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
154708702|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154708703|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154708704|NCT00185692|Prednisolone|prednisolone|mesh-list
154708705|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
154708706|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
154708707|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154708708|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154708709|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154708710|NCT00185692|Cyclosporins|cyclosporins|mesh-list
154708711|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154708712|NCT00185692|Lenograstim|lenograstim|mesh-list
154708713|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154708714|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
154708715|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708716|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708717|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708718|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
154708719|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708720|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
154708721|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708722|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
154708723|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708724|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154708725|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154708726|NCT00185692|Analgesics|analgesics|mesh-ancestor
154708727|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
154708728|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708729|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
154708730|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154708731|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708732|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154708733|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
154708734|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154708735|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708736|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
154708737|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
154708738|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154708739|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
154708741|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708742|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154708743|NCT00185692|Protective Agents|protective agents|mesh-ancestor
154708744|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154708745|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154708746|NCT01526733|Insulin|insulin|mesh-list
154708747|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154708748|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
154708749|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
154708750|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708751|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708752|NCT00094900|Rilonacept|rilonacept|mesh-list
154708753|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708754|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
154708755|NCT00096460|Carmustine|carmustine|mesh-list
154708756|NCT00096460|Rituximab|rituximab|mesh-list
154708757|NCT00096460|Methotrexate|methotrexate|mesh-list
154708758|NCT00096460|Fludarabine|fludarabine|mesh-list
154708759|NCT00096460|Etoposide|etoposide|mesh-list
154708760|NCT00096460|Tacrolimus|tacrolimus|mesh-list
154708761|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708762|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
154708763|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708764|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708765|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154708766|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
154708767|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708768|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708769|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154708770|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154708771|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154708772|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
154708773|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154708774|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708775|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
154708776|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
154708777|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708778|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154708779|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154708780|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154708781|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154708782|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154708783|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154708784|NCT00006178|Sirolimus|sirolimus|mesh-list
154708785|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
154708786|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154708787|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708788|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154708789|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708790|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
154708791|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708792|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
154708793|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708794|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
154708795|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154708796|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708797|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708798|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154708799|NCT00098956|Topotecan|topotecan|mesh-list
154708800|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
154708801|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154708802|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154708803|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708804|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708805|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708806|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708807|NCT02197156|Acetaminophen|acetaminophen|mesh-list
154708808|NCT02197156|Hydrocodone|hydrocodone|mesh-list
154708809|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154708810|NCT02197156|Analgesics|analgesics|mesh-ancestor
154708811|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
154708812|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708813|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708814|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
154708815|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154708816|NCT02197156|Narcotics|narcotics|mesh-ancestor
154708817|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154708818|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
154708819|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
154708820|NCT00187720|Metformin|metformin|mesh-list
154708821|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708822|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708823|NCT00006244|Interferons|interferons|mesh-list
154708824|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
154708825|NCT00006244|Aldesleukin|aldesleukin|mesh-list
154708826|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
154708827|NCT00006244|Melphalan|melphalan|mesh-list
154708828|NCT00006244|Interleukin-2|interleukin-2|mesh-list
154708829|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708830|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
154708831|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708832|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154708833|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
154708834|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708835|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154708836|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708837|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
154708838|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708839|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154708840|NCT00006244|Analgesics|analgesics|mesh-ancestor
154708841|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
154708842|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708843|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154708844|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154708845|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
154708846|NCT01525875|Antacids|antacids|mesh-ancestor
154708847|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708848|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154708849|NCT01525641|Pramipexole|pramipexole|mesh-list
154708850|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
154708851|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708852|NCT01525641|Protective Agents|protective agents|mesh-ancestor
154708853|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708854|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154708855|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154708856|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
154708857|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
154708858|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708859|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
154708860|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708861|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
154708862|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708863|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708864|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154708865|NCT01496469|Febuxostat|febuxostat|mesh-list
154708866|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
154708867|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708868|NCT00189436|Budesonide|budesonide|mesh-list
154708869|NCT00189436|Albuterol|albuterol|mesh-list
154708870|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708871|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154708872|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
154708873|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708874|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708875|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154708876|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
154708877|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
154708878|NCT00189436|Hormones|hormones|mesh-ancestor
154708879|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154708880|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
154708881|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154708882|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154708883|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154708884|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154708885|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
154708886|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963706|NCT02789397|Azathioprine|azathioprine|mesh-list
154708887|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708888|NCT01471353|Capecitabine|capecitabine|mesh-list
154708889|NCT01471353|Sorafenib|sorafenib|mesh-list
154708890|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708891|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
154708892|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708893|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708894|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708895|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708896|NCT01525407|Atorvastatin|atorvastatin|mesh-list
154708897|NCT01525407|Calcium|calcium|mesh-list
154708898|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154708899|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708900|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154708901|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154708902|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
154708903|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708904|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154708905|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154708906|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708907|NCT01471197|Pemetrexed|pemetrexed|mesh-list
154708908|NCT01471197|Ipilimumab|ipilimumab|mesh-list
154708909|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708910|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708911|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708912|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154708913|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154708914|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154708915|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154708916|NCT04408989|Bevacizumab|bevacizumab|mesh-list
154708917|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154708918|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708919|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154708920|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154708921|NCT04408989|Growth Substances|growth substances|mesh-ancestor
154708922|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708923|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
154708924|NCT00011986|Paclitaxel|paclitaxel|mesh-list
154708925|NCT00011986|Carboplatin|carboplatin|mesh-list
154708926|NCT00011986|Gemcitabine|gemcitabine|mesh-list
154708927|NCT00011986|Doxorubicin|doxorubicin|mesh-list
154708928|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154708929|NCT00011986|Topotecan|topotecan|mesh-list
154708930|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154708931|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708932|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
154708933|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
154708934|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
154708935|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708936|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154708937|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
154708938|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154708939|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154708940|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154708941|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708942|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154708943|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154708944|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154708945|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
154708946|NCT01524783|Everolimus|everolimus|mesh-list
154708947|NCT01524783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154708948|NCT01524783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154708949|NCT01524783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154708950|NCT01524783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708951|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708952|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
154708953|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708954|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708955|NCT01494987|Glimepiride|glimepiride|mesh-list
154708956|NCT01494987|Ranolazine|ranolazine|mesh-list
154708957|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154708958|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154708959|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708960|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154708961|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
154708962|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154708963|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154708964|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708965|NCT04409769|Ceftaroline|ceftaroline|mesh-list
154708966|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
154708967|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154708968|NCT04409769|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154708969|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154708970|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708971|NCT01524627|Varenicline|varenicline|mesh-list
154708972|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154708973|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154708974|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
154708975|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154708976|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154708977|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708978|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
154708979|NCT01469637|Mesalamine|mesalamine|mesh-list
154708980|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154708981|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154708982|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154708983|NCT01469637|Analgesics|analgesics|mesh-ancestor
154708984|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
154708985|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154708986|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708987|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154708988|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708989|NCT00012298|Rituximab|rituximab|mesh-list
154708990|NCT00012298|Oprelvekin|oprelvekin|mesh-list
154708991|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154708992|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154708993|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154708994|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
154708995|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154708996|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154708997|NCT00193258|Bevacizumab|bevacizumab|mesh-list
154708998|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154708999|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
154709000|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709001|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709002|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154709003|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154709004|NCT00193258|Growth Substances|growth substances|mesh-ancestor
154709005|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709006|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
154709007|NCT00193258|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154709008|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709009|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709010|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709011|NCT00029536|Progesterone|progesterone|mesh-list
154709012|NCT00029536|Progestins|progestins|mesh-ancestor
154709013|NCT00029536|Hormones|hormones|mesh-ancestor
154709014|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709015|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709016|NCT00193492|Bevacizumab|bevacizumab|mesh-list
154709017|NCT00193492|Rituximab|rituximab|mesh-list
154709018|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709019|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709020|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154709021|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154709022|NCT00193492|Growth Substances|growth substances|mesh-ancestor
154709023|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709024|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
154709025|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
154709026|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709027|NCT00194116|Valproic Acid|valproic acid|mesh-list
154709028|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
154709029|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709030|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709031|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
154709032|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709033|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709034|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
154709035|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154709036|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154709037|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154709038|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
154709039|NCT02096458|Lansoprazole|lansoprazole|mesh-list
154709040|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154709041|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154709042|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154709043|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709044|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709045|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
154709046|NCT00194896|Glyburide|glyburide|mesh-list
154709047|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154709048|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709049|NCT04348474|Azithromycin|azithromycin|mesh-list
154709050|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
154709051|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154709052|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709053|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
154709054|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154709055|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154709056|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709057|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709058|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709059|NCT00107536|Lapatinib|lapatinib|mesh-list
154709060|NCT00107536|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154709061|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709062|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709063|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709064|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709065|NCT00108550|Gabapentin|gabapentin|mesh-list
154709066|NCT00108550|Analgesics|analgesics|mesh-ancestor
154709067|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
154709068|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709069|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709070|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
154709071|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154709072|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154709073|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154709074|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154709075|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154709076|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154709077|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709078|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709079|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
154709080|NCT02093962|Pemetrexed|pemetrexed|mesh-list
154709081|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709082|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709083|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709084|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154709085|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154709086|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154709087|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154709088|NCT00200902|Escitalopram|escitalopram|mesh-list
154709089|NCT00200902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154709090|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154709091|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154709092|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709093|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709094|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
154709095|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709096|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709097|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154709098|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
154709099|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154709100|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154709101|NCT00200902|Analgesics|analgesics|mesh-ancestor
154709102|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
154709103|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
154709104|NCT00201448|Vaccines|vaccines|mesh-list
153963971|NCT01054820|Diclofenac|diclofenac|mesh-list
154709105|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
154709106|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709107|NCT00201760|Gemcitabine|gemcitabine|mesh-list
154709108|NCT00201760|Trastuzumab|trastuzumab|mesh-list
154709109|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709110|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709111|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
154709112|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709113|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709114|NCT00201838|Etanercept|etanercept|mesh-list
154709115|NCT00201838|Gemcitabine|gemcitabine|mesh-list
154709116|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709117|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
154709118|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709119|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709120|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154709121|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154709122|NCT00201838|Analgesics|analgesics|mesh-ancestor
154709123|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
154709124|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709125|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709126|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154709127|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709128|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154709129|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709130|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
154709131|NCT00040846|Cyclosporine|cyclosporine|mesh-list
154709132|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
154709133|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154709134|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
154709135|NCT00040846|Fludarabine|fludarabine|mesh-list
154709136|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
154709137|NCT00040846|Antibodies|antibodies|mesh-list
154709138|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
154709139|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154709140|NCT00040846|Cyclosporins|cyclosporins|mesh-list
154709141|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
154709142|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709143|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709144|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709145|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
154709146|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709147|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709148|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709149|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
154709150|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709151|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
154709152|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709153|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154709154|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154709155|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154709156|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
154709157|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154709158|NCT00041938|Aspirin|aspirin|mesh-list
154709159|NCT00041938|Warfarin|warfarin|mesh-list
154709160|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154709161|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154709162|NCT00041938|Analgesics|analgesics|mesh-ancestor
154709163|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
154709164|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709165|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709166|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154709167|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709168|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154461129|NCT02808819|Benralizumab|benralizumab|mesh-list
154709169|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154709170|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709171|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154709172|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154709173|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709174|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
154709175|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
154709176|NCT00202930|Rituximab|rituximab|mesh-list
154709177|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709178|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709179|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
154709180|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709181|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709182|NCT00044044|Haloperidol|haloperidol|mesh-list
154709183|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
154709184|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154709185|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
154709186|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
154709187|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709188|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709189|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154709190|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154709191|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154709192|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154709193|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154709194|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154709195|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
154709196|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709197|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709198|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154709199|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154709200|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154709201|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154709202|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
154709203|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154709204|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154709205|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
154709206|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154709207|NCT00112918|Leucovorin|leucovorin|mesh-list
154709208|NCT00112918|Bevacizumab|bevacizumab|mesh-list
154709209|NCT00112918|Capecitabine|capecitabine|mesh-list
154709210|NCT00112918|Fluorouracil|fluorouracil|mesh-list
154709211|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
154709212|NCT00112918|Calcium|calcium|mesh-list
154709213|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
154709214|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709215|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709216|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154709217|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154709218|NCT00112918|Growth Substances|growth substances|mesh-ancestor
154709219|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709220|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
154709221|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154709222|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709223|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
154709224|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709225|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709226|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
154709227|NCT00112918|Antidotes|antidotes|mesh-ancestor
154709228|NCT00112918|Protective Agents|protective agents|mesh-ancestor
154709229|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
154709230|NCT00112918|Vitamins|vitamins|mesh-ancestor
154709231|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
154709232|NCT00046228|Reteplase|reteplase|mesh-list
154709233|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154709234|NCT00046228|Abciximab|abciximab|mesh-list
154709235|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
154709236|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154709237|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154709238|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154709239|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709240|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
154709241|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154709242|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154709243|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
154709244|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154709245|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709246|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154709247|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154709248|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154709249|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154709250|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709251|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154709252|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154709253|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709254|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709255|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709256|NCT00113230|Bevacizumab|bevacizumab|mesh-list
154709257|NCT00113230|Capecitabine|capecitabine|mesh-list
154709258|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709259|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709260|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154709261|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154709262|NCT00113230|Growth Substances|growth substances|mesh-ancestor
154709263|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709264|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
154709265|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709266|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
154709267|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709268|NCT00049036|Prednisone|prednisone|mesh-list
154709269|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
154709270|NCT00049036|Rituximab|rituximab|mesh-list
154709271|NCT00049036|Doxorubicin|doxorubicin|mesh-list
154709272|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154709273|NCT00049036|Etoposide|etoposide|mesh-list
154709274|NCT00049036|Vincristine|vincristine|mesh-list
154709275|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
154709276|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709277|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
154709278|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709279|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709280|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709281|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
154709282|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709283|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709284|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154709285|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709286|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154709287|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154709288|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154709289|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709290|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154709291|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
154709292|NCT00049036|Hormones|hormones|mesh-ancestor
154709293|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709294|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154709295|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154709296|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
154709297|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
154709298|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
154709299|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
154709300|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
154709301|NCT00049504|Fludarabine|fludarabine|mesh-list
154709302|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
154709303|NCT00049504|Tacrolimus|tacrolimus|mesh-list
154709304|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709305|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
154709306|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709307|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709308|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709309|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
154709310|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709311|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709312|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154709313|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709314|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
154709315|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154709316|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709317|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154709318|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154461284|NCT02037399|Dexamethasone|dexamethasone|mesh-list
154709319|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
154709320|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154709321|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709322|NCT00050986|Temozolomide|temozolomide|mesh-list
154709323|NCT00050986|Tipifarnib|tipifarnib|mesh-list
154709324|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709325|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
154709326|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709327|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709328|NCT00118144|Bortezomib|bortezomib|mesh-list
154709329|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709330|NCT00118378|Modafinil|modafinil|mesh-list
154709331|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154709332|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709333|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154709334|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154709335|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154709336|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709337|NCT00217438|Melphalan|melphalan|mesh-list
154709338|NCT00217438|Amifostine|amifostine|mesh-list
154709339|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709340|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
154709341|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709342|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709343|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154709344|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709345|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
154709346|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709347|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154709348|NCT00217438|Protective Agents|protective agents|mesh-ancestor
154709349|NCT04480450|Rituximab|rituximab|mesh-list
154709350|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709351|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709352|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
154709353|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709354|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709355|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
154709356|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709357|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709358|NCT00052078|Sertraline|sertraline|mesh-list
154709359|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
154709360|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154709361|NCT00052078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154709362|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154709363|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154709364|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709365|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709366|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
154709367|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709368|NCT05820048|Lansoprazole|lansoprazole|mesh-list
154709369|NCT05820048|Dexlansoprazole|dexlansoprazole|mesh-list
154709370|NCT05820048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154709371|NCT05820048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154709372|NCT05820048|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154709373|NCT05820048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709374|NCT05820048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709375|NCT05819983|Ivermectin|ivermectin|mesh-list
154709376|NCT05819983|Permethrin|permethrin|mesh-list
154709377|NCT05819983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154709378|NCT05819983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709379|NCT05819983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709380|NCT05819983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709381|NCT05819970|Allyl sulfide|allyl sulfide|mesh-list
154709382|NCT05819970|Antioxidants|antioxidants|mesh-ancestor
154709383|NCT05819970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709384|NCT05819970|Protective Agents|protective agents|mesh-ancestor
154709385|NCT05819970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709386|NCT05819970|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154709387|NCT05819970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709388|NCT05819970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154709389|NCT05819970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709390|NCT05819632|Curcumin|curcumin|mesh-list
154709391|NCT05819632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154709392|NCT05819632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154709393|NCT05819632|Analgesics|analgesics|mesh-ancestor
154709394|NCT05819632|Sensory System Agents|sensory system agents|mesh-ancestor
154709395|NCT05819632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709396|NCT05819632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709397|NCT05819632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154709398|NCT05819632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709399|NCT05819632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709400|NCT05819632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709401|NCT05819632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709402|NCT05819229|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154709403|NCT05819229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709404|NCT05819060|Bevacizumab|bevacizumab|mesh-list
154709405|NCT05819060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709406|NCT05819060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709407|NCT05819060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154709408|NCT05819060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154709409|NCT05819060|Growth Substances|growth substances|mesh-ancestor
154709410|NCT05819060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709411|NCT05819060|Growth Inhibitors|growth inhibitors|mesh-ancestor
154709412|NCT05818995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154709413|NCT05818995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154709414|NCT05818995|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154709415|NCT05818995|Calcium Channel Blockers|calcium channel blockers|mesh-list
154709416|NCT05818995|Angiotensin II|angiotensin ii|mesh-list
154709417|NCT05818995|Giapreza|giapreza|mesh-list
154709418|NCT05818995|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154709419|NCT05818995|Angiotensinogen|angiotensinogen|mesh-list
154709420|NCT05818995|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154709421|NCT05818995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154709422|NCT05818995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154709423|NCT05818995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709424|NCT05818995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709425|NCT05818995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154709426|NCT05818995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154709427|NCT05818995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154709428|NCT05818995|Protease Inhibitors|protease inhibitors|mesh-ancestor
154709429|NCT05818995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154709430|NCT05818982|Irinotecan|irinotecan|mesh-list
154709431|NCT05818982|Afatinib|afatinib|mesh-list
154709432|NCT05818982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154709433|NCT05818982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154709434|NCT05818982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709435|NCT05818982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709436|NCT05818982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709437|NCT05818982|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154709438|NCT05818982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709439|NCT05818670|Tadalafil|tadalafil|mesh-list
154709440|NCT05818670|Tamsulosin|tamsulosin|mesh-list
154709441|NCT05818670|Vasodilator Agents|vasodilator agents|mesh-ancestor
154709442|NCT05818670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154709443|NCT05818670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154709444|NCT05818670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709445|NCT05818670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709446|NCT05818670|Urological Agents|urological agents|mesh-ancestor
154709447|NCT05818670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154709448|NCT05818670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154709449|NCT05818670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154709450|NCT05818670|Adrenergic Agents|adrenergic agents|mesh-ancestor
154709451|NCT05818670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709452|NCT05818670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709453|NCT05816512|Chlorhexidine|chlorhexidine|mesh-list
154709454|NCT05816512|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154709455|NCT05816512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154709456|NCT05816512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709457|NCT05816512|Disinfectants|disinfectants|mesh-ancestor
154709458|NCT05816512|Dermatologic Agents|dermatologic agents|mesh-ancestor
154709459|NCT05816499|Docetaxel|docetaxel|mesh-list
154709460|NCT05816499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709461|NCT05816499|Tubulin Modulators|tubulin modulators|mesh-ancestor
154709462|NCT05816499|Antimitotic Agents|antimitotic agents|mesh-ancestor
154709463|NCT05816499|Mitosis Modulators|mitosis modulators|mesh-ancestor
154709464|NCT05816499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709465|NCT05815901|Febuxostat|febuxostat|mesh-list
154709466|NCT05815901|Gout Suppressants|gout suppressants|mesh-ancestor
154709467|NCT05815901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709468|NCT05815784|Atropine|atropine|mesh-list
154709469|NCT05815784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154709470|NCT05815784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154709471|NCT05815784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154709472|NCT05815784|Autonomic Agents|autonomic agents|mesh-ancestor
154709473|NCT05815784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709474|NCT05815784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709475|NCT05815784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154709476|NCT05815784|Respiratory System Agents|respiratory system agents|mesh-ancestor
154709477|NCT05815784|Mydriatics|mydriatics|mesh-ancestor
154709478|NCT05815784|Parasympatholytics|parasympatholytics|mesh-ancestor
154709479|NCT05815784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154709480|NCT05815784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154709481|NCT05815784|Cholinergic Agents|cholinergic agents|mesh-ancestor
154709482|NCT05815784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709483|NCT05815784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709484|NCT05815719|Hormones|hormones|mesh-list
154709485|NCT05815719|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154709486|NCT05815719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709487|NCT05815719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709488|NCT05815654|Analgesics|analgesics|mesh-list
154709489|NCT05815654|Sensory System Agents|sensory system agents|mesh-ancestor
154709490|NCT05815654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709491|NCT05815654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709492|NCT05815303|Capecitabine|capecitabine|mesh-list
154709493|NCT05815303|Oxaliplatin|oxaliplatin|mesh-list
154709494|NCT05815303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709495|NCT05815303|Antimetabolites|antimetabolites|mesh-ancestor
154709496|NCT05815303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709497|NCT05815303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709498|NCT05814874|Selenium|selenium|mesh-list
154709499|NCT05814874|Antioxidants|antioxidants|mesh-ancestor
154709500|NCT05814874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709501|NCT05814874|Protective Agents|protective agents|mesh-ancestor
154709502|NCT05814874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709503|NCT05814874|Trace Elements|trace elements|mesh-ancestor
154709504|NCT05814874|Micronutrients|micronutrients|mesh-ancestor
154709505|NCT05814770|Spironolactone|spironolactone|mesh-list
154709506|NCT05814770|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154709507|NCT05814770|Hormone Antagonists|hormone antagonists|mesh-ancestor
153964351|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154709508|NCT05814770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709509|NCT05814770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709510|NCT05814770|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154709511|NCT05814770|Diuretics|diuretics|mesh-ancestor
154709512|NCT05814770|Natriuretic Agents|natriuretic agents|mesh-ancestor
154709513|NCT05814731|Cytarabine|cytarabine|mesh-list
154709514|NCT05814731|Cyclophosphamide|cyclophosphamide|mesh-list
154709515|NCT05814731|Busulfan|busulfan|mesh-list
154709516|NCT05814731|Semustine|semustine|mesh-list
154709517|NCT05814731|Mitoxantrone|mitoxantrone|mesh-list
154709518|NCT05814731|Thymoglobulin|thymoglobulin|mesh-list
154709519|NCT05814731|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154709520|NCT05814731|Immunoglobulins|immunoglobulins|mesh-list
154709521|NCT05814731|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154709522|NCT05814731|Antibodies|antibodies|mesh-list
154709523|NCT05814731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709524|NCT05814731|Immunologic Factors|immunologic factors|mesh-ancestor
154709525|NCT05814731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709526|NCT05814731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709527|NCT05814731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709528|NCT05814731|Alkylating Agents|alkylating agents|mesh-ancestor
154709529|NCT05814731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709530|NCT05814731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709531|NCT05814731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154709532|NCT05814731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709533|NCT05814731|Antimetabolites|antimetabolites|mesh-ancestor
154709534|NCT05814731|Antiviral Agents|antiviral agents|mesh-ancestor
154709535|NCT05814731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709536|NCT05814731|Analgesics|analgesics|mesh-ancestor
154709537|NCT05814731|Sensory System Agents|sensory system agents|mesh-ancestor
154709538|NCT05814731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709539|NCT05814731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154709540|NCT05814731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154709541|NCT05814731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709542|NCT05814718|Cytarabine|cytarabine|mesh-list
154709543|NCT05814718|Etoposide|etoposide|mesh-list
154709544|NCT05814718|Mitoxantrone|mitoxantrone|mesh-list
154709545|NCT05814718|Etoposide phosphate|etoposide phosphate|mesh-list
154709546|NCT05814718|Melphalan|melphalan|mesh-list
154709547|NCT05814718|Carmustine|carmustine|mesh-list
154709548|NCT05814718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154709549|NCT05814718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709550|NCT05814718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154709551|NCT05814718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154709552|NCT05814718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709553|NCT05814718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709554|NCT05814718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154709555|NCT05814718|Antimetabolites|antimetabolites|mesh-ancestor
154709556|NCT05814718|Antiviral Agents|antiviral agents|mesh-ancestor
154709557|NCT05814718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709558|NCT05814718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709559|NCT05814718|Immunologic Factors|immunologic factors|mesh-ancestor
154709560|NCT05814718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709561|NCT05814718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709562|NCT05814718|Alkylating Agents|alkylating agents|mesh-ancestor
153964399|NCT02848794|Apatinib|apatinib|mesh-list
154709563|NCT05814718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154709564|NCT05814718|Analgesics|analgesics|mesh-ancestor
154709565|NCT05814718|Sensory System Agents|sensory system agents|mesh-ancestor
154709566|NCT05814718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709567|NCT05814601|Norepinephrine|norepinephrine|mesh-list
154709568|NCT05814601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154709569|NCT05814601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154709570|NCT05814601|Adrenergic Agents|adrenergic agents|mesh-ancestor
154709571|NCT05814601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709572|NCT05814601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709573|NCT05814601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709574|NCT05814601|Sympathomimetics|sympathomimetics|mesh-ancestor
154709575|NCT05814601|Autonomic Agents|autonomic agents|mesh-ancestor
154709576|NCT05814601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709577|NCT05814601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154709578|NCT05795257|Dimercaprol|dimercaprol|mesh-list
154709579|NCT05795257|Chelating Agents|chelating agents|mesh-ancestor
154709580|NCT05795257|Sequestering Agents|sequestering agents|mesh-ancestor
154709581|NCT05795257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709582|NCT05786378|Anesthetics|anesthetics|mesh-list
154709583|NCT05786378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154709584|NCT05786378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709585|NCT05766358|Tirzepatide|tirzepatide|mesh-list
154709586|NCT05766358|Incretins|incretins|mesh-ancestor
154709587|NCT05766358|Hormones|hormones|mesh-ancestor
154709588|NCT05766358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709589|NCT05766358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709590|NCT05751317|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154709591|NCT05751317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709592|NCT05716984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154709593|NCT05716984|Natriuretic Agents|natriuretic agents|mesh-ancestor
154709594|NCT05716984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709595|NCT05688904|Imipramine|imipramine|mesh-list
154709596|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154709597|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
154709598|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154709599|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154709600|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154709601|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154709602|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709603|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
154709604|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709605|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709606|NCT05687357|Paclitaxel|paclitaxel|mesh-list
154709607|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
154709608|NCT05687357|Tislelizumab|tislelizumab|mesh-list
154709609|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154709610|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709611|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
154709612|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
154709613|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
153964458|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709614|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709615|NCT05687357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709616|NCT05675943|Antibodies|antibodies|mesh-list
154709617|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
154709618|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709619|NCT05565222|Meropenem|meropenem|mesh-list
154709620|NCT05565222|Tazobactam|tazobactam|mesh-list
154709621|NCT05565222|Piperacillin|piperacillin|mesh-list
154709622|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154709623|NCT05565222|Temocillin|temocillin|mesh-list
154709624|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154709625|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709626|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154709627|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709628|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709629|NCT05474950|Minocycline|minocycline|mesh-list
154709630|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154709631|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709632|NCT05461404|Emollients|emollients|mesh-list
154709633|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
154709634|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154709635|NCT05445076|Antibodies|antibodies|mesh-list
154709636|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
154709637|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154709638|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
154709639|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709640|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709641|NCT05389722|Itraconazole|itraconazole|mesh-list
154709642|NCT05389722|Rifampin|rifampin|mesh-list
154709643|NCT05389722|Digoxin|digoxin|mesh-list
154709644|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154709645|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154709646|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154709647|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
154709648|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709649|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154709650|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154709651|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709652|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
154709653|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709654|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154709655|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154709656|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154709657|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
154709658|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709659|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709660|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154709661|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154709662|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
154709663|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154709664|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
154709665|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154709666|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154709667|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154709668|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154709669|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154709670|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154709671|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154709672|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154709673|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154709674|NCT05389722|Protective Agents|protective agents|mesh-ancestor
154709675|NCT05373680|Metformin|metformin|mesh-list
154709676|NCT05373680|Empagliflozin|empagliflozin|mesh-list
154709677|NCT05373680|Biguanides|biguanides|mesh-list
154709678|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154709679|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709680|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154709681|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709682|NCT05353348|Iron|iron|mesh-list
154709683|NCT05353348|Ascorbic Acid|ascorbic acid|mesh-list
154709684|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
154709685|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154709686|NCT05353348|Trace Elements|trace elements|mesh-ancestor
154709687|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
154709688|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709689|NCT05353348|Antioxidants|antioxidants|mesh-ancestor
154709690|NCT05353348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709691|NCT05353348|Protective Agents|protective agents|mesh-ancestor
154709692|NCT05353348|Vitamins|vitamins|mesh-ancestor
154709693|NCT05353348|Hematinics|hematinics|mesh-ancestor
154461683|NCT01333059|Midazolam|midazolam|mesh-list
154709695|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154709696|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154709697|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
154709698|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709699|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709700|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709701|NCT05271916|Dacomitinib|dacomitinib|mesh-list
154709702|NCT05271916|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154709703|NCT05271916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709704|NCT05271916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709705|NCT05271916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709706|NCT05261594|Caffeine|caffeine|mesh-list
154709707|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154709708|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709709|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154709710|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709711|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709712|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154709713|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154709714|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
154709715|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709716|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
154709717|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709718|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709719|NCT05220748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154709720|NCT05220748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709721|NCT05180357|Benralizumab|benralizumab|mesh-list
154709722|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154709723|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
154709724|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154709725|NCT05085808|Trazodone|trazodone|mesh-list
154709726|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
154709727|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154709728|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154709729|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154709730|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154709731|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709732|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154709733|NCT05085808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154709734|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154709735|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154709736|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709737|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709738|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
154709739|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154709740|NCT05078944|Donepezil|donepezil|mesh-list
154709741|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154709742|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709743|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709744|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
154709745|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709746|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709747|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
154709748|NCT05076019|Atorvastatin|atorvastatin|mesh-list
154709749|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154709750|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154709751|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
154709752|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709753|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154709754|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154709755|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709756|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
154709757|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
154709758|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709759|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
154709760|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709761|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709762|NCT05036005|Pertuzumab|pertuzumab|mesh-list
154709763|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709764|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709765|NCT05033769|Paclitaxel|paclitaxel|mesh-list
154709766|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154709767|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154709768|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709769|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
154709770|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
154709771|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
154709772|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709773|NCT05019846|Bicalutamide|bicalutamide|mesh-list
154709774|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154709775|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
154709776|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
154709777|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709778|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709779|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709780|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
154709781|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154709782|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
154709783|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154709784|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154709785|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154709786|NCT05004025|Nivolumab|nivolumab|mesh-list
154709787|NCT05004025|Ipilimumab|ipilimumab|mesh-list
154709788|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709789|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709790|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154709791|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709792|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
154709793|NCT04998240|Paraproteins|paraproteins|mesh-list
154709794|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
154709795|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709796|NCT04952324|Folic Acid|folic acid|mesh-list
154709797|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
154709798|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
154709799|NCT04952324|Vitamins|vitamins|mesh-ancestor
154709800|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
154709801|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709802|NCT04952324|Hematinics|hematinics|mesh-ancestor
154709803|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
154709804|NCT04951726|Neostigmine|neostigmine|mesh-list
154709805|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154709806|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709807|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709808|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
154709809|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709810|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709811|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154709812|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
154709813|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709814|NCT04948892|Anesthetics|anesthetics|mesh-list
154709815|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154709816|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709817|NCT04926571|Dexamethasone|dexamethasone|mesh-list
154709818|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154709819|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
154709820|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
154709821|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709822|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709823|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154709824|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
154709825|NCT04926571|Hormones|hormones|mesh-ancestor
154709826|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709827|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154709828|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709829|NCT04918823|Cyclosporine|cyclosporine|mesh-list
154709830|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154709831|NCT04918823|Cyclosporins|cyclosporins|mesh-list
154709832|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709833|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709834|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709835|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
154709836|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709837|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
154709838|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709839|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
154461810|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
154709840|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709841|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154709842|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154709843|NCT04909073|Afatinib|afatinib|mesh-list
154709844|NCT04909073|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154709845|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709846|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709847|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709848|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709849|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
154709850|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154709851|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154709852|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709853|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
154709854|NCT04785651|Coagulants|coagulants|mesh-ancestor
154709855|NCT04780204|Tenofovir|tenofovir|mesh-list
154709856|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
154709857|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709858|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154709859|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154709860|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709861|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709862|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154709863|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154709864|NCT04748588|Sotrovimab|sotrovimab|mesh-list
154709865|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
154709866|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
154709867|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709868|NCT04735510|Cyclosporine|cyclosporine|mesh-list
154709869|NCT04735510|Cyclosporins|cyclosporins|mesh-list
154709870|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709871|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709872|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709873|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
154709874|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709875|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
154709876|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709877|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
154709878|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709879|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154709880|NCT04696523|Xenon|xenon|mesh-list
154709881|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154709882|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
154709883|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
154709884|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154709885|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709886|NCT04655222|Interferons|interferons|mesh-list
154709887|NCT04655222|Interferon-beta|interferon-beta|mesh-list
154709888|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709889|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
154709890|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154709891|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
154709892|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709893|NCT04652440|Tislelizumab|tislelizumab|mesh-list
154709894|NCT04652440|Antibodies|antibodies|mesh-list
154709895|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154709896|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
154709897|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709898|NCT04652440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154709899|NCT04652440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709900|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
154709901|NCT04604067|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154709902|NCT04604067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709903|NCT04604067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709904|NCT04604067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709905|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709906|NCT04585711|Etanercept|etanercept|mesh-list
154709907|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154709908|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154709909|NCT04585711|Analgesics|analgesics|mesh-ancestor
154709910|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
154709911|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709912|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709913|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154709914|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154709915|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154709916|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154709917|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
154709919|NCT04551495|Goserelin|goserelin|mesh-list
154709920|NCT04551495|Entrectinib|entrectinib|mesh-list
154709921|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709922|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154709923|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154709924|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709925|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709926|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154709927|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
154709928|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154709929|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709930|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154709931|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709932|NCT04501718|Etoposide|etoposide|mesh-list
154709933|NCT04501718|Temozolomide|temozolomide|mesh-list
154709934|NCT04501718|Apatinib|apatinib|mesh-list
154709935|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154709936|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709937|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154709938|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154709939|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709940|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709941|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709942|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
154709943|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709944|NCT04501705|Apatinib|apatinib|mesh-list
154709945|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709946|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709947|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709948|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709949|NCT04463394|Vasopressins|vasopressins|mesh-list
154709950|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
154709951|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
154709952|NCT04463394|Coagulants|coagulants|mesh-ancestor
154709953|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154709954|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154709955|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
154709956|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709957|NCT04454905|Apatinib|apatinib|mesh-list
154709958|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709959|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154709960|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709961|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709962|NCT04436601|Lactulose|lactulose|mesh-list
154709963|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154709964|NCT04373785|Temozolomide|temozolomide|mesh-list
154709965|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709966|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
154709967|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709968|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709969|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
154709970|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
154709971|NCT04275180|Argatroban|argatroban|mesh-list
154709972|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
154709973|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154709974|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
154709975|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709976|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709977|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
154709978|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154709979|NCT04271332|Baclofen|baclofen|mesh-list
154709980|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154709981|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154709982|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154709983|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154709984|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154709985|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
154709986|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
154709987|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154709988|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709989|NCT04267978|Irinotecan|irinotecan|mesh-list
154709990|NCT04267978|Temozolomide|temozolomide|mesh-list
154709991|NCT04267978|Endostatins|endostatins|mesh-list
154709992|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154709993|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154709994|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154709995|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154709996|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154709997|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154709998|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
154709999|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154710000|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154710001|NCT04267978|Growth Substances|growth substances|mesh-ancestor
154710002|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710003|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
154710004|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154710005|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154710006|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710007|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710008|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154710009|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
154710010|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710011|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710012|NCT04117178|Memantine|memantine|mesh-list
154710013|NCT04117178|Donepezil|donepezil|mesh-list
154710014|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154710015|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710016|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710017|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
154710018|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710019|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710020|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
154710021|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154710022|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154710023|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
154710024|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154710025|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154710026|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
154710027|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
154710028|NCT03979599|Analgesics|analgesics|mesh-ancestor
154710029|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
154710030|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710031|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710032|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
154710033|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710034|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710035|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
154710036|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154710037|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710038|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710039|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154710040|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
154710041|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154710042|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
154710043|NCT03946514|Losartan|losartan|mesh-list
154710044|NCT03946514|Amlodipine|amlodipine|mesh-list
154710045|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154710046|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154710047|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154710048|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710049|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710050|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154710051|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710052|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
154710053|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710054|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154710055|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154710056|NCT03946514|Diuretics|diuretics|mesh-ancestor
154710057|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
154710058|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154710059|NCT03935958|Curcumin|curcumin|mesh-list
154710060|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154710061|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154710062|NCT03935958|Analgesics|analgesics|mesh-ancestor
154710063|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
154710064|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710065|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710066|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154710067|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710068|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710069|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710070|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710071|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154710072|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154710073|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154710074|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710075|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710076|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
153964915|NCT02779413|Insulin|insulin|mesh-list
154710077|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710078|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710079|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154710080|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710081|NCT03915444|Paclitaxel|paclitaxel|mesh-list
154710082|NCT03915444|Gemcitabine|gemcitabine|mesh-list
154710083|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154710084|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710085|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
154710086|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
154710087|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
154710088|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710089|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154710090|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
154710091|NCT03892785|Prednisone|prednisone|mesh-list
154710092|NCT03892785|Methotrexate|methotrexate|mesh-list
154710093|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154710094|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
154710095|NCT03892785|Hormones|hormones|mesh-ancestor
154710096|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710097|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710098|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154710099|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710100|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154710101|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
154710102|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154710103|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154710104|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
154710105|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710106|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154710107|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710108|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154710109|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710110|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
154710111|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710112|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154710113|NCT03869034|Leucovorin|leucovorin|mesh-list
154710114|NCT03869034|Fluorouracil|fluorouracil|mesh-list
154710115|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
154710116|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
154710117|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710118|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154710119|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710120|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710121|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
154710122|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710123|NCT03869034|Antidotes|antidotes|mesh-ancestor
154710124|NCT03869034|Protective Agents|protective agents|mesh-ancestor
154710125|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
154710126|NCT03869034|Vitamins|vitamins|mesh-ancestor
154710127|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
154710128|NCT03841097|Tacrolimus|tacrolimus|mesh-list
154710129|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710130|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
154710131|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710132|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154710133|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710134|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710135|NCT03831776|Bosutinib|bosutinib|mesh-list
154710136|NCT03831776|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154710137|NCT03831776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154710138|NCT03831776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860367|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154462115|NCT02613208|Paclitaxel|paclitaxel|mesh-list
154710139|NCT03831776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710140|NCT03831425|Ubiquinone|ubiquinone|mesh-list
154710141|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
154710142|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
154710143|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710144|NCT03831425|Vitamins|vitamins|mesh-ancestor
154710145|NCT03790111|Cisplatin|cisplatin|mesh-list
154710146|NCT03790111|Gemcitabine|gemcitabine|mesh-list
154710147|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710148|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154710149|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
154710150|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710151|NCT03780543|Tenofovir|tenofovir|mesh-list
154710152|NCT03780543|Entecavir|entecavir|mesh-list
154710153|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154710154|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
154710155|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154710156|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154710157|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710158|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710159|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154710160|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154710161|NCT03772314|Modafinil|modafinil|mesh-list
154710162|NCT03772314|Amphetamine|amphetamine|mesh-list
154710163|NCT03772314|Adderall|adderall|mesh-list
154710164|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
154710165|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154710166|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710167|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154710168|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153965017|NCT02779569|Decitabine|decitabine|mesh-list
154710169|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154710170|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710171|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
154710172|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
154710173|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710174|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
154710175|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710176|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
154710177|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154710178|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154710179|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710180|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154710181|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
154710182|NCT03760575|Pemetrexed|pemetrexed|mesh-list
154710183|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710184|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154710185|NCT03760575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154710186|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710187|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710188|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154710189|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154710190|NCT03720522|Adenosine|adenosine|mesh-list
154710191|NCT03720522|Analgesics|analgesics|mesh-ancestor
154710192|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
154710193|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710194|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710195|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710196|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
154710197|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154710198|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
154710199|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
154710200|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710201|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710202|NCT03699631|Methotrexate|methotrexate|mesh-list
154710203|NCT03699631|Tacrolimus|tacrolimus|mesh-list
154710204|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154710205|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
154710206|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154710207|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710208|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154710209|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
154710210|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710211|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710212|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
154462200|NCT03340974|Manganese|manganese|mesh-list
154710213|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710214|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154710215|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710216|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
154710217|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710218|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154710219|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154710220|NCT03686150|Vitamin D|vitamin d|mesh-list
154710221|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
154710222|NCT03686150|Vitamins|vitamins|mesh-ancestor
154710223|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
154710224|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710225|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154710226|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154710227|NCT03678233|Testosterone|testosterone|mesh-list
154710228|NCT03678233|Androgens|androgens|mesh-ancestor
154710229|NCT03678233|Hormones|hormones|mesh-ancestor
154710230|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710231|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710232|NCT03606642|Clopidogrel|clopidogrel|mesh-list
154710233|NCT03606642|Ticagrelor|ticagrelor|mesh-list
154710234|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154710235|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710236|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710237|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154710238|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154710239|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154710240|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154710241|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
154710242|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710243|NCT03458221|Itraconazole|itraconazole|mesh-list
154710244|NCT03458221|Everolimus|everolimus|mesh-list
154710245|NCT03458221|Letrozole|letrozole|mesh-list
154710246|NCT03458221|Bicalutamide|bicalutamide|mesh-list
154710247|NCT03458221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154710248|NCT03458221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154710249|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710250|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710251|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710252|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
154710253|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710254|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710255|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154710256|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154710257|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154710258|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
154710259|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710260|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
154710261|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154710262|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154710263|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154710264|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154710265|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
154710266|NCT03451487|Acetaminophen|acetaminophen|mesh-list
154710267|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154710268|NCT03451487|Analgesics|analgesics|mesh-ancestor
154710269|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
154710270|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710271|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710272|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
154710273|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
154710274|NCT03410030|Paclitaxel|paclitaxel|mesh-list
154710275|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154710276|NCT03410030|Cisplatin|cisplatin|mesh-list
154710277|NCT03410030|Gemcitabine|gemcitabine|mesh-list
154710278|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154710279|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710280|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154710281|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154710282|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154710283|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710284|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154710285|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
154710286|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
154710287|NCT03410030|Protective Agents|protective agents|mesh-ancestor
154710288|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710289|NCT03410030|Vitamins|vitamins|mesh-ancestor
154710290|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
154710291|NCT03382301|Cyclosporine|cyclosporine|mesh-list
154710292|NCT03382301|Cyclosporins|cyclosporins|mesh-list
154710293|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710294|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710295|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710296|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
154710297|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710298|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
154710299|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154710300|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
154710301|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710302|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154710303|NCT03290391|Naltrexone|naltrexone|mesh-list
154710304|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710305|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
154710306|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710307|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154710308|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154710309|NCT03280030|Midostaurin|midostaurin|mesh-list
154710310|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710311|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154710312|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710313|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710314|NCT03194867|Cemiplimab|cemiplimab|mesh-list
154710315|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154710316|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710317|NCT03138720|Paclitaxel|paclitaxel|mesh-list
154710318|NCT03138720|Cisplatin|cisplatin|mesh-list
154710319|NCT03138720|Gemcitabine|gemcitabine|mesh-list
154710320|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154710321|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154710322|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710323|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
154710324|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
154710325|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
154710326|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965163|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710327|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154710328|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
154710329|NCT03131726|Simvastatin|simvastatin|mesh-list
154710330|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154710331|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154710332|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
154710333|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710334|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154710335|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154710336|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710337|NCT03112590|Interferons|interferons|mesh-list
154710338|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
154710339|NCT03112590|Paclitaxel|paclitaxel|mesh-list
154710340|NCT03112590|Trastuzumab|trastuzumab|mesh-list
154710341|NCT03112590|Pertuzumab|pertuzumab|mesh-list
154710342|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154710343|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710344|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
154710345|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
154710346|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
154710347|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710348|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154710349|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
154710350|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154710351|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
154710352|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154710353|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154710354|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710355|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
154710356|NCT03085394|Coagulants|coagulants|mesh-ancestor
154710357|NCT03065621|Palbociclib|palbociclib|mesh-list
154710358|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710359|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154710360|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710361|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710362|NCT03060434|Acetaminophen|acetaminophen|mesh-list
154710363|NCT03060434|Ibuprofen|ibuprofen|mesh-list
154710364|NCT03060434|Pregabalin|pregabalin|mesh-list
154710365|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
154860368|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710366|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154710367|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154710368|NCT03060434|Analgesics|analgesics|mesh-ancestor
154710369|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
154710370|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710371|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710372|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154710373|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710374|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154710375|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710376|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710377|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
154710378|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154710379|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710380|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154710381|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153965228|NCT02844270|Sirolimus|sirolimus|mesh-list
154710382|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154710383|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710384|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154710385|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
154710386|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154710387|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154710388|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154710389|NCT03060434|Protective Agents|protective agents|mesh-ancestor
154710390|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
154710391|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154710392|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
154710393|NCT03021486|Haloperidol|haloperidol|mesh-list
154710394|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
154710395|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
154710396|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
154710397|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
154710398|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710399|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710400|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154710401|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154710402|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154710403|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710404|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154710405|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154710406|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
154710407|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710408|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710409|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154710410|NCT02923115|Enoxaparin|enoxaparin|mesh-list
154710411|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
154710412|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154710413|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154710414|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710415|NCT02910583|Venetoclax|venetoclax|mesh-list
154710416|NCT02910583|Ibrutinib|ibrutinib|mesh-list
154710417|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710418|NCT02910583|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154710419|NCT02910583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154710420|NCT02910583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710421|NCT02910583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710422|NCT02820857|Bevacizumab|bevacizumab|mesh-list
154710423|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154710424|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710425|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154710426|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154710427|NCT02820857|Growth Substances|growth substances|mesh-ancestor
154710428|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710429|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
154710430|NCT02790710|Propranolol|propranolol|mesh-list
154710431|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154710432|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154710433|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
154710434|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710435|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710436|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710437|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153965285|NCT01027754|Varenicline|varenicline|mesh-list
154710438|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154710439|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
154710440|NCT02604732|Aspirin|aspirin|mesh-list
154710441|NCT02604732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154710442|NCT02604732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154710443|NCT02604732|Analgesics|analgesics|mesh-ancestor
154710444|NCT02604732|Sensory System Agents|sensory system agents|mesh-ancestor
154710445|NCT02604732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710446|NCT02604732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710447|NCT02604732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154710448|NCT02604732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710449|NCT02604732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154710450|NCT02604732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154710451|NCT02604732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710452|NCT02604732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154710453|NCT02604732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154710454|NCT02604732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710455|NCT02604732|Antipyretics|antipyretics|mesh-ancestor
154710456|NCT06296836|Metformin|metformin|mesh-list
154710457|NCT06296836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154710458|NCT06296836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710459|NCT06296797|Contraceptive Agents|contraceptive agents|mesh-list
154710460|NCT06296797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154710461|NCT06296797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710462|NCT06296758|Anesthetics|anesthetics|mesh-list
154710463|NCT06296758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710464|NCT06296758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710465|NCT06296745|Pemetrexed|pemetrexed|mesh-list
154710466|NCT06296745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710467|NCT06296745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710468|NCT06296745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710469|NCT06296745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154710470|NCT06296745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154710471|NCT06296706|Docetaxel|docetaxel|mesh-list
154710472|NCT06296706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710473|NCT06296706|Tubulin Modulators|tubulin modulators|mesh-ancestor
154710474|NCT06296706|Antimitotic Agents|antimitotic agents|mesh-ancestor
154710475|NCT06296706|Mitosis Modulators|mitosis modulators|mesh-ancestor
154710476|NCT06296706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710477|NCT06296563|Apatinib|apatinib|mesh-list
154710478|NCT06296563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710479|NCT06296563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154710480|NCT06296563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710481|NCT06296563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710482|NCT06296407|Oxymetazoline|oxymetazoline|mesh-list
154710483|NCT06296407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154710484|NCT06296407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154710485|NCT06296407|Adrenergic Agents|adrenergic agents|mesh-ancestor
154710486|NCT06296407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710487|NCT06296407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710488|NCT06296407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710489|NCT06296407|Sympathomimetics|sympathomimetics|mesh-ancestor
154710490|NCT06296407|Autonomic Agents|autonomic agents|mesh-ancestor
154710491|NCT06296407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710492|NCT06296407|Nasal Decongestants|nasal decongestants|mesh-ancestor
154710493|NCT06296407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154710494|NCT06296407|Respiratory System Agents|respiratory system agents|mesh-ancestor
154710495|NCT06296212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154710496|NCT06296121|Daratumumab|daratumumab|mesh-list
154710497|NCT06296121|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154710498|NCT06296121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710499|NCT06296121|Immunologic Factors|immunologic factors|mesh-ancestor
154710500|NCT06296121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710501|NCT06296082|Botulinum Toxins|botulinum toxins|mesh-list
154710502|NCT06296082|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154710503|NCT06296082|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154710504|NCT06296082|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154710505|NCT06296082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710506|NCT06296082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710507|NCT06296082|Cholinergic Agents|cholinergic agents|mesh-ancestor
154710508|NCT06296082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710509|NCT06296082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710510|NCT06296082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154710511|NCT06296082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710512|NCT06295952|Pasireotide|pasireotide|mesh-list
154710513|NCT06295952|Hormones|hormones|mesh-ancestor
154710514|NCT06295952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710515|NCT06295952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710516|NCT06295926|Cisplatin|cisplatin|mesh-list
154710517|NCT06295926|Carboplatin|carboplatin|mesh-list
154710518|NCT06295926|Etoposide|etoposide|mesh-list
154710519|NCT06295926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710520|NCT06295926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154710521|NCT06295926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154710522|NCT06295926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154710523|NCT06295926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710524|NCT06295926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710525|NCT06295913|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154710526|NCT06295913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154710527|NCT06295913|Antioxidants|antioxidants|mesh-ancestor
154710528|NCT06295913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710529|NCT06295913|Protective Agents|protective agents|mesh-ancestor
154710530|NCT06295913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710531|NCT06295913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154710532|NCT06295770|Obinutuzumab|obinutuzumab|mesh-list
154710533|NCT06295770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154710534|NCT06295770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710535|NCT06295731|Pembrolizumab|pembrolizumab|mesh-list
154710536|NCT06295731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154710537|NCT06295731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710538|NCT06295731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154710539|NCT06295731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710540|NCT06295588|Fucoidan|fucoidan|mesh-list
154710541|NCT06295588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154710542|NCT06295588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154710543|NCT06295588|Anticoagulants|anticoagulants|mesh-ancestor
154710544|NCT06295588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710545|NCT06295341|Hormones|hormones|mesh-list
154710546|NCT06295341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710547|NCT06295341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710548|NCT06295328|Tenofovir|tenofovir|mesh-list
154710549|NCT06295328|Terbinafine|terbinafine|mesh-list
154710550|NCT06295328|Antiviral Agents|antiviral agents|mesh-ancestor
154710551|NCT06295328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154710552|NCT06295328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154710553|NCT06295328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154710554|NCT06295328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710555|NCT06295328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710556|NCT06295328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154710557|NCT06295328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154710558|NCT06295328|Antifungal Agents|antifungal agents|mesh-ancestor
154710559|NCT06295289|Insulin|insulin|mesh-list
154710560|NCT06295289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154710561|NCT06295289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154710562|NCT06295289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710563|NCT06295094|Doxorubicin|doxorubicin|mesh-list
154710564|NCT06295094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710565|NCT06295094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154710566|NCT06295094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154710567|NCT06295094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154710568|NCT06295094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710569|NCT06295094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710570|NCT06294990|Methyltestosterone|methyltestosterone|mesh-list
154710571|NCT06294990|Testosterone|testosterone|mesh-list
154710572|NCT06294990|Testosterone undecanoate|testosterone undecanoate|mesh-list
154710573|NCT06294990|Testosterone enanthate|testosterone enanthate|mesh-list
154710574|NCT06294990|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154710575|NCT06294990|Androgens|androgens|mesh-ancestor
154710576|NCT06294990|Hormones|hormones|mesh-ancestor
154710577|NCT06294990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710578|NCT06294990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710579|NCT06294990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154710580|NCT06294990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710581|NCT06294990|Anabolic Agents|anabolic agents|mesh-ancestor
154710582|NCT06294912|Artesunate|artesunate|mesh-list
154710583|NCT06294912|Lumefantrine|lumefantrine|mesh-list
154710584|NCT06294912|Artemether|artemether|mesh-list
154710585|NCT06294912|Primaquine|primaquine|mesh-list
154710586|NCT06294912|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154710587|NCT06294912|Atovaquone|atovaquone|mesh-list
154710588|NCT06294912|Proguanil|proguanil|mesh-list
154462564|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
154710589|NCT06294912|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154710590|NCT06294912|Antimalarials|antimalarials|mesh-ancestor
154710591|NCT06294912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154710592|NCT06294912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154710593|NCT06294912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154710594|NCT06294912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710595|NCT06294912|Antiviral Agents|antiviral agents|mesh-ancestor
154710596|NCT06294912|Schistosomicides|schistosomicides|mesh-ancestor
154710597|NCT06294912|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154710598|NCT06294912|Anthelmintics|anthelmintics|mesh-ancestor
154710599|NCT06294912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710600|NCT06294912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710601|NCT06294912|Antimetabolites|antimetabolites|mesh-ancestor
154710602|NCT06294847|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154710603|NCT06294847|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154710604|NCT06294847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154710605|NCT06294743|Acetaminophen|acetaminophen|mesh-list
154710606|NCT06294743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154710607|NCT06294743|Analgesics|analgesics|mesh-ancestor
154710608|NCT06294743|Sensory System Agents|sensory system agents|mesh-ancestor
153965474|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
154710609|NCT06294743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710610|NCT06294743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710611|NCT06294743|Antipyretics|antipyretics|mesh-ancestor
154710612|NCT06292091|Captopril|captopril|mesh-list
154710613|NCT06292091|Torsemide|torsemide|mesh-list
154710614|NCT06292091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154710615|NCT06292091|Protease Inhibitors|protease inhibitors|mesh-ancestor
154710616|NCT06292091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710617|NCT06292091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710618|NCT06292091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154710619|NCT06292091|Diuretics|diuretics|mesh-ancestor
154710620|NCT06292091|Natriuretic Agents|natriuretic agents|mesh-ancestor
154710621|NCT06292091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710622|NCT06292091|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154710623|NCT06292091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710624|NCT06291987|Ivosidenib|ivosidenib|mesh-list
154710625|NCT06291987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710626|NCT06291987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710627|NCT06291987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710628|NCT06290869|Nicotine|nicotine|mesh-list
154710629|NCT06290869|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154710630|NCT06290869|Autonomic Agents|autonomic agents|mesh-ancestor
154710631|NCT06290869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710632|NCT06290869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710633|NCT06290869|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154710634|NCT06290869|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154710635|NCT06290869|Cholinergic Agents|cholinergic agents|mesh-ancestor
154710636|NCT06290869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710637|NCT06290869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710638|NCT06290596|Vasopressins|vasopressins|mesh-list
154710639|NCT06290596|Arginine Vasopressin|arginine vasopressin|mesh-list
154710640|NCT06290596|Tranexamic Acid|tranexamic acid|mesh-list
154710641|NCT06290596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154710642|NCT06290596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154710643|NCT06290596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710644|NCT06290596|Hemostatics|hemostatics|mesh-ancestor
154710645|NCT06290596|Coagulants|coagulants|mesh-ancestor
154710646|NCT06290596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154710647|NCT06290596|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154710648|NCT06290596|Natriuretic Agents|natriuretic agents|mesh-ancestor
154710649|NCT06290596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710650|NCT06288113|Edetic Acid|edetic acid|mesh-list
154710651|NCT06288113|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154710652|NCT06288113|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154710653|NCT06288113|Pluvicto|pluvicto|mesh-list
154710654|NCT06288113|Chelating Agents|chelating agents|mesh-ancestor
154710655|NCT06288113|Sequestering Agents|sequestering agents|mesh-ancestor
154710656|NCT06288113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710657|NCT06288113|Anticoagulants|anticoagulants|mesh-ancestor
154710658|NCT06288113|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154710659|NCT06288113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154710660|NCT06280703|Insulin|insulin|mesh-list
154710661|NCT06280703|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154710662|NCT06280703|Insulin Lispro|insulin lispro|mesh-list
154710663|NCT06280703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154710664|NCT06280703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710665|NCT06265259|Norepinephrine|norepinephrine|mesh-list
154710666|NCT06265259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154710667|NCT06265259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154710668|NCT06265259|Adrenergic Agents|adrenergic agents|mesh-ancestor
154710669|NCT06265259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710670|NCT06265259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710671|NCT06265259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710672|NCT06265259|Sympathomimetics|sympathomimetics|mesh-ancestor
154710673|NCT06265259|Autonomic Agents|autonomic agents|mesh-ancestor
154710674|NCT06265259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710675|NCT06265259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154710676|NCT06263452|Propranolol|propranolol|mesh-list
154710677|NCT06263452|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154710678|NCT06263452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154710679|NCT06263452|Adrenergic Agents|adrenergic agents|mesh-ancestor
154710680|NCT06263452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710681|NCT06263452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710682|NCT06263452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710683|NCT06263452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710684|NCT06263452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154710685|NCT06263452|Vasodilator Agents|vasodilator agents|mesh-ancestor
154710686|NCT06259006|Dexamethasone|dexamethasone|mesh-list
154710687|NCT06259006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154710688|NCT06259006|Antiemetics|antiemetics|mesh-ancestor
154710689|NCT06259006|Autonomic Agents|autonomic agents|mesh-ancestor
154710690|NCT06259006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710691|NCT06259006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710692|NCT06259006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154710693|NCT06259006|Glucocorticoids|glucocorticoids|mesh-ancestor
154710694|NCT06259006|Hormones|hormones|mesh-ancestor
154710695|NCT06259006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710696|NCT06259006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154710697|NCT06259006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710698|NCT06257576|Tamsulosin|tamsulosin|mesh-list
154710699|NCT06257576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154710700|NCT06257576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154710701|NCT06257576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154710702|NCT06257576|Adrenergic Agents|adrenergic agents|mesh-ancestor
154710703|NCT06257576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710704|NCT06257576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710705|NCT06257576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710706|NCT06257576|Urological Agents|urological agents|mesh-ancestor
154710707|NCT06255730|Lidocaine|lidocaine|mesh-list
154710708|NCT06255730|Anesthetics, Local|anesthetics, local|mesh-ancestor
154710709|NCT06255730|Anesthetics|anesthetics|mesh-ancestor
154710710|NCT06255730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710711|NCT06255730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710712|NCT06255730|Sensory System Agents|sensory system agents|mesh-ancestor
154710713|NCT06255730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710714|NCT06255730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710715|NCT06255730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154710716|NCT06255730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154710717|NCT06255730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710718|NCT06255730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710719|NCT06250335|Nivolumab|nivolumab|mesh-list
154710720|NCT06250335|Ipilimumab|ipilimumab|mesh-list
154710721|NCT06250335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154710722|NCT06250335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710723|NCT06250335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154710724|NCT06250335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710725|NCT06249490|Lidocaine|lidocaine|mesh-list
154710726|NCT06249490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154710727|NCT06249490|Anesthetics|anesthetics|mesh-ancestor
154710728|NCT06249490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710729|NCT06249490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710730|NCT06249490|Sensory System Agents|sensory system agents|mesh-ancestor
154710731|NCT06249490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710732|NCT06249490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710733|NCT06249490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154710734|NCT06249490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154710735|NCT06249490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710736|NCT06249490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710737|NCT06249464|Lidocaine|lidocaine|mesh-list
154710738|NCT06249464|Anesthetics, Local|anesthetics, local|mesh-ancestor
154710739|NCT06249464|Anesthetics|anesthetics|mesh-ancestor
154710740|NCT06249464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710741|NCT06249464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710742|NCT06249464|Sensory System Agents|sensory system agents|mesh-ancestor
154710743|NCT06249464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710744|NCT06249464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710745|NCT06249464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154710746|NCT06249464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154710747|NCT06249464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710748|NCT06249464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710749|NCT06234111|Semaglutide|semaglutide|mesh-list
154710750|NCT06234111|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154710751|NCT06234111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154710752|NCT06234111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710753|NCT06226415|Lidocaine|lidocaine|mesh-list
154710754|NCT06226415|Anesthetics, Local|anesthetics, local|mesh-ancestor
154710755|NCT06226415|Anesthetics|anesthetics|mesh-ancestor
154710756|NCT06226415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710757|NCT06226415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710758|NCT06226415|Sensory System Agents|sensory system agents|mesh-ancestor
154710759|NCT06226415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710760|NCT06226415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710761|NCT06226415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154710762|NCT06226415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154710763|NCT06226415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710764|NCT06226415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710765|NCT06218823|Nicotine|nicotine|mesh-list
154710766|NCT06218823|Varenicline|varenicline|mesh-list
154710767|NCT06218823|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154710768|NCT06218823|Autonomic Agents|autonomic agents|mesh-ancestor
154710769|NCT06218823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710770|NCT06218823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710771|NCT06218823|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154710772|NCT06218823|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154710773|NCT06218823|Cholinergic Agents|cholinergic agents|mesh-ancestor
154710774|NCT06218823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710775|NCT06218823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710776|NCT06203600|Paclitaxel|paclitaxel|mesh-list
154710777|NCT06203600|Nivolumab|nivolumab|mesh-list
154710778|NCT06203600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154710779|NCT06203600|Ramucirumab|ramucirumab|mesh-list
154710780|NCT06203600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154710781|NCT06203600|Antibodies|antibodies|mesh-list
154710782|NCT06203600|Immunoglobulins|immunoglobulins|mesh-list
154710783|NCT06203600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154710784|NCT06203600|Lexatumumab|lexatumumab|mesh-list
154710785|NCT06203600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154710786|NCT06203600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710787|NCT06203600|Tubulin Modulators|tubulin modulators|mesh-ancestor
154710788|NCT06203600|Antimitotic Agents|antimitotic agents|mesh-ancestor
154710789|NCT06203600|Mitosis Modulators|mitosis modulators|mesh-ancestor
154710790|NCT06203600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710791|NCT06203600|Immunologic Factors|immunologic factors|mesh-ancestor
154710792|NCT06203600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710793|NCT06203600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154710794|NCT06203600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154710795|NCT06203600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154710796|NCT06203600|Growth Substances|growth substances|mesh-ancestor
154710797|NCT06203600|Growth Inhibitors|growth inhibitors|mesh-ancestor
154710798|NCT06199713|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154710799|NCT06199713|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154710800|NCT06199713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710801|NCT06196580|Repaglinide|repaglinide|mesh-list
154710802|NCT06196580|Midazolam|midazolam|mesh-list
154710803|NCT06196580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154710804|NCT06196580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154710805|NCT06196580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710806|NCT06196580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710807|NCT06196580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154710808|NCT06196580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154710809|NCT06196580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154710810|NCT06196580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154710811|NCT06196580|Anesthetics, General|anesthetics, general|mesh-ancestor
154710812|NCT06196580|Anesthetics|anesthetics|mesh-ancestor
154462785|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
154710813|NCT06196580|GABA Modulators|gaba modulators|mesh-ancestor
154710814|NCT06196580|GABA Agents|gaba agents|mesh-ancestor
154710815|NCT06196580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710816|NCT06196580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710817|NCT06196580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154710818|NCT06195241|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154710819|NCT06195241|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154710820|NCT06195241|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154710821|NCT06195241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710822|NCT06195241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710823|NCT06195241|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154710824|NCT06195241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710825|NCT06195241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710826|NCT06195241|Cholinergic Agents|cholinergic agents|mesh-ancestor
154710827|NCT06195241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710828|NCT06185595|Glycerol|glycerol|mesh-list
154710829|NCT06185595|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154710830|NCT06185595|Protective Agents|protective agents|mesh-ancestor
154710831|NCT06185595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710832|NCT06180200|Analgesics, Opioid|analgesics, opioid|mesh-list
154710833|NCT06180200|Narcotics|narcotics|mesh-ancestor
154710834|NCT06180200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710835|NCT06180200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710836|NCT06180200|Analgesics|analgesics|mesh-ancestor
154710837|NCT06180200|Sensory System Agents|sensory system agents|mesh-ancestor
154710838|NCT06180200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710839|NCT06179706|Choline|choline|mesh-list
154710840|NCT06179706|Lipotropic Agents|lipotropic agents|mesh-ancestor
154710841|NCT06179706|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154710842|NCT06179706|Antimetabolites|antimetabolites|mesh-ancestor
154710843|NCT06179706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710844|NCT06179706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154710845|NCT06179706|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154710846|NCT06179706|Nootropic Agents|nootropic agents|mesh-ancestor
154710847|NCT06173596|Itraconazole|itraconazole|mesh-list
154710848|NCT06173596|Fluconazole|fluconazole|mesh-list
154710849|NCT06173596|Carbamazepine|carbamazepine|mesh-list
154710850|NCT06173596|Antifungal Agents|antifungal agents|mesh-ancestor
154710851|NCT06173596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154710852|NCT06173596|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154710853|NCT06173596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154710854|NCT06173596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710855|NCT06173596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710856|NCT06173596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154710857|NCT06173596|Hormone Antagonists|hormone antagonists|mesh-ancestor
154710858|NCT06173596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154710859|NCT06173596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710860|NCT06173596|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154710861|NCT06173596|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154710862|NCT06173596|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154710863|NCT06173596|Anticonvulsants|anticonvulsants|mesh-ancestor
154710864|NCT06173596|Antimanic Agents|antimanic agents|mesh-ancestor
154710865|NCT06173596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154710866|NCT06173596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710867|NCT06173596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154710868|NCT06173596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154710869|NCT06173596|Analgesics|analgesics|mesh-ancestor
154710870|NCT06173596|Sensory System Agents|sensory system agents|mesh-ancestor
154710871|NCT06173596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710872|NCT06173596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154710873|NCT06173596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710874|NCT06173596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154710875|NCT06173596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154710876|NCT06160414|Metformin|metformin|mesh-list
154710877|NCT06160414|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154710878|NCT06160414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154710879|NCT06160414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710880|NCT06160414|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154710881|NCT06160414|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154710882|NCT06160414|Antimetabolites|antimetabolites|mesh-ancestor
154710883|NCT06160414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710884|NCT06160414|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154710885|NCT06160414|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154710887|NCT06160284|Psilocybin|psilocybin|mesh-list
154710888|NCT06160284|Hallucinogens|hallucinogens|mesh-ancestor
154710889|NCT06160284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710890|NCT06160284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154710891|NCT06159907|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154710892|NCT06159907|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154710893|NCT06159907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710894|NCT06158542|Anesthetics|anesthetics|mesh-list
154710895|NCT06158542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710896|NCT06158542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710897|NCT06154070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154710898|NCT06154070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154710899|NCT06154070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154710900|NCT06154070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710901|NCT06154070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710902|NCT06154070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154710903|NCT06154070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710904|NCT06154070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710905|NCT06154070|Cholinergic Agents|cholinergic agents|mesh-ancestor
154710906|NCT06154070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710907|NCT06150742|Nafamostat|nafamostat|mesh-list
154710908|NCT06150742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154710909|NCT06150742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154710910|NCT06150742|Analgesics|analgesics|mesh-ancestor
154710911|NCT06150742|Sensory System Agents|sensory system agents|mesh-ancestor
154710912|NCT06150742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710913|NCT06150742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710914|NCT06150742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154710915|NCT06150742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710916|NCT06150742|Anticoagulants|anticoagulants|mesh-ancestor
154710917|NCT06150742|Protease Inhibitors|protease inhibitors|mesh-ancestor
154710918|NCT06150742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710919|NCT06150742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710920|NCT06150742|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154710921|NCT06150742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154710922|NCT06150742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154710923|NCT06150742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710924|NCT06150742|Immunologic Factors|immunologic factors|mesh-ancestor
154710925|NCT06137040|Magnesium Sulfate|magnesium sulfate|mesh-list
154710926|NCT06137040|Analgesics|analgesics|mesh-ancestor
154710927|NCT06137040|Sensory System Agents|sensory system agents|mesh-ancestor
154710928|NCT06137040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710929|NCT06137040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710930|NCT06137040|Anesthetics|anesthetics|mesh-ancestor
154710931|NCT06137040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710932|NCT06137040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154710933|NCT06137040|Anticonvulsants|anticonvulsants|mesh-ancestor
154710934|NCT06137040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154710935|NCT06137040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154710936|NCT06137040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710937|NCT06137040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154710938|NCT06137040|Tocolytic Agents|tocolytic agents|mesh-ancestor
154710939|NCT06137040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154710940|NCT06135545|Bupivacaine|bupivacaine|mesh-list
154710941|NCT06135545|Anesthetics, Local|anesthetics, local|mesh-ancestor
154710942|NCT06135545|Anesthetics|anesthetics|mesh-ancestor
154710943|NCT06135545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154710944|NCT06135545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710945|NCT06135545|Sensory System Agents|sensory system agents|mesh-ancestor
154710946|NCT06135545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710947|NCT06112379|Paclitaxel|paclitaxel|mesh-list
154710948|NCT06112379|Cyclophosphamide|cyclophosphamide|mesh-list
154710949|NCT06112379|Carboplatin|carboplatin|mesh-list
154710950|NCT06112379|Doxorubicin|doxorubicin|mesh-list
154710951|NCT06112379|Pembrolizumab|pembrolizumab|mesh-list
154710952|NCT06112379|Capecitabine|capecitabine|mesh-list
154710953|NCT06112379|Durvalumab|durvalumab|mesh-list
154710954|NCT06112379|Epirubicin|epirubicin|mesh-list
154710955|NCT06112379|Olaparib|olaparib|mesh-list
154710956|NCT06112379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154710957|NCT06112379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710958|NCT06112379|Tubulin Modulators|tubulin modulators|mesh-ancestor
154710959|NCT06112379|Antimitotic Agents|antimitotic agents|mesh-ancestor
154710960|NCT06112379|Mitosis Modulators|mitosis modulators|mesh-ancestor
154710961|NCT06112379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710962|NCT06112379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710963|NCT06112379|Immunologic Factors|immunologic factors|mesh-ancestor
154710964|NCT06112379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710965|NCT06112379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710966|NCT06112379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154710967|NCT06112379|Alkylating Agents|alkylating agents|mesh-ancestor
154710968|NCT06112379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154710969|NCT06112379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154710970|NCT06112379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154710971|NCT06112379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154710972|NCT06112379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154710973|NCT06112379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154710974|NCT06112379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154710975|NCT06112379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154710976|NCT06112379|Antimetabolites|antimetabolites|mesh-ancestor
154710977|NCT06112379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154710978|NCT06101082|Cyclophosphamide|cyclophosphamide|mesh-list
154710979|NCT06101082|Fludarabine|fludarabine|mesh-list
154710980|NCT06101082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154710981|NCT06101082|Immunologic Factors|immunologic factors|mesh-ancestor
154710982|NCT06101082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710983|NCT06101082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154710984|NCT06101082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154710985|NCT06101082|Alkylating Agents|alkylating agents|mesh-ancestor
154710986|NCT06101082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710987|NCT06101082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154710988|NCT06101082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154710989|NCT06096714|Nicotine|nicotine|mesh-list
154710990|NCT06096714|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154710991|NCT06096714|Autonomic Agents|autonomic agents|mesh-ancestor
154710992|NCT06096714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154710993|NCT06096714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154710994|NCT06096714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154710995|NCT06096714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154710996|NCT06096714|Cholinergic Agents|cholinergic agents|mesh-ancestor
154710997|NCT06096714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154710998|NCT06096714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154710999|NCT06094842|Cyclophosphamide|cyclophosphamide|mesh-list
154711000|NCT06094842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154711001|NCT06094842|Fludarabine|fludarabine|mesh-list
154711002|NCT06094842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711003|NCT06094842|Immunologic Factors|immunologic factors|mesh-ancestor
154711004|NCT06094842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711005|NCT06094842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711006|NCT06094842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154711007|NCT06094842|Alkylating Agents|alkylating agents|mesh-ancestor
154711008|NCT06094842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711009|NCT06094842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711010|NCT06094842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154711011|NCT06094296|Paclitaxel|paclitaxel|mesh-list
154711012|NCT06094296|Carboplatin|carboplatin|mesh-list
154711013|NCT06094296|Nivolumab|nivolumab|mesh-list
154711014|NCT06094296|Pemetrexed|pemetrexed|mesh-list
154711015|NCT06094296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711016|NCT06094296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711017|NCT06094296|Tubulin Modulators|tubulin modulators|mesh-ancestor
154711018|NCT06094296|Antimitotic Agents|antimitotic agents|mesh-ancestor
154711019|NCT06094296|Mitosis Modulators|mitosis modulators|mesh-ancestor
154711020|NCT06094296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711021|NCT06094296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711022|NCT06094296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711023|NCT06094296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711024|NCT06094296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154711025|NCT06094296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154711026|NCT06064097|Cisplatin|cisplatin|mesh-list
154711027|NCT06064097|Gemcitabine|gemcitabine|mesh-list
154711028|NCT06064097|Nivolumab|nivolumab|mesh-list
154711029|NCT06064097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711030|NCT06064097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154711031|NCT06064097|Antimetabolites|antimetabolites|mesh-ancestor
154711032|NCT06064097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711033|NCT06064097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711034|NCT06064097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711035|NCT06054815|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154711036|NCT06054815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154711037|NCT06054815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711038|NCT06054815|Incretins|incretins|mesh-ancestor
154711039|NCT06054815|Hormones|hormones|mesh-ancestor
154711040|NCT06054815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711041|NCT06054815|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154711042|NCT06054815|Protease Inhibitors|protease inhibitors|mesh-ancestor
154711043|NCT06054815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711044|NCT06054815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711045|NCT06051474|Nicotine|nicotine|mesh-list
154711046|NCT06051474|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154711047|NCT06051474|Autonomic Agents|autonomic agents|mesh-ancestor
154711048|NCT06051474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711049|NCT06051474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711050|NCT06051474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154711051|NCT06051474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154711052|NCT06051474|Cholinergic Agents|cholinergic agents|mesh-ancestor
154711053|NCT06051474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711054|NCT06051474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711055|NCT06043323|Acetaminophen|acetaminophen|mesh-list
154711056|NCT06043323|Diphenhydramine|diphenhydramine|mesh-list
154711057|NCT06043323|Promethazine|promethazine|mesh-list
154711058|NCT06043323|Prednisone|prednisone|mesh-list
154711059|NCT06043323|Cyclophosphamide|cyclophosphamide|mesh-list
154711060|NCT06043323|Fludarabine|fludarabine|mesh-list
154711061|NCT06043323|Fludarabine phosphate|fludarabine phosphate|mesh-list
154711062|NCT06043323|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154711063|NCT06043323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711064|NCT06043323|Immunologic Factors|immunologic factors|mesh-ancestor
154711065|NCT06043323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711066|NCT06043323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711067|NCT06043323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154711068|NCT06043323|Alkylating Agents|alkylating agents|mesh-ancestor
154711069|NCT06043323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711070|NCT06043323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711071|NCT06043323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154711072|NCT06043323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711073|NCT06043323|Glucocorticoids|glucocorticoids|mesh-ancestor
154711074|NCT06043323|Hormones|hormones|mesh-ancestor
154711075|NCT06043323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711076|NCT06043323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154711077|NCT06043323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154711078|NCT06043323|Antimetabolites|antimetabolites|mesh-ancestor
154711079|NCT06043323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154711080|NCT06043323|Analgesics|analgesics|mesh-ancestor
154711081|NCT06043323|Sensory System Agents|sensory system agents|mesh-ancestor
154711082|NCT06043323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711083|NCT06043323|Antipyretics|antipyretics|mesh-ancestor
154711084|NCT06043323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154711085|NCT06043323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154711086|NCT06043323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154711087|NCT06043323|Anesthetics, Local|anesthetics, local|mesh-ancestor
154711088|NCT06043323|Anesthetics|anesthetics|mesh-ancestor
154711089|NCT06043323|Antiemetics|antiemetics|mesh-ancestor
154711090|NCT06043323|Autonomic Agents|autonomic agents|mesh-ancestor
154711091|NCT06043323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154711092|NCT06043323|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154711093|NCT06043323|Histamine Antagonists|histamine antagonists|mesh-ancestor
154711094|NCT06043323|Histamine Agents|histamine agents|mesh-ancestor
154711095|NCT06043323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711096|NCT06043323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154711097|NCT06043323|Antipruritics|antipruritics|mesh-ancestor
154711098|NCT06043323|Dermatologic Agents|dermatologic agents|mesh-ancestor
154711099|NCT06043323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711100|NCT06019728|Acetaminophen|acetaminophen|mesh-list
154711101|NCT06019728|Diphenhydramine|diphenhydramine|mesh-list
154711102|NCT06019728|Promethazine|promethazine|mesh-list
154711103|NCT06019728|Dexamethasone|dexamethasone|mesh-list
154711104|NCT06019728|Montelukast|montelukast|mesh-list
154711105|NCT06019728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711106|NCT06019728|Antiemetics|antiemetics|mesh-ancestor
154711107|NCT06019728|Autonomic Agents|autonomic agents|mesh-ancestor
154711108|NCT06019728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711109|NCT06019728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711110|NCT06019728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154711111|NCT06019728|Glucocorticoids|glucocorticoids|mesh-ancestor
154711112|NCT06019728|Hormones|hormones|mesh-ancestor
154711113|NCT06019728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711114|NCT06019728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154711115|NCT06019728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711116|NCT06019728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154711117|NCT06019728|Analgesics|analgesics|mesh-ancestor
154711118|NCT06019728|Sensory System Agents|sensory system agents|mesh-ancestor
154711119|NCT06019728|Antipyretics|antipyretics|mesh-ancestor
154711120|NCT06019728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154711121|NCT06019728|Respiratory System Agents|respiratory system agents|mesh-ancestor
154711122|NCT06019728|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154711123|NCT06019728|Hormone Antagonists|hormone antagonists|mesh-ancestor
154711124|NCT06019728|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154711125|NCT06019728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154711126|NCT06019728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711127|NCT06019728|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154711128|NCT06019728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154711129|NCT06019728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154711130|NCT06019728|Anesthetics, Local|anesthetics, local|mesh-ancestor
154711131|NCT06019728|Anesthetics|anesthetics|mesh-ancestor
154711132|NCT06019728|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154711133|NCT06019728|Histamine Antagonists|histamine antagonists|mesh-ancestor
154711134|NCT06019728|Histamine Agents|histamine agents|mesh-ancestor
154711135|NCT06019728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711136|NCT06019728|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154711137|NCT06019728|Antipruritics|antipruritics|mesh-ancestor
154711138|NCT06019728|Dermatologic Agents|dermatologic agents|mesh-ancestor
154711139|NCT06014138|Propofol|propofol|mesh-list
154711140|NCT06014138|Isoflurane|isoflurane|mesh-list
154711141|NCT06014138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154711142|NCT06014138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154711143|NCT06014138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711144|NCT06014138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154711145|NCT06014138|Anesthetics, General|anesthetics, general|mesh-ancestor
154711146|NCT06014138|Anesthetics|anesthetics|mesh-ancestor
154711147|NCT06014138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154711148|NCT05972772|Azithromycin|azithromycin|mesh-list
154711149|NCT05972772|Doxycycline|doxycycline|mesh-list
154711150|NCT05972772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154711151|NCT05972772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711152|NCT05972772|Antimalarials|antimalarials|mesh-ancestor
154711153|NCT05972772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154711154|NCT05972772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154711155|NCT05962320|Analgesics, Opioid|analgesics, opioid|mesh-list
154711156|NCT05962320|Narcotics|narcotics|mesh-ancestor
154711157|NCT05962320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154711158|NCT05962320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711159|NCT05962320|Analgesics|analgesics|mesh-ancestor
154711160|NCT05962320|Sensory System Agents|sensory system agents|mesh-ancestor
154711161|NCT05962320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711162|NCT05961488|Calcium|calcium|mesh-list
154711163|NCT05961488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154711164|NCT05961488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711165|NCT05960578|Golimumab|golimumab|mesh-list
154711166|NCT05960578|Immunoglobulins|immunoglobulins|mesh-list
154711167|NCT05960578|Immunoglobulin G|immunoglobulin g|mesh-list
154711168|NCT05960578|Immunologic Factors|immunologic factors|mesh-ancestor
154711169|NCT05960578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711170|NCT05960578|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154711171|NCT05960578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711172|NCT05960578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711173|NCT05954871|Cetuximab|cetuximab|mesh-list
154711174|NCT05954871|Osimertinib|osimertinib|mesh-list
154711175|NCT05954871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711176|NCT05954871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711177|NCT05954871|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154711178|NCT05954871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154711179|NCT05954871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711180|NCT05954871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711181|NCT05952453|Carboplatin|carboplatin|mesh-list
154711182|NCT05952453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711183|NCT05951959|Rituximab|rituximab|mesh-list
154711184|NCT05951959|Venetoclax|venetoclax|mesh-list
154711185|NCT05951959|Acalabrutinib|acalabrutinib|mesh-list
154711186|NCT05951959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711187|NCT05951959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711188|NCT05951959|Immunologic Factors|immunologic factors|mesh-ancestor
154711189|NCT05951959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711191|NCT05951959|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154711192|NCT05951959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154711193|NCT05951959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711194|NCT05951959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711195|NCT05936229|Interferons|interferons|mesh-list
154711196|NCT05936229|Interferon-beta|interferon-beta|mesh-list
154711197|NCT05936229|Interferon beta-1a|interferon beta-1a|mesh-list
154711198|NCT05936229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711199|NCT05936229|Antiviral Agents|antiviral agents|mesh-ancestor
154711200|NCT05936229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711201|NCT05936229|Immunologic Factors|immunologic factors|mesh-ancestor
154711202|NCT05936229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711203|NCT05936229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154711204|NCT05935306|Ibuprofen|ibuprofen|mesh-list
154711205|NCT05935306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154711206|NCT05935306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154711207|NCT05935306|Analgesics|analgesics|mesh-ancestor
154711208|NCT05935306|Sensory System Agents|sensory system agents|mesh-ancestor
154711209|NCT05935306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711210|NCT05935306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711211|NCT05935306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711212|NCT05935306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711213|NCT05935306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154711214|NCT05935306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711215|NCT05935306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711216|NCT05924880|Durvalumab|durvalumab|mesh-list
154711217|NCT05924880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711218|NCT05924880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711219|NCT05912244|Nivolumab|nivolumab|mesh-list
154711220|NCT05912244|Relatlimab|relatlimab|mesh-list
154711221|NCT05912244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711222|NCT05912244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711223|NCT05912244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711224|NCT05912244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711225|NCT05911295|Carboplatin|carboplatin|mesh-list
154711226|NCT05911295|Gemcitabine|gemcitabine|mesh-list
154711227|NCT05911295|Pembrolizumab|pembrolizumab|mesh-list
154711228|NCT05911295|Disitamab vedotin|disitamab vedotin|mesh-list
154711229|NCT05911295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711230|NCT05911295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154711231|NCT05911295|Antimetabolites|antimetabolites|mesh-ancestor
154711232|NCT05911295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711233|NCT05911295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711234|NCT05911295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711235|NCT05911295|Immunoconjugates|immunoconjugates|mesh-ancestor
154711236|NCT05911295|Immunologic Factors|immunologic factors|mesh-ancestor
154711237|NCT05911295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711238|NCT05910177|Etoposide|etoposide|mesh-list
154711239|NCT05910177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711240|NCT05910177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711241|NCT05910177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154711242|NCT05910177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154711243|NCT05910177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711244|NCT05910177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711245|NCT05904379|Paclitaxel|paclitaxel|mesh-list
154711246|NCT05904379|Docetaxel|docetaxel|mesh-list
154711247|NCT05904379|Carboplatin|carboplatin|mesh-list
154711248|NCT05904379|Pemetrexed|pemetrexed|mesh-list
154711249|NCT05904379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711250|NCT05904379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711251|NCT05904379|Tubulin Modulators|tubulin modulators|mesh-ancestor
154711252|NCT05904379|Antimitotic Agents|antimitotic agents|mesh-ancestor
154711253|NCT05904379|Mitosis Modulators|mitosis modulators|mesh-ancestor
154711254|NCT05904379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711255|NCT05904379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711256|NCT05904379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154711257|NCT05904379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154711258|NCT05903092|Carboplatin|carboplatin|mesh-list
154711259|NCT05903092|Etoposide|etoposide|mesh-list
154711260|NCT05903092|Durvalumab|durvalumab|mesh-list
154711261|NCT05903092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711262|NCT05903092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711263|NCT05903092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154711265|NCT05903092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711266|NCT05903092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711267|NCT05903092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711268|NCT05889182|Upadacitinib|upadacitinib|mesh-list
154711269|NCT05889182|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154711270|NCT05889182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154711271|NCT05889182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711272|NCT05889182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711273|NCT05889182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711274|NCT05844618|Triamcinolone|triamcinolone|mesh-list
154711275|NCT05844618|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154711276|NCT05844618|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154711277|NCT05844618|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154711278|NCT05844618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711279|NCT05844618|Glucocorticoids|glucocorticoids|mesh-ancestor
154711280|NCT05844618|Hormones|hormones|mesh-ancestor
154711281|NCT05844618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711282|NCT05844618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711283|NCT05844618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711284|NCT05844618|Immunologic Factors|immunologic factors|mesh-ancestor
154711285|NCT05844618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711286|NCT05844618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711287|NCT05841758|Hydroxychloroquine|hydroxychloroquine|mesh-list
154711288|NCT05841758|Antimalarials|antimalarials|mesh-ancestor
154711289|NCT05841758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154711290|NCT05841758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154711291|NCT05841758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711292|NCT05841758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711293|NCT05841758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711294|NCT05841758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711295|NCT05816343|Orlistat|orlistat|mesh-list
154711296|NCT05816343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711297|NCT05816343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711298|NCT05816343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154711299|NCT05816343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154711300|NCT05807126|Olaparib|olaparib|mesh-list
154711301|NCT05807126|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154711302|NCT05807126|Magrolimab|magrolimab|mesh-list
154711303|NCT05807126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711304|NCT05807126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711305|NCT05807126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711306|NCT05807126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711307|NCT05788094|Chloroquine|chloroquine|mesh-list
154711308|NCT05788094|Lumefantrine|lumefantrine|mesh-list
154711309|NCT05788094|Artemether|artemether|mesh-list
154711310|NCT05788094|Piperaquine|piperaquine|mesh-list
154711311|NCT05788094|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154711312|NCT05788094|Artenimol|artenimol|mesh-list
154711313|NCT05788094|Tafenoquine|tafenoquine|mesh-list
154711314|NCT05788094|Amebicides|amebicides|mesh-ancestor
154711315|NCT05788094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154711316|NCT05788094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154711317|NCT05788094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711318|NCT05788094|Antimalarials|antimalarials|mesh-ancestor
154711319|NCT05788094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711320|NCT05783661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154711321|NCT05783661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711322|NCT05770375|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154711323|NCT05770375|Hallucinogens|hallucinogens|mesh-ancestor
154711324|NCT05770375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711325|NCT05770375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154711326|NCT05770375|Serotonin Agents|serotonin agents|mesh-ancestor
154711327|NCT05770375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711328|NCT05770375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711329|NCT05770375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154711330|NCT05770375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154711331|NCT05770375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154711332|NCT05770375|Adrenergic Agents|adrenergic agents|mesh-ancestor
154711333|NCT05724108|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154711334|NCT05724108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711335|NCT05724108|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154711336|NCT05716295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154463309|NCT04874311|Doxorubicin|doxorubicin|mesh-list
154711337|NCT05716295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711338|NCT05716295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711339|NCT05716295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711341|NCT05715281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154711342|NCT05715281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711343|NCT05715281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711344|NCT05715281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711345|NCT05715281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711346|NCT05715281|Immunologic Factors|immunologic factors|mesh-ancestor
154711347|NCT05715281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711348|NCT05707234|Midazolam|midazolam|mesh-list
154711349|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154711350|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154711351|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154711352|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711353|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154711354|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154711355|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154711356|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154711357|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
154711358|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
154711359|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
154711360|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
154711361|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711362|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711363|NCT05691517|Exatecan|exatecan|mesh-list
154711364|NCT05691517|Camptothecin|camptothecin|mesh-list
154711365|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154711366|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154711367|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711368|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711369|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711370|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711371|NCT05691491|Temozolomide|temozolomide|mesh-list
154711372|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154711373|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
154711374|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711375|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711376|NCT05687123|Sunitinib|sunitinib|mesh-list
154711377|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154711378|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711379|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154711380|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154711381|NCT05687123|Growth Substances|growth substances|mesh-ancestor
154711382|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711383|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
154711384|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154711385|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711386|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711387|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154711388|NCT05668286|Triamcinolone|triamcinolone|mesh-list
154711389|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154711390|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154711391|NCT05668286|Prilocaine|prilocaine|mesh-list
154711392|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154711393|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711394|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
154711395|NCT05668286|Hormones|hormones|mesh-ancestor
154711396|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711397|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711398|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711399|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
154711400|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711401|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711402|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
154711403|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
154711404|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154711405|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
154711406|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711407|NCT05660850|Mannitol|mannitol|mesh-list
154711408|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154463390|NCT04366050|Ramipril|ramipril|mesh-list
154711409|NCT05660850|Diuretics|diuretics|mesh-ancestor
154711410|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
154711411|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711412|NCT05627375|Anticoagulants|anticoagulants|mesh-list
154711413|NCT05610319|Faricimab|faricimab|mesh-list
154711414|NCT05610319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154711415|NCT05610319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154711416|NCT05610319|Growth Substances|growth substances|mesh-ancestor
154711417|NCT05610319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711418|NCT05610319|Growth Inhibitors|growth inhibitors|mesh-ancestor
154711419|NCT05610319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711420|NCT05602597|Itraconazole|itraconazole|mesh-list
154711421|NCT05602597|Fluconazole|fluconazole|mesh-list
154711422|NCT05602597|Rifampin|rifampin|mesh-list
154711423|NCT05602597|Rabeprazole|rabeprazole|mesh-list
154711424|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
154711425|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711426|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154711427|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154711428|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711429|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711430|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154711431|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
154711432|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711433|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711434|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154711435|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154711436|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154711437|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154711438|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154711439|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
154711440|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154711441|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
154711442|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154711443|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154711444|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154711445|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154711446|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154711447|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154711448|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154711449|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154711450|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154711451|NCT05601999|Tenecteplase|tenecteplase|mesh-list
154711452|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154711453|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154711454|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711455|NCT05594563|Eflornithine|eflornithine|mesh-list
154711456|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711457|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154711458|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154711459|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154711460|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711461|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154711462|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711463|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711464|NCT05583617|Dexamethasone|dexamethasone|mesh-list
154711465|NCT05583617|Lenalidomide|lenalidomide|mesh-list
154711466|NCT05583617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711467|NCT05583617|Antiemetics|antiemetics|mesh-ancestor
154711468|NCT05583617|Autonomic Agents|autonomic agents|mesh-ancestor
154711469|NCT05583617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711470|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711471|NCT05583617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154711472|NCT05583617|Glucocorticoids|glucocorticoids|mesh-ancestor
154711473|NCT05583617|Hormones|hormones|mesh-ancestor
154711474|NCT05583617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711475|NCT05583617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154711476|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711477|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
154711478|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154711479|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154711480|NCT05583617|Growth Substances|growth substances|mesh-ancestor
154711481|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
154711482|NCT05582499|Paclitaxel|paclitaxel|mesh-list
154711483|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
154711484|NCT05582499|Carboplatin|carboplatin|mesh-list
154711485|NCT05582499|Trastuzumab|trastuzumab|mesh-list
154711486|NCT05582499|Letrozole|letrozole|mesh-list
154711487|NCT05582499|Epirubicin|epirubicin|mesh-list
154711488|NCT05582499|Pertuzumab|pertuzumab|mesh-list
154711489|NCT05582499|Goserelin|goserelin|mesh-list
154711490|NCT05582499|Fluzoparib|fluzoparib|mesh-list
154711491|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711492|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711493|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
154711494|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
154711495|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
154711496|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711497|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711498|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
154711499|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711500|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711501|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154711502|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
154711503|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154711504|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711505|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154711506|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154711507|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711508|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154711509|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
154711510|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711511|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154711512|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154711513|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154711514|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154711515|NCT05582499|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154711516|NCT05568888|Thrombin|thrombin|mesh-list
154711517|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
154711518|NCT05568888|Coagulants|coagulants|mesh-ancestor
154711519|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
154711520|NCT05564403|Leucovorin|leucovorin|mesh-list
154711521|NCT05564403|Folic Acid|folic acid|mesh-list
154711522|NCT05564403|Fluorouracil|fluorouracil|mesh-list
154711523|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
154711524|NCT05564403|Calcium|calcium|mesh-list
154711525|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
154711526|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154711527|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711528|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154711529|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
154711530|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711531|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154711532|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711533|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711534|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
154711535|NCT05564403|Antidotes|antidotes|mesh-ancestor
154711536|NCT05564403|Protective Agents|protective agents|mesh-ancestor
154711537|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
154711538|NCT05564403|Vitamins|vitamins|mesh-ancestor
154711539|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
154711540|NCT05564403|Hematinics|hematinics|mesh-ancestor
154711541|NCT05558449|Midazolam|midazolam|mesh-list
154711542|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154711543|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154711544|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154711545|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711546|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154711547|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154711548|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154711549|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154711550|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
154711551|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
154711552|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
154711553|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
154711554|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711555|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711556|NCT05554341|Paclitaxel|paclitaxel|mesh-list
154711557|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154711558|NCT05554341|Nilotinib|nilotinib|mesh-list
154711559|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711560|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711561|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
154711562|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
154711563|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
154711564|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711565|NCT05554341|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154711566|NCT05554341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153966430|NCT04217265|Letrozole|letrozole|mesh-list
154711567|NCT05554341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711568|NCT05551104|Labetalol|labetalol|mesh-list
154711569|NCT05551104|Nifedipine|nifedipine|mesh-list
154711570|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154711571|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154711572|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711573|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154711574|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711575|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
154711576|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
154711577|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154711578|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154711579|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154711580|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
154711581|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711582|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154711583|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
154711584|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
154711585|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711586|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154711587|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154711588|NCT05536882|Adapalene|adapalene|mesh-list
154711589|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154711590|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
154711591|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154711592|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154711593|NCT05536882|Analgesics|analgesics|mesh-ancestor
154711594|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
154711595|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711596|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711597|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711598|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711599|NCT05527418|Dasatinib|dasatinib|mesh-list
154711600|NCT05527418|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154711601|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154711602|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711603|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711604|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711605|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
154711606|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711607|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711608|NCT05518032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711609|NCT05518032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711610|NCT05478499|Deucravacitinib|deucravacitinib|mesh-list
153966469|NCT02750163|Acetaminophen|acetaminophen|mesh-list
154711611|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
154711612|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154711613|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711614|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711615|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
154711616|NCT05451849|Fludarabine|fludarabine|mesh-list
154711617|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711618|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
154711619|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711620|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711621|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154711622|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
154711623|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711624|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711625|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154711626|NCT05442567|Vedolizumab|vedolizumab|mesh-list
154711627|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154711628|NCT05427630|Dronabinol|dronabinol|mesh-list
154711629|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
154711630|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711631|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154711632|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154711633|NCT05427630|Analgesics|analgesics|mesh-ancestor
154711634|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
154711635|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711636|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154711637|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154711638|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711639|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711640|NCT05427630|Hormones|hormones|mesh-ancestor
154711641|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711642|NCT05422794|Paclitaxel|paclitaxel|mesh-list
154711643|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154711644|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
154711645|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711646|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711647|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
154711648|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
154711649|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
154711650|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711651|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711652|NCT05422794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711653|NCT05416021|Dapivirine|dapivirine|mesh-list
154711654|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154711655|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154711656|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
154711657|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711658|NCT05405166|Dexamethasone|dexamethasone|mesh-list
154711659|NCT05405166|Pomalidomide|pomalidomide|mesh-list
154711660|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154711661|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711662|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
154711663|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
154711664|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711665|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711666|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154711667|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
154711668|NCT05405166|Hormones|hormones|mesh-ancestor
154711669|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711670|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154711671|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711672|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
154711673|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154711674|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154711675|NCT05405166|Growth Substances|growth substances|mesh-ancestor
154711676|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
154711677|NCT05393674|Nivolumab|nivolumab|mesh-list
154711678|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711679|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711680|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711681|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711682|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
154711683|NCT05389527|Lenvatinib|lenvatinib|mesh-list
154711684|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711685|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711686|NCT05389527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711687|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711688|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154711689|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711690|NCT05383742|Rifampin|rifampin|mesh-list
154711691|NCT05383742|Isoniazid|isoniazid|mesh-list
154711692|NCT05383742|Linezolid|linezolid|mesh-list
154711693|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
154711694|NCT05383742|Ethambutol|ethambutol|mesh-list
154711695|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154711696|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
154711697|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154711698|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711699|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
154711700|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154711701|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711702|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711703|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154711704|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154711705|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154711706|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154711707|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154711708|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154711709|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154711710|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154711711|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
154711712|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154711713|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154711714|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
154711715|NCT05370547|Fludarabine|fludarabine|mesh-list
154711716|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711717|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
154711718|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711719|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711720|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154711721|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
154711722|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711723|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711724|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154711725|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
154711726|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711727|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154711728|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711729|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711730|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
154711731|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711732|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711733|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154711734|NCT05324852|Midazolam|midazolam|mesh-list
154711735|NCT05324852|Loxapine|loxapine|mesh-list
154711736|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154711737|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154711738|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154711739|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711740|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154711741|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154711742|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154711743|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154711744|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
154711745|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
154711746|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
154711747|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
154711748|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154711749|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711750|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154711751|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154711752|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
154711753|NCT05304520|Natalizumab|natalizumab|mesh-list
154711754|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
154711755|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711756|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
154711757|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154711758|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
154711759|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711760|NCT05287724|Expectorants|expectorants|mesh-ancestor
154711761|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
154711762|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154711763|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
154711764|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711765|NCT05287724|Protective Agents|protective agents|mesh-ancestor
154711766|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711767|NCT05287724|Antidotes|antidotes|mesh-ancestor
154711768|NCT05272384|Nivolumab|nivolumab|mesh-list
154711769|NCT05272384|Decitabine|decitabine|mesh-list
154711770|NCT05272384|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154711771|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711772|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711773|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711774|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711775|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154711776|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
154711777|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711778|NCT05257083|Dexamethasone|dexamethasone|mesh-list
154711779|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
154711780|NCT05257083|Fludarabine|fludarabine|mesh-list
154711781|NCT05257083|Lenalidomide|lenalidomide|mesh-list
154711782|NCT05257083|Bortezomib|bortezomib|mesh-list
154711783|NCT05257083|Daratumumab|daratumumab|mesh-list
154711784|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711785|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
154711786|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711787|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711788|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154711789|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
154711790|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711791|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711792|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154711793|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711794|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
154711795|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
154711796|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711797|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154711798|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
154711799|NCT05257083|Hormones|hormones|mesh-ancestor
154711800|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711801|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154711802|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154711803|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154711804|NCT05257083|Growth Substances|growth substances|mesh-ancestor
154711805|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
154711806|NCT05253846|Fluorouracil|fluorouracil|mesh-list
154711807|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
154711808|NCT05253846|Irinotecan|irinotecan|mesh-list
154711809|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
154711810|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711811|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154711812|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711813|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711814|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
154711815|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711816|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154711817|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154711818|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711819|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154711820|NCT05204147|Antibodies|antibodies|mesh-list
154711821|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
154711822|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154711823|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154711824|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
154711825|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711826|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711827|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
154711828|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
154711829|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711830|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154711831|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154711832|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
154711833|NCT05198830|Cisplatin|cisplatin|mesh-list
154711834|NCT05198830|Pemetrexed|pemetrexed|mesh-list
154711835|NCT05198830|Durvalumab|durvalumab|mesh-list
154711836|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
154711837|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154711838|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
154711839|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711840|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711841|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711842|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154711843|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153966700|NCT00839254|Vaccines|vaccines|mesh-list
154711844|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711845|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
154711846|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711847|NCT05190770|Triamcinolone|triamcinolone|mesh-list
154711848|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154711849|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154711850|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154711851|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711852|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
154711853|NCT05190770|Hormones|hormones|mesh-ancestor
154711854|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711855|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711856|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154711857|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
154711858|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711859|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463826|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
154711861|NCT05176483|Ipilimumab|ipilimumab|mesh-list
154711862|NCT05176483|Relatlimab|relatlimab|mesh-list
154711863|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711864|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711865|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154711866|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711867|NCT05142241|Temozolomide|temozolomide|mesh-list
154711868|NCT05142241|Talazoparib|talazoparib|mesh-list
154711869|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154711870|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
154711871|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711872|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711873|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154711874|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711875|NCT05142189|Paclitaxel|paclitaxel|mesh-list
154711876|NCT05142189|Docetaxel|docetaxel|mesh-list
154711877|NCT05142189|Carboplatin|carboplatin|mesh-list
154711878|NCT05142189|Cemiplimab|cemiplimab|mesh-list
154711879|NCT05142189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711880|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711881|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
154711882|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
154711883|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
154711884|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711885|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711886|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154711887|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711888|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711889|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
154711890|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154711891|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154711892|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711893|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
154711894|NCT05099276|Coagulants|coagulants|mesh-ancestor
154711895|NCT05080946|Aspirin|aspirin|mesh-list
154711896|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154711897|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154711898|NCT05080946|Analgesics|analgesics|mesh-ancestor
154711899|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
154711900|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711901|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711902|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711903|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711904|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154711905|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154711906|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711907|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154711908|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154711909|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711910|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
154711911|NCT05066607|Dexamethasone|dexamethasone|mesh-list
154711912|NCT05066607|Pomalidomide|pomalidomide|mesh-list
154711913|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711914|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
154711915|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
154711916|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154711917|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711918|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154711919|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
154711920|NCT05066607|Hormones|hormones|mesh-ancestor
154711921|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154711922|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154711923|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711924|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
154711925|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154711926|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154711927|NCT05066607|Growth Substances|growth substances|mesh-ancestor
154711928|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
154711929|NCT05065957|Capecitabine|capecitabine|mesh-list
154711930|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154711931|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
154711932|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711933|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711934|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
154711935|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154711936|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711937|NCT05050136|Volixibat|volixibat|mesh-list
154711938|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154711939|NCT05033522|Sorafenib|sorafenib|mesh-list
154711940|NCT05033522|Lenvatinib|lenvatinib|mesh-list
154711941|NCT05033522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711942|NCT05033522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154711943|NCT05033522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711944|NCT05033522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711945|NCT05025800|Rituximab|rituximab|mesh-list
154711946|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154711947|NCT05025800|Lenalidomide|lenalidomide|mesh-list
154711948|NCT05025800|Antibodies|antibodies|mesh-list
154711949|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
154711950|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154711951|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
154711952|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154711953|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711954|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154711955|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154711956|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154711957|NCT05025800|Growth Substances|growth substances|mesh-ancestor
154711958|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
154711959|NCT05019716|Cisplatin|cisplatin|mesh-list
154711960|NCT05019716|Etoposide|etoposide|mesh-list
154711961|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
154711962|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
154711963|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154711964|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154711965|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154711966|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154711967|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711968|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711969|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
154711970|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
154711971|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
154711972|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
154711973|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
154711974|NCT05007821|Linezolid|linezolid|mesh-list
154711975|NCT05007821|Bedaquiline|bedaquiline|mesh-list
154711976|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
154711977|NCT05007821|Clofazimine|clofazimine|mesh-list
154711978|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154711979|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711980|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154711981|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711982|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711983|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
154711984|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154711985|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
154711986|NCT05005507|Tenofovir|tenofovir|mesh-list
154711987|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154711988|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
154711989|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154711990|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154711991|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154711992|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154711993|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154711994|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154711995|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154711996|NCT04981509|Listerine|listerine|mesh-list
154711997|NCT04981509|Bevacizumab|bevacizumab|mesh-list
154711998|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154711999|NCT04981509|Atezolizumab|atezolizumab|mesh-list
154712000|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
154712001|NCT04981509|Antibodies|antibodies|mesh-list
154712002|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
154712003|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712004|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
154712005|NCT04981509|Fluorides|fluorides|mesh-list
154712006|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
154712007|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712008|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154712009|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154712010|NCT04981509|Growth Substances|growth substances|mesh-ancestor
154463975|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712011|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712012|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
154712013|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
154712014|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712015|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
154712016|NCT04981509|Protective Agents|protective agents|mesh-ancestor
154712017|NCT04981509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712018|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154712019|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712020|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
154712021|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
154712022|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712023|NCT04947020|Metformin|metformin|mesh-list
154712024|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154712025|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712026|NCT04937153|Pembrolizumab|pembrolizumab|mesh-list
154712027|NCT04937153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712028|NCT04937153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712029|NCT04937153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712030|NCT04937153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712031|NCT04935229|Nivolumab|nivolumab|mesh-list
154712032|NCT04935229|Ipilimumab|ipilimumab|mesh-list
154712033|NCT04935229|Relatlimab|relatlimab|mesh-list
154712034|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712035|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712036|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712037|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712038|NCT04915612|Cytarabine|cytarabine|mesh-list
154712039|NCT04915612|Daunorubicin|daunorubicin|mesh-list
154712040|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
154712041|NCT04915612|Calicheamicins|calicheamicins|mesh-list
154712042|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712043|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
154712044|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712045|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712046|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
154712047|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712048|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712049|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
154712050|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712051|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712052|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154712053|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712054|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712055|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712056|NCT04915612|Immunotoxins|immunotoxins|mesh-ancestor
154712057|NCT04915612|Immunoconjugates|immunoconjugates|mesh-ancestor
154712058|NCT04910568|Dexamethasone|dexamethasone|mesh-list
154712059|NCT04910568|Daratumumab|daratumumab|mesh-list
154712060|NCT04910568|Pomalidomide|pomalidomide|mesh-list
154712061|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154712062|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
154712063|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
154712064|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712065|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712066|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154712067|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
154712068|NCT04910568|Hormones|hormones|mesh-ancestor
154712069|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154712070|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154712071|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712072|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
154712073|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154712074|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154712075|NCT04910568|Growth Substances|growth substances|mesh-ancestor
154712076|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
154712077|NCT04882241|Leucovorin|leucovorin|mesh-list
154712078|NCT04882241|Docetaxel|docetaxel|mesh-list
154712079|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
154712080|NCT04882241|Capecitabine|capecitabine|mesh-list
154712081|NCT04882241|Fluorouracil|fluorouracil|mesh-list
154712082|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
154712083|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712084|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712085|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712086|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712087|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712088|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712089|NCT04882241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712090|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712091|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
154712092|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712093|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
154712094|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712096|NCT04882241|Protective Agents|protective agents|mesh-ancestor
154712097|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
154712098|NCT04882241|Vitamins|vitamins|mesh-ancestor
154712099|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
154712100|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
154712101|NCT04881240|Fludarabine|fludarabine|mesh-list
154712102|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712103|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
154712104|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712105|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712106|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154712107|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
154712108|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712109|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712110|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154712111|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
154712112|NCT04879329|Disitamab vedotin|disitamab vedotin|mesh-list
154712113|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712114|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712115|NCT04879329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712116|NCT04879329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712117|NCT04879329|Immunoconjugates|immunoconjugates|mesh-ancestor
154712118|NCT04879329|Immunologic Factors|immunologic factors|mesh-ancestor
154712119|NCT04879329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712120|NCT04858269|Paclitaxel|paclitaxel|mesh-list
154712121|NCT04858269|Carboplatin|carboplatin|mesh-list
154712122|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
154712123|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712124|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712125|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712126|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712127|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712128|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712129|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712130|NCT04858269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712131|NCT04840589|Nivolumab|nivolumab|mesh-list
154712132|NCT04840589|Ipilimumab|ipilimumab|mesh-list
154712133|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153966984|NCT06163352|Dopamine|dopamine|mesh-list
154712134|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712135|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712136|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712137|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
154712138|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154712139|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712140|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154712141|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712142|NCT04751383|Dinutuximab|dinutuximab|mesh-list
154712143|NCT04751383|Magrolimab|magrolimab|mesh-list
154712144|NCT04751383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712145|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712146|NCT04751383|Immunologic Factors|immunologic factors|mesh-ancestor
154712147|NCT04751383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712148|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712149|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154712150|NCT04750954|Peposertib|peposertib|mesh-list
154712151|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712152|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154712153|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712154|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712155|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154712156|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154712157|NCT04657289|Ranibizumab|ranibizumab|mesh-list
154712158|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154712159|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154712160|NCT04657289|Growth Substances|growth substances|mesh-ancestor
154712161|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712162|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
154712163|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712164|NCT04652960|Nivolumab|nivolumab|mesh-list
154712165|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712166|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712167|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712168|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712169|NCT04638816|Lidocaine|lidocaine|mesh-list
154712170|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
154712171|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
154712172|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
154712173|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154712174|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712175|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
154712176|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712177|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154712178|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154712179|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154712180|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153967037|NCT06017479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712181|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712182|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154712183|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
154712184|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
154712185|NCT04638816|Protective Agents|protective agents|mesh-ancestor
154712186|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
154712187|NCT04637763|Fludarabine|fludarabine|mesh-list
154712188|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712189|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
154712190|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712191|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712192|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154712193|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
154712194|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712195|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712196|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154712197|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
154712198|NCT04627012|Tislelizumab|tislelizumab|mesh-list
154712199|NCT04627012|Lenvatinib|lenvatinib|mesh-list
154712200|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712201|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712202|NCT04627012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712203|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712204|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712205|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712206|NCT04618367|Lenvatinib|lenvatinib|mesh-list
154712207|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712208|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712209|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712210|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712211|NCT04612179|Sirolimus|sirolimus|mesh-list
154712212|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154712213|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712214|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712215|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712216|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
154712217|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712218|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
154712219|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712220|NCT04609046|Rituximab|rituximab|mesh-list
154712221|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154712222|NCT04609046|Nivolumab|nivolumab|mesh-list
154712223|NCT04609046|Methotrexate|methotrexate|mesh-list
154712224|NCT04609046|Lenalidomide|lenalidomide|mesh-list
154712225|NCT04609046|Antibodies|antibodies|mesh-list
154712226|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
154712227|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712228|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
154712229|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967087|NCT05917340|Antipyretics|antipyretics|mesh-ancestor
154712230|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712231|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712232|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712233|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712234|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154712235|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
154712236|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154712237|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712238|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
154712239|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
154712240|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712241|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154712242|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712243|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154712244|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154712245|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154712246|NCT04609046|Growth Substances|growth substances|mesh-ancestor
154712247|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
154712248|NCT04608318|Venetoclax|venetoclax|mesh-list
154712249|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
154712250|NCT04608318|Ibrutinib|ibrutinib|mesh-list
154712251|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712252|NCT04608318|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154712253|NCT04608318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712254|NCT04608318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712255|NCT04608318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712256|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712257|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
154712258|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
154712259|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712260|NCT04604548|Protective Agents|protective agents|mesh-ancestor
154712261|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712262|NCT04601584|Antibodies|antibodies|mesh-list
154712263|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
154712264|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
154712265|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712266|NCT04587791|Cannabidiol|cannabidiol|mesh-list
154712267|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
154712268|NCT04581473|Paclitaxel|paclitaxel|mesh-list
154712269|NCT04581473|Irinotecan|irinotecan|mesh-list
154712270|NCT04581473|Apatinib|apatinib|mesh-list
154712271|NCT04581473|Antibodies|antibodies|mesh-list
154712272|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712273|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712274|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712275|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712276|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712277|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712278|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
154712279|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712280|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154712281|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712282|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712283|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712284|NCT04580121|Acetaminophen|acetaminophen|mesh-list
154712285|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
154712286|NCT04580121|Promethazine|promethazine|mesh-list
154712287|NCT04580121|Dexamethasone|dexamethasone|mesh-list
154712288|NCT04580121|Dasatinib|dasatinib|mesh-list
154712289|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154712290|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
154712291|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
154712292|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712293|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712294|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154712295|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
154712296|NCT04580121|Hormones|hormones|mesh-ancestor
154712297|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154712298|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154712299|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712300|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154712301|NCT04580121|Analgesics|analgesics|mesh-ancestor
154712302|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
154712303|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
154712304|NCT04580121|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154712305|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712306|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712307|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712308|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154712309|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154712310|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154712311|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
154712312|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
154712313|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154712314|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
154712315|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
154712316|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154712317|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154712318|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
154712319|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
154712320|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
154712321|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712322|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712323|NCT04576091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712324|NCT04576091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712325|NCT04550494|Talazoparib|talazoparib|mesh-list
154712326|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154712327|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712328|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712329|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712330|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
154712331|NCT04541017|Magrolimab|magrolimab|mesh-list
154712332|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
153967174|NCT05546515|Suvorexant|suvorexant|mesh-list
154712333|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
154712334|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
154712335|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712336|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712337|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712338|NCT04539938|Trastuzumab|trastuzumab|mesh-list
154712339|NCT04539938|Tucatinib|tucatinib|mesh-list
154712340|NCT04539938|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154712341|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712342|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712343|NCT04539938|Immunoconjugates|immunoconjugates|mesh-ancestor
154712344|NCT04539938|Immunologic Factors|immunologic factors|mesh-ancestor
154712345|NCT04539938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712346|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712347|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712348|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712349|NCT04536298|Vitamin D|vitamin d|mesh-list
154712350|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
154712351|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
154712352|NCT04536298|Vitamins|vitamins|mesh-list
154712353|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
154712354|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712355|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154712356|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154712357|NCT04526899|Cemiplimab|cemiplimab|mesh-list
154712358|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712359|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712360|NCT04525755|Nicotine|nicotine|mesh-list
154712361|NCT04525755|Varenicline|varenicline|mesh-list
154712362|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154712363|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
154712364|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712365|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712366|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154712367|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154712368|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
154712369|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154712370|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712371|NCT04522323|Lenvatinib|lenvatinib|mesh-list
154712372|NCT04522323|Axitinib|axitinib|mesh-list
154712373|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712374|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712375|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712376|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712377|NCT04514497|Irinotecan|irinotecan|mesh-list
154712378|NCT04514497|Topotecan|topotecan|mesh-list
154712379|NCT04514497|Camptothecin|camptothecin|mesh-list
154712380|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154712381|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712382|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712383|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712384|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712385|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712386|NCT04514484|Nivolumab|nivolumab|mesh-list
154712387|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712388|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712389|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712390|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712391|NCT04505566|Ketorolac|ketorolac|mesh-list
154712392|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154712393|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
154712394|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154712395|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154712396|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154712398|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
154712399|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712400|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712401|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154712402|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712403|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154712404|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712405|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712406|NCT04405037|Alvimopan|alvimopan|mesh-list
154712407|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154712408|NCT04345913|Halichondrin B|halichondrin b|mesh-list
154712409|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712410|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712411|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712412|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712413|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712414|NCT04340843|Decitabine|decitabine|mesh-list
154712415|NCT04340843|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154712416|NCT04340843|Azacitidine|azacitidine|mesh-list
154712417|NCT04340843|Belinostat|belinostat|mesh-list
154712418|NCT04340843|Guadecitabine|guadecitabine|mesh-list
154712419|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712420|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
154712421|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712422|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712423|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712424|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154712425|NCT04339738|Paclitaxel|paclitaxel|mesh-list
154712426|NCT04339738|Nivolumab|nivolumab|mesh-list
154712427|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154712428|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712429|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712430|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712431|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712432|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712433|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712434|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712435|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712436|NCT04334941|Atezolizumab|atezolizumab|mesh-list
154712437|NCT04334941|Talazoparib|talazoparib|mesh-list
154712438|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712439|NCT04334941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712440|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712441|NCT04334941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712442|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712443|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
154712444|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712445|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154712446|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712447|NCT04317105|Nivolumab|nivolumab|mesh-list
154712448|NCT04317105|Ipilimumab|ipilimumab|mesh-list
154712449|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712450|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712451|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712452|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712453|NCT04310943|Paclitaxel|paclitaxel|mesh-list
154712454|NCT04310943|Tislelizumab|tislelizumab|mesh-list
154712455|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712456|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712457|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712458|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712459|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712460|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712461|NCT04310943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712462|NCT04310007|Paclitaxel|paclitaxel|mesh-list
154712463|NCT04310007|Docetaxel|docetaxel|mesh-list
154712464|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154712465|NCT04310007|Gemcitabine|gemcitabine|mesh-list
154712466|NCT04310007|Nivolumab|nivolumab|mesh-list
154712467|NCT04310007|Ramucirumab|ramucirumab|mesh-list
154712468|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154712469|NCT04310007|Antibodies|antibodies|mesh-list
154712470|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
154712471|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712472|NCT04310007|Lexatumumab|lexatumumab|mesh-list
154712473|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712474|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712475|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712476|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712477|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712478|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712479|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
154712480|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712481|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712482|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
154712483|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712484|NCT04310007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154712485|NCT04310007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154712486|NCT04310007|Growth Substances|growth substances|mesh-ancestor
154712487|NCT04310007|Growth Inhibitors|growth inhibitors|mesh-ancestor
154712488|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
154712489|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154712490|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
154712491|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712492|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712493|NCT04301076|Prednisone|prednisone|mesh-list
154712494|NCT04301076|Cortisone|cortisone|mesh-list
154712495|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
154712496|NCT04301076|Doxorubicin|doxorubicin|mesh-list
154712497|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154712498|NCT04301076|Etoposide|etoposide|mesh-list
154712499|NCT04301076|Vincristine|vincristine|mesh-list
154712500|NCT04301076|Lenalidomide|lenalidomide|mesh-list
154712501|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
154712502|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
154712503|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712504|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
154712505|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712506|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712507|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154712508|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
154712509|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712510|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712511|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154712512|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712513|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154712514|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712515|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712516|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154712517|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
154712518|NCT04301076|Hormones|hormones|mesh-ancestor
154712519|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154712520|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154712521|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712522|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712523|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712524|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712525|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154712526|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154712527|NCT04301076|Growth Substances|growth substances|mesh-ancestor
154712528|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
154712529|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
154712530|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
154712531|NCT04294628|Trastuzumab|trastuzumab|mesh-list
154712532|NCT04294628|Camptothecin|camptothecin|mesh-list
154712533|NCT04294628|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154712534|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
154712535|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712536|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712537|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
154712538|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712539|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712540|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154712541|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712542|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712543|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712544|NCT04284774|Tipifarnib|tipifarnib|mesh-list
154712545|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712546|NCT04262843|Vidarabine|vidarabine|mesh-list
154712547|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
154712548|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
154712549|NCT04262843|Fludarabine|fludarabine|mesh-list
154712550|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
154712551|NCT04262843|Tacrolimus|tacrolimus|mesh-list
154712552|NCT04262843|Lenograstim|lenograstim|mesh-list
154712553|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712554|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
154712555|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712556|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712557|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154712558|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
154712559|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712560|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712561|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154712562|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712563|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
154712564|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
154712565|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712566|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154712567|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712568|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712569|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154712570|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
154712571|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154712572|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154712573|NCT04248205|Ketamine|ketamine|mesh-list
154712574|NCT04248205|Analgesics|analgesics|mesh-ancestor
154712575|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
154712576|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712577|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712578|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154712579|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154712580|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
154712581|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
154712582|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154712583|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154712584|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154712585|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154712586|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712587|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154712588|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712589|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154712590|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
154712591|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154712592|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
154712593|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712594|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712595|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154712596|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
154712597|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154712598|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
154712599|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712600|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154712601|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154712602|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
154712603|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
154712604|NCT04231760|Protective Agents|protective agents|mesh-ancestor
154712605|NCT04216290|Cisplatin|cisplatin|mesh-list
154712606|NCT04216290|Gemcitabine|gemcitabine|mesh-list
154712607|NCT04216290|Fluorouracil|fluorouracil|mesh-list
154712608|NCT04216290|Durvalumab|durvalumab|mesh-list
154712609|NCT04216290|Mitomycins|mitomycins|mesh-list
154712610|NCT04216290|Mitomycin|mitomycin|mesh-list
154712611|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
154712612|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712613|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
154712614|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712615|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712616|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
154712617|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712618|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712619|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
154712620|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712621|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712622|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712623|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
154712624|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154712625|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712626|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
154712627|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712628|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712629|NCT04214067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712630|NCT04214067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712631|NCT04195399|Imidazole|imidazole|mesh-list
154712632|NCT04195399|Nirogacestat|nirogacestat|mesh-list
154712633|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712634|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712635|NCT04195399|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154712636|NCT04191499|Fulvestrant|fulvestrant|mesh-list
154712637|NCT04191499|Palbociclib|palbociclib|mesh-list
154712638|NCT04191499|Inavolisib|inavolisib|mesh-list
154712639|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154712640|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712641|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154712642|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154712643|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
153967510|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154712644|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154712645|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712646|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712647|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712648|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712649|NCT04191499|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154712650|NCT04137185|Hormones|hormones|mesh-list
154712651|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154712652|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712653|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
154712654|NCT04130516|Antibodies|antibodies|mesh-list
154712655|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
154712656|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712657|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712658|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712659|NCT04130516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712660|NCT04130516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712661|NCT04125836|Octreotide|octreotide|mesh-list
154712662|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154712663|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154712664|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712665|NCT04096638|Atezolizumab|atezolizumab|mesh-list
154712666|NCT04096638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712667|NCT04096638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712668|NCT04096638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712669|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712670|NCT04048707|Octreotide|octreotide|mesh-list
154712671|NCT04048707|Midodrine|midodrine|mesh-list
154712672|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
154712673|NCT04048707|Giapreza|giapreza|mesh-list
154712674|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
154712675|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154712676|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154712677|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712678|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
154712679|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
154712680|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712681|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725166|NCT00116493|Folic Acid|folic acid|mesh-list
154712682|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154712683|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154712684|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154712685|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154712686|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
154712687|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154712688|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712689|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154712690|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
154712691|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712692|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
154712693|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154712695|NCT03984448|Cortisone|cortisone|mesh-list
154712696|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
154712697|NCT03984448|Rituximab|rituximab|mesh-list
154712698|NCT03984448|Doxorubicin|doxorubicin|mesh-list
154712699|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154712700|NCT03984448|Etoposide|etoposide|mesh-list
154712701|NCT03984448|Vincristine|vincristine|mesh-list
154712702|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
154712703|NCT03984448|Venetoclax|venetoclax|mesh-list
154712704|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
154712705|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154712706|NCT03984448|Antibodies|antibodies|mesh-list
154712707|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
154712708|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712709|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712710|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
154712711|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712712|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712713|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154712714|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
154712715|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712716|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712717|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154712718|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712719|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154712720|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712721|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712722|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154712723|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
154712724|NCT03984448|Hormones|hormones|mesh-ancestor
154712725|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154712726|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154712727|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712728|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712729|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712730|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712731|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
154712732|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
154712733|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
154712734|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
154712735|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712736|NCT03968406|Talazoparib|talazoparib|mesh-list
154712737|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154712738|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712739|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712740|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712741|NCT03952585|Deoxyglucose|deoxyglucose|mesh-list
154712742|NCT03952585|Cisplatin|cisplatin|mesh-list
154712743|NCT03952585|Nivolumab|nivolumab|mesh-list
154712744|NCT03952585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154712745|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712746|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712747|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712748|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712749|NCT03952585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154712750|NCT03952585|Antimetabolites|antimetabolites|mesh-ancestor
154712751|NCT03952585|Antiviral Agents|antiviral agents|mesh-ancestor
154712752|NCT03952585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712753|NCT03941860|Lenalidomide|lenalidomide|mesh-list
154712754|NCT03941860|Ixazomib|ixazomib|mesh-list
154712755|NCT03941860|Glycine|glycine|mesh-list
154712756|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
154712757|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712758|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154712759|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154712760|NCT03941860|Growth Substances|growth substances|mesh-ancestor
154712761|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
154712762|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712763|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712764|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
154712765|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712766|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
154712767|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154712768|NCT03934216|Deucravacitinib|deucravacitinib|mesh-list
154712769|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
154712770|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712771|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712772|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712774|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154712775|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154712776|NCT03926338|Analgesics|analgesics|mesh-ancestor
154712777|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
154712778|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712779|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712780|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154712781|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712782|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154712783|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154712784|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712785|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712786|NCT03914300|Nivolumab|nivolumab|mesh-list
154712787|NCT03914300|Ipilimumab|ipilimumab|mesh-list
154712788|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712789|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712790|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153967654|NCT03384654|Hormones|hormones|mesh-ancestor
154712791|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712792|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
154712793|NCT03907852|Nivolumab|nivolumab|mesh-list
154712794|NCT03907852|Fludarabine|fludarabine|mesh-list
154712795|NCT03907852|Ipilimumab|ipilimumab|mesh-list
154712796|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712797|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
154712798|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712799|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154712800|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154712801|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
154712802|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712803|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712804|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154712805|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712806|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712807|NCT03907475|Paclitaxel|paclitaxel|mesh-list
154712808|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154712809|NCT03907475|Carboplatin|carboplatin|mesh-list
154712810|NCT03907475|Gemcitabine|gemcitabine|mesh-list
154712811|NCT03907475|Doxorubicin|doxorubicin|mesh-list
154712812|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154712813|NCT03907475|Capecitabine|capecitabine|mesh-list
154712814|NCT03907475|Durvalumab|durvalumab|mesh-list
154712815|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
154712816|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712817|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
154712818|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712819|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712820|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
154712821|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712822|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712823|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712824|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712825|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
154712826|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712827|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154712828|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712829|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712830|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712831|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
154712832|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712833|NCT03896269|Cytarabine|cytarabine|mesh-list
154712834|NCT03896269|Daunorubicin|daunorubicin|mesh-list
154712835|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712836|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
153967697|NCT03088878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712837|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712838|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712839|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
154712840|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712841|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712842|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
154712843|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712844|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712845|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154712846|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712847|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712848|NCT03878095|Olaparib|olaparib|mesh-list
154712849|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154712850|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712851|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712852|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712853|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
154712854|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
154712855|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712856|NCT03842228|Durvalumab|durvalumab|mesh-list
154712857|NCT03842228|Olaparib|olaparib|mesh-list
154712858|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154712859|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
154712860|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712861|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
154712862|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712863|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712864|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
154712865|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712866|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712867|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712868|NCT03835065|Calpastatin|calpastatin|mesh-list
154712869|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154712870|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
154712871|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712872|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712873|NCT03831932|Osimertinib|osimertinib|mesh-list
154712874|NCT03831932|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154712875|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712876|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712877|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712878|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712879|NCT03820830|Palbociclib|palbociclib|mesh-list
154712880|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712881|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712882|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712883|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712884|NCT03784014|Durvalumab|durvalumab|mesh-list
154712885|NCT03784014|Olaparib|olaparib|mesh-list
154712886|NCT03784014|Palbociclib|palbociclib|mesh-list
154712887|NCT03784014|Lapatinib|lapatinib|mesh-list
154712888|NCT03784014|Trametinib|trametinib|mesh-list
154712889|NCT03784014|Dabrafenib|dabrafenib|mesh-list
154712890|NCT03784014|Ceritinib|ceritinib|mesh-list
154712891|NCT03784014|Futibatinib|futibatinib|mesh-list
154712892|NCT03784014|Nilotinib|nilotinib|mesh-list
154712893|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712894|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712895|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154712896|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712897|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712898|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712899|NCT03784014|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154712900|NCT03744793|Pemetrexed|pemetrexed|mesh-list
154712901|NCT03744793|Avelumab|avelumab|mesh-list
154712902|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154712903|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712904|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712905|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712906|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154712907|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154712908|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712909|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
154712910|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712911|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
154712912|NCT03722420|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154712913|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712914|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712915|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712916|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712917|NCT03672539|Cytarabine|cytarabine|mesh-list
154712918|NCT03672539|Daunorubicin|daunorubicin|mesh-list
154712919|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
154712920|NCT03672539|Calicheamicins|calicheamicins|mesh-list
154712921|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154464879|NCT05707208|Lidocaine|lidocaine|mesh-list
154712922|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
154712923|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712924|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712926|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712927|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712928|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
154712929|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712930|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712931|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154712932|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712933|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712934|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712935|NCT03672539|Immunotoxins|immunotoxins|mesh-ancestor
154712936|NCT03672539|Immunoconjugates|immunoconjugates|mesh-ancestor
154712937|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
154712938|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712939|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712940|NCT03666273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154712941|NCT03666273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712942|NCT03661307|Venetoclax|venetoclax|mesh-list
154712943|NCT03661307|Decitabine|decitabine|mesh-list
154712944|NCT03661307|Quizartinib|quizartinib|mesh-list
154712945|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712946|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712947|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
154712948|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712949|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712950|NCT03661307|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154712951|NCT03661307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154712952|NCT03652428|Paclitaxel|paclitaxel|mesh-list
154712953|NCT03652428|Gemcitabine|gemcitabine|mesh-list
154712954|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154712955|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712956|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
153967800|NCT02720445|Nicotine|nicotine|mesh-list
154712957|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
154712958|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
154712959|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712960|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712961|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
154712962|NCT03629171|Cytarabine|cytarabine|mesh-list
154712963|NCT03629171|Daunorubicin|daunorubicin|mesh-list
154712964|NCT03629171|Venetoclax|venetoclax|mesh-list
154712965|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154712966|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
154712967|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712968|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712969|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
154712970|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154712971|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154712972|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
154712973|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712974|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154712975|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154712976|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154712977|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712978|NCT03606980|Dexamethasone|dexamethasone|mesh-list
154712979|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
154712980|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154712981|NCT03606980|BB 1101|bb 1101|mesh-list
154712982|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154712983|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
154712984|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
154712985|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154712986|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154712987|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154712988|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
154712989|NCT03606980|Hormones|hormones|mesh-ancestor
154712990|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154712991|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154712992|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154712993|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
154712994|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154712995|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154712996|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
154712997|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
154712998|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154712999|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713000|NCT03598998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713001|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713002|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154713003|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713005|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154713006|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
154713007|NCT03595592|Carboplatin|carboplatin|mesh-list
154713008|NCT03595592|Doxorubicin|doxorubicin|mesh-list
154713009|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154713010|NCT03595592|Trastuzumab|trastuzumab|mesh-list
154713011|NCT03595592|Atezolizumab|atezolizumab|mesh-list
154713012|NCT03595592|Pertuzumab|pertuzumab|mesh-list
154713013|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154713014|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713015|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
154713016|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
154713017|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
154713018|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713019|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713020|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
154713021|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713022|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713023|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154713024|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
154713025|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154713026|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154713027|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154713028|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154713029|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713030|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713031|NCT03595592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713032|NCT03549715|Durvalumab|durvalumab|mesh-list
154713033|NCT03549715|Tremelimumab|tremelimumab|mesh-list
154713034|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713035|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713036|NCT03502733|Nivolumab|nivolumab|mesh-list
154713037|NCT03502733|Ipilimumab|ipilimumab|mesh-list
154713038|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713039|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713040|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713041|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713042|NCT03467789|Vitamin D|vitamin d|mesh-list
154713043|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
154713044|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
154713045|NCT03467789|Vitamins|vitamins|mesh-list
154713046|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
154713047|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713048|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154713049|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154713050|NCT03421639|Leuprolide|leuprolide|mesh-list
154713051|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154713052|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154713053|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154713054|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
154713055|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154713056|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713057|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154713058|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713059|NCT03421639|Hormones|hormones|mesh-ancestor
154713060|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713061|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154713062|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713063|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713064|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154713065|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
154713066|NCT03340675|Ifetroban|ifetroban|mesh-list
154713067|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154713068|NCT03321643|Rituximab|rituximab|mesh-list
154713069|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154713070|NCT03321643|Atezolizumab|atezolizumab|mesh-list
154713071|NCT03321643|Gemcitabine|gemcitabine|mesh-list
154713072|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
154713073|NCT03321643|Antibodies|antibodies|mesh-list
154713074|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
154713075|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154713076|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
154713077|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713078|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713079|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713080|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154713081|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
154713082|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713083|NCT03321643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713084|NCT03317392|Olaparib|olaparib|mesh-list
154713085|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154713086|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154713087|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713088|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713089|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713090|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154713091|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
154713092|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713093|NCT03278925|Protective Agents|protective agents|mesh-ancestor
154713094|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713095|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154713096|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154713097|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713098|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154713099|NCT03252938|Avelumab|avelumab|mesh-list
154713100|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713101|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713102|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
154713103|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713104|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713105|NCT03244384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713106|NCT03244384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713107|NCT03228732|Fluoxetine|fluoxetine|mesh-list
154713108|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154713109|NCT03228732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154713110|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154713111|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154713112|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713113|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154713114|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
154713115|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713116|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154713117|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
154713118|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154713119|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154713120|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154713121|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713122|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154713123|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
154713124|NCT03221426|Leucovorin|leucovorin|mesh-list
154713125|NCT03221426|Docetaxel|docetaxel|mesh-list
154713126|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
154713127|NCT03221426|Capecitabine|capecitabine|mesh-list
154713128|NCT03221426|Fluorouracil|fluorouracil|mesh-list
154713129|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
154713130|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713131|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
154713132|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
154713133|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
154713134|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713135|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713136|NCT03221426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713137|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154713138|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
154713139|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713140|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
154713141|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713142|NCT03221426|Antidotes|antidotes|mesh-ancestor
154713143|NCT03221426|Protective Agents|protective agents|mesh-ancestor
154713144|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
154713145|NCT03221426|Vitamins|vitamins|mesh-ancestor
154713146|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
154713147|NCT03212274|Olaparib|olaparib|mesh-list
154465100|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154713148|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154713149|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713150|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713151|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713152|NCT03141684|Bevacizumab|bevacizumab|mesh-list
154713153|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154713154|NCT03141684|Atezolizumab|atezolizumab|mesh-list
154713155|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
154713156|NCT03141684|Antibodies|antibodies|mesh-list
154713157|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
154713158|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154713159|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
154713160|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713161|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154713162|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154713163|NCT03141684|Growth Substances|growth substances|mesh-ancestor
154713164|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713165|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
154713166|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
154713167|NCT03141684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713168|NCT03141684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713169|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
154713170|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713171|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713172|NCT03051659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713173|NCT03051659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713174|NCT03033576|Nivolumab|nivolumab|mesh-list
154713175|NCT03033576|Ipilimumab|ipilimumab|mesh-list
154713176|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713177|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713178|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713179|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713180|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
154713181|NCT03030378|Interleukin-12|interleukin-12|mesh-list
154713182|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713183|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713184|NCT03030378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713185|NCT03030378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713186|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154713187|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
154713188|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713189|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154713190|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154713191|NCT03030378|Growth Substances|growth substances|mesh-ancestor
154713192|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
154713193|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154713194|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713195|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
154713196|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154713197|NCT02950051|Rituximab|rituximab|mesh-list
154713198|NCT02950051|Fludarabine|fludarabine|mesh-list
154713199|NCT02950051|Venetoclax|venetoclax|mesh-list
154713200|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
154713201|NCT02950051|Ibrutinib|ibrutinib|mesh-list
154713202|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713203|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
154713204|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713205|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713206|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154713207|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
154713208|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713209|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713210|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154713211|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713212|NCT02950051|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154713213|NCT02950051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154713214|NCT02950051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713215|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
154713216|NCT02926833|Fludarabine|fludarabine|mesh-list
154713217|NCT02926833|Atezolizumab|atezolizumab|mesh-list
154713218|NCT02926833|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154713219|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713220|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
154713221|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713222|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713223|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154713224|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
154713225|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713226|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713227|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154713228|NCT02926833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713229|NCT02926833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713230|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154713231|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713232|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713233|NCT02862275|Atezolizumab|atezolizumab|mesh-list
154713234|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154713235|NCT02862275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713236|NCT02862275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713237|NCT02862275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713238|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713239|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
154713240|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713241|NCT02849496|Atezolizumab|atezolizumab|mesh-list
154713242|NCT02849496|Olaparib|olaparib|mesh-list
154713243|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154713244|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154713245|NCT02849496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713246|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713247|NCT02849496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713248|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713249|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713250|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
154713251|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713252|NCT02834013|Nivolumab|nivolumab|mesh-list
154713253|NCT02834013|Ipilimumab|ipilimumab|mesh-list
154713254|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713255|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713256|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713257|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713258|NCT02752685|Paclitaxel|paclitaxel|mesh-list
154713259|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
154713260|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154713261|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713262|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
154713263|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
154713264|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
154713265|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713266|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713267|NCT02752685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713268|NCT02692313|Epinephrine|epinephrine|mesh-list
154713269|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154713270|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154713271|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
154713272|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154713273|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713274|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713275|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154713276|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154713277|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
154713278|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713279|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154713280|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
154713281|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
154713282|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
154713283|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154713284|NCT02649582|Temozolomide|temozolomide|mesh-list
154713285|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154713286|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
154713287|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713288|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713289|NCT02620280|Paclitaxel|paclitaxel|mesh-list
154713290|NCT02620280|Carboplatin|carboplatin|mesh-list
154713291|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154713292|NCT02620280|Atezolizumab|atezolizumab|mesh-list
154713293|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154713294|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713295|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
154713297|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
154713298|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713299|NCT02620280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713300|NCT02620280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713301|NCT02595931|Irinotecan|irinotecan|mesh-list
154713302|NCT02595931|Camptothecin|camptothecin|mesh-list
153968162|NCT00743509|Temsirolimus|temsirolimus|mesh-list
154713303|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154713304|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154713305|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713306|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713307|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713308|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154713309|NCT02506153|Interferons|interferons|mesh-list
154713310|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
154713311|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
154713312|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
154713313|NCT02506153|Ipilimumab|ipilimumab|mesh-list
154713314|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713315|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713316|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713317|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713318|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
154713319|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154713320|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
154713321|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713322|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
154713323|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154713324|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713325|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713326|NCT02496208|Nivolumab|nivolumab|mesh-list
154713327|NCT02496208|Ipilimumab|ipilimumab|mesh-list
154713328|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713329|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713330|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713331|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713332|NCT02485418|Propofol|propofol|mesh-list
154713333|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154713334|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713335|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713336|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154713337|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
154713338|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
154713339|NCT02392429|Cytarabine|cytarabine|mesh-list
154713340|NCT02392429|Alovudine|alovudine|mesh-list
154713341|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154713342|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
154713343|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713344|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713345|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
154713346|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154713347|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713348|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
154713349|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713350|NCT02314169|Nivolumab|nivolumab|mesh-list
154713351|NCT02314169|Ipilimumab|ipilimumab|mesh-list
154713352|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713353|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713354|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713355|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713356|NCT02311933|Tamoxifen|tamoxifen|mesh-list
154713357|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154713358|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
154713359|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713360|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713361|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154713362|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713363|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154713364|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154713365|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154713366|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
154713367|NCT02298959|Aflibercept|aflibercept|mesh-list
154713368|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
154713369|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713370|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713371|NCT02298959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713372|NCT02298959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713373|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154713374|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154713375|NCT02298959|Growth Substances|growth substances|mesh-ancestor
154713376|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713377|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
154713378|NCT02286726|Cytarabine|cytarabine|mesh-list
154713379|NCT02286726|Daunorubicin|daunorubicin|mesh-list
154713380|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154713381|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
153968252|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154713382|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713383|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713384|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
154713385|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154713386|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713387|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
154713388|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713389|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154713390|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154713391|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154713392|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713393|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154713394|NCT02240498|Methylene Blue|methylene blue|mesh-list
154713395|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713396|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713397|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154713398|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154713399|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154713400|NCT02224781|Nivolumab|nivolumab|mesh-list
154713401|NCT02224781|Ipilimumab|ipilimumab|mesh-list
154713402|NCT02224781|Trametinib|trametinib|mesh-list
154713403|NCT02224781|Dabrafenib|dabrafenib|mesh-list
154713404|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154713405|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713406|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713407|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713408|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713409|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154713410|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713411|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154713412|NCT02224781|Protective Agents|protective agents|mesh-ancestor
154713413|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713414|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154713415|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
154713416|NCT02196181|Trametinib|trametinib|mesh-list
154713417|NCT02196181|Dabrafenib|dabrafenib|mesh-list
154713418|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154713419|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713420|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154713421|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713422|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713423|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154713424|NCT02196181|Protective Agents|protective agents|mesh-ancestor
154713425|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713426|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154713427|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
154713428|NCT02160015|Rituximab|rituximab|mesh-list
154713429|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154713430|NCT02160015|Lenalidomide|lenalidomide|mesh-list
154713431|NCT02160015|Antibodies|antibodies|mesh-list
154713432|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
154713433|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154713434|NCT02160015|Ibrutinib|ibrutinib|mesh-list
154713435|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
154713436|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713437|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713438|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713439|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154713440|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154713441|NCT02160015|Growth Substances|growth substances|mesh-ancestor
154713442|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
154713443|NCT02160015|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154713444|NCT02160015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154713445|NCT02160015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713446|NCT02160015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713447|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
154713448|NCT02094794|Etoposide|etoposide|mesh-list
154713449|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
154713450|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713451|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
154713452|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713453|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713454|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154713455|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
154713456|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713457|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713458|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154713459|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154713460|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154713461|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154713462|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713463|NCT02024152|Cetirizine|cetirizine|mesh-list
154713464|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154713465|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154713466|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154713467|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
154713468|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
154713469|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154713470|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713471|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713472|NCT01989585|Trametinib|trametinib|mesh-list
154713473|NCT01989585|Dabrafenib|dabrafenib|mesh-list
154713474|NCT01989585|Navitoclax|navitoclax|mesh-list
154713475|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713476|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154713477|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713478|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713479|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154713480|NCT01896999|Nivolumab|nivolumab|mesh-list
154713481|NCT01896999|Ipilimumab|ipilimumab|mesh-list
154713482|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154713483|NCT01896999|Antibodies|antibodies|mesh-list
154713484|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
154713485|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154713486|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
154713487|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
154713488|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713489|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713490|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713491|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713492|NCT01896999|Immunotoxins|immunotoxins|mesh-ancestor
154713493|NCT01858896|Glucagon|glucagon|mesh-list
154713494|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154713495|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154713496|NCT01858896|Hormones|hormones|mesh-ancestor
154713497|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713498|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713499|NCT01858896|Incretins|incretins|mesh-ancestor
154713500|NCT01849146|Temozolomide|temozolomide|mesh-list
154713501|NCT01849146|Adavosertib|adavosertib|mesh-list
154713502|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154713503|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
154713504|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713505|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713506|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713507|NCT01783587|Docetaxel|docetaxel|mesh-list
154713508|NCT01783587|Afatinib|afatinib|mesh-list
154713509|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713510|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
154713511|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
154713512|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
154713513|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713514|NCT01783587|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154713515|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154713516|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713517|NCT01712763|Leuprolide|leuprolide|mesh-list
154713518|NCT01712763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154713519|NCT01712763|Fertility Agents|fertility agents|mesh-ancestor
154713520|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154713521|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713522|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154713523|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713524|NCT01585805|Cisplatin|cisplatin|mesh-list
154713525|NCT01585805|Gemcitabine|gemcitabine|mesh-list
154713526|NCT01585805|Veliparib|veliparib|mesh-list
154713527|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713528|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154713529|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
154713530|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713531|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154713532|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713533|NCT01149083|Carboplatin|carboplatin|mesh-list
154713534|NCT01149083|Veliparib|veliparib|mesh-list
154713535|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713536|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154713537|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713538|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713539|NCT00569127|Interferons|interferons|mesh-list
154713540|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
154713541|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
154713542|NCT00569127|Bevacizumab|bevacizumab|mesh-list
154713543|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154713544|NCT00569127|Octreotide|octreotide|mesh-list
154713545|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
154713546|NCT00569127|Antibodies|antibodies|mesh-list
154713547|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
154713548|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154713549|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
154713550|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713551|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154713552|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154713553|NCT00569127|Growth Substances|growth substances|mesh-ancestor
154713554|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713555|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
154713556|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
154713557|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
154713558|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154713559|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154713560|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154713561|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
154713562|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154713563|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154713564|NCT02444429|Prednisolone|prednisolone|mesh-list
154713565|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
154713566|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154713567|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
154713568|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154713569|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
154713570|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
154713571|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713572|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713573|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154713574|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
154713575|NCT02444429|Hormones|hormones|mesh-ancestor
154713576|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713577|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154713578|NCT02444429|Protective Agents|protective agents|mesh-ancestor
154713579|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154713580|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713581|NCT02318342|Warfarin|warfarin|mesh-list
154713582|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
154713583|NCT02134184|Vaccines|vaccines|mesh-list
154713584|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
154713585|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713586|NCT02029846|Metformin|metformin|mesh-list
154713587|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154713588|NCT02029846|Incretins|incretins|mesh-list
154713589|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154713590|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713591|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
154713592|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713593|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713594|NCT02029846|Hormones|hormones|mesh-ancestor
154713595|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713596|NCT06018597|Sevoflurane|sevoflurane|mesh-list
154713597|NCT06018597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154713598|NCT06018597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154713599|NCT06018597|Anesthetics, General|anesthetics, general|mesh-ancestor
154713600|NCT06018597|Anesthetics|anesthetics|mesh-ancestor
154713601|NCT06018597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713602|NCT06018597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713603|NCT06018207|Midazolam|midazolam|mesh-list
154713604|NCT06018207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154713605|NCT06018207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154713606|NCT06018207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713607|NCT06018207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713608|NCT06018207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154713609|NCT06018207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154713610|NCT06018207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154713611|NCT06018207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154713612|NCT06018207|Anesthetics, General|anesthetics, general|mesh-ancestor
154713613|NCT06018207|Anesthetics|anesthetics|mesh-ancestor
154713614|NCT06018207|GABA Modulators|gaba modulators|mesh-ancestor
154713615|NCT06018207|GABA Agents|gaba agents|mesh-ancestor
154713616|NCT06018207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154713617|NCT06018207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713618|NCT06017726|Insulin|insulin|mesh-list
154713619|NCT06017726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154713620|NCT06017726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713621|NCT06017167|Dexamethasone|dexamethasone|mesh-list
154713622|NCT06017167|Dexamethasone acetate|dexamethasone acetate|mesh-list
154713623|NCT06017167|Dexmedetomidine|dexmedetomidine|mesh-list
154713624|NCT06017167|Ondansetron|ondansetron|mesh-list
154713625|NCT06017167|BB 1101|bb 1101|mesh-list
154713626|NCT06017167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154713627|NCT06017167|Antiemetics|antiemetics|mesh-ancestor
154713628|NCT06017167|Autonomic Agents|autonomic agents|mesh-ancestor
154713629|NCT06017167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713630|NCT06017167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968478|NCT02595541|Urological Agents|urological agents|mesh-ancestor
154713631|NCT06017167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154713632|NCT06017167|Glucocorticoids|glucocorticoids|mesh-ancestor
154713633|NCT06017167|Hormones|hormones|mesh-ancestor
154713634|NCT06017167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713635|NCT06017167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154713636|NCT06017167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713637|NCT06017167|Protease Inhibitors|protease inhibitors|mesh-ancestor
154713638|NCT06017167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713639|NCT06017167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713640|NCT06017167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154713641|NCT06017167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713642|NCT06017167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154713643|NCT06017167|Analgesics|analgesics|mesh-ancestor
154713644|NCT06017167|Sensory System Agents|sensory system agents|mesh-ancestor
154713645|NCT06017167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154713646|NCT06017167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154713647|NCT06017167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154713648|NCT06017167|Adrenergic Agents|adrenergic agents|mesh-ancestor
154713649|NCT06017167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154713650|NCT06017167|Antipruritics|antipruritics|mesh-ancestor
154713651|NCT06017167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154713652|NCT06017167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154713653|NCT06017167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154713654|NCT06017167|Serotonin Agents|serotonin agents|mesh-ancestor
154713655|NCT06017141|Fentanyl|fentanyl|mesh-list
154713656|NCT06017141|Propofol|propofol|mesh-list
154713657|NCT06017141|Sevoflurane|sevoflurane|mesh-list
154713658|NCT06017141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154713659|NCT06017141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713660|NCT06017141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713661|NCT06017141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154713662|NCT06017141|Anesthetics, General|anesthetics, general|mesh-ancestor
154713663|NCT06017141|Anesthetics|anesthetics|mesh-ancestor
154713664|NCT06017141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154713665|NCT06017141|Narcotics|narcotics|mesh-ancestor
154713666|NCT06017141|Analgesics|analgesics|mesh-ancestor
154713667|NCT06017141|Sensory System Agents|sensory system agents|mesh-ancestor
154713668|NCT06017141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713669|NCT06017141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154713670|NCT06017141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154713671|NCT06017141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154713672|NCT06017037|Citalopram|citalopram|mesh-list
154713673|NCT06017037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154713674|NCT06017037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154713675|NCT06017037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154713676|NCT06017037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713678|NCT06017037|Serotonin Agents|serotonin agents|mesh-ancestor
154713679|NCT06017037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713680|NCT06017037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154713681|NCT06017037|Antidepressive Agents|antidepressive agents|mesh-ancestor
154713682|NCT06017037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154713683|NCT06011330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154713684|NCT06011330|Antibodies|antibodies|mesh-list
154713685|NCT06011330|Immunologic Factors|immunologic factors|mesh-ancestor
154713686|NCT06011330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713687|NCT06011330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713688|NCT06011330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713689|NCT06011330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713690|NCT06007391|Niacinamide|niacinamide|mesh-list
154713691|NCT06007391|Niacin|niacin|mesh-list
154713692|NCT06007391|Nicotinic Acids|nicotinic acids|mesh-list
154713693|NCT06007391|Vitamin B Complex|vitamin b complex|mesh-ancestor
154713694|NCT06007391|Vitamins|vitamins|mesh-ancestor
154713695|NCT06007391|Micronutrients|micronutrients|mesh-ancestor
154713696|NCT06007391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713697|NCT06007391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154713698|NCT06007391|Antimetabolites|antimetabolites|mesh-ancestor
154713699|NCT06007391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713700|NCT06007391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154713701|NCT06007391|Vasodilator Agents|vasodilator agents|mesh-ancestor
154713702|NCT05997563|Progesterone|progesterone|mesh-list
154713703|NCT05997563|Progestins|progestins|mesh-ancestor
154713704|NCT05997563|Hormones|hormones|mesh-ancestor
154713705|NCT05997563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713706|NCT05997563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713707|NCT05980572|Triamcinolone|triamcinolone|mesh-list
154713708|NCT05980572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154713709|NCT05980572|Aceclofenac|aceclofenac|mesh-list
154713710|NCT05980572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154713711|NCT05980572|Glucocorticoids|glucocorticoids|mesh-ancestor
154713712|NCT05980572|Hormones|hormones|mesh-ancestor
154713713|NCT05980572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713714|NCT05980572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713715|NCT05980572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154713716|NCT05980572|Analgesics|analgesics|mesh-ancestor
154713717|NCT05980572|Sensory System Agents|sensory system agents|mesh-ancestor
154713718|NCT05980572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713719|NCT05980572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713720|NCT05936606|Clopidogrel|clopidogrel|mesh-list
154713721|NCT05936606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154713722|NCT05936606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154713723|NCT05936606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154713724|NCT05936606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154713725|NCT05936606|Purinergic Agents|purinergic agents|mesh-ancestor
154713726|NCT05936606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154713727|NCT05936606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713728|NCT05936606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713729|NCT05936086|Cyclosporine|cyclosporine|mesh-list
154713730|NCT05936086|Dexamethasone|dexamethasone|mesh-list
154713731|NCT05936086|Etoposide|etoposide|mesh-list
154713732|NCT05936086|Cyclophosphamide|cyclophosphamide|mesh-list
154713733|NCT05936086|Cyclosporins|cyclosporins|mesh-list
154713734|NCT05936086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154713735|NCT05936086|Antiemetics|antiemetics|mesh-ancestor
154713736|NCT05936086|Autonomic Agents|autonomic agents|mesh-ancestor
154713737|NCT05936086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713738|NCT05936086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713739|NCT05936086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154713740|NCT05936086|Glucocorticoids|glucocorticoids|mesh-ancestor
154713741|NCT05936086|Hormones|hormones|mesh-ancestor
154713742|NCT05936086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713743|NCT05936086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154713744|NCT05936086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713745|NCT05936086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154713746|NCT05936086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154713747|NCT05936086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154713748|NCT05936086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713749|NCT05936086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713750|NCT05936086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713751|NCT05936086|Immunologic Factors|immunologic factors|mesh-ancestor
154713752|NCT05936086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713753|NCT05936086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154713754|NCT05936086|Alkylating Agents|alkylating agents|mesh-ancestor
154713755|NCT05936086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154713756|NCT05936086|Antifungal Agents|antifungal agents|mesh-ancestor
154713757|NCT05936086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154713758|NCT05936086|Dermatologic Agents|dermatologic agents|mesh-ancestor
154713759|NCT05936086|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154713760|NCT05932511|Ascorbic Acid|ascorbic acid|mesh-list
154713761|NCT05932511|Antioxidants|antioxidants|mesh-ancestor
154713762|NCT05932511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713763|NCT05932511|Protective Agents|protective agents|mesh-ancestor
154713764|NCT05932511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713765|NCT05932511|Vitamins|vitamins|mesh-ancestor
154713766|NCT05932511|Micronutrients|micronutrients|mesh-ancestor
154713767|NCT05882903|Betamethasone|betamethasone|mesh-list
154713768|NCT05882903|Betamethasone Valerate|betamethasone valerate|mesh-list
154713769|NCT05882903|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154713770|NCT05882903|Betamethasone benzoate|betamethasone benzoate|mesh-list
154713771|NCT05882903|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154713772|NCT05882903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154713773|NCT05882903|Glucocorticoids|glucocorticoids|mesh-ancestor
154713774|NCT05882903|Hormones|hormones|mesh-ancestor
154713775|NCT05882903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713776|NCT05882903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713777|NCT05882903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154713778|NCT05882903|Respiratory System Agents|respiratory system agents|mesh-ancestor
154713779|NCT05872451|Bromides|bromides|mesh-list
154713780|NCT05872451|Rocuronium|rocuronium|mesh-list
154713781|NCT05872451|Anticonvulsants|anticonvulsants|mesh-ancestor
154713782|NCT05872451|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154713783|NCT05872451|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154713784|NCT05872451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154713785|NCT05872451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713786|NCT05872451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713787|NCT05861921|Lithium Carbonate|lithium carbonate|mesh-list
154713788|NCT05861921|Antidepressive Agents|antidepressive agents|mesh-ancestor
154713789|NCT05861921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154713790|NCT05861921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713791|NCT05861921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713792|NCT05861921|Antimanic Agents|antimanic agents|mesh-ancestor
154713793|NCT05861921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154713794|NCT05861921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713795|NCT05861921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713796|NCT05854498|Bevacizumab|bevacizumab|mesh-list
154713797|NCT05854498|Irinotecan|irinotecan|mesh-list
154713798|NCT05854498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713799|NCT05854498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713800|NCT05854498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154713801|NCT05854498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154713802|NCT05854498|Growth Substances|growth substances|mesh-ancestor
154713803|NCT05854498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713804|NCT05854498|Growth Inhibitors|growth inhibitors|mesh-ancestor
154713805|NCT05854498|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154713806|NCT05854498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154713807|NCT05854498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713808|NCT05854498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713809|NCT05841472|Carboplatin|carboplatin|mesh-list
154713810|NCT05841472|Pemetrexed|pemetrexed|mesh-list
154713811|NCT05841472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713812|NCT05841472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713813|NCT05841472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713814|NCT05841472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154713815|NCT05841472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154713816|NCT05831449|Ropivacaine|ropivacaine|mesh-list
154713817|NCT05831449|Anesthetics, Local|anesthetics, local|mesh-list
154713818|NCT05831449|Anesthetics|anesthetics|mesh-list
154713819|NCT05831449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713820|NCT05831449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713821|NCT05831449|Sensory System Agents|sensory system agents|mesh-ancestor
154713822|NCT05831449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465787|NCT03793114|Hormones|hormones|mesh-ancestor
154713823|NCT05821725|Hyaluronic Acid|hyaluronic acid|mesh-list
154713824|NCT05821725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154713825|NCT05821725|Immunologic Factors|immunologic factors|mesh-ancestor
154713826|NCT05821725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713827|NCT05821725|Viscosupplements|viscosupplements|mesh-ancestor
154713828|NCT05821725|Protective Agents|protective agents|mesh-ancestor
154713829|NCT05810233|Ascorbic Acid|ascorbic acid|mesh-list
154713830|NCT05810233|Vitamins|vitamins|mesh-ancestor
154713831|NCT05810233|Micronutrients|micronutrients|mesh-ancestor
154713832|NCT05810233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713833|NCT05810233|Antioxidants|antioxidants|mesh-ancestor
154713834|NCT05810233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713835|NCT05810233|Protective Agents|protective agents|mesh-ancestor
154713836|NCT05805891|Bortezomib|bortezomib|mesh-list
154713837|NCT05805891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713838|NCT06133764|Ethanol|ethanol|mesh-list
154713839|NCT06133764|Acetic Acid|acetic acid|mesh-list
154713840|NCT06133764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154713841|NCT06133764|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154713842|NCT06133764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154713843|NCT06133764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713844|NCT06133764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713845|NCT06133764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154713846|NCT06133686|Tenofovir|tenofovir|mesh-list
154713847|NCT06133686|Emtricitabine|emtricitabine|mesh-list
154713848|NCT06133686|Cabotegravir|cabotegravir|mesh-list
154713849|NCT06133686|Antiviral Agents|antiviral agents|mesh-ancestor
154713850|NCT06133686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154713851|NCT06133686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154713852|NCT06133686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154713853|NCT06133686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713854|NCT06133686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713855|NCT06133686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154713856|NCT06133686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154713857|NCT06133686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154713858|NCT06133686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154713859|NCT06133231|Micronutrients|micronutrients|mesh-list
154713860|NCT06133231|Trace Elements|trace elements|mesh-list
154713861|NCT06133231|Antioxidants|antioxidants|mesh-list
154713862|NCT06133231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713863|NCT06133231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713864|NCT06133231|Protective Agents|protective agents|mesh-ancestor
154713865|NCT06133088|Gossypol acetic acid|gossypol acetic acid|mesh-list
154713866|NCT06133088|Gossypol|gossypol|mesh-list
154713867|NCT06133088|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154713868|NCT06133088|Contraceptive Agents|contraceptive agents|mesh-ancestor
154713869|NCT06133088|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153968705|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154713870|NCT06133088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713871|NCT06133088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154713872|NCT06133088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713873|NCT06133088|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154713874|NCT06133088|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154713875|NCT06133088|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154713876|NCT06133049|Ozanimod|ozanimod|mesh-list
154713877|NCT06133049|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154713878|NCT06133049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713879|NCT06133049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154713880|NCT06133049|Immunologic Factors|immunologic factors|mesh-ancestor
154713881|NCT06133049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713882|NCT06132945|Nivolumab|nivolumab|mesh-list
154713883|NCT06132945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713884|NCT06132945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713885|NCT06132945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713886|NCT06132945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713887|NCT06132815|Astringents|astringents|mesh-list
154713888|NCT06132815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713889|NCT06132815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154713890|NCT06132451|Antihypertensive Agents|antihypertensive agents|mesh-list
154713891|NCT06132308|Bupivacaine|bupivacaine|mesh-list
154713892|NCT06132308|Anesthetics, Local|anesthetics, local|mesh-ancestor
154713893|NCT06132308|Anesthetics|anesthetics|mesh-ancestor
154713894|NCT06132308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713895|NCT06132308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713896|NCT06132308|Sensory System Agents|sensory system agents|mesh-ancestor
154713897|NCT06132308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713898|NCT06132191|Cemiplimab|cemiplimab|mesh-list
154713899|NCT06132191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713900|NCT06132191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713901|NCT06132035|Aflibercept|aflibercept|mesh-list
154713902|NCT06132035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154713903|NCT06132035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154713904|NCT06132035|Growth Substances|growth substances|mesh-ancestor
154713905|NCT06132035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713906|NCT06132035|Growth Inhibitors|growth inhibitors|mesh-ancestor
154713907|NCT06132035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713908|NCT06129188|Propofol|propofol|mesh-list
154713909|NCT06129188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154713910|NCT06129188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713911|NCT06129188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713912|NCT06129188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153968768|NCT05753722|Pembrolizumab|pembrolizumab|mesh-list
154713913|NCT06129188|Anesthetics, General|anesthetics, general|mesh-ancestor
154713914|NCT06129188|Anesthetics|anesthetics|mesh-ancestor
154713915|NCT06039774|Chitosan|chitosan|mesh-list
154713916|NCT06039774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154713917|NCT06039774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154713918|NCT06039774|Antimetabolites|antimetabolites|mesh-ancestor
154713919|NCT06039774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713920|NCT06039774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154713921|NCT06039774|Chelating Agents|chelating agents|mesh-ancestor
154713922|NCT06039774|Sequestering Agents|sequestering agents|mesh-ancestor
154713923|NCT06039774|Hemostatics|hemostatics|mesh-ancestor
154713924|NCT06039774|Coagulants|coagulants|mesh-ancestor
154713925|NCT06037980|Paclitaxel|paclitaxel|mesh-list
154713926|NCT06037980|Gemcitabine|gemcitabine|mesh-list
154713927|NCT06037980|Capecitabine|capecitabine|mesh-list
154713928|NCT06037980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154713929|NCT06037980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713930|NCT06037980|Tubulin Modulators|tubulin modulators|mesh-ancestor
154713931|NCT06037980|Antimitotic Agents|antimitotic agents|mesh-ancestor
154713932|NCT06037980|Mitosis Modulators|mitosis modulators|mesh-ancestor
154713933|NCT06037980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713934|NCT06037980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154713935|NCT06037980|Antimetabolites|antimetabolites|mesh-ancestor
154713936|NCT06023602|Cetrorelix|cetrorelix|mesh-list
154713937|NCT06023602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154713938|NCT06023602|Fertility Agents|fertility agents|mesh-ancestor
154713939|NCT06023602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154713940|NCT06023602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713941|NCT06023602|Hormone Antagonists|hormone antagonists|mesh-ancestor
154713942|NCT06023602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154713943|NCT06006286|Bevacizumab|bevacizumab|mesh-list
154713944|NCT06006286|Atezolizumab|atezolizumab|mesh-list
154713945|NCT06006286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713946|NCT06006286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713947|NCT06006286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154713948|NCT06006286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154713949|NCT06006286|Growth Substances|growth substances|mesh-ancestor
154713950|NCT06006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713951|NCT06006286|Growth Inhibitors|growth inhibitors|mesh-ancestor
154713952|NCT06006286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154713953|NCT06006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713954|NCT06004115|Lorazepam|lorazepam|mesh-list
154713955|NCT06004115|Anticonvulsants|anticonvulsants|mesh-ancestor
154713956|NCT06004115|Antiemetics|antiemetics|mesh-ancestor
154713957|NCT06004115|Autonomic Agents|autonomic agents|mesh-ancestor
154713958|NCT06004115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713959|NCT06004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713960|NCT06004115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154713961|NCT06004115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154713962|NCT06004115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154713963|NCT06004115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154713964|NCT06004115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154713965|NCT06004115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154713966|NCT06004115|GABA Modulators|gaba modulators|mesh-ancestor
154713967|NCT06004115|GABA Agents|gaba agents|mesh-ancestor
154713968|NCT06004115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154713969|NCT06004115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713970|NCT05968690|Propranolol|propranolol|mesh-list
154713971|NCT05968690|Naltrexone|naltrexone|mesh-list
154713972|NCT05968690|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154465935|NCT03571321|Methotrexate|methotrexate|mesh-list
154713973|NCT05968690|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154713974|NCT05968690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713975|NCT05968690|Sensory System Agents|sensory system agents|mesh-ancestor
154713976|NCT05968690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154713977|NCT05968690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154713978|NCT05968690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154713979|NCT05968690|Adrenergic Agents|adrenergic agents|mesh-ancestor
154713980|NCT05968690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154713981|NCT05968690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713982|NCT05968690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154713983|NCT05968690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154713984|NCT05968690|Vasodilator Agents|vasodilator agents|mesh-ancestor
154713985|NCT05963048|Rituximab|rituximab|mesh-list
154713986|NCT05963048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713987|NCT05963048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713988|NCT05963048|Immunologic Factors|immunologic factors|mesh-ancestor
154713989|NCT05963048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154713990|NCT05963048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154713991|NCT05935579|Durvalumab|durvalumab|mesh-list
154713992|NCT05935579|Lenvatinib|lenvatinib|mesh-list
154713993|NCT05935579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154713994|NCT05935579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154713995|NCT05935579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154713996|NCT05935579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154713997|NCT05935579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154713998|NCT05839470|Leucovorin|leucovorin|mesh-list
154713999|NCT05839470|Oxaliplatin|oxaliplatin|mesh-list
154714000|NCT05839470|Irinotecan|irinotecan|mesh-list
154714001|NCT05839470|Levoleucovorin|levoleucovorin|mesh-list
154714002|NCT05839470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714003|NCT05839470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154714004|NCT05839470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714005|NCT05839470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714006|NCT05839470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714007|NCT05839470|Antidotes|antidotes|mesh-ancestor
154714008|NCT05839470|Protective Agents|protective agents|mesh-ancestor
154714009|NCT05839470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714010|NCT05839470|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714011|NCT05839470|Vitamins|vitamins|mesh-ancestor
154714012|NCT05839470|Micronutrients|micronutrients|mesh-ancestor
154714013|NCT05767749|Lidocaine|lidocaine|mesh-list
154714014|NCT05767749|Epinephrine|epinephrine|mesh-list
154714015|NCT05767749|Racepinephrine|racepinephrine|mesh-list
154714016|NCT05767749|Bupivacaine|bupivacaine|mesh-list
154714017|NCT05767749|Ropivacaine|ropivacaine|mesh-list
154714018|NCT05767749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154714019|NCT05767749|Epinephryl borate|epinephryl borate|mesh-list
154714020|NCT05767749|Anesthetics, Local|anesthetics, local|mesh-ancestor
154714021|NCT05767749|Anesthetics|anesthetics|mesh-ancestor
154714022|NCT05767749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154714023|NCT05767749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714024|NCT05767749|Sensory System Agents|sensory system agents|mesh-ancestor
154714025|NCT05767749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154714026|NCT05767749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154714027|NCT05767749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154714028|NCT05767749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154714029|NCT05767749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154714030|NCT05767749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714031|NCT05767749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154714032|NCT05767749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154714033|NCT05767749|Adrenergic Agents|adrenergic agents|mesh-ancestor
154714034|NCT05767749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154714035|NCT05767749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154714036|NCT05767749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154714037|NCT05767749|Autonomic Agents|autonomic agents|mesh-ancestor
154714038|NCT05767749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154714039|NCT05767749|Respiratory System Agents|respiratory system agents|mesh-ancestor
154714040|NCT05767749|Mydriatics|mydriatics|mesh-ancestor
154714041|NCT05767749|Sympathomimetics|sympathomimetics|mesh-ancestor
154714042|NCT05767749|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154714043|NCT05725837|Paroxetine|paroxetine|mesh-list
154714044|NCT05725837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154714045|NCT05725837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154714046|NCT05725837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154714047|NCT05725837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714048|NCT05725837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154714049|NCT05725837|Serotonin Agents|serotonin agents|mesh-ancestor
154714050|NCT05725837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714051|NCT05725837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154714052|NCT05725837|Antidepressive Agents|antidepressive agents|mesh-ancestor
154714053|NCT05725837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154714054|NCT05725837|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154714055|NCT05725837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154714056|NCT05725837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714057|NCT05716516|Estradiol|estradiol|mesh-list
154714058|NCT05716516|Estrogens|estrogens|mesh-ancestor
154714059|NCT05716516|Hormones|hormones|mesh-ancestor
154714060|NCT05716516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154714061|NCT05716516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714062|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154714063|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
154714064|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714065|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
154714066|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714067|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
154714068|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714069|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714070|NCT05653882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714071|NCT05653882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714072|NCT05650476|Talazoparib|talazoparib|mesh-list
154714073|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154714074|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714075|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714076|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714077|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154714078|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154714079|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154714080|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154714081|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154714082|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714083|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154714084|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154714085|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714086|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
154714087|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154714088|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
154714089|NCT05577000|Fludarabine|fludarabine|mesh-list
154714090|NCT05577000|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154714091|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714092|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
154714093|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714094|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714095|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714096|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
154714097|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714098|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714099|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154714100|NCT05577000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714101|NCT05543629|Paclitaxel|paclitaxel|mesh-list
154714102|NCT05543629|Docetaxel|docetaxel|mesh-list
154714103|NCT05543629|Carboplatin|carboplatin|mesh-list
154714104|NCT05543629|Nivolumab|nivolumab|mesh-list
154714105|NCT05543629|Taxane|taxane|mesh-list
154714106|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714107|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714108|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714109|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714110|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714111|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714112|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714113|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714114|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
154714115|NCT05517265|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154714116|NCT05517265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714117|NCT05517265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714118|NCT05517265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714119|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714120|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
154714121|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
154714122|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
154714123|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154714124|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154714125|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
154714126|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
154714127|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154714128|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714129|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714130|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154714131|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
154714132|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154714133|NCT05466578|Abrocitinib|abrocitinib|mesh-list
154714134|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714135|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714136|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714137|NCT05458102|Voriconazole|voriconazole|mesh-list
154714138|NCT05458102|Cobicistat|cobicistat|mesh-list
154714139|NCT05458102|Rifabutin|rifabutin|mesh-list
154714140|NCT05458102|Vesatolimod|vesatolimod|mesh-list
154714141|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
154714142|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714143|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154714144|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154714145|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714146|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714147|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154714148|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
154714149|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154714150|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714151|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154714152|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154714153|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154714154|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
154714155|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154714156|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154714157|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
154714158|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
154714159|NCT05431413|Fluoxetine|fluoxetine|mesh-list
154714160|NCT05431413|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154714161|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154714162|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154714163|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714164|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154714165|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
154714166|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714167|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154714168|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
154714169|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154714170|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154714171|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154714172|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714173|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154714174|NCT05431413|Protective Agents|protective agents|mesh-ancestor
154714175|NCT05395507|Interferons|interferons|mesh-list
154714176|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
154714177|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
154714178|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154714179|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714180|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
154714181|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714182|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
154714183|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714184|NCT05337566|Azithromycin|azithromycin|mesh-list
154714185|NCT05337566|Cefuroxime|cefuroxime|mesh-list
154714186|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
154714187|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154714188|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714189|NCT05279417|Methotrexate|methotrexate|mesh-list
154714190|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154714191|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
154714192|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154714193|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714194|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714195|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
154714196|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714197|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466170|NCT02807805|Niclosamide|niclosamide|mesh-list
154714198|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
154714199|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714200|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154714201|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714202|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
154714203|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714204|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154714205|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
154714206|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154714207|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154714208|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714209|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154714210|NCT05215158|Analgesics|analgesics|mesh-ancestor
154714211|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
154714212|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154714213|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154714214|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154714215|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154714216|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
154714217|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154714218|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714219|NCT05168813|Vaccines|vaccines|mesh-list
154714220|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
154714221|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714222|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
154714223|NCT05165225|Docetaxel|docetaxel|mesh-list
154714224|NCT05165225|Epirubicin|epirubicin|mesh-list
154714225|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714226|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
154714227|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714228|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714229|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714230|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
154714231|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714232|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714233|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154714234|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714235|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714236|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714237|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154714238|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154714239|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714240|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714241|NCT05145400|Dexamethasone|dexamethasone|mesh-list
154714242|NCT05145400|Lenalidomide|lenalidomide|mesh-list
154714243|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154714244|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
154714245|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
154714246|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154714247|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714248|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154714249|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
154714250|NCT05145400|Hormones|hormones|mesh-ancestor
154714251|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154714252|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154714253|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714254|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
154714255|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154714256|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154714257|NCT05145400|Growth Substances|growth substances|mesh-ancestor
154714258|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
154714259|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154714260|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714261|NCT05142709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714262|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714263|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
154714264|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154714265|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
154714266|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154714267|NCT05114941|Antibodies|antibodies|mesh-list
154714268|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
154714269|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154714270|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
154714271|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714272|NCT05012371|Everolimus|everolimus|mesh-list
154466235|NCT02486133|Ritonavir|ritonavir|mesh-list
154714273|NCT05012371|Lenvatinib|lenvatinib|mesh-list
154714274|NCT05012371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154714275|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714276|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714277|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714278|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714279|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
154714280|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714281|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714282|NCT05002816|Elotuzumab|elotuzumab|mesh-list
154714283|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714284|NCT04999332|Leucovorin|leucovorin|mesh-list
154714285|NCT04999332|Docetaxel|docetaxel|mesh-list
154714286|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
154714287|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
154714288|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714289|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714290|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714291|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714292|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714293|NCT04999332|Antidotes|antidotes|mesh-ancestor
154714294|NCT04999332|Protective Agents|protective agents|mesh-ancestor
154714295|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714296|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714297|NCT04999332|Vitamins|vitamins|mesh-ancestor
154714298|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
154714299|NCT04944992|Semaglutide|semaglutide|mesh-list
154714300|NCT04944992|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154714301|NCT04944992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154714302|NCT04944992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714303|NCT04874194|Venetoclax|venetoclax|mesh-list
154714304|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
154714305|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714306|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714307|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154714308|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714309|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714310|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
154714311|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714312|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714313|NCT04862455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714314|NCT04862455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714315|NCT04837209|Niraparib|niraparib|mesh-list
154714316|NCT04837209|Dostarlimab|dostarlimab|mesh-list
154714317|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153969155|NCT01999569|Letrozole|letrozole|mesh-list
154714318|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714319|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714320|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714321|NCT04797767|Cytarabine|cytarabine|mesh-list
154714322|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154714323|NCT04797767|Venetoclax|venetoclax|mesh-list
154714324|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
154714325|NCT04797767|Cladribine|cladribine|mesh-list
154714326|NCT04797767|Lenograstim|lenograstim|mesh-list
154714327|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714328|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
154714329|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714330|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714331|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
154714332|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714333|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714334|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
154714335|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714336|NCT04797767|Analgesics|analgesics|mesh-ancestor
154714337|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
154714338|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154714339|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154714340|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714341|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714342|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154714343|NCT04752163|Leucovorin|leucovorin|mesh-list
154714344|NCT04752163|Cytarabine|cytarabine|mesh-list
154714345|NCT04752163|Voriconazole|voriconazole|mesh-list
154714346|NCT04752163|Posaconazole|posaconazole|mesh-list
154714347|NCT04752163|Dexamethasone|dexamethasone|mesh-list
154714348|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
154714349|NCT04752163|Prednisone|prednisone|mesh-list
154466315|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
154714350|NCT04752163|Cortisone|cortisone|mesh-list
154714352|NCT04752163|Rituximab|rituximab|mesh-list
154714353|NCT04752163|Methotrexate|methotrexate|mesh-list
154714354|NCT04752163|Vincristine|vincristine|mesh-list
154714355|NCT04752163|Azacitidine|azacitidine|mesh-list
154714356|NCT04752163|Venetoclax|venetoclax|mesh-list
154714357|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154714358|NCT04752163|Antibodies|antibodies|mesh-list
154714359|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
154714360|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154714361|NCT04752163|Lenograstim|lenograstim|mesh-list
154714362|NCT04752163|BB 1101|bb 1101|mesh-list
154714363|NCT04752163|Mesna|mesna|mesh-list
154714364|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714365|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
154714366|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714367|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714368|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714369|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
154714370|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714371|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714372|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154714373|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154714374|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
154714375|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
154714376|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154714377|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154714378|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
154714379|NCT04752163|Hormones|hormones|mesh-ancestor
154714380|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154714381|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154714382|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
154714383|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714384|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154714385|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
154714386|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154714387|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714388|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
154714389|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
154714390|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154714391|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154714392|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
154714393|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714394|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154714395|NCT04752163|Antidotes|antidotes|mesh-ancestor
154714396|NCT04752163|Protective Agents|protective agents|mesh-ancestor
154714397|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714398|NCT04752163|Vitamins|vitamins|mesh-ancestor
154714399|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
154714400|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714401|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714402|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714403|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714404|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
154714405|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154714406|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154714407|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154714408|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
154714409|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154714410|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154714411|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154714412|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154714413|NCT04732598|Paclitaxel|paclitaxel|mesh-list
154714414|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154714415|NCT04732598|Bevacizumab|bevacizumab|mesh-list
154714416|NCT04732598|Atezolizumab|atezolizumab|mesh-list
154714417|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714418|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714419|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714420|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714421|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714422|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714423|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714424|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154714425|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154714426|NCT04732598|Growth Substances|growth substances|mesh-ancestor
154714427|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714428|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
154714429|NCT04732598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714430|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
154714431|NCT04539808|Leucovorin|leucovorin|mesh-list
154714432|NCT04539808|Folic Acid|folic acid|mesh-list
154714433|NCT04539808|Capecitabine|capecitabine|mesh-list
154714434|NCT04539808|Fluorouracil|fluorouracil|mesh-list
154714435|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
154714436|NCT04539808|Irinotecan|irinotecan|mesh-list
154714437|NCT04539808|Camptothecin|camptothecin|mesh-list
154714438|NCT04539808|Losartan|losartan|mesh-list
154714439|NCT04539808|Calcium|calcium|mesh-list
154714440|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
154714441|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154714442|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714443|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153969283|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714444|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714445|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
154714446|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714447|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714448|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714449|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
154714450|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154714451|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714452|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714453|NCT04539808|Antidotes|antidotes|mesh-ancestor
154714454|NCT04539808|Protective Agents|protective agents|mesh-ancestor
154714455|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714456|NCT04539808|Vitamins|vitamins|mesh-ancestor
154714457|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
154714458|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154714459|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154714460|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154714461|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154714462|NCT04539808|Hematinics|hematinics|mesh-ancestor
154714463|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714464|NCT04530487|Cyclosporine|cyclosporine|mesh-list
154714465|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
154714466|NCT04530487|Fludarabine|fludarabine|mesh-list
154714467|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
154714468|NCT04530487|Etoposide|etoposide|mesh-list
154714469|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
154714470|NCT04530487|Melphalan|melphalan|mesh-list
154714471|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
154714472|NCT04530487|Thiotepa|thiotepa|mesh-list
154714473|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
154714474|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154714475|NCT04530487|Tacrolimus|tacrolimus|mesh-list
154714476|NCT04530487|Cyclosporins|cyclosporins|mesh-list
154714477|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
154714478|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154714479|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
154714480|NCT04530487|Antibodies|antibodies|mesh-list
154714481|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
154714482|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154714483|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154714484|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714485|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714486|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
154714487|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714488|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714489|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
154714490|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714491|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714492|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154714493|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714494|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714495|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154714496|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
154714497|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714498|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
154714499|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714500|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154714501|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154714502|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
154714503|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154714504|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714505|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
154714506|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154714507|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
154714508|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714509|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714510|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714511|NCT04528680|Paclitaxel|paclitaxel|mesh-list
154714512|NCT04528680|Carboplatin|carboplatin|mesh-list
154714513|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154714514|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714515|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714516|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714517|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714518|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714519|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714520|NCT04513808|Anesthetics|anesthetics|mesh-list
154714521|NCT04513808|Propofol|propofol|mesh-list
154714522|NCT04513808|Sevoflurane|sevoflurane|mesh-list
154714523|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154714524|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714525|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154714526|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154714527|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
154714528|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154714529|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154714530|NCT04478734|Thiamine|thiamine|mesh-list
154714531|NCT04478734|Biotin|biotin|mesh-list
154714532|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714533|NCT04478734|Vitamins|vitamins|mesh-ancestor
154714534|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
154714535|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714536|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
154714537|NCT04478292|Cisplatin|cisplatin|mesh-list
154714538|NCT04478292|Carboplatin|carboplatin|mesh-list
154714539|NCT04478292|Doxorubicin|doxorubicin|mesh-list
154714540|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154714541|NCT04478292|Fluorouracil|fluorouracil|mesh-list
154714542|NCT04478292|Irinotecan|irinotecan|mesh-list
154714543|NCT04478292|Vincristine|vincristine|mesh-list
154714544|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714545|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154714546|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154714547|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714548|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714549|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714550|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
154714551|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714552|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714553|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
154714554|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714555|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154714556|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714557|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714558|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714559|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714560|NCT04478292|Antidotes|antidotes|mesh-ancestor
154714561|NCT04478292|Protective Agents|protective agents|mesh-ancestor
154714562|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
154714563|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
154714564|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154714565|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714566|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
154714567|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
154714568|NCT04464174|Carboplatin|carboplatin|mesh-list
154714569|NCT04464174|Gemcitabine|gemcitabine|mesh-list
154714570|NCT04464174|Capecitabine|capecitabine|mesh-list
154714571|NCT04464174|Ipatasertib|ipatasertib|mesh-list
154714572|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714573|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714574|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
154714575|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714576|NCT04464174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714577|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714578|NCT04459117|Acetaminophen|acetaminophen|mesh-list
154714579|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154714580|NCT04459117|Analgesics|analgesics|mesh-ancestor
154714581|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
154714582|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154714583|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714584|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
154714585|NCT04407754|Inositol|inositol|mesh-list
154714586|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714587|NCT04407754|Vitamins|vitamins|mesh-ancestor
154714588|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
154714589|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714590|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
154714591|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154714592|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154714593|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714594|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
154714595|NCT04387305|Coagulants|coagulants|mesh-ancestor
154714596|NCT04297254|Lenvatinib|lenvatinib|mesh-list
154714597|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714598|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714599|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714600|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714601|NCT04244981|Thrombin|thrombin|mesh-list
154714602|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
154714603|NCT04244981|Coagulants|coagulants|mesh-ancestor
154714604|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
154714605|NCT04198922|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154714606|NCT04198922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714607|NCT04198922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714608|NCT04198922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714609|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714610|NCT04182373|Antithrombins|antithrombins|mesh-list
154714611|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
154714612|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154714613|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
154714614|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714615|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714616|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
154714617|NCT04180085|Abatacept|abatacept|mesh-list
154714618|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714619|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714620|NCT04180085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714621|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714622|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714623|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
154714624|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714625|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714626|NCT04140305|Ozanimod|ozanimod|mesh-list
154714627|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154714628|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714629|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714630|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
154714631|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714632|NCT04133948|Nivolumab|nivolumab|mesh-list
154714633|NCT04133948|Ipilimumab|ipilimumab|mesh-list
154714634|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714635|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714636|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153969459|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154714637|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714638|NCT04068610|Bevacizumab|bevacizumab|mesh-list
154714639|NCT04068610|Durvalumab|durvalumab|mesh-list
154714640|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714641|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714642|NCT04068610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154714643|NCT04068610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154714644|NCT04068610|Growth Substances|growth substances|mesh-ancestor
154714645|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714646|NCT04068610|Growth Inhibitors|growth inhibitors|mesh-ancestor
154714647|NCT03997370|Carboplatin|carboplatin|mesh-list
154714648|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714649|NCT03961971|Spartalizumab|spartalizumab|mesh-list
154714650|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714651|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714652|NCT03961971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714653|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714654|NCT03879135|Factor VIII|factor viii|mesh-list
154714655|NCT03879135|Coagulants|coagulants|mesh-ancestor
154714656|NCT03860844|Cytarabine|cytarabine|mesh-list
154714657|NCT03860844|Dexamethasone|dexamethasone|mesh-list
154714658|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
154714659|NCT03860844|Doxorubicin|doxorubicin|mesh-list
154714660|NCT03860844|Methotrexate|methotrexate|mesh-list
154714661|NCT03860844|Fludarabine|fludarabine|mesh-list
154466604|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
154714662|NCT03860844|Etoposide|etoposide|mesh-list
154714663|NCT03860844|Vincristine|vincristine|mesh-list
154714664|NCT03860844|Daunorubicin|daunorubicin|mesh-list
154714665|NCT03860844|Asparaginase|asparaginase|mesh-list
154714666|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
154714667|NCT03860844|Idarubicin|idarubicin|mesh-list
154714668|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
154714669|NCT03860844|Pegaspargase|pegaspargase|mesh-list
154714670|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714671|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
154714672|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714673|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714674|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714675|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
154714676|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714677|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714678|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154714679|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154714680|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
154714681|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
154714682|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154714683|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154714684|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
154714685|NCT03860844|Hormones|hormones|mesh-ancestor
154714686|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154714687|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154714688|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154714689|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154714690|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714691|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714692|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154714693|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
154714694|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154714695|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714696|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
154714697|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
154714698|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154714699|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154714700|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714701|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
154714702|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714703|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
153969527|NCT02777619|Analgesics|analgesics|mesh-ancestor
154714704|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714705|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714706|NCT03860844|Analgesics|analgesics|mesh-ancestor
154714707|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
154714708|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
154714709|NCT03853304|Folic Acid|folic acid|mesh-list
154714710|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
154714711|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
154714712|NCT03853304|Vitamins|vitamins|mesh-ancestor
154714713|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
154714714|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714715|NCT03853304|Hematinics|hematinics|mesh-ancestor
154714716|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714717|NCT03787264|Venetoclax|venetoclax|mesh-list
154714718|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154714719|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
154714720|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
154714721|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714722|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714723|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
154714724|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714725|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714726|NCT03787264|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154714727|NCT03787264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714728|NCT03787264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714729|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
154714730|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714731|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714732|NCT03732950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714733|NCT03732950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714734|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
154714735|NCT03721068|Fludarabine|fludarabine|mesh-list
154714736|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714737|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
154714738|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714739|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714740|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714741|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
154714742|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714743|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714744|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154714746|NCT03691493|Letrozole|letrozole|mesh-list
154714747|NCT03691493|Fulvestrant|fulvestrant|mesh-list
154714748|NCT03691493|Palbociclib|palbociclib|mesh-list
154714749|NCT03691493|Anastrozole|anastrozole|mesh-list
154714750|NCT03691493|Exemestane|exemestane|mesh-list
154714751|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714752|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154714753|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154714754|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714755|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714756|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154714757|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
154714758|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154714759|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714760|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154714761|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154714762|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154714763|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154714764|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154714765|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714766|NCT03529422|Durvalumab|durvalumab|mesh-list
154714767|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714768|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714769|NCT03493685|Irbesartan|irbesartan|mesh-list
154714770|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154714771|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154714772|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154714773|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714774|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
154714775|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714776|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714777|NCT03486197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714778|NCT03486197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714779|NCT03370406|Fluorouracil|fluorouracil|mesh-list
154714780|NCT03370406|Imiquimod|imiquimod|mesh-list
154714781|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
154714782|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714783|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714784|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714785|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714786|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
154714787|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714788|NCT03370406|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154714789|NCT03370406|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154714790|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154714791|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
154714792|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
154714793|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714794|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714795|NCT03362060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714796|NCT03362060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714797|NCT03298984|Cytarabine|cytarabine|mesh-list
154714798|NCT03298984|Daunorubicin|daunorubicin|mesh-list
154714799|NCT03298984|Alvocidib|alvocidib|mesh-list
154714800|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714801|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
154714802|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714803|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714804|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
154714805|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714806|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714807|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
154714808|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714809|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154714810|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154714811|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714812|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714813|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
154714814|NCT03298984|Growth Substances|growth substances|mesh-ancestor
154714815|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714816|NCT03248492|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154714817|NCT03248492|Immunoconjugates|immunoconjugates|mesh-ancestor
154714818|NCT03248492|Immunologic Factors|immunologic factors|mesh-ancestor
154714819|NCT03248492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714820|NCT03219528|Rifaximin|rifaximin|mesh-list
154714821|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154714822|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154714823|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154714824|NCT03149003|Bevacizumab|bevacizumab|mesh-list
154714825|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714826|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714827|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154714828|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154714829|NCT03149003|Growth Substances|growth substances|mesh-ancestor
154714830|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714831|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
154714832|NCT03148275|Trametinib|trametinib|mesh-list
154714833|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714834|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154714835|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714836|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714837|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
154714838|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714839|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714840|NCT03089606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714841|NCT03089606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714842|NCT02993731|Paclitaxel|paclitaxel|mesh-list
154714843|NCT02993731|Gemcitabine|gemcitabine|mesh-list
154714844|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714845|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714846|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714847|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714848|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714849|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714850|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714851|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
154714852|NCT02977052|Nivolumab|nivolumab|mesh-list
154714853|NCT02977052|Ipilimumab|ipilimumab|mesh-list
154714854|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714855|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714856|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714857|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714858|NCT02934529|Leucovorin|leucovorin|mesh-list
154714859|NCT02934529|Folic Acid|folic acid|mesh-list
154714860|NCT02934529|Bevacizumab|bevacizumab|mesh-list
154714861|NCT02934529|Cetuximab|cetuximab|mesh-list
154714862|NCT02934529|Capecitabine|capecitabine|mesh-list
154714863|NCT02934529|Fluorouracil|fluorouracil|mesh-list
154714864|NCT02934529|Irinotecan|irinotecan|mesh-list
154714865|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
154714866|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714867|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714868|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154714869|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154714870|NCT02934529|Growth Substances|growth substances|mesh-ancestor
154714871|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714872|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
154714873|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714874|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
154714875|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714876|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714877|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
154714878|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154714879|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714880|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714881|NCT02934529|Antidotes|antidotes|mesh-ancestor
154714882|NCT02934529|Protective Agents|protective agents|mesh-ancestor
154714883|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714884|NCT02934529|Vitamins|vitamins|mesh-ancestor
154714885|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
154714886|NCT02934529|Hematinics|hematinics|mesh-ancestor
154714887|NCT02903368|Prednisone|prednisone|mesh-list
154714888|NCT02903368|Leuprolide|leuprolide|mesh-list
154714889|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
154714890|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154714891|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
154714893|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154714894|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714895|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154714896|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714897|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154714898|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
154714899|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154714900|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154714901|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714902|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714903|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
154714904|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154714905|NCT02841839|Fluorides|fluorides|mesh-list
154714906|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
154714907|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
154714908|NCT02841839|Protective Agents|protective agents|mesh-ancestor
154714909|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714910|NCT02826161|Paclitaxel|paclitaxel|mesh-list
154714911|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154714912|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714913|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
154714914|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
154714915|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
154714916|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714917|NCT02799901|Nivolumab|nivolumab|mesh-list
154714918|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714919|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714920|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714921|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714922|NCT02753127|Leucovorin|leucovorin|mesh-list
154714923|NCT02753127|Bevacizumab|bevacizumab|mesh-list
154714924|NCT02753127|Fluorouracil|fluorouracil|mesh-list
154714925|NCT02753127|Irinotecan|irinotecan|mesh-list
154714926|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714927|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714928|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154714929|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154714930|NCT02753127|Growth Substances|growth substances|mesh-ancestor
154714931|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714932|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
154714933|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
154714934|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714935|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714936|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714937|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
154714938|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154714939|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714940|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714941|NCT02753127|Antidotes|antidotes|mesh-ancestor
154714942|NCT02753127|Protective Agents|protective agents|mesh-ancestor
154714943|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
154714944|NCT02753127|Vitamins|vitamins|mesh-ancestor
154714945|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
154714946|NCT02746796|Capecitabine|capecitabine|mesh-list
154714947|NCT02746796|Tegafur|tegafur|mesh-list
154714948|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
154714949|NCT02746796|Nivolumab|nivolumab|mesh-list
154714950|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154714951|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
154714952|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714953|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714954|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714955|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154714956|NCT02735928|Doxorubicin|doxorubicin|mesh-list
154714957|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714958|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154714959|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154714960|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154714961|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154714962|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714963|NCT02580604|Calcium|calcium|mesh-list
154714964|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154714965|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714966|NCT02527434|Durvalumab|durvalumab|mesh-list
154714967|NCT02527434|Tremelimumab|tremelimumab|mesh-list
154714968|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154714969|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154714970|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714971|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
154714972|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714973|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
154714974|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154714975|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714976|NCT02320292|Rituximab|rituximab|mesh-list
154714977|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154714978|NCT02320292|Antibodies|antibodies|mesh-list
154714979|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
154714980|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154714981|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
154714982|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714983|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714984|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714985|NCT02315534|Temozolomide|temozolomide|mesh-list
154714986|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714987|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
154714988|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154714989|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154714990|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
154714991|NCT02278887|Fludarabine|fludarabine|mesh-list
154714992|NCT02278887|Ipilimumab|ipilimumab|mesh-list
154714993|NCT02278887|Interleukin-2|interleukin-2|mesh-list
154714994|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154714995|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
154714996|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154714997|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154714998|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154714999|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
154715000|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715001|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715002|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154715003|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715004|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715005|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715006|NCT02278887|Analgesics|analgesics|mesh-ancestor
154715007|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
154715008|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715009|NCT02231749|Nivolumab|nivolumab|mesh-list
154715010|NCT02231749|Ipilimumab|ipilimumab|mesh-list
154715011|NCT02231749|Sunitinib|sunitinib|mesh-list
154715012|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715013|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715014|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715015|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715016|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154715017|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154715018|NCT02231749|Growth Substances|growth substances|mesh-ancestor
154715019|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715020|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
154715021|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715022|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715023|NCT02188745|Letrozole|letrozole|mesh-list
154715024|NCT02188745|Anastrozole|anastrozole|mesh-list
154715025|NCT02188745|Exemestane|exemestane|mesh-list
154715026|NCT02188745|Estradiol|estradiol|mesh-list
154715027|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154715028|NCT02188745|Estrogens|estrogens|mesh-ancestor
154715029|NCT02188745|Hormones|hormones|mesh-ancestor
154715030|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715031|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715032|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715033|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154715034|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715035|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715036|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154715037|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
154715038|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154715039|NCT02024607|Leucovorin|leucovorin|mesh-list
154715040|NCT02024607|Bevacizumab|bevacizumab|mesh-list
154715041|NCT02024607|Capecitabine|capecitabine|mesh-list
154715042|NCT02024607|Fluorouracil|fluorouracil|mesh-list
154715043|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
154715044|NCT02024607|Irinotecan|irinotecan|mesh-list
154715045|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715046|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715047|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154715048|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154715049|NCT02024607|Growth Substances|growth substances|mesh-ancestor
154715050|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715051|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
154715052|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154715053|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
154715054|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715055|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715056|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
154715057|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154715058|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154715059|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715060|NCT02024607|Antidotes|antidotes|mesh-ancestor
154715061|NCT02024607|Protective Agents|protective agents|mesh-ancestor
154715062|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
154715063|NCT02024607|Vitamins|vitamins|mesh-ancestor
154715064|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
154715065|NCT01938248|Aspirin|aspirin|mesh-list
154715066|NCT01938248|Apixaban|apixaban|mesh-list
154715067|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154715068|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715069|NCT01938248|Analgesics|analgesics|mesh-ancestor
154715070|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
154715071|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715072|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715073|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154715074|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715075|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154715076|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154715077|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715078|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154715079|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154715080|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715081|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
154715082|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154715083|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
154715084|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154715085|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
154715086|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
154715087|NCT01776307|Capecitabine|capecitabine|mesh-list
154715088|NCT01776307|Cetuximab|cetuximab|mesh-list
154715089|NCT01776307|Panitumumab|panitumumab|mesh-list
154715090|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154715091|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
154715092|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715093|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715094|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715095|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
154715096|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154715097|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
154715098|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
154715099|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715100|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715101|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715102|NCT01622322|Analgesics|analgesics|mesh-ancestor
154715103|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
154715104|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715105|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154715106|NCT01325441|Paclitaxel|paclitaxel|mesh-list
154715107|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154715108|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715109|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154715110|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154715111|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154715112|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715113|NCT00742807|Alfentanil|alfentanil|mesh-list
154715114|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154715115|NCT00742807|Narcotics|narcotics|mesh-ancestor
154715116|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715117|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715118|NCT00742807|Analgesics|analgesics|mesh-ancestor
154715119|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
154467052|NCT02056782|Heparin|heparin|mesh-list
154715120|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715121|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154715122|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
154715123|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
154715124|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154715125|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
154715126|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715127|NCT05783648|Tranexamic Acid|tranexamic acid|mesh-list
154715128|NCT05783648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154715129|NCT05783648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154715130|NCT05783648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715131|NCT05783648|Hemostatics|hemostatics|mesh-ancestor
154715132|NCT05783648|Coagulants|coagulants|mesh-ancestor
154715133|NCT05739474|Vaccines|vaccines|mesh-list
154715134|NCT05739474|Immunologic Factors|immunologic factors|mesh-ancestor
154715135|NCT05739474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715136|NCT05690698|Haloperidol|haloperidol|mesh-list
154715137|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
154715138|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
154715139|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
154715140|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715141|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715142|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154715143|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154715144|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154715145|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715146|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154715147|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154715148|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
154715149|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715150|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715151|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154715152|NCT05636189|Anesthetics|anesthetics|mesh-list
154715153|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715154|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715155|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
154715156|NCT05626998|Gabapentin|gabapentin|mesh-list
154715157|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154715158|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715159|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715160|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715161|NCT05626998|Analgesics|analgesics|mesh-ancestor
154715162|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
154715163|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715164|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154715165|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154715166|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154715167|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
154715168|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715169|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715170|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
154715171|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154715172|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154715173|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154715174|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154715175|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154715176|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
154715177|NCT05582174|Esomeprazole|esomeprazole|mesh-list
154715178|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154715179|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154715180|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154715181|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715182|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715183|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
154715184|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715185|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715186|NCT05578664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715187|NCT05578664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715188|NCT05555901|Bevacizumab|bevacizumab|mesh-list
154715189|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715190|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715191|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154715192|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154715193|NCT05555901|Growth Substances|growth substances|mesh-ancestor
154467128|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
154715194|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715195|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
154715196|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
154715197|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154715198|NCT05418972|Nivolumab|nivolumab|mesh-list
154715199|NCT05418972|Relatlimab|relatlimab|mesh-list
154715200|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715201|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715202|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715203|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715204|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154715205|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
154715206|NCT05399173|Coagulants|coagulants|mesh-ancestor
154715207|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154715208|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
154715209|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715210|NCT05371899|Chiauranib|chiauranib|mesh-list
154715211|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715212|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715213|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715214|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715215|NCT05322707|Budesonide|budesonide|mesh-list
154715216|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
154715217|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154715218|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154715219|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154715220|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
154715221|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715222|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715223|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154715224|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
154715225|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
154715226|NCT05322707|Hormones|hormones|mesh-ancestor
154715227|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715228|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154715229|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154715230|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154715231|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
154715232|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715233|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715234|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
154715235|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154715236|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
154715237|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715238|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
154715239|NCT05316233|Protective Agents|protective agents|mesh-ancestor
154715240|NCT05251636|Aflibercept|aflibercept|mesh-list
154715241|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154715242|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154715243|NCT05251636|Growth Substances|growth substances|mesh-ancestor
154715244|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715245|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
154715246|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715247|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154715248|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154715249|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715250|NCT05163522|Midazolam|midazolam|mesh-list
154715251|NCT05163522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154715252|NCT05163522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154715253|NCT05163522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715254|NCT05163522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715255|NCT05163522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154715256|NCT05163522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154715257|NCT05163522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154715258|NCT05163522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154715259|NCT05163522|Anesthetics, General|anesthetics, general|mesh-ancestor
154715260|NCT05163522|Anesthetics|anesthetics|mesh-ancestor
154715261|NCT05163522|GABA Modulators|gaba modulators|mesh-ancestor
154715262|NCT05163522|GABA Agents|gaba agents|mesh-ancestor
154715263|NCT05163522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715264|NCT05163522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715265|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
154715266|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154715267|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467206|NCT05118776|Growth Substances|growth substances|mesh-ancestor
154715268|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715269|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715270|NCT05134363|Analgesics|analgesics|mesh-ancestor
154715271|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
154715272|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715273|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154715274|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154715275|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154715276|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
154715277|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715278|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715279|NCT05020899|Nicotine|nicotine|mesh-list
154715280|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154715281|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
154715282|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715283|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715284|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154715285|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154715286|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
154715287|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715288|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715289|NCT04934748|Phenylephrine|phenylephrine|mesh-list
154715290|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
154715291|NCT04934748|Norepinephrine|norepinephrine|mesh-list
154715292|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154715293|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
154715294|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
154715295|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715296|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715297|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
154715298|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154715299|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
154715300|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
154715301|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154715302|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154715303|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154715304|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
154715305|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715306|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715307|NCT04934748|Protective Agents|protective agents|mesh-ancestor
154715308|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154715309|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715310|NCT04830813|Chiauranib|chiauranib|mesh-list
154715311|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715312|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715313|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715314|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715315|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
154715316|NCT04788108|Progestins|progestins|mesh-ancestor
154715317|NCT04788108|Hormones|hormones|mesh-ancestor
154715318|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715319|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715320|NCT04741438|Nivolumab|nivolumab|mesh-list
154715321|NCT04741438|Ipilimumab|ipilimumab|mesh-list
154715322|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715323|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715324|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715325|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715326|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154715327|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154715328|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154715329|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715330|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715331|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154715332|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154715333|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715334|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
154715335|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715336|NCT04648540|Acetaminophen|acetaminophen|mesh-list
154715337|NCT04648540|Celecoxib|celecoxib|mesh-list
154715338|NCT04648540|Ketorolac|ketorolac|mesh-list
154715339|NCT04648540|Lidocaine|lidocaine|mesh-list
154715340|NCT04648540|Pregabalin|pregabalin|mesh-list
154715341|NCT04648540|Fentanyl|fentanyl|mesh-list
154715342|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
154715343|NCT04648540|Morphine|morphine|mesh-list
154715345|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
154715346|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715347|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715348|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
154715349|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715350|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154715351|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154715352|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154715353|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970176|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154715354|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715355|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154715356|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715357|NCT04648540|Analgesics|analgesics|mesh-ancestor
154715358|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154715359|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154715360|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154715361|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
154715362|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715363|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154715364|NCT04648540|Narcotics|narcotics|mesh-ancestor
154715365|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154715366|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154715367|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
154715368|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
154715369|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
154715370|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154715371|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154715372|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154715373|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154715374|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154715375|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154715376|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154715377|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715378|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154715379|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154715380|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715381|NCT04645823|Lidocaine|lidocaine|mesh-list
154715382|NCT04645823|Fentanyl|fentanyl|mesh-list
154715383|NCT04645823|Citric Acid|citric acid|mesh-list
154715384|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
154715385|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
154715386|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
154715387|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715388|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715389|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
154715390|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715391|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154715392|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154715393|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154715394|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154715395|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715396|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154715397|NCT04645823|Narcotics|narcotics|mesh-ancestor
154715398|NCT04645823|Analgesics|analgesics|mesh-ancestor
154715399|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154715400|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154715401|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
154715402|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
154715403|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154715404|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
154715405|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
154715406|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
154715407|NCT04594382|Narcotics|narcotics|mesh-ancestor
154715408|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715409|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715410|NCT04594382|Analgesics|analgesics|mesh-ancestor
154715411|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
154715412|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715413|NCT04558112|Levodopa|levodopa|mesh-list
154715414|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154715415|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154715416|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
154715417|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715418|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715419|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715420|NCT04473482|Ethanol|ethanol|mesh-list
154715421|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154715422|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715423|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715424|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715425|NCT04440735|Atezolizumab|atezolizumab|mesh-list
154715426|NCT04440735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715427|NCT04440735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715428|NCT04440735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715429|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715430|NCT04422392|Paclitaxel|paclitaxel|mesh-list
154715431|NCT04422392|Carboplatin|carboplatin|mesh-list
154715432|NCT04422392|Pemetrexed|pemetrexed|mesh-list
154715433|NCT04422392|Antibodies|antibodies|mesh-list
154715434|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154715435|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715436|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
154715437|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
154715438|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
154715439|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715440|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
154715441|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715442|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715443|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154715444|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154715445|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154715446|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
154715447|NCT04414761|Cetrorelix|cetrorelix|mesh-list
154715448|NCT04414761|Progesterone|progesterone|mesh-list
154715449|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
154715450|NCT04414761|Ganirelix|ganirelix|mesh-list
154715451|NCT04414761|Progestins|progestins|mesh-ancestor
154715452|NCT04414761|Hormones|hormones|mesh-ancestor
154715453|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715454|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715455|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154715456|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154715457|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154715458|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
154715459|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154715460|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154715461|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154715462|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154715463|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154715464|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715465|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
154715466|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154715467|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
154715468|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
154715469|NCT04318678|Rituximab|rituximab|mesh-list
154715470|NCT04318678|Fludarabine|fludarabine|mesh-list
154715471|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715472|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
154715473|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715474|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715475|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154715476|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
154715477|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715478|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715479|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154715480|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715481|NCT04307238|Anesthetics|anesthetics|mesh-list
154715482|NCT04307238|Propofol|propofol|mesh-list
154715483|NCT04307238|Sevoflurane|sevoflurane|mesh-list
154715484|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715485|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715486|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154715487|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154715488|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
154715489|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154715490|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154715491|NCT04224571|Rituximab|rituximab|mesh-list
154715492|NCT04224571|Bortezomib|bortezomib|mesh-list
154715493|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715494|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715495|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
154715496|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715497|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715498|NCT04222062|Carmustine|carmustine|mesh-list
154715499|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154715500|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
154715501|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715502|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715503|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154715504|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
154715505|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154715506|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
154715507|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154715508|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715509|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154715510|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154715511|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715512|NCT04050462|Nivolumab|nivolumab|mesh-list
154715513|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715514|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715515|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715516|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715517|NCT03934814|Rituximab|rituximab|mesh-list
154715518|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
154715519|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715520|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715521|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
154715522|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715523|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715524|NCT03934814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715525|NCT03934814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715526|NCT03919799|Belumosudil|belumosudil|mesh-list
154715527|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715528|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715529|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715530|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154715531|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154715532|NCT03691649|Timolol|timolol|mesh-list
154715533|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154715534|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154715535|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715536|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154715537|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154715538|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
154715539|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715540|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715541|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154715542|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154715543|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
154715544|NCT03655002|Nivolumab|nivolumab|mesh-list
154715545|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715546|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
154715547|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715548|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715549|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154715550|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
154715551|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715552|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715553|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154715554|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715555|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715556|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
154715557|NCT03596424|Ketamine|ketamine|mesh-list
154715558|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154715559|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715560|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715561|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715562|NCT03596424|Analgesics|analgesics|mesh-ancestor
154715563|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
154715564|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715565|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154715566|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154715567|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154715568|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
154715569|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715570|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715571|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154715572|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154715573|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
154715574|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
154715575|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154715576|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154715577|NCT03531918|Cytarabine|cytarabine|mesh-list
154715578|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154715579|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
154715580|NCT03531918|Cladribine|cladribine|mesh-list
154715581|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
154715582|NCT03531918|Calicheamicins|calicheamicins|mesh-list
154715583|NCT03531918|Lenograstim|lenograstim|mesh-list
154715584|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154715585|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
154715586|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715587|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715588|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
154715589|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715590|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715591|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
154715592|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715593|NCT03531918|Analgesics|analgesics|mesh-ancestor
154715594|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
154715595|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715596|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154715597|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154715598|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715599|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154715600|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715601|NCT03531918|Immunotoxins|immunotoxins|mesh-ancestor
154715602|NCT03531918|Immunoconjugates|immunoconjugates|mesh-ancestor
154715603|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154715604|NCT03499704|Metformin|metformin|mesh-list
154715605|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
154715606|NCT03499704|Pioglitazone|pioglitazone|mesh-list
154715607|NCT03499704|Alogliptin|alogliptin|mesh-list
154715608|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154715609|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715610|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154715611|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715612|NCT03499704|Incretins|incretins|mesh-ancestor
154715613|NCT03499704|Hormones|hormones|mesh-ancestor
154715614|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715615|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154715616|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
154715617|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715618|NCT03362515|Furosemide|furosemide|mesh-list
154715619|NCT03362515|Diuretics|diuretics|mesh-ancestor
154715620|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
154715621|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715622|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153970443|NCT02692365|Manganese|manganese|mesh-list
154715623|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154715624|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715625|NCT03292926|Dexamethasone|dexamethasone|mesh-list
154715626|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
154715627|NCT03292926|Bupivacaine|bupivacaine|mesh-list
154715628|NCT03292926|BB 1101|bb 1101|mesh-list
154715629|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154715630|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
154715631|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
154715632|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715633|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715634|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154715635|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
154715636|NCT03292926|Hormones|hormones|mesh-ancestor
154715637|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715638|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154715639|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715640|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
154715641|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715642|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715643|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
154715644|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
154715645|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715646|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
154715647|NCT03288324|Tofacitinib|tofacitinib|mesh-list
154715648|NCT03288324|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154715649|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715650|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715651|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715652|NCT03245151|Everolimus|everolimus|mesh-list
154715653|NCT03245151|Lenvatinib|lenvatinib|mesh-list
154715654|NCT03245151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154715655|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715656|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715657|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715658|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715659|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
154715660|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715661|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715662|NCT03216343|Chiauranib|chiauranib|mesh-list
154715663|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715664|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715665|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715666|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715667|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
154715668|NCT03096275|Hormones|hormones|mesh-ancestor
154715669|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715670|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715671|NCT03070223|Pitavastatin|pitavastatin|mesh-list
154715672|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154715673|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154715674|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154715675|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
154715676|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715677|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715678|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154715679|NCT03012321|Prednisone|prednisone|mesh-list
154715680|NCT03012321|Olaparib|olaparib|mesh-list
154715681|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
154715682|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154715683|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
154715684|NCT03012321|Hormones|hormones|mesh-ancestor
154715685|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715686|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715687|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154715688|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715689|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154715690|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715691|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970492|NCT03387657|Diuretics|diuretics|mesh-ancestor
154715692|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154715693|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
154715694|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154715695|NCT02985593|KHK4083|khk4083|mesh-list
154715696|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
154715697|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
154715698|NCT02858921|Trametinib|trametinib|mesh-list
154715699|NCT02858921|Dabrafenib|dabrafenib|mesh-list
154715700|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715701|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715702|NCT02858921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154715703|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715704|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715705|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715706|NCT02645149|Trametinib|trametinib|mesh-list
154715707|NCT02645149|Ceritinib|ceritinib|mesh-list
154715708|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715709|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715710|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715711|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715712|NCT02645149|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154715713|NCT02523859|Propofol|propofol|mesh-list
154715714|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154715715|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715716|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715717|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154715719|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
154715720|NCT02370329|Interferons|interferons|mesh-list
154715721|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
154715722|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
154715723|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154715724|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154715725|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715726|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
154715727|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715728|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
154715729|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715730|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
154715731|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715732|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715733|NCT02087865|Donepezil|donepezil|mesh-list
154715734|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154715735|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715736|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715737|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
154715738|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715739|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715740|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
154715741|NCT01980823|Metformin|metformin|mesh-list
154715742|NCT01980823|Atorvastatin|atorvastatin|mesh-list
154715743|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154715744|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715745|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154715746|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154715747|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
154715748|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715749|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154715750|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154715751|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715752|NCT01972347|Trametinib|trametinib|mesh-list
154715753|NCT01972347|Dabrafenib|dabrafenib|mesh-list
154715754|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715755|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715756|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715757|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715758|NCT01889992|Sirolimus|sirolimus|mesh-list
154715759|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154715760|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715761|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154715762|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715763|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
154715764|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715765|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
154715766|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715767|NCT01858740|Methotrexate|methotrexate|mesh-list
154715768|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
154715769|NCT01858740|Fludarabine|fludarabine|mesh-list
154715770|NCT01858740|Thiotepa|thiotepa|mesh-list
154715771|NCT01858740|Tacrolimus|tacrolimus|mesh-list
154715772|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154715773|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
154715774|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154715775|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715776|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154715777|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
154715778|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715779|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715780|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
154715781|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715782|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154715783|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715784|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
154715785|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715786|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154715787|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154715788|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154715789|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
154715790|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154715791|NCT01839734|Lubiprostone|lubiprostone|mesh-list
154715792|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154715793|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154715794|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715795|NCT01682083|Trametinib|trametinib|mesh-list
154715796|NCT01682083|Dabrafenib|dabrafenib|mesh-list
154715797|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715798|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715799|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715800|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715801|NCT01511068|Sargramostim|sargramostim|mesh-list
154715802|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
154715803|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715804|NCT01180790|Interferons|interferons|mesh-list
154715805|NCT01180790|Ribavirin|ribavirin|mesh-list
154715806|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
154715807|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
154715808|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154715809|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715810|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
154715811|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715812|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
154715813|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715814|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
154715815|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715816|NCT00721526|Disulfiram|disulfiram|mesh-list
154715817|NCT00721526|Lorazepam|lorazepam|mesh-list
154715818|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
154715819|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
154715820|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
154715821|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715822|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715823|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154715824|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154715825|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154715826|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154715827|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154715828|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154715829|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
154715830|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
154715831|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154715832|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715833|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154715834|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154715835|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715836|NCT00679042|Exenatide|exenatide|mesh-list
154715837|NCT00679042|Sirolimus|sirolimus|mesh-list
154715838|NCT00679042|Etanercept|etanercept|mesh-list
154715839|NCT00679042|Tacrolimus|tacrolimus|mesh-list
154715840|NCT00679042|Basiliximab|basiliximab|mesh-list
154715841|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715842|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
154715843|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715844|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154715845|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715846|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715847|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154715848|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715849|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154715850|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715851|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
154715852|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154715853|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715854|NCT00679042|Analgesics|analgesics|mesh-ancestor
154715855|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
154715856|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715857|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154715858|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715859|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154715860|NCT00679042|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154715861|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154715862|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154715863|NCT00679042|Incretins|incretins|mesh-ancestor
154715864|NCT00679042|Hormones|hormones|mesh-ancestor
154715865|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154715866|NCT00505063|Vaccines|vaccines|mesh-list
154715867|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154715868|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
154715869|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715870|NCT00350272|Tenofovir|tenofovir|mesh-list
154715872|NCT00350272|Efavirenz|efavirenz|mesh-list
154715873|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
154715874|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
154715875|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715876|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154715877|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154715878|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715879|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715880|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154715881|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154715882|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154715883|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154715884|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154715885|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154715886|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154715887|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154715888|NCT02020694|Vitamin D|vitamin d|mesh-list
154715889|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
154715890|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
154715891|NCT02020694|Vitamins|vitamins|mesh-list
154715892|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
154715893|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715894|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154715895|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154715896|NCT02019875|Clarithromycin|clarithromycin|mesh-list
154715897|NCT02019875|Rifampin|rifampin|mesh-list
154715898|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154715899|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715900|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154715901|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715902|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715903|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154715904|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154715905|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154715906|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
154715907|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
154715908|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154715909|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154715910|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154715911|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154715912|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154715913|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154715914|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154715915|NCT01907009|Melphalan|melphalan|mesh-list
154715916|NCT01907009|Lenograstim|lenograstim|mesh-list
154715917|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154715918|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
154715919|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715920|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715921|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154715922|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715923|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
154715924|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715925|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154715926|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
154715927|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715928|NCT01686126|Metformin|metformin|mesh-list
154715929|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
154715930|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154715931|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715932|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154715933|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
154715934|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154715935|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154715936|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154715937|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154715938|NCT01531582|Minocycline|minocycline|mesh-list
154715939|NCT01531582|Tetracycline|tetracycline|mesh-list
154715940|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154715941|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715942|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154715943|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715944|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715945|NCT01512888|Busulfan|busulfan|mesh-list
154715946|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
154715947|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715948|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715949|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
154715950|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715951|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154715952|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715953|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154715954|NCT01500733|Ibrutinib|ibrutinib|mesh-list
154715955|NCT01500733|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154715956|NCT01500733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154715957|NCT01500733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154715958|NCT01500733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715959|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
154715960|NCT01493453|Fludarabine|fludarabine|mesh-list
154715961|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154715962|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
154715963|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715964|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715965|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154715966|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
154715967|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154715968|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715969|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154715970|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154715971|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715972|NCT00460486|Formaldehyde|formaldehyde|mesh-list
154715973|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
154715974|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154715975|NCT00139477|Metformin|metformin|mesh-list
154715976|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153970777|NCT02803203|Bevacizumab|bevacizumab|mesh-list
154715977|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715978|NCT00004935|Trastuzumab|trastuzumab|mesh-list
154715979|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154715980|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154715981|NCT00119158|Fluticasone|fluticasone|mesh-list
154715982|NCT00119158|Xhance|xhance|mesh-list
154715983|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
154715984|NCT00119158|Tacrolimus|tacrolimus|mesh-list
154715985|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154715986|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154715987|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
154715988|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154715989|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154715990|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154715991|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
154715992|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
154715993|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154715994|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154715995|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154715996|NCT00119158|Analgesics|analgesics|mesh-ancestor
154715997|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
154715998|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154715999|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716000|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
154716001|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154716002|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716003|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716004|NCT00119392|Cyclosporine|cyclosporine|mesh-list
154716005|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
154716006|NCT00119392|Rituximab|rituximab|mesh-list
154716007|NCT00119392|Fludarabine|fludarabine|mesh-list
154716008|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
154716009|NCT00119392|Cyclosporins|cyclosporins|mesh-list
154716010|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154716011|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716012|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716013|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
154716014|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716015|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716016|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716017|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
154716018|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716019|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716020|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716021|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
154716022|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716023|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
154716024|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154716025|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154716026|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154716027|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
154716028|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716030|NCT00218062|Amphetamine|amphetamine|mesh-list
154716031|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
154716032|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153970848|NCT04301336|Narcotics|narcotics|mesh-ancestor
154716033|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716034|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154716035|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154716036|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154716037|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716038|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
154716039|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
154716040|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716041|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
154716042|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716043|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154716044|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154716045|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154716046|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716047|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154716048|NCT00121186|Methotrexate|methotrexate|mesh-list
154716049|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
154716050|NCT00121186|Fludarabine|fludarabine|mesh-list
154716051|NCT00121186|Melphalan|melphalan|mesh-list
154716052|NCT00121186|Tacrolimus|tacrolimus|mesh-list
154716053|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154716054|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
154716055|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154716056|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716057|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716058|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
154716059|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716060|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716061|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
154716062|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716063|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154716064|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716065|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
154716066|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716067|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154716068|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154716069|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154716070|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
154716071|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154716072|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
154716073|NCT00121810|Sirolimus|sirolimus|mesh-list
154716074|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154716075|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154716076|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716077|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154716078|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
154716079|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716080|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716081|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716082|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716083|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
154716084|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716085|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
154716086|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716087|NCT00053014|Cyclosporine|cyclosporine|mesh-list
154716088|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
154716089|NCT00053014|Fludarabine|fludarabine|mesh-list
154716090|NCT00053014|Cyclosporins|cyclosporins|mesh-list
154716091|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716092|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716093|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716094|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
154716095|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716096|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716097|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
154716098|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716099|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
154716100|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716101|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154716102|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154716103|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154716104|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
154716105|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716106|NCT00123604|Metoprolol|metoprolol|mesh-list
154716107|NCT00123604|Carvedilol|carvedilol|mesh-list
154716108|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154716109|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154716110|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
154716111|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
154716112|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716113|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716114|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154716115|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154716116|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154716117|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
154716118|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716119|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716120|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
154716121|NCT00123604|Protective Agents|protective agents|mesh-ancestor
154716122|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154716123|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716124|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154716125|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
154716126|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154716127|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154716128|NCT00221338|Gabapentin|gabapentin|mesh-list
154716129|NCT00221338|Analgesics|analgesics|mesh-ancestor
154716130|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
154716131|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716132|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716133|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
154716134|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154716135|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154716136|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716137|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154716138|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154716139|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154716140|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716141|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716142|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
154716143|NCT00223678|Sirolimus|sirolimus|mesh-list
154716144|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716145|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716146|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154716147|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716148|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
154716149|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716150|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
154716151|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716152|NCT00130780|Bevacizumab|bevacizumab|mesh-list
154716153|NCT00130780|Docetaxel|docetaxel|mesh-list
154716154|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716155|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716156|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154716157|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154716158|NCT00130780|Growth Substances|growth substances|mesh-ancestor
154716159|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716160|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
154716161|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
154716162|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
154716163|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
154716164|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716165|NCT00225784|Gemcitabine|gemcitabine|mesh-list
154716166|NCT00225784|Cetuximab|cetuximab|mesh-list
154716167|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716168|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
154716169|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716170|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716171|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716172|NCT02092168|Opicapone|opicapone|mesh-list
154716173|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154716174|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716175|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716176|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154716177|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154716178|NCT00133978|Selenium|selenium|mesh-list
154716179|NCT00133978|Antioxidants|antioxidants|mesh-list
154716180|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716181|NCT00133978|Protective Agents|protective agents|mesh-ancestor
154716182|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716183|NCT00133978|Trace Elements|trace elements|mesh-ancestor
154716184|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
154716185|NCT01897324|Hormones|hormones|mesh-list
154716186|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154716187|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716188|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
154716189|NCT00254410|Rituximab|rituximab|mesh-list
154716190|NCT00254410|Fludarabine|fludarabine|mesh-list
154716191|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
154716192|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716193|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
154716194|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716195|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716196|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154716197|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
154716198|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716199|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716200|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154716201|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716202|NCT00254410|Analgesics|analgesics|mesh-ancestor
154716203|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
154716204|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716205|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154716206|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154716207|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716208|NCT00254488|Valproic Acid|valproic acid|mesh-list
154716209|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154716210|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716211|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716212|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
154716213|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154716214|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716215|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716216|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
154716217|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
154716218|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716219|NCT01899118|Capecitabine|capecitabine|mesh-list
154716220|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
154716221|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
154716222|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716223|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
154716224|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716225|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716226|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716227|NCT00231868|Paclitaxel|paclitaxel|mesh-list
154716228|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154716229|NCT00231868|Carboplatin|carboplatin|mesh-list
154716230|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154716231|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716232|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
154716233|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
154716234|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
154716235|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716236|NCT00257686|Pravastatin|pravastatin|mesh-list
154716237|NCT00257686|Pitavastatin|pitavastatin|mesh-list
154716238|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154716239|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154716240|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
154716241|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716242|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154716243|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154716244|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716245|NCT01469013|Methotrexate|methotrexate|mesh-list
154716246|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154716247|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
154716248|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154716249|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716250|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716251|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
154716252|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716253|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716254|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
154716255|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716256|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154716257|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716258|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
154716259|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716260|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154716261|NCT01493427|Travoprost|travoprost|mesh-list
154716262|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154716263|NCT01523457|Folfirinox|folfirinox|mesh-list
154716264|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716265|NCT01523301|Rotigotine|rotigotine|mesh-list
154716266|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
154716267|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
154716268|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716269|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971104|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716270|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716271|NCT01766336|Inositol|inositol|mesh-list
154716272|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
154716273|NCT01766336|Vitamins|vitamins|mesh-ancestor
154716274|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
154716275|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716276|NCT01797302|Vitamin D|vitamin d|mesh-list
154716277|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
154716278|NCT01797302|Vitamins|vitamins|mesh-ancestor
154716279|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
154716280|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716281|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154716282|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154716283|NCT01804946|Oseltamivir|oseltamivir|mesh-list
154716284|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
154716285|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716286|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716287|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716288|NCT01795898|Fentanyl|fentanyl|mesh-list
154716289|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154716290|NCT01795898|Narcotics|narcotics|mesh-ancestor
154716291|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716292|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716293|NCT01795898|Analgesics|analgesics|mesh-ancestor
154716294|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
154716295|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716296|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154716297|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154716298|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
154716299|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
154716300|NCT01736696|Tofacitinib|tofacitinib|mesh-list
154716301|NCT01736696|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154716302|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154716303|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716304|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716305|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
154716306|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154716307|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
154716308|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154716309|NCT01764464|Gabapentin|gabapentin|mesh-list
154716310|NCT01764464|Analgesics|analgesics|mesh-ancestor
154716311|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
154716312|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716313|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716314|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
154716315|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154716316|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154716317|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716318|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154716319|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154716320|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154716321|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716322|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716324|NCT01763918|Evolocumab|evolocumab|mesh-list
154716325|NCT01763918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154716326|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154716327|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154716328|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
154716329|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716330|NCT01763918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154716331|NCT01763918|Protease Inhibitors|protease inhibitors|mesh-ancestor
154716332|NCT01763918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716333|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154716334|NCT01606748|Gemcitabine|gemcitabine|mesh-list
154716335|NCT01606748|Necitumumab|necitumumab|mesh-list
154716336|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716337|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716338|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
154716339|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716340|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716341|NCT01597622|Belimumab|belimumab|mesh-list
154716342|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716343|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
154716344|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716345|NCT01761266|Sorafenib|sorafenib|mesh-list
154716346|NCT01761266|Lenvatinib|lenvatinib|mesh-list
154716347|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716348|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154716349|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716350|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716351|NCT01759862|Aminophylline|aminophylline|mesh-list
154716352|NCT01759862|Theophylline|theophylline|mesh-list
154716353|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154716354|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
154716355|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716356|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716357|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154716358|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
154716359|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154716360|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716361|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716362|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
154716363|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154716364|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154716365|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
154716366|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716367|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154716368|NCT01759862|Protective Agents|protective agents|mesh-ancestor
154716369|NCT01790828|Factor VIII|factor viii|mesh-list
154716370|NCT01790828|Coagulants|coagulants|mesh-ancestor
154716371|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
154716372|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
154716373|NCT01790594|Abatacept|abatacept|mesh-list
154716374|NCT01790594|Tacrolimus|tacrolimus|mesh-list
154716375|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
154716376|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154716377|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716378|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
154716379|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716380|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154716381|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716382|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716383|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154716384|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716385|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154716386|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
154716387|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716388|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716389|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154716390|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
154716391|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
154716392|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716393|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154716394|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
154716395|NCT01790594|Hormones|hormones|mesh-ancestor
154716396|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468306|NCT02807454|Pomalidomide|pomalidomide|mesh-list
154716397|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154716398|NCT01790594|Protective Agents|protective agents|mesh-ancestor
154716399|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154716400|NCT01790594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716401|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716403|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716404|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716405|NCT01790438|Insulin|insulin|mesh-list
154716406|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154716407|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
154716408|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
154716409|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
154716410|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154716411|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716412|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154716413|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154716414|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716415|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154716416|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716417|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
153971243|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
154716418|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154716419|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
154716420|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154716421|NCT01734902|Scopolamine|scopolamine|mesh-list
154716422|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154716423|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154716424|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
154716425|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
154716426|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716427|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716428|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154716429|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
154716430|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154716431|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
154716432|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716433|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716434|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154716435|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
154716436|NCT01789970|Hydrocodone|hydrocodone|mesh-list
154716437|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154716438|NCT01789970|Narcotics|narcotics|mesh-ancestor
154716439|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716440|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716441|NCT01789970|Analgesics|analgesics|mesh-ancestor
154716442|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
154716443|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716444|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
154716445|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
154716446|NCT01788566|Gemcitabine|gemcitabine|mesh-list
154716447|NCT01788566|Necitumumab|necitumumab|mesh-list
154716448|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716449|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716450|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
154716451|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716452|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716453|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154716454|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
154716455|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154716456|NCT01732796|Ribavirin|ribavirin|mesh-list
153971289|NCT00798304|Vaccines|vaccines|mesh-list
154716457|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
154716458|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716459|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
154716460|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716461|NCT01732640|Paclitaxel|paclitaxel|mesh-list
154716462|NCT01732640|Cisplatin|cisplatin|mesh-list
154716463|NCT01732640|Carboplatin|carboplatin|mesh-list
154716464|NCT01732640|Afatinib|afatinib|mesh-list
154716465|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154716466|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716467|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
154716468|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
154716469|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
154716470|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468385|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716471|NCT01732640|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154716472|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154716473|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716474|NCT04560686|Atezolizumab|atezolizumab|mesh-list
154716475|NCT04560686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154716476|NCT04560686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716477|NCT04560686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716478|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716479|NCT01757288|Paclitaxel|paclitaxel|mesh-list
154716480|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154716481|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154716482|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716483|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
154716484|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
154716485|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
154716486|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716487|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154716488|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
154716489|NCT01731938|Coagulants|coagulants|mesh-ancestor
154716490|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154716491|NCT01731002|Latanoprost|latanoprost|mesh-list
154716492|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154716493|NCT01783886|Aflibercept|aflibercept|mesh-list
154716494|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154716495|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154716496|NCT01783886|Growth Substances|growth substances|mesh-ancestor
154716497|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716498|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
154716499|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716500|NCT01609556|Maytansine|maytansine|mesh-list
154716501|NCT01609556|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154716502|NCT01609556|Immunoconjugates|immunoconjugates|mesh-ancestor
154716503|NCT01609556|Immunologic Factors|immunologic factors|mesh-ancestor
154716504|NCT01609556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716505|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154716506|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716507|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154716508|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154716509|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154716510|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716511|NCT00234832|Sibutramine|sibutramine|mesh-list
154716512|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
154716513|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154716514|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
154716515|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154716516|NCT00259090|Fulvestrant|fulvestrant|mesh-list
154716517|NCT00259090|Anastrozole|anastrozole|mesh-list
154716518|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154716519|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716520|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154716521|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154716522|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
154716523|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154716524|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716525|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154716526|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154716527|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716528|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716529|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
154716530|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154716531|NCT00236938|Hematinics|hematinics|mesh-ancestor
154716533|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
154716534|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
154716535|NCT01898728|Povidone|povidone|mesh-list
154716536|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154716537|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154716538|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154716539|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716540|NCT01898728|Trace Elements|trace elements|mesh-ancestor
154716541|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
154716542|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716543|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
154716544|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
154716545|NCT00260962|Olanzapine|olanzapine|mesh-list
154716546|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
154716547|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
154716548|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716549|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716550|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154716551|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154716552|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154716553|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716554|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154716555|NCT00260962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154716556|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154716557|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716558|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716559|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716560|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
154716561|NCT00237718|Vitamin E|vitamin e|mesh-list
154716562|NCT00237718|Tocopherols|tocopherols|mesh-list
154716563|NCT00237718|Tocotrienols|tocotrienols|mesh-list
154716564|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
154716565|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
154716566|NCT00237718|Vitamins|vitamins|mesh-ancestor
154716567|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
154716568|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716569|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
154716570|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716571|NCT00237718|Protective Agents|protective agents|mesh-ancestor
154716572|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
154716573|NCT00238108|Melatonin|melatonin|mesh-list
154716574|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
154716575|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716576|NCT00238108|Protective Agents|protective agents|mesh-ancestor
154716577|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716578|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716579|NCT00266110|Trastuzumab|trastuzumab|mesh-list
154716580|NCT00266110|Vinorelbine|vinorelbine|mesh-list
154716581|NCT00266110|Sargramostim|sargramostim|mesh-list
154716582|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716583|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716584|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154716585|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154716586|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154716587|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154716588|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716589|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
154716590|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716591|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
154716592|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154716593|NCT00240526|Antibodies|antibodies|mesh-list
154716594|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
154716595|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716596|NCT00242632|Memantine|memantine|mesh-list
154716597|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154716598|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154716599|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
154716600|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716601|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716602|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716603|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154716604|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154716605|NCT01899430|Metformin|metformin|mesh-list
154716606|NCT01899430|Liraglutide|liraglutide|mesh-list
154716607|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154716608|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716609|NCT01899430|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154716610|NCT01899430|Incretins|incretins|mesh-ancestor
154716611|NCT01899430|Hormones|hormones|mesh-ancestor
154716612|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154716613|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
154716614|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154716615|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716616|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716617|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154716618|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154716619|NCT00267670|Protective Agents|protective agents|mesh-ancestor
154716620|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716621|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
154716622|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154468533|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
154716623|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
154716624|NCT00247624|Eszopiclone|eszopiclone|mesh-list
154716625|NCT00247624|Fluoxetine|fluoxetine|mesh-list
154716626|NCT00247624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154716627|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154716628|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716629|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716630|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716631|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
154716632|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716633|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154716634|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
154716635|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154716636|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154716637|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154716638|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716639|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154716640|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716641|NCT00248560|Gemcitabine|gemcitabine|mesh-list
154716642|NCT00248560|Docetaxel|docetaxel|mesh-list
154716643|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716644|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
154716645|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716646|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716647|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
154716648|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
154716649|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
154716650|NCT00268762|Argatroban|argatroban|mesh-list
154716651|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
154716652|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154716653|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
154716654|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716655|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716656|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
154716657|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154716658|NCT00270634|Tacrolimus|tacrolimus|mesh-list
154716659|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716660|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
154716661|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716662|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154716663|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716664|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716665|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
154716666|NCT04110340|Gentamicins|gentamicins|mesh-list
154716667|NCT04110340|Streptomycin|streptomycin|mesh-list
154716668|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716669|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716670|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154716671|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154716672|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716673|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716674|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716675|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154716676|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154716677|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154716678|NCT00270790|Carboplatin|carboplatin|mesh-list
154716679|NCT00270790|Amifostine|amifostine|mesh-list
154716680|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716681|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154716682|NCT00270790|Protective Agents|protective agents|mesh-ancestor
154716683|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716684|NCT00271570|Infliximab|infliximab|mesh-list
154716685|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
154716686|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154716687|NCT00271570|Antibodies|antibodies|mesh-list
154716688|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
154716689|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154716690|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
154716691|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716692|NCT00271570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154716693|NCT00271570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154716694|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
154716695|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154716696|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468608|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
154716697|NCT05237596|Acetaminophen|acetaminophen|mesh-list
154716698|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154716699|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154716700|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154716701|NCT05237596|Analgesics|analgesics|mesh-ancestor
154716702|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
154716703|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716704|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716705|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
154716706|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716707|NCT02102932|Metformin|metformin|mesh-list
154716708|NCT02102932|Empagliflozin|empagliflozin|mesh-list
154716709|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154716710|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716711|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154716712|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716713|NCT00273754|Caffeine|caffeine|mesh-list
154716714|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154716715|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716716|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154716717|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716718|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716719|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154716720|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154716721|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
154716722|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716723|NCT04751344|Bupivacaine|bupivacaine|mesh-list
154716724|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
154716725|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
154716726|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716727|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716728|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
154716729|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716730|NCT05211232|Tislelizumab|tislelizumab|mesh-list
154716731|NCT05211232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716732|NCT05211232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716733|NCT00273910|Imiquimod|imiquimod|mesh-list
154716734|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154716735|NCT00273910|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154716736|NCT00273910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716737|NCT00273910|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154716738|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
154716739|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716740|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154716741|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716742|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
154716743|NCT00274768|Capecitabine|capecitabine|mesh-list
154716744|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154716745|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
154716746|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716747|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716748|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154716749|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
154716750|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154716751|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154716752|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154716753|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716754|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716755|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
154716756|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716757|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716758|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154716759|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716760|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154716761|NCT01763996|Febuxostat|febuxostat|mesh-list
154716762|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
154716763|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716764|NCT01790464|Lidocaine|lidocaine|mesh-list
154716765|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
154716766|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
154716767|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716768|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716769|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
154716770|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716771|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154716772|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154716773|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154716774|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716775|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716777|NCT01790542|Trace Elements|trace elements|mesh-ancestor
154716778|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
154716779|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716780|NCT01899820|Lumefantrine|lumefantrine|mesh-list
154716781|NCT01899820|Artemether|artemether|mesh-list
154716782|NCT01899820|Piperaquine|piperaquine|mesh-list
154716783|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154716784|NCT01899820|Artenimol|artenimol|mesh-list
154716785|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
154716786|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154716787|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154716788|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716789|NCT02100748|Morphine|morphine|mesh-list
154716790|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154716791|NCT02100748|Narcotics|narcotics|mesh-ancestor
154716792|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716793|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716794|NCT02100748|Analgesics|analgesics|mesh-ancestor
154716795|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
154716796|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716797|NCT00283504|Omalizumab|omalizumab|mesh-list
154716798|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154716799|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154716800|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
154716801|NCT00283816|Metformin|metformin|mesh-list
154716802|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
154716803|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
154716804|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154716805|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154716806|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716807|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154716808|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154716809|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
154716810|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154716811|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154716812|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154716813|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716814|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716815|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
154716816|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716817|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716818|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154716819|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716820|NCT04339426|Azithromycin|azithromycin|mesh-list
154716821|NCT04339426|Atovaquone|atovaquone|mesh-list
154716822|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716823|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716824|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
154716825|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154716826|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154716827|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716828|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716829|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
154716830|NCT00287716|Pirfenidone|pirfenidone|mesh-list
154716831|NCT00287716|Analgesics|analgesics|mesh-ancestor
154716832|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
154716833|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716834|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716835|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154716836|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154716837|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154716838|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716839|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716840|NCT00287872|Thalidomide|thalidomide|mesh-list
154716841|NCT00287872|Bortezomib|bortezomib|mesh-list
154716842|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716843|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154468758|NCT02063139|Fluticasone|fluticasone|mesh-list
154716844|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
154716845|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716846|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
154716847|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716848|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716849|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154716850|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154716851|NCT00287872|Growth Substances|growth substances|mesh-ancestor
154716852|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
154716853|NCT00288574|Fluoxetine|fluoxetine|mesh-list
154716854|NCT00288574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154716855|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154716856|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716857|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716858|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716859|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
154716860|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716861|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154716862|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
154716863|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154716864|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154716865|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154716866|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716867|NCT04061590|Cisplatin|cisplatin|mesh-list
154716868|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
154716869|NCT04061590|Pemetrexed|pemetrexed|mesh-list
154716870|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716871|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154716872|NCT04061590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154716873|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716874|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716875|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154716876|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154716877|NCT01791088|Sirolimus|sirolimus|mesh-list
154716878|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154716879|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716880|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154716881|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154716882|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
154716883|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716884|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
154716885|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716886|NCT00291226|Glycine|glycine|mesh-list
154716887|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
154716888|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716889|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716890|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716891|NCT01791166|Antibodies|antibodies|mesh-list
154716892|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
154716893|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716894|NCT00291694|Celecoxib|celecoxib|mesh-list
154716895|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154716896|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154716897|NCT00291694|Analgesics|analgesics|mesh-ancestor
154716898|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
154716899|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716900|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716901|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154716902|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716903|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154716904|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154716905|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716906|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716907|NCT00292162|Metoprolol|metoprolol|mesh-list
154716908|NCT00292162|Carvedilol|carvedilol|mesh-list
154716909|NCT00292162|Ramipril|ramipril|mesh-list
154716910|NCT00292162|Enalapril|enalapril|mesh-list
154716911|NCT00292162|Lisinopril|lisinopril|mesh-list
154716912|NCT00292162|Bisoprolol|bisoprolol|mesh-list
154716913|NCT00292162|Perindopril|perindopril|mesh-list
154716914|NCT00292162|Captopril|captopril|mesh-list
154716915|NCT00292162|Spironolactone|spironolactone|mesh-list
154716916|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154716917|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154716918|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154716919|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154716920|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154716921|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
154716922|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
154716923|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716924|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716925|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154716926|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154716927|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
154716928|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716929|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716930|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
154716931|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154716932|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154716933|NCT00292162|Diuretics|diuretics|mesh-ancestor
154716934|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
154716935|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
154716936|NCT00292162|Protective Agents|protective agents|mesh-ancestor
154716937|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154716938|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154716939|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154716940|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
154716941|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154716942|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154716943|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
154716944|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716945|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153971795|NCT00915694|Nelfinavir|nelfinavir|mesh-list
154716946|NCT00296296|Cyclosporine|cyclosporine|mesh-list
154716947|NCT00296296|Tacrolimus|tacrolimus|mesh-list
154716948|NCT00296296|Cyclosporins|cyclosporins|mesh-list
154716949|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154716950|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
154716951|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716952|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154716953|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716954|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716955|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
154716956|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154716957|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
154716958|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154716959|NCT01791400|Sumatriptan|sumatriptan|mesh-list
154716960|NCT01791400|Metoclopramide|metoclopramide|mesh-list
154716961|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
154716962|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
154716963|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716964|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716965|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154716966|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154716967|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154716968|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
154716969|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154716970|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716971|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154716972|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154716973|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154716974|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
154716975|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
154716976|NCT00300430|Atorvastatin|atorvastatin|mesh-list
154716977|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154716978|NCT00300430|Simvastatin|simvastatin|mesh-list
154716979|NCT00300430|Fenofibrate|fenofibrate|mesh-list
154716980|NCT00300430|Calcium|calcium|mesh-list
154716981|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154716982|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716983|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154716984|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154716985|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154716986|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
154716987|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154716988|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154716989|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154716990|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154716991|NCT02104414|Epinephrine|epinephrine|mesh-list
154716992|NCT02104414|Bupivacaine|bupivacaine|mesh-list
154716993|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
154716994|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
154716995|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154716996|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154716997|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
154716998|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154716999|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154717000|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154717001|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
154717002|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717003|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717004|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154717005|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154717006|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
154717007|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154717008|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
154717009|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
154717010|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
154717011|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154717012|NCT02100826|Cephalexin|cephalexin|mesh-list
154717013|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717014|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717015|NCT02101918|Aflibercept|aflibercept|mesh-list
154717016|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
154717017|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154717018|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154717019|NCT02101918|Growth Substances|growth substances|mesh-ancestor
154717020|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717021|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
154717022|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717023|NCT00300742|Topiramate|topiramate|mesh-list
154717024|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
154717025|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154717026|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717027|NCT00301756|Belinostat|belinostat|mesh-list
154717028|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717029|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154717030|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717031|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717032|NCT00302068|Sertraline|sertraline|mesh-list
154717033|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
154717034|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717035|NCT00302068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154717036|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154717037|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154717038|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717039|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717040|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
154717041|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717042|NCT00302848|Drospirenone|drospirenone|mesh-list
154717043|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
154717044|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
154717045|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
154717046|NCT00302848|Progestins|progestins|mesh-list
154717047|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154717048|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717049|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154717050|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154717051|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154717052|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154717053|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
154717054|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717055|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154717056|NCT00302848|Diuretics|diuretics|mesh-ancestor
154717057|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
154717058|NCT00302848|Hormones|hormones|mesh-ancestor
154717059|NCT00303862|Cediranib|cediranib|mesh-list
154717060|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558056|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154558057|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154558058|NCT05540834|Plasminogen|plasminogen|mesh-list
154558059|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154558060|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153971869|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154558061|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558062|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
154558063|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154558064|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558065|NCT02407899|Vitamin D|vitamin d|mesh-list
154558066|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
154558067|NCT02407899|Insulin|insulin|mesh-list
154558068|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154717061|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717062|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717063|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717064|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154717065|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154717066|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
154717067|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717068|NCT05267392|Durvalumab|durvalumab|mesh-list
154717069|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717070|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717071|NCT00142168|Rituximab|rituximab|mesh-list
154717072|NCT00142168|Lenalidomide|lenalidomide|mesh-list
154717073|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717074|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717075|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
154717076|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717077|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717078|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154717079|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154717080|NCT00142168|Growth Substances|growth substances|mesh-ancestor
154717081|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
154717082|NCT02501434|Heparin|heparin|mesh-list
154717083|NCT02501434|Calcium heparin|calcium heparin|mesh-list
154717084|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
154717085|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154717086|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154717087|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717088|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154717089|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154717090|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154717091|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717092|NCT00148798|Cisplatin|cisplatin|mesh-list
154717093|NCT00148798|Cetuximab|cetuximab|mesh-list
154717094|NCT00148798|Vinorelbine|vinorelbine|mesh-list
154717095|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717096|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717097|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154717098|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
154717099|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
154717100|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
154717101|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717102|NCT00149734|Ondansetron|ondansetron|mesh-list
154717103|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
154717104|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
154717105|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717106|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717107|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154717108|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
154717109|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
154717110|NCT00149734|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154717111|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154717112|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
154717113|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717114|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717115|NCT00198328|Bleomycin|bleomycin|mesh-list
154717116|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154717117|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717118|NCT00305578|Memantine|memantine|mesh-list
154717119|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154717120|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154717121|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
154717122|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717123|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717124|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717125|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154717126|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154717127|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
154717128|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717129|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154717130|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154717131|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717132|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717133|NCT01468311|Daclizumab|daclizumab|mesh-list
154717134|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154717135|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
153786015|NCT01649284|Afatinib|afatinib|mesh-list
154717136|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717137|NCT00306202|Dasatinib|dasatinib|mesh-list
154717138|NCT00306202|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154717139|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717140|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717141|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717142|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717143|NCT00325078|Infliximab|infliximab|mesh-list
154717144|NCT00325078|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154717145|NCT00325078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154717146|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
154717147|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154717148|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717149|NCT00325780|Pitavastatin|pitavastatin|mesh-list
154717150|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154717151|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154717152|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154717153|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
154717154|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717155|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717156|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154717157|NCT00326170|Azacitidine|azacitidine|mesh-list
154717158|NCT00326170|Tretinoin|tretinoin|mesh-list
154717159|NCT00326170|Valproic Acid|valproic acid|mesh-list
154717160|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154717161|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
154717162|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717163|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717164|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717165|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
154717166|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
154717167|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
154717168|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
154717169|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717170|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717171|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
154717172|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154717173|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717174|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717175|NCT00326872|Cediranib|cediranib|mesh-list
154717176|NCT00326872|Maleic acid|maleic acid|mesh-list
154717177|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717178|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717179|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717180|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717181|NCT05266690|Dextrans|dextrans|mesh-list
154717182|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
154717183|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
154717184|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
154717185|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
154717186|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154717187|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717188|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154717189|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717190|NCT05266534|Terlipressin|terlipressin|mesh-list
154717191|NCT05266534|Carbetocin|carbetocin|mesh-list
154717192|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
154717193|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154717194|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717195|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154717196|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154717197|NCT01730378|Vaccines|vaccines|mesh-list
154717198|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
154717199|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717200|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
154717201|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154717202|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
154717203|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717204|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154717205|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717206|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717207|NCT01790308|Liraglutide|liraglutide|mesh-list
154717208|NCT01790308|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154717209|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154558069|NCT02407899|Metformin|metformin|mesh-list
154717210|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717211|NCT01790308|Incretins|incretins|mesh-ancestor
154717212|NCT01790308|Hormones|hormones|mesh-ancestor
154717213|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717214|NCT01609010|Interferons|interferons|mesh-list
154717215|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
154717216|NCT01609010|Rituximab|rituximab|mesh-list
154717217|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717218|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717219|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
154717220|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717221|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717222|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
154717223|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357234|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153357239|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153731328|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
154717224|NCT01608308|Acetaminophen|acetaminophen|mesh-list
154717225|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154717226|NCT01608308|Analgesics|analgesics|mesh-ancestor
154717227|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
154717228|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717229|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717230|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
154717231|NCT00332644|Bupropion|bupropion|mesh-list
154717232|NCT00332644|Nicotine|nicotine|mesh-list
154717233|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154717234|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
154717235|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717236|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717237|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154717238|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154717239|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
154717240|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717241|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717242|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154717243|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
154717244|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717245|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154717246|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154717247|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154717248|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
154717249|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154717250|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154717251|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717252|NCT01755416|Insulin|insulin|mesh-list
154717253|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154717254|NCT01755416|Liraglutide|liraglutide|mesh-list
154717255|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154717256|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717257|NCT01755416|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154717258|NCT01755416|Incretins|incretins|mesh-ancestor
154717259|NCT01755416|Hormones|hormones|mesh-ancestor
154717260|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717261|NCT01755026|Cefazolin|cefazolin|mesh-list
154717262|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717263|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717264|NCT00333814|Dexamethasone|dexamethasone|mesh-list
154717265|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
154717266|NCT00333814|BB 1101|bb 1101|mesh-list
154717267|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154717268|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
154717269|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
154717270|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717271|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717272|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154717273|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
154717274|NCT00333814|Hormones|hormones|mesh-ancestor
154717275|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717276|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154717277|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717278|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
154717279|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717280|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717281|NCT01728584|Bromides|bromides|mesh-list
154717282|NCT01728584|Rocuronium|rocuronium|mesh-list
154717283|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
154717284|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154717285|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154717286|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154717287|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717288|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717290|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154717291|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154717292|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154717293|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
154717294|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717295|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717296|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154717297|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
154717298|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
154717299|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
153357279|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153357288|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
153357290|NCT01270256|Budesonide|budesonide|mesh-list
153731389|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810683|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153810693|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
153357326|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153731390|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357328|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
153357336|NCT00744380|Analgesics|analgesics|mesh-ancestor
154717300|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154717301|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154717302|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
154717303|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717304|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717305|NCT01522443|Prednisone|prednisone|mesh-list
154717306|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
154717307|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154717308|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
154717309|NCT01522443|Hormones|hormones|mesh-ancestor
154717310|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717311|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717312|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154717313|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717314|NCT01522443|Analgesics|analgesics|mesh-ancestor
154717315|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
154717316|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717317|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154717318|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154717319|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717320|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717321|NCT00336700|Gemcitabine|gemcitabine|mesh-list
154717322|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154717323|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154717324|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
154717325|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717326|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717327|NCT00336700|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154717328|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717329|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717330|NCT01468233|Adalimumab|adalimumab|mesh-list
154717331|NCT01468233|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154717332|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154717333|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717334|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154717335|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
154717336|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717337|NCT01782872|Ropivacaine|ropivacaine|mesh-list
154717338|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
154717339|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
154717340|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717341|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717342|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
154717343|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717344|NCT01490697|Cycloserine|cycloserine|mesh-list
154717345|NCT01490697|Mifepristone|mifepristone|mesh-list
154717346|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154717347|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
154717348|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154717349|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717350|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153357397|NCT01278134|Ritonavir|ritonavir|mesh-list
153357405|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153731404|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153731405|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357417|NCT01271348|Analgesics|analgesics|mesh-ancestor
153731406|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717351|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154717352|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154717353|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
154717354|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154717355|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154717356|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
154717357|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717358|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
154717359|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154558070|NCT02407899|Saxagliptin|saxagliptin|mesh-list
154717360|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154717361|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154717362|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717363|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154717364|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
154717365|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717366|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
154717367|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717368|NCT01728194|Escitalopram|escitalopram|mesh-list
154717369|NCT01728194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154717370|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154717371|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154717372|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717373|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717374|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
154717375|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717377|NCT04408911|Lormetazepam|lormetazepam|mesh-list
154717378|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154717379|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154717380|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717381|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717382|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154717383|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154717384|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717385|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154717386|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
154717387|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
154717388|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
154717389|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
154717390|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717391|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717392|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
154717393|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154717394|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154717395|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154717396|NCT01466673|Desogestrel|desogestrel|mesh-list
154717397|NCT01466673|Norgestimate|norgestimate|mesh-list
153731436|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153731438|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731439|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717398|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154717399|NCT01466673|Estradiol|estradiol|mesh-list
154717400|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154717401|NCT01466673|Estrogens|estrogens|mesh-ancestor
154717402|NCT01466673|Hormones|hormones|mesh-ancestor
154717403|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717404|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717405|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154717406|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
154717407|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154717408|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154717409|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154717410|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154717411|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154717412|NCT01466673|Progestins|progestins|mesh-ancestor
154717413|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717414|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717415|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154717416|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154717417|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717418|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717419|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717420|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154717421|NCT01753856|Vitamin D|vitamin d|mesh-list
154717422|NCT01753856|Denosumab|denosumab|mesh-list
154717423|NCT01753856|Teriparatide|teriparatide|mesh-list
154717424|NCT01753856|Tetracycline|tetracycline|mesh-list
154717425|NCT01753856|Demeclocycline|demeclocycline|mesh-list
154717426|NCT01753856|Calcium|calcium|mesh-list
154717427|NCT01753856|Vitamins|vitamins|mesh-ancestor
154717428|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
154717429|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717430|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154717431|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154717432|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717433|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717434|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154717435|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717436|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717437|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
154717438|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154717439|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154717440|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154717441|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154717442|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717443|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
154717444|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717445|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717446|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154717447|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357629|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
154717449|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154717450|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717451|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717452|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
154717453|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717454|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717455|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
154717456|NCT01466595|Rifaximin|rifaximin|mesh-list
154717457|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717458|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717459|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154717460|NCT02073747|Albuterol|albuterol|mesh-list
154717461|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154717462|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
154717463|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717464|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717465|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154717466|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
154717467|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
154717468|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154717469|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154717470|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154717471|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154717472|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
154717473|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717474|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717475|NCT01465659|Temozolomide|temozolomide|mesh-list
154717476|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154717477|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
154717478|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717479|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717480|NCT01462929|Bromides|bromides|mesh-list
154717481|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
154717482|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154717483|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
154717484|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717485|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717486|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154717487|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
154717488|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
154717489|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153357659|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
153731498|NCT00154050|Candesartan|candesartan|mesh-list
154717490|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
154717491|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717492|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717493|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
154717494|NCT01462695|Sunitinib|sunitinib|mesh-list
154717495|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717496|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154717497|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154717498|NCT01462695|Growth Substances|growth substances|mesh-ancestor
154717499|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717500|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
154717501|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717502|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717503|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717504|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
154717505|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
154717506|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717507|NCT01465347|Protective Agents|protective agents|mesh-ancestor
154717508|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717509|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154717510|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717512|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154717513|NCT01465191|Narcotics|narcotics|mesh-ancestor
154717514|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717515|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717516|NCT01465191|Analgesics|analgesics|mesh-ancestor
154717517|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
154717518|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717519|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
154717520|NCT01519947|Hematinics|hematinics|mesh-ancestor
154717521|NCT01462227|Naltrexone|naltrexone|mesh-list
154717522|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154717523|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154717524|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717525|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
154717526|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717527|NCT01464879|Testosterone|testosterone|mesh-list
153731512|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717528|NCT01464879|Androgens|androgens|mesh-ancestor
154717529|NCT01464879|Hormones|hormones|mesh-ancestor
154717530|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717531|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717532|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
154717533|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154717534|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717535|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
154717536|NCT01519791|Methotrexate|methotrexate|mesh-list
154717537|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154717538|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
154717539|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154717540|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717541|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154717542|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
154717543|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717544|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717545|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
154717546|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717547|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154717548|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154717549|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
154717550|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717551|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154717552|NCT01519791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154717553|NCT01519791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154717554|NCT01439373|Interferons|interferons|mesh-list
154717555|NCT01439373|Ribavirin|ribavirin|mesh-list
154717556|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
154717557|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
154717558|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154717559|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717560|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
154717561|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717562|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
154717563|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717564|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
154717565|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717566|NCT01461369|Diclofenac|diclofenac|mesh-list
154717567|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154717568|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154717569|NCT01461369|Analgesics|analgesics|mesh-ancestor
154717570|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
154717571|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717572|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717573|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154717574|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717575|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154717576|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717577|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717578|NCT01727258|Fluorides|fluorides|mesh-list
154717579|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
154469488|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717580|NCT01727258|Protective Agents|protective agents|mesh-ancestor
153731518|NCT00154089|Analgesics|analgesics|mesh-ancestor
153730785|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730786|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
153730787|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
153730788|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730789|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153730790|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153730791|NCT00135122|Protective Agents|protective agents|mesh-ancestor
153730793|NCT00142350|Irinotecan|irinotecan|mesh-list
153730794|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730795|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
154717581|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717582|NCT01781234|Insulin|insulin|mesh-list
154717583|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154717584|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717585|NCT01752842|Fenofibrate|fenofibrate|mesh-list
154717586|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154717587|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
154717588|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717589|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154717590|NCT01461057|Capecitabine|capecitabine|mesh-list
154717591|NCT01461057|Trastuzumab|trastuzumab|mesh-list
154717592|NCT01461057|Pertuzumab|pertuzumab|mesh-list
154717593|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717594|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154717595|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
154717596|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717597|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717598|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154717599|NCT01519635|Aliskiren|aliskiren|mesh-list
154717600|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154717601|NCT01519635|Diuretics|diuretics|mesh-ancestor
154717602|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
154717603|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717604|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154717605|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154717606|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717607|NCT01519635|Renin Inhibitors|renin inhibitors|mesh-ancestor
154717608|NCT01519635|Protease Inhibitors|protease inhibitors|mesh-ancestor
154717609|NCT01519635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717610|NCT01519323|Vemurafenib|vemurafenib|mesh-list
154717611|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717612|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717613|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717614|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717615|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
154717616|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154717617|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154717618|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717619|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
154717620|NCT01519245|Coagulants|coagulants|mesh-ancestor
154717621|NCT01519167|Midazolam|midazolam|mesh-list
154717622|NCT01519167|Fentanyl|fentanyl|mesh-list
154717623|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
154717624|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154717625|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717626|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717627|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154717628|NCT01519167|Analgesics|analgesics|mesh-ancestor
154717629|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
154717630|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717631|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154717632|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154717633|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154717634|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
154717635|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717636|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717637|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154717638|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154717639|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154717640|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717641|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154717642|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
154717643|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
154717644|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
154717645|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
154717646|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154717647|NCT01519167|Narcotics|narcotics|mesh-ancestor
154717648|NCT00318136|Paclitaxel|paclitaxel|mesh-list
154717649|NCT00318136|Bevacizumab|bevacizumab|mesh-list
154717650|NCT00318136|Carboplatin|carboplatin|mesh-list
154717651|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154717652|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717653|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
154717654|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
154717655|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
154717656|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717657|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717658|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154717659|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154717660|NCT00318136|Growth Substances|growth substances|mesh-ancestor
154717661|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717662|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
154717663|NCT00318292|Epinephrine|epinephrine|mesh-list
154717664|NCT00318292|Bupivacaine|bupivacaine|mesh-list
154717665|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
154717666|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
154717667|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717668|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717669|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
153730866|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730867|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730868|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717670|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717671|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154717672|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154717673|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
154717674|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717675|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717676|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154717677|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154717678|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
154717679|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154717680|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
154717681|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
154717682|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
154717683|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154717684|NCT01791868|Valproic Acid|valproic acid|mesh-list
154717685|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
154717686|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717687|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717688|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
154717689|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717690|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717691|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
154717692|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154717693|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717694|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717695|NCT00348946|Androgens|androgens|mesh-list
154717696|NCT00348946|Oxandrolone|oxandrolone|mesh-list
154717697|NCT00348946|Hormones|hormones|mesh-ancestor
154717698|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717699|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717700|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
154717701|NCT00349336|Bevacizumab|bevacizumab|mesh-list
154717702|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717703|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717704|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154717705|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154717706|NCT00349336|Growth Substances|growth substances|mesh-ancestor
154717707|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717708|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
154717709|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154717710|NCT04751188|Bezafibrate|bezafibrate|mesh-list
154717711|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154717712|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154717713|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154717714|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
153730904|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730905|NCT00135785|Bupropion|bupropion|mesh-list
153730906|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153730907|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
153730908|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730909|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154717715|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717716|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154717717|NCT00352612|Clindamycin|clindamycin|mesh-list
154717718|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
154717719|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
154717720|NCT00352612|Cephalexin|cephalexin|mesh-list
154717721|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717722|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717723|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154717724|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717725|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717726|NCT00323362|Gemcitabine|gemcitabine|mesh-list
154717727|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
154717728|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154717729|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
154469641|NCT02073357|Anesthetics|anesthetics|mesh-list
154717730|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717731|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717732|NCT00323362|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154717733|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717734|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717735|NCT00390364|Everolimus|everolimus|mesh-list
154717736|NCT00390364|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154717737|NCT00390364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154717738|NCT00390364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717739|NCT00390364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717740|NCT00390364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717741|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154717742|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
154717743|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717744|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717745|NCT00354640|Anastrozole|anastrozole|mesh-list
154717746|NCT00354640|Simvastatin|simvastatin|mesh-list
154717747|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154717748|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154717749|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
154717750|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717751|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153730937|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153730939|NCT00152841|Vitamins|vitamins|mesh-ancestor
153730940|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
153730941|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782134|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
153782135|NCT04564456|Hormones|hormones|mesh-ancestor
153730944|NCT00152841|Protective Agents|protective agents|mesh-ancestor
154717752|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154717753|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717754|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154717755|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717756|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154717757|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154717758|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154717759|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
154717760|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717761|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717762|NCT00392392|Paclitaxel|paclitaxel|mesh-list
154717763|NCT00392392|Bevacizumab|bevacizumab|mesh-list
154717764|NCT00392392|Trastuzumab|trastuzumab|mesh-list
154717765|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154717766|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717767|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
154717768|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
154717769|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
154717770|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717771|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717772|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154717773|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154717774|NCT00392392|Growth Substances|growth substances|mesh-ancestor
154717775|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717776|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
154717777|NCT01519089|Tofacitinib|tofacitinib|mesh-list
154717778|NCT01519089|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154717779|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717780|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717781|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717782|NCT00392704|Paclitaxel|paclitaxel|mesh-list
154717783|NCT00392704|Bevacizumab|bevacizumab|mesh-list
154717784|NCT00392704|Fluorouracil|fluorouracil|mesh-list
154717785|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154717786|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154717787|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717788|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
154717789|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
154717790|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
153730970|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
153730971|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154717791|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717792|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717793|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154717794|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154717795|NCT00392704|Growth Substances|growth substances|mesh-ancestor
154717796|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717797|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
154717798|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
154717799|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154717800|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154717801|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
154717802|NCT00392704|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154717803|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717804|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717805|NCT00392782|Fludarabine|fludarabine|mesh-list
154717806|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
154717807|NCT00392782|Thiotepa|thiotepa|mesh-list
154717808|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154717809|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717810|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154717811|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
154717812|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717813|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154717814|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
154717815|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717816|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154717817|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
154717818|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154717819|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
154717820|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154717821|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717822|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717823|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154717824|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154717825|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717826|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717827|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717828|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154717829|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
154717830|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154717831|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717832|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154717833|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154717834|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154717835|NCT01518309|Pimavanserin|pimavanserin|mesh-list
154717836|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154717837|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154717838|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154717839|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154717840|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717841|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717842|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717843|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154717844|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154717845|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
154717846|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717847|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717848|NCT01419717|Denosumab|denosumab|mesh-list
154717849|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154717850|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717851|NCT01458951|Tofacitinib|tofacitinib|mesh-list
154717852|NCT01458951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154717853|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717854|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717855|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717857|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154717858|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
154717859|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
154717860|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717861|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717862|NCT00393796|Sunitinib|sunitinib|mesh-list
154717863|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717864|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154717865|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154717866|NCT00393796|Growth Substances|growth substances|mesh-ancestor
154717867|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717868|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
154717869|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154717870|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717871|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717872|NCT00393874|Prazosin|prazosin|mesh-list
154717873|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154717874|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154717875|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154717876|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154717877|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154717878|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717879|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717880|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717881|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
154717882|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
154717883|NCT01458171|Antibodies|antibodies|mesh-list
154717884|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
154717885|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154717886|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154717887|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
154717888|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717889|NCT00395044|Gabapentin|gabapentin|mesh-list
154717890|NCT00395044|Analgesics|analgesics|mesh-ancestor
154717891|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
154717892|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717893|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717894|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
154717895|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154717896|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154717897|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154717898|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717899|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154717900|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154717901|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717902|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717903|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
154717904|NCT01457703|Letrozole|letrozole|mesh-list
154717905|NCT01457703|Cetrorelix|cetrorelix|mesh-list
154717906|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154717907|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717908|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154717909|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154717910|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717911|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717912|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154717913|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
154717914|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154717915|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717916|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154717917|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
154717918|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154717919|NCT01457703|Hormones|hormones|mesh-ancestor
154717920|NCT02076321|Acetaminophen|acetaminophen|mesh-list
154717921|NCT02076321|Ibuprofen|ibuprofen|mesh-list
154717922|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154717923|NCT02076321|Analgesics|analgesics|mesh-ancestor
154717924|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
154717925|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717926|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717927|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
154717928|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154717929|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154717930|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717931|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154717932|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154717933|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717934|NCT00358462|Azithromycin|azithromycin|mesh-list
154717935|NCT00358462|Doxycycline|doxycycline|mesh-list
154717936|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154717937|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154717938|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
154717939|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154717940|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154717941|NCT01437267|Vaccines|vaccines|mesh-list
154717942|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154717943|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
154717944|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717945|NCT01437111|Vitamin D|vitamin d|mesh-list
153731131|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154717946|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
154717947|NCT01437111|Alendronate|alendronate|mesh-list
154717948|NCT01437111|Vitamins|vitamins|mesh-ancestor
154717949|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
154717950|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717951|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154717952|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154717953|NCT04065555|Cetuximab|cetuximab|mesh-list
154717954|NCT04065555|Avelumab|avelumab|mesh-list
154717955|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154717956|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717957|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717958|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
154717959|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717960|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154717961|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154717962|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154717963|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154717964|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717965|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154717966|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717967|NCT00360724|Analgesics|analgesics|mesh-ancestor
154717968|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
154717969|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717970|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
154717971|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154717972|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
154717973|NCT00398398|Capecitabine|capecitabine|mesh-list
154717974|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
154717975|NCT00398398|Cetuximab|cetuximab|mesh-list
154717976|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154717977|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
154717978|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154717979|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154717980|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154717981|NCT00398476|Fluticasone|fluticasone|mesh-list
154717982|NCT00398476|Xhance|xhance|mesh-list
154717983|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154717984|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154717985|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
154717986|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154717987|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154717988|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154717989|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
154717990|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
154717991|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154717992|NCT01436643|Fluoxetine|fluoxetine|mesh-list
154717993|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154717994|NCT01436643|Citalopram|citalopram|mesh-list
154717995|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154717996|NCT01436643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154717997|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154717998|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154717999|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718000|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718001|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
154718002|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718003|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154718004|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
154718005|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154718006|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154718007|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154718008|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731132|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153731177|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731178|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153731179|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153731180|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153731181|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153731182|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731183|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731184|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
153731185|NCT00136565|Hormones|hormones|mesh-ancestor
153360242|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360245|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
153360246|NCT01355705|Lenalidomide|lenalidomide|mesh-list
153360248|NCT01355705|BB 1101|bb 1101|mesh-list
153360251|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
154718009|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154718010|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154718011|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718012|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
154718013|NCT00361972|Lansoprazole|lansoprazole|mesh-list
154718014|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
154718015|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154718016|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718017|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154718018|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718019|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718020|NCT00362440|Metformin|metformin|mesh-list
154718021|NCT00362440|Pioglitazone|pioglitazone|mesh-list
154718022|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154718023|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718024|NCT02109640|Oxycodone|oxycodone|mesh-list
154718025|NCT02109640|Naloxone|naloxone|mesh-list
154718026|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154718027|NCT02109640|Narcotics|narcotics|mesh-ancestor
154718028|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154718029|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718030|NCT02109640|Analgesics|analgesics|mesh-ancestor
154718031|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
154718032|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718033|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154718034|NCT01454739|Factor VIII|factor viii|mesh-list
154718035|NCT01454739|Coagulants|coagulants|mesh-ancestor
154718036|NCT00366106|Dexamethasone|dexamethasone|mesh-list
154718037|NCT00366106|Doxorubicin|doxorubicin|mesh-list
154718038|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154718039|NCT00366106|Bortezomib|bortezomib|mesh-list
154718040|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154718041|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
154718042|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
154718043|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718044|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718045|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718046|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
154718047|NCT00366106|Hormones|hormones|mesh-ancestor
154718048|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718049|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154718050|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718051|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154718052|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154718053|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154718054|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718055|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718056|NCT00368290|Modafinil|modafinil|mesh-list
154718057|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154718058|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718059|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154718060|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154718061|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154718062|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718063|NCT00369226|Methotrexate|methotrexate|mesh-list
154718064|NCT00369226|Bortezomib|bortezomib|mesh-list
154718065|NCT00369226|Tacrolimus|tacrolimus|mesh-list
154718066|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154718067|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
154718068|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154718069|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718070|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718071|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
154718072|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718073|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718074|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
154718075|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718076|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154718077|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718078|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
154718079|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718080|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154718081|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154718082|NCT01416441|Aripiprazole|aripiprazole|mesh-list
154718083|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
154718084|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154718085|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154718086|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154718087|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154718088|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718089|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
154718090|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
154718091|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718092|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718093|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154718094|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154718095|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
154718096|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154718097|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154718098|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154718099|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154718100|NCT00406276|Docetaxel|docetaxel|mesh-list
154718101|NCT00406276|Everolimus|everolimus|mesh-list
154718102|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718103|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718104|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718105|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718106|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718107|NCT00406276|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154718108|NCT00406276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718109|NCT00406276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718110|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718111|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
154718112|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718113|NCT00408070|Paclitaxel|paclitaxel|mesh-list
154718114|NCT00408070|Bevacizumab|bevacizumab|mesh-list
154718115|NCT00408070|Carboplatin|carboplatin|mesh-list
154718116|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718117|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718118|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718119|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718120|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718121|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718122|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718123|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154718124|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154718125|NCT00408070|Growth Substances|growth substances|mesh-ancestor
154718126|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718127|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
154718128|NCT00408460|Paclitaxel|paclitaxel|mesh-list
154718129|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
154718130|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718131|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718132|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718133|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718134|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718135|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718136|NCT00408460|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154718137|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718138|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718139|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
154718140|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154718141|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718142|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
154718143|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154718144|NCT02111746|Bupivacaine|bupivacaine|mesh-list
154718145|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
154718146|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
154718147|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154718148|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718149|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
154718150|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718151|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
154718152|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154718153|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718154|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718155|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154718156|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154718157|NCT01793272|Protective Agents|protective agents|mesh-ancestor
154718158|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718159|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
154718160|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154718161|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
154718162|NCT00410488|Dexamethasone|dexamethasone|mesh-list
154718163|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
154718164|NCT00410488|Doxorubicin|doxorubicin|mesh-list
154718165|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154718166|NCT00410488|Vincristine|vincristine|mesh-list
154718167|NCT00410488|Ifosfamide|ifosfamide|mesh-list
154718168|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
154718169|NCT00410488|Palonosetron|palonosetron|mesh-list
154718170|NCT00410488|BB 1101|bb 1101|mesh-list
154718171|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154718172|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
154718173|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
154718174|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718175|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718176|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718177|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
154718178|NCT00410488|Hormones|hormones|mesh-ancestor
154718179|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718180|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154718181|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718182|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
154718183|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718184|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718185|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154718186|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154718187|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154718188|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718189|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718190|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718191|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718192|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154718193|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
154718194|NCT00410488|Protective Agents|protective agents|mesh-ancestor
154718195|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154718196|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154718197|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
154718198|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718199|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154718200|NCT01793350|Benphothiamine|benphothiamine|mesh-list
154718201|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154718202|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
154718203|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718204|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
154718205|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
154718206|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718207|NCT00416494|Bevacizumab|bevacizumab|mesh-list
154718208|NCT00416494|Capecitabine|capecitabine|mesh-list
154718209|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
154718210|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718211|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718212|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154718213|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154718214|NCT00416494|Growth Substances|growth substances|mesh-ancestor
154718215|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718216|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
154718217|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718218|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
154718219|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718220|NCT00417274|Quinacrine|quinacrine|mesh-list
154718221|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
154718222|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154718223|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
154718224|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154718225|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154718226|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
154718227|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154718228|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
154718229|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718230|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718231|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718232|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154718233|NCT04749940|Laxatives|laxatives|mesh-ancestor
154718234|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718235|NCT05286346|Tenofovir|tenofovir|mesh-list
154718236|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
154718237|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154718238|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154718239|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154718240|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718241|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718242|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154718243|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154718244|NCT05286268|Plasminogen|plasminogen|mesh-list
154718245|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154718246|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154718247|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718248|NCT00422032|Clofarabine|clofarabine|mesh-list
154718249|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718250|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
154718251|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718252|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718253|NCT01388920|Tesamorelin|tesamorelin|mesh-list
154718254|NCT01388920|Growth Substances|growth substances|mesh-ancestor
154718255|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718256|NCT00423358|Vitamin D|vitamin d|mesh-list
154718257|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
154470158|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718258|NCT00423358|Vitamins|vitamins|mesh-ancestor
154718259|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
154718260|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718261|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154718262|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154718263|NCT00424840|Bevacizumab|bevacizumab|mesh-list
154718264|NCT00424840|Carboplatin|carboplatin|mesh-list
154718265|NCT00424840|Bortezomib|bortezomib|mesh-list
154718266|NCT00424840|Docetaxel|docetaxel|mesh-list
154718267|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718268|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718269|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154718270|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154718271|NCT00424840|Growth Substances|growth substances|mesh-ancestor
154718272|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718273|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
153351869|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153352021|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
153352618|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
153352762|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154718274|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718275|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718276|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718277|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718278|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154718279|NCT00425386|Sunitinib|sunitinib|mesh-list
154718280|NCT00425386|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154718281|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718282|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718283|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718284|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718285|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154718286|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154718287|NCT00425386|Growth Substances|growth substances|mesh-ancestor
154718288|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718289|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
154718290|NCT01164202|Sunitinib|sunitinib|mesh-list
154718291|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718292|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154718293|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154718294|NCT01164202|Growth Substances|growth substances|mesh-ancestor
154718295|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718296|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
154718297|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718298|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718299|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718300|NCT02112370|Epinephrine|epinephrine|mesh-list
154718301|NCT02112370|Racepinephrine|racepinephrine|mesh-list
154718302|NCT02112370|Ropivacaine|ropivacaine|mesh-list
154718303|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
154718304|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
154718305|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
154718306|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154718307|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718308|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
154718309|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718310|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154718311|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154718312|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
154718313|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731266|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153731267|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731268|NCT00137072|Urological Agents|urological agents|mesh-ancestor
153377776|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
153378507|NCT05045937|Analgesics|analgesics|mesh-ancestor
154718314|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718315|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154718316|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153731269|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
154718317|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
154718318|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154718319|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
154718320|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
154718321|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
154718322|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154718323|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
154718324|NCT00427336|Fludarabine|fludarabine|mesh-list
154718325|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
154718326|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
154718327|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154718328|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154470233|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
154718329|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
154718330|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718331|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718332|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154718333|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
154718334|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718335|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718336|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154718337|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718338|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
154718339|NCT00371176|Cycloserine|cycloserine|mesh-list
154718340|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154718341|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154718342|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154718343|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
154718344|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154718345|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
154718346|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718347|NCT00428584|Interferons|interferons|mesh-list
154718348|NCT00428584|Interferon-beta|interferon-beta|mesh-list
154718349|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
154718350|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718351|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
154718352|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154718353|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
154718354|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718355|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154718356|NCT05187286|Apixaban|apixaban|mesh-list
154718357|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154718358|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
154718359|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154718360|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
154718361|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718362|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718363|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
154718364|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
154718365|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154718366|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153731281|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731283|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153731284|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731285|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153731286|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731287|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
153731288|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153731289|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
153731290|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731291|NCT00137462|Atorvastatin|atorvastatin|mesh-list
153731292|NCT00137462|Torcetrapib|torcetrapib|mesh-list
154718367|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154718368|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154718369|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718370|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
154718371|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718372|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718373|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154718374|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718375|NCT00373360|Treprostinil|treprostinil|mesh-list
154718376|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154718377|NCT00455650|Mecamylamine|mecamylamine|mesh-list
154718378|NCT00455650|Varenicline|varenicline|mesh-list
154718379|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154718380|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154718381|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
154718382|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718383|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718384|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718385|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154718386|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154718387|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
154718388|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718389|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154718390|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154718391|NCT00431626|Dutasteride|dutasteride|mesh-list
154718392|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154718393|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154718394|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718395|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718396|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
154718397|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718398|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718399|NCT00455962|Estradiol|estradiol|mesh-list
154718400|NCT00455962|Progesterone|progesterone|mesh-list
154718401|NCT00455962|Estrogens|estrogens|mesh-ancestor
154718402|NCT00455962|Hormones|hormones|mesh-ancestor
154718403|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731307|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731308|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153731309|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731310|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
153731311|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
153731312|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153731313|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153731314|NCT00153660|Celecoxib|celecoxib|mesh-list
154718404|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718405|NCT00455962|Progestins|progestins|mesh-ancestor
154718406|NCT00434356|Paclitaxel|paclitaxel|mesh-list
154470306|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154718407|NCT00434356|Bevacizumab|bevacizumab|mesh-list
154718408|NCT00434356|Sunitinib|sunitinib|mesh-list
154718409|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718410|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718411|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718412|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718413|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718414|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718415|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718416|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154718417|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154718418|NCT00434356|Growth Substances|growth substances|mesh-ancestor
154718419|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718420|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
154718421|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718422|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718423|NCT00376948|Gemcitabine|gemcitabine|mesh-list
154718424|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154718425|NCT00376948|Genistein|genistein|mesh-list
154718426|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718427|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
154718428|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718429|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718430|NCT00376948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154718431|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718432|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718433|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154718434|NCT00376948|Protective Agents|protective agents|mesh-ancestor
154718435|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718436|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
154718437|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154718438|NCT00376948|Estrogens|estrogens|mesh-ancestor
154718439|NCT00376948|Hormones|hormones|mesh-ancestor
154718440|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718441|NCT00438100|Capecitabine|capecitabine|mesh-list
154718442|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718443|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
154718444|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718445|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718446|NCT00456508|Ecallantide|ecallantide|mesh-list
154718447|NCT00456508|Analgesics|analgesics|mesh-ancestor
154718448|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
154718449|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718450|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718451|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154718452|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154718453|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154718454|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718455|NCT00457366|Lorazepam|lorazepam|mesh-list
154718456|NCT00457366|Haloperidol|haloperidol|mesh-list
154718457|NCT00457366|Benztropine|benztropine|mesh-list
154718458|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154718459|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
154718460|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
154718461|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154718462|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154718463|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154718464|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154718465|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718466|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
154718467|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
154718468|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718469|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718470|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154718471|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
154718472|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718473|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718474|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154718475|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
154718476|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154718477|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154718478|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
154718479|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
154718480|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154718481|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
154718482|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154718483|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154718484|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
154718485|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154718486|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154718487|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154718488|NCT00458848|Prednisone|prednisone|mesh-list
154718489|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
154718490|NCT00458848|Methotrexate|methotrexate|mesh-list
154718491|NCT00458848|Etoposide|etoposide|mesh-list
154718492|NCT00458848|Vincristine|vincristine|mesh-list
154718493|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
154718494|NCT00458848|Daunorubicin|daunorubicin|mesh-list
154718495|NCT00458848|Asparaginase|asparaginase|mesh-list
154718496|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
154718497|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
154718498|NCT00458848|Idarubicin|idarubicin|mesh-list
154718499|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154718500|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
154718501|NCT00458848|Hormones|hormones|mesh-ancestor
154718502|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733917|NCT00148863|Interferons|interferons|mesh-list
154718503|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718504|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154718505|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718506|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154718507|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
154718508|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154718509|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718510|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
154718511|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718512|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
154718513|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718514|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154718515|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718516|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
154718517|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718518|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154718519|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718520|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154718521|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154718522|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718523|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718524|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718525|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
154718526|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
154718527|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718528|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718529|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154718530|NCT00458848|Protective Agents|protective agents|mesh-ancestor
154718531|NCT00458848|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154718532|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718533|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154718534|NCT00458848|Analgesics|analgesics|mesh-ancestor
154718535|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
154718536|NCT00438802|Alefacept|alefacept|mesh-list
154718537|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
154718538|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
154718539|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718540|NCT00377572|Omalizumab|omalizumab|mesh-list
154718541|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154718542|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154718543|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154718544|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
154718545|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
154718546|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718547|NCT00438880|Rituximab|rituximab|mesh-list
154718548|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154718549|NCT00438880|Antibodies|antibodies|mesh-list
154718550|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
154718551|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154718552|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
154718553|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718554|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718555|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718556|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
154718557|NCT00378352|Hematinics|hematinics|mesh-ancestor
154718558|NCT00462280|Lovastatin|lovastatin|mesh-list
154718559|NCT00462280|L 647318|l 647318|mesh-list
154718560|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
154718561|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154718562|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154718563|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
154718564|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718565|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154718566|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154718567|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718568|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
154718569|NCT00381004|Rituximab|rituximab|mesh-list
154718570|NCT00381004|Fludarabine|fludarabine|mesh-list
154718571|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
154718572|NCT00381004|Sargramostim|sargramostim|mesh-list
154718573|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718574|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
154718575|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718576|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718577|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154718578|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
154718579|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718580|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718581|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154718582|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718583|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718584|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
154718585|NCT00381550|Fludarabine|fludarabine|mesh-list
154718586|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
154718587|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718588|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718589|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
154718590|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718591|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718592|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
154718593|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718594|NCT00440830|Nicotine|nicotine|mesh-list
154718595|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154718596|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
154718597|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718598|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718599|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154718600|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153734354|NCT06245707|Hormones|hormones|mesh-ancestor
154718601|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
154718602|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718603|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718604|NCT00427804|Calcitriol|calcitriol|mesh-list
154718605|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154718606|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718607|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154718608|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154718609|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718610|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154718611|NCT00427804|Vitamins|vitamins|mesh-ancestor
154718612|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
154718613|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154718614|NCT00381862|Leucovorin|leucovorin|mesh-list
154718615|NCT00381862|Dexamethasone|dexamethasone|mesh-list
154718616|NCT00381862|Fluorouracil|fluorouracil|mesh-list
154718617|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
154718618|NCT00381862|Irinotecan|irinotecan|mesh-list
154718619|NCT00381862|Camptothecin|camptothecin|mesh-list
154718620|NCT00381862|Aprepitant|aprepitant|mesh-list
154718621|NCT00381862|Palonosetron|palonosetron|mesh-list
154718622|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
154718623|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154718624|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
154718625|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
154718626|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718627|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718628|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718629|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
154718630|NCT00381862|Hormones|hormones|mesh-ancestor
154718631|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718632|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154718633|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718634|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
154718635|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718636|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718637|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718638|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
154718639|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154718640|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154718641|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718642|NCT00381862|Antidotes|antidotes|mesh-ancestor
154718643|NCT00381862|Protective Agents|protective agents|mesh-ancestor
154718644|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
154718645|NCT00381862|Vitamins|vitamins|mesh-ancestor
154718646|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
154718647|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154718648|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718649|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154718650|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154718651|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
154718652|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718653|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154718654|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154718655|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154718656|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154718657|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718658|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718659|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718660|NCT00464698|Analgesics|analgesics|mesh-ancestor
154718661|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
154718662|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718663|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
154718664|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154718665|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
154718666|NCT00465088|Niacin|niacin|mesh-list
154718667|NCT00465088|Niacinamide|niacinamide|mesh-list
154718668|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
154718669|NCT00465088|Atorvastatin|atorvastatin|mesh-list
154718670|NCT00465088|Simvastatin|simvastatin|mesh-list
154718671|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154718672|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154718673|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
154718674|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718675|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154718676|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154718677|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718678|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
154718679|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
154718680|NCT00465088|Vitamins|vitamins|mesh-ancestor
154718681|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
154718682|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718683|NCT01796782|Capecitabine|capecitabine|mesh-list
154718684|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718685|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
154718686|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718687|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718688|NCT00466960|Paclitaxel|paclitaxel|mesh-list
154718689|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154718690|NCT00466960|Sargramostim|sargramostim|mesh-list
154718691|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718692|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718693|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718694|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718695|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718696|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718697|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
154718698|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718699|NCT00383266|Carboplatin|carboplatin|mesh-list
154718700|NCT00383266|Pemetrexed|pemetrexed|mesh-list
154718701|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718702|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718703|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718704|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154718705|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154718706|NCT00384670|Vaccines|vaccines|mesh-list
154718707|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
154718708|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718709|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154718710|NCT00467350|Laxatives|laxatives|mesh-ancestor
154718711|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718712|NCT00444028|Loxapine|loxapine|mesh-list
154470606|NCT05616364|Analgesics|analgesics|mesh-ancestor
154718713|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154718714|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154718715|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154718716|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718717|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154718718|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154718719|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
154718720|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718721|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718722|NCT00444964|Hormones|hormones|mesh-list
154718723|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718724|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718725|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154718726|NCT00445588|Sorafenib|sorafenib|mesh-list
154718727|NCT00445588|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154718728|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718729|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718730|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718731|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718732|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
154718733|NCT00445744|Busulfan|busulfan|mesh-list
154718734|NCT00445744|Methotrexate|methotrexate|mesh-list
154718735|NCT00445744|Tacrolimus|tacrolimus|mesh-list
154718736|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718737|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
154718738|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718739|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718740|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154718741|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
154718742|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718743|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718744|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154718745|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154718746|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
154718747|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154718748|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718749|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
154718750|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
154718751|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718752|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154718753|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154718754|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154718755|NCT00468208|Abatacept|abatacept|mesh-list
154718756|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154718757|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718758|NCT00468208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718759|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718760|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718761|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
154718762|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718763|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718764|NCT00385138|Clopidogrel|clopidogrel|mesh-list
154718765|NCT00385138|Cangrelor|cangrelor|mesh-list
154718766|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154718767|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154718768|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154718769|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154718770|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
154718771|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718772|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718773|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718774|NCT00446290|Docetaxel|docetaxel|mesh-list
154718775|NCT00446290|Capecitabine|capecitabine|mesh-list
154718776|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
154718777|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718778|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718779|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718780|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718781|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718782|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718783|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
154718784|NCT00385216|Nicotine|nicotine|mesh-list
154718785|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154470679|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154718786|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
154718787|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718788|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718789|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154718790|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154718791|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
154718792|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718793|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718794|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154718795|NCT00385996|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154718796|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718797|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718798|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718799|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718800|NCT00470392|Clobetasol|clobetasol|mesh-list
154718801|NCT00470392|Imiquimod|imiquimod|mesh-list
154718802|NCT00470392|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154718803|NCT00470392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718804|NCT00470392|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154718805|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
154718806|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718807|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154718808|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718809|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
154718810|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154718811|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
154718812|NCT00470392|Hormones|hormones|mesh-ancestor
154718813|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718814|NCT00470548|Paclitaxel|paclitaxel|mesh-list
154718815|NCT00470548|Pemetrexed|pemetrexed|mesh-list
154718816|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154718817|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718818|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735398|NCT04902443|Nivolumab|nivolumab|mesh-list
153735399|NCT04902443|Pomalidomide|pomalidomide|mesh-list
154718819|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718820|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718821|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718822|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718823|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718824|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154718825|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154718826|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154718827|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154718828|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154718829|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154718830|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718831|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718832|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718833|NCT00388414|Analgesics|analgesics|mesh-ancestor
154718834|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
154718835|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718836|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
154718837|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154718838|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
154718839|NCT00475150|Cediranib|cediranib|mesh-list
154718840|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718841|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718842|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718843|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718844|NCT00451048|Sunitinib|sunitinib|mesh-list
154718845|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718846|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154718847|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154718848|NCT00451048|Growth Substances|growth substances|mesh-ancestor
154718849|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718850|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
154718851|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718852|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718853|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718854|NCT00388804|Leuprolide|leuprolide|mesh-list
154718855|NCT00388804|Goserelin|goserelin|mesh-list
153753854|NCT02906722|Colistin|colistin|mesh-list
154718856|NCT00388804|Flutamide|flutamide|mesh-list
154718857|NCT00388804|Bicalutamide|bicalutamide|mesh-list
154718858|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154718859|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
154718860|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154718861|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718862|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154718863|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718864|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
154718865|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
154718866|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718867|NCT00389818|Prednisone|prednisone|mesh-list
154718868|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
154718869|NCT00389818|Rituximab|rituximab|mesh-list
154718870|NCT00389818|Doxorubicin|doxorubicin|mesh-list
154718871|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154718872|NCT00389818|Vincristine|vincristine|mesh-list
154718873|NCT00389818|Sargramostim|sargramostim|mesh-list
154718874|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718875|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
154718876|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718877|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718878|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154718879|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
154718880|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718881|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718882|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154718883|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718884|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154718885|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154718886|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154718887|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718888|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154718889|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
154718890|NCT00389818|Hormones|hormones|mesh-ancestor
154718891|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718892|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154718893|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154718894|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
154718895|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
154718896|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
154718897|NCT00452374|Cytarabine|cytarabine|mesh-list
154718898|NCT00452374|Rituximab|rituximab|mesh-list
154718899|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
154718900|NCT00452374|Fludarabine|fludarabine|mesh-list
154718901|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
154718902|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718903|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718904|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
154718905|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718906|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718907|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718908|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
154718909|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718910|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718911|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
154718912|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154718913|NCT01454583|Aliskiren|aliskiren|mesh-list
154718914|NCT01454583|Renin Inhibitors|renin inhibitors|mesh-ancestor
154718915|NCT01454583|Protease Inhibitors|protease inhibitors|mesh-ancestor
154718916|NCT01454583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718917|NCT01454583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718918|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
154718919|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154718920|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718921|NCT03286114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154718922|NCT03286114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718923|NCT00476242|Naltrexone|naltrexone|mesh-list
154718924|NCT00476242|Memantine|memantine|mesh-list
154718925|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154718926|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154718927|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
154718928|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718929|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718930|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718931|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154718932|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154718933|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154470829|NCT02091297|Acetaminophen|acetaminophen|mesh-list
154718934|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154718935|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
154718936|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154718938|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154718939|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154718940|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718941|NCT01795144|Glucagon|glucagon|mesh-list
154718942|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154718943|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154718944|NCT01795144|Hormones|hormones|mesh-ancestor
154718945|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154718946|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718947|NCT01795144|Incretins|incretins|mesh-ancestor
154718948|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154718949|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
154718950|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154718951|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154718952|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718953|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154718954|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154718955|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154718956|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718957|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
154718958|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154718959|NCT00453388|Cyclosporine|cyclosporine|mesh-list
154718960|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
154718961|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
154718962|NCT00453388|Fludarabine|fludarabine|mesh-list
154718963|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
154718964|NCT00453388|Cyclosporins|cyclosporins|mesh-list
154718965|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718966|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
154718967|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718968|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154718969|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154718970|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
154718971|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718972|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718973|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154718974|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154718975|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
154718976|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718977|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
154718978|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154718979|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
154718980|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154718981|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154718982|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154718983|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
154718984|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154718985|NCT00389974|Sunitinib|sunitinib|mesh-list
154718986|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154718987|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154718988|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154718989|NCT00389974|Growth Substances|growth substances|mesh-ancestor
154718990|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154718991|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
154718992|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154718993|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154718994|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154718995|NCT01453725|Golimumab|golimumab|mesh-list
154718996|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154718997|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154718998|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154718999|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
154719000|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719001|NCT00454324|Paclitaxel|paclitaxel|mesh-list
154719002|NCT00454324|Carboplatin|carboplatin|mesh-list
154719003|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154719004|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154719005|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719006|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
154719007|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
154719008|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
154719009|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719010|NCT02110264|Naltrexone|naltrexone|mesh-list
154719011|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154719012|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154719013|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719014|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
154719015|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719016|NCT01795222|Midazolam|midazolam|mesh-list
154719017|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154719018|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154719019|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719020|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719021|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154719022|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154719023|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154719024|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154719025|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
154719026|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
154719027|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
154719028|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
154719029|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719030|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719031|NCT01415349|Omeprazole|omeprazole|mesh-list
154719032|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154719033|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719034|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154719035|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719036|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719037|NCT00528190|Itraconazole|itraconazole|mesh-list
154719038|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
154719039|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719040|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154719041|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154719042|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719043|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719044|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154719045|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
154719046|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719047|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719048|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154719049|NCT02334813|Dexamethasone|dexamethasone|mesh-list
154719050|NCT02334813|Prednisone|prednisone|mesh-list
154719051|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719052|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
154719053|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
154719054|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719055|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719056|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719057|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
154719058|NCT02334813|Hormones|hormones|mesh-ancestor
154719059|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719060|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154719061|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719062|NCT00478036|Prednisolone|prednisolone|mesh-list
154719063|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
154719064|NCT00478036|Ketorolac|ketorolac|mesh-list
154719065|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154719066|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154719067|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719068|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
154719069|NCT00478036|Hormones|hormones|mesh-ancestor
154719070|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719071|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719072|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154719073|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719074|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754617|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
154719075|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719076|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154719077|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154719078|NCT00478036|Analgesics|analgesics|mesh-ancestor
154719079|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
154719080|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719081|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154719082|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719083|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719084|NCT00478036|Laxatives|laxatives|mesh-ancestor
154719085|NCT04048863|Imidacloprid|imidacloprid|mesh-list
154719086|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
154719087|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719088|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719089|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719090|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
154719091|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719092|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
154719093|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719094|NCT01453023|Fluticasone|fluticasone|mesh-list
154719095|NCT01453023|Xhance|xhance|mesh-list
154719096|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719097|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154719098|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
154719099|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719100|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719101|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154719102|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
154719103|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
154719104|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154719105|NCT01452789|Morphine|morphine|mesh-list
154719106|NCT01452789|Buprenorphine|buprenorphine|mesh-list
154719107|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154719108|NCT01452789|Narcotics|narcotics|mesh-ancestor
154719109|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719110|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719111|NCT01452789|Analgesics|analgesics|mesh-ancestor
154719112|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
154719113|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719114|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154719115|NCT00478192|Conivaptan|conivaptan|mesh-list
154719116|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154719117|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719118|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
154719119|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719120|NCT01414257|Methotrexate|methotrexate|mesh-list
154719121|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154719122|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
154719123|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154719124|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719125|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154719126|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
154719127|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719128|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719129|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
154719130|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719131|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154719132|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719133|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
154719134|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719135|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154719136|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154719137|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719138|NCT00528580|Simvastatin|simvastatin|mesh-list
154719139|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154719140|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154719141|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
154719142|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719143|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154719144|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154719145|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719146|NCT00529126|Epinephrine|epinephrine|mesh-list
154719147|NCT00529126|Bupivacaine|bupivacaine|mesh-list
154719148|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
154719149|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
154719150|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719151|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719152|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
154719153|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719154|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154719155|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154719156|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
154471053|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154719157|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719158|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719159|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154719160|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154719161|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
154719162|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154719163|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
154719165|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
154719166|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154719167|NCT00529204|Exenatide|exenatide|mesh-list
154719168|NCT00529204|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154719169|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154719170|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719171|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154719172|NCT00529204|Incretins|incretins|mesh-ancestor
154719173|NCT00529204|Hormones|hormones|mesh-ancestor
153754725|NCT03854370|Povidone|povidone|mesh-list
154719174|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719175|NCT01451541|Ciclesonide|ciclesonide|mesh-list
154719176|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
154719177|NCT01451541|Hormones|hormones|mesh-ancestor
154719178|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719179|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719180|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154719181|NCT00530764|Nabiximols|nabiximols|mesh-list
154719182|NCT00530764|Dronabinol|dronabinol|mesh-list
154719183|NCT00530764|Cannabidiol|cannabidiol|mesh-list
154719184|NCT00530764|Analgesics|analgesics|mesh-ancestor
154719185|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
154719186|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719187|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719188|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
154719189|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
154719190|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154719191|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154719192|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154719193|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154719194|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719195|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719196|NCT00530764|Hormones|hormones|mesh-ancestor
154719197|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719198|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154719199|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154719200|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154719201|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154719202|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719203|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719204|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719205|NCT00532480|Analgesics|analgesics|mesh-ancestor
154719206|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
154719207|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719208|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
154719209|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154719210|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
154719211|NCT00483262|Bortezomib|bortezomib|mesh-list
154719212|NCT00483262|Temsirolimus|temsirolimus|mesh-list
154719213|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719214|NCT00483262|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154719215|NCT00483262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154719216|NCT00483262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719217|NCT00483262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719218|NCT00483262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719219|NCT00483262|Immunologic Factors|immunologic factors|mesh-ancestor
154719220|NCT00483262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719221|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
154719222|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
154719223|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154719224|NCT00483496|Protective Agents|protective agents|mesh-ancestor
154719225|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719226|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
154719227|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154719228|NCT00485836|Ranibizumab|ranibizumab|mesh-list
154719229|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154719230|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154719231|NCT00485836|Growth Substances|growth substances|mesh-ancestor
154719232|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719233|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
154719234|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719235|NCT00488488|Tigecycline|tigecycline|mesh-list
154719236|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154719237|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719238|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154719239|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719240|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719241|NCT01450761|Carboplatin|carboplatin|mesh-list
154719242|NCT01450761|Etoposide|etoposide|mesh-list
154719243|NCT01450761|Ipilimumab|ipilimumab|mesh-list
154719244|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719245|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154719246|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154719247|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154719248|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719249|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719250|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154719251|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154719252|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
154719253|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719254|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
154719255|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154719256|NCT00538642|Ziprasidone|ziprasidone|mesh-list
154719257|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154719258|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
154719259|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719260|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719261|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719262|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154719263|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154719264|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719265|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154719266|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154719267|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
154719268|NCT01433991|Lenvatinib|lenvatinib|mesh-list
154719269|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719270|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154719271|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719272|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719273|NCT01450683|Itraconazole|itraconazole|mesh-list
154719274|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
154719275|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719276|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153755218|NCT00169247|Cetuximab|cetuximab|mesh-list
153755379|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719277|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154719278|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719279|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719280|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154719281|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
154719282|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719283|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719284|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154719285|NCT01433055|Minocycline|minocycline|mesh-list
154719286|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154719287|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719288|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
154719289|NCT01450137|Hormones|hormones|mesh-ancestor
154719290|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719291|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719292|NCT01412229|Paclitaxel|paclitaxel|mesh-list
154719293|NCT01412229|Carboplatin|carboplatin|mesh-list
154719294|NCT01412229|Cetuximab|cetuximab|mesh-list
154719295|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154719296|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719297|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
154719298|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
154719299|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
154719300|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719301|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154719302|NCT01432275|Insulin|insulin|mesh-list
154719303|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154719304|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719305|NCT01411995|Lidocaine|lidocaine|mesh-list
154719306|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
154719307|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
154719308|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719309|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719310|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
154719311|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719312|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154719313|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154719314|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153755536|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755537|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154719315|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154719316|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719317|NCT01411215|Etanercept|etanercept|mesh-list
154719318|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154719319|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154719320|NCT01411215|Analgesics|analgesics|mesh-ancestor
154719321|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
154719322|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719323|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719324|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719325|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719326|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719327|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719328|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
154719329|NCT01449279|Ipilimumab|ipilimumab|mesh-list
154719330|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154719331|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719332|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154719333|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719334|NCT01431963|Lamotrigine|lamotrigine|mesh-list
154719335|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
154719336|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154719337|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154719338|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719339|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154719340|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719341|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154719342|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154719343|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719344|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154719345|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154719346|NCT01447407|Vaccines|vaccines|mesh-list
154719347|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
154719348|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
154719349|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719350|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154719351|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154719352|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
154719353|NCT00540982|Vinorelbine|vinorelbine|mesh-list
154719354|NCT00540982|Lidocaine|lidocaine|mesh-list
154719355|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
154719356|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
154719357|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719358|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719359|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
154719360|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719361|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154719362|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154719363|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154719364|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154719365|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719366|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154719367|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719368|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
154719369|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
154719370|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
154719371|NCT00542620|Insulin|insulin|mesh-list
154719372|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154719373|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
154719374|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
154719375|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154719376|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
154719377|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154471276|NCT02096289|Thioridazine|thioridazine|mesh-list
154719378|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719379|NCT00543400|Heparin|heparin|mesh-list
154719380|NCT00543400|Calcium heparin|calcium heparin|mesh-list
154719381|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
154719382|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154719383|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154719384|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719385|NCT01796938|Lacosamide|lacosamide|mesh-list
154719386|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
154719387|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154719388|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154719389|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154719390|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719391|NCT00492544|Vaccines|vaccines|mesh-list
154719392|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
154719393|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719394|NCT00492622|Omeprazole|omeprazole|mesh-list
154719395|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154719396|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719397|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154719398|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719399|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719400|NCT00494494|Nepafenac|nepafenac|mesh-list
154719401|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154719402|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154719403|NCT00494494|Analgesics|analgesics|mesh-ancestor
154719404|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
154719405|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719406|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719407|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719408|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719409|NCT03145558|Doxorubicin|doxorubicin|mesh-list
154719410|NCT03145558|Tirapazamine|tirapazamine|mesh-list
154719411|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154719412|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719413|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154719414|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154719415|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719416|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719417|NCT00497770|Pemetrexed|pemetrexed|mesh-list
154719418|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719419|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719420|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719421|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154719422|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154719423|NCT00498550|Clozapine|clozapine|mesh-list
154719424|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154719425|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
154719426|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719427|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719428|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719429|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154719430|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154719431|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719432|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154719433|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
154719434|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
154719435|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154719436|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
154719437|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154719438|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154719439|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154719440|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719441|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719442|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154719443|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154719444|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719445|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719446|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154719447|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
154719448|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719449|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719450|NCT00499408|Vitamin D|vitamin d|mesh-list
154719451|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
154719452|NCT00499408|Vitamins|vitamins|mesh-ancestor
154719453|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
154719454|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719455|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154719456|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154719457|NCT03019666|Niacinamide|niacinamide|mesh-list
154719458|NCT03019666|Niacin|niacin|mesh-list
154719459|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
154719460|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
154719461|NCT03019666|Vitamins|vitamins|mesh-ancestor
154719462|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
154719463|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719464|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154719465|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
154719466|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719467|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154719468|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
154719469|NCT00500578|Ribavirin|ribavirin|mesh-list
154719470|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
154719471|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719472|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
154719473|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719474|NCT01430559|Meloxicam|meloxicam|mesh-list
154719475|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154719476|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154719477|NCT01430559|Analgesics|analgesics|mesh-ancestor
154719478|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
154719479|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719480|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719481|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719482|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719483|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154719484|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154719485|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719486|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719487|NCT00500656|Icatibant|icatibant|mesh-list
154719488|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
154719489|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154719490|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154719491|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719492|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
154719493|NCT00500656|Coagulants|coagulants|mesh-ancestor
154719494|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154719495|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154719496|NCT00500656|Analgesics|analgesics|mesh-ancestor
154719497|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
154719498|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719499|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719500|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719501|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719502|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154719503|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154719504|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154719505|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719506|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
154719507|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
154719508|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154719509|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719510|NCT01445847|Lidocaine|lidocaine|mesh-list
154719511|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
154719512|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
154719513|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719514|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719515|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
154719516|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719517|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154719518|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154719519|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154719520|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154719521|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719522|NCT00502216|Naltrexone|naltrexone|mesh-list
154719523|NCT00502216|Varenicline|varenicline|mesh-list
154719524|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154719525|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154719526|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719527|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
154719529|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154719530|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154719531|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
154719532|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719533|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719534|NCT00545662|Choline|choline|mesh-list
154719535|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154719536|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
154719537|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154719538|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
154719539|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756390|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
154719540|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719541|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154719542|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
154719543|NCT00545974|Memantine|memantine|mesh-list
154719544|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154719545|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154719546|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
154719547|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719548|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719549|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719550|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154719551|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154719552|NCT00548470|Varenicline|varenicline|mesh-list
154719553|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154719554|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154719555|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
154719556|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719557|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719558|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719559|NCT00509002|Gefitinib|gefitinib|mesh-list
154719560|NCT00509002|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154719561|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154719562|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719563|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719564|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719565|NCT00887380|Anastrozole|anastrozole|mesh-list
154719566|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154719567|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719568|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154719569|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154719570|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719571|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719572|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154719573|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
154719574|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719575|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719576|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154719577|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719578|NCT00557284|Montelukast|montelukast|mesh-list
154719579|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154719580|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
154719581|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154719582|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
154719583|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719584|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719585|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154719586|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153756561|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
154719587|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719588|NCT00557362|Voriconazole|voriconazole|mesh-list
154719589|NCT00557362|Natamycin|natamycin|mesh-list
154719590|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
154719591|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719592|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154719593|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154719594|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719595|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719596|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154719597|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
154471498|NCT05816668|Tranexamic Acid|tranexamic acid|mesh-list
154719598|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719599|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719600|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154719601|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154719602|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154719603|NCT00512278|Infliximab|infliximab|mesh-list
154719604|NCT00512278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154719605|NCT00512278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719606|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
154719607|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719608|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719609|NCT01445535|Prednisone|prednisone|mesh-list
154719610|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
154719611|NCT01445535|Rituximab|rituximab|mesh-list
154719612|NCT01445535|Doxorubicin|doxorubicin|mesh-list
154719613|NCT01445535|Etoposide|etoposide|mesh-list
154719614|NCT01445535|Vincristine|vincristine|mesh-list
154719615|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719616|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
154719617|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719618|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719619|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154719620|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
154719621|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719622|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719623|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154719624|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154719625|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154719626|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154719627|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154719628|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719629|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719630|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
154719631|NCT01445535|Hormones|hormones|mesh-ancestor
154719632|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719633|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154719634|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154719635|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
154719636|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
154719637|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
154719638|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
154719639|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
154719640|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154719641|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153756802|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154719642|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719643|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719644|NCT01409031|Urological Agents|urological agents|mesh-ancestor
154719645|NCT01430403|Fluticasone|fluticasone|mesh-list
154719646|NCT01430403|Xhance|xhance|mesh-list
154719647|NCT01430403|Omalizumab|omalizumab|mesh-list
154719648|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154719649|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719650|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154719651|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
154719652|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719653|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719654|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154719655|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
154719656|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154719657|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154719658|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
154719659|NCT01408641|Topiramate|topiramate|mesh-list
154719660|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
154719661|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154719662|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719663|NCT01429077|Levodopa|levodopa|mesh-list
154719664|NCT01429077|Carbidopa|carbidopa|mesh-list
154719665|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154719666|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154719667|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
154719668|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719669|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719670|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719671|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154719672|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471574|NCT05640453|Pregabalin|pregabalin|mesh-list
154719674|NCT01408563|Melphalan|melphalan|mesh-list
154719675|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719676|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719677|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719678|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
154719679|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719680|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154719681|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
154719682|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154719683|NCT01442493|Methadone|methadone|mesh-list
154719684|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154719685|NCT01442493|Narcotics|narcotics|mesh-ancestor
154719686|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719687|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719688|NCT01442493|Analgesics|analgesics|mesh-ancestor
154719689|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
154719690|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719691|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
154719692|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
154719693|NCT04407975|Betamethasone|betamethasone|mesh-list
154719694|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719695|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
154719696|NCT04407975|Hormones|hormones|mesh-ancestor
154719697|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719698|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719699|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154719700|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
154719701|NCT01428063|Interferons|interferons|mesh-list
154719702|NCT01428063|Ribavirin|ribavirin|mesh-list
154719703|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
154719704|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
154719705|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154719706|NCT01428063|Asunaprevir|asunaprevir|mesh-list
154719707|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719708|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
154719709|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719710|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
154719711|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719712|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
154719713|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719714|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
154719715|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719716|NCT00513292|Paclitaxel|paclitaxel|mesh-list
154719717|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
154719718|NCT00513292|Trastuzumab|trastuzumab|mesh-list
154719719|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154719720|NCT00513292|Epirubicin|epirubicin|mesh-list
154719721|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154719722|NCT00513292|Antibodies|antibodies|mesh-list
153757204|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
154719723|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
154719724|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154719725|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154719726|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719727|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
154719728|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
154719729|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
154719730|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719731|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719732|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
154719733|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719734|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719735|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154719736|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
154719737|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154719738|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154719739|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154719740|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154719741|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719742|NCT00513370|Adalimumab|adalimumab|mesh-list
154719743|NCT00513370|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154719744|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719745|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719746|NCT00559468|Bromides|bromides|mesh-list
154719747|NCT00559468|Propofol|propofol|mesh-list
154719748|NCT00559468|Sevoflurane|sevoflurane|mesh-list
154719749|NCT00559468|Rocuronium|rocuronium|mesh-list
154471650|NCT05445232|Midazolam|midazolam|mesh-list
154719750|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154719751|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154719752|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719753|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154719754|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
154719755|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
154719756|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154719757|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154719758|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
154719759|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154719760|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154719761|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154719762|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719763|NCT00561418|Vorinostat|vorinostat|mesh-list
154719764|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719765|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154719766|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719767|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719768|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154719769|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
154719770|NCT00514852|Glycerol|glycerol|mesh-list
154719771|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154719772|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154719773|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154719774|NCT00514852|Protective Agents|protective agents|mesh-ancestor
154719775|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719776|NCT00514852|Laxatives|laxatives|mesh-ancestor
154719777|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719778|NCT00555880|Midodrine|midodrine|mesh-list
154719779|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
154719780|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
154719781|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719782|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719783|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154719784|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154719785|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154719786|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154719787|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
154719788|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719789|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719790|NCT00563290|Dasatinib|dasatinib|mesh-list
154719791|NCT00563290|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154719792|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154719793|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719794|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719795|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719796|NCT00556504|Ribavirin|ribavirin|mesh-list
154719797|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154719798|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154719799|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
154719800|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719801|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
154719802|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719803|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
154719804|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154719805|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719806|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154719807|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154719808|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
154719809|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719810|NCT00520234|Caspofungin|caspofungin|mesh-list
154719811|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
154719812|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719813|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757327|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719814|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719815|NCT00520468|Cyclosporine|cyclosporine|mesh-list
154719816|NCT00520468|Prednisone|prednisone|mesh-list
154719817|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
154719818|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
154719819|NCT00520468|Cyclosporins|cyclosporins|mesh-list
154719820|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719821|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
154719822|NCT00520468|Hormones|hormones|mesh-ancestor
154719823|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719824|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471725|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
154719825|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154719826|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719827|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719828|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719829|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719830|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
154719831|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
154719832|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719833|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
154719834|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719835|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154719836|NCT00520468|Hematinics|hematinics|mesh-ancestor
154719837|NCT05559268|Denosumab|denosumab|mesh-list
154719838|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154719839|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719840|NCT02121418|Cytarabine|cytarabine|mesh-list
154719841|NCT02121418|Decitabine|decitabine|mesh-list
154719842|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154719843|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
154719844|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719845|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719846|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
154719847|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719848|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719849|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
154719850|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719851|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719852|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154719853|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154719854|NCT01441635|Norethindrone|norethindrone|mesh-list
154719855|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
154719856|NCT01441635|Estradiol|estradiol|mesh-list
154719857|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154719858|NCT01441635|Progesterone|progesterone|mesh-list
154719859|NCT01441635|Estrogens|estrogens|mesh-ancestor
154719860|NCT01441635|Hormones|hormones|mesh-ancestor
154719861|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719862|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719863|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154719864|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
154719865|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154719866|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154719867|NCT01441635|Progestins|progestins|mesh-ancestor
154719868|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154719869|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154719870|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154719871|NCT01427907|Calcium|calcium|mesh-list
154719872|NCT01427907|Sevelamer|sevelamer|mesh-list
154719873|NCT01427907|Calcium acetate|calcium acetate|mesh-list
154719874|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154719875|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719876|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
154719877|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
154719878|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719879|NCT02985333|Dexamethasone|dexamethasone|mesh-list
154719880|NCT02985333|Paclitaxel|paclitaxel|mesh-list
154719881|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
154719882|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154719883|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719884|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
154719885|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
154719886|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
154719887|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719888|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719889|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
154719890|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719891|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719892|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154719893|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
154719894|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154719895|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719896|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
154719897|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
154719898|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719899|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719900|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
154719901|NCT02985333|Hormones|hormones|mesh-ancestor
154719902|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719903|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154719904|NCT01427751|Dexamethasone|dexamethasone|mesh-list
154719905|NCT01427751|Ranibizumab|ranibizumab|mesh-list
154719906|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154719907|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
154719908|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
154719909|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154719910|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719911|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154719912|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
154719914|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719915|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154719916|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719917|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154719918|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154719919|NCT01427751|Growth Substances|growth substances|mesh-ancestor
154719920|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
154719921|NCT01920061|Docetaxel|docetaxel|mesh-list
154719922|NCT01920061|Dacomitinib|dacomitinib|mesh-list
154719923|NCT01920061|Gedatolisib|gedatolisib|mesh-list
154719924|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719925|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
154719926|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757676|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719927|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
154719928|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719929|NCT01920061|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154719930|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154719931|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719932|NCT01426347|Vitamin D|vitamin d|mesh-list
154719933|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
154719934|NCT01426347|Vitamins|vitamins|mesh-ancestor
154719935|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
154719936|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719937|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154719938|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154719939|NCT04612309|Immunomodulating Agents|immunomodulating agents|mesh-list
154719940|NCT04612309|Immunologic Factors|immunologic factors|mesh-ancestor
154719941|NCT04612309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719942|NCT04415983|Metronidazole|metronidazole|mesh-list
154719943|NCT04415983|Clarithromycin|clarithromycin|mesh-list
154719944|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
154719945|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154719946|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719947|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154719948|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154719949|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154719950|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154719951|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719952|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719953|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154719954|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154719955|NCT01426269|Metronidazole|metronidazole|mesh-list
154719956|NCT01426269|Doxycycline|doxycycline|mesh-list
154719957|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154719958|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154719959|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154719960|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154719961|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
154719962|NCT01426113|Timolol|timolol|mesh-list
154719963|NCT01426113|Bimatoprost|bimatoprost|mesh-list
154719964|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154719965|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154719966|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154719967|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154719968|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
153757767|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
154719969|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154719970|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719971|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719972|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154719973|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154719974|NCT01393899|Tofacitinib|tofacitinib|mesh-list
154471876|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154719975|NCT01393899|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154719976|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154719977|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719978|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719979|NCT02078193|Abatacept|abatacept|mesh-list
154719980|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154719981|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719982|NCT02078193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154719983|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154719984|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154719985|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
154719986|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719987|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154719988|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154719989|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154719990|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154719991|NCT01405911|Incretins|incretins|mesh-ancestor
154719992|NCT01405911|Hormones|hormones|mesh-ancestor
154719993|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154719994|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154719995|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
154719996|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154719997|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154719998|NCT01425801|Albuterol|albuterol|mesh-list
154719999|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154720000|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
154720001|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720002|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720003|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154720004|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720005|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
154720006|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154720007|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154720008|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154720009|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153757867|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154720010|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
154720011|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720012|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720013|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
154720014|NCT02076243|Paclitaxel|paclitaxel|mesh-list
154720015|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154720016|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720017|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720018|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720019|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720020|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720021|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
154720022|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154720023|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154720024|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154720025|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154720026|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720027|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
154720028|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720029|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720030|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154720031|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720032|NCT01392573|Insulin|insulin|mesh-list
154720033|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154720034|NCT01392573|Liraglutide|liraglutide|mesh-list
154720035|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
154720036|NCT01392573|Xultophy|xultophy|mesh-list
154720037|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154720038|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720039|NCT01392573|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154720040|NCT01392573|Incretins|incretins|mesh-ancestor
154720041|NCT01392573|Hormones|hormones|mesh-ancestor
154720042|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720043|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
154720044|NCT01392495|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154720045|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720046|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720047|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720048|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720049|NCT01405053|Rufinamide|rufinamide|mesh-list
154720050|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
154720051|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154720052|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154720053|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154720054|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720055|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154720056|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
154720057|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720058|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
154720059|NCT01392183|Sirolimus|sirolimus|mesh-list
154720060|NCT01392183|Temsirolimus|temsirolimus|mesh-list
154720061|NCT01392183|MTOR Inhibitors|mtor inhibitors|mesh-list
154720062|NCT01392183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720063|NCT01392183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720064|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720065|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720066|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
154720067|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720068|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720069|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720070|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720071|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154720072|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
154720073|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154720074|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154720075|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720076|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
154720077|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
154720078|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
154720079|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720080|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
154720081|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
154720082|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154720083|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154720084|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
154720085|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
154720086|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720087|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154720088|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
154720089|NCT01402947|Mesalamine|mesalamine|mesh-list
154720090|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720091|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720092|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154720093|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154720094|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720095|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720096|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720097|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154720098|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154720099|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154720100|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154720101|NCT01402947|Analgesics|analgesics|mesh-ancestor
154720102|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
154720103|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720104|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720105|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720106|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720107|NCT03025893|Sunitinib|sunitinib|mesh-list
154720108|NCT03025893|Lomustine|lomustine|mesh-list
154720109|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720110|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154720111|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154720112|NCT03025893|Growth Substances|growth substances|mesh-ancestor
154720113|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720114|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
154720115|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720116|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720117|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720118|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154720119|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
154720120|NCT01402869|Lidocaine|lidocaine|mesh-list
154720121|NCT01402869|Epinephrine|epinephrine|mesh-list
154472029|NCT03714958|Trametinib|trametinib|mesh-list
154720122|NCT01402869|Prilocaine|prilocaine|mesh-list
154720123|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
154720125|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720126|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720127|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
154720128|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720129|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154720130|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154720131|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154720132|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154720133|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720134|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154720135|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154720136|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
154720137|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720138|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154720139|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154720140|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
154720141|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154720142|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720143|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
154720144|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
154720145|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154720146|NCT01391793|Dexamethasone|dexamethasone|mesh-list
154720147|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720148|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
154720149|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
154720150|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720151|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720152|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154720153|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
154720154|NCT01391793|Hormones|hormones|mesh-ancestor
154720155|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720156|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154720157|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720158|NCT01422915|Colestipol|colestipol|mesh-list
154720159|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154720160|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
154720161|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720162|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154720163|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
154720164|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
154720165|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154720166|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
154720167|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720168|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720169|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154720170|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720171|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
154720172|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154720173|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
154720174|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720175|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720176|NCT01422213|Vortioxetine|vortioxetine|mesh-list
154720177|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
154720178|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154720179|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154720180|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154720181|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720182|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720183|NCT01422213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154720184|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154720185|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154720186|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720187|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720188|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
154720189|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154720190|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154720191|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154720192|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154720193|NCT01390857|Valacyclovir|valacyclovir|mesh-list
154720194|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
154720195|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720196|NCT01725386|Capecitabine|capecitabine|mesh-list
154720197|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154720198|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
154720199|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720200|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720201|NCT01402011|Lidocaine|lidocaine|mesh-list
154720202|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
154720203|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
154720204|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720205|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720206|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
154720207|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720208|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154720209|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154720210|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154720211|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154720212|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720213|NCT01421667|Rituximab|rituximab|mesh-list
154720214|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153758461|NCT00200655|Pravastatin|pravastatin|mesh-list
154720215|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720216|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720217|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
154720218|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720219|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720220|NCT01421667|Immunotoxins|immunotoxins|mesh-ancestor
154720221|NCT01421667|Immunoconjugates|immunoconjugates|mesh-ancestor
154720222|NCT01891669|PF-06263507|pf-06263507|mesh-list
154720223|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720224|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720225|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720226|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720227|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720228|NCT01421511|Linezolid|linezolid|mesh-list
154720229|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720230|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720231|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154720232|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720233|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720234|NCT01891357|Paclitaxel|paclitaxel|mesh-list
154720235|NCT01891357|Trastuzumab|trastuzumab|mesh-list
154720236|NCT01891357|Lapatinib|lapatinib|mesh-list
154720237|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154720238|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720239|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720240|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720241|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720242|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720243|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720244|NCT01891357|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154720245|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720246|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720247|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
154720248|NCT01420965|Antibodies|antibodies|mesh-list
154720249|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
154720250|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720251|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
154720252|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720253|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720254|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154720255|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
154720256|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720257|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720258|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154720259|NCT04033575|Listerine|listerine|mesh-list
154720260|NCT04033575|Fluorides|fluorides|mesh-list
154720261|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
154720262|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
154720263|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
154720264|NCT04033575|Protective Agents|protective agents|mesh-ancestor
154720265|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720266|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154720267|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720268|NCT01390389|Ubiquinone|ubiquinone|mesh-list
154720269|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
154720270|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
154720271|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720272|NCT01390389|Vitamins|vitamins|mesh-ancestor
154720273|NCT03835533|Nivolumab|nivolumab|mesh-list
154720274|NCT03835533|Poly ICLC|poly iclc|mesh-list
154720275|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720276|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720277|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154720278|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720279|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
154720280|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
154720281|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720282|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
154720283|NCT01401465|Ciclesonide|ciclesonide|mesh-list
154720284|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720285|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154720286|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154720287|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
154720288|NCT01401465|Hormones|hormones|mesh-ancestor
154720289|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720290|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720291|NCT01890967|Atorvastatin|atorvastatin|mesh-list
154720292|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154720293|NCT01890967|Simvastatin|simvastatin|mesh-list
154720294|NCT01890967|Ezetimibe|ezetimibe|mesh-list
154720295|NCT01890967|Pravastatin|pravastatin|mesh-list
154720296|NCT01890967|Pitavastatin|pitavastatin|mesh-list
154720297|NCT01890967|Lovastatin|lovastatin|mesh-list
154720298|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154720299|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154720300|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
154720301|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720302|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154720303|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154720304|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720305|NCT01863667|Glimepiride|glimepiride|mesh-list
154720306|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154720307|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154720308|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720309|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720310|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
154720311|NCT01614769|Glimepiride|glimepiride|mesh-list
154720312|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154720313|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154720314|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720315|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720316|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
154720317|NCT01614457|Ivacaftor|ivacaftor|mesh-list
154720318|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154720319|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154720320|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720321|NCT01835431|Insulin|insulin|mesh-list
154720322|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154720323|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
154720324|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
154720325|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154720326|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
153758925|NCT00201396|Epirubicin|epirubicin|mesh-list
154720327|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154720328|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720329|NCT01880593|Ketamine|ketamine|mesh-list
154720330|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
154720331|NCT01880593|Analgesics|analgesics|mesh-ancestor
154720332|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
154720333|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720334|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720335|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154720336|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154720337|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
154720338|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
154720339|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720340|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154720341|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154720342|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720343|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720344|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
154720345|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154720346|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720347|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
154720348|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154720349|NCT01400451|Ipilimumab|ipilimumab|mesh-list
154720350|NCT01400451|Vemurafenib|vemurafenib|mesh-list
154720351|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720352|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720353|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154720354|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720355|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720356|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720357|NCT01400139|Hydrocodone|hydrocodone|mesh-list
154720358|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154720359|NCT01400139|Narcotics|narcotics|mesh-ancestor
154720360|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720361|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720362|NCT01400139|Analgesics|analgesics|mesh-ancestor
154720363|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
154720364|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720365|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
154720366|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720367|NCT01399905|Carbidopa|carbidopa|mesh-list
154720368|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154720369|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154720370|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
154720371|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720372|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720373|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720374|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154720375|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720376|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154720377|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
154720378|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154720379|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154720380|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154720381|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720382|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720383|NCT01724528|Allopurinol|allopurinol|mesh-list
154720384|NCT01724528|Febuxostat|febuxostat|mesh-list
154720385|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
154720386|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720387|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720388|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
154720389|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720390|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154720391|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
154720392|NCT01724528|Protective Agents|protective agents|mesh-ancestor
154720393|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720394|NCT01750268|Topiramate|topiramate|mesh-list
154720395|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
154720396|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154720397|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720398|NCT01880437|Cytarabine|cytarabine|mesh-list
154720399|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154720400|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
154720401|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720402|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720403|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
154720404|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720405|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720406|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
154720407|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720408|NCT01861717|Lanreotide|lanreotide|mesh-list
154720409|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720410|NCT01834729|Alfuzosin|alfuzosin|mesh-list
154720411|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154720412|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154720413|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154720414|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
154720415|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720416|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720417|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720418|NCT01834729|Urological Agents|urological agents|mesh-ancestor
154720419|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
154720420|NCT01860703|Deferiprone|deferiprone|mesh-list
154720421|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720422|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720423|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154720424|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154720425|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720426|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720427|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720428|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154720429|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
154720430|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
154720431|NCT01399593|Eculizumab|eculizumab|mesh-list
154720432|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154720433|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720434|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
154720435|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720436|NCT01388985|Vaccines|vaccines|mesh-list
154720437|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
154720438|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720439|NCT01388361|Insulin|insulin|mesh-list
154720440|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154720441|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
154720442|NCT01388361|Liraglutide|liraglutide|mesh-list
154720443|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154720444|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720445|NCT01388361|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154720446|NCT01388361|Incretins|incretins|mesh-ancestor
154720447|NCT01388361|Hormones|hormones|mesh-ancestor
154720448|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720449|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
154720450|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154720451|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720452|NCT01399125|Rivastigmine|rivastigmine|mesh-list
154720453|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154720454|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720455|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720456|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
154720457|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720458|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720459|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154720460|NCT01399125|Protective Agents|protective agents|mesh-ancestor
154720461|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
154720462|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154720463|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720464|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154720465|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
154720466|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720467|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720468|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720469|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720470|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154720471|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154720472|NCT04012827|Doxorubicin|doxorubicin|mesh-list
154720473|NCT04012827|Apatinib|apatinib|mesh-list
154720474|NCT04012827|Ifosfamide|ifosfamide|mesh-list
154720475|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154720476|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720477|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154720478|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154720479|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720480|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720481|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720482|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154720483|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
154720484|NCT01879579|Insulin|insulin|mesh-list
154720485|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154720486|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720487|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
154720488|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154720489|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
154720490|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720491|NCT01386645|Expectorants|expectorants|mesh-ancestor
154720492|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720493|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154720494|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
154720495|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720496|NCT01386645|Protective Agents|protective agents|mesh-ancestor
154720497|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720498|NCT01386645|Antidotes|antidotes|mesh-ancestor
154720499|NCT01831765|Insulin|insulin|mesh-list
154720500|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154720501|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
154720502|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
154720503|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154720504|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
154720505|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154720506|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720507|NCT01830595|Lactoferrin|lactoferrin|mesh-list
154720508|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720509|NCT01748162|Fluticasone|fluticasone|mesh-list
154720510|NCT01748162|Prednisolone|prednisolone|mesh-list
154720511|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720512|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154720513|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
154720514|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720515|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720516|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154720517|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720518|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
154720519|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154720520|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
154720521|NCT01748162|Hormones|hormones|mesh-ancestor
154720522|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720523|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154720524|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720525|NCT01723904|Rotigotine|rotigotine|mesh-list
154720526|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
154720527|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
154720528|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720529|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720530|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720531|NCT01830127|Ribavirin|ribavirin|mesh-list
154720532|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
154720533|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720534|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
154720535|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720536|NCT01614067|Ganirelix|ganirelix|mesh-list
154720537|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
154720538|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720539|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720540|NCT01397409|Ranibizumab|ranibizumab|mesh-list
154720541|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154720542|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154720543|NCT01397409|Growth Substances|growth substances|mesh-ancestor
154720544|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720545|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
154720546|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720547|NCT04766775|Fluorides|fluorides|mesh-list
154720548|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
154720549|NCT04766775|Protective Agents|protective agents|mesh-ancestor
154720550|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720551|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
154720552|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154720553|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
154720554|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720555|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720556|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154720557|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720558|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
154720559|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154720560|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
154720561|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720562|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720563|NCT03024879|Erythromycin|erythromycin|mesh-list
154720564|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
154720565|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154720566|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
154720567|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720568|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720569|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154720570|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154720571|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720572|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720573|NCT01383993|Voriconazole|voriconazole|mesh-list
154720574|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
154720575|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720576|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154720577|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154720578|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720579|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720580|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154720581|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
154720582|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720583|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720584|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154720585|NCT01396395|Nicorandil|nicorandil|mesh-list
154720586|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154720587|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154720588|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
154720589|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
154720590|NCT01396395|Vitamins|vitamins|mesh-ancestor
154720591|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
154720592|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720593|NCT01396083|Dexamethasone|dexamethasone|mesh-list
154720594|NCT01396083|Ranibizumab|ranibizumab|mesh-list
154720595|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720596|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
154720597|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
154720598|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720599|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720600|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154720601|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
154720602|NCT01396083|Hormones|hormones|mesh-ancestor
154720603|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720604|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154720605|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720606|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154720607|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154720608|NCT01396083|Growth Substances|growth substances|mesh-ancestor
154720609|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
154720610|NCT01776008|Anastrozole|anastrozole|mesh-list
154720611|NCT01776008|Goserelin|goserelin|mesh-list
154720612|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154720613|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720614|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154720615|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154720616|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720617|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720618|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154720619|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
154720620|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720621|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720622|NCT01858363|Paclitaxel|paclitaxel|mesh-list
154720623|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154720624|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720625|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720626|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720627|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720628|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720629|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154720630|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
154720631|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720632|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154720633|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154720634|NCT01396005|Buprenorphine|buprenorphine|mesh-list
154720635|NCT01396005|Methadone|methadone|mesh-list
154720636|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154720637|NCT01396005|Naloxone|naloxone|mesh-list
154720638|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154720639|NCT01396005|Narcotics|narcotics|mesh-ancestor
154720640|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720641|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720642|NCT01396005|Analgesics|analgesics|mesh-ancestor
154720643|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
154720644|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720645|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154720646|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
154720647|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720648|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
154720649|NCT03024957|Morphine|morphine|mesh-list
154720650|NCT03024957|Bupivacaine|bupivacaine|mesh-list
154720651|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
154720652|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
154720653|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720654|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720655|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
154720656|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720657|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154720658|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154720660|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154720661|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154720662|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154720663|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
154720664|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720665|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720666|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154720667|NCT03024957|Narcotics|narcotics|mesh-ancestor
154720668|NCT03025113|Ketoprofen|ketoprofen|mesh-list
154720669|NCT03025113|Amitriptyline|amitriptyline|mesh-list
154720670|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
154720671|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154720672|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154720673|NCT03025113|Analgesics|analgesics|mesh-ancestor
154720674|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
154720675|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720676|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720677|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720678|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720679|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154720680|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720681|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720682|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154720683|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
154720684|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154720685|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154720686|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154720687|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154720688|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720689|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154720690|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154720691|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154720692|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
154720693|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720694|NCT01877083|Lenvatinib|lenvatinib|mesh-list
154720695|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720696|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720697|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720698|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720699|NCT01380327|Immunomodulating Agents|immunomodulating agents|mesh-list
154720700|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
154720701|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720702|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154720703|NCT01829425|Oxybutynin|oxybutynin|mesh-list
154720704|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154720705|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154720706|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
154720707|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720708|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720709|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720710|NCT01829425|Urological Agents|urological agents|mesh-ancestor
154720711|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
154720712|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
154720713|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720714|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
154720715|NCT01394991|Hematinics|hematinics|mesh-ancestor
154720716|NCT01394523|Bupivacaine|bupivacaine|mesh-list
154720717|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
154720718|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
154720719|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720720|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720721|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
154720722|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720723|NCT01857583|PENTA|penta|mesh-list
154720724|NCT01857583|Edoxaban|edoxaban|mesh-list
154720725|NCT01857583|Fondaparinux|fondaparinux|mesh-list
154720726|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154720727|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
154720728|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154720729|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
154720730|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720731|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720732|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
154720733|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154720734|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154720735|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154720736|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
154720737|NCT00211185|Prednisone|prednisone|mesh-list
154720738|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
154720739|NCT00211185|Doxorubicin|doxorubicin|mesh-list
154720740|NCT00211185|Vincristine|vincristine|mesh-list
154720741|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
154720742|NCT00211185|Lenograstim|lenograstim|mesh-list
154720743|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720744|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
154720745|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720746|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720747|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154720748|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
154720749|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720750|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720751|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154720752|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154720753|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154720754|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154720755|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720756|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720757|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
154720758|NCT00211185|Hormones|hormones|mesh-ancestor
154720759|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720760|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154720761|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154720762|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720763|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720764|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720765|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154720766|NCT00219297|Epothilone B|epothilone b|mesh-list
154720767|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720768|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720769|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720770|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720771|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720772|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154720773|NCT01857271|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154720774|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720775|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720776|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720777|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720778|NCT01721486|Acetaminophen|acetaminophen|mesh-list
154720779|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154720780|NCT01721486|Analgesics|analgesics|mesh-ancestor
154720781|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
154720782|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720783|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720784|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
154720785|NCT01721408|Imipenem|imipenem|mesh-list
154720786|NCT01721408|Tigecycline|tigecycline|mesh-list
154720787|NCT01721408|Cilastatin|cilastatin|mesh-list
154720788|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720789|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720790|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154720791|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720792|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720793|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
154720794|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154720795|NCT03998709|Somatostatin|somatostatin|mesh-list
154720796|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720797|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154720798|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154720799|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154720800|NCT03998709|Hormones|hormones|mesh-ancestor
154720801|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720802|NCT01744496|Rotigotine|rotigotine|mesh-list
154720803|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
154720804|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
154720805|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720806|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720807|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720808|NCT01721330|Naltrexone|naltrexone|mesh-list
154720809|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154720810|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154720811|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720812|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
154720813|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720814|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
154720815|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720816|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720817|NCT03592407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153759541|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154720818|NCT03592407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720819|NCT01828021|Margetuximab|margetuximab|mesh-list
154720820|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720821|NCT03784599|Trastuzumab|trastuzumab|mesh-list
154720822|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154720823|NCT03784599|Osimertinib|osimertinib|mesh-list
154720824|NCT03784599|Maytansine|maytansine|mesh-list
154720825|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720826|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720827|NCT03784599|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154720828|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720829|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720830|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720831|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154720832|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720833|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720834|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720835|NCT03784599|Immunotoxins|immunotoxins|mesh-ancestor
154720836|NCT03784599|Immunoconjugates|immunoconjugates|mesh-ancestor
154720837|NCT03784599|Immunologic Factors|immunologic factors|mesh-ancestor
154720838|NCT03784599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720839|NCT01827943|Sirolimus|sirolimus|mesh-list
154720840|NCT01827943|Temsirolimus|temsirolimus|mesh-list
154720841|NCT01827943|MTOR Inhibitors|mtor inhibitors|mesh-list
154720842|NCT01827943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720843|NCT01827943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720844|NCT01827943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720845|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720846|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
154720847|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720848|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720849|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720850|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720851|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154720852|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
154720853|NCT02985255|Docetaxel|docetaxel|mesh-list
154720854|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720855|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720856|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720857|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720858|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720859|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154720860|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720861|NCT00217971|Dronabinol|dronabinol|mesh-list
154720862|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
154720863|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720864|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154720865|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154720866|NCT00217971|Analgesics|analgesics|mesh-ancestor
154720867|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
154720868|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720869|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154720870|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154720871|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154720872|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720873|NCT00217971|Hormones|hormones|mesh-ancestor
154720874|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720875|NCT00217581|Bevacizumab|bevacizumab|mesh-list
154720876|NCT00217581|Docetaxel|docetaxel|mesh-list
154720877|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
154720878|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472770|NCT03406832|Nitroprusside|nitroprusside|mesh-list
154720879|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720880|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154720881|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154720882|NCT00217581|Growth Substances|growth substances|mesh-ancestor
154720883|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720884|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
154720885|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720886|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720887|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720888|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720889|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
154720890|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
154720891|NCT01856257|Abatacept|abatacept|mesh-list
154720892|NCT01856257|Tacrolimus|tacrolimus|mesh-list
154720893|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
154720894|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154720895|NCT01856257|Basiliximab|basiliximab|mesh-list
154720896|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720897|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
154720898|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720899|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154720900|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720901|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720902|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154720903|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720904|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154720905|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
154720906|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720907|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720908|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720909|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
154720910|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
154720911|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720912|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154720913|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
154720914|NCT01856257|Hormones|hormones|mesh-ancestor
154720915|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720916|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154720917|NCT01856257|Protective Agents|protective agents|mesh-ancestor
154720918|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154720919|NCT01856257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720920|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720921|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
154720922|NCT00215943|Thalidomide|thalidomide|mesh-list
154720923|NCT00215943|Dexamethasone|dexamethasone|mesh-list
154720924|NCT00215943|Doxorubicin|doxorubicin|mesh-list
154720925|NCT00215943|Vincristine|vincristine|mesh-list
154720926|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154720927|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154720928|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
154720929|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
154720930|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154720931|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720932|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154720933|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
154720934|NCT00215943|Hormones|hormones|mesh-ancestor
154720935|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154720936|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154720937|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720938|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154720939|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154720940|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154720941|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720942|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720943|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154720944|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720945|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720946|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720947|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720948|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
154720949|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
154720950|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154720951|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720952|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154720953|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154720954|NCT00215943|Growth Substances|growth substances|mesh-ancestor
154720956|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154720957|NCT01827163|Paclitaxel|paclitaxel|mesh-list
154720958|NCT01827163|Trastuzumab|trastuzumab|mesh-list
154720959|NCT01827163|Lapatinib|lapatinib|mesh-list
154720960|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154720961|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720962|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154720963|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154720964|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154720965|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154720966|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154720967|NCT01827163|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154720968|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154720969|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154720970|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154720971|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
154720972|NCT00214461|Vaccines|vaccines|mesh-list
154720973|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
154720974|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720975|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
154720976|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154720977|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154720978|NCT00211887|Interferons|interferons|mesh-list
154720979|NCT00211887|Interferon-beta|interferon-beta|mesh-list
154720980|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
154720981|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
154720982|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
154720983|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154720984|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
154720985|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720986|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
154720987|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720988|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154720989|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154720990|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154720991|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154720992|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154720993|NCT03592485|Acetaminophen|acetaminophen|mesh-list
154720994|NCT03592485|Oxycodone|oxycodone|mesh-list
154720995|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154720996|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154720997|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154720998|NCT03592485|Analgesics|analgesics|mesh-ancestor
154720999|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
154721000|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721001|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
154721002|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154721003|NCT03592485|Narcotics|narcotics|mesh-ancestor
154721004|NCT04199013|Fentanyl|fentanyl|mesh-list
154721005|NCT04199013|Ropivacaine|ropivacaine|mesh-list
154721006|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
154721007|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
154721008|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721009|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721010|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
154721011|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721012|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154721013|NCT04199013|Narcotics|narcotics|mesh-ancestor
154721014|NCT04199013|Analgesics|analgesics|mesh-ancestor
154721015|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154721016|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154721017|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
154721018|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
154721019|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154721020|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
154721021|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721022|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
154721023|NCT04198467|Protective Agents|protective agents|mesh-ancestor
154721024|NCT03599427|Lidocaine|lidocaine|mesh-list
154721025|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
154721026|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
154721027|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721028|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721029|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
154721030|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721031|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154721032|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154721033|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154721034|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154721035|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721036|NCT01855789|Methotrexate|methotrexate|mesh-list
154721037|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154721038|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
154721039|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154721040|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721041|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154721042|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
154721043|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721044|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721045|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
154721046|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721047|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154721048|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721049|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
154721050|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721051|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154721052|NCT04198233|Diazepam|diazepam|mesh-list
154721053|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154721054|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
154721055|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
154721056|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
154721057|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721058|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721059|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721060|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154721061|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721062|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154721063|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154721064|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154721065|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154721066|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154721067|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154721068|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
154721069|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
154721070|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
154721071|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
154721072|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154721073|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721074|NCT03591471|Prednisone|prednisone|mesh-list
154721075|NCT03591471|Benazepril|benazepril|mesh-list
154721076|NCT03591471|Heparin|heparin|mesh-list
154721077|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154721078|NCT03591471|Tinzaparin|tinzaparin|mesh-list
154721079|NCT03591471|Dalteparin|dalteparin|mesh-list
154721080|NCT03591471|Calcium heparin|calcium heparin|mesh-list
154721081|NCT03591471|Dipyridamole|dipyridamole|mesh-list
154721082|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721083|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721084|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
154721085|NCT03591471|Hormones|hormones|mesh-ancestor
154721086|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154721087|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154721088|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721089|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
154721090|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154721091|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154721092|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721093|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154721094|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721095|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154721096|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
154721097|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154721098|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
154721099|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154721100|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154721101|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
154721102|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721103|NCT01876381|Tolvaptan|tolvaptan|mesh-list
154721104|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154721105|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721106|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
154472990|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154721107|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721108|NCT03591003|Antibodies|antibodies|mesh-list
154721109|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
154721110|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
154721111|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721112|NCT01875991|Etanercept|etanercept|mesh-list
154721113|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154721114|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721115|NCT01875991|Analgesics|analgesics|mesh-ancestor
154721116|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
154721117|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721118|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721119|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721120|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721121|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721122|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721123|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
154721124|NCT04203927|Empagliflozin|empagliflozin|mesh-list
154721125|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154721126|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721127|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154721128|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721129|NCT01855243|Insulin|insulin|mesh-list
154721130|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154721131|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154721132|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721133|NCT04196829|Fluorides|fluorides|mesh-list
154721134|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
153760129|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721135|NCT04196829|Protective Agents|protective agents|mesh-ancestor
154721136|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721137|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154721138|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
154721139|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154721140|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154721141|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154721142|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721143|NCT01854697|Interferons|interferons|mesh-list
154721144|NCT01854697|Ribavirin|ribavirin|mesh-list
154721145|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
154721146|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
154721147|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154721148|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721149|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
154721150|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721151|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
154721152|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721153|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
154721154|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721155|NCT01824823|Afatinib|afatinib|mesh-list
154721156|NCT01824823|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154721157|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154721158|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721159|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721160|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721161|NCT03598725|Prednisone|prednisone|mesh-list
154721162|NCT03598725|Rituximab|rituximab|mesh-list
154721163|NCT03598725|Factor VIII|factor viii|mesh-list
154721164|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721165|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721166|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
154721167|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721168|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721169|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721170|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
154721171|NCT03598725|Hormones|hormones|mesh-ancestor
154721172|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154721173|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154721174|NCT03598725|Coagulants|coagulants|mesh-ancestor
154721175|NCT04766307|Interleukin-2|interleukin-2|mesh-list
154721176|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721177|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721178|NCT04766307|Analgesics|analgesics|mesh-ancestor
154721179|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
154721180|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721181|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760215|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473072|NCT03398876|Nicotine|nicotine|mesh-list
154721182|NCT01875367|Trastuzumab|trastuzumab|mesh-list
154721183|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721184|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721185|NCT04194957|Capecitabine|capecitabine|mesh-list
154721186|NCT04194957|Fluorouracil|fluorouracil|mesh-list
154721187|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154721188|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
154721189|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721190|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721191|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721192|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
154721193|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721194|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
154721195|NCT04194255|Trace Elements|trace elements|mesh-ancestor
154721196|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
154721197|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721198|NCT04406883|Simvastatin|simvastatin|mesh-list
154721199|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154721200|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154721201|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
154721202|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721203|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154721204|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154721205|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721207|NCT03597867|Indomethacin|indomethacin|mesh-list
154721208|NCT03597867|Nepafenac|nepafenac|mesh-list
154721209|NCT03597867|Bromfenac|bromfenac|mesh-list
154721210|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154721211|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154721212|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154721213|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721214|NCT03597867|Analgesics|analgesics|mesh-ancestor
154721215|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
154721216|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721217|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721218|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721219|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721220|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154721221|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721222|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721223|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
154721224|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
154721225|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154721226|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
154721227|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154721228|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721229|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721230|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721231|NCT03597477|Analgesics|analgesics|mesh-ancestor
154721232|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
154721233|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721234|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154721235|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154721236|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154721237|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
154721238|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154721239|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721240|NCT04193319|Fluconazole|fluconazole|mesh-list
154721241|NCT04193319|Fluzoparib|fluzoparib|mesh-list
154721242|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
154721243|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721244|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154721245|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154721246|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721247|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721248|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154721249|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
154721250|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154721251|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721252|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154721253|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154721254|NCT04193319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154721255|NCT04193319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721256|NCT04192617|Methotrexate|methotrexate|mesh-list
154721257|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154721258|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
154721259|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154721260|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721261|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154721262|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
154721263|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721264|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721265|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
154721266|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721267|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154721268|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721269|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
154721270|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721271|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154721272|NCT01874665|Ponatinib|ponatinib|mesh-list
154721273|NCT01874665|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154721274|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154721275|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721276|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721277|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721278|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
154721279|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
154721280|NCT04028739|Curcumin|curcumin|mesh-list
154721281|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154721282|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721283|NCT04028739|Analgesics|analgesics|mesh-ancestor
154721284|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
154721285|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721286|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721287|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721288|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721289|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721290|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721291|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721292|NCT04028505|Terlipressin|terlipressin|mesh-list
154721293|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154721294|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154721295|NCT04190745|Paclitaxel|paclitaxel|mesh-list
154721296|NCT04190745|Apatinib|apatinib|mesh-list
154721297|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154721298|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721299|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
154721300|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
154721301|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
154721302|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760356|NCT00587119|Budesonide|budesonide|mesh-list
154721303|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154721304|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721305|NCT04028349|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154721306|NCT04028349|Antiviral Agents|antiviral agents|mesh-ancestor
154721307|NCT04028349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721308|NCT01873729|Naltrexone|naltrexone|mesh-list
154721309|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154721310|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154721311|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721312|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
154721313|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721314|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
154721315|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154721316|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721317|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154721318|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721319|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721320|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
154721321|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
154721322|NCT04027959|Vitamins|vitamins|mesh-ancestor
154721323|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
154721324|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721325|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
154721326|NCT04027959|Hematinics|hematinics|mesh-ancestor
154721327|NCT04344951|Chloroquine|chloroquine|mesh-list
154721328|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154721329|NCT04344951|Amebicides|amebicides|mesh-ancestor
154721330|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154721331|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154721332|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721333|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
154721334|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721335|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154721336|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721337|NCT04344951|Analgesics|analgesics|mesh-ancestor
154721338|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
154721339|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721340|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721341|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721342|NCT04344951|Filaricides|filaricides|mesh-ancestor
154721343|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
154721344|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
154721345|NCT01822561|Eplerenone|eplerenone|mesh-list
154721346|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154721347|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
153760392|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
154721348|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154721349|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721350|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154721351|NCT01822561|Diuretics|diuretics|mesh-ancestor
154721352|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
154721353|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154721354|NCT02080455|Atorvastatin|atorvastatin|mesh-list
154721355|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154721356|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154721357|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
154721358|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721359|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154721360|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154721361|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721362|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154721363|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
154721364|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721365|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
154721366|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154721367|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154721368|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721369|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
154721370|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154721371|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154721372|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154721373|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154721374|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721375|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
154721376|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154721377|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721378|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154721379|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721380|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154721381|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154721382|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154721383|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154721384|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721385|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
154721386|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154721387|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721388|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154721389|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721390|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
154721391|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154721392|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154721393|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721394|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
154721395|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
154721396|NCT04199169|Vaccines|vaccines|mesh-list
154721397|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
154721398|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721399|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
154721400|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154721401|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154721402|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154721403|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
154721405|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154721406|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154721407|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
154721408|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154721409|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
154721410|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721411|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
154721412|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721413|NCT01872715|Doxycycline|doxycycline|mesh-list
154721414|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154721415|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721416|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
154721417|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154721418|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154721419|NCT01613599|Rituximab|rituximab|mesh-list
154721420|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721421|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721422|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
154721423|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721424|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721425|NCT03930771|Capecitabine|capecitabine|mesh-list
154721426|NCT03930771|Temozolomide|temozolomide|mesh-list
154721427|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154721428|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
154721429|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721430|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721431|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154721432|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
154721433|NCT04024683|Ropivacaine|ropivacaine|mesh-list
154721434|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
154721435|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
154721436|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721437|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721438|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
154721439|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721440|NCT04024527|Amoxicillin|amoxicillin|mesh-list
154721441|NCT04024527|Metronidazole|metronidazole|mesh-list
154721442|NCT04024527|Esomeprazole|esomeprazole|mesh-list
154721443|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154721444|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721445|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154721446|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154721447|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154721448|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721449|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154721450|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721451|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721452|NCT06061835|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154721453|NCT06061835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154721454|NCT06061835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721455|NCT06061835|Analgesics|analgesics|mesh-ancestor
154721456|NCT06061835|Sensory System Agents|sensory system agents|mesh-ancestor
154721457|NCT06061835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721458|NCT06061835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721459|NCT06061835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721460|NCT06061835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721461|NCT06061718|Travoprost|travoprost|mesh-list
154721462|NCT06061718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154721463|NCT06061666|Glycerol|glycerol|mesh-list
154721464|NCT06061666|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154721465|NCT06061666|Protective Agents|protective agents|mesh-ancestor
154721466|NCT06061666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721467|NCT06061484|Amoxicillin|amoxicillin|mesh-list
154721468|NCT06061484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154721469|NCT06061484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721470|NCT06061445|Antibodies|antibodies|mesh-list
154721471|NCT06061445|Immunologic Factors|immunologic factors|mesh-ancestor
154721472|NCT06061445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721473|NCT06061315|Silicon|silicon|mesh-list
154721474|NCT06061315|Trace Elements|trace elements|mesh-ancestor
154721475|NCT06061315|Micronutrients|micronutrients|mesh-ancestor
154721476|NCT06061315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721477|NCT06061276|Lenvatinib|lenvatinib|mesh-list
154721478|NCT06061276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721479|NCT06061276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154721480|NCT06061276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721481|NCT06061276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721482|NCT06061094|Imatinib Mesylate|imatinib mesylate|mesh-list
154721483|NCT06061094|Blinatumomab|blinatumomab|mesh-list
154721484|NCT06061094|Ponatinib|ponatinib|mesh-list
154721485|NCT06061094|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154721486|NCT06061094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154721487|NCT06061094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721488|NCT06061094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721489|NCT06061094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721490|NCT06060990|Trace Elements|trace elements|mesh-list
154721491|NCT06060990|Micronutrients|micronutrients|mesh-list
154721492|NCT06060990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721493|NCT06060886|Aripiprazole|aripiprazole|mesh-list
154721494|NCT06060886|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154721495|NCT06060886|Antidepressive Agents|antidepressive agents|mesh-ancestor
154721496|NCT06060886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154721497|NCT06060886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154721498|NCT06060886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154721499|NCT06060886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721500|NCT06060886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721501|NCT06060886|Dopamine Agonists|dopamine agonists|mesh-ancestor
154721502|NCT06060886|Dopamine Agents|dopamine agents|mesh-ancestor
154721503|NCT06060886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154721504|NCT06060886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721505|NCT06060886|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154721506|NCT06060886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154721507|NCT06060886|Serotonin Agents|serotonin agents|mesh-ancestor
154721508|NCT06060886|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154721509|NCT06060886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154721510|NCT06060886|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154721511|NCT06060886|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154721512|NCT06060782|Cytarabine|cytarabine|mesh-list
154721513|NCT06060782|Cyclophosphamide|cyclophosphamide|mesh-list
154721514|NCT06060782|Thiotepa|thiotepa|mesh-list
154721515|NCT06060782|Cladribine|cladribine|mesh-list
154721516|NCT06060782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721517|NCT06060782|Immunologic Factors|immunologic factors|mesh-ancestor
154721518|NCT06060782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721519|NCT06060782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721520|NCT06060782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154721521|NCT06060782|Alkylating Agents|alkylating agents|mesh-ancestor
154721522|NCT06060782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721523|NCT06060782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721524|NCT06060782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153760687|NCT00589264|Copper|copper|mesh-list
154721525|NCT06060782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154721526|NCT06060782|Antimetabolites|antimetabolites|mesh-ancestor
154721527|NCT06060782|Antiviral Agents|antiviral agents|mesh-ancestor
154721528|NCT06060782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721529|NCT06060743|Insulin|insulin|mesh-list
154721530|NCT06060743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154721531|NCT06060743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721532|NCT06060327|Misoprostol|misoprostol|mesh-list
154721533|NCT06060327|Tranexamic Acid|tranexamic acid|mesh-list
154721534|NCT06060327|Oxytocin|oxytocin|mesh-list
154721535|NCT06060327|Carbetocin|carbetocin|mesh-list
154721536|NCT06060327|Oxytocics|oxytocics|mesh-ancestor
154721537|NCT06060327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154721538|NCT06060327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721539|NCT06060327|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154721540|NCT06060327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154721541|NCT06060327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721542|NCT06060327|Hemostatics|hemostatics|mesh-ancestor
154721543|NCT06060327|Coagulants|coagulants|mesh-ancestor
154721544|NCT06060327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154721545|NCT06060327|Abortifacient Agents|abortifacient agents|mesh-ancestor
154721546|NCT06060327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154721547|NCT06060327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721548|NCT06060301|Sulfasalazine|sulfasalazine|mesh-list
154721549|NCT06060301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721550|NCT06060301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154721551|NCT06060301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721552|NCT06060301|Analgesics|analgesics|mesh-ancestor
154721553|NCT06060301|Sensory System Agents|sensory system agents|mesh-ancestor
154721554|NCT06060301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721555|NCT06060301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473442|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154721556|NCT06060301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721557|NCT06060301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721558|NCT06060301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721559|NCT06060132|Arsenic Trioxide|arsenic trioxide|mesh-list
154721560|NCT06060132|Sodium arsenite|sodium arsenite|mesh-list
154721561|NCT06060132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721562|NCT06060132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721563|NCT06060132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721564|NCT06060080|Lenograstim|lenograstim|mesh-list
154721565|NCT06060080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154721566|NCT06060080|Immunologic Factors|immunologic factors|mesh-ancestor
154721567|NCT06060080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721568|NCT06060015|Bupivacaine|bupivacaine|mesh-list
154721569|NCT06060015|Anesthetics, Local|anesthetics, local|mesh-ancestor
154721570|NCT06060015|Anesthetics|anesthetics|mesh-ancestor
154721571|NCT06060015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721572|NCT06060015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721573|NCT06060015|Sensory System Agents|sensory system agents|mesh-ancestor
154721574|NCT06060015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721575|NCT06059989|Folic Acid|folic acid|mesh-list
154721576|NCT06059989|Infliximab|infliximab|mesh-list
154721577|NCT06059989|Methotrexate|methotrexate|mesh-list
154721578|NCT06059989|Mercaptopurine|mercaptopurine|mesh-list
154721579|NCT06059989|Azathioprine|azathioprine|mesh-list
154721580|NCT06059989|Thioguanine|thioguanine|mesh-list
154721581|NCT06059989|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154721582|NCT06059989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154721583|NCT06059989|Abortifacient Agents|abortifacient agents|mesh-ancestor
154721584|NCT06059989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154721585|NCT06059989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721586|NCT06059989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154721587|NCT06059989|Antimetabolites|antimetabolites|mesh-ancestor
154721588|NCT06059989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721589|NCT06059989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721590|NCT06059989|Dermatologic Agents|dermatologic agents|mesh-ancestor
154721591|NCT06059989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721592|NCT06059989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154721593|NCT06059989|Immunologic Factors|immunologic factors|mesh-ancestor
154721594|NCT06059989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721595|NCT06059989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154721596|NCT06059989|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154721597|NCT06059989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721598|NCT06059989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721599|NCT06059989|Hematinics|hematinics|mesh-ancestor
154721600|NCT06059989|Vitamin B Complex|vitamin b complex|mesh-ancestor
154721601|NCT06059989|Vitamins|vitamins|mesh-ancestor
154721602|NCT06059989|Micronutrients|micronutrients|mesh-ancestor
154721603|NCT06059885|Tislelizumab|tislelizumab|mesh-list
154721604|NCT06059885|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154721605|NCT06059885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721606|NCT06059885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721607|NCT06059885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154721608|NCT06059885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721609|NCT06059885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721610|NCT06057896|Inositol|inositol|mesh-list
154721611|NCT06057896|Phytoestrogens|phytoestrogens|mesh-list
154721612|NCT06057896|Vitamin B Complex|vitamin b complex|mesh-ancestor
154721613|NCT06057896|Vitamins|vitamins|mesh-ancestor
154721614|NCT06057896|Micronutrients|micronutrients|mesh-ancestor
154721615|NCT06057896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721616|NCT06057896|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154721617|NCT06057896|Estrogens|estrogens|mesh-ancestor
154721618|NCT06057896|Hormones|hormones|mesh-ancestor
154721619|NCT06057896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154721620|NCT06057610|Docetaxel|docetaxel|mesh-list
154721621|NCT06057610|Trastuzumab|trastuzumab|mesh-list
154721622|NCT06057610|Pertuzumab|pertuzumab|mesh-list
154721623|NCT06057610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721624|NCT06057610|Tubulin Modulators|tubulin modulators|mesh-ancestor
154721625|NCT06057610|Antimitotic Agents|antimitotic agents|mesh-ancestor
154721626|NCT06057610|Mitosis Modulators|mitosis modulators|mesh-ancestor
154721627|NCT06057610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721628|NCT06057610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721629|NCT06057545|Tacrolimus|tacrolimus|mesh-list
154721630|NCT06057545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721631|NCT06057545|Immunologic Factors|immunologic factors|mesh-ancestor
154721632|NCT06057545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721633|NCT06057545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154721634|NCT06057545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721635|NCT06057545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721636|NCT06057194|Letermovir|letermovir|mesh-list
154721637|NCT06057194|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154721638|NCT06057194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721639|NCT06057194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721640|NCT06057194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721641|NCT06057194|Antiviral Agents|antiviral agents|mesh-ancestor
154721642|NCT06057194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721643|NCT06057168|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154721644|NCT06057168|Chelating Agents|chelating agents|mesh-ancestor
154721645|NCT06057168|Sequestering Agents|sequestering agents|mesh-ancestor
154721646|NCT06057168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721647|NCT06057103|Oseltamivir|oseltamivir|mesh-list
154721648|NCT06057103|Antiviral Agents|antiviral agents|mesh-ancestor
154721649|NCT06057103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721650|NCT06057103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721651|NCT06057103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721652|NCT06057077|Semaglutide|semaglutide|mesh-list
154721653|NCT06057077|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154721654|NCT06057077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154721655|NCT06057077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721656|NCT06056570|Allopurinol|allopurinol|mesh-list
154721657|NCT06056570|Dotinurad|dotinurad|mesh-list
154721658|NCT06056570|Antimetabolites|antimetabolites|mesh-ancestor
154721659|NCT06056570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721660|NCT06056570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721661|NCT06056570|Gout Suppressants|gout suppressants|mesh-ancestor
154721662|NCT06056570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721663|NCT06056570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154721664|NCT06056570|Antioxidants|antioxidants|mesh-ancestor
154721665|NCT06056570|Protective Agents|protective agents|mesh-ancestor
154721666|NCT06056570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721667|NCT06056570|Uricosuric Agents|uricosuric agents|mesh-ancestor
154721668|NCT06056492|Nitrous Oxide|nitrous oxide|mesh-list
154721669|NCT06056492|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154721670|NCT06056492|Anesthetics, General|anesthetics, general|mesh-ancestor
154721671|NCT06056492|Anesthetics|anesthetics|mesh-ancestor
154721672|NCT06056492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721673|NCT06056492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721674|NCT06056492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721675|NCT06056492|Analgesics|analgesics|mesh-ancestor
154721676|NCT06056492|Sensory System Agents|sensory system agents|mesh-ancestor
154721677|NCT06056492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721678|NCT06056336|Paclitaxel|paclitaxel|mesh-list
154721679|NCT06056336|Carboplatin|carboplatin|mesh-list
154721680|NCT06056336|Tislelizumab|tislelizumab|mesh-list
154721681|NCT06056336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154721682|NCT06056336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154721683|NCT06056336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721684|NCT06056336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154721685|NCT06056336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154721686|NCT06056336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154721687|NCT06056336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721688|NCT06056336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721689|NCT06056167|Insulin|insulin|mesh-list
154721690|NCT06056167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154721691|NCT06056167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721692|NCT06056115|Tislelizumab|tislelizumab|mesh-list
154721693|NCT06056115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721694|NCT06056115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721695|NCT06056089|Amoxicillin|amoxicillin|mesh-list
154721696|NCT06056089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154721697|NCT06056089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721698|NCT06055907|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154721699|NCT06055907|Dalteparin|dalteparin|mesh-list
154721700|NCT06055907|Anticoagulants|anticoagulants|mesh-ancestor
154721701|NCT06055907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154721702|NCT06055907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154721703|NCT06055907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721704|NCT06055829|Insulin|insulin|mesh-list
154721705|NCT06055829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154721706|NCT06055829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721707|NCT06055816|Endostar protein|endostar protein|mesh-list
154721708|NCT06055816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153760951|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154721709|NCT06055816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154721710|NCT06055816|Growth Substances|growth substances|mesh-ancestor
154721711|NCT06055816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721712|NCT06055816|Growth Inhibitors|growth inhibitors|mesh-ancestor
154721713|NCT06055816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721714|NCT06055777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154721715|NCT06055777|beta-Lactams|beta-lactams|mesh-list
154721716|NCT06055777|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
154721717|NCT06055777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721718|NCT06055738|Paclitaxel|paclitaxel|mesh-list
154721719|NCT06055738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154721720|NCT06055738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154721721|NCT06055738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721722|NCT06055738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154721723|NCT06055738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154721724|NCT06055738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154721725|NCT06055738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721726|NCT06053385|Melatonin|melatonin|mesh-list
154721727|NCT06053385|Antioxidants|antioxidants|mesh-ancestor
154721728|NCT06053385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721729|NCT06053385|Protective Agents|protective agents|mesh-ancestor
154721730|NCT06053385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721731|NCT06053385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721732|NCT06052956|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154721733|NCT06052956|Methylene Blue|methylene blue|mesh-list
154721734|NCT06052956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721735|NCT06052956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721736|NCT06052956|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154721737|NCT06052956|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154721738|NCT06052956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154721739|NCT06052787|Amantadine|amantadine|mesh-list
154721740|NCT06052787|Cerebrolysin|cerebrolysin|mesh-list
154721741|NCT06052787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154721742|NCT06052787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154721743|NCT06052787|Antiviral Agents|antiviral agents|mesh-ancestor
154721744|NCT06052787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721745|NCT06052787|Dopamine Agents|dopamine agents|mesh-ancestor
154721746|NCT06052787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154721747|NCT06052787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721748|NCT06052787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721749|NCT06052787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154721750|NCT06052787|Analgesics|analgesics|mesh-ancestor
154721751|NCT06052787|Sensory System Agents|sensory system agents|mesh-ancestor
154721752|NCT06052787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721753|NCT06052787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154721754|NCT06052787|Protective Agents|protective agents|mesh-ancestor
154721755|NCT06052787|Nootropic Agents|nootropic agents|mesh-ancestor
154721756|NCT06052020|Atorvastatin|atorvastatin|mesh-list
154721757|NCT06052020|Alirocumab|alirocumab|mesh-list
154721758|NCT06052020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154721759|NCT06052020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154721760|NCT06052020|Antimetabolites|antimetabolites|mesh-ancestor
154721761|NCT06052020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721762|NCT06052020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154721763|NCT06052020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154721764|NCT06052020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721765|NCT06052020|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154721766|NCT06052020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154721767|NCT06052020|Protease Inhibitors|protease inhibitors|mesh-ancestor
154721768|NCT06051487|Titanium dioxide|titanium dioxide|mesh-list
154721769|NCT06051487|Sunscreening Agents|sunscreening agents|mesh-ancestor
154721770|NCT06051487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154721771|NCT06051487|Protective Agents|protective agents|mesh-ancestor
154721772|NCT06051487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721773|NCT06051487|Dermatologic Agents|dermatologic agents|mesh-ancestor
154721774|NCT06051487|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154721775|NCT06051253|Infliximab|infliximab|mesh-list
154721776|NCT06051253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154721777|NCT06051253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721778|NCT06051253|Dermatologic Agents|dermatologic agents|mesh-ancestor
154721779|NCT06051253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721780|NCT06051253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721781|NCT06045351|Vitamin D|vitamin d|mesh-list
154558071|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154721782|NCT06045351|Vitamins|vitamins|mesh-ancestor
154721783|NCT06045351|Micronutrients|micronutrients|mesh-ancestor
154721784|NCT06045351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721785|NCT06045351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154721786|NCT06044558|Mycophenolic Acid|mycophenolic acid|mesh-list
154721787|NCT06044558|Voriconazole|voriconazole|mesh-list
154721788|NCT06044558|Caspofungin|caspofungin|mesh-list
154721789|NCT06044558|Methylprednisolone|methylprednisolone|mesh-list
154721790|NCT06044558|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154721791|NCT06044558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154721792|NCT06044558|Prednisolone|prednisolone|mesh-list
154721793|NCT06044558|Prednisolone acetate|prednisolone acetate|mesh-list
154721794|NCT06044558|Tacrolimus|tacrolimus|mesh-list
154721795|NCT06044558|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154721796|NCT06044558|Prednisolone phosphate|prednisolone phosphate|mesh-list
154721797|NCT06044558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721798|NCT06044558|Immunologic Factors|immunologic factors|mesh-ancestor
154721799|NCT06044558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721800|NCT06044558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154721801|NCT06044558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721802|NCT06044558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721803|NCT06044558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154721804|NCT06044558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721805|NCT06044558|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154721806|NCT06044558|Antitubercular Agents|antitubercular agents|mesh-ancestor
154721807|NCT06044558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154721808|NCT06044558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721809|NCT06044558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721810|NCT06044558|Antiemetics|antiemetics|mesh-ancestor
154721811|NCT06044558|Autonomic Agents|autonomic agents|mesh-ancestor
154721812|NCT06044558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721813|NCT06044558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721814|NCT06044558|Glucocorticoids|glucocorticoids|mesh-ancestor
154721815|NCT06044558|Hormones|hormones|mesh-ancestor
154721816|NCT06044558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761148|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721817|NCT06044558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154721818|NCT06044558|Protective Agents|protective agents|mesh-ancestor
154721819|NCT06044558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154721820|NCT06044558|Antifungal Agents|antifungal agents|mesh-ancestor
154721821|NCT06044558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154721822|NCT06044558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154721823|NCT06044558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154721824|NCT06044558|Hormone Antagonists|hormone antagonists|mesh-ancestor
154721825|NCT06044558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154721826|NCT06043063|Lidocaine|lidocaine|mesh-list
154721827|NCT06043063|Bupivacaine|bupivacaine|mesh-list
154721828|NCT06043063|Anesthetics, Local|anesthetics, local|mesh-list
154721829|NCT06043063|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154721830|NCT06043063|Anesthetics|anesthetics|mesh-list
154721831|NCT06043063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721832|NCT06043063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721833|NCT06043063|Sensory System Agents|sensory system agents|mesh-ancestor
154721834|NCT06043063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721835|NCT06043063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154721836|NCT06043063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154721837|NCT06043063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154721838|NCT06043063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154721839|NCT06043063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721840|NCT06043063|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154721841|NCT06034821|Ketamine|ketamine|mesh-list
154721842|NCT06034821|Analgesics|analgesics|mesh-ancestor
154721843|NCT06034821|Sensory System Agents|sensory system agents|mesh-ancestor
154721844|NCT06034821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721845|NCT06034821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721846|NCT06034821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154721847|NCT06034821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154721848|NCT06034821|Anesthetics, General|anesthetics, general|mesh-ancestor
154721849|NCT06034821|Anesthetics|anesthetics|mesh-ancestor
154721850|NCT06034821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721851|NCT06034821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154721852|NCT06034821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154721853|NCT06034821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154721854|NCT06034821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721855|NCT06016465|Dexamethasone|dexamethasone|mesh-list
154721856|NCT06016465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154721857|NCT06016465|Antiemetics|antiemetics|mesh-ancestor
154721859|NCT06016465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721860|NCT06016465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721861|NCT06016465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721862|NCT06016465|Glucocorticoids|glucocorticoids|mesh-ancestor
154721863|NCT06016465|Hormones|hormones|mesh-ancestor
154721864|NCT06016465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154721865|NCT06016465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154721866|NCT06016465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721867|NCT06006117|Rituximab|rituximab|mesh-list
154721868|NCT06006117|Lenalidomide|lenalidomide|mesh-list
154721869|NCT06006117|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154721870|NCT06006117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721871|NCT06006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721872|NCT06006117|Immunologic Factors|immunologic factors|mesh-ancestor
154721873|NCT06006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721874|NCT06006117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721875|NCT06006117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154721876|NCT06006117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154721877|NCT06006117|Growth Substances|growth substances|mesh-ancestor
154721878|NCT06006117|Growth Inhibitors|growth inhibitors|mesh-ancestor
154721879|NCT06006117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154721880|NCT06006117|Alkylating Agents|alkylating agents|mesh-ancestor
154721881|NCT06006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721882|NCT05985590|Drospirenone|drospirenone|mesh-list
154721883|NCT05985590|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154721884|NCT05985590|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154721885|NCT05985590|Estradiol|estradiol|mesh-list
154721886|NCT05985590|Estrogens|estrogens|mesh-ancestor
154721887|NCT05985590|Hormones|hormones|mesh-ancestor
154721888|NCT05985590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154721889|NCT05985590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721890|NCT05985590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154721891|NCT05985590|Contraceptive Agents|contraceptive agents|mesh-ancestor
154721892|NCT05985590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154721893|NCT05985590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154721894|NCT05985590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154721895|NCT05985590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154721896|NCT05985590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154721897|NCT05985590|Hormone Antagonists|hormone antagonists|mesh-ancestor
154721898|NCT05985590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154721899|NCT05985590|Diuretics|diuretics|mesh-ancestor
154721900|NCT05985590|Natriuretic Agents|natriuretic agents|mesh-ancestor
154721901|NCT05979493|Bupivacaine|bupivacaine|mesh-list
154721902|NCT05979493|Anesthetics, Local|anesthetics, local|mesh-ancestor
154721903|NCT05979493|Anesthetics|anesthetics|mesh-ancestor
154721904|NCT05979493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721905|NCT05979493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721906|NCT05979493|Sensory System Agents|sensory system agents|mesh-ancestor
154721907|NCT05979493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721908|NCT05939765|Antipsychotic Agents|antipsychotic agents|mesh-list
154721909|NCT05939765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154721910|NCT05939765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721911|NCT05939765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721912|NCT05939765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154721913|NCT05926336|Anesthetics|anesthetics|mesh-list
154721914|NCT05926336|Propofol|propofol|mesh-list
154721915|NCT05926336|Sevoflurane|sevoflurane|mesh-list
154721916|NCT05926336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721917|NCT05926336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721918|NCT05926336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154721919|NCT05926336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154721920|NCT05926336|Anesthetics, General|anesthetics, general|mesh-ancestor
154721921|NCT05926336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154721922|NCT05926336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154721923|NCT05912062|Paclitaxel|paclitaxel|mesh-list
154721924|NCT05912062|Trastuzumab|trastuzumab|mesh-list
154721925|NCT05912062|Pertuzumab|pertuzumab|mesh-list
154721926|NCT05912062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154721927|NCT05912062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721928|NCT05912062|Tubulin Modulators|tubulin modulators|mesh-ancestor
154721929|NCT05912062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154721930|NCT05912062|Mitosis Modulators|mitosis modulators|mesh-ancestor
154721931|NCT05912062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721932|NCT05912062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154721933|NCT05886335|Cyclophosphamide|cyclophosphamide|mesh-list
154721934|NCT05886335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721935|NCT05886335|Immunologic Factors|immunologic factors|mesh-ancestor
154721936|NCT05886335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721937|NCT05886335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154721938|NCT05886335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154721939|NCT05886335|Alkylating Agents|alkylating agents|mesh-ancestor
154721940|NCT05886335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721941|NCT05886335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721942|NCT05886335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154721944|NCT05880394|Trace Elements|trace elements|mesh-ancestor
154721945|NCT05880394|Micronutrients|micronutrients|mesh-ancestor
154721946|NCT05880394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721947|NCT05857007|Glucocorticoids|glucocorticoids|mesh-list
154721948|NCT05857007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721949|NCT05857007|Hormones|hormones|mesh-ancestor
154721950|NCT05857007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154721951|NCT05837897|Vedolizumab|vedolizumab|mesh-list
154721952|NCT05837897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154721953|NCT05813132|Cytarabine|cytarabine|mesh-list
154721954|NCT05813132|Carboplatin|carboplatin|mesh-list
154721955|NCT05813132|Etoposide|etoposide|mesh-list
154721956|NCT05813132|Etoposide phosphate|etoposide phosphate|mesh-list
154721957|NCT05813132|Melphalan|melphalan|mesh-list
154721958|NCT05813132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154721959|NCT05813132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154721960|NCT05813132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154721961|NCT05813132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154721962|NCT05813132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154721963|NCT05813132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154721964|NCT05813132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721965|NCT05813132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154721966|NCT05813132|Antimetabolites|antimetabolites|mesh-ancestor
154721967|NCT05813132|Antiviral Agents|antiviral agents|mesh-ancestor
154721968|NCT05813132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154721969|NCT05813132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154721970|NCT05813132|Immunologic Factors|immunologic factors|mesh-ancestor
154721971|NCT05813132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721972|NCT05813132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154721973|NCT05813132|Alkylating Agents|alkylating agents|mesh-ancestor
154721974|NCT05813132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154721975|NCT05800834|Lidocaine|lidocaine|mesh-list
154721976|NCT05800834|Morphine|morphine|mesh-list
154721977|NCT05800834|Anesthetics, Local|anesthetics, local|mesh-ancestor
154721978|NCT05800834|Anesthetics|anesthetics|mesh-ancestor
154721979|NCT05800834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721980|NCT05800834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721981|NCT05800834|Sensory System Agents|sensory system agents|mesh-ancestor
154721982|NCT05800834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721983|NCT05800834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154721984|NCT05800834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154721985|NCT05800834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154721986|NCT05800834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154721987|NCT05800834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154721988|NCT05800834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154721989|NCT05800834|Narcotics|narcotics|mesh-ancestor
154721990|NCT05800834|Analgesics|analgesics|mesh-ancestor
154721991|NCT05793905|Lidocaine|lidocaine|mesh-list
154721992|NCT05793905|Anesthetics, Local|anesthetics, local|mesh-ancestor
154721993|NCT05793905|Anesthetics|anesthetics|mesh-ancestor
154721994|NCT05793905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154721995|NCT05793905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154721996|NCT05793905|Sensory System Agents|sensory system agents|mesh-ancestor
154721997|NCT05793905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154721998|NCT05793905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154721999|NCT05793905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154722000|NCT05793905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154722001|NCT05793905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154722002|NCT05793905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722003|NCT05793099|Propolis|propolis|mesh-list
154722004|NCT05793099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722005|NCT05785819|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154473902|NCT02123589|Midazolam|midazolam|mesh-list
154722006|NCT05785819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722008|NCT05781711|Levodopa|levodopa|mesh-list
154722009|NCT05781711|Carbidopa|carbidopa|mesh-list
154722010|NCT05781711|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154722011|NCT05781711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154722012|NCT05781711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722013|NCT05781711|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154722014|NCT05781711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154722015|NCT05781711|Dopamine Agents|dopamine agents|mesh-ancestor
154722016|NCT05781711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722017|NCT05781711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722018|NCT05781711|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154722019|NCT05781711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722020|NCT05781711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154722021|NCT05781711|Immunologic Factors|immunologic factors|mesh-ancestor
154722022|NCT05781711|Dopamine Agonists|dopamine agonists|mesh-ancestor
154722023|NCT05778591|Buprenorphine|buprenorphine|mesh-list
154722024|NCT05778591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154722025|NCT05778591|Narcotics|narcotics|mesh-ancestor
154722026|NCT05778591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722027|NCT05778591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722028|NCT05778591|Analgesics|analgesics|mesh-ancestor
154722029|NCT05778591|Sensory System Agents|sensory system agents|mesh-ancestor
154722030|NCT05778591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722031|NCT05778591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154722032|NCT05753787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154722033|NCT05753787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154722034|NCT05743400|Thymoglobulin|thymoglobulin|mesh-list
154722035|NCT05743400|Immunologic Factors|immunologic factors|mesh-ancestor
154722036|NCT05743400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722037|NCT05743400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154722038|NCT05734807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154722039|NCT05734807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154722040|NCT05734807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722041|NCT05734807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722042|NCT05734807|Antiviral Agents|antiviral agents|mesh-ancestor
154722043|NCT05734807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722044|NCT05732077|Dopamine|dopamine|mesh-list
154722045|NCT05732077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154722046|NCT05732077|Sympathomimetics|sympathomimetics|mesh-ancestor
154722047|NCT05732077|Autonomic Agents|autonomic agents|mesh-ancestor
154722048|NCT05732077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722049|NCT05732077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722050|NCT05732077|Dopamine Agents|dopamine agents|mesh-ancestor
154722051|NCT05732077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722052|NCT05732077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722053|NCT05732077|Protective Agents|protective agents|mesh-ancestor
154722054|NCT05717062|Varespladib methyl|varespladib methyl|mesh-list
154722055|NCT05717062|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154722056|NCT05717062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722057|NCT05717062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722058|NCT05709301|Donepezil|donepezil|mesh-list
154722059|NCT05709301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154722060|NCT05709301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722061|NCT05709301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722062|NCT05709301|Cholinergic Agents|cholinergic agents|mesh-ancestor
154722063|NCT05709301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722064|NCT05709301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722065|NCT05709301|Nootropic Agents|nootropic agents|mesh-ancestor
154722066|NCT05649059|Cannabidiol|cannabidiol|mesh-list
154722067|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
154722068|NCT05638620|Bupivacaine|bupivacaine|mesh-list
154722069|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154722070|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
154722071|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722072|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722073|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
154722074|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722075|NCT05637606|Etilefrine|etilefrine|mesh-list
154722076|NCT05637606|Norepinephrine|norepinephrine|mesh-list
154722077|NCT05637606|Ephedrine|ephedrine|mesh-list
154722078|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
154722079|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154722080|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154473972|NCT02123979|Rotigotine|rotigotine|mesh-list
154722081|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
154722082|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722083|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722084|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722085|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
154722086|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
154722087|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722088|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154722089|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154722090|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154722091|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154722092|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
154722093|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
154722094|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154722095|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154722096|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154722097|NCT05637606|Protective Agents|protective agents|mesh-ancestor
154722098|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
154722099|NCT05623774|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154722100|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154722101|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722102|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722103|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722104|NCT05582538|Paclitaxel|paclitaxel|mesh-list
154722105|NCT05582538|Durvalumab|durvalumab|mesh-list
154722106|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154722107|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722108|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
154722109|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
154722110|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
154722111|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722112|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722113|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
154722114|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154722115|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722116|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154722117|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722118|NCT05562518|Estrogens|estrogens|mesh-list
154722119|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154722120|NCT05562518|Hormones|hormones|mesh-ancestor
153761539|NCT00218244|Lobeline|lobeline|mesh-list
154722121|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154722122|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722123|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154722124|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
154722125|NCT05556356|Acetaminophen|acetaminophen|mesh-list
154722126|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154722127|NCT05556356|Analgesics|analgesics|mesh-ancestor
154722128|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
154722129|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722130|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722131|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
154722132|NCT05553522|Capecitabine|capecitabine|mesh-list
154722133|NCT05553522|Trastuzumab|trastuzumab|mesh-list
154722134|NCT05553522|Tucatinib|tucatinib|mesh-list
154722135|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154722136|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
154722137|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722138|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722139|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722140|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154722141|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722142|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154722143|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
154722144|NCT05553132|Coagulants|coagulants|mesh-ancestor
154722145|NCT05544734|Acetaminophen|acetaminophen|mesh-list
154722146|NCT05544734|Ibuprofen|ibuprofen|mesh-list
154722147|NCT05544734|Hydrocodone|hydrocodone|mesh-list
154722148|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154722149|NCT05544734|Analgesics|analgesics|mesh-ancestor
154722150|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
154722151|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722152|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722153|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
154722154|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154722155|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154722157|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154722158|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722159|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722160|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154722161|NCT05544734|Narcotics|narcotics|mesh-ancestor
154722162|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722163|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
154722164|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154722165|NCT05515939|Insulin|insulin|mesh-list
154722166|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154722167|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722168|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
154722169|NCT05515029|Abatacept|abatacept|mesh-list
154722170|NCT05515029|Vedolizumab|vedolizumab|mesh-list
154722171|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154722172|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153761648|NCT00211419|Hormones|hormones|mesh-ancestor
154722173|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
154722174|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722175|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722176|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154722177|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
154722178|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722179|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722180|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154722181|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722182|NCT05515029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722183|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154722184|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722185|NCT05514483|Ondansetron|ondansetron|mesh-list
154722186|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
154722187|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
154722188|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722189|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722190|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154722191|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
154722192|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
154722193|NCT05514483|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154722194|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154722195|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
154722196|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722197|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722198|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154722199|NCT05499052|Hormones|hormones|mesh-ancestor
154722200|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154722201|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722202|NCT05484557|Enoxaparin|enoxaparin|mesh-list
154722203|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
154722204|NCT05484557|Apixaban|apixaban|mesh-list
154722205|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
154722206|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154722207|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154722208|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722209|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154722210|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
154722211|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154722212|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
154722213|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722214|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154722215|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722216|NCT05430828|Evolocumab|evolocumab|mesh-list
154722217|NCT05430828|Alirocumab|alirocumab|mesh-list
154722218|NCT05430828|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154722219|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154722220|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154722221|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
154722222|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722223|NCT05430828|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154722224|NCT05430828|Protease Inhibitors|protease inhibitors|mesh-ancestor
154722225|NCT05430828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722226|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154722227|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154722228|NCT05428488|Abatacept|abatacept|mesh-list
154722229|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722230|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722231|NCT05428488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722232|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722233|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154722234|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
154722235|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722236|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722237|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154722238|NCT05428007|Nivolumab|nivolumab|mesh-list
154722239|NCT05428007|Ipilimumab|ipilimumab|mesh-list
154722240|NCT05428007|Relatlimab|relatlimab|mesh-list
154722241|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722242|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722243|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722244|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722245|NCT05400031|Propolis|propolis|mesh-list
154722246|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722247|NCT05379790|Irinotecan|irinotecan|mesh-list
154722248|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154722249|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154722250|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722251|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722252|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722253|NCT05374538|Sotorasib|sotorasib|mesh-list
154722254|NCT05374538|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722255|NCT05374538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722256|NCT05374538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722257|NCT05374538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722258|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154722259|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154722260|NCT05373264|Diuretics|diuretics|mesh-ancestor
154722261|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
154722262|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722263|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154722264|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154722265|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761761|NCT00211848|Interferons|interferons|mesh-list
154722266|NCT05370040|Vaccines|vaccines|mesh-list
154722267|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
154722268|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722269|NCT05368376|Metoprolol|metoprolol|mesh-list
154722270|NCT05368376|Labetalol|labetalol|mesh-list
154722271|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154722272|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154722273|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
154722274|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
154722275|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722276|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722277|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154722278|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154722279|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154722280|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
154722281|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722282|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722283|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
154722284|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154722285|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154722286|NCT05317806|Metformin|metformin|mesh-list
154722287|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154722288|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722289|NCT05309928|Amoxicillin|amoxicillin|mesh-list
154722290|NCT05309928|Probenecid|probenecid|mesh-list
154722291|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154722292|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722293|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
154722294|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
154722295|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722296|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
154722297|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722298|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722299|NCT05309421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722300|NCT05309421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722301|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
154722302|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154722303|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
154722304|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722305|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
154722306|NCT05290727|Protective Agents|protective agents|mesh-ancestor
154722307|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154722308|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722309|NCT05271604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722310|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722311|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
154722312|NCT05255302|Pemetrexed|pemetrexed|mesh-list
154722313|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722314|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722315|NCT05255302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722316|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722317|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722318|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154722319|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154722320|NCT05243550|Mitomycins|mitomycins|mesh-list
154722321|NCT05243550|Mitomycin|mitomycin|mesh-list
154722322|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154722323|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722324|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
154722325|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722326|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154722327|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722328|NCT05243290|Niacinamide|niacinamide|mesh-list
154722329|NCT05243290|Niacin|niacin|mesh-list
154722330|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
154722331|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
154722332|NCT05243290|Vitamins|vitamins|mesh-ancestor
154722333|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
154722334|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722335|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154722336|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
154722337|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722338|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154722339|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
154722340|NCT05239546|Dostarlimab|dostarlimab|mesh-list
154722341|NCT05239546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722342|NCT05236517|Semaglutide|semaglutide|mesh-list
154722343|NCT05236517|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154722344|NCT05236517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154722345|NCT05236517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722346|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154722347|NCT05174832|Paclitaxel|paclitaxel|mesh-list
154722348|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
154722349|NCT05174832|Olaparib|olaparib|mesh-list
154722350|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154722351|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722352|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
154722353|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
154722354|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
154722355|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722356|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722357|NCT05174832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722358|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154722359|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722360|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
154722361|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154722362|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722363|NCT05128630|Durvalumab|durvalumab|mesh-list
154722364|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722365|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722366|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
154722367|NCT05109429|Narcotics|narcotics|mesh-ancestor
154722368|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722369|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722370|NCT05109429|Analgesics|analgesics|mesh-ancestor
154722371|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
154722372|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722373|NCT05080803|Bevacizumab|bevacizumab|mesh-list
154722374|NCT05080803|Ranibizumab|ranibizumab|mesh-list
154722375|NCT05080803|Aflibercept|aflibercept|mesh-list
154722376|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722377|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722378|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154722379|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154722380|NCT05080803|Growth Substances|growth substances|mesh-ancestor
154722381|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722382|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
154722383|NCT05055830|Acetaminophen|acetaminophen|mesh-list
154722384|NCT05055830|Milrinone|milrinone|mesh-list
154722385|NCT05055830|Methadone|methadone|mesh-list
154722386|NCT05055830|Caffeine|caffeine|mesh-list
154722387|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154722388|NCT05055830|Analgesics|analgesics|mesh-ancestor
154722389|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
154722390|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722391|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722392|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
154722393|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154722394|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154722395|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722396|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722397|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154722398|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154722399|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
154722400|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722401|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154722402|NCT05055830|Narcotics|narcotics|mesh-ancestor
154722403|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722404|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
154722405|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
154722406|NCT05055830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154722407|NCT05055830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154722408|NCT05055830|Vasodilator Agents|vasodilator agents|mesh-ancestor
154722409|NCT05055830|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154722410|NCT05055830|Protective Agents|protective agents|mesh-ancestor
154722411|NCT05048069|Rebamipide|rebamipide|mesh-list
154722412|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154722413|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154722414|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
154722415|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722416|NCT05048069|Protective Agents|protective agents|mesh-ancestor
154722417|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722418|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722419|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
154722420|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154722421|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
154722422|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154722423|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
154722424|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722425|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722426|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
154722427|NCT04994808|Fludarabine|fludarabine|mesh-list
154722428|NCT04994808|Clofarabine|clofarabine|mesh-list
154722429|NCT04994808|Treosulfan|treosulfan|mesh-list
154722430|NCT04994808|Busulfan|busulfan|mesh-list
154722431|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722432|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154722433|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
154722434|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722435|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154722436|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
154722437|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722438|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154722439|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
154722440|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154722441|NCT04954781|Tislelizumab|tislelizumab|mesh-list
154722442|NCT04954781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722443|NCT04954781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722444|NCT04936685|Vaccines|vaccines|mesh-list
154722445|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
154722446|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722447|NCT04921371|Listerine|listerine|mesh-list
154722448|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154722449|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722450|NCT04893096|Felzartamab|felzartamab|mesh-list
154722451|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722452|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
154722453|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722454|NCT04889183|Semaglutide|semaglutide|mesh-list
154722455|NCT04889183|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154722456|NCT04889183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154722457|NCT04889183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722458|NCT04888741|Cyclosporine|cyclosporine|mesh-list
154722460|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
154722461|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
154722462|NCT04888741|Cyclosporins|cyclosporins|mesh-list
154722463|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
154722464|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154722465|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
154722466|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722467|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722468|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154722469|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
154722470|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722471|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722472|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154722473|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722474|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
154722475|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722476|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
154722477|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154722478|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154722479|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154722480|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
154722481|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154722482|NCT04869358|Ofatumumab|ofatumumab|mesh-list
154722483|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722484|NCT04825223|Vaccines|vaccines|mesh-list
154722485|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
153762046|NCT00188864|Dexamethasone|dexamethasone|mesh-list
154722486|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722487|NCT04822649|Adenosine|adenosine|mesh-list
154722488|NCT04822649|Analgesics|analgesics|mesh-ancestor
154722489|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
154722490|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722491|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722492|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154722493|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
154722494|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154722495|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
154722496|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
154722497|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722498|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722499|NCT04753372|Aspirin|aspirin|mesh-list
154722500|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
154722501|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154722502|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
154722503|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154722504|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
154722505|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722506|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722507|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
154722508|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154722509|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154722510|NCT04753372|Analgesics|analgesics|mesh-ancestor
154722511|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
154722512|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722513|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722514|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154722515|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722516|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154722517|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154722518|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154722519|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154722520|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
154722521|NCT04748042|Prednisone|prednisone|mesh-list
154722522|NCT04748042|Olaparib|olaparib|mesh-list
154722523|NCT04748042|Androgens|androgens|mesh-list
154722524|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154722525|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
154722526|NCT04748042|Hormones|hormones|mesh-ancestor
154722527|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154722528|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722529|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154722530|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722531|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154722532|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722533|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722534|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
154722535|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154722536|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722537|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722538|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154722539|NCT04730609|Analgesics|analgesics|mesh-ancestor
154722540|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
154722541|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722542|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154722543|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154722544|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154722545|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154722546|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722547|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722548|NCT04713176|Remdesivir|remdesivir|mesh-list
154722549|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
154722550|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722551|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
154722552|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722553|NCT04703621|Daratumumab|daratumumab|mesh-list
154722554|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722555|NCT04696146|Complement C1s|complement c1s|mesh-list
154722556|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154722557|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154722558|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
154722559|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722560|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154722561|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154722562|NCT04669665|Ketamine|ketamine|mesh-list
154722563|NCT04669665|Analgesics|analgesics|mesh-ancestor
154722564|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
154722565|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722566|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722567|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154722568|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154722569|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
154722570|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
154722571|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722572|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154722573|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154722574|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722575|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722576|NCT04588233|Melatonin|melatonin|mesh-list
154722577|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
154722578|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722579|NCT04588233|Protective Agents|protective agents|mesh-ancestor
154722580|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722581|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722582|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
154722583|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
154722584|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154722585|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154722586|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
154722587|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722588|NCT04534153|Fexofenadine|fexofenadine|mesh-list
154722589|NCT04534153|Terfenadine|terfenadine|mesh-list
154722590|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154722591|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154722592|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154722593|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
154722594|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
154722595|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722596|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722597|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722598|NCT04524611|Ustekinumab|ustekinumab|mesh-list
154722599|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154722600|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
154722601|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
154722602|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722603|NCT04515147|Vaccines|vaccines|mesh-list
154722604|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154722605|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
154722606|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722607|NCT04491877|Vaccines|vaccines|mesh-list
154722608|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
154722609|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722610|NCT04471818|Ketamine|ketamine|mesh-list
154722611|NCT04471818|Analgesics|analgesics|mesh-ancestor
154722612|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
154722613|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722614|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722615|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154722616|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154722617|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
154722618|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
154722619|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722620|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154722621|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154722622|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722623|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722624|NCT04454658|Navitoclax|navitoclax|mesh-list
154722625|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722626|NCT04434482|Temozolomide|temozolomide|mesh-list
154722627|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154722628|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
154722629|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722630|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722631|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
154722632|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154722633|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154722634|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
154722635|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722636|NCT04419909|Tisagenlecleucel|tisagenlecleucel|mesh-list
154722637|NCT04419909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722638|NCT04419909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722639|NCT04364776|Durvalumab|durvalumab|mesh-list
154722640|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722641|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722642|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
154722643|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
154722644|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154722645|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722646|NCT04338529|Vitamins|vitamins|mesh-ancestor
154722647|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
154722648|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154722649|NCT04338529|Antacids|antacids|mesh-ancestor
154722650|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722651|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154722652|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
154722653|NCT04262466|Atezolizumab|atezolizumab|mesh-list
154722654|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722655|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722656|NCT04262466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722657|NCT04262466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722658|NCT04259944|Capecitabine|capecitabine|mesh-list
154722659|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154722660|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
154722661|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722662|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722663|NCT04256941|Letrozole|letrozole|mesh-list
154722664|NCT04256941|Fulvestrant|fulvestrant|mesh-list
154722665|NCT04256941|Palbociclib|palbociclib|mesh-list
154722666|NCT04256941|Anastrozole|anastrozole|mesh-list
154722667|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722668|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154722669|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154722670|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722671|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722672|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154722673|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
154722674|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154722675|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722676|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154722677|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154722678|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154722679|NCT04254692|Bupivacaine|bupivacaine|mesh-list
154722680|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
154722681|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
154474569|NCT06221969|Tirzepatide|tirzepatide|mesh-list
154722682|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722683|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722684|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
154722685|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722686|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154722687|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154722688|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154722689|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
154722691|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154722692|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
154722693|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154722694|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722695|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
154722696|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
154722697|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
154722698|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722699|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722700|NCT04212364|Naloxone|naloxone|mesh-list
153762300|NCT00213252|Prednisolone|prednisolone|mesh-list
154722701|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154722702|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722703|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
154722704|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722705|NCT04205643|Infliximab|infliximab|mesh-list
154722706|NCT04205643|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154722707|NCT04205643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154722708|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
154722709|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154722710|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722711|NCT04145440|Felzartamab|felzartamab|mesh-list
154722712|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722713|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
154722714|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722715|NCT04127227|Gemcitabine|gemcitabine|mesh-list
154722716|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
154722717|NCT04127227|Pegaspargase|pegaspargase|mesh-list
154722718|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154722719|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
154722720|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722721|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722722|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
154722723|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154722724|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154722725|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722726|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
154722727|NCT04089865|Coagulants|coagulants|mesh-ancestor
154722728|NCT04074512|Copper|copper|mesh-list
154722729|NCT04074512|Trace Elements|trace elements|mesh-ancestor
154722730|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
154722731|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722732|NCT04062708|Durvalumab|durvalumab|mesh-list
154722733|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722734|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722735|NCT04036435|Deucravacitinib|deucravacitinib|mesh-list
154722736|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
154722737|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154722738|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722739|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722740|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
154722741|NCT04033107|Metformin|metformin|mesh-list
154722742|NCT04033107|Vitamins|vitamins|mesh-ancestor
154722743|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
154722744|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722745|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154722746|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
154722747|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722748|NCT04033107|Protective Agents|protective agents|mesh-ancestor
154722749|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154722750|NCT04017832|Semaglutide|semaglutide|mesh-list
154722751|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154722752|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722753|NCT04017832|Incretins|incretins|mesh-ancestor
154722754|NCT04017832|Hormones|hormones|mesh-ancestor
154722755|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154722756|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154558072|NCT02407899|Vitamins|vitamins|mesh-ancestor
154722757|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
154722758|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722759|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722760|NCT04017832|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154722761|NCT04006262|Nivolumab|nivolumab|mesh-list
154722762|NCT04006262|Ipilimumab|ipilimumab|mesh-list
154722763|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722764|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722765|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722766|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722767|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
154722768|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722769|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154722770|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722771|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722772|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
154722773|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154722774|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722775|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154722776|NCT03994627|Olaratumab|olaratumab|mesh-list
154722777|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722778|NCT03978611|Ipilimumab|ipilimumab|mesh-list
154722779|NCT03978611|Relatlimab|relatlimab|mesh-list
154722780|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722781|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722782|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154722783|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722784|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
154722785|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154722786|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154722787|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154722788|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154722789|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722790|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
154722791|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722792|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722793|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154722794|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722795|NCT03944577|Evolocumab|evolocumab|mesh-list
154722796|NCT03944577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154722797|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154722798|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154722799|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
153762363|NCT00412503|Temozolomide|temozolomide|mesh-list
154722800|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722801|NCT03944577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154722802|NCT03944577|Protease Inhibitors|protease inhibitors|mesh-ancestor
154722803|NCT03944577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722804|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154722805|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
154722806|NCT03925025|Nimodipine|nimodipine|mesh-list
154722807|NCT03925025|Analgesics|analgesics|mesh-ancestor
154722808|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
154722809|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722810|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722811|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
154722812|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722813|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154722814|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
154722815|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154722816|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154722817|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722818|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154722819|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
154722820|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154722821|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154722822|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
154722823|NCT03924947|Pancrelipase|pancrelipase|mesh-list
154722824|NCT03924947|Pancreatin|pancreatin|mesh-list
154722825|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154722826|NCT03914118|Modafinil|modafinil|mesh-list
154722827|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154722828|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722829|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154722830|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154722831|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154722832|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722834|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154722835|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154722836|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154722837|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154722838|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722839|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
154722840|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722841|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722842|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154722843|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722844|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
154722845|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154722846|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722847|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762418|NCT00190307|Aspirin|aspirin|mesh-list
154722848|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154722849|NCT03892928|Analgesics|analgesics|mesh-ancestor
154722850|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
154722851|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722852|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154722853|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154722854|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154722855|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
154722856|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722857|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722858|NCT03864094|Phenylephrine|phenylephrine|mesh-list
154722859|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
154722860|NCT03864094|Norepinephrine|norepinephrine|mesh-list
154722861|NCT03864094|Ephedrine|ephedrine|mesh-list
154722862|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
154722863|NCT03864094|Remifentanil|remifentanil|mesh-list
154722864|NCT03864094|Propofol|propofol|mesh-list
154722865|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154722866|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722867|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722868|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154722869|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
154722870|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
154722871|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154722872|NCT03864094|Narcotics|narcotics|mesh-ancestor
154722873|NCT03864094|Analgesics|analgesics|mesh-ancestor
154722874|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
154722875|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722876|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154722877|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
154722878|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
154722879|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
154722880|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154722881|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
154722882|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
154722883|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154722884|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154722885|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154722886|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
154722887|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154722888|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722889|NCT03864094|Protective Agents|protective agents|mesh-ancestor
154722890|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154722891|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154722892|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154722893|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
154722894|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154722895|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
154722896|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
154722897|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722898|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722899|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154722900|NCT03826693|Analgesics|analgesics|mesh-ancestor
154722901|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
154722902|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154722903|NCT03765983|Trastuzumab|trastuzumab|mesh-list
154722904|NCT03765983|GDC-0084|gdc-0084|mesh-list
154722905|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722906|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722907|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722908|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722909|NCT03761225|Prednisone|prednisone|mesh-list
154722910|NCT03761225|Docetaxel|docetaxel|mesh-list
154722911|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722912|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
154722913|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
154722914|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
154722915|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722916|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154722917|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
154722918|NCT03761225|Hormones|hormones|mesh-ancestor
154722919|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154722920|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722921|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154722922|NCT03755804|Prednisone|prednisone|mesh-list
154722923|NCT03755804|Prednisolone|prednisolone|mesh-list
154722924|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
154722925|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154722926|NCT03755804|Dacarbazine|dacarbazine|mesh-list
154722927|NCT03755804|Doxorubicin|doxorubicin|mesh-list
154722928|NCT03755804|Etoposide|etoposide|mesh-list
154722929|NCT03755804|Vincristine|vincristine|mesh-list
154722930|NCT03755804|Bleomycin|bleomycin|mesh-list
154722931|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154722932|NCT03755804|Vinblastine|vinblastine|mesh-list
154722933|NCT03755804|Imidazole|imidazole|mesh-list
154722934|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154722935|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
154722936|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722937|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722938|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154722939|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
154722940|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722941|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722942|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153762590|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154722943|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154722944|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154722945|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154722946|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722947|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154722948|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
154722949|NCT03755804|Hormones|hormones|mesh-ancestor
154722950|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154722951|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154722952|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154722953|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
154722954|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
154722955|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
154722956|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722957|NCT03755804|Immunotoxins|immunotoxins|mesh-ancestor
154722958|NCT03755804|Immunoconjugates|immunoconjugates|mesh-ancestor
154722959|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
154722960|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154722961|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
154722962|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722963|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722964|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154722965|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
154722966|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722967|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722968|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154722969|NCT03674424|Avelumab|avelumab|mesh-list
154722970|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154722971|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722972|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
154722973|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154722974|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154722975|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
154722976|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
154722977|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154722978|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722979|NCT03571308|Prednisolone|prednisolone|mesh-list
154722980|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
154474876|NCT06081101|Hormones|hormones|mesh-ancestor
154722981|NCT03571308|Doxorubicin|doxorubicin|mesh-list
154722982|NCT03571308|Vincristine|vincristine|mesh-list
154722983|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
154722984|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154722985|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
154722986|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154722987|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154722988|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154722989|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
154722990|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154722991|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154722992|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154722993|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154722994|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154722995|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154722996|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154722997|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154722998|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
154722999|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
154723000|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
154723001|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723002|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
154723003|NCT03571308|Hormones|hormones|mesh-ancestor
154723004|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723005|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723006|NCT03571308|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154723007|NCT03571308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154723008|NCT03529448|Temozolomide|temozolomide|mesh-list
154723009|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723010|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
154723011|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723012|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723013|NCT03526250|Palbociclib|palbociclib|mesh-list
154723014|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723015|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154723016|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723017|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723018|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
154723019|NCT03519412|Temozolomide|temozolomide|mesh-list
154723020|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723021|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723022|NCT03519412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723023|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723024|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723025|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
154723026|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
154723027|NCT03513406|Neostigmine|neostigmine|mesh-list
154723028|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154723029|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723030|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723031|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
154723032|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154723033|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723034|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154723035|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
154723036|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723037|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154723038|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154723039|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154723040|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
154723041|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
154723042|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723043|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723044|NCT03504163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723045|NCT03504163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723046|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154723047|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
154723048|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723049|NCT03435952|Doxycycline|doxycycline|mesh-list
154723050|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
154723051|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723052|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723053|NCT03435952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154474950|NCT06043362|Nicotine|nicotine|mesh-list
154723054|NCT03435952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723055|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154723056|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723057|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
154723058|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154723059|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154723060|NCT03418779|Prednisolone|prednisolone|mesh-list
154723061|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
154723062|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154723063|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
154723064|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723065|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723066|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723067|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
154723068|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723069|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723070|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154723071|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723072|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
153762756|NCT06116214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723073|NCT03418779|Hormones|hormones|mesh-ancestor
154723074|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723075|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723076|NCT03409588|Riociguat|riociguat|mesh-list
154723077|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
154723078|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723079|NCT03387085|Leucovorin|leucovorin|mesh-list
154723080|NCT03387085|Paclitaxel|paclitaxel|mesh-list
154723081|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
154723082|NCT03387085|Bevacizumab|bevacizumab|mesh-list
154723083|NCT03387085|Capecitabine|capecitabine|mesh-list
154723084|NCT03387085|Fluorouracil|fluorouracil|mesh-list
154723085|NCT03387085|Avelumab|avelumab|mesh-list
154723086|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154723087|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723088|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
154723089|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
154723090|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
154723091|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723092|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723093|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
154723094|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723095|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723096|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723097|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
154723098|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154723099|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723100|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154723101|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154723102|NCT03387085|Growth Substances|growth substances|mesh-ancestor
154723103|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
154723104|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723105|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
154723106|NCT03387085|Antidotes|antidotes|mesh-ancestor
154723107|NCT03387085|Protective Agents|protective agents|mesh-ancestor
154723108|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
154723109|NCT03387085|Vitamins|vitamins|mesh-ancestor
154723110|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
154723111|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
154723112|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154723113|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154723114|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723115|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
154723116|NCT03385928|Coagulants|coagulants|mesh-ancestor
154723117|NCT03374254|Leucovorin|leucovorin|mesh-list
154723118|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
154723119|NCT03374254|Fluorouracil|fluorouracil|mesh-list
154723120|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
154723121|NCT03374254|Irinotecan|irinotecan|mesh-list
154723122|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723123|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723124|NCT03374254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723125|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723126|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723127|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
154723128|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723129|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723130|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
154723131|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154723133|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723134|NCT03374254|Antidotes|antidotes|mesh-ancestor
154723135|NCT03374254|Protective Agents|protective agents|mesh-ancestor
154723136|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
154723137|NCT03374254|Vitamins|vitamins|mesh-ancestor
154723138|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
154723139|NCT03354728|Vaccines|vaccines|mesh-list
154723140|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
154723141|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723142|NCT03350126|Nivolumab|nivolumab|mesh-list
154723143|NCT03350126|Ipilimumab|ipilimumab|mesh-list
154723144|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723145|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723146|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723147|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723148|NCT03347929|Naproxen|naproxen|mesh-list
154723149|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154723150|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154723151|NCT03347929|Analgesics|analgesics|mesh-ancestor
154723152|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
154723153|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723154|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723155|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723156|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723157|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
154723158|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154723159|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723160|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723161|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
154723162|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723163|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723164|NCT03248570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153762854|NCT05913232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723165|NCT03248570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723166|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
154723167|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723168|NCT03233204|Olaparib|olaparib|mesh-list
154723169|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154723170|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723171|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723172|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723173|NCT03216525|Alvimopan|alvimopan|mesh-list
154723174|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154723175|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154723176|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154723177|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723178|NCT03190915|Trametinib|trametinib|mesh-list
154723179|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723180|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154723181|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723182|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723183|NCT03143270|Nivolumab|nivolumab|mesh-list
154723184|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723185|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723186|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723187|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723188|NCT03113968|Ketamine|ketamine|mesh-list
154723189|NCT03113968|Analgesics|analgesics|mesh-ancestor
154723190|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
154723191|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723192|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723193|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154723194|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154723195|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
154723196|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
154723197|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154723198|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154723199|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154723200|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154723201|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723202|NCT03112174|Venetoclax|venetoclax|mesh-list
154723203|NCT03112174|Ibrutinib|ibrutinib|mesh-list
154723204|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723205|NCT03112174|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154723206|NCT03112174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154723207|NCT03112174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723208|NCT03112174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723210|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154723211|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723212|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723213|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723214|NCT03028857|Choline|choline|mesh-list
154723215|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
154723216|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154723217|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
154723218|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723219|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154723220|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154723221|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
154723222|NCT02994576|Atezolizumab|atezolizumab|mesh-list
154723223|NCT02994576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723224|NCT02994576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723225|NCT02994576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723226|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723227|NCT02973789|Docetaxel|docetaxel|mesh-list
154723228|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154723229|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723230|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
154723231|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
154723232|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
154723233|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723234|NCT02973789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723235|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
154723236|NCT02883049|Leucovorin|leucovorin|mesh-list
154723237|NCT02883049|Folic Acid|folic acid|mesh-list
154723238|NCT02883049|Cytarabine|cytarabine|mesh-list
154723239|NCT02883049|Dexamethasone|dexamethasone|mesh-list
154723240|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
154723241|NCT02883049|Prednisone|prednisone|mesh-list
154723242|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
154723243|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154723244|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154723245|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154723246|NCT02883049|Cortisone|cortisone|mesh-list
154723247|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
154723248|NCT02883049|Doxorubicin|doxorubicin|mesh-list
154723249|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154723250|NCT02883049|Methotrexate|methotrexate|mesh-list
154723251|NCT02883049|Etoposide|etoposide|mesh-list
154723252|NCT02883049|Vincristine|vincristine|mesh-list
154723253|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
154723254|NCT02883049|Daunorubicin|daunorubicin|mesh-list
154723255|NCT02883049|Asparaginase|asparaginase|mesh-list
154723256|NCT02883049|Dasatinib|dasatinib|mesh-list
154723257|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
154723258|NCT02883049|Clofarabine|clofarabine|mesh-list
154723259|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
154723260|NCT02883049|Pegaspargase|pegaspargase|mesh-list
154723261|NCT02883049|Thioguanine|thioguanine|mesh-list
154723262|NCT02883049|BB 1101|bb 1101|mesh-list
154723263|NCT02883049|Calcium|calcium|mesh-list
154723264|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
154723265|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
154723266|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723267|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
154723268|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723269|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723270|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723271|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
154723272|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723273|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723274|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154723275|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723276|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
154723277|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
154723278|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723279|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154723280|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
154558073|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
154723281|NCT02883049|Hormones|hormones|mesh-ancestor
154723282|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723283|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723284|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
154723285|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723286|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154723287|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154723288|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154723289|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154723290|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154723291|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154723292|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
154723293|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154723294|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723295|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
154723296|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
154723297|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154723298|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154723299|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154723300|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
154723301|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723302|NCT02883049|Antidotes|antidotes|mesh-ancestor
154723303|NCT02883049|Protective Agents|protective agents|mesh-ancestor
154723304|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
153763072|NCT06317662|Asparaginase|asparaginase|mesh-list
154723305|NCT02883049|Vitamins|vitamins|mesh-ancestor
154723306|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
154723307|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
154723308|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
154723309|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
154723310|NCT02883049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154723311|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154723312|NCT02883049|Hematinics|hematinics|mesh-ancestor
154723313|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
154723314|NCT02864251|Carboplatin|carboplatin|mesh-list
154723315|NCT02864251|Nivolumab|nivolumab|mesh-list
154723316|NCT02864251|Pemetrexed|pemetrexed|mesh-list
154723317|NCT02864251|Ipilimumab|ipilimumab|mesh-list
154723318|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723319|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723320|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723321|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723322|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723323|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154723324|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154723325|NCT02774148|Acetaminophen|acetaminophen|mesh-list
154723326|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154723327|NCT02774148|Analgesics|analgesics|mesh-ancestor
154723328|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
154723329|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723330|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723331|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
154723332|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
154723333|NCT02771197|Fludarabine|fludarabine|mesh-list
154723334|NCT02771197|Melphalan|melphalan|mesh-list
154723335|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723336|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723337|NCT02771197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723338|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723339|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723340|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
154723341|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723342|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723343|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
154723344|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154723345|NCT02722421|Efavirenz|efavirenz|mesh-list
154723346|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
154723347|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154723348|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154723349|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723350|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723351|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
154723352|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723353|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154723354|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154723355|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154475249|NCT05881915|Autonomic Agents|autonomic agents|mesh-ancestor
153763132|NCT06317649|Venetoclax|venetoclax|mesh-list
154723356|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154723357|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154723358|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154723359|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154723361|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154723362|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723363|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154723364|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154723365|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154723366|NCT02693184|Vitamin D|vitamin d|mesh-list
154723367|NCT02693184|Calcium|calcium|mesh-list
154723368|NCT02693184|Vitamins|vitamins|mesh-ancestor
154723369|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
154723370|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723371|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154723372|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154723373|NCT02659241|Adavosertib|adavosertib|mesh-list
154723374|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723375|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723376|NCT02647385|Lidocaine|lidocaine|mesh-list
154723377|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
154723378|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
154723379|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154723380|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723381|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
154723382|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723383|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154723384|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154723385|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154723386|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154723387|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723388|NCT02588677|Riluzole|riluzole|mesh-list
154723389|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
154723390|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154723391|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154723392|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154723393|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723394|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723395|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154723396|NCT02588677|Protective Agents|protective agents|mesh-ancestor
154723397|NCT02565914|Ivacaftor|ivacaftor|mesh-list
153763133|NCT06317649|Gilteritinib|gilteritinib|mesh-list
154723398|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154723399|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154723400|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723401|NCT02535078|Durvalumab|durvalumab|mesh-list
154723402|NCT02535078|Tremelimumab|tremelimumab|mesh-list
154723403|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723404|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723405|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
154723406|NCT02338518|Etoposide|etoposide|mesh-list
154723407|NCT02338518|Epirubicin|epirubicin|mesh-list
154723408|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723409|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154723410|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154723411|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154723412|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723413|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723414|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154723415|NCT02286687|Talazoparib|talazoparib|mesh-list
154723416|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154723417|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723418|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723419|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723420|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
154723421|NCT02248701|Finasteride|finasteride|mesh-list
154723422|NCT02248701|Testosterone|testosterone|mesh-list
154723423|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
154723424|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
154723425|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154723426|NCT02248701|Androgens|androgens|mesh-ancestor
154723427|NCT02248701|Hormones|hormones|mesh-ancestor
154723428|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723429|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723430|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723431|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723432|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
154723433|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154723434|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154723435|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723436|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723437|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
154723438|NCT02248701|Urological Agents|urological agents|mesh-ancestor
154723439|NCT02204982|Rituximab|rituximab|mesh-list
154723440|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723441|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723442|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
154723443|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723444|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723445|NCT02086175|Rituximab|rituximab|mesh-list
154723446|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723447|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723448|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
154723449|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723450|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723451|NCT02073838|Ribavirin|ribavirin|mesh-list
154723452|NCT02073838|Decitabine|decitabine|mesh-list
154723453|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
154723454|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723455|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
154723456|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723457|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723458|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723459|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723460|NCT02068443|Metformin|metformin|mesh-list
154723461|NCT02068443|Alogliptin|alogliptin|mesh-list
154723462|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154723463|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723464|NCT02068443|Incretins|incretins|mesh-ancestor
154723465|NCT02068443|Hormones|hormones|mesh-ancestor
154723466|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723467|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154723468|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
154723469|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723470|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723471|NCT02021006|Amoxicillin|amoxicillin|mesh-list
154723472|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
154723473|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
154723474|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154723475|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
154723476|NCT02021006|Cefixime|cefixime|mesh-list
154723477|NCT02021006|Trimethoprim|trimethoprim|mesh-list
154723478|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
154723479|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154723480|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723481|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154723482|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
154723483|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154723484|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154723485|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154723486|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723487|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723488|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154723489|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154723490|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154723491|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154723492|NCT02021006|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154723493|NCT02021006|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154723494|NCT02018861|Rituximab|rituximab|mesh-list
154723495|NCT02018861|Carboplatin|carboplatin|mesh-list
154723496|NCT02018861|Etoposide|etoposide|mesh-list
154723497|NCT02018861|Ifosfamide|ifosfamide|mesh-list
154723498|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723499|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723500|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
154723501|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723502|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723503|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154723504|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154723505|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154723506|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723507|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723508|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723509|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
154723510|NCT01995578|Azacitidine|azacitidine|mesh-list
154723511|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723512|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
154723513|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723514|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723515|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723516|NCT01949337|Prednisone|prednisone|mesh-list
154723517|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723518|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
154723519|NCT01949337|Hormones|hormones|mesh-ancestor
154723520|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723521|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723522|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723523|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723524|NCT01827384|Carboplatin|carboplatin|mesh-list
154723525|NCT01827384|Everolimus|everolimus|mesh-list
154723526|NCT01827384|Temozolomide|temozolomide|mesh-list
154723527|NCT01827384|Trametinib|trametinib|mesh-list
154723528|NCT01827384|Veliparib|veliparib|mesh-list
154723529|NCT01827384|Adavosertib|adavosertib|mesh-list
154723530|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723531|NCT01827384|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154723532|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154723533|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723534|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723535|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723536|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
154723537|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723538|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723539|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
154723540|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154723541|NCT01560663|Carboplatin|carboplatin|mesh-list
154723542|NCT01560663|Docetaxel|docetaxel|mesh-list
154723543|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763357|NCT06277882|Vaccines|vaccines|mesh-list
154723544|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
154723545|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
154723546|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
154723547|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723548|NCT01463371|Azithromycin|azithromycin|mesh-list
154723549|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154723550|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723551|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154723552|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154723553|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723554|NCT01377389|Ipilimumab|ipilimumab|mesh-list
154723555|NCT01377389|Leuprolide|leuprolide|mesh-list
154723556|NCT01377389|Goserelin|goserelin|mesh-list
154723557|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723558|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723559|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723560|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723561|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154723562|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
154723563|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154723564|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723565|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723566|NCT01194271|Ipilimumab|ipilimumab|mesh-list
154723567|NCT01194271|Leuprolide|leuprolide|mesh-list
154723568|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723569|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723570|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723571|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723572|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154723573|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
154723574|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154723575|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723576|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723577|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
154723578|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
154723579|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154723580|NCT01172418|Daclizumab|daclizumab|mesh-list
154723581|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
154723582|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723583|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723584|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723585|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723587|NCT01119508|Ipilimumab|ipilimumab|mesh-list
154723588|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723589|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
154723590|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723591|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723592|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723593|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154723594|NCT00958737|Capecitabine|capecitabine|mesh-list
154723595|NCT00958737|Fluorouracil|fluorouracil|mesh-list
154723596|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
154723597|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723598|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
154723599|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723600|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723601|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723602|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
154723603|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723604|NCT00917592|Amoxicillin|amoxicillin|mesh-list
154723605|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
154723606|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
154723607|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154723608|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723609|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723610|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723611|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154723612|NCT00754338|Dipivefrin|dipivefrin|mesh-list
154723613|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154723614|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
154723615|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154723616|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723617|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723618|NCT00752154|Curcumin|curcumin|mesh-list
154723619|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154723620|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154723621|NCT00752154|Analgesics|analgesics|mesh-ancestor
154723622|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
154723623|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723624|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723625|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723626|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723627|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723628|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723629|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723630|NCT00745134|Curcumin|curcumin|mesh-list
154723631|NCT00745134|Capecitabine|capecitabine|mesh-list
154723632|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723633|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
153763482|NCT06225622|Oxaliplatin|oxaliplatin|mesh-list
154723634|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723635|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723636|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154723637|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154723638|NCT00745134|Analgesics|analgesics|mesh-ancestor
154723639|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
154723640|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723641|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723642|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723643|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723644|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723645|NCT00673010|Iodine|iodine|mesh-list
154723646|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154723647|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723648|NCT00673010|Trace Elements|trace elements|mesh-ancestor
154723649|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
154723650|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723651|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
154723652|NCT00610883|Methotrexate|methotrexate|mesh-list
154723653|NCT00610883|Asparaginase|asparaginase|mesh-list
154723654|NCT00610883|Daunorubicin|daunorubicin|mesh-list
154723655|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723656|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
154723657|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723658|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723659|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723660|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
154723661|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723662|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723663|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154723664|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154723665|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
154723666|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154723667|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723668|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
154723669|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
154723670|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723671|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154723672|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154723673|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154723674|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154723675|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154723676|NCT00574496|Cyclosporine|cyclosporine|mesh-list
154723677|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
154723678|NCT00574496|Prednisone|prednisone|mesh-list
154723679|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
154723680|NCT00574496|Melphalan|melphalan|mesh-list
154723681|NCT00574496|Ifosfamide|ifosfamide|mesh-list
154723682|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
154723683|NCT00574496|Gemcitabine|gemcitabine|mesh-list
154723684|NCT00574496|Methotrexate|methotrexate|mesh-list
154723685|NCT00574496|Fludarabine|fludarabine|mesh-list
154723686|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
154723687|NCT00574496|Vincristine|vincristine|mesh-list
154723688|NCT00574496|Vinorelbine|vinorelbine|mesh-list
154723689|NCT00574496|Procarbazine|procarbazine|mesh-list
154723690|NCT00574496|Cyclosporins|cyclosporins|mesh-list
154723691|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723692|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
154723693|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723694|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723695|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723696|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
154723697|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723698|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723699|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154723700|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723701|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
154723702|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723703|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
154723704|NCT00574496|Hormones|hormones|mesh-ancestor
154723705|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723706|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723707|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154723708|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
154723709|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154723710|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
154723711|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723712|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154723713|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154723714|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154723715|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
154723716|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
154723717|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
154723718|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
154723719|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723720|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154723721|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154723722|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154723723|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
154723724|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154723725|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
154723726|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154723727|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723728|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154723729|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
154723730|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153763626|NCT06149286|Rituximab|rituximab|mesh-list
154723731|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723732|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723733|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723734|NCT00499083|Tamoxifen|tamoxifen|mesh-list
154723735|NCT00499083|Paclitaxel|paclitaxel|mesh-list
154723736|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
154723737|NCT00499083|Doxorubicin|doxorubicin|mesh-list
154723738|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154723739|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154723740|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154723741|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723742|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
154723743|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
154723744|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154723745|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723746|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723747|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
154723748|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723749|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723750|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723751|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
154723752|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154723753|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154723754|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154723755|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154723756|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723757|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154723758|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
154723759|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723760|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723761|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154723762|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154723763|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154723764|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154723765|NCT00418886|Pemetrexed|pemetrexed|mesh-list
154723766|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723767|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723768|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723769|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154723770|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154723771|NCT00089024|Leucovorin|leucovorin|mesh-list
154723772|NCT00089024|Folic Acid|folic acid|mesh-list
154723773|NCT00089024|Gemcitabine|gemcitabine|mesh-list
154723774|NCT00089024|Fluorouracil|fluorouracil|mesh-list
154723775|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
154723776|NCT00089024|Calcium|calcium|mesh-list
154723777|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
154723778|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723779|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
154723780|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723781|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723782|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154723783|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723784|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723785|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
154723786|NCT00089024|Antidotes|antidotes|mesh-ancestor
154723787|NCT00089024|Protective Agents|protective agents|mesh-ancestor
154723788|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
154723789|NCT00089024|Vitamins|vitamins|mesh-ancestor
154723790|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
154723791|NCT00089024|Hematinics|hematinics|mesh-ancestor
153763772|NCT06073184|Incretins|incretins|mesh-ancestor
154723792|NCT01819129|Insulin|insulin|mesh-list
154723793|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154723794|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
154723795|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
154723796|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
154723797|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154723798|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154723799|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723800|NCT04025775|Insulin|insulin|mesh-list
154723801|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154723802|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723803|NCT04022811|Tobramycin|tobramycin|mesh-list
154723804|NCT04022811|Dexamethasone|dexamethasone|mesh-list
154723805|NCT04022811|Bromfenac|bromfenac|mesh-list
154723806|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
154723807|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475698|NCT05541172|Hormones|hormones|mesh-ancestor
154723808|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
154723809|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
154723810|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723811|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723812|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154723813|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
154723814|NCT04022811|Hormones|hormones|mesh-ancestor
154723815|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723816|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723817|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723818|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154723819|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
154723820|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
154723821|NCT04022811|Protective Agents|protective agents|mesh-ancestor
154723822|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154723823|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723824|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154723825|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154723826|NCT04022811|Analgesics|analgesics|mesh-ancestor
154723827|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
154723828|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723829|NCT04145583|Voriconazole|voriconazole|mesh-list
154723830|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
154723831|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723832|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154723833|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154723834|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723835|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723836|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154723837|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
154723838|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723839|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723840|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154723841|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
154723842|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
154723843|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154723844|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154723845|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723846|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723847|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723848|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723849|NCT04145193|Leucovorin|leucovorin|mesh-list
154723850|NCT04145193|Fluorouracil|fluorouracil|mesh-list
154723851|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
154723852|NCT04145193|Durvalumab|durvalumab|mesh-list
154723853|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154723854|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
154723855|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723856|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723857|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723858|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723859|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
154723860|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723861|NCT04145193|Antidotes|antidotes|mesh-ancestor
154723862|NCT04145193|Protective Agents|protective agents|mesh-ancestor
154723863|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
154723864|NCT04145193|Vitamins|vitamins|mesh-ancestor
154723865|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
154723866|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154723867|NCT04147845|Triamcinolone|triamcinolone|mesh-list
154723868|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154723869|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154723870|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154723871|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723872|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
154723873|NCT04147845|Hormones|hormones|mesh-ancestor
154723874|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723875|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723876|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723877|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
154723878|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723879|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723880|NCT01849783|Thalidomide|thalidomide|mesh-list
154723881|NCT01849783|Dexamethasone|dexamethasone|mesh-list
154723882|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
154723883|NCT01849783|Melphalan|melphalan|mesh-list
154723884|NCT01849783|Doxorubicin|doxorubicin|mesh-list
154475772|NCT05489211|Leucovorin|leucovorin|mesh-list
154723885|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154723886|NCT01849783|Etoposide|etoposide|mesh-list
154723887|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
154723888|NCT01849783|Bortezomib|bortezomib|mesh-list
154723889|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723890|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
154723891|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723892|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723893|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154723894|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
154723895|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723896|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723897|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154723898|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154723899|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
154723900|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
154723901|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723902|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154723903|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
154723904|NCT01849783|Hormones|hormones|mesh-ancestor
154723905|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723906|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154723907|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154723908|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154723909|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154723910|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723911|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154723912|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
154723913|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154723914|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154723915|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154723916|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154723917|NCT01849783|Growth Substances|growth substances|mesh-ancestor
154723918|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
154723919|NCT01611883|Ezetimibe|ezetimibe|mesh-list
154723920|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154723921|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154723922|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
154723923|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723924|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154723925|NCT04170517|Progesterone|progesterone|mesh-list
154723926|NCT04170517|Progestins|progestins|mesh-ancestor
154723927|NCT04170517|Hormones|hormones|mesh-ancestor
154723928|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723929|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723930|NCT01848457|Methotrexate|methotrexate|mesh-list
154723931|NCT01848457|Pantoprazole|pantoprazole|mesh-list
154723932|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154723933|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
154723934|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154723935|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723936|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154723937|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
154723938|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723939|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723940|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
154723941|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154723942|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154723943|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154723944|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
154723945|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154723946|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154723947|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154723948|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154723949|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154723950|NCT01870999|Aripiprazole|aripiprazole|mesh-list
154723951|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
154723952|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154723953|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154723954|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154723955|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154723956|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723957|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
154723958|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
154723959|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154723960|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723961|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154723962|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154723963|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
154723964|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154723965|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154723966|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154723967|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154723968|NCT01870921|Ticagrelor|ticagrelor|mesh-list
154723969|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154723970|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154723971|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154723972|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154723973|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
154723974|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154723975|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723976|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723977|NCT00526474|Vorapaxar|vorapaxar|mesh-list
154723978|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154723979|NCT01848145|Ofatumumab|ofatumumab|mesh-list
154723980|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154723981|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154723982|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154723983|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
154723984|NCT00527644|Hormones|hormones|mesh-ancestor
154723985|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154723986|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723987|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154723988|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723989|NCT01847443|Nicotine|nicotine|mesh-list
154723990|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154723991|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
154723992|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154723993|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154723994|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154723995|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154723996|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
154723997|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154723998|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154723999|NCT00527878|Ranitidine|ranitidine|mesh-list
154724000|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154724001|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154724002|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154724003|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154724004|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
154724005|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
154724006|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724007|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724008|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724009|NCT05558878|Ambroxol|ambroxol|mesh-list
154724010|NCT05558878|Expectorants|expectorants|mesh-ancestor
154724011|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724012|NCT05621434|Maleic acid|maleic acid|mesh-list
154724013|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724014|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724015|NCT01870843|Escitalopram|escitalopram|mesh-list
154724016|NCT01870843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154724017|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154724018|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724019|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724020|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724021|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
154724022|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724023|NCT01816477|Ropivacaine|ropivacaine|mesh-list
154724024|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
154724025|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
154724026|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724027|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724028|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
154724029|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724030|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
154724031|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154475920|NCT05390307|Hormones|hormones|mesh-ancestor
154724032|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154724033|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724034|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
154724035|NCT01846507|Coagulants|coagulants|mesh-ancestor
154724036|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
154724037|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154724038|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
154724039|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724040|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
154724041|NCT01846039|Protective Agents|protective agents|mesh-ancestor
154724042|NCT01610167|Listerine|listerine|mesh-list
154724043|NCT01610167|Fluorides|fluorides|mesh-list
154724044|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
154724045|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
154724046|NCT01610167|Protective Agents|protective agents|mesh-ancestor
154724047|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724048|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154724049|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724050|NCT04478500|Minocycline|minocycline|mesh-list
154724051|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154724052|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724053|NCT01816243|Fentanyl|fentanyl|mesh-list
154724054|NCT01816243|Morphine|morphine|mesh-list
154724055|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154724056|NCT01816243|Narcotics|narcotics|mesh-ancestor
154724057|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724058|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724059|NCT01816243|Analgesics|analgesics|mesh-ancestor
154724060|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
154724061|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724062|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154724063|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154724064|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
154724065|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
154724066|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
154724067|NCT05576896|Cetuximab|cetuximab|mesh-list
154724068|NCT05576896|Panitumumab|panitumumab|mesh-list
154724069|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154724070|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724071|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
154724072|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154724073|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154724074|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724075|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724076|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724077|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724078|NCT01845805|Azacitidine|azacitidine|mesh-list
154724079|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154724080|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
154724081|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724082|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724083|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724084|NCT01845025|Fluticasone|fluticasone|mesh-list
154724085|NCT01845025|Xhance|xhance|mesh-list
154724086|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
154724087|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724088|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154724089|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
154724090|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724091|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724092|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154724093|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724094|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
154724095|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154724096|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154724097|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154724098|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154724099|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
154724100|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724101|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724102|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154724103|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154724104|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724105|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724106|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154724107|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724108|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724109|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
154724110|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724111|NCT04847440|Tenofovir|tenofovir|mesh-list
154724112|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
154724113|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724114|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153764149|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
154724115|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154724116|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724117|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724118|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154724119|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154724120|NCT01870297|Liraglutide|liraglutide|mesh-list
154724121|NCT01870297|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154724122|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154724123|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724124|NCT01870297|Incretins|incretins|mesh-ancestor
154724125|NCT01870297|Hormones|hormones|mesh-ancestor
154724126|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724127|NCT01814761|Bimatoprost|bimatoprost|mesh-list
154724128|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154724129|NCT01798030|Vitamin D|vitamin d|mesh-list
154724130|NCT01798030|Vitamins|vitamins|mesh-ancestor
154724131|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
154724132|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724133|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154724134|NCT01814371|Mupirocin|mupirocin|mesh-list
154724135|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154724136|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724137|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154724138|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724139|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724140|NCT03232138|Sulforaphane|sulforaphane|mesh-list
154724141|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154724142|NCT03232138|Protective Agents|protective agents|mesh-ancestor
154724143|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724144|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724145|NCT01814137|Insulin|insulin|mesh-list
154724146|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154724147|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
154724148|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
154724149|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154724150|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154724151|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724152|NCT01813435|Aspirin|aspirin|mesh-list
154724153|NCT01813435|Clopidogrel|clopidogrel|mesh-list
154724154|NCT01813435|Ticagrelor|ticagrelor|mesh-list
154724155|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154724156|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153764270|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724157|NCT01813435|Analgesics|analgesics|mesh-ancestor
154724158|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
154724159|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724160|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724161|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724162|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724163|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154724164|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154724165|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724166|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154724167|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154724168|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724169|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
154724170|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154724171|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154724172|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154724173|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
154724174|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724175|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
154724176|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154724177|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
154724178|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724179|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
154724180|NCT01798498|Protective Agents|protective agents|mesh-ancestor
154724181|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154724182|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154724183|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154724184|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
154724185|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724186|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154724187|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154724188|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724189|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154724190|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724192|NCT01811953|Empagliflozin|empagliflozin|mesh-list
154724193|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154724194|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724195|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154724196|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724197|NCT03895762|Fentanyl|fentanyl|mesh-list
154724198|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154724199|NCT03895762|Narcotics|narcotics|mesh-ancestor
154724200|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724201|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724202|NCT03895762|Analgesics|analgesics|mesh-ancestor
154724203|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
154724204|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724205|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154724206|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154724207|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
154724208|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
154724209|NCT01033552|Cyclosporine|cyclosporine|mesh-list
154724210|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
154724211|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
154724212|NCT01033552|Fludarabine|fludarabine|mesh-list
154724213|NCT01033552|Cyclosporins|cyclosporins|mesh-list
154724214|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154724215|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154724216|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
154724217|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724218|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724219|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154724220|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
154724221|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724222|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724223|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154724224|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724225|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
154724226|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724227|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
154724228|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154724229|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154724230|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154724231|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
154724232|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154724233|NCT00997906|Paclitaxel|paclitaxel|mesh-list
154724234|NCT00997906|Carboplatin|carboplatin|mesh-list
154724235|NCT00997906|Gemcitabine|gemcitabine|mesh-list
154724236|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154724237|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724238|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
154724239|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
154724240|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
154724241|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724242|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154724243|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
154724244|NCT01798576|Interferons|interferons|mesh-list
154724245|NCT01798576|Ribavirin|ribavirin|mesh-list
154724246|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
154724247|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
154724248|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153764375|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
154724249|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724250|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
154724251|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724252|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
154724253|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724254|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
154724255|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724256|NCT00565084|Ibuprofen|ibuprofen|mesh-list
154724257|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154724258|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154724259|NCT00565084|Analgesics|analgesics|mesh-ancestor
154724260|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
154724261|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724262|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724263|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724264|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724265|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154724266|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724267|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724269|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
154724270|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724271|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724272|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724273|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
154724274|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
154724275|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154724276|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154724277|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724278|NCT01613131|Estradiol|estradiol|mesh-list
154724279|NCT01613131|Estrogens|estrogens|mesh-ancestor
154724280|NCT01613131|Hormones|hormones|mesh-ancestor
154724281|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724282|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724283|NCT05362942|Cytarabine|cytarabine|mesh-list
154724284|NCT05362942|Azacitidine|azacitidine|mesh-list
154724285|NCT05362942|Decitabine|decitabine|mesh-list
154724286|NCT05362942|Venetoclax|venetoclax|mesh-list
154724287|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154724288|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
154724289|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724290|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724291|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
154724292|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724293|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154724294|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
154724295|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724296|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724297|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
154724298|NCT01868893|Chlorambucil|chlorambucil|mesh-list
154724299|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764502|NCT05088876|Analgesics|analgesics|mesh-ancestor
154724300|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724301|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154724302|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
154724303|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724304|NCT01868503|Lapatinib|lapatinib|mesh-list
154724305|NCT01868503|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154724306|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154724307|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724308|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724309|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724310|NCT05204368|Meropenem|meropenem|mesh-list
154724311|NCT05204368|Imipenem|imipenem|mesh-list
154724312|NCT05204368|Cilastatin|cilastatin|mesh-list
154724313|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154724314|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724315|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
154724316|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724317|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724318|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
154724319|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724320|NCT04414969|Asparaginase|asparaginase|mesh-list
154724321|NCT04414969|Pegaspargase|pegaspargase|mesh-list
154724322|NCT04414969|Antibodies|antibodies|mesh-list
154724323|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
154724324|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
154724325|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724326|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724327|NCT01609933|Interferons|interferons|mesh-list
154724328|NCT01609933|Ritonavir|ritonavir|mesh-list
154724329|NCT01609933|Ribavirin|ribavirin|mesh-list
154724330|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
154724331|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
154724332|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154724333|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724334|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
154724335|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724336|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154724337|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154724338|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
154724339|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764503|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
154724340|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724341|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154724342|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154724343|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154724344|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154724345|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
154724346|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
154724347|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724348|NCT05361772|Colchicine|colchicine|mesh-list
154724349|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
154724350|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724351|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
154724352|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
154724353|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
154724354|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724355|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724356|NCT02958514|Tobramycin|tobramycin|mesh-list
154724357|NCT02958514|Dexamethasone|dexamethasone|mesh-list
154724358|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724359|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
154724360|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
154724361|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724362|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724363|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154724364|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
154724365|NCT02958514|Hormones|hormones|mesh-ancestor
154724366|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724367|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154724368|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724369|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154724370|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724371|NCT01867021|Vaccines|vaccines|mesh-list
154724372|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
154724373|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724374|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
154724375|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
154724376|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
154724377|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724378|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
154724379|NCT01841593|Amlodipine|amlodipine|mesh-list
154724380|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154724381|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154724382|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724383|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724384|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154724385|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724386|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
154724387|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154724388|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154724389|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
153764754|NCT04607421|Irinotecan|irinotecan|mesh-list
154724390|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724391|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154724392|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154724393|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724394|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
154724395|NCT02454322|Analgesics|analgesics|mesh-ancestor
154724396|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
154724397|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724398|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724399|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
154724400|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724401|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154724402|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
154724403|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154724404|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724405|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724406|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154724407|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
154724408|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154724409|NCT04789330|Phenylephrine|phenylephrine|mesh-list
154724410|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
154724411|NCT04789330|Norepinephrine|norepinephrine|mesh-list
154724412|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154724413|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
154724414|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
154724415|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724416|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724417|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
154724418|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154724419|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
154724420|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724421|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154724422|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154724423|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154724424|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
154724425|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724426|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724427|NCT04789330|Protective Agents|protective agents|mesh-ancestor
154724428|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
154724429|NCT02339038|Ledipasvir|ledipasvir|mesh-list
154724430|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
154724431|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724432|NCT04497298|Vaccines|vaccines|mesh-list
154724433|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
154724434|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724435|NCT04387786|Albuterol|albuterol|mesh-list
154724436|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154724437|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
154724438|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724439|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724440|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154724441|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
153764833|NCT04488081|Famotidine|famotidine|mesh-list
154724442|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
154724443|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154724444|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154724445|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154724446|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154724447|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
154724448|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724449|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724450|NCT00569530|Calfactant|calfactant|mesh-list
154724451|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154724452|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724453|NCT04509622|Cytarabine|cytarabine|mesh-list
154724454|NCT04509622|Venetoclax|venetoclax|mesh-list
154724455|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154724456|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
154724457|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724458|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724459|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
154724460|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724461|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154724462|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
154724463|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724464|NCT00570700|Dasatinib|dasatinib|mesh-list
154724465|NCT00570700|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154724466|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154724467|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724468|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724469|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724470|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
154724471|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154724472|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154724473|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
154724474|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724475|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724476|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724477|NCT00573508|Urological Agents|urological agents|mesh-ancestor
154724478|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154724479|NCT00574834|Ramipril|ramipril|mesh-list
154724480|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154724481|NCT00574834|Diuretics|diuretics|mesh-ancestor
154724482|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
154724483|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724484|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154724485|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724486|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724487|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154724488|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
154724489|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724491|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154724492|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
154724493|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724494|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724495|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724496|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154724497|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154724498|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724499|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154724500|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154724501|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
154724502|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154724503|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724504|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
154724505|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154724506|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
154724507|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724508|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724509|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154724510|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724511|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
154724512|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154724513|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
154724514|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724515|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724516|NCT00579280|Valproic Acid|valproic acid|mesh-list
154724517|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154724518|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
154724519|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154724520|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154724521|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154724522|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724523|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724524|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
154724525|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724526|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724527|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
154724528|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724529|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
154724530|NCT00580294|Oxymorphone|oxymorphone|mesh-list
154724531|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154724532|NCT00580294|Narcotics|narcotics|mesh-ancestor
154724533|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724534|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724535|NCT00580294|Analgesics|analgesics|mesh-ancestor
154724536|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
154724537|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724538|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154724539|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
154724540|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154724541|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
154724542|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724543|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724544|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154724545|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
154724546|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724547|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724548|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154724549|NCT02134210|Etanercept|etanercept|mesh-list
154724550|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154724551|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154724552|NCT02134210|Analgesics|analgesics|mesh-ancestor
154724553|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
154724554|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724555|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724556|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724557|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724558|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154724559|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154724560|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
154724561|NCT00607594|Saracatinib|saracatinib|mesh-list
154724562|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724563|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724564|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724565|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
154724567|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154724568|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724569|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154724570|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724571|NCT00607672|Candesartan|candesartan|mesh-list
154724572|NCT00607672|Candesartan cilexetil|candesartan cilexetil|mesh-list
154724573|NCT00607672|Ramipril|ramipril|mesh-list
154724574|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154724575|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154724576|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154724577|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724578|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154724579|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
154724580|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724581|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154724582|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154724583|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154724584|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724585|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724586|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
154724587|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724588|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724589|NCT01802437|Fluoxetine|fluoxetine|mesh-list
154724590|NCT01802437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154724591|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154724592|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724593|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724594|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724595|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
154724596|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724597|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154724598|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
154724599|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154724600|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154724601|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154724602|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724603|NCT00608062|Estradiol|estradiol|mesh-list
154724604|NCT00608062|Ganirelix|ganirelix|mesh-list
154724605|NCT00608062|Estrogens|estrogens|mesh-ancestor
154724606|NCT00608062|Hormones|hormones|mesh-ancestor
154724607|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724608|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724609|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
154724610|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
154724611|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154724612|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154724613|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
154724614|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724615|NCT01801735|Meloxicam|meloxicam|mesh-list
154724616|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154724617|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154724618|NCT01801735|Analgesics|analgesics|mesh-ancestor
154724619|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
154724620|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724621|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724622|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724623|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724624|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154724625|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154724626|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724627|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724628|NCT00612430|Bevacizumab|bevacizumab|mesh-list
154724629|NCT00612430|Etoposide|etoposide|mesh-list
154724630|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
154724631|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154724632|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724633|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154724634|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154724635|NCT00612430|Growth Substances|growth substances|mesh-ancestor
154724636|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724637|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
154724638|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154724639|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154724640|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154724641|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724642|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724643|NCT01571128|Tenofovir|tenofovir|mesh-list
154724644|NCT01571128|Emtricitabine|emtricitabine|mesh-list
154724645|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
154724646|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724647|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154724648|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154724649|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724650|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724651|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154724652|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154724653|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
154724654|NCT00614458|Valproic Acid|valproic acid|mesh-list
154724655|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154724656|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154724657|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
154724658|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154724659|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154724660|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154724661|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724662|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724663|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
154724664|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
154724665|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724666|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724667|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
154724668|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154724669|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724670|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154724671|NCT01429168|Etoricoxib|etoricoxib|mesh-list
154724672|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154724673|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154724674|NCT01429168|Analgesics|analgesics|mesh-ancestor
154724675|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
154724676|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765073|NCT04069312|Azithromycin|azithromycin|mesh-list
154724677|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724678|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724679|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724680|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154724681|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154724682|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724683|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724684|NCT00771160|Montelukast|montelukast|mesh-list
154724685|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154724686|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724687|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154724688|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
154724689|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724690|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724691|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154724692|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154724693|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724694|NCT00756418|Theophylline|theophylline|mesh-list
154724695|NCT00756418|Montelukast|montelukast|mesh-list
154724696|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154724697|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724698|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154724699|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
154724700|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724701|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724702|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154724703|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154724704|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724705|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154724706|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
154476596|NCT06173531|Carbetocin|carbetocin|mesh-list
154724707|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724708|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154724709|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724710|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
154724711|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154724712|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154724713|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
154724714|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724715|NCT00615472|Remifentanil|remifentanil|mesh-list
154724716|NCT00615472|Propofol|propofol|mesh-list
154724717|NCT00615472|Isoflurane|isoflurane|mesh-list
154724718|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154724719|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724720|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724721|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154724722|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
154724723|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
154724724|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154724725|NCT00615472|Narcotics|narcotics|mesh-ancestor
154724726|NCT00615472|Analgesics|analgesics|mesh-ancestor
154724727|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
154724728|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724729|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154724730|NCT00615784|Bexarotene|bexarotene|mesh-list
154724731|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724732|NCT00755794|Montelukast|montelukast|mesh-list
154724733|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154724734|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724735|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154724736|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
154724737|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724738|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724739|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154724740|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154724741|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724742|NCT00652444|Simvastatin|simvastatin|mesh-list
154724743|NCT00652444|Ezetimibe|ezetimibe|mesh-list
154724744|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154724745|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154724746|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
154724747|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724748|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154724749|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154724750|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724751|NCT00585910|Methylphenidate|methylphenidate|mesh-list
154724752|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154724753|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154724754|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724755|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154724756|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154724757|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724758|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724759|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
154724760|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724761|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154724762|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
154724763|NCT00489346|Fluticasone|fluticasone|mesh-list
154724764|NCT00489346|Xhance|xhance|mesh-list
154724765|NCT00489346|Montelukast|montelukast|mesh-list
154724766|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724767|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154724768|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
154724769|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724770|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724771|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154724772|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724773|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
154724774|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154724775|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724776|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154724777|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
154724778|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724779|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154476672|NCT06124157|Antimetabolites|antimetabolites|mesh-ancestor
154724780|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154724781|NCT00617188|Fulvestrant|fulvestrant|mesh-list
154724782|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154724783|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724784|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154724785|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154724786|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
154724787|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724788|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724789|NCT00618436|Phenytoin|phenytoin|mesh-list
154724790|NCT00618436|Levetiracetam|levetiracetam|mesh-list
154724791|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
154724792|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
154724793|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154724794|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154724795|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724796|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724797|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154724798|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154724799|NCT00619060|Niacin|niacin|mesh-list
154724800|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
154724801|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154724802|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
154724803|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724804|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154724805|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
154724806|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
154724807|NCT00619060|Vitamins|vitamins|mesh-ancestor
154724808|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
154724809|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724810|NCT00092716|Atorvastatin|atorvastatin|mesh-list
154724811|NCT00092716|Ezetimibe|ezetimibe|mesh-list
154724812|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154724813|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154724814|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
154724815|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724816|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154724817|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154724818|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724819|NCT00619684|Lenalidomide|lenalidomide|mesh-list
154724820|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
154724821|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724822|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154724823|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154724824|NCT00619684|Growth Substances|growth substances|mesh-ancestor
154724825|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
154724826|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724827|NCT00588406|Prednisone|prednisone|mesh-list
154724828|NCT00588406|Budesonide|budesonide|mesh-list
154724829|NCT00588406|Bromides|bromides|mesh-list
154724830|NCT00588406|Albuterol|albuterol|mesh-list
154724831|NCT00588406|Ipratropium|ipratropium|mesh-list
154724832|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154724833|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
154724834|NCT00588406|Hormones|hormones|mesh-ancestor
154724835|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724836|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724837|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154724838|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724839|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154724840|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
154724841|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765376|NCT02408861|Ipilimumab|ipilimumab|mesh-list
154724842|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154724843|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
154724844|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
154724845|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
154724846|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154724847|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154724848|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154724849|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154724850|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
154724851|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724852|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724853|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154724854|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
154724855|NCT00668434|Prednisone|prednisone|mesh-list
154724857|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
154724858|NCT00668434|Hormones|hormones|mesh-ancestor
154724859|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154724860|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724861|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154724862|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724863|NCT00668902|Pantoprazole|pantoprazole|mesh-list
154724864|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154724865|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154724866|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154724867|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724868|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724869|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154724870|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154724871|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154724872|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154724873|NCT00621946|Dexetimide|dexetimide|mesh-list
154724874|NCT00621946|Citalopram|citalopram|mesh-list
154724875|NCT00621946|Escitalopram|escitalopram|mesh-list
154724876|NCT00621946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154724877|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154724878|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154724879|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724880|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154724881|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
154724882|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724883|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154724884|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154724885|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
154724886|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
154724887|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724888|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154724889|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154724890|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
154724891|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154724892|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
154724893|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154724894|NCT02139358|Gemcitabine|gemcitabine|mesh-list
154724895|NCT02139358|Trastuzumab|trastuzumab|mesh-list
154724896|NCT02139358|Pertuzumab|pertuzumab|mesh-list
154724897|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154724898|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
154724899|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724900|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724901|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154724902|NCT02140372|Colchicine|colchicine|mesh-list
154724903|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
154724904|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724905|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
154724906|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
154724907|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
154724908|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724909|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724910|NCT00670774|Eculizumab|eculizumab|mesh-list
154724911|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154724912|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154724913|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
154724914|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724915|NCT00672100|Ropivacaine|ropivacaine|mesh-list
154724916|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
154724917|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
154724918|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724919|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724920|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
154724921|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724922|NCT00593866|Gemcitabine|gemcitabine|mesh-list
154724923|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154724924|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
154724925|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724926|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724927|NCT00624910|Bupivacaine|bupivacaine|mesh-list
154724928|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
154724929|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
154724930|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724931|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724932|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
154724933|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154724935|NCT00626626|Clofarabine|clofarabine|mesh-list
154724936|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
154724937|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154724938|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724939|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154724940|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
154724941|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724942|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154724943|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
154724944|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724945|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154724946|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154724947|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
154724948|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154724949|NCT00626782|Ranibizumab|ranibizumab|mesh-list
154724950|NCT00626782|Mitomycins|mitomycins|mesh-list
154724951|NCT00626782|Mitomycin|mitomycin|mesh-list
154724952|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154724953|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154724954|NCT00626782|Growth Substances|growth substances|mesh-ancestor
154724955|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724956|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
154724957|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724958|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154724959|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
154724960|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724961|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154724962|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154724963|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
154724964|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154724965|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154724966|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
154724967|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
154724968|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154724969|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724970|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154724971|NCT00627406|Buserelin|buserelin|mesh-list
154724972|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154724973|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724974|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154724975|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
154724976|NCT00673738|Docetaxel|docetaxel|mesh-list
154724977|NCT00673738|Cetuximab|cetuximab|mesh-list
154724978|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724979|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154724980|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154724981|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154724982|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724983|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154724984|NCT00674206|Gemcitabine|gemcitabine|mesh-list
154724985|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
154724986|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154724987|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
154724988|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724989|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154724990|NCT00595270|Vaccines|vaccines|mesh-list
154724991|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
154724992|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154724993|NCT00628498|Defibrotide|defibrotide|mesh-list
154724994|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154724995|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154724996|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154724997|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154724998|NCT00629122|Clotrimazole|clotrimazole|mesh-list
154724999|NCT00629122|Miconazole|miconazole|mesh-list
154725000|NCT00629122|Nystatin|nystatin|mesh-list
154725001|NCT00629122|Tacrolimus|tacrolimus|mesh-list
154725002|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725003|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
154476909|NCT05934669|Midazolam|midazolam|mesh-list
154725004|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725005|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154725006|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725007|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725008|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154725009|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725010|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
154725011|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154725012|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154725013|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154725014|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
154725015|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154725016|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154725017|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154725018|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725020|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725021|NCT00596440|Nicotine|nicotine|mesh-list
154725022|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154725023|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
154725024|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725025|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725026|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154725027|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154725028|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725029|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725030|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725031|NCT00632632|Cycloserine|cycloserine|mesh-list
154725032|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154725033|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725034|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154725035|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
154725036|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725037|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
154725038|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725039|NCT00633256|Isoniazid|isoniazid|mesh-list
154725040|NCT00633256|Cycloserine|cycloserine|mesh-list
154725041|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
154725042|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725043|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725044|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154725045|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154725046|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
154725047|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725048|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154725049|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154725050|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154725051|NCT00634270|Sirolimus|sirolimus|mesh-list
154725052|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725053|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725054|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154725055|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725056|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
154725057|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725058|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
154725059|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725060|NCT00678418|Naltrexone|naltrexone|mesh-list
154725061|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154725062|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154725063|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725064|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
154725065|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725066|NCT00600340|Paclitaxel|paclitaxel|mesh-list
154725067|NCT00600340|Bevacizumab|bevacizumab|mesh-list
154725068|NCT00600340|Capecitabine|capecitabine|mesh-list
154725069|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154725070|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725071|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
154725072|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
154725073|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
154725074|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725075|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154725076|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154725077|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154725078|NCT00600340|Growth Substances|growth substances|mesh-ancestor
154725079|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725080|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
154725081|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154725082|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
154725083|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154725084|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
154725085|NCT01799356|Metronidazole|metronidazole|mesh-list
154725086|NCT01799356|Ofloxacin|ofloxacin|mesh-list
154725087|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154725088|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725089|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
154725090|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154725091|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154725092|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725093|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725094|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725095|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154725096|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154725097|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154725098|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154725099|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154725100|NCT00602290|Methylphenidate|methylphenidate|mesh-list
154725101|NCT00602290|Citalopram|citalopram|mesh-list
154725102|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154725103|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725104|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154725105|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154725106|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725107|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725108|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
154725109|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725110|NCT00602290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154725111|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
154725112|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154725113|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
154725114|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154725115|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
154725116|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725117|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154725118|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154725119|NCT00637780|Analgesics|analgesics|mesh-ancestor
154725120|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
154725121|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725122|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725123|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725124|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725125|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154725126|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
154725127|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154725128|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154725129|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725130|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725131|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725132|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725133|NCT01799902|Urological Agents|urological agents|mesh-ancestor
154725134|NCT00602446|Deferasirox|deferasirox|mesh-list
154725135|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154725136|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
154725137|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
153765722|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154725138|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725139|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
154725140|NCT00602836|Rituximab|rituximab|mesh-list
154725141|NCT00602836|Lenalidomide|lenalidomide|mesh-list
154725142|NCT00602836|Pentostatin|pentostatin|mesh-list
154725143|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725144|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
154725145|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725146|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725147|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154725148|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
154725149|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725150|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725151|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154725152|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154725153|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154725154|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154725155|NCT00602836|Growth Substances|growth substances|mesh-ancestor
154725156|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
154725157|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154725158|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725159|NCT00683332|Tigecycline|tigecycline|mesh-list
154725160|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725161|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725162|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154725163|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725164|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725165|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154725166|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
154725167|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725168|NCT00640822|Calcitriol|calcitriol|mesh-list
154725169|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
154725170|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154725171|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154725172|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154725173|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
154725174|NCT00640822|Calcipotriene|calcipotriene|mesh-list
154725175|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725176|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
154725177|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154725178|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725179|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154725180|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725181|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725182|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154725183|NCT00640822|Vitamins|vitamins|mesh-ancestor
154725184|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
154725185|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154725186|NCT00642694|Dexetimide|dexetimide|mesh-list
154725187|NCT00642694|Citalopram|citalopram|mesh-list
154725188|NCT00642694|Escitalopram|escitalopram|mesh-list
154725189|NCT00642694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154725190|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154725191|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725192|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725193|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725194|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
154725195|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725196|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154725197|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154725198|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
154725199|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
154725200|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725201|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154725202|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154725203|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725204|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154725205|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
154725206|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154725207|NCT00705874|Leucovorin|leucovorin|mesh-list
154725208|NCT00705874|Bevacizumab|bevacizumab|mesh-list
154725209|NCT00705874|Sunitinib|sunitinib|mesh-list
154725210|NCT00705874|Gemcitabine|gemcitabine|mesh-list
154725211|NCT00705874|Docetaxel|docetaxel|mesh-list
154725212|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154725213|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154725214|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725215|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154725216|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154725217|NCT00705874|Growth Substances|growth substances|mesh-ancestor
154725218|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725219|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
154725220|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154725221|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
154725222|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725223|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
154725224|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
154725225|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
154725226|NCT00705874|Antidotes|antidotes|mesh-ancestor
154725227|NCT00705874|Protective Agents|protective agents|mesh-ancestor
154725228|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
154725229|NCT00705874|Vitamins|vitamins|mesh-ancestor
154725230|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
154725231|NCT00705874|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154725232|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154725233|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725234|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
154725235|NCT00647998|Hematinics|hematinics|mesh-ancestor
154725236|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
154725237|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154725238|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725239|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725240|NCT00687076|Aspirin|aspirin|mesh-list
154725242|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
154725243|NCT00687076|Clopidogrel|clopidogrel|mesh-list
154725244|NCT00687076|Ezetimibe|ezetimibe|mesh-list
154725245|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154725246|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154725247|NCT00687076|Analgesics|analgesics|mesh-ancestor
154725248|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
154725249|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725250|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725251|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725252|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725253|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154725254|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154725255|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725256|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154725257|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154725258|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725259|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
154725260|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154725261|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154725262|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154725263|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
154725264|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725265|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154725266|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154725267|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
154725268|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154725269|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
154725270|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
154725271|NCT00687076|Vitamins|vitamins|mesh-ancestor
154725272|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
154725273|NCT00687544|Ribavirin|ribavirin|mesh-list
154725274|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154725275|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
154725276|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725277|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
154725278|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725279|NCT02143648|Nalbuphine|nalbuphine|mesh-list
154725280|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154725281|NCT02143648|Narcotics|narcotics|mesh-ancestor
154725282|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154725283|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725284|NCT02143648|Analgesics|analgesics|mesh-ancestor
154725285|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
154725286|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725287|NCT02997982|Valacyclovir|valacyclovir|mesh-list
154725288|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
154725289|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725290|NCT00689572|Ondansetron|ondansetron|mesh-list
154725291|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
154725292|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
154725293|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725294|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725295|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154725296|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
154725297|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
154725298|NCT00689572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154725299|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154725300|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
154725301|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725302|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477201|NCT05533775|Rituximab|rituximab|mesh-list
154725303|NCT01840579|Paclitaxel|paclitaxel|mesh-list
154725304|NCT01840579|Etoposide|etoposide|mesh-list
154725305|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154725306|NCT01840579|Carboplatin|carboplatin|mesh-list
154725307|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
154725308|NCT01840579|Pemetrexed|pemetrexed|mesh-list
154725309|NCT01840579|Ipilimumab|ipilimumab|mesh-list
154725310|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154725311|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725312|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
154725313|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
154725314|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
154725315|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725316|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154725317|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154725318|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154725319|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154725320|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725321|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154725322|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154725323|NCT00651040|Prednisone|prednisone|mesh-list
154725324|NCT00651040|Prednisolone|prednisolone|mesh-list
154725325|NCT00651040|Methotrexate|methotrexate|mesh-list
154725326|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725327|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
154725328|NCT00651040|Hormones|hormones|mesh-ancestor
154725329|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154725330|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725331|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154725332|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725333|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154725334|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
154725335|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154725336|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154725337|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
154725338|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725339|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
154725340|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725341|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154725342|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725343|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
154725344|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725345|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154725346|NCT00654784|Idebenone|idebenone|mesh-list
154725347|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
154725348|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725349|NCT00654784|Protective Agents|protective agents|mesh-ancestor
154725350|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725351|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154725352|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154725353|NCT01801111|Alectinib|alectinib|mesh-list
154725354|NCT01801111|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154725355|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154725356|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725357|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725358|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725359|NCT00691600|Trimethoprim|trimethoprim|mesh-list
154725360|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
154725361|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154725362|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725363|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
154725364|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154725365|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154725366|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154725367|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725368|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765991|NCT03713294|Hormones|hormones|mesh-ancestor
154725369|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154725370|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154725371|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154725372|NCT00655642|Promethazine|promethazine|mesh-list
154725373|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
154725374|NCT00655642|Ondansetron|ondansetron|mesh-list
154725375|NCT00655642|Metoclopramide|metoclopramide|mesh-list
154725376|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
154477272|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
154725377|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
154725378|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725379|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725380|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154725381|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
154725382|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
154725383|NCT00655642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154725384|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154725385|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
154725386|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725387|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725388|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154725389|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154725390|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
154725391|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154725392|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
154725393|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
154725394|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154725395|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154725396|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154725397|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154725398|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
154725399|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
154725400|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
154725401|NCT00656656|Dexamethasone|dexamethasone|mesh-list
154725403|NCT00656656|Azathioprine|azathioprine|mesh-list
154725404|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154725405|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725406|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
154725407|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725408|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725409|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725410|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
154725411|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
154725412|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725413|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154725414|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
154725415|NCT00656656|Hormones|hormones|mesh-ancestor
154725416|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154725417|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154725418|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
154725419|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725420|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154725421|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725422|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
154725423|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
154725424|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725425|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
154725426|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725427|NCT00656968|Esomeprazole|esomeprazole|mesh-list
154725428|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154725429|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154725430|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154725431|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725432|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725433|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154725434|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154725435|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725436|NCT00657280|Incretins|incretins|mesh-ancestor
154725437|NCT00657280|Hormones|hormones|mesh-ancestor
154725438|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154725439|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154725440|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
154725441|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725442|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725443|NCT00693160|Ketorolac|ketorolac|mesh-list
154725444|NCT00693160|Remifentanil|remifentanil|mesh-list
154725445|NCT00693160|Capsaicin|capsaicin|mesh-list
154725446|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154725447|NCT00693160|Narcotics|narcotics|mesh-ancestor
154725448|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154725449|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725450|NCT00693160|Analgesics|analgesics|mesh-ancestor
154725451|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
154725452|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725453|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154725454|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154725455|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725456|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725457|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154725458|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725459|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725461|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
154725462|NCT00695188|Methotrexate|methotrexate|mesh-list
154725463|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154725464|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
154725465|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153766132|NCT02994069|Cisplatin|cisplatin|mesh-list
154725466|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725467|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154725468|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
154725469|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725470|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725471|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
154725472|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725473|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154725474|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725475|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
154725476|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725477|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154725478|NCT00706264|Silicon|silicon|mesh-list
154725479|NCT00706264|Trace Elements|trace elements|mesh-ancestor
154725480|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
154725481|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725482|NCT00695500|Varenicline|varenicline|mesh-list
154725483|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154725484|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154725485|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725486|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725487|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725488|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725489|NCT00695578|Bacitracin|bacitracin|mesh-list
154725490|NCT00695578|Biafine|biafine|mesh-list
154725491|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154725492|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725493|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725494|NCT00695578|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154725495|NCT00695578|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154725496|NCT00695578|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154725497|NCT01792102|Dexamethasone|dexamethasone|mesh-list
154725498|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725499|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
154725500|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
154725501|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725502|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725503|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154725504|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
154725505|NCT01792102|Hormones|hormones|mesh-ancestor
154725506|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154725507|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154725508|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725509|NCT02996734|Denosumab|denosumab|mesh-list
154725510|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154725511|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725512|NCT00699010|Oxycodone|oxycodone|mesh-list
154725513|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154725514|NCT00699010|Narcotics|narcotics|mesh-ancestor
154725515|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154725516|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725517|NCT00699010|Analgesics|analgesics|mesh-ancestor
154725518|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
154725519|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725520|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
154725521|NCT00706810|Verapamil|verapamil|mesh-list
154725522|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725523|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
154725524|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725525|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725526|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154725527|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154725528|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154725529|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725530|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154725531|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725532|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
154725533|NCT00661960|Efavirenz|efavirenz|mesh-list
154725534|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
154725535|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154725536|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154725537|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725538|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725539|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
154725540|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725541|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154725542|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154725543|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154725544|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154725545|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154725546|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154725547|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154725548|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154725549|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154725550|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154725551|NCT00662818|Acetaminophen|acetaminophen|mesh-list
154725552|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154725553|NCT00662818|Analgesics|analgesics|mesh-ancestor
154725554|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
154725555|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725556|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725557|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
154725558|NCT00699556|Nicotine|nicotine|mesh-list
154725559|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154725560|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
154725561|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725562|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725563|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154725564|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154725565|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725566|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725567|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725568|NCT00700336|Cisplatin|cisplatin|mesh-list
154725569|NCT00700336|Pemetrexed|pemetrexed|mesh-list
154725570|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725571|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725572|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725573|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154725574|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154725575|NCT01795846|Immunomodulating Agents|immunomodulating agents|mesh-list
154725576|NCT01795846|Immunologic Factors|immunologic factors|mesh-ancestor
154725577|NCT01795846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725578|NCT00701896|Nicotine|nicotine|mesh-list
154725579|NCT00701896|Varenicline|varenicline|mesh-list
154725580|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154725581|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
154725582|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725583|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725584|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154725585|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154725586|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725587|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725588|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725589|NCT01839487|Dexamethasone|dexamethasone|mesh-list
154725590|NCT01839487|Paclitaxel|paclitaxel|mesh-list
154725591|NCT01839487|Gemcitabine|gemcitabine|mesh-list
154725592|NCT01839487|Enoxaparin|enoxaparin|mesh-list
154725593|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154725594|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725595|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
154725596|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
154725597|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
154725598|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725599|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725600|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
154725601|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
154725602|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725603|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725604|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154725605|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
154725606|NCT01839487|Hormones|hormones|mesh-ancestor
154725607|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154725608|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154725609|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154725610|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
154725611|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
154725612|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154725613|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154725614|NCT00665470|Aldesleukin|aldesleukin|mesh-list
154725615|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725616|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154725617|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154725618|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
154725619|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725620|NCT00666406|Factor VIII|factor viii|mesh-list
154725621|NCT00666406|Coagulants|coagulants|mesh-ancestor
154725622|NCT02995954|Amlodipine|amlodipine|mesh-list
154725623|NCT02995954|Perindopril|perindopril|mesh-list
154725624|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154725625|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154725626|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725627|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725628|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154725629|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725630|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
154725631|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154725632|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
154725633|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725634|NCT01799941|Quinidine|quinidine|mesh-list
154725635|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
154725636|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
154725637|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
154725638|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154725639|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154725640|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725641|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725642|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725643|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154725644|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154725645|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
154725646|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154725647|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
154725648|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154725649|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154725650|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725651|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725652|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154725653|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154725654|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725655|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154725656|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154725657|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725658|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154725659|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154725660|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154725661|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154725662|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154725663|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725664|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725665|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
154725666|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725667|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725668|NCT00713284|Sirolimus|sirolimus|mesh-list
154725669|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725670|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725671|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154725672|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725673|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
154725674|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725675|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
154725676|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725677|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154725678|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
154725679|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154725680|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154725681|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154725682|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725683|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725684|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725685|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725686|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725687|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154725688|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725689|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154725690|NCT02995720|Amlodipine|amlodipine|mesh-list
154725691|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154725692|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154725693|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153766402|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
153766470|NCT00221286|Tenofovir|tenofovir|mesh-list
154725694|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725695|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725696|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154725697|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725698|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
154725699|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154725700|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154725701|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
154725702|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154725703|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154725704|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725705|NCT02990728|Metformin|metformin|mesh-list
154725706|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154725707|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725708|NCT02990884|Ketamine|ketamine|mesh-list
154725709|NCT02990884|Analgesics|analgesics|mesh-ancestor
154725710|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
154725711|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725712|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725713|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154725714|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154725715|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
154725716|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
154725717|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154725718|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154725719|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154725720|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725721|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725722|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
154725723|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154725724|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725725|NCT02990416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154725726|NCT02990416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725727|NCT02999776|Etanercept|etanercept|mesh-list
154725728|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154725729|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154725730|NCT02999776|Analgesics|analgesics|mesh-ancestor
154725731|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
154725732|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725733|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725734|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154725735|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725736|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154725737|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725738|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
154725739|NCT02996656|Cefazolin|cefazolin|mesh-list
154725740|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
154725741|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725742|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725743|NCT02996656|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154725744|NCT02996656|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154725745|NCT04387630|Metformin|metformin|mesh-list
154725746|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154725747|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725748|NCT04270318|Pemetrexed|pemetrexed|mesh-list
154725749|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477651|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
154725750|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725751|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725752|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154725753|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154725754|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
154725755|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725756|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
154725757|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725758|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725759|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154725760|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
154725761|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725762|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725763|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154725764|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
154725765|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154725766|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154725767|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725768|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154725769|NCT04270708|Analgesics|analgesics|mesh-ancestor
154725770|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
154725771|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725772|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154725773|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154725774|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154725775|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
154725776|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725777|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725778|NCT00704938|Aldesleukin|aldesleukin|mesh-list
154725779|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
154725780|NCT00704938|Fludarabine|fludarabine|mesh-list
154725781|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
154725782|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725783|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
154725784|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725785|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725786|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154725787|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
154725788|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725789|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725790|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154725791|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154725792|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
154725793|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154725794|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154725795|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
154725796|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725797|NCT02994082|Bupropion|bupropion|mesh-list
154725798|NCT02994082|Nicotine|nicotine|mesh-list
154725799|NCT02994082|Varenicline|varenicline|mesh-list
154725800|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154725801|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
154725802|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725803|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725804|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154725805|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154725806|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725807|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725808|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725809|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154725810|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
154725811|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154725812|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154725813|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154725814|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725815|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
154725816|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154725817|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154725818|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725819|NCT02995096|Sirolimus|sirolimus|mesh-list
154725820|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154725821|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725822|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154725823|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725824|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
154725825|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725826|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
154725827|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725829|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154725830|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154725831|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
154725832|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725833|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154725834|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725835|NCT01270438|Leucovorin|leucovorin|mesh-list
154725836|NCT01270438|Bevacizumab|bevacizumab|mesh-list
154725837|NCT01270438|Fluorouracil|fluorouracil|mesh-list
154725838|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
154725839|NCT01270438|Calcium|calcium|mesh-list
154725840|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
154725841|NCT01270438|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154725842|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154725843|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725844|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154725845|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154725846|NCT01270438|Growth Substances|growth substances|mesh-ancestor
154725847|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725848|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
154725849|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154725850|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
154725851|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725852|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154725853|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725854|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
154725855|NCT01270438|Antidotes|antidotes|mesh-ancestor
154725856|NCT01270438|Protective Agents|protective agents|mesh-ancestor
154725857|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
154725858|NCT01270438|Vitamins|vitamins|mesh-ancestor
154725859|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
154725860|NCT01270438|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154725861|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725862|NCT01270672|Carvedilol|carvedilol|mesh-list
154725863|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154725864|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154725865|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154725866|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
154725867|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725868|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725869|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725870|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154725871|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
154725872|NCT01270672|Protective Agents|protective agents|mesh-ancestor
154725873|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154725874|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725875|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154725876|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
154725877|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154725878|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154725879|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
154725880|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154725881|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
154725882|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154725883|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154725884|NCT01276210|Sorafenib|sorafenib|mesh-list
154725885|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725886|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154725887|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725888|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725889|NCT00727636|Vaccines|vaccines|mesh-list
154725890|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
154725891|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725892|NCT01270750|Bosentan|bosentan|mesh-list
154725893|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154725894|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154725895|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725896|NCT00709696|Varenicline|varenicline|mesh-list
153766718|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154477799|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
154725897|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154725898|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154725899|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
154725900|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154725901|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725902|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725903|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
154725904|NCT01270984|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154725905|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154725906|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725907|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725908|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725910|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154725911|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725912|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725913|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154725914|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154725915|NCT02992678|Protective Agents|protective agents|mesh-ancestor
154725916|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725917|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
154725918|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154725919|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
154725920|NCT02992912|Atezolizumab|atezolizumab|mesh-list
154725921|NCT02992912|Antibodies|antibodies|mesh-list
154725922|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
154725923|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725924|NCT02992912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154725925|NCT02992912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725926|NCT02992912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154725927|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725928|NCT01271140|Insulin|insulin|mesh-list
154725929|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154725930|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725931|NCT01271374|Losartan|losartan|mesh-list
154725932|NCT01271374|Amlodipine|amlodipine|mesh-list
154725933|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154725934|NCT01271374|Olmesartan|olmesartan|mesh-list
154725935|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
154725936|NCT01271374|Spironolactone|spironolactone|mesh-list
154725937|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154725938|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154725939|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154725940|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725941|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154725942|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725943|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
154725944|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154725945|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154725946|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154725947|NCT01271374|Diuretics|diuretics|mesh-ancestor
154725948|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
154725949|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154725950|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154725951|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
154725952|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154725953|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154725954|NCT01276834|Everolimus|everolimus|mesh-list
154725955|NCT01276834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154725956|NCT01276834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154725957|NCT01276834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725958|NCT01276834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725959|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725960|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
154725961|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725962|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154725963|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
154725964|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154725965|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725966|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
154725967|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154558074|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725968|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725969|NCT00717418|Cyclosporine|cyclosporine|mesh-list
154725970|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
154725971|NCT00717418|Cyclosporins|cyclosporins|mesh-list
154725972|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154725973|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154725974|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154725975|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
154725976|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725977|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
154725978|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154725979|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
154725980|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154725981|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154725982|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154725983|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154725984|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
154725985|NCT00717574|Propofol|propofol|mesh-list
154725986|NCT00717574|Sevoflurane|sevoflurane|mesh-list
154725987|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154725988|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154725989|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154725990|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154725991|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
154725992|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
154725993|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154725994|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154725995|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154725996|NCT00717574|Analgesics|analgesics|mesh-ancestor
154725997|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
154725998|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154725999|NCT00719134|Rizatriptan|rizatriptan|mesh-list
154726000|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154726001|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
154726002|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726003|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726004|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726005|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
154726006|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154726007|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
154726008|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726009|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154726010|NCT00721162|Ramucirumab|ramucirumab|mesh-list
154726011|NCT00721162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154726012|NCT00721162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154726013|NCT00721162|Growth Substances|growth substances|mesh-ancestor
154726014|NCT00721162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726015|NCT00721162|Growth Inhibitors|growth inhibitors|mesh-ancestor
154726016|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726017|NCT01838941|Betaine|betaine|mesh-list
154726018|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154726019|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
154726020|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154726021|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
154726022|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726023|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154726024|NCT01773109|Irinotecan|irinotecan|mesh-list
154726025|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
154726026|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
154726027|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154726028|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726029|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726030|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726031|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154726032|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
154726033|NCT01772719|Simvastatin|simvastatin|mesh-list
154726034|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154726035|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154726036|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
154726037|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726038|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154726039|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154726040|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726041|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154726042|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726043|NCT04144101|Etoricoxib|etoricoxib|mesh-list
154726045|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154726046|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154726047|NCT04144101|Analgesics|analgesics|mesh-ancestor
154726048|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
154726049|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726050|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726051|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726052|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726053|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154726054|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154726055|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726056|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726057|NCT01278004|Ethosuximide|ethosuximide|mesh-list
154726058|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
154726059|NCT01278238|Phenylephrine|phenylephrine|mesh-list
154726060|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
154726061|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154726062|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
154726063|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
154726064|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726065|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726066|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
154726067|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154726068|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
154726069|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
154726070|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154726071|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154726072|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154726073|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
154726074|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726075|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726076|NCT01278238|Protective Agents|protective agents|mesh-ancestor
154726077|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154726078|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154726079|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154726080|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726081|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726082|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154726083|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154726084|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726085|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
154726086|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726087|NCT01272310|Interferons|interferons|mesh-list
154726088|NCT01272310|Ribavirin|ribavirin|mesh-list
154726089|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
154726090|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
154726091|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154726092|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
154726093|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726094|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
154726095|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726096|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
153766944|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
154726097|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726098|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
154726099|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726100|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
154726101|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154726102|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154726103|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726104|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726105|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154726106|NCT04386850|Calcifediol|calcifediol|mesh-list
154726107|NCT04386850|Vitamins|vitamins|mesh-ancestor
154726108|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
154726109|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726110|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154726111|NCT01272778|Lorazepam|lorazepam|mesh-list
154726112|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
154726113|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
154726114|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
154726115|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726116|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726117|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154726118|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154726119|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726120|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154726121|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154726122|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154726123|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
154726124|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
154726125|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726126|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726127|NCT01272856|Abatacept|abatacept|mesh-list
154726128|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154726129|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726130|NCT01272856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726131|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726132|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154726133|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
154726134|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726135|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726136|NCT01273090|Imetelstat|imetelstat|mesh-list
154726137|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
154726138|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726139|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726140|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726141|NCT01273246|Vaccines|vaccines|mesh-list
154726142|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
154726143|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726144|NCT00730522|Vigabatrin|vigabatrin|mesh-list
154726145|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
154726146|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726147|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726148|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
154726149|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726150|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726151|NCT04345276|Ritonavir|ritonavir|mesh-list
154726152|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154726153|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154726154|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
154726155|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726156|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726157|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154726158|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154726159|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
154726160|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726161|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154726162|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154726163|NCT01273558|Canagliflozin|canagliflozin|mesh-list
154726164|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154726165|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726166|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154726167|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726168|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
154726169|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154726170|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154726171|NCT00733096|Prednisolone|prednisolone|mesh-list
154726172|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
154726173|NCT00733096|Etanercept|etanercept|mesh-list
154726174|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154726175|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
154726176|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726177|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
154726178|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
154726179|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726180|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726181|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154726182|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
154726183|NCT00733096|Hormones|hormones|mesh-ancestor
154726184|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154726185|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154726186|NCT00733096|Protective Agents|protective agents|mesh-ancestor
154726187|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154726188|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726189|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154726190|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154726191|NCT00733096|Analgesics|analgesics|mesh-ancestor
154726192|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
154726193|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726194|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154726195|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
154726197|NCT02991196|DS-8273a|ds-8273a|mesh-list
154726198|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792579|NCT05311228|Azithromycin|azithromycin|mesh-list
154726199|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726200|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154726201|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726202|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
154726203|NCT01278784|Chitosan|chitosan|mesh-list
154726204|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154726205|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154726206|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154726207|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
154726208|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726209|NCT01278784|Expectorants|expectorants|mesh-ancestor
154726210|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
154726211|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154726212|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
154726213|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726214|NCT01278784|Protective Agents|protective agents|mesh-ancestor
154726215|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726216|NCT01278784|Antidotes|antidotes|mesh-ancestor
154726217|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154726218|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154726219|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
154726220|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154726221|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
154726222|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
154726223|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
154726224|NCT01278784|Coagulants|coagulants|mesh-ancestor
154726225|NCT01276288|Empagliflozin|empagliflozin|mesh-list
154726226|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154726227|NCT01276288|Torsemide|torsemide|mesh-list
154726228|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154726229|NCT01276288|Diuretics|diuretics|mesh-ancestor
154726230|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
154726231|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726232|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154726233|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154726234|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726235|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154726236|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154726237|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154726238|NCT00722566|Bortezomib|bortezomib|mesh-list
154726239|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726240|NCT00722722|Bortezomib|bortezomib|mesh-list
154726241|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726242|NCT00723580|Risperidone|risperidone|mesh-list
154726243|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154726244|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
154726245|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726246|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726247|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726248|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154726249|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154726250|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726251|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154726252|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154726253|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
154726254|NCT01273948|Interferons|interferons|mesh-list
154726255|NCT01273948|Bavituximab|bavituximab|mesh-list
154726256|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726257|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
154726258|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726259|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726260|NCT00734344|Tenofovir|tenofovir|mesh-list
154726261|NCT00734344|Efavirenz|efavirenz|mesh-list
154726262|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
154726263|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
154726264|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726265|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154726266|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154726267|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726268|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558075|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154726269|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154726270|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154726271|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154726272|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154726273|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154726274|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154726275|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154726276|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154726277|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154726278|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154726279|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
154726280|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726281|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767285|NCT00193310|Paclitaxel|paclitaxel|mesh-list
154726282|NCT04148937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154726283|NCT04148937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726284|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
154726285|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726286|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726287|NCT03021057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154726288|NCT03021057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726289|NCT00734500|Anidulafungin|anidulafungin|mesh-list
154726290|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
154726291|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726292|NCT04143321|Empagliflozin|empagliflozin|mesh-list
154726293|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154726294|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726295|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154726296|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726297|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
154726298|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154726299|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726300|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154726301|NCT00735436|Bevacizumab|bevacizumab|mesh-list
154726302|NCT00735436|Irinotecan|irinotecan|mesh-list
154726303|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726304|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726305|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154726306|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154726307|NCT00735436|Growth Substances|growth substances|mesh-ancestor
154726308|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726309|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
154726310|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154726311|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154726312|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726313|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726314|NCT04143165|Lidocaine|lidocaine|mesh-list
154726315|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
154726316|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
154726317|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726318|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726319|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
154726320|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726321|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154726322|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154726323|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154726324|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154726325|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726326|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154726327|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154726328|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154726329|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154726330|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726331|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726332|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726333|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154726334|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
154726335|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154726336|NCT00735826|Vorinostat|vorinostat|mesh-list
154726337|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726338|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154726339|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767294|NCT00193349|Irinotecan|irinotecan|mesh-list
154478243|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726340|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726341|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154726342|NCT01276054|Methylene Blue|methylene blue|mesh-list
154726343|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154726344|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726345|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726346|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154726347|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
154726348|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154726349|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
154726350|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726351|NCT00724594|Expectorants|expectorants|mesh-ancestor
154726352|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
154726353|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154726354|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
154726355|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726356|NCT00724594|Protective Agents|protective agents|mesh-ancestor
154726357|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726358|NCT00724594|Antidotes|antidotes|mesh-ancestor
154726359|NCT04142931|Nivolumab|nivolumab|mesh-list
154726360|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726361|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726362|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154726363|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726364|NCT04143477|Peficitinib|peficitinib|mesh-list
154726365|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726366|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726367|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154726368|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
154726369|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726370|NCT05586009|Cisplatin|cisplatin|mesh-list
154726371|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726372|NCT03020979|Apatinib|apatinib|mesh-list
154726373|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726374|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726375|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726376|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726377|NCT04142151|Aspirin|aspirin|mesh-list
154726378|NCT04142151|Clopidogrel|clopidogrel|mesh-list
154726379|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154726380|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154726381|NCT04142151|Analgesics|analgesics|mesh-ancestor
154726382|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
154726383|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726384|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726385|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726386|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726387|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154726388|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154726389|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726390|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154726391|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154726392|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726393|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
154726394|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154726395|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154726396|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154726397|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
154726398|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726399|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154726400|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154726401|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154726402|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
154726403|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726404|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154726405|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154726406|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726407|NCT03904329|Anticoagulants|anticoagulants|mesh-list
154726408|NCT04149483|Atorvastatin|atorvastatin|mesh-list
154726409|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154726410|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154726411|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
154726412|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726413|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154726414|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154726415|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726416|NCT04149327|Amoxicillin|amoxicillin|mesh-list
154726417|NCT04149327|Metronidazole|metronidazole|mesh-list
154726418|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154726419|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767454|NCT00409721|Memantine|memantine|mesh-list
154726420|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154726421|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154726422|NCT05582577|Bevacizumab|bevacizumab|mesh-list
154726423|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726424|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726425|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154726426|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154726427|NCT05582577|Growth Substances|growth substances|mesh-ancestor
154726428|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726429|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
154726430|NCT04149015|Paclitaxel|paclitaxel|mesh-list
154726431|NCT04149015|Fluorouracil|fluorouracil|mesh-list
154726432|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
154726433|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154726434|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726435|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
154726436|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
154726437|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
154726438|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726439|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
154726440|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154726441|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154726442|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
154726443|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726444|NCT04140591|Propranolol|propranolol|mesh-list
154726445|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154726446|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154726447|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154726448|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
154726449|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726450|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726451|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726452|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154726453|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154726454|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
154726455|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726456|NCT05582109|Lenvatinib|lenvatinib|mesh-list
154726457|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726458|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726459|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726460|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767533|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154726461|NCT03020901|Teicoplanin|teicoplanin|mesh-list
154726462|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154726463|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726464|NCT04140201|Simvastatin|simvastatin|mesh-list
154726465|NCT04140201|Fenofibrate|fenofibrate|mesh-list
154726466|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154726467|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154726468|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
154726469|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726470|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154726471|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154726472|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726473|NCT05581875|Dexamethasone|dexamethasone|mesh-list
154726474|NCT05581875|Daratumumab|daratumumab|mesh-list
154726475|NCT05581875|Pomalidomide|pomalidomide|mesh-list
154726476|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726477|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
154726478|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
154726479|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726480|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726481|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154726482|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
154726483|NCT05581875|Hormones|hormones|mesh-ancestor
154726484|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154726485|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154726486|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726487|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
154726488|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154726489|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154726490|NCT05581875|Growth Substances|growth substances|mesh-ancestor
154726491|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
154726492|NCT04406025|Anesthetics|anesthetics|mesh-list
154726493|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726494|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726495|NCT05582421|Diclofenac|diclofenac|mesh-list
154726496|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154726497|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154726498|NCT05582421|Analgesics|analgesics|mesh-ancestor
154726499|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
154726500|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726501|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726502|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726503|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726504|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154726505|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726506|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726507|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
154726508|NCT03580473|Dexamethasone|dexamethasone|mesh-list
154726509|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154726510|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726511|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
154726512|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
154726513|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726514|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726515|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154726516|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
154726517|NCT03580473|Hormones|hormones|mesh-ancestor
154726518|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154726519|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154726520|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726521|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726522|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726523|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154726524|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726525|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154726526|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154726527|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154726528|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
154726529|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154726530|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154726531|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154726532|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154726533|NCT03897309|Vaccines|vaccines|mesh-list
154726534|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
154726535|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726536|NCT03588429|Sevoflurane|sevoflurane|mesh-list
154726537|NCT03588429|Isoflurane|isoflurane|mesh-list
154726538|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154726539|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154726540|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
154726541|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
154726542|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726543|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726544|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
154726545|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
154726546|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
154726547|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
154726548|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154726549|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726550|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
154726551|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154726552|NCT03588351|Chitosan|chitosan|mesh-list
154726553|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154726554|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726555|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
154726556|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
154726557|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154726558|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154726559|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
154726560|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726561|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154726562|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
154726563|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
154726564|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
154726565|NCT03588351|Coagulants|coagulants|mesh-ancestor
154726566|NCT03588273|Amoxicillin|amoxicillin|mesh-list
154726567|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154726568|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726569|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
154726570|NCT02984865|Sufentanil|sufentanil|mesh-list
154726571|NCT02984865|Nalbuphine|nalbuphine|mesh-list
154726572|NCT02984865|Dsuvia|dsuvia|mesh-list
154726573|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154726574|NCT02984865|Narcotics|narcotics|mesh-ancestor
154726575|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726576|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726577|NCT02984865|Analgesics|analgesics|mesh-ancestor
154726578|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
154726579|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726580|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154726581|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154726582|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
154726583|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
154726584|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154726585|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154726586|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726587|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726588|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154726589|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726590|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726591|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154726592|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154726593|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154726594|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
154726595|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726596|NCT01611259|Rituximab|rituximab|mesh-list
154726597|NCT01611259|Lenalidomide|lenalidomide|mesh-list
154726598|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726599|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726600|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
154726601|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726602|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726603|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154726604|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154726605|NCT01611259|Growth Substances|growth substances|mesh-ancestor
154726606|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
154726607|NCT03586869|Leucovorin|leucovorin|mesh-list
154726608|NCT03586869|Paclitaxel|paclitaxel|mesh-list
154726609|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
154726610|NCT03586869|Bevacizumab|bevacizumab|mesh-list
154726611|NCT03586869|Capecitabine|capecitabine|mesh-list
154726612|NCT03586869|Fluorouracil|fluorouracil|mesh-list
154726613|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
154726614|NCT03586869|Avelumab|avelumab|mesh-list
154726615|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154726616|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726617|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
154726618|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
154726619|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
154726620|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726621|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154726622|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
154726623|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726624|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726625|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154726626|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
154726627|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154726628|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726629|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154726630|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154726631|NCT03586869|Growth Substances|growth substances|mesh-ancestor
154726632|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
154726633|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154726634|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
154726635|NCT03586869|Antidotes|antidotes|mesh-ancestor
154726636|NCT03586869|Protective Agents|protective agents|mesh-ancestor
154726637|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
154726638|NCT03586869|Vitamins|vitamins|mesh-ancestor
154726639|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
154726640|NCT03586791|Anesthetics|anesthetics|mesh-list
154726641|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726642|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726643|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
154726644|NCT01795495|Remifentanil|remifentanil|mesh-list
154726645|NCT01795495|Methadone|methadone|mesh-list
154726646|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154726647|NCT01795495|Narcotics|narcotics|mesh-ancestor
154726648|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726649|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726650|NCT01795495|Analgesics|analgesics|mesh-ancestor
154726651|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
154726652|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726653|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
154726654|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154726655|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
154726656|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154726657|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154726658|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726659|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154726660|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
154726661|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154726662|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
154726663|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
154726664|NCT04765527|Turmeric extract|turmeric extract|mesh-list
154726665|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
154726666|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726667|NCT04765527|Protective Agents|protective agents|mesh-ancestor
154726668|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726669|NCT02947503|Metformin|metformin|mesh-list
154726670|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154726671|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726672|NCT03586323|Lidocaine|lidocaine|mesh-list
154726673|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
154726674|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
154726675|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726676|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726677|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
154726678|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726679|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154726680|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154726681|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154726682|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154726683|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726684|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
154726685|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153767810|NCT00125489|Chloroquine|chloroquine|mesh-list
154726686|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726687|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154726688|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726689|NCT03580395|Paclitaxel|paclitaxel|mesh-list
154726690|NCT03580395|Apatinib|apatinib|mesh-list
154726691|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154726692|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726693|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
154726694|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
154726695|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
154726696|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726697|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726698|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726699|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154726700|NCT01609543|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154726701|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726702|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726703|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726704|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726705|NCT03580239|Everolimus|everolimus|mesh-list
154726706|NCT03580239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154726707|NCT03580239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726708|NCT03580239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726709|NCT03580239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726710|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154726711|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
154726712|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726713|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726714|NCT03156153|Bumetanide|bumetanide|mesh-list
154726715|NCT03156153|Diuretics|diuretics|mesh-ancestor
154726716|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
154726717|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726718|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154726719|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154726720|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726721|NCT03156231|Acetazolamide|acetazolamide|mesh-list
154726722|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
154726723|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154726724|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726725|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726726|NCT03156231|Diuretics|diuretics|mesh-ancestor
154726727|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
154726728|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726729|NCT05702151|Morphine|morphine|mesh-list
154726730|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154726731|NCT05702151|Narcotics|narcotics|mesh-ancestor
154726732|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726733|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726734|NCT05702151|Analgesics|analgesics|mesh-ancestor
154726735|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
153767865|NCT00473083|Minocycline|minocycline|mesh-list
154726736|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726737|NCT01985321|Ethanol|ethanol|mesh-list
154726738|NCT01985321|Glycolic acid|glycolic acid|mesh-list
154726739|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154726740|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726741|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726742|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726743|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
154726744|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
154726745|NCT03584919|Doxycycline|doxycycline|mesh-list
154726746|NCT03584919|Cefuroxime|cefuroxime|mesh-list
154726747|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
154726748|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154726749|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726750|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
154726751|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154726752|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154726753|NCT03584841|Pilocarpine|pilocarpine|mesh-list
154726754|NCT03584841|Miotics|miotics|mesh-ancestor
154726755|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
154726756|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726757|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726758|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154726759|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154726760|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
154726761|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726762|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726763|NCT02000921|Nicotine|nicotine|mesh-list
154726764|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154726765|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
154726766|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726767|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726768|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154726769|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154726770|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
154726771|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726772|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726773|NCT03586947|Vitamin D|vitamin d|mesh-list
154726774|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
154726775|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
154726776|NCT03586947|Vitamins|vitamins|mesh-list
154726777|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
154726778|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726779|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154726780|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154726781|NCT03584529|Vitamin D|vitamin d|mesh-list
154726782|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
154726783|NCT03584529|Vitamins|vitamins|mesh-ancestor
154726784|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
154726785|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726786|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154726787|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154726788|NCT00724984|Abexinostat|abexinostat|mesh-list
154726789|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154726790|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726791|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726792|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
154726793|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154726794|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154726795|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726796|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
154726797|NCT03113253|Coagulants|coagulants|mesh-ancestor
154726798|NCT01836523|Liraglutide|liraglutide|mesh-list
154726799|NCT01836523|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154726800|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154726801|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726802|NCT01836523|Incretins|incretins|mesh-ancestor
154726803|NCT01836523|Hormones|hormones|mesh-ancestor
154726804|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154726805|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
154726806|NCT01275196|Nilotinib|nilotinib|mesh-list
154726807|NCT01275196|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154726808|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726809|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726810|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726811|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726812|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154726813|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154726814|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726815|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
154726816|NCT02000531|Cisplatin|cisplatin|mesh-list
154726817|NCT02000531|Gemcitabine|gemcitabine|mesh-list
154726818|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154726819|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726820|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154726821|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
154726822|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726823|NCT02000531|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154726824|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726825|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726826|NCT01609231|Irinotecan|irinotecan|mesh-list
154726827|NCT01609231|Cetuximab|cetuximab|mesh-list
154726828|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154726829|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154726830|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726831|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726832|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726833|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726834|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
154726835|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153768012|NCT00472303|Morphine|morphine|mesh-list
153768044|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154726836|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154726837|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154726838|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154726839|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726840|NCT04405011|Entecavir|entecavir|mesh-list
154726841|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
154726842|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726843|NCT01769443|Bortezomib|bortezomib|mesh-list
154726844|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726845|NCT03154827|Atezolizumab|atezolizumab|mesh-list
154726846|NCT03154827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154726847|NCT03154827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726848|NCT03154827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726849|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726850|NCT01274182|Rituximab|rituximab|mesh-list
154726851|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154726852|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726853|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
154726854|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726855|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726856|NCT01984229|Posaconazole|posaconazole|mesh-list
154726857|NCT01984229|Alectinib|alectinib|mesh-list
154726858|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
154726859|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726860|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154726861|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154726862|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154726863|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154726864|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154726865|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726866|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726867|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154726868|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
154726869|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154726870|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726871|NCT01984229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154726872|NCT01984229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726873|NCT01274104|Vitamin D|vitamin d|mesh-list
154726874|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
154726875|NCT01274104|Vitamins|vitamins|mesh-ancestor
154726876|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
154726877|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768050|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
154726878|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154726879|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154726880|NCT01279096|Dexamethasone|dexamethasone|mesh-list
154726881|NCT01279096|Etoposide|etoposide|mesh-list
154726882|NCT01279096|Asparaginase|asparaginase|mesh-list
154726883|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
154726884|NCT01279096|Clofarabine|clofarabine|mesh-list
154726885|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726886|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
154726887|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
154726888|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726889|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726890|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154726891|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
154726892|NCT01279096|Hormones|hormones|mesh-ancestor
154726893|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154726894|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154726895|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726896|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726897|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726898|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154726899|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154726900|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154726901|NCT01279096|Analgesics|analgesics|mesh-ancestor
154726902|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
154726903|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154726904|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
154726905|NCT01272934|Diclofenac|diclofenac|mesh-list
154726906|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154726907|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154726908|NCT01272934|Analgesics|analgesics|mesh-ancestor
154726909|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
154726910|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726911|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726912|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726913|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154726914|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154726915|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726916|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726917|NCT01279252|Metronidazole|metronidazole|mesh-list
154726918|NCT01279252|Clarithromycin|clarithromycin|mesh-list
154726919|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
154726920|NCT01279252|Lansoprazole|lansoprazole|mesh-list
154726921|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
154726922|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726923|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154726924|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154726925|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154726926|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154726927|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726928|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726929|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154726930|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154726931|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154726932|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154726933|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726934|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154726935|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154726936|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154726937|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154726938|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154726939|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
154726940|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154726941|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154726943|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726944|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726945|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
154726946|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154726947|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154726948|NCT01274260|Prednisolone|prednisolone|mesh-list
154726949|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
154726950|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154726951|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
154726952|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154726953|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
154726954|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
154726955|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154726956|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726957|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154726958|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
154726959|NCT01274260|Hormones|hormones|mesh-ancestor
154726960|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154726961|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154726962|NCT01274260|Protective Agents|protective agents|mesh-ancestor
154726963|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154726964|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726965|NCT03154983|Docetaxel|docetaxel|mesh-list
154726966|NCT03154983|Apatinib|apatinib|mesh-list
154726967|NCT03154983|Tegafur|tegafur|mesh-list
154726968|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154726969|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
154726970|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
154726971|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
154726972|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726973|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154726974|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726975|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154726976|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
154726977|NCT01983683|Vancomycin|vancomycin|mesh-list
154726978|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
154726979|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154726980|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726981|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154726982|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154726983|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726984|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
154726985|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
154726986|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154726987|NCT03158025|Zolpidem|zolpidem|mesh-list
154726988|NCT03158025|Suvorexant|suvorexant|mesh-list
154726989|NCT03158025|Lemborexant|lemborexant|mesh-list
154726990|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154726991|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154726992|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154726993|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154726994|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154726995|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
154726996|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
154726997|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154726998|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154726999|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154727000|NCT01998893|Rituximab|rituximab|mesh-list
154727001|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727002|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727003|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
154727004|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727005|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727006|NCT01791985|Letrozole|letrozole|mesh-list
154727007|NCT01791985|Anastrozole|anastrozole|mesh-list
154727008|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727009|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154727010|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154727011|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727012|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727013|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154727014|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
154727015|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727016|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727017|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154727018|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154727019|NCT03154281|Everolimus|everolimus|mesh-list
154727020|NCT03154281|Niraparib|niraparib|mesh-list
154727021|NCT03154281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154727022|NCT03154281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154727023|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727024|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727025|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727026|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
154727027|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727028|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727029|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154727030|NCT03157791|Simethicone|simethicone|mesh-list
154727031|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
154727032|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727033|NCT03157791|Emollients|emollients|mesh-ancestor
154727034|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
154727035|NCT03157479|Anesthetics|anesthetics|mesh-list
154727036|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
154727037|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727038|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727039|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
154727040|NCT03013491|Ipilimumab|ipilimumab|mesh-list
154727041|NCT03013491|Vemurafenib|vemurafenib|mesh-list
154727042|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727043|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727044|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154727045|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727046|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154727047|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727048|NCT01272232|Liraglutide|liraglutide|mesh-list
154727049|NCT01272232|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154727050|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154727051|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727052|NCT01272232|Incretins|incretins|mesh-ancestor
154727053|NCT01272232|Hormones|hormones|mesh-ancestor
154727054|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727055|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
154727056|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154727057|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154727058|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727059|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
154727060|NCT03157401|Coagulants|coagulants|mesh-ancestor
154727061|NCT03153813|Capsaicin|capsaicin|mesh-list
154727062|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
154727063|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
154727064|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
154727065|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727066|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727067|NCT03156855|Bismuth|bismuth|mesh-list
154727068|NCT03156855|Antacids|antacids|mesh-ancestor
154727069|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727070|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727071|NCT00739960|Abatacept|abatacept|mesh-list
154727072|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154727073|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727074|NCT00739960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727075|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727076|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727077|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
154727078|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727079|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727080|NCT03153657|Piroxicam|piroxicam|mesh-list
154727081|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
154727082|NCT03153657|Betadex|betadex|mesh-list
154727083|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154727084|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154727085|NCT03153657|Analgesics|analgesics|mesh-ancestor
154727086|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
154727087|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727088|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727089|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727090|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478993|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
154727091|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154727092|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727093|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727094|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
154727095|NCT01670955|Folic Acid|folic acid|mesh-list
154727096|NCT01670955|Hematinics|hematinics|mesh-ancestor
154727097|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
154727098|NCT01670955|Vitamins|vitamins|mesh-ancestor
154727099|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
153768365|NCT00225303|Etravirine|etravirine|mesh-list
154727100|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727101|NCT01275274|Tretinoin|tretinoin|mesh-list
154727102|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727103|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
154727104|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
154727105|NCT01997333|Capecitabine|capecitabine|mesh-list
154727106|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154727107|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
154727108|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727109|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727110|NCT01271920|Trastuzumab|trastuzumab|mesh-list
154727111|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727112|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727113|NCT01275352|Eplerenone|eplerenone|mesh-list
154727114|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154727115|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
154727116|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727117|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727118|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154727119|NCT01275352|Diuretics|diuretics|mesh-ancestor
154727120|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
154727121|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154727122|NCT01676259|Paclitaxel|paclitaxel|mesh-list
154727123|NCT01676259|Gemcitabine|gemcitabine|mesh-list
154727124|NCT01676259|Folfirinox|folfirinox|mesh-list
154727125|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154727126|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727127|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
154727128|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
154727129|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
154727130|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727131|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154727132|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
154727133|NCT02662257|Propofol|propofol|mesh-list
154727134|NCT02662257|Sevoflurane|sevoflurane|mesh-list
154727135|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154727136|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727137|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727138|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154727139|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
154727140|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
154727141|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154727142|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154727143|NCT03153267|Doxycycline|doxycycline|mesh-list
154727144|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727145|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727146|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
154727147|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154727148|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154727149|NCT00746512|Prednisone|prednisone|mesh-list
154727150|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727151|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
154727152|NCT00746512|Hormones|hormones|mesh-ancestor
154727153|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727154|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727155|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154727156|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727157|NCT05409027|Cortisone|cortisone|mesh-list
154727158|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154727159|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
154727160|NCT05409027|Hormones|hormones|mesh-ancestor
154727161|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727162|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479070|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727163|NCT01982435|Ranibizumab|ranibizumab|mesh-list
154727164|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154727165|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154727166|NCT01982435|Growth Substances|growth substances|mesh-ancestor
154727167|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727168|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
154727169|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727170|NCT00747214|Prednisolone|prednisolone|mesh-list
154727171|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
154727172|NCT00747214|Dipyridamole|dipyridamole|mesh-list
154727173|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727174|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
154727175|NCT00747214|Hormones|hormones|mesh-ancestor
154727176|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727177|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727178|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154727179|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727180|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154727181|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727182|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727183|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154727184|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
154727185|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154727186|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154727187|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154727188|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154727189|NCT01279876|Melatonin|melatonin|mesh-list
154727190|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
154727191|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727192|NCT01279876|Protective Agents|protective agents|mesh-ancestor
154727193|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727194|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727195|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154727196|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
154727197|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154727198|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154727199|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727200|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
154727201|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
154727202|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727203|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
154727204|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727205|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727206|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154727207|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
154727208|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727209|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727210|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154727211|NCT01279954|Abatacept|abatacept|mesh-list
154727212|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154727213|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727214|NCT01279954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727215|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727216|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727217|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
154727218|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727219|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727220|NCT00763048|Triclosan|triclosan|mesh-list
154727221|NCT00763048|Fluorides|fluorides|mesh-list
154727222|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
154727223|NCT00763048|Protective Agents|protective agents|mesh-ancestor
154727224|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727225|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154727226|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727227|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154727228|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154727229|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
154727230|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727231|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154727232|NCT01278394|Tavaborole|tavaborole|mesh-list
154727233|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
154727234|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727235|NCT00240916|Vaccines|vaccines|mesh-list
154727236|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
154727237|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727238|NCT01278160|Insulin|insulin|mesh-list
154727239|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154479141|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154727240|NCT01278160|Metformin|metformin|mesh-list
154727241|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
154727242|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
154727243|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154727244|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
154727245|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154727246|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
154727247|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154727248|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727249|NCT00748072|Vasopressins|vasopressins|mesh-list
154727250|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
154727251|NCT00748072|Coagulants|coagulants|mesh-ancestor
154727252|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154727253|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154727254|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
154727255|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727256|NCT01835587|Cc-486|cc-486|mesh-list
154727257|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727258|NCT01736917|Dexamethasone|dexamethasone|mesh-list
154727259|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
154727260|NCT01736917|Aprepitant|aprepitant|mesh-list
154727261|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727262|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
154727263|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
154727264|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727265|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727266|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727267|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
154727268|NCT01736917|Hormones|hormones|mesh-ancestor
154727269|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727270|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154727271|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727272|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154727273|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727274|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727275|NCT01277302|Ranibizumab|ranibizumab|mesh-list
154727276|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154727277|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154727278|NCT01277302|Growth Substances|growth substances|mesh-ancestor
154727279|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727280|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
154727281|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727282|NCT04414579|Insulin|insulin|mesh-list
154727283|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154727284|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
154727285|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
154727286|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154727287|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154727288|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727289|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
154727290|NCT01980875|Idelalisib|idelalisib|mesh-list
154727291|NCT01980875|Chlorambucil|chlorambucil|mesh-list
154727292|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727293|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727294|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727295|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727296|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154727297|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
154727298|NCT01967225|Linezolid|linezolid|mesh-list
154727299|NCT01967225|Tedizolid|tedizolid|mesh-list
154727300|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
154727301|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727302|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727303|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154727304|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727305|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727306|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154727307|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154727308|NCT01790503|Temozolomide|temozolomide|mesh-list
154727309|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154727310|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
154727311|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727312|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727313|NCT01765543|Rifampin|rifampin|mesh-list
154727314|NCT01765543|Vemurafenib|vemurafenib|mesh-list
154727315|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154727316|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
154727317|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727318|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727319|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
154727320|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154727321|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727322|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727323|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154727324|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154727325|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154727326|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154727327|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154727328|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154727329|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727330|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154727331|NCT00248170|Letrozole|letrozole|mesh-list
154727332|NCT00248170|Anastrozole|anastrozole|mesh-list
154727333|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727334|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154727335|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154727336|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768678|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727337|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727338|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154727339|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154727340|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727341|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727342|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154727343|NCT01764997|Adalimumab|adalimumab|mesh-list
154727344|NCT01764997|Etanercept|etanercept|mesh-list
154727345|NCT01764997|Methotrexate|methotrexate|mesh-list
154727346|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154727347|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
154727348|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154727349|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727350|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154727351|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
154727352|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727353|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727354|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
154727355|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727356|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154727357|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727358|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
154727359|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727360|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154727361|NCT01764997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154727362|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727363|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154727364|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154727365|NCT01764997|Analgesics|analgesics|mesh-ancestor
154727366|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
154727367|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727368|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727369|NCT01276756|Interferons|interferons|mesh-list
154727370|NCT01276756|Ribavirin|ribavirin|mesh-list
154727371|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
154727372|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
154727373|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154727374|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
154727375|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727376|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
154727377|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727378|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
154727379|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727380|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
154727381|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727382|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154727384|NCT00246376|Fenofibrate|fenofibrate|mesh-list
154727385|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154727386|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
154727387|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727388|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154727389|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
154727390|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
154727391|NCT00246376|Vitamins|vitamins|mesh-ancestor
154727392|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
154727393|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727394|NCT03806062|Domperidone|domperidone|mesh-list
154727395|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
154727396|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
154727397|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727398|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727399|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727400|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154727401|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
154727402|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727403|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727404|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
154727405|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154727406|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
154727407|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727408|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727409|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154727410|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
154727411|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154727412|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154727413|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154727414|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154727415|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727416|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727417|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
154727418|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727419|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727420|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154727421|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154727422|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727423|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727424|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727425|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154727426|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154727427|NCT00245050|Pyridoxine|pyridoxine|mesh-list
154727428|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
154727429|NCT00245050|Doxorubicin|doxorubicin|mesh-list
154727430|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154727431|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154727432|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727433|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154727434|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154727435|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727436|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727437|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
154727438|NCT00245050|Vitamins|vitamins|mesh-ancestor
154727439|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
154727440|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727441|NCT04345588|Dexamethasone|dexamethasone|mesh-list
154727442|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
154727443|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727444|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
154727445|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
154727446|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727447|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727448|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727449|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
154727450|NCT04345588|Hormones|hormones|mesh-ancestor
154727451|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727452|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154727453|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727454|NCT03806374|Lidocaine|lidocaine|mesh-list
154727455|NCT03806374|Fentanyl|fentanyl|mesh-list
154727456|NCT03806374|Ketamine|ketamine|mesh-list
154727457|NCT03806374|Propofol|propofol|mesh-list
154727458|NCT03806374|Cisatracurium|cisatracurium|mesh-list
154727459|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
154727460|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
154727461|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727462|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727463|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
154727464|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727465|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154727466|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154727467|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154727468|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154727469|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727470|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154727471|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154727472|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
154727473|NCT03806374|Analgesics|analgesics|mesh-ancestor
154727474|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154727475|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154727476|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154727477|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727478|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154727479|NCT03806374|Narcotics|narcotics|mesh-ancestor
154727480|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154727481|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154727482|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154727483|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
154727484|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154727485|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
154727486|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727487|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
154727488|NCT00763360|Protective Agents|protective agents|mesh-ancestor
154727489|NCT00756106|Temozolomide|temozolomide|mesh-list
154727490|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154727491|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
154727492|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727493|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727494|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
154727496|NCT00243412|Methotrexate|methotrexate|mesh-list
154727497|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727498|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727499|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
154727500|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727501|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727502|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154727503|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
154727504|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154727505|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154727506|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
154727507|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727508|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
154727509|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727510|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154727511|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727512|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154727513|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727514|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
154727515|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
154727516|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768911|NCT00208299|Adenosine|adenosine|mesh-list
153768988|NCT00410657|Protective Agents|protective agents|mesh-ancestor
154727517|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727518|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
154727519|NCT00243412|Hormones|hormones|mesh-ancestor
154727520|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727521|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154727522|NCT00243412|Protective Agents|protective agents|mesh-ancestor
154727523|NCT00765232|Ketorolac|ketorolac|mesh-list
154727524|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154727525|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154727526|NCT00765232|Analgesics|analgesics|mesh-ancestor
154727527|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
154727528|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727529|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727530|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727531|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727532|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154727533|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727534|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727535|NCT03805282|Lidocaine|lidocaine|mesh-list
154727536|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
154727537|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
154727538|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727539|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727540|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
154727541|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727542|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154727543|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154727544|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154727545|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154727546|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727547|NCT03805750|Dronabinol|dronabinol|mesh-list
154727548|NCT03805750|Cannabidiol|cannabidiol|mesh-list
154727549|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
154727550|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
154727551|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727552|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154727553|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154727554|NCT03805750|Analgesics|analgesics|mesh-ancestor
154727555|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
154727556|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727557|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154727558|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154727559|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727560|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727561|NCT03805750|Hormones|hormones|mesh-ancestor
154727562|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727563|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154727564|NCT03804268|Pilocarpine|pilocarpine|mesh-list
154727565|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154727566|NCT03804268|Miotics|miotics|mesh-ancestor
154727567|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
154727568|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727569|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727570|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154727571|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154727572|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
154727573|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727574|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727575|NCT00765856|Oxymorphone|oxymorphone|mesh-list
154727576|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154727577|NCT00765856|Narcotics|narcotics|mesh-ancestor
154727578|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727579|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727580|NCT00765856|Analgesics|analgesics|mesh-ancestor
154727581|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
154727582|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727583|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154727584|NCT00780208|Methylphenidate|methylphenidate|mesh-list
154727585|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154727586|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727587|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154727588|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154727589|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154727590|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727591|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
154727592|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727593|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
154727594|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
154727595|NCT00243022|Vitamins|vitamins|mesh-ancestor
154727596|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
154727597|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727598|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
154727599|NCT00243022|Hematinics|hematinics|mesh-ancestor
154727600|NCT03805360|Ropivacaine|ropivacaine|mesh-list
154727601|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
154727602|NCT03805360|Anesthetics|anesthetics|mesh-list
154727603|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727604|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727605|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
154727606|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727607|NCT00756964|Rasburicase|rasburicase|mesh-list
154727608|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
154727609|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727610|NCT00780442|Cycloserine|cycloserine|mesh-list
154727611|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154727612|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727613|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154727614|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
154727615|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727616|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
154727617|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727618|NCT04384666|Rotigotine|rotigotine|mesh-list
154727619|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
154727620|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
154727621|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727622|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727623|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727624|NCT00767572|Atorvastatin|atorvastatin|mesh-list
154727625|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154727626|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154727627|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
154727628|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727629|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154727630|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154727631|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727632|NCT00780676|Dasatinib|dasatinib|mesh-list
154727633|NCT00780676|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154727634|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154727635|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727636|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727637|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727638|NCT00768118|Curcumin|curcumin|mesh-list
154727639|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154727640|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154727641|NCT00768118|Analgesics|analgesics|mesh-ancestor
154727642|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
154727643|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727644|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727645|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727646|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727647|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727648|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727649|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727650|NCT04345432|Gabapentin|gabapentin|mesh-list
154727651|NCT04345432|Analgesics|analgesics|mesh-ancestor
154727652|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
154727653|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727654|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727655|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
154727656|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154727657|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154727658|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727659|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154727660|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154727661|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154727662|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727663|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727664|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
154727665|NCT00757822|Dronabinol|dronabinol|mesh-list
154727666|NCT00757822|Ondansetron|ondansetron|mesh-list
154727667|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
154727668|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
154727669|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727670|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727671|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727672|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
154727673|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
154727674|NCT00757822|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154727675|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154727676|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
154727677|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727678|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727679|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
154727680|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154727681|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154727682|NCT00757822|Analgesics|analgesics|mesh-ancestor
154727683|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
154727684|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154727685|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154727686|NCT00757822|Hormones|hormones|mesh-ancestor
154727687|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727688|NCT00758836|Acetaminophen|acetaminophen|mesh-list
154479588|NCT04367311|Atezolizumab|atezolizumab|mesh-list
154727690|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154727691|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154727692|NCT00758836|Analgesics|analgesics|mesh-ancestor
154727693|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
154727694|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727695|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727696|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727697|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727698|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154727699|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727700|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727701|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
154727702|NCT00769600|Itraconazole|itraconazole|mesh-list
154727703|NCT00769600|Pemetrexed|pemetrexed|mesh-list
154727704|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727705|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727706|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727707|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154727708|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154727709|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
154727710|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727711|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154727712|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154727713|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154727714|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
154727715|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727716|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727717|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154727718|NCT03809650|Macitentan|macitentan|mesh-list
154727719|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154727720|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154727721|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727722|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154727723|NCT03809260|Metformin|metformin|mesh-list
154727724|NCT03809260|Vancomycin|vancomycin|mesh-list
154727725|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154727726|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727727|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727728|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727729|NCT01763905|Ezetimibe|ezetimibe|mesh-list
154727730|NCT01763905|Evolocumab|evolocumab|mesh-list
154727731|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154727732|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154727733|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154727734|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
154727735|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727736|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154727737|NCT01763905|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154727738|NCT01763905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154727739|NCT01763905|Protease Inhibitors|protease inhibitors|mesh-ancestor
154727740|NCT01763905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727741|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
154727742|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727743|NCT03803254|Lenvatinib|lenvatinib|mesh-list
154727744|NCT03803254|Antibodies|antibodies|mesh-list
154727745|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
154727746|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727747|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727748|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154727749|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727750|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727751|NCT04730999|Bevacizumab|bevacizumab|mesh-list
154727752|NCT04730999|Atezolizumab|atezolizumab|mesh-list
154727753|NCT04730999|Carboplatin|carboplatin|mesh-list
154727754|NCT04730999|Etoposide|etoposide|mesh-list
154727755|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727756|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727757|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154727758|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154727759|NCT04730999|Growth Substances|growth substances|mesh-ancestor
154727760|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727761|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
154727762|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154727763|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154727764|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154727765|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727766|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727767|NCT04730999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154727768|NCT00759772|Teriparatide|teriparatide|mesh-list
154727769|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154727770|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727771|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154727772|NCT01977677|Plerixafor|plerixafor|mesh-list
154727773|NCT01977677|Temozolomide|temozolomide|mesh-list
154727774|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154727775|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
154727776|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727777|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727778|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154727779|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154727780|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
154727781|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727782|NCT04384744|Hormones|hormones|mesh-list
154727783|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727784|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727785|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
154727786|NCT01736215|Hematinics|hematinics|mesh-ancestor
154727787|NCT01786603|Rasagiline|rasagiline|mesh-list
154727788|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154727789|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727790|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727791|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154727792|NCT01786603|Protective Agents|protective agents|mesh-ancestor
154727793|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727794|NCT00786916|Lidocaine|lidocaine|mesh-list
154727795|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
154727796|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
154727797|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727798|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727799|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
154727800|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727801|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154727802|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154727803|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154727804|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154727805|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727806|NCT04414267|Vaccines|vaccines|mesh-list
154727807|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
154727808|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
154727809|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727810|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154727811|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
154727812|NCT01619423|Edetic Acid|edetic acid|mesh-list
154727813|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
154727814|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154727815|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
154727816|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
154727817|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727818|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
154727819|NCT01619423|Vitamins|vitamins|mesh-ancestor
154727820|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
154727821|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727822|NCT03802552|Cephalexin|cephalexin|mesh-list
154727823|NCT03802552|Cefadroxil|cefadroxil|mesh-list
154727824|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727825|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727826|NCT01735279|Mineral Oil|mineral oil|mesh-list
154727827|NCT01735279|Emollients|emollients|mesh-ancestor
154727828|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
154727829|NCT03802318|Amoxicillin|amoxicillin|mesh-list
154727830|NCT03802318|Rabeprazole|rabeprazole|mesh-list
154727831|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727832|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727833|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154727834|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727835|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154727836|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727837|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727838|NCT01758523|Dutasteride|dutasteride|mesh-list
154727839|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154727840|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154727841|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727842|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727843|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
154727844|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727845|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727846|NCT00773422|Naltrexone|naltrexone|mesh-list
154727847|NCT00773422|Varenicline|varenicline|mesh-list
154727848|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154727849|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154727850|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727851|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
154727852|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727853|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154727854|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154727855|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
154727856|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727857|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727858|NCT00786994|Petrolatum|petrolatum|mesh-list
154727859|NCT00786994|Emollients|emollients|mesh-ancestor
154727860|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
154727861|NCT00774202|Prednisone|prednisone|mesh-list
154727862|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
154727863|NCT00774202|Rituximab|rituximab|mesh-list
154727864|NCT00774202|Vincristine|vincristine|mesh-list
154727865|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727866|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
154727867|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727868|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154727869|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154727870|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
154727871|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727872|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727873|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154727874|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727875|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154727876|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
154727877|NCT00774202|Hormones|hormones|mesh-ancestor
154727878|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727879|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154727880|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154727881|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
154727882|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
154727883|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
154727884|NCT03808168|Nivolumab|nivolumab|mesh-list
154727885|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154727886|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727887|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154727888|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727889|NCT03802162|Memantine|memantine|mesh-list
154727890|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154727891|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154727892|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
154727893|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727894|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727895|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727896|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154727897|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154727898|NCT01757275|Esomeprazole|esomeprazole|mesh-list
154727899|NCT01757275|Cimetidine|cimetidine|mesh-list
154727900|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154727901|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727902|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154727903|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727904|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727905|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154727906|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
154727907|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
154727908|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727909|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727910|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154727911|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154727912|NCT00787852|Paclitaxel|paclitaxel|mesh-list
154727913|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154727914|NCT00787852|Dasatinib|dasatinib|mesh-list
154727915|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154727916|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727917|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
154727918|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
154727919|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
154727920|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727921|NCT00787852|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154727922|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154727923|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727924|NCT00788008|Propofol|propofol|mesh-list
154727925|NCT00788008|Isoflurane|isoflurane|mesh-list
154727926|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
154727927|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154727928|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727929|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154727930|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154727931|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
154727932|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154727933|NCT00760006|Ampicillin|ampicillin|mesh-list
154727934|NCT00760006|Sulbactam|sulbactam|mesh-list
154727935|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154727936|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154727937|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154727938|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154727939|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154727940|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727941|NCT01784965|Liraglutide|liraglutide|mesh-list
154727942|NCT01784965|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154727943|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154727944|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727945|NCT01784965|Incretins|incretins|mesh-ancestor
154727946|NCT01784965|Hormones|hormones|mesh-ancestor
154727947|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727948|NCT05742724|Dronabinol|dronabinol|mesh-list
154727949|NCT05742724|Nabiximols|nabiximols|mesh-list
154727950|NCT05742724|Cannabidiol|cannabidiol|mesh-list
154727951|NCT05742724|Anticonvulsants|anticonvulsants|mesh-ancestor
154727952|NCT05742724|Hallucinogens|hallucinogens|mesh-ancestor
154727953|NCT05742724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727954|NCT05742724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154727955|NCT05742724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154727956|NCT05742724|Analgesics|analgesics|mesh-ancestor
154727957|NCT05742724|Sensory System Agents|sensory system agents|mesh-ancestor
154727958|NCT05742724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154727959|NCT05742724|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154727960|NCT05742724|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154727961|NCT05742724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154727962|NCT05742724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727963|NCT05742724|Hormones|hormones|mesh-ancestor
154727964|NCT05742724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154727965|NCT01784419|Ivacaftor|ivacaftor|mesh-list
154727966|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154727967|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154727968|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727969|NCT01784029|Vitamin D|vitamin d|mesh-list
154727970|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
154727971|NCT01784029|Vitamins|vitamins|mesh-ancestor
154727972|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
154727973|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727974|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154727975|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154727976|NCT00789256|Bortezomib|bortezomib|mesh-list
154727977|NCT00789256|Melphalan|melphalan|mesh-list
154727978|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154727979|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154727980|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
154727981|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154727982|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154727983|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154727984|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
154727985|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479915|NCT03959085|Vitamins|vitamins|mesh-ancestor
154727986|NCT01733329|Folic Acid|folic acid|mesh-list
154727987|NCT01733329|Misoprostol|misoprostol|mesh-list
154727988|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154727990|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154727991|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154727992|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154727993|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154727994|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
154727995|NCT01733329|Hematinics|hematinics|mesh-ancestor
154727996|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
154727997|NCT01733329|Vitamins|vitamins|mesh-ancestor
154727998|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
154727999|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
154728000|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154728001|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154728002|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154728003|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154728004|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728005|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
154728006|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728007|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728008|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154728009|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728010|NCT01607593|Sertraline|sertraline|mesh-list
154728011|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
154728012|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154728013|NCT01607593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154728014|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154728015|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154728016|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728017|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728018|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
154728019|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728020|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154728021|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154728022|NCT01755637|Albendazole|albendazole|mesh-list
154728023|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
154728024|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154728025|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728026|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
154728027|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154728028|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154728029|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
154728030|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
154728031|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
154728032|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728033|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728034|NCT03801226|Calcium|calcium|mesh-list
154728035|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154728036|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728037|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
154728038|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728039|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154728040|NCT02148874|Vaccines|vaccines|mesh-list
154728041|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
154728042|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728043|NCT01755091|Dronabinol|dronabinol|mesh-list
154728044|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
154728045|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728046|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154728047|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154728048|NCT01755091|Analgesics|analgesics|mesh-ancestor
154728049|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
154728050|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728051|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154728052|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154728053|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728054|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728055|NCT01755091|Hormones|hormones|mesh-ancestor
154728056|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728057|NCT00789802|Naproxen|naproxen|mesh-list
154728058|NCT00789802|Estradiol|estradiol|mesh-list
154728059|NCT00789802|Estrogens|estrogens|mesh-ancestor
154728060|NCT00789802|Hormones|hormones|mesh-ancestor
154728061|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728062|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728063|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154728064|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154728065|NCT00789802|Analgesics|analgesics|mesh-ancestor
154728066|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
154728067|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728068|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728069|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154728070|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
154728071|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154728072|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728073|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728074|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
154728075|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154728076|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728077|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154728078|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154728079|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154728080|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
154728081|NCT01783015|Etanercept|etanercept|mesh-list
154728082|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154728083|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154728084|NCT01783015|Analgesics|analgesics|mesh-ancestor
154728085|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
154728086|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728087|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728088|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728089|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154728090|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154728091|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154728092|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
154728093|NCT01782859|Prednisone|prednisone|mesh-list
154728094|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
154728095|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154728096|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154728097|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154728098|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728099|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
154728100|NCT01782859|Hormones|hormones|mesh-ancestor
154728101|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728102|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728103|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154728104|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728105|NCT01782313|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154728106|NCT01782313|Tivozanib|tivozanib|mesh-list
154728107|NCT01782313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153769727|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
153769824|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
154728108|NCT01782313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728109|NCT01782313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728110|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154728111|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154728112|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
154728113|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154728114|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154728115|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154728116|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728117|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728118|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154728119|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154728120|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154728121|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728122|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728123|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728124|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154728125|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154728126|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
154728127|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154728128|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154728129|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
154728130|NCT01781611|Aspirin|aspirin|mesh-list
154728131|NCT01781611|Dipyridamole|dipyridamole|mesh-list
154728132|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154728133|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154728134|NCT01781611|Analgesics|analgesics|mesh-ancestor
154728135|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
154728136|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728137|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728138|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728139|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154728140|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154728141|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154728142|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728143|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154728144|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154728145|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728146|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
154728147|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154728148|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
154728150|NCT00790270|Amitriptyline|amitriptyline|mesh-list
154728151|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
154728152|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154728153|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154728154|NCT00790270|Analgesics|analgesics|mesh-ancestor
154728155|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
154728156|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728157|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728158|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728159|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154728160|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154728161|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728162|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728163|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154728164|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
154728165|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154728166|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154728167|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154728168|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154728169|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728170|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154728171|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154728172|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154728173|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728174|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728175|NCT01780987|Heparin|heparin|mesh-list
154728176|NCT01780987|Calcium heparin|calcium heparin|mesh-list
154728177|NCT01780987|Warfarin|warfarin|mesh-list
154728178|NCT01780987|Apixaban|apixaban|mesh-list
154728179|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
154728180|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154728181|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154728182|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728183|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154728184|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
154728185|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154728186|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
154728187|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728188|NCT03800290|Clenbuterol|clenbuterol|mesh-list
154728189|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154728190|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728191|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728192|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728193|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728194|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728195|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154728196|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
154728197|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728198|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154728199|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
154728200|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
154728201|NCT05709184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154728202|NCT05709184|Vancomycin|vancomycin|mesh-list
154728203|NCT05709184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728204|NCT00809848|Bimatoprost|bimatoprost|mesh-list
154728205|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154728206|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154728207|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154728208|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154728209|NCT01730053|Ezetimibe|ezetimibe|mesh-list
154728210|NCT01730053|Alirocumab|alirocumab|mesh-list
154728211|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154728212|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154728213|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
154728214|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728215|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154728216|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154728217|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728218|NCT01730053|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154728219|NCT01730053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154728220|NCT01730053|Protease Inhibitors|protease inhibitors|mesh-ancestor
154728221|NCT01751113|Fluticasone|fluticasone|mesh-list
154728222|NCT01751113|Xhance|xhance|mesh-list
154728223|NCT01751113|Bromides|bromides|mesh-list
154728224|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
154728225|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154728226|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154728227|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728228|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154728229|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
154728230|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728231|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728232|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154728233|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
154728234|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
154728235|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154728236|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
154728237|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154728238|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
154728239|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728240|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728241|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154728242|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154728243|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728244|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728245|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
154728246|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
154728247|NCT01751113|Hormones|hormones|mesh-ancestor
154728248|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728249|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
154728250|NCT01719380|Cetuximab|cetuximab|mesh-list
154728251|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154728252|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728253|NCT00792142|Thalidomide|thalidomide|mesh-list
154728254|NCT00792142|Dexamethasone|dexamethasone|mesh-list
154728255|NCT00792142|Bortezomib|bortezomib|mesh-list
154728256|NCT00792142|Melphalan|melphalan|mesh-list
154728257|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728258|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
154728259|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
154728260|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728261|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728262|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154728263|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
154728264|NCT00792142|Hormones|hormones|mesh-ancestor
154728265|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728266|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154728267|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728268|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154728269|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
154728270|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728271|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154728272|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154728273|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
154728274|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
154728275|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154728276|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728277|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154728278|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154728279|NCT00792142|Growth Substances|growth substances|mesh-ancestor
154728280|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
154728281|NCT01743560|Everolimus|everolimus|mesh-list
154728282|NCT01743560|Exemestane|exemestane|mesh-list
154728283|NCT01743560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154558076|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154728284|NCT01743560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154728285|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728286|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728287|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154728288|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
154728289|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728290|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728291|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154728292|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154728293|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154728294|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
154728295|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728296|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154728297|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154728298|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
154728299|NCT00792922|Azithromycin|azithromycin|mesh-list
154728300|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154728301|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728302|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
154728303|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154728304|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154728305|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
154728306|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728307|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154728308|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154728309|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728310|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728311|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
154728312|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154728313|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728314|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728315|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154728316|NCT04382170|Analgesics|analgesics|mesh-ancestor
154728317|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
154728318|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728319|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154728320|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154728321|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728322|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728323|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728324|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728325|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154728326|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
154728327|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154728328|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
154728329|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154728330|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728331|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154728332|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154728333|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728334|NCT04718350|Simendan|simendan|mesh-list
154728335|NCT04718350|Milrinone|milrinone|mesh-list
154728336|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154728337|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
154728338|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154728339|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154728340|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728341|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728342|NCT04718350|Protective Agents|protective agents|mesh-ancestor
154728343|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728344|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154728345|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154728346|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154728347|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154728348|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154728349|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
154728350|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728351|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728352|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728353|NCT01729819|Urological Agents|urological agents|mesh-ancestor
154728354|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
154728355|NCT01729819|Coagulants|coagulants|mesh-ancestor
154728356|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154728357|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
154728358|NCT00811564|Timolol|timolol|mesh-list
154728359|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154728360|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154728361|NCT00811564|Latanoprost|latanoprost|mesh-list
154728362|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154728363|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728364|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154728365|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154728366|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728367|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728368|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728369|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154728370|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154728371|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154728372|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154728373|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728375|NCT01709084|Emtricitabine|emtricitabine|mesh-list
154728376|NCT01709084|Efavirenz|efavirenz|mesh-list
154728377|NCT01709084|Rilpivirine|rilpivirine|mesh-list
154728378|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
154728379|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728380|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154728381|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154728382|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728383|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728384|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154728385|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154728386|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154728387|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154728388|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154728389|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154728390|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154728391|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154728392|NCT01741532|Deferiprone|deferiprone|mesh-list
154728393|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154728394|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
154728395|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
154728396|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728397|NCT01727713|Aripiprazole|aripiprazole|mesh-list
154728398|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
154728399|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154728400|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154728401|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154728402|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728403|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728404|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
154728405|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
154728406|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728407|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728408|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154728409|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154728410|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
154728411|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154728412|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154728413|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154728414|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154728415|NCT04658927|Dexamethasone|dexamethasone|mesh-list
154728416|NCT04658927|Prednisone|prednisone|mesh-list
154728417|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728418|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
154728419|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
154728420|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728421|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728422|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154728423|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
154728424|NCT04658927|Hormones|hormones|mesh-ancestor
154728425|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728426|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154728427|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728428|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
154728429|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154728430|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728431|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154728432|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154728433|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728434|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728435|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728436|NCT01976507|Dabigatran|dabigatran|mesh-list
154728437|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
154728438|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154728439|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
154728440|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728441|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728442|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
154728443|NCT01964963|Alogliptin|alogliptin|mesh-list
154728444|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154728445|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728446|NCT01964963|Incretins|incretins|mesh-ancestor
154728447|NCT01964963|Hormones|hormones|mesh-ancestor
154728448|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728449|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154728450|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
154728451|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728452|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728453|NCT01974323|Dapsone|dapsone|mesh-list
154728454|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728455|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
154728456|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154728457|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154728458|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154728459|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728460|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728461|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
154728462|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154728463|NCT01973387|Rituximab|rituximab|mesh-list
154728464|NCT01973387|Ibrutinib|ibrutinib|mesh-list
154728465|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154728466|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728467|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
154728468|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728469|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154728470|NCT01973387|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154728471|NCT01973387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154728472|NCT01973387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728473|NCT01973387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728474|NCT01973231|Liraglutide|liraglutide|mesh-list
154728475|NCT01973231|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154728476|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154728477|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728478|NCT01973231|Incretins|incretins|mesh-ancestor
154728479|NCT01973231|Hormones|hormones|mesh-ancestor
154728480|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728481|NCT02151994|Zamicastat|zamicastat|mesh-list
154728482|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728483|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728484|NCT04382950|Tretinoin|tretinoin|mesh-list
154728485|NCT04382950|Isotretinoin|isotretinoin|mesh-list
154728486|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728487|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
154728488|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
154728489|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
154728490|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154728491|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728492|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728493|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154728494|NCT04383418|Analgesics|analgesics|mesh-ancestor
154728495|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
154728496|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728497|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154728498|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154728499|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728500|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728501|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728502|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728503|NCT03414112|Oxytocin|oxytocin|mesh-list
154728504|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
154728505|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154728506|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728507|NCT03839134|Lidocaine|lidocaine|mesh-list
154728508|NCT03839134|Epinephrine|epinephrine|mesh-list
154728509|NCT03839134|Racepinephrine|racepinephrine|mesh-list
154728510|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
154728511|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
154728512|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
154728513|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728514|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728515|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
154728516|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728517|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154728518|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154728519|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154728520|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154728521|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728522|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154728523|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728524|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728525|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728526|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154728527|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154728528|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
154728529|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154728530|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
154728531|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
154728532|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
154728533|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154728534|NCT03906526|Nivolumab|nivolumab|mesh-list
154728535|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154728536|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728537|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154728538|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728539|NCT03088930|Crizotinib|crizotinib|mesh-list
154728540|NCT03088930|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154728541|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154728542|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728543|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728544|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728545|NCT02152696|Methotrexate|methotrexate|mesh-list
154728546|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154728547|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
154728548|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154728549|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728550|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154728551|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
154728552|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728553|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728554|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
154728555|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728556|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154728557|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154728558|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
154728559|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154728560|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154728561|NCT01905436|Ivermectin|ivermectin|mesh-list
154728562|NCT01905436|Albendazole|albendazole|mesh-list
154728563|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154728564|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728565|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
154728566|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
154728567|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154728568|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154728569|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154728570|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154728571|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154728572|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728573|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728574|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
154728575|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154728576|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
154728577|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728578|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728579|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154728580|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
154728581|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154728582|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154728583|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728584|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728585|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728586|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728587|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
154728588|NCT01972841|Mirabegron|mirabegron|mesh-list
154728589|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154728590|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154728591|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
154728592|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728593|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728594|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728595|NCT01972841|Urological Agents|urological agents|mesh-ancestor
154728596|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154728597|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154728598|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728599|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728600|NCT01774903|Fentanyl|fentanyl|mesh-list
154728601|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154728602|NCT01774903|Narcotics|narcotics|mesh-ancestor
154728603|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728604|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728605|NCT01774903|Analgesics|analgesics|mesh-ancestor
154728606|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
154728607|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728608|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154728609|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154728610|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
154728611|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
154728612|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154728613|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154728614|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154728615|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728616|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
154728617|NCT01708915|Capsaicin|capsaicin|mesh-list
154728618|NCT01708915|Nonivamide|nonivamide|mesh-list
154728619|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
154728620|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728621|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728622|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
154728623|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
154728624|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
154728625|NCT01708915|Vitamins|vitamins|mesh-ancestor
154728626|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
154728627|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
154728628|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154728629|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
154728630|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728631|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728632|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154728633|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
154728634|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
154728635|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154728636|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
154728637|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728638|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728639|NCT01747915|Pregabalin|pregabalin|mesh-list
154728640|NCT01747915|Analgesics|analgesics|mesh-ancestor
154728641|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
154728642|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728643|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728644|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
154728645|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154728646|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154728647|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728648|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154728649|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154728650|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154728651|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728652|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154728653|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
154728654|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154728655|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154728656|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
154728657|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
154728658|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728659|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728660|NCT04656041|Paclitaxel|paclitaxel|mesh-list
154728661|NCT04656041|Carboplatin|carboplatin|mesh-list
154728662|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154728663|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728664|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
154728665|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
154728666|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
154728667|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728668|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154728669|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
154728670|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154728671|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154728672|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154728673|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728674|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728675|NCT01970501|Metoprolol|metoprolol|mesh-list
154728676|NCT01970501|Bucindolol|bucindolol|mesh-list
154728677|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154728678|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154728679|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
154728680|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
154728681|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728682|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728683|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154728684|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154728685|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154728686|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728687|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728688|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728689|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
154728690|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
154728691|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154728692|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153770668|NCT00233571|Adalimumab|adalimumab|mesh-list
154728693|NCT01969799|Amikacin|amikacin|mesh-list
154728694|NCT01969799|Fosfomycin|fosfomycin|mesh-list
154728695|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154728696|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728697|NCT01969721|Fluticasone|fluticasone|mesh-list
154728698|NCT01969721|Xhance|xhance|mesh-list
154728699|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
154728700|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154728701|NCT01969721|Olodaterol|olodaterol|mesh-list
154728702|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728703|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154728704|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
154728705|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728706|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728707|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154728708|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
154728709|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
154728710|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154728711|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
154728712|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154728713|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
154728714|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728715|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728716|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154728717|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154728718|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728719|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728720|NCT01969565|Dexamethasone|dexamethasone|mesh-list
154728721|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728722|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
154728723|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
154728724|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728725|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728726|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154728727|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
154728728|NCT01969565|Hormones|hormones|mesh-ancestor
154728729|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728730|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154728731|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728732|NCT01968707|Ethanol|ethanol|mesh-list
154728733|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
154728734|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154728735|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154728736|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728737|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728738|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728739|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
154728740|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
154728741|NCT01746901|Naltrexone|naltrexone|mesh-list
154728742|NCT01746901|Oxycodone|oxycodone|mesh-list
154728743|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154728744|NCT01746901|Narcotics|narcotics|mesh-ancestor
154728745|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728746|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728747|NCT01746901|Analgesics|analgesics|mesh-ancestor
154728748|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
154728749|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728750|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154728751|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154728752|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154728753|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154728754|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154728755|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
154728756|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728757|NCT01946165|Prednisone|prednisone|mesh-list
154728758|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
154728759|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154728760|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
154728761|NCT01946165|Hormones|hormones|mesh-ancestor
154728762|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728763|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728764|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154728765|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728766|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154728767|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728768|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728769|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
154728770|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154728771|NCT01707667|Prucalopride|prucalopride|mesh-list
154728772|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154728773|NCT01707667|Laxatives|laxatives|mesh-ancestor
154728774|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154728775|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154728776|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154728777|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
154728778|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728779|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728780|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728781|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154728782|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
154728783|NCT01959503|Coagulants|coagulants|mesh-ancestor
154728784|NCT01706575|Interferons|interferons|mesh-list
154728785|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728786|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
154728787|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728788|NCT01725529|Ribavirin|ribavirin|mesh-list
154728789|NCT01725529|Simeprevir|simeprevir|mesh-list
154728790|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
154728791|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728792|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
154728793|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728794|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
154728795|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728796|NCT01744093|Doxycycline|doxycycline|mesh-list
154728797|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154728798|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728799|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
154728800|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154728801|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154728802|NCT01725451|Testosterone|testosterone|mesh-list
154728803|NCT01725451|Androgens|androgens|mesh-ancestor
154728804|NCT01725451|Hormones|hormones|mesh-ancestor
154728805|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728806|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728807|NCT01707290|Ivacaftor|ivacaftor|mesh-list
154728808|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154728809|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154728810|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728811|NCT01717040|Pioglitazone|pioglitazone|mesh-list
154728812|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154728813|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728814|NCT00803062|Paclitaxel|paclitaxel|mesh-list
154728815|NCT00803062|Bevacizumab|bevacizumab|mesh-list
154728816|NCT00803062|Cisplatin|cisplatin|mesh-list
154728817|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154728818|NCT00803062|Topotecan|topotecan|mesh-list
154728819|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154728820|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
154728821|NCT00803062|Antibodies|antibodies|mesh-list
154728822|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
154728823|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154728824|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
154728825|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154728826|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728827|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
154728828|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154728829|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
154728830|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728831|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154728832|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154728833|NCT00803062|Growth Substances|growth substances|mesh-ancestor
154728834|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728835|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
154728836|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
154728837|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154728838|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154728839|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728840|NCT01743001|Macitentan|macitentan|mesh-list
154728841|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154728842|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154728843|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728844|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154728845|NCT01704079|Calcifediol|calcifediol|mesh-list
154728846|NCT01704079|Vitamins|vitamins|mesh-ancestor
154728847|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
154728848|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728849|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154728850|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
154728851|NCT01703845|Olodaterol|olodaterol|mesh-list
154728852|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154728853|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
154728854|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728855|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728856|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154728857|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
154728858|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
154728859|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154728860|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
154728861|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728862|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728863|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154728864|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154728865|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154728866|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728867|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728868|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154728869|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154728870|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154728871|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
154728872|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728873|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728874|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154728875|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154728876|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
154728877|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154728878|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154728879|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728880|NCT01703221|Incretins|incretins|mesh-ancestor
154728881|NCT01703221|Hormones|hormones|mesh-ancestor
153770801|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
153770876|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
154728882|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728883|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154728884|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
154728885|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728886|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728887|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
154728888|NCT00803686|Calcitonin|calcitonin|mesh-list
154728889|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154728890|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728891|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154728892|NCT00823966|Delavirdine|delavirdine|mesh-list
154728893|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154728894|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154728895|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728896|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728897|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
154728898|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154728899|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154728900|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154728901|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
154728902|NCT01702987|Atorvastatin|atorvastatin|mesh-list
154728903|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154728904|NCT01702987|Simvastatin|simvastatin|mesh-list
154728905|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154728906|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154728907|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
154728908|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728909|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154728910|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154728911|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728912|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
154728913|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728914|NCT01702987|Vitamins|vitamins|mesh-ancestor
154728915|NCT00824044|Escitalopram|escitalopram|mesh-list
154728916|NCT00824044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154728917|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154728918|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154728919|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728920|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728921|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
154728922|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728923|NCT01702519|Nicotine|nicotine|mesh-list
154728924|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154728925|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
154728926|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728927|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728928|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154728929|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154728930|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
154728931|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728932|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728933|NCT01739335|Mifepristone|mifepristone|mesh-list
154728934|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154728935|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
154728936|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154728937|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728938|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154728939|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154728940|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154728941|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
153770877|NCT00208715|Modafinil|modafinil|mesh-list
154728942|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154728943|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154728944|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
154728945|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728946|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
154728947|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154728948|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154728949|NCT00824746|Gefitinib|gefitinib|mesh-list
154728950|NCT00824746|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154728951|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154728952|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728953|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728954|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154728955|NCT01722097|Rocuronium|rocuronium|mesh-list
154728956|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154728957|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154728958|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154728959|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480879|NCT01719016|Adenosine|adenosine|mesh-list
154728960|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728961|NCT00824824|Timolol|timolol|mesh-list
154728962|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154728963|NCT00824824|Dorzolamide|dorzolamide|mesh-list
154728964|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154728965|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154728966|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
154728967|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154728968|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728969|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728970|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154728971|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154728972|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154728973|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154728974|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154728975|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154728976|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728977|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154728978|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154728979|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728980|NCT01701973|Incretins|incretins|mesh-ancestor
154728981|NCT01701973|Hormones|hormones|mesh-ancestor
154728982|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154728983|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154728984|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
154728985|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154728986|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728987|NCT00825370|Hydromorphone|hydromorphone|mesh-list
154728988|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154728989|NCT00825370|Narcotics|narcotics|mesh-ancestor
154728990|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154728991|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154728992|NCT00825370|Analgesics|analgesics|mesh-ancestor
154728993|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
154728994|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154728995|NCT01721317|Ezogabine|ezogabine|mesh-list
154728996|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
154728997|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154728998|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154728999|NCT00828412|Desonide|desonide|mesh-list
154729000|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729001|NCT01959035|Aripiprazole|aripiprazole|mesh-list
154729002|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
154729003|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729004|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154729005|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154729006|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729007|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729008|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
154729009|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
154729010|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729011|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729012|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154729013|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154729014|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
154729015|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154729016|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154729017|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154729018|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154729019|NCT01700959|Melatonin|melatonin|mesh-list
154729020|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
154729021|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729022|NCT01700959|Protective Agents|protective agents|mesh-ancestor
154729023|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729024|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729025|NCT00829738|Pantoprazole|pantoprazole|mesh-list
154729026|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154729027|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729028|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154729029|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729030|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729031|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
154729032|NCT01737931|Promethazine|promethazine|mesh-list
154480953|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
154729034|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154729035|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
154729036|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729037|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
154729038|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
154729039|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729040|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729041|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729042|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
154729043|NCT01737931|Hormones|hormones|mesh-ancestor
154729044|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729045|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154729046|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729047|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154729048|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154729049|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729050|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
154729051|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
154729052|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
154729053|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
154729054|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729055|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729056|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154729057|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
154729058|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
154729059|NCT01958489|Pravastatin|pravastatin|mesh-list
154729060|NCT01958489|Evacetrapib|evacetrapib|mesh-list
154729061|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154729062|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154729063|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
154729064|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771050|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
154729065|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154729066|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154729067|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729068|NCT00830362|Propranolol|propranolol|mesh-list
154729069|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154729070|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154729071|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
154729072|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729073|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729074|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729075|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154729076|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154729077|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
154729078|NCT01720225|Azacitidine|azacitidine|mesh-list
154729079|NCT01720225|Decitabine|decitabine|mesh-list
154729080|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154729081|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
154729082|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729083|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729084|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729085|NCT01943435|Acetaminophen|acetaminophen|mesh-list
154729086|NCT01943435|Ibuprofen|ibuprofen|mesh-list
154729087|NCT01943435|Celecoxib|celecoxib|mesh-list
154729088|NCT01943435|Diclofenac|diclofenac|mesh-list
154729089|NCT01943435|Gabapentin|gabapentin|mesh-list
154729090|NCT01943435|Tramadol|tramadol|mesh-list
154729091|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154729092|NCT01943435|Analgesics|analgesics|mesh-list
154729093|NCT01943435|Mirtazapine|mirtazapine|mesh-list
154729094|NCT01943435|Trazodone|trazodone|mesh-list
154729095|NCT01943435|Sertraline|sertraline|mesh-list
154729096|NCT01943435|Nortriptyline|nortriptyline|mesh-list
154729097|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
154729098|NCT01943435|Misoprostol|misoprostol|mesh-list
154729099|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154729100|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
154729101|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729102|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729103|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
154729104|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154729105|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729106|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729107|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154729108|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729109|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729110|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154729111|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154729112|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
153771179|NCT01081132|Guanfacine|guanfacine|mesh-list
154729113|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154729114|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154729115|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729116|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
154729117|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
154729118|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154729119|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154729120|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729121|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729122|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154729123|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154729124|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729125|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
154729126|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154729127|NCT01943435|Narcotics|narcotics|mesh-ancestor
154729128|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154729129|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154729130|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729131|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
154729132|NCT01943435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154729133|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
154729134|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154729135|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
154729136|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
154729137|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154729138|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154729139|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154729140|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
154729141|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154729142|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154729143|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154729144|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154729145|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154729146|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154729147|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
154729148|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
154729149|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729150|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729151|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729152|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
154729153|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
154729154|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154729155|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154729156|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
154729157|NCT00807586|Prednisolone|prednisolone|mesh-list
154729158|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
154729159|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154729160|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
154729161|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729162|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
154729163|NCT00807586|Hormones|hormones|mesh-ancestor
154729164|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729165|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729166|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154729167|NCT00807586|Protective Agents|protective agents|mesh-ancestor
154729168|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154729169|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729170|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
154729171|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
154729172|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729173|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729174|NCT01698775|Glipizide|glipizide|mesh-list
154729175|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729176|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729177|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
154729178|NCT01941095|Chloroquine|chloroquine|mesh-list
154729179|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
154729180|NCT01941095|Methotrexate|methotrexate|mesh-list
154729181|NCT01941095|Azathioprine|azathioprine|mesh-list
154729182|NCT01941095|Leflunomide|leflunomide|mesh-list
154729183|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154729184|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
154729185|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154729186|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729187|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154729189|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729190|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729191|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
154729192|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729193|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154729194|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154729195|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
154729196|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729197|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154729198|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
154729199|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154729200|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154729201|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729202|NCT01941095|Amebicides|amebicides|mesh-ancestor
154729203|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154729204|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154729205|NCT01941095|Analgesics|analgesics|mesh-ancestor
154729206|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
154729207|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729208|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729209|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729210|NCT00831766|Cytarabine|cytarabine|mesh-list
154729211|NCT00831766|Lenalidomide|lenalidomide|mesh-list
154729212|NCT00831766|Idarubicin|idarubicin|mesh-list
154729213|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
154729214|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154729215|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
154729216|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729217|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
154729218|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729219|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154729220|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
154729221|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729222|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154729223|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154729224|NCT00831766|Growth Substances|growth substances|mesh-ancestor
154729225|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
154729226|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154729227|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154729228|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154729229|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729230|NCT01957709|Interferons|interferons|mesh-list
154729231|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
154729232|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729233|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
154729234|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729235|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154729236|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729237|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729238|NCT00832390|Incretins|incretins|mesh-ancestor
154729239|NCT00832390|Hormones|hormones|mesh-ancestor
154729240|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729241|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154729242|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
154729243|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729244|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729245|NCT00844090|Methylphenidate|methylphenidate|mesh-list
154729246|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154729247|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729248|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154729249|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154729250|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729251|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729252|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
154729253|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729254|NCT00844714|Rituximab|rituximab|mesh-list
154729255|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154729256|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729257|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
154481179|NCT00058266|Estrogens|estrogens|mesh-ancestor
154729258|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729259|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729260|NCT00834652|Metformin|metformin|mesh-list
154729261|NCT00834652|Sertraline|sertraline|mesh-list
154729262|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729263|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729264|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
154729265|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729266|NCT00834652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154729267|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154729268|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729269|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729270|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729271|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
154729272|NCT00834808|Tramadol|tramadol|mesh-list
154729273|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154729274|NCT00834808|Narcotics|narcotics|mesh-ancestor
154729275|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729276|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729277|NCT00834808|Analgesics|analgesics|mesh-ancestor
154729278|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
154729279|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729280|NCT00850096|Insulin|insulin|mesh-list
154729281|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729282|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729283|NCT00834886|Melatonin|melatonin|mesh-list
154729284|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
154729285|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729286|NCT00834886|Protective Agents|protective agents|mesh-ancestor
154729287|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729288|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729289|NCT00835198|Dapsone|dapsone|mesh-list
154729290|NCT00835198|Tretinoin|tretinoin|mesh-list
154729291|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729292|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
154729293|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
154729294|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729295|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
154729296|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154729297|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154729298|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154729299|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729300|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729301|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
154729302|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154729303|NCT00835510|Butenafine|butenafine|mesh-list
154729304|NCT00835510|Clotrimazole|clotrimazole|mesh-list
154729305|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
154729306|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729307|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154729308|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154729309|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154729310|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729311|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729312|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154729313|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
154729314|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729315|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729316|NCT00835900|Varenicline|varenicline|mesh-list
154729317|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154729318|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154729319|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
154729320|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729321|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729322|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729323|NCT01954121|Carbamazepine|carbamazepine|mesh-list
154729324|NCT01954121|Levetiracetam|levetiracetam|mesh-list
154729325|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
154729326|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
154729327|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
154729328|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154729329|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729330|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729331|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729332|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154729333|NCT01954121|Analgesics|analgesics|mesh-ancestor
154729334|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
154729335|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729336|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154729337|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729338|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729339|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154729340|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154729342|NCT00838162|TMC-310911|tmc-310911|mesh-list
154729343|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154729344|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154729345|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
154729346|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729347|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729348|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154729349|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154729350|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
154729351|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729352|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154729353|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154729354|NCT00841204|Sulindac|sulindac|mesh-list
154729355|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154729356|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154729357|NCT00841204|Analgesics|analgesics|mesh-ancestor
154729358|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
154729359|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729360|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729361|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729362|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729363|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729364|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154729365|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729366|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729367|NCT00853840|Maraviroc|maraviroc|mesh-list
154729368|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154729369|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154729370|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154729371|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729372|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154729373|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154729374|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
154729375|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729376|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154729377|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
154729378|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154729379|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154729380|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729381|NCT00853840|Urological Agents|urological agents|mesh-ancestor
154729382|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
154729383|NCT00841828|Docetaxel|docetaxel|mesh-list
154729384|NCT00841828|Trastuzumab|trastuzumab|mesh-list
154729385|NCT00841828|Epirubicin|epirubicin|mesh-list
154729386|NCT00841828|Lapatinib|lapatinib|mesh-list
154729387|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154729388|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
154729389|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771455|NCT00210158|Analgesics|analgesics|mesh-ancestor
154729390|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729391|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154729392|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
154729393|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729394|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729395|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154729396|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
154729397|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
154729398|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
154729399|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154729400|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154729401|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154729402|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154729403|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729404|NCT00841828|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154729405|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154729406|NCT00855010|Pioglitazone|pioglitazone|mesh-list
154729407|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729408|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729409|NCT00842608|Haloperidol|haloperidol|mesh-list
154729410|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
154729411|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154729412|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
154729413|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
154729414|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729415|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729416|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729417|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154729418|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154729419|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729420|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729421|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154729422|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
154729423|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729424|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729425|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154729426|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
154729427|NCT00856024|Ribavirin|ribavirin|mesh-list
154729428|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154729429|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
154729430|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729431|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
154729432|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729433|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
154729434|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154729435|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154729436|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154729437|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729438|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729439|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
154729440|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729441|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729442|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154729443|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729444|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
154729445|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154729446|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729447|NCT00857272|Bisacodyl|bisacodyl|mesh-list
153771535|NCT02210260|Heroin|heroin|mesh-list
154729448|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154729449|NCT00857272|Cathartics|cathartics|mesh-ancestor
154729450|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729451|NCT00857272|Laxatives|laxatives|mesh-ancestor
154729452|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
154729453|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154729454|NCT03696784|Fludarabine|fludarabine|mesh-list
154729455|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154729456|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
154729457|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729458|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729459|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154729460|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
154729461|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729462|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729463|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154729464|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
154729465|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154729466|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154729467|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154729468|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
154729469|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729470|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729471|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729472|NCT04400890|Vitamin D|vitamin d|mesh-list
154729473|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
154729474|NCT04400890|Resveratrol|resveratrol|mesh-list
154729475|NCT04400890|Vitamins|vitamins|mesh-ancestor
154729476|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
154729477|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729478|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154729479|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154729480|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
154729481|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729482|NCT04400890|Protective Agents|protective agents|mesh-ancestor
154729483|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729484|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154729485|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154729486|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729487|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729488|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729489|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154729490|NCT00890656|Dexamethasone|dexamethasone|mesh-list
154729491|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
154729492|NCT00890656|Doxorubicin|doxorubicin|mesh-list
154729493|NCT00890656|Methotrexate|methotrexate|mesh-list
154729494|NCT00890656|Vincristine|vincristine|mesh-list
154729495|NCT00890656|Asparaginase|asparaginase|mesh-list
154729496|NCT00890656|Pegaspargase|pegaspargase|mesh-list
154729497|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154729498|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
154729499|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729500|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729501|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154729502|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
154729503|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729504|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729505|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154729506|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729507|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
154729508|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
154729509|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729510|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729511|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
154729512|NCT00890656|Hormones|hormones|mesh-ancestor
153608799|NCT01942551|Urological Agents|urological agents|mesh-ancestor
153771743|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154729513|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729514|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154729515|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729516|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154729517|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154729518|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154729519|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154729520|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
154729521|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154729522|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154729523|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
154729524|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
154729525|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154729526|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154729527|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154729528|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
154729529|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
154729530|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
154729531|NCT00814138|Methotrexate|methotrexate|mesh-list
154729532|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154729533|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
154729534|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154729535|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729536|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154729537|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
154729538|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729539|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729540|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
154729541|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729542|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154729543|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154729544|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
154729545|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729546|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154729547|NCT00860938|Budesonide|budesonide|mesh-list
154729548|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729549|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154729550|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
154729551|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729552|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729553|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154729554|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
154729555|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
154729556|NCT00860938|Hormones|hormones|mesh-ancestor
154729557|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729558|NCT01719757|Oxycodone|oxycodone|mesh-list
154729559|NCT01719757|Naloxone|naloxone|mesh-list
154729560|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154729561|NCT01719757|Narcotics|narcotics|mesh-ancestor
154729562|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729563|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729564|NCT01719757|Analgesics|analgesics|mesh-ancestor
154729565|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
154729566|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729567|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154729568|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154729569|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154729570|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729571|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154729572|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154729573|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729574|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729575|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
154729576|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729577|NCT00862810|Vaccines|vaccines|mesh-list
154729578|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
154729579|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729580|NCT00863122|Lapatinib|lapatinib|mesh-list
154729581|NCT00863122|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154729582|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154729583|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729584|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729585|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729586|NCT01604785|Dopamine|dopamine|mesh-list
154729587|NCT01604785|Propofol|propofol|mesh-list
154729588|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
154729589|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154729590|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729591|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729592|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154729593|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
154729594|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
154729595|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154729596|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
154729597|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
154729598|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729599|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
154729600|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729601|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729602|NCT01604785|Protective Agents|protective agents|mesh-ancestor
154729603|NCT01681849|Paroxetine|paroxetine|mesh-list
154729604|NCT01681849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154729605|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154729606|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729607|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729608|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729609|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
154729610|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729611|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154729612|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
154729613|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729614|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154729615|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154729616|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729617|NCT00863356|Hemostatics|hemostatics|mesh-list
154729618|NCT00863356|Chitosan|chitosan|mesh-list
154729619|NCT00863356|Coagulants|coagulants|mesh-ancestor
154729620|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154729621|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154729622|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
154729623|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729624|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154729625|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
154729626|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
154729627|NCT00863434|Cytarabine|cytarabine|mesh-list
154729628|NCT00863434|Clofarabine|clofarabine|mesh-list
154729629|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154729630|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
154729631|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729632|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729633|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
154729634|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729635|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154729636|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
154729637|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729638|NCT04209790|Temozolomide|temozolomide|mesh-list
154729639|NCT04209790|Benzolamide|benzolamide|mesh-list
154729640|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154729641|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
154729642|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729643|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729644|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154729645|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729646|NCT01718353|Prednisone|prednisone|mesh-list
154729647|NCT01718353|Docetaxel|docetaxel|mesh-list
154729648|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729649|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
154729650|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
154729651|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
154729652|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729653|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729654|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
154729655|NCT01718353|Hormones|hormones|mesh-ancestor
154729656|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729657|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729658|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154729659|NCT01716715|Paclitaxel|paclitaxel|mesh-list
154729660|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154729661|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154729662|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729663|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
154729664|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
154729665|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
154729666|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729667|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
154729668|NCT01696279|Calcium|calcium|mesh-list
154729669|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154729670|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729671|NCT01696279|Antacids|antacids|mesh-ancestor
153796033|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
154729672|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729673|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729674|NCT01936181|Infliximab|infliximab|mesh-list
154729675|NCT01936181|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154729676|NCT01936181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729677|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
154729678|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729679|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729680|NCT01696045|Ipilimumab|ipilimumab|mesh-list
154729681|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154729682|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729683|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154729684|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729685|NCT01935947|Gemcitabine|gemcitabine|mesh-list
154729686|NCT01935947|Azacitidine|azacitidine|mesh-list
154729687|NCT01935947|Docetaxel|docetaxel|mesh-list
154729688|NCT01935947|Irinotecan|irinotecan|mesh-list
154729689|NCT01935947|Pemetrexed|pemetrexed|mesh-list
154729690|NCT01935947|Camptothecin|camptothecin|mesh-list
154729691|NCT01935947|Entinostat|entinostat|mesh-list
154729692|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154729693|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154729694|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
154729695|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729696|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729697|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
154729698|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
154729699|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
154729700|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154729701|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154729702|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729703|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154729704|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154729705|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154729706|NCT02986321|Budesonide|budesonide|mesh-list
154729707|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729708|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154729709|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
154729710|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729711|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729712|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154729713|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
154729714|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
154729715|NCT02986321|Hormones|hormones|mesh-ancestor
154729716|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729717|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154729718|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154729719|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729720|NCT01951157|Gemcitabine|gemcitabine|mesh-list
154729721|NCT01951157|Docetaxel|docetaxel|mesh-list
154729722|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154729723|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
154729724|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729725|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729726|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
154729727|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
154729728|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
154729729|NCT01363349|Risperidone|risperidone|mesh-list
154729730|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154729731|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
154729732|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729733|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729734|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729735|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154729736|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154729737|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729738|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729739|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154729740|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
154729741|NCT00818272|Infliximab|infliximab|mesh-list
154729742|NCT00818272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154729743|NCT00818272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729744|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
154729745|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729746|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729747|NCT00868348|Ketorolac|ketorolac|mesh-list
154729748|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154729749|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154729750|NCT00868348|Analgesics|analgesics|mesh-ancestor
154729751|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
154729752|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729753|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729754|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729755|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729756|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154729757|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729758|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729759|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
154729760|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729761|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729762|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154729763|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154729764|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729765|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729766|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729767|NCT01933919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154729768|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154729769|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729770|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729771|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
154729772|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154729773|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
154729774|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154729775|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154729776|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154729777|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
154729778|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154729779|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729780|NCT01933217|Methylphenidate|methylphenidate|mesh-list
154729781|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154729782|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729783|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154729784|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154729785|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729786|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729787|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
154729788|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729789|NCT01949051|Levocabastine|levocabastine|mesh-list
154729790|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154729791|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154729792|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
154729793|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
154729794|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729795|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729796|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729797|NCT01692301|Amlodipine|amlodipine|mesh-list
154729798|NCT01692301|Valsartan|valsartan|mesh-list
154729799|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154729800|NCT01692301|Olmesartan|olmesartan|mesh-list
154729801|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154729802|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154729803|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154729804|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154729805|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729806|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729807|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154729808|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729809|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
154729810|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154729811|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154729812|NCT01692301|Diuretics|diuretics|mesh-ancestor
154729813|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
154729814|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154729815|NCT01592773|Memantine|memantine|mesh-list
154729816|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154729817|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154729818|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
154729819|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729820|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729821|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729822|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154729823|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154729824|NCT01592695|Ethanol|ethanol|mesh-list
154729825|NCT01592695|Bupropion|bupropion|mesh-list
154729826|NCT01592695|Nicotine|nicotine|mesh-list
154729827|NCT01592695|Varenicline|varenicline|mesh-list
154729828|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154729829|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
154729830|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729831|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729832|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154729833|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154729834|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
154729835|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729836|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729837|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154729838|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729839|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729840|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154729841|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
154729842|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729843|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154729844|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154729845|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154729846|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
154729847|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154729848|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154729849|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729850|NCT01929863|Metformin|metformin|mesh-list
154729851|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729852|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729854|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729855|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154729856|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729857|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729858|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
154729859|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
154729860|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729861|NCT04768075|Paclitaxel|paclitaxel|mesh-list
154729862|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154729863|NCT04768075|Carboplatin|carboplatin|mesh-list
154729864|NCT04768075|Pemetrexed|pemetrexed|mesh-list
154729865|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154729866|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729867|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
154729868|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
154729869|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
154729870|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729871|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729872|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154729873|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154729874|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154729875|NCT01592383|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154729876|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154729877|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729878|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729879|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729880|NCT01929317|Ropinirole|ropinirole|mesh-list
154729881|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154729882|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154729883|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
154729884|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
154729885|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729886|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729887|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729888|NCT01711879|Aflibercept|aflibercept|mesh-list
154729889|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154729890|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154729891|NCT01711879|Growth Substances|growth substances|mesh-ancestor
154729892|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729893|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
154729894|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154729895|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
154729896|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154729897|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729898|NCT01689649|Topiramate|topiramate|mesh-list
154729899|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
154729900|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729901|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729902|NCT01929083|Ibutilide|ibutilide|mesh-list
154729903|NCT01929083|Progesterone|progesterone|mesh-list
154729904|NCT01929083|Progestins|progestins|mesh-ancestor
154729905|NCT01929083|Hormones|hormones|mesh-ancestor
154729906|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729907|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729908|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154729909|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
154729910|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729911|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729912|NCT00891436|Fluticasone|fluticasone|mesh-list
154729913|NCT00891436|Xhance|xhance|mesh-list
154729914|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729915|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154729916|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
154729917|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729918|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729919|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154729920|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
154729921|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
154729922|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154729923|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
154729924|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154729925|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
154729926|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729927|NCT01711645|Antacids|antacids|mesh-ancestor
154729928|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729929|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154729930|NCT00820534|Penciclovir|penciclovir|mesh-list
154729931|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
154729932|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154729933|NCT01590433|Exenatide|exenatide|mesh-list
154729934|NCT01590433|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154729935|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154729936|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729937|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154729938|NCT01590433|Incretins|incretins|mesh-ancestor
154729939|NCT01590433|Hormones|hormones|mesh-ancestor
154729940|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154729941|NCT00820612|Indomethacin|indomethacin|mesh-list
154729942|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154729943|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154729944|NCT00820612|Analgesics|analgesics|mesh-ancestor
154729945|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
154729946|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729947|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729948|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154729949|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154729950|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
154729951|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
154729952|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154729953|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154729954|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154729955|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729956|NCT01928927|Telmisartan|telmisartan|mesh-list
154729957|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154729958|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154729959|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154729960|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729961|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
154729962|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154729963|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729964|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729965|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154729966|NCT00871624|Analgesics|analgesics|mesh-ancestor
154729967|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
154729968|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154729969|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154729970|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154729971|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154729972|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
154729973|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729974|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729975|NCT01710709|Aripiprazole|aripiprazole|mesh-list
154729976|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
154729977|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154729978|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154729979|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154729980|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154729981|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154729982|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
154729983|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
154729984|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154729985|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154729986|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154729987|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154729988|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
154729989|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154729990|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154729991|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154729992|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154729993|NCT01709695|Guanfacine|guanfacine|mesh-list
154729994|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154729995|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154729996|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154729997|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153772329|NCT00211952|Analgesics|analgesics|mesh-ancestor
154729998|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
154729999|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730000|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730001|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730002|NCT05236504|Melatonin|melatonin|mesh-list
154730003|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
154730004|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730005|NCT05236504|Protective Agents|protective agents|mesh-ancestor
154730006|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730007|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730008|NCT01685983|Prednisolone|prednisolone|mesh-list
154730009|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
154730010|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730011|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
154730012|NCT01685983|Hormones|hormones|mesh-ancestor
154730013|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730014|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730015|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154730016|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730017|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154730018|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730019|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730020|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
154730021|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154730022|NCT02151448|Interferons|interferons|mesh-list
154730023|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
154730024|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
154730025|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154730026|NCT02151448|Celecoxib|celecoxib|mesh-list
154730027|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730028|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
154730029|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730030|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
154730031|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730032|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154730033|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730034|NCT02151448|Analgesics|analgesics|mesh-ancestor
154730035|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
154730036|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730037|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730038|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730039|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154730040|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154730041|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730042|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730043|NCT00875212|Calcium|calcium|mesh-list
154730044|NCT00875212|Fluorides|fluorides|mesh-list
154730045|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
154730046|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154730047|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730048|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
154730049|NCT00875212|Protective Agents|protective agents|mesh-ancestor
154730050|NCT00875836|Buspirone|buspirone|mesh-list
154730051|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154730052|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154730053|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730054|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730055|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154730056|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154730057|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
154730058|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730059|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730060|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
154730061|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
154730062|NCT01685203|Ribavirin|ribavirin|mesh-list
154730063|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
154730064|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730065|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
154730066|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730067|NCT01928771|Benralizumab|benralizumab|mesh-list
154730068|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154730069|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
154730070|NCT01589653|Insulin|insulin|mesh-list
154730071|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154730072|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
154730073|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
154730074|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154730075|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
154860369|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730076|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154730077|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
154730078|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154730079|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730080|NCT01928615|Trastuzumab|trastuzumab|mesh-list
154730081|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154730082|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730083|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730084|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
154730085|NCT01589497|Rifampin|rifampin|mesh-list
154730086|NCT01589497|Isoniazid|isoniazid|mesh-list
154730087|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
154730088|NCT01589497|Ethambutol|ethambutol|mesh-list
154730089|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154730090|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730091|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154730092|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154730093|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730094|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730095|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730096|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154730097|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
154730098|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
154730099|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154730100|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154730101|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154730102|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154730103|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154730104|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154730105|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154730106|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154730107|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154730108|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
154730109|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154730110|NCT01928381|Pregabalin|pregabalin|mesh-list
154730111|NCT01928381|Analgesics|analgesics|mesh-ancestor
154730112|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
154730113|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730114|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730115|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
154730116|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154730117|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730118|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730119|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154730120|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154730121|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154730122|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730123|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154730124|NCT01928225|Vaccines|vaccines|mesh-list
154730125|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
154730126|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730127|NCT01927757|Etanercept|etanercept|mesh-list
154730128|NCT01927757|Methotrexate|methotrexate|mesh-list
154730129|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154730130|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
154730131|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154730132|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730133|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154730134|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
154730135|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730136|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730137|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
154730138|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730139|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154730140|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730141|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
154730142|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730143|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154730144|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154730145|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730146|NCT01927757|Analgesics|analgesics|mesh-ancestor
154730147|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
154730148|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482086|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730149|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730150|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154730151|NCT01913639|Leucovorin|leucovorin|mesh-list
154730152|NCT01913639|Fluorouracil|fluorouracil|mesh-list
154730153|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
154730154|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
154730155|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730156|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154730157|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730158|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730159|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
154730160|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730161|NCT01913639|Antidotes|antidotes|mesh-ancestor
154730162|NCT01913639|Protective Agents|protective agents|mesh-ancestor
154730163|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
154730164|NCT01913639|Vitamins|vitamins|mesh-ancestor
154730165|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
154730166|NCT01913483|Heparin|heparin|mesh-list
154730167|NCT01913483|Calcium heparin|calcium heparin|mesh-list
154730168|NCT01913483|Bivalirudin|bivalirudin|mesh-list
154730169|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
154730170|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154730171|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154730172|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730173|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
154730174|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154730175|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730176|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730177|NCT01913405|Factor VIII|factor viii|mesh-list
153772640|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
154730178|NCT01913405|BAX 855|bax 855|mesh-list
154730179|NCT01913405|Coagulants|coagulants|mesh-ancestor
154730180|NCT01927055|Mannitol|mannitol|mesh-list
154730181|NCT01927055|Droxidopa|droxidopa|mesh-list
154730182|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154730183|NCT01927055|Diuretics|diuretics|mesh-ancestor
154730184|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
154730185|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730186|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154730187|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154730188|NCT01913327|Risperidone|risperidone|mesh-list
154730189|NCT01913327|Aripiprazole|aripiprazole|mesh-list
154730190|NCT01913327|Modafinil|modafinil|mesh-list
154730191|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154730192|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
154730193|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730194|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730195|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730196|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154730197|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154730198|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730199|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154730200|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154730201|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
154730202|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
154730203|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
154730204|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154730205|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154730206|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154730207|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154730208|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154730209|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154730210|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154730211|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154730212|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154730213|NCT01911845|Ribavirin|ribavirin|mesh-list
154730214|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
154730215|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730216|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
154730217|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730218|NCT01925183|Interferons|interferons|mesh-list
154730219|NCT01925183|Ribavirin|ribavirin|mesh-list
154730220|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
154482160|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730221|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
154730222|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154730223|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730224|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
154730225|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730226|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
154730227|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730228|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
154730229|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730231|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
154730232|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730233|NCT01910441|Metformin|metformin|mesh-list
154730234|NCT01910441|Glimepiride|glimepiride|mesh-list
154730235|NCT01910441|Vildagliptin|vildagliptin|mesh-list
154730236|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154730237|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730238|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154730239|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730240|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
154730241|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154730242|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730243|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730244|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730245|NCT01923467|Nicotine|nicotine|mesh-list
154730246|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154730247|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
154730248|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730249|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730250|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154730251|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154730252|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
154730253|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730254|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730255|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
154730256|NCT01908803|Dexamethasone|dexamethasone|mesh-list
154730257|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730258|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
154730259|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
154730260|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730261|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730262|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154730263|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
154730264|NCT01908803|Hormones|hormones|mesh-ancestor
154730265|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730266|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154730267|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730268|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154730269|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730270|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154730271|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154730272|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730273|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730274|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154730275|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154730276|NCT01908101|Halichondrin B|halichondrin b|mesh-list
154730277|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
154730278|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
154730279|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
154730280|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730281|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730282|NCT01588951|Cytarabine|cytarabine|mesh-list
154730283|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154730284|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
154730285|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730286|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730287|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
154730288|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730289|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730290|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
154730291|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730292|NCT01588405|Treprostinil|treprostinil|mesh-list
154730293|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154730294|NCT01923311|Elvitegravir|elvitegravir|mesh-list
154730295|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154730296|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154730297|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
154730298|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482237|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
154730299|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154730300|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730301|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730302|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
154730303|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154730304|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154730305|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154730306|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730307|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730308|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
154730309|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730310|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730311|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154730312|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730313|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
154730314|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154730315|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154730316|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154730317|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154730318|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730319|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730320|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
154730321|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730322|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730323|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154730324|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730325|NCT01921829|Diuretics|diuretics|mesh-list
154730326|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
154730327|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730328|NCT01904903|Trastuzumab|trastuzumab|mesh-list
154730329|NCT01904903|Pertuzumab|pertuzumab|mesh-list
154730330|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154730331|NCT01904903|Maytansine|maytansine|mesh-list
154730332|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730333|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730334|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154730335|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
154730336|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
154730337|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
154730338|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730339|NCT01904903|Immunotoxins|immunotoxins|mesh-ancestor
154730340|NCT01904903|Immunoconjugates|immunoconjugates|mesh-ancestor
154730341|NCT01904903|Immunologic Factors|immunologic factors|mesh-ancestor
154730342|NCT01904903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730343|NCT01921205|Lacosamide|lacosamide|mesh-list
154730344|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
154730345|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154730346|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154730347|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730348|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730349|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
154730350|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154730351|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730352|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
154730353|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154730354|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
154730355|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730356|NCT01709305|Metformin|metformin|mesh-list
154730357|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154730358|NCT01709305|Glimepiride|glimepiride|mesh-list
154730359|NCT01709305|Acarbose|acarbose|mesh-list
154730360|NCT01709305|Repaglinide|repaglinide|mesh-list
154730361|NCT01709305|Gliclazide|gliclazide|mesh-list
154730362|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154730363|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730364|NCT01709305|Incretins|incretins|mesh-ancestor
153772908|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
154730365|NCT01709305|Hormones|hormones|mesh-ancestor
154730366|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730367|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154730368|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730369|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730370|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730371|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154730372|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730373|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
154730374|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154730375|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
154730376|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154730377|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
154730378|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154730379|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730380|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730381|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730382|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
154730383|NCT01709227|Furosemide|furosemide|mesh-list
154730384|NCT01709227|Diuretics|diuretics|mesh-ancestor
154730385|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
154730386|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730387|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154730388|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730389|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730390|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
154730391|NCT00879034|Pravastatin|pravastatin|mesh-list
154730392|NCT00879034|Lonafarnib|lonafarnib|mesh-list
154730393|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154730394|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730395|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154730396|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154730397|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
154730398|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730399|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154730400|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154730401|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730402|NCT00879190|Gentamicins|gentamicins|mesh-list
154730403|NCT00879190|Ampicillin|ampicillin|mesh-list
154730404|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154730405|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730406|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154730407|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730408|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730409|NCT01903811|Dexamethasone|dexamethasone|mesh-list
154730410|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
154730411|NCT01903811|Ichthammol|ichthammol|mesh-list
154730412|NCT01903811|BB 1101|bb 1101|mesh-list
154730413|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730414|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
154730415|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
154730416|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730417|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772977|NCT00215267|Praziquantel|praziquantel|mesh-list
154730418|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154730419|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
154730420|NCT01903811|Hormones|hormones|mesh-ancestor
154730421|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730422|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154730423|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730424|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730425|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730426|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730427|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154730428|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
154730429|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730430|NCT01709149|Riluzole|riluzole|mesh-list
154730431|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
154730432|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154730433|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154730434|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730435|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730436|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730437|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154730438|NCT01709149|Protective Agents|protective agents|mesh-ancestor
154730439|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
154730440|NCT05214196|Povidone|povidone|mesh-list
154730441|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
154730442|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
154730443|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154730444|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730445|NCT04382014|Curcumin|curcumin|mesh-list
154730446|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154730447|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730448|NCT04382014|Analgesics|analgesics|mesh-ancestor
154730449|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
154730450|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730451|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730452|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730453|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730454|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730455|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730456|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730457|NCT00892606|Morphine|morphine|mesh-list
154730458|NCT00892606|Methadone|methadone|mesh-list
154730459|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154730460|NCT00892606|Narcotics|narcotics|mesh-ancestor
154730461|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730462|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730463|NCT00892606|Analgesics|analgesics|mesh-ancestor
154730464|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
154730465|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730466|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
154730467|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
154730468|NCT04416035|Paclitaxel|paclitaxel|mesh-list
154730469|NCT04416035|Bevacizumab|bevacizumab|mesh-list
154730470|NCT04416035|Carboplatin|carboplatin|mesh-list
154730471|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154730472|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730473|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
154730474|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
154730475|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
154730476|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730477|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730478|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154730479|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154730480|NCT04416035|Growth Substances|growth substances|mesh-ancestor
154730481|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730482|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
154730483|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
154730484|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154730485|NCT04381858|Antibodies|antibodies|mesh-list
154730486|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
154730487|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730488|NCT01903031|Ritonavir|ritonavir|mesh-list
154730489|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154730490|NCT01903031|Tenofovir|tenofovir|mesh-list
154730491|NCT01903031|Efavirenz|efavirenz|mesh-list
154730492|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154730493|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154730494|NCT01903031|Etonogestrel|etonogestrel|mesh-list
154730495|NCT01903031|NuvaRing|nuvaring|mesh-list
154730496|NCT01903031|Estradiol|estradiol|mesh-list
154730497|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154730498|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154730499|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730500|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730501|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730502|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154730503|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154730504|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
154730505|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730506|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154730507|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154730508|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154730509|NCT01903031|Estrogens|estrogens|mesh-ancestor
154730510|NCT01903031|Hormones|hormones|mesh-ancestor
154730511|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730512|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730513|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154730514|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
154730515|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154730516|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154730517|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154730518|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154730519|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154730520|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154730521|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154730522|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154730523|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154730524|NCT00883168|Fluticasone|fluticasone|mesh-list
154730525|NCT00883168|Xhance|xhance|mesh-list
154482452|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154730526|NCT00883168|Azelastine|azelastine|mesh-list
154730527|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730528|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154730529|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
154730530|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730531|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730532|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154730533|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
154730534|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
154730535|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154730536|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154730537|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730538|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730539|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154730540|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154730541|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
154730542|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
154730543|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730544|NCT01616693|Zinc|zinc|mesh-list
154730545|NCT01616693|Vaccines|vaccines|mesh-list
154730546|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
154730547|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730548|NCT01616693|Trace Elements|trace elements|mesh-ancestor
154730549|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
154730550|NCT00893074|Dronabinol|dronabinol|mesh-list
154730551|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
154730552|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730553|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154730554|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730555|NCT00893074|Analgesics|analgesics|mesh-ancestor
154730556|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
154730557|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730558|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154730559|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154730560|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730561|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730562|NCT00893074|Hormones|hormones|mesh-ancestor
154730563|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730564|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
154730565|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154730566|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154730567|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730568|NCT00887458|Itraconazole|itraconazole|mesh-list
154730569|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154730570|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
154730571|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730572|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154730573|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154730574|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730575|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730576|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154730577|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
153773129|NCT04667299|Diuretics|diuretics|mesh-ancestor
154730578|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730579|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730580|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154730581|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
154730582|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154730583|NCT03216304|Calcium|calcium|mesh-list
154730584|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154730585|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730586|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154730587|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154730588|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154730589|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
154730590|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730591|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154730592|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154730593|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730594|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
154730595|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154730596|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
154730597|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482534|NCT05699356|Estrogens|estrogens|mesh-list
154730598|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730599|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154730600|NCT03216538|Protective Agents|protective agents|mesh-ancestor
154730601|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154730602|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154730603|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730604|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730605|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
154730606|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730607|NCT03218722|Thrombin|thrombin|mesh-list
154730608|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
154730609|NCT03218722|Coagulants|coagulants|mesh-ancestor
154730610|NCT00888628|Etanercept|etanercept|mesh-list
154730611|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154730612|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730613|NCT00888628|Analgesics|analgesics|mesh-ancestor
154730614|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
154730615|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730616|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730617|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730618|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730619|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154730620|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730621|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
154730622|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
154730623|NCT03837886|Calcium|calcium|mesh-list
154730624|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154730625|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730626|NCT03837886|Antacids|antacids|mesh-ancestor
154730627|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730628|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154730629|NCT03219970|Osimertinib|osimertinib|mesh-list
154730630|NCT03219970|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154730631|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154730632|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730633|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730634|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730635|NCT00889330|Alcaftadine|alcaftadine|mesh-list
154730636|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154730637|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
154730638|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
154730639|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730640|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730641|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730642|NCT03219580|Fluorouracil|fluorouracil|mesh-list
154730643|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
154730644|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730645|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154730646|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730647|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730648|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
154730649|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730650|NCT03215446|Anesthetics|anesthetics|mesh-list
154730651|NCT03215446|Propofol|propofol|mesh-list
154730652|NCT03215446|Sevoflurane|sevoflurane|mesh-list
154730653|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730654|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730655|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154730656|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154730657|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
154730658|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154730659|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154730660|NCT00896038|Aprepitant|aprepitant|mesh-list
154730661|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
154730662|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
154730663|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730664|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730665|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154730666|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154730667|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730668|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730669|NCT04381234|Citric Acid|citric acid|mesh-list
154730670|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
154730671|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
154730672|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
154730673|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154730674|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
154730675|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
154730676|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730677|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154730678|NCT01616459|Vaccines|vaccines|mesh-list
154730679|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154730680|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
154730681|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730682|NCT03218254|Methylphenidate|methylphenidate|mesh-list
154730683|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154730684|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730685|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154730686|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154730687|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730688|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730689|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
154730690|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730691|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
154730692|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154730693|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
154730694|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
154730695|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730696|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730697|NCT01919801|Icatibant|icatibant|mesh-list
154730698|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154730699|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730700|NCT01919801|Analgesics|analgesics|mesh-ancestor
154730701|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
154730702|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730703|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730704|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730705|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730706|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154730707|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154730708|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730709|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154730710|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730711|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
154730712|NCT01919723|Ticagrelor|ticagrelor|mesh-list
154730713|NCT01919723|Eptifibatide|eptifibatide|mesh-list
154730714|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154730715|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154730716|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154730717|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154730718|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
154730719|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730720|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730721|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730722|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
154730723|NCT01919489|Liraglutide|liraglutide|mesh-list
154730724|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154730725|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730726|NCT01919489|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154730727|NCT01919489|Incretins|incretins|mesh-ancestor
154730728|NCT01919489|Hormones|hormones|mesh-ancestor
154730729|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730730|NCT01919411|Amoxicillin|amoxicillin|mesh-list
154730731|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
154730732|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
154730733|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154730734|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154730735|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730736|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154730737|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730738|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730739|NCT01901393|Ibuprofen|ibuprofen|mesh-list
154730740|NCT01901393|Ketorolac|ketorolac|mesh-list
154730741|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154730742|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154730743|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730744|NCT01901393|Analgesics|analgesics|mesh-ancestor
154730745|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
154730746|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730747|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730748|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730749|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730750|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154730751|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730752|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730753|NCT01890707|Anesthetics|anesthetics|mesh-list
154730754|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730755|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730756|NCT01890473|Abatacept|abatacept|mesh-list
154730757|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154730758|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730759|NCT01890473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730760|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730761|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730762|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
154730763|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730764|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730765|NCT01889069|Prednisone|prednisone|mesh-list
154730766|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
154730767|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154730768|NCT01889069|Rituximab|rituximab|mesh-list
154730769|NCT01889069|Doxorubicin|doxorubicin|mesh-list
154730770|NCT01889069|Vincristine|vincristine|mesh-list
154730771|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154730772|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
154730773|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730774|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730775|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154730776|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
154730777|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730778|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730779|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154730780|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730781|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154730782|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154730783|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154730784|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730785|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730786|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
154730787|NCT01889069|Hormones|hormones|mesh-ancestor
154730788|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730789|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154730790|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154730791|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
154730792|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
154730793|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
154730794|NCT00898222|Aspirin|aspirin|mesh-list
154730795|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154730796|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730797|NCT00898222|Analgesics|analgesics|mesh-ancestor
154730798|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
154730799|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730800|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730801|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730802|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730803|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154730804|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154730805|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730806|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154730807|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154730808|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730809|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
154730810|NCT01830556|Cetuximab|cetuximab|mesh-list
154730811|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730812|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730813|NCT03217942|Mitogens|mitogens|mesh-list
154730814|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
154730815|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730816|NCT00903448|Omeprazole|omeprazole|mesh-list
154730817|NCT00903448|Lansoprazole|lansoprazole|mesh-list
154730818|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154730819|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154730820|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154730821|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730822|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730824|NCT00895180|Olaratumab|olaratumab|mesh-list
154730825|NCT00895180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154730826|NCT00895180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154730827|NCT00895180|Growth Substances|growth substances|mesh-ancestor
154730828|NCT00895180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730829|NCT00895180|Growth Inhibitors|growth inhibitors|mesh-ancestor
154730830|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730831|NCT01830868|Zonisamide|zonisamide|mesh-list
154730832|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
154730833|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154730834|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730835|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730836|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154730837|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730838|NCT03213964|Interleukin-2|interleukin-2|mesh-list
154730839|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730840|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730841|NCT03213964|Analgesics|analgesics|mesh-ancestor
154730842|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
154730843|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730844|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730845|NCT03217474|Ganciclovir|ganciclovir|mesh-list
154730846|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154730847|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
154730848|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730849|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154730850|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730851|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730852|NCT01830946|Caseins|caseins|mesh-list
154730853|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
154730854|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
154730855|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730856|NCT03213886|Vitamin D|vitamin d|mesh-list
154730857|NCT03213886|Calcifediol|calcifediol|mesh-list
154730858|NCT03213886|Vitamins|vitamins|mesh-ancestor
154730859|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
154730860|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730861|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154730862|NCT03217084|Fluorides|fluorides|mesh-list
154730863|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
154730864|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
154730865|NCT03217084|Protective Agents|protective agents|mesh-ancestor
154730866|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730867|NCT00899470|Metformin|metformin|mesh-list
154730868|NCT00899470|Saxagliptin|saxagliptin|mesh-list
154730869|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154730870|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730871|NCT00899470|Incretins|incretins|mesh-ancestor
154730872|NCT00899470|Hormones|hormones|mesh-ancestor
154730873|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154730874|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154730875|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730876|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730877|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730878|NCT01738646|Bevacizumab|bevacizumab|mesh-list
154730879|NCT01738646|Vorinostat|vorinostat|mesh-list
154730880|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730881|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730882|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154730883|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154730884|NCT01738646|Growth Substances|growth substances|mesh-ancestor
154730885|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730886|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
153773583|NCT00241332|Fentanyl|fentanyl|mesh-list
154730887|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154730888|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730889|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730890|NCT00904618|Lidocaine|lidocaine|mesh-list
154730891|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
154730892|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
154730893|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154730894|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730895|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
154730896|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730897|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154730898|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154730899|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154730900|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730901|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730902|NCT01839370|Pramlintide|pramlintide|mesh-list
154730903|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154730904|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730905|NCT00907426|Bimatoprost|bimatoprost|mesh-list
154730906|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154730907|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154730908|NCT01832662|Caffeine|caffeine|mesh-list
154730909|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154730910|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730911|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154730912|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730913|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730914|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154730915|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154730916|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
154730917|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154730918|NCT00909064|PENTA|penta|mesh-list
154730919|NCT00909064|Fondaparinux|fondaparinux|mesh-list
154730920|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154730921|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
154730922|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154730923|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730924|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730925|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730926|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
154730927|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154730928|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154730929|NCT01832896|Ecallantide|ecallantide|mesh-list
154730930|NCT01832896|Analgesics|analgesics|mesh-ancestor
154730931|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
154730932|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154730933|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730934|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154730935|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154730936|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154730937|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730938|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154730939|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
154730940|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154730941|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154730942|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154730943|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730944|NCT01830478|Rituximab|rituximab|mesh-list
154730945|NCT01830478|Lenalidomide|lenalidomide|mesh-list
154730946|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730947|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730948|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
154730949|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730950|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154730951|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154730952|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154730953|NCT01830478|Growth Substances|growth substances|mesh-ancestor
154730954|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
154730955|NCT04426695|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154730956|NCT04426695|Antiviral Agents|antiviral agents|mesh-ancestor
154730957|NCT04426695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730958|NCT01838200|Isoniazid|isoniazid|mesh-list
154730959|NCT01838200|Ipilimumab|ipilimumab|mesh-list
154730960|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
154730961|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154730962|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154730963|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154730964|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730965|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
154730966|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154730967|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154730968|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154730969|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154730970|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
154730971|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154730972|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154730973|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
154730974|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730975|NCT01720030|Simendan|simendan|mesh-list
154730976|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154730977|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
154730978|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154730979|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153773770|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730980|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730981|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730982|NCT01720030|Protective Agents|protective agents|mesh-ancestor
154730983|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154730984|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
154730985|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154730986|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
154730987|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154730988|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
154730989|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154730990|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154730991|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
154730992|NCT04380220|Protein C|protein c|mesh-list
154730993|NCT04380220|Antithrombins|antithrombins|mesh-list
154730994|NCT04380220|Protein S|protein s|mesh-list
154730995|NCT04380220|Factor VIII|factor viii|mesh-list
154730996|NCT04380220|Complement C3|complement c3|mesh-list
154730997|NCT04380220|Coagulants|coagulants|mesh-ancestor
154730998|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154730999|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731000|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154731001|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
154731002|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731003|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
154731004|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154731005|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
154731006|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731007|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154731008|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
154731009|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154731010|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731011|NCT01671813|Immunotoxins|immunotoxins|mesh-ancestor
154731012|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
154731013|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731014|NCT03830398|Acetaminophen|acetaminophen|mesh-list
154731015|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731016|NCT03830398|Analgesics|analgesics|mesh-ancestor
154731017|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
154731018|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731019|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731020|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
154731021|NCT04405323|Itraconazole|itraconazole|mesh-list
154731022|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
154731023|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773772|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
154731024|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154731025|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154731026|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731027|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731028|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154731029|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
154731030|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731031|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731032|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154731033|NCT01720498|Remifentanil|remifentanil|mesh-list
154731034|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154731035|NCT01720498|Narcotics|narcotics|mesh-ancestor
154731036|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731037|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731038|NCT01720498|Analgesics|analgesics|mesh-ancestor
154731039|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
154731040|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731041|NCT01672047|Vitamin D|vitamin d|mesh-list
154731042|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
154731043|NCT01672047|Vitamins|vitamins|mesh-ancestor
154731044|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
154731045|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731046|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154731047|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154731048|NCT00911326|Dextrans|dextrans|mesh-list
154731049|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
154731050|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
154731051|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
154731052|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
154731053|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
154731054|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
154731055|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731056|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154731057|NCT01833676|Sevoflurane|sevoflurane|mesh-list
154731058|NCT01833676|Desflurane|desflurane|mesh-list
154731059|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154731060|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154731061|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
154731062|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
154731063|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731064|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731065|NCT04380376|Melphalan|melphalan|mesh-list
154731066|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154731067|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
154731068|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731069|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731070|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154731071|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154731072|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
154731073|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731074|NCT04380298|Ketorolac|ketorolac|mesh-list
154731075|NCT04380298|Epinephrine|epinephrine|mesh-list
154731076|NCT04380298|Ropivacaine|ropivacaine|mesh-list
154731077|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
154731078|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
154731079|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731080|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731081|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
154731082|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731083|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154731084|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154731085|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154731086|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731087|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731088|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154731089|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154731090|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
154731091|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154731092|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
154731093|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
154731094|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
154731095|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154731096|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154731097|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731098|NCT04380298|Analgesics|analgesics|mesh-ancestor
154731099|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154731100|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731101|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154731102|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731103|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154731104|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154731105|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154731106|NCT03210610|Colchicine|colchicine|mesh-list
154731107|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
154731108|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731109|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
154731110|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
154731111|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
154731112|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731113|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731114|NCT03152955|Sufentanil|sufentanil|mesh-list
154731115|NCT03152955|Ketamine|ketamine|mesh-list
154731116|NCT03152955|Ondansetron|ondansetron|mesh-list
154731117|NCT03152955|Analgesics|analgesics|mesh-ancestor
154731118|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
154731119|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731120|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731121|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154731122|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154731123|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
154731124|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
154731125|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731126|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154731127|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154731128|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731129|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731130|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
154731131|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
154731132|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154731133|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
154731134|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
154731135|NCT03152955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154731136|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154731137|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
154731138|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154731139|NCT03152955|Narcotics|narcotics|mesh-ancestor
154731140|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154731141|NCT01676493|Codeine|codeine|mesh-list
154731142|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154731143|NCT01676493|Narcotics|narcotics|mesh-ancestor
154731144|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731145|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731146|NCT01676493|Analgesics|analgesics|mesh-ancestor
154731147|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
154731148|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731149|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
154731150|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
154731151|NCT01721434|Simendan|simendan|mesh-list
154731152|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154731153|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
154731154|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154731155|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154731156|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731157|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731158|NCT01721434|Protective Agents|protective agents|mesh-ancestor
154731159|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731160|NCT03210532|Amlodipine|amlodipine|mesh-list
154731161|NCT03210532|Telmisartan|telmisartan|mesh-list
154731162|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154731163|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154731164|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154731165|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154731166|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154731167|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731168|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154731169|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731170|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
154731171|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154731172|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154731173|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
154731174|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154731175|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154731176|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731177|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154731178|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154731179|NCT03152565|Avelumab|avelumab|mesh-list
154731180|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154731181|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731182|NCT03210064|Fluorouracil|fluorouracil|mesh-list
154731183|NCT03210064|Apatinib|apatinib|mesh-list
154731184|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
154731185|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731186|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154731187|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731188|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154731189|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
154731190|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731191|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154731192|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731193|NCT05372991|Atropine|atropine|mesh-list
154731194|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154731195|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154731196|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154483155|NCT03389126|Avelumab|avelumab|mesh-list
154731197|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
154731198|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731199|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731200|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154731201|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
154731202|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
154731203|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
154731204|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154731205|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154731206|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
154731207|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731208|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731209|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154731210|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731211|NCT01722448|Choline|choline|mesh-list
154731212|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
154731213|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154731214|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
154731215|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731216|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154731217|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154731218|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
154731219|NCT01834768|Eplerenone|eplerenone|mesh-list
154731220|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154731221|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
154731222|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731223|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731224|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154731225|NCT01834768|Diuretics|diuretics|mesh-ancestor
154731226|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
154731227|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154731228|NCT01672671|Paclitaxel|paclitaxel|mesh-list
154731229|NCT01672671|Doxorubicin|doxorubicin|mesh-list
154731230|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154731231|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731232|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
154731233|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
154731234|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
154731235|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731236|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154731237|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154731238|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154731239|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731240|NCT02459457|Paclitaxel|paclitaxel|mesh-list
154731241|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154731242|NCT02459457|Carboplatin|carboplatin|mesh-list
154731243|NCT02459457|Fluorouracil|fluorouracil|mesh-list
154731244|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154731245|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731246|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
154731247|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
154731248|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
154731249|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731250|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
154731251|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154731252|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154731253|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
154731254|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731255|NCT01835236|Paclitaxel|paclitaxel|mesh-list
154731256|NCT01835236|Vinorelbine|vinorelbine|mesh-list
154731257|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154731258|NCT01835236|Trastuzumab|trastuzumab|mesh-list
154731259|NCT01835236|Pertuzumab|pertuzumab|mesh-list
154731260|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154731261|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731262|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
154731263|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
154731264|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
154731265|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731266|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154731267|NCT01835236|Immunotoxins|immunotoxins|mesh-ancestor
154731268|NCT01835236|Immunoconjugates|immunoconjugates|mesh-ancestor
154731269|NCT01835236|Immunologic Factors|immunologic factors|mesh-ancestor
154731270|NCT01835236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731271|NCT01671891|Capecitabine|capecitabine|mesh-list
154731272|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
154731273|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154731274|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
154731275|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731276|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731277|NCT01830322|Gemcitabine|gemcitabine|mesh-list
154731278|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154731279|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
154731280|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731281|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731282|NCT01835314|Stiripentol|stiripentol|mesh-list
154731283|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
154731284|NCT01706198|Fluticasone|fluticasone|mesh-list
154731285|NCT01706198|Xhance|xhance|mesh-list
154731286|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154731287|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154731288|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
154731289|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731290|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731291|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154731292|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
154731293|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
154731294|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154731295|NCT04378972|Vitamin D|vitamin d|mesh-list
154731296|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
154731297|NCT04378972|Curcumin|curcumin|mesh-list
154731298|NCT04378972|Tramiprosate|tramiprosate|mesh-list
154731299|NCT04378972|Vitamins|vitamins|mesh-ancestor
154731300|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
154731301|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731302|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154731303|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154731304|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154731305|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731306|NCT04378972|Analgesics|analgesics|mesh-ancestor
154731307|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
154731308|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731309|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154731310|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731311|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731312|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731313|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731314|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
154731315|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
154731316|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
154731317|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731318|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
154731319|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
154731320|NCT01723150|Ertapenem|ertapenem|mesh-list
154731321|NCT01723150|Trimethoprim|trimethoprim|mesh-list
154731322|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
154731323|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154731324|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731325|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154731326|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154731327|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731328|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731329|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731330|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154731331|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154731332|NCT01723150|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154731333|NCT01723150|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154731334|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154731335|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
154731336|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154731337|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154731338|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154731339|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154731340|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154731341|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154731342|NCT01835938|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154731343|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154731344|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731345|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731346|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731347|NCT01836016|Fluticasone|fluticasone|mesh-list
154731348|NCT01836016|Xhance|xhance|mesh-list
154731349|NCT01836016|Albuterol|albuterol|mesh-list
154731350|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
154731351|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154731352|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154731353|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154731354|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154731355|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
154731356|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731357|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731358|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154731359|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
154731360|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
154731361|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154731362|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154731363|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154731364|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154731365|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154731366|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731367|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731368|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
154731369|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154731370|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
154731371|NCT01836016|Hormones|hormones|mesh-ancestor
154731372|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731373|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
154731374|NCT01836094|Methylene Blue|methylene blue|mesh-list
154731375|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731376|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731377|NCT01726192|Ropivacaine|ropivacaine|mesh-list
154731378|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
154731379|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
154731380|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731381|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731382|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
154731383|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731384|NCT01836328|Methadone|methadone|mesh-list
154731385|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154731386|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154731387|NCT01836328|Narcotics|narcotics|mesh-ancestor
154731388|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731389|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731390|NCT01836328|Analgesics|analgesics|mesh-ancestor
154731391|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
154731392|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731393|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
154731394|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
154731395|NCT01836406|Ketorolac|ketorolac|mesh-list
154731396|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154731397|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154731398|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731399|NCT01836406|Analgesics|analgesics|mesh-ancestor
154731400|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
154731401|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731402|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731403|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154731404|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731405|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154731406|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731407|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731408|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154731409|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154731410|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731411|NCT01726816|Probucol|probucol|mesh-list
154731412|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154731413|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154731414|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
154731415|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731416|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154731417|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
154731418|NCT01726816|Protective Agents|protective agents|mesh-ancestor
154731419|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731420|NCT00915538|Budesonide|budesonide|mesh-list
154731421|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154731422|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154731423|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154731424|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
154731425|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731426|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731427|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154731428|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
154731429|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
154731430|NCT00915538|Hormones|hormones|mesh-ancestor
154731431|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731432|NCT01724086|Interferons|interferons|mesh-list
154731433|NCT01724086|Ritonavir|ritonavir|mesh-list
154731434|NCT01724086|Ribavirin|ribavirin|mesh-list
154731435|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
153774461|NCT00561964|Irbesartan|irbesartan|mesh-list
154731436|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
154731437|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154731438|NCT01724086|Simeprevir|simeprevir|mesh-list
154731439|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731440|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
154731441|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731442|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154731443|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154731444|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
154731445|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731446|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731447|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154731448|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154731449|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154731450|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154731451|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
154731452|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
154731453|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731454|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154731455|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
154731456|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731457|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731458|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731459|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154731460|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
154731461|NCT01727050|Coagulants|coagulants|mesh-ancestor
154731462|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
154731463|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154731464|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154731465|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731466|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
154731467|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731468|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731469|NCT01837108|Eplerenone|eplerenone|mesh-list
154731470|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154731471|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
154731472|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731473|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731474|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154731475|NCT01837108|Diuretics|diuretics|mesh-ancestor
154731476|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
154731477|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154731478|NCT01724554|Aflibercept|aflibercept|mesh-list
154731479|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154731480|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154731481|NCT01724554|Growth Substances|growth substances|mesh-ancestor
154731482|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731483|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
154731484|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731485|NCT01724788|Furosemide|furosemide|mesh-list
154731486|NCT01724788|Diuretics|diuretics|mesh-ancestor
154731487|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
154731488|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731489|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154731490|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154731491|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774584|NCT00242736|Esomeprazole|esomeprazole|mesh-list
154731492|NCT01837498|Neostigmine|neostigmine|mesh-list
154731493|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154731494|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731495|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731496|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
154731497|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731498|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731499|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154731500|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
154731501|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731502|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154731503|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
154731504|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731505|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154731506|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154731507|NCT01837576|Calcipotriene|calcipotriene|mesh-list
154731508|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
154731509|NCT01728298|Immunomodulating Agents|immunomodulating agents|mesh-list
154731510|NCT01728298|Immunologic Factors|immunologic factors|mesh-ancestor
154731511|NCT01728298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731512|NCT01737710|Vaccines|vaccines|mesh-list
154731513|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
154731514|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731515|NCT01837810|Ibuprofen|ibuprofen|mesh-list
154731516|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154731517|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731518|NCT01837810|Analgesics|analgesics|mesh-ancestor
154731519|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
154731520|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731521|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731522|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154731523|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731524|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154731525|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731526|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731527|NCT01725100|Trametinib|trametinib|mesh-list
154731528|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154731529|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731530|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154731531|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731532|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731533|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154731534|NCT01725100|Protective Agents|protective agents|mesh-ancestor
154731535|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731536|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154731537|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
154731538|NCT01725412|Thiamine|thiamine|mesh-list
154731539|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
154731540|NCT01725412|Vitamins|vitamins|mesh-ancestor
154731541|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
154731542|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731543|NCT01725490|Metformin|metformin|mesh-list
154731544|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154731545|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731546|NCT01838434|Lenalidomide|lenalidomide|mesh-list
154731547|NCT01838434|Idelalisib|idelalisib|mesh-list
154731548|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
154731549|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731550|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154731551|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154731552|NCT01838434|Growth Substances|growth substances|mesh-ancestor
154731553|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
154731554|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731555|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774585|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154731556|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731557|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154731558|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
154731559|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154731560|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
154731561|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731562|NCT04377646|Zinc|zinc|mesh-list
154731563|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
154731564|NCT04377646|Trace Elements|trace elements|mesh-ancestor
154731565|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
154731566|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731567|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
154731568|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154731569|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154731570|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731571|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731572|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731573|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731574|NCT01728922|Vitamin D|vitamin d|mesh-list
154731575|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
154731576|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
154731577|NCT01728922|Vitamins|vitamins|mesh-list
154731578|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
154731579|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731580|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154731581|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154731582|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
154731583|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
154731584|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731585|NCT01838902|Primaquine|primaquine|mesh-list
154731586|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
154731587|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154731588|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154731589|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731590|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
154731591|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
154731592|NCT01714544|Hormones|hormones|mesh-ancestor
154731593|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731594|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731595|NCT01703858|Pantoprazole|pantoprazole|mesh-list
154731596|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154731597|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154731598|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154731599|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731600|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731601|NCT01729468|Aspirin|aspirin|mesh-list
154731602|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154731603|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731604|NCT01729468|Analgesics|analgesics|mesh-ancestor
154731605|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
154731606|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731607|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731608|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154731609|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731610|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154731611|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154731612|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731613|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154731614|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154731615|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731616|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
154731617|NCT04376788|Methylene Blue|methylene blue|mesh-list
154731618|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774675|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
154731619|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731620|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154731621|NCT01714310|Fluoxetine|fluoxetine|mesh-list
154731622|NCT01714310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154731623|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154731624|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154731625|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731626|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731627|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
154731628|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731629|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154731630|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
154731631|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154731632|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154731633|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154731634|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731635|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154731636|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154731637|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
154731638|NCT01728064|Ubiquinone|ubiquinone|mesh-list
154731639|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
154731640|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731641|NCT03405142|Panitumumab|panitumumab|mesh-list
154731642|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
154731643|NCT03405142|Dextrans|dextrans|mesh-list
154731644|NCT03405142|Edetic Acid|edetic acid|mesh-list
154731645|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
154731646|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154731647|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731648|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
154731649|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
154731650|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
154731651|NCT03405142|Antidotes|antidotes|mesh-ancestor
154731652|NCT03405142|Protective Agents|protective agents|mesh-ancestor
154731653|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731654|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
154731655|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
154731656|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731657|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154731658|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154731659|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154731660|NCT03407872|Esketamine|esketamine|mesh-list
154731661|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
154731662|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154731663|NCT03834610|Tadalafil|tadalafil|mesh-list
154731664|NCT03834610|Testosterone|testosterone|mesh-list
154731665|NCT03834610|Androgens|androgens|mesh-ancestor
154731666|NCT03834610|Hormones|hormones|mesh-ancestor
154731667|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731668|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731669|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
154731670|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154731671|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154731672|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731673|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731674|NCT03834610|Urological Agents|urological agents|mesh-ancestor
154731675|NCT01681472|Leucovorin|leucovorin|mesh-list
154731676|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
154731677|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
154731678|NCT01681472|Antidotes|antidotes|mesh-ancestor
154731679|NCT01681472|Protective Agents|protective agents|mesh-ancestor
154731680|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731681|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
154731682|NCT01681472|Vitamins|vitamins|mesh-ancestor
154731683|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
154731684|NCT00915928|Perindopril|perindopril|mesh-list
154731685|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154731686|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
154731687|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731688|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731689|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154731690|NCT03407404|Midazolam|midazolam|mesh-list
154731691|NCT03407404|Ketamine|ketamine|mesh-list
154731692|NCT03407404|Morphine|morphine|mesh-list
154731693|NCT03407404|Analgesics|analgesics|mesh-ancestor
154731694|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
154731695|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731696|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731697|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154731698|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154731699|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
154731700|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
154731701|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731702|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154731703|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154731704|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731705|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731706|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154731707|NCT03407404|Narcotics|narcotics|mesh-ancestor
154731708|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154731709|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154731710|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154731711|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154731712|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154731713|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
154731714|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
154731715|NCT03830086|Midazolam|midazolam|mesh-list
154731716|NCT03830086|Sufentanil|sufentanil|mesh-list
154731717|NCT03830086|Bupivacaine|bupivacaine|mesh-list
154731718|NCT03830086|Propofol|propofol|mesh-list
154731719|NCT03830086|Sevoflurane|sevoflurane|mesh-list
154731720|NCT03830086|Rocuronium|rocuronium|mesh-list
154731721|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
154731722|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
154731723|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731724|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731725|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
154731726|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731727|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154731728|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154731729|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
154731730|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154731731|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154731732|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154731733|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154731734|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
154731735|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
154731736|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731737|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731738|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154731739|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154731740|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154731741|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154731742|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154731743|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154731744|NCT03830086|Narcotics|narcotics|mesh-ancestor
154731745|NCT03830086|Analgesics|analgesics|mesh-ancestor
154731746|NCT02240212|Paclitaxel|paclitaxel|mesh-list
154731747|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154731748|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731749|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
154731750|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
154731751|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
154731752|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731753|NCT01047436|Artemether|artemether|mesh-list
154731754|NCT01047436|Quinine|quinine|mesh-list
154731755|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
154731756|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154731757|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154731758|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731759|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154731760|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731761|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154731762|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731763|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731764|NCT01047436|Analgesics|analgesics|mesh-ancestor
154731765|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
154731766|NCT03406936|Midazolam|midazolam|mesh-list
154731767|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154731768|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154731769|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731770|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731771|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154731772|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154731773|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154731774|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154731775|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
154731776|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
154731777|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
154731778|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
154731779|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731780|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731781|NCT02240602|Oxycodone|oxycodone|mesh-list
154731782|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154731783|NCT02240602|Narcotics|narcotics|mesh-ancestor
154731784|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774926|NCT00220649|Protective Agents|protective agents|mesh-ancestor
154731785|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731786|NCT02240602|Analgesics|analgesics|mesh-ancestor
154731787|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
154731788|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731789|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
154731790|NCT03406546|Remifentanil|remifentanil|mesh-list
154731791|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154731792|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731793|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731794|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731795|NCT03406546|Analgesics|analgesics|mesh-ancestor
154731796|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
154731797|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731798|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154731799|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154731800|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154731801|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154731802|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731803|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731804|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154483761|NCT03386630|Dsuvia|dsuvia|mesh-list
154731805|NCT03406546|Narcotics|narcotics|mesh-ancestor
154731806|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154731807|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154731808|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731809|NCT01046110|Incretins|incretins|mesh-ancestor
154731810|NCT01046110|Hormones|hormones|mesh-ancestor
154731811|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731812|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154731813|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
154731814|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731815|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731816|NCT01713530|Insulin|insulin|mesh-list
154731817|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154731818|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
154731819|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
154731820|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154731821|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154731822|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731823|NCT01045798|Caspofungin|caspofungin|mesh-list
154731824|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
154731825|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731826|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731827|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731828|NCT02982694|Bevacizumab|bevacizumab|mesh-list
154731829|NCT02982694|Atezolizumab|atezolizumab|mesh-list
154731830|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154731831|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731832|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154731833|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154731834|NCT02982694|Growth Substances|growth substances|mesh-ancestor
154731835|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731836|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
154731837|NCT02982694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154731838|NCT02982694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731839|NCT01712984|Fluconazole|fluconazole|mesh-list
154731840|NCT01712984|Vaccines|vaccines|mesh-list
154731841|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
154731842|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731843|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
154731844|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731845|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153774979|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154731846|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154731847|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731848|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731849|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154731850|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
154731851|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154731852|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154731853|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154731854|NCT00921310|Sirolimus|sirolimus|mesh-list
154731855|NCT00921310|Pemetrexed|pemetrexed|mesh-list
154731856|NCT00921310|Temsirolimus|temsirolimus|mesh-list
154731857|NCT00921310|MTOR Inhibitors|mtor inhibitors|mesh-list
154731858|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731859|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731860|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731861|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154731862|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154731863|NCT00921310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154731864|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154731865|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
154731866|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731867|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154731868|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154731869|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154731870|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
154731871|NCT02241148|Acetaminophen|acetaminophen|mesh-list
154731872|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154731873|NCT02241148|Analgesics|analgesics|mesh-ancestor
154731874|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
154731875|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731876|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731877|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
154731878|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
154731879|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154731880|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154731881|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154731882|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
154731883|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731884|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731885|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731886|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
154731887|NCT01040728|Olodaterol|olodaterol|mesh-list
154731888|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154731889|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
154731890|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731891|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731892|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154731893|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
154731894|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
154731895|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154731896|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
154731897|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731898|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731899|NCT01593020|Paclitaxel|paclitaxel|mesh-list
154731900|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
154731901|NCT01593020|Doxorubicin|doxorubicin|mesh-list
154731902|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154731903|NCT01593020|Fluorouracil|fluorouracil|mesh-list
154731904|NCT01593020|Epirubicin|epirubicin|mesh-list
154731905|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154731906|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731907|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
154731908|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
154731909|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
154731910|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731911|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154731912|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
154731913|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731914|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731915|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154731916|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
154731917|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154731918|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154731919|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154731920|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154731921|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154731922|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
154731923|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154731924|NCT01040260|Nicotine|nicotine|mesh-list
154731925|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154731926|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
154731927|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731928|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731929|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154731930|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154731931|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
154731932|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731933|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731934|NCT01046422|Metformin|metformin|mesh-list
154731935|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154731936|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731937|NCT03405376|Aflibercept|aflibercept|mesh-list
154731938|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154731939|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154731940|NCT03405376|Growth Substances|growth substances|mesh-ancestor
154731941|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731942|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
154731943|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154731944|NCT02241460|Lidocaine|lidocaine|mesh-list
154731945|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
154731946|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
154731947|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731948|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731949|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
154731950|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731951|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154731952|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154483866|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731953|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154731954|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154731955|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731956|NCT01712204|Febuxostat|febuxostat|mesh-list
154731957|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
154731958|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154731959|NCT01592864|Fluorides|fluorides|mesh-list
154731960|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
154731961|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
154731962|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
154731963|NCT01592864|Protective Agents|protective agents|mesh-ancestor
154731964|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731965|NCT01592786|Memantine|memantine|mesh-list
154731966|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154731967|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154731968|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
154731969|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154731970|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154731971|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731972|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154731973|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154731974|NCT01592708|Erythromycin|erythromycin|mesh-list
154731975|NCT01592708|Ibuprofen|ibuprofen|mesh-list
154731976|NCT01592708|Ketorolac|ketorolac|mesh-list
154731977|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154731978|NCT01592708|Fentanyl|fentanyl|mesh-list
154731979|NCT01592708|Scopolamine|scopolamine|mesh-list
154731980|NCT01592708|Droperidol|droperidol|mesh-list
154731981|NCT01592708|Remifentanil|remifentanil|mesh-list
154731982|NCT01592708|Hydrocodone|hydrocodone|mesh-list
154731983|NCT01592708|Ondansetron|ondansetron|mesh-list
154731984|NCT01592708|Antiemetics|antiemetics|mesh-list
154731985|NCT01592708|Propofol|propofol|mesh-list
154731986|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
154731987|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154731988|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154731989|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154731990|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154731991|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
154731992|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154731993|NCT01592708|Narcotics|narcotics|mesh-ancestor
154731994|NCT01592708|Analgesics|analgesics|mesh-ancestor
154731995|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
154731996|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154731997|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154731998|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154731999|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154732000|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732001|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732002|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154732003|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732004|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732005|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
154732006|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154732007|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
154732008|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
154732009|NCT01592708|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154732010|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154732011|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
154732012|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732013|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
154732014|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
154732015|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154732016|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732017|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154732018|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
154732019|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154732020|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
154732021|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154732022|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
154732023|NCT01592708|Hormones|hormones|mesh-ancestor
154732024|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154732025|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154732026|NCT01592708|Protective Agents|protective agents|mesh-ancestor
154732027|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154732028|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732029|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154732030|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154732031|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154732032|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154732033|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154732034|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
154732035|NCT01042522|Paclitaxel|paclitaxel|mesh-list
154732036|NCT01042522|Etoposide|etoposide|mesh-list
154732037|NCT01042522|Cisplatin|cisplatin|mesh-list
154732038|NCT01042522|Carboplatin|carboplatin|mesh-list
154732039|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154732040|NCT01042522|Bleomycin|bleomycin|mesh-list
154732041|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
154732042|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154732043|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732044|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
154732045|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
154732046|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
154732047|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732048|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154732049|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154732050|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732051|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154732052|NCT01702844|Paclitaxel|paclitaxel|mesh-list
154732053|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154732054|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732055|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
154732056|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
154732057|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
154732058|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732059|NCT01702532|Nicotine|nicotine|mesh-list
154732060|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154732061|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
154732062|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732063|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732064|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154732065|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154732066|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
154732067|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732068|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732069|NCT02241616|Entecavir|entecavir|mesh-list
154732070|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
154732071|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732072|NCT03400306|Paclitaxel|paclitaxel|mesh-list
154732073|NCT03400306|Carboplatin|carboplatin|mesh-list
154732074|NCT03400306|Veliparib|veliparib|mesh-list
154732075|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154732076|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732077|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
154732078|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
154732079|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
154732080|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732081|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154732082|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732083|NCT03405064|Linezolid|linezolid|mesh-list
154732084|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
154732085|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154732086|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732087|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154732088|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732089|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732090|NCT03405064|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154732091|NCT01702298|Metformin|metformin|mesh-list
154732092|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154732093|NCT01702298|Simvastatin|simvastatin|mesh-list
154732094|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154732095|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732096|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154732097|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154732098|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
154732099|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732100|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154732101|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154732102|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732103|NCT01702298|Incretins|incretins|mesh-ancestor
154732104|NCT01702298|Hormones|hormones|mesh-ancestor
154732105|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154732106|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154732107|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
154732108|NCT03404752|Lenograstim|lenograstim|mesh-list
154732109|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154732110|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
154732111|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732112|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
154732113|NCT03401710|Hematinics|hematinics|mesh-ancestor
154732114|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154732115|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154732116|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154732117|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732118|NCT01701362|Pregabalin|pregabalin|mesh-list
154732119|NCT01701362|Analgesics|analgesics|mesh-ancestor
154732120|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
154732121|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732122|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732123|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
154732124|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154732125|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732126|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732127|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154732128|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154732129|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154732130|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732131|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154732132|NCT00919126|Xenon|xenon|mesh-list
154732133|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154732134|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
154732135|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
154732136|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732137|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775421|NCT06140186|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154732138|NCT01710800|Esomeprazole|esomeprazole|mesh-list
154732139|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154732140|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154732141|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154732142|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732143|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732144|NCT01710020|Tofacitinib|tofacitinib|mesh-list
154732145|NCT01710020|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154732146|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154732147|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732148|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732149|NCT02982850|Aspirin|aspirin|mesh-list
154732150|NCT02982850|Warfarin|warfarin|mesh-list
154732151|NCT02982850|Dabigatran|dabigatran|mesh-list
154732152|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154732153|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154732154|NCT02982850|Analgesics|analgesics|mesh-ancestor
154732155|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
154732156|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732157|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732158|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732159|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732160|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154732161|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154732162|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732163|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154732164|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154732165|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732166|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
154732167|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
154732168|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
154732169|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154732170|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
154732171|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
154732172|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
154732173|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154732174|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
154732175|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732176|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732177|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154732178|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
154732179|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154732180|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154484091|NCT02142777|Equol|equol|mesh-list
154732181|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154732182|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
154732183|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732184|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732185|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
154732186|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154732187|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
154732189|NCT03403972|Simvastatin|simvastatin|mesh-list
154732190|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154732191|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154732192|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
154732193|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732194|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154732195|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154732196|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732197|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153775517|NCT06015750|Hematinics|hematinics|mesh-ancestor
154732198|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732199|NCT02242318|Valsartan|valsartan|mesh-list
154732200|NCT02242318|Telmisartan|telmisartan|mesh-list
154732201|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154732202|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154732203|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154732204|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732205|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
154732206|NCT01700192|Loratadine|loratadine|mesh-list
154732207|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154732208|NCT01700192|Epinephrine|epinephrine|mesh-list
154732209|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154732210|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154732211|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154732212|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
154732213|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732214|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732215|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732216|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154732217|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154732218|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
154732219|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732220|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154732221|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
154732222|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
154732223|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
154732224|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154732225|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732226|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
154732227|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154732228|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
154732229|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154732230|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154732231|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
154732232|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
154732233|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154732234|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154732235|NCT01700192|Analgesics|analgesics|mesh-ancestor
154732236|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
154732237|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732238|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154732239|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154732240|NCT02242396|Telmisartan|telmisartan|mesh-list
154732241|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154732242|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154732243|NCT02242396|Diuretics|diuretics|mesh-ancestor
154732244|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
154732245|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732246|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154732247|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732248|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732249|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154732250|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154732251|NCT02242474|Adalimumab|adalimumab|mesh-list
154732252|NCT02242474|Infliximab|infliximab|mesh-list
154732253|NCT02242474|Golimumab|golimumab|mesh-list
154732254|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
154732255|NCT02242474|Etanercept|etanercept|mesh-list
154732256|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154732257|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154732258|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732259|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732260|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
154732261|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154732262|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154732263|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154732265|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
154732266|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732267|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732268|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154732269|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
154732270|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
154732271|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154732272|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154732273|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154732274|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
154732275|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732276|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732277|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732278|NCT04878315|Captopril|captopril|mesh-list
154732279|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154732280|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
154732281|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732282|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732283|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154732284|NCT04374604|Mitogens|mitogens|mesh-list
154732285|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
154732286|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732287|NCT02242864|Telmisartan|telmisartan|mesh-list
154732288|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154732289|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154732290|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154732291|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154732292|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732293|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154732294|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732295|NCT02242864|Diuretics|diuretics|mesh-ancestor
154732296|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
154732297|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732298|NCT01709708|Bupivacaine|bupivacaine|mesh-list
154732299|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
154732300|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
154732301|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732302|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732303|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
154732304|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732305|NCT02243098|Semaglutide|semaglutide|mesh-list
154732306|NCT02243098|Digoxin|digoxin|mesh-list
154732307|NCT02243098|Atorvastatin|atorvastatin|mesh-list
154732308|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154732309|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154732310|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
154732311|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732312|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154732313|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154732314|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732315|NCT02243098|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154732316|NCT02243098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154732317|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732318|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154732319|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154732320|NCT02243098|Protective Agents|protective agents|mesh-ancestor
154732321|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154732322|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154732323|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154732324|NCT01709318|Etonogestrel|etonogestrel|mesh-list
154732325|NCT01709318|Estradiol|estradiol|mesh-list
154732326|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154732327|NCT01709318|Estrogens|estrogens|mesh-ancestor
154732328|NCT01709318|Hormones|hormones|mesh-ancestor
154732329|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154732330|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732331|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154732332|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
154732333|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154732334|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154732335|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154732336|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154732337|NCT02243254|Ibuprofen|ibuprofen|mesh-list
154732338|NCT02243254|Remifentanil|remifentanil|mesh-list
154732339|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154732340|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154732341|NCT02243254|Analgesics|analgesics|mesh-ancestor
154732342|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
154732343|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732344|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732345|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732346|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732347|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154732348|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775647|NCT05317546|Cannabidiol|cannabidiol|mesh-list
154732349|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732350|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154732351|NCT02243254|Narcotics|narcotics|mesh-ancestor
154732352|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732353|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
154732354|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
154732355|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
154732356|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154732357|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732358|NCT03402880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154732359|NCT03402880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732360|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
154732361|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732362|NCT01673997|Metoprolol|metoprolol|mesh-list
154732363|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154732364|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154732365|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
154732366|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
154732367|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732368|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732369|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154732370|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154732371|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154732372|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
154732373|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732374|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732375|NCT04373824|Ivermectin|ivermectin|mesh-list
154732376|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154732377|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732378|NCT01676571|Vortioxetine|vortioxetine|mesh-list
154732379|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
154732380|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154732381|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154732382|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154732383|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732384|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732385|NCT01676571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154732386|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154732387|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732388|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732389|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732390|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
154732391|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154732392|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154732393|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154732394|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154732395|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
154732396|NCT01699178|Testosterone|testosterone|mesh-list
154732397|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
154732398|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
154732399|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154732400|NCT01699178|Androgens|androgens|mesh-ancestor
154732401|NCT01699178|Hormones|hormones|mesh-ancestor
154732402|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154732403|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732404|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154732405|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732406|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
154732407|NCT02077959|Lenalidomide|lenalidomide|mesh-list
154732408|NCT02077959|Pidilizumab|pidilizumab|mesh-list
154732409|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
154732410|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732411|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154732412|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154732413|NCT02077959|Growth Substances|growth substances|mesh-ancestor
154732414|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
154732415|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732416|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154732418|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
154732419|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732420|NCT01699022|CycloProvera|cycloprovera|mesh-list
154732421|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154732422|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154732423|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154732424|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
154732425|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154732426|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732427|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154732428|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154732429|NCT01670175|Sirolimus|sirolimus|mesh-list
154732430|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
154732431|NCT01670175|Topotecan|topotecan|mesh-list
154732432|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154732433|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
154732434|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732435|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732436|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154732437|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
154732438|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732439|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732440|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154732441|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154732442|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732443|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154732444|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
154732445|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775773|NCT05023369|Hormones|hormones|mesh-ancestor
154732446|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154732447|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154732448|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154732449|NCT02243566|Telmisartan|telmisartan|mesh-list
154732450|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154732451|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154732452|NCT02243566|Diuretics|diuretics|mesh-ancestor
154732453|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
154732454|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732455|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154732456|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732457|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732458|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154732459|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154732460|NCT02243644|Albendazole|albendazole|mesh-list
154732461|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
154732462|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154732463|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732464|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
154732465|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154732466|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154732467|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
154732468|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
154732469|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
154732470|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732471|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732472|NCT04373356|Listerine|listerine|mesh-list
154732473|NCT04373356|Fluorides|fluorides|mesh-list
154732474|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
154732475|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
154732476|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
154732477|NCT04373356|Protective Agents|protective agents|mesh-ancestor
154732478|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732479|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154732480|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732481|NCT01745757|Paclitaxel|paclitaxel|mesh-list
154732482|NCT01745757|Bevacizumab|bevacizumab|mesh-list
154732483|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154732484|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732485|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
154732486|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
154732487|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
154732488|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732489|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154732490|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154732491|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154732492|NCT01745757|Growth Substances|growth substances|mesh-ancestor
154732493|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732494|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
154732495|NCT01709162|Ipilimumab|ipilimumab|mesh-list
154732496|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154732497|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732498|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154732499|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732500|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
154732501|NCT02243800|Vitamin D|vitamin d|mesh-list
154732502|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154732503|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732504|NCT02243800|Vitamins|vitamins|mesh-ancestor
154732505|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
154732506|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154732507|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154732508|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154732509|NCT04764045|Ropivacaine|ropivacaine|mesh-list
154732510|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
154732511|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
154732512|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732513|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732514|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
154732515|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732516|NCT01698554|Bimatoprost|bimatoprost|mesh-list
154732517|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154732518|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154732519|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154732520|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732521|NCT00895791|Umirolimus|umirolimus|mesh-list
154732522|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732523|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154732524|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
154732525|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732526|NCT01698320|Albuterol|albuterol|mesh-list
154732527|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154732528|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
154732529|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732530|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732531|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154732532|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
154732533|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
154732534|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154732535|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154732536|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154732537|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154732538|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
154732539|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732540|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732541|NCT03401476|Morphine|morphine|mesh-list
154732542|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154732543|NCT03401476|Narcotics|narcotics|mesh-ancestor
154732544|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775887|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732545|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732546|NCT03401476|Analgesics|analgesics|mesh-ancestor
154732547|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
154732548|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732549|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
154732550|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154732551|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732552|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154732553|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732554|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154732555|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154732556|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154732557|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
154732558|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732559|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154732560|NCT01674855|Lenograstim|lenograstim|mesh-list
154732561|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154732562|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
154732563|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732564|NCT00924352|Dasatinib|dasatinib|mesh-list
154732565|NCT00924352|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154732566|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154732567|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732568|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732569|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732570|NCT01674933|Listerine|listerine|mesh-list
154732571|NCT01674933|Fluorides|fluorides|mesh-list
154732572|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
154732573|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
154732574|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
154732575|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
154732576|NCT01674933|Protective Agents|protective agents|mesh-ancestor
154732577|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732578|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154732579|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732580|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
154732581|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
154732582|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154732583|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154732584|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732585|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732586|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732587|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732588|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
154732589|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154732590|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732591|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
154732592|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154732593|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154732594|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154732595|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
154732596|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732597|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732598|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732599|NCT01569152|Methotrexate|methotrexate|mesh-list
154732600|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154732601|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
154732602|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154732603|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732604|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154732605|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
154732606|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732607|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732608|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
154732609|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732610|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154732611|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154732612|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
154732613|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732614|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154732615|NCT01675557|Vitamin D|vitamin d|mesh-list
154732616|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
154732617|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
154732618|NCT01675557|Vitamins|vitamins|mesh-list
154732619|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
154732620|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732621|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154732622|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154732623|NCT01675947|Sirolimus|sirolimus|mesh-list
154732624|NCT01675947|Lidocaine|lidocaine|mesh-list
154732625|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
154732626|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
154732627|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860370|NCT03221764|Amiodarone|amiodarone|mesh-list
154732628|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732629|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
154732630|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732631|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154732632|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154732633|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154732634|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732635|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732636|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154732637|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732638|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154732639|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732640|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
154732641|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154732642|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
154732643|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154732644|NCT01567826|Atorvastatin|atorvastatin|mesh-list
154732645|NCT01567826|Simvastatin|simvastatin|mesh-list
154732646|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154732647|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154732648|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
154732649|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732650|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154732651|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154732652|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732653|NCT02083107|Misoprostol|misoprostol|mesh-list
154732654|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154732655|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
154732656|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154732657|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732658|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154732659|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154732660|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
154732661|NCT02335905|Ceftaroline|ceftaroline|mesh-list
154732662|NCT02335905|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154732663|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154732664|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732665|NCT00925756|Maraviroc|maraviroc|mesh-list
154732666|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154732667|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154732668|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732669|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154732670|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154732671|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
154732672|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732673|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154732674|NCT04372732|Autoantibodies|autoantibodies|mesh-list
154732675|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
154732676|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732677|NCT02245126|Lidocaine|lidocaine|mesh-list
154732678|NCT02245126|Bupivacaine|bupivacaine|mesh-list
154732679|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
154732680|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
154732681|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732682|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732683|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
154732684|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732685|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154732686|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154732687|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154732688|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732689|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732690|NCT04372342|Remifentanil|remifentanil|mesh-list
154732691|NCT04372342|Nalbuphine|nalbuphine|mesh-list
154732692|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154732693|NCT04372342|Narcotics|narcotics|mesh-ancestor
154732694|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732695|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732696|NCT04372342|Analgesics|analgesics|mesh-ancestor
154732697|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
154732698|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732699|NCT04372264|Acetaminophen|acetaminophen|mesh-list
154732700|NCT04372264|Ibuprofen|ibuprofen|mesh-list
154732701|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154732702|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154732703|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154732704|NCT04372264|Analgesics|analgesics|mesh-ancestor
154732705|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
154732706|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732707|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732708|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732709|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732710|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154732711|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732712|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732713|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
154732714|NCT02083809|Oxytocin|oxytocin|mesh-list
154732715|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
154732716|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154732717|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732718|NCT02244112|Midazolam|midazolam|mesh-list
154732719|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154732720|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154732721|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732722|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732723|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154732724|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154732725|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154732726|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154732727|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
154732728|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
154732729|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
154732730|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
154732731|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732732|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732733|NCT03723681|Quizartinib|quizartinib|mesh-list
154732734|NCT03723681|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154732735|NCT03723681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154732736|NCT03723681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732737|NCT03723681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732738|NCT02244190|Ritonavir|ritonavir|mesh-list
154732739|NCT02244190|Tipranavir|tipranavir|mesh-list
154732740|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154732741|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154732742|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
154732743|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732744|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732745|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154732746|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154732747|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
154732748|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732749|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154732750|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154732751|NCT00926380|Denosumab|denosumab|mesh-list
154732752|NCT00926380|Teriparatide|teriparatide|mesh-list
154732753|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154732754|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732755|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154732756|NCT02244268|Tamsulosin|tamsulosin|mesh-list
154732757|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154732758|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154732759|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154732760|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
154732761|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732762|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732763|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732764|NCT02244268|Urological Agents|urological agents|mesh-ancestor
154732765|NCT03630315|Bevacizumab|bevacizumab|mesh-list
154732766|NCT03630315|Ranibizumab|ranibizumab|mesh-list
154732767|NCT03630315|Aflibercept|aflibercept|mesh-list
154732768|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154732769|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732770|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154732771|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154732772|NCT03630315|Growth Substances|growth substances|mesh-ancestor
154732773|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732774|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
154732775|NCT00929344|Pregabalin|pregabalin|mesh-list
154732776|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154732777|NCT00929344|Analgesics|analgesics|mesh-ancestor
154732778|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
154732779|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732780|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732781|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
154732782|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154732783|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732784|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732785|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154732786|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154732787|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154732788|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732789|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154732790|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154732791|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154732792|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732793|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
154732794|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
154732795|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
154732796|NCT03630159|Tisagenlecleucel|tisagenlecleucel|mesh-list
154732797|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154732798|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732799|NCT03630159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154732800|NCT03630159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732801|NCT04371874|Aspirin|aspirin|mesh-list
154732802|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154732803|NCT04371874|Captopril|captopril|mesh-list
154732804|NCT04371874|Nitrendipine|nitrendipine|mesh-list
154732805|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154732806|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154732807|NCT04371874|Analgesics|analgesics|mesh-ancestor
154732808|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
154732809|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732810|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732811|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732812|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732813|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154732814|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154732815|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732816|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154732817|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154732818|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732819|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
154732820|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154732821|NCT04371874|Diuretics|diuretics|mesh-ancestor
154732822|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
154732823|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154732824|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732825|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154732826|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
154732827|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154732828|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154732829|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
154732830|NCT04376554|Amoxicillin|amoxicillin|mesh-list
154732831|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
154732832|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
154732833|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154732834|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154732835|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732836|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154732837|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732838|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732839|NCT03627741|Triamcinolone|triamcinolone|mesh-list
154732840|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154732841|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154732842|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154732843|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154732844|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
154732845|NCT03627741|Hormones|hormones|mesh-ancestor
154732846|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154732847|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732848|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154732849|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
154732850|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484768|NCT03515538|Cisplatin|cisplatin|mesh-list
154732851|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732852|NCT03626337|Thiamine|thiamine|mesh-list
154732853|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
154732854|NCT03626337|Vitamins|vitamins|mesh-ancestor
154732855|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
154732856|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732857|NCT00929578|Fluphenazine|fluphenazine|mesh-list
154732858|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
154732859|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
154732860|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154732861|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154732862|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732863|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732864|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154732865|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154732866|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
154732867|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732868|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732869|NCT04371406|Azithromycin|azithromycin|mesh-list
154732870|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
154732871|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154732872|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732873|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
154732874|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154732875|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154732876|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732877|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732878|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732879|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
154732880|NCT03716739|Testosterone|testosterone|mesh-list
154732881|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
154732882|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
154732883|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154732884|NCT03716739|Androgens|androgens|mesh-ancestor
154732885|NCT03716739|Hormones|hormones|mesh-ancestor
154732886|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154732887|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732888|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154732889|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732890|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
154732891|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
154732892|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154732893|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154732894|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154732895|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154732896|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732897|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
154732898|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732899|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732900|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154732901|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154732902|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
154732903|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154732904|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732905|NCT03705429|Paclitaxel|paclitaxel|mesh-list
154732906|NCT03705429|Docetaxel|docetaxel|mesh-list
154732907|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154732908|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
154732909|NCT03705429|Trastuzumab|trastuzumab|mesh-list
154732910|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154732911|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732912|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
154732913|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
154732914|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
154732915|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732916|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154732917|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
154732918|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732919|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732920|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154732921|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
154732922|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153776385|NCT02727803|Melphalan|melphalan|mesh-list
153776424|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732923|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154732924|NCT04370782|Azithromycin|azithromycin|mesh-list
154732925|NCT04370782|Doxycycline|doxycycline|mesh-list
154732926|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
154732927|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
154732928|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154732929|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732930|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
154732931|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154732932|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154732933|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732934|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732935|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154732936|NCT04370782|Astringents|astringents|mesh-ancestor
154732937|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732938|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
154732939|NCT03604653|Cisplatin|cisplatin|mesh-list
154732940|NCT03604653|Doxorubicin|doxorubicin|mesh-list
154732941|NCT03604653|Mitomycins|mitomycins|mesh-list
154732942|NCT03604653|Mitomycin|mitomycin|mesh-list
154732943|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732944|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154732945|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154732946|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154732947|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154732948|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732949|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
154732950|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154732951|NCT04376086|Anesthetics|anesthetics|mesh-list
154732952|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154732953|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732954|NCT04375852|Autoantibodies|autoantibodies|mesh-list
154732955|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
154732956|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732957|NCT04364464|Riociguat|riociguat|mesh-list
154732958|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
154732959|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732960|NCT01592240|Bococizumab|bococizumab|mesh-list
154732961|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154732962|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154732963|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
154732964|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732965|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154732966|NCT05620654|Paclitaxel|paclitaxel|mesh-list
154732967|NCT05620654|Cisplatin|cisplatin|mesh-list
154732968|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154732969|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154732970|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
154732971|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
154732972|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
154732973|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732974|NCT04357522|Vaccines|vaccines|mesh-list
154732975|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154732976|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
154732977|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732978|NCT00005901|Pamidronate|pamidronate|mesh-list
154732979|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154732980|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732981|NCT04369534|Clopidogrel|clopidogrel|mesh-list
154732982|NCT04369534|Ticagrelor|ticagrelor|mesh-list
154732983|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154732984|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154732985|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154732986|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154732987|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
154732988|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154732989|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154732990|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154732991|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
154732992|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154732993|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
154732994|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
154732995|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
154732996|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
154732997|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
154732998|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154732999|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154733000|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733001|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733002|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733003|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733005|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154733006|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154733007|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154733008|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733009|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733010|NCT04370080|Fluorides|fluorides|mesh-list
154733011|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
154733012|NCT04370080|Protective Agents|protective agents|mesh-ancestor
154733013|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733014|NCT01591616|Lidocaine|lidocaine|mesh-list
154733015|NCT01591616|Prilocaine|prilocaine|mesh-list
154733016|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
154733017|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
154733018|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733019|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733020|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
154733021|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733022|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154733023|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154733024|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154733025|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733026|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733027|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
154733028|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154733029|NCT00938314|Hematinics|hematinics|mesh-ancestor
154733030|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154733031|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733032|NCT04370392|Anesthetics|anesthetics|mesh-list
154733033|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
154733034|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733035|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733036|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
154733037|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733038|NCT04369222|Acetaminophen|acetaminophen|mesh-list
154733039|NCT04369222|Aspirin|aspirin|mesh-list
154733040|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
154733041|NCT04369222|Salicylates|salicylates|mesh-list
154733042|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154733043|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154733044|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154733045|NCT04369222|Analgesics|analgesics|mesh-ancestor
154733046|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
154733047|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733048|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733049|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
154733050|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733051|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
154733052|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
154733053|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
154733054|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733055|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154733056|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733057|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733058|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154733059|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154733060|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154733061|NCT01591460|Ribavirin|ribavirin|mesh-list
154733062|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154733063|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
154733064|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
154733065|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733066|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
154733067|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733068|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
154733069|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733070|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
154733071|NCT04363216|Vitamins|vitamins|mesh-ancestor
154733072|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
154733073|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733074|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
154733075|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733076|NCT04363216|Protective Agents|protective agents|mesh-ancestor
154484991|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
154733077|NCT03678675|Ketorolac|ketorolac|mesh-list
154733078|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154733079|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154733080|NCT03678675|Analgesics|analgesics|mesh-ancestor
154733081|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
154733082|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733083|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733084|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733085|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733086|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154733087|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733088|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733089|NCT04363060|Amoxicillin|amoxicillin|mesh-list
154733090|NCT04363060|Azithromycin|azithromycin|mesh-list
154733091|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
154733092|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
154733093|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154733094|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154733095|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733096|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154733097|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733098|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733099|NCT01591382|Ketamine|ketamine|mesh-list
154733100|NCT01591382|Hydromorphone|hydromorphone|mesh-list
154733101|NCT01591382|Analgesics|analgesics|mesh-ancestor
154733102|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
154733103|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733104|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733105|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154733106|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154733107|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
154733108|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
154733109|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733110|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154733111|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154733112|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733113|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733114|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154733115|NCT01591382|Narcotics|narcotics|mesh-ancestor
154733116|NCT03677817|Lidocaine|lidocaine|mesh-list
154733117|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
154733118|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
154733119|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733120|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733121|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
154733122|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733123|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154733124|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154733125|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154733126|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733127|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733128|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
154733129|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154733130|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733131|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733132|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154733133|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
154733134|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154733135|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733136|NCT00928174|Fluorides|fluorides|mesh-list
154733137|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
154733138|NCT00928174|Protective Agents|protective agents|mesh-ancestor
154733139|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733140|NCT01696214|Fluticasone|fluticasone|mesh-list
154733141|NCT01696214|Xhance|xhance|mesh-list
154733142|NCT01696214|Theophylline|theophylline|mesh-list
154733143|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154733144|NCT01696214|Ipratropium|ipratropium|mesh-list
154733145|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154733146|NCT01696214|Montelukast|montelukast|mesh-list
154733147|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733148|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154733149|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
154733150|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733151|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733152|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154733153|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
154733155|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154733156|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154733157|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154733158|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154733159|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
154733160|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733161|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733162|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154733163|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
154733164|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154733165|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154733166|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154733167|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154733168|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
154733169|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154733170|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733171|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
154733172|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154733173|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154733174|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
154733175|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
154733176|NCT01696214|Hormones|hormones|mesh-ancestor
154733177|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
154733178|NCT03794037|Montelukast|montelukast|mesh-list
154733179|NCT03794037|Progesterone|progesterone|mesh-list
154733180|NCT03794037|Progestins|progestins|mesh-ancestor
154733181|NCT03794037|Hormones|hormones|mesh-ancestor
154733182|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154733183|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733184|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154733185|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
154733186|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154733187|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
154733188|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153776676|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
154733189|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154733190|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733191|NCT04356508|Nivolumab|nivolumab|mesh-list
154733192|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154733193|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733194|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154733195|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733196|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
154733197|NCT04368598|Dexamethasone|dexamethasone|mesh-list
154733198|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
154733199|NCT04368598|BB 1101|bb 1101|mesh-list
154733200|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154733201|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733202|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
154733203|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
154733204|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733205|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733206|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154733207|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
154733208|NCT04368598|Hormones|hormones|mesh-ancestor
154733209|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154733210|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154733211|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733212|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
154733213|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733214|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733215|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
154733216|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733217|NCT04368598|Expectorants|expectorants|mesh-ancestor
154733218|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
154733219|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154733220|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
154733221|NCT04368598|Protective Agents|protective agents|mesh-ancestor
154733222|NCT04368598|Antidotes|antidotes|mesh-ancestor
154733223|NCT05347641|Cytarabine|cytarabine|mesh-list
154733224|NCT05347641|Methotrexate|methotrexate|mesh-list
154733225|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485138|NCT04525664|Amoxicillin|amoxicillin|mesh-list
154733226|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
154733227|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733228|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733229|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154733230|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
154733231|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154733232|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154733233|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
154733234|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733235|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
154733236|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733237|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154733238|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154733239|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154733240|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
154733241|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733242|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
154733243|NCT01696058|Olodaterol|olodaterol|mesh-list
154733244|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154733245|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
154733246|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733247|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733248|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154733249|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
154733250|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
154733251|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153776771|NCT00563485|Doxazosin|doxazosin|mesh-list
154733252|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
154733253|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733254|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733255|NCT04368520|Vitamin D|vitamin d|mesh-list
154733256|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
154733257|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
154733258|NCT04368520|Vitamins|vitamins|mesh-list
154733259|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
154733260|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733261|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154733262|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154733263|NCT03790137|Fenfluramine|fenfluramine|mesh-list
154733264|NCT03790137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154733265|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154733266|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733267|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733268|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733269|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
154733270|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733271|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154733272|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154733273|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154733274|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
154733275|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733276|NCT03580317|Carbamazepine|carbamazepine|mesh-list
154733277|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
154733278|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
154733279|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154733280|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733281|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733282|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154733283|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154733284|NCT03580317|Analgesics|analgesics|mesh-ancestor
154733285|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
154733286|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733287|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154733288|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733289|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733290|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154733291|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154733292|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
154733293|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154733294|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
154733295|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733296|NCT04356118|Methotrexate|methotrexate|mesh-list
154733297|NCT04356118|Endostatins|endostatins|mesh-list
154733298|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154733299|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
154733301|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733302|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154733303|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
154733304|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733305|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733306|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
154733307|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733308|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154733309|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154733310|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
154733311|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733312|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154733313|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154733314|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154733315|NCT04356118|Growth Substances|growth substances|mesh-ancestor
154733316|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154733317|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
154733318|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
154733319|NCT04361812|Omalizumab|omalizumab|mesh-list
154733320|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154733321|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154733322|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154733323|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
154733324|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
154733325|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733326|NCT04355962|Sevoflurane|sevoflurane|mesh-list
154733327|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154733328|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154733329|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
154733330|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
154733331|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733332|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733333|NCT00705081|Ezetimibe|ezetimibe|mesh-list
154733334|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154733335|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154733336|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
154733337|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733338|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154733339|NCT00704769|Desloratadine|desloratadine|mesh-list
154733340|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154733341|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
154733342|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733343|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733344|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733345|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154733346|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154733347|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
154733348|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
154733349|NCT00938548|Pregabalin|pregabalin|mesh-list
154733350|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733351|NCT00938548|Analgesics|analgesics|mesh-ancestor
154733352|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
154733353|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733354|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
154733355|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154733356|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733357|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733358|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154733359|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154733360|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154733361|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733362|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154733363|NCT00932620|Simvastatin|simvastatin|mesh-list
154733364|NCT00932620|Ezetimibe|ezetimibe|mesh-list
154733365|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154733366|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154733367|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
154733368|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733369|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154733370|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154733371|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733372|NCT04361188|Anesthetics|anesthetics|mesh-list
154485289|NCT03510000|Hormones|hormones|mesh-list
154733373|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733374|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733375|NCT04367818|Anesthetics|anesthetics|mesh-list
154733376|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
154733377|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733378|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733379|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
154733380|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733381|NCT01677273|Caseins|caseins|mesh-list
154733382|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
154733383|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
154733384|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733385|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154733386|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154733387|NCT04355806|Vaccines|vaccines|mesh-list
154733388|NCT04355806|Antibodies|antibodies|mesh-list
154733389|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
154733390|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154733391|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
154733392|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733393|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733394|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733395|NCT01677351|Clonidine|clonidine|mesh-list
154733396|NCT01677351|Analgesics|analgesics|mesh-ancestor
154733397|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
154733398|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733399|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733400|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154733401|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
154733402|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
154733403|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154733404|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154733405|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154733406|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
154733407|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733408|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733409|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154733410|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
154733411|NCT00938704|Glycerol|glycerol|mesh-list
154733412|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154733413|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
154733414|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733415|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
154733416|NCT00938704|Protective Agents|protective agents|mesh-ancestor
154733417|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154733418|NCT00938704|Laxatives|laxatives|mesh-ancestor
154733419|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154733420|NCT03666351|Losartan|losartan|mesh-list
154733421|NCT03666351|Amlodipine|amlodipine|mesh-list
154733422|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
154733423|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154733424|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154733425|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733426|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733427|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154733428|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733429|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
154733430|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154733431|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154733432|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154733433|NCT03666351|Diuretics|diuretics|mesh-ancestor
154733434|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
154733435|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154733436|NCT00928642|Gemcitabine|gemcitabine|mesh-list
154733437|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
154733438|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154733439|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
154733440|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733441|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733442|NCT00928642|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154733443|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154733444|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733445|NCT04361422|Isotretinoin|isotretinoin|mesh-list
154733446|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
154733447|NCT03579615|Insulin|insulin|mesh-list
154733448|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
154733449|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154733450|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733452|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154733453|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154733454|NCT04355416|Analgesics|analgesics|mesh-ancestor
154733455|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
154733456|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733457|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733458|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733459|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733460|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733461|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733462|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733463|NCT04355494|Eculizumab|eculizumab|mesh-list
154733464|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154733465|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154733466|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
154733467|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733468|NCT00934024|Varenicline|varenicline|mesh-list
154733469|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154733470|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154733471|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
154733472|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733473|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733474|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733475|NCT04361032|Deferoxamine|deferoxamine|mesh-list
154733476|NCT04361032|Siderophores|siderophores|mesh-ancestor
154733477|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154733478|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
154733479|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
153777079|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154733480|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733481|NCT00928954|Gabapentin|gabapentin|mesh-list
154733482|NCT00928954|Memantine|memantine|mesh-list
154733483|NCT00928954|Analgesics|analgesics|mesh-ancestor
154733484|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
154733485|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733486|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733487|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
154733488|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154733489|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154733490|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733491|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154733492|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154733493|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154733494|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733495|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733496|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
154733497|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154733498|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154733499|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
154733500|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
154733501|NCT04355026|Bromhexine|bromhexine|mesh-list
154733502|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
154733503|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154733504|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154733505|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733506|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733507|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733508|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733509|NCT04355026|Expectorants|expectorants|mesh-ancestor
154733510|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
154733511|NCT03548571|Temozolomide|temozolomide|mesh-list
154733512|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154733513|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
154733514|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733515|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733516|NCT00939562|Doxycycline|doxycycline|mesh-list
154733517|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154733518|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733519|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
154733520|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154733521|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154733522|NCT04359862|Propofol|propofol|mesh-list
154733523|NCT04359862|Sevoflurane|sevoflurane|mesh-list
154733524|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154733525|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733526|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733527|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154733528|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
154733529|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
154733530|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154733531|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154733532|NCT04366960|Enoxaparin|enoxaparin|mesh-list
154733533|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
154733534|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154733535|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154733536|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733537|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154733538|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154733539|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154733540|NCT03539445|Protective Agents|protective agents|mesh-ancestor
154733541|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733542|NCT04360876|Dexamethasone|dexamethasone|mesh-list
153777219|NCT00199121|Zidovudine|zidovudine|mesh-list
154733543|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
154733544|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733545|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
154733546|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
154733547|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733548|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733549|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154733550|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
154733551|NCT04360876|Hormones|hormones|mesh-ancestor
154733552|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154733553|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154733554|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733555|NCT04359550|Antibodies|antibodies|mesh-list
154733556|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154733557|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
154733558|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733559|NCT02084511|Celecoxib|celecoxib|mesh-list
154733560|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154733561|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154733562|NCT02084511|Analgesics|analgesics|mesh-ancestor
154733563|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
154733564|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733565|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733566|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733567|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733568|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154733569|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154733570|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733571|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733572|NCT00942448|Diclofenac|diclofenac|mesh-list
154733573|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154733574|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154733575|NCT00942448|Analgesics|analgesics|mesh-ancestor
154733576|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
154733577|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733578|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733579|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733580|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733581|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154733582|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733583|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733584|NCT02982148|Methylene Blue|methylene blue|mesh-list
154733585|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733586|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733587|NCT04359316|Azithromycin|azithromycin|mesh-list
154733588|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
154733589|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154733590|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733591|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
154733592|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154733593|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154733594|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733595|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733596|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733597|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
154733598|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154733599|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153777304|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
154733600|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
154733601|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733602|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154733603|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154733604|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733605|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733606|NCT03557385|Adenosine|adenosine|mesh-list
154733607|NCT03557385|Analgesics|analgesics|mesh-ancestor
154733608|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
154733609|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733610|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733611|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154733612|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
154733613|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154733614|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
154733615|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
154733616|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733617|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733618|NCT05346861|Trastuzumab|trastuzumab|mesh-list
154733619|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154733620|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733621|NCT04358614|Ritonavir|ritonavir|mesh-list
154733622|NCT04358614|Lopinavir|lopinavir|mesh-list
154733623|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154733624|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154733625|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
154733626|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733627|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733628|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154733629|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154733630|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
154733631|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733632|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154733633|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154733634|NCT01670409|Cisplatin|cisplatin|mesh-list
154733635|NCT01670409|Fluorouracil|fluorouracil|mesh-list
154733636|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733637|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
154733638|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733639|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154733640|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154733641|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
154733642|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733643|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154733644|NCT04761705|Latanoprost|latanoprost|mesh-list
154733645|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154733646|NCT04358770|Clocortolone|clocortolone|mesh-list
154733647|NCT04358770|Fluocortolone|fluocortolone|mesh-list
154733648|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
154733649|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733650|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
154733651|NCT04358770|Hormones|hormones|mesh-ancestor
153777305|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
153777372|NCT00565006|Anacetrapib|anacetrapib|mesh-list
154733652|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154733653|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733654|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
154733655|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154733656|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154733657|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154733658|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733659|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733660|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
154733661|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733662|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733663|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154733664|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733665|NCT04358146|Locust bean gum|locust bean gum|mesh-list
154733666|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
154733667|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154733668|NCT05620498|Lenvatinib|lenvatinib|mesh-list
154733669|NCT05620498|Tislelizumab|tislelizumab|mesh-list
154733670|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733671|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154733672|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733673|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733674|NCT05620498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154733675|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
154733676|NCT01670565|Belimumab|belimumab|mesh-list
154733677|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154733678|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733679|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154733680|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
154733681|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154733682|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733683|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733684|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733685|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154733686|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
154733687|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733688|NCT01670799|Ketorolac|ketorolac|mesh-list
154733689|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154733690|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154733691|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154733692|NCT01670799|Analgesics|analgesics|mesh-ancestor
154733693|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
154733694|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733695|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733696|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733697|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733698|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154733699|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733700|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733701|NCT02404935|Cetuximab|cetuximab|mesh-list
154733702|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154733703|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733704|NCT04320940|Phenobarbital|phenobarbital|mesh-list
154733705|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
154733706|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154733707|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733708|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733709|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154733710|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154733711|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733712|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733713|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
154733714|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
154733715|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154733716|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154733717|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154733718|NCT03422523|Rituximab|rituximab|mesh-list
154733719|NCT03422523|Atezolizumab|atezolizumab|mesh-list
154733720|NCT03422523|Gemcitabine|gemcitabine|mesh-list
154733721|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
154733722|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154733723|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733724|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
154733725|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733726|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733727|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154733728|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
154733729|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733730|NCT03422523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154733731|NCT03032536|Tenofovir|tenofovir|mesh-list
154733732|NCT03032536|Entecavir|entecavir|mesh-list
154733733|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
154733734|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733735|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154733736|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154733737|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733738|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733739|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154733740|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154733741|NCT03032614|Carboplatin|carboplatin|mesh-list
154733742|NCT03032614|Veliparib|veliparib|mesh-list
154733743|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733744|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154733745|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733746|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733747|NCT03032458|Ketorolac|ketorolac|mesh-list
154733748|NCT03032458|Lidocaine|lidocaine|mesh-list
154485685|NCT02304354|Rituximab|rituximab|mesh-list
154733750|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
154733751|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
154733752|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154733753|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733754|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
154733755|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733756|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154733757|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154733758|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154733759|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154733760|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733761|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154733762|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154733763|NCT03032458|Analgesics|analgesics|mesh-ancestor
154733764|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733765|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733766|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154733767|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733768|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154733769|NCT03032458|Narcotics|narcotics|mesh-ancestor
154733770|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154733771|NCT02245438|Ritonavir|ritonavir|mesh-list
154733772|NCT02245438|Tipranavir|tipranavir|mesh-list
154733773|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154733774|NCT02245438|Norethindrone|norethindrone|mesh-list
154733775|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
154733776|NCT02245438|Norinyl|norinyl|mesh-list
154733777|NCT02245438|Estradiol|estradiol|mesh-list
154733778|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154733779|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154733780|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
154733781|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733782|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733783|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154733784|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154733785|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
154733786|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733787|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154733788|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154733789|NCT02245438|Estrogens|estrogens|mesh-ancestor
154733790|NCT02245438|Hormones|hormones|mesh-ancestor
154733791|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154733792|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733793|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154733794|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
154733795|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154733796|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154733797|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154733798|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154733799|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154733800|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154733801|NCT03087669|Norepinephrine|norepinephrine|mesh-list
154733802|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154733803|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154733804|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
154733805|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733806|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733807|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733808|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
154733809|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
154733810|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733811|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154733812|NCT00939952|Ertapenem|ertapenem|mesh-list
154733813|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154733814|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733815|NCT02401815|Sunitinib|sunitinib|mesh-list
154733816|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733817|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154733818|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154733819|NCT02401815|Growth Substances|growth substances|mesh-ancestor
154733820|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733821|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
154733822|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154733823|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733824|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733825|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
154733826|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
154733827|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154733828|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
154733829|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733830|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154733831|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733832|NCT03456687|Exenatide|exenatide|mesh-list
154733833|NCT03456687|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154733834|NCT03456687|Glucagon|glucagon|mesh-list
154733835|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154733836|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154733837|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733838|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154733839|NCT03456687|Incretins|incretins|mesh-ancestor
154733840|NCT03456687|Hormones|hormones|mesh-ancestor
154733841|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154733842|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154733843|NCT00948298|Vitamin D|vitamin d|mesh-list
154733844|NCT00948298|Vitamins|vitamins|mesh-ancestor
154733845|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
154733846|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733847|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154733848|NCT00948610|Infliximab|infliximab|mesh-list
154733849|NCT00948610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154733850|NCT00948610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154733851|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
154733852|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154733853|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733854|NCT03031834|Quinapril|quinapril|mesh-list
154733855|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154733856|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
154733857|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733858|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733859|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154733860|NCT00944554|Varenicline|varenicline|mesh-list
154733861|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154733862|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154733863|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
154733864|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777533|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
154733865|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733866|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733867|NCT03031756|Glycine|glycine|mesh-list
154733868|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
154733869|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733870|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733871|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733872|NCT00944710|Atropine|atropine|mesh-list
154733873|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154733874|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154733875|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154733876|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
154733877|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154733878|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733879|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154733880|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
154733881|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
154733882|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
154733883|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154733884|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154733885|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
154733886|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154733887|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733888|NCT00949078|Omalizumab|omalizumab|mesh-list
154733889|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154733890|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154733891|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
154733892|NCT00945256|Nitroprusside|nitroprusside|mesh-list
154733893|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154733894|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
154733895|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154733896|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733897|NCT03854032|Nivolumab|nivolumab|mesh-list
154733898|NCT03854032|Linrodostat|linrodostat|mesh-list
154733899|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154733900|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733901|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154733902|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733903|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733905|NCT03031444|Cetuximab|cetuximab|mesh-list
154733906|NCT03031444|Fluorouracil|fluorouracil|mesh-list
154733907|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
154733908|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154733909|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733910|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
154733911|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733912|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154733913|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154733914|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
153777622|NCT00252603|Galantamine|galantamine|mesh-list
154733915|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733916|NCT03031444|Antidotes|antidotes|mesh-ancestor
154733917|NCT03031444|Protective Agents|protective agents|mesh-ancestor
154733918|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
154733919|NCT03031444|Vitamins|vitamins|mesh-ancestor
154733920|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
154733921|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
154733922|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154733923|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
154733924|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733925|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
154733926|NCT03031054|Protective Agents|protective agents|mesh-ancestor
154733927|NCT00945334|Rifaximin|rifaximin|mesh-list
154733928|NCT00945334|Neomycin|neomycin|mesh-list
154733929|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154733930|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733931|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154733932|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154733933|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733934|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733935|NCT03559114|Dalteparin|dalteparin|mesh-list
154733936|NCT03559114|Tinzaparin|tinzaparin|mesh-list
154733937|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154733938|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
154733939|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154733940|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154733941|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733942|NCT05153590|Liraglutide|liraglutide|mesh-list
154733943|NCT05153590|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154733944|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154733945|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733946|NCT05153590|Incretins|incretins|mesh-ancestor
154733947|NCT05153590|Hormones|hormones|mesh-ancestor
154733948|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154733949|NCT04402203|Favipiravir|favipiravir|mesh-list
154733950|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
154733951|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733952|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
154733953|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154733954|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
154733955|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733956|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154733957|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154733958|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
154733959|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733960|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733961|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154733962|NCT00949234|Ritonavir|ritonavir|mesh-list
154733963|NCT00949234|Lopinavir|lopinavir|mesh-list
154733964|NCT00949234|Tenofovir|tenofovir|mesh-list
154733965|NCT00949234|Emtricitabine|emtricitabine|mesh-list
154733966|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154733967|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154733968|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
154733969|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154733970|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733971|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154733972|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154733973|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
154733974|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154733975|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154485893|NCT05532280|Etoricoxib|etoricoxib|mesh-list
154733976|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154733977|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154733978|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154733979|NCT03090880|Tinzaparin|tinzaparin|mesh-list
154733980|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154733981|NCT03090880|Dalteparin|dalteparin|mesh-list
154733982|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
153777678|NCT04598191|Iloprost|iloprost|mesh-list
154733983|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154733984|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154733985|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154733986|NCT03030430|Bevacizumab|bevacizumab|mesh-list
154733987|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154733988|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154733989|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154733990|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154733991|NCT03030430|Growth Substances|growth substances|mesh-ancestor
154733992|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733993|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
154733994|NCT00089661|Denosumab|denosumab|mesh-list
154733995|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154733996|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154733997|NCT00941668|Triclosan|triclosan|mesh-list
154733998|NCT00941668|Fluorides|fluorides|mesh-list
154733999|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
154734000|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
154734001|NCT00941668|Protective Agents|protective agents|mesh-ancestor
154734002|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734003|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154734004|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734005|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154734006|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154734007|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
154734008|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734009|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154734010|NCT01597414|Trastuzumab|trastuzumab|mesh-list
154734011|NCT01597414|Pertuzumab|pertuzumab|mesh-list
154734012|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154734013|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734014|NCT04984330|Dexamethasone|dexamethasone|mesh-list
154734015|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734016|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
154734017|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
154734018|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734019|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734020|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154734021|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
154734022|NCT04984330|Hormones|hormones|mesh-ancestor
154734023|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734024|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154734025|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734026|NCT03030196|Denosumab|denosumab|mesh-list
154734027|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154734028|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734029|NCT03035578|Morphine|morphine|mesh-list
154734030|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154734031|NCT03035578|Narcotics|narcotics|mesh-ancestor
154734032|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734033|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734034|NCT03035578|Analgesics|analgesics|mesh-ancestor
154734035|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
154734036|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734037|NCT04933942|Lomustine|lomustine|mesh-list
154734038|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154734039|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
154734040|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734041|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734042|NCT00089583|Ritonavir|ritonavir|mesh-list
154734043|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
154734044|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154734045|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154734046|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
154734047|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734048|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734049|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154734050|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154485979|NCT03353948|Metformin|metformin|mesh-list
154734051|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
154734052|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734053|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154734054|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154734055|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
154734056|NCT03029494|Vitamins|vitamins|mesh-ancestor
154734057|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
154734058|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734059|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
154734060|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734061|NCT03029494|Protective Agents|protective agents|mesh-ancestor
154734062|NCT04402047|Diclofenac|diclofenac|mesh-list
154734063|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154734064|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154734065|NCT04402047|Analgesics|analgesics|mesh-ancestor
154734066|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
154734067|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734068|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734069|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734070|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734071|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154734072|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734073|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734074|NCT03017248|Ketamine|ketamine|mesh-list
154734075|NCT03017248|Morphine|morphine|mesh-list
154734076|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154734077|NCT03017248|Analgesics|analgesics|mesh-ancestor
154734078|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
154734079|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734080|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734081|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154734082|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154734083|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
154734084|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
154734085|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734086|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154734087|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154734088|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734089|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734090|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154734091|NCT03017248|Narcotics|narcotics|mesh-ancestor
154734092|NCT00088881|Prednisone|prednisone|mesh-list
154734093|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
154734094|NCT00088881|Rituximab|rituximab|mesh-list
154734095|NCT00088881|Doxorubicin|doxorubicin|mesh-list
154734096|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154734097|NCT00088881|Vincristine|vincristine|mesh-list
154734098|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154734099|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
154734100|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734101|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734102|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154734103|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
154734104|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734105|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734106|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154734107|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154734108|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154734109|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154734110|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154734111|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734112|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734113|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
154734114|NCT00088881|Hormones|hormones|mesh-ancestor
154734115|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734116|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154734117|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154734118|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
154734119|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
154734120|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
154734121|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
154734122|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154734123|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734124|NCT02981914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154860371|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154734125|NCT02981914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734126|NCT03025750|Vaccines|vaccines|mesh-list
154734127|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
154734128|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734129|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
154734130|NCT03017404|Docetaxel|docetaxel|mesh-list
154734131|NCT03017404|Doxorubicin|doxorubicin|mesh-list
154734132|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154734133|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154734134|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
154734135|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734136|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734137|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154734138|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
154734139|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734140|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734141|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154734142|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
154734143|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
154734144|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
154734145|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154734146|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154734147|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154734148|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734149|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
154734150|NCT00953212|Amiodarone|amiodarone|mesh-list
154734151|NCT00953212|Metoprolol|metoprolol|mesh-list
154734152|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154734153|NCT00953212|Vitamins|vitamins|mesh-ancestor
154734154|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
154734155|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734156|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
154734157|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734158|NCT00953212|Protective Agents|protective agents|mesh-ancestor
154734159|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154734160|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
154734161|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734162|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154734163|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
154734164|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154734165|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154734166|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154734167|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154734168|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154734169|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734170|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154734171|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154734172|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154734173|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154734174|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
154734175|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
154734176|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734177|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154734178|NCT03034408|Mannitol|mannitol|mesh-list
154734179|NCT03034408|Baclofen|baclofen|mesh-list
154734180|NCT03034408|Nalmefene|nalmefene|mesh-list
154734181|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154734182|NCT03034408|Diuretics|diuretics|mesh-ancestor
154734183|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
154734184|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734185|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154734186|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154734187|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734188|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154734189|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
154734190|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
154734191|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734192|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734193|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154734194|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
154734195|NCT03023020|Aspirin|aspirin|mesh-list
154734196|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154734197|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154486119|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
154734198|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154734199|NCT03023020|Analgesics|analgesics|mesh-ancestor
154734200|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
154734201|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734202|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734203|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734204|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734205|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154734206|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154734207|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734208|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154734209|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734210|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
154734211|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
154734212|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154734213|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154734214|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154734215|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
154734216|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
154734217|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734218|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734219|NCT03022318|Levodopa|levodopa|mesh-list
154734220|NCT03022318|Carbidopa|carbidopa|mesh-list
154734221|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154734222|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154734223|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154734224|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
154734225|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734226|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734227|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734228|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154734229|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734230|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154734231|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
154734232|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
154734233|NCT01677897|Metformin|metformin|mesh-list
154734234|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154734235|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734236|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154734237|NCT03483363|Bacitracin|bacitracin|mesh-list
154734238|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154734239|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734240|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
154734241|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154734242|NCT03086733|Metformin|metformin|mesh-list
154734243|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154734244|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734245|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
154734246|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734247|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154734248|NCT00085917|Interferons|interferons|mesh-list
154734249|NCT00085917|Ribavirin|ribavirin|mesh-list
154734250|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
154734251|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154734252|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734253|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
154734254|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734255|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
154734256|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734257|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
154734258|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734259|NCT00084747|Bortezomib|bortezomib|mesh-list
154734260|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734261|NCT04402671|Glutaral|glutaral|mesh-list
154734262|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
154734263|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734264|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
154734265|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154734266|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734267|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154734268|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734269|NCT01678365|Metronidazole|metronidazole|mesh-list
154734270|NCT01678365|Gentamicins|gentamicins|mesh-list
154734271|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
154734272|NCT01678365|Ampicillin|ampicillin|mesh-list
154734273|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734274|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154734275|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154734276|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154734277|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154734278|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734279|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734280|NCT01678365|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154734281|NCT01678365|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154734282|NCT00946270|Thalidomide|thalidomide|mesh-list
154734284|NCT00946270|Pomalidomide|pomalidomide|mesh-list
154734285|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734286|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
154734287|NCT00946270|Hormones|hormones|mesh-ancestor
154734288|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734289|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734290|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154734291|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734292|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
154734293|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154734294|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154734295|NCT00946270|Growth Substances|growth substances|mesh-ancestor
154734296|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
154734297|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154734298|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
154734299|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154734300|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734301|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
154734302|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154734303|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734304|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154734305|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154734306|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734307|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734308|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734309|NCT03021694|Caseins|caseins|mesh-list
154734310|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
154734311|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
154734312|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734313|NCT00956254|Fentanyl|fentanyl|mesh-list
154734314|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154734315|NCT00956254|Narcotics|narcotics|mesh-ancestor
154734316|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734317|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734318|NCT00956254|Analgesics|analgesics|mesh-ancestor
154734319|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
154734320|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734321|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154734322|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154734323|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
154734324|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
154734325|NCT03020680|Ubiquinone|ubiquinone|mesh-list
154734326|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
154734327|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
154734328|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734329|NCT03020680|Vitamins|vitamins|mesh-ancestor
154734330|NCT01678599|Benzonidazole|benzonidazole|mesh-list
154734331|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154734332|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
154734333|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734334|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154734335|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154734336|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154734337|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734338|NCT03019822|Amphetamine|amphetamine|mesh-list
154734339|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
154734340|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154734341|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154734342|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154734343|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734344|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
154734345|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
154734346|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734347|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
154734348|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734349|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734350|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
154734351|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154486269|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
154734352|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154734353|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154734354|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154734355|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
154734356|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154734357|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
154734358|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154734359|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154734360|NCT01678677|Vaccines|vaccines|mesh-list
154734361|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
154734362|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734363|NCT00946348|Dronabinol|dronabinol|mesh-list
154734364|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
154734365|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734366|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154734367|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154734368|NCT00946348|Analgesics|analgesics|mesh-ancestor
154734369|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
154734370|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734371|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154734372|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154734373|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734374|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734375|NCT00946348|Hormones|hormones|mesh-ancestor
154734376|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734377|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
154734378|NCT00081159|Doxorubicin|doxorubicin|mesh-list
154734379|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154734380|NCT00081159|Leuprolide|leuprolide|mesh-list
154734381|NCT00081159|Goserelin|goserelin|mesh-list
154734382|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154734383|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734384|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154734385|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154734386|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734387|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734388|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154734389|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734390|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154734391|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
154734392|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154734393|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154734394|NCT03033472|Clindamycin|clindamycin|mesh-list
154734395|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
154734396|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
154734397|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154734398|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734399|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154734400|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734401|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734402|NCT02981836|Vaccines|vaccines|mesh-list
154734403|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
154734404|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734405|NCT03033160|Estradiol|estradiol|mesh-list
154734406|NCT03033160|Estrogens|estrogens|mesh-ancestor
154734407|NCT03033160|Hormones|hormones|mesh-ancestor
154734408|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734409|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734410|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154734411|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154734412|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734413|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154734414|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154734415|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154734416|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734417|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
154734418|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734419|NCT03033316|Dexamethasone|dexamethasone|mesh-list
154734420|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734421|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
154734422|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
154734423|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734424|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734425|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154734426|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
154734427|NCT03033316|Hormones|hormones|mesh-ancestor
154734428|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615450|NCT01975441|Ivermectin|ivermectin|mesh-list
154734429|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154734430|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734431|NCT03032848|Estrogens|estrogens|mesh-list
154734432|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154734433|NCT03032848|Hormones|hormones|mesh-ancestor
154734434|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734435|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734436|NCT00080223|Pirfenidone|pirfenidone|mesh-list
154734437|NCT00080223|Analgesics|analgesics|mesh-ancestor
154734438|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
154734439|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734440|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734441|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154734442|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154734443|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734444|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734445|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734446|NCT04402359|Meropenem|meropenem|mesh-list
154734447|NCT04402359|Ceftazidime|ceftazidime|mesh-list
154734448|NCT04402359|Avibactam|avibactam|mesh-list
154734449|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154734450|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734451|NCT04402359|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154734452|NCT04402359|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154734453|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154734454|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734455|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734456|NCT00959764|Calcitonin|calcitonin|mesh-list
154734457|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
154734458|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154734459|NCT00959764|Katacalcin|katacalcin|mesh-list
154734460|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154734461|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734462|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154734463|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
154734464|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
154734465|NCT01005706|Sirolimus|sirolimus|mesh-list
154734466|NCT01005706|Temsirolimus|temsirolimus|mesh-list
154734467|NCT01005706|MTOR Inhibitors|mtor inhibitors|mesh-list
154734468|NCT01005706|Tacrolimus|tacrolimus|mesh-list
154734469|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154734470|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
154734471|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734472|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154734473|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734474|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734475|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154734476|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734477|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154734478|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
154734479|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154734480|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734481|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
154734482|NCT01005706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154734483|NCT01679691|Anesthetics|anesthetics|mesh-list
154734484|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734485|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734486|NCT03470805|Olaparib|olaparib|mesh-list
154734487|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154734488|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734489|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734490|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734491|NCT03084549|Ropivacaine|ropivacaine|mesh-list
154734492|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
154734493|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
154734494|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734495|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734496|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
154734497|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734498|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154734499|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734500|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154734501|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734502|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154734503|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154734504|NCT01006252|Paclitaxel|paclitaxel|mesh-list
154734505|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154734506|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734507|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
154734508|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
154734509|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
154734510|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734511|NCT03080805|Capecitabine|capecitabine|mesh-list
154734512|NCT03080805|Lapatinib|lapatinib|mesh-list
154734513|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154734514|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
154734515|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734516|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734517|NCT03080805|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154734518|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154734519|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734520|NCT03019120|Vitamin D|vitamin d|mesh-list
154734521|NCT03019120|Vitamins|vitamins|mesh-ancestor
154734522|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
154734523|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734524|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154734525|NCT00960622|Tenofovir|tenofovir|mesh-list
154734526|NCT00960622|Lamivudine|lamivudine|mesh-list
154734527|NCT00960622|Emtricitabine|emtricitabine|mesh-list
154734528|NCT00960622|Zidovudine|zidovudine|mesh-list
154734529|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154734530|NCT00960622|Abacavir|abacavir|mesh-list
154734531|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
154734532|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154734533|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
154734534|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734535|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154734536|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154734537|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734538|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734539|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154734540|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154734541|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
153778422|NCT00253929|Adenosine|adenosine|mesh-list
154734542|NCT03430947|Vemurafenib|vemurafenib|mesh-list
154734543|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734544|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154734545|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734546|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734547|NCT00960778|Nicotine|nicotine|mesh-list
154734548|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154734549|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
154734550|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734551|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734552|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154734553|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154734554|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
154734555|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734556|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734557|NCT03080181|Pasireotide|pasireotide|mesh-list
154734558|NCT03080181|Hormones|hormones|mesh-ancestor
154734559|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734560|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734561|NCT03088293|Infliximab|infliximab|mesh-list
154734562|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
154734563|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154734564|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
154734565|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734566|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734567|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154734568|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
154734569|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734570|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734571|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154734572|NCT03088293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154734573|NCT03088293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734574|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
154734575|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154734576|NCT01008280|Baclofen|baclofen|mesh-list
154734577|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154734578|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734579|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154734580|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734581|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154734582|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
154734583|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
154734584|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734585|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734586|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154734587|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
154734588|NCT03089073|Coagulants|coagulants|mesh-ancestor
154734589|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154734590|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
154734591|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734592|NCT05688813|Anesthetics|anesthetics|mesh-list
154734593|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734594|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734595|NCT01009918|Carvedilol|carvedilol|mesh-list
154734596|NCT01009918|Lisinopril|lisinopril|mesh-list
154734597|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154734598|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154734599|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
154734600|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734601|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734602|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734603|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154734604|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
154734605|NCT01009918|Protective Agents|protective agents|mesh-ancestor
154734606|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154734607|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154734608|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154734609|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
154734610|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154734611|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154734612|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154734613|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
154734614|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734615|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154734616|NCT04401657|Adenosine|adenosine|mesh-list
154734617|NCT04401657|Analgesics|analgesics|mesh-ancestor
154734618|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
154734619|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734620|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734621|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154734622|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
154734623|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154734624|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
154734625|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
154734626|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734627|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734628|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
154734629|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154734630|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154734631|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734632|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
154734633|NCT03019198|Coagulants|coagulants|mesh-ancestor
154734634|NCT03083613|Paclitaxel|paclitaxel|mesh-list
154734635|NCT03083613|Raltitrexed|raltitrexed|mesh-list
154734636|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154734637|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734638|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
154734639|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
154734640|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
154734641|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734642|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154734643|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
154734644|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154734645|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734646|NCT00963508|Permethrin|permethrin|mesh-list
154734647|NCT00963508|Malathion|malathion|mesh-list
154734648|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734649|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734650|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154734651|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
154734652|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734653|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734655|NCT03088371|Bupivacaine|bupivacaine|mesh-list
154734656|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
154734657|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
154734658|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734659|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734660|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
154734661|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734662|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154734663|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154734664|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154734665|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154734666|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734667|NCT05685537|Simendan|simendan|mesh-list
154734668|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154734669|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
154734670|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154734671|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154734672|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734673|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734674|NCT05685537|Protective Agents|protective agents|mesh-ancestor
154734675|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734676|NCT04400721|Ropivacaine|ropivacaine|mesh-list
154734677|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
154734678|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
154734679|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734680|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734681|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
154734682|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734683|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154734684|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
154734685|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
154734686|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734687|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
154734688|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154734689|NCT03018652|Antibodies|antibodies|mesh-list
154734690|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
154734691|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154734692|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
154734693|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734694|NCT01012336|Dexamethasone|dexamethasone|mesh-list
154734695|NCT01012336|Aprepitant|aprepitant|mesh-list
154734696|NCT01012336|Ramosetron|ramosetron|mesh-list
154734697|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734698|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
154734699|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
154734700|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734701|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734702|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154734703|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
154734704|NCT01012336|Hormones|hormones|mesh-ancestor
154734705|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734706|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154734707|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734708|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154734709|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734710|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734711|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154734712|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
154734713|NCT03387501|Mitogens|mitogens|mesh-list
154734714|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
154734715|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734716|NCT01012492|Abatacept|abatacept|mesh-list
154734717|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154734718|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734719|NCT01012492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154734720|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734721|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154734722|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
154486645|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154734723|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734724|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734725|NCT03083457|Anesthetics|anesthetics|mesh-list
154734726|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
154734727|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734728|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734729|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
154734730|NCT04401345|Bromides|bromides|mesh-list
154734731|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
154734732|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154734733|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154734734|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154734735|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
154734736|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734737|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734738|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734739|NCT01015534|Temozolomide|temozolomide|mesh-list
154734740|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154734741|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
154734742|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734743|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734744|NCT00968890|Vaccines|vaccines|mesh-list
154734745|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
154734746|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734747|NCT00970216|Telbivudine|telbivudine|mesh-list
154734748|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
154734749|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734750|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154734751|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734752|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734753|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
154734754|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154734755|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154734756|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154734757|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154734758|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734759|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
154734760|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734761|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734762|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154734763|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734764|NCT01884922|Vinblastine|vinblastine|mesh-list
154734765|NCT01884922|Nilotinib|nilotinib|mesh-list
154734766|NCT01884922|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154734767|NCT01884922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154734768|NCT01884922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734769|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734770|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154734771|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734772|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
154734773|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
154734774|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
154734775|NCT05687409|Entecavir|entecavir|mesh-list
154734776|NCT05687409|Lactulose|lactulose|mesh-list
154734777|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154734778|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
154734779|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734780|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154734781|NCT02162680|Lidocaine|lidocaine|mesh-list
154734782|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
154734783|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
154734784|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734785|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734786|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
154734787|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734788|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154734789|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154734790|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154734791|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154734792|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734793|NCT01017250|Bevacizumab|bevacizumab|mesh-list
154734794|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154734795|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734796|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154734797|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154734798|NCT01017250|Growth Substances|growth substances|mesh-ancestor
154734799|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734800|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
154734801|NCT00812032|Aspirin|aspirin|mesh-list
154734802|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154734803|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154734804|NCT00812032|Analgesics|analgesics|mesh-ancestor
154734805|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
154734806|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734807|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734808|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734809|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734810|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154734811|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154734812|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734813|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154734814|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154734815|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734816|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
154734817|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
154734818|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154734819|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734820|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154734821|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734822|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734823|NCT00417664|Midazolam|midazolam|mesh-list
154734824|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
154734825|NCT00417664|Propofol|propofol|mesh-list
154734826|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154734827|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734828|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734829|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154734830|NCT00417664|Analgesics|analgesics|mesh-ancestor
154734831|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
154734832|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734833|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154734834|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154734835|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154734836|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
154734837|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734838|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734839|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154734840|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
154734841|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
154734842|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154734843|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154734844|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154734845|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154734846|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
154734847|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
154734848|NCT01021618|Dipyridamole|dipyridamole|mesh-list
154734849|NCT01021618|Regadenoson|regadenoson|mesh-list
154734850|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154734851|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154734852|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
154734853|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
154734854|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154734855|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734856|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734857|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154734858|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734859|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154734860|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
154734861|NCT03082053|Capecitabine|capecitabine|mesh-list
154734862|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154734863|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
154734864|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734865|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734866|NCT03358563|Docetaxel|docetaxel|mesh-list
154734867|NCT03358563|Bicalutamide|bicalutamide|mesh-list
154734868|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154734869|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734870|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
154486795|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154734871|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
154734872|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
154734873|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734874|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
154734875|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
154734876|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734877|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734878|NCT03358563|Hematinics|hematinics|mesh-ancestor
154734879|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154734880|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154734881|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
154734882|NCT01018420|Colchicine|colchicine|mesh-list
154734883|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154734884|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734885|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154734886|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154734887|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734888|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734889|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734890|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
154734891|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734892|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
154734893|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
154734894|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
154734895|NCT00974350|Bupivacaine|bupivacaine|mesh-list
154734896|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
154734897|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
154734898|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734899|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734900|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
154734901|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734902|NCT05395702|Interferons|interferons|mesh-list
154734903|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
154734904|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734905|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
154734906|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734907|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154734908|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154734909|NCT01023178|Estradiol|estradiol|mesh-list
154734910|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154734911|NCT01023178|Estrogens|estrogens|mesh-list
154734912|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154734913|NCT01023178|Progesterone|progesterone|mesh-list
154734914|NCT01023178|Hormones|hormones|mesh-ancestor
154734915|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154734916|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734917|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154734918|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
154734919|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154734920|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154734921|NCT01023178|Progestins|progestins|mesh-ancestor
154734922|NCT03373851|Sufentanil|sufentanil|mesh-list
154734923|NCT03373851|Dsuvia|dsuvia|mesh-list
154734924|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154734925|NCT03373851|Narcotics|narcotics|mesh-ancestor
154734926|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154734927|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734928|NCT03373851|Analgesics|analgesics|mesh-ancestor
154734929|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
154734930|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734931|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154734932|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154734933|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
154734934|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
154734935|NCT01023724|Ketorolac|ketorolac|mesh-list
154734936|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154734937|NCT01023724|Bromfenac|bromfenac|mesh-list
154734938|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154734939|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154734940|NCT01023724|Analgesics|analgesics|mesh-ancestor
154734941|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
154734942|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154734943|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734944|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154734945|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734946|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154734947|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734948|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734950|NCT00974818|Mitomycin|mitomycin|mesh-list
154734951|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
154734952|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154734953|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734954|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
154734955|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734956|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154734957|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734958|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154734959|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
154734960|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734961|NCT03371667|Methotrexate|methotrexate|mesh-list
154734962|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154734963|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
154734964|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154734965|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734966|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154734967|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
154734968|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734969|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154734970|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
154734971|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154734972|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154734973|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154734974|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
154734975|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154734976|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154734977|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
154734978|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154734979|NCT01024738|Triclosan|triclosan|mesh-list
154734980|NCT01024738|Fluorides|fluorides|mesh-list
154734981|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
154734982|NCT01024738|Protective Agents|protective agents|mesh-ancestor
154734983|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734984|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154734985|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154734986|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
154734987|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
154734988|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154734989|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154734990|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
154734991|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154734992|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154734993|NCT01024972|Mannitol|mannitol|mesh-list
154734994|NCT01024972|Dantrolene|dantrolene|mesh-list
154734995|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154734996|NCT01024972|Diuretics|diuretics|mesh-ancestor
154734997|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
154734998|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154734999|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154735000|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154735001|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735002|NCT05686395|Bupivacaine|bupivacaine|mesh-list
154735003|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
154735004|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
154735005|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735006|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735007|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
154735008|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735009|NCT01025830|Lamivudine|lamivudine|mesh-list
154735010|NCT01025830|Nevirapine|nevirapine|mesh-list
154735011|NCT01025830|Stavudine|stavudine|mesh-list
154735012|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
154735013|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154735014|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154735015|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735016|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735017|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
154735018|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735019|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154735020|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154735021|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154735022|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154735023|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
154735024|NCT03081039|Carboplatin|carboplatin|mesh-list
154735025|NCT03081039|Gemcitabine|gemcitabine|mesh-list
154735026|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735027|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154735028|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
154735029|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735030|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
154735031|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154735032|NCT01026844|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154735033|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735034|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735035|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735036|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735037|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
154735038|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154735039|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154735040|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735041|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735042|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
154735043|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154735044|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735045|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
154735046|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735047|NCT00979732|Protective Agents|protective agents|mesh-ancestor
154735048|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735049|NCT01027468|Bevacizumab|bevacizumab|mesh-list
154735050|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735051|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735052|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154735053|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154735054|NCT01027468|Growth Substances|growth substances|mesh-ancestor
154735055|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735056|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
154735057|NCT04278807|Anesthetics|anesthetics|mesh-list
154735058|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735059|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735060|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154735061|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735062|NCT03274401|Anticoagulants|anticoagulants|mesh-list
154735063|NCT05086107|Rifabutin|rifabutin|mesh-list
154735064|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154735065|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735066|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154735067|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
154735068|NCT01029730|Rituximab|rituximab|mesh-list
154735069|NCT01029730|Bortezomib|bortezomib|mesh-list
154735070|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154735071|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735072|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735073|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
154735074|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735075|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735076|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154735077|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
154735078|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735079|NCT05066997|Dexamethasone|dexamethasone|mesh-list
154735080|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
154735081|NCT05066997|BB 1101|bb 1101|mesh-list
154735082|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735083|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
154735084|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
154735085|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735086|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735087|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154735088|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
154735089|NCT05066997|Hormones|hormones|mesh-ancestor
154735090|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735091|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154735092|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735093|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
154735094|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735095|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735096|NCT05025033|Paclitaxel|paclitaxel|mesh-list
154735097|NCT05025033|Irinotecan|irinotecan|mesh-list
154735098|NCT05025033|Apatinib|apatinib|mesh-list
154735099|NCT05025033|Antibodies|antibodies|mesh-list
154735100|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
154735101|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154735102|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735103|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
154735104|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
154735105|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
154735106|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735107|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
154735108|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735109|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154735110|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154735111|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735112|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735113|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154735114|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
154735115|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154735116|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154735117|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735118|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735119|NCT00981214|Pancrelipase|pancrelipase|mesh-list
154735120|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154735121|NCT05415657|Denosumab|denosumab|mesh-list
154735122|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154735123|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735124|NCT03016234|Propofol|propofol|mesh-list
154735125|NCT03016234|Desflurane|desflurane|mesh-list
154735126|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154735127|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735128|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735129|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154735130|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
154735131|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
154735132|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154735133|NCT02167204|Alovudine|alovudine|mesh-list
154735134|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
154735135|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735136|NCT00982072|Prednisolone|prednisolone|mesh-list
154735137|NCT00982072|Tacrolimus|tacrolimus|mesh-list
154735138|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735139|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
154735140|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735141|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154735142|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735143|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735144|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735145|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
154735146|NCT00982072|Hormones|hormones|mesh-ancestor
154735147|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735148|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154735149|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735150|NCT01899053|Serabelisib|serabelisib|mesh-list
154735151|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735152|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735153|NCT01032694|Azithromycin|azithromycin|mesh-list
154735154|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154735155|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735156|NCT01032850|Capecitabine|capecitabine|mesh-list
154735157|NCT01032850|Sorafenib|sorafenib|mesh-list
154735158|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154735159|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
154735160|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735161|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735162|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735163|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735164|NCT00983242|Colchicine|colchicine|mesh-list
154735165|NCT00983242|Verapamil|verapamil|mesh-list
154735166|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
154735167|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735168|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
154735169|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
154735170|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
154735171|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735172|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735173|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154735174|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154735175|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735176|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154735177|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735178|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
154735179|NCT00984334|Naloxone|naloxone|mesh-list
154735180|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154735181|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735182|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
154735183|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735184|NCT02168062|Leuprolide|leuprolide|mesh-list
154735185|NCT02168062|Goserelin|goserelin|mesh-list
154735186|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154735187|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154735188|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
154735189|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154735190|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735191|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154735192|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735193|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
154735194|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154735195|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
154735196|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154735197|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154735198|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735199|NCT05343117|Palbociclib|palbociclib|mesh-list
154735200|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735201|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735202|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735203|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735204|NCT01898195|Varenicline|varenicline|mesh-list
154735205|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154735206|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154735207|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
154735208|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735209|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735210|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735211|NCT01897727|Spironolactone|spironolactone|mesh-list
154735212|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154735213|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
154735214|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735215|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735216|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154735217|NCT01897727|Diuretics|diuretics|mesh-ancestor
154735218|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
154735219|NCT01897493|Digoxin|digoxin|mesh-list
154735220|NCT01897493|Evacetrapib|evacetrapib|mesh-list
154735221|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154735222|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154735223|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735224|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735225|NCT01897493|Protective Agents|protective agents|mesh-ancestor
154735226|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735227|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154735228|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154735229|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
154735230|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154735231|NCT01887353|Ranolazine|ranolazine|mesh-list
154735232|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154735233|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735234|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735235|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154735236|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
153779393|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779394|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154735237|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154735238|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154735239|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735240|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735241|NCT02160730|Roscovitine|roscovitine|mesh-list
154735242|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735243|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
154735244|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735245|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735246|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735247|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735248|NCT01896869|Ipilimumab|ipilimumab|mesh-list
154735249|NCT01896869|Folfirinox|folfirinox|mesh-list
154735250|NCT01896869|Vaccines|vaccines|mesh-list
154735251|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
154735252|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735253|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735254|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735255|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154735256|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735257|NCT03329001|Niraparib|niraparib|mesh-list
154735258|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154735259|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735260|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735261|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735262|NCT01896557|Omeprazole|omeprazole|mesh-list
154735263|NCT01896557|Ranitidine|ranitidine|mesh-list
154735264|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154735265|NCT01896557|Clopidogrel|clopidogrel|mesh-list
154735266|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
154735267|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154735268|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154735269|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154735270|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
154735271|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735272|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735273|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735274|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154735275|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154735276|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154735277|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735278|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154735279|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
154735280|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
154735281|NCT02160808|Secretin|secretin|mesh-list
154735282|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154735283|NCT02160808|Hormones|hormones|mesh-ancestor
154735284|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735285|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735286|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
154735287|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154735288|NCT01886105|Analgesics|analgesics|mesh-ancestor
154735289|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
154735290|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735291|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735292|NCT03262779|Nivolumab|nivolumab|mesh-list
154735293|NCT03262779|Ipilimumab|ipilimumab|mesh-list
154735294|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735295|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735296|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154735297|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735298|NCT05022394|Nivolumab|nivolumab|mesh-list
154735299|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735300|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735301|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154735302|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735303|NCT01895777|Dabigatran|dabigatran|mesh-list
154735304|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
154735305|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154735306|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
154735307|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735308|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735309|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
154735310|NCT00992602|Cytarabine|cytarabine|mesh-list
154735311|NCT00992602|Methotrexate|methotrexate|mesh-list
153779447|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
153779495|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779496|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
154735312|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154735313|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
154735314|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154735315|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735316|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154735317|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
154735318|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735319|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735320|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
154735321|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735322|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154735323|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735324|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
154735325|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735326|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154735327|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
154735328|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735329|NCT00993226|Bupivacaine|bupivacaine|mesh-list
154735330|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
154735331|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
154735332|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735333|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735334|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
154735335|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735336|NCT01885559|Telmisartan|telmisartan|mesh-list
154735337|NCT01885559|Lisinopril|lisinopril|mesh-list
154735338|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154735339|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154735340|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154735341|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154735342|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735343|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
154735344|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735345|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154735346|NCT01885559|Protective Agents|protective agents|mesh-ancestor
154735347|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735348|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
154735349|NCT00994318|Hematinics|hematinics|mesh-ancestor
154735350|NCT00995722|Prednisone|prednisone|mesh-list
154735351|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735352|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
154735353|NCT00995722|Hormones|hormones|mesh-ancestor
154735354|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735355|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735356|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154735357|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735358|NCT00996346|Sirolimus|sirolimus|mesh-list
154735359|NCT00996346|Irinotecan|irinotecan|mesh-list
154735360|NCT00996346|Temsirolimus|temsirolimus|mesh-list
154735361|NCT00996346|MTOR Inhibitors|mtor inhibitors|mesh-list
154735362|NCT00996346|Complement Factor H|complement factor h|mesh-list
154735363|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154735364|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154735365|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735366|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735367|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735368|NCT00996346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735369|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735370|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
154735371|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735372|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154735373|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735374|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154735375|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
154735376|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154735377|NCT03016468|Treprostinil|treprostinil|mesh-list
154735378|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154735379|NCT00997204|Icatibant|icatibant|mesh-list
154735380|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154735381|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154735382|NCT00997204|Analgesics|analgesics|mesh-ancestor
154735383|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
154735384|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735385|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735386|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735387|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735388|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154735389|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154735390|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735391|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154735392|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735393|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
154735394|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154735395|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
154735396|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735397|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
154735398|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735399|NCT04225390|Dacarbazine|dacarbazine|mesh-list
154735400|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154735401|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
154735402|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735403|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735404|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
154735405|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
154735406|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154735407|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735408|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735409|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
154735410|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154735411|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735412|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735413|NCT04606797|Nicotine|nicotine|mesh-list
154735414|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154735415|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
154735416|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735417|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735418|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154735419|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154735420|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
154735421|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735422|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735423|NCT02164240|Sunitinib|sunitinib|mesh-list
154735424|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735425|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154735426|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154735427|NCT02164240|Growth Substances|growth substances|mesh-ancestor
154735428|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735429|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
154735430|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735431|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735432|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735433|NCT02169466|Opicapone|opicapone|mesh-list
154735434|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
154735435|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154735436|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735437|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735438|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154735439|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154735440|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
154735441|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735442|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735443|NCT01001806|Ketorolac|ketorolac|mesh-list
154735444|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154735445|NCT01001806|Nepafenac|nepafenac|mesh-list
154735446|NCT01001806|Bromfenac|bromfenac|mesh-list
154735447|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154735448|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154735449|NCT01001806|Analgesics|analgesics|mesh-ancestor
154735450|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
154735451|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735452|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735453|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735454|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735455|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154735456|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735457|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735458|NCT04021264|Sufentanil|sufentanil|mesh-list
154735459|NCT04021264|Ropivacaine|ropivacaine|mesh-list
154735460|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
154735461|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
154735462|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735463|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735464|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
154735465|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735466|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154735467|NCT04021264|Narcotics|narcotics|mesh-ancestor
154735468|NCT04021264|Analgesics|analgesics|mesh-ancestor
154735469|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154735470|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154735471|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
154735472|NCT03232593|Atezolizumab|atezolizumab|mesh-list
154735473|NCT03232593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154735474|NCT03232593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735475|NCT03232593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735476|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735477|NCT01895309|Etanercept|etanercept|mesh-list
154735478|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154735479|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154735480|NCT01895309|Analgesics|analgesics|mesh-ancestor
154735481|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
153779700|NCT04573153|Cathartics|cathartics|mesh-ancestor
154735482|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735483|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735484|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735485|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735486|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154735487|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735488|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
154735489|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154735490|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154735491|NCT04323748|Rituximab|rituximab|mesh-list
154735492|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735493|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735494|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
154735495|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735496|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735497|NCT02808364|Vaccines|vaccines|mesh-list
154735498|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
154735499|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735500|NCT02709616|Vaccines|vaccines|mesh-list
154735501|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
154735502|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735503|NCT01894919|Vaccines|vaccines|mesh-list
154735504|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
154735505|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735506|NCT04130698|Nicotine|nicotine|mesh-list
154735507|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154735508|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
154735509|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735510|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735511|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154735512|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154735513|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
154735514|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735515|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735516|NCT05306223|Levofloxacin|levofloxacin|mesh-list
154735517|NCT05306223|Cycloserine|cycloserine|mesh-list
154735518|NCT05306223|Linezolid|linezolid|mesh-list
154735519|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
154735520|NCT05306223|Bedaquiline|bedaquiline|mesh-list
154735521|NCT05306223|Clofazimine|clofazimine|mesh-list
154735522|NCT05306223|Prothionamide|prothionamide|mesh-list
154735523|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154735524|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735525|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154735526|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154735527|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154735528|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735529|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735530|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735531|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154735532|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154735533|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154735534|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154735535|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
154735536|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
154735537|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735538|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
154735539|NCT03016000|Thalidomide|thalidomide|mesh-list
154735540|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735541|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
154735542|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735543|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
154735544|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154735545|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735546|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154735547|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154735548|NCT03016000|Growth Substances|growth substances|mesh-ancestor
154735549|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
154735550|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735551|NCT04130152|Letrozole|letrozole|mesh-list
154735552|NCT04130152|Palbociclib|palbociclib|mesh-list
154735553|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735554|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154735555|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154735556|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735557|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735558|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154735559|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
154735560|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735561|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735562|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735563|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
154735564|NCT03254589|Methotrexate|methotrexate|mesh-list
154735565|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154735566|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
154735567|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154735568|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779748|NCT00255606|Prednisone|prednisone|mesh-list
154735569|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154735570|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
154735571|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735572|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735573|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
154735574|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735575|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154735576|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735577|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
154735578|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735579|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154735580|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735581|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154735582|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154735583|NCT03254589|Analgesics|analgesics|mesh-ancestor
154735584|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
154735585|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735586|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735587|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154735588|NCT04399395|Naltrexone|naltrexone|mesh-list
154735589|NCT04399395|Bupropion|bupropion|mesh-list
154735590|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154735591|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154735592|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735593|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
154735594|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735595|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154735596|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
154735597|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154735598|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154735599|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154735600|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735601|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735602|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
154735603|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735604|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154735605|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154735606|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735607|NCT02000596|Trastuzumab|trastuzumab|mesh-list
154735608|NCT02000596|Pertuzumab|pertuzumab|mesh-list
154735609|NCT02000596|Fulvestrant|fulvestrant|mesh-list
154735610|NCT02000596|Anastrozole|anastrozole|mesh-list
154735611|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735612|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735613|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154735614|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154735615|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154735616|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
154735617|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735618|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735619|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154735620|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154487552|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
154735621|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735622|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735623|NCT03223779|Trifluridine|trifluridine|mesh-list
154735624|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
154735625|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735626|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
154735627|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735629|NCT01882985|Docetaxel|docetaxel|mesh-list
154735630|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735631|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
154735632|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
154735633|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
154735634|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735635|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735636|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
154735637|NCT01882985|Protective Agents|protective agents|mesh-ancestor
154735638|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735639|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154735640|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154735641|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
154735642|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154735643|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735644|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735645|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154735646|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
154735647|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735648|NCT03015922|Lenalidomide|lenalidomide|mesh-list
154735649|NCT03015922|Pomalidomide|pomalidomide|mesh-list
154735650|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
154735651|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735652|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154735653|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154735654|NCT03015922|Growth Substances|growth substances|mesh-ancestor
154735655|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
154735656|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735657|NCT01893827|Naltrexone|naltrexone|mesh-list
154735658|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154735659|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154735660|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735661|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
154735662|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735663|NCT01882907|Pioglitazone|pioglitazone|mesh-list
154735664|NCT01882907|Vildagliptin|vildagliptin|mesh-list
154735665|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154735666|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735667|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154735668|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
154735669|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735670|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735671|NCT01051570|Prednisone|prednisone|mesh-list
154735672|NCT01051570|Carboplatin|carboplatin|mesh-list
154735673|NCT01051570|Everolimus|everolimus|mesh-list
154735674|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735675|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735676|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
154735677|NCT01051570|Hormones|hormones|mesh-ancestor
154735678|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735679|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735680|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153779946|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154735681|NCT01051570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154735682|NCT01051570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735683|NCT01051570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735684|NCT01051570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735685|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735686|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
154735687|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
154735688|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154735689|NCT01893281|Testosterone|testosterone|mesh-list
154735690|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
154735691|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
154735692|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154735693|NCT01893281|Androgens|androgens|mesh-ancestor
154735694|NCT01893281|Hormones|hormones|mesh-ancestor
154735695|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735696|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735697|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154735698|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735699|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
154735700|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154735701|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154735702|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
154735703|NCT05263947|Bevacizumab|bevacizumab|mesh-list
154735704|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154735705|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735706|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154735707|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154735708|NCT05263947|Growth Substances|growth substances|mesh-ancestor
154735709|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735710|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
154735711|NCT04415567|Lenvatinib|lenvatinib|mesh-list
154735712|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735713|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735714|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735715|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735716|NCT03280251|Methylphenidate|methylphenidate|mesh-list
154735717|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154735718|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735719|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154735720|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154735721|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735722|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735723|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
154735724|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735725|NCT01882829|Quinidine|quinidine|mesh-list
154735726|NCT01882829|Levomethorphan|levomethorphan|mesh-list
154735727|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
154735728|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
154735729|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
154735730|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154735731|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154735732|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735733|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735734|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735735|NCT01882829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154735736|NCT01882829|Narcotics|narcotics|mesh-ancestor
154735737|NCT01882829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735738|NCT01882829|Analgesics|analgesics|mesh-ancestor
154735739|NCT01882829|Sensory System Agents|sensory system agents|mesh-ancestor
154735740|NCT01882829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735741|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154735742|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154735743|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
154735744|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154735745|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
154735746|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154735747|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154735748|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735749|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735750|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154735751|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154735752|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154735753|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154735754|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154735755|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735756|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154735757|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154735758|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
154735759|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154735760|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154735761|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735762|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
154735763|NCT04760301|Coagulants|coagulants|mesh-ancestor
154735764|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
154735765|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
154735766|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
154735767|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735768|NCT01054768|Protective Agents|protective agents|mesh-ancestor
154487741|NCT02503904|Lidocaine|lidocaine|mesh-list
154735769|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735770|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
154735771|NCT01054768|Vitamins|vitamins|mesh-ancestor
154735772|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
154735773|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
154735774|NCT04387617|Cannabidiol|cannabidiol|mesh-list
154735775|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
154735776|NCT03014830|Alirocumab|alirocumab|mesh-list
154735777|NCT03014830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154735778|NCT03014830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154735779|NCT03014830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154735780|NCT03014830|Antimetabolites|antimetabolites|mesh-ancestor
154735781|NCT03014830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735782|NCT03014830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154735783|NCT03014830|Protease Inhibitors|protease inhibitors|mesh-ancestor
154735784|NCT03014830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735785|NCT03014830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154735786|NCT01055704|Naltrexone|naltrexone|mesh-list
154735787|NCT01055704|Codeine|codeine|mesh-list
154735788|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
154735789|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154735790|NCT01055704|Narcotics|narcotics|mesh-ancestor
154735791|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735792|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735793|NCT01055704|Analgesics|analgesics|mesh-ancestor
154735794|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
154735795|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735796|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
154735797|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
154735798|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154735799|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154735800|NCT03280017|Ketamine|ketamine|mesh-list
154735801|NCT03280017|Analgesics|analgesics|mesh-ancestor
154735802|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
154735803|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735804|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735805|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154735806|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154735807|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
154735808|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
154735809|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735810|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154735811|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154735812|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735813|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735814|NCT01882439|Tofacitinib|tofacitinib|mesh-list
154735815|NCT01882439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154735816|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154735817|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735818|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735819|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
154735820|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
154735821|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154735822|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154735823|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735824|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735825|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735826|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735827|NCT05225805|Lefamulin|lefamulin|mesh-list
154735828|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154735829|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735830|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154735831|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
154735832|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735833|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735834|NCT01109056|Cyclosporine|cyclosporine|mesh-list
154735835|NCT01109056|Cyclosporins|cyclosporins|mesh-list
154735836|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735837|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735838|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735839|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
154735840|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735841|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
154735842|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154735843|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
154735844|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735845|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154735846|NCT03870399|Tamoxifen|tamoxifen|mesh-list
154735847|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154735848|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
154735849|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735850|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735851|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154735852|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735853|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154735854|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154735855|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154735856|NCT04333407|Aspirin|aspirin|mesh-list
154735857|NCT04333407|Omeprazole|omeprazole|mesh-list
154735858|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
154735859|NCT04333407|Clopidogrel|clopidogrel|mesh-list
154735860|NCT04333407|Atorvastatin|atorvastatin|mesh-list
154735861|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154735862|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154735863|NCT04333407|Analgesics|analgesics|mesh-ancestor
154735864|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
154735865|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735866|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735867|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735868|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154735869|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154735870|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154735871|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735872|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154735873|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154735874|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735875|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
154735876|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154735877|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154735878|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
154735879|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154735880|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154735881|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154735882|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154735883|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154735884|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
154735885|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735886|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154735887|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
154735888|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154735889|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
154735890|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
154735891|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154735892|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154735893|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154735894|NCT04398927|Folfirinox|folfirinox|mesh-list
154735895|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735896|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
154735897|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154735898|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154735899|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
154735900|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735901|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154735902|NCT04399083|Caffeine|caffeine|mesh-list
154735903|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154735904|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735905|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154735906|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735907|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735908|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154735909|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154735910|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
154735911|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735912|NCT01892345|Eculizumab|eculizumab|mesh-list
154735913|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154735914|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154735915|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
154735916|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735917|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
154735918|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
154735919|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154860372|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
154735920|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154735921|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735922|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735923|NCT01059994|Urological Agents|urological agents|mesh-ancestor
154735924|NCT01111318|Empagliflozin|empagliflozin|mesh-list
154735925|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154735926|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735927|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154735928|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735929|NCT01892189|Ketamine|ketamine|mesh-list
154735930|NCT01892189|Analgesics|analgesics|mesh-ancestor
154735931|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
154735932|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735933|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735934|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154735935|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154735936|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
154735937|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
154735938|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154735939|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154735940|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154735941|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735942|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735943|NCT01062568|Dexamethasone|dexamethasone|mesh-list
154735944|NCT01062568|Cosyntropin|cosyntropin|mesh-list
154735945|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154735946|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154735947|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
154735948|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154735949|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
154735950|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
154735951|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154735952|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735953|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154735954|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
154735955|NCT01062568|Hormones|hormones|mesh-ancestor
153780249|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
154735956|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154735957|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154735958|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154735959|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154735960|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735961|NCT05155137|Amlodipine|amlodipine|mesh-list
154735962|NCT05155137|Valsartan|valsartan|mesh-list
154735963|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154735964|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154735965|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154735966|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154735967|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735968|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154735969|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154735970|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
154735971|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154735972|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154735973|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
154735974|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154735975|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154735976|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735977|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154735978|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154735979|NCT01064284|Factor VIII|factor viii|mesh-list
154735980|NCT01064284|Coagulants|coagulants|mesh-ancestor
154735981|NCT01064362|Heparin|heparin|mesh-list
154735982|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154735983|NCT01064362|Tinzaparin|tinzaparin|mesh-list
154735984|NCT01064362|Dalteparin|dalteparin|mesh-list
154735985|NCT01064362|PENTA|penta|mesh-list
154735986|NCT01064362|Fondaparinux|fondaparinux|mesh-list
154735987|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
154735988|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154735989|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154735990|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154735991|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154735992|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
154487944|NCT02172495|Bromides|bromides|mesh-list
154735993|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154735994|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
154735995|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154735997|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
154735998|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
154735999|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154736000|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736001|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736002|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
154736003|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154736004|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736005|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736006|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
154736007|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154736008|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736009|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154736010|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154736011|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154736012|NCT01064830|Cyclosporine|cyclosporine|mesh-list
154736013|NCT01064830|Cyclosporins|cyclosporins|mesh-list
154736014|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736015|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736016|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154736017|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
154736018|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736019|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
154736020|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736021|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
154736022|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736023|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154736024|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154736025|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154736026|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736027|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154736028|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154736029|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736030|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736031|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
154736032|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736033|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154736034|NCT01066624|Calcium|calcium|mesh-list
154736035|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154736036|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736037|NCT04398771|Valsartan|valsartan|mesh-list
154736038|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154736039|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154736040|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154736041|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
154736042|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736043|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154736044|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154736045|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736046|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154736047|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154736048|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154736049|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154736050|NCT01863953|Bimatoprost|bimatoprost|mesh-list
154736051|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154736052|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154736053|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154736054|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154736055|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154736056|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154736057|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
154736058|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736059|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736060|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736061|NCT01068964|Timolol|timolol|mesh-list
154736062|NCT01068964|Bimatoprost|bimatoprost|mesh-list
154736063|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154736064|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154736065|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154488016|NCT02502968|Cytarabine|cytarabine|mesh-list
154736066|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154736067|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
154736068|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736069|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736070|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736071|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154736072|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154736073|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154736074|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
154736075|NCT02984475|Metformin|metformin|mesh-list
154736076|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154736077|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736078|NCT01069354|Lidocaine|lidocaine|mesh-list
154736079|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
154736080|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
154736081|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736082|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736083|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
154736084|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736085|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154736086|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154736087|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154736088|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736089|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736090|NCT01069510|Spironolactone|spironolactone|mesh-list
154736091|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154736092|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
154736093|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736094|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736095|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154736096|NCT01069510|Diuretics|diuretics|mesh-ancestor
154736097|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
154736098|NCT04278495|Losartan|losartan|mesh-list
154736099|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154736100|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154736101|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154736102|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154736103|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736104|NCT04276545|Midazolam|midazolam|mesh-list
154736105|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154736106|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154736107|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736108|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736109|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154736110|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154736111|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154736112|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154736113|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
154736114|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
154736115|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
154736116|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
154736117|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736118|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736119|NCT01117948|Lornoxicam|lornoxicam|mesh-list
154736120|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154736121|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154736122|NCT01117948|Analgesics|analgesics|mesh-ancestor
154736123|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
154736124|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736125|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736126|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736127|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736128|NCT03014440|Cannabidiol|cannabidiol|mesh-list
154736129|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
154736130|NCT03013036|Midazolam|midazolam|mesh-list
154736131|NCT03013036|Fentanyl|fentanyl|mesh-list
154736132|NCT03013036|Propofol|propofol|mesh-list
154736133|NCT03013036|Sevoflurane|sevoflurane|mesh-list
154736134|NCT03013036|Rocuronium|rocuronium|mesh-list
154736135|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154736136|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736137|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736138|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154736139|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
154736140|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
154736141|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154736142|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154736143|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154736144|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154736145|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
154736146|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
154736147|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736148|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736149|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154736150|NCT03013036|Narcotics|narcotics|mesh-ancestor
154736151|NCT03013036|Analgesics|analgesics|mesh-ancestor
154736152|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
154736153|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736154|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154736155|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154736156|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154736157|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154736158|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154736159|NCT01071538|Buprenorphine|buprenorphine|mesh-list
154736160|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154736161|NCT01071538|Narcotics|narcotics|mesh-ancestor
154736162|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736163|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736164|NCT01071538|Analgesics|analgesics|mesh-ancestor
154736165|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
154736166|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736167|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154736168|NCT04352686|Buspirone|buspirone|mesh-list
154736169|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154736170|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154736171|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736172|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736173|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154736174|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154736175|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
154736176|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736177|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736178|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154736179|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736180|NCT02172742|Digoxin|digoxin|mesh-list
154736181|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154736182|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154736183|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154736184|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736185|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736186|NCT02172742|Protective Agents|protective agents|mesh-ancestor
154736187|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736188|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
154736189|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154736190|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154736191|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736192|NCT01075204|Clarithromycin|clarithromycin|mesh-list
154736193|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154736194|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736195|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154736196|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736197|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736198|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153780624|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154736199|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154736200|NCT01120834|Azacitidine|azacitidine|mesh-list
154736201|NCT01120834|Vorinostat|vorinostat|mesh-list
154736202|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154736203|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
154736204|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736205|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736206|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736207|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154736208|NCT01122160|Omeprazole|omeprazole|mesh-list
154736209|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154736210|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154736211|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154736212|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736213|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488160|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736214|NCT02623816|Omeprazole|omeprazole|mesh-list
154736215|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154736216|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154736217|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154736218|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736219|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736220|NCT01122238|Nicotine|nicotine|mesh-list
154736221|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154736222|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
154736223|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736224|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736225|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154736226|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154736227|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
154736228|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736229|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736230|NCT01122316|Metformin|metformin|mesh-list
154736231|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154736232|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736233|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
154736234|NCT03049449|Fludarabine|fludarabine|mesh-list
154736235|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154736236|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
154736237|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736238|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736239|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154736240|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
154736241|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736242|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736243|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154736244|NCT02399943|Panitumumab|panitumumab|mesh-list
154736245|NCT02399943|Trametinib|trametinib|mesh-list
154736246|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736247|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736248|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154736249|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736250|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736251|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
154736252|NCT03186027|Ubiquinone|ubiquinone|mesh-list
154736253|NCT03186027|Vitamins|vitamins|mesh-ancestor
154736254|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
154736255|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736256|NCT04397913|Acetaminophen|acetaminophen|mesh-list
154736257|NCT04397913|Ibuprofen|ibuprofen|mesh-list
154736258|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154736259|NCT04397913|Analgesics|analgesics|mesh-ancestor
154736260|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
154736261|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736262|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736263|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
154736264|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154736265|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736266|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736267|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154736268|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736269|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736270|NCT02176486|Ixazomib|ixazomib|mesh-list
154736271|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736272|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
154736273|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736274|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736275|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154736276|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154736277|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154736278|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736279|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736280|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736281|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736282|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154736283|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
154736284|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154736285|NCT03013114|Bortezomib|bortezomib|mesh-list
154736286|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736287|NCT01077310|Naltrexone|naltrexone|mesh-list
154736288|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154736289|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154736290|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736292|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736293|NCT02989857|Ivosidenib|ivosidenib|mesh-list
154736294|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736295|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736296|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736297|NCT02393937|Metronidazole|metronidazole|mesh-list
154736298|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736299|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154736300|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154736301|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154736302|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
154736303|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154736304|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
154736305|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154736306|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
154736307|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736308|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736309|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
154736310|NCT04397601|Bevacizumab|bevacizumab|mesh-list
154736311|NCT04397601|Aflibercept|aflibercept|mesh-list
154736312|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736313|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736314|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154736315|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154736316|NCT04397601|Growth Substances|growth substances|mesh-ancestor
154736317|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736318|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
154736319|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
154736320|NCT02870829|Vitamin K|vitamin k|mesh-list
154736321|NCT02870829|Menaquinone 7|menaquinone 7|mesh-list
154736322|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154736323|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154736324|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736325|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
154736326|NCT02870829|Coagulants|coagulants|mesh-ancestor
154736327|NCT02870829|Vitamins|vitamins|mesh-ancestor
154736328|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
154736329|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736330|NCT01876823|Memantine|memantine|mesh-list
154736331|NCT01876823|Citalopram|citalopram|mesh-list
154736332|NCT01876823|Escitalopram|escitalopram|mesh-list
154736333|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154736334|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154736335|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
154736336|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736337|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736338|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736339|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154736340|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154736341|NCT01876823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154736342|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154736343|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736344|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
154736345|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154736346|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
154736347|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154736348|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
154736349|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736350|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736351|NCT01876511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154736352|NCT01876511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736353|NCT01993719|Vidarabine|vidarabine|mesh-list
154736354|NCT01993719|Aldesleukin|aldesleukin|mesh-list
154736355|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
154736356|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
154736357|NCT01993719|Fludarabine|fludarabine|mesh-list
154736358|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
154736359|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154736360|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
154736361|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736362|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736363|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154736364|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
154488307|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
154736365|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736366|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736367|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154736368|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736369|NCT01993719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154736370|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154736371|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
154736372|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
154736373|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736374|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154736375|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154736376|NCT02758665|Venetoclax|venetoclax|mesh-list
154736377|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
154736378|NCT02758665|Ibrutinib|ibrutinib|mesh-list
154736379|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736380|NCT02758665|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154736381|NCT02758665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154736382|NCT02758665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736383|NCT02758665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736384|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736385|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154736386|NCT03182673|Fluzoparib|fluzoparib|mesh-list
154736387|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736388|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736389|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736390|NCT00638157|Gentamicins|gentamicins|mesh-list
154736391|NCT00638157|Daptomycin|daptomycin|mesh-list
154736392|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154736393|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736394|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154736395|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736396|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736397|NCT00637377|Ranibizumab|ranibizumab|mesh-list
154736398|NCT00637377|Aflibercept|aflibercept|mesh-list
154736399|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154736400|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154736401|NCT00637377|Growth Substances|growth substances|mesh-ancestor
154736402|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736403|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
154736404|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736405|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
154736406|NCT01475110|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154736407|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154736408|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736409|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736410|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736411|NCT05307718|Anticoagulants|anticoagulants|mesh-list
154736412|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
154736413|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154736414|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154736415|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
154736416|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154736417|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154736418|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
154736419|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736420|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736421|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154736422|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154736423|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154736424|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
154736425|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736426|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736427|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
154736428|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154736429|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
154736430|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
154736431|NCT01033864|Prednisone|prednisone|mesh-list
154736432|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736433|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
154736434|NCT01033864|Hormones|hormones|mesh-ancestor
154736435|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736436|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736437|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154488381|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154736438|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736439|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154736440|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154736441|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
154736442|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154736443|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736445|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736446|NCT01082380|Crizotinib|crizotinib|mesh-list
154736447|NCT01082380|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154736448|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154736449|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736450|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736451|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736452|NCT01083706|Azacitidine|azacitidine|mesh-list
154736453|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154736454|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
154736455|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736456|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736457|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736458|NCT01035346|Ibuprofen|ibuprofen|mesh-list
154736459|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154736460|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154736461|NCT01035346|Analgesics|analgesics|mesh-ancestor
154736462|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
154736463|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736464|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736465|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736466|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736467|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154736468|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736469|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736470|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154736471|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154736472|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736473|NCT01085344|Factor VIII|factor viii|mesh-list
154736474|NCT01085344|Coagulants|coagulants|mesh-ancestor
154736475|NCT01035658|Doxorubicin|doxorubicin|mesh-list
154736476|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154736477|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154736478|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736479|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154736480|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154736481|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736482|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736483|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
154736484|NCT01037452|Lansoprazole|lansoprazole|mesh-list
154736485|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
154736486|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
154736487|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154736488|NCT01037452|Calcium|calcium|mesh-list
154736489|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154736490|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736491|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154736492|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154736493|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154736494|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154736495|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736496|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736497|NCT01037452|Antacids|antacids|mesh-ancestor
154736498|NCT03012646|Treprostinil|treprostinil|mesh-list
154736499|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154736500|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
154736501|NCT00636441|Docetaxel|docetaxel|mesh-list
154736502|NCT00636441|Doxorubicin|doxorubicin|mesh-list
154736503|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154736504|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154736505|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
154736506|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736507|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736508|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154736509|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
154736510|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736511|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736512|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154736513|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154736514|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154736515|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154736516|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154736517|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154736518|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154736519|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736520|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154736521|NCT02984397|Ketotifen|ketotifen|mesh-list
154736522|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
154736523|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
154736524|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154736525|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
154736526|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
154736527|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736528|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736529|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736530|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154736531|NCT01922427|RNS60|rns60|mesh-list
154736532|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154736533|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154736534|NCT01922427|Analgesics|analgesics|mesh-ancestor
154736535|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
154736536|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736537|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736538|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736539|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736540|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153566861|NCT06233058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154736541|NCT01088464|Necitumumab|necitumumab|mesh-list
154736542|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154736543|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736544|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736545|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
154736546|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736547|NCT01090180|Dexamethasone|dexamethasone|mesh-list
154736548|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736549|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
154736550|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
154736551|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736552|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736553|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154736554|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
154736555|NCT01090180|Hormones|hormones|mesh-ancestor
154736556|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736557|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154736558|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736559|NCT00636207|Montelukast|montelukast|mesh-list
154736560|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154736561|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
154736562|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154736563|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
154736564|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736565|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736566|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154736567|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154736568|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736569|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
154736570|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154736571|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154736572|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736573|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154736574|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154736575|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
154736576|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736577|NCT01092676|Ibuprofen|ibuprofen|mesh-list
154736578|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154736579|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154736580|NCT01092676|Analgesics|analgesics|mesh-ancestor
154736581|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
154736582|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736583|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736584|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736585|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736586|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154736587|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736588|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736589|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
154736590|NCT01039792|Vitamins|vitamins|mesh-ancestor
154736591|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
154736592|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736593|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
154736594|NCT01041274|Citalopram|citalopram|mesh-list
154736595|NCT01041274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154736596|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154736597|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736598|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736599|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736600|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
154736601|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736602|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154736603|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
154736604|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154736605|NCT00635349|Acetaminophen|acetaminophen|mesh-list
154736606|NCT00635349|Meloxicam|meloxicam|mesh-list
154736607|NCT00635349|Aceclofenac|aceclofenac|mesh-list
154736608|NCT00635349|Tramadol|tramadol|mesh-list
154736609|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154736610|NCT00635349|Analgesics|analgesics|mesh-ancestor
154736611|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
154736612|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736613|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736614|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
154736615|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154736616|NCT00635349|Narcotics|narcotics|mesh-ancestor
154736617|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736618|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154736619|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736620|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736621|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154736622|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154736623|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736624|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736625|NCT00634803|Buprenorphine|buprenorphine|mesh-list
154736626|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154736627|NCT00634803|Narcotics|narcotics|mesh-ancestor
154736628|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736629|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736630|NCT00634803|Analgesics|analgesics|mesh-ancestor
154736631|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
154736632|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736633|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154736634|NCT01042288|Carboplatin|carboplatin|mesh-list
154736635|NCT01042288|Pemetrexed|pemetrexed|mesh-list
154736636|NCT01042288|Panitumumab|panitumumab|mesh-list
154736637|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736638|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736639|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736640|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154736641|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154736642|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736643|NCT01043926|Suvorexant|suvorexant|mesh-list
154736644|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154736645|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154736646|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736647|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736648|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154736649|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736650|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736651|NCT01044706|Bicalutamide|bicalutamide|mesh-list
154736652|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
154736653|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
154736654|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736655|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736656|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736658|NCT04447534|Chloroquine|chloroquine|mesh-list
154736659|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154736660|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
154736661|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154736662|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154736663|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567440|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
154736664|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736665|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736666|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736667|NCT04447534|Amebicides|amebicides|mesh-ancestor
154736668|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154736669|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154736670|NCT04447534|Analgesics|analgesics|mesh-ancestor
154736671|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
154736672|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736673|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736674|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736675|NCT04447534|Filaricides|filaricides|mesh-ancestor
154736676|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
154736677|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
154736678|NCT01044862|Letrozole|letrozole|mesh-list
154736679|NCT01044862|Clomiphene|clomiphene|mesh-list
154736680|NCT01044862|Enclomiphene|enclomiphene|mesh-list
154736681|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
154736682|NCT01044862|Hormones|hormones|mesh-list
154736683|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154736684|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154736685|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736686|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736687|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736688|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736689|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154736690|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736691|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154736692|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
154736693|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154736694|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
154736695|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154736696|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154736697|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154736698|NCT04361656|Lubiprostone|lubiprostone|mesh-list
154736699|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154736700|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736701|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736702|NCT01047358|Exemestane|exemestane|mesh-list
154736703|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736704|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154736705|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154736706|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736707|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736708|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153567633|NCT05194111|Valsartan|valsartan|mesh-list
154736709|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
154736710|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736711|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736712|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
154736713|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154736714|NCT01048606|Estrogens|estrogens|mesh-ancestor
154736715|NCT01048606|Hormones|hormones|mesh-ancestor
154736716|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736717|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736718|NCT04224766|Bupivacaine|bupivacaine|mesh-list
154736719|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
154736720|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
154736721|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736722|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736723|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
154736724|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736725|NCT01772004|Avelumab|avelumab|mesh-list
154736726|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736727|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736728|NCT02930044|Insulin|insulin|mesh-list
154736729|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154736730|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
154736731|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154736732|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736733|NCT03683524|Dolutegravir|dolutegravir|mesh-list
154736734|NCT03683524|Darunavir|darunavir|mesh-list
154736735|NCT03683524|Cobicistat|cobicistat|mesh-list
154736736|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154736737|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154736738|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154736739|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736740|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736741|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154736742|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154736743|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
154736744|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736745|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154736746|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154736747|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
154736748|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154736749|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154736750|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
154736751|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154736752|NCT02246842|Antibodies|antibodies|mesh-list
154736753|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154736754|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
154736755|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
154736756|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736757|NCT02182492|Clarithromycin|clarithromycin|mesh-list
154736758|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
154736759|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154736760|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736761|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154736762|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736763|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736764|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154736765|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154736766|NCT02182492|Hormones|hormones|mesh-ancestor
154736767|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736768|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736769|NCT01163656|Cobalt|cobalt|mesh-list
154736770|NCT01163656|Trace Elements|trace elements|mesh-ancestor
154736771|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
154736772|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736773|NCT01165840|Dapsone|dapsone|mesh-list
154736774|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736775|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
154736776|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154736777|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154736778|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154736779|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736780|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736781|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
154736782|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154736783|NCT00952692|Lapatinib|lapatinib|mesh-list
154736784|NCT00952692|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154736785|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154736786|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736787|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736788|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736789|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154736790|NCT01170754|Laxatives|laxatives|mesh-ancestor
154736791|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154736792|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154736793|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
154736794|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
154736795|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736796|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
154736797|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736798|NCT01131052|Insulin|insulin|mesh-list
154736799|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154736800|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
154736801|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
154736802|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154736803|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736804|NCT01379274|Lenalidomide|lenalidomide|mesh-list
154736805|NCT01379274|Azacitidine|azacitidine|mesh-list
154736806|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
154736807|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736808|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154736809|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154736810|NCT01379274|Growth Substances|growth substances|mesh-ancestor
154736811|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
154736812|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736813|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154736814|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
154736815|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568077|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154736816|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736817|NCT01171690|Teriparatide|teriparatide|mesh-list
154736818|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154736819|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736820|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154736821|NCT05389176|Esmolol|esmolol|mesh-list
154736822|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154736823|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154736824|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154736825|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
154736826|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736827|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736828|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736829|NCT01132846|Dopamine|dopamine|mesh-list
154736830|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154736831|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154736832|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
154736833|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
154736834|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736835|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736836|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
154736837|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736838|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736839|NCT01132846|Protective Agents|protective agents|mesh-ancestor
154736840|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
154736841|NCT01133158|Dexamethasone|dexamethasone|mesh-list
154736842|NCT01133158|Rituximab|rituximab|mesh-list
154736843|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154736844|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
154736845|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736846|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736847|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
154736848|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736849|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736850|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736851|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
154736852|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
154736853|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736854|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154736855|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
154736856|NCT01133158|Hormones|hormones|mesh-ancestor
154736857|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736858|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154736859|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154736860|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
154736861|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736862|NCT01133158|Analgesics|analgesics|mesh-ancestor
154736863|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
153568176|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
154736864|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154736865|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154736866|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736867|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
154736868|NCT01134952|Sirolimus|sirolimus|mesh-list
154736869|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154736870|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736871|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154736872|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
154736873|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154736874|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736875|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736876|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736877|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
154736878|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154736879|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
154736880|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736881|NCT01175902|Timolol|timolol|mesh-list
154736882|NCT01175902|Dorzolamide|dorzolamide|mesh-list
154736883|NCT01175902|Latanoprost|latanoprost|mesh-list
154736884|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154736885|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154736886|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
154736887|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154736888|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736889|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736890|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154736891|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154736892|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154736893|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154736894|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154736895|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736896|NCT01135186|Verapamil|verapamil|mesh-list
154736897|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154736898|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154736899|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154736900|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736901|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154736902|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736903|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
154736904|NCT05376228|Vancomycin|vancomycin|mesh-list
154736905|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154736906|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154736907|NCT05164848|Afatinib|afatinib|mesh-list
154736908|NCT05164848|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154736909|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154736910|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736911|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736912|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736913|NCT05164770|Prednisone|prednisone|mesh-list
154736914|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
154736915|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
154736916|NCT05164770|Vincristine|vincristine|mesh-list
154736917|NCT05164770|Rituximab|rituximab|mesh-list
154736918|NCT05164770|Doxorubicin|doxorubicin|mesh-list
154736919|NCT05164770|Etoposide|etoposide|mesh-list
154736920|NCT05164770|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153568177|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568420|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736921|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154736922|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736923|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736924|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736925|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154736926|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
154736927|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736928|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736929|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154736930|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
154736931|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154736932|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736933|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
154736934|NCT05164770|Hormones|hormones|mesh-ancestor
154736935|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736936|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154736937|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154736938|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
154736939|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
154736940|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
154736941|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154736942|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154736943|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154736944|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154736945|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
154736946|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154736947|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154736948|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
154736949|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736950|NCT01175980|Vorinostat|vorinostat|mesh-list
154736951|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154736952|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154736953|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736954|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736955|NCT04246554|Acetaminophen|acetaminophen|mesh-list
154736956|NCT04246554|Ketorolac|ketorolac|mesh-list
154736957|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154736958|NCT04246554|Oxycodone|oxycodone|mesh-list
154736959|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154736960|NCT04246554|Analgesics|analgesics|mesh-ancestor
154736961|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
154736962|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154736963|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736964|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
154736965|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154736966|NCT04246554|Narcotics|narcotics|mesh-ancestor
154736967|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154736968|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154736969|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154736970|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154736971|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154736972|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736973|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736974|NCT01922817|Saxagliptin|saxagliptin|mesh-list
154736975|NCT01922817|Incretins|incretins|mesh-ancestor
154736976|NCT01922817|Hormones|hormones|mesh-ancestor
154736977|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154736978|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154736979|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154736980|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
154736981|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736982|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736983|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154736984|NCT04397289|Heparin|heparin|mesh-list
154736985|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
154736986|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
154736987|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154736988|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154736989|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154736990|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154736991|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
154736992|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154736993|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
154736994|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154736995|NCT00634179|Prednisone|prednisone|mesh-list
154736996|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
154736997|NCT00634179|Rituximab|rituximab|mesh-list
154736998|NCT00634179|Doxorubicin|doxorubicin|mesh-list
154736999|NCT00634179|Vincristine|vincristine|mesh-list
154737000|NCT00634179|Bortezomib|bortezomib|mesh-list
154737001|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154737002|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
154737003|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737004|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737005|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154737006|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
154737007|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737008|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737009|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154737010|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154737011|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154737012|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154737013|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154737014|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737015|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737016|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
154737017|NCT00634179|Hormones|hormones|mesh-ancestor
154737018|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568543|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568544|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
154737019|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154737020|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154737021|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
154737022|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
154737023|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
154737024|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
154737025|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
154737026|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737027|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154737028|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737029|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737030|NCT01179490|Prednisolone|prednisolone|mesh-list
154737031|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488983|NCT03537807|Riluzole|riluzole|mesh-list
154737032|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
154737033|NCT01179490|Hormones|hormones|mesh-ancestor
154737034|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737035|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737036|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154737037|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737038|NCT01179568|Citalopram|citalopram|mesh-list
154737039|NCT01179568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154737040|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154737041|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154737042|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737043|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737044|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
154737045|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737046|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154737047|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
154737048|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154737049|NCT01180036|Cyclosporine|cyclosporine|mesh-list
154737050|NCT01180036|Rituximab|rituximab|mesh-list
154737051|NCT01180036|Cyclosporins|cyclosporins|mesh-list
154737052|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154737053|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737054|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
154737055|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737056|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737057|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737058|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737059|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154737060|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
154737061|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737062|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
154737063|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154737064|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154737065|NCT01180894|Hematinics|hematinics|mesh-ancestor
154737066|NCT01181674|Insulin|insulin|mesh-list
154737067|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154737068|NCT01181674|Metformin|metformin|mesh-list
154737069|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
154737070|NCT01181674|Acarbose|acarbose|mesh-list
154737071|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154737072|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737073|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154737074|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737075|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737076|NCT01182376|Dronedarone|dronedarone|mesh-list
154737077|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154737078|NCT01183312|Flumazenil|flumazenil|mesh-list
154737079|NCT01183312|Antidotes|antidotes|mesh-ancestor
154737080|NCT01183312|Protective Agents|protective agents|mesh-ancestor
154737081|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737082|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
154737083|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
154737084|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737085|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737086|NCT03188172|Dexamethasone|dexamethasone|mesh-list
154737087|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
154737088|NCT03188172|Melphalan|melphalan|mesh-list
154737089|NCT03188172|Lenalidomide|lenalidomide|mesh-list
154737090|NCT03188172|Bortezomib|bortezomib|mesh-list
154737091|NCT03188172|Daratumumab|daratumumab|mesh-list
154737092|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154737093|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
154737094|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737095|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737096|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154737097|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
154737098|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737099|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737100|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154737101|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737102|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
154737103|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
154737104|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737105|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737106|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
154737107|NCT03188172|Hormones|hormones|mesh-ancestor
154737108|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489070|NCT02491970|Hormones|hormones|mesh-ancestor
154737109|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154737110|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154737111|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154737112|NCT03188172|Growth Substances|growth substances|mesh-ancestor
154737113|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
154737114|NCT01184014|Insulin|insulin|mesh-list
154737115|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154737116|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
154737117|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
154737118|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
154737119|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
154737120|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
154737121|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154737122|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737123|NCT01185028|Interferons|interferons|mesh-list
154737124|NCT01185028|Ribavirin|ribavirin|mesh-list
154737125|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
154737126|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737127|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
154737128|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737129|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
154737130|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737131|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154737132|NCT02187016|Listerine|listerine|mesh-list
154737133|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154737134|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737135|NCT05439798|Dexamethasone|dexamethasone|mesh-list
154737136|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
154737137|NCT05439798|Ondansetron|ondansetron|mesh-list
154737138|NCT05439798|Palonosetron|palonosetron|mesh-list
154737139|NCT05439798|BB 1101|bb 1101|mesh-list
154737140|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737141|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
154737142|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
154737143|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737144|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737145|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737146|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
154737147|NCT05439798|Hormones|hormones|mesh-ancestor
154737148|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737149|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154737150|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737151|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
154737152|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737153|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737154|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
154737155|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
154737156|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154737157|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154737158|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
154737159|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737160|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
154737161|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154737162|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154737163|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737164|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
154737165|NCT02188576|Coagulants|coagulants|mesh-ancestor
154737166|NCT02189122|Aspirin|aspirin|mesh-list
154737167|NCT02189122|Bradykinin|bradykinin|mesh-list
154737168|NCT02189122|Kininogens|kininogens|mesh-list
154737169|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154737170|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154737171|NCT02189122|Analgesics|analgesics|mesh-ancestor
154737172|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
154737173|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737174|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737175|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737176|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737177|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154737178|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154737179|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737180|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154737181|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154737182|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737183|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
154737184|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
154737185|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154737186|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
154737187|NCT05309460|Labetalol|labetalol|mesh-list
154737188|NCT05309460|Nifedipine|nifedipine|mesh-list
154737189|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154737190|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154737191|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737192|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154737193|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737194|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
154737195|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
154737196|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154737197|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154737198|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154737199|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
154737200|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737201|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154737202|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
154737203|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
154737204|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737205|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154737206|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154737207|NCT01093690|Metoclopramide|metoclopramide|mesh-list
154737208|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
154737209|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
154737210|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737211|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737212|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737213|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154737214|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154737215|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
154737216|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737217|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737218|NCT01143688|Albuterol|albuterol|mesh-list
154737219|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154737220|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
154737221|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737222|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737223|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154737224|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
153569001|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154737225|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
154737226|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154737227|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154737228|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154737229|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154737230|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154737231|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737232|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737233|NCT04455594|Carboplatin|carboplatin|mesh-list
154737234|NCT04455594|Pemetrexed|pemetrexed|mesh-list
154737235|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154737236|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737237|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737238|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737239|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154737240|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154737241|NCT04455594|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154737242|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154737243|NCT05439408|Dasatinib|dasatinib|mesh-list
154737244|NCT05439408|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154737245|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154737246|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737247|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737248|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737249|NCT03011476|Donepezil|donepezil|mesh-list
154737250|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154737251|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737252|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737253|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
154737254|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737255|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737256|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
154737257|NCT02522754|Vaccines|vaccines|mesh-list
154737258|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
154737259|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737260|NCT01188694|Methylene Blue|methylene blue|mesh-list
153569136|NCT04562129|Nivolumab|nivolumab|mesh-list
154737261|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737262|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737263|NCT01188928|Betamethasone|betamethasone|mesh-list
154737264|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
154737265|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154737266|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
154737267|NCT01188928|Calcipotriene|calcipotriene|mesh-list
154737268|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154737269|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737270|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
154737271|NCT01188928|Hormones|hormones|mesh-ancestor
154737272|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737273|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737274|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154737275|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
154737276|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
154737277|NCT05438706|Carboplatin|carboplatin|mesh-list
154737278|NCT05438706|Capecitabine|capecitabine|mesh-list
154737279|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737280|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154737281|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
154737282|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737283|NCT01189240|Bevacizumab|bevacizumab|mesh-list
154737284|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154737285|NCT01189240|Antibodies|antibodies|mesh-list
154737286|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
154737287|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154737288|NCT01189240|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154737289|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737290|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154737291|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154737292|NCT01189240|Growth Substances|growth substances|mesh-ancestor
154737293|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737294|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
154737295|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
154737296|NCT01189240|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154737297|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737298|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737299|NCT03467334|Simethicone|simethicone|mesh-list
154737300|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
154737301|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737302|NCT03467334|Emollients|emollients|mesh-ancestor
154737303|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
154737304|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
154737305|NCT02874144|Fluticasone|fluticasone|mesh-list
154737306|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737307|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
154737308|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154737309|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154737310|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
154737311|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737312|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737313|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154737314|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
154737315|NCT03467178|Paclitaxel|paclitaxel|mesh-list
154737316|NCT03467178|Carboplatin|carboplatin|mesh-list
154737317|NCT03467178|Gemcitabine|gemcitabine|mesh-list
154737318|NCT03467178|Doxorubicin|doxorubicin|mesh-list
154737319|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154737320|NCT03467178|Decitabine|decitabine|mesh-list
154737321|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154737322|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737323|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
154737324|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
154737325|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
154737326|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737327|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154737328|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
154737329|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154737330|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154737331|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154737332|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737333|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154737334|NCT02835534|Plasminogen|plasminogen|mesh-list
154489281|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
154737335|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154737336|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154737337|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737338|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
154737339|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737340|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
154737341|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154737342|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
154737343|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737344|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737345|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154737346|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
154737347|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737348|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737349|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154737350|NCT02611830|Vedolizumab|vedolizumab|mesh-list
154737351|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737352|NCT03461718|Midazolam|midazolam|mesh-list
154737353|NCT03461718|Fentanyl|fentanyl|mesh-list
154737354|NCT03461718|Ketamine|ketamine|mesh-list
154737355|NCT03461718|Analgesics|analgesics|mesh-ancestor
154737356|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
154737357|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737358|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737359|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154737360|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154737361|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
154737362|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
154737363|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737364|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154737365|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154737366|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737367|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737368|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154737369|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154737370|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154737371|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154737372|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154737373|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
154737374|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
154737375|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154737376|NCT03461718|Narcotics|narcotics|mesh-ancestor
154737377|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
154737378|NCT03467022|Vitamins|vitamins|mesh-ancestor
154737379|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
154737380|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737381|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
154737382|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737383|NCT03467022|Protective Agents|protective agents|mesh-ancestor
154737384|NCT03129594|Glucagon|glucagon|mesh-list
154737385|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154737386|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737387|NCT03129594|Hormones|hormones|mesh-ancestor
154737388|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737389|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737390|NCT03129594|Incretins|incretins|mesh-ancestor
154737391|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
154737392|NCT03466632|Propofol|propofol|mesh-list
154737393|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154737394|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737395|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737396|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154737397|NCT03466632|Analgesics|analgesics|mesh-ancestor
154737398|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
154737399|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737400|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154737401|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154737402|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154737403|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
154737404|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737405|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737406|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154737407|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
154737408|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
154737409|NCT05339334|Ritonavir|ritonavir|mesh-list
154737410|NCT05339334|Nirmatrelvir|nirmatrelvir|mesh-list
154737411|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154737412|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154737413|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
154737414|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737415|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737416|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154737417|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154737418|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
154737419|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737420|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154737421|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154737422|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
154737423|NCT03461328|Analgesics|analgesics|mesh-ancestor
154737424|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
154737425|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737426|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737427|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
154737428|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737429|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154737430|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
154737431|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154737432|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154737433|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737434|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154737435|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
154737436|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154737437|NCT01145638|Iron|iron|mesh-list
154737438|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154737439|NCT01145638|Trace Elements|trace elements|mesh-ancestor
154737440|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
154737441|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737442|NCT01145638|Hematinics|hematinics|mesh-ancestor
154737443|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
154737444|NCT03466320|Fludarabine|fludarabine|mesh-list
154737445|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154737446|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
154737447|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737448|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737449|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154737450|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
154737451|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737452|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737453|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154737454|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
154737455|NCT03466242|Ketamine|ketamine|mesh-list
154737456|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154737457|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737458|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737459|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154737460|NCT03466242|Analgesics|analgesics|mesh-ancestor
154737461|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
154737462|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737463|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154737464|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154737465|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154737466|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
154737467|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737468|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737469|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154737470|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154737471|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
154737472|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
154737473|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154737474|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154737475|NCT01190878|Bromfenac|bromfenac|mesh-list
154737476|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154737477|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154737478|NCT01190878|Analgesics|analgesics|mesh-ancestor
154737479|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
154737480|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737481|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737482|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737483|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737484|NCT01146808|Adefovir|adefovir|mesh-list
154737485|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154737486|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
154737487|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737488|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154737489|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154737490|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737491|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737492|NCT02522130|Naproxen|naproxen|mesh-list
154737493|NCT02522130|Lidocaine|lidocaine|mesh-list
154737494|NCT02522130|Misoprostol|misoprostol|mesh-list
154737495|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
154737496|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
154737497|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737498|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737499|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
154737500|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737501|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154737502|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154737503|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154737504|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154737505|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737506|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154737507|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
154737508|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153569911|NCT01690325|Trastuzumab|trastuzumab|mesh-list
154737509|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154737510|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737511|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
154737512|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154737513|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154737514|NCT02522130|Analgesics|analgesics|mesh-ancestor
154737515|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737516|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737517|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
154737518|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154737519|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737520|NCT01148524|Vaccines|vaccines|mesh-list
154737521|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
154737522|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737523|NCT03460860|Tocopherols|tocopherols|mesh-list
154737524|NCT03460860|Vitamin E|vitamin e|mesh-list
154737525|NCT03460860|Tocotrienols|tocotrienols|mesh-list
154737526|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
154737527|NCT03460860|Lycopene|lycopene|mesh-list
154737528|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
154737529|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737530|NCT03460860|Protective Agents|protective agents|mesh-ancestor
154737531|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737532|NCT03460860|Vitamins|vitamins|mesh-ancestor
154737533|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
154737534|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737535|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154737536|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154737537|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737538|NCT03460782|Ipilimumab|ipilimumab|mesh-list
154737539|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154737540|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737541|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154737542|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737543|NCT01099618|Metformin|metformin|mesh-list
154737544|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154737545|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154737546|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737547|NCT01099618|Incretins|incretins|mesh-ancestor
154737548|NCT01099618|Hormones|hormones|mesh-ancestor
154737549|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737550|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154737551|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
154737552|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737553|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737554|NCT01099774|Bimatoprost|bimatoprost|mesh-list
154737555|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154737556|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154737557|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154737558|NCT01100242|Bortezomib|bortezomib|mesh-list
154737559|NCT01100242|Sorafenib|sorafenib|mesh-list
154737560|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737561|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154737562|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737563|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737564|NCT01148836|Ubiquinone|ubiquinone|mesh-list
154737565|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
154737566|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
154737567|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737568|NCT01148836|Vitamins|vitamins|mesh-ancestor
154737569|NCT01149616|Dexamethasone|dexamethasone|mesh-list
154737570|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737571|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
154737572|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
154737573|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737574|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737575|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737576|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
154737577|NCT01149616|Hormones|hormones|mesh-ancestor
153570068|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154737578|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737579|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154737580|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737581|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
154737582|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
154737583|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154737584|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154737585|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737586|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737587|NCT03460470|Urological Agents|urological agents|mesh-ancestor
154737588|NCT01101100|Brodalumab|brodalumab|mesh-list
154737589|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
154737590|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154737591|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737592|NCT01101880|Cytarabine|cytarabine|mesh-list
154737593|NCT01101880|Clofarabine|clofarabine|mesh-list
154737594|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154737595|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
154737596|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737597|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737598|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
154737599|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737600|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154737601|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
154737602|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737603|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154737604|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
154737605|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737606|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
154737607|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737608|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154737609|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154737610|NCT01102270|Eszopiclone|eszopiclone|mesh-list
154737611|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154737612|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737613|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737614|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
154737615|NCT01103440|Tirofiban|tirofiban|mesh-list
154737616|NCT01103440|Ticlopidine|ticlopidine|mesh-list
154737617|NCT01103440|Abciximab|abciximab|mesh-list
154737618|NCT01103440|Clopidogrel|clopidogrel|mesh-list
154737619|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154737620|NCT01103440|Cangrelor|cangrelor|mesh-list
154737621|NCT01103440|Eptifibatide|eptifibatide|mesh-list
154737622|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154737623|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153570422|NCT01693640|Abatacept|abatacept|mesh-list
154737624|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154737625|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154737626|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
154737627|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737628|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737629|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737630|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
154737631|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154737632|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154737633|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154737634|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
154737635|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154737636|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737637|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
154737638|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737639|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
154737640|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154737641|NCT01103440|Protective Agents|protective agents|mesh-ancestor
154737642|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154737643|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154737644|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737645|NCT01105312|Letrozole|letrozole|mesh-list
154737646|NCT01105312|Panobinostat|panobinostat|mesh-list
154737647|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737648|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154737649|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154737650|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737651|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737652|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154737653|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
154737654|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737655|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737656|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154737657|NCT04488978|Amlodipine|amlodipine|mesh-list
154737658|NCT04488978|Irbesartan|irbesartan|mesh-list
154737659|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154737660|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154737661|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154737662|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737663|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154737664|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737665|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
154737666|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154737667|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154737668|NCT03460002|Vaccines|vaccines|mesh-list
154737669|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
154737670|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570478|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570479|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
154737671|NCT01105702|Bevacizumab|bevacizumab|mesh-list
154737672|NCT01105702|Temozolomide|temozolomide|mesh-list
154737673|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
154737674|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154737675|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737676|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154737677|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154737678|NCT01105702|Growth Substances|growth substances|mesh-ancestor
154737679|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737680|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
154737681|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154737682|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
154737683|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737684|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
154737685|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154737686|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737687|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
154737688|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154737689|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737690|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154737691|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154737692|NCT04453332|Hormones|hormones|mesh-list
154737693|NCT04453332|Estradiol|estradiol|mesh-list
154737694|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154737695|NCT04453332|Progesterone|progesterone|mesh-list
154737696|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737697|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737698|NCT04453332|Estrogens|estrogens|mesh-ancestor
154737699|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154737700|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
154737701|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154737702|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154737703|NCT04453332|Progestins|progestins|mesh-ancestor
154737704|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
154737705|NCT03456570|Progestins|progestins|mesh-ancestor
154737706|NCT03456570|Hormones|hormones|mesh-ancestor
154737707|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737708|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737709|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154737710|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154737711|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154737712|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154737713|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737714|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154737715|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737716|NCT03468348|Analgesics|analgesics|mesh-ancestor
154737717|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
154737718|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737719|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
154737720|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154737721|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
154737722|NCT03464682|Atorvastatin|atorvastatin|mesh-list
154737723|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154737724|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154737725|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
154737726|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737727|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154737728|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154737729|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737730|NCT03464058|Rabeprazole|rabeprazole|mesh-list
154737731|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154737732|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737733|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154737734|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737735|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737736|NCT03451734|Metformin|metformin|mesh-list
154737737|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
154737738|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154737739|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737740|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154737741|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737742|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154737743|NCT03130218|Peppermint oil|peppermint oil|mesh-list
154737744|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
154737745|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
154737746|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737747|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737748|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737749|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
154737750|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
154737751|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737752|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154737753|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737754|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737755|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
154737756|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737757|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737758|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154737759|NCT01199926|Vitamin D|vitamin d|mesh-list
154737760|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
154737761|NCT01199926|Vitamins|vitamins|mesh-ancestor
154737762|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
154737763|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737764|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154737765|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154737766|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
154737767|NCT01106950|Fludarabine|fludarabine|mesh-list
154737768|NCT01106950|Interleukin-2|interleukin-2|mesh-list
154737769|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
154737770|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154737771|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
154737772|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737773|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737774|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154737775|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
154737776|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737777|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737778|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154737779|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154737780|NCT01106950|Analgesics|analgesics|mesh-ancestor
154737781|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
154737782|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737783|NCT03463044|Nangibotide|nangibotide|mesh-list
154737784|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737785|NCT02522208|Hydralazine|hydralazine|mesh-list
154737786|NCT02522208|Isosorbide|isosorbide|mesh-list
154489746|NCT05620784|Furosemide|furosemide|mesh-list
154737787|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154737788|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154737789|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154737790|NCT02522208|Diuretics|diuretics|mesh-ancestor
154737791|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
154737792|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737793|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
154737794|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154737795|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737796|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154737797|NCT05684172|Tenecteplase|tenecteplase|mesh-list
154737798|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154737799|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154737800|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737802|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154737803|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
154737804|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737805|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154737806|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
154737807|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
154737808|NCT01200160|Vitamins|vitamins|mesh-ancestor
154737809|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
154737810|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737811|NCT01153672|Letrozole|letrozole|mesh-list
154737812|NCT01153672|Anastrozole|anastrozole|mesh-list
154737813|NCT01153672|Vorinostat|vorinostat|mesh-list
154737814|NCT01153672|Exemestane|exemestane|mesh-list
154737815|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737816|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154737817|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154737818|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737819|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737820|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154737821|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
154737822|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737823|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737824|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154737825|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154737826|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
154737827|NCT03010072|Hematinics|hematinics|mesh-ancestor
154737828|NCT03462810|Cabotegravir|cabotegravir|mesh-list
154737829|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154737830|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154737831|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737832|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737833|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154737834|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154737835|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
154737836|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737837|NCT01219738|Budesonide|budesonide|mesh-list
154737838|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737839|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154737840|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
154737841|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737842|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737843|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154737844|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
154737845|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
154737846|NCT01219738|Hormones|hormones|mesh-ancestor
154737847|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737848|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
154737849|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154737850|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737851|NCT03848754|Immunotoxins|immunotoxins|mesh-ancestor
154737852|NCT03848754|Immunoconjugates|immunoconjugates|mesh-ancestor
154737853|NCT03848754|Immunologic Factors|immunologic factors|mesh-ancestor
154737854|NCT03848754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737855|NCT01155154|Clindamycin|clindamycin|mesh-list
154737856|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
154737857|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
154737858|NCT01155154|Cephalexin|cephalexin|mesh-list
154737859|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154737860|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489812|NCT05318794|Doxorubicin|doxorubicin|mesh-list
154737861|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154737862|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737863|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737864|NCT04614714|Niacinamide|niacinamide|mesh-list
154737865|NCT04614714|Niacin|niacin|mesh-list
154737866|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
154737867|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
154737868|NCT04614714|Vitamins|vitamins|mesh-ancestor
154737869|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
154737870|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737871|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154737872|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
154737873|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737874|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154737875|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
154737876|NCT01221298|Ritonavir|ritonavir|mesh-list
154737877|NCT01221298|Ribavirin|ribavirin|mesh-list
154737878|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154737879|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154737880|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
154737881|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154737882|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737883|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154737884|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154737885|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
154737886|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737887|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154737888|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154737889|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
154737890|NCT01222234|Vitamin D|vitamin d|mesh-list
154737891|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
154737892|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
154737893|NCT01222234|Calcitriol|calcitriol|mesh-list
154737894|NCT01222234|Vitamins|vitamins|mesh-list
154737895|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
154737896|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737897|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154737898|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153571708|NCT05797597|Antipyretics|antipyretics|mesh-ancestor
154737899|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154737900|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154737901|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737902|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154737903|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154737904|NCT01203046|Ertapenem|ertapenem|mesh-list
154737905|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737906|NCT02460588|Prednisolone|prednisolone|mesh-list
154737907|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
154737908|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154737909|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
154737910|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737911|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737912|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154737913|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
154737914|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737915|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737916|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154737917|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737918|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
154737919|NCT02460588|Hormones|hormones|mesh-ancestor
154737920|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737921|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154737922|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154737923|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
154737924|NCT03449082|Coagulants|coagulants|mesh-ancestor
154737925|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154737926|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154737927|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154737928|NCT03413202|Protective Agents|protective agents|mesh-ancestor
154737929|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737930|NCT04169100|Prednisone|prednisone|mesh-list
154737931|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737932|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
154737933|NCT04169100|Hormones|hormones|mesh-ancestor
154737934|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737935|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737936|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154489884|NCT05067621|Semaglutide|semaglutide|mesh-list
154737937|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737938|NCT04155840|Rituximab|rituximab|mesh-list
154737939|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154737940|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154737941|NCT04155840|Antibodies|antibodies|mesh-list
154737942|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
154737943|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154737944|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
154737945|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737946|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737947|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154737948|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154737949|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
154737950|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737951|NCT03448770|Lactulose|lactulose|mesh-list
154737952|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737953|NCT03443778|Dexamethasone|dexamethasone|mesh-list
154737954|NCT03443778|Bupivacaine|bupivacaine|mesh-list
154737955|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154737956|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
154737957|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
154737958|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737959|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737960|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154737961|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
154737962|NCT03443778|Hormones|hormones|mesh-ancestor
153571709|NCT05794750|Capecitabine|capecitabine|mesh-list
154737963|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737964|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154737965|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154737966|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
154737967|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
154737968|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154737969|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
154737970|NCT03011008|Liraglutide|liraglutide|mesh-list
154737971|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154737972|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737973|NCT03011008|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154737974|NCT03011008|Incretins|incretins|mesh-ancestor
154737975|NCT03011008|Hormones|hormones|mesh-ancestor
154737976|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154737977|NCT01157416|Cycloserine|cycloserine|mesh-list
154737978|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154737979|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154737980|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154737981|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
154737982|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154737983|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
154737984|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737985|NCT01206478|Megestrol|megestrol|mesh-list
154737986|NCT01206478|Amitriptyline|amitriptyline|mesh-list
154737987|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154737988|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
154737989|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154737990|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154737991|NCT01206478|Analgesics|analgesics|mesh-ancestor
154737992|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
154737993|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154737994|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154737995|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154737996|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154737997|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154737998|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154737999|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
154738000|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738001|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154738002|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154738003|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154738004|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
154738005|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154738006|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154738007|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154738008|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153572112|NCT03452930|Benzimidazole|benzimidazole|mesh-list
154738009|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738010|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
154738011|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
154738012|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154738013|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738014|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738015|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
154738016|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154738017|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738018|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738019|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
154738020|NCT01158820|Midazolam|midazolam|mesh-list
154738021|NCT01158820|Fentanyl|fentanyl|mesh-list
154738022|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
154738023|NCT01158820|Ketamine|ketamine|mesh-list
154738024|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154738025|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738026|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738027|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738028|NCT01158820|Analgesics|analgesics|mesh-ancestor
154738029|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
154738030|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738031|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154738032|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154738033|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154738034|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
154738035|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738036|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738037|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154738038|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154738039|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
154738040|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
154738041|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154738042|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154738043|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154738044|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154738045|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154738046|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154738047|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
154738048|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
154738049|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154738050|NCT01158820|Narcotics|narcotics|mesh-ancestor
154738051|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154738052|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
154738053|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
154738054|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
154738055|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738056|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154738057|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
154738058|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
154738059|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154738060|NCT03707028|Paclitaxel|paclitaxel|mesh-list
154738061|NCT03707028|Apatinib|apatinib|mesh-list
154738062|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154738063|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738064|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
154738065|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
154738066|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
154738067|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738068|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154738069|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738070|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
154738071|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154738072|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738073|NCT03447678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153572276|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
154738074|NCT03447678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738075|NCT01225354|Calcium|calcium|mesh-list
154738076|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154738077|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738078|NCT02521662|Nicotine|nicotine|mesh-list
154738079|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154738080|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
154738081|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738082|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738083|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154738084|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154738085|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
154738086|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738087|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738088|NCT05183880|Vitamins|vitamins|mesh-list
154738089|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
154738090|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
154738091|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738092|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
154738093|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738094|NCT05183880|Protective Agents|protective agents|mesh-ancestor
154738095|NCT01159054|Niacin|niacin|mesh-list
154738096|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
154738097|NCT01159054|Niacinamide|niacinamide|mesh-list
154738098|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154738099|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
154738100|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738101|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154738102|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
154738103|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
154738104|NCT01159054|Vitamins|vitamins|mesh-ancestor
154738105|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
154738106|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738107|NCT01209442|Bevacizumab|bevacizumab|mesh-list
154738108|NCT01209442|Temozolomide|temozolomide|mesh-list
154738109|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154738110|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738111|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154738112|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154738113|NCT01209442|Growth Substances|growth substances|mesh-ancestor
154738114|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738115|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
154738116|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154738117|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
154738118|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738119|NCT01160380|Modafinil|modafinil|mesh-list
154738120|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154738121|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738122|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154738123|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154738124|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154738125|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738126|NCT04956042|Cytarabine|cytarabine|mesh-list
154738127|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154738128|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
154738129|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738130|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738131|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
154738132|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738133|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154738134|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
154738135|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738136|NCT01228084|Sulforaphane|sulforaphane|mesh-list
154738137|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154738138|NCT01228084|Protective Agents|protective agents|mesh-ancestor
154738139|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738140|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738141|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154738142|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154738143|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154738144|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154738145|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154738146|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
154738147|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738148|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738149|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738150|NCT01212484|Carbidopa|carbidopa|mesh-list
154738151|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154738152|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154738153|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
154738154|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738155|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738156|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738157|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154738158|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738159|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154738160|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
154738161|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738162|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
154738163|NCT01212874|Esmolol|esmolol|mesh-list
154738164|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
154738165|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154738166|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154738167|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154738168|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154738169|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738170|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738171|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738172|NCT01859741|Carboplatin|carboplatin|mesh-list
154738173|NCT01859741|Etoposide|etoposide|mesh-list
154738174|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738175|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154738176|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153573294|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738177|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154738178|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738179|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738180|NCT01212952|Dexamethasone|dexamethasone|mesh-list
154738181|NCT01212952|Bortezomib|bortezomib|mesh-list
154738182|NCT01212952|Pomalidomide|pomalidomide|mesh-list
154738183|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738184|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
154738185|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
154738186|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738187|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738188|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738189|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
154738190|NCT01212952|Hormones|hormones|mesh-ancestor
154738191|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738192|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154738193|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738194|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
154738195|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154738196|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154738197|NCT01212952|Growth Substances|growth substances|mesh-ancestor
154738198|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
154738199|NCT04609865|Lidocaine|lidocaine|mesh-list
154738200|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
154738201|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
154738202|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738203|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738204|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
154738205|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738206|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154738207|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154738208|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154738209|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154738210|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738211|NCT01873859|Metformin|metformin|mesh-list
154738212|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154738213|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738214|NCT00493896|Enoxaparin|enoxaparin|mesh-list
154738215|NCT00493896|PENTA|penta|mesh-list
154738216|NCT00493896|Fondaparinux|fondaparinux|mesh-list
154738217|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
154738218|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154738219|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154738220|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738221|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154738222|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
154738223|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154738224|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
154738225|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738226|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154738227|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
154738228|NCT03449940|Diclofenac|diclofenac|mesh-list
154738229|NCT03449940|Lidocaine|lidocaine|mesh-list
154738230|NCT03449940|Analgesics|analgesics|mesh-list
154738231|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
154738232|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
154738233|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738234|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738235|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
154738236|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738237|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154738238|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154738239|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154738240|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154738241|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738242|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738243|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154738244|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738245|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738246|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154738247|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154738248|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738249|NCT03449940|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154738250|NCT03449940|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154738251|NCT01230424|Triamcinolone|triamcinolone|mesh-list
154738252|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154738253|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154738254|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154738255|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738256|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
154738257|NCT01230424|Hormones|hormones|mesh-ancestor
154738258|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738259|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738260|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154738261|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
154738262|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738263|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738264|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
154738265|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154738266|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738267|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154738268|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
154738269|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154738270|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738271|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738272|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738273|NCT03438240|Fentanyl|fentanyl|mesh-list
154738274|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
154738275|NCT03438240|Bupivacaine|bupivacaine|mesh-list
154738276|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
154738277|NCT03438240|Anesthetics|anesthetics|mesh-list
154738278|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
154738279|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738280|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738281|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
154738282|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738283|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154738284|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738285|NCT03438240|Analgesics|analgesics|mesh-ancestor
154738286|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154738287|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153574444|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
154738288|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154738289|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
154738290|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738291|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738292|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154738293|NCT03438240|Narcotics|narcotics|mesh-ancestor
154738294|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154738295|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154738296|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
154738297|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
154738298|NCT01160848|Ethanol|ethanol|mesh-list
154738299|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154738300|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738301|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738302|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738303|NCT01213576|Ivermectin|ivermectin|mesh-list
154738304|NCT01213576|Albendazole|albendazole|mesh-list
154738305|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154738306|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738307|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
154738308|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
154738309|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154738310|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154738311|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
154738312|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
154738313|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
154738314|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738315|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738316|NCT04452318|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154738317|NCT04452318|Antiviral Agents|antiviral agents|mesh-ancestor
154738318|NCT04452318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738319|NCT01161862|Glucagon|glucagon|mesh-list
154738320|NCT01161862|Pancrelipase|pancrelipase|mesh-list
154738321|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738322|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738323|NCT01161862|Hormones|hormones|mesh-ancestor
154738324|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738325|NCT01214356|Vitamin D|vitamin d|mesh-list
154738326|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
154738327|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
154738328|NCT01214356|Vitamins|vitamins|mesh-list
154738329|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
154738330|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738331|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154738332|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154738333|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
154738334|NCT01232920|Methotrexate|methotrexate|mesh-list
154738335|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154738336|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
154738337|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154738338|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738339|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154738340|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
154738341|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738342|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738343|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
154738344|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738345|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154738346|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154738347|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
154738348|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154738349|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154738350|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154738351|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154738352|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
154738353|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154738354|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738355|NCT03445182|Anesthetics|anesthetics|mesh-list
154738356|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738357|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738358|NCT03010540|Fentanyl|fentanyl|mesh-list
154738359|NCT03010540|Morphine|morphine|mesh-list
154738360|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154738361|NCT03010540|Narcotics|narcotics|mesh-ancestor
154738362|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738363|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738364|NCT03010540|Analgesics|analgesics|mesh-ancestor
154738365|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
154738366|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738367|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154738368|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154738369|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
154738370|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
154738371|NCT03445104|Huperzine A|huperzine a|mesh-list
154738372|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154738373|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738374|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738375|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
154738376|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738377|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738378|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154738379|NCT03445104|Protective Agents|protective agents|mesh-ancestor
154738380|NCT01234714|Liver Extracts|liver extracts|mesh-list
154738381|NCT01234714|Hematinics|hematinics|mesh-ancestor
154738382|NCT03440502|Anesthetics|anesthetics|mesh-list
154738383|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738384|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738385|NCT01234870|Adenosine|adenosine|mesh-list
154738386|NCT01234870|Analgesics|analgesics|mesh-ancestor
154738387|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
154738388|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738389|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738390|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153575497|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738391|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
154738392|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154738393|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
154738394|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
154738395|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738396|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738397|NCT03437460|Ibuprofen|ibuprofen|mesh-list
154738398|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738399|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154738400|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738401|NCT03437460|Analgesics|analgesics|mesh-ancestor
154738402|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
154738403|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738404|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738405|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154738406|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154738407|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738408|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738409|NCT03444636|Fentanyl|fentanyl|mesh-list
154738410|NCT03444636|Bupivacaine|bupivacaine|mesh-list
154738411|NCT03444636|Ropivacaine|ropivacaine|mesh-list
154738412|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
154738413|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
154738414|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738415|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738416|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
154738417|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738418|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154738419|NCT03444636|Narcotics|narcotics|mesh-ancestor
154738420|NCT03444636|Analgesics|analgesics|mesh-ancestor
154738421|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154738422|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154738423|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
154738424|NCT01215292|Ketoconazole|ketoconazole|mesh-list
154738425|NCT01215292|Anastrozole|anastrozole|mesh-list
154738426|NCT01215292|Testosterone|testosterone|mesh-list
154738427|NCT01215292|Dutasteride|dutasteride|mesh-list
154738428|NCT01215292|Acyline|acyline|mesh-list
154738429|NCT01215292|Androgens|androgens|mesh-ancestor
154738430|NCT01215292|Hormones|hormones|mesh-ancestor
154738431|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738432|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738433|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154738434|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738435|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154738436|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154738437|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738438|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738439|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154738440|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
154738441|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
154738442|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738443|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154738444|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154738445|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154738446|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154738447|NCT04796454|Gemcitabine|gemcitabine|mesh-list
154738448|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
154738449|NCT04796454|Temozolomide|temozolomide|mesh-list
154738450|NCT04796454|Pamiparib|pamiparib|mesh-list
154738451|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738452|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154738453|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
154738454|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738455|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154738456|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
154738457|NCT04796454|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154738458|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738459|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154738460|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154738461|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738462|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154738463|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738464|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738465|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
154738466|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154738467|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738468|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154738469|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
154738470|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154738471|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738472|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738473|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738475|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154738476|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
154738477|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154738478|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154738479|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738480|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738481|NCT03437226|Protective Agents|protective agents|mesh-ancestor
154738482|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738483|NCT04788420|Sorafenib|sorafenib|mesh-list
154738484|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738485|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154738486|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738487|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738488|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154738489|NCT01282138|Dextrans|dextrans|mesh-list
154738490|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154738491|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154738492|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
154738493|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
154738494|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
154738495|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154738496|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738497|NCT01282138|Analgesics|analgesics|mesh-ancestor
154738498|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
154738499|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738500|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738501|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738502|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154738503|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154738504|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154738505|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154738506|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
154738507|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
154738508|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738509|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738510|NCT03444402|Esomeprazole|esomeprazole|mesh-list
154738511|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154738512|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738513|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154738514|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738515|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738516|NCT01238536|Dexamethasone|dexamethasone|mesh-list
154738517|NCT01238536|Betamethasone|betamethasone|mesh-list
154738518|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154738519|NCT01238536|Lidocaine|lidocaine|mesh-list
154738520|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
154738521|NCT01238536|Anesthetics|anesthetics|mesh-list
154738522|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738523|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
154738524|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
154738525|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738526|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738527|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738528|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
154738529|NCT01238536|Hormones|hormones|mesh-ancestor
154738530|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738531|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154738532|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738533|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738534|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738535|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
154738536|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154738537|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154490478|NCT01592370|Nivolumab|nivolumab|mesh-list
154738538|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154738539|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154738540|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154738541|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
154738543|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154738544|NCT03437070|Trabectedin|trabectedin|mesh-list
154738545|NCT03437070|Olaratumab|olaratumab|mesh-list
154738546|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154738547|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738548|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154738549|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154738550|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738551|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738552|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154738553|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
154738554|NCT03128736|Esomeprazole|esomeprazole|mesh-list
154738555|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
154738556|NCT03128736|Lansoprazole|lansoprazole|mesh-list
154738557|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154738558|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738559|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154738560|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738561|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738562|NCT01218958|Naltrexone|naltrexone|mesh-list
154738563|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154738564|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154738565|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738566|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
154738567|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738568|NCT03444246|Iodine|iodine|mesh-list
154738569|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
154738570|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154738571|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738572|NCT03444246|Trace Elements|trace elements|mesh-ancestor
154738573|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
154738574|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738575|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
154738576|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154738577|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
154738578|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738579|NCT03440268|Expectorants|expectorants|mesh-ancestor
154738580|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
154738581|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154738582|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
154738583|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738584|NCT03440268|Protective Agents|protective agents|mesh-ancestor
154738585|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738586|NCT03440268|Antidotes|antidotes|mesh-ancestor
154738587|NCT04369014|Anesthetics|anesthetics|mesh-list
154738588|NCT04369014|Propofol|propofol|mesh-list
154738589|NCT04369014|Etomidate|etomidate|mesh-list
154738590|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738591|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738592|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154738593|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154738594|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
154738595|NCT03436836|Lidocaine|lidocaine|mesh-list
154738596|NCT03436836|Nalbuphine|nalbuphine|mesh-list
154738597|NCT03436836|Bupivacaine|bupivacaine|mesh-list
154738598|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
154738599|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
154738600|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738601|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738602|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
154738603|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738604|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154738605|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154738606|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154738607|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154738608|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738609|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154738610|NCT03436836|Narcotics|narcotics|mesh-ancestor
154738611|NCT03436836|Analgesics|analgesics|mesh-ancestor
154738612|NCT03444012|Ticagrelor|ticagrelor|mesh-list
154738613|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154738614|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154738615|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154738616|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154738617|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
154738618|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738619|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738620|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738621|NCT03440034|Pioglitazone|pioglitazone|mesh-list
154738622|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154738623|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738624|NCT03433326|Grazoprevir|grazoprevir|mesh-list
154738625|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154738626|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
154738627|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738628|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154738629|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
154738630|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154738631|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154738632|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154738633|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738634|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738635|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154738636|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154738637|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738638|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
154738639|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738640|NCT04276389|Paclitaxel|paclitaxel|mesh-list
154738641|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154738642|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154738643|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738644|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
154738645|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
154738646|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
154738647|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738648|NCT03128619|Letrozole|letrozole|mesh-list
154738649|NCT03128619|Palbociclib|palbociclib|mesh-list
154738650|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738651|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154738652|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154738653|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738654|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738655|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153578625|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738656|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
154738657|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738658|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738659|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154738660|NCT03433092|Carotenoids|carotenoids|mesh-list
154738661|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
154738662|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738663|NCT03433092|Protective Agents|protective agents|mesh-ancestor
154738664|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738665|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
154738666|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
154738667|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
154738668|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738669|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738670|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
154738671|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738672|NCT01872689|Pirfenidone|pirfenidone|mesh-list
154738673|NCT01872689|Analgesics|analgesics|mesh-ancestor
154738674|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
154738675|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738676|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738677|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154738678|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738679|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738680|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154738681|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738682|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154738683|NCT03435900|Metronidazole|metronidazole|mesh-list
154738684|NCT03435900|Fosfomycin|fosfomycin|mesh-list
154738685|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154738686|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738687|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
154490627|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154738688|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154738689|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154738691|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738692|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154738693|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738694|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738695|NCT01857323|Albuterol|albuterol|mesh-list
154738696|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154738697|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
154738698|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738699|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738700|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154738701|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
154738702|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
154738703|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154738704|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154738705|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154738706|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154738707|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
154738708|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738709|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738710|NCT03104439|Nivolumab|nivolumab|mesh-list
154738711|NCT03104439|Ipilimumab|ipilimumab|mesh-list
154738712|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153578634|NCT01734057|Dexamethasone|dexamethasone|mesh-list
154738713|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738714|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154738715|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738716|NCT03432780|Docetaxel|docetaxel|mesh-list
154738717|NCT03432780|Hormones|hormones|mesh-list
154738718|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738719|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
154738720|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
154738721|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
154738722|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738723|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738724|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738725|NCT00055731|Aspirin|aspirin|mesh-list
154738726|NCT00055731|Docetaxel|docetaxel|mesh-list
154738727|NCT00055731|Goserelin|goserelin|mesh-list
154738728|NCT00055731|Bicalutamide|bicalutamide|mesh-list
154738729|NCT00055731|Estramustine|estramustine|mesh-list
154738730|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738731|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
154738732|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
154738733|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
154738734|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738735|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154738736|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738737|NCT00055731|Analgesics|analgesics|mesh-ancestor
154738738|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
154738739|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738740|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738741|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738742|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154738743|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154738744|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154738745|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154738746|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154738747|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738748|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
154738749|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154738750|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
154738751|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
154738752|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738753|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154738754|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
154738755|NCT03435744|Simvastatin|simvastatin|mesh-list
154738756|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154738757|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154738758|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
154738759|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738760|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154490704|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154738761|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154738762|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738763|NCT03435666|Capecitabine|capecitabine|mesh-list
154738764|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154738765|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
154738766|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738767|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738768|NCT00632541|Bevacizumab|bevacizumab|mesh-list
154738769|NCT00632541|Sorafenib|sorafenib|mesh-list
154738770|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154738771|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738772|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154738773|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154738774|NCT00632541|Growth Substances|growth substances|mesh-ancestor
154738775|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738776|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
154738777|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154738778|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738779|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738780|NCT01872611|Prednisolone|prednisolone|mesh-list
154738781|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154738782|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
154738783|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154738784|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
154738785|NCT01872611|Nepafenac|nepafenac|mesh-list
154738786|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154738787|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
154738788|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738789|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
154738790|NCT01872611|Hormones|hormones|mesh-ancestor
154738791|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738792|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738793|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154738794|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738795|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
154738796|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
154738797|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738798|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738799|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154738800|NCT01872611|Protective Agents|protective agents|mesh-ancestor
154738801|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154738802|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738803|NCT01872611|Analgesics|analgesics|mesh-ancestor
154738804|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
154738805|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154738806|NCT03432468|Valsartan|valsartan|mesh-list
154738807|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154738808|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154738809|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154738810|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738811|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
154738812|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738813|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
154738814|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154738815|NCT03432312|Nicotine|nicotine|mesh-list
154738816|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154738817|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
154738818|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738819|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738820|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154738821|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154738822|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
154738823|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738824|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738825|NCT03438942|Folic Acid|folic acid|mesh-list
154738826|NCT03438942|Hematinics|hematinics|mesh-ancestor
154738827|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
154738828|NCT03438942|Vitamins|vitamins|mesh-ancestor
154738829|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
154738830|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738831|NCT03432156|Immunomodulating Agents|immunomodulating agents|mesh-list
154738832|NCT03432156|Immunologic Factors|immunologic factors|mesh-ancestor
154738833|NCT03432156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738834|NCT04450680|Lactams|lactams|mesh-list
154738835|NCT04450680|beta-Lactams|beta-lactams|mesh-list
154490781|NCT02490176|Liraglutide|liraglutide|mesh-list
154738836|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154738837|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738838|NCT03438708|Axitinib|axitinib|mesh-list
154738839|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738840|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154738841|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738842|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738843|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154738844|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
154738845|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738846|NCT01923597|Protective Agents|protective agents|mesh-ancestor
154738847|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738848|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154738849|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154738850|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738851|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154738852|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154738853|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154738854|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154738855|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738856|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738857|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154738858|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154738859|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154738860|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
154738861|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738862|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738863|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154738864|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154738865|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
154738866|NCT00631137|Testosterone|testosterone|mesh-list
154738867|NCT00631137|Androgens|androgens|mesh-ancestor
154738868|NCT00631137|Hormones|hormones|mesh-ancestor
154738869|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738870|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738871|NCT03428880|Morphine|morphine|mesh-list
154738872|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154738873|NCT03428880|Narcotics|narcotics|mesh-ancestor
154738874|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738875|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738876|NCT03428880|Analgesics|analgesics|mesh-ancestor
154738877|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
154738878|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738879|NCT01923831|Dexamethasone|dexamethasone|mesh-list
154738880|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
154738881|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738882|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
154738883|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
154738884|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738885|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738886|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738887|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
154738888|NCT01923831|Hormones|hormones|mesh-ancestor
154738889|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738890|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154738891|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738892|NCT01923831|Analgesics|analgesics|mesh-ancestor
154738893|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
154738894|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
154738895|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738896|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154738897|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
154738898|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154738899|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154738900|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738901|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154738902|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
154738903|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154738904|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154738905|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738906|NCT04892940|Analgesics|analgesics|mesh-list
154738907|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
154738908|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738909|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738910|NCT03085563|Midazolam|midazolam|mesh-list
154738911|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
154738912|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154738913|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154738914|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154738915|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738916|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154738917|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153579000|NCT01736761|Darunavir|darunavir|mesh-list
154738918|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154738919|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154738920|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
154738921|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
154738922|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
154738923|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
154738924|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738925|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738926|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154738927|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154738928|NCT03085563|Analgesics|analgesics|mesh-ancestor
154738929|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
154738930|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738931|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
154738932|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154738933|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738934|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
154738936|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154738937|NCT04450446|Tinzaparin|tinzaparin|mesh-list
154738938|NCT04450446|Dalteparin|dalteparin|mesh-list
154738939|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
154738940|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154738941|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154738942|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738943|NCT03274752|Paroxetine|paroxetine|mesh-list
154738944|NCT03274752|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154738945|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154738946|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154738947|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738948|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738949|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
154738950|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738951|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154738952|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
154738953|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154738954|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154738955|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154738956|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738957|NCT03428568|Clarithromycin|clarithromycin|mesh-list
154738958|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154738959|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154738960|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154738961|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154738962|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738963|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154738964|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154738965|NCT00630825|Dulaglutide|dulaglutide|mesh-list
154738966|NCT00630825|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154738967|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154738968|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738969|NCT03434340|Dexamethasone|dexamethasone|mesh-list
154738970|NCT03434340|Granisetron|granisetron|mesh-list
154738971|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154738972|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
154738973|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
154738974|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154738975|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738976|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154738977|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
154738978|NCT03434340|Hormones|hormones|mesh-ancestor
154738979|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154738980|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154738981|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738982|NCT03434340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154738983|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154738984|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
154738985|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154738986|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154738987|NCT01923987|Cetuximab|cetuximab|mesh-list
154738988|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154738989|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154738990|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
154738991|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154738992|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
154738993|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154738994|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
154738995|NCT03101163|Protective Agents|protective agents|mesh-ancestor
154738996|NCT01924065|Anticoagulants|anticoagulants|mesh-list
154738997|NCT03434106|Dextrans|dextrans|mesh-list
154738998|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
154738999|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
154739000|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
154739001|NCT01241344|Brincidofovir|brincidofovir|mesh-list
154739002|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
154739003|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739004|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154739005|NCT03009682|Olaparib|olaparib|mesh-list
154739006|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154739007|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739008|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739009|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739010|NCT03431142|Aspirin|aspirin|mesh-list
154739011|NCT03431142|Clopidogrel|clopidogrel|mesh-list
154739012|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154739013|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154739014|NCT03431142|Analgesics|analgesics|mesh-ancestor
154739015|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
154739016|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739017|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739018|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739019|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739020|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154739021|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154739022|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739023|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154739024|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154739025|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739026|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
154739027|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154739028|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154739029|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154739030|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
154739031|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739032|NCT03831321|Diclofenac|diclofenac|mesh-list
154739033|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154739034|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154739035|NCT03831321|Analgesics|analgesics|mesh-ancestor
154739036|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
154739037|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739038|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739039|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739040|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739041|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154739042|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739043|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739044|NCT04450134|Fexofenadine|fexofenadine|mesh-list
154739045|NCT04450134|Famotidine|famotidine|mesh-list
154739046|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154739047|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739048|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154739049|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
154739050|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
154739051|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739052|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579141|NCT01737580|Resiquimod|resiquimod|mesh-list
154739053|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739054|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154739055|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154739056|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154739057|NCT01286818|Leucovorin|leucovorin|mesh-list
154739058|NCT01286818|Fluorouracil|fluorouracil|mesh-list
154739059|NCT01286818|Irinotecan|irinotecan|mesh-list
154739060|NCT01286818|Ramucirumab|ramucirumab|mesh-list
154739061|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154739062|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
154739063|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
154739064|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739065|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154739066|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739067|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154739068|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
154739069|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739070|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154739071|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154739072|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739073|NCT01286818|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154739074|NCT01286818|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154739075|NCT01286818|Growth Substances|growth substances|mesh-ancestor
154739076|NCT01286818|Growth Inhibitors|growth inhibitors|mesh-ancestor
154739077|NCT01286818|Antidotes|antidotes|mesh-ancestor
154739078|NCT01286818|Protective Agents|protective agents|mesh-ancestor
154739079|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
154739080|NCT01286818|Vitamins|vitamins|mesh-ancestor
154739081|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
154739082|NCT03428256|Anesthetics|anesthetics|mesh-list
154739083|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739084|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739085|NCT00635505|Albuterol|albuterol|mesh-list
154739086|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154739087|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
154739088|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739089|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739090|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154739091|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
154739092|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
154739093|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154739094|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154739095|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154739096|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154739097|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
154739098|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739099|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739100|NCT01243450|Tretinoin|tretinoin|mesh-list
154739101|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739102|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
154739103|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
154739104|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
154739105|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
154739106|NCT05249751|Coagulants|coagulants|mesh-ancestor
153579180|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
154739107|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154739108|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154739109|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
154739110|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739111|NCT00635193|Doxorubicin|doxorubicin|mesh-list
154739112|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154739113|NCT00635193|Volociximab|volociximab|mesh-list
154739114|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154739115|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154739116|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739117|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154739118|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154739119|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739120|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739121|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154739122|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154739123|NCT00635193|Growth Substances|growth substances|mesh-ancestor
154739124|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739125|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
154739126|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
154739127|NCT00630201|Buprenorphine|buprenorphine|mesh-list
154739128|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154739129|NCT00630201|Narcotics|narcotics|mesh-ancestor
154739130|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739131|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739132|NCT00630201|Analgesics|analgesics|mesh-ancestor
154739133|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
154739134|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739135|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154491076|NCT02184273|Analgesics|analgesics|mesh-ancestor
154739136|NCT01925547|Curcumin|curcumin|mesh-list
154739137|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154739138|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154739140|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
154739141|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739142|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739143|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739144|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739145|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739146|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739147|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739148|NCT03122301|Bupivacaine|bupivacaine|mesh-list
154739149|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
154739150|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
154739151|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739152|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739153|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
154739154|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739155|NCT01925859|Dexamethasone|dexamethasone|mesh-list
154739156|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
154739157|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154739158|NCT01925859|BB 1101|bb 1101|mesh-list
154739159|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739160|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
154739161|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
154739162|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739163|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739164|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739165|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
154739166|NCT01925859|Hormones|hormones|mesh-ancestor
154739167|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739168|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154739169|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739170|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
154739171|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739172|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739173|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153579246|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
154739174|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154739175|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154739176|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739177|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739178|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154739179|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154739180|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739181|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
154739182|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739183|NCT01926639|Rituximab|rituximab|mesh-list
154739184|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739185|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739186|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
154739187|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739188|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739189|NCT02199496|Ustekinumab|ustekinumab|mesh-list
154739190|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
154739191|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
154739192|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154739193|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
154739194|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739195|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
154739196|NCT04395417|Protective Agents|protective agents|mesh-ancestor
154739197|NCT02199574|Bupivacaine|bupivacaine|mesh-list
154739198|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
154739199|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
154739200|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739201|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739202|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
154739203|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739204|NCT02199652|Prazosin|prazosin|mesh-list
154739205|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154739206|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154739207|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154739208|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154739209|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
154739210|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739211|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739212|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739213|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154739214|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154739215|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154739216|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
154739217|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739218|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154739219|NCT01927029|Progesterone|progesterone|mesh-list
154739220|NCT01927029|Progestins|progestins|mesh-ancestor
154739221|NCT01927029|Hormones|hormones|mesh-ancestor
154739222|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739223|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739224|NCT01921647|Amoxicillin|amoxicillin|mesh-list
154739225|NCT01921647|Clarithromycin|clarithromycin|mesh-list
153579339|NCT01738945|Amlodipine|amlodipine|mesh-list
154739226|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739227|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739228|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154739229|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739230|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739231|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154739232|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154739233|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
154739234|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154739235|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
154739236|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739237|NCT01339858|Expectorants|expectorants|mesh-ancestor
154739238|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
154739239|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154739240|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
154739241|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739242|NCT01339858|Protective Agents|protective agents|mesh-ancestor
154739243|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739244|NCT01339858|Antidotes|antidotes|mesh-ancestor
154739245|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154739246|NCT01339936|Glycerol|glycerol|mesh-list
154739247|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154739248|NCT01339936|Protective Agents|protective agents|mesh-ancestor
154739249|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739250|NCT01339936|Laxatives|laxatives|mesh-ancestor
154739251|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739252|NCT05246865|Androgens|androgens|mesh-list
154739253|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154739254|NCT05246865|Hormones|hormones|mesh-ancestor
154739255|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739256|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739257|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154739258|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
154739259|NCT03111537|Nicotine|nicotine|mesh-list
154739260|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154739261|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
154739262|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739263|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739264|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154739265|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154739266|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
154739267|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739268|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739269|NCT01927263|Infliximab|infliximab|mesh-list
154739270|NCT01927263|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154739271|NCT01927263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739272|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
154739273|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739274|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739275|NCT01341730|Pioglitazone|pioglitazone|mesh-list
154739276|NCT01341730|Atorvastatin|atorvastatin|mesh-list
154739277|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154739278|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154739279|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
154739280|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739281|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154739282|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154739283|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739284|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154739285|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739287|NCT01247272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154739288|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154739289|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154739290|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739291|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739292|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
154739293|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739294|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154739295|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
154739296|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154739297|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154739298|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154739299|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739300|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
154739301|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
154739302|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154739303|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154739304|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739305|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739306|NCT01290484|Urological Agents|urological agents|mesh-ancestor
154739307|NCT04396743|Clotrimazole|clotrimazole|mesh-list
154739308|NCT04396743|Miconazole|miconazole|mesh-list
154739309|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154739310|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739311|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
154739312|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154739313|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154739314|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739315|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739316|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154739317|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
154739318|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739319|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739320|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154739321|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154739322|NCT01928043|Curcumin|curcumin|mesh-list
153579466|NCT01739855|Vitamins|vitamins|mesh-ancestor
153579519|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
154739323|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154739324|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154739325|NCT01928043|Analgesics|analgesics|mesh-ancestor
154739326|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
154739327|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739328|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739329|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739330|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739331|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739332|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739333|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739334|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154739335|NCT02979886|Menotropins|menotropins|mesh-list
154739336|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
154739337|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154739338|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
154739339|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154739340|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739341|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154739342|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154739343|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739344|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154739345|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
154739346|NCT01928511|Interferons|interferons|mesh-list
154739347|NCT01928511|Tenofovir|tenofovir|mesh-list
154739348|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
154739349|NCT01928511|Lamivudine|lamivudine|mesh-list
154739350|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
154739351|NCT01928511|Entecavir|entecavir|mesh-list
154739352|NCT01928511|Adefovir|adefovir|mesh-list
154739353|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154739354|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739355|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
154739356|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739357|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154491302|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154739358|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154739359|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739360|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739362|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154739363|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
154739364|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739365|NCT01928823|Cycloserine|cycloserine|mesh-list
154739366|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154739367|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579521|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
154739368|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154739369|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
154739370|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739371|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
154739372|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739373|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
154739374|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
154739375|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154739376|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154739377|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
154739378|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739379|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739380|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154739381|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
154739382|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154739383|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154739384|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154739385|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154739386|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739387|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739388|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
154739389|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154739390|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
154739391|NCT02977494|Dexamethasone|dexamethasone|mesh-list
154739392|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
154739393|NCT02977494|Bortezomib|bortezomib|mesh-list
154739394|NCT02977494|Daratumumab|daratumumab|mesh-list
154739395|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739396|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
154739397|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
154739398|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739399|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739400|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739401|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
154739402|NCT02977494|Hormones|hormones|mesh-ancestor
154739403|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739404|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154739405|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739406|NCT01929603|Rifampin|rifampin|mesh-list
154739407|NCT01929603|Olaparib|olaparib|mesh-list
154739408|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154739409|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739410|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739411|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739412|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154739413|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
154739414|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739415|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739416|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
154739417|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154739418|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154739419|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154739420|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154739421|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154739422|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154739423|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154739424|NCT04178460|Niraparib|niraparib|mesh-list
154739425|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154739426|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739427|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739428|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739429|NCT01928901|Thymol|thymol|mesh-list
154739430|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739431|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154739432|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
154739433|NCT04395105|Dexamethasone|dexamethasone|mesh-list
154739434|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739435|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
154739436|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
154739437|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739438|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739439|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739440|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
154739441|NCT04395105|Hormones|hormones|mesh-ancestor
154739442|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739443|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154739444|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739445|NCT04072770|Caseins|caseins|mesh-list
154739446|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
154739447|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
154739448|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739449|NCT01291108|Bimatoprost|bimatoprost|mesh-list
154739450|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154739451|NCT01929213|Bosentan|bosentan|mesh-list
154739452|NCT01929213|Udenafil|udenafil|mesh-list
154739453|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154739454|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154739455|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739456|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154739457|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154739458|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739459|NCT03430518|Durvalumab|durvalumab|mesh-list
154739460|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739461|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739462|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154739463|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739464|NCT01925937|Ubiquinone|ubiquinone|mesh-list
154739465|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
154739466|NCT01925937|Atorvastatin|atorvastatin|mesh-list
154739467|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154739468|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154739469|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
154739470|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739471|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154739472|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154739473|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739474|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
154739475|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739476|NCT01925937|Vitamins|vitamins|mesh-ancestor
154739477|NCT03430362|Scopolamine|scopolamine|mesh-list
154739478|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154739479|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154739480|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
154739481|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
154739482|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739483|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739484|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739485|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
154739486|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154739487|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
154739488|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739489|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739490|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154739491|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
154739492|NCT03428022|Apatinib|apatinib|mesh-list
154739493|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739494|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154739495|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739496|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739497|NCT00989781|Dexamethasone|dexamethasone|mesh-list
154739498|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154739499|NCT00989781|Hormones|hormones|mesh-list
154739500|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154739501|NCT00989781|Cosyntropin|cosyntropin|mesh-list
154739502|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154739503|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154739504|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
154739505|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739506|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
154491453|NCT02476526|Protective Agents|protective agents|mesh-ancestor
154739507|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
154739508|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739509|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739510|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739511|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
154739512|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739513|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154739514|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739515|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154739516|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739517|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739518|NCT03430128|Immunomodulating Agents|immunomodulating agents|mesh-list
154739519|NCT03430128|Immunologic Factors|immunologic factors|mesh-ancestor
154739520|NCT03430128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739521|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
154739523|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154739524|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739525|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
154739526|NCT03427944|Coagulants|coagulants|mesh-ancestor
154739527|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154739528|NCT01922193|Hormones|hormones|mesh-ancestor
154739529|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739530|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739531|NCT03429972|Paclitaxel|paclitaxel|mesh-list
154739532|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154739533|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739534|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
154739535|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
154739536|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
154739537|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739538|NCT01347034|Immunomodulating Agents|immunomodulating agents|mesh-list
154739539|NCT01347034|Immunologic Factors|immunologic factors|mesh-ancestor
154739540|NCT01347034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739541|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
154739542|NCT03079167|Hematinics|hematinics|mesh-ancestor
154739543|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154739544|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
154739545|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154739546|NCT03427632|Protective Agents|protective agents|mesh-ancestor
154739547|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739548|NCT03427554|Tretinoin|tretinoin|mesh-list
154739549|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739550|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
154739551|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
154739552|NCT01349920|Infliximab|infliximab|mesh-list
154739553|NCT01349920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154739554|NCT01349920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739555|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
154739556|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739557|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739558|NCT03128346|Aspirin|aspirin|mesh-list
154739559|NCT03128346|Acetaminophen|acetaminophen|mesh-list
154739560|NCT03128346|Fentanyl|fentanyl|mesh-list
154739561|NCT03128346|Hydromorphone|hydromorphone|mesh-list
154739562|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154739563|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154739564|NCT03128346|Analgesics|analgesics|mesh-ancestor
154739565|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
154739566|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739567|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739568|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739569|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739570|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154739571|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154739572|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739573|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154739574|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154739575|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739576|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
154739577|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154739578|NCT03128346|Narcotics|narcotics|mesh-ancestor
154739579|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739580|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154739581|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154739582|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
154739583|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
154739585|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
154739586|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739587|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739588|NCT03427242|Apatinib|apatinib|mesh-list
154739589|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739590|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154739591|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739592|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739593|NCT01252732|Vancomycin|vancomycin|mesh-list
154739594|NCT01252732|Oritavancin|oritavancin|mesh-list
154739595|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739596|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739597|NCT00989235|Abatacept|abatacept|mesh-list
154739598|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154739599|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739600|NCT00989235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739601|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739602|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154739603|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
154739604|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739605|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739606|NCT06154096|Glucagon|glucagon|mesh-list
154739607|NCT06154096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739608|NCT06154096|Hormones|hormones|mesh-ancestor
154739609|NCT06154096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739610|NCT06154096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739611|NCT06154018|Protamines|protamines|mesh-list
154739612|NCT06154018|Heparin Antagonists|heparin antagonists|mesh-ancestor
154739613|NCT06154018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739614|NCT06154018|Coagulants|coagulants|mesh-ancestor
154739615|NCT06153784|Thalidomide|thalidomide|mesh-list
154739616|NCT06153784|Hydroxyurea|hydroxyurea|mesh-list
154739617|NCT06153784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154739618|NCT06153784|Immunologic Factors|immunologic factors|mesh-ancestor
154739619|NCT06153784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739620|NCT06153784|Leprostatic Agents|leprostatic agents|mesh-ancestor
154739621|NCT06153784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739622|NCT06153784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739623|NCT06153784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154739624|NCT06153784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154739625|NCT06153784|Growth Substances|growth substances|mesh-ancestor
154739626|NCT06153784|Growth Inhibitors|growth inhibitors|mesh-ancestor
154739627|NCT06153784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739628|NCT06153784|Antisickling Agents|antisickling agents|mesh-ancestor
154739629|NCT06153784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739630|NCT06153784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739631|NCT06153784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154739632|NCT06153706|Metronidazole|metronidazole|mesh-list
154739633|NCT06153706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739634|NCT06153706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739635|NCT06153706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154739636|NCT06153706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154739637|NCT06153602|Nalbuphine|nalbuphine|mesh-list
154739638|NCT06153602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154739639|NCT06153602|Narcotics|narcotics|mesh-ancestor
154739640|NCT06153602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739641|NCT06153602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739642|NCT06153602|Analgesics|analgesics|mesh-ancestor
154739643|NCT06153602|Sensory System Agents|sensory system agents|mesh-ancestor
154739644|NCT06153602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739645|NCT06153433|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154739646|NCT06153433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154739647|NCT06153433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154739648|NCT06153433|Antimetabolites|antimetabolites|mesh-ancestor
154739649|NCT06153433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739650|NCT06153433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154739651|NCT06153433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154739652|NCT06153433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739653|NCT06153329|Insulin Lispro|insulin lispro|mesh-list
153579933|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739654|NCT06153329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154739655|NCT06153329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739656|NCT06153186|Flunarizine|flunarizine|mesh-list
154739657|NCT06153186|Anticonvulsants|anticonvulsants|mesh-ancestor
154739658|NCT06153186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154739659|NCT06153186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154739660|NCT06153186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739661|NCT06153186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154739662|NCT06153186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739663|NCT06153186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154739664|NCT06153186|Histamine Antagonists|histamine antagonists|mesh-ancestor
154739665|NCT06153186|Histamine Agents|histamine agents|mesh-ancestor
154739666|NCT06153186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739667|NCT06153186|Vasodilator Agents|vasodilator agents|mesh-ancestor
154739668|NCT06153134|Kojic acid|kojic acid|mesh-list
154739669|NCT06153134|Antioxidants|antioxidants|mesh-ancestor
154739670|NCT06153134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739671|NCT06153134|Protective Agents|protective agents|mesh-ancestor
154739672|NCT06153134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739673|NCT06152939|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154739674|NCT06152939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154739675|NCT06152939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739676|NCT06152926|Immunomodulating Agents|immunomodulating agents|mesh-list
154739677|NCT06152926|Immunologic Factors|immunologic factors|mesh-ancestor
154739678|NCT06152926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739679|NCT06152822|Bevacizumab|bevacizumab|mesh-list
154739680|NCT06152822|Capecitabine|capecitabine|mesh-list
154739681|NCT06152822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739682|NCT06152822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739683|NCT06152822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154739684|NCT06152822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154739685|NCT06152822|Growth Substances|growth substances|mesh-ancestor
154739686|NCT06152822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739687|NCT06152822|Growth Inhibitors|growth inhibitors|mesh-ancestor
154739688|NCT06152822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154739689|NCT06152822|Antimetabolites|antimetabolites|mesh-ancestor
154739690|NCT06152822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739691|NCT06152796|Acetaminophen|acetaminophen|mesh-list
154739692|NCT06152796|Ibuprofen|ibuprofen|mesh-list
154739693|NCT06152796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154739694|NCT06152796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154739695|NCT06152796|Analgesics|analgesics|mesh-ancestor
154739696|NCT06152796|Sensory System Agents|sensory system agents|mesh-ancestor
154739697|NCT06152796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739698|NCT06152796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739699|NCT06152796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739700|NCT06152796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739701|NCT06152796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154739702|NCT06152796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579934|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739703|NCT06152796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739704|NCT06152796|Antipyretics|antipyretics|mesh-ancestor
154739705|NCT06150794|Methotrexate|methotrexate|mesh-list
154739706|NCT06150794|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154739707|NCT06150794|Abortifacient Agents|abortifacient agents|mesh-ancestor
154739708|NCT06150794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154739709|NCT06150794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739710|NCT06150794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154739711|NCT06150794|Antimetabolites|antimetabolites|mesh-ancestor
154739712|NCT06150794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739713|NCT06150794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739714|NCT06150794|Dermatologic Agents|dermatologic agents|mesh-ancestor
154739715|NCT06150794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739716|NCT06150794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154739717|NCT06150794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154739718|NCT06150794|Immunologic Factors|immunologic factors|mesh-ancestor
154739719|NCT06150794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739720|NCT06150794|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154739721|NCT06150040|Azacitidine|azacitidine|mesh-list
154739722|NCT06150040|Venetoclax|venetoclax|mesh-list
154739723|NCT06150040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154739724|NCT06150040|Antimetabolites|antimetabolites|mesh-ancestor
154739725|NCT06150040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739726|NCT06150040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739727|NCT06150040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739728|NCT06080217|Ascorbic Acid|ascorbic acid|mesh-list
154739729|NCT06080217|Antioxidants|antioxidants|mesh-ancestor
154860373|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154491688|NCT02477852|Rifampin|rifampin|mesh-list
154739730|NCT06080217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739731|NCT06080217|Protective Agents|protective agents|mesh-ancestor
154739732|NCT06080217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739733|NCT06080217|Vitamins|vitamins|mesh-ancestor
154739734|NCT06080217|Micronutrients|micronutrients|mesh-ancestor
154739735|NCT06045793|Cocaine|cocaine|mesh-list
154739736|NCT06045793|Anesthetics, Local|anesthetics, local|mesh-ancestor
154739737|NCT06045793|Anesthetics|anesthetics|mesh-ancestor
154739738|NCT06045793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739739|NCT06045793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739740|NCT06045793|Sensory System Agents|sensory system agents|mesh-ancestor
154739741|NCT06045793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739742|NCT06045793|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154739743|NCT06045793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154739744|NCT06045793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154739745|NCT06045793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154739746|NCT06045793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739747|NCT06045793|Dopamine Agents|dopamine agents|mesh-ancestor
154739748|NCT06045793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739749|NCT06036446|Progesterone|progesterone|mesh-list
154739750|NCT06036446|Progestins|progestins|mesh-ancestor
154739751|NCT06036446|Hormones|hormones|mesh-ancestor
154739752|NCT06036446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739753|NCT06036446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739754|NCT06029049|Rocuronium|rocuronium|mesh-list
154739755|NCT06029049|Succinylcholine|succinylcholine|mesh-list
154739756|NCT06029049|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154739757|NCT06029049|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154739758|NCT06029049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154739759|NCT06029049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739760|NCT06029049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739761|NCT06029049|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154739762|NCT05999812|Bevacizumab|bevacizumab|mesh-list
154739763|NCT05999812|Atezolizumab|atezolizumab|mesh-list
154739764|NCT05999812|Tretinoin|tretinoin|mesh-list
154739765|NCT05999812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739766|NCT05999812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739767|NCT05999812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154739768|NCT05999812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154739769|NCT05999812|Growth Substances|growth substances|mesh-ancestor
154739770|NCT05999812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739771|NCT05999812|Growth Inhibitors|growth inhibitors|mesh-ancestor
154739772|NCT05999812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154739773|NCT05999812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739774|NCT05999812|Keratolytic Agents|keratolytic agents|mesh-ancestor
153580054|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
154739775|NCT05999812|Dermatologic Agents|dermatologic agents|mesh-ancestor
154739776|NCT05998837|Dapagliflozin|dapagliflozin|mesh-list
154739777|NCT05998837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154739778|NCT05998837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739779|NCT05998837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154739780|NCT05998837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739781|NCT05918952|Antibodies|antibodies|mesh-list
154739782|NCT05918952|Immunologic Factors|immunologic factors|mesh-ancestor
154739783|NCT05918952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739784|NCT05909553|Venetoclax|venetoclax|mesh-list
154739785|NCT05909553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739786|NCT05872789|Diazepam|diazepam|mesh-list
154739787|NCT05872789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154739788|NCT05872789|Anticonvulsants|anticonvulsants|mesh-ancestor
154739789|NCT05872789|Antiemetics|antiemetics|mesh-ancestor
154739790|NCT05872789|Autonomic Agents|autonomic agents|mesh-ancestor
154739791|NCT05872789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739792|NCT05872789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739793|NCT05872789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739794|NCT05872789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154739795|NCT05872789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739796|NCT05872789|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154739797|NCT05872789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154739798|NCT05872789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154739799|NCT05872789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154739800|NCT05872789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154739801|NCT05872789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154739802|NCT05872789|Anesthetics, General|anesthetics, general|mesh-ancestor
154739803|NCT05872789|Anesthetics|anesthetics|mesh-ancestor
154491759|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739805|NCT05872789|GABA Agents|gaba agents|mesh-ancestor
154739806|NCT05872789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739807|NCT05872789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739808|NCT05847322|Azithromycin|azithromycin|mesh-list
154739809|NCT05847322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739810|NCT05847322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739811|NCT05802056|Calcium, Dietary|calcium, dietary|mesh-list
154739812|NCT05802056|Leucovorin|leucovorin|mesh-list
154739813|NCT05802056|Folic Acid|folic acid|mesh-list
154739814|NCT05802056|Aldesleukin|aldesleukin|mesh-list
154739815|NCT05802056|Nivolumab|nivolumab|mesh-list
154739816|NCT05802056|Fluorouracil|fluorouracil|mesh-list
154739817|NCT05802056|Oxaliplatin|oxaliplatin|mesh-list
154739818|NCT05802056|Interleukin-2|interleukin-2|mesh-list
154739819|NCT05802056|Calcium|calcium|mesh-list
154739820|NCT05802056|Levoleucovorin|levoleucovorin|mesh-list
154739821|NCT05802056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154739822|NCT05802056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739823|NCT05802056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154739824|NCT05802056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739825|NCT05802056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739826|NCT05802056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154739827|NCT05802056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739828|NCT05802056|Antimetabolites|antimetabolites|mesh-ancestor
154739829|NCT05802056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154739830|NCT05802056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154739831|NCT05802056|Immunologic Factors|immunologic factors|mesh-ancestor
154739832|NCT05802056|Antidotes|antidotes|mesh-ancestor
154739833|NCT05802056|Protective Agents|protective agents|mesh-ancestor
154739834|NCT05802056|Vitamin B Complex|vitamin b complex|mesh-ancestor
154739835|NCT05802056|Vitamins|vitamins|mesh-ancestor
154739836|NCT05802056|Micronutrients|micronutrients|mesh-ancestor
154739837|NCT05802056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154739838|NCT05802056|Analgesics|analgesics|mesh-ancestor
154739839|NCT05802056|Sensory System Agents|sensory system agents|mesh-ancestor
154739840|NCT05802056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739841|NCT05802056|Hematinics|hematinics|mesh-ancestor
154739842|NCT05802056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154739843|NCT05802056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154739844|NCT05802056|Antiviral Agents|antiviral agents|mesh-ancestor
154739845|NCT05802056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739846|NCT05787743|Tocotrienols|tocotrienols|mesh-list
154739847|NCT05787743|Vitamin E|vitamin e|mesh-list
154739848|NCT05787743|Tocopherols|tocopherols|mesh-list
154739849|NCT05787743|Antioxidants|antioxidants|mesh-ancestor
154739850|NCT05787743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739851|NCT05787743|Protective Agents|protective agents|mesh-ancestor
154739852|NCT05787743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739853|NCT05787743|Vitamins|vitamins|mesh-ancestor
154739854|NCT05787743|Micronutrients|micronutrients|mesh-ancestor
154739855|NCT05761860|Oxycodone|oxycodone|mesh-list
154739856|NCT05761860|Oxytocin|oxytocin|mesh-list
154739857|NCT05761860|Oxytocics|oxytocics|mesh-ancestor
154739858|NCT05761860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154739859|NCT05761860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739860|NCT05761860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154739861|NCT05761860|Narcotics|narcotics|mesh-ancestor
154739862|NCT05761860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154739863|NCT05761860|Analgesics|analgesics|mesh-ancestor
154739864|NCT05761860|Sensory System Agents|sensory system agents|mesh-ancestor
154739865|NCT05761860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739866|NCT05694312|Ibrutinib|ibrutinib|mesh-list
154739867|NCT05694312|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154739868|NCT05694312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154739869|NCT05694312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739870|NCT05694312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739871|NCT05693545|Penicillins|penicillins|mesh-list
154739872|NCT05693545|Penicillin G|penicillin g|mesh-list
154739873|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154739874|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
154739875|NCT05693545|Penicillin V|penicillin v|mesh-list
154739876|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739877|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739878|NCT05682339|Quinine|quinine|mesh-list
154739879|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
154739880|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154739881|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154739882|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739883|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154739884|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739886|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739887|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154739888|NCT05682339|Analgesics|analgesics|mesh-ancestor
154739889|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
154739890|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
154739891|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
154739892|NCT05676463|Hormones|hormones|mesh-list
154739893|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154739894|NCT05676463|Androgens|androgens|mesh-list
154739895|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
154739896|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739897|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739898|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
154739899|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739900|NCT05676463|Protective Agents|protective agents|mesh-ancestor
154739901|NCT05676463|Vitamins|vitamins|mesh-ancestor
154739902|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
154739903|NCT05676463|Estrogens|estrogens|mesh-ancestor
154739904|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154739905|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739906|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
154739907|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
154739908|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
154739909|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739910|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739911|NCT05635344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154739912|NCT05635344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739913|NCT05630183|Paclitaxel|paclitaxel|mesh-list
154739914|NCT05630183|Gemcitabine|gemcitabine|mesh-list
154739915|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154739916|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739917|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
154739918|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
153580222|NCT01744288|Clopidogrel|clopidogrel|mesh-list
154739919|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
154739920|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739921|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154739922|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
154739923|NCT05586360|Simvastatin|simvastatin|mesh-list
154739924|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154739925|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154739926|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
154739927|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739928|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154739929|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154739930|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739931|NCT05570812|Neurosteroids|neurosteroids|mesh-list
154739932|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154739933|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739934|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739935|NCT05551936|Rituximab|rituximab|mesh-list
154739936|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154739937|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739938|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739939|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
154739940|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739941|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154739942|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154739943|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
154739944|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739945|NCT05535075|Vancomycin|vancomycin|mesh-list
154739946|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154739947|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154739948|NCT05523609|Vitamin D|vitamin d|mesh-list
154739949|NCT05523609|Cholecalciferol|cholecalciferol|mesh-list
154739950|NCT05523609|Letrozole|letrozole|mesh-list
154739951|NCT05523609|Calcium|calcium|mesh-list
154739952|NCT05523609|Vitamins|vitamins|mesh-ancestor
154739953|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
154739954|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739955|NCT05523609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154739956|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154739957|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739958|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154739959|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154739960|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154739961|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739962|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154739963|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
154739964|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739965|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154739966|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154739967|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739968|NCT05481437|Immunotoxins|immunotoxins|mesh-ancestor
154739969|NCT05481437|Immunoconjugates|immunoconjugates|mesh-ancestor
154739970|NCT05481437|Immunologic Factors|immunologic factors|mesh-ancestor
154739971|NCT05481437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739972|NCT05475678|Carboplatin|carboplatin|mesh-list
154739973|NCT05475678|Docetaxel|docetaxel|mesh-list
154739974|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739975|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
154739976|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
154739977|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
154739978|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739979|NCT05468203|Dapagliflozin|dapagliflozin|mesh-list
154739980|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154739981|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154739982|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154739983|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739984|NCT05280275|Dexamethasone|dexamethasone|mesh-list
154739985|NCT05280275|Lenalidomide|lenalidomide|mesh-list
154739986|NCT05280275|Daratumumab|daratumumab|mesh-list
154739987|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154739988|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
154739989|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
154739990|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154739991|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154739992|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154739993|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
154739994|NCT05280275|Hormones|hormones|mesh-ancestor
154739995|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154739996|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154739997|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154739998|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
154739999|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154740000|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154740001|NCT05280275|Growth Substances|growth substances|mesh-ancestor
154740002|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
154740003|NCT05278065|Nicotine|nicotine|mesh-list
154740004|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154740005|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
154740006|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740007|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740008|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154740009|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154740010|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
154740011|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740012|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740013|NCT05244226|Fentanyl|fentanyl|mesh-list
154740014|NCT05244226|Methadone|methadone|mesh-list
154740015|NCT05244226|Hydromorphone|hydromorphone|mesh-list
154740016|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154740017|NCT05244226|Narcotics|narcotics|mesh-ancestor
154740018|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740019|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740020|NCT05244226|Analgesics|analgesics|mesh-ancestor
154740021|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
154740022|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740023|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154740024|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154740025|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
154740026|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
154740027|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
154740028|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740029|NCT05194124|alpha-MSH|alpha-msh|mesh-list
154740030|NCT05194124|Hormones|hormones|mesh-ancestor
154740031|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740032|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740033|NCT05157464|Losartan|losartan|mesh-list
154740034|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154740035|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153580336|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
153580395|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154740036|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154740037|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154740038|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740039|NCT05116241|Vaccines|vaccines|mesh-list
154740040|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
154740041|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740042|NCT05079620|Amoxicillin|amoxicillin|mesh-list
154740043|NCT05079620|Vancomycin|vancomycin|mesh-list
154740044|NCT05079620|Levofloxacin|levofloxacin|mesh-list
154740045|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
154740046|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154740047|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
154740048|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
154740049|NCT05079620|Cefepime|cefepime|mesh-list
154740050|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154740051|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740052|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154740053|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154740054|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154740055|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740056|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740057|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740058|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154740059|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154740060|NCT05079620|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154740061|NCT05079620|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154740062|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154740063|NCT04969198|Nicotine|nicotine|mesh-list
154740064|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154740065|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
154740066|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740067|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740068|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154740069|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154740070|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
154740071|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740072|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740073|NCT04943900|Nivolumab|nivolumab|mesh-list
154740074|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740075|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740076|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154740077|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740078|NCT04935034|Vitamin D|vitamin d|mesh-list
154740079|NCT04935034|Vitamins|vitamins|mesh-ancestor
154740080|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
154740081|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740082|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154740083|NCT04928664|Bupivacaine|bupivacaine|mesh-list
154740084|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
154740085|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
154740086|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740087|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740088|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
154740089|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740090|NCT04928261|Trastuzumab|trastuzumab|mesh-list
154740091|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740092|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740093|NCT04916392|Bupivacaine|bupivacaine|mesh-list
154740094|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
154740095|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
154740096|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740097|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740098|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
154740099|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740100|NCT04854668|Bevacizumab|bevacizumab|mesh-list
154740101|NCT04854668|Capecitabine|capecitabine|mesh-list
154740102|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
154740103|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740104|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740105|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154740106|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154740107|NCT04854668|Growth Substances|growth substances|mesh-ancestor
154740108|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740109|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
154740110|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154740111|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
154740112|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740113|NCT04830410|Levan|levan|mesh-list
154740114|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740115|NCT04786093|Durvalumab|durvalumab|mesh-list
154740116|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740117|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740118|NCT04621227|Midazolam|midazolam|mesh-list
154740119|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154740120|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154740121|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154740122|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740123|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740124|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154740125|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154740126|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154740127|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154740128|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
154740129|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
154740130|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
154740131|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
154740132|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740133|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740134|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154740135|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154740136|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
154740137|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153580465|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740138|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154740139|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740140|NCT04597918|Faricimab|faricimab|mesh-list
154740141|NCT04597918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154740142|NCT04597918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154740143|NCT04597918|Growth Substances|growth substances|mesh-ancestor
154740144|NCT04597918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740145|NCT04597918|Growth Inhibitors|growth inhibitors|mesh-ancestor
154740146|NCT04597918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740147|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
154740148|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154740149|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154740150|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154740151|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740152|NCT04546126|Dexamethasone|dexamethasone|mesh-list
154740153|NCT04546126|Cosyntropin|cosyntropin|mesh-list
154740154|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740155|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
154740156|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
154740157|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740158|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740159|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154740160|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
154740161|NCT04546126|Hormones|hormones|mesh-ancestor
154740162|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740163|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154740164|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740165|NCT04451863|Caryophyllene|caryophyllene|mesh-list
154740166|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740167|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154740168|NCT04451863|Analgesics|analgesics|mesh-ancestor
154740169|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
154740170|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740171|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154740172|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740173|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740174|NCT04398706|Vaccines|vaccines|mesh-list
154740175|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154740176|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
154740177|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740178|NCT04334759|Cisplatin|cisplatin|mesh-list
154740179|NCT04334759|Carboplatin|carboplatin|mesh-list
154740180|NCT04334759|Nivolumab|nivolumab|mesh-list
154740181|NCT04334759|Pemetrexed|pemetrexed|mesh-list
154740182|NCT04334759|Ipilimumab|ipilimumab|mesh-list
154740183|NCT04334759|Durvalumab|durvalumab|mesh-list
154740184|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740185|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740186|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154740187|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740188|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740189|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154740190|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154740191|NCT04210713|Minocycline|minocycline|mesh-list
154740192|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154740193|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740194|NCT04133376|Nicotine|nicotine|mesh-list
154740195|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154740196|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
154740197|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740198|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740199|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154740200|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154740201|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
154740202|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740203|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740204|NCT04083170|Vidarabine|vidarabine|mesh-list
154740205|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
154740206|NCT04083170|Thiotepa|thiotepa|mesh-list
154740207|NCT04083170|Fludarabine|fludarabine|mesh-list
154740208|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
154740209|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154740210|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
154740211|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740212|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740213|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154740214|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
154740215|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740216|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740217|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154740218|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154740219|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
154740220|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
154740221|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740222|NCT04056910|Nivolumab|nivolumab|mesh-list
154740223|NCT04056910|Ivosidenib|ivosidenib|mesh-list
154740224|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740225|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740226|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154740227|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740228|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740229|NCT04048278|Lidocaine|lidocaine|mesh-list
154740230|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
154740231|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
154740232|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740233|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740234|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
154740235|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740236|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154740237|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154740238|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154740239|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154740240|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740241|NCT04003506|Bupivacaine|bupivacaine|mesh-list
154740242|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
154740243|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
154740244|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740245|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740246|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
154740247|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740248|NCT03964493|Vancomycin|vancomycin|mesh-list
154740249|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154740250|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740251|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
154740252|NCT03939026|Fludarabine|fludarabine|mesh-list
154740253|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154740254|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
154740255|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740256|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740257|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154740258|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
154740259|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740260|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492206|NCT02199951|Piperaquine|piperaquine|mesh-list
154740261|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154740262|NCT03902912|Prednisolone|prednisolone|mesh-list
154740263|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740264|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
154740265|NCT03902912|Hormones|hormones|mesh-ancestor
154740266|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740267|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740268|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154740269|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740270|NCT03864406|Darunavir|darunavir|mesh-list
154740271|NCT03864406|Cobicistat|cobicistat|mesh-list
154740272|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154740273|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
154740274|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154740275|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
154740276|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154740277|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
154740278|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740279|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740280|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
154740281|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154740282|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154740283|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154740284|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154740285|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
154740286|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740287|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154740288|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154740289|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154740290|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154740291|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154740292|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740293|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740294|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
154740295|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740296|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154740297|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154740298|NCT03823534|Acetaminophen|acetaminophen|mesh-list
154740299|NCT03823534|Ketorolac|ketorolac|mesh-list
154740300|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154740301|NCT03823534|Morphine|morphine|mesh-list
154740302|NCT03823534|Oxycodone|oxycodone|mesh-list
154740303|NCT03823534|Hydrocodone|hydrocodone|mesh-list
154740304|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154740305|NCT03823534|Narcotics|narcotics|mesh-ancestor
154740306|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740307|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740308|NCT03823534|Analgesics|analgesics|mesh-ancestor
154740309|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
154740310|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740311|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154740312|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
154740313|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154740314|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740315|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580754|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
154740316|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154740317|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740318|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740319|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
154740320|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740321|NCT03807440|Empagliflozin|empagliflozin|mesh-list
154740322|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154740323|NCT03807440|Linagliptin|linagliptin|mesh-list
154740324|NCT03807440|Metformin|metformin|mesh-list
154740325|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154740326|NCT03807440|Glucagon|glucagon|mesh-list
154740327|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154740328|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740329|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154740330|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740331|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154740332|NCT03807440|Hormones|hormones|mesh-ancestor
154740333|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740334|NCT03807440|Incretins|incretins|mesh-ancestor
154740335|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
154740336|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740337|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
154740338|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
154740339|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740340|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
154740341|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740342|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740343|NCT03783403|Rituximab|rituximab|mesh-list
154740344|NCT03783403|Cetuximab|cetuximab|mesh-list
154740345|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740346|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740347|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
154740348|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740349|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740350|NCT03770338|Teriparatide|teriparatide|mesh-list
154740351|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154740352|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740353|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154740354|NCT03710161|Vitamin D|vitamin d|mesh-list
154740355|NCT03710161|Vitamins|vitamins|mesh-ancestor
154740356|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
154740357|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740358|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154740359|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
154740360|NCT03682536|Luspatercept|luspatercept|mesh-list
154740361|NCT03682536|Hematinics|hematinics|mesh-ancestor
154740362|NCT03498378|Cetuximab|cetuximab|mesh-list
154740363|NCT03498378|Avelumab|avelumab|mesh-list
154740364|NCT03498378|Palbociclib|palbociclib|mesh-list
154740365|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740366|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740367|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154740368|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740369|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740370|NCT03493165|Everolimus|everolimus|mesh-list
154740371|NCT03493165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154740372|NCT03493165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154740373|NCT03493165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740374|NCT03493165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740375|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154740376|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
154740377|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740378|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740379|NCT03478956|Etrolizumab|etrolizumab|mesh-list
154740380|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154740381|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
154740382|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740383|NCT03477110|Temozolomide|temozolomide|mesh-list
154740384|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154740385|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
154740386|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740387|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740388|NCT03467113|Cannabidiol|cannabidiol|mesh-list
154740389|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
154740390|NCT03415828|Ethanol|ethanol|mesh-list
154740391|NCT03415828|Prednisolone|prednisolone|mesh-list
154740392|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154740393|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
154740394|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154740395|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
154740396|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154740397|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
154740398|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740399|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
154740400|NCT03415828|Hormones|hormones|mesh-ancestor
154740401|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740402|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740403|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154740404|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740405|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
154740406|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
154740407|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740408|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154740409|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154492361|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740410|NCT03415828|Protective Agents|protective agents|mesh-ancestor
154740411|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154740412|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740413|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740414|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154740415|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154740416|NCT03332303|Estradiol|estradiol|mesh-list
154740417|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154740418|NCT03332303|Estrogens|estrogens|mesh-ancestor
154740419|NCT03332303|Hormones|hormones|mesh-ancestor
154740420|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740421|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740422|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154740423|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
154740424|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154740425|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154740426|NCT03093909|Gemcitabine|gemcitabine|mesh-list
154740427|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154740428|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
154740429|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580892|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154740430|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740431|NCT03083431|Propranolol|propranolol|mesh-list
154740432|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154740433|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154740434|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
154740435|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740436|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740437|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740438|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154740439|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154740440|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
154740441|NCT02927769|Nivolumab|nivolumab|mesh-list
154740442|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154740443|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154740444|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740445|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740446|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154740447|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740448|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154740449|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
154740450|NCT02927769|Immunotoxins|immunotoxins|mesh-ancestor
154740451|NCT02927769|Immunoconjugates|immunoconjugates|mesh-ancestor
154740452|NCT02927769|Immunologic Factors|immunologic factors|mesh-ancestor
154740453|NCT02927769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740454|NCT02827435|Bromides|bromides|mesh-list
154740455|NCT02827435|Rocuronium|rocuronium|mesh-list
154740456|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
154740457|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154740458|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154740459|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154740460|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740461|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740462|NCT02788773|Durvalumab|durvalumab|mesh-list
154740463|NCT02788773|Tremelimumab|tremelimumab|mesh-list
154740464|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740465|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740466|NCT02688400|Celecoxib|celecoxib|mesh-list
154740467|NCT02688400|Diacerein|diacerein|mesh-list
154740468|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154740469|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154740470|NCT02688400|Analgesics|analgesics|mesh-ancestor
154740471|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
154740472|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740473|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740474|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740475|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740476|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154740477|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154740478|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740479|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740480|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154740481|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
154740482|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740483|NCT02626455|Prednisone|prednisone|mesh-list
154740484|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
154740485|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154740486|NCT02626455|Rituximab|rituximab|mesh-list
154740487|NCT02626455|Doxorubicin|doxorubicin|mesh-list
154740488|NCT02626455|Vincristine|vincristine|mesh-list
154740489|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154740490|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
154740491|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740492|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740493|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154740494|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
154740495|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740496|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740497|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154740498|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740499|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154740500|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154740501|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154740502|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740503|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740504|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
154740505|NCT02626455|Hormones|hormones|mesh-ancestor
154740506|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740507|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154740508|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154740509|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
154740510|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
154740511|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
154740512|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
154740513|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154740514|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
154740515|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740516|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740517|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154740518|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740519|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
154740520|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154740521|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
154740522|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740523|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740524|NCT02193347|Temozolomide|temozolomide|mesh-list
154740525|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154740526|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
154740527|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740528|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740529|NCT02004275|Dexamethasone|dexamethasone|mesh-list
154740530|NCT02004275|Pomalidomide|pomalidomide|mesh-list
154740531|NCT02004275|Ixazomib|ixazomib|mesh-list
154740532|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740533|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
154740534|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
154740535|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740536|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740537|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154740538|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
154740539|NCT02004275|Hormones|hormones|mesh-ancestor
154740540|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740541|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154740542|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740543|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
154740544|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154740545|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154740546|NCT02004275|Growth Substances|growth substances|mesh-ancestor
154740547|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
154740548|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
154740549|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740550|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740551|NCT01731444|Phenylephrine|phenylephrine|mesh-list
154740552|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
154740553|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154740554|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
154740555|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
154740556|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740557|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740558|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
154740559|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154740560|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
154740561|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740562|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154740563|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154740564|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154740565|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
154740566|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740567|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740568|NCT01731444|Protective Agents|protective agents|mesh-ancestor
154740569|NCT01559129|Pomalidomide|pomalidomide|mesh-list
154740570|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
154740571|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740572|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154740573|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154740574|NCT01559129|Growth Substances|growth substances|mesh-ancestor
154740575|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
153581011|NCT01748773|Capecitabine|capecitabine|mesh-list
153581069|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
154740576|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740577|NCT01005303|Vitamin D|vitamin d|mesh-list
154740578|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
154740579|NCT01005303|Vitamins|vitamins|mesh-ancestor
154740580|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
154740581|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740582|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154740583|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154740584|NCT01003028|Remifentanil|remifentanil|mesh-list
154740585|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154740586|NCT01003028|Narcotics|narcotics|mesh-ancestor
154740587|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740588|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740589|NCT01003028|Analgesics|analgesics|mesh-ancestor
154740590|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
154740591|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740592|NCT00388882|Bromides|bromides|mesh-list
154740593|NCT00388882|Albuterol|albuterol|mesh-list
154740594|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
154740595|NCT00388882|Ipratropium|ipratropium|mesh-list
154740596|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154740597|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
154740598|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740599|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740600|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154740601|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740602|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
154740603|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154740604|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
154740605|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740606|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740607|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
154740608|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
154740609|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154740610|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154740611|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154740612|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154740613|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
154740614|NCT00275444|Tipranavir|tipranavir|mesh-list
154740615|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154740616|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154740617|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
154740618|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740619|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
154740620|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154740621|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154740622|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
154740623|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740624|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740625|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154740626|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740627|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
154740628|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154740629|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
154740630|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740631|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740632|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154740633|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154740634|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154740635|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
154740636|NCT00274508|Bromides|bromides|mesh-list
154740637|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
154740638|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154740639|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
154740640|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740641|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740642|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154740643|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740644|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
154740645|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154740646|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
154740647|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740648|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740649|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
154740650|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
154740651|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154740652|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
154740653|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740654|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740655|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154740656|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740657|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
154740658|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154740659|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
154740660|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740661|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740662|NCT00144248|Nevirapine|nevirapine|mesh-list
154740663|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154740664|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154740665|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740666|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740667|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
154740668|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740669|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154740670|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154740671|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154740672|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154740673|NCT00056641|Ritonavir|ritonavir|mesh-list
154740674|NCT00056641|Lopinavir|lopinavir|mesh-list
154740675|NCT00056641|Saquinavir|saquinavir|mesh-list
154740676|NCT00056641|Amprenavir|amprenavir|mesh-list
154740677|NCT00056641|Tipranavir|tipranavir|mesh-list
154740678|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154740679|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154740680|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
154740681|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740682|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740683|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154740684|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154740685|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
154740686|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740687|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154740688|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154740689|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154740690|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
154740691|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154740692|NCT03422874|Nelfinavir|nelfinavir|mesh-list
154740693|NCT03422874|Ixazomib|ixazomib|mesh-list
154740694|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740695|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
154740696|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740697|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740698|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154740699|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154740700|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154740701|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154740702|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
154740703|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740704|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154740705|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154740706|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154740707|NCT01253824|Norethindrone|norethindrone|mesh-list
154740708|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
154740709|NCT01253824|Norinyl|norinyl|mesh-list
154740710|NCT01253824|Mestranol|mestranol|mesh-list
154740711|NCT01253824|Estradiol|estradiol|mesh-list
154740712|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154740713|NCT01253824|Estrogens|estrogens|mesh-ancestor
154740714|NCT01253824|Hormones|hormones|mesh-ancestor
154740715|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740716|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740717|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154740718|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
154740719|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154740720|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154740721|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154740722|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154740723|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154740724|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154740725|NCT03422796|Cilostazol|cilostazol|mesh-list
154740726|NCT03422796|Sumatriptan|sumatriptan|mesh-list
154740727|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154740728|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
154740729|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740730|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740731|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154740732|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740733|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154740734|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154740735|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740736|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154740737|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
154740738|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154740739|NCT03422796|Protective Agents|protective agents|mesh-ancestor
154740740|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154740741|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154740742|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740743|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154740744|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154740745|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153581205|NCT01749514|Luspatercept|luspatercept|mesh-list
154740746|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
154740747|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740748|NCT04396977|Histamine|histamine|mesh-list
154740749|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
154740750|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
154740751|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740752|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740753|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740754|NCT03429738|Ibuprofen|ibuprofen|mesh-list
154740755|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
154740756|NCT03429738|Ephedrine|ephedrine|mesh-list
154740757|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154740758|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154740759|NCT03429738|Analgesics|analgesics|mesh-ancestor
154740760|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
154740761|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740762|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740763|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740764|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740765|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154740766|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740767|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740768|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154740769|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
154740770|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154740771|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740772|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
154740773|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154740774|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154740775|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
154740776|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
154740777|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740778|NCT01253902|Bimatoprost|bimatoprost|mesh-list
154740779|NCT01253902|Travoprost|travoprost|mesh-list
154740780|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154740781|NCT01253902|Latanoprost|latanoprost|mesh-list
154740782|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154740783|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154740784|NCT01253980|Amoxicillin|amoxicillin|mesh-list
154740785|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154740786|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740787|NCT00988533|Ivermectin|ivermectin|mesh-list
154740788|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154740789|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740790|NCT01350388|Febuxostat|febuxostat|mesh-list
154740791|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
154740792|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740793|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
154740794|NCT03154749|Carboplatin|carboplatin|mesh-list
154740795|NCT03154749|Docetaxel|docetaxel|mesh-list
154740796|NCT03154749|Epirubicin|epirubicin|mesh-list
154740797|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154740798|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
154740799|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740800|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740801|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154740802|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
154740803|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740804|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740805|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154740806|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
154740807|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
154740808|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
154740809|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154740810|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154740811|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154740812|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740813|NCT03422640|Apremilast|apremilast|mesh-list
154740814|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154740815|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154740816|NCT03422640|Analgesics|analgesics|mesh-ancestor
154740817|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
154740818|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740819|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740820|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740821|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740822|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154740823|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154740824|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740825|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740826|NCT01351090|Ketorolac|ketorolac|mesh-list
154740827|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154740828|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154740829|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154740830|NCT01351090|Analgesics|analgesics|mesh-ancestor
154740831|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
154740832|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740833|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740834|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740835|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740836|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154740837|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740838|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740839|NCT01918644|Capecitabine|capecitabine|mesh-list
154740840|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154740841|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
154740842|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740843|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740844|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
154740845|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154740846|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740847|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
154740848|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
154740849|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740850|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581385|NCT06175702|Hormones|hormones|mesh-ancestor
153581404|NCT06175702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154740851|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154740852|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
154740853|NCT00987831|Hormones|hormones|mesh-ancestor
154740854|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740855|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154740856|NCT00987831|Protective Agents|protective agents|mesh-ancestor
154740857|NCT03608358|Metformin|metformin|mesh-list
154740858|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
154740859|NCT03608358|Saxagliptin|saxagliptin|mesh-list
154740860|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154740861|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740862|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154740863|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740864|NCT03608358|Incretins|incretins|mesh-ancestor
154740865|NCT03608358|Hormones|hormones|mesh-ancestor
154740866|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740867|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154740868|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
154740869|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740870|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
154740871|NCT04274907|Venetoclax|venetoclax|mesh-list
154740872|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154740873|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740874|NCT04274907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154740875|NCT04274907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740876|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154740877|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154740878|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
154740879|NCT01256164|Coagulants|coagulants|mesh-ancestor
154740880|NCT03427086|Biotin|biotin|mesh-list
154740881|NCT03427086|Vitamins|vitamins|mesh-ancestor
154740882|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
154740883|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740884|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
154740885|NCT01887522|Vinblastine|vinblastine|mesh-list
154740886|NCT01887522|Nilotinib|nilotinib|mesh-list
154740887|NCT01887522|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154740888|NCT01887522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154740889|NCT01887522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740890|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740891|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154740892|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740893|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
154740894|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
154740895|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
154740896|NCT03422406|Iodine|iodine|mesh-list
154740897|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154740898|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740899|NCT03422406|Trace Elements|trace elements|mesh-ancestor
154740900|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
154740901|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740902|NCT00986427|Cyclosporine|cyclosporine|mesh-list
154740903|NCT00986427|Cyclosporins|cyclosporins|mesh-list
154740904|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740905|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740906|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154740907|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
154740908|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740909|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
154740910|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740911|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
154740912|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154740913|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154740914|NCT03426462|Propofol|propofol|mesh-list
154740915|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154740916|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154740917|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740918|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154740919|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
154740920|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
154740921|NCT03421860|Phenylephrine|phenylephrine|mesh-list
154740922|NCT03421860|Epinephrine|epinephrine|mesh-list
154740923|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
154740924|NCT03421860|Ephedrine|ephedrine|mesh-list
154740925|NCT03421860|Norepinephrine|norepinephrine|mesh-list
154740926|NCT03421860|Ondansetron|ondansetron|mesh-list
154740927|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154740928|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154740929|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
154740930|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740931|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740932|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740933|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154740934|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154740935|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
154740936|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154740937|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154740938|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
154740939|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
154740940|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
154740941|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154740942|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
154740943|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154740944|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
153581517|NCT06100432|Antioxidants|antioxidants|mesh-ancestor
154740945|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
154740946|NCT03421860|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154740947|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154740948|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
154740949|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154740950|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
154740951|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154740952|NCT03421860|Protective Agents|protective agents|mesh-ancestor
154740953|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154740954|NCT03421314|Selenium|selenium|mesh-list
154740955|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
154740956|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740957|NCT03421314|Protective Agents|protective agents|mesh-ancestor
154740958|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740959|NCT03421314|Trace Elements|trace elements|mesh-ancestor
154740960|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
154740961|NCT03425994|Emtricitabine|emtricitabine|mesh-list
154740962|NCT03425994|Cobicistat|cobicistat|mesh-list
154740963|NCT03425994|Elvitegravir|elvitegravir|mesh-list
154740964|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
154740965|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740966|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154740967|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154740968|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154740969|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740970|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154740971|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154740972|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154740973|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154740974|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154740975|NCT03421002|Micafungin|micafungin|mesh-list
154740976|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
154740977|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154740978|NCT02521038|Ticagrelor|ticagrelor|mesh-list
154740979|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154740980|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154740981|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154740982|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154740983|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
154740984|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154740985|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154740986|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740987|NCT00985959|Prednisolone|prednisolone|mesh-list
153581600|NCT05975307|Gemcitabine|gemcitabine|mesh-list
154740988|NCT00985959|Bortezomib|bortezomib|mesh-list
154740989|NCT00985959|Melphalan|melphalan|mesh-list
154740990|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154740991|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154740992|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
154740993|NCT00985959|Hormones|hormones|mesh-ancestor
154740994|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154740995|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154740996|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154740997|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154740998|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
154740999|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741000|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154741001|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741002|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
154741003|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154741004|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154741005|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741006|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154741007|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154741008|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741009|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741010|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
154741011|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741012|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154741013|NCT01294306|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154741014|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741015|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741016|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741017|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741018|NCT01351480|Abatacept|abatacept|mesh-list
154741019|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154741020|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741021|NCT01351480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154741022|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741023|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741024|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
153581605|NCT05924971|Aspirin|aspirin|mesh-list
154741025|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741026|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741028|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154741029|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741030|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
154741031|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154741032|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741033|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154741034|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741035|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154741036|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154741037|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154741038|NCT01294384|Laxatives|laxatives|mesh-ancestor
154741039|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741040|NCT01257802|Leuprolide|leuprolide|mesh-list
154741041|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154741042|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
154741043|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154741044|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741045|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154741046|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741047|NCT05607303|Estrogens|estrogens|mesh-list
154741048|NCT05607303|Hormones|hormones|mesh-ancestor
154741049|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741050|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741051|NCT00984009|Colchicine|colchicine|mesh-list
154741052|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
154741053|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741054|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
154741055|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
154741056|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
154741057|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741058|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741059|NCT00983931|Cyclosporine|cyclosporine|mesh-list
154741060|NCT00983931|Colchicine|colchicine|mesh-list
154741061|NCT00983931|Cyclosporins|cyclosporins|mesh-list
154741062|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741063|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741064|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741065|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
154741066|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741067|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
154741068|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741069|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
154741070|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741071|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154741072|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
154741073|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
154741074|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
154741075|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154741076|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741077|NCT00983853|Ribavirin|ribavirin|mesh-list
154741078|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154741079|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
154741080|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741081|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
154741082|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741083|NCT05604261|Rabeprazole|rabeprazole|mesh-list
154741084|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154741085|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741086|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154741087|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741088|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741089|NCT05603013|Vinorelbine|vinorelbine|mesh-list
154741090|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154741091|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154741092|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741093|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
154741094|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
154741095|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
154741096|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741097|NCT05603013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154741098|NCT00983073|Tapentadol|tapentadol|mesh-list
154741099|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154741100|NCT00983073|Narcotics|narcotics|mesh-ancestor
154741101|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741102|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741103|NCT00983073|Analgesics|analgesics|mesh-ancestor
154741104|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
154741105|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741106|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154741107|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154741108|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741109|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741110|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
154741111|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741112|NCT05603715|Bromides|bromides|mesh-list
154741113|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154741114|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
154741115|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154741116|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741117|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741118|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
154741119|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741120|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741121|NCT00981747|Losartan|losartan|mesh-list
154741122|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
154741123|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154741124|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154741125|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154741126|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154741127|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741128|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
154741129|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154741130|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154741131|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741132|NCT00981747|Urological Agents|urological agents|mesh-ancestor
154741133|NCT03029169|Amiodarone|amiodarone|mesh-list
154741134|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154741135|NCT03029169|Propafenone|propafenone|mesh-list
154741136|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
154741137|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154741138|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741139|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741140|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154741141|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154741142|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154741143|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741144|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154741145|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154741146|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154741147|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154741148|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
154741149|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154741150|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
154741151|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741152|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741153|NCT01353976|Econazole|econazole|mesh-list
154741154|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
154741155|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741156|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154741157|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154741158|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741159|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741160|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154741161|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
154741162|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741163|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741164|NCT01354444|Carvedilol|carvedilol|mesh-list
154493108|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
154741165|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154741166|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154741167|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
154741168|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741169|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741170|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741171|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154741172|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
154741173|NCT01354444|Protective Agents|protective agents|mesh-ancestor
154741174|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154741175|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741176|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154741177|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
154741178|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154741179|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154741180|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
154741181|NCT03009526|Piperaquine|piperaquine|mesh-list
154741182|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
154741183|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154741184|NCT03009526|Artenimol|artenimol|mesh-list
154741185|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
154741186|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154741187|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154741188|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741189|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154741190|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741191|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741192|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154741193|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154741194|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153581807|NCT05259722|Alitretinoin|alitretinoin|mesh-list
154741195|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741196|NCT01354990|Incretins|incretins|mesh-ancestor
154741197|NCT01354990|Hormones|hormones|mesh-ancestor
154741198|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741199|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154741200|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
154741201|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741202|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741203|NCT01260454|Capsaicin|capsaicin|mesh-list
154741204|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
154741205|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
154741206|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
154741207|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741208|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741209|NCT01296646|Naltrexone|naltrexone|mesh-list
154741210|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154741211|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154741212|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741213|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
154741214|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741215|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154741216|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154741217|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
154741218|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154741219|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154741220|NCT01297348|Norinyl|norinyl|mesh-list
154741221|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
154741222|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
154741223|NCT01297348|Estradiol|estradiol|mesh-list
154741224|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154741225|NCT01297348|Estrogens|estrogens|mesh-ancestor
154741226|NCT01297348|Hormones|hormones|mesh-ancestor
154741227|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741228|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741229|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154741230|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154741231|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154741232|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154741233|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154741234|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154493182|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154493183|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154493184|NCT03482232|Expectorants|expectorants|mesh-list
154493185|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
154741235|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154741236|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154741237|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
154741238|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741239|NCT01260688|Dasatinib|dasatinib|mesh-list
153581988|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741240|NCT01260688|Cediranib|cediranib|mesh-list
154741241|NCT01260688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154741242|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741243|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741244|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741245|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741246|NCT01298128|NuvaRing|nuvaring|mesh-list
154741247|NCT01298128|Desogestrel|desogestrel|mesh-list
154741248|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154741249|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
154741250|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154741251|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741252|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154741253|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154741254|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154741255|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154741256|NCT01298128|Progestins|progestins|mesh-ancestor
154741257|NCT01298128|Hormones|hormones|mesh-ancestor
154741258|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741259|NCT02199964|Cyclosporine|cyclosporine|mesh-list
154741260|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
154741261|NCT02199964|Cyclosporins|cyclosporins|mesh-list
154741262|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741263|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741264|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741265|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
154741266|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741267|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
154741268|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741269|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
154741270|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741271|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154741272|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154741273|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154741274|NCT02323048|Methamphetamine|methamphetamine|mesh-list
154741275|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154741276|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741277|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
154741278|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
154741279|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741280|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
154741281|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741282|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741283|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
154741284|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154741285|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154741286|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741287|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154741288|NCT01265446|Lidocaine|lidocaine|mesh-list
154741289|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
154741290|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
154741291|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741292|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741293|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
154741294|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741295|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154741296|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154741297|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154741298|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741299|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741300|NCT04352062|Amoxicillin|amoxicillin|mesh-list
154741301|NCT04352062|Levofloxacin|levofloxacin|mesh-list
154741302|NCT04352062|Ofloxacin|ofloxacin|mesh-list
154741303|NCT04352062|Melatonin|melatonin|mesh-list
154741304|NCT04352062|Pantoprazole|pantoprazole|mesh-list
154741305|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154741306|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741307|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
154741308|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493254|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
154741309|NCT04352062|Protective Agents|protective agents|mesh-ancestor
154741310|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741311|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741312|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154741313|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154741314|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154741315|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741316|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741317|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154741318|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154741319|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154741320|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741321|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154741322|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154741323|NCT01302808|Romidepsin|romidepsin|mesh-list
154741324|NCT01302808|Antiemetics|antiemetics|mesh-list
154741325|NCT01302808|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154741326|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741327|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741328|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741329|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741330|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154741331|NCT01302808|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154741332|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
154741333|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741334|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741335|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741336|NCT01267240|Capecitabine|capecitabine|mesh-list
154741337|NCT01267240|Vorinostat|vorinostat|mesh-list
154741338|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154741339|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
154741340|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741341|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741342|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154741343|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741344|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154741345|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154741346|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154741347|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741348|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741349|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741350|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741351|NCT01855919|Analgesics|analgesics|mesh-ancestor
154741352|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
154741353|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741354|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
154741355|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154741356|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
154741357|NCT01871285|Morphine|morphine|mesh-list
154741358|NCT01871285|Oxycodone|oxycodone|mesh-list
154741359|NCT01871285|Buprenorphine|buprenorphine|mesh-list
154741360|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154741361|NCT01871285|Narcotics|narcotics|mesh-ancestor
154741362|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741363|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741364|NCT01871285|Analgesics|analgesics|mesh-ancestor
154741365|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
154741366|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741367|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154741368|NCT01358266|Sirolimus|sirolimus|mesh-list
154741369|NCT01358266|Temsirolimus|temsirolimus|mesh-list
154741370|NCT01358266|MTOR Inhibitors|mtor inhibitors|mesh-list
154741371|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154741372|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741373|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154741374|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741375|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
154741376|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741377|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
154741378|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741379|NCT01358266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741380|NCT01358266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741381|NCT01358266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493345|NCT05782751|Mitogens|mitogens|mesh-list
154741383|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154741384|NCT01870973|Analgesics|analgesics|mesh-list
154741385|NCT01870973|Anesthetics|anesthetics|mesh-list
154741386|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741387|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741388|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741389|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
154741390|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
154741391|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741392|NCT01267864|Ketorolac|ketorolac|mesh-list
154741393|NCT01267864|Valproic Acid|valproic acid|mesh-list
154741394|NCT01267864|Metoclopramide|metoclopramide|mesh-list
154741395|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154741396|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154741397|NCT01267864|Analgesics|analgesics|mesh-ancestor
154741398|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
154741399|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741400|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741401|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154741402|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741403|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154741404|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741405|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741406|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
154741407|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
154741408|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741409|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
154741410|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154741411|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741412|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154741413|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
154741414|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
154741415|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741416|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154741417|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154741418|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
154741419|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
154741420|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154741421|NCT01854827|Antibodies|antibodies|mesh-list
154741422|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
154741423|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154741424|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
154741425|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741426|NCT01360450|Clonidine|clonidine|mesh-list
154741427|NCT01360450|Analgesics|analgesics|mesh-ancestor
154741428|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
154741429|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741430|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741431|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154741432|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
154741433|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
154741434|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154741435|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154741436|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154741437|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
154741438|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741439|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741440|NCT01303744|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
154741441|NCT01303744|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154741442|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741443|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741444|NCT01361620|Aspirin|aspirin|mesh-list
154741445|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154741446|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154741447|NCT01361620|Analgesics|analgesics|mesh-ancestor
154741448|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
154741449|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741450|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741451|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154741452|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741453|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154741454|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154741455|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741456|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154741457|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154741458|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741459|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
154741460|NCT01305772|Panitumumab|panitumumab|mesh-list
154741461|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154741462|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741463|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
154741464|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154741465|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154741466|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154741467|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741468|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741469|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
154741470|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741471|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741472|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154741473|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741474|NCT01271686|Bimatoprost|bimatoprost|mesh-list
154741475|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154741476|NCT01854047|Albuterol|albuterol|mesh-list
154741477|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154741478|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
154741479|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741480|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741481|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154741482|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154741483|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
154741484|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154741485|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154741486|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154741487|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154741488|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154741489|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741490|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741491|NCT01870739|Amlodipine|amlodipine|mesh-list
154741492|NCT01870739|Valsartan|valsartan|mesh-list
154741493|NCT01870739|Olmesartan|olmesartan|mesh-list
154741494|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154741495|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154741496|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154741497|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154741498|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741499|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741500|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154741501|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741502|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
154741503|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154741504|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154741505|NCT01272388|Tadalafil|tadalafil|mesh-list
154741506|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
154741507|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154741508|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154741509|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741510|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741511|NCT01272388|Urological Agents|urological agents|mesh-ancestor
154741512|NCT01870583|Iodine|iodine|mesh-list
154741513|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
154741514|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154741515|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
154741516|NCT01870583|Povidone|povidone|mesh-list
154741517|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154741518|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741519|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
154741520|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
154741521|NCT01870583|Trace Elements|trace elements|mesh-ancestor
154741522|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
154741523|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741524|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
154741525|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
154741526|NCT04351594|Menthol|menthol|mesh-list
154741527|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
154741528|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
154741529|NCT01308814|Estradiol|estradiol|mesh-list
154741530|NCT01308814|Estrogens|estrogens|mesh-ancestor
154741531|NCT01308814|Hormones|hormones|mesh-ancestor
154741532|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741533|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741534|NCT03009604|Simethicone|simethicone|mesh-list
154741535|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
154741536|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741537|NCT03009604|Emollients|emollients|mesh-ancestor
154741538|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
154741539|NCT01275586|Nilotinib|nilotinib|mesh-list
154741540|NCT01275586|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154741541|NCT01275586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741542|NCT01275586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741543|NCT01275586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741544|NCT01275664|Dexamethasone|dexamethasone|mesh-list
154741545|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
154741546|NCT01275664|Cisplatin|cisplatin|mesh-list
154741547|NCT01275664|Carboplatin|carboplatin|mesh-list
154741548|NCT01275664|Aprepitant|aprepitant|mesh-list
154741549|NCT01275664|Granisetron|granisetron|mesh-list
154741550|NCT01275664|Ichthammol|ichthammol|mesh-list
154741551|NCT01275664|BB 1101|bb 1101|mesh-list
154741552|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741553|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154741554|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
154741555|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
154741556|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741557|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741558|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741559|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
154741560|NCT01275664|Hormones|hormones|mesh-ancestor
154741561|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741562|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154741563|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
154741564|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741565|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741566|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154741567|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741568|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
154741569|NCT01275664|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154741570|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154741571|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
154741572|NCT01613027|Rituximab|rituximab|mesh-list
154741573|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154741574|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741575|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
154741576|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741577|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741578|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
154741579|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154741580|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154741581|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154741582|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741583|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741584|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
154741585|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741586|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741587|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154741588|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741589|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
154741590|NCT01369732|Hematinics|hematinics|mesh-ancestor
154741591|NCT01869725|Octreotide|octreotide|mesh-list
154741592|NCT01869725|Edotreotide|edotreotide|mesh-list
154741593|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
154741594|NCT01869725|Somatostatin|somatostatin|mesh-list
154741595|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741596|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154741597|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741598|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741599|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741600|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154741601|NCT01869725|Hormones|hormones|mesh-ancestor
154741602|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741603|NCT01309360|Midazolam|midazolam|mesh-list
154741604|NCT01309360|Prilocaine|prilocaine|mesh-list
154741605|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154741606|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154493561|NCT05323019|Ketamine|ketamine|mesh-list
154741607|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741608|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741609|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154741610|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154741611|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154741612|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154741613|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
154741614|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
154741615|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
154741616|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
154741617|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741618|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741619|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
154741620|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
154741621|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741622|NCT01851863|Flupenthixol|flupenthixol|mesh-list
154741623|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154741624|NCT01851863|Omeprazole|omeprazole|mesh-list
154741625|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154741626|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741627|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154741628|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741629|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741630|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154741631|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154741632|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741633|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741634|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154741635|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154741636|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
154741637|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741638|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
154741639|NCT01369888|Fludarabine|fludarabine|mesh-list
154741640|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741641|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
154741642|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741643|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741644|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154741645|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
154741646|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741647|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741648|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154741649|NCT01850615|Insulin|insulin|mesh-list
154741650|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154741651|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
154741652|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154741653|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741654|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154741655|NCT01280110|Laxatives|laxatives|mesh-ancestor
154741656|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741657|NCT01374802|Ritonavir|ritonavir|mesh-list
154741658|NCT01374802|Darunavir|darunavir|mesh-list
154741659|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154741660|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154741661|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
154741662|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741663|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741664|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154741665|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154741666|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
154741667|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741668|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154741669|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154741670|NCT01375660|Vitamin D|vitamin d|mesh-list
154741671|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
154741672|NCT01375660|Vitamins|vitamins|mesh-ancestor
154741673|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
154741674|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741675|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154741676|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154741677|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
154741678|NCT01868477|Deferasirox|deferasirox|mesh-list
154741679|NCT01868477|Hematinics|hematinics|mesh-ancestor
154741680|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154741681|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
154493630|NCT06144697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741682|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
154741683|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741685|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154741686|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
154741687|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153582501|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741688|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741689|NCT01868243|Warfarin|warfarin|mesh-list
154741690|NCT01868243|Dabigatran|dabigatran|mesh-list
154741691|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
154741692|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
154741693|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154741694|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
154741695|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741696|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741697|NCT01611935|Vasopressins|vasopressins|mesh-list
154741698|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
154741699|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
154741700|NCT01611935|Coagulants|coagulants|mesh-ancestor
154741701|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154741702|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154741703|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
154741704|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741705|NCT02201212|Everolimus|everolimus|mesh-list
154741706|NCT02201212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154741707|NCT02201212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741708|NCT02201212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741709|NCT02201212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741710|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741711|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
154741712|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741713|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741714|NCT01376362|Interferons|interferons|mesh-list
154741715|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
154741716|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741717|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
154741718|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741719|NCT03009292|Lenvatinib|lenvatinib|mesh-list
154741720|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741721|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741722|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741723|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741724|NCT01962792|Dexamethasone|dexamethasone|mesh-list
154741725|NCT01962792|Ibrutinib|ibrutinib|mesh-list
154741726|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154741727|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
154741728|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
154741729|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741730|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741731|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741732|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
154741733|NCT01962792|Hormones|hormones|mesh-ancestor
154741734|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741735|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154741736|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741737|NCT01962792|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154741738|NCT01962792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741739|NCT01962792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741740|NCT01962792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741741|NCT01849055|Celecoxib|celecoxib|mesh-list
154741742|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154741743|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154741744|NCT01849055|Analgesics|analgesics|mesh-ancestor
154741745|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
154741746|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741747|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741748|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154741749|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582577|NCT01884038|Treprostinil|treprostinil|mesh-list
153582648|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154741750|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154741751|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154741752|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741753|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741754|NCT01404832|Lansoprazole|lansoprazole|mesh-list
154741755|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
154741756|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154741757|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741758|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154741759|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741760|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741761|NCT03420534|Iloperidone|iloperidone|mesh-list
154741762|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154741763|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154741764|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741765|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741766|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154741767|NCT01313494|Albuterol|albuterol|mesh-list
154741768|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154741769|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
154741770|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741771|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741772|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154741773|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
154741774|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
154741775|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154741776|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154741777|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154741778|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154741779|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
154741780|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741781|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741782|NCT01407094|Sertraline|sertraline|mesh-list
154741783|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
154741784|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154741785|NCT01407094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154741786|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154741787|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741788|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741789|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741790|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
154741791|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741792|NCT01867307|Empagliflozin|empagliflozin|mesh-list
154741793|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154741794|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741795|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154741796|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741797|NCT01845077|Metformin|metformin|mesh-list
154741798|NCT01845077|Linagliptin|linagliptin|mesh-list
154741799|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154741800|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741801|NCT01845077|Incretins|incretins|mesh-ancestor
154741802|NCT01845077|Hormones|hormones|mesh-ancestor
154741803|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741804|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154741805|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
154741806|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741807|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741808|NCT01866917|Ropivacaine|ropivacaine|mesh-list
154741809|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
154741810|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
154741811|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741812|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741813|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
154741814|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741815|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154741816|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154741817|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154741818|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154741819|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741820|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741821|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741822|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
154741823|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154741824|NCT01410058|Efavirenz|efavirenz|mesh-list
154741825|NCT01410058|Nevirapine|nevirapine|mesh-list
154741826|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154741827|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154741828|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741829|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741830|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
154741831|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741832|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154741833|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154741834|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154741835|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154741836|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154741837|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154741838|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154741839|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154741840|NCT01380106|Lenalidomide|lenalidomide|mesh-list
154741841|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
154741842|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741843|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154741844|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154741845|NCT01380106|Growth Substances|growth substances|mesh-ancestor
154741846|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
154741847|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741848|NCT01381120|Acetaminophen|acetaminophen|mesh-list
154741850|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
154741851|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154741852|NCT01381120|Analgesics|analgesics|mesh-ancestor
154741853|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
154741854|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741855|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741856|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
154741857|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154741858|NCT01381120|Narcotics|narcotics|mesh-ancestor
154741859|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154741860|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154741861|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154741862|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
154741863|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154741864|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741865|NCT01381120|Urological Agents|urological agents|mesh-ancestor
154741866|NCT01316770|Dexamethasone|dexamethasone|mesh-list
154741867|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154741868|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
154741869|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
154741870|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154741871|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741872|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741873|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
154741874|NCT01316770|Hormones|hormones|mesh-ancestor
154741875|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741876|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154741877|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741878|NCT01318408|Levetiracetam|levetiracetam|mesh-list
154741879|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
154741880|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
154741881|NCT01319110|Ubiquinone|ubiquinone|mesh-list
154741882|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
154741883|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
154741884|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741885|NCT01319110|Vitamins|vitamins|mesh-ancestor
154741886|NCT03008512|Paclitaxel|paclitaxel|mesh-list
154741887|NCT03008512|genexol-PM|genexol-pm|mesh-list
154741888|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154741889|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741890|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
154741891|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
154741892|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
154741893|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741894|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
154741895|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
154741896|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154741897|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154741898|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741899|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741900|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741901|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741902|NCT01411696|Dexamethasone|dexamethasone|mesh-list
154741903|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154741904|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
154741905|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
154741906|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493878|NCT05882643|Iodine|iodine|mesh-list
154741907|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741908|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154741909|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
154741910|NCT01411696|Hormones|hormones|mesh-ancestor
154741911|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154741912|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154741913|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741914|NCT01844765|Nilotinib|nilotinib|mesh-list
154741915|NCT01844765|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154741916|NCT01844765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741917|NCT01844765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741918|NCT01844765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741919|NCT01412164|Sirolimus|sirolimus|mesh-list
154741920|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154741921|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741922|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154741923|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741924|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
154741925|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741926|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
154741927|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741928|NCT01844687|Cannabidiol|cannabidiol|mesh-list
154741929|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
154741930|NCT01844531|Metformin|metformin|mesh-list
154741931|NCT01844531|Empagliflozin|empagliflozin|mesh-list
154741932|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154741933|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741934|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154741935|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741936|NCT02367456|Azacitidine|azacitidine|mesh-list
154741937|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154741938|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
154741939|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741940|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741941|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741942|NCT03420378|Vitamin D|vitamin d|mesh-list
154741943|NCT03420378|Vitamins|vitamins|mesh-ancestor
154741944|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
154741945|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741946|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154741947|NCT03425448|Heparin|heparin|mesh-list
154741948|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
154741949|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154741950|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154741951|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741952|NCT03419910|Cyclosporine|cyclosporine|mesh-list
154741953|NCT03419910|Deucravacitinib|deucravacitinib|mesh-list
154741954|NCT03419910|Cyclosporins|cyclosporins|mesh-list
154741955|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741956|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741957|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741958|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
154741959|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741960|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
154741961|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741962|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
154741963|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154741964|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154741965|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741966|NCT03415386|Anticoagulants|anticoagulants|mesh-list
154741967|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154741968|NCT01865747|Everolimus|everolimus|mesh-list
154741969|NCT01865747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154741970|NCT01865747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741971|NCT01865747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741972|NCT01865747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741973|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154741974|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
154741975|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741976|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154741977|NCT03424980|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154741978|NCT03424980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154741979|NCT03424980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741980|NCT03424980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493933|NCT05774067|Adrenergic Agents|adrenergic agents|mesh-ancestor
154741981|NCT03424746|Edetic Acid|edetic acid|mesh-list
154741982|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
154741983|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
154741984|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154741985|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
154741986|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
154741987|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741988|NCT03424746|Antidotes|antidotes|mesh-ancestor
154741989|NCT03424746|Protective Agents|protective agents|mesh-ancestor
154741990|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154741991|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154741992|NCT03414918|Clarithromycin|clarithromycin|mesh-list
154741993|NCT03414918|Roxithromycin|roxithromycin|mesh-list
154741994|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154741995|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154741996|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154741997|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154741998|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154741999|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154742000|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154742001|NCT04448496|Dexamethasone|dexamethasone|mesh-list
154742002|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742003|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
154742004|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
154742005|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742006|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742007|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742008|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
154742009|NCT04448496|Hormones|hormones|mesh-ancestor
154742010|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154742011|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154742012|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742013|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
154742014|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
154742015|NCT03419442|Docetaxel|docetaxel|mesh-list
154742016|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742017|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
154742018|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
154742019|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
154742020|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742021|NCT01412710|Vitamin D|vitamin d|mesh-list
154742022|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
154742023|NCT01412710|Vitamins|vitamins|mesh-ancestor
154742024|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
154742025|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742026|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154742027|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154742028|NCT01843205|Methamphetamine|methamphetamine|mesh-list
154742029|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154742030|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742031|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
154742032|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
154742033|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742034|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
154742035|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742036|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742037|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742038|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154742039|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154742040|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742041|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154742042|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
154742043|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154742044|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742045|NCT03419130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154742046|NCT03419130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742047|NCT03414840|Atorvastatin|atorvastatin|mesh-list
154742048|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153582965|NCT01752244|Vitamins|vitamins|mesh-ancestor
154742049|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154742050|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
154742051|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742052|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154742053|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154742054|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742055|NCT03418974|Atorvastatin|atorvastatin|mesh-list
154742056|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154742057|NCT03418974|Pitavastatin|pitavastatin|mesh-list
154742058|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154742059|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154742060|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
154742061|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742062|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154742063|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154742064|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742065|NCT03424356|Fentanyl|fentanyl|mesh-list
154742066|NCT03424356|Narcotics|narcotics|mesh-list
154742067|NCT03424356|Analgesics|analgesics|mesh-list
154742068|NCT03424356|Bromides|bromides|mesh-list
154742069|NCT03424356|Propofol|propofol|mesh-list
154742070|NCT03424356|Rocuronium|rocuronium|mesh-list
154742071|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154742072|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742073|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742074|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154742075|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
154742076|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
154742077|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154742078|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
154742079|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742080|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154742081|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
154742082|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154742083|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154742084|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154742085|NCT03414450|Dasatinib|dasatinib|mesh-list
154742086|NCT03414450|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154742087|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154742088|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742089|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742090|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742091|NCT01389076|Methotrexate|methotrexate|mesh-list
154742092|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
154742093|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154742094|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
154742095|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742096|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742097|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742098|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
154742099|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742100|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742101|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
154742102|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742103|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154742104|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742105|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
154742106|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742107|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154742108|NCT03127800|Morphine|morphine|mesh-list
154742109|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154742110|NCT03127800|Narcotics|narcotics|mesh-ancestor
154742111|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742112|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742113|NCT03127800|Analgesics|analgesics|mesh-ancestor
154742114|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
154742115|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742116|NCT01389856|Bosentan|bosentan|mesh-list
154742117|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154742118|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154742119|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742120|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154742121|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742122|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742123|NCT01323010|Albuterol|albuterol|mesh-list
154742124|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154742125|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
154742126|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742127|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742128|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154742129|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
154494082|NCT05502900|Melatonin|melatonin|mesh-list
154742130|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
154742131|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742132|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154742133|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154742134|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154742135|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742136|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742137|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742138|NCT03423810|Hydralazine|hydralazine|mesh-list
154742139|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154742140|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
154742141|NCT01390246|Bupropion|bupropion|mesh-list
154742142|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154742143|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
154742144|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154742145|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154742146|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154742147|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742148|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742149|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
154742150|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742151|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742152|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154742153|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154742154|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742155|NCT01390870|Alfuzosin|alfuzosin|mesh-list
154742156|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742157|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742158|NCT01390870|Urological Agents|urological agents|mesh-ancestor
154742159|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154742160|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154742161|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154742162|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742163|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742164|NCT03418506|Lobeline|lobeline|mesh-list
154742165|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154742166|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
154742167|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742168|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742169|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154742170|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154742171|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
154742172|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742173|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742174|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
154742175|NCT01842581|Rifaximin|rifaximin|mesh-list
154742176|NCT01842581|Lactulose|lactulose|mesh-list
154742177|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154742178|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742179|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742180|NCT04448028|Esomeprazole|esomeprazole|mesh-list
154742181|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154742182|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154742183|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742184|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742185|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742186|NCT01833533|Ribavirin|ribavirin|mesh-list
154742187|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
154742188|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742189|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
154742190|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742191|NCT03413436|Cisplatin|cisplatin|mesh-list
154742192|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742193|NCT01833455|Flecainide|flecainide|mesh-list
154742194|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154742195|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154742196|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154742197|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742198|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742199|NCT03413358|Carboplatin|carboplatin|mesh-list
154742200|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742201|NCT01833143|Acyclovir|acyclovir|mesh-list
154742202|NCT01833143|Bortezomib|bortezomib|mesh-list
154742203|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742204|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
154742205|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742207|NCT03417648|Vitamins|vitamins|mesh-ancestor
154742208|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
154742209|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742210|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
154742211|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742212|NCT03417648|Protective Agents|protective agents|mesh-ancestor
154742213|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
154742214|NCT01831817|Listerine|listerine|mesh-list
154742215|NCT01831817|Calcium|calcium|mesh-list
154742216|NCT01831817|Fluorides|fluorides|mesh-list
154742217|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
154742218|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
154742219|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154742220|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742221|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154742222|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
154742223|NCT01831817|Protective Agents|protective agents|mesh-ancestor
154742224|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154742225|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742226|NCT03412500|Vancomycin|vancomycin|mesh-list
154742227|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154742228|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742229|NCT01840943|Topotecan|topotecan|mesh-list
154742230|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154742231|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154742232|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583287|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742233|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742234|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742235|NCT05171400|Insulin|insulin|mesh-list
154742236|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154742237|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742238|NCT02203630|Phenylephrine|phenylephrine|mesh-list
154742239|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
154742240|NCT02203630|Norepinephrine|norepinephrine|mesh-list
154742241|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154742242|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
154742243|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
154742244|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742245|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742246|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
154742247|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154742248|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
154742249|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
154742250|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154742251|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154742252|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154742253|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742254|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742255|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742256|NCT02203630|Protective Agents|protective agents|mesh-ancestor
154742257|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154742258|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154742259|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742260|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154742261|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154742262|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742263|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742264|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
154742265|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742266|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154742267|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154742268|NCT02520570|Urinastatin|urinastatin|mesh-list
154742269|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
154742270|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154742271|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
154742272|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742273|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742274|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
154742275|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
154742276|NCT03411798|Methotrexate|methotrexate|mesh-list
153583288|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742277|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154742278|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
154742279|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742280|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742281|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742282|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
154742283|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742284|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742285|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
154742286|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742287|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154742288|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742289|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
154742290|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742291|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154742292|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
154742293|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154742294|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154742295|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742296|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154742297|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742298|NCT03411798|Analgesics|analgesics|mesh-ancestor
154742299|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
154742300|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742301|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742302|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742303|NCT03408756|Methotrexate|methotrexate|mesh-list
154742304|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154742305|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
154742306|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742307|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742308|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742309|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
154742310|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742311|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742312|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
154742313|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742314|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154742315|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742316|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
154742317|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742318|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154742319|NCT01394614|Vaccines|vaccines|mesh-list
154742320|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
154742321|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742322|NCT04588818|Adalimumab|adalimumab|mesh-list
154742323|NCT04588818|Methotrexate|methotrexate|mesh-list
154742324|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154742325|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
154742326|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742327|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742328|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742329|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
154742330|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742331|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742332|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
154742333|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742334|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153583357|NCT01755520|Ticagrelor|ticagrelor|mesh-list
153583435|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154742335|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742336|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
154742337|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742338|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154742339|NCT04588818|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154742340|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742341|NCT01422226|Alprostadil|alprostadil|mesh-list
154742342|NCT01422226|Misoprostol|misoprostol|mesh-list
154742343|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154742344|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
154742345|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742346|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742347|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154742348|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742349|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
154742350|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154742351|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
154742352|NCT01422226|Urological Agents|urological agents|mesh-ancestor
154742353|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
154742354|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
154742355|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742357|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742358|NCT01423162|Vitamins|vitamins|mesh-ancestor
154742359|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
154742360|NCT01328782|Acetaminophen|acetaminophen|mesh-list
154742361|NCT01328782|Oxycodone|oxycodone|mesh-list
154742362|NCT01328782|Bupivacaine|bupivacaine|mesh-list
154742363|NCT01328782|Ropivacaine|ropivacaine|mesh-list
154742364|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742365|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
154742366|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742367|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742368|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
154742369|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742370|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742371|NCT01328782|Analgesics|analgesics|mesh-ancestor
154742372|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
154742373|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154742374|NCT01328782|Narcotics|narcotics|mesh-ancestor
154742375|NCT04447326|Endostar protein|endostar protein|mesh-list
154742376|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154742377|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154742378|NCT04447326|Growth Substances|growth substances|mesh-ancestor
154742379|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742380|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
154742381|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742382|NCT03411330|Lidocaine|lidocaine|mesh-list
154742383|NCT03411330|Bupivacaine|bupivacaine|mesh-list
154742384|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742385|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
154742386|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742387|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742388|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
154742389|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742390|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154742391|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154742392|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154742393|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742394|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742395|NCT03411252|Mirabegron|mirabegron|mesh-list
154742396|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154742397|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154742398|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154742399|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742400|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742401|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742402|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742403|NCT03411252|Urological Agents|urological agents|mesh-ancestor
154742404|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154742405|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
154742406|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742407|NCT01830881|Ibuprofen|ibuprofen|mesh-list
154742408|NCT01830881|Lidocaine|lidocaine|mesh-list
154742409|NCT01830881|Midazolam|midazolam|mesh-list
154742410|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742411|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
154742412|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742413|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742414|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
154742415|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742416|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154742417|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154742418|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154742419|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742420|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742421|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154742422|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154742423|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154742424|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154742425|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154742426|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154742427|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
154742428|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
154742429|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
154742430|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494387|NCT04905810|Azacitidine|azacitidine|mesh-list
154742431|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154742432|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742433|NCT01830881|Analgesics|analgesics|mesh-ancestor
154742434|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742435|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742436|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154742437|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742439|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
154742440|NCT01396486|Vitamins|vitamins|mesh-ancestor
154742441|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
153583490|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
153583556|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154742442|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742443|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
154742444|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
154742445|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742446|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742447|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742448|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
154742449|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
154742450|NCT03404544|Carbetocin|carbetocin|mesh-list
154742451|NCT03404544|Oxytocin|oxytocin|mesh-list
154742452|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
154742453|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742454|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742455|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
154742456|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154742457|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154742458|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742459|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
154742460|NCT01398280|Coagulants|coagulants|mesh-ancestor
154742461|NCT03403842|Sufentanil|sufentanil|mesh-list
154742462|NCT03403842|Morphine|morphine|mesh-list
154742463|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154742464|NCT03403842|Narcotics|narcotics|mesh-ancestor
154742465|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742466|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742467|NCT03403842|Analgesics|analgesics|mesh-ancestor
154742468|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
154742469|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742470|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154742471|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154742472|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
154742473|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
154742474|NCT01398982|Bupivacaine|bupivacaine|mesh-list
154742475|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742476|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
154742477|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742478|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742479|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
154742480|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742481|NCT04447560|Bupivacaine|bupivacaine|mesh-list
154742482|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742483|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
154742484|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742485|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742486|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
154742487|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742488|NCT03401736|Midazolam|midazolam|mesh-list
154742489|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
154742490|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154742491|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742492|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742493|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742494|NCT03401736|Analgesics|analgesics|mesh-ancestor
154742495|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
154742496|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742497|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154742498|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154742499|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154742500|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742501|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742502|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742503|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154742504|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154742505|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154742506|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154742507|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154742508|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
154742510|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
154742511|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
154742512|NCT02203786|Haloperidol|haloperidol|mesh-list
154742513|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
154742514|NCT02203786|Fluphenazine|fluphenazine|mesh-list
154742515|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
154742516|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
154742517|NCT02203786|Amphetamine|amphetamine|mesh-list
154742518|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
154742519|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
154742520|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
154742521|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742522|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742523|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742524|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154742525|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154742526|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742527|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154742528|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154742529|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
154742530|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742531|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742532|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154742533|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154742534|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
154742535|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742536|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154742537|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154742538|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742539|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154742540|NCT03009058|Leucovorin|leucovorin|mesh-list
154742541|NCT03009058|Folic Acid|folic acid|mesh-list
154742542|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
154742543|NCT03009058|Gemcitabine|gemcitabine|mesh-list
154742544|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
154742545|NCT03009058|Capecitabine|capecitabine|mesh-list
154742546|NCT03009058|Nivolumab|nivolumab|mesh-list
154742547|NCT03009058|Fluorouracil|fluorouracil|mesh-list
154742548|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
154742549|NCT03009058|Irinotecan|irinotecan|mesh-list
154742550|NCT03009058|Cetuximab|cetuximab|mesh-list
154742551|NCT03009058|Ipilimumab|ipilimumab|mesh-list
154742552|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154742553|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
154742554|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742555|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
154742556|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742557|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742558|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154742559|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
154742560|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742561|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742562|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154742563|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742564|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
154742565|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154742566|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154742567|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154742568|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154742569|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742570|NCT03009058|Antidotes|antidotes|mesh-ancestor
154742571|NCT03009058|Protective Agents|protective agents|mesh-ancestor
154742572|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
154742573|NCT03009058|Vitamins|vitamins|mesh-ancestor
154742574|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
154742575|NCT03009058|Hematinics|hematinics|mesh-ancestor
154742576|NCT01611857|Leucovorin|leucovorin|mesh-list
154742577|NCT01611857|Fluorouracil|fluorouracil|mesh-list
154742578|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
154742579|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
154742580|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
154742581|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742582|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742583|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742584|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742585|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
154742586|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742587|NCT01611857|Antidotes|antidotes|mesh-ancestor
154742588|NCT01611857|Protective Agents|protective agents|mesh-ancestor
154742589|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
154742591|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
154742592|NCT03393702|Gabapentin|gabapentin|mesh-list
154742593|NCT03393702|Analgesics|analgesics|mesh-ancestor
154742594|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
154742595|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742596|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742597|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
154742598|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154742599|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154742600|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742601|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154742602|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154742603|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154742604|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742605|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742606|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
154742607|NCT01829477|Glimepiride|glimepiride|mesh-list
154742608|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154742609|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154742610|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742611|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742612|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
154742613|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
154742614|NCT03126864|Fludarabine|fludarabine|mesh-list
154742615|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
154742616|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742617|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
154742618|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742619|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742620|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154742621|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
154742622|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742623|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742624|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154742625|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742626|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
154742627|NCT03399708|Apremilast|apremilast|mesh-list
154742628|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154742629|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742630|NCT03399708|Analgesics|analgesics|mesh-ancestor
154742631|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
154742632|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742633|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742634|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742635|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742636|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154742637|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154742638|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742639|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742640|NCT03395730|Oxytocin|oxytocin|mesh-list
154742641|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
154742642|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742643|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742644|NCT01334086|Aprepitant|aprepitant|mesh-list
154742645|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
154742646|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
154742647|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742648|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742649|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742650|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154742651|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583729|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153583837|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
154742652|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742653|NCT03399474|Lidocaine|lidocaine|mesh-list
154742654|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
154742655|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742656|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
154742657|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742658|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742659|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
154742660|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742661|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154494612|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742662|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154742663|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154742664|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742665|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742666|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154742667|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742668|NCT03399474|Analgesics|analgesics|mesh-ancestor
154742669|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154742670|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154742671|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154742672|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742673|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742674|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154742675|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154742676|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154742677|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742678|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742679|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742680|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742681|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154742682|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
154742683|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154742684|NCT01430182|Morphine|morphine|mesh-list
154742685|NCT01430182|Methadone|methadone|mesh-list
154742686|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154742687|NCT01430182|Narcotics|narcotics|mesh-ancestor
154742688|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742689|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742690|NCT01430182|Analgesics|analgesics|mesh-ancestor
154742691|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
154742692|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742693|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
154742694|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
154742695|NCT05097768|Dexamethasone|dexamethasone|mesh-list
154742696|NCT05097768|Ibuprofen|ibuprofen|mesh-list
154742697|NCT05097768|Ketorolac|ketorolac|mesh-list
154742698|NCT05097768|Meloxicam|meloxicam|mesh-list
154742699|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742700|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
154742701|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
154742702|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742703|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742704|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742705|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
154742706|NCT05097768|Hormones|hormones|mesh-ancestor
154742707|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154742708|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154742709|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742710|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154742711|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742712|NCT05097768|Analgesics|analgesics|mesh-ancestor
154742713|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
154742714|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742715|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154742716|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742717|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742718|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154742719|NCT01829243|Milnacipran|milnacipran|mesh-list
154742720|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
154742721|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154742722|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154742723|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742724|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742725|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742726|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742727|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742728|NCT01829243|Analgesics|analgesics|mesh-ancestor
154742729|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
154742730|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583906|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
153583992|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742731|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
154742732|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154742733|NCT01838447|Vitamin D|vitamin d|mesh-list
154742734|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
154742735|NCT01838447|Vitamins|vitamins|mesh-ancestor
154742736|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
154742737|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742738|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154742739|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154742740|NCT03395574|Terlipressin|terlipressin|mesh-list
154742741|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154742742|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154742743|NCT04982172|Infliximab|infliximab|mesh-list
154742744|NCT04982172|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154742745|NCT04982172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742746|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154742747|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742748|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742749|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154742750|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154742751|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154742752|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
154742753|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742754|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154742755|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154742756|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742757|NCT03395262|Caffeine|caffeine|mesh-list
154742758|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154742759|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742760|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154742761|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742762|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742763|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154742764|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154742765|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
154742766|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742767|NCT03852888|Methotrexate|methotrexate|mesh-list
154742768|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
154742769|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154742770|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
154742771|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742772|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742773|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742774|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
154742775|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742776|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742777|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
154742778|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742779|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154742780|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742781|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
154742782|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742783|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154742784|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
154742785|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154742786|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
154742787|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742788|NCT04755972|Expectorants|expectorants|mesh-ancestor
154742789|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
154742790|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154742791|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
154742792|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742793|NCT04755972|Protective Agents|protective agents|mesh-ancestor
154742794|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742795|NCT04755972|Antidotes|antidotes|mesh-ancestor
154742796|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
154742797|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154742798|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154742799|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
154742800|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742801|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154742802|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154742803|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742804|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742805|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154742806|NCT04697693|Escitalopram|escitalopram|mesh-list
154742807|NCT04697693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154742808|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154494763|NCT04167163|Abaloparatide|abaloparatide|mesh-list
154742809|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742810|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742811|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742812|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
154742813|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742814|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742815|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
154742816|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154742817|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154742819|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
154742820|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
154742821|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
154742822|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154742823|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
154742824|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742825|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742826|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154742827|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154742828|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154742829|NCT01827839|Vaccines|vaccines|mesh-list
154742830|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
154742831|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742832|NCT04709250|Bupivacaine|bupivacaine|mesh-list
154742833|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742834|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
154742835|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742836|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742837|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
154742838|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742839|NCT01401166|Trastuzumab|trastuzumab|mesh-list
154742840|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154742841|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742842|NCT03395028|Lenograstim|lenograstim|mesh-list
154742843|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154742844|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
154742845|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742846|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154742847|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154742848|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154742849|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742850|NCT04567992|Bupivacaine|bupivacaine|mesh-list
154742851|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742852|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
154742853|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742854|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742855|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
154742856|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742857|NCT01335724|Diclofenac|diclofenac|mesh-list
154742858|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154742859|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742860|NCT01335724|Analgesics|analgesics|mesh-ancestor
154742861|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
154742862|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742863|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742864|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742865|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742866|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154742867|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742868|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742869|NCT01476202|Nicotine|nicotine|mesh-list
154742870|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154742871|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
154742872|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742873|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742874|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154742875|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154742876|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
154742877|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742878|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742879|NCT01477762|Dexamethasone|dexamethasone|mesh-list
154742880|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154742881|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
154494837|NCT03996265|Bupropion|bupropion|mesh-list
154742883|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742884|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742885|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742886|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
154742887|NCT01477762|Hormones|hormones|mesh-ancestor
154742888|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154742889|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154742890|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742891|NCT01434472|Vidarabine|vidarabine|mesh-list
154742892|NCT01434472|Cyclosporine|cyclosporine|mesh-list
154742893|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
154742894|NCT01434472|Rituximab|rituximab|mesh-list
154742895|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154742896|NCT01434472|Fludarabine|fludarabine|mesh-list
154742897|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
154742898|NCT01434472|Antibodies|antibodies|mesh-list
154742899|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
154742900|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154742901|NCT01434472|Cyclosporins|cyclosporins|mesh-list
154742902|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
154742903|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742904|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154742905|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742906|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154742907|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
154742908|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742909|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154742910|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
154742911|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742912|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742913|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
154742914|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
154742915|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154742916|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154742917|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154742918|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
154742919|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154742920|NCT01435174|Ranolazine|ranolazine|mesh-list
154742921|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
154742922|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154742923|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154742924|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154742925|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742926|NCT01436266|Folic Acid|folic acid|mesh-list
154742927|NCT01436266|Misoprostol|misoprostol|mesh-list
154742928|NCT01436266|Vitamins|vitamins|mesh-ancestor
154742929|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
154742930|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742931|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154742932|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
154742933|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154742934|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154742935|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154742936|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
154742937|NCT01436266|Hematinics|hematinics|mesh-ancestor
154742938|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
154742939|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154742940|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154742941|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
154742942|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154742943|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742944|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154742945|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742946|NCT04409262|Remdesivir|remdesivir|mesh-list
154742947|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
154742948|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742949|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
154742950|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154742951|NCT01481740|Phenylephrine|phenylephrine|mesh-list
154742952|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
154742953|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154742954|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
154742955|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
154742956|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742957|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742958|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
154742959|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154742961|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
154742962|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154742963|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153584341|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
154742964|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154742965|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
154742966|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154742967|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742968|NCT01481740|Protective Agents|protective agents|mesh-ancestor
154742969|NCT01544062|Acetaminophen|acetaminophen|mesh-list
154742970|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742971|NCT01544062|Analgesics|analgesics|mesh-ancestor
154742972|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
154742973|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742974|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742975|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
154742976|NCT03126084|Acetaminophen|acetaminophen|mesh-list
154742977|NCT03126084|Tramadol|tramadol|mesh-list
154742978|NCT03126084|Bupivacaine|bupivacaine|mesh-list
154742979|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
154742980|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
154742981|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154742982|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154742983|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
154742984|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154742985|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154742986|NCT03126084|Analgesics|analgesics|mesh-ancestor
154742987|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
154742988|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154742989|NCT03126084|Narcotics|narcotics|mesh-ancestor
154742990|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154742991|NCT01544998|Tadalafil|tadalafil|mesh-list
154742992|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
154742993|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154742994|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154742995|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154742996|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154742997|NCT01544998|Urological Agents|urological agents|mesh-ancestor
154742998|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
154742999|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743000|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
154743001|NCT03391830|Atorvastatin|atorvastatin|mesh-list
154743002|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154743003|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154743004|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
154743005|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743006|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154743007|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154743008|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743009|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
154743010|NCT03391830|Protective Agents|protective agents|mesh-ancestor
154743011|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743012|NCT03391830|Vitamins|vitamins|mesh-ancestor
154743013|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
154743014|NCT01441570|Metoprolol|metoprolol|mesh-list
154743015|NCT01441570|Nebivolol|nebivolol|mesh-list
154743016|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154743017|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154743018|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
154743019|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
154743020|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743021|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743022|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154743023|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154743024|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154743025|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
154743026|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743027|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743028|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
154743029|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154743030|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154743031|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154743032|NCT05238012|Atorvastatin|atorvastatin|mesh-list
154743033|NCT05238012|Calcium|calcium|mesh-list
154743034|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154743035|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743036|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154743037|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154743038|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
154743039|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743040|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154743041|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154743042|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743043|NCT01441882|Dasatinib|dasatinib|mesh-list
154743044|NCT01441882|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154743045|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154743046|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743047|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743048|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743049|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154743050|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154743051|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
154743052|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743053|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743054|NCT01545700|Dexamethasone|dexamethasone|mesh-list
154743055|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
154743056|NCT01545700|BB 1101|bb 1101|mesh-list
154743057|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743058|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
154743059|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
154743060|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743061|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743062|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154743063|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
154743064|NCT01545700|Hormones|hormones|mesh-ancestor
154743065|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584434|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743066|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154743067|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743068|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
154743069|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743070|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743071|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154743072|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154743073|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743074|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154743075|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154743076|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154743077|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743078|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
154743079|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743080|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154743081|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
154743082|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154743083|NCT01444924|Bupivacaine|bupivacaine|mesh-list
154743084|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
154743085|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
154743086|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743087|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743088|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
154743089|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743090|NCT01546402|Dexamethasone|dexamethasone|mesh-list
154743091|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
154743092|NCT01546402|BB 1101|bb 1101|mesh-list
154743093|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743094|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
154743095|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
154743096|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743097|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743098|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154743099|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
154743100|NCT01546402|Hormones|hormones|mesh-ancestor
154743101|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743102|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154743103|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743104|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
154743105|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743106|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495063|NCT03199053|Hormones|hormones|mesh-ancestor
154743107|NCT03389490|Insulin|insulin|mesh-list
154743108|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154743109|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
154743110|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
154743111|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
154743112|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
154743113|NCT03389490|Protamines|protamines|mesh-list
154743114|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154743115|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743116|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
154743117|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743118|NCT03389490|Coagulants|coagulants|mesh-ancestor
154743119|NCT01547806|Plerixafor|plerixafor|mesh-list
154743120|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154743121|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154743122|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
154743123|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743124|NCT01445626|Dexamethasone|dexamethasone|mesh-list
154743125|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743126|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
154743127|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
154743128|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743129|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743130|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154743131|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
154743132|NCT01445626|Hormones|hormones|mesh-ancestor
154743133|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743134|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154743135|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743136|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
154743137|NCT02744742|Busulfan|busulfan|mesh-list
154743138|NCT02744742|Decitabine|decitabine|mesh-list
154743139|NCT02744742|Lenograstim|lenograstim|mesh-list
154743140|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743141|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
154743142|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743143|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743144|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154743145|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
154743146|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743147|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743148|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154743149|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154743150|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
154743151|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743152|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154743153|NCT03125772|Paclitaxel|paclitaxel|mesh-list
154743154|NCT03125772|Everolimus|everolimus|mesh-list
154743155|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154743156|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584557|NCT01761656|Atorvastatin|atorvastatin|mesh-list
154743157|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
154743158|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
154743159|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
154743160|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743161|NCT03125772|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154743162|NCT03125772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154743163|NCT03125772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743164|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743165|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
154743166|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743167|NCT01447888|Morphine|morphine|mesh-list
154743168|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154743169|NCT01447888|Narcotics|narcotics|mesh-ancestor
154743170|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743171|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743172|NCT01447888|Analgesics|analgesics|mesh-ancestor
154743173|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
154743174|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743175|NCT03389256|Apatinib|apatinib|mesh-list
154743176|NCT03389256|Gefitinib|gefitinib|mesh-list
154743177|NCT03389256|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154743178|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154743179|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743180|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743181|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743182|NCT01490788|Amitriptyline|amitriptyline|mesh-list
154743183|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
154743184|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154743185|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
154743186|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154743187|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154743188|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743189|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154743190|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743191|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154743192|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743193|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154743194|NCT01490788|Analgesics|analgesics|mesh-ancestor
154743195|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
154743196|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154743197|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154743198|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154743199|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743200|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
154743201|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743202|NCT03391050|Dabrafenib|dabrafenib|mesh-list
154743203|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743204|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154743205|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743206|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743207|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
154743208|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154743209|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
154743210|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154743211|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743212|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743213|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154743214|NCT03390972|Analgesics|analgesics|mesh-ancestor
154743215|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
154743216|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743217|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154743218|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154743219|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154743220|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
154743221|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743222|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743223|NCT01550224|Temozolomide|temozolomide|mesh-list
154743224|NCT01550224|Vorinostat|vorinostat|mesh-list
154743225|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154743226|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
154743227|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743228|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743229|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154743230|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743231|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
154743232|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154743233|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154743234|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743235|NCT00782184|Atorvastatin|atorvastatin|mesh-list
154743236|NCT00782184|Simvastatin|simvastatin|mesh-list
154743237|NCT00782184|Ezetimibe|ezetimibe|mesh-list
154743238|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154743239|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154743240|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154743241|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
154743242|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743243|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154743244|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154743245|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743246|NCT03397914|Colistin|colistin|mesh-list
154743247|NCT03397914|Polymyxins|polymyxins|mesh-list
154743248|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154743249|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743250|NCT03126708|Paclitaxel|paclitaxel|mesh-list
154743251|NCT03126708|Cetuximab|cetuximab|mesh-list
154743252|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154743253|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743254|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154743255|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154743256|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154860374|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154495213|NCT02542696|Apomorphine|apomorphine|mesh-list
154743257|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743258|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154743260|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154743261|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743262|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154743263|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743264|NCT03390582|Methimazole|methimazole|mesh-list
154743265|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
154743266|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
154743267|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743268|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743269|NCT03385356|Vitamin D|vitamin d|mesh-list
154743270|NCT03385356|Vitamins|vitamins|mesh-ancestor
154743271|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
154743272|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743273|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154743274|NCT03388866|Immunomodulating Agents|immunomodulating agents|mesh-list
154743275|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
154743276|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743277|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154743278|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
154743279|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
154743280|NCT01873170|Etonogestrel|etonogestrel|mesh-list
154743281|NCT01873170|Desogestrel|desogestrel|mesh-list
154743282|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
154743283|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154743284|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154743285|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743286|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154743287|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154743288|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154743289|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154743290|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154743291|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743292|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154743293|NCT01873170|Progestins|progestins|mesh-ancestor
154743294|NCT01873170|Hormones|hormones|mesh-ancestor
154743295|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743296|NCT03125694|Pioglitazone|pioglitazone|mesh-list
154743297|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154743298|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154743299|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743300|NCT03125694|Incretins|incretins|mesh-ancestor
154743301|NCT03125694|Hormones|hormones|mesh-ancestor
154743302|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743303|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154743304|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
154743305|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743306|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743307|NCT02731638|Voriconazole|voriconazole|mesh-list
154743308|NCT02731638|Natamycin|natamycin|mesh-list
153584772|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
154743309|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
154743310|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743311|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154743312|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154743313|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743314|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743315|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154743316|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
154743317|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743318|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743319|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154743320|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154743321|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154743322|NCT01451632|Irinotecan|irinotecan|mesh-list
154743323|NCT01451632|Cetuximab|cetuximab|mesh-list
154743324|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154743325|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154743326|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743327|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743328|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743329|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154743330|NCT01491958|Methotrexate|methotrexate|mesh-list
154743331|NCT01491958|Atorvastatin|atorvastatin|mesh-list
154743332|NCT01491958|Tacrolimus|tacrolimus|mesh-list
154743333|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154743334|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
154743335|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154743336|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743337|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154743338|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
154743339|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743340|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743341|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
154743342|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743343|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153584773|NCT01762787|Cantharidin|cantharidin|mesh-list
154743344|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743345|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
154743346|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743347|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154743348|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154743349|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154743350|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154743351|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154743352|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154743353|NCT01492582|Vaccines|vaccines|mesh-list
154743354|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
154743355|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743356|NCT01495858|Naproxen|naproxen|mesh-list
154743357|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154743358|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154743359|NCT01495858|Analgesics|analgesics|mesh-ancestor
154743360|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
154743361|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743362|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743363|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743364|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743365|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
154743366|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154743367|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743368|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743369|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
154743370|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154743371|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154743372|NCT01497496|Prednisolone|prednisolone|mesh-list
154743373|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
154743374|NCT01497496|Lenalidomide|lenalidomide|mesh-list
154743375|NCT01497496|Ofatumumab|ofatumumab|mesh-list
154743376|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154743377|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
154743378|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
154743379|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743380|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154743381|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154743382|NCT01497496|Growth Substances|growth substances|mesh-ancestor
154743383|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
154743384|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743385|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743386|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
154743387|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
154743388|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743389|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154743390|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
154743391|NCT01497496|Hormones|hormones|mesh-ancestor
154743392|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743393|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154743394|NCT01497496|Protective Agents|protective agents|mesh-ancestor
154743395|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154743396|NCT02208310|Vitamin D|vitamin d|mesh-list
154743397|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
154743398|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
154743399|NCT02208310|Vitamins|vitamins|mesh-list
154743400|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
154743401|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743402|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154495381|NCT01020903|Aprepitant|aprepitant|mesh-list
154743403|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154743404|NCT01454362|Nicotine|nicotine|mesh-list
154743405|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154743406|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
154743407|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743408|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743409|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154743410|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154743411|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
154743412|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743413|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743414|NCT01497808|Ipilimumab|ipilimumab|mesh-list
154743415|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154743416|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743417|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154743418|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743419|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
154743420|NCT01498588|Doxorubicin|doxorubicin|mesh-list
154743421|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743422|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
154743423|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743424|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743425|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154743426|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
154743427|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743428|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743429|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154743430|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154743431|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154743432|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154743433|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743434|NCT01498744|Clindamycin|clindamycin|mesh-list
154743435|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
154743436|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
154743437|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154743438|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743439|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154743440|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743441|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743442|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154743443|NCT01498978|Ipilimumab|ipilimumab|mesh-list
154743444|NCT01498978|Antibodies|antibodies|mesh-list
154743445|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
154743446|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154743447|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
154743448|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743449|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743450|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154743451|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743452|NCT01458418|Montelukast|montelukast|mesh-list
154743453|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154743454|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
154743455|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154743456|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
154743457|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743458|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743459|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154743460|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154743461|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743462|NCT01557322|Etanercept|etanercept|mesh-list
154743463|NCT01557322|Methotrexate|methotrexate|mesh-list
154743464|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154743465|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
154743466|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154743467|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743468|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154743469|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
154743470|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743471|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743472|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
154743473|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743474|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154743475|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743476|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
154743477|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743478|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154743479|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154743480|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154743481|NCT01557322|Analgesics|analgesics|mesh-ancestor
154743482|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
154743483|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743484|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743485|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154743486|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154743487|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154743488|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
154743489|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154743490|NCT01459588|Laxatives|laxatives|mesh-ancestor
154743491|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584988|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
154743492|NCT01501162|Ethanol|ethanol|mesh-list
154743493|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154743494|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743495|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743496|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743497|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
154743498|NCT01557868|Hylan|hylan|mesh-list
154743499|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154743500|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
154743501|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743502|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
154743503|NCT01557868|Protective Agents|protective agents|mesh-ancestor
154743504|NCT02208466|Fluoxetine|fluoxetine|mesh-list
154743505|NCT02208466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154743506|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154743507|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154743508|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743509|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743510|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
154743511|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743512|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154743513|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
154743514|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154743515|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154743516|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154743517|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743518|NCT02209948|Temozolomide|temozolomide|mesh-list
154743519|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154743520|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
154743521|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743522|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743523|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
154743524|NCT02981212|Prednisolone|prednisolone|mesh-list
154743525|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154743526|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154743527|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743528|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154743529|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
154743530|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154743531|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743532|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743533|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743534|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743535|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
154743536|NCT02981212|Hormones|hormones|mesh-ancestor
154743537|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743538|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743539|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154743540|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
154743541|NCT01464190|Sevelamer|sevelamer|mesh-list
154743542|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
154743543|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
154743544|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743545|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154743546|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743547|NCT01563406|Ethanol|ethanol|mesh-list
154743548|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
154743549|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154495513|NCT04763512|Caseins|caseins|mesh-list
154743550|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743551|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743552|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743553|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
154743555|NCT01468012|Carbidopa|carbidopa|mesh-list
154743556|NCT01468012|Entacapone|entacapone|mesh-list
154743557|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154743558|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154743559|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154743560|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
154743561|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743562|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743563|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743564|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154743565|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743566|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154743567|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154743568|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
154743569|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
154743570|NCT01468558|Ketoconazole|ketoconazole|mesh-list
154743571|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
154743572|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743573|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154743574|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154743575|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743576|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743577|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154743578|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
154743579|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743580|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743581|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154743582|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
154743583|NCT03730662|Tirzepatide|tirzepatide|mesh-list
154743584|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154743585|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743586|NCT03730662|Incretins|incretins|mesh-ancestor
154743587|NCT03730662|Hormones|hormones|mesh-ancestor
154743588|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743589|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154743590|NCT01470118|Dextrans|dextrans|mesh-list
154743591|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154743592|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154743593|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
154743594|NCT01470118|Alcaftadine|alcaftadine|mesh-list
154743595|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
154743596|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
154743597|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
154743598|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154743599|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154743600|NCT01470118|Analgesics|analgesics|mesh-ancestor
154743601|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
154743602|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743603|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743604|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743605|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743606|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154743607|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154743608|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154743609|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
154743610|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
154743611|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743612|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743613|NCT01470196|Dexamethasone|dexamethasone|mesh-list
154743614|NCT01470196|Rituximab|rituximab|mesh-list
154743615|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154743616|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743617|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
154743618|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743619|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743620|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743621|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
154743622|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
154743623|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743624|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154743625|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
154743626|NCT01470196|Hormones|hormones|mesh-ancestor
154743627|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743628|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154743629|NCT03389958|Copper|copper|mesh-list
154743630|NCT03389958|Trace Elements|trace elements|mesh-ancestor
154743631|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
154743632|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743633|NCT04446234|Risperidone|risperidone|mesh-list
154743634|NCT04446234|Aripiprazole|aripiprazole|mesh-list
154743635|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154743636|NCT04446234|Ziprasidone|ziprasidone|mesh-list
154743637|NCT04446234|Amisulpride|amisulpride|mesh-list
154743638|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154743639|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
154743640|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743641|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743642|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743643|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154743644|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154743645|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743646|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154743647|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154743648|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
154743649|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
154743650|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
154743651|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154743652|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154743653|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154743654|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154743655|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154743656|NCT03613506|Captopril|captopril|mesh-list
154743657|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154743658|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
154743659|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743660|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743661|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154743662|NCT01565902|Siponimod|siponimod|mesh-list
154743663|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154743664|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743665|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743666|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
154743667|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743668|NCT01566448|Ketamine|ketamine|mesh-list
154743669|NCT01566448|Analgesics|analgesics|mesh-ancestor
154743670|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
154743671|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743672|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743673|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154743674|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154743675|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
154743676|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
154743677|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743678|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154743679|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154743680|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743681|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743682|NCT05565976|Aspirin|aspirin|mesh-list
154743683|NCT05565976|Insulin|insulin|mesh-list
154743684|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154743685|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
154743686|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
154743687|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
154743688|NCT05565976|Biguanides|biguanides|mesh-list
154743689|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154743690|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154743691|NCT05565976|Meglitinide|meglitinide|mesh-list
154743692|NCT05565976|Clopidogrel|clopidogrel|mesh-list
154743693|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154743694|NCT05565976|Atorvastatin|atorvastatin|mesh-list
154743695|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154743696|NCT05565976|Pravastatin|pravastatin|mesh-list
154495668|NCT03060577|Evolocumab|evolocumab|mesh-list
154743697|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743698|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154743699|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154743700|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
154743701|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743702|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154743703|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154743704|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743705|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154743706|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154743707|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154743708|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
154743709|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743710|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154743711|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154743712|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154743714|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
154743715|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743716|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743717|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743718|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154743719|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154743720|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154743721|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
154743722|NCT01566526|Dexamethasone|dexamethasone|mesh-list
154743723|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743724|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
154743725|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
154743726|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743727|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743728|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154743729|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
154743730|NCT01566526|Hormones|hormones|mesh-ancestor
154743731|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154743732|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154743733|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743734|NCT01566838|Bupivacaine|bupivacaine|mesh-list
154743735|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
154743736|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
154743737|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743738|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743739|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
154743740|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743741|NCT03125616|Vaccines|vaccines|mesh-list
154743742|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
154743743|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743744|NCT01568008|Bimatoprost|bimatoprost|mesh-list
154743745|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154743746|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154743747|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154743748|NCT05658120|Epinephrine|epinephrine|mesh-list
154743749|NCT05658120|Racepinephrine|racepinephrine|mesh-list
154743750|NCT05658120|Norepinephrine|norepinephrine|mesh-list
154743751|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
154743752|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154743753|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154743754|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
154743755|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743756|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743757|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743758|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154743759|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154743760|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
154743761|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743762|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154743763|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
154743764|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
154743765|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
154743766|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154743767|NCT01514734|Timolol|timolol|mesh-list
154743768|NCT01514734|Brinzolamide|brinzolamide|mesh-list
154743769|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743770|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743771|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154743772|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154743773|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
154495735|NCT02500576|Interleukin-2|interleukin-2|mesh-list
154743774|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743775|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743776|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154743777|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154743778|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154743779|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
154743780|NCT01515046|Gemcitabine|gemcitabine|mesh-list
154743781|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154743782|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
154743783|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743784|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743785|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
154743786|NCT01515046|Protective Agents|protective agents|mesh-ancestor
154743787|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743788|NCT01515046|Vitamins|vitamins|mesh-ancestor
154743789|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
154743790|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154743791|NCT01568944|Lansoprazole|lansoprazole|mesh-list
154743792|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743793|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154743794|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154743795|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154743796|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743797|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743798|NCT05565274|Pentazocine|pentazocine|mesh-list
154743799|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154743800|NCT05565274|Narcotics|narcotics|mesh-ancestor
154743801|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585288|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154743802|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743803|NCT05565274|Analgesics|analgesics|mesh-ancestor
154743804|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
154743805|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743806|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154743807|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154743808|NCT05173584|Albuterol|albuterol|mesh-list
154743809|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154743810|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
154743811|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743812|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743813|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154743814|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
154743815|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
154743816|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154743817|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154743818|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154743819|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154743820|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
154743821|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743822|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743823|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
154743824|NCT04671030|Neostigmine|neostigmine|mesh-list
154743825|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154743826|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743827|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743828|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
154743829|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743830|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743831|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154743832|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
154743833|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743834|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154743835|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154743836|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154743837|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
154743838|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154743839|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154743840|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743841|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154743842|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154743843|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743844|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743845|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743846|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154743847|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
154743848|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154743849|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743850|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154743851|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154743852|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154743853|NCT04632264|Oxytocin|oxytocin|mesh-list
154743854|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
154743855|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154743856|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743857|NCT04607928|Pirfenidone|pirfenidone|mesh-list
154743858|NCT04607928|Analgesics|analgesics|mesh-ancestor
153585364|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585446|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
154743859|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
154743860|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743861|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743862|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154743863|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154743864|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154743865|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743866|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743867|NCT03380442|Ketamine|ketamine|mesh-list
154743868|NCT03380442|Psilocybin|psilocybin|mesh-list
154743869|NCT03380442|Analgesics|analgesics|mesh-ancestor
154743870|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
154743871|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743872|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743873|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154743874|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154743875|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
154743876|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
154743877|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743878|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154743879|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154743880|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154743881|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743882|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
154743883|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154743884|NCT03380130|Nivolumab|nivolumab|mesh-list
154743885|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154743886|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743887|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154743888|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743889|NCT03386838|Carboplatin|carboplatin|mesh-list
154743890|NCT03386838|Nivolumab|nivolumab|mesh-list
154743891|NCT03386838|Fluorouracil|fluorouracil|mesh-list
154743892|NCT03386838|Cetuximab|cetuximab|mesh-list
154743893|NCT03386838|Linrodostat|linrodostat|mesh-list
154743894|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743895|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154743896|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154743897|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743898|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
154743899|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154743900|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743901|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
154743902|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743903|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743904|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154743905|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
154743906|NCT03379974|Coagulants|coagulants|mesh-ancestor
154743907|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154743908|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
154743909|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743910|NCT01570036|Trastuzumab|trastuzumab|mesh-list
154743911|NCT01570036|Molgramostim|molgramostim|mesh-list
154743912|NCT01570036|Sargramostim|sargramostim|mesh-list
154743913|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154743914|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743915|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
154743916|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743917|NCT01516684|Lidocaine|lidocaine|mesh-list
154743918|NCT01516684|Fentanyl|fentanyl|mesh-list
154743919|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
154743920|NCT01516684|Prilocaine|prilocaine|mesh-list
154743921|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154743922|NCT01516684|Propofol|propofol|mesh-list
154743923|NCT01516684|Anesthetics|anesthetics|mesh-list
154743924|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154743925|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743926|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
154743927|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154743928|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154743929|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154743930|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154743931|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154743932|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743933|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154743934|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154743935|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
154743936|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154743938|NCT01516684|Analgesics|analgesics|mesh-ancestor
154743939|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154743940|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154743941|NCT01517074|Sirolimus|sirolimus|mesh-list
154743942|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154743943|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743944|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154743945|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743946|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
154743947|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743948|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
154743949|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743950|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
154743951|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
154743952|NCT01570348|Fludarabine|fludarabine|mesh-list
154743953|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
154743954|NCT01570348|Tacrolimus|tacrolimus|mesh-list
154743955|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743956|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
154743957|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743958|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743959|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154743960|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
154743961|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743962|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743963|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154743964|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154743965|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
154743966|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154743967|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743968|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154743969|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154743970|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
154743971|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154743972|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743973|NCT03383406|Cytarabine|cytarabine|mesh-list
154743974|NCT03383406|Methotrexate|methotrexate|mesh-list
154743975|NCT03383406|Etoposide|etoposide|mesh-list
154743976|NCT03383406|Ifosfamide|ifosfamide|mesh-list
154743977|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154743978|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
154743979|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154743980|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154743981|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154743982|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
154743983|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154743984|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154743985|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
154743986|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154743987|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154743988|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154743989|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
154743990|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154743991|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154743992|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154743993|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154743994|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154743995|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
154743996|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154743997|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154743998|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
154743999|NCT04445922|Anastrozole|anastrozole|mesh-list
154744000|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154744001|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744002|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154744003|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154744004|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744005|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744006|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154744007|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
154744008|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744009|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744010|NCT03383328|Prednisolone|prednisolone|mesh-list
154744011|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154744012|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
154744013|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154744014|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
154744015|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154744016|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154744017|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
154744018|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744019|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
154744020|NCT03383328|Hormones|hormones|mesh-ancestor
154744021|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744022|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744023|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154744024|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744025|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
154744026|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
154744027|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744028|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744029|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154744030|NCT03383328|Protective Agents|protective agents|mesh-ancestor
154744031|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744032|NCT03383328|Analgesics|analgesics|mesh-ancestor
154744033|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
154744034|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744035|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154744036|NCT01573702|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154744037|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154744038|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744039|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744040|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744041|NCT03093246|Aspirin|aspirin|mesh-list
154744042|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154744043|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744044|NCT03093246|Analgesics|analgesics|mesh-ancestor
154744045|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
154744046|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744047|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744048|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744049|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744050|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154744051|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154744052|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744053|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154744054|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154744055|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744056|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
154744057|NCT02969928|Amoxicillin|amoxicillin|mesh-list
154744058|NCT02969928|Metronidazole|metronidazole|mesh-list
154744059|NCT02969928|Clarithromycin|clarithromycin|mesh-list
154744060|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154744061|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744062|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154744063|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154744064|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154744065|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744066|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744067|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154744068|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154744069|NCT02968446|Vitamin D|vitamin d|mesh-list
154744070|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
154744071|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
154744072|NCT02968446|Vitamins|vitamins|mesh-ancestor
154744073|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
154744074|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496037|NCT02470832|Itraconazole|itraconazole|mesh-list
154744075|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154744076|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154744077|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
154744078|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744079|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154744080|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744082|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154744083|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744084|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154744085|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744086|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744087|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
154744088|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
154744089|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744090|NCT03378726|Micronutrients|micronutrients|mesh-list
154744091|NCT03378726|Trace Elements|trace elements|mesh-list
154744092|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744093|NCT03378648|Bromides|bromides|mesh-list
154744094|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
154744095|NCT01519882|Rotigotine|rotigotine|mesh-list
154744096|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
154744097|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
154744098|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744099|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744100|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744101|NCT01576276|Ketorolac|ketorolac|mesh-list
154744102|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154744103|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744104|NCT01576276|Analgesics|analgesics|mesh-ancestor
154744105|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
154744106|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744107|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744108|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744109|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744110|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154744111|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744112|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744113|NCT01576588|Rituximab|rituximab|mesh-list
154744114|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
154744115|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744116|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744117|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
154744118|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744119|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744120|NCT01576588|Hormones|hormones|mesh-ancestor
154744121|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744122|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
154744123|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
154744124|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744125|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
154744126|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154744127|NCT02247154|Antibodies|antibodies|mesh-list
154744128|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
154744129|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744130|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
154744131|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154744132|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154744133|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
154744134|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744135|NCT03007810|Hemay005|hemay005|mesh-list
154744136|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
154744137|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154744138|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154744139|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744140|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744141|NCT01578772|Telmisartan|telmisartan|mesh-list
154744142|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154744143|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154744144|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154744145|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744146|NCT01804049|Metformin|metformin|mesh-list
154744147|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154744148|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496146|NCT03309644|Iodine|iodine|mesh-list
154744149|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154744150|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154744151|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744152|NCT02346630|Levodopa|levodopa|mesh-list
154744153|NCT02346630|Carbidopa|carbidopa|mesh-list
154744154|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154744155|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154744156|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
154744157|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744158|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744159|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744160|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154744161|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744162|NCT03385668|Pirfenidone|pirfenidone|mesh-list
154744163|NCT03385668|Analgesics|analgesics|mesh-ancestor
154744164|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
154744165|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744166|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744167|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154744168|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744169|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744170|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585804|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
154744171|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744172|NCT04947072|Anesthetics|anesthetics|mesh-list
154744173|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154744174|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744175|NCT04942158|Eugenol|eugenol|mesh-list
154744176|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
154744177|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
154744178|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
154744179|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154744180|NCT04942158|Protective Agents|protective agents|mesh-ancestor
154744181|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744182|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744183|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
154744184|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154744185|NCT03387774|Urinastatin|urinastatin|mesh-list
154744186|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154744187|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154744188|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
154744189|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744190|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744191|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
154744192|NCT03382314|Vitamin D|vitamin d|mesh-list
154744193|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
154744194|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154744195|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744196|NCT03382314|Vitamins|vitamins|mesh-ancestor
154744197|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
154744198|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154744199|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154744200|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154744201|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
154744202|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744203|NCT03124524|Dienogest|dienogest|mesh-list
154744204|NCT03124524|Drospirenone|drospirenone|mesh-list
154744205|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154744206|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154744207|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154744208|NCT03124524|Estradiol|estradiol|mesh-list
154744209|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154744210|NCT03124524|Estrogens|estrogens|mesh-ancestor
154744211|NCT03124524|Hormones|hormones|mesh-ancestor
154744212|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744213|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744214|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154744215|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
154744216|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154744217|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153585825|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154744218|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154744219|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
154744220|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154744221|NCT03124524|Diuretics|diuretics|mesh-ancestor
154744222|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
154744223|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154744224|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154744225|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154744226|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154744227|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744228|NCT03377400|Cisplatin|cisplatin|mesh-list
154744229|NCT03377400|Durvalumab|durvalumab|mesh-list
154744230|NCT03377400|Tremelimumab|tremelimumab|mesh-list
154744231|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744232|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744233|NCT01803269|Topotecan|topotecan|mesh-list
154744234|NCT01803269|Camptothecin|camptothecin|mesh-list
154744235|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154744236|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154744237|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744238|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744239|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744240|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154744241|NCT01802879|Panobinostat|panobinostat|mesh-list
154744242|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744243|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154744244|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744245|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744246|NCT01825577|Methylphenidate|methylphenidate|mesh-list
154744247|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154744248|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744249|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154744250|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154744251|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154744252|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744253|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
154744254|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744255|NCT03375138|Abatacept|abatacept|mesh-list
154744256|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154744257|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744258|NCT03375138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744259|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744260|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154744261|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
154744262|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744263|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744264|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
154744265|NCT03124680|Narcotics|narcotics|mesh-ancestor
154744266|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154744267|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744268|NCT03124680|Analgesics|analgesics|mesh-ancestor
154744269|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
154744270|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744271|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
154744272|NCT02963610|Lenalidomide|lenalidomide|mesh-list
154744273|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744274|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744275|NCT02963610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154744276|NCT02963610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744277|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
154744278|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744279|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154744280|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154744281|NCT02963610|Growth Substances|growth substances|mesh-ancestor
154744282|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
154744283|NCT03376932|Albuterol|albuterol|mesh-list
154744284|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
154744285|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154744286|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
154744287|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744288|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744289|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154744290|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
154744291|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
154744292|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154744293|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
154744294|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744295|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744296|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
154744297|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154496263|NCT01933724|Prednisone|prednisone|mesh-list
154744298|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154744299|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154744300|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154744301|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
154744302|NCT03007342|Amoxicillin|amoxicillin|mesh-list
154744303|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
154744304|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
154744305|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154744306|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154744307|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744308|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154744309|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744310|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744311|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154744312|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154744313|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744314|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744315|NCT01579162|Cholic Acids|cholic acids|mesh-list
154744316|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744317|NCT03007654|Chitosan|chitosan|mesh-list
154744318|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154744319|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154744320|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
154744321|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744322|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154744323|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
154744324|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
154744325|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
154744326|NCT03007654|Coagulants|coagulants|mesh-ancestor
154744327|NCT03374514|Dexamethasone|dexamethasone|mesh-list
154744328|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744329|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
154744330|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
154744331|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744332|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744333|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744334|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
154744335|NCT03374514|Hormones|hormones|mesh-ancestor
154744336|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744337|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154744338|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744339|NCT01526356|Sirolimus|sirolimus|mesh-list
154744340|NCT01526356|Temsirolimus|temsirolimus|mesh-list
154744341|NCT01526356|MTOR Inhibitors|mtor inhibitors|mesh-list
154744342|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154744343|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744344|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154744345|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744346|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
154744347|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154744348|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
154744349|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744350|NCT01526356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154744351|NCT01526356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744352|NCT01526356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744353|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154744354|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154744355|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744356|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744357|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154744358|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154744359|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744360|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
154744361|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586075|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586076|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744362|NCT03374280|Cisplatin|cisplatin|mesh-list
154744363|NCT03374280|Pemetrexed|pemetrexed|mesh-list
154744364|NCT03374280|Gefitinib|gefitinib|mesh-list
154744365|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744366|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744367|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744368|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154744369|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154744370|NCT03374280|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154744371|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154744372|NCT03381066|Cisplatin|cisplatin|mesh-list
154744373|NCT03381066|Pemetrexed|pemetrexed|mesh-list
154744374|NCT03381066|Vinorelbine|vinorelbine|mesh-list
154744375|NCT03381066|Gefitinib|gefitinib|mesh-list
154744376|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744377|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744378|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744379|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154744380|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154744381|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154744382|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
154744383|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
154744384|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
154744385|NCT03381066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154744386|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154744387|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154744388|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
154744389|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154744390|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
154744391|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
154744392|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744393|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744394|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
154744395|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154744396|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154744397|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
154744398|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744399|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744400|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
154744401|NCT01580410|Mitomycins|mitomycins|mesh-list
154744402|NCT01580410|Mitomycin|mitomycin|mesh-list
154744403|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744404|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154744405|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
154744406|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744407|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154744408|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744409|NCT01581658|Empagliflozin|empagliflozin|mesh-list
154744410|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154744411|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744412|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154744413|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744414|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154744415|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154744416|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744417|NCT01530178|Incretins|incretins|mesh-ancestor
154744418|NCT01530178|Hormones|hormones|mesh-ancestor
154744419|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744420|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154744421|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
154744422|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744423|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744424|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
154744425|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154744426|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154744427|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154744428|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154744429|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744430|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
154744431|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744432|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744433|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154744434|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744435|NCT03006874|Esomeprazole|esomeprazole|mesh-list
154744436|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154744437|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744438|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154744439|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744440|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744441|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
154744442|NCT01581970|Cetuximab|cetuximab|mesh-list
154744443|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154744444|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
154744445|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744446|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154496413|NCT02259309|Misoprostol|misoprostol|mesh-list
154744447|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154744448|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
154744449|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744450|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744451|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154744452|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744453|NCT01583686|Aldesleukin|aldesleukin|mesh-list
154744454|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
154744455|NCT01583686|Fludarabine|fludarabine|mesh-list
154744456|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154744457|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
154744458|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744459|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744460|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154744461|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
154744462|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744463|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744464|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154744465|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154744466|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154744467|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
154744468|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744469|NCT01532128|Opicapone|opicapone|mesh-list
154744470|NCT01532128|Rasagiline|rasagiline|mesh-list
154744471|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154744472|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744473|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744474|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154744475|NCT01532128|Protective Agents|protective agents|mesh-ancestor
154744476|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744477|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154744478|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154744479|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154744480|NCT01584388|Rituximab|rituximab|mesh-list
154744481|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744482|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744483|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
154744484|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744485|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744486|NCT01584544|Capecitabine|capecitabine|mesh-list
154744487|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154744488|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
154744489|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744490|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744491|NCT03006952|Losartan|losartan|mesh-list
154744492|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
154744493|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154744494|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154744495|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154744496|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154744497|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744498|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154744499|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744500|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154744501|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154744502|NCT03006952|Protective Agents|protective agents|mesh-ancestor
154744503|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744504|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
154744505|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154744506|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
154744507|NCT01802333|Cytarabine|cytarabine|mesh-list
154744508|NCT01802333|Daunorubicin|daunorubicin|mesh-list
154744509|NCT01802333|Vorinostat|vorinostat|mesh-list
154744510|NCT01802333|Idarubicin|idarubicin|mesh-list
154744511|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154744512|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
154744513|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744514|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744515|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
154744516|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744517|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154744518|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
154744519|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744520|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154744521|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154744523|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744524|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154744525|NCT01585324|Ribavirin|ribavirin|mesh-list
154744526|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154744527|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
154744528|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744529|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
154744530|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744531|NCT01586962|Acetaminophen|acetaminophen|mesh-list
154744532|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
154744533|NCT01586962|Ephedrine|ephedrine|mesh-list
154744534|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744535|NCT01586962|Analgesics|analgesics|mesh-ancestor
154744536|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
154744537|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744538|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744539|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
154744540|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154744541|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
154744542|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154744543|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
154744544|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
154744545|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154744546|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154744547|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
154744548|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
154744549|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744550|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744551|NCT03006250|Sevoflurane|sevoflurane|mesh-list
154744552|NCT03006250|Desflurane|desflurane|mesh-list
154744553|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154744554|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154744555|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
154744556|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
154744557|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154744558|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744559|NCT04129437|Ibuprofen|ibuprofen|mesh-list
154744560|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154744561|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744562|NCT04129437|Analgesics|analgesics|mesh-ancestor
154744563|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
154744564|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744565|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744566|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744567|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744568|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154744569|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744570|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744571|NCT01801475|Ondansetron|ondansetron|mesh-list
154744572|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
154744573|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
154744574|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744575|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744576|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744577|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
154744578|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154744579|NCT01801475|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154744580|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154744581|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
154744582|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744583|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744584|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
154744585|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154744586|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
154744587|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744588|NCT03063021|Expectorants|expectorants|mesh-ancestor
154744589|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
154744590|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154744591|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
154744592|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744593|NCT03063021|Protective Agents|protective agents|mesh-ancestor
154744594|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744595|NCT03063021|Antidotes|antidotes|mesh-ancestor
154744596|NCT02337933|Ursolic Acid|ursolic acid|mesh-list
154496559|NCT05154396|Loperamide|loperamide|mesh-list
154744597|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744598|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744599|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154744600|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744601|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154744603|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154744604|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744605|NCT02337933|Analgesics|analgesics|mesh-ancestor
154744606|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
154744607|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744608|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744609|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744610|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744611|NCT03062943|Nintedanib|nintedanib|mesh-list
154744612|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744613|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154744614|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744615|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744616|NCT01536886|Betamethasone|betamethasone|mesh-list
154744617|NCT01536886|Calcipotriene|calcipotriene|mesh-list
154744618|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744619|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
154744620|NCT01536886|Hormones|hormones|mesh-ancestor
154744621|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744622|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744623|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154744624|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
154744625|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
154744626|NCT02247310|Interferons|interferons|mesh-list
154744627|NCT02247310|Interferon-beta|interferon-beta|mesh-list
154744628|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
154744629|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744630|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
154744631|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744632|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
154744633|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744634|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154744635|NCT03061539|Nivolumab|nivolumab|mesh-list
154744636|NCT03061539|Ipilimumab|ipilimumab|mesh-list
154744637|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744638|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744639|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154744640|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744641|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
154744642|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154744643|NCT05609253|Itraconazole|itraconazole|mesh-list
154744644|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154744645|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
154744646|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744647|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154744648|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154744649|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744650|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744651|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154744652|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
154744653|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744654|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744655|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154744656|NCT01822535|Midodrine|midodrine|mesh-list
154744657|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
154744658|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
154744659|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744660|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744661|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154744662|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154744663|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154744664|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154744665|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
154744666|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744667|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744668|NCT01537666|Vancomycin|vancomycin|mesh-list
154744669|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154744670|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744671|NCT01537900|Grazoprevir|grazoprevir|mesh-list
154744672|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
154744673|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744674|NCT01799993|Amikacin|amikacin|mesh-list
154744675|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154744676|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744677|NCT01593592|Amoxicillin|amoxicillin|mesh-list
154744678|NCT01593592|Clarithromycin|clarithromycin|mesh-list
154744679|NCT01593592|Omeprazole|omeprazole|mesh-list
154744680|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154744681|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744682|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154744683|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744684|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154744685|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744686|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744687|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154744688|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154744689|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154744690|NCT03001960|Clopidogrel|clopidogrel|mesh-list
154744691|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154744692|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154744693|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154744694|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154744695|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
154744696|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744697|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744698|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744699|NCT01593670|Decitabine|decitabine|mesh-list
154744700|NCT01593670|Interleukin-2|interleukin-2|mesh-list
154744701|NCT01593670|Vorinostat|vorinostat|mesh-list
154744702|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154744703|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
154744704|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744705|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744706|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744707|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744708|NCT01593670|Analgesics|analgesics|mesh-ancestor
154744709|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
154744710|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744711|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744712|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154744713|NCT01593748|Gemcitabine|gemcitabine|mesh-list
154744714|NCT01593748|Docetaxel|docetaxel|mesh-list
154744715|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154744716|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
154744717|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744718|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744719|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
154744720|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
154744721|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
154744722|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
154744723|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154744724|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
154744725|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744726|NCT03005704|Aspirin|aspirin|mesh-list
154744727|NCT03005704|Ticagrelor|ticagrelor|mesh-list
154744728|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154744729|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154744730|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154744731|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154744732|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
154744733|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744734|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744735|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744736|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154744737|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154744738|NCT03005704|Analgesics|analgesics|mesh-ancestor
154744739|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
154744740|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744741|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744742|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154744743|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154744744|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154744745|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154744746|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744748|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
154744749|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154744750|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744751|NCT01595854|Dabigatran|dabigatran|mesh-list
154744752|NCT01595854|Ticagrelor|ticagrelor|mesh-list
154744753|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154744754|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154744755|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154744756|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154744757|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
154744758|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744759|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744760|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744761|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
154744762|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154744763|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
154744764|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744765|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
154744766|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
154744767|NCT01596088|Razoxane|razoxane|mesh-list
154744768|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744769|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154744770|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154744771|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154744772|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744773|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744774|NCT01596088|Protective Agents|protective agents|mesh-ancestor
154744775|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744776|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
154744777|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
154744778|NCT02228382|Bosutinib|bosutinib|mesh-list
154744779|NCT02228382|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154744780|NCT02228382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154744781|NCT02228382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744782|NCT02228382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744783|NCT02216422|Ritonavir|ritonavir|mesh-list
154744784|NCT02216422|Ribavirin|ribavirin|mesh-list
154744785|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154744786|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154744787|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
154744788|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744789|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744790|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154744791|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154744792|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
154744793|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744794|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154744795|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154744796|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
154744797|NCT03001570|Cetuximab|cetuximab|mesh-list
154744798|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744799|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744800|NCT03005548|Morphine|morphine|mesh-list
154744801|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154744802|NCT03005548|Narcotics|narcotics|mesh-ancestor
154744803|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154744804|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744805|NCT03005548|Analgesics|analgesics|mesh-ancestor
154744806|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
154744807|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744808|NCT03373266|Anesthetics|anesthetics|mesh-list
154744809|NCT03373266|Sevoflurane|sevoflurane|mesh-list
154744810|NCT03373266|Isoflurane|isoflurane|mesh-list
154744811|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154744812|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744813|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153586739|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154744814|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154744815|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
154744816|NCT02217904|Islatravir|islatravir|mesh-list
154744817|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
154744818|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744819|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744820|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744821|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154744822|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154744823|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154744824|NCT01900002|Sorafenib|sorafenib|mesh-list
154744825|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744826|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154744827|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744828|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744829|NCT03005002|Durvalumab|durvalumab|mesh-list
154744830|NCT03005002|Ipilimumab|ipilimumab|mesh-list
154744831|NCT03005002|Tremelimumab|tremelimumab|mesh-list
154744832|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
154744833|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154744834|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
154744835|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154744836|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744837|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
154744838|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744839|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154744840|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744841|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
154744842|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154744843|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
154744844|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154744845|NCT03001102|Povidone|povidone|mesh-list
154744846|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744847|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
154744848|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
154744849|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
154744850|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
154744851|NCT03000946|Octreotide|octreotide|mesh-list
154744852|NCT03000946|Somatostatin|somatostatin|mesh-list
154744853|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744854|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154744855|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744856|NCT03000946|Hormones|hormones|mesh-ancestor
154744857|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744858|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744859|NCT03004768|Deucravacitinib|deucravacitinib|mesh-list
154744860|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
154744861|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154744862|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744863|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744864|NCT03005236|Tacrolimus|tacrolimus|mesh-list
154744865|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154744866|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
154744867|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744868|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154744869|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744870|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744871|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
154744872|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744873|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
154744874|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
154744875|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
154744876|NCT02519010|Amlodipine|amlodipine|mesh-list
154744877|NCT02519010|Valsartan|valsartan|mesh-list
154744878|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154744879|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154744880|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154744881|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154744882|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744883|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154744884|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744885|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
154744886|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154744887|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154744888|NCT03004612|Metformin|metformin|mesh-list
154744889|NCT03004612|Linagliptin|linagliptin|mesh-list
154744890|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154744891|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744892|NCT03004612|Incretins|incretins|mesh-ancestor
154744893|NCT03004612|Hormones|hormones|mesh-ancestor
154744894|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744895|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154744896|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
154744897|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744898|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744899|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
154744900|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154744901|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
154744902|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154744903|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
154744904|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744905|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744906|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
154744907|NCT03372486|Bupivacaine|bupivacaine|mesh-list
154744908|NCT03372486|Naloxone|naloxone|mesh-list
154744909|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
154744910|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
154744911|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154744912|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744913|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
154744914|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744915|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154744916|NCT05035888|Phenylephrine|phenylephrine|mesh-list
154744917|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
154744918|NCT05035888|Norepinephrine|norepinephrine|mesh-list
154744919|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154744920|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154744921|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
154744922|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
154744923|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744924|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744925|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
154744926|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
154744927|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
154744928|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153586898|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154744929|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154744930|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154744931|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
154744932|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154744933|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744934|NCT05035888|Protective Agents|protective agents|mesh-ancestor
154744935|NCT03362814|Ritonavir|ritonavir|mesh-list
154744936|NCT03362814|Ribavirin|ribavirin|mesh-list
154744937|NCT03362814|Lactams|lactams|mesh-list
154744938|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154744939|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154744940|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
154744941|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154744942|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154744943|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154744944|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154744945|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
154744946|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744947|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154744948|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154744949|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
154744950|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154744951|NCT03004066|Daptomycin|daptomycin|mesh-list
154744952|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154744953|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154744954|NCT03362736|Ustekinumab|ustekinumab|mesh-list
154744955|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
154744956|NCT03004222|Bupivacaine|bupivacaine|mesh-list
154744957|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
154744958|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
154744959|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154744960|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744961|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
154744962|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744963|NCT03000634|Dexamethasone|dexamethasone|mesh-list
154744964|NCT03000634|Lenalidomide|lenalidomide|mesh-list
154744965|NCT03000634|Bortezomib|bortezomib|mesh-list
154744966|NCT03000634|Elotuzumab|elotuzumab|mesh-list
154744967|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154744968|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
154744969|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
154744970|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154744971|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744972|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154744973|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
154744974|NCT03000634|Hormones|hormones|mesh-ancestor
154744975|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154744976|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154744977|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154744978|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
154744979|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154744980|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154744981|NCT03000634|Growth Substances|growth substances|mesh-ancestor
154744982|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
154744984|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
154744985|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744986|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154744987|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
154744988|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154744989|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154744990|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
154744991|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744992|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
154744993|NCT03000556|Protective Agents|protective agents|mesh-ancestor
154744994|NCT03371862|Liraglutide|liraglutide|mesh-list
154744995|NCT03371862|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154744996|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154744997|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154744998|NCT03371862|Incretins|incretins|mesh-ancestor
154744999|NCT03371862|Hormones|hormones|mesh-ancestor
154745000|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745001|NCT03368430|Melatonin|melatonin|mesh-list
154745002|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
154745003|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745004|NCT03368430|Protective Agents|protective agents|mesh-ancestor
154745005|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745006|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745007|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
154745008|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745009|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
154745010|NCT03003832|Analgesics|analgesics|mesh-list
154745011|NCT03003832|Narcotics|narcotics|mesh-ancestor
154745012|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745013|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745014|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
154745015|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745016|NCT03368352|Melatonin|melatonin|mesh-list
154745017|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
154745018|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745019|NCT03368352|Protective Agents|protective agents|mesh-ancestor
154745020|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745021|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745022|NCT02248012|Everolimus|everolimus|mesh-list
154745023|NCT02248012|Temozolomide|temozolomide|mesh-list
154745024|NCT02248012|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154745025|NCT02248012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154745026|NCT02248012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745027|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745028|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154745029|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
154745030|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745031|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745032|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154745033|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
154745034|NCT03362268|Omeprazole|omeprazole|mesh-list
154745035|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154745036|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154745037|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154745038|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745039|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745040|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154745041|NCT04523844|Brinzolamide|brinzolamide|mesh-list
154745042|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154745043|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154745044|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154745045|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154745046|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
154745047|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745048|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745049|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745050|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154745052|NCT03361878|Metformin|metformin|mesh-list
154745053|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154745054|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745055|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
154745056|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745057|NCT02998606|Naloxegol|naloxegol|mesh-list
154745058|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154745059|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745060|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
154745061|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745062|NCT05365438|Atorvastatin|atorvastatin|mesh-list
154745063|NCT05365438|Ezetimibe|ezetimibe|mesh-list
154745064|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154745065|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154745066|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
154745067|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745068|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154745069|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154745070|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745071|NCT02248168|Pramipexole|pramipexole|mesh-list
154745072|NCT02248168|Dexpramipexole|dexpramipexole|mesh-list
154745073|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
154745074|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745075|NCT02248168|Protective Agents|protective agents|mesh-ancestor
154745076|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745077|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154745078|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154745079|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
154745080|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
154745081|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745082|NCT03002428|Teriparatide|teriparatide|mesh-list
154745083|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154745084|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745085|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154745086|NCT03371550|Docetaxel|docetaxel|mesh-list
154745087|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745088|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
154745089|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
154745090|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
154745091|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745092|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
154745093|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
154745094|NCT05669872|Hematinics|hematinics|mesh-ancestor
154745095|NCT04861948|Bevacizumab|bevacizumab|mesh-list
154745096|NCT04861948|Carboplatin|carboplatin|mesh-list
154745097|NCT04861948|Pemetrexed|pemetrexed|mesh-list
154745098|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154745099|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745100|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154745101|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154745102|NCT04861948|Growth Substances|growth substances|mesh-ancestor
154745103|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745104|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
154745105|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745106|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745107|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153587062|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
153587164|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
153587165|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745108|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154745109|NCT04526028|Fulvestrant|fulvestrant|mesh-list
154745110|NCT04526028|Palbociclib|palbociclib|mesh-list
154745111|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154745112|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745113|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154745114|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154745115|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
154745116|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745117|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745118|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154745119|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745120|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745121|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154745122|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745123|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154745124|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745126|NCT03368274|Hormones|hormones|mesh-ancestor
154745127|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745128|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745129|NCT02247544|Trabectedin|trabectedin|mesh-list
154745130|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154745131|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
154745132|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745133|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745134|NCT03370848|Aspirin|aspirin|mesh-list
154745135|NCT03370848|Psyllium|psyllium|mesh-list
154745136|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154745137|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154745138|NCT03370848|Analgesics|analgesics|mesh-ancestor
154745139|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
154745140|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745141|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745142|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745143|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154745144|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154745145|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154745146|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745147|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154745148|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154745149|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745150|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
154745151|NCT03370848|Cathartics|cathartics|mesh-ancestor
154745152|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154745153|NCT02248792|Methotrexate|methotrexate|mesh-list
154745154|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154745155|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
154745156|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154745157|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745158|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154745159|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
154745160|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745161|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745162|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
154745163|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745164|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154745165|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154745166|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
154745167|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154745168|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154745169|NCT03367728|Ropivacaine|ropivacaine|mesh-list
154745170|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
154745171|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
154745172|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745173|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745174|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
154745175|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745176|NCT02248870|Dexamethasone|dexamethasone|mesh-list
154745177|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745178|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
154745179|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
154745180|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745181|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745182|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154745183|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
154745184|NCT02248870|Hormones|hormones|mesh-ancestor
154745185|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745186|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154745187|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745188|NCT04073056|Bupivacaine|bupivacaine|mesh-list
154745189|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
154745190|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
154745191|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745192|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745193|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
154745194|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745195|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
154745196|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154745197|NCT03361098|Exenatide|exenatide|mesh-list
153587205|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154745198|NCT03361098|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154745199|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745200|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154745201|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745202|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154745203|NCT03361098|Incretins|incretins|mesh-ancestor
154745204|NCT03361098|Hormones|hormones|mesh-ancestor
154745205|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745206|NCT03367494|Bromides|bromides|mesh-list
154745207|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
154745208|NCT05594290|Etoposide|etoposide|mesh-list
154745209|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745210|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154745211|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154745212|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154745213|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745214|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745215|NCT03370380|Aflibercept|aflibercept|mesh-list
154745216|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154745217|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154745218|NCT03370380|Growth Substances|growth substances|mesh-ancestor
154745219|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745220|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
154745221|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745222|NCT03367182|Paclitaxel|paclitaxel|mesh-list
154745223|NCT03367182|Bevacizumab|bevacizumab|mesh-list
154745224|NCT03367182|Doxorubicin|doxorubicin|mesh-list
154745225|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154745226|NCT03367182|Topotecan|topotecan|mesh-list
154745227|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154745228|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745229|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
154745230|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
154745231|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
154745232|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745233|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154745234|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154745235|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154745236|NCT03367182|Growth Substances|growth substances|mesh-ancestor
154745237|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745238|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
154745239|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154745240|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154745241|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154745242|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745243|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154745244|NCT05561764|Imipenem|imipenem|mesh-list
154745245|NCT05561764|Relebactam|relebactam|mesh-list
154745246|NCT05561764|Cilastatin|cilastatin|mesh-list
154745247|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154745248|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745249|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
153587305|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
153587370|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
154745250|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587371|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
154745251|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745252|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154745253|NCT03358212|Denosumab|denosumab|mesh-list
154745254|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154745255|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745256|NCT03109392|Lidocaine|lidocaine|mesh-list
154745257|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
154745258|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
154745259|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745260|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745261|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
154745262|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745263|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154745264|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154745265|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154745266|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154745267|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745268|NCT03357900|Remifentanil|remifentanil|mesh-list
154745269|NCT03357900|Propofol|propofol|mesh-list
154745270|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154745271|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745272|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745273|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154745274|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
154745276|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154745277|NCT03357900|Narcotics|narcotics|mesh-ancestor
154745278|NCT03357900|Analgesics|analgesics|mesh-ancestor
154745279|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
154745280|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745281|NCT04525326|Bevacizumab|bevacizumab|mesh-list
154745282|NCT04525326|Cetuximab|cetuximab|mesh-list
154745283|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154745284|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745285|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154745286|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154745287|NCT04525326|Growth Substances|growth substances|mesh-ancestor
154745288|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745289|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
154745290|NCT03357822|Interferons|interferons|mesh-list
154745291|NCT03357822|Tenofovir|tenofovir|mesh-list
154745292|NCT03357822|Entecavir|entecavir|mesh-list
154745293|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745294|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
154745295|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745296|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154745297|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154745298|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745299|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745300|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154745301|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154745302|NCT03359694|Docetaxel|docetaxel|mesh-list
154745303|NCT03359694|Doxorubicin|doxorubicin|mesh-list
154745304|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154745305|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745306|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
154745307|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
153587374|NCT01780311|Sotalol|sotalol|mesh-list
154745308|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
154745309|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745310|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154745311|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154745312|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154745313|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745314|NCT03123276|Gemcitabine|gemcitabine|mesh-list
154745315|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
154745316|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154745317|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
154745318|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745319|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745320|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154745321|NCT03123276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154745322|NCT03357276|Immunomodulating Agents|immunomodulating agents|mesh-list
154745323|NCT03357276|Immunologic Factors|immunologic factors|mesh-ancestor
154745324|NCT03357276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745325|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154745326|NCT02249026|Buprenorphine|buprenorphine|mesh-list
154745327|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
154745328|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154745329|NCT02249026|Narcotics|narcotics|mesh-ancestor
154745330|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745331|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745332|NCT02249026|Analgesics|analgesics|mesh-ancestor
154745333|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
154745334|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745335|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154745336|NCT04521192|Fluzoparib|fluzoparib|mesh-list
154745337|NCT04521192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154745338|NCT04521192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745339|NCT04521192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745340|NCT04521192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745341|NCT03359070|Miconazole|miconazole|mesh-list
154745342|NCT03359070|Clotrimazole|clotrimazole|mesh-list
154745343|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
154745344|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497317|NCT02840136|Meropenem|meropenem|mesh-list
154745345|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154745346|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154745347|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745348|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745349|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154745350|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
154745351|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745352|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745353|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153587551|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154745354|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154745355|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154745356|NCT03366246|Lidocaine|lidocaine|mesh-list
154745357|NCT03366246|Prilocaine|prilocaine|mesh-list
154745358|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154745359|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
154745360|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
154745361|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745362|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745363|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
154745364|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745365|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154745366|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154745367|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154745368|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154745369|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745370|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154745371|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
154745372|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
154745373|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154745374|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745375|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154745376|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154745377|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154745378|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154745379|NCT04520646|Empagliflozin|empagliflozin|mesh-list
154745380|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154745381|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745382|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154745383|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745384|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
154745385|NCT01624948|Everolimus|everolimus|mesh-list
154745386|NCT01624948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154745387|NCT01624948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154745388|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745389|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745390|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154745391|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
154745392|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745393|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745394|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154745395|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154745396|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
154745397|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154745398|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745399|NCT04520880|Antibodies|antibodies|mesh-list
153587597|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154745400|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
154745401|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
154745402|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
154745403|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745404|NCT03365466|Aspirin|aspirin|mesh-list
154745405|NCT03365466|Heparin|heparin|mesh-list
154745406|NCT03365466|Calcium heparin|calcium heparin|mesh-list
154745407|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154745408|NCT03365466|Tinzaparin|tinzaparin|mesh-list
154745409|NCT03365466|Dalteparin|dalteparin|mesh-list
154745410|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154745411|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154745412|NCT03365466|Analgesics|analgesics|mesh-ancestor
154745413|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
154745414|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745415|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745416|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745417|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154745418|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154745419|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154745420|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745421|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154745422|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154745423|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745424|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
154745425|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
154745427|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154745428|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745429|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745430|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
154745431|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154745432|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154745433|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154745434|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154745435|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745436|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
154745437|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745438|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745439|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154745440|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745441|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
154745442|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154745443|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
154745444|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745445|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
154745446|NCT03365388|Protective Agents|protective agents|mesh-ancestor
154745447|NCT03123744|Palbociclib|palbociclib|mesh-list
154745448|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745449|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154745450|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745451|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745452|NCT03358524|Vitamins|vitamins|mesh-list
154745453|NCT03358524|Vitamin E|vitamin e|mesh-list
154745454|NCT03358524|Tocopherols|tocopherols|mesh-list
154745455|NCT03358524|Tocotrienols|tocotrienols|mesh-list
154745456|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
154745457|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
154745458|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745459|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
154745460|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745461|NCT03358524|Protective Agents|protective agents|mesh-ancestor
154745462|NCT04444986|Favipiravir|favipiravir|mesh-list
154745463|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
154745464|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745465|NCT03356730|Vitamin D|vitamin d|mesh-list
154745466|NCT03356730|Vitamins|vitamins|mesh-ancestor
154745467|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
154745468|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745469|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154745470|NCT03364998|Factor VIII|factor viii|mesh-list
154745471|NCT03364998|Coagulants|coagulants|mesh-ancestor
154745472|NCT04508946|Thiamine|thiamine|mesh-list
154745473|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
154745474|NCT04508946|Vitamins|vitamins|mesh-ancestor
154745475|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
154745476|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745477|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745478|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
154745479|NCT03364842|Furosemide|furosemide|mesh-list
154745480|NCT03364842|Diuretics|diuretics|mesh-ancestor
154745481|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
154745482|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745483|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154745484|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154745485|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745486|NCT03364764|Sirolimus|sirolimus|mesh-list
154745487|NCT03364764|Temsirolimus|temsirolimus|mesh-list
154745488|NCT03364764|MTOR Inhibitors|mtor inhibitors|mesh-list
154745489|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154745490|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745491|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154745492|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745493|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
154745494|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154745495|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
154745496|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745497|NCT03364764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154745498|NCT03364764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745499|NCT03364764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745500|NCT02519400|Amitriptyline|amitriptyline|mesh-list
154745501|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154745502|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
154745503|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154745504|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154745505|NCT02519400|Analgesics|analgesics|mesh-ancestor
154745506|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
154745507|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745508|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745509|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154745510|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154745511|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154745512|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745513|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
154745514|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745515|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
154745516|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
154745517|NCT04509258|Ondansetron|ondansetron|mesh-list
154745518|NCT04509258|Mineral Oil|mineral oil|mesh-list
154745519|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154745520|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
154745521|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
154745522|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745523|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745524|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154745525|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
154745526|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
154745527|NCT04509258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154745528|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154745529|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
154745530|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745531|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745532|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
154745533|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745534|NCT04509258|Expectorants|expectorants|mesh-ancestor
154745535|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
154745536|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154745537|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
154745538|NCT04509258|Protective Agents|protective agents|mesh-ancestor
154745539|NCT04509258|Antidotes|antidotes|mesh-ancestor
154745540|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
154745541|NCT04509258|Vitamins|vitamins|mesh-ancestor
154745542|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
154745543|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
154745544|NCT04509258|Emollients|emollients|mesh-ancestor
154745545|NCT03354624|Mitogens|mitogens|mesh-list
154745546|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
154745547|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745548|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
154745549|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154745550|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
154745551|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745552|NCT03364218|Expectorants|expectorants|mesh-ancestor
154745553|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
154745554|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154745555|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
154745556|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745557|NCT03364218|Protective Agents|protective agents|mesh-ancestor
154745558|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745559|NCT03364218|Antidotes|antidotes|mesh-ancestor
154745560|NCT04444284|Vaccines|vaccines|mesh-list
154745561|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
154745562|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745563|NCT03354312|Lidocaine|lidocaine|mesh-list
154745564|NCT03354312|Epinephrine|epinephrine|mesh-list
154745565|NCT03354312|Racepinephrine|racepinephrine|mesh-list
154745566|NCT03354312|Carticaine|carticaine|mesh-list
154745567|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
154745568|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
154745569|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
154745570|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745571|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745572|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
154745573|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745574|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154745575|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154745576|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154745577|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154745578|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745579|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154745580|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153587829|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154745581|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
154745582|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745583|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154745584|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154745585|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
154745586|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154745587|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
154745588|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
154745589|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
154745590|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154745591|NCT03363984|Midazolam|midazolam|mesh-list
154745592|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154745593|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154745594|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745595|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745596|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154745597|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154745598|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154745599|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154745600|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
154745601|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
154745602|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
154745603|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
154745604|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745605|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745606|NCT03355716|Fentanyl|fentanyl|mesh-list
154745607|NCT03355716|Ketamine|ketamine|mesh-list
154745608|NCT03355716|Morphine|morphine|mesh-list
154745609|NCT03355716|Bupivacaine|bupivacaine|mesh-list
154745610|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
154745611|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
154745612|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745613|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745614|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
154745615|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745616|NCT03355716|Analgesics|analgesics|mesh-ancestor
154745617|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154745618|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154745619|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
154745620|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154745621|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154745622|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745623|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745624|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154745625|NCT03355716|Narcotics|narcotics|mesh-ancestor
154745626|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154745627|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
154745628|NCT03355638|Aflibercept|aflibercept|mesh-list
154745629|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154745630|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154745631|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154745632|NCT03355638|Growth Substances|growth substances|mesh-ancestor
154745633|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745634|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
154745635|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745636|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154745637|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154745638|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154745639|NCT03355638|Analgesics|analgesics|mesh-ancestor
154745640|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
154745641|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745642|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745643|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154745644|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
154745645|NCT01626664|Gemcitabine|gemcitabine|mesh-list
154745646|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
154745647|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
154497608|NCT01366131|Paclitaxel|paclitaxel|mesh-list
154745648|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154745649|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
154745650|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745651|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745652|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
154745653|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154745654|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154745655|NCT04515966|Prednisolone|prednisolone|mesh-list
154745656|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
154745657|NCT04515966|Lidocaine|lidocaine|mesh-list
154745658|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154745659|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
154745660|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
154745661|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
154745662|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745663|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745664|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
154745665|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745666|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154745667|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154745668|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154745669|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154745670|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745671|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745672|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
154745673|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
154745674|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154745675|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
154745676|NCT04515966|Hormones|hormones|mesh-ancestor
154745677|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745678|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154745679|NCT04515966|Protective Agents|protective agents|mesh-ancestor
154745680|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154745681|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745682|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154745683|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154745684|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745685|NCT03355248|Acetaminophen|acetaminophen|mesh-list
154745686|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154745687|NCT03355248|Oxycodone|oxycodone|mesh-list
154745688|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154745689|NCT03355248|Analgesics|analgesics|mesh-ancestor
154745690|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
154745691|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745692|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745693|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
154745694|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154745695|NCT03355248|Narcotics|narcotics|mesh-ancestor
154745696|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745697|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154745698|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153587941|NCT01784913|Sargramostim|sargramostim|mesh-list
154745699|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154745700|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154745701|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154745702|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154745703|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154745704|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745705|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745706|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745707|NCT03350334|Analgesics|analgesics|mesh-ancestor
154745708|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
154745709|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745710|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
154745711|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154745712|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
154745713|NCT02230696|Fluticasone|fluticasone|mesh-list
154745714|NCT02230696|Xhance|xhance|mesh-list
154745715|NCT02230696|Azelastine|azelastine|mesh-list
154745716|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745717|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154745718|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
154745719|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745720|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745721|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154745722|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
154745723|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
154745724|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154745725|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154745726|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745727|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745728|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154745729|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154745730|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
154745731|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
154745732|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745734|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154745735|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745736|NCT02231086|Leucovorin|leucovorin|mesh-list
154745737|NCT02231086|Capecitabine|capecitabine|mesh-list
154745738|NCT02231086|Fluorouracil|fluorouracil|mesh-list
154745739|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
154745740|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154745741|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
154745742|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745743|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745744|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154745745|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
154745746|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745747|NCT02231086|Antidotes|antidotes|mesh-ancestor
154745748|NCT02231086|Protective Agents|protective agents|mesh-ancestor
154745749|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
154745750|NCT02231086|Vitamins|vitamins|mesh-ancestor
154745751|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
154745752|NCT03353298|Allopurinol|allopurinol|mesh-list
154745753|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
154745754|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745755|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745756|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
154745757|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154745758|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154745759|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
154745760|NCT03353298|Protective Agents|protective agents|mesh-ancestor
154745761|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745762|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154745763|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154745764|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745765|NCT03187210|Immunotoxins|immunotoxins|mesh-ancestor
154745766|NCT03187210|Immunoconjugates|immunoconjugates|mesh-ancestor
154745767|NCT03187210|Immunologic Factors|immunologic factors|mesh-ancestor
154745768|NCT03187210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745769|NCT03349866|Capecitabine|capecitabine|mesh-list
154745770|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
154745771|NCT03349866|Apatinib|apatinib|mesh-list
154745772|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154745773|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
154745774|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745775|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745776|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154745777|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745778|NCT01631110|Vaccines|vaccines|mesh-list
154745779|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
154745780|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745781|NCT01631656|Azelaic acid|azelaic acid|mesh-list
154745782|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745783|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
154745784|NCT02985190|Azacitidine|azacitidine|mesh-list
154745785|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154745786|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
154745787|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745788|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745789|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745790|NCT01376310|Paclitaxel|paclitaxel|mesh-list
154745791|NCT01376310|Docetaxel|docetaxel|mesh-list
154745792|NCT01376310|Carboplatin|carboplatin|mesh-list
154745793|NCT01376310|Gemcitabine|gemcitabine|mesh-list
154745794|NCT01376310|Pemetrexed|pemetrexed|mesh-list
154745795|NCT01376310|Everolimus|everolimus|mesh-list
154745796|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154745797|NCT01376310|Trametinib|trametinib|mesh-list
153588077|NCT01785693|Clonidine|clonidine|mesh-list
153588149|NCT01786018|Cyclosporins|cyclosporins|mesh-list
154745798|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154745799|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745800|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
154745801|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
154745802|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
154745803|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745804|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154745805|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
154745806|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745807|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154745808|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154745809|NCT01376310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154745810|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154745811|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154745812|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
154745813|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745814|NCT01376310|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154745815|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
154745816|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154745817|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745818|NCT01638052|Clonidine|clonidine|mesh-list
154745819|NCT01638052|Bupivacaine|bupivacaine|mesh-list
154745820|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
154745821|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
154745822|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745823|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745824|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
154745825|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745826|NCT01638052|Analgesics|analgesics|mesh-ancestor
154745827|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154745828|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
154745829|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
154745830|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154745831|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154745832|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154745833|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
154745834|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745835|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745836|NCT02518152|Alendronate|alendronate|mesh-list
154745837|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154745838|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745839|NCT01229878|Vitamin D|vitamin d|mesh-list
154745840|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
154745841|NCT01229878|Vitamins|vitamins|mesh-ancestor
154745842|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
154745843|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745844|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154745845|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154745846|NCT03352674|Insulin|insulin|mesh-list
154745847|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154745848|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
154745849|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154745850|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745851|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
154745852|NCT01639222|Vitamin D|vitamin d|mesh-list
154745853|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
154745854|NCT01639222|Calcium|calcium|mesh-list
154745855|NCT01639222|Vitamins|vitamins|mesh-ancestor
154745856|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
154745857|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745858|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154745859|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154745860|NCT04443270|Chloroquine|chloroquine|mesh-list
154745861|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154745862|NCT04443270|Amebicides|amebicides|mesh-ancestor
154745863|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154745864|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154745865|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745866|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
154745867|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154745868|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154745869|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154745870|NCT04443270|Analgesics|analgesics|mesh-ancestor
154745871|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
154745872|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745873|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745874|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745875|NCT04443270|Filaricides|filaricides|mesh-ancestor
154745876|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
154745877|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
154745878|NCT03349008|Entecavir|entecavir|mesh-list
154497833|NCT01111773|Lidocaine|lidocaine|mesh-list
154745879|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154745880|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
154745881|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745882|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745883|NCT03352362|Acetaminophen|acetaminophen|mesh-list
154745884|NCT03352362|Ibuprofen|ibuprofen|mesh-list
154745885|NCT03352362|Propacetamol|propacetamol|mesh-list
154745886|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154745887|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154745888|NCT03352362|Analgesics|analgesics|mesh-ancestor
154745889|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
154745890|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745891|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745892|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745893|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154745894|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154745895|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745896|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745897|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
154745898|NCT01598740|Spironolactone|spironolactone|mesh-list
154745899|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154745900|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
154745901|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745902|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745903|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154745904|NCT01598740|Diuretics|diuretics|mesh-ancestor
154745905|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
154745906|NCT00709098|Iloprost|iloprost|mesh-list
154745907|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154745908|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
154745909|NCT03348696|Dexamethasone|dexamethasone|mesh-list
154745910|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
154745911|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154745912|NCT03348696|BB 1101|bb 1101|mesh-list
154745913|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154745914|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
154745915|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
154745916|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154745917|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745918|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154745919|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
154745920|NCT03348696|Hormones|hormones|mesh-ancestor
154745921|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745922|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154745923|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745924|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
154745925|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745926|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745927|NCT04506450|Anesthetics|anesthetics|mesh-list
154745928|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154745929|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745930|NCT03352128|Calcium|calcium|mesh-list
154745931|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154745932|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745933|NCT03122730|Epoprostenol|epoprostenol|mesh-list
154745934|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154745935|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154745936|NCT04505904|Oxytocin|oxytocin|mesh-list
154745937|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
154745938|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154745939|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745940|NCT03348462|Anthralin|anthralin|mesh-list
154745941|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
154745942|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154745943|NCT04505514|Hematinics|hematinics|mesh-ancestor
154745944|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
154745945|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154745946|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154745947|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745948|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
154745949|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
154745950|NCT05098704|Clopidogrel|clopidogrel|mesh-list
154745951|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154745952|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154745953|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154745954|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154745955|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
154745956|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154745957|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745958|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745959|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
154745960|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
154745961|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154745962|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154745963|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154745964|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745965|NCT05584956|Urological Agents|urological agents|mesh-ancestor
154745966|NCT01376700|Factor VIII|factor viii|mesh-list
154745967|NCT01376700|Coagulants|coagulants|mesh-ancestor
153588499|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154745968|NCT01797965|Daclizumab|daclizumab|mesh-list
154745969|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154745970|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
154745971|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745972|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154745973|NCT01601236|Hormones|hormones|mesh-ancestor
154745974|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154745975|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745976|NCT05584878|Chitosan|chitosan|mesh-list
154745977|NCT05584878|Calcium|calcium|mesh-list
154745978|NCT05584878|Caseins|caseins|mesh-list
154745979|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154745980|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154745981|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
154745982|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
154745983|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745984|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154745985|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154745986|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
154745987|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154745988|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
154745989|NCT05584878|Coagulants|coagulants|mesh-ancestor
154745990|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154745991|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154745992|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154745993|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745994|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
154745995|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154745996|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
154745997|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154745998|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154745999|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
154746000|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
154746001|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746002|NCT03347916|Gabapentin|gabapentin|mesh-list
154746003|NCT03347916|Analgesics|analgesics|mesh-ancestor
154746004|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
154746005|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746006|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746007|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
154746008|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154746009|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154746010|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746011|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154746012|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154746013|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154746014|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588501|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154746015|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746016|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
154746017|NCT01821677|Danazol|danazol|mesh-list
154746018|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154746019|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
154746020|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746021|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746022|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
154746023|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154746024|NCT00709722|Gusperimus|gusperimus|mesh-list
154746025|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154746026|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746027|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746028|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746029|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154746030|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
154746031|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154746032|NCT00709722|Protective Agents|protective agents|mesh-ancestor
154746033|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154746034|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
154746035|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154746036|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154746037|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154746038|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746040|NCT02253108|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154746041|NCT02253108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154746042|NCT02253108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746043|NCT02253108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746044|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154746045|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
154746046|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746047|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746048|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
154746049|NCT01603420|Docetaxel|docetaxel|mesh-list
154746050|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
154746051|NCT01603420|Hormones|hormones|mesh-list
154746052|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154746053|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154746054|NCT01603420|Androgens|androgens|mesh-list
154746055|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746056|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
154746057|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
154746058|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
154746059|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746060|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746061|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746062|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
154746063|NCT01603420|Protective Agents|protective agents|mesh-ancestor
154746064|NCT01603420|Vitamins|vitamins|mesh-ancestor
154746065|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
154746066|NCT01603420|Estrogens|estrogens|mesh-ancestor
154746067|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154746068|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
154746069|NCT02064036|Leuprolide|leuprolide|mesh-list
154746070|NCT02064036|Goserelin|goserelin|mesh-list
154746071|NCT02064036|Bicalutamide|bicalutamide|mesh-list
154746072|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154746073|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
154746074|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154746075|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746076|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154746077|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746078|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
154746079|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
154746080|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746081|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154746082|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154746083|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746084|NCT04551300|Sevelamer|sevelamer|mesh-list
154746085|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
154746086|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
154746087|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746088|NCT04974580|Nicotine|nicotine|mesh-list
154746089|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154746090|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
154746091|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746092|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746093|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154746094|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154746095|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
154746096|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746097|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746098|NCT01691326|Vaccines|vaccines|mesh-list
154746099|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
154746100|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746101|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
154746102|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154746103|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746104|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746105|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154746106|NCT01606852|Analgesics|analgesics|mesh-ancestor
154746107|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
154746108|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746109|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154746110|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154746111|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154746112|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
154746113|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746114|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746115|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
154746116|NCT01691560|Listerine|listerine|mesh-list
154746117|NCT01691560|Calcium|calcium|mesh-list
154746118|NCT01691560|Fluorides|fluorides|mesh-list
154746119|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
154746120|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
154746121|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154746122|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746123|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154746124|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
154746125|NCT01691560|Protective Agents|protective agents|mesh-ancestor
154746126|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154746127|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746128|NCT03346200|Tamoxifen|tamoxifen|mesh-list
154746129|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154746130|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
154746131|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746132|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746133|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154746134|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746135|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154746136|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154746137|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154746138|NCT01692340|Lycopene|lycopene|mesh-list
154746139|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154746140|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
154746141|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746142|NCT01692340|Protective Agents|protective agents|mesh-ancestor
154746143|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746144|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154746145|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154746146|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746147|NCT02517372|Pemirolast|pemirolast|mesh-list
154746148|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
154746149|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
154746150|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746151|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746152|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746153|NCT02516826|Olmesartan|olmesartan|mesh-list
154746154|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154746155|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154746156|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154746157|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154746158|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
154746159|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746160|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154746161|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154746162|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746163|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154746164|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154746165|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154746166|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
154746167|NCT01650298|Thrombin|thrombin|mesh-list
154746168|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
154746169|NCT01650298|Coagulants|coagulants|mesh-ancestor
154746170|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
154746171|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154746172|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
154746173|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746174|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746175|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
153588822|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153588823|NCT01796132|Sertraline|sertraline|mesh-list
154746176|NCT01795937|Itraconazole|itraconazole|mesh-list
154746177|NCT01795937|Atorvastatin|atorvastatin|mesh-list
154746178|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154498132|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154746179|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154746180|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154746181|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
154746182|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746183|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154746184|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154746185|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746186|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
154746187|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746188|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154746189|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154746190|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154746191|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
154746192|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746193|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746194|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154746195|NCT04501224|Tenofovir|tenofovir|mesh-list
154746196|NCT04501224|Entecavir|entecavir|mesh-list
154746197|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
154746198|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746199|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154746200|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154746201|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746202|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746203|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154746204|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154746205|NCT01817777|Metformin|metformin|mesh-list
154746206|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746207|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746208|NCT01795547|Aripiprazole|aripiprazole|mesh-list
154746209|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154746210|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
154746211|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154746212|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154746213|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154746214|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746215|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746216|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
154746217|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
154746218|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588824|NCT01796132|Escitalopram|escitalopram|mesh-list
153466275|NCT00353418|Ribavirin|ribavirin|mesh-list
154746219|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746220|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154746221|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154746222|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
154746223|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154746224|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154746225|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154746226|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154746227|NCT02516904|Rezafungin|rezafungin|mesh-list
154746228|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
154746229|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746230|NCT01794845|Docetaxel|docetaxel|mesh-list
154746231|NCT01794845|Cetuximab|cetuximab|mesh-list
154746232|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746233|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
154746234|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
154746235|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
154746236|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746237|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154746238|NCT01794689|Morphine|morphine|mesh-list
154746239|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154746240|NCT01794689|Narcotics|narcotics|mesh-ancestor
154746241|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746242|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746243|NCT01794689|Analgesics|analgesics|mesh-ancestor
154746244|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
154746245|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746246|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
154746247|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154746248|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154746249|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746250|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
154746251|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
154746252|NCT00708552|Donepezil|donepezil|mesh-list
154498208|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154746253|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154746254|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746255|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746256|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
154746257|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746258|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746259|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
154746260|NCT02516436|Buprenorphine|buprenorphine|mesh-list
154746261|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154746262|NCT02516436|Narcotics|narcotics|mesh-ancestor
154746263|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746264|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746265|NCT02516436|Analgesics|analgesics|mesh-ancestor
154746266|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
154746267|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746268|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154746269|NCT03347526|Vigabatrin|vigabatrin|mesh-list
154746270|NCT03347526|Cosyntropin|cosyntropin|mesh-list
154746271|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
154746272|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746273|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746274|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
154746275|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746276|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746277|NCT03347526|Hormones|hormones|mesh-ancestor
154746278|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746279|NCT03347370|Interferons|interferons|mesh-list
154746280|NCT03347370|Interferon-beta|interferon-beta|mesh-list
154746281|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
154746282|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
154746283|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746284|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
154746285|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746286|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
154746287|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746288|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154746289|NCT02515968|Propofol|propofol|mesh-list
154746290|NCT02515968|Desflurane|desflurane|mesh-list
154746291|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154746292|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746293|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746294|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154746295|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
154746296|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
154746297|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154746298|NCT03345966|Antibodies|antibodies|mesh-list
154746299|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
154746300|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746301|NCT02507700|Bupivacaine|bupivacaine|mesh-list
154746302|NCT02507700|Sevoflurane|sevoflurane|mesh-list
154746303|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
154746304|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
154746305|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746306|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746307|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
154746308|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746309|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154746310|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154746311|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
154746312|NCT02513004|Clopidogrel|clopidogrel|mesh-list
154746313|NCT02513004|Ticagrelor|ticagrelor|mesh-list
154746314|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154746315|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154746316|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154746317|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154746318|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
154746319|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746320|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746321|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746322|NCT04500522|Isoniazid|isoniazid|mesh-list
154746323|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
154746324|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154498286|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154746325|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746326|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154746327|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154746328|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
154746329|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589015|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746330|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154746331|NCT02507232|Temozolomide|temozolomide|mesh-list
154746332|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154746333|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
154746334|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746335|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746336|NCT02506998|Histamine|histamine|mesh-list
154746337|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
154746338|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154746339|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
154746340|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
154746341|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
154746342|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746343|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746344|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746345|NCT02507076|Melphalan|melphalan|mesh-list
154746346|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154746347|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
154746348|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746349|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746350|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154746351|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154746352|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
154746353|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746354|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154746355|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154746356|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154746357|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154746358|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746359|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746360|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746361|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154746362|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
154746363|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154746364|NCT04500678|Metformin|metformin|mesh-list
154746365|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746366|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746367|NCT02507154|Cetuximab|cetuximab|mesh-list
154746368|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154746369|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746370|NCT02515734|Leucovorin|leucovorin|mesh-list
154746371|NCT02515734|Bevacizumab|bevacizumab|mesh-list
154746372|NCT02515734|Cetuximab|cetuximab|mesh-list
154746373|NCT02515734|Fluorouracil|fluorouracil|mesh-list
154746374|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
154746375|NCT02515734|Irinotecan|irinotecan|mesh-list
154746376|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154746377|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746378|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154746379|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154746380|NCT02515734|Growth Substances|growth substances|mesh-ancestor
154746381|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746382|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
154746383|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
154746384|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746385|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154746386|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154746387|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
154746388|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154746389|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154746390|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746391|NCT02515734|Antidotes|antidotes|mesh-ancestor
154746392|NCT02515734|Protective Agents|protective agents|mesh-ancestor
154746393|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
154746394|NCT02515734|Vitamins|vitamins|mesh-ancestor
154746395|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
154746396|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
154746397|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154746398|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154746399|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154746400|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154746401|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746402|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
154746403|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746404|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746405|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154746406|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746408|NCT02506842|Folic Acid|folic acid|mesh-list
154746409|NCT02506842|Gemcitabine|gemcitabine|mesh-list
154746410|NCT02506842|Fluorouracil|fluorouracil|mesh-list
154746411|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
154746412|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
154746413|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746414|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746415|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154746416|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
154746417|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154746418|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
154746419|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746420|NCT02506842|Antidotes|antidotes|mesh-ancestor
154746421|NCT02506842|Protective Agents|protective agents|mesh-ancestor
154746422|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
154746423|NCT02506842|Vitamins|vitamins|mesh-ancestor
154746424|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
154746425|NCT02506842|Hematinics|hematinics|mesh-ancestor
154746426|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
154746427|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154746428|NCT03345498|Entecavir|entecavir|mesh-list
154746429|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
154746430|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746431|NCT02506686|Meropenem|meropenem|mesh-list
154746432|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154746433|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746434|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154746435|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154746436|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746437|NCT02512380|Docetaxel|docetaxel|mesh-list
154746438|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
154746439|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746440|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
154746441|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
154746442|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
154746443|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746444|NCT04497792|Metformin|metformin|mesh-list
154746445|NCT04497792|Empagliflozin|empagliflozin|mesh-list
154746446|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154746447|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746448|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154746449|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746450|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
154746451|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154746452|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154746453|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154746454|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154746455|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746456|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
154746457|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746458|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746459|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154746460|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746461|NCT02515422|Ketamine|ketamine|mesh-list
154746462|NCT02515422|Bupivacaine|bupivacaine|mesh-list
154746463|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
154746464|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
154746465|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746466|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746467|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
154746468|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746469|NCT02515422|Analgesics|analgesics|mesh-ancestor
154746470|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154746471|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154746472|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
154746473|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154746474|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154746475|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746476|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746477|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154746478|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
154746479|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746480|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746481|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746482|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746484|NCT02506140|Clopidogrel|clopidogrel|mesh-list
154746485|NCT02506140|Ticagrelor|ticagrelor|mesh-list
154746486|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154746487|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154746488|NCT02506140|Analgesics|analgesics|mesh-ancestor
154746489|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
154746490|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746491|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746492|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154746493|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154746494|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154746495|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154746496|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746497|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154746498|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154746499|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746500|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
154746501|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154746502|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154746503|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154746504|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
154746505|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746506|NCT02515188|Acetaminophen|acetaminophen|mesh-list
154746507|NCT02515188|Propacetamol|propacetamol|mesh-list
154746508|NCT02515188|Analgesics|analgesics|mesh-ancestor
154746509|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
154746510|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746511|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746512|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154746513|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154746514|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154746515|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154746516|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
154746517|NCT01696084|Cytarabine|cytarabine|mesh-list
154746518|NCT01696084|Daunorubicin|daunorubicin|mesh-list
154746519|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154746520|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
154746521|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746522|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746523|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
154746524|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746525|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154746526|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
154746527|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746528|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154746529|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154746530|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154746531|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746532|NCT02228824|Nicotine|nicotine|mesh-list
154746533|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154746534|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
154746535|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746536|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746537|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154746538|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154746539|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
154746540|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746541|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746542|NCT02511366|Caseins|caseins|mesh-list
154746543|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
154746544|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
154746545|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746546|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
154746547|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746548|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746549|NCT04443036|Paclitaxel|paclitaxel|mesh-list
154746550|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154746551|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154746552|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746553|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
154746554|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
154746555|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
154746556|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746557|NCT01653418|Cytarabine|cytarabine|mesh-list
154746558|NCT01653418|Etoposide|etoposide|mesh-list
154746559|NCT01653418|Bortezomib|bortezomib|mesh-list
154746560|NCT01653418|Melphalan|melphalan|mesh-list
154746561|NCT01653418|Carmustine|carmustine|mesh-list
154746562|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154746563|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746564|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154746565|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154746566|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589332|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154746567|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746568|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154746569|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
154746570|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
154746571|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746572|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154746573|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
154746574|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746575|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154746576|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
154746577|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154746578|NCT02514642|Clopidogrel|clopidogrel|mesh-list
154746579|NCT02514642|Ticagrelor|ticagrelor|mesh-list
154746580|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154746581|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154746582|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154746583|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154746584|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
154746585|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746586|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746587|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746588|NCT02511210|Anesthetics|anesthetics|mesh-list
154746589|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746590|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746591|NCT02237950|Metronidazole|metronidazole|mesh-list
154746592|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746593|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154746594|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154746595|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154746596|NCT02511054|Chloroquine|chloroquine|mesh-list
154746597|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
154746598|NCT02511054|Amebicides|amebicides|mesh-ancestor
154746599|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154746600|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154746601|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746602|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
154746603|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154746604|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154746605|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746606|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746607|NCT04499118|Paclitaxel|paclitaxel|mesh-list
154746608|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154746609|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154746610|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746611|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154746612|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154746613|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154746614|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746615|NCT01612546|Camptothecin|camptothecin|mesh-list
154746616|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154746617|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746618|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154746619|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154746620|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746621|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746622|NCT04499898|Carvedilol|carvedilol|mesh-list
154746623|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153589429|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154746624|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154746625|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
154746626|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746627|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746628|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746629|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154746630|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
154746631|NCT04499898|Protective Agents|protective agents|mesh-ancestor
154746632|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154746633|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154746634|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154746635|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
154746636|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154746637|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154746638|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
154746639|NCT02514330|Vitamins|vitamins|mesh-ancestor
154746640|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
154746641|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746642|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154746643|NCT02510976|Prucalopride|prucalopride|mesh-list
154746644|NCT02510976|Laxatives|laxatives|mesh-ancestor
154746645|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154746646|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154746647|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154746648|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
154746649|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746650|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746651|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746652|NCT02505516|Metformin|metformin|mesh-list
154746653|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746654|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746655|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
154746656|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154746657|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
154746658|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746659|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
153589436|NCT01803503|Sunitinib|sunitinib|mesh-list
154746660|NCT02505360|Protective Agents|protective agents|mesh-ancestor
154746661|NCT04499586|Irinotecan|irinotecan|mesh-list
154746662|NCT04499586|Raltitrexed|raltitrexed|mesh-list
154746663|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154746664|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154746665|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746666|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746667|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746668|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154746669|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
154746670|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154746671|NCT02505282|Vitamin K|vitamin k|mesh-list
154746672|NCT02505282|Vitamins|vitamins|mesh-ancestor
154746673|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
154746674|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746675|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154746676|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154746677|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746678|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
154746679|NCT02505282|Coagulants|coagulants|mesh-ancestor
154746680|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
154746681|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154746682|NCT01816295|Testosterone|testosterone|mesh-list
154746683|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
154746684|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
154746685|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154746686|NCT01816295|Androgens|androgens|mesh-ancestor
154746687|NCT01816295|Hormones|hormones|mesh-ancestor
154746688|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746689|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746690|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154746691|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746692|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
154746693|NCT02514018|Vaccines|vaccines|mesh-list
154746694|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
154746695|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746696|NCT02513862|Heparin|heparin|mesh-list
154746697|NCT02513862|Protamines|protamines|mesh-list
154746698|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
154746699|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154746700|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154746701|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746702|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
154746703|NCT02513862|Coagulants|coagulants|mesh-ancestor
154746704|NCT02510586|Sevoflurane|sevoflurane|mesh-list
154746705|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154746706|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154746707|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
154746708|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
154746709|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746710|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746711|NCT01610297|Deferasirox|deferasirox|mesh-list
154746712|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154746713|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
154746714|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
154746715|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746716|NCT01660672|Levetiracetam|levetiracetam|mesh-list
154746717|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
154746718|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
154746720|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154746721|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746722|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746723|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746724|NCT01793051|Minocycline|minocycline|mesh-list
154746725|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154746726|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746727|NCT01792115|Vitamins|vitamins|mesh-list
154746728|NCT01792115|Vitamin E|vitamin e|mesh-list
154746729|NCT01792115|Tocopherols|tocopherols|mesh-list
154746730|NCT01792115|Tocotrienols|tocotrienols|mesh-list
154746731|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
154746732|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
154746733|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746734|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
154746735|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746736|NCT01792115|Protective Agents|protective agents|mesh-ancestor
154746737|NCT01791803|Nicotine|nicotine|mesh-list
154746738|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154746739|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
154746740|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746741|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746742|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154746743|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154746744|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
154746745|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746746|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746747|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154746748|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
154746749|NCT01662856|Coagulants|coagulants|mesh-ancestor
154746750|NCT04499976|Misoprostol|misoprostol|mesh-list
154746751|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154746752|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
154746753|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154746754|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746755|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154746756|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154746757|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
154746758|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154746759|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
154746760|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154746761|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154746762|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154746763|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
154746764|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154746765|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746766|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154746767|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154746768|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154746769|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154746770|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746771|NCT02509806|Apatinib|apatinib|mesh-list
154746772|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746773|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154746774|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781669|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
154746775|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746776|NCT02509728|Choline|choline|mesh-list
154746777|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
154746778|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154746779|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
154746780|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498732|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154746781|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154746782|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154746783|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
154746784|NCT02501616|Metformin|metformin|mesh-list
154746785|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
154746786|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746787|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746788|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154746789|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746790|NCT01788215|Doxycycline|doxycycline|mesh-list
154746791|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154746792|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746793|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
154746794|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154746795|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154746796|NCT01812707|Atorvastatin|atorvastatin|mesh-list
154746797|NCT01812707|Alirocumab|alirocumab|mesh-list
154746798|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154746799|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154746800|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154746801|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
154746802|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746803|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154746804|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154746805|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746806|NCT01812707|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154746807|NCT01812707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154746808|NCT01812707|Protease Inhibitors|protease inhibitors|mesh-ancestor
154746809|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
154746810|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746811|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154746812|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
154746813|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746814|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
154746815|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154746816|NCT02728206|Velpatasvir|velpatasvir|mesh-list
154746817|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
154746818|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746819|NCT01811225|Progesterone|progesterone|mesh-list
154746820|NCT01811225|Progestins|progestins|mesh-ancestor
154746821|NCT01811225|Hormones|hormones|mesh-ancestor
154746822|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746823|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746824|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154746825|NCT02508870|Azacitidine|azacitidine|mesh-list
154746826|NCT02508870|Atezolizumab|atezolizumab|mesh-list
154746827|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154746828|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
154746829|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746830|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746831|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746832|NCT02508870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154746833|NCT02508870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154746834|NCT01786109|Dronabinol|dronabinol|mesh-list
154746835|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
153589628|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154746836|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746837|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154746838|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154746839|NCT01786109|Analgesics|analgesics|mesh-ancestor
154746840|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
154746841|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746842|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154746843|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154746844|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746845|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746846|NCT01786109|Hormones|hormones|mesh-ancestor
154746847|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746848|NCT02509104|Tamsulosin|tamsulosin|mesh-list
154746849|NCT02509104|Dutasteride|dutasteride|mesh-list
154746850|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154746851|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154746852|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154746853|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
154746854|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154746855|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746856|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746857|NCT02509104|Urological Agents|urological agents|mesh-ancestor
154746858|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154746859|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154746860|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746861|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
154746862|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746863|NCT02500680|Vaccines|vaccines|mesh-list
154746864|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
154746865|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746866|NCT02500446|Dolutegravir|dolutegravir|mesh-list
154746867|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154746868|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154746869|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746870|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746871|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154746872|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154746873|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
154746874|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746875|NCT02500524|Permethrin|permethrin|mesh-list
154746876|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746877|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746878|NCT02508402|Dexamethasone|dexamethasone|mesh-list
154746879|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154746880|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
154746881|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
154746882|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746883|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746884|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154746885|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
154746886|NCT02508402|Hormones|hormones|mesh-ancestor
154746887|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746888|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154746889|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746890|NCT02500212|Tacrolimus|tacrolimus|mesh-list
154746891|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154746892|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
153589729|NCT01808495|Mitomycins|mitomycins|mesh-list
153589730|NCT01808495|Mitomycin|mitomycin|mesh-list
154746893|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746894|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154746895|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746896|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746897|NCT02508168|Metformin|metformin|mesh-list
154746898|NCT02508168|Alogliptin|alogliptin|mesh-list
154746899|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746900|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746901|NCT02508168|Incretins|incretins|mesh-ancestor
154746902|NCT02508168|Hormones|hormones|mesh-ancestor
154746903|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154746904|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154746905|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
154746906|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746907|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746908|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154746909|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154746910|NCT02508246|Cisplatin|cisplatin|mesh-list
154746911|NCT02508246|Docetaxel|docetaxel|mesh-list
154746912|NCT02508246|Adavosertib|adavosertib|mesh-list
154746913|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746914|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
154746915|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
154746916|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
154746917|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746918|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746919|NCT01617148|Aflibercept|aflibercept|mesh-list
154746920|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154746921|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154746922|NCT01617148|Growth Substances|growth substances|mesh-ancestor
154746923|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746924|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
154746925|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746926|NCT02499978|Dolutegravir|dolutegravir|mesh-list
154746927|NCT02499978|Darunavir|darunavir|mesh-list
154746928|NCT02499978|Cobicistat|cobicistat|mesh-list
154746929|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154746930|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154746931|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154746932|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589731|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153589786|NCT01808898|Bupivacaine|bupivacaine|mesh-list
154746933|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746934|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154746935|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154746936|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
154746937|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154746938|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154746939|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154746940|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
154746941|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154746942|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154746943|NCT01620190|Paclitaxel|paclitaxel|mesh-list
154746944|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154746945|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154746946|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746947|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
154746948|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
154746949|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
154746950|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746951|NCT04498884|Insulin|insulin|mesh-list
154746952|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154746953|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154746954|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746955|NCT01621672|Lenalidomide|lenalidomide|mesh-list
154746956|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
154746957|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746958|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154746959|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154746960|NCT01621672|Growth Substances|growth substances|mesh-ancestor
154746961|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
154746962|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746963|NCT03344328|Bortezomib|bortezomib|mesh-list
154746964|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746965|NCT02499822|Ramipril|ramipril|mesh-list
154746966|NCT02499822|Nifedipine|nifedipine|mesh-list
154746967|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153589788|NCT01808898|Mepivacaine|mepivacaine|mesh-list
154746968|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
154746969|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746970|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746971|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154746972|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154746973|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154746974|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154746975|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746976|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
154746977|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
154746978|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154746979|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
154746980|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154746981|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154746982|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154746983|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154746984|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746985|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
154746986|NCT03343548|Analgesics|analgesics|mesh-ancestor
154746987|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
154746988|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154746989|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154746990|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
154746991|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154746992|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154746993|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
154746994|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154746995|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154746996|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154746997|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154746998|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
154746999|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154747000|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
154747001|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154747002|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
154747003|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747004|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
154498958|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154747005|NCT02507934|Protective Agents|protective agents|mesh-ancestor
154747007|NCT01622296|Epinephrine|epinephrine|mesh-list
154747008|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
154747009|NCT01622296|Anesthetics|anesthetics|mesh-list
154747010|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747011|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747012|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
154747013|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747014|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153589890|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747015|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154747016|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154747017|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154747018|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747019|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154747020|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154747021|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
154747022|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747023|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154747024|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154747025|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
154747026|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154747027|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
154747028|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
154747029|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
154747030|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154747031|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154747032|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154747033|NCT01705288|Morphine|morphine|mesh-list
154747034|NCT01705288|Narcotics|narcotics|mesh-list
154747035|NCT01705288|Anesthetics|anesthetics|mesh-list
154747036|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747037|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747038|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747039|NCT01705288|Analgesics|analgesics|mesh-ancestor
154747040|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
154747041|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747042|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154747043|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154747044|NCT03343002|Fentanyl|fentanyl|mesh-list
154747045|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747046|NCT03343002|Narcotics|narcotics|mesh-ancestor
154747047|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747048|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747049|NCT03343002|Analgesics|analgesics|mesh-ancestor
154747050|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
154747051|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747052|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154747053|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747054|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
154747055|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
154747056|NCT03120936|Tenofovir|tenofovir|mesh-list
154747057|NCT03120936|Emtricitabine|emtricitabine|mesh-list
154747058|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
154747059|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747060|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154747061|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154747062|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747063|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747064|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153589952|NCT01810458|Lidocaine|lidocaine|mesh-list
154747065|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154747066|NCT02234752|Memantine|memantine|mesh-list
154747067|NCT02234752|Galantamine|galantamine|mesh-list
154747068|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154747069|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154747070|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
154747071|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747072|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747073|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747074|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154747075|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154747076|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154747077|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747078|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
154747079|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154747080|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
154747081|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747082|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
154747083|NCT01665508|Nebivolol|nebivolol|mesh-list
154747084|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154747085|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
154747086|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154747087|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154747088|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154747089|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
154747090|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747091|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747092|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747093|NCT03344094|Interferons|interferons|mesh-list
154747094|NCT03344094|Interferon-beta|interferon-beta|mesh-list
154747095|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
154747096|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747097|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
154747098|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747099|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
154747100|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747101|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
154747102|NCT02498496|Analgesics|analgesics|mesh-ancestor
154747103|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
154747104|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747105|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747106|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
154747107|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747108|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154747109|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
154747110|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154747111|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154747112|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747113|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154747114|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
154747115|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154747116|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
154747117|NCT02502708|Temozolomide|temozolomide|mesh-list
154747118|NCT02502708|Etoposide|etoposide|mesh-list
154747119|NCT02502708|Tryptophan|tryptophan|mesh-list
154747120|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154747121|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
154747122|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747123|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154747124|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153590028|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
154747125|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
154747126|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747127|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747128|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154747129|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154747130|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154747131|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154747132|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747133|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154747134|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
154747135|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747136|NCT01666210|Dexamethasone|dexamethasone|mesh-list
154747137|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747138|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
154747139|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
154747140|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747141|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747142|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154747143|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
154747144|NCT01666210|Hormones|hormones|mesh-ancestor
154747145|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747146|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154747147|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747148|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
154747149|NCT01666912|Etonogestrel|etonogestrel|mesh-list
154747150|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154747151|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747152|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154747153|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154747154|NCT03341988|Ritonavir|ritonavir|mesh-list
154747155|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154747156|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154747157|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
154747158|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747159|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747160|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154747161|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154747162|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
154747163|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747164|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154747165|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154747166|NCT02501850|Metformin|metformin|mesh-list
154747167|NCT02501850|Liraglutide|liraglutide|mesh-list
154747168|NCT02501850|Exenatide|exenatide|mesh-list
154747169|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154747170|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747171|NCT02501850|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154747172|NCT02501850|Incretins|incretins|mesh-ancestor
154747173|NCT02501850|Hormones|hormones|mesh-ancestor
154747174|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747175|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154747176|NCT01709032|Deferasirox|deferasirox|mesh-list
154747177|NCT01709032|Deferiprone|deferiprone|mesh-list
154747178|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154747179|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
154747180|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
154747181|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747182|NCT02496078|Asunaprevir|asunaprevir|mesh-list
154747183|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
154747184|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747185|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590108|NCT01811251|Analgesics|analgesics|mesh-ancestor
154747186|NCT02495922|Dexamethasone|dexamethasone|mesh-list
154747187|NCT02495922|Lenalidomide|lenalidomide|mesh-list
154747188|NCT02495922|Bortezomib|bortezomib|mesh-list
154747189|NCT02495922|Elotuzumab|elotuzumab|mesh-list
154747190|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747191|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
154747192|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
154747193|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747194|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747195|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154747196|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
154747197|NCT02495922|Hormones|hormones|mesh-ancestor
154747198|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747199|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154747200|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747201|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
154747202|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154747203|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154747204|NCT02495922|Growth Substances|growth substances|mesh-ancestor
154747205|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
154747206|NCT01709422|Midazolam|midazolam|mesh-list
154747207|NCT01709422|Meperidine|meperidine|mesh-list
154747208|NCT01709422|Propofol|propofol|mesh-list
154747209|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154747210|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747211|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747212|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747213|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
154747214|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
154747215|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154747216|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154747217|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154747218|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747219|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
154747220|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
154747221|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747222|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747223|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747224|NCT01709422|Narcotics|narcotics|mesh-ancestor
154747225|NCT01709422|Analgesics|analgesics|mesh-ancestor
154747226|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
154747227|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747228|NCT01669642|Ketamine|ketamine|mesh-list
154747229|NCT01669642|Analgesics|analgesics|mesh-ancestor
154747230|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
154747231|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747232|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747233|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154747235|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
154747236|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
154747237|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747238|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154747239|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154747240|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747241|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747242|NCT01669720|Aflibercept|aflibercept|mesh-list
154747243|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154747244|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154747245|NCT01669720|Growth Substances|growth substances|mesh-ancestor
154747246|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747247|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
154747248|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747249|NCT01670110|Pasireotide|pasireotide|mesh-list
154747250|NCT01670110|Hormones|hormones|mesh-ancestor
154747251|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747252|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747253|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154747254|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154747255|NCT01677286|Doxycycline|doxycycline|mesh-list
154747256|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154747257|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747258|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
154747259|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154747260|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154747261|NCT04498260|Triamcinolone|triamcinolone|mesh-list
154747262|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154747263|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154747264|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154747265|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747266|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
154747267|NCT04498260|Hormones|hormones|mesh-ancestor
154747268|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747269|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747270|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154747271|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
154747272|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747273|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747274|NCT01680172|Ketamine|ketamine|mesh-list
154747275|NCT01680172|Analgesics|analgesics|mesh-ancestor
154747276|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
154747277|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747278|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747279|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154747280|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747281|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
154747282|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
154747283|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747284|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154747285|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154747286|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747287|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747288|NCT02235064|Sertraline|sertraline|mesh-list
154747289|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
154747290|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747291|NCT02235064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154747292|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154747293|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154747294|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747295|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747296|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
154747297|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747298|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154747299|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
154747300|NCT01681030|Coagulants|coagulants|mesh-ancestor
154747301|NCT02249416|Ritonavir|ritonavir|mesh-list
154747302|NCT02249416|Zidovudine|zidovudine|mesh-list
154747303|NCT02249416|Tipranavir|tipranavir|mesh-list
154747304|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154747305|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154747306|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
154747307|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747308|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747309|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154747310|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154747311|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
154747312|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747313|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154747314|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154747315|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
154747316|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154747317|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154747318|NCT01685242|Cetirizine|cetirizine|mesh-list
154747319|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154747320|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154747321|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154747322|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
154747323|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
154747324|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747325|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747326|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747327|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
154747328|NCT00708162|Elvitegravir|elvitegravir|mesh-list
154747329|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154747330|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154747331|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
154747332|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747333|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154747334|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154747335|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747336|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747337|NCT04930042|Ustekinumab|ustekinumab|mesh-list
154747338|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
154747339|NCT04898920|Dexamethasone|dexamethasone|mesh-list
154747340|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747341|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
154747342|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
154747343|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747344|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747345|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154747346|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
154747347|NCT04898920|Hormones|hormones|mesh-ancestor
154747348|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747349|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154747350|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747351|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
154747352|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154747353|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747354|NCT01686646|Acetaminophen|acetaminophen|mesh-list
154747355|NCT01686646|Caffeine|caffeine|mesh-list
154747356|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154747357|NCT01686646|Analgesics|analgesics|mesh-ancestor
154747358|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
154747359|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747360|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747361|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
154747362|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154747363|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154747364|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747365|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747366|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154747367|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154747368|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
154747369|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747370|NCT02495688|Anesthetics|anesthetics|mesh-list
154747371|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747372|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747373|NCT01688596|Bupivacaine|bupivacaine|mesh-list
154747374|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
154747375|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
154747376|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747377|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747378|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
154747379|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747380|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154747381|NCT04869592|Vaccines|vaccines|mesh-list
154499332|NCT05489692|Fluorouracil|fluorouracil|mesh-list
154747382|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
154747383|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747384|NCT01690000|Melatonin|melatonin|mesh-list
154747385|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
154747386|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747387|NCT01690000|Protective Agents|protective agents|mesh-ancestor
154747388|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747389|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747390|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
154747391|NCT02495220|Bupivacaine|bupivacaine|mesh-list
154747392|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
154747393|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
154747394|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747395|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747396|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
154747397|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747398|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154747399|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154747400|NCT02495220|Analgesics|analgesics|mesh-ancestor
154747401|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154747402|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154747403|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154747404|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
154747405|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747406|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747407|NCT01690546|Naltrexone|naltrexone|mesh-list
154747408|NCT01690546|Buprenorphine|buprenorphine|mesh-list
154747409|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154747410|NCT01690546|Naloxone|naloxone|mesh-list
154747411|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747412|NCT01690546|Narcotics|narcotics|mesh-ancestor
154747413|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747414|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747415|NCT01690546|Analgesics|analgesics|mesh-ancestor
154747416|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
154747417|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747418|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154747419|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154747420|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
154747421|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747422|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
154747423|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747424|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747425|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
154747426|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154747427|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747428|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747429|NCT02494830|Ketamine|ketamine|mesh-list
154747430|NCT02494830|Analgesics|analgesics|mesh-ancestor
154747431|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
154747432|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747433|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747434|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154747435|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747436|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
154747437|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
154747438|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747439|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154747440|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154747441|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747442|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747443|NCT03336840|Metformin|metformin|mesh-list
154747444|NCT03336840|Promethazine|promethazine|mesh-list
154747445|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
154747446|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154747447|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747448|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
154747449|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
154747450|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154747451|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
154747452|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
154747453|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747454|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747455|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154747456|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154747457|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154747458|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747459|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
154747461|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
154747462|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747463|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
154747464|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
154747465|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154747466|NCT02497638|Metformin|metformin|mesh-list
154747467|NCT02497638|Biguanides|biguanides|mesh-list
154747468|NCT02497638|Atorvastatin|atorvastatin|mesh-list
154747469|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154747470|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747471|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154747472|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154747473|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
154747474|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747475|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154747476|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154747477|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747478|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
154747479|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747480|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
154747481|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154747482|NCT02493192|Meperidine|meperidine|mesh-list
154747483|NCT02493192|Haloperidol|haloperidol|mesh-list
154747484|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
154747485|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
153590931|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154747486|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
154747487|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747488|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747489|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154747490|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154747491|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154747492|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747493|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747494|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154747495|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
154747496|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747497|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747498|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154747499|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747500|NCT02493192|Narcotics|narcotics|mesh-ancestor
154747501|NCT02493192|Analgesics|analgesics|mesh-ancestor
154747502|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
154747503|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154747504|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
154747505|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154747506|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
154747507|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154747508|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
154747509|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747510|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747511|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
154747512|NCT02238808|Estradiol|estradiol|mesh-list
154747513|NCT02238808|Estrogens|estrogens|mesh-list
154747514|NCT02238808|Hormones|hormones|mesh-ancestor
154747515|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747516|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747517|NCT02497326|Heparin|heparin|mesh-list
154747518|NCT02497326|Tramadol|tramadol|mesh-list
154747519|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
154747520|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154747521|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154747522|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747523|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747524|NCT02497326|Narcotics|narcotics|mesh-ancestor
154747525|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747526|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747527|NCT02497326|Analgesics|analgesics|mesh-ancestor
154747528|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
154747529|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747530|NCT02245672|Fluticasone|fluticasone|mesh-list
154499481|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747531|NCT02245672|Xhance|xhance|mesh-list
154747532|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154747533|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747534|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154747535|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
154747536|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747537|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747538|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154747539|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
154747540|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
154747541|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154747542|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154747543|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154747544|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154747545|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
154747546|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747547|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747548|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
154747550|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747551|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747552|NCT03335904|Losartan|losartan|mesh-list
154747553|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154747554|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154747555|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154747556|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154747557|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747558|NCT03335826|Anesthetics|anesthetics|mesh-list
154747559|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747560|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747561|NCT03340740|Cetirizine|cetirizine|mesh-list
154747562|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154747563|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154747564|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154747565|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
154747566|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
154747567|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747568|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747569|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747570|NCT03340662|Itraconazole|itraconazole|mesh-list
154747571|NCT03340662|Rifampin|rifampin|mesh-list
154747572|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
154747573|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
154747574|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747575|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154747576|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154747577|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747578|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747579|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154747580|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
154747581|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747582|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747583|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154747584|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154747585|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
154747586|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154747587|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
154747588|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154747589|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154747590|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154747591|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154747592|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154747593|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154747594|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154747595|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154747596|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154747597|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747598|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747599|NCT03340662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154747600|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154747601|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154747602|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499557|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
154747603|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
154747604|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154747605|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
154747606|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154747607|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154747608|NCT03342300|Doxorubicin|doxorubicin|mesh-list
154747609|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154747610|NCT03342300|Pirarubicin|pirarubicin|mesh-list
154747611|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154747612|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747613|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154747614|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154747615|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747616|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747617|NCT01711918|Domperidone|domperidone|mesh-list
154747618|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
154747619|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
154747620|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747621|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747622|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154747623|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154747624|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
154747625|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747626|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747628|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
154747629|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154747630|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
154747631|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154747632|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747633|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
154747634|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747635|NCT03120468|Expectorants|expectorants|mesh-ancestor
154747636|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
154747637|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154747638|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
154747639|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747640|NCT03120468|Protective Agents|protective agents|mesh-ancestor
154747641|NCT03120468|Antidotes|antidotes|mesh-ancestor
154747642|NCT01712230|Leuprolide|leuprolide|mesh-list
154747643|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154747644|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
154747645|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154747646|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747647|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154747648|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747649|NCT03335436|Gabapentin|gabapentin|mesh-list
154747650|NCT03335436|Analgesics|analgesics|mesh-ancestor
154747651|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
154747652|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747653|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747654|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
154747655|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154747656|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154747657|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747658|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747659|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154747660|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154747661|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747662|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747663|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
154747664|NCT02494284|Aspirin|aspirin|mesh-list
154747665|NCT02494284|Clopidogrel|clopidogrel|mesh-list
154747666|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154747667|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154747668|NCT02494284|Analgesics|analgesics|mesh-ancestor
154747669|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
154747670|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747671|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747672|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747673|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154747674|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154747675|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154747676|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747677|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154747678|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154747679|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747680|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
154747681|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154747682|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154747683|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154747684|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
154747685|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747686|NCT01713400|Sirolimus|sirolimus|mesh-list
154747687|NCT01713400|Ustekinumab|ustekinumab|mesh-list
154747688|NCT01713400|Tacrolimus|tacrolimus|mesh-list
154747689|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154747690|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
154747691|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747692|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154747693|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747694|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747695|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154747696|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747697|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154747698|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747699|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
154747700|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
154747701|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
154747702|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154747703|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747704|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747705|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154747706|NCT04494828|Analgesics|analgesics|mesh-ancestor
154747707|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
154747708|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747709|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154747710|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154747711|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154747712|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
154747713|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747714|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747715|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
154747716|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154747717|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154747718|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747719|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
154747720|NCT01714336|Coagulants|coagulants|mesh-ancestor
154747721|NCT01716208|Ofatumumab|ofatumumab|mesh-list
154747722|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747723|NCT00706992|Aldesleukin|aldesleukin|mesh-list
154747724|NCT00706992|Vaccines|vaccines|mesh-list
154747725|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
153593120|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593121|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154747726|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
154747727|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747728|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747729|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154747730|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154747731|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
154747732|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747733|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154747734|NCT03335124|Vitamins|vitamins|mesh-list
154747735|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
154747736|NCT03335124|Thiamine|thiamine|mesh-list
154747737|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
154747738|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
154747739|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747740|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747741|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
154747742|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747743|NCT03335124|Protective Agents|protective agents|mesh-ancestor
154747744|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
154747745|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
154747746|NCT03339804|Doxorubicin|doxorubicin|mesh-list
154747747|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154747748|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
154747749|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747750|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154747751|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154747752|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
154747753|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499705|NCT03284294|Vitamin D|vitamin d|mesh-list
154747754|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747755|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154747756|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154747757|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154747758|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154747759|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747760|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154747761|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747762|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747763|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
154747764|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747765|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747766|NCT02491320|Letrozole|letrozole|mesh-list
154747767|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747768|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154747769|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154747770|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593124|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
153593322|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154747771|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747772|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154747773|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
154747774|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747775|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747776|NCT02491242|Dolutegravir|dolutegravir|mesh-list
154747777|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154747778|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154747779|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747780|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747781|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154747782|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154747783|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
154747784|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747785|NCT03330990|Midazolam|midazolam|mesh-list
154747786|NCT03330990|Entrectinib|entrectinib|mesh-list
154747787|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154747788|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154747789|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747790|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747791|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154747792|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154747793|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747794|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747795|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
154747796|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
154747797|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
154747798|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
154747799|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747800|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747801|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154747802|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747803|NCT03339024|Oxytocin|oxytocin|mesh-list
154747804|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
154747805|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154747806|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747807|NCT06038526|Carbon Monoxide|carbon monoxide|mesh-list
154747808|NCT06038526|Antimetabolites|antimetabolites|mesh-ancestor
154747809|NCT06038526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747810|NCT06038526|Gasotransmitters|gasotransmitters|mesh-ancestor
154747811|NCT06038526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747812|NCT06038526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747813|NCT06038461|Temozolomide|temozolomide|mesh-list
154747814|NCT06038461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154747815|NCT06038461|Alkylating Agents|alkylating agents|mesh-ancestor
154747816|NCT06038461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747817|NCT06038461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747818|NCT06038409|Ketamine|ketamine|mesh-list
154747819|NCT06038409|Analgesics|analgesics|mesh-ancestor
154747820|NCT06038409|Sensory System Agents|sensory system agents|mesh-ancestor
154747821|NCT06038409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747822|NCT06038409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747823|NCT06038409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154747824|NCT06038409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747825|NCT06038409|Anesthetics, General|anesthetics, general|mesh-ancestor
154499780|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
154747826|NCT06038409|Anesthetics|anesthetics|mesh-ancestor
154747827|NCT06038409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747828|NCT06038409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154747829|NCT06038409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154747830|NCT06038409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747831|NCT06038409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594311|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154747832|NCT06037577|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
154747833|NCT06037577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747834|NCT06037473|Hormones|hormones|mesh-list
154747835|NCT06037473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747836|NCT06037473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747837|NCT06037395|Denosumab|denosumab|mesh-list
154747838|NCT06037395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154747839|NCT06037395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747840|NCT06036797|Sufentanil|sufentanil|mesh-list
154747841|NCT06036797|Hydromorphone|hydromorphone|mesh-list
154747842|NCT06036797|Ropivacaine|ropivacaine|mesh-list
154747843|NCT06036797|Anesthetics, Local|anesthetics, local|mesh-ancestor
154747844|NCT06036797|Anesthetics|anesthetics|mesh-ancestor
154747845|NCT06036797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747846|NCT06036797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747847|NCT06036797|Sensory System Agents|sensory system agents|mesh-ancestor
154747848|NCT06036797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747849|NCT06036797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747850|NCT06036797|Narcotics|narcotics|mesh-ancestor
154747851|NCT06036797|Analgesics|analgesics|mesh-ancestor
154747852|NCT06036797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154747853|NCT06036797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747854|NCT06036797|Anesthetics, General|anesthetics, general|mesh-ancestor
154747855|NCT06033989|Hyaluronic Acid|hyaluronic acid|mesh-list
154747856|NCT06033989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154747857|NCT06033989|Immunologic Factors|immunologic factors|mesh-ancestor
154747858|NCT06033989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747859|NCT06033989|Viscosupplements|viscosupplements|mesh-ancestor
154747860|NCT06033989|Protective Agents|protective agents|mesh-ancestor
154747861|NCT06033846|Minocycline|minocycline|mesh-list
154747862|NCT06033846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154747863|NCT06033846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154747864|NCT06033729|Midazolam|midazolam|mesh-list
154747865|NCT06033729|Fentanyl|fentanyl|mesh-list
154747866|NCT06033729|Remifentanil|remifentanil|mesh-list
154747867|NCT06033729|Propofol|propofol|mesh-list
154747868|NCT06033729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154747869|NCT06033729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747870|NCT06033729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747871|NCT06033729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747872|NCT06033729|Anesthetics, General|anesthetics, general|mesh-ancestor
154747873|NCT06033729|Anesthetics|anesthetics|mesh-ancestor
154747874|NCT06033729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154747875|NCT06033729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154747876|NCT06033729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154747877|NCT06033729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747878|NCT06033729|GABA Modulators|gaba modulators|mesh-ancestor
154747879|NCT06033729|GABA Agents|gaba agents|mesh-ancestor
154747880|NCT06033729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747881|NCT06033729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747882|NCT06033729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747883|NCT06033729|Narcotics|narcotics|mesh-ancestor
154747884|NCT06033729|Analgesics|analgesics|mesh-ancestor
154747885|NCT06033729|Sensory System Agents|sensory system agents|mesh-ancestor
154747886|NCT06033729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747887|NCT06033612|Midazolam|midazolam|mesh-list
154747888|NCT06033612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154747889|NCT06033612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154747890|NCT06033612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747891|NCT06033612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747892|NCT06033612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154747893|NCT06033612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154747894|NCT06033612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154747895|NCT06033612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154747896|NCT06033612|Anesthetics, General|anesthetics, general|mesh-ancestor
154747897|NCT06033612|Anesthetics|anesthetics|mesh-ancestor
154747898|NCT06033612|GABA Modulators|gaba modulators|mesh-ancestor
154747899|NCT06033612|GABA Agents|gaba agents|mesh-ancestor
154747900|NCT06033612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154747901|NCT06033612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747902|NCT06033469|Adalimumab|adalimumab|mesh-list
154747903|NCT06033469|Infliximab|infliximab|mesh-list
154747904|NCT06033469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154747905|NCT06033469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747906|NCT06033469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154747907|NCT06033469|Dermatologic Agents|dermatologic agents|mesh-ancestor
154747908|NCT06033469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154747909|NCT06033118|Gemcitabine|gemcitabine|mesh-list
154747910|NCT06033118|Oxaliplatin|oxaliplatin|mesh-list
154747911|NCT06033118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154747912|NCT06033118|Antimetabolites|antimetabolites|mesh-ancestor
154747913|NCT06033118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747914|NCT06033118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747915|NCT06032936|Osimertinib|osimertinib|mesh-list
154747916|NCT06032936|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154747917|NCT06032936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154747918|NCT06032936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747919|NCT06032936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747920|NCT06032936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747921|NCT06032858|Apremilast|apremilast|mesh-list
154747922|NCT06032858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154747923|NCT06032858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154747924|NCT06032858|Analgesics|analgesics|mesh-ancestor
154747925|NCT06032858|Sensory System Agents|sensory system agents|mesh-ancestor
154747926|NCT06032858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747927|NCT06032858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747928|NCT06032858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747929|NCT06032858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154747930|NCT06032858|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154747931|NCT06032858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154747932|NCT06032858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747933|NCT06032858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747934|NCT06032845|Lenvatinib|lenvatinib|mesh-list
154747935|NCT06032845|Tislelizumab|tislelizumab|mesh-list
154747936|NCT06032845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747937|NCT06032845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154747938|NCT06032845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747939|NCT06032845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747940|NCT06032845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154747941|NCT06032728|Sunitinib|sunitinib|mesh-list
154747942|NCT06032728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747943|NCT06032728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154747944|NCT06032728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154747945|NCT06032728|Growth Substances|growth substances|mesh-ancestor
154747946|NCT06032728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747947|NCT06032728|Growth Inhibitors|growth inhibitors|mesh-ancestor
154747948|NCT06032728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154747949|NCT06032728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747950|NCT06032728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747951|NCT06031597|Cisplatin|cisplatin|mesh-list
154747952|NCT06031597|Pembrolizumab|pembrolizumab|mesh-list
154747953|NCT06031597|Nivolumab|nivolumab|mesh-list
154747954|NCT06031597|Atezolizumab|atezolizumab|mesh-list
154747955|NCT06031597|Durvalumab|durvalumab|mesh-list
154747956|NCT06031597|Tislelizumab|tislelizumab|mesh-list
154747957|NCT06031597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154747958|NCT06031597|Immunomodulating Agents|immunomodulating agents|mesh-list
154747959|NCT06031597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747960|NCT06031597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154747961|NCT06031597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154747962|NCT06031597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747963|NCT06031597|Immunologic Factors|immunologic factors|mesh-ancestor
154747964|NCT06031597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747965|NCT06016205|Morphine|morphine|mesh-list
154747966|NCT06016205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154747967|NCT06016205|Narcotics|narcotics|mesh-ancestor
154747968|NCT06016205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154747969|NCT06016205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747970|NCT06016205|Analgesics|analgesics|mesh-ancestor
154747971|NCT06016205|Sensory System Agents|sensory system agents|mesh-ancestor
154747972|NCT06016205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747973|NCT06000462|Metformin|metformin|mesh-list
154747974|NCT06000462|Dapagliflozin|dapagliflozin|mesh-list
154747975|NCT06000462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154747976|NCT06000462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747977|NCT06000462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154747978|NCT06000462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747979|NCT05994183|Dexamethasone|dexamethasone|mesh-list
154499929|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
154747980|NCT05994183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154747981|NCT05994183|Antiemetics|antiemetics|mesh-ancestor
154747982|NCT05994183|Autonomic Agents|autonomic agents|mesh-ancestor
154747983|NCT05994183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154747984|NCT05994183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154747985|NCT05994183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154747986|NCT05994183|Glucocorticoids|glucocorticoids|mesh-ancestor
154747987|NCT05994183|Hormones|hormones|mesh-ancestor
154747988|NCT05994183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154747989|NCT05994183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154747990|NCT05994183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747991|NCT05992584|Lenvatinib|lenvatinib|mesh-list
154747992|NCT05992584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154747993|NCT05992584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154747994|NCT05992584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154747995|NCT05992584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154747996|NCT05979948|Rituximab|rituximab|mesh-list
154747997|NCT05979948|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154747998|NCT05979948|Zanubrutinib|zanubrutinib|mesh-list
154747999|NCT05979948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748000|NCT05979948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748001|NCT05979948|Immunologic Factors|immunologic factors|mesh-ancestor
154748002|NCT05979948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748003|NCT05979948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154748004|NCT05979948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154748005|NCT05979948|Alkylating Agents|alkylating agents|mesh-ancestor
154748006|NCT05979948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748007|NCT05979948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154748008|NCT05979948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154748009|NCT05979948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748010|NCT05975671|Vancomycin|vancomycin|mesh-list
154748011|NCT05975671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154748012|NCT05975671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748013|NCT05967741|Erythritol|erythritol|mesh-list
154748014|NCT05967741|Vasodilator Agents|vasodilator agents|mesh-ancestor
154748015|NCT05965219|Metformin|metformin|mesh-list
154748016|NCT05965219|Itraconazole|itraconazole|mesh-list
154748017|NCT05965219|Carbamazepine|carbamazepine|mesh-list
154748018|NCT05965219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748019|NCT05965219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748020|NCT05965219|Antifungal Agents|antifungal agents|mesh-ancestor
154748021|NCT05965219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748022|NCT05965219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154748023|NCT05965219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154748024|NCT05965219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748025|NCT05965219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748026|NCT05965219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154748027|NCT05965219|Hormone Antagonists|hormone antagonists|mesh-ancestor
154748028|NCT05965219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748029|NCT05965219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154748030|NCT05965219|Anticonvulsants|anticonvulsants|mesh-ancestor
154748031|NCT05965219|Antimanic Agents|antimanic agents|mesh-ancestor
154748032|NCT05965219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154748033|NCT05965219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748034|NCT05965219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154748035|NCT05965219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154748036|NCT05965219|Analgesics|analgesics|mesh-ancestor
154748037|NCT05965219|Sensory System Agents|sensory system agents|mesh-ancestor
154748038|NCT05965219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748039|NCT05965219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154748040|NCT05965219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154748041|NCT05965219|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154748042|NCT05965219|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154748043|NCT05946798|Insulin Aspart|insulin aspart|mesh-list
154748044|NCT05946798|Acetylcholine|acetylcholine|mesh-list
154748045|NCT05946798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748046|NCT05946798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748047|NCT05946798|Vasodilator Agents|vasodilator agents|mesh-ancestor
154748048|NCT05946798|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154748049|NCT05946798|Cholinergic Agents|cholinergic agents|mesh-ancestor
154748050|NCT05946798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748051|NCT05946798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748052|NCT05946785|Insulin Aspart|insulin aspart|mesh-list
154748053|NCT05946785|Acetylcholine|acetylcholine|mesh-list
154748054|NCT05946785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748055|NCT05946785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748056|NCT05946785|Vasodilator Agents|vasodilator agents|mesh-ancestor
154748057|NCT05946785|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154748058|NCT05946785|Cholinergic Agents|cholinergic agents|mesh-ancestor
154748059|NCT05946785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748060|NCT05946785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748061|NCT05940961|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154748062|NCT05940961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748063|NCT05940961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748064|NCT05940961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154748065|NCT05940961|Immunotoxins|immunotoxins|mesh-ancestor
154748066|NCT05940961|Immunoconjugates|immunoconjugates|mesh-ancestor
154748067|NCT05940961|Immunologic Factors|immunologic factors|mesh-ancestor
154748068|NCT05940961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748069|NCT05939518|Anesthetics|anesthetics|mesh-list
154748070|NCT05939518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748071|NCT05939518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748072|NCT05934500|Cannabidiol|cannabidiol|mesh-list
154748073|NCT05934500|Anticonvulsants|anticonvulsants|mesh-ancestor
154748074|NCT05920863|Lenvatinib|lenvatinib|mesh-list
154748075|NCT05920863|Tislelizumab|tislelizumab|mesh-list
154748076|NCT05920863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748077|NCT05920863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153595863|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
153596228|NCT01860508|Carboplatin|carboplatin|mesh-list
154748078|NCT05920863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748079|NCT05920863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748080|NCT05920863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748081|NCT05917587|Metformin|metformin|mesh-list
154748082|NCT05917587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748083|NCT05917587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748084|NCT05908799|Pembrolizumab|pembrolizumab|mesh-list
154748085|NCT05908799|Pemetrexed|pemetrexed|mesh-list
154748086|NCT05908799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748087|NCT05908799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748088|NCT05908799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154748089|NCT05908799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748090|NCT05908799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748091|NCT05908799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154748092|NCT05908799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154748093|NCT05906303|Sodium Benzoate|sodium benzoate|mesh-list
154748094|NCT05906303|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
154748095|NCT05906303|Caffeine|caffeine|mesh-list
154748096|NCT05906303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154748097|NCT05906303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748098|NCT05906303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154748099|NCT05906303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748100|NCT05906303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748101|NCT05906303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154748102|NCT05906303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154748103|NCT05906303|Purinergic Agents|purinergic agents|mesh-ancestor
154748104|NCT05906303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748105|NCT05906303|Antifungal Agents|antifungal agents|mesh-ancestor
154748106|NCT05906303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748107|NCT05906303|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154748108|NCT05906303|Protective Agents|protective agents|mesh-ancestor
154748109|NCT05906303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154748110|NCT05906303|Analgesics|analgesics|mesh-ancestor
154748111|NCT05906303|Sensory System Agents|sensory system agents|mesh-ancestor
154748112|NCT05906303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748113|NCT05900427|Bupivacaine|bupivacaine|mesh-list
154748114|NCT05900427|Anesthetics, Local|anesthetics, local|mesh-ancestor
154748115|NCT05900427|Anesthetics|anesthetics|mesh-ancestor
154748116|NCT05900427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748117|NCT05900427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748118|NCT05900427|Sensory System Agents|sensory system agents|mesh-ancestor
154748119|NCT05900427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748120|NCT05897307|Ropivacaine|ropivacaine|mesh-list
154748121|NCT05897307|Anesthetics, Local|anesthetics, local|mesh-ancestor
154748122|NCT05897307|Anesthetics|anesthetics|mesh-ancestor
154748123|NCT05897307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748124|NCT05897307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748125|NCT05897307|Sensory System Agents|sensory system agents|mesh-ancestor
154748126|NCT05897307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596229|NCT01860508|Pemetrexed|pemetrexed|mesh-list
154748127|NCT05897086|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154500078|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
154748128|NCT05897086|Laxatives|laxatives|mesh-ancestor
154748129|NCT05897086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154748130|NCT05896683|Lazertinib|lazertinib|mesh-list
154748131|NCT05896683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154748132|NCT05896683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748133|NCT05896683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748134|NCT05875025|Norflurane|norflurane|mesh-list
154748135|NCT05875025|Anesthetics|anesthetics|mesh-ancestor
154748136|NCT05875025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748137|NCT05875025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748138|NCT05869760|Carotenoids|carotenoids|mesh-list
154748139|NCT05869760|Antioxidants|antioxidants|mesh-ancestor
154748140|NCT05869760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748141|NCT05869760|Protective Agents|protective agents|mesh-ancestor
154748142|NCT05869760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748143|NCT05823623|Vinorelbine|vinorelbine|mesh-list
154748144|NCT05823623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154748145|NCT05823623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748146|NCT05823623|Tubulin Modulators|tubulin modulators|mesh-ancestor
154748147|NCT05823623|Antimitotic Agents|antimitotic agents|mesh-ancestor
154748148|NCT05823623|Mitosis Modulators|mitosis modulators|mesh-ancestor
154748149|NCT05823623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748150|NCT05795309|Insulin|insulin|mesh-list
154748151|NCT05795309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748152|NCT05795309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748153|NCT05750030|Bevacizumab|bevacizumab|mesh-list
154748154|NCT05750030|Atezolizumab|atezolizumab|mesh-list
154748155|NCT05750030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748156|NCT05750030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748157|NCT05750030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154748158|NCT05750030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154748159|NCT05750030|Growth Substances|growth substances|mesh-ancestor
154748160|NCT05750030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748161|NCT05750030|Growth Inhibitors|growth inhibitors|mesh-ancestor
154748162|NCT05750030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154748163|NCT05750030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748164|NCT05742958|Morphine|morphine|mesh-list
154748165|NCT05742958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154748166|NCT05742958|Narcotics|narcotics|mesh-ancestor
154748167|NCT05742958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748168|NCT05742958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748169|NCT05742958|Analgesics|analgesics|mesh-ancestor
154748170|NCT05742958|Sensory System Agents|sensory system agents|mesh-ancestor
154748171|NCT05742958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748172|NCT05735535|Antiviral Agents|antiviral agents|mesh-list
154748173|NCT05735535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748174|NCT05720715|Cyclosporine|cyclosporine|mesh-list
154748175|NCT05720715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154748176|NCT05720715|Cyclosporins|cyclosporins|mesh-list
154748177|NCT05720715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748178|NCT05720715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748179|NCT05720715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154748180|NCT05720715|Immunologic Factors|immunologic factors|mesh-ancestor
154748181|NCT05720715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748182|NCT05720715|Antifungal Agents|antifungal agents|mesh-ancestor
154748183|NCT05720715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748184|NCT05720715|Dermatologic Agents|dermatologic agents|mesh-ancestor
154748185|NCT05720715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154748186|NCT05720715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154748187|NCT05720715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154748188|NCT05680792|Ritonavir|ritonavir|mesh-list
154748189|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154748190|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
154748191|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154748192|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154748193|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
153596853|NCT01864616|Vitamin D|vitamin d|mesh-list
153597384|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597973|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748194|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748195|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748196|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154748197|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154748198|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
154748199|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748200|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154748201|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154748202|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154748203|NCT05655598|Palbociclib|palbociclib|mesh-list
154748204|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748205|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154748206|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748207|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748208|NCT05617742|FAPI-46|fapi-46|mesh-list
154748209|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154748210|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748211|NCT05598580|Lenalidomide|lenalidomide|mesh-list
154748212|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
154748213|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748214|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154748215|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154748216|NCT05598580|Growth Substances|growth substances|mesh-ancestor
154748217|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
154748218|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748219|NCT05597280|Rifampin|rifampin|mesh-list
154748220|NCT05597280|Bedaquiline|bedaquiline|mesh-list
154748221|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154748222|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
154748223|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154748224|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748225|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
154748226|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154748227|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748228|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748229|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154748230|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154748231|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154748232|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154748233|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154748234|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154748235|NCT05593757|Quinidine|quinidine|mesh-list
154748236|NCT05593757|Verapamil|verapamil|mesh-list
154748237|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154748238|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154748239|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154748240|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748241|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154748242|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748243|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
154748244|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154748245|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154748246|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
154748247|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748248|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
154748249|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154748250|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154748251|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748252|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748253|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153598820|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154748254|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154748255|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
154748256|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154748257|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154748258|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154748259|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154748260|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154748261|NCT05548283|Lactams|lactams|mesh-list
154748262|NCT05548283|beta-Lactams|beta-lactams|mesh-list
154748263|NCT05548283|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
154748264|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748265|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
154748266|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
154748267|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
154748268|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748269|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748270|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
154748271|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748272|NCT05527704|Albuterol|albuterol|mesh-list
154748273|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154748274|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
154748275|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748276|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748277|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154748278|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
154748279|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
154748280|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154748281|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154748282|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154748283|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154748284|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
154748285|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748286|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748287|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
154748288|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748289|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748290|NCT05465954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154748291|NCT05465954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748292|NCT05454358|Letrozole|letrozole|mesh-list
154748293|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748294|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154748295|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154748296|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748297|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748298|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154748299|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
154748300|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748301|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748302|NCT05364190|Empagliflozin|empagliflozin|mesh-list
154748303|NCT05364190|Canagliflozin|canagliflozin|mesh-list
154748304|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154748305|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748306|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748307|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748308|NCT05315479|Meloxicam|meloxicam|mesh-list
154748309|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154748310|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154748311|NCT05315479|Analgesics|analgesics|mesh-ancestor
154748312|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
154748313|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748314|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748315|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154748316|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154748317|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154748318|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154748319|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748320|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748321|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154748322|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
154748323|NCT05311254|Fosfomycin|fosfomycin|mesh-list
154748324|NCT05311254|Calcium|calcium|mesh-list
154748325|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154748326|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748327|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154748328|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748329|NCT05299580|Trametinib|trametinib|mesh-list
154748330|NCT05299580|Dabrafenib|dabrafenib|mesh-list
154748331|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748332|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154748333|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748334|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748335|NCT05278676|Dotinurad|dotinurad|mesh-list
154748336|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
154748337|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
154748338|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154748339|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154748340|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748341|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748342|NCT05197075|Darunavir|darunavir|mesh-list
154748343|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154748344|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154748345|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
154748346|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748347|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748348|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154748349|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154748350|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
154748351|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500307|NCT02743221|Growth Substances|growth substances|mesh-ancestor
154748353|NCT05168735|Analgesics|analgesics|mesh-ancestor
154748354|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
154748355|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748356|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748357|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154748358|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154748359|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
154748360|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
154748361|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748362|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154748363|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154748364|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748365|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748366|NCT05070104|Bevacizumab|bevacizumab|mesh-list
154748367|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748368|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748369|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154748370|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154748371|NCT05070104|Growth Substances|growth substances|mesh-ancestor
154748372|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748373|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
154748374|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
154748375|NCT05063513|Rituximab|rituximab|mesh-list
154748376|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748377|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748378|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
154748379|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748380|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154748381|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154748382|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154748383|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
154748384|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154748385|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748386|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748387|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748388|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154748389|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748390|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748391|NCT04962009|Travoprost|travoprost|mesh-list
154748392|NCT04962009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154748393|NCT04954599|Carboplatin|carboplatin|mesh-list
154748394|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
154748395|NCT04954599|Nivolumab|nivolumab|mesh-list
154748396|NCT04954599|Ipilimumab|ipilimumab|mesh-list
154748397|NCT04954599|Atezolizumab|atezolizumab|mesh-list
154748398|NCT04954599|Durvalumab|durvalumab|mesh-list
154748399|NCT04954599|Avelumab|avelumab|mesh-list
154748400|NCT04954599|Cemiplimab|cemiplimab|mesh-list
154748401|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154748402|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748403|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748404|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748405|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154748406|NCT04926545|Fluorouracil|fluorouracil|mesh-list
154748407|NCT04926545|Irinotecan|irinotecan|mesh-list
154748408|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
154748409|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748410|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154748411|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748412|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154748413|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
154748414|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748415|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154748416|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154748417|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748418|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154748419|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
154748420|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748421|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154748422|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154748423|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154748424|NCT04916548|Ketamine|ketamine|mesh-list
154748425|NCT04916548|Analgesics|analgesics|mesh-ancestor
154500382|NCT02281305|Colchicine|colchicine|mesh-list
154748426|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
154748427|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748428|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748429|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154748430|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154748431|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
154748432|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
154748433|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748434|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154748435|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154748436|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748437|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748438|NCT04848480|Insulin|insulin|mesh-list
154748439|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154748440|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
154748441|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748442|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748443|NCT04841018|Dexamethasone|dexamethasone|mesh-list
154748444|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
154748445|NCT04841018|BB 1101|bb 1101|mesh-list
154748446|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154748447|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
154748448|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
154748449|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748450|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748451|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154748452|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
154748453|NCT04841018|Hormones|hormones|mesh-ancestor
154748454|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748455|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154748456|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748457|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
154748458|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748459|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748460|NCT04837859|Tislelizumab|tislelizumab|mesh-list
154748461|NCT04837859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748462|NCT04837859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748463|NCT04837066|Imidacloprid|imidacloprid|mesh-list
154748464|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
154748465|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748466|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748467|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748468|NCT04833855|Omalizumab|omalizumab|mesh-list
154748469|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154748470|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154748471|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154748472|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
154748473|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
154748474|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748475|NCT04788823|Prednisone|prednisone|mesh-list
154748476|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154748477|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
154748478|NCT04788823|Hormones|hormones|mesh-ancestor
154748479|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748480|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748481|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154748482|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748483|NCT04747496|Edoxaban|edoxaban|mesh-list
154748484|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154748485|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
154748486|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154748487|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
154748488|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748489|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748490|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
154748491|NCT04747145|Temozolomide|temozolomide|mesh-list
154748492|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154748493|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
154748494|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748495|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748496|NCT04729205|Mitomycins|mitomycins|mesh-list
154748497|NCT04729205|Mitomycin|mitomycin|mesh-list
154748498|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154748499|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748500|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
154748501|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748502|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153599263|NCT01874002|Sirolimus|sirolimus|mesh-list
154748503|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748504|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
154748505|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154748506|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154748507|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
154748508|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154748509|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748510|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
154748511|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
154748512|NCT04665648|Nicorandil|nicorandil|mesh-list
154748513|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154748514|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154748515|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
154748516|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
154748517|NCT04665648|Vitamins|vitamins|mesh-ancestor
154748518|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
154748519|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748520|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
154748521|NCT04637594|Nivolumab|nivolumab|mesh-list
154748522|NCT04637594|Atezolizumab|atezolizumab|mesh-list
154748523|NCT04637594|Durvalumab|durvalumab|mesh-list
154748524|NCT04637594|Avelumab|avelumab|mesh-list
154748525|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748526|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748527|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154748528|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748529|NCT04623099|Escitalopram|escitalopram|mesh-list
154748530|NCT04623099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154748531|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154748532|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154748533|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748534|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748535|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
154748536|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748537|NCT04619680|Nintedanib|nintedanib|mesh-list
154748538|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748539|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154748540|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748541|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748542|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154748543|NCT04579367|Ezetimibe|ezetimibe|mesh-list
154748544|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154748545|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154748546|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
154748547|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748548|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154748549|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748550|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748551|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748552|NCT04572256|Montelukast|montelukast|mesh-list
154748553|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154748554|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
154748555|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154748556|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
154748557|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748558|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748559|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154748560|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154748561|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748562|NCT04571580|Reteplase|reteplase|mesh-list
154748563|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154748564|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153599321|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748565|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154748566|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748567|NCT04567108|Benzocaine|benzocaine|mesh-list
154748568|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
154748569|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
154748570|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748571|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748572|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
154748573|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500530|NCT03250910|Ribavirin|ribavirin|mesh-list
154748574|NCT04542070|Rilpivirine|rilpivirine|mesh-list
154748575|NCT04542070|Cabotegravir|cabotegravir|mesh-list
154748576|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154748577|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154748578|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748579|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748580|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
154748581|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748582|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154748583|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154748584|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154748585|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154748586|NCT04538950|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154748587|NCT04538950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748588|NCT04530305|Upadacitinib|upadacitinib|mesh-list
154748589|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154748590|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154748591|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748592|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748593|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154748594|NCT04513951|Leucovorin|leucovorin|mesh-list
154748595|NCT04513951|Fluorouracil|fluorouracil|mesh-list
154748596|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
154748597|NCT04513951|Irinotecan|irinotecan|mesh-list
154748598|NCT04513951|Cetuximab|cetuximab|mesh-list
154748599|NCT04513951|Avelumab|avelumab|mesh-list
154748600|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
154748601|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
154748602|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748603|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154748604|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748605|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154748606|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
154748607|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748608|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154748609|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154748610|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748611|NCT04513951|Antidotes|antidotes|mesh-ancestor
154748612|NCT04513951|Protective Agents|protective agents|mesh-ancestor
154748613|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
154748614|NCT04513951|Vitamins|vitamins|mesh-ancestor
154748615|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
154748616|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748617|NCT04509596|Capecitabine|capecitabine|mesh-list
154748618|NCT04509596|Trastuzumab|trastuzumab|mesh-list
154748619|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154748620|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
154748621|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748622|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748623|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748624|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
154748625|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154748626|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
154748627|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154748628|NCT04476446|Esketamine|esketamine|mesh-list
154748629|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
154748630|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154748631|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154748632|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
154748633|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154748634|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154748635|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154748636|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154748637|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154748638|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748639|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154748640|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748641|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748642|NCT04436250|Ketamine|ketamine|mesh-list
154748643|NCT04436250|Esketamine|esketamine|mesh-list
154748644|NCT04436250|Analgesics|analgesics|mesh-ancestor
154748645|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
154748646|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748647|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748648|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154748649|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154748650|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
154748652|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748653|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154748654|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154748655|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748656|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748657|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
154748658|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154748659|NCT04355832|Glucagon|glucagon|mesh-list
154748660|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154748661|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154748662|NCT04355832|Hormones|hormones|mesh-ancestor
154748663|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748664|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748665|NCT04355832|Incretins|incretins|mesh-ancestor
154748666|NCT04249882|Naltrexone|naltrexone|mesh-list
154748667|NCT04249882|Varenicline|varenicline|mesh-list
154748668|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154748669|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154748670|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748671|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
154748672|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748673|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154748674|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154748675|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
154748676|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748677|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748678|NCT04249401|Warfarin|warfarin|mesh-list
154748679|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
154748680|NCT04249401|Dabigatran|dabigatran|mesh-list
154748681|NCT04249401|Apixaban|apixaban|mesh-list
154748682|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
154748683|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154748684|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
154748685|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154748686|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
154748687|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748688|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748689|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154748690|NCT04245748|Escitalopram|escitalopram|mesh-list
154748691|NCT04245748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154748692|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154748693|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154748694|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748695|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748696|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
154748697|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748698|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748699|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
154748700|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154748701|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154748702|NCT04245748|Analgesics|analgesics|mesh-ancestor
154748703|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
154748704|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
154748705|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154748706|NCT04245436|Escitalopram|escitalopram|mesh-list
154748707|NCT04245436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154748708|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154748709|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154748710|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748711|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748712|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
154748713|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748714|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748715|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
154748716|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154748717|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154748718|NCT04245436|Analgesics|analgesics|mesh-ancestor
154748719|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
154748720|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
154748721|NCT04221997|Sertraline|sertraline|mesh-list
154748722|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
154748723|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154500706|NCT03253250|Tenofovir|tenofovir|mesh-list
154748724|NCT04221997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154748725|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154748726|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154748727|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748728|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748729|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
154748730|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748732|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
154748733|NCT04194554|Niraparib|niraparib|mesh-list
154748734|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154748735|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
154748736|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154748737|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748738|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154748739|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748740|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154748741|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748742|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748743|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
154748744|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748745|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154748746|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154748747|NCT04191889|Apatinib|apatinib|mesh-list
154748748|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748749|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154748750|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748751|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748752|NCT04181255|Poractant alfa|poractant alfa|mesh-list
154748753|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154748754|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
154748755|NCT04153760|Aspirin|aspirin|mesh-list
154748756|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154748757|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154748758|NCT04153760|Analgesics|analgesics|mesh-ancestor
154748759|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
154748760|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748761|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748762|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154748763|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154748764|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154748765|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154748766|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748767|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154748768|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154748769|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748770|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
154748771|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154748772|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154748773|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748774|NCT04085094|Pilocarpine|pilocarpine|mesh-list
154748775|NCT04085094|Miotics|miotics|mesh-ancestor
154748776|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
154748777|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748778|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748779|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154748780|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154748781|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
154748782|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748783|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748784|NCT04081805|Estradiol|estradiol|mesh-list
154748785|NCT04081805|Estrogens|estrogens|mesh-ancestor
154748786|NCT04081805|Hormones|hormones|mesh-ancestor
154748787|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748788|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748789|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
154748790|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
154748791|NCT04002115|Busulfan|busulfan|mesh-list
154748792|NCT04002115|Fludarabine|fludarabine|mesh-list
154748793|NCT04002115|Clofarabine|clofarabine|mesh-list
154748794|NCT04002115|Tacrolimus|tacrolimus|mesh-list
154748795|NCT04002115|Lenograstim|lenograstim|mesh-list
154748796|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154748797|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
154748798|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748799|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154748800|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154748801|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
154748802|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748803|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748804|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154748805|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154748806|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
154748807|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154748808|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748809|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154748810|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154748811|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
154748812|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154748813|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748814|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154748815|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154748816|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154748817|NCT03976544|Estradiol|estradiol|mesh-list
154748818|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154748819|NCT03976544|Progesterone|progesterone|mesh-list
154748820|NCT03976544|Estrogens|estrogens|mesh-ancestor
154748821|NCT03976544|Hormones|hormones|mesh-ancestor
154748822|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748823|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748824|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154748825|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
154748826|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154748827|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154748828|NCT03976544|Progestins|progestins|mesh-ancestor
154748829|NCT03960866|Phentolamine|phentolamine|mesh-list
154748830|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154748831|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154748832|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154748833|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154748834|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
154748835|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748836|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748837|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748838|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154748839|NCT03953833|Antibodies|antibodies|mesh-list
154748840|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154748841|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
154748842|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748843|NCT03944512|Pravastatin|pravastatin|mesh-list
154748844|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154748845|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154748846|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
154748847|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748848|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154748849|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154748850|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748851|NCT04208516|Dexamethasone|dexamethasone|mesh-list
154748852|NCT04208516|Lidocaine|lidocaine|mesh-list
154748853|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
154748854|NCT04208516|Ropivacaine|ropivacaine|mesh-list
154748855|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154748856|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
154748857|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
154748858|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154748859|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748860|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154748861|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
154748862|NCT04208516|Hormones|hormones|mesh-ancestor
154748863|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748864|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154748865|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748866|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
154748867|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
154748868|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154748869|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
154748870|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154748871|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154748872|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154748873|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154748874|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748875|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154748876|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154748877|NCT04208516|Analgesics|analgesics|mesh-ancestor
154748878|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154748879|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154748880|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154748881|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
154748882|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154748883|NCT03860207|Antibodies|antibodies|mesh-list
154748884|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
154748885|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154748886|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
154748887|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748888|NCT03807479|Ponatinib|ponatinib|mesh-list
154748889|NCT03807479|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154748890|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154748891|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748892|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748893|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748894|NCT03757130|Liraglutide|liraglutide|mesh-list
154748895|NCT03757130|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154748896|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748897|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748898|NCT03757130|Incretins|incretins|mesh-ancestor
154748899|NCT03757130|Hormones|hormones|mesh-ancestor
154748900|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748901|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154748902|NCT03712202|Nivolumab|nivolumab|mesh-list
154748903|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154748904|NCT03712202|Doxorubicin|doxorubicin|mesh-list
154748905|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154748906|NCT03712202|Daunorubicin|daunorubicin|mesh-list
154748907|NCT03712202|Bleomycin|bleomycin|mesh-list
154748908|NCT03712202|Dacarbazine|dacarbazine|mesh-list
154748909|NCT03712202|Vinblastine|vinblastine|mesh-list
154748910|NCT03712202|Antibodies|antibodies|mesh-list
154748911|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
154748912|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154748913|NCT03712202|Imidazole|imidazole|mesh-list
154748914|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
154748915|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
154748916|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748917|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748918|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154748919|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154748920|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154748921|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748922|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748923|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154748924|NCT03712202|Immunotoxins|immunotoxins|mesh-ancestor
154748925|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154748926|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
154748927|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154748928|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
154748929|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
154748930|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
154748931|NCT03692065|Apixaban|apixaban|mesh-list
154748932|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154748933|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
154748934|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154748935|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
154748936|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748937|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748938|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
154748939|NCT03682068|Carboplatin|carboplatin|mesh-list
154748940|NCT03682068|Gemcitabine|gemcitabine|mesh-list
154748941|NCT03682068|Durvalumab|durvalumab|mesh-list
154748942|NCT03682068|Tremelimumab|tremelimumab|mesh-list
154748943|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748944|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154748945|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
154748946|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748947|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154748948|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154748949|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
154748950|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
154748952|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154748953|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
154748954|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154748955|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748956|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154748957|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154748958|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154748959|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154748960|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154748961|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154748962|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748963|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154748964|NCT03643198|Metronidazole|metronidazole|mesh-list
154748965|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
154748966|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748967|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154748968|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154748969|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154748970|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154748971|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154748972|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748973|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748974|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154748975|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154748976|NCT03598842|Metronidazole|metronidazole|mesh-list
154748977|NCT03598842|Ivermectin|ivermectin|mesh-list
154748978|NCT03598842|Albendazole|albendazole|mesh-list
154748979|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
154748980|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154748981|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154748982|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154748983|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
154748984|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
154748985|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154748986|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
154748987|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
154748988|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
154748989|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154748990|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154748991|NCT03555565|Metformin|metformin|mesh-list
154748992|NCT03555565|Alogliptin|alogliptin|mesh-list
154748993|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154748994|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154748995|NCT03555565|Incretins|incretins|mesh-ancestor
154748996|NCT03555565|Hormones|hormones|mesh-ancestor
154748997|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154748998|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154748999|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
154749000|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749001|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749002|NCT03519386|Travoprost|travoprost|mesh-list
154749003|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154749004|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154749005|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154749006|NCT03452332|Durvalumab|durvalumab|mesh-list
154749007|NCT03452332|Ipilimumab|ipilimumab|mesh-list
154749008|NCT03452332|Tremelimumab|tremelimumab|mesh-list
154749009|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
154749010|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154749011|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
154749012|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749013|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749014|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
154749015|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749016|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154749017|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749018|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
154749019|NCT03405792|Temozolomide|temozolomide|mesh-list
154749020|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749021|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749022|NCT03405792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154749023|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749024|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154749025|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
154749026|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
154749027|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749028|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749029|NCT03391973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154749030|NCT03391973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749031|NCT03369665|Cladribine|cladribine|mesh-list
154749032|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749033|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154749034|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
154749035|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749036|NCT03226522|Bupropion|bupropion|mesh-list
154749037|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154749038|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
154749039|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154749040|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154749041|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154749042|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749043|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749044|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
154749045|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749046|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749047|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154749048|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153600227|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154749049|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749050|NCT03189706|Irinotecan|irinotecan|mesh-list
154749051|NCT03189706|Temozolomide|temozolomide|mesh-list
154749052|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154749053|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154749054|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749055|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749056|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749057|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154749058|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
154749059|NCT03128879|Venetoclax|venetoclax|mesh-list
154749060|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
154749061|NCT03128879|Ibrutinib|ibrutinib|mesh-list
154749062|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749063|NCT03128879|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154749064|NCT03128879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749065|NCT03128879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749066|NCT03128879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749067|NCT03077243|Cisplatin|cisplatin|mesh-list
154749068|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749069|NCT03064035|Thrombin|thrombin|mesh-list
154749070|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
154749071|NCT03064035|Coagulants|coagulants|mesh-ancestor
154749072|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
154749073|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
154749074|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749075|NCT02971891|Furosemide|furosemide|mesh-list
154749076|NCT02971891|Diuretics|diuretics|mesh-ancestor
154749077|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
154749078|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154749079|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154749080|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154749081|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749082|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
154749083|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154749084|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154749085|NCT02872025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154749086|NCT02872025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749087|NCT02824029|Ibrutinib|ibrutinib|mesh-list
154749088|NCT02824029|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154749089|NCT02824029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154749090|NCT02824029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749091|NCT02824029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749092|NCT02822573|Donepezil|donepezil|mesh-list
154749093|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154749094|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154749095|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154749096|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
154749097|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154749098|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138179|NCT02580773|Tinzaparin|tinzaparin|mesh-list
153978134|NCT00712465|Protective Agents|protective agents|mesh-ancestor
153978135|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978136|NCT00715975|Clobetasol|clobetasol|mesh-list
153978137|NCT00715975|Halobetasol|halobetasol|mesh-list
153978138|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978139|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
153978140|NCT00715975|Hormones|hormones|mesh-ancestor
153978141|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978142|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978143|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153978144|NCT02572687|Durvalumab|durvalumab|mesh-list
153978145|NCT02572687|Ramucirumab|ramucirumab|mesh-list
153978146|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153978147|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600312|NCT01883011|Piracetam|piracetam|mesh-list
153978148|NCT02572687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153978149|NCT02572687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153978181|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153978182|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978183|NCT00639015|Phenylephrine|phenylephrine|mesh-list
153978184|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
153978185|NCT00639015|Norepinephrine|norepinephrine|mesh-list
153978186|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153978187|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
153978188|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
153978189|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978190|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978191|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
153978192|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153978193|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
153978202|NCT00712855|Sorafenib|sorafenib|mesh-list
153978203|NCT00712855|Mapatumumab|mapatumumab|mesh-list
153978204|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978205|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153978206|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978207|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978208|NCT02537925|Celecoxib|celecoxib|mesh-list
153978209|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
153978210|NCT02537925|Nedaplatin|nedaplatin|mesh-list
153978211|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153978212|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153978213|NCT02537925|Analgesics|analgesics|mesh-ancestor
153978214|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
153978215|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978216|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978217|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978218|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978219|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153978220|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978221|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978222|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978223|NCT00713011|Nifedipine|nifedipine|mesh-list
153978224|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153978225|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153978226|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978227|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153978228|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978229|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
153978230|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
153978231|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153978232|NCT04185675|Anesthetics|anesthetics|mesh-list
153978233|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978234|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978235|NCT04208061|Ritonavir|ritonavir|mesh-list
153978236|NCT04208061|Darunavir|darunavir|mesh-list
153978237|NCT04208061|Dabigatran|dabigatran|mesh-list
153978238|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153978239|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153978240|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
153978241|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978242|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978243|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153735809|NCT04118010|Vitamin D|vitamin d|mesh-list
153978244|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153978245|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
153978246|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860878|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154138246|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978247|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153978248|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153978249|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
153978250|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153978251|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
153978252|NCT00988208|Prednisone|prednisone|mesh-list
153978253|NCT00988208|Docetaxel|docetaxel|mesh-list
153978254|NCT00988208|Lenalidomide|lenalidomide|mesh-list
153978255|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978256|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
153978257|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
153978258|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
153765254|NCT03464305|Analgesics|analgesics|mesh-ancestor
153978272|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
153978273|NCT04185831|Everolimus|everolimus|mesh-list
153978274|NCT04185831|Atezolizumab|atezolizumab|mesh-list
153978275|NCT04185831|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153978276|NCT04185831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153978277|NCT04185831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978278|NCT04185831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978279|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978280|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
153978281|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978282|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978283|NCT04185831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153978284|NCT04185831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153978285|NCT02686983|Betamethasone|betamethasone|mesh-list
153978286|NCT02686983|Anesthetics|anesthetics|mesh-list
153978287|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
153978288|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978289|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978290|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
153978291|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978292|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978293|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
153978294|NCT02686983|Hormones|hormones|mesh-ancestor
153978295|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978296|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153978297|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
153978298|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
153978299|NCT02686905|Vitamin D|vitamin d|mesh-list
153978300|NCT02686905|Vitamins|vitamins|mesh-list
153978301|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
153978302|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
153978303|NCT02686905|Calcium|calcium|mesh-list
153978304|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
153978305|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978306|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153978307|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153978308|NCT02686905|Hematinics|hematinics|mesh-ancestor
153978309|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
153978310|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
153978311|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978312|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
153600387|NCT01883869|Ticagrelor|ticagrelor|mesh-list
153600452|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
153978313|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153978314|NCT00990704|Protective Agents|protective agents|mesh-ancestor
153978315|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978316|NCT00639327|Irinotecan|irinotecan|mesh-list
153978317|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153978318|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153978319|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978320|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978336|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
153978337|NCT02686827|Vitamins|vitamins|mesh-ancestor
153978338|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
153978339|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978340|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153978341|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153978342|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
153978343|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153978344|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978345|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
153978346|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978347|NCT00713167|Protective Agents|protective agents|mesh-ancestor
153978348|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860879|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978349|NCT00716521|Zolpidem|zolpidem|mesh-list
153978350|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153978351|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153978352|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978353|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978354|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153978355|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
153978356|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
153978357|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978358|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978359|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
153978360|NCT00993668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153978361|NCT00993668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978362|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978363|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
153978364|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978365|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978366|NCT00778102|Leucovorin|leucovorin|mesh-list
153978367|NCT00778102|Bevacizumab|bevacizumab|mesh-list
153978368|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
153978369|NCT00778102|Irinotecan|irinotecan|mesh-list
153978370|NCT00778102|Fluorouracil|fluorouracil|mesh-list
153978371|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
153978372|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153600525|NCT01884506|Vitamins|vitamins|mesh-ancestor
153978373|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978374|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153978375|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153978376|NCT00778102|Growth Substances|growth substances|mesh-ancestor
153978377|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978378|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
153978379|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153978380|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153978381|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978394|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153978395|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978396|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153978397|NCT00719095|Naltrexone|naltrexone|mesh-list
153978398|NCT00719095|Buprenorphine|buprenorphine|mesh-list
153978399|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153978400|NCT00719095|Narcotics|narcotics|mesh-ancestor
153978401|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978402|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978403|NCT00719095|Analgesics|analgesics|mesh-ancestor
153978404|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
153978405|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978406|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153978407|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153978408|NCT00916630|Pemetrexed|pemetrexed|mesh-list
153978409|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978410|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978411|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978412|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153978413|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153978414|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
153978415|NCT02572375|Codeine|codeine|mesh-list
153978416|NCT02572375|Guaifenesin|guaifenesin|mesh-list
153978417|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153978418|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153978419|NCT02572375|Narcotics|narcotics|mesh-ancestor
153978420|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978421|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978422|NCT02572375|Analgesics|analgesics|mesh-ancestor
153978423|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
153978424|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978425|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
153978426|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
153978427|NCT02572375|Expectorants|expectorants|mesh-ancestor
153978428|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153978429|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153978430|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
153978431|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978432|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978433|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
153978434|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153978435|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
153978436|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
153978437|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
153978438|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153978439|NCT00716911|Ganciclovir|ganciclovir|mesh-list
153978440|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153978441|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
153978442|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978443|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153978444|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978488|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
153978489|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978490|NCT02573935|Clarithromycin|clarithromycin|mesh-list
153978491|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153978492|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978493|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153978494|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978495|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978496|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153978497|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153978498|NCT00984620|Interferons|interferons|mesh-list
153978499|NCT00984620|Ribavirin|ribavirin|mesh-list
153978500|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
153978501|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978502|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
153978503|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978504|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
153978505|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978506|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
153978507|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978508|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
153978509|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
153978510|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153978511|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153978512|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978513|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153978514|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978515|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153978516|NCT00639483|Celecoxib|celecoxib|mesh-list
153978517|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153978518|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153978519|NCT00639483|Analgesics|analgesics|mesh-ancestor
153978520|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
153978521|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978522|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978523|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978524|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978525|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153978526|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153978527|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978528|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978529|NCT00777946|Amlodipine|amlodipine|mesh-list
153978530|NCT00777946|Aliskiren|aliskiren|mesh-list
153978531|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153978532|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153978533|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153632147|NCT00006028|Gemcitabine|gemcitabine|mesh-list
153978534|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978535|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153978536|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978537|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
153978538|NCT00777946|Renin Inhibitors|renin inhibitors|mesh-ancestor
153765548|NCT05646303|Psilocybin|psilocybin|mesh-list
153978555|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153978556|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153978557|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978558|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978559|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153978560|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153978561|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153978562|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153978563|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153978564|NCT00990314|Epoprostenol|epoprostenol|mesh-list
153978565|NCT00990314|Beraprost|beraprost|mesh-list
153978566|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154138477|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
153978567|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
153978568|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153978569|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
153978570|NCT00909831|Sirolimus|sirolimus|mesh-list
153978571|NCT00909831|Temsirolimus|temsirolimus|mesh-list
153978572|NCT00909831|MTOR Inhibitors|mtor inhibitors|mesh-list
153978573|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
153978574|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153978575|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153978576|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978577|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978578|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978579|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978580|NCT00909831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153978581|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978582|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
153978583|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978584|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978585|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153978586|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153978587|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
153978588|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
153978589|NCT00717379|Prednisone|prednisone|mesh-list
153978590|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
153978591|NCT00717379|Tacrolimus|tacrolimus|mesh-list
153978592|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978593|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
153978594|NCT00717379|Hormones|hormones|mesh-ancestor
153978595|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978596|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978597|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153978598|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978599|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978600|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
153765595|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978608|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978610|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
153978611|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978612|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153978613|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153978614|NCT00717379|Protective Agents|protective agents|mesh-ancestor
153978615|NCT02867306|Methotrexate|methotrexate|mesh-list
153978616|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153978617|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
153978618|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153978619|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978620|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153978622|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978623|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978624|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
153978625|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978626|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153978627|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978628|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
153978629|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978630|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153978631|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
153978632|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153978633|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
153978634|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153978635|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978636|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153978637|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153978638|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153978639|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
153978640|NCT02685657|Docetaxel|docetaxel|mesh-list
153978641|NCT02685657|Doxorubicin|doxorubicin|mesh-list
153978642|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978643|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
153978644|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978645|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978646|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153978647|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
153978648|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860880|NCT01921790|Dexamethasone|dexamethasone|mesh-list
154138548|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153978649|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978650|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153978651|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
153978652|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
153978653|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
153978654|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153978655|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153978656|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153978657|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978658|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
153978659|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153978660|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153978661|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978662|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
153978663|NCT04290884|Coagulants|coagulants|mesh-ancestor
153978664|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
153978665|NCT00719407|Hematinics|hematinics|mesh-ancestor
153978666|NCT00714025|Everolimus|everolimus|mesh-list
153978667|NCT00714025|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153978668|NCT00714025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153978684|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153978685|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978687|NCT04096768|Ketamine|ketamine|mesh-list
153978688|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153978689|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978690|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978691|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153978692|NCT04096768|Analgesics|analgesics|mesh-ancestor
153978693|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
153978694|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736263|NCT03375203|Zolpidem|zolpidem|mesh-list
153978695|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153978696|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153978698|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
153978699|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978700|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978701|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153978702|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153978703|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
153978704|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
153978705|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153978706|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153978707|NCT00714103|Adenosine|adenosine|mesh-list
153978708|NCT00714103|Analgesics|analgesics|mesh-ancestor
153978709|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
153978710|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978711|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978712|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153978713|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
153978714|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153978715|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
153978716|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
153978717|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978718|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978719|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
153978720|NCT00714181|Temozolomide|temozolomide|mesh-list
153978721|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153978722|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
153978723|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978724|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978725|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
153600822|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
153978726|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153978727|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153765735|NCT04862221|Hormones|hormones|mesh-ancestor
153978738|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978739|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978740|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978741|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153978742|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153978743|NCT00639873|Doxycycline|doxycycline|mesh-list
153978744|NCT00639873|Artesunate|artesunate|mesh-list
154860881|NCT01921790|Gemcitabine|gemcitabine|mesh-list
153978745|NCT00639873|Quinine|quinine|mesh-list
153978746|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153978747|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978748|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
153978749|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153978750|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153978751|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978752|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
153978753|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
153978754|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153978755|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
153978756|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153978757|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978758|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153978759|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978760|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153978761|NCT00639873|Analgesics|analgesics|mesh-ancestor
154176482|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978762|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
153978764|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978765|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153978766|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
153978767|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978768|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978769|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153978770|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153978771|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
153978773|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978774|NCT02868944|Sufentanil|sufentanil|mesh-list
153978775|NCT02868944|Morphine|morphine|mesh-list
153978776|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
153978777|NCT02868944|Anesthetics|anesthetics|mesh-list
153978778|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
153978779|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153978780|NCT02868944|Narcotics|narcotics|mesh-ancestor
153978781|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978782|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978783|NCT02868944|Analgesics|analgesics|mesh-ancestor
153978784|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
153978785|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978786|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153978787|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153978788|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
153978789|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153978790|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153978791|NCT00722839|Vaccines|vaccines|mesh-list
153978792|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
153978793|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978794|NCT04096690|Pegaspargase|pegaspargase|mesh-list
153978795|NCT04096690|Antibodies|antibodies|mesh-list
153978813|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
153978814|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153600901|NCT01887379|Furosemide|furosemide|mesh-list
153978815|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
153978816|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978817|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153978818|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978819|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
153978820|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153978821|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153978822|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978823|NCT00719797|Antidotes|antidotes|mesh-ancestor
153978824|NCT00719797|Protective Agents|protective agents|mesh-ancestor
153978825|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
153978826|NCT00719797|Vitamins|vitamins|mesh-ancestor
153978827|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
153978828|NCT00979628|Insulin|insulin|mesh-list
153978829|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153978830|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
153978831|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
153978832|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153978833|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978834|NCT00719875|Vorinostat|vorinostat|mesh-list
153978835|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153978836|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978837|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978838|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978839|NCT02685111|Lenograstim|lenograstim|mesh-list
153978840|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153632446|NCT05285683|Levodopa|levodopa|mesh-list
153978841|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
153978842|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138698|NCT00874484|Enoxaparin|enoxaparin|mesh-list
153978843|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153978844|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153978845|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978846|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153978847|NCT00717925|Immunotoxins|immunotoxins|mesh-ancestor
153978848|NCT00717925|Immunoconjugates|immunoconjugates|mesh-ancestor
153978849|NCT00717925|Immunologic Factors|immunologic factors|mesh-ancestor
153978850|NCT00717925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978851|NCT00640029|Meloxicam|meloxicam|mesh-list
153978852|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153978853|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153978854|NCT00640029|Analgesics|analgesics|mesh-ancestor
153978855|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
153765862|NCT04332874|Dactinomycin|dactinomycin|mesh-list
153978873|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
153978874|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
153978875|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978876|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978877|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153978878|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153978879|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153978880|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
153978881|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978882|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153978883|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978884|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978885|NCT00992108|Lidocaine|lidocaine|mesh-list
153978886|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
153978887|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
153978888|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978889|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978890|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
153978891|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978892|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153978893|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153978894|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153978895|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153978896|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978897|NCT00752986|Fulvestrant|fulvestrant|mesh-list
153978898|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153978899|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978900|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153978901|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153978902|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
153978903|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978904|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978905|NCT02684487|Vitamin D|vitamin d|mesh-list
153978906|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
153978907|NCT02684487|Vitamins|vitamins|mesh-ancestor
153978908|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
153978909|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978910|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153978911|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153978916|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
153978917|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978918|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978919|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978920|NCT00762892|Tenofovir|tenofovir|mesh-list
153978921|NCT00762892|Emtricitabine|emtricitabine|mesh-list
153736489|NCT01824875|Capecitabine|capecitabine|mesh-list
153978922|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153978923|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
153978924|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153978925|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
153978926|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978927|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153978928|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153978929|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978930|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978931|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153978932|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153978933|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154860882|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
154860883|NCT01921790|Bevacizumab|bevacizumab|mesh-list
153978934|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153978935|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153978936|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153978937|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
153978938|NCT04290572|Isotretinoin|isotretinoin|mesh-list
153978939|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
153978940|NCT04069429|Heparin|heparin|mesh-list
153978941|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
153978942|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153978943|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153978944|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978945|NCT00755716|Topiramate|topiramate|mesh-list
153978946|NCT00755716|Nicotine|nicotine|mesh-list
153978947|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153978948|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
153978949|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978950|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978951|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153601030|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978952|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153978953|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
153978954|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978955|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978956|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
153978957|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153978958|NCT00629252|Risperidone|risperidone|mesh-list
153978959|NCT00629252|Sertindole|sertindole|mesh-list
153978960|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153978961|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
153978962|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978963|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978964|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978965|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153978966|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153978967|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978968|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153978969|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153978970|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
153978971|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
153978972|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153978973|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978974|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978975|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
153978976|NCT04095754|Anesthetics|anesthetics|mesh-list
153978977|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978978|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978992|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
153978993|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978994|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153978995|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978996|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978998|NCT02600650|Androgens|androgens|mesh-ancestor
153978999|NCT02600650|Hormones|hormones|mesh-ancestor
153979000|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153979001|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979002|NCT03084471|Durvalumab|durvalumab|mesh-list
153979003|NCT03084471|Tremelimumab|tremelimumab|mesh-list
153979004|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153979005|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153979006|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979007|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
153979008|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979009|NCT00718471|Heparin|heparin|mesh-list
153979010|NCT00718471|Enoxaparin|enoxaparin|mesh-list
153979011|NCT00718471|Calcium heparin|calcium heparin|mesh-list
153979012|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
153979013|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153979014|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153979015|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979016|NCT00723307|Metformin|metformin|mesh-list
153979017|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153979018|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979019|NCT00723385|Vitamin D|vitamin d|mesh-list
153979020|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
153979021|NCT00723385|Vitamins|vitamins|mesh-ancestor
153979022|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
153979023|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979024|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153979025|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153979026|NCT00754936|Escitalopram|escitalopram|mesh-list
153979027|NCT00754936|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153979028|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153979029|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153979030|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979031|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979032|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
153979033|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979034|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
153979035|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
153979036|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153979037|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979038|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766036|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
153979053|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153979054|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153979055|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
153979056|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153979058|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
153979059|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
153979060|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
153979061|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979062|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979063|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153979064|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153979065|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979066|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153979067|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153979068|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153979069|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
153979070|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
153979071|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979072|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979073|NCT02689713|Voriconazole|voriconazole|mesh-list
153979074|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
153979075|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979076|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153979077|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153979078|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979079|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979080|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153979081|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
153979082|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153979083|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979084|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153979085|NCT02601508|Rocuronium|rocuronium|mesh-list
153979086|NCT02601508|Atracurium|atracurium|mesh-list
153979087|NCT02601508|Cisatracurium|cisatracurium|mesh-list
153979088|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153979089|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153979090|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153979091|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979092|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979093|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153979094|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153979095|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
153979096|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979097|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979112|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979113|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979114|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979115|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153979116|NCT02570581|Analgesics|analgesics|mesh-ancestor
153979117|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
153979118|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979119|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
153979120|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153979121|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979122|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
153979123|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
153979124|NCT02570581|Diuretics|diuretics|mesh-ancestor
153979125|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
153979126|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153979127|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153979128|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153979129|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153979130|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
153979131|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153979132|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153979133|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153979134|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
153979135|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153979136|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153979137|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979138|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153979139|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153979140|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153979141|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
153979142|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
153979143|NCT00640263|Ritonavir|ritonavir|mesh-list
153979144|NCT00640263|Lopinavir|lopinavir|mesh-list
153979145|NCT00640263|Lamivudine|lamivudine|mesh-list
153979146|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153979147|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153979148|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
153979149|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979150|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979151|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153979152|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153979153|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
153979154|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979155|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153979156|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153979157|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153979158|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153979159|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153979160|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
153979161|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979162|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
153979173|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153979174|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979175|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979176|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153979178|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
153979179|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979180|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153979181|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153979182|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153979183|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
153979184|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601274|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153979185|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979186|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153979187|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
153979188|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
153979189|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153979190|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153979191|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153979192|NCT02570893|Paclitaxel|paclitaxel|mesh-list
153979193|NCT02570893|Carboplatin|carboplatin|mesh-list
153979194|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153979195|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979196|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
153979197|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
153979198|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
153979199|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979200|NCT02538081|Risperidone|risperidone|mesh-list
153979201|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153979202|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
153979203|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979204|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979205|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979206|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153979207|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154138996|NCT03967327|Morphine|morphine|mesh-list
153979208|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979209|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153979210|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153979211|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
153979212|NCT02570971|Mannitol|mannitol|mesh-list
153979213|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153979214|NCT02570971|Diuretics|diuretics|mesh-ancestor
153979215|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
153979216|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979217|NCT02866214|Febuxostat|febuxostat|mesh-list
153979218|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
153979219|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979220|NCT02866448|Aspirin|aspirin|mesh-list
153979221|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153979222|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153979223|NCT02866448|Analgesics|analgesics|mesh-ancestor
153979224|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
153979225|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979226|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979227|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153979236|NCT00578227|Vaccines|vaccines|mesh-list
153979237|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
153979238|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979239|NCT00720577|Pioglitazone|pioglitazone|mesh-list
153979240|NCT00720577|Losartan|losartan|mesh-list
153979241|NCT00720577|Simvastatin|simvastatin|mesh-list
153979242|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153979243|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153979244|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
153979245|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979246|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153979247|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153979248|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979249|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153979250|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979251|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153979252|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153979253|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153979254|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153979255|NCT05373277|Ticagrelor|ticagrelor|mesh-list
153979256|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153979257|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153979258|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153979259|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
153979260|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979261|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153979262|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153979263|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979264|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153979265|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153979266|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153979267|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153979268|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
153979269|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979270|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979271|NCT00724321|Iloprost|iloprost|mesh-list
153979272|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153979273|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
153979274|NCT00720811|Acetaminophen|acetaminophen|mesh-list
153979275|NCT00720811|Amoxicillin|amoxicillin|mesh-list
153979276|NCT00720811|Lumefantrine|lumefantrine|mesh-list
153979277|NCT00720811|Artemether|artemether|mesh-list
153979278|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153979279|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153979280|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979281|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153979282|NCT00720811|Analgesics|analgesics|mesh-ancestor
153979283|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
153979284|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979285|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979286|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
153979287|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
153979288|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153979289|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153979290|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
154860884|NCT01921790|Pegaspargase|pegaspargase|mesh-list
153979291|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153979292|NCT00577993|Interferons|interferons|mesh-list
153979293|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
153979294|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
153979295|NCT00577993|Dexamethasone|dexamethasone|mesh-list
153979312|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
153979313|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979314|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
153979315|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979316|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979317|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153979318|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
153979319|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979320|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979321|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153979322|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153979323|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
153979324|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
153979325|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979326|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153979327|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
153979328|NCT00577993|Hormones|hormones|mesh-ancestor
153979329|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153979330|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153979331|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979332|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153979333|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153979334|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153601435|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
153979335|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153979336|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153979337|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
153979338|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979339|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
153979340|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
153979341|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
153979342|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153979343|NCT00577993|Protective Agents|protective agents|mesh-ancestor
153979344|NCT00577993|Analgesics|analgesics|mesh-ancestor
153979345|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
153979346|NCT00975806|Lenalidomide|lenalidomide|mesh-list
153979347|NCT00975806|Sunitinib|sunitinib|mesh-list
153979348|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
153979349|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979350|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153979351|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153979352|NCT00975806|Growth Substances|growth substances|mesh-ancestor
153979353|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
153979354|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979355|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153979356|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979357|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979358|NCT00721201|Mifepristone|mifepristone|mesh-list
153979359|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153979376|NCT02866370|Doxorubicin|doxorubicin|mesh-list
153979377|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153979379|NCT02866370|Nintedanib|nintedanib|mesh-list
153979380|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153979381|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979382|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
153979383|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
153979384|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
153979385|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979386|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153979387|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153979388|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153979389|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979390|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153979391|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153979392|NCT00978068|Ritonavir|ritonavir|mesh-list
153979393|NCT00978068|Lopinavir|lopinavir|mesh-list
153979394|NCT00978068|Nevirapine|nevirapine|mesh-list
153979395|NCT00978068|Efavirenz|efavirenz|mesh-list
153979396|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153979397|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153979398|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153979399|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
153979400|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979401|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979402|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153979403|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153979404|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
153979405|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979406|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153979407|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153979408|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153979409|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153979410|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153979411|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153979412|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153979413|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153979414|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
153979415|NCT00629642|Oxybutynin|oxybutynin|mesh-list
153979416|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153766427|NCT00214110|Tamoxifen|tamoxifen|mesh-list
153979435|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
153979436|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979437|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153979439|NCT04287842|Desflurane|desflurane|mesh-list
153979440|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153979441|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153979442|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
153979443|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
153979444|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979445|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979446|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
153979447|NCT00721747|Docetaxel|docetaxel|mesh-list
153979448|NCT00721747|Doxorubicin|doxorubicin|mesh-list
153979449|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153979450|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979451|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
153979452|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979453|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979454|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153979455|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
153979456|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979457|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979458|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153979459|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
153979460|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
153979461|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
153979462|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153979463|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153979464|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153979465|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979466|NCT00603525|Ofatumumab|ofatumumab|mesh-list
153979467|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979468|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153979469|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
153979470|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979471|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153979472|NCT02689401|Hematinics|hematinics|mesh-ancestor
153979473|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153979478|NCT00640575|Lidocaine|lidocaine|mesh-list
153979479|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153979480|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
153979481|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
153979482|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979483|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979484|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
153979485|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979486|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153979487|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153979488|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153979489|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153979490|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979491|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153979492|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
153979493|NCT00640575|Hormones|hormones|mesh-ancestor
153979494|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153979495|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154255911|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153979496|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
153979497|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979498|NCT04067791|Melatonin|melatonin|mesh-list
153979499|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
153979500|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979501|NCT04067791|Protective Agents|protective agents|mesh-ancestor
153979502|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979503|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979504|NCT00762034|Paclitaxel|paclitaxel|mesh-list
153979505|NCT00762034|Bevacizumab|bevacizumab|mesh-list
153979506|NCT00762034|Carboplatin|carboplatin|mesh-list
153979507|NCT00762034|Pemetrexed|pemetrexed|mesh-list
153979508|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153979509|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979510|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
153979511|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
153979512|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
153979513|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979514|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153979515|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153979516|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153979517|NCT00762034|Growth Substances|growth substances|mesh-ancestor
153979518|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979519|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
153979520|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979521|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153979522|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153979524|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
153979525|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
153979527|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979528|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
153979529|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979530|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979531|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153979532|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
153979533|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979534|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979535|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153979536|NCT04184115|Scopolamine|scopolamine|mesh-list
153979537|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153979538|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
153979539|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
153979540|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979541|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979542|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153979543|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
153979544|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153979545|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
153979546|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979559|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153979560|NCT00640809|Ibuprofen|ibuprofen|mesh-list
153979561|NCT00640809|Celecoxib|celecoxib|mesh-list
153979562|NCT00640809|Omeprazole|omeprazole|mesh-list
153979563|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153979564|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153979565|NCT00640809|Analgesics|analgesics|mesh-ancestor
153979566|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
153979567|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979568|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979569|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153979570|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979571|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153979572|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979573|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979574|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153979575|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153979576|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153979577|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153979578|NCT00754624|Insulin|insulin|mesh-list
153979579|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153979580|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979581|NCT00722293|Doxorubicin|doxorubicin|mesh-list
153979582|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153979583|NCT00722293|Epirubicin|epirubicin|mesh-list
154860885|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255060|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979584|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153979585|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979586|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153979587|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153979588|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979589|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979590|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
153979591|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153979592|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979593|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153979594|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979596|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153979597|NCT02683005|Ledipasvir|ledipasvir|mesh-list
153979598|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
153737181|NCT05822765|Autonomic Agents|autonomic agents|mesh-ancestor
153979599|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979600|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
153979601|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
153979602|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153979603|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153979604|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
153979605|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979606|NCT02571283|Epinephrine|epinephrine|mesh-list
153979607|NCT02571283|Bupivacaine|bupivacaine|mesh-list
153979616|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153979618|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
153979619|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979620|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153979621|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153979622|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153979623|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
153979624|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
153979625|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
153979626|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153979627|NCT02682693|Denosumab|denosumab|mesh-list
153979628|NCT02682693|Paclitaxel|paclitaxel|mesh-list
153979629|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
153979630|NCT02682693|Carboplatin|carboplatin|mesh-list
153979631|NCT02682693|Trastuzumab|trastuzumab|mesh-list
153979632|NCT02682693|Epirubicin|epirubicin|mesh-list
153979633|NCT02682693|Pertuzumab|pertuzumab|mesh-list
153979634|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153979635|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979636|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
153979637|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
153979638|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
153979639|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601655|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153979640|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979641|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
153979642|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979643|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979644|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153979645|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
153979646|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153979647|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153979648|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153979649|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153979650|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153979651|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979652|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153979653|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
153979654|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153979655|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153979656|NCT02571517|Prednisolone|prednisolone|mesh-list
153979657|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
153979658|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153979659|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
153979660|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
153979661|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153979662|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
153979663|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
153979664|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979665|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979666|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154860886|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
154860887|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
153979668|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153633278|NCT00006214|Flutamide|flutamide|mesh-list
153979669|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153979670|NCT02571517|Protective Agents|protective agents|mesh-ancestor
153979671|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153979672|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979673|NCT00586846|Doxorubicin|doxorubicin|mesh-list
153979693|NCT04144465|Phenylephrine|phenylephrine|mesh-list
153979694|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
153979695|NCT04144465|Norepinephrine|norepinephrine|mesh-list
153979696|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153979697|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
153979698|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
153979699|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979700|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979701|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
153979702|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153979703|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
153979704|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
153979705|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153979706|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153979707|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153979708|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
153979709|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979710|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979711|NCT04144465|Protective Agents|protective agents|mesh-ancestor
153979712|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
153979713|NCT00754390|Calcium|calcium|mesh-list
153601806|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153979714|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153979715|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979716|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153979717|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
153979718|NCT04066621|Sulbactam|sulbactam|mesh-list
153979719|NCT04066621|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153979720|NCT04066621|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153979721|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153979722|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979723|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153979724|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979725|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979726|NCT00629564|Esomeprazole|esomeprazole|mesh-list
153979727|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153979728|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153979741|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153979742|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153979743|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979744|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153979745|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153979746|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979747|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
153979748|NCT02570035|Mirabegron|mirabegron|mesh-list
153737329|NCT05443568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979749|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153979750|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153979751|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153979752|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
153979753|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979754|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979755|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979756|NCT02570035|Urological Agents|urological agents|mesh-ancestor
153979757|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
153979758|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153979759|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979760|NCT04098796|Antibodies|antibodies|mesh-list
153979761|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
153979762|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979763|NCT00522145|XL647|xl647|mesh-list
153979764|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979765|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153979766|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979767|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979768|NCT00726973|Ranibizumab|ranibizumab|mesh-list
153979769|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153979770|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139451|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
153979771|NCT00726973|Growth Substances|growth substances|mesh-ancestor
153979772|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979773|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
153979774|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979775|NCT02571361|Acetaminophen|acetaminophen|mesh-list
153979776|NCT02571361|Ibuprofen|ibuprofen|mesh-list
153979777|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153979778|NCT02571361|Analgesics|analgesics|mesh-ancestor
153979779|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
153979780|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979781|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979782|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
153979783|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153979784|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153979785|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979786|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153979787|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766799|NCT00474994|Sunitinib|sunitinib|mesh-list
153979810|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153979811|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
153979812|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979813|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979814|NCT04290026|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153979815|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153979816|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
153979818|NCT00640887|Lopinavir|lopinavir|mesh-list
153979819|NCT00640887|Nevirapine|nevirapine|mesh-list
153979820|NCT00640887|Efavirenz|efavirenz|mesh-list
153979821|NCT00640887|Rifabutin|rifabutin|mesh-list
153979822|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153979823|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153979824|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
153979825|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979826|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979827|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153979828|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153979829|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
153979830|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979831|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153979832|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153979833|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153979834|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153979835|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153979836|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153979837|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153979838|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153979839|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153979854|NCT00727129|Estrogens|estrogens|mesh-ancestor
153979855|NCT00727129|Hormones|hormones|mesh-ancestor
153979856|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153979857|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979858|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153979859|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
153979860|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153979861|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153979862|NCT04183725|Oseltamivir|oseltamivir|mesh-list
153979863|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
153979864|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979865|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979866|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979867|NCT00730249|Methylphenidate|methylphenidate|mesh-list
153979868|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153979869|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979870|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153979871|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153979872|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153979873|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979874|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
153979875|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979876|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153979877|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154860888|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255061|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139540|NCT00936546|Rituximab|rituximab|mesh-list
153979878|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979879|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153979880|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979881|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979882|NCT01632657|Sumatriptan|sumatriptan|mesh-list
153979883|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153979884|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153979885|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153979886|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
153979887|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979888|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979889|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979890|NCT00727207|Everolimus|everolimus|mesh-list
153979891|NCT00727207|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153979892|NCT00727207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153979893|NCT00727207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979894|NCT00727207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979895|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979896|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
153737479|NCT05259696|Cemiplimab|cemiplimab|mesh-list
153979897|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979898|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979899|NCT02682459|Lisinopril|lisinopril|mesh-list
153979914|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979915|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153979916|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153979917|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
153979918|NCT02682225|Ketamine|ketamine|mesh-list
153979919|NCT02682225|Esketamine|esketamine|mesh-list
153979920|NCT02682225|Analgesics|analgesics|mesh-ancestor
153979921|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
153979922|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979923|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979924|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153979925|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153979926|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
153979927|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
153979928|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979929|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153979930|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153979931|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979932|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979933|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
153979934|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153979935|NCT04066231|Erythromycin|erythromycin|mesh-list
153979936|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
153979937|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153979938|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
153979939|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
153979940|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153979941|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979942|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153979943|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153979944|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979945|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979946|NCT04183491|Interferons|interferons|mesh-list
153979947|NCT04183491|Interferon-beta|interferon-beta|mesh-list
153979948|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
153979949|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979950|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
153979951|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979952|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
153979953|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979954|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153979955|NCT03702283|Penicillins|penicillins|mesh-list
153979956|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153979957|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979958|NCT00727753|Bevacizumab|bevacizumab|mesh-list
153979959|NCT00727753|Ranibizumab|ranibizumab|mesh-list
153979978|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979979|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979980|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
154860889|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979982|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153979983|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979984|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
153979985|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979986|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153979987|NCT00727831|Antidotes|antidotes|mesh-ancestor
153979988|NCT00727831|Protective Agents|protective agents|mesh-ancestor
153979989|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
153979990|NCT00727831|Vitamins|vitamins|mesh-ancestor
153979991|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
153979992|NCT00727987|Golimumab|golimumab|mesh-list
153979993|NCT00727987|Methotrexate|methotrexate|mesh-list
153979994|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153979995|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
153979996|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153979997|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979998|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153979999|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
153980000|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980001|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980002|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
153980003|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980004|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153980005|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153980006|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
153980007|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980008|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153980009|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153980010|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980011|NCT02681913|Adenosine|adenosine|mesh-list
153980012|NCT02681913|Analgesics|analgesics|mesh-ancestor
153980013|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
153980014|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980015|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767009|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
153980058|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
153980059|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153980060|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
153980061|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980062|NCT02680977|Levodopa|levodopa|mesh-list
153980063|NCT02680977|Benserazide|benserazide|mesh-list
153980064|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153980065|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153980066|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
153980067|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980068|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980069|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980070|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980071|NCT00734695|Vitamins|vitamins|mesh-list
153980072|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
153980073|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
153980074|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980075|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
153980076|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980077|NCT00734695|Protective Agents|protective agents|mesh-ancestor
153980078|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153980079|NCT00586690|Antibodies|antibodies|mesh-list
153980080|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
153980081|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153980082|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
153980083|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980084|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980085|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
153980086|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153980087|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
153980088|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980089|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
153980090|NCT00728611|Protective Agents|protective agents|mesh-ancestor
153980091|NCT05663775|Mesalamine|mesalamine|mesh-list
153980092|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153980114|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
154176485|NCT05643846|Anesthetics|anesthetics|mesh-list
153980115|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980116|NCT00760474|Pregabalin|pregabalin|mesh-list
153980117|NCT00760474|Analgesics|analgesics|mesh-ancestor
153980118|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
154139670|NCT00889850|Esomeprazole|esomeprazole|mesh-list
153980119|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980120|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980121|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
153980122|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153980123|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980124|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980125|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153980127|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153980128|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980129|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153980130|NCT02680119|Esomeprazole|esomeprazole|mesh-list
153980131|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153980132|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153980133|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153980134|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980135|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980137|NCT00734773|Rituximab|rituximab|mesh-list
153980138|NCT00734773|Methotrexate|methotrexate|mesh-list
153980139|NCT00734773|Vincristine|vincristine|mesh-list
153980140|NCT00734773|Procarbazine|procarbazine|mesh-list
153980141|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
153980142|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153980143|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980144|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
153980145|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980169|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980170|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153980171|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
153980172|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
153980173|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153980174|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153980175|NCT00975416|Oxytocin|oxytocin|mesh-list
153980176|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
153980177|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153980178|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980179|NCT02679963|Olaparib|olaparib|mesh-list
153980180|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153980181|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980182|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980183|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980184|NCT00760084|Decitabine|decitabine|mesh-list
153980185|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153980186|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
153980187|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980188|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980189|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980190|NCT00735241|Leucovorin|leucovorin|mesh-list
153980191|NCT00735241|Folic Acid|folic acid|mesh-list
153980192|NCT00735241|Bevacizumab|bevacizumab|mesh-list
153980193|NCT00735241|Fluorouracil|fluorouracil|mesh-list
153980194|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
153980195|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
153980196|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153980197|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980216|NCT00641979|Budesonide|budesonide|mesh-list
153980217|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980218|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153980219|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
153980220|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980221|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980222|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153980223|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
153980224|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
153980225|NCT00641979|Hormones|hormones|mesh-ancestor
153980226|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980227|NCT02679339|Lidocaine|lidocaine|mesh-list
153980228|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
153980229|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
153980230|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980231|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980232|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
153980233|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980234|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154860890|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153980235|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153980236|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153980237|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980238|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980239|NCT02679261|Atorvastatin|atorvastatin|mesh-list
153980240|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153980241|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153980242|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
153980243|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980244|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153980245|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153602267|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153980246|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980247|NCT00752206|Saracatinib|saracatinib|mesh-list
153980248|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980249|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980250|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980251|NCT02678949|Fluticasone|fluticasone|mesh-list
153980252|NCT02678949|Xhance|xhance|mesh-list
153980253|NCT02678949|Albuterol|albuterol|mesh-list
153980254|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980255|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153980272|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
153980273|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153980274|NCT00642135|Tropicamide|tropicamide|mesh-list
153980275|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153980276|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
153980277|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
153980278|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980279|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980280|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
153980281|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153980282|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
153980283|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
153980284|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153980285|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153980286|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153980287|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
153980288|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980289|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980290|NCT00642135|Protective Agents|protective agents|mesh-ancestor
153980291|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153980292|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153980293|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153980294|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
153980296|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
153980297|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980298|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153980299|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153980300|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980301|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980302|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153980303|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153980304|NCT02600260|Enoxaparin|enoxaparin|mesh-list
153980305|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
153980306|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
153980307|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153980308|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153980309|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980310|NCT02537379|Ribavirin|ribavirin|mesh-list
153980311|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
153980312|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980313|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
153980314|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767303|NCT00193388|Topotecan|topotecan|mesh-list
153980325|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153980326|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153980327|NCT02675205|Analgesics|analgesics|mesh-ancestor
153980328|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
153980329|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980330|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980331|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980332|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980333|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153980334|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153980335|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139826|NCT00890630|Oxytocin|oxytocin|mesh-list
153980336|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153980337|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153980338|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980339|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
153980340|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153980341|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153980342|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153980343|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
153980344|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980345|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
153980346|NCT00753454|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153980347|NCT00753454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980348|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153980349|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
153980350|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980351|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980352|NCT00643539|Azithromycin|azithromycin|mesh-list
153980353|NCT00643539|Amoxicillin|amoxicillin|mesh-list
153980354|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153980355|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980356|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
153980357|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153980358|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153980359|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153980360|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153980361|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980362|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153980363|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153980364|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980365|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980366|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980367|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153980368|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
153980369|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153980370|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980371|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153980372|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153980373|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153980375|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
153980376|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153980377|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153980378|NCT00910065|Analgesics|analgesics|mesh-ancestor
153980379|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
153980401|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980403|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
153980404|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980405|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153980406|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153980407|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
153980408|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980409|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153980410|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
153980411|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153980412|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980413|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980414|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153980415|NCT02675049|Analgesics|analgesics|mesh-ancestor
153602389|NCT01904500|Cefazolin|cefazolin|mesh-list
153980416|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
153980417|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980418|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153980419|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153980420|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153980421|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
153980422|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980423|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980424|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
153980425|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
153980426|NCT02674737|Tramadol|tramadol|mesh-list
153980427|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153980428|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980429|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767423|NCT00473746|Dexamethasone|dexamethasone|mesh-list
154860891|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
153980442|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153980443|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980444|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980445|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153980446|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980447|NCT02674893|Liraglutide|liraglutide|mesh-list
153980448|NCT02674893|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153980449|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153980450|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980451|NCT02674893|Incretins|incretins|mesh-ancestor
153980452|NCT02674893|Hormones|hormones|mesh-ancestor
153980453|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980454|NCT02717455|Panobinostat|panobinostat|mesh-list
153980455|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980456|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153980457|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980458|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980459|NCT02674581|Fostemsavir|fostemsavir|mesh-list
153980460|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153980461|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153980462|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
153980463|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980464|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153980465|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153980466|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980467|NCT04065919|Epinephrine|epinephrine|mesh-list
153980468|NCT04065919|Bupivacaine|bupivacaine|mesh-list
153980469|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
153980470|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
153980471|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980472|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980473|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
153980474|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980475|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153980476|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153980477|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
153980478|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980479|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980480|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153602461|NCT01904786|Melatonin|melatonin|mesh-list
153980481|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153602519|NCT01905150|Irinotecan|irinotecan|mesh-list
153980482|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
153980483|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153980484|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
153980485|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
153980486|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
153980487|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153980489|NCT04065529|Trace Elements|trace elements|mesh-ancestor
153980490|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
153980491|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980492|NCT04179045|Sirolimus|sirolimus|mesh-list
153980493|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153980510|NCT00644085|Aspirin|aspirin|mesh-list
153980511|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153980512|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153980513|NCT00644085|Analgesics|analgesics|mesh-ancestor
153980514|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
153980515|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980516|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980517|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980518|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980519|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153980520|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153980521|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980522|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153980523|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153980524|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980525|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
153980526|NCT00731575|Prednisolone|prednisolone|mesh-list
153980527|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153980528|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
153980529|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153980530|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
153980531|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153980532|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
154139974|NCT00886574|Analgesics|analgesics|mesh-ancestor
153980533|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980534|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
153980535|NCT00731575|Hormones|hormones|mesh-ancestor
153980536|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980537|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980538|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153980539|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980540|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
153980541|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
153980542|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980543|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153980544|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153980545|NCT00731575|Protective Agents|protective agents|mesh-ancestor
153980546|NCT02674191|Clindamycin|clindamycin|mesh-list
153980547|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
153980548|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
153980549|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
153980550|NCT02674191|Mepivacaine|mepivacaine|mesh-list
153980551|NCT02674191|Benzocaine|benzocaine|mesh-list
153980552|NCT02674191|Povidone|povidone|mesh-list
153980553|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153980554|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980555|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153980556|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767536|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153980581|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
153602520|NCT01905150|Mitomycins|mitomycins|mesh-list
153980582|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153980583|NCT00738517|Antibodies|antibodies|mesh-list
153980584|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
153980585|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980586|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153980587|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153980588|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153980589|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980590|NCT00738595|Nicotine|nicotine|mesh-list
153980591|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153980592|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
153980593|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980594|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980595|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153980596|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153980597|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
153980598|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980599|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980600|NCT05273775|Vitamin K|vitamin k|mesh-list
153980601|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
153980602|NCT05273775|Digoxin|digoxin|mesh-list
153980603|NCT05273775|Midazolam|midazolam|mesh-list
153980616|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153980617|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
153980618|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
153980619|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
153980620|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
153980621|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980622|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980623|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153980624|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153980625|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
153980626|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153980627|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153980628|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980629|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
153980630|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153980631|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153980632|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153980633|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153980634|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153980635|NCT05273775|Protective Agents|protective agents|mesh-ancestor
153980636|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153980637|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153980638|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
153980639|NCT05273775|Coagulants|coagulants|mesh-ancestor
153980640|NCT02671851|Acetaminophen|acetaminophen|mesh-list
153980641|NCT02671851|Dipyrone|dipyrone|mesh-list
153980642|NCT02671851|Fentanyl|fentanyl|mesh-list
153980643|NCT02671851|Tramadol|tramadol|mesh-list
153980644|NCT02671851|Bupivacaine|bupivacaine|mesh-list
153980645|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
154860892|NCT01921790|Hormones|hormones|mesh-ancestor
153980646|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
153980647|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980648|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980649|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
153980650|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980651|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153980652|NCT02671851|Narcotics|narcotics|mesh-ancestor
153980653|NCT02671851|Analgesics|analgesics|mesh-ancestor
153980655|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153980656|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
153980657|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153980658|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
153980659|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153980660|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980661|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980662|NCT02671695|Amlodipine|amlodipine|mesh-list
153980663|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153980664|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153980665|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980666|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980667|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153980668|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980669|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
153980670|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
153980671|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
153980681|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
153980682|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980683|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980684|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153980685|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153980686|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
153980687|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980688|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153980689|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153980690|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153980691|NCT00738751|Panobinostat|panobinostat|mesh-list
153980692|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153980693|NCT00738751|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153980694|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153980695|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980696|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980697|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980698|NCT05243823|Estradiol|estradiol|mesh-list
153980699|NCT05243823|Estrogens|estrogens|mesh-ancestor
153980700|NCT05243823|Hormones|hormones|mesh-ancestor
153980701|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980702|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980703|NCT00736801|Fluticasone|fluticasone|mesh-list
153980704|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153980705|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980706|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153980707|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
153980708|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980709|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980710|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153980711|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
153980712|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
153980713|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153980714|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153980715|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153980716|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153980717|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
153980718|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980719|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980720|NCT00738829|Rituximab|rituximab|mesh-list
153980721|NCT00738829|Fludarabine|fludarabine|mesh-list
153980722|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
153602664|NCT01906580|Entecavir|entecavir|mesh-list
153602731|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153980723|NCT00738829|Lenalidomide|lenalidomide|mesh-list
153980724|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153980725|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980726|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
153738316|NCT02660580|Adalimumab|adalimumab|mesh-list
153980727|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980728|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980729|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153980730|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
153980731|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980732|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153980733|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153980734|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153980735|NCT00738829|Growth Substances|growth substances|mesh-ancestor
153980762|NCT05216211|Bupivacaine|bupivacaine|mesh-list
153980763|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
153980764|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
153980765|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980766|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980767|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
153980768|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980769|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153980770|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153980771|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980772|NCT00732121|Incretins|incretins|mesh-ancestor
153980773|NCT00732121|Hormones|hormones|mesh-ancestor
153980774|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980775|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153980776|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
153980777|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980778|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980779|NCT02537223|Cisplatin|cisplatin|mesh-list
153980780|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980781|NCT02568943|Panobinostat|panobinostat|mesh-list
153980782|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980797|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
153980798|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153980799|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153980800|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153980801|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153980802|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980803|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980804|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
153980805|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980806|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980807|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153980808|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980809|NCT00737113|Hormones|hormones|mesh-list
153602750|NCT01907165|Disulfiram|disulfiram|mesh-list
153980810|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980811|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980812|NCT00737191|Olanzapine|olanzapine|mesh-list
153980813|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
153980814|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
153980815|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980816|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980817|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153980818|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153980819|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153980820|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980821|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153980822|NCT00737191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153980823|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153980824|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980825|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980826|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980827|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
153980828|NCT04175067|Antioxidants|antioxidants|mesh-list
153980829|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980830|NCT04175067|Protective Agents|protective agents|mesh-ancestor
153980831|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980832|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
153980833|NCT00758602|Tacrolimus|tacrolimus|mesh-list
153980834|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153980835|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
153980836|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980837|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153980838|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767822|NCT00125489|Analgesics|analgesics|mesh-ancestor
153980859|NCT00732511|Carvedilol|carvedilol|mesh-list
153980860|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153980861|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153980862|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
153980863|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
153980864|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980865|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980866|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153980867|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153980868|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153980869|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
153980870|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980871|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980872|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
153980873|NCT00732511|Protective Agents|protective agents|mesh-ancestor
153980874|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153980875|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980876|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153980877|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
153980878|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153980879|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153980880|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
153980881|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153980882|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
153980883|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980884|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980885|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153980886|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
153980887|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153980888|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
153980889|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980890|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767882|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
153980902|NCT00711529|Gabapentin|gabapentin|mesh-list
153980903|NCT00711529|Analgesics|analgesics|mesh-ancestor
153980904|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
153980905|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980906|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980907|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
153980908|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153980909|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153980910|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980911|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153980912|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153980913|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153980914|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980915|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980916|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
153980917|NCT00732589|Lidocaine|lidocaine|mesh-list
153980918|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
153980919|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
153980920|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980921|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980922|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
153980923|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980924|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153980925|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153980926|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153980927|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980928|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980929|NCT00645879|Citric Acid|citric acid|mesh-list
153980930|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
153980931|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
153980932|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153980933|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
153980934|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
153980935|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980936|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
153980937|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153980938|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980939|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153980940|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
153980941|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153980942|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980943|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980944|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980946|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153980947|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153980948|NCT02666703|Prednisolone|prednisolone|mesh-list
153980949|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
153980950|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153980951|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
153980952|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980953|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
153980954|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
153980964|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980966|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
153980967|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
153980968|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
153980969|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980970|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980971|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
153980972|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980973|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153980974|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153980975|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153980976|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980977|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980978|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153980979|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
153980980|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
153980981|NCT04174131|Protective Agents|protective agents|mesh-ancestor
153980982|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
153980983|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153980984|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980985|NCT00646035|Vitamins|vitamins|mesh-ancestor
153980986|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
153980987|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153980988|NCT00646191|Adalimumab|adalimumab|mesh-list
153980989|NCT00646191|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153980990|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980991|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980992|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
153980993|NCT02666157|Apixaban|apixaban|mesh-list
153980994|NCT02666157|Dabigatran|dabigatran|mesh-list
153980995|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153980996|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
153980997|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153980998|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
153980999|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981000|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981001|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
153981002|NCT02666001|Fostemsavir|fostemsavir|mesh-list
153981003|NCT02666001|Buprenorphine|buprenorphine|mesh-list
153981004|NCT02666001|Methadone|methadone|mesh-list
153981005|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153981006|NCT02666001|Narcotics|narcotics|mesh-ancestor
153981007|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981008|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981009|NCT02666001|Analgesics|analgesics|mesh-ancestor
153981010|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
153981011|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981012|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153981013|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
153981014|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
153981015|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153981016|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153981017|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
153981018|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981019|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153981020|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153981048|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981049|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153981050|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981051|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981052|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603039|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981053|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981054|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153981055|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153981056|NCT02665533|Analgesics|analgesics|mesh-ancestor
153981057|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
153981058|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981059|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154255062|NCT05617664|Urological Agents|urological agents|mesh-ancestor
153981060|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153981062|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981063|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
153981064|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
153981065|NCT00646503|Telbivudine|telbivudine|mesh-list
153981066|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
153981067|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981068|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153981080|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
153981081|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
153981082|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981083|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
153981084|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153981085|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981086|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
153981087|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981088|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153981089|NCT00648531|Balsalazide|balsalazide|mesh-list
153981090|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153981091|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153981092|NCT00648531|Analgesics|analgesics|mesh-ancestor
153981093|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
153981094|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981095|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981096|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153981097|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981098|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153981100|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153981101|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153981102|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981103|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153981104|NCT00648843|Oxybutynin|oxybutynin|mesh-list
153981105|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
153981106|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
153981107|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981108|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981109|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153981110|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153981111|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
153981112|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981113|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981114|NCT00648843|Urological Agents|urological agents|mesh-ancestor
153981115|NCT02662959|Irinotecan|irinotecan|mesh-list
153981116|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153981117|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153981118|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981119|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981120|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981121|NCT02662647|Cytarabine|cytarabine|mesh-list
153981122|NCT02662647|Decitabine|decitabine|mesh-list
153981123|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
153981124|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153981125|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
153981126|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981127|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981128|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
153981129|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981130|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981131|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
153981132|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981133|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981134|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153981155|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981157|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
153981158|NCT02662491|Vitamin D|vitamin d|mesh-list
153981159|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
153981160|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
153981161|NCT02662491|Vitamins|vitamins|mesh-list
153981162|NCT02662491|Calcium|calcium|mesh-list
153981163|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
153981164|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981165|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153981166|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154140423|NCT00896948|Antibodies|antibodies|mesh-list
153981167|NCT00648999|Ritonavir|ritonavir|mesh-list
153981168|NCT00648999|Lopinavir|lopinavir|mesh-list
153981169|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153981170|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153981171|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981172|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981173|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981174|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153981175|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153981176|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
153981177|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981178|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153981179|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153981180|NCT02661711|Aflibercept|aflibercept|mesh-list
153981181|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153981182|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153981183|NCT02661711|Growth Substances|growth substances|mesh-ancestor
153981184|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981185|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
153981186|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981187|NCT02661789|Goserelin|goserelin|mesh-list
153981216|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981217|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981218|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
153981219|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
153981221|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
153981222|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153981223|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153981224|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981225|NCT00649935|Azithromycin|azithromycin|mesh-list
153603152|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
153981226|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153981227|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981228|NCT02655705|Cyclosporine|cyclosporine|mesh-list
153981229|NCT02655705|Methotrexate|methotrexate|mesh-list
153981230|NCT02655705|Cyclosporins|cyclosporins|mesh-list
153981231|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153981232|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
153981233|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153981234|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981248|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153981249|NCT02655471|Zidovudine|zidovudine|mesh-list
153981250|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
153981251|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
153981252|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981253|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153981254|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153981255|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981256|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
153981257|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981258|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153981259|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153981260|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153981261|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153981262|NCT00650013|Midodrine|midodrine|mesh-list
153981263|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
153981264|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
153981265|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981266|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981267|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153981268|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153981269|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153981270|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153981271|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
153981272|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981273|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981274|NCT00712933|Belimumab|belimumab|mesh-list
153981275|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981276|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
153981277|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981278|NCT02654847|Norepinephrine|norepinephrine|mesh-list
153981279|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153981280|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153981281|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
153981282|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860893|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140498|NCT06089733|Rifampin|rifampin|mesh-list
153981283|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981284|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981285|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
153981286|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
153981287|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981288|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153981289|NCT02536209|Oxycodone|oxycodone|mesh-list
153981290|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153981291|NCT02536209|Narcotics|narcotics|mesh-ancestor
153981292|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981293|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981294|NCT02536209|Analgesics|analgesics|mesh-ancestor
153981295|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
153981296|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981297|NCT00732745|Docetaxel|docetaxel|mesh-list
153981298|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
153981308|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153981309|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981310|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
153603280|NCT01910428|Asparaginase|asparaginase|mesh-list
153981311|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981312|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981313|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153981314|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
153981315|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
153981316|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981317|NCT00712543|Lactulose|lactulose|mesh-list
153981318|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153981319|NCT00650169|Clopidogrel|clopidogrel|mesh-list
153981320|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153634930|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
153981321|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153981322|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153981323|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153738920|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
153981324|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
153981325|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981326|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981327|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981328|NCT04064125|Minocycline|minocycline|mesh-list
153981329|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153981330|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981331|NCT00740389|Etravirine|etravirine|mesh-list
153981332|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153981333|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153981334|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981335|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981336|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
153981337|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981338|NCT00740467|Cyclosporine|cyclosporine|mesh-list
153981339|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
153981340|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
153981341|NCT00740467|Busulfan|busulfan|mesh-list
153981342|NCT00740467|Fludarabine|fludarabine|mesh-list
153981343|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
153981344|NCT00740467|Cyclosporins|cyclosporins|mesh-list
153981345|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153981346|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981347|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
153981348|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981349|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981350|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153981351|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
153981352|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981353|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981354|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153981355|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153981356|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
153981357|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981358|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
153981359|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981360|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
153981361|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153981362|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154860894|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153981376|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981378|NCT00733057|Minocycline|minocycline|mesh-list
153981379|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153981380|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981381|NCT00737971|Triamcinolone|triamcinolone|mesh-list
153981382|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153981383|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153981384|NCT00737971|Bevacizumab|bevacizumab|mesh-list
153981385|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153981386|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153981387|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981388|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153981389|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153981390|NCT00737971|Growth Substances|growth substances|mesh-ancestor
153981391|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981392|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
153981393|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153981394|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
153981395|NCT00737971|Hormones|hormones|mesh-ancestor
153981396|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981397|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981398|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
153981399|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981400|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981401|NCT00650247|Sumatriptan|sumatriptan|mesh-list
153981402|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153981403|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153981404|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153981405|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
153981406|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981407|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981408|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981410|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
153981411|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153981412|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981413|NCT02653209|Pioglitazone|pioglitazone|mesh-list
153981414|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153981415|NCT02653209|Canagliflozin|canagliflozin|mesh-list
153981416|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153981417|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981418|NCT02653209|Incretins|incretins|mesh-ancestor
153981420|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981421|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153981422|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981423|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981424|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981432|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981434|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981435|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981436|NCT02652585|Naltrexone|naltrexone|mesh-list
153981437|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153981438|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153981439|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981440|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
153981441|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981442|NCT00741169|Rifampin|rifampin|mesh-list
153981443|NCT00741169|Simeprevir|simeprevir|mesh-list
153981444|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153981445|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
153981446|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153981447|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981448|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
153981449|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153981450|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981451|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981452|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153981453|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153981454|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153981455|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153981456|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153981457|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153981458|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
153981459|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981460|NCT00741325|Plerixafor|plerixafor|mesh-list
153981461|NCT00741325|Lenograstim|lenograstim|mesh-list
153981462|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153981463|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
153981464|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981465|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153981466|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153981467|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
153981468|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981469|NCT02652741|Enalapril|enalapril|mesh-list
153981471|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153981472|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
153739068|NCT00337051|Propofol|propofol|mesh-list
153981473|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981474|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981475|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153981476|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
153981478|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153981479|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981480|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981481|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153981482|NCT02652507|Analgesics|analgesics|mesh-ancestor
153981483|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
153981484|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981485|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153981486|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153981487|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153981488|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
153981489|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981490|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768467|NCT00479713|Ezetimibe|ezetimibe|mesh-list
153981500|NCT02652273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153981502|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981503|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
153981504|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981505|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981506|NCT00650325|Sertraline|sertraline|mesh-list
153981507|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
153981508|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153981509|NCT00650325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153981510|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153981511|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153981512|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981513|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981514|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
153981515|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981516|NCT00650403|Paroxetine|paroxetine|mesh-list
153981517|NCT00650403|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153981518|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153981519|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153981520|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981521|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981522|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
153981523|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981524|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153981525|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
153981526|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153981527|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153981528|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153981529|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981530|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153981531|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153981532|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
153981533|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981534|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981535|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153981536|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
153981537|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153981538|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153981539|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153981540|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
153981541|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255063|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
153981542|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981543|NCT00920803|Resveratrol|resveratrol|mesh-list
153981544|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
153981545|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981546|NCT00920803|Protective Agents|protective agents|mesh-ancestor
153981547|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981548|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981549|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153981550|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
153981551|NCT04316169|Letrozole|letrozole|mesh-list
153981552|NCT04316169|Fulvestrant|fulvestrant|mesh-list
153981576|NCT05740969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981577|NCT05740969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981578|NCT05740969|Immunologic Factors|immunologic factors|mesh-ancestor
153981579|NCT05740969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981580|NCT05740969|Antioxidants|antioxidants|mesh-ancestor
153981581|NCT05740969|Protective Agents|protective agents|mesh-ancestor
153981582|NCT05740969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981583|NCT05740969|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153981584|NCT05740969|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153981585|NCT05740969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153981586|NCT05740969|Interferon Inducers|interferon inducers|mesh-ancestor
153981587|NCT02568241|Interferons|interferons|mesh-list
153981588|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
153981589|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
153981590|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981591|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
153981592|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981593|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
153981594|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981595|NCT05551897|Itraconazole|itraconazole|mesh-list
153981596|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
153981597|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981598|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153981599|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153981600|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981601|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981602|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153981603|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
153981629|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
153981630|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981631|NCT03818763|Factor VIII|factor viii|mesh-list
153981632|NCT03818763|Coagulants|coagulants|mesh-ancestor
153981633|NCT02647047|Acetaminophen|acetaminophen|mesh-list
153981634|NCT02647047|Ketorolac|ketorolac|mesh-list
153981635|NCT02647047|Sufentanil|sufentanil|mesh-list
153981636|NCT02647047|Ropivacaine|ropivacaine|mesh-list
153981637|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
153981638|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
153981639|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981640|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981641|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
153981642|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981643|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153981644|NCT02647047|Analgesics|analgesics|mesh-ancestor
153981645|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
153603590|NCT01912443|Bevacizumab|bevacizumab|mesh-list
153981646|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153981647|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153981648|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768646|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153981659|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153981660|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153981661|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
153981662|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981663|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981664|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153981665|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
153981666|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
153981667|NCT00651651|Hormones|hormones|mesh-ancestor
153981668|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981669|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153981670|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153981671|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153981672|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
153981673|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860895|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981674|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981675|NCT00709111|Maraviroc|maraviroc|mesh-list
153981676|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153981677|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153981678|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981679|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153981680|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153981681|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
153981682|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981683|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153981684|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
153981685|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153981686|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153981687|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153981688|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153981689|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981690|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
153981691|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981692|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981694|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981695|NCT02646735|Fulvestrant|fulvestrant|mesh-list
153981696|NCT02646735|Exemestane|exemestane|mesh-list
153981697|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153981698|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981699|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153981700|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153981701|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
153981702|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981703|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981704|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153981705|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153981706|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981707|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981708|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153981709|NCT02646657|Vedolizumab|vedolizumab|mesh-list
153981710|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153981711|NCT00652041|Thalidomide|thalidomide|mesh-list
153981712|NCT00652041|Bortezomib|bortezomib|mesh-list
153768693|NCT00196391|Progesterone|progesterone|mesh-list
153981735|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
153981736|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
153981737|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981738|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153981739|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153981740|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153981741|NCT00652119|Growth Substances|growth substances|mesh-ancestor
153981742|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981743|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
153981744|NCT05740657|Fentanyl|fentanyl|mesh-list
153981745|NCT05740657|Sufentanil|sufentanil|mesh-list
153981746|NCT05740657|Morphine|morphine|mesh-list
153981747|NCT05740657|Remifentanil|remifentanil|mesh-list
153981748|NCT05740657|Oxycodone|oxycodone|mesh-list
153981749|NCT05740657|Hydromorphone|hydromorphone|mesh-list
153981750|NCT05740657|Alfentanil|alfentanil|mesh-list
153981751|NCT05740657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153981752|NCT05740657|Narcotics|narcotics|mesh-ancestor
153981753|NCT05740657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981754|NCT05740657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981755|NCT05740657|Analgesics|analgesics|mesh-ancestor
153981756|NCT05740657|Sensory System Agents|sensory system agents|mesh-ancestor
153981757|NCT05740657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981758|NCT05740657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153981759|NCT05740657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153981760|NCT05740657|Anesthetics, General|anesthetics, general|mesh-ancestor
153981761|NCT05740657|Anesthetics|anesthetics|mesh-ancestor
153981762|NCT02646267|Warfarin|warfarin|mesh-list
153981763|NCT02646267|Dabigatran|dabigatran|mesh-list
153981764|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
153981765|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
153739373|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
153981766|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153981767|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981768|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981782|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
153981783|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153981784|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154140874|NCT05795413|Anesthetics|anesthetics|mesh-ancestor
153981786|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
153981787|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
153981788|NCT02645565|Azathioprine|azathioprine|mesh-list
153981789|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153981790|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
153981791|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981792|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
153981793|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981794|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981795|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153981796|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
153981797|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981798|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981799|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153981800|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153981801|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
153981802|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
153981803|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981804|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153981805|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
153981806|NCT02645565|Hormones|hormones|mesh-ancestor
153981807|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981808|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153981809|NCT02645565|Protective Agents|protective agents|mesh-ancestor
153981810|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153981811|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
153981812|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153981813|NCT00699907|Flutamide|flutamide|mesh-list
153981814|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
153981815|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
153981816|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981817|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981818|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153981819|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981820|NCT00599313|Sunitinib|sunitinib|mesh-list
153981821|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981822|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153981823|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153981824|NCT00599313|Growth Substances|growth substances|mesh-ancestor
153981825|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981826|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
153981827|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153981828|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981829|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981830|NCT00708175|Pioglitazone|pioglitazone|mesh-list
153981831|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153981832|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739445|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153981843|NCT00733525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153981844|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153981845|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153981846|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981847|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981848|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
153981849|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981850|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153981851|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
153981852|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153981853|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153981854|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153981855|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981856|NCT02567149|Cidofovir|cidofovir|mesh-list
153981857|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
153981858|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981859|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981860|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981861|NCT00707239|Imipenem|imipenem|mesh-list
153981862|NCT00707239|Tigecycline|tigecycline|mesh-list
153981863|NCT00707239|Cilastatin|cilastatin|mesh-list
153981864|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153981865|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981866|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154860896|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153603752|NCT01913431|Entecavir|entecavir|mesh-list
153603819|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
153981867|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981868|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981869|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981870|NCT00968708|Alogliptin|alogliptin|mesh-list
153981871|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153981872|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981873|NCT00968708|Incretins|incretins|mesh-ancestor
153981874|NCT00968708|Hormones|hormones|mesh-ancestor
153981875|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981876|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153981877|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981878|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981879|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981880|NCT04062565|Treprostinil|treprostinil|mesh-list
153981881|NCT04062565|Riociguat|riociguat|mesh-list
153981882|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153981883|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
153981884|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981885|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
153981886|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153981887|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
153981888|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
153981889|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981890|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981891|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153981892|NCT00967694|Analgesics|analgesics|mesh-ancestor
153981893|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
153981894|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981895|NCT04288700|Timolol|timolol|mesh-list
153981912|NCT02863406|Dimercaprol|dimercaprol|mesh-list
153981913|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
153981914|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
153981915|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739524|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153981916|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
153981917|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981918|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981919|NCT00629720|Alfuzosin|alfuzosin|mesh-list
153981920|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153981921|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153981922|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153981923|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
153981924|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981925|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981926|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981927|NCT00629720|Urological Agents|urological agents|mesh-ancestor
153981928|NCT00967616|Leucovorin|leucovorin|mesh-list
153981929|NCT00967616|Fluorouracil|fluorouracil|mesh-list
153981930|NCT00967616|Irinotecan|irinotecan|mesh-list
153981931|NCT00967616|Efatutazone|efatutazone|mesh-list
153981932|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
153981933|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
153981934|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981935|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153981936|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603821|NCT01914042|Narcotics|narcotics|mesh-ancestor
153981937|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981938|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
153981939|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981940|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153981941|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153981942|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981943|NCT00967616|Antidotes|antidotes|mesh-ancestor
153981944|NCT00967616|Protective Agents|protective agents|mesh-ancestor
153981945|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
153981946|NCT00967616|Vitamins|vitamins|mesh-ancestor
153981947|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
153981948|NCT04288232|Aflibercept|aflibercept|mesh-list
153981949|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153981950|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153981951|NCT04288232|Growth Substances|growth substances|mesh-ancestor
153981952|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981953|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
153768939|NCT00196703|Memantine|memantine|mesh-list
153981972|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153981973|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
153981975|NCT00653757|Goserelin|goserelin|mesh-list
153981976|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153981977|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
153981978|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153981979|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981980|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153981981|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981982|NCT00654225|Atorvastatin|atorvastatin|mesh-list
153981983|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153981984|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153981985|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153981986|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
153981987|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981988|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153981989|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153981990|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981991|NCT00974090|Glimepiride|glimepiride|mesh-list
153981992|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153981993|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153981994|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981996|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
153981997|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153981998|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153981999|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153982000|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
153982001|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982002|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153982003|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153982004|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982005|NCT02639091|Pemetrexed|pemetrexed|mesh-list
153982006|NCT02639091|Anetumab ravtansine|anetumab ravtansine|mesh-list
153982007|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982008|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982009|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982010|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153982011|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153982012|NCT02639091|Immunoconjugates|immunoconjugates|mesh-ancestor
153982013|NCT02639091|Immunologic Factors|immunologic factors|mesh-ancestor
153768999|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
153982029|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982030|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153982031|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153982032|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982034|NCT02638857|Mitomycins|mitomycins|mesh-list
153982035|NCT02638857|Mitomycin|mitomycin|mesh-list
153982036|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
153982037|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153982038|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982039|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153982040|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153982041|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982042|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982043|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
153982044|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153982045|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
153982046|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153982047|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153982048|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982049|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153982050|NCT02638545|Analgesics|analgesics|mesh-ancestor
153982051|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
153982052|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982053|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153982054|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153982055|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153982056|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
153982057|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982058|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982059|NCT02638467|Bosutinib|bosutinib|mesh-list
153982060|NCT02638467|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153982061|NCT02638467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153982062|NCT02638467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982063|NCT02638467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982064|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
153982065|NCT02638233|Ledipasvir|ledipasvir|mesh-list
153982066|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
153982067|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982069|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153982070|NCT04285268|Bortezomib|bortezomib|mesh-list
153982071|NCT04285268|Venetoclax|venetoclax|mesh-list
153982072|NCT04285268|Antibodies|antibodies|mesh-list
153982073|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
153982074|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153982075|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
153982103|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153982104|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153982105|NCT02635893|Cycloserine|cycloserine|mesh-list
153982106|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153982107|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982108|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153982109|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
153982110|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153982111|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
153982112|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982113|NCT02567773|Itraconazole|itraconazole|mesh-list
153982114|NCT02567773|GSK2881078|gsk2881078|mesh-list
153982115|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
153982116|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982117|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153982118|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153982119|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982120|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982145|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
153982146|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153982147|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153982148|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153982150|NCT00964886|Desipramine|desipramine|mesh-list
153982151|NCT00964886|Clomipramine|clomipramine|mesh-list
153982152|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153982153|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
153982154|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153982155|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982156|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982157|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153982158|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153982159|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153982160|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
153982161|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982162|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982163|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153982164|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153982165|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
153982166|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
153982167|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982168|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153769161|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
153982175|NCT02861222|Doxorubicin|doxorubicin|mesh-list
153982176|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153982177|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982178|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153982179|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153982180|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982181|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982182|NCT04062019|Aldesleukin|aldesleukin|mesh-list
153982183|NCT04062019|Interleukin-2|interleukin-2|mesh-list
153982184|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982185|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153982186|NCT04062019|Analgesics|analgesics|mesh-ancestor
153982187|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
153982188|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982189|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982190|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153982191|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153982192|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
153982193|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982194|NCT04061863|Nivolumab|nivolumab|mesh-list
153982195|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982196|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982197|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982198|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982199|NCT02861378|Phentolamine|phentolamine|mesh-list
154860897|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
153982200|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153982201|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153982202|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
153982203|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982204|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982205|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982206|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153982207|NCT00705757|Bimatoprost|bimatoprost|mesh-list
153982208|NCT00705757|Travoprost|travoprost|mesh-list
153982209|NCT00705757|Latanoprost|latanoprost|mesh-list
153982210|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153982211|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153982212|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153982213|NCT04284644|Propofol|propofol|mesh-list
153982214|NCT04284644|Sevoflurane|sevoflurane|mesh-list
153982215|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153982216|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153982217|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982218|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153982219|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
153982221|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153982222|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153982223|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153982224|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
153982225|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982227|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153982228|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982229|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
153982230|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
153982231|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153982232|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153982233|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982234|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982235|NCT04283240|Urological Agents|urological agents|mesh-ancestor
153982236|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
153982237|NCT03588884|Vitamin D|vitamin d|mesh-list
153982238|NCT03588884|Calcifediol|calcifediol|mesh-list
153982239|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153769209|NCT00203723|Risperidone|risperidone|mesh-list
153982268|NCT00758524|Eplerenone|eplerenone|mesh-list
153982269|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153982270|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
153982271|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982272|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982273|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153982274|NCT00758524|Diuretics|diuretics|mesh-ancestor
153982275|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
153982276|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153982277|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
153982278|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153982279|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
153982280|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153982281|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982282|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153982283|NCT00757588|Insulin|insulin|mesh-list
153982284|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153769278|NCT00208923|Busulfan|busulfan|mesh-list
153604182|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982304|NCT00705679|Tenofovir|tenofovir|mesh-list
153982305|NCT00705679|Emtricitabine|emtricitabine|mesh-list
153982306|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153982307|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
153982308|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982309|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153982310|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153982311|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982312|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982313|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153982314|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153982315|NCT04092868|Protamines|protamines|mesh-list
153982316|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
153982317|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982318|NCT04092868|Coagulants|coagulants|mesh-ancestor
153982319|NCT00916942|Lidocaine|lidocaine|mesh-list
153982320|NCT00916942|Prilocaine|prilocaine|mesh-list
153982321|NCT00916942|Capsaicin|capsaicin|mesh-list
153982322|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
153982323|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
153982324|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153982325|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982326|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
153982327|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982328|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153982329|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153982330|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153982331|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153982332|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982333|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
153982334|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
153982335|NCT00751114|Metformin|metformin|mesh-list
153982336|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
153982337|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153982351|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982353|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153982354|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982355|NCT02598466|Abatacept|abatacept|mesh-list
153982356|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982357|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982358|NCT02598466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982359|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982360|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153982361|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
153982362|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635993|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
153982363|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982364|NCT05973370|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153982365|NCT05973370|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153982366|NCT05973370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153982367|NCT05973318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153982368|NCT05973318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153982369|NCT05973305|Dorzolamide|dorzolamide|mesh-list
153982370|NCT05973305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153982371|NCT05973305|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153982372|NCT05973305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982373|NCT05973305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982374|NCT05973253|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153982375|NCT05973253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153982376|NCT05973253|Contraceptive Agents|contraceptive agents|mesh-ancestor
153982377|NCT05973253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153982378|NCT05973253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982379|NCT05973253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153982380|NCT05973253|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153982381|NCT05973253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153982382|NCT05973253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982383|NCT05973188|Warfarin|warfarin|mesh-list
153982384|NCT05973188|Rivaroxaban|rivaroxaban|mesh-list
153982385|NCT05973188|Apixaban|apixaban|mesh-list
153982386|NCT05973188|Anticoagulants|anticoagulants|mesh-ancestor
153982387|NCT05973188|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153982388|NCT05973188|Antithrombins|antithrombins|mesh-ancestor
153982389|NCT05973188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153982390|NCT05973188|Protease Inhibitors|protease inhibitors|mesh-ancestor
153982391|NCT05973188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982392|NCT05973188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982393|NCT05973071|Contraceptive Agents|contraceptive agents|mesh-list
153982394|NCT05973071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153769377|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
153982411|NCT05972902|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153982412|NCT05972902|Cetrorelix|cetrorelix|mesh-list
153982413|NCT05972902|Dydrogesterone|dydrogesterone|mesh-list
153982414|NCT05972902|Luteolytic Agents|luteolytic agents|mesh-ancestor
153982415|NCT05972902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153982416|NCT05972902|Contraceptive Agents|contraceptive agents|mesh-ancestor
153982417|NCT05972902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153982418|NCT05972902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982419|NCT05972902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153982420|NCT05972902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153982421|NCT05972902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982422|NCT05972902|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153982423|NCT05972902|Fertility Agents|fertility agents|mesh-ancestor
153982424|NCT05972902|Hormone Antagonists|hormone antagonists|mesh-ancestor
153982425|NCT05972902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982426|NCT05972902|Progestins|progestins|mesh-ancestor
153982427|NCT05972902|Hormones|hormones|mesh-ancestor
153982428|NCT05972785|Calcium Channel Blockers|calcium channel blockers|mesh-list
153982429|NCT05972785|Calcium|calcium|mesh-list
153982430|NCT05972785|Diuretics|diuretics|mesh-list
153982431|NCT05972785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153982432|NCT05972785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153982433|NCT05972785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982434|NCT05972785|Natriuretic Agents|natriuretic agents|mesh-ancestor
153982435|NCT05972785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153982436|NCT05972785|Adrenergic Agents|adrenergic agents|mesh-ancestor
153982437|NCT05972785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982438|NCT05972785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982439|NCT05972785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153982440|NCT05972603|Vancomycin|vancomycin|mesh-list
153982441|NCT05972603|Povidone-Iodine|povidone-iodine|mesh-list
153982442|NCT05972603|Povidone|povidone|mesh-list
153982443|NCT05972603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153982444|NCT05972603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982445|NCT05972603|Plasma Substitutes|plasma substitutes|mesh-ancestor
153982446|NCT05972603|Blood Substitutes|blood substitutes|mesh-ancestor
153982447|NCT05972603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153982448|NCT05972434|Sunscreening Agents|sunscreening agents|mesh-list
153982449|NCT05972434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153982450|NCT05972434|Protective Agents|protective agents|mesh-ancestor
153982451|NCT05972434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769439|NCT00204308|Tenofovir|tenofovir|mesh-list
153982467|NCT05971550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153982469|NCT05971550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982470|NCT05971550|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153982471|NCT05971550|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153982472|NCT05971394|Sirolimus|sirolimus|mesh-list
153982473|NCT05971394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153982474|NCT05971394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982475|NCT05971394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153982476|NCT05971394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982477|NCT05971394|Antifungal Agents|antifungal agents|mesh-ancestor
153982478|NCT05971394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153982479|NCT05971394|Immunologic Factors|immunologic factors|mesh-ancestor
153982480|NCT05971394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982481|NCT05971186|Ibuprofen|ibuprofen|mesh-list
153982482|NCT05971186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153982483|NCT05971186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153982484|NCT05971186|Analgesics|analgesics|mesh-ancestor
153982485|NCT05971186|Sensory System Agents|sensory system agents|mesh-ancestor
153982486|NCT05971186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982487|NCT05971186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982488|NCT05971186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982489|NCT05971186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982490|NCT05971186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153982491|NCT05971186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982492|NCT05971186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982493|NCT05971004|Methylprednisolone|methylprednisolone|mesh-list
153982494|NCT05971004|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153982495|NCT05971004|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153982496|NCT05971004|Prednisolone|prednisolone|mesh-list
153982497|NCT05971004|Prednisolone acetate|prednisolone acetate|mesh-list
153982498|NCT05971004|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153982499|NCT05971004|Prednisolone phosphate|prednisolone phosphate|mesh-list
153982500|NCT05971004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982501|NCT05971004|Antiemetics|antiemetics|mesh-ancestor
153982502|NCT05971004|Autonomic Agents|autonomic agents|mesh-ancestor
153982503|NCT05971004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982504|NCT05971004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982505|NCT05971004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153982506|NCT05971004|Glucocorticoids|glucocorticoids|mesh-ancestor
153982507|NCT05971004|Hormones|hormones|mesh-ancestor
153982508|NCT05971004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982509|NCT05971004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153982510|NCT05971004|Protective Agents|protective agents|mesh-ancestor
153982511|NCT05971004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153982512|NCT05971004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982530|NCT05916352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982532|NCT05916352|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153982533|NCT05916352|Purinergic Agents|purinergic agents|mesh-ancestor
153982534|NCT05916352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982535|NCT05813964|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153982536|NCT05813964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153982537|NCT05813964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153982538|NCT05813964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153982539|NCT05813964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982540|NCT05813964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982541|NCT05813964|Antiviral Agents|antiviral agents|mesh-ancestor
153982542|NCT05813964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982543|NCT05813964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153982544|NCT05813964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153982545|NCT05739006|Pembrolizumab|pembrolizumab|mesh-list
153982546|NCT05739006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982547|NCT05739006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982548|NCT05739006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982549|NCT05739006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982550|NCT05695027|Niacinamide|niacinamide|mesh-list
153982551|NCT05695027|Niacin|niacin|mesh-list
153982552|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
153982553|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
153982554|NCT05695027|Vitamins|vitamins|mesh-ancestor
153982555|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
153982556|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982557|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153982558|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
153982559|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982560|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153982561|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
153982562|NCT05631795|Fulvestrant|fulvestrant|mesh-list
153982563|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153982564|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982565|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153982566|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153982567|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
153982568|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769557|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
153982577|NCT05480384|Trastuzumab|trastuzumab|mesh-list
153982578|NCT05480384|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153982579|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982580|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982581|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982582|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982583|NCT05480384|Immunoconjugates|immunoconjugates|mesh-ancestor
153982584|NCT05480384|Immunologic Factors|immunologic factors|mesh-ancestor
153982585|NCT05480384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982586|NCT05388149|Neratinib|neratinib|mesh-list
153982587|NCT05388149|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153982588|NCT05388149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153982589|NCT05388149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982590|NCT05388149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982592|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153982593|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982594|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
153982595|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153982596|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153982597|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153982598|NCT05303324|Choline|choline|mesh-list
153982599|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
153982600|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153982601|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
153982602|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982603|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153982604|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153982605|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
153982606|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
153982607|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
153982608|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982609|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153982610|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153982611|NCT05303324|Growth Substances|growth substances|mesh-ancestor
154141486|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
153982612|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982613|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
153982614|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982616|NCT05238207|Cathartics|cathartics|mesh-ancestor
153982617|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153982618|NCT05213104|Flecainide|flecainide|mesh-list
153982619|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153982620|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153982621|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153982622|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153982623|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982624|NCT05195177|Anesthetics|anesthetics|mesh-list
153982625|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
153982626|NCT05195177|Histamine|histamine|mesh-list
153982627|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
153982628|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153982629|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153982630|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982631|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
153982632|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982633|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
153982634|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
153982635|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982636|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982637|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
153982647|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153982648|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153982649|NCT05150431|Analgesics|analgesics|mesh-ancestor
153982650|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
153982651|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982652|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982653|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982654|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982655|NCT05013502|Empagliflozin|empagliflozin|mesh-list
153982656|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153982657|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982658|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153982659|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982660|NCT05007392|Febuxostat|febuxostat|mesh-list
153982662|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
153982663|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153740267|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982664|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
153982665|NCT04909853|Ritonavir|ritonavir|mesh-list
153982666|NCT04909853|Nirmatrelvir|nirmatrelvir|mesh-list
153982667|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153982668|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153982669|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
153982670|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982671|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982672|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153982673|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153982674|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
153982675|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982676|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153982677|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153982678|NCT04733534|Dasatinib|dasatinib|mesh-list
153982679|NCT04733534|Quercetin|quercetin|mesh-list
153982680|NCT04733534|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153982681|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153982682|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982683|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982684|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982685|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
153982686|NCT04733534|Protective Agents|protective agents|mesh-ancestor
153982687|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982688|NCT04727307|Bevacizumab|bevacizumab|mesh-list
153982689|NCT04727307|Atezolizumab|atezolizumab|mesh-list
153982690|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153982691|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982692|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982693|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153982694|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153982695|NCT04727307|Growth Substances|growth substances|mesh-ancestor
153982696|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982697|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
153982698|NCT04727307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982699|NCT04727307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982700|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
153982722|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982724|NCT04528173|Fentanyl|fentanyl|mesh-list
153982725|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
153982726|NCT04528173|Morphine|morphine|mesh-list
153982727|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153982728|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153982729|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982730|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153982731|NCT04528173|Analgesics|analgesics|mesh-ancestor
153982732|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
153982733|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982734|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153982735|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153982736|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153982737|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
153982738|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982739|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604619|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982740|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153982741|NCT04528173|Narcotics|narcotics|mesh-ancestor
153982742|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153982743|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153982744|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
153982745|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
153982746|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153982747|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982748|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982749|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153982750|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982751|NCT04519944|Edoxaban|edoxaban|mesh-list
153982752|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153982753|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
153769754|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
153982771|NCT04353661|Azithromycin|azithromycin|mesh-list
153982772|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153982773|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982774|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
153982775|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153982776|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
153982777|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982778|NCT04154982|Expectorants|expectorants|mesh-ancestor
153982779|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
153982780|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153982781|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
153982782|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982783|NCT04154982|Protective Agents|protective agents|mesh-ancestor
153982784|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982785|NCT04154982|Antidotes|antidotes|mesh-ancestor
153982786|NCT04040231|Nivolumab|nivolumab|mesh-list
153982787|NCT04040231|Sargramostim|sargramostim|mesh-list
153982788|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982789|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982790|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982791|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982792|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
153982793|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982794|NCT04026256|Denosumab|denosumab|mesh-list
153982795|NCT04026256|Teriparatide|teriparatide|mesh-list
153982796|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153982797|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982798|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153982799|NCT03928288|Cabergoline|cabergoline|mesh-list
153982800|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153982801|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153982802|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
153982803|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
153982804|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982805|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982806|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982807|NCT03789604|Antibodies|antibodies|mesh-list
153982808|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153982809|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
153982810|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769798|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
153982821|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982822|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
153982824|NCT03662074|Nivolumab|nivolumab|mesh-list
153982825|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153982826|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
153982827|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982828|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982829|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982830|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982831|NCT03602859|Niraparib|niraparib|mesh-list
153982832|NCT03602859|Dostarlimab|dostarlimab|mesh-list
153982833|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153982834|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982835|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982836|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982837|NCT03542175|Rucaparib|rucaparib|mesh-list
153982838|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153982839|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982840|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982841|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982842|NCT03519230|Pamiparib|pamiparib|mesh-list
153982843|NCT03519230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153982844|NCT03519230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982845|NCT03519230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982846|NCT03519230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982847|NCT03402503|Montelukast|montelukast|mesh-list
153982848|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153982849|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
153982850|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153982851|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
153982852|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982853|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982854|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153982855|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153982856|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982857|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153982858|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
153982859|NCT03389412|Coagulants|coagulants|mesh-ancestor
153982860|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153982861|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
153982862|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982863|NCT03260023|Avelumab|avelumab|mesh-list
153982864|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982865|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982866|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
153982867|NCT03220477|Guadecitabine|guadecitabine|mesh-list
153982868|NCT03220477|Mocetinostat|mocetinostat|mesh-list
153982869|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982870|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982871|NCT03220477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982872|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982873|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153982874|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982875|NCT03095612|Docetaxel|docetaxel|mesh-list
153982937|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153982938|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153982939|NCT02632175|Adalimumab|adalimumab|mesh-list
153982940|NCT02632175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153982941|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982942|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982943|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
153982944|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
153982945|NCT02566304|Fludarabine|fludarabine|mesh-list
153982946|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
153982947|NCT02566304|Tacrolimus|tacrolimus|mesh-list
153982948|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153982949|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
153982950|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982951|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982952|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153982953|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
153982954|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982955|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982956|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153982957|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153604712|NCT01919203|Analgesics|analgesics|mesh-ancestor
153604792|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153982959|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982960|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154176486|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769963|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
153982979|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153982980|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
153982981|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982982|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982983|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153982984|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982985|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153982986|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153982987|NCT01946529|Growth Substances|growth substances|mesh-ancestor
153982988|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
153982989|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153982990|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153982991|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153982992|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982993|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153982994|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
153982995|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
153982996|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
153982997|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153982998|NCT01946529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153982999|NCT00878254|Leucovorin|leucovorin|mesh-list
153983000|NCT00878254|Cytarabine|cytarabine|mesh-list
153983001|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
153983002|NCT00878254|Ifosfamide|ifosfamide|mesh-list
153983003|NCT00878254|Rituximab|rituximab|mesh-list
153983004|NCT00878254|Doxorubicin|doxorubicin|mesh-list
153983005|NCT00878254|Methotrexate|methotrexate|mesh-list
153983006|NCT00878254|Etoposide|etoposide|mesh-list
153983007|NCT00878254|Vincristine|vincristine|mesh-list
153983008|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983009|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
153983010|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983011|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983012|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153983013|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
153983014|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983015|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983016|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153983017|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983018|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153983019|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153983020|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153983021|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770010|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
153983043|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983044|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153983045|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153983046|NCT00813423|Growth Substances|growth substances|mesh-ancestor
153983047|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983048|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
153983049|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153983050|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983051|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983052|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
153983053|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153983054|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153983055|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983056|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983058|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
153983059|NCT00146562|Doxorubicin|doxorubicin|mesh-list
153983060|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
153983061|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153983062|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983063|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
154255066|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
153983064|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983065|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983066|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983067|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983068|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
153983069|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983070|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983071|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153983072|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
153983073|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153983074|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153983075|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153983076|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153983090|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153983091|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983092|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983093|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983094|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153983095|NCT04089592|Narcotics|narcotics|mesh-ancestor
153983096|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153983097|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153983098|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
153983099|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
153983100|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
153983101|NCT00751036|Nilotinib|nilotinib|mesh-list
153983102|NCT00751036|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153983103|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153983104|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983105|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983106|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983107|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153983108|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153983109|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153983110|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153983111|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176487|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983112|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983113|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983114|NCT00961298|Analgesics|analgesics|mesh-ancestor
153983115|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
153983116|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983117|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
153983118|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153983119|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
153983121|NCT00744328|Estradiol|estradiol|mesh-list
153983122|NCT00744328|Estrogens|estrogens|mesh-ancestor
153983123|NCT00744328|Hormones|hormones|mesh-ancestor
153983124|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983125|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983126|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
153983127|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153983128|NCT00744328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153983129|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153983130|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153983131|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983132|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983133|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
153983134|NCT04019782|Hylan|hylan|mesh-list
153983135|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
153983136|NCT04019782|Protective Agents|protective agents|mesh-ancestor
153983137|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983155|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
153983156|NCT03245840|Hormones|hormones|mesh-ancestor
153983157|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983158|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
153983159|NCT04091698|Ubiquinone|ubiquinone|mesh-list
153983160|NCT04091698|Vitamins|vitamins|mesh-ancestor
153983161|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
153983162|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983163|NCT04281290|Bleomycin|bleomycin|mesh-list
153983164|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153983165|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860898|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983166|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
153983167|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153983168|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983169|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983170|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983171|NCT00959894|Tenofovir|tenofovir|mesh-list
153983172|NCT00959894|Emtricitabine|emtricitabine|mesh-list
153983173|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153983174|NCT00959894|Etravirine|etravirine|mesh-list
153983175|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
153983176|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983177|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153983178|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153983179|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983180|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983181|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153983182|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153983183|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
153983184|NCT02599168|Propofol|propofol|mesh-list
153983185|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153983186|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176488|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
153983187|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983188|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153983189|NCT02599168|Analgesics|analgesics|mesh-ancestor
153983190|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
153983191|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983192|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153983193|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153983211|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153983212|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153983213|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983214|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983215|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983216|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605039|NCT01930331|Artemisinin|artemisinin|mesh-list
153983217|NCT00749944|Varenicline|varenicline|mesh-list
153983218|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153983219|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153983220|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
153983221|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983222|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983223|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983224|NCT02597140|Lidocaine|lidocaine|mesh-list
153983225|NCT02597140|Propofol|propofol|mesh-list
153983226|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
153983227|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
153983228|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983229|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983230|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
153983231|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983232|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153983233|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153983234|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153983235|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153983236|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983237|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153983238|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153983239|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
153983240|NCT02598310|Paclitaxel|paclitaxel|mesh-list
153983241|NCT02598310|Trastuzumab|trastuzumab|mesh-list
153983242|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153983243|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983244|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983245|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983246|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983247|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983248|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983249|NCT04091074|Clopidogrel|clopidogrel|mesh-list
153983260|NCT00749398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153983261|NCT00749398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153983262|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
153983263|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153983264|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983265|NCT01012973|Aflibercept|aflibercept|mesh-list
153983266|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153983267|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153983268|NCT01012973|Growth Substances|growth substances|mesh-ancestor
153983269|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983270|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
153983271|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983272|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
153983273|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
153983274|NCT03974464|Coagulants|coagulants|mesh-ancestor
153983275|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153983276|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153983277|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
153983278|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983279|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
153983281|NCT00742924|Cisplatin|cisplatin|mesh-list
153983282|NCT00742924|Doxorubicin|doxorubicin|mesh-list
153983283|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153983284|NCT00742924|Methotrexate|methotrexate|mesh-list
153983285|NCT00742924|Etoposide|etoposide|mesh-list
153983286|NCT00742924|Ifosfamide|ifosfamide|mesh-list
153983287|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
153983288|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
153983289|NCT00742924|Razoxane|razoxane|mesh-list
153983290|NCT00742924|Imidazole|imidazole|mesh-list
153983291|NCT00742924|Lenograstim|lenograstim|mesh-list
153983292|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
153983293|NCT00742924|Mesna|mesna|mesh-list
153983294|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983295|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153983296|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153983297|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153983298|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983299|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983300|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983301|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153983302|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
153983303|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153983304|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153983305|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
153983306|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153983307|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153983308|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983309|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
153983310|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983311|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153983312|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153983313|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153983314|NCT00742924|Antidotes|antidotes|mesh-ancestor
153983315|NCT00742924|Protective Agents|protective agents|mesh-ancestor
153983316|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
153983336|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153983337|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153740947|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154176489|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983338|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153983339|NCT00698815|Growth Substances|growth substances|mesh-ancestor
153983340|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983341|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
153983342|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153983344|NCT02599090|Sorafenib|sorafenib|mesh-list
153983345|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153983346|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
153983347|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983348|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983349|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153983350|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983351|NCT00745498|Bevacizumab|bevacizumab|mesh-list
153983352|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983353|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983354|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153983355|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153983356|NCT00745498|Growth Substances|growth substances|mesh-ancestor
153983357|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983358|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
153983359|NCT02596828|Sirolimus|sirolimus|mesh-list
153983360|NCT02596828|Irinotecan|irinotecan|mesh-list
153983361|NCT02596828|Temozolomide|temozolomide|mesh-list
153983362|NCT02596828|Dasatinib|dasatinib|mesh-list
153983363|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153983364|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153983365|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983366|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983367|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983368|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153983369|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
153983370|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153983371|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983384|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
153983385|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983387|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153983388|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983389|NCT00576901|Bevacizumab|bevacizumab|mesh-list
153983390|NCT00576901|Docetaxel|docetaxel|mesh-list
153983391|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983392|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983393|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153983394|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153983395|NCT00576901|Growth Substances|growth substances|mesh-ancestor
153983396|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983397|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
153983398|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983399|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983400|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983401|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983402|NCT00699283|Brivaracetam|brivaracetam|mesh-list
153983403|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
153983404|NCT04062721|Immunomodulating Agents|immunomodulating agents|mesh-list
153983405|NCT04062721|Immunologic Factors|immunologic factors|mesh-ancestor
153983406|NCT04062721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983407|NCT01023815|Cyclosporine|cyclosporine|mesh-list
153983408|NCT01023815|Everolimus|everolimus|mesh-list
153983409|NCT01023815|Cyclosporins|cyclosporins|mesh-list
153983410|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983411|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983412|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983413|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
153983414|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983415|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
153983416|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983417|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
153983418|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983419|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153983420|NCT01023815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153983421|NCT01023815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153983422|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983423|NCT02567383|Docetaxel|docetaxel|mesh-list
153983424|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983425|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983426|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983427|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983428|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983429|NCT01023659|Bupropion|bupropion|mesh-list
153983430|NCT01023659|Varenicline|varenicline|mesh-list
153983431|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153983432|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
153983433|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153983434|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153770424|NCT00229944|Azithromycin|azithromycin|mesh-list
153983454|NCT02567461|Edoxaban|edoxaban|mesh-list
153983455|NCT02567461|Clopidogrel|clopidogrel|mesh-list
153983456|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153983457|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153983458|NCT02567461|Analgesics|analgesics|mesh-ancestor
153983459|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
153983460|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983461|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983462|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153983463|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983464|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153983465|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153983466|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983467|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153983468|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153983469|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983470|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
153983471|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153983472|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153983473|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153983474|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
153983475|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983476|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153983477|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
153983478|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153983479|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
153983480|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
153983481|NCT00698581|Brivaracetam|brivaracetam|mesh-list
153983482|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
153983483|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
153983484|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
153983485|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153983486|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153983487|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983488|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176490|NCT00841139|Perhexiline|perhexiline|mesh-list
153770478|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983498|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153983500|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983501|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983502|NCT05571787|Rabeprazole|rabeprazole|mesh-list
153983503|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153983504|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153983505|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153983506|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983507|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983508|NCT04063189|Clarithromycin|clarithromycin|mesh-list
153983509|NCT04063189|Dexamethasone|dexamethasone|mesh-list
153983510|NCT04063189|Lenalidomide|lenalidomide|mesh-list
153983511|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153983512|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
153983513|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
153983514|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983515|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983516|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153983517|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
153983518|NCT04063189|Hormones|hormones|mesh-ancestor
153983519|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983520|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153983521|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983522|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
153983523|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153983524|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153983525|NCT04063189|Growth Substances|growth substances|mesh-ancestor
153983526|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
153983527|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153605288|NCT01931592|Fosfomycin|fosfomycin|mesh-list
153983528|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983529|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153983530|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983531|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983532|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153983533|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153983534|NCT02567929|Propofol|propofol|mesh-list
153983535|NCT02567929|Sevoflurane|sevoflurane|mesh-list
153983536|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153983537|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983538|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983539|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153983540|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
153983541|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
153983542|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153983543|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153983544|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153983545|NCT05188417|Tirofiban|tirofiban|mesh-list
153983546|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153983547|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153983548|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983549|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153770532|NCT00207701|Infliximab|infliximab|mesh-list
153983572|NCT00734656|Ethanol|ethanol|mesh-list
153983573|NCT00734656|Dutasteride|dutasteride|mesh-list
153983574|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153983575|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983576|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983577|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983578|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153983579|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153983580|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983581|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983582|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
153983583|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983584|NCT04644289|Durvalumab|durvalumab|mesh-list
153983585|NCT04644289|Olaparib|olaparib|mesh-list
153983586|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983587|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983588|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153983589|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983590|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983591|NCT02565979|Resveratrol|resveratrol|mesh-list
153983592|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
153983593|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983594|NCT02565979|Protective Agents|protective agents|mesh-ancestor
153983595|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983596|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983597|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153983598|NCT04062175|Azithromycin|azithromycin|mesh-list
153983599|NCT04062175|Cephalosporins|cephalosporins|mesh-list
153983600|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153983601|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983602|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
153983603|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153983604|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153983624|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153983625|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153983626|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983627|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983628|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983629|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153605384|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
153983630|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153983631|NCT01032239|Baclofen|baclofen|mesh-list
153983632|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153983633|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983634|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153983635|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983636|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153983637|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
153983638|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
153983639|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983640|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983641|NCT02871713|Morphine|morphine|mesh-list
153983642|NCT02871713|Ropivacaine|ropivacaine|mesh-list
153983643|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153983644|NCT02871713|Narcotics|narcotics|mesh-ancestor
153983645|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983646|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983647|NCT02871713|Analgesics|analgesics|mesh-ancestor
153983648|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
153983649|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983650|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
153983651|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
153983652|NCT00734578|Guanfacine|guanfacine|mesh-list
153983653|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153983654|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153983655|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153983656|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153983657|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983658|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983659|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770655|NCT00233532|Verapamil|verapamil|mesh-list
153983669|NCT00637715|Urological Agents|urological agents|mesh-ancestor
154142221|NCT00132691|Chlorambucil|chlorambucil|mesh-list
153983671|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983672|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983673|NCT02593708|Paclitaxel|paclitaxel|mesh-list
153983674|NCT02593708|Trastuzumab|trastuzumab|mesh-list
153983675|NCT02593708|Pertuzumab|pertuzumab|mesh-list
153983676|NCT02593708|Neratinib|neratinib|mesh-list
153983677|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153983678|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983679|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983680|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983681|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983682|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983683|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983684|NCT02593708|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153983685|NCT02593708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153983686|NCT02593708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983687|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
153983688|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153983689|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
153983690|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983691|NCT00696787|Pregabalin|pregabalin|mesh-list
153983692|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153983693|NCT00696787|Analgesics|analgesics|mesh-ancestor
153983694|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
153983695|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983696|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983697|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
153983698|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153983699|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153983700|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983701|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153983702|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153983703|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153983704|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983705|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153605595|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983706|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153983707|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153983708|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983709|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
153983710|NCT01012037|Linagliptin|linagliptin|mesh-list
153983711|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153983712|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983713|NCT01012037|Incretins|incretins|mesh-ancestor
153983714|NCT01012037|Hormones|hormones|mesh-ancestor
153983715|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741320|NCT00517309|Vaccines|vaccines|mesh-list
153983716|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153983717|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
153983718|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983719|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983721|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983722|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983736|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
153983737|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983738|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153983739|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153983740|NCT04284098|Analgesics|analgesics|mesh-ancestor
153983741|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153983742|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153983743|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153983744|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983745|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983746|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983747|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153983748|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153983749|NCT00733954|Clobetasol|clobetasol|mesh-list
153983750|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153983751|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
153983752|NCT00733954|Hormones|hormones|mesh-ancestor
153983753|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983754|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983755|NCT02595268|Pitavastatin|pitavastatin|mesh-list
154860899|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983756|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153983757|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153983758|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153983759|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
153983760|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983761|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983762|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153983763|NCT00921505|Acetaminophen|acetaminophen|mesh-list
153983764|NCT00921505|Ibuprofen|ibuprofen|mesh-list
153983765|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153983766|NCT00921505|Analgesics|analgesics|mesh-ancestor
153983767|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
153983768|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983769|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983770|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
153983771|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153983772|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153983773|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983774|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153983775|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983776|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983777|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153605600|NCT01933906|Interferons|interferons|mesh-list
153983778|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153983779|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983780|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983781|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
153983782|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983796|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
153983797|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153983798|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153983799|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983800|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153983801|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153983802|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153983803|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983804|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983805|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
153983806|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153983807|NCT02595190|Narcotics|narcotics|mesh-ancestor
153983808|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153983809|NCT04061473|Empagliflozin|empagliflozin|mesh-list
153983810|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153983811|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983812|NCT04061473|Incretins|incretins|mesh-ancestor
153983813|NCT04061473|Hormones|hormones|mesh-ancestor
153983814|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983815|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153983816|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
153983817|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983818|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983819|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153983820|NCT00733408|Paclitaxel|paclitaxel|mesh-list
153983821|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153983822|NCT00733408|Bevacizumab|bevacizumab|mesh-list
153983823|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153983824|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153983825|NCT00733408|Antibodies|antibodies|mesh-list
153983826|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
153983827|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153983828|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153983829|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983830|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983831|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983832|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983833|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983834|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153983835|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153983836|NCT00733408|Growth Substances|growth substances|mesh-ancestor
153983837|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983838|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
153983839|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
153983840|NCT00733408|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153983841|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154255068|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983842|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983843|NCT04296383|Azithromycin|azithromycin|mesh-list
153983844|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153983845|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983846|NCT00576823|Alfuzosin|alfuzosin|mesh-list
153983856|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983857|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
153983858|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983859|NCT00962390|Equol|equol|mesh-list
153983860|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
153983861|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153983862|NCT00962390|Estrogens|estrogens|mesh-ancestor
153983863|NCT00962390|Hormones|hormones|mesh-ancestor
153983864|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983865|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983866|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153983867|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153983868|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153983869|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153983870|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983871|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983872|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983874|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
153983875|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983876|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
153983877|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153983878|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
153983879|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153983880|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983881|NCT00958880|Yohimbine|yohimbine|mesh-list
153983882|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
153983883|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
153983884|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983885|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983886|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153983887|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153983888|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153983889|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983890|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983891|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983892|NCT00958880|Urological Agents|urological agents|mesh-ancestor
153983893|NCT02595034|Clindamycin|clindamycin|mesh-list
153983894|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
153983895|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
153983896|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153983897|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153983898|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983899|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153983900|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983901|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983902|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
153983903|NCT00958724|Vinorelbine|vinorelbine|mesh-list
153983904|NCT00958724|Neratinib|neratinib|mesh-list
153983905|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153983906|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983907|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983908|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983909|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983910|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983911|NCT00958724|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153983925|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983926|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983927|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153983929|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153983930|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983931|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153983932|NCT00958568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153983933|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153983934|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153983935|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860900|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153983937|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
153983938|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153983939|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
153983940|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153983941|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153983942|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983943|NCT00630500|Memantine|memantine|mesh-list
153983944|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153983945|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153983946|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
153983947|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983948|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983949|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983950|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153983951|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153983952|NCT02858804|Cytarabine|cytarabine|mesh-list
153983953|NCT02858804|Thalidomide|thalidomide|mesh-list
153983954|NCT02858804|Dexamethasone|dexamethasone|mesh-list
153983955|NCT02858804|Prednisone|prednisone|mesh-list
153983956|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
153983957|NCT02858804|Rituximab|rituximab|mesh-list
153983958|NCT02858804|Doxorubicin|doxorubicin|mesh-list
153983959|NCT02858804|Etoposide|etoposide|mesh-list
153983960|NCT02858804|Vincristine|vincristine|mesh-list
153983961|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983962|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
153983963|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983964|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983965|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153983966|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
153983967|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983968|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983969|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153983970|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153983971|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
153983972|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
153770956|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
153983987|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
153983988|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983989|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983990|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983991|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983992|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
153983993|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153983994|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153983995|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153983996|NCT02858804|Growth Substances|growth substances|mesh-ancestor
153983997|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
153983998|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
153983999|NCT00958256|Rituximab|rituximab|mesh-list
153984000|NCT00958256|Bortezomib|bortezomib|mesh-list
153984001|NCT00958256|Lenograstim|lenograstim|mesh-list
153984002|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984003|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
153984004|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984005|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153984006|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153984007|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
153984008|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984009|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984010|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153984011|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153984012|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153984014|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153984015|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984016|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984017|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
153984018|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984019|NCT02861690|Paclitaxel|paclitaxel|mesh-list
153984020|NCT02861690|Nedaplatin|nedaplatin|mesh-list
153984021|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153984022|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984023|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
153984024|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
153984025|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
154142525|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
153984026|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984027|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
153984028|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153984029|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984030|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153984031|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984062|NCT00743587|Oxycodone|oxycodone|mesh-list
153984063|NCT00743587|Tramadol|tramadol|mesh-list
153984064|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153984065|NCT00743587|Narcotics|narcotics|mesh-ancestor
153984066|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153984067|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984068|NCT00743587|Analgesics|analgesics|mesh-ancestor
153984069|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
153984070|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984071|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153984072|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153984073|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153984074|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153984075|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
153984076|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153984081|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
153984082|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984083|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984084|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984086|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
153984087|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153984088|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
153984089|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153984090|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984091|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
153984092|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984093|NCT04296149|Octreotide|octreotide|mesh-list
153984094|NCT04296149|Edotreotide|edotreotide|mesh-list
153984095|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984096|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153984097|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984098|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153984099|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984100|NCT01005875|Sorafenib|sorafenib|mesh-list
153984101|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984102|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984103|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984104|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984105|NCT02701088|Mitomycins|mitomycins|mesh-list
153984106|NCT02701088|Mitomycin|mitomycin|mesh-list
153984107|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153984108|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984109|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
153984110|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984111|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153605916|NCT01935557|Heparin|heparin|mesh-list
153984112|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984113|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
153984114|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153984115|NCT04279106|Listerine|listerine|mesh-list
153984116|NCT04279106|Fluorides|fluorides|mesh-list
153984117|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
153984118|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
153984119|NCT04279106|Protective Agents|protective agents|mesh-ancestor
153984120|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984121|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153984122|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984123|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
153984124|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153984125|NCT00743743|Resveratrol|resveratrol|mesh-list
153984126|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
153984127|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984128|NCT00743743|Protective Agents|protective agents|mesh-ancestor
153984129|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984130|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984131|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153984132|NCT01005719|Omeprazole|omeprazole|mesh-list
153984133|NCT01005719|Lansoprazole|lansoprazole|mesh-list
154860901|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154860902|NCT01921790|Growth Substances|growth substances|mesh-ancestor
154142601|NCT05264896|Leucovorin|leucovorin|mesh-list
153984134|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
153984135|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153984136|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984137|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153984138|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984139|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984140|NCT02856854|Cocaine|cocaine|mesh-list
153984141|NCT02856854|Oxazepam|oxazepam|mesh-list
153984142|NCT02856854|Metyrapone|metyrapone|mesh-list
153984143|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
153984144|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
153984145|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153984146|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984147|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
153984148|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984149|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153984173|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984174|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
153984175|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984176|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984177|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
153984178|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153984179|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153984180|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153984181|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153984183|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
153984184|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
153984185|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984186|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984187|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984188|NCT02563951|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153984189|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153984190|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
153984191|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984192|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984193|NCT00953576|Ketoconazole|ketoconazole|mesh-list
153984194|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
153984195|NCT00953576|Lapatinib|lapatinib|mesh-list
153984196|NCT00953576|Dutasteride|dutasteride|mesh-list
153984197|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605996|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
153984198|NCT00953576|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153984199|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984207|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153984208|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
153984209|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984210|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984211|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153984212|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153984214|NCT01005329|Bevacizumab|bevacizumab|mesh-list
153984215|NCT01005329|Cisplatin|cisplatin|mesh-list
153984216|NCT01005329|Carboplatin|carboplatin|mesh-list
153984217|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153984218|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153984219|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
153984220|NCT01005329|Antibodies|antibodies|mesh-list
153984221|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
153984222|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153984223|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
153984224|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153984225|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984226|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
153984227|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
153984228|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
153984229|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984230|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153984231|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153984232|NCT01005329|Growth Substances|growth substances|mesh-ancestor
154176491|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153984233|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984234|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
153984235|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
153984236|NCT00921349|Nadolol|nadolol|mesh-list
153984237|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154860903|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
153984238|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153984239|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
153984240|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984241|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984242|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984243|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153984244|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153984245|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
153984246|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
153984247|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984248|NCT01005251|Lesogaberan|lesogaberan|mesh-list
153984249|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984250|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153984251|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
153984252|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
153984253|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984254|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984255|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984256|NCT03048578|Liraglutide|liraglutide|mesh-list
153984257|NCT03048578|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153984258|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153984259|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984260|NCT03048578|Incretins|incretins|mesh-ancestor
153984261|NCT03048578|Hormones|hormones|mesh-ancestor
153984262|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984263|NCT02856776|Vitamin D|vitamin d|mesh-list
153984264|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
153984283|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153984284|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984285|NCT02857946|Incretins|incretins|mesh-ancestor
153984286|NCT02857946|Hormones|hormones|mesh-ancestor
153984287|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606156|NCT06070766|Ketamine|ketamine|mesh-list
153984288|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153984289|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
153984290|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984291|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984292|NCT02857712|Axitinib|axitinib|mesh-list
153984293|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984294|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984295|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984296|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984297|NCT00696241|Olmesartan|olmesartan|mesh-list
153984298|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153984299|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153984300|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153984301|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153984302|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153984303|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984304|NCT00630968|Levetiracetam|levetiracetam|mesh-list
153984305|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
153984306|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
153984307|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
153984308|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
153984309|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984311|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153984312|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
153984313|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153984314|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153984315|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153984316|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153984317|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984318|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
153984319|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984320|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984321|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153984322|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153984351|NCT02857868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984352|NCT02857868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984354|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153984355|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984356|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153984357|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142761|NCT04802408|Listerine|listerine|mesh-list
153984358|NCT03881917|Cystatins|cystatins|mesh-list
153984359|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153984360|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
153984361|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984362|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984363|NCT00744679|Natalizumab|natalizumab|mesh-list
153984364|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
153984365|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984366|NCT04060459|Paclitaxel|paclitaxel|mesh-list
153984367|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153984368|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984369|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
153984370|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
153984382|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
153984383|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984384|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153606157|NCT06070766|Analgesics|analgesics|mesh-ancestor
153984385|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984386|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
153984387|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153984388|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153984389|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
153984390|NCT00948896|Piperaquine|piperaquine|mesh-list
153984391|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
153984392|NCT00948896|Trimethoprim|trimethoprim|mesh-list
153984393|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153984394|NCT00948896|Artenimol|artenimol|mesh-list
153984395|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153984396|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
153984397|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
153984398|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153984399|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153984400|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984401|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153984402|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984403|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984404|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153984405|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153984406|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153984407|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153984408|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153984409|NCT01004159|Irinotecan|irinotecan|mesh-list
153984410|NCT01004159|Cetuximab|cetuximab|mesh-list
153984411|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153984412|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153984413|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984414|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984415|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984416|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153984417|NCT00948818|Linaclotide|linaclotide|mesh-list
153984418|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153984419|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
153984420|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984421|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984422|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153984423|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153984424|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153984425|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984426|NCT00948506|Cidofovir|cidofovir|mesh-list
153984427|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
153984428|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984440|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
153984441|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984442|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984443|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984444|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
153984445|NCT04060771|Hormones|hormones|mesh-ancestor
153984446|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984447|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153984448|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984449|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153984450|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153984451|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
153984452|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860904|NCT02153541|Antipyrine|antipyrine|mesh-list
154255070|NCT01148264|Metoclopramide|metoclopramide|mesh-list
153606245|NCT06065592|Antithrombins|antithrombins|mesh-ancestor
153984453|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984454|NCT00744913|Nicotine|nicotine|mesh-list
153984455|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153984456|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
153984457|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984458|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984459|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153984460|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153984461|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
153984462|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984463|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984464|NCT01875445|Inositol|inositol|mesh-list
153984465|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
153984466|NCT01875445|Vitamins|vitamins|mesh-ancestor
153984467|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
153984468|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984469|NCT00745069|Tapentadol|tapentadol|mesh-list
153984470|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153984471|NCT00745069|Narcotics|narcotics|mesh-ancestor
153984472|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153984473|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984474|NCT00745069|Analgesics|analgesics|mesh-ancestor
153984475|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
153984476|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984477|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153984478|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153984479|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153984480|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984481|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
153984482|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984483|NCT00745147|Laxatives|laxatives|mesh-list
153984484|NCT00745147|Lactulose|lactulose|mesh-list
153984485|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984486|NCT00688909|Letrozole|letrozole|mesh-list
153984487|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984488|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153984489|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153984490|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984491|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771438|NCT04997941|Tamoxifen|tamoxifen|mesh-list
153984508|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984509|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984510|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153984511|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
153984512|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153984513|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
153984514|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984515|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984516|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153984517|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
153984518|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
153984519|NCT00948194|Protective Agents|protective agents|mesh-ancestor
153984520|NCT00691483|Varenicline|varenicline|mesh-list
153984521|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153984522|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153984523|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
153984524|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984525|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984526|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984527|NCT00691093|Fesoterodine|fesoterodine|mesh-list
153984528|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153984529|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153984530|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
153984531|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984532|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984533|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984534|NCT00691093|Urological Agents|urological agents|mesh-ancestor
153984536|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984537|NCT03646825|Protective Agents|protective agents|mesh-ancestor
153984538|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984539|NCT00745225|Pioglitazone|pioglitazone|mesh-list
153984540|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153984541|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860905|NCT02153541|Benzocaine|benzocaine|mesh-list
154142898|NCT04461535|Hormones|hormones|mesh-list
153984542|NCT02856542|Betamethasone|betamethasone|mesh-list
153984543|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
153984544|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153984545|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
153984546|NCT02856542|Calcipotriene|calcipotriene|mesh-list
153984547|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153984548|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153984549|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
153984573|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984574|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153984575|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153984576|NCT02856230|Paclitaxel|paclitaxel|mesh-list
153984577|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153984578|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984579|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
153984580|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
153984581|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
153984582|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984583|NCT00631124|Drospirenone|drospirenone|mesh-list
153984584|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153984585|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153984586|NCT00631124|Estradiol|estradiol|mesh-list
153984587|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153984588|NCT00631124|Estrogens|estrogens|mesh-ancestor
153984589|NCT00631124|Hormones|hormones|mesh-ancestor
153984590|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984591|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984592|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153984593|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
153984594|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153984595|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153984596|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153984597|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
153984598|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153984614|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153984615|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
153984616|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153984617|NCT04274270|Endostar protein|endostar protein|mesh-list
153984618|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153984619|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153984620|NCT04274270|Growth Substances|growth substances|mesh-ancestor
153984621|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984622|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
153984623|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984624|NCT02855294|Drospirenone|drospirenone|mesh-list
153984625|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153984626|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
153984627|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984628|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984629|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153984630|NCT02855294|Diuretics|diuretics|mesh-ancestor
153984631|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
153984632|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153984633|NCT00950690|Latanoprost|latanoprost|mesh-list
153984634|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153984635|NCT02855138|Isotretinoin|isotretinoin|mesh-list
153984636|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
153984637|NCT00694369|Acetaminophen|acetaminophen|mesh-list
153984638|NCT00694369|Ibuprofen|ibuprofen|mesh-list
153984639|NCT00694369|Etoricoxib|etoricoxib|mesh-list
153984640|NCT00694369|Codeine|codeine|mesh-list
153984641|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153984642|NCT00694369|Analgesics|analgesics|mesh-ancestor
153984643|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
153984644|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984645|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984646|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
153984647|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153984648|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153984649|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153984650|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153984651|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984652|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984653|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154860906|NCT02153541|Glycerol|glycerol|mesh-list
153984654|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153984655|NCT00694369|Narcotics|narcotics|mesh-ancestor
153984656|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153984657|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
153984658|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
153984682|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
153984683|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153984684|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153984685|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984686|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153984687|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984688|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153984689|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153984690|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153984691|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153984692|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153984694|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153984695|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153984696|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984697|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
153984698|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984699|NCT00954512|Leucovorin|leucovorin|mesh-list
153984700|NCT00954512|Folic Acid|folic acid|mesh-list
153984701|NCT00954512|Carboplatin|carboplatin|mesh-list
153984702|NCT00954512|Gemcitabine|gemcitabine|mesh-list
153984703|NCT00954512|Trastuzumab|trastuzumab|mesh-list
153984704|NCT00954512|Irinotecan|irinotecan|mesh-list
153984705|NCT00954512|Cetuximab|cetuximab|mesh-list
153984706|NCT00954512|Everolimus|everolimus|mesh-list
153984707|NCT00954512|Epirubicin|epirubicin|mesh-list
153984708|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
153984709|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984745|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153984746|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
153984747|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984748|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984749|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153984750|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153984751|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153984752|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
153771717|NCT04569214|PAZ320|paz320|mesh-list
153984775|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
153984776|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
153984777|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153984778|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153984779|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153984780|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153984781|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153984782|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984783|NCT00949988|Rituximab|rituximab|mesh-list
153984784|NCT00949988|Dasatinib|dasatinib|mesh-list
153984785|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153984786|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984787|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
153984788|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984789|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153984790|NCT00949988|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153984791|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984792|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984793|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984794|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153984795|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153984796|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984797|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984798|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
153984799|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984800|NCT02593474|Naltrexone|naltrexone|mesh-list
153984801|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153984802|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153984803|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984810|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984812|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153984813|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984814|NCT00730912|Loratadine|loratadine|mesh-list
153984815|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
153984816|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
153984817|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153984818|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153984819|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153984820|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
153984821|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
153984822|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984823|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984824|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984825|NCT00730756|Fluticasone|fluticasone|mesh-list
153984826|NCT00730756|Xhance|xhance|mesh-list
153638463|NCT00001221|Hormones|hormones|mesh-list
153984827|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153984828|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153984830|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984831|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984832|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153984833|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
153984834|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
153742435|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
153984835|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153984836|NCT00730132|Ezetimibe|ezetimibe|mesh-list
153984837|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153984838|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153984839|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
153984840|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984841|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153984842|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
153984843|NCT00737464|Hematinics|hematinics|mesh-ancestor
153984844|NCT00729586|Tamoxifen|tamoxifen|mesh-list
153984845|NCT00729586|Sirolimus|sirolimus|mesh-list
153984846|NCT00729586|Temsirolimus|temsirolimus|mesh-list
153984847|NCT00729586|Megestrol|megestrol|mesh-list
153984848|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
153984849|NCT00729586|MTOR Inhibitors|mtor inhibitors|mesh-list
153984850|NCT00729586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984851|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153984852|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984853|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153984854|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984855|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
153984856|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984857|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
153984858|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984859|NCT00729586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984860|NCT00729586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984861|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153984862|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
153984863|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984864|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153984865|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153984866|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153984867|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153984868|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153984869|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153984870|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153984871|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
153984893|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984894|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
153984895|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984896|NCT00686959|Paclitaxel|paclitaxel|mesh-list
153984897|NCT00686959|Etoposide|etoposide|mesh-list
153984898|NCT00686959|Vinorelbine|vinorelbine|mesh-list
153984899|NCT00686959|Carboplatin|carboplatin|mesh-list
153984900|NCT00686959|Pemetrexed|pemetrexed|mesh-list
153984901|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153984902|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984904|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
153984905|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
153984906|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984907|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153984908|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153742524|NCT03225755|Hormones|hormones|mesh-list
153984909|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984910|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153984911|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153984913|NCT04088110|Letrozole|letrozole|mesh-list
153984914|NCT04088110|Anastrozole|anastrozole|mesh-list
153984915|NCT04088110|Exemestane|exemestane|mesh-list
153984916|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153984917|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153984918|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984919|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153984920|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984921|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984922|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153984923|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
153771871|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984938|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153984940|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984941|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984942|NCT00602342|Terbinafine|terbinafine|mesh-list
153984943|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
153984944|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984945|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984946|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984947|NCT00602498|Clarithromycin|clarithromycin|mesh-list
153984948|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153984949|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984950|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153984951|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984952|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984953|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153984954|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153984955|NCT00749359|Paroxetine|paroxetine|mesh-list
153984956|NCT00749359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153984957|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153984958|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153984959|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984960|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984961|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
153984962|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984963|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153984964|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
153984965|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153984966|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153984967|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153984968|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984969|NCT00946088|Progesterone|progesterone|mesh-list
153984970|NCT00946088|Progestins|progestins|mesh-ancestor
153984971|NCT00946088|Hormones|hormones|mesh-ancestor
153984972|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984973|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984974|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
153984975|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153984976|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984977|NCT00736996|Pioglitazone|pioglitazone|mesh-list
153984978|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153984979|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984980|NCT00741949|Propofol|propofol|mesh-list
153984981|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153985002|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153985004|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
153985005|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985006|NCT02594410|Lercanidipine|lercanidipine|mesh-list
153985007|NCT02594410|Clopidogrel|clopidogrel|mesh-list
153985008|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153985009|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153985010|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153985011|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153985012|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
153985013|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985014|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985015|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985016|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153985017|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153985018|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153985019|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153985020|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153985021|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
153985022|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153985023|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153985024|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153985025|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985026|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985027|NCT00586066|Memantine|memantine|mesh-list
153985028|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153985029|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153985030|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
153985031|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985032|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985033|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985034|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153985035|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153985048|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
153985049|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985051|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153985052|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985053|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985054|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153985055|NCT02854904|Analgesics|analgesics|mesh-ancestor
153742661|NCT02945956|Entecavir|entecavir|mesh-list
153985056|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
153985057|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985058|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153985059|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153985060|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153985061|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
153985062|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985063|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985064|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
153985065|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153985066|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
153985067|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153985068|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
153985069|NCT00941330|Docetaxel|docetaxel|mesh-list
153985070|NCT00941330|Exemestane|exemestane|mesh-list
153985071|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153985072|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
153985073|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985074|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153985075|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153985076|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
153985077|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985078|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985079|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153985080|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
153985081|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
153985082|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
153985083|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153985084|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153985085|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985086|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153985087|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
153985088|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985089|NCT00686881|Interferons|interferons|mesh-list
153985090|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
153985091|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
153985092|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153985093|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985094|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
153985095|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985096|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
153985097|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985124|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
153985125|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985126|NCT00921661|Aflibercept|aflibercept|mesh-list
153985127|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153985128|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153985129|NCT00921661|Growth Substances|growth substances|mesh-ancestor
153985130|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985131|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
153985132|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985134|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153985135|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985136|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985137|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153985138|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985139|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985140|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153985141|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
153985142|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985143|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985144|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
153985152|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153985153|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
153985154|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985155|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153985156|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985157|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
153985158|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
153985159|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153985160|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153985161|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985162|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
153985163|NCT02561923|Coagulants|coagulants|mesh-ancestor
153985164|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153985165|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
153985166|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153985167|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
153985168|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985169|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
153985170|NCT00918190|Dexamethasone|dexamethasone|mesh-list
153985171|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
153985172|NCT00918190|Midazolam|midazolam|mesh-list
153985173|NCT00918190|Ondansetron|ondansetron|mesh-list
153985174|NCT00918190|BB 1101|bb 1101|mesh-list
153985175|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153985176|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
153985177|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
153985178|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985179|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985180|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153985181|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
153985182|NCT00918190|Hormones|hormones|mesh-ancestor
153985183|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985184|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153985185|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985186|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
153985187|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985188|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985189|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153985190|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153985191|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985192|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153985193|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153985194|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153985195|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153985196|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
153985197|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
153985198|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
153985199|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
153985200|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985201|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
153985202|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
153985203|NCT00918190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153985204|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153985205|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
153985206|NCT02563327|Pyridoxine|pyridoxine|mesh-list
153985207|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
153985208|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
153985209|NCT02563327|Rifampin|rifampin|mesh-list
153985210|NCT02563327|Isoniazid|isoniazid|mesh-list
153985211|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
153985212|NCT02563327|Ethambutol|ethambutol|mesh-list
153985213|NCT02563327|Rifapentine|rifapentine|mesh-list
153985214|NCT02563327|Vitamins|vitamins|mesh-ancestor
153985215|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
154255071|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
154143352|NCT00572013|Rituximab|rituximab|mesh-list
153985216|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985217|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153985227|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
153985228|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153985229|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153985230|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153985231|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153985232|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153985233|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153985234|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153985235|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153985236|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153985237|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
153985238|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153985240|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985241|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153985242|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
153985243|NCT02593942|Remifentanil|remifentanil|mesh-list
153985244|NCT02593942|Propofol|propofol|mesh-list
153985245|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153985246|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985247|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985248|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153985249|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
153985250|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
153985251|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153985252|NCT02593942|Narcotics|narcotics|mesh-ancestor
153985253|NCT02593942|Analgesics|analgesics|mesh-ancestor
153985254|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
153985255|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985256|NCT00742339|Octreotide|octreotide|mesh-list
153985257|NCT00742339|Terlipressin|terlipressin|mesh-list
153985258|NCT00742339|Midodrine|midodrine|mesh-list
153985259|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153985260|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153985261|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985262|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
153985263|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
153985264|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985265|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985266|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153985267|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153985268|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153985269|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153985270|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
153985271|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985272|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985273|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153985274|NCT02592772|Menthol|menthol|mesh-list
154176493|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985275|NCT02592772|Nicotine|nicotine|mesh-list
153985276|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153985277|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
153985278|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985279|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985280|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153985281|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153985301|NCT00686725|Temozolomide|temozolomide|mesh-list
153985302|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153985303|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
153985304|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985305|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985306|NCT04055623|Aldesleukin|aldesleukin|mesh-list
153985307|NCT04055623|Interleukin-2|interleukin-2|mesh-list
153985308|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985309|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153985310|NCT04055623|Analgesics|analgesics|mesh-ancestor
153985311|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
153985312|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985313|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985314|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153985315|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154860907|NCT02153541|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154860908|NCT02153541|Protective Agents|protective agents|mesh-ancestor
153985317|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985318|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153607072|NCT04176419|Acetaminophen|acetaminophen|mesh-list
153985319|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153985320|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153985321|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
153985322|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985323|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153985324|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153985325|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985326|NCT00727246|Choline|choline|mesh-list
153985327|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153985328|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
153985329|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153985330|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
153985331|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985332|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153985333|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153985334|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
153985335|NCT05381558|Triamcinolone|triamcinolone|mesh-list
153985336|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153985337|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
153985338|NCT05381558|Hormones|hormones|mesh-ancestor
154182201|NCT05856695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985347|NCT04268966|Brincidofovir|brincidofovir|mesh-list
153985348|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
153985349|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985350|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
153985351|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153985352|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985353|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985354|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153985355|NCT04269278|Analgesics|analgesics|mesh-ancestor
153985356|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
153985357|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985358|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153985359|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153985360|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153985362|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985363|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985364|NCT02853578|Budesonide|budesonide|mesh-list
153985365|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153985366|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153985367|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
153985368|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985369|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985370|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153985371|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
153985372|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
153985373|NCT02853578|Hormones|hormones|mesh-ancestor
153985374|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985375|NCT02592694|Tenecteplase|tenecteplase|mesh-list
153985376|NCT02592694|Tirofiban|tirofiban|mesh-list
153985377|NCT02592694|Bivalirudin|bivalirudin|mesh-list
153985378|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153985379|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153985380|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985381|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
153985382|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153985383|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
153985384|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985385|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
153985386|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153985387|NCT02591836|Atorvastatin|atorvastatin|mesh-list
153607130|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
153985388|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153985389|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153985390|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
153985391|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985392|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153985393|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153985394|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985395|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
153985396|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153985397|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
153985398|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985399|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985400|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153985401|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
153985402|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153985403|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
153985404|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985405|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985427|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153985428|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153985429|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
153985430|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985431|NCT00747097|Gemcitabine|gemcitabine|mesh-list
153985432|NCT00747097|Cetuximab|cetuximab|mesh-list
153985433|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153985434|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
153985435|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985436|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985437|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985438|NCT00747331|Fenoldopam|fenoldopam|mesh-list
153985439|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153985440|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
153985441|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
153985442|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
153985443|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985444|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985445|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985446|NCT00747409|Insulin|insulin|mesh-list
153985447|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153985448|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
153985449|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
153985450|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
153985451|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153985452|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
153985453|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
153985454|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
153985455|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153985456|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985457|NCT00752011|Carboplatin|carboplatin|mesh-list
153985458|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985469|NCT00943826|Growth Substances|growth substances|mesh-ancestor
153985470|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985471|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
153985472|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153985473|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
153985474|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985475|NCT04268888|Nivolumab|nivolumab|mesh-list
153985476|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
153985477|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985478|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985479|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153985480|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985481|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153985482|NCT04268888|Estrogens|estrogens|mesh-ancestor
153985483|NCT04268888|Hormones|hormones|mesh-ancestor
153985484|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985485|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985486|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153985487|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153985488|NCT00603356|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153985489|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153985490|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985491|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985492|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985493|NCT02851394|Tramadol|tramadol|mesh-list
153985494|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
153985495|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153985496|NCT02851394|Narcotics|narcotics|mesh-ancestor
153985497|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985498|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985499|NCT02851394|Analgesics|analgesics|mesh-ancestor
153985500|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
153985501|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985502|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
153985504|NCT00603434|Methylphenidate|methylphenidate|mesh-list
153985505|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153985506|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985507|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153985508|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153985509|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153985510|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985511|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
153985512|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985513|NCT01004003|Sorafenib|sorafenib|mesh-list
153985514|NCT01004003|Nintedanib|nintedanib|mesh-list
153985515|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985516|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153985517|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985518|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985519|NCT00943670|Trastuzumab|trastuzumab|mesh-list
153985520|NCT00943670|Pertuzumab|pertuzumab|mesh-list
153985521|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153985522|NCT00943670|Maytansine|maytansine|mesh-list
153772461|NCT00239421|Xhance|xhance|mesh-list
153985538|NCT02851004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985539|NCT00938366|Cladribine|cladribine|mesh-list
153985540|NCT00938366|Pantoprazole|pantoprazole|mesh-list
153985541|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153985542|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153985543|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153985544|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985545|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985546|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985547|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153985548|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
153985549|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985550|NCT00943592|Melphalan|melphalan|mesh-list
153985551|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
153985552|NCT00943592|Clofarabine|clofarabine|mesh-list
153985553|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153985554|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
153985555|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985556|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985557|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153985558|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153985559|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
153985560|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985561|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985562|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153985563|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
153985564|NCT00943124|Niacin|niacin|mesh-list
153985565|NCT00943124|Niacinamide|niacinamide|mesh-list
153985566|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
153985567|NCT00943124|Simvastatin|simvastatin|mesh-list
153985568|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153985569|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153985570|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
153985571|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985572|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153985573|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153985574|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985575|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
153985576|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
153985577|NCT00943124|Vitamins|vitamins|mesh-ancestor
153985578|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
153985579|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985580|NCT00940316|Irinotecan|irinotecan|mesh-list
153985581|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153985582|NCT00940316|Panitumumab|panitumumab|mesh-list
153985598|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985599|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153985600|NCT05381168|Antacids|antacids|mesh-ancestor
153985601|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985602|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153985603|NCT00726388|Diclofenac|diclofenac|mesh-list
153985604|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153985605|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153985606|NCT00726388|Analgesics|analgesics|mesh-ancestor
153985607|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
153985608|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985609|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985610|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153985611|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153985612|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153985613|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985614|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985615|NCT00572455|Latanoprost|latanoprost|mesh-list
153985616|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153985617|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153985618|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153985619|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153985620|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
153985621|NCT00686335|Prednisone|prednisone|mesh-list
153985622|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153985623|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
153985624|NCT00686335|Hormones|hormones|mesh-ancestor
153985625|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985626|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985627|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153985628|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985629|NCT00685945|Isosorbide|isosorbide|mesh-list
153985630|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153985631|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153985632|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
153985633|NCT00685945|Bradykinin|bradykinin|mesh-list
153985634|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153985635|NCT00685945|Kininogens|kininogens|mesh-list
153985636|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
153985637|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153985638|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153985639|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985640|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985641|NCT00685945|Urological Agents|urological agents|mesh-ancestor
153985642|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153985672|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153985673|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985674|NCT00752401|Vitamin D|vitamin d|mesh-list
153985675|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
153985676|NCT00752401|Vitamins|vitamins|mesh-ancestor
153985677|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
153985678|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985679|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153985680|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153985681|NCT00750451|Heparin|heparin|mesh-list
153985682|NCT00750451|Enoxaparin|enoxaparin|mesh-list
153985683|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153985684|NCT00750451|Tinzaparin|tinzaparin|mesh-list
153985685|NCT00750451|Dalteparin|dalteparin|mesh-list
153985686|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
153985687|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
153985688|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153985714|NCT02561767|Tacrolimus|tacrolimus|mesh-list
153985715|NCT02561767|Basiliximab|basiliximab|mesh-list
153985716|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153985717|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
153985718|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985719|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153985720|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985721|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985722|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153985723|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985724|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153985725|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
153985726|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153985727|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985728|NCT00747799|Fluorouracil|fluorouracil|mesh-list
153985729|NCT00747799|Sorafenib|sorafenib|mesh-list
153985730|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985731|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
153985732|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985733|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153985734|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153985735|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
153985744|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985746|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985747|NCT04294511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985748|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985749|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
153607514|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153985751|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153985752|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985753|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985754|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153985755|NCT01001429|Analgesics|analgesics|mesh-ancestor
153985756|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
153985757|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985758|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153985759|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153985760|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153985761|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
153985762|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985763|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985764|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153985765|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
153985766|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
153985767|NCT01000961|Cysteamine|cysteamine|mesh-list
153985768|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153985769|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985770|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153985771|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153985772|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153985773|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153985774|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985775|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985776|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985777|NCT01000805|Analgesics|analgesics|mesh-ancestor
153985778|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
153985779|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985780|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
153985781|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153985782|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
153985783|NCT00684307|Vitamin K|vitamin k|mesh-list
153985784|NCT00684307|Warfarin|warfarin|mesh-list
153985785|NCT00684307|Vitamins|vitamins|mesh-ancestor
153985786|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
153985787|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985788|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
153985789|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153985790|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153985791|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985792|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
153985793|NCT00684307|Coagulants|coagulants|mesh-ancestor
153985794|NCT00683917|Leuprolide|leuprolide|mesh-list
153985795|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153985796|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
153985797|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153985798|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985799|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153985800|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985801|NCT00750529|Donepezil|donepezil|mesh-list
153985808|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985809|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
153985810|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153985811|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
153985812|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985813|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
153985814|NCT00747877|Melphalan|melphalan|mesh-list
153985815|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153985816|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
153985817|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985818|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153985819|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153985820|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
153985821|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985822|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985823|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153985824|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
153985825|NCT00750763|Cathartics|cathartics|mesh-ancestor
153985826|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153985827|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
153985828|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
154255073|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985829|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153985830|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153985831|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153985832|NCT00752635|Norgestimate|norgestimate|mesh-list
153985833|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153985834|NCT00752635|Estradiol|estradiol|mesh-list
153985835|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153985836|NCT00752635|Cyproterone|cyproterone|mesh-list
153985837|NCT00752635|Estrogens|estrogens|mesh-ancestor
153985838|NCT00752635|Hormones|hormones|mesh-ancestor
153985839|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985840|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985841|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153985842|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
153985843|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153985844|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153985845|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153985846|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153985847|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
153985848|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
153985849|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985850|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153985851|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153985852|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153985853|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985854|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153985855|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153985856|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985857|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985858|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153985859|NCT00750997|Dextrans|dextrans|mesh-list
153985860|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
153985861|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
153985862|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
153985863|NCT00748345|Caspofungin|caspofungin|mesh-list
153985864|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
153985865|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985866|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985867|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985868|NCT00752869|Dutasteride|dutasteride|mesh-list
153607617|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
153985869|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153985870|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153985871|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182202|NCT05856695|Tubulin Modulators|tubulin modulators|mesh-ancestor
153985886|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153985887|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153985888|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
153985890|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153985891|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
153985892|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985893|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985894|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153985895|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
153985896|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153985898|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985899|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985900|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153985901|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
153985902|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
153985903|NCT00748423|Protective Agents|protective agents|mesh-ancestor
153985904|NCT00687271|Atorvastatin|atorvastatin|mesh-list
153985906|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153985907|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985908|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153985909|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153985910|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
153985911|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985912|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153985913|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153985914|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985915|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
154860909|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860910|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
153985916|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985917|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985918|NCT02562625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153985919|NCT02562625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985920|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
153985921|NCT00752947|Metronidazole|metronidazole|mesh-list
153985922|NCT00752947|Levofloxacin|levofloxacin|mesh-list
153985923|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153985924|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985925|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153985926|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153985927|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985928|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985929|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985930|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153985948|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985949|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985950|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153985951|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153985952|NCT01031381|Growth Substances|growth substances|mesh-ancestor
153985953|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985954|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
153985955|NCT01031381|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153985956|NCT01031381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153985957|NCT01031381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985958|NCT01031381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985959|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153985960|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
153985961|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153985962|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
153985963|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985964|NCT00751699|Mesalamine|mesalamine|mesh-list
153985965|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153985966|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153985967|NCT00751699|Analgesics|analgesics|mesh-ancestor
153985968|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
153985969|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985970|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985971|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153985972|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153985973|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
153985974|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
153985975|NCT00753103|Prednisolone|prednisolone|mesh-list
153985976|NCT00753103|Infliximab|infliximab|mesh-list
153985977|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
153985978|NCT00753103|Azathioprine|azathioprine|mesh-list
153985979|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153985980|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
153985981|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985982|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153985983|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153985984|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
153985985|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985986|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985987|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153986034|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
153986035|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153986036|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153986037|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986038|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986039|NCT00753571|Protective Agents|protective agents|mesh-ancestor
153986040|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986041|NCT00753727|Sunitinib|sunitinib|mesh-list
153986042|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986043|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153986044|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153986045|NCT00753727|Growth Substances|growth substances|mesh-ancestor
153986046|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986047|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
153986048|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153986049|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986050|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986051|NCT00755989|Morphine|morphine|mesh-list
153986052|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153986053|NCT00755989|Narcotics|narcotics|mesh-ancestor
154143951|NCT00464542|Metronidazole|metronidazole|mesh-list
153986054|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986055|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986056|NCT00755989|Analgesics|analgesics|mesh-ancestor
153986057|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
153986058|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986059|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153986060|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
153986061|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986062|NCT04053205|Paclitaxel|paclitaxel|mesh-list
153986063|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153986064|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986065|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
153986066|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
153986067|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
153986068|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986069|NCT02559973|Buprenorphine|buprenorphine|mesh-list
153986070|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153986071|NCT02559973|Naloxone|naloxone|mesh-list
153607753|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
153986072|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153986073|NCT02559973|Narcotics|narcotics|mesh-ancestor
153986074|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986075|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986076|NCT02559973|Analgesics|analgesics|mesh-ancestor
153986077|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
153986078|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986079|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153986080|NCT00753883|Simvastatin|simvastatin|mesh-list
153986081|NCT00753883|Ezetimibe|ezetimibe|mesh-list
153986082|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153986095|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
153986096|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986097|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986098|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153986099|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
153986100|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153986101|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986102|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986103|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153986104|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153986105|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
153986107|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986108|NCT00754039|Fenofibrate|fenofibrate|mesh-list
153986109|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153743708|NCT00146120|Etoposide|etoposide|mesh-list
153986110|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153986111|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
153986112|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986113|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153986114|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153986115|NCT02560909|Vaccines|vaccines|mesh-list
153986116|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
153986117|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986118|NCT02592226|Anesthetics|anesthetics|mesh-list
153986119|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986120|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986121|NCT00756301|Lidocaine|lidocaine|mesh-list
153986122|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
153986123|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
153986124|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986125|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986126|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
153986127|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986128|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153986129|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153986130|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153986131|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153986132|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986133|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153986134|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153986135|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986136|NCT00720226|Losartan|losartan|mesh-list
153986137|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154860911|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
153986138|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153986139|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153986140|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153986141|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986142|NCT00725920|Topiramate|topiramate|mesh-list
153986143|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
153986160|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986161|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986162|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
153607911|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986163|NCT04051723|Hormones|hormones|mesh-ancestor
153607912|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
153986164|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986165|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153986166|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986167|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
153986168|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
153986169|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986170|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
153986171|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
153986172|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
153986173|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153986174|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153986175|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153986176|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986177|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153986178|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153986180|NCT00756847|Carboplatin|carboplatin|mesh-list
153986181|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153986182|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986183|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
153986184|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
153986185|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
153986186|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986187|NCT04051567|Aspirin|aspirin|mesh-list
153986188|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153986189|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153986190|NCT04051567|Analgesics|analgesics|mesh-ancestor
153986191|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
153986192|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986193|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986194|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986195|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986196|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153986197|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153986198|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986199|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153986200|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153986201|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986202|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
153986203|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
153986223|NCT00757393|Vitamins|vitamins|mesh-list
153986224|NCT00757393|Calcium|calcium|mesh-list
153986225|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
153986226|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986227|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153986228|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153986229|NCT00754351|Bevacizumab|bevacizumab|mesh-list
153986230|NCT00754351|Gemcitabine|gemcitabine|mesh-list
153986231|NCT00754351|Docetaxel|docetaxel|mesh-list
153986232|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153986233|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986234|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153986235|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153986236|NCT00754351|Growth Substances|growth substances|mesh-ancestor
153986237|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986238|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
153986239|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153986240|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
153986241|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986242|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
153986243|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
153986244|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
153986245|NCT00754429|Losartan|losartan|mesh-list
153986246|NCT00754429|Amlodipine|amlodipine|mesh-list
153986247|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154255074|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986248|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153986249|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153986250|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639897|NCT00392080|Naproxen|naproxen|mesh-list
153986251|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153986253|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
153986254|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153986255|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153986256|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153986257|NCT00754507|Atorvastatin|atorvastatin|mesh-list
153986258|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153986259|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153986267|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153986269|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153986270|NCT00725608|Narcotics|narcotics|mesh-ancestor
153986271|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986272|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986273|NCT00725608|Analgesics|analgesics|mesh-ancestor
153986274|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
153986275|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986276|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153986277|NCT00725452|Infliximab|infliximab|mesh-list
153986278|NCT00725452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153986279|NCT00725452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986280|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
153986281|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986282|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986283|NCT00725296|Infliximab|infliximab|mesh-list
153986284|NCT00725296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153986285|NCT00725296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986286|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
153986287|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986288|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986289|NCT00585052|Paclitaxel|paclitaxel|mesh-list
153986290|NCT00585052|Lovastatin|lovastatin|mesh-list
153986291|NCT00585052|L 647318|l 647318|mesh-list
153986292|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
153986293|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153986294|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986295|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
153986296|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
153986297|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
153986298|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986299|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153986300|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153986301|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
153986302|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153986303|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153986304|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986305|NCT00724282|Eszopiclone|eszopiclone|mesh-list
153986306|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153986307|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986308|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986309|NCT04086238|Decitabine|decitabine|mesh-list
153986310|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
153986311|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153986312|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
153986313|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986314|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986315|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986316|NCT00724126|Rifaximin|rifaximin|mesh-list
153986317|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153986318|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986319|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986320|NCT00723892|Ribavirin|ribavirin|mesh-list
153986321|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153986322|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
153986323|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
153986324|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986325|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
153986326|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986328|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986329|NCT04086940|Esmolol|esmolol|mesh-list
154860912|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860913|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
153986330|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153986364|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
153986365|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986366|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986367|NCT00722800|Drospirenone|drospirenone|mesh-list
153986368|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153986369|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153986370|NCT00722800|Estradiol|estradiol|mesh-list
153986371|NCT00722800|Estrogens|estrogens|mesh-ancestor
153986372|NCT00722800|Hormones|hormones|mesh-ancestor
153986387|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153986388|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986389|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986390|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
153986391|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986392|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986393|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153986394|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
153986395|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986396|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
153986398|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153986399|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153986400|NCT03947632|Analgesics|analgesics|mesh-ancestor
153986401|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
153986402|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986403|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986404|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986405|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986406|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
153744002|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
153986407|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153608071|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
153986408|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153986409|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986411|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
153986412|NCT00741286|Aspirin|aspirin|mesh-list
153986413|NCT00741286|Cilostazol|cilostazol|mesh-list
153986414|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153986415|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153986416|NCT00741286|Analgesics|analgesics|mesh-ancestor
153986417|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
153986418|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986419|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986420|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986421|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986422|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153986423|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153986424|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986425|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153986426|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153986427|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986428|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
153986429|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153986430|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
153773365|NCT04664725|Bupropion|bupropion|mesh-list
153986451|NCT02590510|Methotrexate|methotrexate|mesh-list
153986452|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153986453|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
153986454|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153986455|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986456|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153986457|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
153986458|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986459|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986460|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
153986461|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986462|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153986463|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153986464|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
153986465|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986466|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153986467|NCT00919204|Axitinib|axitinib|mesh-list
153986468|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986469|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153986470|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986471|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986473|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153640158|NCT04526119|Z 338|z 338|mesh-list
153986474|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986475|NCT00919282|Leucovorin|leucovorin|mesh-list
153986476|NCT00919282|Folic Acid|folic acid|mesh-list
153986477|NCT00919282|Gemcitabine|gemcitabine|mesh-list
153986478|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
153986479|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153986480|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
153986481|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608179|NCT01939418|Everolimus|everolimus|mesh-list
153608234|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986482|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986483|NCT00919282|Antidotes|antidotes|mesh-ancestor
153773432|NCT00244920|Squalamine|squalamine|mesh-list
153986499|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153986500|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153986501|NCT00576199|Growth Substances|growth substances|mesh-ancestor
153986502|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986503|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
153986504|NCT00754819|Colchicine|colchicine|mesh-list
153986505|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
153986506|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986507|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
153986508|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
153986509|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
153986510|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986511|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986512|NCT02589652|Interferons|interferons|mesh-list
153986513|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
153986514|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
153986515|NCT02589652|Entecavir|entecavir|mesh-list
153986516|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153986517|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986518|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
153986519|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986520|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
153986521|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986522|NCT00679627|Galantamine|galantamine|mesh-list
153986523|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153986524|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986525|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986526|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
153986527|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986528|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986529|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153986530|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
153986531|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986532|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
153986533|NCT00714688|Methylphenidate|methylphenidate|mesh-list
153986534|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153986535|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986536|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153986537|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153986538|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153986539|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986540|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
153986541|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986542|NCT05165212|Amoxicillin|amoxicillin|mesh-list
153986543|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153986544|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986545|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
153986546|NCT04051099|Bupivacaine|bupivacaine|mesh-list
153986552|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
153986553|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986554|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153986555|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153986557|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153986558|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153986559|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153986560|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
153986561|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986562|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986563|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153986564|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
153986566|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
153986567|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986568|NCT04084912|Dexamethasone|dexamethasone|mesh-list
153986569|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
153986570|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153986571|NCT04084912|BB 1101|bb 1101|mesh-list
153986572|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986573|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
153986574|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
153986575|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986576|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986577|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986578|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
153986579|NCT04084912|Hormones|hormones|mesh-ancestor
153986580|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986581|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153986582|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986583|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
153986584|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986585|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986586|NCT00755053|Clotrimazole|clotrimazole|mesh-list
153986587|NCT00755053|Miconazole|miconazole|mesh-list
153986588|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153986589|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986590|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
153986591|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153986592|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153986593|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986594|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986595|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153986596|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
153986597|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986598|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986599|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153986600|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153986601|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
153986602|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153986603|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153986604|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986605|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
153986606|NCT00755209|Coagulants|coagulants|mesh-ancestor
153986607|NCT02589340|Buspirone|buspirone|mesh-list
153986608|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153986609|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153986610|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986611|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986612|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153986613|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153986631|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153986632|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153986633|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608399|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986634|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
153986635|NCT05340205|Coagulants|coagulants|mesh-ancestor
153986636|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153986637|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
153986638|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153986639|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986641|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986642|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986643|NCT00755521|Etoricoxib|etoricoxib|mesh-list
153986644|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153986645|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153986646|NCT00755521|Analgesics|analgesics|mesh-ancestor
153986647|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
153986648|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986649|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986650|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986651|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986652|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153986653|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153986654|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986655|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986656|NCT00681187|Lanreotide|lanreotide|mesh-list
154144397|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
153986657|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986658|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153986659|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
153986660|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986661|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153986662|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153986663|NCT02588950|Insulin|insulin|mesh-list
153986664|NCT02588950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153986665|NCT02588950|Insulin, Isophane|insulin, isophane|mesh-list
153986666|NCT02588950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986667|NCT02588950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986668|NCT00680407|Silymarin|silymarin|mesh-list
153986669|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
153986670|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986671|NCT00680407|Protective Agents|protective agents|mesh-ancestor
153986672|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986673|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153986685|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
153986686|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986687|NCT00677365|Levofloxacin|levofloxacin|mesh-list
153986688|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153986689|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986690|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153986691|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153986692|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153986693|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986694|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986695|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986696|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153986697|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153986698|NCT05196958|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153986699|NCT05196958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986700|NCT05196958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986701|NCT05039944|Irinotecan|irinotecan|mesh-list
153986702|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153986703|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153986704|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986705|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986706|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986707|NCT03719131|Rituximab|rituximab|mesh-list
153986708|NCT03719131|Nivolumab|nivolumab|mesh-list
153986709|NCT03719131|Ipilimumab|ipilimumab|mesh-list
153986710|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153986711|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986712|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
153986713|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986714|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153986715|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153986716|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986717|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153986718|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
153986719|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153986720|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153986721|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
153986722|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986723|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153986724|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153986725|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986726|NCT00676663|Exemestane|exemestane|mesh-list
153986727|NCT00676663|Entinostat|entinostat|mesh-list
153986728|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986729|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153986730|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153986731|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986732|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986733|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153986734|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
153986735|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986751|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153986752|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986754|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860914|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986755|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986756|NCT05683912|Aflibercept|aflibercept|mesh-list
153986757|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153986758|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153986759|NCT05683912|Growth Substances|growth substances|mesh-ancestor
153986760|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986761|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
153986762|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986763|NCT00679939|Metformin|metformin|mesh-list
153986764|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
153986765|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986766|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986767|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
153986768|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153986769|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986770|NCT02587390|Simvastatin|simvastatin|mesh-list
153986771|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153986772|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153986773|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
153986774|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986775|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153986776|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153986777|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986778|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
153986779|NCT00760981|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153986780|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153986781|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986782|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986783|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986784|NCT02588716|Terlipressin|terlipressin|mesh-list
153986785|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153986786|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153986787|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153986788|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153986789|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153986790|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
153986791|NCT00761449|Lenalidomide|lenalidomide|mesh-list
153986792|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
153986793|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986794|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153986808|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
153986809|NCT00919438|Diuretics|diuretics|mesh-list
153986810|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
153986811|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986812|NCT04082182|Immunomodulating Agents|immunomodulating agents|mesh-list
153986813|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
153986814|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986815|NCT00571519|Metformin|metformin|mesh-list
153986816|NCT00571519|Pioglitazone|pioglitazone|mesh-list
153986817|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986818|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986819|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153986820|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153986821|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986822|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
153986823|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153986824|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
153986825|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153986826|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986827|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153986828|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153986829|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986830|NCT00921973|Vaccines|vaccines|mesh-list
153986831|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
153986832|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986833|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
153986834|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153986835|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
153986836|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986837|NCT00676195|Expectorants|expectorants|mesh-ancestor
153986838|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
153986839|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153986840|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
153986841|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986842|NCT00676195|Protective Agents|protective agents|mesh-ancestor
153986843|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986844|NCT00676195|Antidotes|antidotes|mesh-ancestor
153986845|NCT02558959|Capecitabine|capecitabine|mesh-list
153986846|NCT02558959|Irinotecan|irinotecan|mesh-list
153986847|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153986848|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
153986849|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986850|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986851|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153986852|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153986853|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986854|NCT04082962|Dexamethasone|dexamethasone|mesh-list
153986855|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986856|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
153986857|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
153986891|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153986892|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986893|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986894|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
153986895|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986896|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986914|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153986915|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153986916|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986917|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153986918|NCT00759421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153986919|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153986920|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153986921|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986922|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986923|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
153986924|NCT00762775|Vitamin D|vitamin d|mesh-list
153986925|NCT00762775|Calcium|calcium|mesh-list
153986926|NCT00762775|Vitamins|vitamins|mesh-ancestor
154176496|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
153986927|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
153986928|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986929|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153986930|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153986931|NCT00763165|Triclosan|triclosan|mesh-list
153986932|NCT00763165|Fluorides|fluorides|mesh-list
153986933|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
153986934|NCT00763165|Protective Agents|protective agents|mesh-ancestor
153986935|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986936|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153986937|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986938|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153986939|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153986940|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
153986941|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986942|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153986943|NCT04049227|Letrozole|letrozole|mesh-list
153986944|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986945|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153986946|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153986947|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986948|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986949|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153986950|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
153986951|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773890|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
153986966|NCT00678379|Bupivacaine|bupivacaine|mesh-list
153986967|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
153986968|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
153986969|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986970|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986971|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
153986972|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986973|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153986974|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153986975|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153986976|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153986977|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986978|NCT00678379|Analgesics|analgesics|mesh-ancestor
153986979|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153986980|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
153986981|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
153986982|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153986983|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153986984|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153986985|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
153986986|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986987|NCT00760279|Azithromycin|azithromycin|mesh-list
153986988|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153986989|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986990|NCT00674323|Ranibizumab|ranibizumab|mesh-list
153986991|NCT00674323|Verteporfin|verteporfin|mesh-list
153986992|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153986993|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153986994|NCT00674323|Growth Substances|growth substances|mesh-ancestor
153986995|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986996|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
153986997|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986998|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153986999|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
153987000|NCT00763633|Vitamins|vitamins|mesh-list
153987001|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
153987002|NCT00763633|Pyridoxal|pyridoxal|mesh-list
153987003|NCT00763633|Pyridoxine|pyridoxine|mesh-list
153987004|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
153987005|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
153987006|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987007|NCT00763789|Remifentanil|remifentanil|mesh-list
153987008|NCT00763789|Anesthetics|anesthetics|mesh-list
153987009|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987010|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987011|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153987012|NCT00763789|Narcotics|narcotics|mesh-ancestor
153987013|NCT00763789|Analgesics|analgesics|mesh-ancestor
153987014|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
153987015|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987045|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987046|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987048|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
153987049|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987050|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
153987051|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
153987052|NCT00939770|Crizotinib|crizotinib|mesh-list
153987053|NCT00939770|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153987054|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987055|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987056|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987057|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987058|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
153987059|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
153987060|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
153987061|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608715|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
153987062|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987078|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
153987079|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987080|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153987081|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153987082|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
153987083|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153987084|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153987085|NCT04674514|Dexamethasone|dexamethasone|mesh-list
153987086|NCT04674514|Lenalidomide|lenalidomide|mesh-list
153744675|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153987087|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987088|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
153987089|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
153987090|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987091|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987092|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987093|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
153987094|NCT04674514|Hormones|hormones|mesh-ancestor
153987095|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987096|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153987097|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987098|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
153987099|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153987100|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153987101|NCT04674514|Growth Substances|growth substances|mesh-ancestor
153987102|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
153987103|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
153987104|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153987105|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
153987106|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987107|NCT04081012|Expectorants|expectorants|mesh-ancestor
153987108|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
153987109|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153987110|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
153987111|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987112|NCT04081012|Protective Agents|protective agents|mesh-ancestor
153987113|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987114|NCT04081012|Antidotes|antidotes|mesh-ancestor
153987115|NCT00942968|Dalteparin|dalteparin|mesh-list
153987116|NCT00942968|Tinzaparin|tinzaparin|mesh-list
153987117|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153987118|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
153987119|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153987120|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153987121|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987143|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987145|NCT00919984|Carboplatin|carboplatin|mesh-list
153987146|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153987147|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987148|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
153987149|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
153987150|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
153987151|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987152|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153987153|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
153987154|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987155|NCT00942422|Protective Agents|protective agents|mesh-ancestor
153987156|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987157|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153987158|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153744752|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987159|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987160|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153987162|NCT00603824|Lepirudin|lepirudin|mesh-list
153987163|NCT00603824|Fondaparinux|fondaparinux|mesh-list
153987164|NCT00603824|Argatroban|argatroban|mesh-list
153987165|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153987166|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
153987167|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153987168|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
153987169|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987170|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987171|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
153987172|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153987173|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153987203|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153987204|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
153987205|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987206|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153987207|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987208|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153987209|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
153987210|NCT00942266|Antidotes|antidotes|mesh-ancestor
153987211|NCT00942266|Protective Agents|protective agents|mesh-ancestor
153987212|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
153987213|NCT00942266|Vitamins|vitamins|mesh-ancestor
153987214|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
153987215|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153987216|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987217|NCT05382182|Androgens|androgens|mesh-list
153987218|NCT05382182|Hormones|hormones|mesh-ancestor
153987219|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987220|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987221|NCT04079374|Etanercept|etanercept|mesh-list
153987222|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153774168|NCT04639804|Celecoxib|celecoxib|mesh-list
153987245|NCT02852798|Apatinib|apatinib|mesh-list
153987246|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987247|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
153987248|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
153987249|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
153987250|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987251|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987252|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987253|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
153987254|NCT02586610|Capecitabine|capecitabine|mesh-list
153987255|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987256|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987257|NCT02586610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153987258|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987259|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153987260|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
153987261|NCT00604682|Apremilast|apremilast|mesh-list
153987262|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153987263|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153987264|NCT00604682|Analgesics|analgesics|mesh-ancestor
153987265|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
153987266|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987267|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987268|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987269|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153987270|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153987271|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153987272|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182203|NCT05856695|Antimitotic Agents|antimitotic agents|mesh-ancestor
153987288|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153987289|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153987291|NCT00920296|Etravirine|etravirine|mesh-list
153987292|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153987293|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153987294|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608937|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987295|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987296|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153987297|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153987298|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
153987299|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987300|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153987301|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153987302|NCT04080388|Diuretics|diuretics|mesh-list
153987303|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
153987304|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987305|NCT00765115|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
153987306|NCT00765115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153987307|NCT00765115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744900|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987308|NCT00765115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987309|NCT04080622|Selenium|selenium|mesh-list
153987311|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987312|NCT04080622|Protective Agents|protective agents|mesh-ancestor
153987313|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987314|NCT04080622|Trace Elements|trace elements|mesh-ancestor
153987315|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
153987316|NCT04079140|Dinoprostone|dinoprostone|mesh-list
153987317|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
153987318|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153987319|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987320|NCT00673465|Metformin|metformin|mesh-list
153987321|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987322|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987323|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
153987324|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153987325|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153987326|NCT00764413|Prednisolone|prednisolone|mesh-list
153774263|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
153987352|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
153987353|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987354|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987355|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
153987356|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987357|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153987358|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
153987359|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987360|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153987361|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153987362|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153987363|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153987364|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987365|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
153987366|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
153987367|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987368|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153987369|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153987370|NCT00605930|Niacinamide|niacinamide|mesh-list
153987372|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
153987373|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
153987374|NCT00605930|Vitamins|vitamins|mesh-ancestor
153987375|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
153987376|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987377|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153987378|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
153987405|NCT05857306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153609004|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153987406|NCT05857306|Analgesics|analgesics|mesh-ancestor
153987407|NCT05857306|Sensory System Agents|sensory system agents|mesh-ancestor
153987408|NCT05857306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987409|NCT05857306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987410|NCT05857306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987411|NCT05857306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153987412|NCT05857267|Timolol|timolol|mesh-list
153987413|NCT05857267|Dorzolamide|dorzolamide|mesh-list
153987414|NCT05857267|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153987415|NCT05857267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153987416|NCT05857267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153987417|NCT05857267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153987418|NCT05857267|Adrenergic Agents|adrenergic agents|mesh-ancestor
154176497|NCT00844337|Amoxicillin|amoxicillin|mesh-list
154176498|NCT00844337|Gentamicins|gentamicins|mesh-list
154176499|NCT00844337|Penicillins|penicillins|mesh-list
154176500|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176501|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176502|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154176503|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182204|NCT05856695|Mitosis Modulators|mitosis modulators|mesh-ancestor
153987424|NCT05857267|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153987425|NCT05857267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987426|NCT05857202|Analgesics, Opioid|analgesics, opioid|mesh-list
153987428|NCT05857202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
153987429|NCT05857202|Narcotics|narcotics|mesh-ancestor
153987430|NCT05857202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987431|NCT05857202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987432|NCT05857202|Sensory System Agents|sensory system agents|mesh-ancestor
153987433|NCT05857202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987435|NCT05857085|Empagliflozin|empagliflozin|mesh-list
153987436|NCT05857085|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153987437|NCT05857085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987438|NCT05857085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987439|NCT05857085|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153987440|NCT05857085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987441|NCT05856630|Goserelin|goserelin|mesh-list
153987442|NCT05856630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153987443|NCT05856630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987444|NCT05856578|Canagliflozin|canagliflozin|mesh-list
153987445|NCT05856578|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153987446|NCT05856578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153987447|NCT05856578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987448|NCT05856578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987449|NCT05856396|Vaccines|vaccines|mesh-list
153987450|NCT05856396|Immunologic Factors|immunologic factors|mesh-ancestor
153987451|NCT05856396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987452|NCT05856383|Vinorelbine|vinorelbine|mesh-list
153987453|NCT05856383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153987454|NCT05856383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987455|NCT05856383|Tubulin Modulators|tubulin modulators|mesh-ancestor
153987456|NCT05856383|Antimitotic Agents|antimitotic agents|mesh-ancestor
153987457|NCT05856383|Mitosis Modulators|mitosis modulators|mesh-ancestor
153987458|NCT05856383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987459|NCT05851313|Vitamin D|vitamin d|mesh-list
153987460|NCT05851313|Vitamins|vitamins|mesh-ancestor
153987481|NCT05766540|Metformin|metformin|mesh-list
153987482|NCT05766540|Aripiprazole|aripiprazole|mesh-list
153987483|NCT05766540|Clozapine|clozapine|mesh-list
153987484|NCT05766540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987485|NCT05766540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987486|NCT05766540|Antidepressive Agents|antidepressive agents|mesh-ancestor
153987487|NCT05766540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153987488|NCT05766540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153987489|NCT05766540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153987490|NCT05766540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987491|NCT05766540|Dopamine Agonists|dopamine agonists|mesh-ancestor
153987492|NCT05766540|Dopamine Agents|dopamine agents|mesh-ancestor
153987493|NCT05766540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987494|NCT05766540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987495|NCT05766540|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153987496|NCT05766540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153987497|NCT05766540|Serotonin Agents|serotonin agents|mesh-ancestor
153987498|NCT05766540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153987499|NCT05766540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153987500|NCT05766540|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153987501|NCT05766540|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153987502|NCT05766540|GABA Antagonists|gaba antagonists|mesh-ancestor
153987503|NCT05766540|GABA Agents|gaba agents|mesh-ancestor
153987504|NCT05746806|Androgens|androgens|mesh-list
153987505|NCT05746806|Hormones|hormones|mesh-ancestor
153987506|NCT05746806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987507|NCT05746806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987509|NCT05733715|Lenvatinib|lenvatinib|mesh-list
153987510|NCT05733715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987511|NCT05733715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987512|NCT05733715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153987513|NCT05733715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987514|NCT05733715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987526|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153987527|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987528|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987529|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987530|NCT05604794|Ketamine|ketamine|mesh-list
153987531|NCT05604794|Analgesics|analgesics|mesh-ancestor
153987532|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
153987533|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987534|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987537|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
153987538|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
153987539|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987540|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153987541|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153987542|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987543|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987544|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153987547|NCT05366829|Tislelizumab|tislelizumab|mesh-list
153987548|NCT05366829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987549|NCT05366829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987550|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
153987551|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153987552|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987553|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987554|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153987555|NCT05305248|Analgesics|analgesics|mesh-ancestor
153987556|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
153987557|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987558|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153987559|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153987560|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153987561|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
153987562|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987563|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987564|NCT05286996|Anesthetics|anesthetics|mesh-list
153987565|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
153987566|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987567|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987568|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
153987569|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987570|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
153987571|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
153987572|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987573|NCT05210166|Protective Agents|protective agents|mesh-ancestor
153987574|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987575|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153987576|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987578|NCT05158153|Diuretics|diuretics|mesh-ancestor
153987579|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
153987580|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987581|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153987591|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987592|NCT05098366|Furosemide|furosemide|mesh-list
153987593|NCT05098366|Diuretics|diuretics|mesh-ancestor
153987594|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
153987595|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987596|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153987597|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153987598|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987599|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
153987600|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153987601|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
153987602|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987603|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
153987604|NCT05082480|Protective Agents|protective agents|mesh-ancestor
153987605|NCT05073250|Rituximab|rituximab|mesh-list
153987606|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987607|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987608|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
153987609|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987610|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153987611|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
153987612|NCT05041270|Nalbuphine|nalbuphine|mesh-list
153987613|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153987614|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987615|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987616|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153987617|NCT05041270|Analgesics|analgesics|mesh-ancestor
153987618|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
153987619|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987620|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153987621|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153987622|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153987623|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
153987624|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987625|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987626|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153987627|NCT05041270|Narcotics|narcotics|mesh-ancestor
153987628|NCT05039736|Nivolumab|nivolumab|mesh-list
153987629|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987630|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987631|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153987632|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987633|NCT05010590|Denosumab|denosumab|mesh-list
153987634|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153987635|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987636|NCT04940637|Niraparib|niraparib|mesh-list
153987637|NCT04940637|Dostarlimab|dostarlimab|mesh-list
153987638|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153987639|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987640|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987641|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987642|NCT04911660|Empagliflozin|empagliflozin|mesh-list
153987643|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153987644|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987663|NCT04752059|Trastuzumab|trastuzumab|mesh-list
153987664|NCT04752059|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153987665|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987666|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987667|NCT04752059|Immunoconjugates|immunoconjugates|mesh-ancestor
153987668|NCT04752059|Immunologic Factors|immunologic factors|mesh-ancestor
153987669|NCT04752059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987670|NCT04750473|Edetic Acid|edetic acid|mesh-list
153987671|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153987672|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
153987673|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
153987674|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987675|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
153987676|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153987677|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153987678|NCT04745351|Remdesivir|remdesivir|mesh-list
153987679|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
153987680|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987681|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
153987682|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987683|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
153987684|NCT04710277|Narcotics|narcotics|mesh-ancestor
153987685|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987686|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987687|NCT04710277|Analgesics|analgesics|mesh-ancestor
153987688|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
153987689|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987690|NCT04665089|Erythromycin|erythromycin|mesh-list
153987691|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
153987692|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153987693|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
153987694|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153987695|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987696|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987697|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153987698|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987699|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987700|NCT04591002|Osimertinib|osimertinib|mesh-list
153987701|NCT04591002|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153987702|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987703|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774654|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153987719|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987720|NCT04493333|Cathartics|cathartics|mesh-ancestor
153987721|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
153987722|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
153987723|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987724|NCT04403165|Norepinephrine|norepinephrine|mesh-list
153987725|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153987726|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153987727|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
153987728|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987729|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987730|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987731|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
153987732|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
153987733|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987734|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153987736|NCT04289779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153987737|NCT04289779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987738|NCT04289779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987739|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987740|NCT03989778|Vitamin D|vitamin d|mesh-list
153987741|NCT03989778|Vitamins|vitamins|mesh-ancestor
153987742|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
153987743|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987744|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153987745|NCT03959527|Azithromycin|azithromycin|mesh-list
153987746|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
153987747|NCT03959527|Zoliflodacin|zoliflodacin|mesh-list
153987748|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153987749|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987750|NCT03959527|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153987751|NCT03959527|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153987752|NCT03959527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153987753|NCT03959527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153987754|NCT03959527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987755|NCT03959527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987756|NCT03959527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987757|NCT03955172|Everolimus|everolimus|mesh-list
153987758|NCT03955172|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153987759|NCT03955172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987760|NCT03955172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987761|NCT03955172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987777|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987778|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987779|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153987780|NCT03889249|Tenecteplase|tenecteplase|mesh-list
153987781|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153987782|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153987783|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987785|NCT03841201|Lenvatinib|lenvatinib|mesh-list
153987786|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987787|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987788|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153987789|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987790|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987791|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987792|NCT03733535|Benralizumab|benralizumab|mesh-list
153987793|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153987794|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
153987795|NCT03719092|Vitamins|vitamins|mesh-list
153987796|NCT03719092|Vitamin A|vitamin a|mesh-list
153987797|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
153987798|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
153987799|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987800|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
153987801|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987802|NCT03719092|Protective Agents|protective agents|mesh-ancestor
153987803|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153987804|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987805|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
153987806|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153987807|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
154176517|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
153987808|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987809|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987810|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153987811|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
153987812|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153987813|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
153987814|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987815|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987816|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153987817|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
153987818|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
153987819|NCT03661385|Protective Agents|protective agents|mesh-ancestor
153987844|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153987845|NCT03617731|Growth Substances|growth substances|mesh-ancestor
153987846|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
153987847|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
153987848|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153987849|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153987850|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987851|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
153987852|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
153987853|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987854|NCT03439124|Cephalosporins|cephalosporins|mesh-list
153987855|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
153987856|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
153987857|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153987858|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987859|NCT03393741|Paclitaxel|paclitaxel|mesh-list
153987860|NCT03393741|Vinorelbine|vinorelbine|mesh-list
153987861|NCT03393741|Docetaxel|docetaxel|mesh-list
153987862|NCT03393741|Epothilones|epothilones|mesh-list
153987863|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
153987864|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153987865|NCT03393741|Taxane|taxane|mesh-list
153987866|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153987867|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987868|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
153987869|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
153987870|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
153987871|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987872|NCT03304093|Nivolumab|nivolumab|mesh-list
153987873|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987874|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774828|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
153987888|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987891|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
153987892|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
153987893|NCT03137173|Cephalosporins|cephalosporins|mesh-list
153987894|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153987895|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987896|NCT03072147|Teriparatide|teriparatide|mesh-list
153987897|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153987898|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987899|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153987900|NCT02723513|Xenon|xenon|mesh-list
153987901|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153987902|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
153987903|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
153987904|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987905|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987906|NCT02706054|Meloxicam|meloxicam|mesh-list
153987907|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153987908|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153987909|NCT02706054|Analgesics|analgesics|mesh-ancestor
153987910|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
153987911|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987912|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987913|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987914|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153987915|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153987916|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153987917|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987918|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987920|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987921|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987922|NCT02600117|Tenofovir|tenofovir|mesh-list
153987923|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
153987924|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987925|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153987926|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153987927|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987928|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987929|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153987930|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153987931|NCT02599714|Fulvestrant|fulvestrant|mesh-list
153987932|NCT02599714|Palbociclib|palbociclib|mesh-list
153987933|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153987934|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987935|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153987936|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153774883|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
153987947|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987949|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
153987950|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153987951|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
153987952|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987953|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987954|NCT02265874|Nicotine|nicotine|mesh-list
153987955|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153987956|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
153987957|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987958|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987959|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153987960|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153987961|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
153987962|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987963|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987965|NCT01996436|Nicardipine|nicardipine|mesh-list
153987966|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
153987967|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
153987968|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153987969|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153987970|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153987971|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987972|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153987973|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987974|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153987976|NCT01845337|Tegafur|tegafur|mesh-list
153987977|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153987978|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
153987979|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987980|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987981|NCT00836537|Benazepril|benazepril|mesh-list
153745571|NCT03460366|Enalapril|enalapril|mesh-list
153987982|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153987983|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
153987984|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987985|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987986|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153987988|NCT00572169|Dexamethasone|dexamethasone|mesh-list
153987989|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
153987990|NCT00572169|Cisplatin|cisplatin|mesh-list
153987991|NCT00572169|Doxorubicin|doxorubicin|mesh-list
153987992|NCT00572169|Etoposide|etoposide|mesh-list
153987993|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153987994|NCT00572169|Bortezomib|bortezomib|mesh-list
153987995|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153987996|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
153987997|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987998|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153987999|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153988000|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
153988011|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988013|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153988014|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153988015|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153988016|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988017|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153988018|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
153988019|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988020|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988021|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153988022|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153988023|NCT00572169|Growth Substances|growth substances|mesh-ancestor
153988024|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
153988025|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
153988026|NCT00941720|Busulfan|busulfan|mesh-list
153988027|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153988028|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
153988029|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988030|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153988031|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153988032|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
153988033|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988034|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988035|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153988036|NCT02583568|Bevacizumab|bevacizumab|mesh-list
153988037|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153988038|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988039|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153988040|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153988041|NCT02583568|Growth Substances|growth substances|mesh-ancestor
153988042|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988043|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
153988044|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
153988045|NCT02852564|Diuretics|diuretics|mesh-ancestor
153988046|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
153988047|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988048|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988049|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988050|NCT05509816|Midazolam|midazolam|mesh-list
153988051|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153988052|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153988053|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988054|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988055|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153745645|NCT03283150|Analgesics|analgesics|mesh-ancestor
153988056|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153988057|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153988058|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153988059|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
153988060|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
153988061|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
153988062|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
153988063|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988081|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
153988083|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988084|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
153988085|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153988086|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
153988087|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988088|NCT00933608|Memantine|memantine|mesh-list
153988089|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153988090|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153988091|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
153988092|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988093|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988094|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988095|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153988096|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153988097|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153988098|NCT02558023|Nicardipine|nicardipine|mesh-list
153988099|NCT02558023|Urapidil|urapidil|mesh-list
153988100|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153988101|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153988102|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153988103|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988104|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153988105|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988106|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
153988107|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153988108|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
154176518|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988109|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988110|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153988111|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153988112|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153988113|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988114|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153988115|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153988116|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153988117|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153988118|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609646|NCT04605614|Copper|copper|mesh-list
153988129|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153988130|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988131|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988132|NCT02584816|Vaccines|vaccines|mesh-list
153988133|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
153988134|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988135|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
153988136|NCT02584738|Prednisolone|prednisolone|mesh-list
153988137|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
153988138|NCT02584738|Bromides|bromides|mesh-list
153988139|NCT02584738|Albuterol|albuterol|mesh-list
153988140|NCT02584738|Ipratropium|ipratropium|mesh-list
153988141|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988142|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
153988143|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
153988144|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988145|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988146|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988147|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
153988148|NCT02584738|Hormones|hormones|mesh-ancestor
153988149|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988150|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153988151|NCT02584738|Protective Agents|protective agents|mesh-ancestor
153988152|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153988153|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988154|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
153988155|NCT02584738|Analgesics|analgesics|mesh-ancestor
153988156|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
153988157|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
153988158|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988159|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153988160|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153988161|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153988162|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988163|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153988164|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
153988165|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153988166|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153988167|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153988168|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
153988169|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153988170|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153988171|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153988172|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988173|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988174|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153988175|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
153988176|NCT00765271|Ritonavir|ritonavir|mesh-list
153988177|NCT00765271|Darunavir|darunavir|mesh-list
153988178|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
153988179|NCT00765271|Abacavir|abacavir|mesh-list
153988180|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153988181|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153988182|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
154176519|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153988183|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988199|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
153988200|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988201|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988202|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745792|NCT00582075|Temozolomide|temozolomide|mesh-list
153988204|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
153988205|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153609699|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
153988206|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
153988207|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153988208|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988209|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988210|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
153988211|NCT00764725|Infliximab|infliximab|mesh-list
153988212|NCT00764725|Methotrexate|methotrexate|mesh-list
153988213|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153988214|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
153988215|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153988216|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988217|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153988218|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
153988219|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988220|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988221|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
153988222|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988223|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153988224|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153988225|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
153988226|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153988227|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153988228|NCT00764725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153988229|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988230|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988231|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988232|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153988233|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988234|NCT00764725|Analgesics|analgesics|mesh-ancestor
153988235|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
153988236|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988237|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
153988238|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153988239|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988253|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988254|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153988255|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
153988256|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154145525|NCT02573987|Analgesics|analgesics|mesh-ancestor
153988257|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153988258|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988259|NCT00606242|Fluticasone|fluticasone|mesh-list
153988260|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988261|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153988262|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
153988263|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988264|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988265|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153988266|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
153988267|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
153988268|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153988269|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153988270|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153988271|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
153988272|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988273|NCT00770263|Sirolimus|sirolimus|mesh-list
153988274|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153988275|NCT00770263|Temsirolimus|temsirolimus|mesh-list
153988276|NCT00770263|MTOR Inhibitors|mtor inhibitors|mesh-list
153988277|NCT00770263|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153988278|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153988280|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988281|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988282|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153988283|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
153988284|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988285|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988286|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988287|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153988288|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
153988289|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
153988290|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153988291|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988292|NCT02691026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153988293|NCT02691026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988294|NCT00765427|Retinol acetate|retinol acetate|mesh-list
153988295|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153988296|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
153988297|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988298|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153988299|NCT00765427|Protective Agents|protective agents|mesh-ancestor
153988300|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988301|NCT02584582|Liraglutide|liraglutide|mesh-list
153988302|NCT02584582|Exenatide|exenatide|mesh-list
153988315|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153988317|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988318|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988319|NCT00775177|Doxycycline|doxycycline|mesh-list
153988320|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988321|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988322|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
153988323|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153988324|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153988325|NCT00770497|Pioglitazone|pioglitazone|mesh-list
153988326|NCT00770497|Ramipril|ramipril|mesh-list
153988327|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153988328|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988329|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153988330|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
153988331|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988332|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988333|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153988334|NCT02581696|Irsogladine|irsogladine|mesh-list
153988335|NCT02581696|Lafutidine|lafutidine|mesh-list
153988336|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988337|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153988338|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988339|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153988340|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
153988341|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
153988342|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988343|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860915|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153988344|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988345|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153988346|NCT02581696|Protective Agents|protective agents|mesh-ancestor
153988347|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153988348|NCT00607958|Ritonavir|ritonavir|mesh-list
153988349|NCT00607958|Tipranavir|tipranavir|mesh-list
153988350|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153988351|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153988352|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
153988353|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988354|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988355|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153988356|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153988357|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
153609851|NCT05414721|Anesthetics|anesthetics|mesh-list
153781752|NCT04559425|Hormones|hormones|mesh-ancestor
153988358|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988359|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153988360|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153988361|NCT00770575|Pioglitazone|pioglitazone|mesh-list
153988362|NCT00770575|Atorvastatin|atorvastatin|mesh-list
153988363|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153988364|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153988365|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
153988381|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988382|NCT00770731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153988383|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153988384|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
153988385|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988386|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988387|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988388|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153988389|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
153988390|NCT00775255|Clarithromycin|clarithromycin|mesh-list
153988391|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988392|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988393|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153988394|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988395|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988396|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153988397|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153988398|NCT00766285|Vaccines|vaccines|mesh-list
153988399|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
153988400|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988401|NCT04265456|Acetaminophen|acetaminophen|mesh-list
153988402|NCT04265456|Pregabalin|pregabalin|mesh-list
153988403|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988404|NCT04265456|Analgesics|analgesics|mesh-ancestor
153988405|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
153988406|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988407|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988409|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
153988410|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153988411|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153988412|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988413|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153988414|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153988415|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153988416|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988417|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153988418|NCT04379518|Interferons|interferons|mesh-list
153988419|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
153988420|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
153988421|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153988422|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988423|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
153988424|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988425|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
153775375|NCT06167057|Mitomycins|mitomycins|mesh-list
153988442|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988443|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153988444|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988445|NCT04378426|Analgesics|analgesics|mesh-ancestor
153988446|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
153609927|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153988447|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988448|NCT02581462|Trastuzumab|trastuzumab|mesh-list
153988449|NCT02581462|Pertuzumab|pertuzumab|mesh-list
153988450|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255076|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153988451|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988452|NCT00668863|Leucovorin|leucovorin|mesh-list
153988453|NCT00668863|Fluorouracil|fluorouracil|mesh-list
153988454|NCT00668863|Irinotecan|irinotecan|mesh-list
153988455|NCT00668863|Sunitinib|sunitinib|mesh-list
153988456|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
153988457|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
153988458|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988459|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153988460|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988461|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153988462|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
153988463|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988464|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153988465|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153988466|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988467|NCT00668863|Antidotes|antidotes|mesh-ancestor
153988468|NCT00668863|Protective Agents|protective agents|mesh-ancestor
153988469|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
153988470|NCT00668863|Vitamins|vitamins|mesh-ancestor
153988471|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
153988472|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153988473|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153988474|NCT00668863|Growth Substances|growth substances|mesh-ancestor
153988475|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
153988476|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153988477|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153988478|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153988479|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988480|NCT00766441|Incretins|incretins|mesh-ancestor
153988481|NCT00766441|Hormones|hormones|mesh-ancestor
153988482|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988483|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153988484|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
153988485|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988486|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988509|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988510|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
153988512|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988513|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988514|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153988515|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
153988516|NCT00771199|Fentanyl|fentanyl|mesh-list
153988517|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153988518|NCT00771199|Narcotics|narcotics|mesh-ancestor
153988519|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988520|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988521|NCT00771199|Analgesics|analgesics|mesh-ancestor
153988522|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
153988523|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988524|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153988525|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153988526|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
153988527|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
153988528|NCT04264130|Artesunate|artesunate|mesh-list
153988529|NCT04264130|Lumefantrine|lumefantrine|mesh-list
153988530|NCT04264130|Artemether|artemether|mesh-list
153988531|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153988532|NCT04264130|Pyronaridine|pyronaridine|mesh-list
153988533|NCT04264130|Artefenomel|artefenomel|mesh-list
153988534|NCT04264130|Ferroquine|ferroquine|mesh-list
153988535|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
153988536|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153988537|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153988538|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988539|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988540|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
153610128|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775493|NCT06035536|Calcium|calcium|mesh-list
153988554|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153988555|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988556|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988557|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988558|NCT00605774|Epinephrine|epinephrine|mesh-list
153988559|NCT00605774|Racepinephrine|racepinephrine|mesh-list
153988560|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
153988561|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154860916|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154860917|NCT02153541|Analgesics|analgesics|mesh-ancestor
153988562|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153988563|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988564|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988565|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988566|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988567|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153988568|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153988569|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
153988570|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988571|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153988572|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
153988573|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
153988574|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
153988575|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153988576|NCT04264286|Esmolol|esmolol|mesh-list
153988577|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153988578|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153988579|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153988580|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988581|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988582|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988583|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988585|NCT02582476|Diuretics|diuretics|mesh-ancestor
153988586|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
153988587|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988588|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153988589|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153988590|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988591|NCT02582320|Ibrutinib|ibrutinib|mesh-list
153988592|NCT02582320|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153988593|NCT02582320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153988594|NCT02582320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988595|NCT02582320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988596|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
153988597|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153988598|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153988599|NCT04078204|Protective Agents|protective agents|mesh-ancestor
153988600|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988601|NCT00668707|Melatonin|melatonin|mesh-list
153988611|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
153988612|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988613|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153988614|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988615|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988616|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
153988617|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988618|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
153988619|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153988620|NCT00771433|Lenograstim|lenograstim|mesh-list
153988621|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153988622|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
153988623|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988624|NCT00668395|Efavirenz|efavirenz|mesh-list
153988625|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153988626|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153988627|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988628|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988629|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
153988630|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988631|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153988632|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153988633|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153988634|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153988635|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153988636|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153988637|NCT00668317|Omeprazole|omeprazole|mesh-list
153988638|NCT00668317|Ranitidine|ranitidine|mesh-list
153988639|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153988640|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153988641|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988642|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154145822|NCT00123487|Dasatinib|dasatinib|mesh-list
153988643|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988644|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988645|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153988646|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
153988647|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
153988648|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988649|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988650|NCT00775879|Sevoflurane|sevoflurane|mesh-list
153988651|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153988652|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153988653|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
153988654|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
153988655|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988657|NCT00767221|Budesonide|budesonide|mesh-list
153988658|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153988659|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153988660|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
153988661|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988662|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988663|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153988664|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
153988665|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
153988666|NCT00767221|Hormones|hormones|mesh-ancestor
153988667|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988683|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610214|NCT02518009|Androgens|androgens|mesh-list
153610292|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153988684|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988686|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
153988687|NCT00776113|Protective Agents|protective agents|mesh-ancestor
153988688|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153988689|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153988690|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153988691|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
153988692|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153988693|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153988694|NCT02580448|Seviteronel|seviteronel|mesh-list
153988695|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988696|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153988697|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988698|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988699|NCT04008238|Trabectedin|trabectedin|mesh-list
153988700|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153988701|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
153988702|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988703|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988704|NCT00672139|Bromides|bromides|mesh-list
153988705|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
153988706|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
153988707|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154176520|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153988708|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988709|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
153988710|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988712|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988713|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988714|NCT00771823|Maraviroc|maraviroc|mesh-list
153988715|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153988716|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153988717|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988718|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153988719|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153988720|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
153988721|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988722|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153988723|NCT03955042|Pemetrexed|pemetrexed|mesh-list
153988724|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988725|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988729|NCT00570739|Metformin|metformin|mesh-list
153988730|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153988731|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153988732|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988733|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153988734|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154860918|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988735|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
153988736|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988737|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153988738|NCT04076098|Minocycline|minocycline|mesh-list
153988739|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988740|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988741|NCT00771979|Saracatinib|saracatinib|mesh-list
153988742|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988743|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988744|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988745|NCT00767689|Pyridoxine|pyridoxine|mesh-list
153988746|NCT00767689|Pyridoxal|pyridoxal|mesh-list
153988747|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
153988748|NCT00767689|Vitamins|vitamins|mesh-ancestor
153988749|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
153988750|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988751|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
153988752|NCT00772057|Propranolol|propranolol|mesh-list
153988753|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153988754|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153988755|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988756|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988757|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988758|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988759|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153988760|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153988761|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
153988762|NCT00776347|Donepezil|donepezil|mesh-list
153988763|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153988764|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988765|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988766|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
153988767|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988768|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988769|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
153988770|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
153988771|NCT00776425|Hematinics|hematinics|mesh-ancestor
153988772|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
153988773|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153988774|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153988775|NCT03913702|Prednisolone|prednisolone|mesh-list
153988776|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
153988777|NCT03913702|Ketorolac|ketorolac|mesh-list
153988778|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153988779|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153988780|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
153988781|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988782|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
153988783|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
153642449|NCT00006122|Cytarabine|cytarabine|mesh-list
153988784|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988785|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988786|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988787|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
153988788|NCT03913702|Hormones|hormones|mesh-ancestor
153988789|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988790|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153988791|NCT03913702|Protective Agents|protective agents|mesh-ancestor
153988792|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153988793|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988794|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153988795|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988796|NCT03913702|Analgesics|analgesics|mesh-ancestor
153988797|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
153988813|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988815|NCT04075006|Analgesics|analgesics|mesh-ancestor
153988816|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
153988817|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988818|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988819|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153610378|NCT01946555|Narcotics|narcotics|mesh-ancestor
153988820|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153988821|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
153988822|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
153988823|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988824|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153988825|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154145967|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153988826|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988827|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988828|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
153988829|NCT04188106|Varenicline|varenicline|mesh-list
153988830|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153988831|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153988832|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
153988833|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988834|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988835|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988836|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
153988837|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153988838|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153988839|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
153988840|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
153988841|NCT00669955|Amoxicillin|amoxicillin|mesh-list
153988842|NCT00669955|Metronidazole|metronidazole|mesh-list
153988843|NCT00669955|Clarithromycin|clarithromycin|mesh-list
153988844|NCT00669955|Tetracycline|tetracycline|mesh-list
153988845|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153988847|NCT00669955|Bismuth|bismuth|mesh-list
153988848|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988849|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988850|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153988851|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153988852|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153988853|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988854|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153988855|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988856|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988872|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153988873|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988874|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153988875|NCT03595150|Diclofenac|diclofenac|mesh-list
153988876|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153988877|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988878|NCT03595150|Analgesics|analgesics|mesh-ancestor
153988879|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
153988880|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988881|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988882|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988884|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153988885|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988886|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988887|NCT00768157|Lamivudine|lamivudine|mesh-list
153988888|NCT00768157|Entecavir|entecavir|mesh-list
153988889|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
153988890|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153988891|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153988892|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988893|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988894|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988895|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153988896|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153610578|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988897|NCT00671749|Clindamycin|clindamycin|mesh-list
153988898|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
153988899|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
153988900|NCT00671749|Adapalene|adapalene|mesh-list
153988901|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153988902|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153988903|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988904|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153988905|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988906|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988907|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
153988908|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153988909|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988910|NCT00671749|Analgesics|analgesics|mesh-ancestor
153988911|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
153988912|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988913|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988938|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153988939|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
154860919|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255078|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988940|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988942|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153988943|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
153988944|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988945|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988946|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153988947|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988949|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
153988950|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988951|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988952|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
153988953|NCT00669877|Hormones|hormones|mesh-ancestor
153988954|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988955|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153988956|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153988957|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153988958|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153988959|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153988960|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988961|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153988962|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
153988963|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153988964|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153988965|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
153988966|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775921|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988979|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
153988980|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988981|NCT00772759|AZD-3199|azd-3199|mesh-list
153988982|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153988983|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153988984|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153988985|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988986|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988987|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988988|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988989|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153988990|NCT00772837|Amoxicillin|amoxicillin|mesh-list
153988991|NCT00772837|Clarithromycin|clarithromycin|mesh-list
153988992|NCT00772837|Omeprazole|omeprazole|mesh-list
153988993|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988994|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153988995|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988996|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153988997|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988998|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988999|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153989000|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153989001|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153989002|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
153989003|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989004|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989005|NCT00768859|Paclitaxel|paclitaxel|mesh-list
153989006|NCT00768859|Carboplatin|carboplatin|mesh-list
153989007|NCT00768859|Trastuzumab|trastuzumab|mesh-list
153989008|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153989009|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989010|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
153989011|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989012|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
153989013|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989014|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989015|NCT00768937|Sorafenib|sorafenib|mesh-list
153989016|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989017|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153989018|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989019|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989020|NCT04047745|Bupivacaine|bupivacaine|mesh-list
153989021|NCT04047745|Ropivacaine|ropivacaine|mesh-list
153989022|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
154860920|NCT03487276|Vilobelimab|vilobelimab|mesh-list
153989023|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
153989024|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989025|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989026|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
153989027|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989028|NCT00777439|Domperidone|domperidone|mesh-list
153989029|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989030|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
153775970|NCT04323046|Nivolumab|nivolumab|mesh-list
153989043|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989044|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989045|NCT00777517|Atorvastatin|atorvastatin|mesh-list
153989046|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153989047|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153989048|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
153989049|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989050|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153989051|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153989052|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989053|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
153989054|NCT00769171|Metronidazole|metronidazole|mesh-list
153989055|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
153989056|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153610718|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153989057|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153989058|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989059|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153989060|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153989061|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989062|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989063|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989064|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153989065|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
153989066|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153989067|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989068|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153989069|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153989070|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153989071|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153989072|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153989073|NCT00769171|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153989074|NCT00769171|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153989075|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
153989076|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153989077|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989078|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153989079|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153989080|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989081|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989082|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989083|NCT00769405|Leucovorin|leucovorin|mesh-list
154176522|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153989084|NCT00769405|Fluorouracil|fluorouracil|mesh-list
153989085|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
153989087|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
153989088|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153989089|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989090|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
153989091|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989092|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153989101|NCT02829502|Exenatide|exenatide|mesh-list
153989102|NCT02829502|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153989103|NCT02829502|Glucagon|glucagon|mesh-list
153989104|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153989105|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153989106|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989107|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153989108|NCT02829502|Incretins|incretins|mesh-ancestor
153989109|NCT02829502|Hormones|hormones|mesh-ancestor
153989110|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153989111|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989112|NCT02635191|Amoxicillin|amoxicillin|mesh-list
153989113|NCT02635191|Metronidazole|metronidazole|mesh-list
153989114|NCT02635191|Clarithromycin|clarithromycin|mesh-list
154146186|NCT00727493|Alendronate|alendronate|mesh-list
153989115|NCT02635191|Esomeprazole|esomeprazole|mesh-list
153989116|NCT02635191|Omeprazole|omeprazole|mesh-list
153989117|NCT02635191|Rabeprazole|rabeprazole|mesh-list
153989118|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153989119|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989120|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153989121|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153989122|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153989123|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989124|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153989125|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989126|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989127|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153989128|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153989129|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153989130|NCT00777673|Paclitaxel|paclitaxel|mesh-list
153989131|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
153989132|NCT00777673|Bevacizumab|bevacizumab|mesh-list
153989133|NCT00777673|Carboplatin|carboplatin|mesh-list
153989134|NCT00777673|Doxorubicin|doxorubicin|mesh-list
153989135|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153989136|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153989137|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989138|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
153989139|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989140|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
153989141|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989142|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153989143|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
153989144|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989145|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989146|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153989147|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
153989148|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153989149|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989150|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153989151|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153989152|NCT00777673|Growth Substances|growth substances|mesh-ancestor
153989153|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
153989154|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153989155|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153989156|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153989157|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989158|NCT02579902|Vitamin D|vitamin d|mesh-list
153989159|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
153989160|NCT02579902|Vitamins|vitamins|mesh-ancestor
153989161|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
153989162|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989163|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153989172|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
153989173|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989174|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153989176|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
153989177|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989178|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
153989179|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153989180|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
153989181|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989182|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989183|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153989184|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153989185|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
153989186|NCT02579590|Desogestrel|desogestrel|mesh-list
153989187|NCT02579590|Etonogestrel|etonogestrel|mesh-list
153989188|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153989189|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153989190|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153989191|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
153989192|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153989193|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989194|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153989195|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153989196|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153989197|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154860921|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154146259|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
153989198|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989199|NCT02579590|Progestins|progestins|mesh-ancestor
153989201|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153989202|NCT02634723|Factor VIII|factor viii|mesh-list
153989203|NCT02634723|Coagulants|coagulants|mesh-ancestor
153989204|NCT02634489|Tamsulosin|tamsulosin|mesh-list
153989205|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
153989206|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153989207|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153989208|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153989209|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
153989210|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989211|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989212|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989213|NCT02634489|Urological Agents|urological agents|mesh-ancestor
153989214|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153989215|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153989216|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
153989217|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
153989218|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
153989219|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989220|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989221|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989222|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
153989223|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153989224|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989225|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989226|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153989227|NCT03920566|Dalteparin|dalteparin|mesh-list
153989228|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
153989229|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153989230|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153776173|NCT03631043|Lenalidomide|lenalidomide|mesh-list
153989236|NCT00582790|Analgesics|analgesics|mesh-ancestor
153989237|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
153989238|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989239|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989240|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153989241|NCT00774007|Mesalamine|mesalamine|mesh-list
153989242|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153989243|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989244|NCT00774007|Analgesics|analgesics|mesh-ancestor
153989245|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
153989246|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989247|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989248|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989249|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989250|NCT00769873|Heparin|heparin|mesh-list
153989251|NCT00769873|Enoxaparin|enoxaparin|mesh-list
153989252|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153989253|NCT00769873|Tinzaparin|tinzaparin|mesh-list
153989254|NCT00769873|Dalteparin|dalteparin|mesh-list
153746845|NCT04687111|Valsartan|valsartan|mesh-list
153989255|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
153989256|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153989257|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153989258|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989259|NCT00777985|Bosentan|bosentan|mesh-list
153989260|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153610888|NCT01949818|Hormones|hormones|mesh-ancestor
153989261|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153989262|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989263|NCT00770107|Thiamine|thiamine|mesh-list
153989264|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
153989265|NCT00770107|Vitamins|vitamins|mesh-ancestor
153989266|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
153989267|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989268|NCT00774241|Bevacizumab|bevacizumab|mesh-list
153989269|NCT00774241|Docetaxel|docetaxel|mesh-list
153989270|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989271|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989272|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153989273|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153989274|NCT00774241|Growth Substances|growth substances|mesh-ancestor
154860922|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153989275|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989276|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
153989277|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
153989278|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989279|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
153989280|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989281|NCT00774319|Cisplatin|cisplatin|mesh-list
153989282|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989283|NCT00881751|Bevacizumab|bevacizumab|mesh-list
153989284|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153989285|NCT00881751|Sorafenib|sorafenib|mesh-list
153989286|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989287|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989288|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153989289|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153989290|NCT00881751|Growth Substances|growth substances|mesh-ancestor
153989291|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989292|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
153989293|NCT00881751|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153989294|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153989295|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989296|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989297|NCT02634255|Fentanyl|fentanyl|mesh-list
153989298|NCT02634255|Propofol|propofol|mesh-list
153989299|NCT02634255|Rocuronium|rocuronium|mesh-list
153989300|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153989301|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989322|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
153989323|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989324|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153989325|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153989326|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153989327|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
153989328|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989329|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989330|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153989331|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153989332|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153989333|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989334|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153989335|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
153989336|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
153989337|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
153989338|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
153989339|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
153989340|NCT04161729|Analgesics|analgesics|mesh-ancestor
153989341|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
153611025|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
153989342|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989343|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989344|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
153989345|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989346|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153989347|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
153989348|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153989349|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153989350|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989351|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153989352|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
153989353|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153989354|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
153989355|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
153989356|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153989357|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153776310|NCT03165994|Paclitaxel|paclitaxel|mesh-list
153989367|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989368|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
153989369|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989370|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
153989371|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989372|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989373|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153989374|NCT00934856|Immunotoxins|immunotoxins|mesh-ancestor
153989375|NCT00934856|Immunoconjugates|immunoconjugates|mesh-ancestor
153989376|NCT00934856|Immunologic Factors|immunologic factors|mesh-ancestor
153989377|NCT00934856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989379|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153989380|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
153989381|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
153989382|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989383|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989384|NCT00669409|Tanezumab|tanezumab|mesh-list
153989385|NCT00669409|Analgesics|analgesics|mesh-ancestor
153989386|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
153989387|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989388|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989389|NCT00778141|Metformin|metformin|mesh-list
153989390|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153989391|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989392|NCT00774475|Clopidogrel|clopidogrel|mesh-list
153989393|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153989394|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153989395|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153989396|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153989397|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
153989398|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989399|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611031|NCT01950884|Ezetimibe|ezetimibe|mesh-list
153989400|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989401|NCT00669331|Mannitol|mannitol|mesh-list
153989402|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153989403|NCT00669331|Diuretics|diuretics|mesh-ancestor
153989404|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
153989405|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989406|NCT00778297|Vaccines|vaccines|mesh-list
153989407|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
153989408|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989409|NCT00779233|Zidovudine|zidovudine|mesh-list
153989410|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
153989411|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989412|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153989413|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153989414|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989415|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
153989416|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989417|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153989418|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153989419|NCT00607178|Vaccines|vaccines|mesh-list
153989420|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
153989421|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989422|NCT02556463|Durvalumab|durvalumab|mesh-list
153989423|NCT02556463|MEDI9197|medi9197|mesh-list
153989424|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989425|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989426|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153989437|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153989438|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153989439|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
153989440|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153989441|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989442|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153989443|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153989444|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153989445|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153989446|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153989447|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153989448|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153989449|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153989450|NCT00778765|Gabapentin|gabapentin|mesh-list
153989451|NCT00778765|Analgesics|analgesics|mesh-ancestor
153989452|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
153989453|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989454|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989455|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
153989456|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153989457|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153989458|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611186|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611187|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153989459|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989460|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153989461|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154176523|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989462|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989463|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989465|NCT00779935|Infliximab|infliximab|mesh-list
154146484|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989466|NCT00779935|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153989467|NCT00779935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989468|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
153989469|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989470|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989471|NCT00780013|Metformin|metformin|mesh-list
153989472|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153989473|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989474|NCT00667225|Cantharidin|cantharidin|mesh-list
153989475|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989476|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989477|NCT00780169|Sorafenib|sorafenib|mesh-list
153989478|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989479|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153989480|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989481|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989482|NCT00780325|Celecoxib|celecoxib|mesh-list
153989483|NCT00780325|Naproxen|naproxen|mesh-list
153989484|NCT00780325|Acetazolamide|acetazolamide|mesh-list
153989485|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153989486|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989487|NCT00780325|Analgesics|analgesics|mesh-ancestor
153989488|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
153989509|NCT00929864|Adalimumab|adalimumab|mesh-list
153989510|NCT00929864|Abatacept|abatacept|mesh-list
153989511|NCT00929864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153989512|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989513|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989514|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153989515|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989516|NCT00929864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989517|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989518|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153989519|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
153989520|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989521|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
153989522|NCT00597753|Hematinics|hematinics|mesh-ancestor
153989523|NCT04262804|Gemcitabine|gemcitabine|mesh-list
153989524|NCT04262804|Capecitabine|capecitabine|mesh-list
153989525|NCT04262804|Trastuzumab|trastuzumab|mesh-list
153989526|NCT04262804|Vinorelbine|vinorelbine|mesh-list
153989527|NCT04262804|Margetuximab|margetuximab|mesh-list
153989528|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153989529|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
153989530|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989531|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989532|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989533|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153989534|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
153989535|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989536|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
153989537|NCT00665431|Celecoxib|celecoxib|mesh-list
153989538|NCT00665431|Antacids|antacids|mesh-list
153989539|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153989540|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989541|NCT00665431|Analgesics|analgesics|mesh-ancestor
153989542|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
153776499|NCT02332902|Everolimus|everolimus|mesh-list
153989555|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989556|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153989557|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153989558|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989559|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989560|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153989561|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
153989562|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153989563|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989564|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153989565|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153989566|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989567|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
153989568|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
154860923|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
153989569|NCT04264988|Protective Agents|protective agents|mesh-ancestor
153989570|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989571|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153989572|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
153989573|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153989574|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153989575|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989576|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989577|NCT00657033|Urological Agents|urological agents|mesh-ancestor
153989578|NCT02633007|Levodopa|levodopa|mesh-list
153989579|NCT02633007|Carbidopa|carbidopa|mesh-list
153989580|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153989581|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153989582|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
153989583|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989584|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989585|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989586|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153989587|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989588|NCT01000727|Darapladib|darapladib|mesh-list
153989589|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153989590|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989591|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989592|NCT00881205|Rivastigmine|rivastigmine|mesh-list
153989593|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153989594|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989595|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989596|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
153989597|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989598|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989599|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153989600|NCT00881205|Protective Agents|protective agents|mesh-ancestor
153989601|NCT00879879|Losartan|losartan|mesh-list
153989602|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153989616|NCT04156425|Citalopram|citalopram|mesh-list
153989617|NCT04156425|Calcium|calcium|mesh-list
153989618|NCT04156425|Escitalopram|escitalopram|mesh-list
153989619|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153989620|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989621|NCT04156425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153989622|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153989623|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153989624|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989625|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989626|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
153989627|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153989628|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153989629|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
153989630|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
153989631|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989632|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153989633|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153989634|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
153989635|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153989636|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
153989637|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989638|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153989639|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989640|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153989641|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
153989642|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
153989643|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153989644|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989645|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153989646|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153989647|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989648|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989649|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989650|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153989651|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153989652|NCT00790075|Risperidone|risperidone|mesh-list
153989653|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153989654|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
153989655|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989656|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146636|NCT00567476|Omalizumab|omalizumab|mesh-list
153989657|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989658|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153989659|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153989660|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989661|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989662|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153989676|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989678|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
153989679|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989680|NCT00790153|Insulin|insulin|mesh-list
153989681|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153989682|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989683|NCT02631603|Prednisolone|prednisolone|mesh-list
154176525|NCT00841841|Dipyrone|dipyrone|mesh-list
153989684|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989685|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
153989687|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153989688|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989689|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153989690|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989691|NCT00790387|Heparin|heparin|mesh-list
153989692|NCT00790387|Enoxaparin|enoxaparin|mesh-list
153989693|NCT00790387|Calcium heparin|calcium heparin|mesh-list
153611390|NCT05875610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153989694|NCT00790387|Tirofiban|tirofiban|mesh-list
153989695|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
153989696|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153989697|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153989698|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989699|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153989700|NCT04156035|Lamotrigine|lamotrigine|mesh-list
153989701|NCT04156035|Ketamine|ketamine|mesh-list
153989702|NCT04156035|Analgesics|analgesics|mesh-ancestor
153989703|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
153989704|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989705|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989706|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153989707|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153989708|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
153989710|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989711|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153989712|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153989713|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989714|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989715|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
153989716|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153989717|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153989718|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153989719|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153989720|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153989721|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989722|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153989723|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
153989724|NCT00662337|Promethazine|promethazine|mesh-list
153989740|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989741|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153989742|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
153989743|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
153989744|NCT00665353|Pioglitazone|pioglitazone|mesh-list
153989745|NCT00665353|Ribavirin|ribavirin|mesh-list
153989746|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
153989747|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989748|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
153989749|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989750|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153989751|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989752|NCT00785395|Oxytocin|oxytocin|mesh-list
153989753|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
153989754|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153989755|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989756|NCT00662571|Acamprosate|acamprosate|mesh-list
153989757|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153989758|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154860924|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989759|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989760|NCT00661635|Valdecoxib|valdecoxib|mesh-list
154146710|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
153989761|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153989762|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153989763|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989764|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989765|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153989766|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989768|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
153989769|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989770|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989771|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989772|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989773|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153989774|NCT02555761|Alcaftadine|alcaftadine|mesh-list
153989775|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153989776|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153989777|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
153989778|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
153989779|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989780|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989781|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747346|NCT00153296|Analgesics|analgesics|mesh-ancestor
153989782|NCT04155879|Colchicine|colchicine|mesh-list
153989783|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
153776742|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
153989799|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
153989800|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
153989801|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153989802|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153989803|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153989804|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153989805|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
153989806|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989807|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989808|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
153989809|NCT00662883|Ketamine|ketamine|mesh-list
153989810|NCT00662883|Analgesics|analgesics|mesh-ancestor
153989811|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
153989812|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989813|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989814|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153989815|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153989816|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
153989817|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
153989818|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989819|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153989820|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153989821|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989822|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989823|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989824|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
153989825|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153989826|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
153989827|NCT00785473|Vitamin D|vitamin d|mesh-list
153989828|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
153989829|NCT00785473|Calcium|calcium|mesh-list
153989830|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153989831|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989832|NCT00785473|Vitamins|vitamins|mesh-ancestor
153989833|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
153989834|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153989835|NCT00785473|Antacids|antacids|mesh-ancestor
153989836|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989837|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989838|NCT00785551|Quinine|quinine|mesh-list
153989839|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
153989840|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153989841|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153989842|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989843|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153989844|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860925|NCT03489850|Ibudilast|ibudilast|mesh-list
153989863|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
153989864|NCT00663195|Furosemide|furosemide|mesh-list
153989865|NCT00663195|Spironolactone|spironolactone|mesh-list
154146788|NCT02569073|Hormones|hormones|mesh-ancestor
153989866|NCT00663195|Diuretics|diuretics|mesh-ancestor
153989867|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
153989868|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989869|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153989870|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153989871|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989872|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153989873|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
153989874|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153989875|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153989876|NCT00791011|Bortezomib|bortezomib|mesh-list
153989877|NCT00791011|Vorinostat|vorinostat|mesh-list
153989878|NCT00791011|Conatumumab|conatumumab|mesh-list
153989879|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989880|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153989881|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989882|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989883|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989884|NCT00781105|Telbivudine|telbivudine|mesh-list
153989885|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
153989886|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989887|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153989888|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989889|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989890|NCT00785863|Ketorolac|ketorolac|mesh-list
153989891|NCT00785863|Parecoxib|parecoxib|mesh-list
153989892|NCT00785863|Remifentanil|remifentanil|mesh-list
153989893|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153989894|NCT00785863|Narcotics|narcotics|mesh-ancestor
153989895|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989896|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989897|NCT00785863|Analgesics|analgesics|mesh-ancestor
153989898|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
153989899|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989912|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989913|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
153989914|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989915|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153989916|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
153611549|NCT05823675|Protective Agents|protective agents|mesh-ancestor
153989917|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989918|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
153989919|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153989920|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989921|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989922|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989923|NCT02555605|Analgesics|analgesics|mesh-ancestor
153989924|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
153989925|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989926|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153989927|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153989928|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153989929|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
153989930|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989931|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989933|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153989934|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153989935|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989936|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989937|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989938|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153989939|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153989940|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
153989941|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989942|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989943|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153989944|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153989945|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
153989947|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989948|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153989949|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860926|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154860927|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
153989950|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989952|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
153989953|NCT00663897|Mosapride|mosapride|mesh-list
153989954|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153989955|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989956|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153989957|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989958|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989959|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153989960|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
153776932|NCT04611958|Bupivacaine|bupivacaine|mesh-list
153989973|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989974|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989975|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989976|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153989977|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153989978|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989979|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153989980|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153989981|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989982|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
153989983|NCT00664287|Niacin|niacin|mesh-list
153989984|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153989985|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
153989986|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989987|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153989988|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
153989989|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
153989990|NCT00664287|Vitamins|vitamins|mesh-ancestor
153989991|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
153989992|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989993|NCT00664599|Rituximab|rituximab|mesh-list
153989994|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153989995|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989996|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
153989997|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989998|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989999|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
153990000|NCT02631135|Remifentanil|remifentanil|mesh-list
153990001|NCT02631135|Propofol|propofol|mesh-list
153990002|NCT02631135|Rocuronium|rocuronium|mesh-list
153990003|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153990004|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747568|NCT00153764|Vitamins|vitamins|mesh-list
153990005|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990006|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153990007|NCT02631135|Analgesics|analgesics|mesh-ancestor
153990008|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
153990009|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990010|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153990011|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153990012|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153990013|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
153990014|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990015|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990016|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153990017|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
153990018|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
153990019|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153990020|NCT02631135|Narcotics|narcotics|mesh-ancestor
153990021|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153990022|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153990023|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153990039|NCT00596817|Vortioxetine|vortioxetine|mesh-list
153990040|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
153990041|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153990042|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153990043|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153990044|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990045|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990046|NCT00596817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153990047|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153990048|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153990049|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990050|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990051|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
153990052|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153990053|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153990054|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153990055|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153990056|NCT01000649|Vasopressins|vasopressins|mesh-list
153990057|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
153990058|NCT01000649|Coagulants|coagulants|mesh-ancestor
153990059|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153990061|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
153990062|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990063|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153990064|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
153990065|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153990066|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153990067|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990068|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990069|NCT00664833|Urological Agents|urological agents|mesh-ancestor
153990070|NCT00879411|Telmisartan|telmisartan|mesh-list
153990071|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153990072|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153990073|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153990074|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990075|NCT00671151|Theophylline|theophylline|mesh-list
153990076|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153747648|NCT00153998|Vitamins|vitamins|mesh-ancestor
153990077|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
153990078|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990079|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990080|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990081|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990082|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153990096|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153990097|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153990098|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990100|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990101|NCT00666757|Analgesics|analgesics|mesh-ancestor
153990102|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
153990103|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990104|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
153990105|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153990106|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
153990107|NCT00666757|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153990108|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
153990109|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153990110|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153990111|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153990112|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990113|NCT01000337|Propofol|propofol|mesh-list
153990114|NCT01000337|Sevoflurane|sevoflurane|mesh-list
153990115|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153990116|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990117|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990118|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153990119|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
153990120|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
153990121|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153990122|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153990123|NCT02869763|Ethanol|ethanol|mesh-list
153990124|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153990125|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990126|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990127|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990128|NCT00671697|Decitabine|decitabine|mesh-list
153990129|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
153990130|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153990131|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
153990132|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990133|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990134|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990135|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
153990136|NCT00666679|Montelukast|montelukast|mesh-list
153990137|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154255080|NCT01148264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153990138|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990139|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153990140|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
153990141|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990142|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990152|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990153|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990154|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153990155|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153990156|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153990157|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
153990158|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990159|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990160|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153990161|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153990162|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
153990163|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153990164|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153990165|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153990166|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153990167|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990168|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990169|NCT00786253|Urological Agents|urological agents|mesh-ancestor
153990170|NCT00595413|Adalimumab|adalimumab|mesh-list
153990171|NCT00595413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153990172|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990173|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153990174|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
153990175|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153990176|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990177|NCT00786331|Carboplatin|carboplatin|mesh-list
153990178|NCT00786331|Pemetrexed|pemetrexed|mesh-list
153990179|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990180|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990181|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990182|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153990183|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153990184|NCT01000025|Dacomitinib|dacomitinib|mesh-list
153990185|NCT01000025|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153990186|NCT01000025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990187|NCT01000025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990188|NCT01000025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990189|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153990190|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153990191|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153990192|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990193|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990194|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153990195|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153990196|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153990197|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
153990198|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990199|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990200|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153990201|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153990202|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
153990203|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
153990204|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153990205|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153990206|NCT00595335|Prednisolone|prednisolone|mesh-list
153990207|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
153990208|NCT00595335|Rituximab|rituximab|mesh-list
153990226|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153990228|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
153990229|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
153990230|NCT00781417|Vitamins|vitamins|mesh-list
153990231|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
153990232|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990233|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153990234|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153990235|NCT00672165|Antibodies|antibodies|mesh-list
154860928|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990236|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153990237|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
153990238|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990239|NCT00672399|Exenatide|exenatide|mesh-list
153990240|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
153990241|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990242|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990243|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153990244|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153990245|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990246|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990247|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990248|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990249|NCT00672399|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153611941|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153990250|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153990251|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153990252|NCT00672399|Incretins|incretins|mesh-ancestor
153990253|NCT00672399|Hormones|hormones|mesh-ancestor
153990254|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990255|NCT00661531|Anastrozole|anastrozole|mesh-list
153990256|NCT00661531|Estradiol|estradiol|mesh-list
153990257|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153990258|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990259|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153990260|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153990261|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990262|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990263|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153990264|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
153777228|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153643941|NCT00400387|Vitamins|vitamins|mesh-ancestor
153990280|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990282|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153990283|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153990284|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153990285|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153990286|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
153990287|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990288|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990289|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990290|NCT00671541|Gentamicins|gentamicins|mesh-list
153990291|NCT00671541|Bacitracin|bacitracin|mesh-list
153990292|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990293|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990294|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153990295|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990296|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990297|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153990298|NCT04152681|Apatinib|apatinib|mesh-list
153990299|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990300|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990301|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990302|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990303|NCT00999713|Calfactant|calfactant|mesh-list
153990304|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153990305|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990306|NCT00672867|Adefovir|adefovir|mesh-list
153990307|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153990308|NCT00672867|Clevudine|clevudine|mesh-list
153990309|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
153990310|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990311|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153990312|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153990313|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990314|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990315|NCT00997373|Letrozole|letrozole|mesh-list
153990316|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990317|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153990318|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153990319|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990320|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990321|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153990322|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
153990323|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147158|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
153990339|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990340|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990342|NCT02870231|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153990343|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153990344|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990345|NCT02870231|Incretins|incretins|mesh-ancestor
153990346|NCT02870231|Hormones|hormones|mesh-ancestor
153990347|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990348|NCT00782041|Leucovorin|leucovorin|mesh-list
153990349|NCT00782041|Folic Acid|folic acid|mesh-list
153990350|NCT00782041|Fluorouracil|fluorouracil|mesh-list
153990351|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
153990352|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
153990353|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
153990354|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990356|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990357|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153990358|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
153990359|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990360|NCT00782041|Antidotes|antidotes|mesh-ancestor
153990361|NCT00782041|Protective Agents|protective agents|mesh-ancestor
153990362|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
153990363|NCT00782041|Vitamins|vitamins|mesh-ancestor
153990364|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
153990365|NCT00782041|Hematinics|hematinics|mesh-ancestor
153990366|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153990367|NCT00673569|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153990368|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990369|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990370|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990371|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990372|NCT00792181|Midazolam|midazolam|mesh-list
153990373|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153990374|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153990375|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990376|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990377|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153990378|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153990379|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153990380|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153990381|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
153990382|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
153990383|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
153990384|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
153777347|NCT00564772|Ritonavir|ritonavir|mesh-list
153990393|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153990394|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990396|NCT00787111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153990397|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153990398|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153990399|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990400|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990401|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
153990402|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990403|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153990404|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
153990405|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153990406|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153990407|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153990408|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990409|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
153990410|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153990411|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
153990412|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990413|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
153990414|NCT00782197|Protective Agents|protective agents|mesh-ancestor
153990415|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153990416|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153990417|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153990418|NCT00996593|Iodine|iodine|mesh-list
153990419|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
153990420|NCT00996593|Antibodies|antibodies|mesh-list
153990421|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
153990422|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
154860929|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147234|NCT00736541|Cystatins|cystatins|mesh-list
153990423|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990424|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153990425|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990426|NCT00996593|Trace Elements|trace elements|mesh-ancestor
153990427|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
153990429|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
153990430|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153990431|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990432|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990433|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
153990434|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990435|NCT00787501|Fluoxetine|fluoxetine|mesh-list
153990436|NCT00787501|Sertraline|sertraline|mesh-list
153990437|NCT00787501|Escitalopram|escitalopram|mesh-list
153990438|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153990439|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153990440|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153990441|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990442|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990443|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
153990444|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990445|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153990446|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
153990447|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153990448|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153777403|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990458|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990459|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153990461|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990462|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990463|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153990464|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153990465|NCT00637637|Ritonavir|ritonavir|mesh-list
153990466|NCT00637637|Indinavir|indinavir|mesh-list
153990467|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153990468|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153990469|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
153990470|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990471|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990472|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153990473|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153990474|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
153990475|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990476|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153990477|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153990478|NCT00878709|Neratinib|neratinib|mesh-list
153990479|NCT00878709|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153990480|NCT00878709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990481|NCT00878709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990482|NCT00878709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990483|NCT00927758|Fluticasone|fluticasone|mesh-list
153990484|NCT00927758|Xhance|xhance|mesh-list
153990485|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153990486|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153990487|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990488|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153990489|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
153990490|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990491|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990492|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990493|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990494|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
153990495|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153990496|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153990497|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153990498|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153990499|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153990500|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990501|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990502|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
153990504|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990505|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
154860930|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990507|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990508|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990509|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
153990510|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153990511|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153990512|NCT00783601|Montelukast|montelukast|mesh-list
153990513|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990514|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990515|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153990516|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
153990517|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990531|NCT00787813|Protective Agents|protective agents|mesh-ancestor
153990532|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990533|NCT00787813|Antidotes|antidotes|mesh-ancestor
153990534|NCT04261634|Mitogens|mitogens|mesh-list
153990535|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
153990536|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990537|NCT00787969|Sirolimus|sirolimus|mesh-list
153990538|NCT00787969|Rituximab|rituximab|mesh-list
153990539|NCT00787969|Temsirolimus|temsirolimus|mesh-list
153990540|NCT00787969|Cladribine|cladribine|mesh-list
153990541|NCT00787969|MTOR Inhibitors|mtor inhibitors|mesh-list
153990542|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153990543|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990544|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
153990545|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990546|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153990547|NCT00787969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990548|NCT00787969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990549|NCT00787969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990550|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153990551|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990552|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990553|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153990554|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
153990555|NCT00609596|Dutasteride|dutasteride|mesh-list
153990556|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153990557|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153990558|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990559|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990560|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
153990561|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990562|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990563|NCT00608816|Epinephrine|epinephrine|mesh-list
153990564|NCT00608816|Racepinephrine|racepinephrine|mesh-list
153990565|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
153990566|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153990567|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153990568|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
153990569|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990570|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990571|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990572|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153990573|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153990574|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
153990575|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990576|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990577|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
153614718|NCT01969942|Melphalan|melphalan|mesh-list
153990590|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153990591|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153990592|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153990593|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990594|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153990595|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153990597|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153990598|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153990600|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
153990601|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990602|NCT00788047|Levomethorphan|levomethorphan|mesh-list
153990603|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
153990604|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
153990605|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154860931|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
154147385|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990606|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153990607|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153990608|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990609|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990610|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990611|NCT00788047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153990612|NCT00788047|Narcotics|narcotics|mesh-ancestor
153990613|NCT00788047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990614|NCT00788047|Analgesics|analgesics|mesh-ancestor
153990615|NCT00788047|Sensory System Agents|sensory system agents|mesh-ancestor
153990616|NCT00788047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990617|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
153990618|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153990619|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
153990620|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153990621|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
153990622|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990623|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990624|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990625|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990626|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153990627|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
153990628|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990629|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990630|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153990631|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
153990632|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
153990633|NCT04259684|Protective Agents|protective agents|mesh-ancestor
153990634|NCT00788515|Lormetazepam|lormetazepam|mesh-list
153990635|NCT00788515|Volinanserin|volinanserin|mesh-list
153990636|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153990637|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990638|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990645|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990646|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153990649|NCT00788749|Prednisolone|prednisolone|mesh-list
153990650|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990651|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153990652|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
153990653|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990654|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990655|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990656|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990657|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
153990658|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153990659|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
153990660|NCT00788749|Hormones|hormones|mesh-ancestor
153990661|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990662|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153990663|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990664|NCT00609752|Prednisolone|prednisolone|mesh-list
153990665|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990666|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
153990667|NCT00609752|Hormones|hormones|mesh-ancestor
153990668|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990669|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990670|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153612442|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153990671|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990673|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153990674|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153990675|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990676|NCT00878553|Zaleplon|zaleplon|mesh-list
153990677|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
153990678|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153990679|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990680|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990681|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
153990682|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
153990683|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990684|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990685|NCT05220020|Lenvatinib|lenvatinib|mesh-list
154255081|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153990686|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990687|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990688|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990689|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990690|NCT00789061|Lansoprazole|lansoprazole|mesh-list
153990691|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153990692|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153990693|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153990694|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990695|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990696|NCT00996437|Ranibizumab|ranibizumab|mesh-list
153990697|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153990698|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153990699|NCT00996437|Growth Substances|growth substances|mesh-ancestor
153990700|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990701|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
153990702|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990703|NCT02628951|Paclitaxel|paclitaxel|mesh-list
153990704|NCT02628951|Ramucirumab|ramucirumab|mesh-list
153990705|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153990706|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990707|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
153990708|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
153990723|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990724|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153990725|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644427|NCT00400855|Xhance|xhance|mesh-list
153990726|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
153990727|NCT00929708|AZD-3199|azd-3199|mesh-list
153990728|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153990729|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
153990730|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990731|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990732|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990733|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990734|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153990735|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153990736|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153990737|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
153990738|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990739|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990740|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153990741|NCT00996281|Olmesartan|olmesartan|mesh-list
153990742|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153990743|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
153990744|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153990745|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153990747|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
153990748|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990749|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153990750|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153990751|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990752|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153990753|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153990754|NCT04046653|Sulforaphane|sulforaphane|mesh-list
153990755|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153990756|NCT04046653|Protective Agents|protective agents|mesh-ancestor
153990757|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990758|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990759|NCT04293887|Interferons|interferons|mesh-list
153990760|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990761|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
153990762|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990763|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153990764|NCT00675207|Dorzolamide|dorzolamide|mesh-list
153990765|NCT00675207|Brinzolamide|brinzolamide|mesh-list
153990766|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153990767|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153990768|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153990769|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153990777|NCT00795223|Bupivacaine|bupivacaine|mesh-list
153990778|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
153990779|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
154860932|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153990780|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990781|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990782|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
153990783|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990784|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153990785|NCT00795223|Narcotics|narcotics|mesh-ancestor
153990786|NCT00795223|Analgesics|analgesics|mesh-ancestor
153990787|NCT00795301|Capecitabine|capecitabine|mesh-list
153990788|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
153990789|NCT00795301|Cetuximab|cetuximab|mesh-list
153990790|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153990791|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
153990792|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990793|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990794|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153990795|NCT00675285|Montelukast|montelukast|mesh-list
153990796|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153990797|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990798|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153990799|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
153990800|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990801|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990802|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153990803|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153990804|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990805|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
153990806|NCT00789763|Gemcitabine|gemcitabine|mesh-list
153990807|NCT00789763|Sorafenib|sorafenib|mesh-list
153990808|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153990809|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
153612527|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
153990810|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990811|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990812|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990813|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990814|NCT02554357|Bupivacaine|bupivacaine|mesh-list
153990815|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
153990816|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
153990817|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990818|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990819|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
153990820|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990821|NCT00877929|Amlodipine|amlodipine|mesh-list
153990822|NCT00877929|Telmisartan|telmisartan|mesh-list
153990823|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153990824|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153990825|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153990826|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990827|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153990828|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990829|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
153990830|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153990831|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153990832|NCT00795457|Poly I-C|poly i-c|mesh-list
153990833|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153990834|NCT00795457|Vaccines|vaccines|mesh-list
153990835|NCT00795457|Poly ICLC|poly iclc|mesh-list
153990836|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
153990861|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153990862|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
153990863|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
153990864|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
153990865|NCT00800761|Deferiprone|deferiprone|mesh-list
153990866|NCT00800761|Deferoxamine|deferoxamine|mesh-list
153990867|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153990868|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
153990869|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
153990870|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990871|NCT00800761|Siderophores|siderophores|mesh-ancestor
153990872|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
153990873|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153990874|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990875|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153990876|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
153990877|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990878|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990879|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990880|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990881|NCT00800917|Sirolimus|sirolimus|mesh-list
153990882|NCT00800917|Bevacizumab|bevacizumab|mesh-list
153990883|NCT00800917|Temsirolimus|temsirolimus|mesh-list
153990884|NCT00800917|MTOR Inhibitors|mtor inhibitors|mesh-list
153990885|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153990886|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990887|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153990888|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153990901|NCT05003102|Fentanyl|fentanyl|mesh-list
153990902|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
153990903|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153990904|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990905|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990906|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153990907|NCT05003102|Analgesics|analgesics|mesh-ancestor
153990908|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
153990909|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990910|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153990911|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153990912|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153612701|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153990913|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
153990914|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990915|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990916|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153990917|NCT05003102|Narcotics|narcotics|mesh-ancestor
153990918|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153990919|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153990920|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
153990921|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
153990922|NCT00676377|Neostigmine|neostigmine|mesh-list
153990923|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153990924|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990925|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990926|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
153990927|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990928|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990929|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153990930|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
153990931|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990932|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
153990933|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990934|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990935|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153990936|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153990937|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990938|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990939|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990940|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153990941|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153990942|NCT00676845|Olmesartan|olmesartan|mesh-list
153990943|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153990944|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153990945|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153990946|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153990947|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990948|NCT04152057|Paclitaxel|paclitaxel|mesh-list
153990949|NCT04152057|Trastuzumab|trastuzumab|mesh-list
153990966|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153990967|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
153990968|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153990969|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
153990970|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153990971|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990972|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990973|NCT04151823|Vitamin D|vitamin d|mesh-list
153990974|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
153990975|NCT04151823|Vitamins|vitamins|mesh-ancestor
153990976|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
153990977|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990978|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153990979|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153990980|NCT05199038|Octreotide|octreotide|mesh-list
153990981|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153990982|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153990983|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990984|NCT00660907|Metformin|metformin|mesh-list
153990985|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
153990986|NCT00660907|Glipizide|glipizide|mesh-list
153990987|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153990988|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990989|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153990990|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990991|NCT04992572|Lidocaine|lidocaine|mesh-list
153990992|NCT04992572|Propofol|propofol|mesh-list
153990993|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
153990994|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
153990995|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990996|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990997|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
153990998|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990999|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153991000|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153991001|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153991002|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153991003|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991004|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153991005|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153991035|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153991036|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153991037|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153991038|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153991039|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153991040|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991041|NCT00795847|Diuretics|diuretics|mesh-ancestor
153991042|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
153748620|NCT00536068|Acetaminophen|acetaminophen|mesh-list
153991043|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991044|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153991045|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153991046|NCT00877773|Sirolimus|sirolimus|mesh-list
153991047|NCT00877773|Temsirolimus|temsirolimus|mesh-list
153991048|NCT00877773|MTOR Inhibitors|mtor inhibitors|mesh-list
153991049|NCT00877773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153991050|NCT00877773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991051|NCT00877773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778024|NCT00567034|Naltrexone|naltrexone|mesh-list
153991061|NCT00994643|Aldesleukin|aldesleukin|mesh-list
153991062|NCT00994643|Rituximab|rituximab|mesh-list
153991063|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153991064|NCT00994643|Interleukin-2|interleukin-2|mesh-list
153991065|NCT00994643|Antibodies|antibodies|mesh-list
153991066|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
153991067|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153991068|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
153991069|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991070|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991071|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153991072|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153991073|NCT00994643|Analgesics|analgesics|mesh-ancestor
153991074|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
153991075|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991076|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153991077|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153991078|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
153991079|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991080|NCT00912171|Budesonide|budesonide|mesh-list
153991081|NCT00912171|Montelukast|montelukast|mesh-list
153991082|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153991083|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153991084|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
153991085|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991086|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991087|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153991088|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991089|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
153991090|NCT00912171|Hormones|hormones|mesh-ancestor
153991091|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991092|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153991093|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
153991094|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153991095|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153991096|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991098|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
153991099|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153991100|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
153991101|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153991102|NCT00629057|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153991103|NCT00629057|Antiviral Agents|antiviral agents|mesh-ancestor
153991104|NCT00629057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991105|NCT00660829|Azelastine|azelastine|mesh-list
153991106|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153991107|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
153991108|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991109|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991110|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153991111|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991112|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153991113|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991114|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991115|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153991116|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153991117|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153991129|NCT00629135|Tazobactam|tazobactam|mesh-list
153991130|NCT00629135|Piperacillin|piperacillin|mesh-list
153991131|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153991132|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153991133|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991134|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153991135|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153991136|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991137|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991138|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991139|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153991140|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153991141|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153991142|NCT00795925|Propiverine|propiverine|mesh-list
153991143|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
153991144|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
153991145|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991146|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991147|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153991148|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153991149|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
153991150|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991151|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991152|NCT00795925|Urological Agents|urological agents|mesh-ancestor
153991153|NCT04293419|Durvalumab|durvalumab|mesh-list
153991154|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991155|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991156|NCT00793429|Prucalopride|prucalopride|mesh-list
153991157|NCT00793429|Laxatives|laxatives|mesh-ancestor
153991158|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153991159|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153991160|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153991161|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
153991162|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991163|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991164|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991165|NCT00801151|Vinorelbine|vinorelbine|mesh-list
153991166|NCT00801151|Vorinostat|vorinostat|mesh-list
153991167|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153991168|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991169|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
153991170|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
153991171|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
153991172|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991173|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153991174|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991175|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153991177|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153991178|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991179|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991180|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153991181|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153991182|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153991194|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153991195|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991196|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
153991197|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153991198|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
153991199|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991200|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991201|NCT00796159|Olmesartan|olmesartan|mesh-list
153991202|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153991203|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153991204|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153991205|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153991206|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991207|NCT00993473|Insulin|insulin|mesh-list
153991208|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153991209|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
153991210|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
153991211|NCT00993473|Protamines|protamines|mesh-list
153991212|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153991213|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991214|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
153991215|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991216|NCT00993473|Coagulants|coagulants|mesh-ancestor
153991217|NCT00660595|Risperidone|risperidone|mesh-list
153991218|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153991219|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153991220|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
153991221|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991222|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991223|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991224|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153991225|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153991226|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991227|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153991228|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153991229|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
153991230|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
153991231|NCT00929240|Bevacizumab|bevacizumab|mesh-list
153991232|NCT00929240|Capecitabine|capecitabine|mesh-list
153991233|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991234|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991235|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153991236|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153991237|NCT00929240|Growth Substances|growth substances|mesh-ancestor
153991238|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991239|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
153991240|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153991241|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
153991242|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991243|NCT00793663|Dexamethasone|dexamethasone|mesh-list
153991244|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
153991262|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991264|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
153991265|NCT00793663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153991266|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153991268|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991269|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991270|NCT02554045|Tadalafil|tadalafil|mesh-list
153991271|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
153991272|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153991273|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153991274|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991275|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991276|NCT02554045|Urological Agents|urological agents|mesh-ancestor
153991277|NCT05330390|Levetiracetam|levetiracetam|mesh-list
153991278|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
153991279|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
153991280|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
153991281|NCT00993317|Methotrexate|methotrexate|mesh-list
154860933|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991282|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153991283|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
153991284|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153991285|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991286|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153991287|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
153991288|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991289|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991290|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
153991291|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991292|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153991293|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153991294|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
153991295|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153991296|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153991297|NCT00993317|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153991298|NCT00993317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153991299|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153991300|NCT00801385|Sorafenib|sorafenib|mesh-list
153991301|NCT00801385|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153991302|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153991313|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153991314|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153991315|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991316|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991317|NCT02868827|Vitamin D|vitamin d|mesh-list
153991318|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
153991319|NCT02868827|Vitamins|vitamins|mesh-ancestor
153991320|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
153991321|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991322|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153644984|NCT00105937|Analgesics|analgesics|mesh-ancestor
154176528|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
153991323|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153991324|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
153991325|NCT00987389|Hormones|hormones|mesh-ancestor
153991326|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991327|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991328|NCT00929162|Paclitaxel|paclitaxel|mesh-list
153991329|NCT00929162|Carboplatin|carboplatin|mesh-list
153991330|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153991331|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991332|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
153991333|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
153991334|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
153991335|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991336|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
153991337|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153991338|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
153991339|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748925|NCT00157235|Bromides|bromides|mesh-list
153991340|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991341|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153991342|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991343|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
153991344|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153991345|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
153991346|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991347|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991348|NCT00678483|Rimonabant|rimonabant|mesh-list
153991349|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153991350|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153991351|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153991352|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991353|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991354|NCT00678483|Hormones|hormones|mesh-ancestor
153991355|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991356|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991357|NCT00610454|Levetiracetam|levetiracetam|mesh-list
153991358|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
153991359|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
153991360|NCT04151355|Atorvastatin|atorvastatin|mesh-list
153991361|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153991362|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153991363|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
153991375|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153991377|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991378|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991379|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153991380|NCT00610610|Paroxetine|paroxetine|mesh-list
153991381|NCT00610610|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153991382|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153991383|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153991384|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991385|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991386|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
153991387|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991388|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153991389|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
153991390|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153991391|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153991392|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153991393|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991394|NCT00912327|Cetuximab|cetuximab|mesh-list
153991395|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991397|NCT04257812|Tazobactam|tazobactam|mesh-list
153991398|NCT04257812|Ceftolozane|ceftolozane|mesh-list
153991399|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153991400|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153991401|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991402|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153991403|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991404|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991405|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153991406|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
153991407|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153991408|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
153991409|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991410|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
153991411|NCT02868749|Protective Agents|protective agents|mesh-ancestor
153991412|NCT00659581|Telmisartan|telmisartan|mesh-list
153991413|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153991414|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153991415|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153991416|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991417|NCT00793741|Somatostatin|somatostatin|mesh-list
153991418|NCT00793741|Hormones|hormones|mesh-ancestor
153991419|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991420|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991421|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153991422|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153991423|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153991424|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991436|NCT00991289|Ribavirin|ribavirin|mesh-list
153991437|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
153991438|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
153991439|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153991440|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
153991441|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991442|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
153991443|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991444|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
153991445|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991446|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
153991447|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991448|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153991449|NCT04046029|Heparin|heparin|mesh-list
153991450|NCT04046029|Bivalirudin|bivalirudin|mesh-list
153991451|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
153991452|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153991453|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153991454|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991455|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
153991456|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153991457|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
153991458|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148081|NCT05823311|Cisplatin|cisplatin|mesh-list
153991459|NCT00679653|Sibutramine|sibutramine|mesh-list
153991460|NCT00679653|Metoprolol|metoprolol|mesh-list
153991461|NCT00679653|Verapamil|verapamil|mesh-list
153991462|NCT00679653|Felodipine|felodipine|mesh-list
153991463|NCT00679653|Ramipril|ramipril|mesh-list
153991464|NCT00679653|Trandolapril|trandolapril|mesh-list
153991465|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153991466|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153991467|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
153991468|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
153991469|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991470|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991471|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153991472|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153991473|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153991474|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
153991475|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991476|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991477|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153991478|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
153991479|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991480|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153991481|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153991482|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153991483|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
153991484|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
153991485|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153991486|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
153749082|NCT00534586|Narcotics|narcotics|mesh-ancestor
153991487|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153991488|NCT00793897|Paclitaxel|paclitaxel|mesh-list
153991489|NCT00793897|Carboplatin|carboplatin|mesh-list
153991502|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991503|NCT00679965|Tavaborole|tavaborole|mesh-list
153991504|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
153991505|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991506|NCT00930644|Teduglutide|teduglutide|mesh-list
153991507|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153991508|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153991509|NCT00930644|Protective Agents|protective agents|mesh-ancestor
153991510|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991511|NCT02627469|Listerine|listerine|mesh-list
153991512|NCT02627469|Fluorides|fluorides|mesh-list
153991513|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
153991514|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
153991515|NCT02627469|Protective Agents|protective agents|mesh-ancestor
153991516|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991517|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153991518|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991519|NCT00680277|Carotenoids|carotenoids|mesh-list
153991520|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
153991521|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991522|NCT00680277|Protective Agents|protective agents|mesh-ancestor
153991523|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991524|NCT00680355|Carotenoids|carotenoids|mesh-list
153991525|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
153991526|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991527|NCT00680355|Protective Agents|protective agents|mesh-ancestor
153991528|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991529|NCT00801697|Vaccines|vaccines|mesh-list
153991530|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
153991531|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991532|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
153991533|NCT00684489|Coal Tar|coal tar|mesh-list
153991534|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
153991535|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
153991536|NCT00990821|Midazolam|midazolam|mesh-list
153991537|NCT00990821|Aprepitant|aprepitant|mesh-list
153991538|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
153991539|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153991540|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153991541|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991542|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991543|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153991544|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153991545|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153991546|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154860934|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255082|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153991547|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
153991548|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
153991549|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
153991550|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
153991551|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991552|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991553|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
153991554|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
153991572|NCT00658567|Pimavanserin|pimavanserin|mesh-list
153991573|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153991574|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153991575|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153991576|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153991577|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991578|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991579|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153991580|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153991581|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153991582|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
153991583|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991584|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991585|NCT00875433|Afatinib|afatinib|mesh-list
153991586|NCT00875433|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153991587|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153991588|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991589|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991590|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991591|NCT00684957|Hormones|hormones|mesh-list
153991592|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991593|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991594|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
153991595|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153991596|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153991597|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
153991598|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991599|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153991600|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153991601|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991602|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991603|NCT00685269|Eszopiclone|eszopiclone|mesh-list
153991604|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153991605|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991606|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991607|NCT00794209|Fentanyl|fentanyl|mesh-list
153991614|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991616|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153991617|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
153991618|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
153991619|NCT00985985|Nicotine|nicotine|mesh-list
153991620|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153991621|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
153991622|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991623|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991624|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153991625|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153991626|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
153991627|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991628|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991629|NCT00685347|Albuterol|albuterol|mesh-list
153991630|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153991631|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
153991632|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991633|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991634|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153991635|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991636|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
153991637|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153991638|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153991639|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153991640|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153991641|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
153991642|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860935|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154860936|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
154148216|NCT05689710|Inositol|inositol|mesh-list
153991643|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991644|NCT00685425|Albuterol|albuterol|mesh-list
153991645|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153991646|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
153991647|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991648|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991649|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153991650|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991651|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
153991652|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153991653|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153991654|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153991655|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153991656|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
153991657|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991658|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991659|NCT04290455|Castor Oil|castor oil|mesh-list
153991660|NCT04290455|Cathartics|cathartics|mesh-ancestor
153991661|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153991662|NCT00685503|Ranibizumab|ranibizumab|mesh-list
153991663|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153991664|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153991665|NCT00685503|Growth Substances|growth substances|mesh-ancestor
153991666|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991667|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
153991668|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991669|NCT00802009|Dexamethasone|dexamethasone|mesh-list
153991670|NCT00802009|Mepivacaine|mepivacaine|mesh-list
153991671|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153991672|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
153991673|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
153991674|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991675|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991676|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153991687|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153991688|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
153991689|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991690|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
153991691|NCT02868437|Protective Agents|protective agents|mesh-ancestor
153991692|NCT00802087|Acetaminophen|acetaminophen|mesh-list
153991693|NCT00802087|Hydrocodone|hydrocodone|mesh-list
153991694|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153991695|NCT00802087|Analgesics|analgesics|mesh-ancestor
153991696|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
153991697|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991698|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991699|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
153991700|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153991701|NCT00802087|Narcotics|narcotics|mesh-ancestor
153991702|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991703|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
153991704|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991705|NCT00923936|Bevacizumab|bevacizumab|mesh-list
153991706|NCT00923936|Doxorubicin|doxorubicin|mesh-list
153991707|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153991708|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991709|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991710|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153991711|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153991712|NCT00923936|Growth Substances|growth substances|mesh-ancestor
153749328|NCT00158132|Amantadine|amantadine|mesh-list
153991713|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991714|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
153991715|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153991716|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153991717|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153991718|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991719|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991721|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153991722|NCT00797017|Narcotics|narcotics|mesh-ancestor
153991723|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991724|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991725|NCT00797017|Analgesics|analgesics|mesh-ancestor
153991726|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
153991727|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860937|NCT03490942|Glucagon|glucagon|mesh-list
153991729|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153991730|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
153991731|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
153991732|NCT05330000|Voriconazole|voriconazole|mesh-list
153991733|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
153991734|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991735|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153991736|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153991737|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991738|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991739|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153991740|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
153991741|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991751|NCT00924950|Hormones|hormones|mesh-ancestor
153991752|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991753|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991754|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153991755|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991756|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153991757|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153991758|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153991759|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991760|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153991761|NCT00924950|Vitamins|vitamins|mesh-ancestor
153613508|NCT01962376|Growth Substances|growth substances|mesh-ancestor
153991762|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
153991763|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153991764|NCT02626065|Nivolumab|nivolumab|mesh-list
153991765|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991766|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991767|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153991768|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991769|NCT00794755|Vitamin K|vitamin k|mesh-list
153991770|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
153991772|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
153991773|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991774|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153991775|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153991776|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991777|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
153991778|NCT00794755|Coagulants|coagulants|mesh-ancestor
153991779|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
153991780|NCT00685971|Vitamin D|vitamin d|mesh-list
153991781|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153991782|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991783|NCT00685971|Vitamins|vitamins|mesh-ancestor
153991784|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
153991785|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153991786|NCT00802243|Leflunomide|leflunomide|mesh-list
153991787|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749377|NCT00190008|Piracetam|piracetam|mesh-list
153991788|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991789|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153991790|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
153991791|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991793|NCT00988637|Clobetasol|clobetasol|mesh-list
153991794|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153991795|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991796|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153991797|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153991798|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991799|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153991800|NCT00988637|Vitamins|vitamins|mesh-ancestor
153991801|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
153991802|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153991803|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153991804|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
153991805|NCT00988637|Hormones|hormones|mesh-ancestor
153991806|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991807|NCT00802321|Dutasteride|dutasteride|mesh-list
153991816|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
153991817|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153991818|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
153991819|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991820|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153991821|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153991822|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
153991824|NCT00686439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153991825|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153991826|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153991827|NCT00797485|Leucovorin|leucovorin|mesh-list
153991828|NCT00797485|Bevacizumab|bevacizumab|mesh-list
153991829|NCT00797485|Capecitabine|capecitabine|mesh-list
153991830|NCT00797485|Fluorouracil|fluorouracil|mesh-list
153991831|NCT00797485|Irinotecan|irinotecan|mesh-list
153991832|NCT00797485|Calcium|calcium|mesh-list
153991833|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
153991834|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991835|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991836|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153991837|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153991838|NCT00797485|Growth Substances|growth substances|mesh-ancestor
153991839|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991840|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
153991841|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153991842|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153991843|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
153991844|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991845|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153991846|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
153991847|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153991848|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153991849|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991850|NCT00797485|Antidotes|antidotes|mesh-ancestor
153991851|NCT00797485|Protective Agents|protective agents|mesh-ancestor
153991852|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
153991853|NCT00797485|Vitamins|vitamins|mesh-ancestor
153991854|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
153991855|NCT00686985|Carboplatin|carboplatin|mesh-list
153991856|NCT00686985|Docetaxel|docetaxel|mesh-list
153991857|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991858|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
153991859|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
153991860|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
153991861|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991862|NCT02866955|Tamoxifen|tamoxifen|mesh-list
153991863|NCT02866955|Estramustine|estramustine|mesh-list
153991864|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153991865|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
153991866|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991867|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991868|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153991869|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991870|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153991871|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153991872|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153991873|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153991889|NCT04257656|Remdesivir|remdesivir|mesh-list
153991890|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
153991891|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991892|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
153991893|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991894|NCT05329844|Vildagliptin|vildagliptin|mesh-list
153991895|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153991896|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991897|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153991898|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
153991899|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991900|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991901|NCT00687999|Interferons|interferons|mesh-list
153991902|NCT00687999|Ribavirin|ribavirin|mesh-list
153991903|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
153991904|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991905|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
153991906|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991907|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
153991908|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991909|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
153991910|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991911|NCT00688077|Calcitonin|calcitonin|mesh-list
153991912|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
153991913|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153991914|NCT00688077|Katacalcin|katacalcin|mesh-list
153991915|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153991916|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991917|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153991918|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
153991919|NCT00923156|Ramipril|ramipril|mesh-list
153991920|NCT00923156|Aliskiren|aliskiren|mesh-list
153991921|NCT00923156|Renin Inhibitors|renin inhibitors|mesh-ancestor
153991922|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
153991923|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991924|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991925|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153991926|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153991927|NCT00688857|Diazoxide|diazoxide|mesh-list
153991928|NCT00688857|Choline|choline|mesh-list
153991929|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
153991930|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153991931|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
153991932|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991933|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153991934|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153991951|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153991953|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991954|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
153991955|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153991956|NCT00687843|Protective Agents|protective agents|mesh-ancestor
153991957|NCT00689169|Cytarabine|cytarabine|mesh-list
153991958|NCT00689169|Rituximab|rituximab|mesh-list
153991959|NCT00689169|Etoposide|etoposide|mesh-list
153991960|NCT00689169|Melphalan|melphalan|mesh-list
153991961|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991962|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991963|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
153991964|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991965|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153991966|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153991967|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153991968|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153991969|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991970|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991971|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153991972|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
153991973|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153991974|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153991975|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153991976|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
153991977|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
153991978|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991979|NCT04203914|Empagliflozin|empagliflozin|mesh-list
153991980|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153991981|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991982|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153991983|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991984|NCT00874731|Sirolimus|sirolimus|mesh-list
153991985|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153991986|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991987|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153991988|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991989|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
153991990|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153991991|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
153778955|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
153992023|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153992024|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153992025|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992026|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992027|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
153992029|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992030|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992031|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153992032|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153992033|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
153992034|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153992035|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153779017|NCT00570856|Folic Acid|folic acid|mesh-list
153992062|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992063|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992064|NCT04256642|Analgesics|analgesics|mesh-ancestor
153992065|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
153992066|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992067|NCT00611000|Folic Acid|folic acid|mesh-list
153992068|NCT00611000|Hematinics|hematinics|mesh-ancestor
153992069|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
153992070|NCT00611000|Vitamins|vitamins|mesh-ancestor
153992071|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
153992072|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992073|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
153992074|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153992075|NCT00690105|Fluticasone|fluticasone|mesh-list
153992076|NCT00690105|Tacrolimus|tacrolimus|mesh-list
153992077|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153992078|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
153992079|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992080|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153992081|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992082|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992083|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153992084|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153992085|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
153992086|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992087|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153992094|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992095|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992096|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
153992097|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
153992098|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992099|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992101|NCT04136613|Trace Elements|trace elements|mesh-ancestor
153992102|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
153992103|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992104|NCT00978731|Dasatinib|dasatinib|mesh-list
153992105|NCT00978731|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153992106|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153992107|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992108|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992109|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992110|NCT04136535|Carboplatin|carboplatin|mesh-list
153992111|NCT04136535|Pemetrexed|pemetrexed|mesh-list
153992112|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992113|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992114|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992115|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153992116|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153992117|NCT00694629|Rifampin|rifampin|mesh-list
153992118|NCT00694629|Rifapentine|rifapentine|mesh-list
153992119|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153992120|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
153992121|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153992122|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992123|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
153992124|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153992125|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992126|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992127|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153992128|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153992129|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153992130|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153992131|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153992132|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153992133|NCT00912639|Paclitaxel|paclitaxel|mesh-list
153992134|NCT00912639|genexol-PM|genexol-pm|mesh-list
153992135|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153992136|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992137|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
153992138|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
153992139|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
154148607|NCT05232851|Vaccines|vaccines|mesh-list
153992140|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992141|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
153992142|NCT02866409|Bupivacaine|bupivacaine|mesh-list
153992143|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
153992144|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
153992145|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992146|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992147|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
153992148|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992149|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153992150|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992151|NCT02866409|Analgesics|analgesics|mesh-ancestor
153992152|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153992153|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153779110|NCT00571753|Isoniazid|isoniazid|mesh-list
153992162|NCT05833919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153992163|NCT05833919|Antimetabolites|antimetabolites|mesh-ancestor
153992164|NCT05833919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992165|NCT05833919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992166|NCT05833815|Everolimus|everolimus|mesh-list
153992167|NCT05833815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153992168|NCT05833815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153992169|NCT05833815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992170|NCT05833815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992171|NCT05833815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153992172|NCT05833815|Immunologic Factors|immunologic factors|mesh-ancestor
153992173|NCT05833815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992174|NCT05833815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992175|NCT05833802|Antineoplastic Agents|antineoplastic agents|mesh-list
153992176|NCT05833477|Epoetin Alfa|epoetin alfa|mesh-list
153992177|NCT05833477|Hematinics|hematinics|mesh-ancestor
153992178|NCT05833399|Carbamazepine|carbamazepine|mesh-list
153992179|NCT05833399|Amitriptyline|amitriptyline|mesh-list
153992180|NCT05833399|Olanzapine|olanzapine|mesh-list
153992181|NCT05833399|Chlorpromazine|chlorpromazine|mesh-list
153992182|NCT05833399|Risperidone|risperidone|mesh-list
153992183|NCT05833399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153992184|NCT05833399|Mirtazapine|mirtazapine|mesh-list
153992185|NCT05833399|Sertraline|sertraline|mesh-list
153992186|NCT05833399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153992187|NCT05833399|Serotonin Agents|serotonin agents|mesh-ancestor
153992188|NCT05833399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992189|NCT05833399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992190|NCT05833399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992191|NCT05833399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153992192|NCT05833399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153992193|NCT05833399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992194|NCT05833399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153992195|NCT05833399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153992196|NCT05833399|Dopamine Agents|dopamine agents|mesh-ancestor
153992197|NCT05833399|Antiemetics|antiemetics|mesh-ancestor
153992198|NCT05833399|Autonomic Agents|autonomic agents|mesh-ancestor
153992199|NCT05833399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992200|NCT05833399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153992201|NCT05833399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153992202|NCT05833399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153992203|NCT05833399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153992204|NCT05833399|Antidepressive Agents|antidepressive agents|mesh-ancestor
153992205|NCT05833399|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153992206|NCT05833399|Histamine Antagonists|histamine antagonists|mesh-ancestor
153992207|NCT05833399|Histamine Agents|histamine agents|mesh-ancestor
153992208|NCT05833399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153992209|NCT05833399|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153992210|NCT05833399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153992211|NCT05833399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153992212|NCT05833399|Adrenergic Agents|adrenergic agents|mesh-ancestor
153992213|NCT05833399|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153992214|NCT05833399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153992215|NCT05833399|Anticonvulsants|anticonvulsants|mesh-ancestor
153992216|NCT05833399|Antimanic Agents|antimanic agents|mesh-ancestor
153992217|NCT05833399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992218|NCT05833399|Analgesics|analgesics|mesh-ancestor
153992219|NCT05833399|Sensory System Agents|sensory system agents|mesh-ancestor
153779180|NCT00234897|Adalimumab|adalimumab|mesh-list
153992237|NCT05832619|Serotonin|serotonin|mesh-list
154860938|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153992238|NCT05832619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153992239|NCT05832619|Serotonin Agents|serotonin agents|mesh-ancestor
153992240|NCT05832619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613873|NCT01964586|Analgesics|analgesics|mesh-ancestor
153992241|NCT05832619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992242|NCT05832619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992243|NCT05832580|Etidronic Acid|etidronic acid|mesh-list
153992244|NCT05832580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153992245|NCT05832580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992246|NCT05832515|Fludarabine|fludarabine|mesh-list
153992247|NCT05832515|Fludarabine phosphate|fludarabine phosphate|mesh-list
153992248|NCT05832515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992249|NCT05832515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153992250|NCT05832515|Antimetabolites|antimetabolites|mesh-ancestor
153992251|NCT05832515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992252|NCT05832515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153992253|NCT05832515|Immunologic Factors|immunologic factors|mesh-ancestor
153992254|NCT05832515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992255|NCT05832333|Vaccines|vaccines|mesh-list
153992256|NCT05832333|Immunologic Factors|immunologic factors|mesh-ancestor
153992257|NCT05832333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992258|NCT05832320|Etoposide|etoposide|mesh-list
153992259|NCT05832320|Daunorubicin|daunorubicin|mesh-list
153992260|NCT05832320|Tretinoin|tretinoin|mesh-list
153992261|NCT05832320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153992262|NCT05832320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992263|NCT05832320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153992264|NCT05832320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153992265|NCT05832320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992266|NCT05832320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992267|NCT05832320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153992268|NCT05832320|Keratolytic Agents|keratolytic agents|mesh-ancestor
153992269|NCT05832320|Dermatologic Agents|dermatologic agents|mesh-ancestor
153992270|NCT05832216|Daratumumab|daratumumab|mesh-list
153992271|NCT05832216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992272|NCT05832073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153992273|NCT05832073|Antibodies|antibodies|mesh-list
153992274|NCT05832073|Immunoglobulins|immunoglobulins|mesh-list
153992275|NCT05832073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153992276|NCT05832073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153992277|NCT05832073|Immunologic Factors|immunologic factors|mesh-ancestor
153992289|NCT05830539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153992290|NCT05830539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992291|NCT05830539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153992292|NCT05830539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153992293|NCT05830539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992294|NCT05830539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992295|NCT05828940|Losartan|losartan|mesh-list
153992296|NCT05828940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153992297|NCT05828940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153992298|NCT05828940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153992299|NCT05828940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153992300|NCT05828940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992301|NCT05818423|Benzocaine|benzocaine|mesh-list
153992302|NCT05818423|Anesthetics, Local|anesthetics, local|mesh-ancestor
153992303|NCT05818423|Anesthetics|anesthetics|mesh-ancestor
153992304|NCT05818423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992305|NCT05818423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992306|NCT05818423|Sensory System Agents|sensory system agents|mesh-ancestor
153992307|NCT05818423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992308|NCT05796401|Leucovorin|leucovorin|mesh-list
153992309|NCT05796401|Folic Acid|folic acid|mesh-list
153992310|NCT05796401|Vitamin B 12|vitamin b 12|mesh-list
153992311|NCT05796401|Levoleucovorin|levoleucovorin|mesh-list
153992312|NCT05796401|Vitamins|vitamins|mesh-ancestor
153992313|NCT05796401|Micronutrients|micronutrients|mesh-ancestor
153992314|NCT05796401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992315|NCT05796401|Antidotes|antidotes|mesh-ancestor
153992316|NCT05796401|Protective Agents|protective agents|mesh-ancestor
153992317|NCT05796401|Vitamin B Complex|vitamin b complex|mesh-ancestor
153992319|NCT05771402|Antibodies|antibodies|mesh-list
153992320|NCT05771402|Immunologic Factors|immunologic factors|mesh-ancestor
153992321|NCT05771402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992322|NCT05769816|Antibodies|antibodies|mesh-list
153992323|NCT05769816|Immunologic Factors|immunologic factors|mesh-ancestor
153992324|NCT05769816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992325|NCT05745142|Sunitinib|sunitinib|mesh-list
153992326|NCT05745142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992327|NCT05745142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153992328|NCT05745142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153992329|NCT05745142|Growth Substances|growth substances|mesh-ancestor
153992330|NCT05745142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992331|NCT05745142|Growth Inhibitors|growth inhibitors|mesh-ancestor
153992332|NCT05745142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153992333|NCT05745142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992334|NCT05745142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992335|NCT05737069|Ibuprofen|ibuprofen|mesh-list
153992336|NCT05737069|Ibuprofen arginine|ibuprofen arginine|mesh-list
153992337|NCT05737069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153992338|NCT05737069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992339|NCT05737069|Analgesics|analgesics|mesh-ancestor
153992340|NCT05737069|Sensory System Agents|sensory system agents|mesh-ancestor
153992341|NCT05737069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992342|NCT05737069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992343|NCT05737069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153992344|NCT05737069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153992372|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153992373|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992374|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992375|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153992376|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153992377|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153992378|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153992379|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
153992381|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
153992382|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
153992383|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992384|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992385|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153992386|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153992387|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
153992388|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153992389|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153992390|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779357|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992406|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
153992407|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153992408|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992409|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153992410|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
153992411|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
153992412|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153992413|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992414|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153992415|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992417|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
153992418|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992419|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153992420|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153992421|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153614042|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992422|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153992423|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153992424|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153992425|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
153992426|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992427|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153992428|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
153992429|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153992430|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153992431|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153992432|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153992433|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
153992434|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153992435|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153992436|NCT05589844|Vaccines|vaccines|mesh-list
153992437|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
153992438|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992439|NCT05485519|Midazolam|midazolam|mesh-list
153992440|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
153992441|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153992442|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992443|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992444|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992445|NCT05485519|Analgesics|analgesics|mesh-ancestor
153992446|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
153992459|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
153992460|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
153992461|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
153992462|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
153992463|NCT05359627|Polymyxins|polymyxins|mesh-list
153992464|NCT05359627|Polymyxin B|polymyxin b|mesh-list
153992465|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153992466|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992467|NCT05246293|Tofacitinib|tofacitinib|mesh-list
153992468|NCT05246293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153992469|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153992470|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992471|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992472|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
153992473|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
153992474|NCT05243147|Coagulants|coagulants|mesh-ancestor
153992475|NCT05212610|Vaccines|vaccines|mesh-list
153992476|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
153992477|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992478|NCT05207280|Terlipressin|terlipressin|mesh-list
153992479|NCT05207280|Norepinephrine|norepinephrine|mesh-list
153992480|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153992481|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153992482|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153992483|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153992484|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
153992485|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992486|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992487|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992488|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
153992489|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
153992490|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992491|NCT05134857|Zonisamide|zonisamide|mesh-list
153992492|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
153992493|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153992494|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153992495|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614122|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
153992496|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153992497|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992498|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
153992499|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153992500|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992501|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153992502|NCT05108935|Buprenorphine|buprenorphine|mesh-list
153992503|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153992504|NCT05108935|Naloxone|naloxone|mesh-list
153992505|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153992506|NCT05108935|Narcotics|narcotics|mesh-ancestor
153992507|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992508|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992525|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992526|NCT04939753|Sevoflurane|sevoflurane|mesh-list
153992527|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153992528|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153992529|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
153992530|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
153992531|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992532|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992533|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
153992534|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153992535|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153992536|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153992537|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
153992538|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992539|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992540|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992541|NCT04902885|Carboplatin|carboplatin|mesh-list
153992542|NCT04902885|Etoposide|etoposide|mesh-list
153992543|NCT04902885|Topotecan|topotecan|mesh-list
153992544|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992545|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153992546|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153992548|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992549|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992550|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153992551|NCT04868058|Ropivacaine|ropivacaine|mesh-list
153992552|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
153992553|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
153992554|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992555|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992556|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
153992557|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992558|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153992559|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153992560|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992561|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
153992562|NCT04525274|Ketamine|ketamine|mesh-list
153992563|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153992564|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992565|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992566|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992578|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
153992579|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
153992580|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153992581|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153992582|NCT04472611|Colchicine|colchicine|mesh-list
153992583|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153992584|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153992585|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153992586|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
153992587|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992588|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153992589|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153992590|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992591|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
153992592|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153992593|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
153992594|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
153992595|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
153992596|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992597|NCT04125563|Capsaicin|capsaicin|mesh-list
153992598|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
153992599|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
153992600|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
153992601|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992602|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992603|NCT04078295|Nivolumab|nivolumab|mesh-list
153992604|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153992605|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992606|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153992607|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992608|NCT03974828|Anesthetics|anesthetics|mesh-list
153992609|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992610|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992611|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
153992612|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153992613|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153992614|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992615|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992616|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992617|NCT03953677|Analgesics|analgesics|mesh-ancestor
153992618|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
153992619|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992620|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153992621|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153992622|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153992623|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
153992624|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992625|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992626|NCT03925480|Azithromycin|azithromycin|mesh-list
153992627|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153992628|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992634|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992635|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992636|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
153992637|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
153992638|NCT03067051|Verteporfin|verteporfin|mesh-list
153992639|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153992640|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
153992641|NCT03013998|Cytarabine|cytarabine|mesh-list
153992642|NCT03013998|Azacitidine|azacitidine|mesh-list
153992643|NCT03013998|Decitabine|decitabine|mesh-list
153992644|NCT03013998|Daunorubicin|daunorubicin|mesh-list
153992645|NCT03013998|Venetoclax|venetoclax|mesh-list
153992646|NCT03013998|AZD5991|azd5991|mesh-list
153992647|NCT03013998|Gilteritinib|gilteritinib|mesh-list
153992648|NCT03013998|Pevonedistat|pevonedistat|mesh-list
153992649|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153992650|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
153992651|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992652|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992653|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
153992654|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992655|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153992656|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
153992657|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992658|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992659|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153992660|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153992661|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153992662|NCT03013998|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153992663|NCT03013998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153992664|NCT02901067|Aspirin|aspirin|mesh-list
153992665|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153992666|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153992667|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992668|NCT02901067|Analgesics|analgesics|mesh-ancestor
153992669|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
153992670|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992671|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992672|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153992673|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153992674|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154176529|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992675|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153992676|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992677|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153992678|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153992679|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992680|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
153992681|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153992682|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153992683|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
153992684|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153992685|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153992686|NCT02859896|Calcitriol|calcitriol|mesh-list
153992687|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153992688|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153992689|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992690|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153992691|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153992692|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992693|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153992694|NCT02859896|Vitamins|vitamins|mesh-ancestor
153992695|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
153992696|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153992697|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153992704|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153992705|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992706|NCT02581527|Rifampin|rifampin|mesh-list
153992707|NCT02581527|Isoniazid|isoniazid|mesh-list
153992708|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
153992709|NCT02581527|Ethambutol|ethambutol|mesh-list
153992710|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153992711|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
153992712|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153992713|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992714|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
153614375|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
153992715|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153992716|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992717|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992718|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153992719|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153992720|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153992721|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153992722|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153992723|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153992724|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153992725|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153992726|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
153992727|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153992728|NCT02466074|Acetazolamide|acetazolamide|mesh-list
153992729|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
153992730|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153992731|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992732|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992733|NCT02466074|Diuretics|diuretics|mesh-ancestor
153992734|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
153992735|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992736|NCT02393794|Nivolumab|nivolumab|mesh-list
153992737|NCT02393794|Romidepsin|romidepsin|mesh-list
153992738|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153992739|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992740|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153992741|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153992742|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992743|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153992744|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992745|NCT02159950|Vaccines|vaccines|mesh-list
153992746|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
153992747|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992748|NCT02152137|Paclitaxel|paclitaxel|mesh-list
153992749|NCT02152137|Efatutazone|efatutazone|mesh-list
153992750|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153992751|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992752|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
153992753|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
153992754|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
153992755|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992756|NCT02007512|Exemestane|exemestane|mesh-list
153992757|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992758|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153992759|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153992760|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992761|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750352|NCT00543361|Metformin|metformin|mesh-list
153992762|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153992763|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
153992764|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153992776|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153992777|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153992778|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
153992779|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153992780|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992781|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153992782|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614471|NCT01968564|Curcumin|curcumin|mesh-list
153992783|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992784|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
153992785|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153992786|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153992787|NCT01838174|Prednisolone|prednisolone|mesh-list
153992788|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
153992789|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153992790|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
153992791|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153992792|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
153992793|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
153992794|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992795|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149119|NCT04290624|Listerine|listerine|mesh-list
153992796|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153992797|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
153992798|NCT01838174|Hormones|hormones|mesh-ancestor
153992799|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153992800|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153992801|NCT01838174|Protective Agents|protective agents|mesh-ancestor
153992802|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153992803|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992804|NCT01743131|Abatacept|abatacept|mesh-list
153992805|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153992806|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992807|NCT01743131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153992808|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992809|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153992810|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
153992811|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992812|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153992813|NCT01685814|Lenalidomide|lenalidomide|mesh-list
153992814|NCT01685814|Bortezomib|bortezomib|mesh-list
153992815|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
153992816|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992817|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153992818|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153992819|NCT01685814|Growth Substances|growth substances|mesh-ancestor
153992820|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
153992821|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992823|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
153992824|NCT01147016|Doxorubicin|doxorubicin|mesh-list
153992825|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153992826|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153992827|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992828|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
153992829|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
153992840|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153992841|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153992842|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992843|NCT00756509|Nilotinib|nilotinib|mesh-list
153992844|NCT00756509|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153992845|NCT00756509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153992846|NCT00756509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992847|NCT00756509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992848|NCT00200200|Bevacizumab|bevacizumab|mesh-list
153992849|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153992850|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992851|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153992852|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153992853|NCT00200200|Growth Substances|growth substances|mesh-ancestor
153992854|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992855|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
153992856|NCT00106587|Paclitaxel|paclitaxel|mesh-list
153614534|NCT01968915|Paclitaxel|paclitaxel|mesh-list
153992857|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153992858|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992859|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
153992860|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
153992861|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
153992862|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992863|NCT00694863|Cosyntropin|cosyntropin|mesh-list
153992864|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
153992865|NCT00694863|Hormones|hormones|mesh-ancestor
153992866|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153992867|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992868|NCT00629213|Acarbose|acarbose|mesh-list
153992869|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153992870|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992871|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992872|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153992873|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992874|NCT00978341|Pregabalin|pregabalin|mesh-list
153992875|NCT00978341|Analgesics|analgesics|mesh-ancestor
153992876|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
153992877|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992878|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992879|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
154860939|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153992880|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153992881|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153992882|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992883|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153992884|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153992885|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153992886|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992887|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153992888|NCT00695331|Misoprostol|misoprostol|mesh-list
153992889|NCT00695331|Oxytocin|oxytocin|mesh-list
153992890|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
153779845|NCT00255762|Antibodies|antibodies|mesh-list
153992917|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153992918|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992919|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992920|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153992921|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
153992922|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153992923|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992924|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153992925|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153992926|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
153992927|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153992928|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
153992929|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153992930|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153992931|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153992932|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153992933|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153992934|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153992935|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153992951|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992952|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992953|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153992954|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153992955|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153992956|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153992957|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
153992958|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
153992959|NCT02623569|Atenolol|atenolol|mesh-list
153992960|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153992961|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153992962|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
153992963|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
153992964|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992965|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992966|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153992967|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153992968|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153992969|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
153992970|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992971|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992972|NCT00977561|Cisplatin|cisplatin|mesh-list
153992973|NCT00977561|Carboplatin|carboplatin|mesh-list
153992974|NCT00977561|Etoposide|etoposide|mesh-list
153992975|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
153992976|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992977|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153992978|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153992979|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153992980|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992981|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992982|NCT04291313|Vitamin D|vitamin d|mesh-list
153992983|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
153992984|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
153750575|NCT00160316|Estradiol|estradiol|mesh-list
153992985|NCT04291313|Vitamins|vitamins|mesh-list
153992986|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
153992987|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992988|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153992989|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154860940|NCT03490942|Hormones|hormones|mesh-ancestor
153992990|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153992991|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153992992|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
153992993|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992994|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153992995|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153992996|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153992997|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153993012|NCT04135287|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153993013|NCT04135287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153993014|NCT04135287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993015|NCT04001621|Capecitabine|capecitabine|mesh-list
153993016|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153993017|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
153993018|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993019|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993020|NCT00976937|Metformin|metformin|mesh-list
153993021|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153993022|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153993023|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993024|NCT00976937|Incretins|incretins|mesh-ancestor
153993025|NCT00976937|Hormones|hormones|mesh-ancestor
153993026|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993027|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153993028|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
153993029|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993030|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993031|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
153993032|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153993033|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153993034|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
153993035|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993036|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993037|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993038|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153993039|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154176530|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176531|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
153993040|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153993042|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153993043|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993044|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
153993045|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993046|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993047|NCT02622555|Mirabegron|mirabegron|mesh-list
153993048|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153993049|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153993050|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153993051|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
153993052|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993053|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993054|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993055|NCT02622555|Urological Agents|urological agents|mesh-ancestor
153993067|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993068|NCT00629447|Tinzaparin|tinzaparin|mesh-list
153993069|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
153993070|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153993071|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153993072|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993073|NCT02622477|Pirfenidone|pirfenidone|mesh-list
153993074|NCT02622477|Analgesics|analgesics|mesh-ancestor
153993075|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
153993076|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993077|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993078|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153993079|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993080|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153993081|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993082|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993083|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
153993084|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
153993085|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153993086|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
153993087|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993088|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993089|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153993090|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
153993091|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
153993092|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153993093|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
153993094|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993095|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993096|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153993097|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153993098|NCT04289675|Interferons|interferons|mesh-list
153993099|NCT04289675|Interferon-beta|interferon-beta|mesh-list
153993100|NCT04289675|Teriflunomide|teriflunomide|mesh-list
153993101|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153993102|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993103|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
153993104|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993105|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
153993106|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993107|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
153993108|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153993109|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153993110|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993111|NCT04289675|Analgesics|analgesics|mesh-ancestor
153993112|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
153993113|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993114|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153993115|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993116|NCT00696579|Gemcitabine|gemcitabine|mesh-list
153993117|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153993118|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
153993119|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993152|NCT00975689|Expectorants|expectorants|mesh-ancestor
153993153|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
153993154|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153993155|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
153993156|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993157|NCT00975689|Protective Agents|protective agents|mesh-ancestor
153993158|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993159|NCT00975689|Antidotes|antidotes|mesh-ancestor
153993161|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153993162|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153993163|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780137|NCT00227942|Zolpidem|zolpidem|mesh-list
153993186|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993187|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993188|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
153993189|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993190|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
153993191|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153993192|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153993193|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993194|NCT02620995|Urological Agents|urological agents|mesh-ancestor
153993195|NCT02620839|Cisplatin|cisplatin|mesh-list
153993196|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993197|NCT02620605|Cabergoline|cabergoline|mesh-list
153993198|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153993199|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153993200|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
153993201|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
153993202|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993203|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750792|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153993204|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993205|NCT00976391|Insulin|insulin|mesh-list
153993206|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153993208|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
153993209|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
153993210|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153993211|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993212|NCT00976391|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153993213|NCT04252664|Remdesivir|remdesivir|mesh-list
153993214|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
153993215|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993216|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
153993217|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993218|NCT00696969|Amphotericin B|amphotericin b|mesh-list
153993224|NCT00696969|Amebicides|amebicides|mesh-ancestor
153993225|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153993226|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153993227|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993228|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153993229|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
153993230|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993231|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153993232|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153993233|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
153993235|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153993236|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153993237|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
153993238|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153993239|NCT02620215|Dinoprostone|dinoprostone|mesh-list
153993240|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
153993241|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153993242|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993243|NCT02620293|Emollients|emollients|mesh-list
153993244|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
153993245|NCT02619981|Lidocaine|lidocaine|mesh-list
153993246|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
153993247|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
153993248|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993249|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993250|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
153993251|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993252|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153993253|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153993254|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153993255|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153993256|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993257|NCT02619669|Letrozole|letrozole|mesh-list
153993258|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993259|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153993260|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153993261|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993262|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993263|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153993264|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
154582990|NCT05429593|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153993265|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993266|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993267|NCT03965117|Norepinephrine|norepinephrine|mesh-list
153993268|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153993269|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153993270|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
153993271|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993272|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993273|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993274|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
153993275|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
153993276|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993277|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153993278|NCT00917462|Sorafenib|sorafenib|mesh-list
153993279|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993280|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153993281|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993282|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993283|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
153993284|NCT02619513|Ropivacaine|ropivacaine|mesh-list
153993285|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153993286|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993287|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780230|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993302|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993303|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153993304|NCT00697125|Vaccines|vaccines|mesh-list
153993305|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
153993306|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993307|NCT04134273|Clindamycin|clindamycin|mesh-list
153993308|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
153993309|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
153993310|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153993311|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993312|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153993313|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993314|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993315|NCT04134117|Tisagenlecleucel|tisagenlecleucel|mesh-list
153993316|NCT04134117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153993317|NCT04134117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993318|NCT03853187|Durvalumab|durvalumab|mesh-list
153993319|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153993320|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153993321|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993322|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
153993323|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993324|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
153993325|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153993326|NCT00697281|Growth Substances|growth substances|mesh-ancestor
153993327|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993328|NCT00979901|Loratadine|loratadine|mesh-list
153993329|NCT00979901|Montelukast|montelukast|mesh-list
153993330|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153993331|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
153993332|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153993333|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
153993334|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993335|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993336|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153993337|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153993338|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993339|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
153993340|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
153993341|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153993342|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153993343|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153993344|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
153993345|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
153993346|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993381|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153993382|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153993383|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993384|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993385|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
153993386|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153993387|NCT02862977|Ketoprofen|ketoprofen|mesh-list
153993388|NCT02862977|Amitriptyline|amitriptyline|mesh-list
153993409|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
153993410|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153993411|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153993412|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153993413|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153993414|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993415|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153993416|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153993417|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153993419|NCT02864927|Vaccines|vaccines|mesh-list
153993420|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
153993421|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993422|NCT02618499|Oxytocin|oxytocin|mesh-list
153993423|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
153993424|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153993425|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993426|NCT04133961|Phenylephrine|phenylephrine|mesh-list
153993427|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
153993428|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153993429|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
153993430|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
153993431|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993432|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993433|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
153993434|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153993435|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
153993436|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
153993437|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153993438|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153993439|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153993440|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
153993441|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993442|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993455|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153993456|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
153993457|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993458|NCT00917384|Ramucirumab|ramucirumab|mesh-list
153993459|NCT00917384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153993460|NCT00917384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153993461|NCT00917384|Growth Substances|growth substances|mesh-ancestor
153993462|NCT00917384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993463|NCT00917384|Growth Inhibitors|growth inhibitors|mesh-ancestor
153993464|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993465|NCT04133571|Lidocaine|lidocaine|mesh-list
153993466|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
153993467|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
153993468|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993469|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993470|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
153993471|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993472|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153993473|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153993474|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153993475|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153993476|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993477|NCT00629681|Pregabalin|pregabalin|mesh-list
153993478|NCT00629681|Analgesics|analgesics|mesh-ancestor
153993479|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
153993480|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993481|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993482|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
153993483|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154582991|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
153615303|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
153993484|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153993485|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993486|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153993487|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153993488|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153993489|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993491|NCT04289207|Danazol|danazol|mesh-list
153993492|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153993493|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
153993494|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993495|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993496|NCT02863835|Albuterol|albuterol|mesh-list
153993497|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153993498|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
153993499|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993500|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993501|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153993502|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
153993503|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
153993504|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153993505|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153993516|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
153993517|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993518|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
153993519|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993520|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153993521|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153993522|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993523|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153993524|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
153993525|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993526|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993527|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153993528|NCT04252274|Darunavir|darunavir|mesh-list
153993530|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
153993531|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153993532|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153993533|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
153993534|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993535|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993536|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153993537|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153993538|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
153993539|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993540|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153993541|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153993542|NCT00864513|Pemetrexed|pemetrexed|mesh-list
153993543|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615304|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153993544|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993545|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993546|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153993547|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153993548|NCT04128891|Valsartan|valsartan|mesh-list
153993549|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153993550|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153993551|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153993552|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153993553|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993554|NCT04251962|Fentanyl|fentanyl|mesh-list
153993555|NCT04251962|Bupivacaine|bupivacaine|mesh-list
153993556|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
153993557|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
153993558|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993559|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647246|NCT00121303|Cytarabine|cytarabine|mesh-list
153993561|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993562|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153993563|NCT04251962|Narcotics|narcotics|mesh-ancestor
153993564|NCT04251962|Analgesics|analgesics|mesh-ancestor
153993565|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153993566|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153993567|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
153993568|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
153780514|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993584|NCT00631514|Acetaminophen|acetaminophen|mesh-list
153993586|NCT00631514|Piroxicam|piroxicam|mesh-list
153993587|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993588|NCT00631514|Analgesics|analgesics|mesh-ancestor
153993589|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
153993590|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993591|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993592|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
153993593|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153993594|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153993595|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993596|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153993597|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993598|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993599|NCT05253014|Acetaminophen|acetaminophen|mesh-list
153993600|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993601|NCT05253014|Analgesics|analgesics|mesh-ancestor
153993602|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
153993603|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993604|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993605|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
153993606|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
153993607|NCT00659425|Immunotoxins|immunotoxins|mesh-ancestor
153993608|NCT00659425|Immunoconjugates|immunoconjugates|mesh-ancestor
153993609|NCT00659425|Immunologic Factors|immunologic factors|mesh-ancestor
153993610|NCT00659425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993611|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993612|NCT00656851|Pioglitazone|pioglitazone|mesh-list
153993613|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153993614|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993615|NCT00803335|Estrogens|estrogens|mesh-list
153993616|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153993617|NCT00803335|Hormones|hormones|mesh-ancestor
153993618|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993619|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993620|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
153993621|NCT00656617|Cytarabine|cytarabine|mesh-list
153993622|NCT00656617|Vorinostat|vorinostat|mesh-list
153993623|NCT00656617|Idarubicin|idarubicin|mesh-list
153993624|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153993625|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
153993626|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993627|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993628|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
153993650|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153993651|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153993652|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
153993653|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
153993654|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
153993655|NCT00803803|Pilocarpine|pilocarpine|mesh-list
153993656|NCT00803803|Miotics|miotics|mesh-ancestor
153993657|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
153993658|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993659|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993660|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153993661|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153993662|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
153993663|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993664|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993665|NCT04775329|Rifaximin|rifaximin|mesh-list
153993666|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153993667|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993668|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153993669|NCT00659269|Vitamins|vitamins|mesh-list
153993670|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
153993671|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
153993672|NCT00659269|Pyridoxal|pyridoxal|mesh-list
153993673|NCT00659269|Pyridoxine|pyridoxine|mesh-list
153993674|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
153993675|NCT00659269|Vincristine|vincristine|mesh-list
153993676|NCT00659269|Vinorelbine|vinorelbine|mesh-list
153993677|NCT00659269|Docetaxel|docetaxel|mesh-list
153993678|NCT00659269|Cisplatin|cisplatin|mesh-list
153993679|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
153993680|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153993681|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993682|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
153993683|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
153993684|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
153993685|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993686|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
153615497|NCT01975727|Dexamethasone|dexamethasone|mesh-list
153993687|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993721|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153993722|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153993723|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153993724|NCT00804115|Miotics|miotics|mesh-ancestor
153993725|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
153993726|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993727|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153993728|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153993729|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
153993730|NCT02554123|Vitamin E|vitamin e|mesh-list
153993731|NCT02554123|Petrolatum|petrolatum|mesh-list
153993732|NCT02554123|Vitamins|vitamins|mesh-ancestor
153993733|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
153993734|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993735|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
153993760|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153993762|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993763|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993764|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993765|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153993766|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153993767|NCT00799201|Naloxone|naloxone|mesh-list
153993768|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153993769|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993770|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
153993771|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993772|NCT00806611|Ethanol|ethanol|mesh-list
153993773|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153993774|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993775|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993776|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993777|NCT00799513|Lenalidomide|lenalidomide|mesh-list
153993778|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
153993779|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993780|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153993781|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153993782|NCT00799513|Growth Substances|growth substances|mesh-ancestor
153993805|NCT00863655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153993806|NCT00863655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153993807|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993808|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751393|NCT00551239|Rituximab|rituximab|mesh-list
153993809|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153993810|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
153993811|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993812|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993813|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153993814|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153993815|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153993816|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
153993817|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993818|NCT00806923|Bevacizumab|bevacizumab|mesh-list
153993819|NCT00806923|Gemcitabine|gemcitabine|mesh-list
153993820|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153993821|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993822|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153993823|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153993824|NCT00806923|Growth Substances|growth substances|mesh-ancestor
153993825|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993826|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
153993827|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153993828|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
153993829|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993830|NCT00698607|Sirolimus|sirolimus|mesh-list
153993831|NCT00698607|Everolimus|everolimus|mesh-list
153993832|NCT00698607|Clopidogrel|clopidogrel|mesh-list
153993833|NCT00698607|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153993834|NCT00698607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153993835|NCT00698607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993836|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993837|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153993838|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
153993872|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153993873|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153993874|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153993875|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993876|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153993877|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993899|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153993900|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
153993901|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153993902|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153993903|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
153993904|NCT00800293|Hormones|hormones|mesh-ancestor
153993905|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993906|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993907|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153993908|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
153993909|NCT00658021|Exenatide|exenatide|mesh-list
153993910|NCT00658021|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153993911|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153993912|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615619|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153993913|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153993914|NCT00658021|Incretins|incretins|mesh-ancestor
153993915|NCT00658021|Hormones|hormones|mesh-ancestor
153993916|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993917|NCT00920816|Sorafenib|sorafenib|mesh-list
153993918|NCT00920816|Axitinib|axitinib|mesh-list
153993919|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993920|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153993921|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993922|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993923|NCT00631592|Dolutegravir|dolutegravir|mesh-list
153993924|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153993925|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153993926|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993927|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993928|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153993929|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153993930|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
153993931|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993932|NCT05251610|Propranolol|propranolol|mesh-list
153993933|NCT05251610|Oxytocin|oxytocin|mesh-list
153993934|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
153993986|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
153993987|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993988|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993989|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
153993990|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993991|NCT00862641|Regadenoson|regadenoson|mesh-list
153993992|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153993993|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153993994|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
153993995|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
153993996|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993997|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993998|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993999|NCT04119921|Ketorolac|ketorolac|mesh-list
153994000|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153994001|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
153994002|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153994003|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994004|NCT04119921|Analgesics|analgesics|mesh-ancestor
153994005|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
153994006|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994007|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615738|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994008|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153994009|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994010|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153994011|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994012|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994013|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153994014|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153994043|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153994044|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994046|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
153994047|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153994048|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994049|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
153994050|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994051|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994052|NCT00700947|Metoprolol|metoprolol|mesh-list
153994053|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153994054|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153994055|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
153994056|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994057|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994058|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994059|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153994060|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153781020|NCT04710329|Vitamins|vitamins|mesh-ancestor
153994090|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
153994091|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994093|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153994094|NCT00805519|Protective Agents|protective agents|mesh-ancestor
153994095|NCT00805519|Amebicides|amebicides|mesh-ancestor
153994096|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153994097|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153994098|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994099|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
153994100|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994101|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153994102|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994103|NCT00805519|Analgesics|analgesics|mesh-ancestor
153994104|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
153994105|NCT00805519|Filaricides|filaricides|mesh-ancestor
153615803|NCT01978457|Cocaine|cocaine|mesh-list
153994106|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
153994107|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
153781066|NCT00200603|Calcium|calcium|mesh-list
153994138|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994139|NCT00701259|Lansoprazole|lansoprazole|mesh-list
153994140|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
153994141|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153994142|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153994143|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153994144|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994145|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994146|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153994147|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153994148|NCT00701337|Estradiol|estradiol|mesh-list
153994149|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153994150|NCT00701337|Estrogens|estrogens|mesh-ancestor
153994151|NCT00701337|Hormones|hormones|mesh-ancestor
153781114|NCT00258336|Rituximab|rituximab|mesh-list
153994182|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153994183|NCT00813631|Laxatives|laxatives|mesh-ancestor
153994184|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153994185|NCT02551861|Ribavirin|ribavirin|mesh-list
153994186|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
153994187|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
153994188|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994189|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
153994190|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994191|NCT00846495|Topiramate|topiramate|mesh-list
153994192|NCT00846495|Frovatriptan|frovatriptan|mesh-list
153994193|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
153994222|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153994223|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994224|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
153994225|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
153994226|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
153994227|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994228|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153994229|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153994230|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153994231|NCT00846027|Growth Substances|growth substances|mesh-ancestor
153994232|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994233|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
153994234|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153994235|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
153994236|NCT00807625|Copper|copper|mesh-list
153615855|NCT01978717|Anesthetics|anesthetics|mesh-list
153994237|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153994238|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
153994239|NCT00807625|Trace Elements|trace elements|mesh-ancestor
153994267|NCT00652327|Atorvastatin|atorvastatin|mesh-list
153994268|NCT00652327|Simvastatin|simvastatin|mesh-list
153994269|NCT00652327|Ezetimibe|ezetimibe|mesh-list
153994270|NCT00652327|Pravastatin|pravastatin|mesh-list
153994271|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153994272|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153994273|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153994274|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
153994275|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994276|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153994277|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994278|NCT00814021|Sunitinib|sunitinib|mesh-list
153994279|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994280|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153994281|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153994282|NCT00814021|Growth Substances|growth substances|mesh-ancestor
153994283|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994284|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
153994285|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153994286|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781243|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153994346|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994347|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153994348|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153994349|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153994350|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994351|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994352|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153994354|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994355|NCT00808171|Analgesics|analgesics|mesh-ancestor
153994356|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153994357|NCT04703257|Dipyrone|dipyrone|mesh-list
153994358|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153994359|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994390|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
153994391|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
153994392|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994394|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
153994395|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153994396|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
153994397|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994398|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994399|NCT00701961|Artesunate|artesunate|mesh-list
153994400|NCT00701961|Mefloquine|mefloquine|mesh-list
153994401|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
153994402|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153994403|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153994404|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994405|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994406|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
153994407|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
153994408|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153994434|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
153615941|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153994435|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994437|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
153994438|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
153994439|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994440|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994441|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153994442|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153994443|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
153994444|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994445|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994446|NCT00844857|Olanzapine|olanzapine|mesh-list
153994447|NCT00844857|Fluoxetine|fluoxetine|mesh-list
153994448|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
153994449|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
153994450|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994451|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994452|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153994453|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153994454|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153994455|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994456|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153994457|NCT00844857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153781409|NCT00266097|Gemcitabine|gemcitabine|mesh-list
153994555|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153994556|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153752128|NCT05807659|Busulfan|busulfan|mesh-list
153994557|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
153994558|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994559|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153994560|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994561|NCT00815269|Sevoflurane|sevoflurane|mesh-list
153994562|NCT00815269|Desflurane|desflurane|mesh-list
153994563|NCT00815269|Isoflurane|isoflurane|mesh-list
153994564|NCT00815269|Halothane|halothane|mesh-list
153994565|NCT00815269|Enflurane|enflurane|mesh-list
153781527|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994690|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994691|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153994692|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153994693|NCT00811291|Hematinics|hematinics|mesh-ancestor
153994694|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
153994695|NCT00811369|Fulvestrant|fulvestrant|mesh-list
153994696|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153994697|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994698|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153994699|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153994700|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
153994701|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994702|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994703|NCT00842361|Insulin|insulin|mesh-list
153994704|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153994705|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
153994706|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
153994707|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154582992|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153994709|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153994710|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153994737|NCT00702975|Growth Substances|growth substances|mesh-ancestor
153994738|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994739|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
153994740|NCT00702975|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153994741|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153994742|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994743|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153994744|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153994745|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994746|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
153994747|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153994748|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994749|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994750|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994751|NCT02612181|Analgesics|analgesics|mesh-ancestor
153994752|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
153994753|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994754|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153994755|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153994756|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153994757|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566844|NCT06233084|Hormones|hormones|mesh-ancestor
153994794|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994795|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153994913|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153994914|NCT04202978|Capecitabine|capecitabine|mesh-list
153994915|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
153994917|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153994918|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
153994919|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994920|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994921|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153994922|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994923|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
153994924|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153994925|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153994926|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153994927|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994928|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995218|NCT04084106|Penicillin V|penicillin v|mesh-list
153995219|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153995220|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995221|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995222|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995223|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153995224|NCT02973542|Ethosuximide|ethosuximide|mesh-list
153995225|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
153995226|NCT02973386|Cisplatin|cisplatin|mesh-list
153995227|NCT02973386|Capecitabine|capecitabine|mesh-list
153995228|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995229|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153995301|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
153995302|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153995303|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153995304|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995305|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153995306|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
153995307|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153995308|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
153995309|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995310|NCT00643123|Allopurinol|allopurinol|mesh-list
153995311|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
153995312|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995313|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995314|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
153995315|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153995316|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153995318|NCT00643123|Protective Agents|protective agents|mesh-ancestor
153995319|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995320|NCT00816673|Melatonin|melatonin|mesh-list
153995321|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
153995322|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995323|NCT00816673|Protective Agents|protective agents|mesh-ancestor
153995324|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995325|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995326|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153995327|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153995328|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995329|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995330|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995331|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995332|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995333|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
153995334|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153995335|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153995336|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153995337|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995338|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995339|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995340|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995341|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995342|NCT00641719|Analgesics|analgesics|mesh-ancestor
153995343|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
153995344|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995345|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
153995346|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153995347|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
153995348|NCT02863367|Gemcitabine|gemcitabine|mesh-list
153995349|NCT02863367|Apatinib|apatinib|mesh-list
153567408|NCT05601154|Protective Agents|protective agents|mesh-ancestor
153995410|NCT03672500|Bupivacaine|bupivacaine|mesh-list
153995411|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
153995412|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
153995413|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995414|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995415|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
153995416|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995417|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153995418|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153995419|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
153995420|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995421|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995422|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153995423|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153995457|NCT00817375|Milnacipran|milnacipran|mesh-list
153995458|NCT00817375|Mirtazapine|mirtazapine|mesh-list
153995460|NCT00817375|Fluoxetine|fluoxetine|mesh-list
153995461|NCT00817375|Paroxetine|paroxetine|mesh-list
153995462|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153995463|NCT00817375|Nortriptyline|nortriptyline|mesh-list
153995464|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
153995479|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
153995480|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
153995481|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153995482|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153995483|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995484|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153995485|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153995486|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153995487|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
153995488|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153995489|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153995490|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153995491|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153995492|NCT00817375|Analgesics|analgesics|mesh-ancestor
153995493|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
153995494|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995495|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153995496|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153995497|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153995498|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
153995499|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
153995500|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153995501|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153995502|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995503|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995504|NCT00818701|Urological Agents|urological agents|mesh-ancestor
153995505|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
153995506|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995508|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153995509|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153995510|NCT00813241|Analgesics|analgesics|mesh-ancestor
153995511|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
153995512|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995513|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995514|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153995515|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153995516|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153995517|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153995518|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995519|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995552|NCT02030990|Fluorometholone|fluorometholone|mesh-list
153995553|NCT02030990|Mitomycins|mitomycins|mesh-list
153995554|NCT02030990|Mitomycin|mitomycin|mesh-list
153995555|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153995556|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995557|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
153995558|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995559|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153995560|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567645|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153995584|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153995585|NCT00822133|Lidocaine|lidocaine|mesh-list
153995586|NCT00822133|Ketamine|ketamine|mesh-list
153995587|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
153995588|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
153995589|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995590|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995591|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
153995592|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995593|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153995594|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153995595|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153995596|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995597|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995598|NCT00822133|Analgesics|analgesics|mesh-ancestor
153995599|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153995600|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153995601|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
153995602|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153995603|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153995604|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995605|NCT00822211|Vildagliptin|vildagliptin|mesh-list
153995606|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153995607|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995608|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153995609|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
153995610|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995611|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995613|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153995614|NCT04018417|Amebicides|amebicides|mesh-ancestor
153995615|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153995616|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153995617|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995618|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153995619|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
153995620|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
153995621|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153995622|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153995623|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153995624|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995625|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995626|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
153995627|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995628|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995629|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153995630|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995631|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
153616293|NCT06327724|Belimumab|belimumab|mesh-list
153616356|NCT06327399|Respiratory System Agents|respiratory system agents|mesh-ancestor
153995632|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
153995633|NCT00826657|Vitamins|vitamins|mesh-ancestor
153995634|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
153995635|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995636|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
153995637|NCT00826657|Hematinics|hematinics|mesh-ancestor
153995638|NCT03597776|Lidocaine|lidocaine|mesh-list
153995639|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
153995640|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
153995641|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995642|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995643|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
153995644|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995645|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153995646|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153995647|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153995648|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995649|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995650|NCT00625183|Selenium|selenium|mesh-list
153995651|NCT00625183|Capecitabine|capecitabine|mesh-list
153995681|NCT02768948|Telmisartan|telmisartan|mesh-list
153995682|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153995683|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153995684|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153995685|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153995686|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995687|NCT00640315|Riociguat|riociguat|mesh-list
153995688|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
153995689|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995690|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
153995691|NCT00904748|Citric Acid|citric acid|mesh-list
153995692|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
153995693|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
153995694|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153995695|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
153995696|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
153995697|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995723|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
153995724|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995725|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153995727|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
153995728|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153995729|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
153995730|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995731|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995732|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
153995733|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
153995734|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153995735|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153995736|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995737|NCT00568555|Naltrexone|naltrexone|mesh-list
153995738|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153995739|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153616406|NCT06326996|Thiamine|thiamine|mesh-list
153995740|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995741|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
153995742|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995743|NCT00819325|Pioglitazone|pioglitazone|mesh-list
153995744|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153995745|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995746|NCT00904670|Methylphenidate|methylphenidate|mesh-list
153567818|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995780|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995781|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153995782|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153995783|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153995784|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995807|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153995808|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995809|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
153995810|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
153995811|NCT00975143|Isotretinoin|isotretinoin|mesh-list
153995812|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
153995813|NCT04288349|Epinephrine|epinephrine|mesh-list
153995814|NCT04288349|Racepinephrine|racepinephrine|mesh-list
153995815|NCT04288349|Ropivacaine|ropivacaine|mesh-list
153995816|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
153995817|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
153995818|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
153995819|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995820|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995821|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
153995822|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995823|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153995824|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153995825|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
153995826|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995827|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995828|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153995829|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153995830|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
153995831|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153995835|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153995836|NCT03667313|Sirolimus|sirolimus|mesh-list
153995837|NCT03667313|Paclitaxel|paclitaxel|mesh-list
153995838|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153995839|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995840|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
153995841|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
153995904|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
153995905|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995906|NCT00629837|Factor VIII|factor viii|mesh-list
153995907|NCT00629837|Coagulants|coagulants|mesh-ancestor
153995908|NCT00827671|Cetuximab|cetuximab|mesh-list
153995909|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153995910|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995911|NCT03643133|Mifamurtide|mifamurtide|mesh-list
153995912|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153995913|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
153995914|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995915|NCT00823849|Cilostazol|cilostazol|mesh-list
153995916|NCT00823849|Probucol|probucol|mesh-list
153995917|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153995918|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
153995919|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995920|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995921|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153995922|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
153995923|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153995924|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153995925|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995926|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153995927|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
153995928|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153995929|NCT00823849|Protective Agents|protective agents|mesh-ancestor
153995961|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153995962|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
153995963|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
153995964|NCT02862509|Hormones|hormones|mesh-ancestor
153995965|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153995966|NCT04285775|Chrysarobin|chrysarobin|mesh-list
153995967|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153995968|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153995969|NCT04285775|Analgesics|analgesics|mesh-ancestor
153995970|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
153995971|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995972|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995973|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153995974|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996001|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996003|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153996004|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
153996005|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996006|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996007|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996008|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996010|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
153996011|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
153996012|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
153996013|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153996014|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
153996015|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
153996016|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996017|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996018|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996019|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153996020|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153996046|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153996048|NCT04283435|Urological Agents|urological agents|mesh-ancestor
153996049|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
153996050|NCT00632125|Hematinics|hematinics|mesh-ancestor
153996051|NCT00903968|Plerixafor|plerixafor|mesh-list
153996052|NCT00903968|Dexamethasone|dexamethasone|mesh-list
153753632|NCT00166868|Neomycin|neomycin|mesh-list
153996053|NCT00903968|Bortezomib|bortezomib|mesh-list
153996054|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996055|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
153996056|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
153996057|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996058|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996059|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996060|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
153996061|NCT00903968|Hormones|hormones|mesh-ancestor
153996062|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996063|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153996064|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996065|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153996066|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153996067|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
153996068|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996069|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
153996070|NCT00632606|Metoclopramide|metoclopramide|mesh-list
153996071|NCT00632606|Analgesics|analgesics|mesh-ancestor
153996106|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996107|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153996108|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996110|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153568196|NCT04200651|Hormones|hormones|mesh-ancestor
153996144|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
153996145|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996146|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
153996147|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
153996148|NCT00626197|Azathioprine|azathioprine|mesh-list
153996149|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
153996150|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153996151|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
153996152|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996153|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568220|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
153996178|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996179|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996180|NCT02847884|Infliximab|infliximab|mesh-list
153996181|NCT02847884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153996182|NCT02847884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996183|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
153996184|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996185|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996186|NCT00623935|Fludarabine|fludarabine|mesh-list
153996187|NCT00623935|Busulfan|busulfan|mesh-list
153996188|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996189|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996190|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153996191|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
153996192|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996193|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
153996194|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153996195|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153996196|NCT00623779|Aspirin|aspirin|mesh-list
153996197|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153996198|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996199|NCT00623779|Analgesics|analgesics|mesh-ancestor
153996200|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
153996201|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996202|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996237|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
153996238|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153996239|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153996240|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153996241|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153996276|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996278|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153996279|NCT02847806|Estradiol|estradiol|mesh-list
153996310|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153996311|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
153996312|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996313|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996314|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
153996315|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153996316|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996317|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996318|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996319|NCT02846090|Analgesics|analgesics|mesh-ancestor
153996320|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
153996321|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996322|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153996323|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153996324|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153996339|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996340|NCT00824785|Capecitabine|capecitabine|mesh-list
153996341|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
153996342|NCT00824785|Epirubicin|epirubicin|mesh-list
153996343|NCT00824785|Panitumumab|panitumumab|mesh-list
153996344|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153996345|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
153996346|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996347|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996348|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153996349|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153996350|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153616907|NCT06044935|Niacin|niacin|mesh-list
153996351|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996352|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153996353|NCT00824863|Ketoconazole|ketoconazole|mesh-list
153996354|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
153996355|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996356|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153996357|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153996359|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996360|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153996361|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
153996362|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996363|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996364|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153996365|NCT02844530|Epratuzumab|epratuzumab|mesh-list
153996366|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153996367|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153996368|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996369|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
153996370|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
153996371|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996372|NCT00820417|Cetuximab|cetuximab|mesh-list
153996373|NCT00820417|Gefitinib|gefitinib|mesh-list
153996374|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153996375|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996376|NCT00820417|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153996377|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153996378|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996379|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996380|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153996381|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
153996382|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996383|NCT02548741|Metformin|metformin|mesh-list
153568434|NCT03197922|Glycerol|glycerol|mesh-list
153996397|NCT00825019|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153996398|NCT00825019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153996399|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153996400|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996401|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996402|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996403|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
153996404|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996405|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153996406|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
153996407|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153996408|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153996409|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153996410|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996411|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153996412|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153996413|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
153996414|NCT00825019|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153996415|NCT00929006|Progesterone|progesterone|mesh-list
153996416|NCT00929006|Progestins|progestins|mesh-ancestor
153996417|NCT00929006|Hormones|hormones|mesh-ancestor
153996418|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996419|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996420|NCT00877214|Rituximab|rituximab|mesh-list
153996421|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153996422|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996423|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
153996424|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996425|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996426|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
153996427|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153996428|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996429|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996430|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
153996431|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996432|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996433|NCT05242718|Palmidrol|palmidrol|mesh-list
153996434|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
153996435|NCT05242718|Curcumin|curcumin|mesh-list
153996436|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153996437|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153996438|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996439|NCT05242718|Analgesics|analgesics|mesh-ancestor
153996440|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
153996441|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996442|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996443|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996444|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996474|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153996475|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153996476|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996477|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
153996478|NCT05337332|Hormones|hormones|mesh-ancestor
153996479|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996480|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996481|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153996482|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
153996483|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996484|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996486|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
153996487|NCT00901394|Hematinics|hematinics|mesh-ancestor
153996488|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
153996489|NCT00901394|Vitamins|vitamins|mesh-ancestor
153996512|NCT00896532|Denosumab|denosumab|mesh-list
153996513|NCT00896532|Alendronate|alendronate|mesh-list
153996514|NCT00896532|Teriparatide|teriparatide|mesh-list
153996515|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153996516|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153996517|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996518|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153996519|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
153996520|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
153996521|NCT00574873|Bosutinib|bosutinib|mesh-list
153996522|NCT00574873|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153996523|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153996524|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996525|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996526|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996527|NCT02843490|Ranibizumab|ranibizumab|mesh-list
153996528|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153996529|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153996530|NCT02843490|Growth Substances|growth substances|mesh-ancestor
153996531|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996532|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
153996533|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996534|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
153996535|NCT00902174|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153996536|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153996537|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996538|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996539|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996540|NCT04201808|Tenofovir|tenofovir|mesh-list
153996541|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
153996542|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996557|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996558|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996559|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153996561|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153996562|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153996563|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
153996564|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153996565|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153996566|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996567|NCT02845388|Urological Agents|urological agents|mesh-ancestor
153996568|NCT02845466|Becaplermin|becaplermin|mesh-list
153996569|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
153996570|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
153617191|NCT05761327|Antioxidants|antioxidants|mesh-ancestor
153996571|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153996572|NCT02845466|Growth Substances|growth substances|mesh-ancestor
153996573|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996574|NCT00623623|Enoxaparin|enoxaparin|mesh-list
153996575|NCT00623623|Tenecteplase|tenecteplase|mesh-list
153996576|NCT00623623|Clopidogrel|clopidogrel|mesh-list
153996577|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153996578|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153754149|NCT00407459|Bevacizumab|bevacizumab|mesh-list
153996579|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153996580|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153996582|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996583|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996584|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996585|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
153996586|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153996587|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153996588|NCT00896454|Denosumab|denosumab|mesh-list
153996589|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153996590|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996591|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153996592|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153996593|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153996594|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996595|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996596|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996597|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996598|NCT04224584|Analgesics|analgesics|mesh-ancestor
153996599|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
153568650|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
153996623|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996624|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996625|NCT00901628|Cefuroxime|cefuroxime|mesh-list
153996626|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
153996627|NCT00901628|Ketorolac|ketorolac|mesh-list
153996628|NCT00901628|Epinephrine|epinephrine|mesh-list
153996629|NCT00901628|Morphine|morphine|mesh-list
153996630|NCT00901628|Ropivacaine|ropivacaine|mesh-list
153996631|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153996632|NCT00901628|Narcotics|narcotics|mesh-ancestor
154176535|NCT02545751|Thymalfasin|thymalfasin|mesh-list
153996633|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996634|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996636|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
153996637|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996638|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
153996639|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
153996640|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153996641|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153617561|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996642|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
153996643|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996644|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996645|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153996646|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153996647|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
153996648|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153996649|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
153996650|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
153996651|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
153996756|NCT02840526|Analgesics|analgesics|mesh-ancestor
153996757|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153996758|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996759|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
153996760|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153996794|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153996795|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153996797|NCT00829777|Naloxone|naloxone|mesh-list
153996798|NCT00829777|Lactulose|lactulose|mesh-list
153996799|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153996819|NCT00633282|Pioglitazone|pioglitazone|mesh-list
153996820|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153996821|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996822|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996823|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
153996824|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
153996825|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
153996826|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996827|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996828|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
153996829|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996830|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153996831|NCT00830245|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153996832|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153996833|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996834|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996835|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996836|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
153996837|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996838|NCT02838030|Aspirin|aspirin|mesh-list
153996839|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153996840|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996841|NCT02838030|Analgesics|analgesics|mesh-ancestor
153996842|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
153996843|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996844|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996845|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996846|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996847|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153996848|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153996849|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996850|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153996851|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153996852|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996867|NCT00830323|Amantadine|amantadine|mesh-list
153996868|NCT00830323|Zanamivir|zanamivir|mesh-list
153996869|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
153996870|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996871|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996872|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996873|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153996874|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153996875|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
153996876|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996877|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996878|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996880|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
153996881|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996882|NCT00830401|Doxycycline|doxycycline|mesh-list
153996883|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153996884|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996885|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
153996886|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153996887|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153996888|NCT04249908|Maleic acid|maleic acid|mesh-list
153996889|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996890|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996891|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153996892|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153996893|NCT02837640|Levodopa|levodopa|mesh-list
153996894|NCT02837640|Carbidopa|carbidopa|mesh-list
153996895|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153996896|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153996897|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153996898|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
153996899|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996900|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996901|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996902|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153996903|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996904|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153996905|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
153996906|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
153996907|NCT02834286|Dexamethasone|dexamethasone|mesh-list
153996908|NCT02834286|Rituximab|rituximab|mesh-list
153996909|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996910|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
153996911|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
153996912|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996913|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996914|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996950|NCT00838539|MTOR Inhibitors|mtor inhibitors|mesh-list
153996952|NCT00838539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153996953|NCT00838539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996954|NCT00838539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996955|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153996991|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996992|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153996994|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996995|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569065|NCT04761393|Xenon|xenon|mesh-list
153997024|NCT05878561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997025|NCT05878561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153997026|NCT05878561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997027|NCT05878561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997029|NCT05878379|Trace Elements|trace elements|mesh-ancestor
153997030|NCT05878379|Micronutrients|micronutrients|mesh-ancestor
153997031|NCT05878379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997032|NCT05878262|Ibuprofen|ibuprofen|mesh-list
153997033|NCT05878262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153997034|NCT05878262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153997035|NCT05878262|Analgesics|analgesics|mesh-ancestor
153997036|NCT05878262|Sensory System Agents|sensory system agents|mesh-ancestor
153997037|NCT05878262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997038|NCT05878262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997039|NCT05878262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153997040|NCT05878262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997041|NCT05878262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153997042|NCT05878262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569101|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153617728|NCT04751669|Trace Elements|trace elements|mesh-list
153617793|NCT04610320|Daratumumab|daratumumab|mesh-list
153997103|NCT05877235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997104|NCT05877131|Ropivacaine|ropivacaine|mesh-list
153997105|NCT05877131|Levobupivacaine|levobupivacaine|mesh-list
153997106|NCT05877131|Anesthetics, Local|anesthetics, local|mesh-ancestor
153997107|NCT05877131|Anesthetics|anesthetics|mesh-ancestor
153997108|NCT05877131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997109|NCT05877131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997110|NCT05877131|Sensory System Agents|sensory system agents|mesh-ancestor
153997111|NCT05877131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997113|NCT05877079|Antipruritics|antipruritics|mesh-ancestor
153997114|NCT05877079|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997115|NCT05877040|Rituximab|rituximab|mesh-list
153997116|NCT05877040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997117|NCT05877040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997118|NCT05877040|Immunologic Factors|immunologic factors|mesh-ancestor
153997119|NCT05877040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997120|NCT05877040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997149|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997150|NCT05663658|Analgesics|analgesics|mesh-ancestor
153997151|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
153997152|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997153|NCT05660135|Amlodipine|amlodipine|mesh-list
153997154|NCT05660135|Olmesartan|olmesartan|mesh-list
153997155|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153997156|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153997157|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153997158|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153997159|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997160|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997161|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153997162|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997163|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
153997164|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153997165|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153997166|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
153997198|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153997199|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
153997200|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
153997201|NCT05411887|Olmesartan|olmesartan|mesh-list
153997202|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153997203|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153997204|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153997205|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153997206|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
153569274|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
153997232|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997234|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997235|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997236|NCT05307458|Buprenorphine|buprenorphine|mesh-list
153997237|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153997238|NCT05307458|Naloxone|naloxone|mesh-list
153997239|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153997240|NCT05307458|Narcotics|narcotics|mesh-ancestor
153997241|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997242|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997243|NCT05307458|Analgesics|analgesics|mesh-ancestor
153997244|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
153997245|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997246|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153997247|NCT05123053|Amifampridine|amifampridine|mesh-list
153997248|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153997249|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997250|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997251|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153997252|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153569337|NCT03593473|Oxytocin|oxytocin|mesh-list
153997281|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997282|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997284|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153997285|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997286|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997287|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997288|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
153997289|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153997290|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997291|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997292|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153997293|NCT04798482|Analgesics|analgesics|mesh-ancestor
153997294|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
153997295|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997296|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153997297|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153997335|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
153997336|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997337|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153997364|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
153997365|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153997366|NCT04427241|Protective Agents|protective agents|mesh-ancestor
153997367|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997368|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
153997369|NCT04315701|Cemiplimab|cemiplimab|mesh-list
153997370|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617848|NCT04519619|Aflibercept|aflibercept|mesh-list
153997371|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997372|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
153997373|NCT04240093|Narcotics|narcotics|mesh-ancestor
153997374|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997375|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997376|NCT04240093|Analgesics|analgesics|mesh-ancestor
153997377|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
153997378|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997379|NCT04115774|Diphosphonates|diphosphonates|mesh-list
153997380|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153569475|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
153997471|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
153997472|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997473|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997474|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153997475|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997476|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
153997477|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997478|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997479|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153997480|NCT02484677|Docetaxel|docetaxel|mesh-list
153997481|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997482|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
153997483|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
153997484|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
153997485|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997486|NCT02476097|Esomeprazole|esomeprazole|mesh-list
153997487|NCT02476097|Omeprazole|omeprazole|mesh-list
153997488|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153997489|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997490|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153997491|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997492|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997493|NCT03946358|Atezolizumab|atezolizumab|mesh-list
153997494|NCT03946358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153997495|NCT03946358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997515|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153997516|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153997517|NCT01264315|Growth Substances|growth substances|mesh-ancestor
153997518|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
153997519|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997520|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
153997521|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153997522|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
153997523|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997524|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997525|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153997526|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
153997527|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153997528|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153617984|NCT04199468|Ketamine|ketamine|mesh-list
153997529|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153997530|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
153997531|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997532|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997533|NCT00890149|Ondansetron|ondansetron|mesh-list
153997534|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
153997535|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
153997536|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997537|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997539|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
153997540|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997541|NCT00890149|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153997542|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153997543|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
153997544|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997545|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997547|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153997548|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
153755132|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
153997607|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997608|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651335|NCT00033358|Norgestrel|norgestrel|mesh-list
153997609|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153997610|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
153997611|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153997612|NCT00703755|Metformin|metformin|mesh-list
153997613|NCT00703755|Fenofibrate|fenofibrate|mesh-list
153997614|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153997615|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997616|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153997617|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
153997618|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997619|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153997620|NCT02838342|Interferons|interferons|mesh-list
153997621|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
153997622|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
153997623|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153997624|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
153997625|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997626|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997627|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153997628|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
153618067|NCT04085445|Paclitaxel|paclitaxel|mesh-list
153997629|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997630|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997631|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153997696|NCT00703989|Vitamins|vitamins|mesh-ancestor
153997697|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
153997698|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153997699|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
153997700|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
153997701|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
153997703|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
153997704|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153997705|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
153997706|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997707|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997708|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
153997709|NCT02836002|Piperaquine|piperaquine|mesh-list
153997710|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
153997730|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
153997731|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997732|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997733|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153997734|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
153997735|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
153997736|NCT02297516|Protective Agents|protective agents|mesh-ancestor
153997737|NCT02842580|Leucovorin|leucovorin|mesh-list
153997738|NCT02842580|Bevacizumab|bevacizumab|mesh-list
153997739|NCT02842580|Capecitabine|capecitabine|mesh-list
153997740|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
153997741|NCT02842580|Irinotecan|irinotecan|mesh-list
153997742|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
153997743|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997744|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997745|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153997746|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153997747|NCT02842580|Growth Substances|growth substances|mesh-ancestor
153997748|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997749|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
153997750|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153997751|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
153997752|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997753|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153997754|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153997755|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997757|NCT02842580|Protective Agents|protective agents|mesh-ancestor
153997758|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
153997759|NCT02842580|Vitamins|vitamins|mesh-ancestor
153997760|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
153997761|NCT00836277|Irinotecan|irinotecan|mesh-list
153997762|NCT00836277|Panitumumab|panitumumab|mesh-list
153618170|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
153997763|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153997764|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153997765|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997766|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997767|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997790|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997791|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
153997792|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997793|NCT00751166|Cetirizine|cetirizine|mesh-list
153997794|NCT00751166|Desloratadine|desloratadine|mesh-list
153997795|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153997796|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153997797|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153997798|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
153997799|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
153997800|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997801|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997802|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997803|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153997804|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
153997805|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153997806|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
153997807|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153997808|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153997809|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153997810|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997811|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997812|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
153997813|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153997814|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997815|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153997816|NCT00704145|Paclitaxel|paclitaxel|mesh-list
153997817|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153997818|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997819|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
153997820|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
153997821|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
153997822|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997860|NCT00574249|Adalimumab|adalimumab|mesh-list
153997861|NCT00574249|Betamethasone|betamethasone|mesh-list
153997884|NCT00896168|Methotrexate|methotrexate|mesh-list
153997885|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153997886|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
153997887|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153997888|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997889|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153997890|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
153997891|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997892|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997893|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997894|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997895|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153997896|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153997897|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
153997898|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997899|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153997900|NCT00896168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153997901|NCT00896168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153997902|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997903|NCT00833703|Clopidogrel|clopidogrel|mesh-list
153997904|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153997905|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153997906|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153997907|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153997908|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
154255083|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997909|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651622|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153997910|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997911|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997912|NCT00833547|Eszopiclone|eszopiclone|mesh-list
153997946|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153997947|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153997948|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997949|NCT00832377|Timolol|timolol|mesh-list
153997950|NCT00832377|Dorzolamide|dorzolamide|mesh-list
153997951|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153997952|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153997989|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997990|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998026|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
153998027|NCT02832726|Vitamins|vitamins|mesh-ancestor
153998028|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
153998029|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998030|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
153998031|NCT02832726|Hematinics|hematinics|mesh-ancestor
153998099|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153998100|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153998101|NCT02832336|Caffeine|caffeine|mesh-list
153998102|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
153998103|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998104|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153998213|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998215|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153998216|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998217|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
153998218|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998219|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153998220|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
153998221|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153998222|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
153998223|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153998224|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153998225|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998226|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153998227|NCT00891462|Bromides|bromides|mesh-list
153998228|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
153998229|NCT04248348|Heparin|heparin|mesh-list
153998230|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153998231|NCT04248348|Tinzaparin|tinzaparin|mesh-list
153998232|NCT04248348|Dalteparin|dalteparin|mesh-list
153998233|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
153998234|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153998235|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153998236|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998237|NCT04245774|Bupivacaine|bupivacaine|mesh-list
153998238|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
153998239|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
153998240|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
153998301|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
153998302|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998303|NCT02843984|Lactoferrin|lactoferrin|mesh-list
153998304|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998305|NCT02840708|Sargramostim|sargramostim|mesh-list
153998306|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
153998307|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998308|NCT00817076|Desloratadine|desloratadine|mesh-list
153998309|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153998310|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
153998311|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998312|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998313|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998314|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153998315|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153998316|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
153998317|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
153998318|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
153998319|NCT02844062|Fludarabine|fludarabine|mesh-list
154860941|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998320|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998321|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
153570400|NCT01693419|Gemcitabine|gemcitabine|mesh-list
153998332|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998333|NCT02830230|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153998334|NCT02830230|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153998335|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153998336|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153998337|NCT00888654|Protective Agents|protective agents|mesh-ancestor
153998338|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998339|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998340|NCT03238430|Morphine|morphine|mesh-list
153998341|NCT03238430|Ropivacaine|ropivacaine|mesh-list
153998342|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153998343|NCT03238430|Narcotics|narcotics|mesh-ancestor
153998344|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998345|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998346|NCT03238430|Analgesics|analgesics|mesh-ancestor
153998347|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
153998348|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998349|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
153998350|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
153998351|NCT02829840|Azacitidine|azacitidine|mesh-list
153998352|NCT02829840|Ponatinib|ponatinib|mesh-list
153998353|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998354|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
153998355|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998357|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998358|NCT02829840|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153998359|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153998360|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153998361|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153998362|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998363|NCT02827890|Incretins|incretins|mesh-ancestor
153998364|NCT02827890|Hormones|hormones|mesh-ancestor
153998365|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998366|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153998367|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
153998368|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998369|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998370|NCT04250792|Naltrexone|naltrexone|mesh-list
153998371|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153998372|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153998373|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998374|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
153998375|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998376|NCT02840162|Celecoxib|celecoxib|mesh-list
153998377|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153998378|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998379|NCT02840162|Analgesics|analgesics|mesh-ancestor
153998380|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
153998381|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998382|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998383|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998384|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998385|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153998386|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153998387|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998409|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153998410|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
153998411|NCT02829372|Antibodies|antibodies|mesh-list
153998412|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153998413|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153998414|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
153998415|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998416|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
153998417|NCT00899678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153998418|NCT00899678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998419|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998420|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
153998421|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998422|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998423|NCT00887484|Clindamycin|clindamycin|mesh-list
153998424|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
153998425|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
153998426|NCT00887484|Adapalene|adapalene|mesh-list
153998427|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153998428|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153998429|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998430|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153998431|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998432|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998433|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
153998434|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153998435|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998437|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
153998438|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998439|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998559|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
153998560|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998561|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153998562|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998563|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
153998564|NCT05018520|Hormones|hormones|mesh-ancestor
153998565|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998566|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153998567|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153998568|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
153998569|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
153998570|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
153998571|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153998572|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153998573|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153998574|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998606|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998607|NCT04243434|Prednisone|prednisone|mesh-list
153998608|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
153998609|NCT04243434|Doxorubicin|doxorubicin|mesh-list
153998610|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153998611|NCT04243434|Vincristine|vincristine|mesh-list
153998612|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998613|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
153998614|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998615|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998781|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998783|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998784|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153998785|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
153998786|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
153998787|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
153998788|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998789|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
153998790|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153998791|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
153998792|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153998793|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998794|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998795|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998796|NCT00839605|Analgesics|analgesics|mesh-ancestor
153998797|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
153998798|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998799|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153998800|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153998801|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153998802|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
153998803|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998895|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
153998896|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998897|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
153998929|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153998930|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
153998931|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998932|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153998933|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153998934|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998935|NCT00834457|Ritonavir|ritonavir|mesh-list
153998936|NCT00834457|Lopinavir|lopinavir|mesh-list
153998937|NCT00834457|Zidovudine|zidovudine|mesh-list
153998938|NCT00834457|Lamivudine|lamivudine|mesh-list
153998939|NCT00834457|Abacavir|abacavir|mesh-list
153998940|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
153998941|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154151456|NCT00439270|Docetaxel|docetaxel|mesh-list
153998942|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153998943|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
153998974|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153998975|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153998976|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998977|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998978|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153998979|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
153998980|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998981|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998982|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153998983|NCT00705471|Infliximab|infliximab|mesh-list
153998984|NCT00705471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153998985|NCT00705471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998986|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
153998987|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153756852|NCT00555100|Hormones|hormones|mesh-ancestor
153999273|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153999274|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153999275|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153999276|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
153999277|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999278|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
153999279|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153999280|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153999281|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
153999282|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153999284|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999285|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
153999286|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999287|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999288|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
153999320|NCT00961571|Growth Substances|growth substances|mesh-ancestor
153999321|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999322|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
153999323|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153999324|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999325|NCT02820948|Vitamins|vitamins|mesh-list
153999326|NCT02820948|Vitamin E|vitamin e|mesh-list
153999327|NCT02820948|Tocopherols|tocopherols|mesh-list
153999328|NCT02820948|Tocotrienols|tocotrienols|mesh-list
153999329|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
153999330|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
153999346|NCT02860949|Narcotics|narcotics|mesh-ancestor
153999347|NCT02860949|Analgesics|analgesics|mesh-ancestor
153999348|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153999349|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153999350|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
153999351|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999352|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999353|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153999354|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153999355|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
153999356|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153388117|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
153388209|NCT00001929|Eliprodil|eliprodil|mesh-list
153388422|NCT02294058|Ozanimod|ozanimod|mesh-list
153389022|NCT00002169|Nelfinavir|nelfinavir|mesh-list
153389338|NCT00002229|Saquinavir|saquinavir|mesh-list
153389482|NCT00002253|Octreotide|octreotide|mesh-list
153389715|NCT04826237|Dexamethasone|dexamethasone|mesh-list
153390250|NCT05690646|Ritonavir|ritonavir|mesh-list
153390773|NCT00606138|Ranibizumab|ranibizumab|mesh-list
153391146|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
153391233|NCT01634191|Apremilast|apremilast|mesh-list
153391307|NCT05447507|Analgesics|analgesics|mesh-ancestor
153391372|NCT00382239|Incretins|incretins|mesh-ancestor
153391523|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
153391759|NCT01940276|Prednisone|prednisone|mesh-list
153391978|NCT04713189|Fentanyl|fentanyl|mesh-list
153392119|NCT01928186|Alovudine|alovudine|mesh-list
153999357|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
153999358|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
153999359|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
153999360|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153999361|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153999362|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153999363|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999364|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999365|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153999366|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999367|NCT00964223|Clindamycin|clindamycin|mesh-list
153999368|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
153999369|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
153999370|NCT00964223|Adapalene|adapalene|mesh-list
153999371|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
153999372|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153999373|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153999374|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999375|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153999376|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860942|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999377|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999378|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999379|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153999380|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153999381|NCT00964223|Analgesics|analgesics|mesh-ancestor
153999382|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
153999383|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999384|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999385|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999386|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999387|NCT00620815|Vaccines|vaccines|mesh-list
153999388|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
153999389|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
153999390|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999391|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153999392|NCT04238988|Paclitaxel|paclitaxel|mesh-list
153999420|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999421|NCT04238832|Nicotine|nicotine|mesh-list
153999422|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153999423|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
153757005|NCT00203658|Tinzaparin|tinzaparin|mesh-list
153999424|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999425|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999426|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153999427|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153999428|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
153999429|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999430|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999432|NCT04622904|Ketamine|ketamine|mesh-list
153999433|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999434|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
153999435|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999436|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999437|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
153999438|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571512|NCT03984890|Vitamin D|vitamin d|mesh-list
153999470|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999581|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153999582|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999584|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153999585|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
153999586|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153999587|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999588|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153999589|NCT04205136|Diuretics|diuretics|mesh-ancestor
153999590|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
153999591|NCT02815332|Minocycline|minocycline|mesh-list
153999592|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153999593|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999594|NCT02811354|Osimertinib|osimertinib|mesh-list
153999595|NCT02811354|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153999596|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153999597|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999598|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999599|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999600|NCT02810808|Ranibizumab|ranibizumab|mesh-list
153999601|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153999602|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153999603|NCT02810808|Growth Substances|growth substances|mesh-ancestor
153999604|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999605|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
153999730|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153999731|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153999732|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999733|NCT02809404|Everolimus|everolimus|mesh-list
153999734|NCT02809404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153999735|NCT02809404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153999736|NCT02809404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999832|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999834|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
153999835|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
153999836|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
153571916|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153999873|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
153999874|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860943|NCT03490942|Incretins|incretins|mesh-ancestor
153999875|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153999876|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
153999877|NCT00852709|Clofarabine|clofarabine|mesh-list
153999878|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153999879|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
153999880|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999881|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999882|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153571958|NCT04500574|Latanoprost|latanoprost|mesh-list
153999938|NCT00852787|Digoxin|digoxin|mesh-list
153999939|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153999940|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153999941|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999942|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999943|NCT00852787|Protective Agents|protective agents|mesh-ancestor
153999944|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999945|NCT02545465|Riociguat|riociguat|mesh-list
153999946|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
153999947|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999948|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
153999949|NCT00961259|Fenofibrate|fenofibrate|mesh-list
153999950|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153999951|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153999952|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
153999953|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572025|NCT03924401|Abatacept|abatacept|mesh-list
153999978|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153999980|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
153999981|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
153999982|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999983|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999984|NCT02807610|Propofol|propofol|mesh-list
153999985|NCT02807610|Etomidate|etomidate|mesh-list
153999986|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999987|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999988|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999989|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153999990|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
153999991|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
153999992|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
153999993|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
153999994|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153999995|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
153999996|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153999997|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153999998|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999999|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154000000|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000001|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000002|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154000028|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154000029|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154000030|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154000031|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154000032|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000033|NCT00924079|Nalbuphine|nalbuphine|mesh-list
154000034|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154000035|NCT00924079|Narcotics|narcotics|mesh-ancestor
154000036|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000037|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000038|NCT00924079|Analgesics|analgesics|mesh-ancestor
154000039|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
154000040|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000041|NCT00817479|Dexamethasone|dexamethasone|mesh-list
154000042|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000043|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
154000044|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
154000045|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000046|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000047|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154000048|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
154000049|NCT00817479|Hormones|hormones|mesh-ancestor
154000050|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000079|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154000080|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
154000081|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
154000082|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
154000083|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154000084|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
154000085|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
154000086|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000087|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
154000088|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154000089|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154000090|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154000091|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154000092|NCT04041427|Albendazole|albendazole|mesh-list
154000093|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
154000094|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154000095|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000096|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
154000097|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154000153|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000154|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000156|NCT00853879|Folic Acid|folic acid|mesh-list
154000157|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
154000158|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
154000159|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
154000160|NCT00853879|Pyridoxal|pyridoxal|mesh-list
154000161|NCT00853879|Pyridoxine|pyridoxine|mesh-list
154000162|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
154000163|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
154000164|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000165|NCT00853879|Hematinics|hematinics|mesh-ancestor
154000166|NCT00815919|Prednisone|prednisone|mesh-list
154000167|NCT00815919|Bortezomib|bortezomib|mesh-list
154000168|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000169|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
154000170|NCT00815919|Hormones|hormones|mesh-ancestor
154000171|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000172|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000173|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154000174|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000175|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154000176|NCT02545153|Aprotinin|aprotinin|mesh-list
154000177|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
154000178|NCT02545153|Coagulants|coagulants|mesh-ancestor
154000179|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154000180|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154000181|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
154000182|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000183|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000184|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154000236|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
154000238|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154000239|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154000240|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154000241|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000242|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
154000243|NCT02858297|Hormones|hormones|mesh-ancestor
154000244|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399255|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
154000245|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000246|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154000247|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
154000248|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000249|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000250|NCT00858325|Daptomycin|daptomycin|mesh-list
154000251|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154000252|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000253|NCT02804490|Vitamin A|vitamin a|mesh-list
154000254|NCT02804490|Beta Carotene|beta carotene|mesh-list
154000255|NCT02804490|Provitamins|provitamins|mesh-list
154000256|NCT02804490|Carotenoids|carotenoids|mesh-list
154000257|NCT02804490|Vitamins|vitamins|mesh-ancestor
154000258|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
153572320|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
154000284|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
154000285|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000286|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000287|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154000288|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154000289|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
154000290|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000291|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
154000292|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000293|NCT02800590|Abp-700|abp-700|mesh-list
154000294|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154000295|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
154000296|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
154000297|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000298|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000299|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000300|NCT00815295|Cetuximab|cetuximab|mesh-list
154000301|NCT00815295|Sorafenib|sorafenib|mesh-list
154000302|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154000303|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000304|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154000305|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000306|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000307|NCT00630383|Histamine|histamine|mesh-list
154000308|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
154000309|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
154000424|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
154000425|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000426|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154000427|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154000428|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
154000429|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000430|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154000431|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154000432|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154000433|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154000468|NCT05980260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000469|NCT05980156|Hydroxychloroquine|hydroxychloroquine|mesh-list
154000470|NCT05980156|Chloroquine|chloroquine|mesh-list
154000471|NCT05980156|Pyrimethamine|pyrimethamine|mesh-list
154000472|NCT05980156|Piperaquine|piperaquine|mesh-list
154000473|NCT05980156|Sulfadoxine|sulfadoxine|mesh-list
154000474|NCT05980156|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154000475|NCT05980156|Artenimol|artenimol|mesh-list
154000563|NCT05978609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000564|NCT05978609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154000565|NCT05978609|Antimetabolites|antimetabolites|mesh-ancestor
154000566|NCT05978609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000568|NCT05978505|Antidepressive Agents|antidepressive agents|mesh-ancestor
154000569|NCT05978505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154000570|NCT05978505|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154000571|NCT05978505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154000572|NCT05978505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154000573|NCT05978505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000574|NCT05978505|Adrenergic Agents|adrenergic agents|mesh-ancestor
154000575|NCT05978505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000668|NCT05977868|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154000669|NCT05977868|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154000670|NCT05977868|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154000671|NCT05977868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154000672|NCT05977868|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154000673|NCT05977868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154000674|NCT05977868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154000675|NCT05977868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154000676|NCT05977868|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154000677|NCT05977868|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154000678|NCT05977868|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154000679|NCT05974241|Aripiprazole|aripiprazole|mesh-list
154000680|NCT05974241|Methylphenidate|methylphenidate|mesh-list
154000681|NCT05974241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154000682|NCT05974241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000683|NCT05974241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154000684|NCT05974241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154000685|NCT05974241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153572748|NCT03424122|Rituximab|rituximab|mesh-list
154000720|NCT05825430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000721|NCT05782270|Warfarin|warfarin|mesh-list
154000722|NCT05782270|Anticoagulants|anticoagulants|mesh-ancestor
154000723|NCT05780710|Antihypertensive Agents|antihypertensive agents|mesh-list
154000724|NCT05602519|Fentanyl|fentanyl|mesh-list
154000725|NCT05602519|Propofol|propofol|mesh-list
154000727|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153572795|NCT02203773|Decitabine|decitabine|mesh-list
154000757|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154000758|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000759|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154000760|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000761|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154000762|NCT05442060|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154000763|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154000764|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000765|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000766|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000767|NCT05406388|Fentanyl|fentanyl|mesh-list
153758351|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000768|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154000769|NCT05406388|Narcotics|narcotics|mesh-ancestor
154000770|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000807|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
154000808|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000809|NCT05074121|Expectorants|expectorants|mesh-ancestor
154000810|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
154000892|NCT04544995|Niraparib|niraparib|mesh-list
154000893|NCT04544995|Dostarlimab|dostarlimab|mesh-list
154000894|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154000895|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000896|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000897|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000898|NCT04479306|Osimertinib|osimertinib|mesh-list
154000899|NCT04479306|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154000900|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154000901|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000902|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001004|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
154001005|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
154001006|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001178|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
154001179|NCT00742859|Betrixaban|betrixaban|mesh-list
154001180|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
154001181|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154001182|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
154001183|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154001184|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001185|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573268|NCT02106195|Belumosudil|belumosudil|mesh-list
154001371|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153758939|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
154001373|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001374|NCT02798874|Clopidogrel|clopidogrel|mesh-list
154001376|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154001377|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154001378|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154001379|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154001380|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
154001381|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001382|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001383|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001384|NCT02799264|Cabotegravir|cabotegravir|mesh-list
154001385|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154001386|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153573456|NCT01187433|Vaccines|vaccines|mesh-list
154001423|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154001424|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154001425|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154001426|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
153399476|NCT02066792|Cycloserine|cycloserine|mesh-list
154001786|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
154001787|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001788|NCT00863863|Griseofulvin|griseofulvin|mesh-list
154001789|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
154001790|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001791|NCT03853044|Prednisone|prednisone|mesh-list
154001792|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
154001793|NCT03853044|Doxorubicin|doxorubicin|mesh-list
154001794|NCT03853044|Vincristine|vincristine|mesh-list
154001795|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154001796|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
154001797|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001798|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154001799|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154001800|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
154001801|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001802|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001803|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154002337|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
154002338|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
154002339|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154002340|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002341|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002342|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154002343|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154002344|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002345|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002346|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002347|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154002348|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
154002349|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154002350|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002351|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154002352|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154002353|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154002354|NCT02787798|Valsartan|valsartan|mesh-list
154002385|NCT04114500|Progesterone|progesterone|mesh-list
154002386|NCT04114500|Estrogens|estrogens|mesh-ancestor
154002388|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002389|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002390|NCT04114500|Progestins|progestins|mesh-ancestor
154002391|NCT05755659|Fosaprepitant|fosaprepitant|mesh-list
154002392|NCT05755659|Aprepitant|aprepitant|mesh-list
154002393|NCT05755659|Antiemetics|antiemetics|mesh-ancestor
154002394|NCT05755659|Autonomic Agents|autonomic agents|mesh-ancestor
154002395|NCT05755659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002549|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002550|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
154002551|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002552|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002553|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
154002555|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002556|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
154002557|NCT00873535|Varenicline|varenicline|mesh-list
154002558|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154002559|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154002587|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002588|NCT00953615|Thalidomide|thalidomide|mesh-list
154002589|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002590|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
154002591|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002592|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
154002593|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002594|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002595|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154002596|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154002597|NCT00953615|Growth Substances|growth substances|mesh-ancestor
154002598|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
154002599|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002600|NCT00873769|Loxapine|loxapine|mesh-list
154002601|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154002602|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154002603|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002604|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002605|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154002638|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154002639|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002640|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154002641|NCT02787018|Analgesics|analgesics|mesh-ancestor
154002642|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
154002643|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154002644|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154002645|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154002646|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
154002741|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
153574819|NCT01702207|Tacrolimus|tacrolimus|mesh-list
154255084|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002860|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154002862|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002863|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002864|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154002865|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154002866|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154002867|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154002868|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002869|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154002870|NCT00874861|Poly ICLC|poly iclc|mesh-list
154002871|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
154002872|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
154002873|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002874|NCT04038853|Vitamin D|vitamin d|mesh-list
154002875|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
154002876|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154002877|NCT04038853|Calcitriol|calcitriol|mesh-list
154002878|NCT04038853|Vitamins|vitamins|mesh-ancestor
154002879|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
154002880|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574938|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
154002949|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002950|NCT00923299|Trastuzumab|trastuzumab|mesh-list
154002952|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154002953|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002954|NCT05753397|Ropivacaine|ropivacaine|mesh-list
154002955|NCT05753397|Anesthetics, Local|anesthetics, local|mesh-ancestor
154002956|NCT05753397|Anesthetics|anesthetics|mesh-ancestor
154002957|NCT05753397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002958|NCT05753397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002959|NCT05753397|Sensory System Agents|sensory system agents|mesh-ancestor
154003047|NCT06166589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154003048|NCT06166589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154003049|NCT06166589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003050|NCT06166589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003051|NCT06165965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154003052|NCT06165965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003053|NCT06165965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154003054|NCT06165965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003055|NCT06165822|Itraconazole|itraconazole|mesh-list
154003056|NCT06165822|Rifampin|rifampin|mesh-list
154003057|NCT06165822|Antifungal Agents|antifungal agents|mesh-ancestor
154003058|NCT06165822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003112|NCT06076694|Rabeprazole|rabeprazole|mesh-list
154003113|NCT06076694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003114|NCT06076694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003115|NCT06076694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154003116|NCT06076694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154003117|NCT06076694|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154003118|NCT06076694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003119|NCT06076694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003120|NCT06027619|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154003121|NCT06027619|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154003122|NCT06027619|Dermatologic Agents|dermatologic agents|mesh-ancestor
154003123|NCT06000787|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154003124|NCT06000787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003125|NCT06000787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003126|NCT06000787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003127|NCT06000787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154003128|NCT05969730|Azathioprine|azathioprine|mesh-list
154003154|NCT05928689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154003155|NCT05928689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154003156|NCT05928689|Vasodilator Agents|vasodilator agents|mesh-ancestor
153781759|NCT00231764|Daclizumab|daclizumab|mesh-list
154003158|NCT05904912|Anesthetics, Local|anesthetics, local|mesh-ancestor
154003159|NCT05904912|Anesthetics|anesthetics|mesh-ancestor
154003160|NCT05904912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003161|NCT05904912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003162|NCT05904912|Sensory System Agents|sensory system agents|mesh-ancestor
154003163|NCT05904912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003165|NCT05882604|Protective Agents|protective agents|mesh-ancestor
154003166|NCT05882604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003168|NCT05860452|Anesthetics, Local|anesthetics, local|mesh-ancestor
154860944|NCT00376870|Pioglitazone|pioglitazone|mesh-list
154152045|NCT00946946|Analgesics|analgesics|mesh-ancestor
154003169|NCT05860452|Anesthetics|anesthetics|mesh-ancestor
154003170|NCT05860452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003171|NCT05860452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003172|NCT05860452|Sensory System Agents|sensory system agents|mesh-ancestor
154003173|NCT05860452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003174|NCT05832047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154003175|NCT05737628|Rituximab|rituximab|mesh-list
154003176|NCT05737628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003308|NCT05360277|Capecitabine|capecitabine|mesh-list
154003309|NCT05360277|Tislelizumab|tislelizumab|mesh-list
154003310|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003311|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
154003312|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003313|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003314|NCT05360277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003315|NCT05335122|Bimatoprost|bimatoprost|mesh-list
153575379|NCT01705743|Analgesics|analgesics|mesh-ancestor
154003392|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003393|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
154003394|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003395|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003396|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154003397|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
154003398|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003399|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003400|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154003401|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154003402|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
154003403|NCT05058404|Hormones|hormones|mesh-ancestor
154003404|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154003405|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154003406|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154003407|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
154003408|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
154003409|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
154003410|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154003411|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154003412|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154003413|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003414|NCT04983849|Metronidazole|metronidazole|mesh-list
154003415|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003416|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003417|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153575465|NCT01706510|Ticagrelor|ticagrelor|mesh-list
154004038|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154004039|NCT03289299|Dexamethasone|dexamethasone|mesh-list
154004040|NCT03289299|Lenalidomide|lenalidomide|mesh-list
154004041|NCT03289299|Daratumumab|daratumumab|mesh-list
154004042|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154004043|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
154004044|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
154004045|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004046|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004047|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004048|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
154004386|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004387|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004388|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154004389|NCT02785068|Leucovorin|leucovorin|mesh-list
154004390|NCT02785068|Fluorouracil|fluorouracil|mesh-list
154004391|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
154004392|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004393|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004394|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004395|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154004396|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
154004397|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004398|NCT02785068|Antidotes|antidotes|mesh-ancestor
154004971|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
154004972|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004973|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004974|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
154004975|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860945|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154004977|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154004978|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154004979|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004980|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004981|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154004982|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154004983|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154005811|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154005812|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005813|NCT00633386|Analgesics|analgesics|mesh-ancestor
154005814|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
154005815|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005816|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005817|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005818|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005819|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154005820|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154005821|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005822|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005823|NCT02771418|Anesthetics|anesthetics|mesh-list
154005824|NCT02771418|Propofol|propofol|mesh-list
154005825|NCT02771418|Sevoflurane|sevoflurane|mesh-list
154005826|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005827|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005828|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154005829|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154005830|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
154005831|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154005832|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154005833|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154005834|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
154005835|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154005836|NCT00888901|Prednisolone|prednisolone|mesh-list
154005837|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
154005838|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154005839|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
154005840|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005841|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
154005842|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
154005843|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005844|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005845|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154005846|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
154005847|NCT00888901|Hormones|hormones|mesh-ancestor
154005848|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005849|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154006307|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154006308|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154006309|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
154006310|NCT02765022|Hormones|hormones|mesh-ancestor
154006311|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006312|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006313|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006314|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006315|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154006316|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154006317|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154006318|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154006319|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006320|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763877|NCT06012760|Epoetin Alfa|epoetin alfa|mesh-list
154006321|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006322|NCT00607789|Analgesics|analgesics|mesh-ancestor
154006323|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
154006324|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006325|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
154006326|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154006327|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
154006328|NCT02761512|Lansoprazole|lansoprazole|mesh-list
154006329|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
154006330|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154006331|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154255086|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154006348|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006349|NCT00887822|Bevacizumab|bevacizumab|mesh-list
154006350|NCT00887822|Capecitabine|capecitabine|mesh-list
154006351|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154006352|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006353|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154006354|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154006355|NCT00887822|Growth Substances|growth substances|mesh-ancestor
154006356|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006357|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
154006358|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154006359|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
154006360|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006361|NCT02542111|Dexamethasone|dexamethasone|mesh-list
154006362|NCT02542111|Gemcitabine|gemcitabine|mesh-list
154006363|NCT02542111|Bortezomib|bortezomib|mesh-list
154006364|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006365|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006366|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
154006367|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
154006368|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006369|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006370|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006371|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
154006372|NCT02542111|Hormones|hormones|mesh-ancestor
154006373|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006374|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154006375|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154006376|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
154006377|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006378|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
154006379|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154006380|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006381|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006382|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154006383|NCT02768688|Analgesics|analgesics|mesh-ancestor
154006384|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
154006385|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006386|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154006387|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154006388|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154006401|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154006402|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154006403|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154006404|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006405|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
154006406|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154006407|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
154006408|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006409|NCT00893425|Ramipril|ramipril|mesh-list
154006410|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154006411|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006412|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006413|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006414|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154006415|NCT00951665|Paclitaxel|paclitaxel|mesh-list
154006416|NCT00951665|Maytansine|maytansine|mesh-list
154006417|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154006418|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154006419|NCT00951665|Trastuzumab|trastuzumab|mesh-list
154006420|NCT00951665|Pertuzumab|pertuzumab|mesh-list
154006421|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154006422|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006423|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
154006424|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
154006425|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
154006426|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006427|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154006428|NCT00951665|Immunotoxins|immunotoxins|mesh-ancestor
154006429|NCT00951665|Immunoconjugates|immunoconjugates|mesh-ancestor
154006430|NCT00951665|Immunologic Factors|immunologic factors|mesh-ancestor
154006431|NCT00951665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860946|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152274|NCT00949182|Doxorubicin|doxorubicin|mesh-list
154006432|NCT02769078|Warfarin|warfarin|mesh-list
153731571|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006433|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
154006434|NCT02769078|Dabigatran|dabigatran|mesh-list
154006435|NCT02769078|Apixaban|apixaban|mesh-list
154006436|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
154006437|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154006438|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
154006439|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154006440|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006441|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006442|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006443|NCT04036201|Bupivacaine|bupivacaine|mesh-list
154006444|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
154006445|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
154006446|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
154006447|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006448|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006449|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
154006450|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006462|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006463|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006464|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
154006465|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154006466|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006467|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006468|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154006469|NCT02768610|Analgesics|analgesics|mesh-ancestor
154006470|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
154006471|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006472|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154006473|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154006474|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154006475|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
154006476|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006477|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006478|NCT02764710|Amoxicillin|amoxicillin|mesh-list
154006479|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
154006480|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
154006481|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154006482|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154006483|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006484|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154006485|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006486|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006488|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
154006489|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006490|NCT02541019|Ondansetron|ondansetron|mesh-list
154006491|NCT02541019|Palonosetron|palonosetron|mesh-list
154006492|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
154006493|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
154006494|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006495|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006496|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006497|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
154006498|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
154006499|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154006500|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154006501|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
154006502|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006503|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006504|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154006505|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
154006506|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154006507|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154006508|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154006509|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006510|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006511|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
154006512|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006513|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154006523|NCT02768376|Fentanyl|fentanyl|mesh-list
154006524|NCT02768376|Bupivacaine|bupivacaine|mesh-list
154006525|NCT02768376|Anesthetics|anesthetics|mesh-list
154006526|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
154860947|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
154006527|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006528|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006529|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
154006530|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006531|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154006532|NCT02768376|Narcotics|narcotics|mesh-ancestor
154006533|NCT02768376|Analgesics|analgesics|mesh-ancestor
154006534|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154006535|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154006536|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
154006537|NCT02696460|Lidocaine|lidocaine|mesh-list
154006538|NCT02696460|Prilocaine|prilocaine|mesh-list
154006539|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154006540|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
154006541|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
154006542|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006543|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006544|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
154006545|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006547|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154006548|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154006549|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154006550|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006551|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154006552|NCT00888043|Bevacizumab|bevacizumab|mesh-list
154006553|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154006554|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006555|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154006556|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154006557|NCT00888043|Growth Substances|growth substances|mesh-ancestor
154006558|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006559|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
154006560|NCT02768220|Empagliflozin|empagliflozin|mesh-list
154006561|NCT02768220|Linagliptin|linagliptin|mesh-list
154006562|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154006563|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006564|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154006565|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006566|NCT02768220|Incretins|incretins|mesh-ancestor
154006567|NCT02768220|Hormones|hormones|mesh-ancestor
154006568|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006569|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154006570|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006571|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006572|NCT02760888|Diclofenac|diclofenac|mesh-list
154006573|NCT02760888|Tramadol|tramadol|mesh-list
154006574|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154006575|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154006576|NCT02760888|Analgesics|analgesics|mesh-ancestor
154006577|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
154006578|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578616|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154006587|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006588|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
154006589|NCT00799617|Testosterone|testosterone|mesh-list
154006590|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
154006591|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
154006592|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153400145|NCT02059213|Palbociclib|palbociclib|mesh-list
154006593|NCT00799617|Androgens|androgens|mesh-ancestor
154006594|NCT00799617|Hormones|hormones|mesh-ancestor
154006595|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006596|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006597|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154006598|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006599|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
154006600|NCT00607087|Insulin|insulin|mesh-list
154006601|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154006602|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
154006603|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
154006604|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
154006605|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154006606|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006607|NCT00610363|Rilonacept|rilonacept|mesh-list
154006608|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006609|NCT00887588|Valsartan|valsartan|mesh-list
154860948|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
154006610|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154006611|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154006612|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154006613|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154006614|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006615|NCT00799383|Vitamin D|vitamin d|mesh-list
154006616|NCT00799383|Calcium|calcium|mesh-list
154006617|NCT00799383|Vitamins|vitamins|mesh-ancestor
154006618|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
154006619|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006620|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154006621|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154006622|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
154006623|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006624|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006625|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
154006626|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006627|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006628|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
154006629|NCT04114149|Narcotics|narcotics|mesh-ancestor
154006630|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006631|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006632|NCT04114149|Analgesics|analgesics|mesh-ancestor
154006633|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
154006634|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006635|NCT00891397|Pregabalin|pregabalin|mesh-list
154006636|NCT00891397|Analgesics|analgesics|mesh-ancestor
154006637|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
154006638|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006639|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006640|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
154006641|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154006642|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154006643|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006644|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154006672|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154006673|NCT00891475|Interferons|interferons|mesh-list
154006674|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
154006676|NCT00891475|Maleic acid|maleic acid|mesh-list
154006677|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006678|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
154006679|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006680|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
154006681|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006682|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154006683|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154006684|NCT00891475|Growth Substances|growth substances|mesh-ancestor
154006685|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
154006686|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154006687|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006688|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006689|NCT00887432|Vitamin D|vitamin d|mesh-list
154006690|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
154006691|NCT00887432|Vitamins|vitamins|mesh-ancestor
154006692|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
154006693|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006694|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154006695|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154006696|NCT04222686|Losartan|losartan|mesh-list
154006697|NCT04222686|Perindopril|perindopril|mesh-list
154006698|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154006705|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006706|NCT04113915|Cyclosporine|cyclosporine|mesh-list
154006707|NCT04113915|Dexamethasone|dexamethasone|mesh-list
153781760|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006708|NCT04113915|Cyclosporins|cyclosporins|mesh-list
154006709|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006710|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
154006711|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
154006712|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006713|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006714|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006715|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
154006716|NCT04113915|Hormones|hormones|mesh-ancestor
154006717|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006718|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154255087|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154006719|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006720|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006721|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006722|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
154006723|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154006724|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006725|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
154006726|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006727|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
154006728|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154006729|NCT02758470|Acetazolamide|acetazolamide|mesh-list
154006730|NCT02758470|Methazolamide|methazolamide|mesh-list
154006731|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
154006732|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154006733|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006734|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006735|NCT02758470|Diuretics|diuretics|mesh-ancestor
154006736|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
154006737|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006738|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
154006739|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154006740|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154006741|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006742|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
154006743|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
154006744|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
154006745|NCT02764008|Bupivacaine|bupivacaine|mesh-list
154006746|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
154006747|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
154006748|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006749|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006750|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
154006751|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006752|NCT00798603|Bevacizumab|bevacizumab|mesh-list
154006753|NCT00798603|Carboplatin|carboplatin|mesh-list
154006754|NCT00798603|Pemetrexed|pemetrexed|mesh-list
154006755|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154006756|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006757|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154006758|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154006759|NCT00798603|Growth Substances|growth substances|mesh-ancestor
154006760|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006761|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
154006762|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006763|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006764|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154006765|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154006766|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
154006810|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006812|NCT00945815|Clofarabine|clofarabine|mesh-list
154006813|NCT00945815|Epratuzumab|epratuzumab|mesh-list
154006814|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154006815|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
154006816|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006817|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006818|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
154006819|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006820|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006821|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
154006822|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006823|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154006824|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154006825|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154006826|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006827|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006828|NCT00798369|Triamcinolone|triamcinolone|mesh-list
154006829|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154006830|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154006831|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154006832|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154006833|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006834|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
154006835|NCT00798369|Hormones|hormones|mesh-ancestor
153626793|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153400366|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
154860949|NCT03256162|Midazolam|midazolam|mesh-list
154860950|NCT03256162|Ketamine|ketamine|mesh-list
154006836|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006837|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006838|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006839|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
154006840|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006841|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006842|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
154006843|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154006844|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006845|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
154006846|NCT02760342|Metformin|metformin|mesh-list
154006847|NCT02760342|Peficitinib|peficitinib|mesh-list
154006848|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154006849|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006850|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006851|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006852|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006853|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
154006854|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154006855|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
154006856|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154006857|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154006858|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154006859|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006860|NCT00894283|Enoxaparin|enoxaparin|mesh-list
154006861|NCT00894283|PENTA|penta|mesh-list
154006862|NCT00894283|Fondaparinux|fondaparinux|mesh-list
154006863|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
154006864|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154006865|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154006866|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006867|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154006891|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006893|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006894|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006895|NCT00895687|Bortezomib|bortezomib|mesh-list
154006896|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154006897|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006898|NCT00895687|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154006899|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154006900|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006901|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006902|NCT02762838|Folic Acid|folic acid|mesh-list
154006903|NCT02762838|Infliximab|infliximab|mesh-list
154006904|NCT02762838|Methotrexate|methotrexate|mesh-list
154006905|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154006906|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
154006907|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154006908|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006909|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154006910|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
154006911|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006912|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006913|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154006914|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006915|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154006916|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006917|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
154006918|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154006946|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154006947|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
154006948|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006949|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154006950|NCT02757534|Domperidone|domperidone|mesh-list
154006951|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
154006952|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
154006953|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006954|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006955|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006956|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154006957|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
154006958|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006959|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006960|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154006961|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154006962|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
153781761|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
154006963|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006964|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006965|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154006966|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
154006967|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154006968|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154006985|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154006986|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006987|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006988|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
154006989|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154006990|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
154006991|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006992|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006993|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154006994|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
154006995|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
154006996|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154006997|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
154006998|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006999|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007000|NCT00608881|Ubiquinone|ubiquinone|mesh-list
154007001|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
154007002|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
154007003|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007004|NCT00608881|Vitamins|vitamins|mesh-ancestor
154007005|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
154007006|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154007007|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007008|NCT04221906|Betamethasone|betamethasone|mesh-list
154007009|NCT04221906|Calcipotriene|calcipotriene|mesh-list
154007010|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154007011|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007012|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
154007013|NCT04221906|Hormones|hormones|mesh-ancestor
154007014|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154007015|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007016|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154007017|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
154007018|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
154007019|NCT00945191|Paclitaxel|paclitaxel|mesh-list
154007020|NCT00945191|Carboplatin|carboplatin|mesh-list
154007021|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154007022|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007023|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
154007024|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
154007025|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
154007026|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007027|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
154007028|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
154007039|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154007040|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154007042|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
154007043|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007044|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007045|NCT02757066|Melatonin|melatonin|mesh-list
154007046|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
154007047|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007048|NCT02757066|Protective Agents|protective agents|mesh-ancestor
154007049|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007050|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007051|NCT00894673|Heparin|heparin|mesh-list
154007052|NCT00894673|Calcium heparin|calcium heparin|mesh-list
154007053|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
154007054|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154007055|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154007056|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007057|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154007058|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154007059|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154007060|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007061|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007062|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154007063|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154007064|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154007065|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
154007066|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007067|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007068|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154007069|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154007070|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
154007072|NCT02752308|Epinephrine|epinephrine|mesh-list
154007073|NCT02752308|Fentanyl|fentanyl|mesh-list
154007074|NCT02752308|Bupivacaine|bupivacaine|mesh-list
154007075|NCT02752308|Neostigmine|neostigmine|mesh-list
154007076|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
154007077|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
154007078|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007079|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007080|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
154007081|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007082|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154007083|NCT02752308|Narcotics|narcotics|mesh-ancestor
154007084|NCT02752308|Analgesics|analgesics|mesh-ancestor
154007085|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154007086|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154007087|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
154007088|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154007089|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154007090|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
154007091|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007092|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007093|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154007103|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154007104|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154007105|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
154007106|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154007107|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007108|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154007109|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
154007111|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154007112|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007113|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007114|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154007115|NCT00894751|Analgesics|analgesics|mesh-ancestor
154007116|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
154007117|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007118|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154007119|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154007120|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154007121|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
154007122|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007123|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007124|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154007125|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
154007126|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
154007127|NCT00896077|Lisofylline|lisofylline|mesh-list
154007128|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154007129|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
154007130|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007131|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154007132|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154007133|NCT00896077|Analgesics|analgesics|mesh-ancestor
154007134|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
154007135|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007136|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007137|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007138|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007139|NCT00792909|Vaccines|vaccines|mesh-list
154007140|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154007141|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
154007142|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007143|NCT00896155|Tamoxifen|tamoxifen|mesh-list
154007144|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154007145|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
154007146|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154007147|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007148|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154007149|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764741|NCT04614311|Hormones|hormones|mesh-ancestor
154007150|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154007151|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154007152|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154007154|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
154007155|NCT02751996|Tenofovir|tenofovir|mesh-list
154007156|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
154007157|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007158|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154007159|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154007174|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
154007175|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007176|NCT02751918|Doxorubicin|doxorubicin|mesh-list
154007177|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154007178|NCT02751918|Maytansine|maytansine|mesh-list
154007179|NCT02751918|Anetumab ravtansine|anetumab ravtansine|mesh-list
154007180|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154007181|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007182|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154007183|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154007184|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007185|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007186|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154007187|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
154007188|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
154007189|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
154007190|NCT02751918|Immunoconjugates|immunoconjugates|mesh-ancestor
154007191|NCT02751918|Immunologic Factors|immunologic factors|mesh-ancestor
154007192|NCT02751918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007193|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
154007194|NCT00901069|Rituximab|rituximab|mesh-list
154007195|NCT00901069|Vincristine|vincristine|mesh-list
154007196|NCT00901069|Azacitidine|azacitidine|mesh-list
154007197|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007198|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
154007199|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007200|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007201|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154007202|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
154007203|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007204|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007205|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154007206|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154007207|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154007208|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
154007209|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
154007210|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
154007211|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007212|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
154007213|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007214|NCT02853539|Denosumab|denosumab|mesh-list
154007215|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154007216|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007217|NCT02751840|Caffeine|caffeine|mesh-list
154007218|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154007219|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007220|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154007221|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579256|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
154007232|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007233|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154007235|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007236|NCT00606229|Aripiprazole|aripiprazole|mesh-list
154007237|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
154007238|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154007239|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154007240|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154007241|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007242|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007243|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
154007244|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
154007245|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860951|NCT03256162|Analgesics|analgesics|mesh-ancestor
154007246|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007247|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154007248|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154007249|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
154007250|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154007251|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154007252|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154007253|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154007254|NCT02756598|Sufentanil|sufentanil|mesh-list
154007255|NCT02756598|Dsuvia|dsuvia|mesh-list
154007256|NCT02756598|Propofol|propofol|mesh-list
154007257|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154007258|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007259|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007260|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154007261|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
154007262|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
154007263|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154007264|NCT02756598|Narcotics|narcotics|mesh-ancestor
154007265|NCT02756598|Analgesics|analgesics|mesh-ancestor
154007266|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
154007267|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007268|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154007269|NCT00950651|Tramadol|tramadol|mesh-list
154007270|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154007271|NCT00950651|Narcotics|narcotics|mesh-ancestor
154007272|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007273|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007274|NCT00950651|Analgesics|analgesics|mesh-ancestor
154007275|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
154007276|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007277|NCT00901147|Bortezomib|bortezomib|mesh-list
154007278|NCT00901147|Panobinostat|panobinostat|mesh-list
154007279|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007280|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154007281|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007282|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007283|NCT04268537|Antibodies|antibodies|mesh-list
154007284|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
154007285|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
153579319|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154007304|NCT00631085|Tocotrienols|tocotrienols|mesh-list
154007305|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
154007306|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
154007307|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
154007308|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007309|NCT00631085|Protective Agents|protective agents|mesh-ancestor
154007310|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007311|NCT00631085|Vitamins|vitamins|mesh-ancestor
154007312|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
154007313|NCT04269863|Aspirin|aspirin|mesh-list
154007314|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154007315|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154007316|NCT04269863|Analgesics|analgesics|mesh-ancestor
154007317|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
154007318|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007319|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007320|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007321|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007322|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154007323|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154007324|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007325|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154007326|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154007327|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007328|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
154007329|NCT00901381|Lenograstim|lenograstim|mesh-list
154007330|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154007331|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
154007332|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007333|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
154007334|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
154007335|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154007336|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007337|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007338|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
154007339|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154255088|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
154152939|NCT00746447|Analgesics|analgesics|mesh-ancestor
154007340|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007341|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007343|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
154007344|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007345|NCT00901537|Azacitidine|azacitidine|mesh-list
154007346|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007358|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154007359|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007360|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
154007361|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007362|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007363|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154007364|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007365|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
154007366|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154007367|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154007368|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007369|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
154007370|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007371|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007372|NCT02751294|Tafenoquine|tafenoquine|mesh-list
154007373|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
154007374|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154007375|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154007376|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007377|NCT00901615|Lenalidomide|lenalidomide|mesh-list
154007378|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
154007379|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007380|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154007381|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154007382|NCT00901615|Growth Substances|growth substances|mesh-ancestor
154007383|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
154007384|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007386|NCT00949325|Doxorubicin|doxorubicin|mesh-list
154007387|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154007388|NCT00949325|Temsirolimus|temsirolimus|mesh-list
154007389|NCT00949325|MTOR Inhibitors|mtor inhibitors|mesh-list
154007390|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154007391|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007392|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154007393|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154007394|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007395|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007396|NCT00949325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154007397|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007398|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
154007399|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007400|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154007401|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007402|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
154007403|NCT02853071|Estramustine|estramustine|mesh-list
154007404|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154007405|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
154007406|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007407|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007408|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154007409|NCT02603757|Vitamin D|vitamin d|mesh-list
154007410|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
154007419|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154007421|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
154007422|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007423|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007424|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007425|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007426|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154007427|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154007428|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007429|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007430|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154007431|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154860952|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
154007432|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
154007434|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154007435|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154007436|NCT00895297|Dasatinib|dasatinib|mesh-list
154007437|NCT00895297|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154007438|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154007439|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007440|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007441|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007442|NCT00943319|Fludarabine|fludarabine|mesh-list
154007443|NCT00943319|Busulfan|busulfan|mesh-list
154007444|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
154007445|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007446|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007447|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007448|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
154007449|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007450|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
154007451|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154007452|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154007453|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154007454|NCT02603991|Levetiracetam|levetiracetam|mesh-list
154007455|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
154007456|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
154007457|NCT02540785|Levofloxacin|levofloxacin|mesh-list
154007458|NCT02540785|Ofloxacin|ofloxacin|mesh-list
154007459|NCT02540785|Tobramycin|tobramycin|mesh-list
154007460|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154007461|NCT02540785|Dexamethasone|dexamethasone|mesh-list
154007462|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
154007463|NCT02540785|BB 1101|bb 1101|mesh-list
154007464|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
154007465|NCT02540785|Dipivefrin|dipivefrin|mesh-list
154007466|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007467|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
154007468|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
154007469|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007470|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007471|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154007472|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
154007473|NCT02540785|Hormones|hormones|mesh-ancestor
154007474|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154007475|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154007476|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007477|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
154007478|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007479|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007488|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
154007489|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
154007490|NCT02540785|Protective Agents|protective agents|mesh-ancestor
153661246|NCT00080275|Niacin|niacin|mesh-list
154007491|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154007492|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
154007493|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007494|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154007495|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154007496|NCT04243278|Aspirin|aspirin|mesh-list
154007497|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154007498|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154007499|NCT04243278|Analgesics|analgesics|mesh-ancestor
154007500|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
154007501|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007502|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007503|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007504|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007505|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154007506|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154007507|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007508|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154007509|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154007510|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007511|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
154007512|NCT00915369|Paclitaxel|paclitaxel|mesh-list
154007513|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154007514|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007515|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
154007516|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
154007517|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
154007518|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007519|NCT00901849|Sirolimus|sirolimus|mesh-list
154007520|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154007521|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154007522|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007523|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154007524|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007525|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
154007526|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007527|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
154007528|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007529|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154007530|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007531|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007532|NCT00901849|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154007533|NCT04268927|Letrozole|letrozole|mesh-list
154007534|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
154007535|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154007536|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007537|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154007538|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154007539|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007540|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007541|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154007542|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
154007566|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007567|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
154007568|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
154007569|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
154007570|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007571|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154007572|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154007573|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154007574|NCT02754882|Growth Substances|growth substances|mesh-ancestor
154007575|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007576|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
154007577|NCT00790569|Nicotine|nicotine|mesh-list
154007578|NCT00790569|Varenicline|varenicline|mesh-list
154007579|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154007580|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
154007581|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007582|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007583|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154007584|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154007585|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
154007586|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007587|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007588|NCT00939029|Nicotine|nicotine|mesh-list
154007589|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154007590|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
154007591|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007592|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007593|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154007611|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
154007612|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154007613|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007614|NCT02754960|Thalidomide|thalidomide|mesh-list
154007615|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007616|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
154007617|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007618|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
154007619|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154007620|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007621|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154007622|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154007623|NCT02754960|Growth Substances|growth substances|mesh-ancestor
154007624|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
154007625|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007626|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
154007627|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154007628|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007629|NCT02540239|Simethicone|simethicone|mesh-list
154007630|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
154007631|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007632|NCT02540239|Emollients|emollients|mesh-ancestor
154007633|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
154007634|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
154007635|NCT02540395|Prednisolone|prednisolone|mesh-list
154007636|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154007637|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
154007638|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154007639|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
154007640|NCT02540395|Tacrolimus|tacrolimus|mesh-list
154007641|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154007642|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
154007643|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007644|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
154007645|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007646|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154007647|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007648|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007649|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154007650|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579693|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007660|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
154007661|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
154007662|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007663|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154007664|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154007665|NCT02540395|Protective Agents|protective agents|mesh-ancestor
154007666|NCT04547166|Bevacizumab|bevacizumab|mesh-list
154007667|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154007668|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007669|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154007670|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154007671|NCT04547166|Growth Substances|growth substances|mesh-ancestor
154007672|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007673|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
154007674|NCT00602693|Sirolimus|sirolimus|mesh-list
154007675|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
154007676|NCT00602693|Fludarabine|fludarabine|mesh-list
154007677|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
154007679|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007680|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
154007681|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007682|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007683|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154007684|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
154007685|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007686|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007687|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154007688|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007689|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
154007690|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154007691|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007692|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154007693|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
154007694|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007695|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
154007696|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154007697|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
154007698|NCT00602693|Protective Agents|protective agents|mesh-ancestor
154007699|NCT00902395|Midazolam|midazolam|mesh-list
154007700|NCT00902395|Ketamine|ketamine|mesh-list
154007701|NCT00902395|Analgesics|analgesics|mesh-ancestor
154007702|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
154007703|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007704|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731572|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007705|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154007706|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154007707|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
154007708|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
154007709|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007710|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154007711|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154007712|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007713|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255089|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154007714|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154007715|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154007716|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154007717|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154007728|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
154007729|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007730|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007731|NCT00905905|Simvastatin|simvastatin|mesh-list
154007732|NCT00905905|Ezetimibe|ezetimibe|mesh-list
154007733|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154007734|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154007735|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154007736|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
154007737|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007738|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154007739|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154007740|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007741|NCT00902473|Topiramate|topiramate|mesh-list
154007742|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
154007743|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154007744|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007745|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
154007746|NCT04104789|Tetracaine|tetracaine|mesh-list
154007747|NCT04104789|Carticaine|carticaine|mesh-list
154007748|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
154007749|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
154007750|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007751|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007752|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
154007753|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007754|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154007755|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154007756|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154007757|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007758|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007759|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
154007760|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
154007761|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
154007762|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154007763|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
154007764|NCT00938717|Linaclotide|linaclotide|mesh-list
154007765|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154007766|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
154007767|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007768|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154007769|NCT00905983|Gemcitabine|gemcitabine|mesh-list
154007770|NCT00905983|Docetaxel|docetaxel|mesh-list
154007771|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007772|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
154007773|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007774|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007775|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
154007776|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
154007777|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
154007778|NCT00906061|Gemcitabine|gemcitabine|mesh-list
154007779|NCT00906061|Docetaxel|docetaxel|mesh-list
154007780|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007781|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
154007782|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007796|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007797|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007798|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154007799|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154007800|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007801|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007802|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154007803|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
154007804|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154007805|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007806|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
154007807|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154007808|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154007809|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153626795|NCT02019056|Pyridoxine|pyridoxine|mesh-list
154860953|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007810|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154007811|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154007812|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154007813|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154007814|NCT02852837|Daratumumab|daratumumab|mesh-list
154007815|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007816|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
154007817|NCT00897871|Carboplatin|carboplatin|mesh-list
154007819|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
154007820|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007821|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
154007822|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007823|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007824|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154007825|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
153765393|NCT02374242|Nivolumab|nivolumab|mesh-list
154007826|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007827|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007828|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154007829|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154007830|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154007831|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154007833|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
154007834|NCT00902707|Guaifenesin|guaifenesin|mesh-list
154007835|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154007836|NCT00902707|Expectorants|expectorants|mesh-ancestor
154007837|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
154007838|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154007839|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154007840|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
154007841|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007842|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007843|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007850|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154007851|NCT00906139|Midazolam|midazolam|mesh-list
154007852|NCT00906139|Fentanyl|fentanyl|mesh-list
154007853|NCT00906139|Propofol|propofol|mesh-list
154007854|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154007855|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154007856|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007857|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154007858|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
154007859|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
154007860|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154007861|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154007862|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154007863|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154007864|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
154007865|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
154007866|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007867|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007868|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154007869|NCT00906139|Narcotics|narcotics|mesh-ancestor
154007870|NCT00906139|Analgesics|analgesics|mesh-ancestor
154007871|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
154007872|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007873|NCT00906295|Chrysarobin|chrysarobin|mesh-list
154007874|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154007875|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154007876|NCT00906295|Analgesics|analgesics|mesh-ancestor
154007877|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
154007878|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007879|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007880|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007881|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154007882|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
154007883|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154007884|NCT02754102|Protective Agents|protective agents|mesh-ancestor
154007885|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007886|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
154007887|NCT00134303|Metformin|metformin|mesh-list
154007888|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154007889|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007890|NCT00902941|Rasagiline|rasagiline|mesh-list
154007891|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154007892|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007893|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007894|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154007895|NCT00902941|Protective Agents|protective agents|mesh-ancestor
154007896|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007897|NCT02754258|Methylphenidate|methylphenidate|mesh-list
154007898|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154007899|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007900|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154007901|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154007902|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154007903|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007904|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
154007905|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007907|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007908|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
154007909|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007910|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154007911|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007912|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007913|NCT02852681|Drospirenone|drospirenone|mesh-list
154007914|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154007935|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007936|NCT00906451|Simvastatin|simvastatin|mesh-list
154007937|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154007938|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154007939|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
154007940|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007941|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154007942|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154007943|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007944|NCT00898417|Paclitaxel|paclitaxel|mesh-list
154007945|NCT00898417|Bevacizumab|bevacizumab|mesh-list
154007946|NCT00898417|Carboplatin|carboplatin|mesh-list
154007947|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154007948|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007949|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
154007950|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
154007951|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
154007952|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007953|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154007954|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154007955|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154007956|NCT00898417|Growth Substances|growth substances|mesh-ancestor
154007957|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007958|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
154007959|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
154007960|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
154007961|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154007962|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007963|NCT00783705|Inositol|inositol|mesh-list
154007964|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
154007965|NCT00783705|Vitamins|vitamins|mesh-ancestor
154007966|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
154007974|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007976|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154007977|NCT04103697|Capecitabine|capecitabine|mesh-list
154007978|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
154007979|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007980|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
154007981|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007982|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007983|NCT00898573|Lapatinib|lapatinib|mesh-list
154007984|NCT00898573|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154007985|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154007986|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007987|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007988|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007989|NCT04321668|Hylan|hylan|mesh-list
154007990|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
154007991|NCT04321668|Protective Agents|protective agents|mesh-ancestor
154007992|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007993|NCT02851745|Linagliptin|linagliptin|mesh-list
154007994|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154007995|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007996|NCT02851745|Incretins|incretins|mesh-ancestor
154007997|NCT02851745|Hormones|hormones|mesh-ancestor
154007998|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154007999|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154008000|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
154008001|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008002|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008003|NCT02602197|Acetaminophen|acetaminophen|mesh-list
154008004|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154008005|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008006|NCT02602197|Analgesics|analgesics|mesh-ancestor
154008007|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
154008008|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008009|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008010|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
154008011|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154008012|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008013|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154008014|NCT02753712|Fluticasone|fluticasone|mesh-list
154008015|NCT02753712|Xhance|xhance|mesh-list
154008016|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
154008017|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008018|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154008019|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
154008020|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008021|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008022|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154008023|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
154008024|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
154008025|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154008026|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154008027|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154008028|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154008029|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
154008030|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580068|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008040|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154008042|NCT02696148|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154008043|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154008044|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008045|NCT02696148|Incretins|incretins|mesh-ancestor
154008046|NCT02696148|Hormones|hormones|mesh-ancestor
154008047|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008048|NCT00887198|Prednisone|prednisone|mesh-list
154008049|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
154008050|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008051|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
154008052|NCT00887198|Hormones|hormones|mesh-ancestor
154008053|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008054|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008055|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154008056|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008057|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154008058|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008059|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008060|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
154008061|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154008062|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154008063|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008064|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008065|NCT00782067|Midostaurin|midostaurin|mesh-list
154008066|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008067|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008068|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008069|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008070|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
154008071|NCT02826746|Analgesics|analgesics|mesh-ancestor
154008072|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
154008073|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008074|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008075|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
154008076|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008077|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154008078|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
154008079|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154008080|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008081|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008082|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154008083|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
154008084|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154008085|NCT02750904|Nicotine|nicotine|mesh-list
154008086|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154008087|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
154008088|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008089|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008090|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154008091|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154008092|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
154008105|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008106|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154008107|NCT02695758|Bupivacaine|bupivacaine|mesh-list
154008108|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
154008109|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
154008110|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008111|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008112|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
154008113|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008114|NCT00605215|Interferons|interferons|mesh-list
154008115|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
154008116|NCT00605215|Interferon-beta|interferon-beta|mesh-list
154008117|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008118|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
154008119|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008120|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154008121|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
154008122|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008124|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008125|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008126|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
154008127|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
154008128|NCT04244708|Temozolomide|temozolomide|mesh-list
154008129|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154008130|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
154008131|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008132|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008133|NCT02750748|Naltrexone|naltrexone|mesh-list
154008134|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154008135|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154008136|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008137|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
153402823|NCT04768296|Topotecan|topotecan|mesh-list
154008138|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008139|NCT00604279|Risperidone|risperidone|mesh-list
154008140|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154008141|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154008142|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
154008143|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008144|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008145|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008146|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154008147|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154008148|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008149|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154008150|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154008151|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
154008152|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153580201|NCT01744236|Liraglutide|liraglutide|mesh-list
154008162|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008163|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154008164|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154008165|NCT00906685|Growth Substances|growth substances|mesh-ancestor
154008166|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008167|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
154008168|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
154008169|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154008170|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154008171|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008172|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154008173|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154008174|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008175|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008176|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008177|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154008178|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
154008179|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154008180|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008181|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154008182|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154008183|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154008184|NCT02695212|Apremilast|apremilast|mesh-list
154008185|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154008186|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008187|NCT02695212|Analgesics|analgesics|mesh-ancestor
154008188|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
154008189|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008190|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008191|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008192|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765766|NCT04739826|Nilotinib|nilotinib|mesh-list
154008194|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154008195|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008196|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008197|NCT05381207|Fluticasone|fluticasone|mesh-list
154008198|NCT05381207|Xhance|xhance|mesh-list
154008199|NCT05381207|Montelukast|montelukast|mesh-list
154008200|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008201|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154008202|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
154008203|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008204|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008205|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154008206|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
154008207|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
154008208|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154008209|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154008210|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
154008211|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008212|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154008213|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154008214|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008215|NCT02750670|Dexamethasone|dexamethasone|mesh-list
154008224|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008225|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
154008226|NCT02750670|Hormones|hormones|mesh-ancestor
154008227|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008228|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154008229|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154008230|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
154008231|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008232|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154008233|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154008234|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154008235|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
154008236|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008237|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008238|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154008239|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
154008240|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154008241|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154008242|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154008243|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
154008244|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008245|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008246|NCT05122208|Famotidine|famotidine|mesh-list
154008247|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154008248|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008249|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154008250|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
154008251|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
154008252|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008253|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008254|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008255|NCT00781911|Octreotide|octreotide|mesh-list
154008256|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008257|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154008258|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008259|NCT00605917|Sertraline|sertraline|mesh-list
154008260|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
154008261|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154008262|NCT00605917|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154008263|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154008264|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008265|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008267|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
154008268|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008269|NCT04919096|Aflibercept|aflibercept|mesh-list
154008270|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154008271|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154008272|NCT04919096|Growth Substances|growth substances|mesh-ancestor
154008273|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008274|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
154008275|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008276|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154008277|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154008278|NCT00781599|Varenicline|varenicline|mesh-list
154008279|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154008280|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154008281|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
154008282|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008301|NCT03240211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154008302|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008303|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154008304|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
154008305|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626800|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
154008306|NCT00899197|Tamoxifen|tamoxifen|mesh-list
154008307|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154008309|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008310|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008311|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154008312|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008313|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154008314|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154008315|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154008316|NCT00603083|Ketorolac|ketorolac|mesh-list
154008317|NCT00603083|Ropivacaine|ropivacaine|mesh-list
154008318|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
154008319|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
154008320|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008321|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008322|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
154008323|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008324|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154008325|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008326|NCT00603083|Analgesics|analgesics|mesh-ancestor
154008327|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008328|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154008329|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154008330|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008331|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008332|NCT05379257|Furosemide|furosemide|mesh-list
154008333|NCT05379257|Diuretics|diuretics|mesh-ancestor
154008334|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
154008335|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008336|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154008345|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008346|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008347|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008348|NCT00899587|Enalapril|enalapril|mesh-list
154008349|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154008350|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
154008351|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008352|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008353|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154008354|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154008355|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154008356|NCT02824406|Acetazolamide|acetazolamide|mesh-list
154008357|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
154008358|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154008359|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008360|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008361|NCT02824406|Diuretics|diuretics|mesh-ancestor
154008362|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
154008363|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008364|NCT04267679|Cannabidiol|cannabidiol|mesh-list
154008365|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
154008366|NCT04951388|Somatomedin B|somatomedin b|mesh-list
154008367|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154008368|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154008369|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
154008370|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008371|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008372|NCT04242914|Midazolam|midazolam|mesh-list
154008373|NCT04242914|Ketamine|ketamine|mesh-list
154008374|NCT04242914|Analgesics|analgesics|mesh-ancestor
154008375|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
154008376|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008377|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008378|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154008379|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154008380|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
154008381|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
154008382|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008383|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154008384|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154008385|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008386|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008387|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154008388|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154008389|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154008390|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154008391|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154008392|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
154008393|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
154008394|NCT00780273|Cimetidine|cimetidine|mesh-list
154008395|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154008396|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008397|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154008398|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
154008399|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
154008400|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008401|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008402|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580453|NCT01745666|Epinephrine|epinephrine|mesh-list
154008426|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008427|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008428|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154008429|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154008430|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
154008431|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008432|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154008433|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154008434|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154008435|NCT00899821|Growth Substances|growth substances|mesh-ancestor
154008436|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
154008437|NCT00005112|Hormones|hormones|mesh-list
154008438|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008439|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008440|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
154008441|NCT04163406|Trace Elements|trace elements|mesh-ancestor
154008442|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
154008443|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008444|NCT04218552|Amlodipine|amlodipine|mesh-list
154008445|NCT04218552|Telmisartan|telmisartan|mesh-list
154008446|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154008447|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154008448|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008449|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008450|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154008451|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008452|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
154008463|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008464|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008465|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
154008466|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
154008467|NCT00904735|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154008468|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008469|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008470|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008471|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008472|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
154008473|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154008474|NCT02823626|Spironolactone|spironolactone|mesh-list
154008475|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154008476|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
154008477|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008478|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008479|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154008480|NCT02823626|Diuretics|diuretics|mesh-ancestor
154008481|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
154008482|NCT00779259|Quinine|quinine|mesh-list
154008483|NCT00779259|Theophylline|theophylline|mesh-list
154008484|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154008485|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
154008487|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008488|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154008489|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
154008490|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154008491|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008492|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008493|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
154008494|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154008495|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154008496|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
154008497|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008498|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
154008499|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154008500|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154008501|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008502|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154008503|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154008504|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008505|NCT00779259|Analgesics|analgesics|mesh-ancestor
154008506|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
154008507|NCT02746380|Adalimumab|adalimumab|mesh-list
154008508|NCT02746380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154008509|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008510|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154008511|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
154008512|NCT02745990|Hematinics|hematinics|mesh-ancestor
154008513|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154008514|NCT00915915|Gestodene|gestodene|mesh-list
154008515|NCT00915915|Femovan|femovan|mesh-list
154008516|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154008517|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153360457|NCT03678506|Apixaban|apixaban|mesh-list
154008523|NCT00915915|Estrogens|estrogens|mesh-ancestor
154008524|NCT00915915|Hormones|hormones|mesh-ancestor
154008525|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008526|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154008527|NCT00915915|Progestins|progestins|mesh-ancestor
154008528|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154008529|NCT02538367|Prucalopride|prucalopride|mesh-list
154008530|NCT02538367|YH12852|yh12852|mesh-list
154008531|NCT02538367|Laxatives|laxatives|mesh-ancestor
154008532|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008533|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154008534|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154008535|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
154008536|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008537|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860954|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153904|NCT00967928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008538|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008540|NCT00900445|Prednisolone|prednisolone|mesh-list
154008541|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154008542|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
154008543|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154008544|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
154008545|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
154008546|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154008547|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154008548|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154008549|NCT00900445|Cortisone|cortisone|mesh-list
154008550|NCT00900445|Vincristine|vincristine|mesh-list
154008551|NCT00900445|Daunorubicin|daunorubicin|mesh-list
154008552|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154008553|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
154008554|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008555|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
154008556|NCT00900445|Hormones|hormones|mesh-ancestor
154008557|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008558|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008559|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154008560|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766141|NCT02664181|Nivolumab|nivolumab|mesh-list
154008561|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154008562|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
154008563|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
154008564|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
154008565|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008566|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
154008567|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
154008568|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008569|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008570|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154008571|NCT00900445|Protective Agents|protective agents|mesh-ancestor
154008572|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154008573|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154008574|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154008575|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008576|NCT03994419|Anesthetics|anesthetics|mesh-list
154008577|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008578|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008579|NCT00936065|Etanercept|etanercept|mesh-list
154008580|NCT00936065|Acitretin|acitretin|mesh-list
154008581|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154008582|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008583|NCT00936065|Analgesics|analgesics|mesh-ancestor
154008584|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
154008585|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580637|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008599|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
154008600|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
154008601|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
154008602|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008603|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154008604|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
154008605|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
154008606|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
154008607|NCT00905047|Leucovorin|leucovorin|mesh-list
154008608|NCT00905047|Folic Acid|folic acid|mesh-list
154008609|NCT00905047|Tegafur|tegafur|mesh-list
154008610|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
154008611|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154008612|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
154008613|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008614|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008615|NCT00905047|Antidotes|antidotes|mesh-ancestor
154008616|NCT00905047|Protective Agents|protective agents|mesh-ancestor
154008617|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008618|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
154008619|NCT00905047|Vitamins|vitamins|mesh-ancestor
154008620|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
154008621|NCT00905047|Hematinics|hematinics|mesh-ancestor
154008622|NCT04102449|Apremilast|apremilast|mesh-list
154008623|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154008624|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008625|NCT04102449|Analgesics|analgesics|mesh-ancestor
154008626|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
154008627|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008628|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008629|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008630|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154008631|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154008632|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154008633|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008634|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008635|NCT02823236|Triamcinolone|triamcinolone|mesh-list
154008636|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154008637|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154008638|NCT02823236|Pirfenidone|pirfenidone|mesh-list
154008639|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154008640|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008641|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
154008642|NCT02823236|Hormones|hormones|mesh-ancestor
154008643|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008644|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008645|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154008646|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
154008647|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008648|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008649|NCT02823236|Analgesics|analgesics|mesh-ancestor
154008663|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
154008664|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
154008665|NCT00633698|Vitamins|vitamins|mesh-ancestor
154008666|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
154008667|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008668|NCT02825342|Citalopram|citalopram|mesh-list
154008669|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154008670|NCT02825342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154008671|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154008672|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008673|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008674|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008675|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
154008676|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008677|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154008678|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
154008679|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154008680|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008681|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
154008682|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154008683|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008685|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154008686|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154008687|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008688|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154008689|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008690|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154008691|NCT04242758|Diuretics|diuretics|mesh-ancestor
154008692|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
154008693|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154008694|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008695|NCT02745912|Metformin|metformin|mesh-list
154008696|NCT02745912|Naltrexone|naltrexone|mesh-list
154008697|NCT02745912|Bupropion|bupropion|mesh-list
154008698|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154008699|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008700|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154008701|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154008702|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
154008703|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008704|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154008705|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
154008706|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154008707|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154008708|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154008709|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008710|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008711|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
154008721|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008722|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008723|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
154008724|NCT02825186|Hormones|hormones|mesh-ancestor
154008725|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008726|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154008727|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008728|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154008729|NCT00604825|Estrogens|estrogens|mesh-ancestor
154008730|NCT00604825|Hormones|hormones|mesh-ancestor
154008731|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008732|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008734|NCT04239560|Trace Elements|trace elements|mesh-ancestor
154008735|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
154008736|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008737|NCT04218162|Lasmiditan|lasmiditan|mesh-list
154008738|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154008739|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
154008740|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008741|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008742|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008743|NCT00606125|Sorafenib|sorafenib|mesh-list
154008744|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008745|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008746|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008747|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008748|NCT04242212|Misoprostol|misoprostol|mesh-list
154008749|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154008750|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
154008751|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154008752|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008753|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154008754|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008755|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
154008756|NCT02851433|Anesthetics|anesthetics|mesh-list
154008757|NCT02851433|Propofol|propofol|mesh-list
154008758|NCT02851433|Sevoflurane|sevoflurane|mesh-list
154008760|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008761|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154008762|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154008763|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
154008764|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154008765|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154008766|NCT05629806|Metformin|metformin|mesh-list
154008767|NCT05629806|Pioglitazone|pioglitazone|mesh-list
154008768|NCT05629806|Acarbose|acarbose|mesh-list
154008769|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154008770|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008771|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154008772|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008773|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008774|NCT02745756|Vaccines|vaccines|mesh-list
154008775|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
154008776|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008777|NCT04242368|Fluticasone|fluticasone|mesh-list
154008779|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008780|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154008792|NCT00905593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008794|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
154008795|NCT04217148|Tretinoin|tretinoin|mesh-list
154008796|NCT04217148|BB 1101|bb 1101|mesh-list
154008797|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008798|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
154008799|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
154008800|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008801|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008802|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008803|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
154008804|NCT04217148|Hormones|hormones|mesh-ancestor
154008805|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008806|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154008807|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008808|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
154008809|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008810|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008811|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
154008812|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
154008814|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
154008815|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
154008816|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008817|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008818|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
154008819|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008820|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
154008821|NCT04216836|Antacids|antacids|mesh-ancestor
154008822|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008823|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008824|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
154008825|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
154008826|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154008827|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
154008828|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008829|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154008830|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154008831|NCT04034173|Leucovorin|leucovorin|mesh-list
154008832|NCT04034173|Folic Acid|folic acid|mesh-list
154008833|NCT04034173|Irinotecan|irinotecan|mesh-list
154008834|NCT04034173|Panitumumab|panitumumab|mesh-list
154008836|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154008837|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154008838|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008839|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008840|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008841|NCT04034173|Antidotes|antidotes|mesh-ancestor
154008842|NCT04034173|Protective Agents|protective agents|mesh-ancestor
154008843|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008844|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
154008845|NCT04034173|Vitamins|vitamins|mesh-ancestor
154008855|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008856|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008857|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008858|NCT00606203|Analgesics|analgesics|mesh-ancestor
154008859|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
154008860|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008861|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
154008862|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154008863|NCT02539849|Adalimumab|adalimumab|mesh-list
154008864|NCT02539849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154008865|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008866|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154008867|NCT02749578|Atorvastatin|atorvastatin|mesh-list
154008868|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154008869|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154008870|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
154008871|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008872|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154008873|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154008874|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008875|NCT05378867|Bevacizumab|bevacizumab|mesh-list
154008876|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154008877|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008878|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154008879|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154008880|NCT05378867|Growth Substances|growth substances|mesh-ancestor
154008881|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008882|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
154008883|NCT02749656|Desoximetasone|desoximetasone|mesh-list
154008884|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008885|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
154008886|NCT02749656|Hormones|hormones|mesh-ancestor
154008887|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008888|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008889|NCT00603317|Amoxicillin|amoxicillin|mesh-list
154008890|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
154008891|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
154008892|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154008893|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154008894|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008895|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008896|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008897|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154008898|NCT02745522|Oxytocin|oxytocin|mesh-list
154008899|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
154008900|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154008901|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008902|NCT02824718|Teriparatide|teriparatide|mesh-list
154008903|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
154008904|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154008905|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
154008906|NCT02824718|Diuretics|diuretics|mesh-list
154008907|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
154008908|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154008909|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008915|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008917|NCT05378711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154008918|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154008919|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008920|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008921|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008922|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
154008923|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008924|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154008925|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
154008926|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154008927|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154008928|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154008929|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008930|NCT00777153|Cediranib|cediranib|mesh-list
154008931|NCT00777153|Lomustine|lomustine|mesh-list
154008932|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008933|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008934|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008935|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008936|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154008937|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
154008939|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154008940|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
154008941|NCT00604955|Paromomycin|paromomycin|mesh-list
154008942|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154008943|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008944|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154008945|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154008946|NCT04266509|Rifampin|rifampin|mesh-list
154008947|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154008948|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
154008949|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154008950|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008951|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
154008952|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154008953|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008954|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008955|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154008956|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154008957|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153781788|NCT04559113|Prednisolone|prednisolone|mesh-list
154008958|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154008959|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154008960|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154008961|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154008962|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154008963|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008964|NCT02824874|Incretins|incretins|mesh-ancestor
154008965|NCT02824874|Hormones|hormones|mesh-ancestor
154008966|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008967|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154008968|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
154008969|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008970|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008971|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
154008972|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154008973|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
154008974|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008975|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
154008976|NCT04204265|Protective Agents|protective agents|mesh-ancestor
154008977|NCT04267913|Dexamethasone|dexamethasone|mesh-list
154008992|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008994|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
154008995|NCT04267913|Hormones|hormones|mesh-ancestor
154008996|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008997|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154008998|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008999|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
154009000|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009001|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009002|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
154009003|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
154009004|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
154009005|NCT04267913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154009006|NCT04267913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154009007|NCT04267913|Growth Substances|growth substances|mesh-ancestor
154009008|NCT04267913|Growth Inhibitors|growth inhibitors|mesh-ancestor
154009009|NCT04216758|Paclitaxel|paclitaxel|mesh-list
154009010|NCT04216758|Gemcitabine|gemcitabine|mesh-list
154009011|NCT04216758|Tegafur|tegafur|mesh-list
154009012|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154009013|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009014|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
154009015|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
154009016|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
154009017|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009018|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009019|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
154009020|NCT00606437|Fludarabine|fludarabine|mesh-list
154009021|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009022|NCT02538211|Vaccines|vaccines|mesh-list
154009023|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154009024|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
154009025|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009026|NCT02821676|Anesthetics|anesthetics|mesh-list
154009027|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009028|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009029|NCT02745054|Anticoagulants|anticoagulants|mesh-list
154009030|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
154009031|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
154009032|NCT00908089|Prednisolone|prednisolone|mesh-list
154009033|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154009034|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
154009035|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154009036|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
154009037|NCT00908089|Infliximab|infliximab|mesh-list
154009038|NCT00908089|Naltrexone|naltrexone|mesh-list
154009039|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154009040|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
154009041|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009042|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
154009055|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
154009056|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009057|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009058|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154009059|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154009060|NCT00908089|Analgesics|analgesics|mesh-ancestor
154009061|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
154009062|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154009063|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154009064|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
154009065|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154009066|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154009067|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009068|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009069|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154009070|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154009071|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009072|NCT03553446|Sevoflurane|sevoflurane|mesh-list
154009073|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154009074|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154009075|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
154009076|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
154009077|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009078|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154352|NCT00973128|Sargramostim|sargramostim|mesh-list
154009079|NCT00908167|Cytarabine|cytarabine|mesh-list
154009080|NCT00908167|Clofarabine|clofarabine|mesh-list
154009081|NCT00908167|Sorafenib|sorafenib|mesh-list
154009082|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009083|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
154009084|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009085|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009086|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
154009087|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009088|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009089|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
154009090|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009091|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154009093|NCT02821052|Insulin|insulin|mesh-list
154009094|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
154009095|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154009096|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009097|NCT05659628|Tislelizumab|tislelizumab|mesh-list
154009098|NCT05659628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154009099|NCT05659628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009100|NCT00606515|Paclitaxel|paclitaxel|mesh-list
154009101|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154009102|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154009103|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009104|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
154009105|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
153581166|NCT01749397|Fluorouracil|fluorouracil|mesh-list
154009117|NCT02749032|Hormones|hormones|mesh-ancestor
154009118|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009119|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154009120|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
154009121|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009122|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009123|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
154009124|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154009125|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154009126|NCT00908713|Prednisolone|prednisolone|mesh-list
154009127|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
154009128|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154009129|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
154009130|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009131|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
154009132|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
154009133|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009134|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009135|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154009136|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
154009137|NCT00908713|Hormones|hormones|mesh-ancestor
154009138|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009139|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154009140|NCT00908713|Protective Agents|protective agents|mesh-ancestor
154009141|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009142|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009143|NCT00908869|Interferons|interferons|mesh-list
154009144|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
154009145|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
154009146|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
154009147|NCT00908869|Vinorelbine|vinorelbine|mesh-list
154009148|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009149|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
154009150|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009151|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009152|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154009153|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
154009154|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009155|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009156|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154009157|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
154009158|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009159|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154009160|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
154009161|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
154009162|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
154009163|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
154860955|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154009164|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
154009165|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154009166|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009168|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154009169|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
154009170|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009171|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009180|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154009181|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154009182|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009184|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009185|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
154009186|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009187|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154009188|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009189|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009190|NCT04015375|Dapsone|dapsone|mesh-list
154009191|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009192|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
154009193|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154009194|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154009195|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154009196|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009197|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009198|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
154009199|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154009200|NCT02850887|Anesthetics|anesthetics|mesh-list
154009201|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009202|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009203|NCT00931645|Cytarabine|cytarabine|mesh-list
154009204|NCT00931645|Dexamethasone|dexamethasone|mesh-list
154009205|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
154009206|NCT00931645|Cisplatin|cisplatin|mesh-list
154009207|NCT00931645|Fludarabine|fludarabine|mesh-list
154009208|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009209|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
154009210|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009211|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009212|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154009213|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
154009214|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009215|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009216|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154009217|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009218|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
154009219|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
154009220|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009221|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154009222|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
154009224|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009225|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009226|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009227|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
154009228|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
154009229|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009230|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
154009231|NCT05658692|Dexamethasone|dexamethasone|mesh-list
154009232|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
154009233|NCT05658692|Simendan|simendan|mesh-list
154009234|NCT05658692|Dopamine|dopamine|mesh-list
154009235|NCT05658692|Isoproterenol|isoproterenol|mesh-list
154009236|NCT05658692|Olprinone|olprinone|mesh-list
154009237|NCT05658692|Epinephrine|epinephrine|mesh-list
154009238|NCT05658692|Norepinephrine|norepinephrine|mesh-list
154009239|NCT05658692|Metaraminol|metaraminol|mesh-list
154009240|NCT05658692|Midazolam|midazolam|mesh-list
153766833|NCT00474487|Vaccines|vaccines|mesh-list
154009254|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009255|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154009256|NCT05658692|Hormones|hormones|mesh-ancestor
154009257|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009258|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009259|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009260|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009261|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009262|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009263|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154009264|NCT05658692|Analgesics|analgesics|mesh-ancestor
154009265|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
154009266|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154009267|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154009268|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154009269|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
154009270|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009271|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154009272|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
154009273|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
154009274|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154009275|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154009276|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154009277|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154009278|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
154009279|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
154009280|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154009281|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154009282|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
154009283|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154009284|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154009285|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154009286|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154009287|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154009288|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
154009289|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
154009290|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
154009291|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154009292|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
154009293|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154009294|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
154009295|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154009296|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154009297|NCT05658692|Protective Agents|protective agents|mesh-ancestor
154009298|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
154009299|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154009300|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154009301|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154009302|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154009303|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154009304|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154009305|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
154009315|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
153766889|NCT04571437|Letrozole|letrozole|mesh-list
154009316|NCT02744508|Hormones|hormones|mesh-ancestor
154009317|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009318|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009319|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009320|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154009321|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154009322|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
154009323|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009324|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009325|NCT00927511|Fulvestrant|fulvestrant|mesh-list
154009326|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009327|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009328|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154009329|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154009330|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
154009331|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009332|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009333|NCT03211338|Progesterone|progesterone|mesh-list
154009334|NCT03211338|Mitogens|mitogens|mesh-list
154009335|NCT03211338|Progestins|progestins|mesh-ancestor
154009336|NCT03211338|Hormones|hormones|mesh-ancestor
154009337|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009338|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009339|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
154009340|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009341|NCT00936611|Panobinostat|panobinostat|mesh-list
154009342|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009343|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154009344|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009345|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009346|NCT02744196|Methotrexate|methotrexate|mesh-list
154154574|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154009347|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009348|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
154009349|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009350|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009351|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154009352|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
154009353|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154009354|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009355|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
154009356|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009357|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
154009358|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009359|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154009360|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009361|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154009362|NCT02139852|Capsaicin|capsaicin|mesh-list
154009363|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
154009364|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154009365|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
154009366|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009367|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009368|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
154009369|NCT05379647|Rituximab|rituximab|mesh-list
154009379|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154009380|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154009381|NCT02748330|Aspirin|aspirin|mesh-list
154009382|NCT02748330|Clopidogrel|clopidogrel|mesh-list
154009383|NCT02748330|Ticagrelor|ticagrelor|mesh-list
154009384|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154009385|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154009386|NCT02748330|Analgesics|analgesics|mesh-ancestor
154009387|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
154009388|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009389|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009390|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009391|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153766959|NCT00124280|Everolimus|everolimus|mesh-list
154009392|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154009393|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154009394|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009395|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154009396|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154009397|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009398|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
154009399|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154009400|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154009401|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154009402|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
154009403|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009404|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
154009405|NCT05379569|Fludarabine|fludarabine|mesh-list
154009406|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009407|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
154009408|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009409|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009410|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154009411|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
154009412|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009413|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009414|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154009415|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
154009416|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154009417|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
154009418|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009419|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
154009420|NCT02818556|Protective Agents|protective agents|mesh-ancestor
154009421|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154009422|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009423|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154009424|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009425|NCT04627142|Irinotecan|irinotecan|mesh-list
154009426|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154009427|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154860956|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154009428|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009429|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009430|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009431|NCT00936221|Dacarbazine|dacarbazine|mesh-list
154009432|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154009433|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
154009449|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
154009450|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009451|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009452|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
154009453|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154009454|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009455|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009456|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154009457|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154009458|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154009459|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009460|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154009461|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154009462|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
154009463|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
154009464|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767048|NCT00215514|Epirubicin|epirubicin|mesh-list
154009465|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
154009467|NCT04238702|Losartan|losartan|mesh-list
154009468|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154009469|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154009470|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154009471|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154009472|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009473|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154009474|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154009475|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009476|NCT00603785|Omalizumab|omalizumab|mesh-list
154009477|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154009478|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154009479|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
154009480|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
154009481|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154009482|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
154009483|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009484|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009485|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154009486|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
154009487|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154009488|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154009489|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154009490|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
154009491|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009492|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009525|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154009526|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
154009527|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009528|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009529|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009530|NCT00606983|Urological Agents|urological agents|mesh-ancestor
154009531|NCT02817932|Ranolazine|ranolazine|mesh-list
154009532|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154009533|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009534|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009535|NCT02743260|Metformin|metformin|mesh-list
154009536|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154009537|NCT02743260|Adefovir|adefovir|mesh-list
154009551|NCT02743260|Protective Agents|protective agents|mesh-ancestor
154009552|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
154009553|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009554|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154009555|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154009556|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154009557|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154009558|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154009559|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
154009560|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154009562|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
154009563|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009564|NCT02819648|Hormones|hormones|mesh-ancestor
154009565|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009566|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009567|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009568|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009569|NCT00934661|Morphine|morphine|mesh-list
154009570|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154009571|NCT00934661|Narcotics|narcotics|mesh-ancestor
154009572|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009573|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009574|NCT00934661|Analgesics|analgesics|mesh-ancestor
154009575|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
154009576|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009577|NCT02743182|Interferons|interferons|mesh-list
154009578|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
154009579|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
154009580|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154009581|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009582|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
154009583|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009584|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
154009585|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009586|NCT00775437|Adalimumab|adalimumab|mesh-list
154009587|NCT00775437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154009588|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009589|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009590|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
154009591|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154009592|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009594|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154009595|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009596|NCT02819414|Acetaminophen|acetaminophen|mesh-list
154009597|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154009598|NCT02819414|Analgesics|analgesics|mesh-ancestor
154009599|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
153581687|NCT05636514|Decitabine|decitabine|mesh-list
154009610|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009612|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
154009613|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009614|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154009615|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154009616|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154009617|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009618|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009619|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154009620|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154009621|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
154009623|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154009624|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154009625|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154009626|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009627|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153781796|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410324|NCT03614221|Tacrolimus|tacrolimus|mesh-list
154009628|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154009629|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154009630|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154009631|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
154009632|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
154009633|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154009634|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
154009635|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154009636|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
154009637|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
154009638|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
154009639|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154009640|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154009641|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
154009642|NCT00775203|Trazodone|trazodone|mesh-list
154009643|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154009644|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154009645|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009646|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009647|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154009648|NCT00775203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154860957|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
154860958|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
154009649|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154009650|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009651|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009652|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009653|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
154009654|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154009655|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
154009656|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154009657|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
154009658|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009659|NCT00607217|Vaccines|vaccines|mesh-list
154009660|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
154009661|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009662|NCT02747316|Iron|iron|mesh-list
154009663|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154009664|NCT02747316|Trace Elements|trace elements|mesh-ancestor
154009665|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
154009666|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009667|NCT05648708|Bupivacaine|bupivacaine|mesh-list
154009691|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154009692|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
154009693|NCT02819570|Ampicillin|ampicillin|mesh-list
154009694|NCT02819570|Cefuroxime|cefuroxime|mesh-list
154009695|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
154009696|NCT02819570|Roxithromycin|roxithromycin|mesh-list
154009697|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154009698|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009699|NCT04239170|Gemcitabine|gemcitabine|mesh-list
154009700|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
154009701|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009702|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
154009703|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009704|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009705|NCT04480190|Gemcitabine|gemcitabine|mesh-list
154009706|NCT04480190|Fluorouracil|fluorouracil|mesh-list
154009707|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009708|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009709|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
154009710|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009711|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009712|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
154009713|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009714|NCT02741856|Paclitaxel|paclitaxel|mesh-list
154009715|NCT02741856|Carboplatin|carboplatin|mesh-list
154009716|NCT02741856|Capecitabine|capecitabine|mesh-list
154009717|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154009718|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009719|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
154009749|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
154009750|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
154009751|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154009753|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154009754|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009755|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009756|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009757|NCT00568321|Tanezumab|tanezumab|mesh-list
154009758|NCT00568321|Analgesics|analgesics|mesh-ancestor
154009759|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
154009760|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009761|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009762|NCT02742480|Dabigatran|dabigatran|mesh-list
154009763|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
154009764|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
154009774|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154009776|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
154009777|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009778|NCT02819102|Berotralstat|berotralstat|mesh-list
154009779|NCT02819102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154009780|NCT02819102|Protease Inhibitors|protease inhibitors|mesh-ancestor
154009781|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009782|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009783|NCT02819180|Vaccines|vaccines|mesh-list
154009784|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
154009785|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009786|NCT04661930|Fenofibrate|fenofibrate|mesh-list
154009787|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154582993|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009789|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009790|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154009791|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
154009792|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154009793|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154009794|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154009795|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009796|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009797|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
154009798|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009799|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009800|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154009801|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009802|NCT02601963|Minocycline|minocycline|mesh-list
154009803|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154009804|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009805|NCT00927979|Ropivacaine|ropivacaine|mesh-list
154009806|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
154009807|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
154009808|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009809|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009810|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
154009811|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009812|NCT00931957|Prednisolone|prednisolone|mesh-list
154009813|NCT00931957|Etanercept|etanercept|mesh-list
154009814|NCT00931957|Methotrexate|methotrexate|mesh-list
154009815|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154009816|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
154009817|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154176577|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009818|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009819|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009820|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
154009821|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009822|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009823|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
154009824|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009825|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154009826|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009837|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154009838|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154009839|NCT00931957|Analgesics|analgesics|mesh-ancestor
154009840|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
154009841|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
153767401|NCT00216138|Docetaxel|docetaxel|mesh-list
154009843|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
154009844|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
154009845|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009846|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009847|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
154009848|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009849|NCT02731950|Analgesics|analgesics|mesh-ancestor
154009850|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154009851|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
154009852|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154009853|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009854|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009855|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154009856|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
154009857|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154009858|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
154009859|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154009860|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154009861|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154009862|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009863|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009864|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
154009865|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009866|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009867|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154009868|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009869|NCT00928213|Heparin|heparin|mesh-list
154154946|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
154009870|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154009871|NCT00928213|Tinzaparin|tinzaparin|mesh-list
154009872|NCT00928213|Dalteparin|dalteparin|mesh-list
154009873|NCT00928213|Progesterone|progesterone|mesh-list
154009874|NCT00928213|Hormones|hormones|mesh-ancestor
154009875|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009876|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009877|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
154009878|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154009879|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154009880|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009881|NCT00928213|Progestins|progestins|mesh-ancestor
154009882|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154009883|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009884|NCT02736240|Vaccines|vaccines|mesh-list
154009885|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154009886|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
154009887|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009888|NCT02741154|Letrozole|letrozole|mesh-list
154009889|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154009890|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009910|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009911|NCT00773097|Poly ICLC|poly iclc|mesh-list
154009912|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
154009913|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
154009914|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009915|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
154009916|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009917|NCT02814110|Lenograstim|lenograstim|mesh-list
154009918|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154009919|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
154009920|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009921|NCT04264481|Lidocaine|lidocaine|mesh-list
154009922|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154009923|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
154009924|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009925|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009926|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
154009927|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009928|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154009929|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154009930|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154009931|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009932|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009933|NCT05303909|Gentamicins|gentamicins|mesh-list
154009934|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154009935|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009936|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154009937|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009938|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009939|NCT04306692|Inositol|inositol|mesh-list
154009940|NCT04306692|Clomiphene|clomiphene|mesh-list
154009941|NCT04306692|Enclomiphene|enclomiphene|mesh-list
154009942|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
154009943|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154009944|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
154009953|NCT04306692|Vitamins|vitamins|mesh-ancestor
154009954|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
154009955|NCT00772941|Varenicline|varenicline|mesh-list
154009956|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154009957|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154009958|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
154009959|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009960|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009961|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009962|NCT02735694|Cycloserine|cycloserine|mesh-list
154009963|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154009964|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731573|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009965|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154009966|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
154009967|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154009968|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
154009969|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009970|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
154009971|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154860959|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009972|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009973|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009974|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154009976|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
154009977|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009978|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154009979|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154009980|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154009981|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
154009982|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009983|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009985|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009986|NCT00928837|Naproxen|naproxen|mesh-list
154009987|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154009988|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154009989|NCT00928837|Analgesics|analgesics|mesh-ancestor
154009990|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
154009991|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009992|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009993|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009994|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009995|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
154009996|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154009997|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009998|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009999|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
154010000|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154010002|NCT00925093|Linezolid|linezolid|mesh-list
154010003|NCT00925093|Teicoplanin|teicoplanin|mesh-list
154010004|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010005|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010006|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154010007|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010008|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010009|NCT01562977|Rituximab|rituximab|mesh-list
154010010|NCT01562977|Gemcitabine|gemcitabine|mesh-list
154010011|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
154010020|NCT00607685|Fluorouracil|fluorouracil|mesh-list
154010021|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
154010022|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
153411002|NCT00362713|Ipilimumab|ipilimumab|mesh-list
154010023|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010024|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154010025|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010026|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154010027|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
154010028|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010029|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154010030|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
154010031|NCT00607685|Protective Agents|protective agents|mesh-ancestor
154010032|NCT04265027|Opicapone|opicapone|mesh-list
154010033|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154010034|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010035|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010036|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154010037|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154010038|NCT00607763|Micafungin|micafungin|mesh-list
154010039|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
154010040|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010041|NCT00928915|Thrombin|thrombin|mesh-list
154010042|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
154010043|NCT00928915|Coagulants|coagulants|mesh-ancestor
154010044|NCT02814500|Amlodipine|amlodipine|mesh-list
154010045|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154010046|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154010047|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154010048|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010049|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010050|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154010051|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010052|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
154010053|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154010054|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154010055|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
154010056|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154155099|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
154010057|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154010058|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010059|NCT00939341|Budesonide|budesonide|mesh-list
154010060|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
154010061|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154010062|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154010063|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154010064|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
154010065|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010066|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010067|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154010068|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
154010069|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
154010070|NCT00939341|Hormones|hormones|mesh-ancestor
154010071|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010072|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154010073|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154010074|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154010075|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010076|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010087|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010088|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154010089|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154010090|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010091|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010092|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154010093|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154010095|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
154010096|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154010097|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010098|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010099|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154010100|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010101|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154010102|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154010103|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010104|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154010105|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154010106|NCT02739906|Insulin|insulin|mesh-list
154010107|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154010108|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
154010109|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154010110|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010111|NCT02739672|Amlodipine|amlodipine|mesh-list
154010112|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154010113|NCT02739672|Telmisartan|telmisartan|mesh-list
154010114|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154010115|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154010116|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154010117|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010118|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010119|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154010120|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010121|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
154010122|NCT02739672|Diuretics|diuretics|mesh-ancestor
154010123|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
154010124|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154010125|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154010126|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154010127|NCT00932971|Tenofovir|tenofovir|mesh-list
154010128|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154010129|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
154010130|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
154010131|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154010132|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
154010133|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010134|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154010135|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154010136|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010137|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767716|NCT00224094|Estrogens|estrogens|mesh-ancestor
154860960|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154010138|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154010139|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154010140|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
154010150|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154010151|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010152|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010153|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154010154|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
154010155|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154010156|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154010157|NCT05788159|Lacosamide|lacosamide|mesh-list
154010158|NCT05788159|Anticonvulsants|anticonvulsants|mesh-ancestor
154010159|NCT05788159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154010160|NCT05788159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154010161|NCT05788159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010162|NCT05788159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010163|NCT05787925|Vitamin E|vitamin e|mesh-list
154010164|NCT05787925|Vitamins|vitamins|mesh-ancestor
154010165|NCT05787925|Micronutrients|micronutrients|mesh-ancestor
154010166|NCT05787925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010167|NCT05787925|Antioxidants|antioxidants|mesh-ancestor
154010168|NCT05787925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010169|NCT05787925|Protective Agents|protective agents|mesh-ancestor
154010170|NCT05787912|Hyaluronic Acid|hyaluronic acid|mesh-list
154010171|NCT05787912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154010172|NCT05787912|Immunologic Factors|immunologic factors|mesh-ancestor
154010173|NCT05787912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010174|NCT05787912|Viscosupplements|viscosupplements|mesh-ancestor
154010175|NCT05787912|Protective Agents|protective agents|mesh-ancestor
154010176|NCT05787808|Vitamin D|vitamin d|mesh-list
154010177|NCT05787808|Vitamins|vitamins|mesh-ancestor
154010178|NCT05787808|Micronutrients|micronutrients|mesh-ancestor
154010179|NCT05787808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010180|NCT05787808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154010181|NCT05787535|Cyclophosphamide|cyclophosphamide|mesh-list
154010182|NCT05787535|Fludarabine|fludarabine|mesh-list
154010183|NCT05787535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154010184|NCT05787535|Immunologic Factors|immunologic factors|mesh-ancestor
154010185|NCT05787535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010186|NCT05787535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154010187|NCT05787535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154010188|NCT05787535|Alkylating Agents|alkylating agents|mesh-ancestor
154010189|NCT05787535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010190|NCT05787535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010191|NCT05787535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154010193|NCT05787509|Progestins|progestins|mesh-ancestor
154010194|NCT05787509|Hormones|hormones|mesh-ancestor
154010195|NCT05787509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010196|NCT05787509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010197|NCT05787002|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154010198|NCT05787002|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154010199|NCT05787002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154010200|NCT05787002|Antimetabolites|antimetabolites|mesh-ancestor
154010201|NCT05787002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010202|NCT05787002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154010203|NCT05787002|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154010204|NCT05787002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010205|NCT05786950|Bromides|bromides|mesh-list
154010206|NCT05786950|Albuterol|albuterol|mesh-list
154010207|NCT05786950|Ipratropium|ipratropium|mesh-list
154010208|NCT05786950|Anticonvulsants|anticonvulsants|mesh-ancestor
154010222|NCT05786950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010224|NCT05786950|Cholinergic Agents|cholinergic agents|mesh-ancestor
154010225|NCT05786885|Vitamins|vitamins|mesh-list
154010226|NCT05786885|Ascorbic Acid|ascorbic acid|mesh-list
154010227|NCT05786885|Micronutrients|micronutrients|mesh-ancestor
154010228|NCT05786885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010229|NCT05786885|Antioxidants|antioxidants|mesh-ancestor
154010230|NCT05786885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010231|NCT05786885|Protective Agents|protective agents|mesh-ancestor
154010232|NCT05786859|Rifaximin|rifaximin|mesh-list
154010233|NCT05786859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010234|NCT05786859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010235|NCT05786859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154010236|NCT05786638|Immunomodulating Agents|immunomodulating agents|mesh-list
154010237|NCT05786638|Immunologic Factors|immunologic factors|mesh-ancestor
154010238|NCT05786638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010240|NCT05784688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010241|NCT05784688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010242|NCT05784688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154010243|NCT05784688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010244|NCT05764044|Gemcitabine|gemcitabine|mesh-list
154010245|NCT05764044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010246|NCT05764044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154010247|NCT05764044|Antimetabolites|antimetabolites|mesh-ancestor
154010248|NCT05764044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010249|NCT05706844|Anesthetics|anesthetics|mesh-list
154010250|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010251|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010252|NCT05702827|Meloxicam|meloxicam|mesh-list
154010253|NCT05702827|Bupivacaine|bupivacaine|mesh-list
154010254|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
154010255|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
154010256|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010257|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010258|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
154010259|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010260|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154010261|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154010262|NCT05702827|Analgesics|analgesics|mesh-ancestor
154010263|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154010264|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154010265|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154010266|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154010281|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010282|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010283|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010285|NCT05649293|Pyridoxal|pyridoxal|mesh-list
154010286|NCT05649293|Pyridoxine|pyridoxine|mesh-list
154010287|NCT05649293|Vitamins|vitamins|mesh-ancestor
154010289|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010290|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
154010291|NCT05618613|Onapristone|onapristone|mesh-list
154010292|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010293|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154010294|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
154010295|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154010296|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010297|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
154010298|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010299|NCT05617963|Durvalumab|durvalumab|mesh-list
154010300|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010301|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010302|NCT05587036|Rifaximin|rifaximin|mesh-list
154010303|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010304|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010305|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154010306|NCT05506046|Nicotine|nicotine|mesh-list
154010307|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154010308|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
154010309|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010310|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010311|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154010312|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154010313|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
154010314|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010315|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010316|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
154010317|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154010318|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
154010319|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154010320|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
154010321|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010322|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010323|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
154010324|NCT05452512|Vitamin D|vitamin d|mesh-list
154010325|NCT05452512|Vitamins|vitamins|mesh-list
154010326|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
154010327|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155337|NCT00988728|Olanzapine|olanzapine|mesh-list
154010328|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154010340|NCT05403723|Etoposide|etoposide|mesh-list
154010341|NCT05403723|Durvalumab|durvalumab|mesh-list
154010342|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010343|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154010344|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154010345|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154010346|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010347|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010348|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010349|NCT05386095|Bupivacaine|bupivacaine|mesh-list
154010350|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
154010351|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
154010352|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010353|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010354|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
154010355|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010356|NCT05360264|Decitabine|decitabine|mesh-list
154010357|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154010358|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
154010359|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010360|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010361|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010362|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154010363|NCT05321524|Cathartics|cathartics|mesh-ancestor
154010364|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154010365|NCT05280496|Metformin|metformin|mesh-list
154010366|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154010367|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010368|NCT05280457|Nivolumab|nivolumab|mesh-list
154010369|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010370|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010371|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154010372|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010373|NCT05247268|Letrozole|letrozole|mesh-list
154010374|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154010375|NCT05247268|Megestrol|megestrol|mesh-list
154010376|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
154010377|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
154010378|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010379|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154010380|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154010381|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010382|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010383|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154010384|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
154010385|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010386|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010387|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154010388|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154010389|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154010390|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
154010391|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154010392|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154010393|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154010394|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154010410|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154010411|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154010412|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010413|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010415|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010416|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010417|NCT04850911|Ketamine|ketamine|mesh-list
154010418|NCT04850911|Analgesics|analgesics|mesh-ancestor
154010419|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
154010420|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010421|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010422|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154010423|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154010424|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
154010425|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
154010426|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860961|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154010427|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154010428|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154010429|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010430|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010431|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
154010432|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154010433|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
154010434|NCT04807127|Durvalumab|durvalumab|mesh-list
154010435|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154010436|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010437|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010438|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010439|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
154010440|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154010441|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010442|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010443|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010444|NCT04642404|Cannabidiol|cannabidiol|mesh-list
154010445|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
154010446|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154010447|NCT04642352|Bupivacaine|bupivacaine|mesh-list
154010448|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
154010449|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
154010450|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010451|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010452|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
154010453|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582552|NCT02471690|Oritavancin|oritavancin|mesh-list
154010462|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
154010463|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010464|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154010465|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154010466|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154010467|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010468|NCT04594408|Epinephrine|epinephrine|mesh-list
154010469|NCT04594408|Racepinephrine|racepinephrine|mesh-list
154010470|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
154010471|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
154010472|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154010473|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154010474|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010475|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
154010476|NCT04594408|Coagulants|coagulants|mesh-ancestor
154010477|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154010478|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154010479|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010480|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010481|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010482|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154010483|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154010484|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
154010485|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010486|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154010487|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
154010488|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
154010489|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
154010490|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154010491|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
154010492|NCT04557215|Rifaximin|rifaximin|mesh-list
154010493|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154010494|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
154010495|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010496|NCT04557215|Expectorants|expectorants|mesh-ancestor
154010497|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
154010498|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154010499|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
154010500|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010501|NCT04557215|Protective Agents|protective agents|mesh-ancestor
154010502|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010503|NCT04557215|Antidotes|antidotes|mesh-ancestor
154010504|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010505|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154010506|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154010507|NCT04423627|Clonidine|clonidine|mesh-list
154010508|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154010509|NCT04423627|Diuretics|diuretics|mesh-ancestor
154010510|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
154010511|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010512|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154010513|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010514|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010515|NCT04423627|Analgesics|analgesics|mesh-ancestor
154010516|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
154010517|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010518|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
154010519|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
154010520|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154010521|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154010541|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154010542|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010543|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010544|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010545|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010546|NCT04208334|Curcumin|curcumin|mesh-list
154010547|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154010548|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154010549|NCT04208334|Analgesics|analgesics|mesh-ancestor
154010550|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
154010551|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010552|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010553|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154010554|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154010555|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010556|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010557|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010558|NCT04073797|Colchicine|colchicine|mesh-list
154010559|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
154010560|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154010561|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
154010562|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
154010564|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010565|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010566|NCT04027309|Midostaurin|midostaurin|mesh-list
154010567|NCT04027309|Gilteritinib|gilteritinib|mesh-list
154010568|NCT04027309|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154010569|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154010570|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010571|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010572|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010573|NCT03988933|Rifampin|rifampin|mesh-list
154010574|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154010575|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
154010576|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010577|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010586|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154010587|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154010588|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
154010589|NCT03958565|Denosumab|denosumab|mesh-list
154010590|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154010591|NCT03958565|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154010592|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154010593|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010594|NCT03958565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154010595|NCT03958565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010596|NCT03958565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010597|NCT03785925|Nivolumab|nivolumab|mesh-list
154010598|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010599|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010600|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154010601|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010602|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154010603|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
154010604|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010605|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010606|NCT03734692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154010607|NCT03734692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010608|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
154010609|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010610|NCT03700476|Gemcitabine|gemcitabine|mesh-list
154010611|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010612|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154010613|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
154010614|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010615|NCT03330106|Paclitaxel|paclitaxel|mesh-list
154010616|NCT03330106|Docetaxel|docetaxel|mesh-list
154010617|NCT03330106|Carboplatin|carboplatin|mesh-list
154010618|NCT03330106|Pevonedistat|pevonedistat|mesh-list
154010619|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154010620|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010621|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
154010622|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
154010623|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
154010624|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010625|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010626|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
154010627|NCT03239145|Trebananib|trebananib|mesh-list
154010628|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010629|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010630|NCT03239145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154010631|NCT03239145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010632|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154010633|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154010634|NCT03239145|Growth Substances|growth substances|mesh-ancestor
154010635|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010637|NCT03164564|Tenofovir|tenofovir|mesh-list
154010638|NCT03164564|Emtricitabine|emtricitabine|mesh-list
154010639|NCT03164564|Cabotegravir|cabotegravir|mesh-list
154010640|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
154010641|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582734|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
154010656|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010657|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
154010658|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
154010659|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
154010660|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010661|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154010662|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
154010663|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154010664|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010665|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154010666|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
154010667|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
154010668|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010669|NCT02987257|Cyclosporine|cyclosporine|mesh-list
154010670|NCT02987257|Etanercept|etanercept|mesh-list
154010671|NCT02987257|Cyclosporins|cyclosporins|mesh-list
154010672|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010673|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010674|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154010675|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
154010676|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010677|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
154010678|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010679|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
154010680|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154010681|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154010682|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154010683|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154010684|NCT02987257|Analgesics|analgesics|mesh-ancestor
154010685|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
154010686|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010687|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154010688|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154010689|NCT02821754|Durvalumab|durvalumab|mesh-list
154010690|NCT02821754|Tremelimumab|tremelimumab|mesh-list
154010691|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010692|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010693|NCT02781883|Decitabine|decitabine|mesh-list
154010694|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154010695|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
154010696|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010697|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010698|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731574|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
153731575|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153731576|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731577|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153731578|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
153731579|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153731580|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731581|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010699|NCT02617589|Nivolumab|nivolumab|mesh-list
154010700|NCT02617589|Temozolomide|temozolomide|mesh-list
154010701|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010702|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010703|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582800|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
154010714|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010715|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010716|NCT02540707|Urological Agents|urological agents|mesh-ancestor
154010717|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154010718|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154010719|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
154010721|NCT02504346|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154010722|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154010723|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010724|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010725|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010726|NCT02340169|Desoximetasone|desoximetasone|mesh-list
154010727|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154010728|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
154010730|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010731|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010732|NCT01899326|Desipramine|desipramine|mesh-list
154010733|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010734|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154010735|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
153768297|NCT00126347|Folic Acid|folic acid|mesh-list
154010736|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154010737|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010738|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010739|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154010740|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154010741|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010742|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010743|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010744|NCT01515137|Sulindac|sulindac|mesh-list
154010745|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153782001|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010746|NCT01515137|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154010747|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154010748|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010749|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010750|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010751|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154010752|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154010753|NCT01515137|Analgesics|analgesics|mesh-ancestor
154010754|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
154010755|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010756|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010757|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154010758|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154010759|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154010760|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
154010761|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010762|NCT01126190|Docetaxel|docetaxel|mesh-list
154010763|NCT01126190|Doxorubicin|doxorubicin|mesh-list
154010764|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010775|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
154010776|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010777|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154010778|NCT00323037|Carvedilol|carvedilol|mesh-list
154010779|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154010780|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154010781|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010782|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010783|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010784|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010785|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154010787|NCT00323037|Protective Agents|protective agents|mesh-ancestor
154010788|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154010789|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010790|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154010791|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
154010792|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154010793|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154010795|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154010796|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010797|NCT00939185|Azithromycin|azithromycin|mesh-list
154010798|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010799|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010800|NCT02808104|Mazindol|mazindol|mesh-list
154010801|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154010802|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010803|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154010804|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154010805|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010806|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010807|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010808|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010809|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154010810|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
154010811|NCT05165771|Tofacitinib|tofacitinib|mesh-list
154010812|NCT05165771|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154010813|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154010814|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010815|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010816|NCT02730624|Tazobactam|tazobactam|mesh-list
154010817|NCT02730624|Piperacillin|piperacillin|mesh-list
154010818|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154010819|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010820|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010821|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154010822|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010823|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010824|NCT02807870|Methylphenidate|methylphenidate|mesh-list
154010825|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154010826|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010827|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153582920|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010842|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010844|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010845|NCT00925951|Acetaminophen|acetaminophen|mesh-list
154010846|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154010847|NCT00925951|Analgesics|analgesics|mesh-ancestor
154010848|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
154010849|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010850|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010851|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
154010852|NCT00933205|Tipranavir|tipranavir|mesh-list
154010853|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154010854|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153664627|NCT00013871|Vaccines|vaccines|mesh-list
154010856|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010857|NCT02813486|Vaccines|vaccines|mesh-list
154010858|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
154010859|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010860|NCT02739516|Letrozole|letrozole|mesh-list
154010861|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154010862|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010863|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154010864|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154010865|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010866|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010867|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154010868|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
154010869|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010870|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010871|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154010872|NCT00933283|Methadone|methadone|mesh-list
154010873|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154010874|NCT00933283|Narcotics|narcotics|mesh-ancestor
154010875|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010876|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010877|NCT00933283|Analgesics|analgesics|mesh-ancestor
154010878|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
154010879|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010880|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
154010881|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
154010882|NCT02813018|Ropivacaine|ropivacaine|mesh-list
154010883|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
154010885|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010886|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010887|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
154010888|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010896|NCT04173962|Analgesics|analgesics|mesh-ancestor
154010897|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
154010898|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010899|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010900|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154010901|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154010902|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
154010903|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
154010904|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010905|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154010906|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154010907|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010908|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010909|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154010910|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154010911|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154010912|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154010913|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154010914|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
154010915|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
154010917|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154010918|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010919|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154010920|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154010921|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154582994|NCT05394350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154010922|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010923|NCT04262999|Levetiracetam|levetiracetam|mesh-list
154010924|NCT04262999|Valproic Acid|valproic acid|mesh-list
154010925|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
154010926|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
154010927|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010928|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010929|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
153664694|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
154010930|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010931|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010932|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
154010933|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154010934|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010935|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154010936|NCT00926107|Sirolimus|sirolimus|mesh-list
154010937|NCT00926107|Temsirolimus|temsirolimus|mesh-list
154010938|NCT00926107|MTOR Inhibitors|mtor inhibitors|mesh-list
154010939|NCT00926107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154010940|NCT00926107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010941|NCT00926107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010942|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154010943|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
154010944|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010945|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010946|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154010947|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154010948|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154010949|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
154010950|NCT02729766|Empagliflozin|empagliflozin|mesh-list
154010951|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154010952|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010953|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154010954|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010955|NCT02812940|Everolimus|everolimus|mesh-list
154010956|NCT02812940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153583044|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
154010972|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
154010973|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155848|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154010974|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
154010975|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154010977|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
154010978|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
154010979|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154010980|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010981|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010982|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
154010983|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154010984|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010985|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010986|NCT02809742|Ropivacaine|ropivacaine|mesh-list
154010987|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
154010988|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
154010989|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154010990|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010991|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
154010992|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010993|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
154010994|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154010995|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
154010996|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010997|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010998|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154010999|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
154011000|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154011001|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154011002|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154176579|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011003|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
154011004|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011005|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011006|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
154011007|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011008|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583111|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
154011031|NCT00926341|Telmisartan|telmisartan|mesh-list
154011032|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154011033|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011034|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154011035|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154011036|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154011037|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011039|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
154011040|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011041|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
154011042|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154011043|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011044|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011045|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154011046|NCT00608231|Analgesics|analgesics|mesh-ancestor
154011047|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
154011048|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011049|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154011050|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154011051|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154011052|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
154011053|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011054|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011055|NCT02739204|Celecoxib|celecoxib|mesh-list
154011056|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154011057|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154011058|NCT02739204|Analgesics|analgesics|mesh-ancestor
154011059|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
154011081|NCT00926653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154011082|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154011083|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154011084|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860962|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011086|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
154011087|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011088|NCT02733822|Naloxone|naloxone|mesh-list
154011089|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154011090|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011091|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
154011092|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011093|NCT00930241|Tacrolimus|tacrolimus|mesh-list
154011094|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011095|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
154011096|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011097|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154011098|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011099|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011100|NCT04260269|Trifluridine|trifluridine|mesh-list
154011101|NCT04260269|Capecitabine|capecitabine|mesh-list
154011103|NCT04260269|Tegafur|tegafur|mesh-list
154011104|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154011105|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
154011106|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011107|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011108|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011109|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
154011110|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011122|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
154011123|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011124|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011125|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
154011126|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011128|NCT00926809|Clarithromycin|clarithromycin|mesh-list
154011129|NCT00926809|Lansoprazole|lansoprazole|mesh-list
154011130|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
154011131|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154011132|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154011133|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011134|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154011135|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011136|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011137|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154011138|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154011139|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154011140|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154011141|NCT02805920|Bupivacaine|bupivacaine|mesh-list
154011142|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
154011143|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
154011144|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011145|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011146|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
154011147|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011148|NCT04262765|Amlodipine|amlodipine|mesh-list
154011149|NCT04262765|Ramipril|ramipril|mesh-list
154011150|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
154011151|NCT04262765|Atorvastatin|atorvastatin|mesh-list
154011152|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154011153|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154011154|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
154011155|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011156|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154011157|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154011158|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011159|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154011160|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154011161|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154011162|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154011163|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011164|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
154011165|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154011166|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
154011167|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
154011168|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154011169|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154011170|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154011171|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154011172|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011173|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
154011191|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011192|NCT00609401|Sorafenib|sorafenib|mesh-list
154011193|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011194|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154011195|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011196|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011197|NCT02805842|Tacrolimus|tacrolimus|mesh-list
154011198|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011199|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
154011200|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011201|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154011202|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011203|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011204|NCT00926965|Olanzapine|olanzapine|mesh-list
154011205|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
154011206|NCT00926965|Amisulpride|amisulpride|mesh-list
154011207|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
154011208|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
154011209|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011210|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011211|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154011212|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154011213|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011214|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154011215|NCT00926965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154011216|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154011217|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154011218|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011219|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011220|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
154176580|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
154011221|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154011222|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
154011223|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154011224|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
154011225|NCT04260113|Apatinib|apatinib|mesh-list
154011226|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011227|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154011250|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011252|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
154011253|NCT02733510|Hormones|hormones|mesh-ancestor
154011254|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011255|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154011256|NCT02733510|Protective Agents|protective agents|mesh-ancestor
154011257|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154011258|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011259|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154011260|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154011261|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011262|NCT00933985|Doxorubicin|doxorubicin|mesh-list
154011263|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154011264|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
154011265|NCT00933985|Vincristine|vincristine|mesh-list
154011266|NCT00933985|Razoxane|razoxane|mesh-list
154011267|NCT00933985|Obatoclax|obatoclax|mesh-list
154011268|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154011269|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011270|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154011271|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153782005|NCT04566211|Clarithromycin|clarithromycin|mesh-list
153413729|NCT05731778|Listerine|listerine|mesh-list
154011272|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011273|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011274|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154011275|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
154011276|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
154011277|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
154011278|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154011279|NCT00933985|Protective Agents|protective agents|mesh-ancestor
154011290|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154011291|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011292|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154011293|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
154011294|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
154011295|NCT00930475|Carboplatin|carboplatin|mesh-list
154011296|NCT00930475|Everolimus|everolimus|mesh-list
154011297|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011299|NCT00930475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154011300|NCT00930475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011301|NCT00930475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011302|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011303|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
154011304|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011305|NCT05623592|Methotrexate|methotrexate|mesh-list
154011306|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154011307|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
154011308|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154011309|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011310|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154011311|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
154011312|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011313|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011314|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
154011315|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011316|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154011317|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011318|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
154011319|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011320|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154011322|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154011323|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768902|NCT00226473|Vindesine|vindesine|mesh-list
154011324|NCT00634400|Candesartan|candesartan|mesh-list
154011325|NCT00634400|Candesartan cilexetil|candesartan cilexetil|mesh-list
154011326|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154011327|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154011328|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154011329|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011330|NCT04262375|Durvalumab|durvalumab|mesh-list
154011331|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011332|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011333|NCT00936793|Ritonavir|ritonavir|mesh-list
154011334|NCT00936793|Darunavir|darunavir|mesh-list
154011335|NCT00936793|Beclomethasone|beclomethasone|mesh-list
154011336|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154011337|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154011338|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
154011339|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011340|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011341|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154011342|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154011343|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
154011344|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011352|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154011353|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
154011354|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
154011355|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154011356|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154011357|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
154011358|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011359|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011360|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011361|NCT02805452|Urological Agents|urological agents|mesh-ancestor
154011362|NCT00937027|Aminopterin|aminopterin|mesh-list
154011363|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154011364|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011365|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011366|NCT02738502|Ritonavir|ritonavir|mesh-list
154011367|NCT02738502|Darunavir|darunavir|mesh-list
154011368|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154011369|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154011370|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
154011371|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011372|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011373|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154011374|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154011375|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
154011376|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011377|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154011378|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154011379|NCT04261907|Ritonavir|ritonavir|mesh-list
154011380|NCT04261907|Lopinavir|lopinavir|mesh-list
154011381|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154011382|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154011383|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
154011384|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011385|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011386|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154011387|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154011388|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
154011389|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011390|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154011391|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154011392|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
154011393|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154011394|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154011395|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154011396|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154011397|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011398|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
154011399|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011400|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011401|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154011402|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011403|NCT02738346|Carboplatin|carboplatin|mesh-list
154011404|NCT02738346|Etoposide|etoposide|mesh-list
154011405|NCT02738346|Topotecan|topotecan|mesh-list
154011406|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011407|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154011408|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154011409|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154011410|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011416|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154011417|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011418|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011419|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154011420|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
154011421|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011422|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011423|NCT00937183|Vaccines|vaccines|mesh-list
154011424|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
154011425|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011426|NCT00937261|Risperidone|risperidone|mesh-list
154011427|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154011428|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154011429|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
154011430|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011431|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011432|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011433|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154011434|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154011435|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011436|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154011437|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154011438|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
154011439|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154011440|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154011441|NCT05906433|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154011442|NCT05906433|Triamcinolone|triamcinolone|mesh-list
154011443|NCT05906433|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154011444|NCT05906433|Bupivacaine|bupivacaine|mesh-list
154011445|NCT05906433|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154011446|NCT05906433|Anesthetics, Local|anesthetics, local|mesh-ancestor
154011447|NCT05906433|Anesthetics|anesthetics|mesh-ancestor
154011448|NCT05906433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011449|NCT05906433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011450|NCT05906433|Sensory System Agents|sensory system agents|mesh-ancestor
154011451|NCT05906433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011452|NCT05906433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011453|NCT05906433|Glucocorticoids|glucocorticoids|mesh-ancestor
154011454|NCT05906433|Hormones|hormones|mesh-ancestor
154011455|NCT05906433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011456|NCT05906433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156227|NCT06271486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154011457|NCT05906433|Immunologic Factors|immunologic factors|mesh-ancestor
154011458|NCT05906433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011459|NCT05906433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011460|NCT05906225|Anesthetics|anesthetics|mesh-list
154011461|NCT05906225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011462|NCT05906225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011463|NCT05906199|Aspirin|aspirin|mesh-list
154011464|NCT05906199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154011465|NCT05906199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154011466|NCT05906199|Analgesics|analgesics|mesh-ancestor
154011467|NCT05906199|Sensory System Agents|sensory system agents|mesh-ancestor
154011468|NCT05906199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011469|NCT05906199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011470|NCT05906199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011471|NCT05906199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011472|NCT05906199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154011473|NCT05906199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154011474|NCT05906199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011475|NCT05906199|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154011476|NCT05906199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154011477|NCT05906199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583577|NCT01756508|Eculizumab|eculizumab|mesh-list
154011493|NCT05905757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011494|NCT05905757|Sensory System Agents|sensory system agents|mesh-ancestor
154011495|NCT05905757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011496|NCT05905757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154011498|NCT05905757|Analgesics|analgesics|mesh-ancestor
154011499|NCT05905757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154011500|NCT05905757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154011501|NCT05905757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154011502|NCT05905757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154011503|NCT05905757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154011504|NCT05905757|Adrenergic Agents|adrenergic agents|mesh-ancestor
154011505|NCT05905757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011506|NCT05905757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011507|NCT05905653|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154011508|NCT05905653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154011509|NCT05905484|Moxifloxacin|moxifloxacin|mesh-list
154011510|NCT05905484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154011511|NCT05905484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011512|NCT05905484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154011513|NCT05905484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154011514|NCT05905484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011515|NCT05905484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011516|NCT05905484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011517|NCT05905315|Paclitaxel|paclitaxel|mesh-list
154011518|NCT05905315|Carboplatin|carboplatin|mesh-list
154011519|NCT05905315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154011520|NCT05905315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011521|NCT05905315|Tubulin Modulators|tubulin modulators|mesh-ancestor
154011522|NCT05905315|Antimitotic Agents|antimitotic agents|mesh-ancestor
154011523|NCT05905315|Mitosis Modulators|mitosis modulators|mesh-ancestor
154011524|NCT05905315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011525|NCT05905185|Vitamin E|vitamin e|mesh-list
154011526|NCT05905185|Tocopherols|tocopherols|mesh-list
154011527|NCT05905185|Tocotrienols|tocotrienols|mesh-list
154011528|NCT05905185|Vitamins|vitamins|mesh-ancestor
154011529|NCT05905185|Micronutrients|micronutrients|mesh-ancestor
154011530|NCT05905185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011531|NCT05905185|Antioxidants|antioxidants|mesh-ancestor
154011532|NCT05905185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011533|NCT05905185|Protective Agents|protective agents|mesh-ancestor
154011534|NCT05843565|Cobalt|cobalt|mesh-list
154011535|NCT05843565|Trace Elements|trace elements|mesh-ancestor
154011536|NCT05843565|Micronutrients|micronutrients|mesh-ancestor
154011537|NCT05843565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011538|NCT05838703|Bromides|bromides|mesh-list
154011539|NCT05838703|Tiotropium Bromide|tiotropium bromide|mesh-list
154011550|NCT05838703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011551|NCT05838703|Anticonvulsants|anticonvulsants|mesh-ancestor
154011552|NCT05807048|Daratumumab|daratumumab|mesh-list
153414390|NCT04341727|Amebicides|amebicides|mesh-ancestor
154011553|NCT05807048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011554|NCT05789992|Remifentanil|remifentanil|mesh-list
154011555|NCT05789992|Propofol|propofol|mesh-list
154860963|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156298|NCT06270407|Hemostatics|hemostatics|mesh-ancestor
154011556|NCT05789992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154011557|NCT05789992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011558|NCT05789992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011559|NCT05789992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154011560|NCT05789992|Anesthetics, General|anesthetics, general|mesh-ancestor
154011561|NCT05789992|Anesthetics|anesthetics|mesh-ancestor
154011562|NCT05789992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154011563|NCT05789992|Narcotics|narcotics|mesh-ancestor
154011564|NCT05789992|Analgesics|analgesics|mesh-ancestor
154011565|NCT05789992|Sensory System Agents|sensory system agents|mesh-ancestor
154011566|NCT05789992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011567|NCT05764993|Immunoglobulins|immunoglobulins|mesh-list
154011568|NCT05764993|gamma-Globulins|gamma-globulins|mesh-list
154011569|NCT05764993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154011570|NCT05764993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154011571|NCT05764993|Immunologic Factors|immunologic factors|mesh-ancestor
154011572|NCT05764993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011573|NCT05743192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154011574|NCT05743192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011575|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
154011576|NCT05701501|Vitamins|vitamins|mesh-ancestor
154011577|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
154011578|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011579|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
154011580|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
154011581|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154011582|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
154011583|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154011584|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011585|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154011586|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154011587|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154011588|NCT05681273|Empagliflozin|empagliflozin|mesh-list
154011589|NCT05681273|Valsartan|valsartan|mesh-list
154011590|NCT05681273|Atorvastatin|atorvastatin|mesh-list
154011591|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154011592|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154011593|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
154011594|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011595|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154011596|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154011597|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011598|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154011599|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154011600|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154011601|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154011602|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154011603|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011604|NCT05656742|Vitamin D|vitamin d|mesh-list
154011605|NCT05656742|Vitamins|vitamins|mesh-ancestor
154011636|NCT05431582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154011637|NCT05431582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011638|NCT05384756|Sirolimus|sirolimus|mesh-list
154011639|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154011640|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
154011641|NCT05384756|Antibodies|antibodies|mesh-list
154011642|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
154011643|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154011644|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
154011645|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011646|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011647|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154011648|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011649|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154011650|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
154011676|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154011677|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
154011678|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011679|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011681|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154011682|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
154011683|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011684|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011685|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154860964|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154156374|NCT06269705|Immunologic Factors|immunologic factors|mesh-ancestor
154011686|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154011687|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
154011688|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011689|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011690|NCT05169008|Vaccines|vaccines|mesh-list
154011691|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
154011692|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011693|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
154011694|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154011695|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011696|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
154011697|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011698|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
154011699|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011700|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011701|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154011702|NCT04537156|Vaccines|vaccines|mesh-list
154011703|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
154011704|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011737|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011738|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011739|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
154011740|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011741|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154011742|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011743|NCT04391309|Remdesivir|remdesivir|mesh-list
154011744|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
154011745|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011746|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
153583866|NCT01758120|Prednisone|prednisone|mesh-list
154011767|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011768|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154011770|NCT04352205|Hormones|hormones|mesh-ancestor
154011771|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011772|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154011773|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011774|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
154011775|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011776|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011777|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
154011778|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154011779|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154011781|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
154011782|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011783|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
154011784|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154011785|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011786|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
154011787|NCT04339140|Zafirlukast|zafirlukast|mesh-list
154011788|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154011789|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
154011790|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154011791|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
154011792|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011793|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011794|NCT04337827|Rituximab|rituximab|mesh-list
154011795|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
154011796|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011797|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011798|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
154011799|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011800|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011801|NCT04337827|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154011802|NCT04337827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154011803|NCT04337827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011804|NCT04337827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011805|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
154011851|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011852|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154011853|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011854|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860965|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154011855|NCT04136756|Rituximab|rituximab|mesh-list
154011856|NCT04136756|Daratumumab|daratumumab|mesh-list
154011857|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011858|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011859|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
154011860|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011861|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011862|NCT04056624|Carotenoids|carotenoids|mesh-list
154011863|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
154011864|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011865|NCT04056624|Protective Agents|protective agents|mesh-ancestor
154011866|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011891|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154011892|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154011893|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154011894|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154011895|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154011896|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154011897|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154011898|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
154011899|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011909|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
154011910|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154011911|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
154011912|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
154011913|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011914|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011915|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
154011916|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011917|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
154011918|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011919|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011920|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154011921|NCT03728556|Antibodies|antibodies|mesh-list
154011922|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154011923|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
154011924|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011925|NCT03634228|Cytarabine|cytarabine|mesh-list
153769502|NCT00204386|Topiramate|topiramate|mesh-list
154011926|NCT03634228|Venetoclax|venetoclax|mesh-list
154011927|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154011928|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
154011929|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011930|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011931|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
154011932|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011933|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011934|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
154011935|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011936|NCT03612973|Insulin|insulin|mesh-list
154011937|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154011938|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011939|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
154011940|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011941|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011942|NCT03603223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154011943|NCT03603223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011944|NCT03587142|Buspirone|buspirone|mesh-list
154011945|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154011946|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154011947|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011948|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011949|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154011950|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154011951|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
154011952|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011953|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011954|NCT03532139|Enoxaparin|enoxaparin|mesh-list
154011955|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
154011956|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154011957|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154011958|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154011959|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
154011960|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011961|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154860966|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154011962|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154011963|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011964|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
154011971|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153782013|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154011972|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011973|NCT03493854|Paclitaxel|paclitaxel|mesh-list
154011974|NCT03493854|Docetaxel|docetaxel|mesh-list
154011975|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
154011976|NCT03493854|Doxorubicin|doxorubicin|mesh-list
154011977|NCT03493854|Trastuzumab|trastuzumab|mesh-list
154011978|NCT03493854|Pertuzumab|pertuzumab|mesh-list
154011979|NCT03493854|Hormones|hormones|mesh-list
154011980|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154011981|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011982|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
154011983|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
154011984|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
154011985|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011986|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011987|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
154011988|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011989|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011990|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154011991|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
154011992|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154011993|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154011994|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154011995|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154011996|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011997|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011998|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011999|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
154012000|NCT03384277|Rituximab|rituximab|mesh-list
154012001|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012002|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
154012003|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012004|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012005|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154012006|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
154012007|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012008|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012009|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154012010|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012011|NCT03370367|Tretinoin|tretinoin|mesh-list
154012012|NCT03370367|Isotretinoin|isotretinoin|mesh-list
154012013|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012014|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
154012015|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
154012016|NCT03317457|Doxorubicin|doxorubicin|mesh-list
154012017|NCT03317457|Durvalumab|durvalumab|mesh-list
154012018|NCT03317457|Tremelimumab|tremelimumab|mesh-list
154012019|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154012020|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012021|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154012022|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154012023|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012024|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012025|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012026|NCT03267836|Avelumab|avelumab|mesh-list
154012027|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012028|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012029|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
154012030|NCT03197506|Temozolomide|temozolomide|mesh-list
154012031|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153584084|NCT01759576|Canagliflozin|canagliflozin|mesh-list
154012049|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012050|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154012051|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154012052|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012053|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
154012054|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154012055|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154012056|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154012057|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
154012058|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860967|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154156600|NCT06265415|Sympathomimetics|sympathomimetics|mesh-ancestor
154012059|NCT03032484|Bevacizumab|bevacizumab|mesh-list
154012060|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012061|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012062|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154012063|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154012064|NCT03032484|Growth Substances|growth substances|mesh-ancestor
154012065|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012066|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
154012068|NCT03003546|Rituximab|rituximab|mesh-list
154012069|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154012070|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012071|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012072|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012073|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012074|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012075|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012076|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012078|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012079|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012080|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154012081|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
154012082|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012083|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
154012084|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012085|NCT02955394|Fulvestrant|fulvestrant|mesh-list
153584163|NCT01759810|Vaccines|vaccines|mesh-list
154012094|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154012096|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
154012097|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012098|NCT02675829|Trastuzumab|trastuzumab|mesh-list
154012099|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154012100|NCT02675829|Maytansine|maytansine|mesh-list
154012101|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012102|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012103|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012104|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012105|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012106|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012107|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012108|NCT02675829|Immunotoxins|immunotoxins|mesh-ancestor
154012109|NCT02675829|Immunoconjugates|immunoconjugates|mesh-ancestor
154012110|NCT02675829|Immunologic Factors|immunologic factors|mesh-ancestor
154012111|NCT02675829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012112|NCT02554851|Mitogens|mitogens|mesh-list
154012113|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012114|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012115|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154012116|NCT02520141|Ramucirumab|ramucirumab|mesh-list
154012117|NCT02520141|Antibodies|antibodies|mesh-list
154012118|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
154012119|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154012120|NCT02520141|Lexatumumab|lexatumumab|mesh-list
154012121|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
154012122|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012123|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012124|NCT02520141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154012125|NCT02520141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154012126|NCT02520141|Growth Substances|growth substances|mesh-ancestor
154012127|NCT02520141|Growth Inhibitors|growth inhibitors|mesh-ancestor
154012128|NCT02513875|Vitamin D|vitamin d|mesh-list
154012129|NCT02513875|Vitamins|vitamins|mesh-ancestor
154012130|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
154012131|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012132|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154012133|NCT02329847|Nivolumab|nivolumab|mesh-list
154012134|NCT02329847|Ibrutinib|ibrutinib|mesh-list
154012135|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012136|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012137|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154012138|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012139|NCT02329847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154012140|NCT02329847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154012141|NCT02329847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012142|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
154012143|NCT02287428|Temozolomide|temozolomide|mesh-list
154012144|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012145|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012146|NCT02287428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154012147|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012148|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154012149|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
153769725|NCT00410033|Insulin|insulin|mesh-list
153584207|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012180|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012181|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012182|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012183|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
154012184|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154012185|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154012186|NCT02119468|Growth Substances|growth substances|mesh-ancestor
154012187|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
154012188|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
154012189|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012190|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
154012191|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012192|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154012193|NCT01935921|Cetuximab|cetuximab|mesh-list
154012194|NCT01935921|Ipilimumab|ipilimumab|mesh-list
154012195|NCT01935921|Antibodies|antibodies|mesh-list
154012196|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
154012216|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154012217|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154012218|NCT01552434|Growth Substances|growth substances|mesh-ancestor
154012219|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012220|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
154012221|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
154012222|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154012223|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012224|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154012225|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
154012226|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012227|NCT01552434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154012228|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012229|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012230|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
154012232|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012233|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
154012234|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154012235|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012236|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154012237|NCT01164228|Gemcitabine|gemcitabine|mesh-list
154012238|NCT01164228|Sunitinib|sunitinib|mesh-list
154012239|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012240|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
154012241|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012242|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012243|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154012244|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154012245|NCT01164228|Growth Substances|growth substances|mesh-ancestor
154012246|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012247|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
154012248|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154012249|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012250|NCT00641030|Melphalan|melphalan|mesh-list
154012251|NCT00641030|Clofarabine|clofarabine|mesh-list
154012252|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154012253|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
154012254|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012255|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012268|NCT00209586|Fospropofol|fospropofol|mesh-list
154012269|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154012270|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012271|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012272|NCT00082797|Leucovorin|leucovorin|mesh-list
154012273|NCT00082797|Methotrexate|methotrexate|mesh-list
154012274|NCT00082797|Calcium|calcium|mesh-list
154012275|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
154012276|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154012277|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012278|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154860968|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154156749|NCT06260618|Anticoagulants|anticoagulants|mesh-ancestor
154012279|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
154012280|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154012281|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012282|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
154012283|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012284|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012285|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
154012286|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012287|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154012288|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012289|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
154012290|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012291|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154012292|NCT00082797|Antidotes|antidotes|mesh-ancestor
154012293|NCT00082797|Protective Agents|protective agents|mesh-ancestor
154012294|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
154012295|NCT00082797|Vitamins|vitamins|mesh-ancestor
154012296|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
154012297|NCT00060398|Dexamethasone|dexamethasone|mesh-list
154012298|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
154012299|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012300|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
154012301|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
154012302|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012303|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012304|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154012305|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
154012307|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012308|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012309|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012310|NCT00060398|Hematinics|hematinics|mesh-ancestor
154012311|NCT00054561|Vitamin E|vitamin e|mesh-list
154012312|NCT00054561|Interferons|interferons|mesh-list
154012313|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
154012314|NCT00054561|Isotretinoin|isotretinoin|mesh-list
154012315|NCT00054561|Vitamins|vitamins|mesh-ancestor
154012316|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
154012317|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012318|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012319|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
154012320|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012321|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
153584379|NCT01760694|Vitamins|vitamins|mesh-ancestor
154012333|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
154012334|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012335|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012336|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154012337|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
154012338|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012339|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012340|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154012341|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012342|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
154012343|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
154012344|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012345|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154012346|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154012347|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154012348|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012349|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012350|NCT00049517|Immunotoxins|immunotoxins|mesh-ancestor
154012351|NCT00049517|Immunoconjugates|immunoconjugates|mesh-ancestor
154012352|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
154012353|NCT00041314|Carboplatin|carboplatin|mesh-list
154012355|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012356|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012357|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
154012358|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012359|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154012360|NCT00041314|Protective Agents|protective agents|mesh-ancestor
154012361|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012362|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154012363|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012364|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154012365|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154012366|NCT00041314|Analgesics|analgesics|mesh-ancestor
154012367|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
154012368|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012369|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012370|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012371|NCT00028990|Paclitaxel|paclitaxel|mesh-list
154012372|NCT00028990|Bevacizumab|bevacizumab|mesh-list
154012373|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012374|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012375|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012376|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
153769956|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012377|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012378|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012379|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154012380|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154012381|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154012382|NCT00028990|Growth Substances|growth substances|mesh-ancestor
154012383|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012384|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
154012386|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
154012387|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154012388|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154012408|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154012409|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
154012410|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012411|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154012412|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
154012413|NCT00026286|Estrogens|estrogens|mesh-list
154012414|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154012415|NCT00026286|Hormones|hormones|mesh-ancestor
154012416|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012417|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012418|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154012419|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154012420|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154012421|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
154012422|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154012423|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154012424|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154012425|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154012426|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012427|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012428|NCT00014118|Paclitaxel|paclitaxel|mesh-list
154012429|NCT00014118|Carboplatin|carboplatin|mesh-list
154012430|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012431|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012432|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012433|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012434|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012435|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012436|NCT00006004|Paclitaxel|paclitaxel|mesh-list
154012437|NCT00006004|Carboplatin|carboplatin|mesh-list
154012438|NCT00006004|Gemcitabine|gemcitabine|mesh-list
154012439|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012440|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012441|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012457|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
154012458|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012459|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
154012460|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012461|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012462|NCT00003864|Carboplatin|carboplatin|mesh-list
154012463|NCT00003864|Docetaxel|docetaxel|mesh-list
154012464|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012465|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012466|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012467|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012468|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012469|NCT00003810|Gemcitabine|gemcitabine|mesh-list
154012470|NCT00003810|Docetaxel|docetaxel|mesh-list
154012471|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012472|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
154012473|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012474|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255091|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012475|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012476|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012477|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012478|NCT00003701|Paclitaxel|paclitaxel|mesh-list
154012479|NCT00003701|Vinblastine|vinblastine|mesh-list
154012480|NCT00003701|Carboplatin|carboplatin|mesh-list
154012481|NCT00003701|Doxorubicin|doxorubicin|mesh-list
154012482|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154012483|NCT00003701|Methotrexate|methotrexate|mesh-list
154012484|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012485|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012486|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012487|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012488|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012489|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012490|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154012491|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154012492|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154012493|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012494|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154012495|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
154012496|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154012497|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012498|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012499|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
154012500|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
154012501|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154012502|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012503|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
154012504|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012505|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154012529|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012530|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012531|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154012532|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012533|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012534|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012535|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154012536|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154012537|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154012538|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012540|NCT00003283|Octreotide|octreotide|mesh-list
154012541|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012542|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
154012543|NCT00003283|Hormones|hormones|mesh-ancestor
154012544|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012545|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012546|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012547|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012548|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154012549|NCT00003235|Paclitaxel|paclitaxel|mesh-list
154012550|NCT00003235|Carboplatin|carboplatin|mesh-list
154012551|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012552|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012553|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012554|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012555|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012556|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012557|NCT00003206|Paclitaxel|paclitaxel|mesh-list
154012558|NCT00003206|Carboplatin|carboplatin|mesh-list
153584622|NCT01762163|Aspirin|aspirin|mesh-list
154012579|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154012580|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154012581|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
154012582|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012583|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154012584|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154012585|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
154012586|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012587|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154012588|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154012589|NCT00002996|Flecainide|flecainide|mesh-list
154012590|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154860969|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
154860970|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
154860971|NCT03493828|Bupivacaine|bupivacaine|mesh-list
154012591|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154012592|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154012593|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154012594|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012595|NCT00002878|Dexamethasone|dexamethasone|mesh-list
154012596|NCT00002878|Doxorubicin|doxorubicin|mesh-list
154012597|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154012598|NCT00002878|Vincristine|vincristine|mesh-list
154012599|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012600|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
154012601|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
154012602|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012603|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012604|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154012605|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
154012606|NCT00002878|Hormones|hormones|mesh-ancestor
154012607|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012609|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012610|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154012611|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154012612|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154012613|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584674|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154012620|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012622|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012623|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012624|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012625|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012626|NCT00002520|Nicotine|nicotine|mesh-list
154012627|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154012628|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
154012629|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012630|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012631|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154012632|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154012633|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
154012634|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012635|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012636|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154012637|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154012638|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154012639|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154012640|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012641|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012642|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012643|NCT00609557|Analgesics|analgesics|mesh-ancestor
154012644|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
154012645|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012646|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
154012647|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154012648|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
154012649|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
154012650|NCT05122481|Vitamins|vitamins|mesh-ancestor
154012651|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
154012652|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012653|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
154012654|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012656|NCT00937417|Docetaxel|docetaxel|mesh-list
154012657|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012658|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012659|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012660|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012661|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012662|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154012663|NCT02728440|Menotropins|menotropins|mesh-list
154012664|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154012665|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012666|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154012667|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
154012668|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154012669|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
154012670|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
154012671|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154012672|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154012673|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012674|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012675|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012676|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012677|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
154012678|NCT00930865|Bumetanide|bumetanide|mesh-list
154012679|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154012680|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012681|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154012691|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154012692|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012693|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154012694|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012695|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012697|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154012698|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012699|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012700|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
154012701|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012702|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012703|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
154012704|NCT00931021|Nicotine|nicotine|mesh-list
154012705|NCT00931021|Varenicline|varenicline|mesh-list
154012706|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154012707|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
154012708|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012709|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012710|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154012711|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154012712|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
154012713|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012714|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012715|NCT00937807|Sevoflurane|sevoflurane|mesh-list
154012716|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154012717|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154012718|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
154012719|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
154012720|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012721|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012722|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
154012723|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154012724|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154012725|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154012726|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154012727|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012728|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
154012729|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012730|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012731|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154012732|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012734|NCT02808728|Ropivacaine|ropivacaine|mesh-list
154012735|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
154012736|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
154012737|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012738|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012739|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
154012740|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012741|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154012742|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154012743|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154012744|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584797|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
154012754|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012756|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
154012757|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154012758|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
154012759|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012760|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012761|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154012762|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
154012763|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
154012764|NCT04996667|Protective Agents|protective agents|mesh-ancestor
154012766|NCT00929669|Hormones|hormones|mesh-ancestor
154012767|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012768|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012769|NCT02804360|Dexamethasone|dexamethasone|mesh-list
154012770|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
154012771|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012772|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
154012773|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
154012774|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012775|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012776|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154012777|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
154012778|NCT02804360|Hormones|hormones|mesh-ancestor
154012779|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012780|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012781|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012782|NCT02727738|Selenium|selenium|mesh-list
154012783|NCT02727738|Methimazole|methimazole|mesh-list
154012784|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
154012785|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012786|NCT02727738|Protective Agents|protective agents|mesh-ancestor
154012787|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012788|NCT02727738|Trace Elements|trace elements|mesh-ancestor
154012789|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
154012790|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
154012791|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
154012792|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012793|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154012794|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
154012795|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
154012796|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154012797|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012798|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154012799|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154012800|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153666577|NCT00022308|Irinotecan|irinotecan|mesh-list
154012801|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012802|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012803|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154012804|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154012805|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154012806|NCT02811692|Aflibercept|aflibercept|mesh-list
154012807|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154012820|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012821|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012822|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154012823|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
154012824|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770400|NCT00206960|Risperidone|risperidone|mesh-list
154012825|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012826|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154012827|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154012829|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154012830|NCT02732262|Narcotics|narcotics|mesh-ancestor
154012831|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012832|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012833|NCT02732262|Analgesics|analgesics|mesh-ancestor
154012834|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
154012835|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012836|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154012837|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
154012838|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154012839|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154012840|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154012841|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012842|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012844|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
154012845|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154012846|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012847|NCT00938197|Amlodipine|amlodipine|mesh-list
154012848|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154012849|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154012850|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154012851|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012852|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154012853|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012854|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
154012855|NCT02727504|Dobutamine|dobutamine|mesh-list
154012856|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154012857|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
154012858|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
154012859|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012860|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012861|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154012862|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154012863|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154012864|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
154012865|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012866|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012867|NCT02727504|Protective Agents|protective agents|mesh-ancestor
154012868|NCT02727348|Anesthetics|anesthetics|mesh-list
154012876|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
154012877|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012879|NCT00610103|Emetics|emetics|mesh-ancestor
154012880|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012881|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
154012882|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012883|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154012884|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
154012885|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
154012886|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154012887|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012888|NCT00938353|Beclomethasone|beclomethasone|mesh-list
154012889|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012890|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
154012891|NCT00938353|Hormones|hormones|mesh-ancestor
154012892|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012893|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012894|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154012895|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
154012896|NCT04259333|Acetaminophen|acetaminophen|mesh-list
154012897|NCT04259333|Celecoxib|celecoxib|mesh-list
154012898|NCT04259333|Codeine|codeine|mesh-list
153770475|NCT00207311|Orlistat|orlistat|mesh-list
154012899|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154012900|NCT04259333|Analgesics|analgesics|mesh-ancestor
154012901|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
154012902|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012903|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012904|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
154012905|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154012906|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012907|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012908|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154012909|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154012910|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012911|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012912|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154012913|NCT04259333|Narcotics|narcotics|mesh-ancestor
154012914|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012915|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
154012916|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
154012917|NCT02721420|Piperaquine|piperaquine|mesh-list
154012918|NCT02721420|Artenimol|artenimol|mesh-list
154012919|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
154012920|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154012921|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154012922|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012923|NCT00608699|Niacin|niacin|mesh-list
154012924|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154012925|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
154012926|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012927|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154012928|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
154012929|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
154012930|NCT00608699|Vitamins|vitamins|mesh-ancestor
154012931|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
154012932|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012933|NCT02726490|Metformin|metformin|mesh-list
154012934|NCT02726490|Glyburide|glyburide|mesh-list
154012935|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154012936|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666733|NCT02971878|Antidotes|antidotes|mesh-ancestor
154012950|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012951|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
154012952|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012953|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012954|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012955|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154012956|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154012957|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
154012958|NCT02721186|Primaquine|primaquine|mesh-list
154012959|NCT02721186|Piperaquine|piperaquine|mesh-list
154012960|NCT02721186|Artenimol|artenimol|mesh-list
154012961|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
154012962|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154012963|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154012964|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012965|NCT02716428|Ribavirin|ribavirin|mesh-list
154012966|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
154012967|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012968|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
154012969|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012970|NCT00931463|Ritonavir|ritonavir|mesh-list
154012971|NCT00931463|Lopinavir|lopinavir|mesh-list
154012972|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
154012973|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154012974|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154012975|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
154012976|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012977|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012978|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154012979|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154012980|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
154012981|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012982|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154012983|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154012984|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154012985|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154012986|NCT03974594|Trifluridine|trifluridine|mesh-list
154012987|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
154012988|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012989|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
154012990|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012991|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
154012992|NCT03964688|Vitamins|vitamins|mesh-ancestor
154012993|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
154012994|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012995|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
154012996|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012997|NCT03964688|Protective Agents|protective agents|mesh-ancestor
154012998|NCT00929201|Metformin|metformin|mesh-list
154012999|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154013000|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013001|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013013|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154013014|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
154013015|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013016|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154013017|NCT02800772|Protective Agents|protective agents|mesh-ancestor
154013018|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013019|NCT02773212|Amphetamine|amphetamine|mesh-list
154013020|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
154013021|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154013022|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013023|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
154013024|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
154013025|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013026|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
154013027|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013028|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013029|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013030|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154013031|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153480920|NCT04764188|Alectinib|alectinib|mesh-list
154013032|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154013033|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154013034|NCT00610493|Sirolimus|sirolimus|mesh-list
154013035|NCT00610493|Bevacizumab|bevacizumab|mesh-list
154013036|NCT00610493|Temsirolimus|temsirolimus|mesh-list
154013037|NCT00610493|MTOR Inhibitors|mtor inhibitors|mesh-list
154013038|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154013039|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013040|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154013041|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154013042|NCT00610493|Growth Substances|growth substances|mesh-ancestor
154013043|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013044|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
154013045|NCT00610493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154013046|NCT00610493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013047|NCT00610493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013048|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154013049|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
154013050|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154013051|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013052|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154013053|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
154013054|NCT02716272|Nivolumab|nivolumab|mesh-list
154013055|NCT02716272|Ipilimumab|ipilimumab|mesh-list
154013056|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154013057|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013058|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154013059|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013060|NCT02720406|Ketamine|ketamine|mesh-list
154013061|NCT02720406|Analgesics|analgesics|mesh-ancestor
154013062|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
154013063|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013064|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013075|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154013076|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154013077|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013078|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013080|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154013081|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154013082|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154013083|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
154013084|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
154013085|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
154013086|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
154013087|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013088|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013089|NCT02802722|Vitamin D|vitamin d|mesh-list
154013090|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
153782017|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154013091|NCT02802722|Vitamins|vitamins|mesh-ancestor
154013092|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
154013093|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013094|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154013095|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154013096|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154013097|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013098|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013099|NCT02802644|Incretins|incretins|mesh-ancestor
154013100|NCT02802644|Hormones|hormones|mesh-ancestor
154013101|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013102|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154013103|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
154013104|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013105|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013106|NCT02744976|Metformin|metformin|mesh-list
154013107|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013108|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013109|NCT00928889|Acarbose|acarbose|mesh-list
154013110|NCT00928889|Nateglinide|nateglinide|mesh-list
154013111|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154013112|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013113|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013114|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013115|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013116|NCT02725398|Scopolamine|scopolamine|mesh-list
154860972|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
154013117|NCT02725398|Bromides|bromides|mesh-list
154013118|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154013119|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
154013120|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154013121|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
154013122|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
154013123|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013124|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013125|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154013126|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
154013127|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154013140|NCT03978091|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154013141|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154013142|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013143|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154013144|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013145|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013147|NCT00610571|Topotecan|topotecan|mesh-list
154013148|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154013149|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
154013150|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013151|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013152|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154013153|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154013154|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013155|NCT02725242|Budesonide|budesonide|mesh-list
154013156|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
154013157|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154013158|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154013159|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
154013160|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013161|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013162|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154013163|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
154013164|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
154013165|NCT02725242|Hormones|hormones|mesh-ancestor
154013166|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013167|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154013168|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154013169|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154013170|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013171|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013172|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013173|NCT00564733|Paclitaxel|paclitaxel|mesh-list
154013174|NCT00564733|Docetaxel|docetaxel|mesh-list
154013175|NCT00564733|Carboplatin|carboplatin|mesh-list
154013176|NCT00564733|Gemcitabine|gemcitabine|mesh-list
154013177|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154013178|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154013179|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013180|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
154013181|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
154013182|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
154013183|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013184|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154013185|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
154013186|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154013187|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
154013188|NCT02725164|Sevoflurane|sevoflurane|mesh-list
153585244|NCT01765790|Antibodies|antibodies|mesh-list
154013197|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
154013198|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013199|NCT02800694|Fentanyl|fentanyl|mesh-list
154013200|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154013201|NCT02800694|Narcotics|narcotics|mesh-ancestor
154013202|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013203|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013204|NCT02800694|Analgesics|analgesics|mesh-ancestor
154013205|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
154013206|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013207|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154013208|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154013209|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
154013210|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
154013211|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
154013212|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154013213|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
154255092|NCT00086580|Vidarabine|vidarabine|mesh-list
154013214|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013215|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013216|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154013217|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
154013218|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154013219|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154013220|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154013221|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013222|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013223|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013224|NCT00938509|Ibuprofen|ibuprofen|mesh-list
154013225|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154013226|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013227|NCT00938509|Analgesics|analgesics|mesh-ancestor
154013228|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
154013229|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013230|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013231|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154013232|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154013233|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154013234|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013235|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013236|NCT02724618|Curcumin|curcumin|mesh-list
154013237|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154013238|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013239|NCT02724618|Analgesics|analgesics|mesh-ancestor
154013240|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
154013241|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013242|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013243|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154013244|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154013245|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013246|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013247|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013248|NCT02801786|Tamoxifen|tamoxifen|mesh-list
154013249|NCT02801786|Lidocaine|lidocaine|mesh-list
154013251|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
154013252|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013253|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013254|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
154013255|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013275|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154013276|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154013277|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013278|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013279|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013280|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013281|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
154013282|NCT02719392|Minocycline|minocycline|mesh-list
154013283|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154013284|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
154013285|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013286|NCT02719392|Expectorants|expectorants|mesh-ancestor
154013287|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
154013288|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154013289|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
153731584|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153731585|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013290|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013291|NCT02719392|Protective Agents|protective agents|mesh-ancestor
154013292|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013293|NCT02719392|Antidotes|antidotes|mesh-ancestor
154013294|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154013295|NCT02802098|Bevacizumab|bevacizumab|mesh-list
154013296|NCT02802098|Durvalumab|durvalumab|mesh-list
154013297|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154013298|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013299|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154013300|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154013301|NCT02802098|Growth Substances|growth substances|mesh-ancestor
154013302|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013303|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
154013304|NCT00938821|Morphine|morphine|mesh-list
154013305|NCT00938821|Bupivacaine|bupivacaine|mesh-list
154013306|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
154860973|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
154255093|NCT00086580|Fludarabine|fludarabine|mesh-list
154013317|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013318|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013319|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013320|NCT02715960|Vitamin A|vitamin a|mesh-list
154013321|NCT02715960|Tretinoin|tretinoin|mesh-list
154013322|NCT02715960|Acitretin|acitretin|mesh-list
154013323|NCT02715960|Vitamins|vitamins|mesh-ancestor
154013324|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
154013325|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013326|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013327|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
154013328|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
154013329|NCT03983018|Rituximab|rituximab|mesh-list
154013330|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154013331|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013332|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
154013333|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013334|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154013335|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
154013336|NCT02794922|Vitamins|vitamins|mesh-ancestor
154013337|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
154013338|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013339|NCT00935467|Saxagliptin|saxagliptin|mesh-list
154013340|NCT00935467|Incretins|incretins|mesh-ancestor
154013341|NCT00935467|Hormones|hormones|mesh-ancestor
154013342|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013343|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013344|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154013345|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
154013346|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013347|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013348|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013349|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154013350|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154013351|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
154013352|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013353|NCT00936013|Oseltamivir|oseltamivir|mesh-list
154013354|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
154013355|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013356|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013357|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013358|NCT00936091|Vitamin A|vitamin a|mesh-list
154013359|NCT00936091|Vitamins|vitamins|mesh-ancestor
154013360|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
154013361|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013362|NCT00563797|Mecamylamine|mecamylamine|mesh-list
154013363|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154013364|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154013365|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
154013366|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013367|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013368|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154013369|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154013370|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
154013371|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013372|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013373|NCT01192698|Interferons|interferons|mesh-list
154013396|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154013397|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013398|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013399|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
154013400|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013401|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013403|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154013404|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154013405|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154013406|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013407|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013408|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154013409|NCT02715336|Leuprolide|leuprolide|mesh-list
154013410|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154013411|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
154013412|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154013413|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860974|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013414|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154013415|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013417|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154013418|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
154013419|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013420|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154013421|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013422|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013423|NCT02799758|Pitavastatin|pitavastatin|mesh-list
154013424|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154013425|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154013426|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154013427|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
154013428|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013430|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154013431|NCT00938899|Simeprevir|simeprevir|mesh-list
154013432|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
154013433|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013434|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
154013435|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013436|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013437|NCT03259165|Diuretics|diuretics|mesh-list
154013438|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154013439|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
154013440|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013441|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154013456|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154013457|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
154013458|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013459|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154013460|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154013461|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
154013462|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013463|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013464|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154013465|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154013466|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
154013467|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
154013468|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013469|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154013470|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
154013471|NCT00564889|Hormones|hormones|mesh-ancestor
154013472|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013473|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154013474|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154013475|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154013476|NCT00564889|Growth Substances|growth substances|mesh-ancestor
154013477|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154013478|NCT02790164|Rocuronium|rocuronium|mesh-list
154013479|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154013480|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154013481|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154013482|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013483|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013484|NCT00939757|Mirabegron|mirabegron|mesh-list
154013485|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154013486|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154013487|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154013488|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013489|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013490|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013491|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013492|NCT00939757|Urological Agents|urological agents|mesh-ancestor
154013493|NCT05415644|Metformin|metformin|mesh-list
154013494|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013495|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013496|NCT00939835|Dexetimide|dexetimide|mesh-list
154013497|NCT00939835|Citalopram|citalopram|mesh-list
154013498|NCT00939835|Escitalopram|escitalopram|mesh-list
154013499|NCT00939835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154013500|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154013501|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154013502|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013513|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013514|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154013515|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154013516|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
154013517|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
154013518|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
154013519|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013520|NCT02690012|Cathartics|cathartics|mesh-ancestor
154013521|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154013522|NCT02690012|Antacids|antacids|mesh-ancestor
154013523|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
154013524|NCT02793986|Propofol|propofol|mesh-list
154013525|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154013526|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013527|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013528|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013529|NCT02793986|Analgesics|analgesics|mesh-ancestor
154013530|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
154013531|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013532|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154013533|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154013534|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154013535|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013536|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013537|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013538|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154013539|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
154013540|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
154013541|NCT00940069|Pemetrexed|pemetrexed|mesh-list
154013542|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013543|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013544|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013545|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154013546|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154013547|NCT00940303|Leucovorin|leucovorin|mesh-list
154013548|NCT00940303|Bevacizumab|bevacizumab|mesh-list
154013549|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
154013550|NCT00940303|Irinotecan|irinotecan|mesh-list
154013551|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154013552|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013553|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154013554|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154013555|NCT00940303|Growth Substances|growth substances|mesh-ancestor
154013556|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013557|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
154013558|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154013559|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154013560|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013561|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013562|NCT00940303|Antidotes|antidotes|mesh-ancestor
154013563|NCT00940303|Protective Agents|protective agents|mesh-ancestor
154013564|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
154013565|NCT00940303|Vitamins|vitamins|mesh-ancestor
154013566|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
154013567|NCT02794220|Nicotine|nicotine|mesh-list
154013568|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154013578|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154013579|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154013580|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
154013581|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013582|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154013583|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154013584|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013585|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013586|NCT04405999|Bromhexine|bromhexine|mesh-list
154013587|NCT04405999|Expectorants|expectorants|mesh-ancestor
154013588|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
154013589|NCT02793908|Progesterone|progesterone|mesh-list
154013590|NCT02793908|Progestins|progestins|mesh-ancestor
154013591|NCT02793908|Hormones|hormones|mesh-ancestor
154013592|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013593|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013594|NCT02789930|Anesthetics|anesthetics|mesh-list
154013595|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013596|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255094|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
154013597|NCT00560833|Mirtazapine|mirtazapine|mesh-list
154013598|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013599|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
154013600|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154013601|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154013602|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
154013603|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
154013604|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013605|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013606|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154013607|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154013608|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013609|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154013610|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154013611|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154013612|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013613|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154013614|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154013615|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
154013616|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154013617|NCT00941161|Metformin|metformin|mesh-list
154013618|NCT00941161|Glimepiride|glimepiride|mesh-list
154013619|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013620|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013621|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154013622|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154013623|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
154013624|NCT00944515|Azithromycin|azithromycin|mesh-list
154013625|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154013626|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013627|NCT00771654|Phentermine|phentermine|mesh-list
154013628|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154013629|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013630|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
154013631|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154013632|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
154013633|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
154013634|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013645|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
154013646|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013647|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154013648|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013649|NCT04235426|Analgesics|analgesics|mesh-ancestor
154013650|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
154013651|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013652|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154013653|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154013654|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154013655|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013656|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013657|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
154013658|NCT04235426|Hematinics|hematinics|mesh-ancestor
154013659|NCT02793440|Cortivazol|cortivazol|mesh-list
154013660|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154013661|NCT02723838|Gemcitabine|gemcitabine|mesh-list
154013662|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013663|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154013664|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
154013665|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013666|NCT02789150|Norepinephrine|norepinephrine|mesh-list
154013667|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154013668|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154013669|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013670|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013671|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013672|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013673|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
154013674|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
154013675|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013676|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154013677|NCT02715024|Tamsulosin|tamsulosin|mesh-list
154013678|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
154013679|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154860975|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013680|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154013681|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154013682|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013683|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013684|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013685|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013686|NCT02715024|Urological Agents|urological agents|mesh-ancestor
154013687|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154013688|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154013689|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
154013690|NCT02798744|Empagliflozin|empagliflozin|mesh-list
154013691|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154013692|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013693|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013694|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013695|NCT00925769|Bevacizumab|bevacizumab|mesh-list
154013696|NCT00925769|Capecitabine|capecitabine|mesh-list
154013697|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154013698|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154013699|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667497|NCT00027885|Docetaxel|docetaxel|mesh-list
154013700|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154013712|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154013713|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154013714|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154013715|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013716|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013717|NCT00562861|Lamotrigine|lamotrigine|mesh-list
154013718|NCT00562861|Carbamazepine|carbamazepine|mesh-list
154013719|NCT00562861|Valproic Acid|valproic acid|mesh-list
154013720|NCT00562861|Citalopram|citalopram|mesh-list
154013721|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
154013722|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154013723|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154013724|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013725|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154013726|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013727|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154013729|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013730|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154013731|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154013732|NCT00562861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154013733|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154013734|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013735|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
154013736|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154013737|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
154013738|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013739|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013740|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
154013741|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
154013742|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013743|NCT00562861|Analgesics|analgesics|mesh-ancestor
154013744|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
154013745|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154013746|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154013747|NCT02723448|Aclarubicin|aclarubicin|mesh-list
154013748|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
154013749|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154013750|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013751|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154013752|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154013753|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013754|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013755|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154013756|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
154013757|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013758|NCT02798510|Gemcitabine|gemcitabine|mesh-list
154013759|NCT02798510|Capecitabine|capecitabine|mesh-list
154013760|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154013761|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
154013762|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013763|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013764|NCT00609011|Temozolomide|temozolomide|mesh-list
154157958|NCT05140148|Analgesics|analgesics|mesh-ancestor
154157959|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
154157960|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157967|NCT05095207|Bicalutamide|bicalutamide|mesh-list
154157968|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
154157969|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
154157970|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157971|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157972|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157973|NCT05088356|Plerixafor|plerixafor|mesh-list
154157974|NCT05088356|Mycophenolic Acid|mycophenolic acid|mesh-list
154157975|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
154157976|NCT05088356|Melphalan|melphalan|mesh-list
154157977|NCT05088356|Thiotepa|thiotepa|mesh-list
154157978|NCT05088356|Fludarabine|fludarabine|mesh-list
154157979|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
154157980|NCT05088356|Tacrolimus|tacrolimus|mesh-list
154157981|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
154157982|NCT05088356|Lenograstim|lenograstim|mesh-list
154157983|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154013765|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154013779|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013780|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154013781|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013782|NCT04260581|Amantadine|amantadine|mesh-list
154013783|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154013784|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154013785|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
154013786|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013787|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
154013788|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013789|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013790|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013791|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013792|NCT04260581|Analgesics|analgesics|mesh-ancestor
154013793|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
154013794|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013795|NCT00770367|Pioglitazone|pioglitazone|mesh-list
154013796|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013797|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013798|NCT04012255|Semaglutide|semaglutide|mesh-list
154013799|NCT04012255|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154013800|NCT04012255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013801|NCT04012255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013802|NCT00941785|Amodiaquine|amodiaquine|mesh-list
154013803|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
154013804|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154013805|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154013806|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013807|NCT02793050|Trabectedin|trabectedin|mesh-list
154013808|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154013809|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
154013810|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013811|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013812|NCT00944905|MDX-1203|mdx-1203|mesh-list
154013813|NCT00944905|Immunoconjugates|immunoconjugates|mesh-ancestor
154013814|NCT00944905|Immunologic Factors|immunologic factors|mesh-ancestor
154860976|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
154860977|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860978|NCT03496324|Ibuprofen|ibuprofen|mesh-list
154860979|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154860980|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154860981|NCT03496324|Analgesics|analgesics|mesh-ancestor
154860982|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
154860983|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860984|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860985|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860986|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860987|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154860988|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860989|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860990|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
154860991|NCT03354598|Probenecid|probenecid|mesh-list
154860992|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154860993|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013815|NCT00944905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013816|NCT00942253|Dopamine|dopamine|mesh-list
154013817|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
154013818|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154013819|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
154013820|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
154013821|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013822|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013823|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
154013824|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013825|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013826|NCT00942253|Protective Agents|protective agents|mesh-ancestor
154013851|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013853|NCT00637988|Rofecoxib|rofecoxib|mesh-list
154013854|NCT00637988|Esomeprazole|esomeprazole|mesh-list
154013855|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154013856|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013857|NCT00637988|Analgesics|analgesics|mesh-ancestor
154013858|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
154013859|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013860|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013861|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154013862|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154013863|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154013864|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154013865|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013866|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154013867|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154013868|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013869|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
154013870|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154013871|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154013872|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154013873|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154013874|NCT04258163|Gemcitabine|gemcitabine|mesh-list
154013875|NCT04258163|Capecitabine|capecitabine|mesh-list
154013876|NCT04258163|Doxorubicin|doxorubicin|mesh-list
154013877|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154013878|NCT04258163|Letrozole|letrozole|mesh-list
154013879|NCT04258163|Fulvestrant|fulvestrant|mesh-list
154013880|NCT04258163|Anastrozole|anastrozole|mesh-list
154013881|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154013882|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
153731586|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731588|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731589|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153731590|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153731591|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731592|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731593|NCT00138710|Letrozole|letrozole|mesh-list
154013883|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585940|NCT01769625|Celecoxib|celecoxib|mesh-list
154013910|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154013911|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
154013912|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013913|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013914|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154013915|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154013916|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
154013917|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013918|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154013919|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154013920|NCT00942565|Acetaminophen|acetaminophen|mesh-list
154013921|NCT00942565|Tramadol|tramadol|mesh-list
154013922|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013923|NCT00942565|Analgesics|analgesics|mesh-ancestor
154013924|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
154013925|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013926|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013927|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
154013929|NCT00942565|Narcotics|narcotics|mesh-ancestor
154013930|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013931|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
154013932|NCT00945373|Calcium|calcium|mesh-list
154013933|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154013942|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013943|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013944|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
154013945|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013946|NCT02792426|Nicotine|nicotine|mesh-list
154013947|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154013948|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
154013949|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013950|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013951|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154013952|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154013953|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
154013954|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013955|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013956|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
154013957|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154013958|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154013959|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154013960|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154013961|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154013962|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013963|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
154013964|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013965|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013966|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154013967|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013968|NCT02792036|Carboplatin|carboplatin|mesh-list
154013969|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013970|NCT02797340|Metformin|metformin|mesh-list
154013971|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013972|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013973|NCT00928187|Ritonavir|ritonavir|mesh-list
153626806|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
154013974|NCT00928187|Lopinavir|lopinavir|mesh-list
154013975|NCT00928187|Darunavir|darunavir|mesh-list
154013976|NCT00928187|Tenofovir|tenofovir|mesh-list
154013977|NCT00928187|Emtricitabine|emtricitabine|mesh-list
154013978|NCT00928187|Abacavir|abacavir|mesh-list
154013979|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154013980|NCT00928187|Didanosine|didanosine|mesh-list
154013981|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154013982|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154013983|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
154013984|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013985|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013986|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154013987|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154013988|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
154013989|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013990|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154013991|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154013992|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154013993|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154013994|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
154013995|NCT04235270|Tadalafil|tadalafil|mesh-list
154013996|NCT04235270|Macitentan|macitentan|mesh-list
154013997|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
154013998|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154013999|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154014000|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014001|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014002|NCT04235270|Urological Agents|urological agents|mesh-ancestor
154014003|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154014014|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014015|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014016|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014017|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154014018|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154014019|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014020|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154014021|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154014022|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014023|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
154014024|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
154014025|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154014026|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
154014027|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154014028|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
153771560|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
154014029|NCT02791958|Ramipril|ramipril|mesh-list
154014030|NCT02791958|Atorvastatin|atorvastatin|mesh-list
154014031|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154014032|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154014033|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
154014034|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014035|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154014036|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154014037|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014038|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154014039|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
154014040|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154014041|NCT02601651|Lidocaine|lidocaine|mesh-list
154014042|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
154014043|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
154014044|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014045|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014046|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
154014047|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014048|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154014049|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154014050|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154014051|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154014052|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014053|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
154014054|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014055|NCT00945919|Oxymorphone|oxymorphone|mesh-list
154014056|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154014057|NCT00945919|Narcotics|narcotics|mesh-ancestor
154014058|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014059|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014060|NCT00945919|Analgesics|analgesics|mesh-ancestor
154014061|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
154014062|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014063|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154014064|NCT00945997|Misoprostol|misoprostol|mesh-list
154014065|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154014066|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
154014067|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154014093|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154014095|NCT02797028|Protective Agents|protective agents|mesh-ancestor
154014096|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014097|NCT00916461|Minocycline|minocycline|mesh-list
154014098|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014099|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014100|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
154014101|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154014102|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
154014103|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154014104|NCT04260035|Protective Agents|protective agents|mesh-ancestor
154014105|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014106|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154014108|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154014109|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014110|NCT00768651|Incretins|incretins|mesh-ancestor
154014112|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014113|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154014114|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
154014115|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014116|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014117|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154014147|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014148|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
154014149|NCT04097613|Budesonide|budesonide|mesh-list
154014150|NCT04097613|Povidone|povidone|mesh-list
154014151|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014152|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154014153|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
154014154|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014155|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014156|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154014157|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
154014158|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
154014159|NCT04097613|Hormones|hormones|mesh-ancestor
154014160|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014161|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
154014162|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
153586228|NCT01770795|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158263|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154158264|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154158265|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158266|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154014181|NCT00916695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014182|NCT00916695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014183|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014184|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
154014185|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014186|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014188|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154014189|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
154014190|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014191|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014192|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154014193|NCT00756717|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
154014194|NCT00756717|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154014195|NCT00756717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014196|NCT00756717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014197|NCT06005714|Cyclosporine|cyclosporine|mesh-list
154014198|NCT06005714|Clarithromycin|clarithromycin|mesh-list
154014199|NCT06005714|Cyclosporins|cyclosporins|mesh-list
154014200|NCT06005714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014201|NCT06005714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014202|NCT06005714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014203|NCT06005714|Immunologic Factors|immunologic factors|mesh-ancestor
154014204|NCT06005714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014205|NCT06005714|Antifungal Agents|antifungal agents|mesh-ancestor
154014206|NCT06005714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014207|NCT06005714|Dermatologic Agents|dermatologic agents|mesh-ancestor
154014208|NCT06005714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014209|NCT06005714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154014210|NCT06005714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014211|NCT06005714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154014212|NCT06005714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154014213|NCT06005714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154014214|NCT06005363|Dexmedetomidine|dexmedetomidine|mesh-list
154014215|NCT06005363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014216|NCT06005363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014235|NCT06005324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014236|NCT06005324|Tubulin Modulators|tubulin modulators|mesh-ancestor
154014237|NCT06005324|Antimitotic Agents|antimitotic agents|mesh-ancestor
154014238|NCT06005324|Mitosis Modulators|mitosis modulators|mesh-ancestor
154014239|NCT06005324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014240|NCT06005324|Antimetabolites|antimetabolites|mesh-ancestor
154014241|NCT06005324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154014242|NCT06005324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014243|NCT06005324|Immunologic Factors|immunologic factors|mesh-ancestor
153420004|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
154014244|NCT06005324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014245|NCT06005324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014246|NCT06005324|Antisickling Agents|antisickling agents|mesh-ancestor
154014247|NCT06005324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014248|NCT06005324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154014249|NCT06005259|Spironolactone|spironolactone|mesh-list
154014250|NCT06005259|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154014251|NCT06005259|Hormone Antagonists|hormone antagonists|mesh-ancestor
154014252|NCT06005259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014253|NCT06005259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014254|NCT06005259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154014255|NCT06005259|Diuretics|diuretics|mesh-ancestor
154014256|NCT06005259|Natriuretic Agents|natriuretic agents|mesh-ancestor
154014257|NCT06005207|Progesterone|progesterone|mesh-list
154014258|NCT06005207|Progestins|progestins|mesh-ancestor
154014259|NCT06005207|Hormones|hormones|mesh-ancestor
154014260|NCT06005207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014261|NCT06005207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860994|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154860995|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154860996|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860997|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158350|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
154158351|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154158352|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
154158354|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154158355|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158356|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158357|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
154158358|NCT04678336|Fludarabine|fludarabine|mesh-list
154158359|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158360|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
154158361|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158362|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014262|NCT06005168|Cefazolin|cefazolin|mesh-list
154014263|NCT06005168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014264|NCT06005168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014265|NCT06005155|Valproic Acid|valproic acid|mesh-list
154014266|NCT06005155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154014267|NCT06005155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014268|NCT06005155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014269|NCT06005155|Antimanic Agents|antimanic agents|mesh-ancestor
154014270|NCT06005155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154014271|NCT06005155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014272|NCT06005155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014273|NCT06005155|Anticonvulsants|anticonvulsants|mesh-ancestor
154014302|NCT06004947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154014304|NCT06004947|Antifungal Agents|antifungal agents|mesh-ancestor
154014305|NCT06004947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014306|NCT06004947|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154014307|NCT06004947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154014308|NCT06004947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154014309|NCT06004947|Hormone Antagonists|hormone antagonists|mesh-ancestor
154014310|NCT06004947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014311|NCT06004947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154014312|NCT06004947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154014313|NCT06004947|Antitubercular Agents|antitubercular agents|mesh-ancestor
154014314|NCT06004947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014315|NCT06004947|Leprostatic Agents|leprostatic agents|mesh-ancestor
154014316|NCT06004947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154014317|NCT06004947|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154014318|NCT06004947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154014319|NCT06004947|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154014320|NCT06004947|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153586383|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
154014339|NCT06004843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154014340|NCT06004843|Anesthetics, General|anesthetics, general|mesh-ancestor
154014341|NCT06004843|Anesthetics|anesthetics|mesh-ancestor
154014342|NCT06004765|Lenalidomide|lenalidomide|mesh-list
154014343|NCT06004765|Azacitidine|azacitidine|mesh-list
154014344|NCT06004765|Immunologic Factors|immunologic factors|mesh-ancestor
154014345|NCT06004765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014346|NCT06004765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154014347|NCT06004765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154014348|NCT06004765|Growth Substances|growth substances|mesh-ancestor
154014349|NCT06004765|Growth Inhibitors|growth inhibitors|mesh-ancestor
154014350|NCT06004765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014351|NCT06004765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154014352|NCT06004765|Antimetabolites|antimetabolites|mesh-ancestor
154014353|NCT06004765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014354|NCT06004765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860998|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860999|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154861000|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154861001|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
154861002|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
154861003|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861004|NCT02169895|Opicapone|opicapone|mesh-list
154861005|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
154861006|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154861007|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861008|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861009|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154014355|NCT06004687|Acetaminophen|acetaminophen|mesh-list
154014356|NCT06004687|Mannitol|mannitol|mesh-list
154255096|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014357|NCT06004687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154014358|NCT06004687|Analgesics|analgesics|mesh-ancestor
154014359|NCT06004687|Sensory System Agents|sensory system agents|mesh-ancestor
154014360|NCT06004687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014361|NCT06004687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014362|NCT06004687|Antipyretics|antipyretics|mesh-ancestor
154014363|NCT06004687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154014364|NCT06004687|Diuretics|diuretics|mesh-ancestor
154014365|NCT06004687|Natriuretic Agents|natriuretic agents|mesh-ancestor
154014366|NCT06004401|Amoxicillin|amoxicillin|mesh-list
154014367|NCT06004401|Metronidazole|metronidazole|mesh-list
154014368|NCT06004401|Clarithromycin|clarithromycin|mesh-list
154014369|NCT06004401|Minocycline|minocycline|mesh-list
154014370|NCT06004401|Rabeprazole|rabeprazole|mesh-list
154014371|NCT06004401|Bismuth|bismuth|mesh-list
154014372|NCT06004401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014373|NCT06004401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014374|NCT06004401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154014375|NCT06004401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154014376|NCT06004401|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154014377|NCT06004401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014378|NCT06004401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014379|NCT06004401|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154014380|NCT06004401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154014396|NCT06003998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154014397|NCT06003998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014398|NCT06003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014399|NCT06003972|Glatiramer Acetate|glatiramer acetate|mesh-list
154014400|NCT06003972|(T,G)-A-L|(t,g)-a-l|mesh-list
154014401|NCT06003972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154014402|NCT06003972|Immunologic Factors|immunologic factors|mesh-ancestor
153771937|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
154014403|NCT06003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014404|NCT06003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014405|NCT06003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014406|NCT05999630|Lubricant Eye Drops|lubricant eye drops|mesh-list
154014407|NCT05999630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154014408|NCT05999630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154014409|NCT05999175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154014410|NCT05999175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014411|NCT05933603|Oxybutynin|oxybutynin|mesh-list
154014412|NCT05933603|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154014413|NCT05933603|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154014414|NCT05933603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154014415|NCT05933603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154014416|NCT05933603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014417|NCT05933603|Adrenergic Agents|adrenergic agents|mesh-ancestor
154014418|NCT05933603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014419|NCT05933603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014420|NCT05933603|Parasympatholytics|parasympatholytics|mesh-ancestor
154014421|NCT05933603|Autonomic Agents|autonomic agents|mesh-ancestor
154014422|NCT05933603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014423|NCT05933603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154014424|NCT05933603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154014425|NCT05933603|Cholinergic Agents|cholinergic agents|mesh-ancestor
154014426|NCT05933603|Urological Agents|urological agents|mesh-ancestor
154014427|NCT05888233|Allopurinol|allopurinol|mesh-list
154014428|NCT05888233|Antimetabolites|antimetabolites|mesh-ancestor
154014429|NCT05888233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014430|NCT05888233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014431|NCT05888233|Gout Suppressants|gout suppressants|mesh-ancestor
154014432|NCT05888233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014433|NCT05888233|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154014434|NCT05888233|Antioxidants|antioxidants|mesh-ancestor
154014435|NCT05888233|Protective Agents|protective agents|mesh-ancestor
154014436|NCT05888233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014437|NCT05887882|Mitogens|mitogens|mesh-list
154014438|NCT05887882|Mitosis Modulators|mitosis modulators|mesh-ancestor
154014439|NCT05887882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014440|NCT05874219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154014441|NCT05874219|Mupirocin|mupirocin|mesh-list
154014462|NCT05790044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014463|NCT05790044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014464|NCT05790044|Sensory System Agents|sensory system agents|mesh-ancestor
154861010|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154861011|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
154158493|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
154014465|NCT05790044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014466|NCT05790044|Analgesics|analgesics|mesh-ancestor
154014467|NCT05790044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154014468|NCT05790044|Sympatholytics|sympatholytics|mesh-ancestor
154014469|NCT05790044|Autonomic Agents|autonomic agents|mesh-ancestor
154014470|NCT05790044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154014471|NCT05790044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154014472|NCT05790044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154014473|NCT05790044|Adrenergic Agents|adrenergic agents|mesh-ancestor
154014474|NCT05790044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014475|NCT05790044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014476|NCT05776030|Methamphetamine|methamphetamine|mesh-list
154014477|NCT05776030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153772059|NCT05427721|Thymol|thymol|mesh-list
154014478|NCT05776030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014479|NCT05776030|Sympathomimetics|sympathomimetics|mesh-ancestor
154014480|NCT05776030|Autonomic Agents|autonomic agents|mesh-ancestor
154014481|NCT05776030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014482|NCT05776030|Dopamine Agents|dopamine agents|mesh-ancestor
154014483|NCT05776030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014484|NCT05776030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014485|NCT05776030|Adrenergic Agents|adrenergic agents|mesh-ancestor
154014486|NCT05776030|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154014487|NCT05776030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154014488|NCT05776030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154014489|NCT05776030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154014490|NCT05773950|Fosaprepitant|fosaprepitant|mesh-list
154014491|NCT05773950|Aprepitant|aprepitant|mesh-list
154014492|NCT05773950|Antiemetics|antiemetics|mesh-ancestor
154014493|NCT05773950|Autonomic Agents|autonomic agents|mesh-ancestor
154014494|NCT05773950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014495|NCT05773950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586545|NCT01773096|Antacids|antacids|mesh-ancestor
154014514|NCT05741632|Moxifloxacin|moxifloxacin|mesh-list
154014515|NCT05741632|Levofloxacin|levofloxacin|mesh-list
154014516|NCT05741632|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154014517|NCT05741632|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154014518|NCT05741632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014519|NCT05741632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014520|NCT05741632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154014521|NCT05741632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154014522|NCT05741632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014523|NCT05741632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014524|NCT05741632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014525|NCT05741632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154014526|NCT05741632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154014527|NCT05741632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154014528|NCT05728645|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154014530|NCT05728645|Blood Substitutes|blood substitutes|mesh-ancestor
154014531|NCT05685342|Acetaminophen|acetaminophen|mesh-list
154014532|NCT05685342|Ibuprofen|ibuprofen|mesh-list
154014533|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154014534|NCT05685342|Analgesics|analgesics|mesh-ancestor
154014535|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
154014536|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014537|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014538|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
154014539|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154014540|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014541|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014542|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154014543|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014544|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014545|NCT05681312|Amoxicillin|amoxicillin|mesh-list
154014546|NCT05681312|Metronidazole|metronidazole|mesh-list
154014547|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014548|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772103|NCT04680091|Efavirenz|efavirenz|mesh-list
154014549|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153586616|NCT01773616|Hormones|hormones|mesh-ancestor
154014564|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014565|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154014566|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154014567|NCT05537402|Growth Substances|growth substances|mesh-ancestor
154861012|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154158565|NCT04384367|Rizatriptan|rizatriptan|mesh-list
154014568|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014569|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
154014570|NCT05537402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154014571|NCT05537402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014572|NCT05529290|Acetaminophen|acetaminophen|mesh-list
154014573|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154014574|NCT05529290|Ketoprofen|ketoprofen|mesh-list
154014575|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154014576|NCT05529290|Analgesics|analgesics|mesh-ancestor
154014577|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
154014578|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014579|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014580|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
154014581|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154014582|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014583|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014584|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154014585|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014586|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014587|NCT05435677|Semaglutide|semaglutide|mesh-list
154014588|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154014589|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014590|NCT05435677|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154014591|NCT05415917|Gemcitabine|gemcitabine|mesh-list
154014592|NCT05415917|Capecitabine|capecitabine|mesh-list
154014593|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154014594|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
154014595|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014596|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014597|NCT05407441|Nivolumab|nivolumab|mesh-list
154014599|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014600|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014601|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154014602|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014603|NCT05367687|Apatinib|apatinib|mesh-list
154014604|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014605|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154014606|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014607|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014608|NCT05353829|Methotrexate|methotrexate|mesh-list
153586653|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
154014619|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154014620|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014621|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
154014622|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014623|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154014624|NCT05345509|Donepezil|donepezil|mesh-list
154014625|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154014626|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014627|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014628|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
154014629|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014630|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014631|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
154014632|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154014633|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154014634|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014635|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014636|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
154014637|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014638|NCT05287035|Dexamethasone|dexamethasone|mesh-list
154014639|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
154014640|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014641|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
154014642|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
154014643|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014644|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014645|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154014646|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
154014648|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014649|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154861013|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014650|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014651|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
154014652|NCT05282069|DA-8010|da-8010|mesh-list
154014653|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154014654|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154014655|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
154014656|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014657|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014658|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014659|NCT05282069|Urological Agents|urological agents|mesh-ancestor
154014660|NCT05251090|Factor VIII|factor viii|mesh-list
154014661|NCT05251090|Coagulants|coagulants|mesh-ancestor
154014662|NCT05249920|Edaravone|edaravone|mesh-list
154014663|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154014664|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
154014665|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014666|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154014667|NCT05249920|Protective Agents|protective agents|mesh-ancestor
154014668|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014669|NCT05193071|Aspirin|aspirin|mesh-list
154014670|NCT05193071|Clopidogrel|clopidogrel|mesh-list
154014671|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153586714|NCT01774565|Insulin|insulin|mesh-list
154014683|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154014684|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014685|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
154014686|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154014687|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154014688|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154014689|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
154014690|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014691|NCT05145010|Infigratinib|infigratinib|mesh-list
154014692|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014693|NCT05113940|Midazolam|midazolam|mesh-list
154014694|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154014695|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154014696|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014697|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014698|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154014699|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154014700|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154014701|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154014702|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
154014703|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
154014704|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
154014705|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
154014706|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014707|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014708|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
154014709|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014710|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014711|NCT05082259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154014712|NCT05082259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014713|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
154014714|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154014715|NCT05073172|Hydrocortisone|hydrocortisone|mesh-list
154014716|NCT05073172|Petrolatum|petrolatum|mesh-list
154014717|NCT05073172|Mineral Oil|mineral oil|mesh-list
154014718|NCT05073172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014719|NCT05073172|Emollients|emollients|mesh-ancestor
154014720|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154014721|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014722|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014723|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154014724|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154014725|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
154014726|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154014727|NCT05065372|Metformin|metformin|mesh-list
154014728|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154014729|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014734|NCT04962672|Anesthetics|anesthetics|mesh-list
154014735|NCT04962672|Propofol|propofol|mesh-list
154014736|NCT04962672|Sevoflurane|sevoflurane|mesh-list
154014737|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014738|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014739|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154014740|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154014784|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255097|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154014786|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014787|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
154014788|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014789|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014790|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
154014791|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
154014792|NCT04516915|Oseltamivir|oseltamivir|mesh-list
154014793|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
154014794|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014795|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014796|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014797|NCT04483466|Methotrexate|methotrexate|mesh-list
154014798|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154014799|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
154014800|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154014801|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014802|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154014803|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
154014804|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014805|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014806|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
154014807|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014808|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154014809|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014810|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
154014811|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014812|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154014813|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
154014814|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154014815|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154014816|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014817|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
154014818|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
154014819|NCT04365088|Deflazacort|deflazacort|mesh-list
154014820|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014821|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014822|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
154014823|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014824|NCT04360421|Bupivacaine|bupivacaine|mesh-list
154014825|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
154014826|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
154014827|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014828|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014829|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
154014830|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014831|NCT04349579|Rifamycins|rifamycins|mesh-list
154014832|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
154014833|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154014834|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014835|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014836|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154014837|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
153586873|NCT01776515|Tramadol|tramadol|mesh-list
154014846|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154014847|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
154014848|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014849|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014850|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154014851|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154014852|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
154014853|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014854|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014855|NCT03994146|Remifentanil|remifentanil|mesh-list
154014856|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154014857|NCT03994146|Narcotics|narcotics|mesh-ancestor
154014858|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014859|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014860|NCT03994146|Analgesics|analgesics|mesh-ancestor
154014861|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
154014862|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014863|NCT03962465|Cytarabine|cytarabine|mesh-list
154014864|NCT03962465|Prednisone|prednisone|mesh-list
154014865|NCT03962465|Methotrexate|methotrexate|mesh-list
154014866|NCT03962465|Vincristine|vincristine|mesh-list
154014867|NCT03962465|Daunorubicin|daunorubicin|mesh-list
154861014|NCT01072669|Ambrisentan|ambrisentan|mesh-list
154255098|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
154014868|NCT03962465|Pegaspargase|pegaspargase|mesh-list
154014869|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154014870|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014871|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
154014872|NCT03962465|Hormones|hormones|mesh-ancestor
154014873|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014874|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014875|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154014876|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014877|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154014878|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
154014879|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154014880|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154014881|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
154014882|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014883|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154014884|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014885|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154014886|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014887|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
154014888|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014889|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154014890|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
154014891|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014892|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154014893|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
154014894|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
154014895|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
154014896|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154014897|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154014898|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154014899|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014900|NCT03962465|Immunotoxins|immunotoxins|mesh-ancestor
154014901|NCT03962465|Immunoconjugates|immunoconjugates|mesh-ancestor
154014902|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
154014903|NCT03952299|Oxybutynin|oxybutynin|mesh-list
154014904|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
154014905|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
154014906|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014907|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014949|NCT03663543|Estrogens|estrogens|mesh-list
154014950|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154014951|NCT03663543|Hormones|hormones|mesh-ancestor
154014952|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014953|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014954|NCT03603899|Xenon|xenon|mesh-list
154014955|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154014956|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
154014957|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
154014958|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014959|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014960|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
154014961|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
154014962|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154014963|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014964|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014965|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154014966|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
154014967|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014968|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014969|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
154014970|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
154014971|NCT03329378|Paclitaxel|paclitaxel|mesh-list
154014972|NCT03329378|Docetaxel|docetaxel|mesh-list
154014973|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154014974|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
154014975|NCT03329378|Carboplatin|carboplatin|mesh-list
154014976|NCT03329378|Doxorubicin|doxorubicin|mesh-list
154014977|NCT03329378|Trastuzumab|trastuzumab|mesh-list
154014978|NCT03329378|Pertuzumab|pertuzumab|mesh-list
154014979|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154014980|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014981|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
154014982|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
154014983|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
154861015|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154255099|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014984|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014985|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154014986|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
154014987|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014988|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014989|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154014990|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
154014991|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154014992|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154014993|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154014994|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154014995|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014996|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014997|NCT03274895|Biguanides|biguanides|mesh-list
154014998|NCT03274895|Polihexanide|polihexanide|mesh-list
154014999|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
154015000|NCT03274895|Propamidine|propamidine|mesh-list
154015001|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
154015002|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015003|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154015032|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154015033|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015034|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154015035|NCT02906332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154015036|NCT02906332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015037|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
154015038|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154015039|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154015040|NCT02906332|Growth Substances|growth substances|mesh-ancestor
154015041|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
154015042|NCT02823665|Atropine|atropine|mesh-list
154015043|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154015044|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154015045|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154015046|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
154015047|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015048|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015049|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154015050|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
154015051|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
154015052|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
154015053|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154015070|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154015071|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015072|NCT02715284|Dostarlimab|dostarlimab|mesh-list
154015073|NCT02715284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015074|NCT02705300|Leucovorin|leucovorin|mesh-list
154015075|NCT02705300|Tocotrienols|tocotrienols|mesh-list
154015076|NCT02705300|Vitamin E|vitamin e|mesh-list
154015077|NCT02705300|Tocopherols|tocopherols|mesh-list
154015078|NCT02705300|Fluorouracil|fluorouracil|mesh-list
153772604|NCT00239889|Katacalcin|katacalcin|mesh-list
154015079|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
154015080|NCT02705300|Irinotecan|irinotecan|mesh-list
154015081|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
154015082|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015083|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
154015084|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015085|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154015086|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015087|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154015088|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
154015089|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154015090|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154015091|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015092|NCT02705300|Antidotes|antidotes|mesh-ancestor
154015093|NCT02705300|Protective Agents|protective agents|mesh-ancestor
154015094|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
154015095|NCT02705300|Vitamins|vitamins|mesh-ancestor
154015096|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
154015097|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
154015098|NCT02598557|Exemestane|exemestane|mesh-list
154015099|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015100|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154015101|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154861016|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
154861017|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
154015102|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015103|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015104|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154015105|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
154015106|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015107|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015108|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
154015109|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015110|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
154015111|NCT02317783|Flutemetamol|flutemetamol|mesh-list
154015112|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
154015113|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015114|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
154015129|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154015130|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154015131|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
153421590|NCT05754684|Diuretics|diuretics|mesh-ancestor
154015132|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015133|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154015134|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154015136|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154015137|NCT01470417|Paclitaxel|paclitaxel|mesh-list
154015138|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154015139|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
154015140|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015141|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015142|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154015143|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
154015144|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
154015145|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
154015146|NCT01409772|Ethanol|ethanol|mesh-list
154015147|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154015148|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015149|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015150|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015151|NCT01241708|Bortezomib|bortezomib|mesh-list
154015152|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015153|NCT01208766|Dexamethasone|dexamethasone|mesh-list
154015154|NCT01208766|Prednisone|prednisone|mesh-list
154015155|NCT01208766|Lenalidomide|lenalidomide|mesh-list
154015156|NCT01208766|Bortezomib|bortezomib|mesh-list
154015157|NCT01208766|Melphalan|melphalan|mesh-list
154015158|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015159|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
154015160|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
154015161|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015163|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015164|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
154015165|NCT01208766|Hormones|hormones|mesh-ancestor
154015166|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015167|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154015168|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015169|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
154015170|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154015171|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154015172|NCT01208766|Growth Substances|growth substances|mesh-ancestor
154015173|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
154015174|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154015175|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
154015176|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015177|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154015204|NCT00992901|Incretins|incretins|mesh-ancestor
154015205|NCT00992901|Hormones|hormones|mesh-ancestor
154015206|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015207|NCT00820248|Panitumumab|panitumumab|mesh-list
154015208|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015209|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154015210|NCT00795340|Paclitaxel|paclitaxel|mesh-list
154015211|NCT00795340|Carboplatin|carboplatin|mesh-list
154015212|NCT00795340|Cediranib|cediranib|mesh-list
154015213|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154015214|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015215|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
154015216|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
154015217|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
154015218|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015219|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255100|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154015220|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154015221|NCT00668642|Dutasteride|dutasteride|mesh-list
154015222|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154015223|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154015224|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015225|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015226|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
154015241|NCT00314756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015243|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
154015244|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015245|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154015246|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015247|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
154015248|NCT00101101|Aldesleukin|aldesleukin|mesh-list
154015249|NCT00101101|Dexamethasone|dexamethasone|mesh-list
154015250|NCT00101101|Prednisone|prednisone|mesh-list
154015251|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
154015252|NCT00101101|Doxorubicin|doxorubicin|mesh-list
154015253|NCT00101101|Vincristine|vincristine|mesh-list
154015254|NCT00101101|Interleukin-2|interleukin-2|mesh-list
154015255|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154015256|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
154015257|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015258|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154015259|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154015260|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
154015261|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015262|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015263|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154015264|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015265|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
154015266|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
154015267|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015268|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015269|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
154015270|NCT00101101|Hormones|hormones|mesh-ancestor
154015271|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015272|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154015273|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154015274|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154015275|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154015276|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015277|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154015278|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
154015279|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
154015280|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
154015281|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154015282|NCT00101101|Analgesics|analgesics|mesh-ancestor
154015283|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
154015284|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154015292|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015294|NCT02600793|Ceftaroline|ceftaroline|mesh-list
154015295|NCT02600793|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154015296|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154015297|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015298|NCT04235894|Propofol|propofol|mesh-list
154015299|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154015300|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015301|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015302|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154015303|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
154015304|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
154015305|NCT04096599|Fluorides|fluorides|mesh-list
154015306|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
154015307|NCT04096599|Protective Agents|protective agents|mesh-ancestor
154015308|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015309|NCT00923351|Vaccines|vaccines|mesh-list
154015310|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
153772827|NCT00240474|Amlodipine|amlodipine|mesh-list
154015311|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015313|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154015314|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
154015315|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015316|NCT02788292|Expectorants|expectorants|mesh-ancestor
154015317|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
154861018|NCT03014713|Dezocine|dezocine|mesh-list
154255101|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
154015318|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154015319|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
154015320|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015321|NCT02788292|Protective Agents|protective agents|mesh-ancestor
154015322|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015323|NCT02788292|Antidotes|antidotes|mesh-ancestor
154015324|NCT00944359|Zinc|zinc|mesh-list
154015325|NCT00944359|Trace Elements|trace elements|mesh-ancestor
154015326|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
154015327|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015328|NCT02791256|Ribavirin|ribavirin|mesh-list
154015329|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154015330|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
154015331|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015332|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
154015333|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015334|NCT04258007|Neostigmine|neostigmine|mesh-list
154015335|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154015336|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015337|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015338|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
154015339|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015340|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015341|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154015342|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
154015343|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015344|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154015345|NCT02787824|Hematinics|hematinics|mesh-ancestor
154015346|NCT02796950|Acipimox|acipimox|mesh-list
154015347|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154015348|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
154015349|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015350|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154015351|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
154015352|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
154015353|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587383|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015381|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015382|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
153772902|NCT00214955|Analgesics|analgesics|mesh-ancestor
154015384|NCT03633110|Nivolumab|nivolumab|mesh-list
154015385|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154015386|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015387|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154015388|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015389|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154015390|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154015391|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015392|NCT02788058|Gefitinib|gefitinib|mesh-list
154015393|NCT02788058|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154015394|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154015395|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015426|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154015427|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
154015428|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154015429|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015430|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154015431|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154015432|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015433|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154015434|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154015435|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015436|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015448|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154015450|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015451|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154015452|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
154015453|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
154015454|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
154015455|NCT02785718|Hemostatics|hemostatics|mesh-list
154015456|NCT02785718|Coagulants|coagulants|mesh-ancestor
154015457|NCT04094805|Calcitriol|calcitriol|mesh-list
153772974|NCT00215228|Analgesics|analgesics|mesh-ancestor
154015458|NCT04094805|Dexamethasone|dexamethasone|mesh-list
154861019|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154015459|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015460|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
154015461|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
154015462|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015463|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015464|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015465|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
154015466|NCT04094805|Hormones|hormones|mesh-ancestor
154015467|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015468|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154015469|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015470|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154015471|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154015472|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154015473|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015474|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154015475|NCT04094805|Vitamins|vitamins|mesh-ancestor
154015476|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
154015477|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154015478|NCT04094727|Lumefantrine|lumefantrine|mesh-list
154015479|NCT04094727|Artemether|artemether|mesh-list
154015480|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154015481|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
154015482|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154015483|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154015484|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015485|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
154015486|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154015487|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154015488|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154015489|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154015490|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015491|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
154015492|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015493|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015494|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154015495|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015496|NCT02786732|Ustekinumab|ustekinumab|mesh-list
154015497|NCT02786732|Brodalumab|brodalumab|mesh-list
154015498|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154015499|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
154015500|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
154015501|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015523|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015525|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154015526|NCT02787278|Protective Agents|protective agents|mesh-ancestor
154015527|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015528|NCT03083678|Afatinib|afatinib|mesh-list
154015529|NCT03083678|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154015530|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154015531|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015532|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015533|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015534|NCT04232150|Midazolam|midazolam|mesh-list
154015535|NCT04232150|Anesthetics|anesthetics|mesh-list
154015536|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015537|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015538|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154015539|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154015540|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154015541|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154015542|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154015543|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154015544|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
154015545|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
154015546|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
154015547|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015548|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015549|NCT04197752|Anesthetics|anesthetics|mesh-list
154015550|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015551|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015552|NCT02336750|Aprepitant|aprepitant|mesh-list
154015553|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
154015569|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154015570|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015571|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154015572|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154015573|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154015574|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
154015575|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154015576|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154015577|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
154015578|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154015579|NCT02784392|Metoclopramide|metoclopramide|mesh-list
154015580|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
154015581|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
154015582|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015583|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015584|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015585|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154015586|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154015587|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
154015588|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015589|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015590|NCT00634556|Levodopa|levodopa|mesh-list
154015591|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154015592|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154015593|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154015594|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
154015595|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015596|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015597|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015598|NCT02784080|Isoantibodies|isoantibodies|mesh-list
154015599|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
154015600|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015601|NCT02784860|Lidocaine|lidocaine|mesh-list
154015602|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
154015603|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
154015604|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015605|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015606|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
154015607|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015608|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154015609|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154015610|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154015611|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154015612|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015613|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
154015627|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015628|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154015629|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154015630|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154015631|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
154015632|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015633|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582955|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015634|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
154015635|NCT02783378|Antacids|antacids|mesh-ancestor
154015636|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015637|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015638|NCT05237726|Heparin|heparin|mesh-list
154015639|NCT05237726|Enoxaparin|enoxaparin|mesh-list
154015640|NCT05237726|Calcium heparin|calcium heparin|mesh-list
154015641|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
154015642|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
154015643|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154015644|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154015645|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015646|NCT02783144|Dexamethasone|dexamethasone|mesh-list
154015647|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
154015648|NCT02783144|BB 1101|bb 1101|mesh-list
154015649|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015650|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
154015651|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
154015652|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015653|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015654|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015656|NCT02783144|Hormones|hormones|mesh-ancestor
154015657|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015658|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154015659|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015660|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
154015661|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015662|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015663|NCT02783222|Paclitaxel|paclitaxel|mesh-list
154015664|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154015665|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015666|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
154015667|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
154015668|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
154015669|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015670|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
154015671|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154015672|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154015673|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154015674|NCT02689856|Lidocaine|lidocaine|mesh-list
154015681|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154015682|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154015683|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154015684|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154015685|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015686|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015687|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154015688|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154015689|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154015690|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154015691|NCT02722746|Epinephrine|epinephrine|mesh-list
154015692|NCT02722746|Ropivacaine|ropivacaine|mesh-list
154015693|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
154015694|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
154015695|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015696|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015697|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
154015698|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015699|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154015700|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154015701|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
154015702|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015703|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015704|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154015705|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154015706|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
154015707|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154015708|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
154015709|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
154015710|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
154015711|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154015712|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
154015713|NCT02784626|Propofol|propofol|mesh-list
154015714|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154015715|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015716|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015717|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154015718|NCT02784626|Analgesics|analgesics|mesh-ancestor
154015719|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
154015720|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015721|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154015722|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154015723|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154015724|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
154015725|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015726|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015727|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154015728|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
154015729|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
154015730|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
154015731|NCT02782754|Carboplatin|carboplatin|mesh-list
154015732|NCT02782754|Etoposide|etoposide|mesh-list
154015733|NCT02782754|Bleomycin|bleomycin|mesh-list
154015734|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154015736|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015737|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154015738|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154015739|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
154015740|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015741|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015742|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154015765|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015766|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015767|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154015768|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154015769|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154015770|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154015771|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154015772|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
154015774|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154015775|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
154015776|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015777|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
154015778|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154015779|NCT02714166|Protective Agents|protective agents|mesh-ancestor
154015780|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015781|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
154015782|NCT04231682|Denosumab|denosumab|mesh-list
154015783|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154015784|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015785|NCT02722356|Oxytocin|oxytocin|mesh-list
154015786|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
154015787|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154015788|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015789|NCT00753675|Gemcitabine|gemcitabine|mesh-list
154015790|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154015791|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
154015792|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015793|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015794|NCT05131178|Bupivacaine|bupivacaine|mesh-list
154015795|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
154015796|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
153587847|NCT01784250|Analgesics|analgesics|mesh-ancestor
154015830|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154015831|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154015833|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
154015834|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015835|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015836|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
154015837|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
154015838|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154015839|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154015840|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587907|NCT01784549|Gemcitabine|gemcitabine|mesh-list
154015854|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154015856|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015857|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
154015858|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
154015859|NCT05453253|Vaccines|vaccines|mesh-list
154015860|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
154015861|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015862|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154015863|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015864|NCT02717052|Ketamine|ketamine|mesh-list
154015865|NCT02717052|Esketamine|esketamine|mesh-list
154015866|NCT02717052|Analgesics|analgesics|mesh-ancestor
154015867|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
154015868|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015869|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015870|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154015871|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154015872|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
154015873|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
154015874|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015875|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154015876|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154015877|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861020|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015878|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015879|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
154015880|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154015882|NCT05342558|Xhance|xhance|mesh-list
154015883|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015884|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154015885|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
154015886|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015887|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015889|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
154015890|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
154015891|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154015892|NCT00923273|Folic Acid|folic acid|mesh-list
154015893|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
154015894|NCT00923273|Sirolimus|sirolimus|mesh-list
154015895|NCT00923273|Dexamethasone|dexamethasone|mesh-list
154015896|NCT00923273|Pemetrexed|pemetrexed|mesh-list
154015897|NCT00923273|Vitamins|vitamins|mesh-ancestor
154015898|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
154015899|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015900|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015901|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
154015902|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
154015903|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015917|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
154015918|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154015919|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
154015920|NCT00923273|Hematinics|hematinics|mesh-ancestor
154015921|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
154015922|NCT04231370|Lenalidomide|lenalidomide|mesh-list
154015923|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
154015924|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015925|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154015926|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154015927|NCT04231370|Growth Substances|growth substances|mesh-ancestor
154015928|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
154015929|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015930|NCT05340530|Meropenem|meropenem|mesh-list
154015931|NCT05340530|Avibactam|avibactam|mesh-list
154015932|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154015933|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015934|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154015935|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015936|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015937|NCT00634712|Candesartan|candesartan|mesh-list
154015938|NCT00634712|Candesartan cilexetil|candesartan cilexetil|mesh-list
154015939|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154015940|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154015941|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154015942|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015943|NCT00923195|Aldesleukin|aldesleukin|mesh-list
154015944|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
154015945|NCT00923195|Fludarabine|fludarabine|mesh-list
154015946|NCT00923195|Interleukin-2|interleukin-2|mesh-list
154015947|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154015948|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154015949|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
154015950|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015951|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154015952|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154015953|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
154015954|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015955|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015956|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154015957|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154015958|NCT00923195|Analgesics|analgesics|mesh-ancestor
154015959|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
154015960|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015961|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154015962|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154015972|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015973|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154015974|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
154015975|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154015976|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154015977|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015978|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154015979|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
154015980|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154015981|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
154015982|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
154015983|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
154015984|NCT02714010|Gefitinib|gefitinib|mesh-list
154015985|NCT02714010|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154015986|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154015987|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015988|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015989|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015990|NCT00917241|Dexamethasone|dexamethasone|mesh-list
154015991|NCT00917241|Methimazole|methimazole|mesh-list
154015992|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015993|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
154015994|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
154015995|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015996|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015997|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015998|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
154015999|NCT00917241|Hormones|hormones|mesh-ancestor
154016000|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154016001|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154016002|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016003|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
154016004|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
154016005|NCT00919061|Gemcitabine|gemcitabine|mesh-list
154016006|NCT00919061|Sorafenib|sorafenib|mesh-list
154016007|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016008|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154016009|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
154016010|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016011|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154016012|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016013|NCT02598687|Paclitaxel|paclitaxel|mesh-list
154016014|NCT02598687|Carboplatin|carboplatin|mesh-list
154016015|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154016016|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016017|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
154016018|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
154016019|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
154016020|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016021|NCT04908605|Melatonin|melatonin|mesh-list
154016022|NCT04908605|Mirtazapine|mirtazapine|mesh-list
154016023|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
154016024|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016025|NCT04908605|Protective Agents|protective agents|mesh-ancestor
154016026|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016027|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016028|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
154016029|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154016043|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154016044|NCT02782208|Acipimox|acipimox|mesh-list
154016045|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154016046|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
154016047|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016048|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154016049|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
154016050|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154016051|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016052|NCT00611286|Sirolimus|sirolimus|mesh-list
154016053|NCT00611286|Paclitaxel|paclitaxel|mesh-list
154016054|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154016055|NCT00611286|Everolimus|everolimus|mesh-list
154016056|NCT00611286|Clopidogrel|clopidogrel|mesh-list
154016057|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
154016058|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154016059|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016060|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
154016061|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
154016062|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
154016063|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016064|NCT00611286|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154016065|NCT00611286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154016066|NCT00611286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016067|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016068|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
154016069|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016070|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154016071|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154016072|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154016073|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
154016074|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016075|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154016076|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016077|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154016078|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
154016079|NCT04257851|Sumatriptan|sumatriptan|mesh-list
154016080|NCT04257851|Theophylline|theophylline|mesh-list
154016081|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154016082|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154016083|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154016084|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
154016085|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016086|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016087|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016088|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154016089|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
153588134|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016179|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016180|NCT00634790|Alprazolam|alprazolam|mesh-list
154016181|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154016182|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016183|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016184|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153423082|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154016185|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154016186|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154016187|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
154016188|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
154016189|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016190|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016191|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
154016192|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016193|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
154016194|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
154016195|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154016196|NCT00917397|Sertraline|sertraline|mesh-list
154016197|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
154016198|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154016199|NCT00917397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154016200|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154016201|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154016202|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016225|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154016226|NCT02712528|Narcotics|narcotics|mesh-ancestor
154016227|NCT02712528|Analgesics|analgesics|mesh-ancestor
154016228|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
154016229|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016230|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154016231|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154016232|NCT04089657|Apatinib|apatinib|mesh-list
154016233|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016234|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154016235|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016236|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016237|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
154016238|NCT02713074|Povidone|povidone|mesh-list
154016239|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
154016240|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
154016241|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154016242|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016243|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
154016244|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154016245|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154016246|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
154016247|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016248|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016249|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016251|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016252|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016253|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016254|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154016255|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154016256|NCT04089813|Metformin|metformin|mesh-list
154016284|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154016285|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154016286|NCT02711982|Prednisolone|prednisolone|mesh-list
154016287|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
154016288|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154016289|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
154016290|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154016291|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
154016292|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
154016293|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016294|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016295|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154016296|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
154016297|NCT02711982|Hormones|hormones|mesh-ancestor
154016298|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154016299|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154016300|NCT02711982|Protective Agents|protective agents|mesh-ancestor
154016301|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154016302|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016330|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
154016331|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016332|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154016333|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154016334|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
154016335|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016336|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016337|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016338|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154016339|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154016340|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016341|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154016342|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154016343|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154016344|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154016345|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016346|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016347|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016348|NCT00940693|Analgesics|analgesics|mesh-ancestor
154016366|NCT02707458|Probucol|probucol|mesh-list
154016367|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154016368|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154016369|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
154016370|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016371|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154016372|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
154016373|NCT02707458|Protective Agents|protective agents|mesh-ancestor
154016374|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016375|NCT00950677|Exenatide|exenatide|mesh-list
154016376|NCT00950677|Pramlintide|pramlintide|mesh-list
154016377|NCT00950677|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154016378|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154016379|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016380|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154016381|NCT00950677|Incretins|incretins|mesh-ancestor
154016382|NCT00950677|Hormones|hormones|mesh-ancestor
153423305|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
154016383|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154016384|NCT05174598|Calcitriol|calcitriol|mesh-list
154016385|NCT05174598|Calcipotriene|calcipotriene|mesh-list
154016386|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
154016387|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154016388|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016389|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154016390|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154016391|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016392|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154016393|NCT05174598|Vitamins|vitamins|mesh-ancestor
154016394|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
154016395|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154016396|NCT05341856|Isosorbide|isosorbide|mesh-list
154016397|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154016398|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154016399|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154016400|NCT05341856|Diuretics|diuretics|mesh-ancestor
154016401|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
154016402|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016403|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
154016404|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154016405|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016406|NCT00951223|Interferons|interferons|mesh-list
154016407|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
154016431|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016432|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016433|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
154016434|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154016435|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154016436|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016437|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154016438|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154016439|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154016440|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016441|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016442|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
154016443|NCT02707224|Candesartan|candesartan|mesh-list
154016444|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
154016445|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153781814|NCT04558684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016446|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154016447|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154016448|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
154016449|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016450|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154016451|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154016452|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016453|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154016454|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154016455|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154016456|NCT04229264|Apixaban|apixaban|mesh-list
154016457|NCT04229264|Clopidogrel|clopidogrel|mesh-list
154016458|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154016459|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154016460|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154016476|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
154016477|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016478|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154016479|NCT02711202|Sirolimus|sirolimus|mesh-list
154016480|NCT02711202|Infliximab|infliximab|mesh-list
154016481|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
154016482|NCT02711202|Tacrolimus|tacrolimus|mesh-list
154016483|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016484|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
154016485|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016486|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154016487|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016488|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016489|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154016490|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016491|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154016492|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016493|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
154016494|NCT02711202|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154016495|NCT02711202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154016496|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
154016497|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154016498|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154016499|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154016500|NCT04227938|ALPN-101|alpn-101|mesh-list
154016501|NCT04227938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016502|NCT04227938|Immunologic Factors|immunologic factors|mesh-ancestor
154016503|NCT04227938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016504|NCT02711358|Indomethacin|indomethacin|mesh-list
154016505|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154016506|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154016507|NCT02711358|Analgesics|analgesics|mesh-ancestor
154016508|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
154016509|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016510|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016511|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154016512|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154016513|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
154016514|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
154016515|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154016516|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154016517|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731602|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731603|NCT01243762|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
153731604|NCT01243762|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153731605|NCT01243762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731606|NCT01243762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731607|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
153731608|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154016518|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016519|NCT00744627|Vortioxetine|vortioxetine|mesh-list
154016520|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
154016535|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154016536|NCT04942886|Entecavir|entecavir|mesh-list
154016537|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
154016538|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016539|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
154016540|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
154016541|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154016542|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154016543|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154016544|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016545|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154016546|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154016547|NCT02711280|Propofol|propofol|mesh-list
154016548|NCT02711280|Sevoflurane|sevoflurane|mesh-list
154016549|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154016550|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016551|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016552|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154016553|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
154016554|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
154016555|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154016556|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154016557|NCT00948493|Insulin|insulin|mesh-list
154016558|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154016559|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154016560|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016561|NCT00952003|Bevacizumab|bevacizumab|mesh-list
154016562|NCT00952003|Docetaxel|docetaxel|mesh-list
154016563|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
154016564|NCT00952003|Irinotecan|irinotecan|mesh-list
154016565|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154016566|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016567|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154016568|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154016569|NCT00952003|Growth Substances|growth substances|mesh-ancestor
154016570|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016571|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
154016572|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
154016573|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
154016574|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
154016575|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774099|NCT00218504|Analgesics|analgesics|mesh-ancestor
154016576|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154016577|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154016617|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
154016618|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153588691|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154016638|NCT02597283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016639|NCT00948649|Varenicline|varenicline|mesh-list
154016640|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154016641|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154016642|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
154016643|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016644|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016645|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016647|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
154016648|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154016649|NCT00952159|Narcotics|narcotics|mesh-ancestor
154016650|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016651|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016652|NCT00952159|Analgesics|analgesics|mesh-ancestor
154016653|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
154016654|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016655|NCT00948727|Cyclosporine|cyclosporine|mesh-list
154016656|NCT00948727|Cyclosporins|cyclosporins|mesh-list
154016657|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016658|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016659|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016660|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
154016661|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016662|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
154016663|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016664|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
154016665|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154016666|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154016667|NCT02778776|Metformin|metformin|mesh-list
154016668|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154016669|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016670|NCT00948805|Goserelin|goserelin|mesh-list
154016671|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154016672|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154016673|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016674|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154016675|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016685|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154016686|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016687|NCT02710266|Gabexate|gabexate|mesh-list
154016688|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
154016689|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154016690|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
154016691|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016692|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016693|NCT00562159|Fluticasone|fluticasone|mesh-list
154016695|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
154016696|NCT00562159|Loratadine|loratadine|mesh-list
154016697|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154016698|NCT00562159|Prednisone|prednisone|mesh-list
154016699|NCT00562159|Albuterol|albuterol|mesh-list
154016700|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154016701|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
154016702|NCT00562159|Hormones|hormones|mesh-ancestor
154016703|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154016704|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016705|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154016706|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016707|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154016708|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
154016709|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016718|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153423679|NCT03383588|Analgesics|analgesics|mesh-ancestor
154016719|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
154016720|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016721|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016722|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
154016723|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154016724|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154016725|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
154016726|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
154016727|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154016728|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154016729|NCT00562159|Analgesics|analgesics|mesh-ancestor
154016730|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
154016731|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154016732|NCT02710110|Capsaicin|capsaicin|mesh-list
154016733|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
154016734|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
154016735|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
154016736|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016737|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016738|NCT00952627|Pycnogenols|pycnogenols|mesh-list
154016739|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154016740|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
154016741|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016742|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
154016743|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016744|NCT00952627|Protective Agents|protective agents|mesh-ancestor
154016745|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154016746|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154016747|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154016748|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154016749|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154016758|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016759|NCT00952861|Doxycycline|doxycycline|mesh-list
154016760|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154016761|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016762|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
154016763|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154016764|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154016765|NCT00949351|Aliskiren|aliskiren|mesh-list
154016766|NCT00949351|Renin Inhibitors|renin inhibitors|mesh-ancestor
154016767|NCT00949351|Protease Inhibitors|protease inhibitors|mesh-ancestor
154016768|NCT00949351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016769|NCT00949351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016778|NCT05109416|Bupivacaine|bupivacaine|mesh-list
154016779|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
154016780|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
154016781|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016782|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016783|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
154016784|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016785|NCT02778308|Gemcitabine|gemcitabine|mesh-list
154016786|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016787|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154016788|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
154016789|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016790|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
154016791|NCT02776202|Sirolimus|sirolimus|mesh-list
154016792|NCT02776202|Fludarabine|fludarabine|mesh-list
154016793|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
154016794|NCT02776202|Melphalan|melphalan|mesh-list
154016795|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016796|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154016797|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
154016798|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016799|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016800|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
154016801|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016802|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154016803|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153774324|NCT04628143|Nafamostat|nafamostat|mesh-list
154016804|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
154016805|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154016806|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016807|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016808|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
154016809|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154016810|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
154016811|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154016812|NCT00921557|Vitamin D|vitamin d|mesh-list
154016813|NCT00921557|Alendronate|alendronate|mesh-list
154016814|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
154016815|NCT00921557|Calcium|calcium|mesh-list
154016816|NCT00921557|Vitamins|vitamins|mesh-ancestor
154016817|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
154016818|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016819|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154016820|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154016821|NCT00921557|Antacids|antacids|mesh-ancestor
154016822|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016823|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154016824|NCT00611754|Fluorouracil|fluorouracil|mesh-list
154016846|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016848|NCT02776436|Prednisone|prednisone|mesh-list
154016849|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154016850|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
154016851|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
154016852|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016853|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160067|NCT00500331|Pioglitazone|pioglitazone|mesh-list
154016854|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154016855|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
154016857|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154176587|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016858|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154016860|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154016861|NCT02775968|Azithromycin|azithromycin|mesh-list
154016862|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
154016863|NCT02775968|Erythromycin|erythromycin|mesh-list
154016864|NCT02775968|Cephalosporins|cephalosporins|mesh-list
154016865|NCT02775968|Cefamandole|cefamandole|mesh-list
154016866|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016867|NCT02775968|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153731611|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153731612|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731613|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153731614|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
153731615|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
153731616|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154016868|NCT02775968|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154016869|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154016870|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154016871|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016872|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016873|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
154016874|NCT02775734|Clomiphene|clomiphene|mesh-list
153774395|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016875|NCT02775734|Enclomiphene|enclomiphene|mesh-list
154016876|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
154016877|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154016878|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016891|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154016892|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154016893|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
154016894|NCT02775734|Protective Agents|protective agents|mesh-ancestor
154016895|NCT02775734|Antidotes|antidotes|mesh-ancestor
154016896|NCT02772926|Benphothiamine|benphothiamine|mesh-list
154016897|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154016898|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
154016899|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016900|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
154016901|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
154016902|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016903|NCT02709564|Misoprostol|misoprostol|mesh-list
154016904|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154016905|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
154016906|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154016907|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016908|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154016909|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154016910|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
154016911|NCT04688814|Morphine|morphine|mesh-list
154016912|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154016913|NCT04688814|Narcotics|narcotics|mesh-ancestor
154016914|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016915|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016916|NCT04688814|Analgesics|analgesics|mesh-ancestor
154016917|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
154016918|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016919|NCT00744237|Metoprolol|metoprolol|mesh-list
154016920|NCT00744237|Nebivolol|nebivolol|mesh-list
154016921|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154016922|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154016923|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
154016924|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
154016925|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016926|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016927|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154016928|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154016929|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154016930|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
154016931|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016932|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016933|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
154016934|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154016935|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154016936|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154016937|NCT05260554|Fosfomycin|fosfomycin|mesh-list
154016938|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154016939|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016940|NCT04089345|Ustekinumab|ustekinumab|mesh-list
154016941|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
154016965|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016966|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154016967|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154016968|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
154016969|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
154016970|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016971|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154016972|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154016973|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016974|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016975|NCT00743145|Naltrexone|naltrexone|mesh-list
154016976|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154016977|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154016978|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016979|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
154016980|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016981|NCT00611910|Sirolimus|sirolimus|mesh-list
154016982|NCT00611910|Paclitaxel|paclitaxel|mesh-list
154016983|NCT00611910|Temsirolimus|temsirolimus|mesh-list
154016984|NCT00611910|MTOR Inhibitors|mtor inhibitors|mesh-list
154016985|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154016986|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016987|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
154016988|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
154016989|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
154016990|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589030|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017003|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154017004|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
154017005|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017006|NCT04251845|Melatonin|melatonin|mesh-list
154017007|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
154017008|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017009|NCT04251845|Protective Agents|protective agents|mesh-ancestor
154017010|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017011|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017012|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
154017013|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
154017014|NCT05207358|Rituximab|rituximab|mesh-list
154017015|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017016|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
154017017|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017018|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017019|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154017020|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
154017021|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017022|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017023|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154017024|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154017025|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154017026|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154017027|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
154017028|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154017029|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017030|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017031|NCT05387031|Ustekinumab|ustekinumab|mesh-list
154017032|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
154017033|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
154017034|NCT04570644|Ibuprofen|ibuprofen|mesh-list
154017035|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154017036|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017037|NCT04570644|Analgesics|analgesics|mesh-ancestor
154017038|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
154017039|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017040|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017041|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017042|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017043|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154017044|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017045|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017046|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154017047|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
154017048|NCT04570644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154017049|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154017050|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
154017051|NCT02775110|Natalizumab|natalizumab|mesh-list
154017070|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154017071|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017072|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
154017073|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
154017074|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
154017075|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017076|NCT02771834|Vitamin D|vitamin d|mesh-list
154017077|NCT02771834|Vitamins|vitamins|mesh-ancestor
154017078|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
154017079|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017080|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154017081|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154176588|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
154017082|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154017083|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
154017084|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017085|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154017086|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154017087|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
154017088|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
154017089|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017090|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017091|NCT00613470|Citalopram|citalopram|mesh-list
154017092|NCT00613470|Escitalopram|escitalopram|mesh-list
154017093|NCT00613470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154017094|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154017095|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154017096|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017097|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017098|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
154017099|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017100|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154017101|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
154017102|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154017103|NCT02771912|Propofol|propofol|mesh-list
154017104|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154017105|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154017106|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589140|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
154017131|NCT04181385|Bromocriptine|bromocriptine|mesh-list
154017132|NCT04181385|Olanzapine|olanzapine|mesh-list
154017133|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
154017134|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
154017135|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017136|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017137|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154017138|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154017139|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154017140|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017141|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154017142|NCT04181385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154017143|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154017144|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154017145|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017146|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017147|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
154017148|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154017149|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154017150|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
154017151|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017152|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
154017153|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
154017154|NCT00924443|Clofarabine|clofarabine|mesh-list
154017155|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154017156|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
154017157|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017158|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017159|NCT02677155|Rituximab|rituximab|mesh-list
154017160|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
154017161|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154017162|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017163|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
154017164|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017165|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017166|NCT02677155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154017167|NCT02677155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017168|NCT02537691|Theophylline|theophylline|mesh-list
154017169|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154017170|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
154017171|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017172|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731626|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731627|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
153731628|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731630|NCT00154401|Liraglutide|liraglutide|mesh-list
154017173|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154017174|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
154017175|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154017176|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017177|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017178|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
154017179|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154017180|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154017181|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
154017182|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017183|NCT04225052|Varenicline|varenicline|mesh-list
154017184|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154017185|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154017186|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
154017198|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
154017199|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017200|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154017201|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154017202|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154017203|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154017204|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017205|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154017206|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154017207|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154017208|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017209|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154017210|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154017211|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
154017212|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154017213|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
154017214|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
154017215|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
154017216|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154017217|NCT03521232|Niclosamide|niclosamide|mesh-list
154017218|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
154017219|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154017220|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
154017221|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154017222|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017223|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
154017224|NCT00924287|Aldesleukin|aldesleukin|mesh-list
154017225|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
154017226|NCT00924287|Fludarabine|fludarabine|mesh-list
154017227|NCT00924287|Interleukin-2|interleukin-2|mesh-list
154017229|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017230|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
154017231|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017233|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154017234|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
154017235|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017236|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017237|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154017238|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017239|NCT00924287|Analgesics|analgesics|mesh-ancestor
154017240|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
154017241|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017242|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154017243|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154017244|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
154017245|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017246|NCT00924287|Protective Agents|protective agents|mesh-ancestor
154017247|NCT02696954|Lumefantrine|lumefantrine|mesh-list
154017248|NCT02696954|Artemether|artemether|mesh-list
154017249|NCT02696954|Primaquine|primaquine|mesh-list
154017250|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154017251|NCT02696954|Amodiaquine|amodiaquine|mesh-list
154255103|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
154017252|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
154017253|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154017267|NCT02773316|Narcotics|narcotics|mesh-ancestor
154017268|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017269|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017270|NCT02773316|Analgesics|analgesics|mesh-ancestor
154017271|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
154017272|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017273|NCT00642681|Insulin|insulin|mesh-list
154017274|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154017275|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017276|NCT02773550|Prednisone|prednisone|mesh-list
154017277|NCT02773550|Bortezomib|bortezomib|mesh-list
154017278|NCT02773550|Melphalan|melphalan|mesh-list
154017279|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017280|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
154017281|NCT02773550|Hormones|hormones|mesh-ancestor
154017282|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017283|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017284|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154017285|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017286|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154017287|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
154017288|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017289|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154017290|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017291|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
154017292|NCT02773472|Morphine|morphine|mesh-list
154017293|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154017294|NCT02773472|Narcotics|narcotics|mesh-ancestor
154017295|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017296|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017297|NCT02773472|Analgesics|analgesics|mesh-ancestor
154017298|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
154017299|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017300|NCT00637871|Tamoxifen|tamoxifen|mesh-list
154017301|NCT00637871|Bicalutamide|bicalutamide|mesh-list
154017302|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154017303|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
154017304|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017305|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017306|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154017307|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017308|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154017309|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154017310|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154017311|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
154017312|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154017313|NCT00635258|Ganirelix|ganirelix|mesh-list
154017314|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589340|NCT01802645|Hematinics|hematinics|mesh-ancestor
154017341|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017342|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154017343|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154017344|NCT02676609|Insulin|insulin|mesh-list
154017345|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154017346|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017347|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
154017348|NCT00642915|Glimepiride|glimepiride|mesh-list
154017349|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154017350|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017351|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154017352|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017353|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
154017354|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
154017355|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154017356|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
154017357|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017358|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017359|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153589410|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
154017373|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154017374|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154017375|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154861021|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255104|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017376|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154017377|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017379|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017380|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
154017381|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017382|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154017383|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017384|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017385|NCT03728634|Vitamin A|vitamin a|mesh-list
154017386|NCT03728634|Vitamins|vitamins|mesh-ancestor
154017387|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
154017388|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017389|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154017390|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154017391|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154017392|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
154017393|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017394|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154017395|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154017396|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017397|NCT04353414|Bupivacaine|bupivacaine|mesh-list
154017398|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
154017399|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
154017400|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017401|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017402|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
154017403|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774920|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
154017404|NCT00643149|Amoxicillin|amoxicillin|mesh-list
154017405|NCT00643149|Azithromycin|azithromycin|mesh-list
154017406|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154017407|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017408|NCT00643227|Azithromycin|azithromycin|mesh-list
154017409|NCT00643227|Clarithromycin|clarithromycin|mesh-list
154017410|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154017411|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017412|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154017413|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017414|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017415|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154017416|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154017417|NCT00613392|Antioxidants|antioxidants|mesh-list
153589448|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017424|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154017425|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
154017426|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017427|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017428|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
154017429|NCT02762864|Clopidogrel|clopidogrel|mesh-list
154017430|NCT02762864|Ticagrelor|ticagrelor|mesh-list
154017431|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017432|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017433|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154017434|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154017435|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154017436|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154017437|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
154017438|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017439|NCT02767154|Mannitol|mannitol|mesh-list
154017440|NCT02767154|Dextrans|dextrans|mesh-list
154017441|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154017442|NCT02767154|Diuretics|diuretics|mesh-ancestor
154017443|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
154017444|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017445|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
154017446|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
154017447|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
154017448|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154017449|NCT02767232|Plasminogen|plasminogen|mesh-list
154017450|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154017451|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154017452|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017453|NCT02767076|Anesthetics|anesthetics|mesh-list
154861022|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017454|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017455|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017456|NCT02766764|Hormones|hormones|mesh-list
154582956|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154017457|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017458|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017459|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
154017460|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154017461|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017462|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017463|NCT02770508|Ritonavir|ritonavir|mesh-list
154017464|NCT02770508|Darunavir|darunavir|mesh-list
154017465|NCT02770508|Tenofovir|tenofovir|mesh-list
154017466|NCT02770508|Lamivudine|lamivudine|mesh-list
154017467|NCT02770508|Emtricitabine|emtricitabine|mesh-list
154017468|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154017469|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154017470|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
154017471|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017472|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017473|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154017474|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154017475|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
154017476|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017477|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154017478|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154017479|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154017480|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154017481|NCT02762942|Misoprostol|misoprostol|mesh-list
154017482|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154017483|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
154017484|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154017485|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017505|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
154017506|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
154017507|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017508|NCT00644319|Ibuprofen|ibuprofen|mesh-list
154017509|NCT00644319|Morphine|morphine|mesh-list
154017510|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154017511|NCT00644319|Narcotics|narcotics|mesh-ancestor
154017512|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017513|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017514|NCT00644319|Analgesics|analgesics|mesh-ancestor
154017515|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
154017516|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017517|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154017518|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017519|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017520|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017521|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154017522|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017523|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017524|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
154017525|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154017526|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154017527|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017528|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
154017529|NCT04224116|Coagulants|coagulants|mesh-ancestor
154017530|NCT02672709|Apixaban|apixaban|mesh-list
154017531|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154017532|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
154017533|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154017534|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
154017535|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017536|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017537|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
154017538|NCT02770274|Aspirin|aspirin|mesh-list
154017539|NCT02770274|Cilostazol|cilostazol|mesh-list
154017540|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154017541|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017542|NCT02770274|Analgesics|analgesics|mesh-ancestor
154017543|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
153589515|NCT01804361|Cyclosporine|cyclosporine|mesh-list
154017557|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154861023|NCT03014713|Analgesics|analgesics|mesh-ancestor
154160585|NCT00753779|Simvastatin|simvastatin|mesh-list
154017558|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
154017559|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
154017560|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154017561|NCT02770274|Protective Agents|protective agents|mesh-ancestor
154017562|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154017563|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154017564|NCT00910221|Atorvastatin|atorvastatin|mesh-list
154017565|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154017566|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154017567|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
154017568|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017569|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154017570|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154017571|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017572|NCT04657562|Tacrolimus|tacrolimus|mesh-list
154017573|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017574|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
154017575|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017576|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154017577|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017578|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017579|NCT05252117|Mepivacaine|mepivacaine|mesh-list
154017580|NCT05252117|Carticaine|carticaine|mesh-list
154017581|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
154017582|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
154017583|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017584|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017585|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
154017586|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017587|NCT04224350|Tacrolimus|tacrolimus|mesh-list
154017588|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017589|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
154017590|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017591|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154017592|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017593|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017594|NCT02770716|Terlipressin|terlipressin|mesh-list
154017595|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154017596|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154017597|NCT02672241|Temozolomide|temozolomide|mesh-list
154017598|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
154017599|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154017600|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
154017601|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017602|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017603|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154017632|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
154017633|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
154017634|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
154017635|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017636|NCT04177641|Antioxidants|antioxidants|mesh-list
154582957|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782021|NCT04566211|Antacids|antacids|mesh-ancestor
154017637|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017638|NCT04177641|Protective Agents|protective agents|mesh-ancestor
154017639|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017640|NCT04178109|Acetaminophen|acetaminophen|mesh-list
154017641|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154017642|NCT04178109|Tramadol|tramadol|mesh-list
154017643|NCT04178109|Ropivacaine|ropivacaine|mesh-list
154017644|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
154017645|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
154017646|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
154017647|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017648|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017649|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
154017650|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017667|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
154017668|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017669|NCT04177719|Oxytocin|oxytocin|mesh-list
154017670|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
154017671|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154017672|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017673|NCT00644553|Amoxicillin|amoxicillin|mesh-list
154017674|NCT00644553|Clarithromycin|clarithromycin|mesh-list
154017675|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
154861024|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
154017676|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154017677|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154017678|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017679|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154017680|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017681|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017682|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154017683|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154017684|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154017685|NCT02762474|Paclitaxel|paclitaxel|mesh-list
154017686|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154017687|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017688|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
154017689|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
154017690|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
154017691|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017692|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
154017693|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154017694|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154017695|NCT00915473|Prednisolone|prednisolone|mesh-list
154017696|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
154017697|NCT00915473|Lidocaine|lidocaine|mesh-list
154017698|NCT00915473|Bupivacaine|bupivacaine|mesh-list
154017699|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154017700|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
154017701|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
154017702|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
154017703|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775224|NCT06177925|Carboplatin|carboplatin|mesh-list
154017704|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017705|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
154017706|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017707|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154017708|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154017728|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017729|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017730|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
154017731|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017732|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154017733|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154017734|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154017735|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154017736|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017737|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154017738|NCT04691726|Narcotics|narcotics|mesh-ancestor
154017739|NCT04691726|Analgesics|analgesics|mesh-ancestor
154017740|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154017741|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017742|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017743|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017744|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
154017745|NCT00614328|Naltrexone|naltrexone|mesh-list
154017746|NCT00614328|Baclofen|baclofen|mesh-list
154017747|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154017748|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154017749|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017750|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
154017751|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017752|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154017753|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154017754|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154017755|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
154017756|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
154017757|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017758|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017759|NCT04177173|Methotrexate|methotrexate|mesh-list
154017760|NCT04177173|Simvastatin|simvastatin|mesh-list
154017761|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154017762|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
154017763|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154017764|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589751|NCT01808586|Lidocaine|lidocaine|mesh-list
154017771|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154017772|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017773|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
154017774|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017775|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154017776|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154017777|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154017778|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154017779|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154017780|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154017781|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154017782|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
154017783|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154017784|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
154017785|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154017786|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017787|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154017788|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154017789|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017792|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154017793|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154017794|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017795|NCT03651804|Analgesics|analgesics|mesh-ancestor
154017796|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
154017797|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017798|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017799|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
154017800|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154017801|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017802|NCT00917267|Exenatide|exenatide|mesh-list
154017803|NCT00917267|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154017804|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154017805|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017806|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154017807|NCT00917267|Incretins|incretins|mesh-ancestor
154017808|NCT00917267|Hormones|hormones|mesh-ancestor
154017809|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017810|NCT02670759|Bupivacaine|bupivacaine|mesh-list
154017811|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
154017812|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
154017813|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017814|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017815|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
154017816|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017817|NCT00644943|Amoxicillin|amoxicillin|mesh-list
154017818|NCT00644943|Cefdinir|cefdinir|mesh-list
154017819|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154017820|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017821|NCT00644943|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154017822|NCT00644943|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154017823|NCT02769884|Pancrelipase|pancrelipase|mesh-list
154017824|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154017825|NCT05213507|Amikacin|amikacin|mesh-list
154017826|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154017827|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017828|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154017829|NCT04253873|Temozolomide|temozolomide|mesh-list
154017830|NCT04253873|Apatinib|apatinib|mesh-list
154017831|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154017833|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017844|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154017845|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
154017846|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017847|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017848|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154017849|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154017850|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
154017852|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154017853|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154017854|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154017855|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017856|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
154017857|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154017858|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154017859|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017860|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017861|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017862|NCT00920699|Ubiquinone|ubiquinone|mesh-list
154017863|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
154017864|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
154017865|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017866|NCT00920699|Vitamins|vitamins|mesh-ancestor
154017867|NCT02670135|Triclosan|triclosan|mesh-list
154017868|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154017869|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017870|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154017871|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154017872|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
154017873|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017874|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154017875|NCT02769494|Riboflavin|riboflavin|mesh-list
154017876|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
154017877|NCT02769494|Mesalamine|mesalamine|mesh-list
154017878|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
154017879|NCT02769494|Vitamins|vitamins|mesh-ancestor
154017880|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
154017881|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017882|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154017883|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
154017884|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154017885|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017886|NCT02769494|Analgesics|analgesics|mesh-ancestor
154017887|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
154017888|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017889|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017890|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017891|NCT02769572|Diclofenac|diclofenac|mesh-list
154017892|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154017893|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017894|NCT02769572|Analgesics|analgesics|mesh-ancestor
154017895|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
154017896|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017897|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017910|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154017911|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017912|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154017913|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017914|NCT02765204|Incretins|incretins|mesh-ancestor
154017915|NCT02765204|Hormones|hormones|mesh-ancestor
154017916|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017917|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154017918|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
154017919|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017920|NCT03342456|Amoxicillin|amoxicillin|mesh-list
154017921|NCT03342456|Doxycycline|doxycycline|mesh-list
154017922|NCT03342456|Furazolidone|furazolidone|mesh-list
154017923|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
154017924|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017925|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154017926|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017927|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
154017928|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154017930|NCT03342456|Diuretics|diuretics|mesh-ancestor
154017931|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
154017932|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017933|NCT03342456|Expectorants|expectorants|mesh-ancestor
154017934|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
154017935|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154017936|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154017937|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154017938|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154017939|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017940|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154017941|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
154017942|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154017943|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
154017944|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017945|NCT02769104|Docetaxel|docetaxel|mesh-list
154017946|NCT02769104|Letrozole|letrozole|mesh-list
154017947|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154017948|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017949|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
154017950|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
154017951|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
154017952|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017953|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154017954|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017955|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154017956|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
154017957|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017958|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017959|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
154017960|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154017961|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017977|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017978|NCT00916721|Propranolol|propranolol|mesh-list
154017979|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154017980|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154017981|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
154017982|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017983|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017984|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017985|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154017986|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154017987|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
154017988|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
154017989|NCT00613782|Testosterone|testosterone|mesh-list
154017990|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
154017991|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
154017992|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154017993|NCT00613782|Androgens|androgens|mesh-ancestor
154017994|NCT00613782|Hormones|hormones|mesh-ancestor
154017995|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017996|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017997|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154017998|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017999|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
154018000|NCT02764736|Atorvastatin|atorvastatin|mesh-list
154018001|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154018002|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154018003|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
154018004|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018006|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154018007|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018008|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
154018009|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154018010|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018011|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154018012|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
154018013|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018014|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018015|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018016|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018017|NCT00646815|Hormones|hormones|mesh-list
154018018|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018019|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018020|NCT00915005|Paclitaxel|paclitaxel|mesh-list
154018021|NCT00915005|Carboplatin|carboplatin|mesh-list
154018036|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018037|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
154018038|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
154018039|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
154018040|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018041|NCT02696642|Immunoconjugates|immunoconjugates|mesh-ancestor
154018042|NCT02696642|Immunologic Factors|immunologic factors|mesh-ancestor
154018043|NCT02696642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018044|NCT00647049|Cytarabine|cytarabine|mesh-list
154018045|NCT00647049|Rituximab|rituximab|mesh-list
154018046|NCT00647049|Methotrexate|methotrexate|mesh-list
154018047|NCT00647049|Thiotepa|thiotepa|mesh-list
154018048|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154018049|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018050|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
154018051|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018052|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154018053|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154018054|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
154018055|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154176589|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154018056|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154018057|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
154018058|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018059|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
154018060|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018061|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154018062|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154018063|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154018064|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
154018065|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018066|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154018067|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
154018068|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154018069|NCT02696330|Enoxaparin|enoxaparin|mesh-list
154018070|NCT02696330|Clopidogrel|clopidogrel|mesh-list
154018071|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154018072|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154018073|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154018074|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154018075|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
154018076|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018077|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018078|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018079|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
154018080|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154018091|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018092|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154018093|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018095|NCT00647127|Buprenorphine|buprenorphine|mesh-list
154018096|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154018097|NCT00647127|Narcotics|narcotics|mesh-ancestor
154018098|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018099|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018100|NCT00647127|Analgesics|analgesics|mesh-ancestor
154018101|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
154018102|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018103|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154018104|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154018105|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
154018106|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
154018107|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154018108|NCT04750070|Dopamine|dopamine|mesh-list
154018109|NCT04750070|Epinephrine|epinephrine|mesh-list
154018110|NCT04750070|Racepinephrine|racepinephrine|mesh-list
154018111|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
154018112|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154018113|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154018114|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
154018115|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018116|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018117|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582958|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
154018118|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154018119|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154018120|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
154018121|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018122|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154018123|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
154018124|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
154018125|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
154018126|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154018127|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154018128|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
154018129|NCT04750070|Protective Agents|protective agents|mesh-ancestor
154018130|NCT02763722|Emollients|emollients|mesh-list
154018131|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
154018132|NCT01143246|Terlipressin|terlipressin|mesh-list
154018133|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154018134|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154018135|NCT00647673|Verapamil|verapamil|mesh-list
154018136|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154018137|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154018138|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018139|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018140|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154018141|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018142|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
154018143|NCT00561925|Nevirapine|nevirapine|mesh-list
154018144|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154018145|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154018146|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018163|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018165|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
154018166|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154018167|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018168|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018169|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154018170|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018171|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154018172|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154018173|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018174|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154018175|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154018176|NCT02536989|Omeprazole|omeprazole|mesh-list
154018177|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154018178|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018179|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154018180|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018181|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018182|NCT00647829|Valdecoxib|valdecoxib|mesh-list
154018183|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154018184|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154018185|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018186|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018187|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154018188|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154018189|NCT00647829|Analgesics|analgesics|mesh-ancestor
154018190|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
154018191|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018192|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018193|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018194|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154018195|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
154018196|NCT02517918|Sirolimus|sirolimus|mesh-list
154018197|NCT02517918|Methotrexate|methotrexate|mesh-list
154018198|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154018199|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
154018200|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018201|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018202|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154018203|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
153590179|NCT01812018|Docetaxel|docetaxel|mesh-list
154018217|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154018218|NCT00647907|Voriconazole|voriconazole|mesh-list
154018219|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
154018220|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018221|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154018222|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154018223|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018224|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018225|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154018226|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
154018227|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018228|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018229|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154018230|NCT04171791|Venetoclax|venetoclax|mesh-list
154018231|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018232|NCT04003818|Teicoplanin|teicoplanin|mesh-list
154018233|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018234|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018235|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154018236|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018237|NCT00949663|Incretins|incretins|mesh-ancestor
154018238|NCT00949663|Hormones|hormones|mesh-ancestor
154018239|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018240|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018241|NCT00647985|Fexofenadine|fexofenadine|mesh-list
154018242|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154018243|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154018244|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154018245|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
154018246|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
154018247|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018248|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018249|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018250|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
154018251|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154018252|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
154018253|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018254|NCT02664051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154018255|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018256|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154018257|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
154018258|NCT00648063|Letrozole|letrozole|mesh-list
154018259|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018260|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154018261|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153590243|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
154018271|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154018272|NCT00648141|Analgesics|analgesics|mesh-ancestor
154018273|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
154018274|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018275|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018276|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018277|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176590|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154018278|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154018279|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154018280|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018281|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018283|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154018284|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
154018285|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018286|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018287|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154018288|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018289|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
154018290|NCT02763098|Remifentanil|remifentanil|mesh-list
154018291|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154018292|NCT02763098|Narcotics|narcotics|mesh-ancestor
154018293|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018294|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018295|NCT02763098|Analgesics|analgesics|mesh-ancestor
154018296|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
154018297|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775818|NCT04916197|Analgesics|analgesics|mesh-ancestor
154018299|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154018300|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154018301|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154018302|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154018303|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018305|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
154018306|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154018307|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154018308|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
154018309|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018310|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018311|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018312|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154018313|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154018314|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
154018315|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
154018316|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018317|NCT00648297|Diuretics|diuretics|mesh-ancestor
154018318|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
154018319|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154018320|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018322|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154018323|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154018324|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154018325|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154018349|NCT02758340|Misoprostol|misoprostol|mesh-list
154018350|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154176591|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018351|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
154018352|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018353|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018354|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154018355|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018356|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
154018357|NCT02768168|Dezocine|dezocine|mesh-list
154018358|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154018359|NCT02768168|Narcotics|narcotics|mesh-ancestor
154018360|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018361|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018362|NCT02768168|Analgesics|analgesics|mesh-ancestor
154018363|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
154018364|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018365|NCT02659683|Esomeprazole|esomeprazole|mesh-list
154018366|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154018367|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018368|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154018369|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775900|NCT04520607|Lorecivivint|lorecivivint|mesh-list
154018370|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018371|NCT02659761|Lamivudine|lamivudine|mesh-list
154018372|NCT02659761|Abacavir|abacavir|mesh-list
154018373|NCT02659761|Dolutegravir|dolutegravir|mesh-list
154018510|NCT00957385|Growth Substances|growth substances|mesh-ancestor
154018511|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
154018512|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018513|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
154018514|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154018515|NCT02462538|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153776050|NCT04092673|Sotorasib|sotorasib|mesh-list
154018517|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018518|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018519|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018520|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154018521|NCT02462538|Immunotoxins|immunotoxins|mesh-ancestor
154018522|NCT02462538|Immunoconjugates|immunoconjugates|mesh-ancestor
154018523|NCT02462538|Immunologic Factors|immunologic factors|mesh-ancestor
154018524|NCT02462538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018525|NCT02752646|Ketorolac|ketorolac|mesh-list
154018526|NCT02752646|Nepafenac|nepafenac|mesh-list
154018527|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154018528|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154018529|NCT02752646|Analgesics|analgesics|mesh-ancestor
154018530|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
154018756|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154018757|NCT02759198|Analgesics|analgesics|mesh-ancestor
154018758|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
154018759|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018760|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018761|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018762|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154018763|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154018764|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154018765|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018766|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018767|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
154018768|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
154018769|NCT02755064|Erythromycin|erythromycin|mesh-list
154018770|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
154018771|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154018772|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
154018773|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
154018774|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018775|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018776|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154255105|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154018777|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154018778|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018779|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018780|NCT02705976|Warfarin|warfarin|mesh-list
154018781|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
154018782|NCT02752412|Insulin|insulin|mesh-list
154018783|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153626807|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154018784|NCT02752412|Metformin|metformin|mesh-list
154018785|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
154018786|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154018787|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018788|NCT02703090|Remifentanil|remifentanil|mesh-list
154018789|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154018790|NCT02703090|Narcotics|narcotics|mesh-ancestor
154018791|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018792|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018793|NCT02703090|Analgesics|analgesics|mesh-ancestor
154018794|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
154018795|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018797|NCT02754362|Poly ICLC|poly iclc|mesh-list
154018798|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154018799|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154018800|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154018882|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018883|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018884|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018885|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
154018886|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590896|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
154018939|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019067|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154019068|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154019069|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
154019070|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019071|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154019072|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154019073|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019074|NCT00914459|Factor VIII|factor viii|mesh-list
154019075|NCT00914459|Coagulants|coagulants|mesh-ancestor
154019076|NCT02701608|Levofloxacin|levofloxacin|mesh-list
154019077|NCT02701608|Rifampin|rifampin|mesh-list
154019078|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
154019079|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154019080|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019081|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154019082|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154019083|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154019084|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019085|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019086|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019087|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154019088|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154019089|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154019090|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
154019091|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
153591093|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019243|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019245|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154019246|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154019247|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
154019248|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154019249|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153591262|NCT01818908|Vincristine|vincristine|mesh-list
154019342|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019344|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154019345|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019346|NCT04453046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154019347|NCT04453046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019348|NCT04217096|Paclitaxel|paclitaxel|mesh-list
154019349|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019350|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019351|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
154861025|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255107|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
154019352|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019353|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019354|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019643|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154019645|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
154019646|NCT00911807|Donepezil|donepezil|mesh-list
154019647|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154019648|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019649|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019650|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
154019651|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019652|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019653|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
154019654|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154019655|NCT00911807|Protective Agents|protective agents|mesh-ancestor
154019656|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154019657|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154019658|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019659|NCT04117451|Propolis|propolis|mesh-list
154019660|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019661|NCT03690089|Atropine|atropine|mesh-list
154019662|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154019663|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154019695|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154019696|NCT04788641|Cyclosporine|cyclosporine|mesh-list
154019697|NCT04788641|Tacrolimus|tacrolimus|mesh-list
154019698|NCT04788641|Cyclosporins|cyclosporins|mesh-list
154019699|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154019700|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
154019701|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019702|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154019703|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019704|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019705|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
154019706|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019738|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019740|NCT05629598|Hematinics|hematinics|mesh-ancestor
154019741|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154019742|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154019743|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154019744|NCT02736032|Estradiol|estradiol|mesh-list
154019745|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154019746|NCT02736032|Progesterone|progesterone|mesh-list
154019747|NCT02736032|Estrogens|estrogens|mesh-ancestor
154019748|NCT02736032|Hormones|hormones|mesh-ancestor
154019749|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591751|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154019778|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782025|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154019780|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
154019781|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019782|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019783|NCT02744378|Clobetasol|clobetasol|mesh-list
153777319|NCT04719507|Meperidine|meperidine|mesh-list
154019784|NCT02744378|Tacrolimus|tacrolimus|mesh-list
154019785|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154019786|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
154019787|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019788|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154019789|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019790|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019791|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154019792|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
154019793|NCT02744378|Hormones|hormones|mesh-ancestor
154019794|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019963|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154019964|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
154019965|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019966|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019967|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020004|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020035|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154861026|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154020036|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020037|NCT03695510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154020038|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020039|NCT03695510|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154020040|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154020041|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020042|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
154020043|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
154020044|NCT02731040|Diphosphonates|diphosphonates|mesh-list
154020045|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
154020046|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154020047|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020048|NCT02734160|Durvalumab|durvalumab|mesh-list
154020049|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154020050|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020051|NCT02730572|Methylphenidate|methylphenidate|mesh-list
153592051|NCT01824264|Licogliflozin|licogliflozin|mesh-list
154020242|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154020243|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154020244|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020245|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020246|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154020247|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
154020248|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
154020249|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
154020250|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020251|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
154020252|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
154020253|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154020288|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020289|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020290|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
154020291|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
154020292|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020293|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
154582959|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
153489098|NCT05495568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153626808|NCT02019160|Fluorides|fluorides|mesh-list
154020712|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020713|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020714|NCT00649857|Cetirizine|cetirizine|mesh-list
154020715|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154020716|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154020717|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154020718|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
154020719|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
154020720|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020721|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020722|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020723|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
154020724|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
154020725|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020726|NCT00764270|Protective Agents|protective agents|mesh-ancestor
154020727|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020728|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
154020729|NCT00764270|Vitamins|vitamins|mesh-ancestor
154020730|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
154020731|NCT00650481|Oxybutynin|oxybutynin|mesh-list
154020732|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
154020733|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
154020734|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020735|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020736|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154020737|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154020738|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
154020739|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020740|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020741|NCT00650481|Urological Agents|urological agents|mesh-ancestor
154020742|NCT02712476|Furosemide|furosemide|mesh-list
154020743|NCT02712476|Mannitol|mannitol|mesh-list
154020744|NCT02712476|Diuretics|diuretics|mesh-ancestor
154020745|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
154020746|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592733|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154020775|NCT02650713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154020777|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
154020778|NCT02650635|Lenograstim|lenograstim|mesh-list
154020779|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020780|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
154020781|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020782|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154020783|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154020784|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
154020785|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020786|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592787|NCT01829841|Sunitinib|sunitinib|mesh-list
154020814|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
154020816|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
154020817|NCT02650479|Palonosetron|palonosetron|mesh-list
154020818|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154020819|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020820|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154020821|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154020822|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020823|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020824|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020825|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020826|NCT02650479|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154020827|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020828|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153778359|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020829|NCT02650479|Incretins|incretins|mesh-ancestor
154020830|NCT02650479|Hormones|hormones|mesh-ancestor
154020831|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153626809|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
154020832|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
154020833|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
154020834|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020835|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592829|NCT01830270|Epirubicin|epirubicin|mesh-list
154020899|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154020900|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154021066|NCT02710448|Metformin|metformin|mesh-list
154021067|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154021068|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021069|NCT04166253|Vitamin D|vitamin d|mesh-list
154021070|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
154021071|NCT04166253|Vitamins|vitamins|mesh-ancestor
154021072|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
154021073|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021074|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154021075|NCT00653055|Cabergoline|cabergoline|mesh-list
154021076|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154021077|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154021078|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
154021079|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
154021080|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021081|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021082|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021083|NCT02643147|Furosemide|furosemide|mesh-list
154021084|NCT02643147|Diuretics|diuretics|mesh-list
154021085|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154021086|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
154021087|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021088|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021089|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021090|NCT02642913|Sorafenib|sorafenib|mesh-list
154021091|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021092|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021093|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593082|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154021186|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154021187|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021188|NCT02641899|Acetaminophen|acetaminophen|mesh-list
154021190|NCT02641899|Digoxin|digoxin|mesh-list
154021191|NCT02641899|Lisinopril|lisinopril|mesh-list
154021192|NCT02641899|Warfarin|warfarin|mesh-list
154021193|NCT02641899|Atorvastatin|atorvastatin|mesh-list
154021194|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154021195|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154021196|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
154021197|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021198|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154021199|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154021200|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021201|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021202|NCT02641899|Analgesics|analgesics|mesh-ancestor
154021203|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
154021204|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582960|NCT05653492|Sulforaphane|sulforaphane|mesh-list
154021205|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021206|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
154021207|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
154021209|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154021210|NCT02641899|Protective Agents|protective agents|mesh-ancestor
154021211|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154021278|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154021279|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021280|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
154021281|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
154021282|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
154021283|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021284|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154021705|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021707|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154021708|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154021864|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154021865|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154021866|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021867|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021868|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
154021869|NCT00659451|Losartan|losartan|mesh-list
154021870|NCT00659451|Amlodipine|amlodipine|mesh-list
154021871|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154021872|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153779406|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154021873|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021901|NCT00659685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154021902|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154021903|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
154021904|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021905|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021906|NCT00659841|Ciclesonide|ciclesonide|mesh-list
154021907|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
154021908|NCT00659841|Hormones|hormones|mesh-ancestor
154021909|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021910|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021911|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154021912|NCT00659919|Trazodone|trazodone|mesh-list
154021913|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154021914|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154021915|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021916|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021917|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154021918|NCT00659919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153593920|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
154021998|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154021999|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022000|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
154022001|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
154022002|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
154022003|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022004|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154022005|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022006|NCT00879333|Everolimus|everolimus|mesh-list
154022007|NCT00879333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154022008|NCT00879333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154022009|NCT00879333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022010|NCT00879333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022011|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154022120|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
154022121|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022122|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022123|NCT00667485|Sirolimus|sirolimus|mesh-list
153626810|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
154022124|NCT00667485|Bevacizumab|bevacizumab|mesh-list
154022125|NCT00667485|Temsirolimus|temsirolimus|mesh-list
153594135|NCT01847404|Pantoprazole|pantoprazole|mesh-list
154022158|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
154022159|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
154022160|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154022161|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154022162|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154022163|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154022164|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
154022165|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022166|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022259|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
154022261|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
154022262|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022263|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154022264|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154022265|NCT03555968|Analgesics|analgesics|mesh-ancestor
154022266|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
154022267|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022268|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154022326|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154022327|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022328|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154022329|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154022330|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022331|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022332|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
154022333|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022334|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154022335|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154022336|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022337|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154022338|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154022360|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154022361|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154022362|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022363|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022364|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
154022365|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154022366|NCT03322280|Estrogens|estrogens|mesh-ancestor
154022367|NCT03322280|Hormones|hormones|mesh-ancestor
154022368|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022369|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022370|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154022371|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022372|NCT04150575|Paclitaxel|paclitaxel|mesh-list
154022373|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154022374|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154022375|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022376|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
154022377|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
154022378|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
154022379|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022380|NCT04349306|Rasburicase|rasburicase|mesh-list
154022381|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
154022382|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022383|NCT00614588|Anesthetics|anesthetics|mesh-list
154022384|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022385|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022386|NCT02699840|Vaccines|vaccines|mesh-list
154022387|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
154022388|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022389|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
154022390|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154022392|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594391|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
154022413|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154022414|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
154022415|NCT05344742|Analgesics|analgesics|mesh-ancestor
154022416|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
154022417|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022418|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022419|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154022420|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154022421|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022422|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154022423|NCT02046434|Glycerol|glycerol|mesh-list
154022424|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154022425|NCT02046434|Protective Agents|protective agents|mesh-ancestor
154022426|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022427|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022428|NCT03930446|Ethanol|ethanol|mesh-list
154022429|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154022430|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022431|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022432|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022433|NCT00614666|Nikkomycin|nikkomycin|mesh-list
154022434|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
154022435|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022436|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022437|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022438|NCT03794336|Aspirin|aspirin|mesh-list
154022439|NCT03794336|Metformin|metformin|mesh-list
154022440|NCT03794336|Alogliptin|alogliptin|mesh-list
154022441|NCT03794336|Acarbose|acarbose|mesh-list
154022442|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154022443|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022444|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154022445|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154022446|NCT03794336|Analgesics|analgesics|mesh-ancestor
154022447|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
154022476|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022477|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
154022478|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154022479|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022480|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154022481|NCT05343728|Hemostatics|hemostatics|mesh-list
154022482|NCT05343728|Coagulants|coagulants|mesh-ancestor
154022483|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
154022484|NCT00436748|Hematinics|hematinics|mesh-ancestor
154022485|NCT02704598|Warfarin|warfarin|mesh-list
154022486|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
154022487|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
154022488|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154022489|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
154022490|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154022491|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
154022492|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022493|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022494|NCT05343338|Sivelestat|sivelestat|mesh-list
153594502|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
154022560|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154022561|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
154022562|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022563|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022564|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154022565|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154022566|NCT00615446|Growth Substances|growth substances|mesh-ancestor
154022567|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022568|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
154022569|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154022570|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022604|NCT02703272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154022605|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154022608|NCT02703194|Leflunomide|leflunomide|mesh-list
154022609|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022610|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
154022611|NCT02703194|Hormones|hormones|mesh-ancestor
154022612|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022613|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594618|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
154022713|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154022714|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154022715|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022716|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022717|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154022718|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
154022719|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022720|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022721|NCT00908141|Sargramostim|sargramostim|mesh-list
154022722|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
154022723|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022751|NCT02706158|Vitamin D|vitamin d|mesh-list
154022752|NCT02706158|Calcium|calcium|mesh-list
154022753|NCT02706158|Vitamins|vitamins|mesh-ancestor
154022754|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
154022755|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022756|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154022757|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154022758|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
154022759|NCT00615602|Docetaxel|docetaxel|mesh-list
154022760|NCT00615602|Trastuzumab|trastuzumab|mesh-list
154022761|NCT00615602|Epirubicin|epirubicin|mesh-list
154022762|NCT00615602|Fluorouracil|fluorouracil|mesh-list
154022763|NCT00615602|Lenograstim|lenograstim|mesh-list
154022764|NCT00615602|Mitogens|mitogens|mesh-list
154022765|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154022766|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
154022767|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022768|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022769|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154022771|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022772|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022833|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
154022834|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
154022835|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022836|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022837|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154022838|NCT02701478|Analgesics|analgesics|mesh-ancestor
154022839|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
154022840|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022841|NCT03314363|Trace Elements|trace elements|mesh-list
154022842|NCT03314363|Micronutrients|micronutrients|mesh-list
154022843|NCT03314363|Citric Acid|citric acid|mesh-list
154022844|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
154022845|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022846|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
154022847|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154022848|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
154022849|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
154023495|NCT01497509|Analgesics|analgesics|mesh-ancestor
154023496|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154023497|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154023498|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
154023499|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154023500|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154023501|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
154023502|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023503|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023504|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154023505|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154023506|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
154023507|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154023508|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
154023509|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
154023510|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
154023511|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154023512|NCT02844881|Apatinib|apatinib|mesh-list
154023513|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023692|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023693|NCT04958772|Lenograstim|lenograstim|mesh-list
154023694|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154023695|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
154023696|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023697|NCT02771249|Pyridoxine|pyridoxine|mesh-list
154023698|NCT02771249|Isoniazid|isoniazid|mesh-list
154023699|NCT02771249|Darunavir|darunavir|mesh-list
154023700|NCT02771249|Cobicistat|cobicistat|mesh-list
154023750|NCT04186026|Glucagon|glucagon|mesh-list
154023751|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154023752|NCT04186026|Incretins|incretins|mesh-ancestor
154023753|NCT04186026|Hormones|hormones|mesh-ancestor
154023754|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023755|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023756|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154023757|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
154023758|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154023759|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
154023760|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023761|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023762|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154023763|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
154023764|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
154023765|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154023766|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
154023767|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023768|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023769|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154023770|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023771|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154023772|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154023773|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023774|NCT00650819|Simvastatin|simvastatin|mesh-list
154023776|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154023777|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154023778|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
154023779|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023780|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154023781|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154023782|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023783|NCT05662410|Aflibercept|aflibercept|mesh-list
154023784|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154023785|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154023786|NCT05662410|Growth Substances|growth substances|mesh-ancestor
154023787|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023788|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
154023789|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023790|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154024153|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154024154|NCT02697162|Octenidine|octenidine|mesh-list
153596192|NCT01860235|Anesthetics|anesthetics|mesh-list
154024258|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024259|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024260|NCT00616460|Bivalirudin|bivalirudin|mesh-list
154024261|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
154024262|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154024263|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
154024264|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024502|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154024503|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024504|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
154024505|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
154024506|NCT02777580|Tenecteplase|tenecteplase|mesh-list
154024507|NCT02777580|Clopidogrel|clopidogrel|mesh-list
154024688|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154024702|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
154024704|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
154024705|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
154024706|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154024707|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
154024708|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
154024709|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024710|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154024711|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024712|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154024713|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024714|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154024715|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154024716|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
154024717|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024718|NCT05662956|Azacitidine|azacitidine|mesh-list
154024719|NCT05662956|Venetoclax|venetoclax|mesh-list
153731636|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731638|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153731639|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
154024720|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154024721|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
154024722|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024723|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024724|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024725|NCT02838173|Ropivacaine|ropivacaine|mesh-list
154024726|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
154024727|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
154024728|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024729|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024730|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
154024731|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024732|NCT00641472|Budesonide|budesonide|mesh-list
154024733|NCT00641472|Montelukast|montelukast|mesh-list
154024734|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024735|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154024736|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
154024737|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024738|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161938|NCT00989508|Perhexiline|perhexiline|mesh-list
154024739|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154024740|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
154024741|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
154024742|NCT00641472|Hormones|hormones|mesh-ancestor
154024743|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024744|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154024745|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
154024746|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154024747|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154024748|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024749|NCT00896051|Ritonavir|ritonavir|mesh-list
154024750|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154024779|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154024780|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154024781|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024782|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154024783|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154024784|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154024785|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024786|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
154024787|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024788|NCT00894647|Imiquimod|imiquimod|mesh-list
154024789|NCT00894647|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154024790|NCT00894647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024791|NCT00894647|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154024792|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
154024793|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024794|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154025007|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154025009|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154025010|NCT02672202|Analgesics|analgesics|mesh-ancestor
154025011|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
154025012|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025013|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025014|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
154025015|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154025016|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025017|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025018|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154025019|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154025020|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154025021|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025022|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597046|NCT01866254|Narcotics|narcotics|mesh-ancestor
153597173|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597174|NCT01867463|Antacids|antacids|mesh-ancestor
153597175|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025173|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154025174|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025175|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154025176|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154025177|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025178|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154025179|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154025180|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025181|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
154025182|NCT02668926|Amphetamine|amphetamine|mesh-list
154025183|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154025184|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
154025185|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154025186|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025309|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154025310|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
154025311|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025312|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025313|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154182210|NCT05752201|Vaccines|vaccines|mesh-list
154025904|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025905|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025906|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154861027|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154025907|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154026321|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026323|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026324|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
154026325|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
154026326|NCT02655276|Glycine|glycine|mesh-list
154026327|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
154026328|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026329|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026330|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026370|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026371|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154026372|NCT00621998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154026373|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154026374|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026375|NCT02655198|Fenfluramine|fenfluramine|mesh-list
154026376|NCT02655198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154026377|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154026378|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026379|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026380|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026381|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
154026382|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026383|NCT00650052|Zonisamide|zonisamide|mesh-list
154026384|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
154026385|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154026386|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026387|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026388|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154026389|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026390|NCT00891527|Bevacizumab|bevacizumab|mesh-list
154026391|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
153598441|NCT05732506|Protease Inhibitors|protease inhibitors|mesh-ancestor
154026419|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
154026420|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026421|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026422|NCT02650752|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154026423|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154026424|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026425|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
154026426|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154026427|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154026428|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
154026429|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154026430|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026431|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026432|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
154026433|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026434|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026435|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153569086|NCT04693468|Palbociclib|palbociclib|mesh-list
154026436|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
154026437|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
154026467|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026468|NCT06096558|Melatonin|melatonin|mesh-list
154026469|NCT06096558|Antioxidants|antioxidants|mesh-ancestor
154026470|NCT06096558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026471|NCT06096558|Protective Agents|protective agents|mesh-ancestor
154026472|NCT06096558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026473|NCT06096558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026474|NCT06096480|Gabapentin|gabapentin|mesh-list
154026475|NCT06096480|Analgesics|analgesics|mesh-ancestor
154026476|NCT06096480|Sensory System Agents|sensory system agents|mesh-ancestor
154026477|NCT06096480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026478|NCT06096480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026479|NCT06096480|Anticonvulsants|anticonvulsants|mesh-ancestor
154026480|NCT06096480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154026481|NCT06096480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154026482|NCT06096480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026518|NCT06096181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154026519|NCT06096181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154026520|NCT06096181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154026521|NCT06096181|Adrenergic Agents|adrenergic agents|mesh-ancestor
154026522|NCT06096181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026523|NCT06096181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026752|NCT05989503|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154026754|NCT05989503|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154026755|NCT05989503|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154026756|NCT05989503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026757|NCT05989503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026758|NCT05989503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026759|NCT05972018|Bupivacaine|bupivacaine|mesh-list
154026760|NCT05972018|Ropivacaine|ropivacaine|mesh-list
154026761|NCT05972018|Anesthetics, Local|anesthetics, local|mesh-ancestor
154026762|NCT05972018|Anesthetics|anesthetics|mesh-ancestor
154182213|NCT05749393|Heparin|heparin|mesh-list
154026957|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569698|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026958|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
154026959|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026960|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026961|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154026962|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154026963|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026965|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
154026966|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026967|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026968|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154026969|NCT05287256|Analgesics|analgesics|mesh-ancestor
154026970|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
154026971|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026972|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154026973|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154026974|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026975|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026976|NCT05287256|Hormones|hormones|mesh-ancestor
154026977|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154026978|NCT05239182|Gemcitabine|gemcitabine|mesh-list
154026979|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154026980|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154026981|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
154026982|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026983|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026984|NCT05204667|Acetaminophen|acetaminophen|mesh-list
154026985|NCT05204667|Aspirin|aspirin|mesh-list
154026986|NCT05204667|Methocarbamol|methocarbamol|mesh-list
154027012|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027013|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154027014|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154027015|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154027016|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027017|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027018|NCT05142696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027019|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
154027020|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
154027021|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154027022|NCT04993352|Antibodies|antibodies|mesh-list
154027023|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154027024|NCT04993352|Mitogens|mitogens|mesh-list
154027025|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
154027026|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
154027027|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027028|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
154027029|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027030|NCT04993352|Growth Substances|growth substances|mesh-ancestor
154027031|NCT04977401|Glycerol|glycerol|mesh-list
154027032|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154027033|NCT04977401|Protective Agents|protective agents|mesh-ancestor
154027034|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027035|NCT04950465|Fluorides|fluorides|mesh-list
154027046|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
154027047|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027048|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027049|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154027050|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
154027051|NCT04889547|Hormones|hormones|mesh-ancestor
154861028|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154027052|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027053|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154027054|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027055|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
154027056|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027057|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027059|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
154027060|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027061|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027062|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
154027063|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027064|NCT04887194|Nivolumab|nivolumab|mesh-list
154027065|NCT04887194|Digoxin|digoxin|mesh-list
154027066|NCT04887194|Midazolam|midazolam|mesh-list
154027067|NCT04887194|Levomethorphan|levomethorphan|mesh-list
154027068|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
154027069|NCT04887194|Warfarin|warfarin|mesh-list
154027070|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154027071|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027072|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027073|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154027074|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027075|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154027076|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154027077|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027078|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027079|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154027080|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154027081|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154027082|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154027083|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
154027084|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
154027085|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
154027086|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
154027087|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027088|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154027089|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154027090|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
154027091|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154027092|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154027093|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027094|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
154027095|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154027096|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154027097|NCT04887194|Protective Agents|protective agents|mesh-ancestor
154027098|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
154027099|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
154027100|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154027101|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154027102|NCT04887194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154027103|NCT04887194|Narcotics|narcotics|mesh-ancestor
154027118|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154027119|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
154027120|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027121|NCT04735185|Anesthetics|anesthetics|mesh-list
154027122|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
154027123|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027124|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027125|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
154027126|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027127|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
154027128|NCT04646395|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154027129|NCT04646395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154027130|NCT04646395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027131|NCT04646395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027132|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027133|NCT04518046|Nivolumab|nivolumab|mesh-list
154027134|NCT04518046|Ipilimumab|ipilimumab|mesh-list
154027135|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027136|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027137|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154027138|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027139|NCT04485052|Azacitidine|azacitidine|mesh-list
154027140|NCT04485052|Decitabine|decitabine|mesh-list
154027141|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154027142|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
154027143|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027144|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027145|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027146|NCT04447183|Iodine|iodine|mesh-list
154027147|NCT04447183|Hormones|hormones|mesh-list
154027148|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027149|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027150|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154027151|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027152|NCT04447183|Trace Elements|trace elements|mesh-ancestor
154027153|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
154027154|NCT04392479|Aflibercept|aflibercept|mesh-list
154027155|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154027156|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154027157|NCT04392479|Growth Substances|growth substances|mesh-ancestor
154027158|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027159|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
154027160|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027161|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
154027162|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027175|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
154027176|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
154027177|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027178|NCT04166773|Tirzepatide|tirzepatide|mesh-list
154027179|NCT04166773|Incretins|incretins|mesh-ancestor
154027180|NCT04166773|Hormones|hormones|mesh-ancestor
154027181|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027182|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027183|NCT04104672|Paclitaxel|paclitaxel|mesh-list
154027184|NCT04104672|Gemcitabine|gemcitabine|mesh-list
154027185|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154027186|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027187|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
154027188|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
154027189|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
154027190|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027191|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154027192|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
154027193|NCT04091217|Bevacizumab|bevacizumab|mesh-list
154027194|NCT04091217|Atezolizumab|atezolizumab|mesh-list
154027195|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027196|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027197|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154027198|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154027199|NCT04091217|Growth Substances|growth substances|mesh-ancestor
154027200|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027201|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
154027202|NCT04091217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154027203|NCT04091217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027204|NCT04074564|Apatinib|apatinib|mesh-list
154027205|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027206|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154027207|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027208|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027209|NCT04008186|Metformin|metformin|mesh-list
154027210|NCT04008186|Repaglinide|repaglinide|mesh-list
154027211|NCT04008186|Itraconazole|itraconazole|mesh-list
154027212|NCT04008186|Digoxin|digoxin|mesh-list
154027213|NCT04008186|Verapamil|verapamil|mesh-list
154027214|NCT04008186|Midazolam|midazolam|mesh-list
154027215|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154027216|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
154027217|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154027218|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027219|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154027220|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154027221|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027222|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154027223|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154027224|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154027225|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154027235|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154861029|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154162311|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027236|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154027237|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027238|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
154027239|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027240|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154027241|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154027242|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154027243|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
154027244|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027245|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154027246|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154027247|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154027248|NCT04008186|Protective Agents|protective agents|mesh-ancestor
154027249|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154027250|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154027251|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154027252|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
154027253|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154027254|NCT03891901|Isoniazid|isoniazid|mesh-list
154027255|NCT03891901|Rifabutin|rifabutin|mesh-list
153569914|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
154027256|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
154027257|NCT03891901|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154027258|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154027259|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027260|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027261|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027262|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
154027263|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154027264|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027265|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154027266|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154027268|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154027269|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154027270|NCT03887936|Testosterone|testosterone|mesh-list
154027271|NCT03887936|Androgens|androgens|mesh-ancestor
154027272|NCT03887936|Hormones|hormones|mesh-ancestor
154027273|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027274|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027275|NCT03872388|Capecitabine|capecitabine|mesh-list
154027276|NCT03872388|Atorvastatin|atorvastatin|mesh-list
154027277|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154027278|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
154027279|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027280|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027281|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154027282|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154027283|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154027284|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154027285|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027286|NCT03827018|Prednisone|prednisone|mesh-list
154027287|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
154027288|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027289|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
154027290|NCT03827018|Hormones|hormones|mesh-ancestor
153599286|NCT01874080|Metformin|metformin|mesh-list
154027326|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027327|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027328|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154027329|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153569989|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154027331|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027332|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
154027333|NCT03465111|Hormones|hormones|mesh-list
154027334|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154027335|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154027336|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
154027337|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027338|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027339|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027340|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861030|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027342|NCT03439254|Cathartics|cathartics|mesh-ancestor
154027343|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154027362|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027363|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154027364|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154027365|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154027366|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027367|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027369|NCT03139916|Bavituximab|bavituximab|mesh-list
154027370|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154027371|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
154027372|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027373|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027374|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027375|NCT03088540|Paclitaxel|paclitaxel|mesh-list
154027376|NCT03088540|Carboplatin|carboplatin|mesh-list
154027377|NCT03088540|Gemcitabine|gemcitabine|mesh-list
154027378|NCT03088540|Pemetrexed|pemetrexed|mesh-list
154027379|NCT03088540|Cemiplimab|cemiplimab|mesh-list
153730480|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176611|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154176612|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176613|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
154176614|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
154176615|NCT00845819|Trace Elements|trace elements|mesh-ancestor
154176616|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
154176617|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176618|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
154176619|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
154176620|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176621|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
154176622|NCT00845819|Ionophores|ionophores|mesh-ancestor
154176623|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154176624|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176625|NCT02546843|Rocuronium|rocuronium|mesh-list
154176626|NCT02546843|Atracurium|atracurium|mesh-list
154176627|NCT02546843|Cisatracurium|cisatracurium|mesh-list
154176628|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154176629|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154176630|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154182215|NCT05749393|Anticoagulants|anticoagulants|mesh-ancestor
154176691|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154176693|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
154176694|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176695|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176696|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154176697|NCT00848861|Narcotics|narcotics|mesh-ancestor
154176698|NCT00848861|Analgesics|analgesics|mesh-ancestor
154176699|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
154176700|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176701|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
154176702|NCT00852371|Piperaquine|piperaquine|mesh-list
154176703|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
154176704|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154176705|NCT00852371|Amodiaquine|amodiaquine|mesh-list
154176706|NCT00852371|Artenimol|artenimol|mesh-list
154176707|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
154176719|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154176720|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176722|NCT01564680|Lornoxicam|lornoxicam|mesh-list
154176723|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154176724|NCT01564680|Analgesics|analgesics|mesh-ancestor
154176725|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
154176726|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176727|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176728|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
154176729|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154176730|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176731|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176732|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
154176733|NCT01564836|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154176734|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154176735|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176736|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176737|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176738|NCT00527982|Celecoxib|celecoxib|mesh-list
154176739|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154176740|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154176741|NCT00527982|Analgesics|analgesics|mesh-ancestor
154176742|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
154176743|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176744|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176745|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176746|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176747|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154176748|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154176749|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176750|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176751|NCT00527904|Naproxen|naproxen|mesh-list
154176752|NCT00527904|Esomeprazole|esomeprazole|mesh-list
154176753|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154176754|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176755|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154176756|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176757|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176758|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154176759|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154176760|NCT00527904|Analgesics|analgesics|mesh-ancestor
154176761|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
153923779|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
154176762|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176763|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176764|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176765|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176766|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
154176767|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154176768|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154176778|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154176779|NCT00842933|Prednisone|prednisone|mesh-list
154176780|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
154176781|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
154176782|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154176783|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154176784|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154176785|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176786|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
154176787|NCT00842933|Hormones|hormones|mesh-ancestor
154176788|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154176789|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176790|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154176791|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176792|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
154176793|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
154176794|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176795|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176796|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154176797|NCT00842933|Protective Agents|protective agents|mesh-ancestor
154176798|NCT00849095|Budesonide|budesonide|mesh-list
154176799|NCT00849095|Terbutaline|terbutaline|mesh-list
154176800|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
154176801|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154176802|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176803|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154176804|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
154176805|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176806|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176807|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154176808|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
154176809|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
154176810|NCT00849095|Hormones|hormones|mesh-ancestor
154176811|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154176812|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154176813|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154176814|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154176815|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
154176816|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176817|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176818|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
154176819|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
154176820|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154176821|NCT00527826|Fluticasone|fluticasone|mesh-list
154176822|NCT00527826|Xhance|xhance|mesh-list
154176823|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154176824|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176825|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154176826|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
154176827|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176828|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176829|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154176830|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
154176831|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
154176832|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154176848|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428128|NCT03758365|Triamcinolone|triamcinolone|mesh-list
154176850|NCT00852683|Analgesics|analgesics|mesh-ancestor
154176851|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
154176852|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176853|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176854|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
154176855|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154176856|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154176857|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176858|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154176859|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154176860|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154176861|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176862|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154176863|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
154176864|NCT00619307|Ibuprofen|ibuprofen|mesh-list
154176865|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154176866|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154176867|NCT00619307|Analgesics|analgesics|mesh-ancestor
154176868|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
154176869|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176870|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176871|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176872|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176873|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154176874|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176875|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176876|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154176877|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
154176878|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176879|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
154176880|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176881|NCT00855881|Tegafur|tegafur|mesh-list
154176882|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154176883|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
154176884|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176885|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176886|NCT00619229|Alprostadil|alprostadil|mesh-list
154176887|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154176888|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
154176889|NCT00619229|Urological Agents|urological agents|mesh-ancestor
154176890|NCT02546297|Budesonide|budesonide|mesh-list
154176891|NCT02546297|Bromides|bromides|mesh-list
154176892|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
154176958|NCT02544893|Bupivacaine|bupivacaine|mesh-list
154176959|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
154176960|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
154176961|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176962|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176963|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
154176964|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176965|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154176966|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154176967|NCT02544893|Analgesics|analgesics|mesh-ancestor
154176968|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154176969|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154176970|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154176971|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
154176972|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176973|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176974|NCT00520572|Etanercept|etanercept|mesh-list
154176987|NCT00853697|Testosterone|testosterone|mesh-list
154176988|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
154176989|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
154176990|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154176991|NCT00853697|Dutasteride|dutasteride|mesh-list
154176992|NCT00853697|Androgens|androgens|mesh-ancestor
154176993|NCT00853697|Hormones|hormones|mesh-ancestor
154176994|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154176995|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176996|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154176997|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176998|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
154176999|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154177000|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154177001|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177002|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177003|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
154177004|NCT00861419|Niacinamide|niacinamide|mesh-list
154177005|NCT00861419|Bevacizumab|bevacizumab|mesh-list
154177006|NCT00861419|Sunitinib|sunitinib|mesh-list
154177007|NCT00861419|Trebananib|trebananib|mesh-list
154177008|NCT00861419|Sorafenib|sorafenib|mesh-list
154177009|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
154177010|NCT00861419|Imetelstat|imetelstat|mesh-list
154177011|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154177012|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177013|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154177014|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154177015|NCT00861419|Growth Substances|growth substances|mesh-ancestor
154177016|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177017|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
154177018|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154177019|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177020|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177021|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
154177022|NCT00861419|Vitamins|vitamins|mesh-ancestor
154177023|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
154177024|NCT00527514|Amlodipine|amlodipine|mesh-list
154177025|NCT00527514|Olmesartan|olmesartan|mesh-list
154177026|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154177027|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154177028|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154177029|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177030|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177031|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154177032|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177033|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
154177034|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154177035|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154177036|NCT03998826|Piroxicam|piroxicam|mesh-list
154177037|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154177053|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177054|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177055|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154177056|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177058|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
154177059|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027380|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154177060|NCT00861731|Simvastatin|simvastatin|mesh-list
154177061|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154177062|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154177063|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
154177064|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177065|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154177066|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154177067|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177068|NCT02544659|Pamidronate|pamidronate|mesh-list
154177069|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154177070|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177071|NCT00861887|Vancomycin|vancomycin|mesh-list
154177072|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154177073|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177074|NCT00857519|Carboplatin|carboplatin|mesh-list
154177075|NCT00857519|Melphalan|melphalan|mesh-list
154177076|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177077|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154177078|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
154177079|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177080|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154177081|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154177082|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
154177083|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177084|NCT00618449|Azithromycin|azithromycin|mesh-list
154177085|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154177086|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177087|NCT00857597|Esomeprazole|esomeprazole|mesh-list
154177088|NCT00857597|Omeprazole|omeprazole|mesh-list
154177089|NCT00857597|Rabeprazole|rabeprazole|mesh-list
154177090|NCT00857597|Pantoprazole|pantoprazole|mesh-list
154177091|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154177092|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154177093|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154177094|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177095|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177125|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154177126|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154177128|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177129|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
154177130|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154177131|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154177132|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177133|NCT00862043|Urological Agents|urological agents|mesh-ancestor
154177134|NCT00519636|Fluticasone|fluticasone|mesh-list
154177135|NCT00519636|Xhance|xhance|mesh-list
154177136|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154177137|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154177138|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
154177139|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177140|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177141|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153489105|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177142|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
154177143|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
154177169|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177170|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
154177171|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154177172|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154177173|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
154177174|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177175|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154177176|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154177177|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177178|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177179|NCT00858299|Valsartan|valsartan|mesh-list
154177180|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154177181|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154177182|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154177183|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177184|NCT00526890|Selenium|selenium|mesh-list
154177185|NCT00526890|Paclitaxel|paclitaxel|mesh-list
154177186|NCT00526890|Carboplatin|carboplatin|mesh-list
154177187|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154177188|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177189|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
154177190|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153599980|NCT01879605|Bisacodyl|bisacodyl|mesh-list
154177218|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154177220|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177221|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177222|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154177223|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
154177224|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
154177225|NCT00854711|Protective Agents|protective agents|mesh-ancestor
154177226|NCT00858455|Dolutegravir|dolutegravir|mesh-list
154177227|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154177228|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154177229|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177230|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177231|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154177232|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154177233|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
154177234|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177235|NCT02544737|Apatinib|apatinib|mesh-list
154177236|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177237|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153781819|NCT00231959|Protective Agents|protective agents|mesh-ancestor
153600029|NCT01880307|Prednisolone|prednisolone|mesh-list
154177246|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
154177247|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154177248|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177249|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177250|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
154177251|NCT00858767|Vitamin K|vitamin k|mesh-list
154177252|NCT00858767|Menaquinone 7|menaquinone 7|mesh-list
154177253|NCT00858767|Caseins|caseins|mesh-list
154177254|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
154177255|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
154177256|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177257|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154177258|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154177259|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
154177260|NCT00858767|Coagulants|coagulants|mesh-ancestor
154177261|NCT00858767|Vitamins|vitamins|mesh-ancestor
154177262|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
154177263|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177264|NCT00617903|Azelaic acid|azelaic acid|mesh-list
154177265|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177266|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154177267|NCT00526110|Docetaxel|docetaxel|mesh-list
154177268|NCT00526110|Fluorouracil|fluorouracil|mesh-list
154177269|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
154177270|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177271|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154177272|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154177273|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154177274|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177275|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
154177276|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154177277|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154177278|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
154177279|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177280|NCT00859079|Insulin|insulin|mesh-list
154177281|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154177282|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154177283|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154177284|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177285|NCT00859079|Incretins|incretins|mesh-ancestor
153924305|NCT01222520|Amlodipine|amlodipine|mesh-list
154177286|NCT00859079|Hormones|hormones|mesh-ancestor
154177287|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177288|NCT02544425|Dexamethasone|dexamethasone|mesh-list
154177289|NCT02544425|Etoposide|etoposide|mesh-list
154177290|NCT02544425|Melphalan|melphalan|mesh-list
154177291|NCT02544425|Busulfan|busulfan|mesh-list
154177292|NCT02544425|Asparaginase|asparaginase|mesh-list
154177293|NCT02544425|Ifosfamide|ifosfamide|mesh-list
154177294|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154177295|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
154177296|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
154177297|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177298|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177299|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154177300|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
154177301|NCT02544425|Hormones|hormones|mesh-ancestor
154177302|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177303|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154177304|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177305|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154177306|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154177350|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154177351|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154177352|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177353|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177354|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154177355|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
154177356|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177357|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177358|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154177360|NCT00573755|Letrozole|letrozole|mesh-list
154177361|NCT00573755|Anastrozole|anastrozole|mesh-list
154177362|NCT00573755|Exemestane|exemestane|mesh-list
153924389|NCT05125146|Trazodone|trazodone|mesh-list
154177363|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177364|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154177365|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177366|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177367|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154177368|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154177369|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154177370|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154177371|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177372|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177373|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154177374|NCT02544191|Goserelin|goserelin|mesh-list
154177375|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154177376|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177377|NCT00524316|Doxorubicin|doxorubicin|mesh-list
154177378|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154177379|NCT00524316|Sunitinib|sunitinib|mesh-list
154177380|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154177381|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177382|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154177383|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154177384|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177385|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600174|NCT01881347|Resveratrol|resveratrol|mesh-list
154177397|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177398|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
154177399|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177400|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177401|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154177402|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177403|NCT02544269|Bupivacaine|bupivacaine|mesh-list
154177404|NCT02544269|Ropivacaine|ropivacaine|mesh-list
154177405|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
154177406|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
154177407|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154177408|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177409|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
154177410|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177411|NCT00434577|Vaccines|vaccines|mesh-list
154177412|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
154177413|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177414|NCT00865085|Dexetimide|dexetimide|mesh-list
154177415|NCT00865085|Citalopram|citalopram|mesh-list
154177416|NCT00865085|Escitalopram|escitalopram|mesh-list
154177417|NCT00865085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154177418|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154177419|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177420|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177421|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177422|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
154177423|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177424|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154177425|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
154177426|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154177427|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154177428|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154177429|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
154177430|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
154177431|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177432|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154177433|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154177434|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
154177435|NCT00796068|Cyclosporine|cyclosporine|mesh-list
154177436|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
154177438|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
154177439|NCT00796068|Treosulfan|treosulfan|mesh-list
154177440|NCT00796068|Busulfan|busulfan|mesh-list
154177441|NCT00796068|Cyclosporins|cyclosporins|mesh-list
154177442|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177443|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154177444|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
154177445|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177446|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154177447|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
154177448|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177449|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177450|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
154177459|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154177460|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
154177461|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154177463|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154177464|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177465|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177466|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
154177467|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177468|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177469|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
154177470|NCT01009476|Nicergoline|nicergoline|mesh-list
154177471|NCT01009476|Piracetam|piracetam|mesh-list
154177472|NCT01009476|Galantamine|galantamine|mesh-list
154177473|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
154177474|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154177475|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177476|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177477|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
154177478|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177479|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177480|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154177481|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
154177482|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177483|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154177484|NCT01009476|Protective Agents|protective agents|mesh-ancestor
154177485|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154177486|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154177487|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177488|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
154177489|NCT00517296|Adalimumab|adalimumab|mesh-list
154177490|NCT00517296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154177491|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154177492|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154177493|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
154177494|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154177495|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154177496|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177497|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
154177498|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
154177499|NCT00523848|Thalidomide|thalidomide|mesh-list
154177500|NCT00523848|Doxorubicin|doxorubicin|mesh-list
154177501|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154177502|NCT00523848|Bortezomib|bortezomib|mesh-list
154177503|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154177504|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177505|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154177506|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154177507|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177508|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177509|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154177510|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
154177511|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177512|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
153924526|NCT02663713|Clopidogrel|clopidogrel|mesh-list
154177514|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177515|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154177516|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154177517|NCT00523848|Growth Substances|growth substances|mesh-ancestor
154177518|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
154177539|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177540|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177541|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154177542|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
154177543|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
154177544|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154177545|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154177546|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154177547|NCT00865241|Metformin|metformin|mesh-list
154177548|NCT00865241|Glyburide|glyburide|mesh-list
154177549|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154162986|NCT01088737|Imiquimod|imiquimod|mesh-list
154177550|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177551|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154177552|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
154177553|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154177554|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177555|NCT00860639|Immunotoxins|immunotoxins|mesh-ancestor
154177556|NCT00860639|Immunoconjugates|immunoconjugates|mesh-ancestor
154177557|NCT00860639|Immunologic Factors|immunologic factors|mesh-ancestor
154177558|NCT00860639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177559|NCT00863291|Buprenorphine|buprenorphine|mesh-list
154177560|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154177561|NCT00863291|Narcotics|narcotics|mesh-ancestor
154177562|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154177563|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177564|NCT00863291|Analgesics|analgesics|mesh-ancestor
154177565|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
154177566|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177567|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154177568|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
154177569|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154177570|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154177571|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177572|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
154177573|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
154177574|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177583|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177584|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154177585|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
154177586|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154177587|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177588|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154177589|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154177590|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154177591|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
154177592|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154177593|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177595|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
154177596|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177597|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
154177598|NCT00510510|Bromides|bromides|mesh-list
154177599|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
154177600|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154177601|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154177602|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154177603|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
154177604|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177605|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177606|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177607|NCT04685694|Misoprostol|misoprostol|mesh-list
154177608|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154177609|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
154177610|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154177611|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177612|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154177613|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154177614|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
154177615|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
154177616|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
154177617|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154177618|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177619|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177620|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
154177621|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154177622|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154177623|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177624|NCT00865631|Gabapentin|gabapentin|mesh-list
154177625|NCT00865631|Analgesics|analgesics|mesh-ancestor
154177626|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
154177627|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177628|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177629|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
154177630|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154177631|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154177632|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861031|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177633|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154177634|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154177635|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154177636|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177637|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177638|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
154177639|NCT00863837|Terlipressin|terlipressin|mesh-list
154177649|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177650|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154177651|NCT01009944|Atenolol|atenolol|mesh-list
154177652|NCT01009944|Lisinopril|lisinopril|mesh-list
154177653|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154177654|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
154177655|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781820|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177656|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177657|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154177658|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154177659|NCT01009944|Protective Agents|protective agents|mesh-ancestor
154177660|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177661|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154177662|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
154177663|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
154177664|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177665|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154177666|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154177667|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154177668|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177669|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177670|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154177671|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
154177672|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
154177673|NCT00864071|Griseofulvin|griseofulvin|mesh-list
154177674|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
154177675|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177676|NCT00864149|Carvedilol|carvedilol|mesh-list
154177677|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154177678|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154177679|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177680|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177681|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177682|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177683|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154177684|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
154177685|NCT00864149|Protective Agents|protective agents|mesh-ancestor
154177686|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154177687|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177688|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154177689|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
154177690|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154177691|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154177692|NCT01010100|Acarbose|acarbose|mesh-list
154177693|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154177694|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177695|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177696|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154177697|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177698|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154177699|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154177700|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
154177701|NCT01010178|Theophylline|theophylline|mesh-list
154177702|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154177703|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
154177704|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177717|NCT00617591|Doxorubicin|doxorubicin|mesh-list
154177718|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154177719|NCT00617591|Lenalidomide|lenalidomide|mesh-list
154177720|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154177721|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
154177722|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
154177723|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177724|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177725|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154177726|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
154177728|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154163134|NCT05359874|Bevacizumab|bevacizumab|mesh-list
154177729|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154177730|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177731|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154177732|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154177733|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428723|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
154177734|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177735|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177736|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
154177737|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154177738|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154177739|NCT00617591|Growth Substances|growth substances|mesh-ancestor
154177740|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
154177742|NCT00864305|Analgesics|analgesics|mesh-ancestor
154177743|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
154177744|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177745|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177746|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
154177747|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154177748|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154177749|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154177750|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154177751|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154177752|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154177753|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177754|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177755|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
154177756|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154177757|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154177758|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154177759|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177760|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177761|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177762|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177763|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177764|NCT00864617|Nifedipine|nifedipine|mesh-list
154177765|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154177766|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177767|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177768|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154177769|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177771|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
154177772|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154177773|NCT00865943|Dexetimide|dexetimide|mesh-list
154177774|NCT00865943|Citalopram|citalopram|mesh-list
154177775|NCT00865943|Escitalopram|escitalopram|mesh-list
154177776|NCT00865943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154177777|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154177778|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177779|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177780|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177781|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
154177782|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177783|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154177784|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
154177785|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154177786|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154177787|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154177788|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
154177789|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
154177790|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177791|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154177792|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154177793|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
154177794|NCT00866021|Ritonavir|ritonavir|mesh-list
153781821|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154177795|NCT00866021|Lopinavir|lopinavir|mesh-list
154177796|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154177797|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154177798|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
154177799|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177800|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177801|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154861032|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154255112|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154177802|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154177803|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
154177804|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177805|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154177806|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154177807|NCT00871247|Finasteride|finasteride|mesh-list
154177808|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154177809|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154177810|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177811|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177812|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
154177813|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177814|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177815|NCT00871247|Urological Agents|urological agents|mesh-ancestor
154177817|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154177818|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154177819|NCT04137120|Growth Substances|growth substances|mesh-ancestor
154177820|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177821|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
154177822|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177823|NCT00616655|Eszopiclone|eszopiclone|mesh-list
154177824|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154177825|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154177826|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177827|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
154177828|NCT00864773|Growth Substances|growth substances|mesh-ancestor
154177829|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177830|NCT01010490|Dipivefrin|dipivefrin|mesh-list
154177831|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154177832|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177833|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177834|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177835|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177836|NCT00516048|Exenatide|exenatide|mesh-list
154177837|NCT00516048|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154177838|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154177855|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177856|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154177857|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154177858|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
154177859|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177860|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154177861|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154177862|NCT00872417|Lamivudine|lamivudine|mesh-list
154177863|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154177864|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154177865|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177866|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177867|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
154177868|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177869|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154177870|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154177871|NCT00876317|Etoricoxib|etoricoxib|mesh-list
154177872|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154177873|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154177874|NCT00876317|Analgesics|analgesics|mesh-ancestor
154177875|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
154177876|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177877|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177878|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154177879|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154177880|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154177881|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153924898|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
154177882|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177883|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177884|NCT00866645|Haloperidol|haloperidol|mesh-list
154177885|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
154177886|NCT00866645|Sulpiride|sulpiride|mesh-list
154177887|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154861033|NCT03014713|Narcotics|narcotics|mesh-ancestor
154177889|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
154177890|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177891|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177892|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154177893|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154177894|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154177895|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154177896|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154177906|NCT00872651|Latanoprost|latanoprost|mesh-list
154177907|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154177908|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154177909|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177910|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177911|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177912|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177913|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154177914|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154177915|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154177916|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154177917|NCT00872963|Vaccines|vaccines|mesh-list
154177918|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
154177919|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177920|NCT00873197|Granisetron|granisetron|mesh-list
154177921|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
154177922|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
154177923|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177924|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177925|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154177926|NCT00873197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154177927|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154177928|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
154177929|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177930|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177931|NCT00873353|Capecitabine|capecitabine|mesh-list
154177932|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154177933|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154177934|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
154177935|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177936|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177937|NCT00873353|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154177938|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154177939|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177940|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
154177941|NCT00877097|Trisequens|trisequens|mesh-list
154177942|NCT00877097|Norethindrone|norethindrone|mesh-list
154177943|NCT00877097|Estradiol|estradiol|mesh-list
154177944|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154177945|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177946|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154177947|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154177948|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154177949|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
154177950|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154177951|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154177952|NCT00877097|Estrogens|estrogens|mesh-ancestor
154177953|NCT00877097|Hormones|hormones|mesh-ancestor
154177954|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177955|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154177956|NCT00877175|Phenylephrine|phenylephrine|mesh-list
154177957|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
154177958|NCT00877175|Tropicamide|tropicamide|mesh-list
154177959|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154177960|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
154177961|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
154177962|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600742|NCT01886196|Analgesics|analgesics|mesh-ancestor
154177974|NCT00877175|Protective Agents|protective agents|mesh-ancestor
154177975|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154177976|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154177977|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
154177978|NCT00420927|Adalimumab|adalimumab|mesh-list
154177979|NCT00420927|Methotrexate|methotrexate|mesh-list
154177980|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154177981|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
154177982|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154177983|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177984|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154177985|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
154177986|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177987|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177988|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
154177989|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177990|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154177991|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154177992|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
154177993|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154177994|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154177995|NCT00420927|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154177996|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154177997|NCT00573443|Quinidine|quinidine|mesh-list
154177998|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
154177999|NCT00573443|Levomethorphan|levomethorphan|mesh-list
154178000|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
154178001|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
154178002|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
154178003|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154178004|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154178005|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178006|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178007|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178008|NCT00573443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154178009|NCT00573443|Narcotics|narcotics|mesh-ancestor
154178010|NCT00573443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178011|NCT00573443|Analgesics|analgesics|mesh-ancestor
154178012|NCT00573443|Sensory System Agents|sensory system agents|mesh-ancestor
154178013|NCT00573443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178014|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154178015|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154178016|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178017|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154178018|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
154178019|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154178020|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154178021|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178022|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178023|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154178024|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154178025|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
154178045|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178046|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178047|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154178048|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154178050|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178051|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178052|NCT00877253|Carboplatin|carboplatin|mesh-list
154178053|NCT00877253|genexol-PM|genexol-pm|mesh-list
154178054|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178055|NCT00877253|Tubulin Modulators|tubulin modulators|mesh-ancestor
154178056|NCT00877253|Antimitotic Agents|antimitotic agents|mesh-ancestor
154178057|NCT00877253|Mitosis Modulators|mitosis modulators|mesh-ancestor
154178058|NCT00877253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178059|NCT05225753|Chrysarobin|chrysarobin|mesh-list
154178060|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154178061|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178062|NCT05225753|Analgesics|analgesics|mesh-ancestor
154178063|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
154178064|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178065|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178066|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178067|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178068|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154178069|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
154178070|NCT00874133|Domperidone|domperidone|mesh-list
154178071|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
154178072|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
154178073|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178074|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178075|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178076|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154178077|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
154255113|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
154178078|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182216|NCT05749393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154178086|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178087|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154178088|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
154178089|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178090|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178091|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154178092|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
154178093|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
154178094|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154178095|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
154178096|NCT00867737|Hormones|hormones|mesh-ancestor
154178097|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178098|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154178099|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154178100|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154178101|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178102|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178103|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178104|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
154178105|NCT04040465|Aspirin|aspirin|mesh-list
154178106|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154178107|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178109|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
154178110|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178111|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178112|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178113|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178114|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154178115|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154178116|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178117|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154178118|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154178119|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178120|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
154178121|NCT00420849|Dexamethasone|dexamethasone|mesh-list
154178122|NCT00420849|Lenalidomide|lenalidomide|mesh-list
154178123|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178124|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
154178125|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
154178126|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178127|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178128|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178129|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
154178130|NCT00420849|Hormones|hormones|mesh-ancestor
154178131|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178132|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154178133|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178134|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
154178135|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154178136|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154178137|NCT00420849|Growth Substances|growth substances|mesh-ancestor
154178138|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
154178139|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
154178140|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154178141|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154178142|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154178143|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
154178144|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178145|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154178146|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154178152|NCT00874601|Valsartan|valsartan|mesh-list
154178153|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154178154|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154178155|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154178156|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178157|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154178158|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
154178159|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154178160|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154861034|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154178162|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178163|NCT00874679|Urological Agents|urological agents|mesh-ancestor
154178164|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154178165|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154178166|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154178167|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154178168|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178169|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178170|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178171|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178172|NCT00420303|Etanercept|etanercept|mesh-list
154178173|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154178174|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178175|NCT00420303|Analgesics|analgesics|mesh-ancestor
154178176|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
154178177|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178178|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925232|NCT00629967|Ribavirin|ribavirin|mesh-list
154178179|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178181|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178182|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154178183|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
154178184|NCT00617123|Vorapaxar|vorapaxar|mesh-list
154178185|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154178186|NCT00877955|Alprazolam|alprazolam|mesh-list
154178187|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154178188|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178189|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178190|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154178191|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154178192|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154178193|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
154178194|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
154178195|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178196|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178197|NCT00419757|Budesonide|budesonide|mesh-list
154178198|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
154178199|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154178200|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178201|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154178202|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
154178203|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178204|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178205|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154178206|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
154178207|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
154178208|NCT00419757|Hormones|hormones|mesh-ancestor
154178209|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178210|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154178211|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154178212|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154178213|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178226|NCT00875069|Ethanol|ethanol|mesh-list
154178227|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154178228|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178229|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178230|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178231|NCT01029639|Insulin|insulin|mesh-list
153429195|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
154178232|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154178233|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
154178234|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154178235|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178236|NCT00875147|Bevacizumab|bevacizumab|mesh-list
154178237|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154178238|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178239|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154178240|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154178241|NCT00875147|Growth Substances|growth substances|mesh-ancestor
154178242|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178243|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
154178244|NCT00433329|Bosentan|bosentan|mesh-list
154178245|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
154178246|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
154163603|NCT01035580|Curcumin|curcumin|mesh-list
154178247|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154178248|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154178249|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178250|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178251|NCT00433329|Urological Agents|urological agents|mesh-ancestor
154178252|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154178253|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154178254|NCT01035021|Rocuronium|rocuronium|mesh-list
154178255|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154178256|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154178257|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154178258|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178259|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178260|NCT00878345|Pentobarbital|pentobarbital|mesh-list
154178261|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
154178262|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154178263|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178264|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178265|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178266|NCT00878345|Analgesics|analgesics|mesh-ancestor
154178267|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
154178268|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178269|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154178270|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154178271|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154178272|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178273|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380948|NCT04350281|Interferons|interferons|mesh-list
154178298|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178299|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154178300|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
154178301|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154178302|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178303|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178304|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178305|NCT00875537|Capsaicin|capsaicin|mesh-list
154178306|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
154178307|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
154178308|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
154178309|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178310|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178311|NCT00875771|Bevacizumab|bevacizumab|mesh-list
154178312|NCT00875771|Capecitabine|capecitabine|mesh-list
154178313|NCT00875771|Irinotecan|irinotecan|mesh-list
154178314|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153781822|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154178315|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178316|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154178317|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154178318|NCT00875771|Growth Substances|growth substances|mesh-ancestor
154178319|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178320|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
154178321|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154178322|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
154178323|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178324|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153601116|NCT01888302|Sirolimus|sirolimus|mesh-list
154178345|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154178346|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178347|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
154178348|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154178349|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
154178350|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178351|NCT00868829|Trace Elements|trace elements|mesh-ancestor
154178352|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
154178353|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
154178354|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
154178355|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154178356|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154178357|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178358|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154178359|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178360|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154861035|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178361|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154178362|NCT00868985|Laxatives|laxatives|mesh-ancestor
154178363|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178365|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154178366|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178367|NCT00869063|Analgesics|analgesics|mesh-ancestor
154178368|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
154178369|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178370|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178371|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178372|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178373|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154178374|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178375|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178376|NCT00869219|Nepafenac|nepafenac|mesh-list
154178377|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154178378|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178379|NCT00869219|Analgesics|analgesics|mesh-ancestor
154178390|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178391|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178392|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154178393|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154178394|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154178395|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
154178396|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178397|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178398|NCT00531284|Dexamethasone|dexamethasone|mesh-list
154178399|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178400|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
153925418|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154178401|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
154178402|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178403|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178404|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178405|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
154178407|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178408|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154178409|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178410|NCT00531206|Ritonavir|ritonavir|mesh-list
154178411|NCT00531206|Tipranavir|tipranavir|mesh-list
154178412|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154178413|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154178414|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
154178415|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178416|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178417|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154178418|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154178419|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
154178420|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178421|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154178422|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154178423|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
154178424|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
154178425|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
154178426|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154178427|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178428|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
154178429|NCT00994994|Coagulants|coagulants|mesh-ancestor
154178430|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
154178431|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154178432|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154178433|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178434|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154178435|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154178436|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178437|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178438|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154178439|NCT00999752|Nebivolol|nebivolol|mesh-list
154178440|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154178441|NCT00999752|Diuretics|diuretics|mesh-ancestor
154178442|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
154178443|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178455|NCT01005758|Prednisone|prednisone|mesh-list
154178456|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
154178457|NCT01005758|Prednisolone|prednisolone|mesh-list
154178458|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
154178459|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154178460|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154178461|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154178462|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
154178463|NCT01005758|Doxorubicin|doxorubicin|mesh-list
154178464|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154178465|NCT01005758|Methotrexate|methotrexate|mesh-list
154178466|NCT01005758|Etoposide|etoposide|mesh-list
154178467|NCT01005758|Vincristine|vincristine|mesh-list
154178468|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
154178469|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
154178470|NCT01005758|Pegaspargase|pegaspargase|mesh-list
154178471|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
153815048|NCT00454233|Metformin|metformin|mesh-list
154178472|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154178473|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
154178474|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178475|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178476|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154178477|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
154178478|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178479|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178480|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154178481|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178482|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
154178483|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
154178484|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178485|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178486|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
154178487|NCT01005758|Hormones|hormones|mesh-ancestor
154178488|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178489|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154178490|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154178491|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154178492|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154178493|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178494|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154178495|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
154178496|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154178497|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154178498|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
154178499|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
154178500|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154178501|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154178502|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154178503|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
154178504|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178505|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
154178506|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
154178507|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
153601289|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
154178516|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178517|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
154178518|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154178519|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
154178520|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178521|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178522|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154178523|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
154178524|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178525|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178526|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154178528|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154178529|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178530|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154178531|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178532|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178533|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
154178534|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154178535|NCT01000298|Amoxicillin|amoxicillin|mesh-list
154178536|NCT01000298|Cefdinir|cefdinir|mesh-list
154178537|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154178538|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861036|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178539|NCT01000298|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154178540|NCT01000298|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154178541|NCT00614939|Saxagliptin|saxagliptin|mesh-list
154178542|NCT00614939|Incretins|incretins|mesh-ancestor
154178543|NCT00614939|Hormones|hormones|mesh-ancestor
154178544|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178545|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178546|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154178547|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
154178548|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178549|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178550|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154178551|NCT00879827|PENTA|penta|mesh-list
154178552|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
154027381|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178553|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154178554|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154178555|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178556|NCT01007084|Propranolol|propranolol|mesh-list
154178557|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154178558|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154178559|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178560|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178561|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178562|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178563|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154178564|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154178565|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
154178566|NCT04040309|Lidocaine|lidocaine|mesh-list
154178567|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
154178568|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
154178569|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178570|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178571|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
153601352|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
154178584|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178585|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178586|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154178587|NCT00879983|Azithromycin|azithromycin|mesh-list
154178588|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154178589|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178590|NCT00869765|Cycloserine|cycloserine|mesh-list
154178591|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154178592|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178593|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154178594|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
154178595|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154178596|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
154178597|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178598|NCT00880373|Ibuprofen|ibuprofen|mesh-list
154178599|NCT00880373|Morphine|morphine|mesh-list
154178600|NCT00880373|Heroin|heroin|mesh-list
154178601|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154178602|NCT00880373|Narcotics|narcotics|mesh-ancestor
154178603|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178604|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178605|NCT00880373|Analgesics|analgesics|mesh-ancestor
154178606|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
154178607|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178608|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154178609|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178610|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178611|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178612|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154178613|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178614|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178615|NCT01007630|Rasagiline|rasagiline|mesh-list
154178616|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154178617|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178618|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178619|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154178620|NCT01007630|Protective Agents|protective agents|mesh-ancestor
154178621|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178622|NCT05883384|Caseins|caseins|mesh-list
154178623|NCT05883384|Chelating Agents|chelating agents|mesh-ancestor
154255114|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178624|NCT05883384|Sequestering Agents|sequestering agents|mesh-ancestor
153925646|NCT00920140|Trametinib|trametinib|mesh-list
154178625|NCT05883384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178627|NCT05883345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154178628|NCT05883345|Antibodies|antibodies|mesh-list
154178629|NCT05883345|Immunoglobulin G|immunoglobulin g|mesh-list
154178630|NCT05883345|Gastrins|gastrins|mesh-list
154178631|NCT05883345|Immunologic Factors|immunologic factors|mesh-ancestor
154178632|NCT05883345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178633|NCT05883345|Hormones|hormones|mesh-ancestor
154178645|NCT05883176|Bevacizumab|bevacizumab|mesh-list
154178646|NCT05883176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154178647|NCT05883176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178648|NCT05883176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154178649|NCT05883176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154178650|NCT05883176|Growth Substances|growth substances|mesh-ancestor
154178651|NCT05883176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178652|NCT05883176|Growth Inhibitors|growth inhibitors|mesh-ancestor
154178653|NCT05883046|Performance-Enhancing Substances|performance-enhancing substances|mesh-list
154178654|NCT05883046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178655|NCT05882864|Triamcinolone|triamcinolone|mesh-list
154178656|NCT05882864|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154178657|NCT05882864|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154178658|NCT05882864|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154178659|NCT05882864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178660|NCT05882864|Glucocorticoids|glucocorticoids|mesh-ancestor
154178661|NCT05882864|Hormones|hormones|mesh-ancestor
154178662|NCT05882864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178663|NCT05882864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178664|NCT05882864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154178665|NCT05882864|Immunologic Factors|immunologic factors|mesh-ancestor
154178666|NCT05882864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178667|NCT05882864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178668|NCT05882630|Carboplatin|carboplatin|mesh-list
154178669|NCT05882630|Etoposide|etoposide|mesh-list
154178670|NCT05882630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178671|NCT05882630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154178672|NCT05882630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154178673|NCT05882630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154178674|NCT05882630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178675|NCT05882630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178676|NCT05881980|Itraconazole|itraconazole|mesh-list
154178677|NCT05881980|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154178678|NCT05881980|Terbinafine|terbinafine|mesh-list
154178679|NCT05881980|Antifungal Agents|antifungal agents|mesh-ancestor
154178680|NCT05881980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178681|NCT05881980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154178682|NCT05881980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154178683|NCT05881980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178684|NCT05881980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178685|NCT05881980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153814060|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178686|NCT05881980|Hormone Antagonists|hormone antagonists|mesh-ancestor
154178687|NCT05881980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178688|NCT05881980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178689|NCT05881980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154178690|NCT05881746|Liver Extracts|liver extracts|mesh-list
154178691|NCT05881746|Hematinics|hematinics|mesh-ancestor
154178692|NCT05881525|Paclitaxel|paclitaxel|mesh-list
154178693|NCT05881525|Cyclophosphamide|cyclophosphamide|mesh-list
154178694|NCT05881525|Fludarabine|fludarabine|mesh-list
154178695|NCT05881525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154178710|NCT05881187|Clotrimazole|clotrimazole|mesh-list
154178711|NCT05881187|Miconazole|miconazole|mesh-list
154178712|NCT05881187|Vitamin B Complex|vitamin b complex|mesh-ancestor
154178713|NCT05881187|Vitamins|vitamins|mesh-ancestor
154178714|NCT05881187|Micronutrients|micronutrients|mesh-ancestor
154178715|NCT05881187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178716|NCT05881187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154178717|NCT05881187|Dermatologic Agents|dermatologic agents|mesh-ancestor
154178718|NCT05881187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178719|NCT05881187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154178720|NCT05881187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154178721|NCT05881187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154861037|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154178722|NCT05881187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178723|NCT05881187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178724|NCT05881187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154178725|NCT05881187|Hormone Antagonists|hormone antagonists|mesh-ancestor
154178726|NCT05881187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178727|NCT05881187|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154178728|NCT05881187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154178729|NCT05880732|Magnesium Sulfate|magnesium sulfate|mesh-list
154178730|NCT05880732|Analgesics|analgesics|mesh-ancestor
154178731|NCT05880732|Sensory System Agents|sensory system agents|mesh-ancestor
154178732|NCT05880732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178733|NCT05880732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178734|NCT05880732|Anesthetics|anesthetics|mesh-ancestor
154178735|NCT05880732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178736|NCT05880732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154178737|NCT05880732|Anticonvulsants|anticonvulsants|mesh-ancestor
154178738|NCT05880732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154178739|NCT05880732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154178740|NCT05880732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178741|NCT05880732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154178742|NCT05880732|Tocolytic Agents|tocolytic agents|mesh-ancestor
154178743|NCT05880732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154178744|NCT05880693|Magnesium Sulfate|magnesium sulfate|mesh-list
154178745|NCT05880693|Dexmedetomidine|dexmedetomidine|mesh-list
154178746|NCT05880693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154178747|NCT05880693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178748|NCT05880693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178749|NCT05880693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178750|NCT05880693|Analgesics|analgesics|mesh-ancestor
154178751|NCT05880693|Sensory System Agents|sensory system agents|mesh-ancestor
154178752|NCT05880693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178753|NCT05880693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154178754|NCT05880693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154178760|NCT05880693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154178761|NCT05880693|Anticonvulsants|anticonvulsants|mesh-ancestor
154178762|NCT05880693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154178763|NCT05880693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154178764|NCT05880693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154178765|NCT05880693|Tocolytic Agents|tocolytic agents|mesh-ancestor
154178766|NCT05880693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154178767|NCT05880342|Methylphenidate|methylphenidate|mesh-list
154178768|NCT05880342|Reboxetine|reboxetine|mesh-list
154178769|NCT05880342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154178770|NCT05880342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178771|NCT05880342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154178772|NCT05880342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154178773|NCT05880342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154178774|NCT05880342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178775|NCT05880342|Dopamine Agents|dopamine agents|mesh-ancestor
154178776|NCT05880342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178777|NCT05880342|Antidepressive Agents|antidepressive agents|mesh-ancestor
154178778|NCT05880342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154178779|NCT05880342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154178780|NCT05880342|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178781|NCT05880186|Caffeine|caffeine|mesh-list
154178782|NCT05880186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154178783|NCT05880186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178784|NCT05880186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154178785|NCT05880186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178786|NCT05880186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178787|NCT05880186|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154178788|NCT05880186|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154178789|NCT05880186|Purinergic Agents|purinergic agents|mesh-ancestor
154178790|NCT05880186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178791|NCT05880082|Cisplatin|cisplatin|mesh-list
154178792|NCT05880082|Carboplatin|carboplatin|mesh-list
154178793|NCT05880082|Tislelizumab|tislelizumab|mesh-list
154178794|NCT05880082|Nedaplatin|nedaplatin|mesh-list
154178795|NCT05880082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178796|NCT05880082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154178797|NCT05880030|Vitamin D|vitamin d|mesh-list
154178798|NCT05880030|Cholecalciferol|cholecalciferol|mesh-list
154178799|NCT05880030|Vitamins|vitamins|mesh-ancestor
154255115|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178800|NCT05880030|Micronutrients|micronutrients|mesh-ancestor
154178801|NCT05880030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178802|NCT05880030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154178803|NCT05880030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154178804|NCT05880017|Morphine|morphine|mesh-list
154178805|NCT05880017|Bupivacaine|bupivacaine|mesh-list
154178806|NCT05880017|Anesthetics, Local|anesthetics, local|mesh-ancestor
154178807|NCT05880017|Anesthetics|anesthetics|mesh-ancestor
154178808|NCT05880017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178809|NCT05880017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178810|NCT05880017|Sensory System Agents|sensory system agents|mesh-ancestor
154178811|NCT05880017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178812|NCT05880017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154178813|NCT05880017|Narcotics|narcotics|mesh-ancestor
154178814|NCT05880017|Analgesics|analgesics|mesh-ancestor
154178815|NCT05879796|Cisplatin|cisplatin|mesh-list
154178816|NCT05879796|Endostatins|endostatins|mesh-list
154178817|NCT05879796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178818|NCT05879796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154178819|NCT05879796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154178820|NCT05879796|Growth Substances|growth substances|mesh-ancestor
154178821|NCT05879796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178822|NCT05879796|Growth Inhibitors|growth inhibitors|mesh-ancestor
154178823|NCT05879627|Exatecan|exatecan|mesh-list
154178824|NCT05879627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154178825|NCT05879627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154178846|NCT05879536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178847|NCT05879536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178848|NCT05879536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154178849|NCT05879536|Narcotics|narcotics|mesh-ancestor
154178850|NCT05879536|Analgesics|analgesics|mesh-ancestor
154178851|NCT05879276|Empagliflozin|empagliflozin|mesh-list
154178852|NCT05879276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154178853|NCT05879276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178854|NCT05879276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154178855|NCT05879276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178856|NCT05879237|Vitamin D|vitamin d|mesh-list
154178857|NCT05879237|Cholecalciferol|cholecalciferol|mesh-list
154178858|NCT05879237|Vitamins|vitamins|mesh-ancestor
154178859|NCT05879237|Micronutrients|micronutrients|mesh-ancestor
154178860|NCT05879237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178861|NCT05879237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154178862|NCT05879237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154178863|NCT05879068|Paclitaxel|paclitaxel|mesh-list
154178864|NCT05879068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154178865|NCT05879068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178866|NCT05879068|Tubulin Modulators|tubulin modulators|mesh-ancestor
154178867|NCT05879068|Antimitotic Agents|antimitotic agents|mesh-ancestor
154178868|NCT05879068|Mitosis Modulators|mitosis modulators|mesh-ancestor
154178869|NCT05879068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178870|NCT05878977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154178871|NCT05878977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178872|NCT05878977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154178873|NCT05878977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178874|NCT05878535|Metformin|metformin|mesh-list
154178875|NCT05878535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154178876|NCT05878535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178877|NCT05875506|Doxycycline|doxycycline|mesh-list
154178878|NCT05875506|Chitosan|chitosan|mesh-list
154178879|NCT05875506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154178880|NCT05875506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178881|NCT05875506|Antimalarials|antimalarials|mesh-ancestor
154178896|NCT05875350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178897|NCT05875350|Sensory System Agents|sensory system agents|mesh-ancestor
154178898|NCT05875350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178899|NCT05871086|Ubiquinone|ubiquinone|mesh-list
154178900|NCT05871086|Coenzyme Q10|coenzyme q10|mesh-list
154178901|NCT05871086|Micronutrients|micronutrients|mesh-ancestor
154178902|NCT05871086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178903|NCT05871086|Vitamins|vitamins|mesh-ancestor
154178904|NCT05864755|Bevacizumab|bevacizumab|mesh-list
154178905|NCT05864755|Durvalumab|durvalumab|mesh-list
154178906|NCT05864755|Tremelimumab|tremelimumab|mesh-list
154178907|NCT05864755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154178908|NCT05864755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861038|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164110|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154178909|NCT05864755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154178910|NCT05864755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154178911|NCT05864755|Growth Substances|growth substances|mesh-ancestor
154178912|NCT05864755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178913|NCT05864755|Growth Inhibitors|growth inhibitors|mesh-ancestor
154178914|NCT05864404|Dexmedetomidine|dexmedetomidine|mesh-list
154178915|NCT05864404|Remifentanil|remifentanil|mesh-list
154178916|NCT05864404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154178917|NCT05864404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178918|NCT05864404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178919|NCT05864404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178920|NCT05864404|Analgesics|analgesics|mesh-ancestor
154178921|NCT05864404|Sensory System Agents|sensory system agents|mesh-ancestor
154178922|NCT05864404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178923|NCT05864404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154178924|NCT05864404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154178925|NCT05864404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154178926|NCT05864404|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178927|NCT05864404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178928|NCT05864404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178929|NCT05864404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154178930|NCT05864404|Narcotics|narcotics|mesh-ancestor
154178931|NCT05856981|Pembrolizumab|pembrolizumab|mesh-list
154178932|NCT05856981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154178933|NCT05856981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178934|NCT05856981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154178935|NCT05856981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178936|NCT05846906|Sildenafil Citrate|sildenafil citrate|mesh-list
154178937|NCT05846906|Citric Acid|citric acid|mesh-list
154178938|NCT05846906|Sodium Citrate|sodium citrate|mesh-list
154178939|NCT05846906|Clomiphene|clomiphene|mesh-list
154178940|NCT05846906|Enclomiphene|enclomiphene|mesh-list
154178941|NCT05846906|Zuclomiphene|zuclomiphene|mesh-list
154178942|NCT05846906|Anticoagulants|anticoagulants|mesh-ancestor
154178943|NCT05846906|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154178944|NCT05846906|Chelating Agents|chelating agents|mesh-ancestor
153601731|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
154178957|NCT05846906|Fertility Agents|fertility agents|mesh-ancestor
154178958|NCT05846906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154178959|NCT05846906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154178960|NCT05846906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154178961|NCT05844462|Tadalafil|tadalafil|mesh-list
154178962|NCT05844462|Vasodilator Agents|vasodilator agents|mesh-ancestor
154178963|NCT05844462|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154178964|NCT05844462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154178965|NCT05844462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178966|NCT05844462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178967|NCT05844462|Urological Agents|urological agents|mesh-ancestor
154178968|NCT05835245|Lenvatinib|lenvatinib|mesh-list
154178969|NCT05835245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178970|NCT05835245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154178971|NCT05835245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178972|NCT05835245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178973|NCT05826327|Sufentanil|sufentanil|mesh-list
154178974|NCT05826327|Esketamine|esketamine|mesh-list
154178975|NCT05826327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154178976|NCT05826327|Narcotics|narcotics|mesh-ancestor
154178977|NCT05826327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178978|NCT05826327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178979|NCT05826327|Analgesics|analgesics|mesh-ancestor
154178980|NCT05826327|Sensory System Agents|sensory system agents|mesh-ancestor
154178981|NCT05826327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178982|NCT05826327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154178983|NCT05826327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154178984|NCT05826327|Anesthetics, General|anesthetics, general|mesh-ancestor
154178985|NCT05826327|Anesthetics|anesthetics|mesh-ancestor
154178986|NCT05826327|Antidepressive Agents|antidepressive agents|mesh-ancestor
154178987|NCT05826327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154178988|NCT05823116|Vancomycin|vancomycin|mesh-list
154178989|NCT05823116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154178990|NCT05823116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178991|NCT05817721|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154178992|NCT05817721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178993|NCT05817721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178994|NCT05814991|Nitroglycerin|nitroglycerin|mesh-list
154861039|NCT01074463|Pramipexole|pramipexole|mesh-list
154178995|NCT05814991|Vasodilator Agents|vasodilator agents|mesh-ancestor
154178996|NCT05814367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154178997|NCT05814367|Lubricant Eye Drops|lubricant eye drops|mesh-list
154178998|NCT05814367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154178999|NCT05794399|Warfarin|warfarin|mesh-list
154179000|NCT05794399|Rivaroxaban|rivaroxaban|mesh-list
154179001|NCT05794399|Anticoagulants|anticoagulants|mesh-ancestor
154179002|NCT05794399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154179003|NCT05794399|Antithrombins|antithrombins|mesh-ancestor
154179004|NCT05794399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154179005|NCT05794399|Protease Inhibitors|protease inhibitors|mesh-ancestor
154179006|NCT05794399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182217|NCT05749393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154179018|NCT05764395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179019|NCT05727371|Hylan|hylan|mesh-list
154179020|NCT05727371|Viscosupplements|viscosupplements|mesh-ancestor
154179021|NCT05727371|Protective Agents|protective agents|mesh-ancestor
154179022|NCT05727371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179023|NCT05714306|Cyclophosphamide|cyclophosphamide|mesh-list
154179024|NCT05714306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179025|NCT05714306|Immunologic Factors|immunologic factors|mesh-ancestor
154179026|NCT05714306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179027|NCT05714306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154179028|NCT05714306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154179029|NCT05714306|Alkylating Agents|alkylating agents|mesh-ancestor
154179030|NCT05714306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179031|NCT05714306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179032|NCT05714306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154179033|NCT05706259|Vitamin D|vitamin d|mesh-list
154179034|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
154179035|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
154179036|NCT05706259|Vitamins|vitamins|mesh-list
154179037|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
154179038|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179039|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154179040|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154179041|NCT05704374|Pregabalin|pregabalin|mesh-list
154179042|NCT05704374|Analgesics|analgesics|mesh-ancestor
154179043|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
154179044|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179045|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179046|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
154179047|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154179048|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154179049|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179050|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154179051|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154179052|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154179053|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179054|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154179055|NCT05680558|Methoxsalen|methoxsalen|mesh-list
154179056|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154179057|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
154179058|NCT05667324|Dexamethasone|dexamethasone|mesh-list
154179059|NCT05667324|Ropivacaine|ropivacaine|mesh-list
154179060|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179061|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
154179062|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
154179063|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179064|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179065|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154179066|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
154179067|NCT05667324|Hormones|hormones|mesh-ancestor
154179068|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179069|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153601856|NCT01900938|Midazolam|midazolam|mesh-list
154179089|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179090|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
154179091|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
154179092|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179093|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179094|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154179095|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
154179096|NCT05656521|Hormones|hormones|mesh-ancestor
154179097|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179098|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179099|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861040|NCT01074463|Dexpramipexole|dexpramipexole|mesh-list
154164257|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179100|NCT05644041|Gemcitabine|gemcitabine|mesh-list
154179101|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154179102|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
154179103|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179104|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179105|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154179106|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
154179107|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179108|NCT05628623|Cytarabine|cytarabine|mesh-list
154179109|NCT05628623|Azacitidine|azacitidine|mesh-list
154179110|NCT05628623|Daunorubicin|daunorubicin|mesh-list
154179111|NCT05628623|Venetoclax|venetoclax|mesh-list
154179112|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154179113|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
154179114|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179115|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179116|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
154179117|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179118|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179119|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
154179120|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179121|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179122|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154179123|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154179124|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154179125|NCT05616923|Trametinib|trametinib|mesh-list
154179126|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179127|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154179128|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179149|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
154179150|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154179151|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154179152|NCT05601336|Metformin|metformin|mesh-list
154179153|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
154179154|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154179155|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179156|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154179157|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179158|NCT05599243|Dutasteride|dutasteride|mesh-list
154179159|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154179160|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154179161|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179162|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179163|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
154179164|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179165|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179167|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154179168|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179169|NCT05556889|Trace Elements|trace elements|mesh-ancestor
154179170|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
154179171|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179172|NCT05504278|Carboplatin|carboplatin|mesh-list
154179173|NCT05504278|Pemetrexed|pemetrexed|mesh-list
154179174|NCT05504278|Cisplatin|cisplatin|mesh-list
154179175|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179176|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179177|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179178|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154179179|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154179180|NCT05490134|Naloxone|naloxone|mesh-list
154179181|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154179190|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154179191|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154179192|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179193|NCT05418049|Memantine|memantine|mesh-list
154179194|NCT05418049|Baclofen|baclofen|mesh-list
154179195|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154179196|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154179197|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
154179198|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179199|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179200|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164332|NCT00772499|Diuretics|diuretics|mesh-ancestor
154179201|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154179202|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154179203|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154179204|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154179205|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179206|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154179207|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
154179208|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
154179209|NCT05369676|Ritonavir|ritonavir|mesh-list
154179210|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154179211|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154179212|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
154179213|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179214|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179215|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154179216|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154179217|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
154179218|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179219|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154179220|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154179221|NCT06014749|Anesthetics|anesthetics|mesh-list
154179222|NCT06014749|Anesthetics, Local|anesthetics, local|mesh-list
154179223|NCT06014749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179224|NCT06014749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179225|NCT06014749|Sensory System Agents|sensory system agents|mesh-ancestor
154179226|NCT06014749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926244|NCT00652795|Doxycycline|doxycycline|mesh-list
154179227|NCT06014606|Propranolol|propranolol|mesh-list
154179228|NCT06014606|Haloperidol|haloperidol|mesh-list
154179229|NCT06014606|Haloperidol decanoate|haloperidol decanoate|mesh-list
154179230|NCT06014606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154179231|NCT06014606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154179232|NCT06014606|Adrenergic Agents|adrenergic agents|mesh-ancestor
154179233|NCT06014606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179234|NCT06014606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179235|NCT06014606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179236|NCT06014606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154179237|NCT06014606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154179238|NCT06014606|Vasodilator Agents|vasodilator agents|mesh-ancestor
154179239|NCT06014606|Antiemetics|antiemetics|mesh-ancestor
154179240|NCT06014606|Autonomic Agents|autonomic agents|mesh-ancestor
154179241|NCT06014606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179242|NCT06014606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154179243|NCT06014606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154179244|NCT06014606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154179245|NCT06014606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179246|NCT06014606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154179247|NCT06014606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154179260|NCT06013956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154179261|NCT06013956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154179262|NCT06013956|Dopamine Agents|dopamine agents|mesh-ancestor
154179263|NCT06013956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179264|NCT06013956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179265|NCT06013956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179266|NCT06013956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154179267|NCT06013956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179268|NCT06013735|Listerine|listerine|mesh-list
154179269|NCT06013735|Fluorides|fluorides|mesh-list
154179270|NCT06013735|Sodium Fluoride|sodium fluoride|mesh-list
154179271|NCT06013735|Cariostatic Agents|cariostatic agents|mesh-ancestor
154179272|NCT06013735|Protective Agents|protective agents|mesh-ancestor
154179273|NCT06013735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179274|NCT06013735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154179275|NCT06013735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179276|NCT06013540|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154179277|NCT06013540|Tretinoin|tretinoin|mesh-list
154179278|NCT06013540|Hydroquinone|hydroquinone|mesh-list
154179279|NCT06013540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179280|NCT06013540|Antioxidants|antioxidants|mesh-ancestor
153489107|NCT05273346|Analgesics|analgesics|mesh-list
154179281|NCT06013540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179282|NCT06013540|Protective Agents|protective agents|mesh-ancestor
154179283|NCT06013540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179284|NCT06013540|Keratolytic Agents|keratolytic agents|mesh-ancestor
154179285|NCT06013540|Dermatologic Agents|dermatologic agents|mesh-ancestor
154861041|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
154179286|NCT06013540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179287|NCT06013540|Glucocorticoids|glucocorticoids|mesh-ancestor
154179288|NCT06013540|Hormones|hormones|mesh-ancestor
154179289|NCT06013540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179290|NCT06013540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154179291|NCT06013436|Cyclosporine|cyclosporine|mesh-list
154179292|NCT06013436|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154179293|NCT06013436|Cyclosporins|cyclosporins|mesh-list
154179294|NCT06013436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179295|NCT06013436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179296|NCT06013436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179297|NCT06013436|Immunologic Factors|immunologic factors|mesh-ancestor
154179298|NCT06013436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027382|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
154179299|NCT06013436|Antifungal Agents|antifungal agents|mesh-ancestor
154179300|NCT06013436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179301|NCT06013436|Dermatologic Agents|dermatologic agents|mesh-ancestor
154179302|NCT06013436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154179303|NCT06013436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154179304|NCT06013436|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154179306|NCT06013293|Dermatologic Agents|dermatologic agents|mesh-ancestor
154179307|NCT06013293|Sunscreening Agents|sunscreening agents|mesh-ancestor
154179308|NCT06013293|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154179309|NCT06013293|Protective Agents|protective agents|mesh-ancestor
154179310|NCT06013293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179311|NCT06013150|Epinephrine|epinephrine|mesh-list
153602094|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
154179334|NCT05997004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179336|NCT05995301|Anesthetics, Local|anesthetics, local|mesh-ancestor
154179337|NCT05995301|Anesthetics|anesthetics|mesh-ancestor
154179338|NCT05995301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179339|NCT05995301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179340|NCT05995301|Sensory System Agents|sensory system agents|mesh-ancestor
154179341|NCT05995301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179342|NCT05759442|Metformin|metformin|mesh-list
154179343|NCT05759442|Acetic Acid|acetic acid|mesh-list
154179344|NCT05759442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154179345|NCT05759442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179346|NCT05759442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154179347|NCT05759442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179348|NCT05728346|Hyaluronic Acid|hyaluronic acid|mesh-list
154179349|NCT05728346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154179350|NCT05728346|Immunologic Factors|immunologic factors|mesh-ancestor
154179351|NCT05728346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179352|NCT05728346|Viscosupplements|viscosupplements|mesh-ancestor
154179353|NCT05728346|Protective Agents|protective agents|mesh-ancestor
154179354|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
154179355|NCT05631886|Ipilimumab|ipilimumab|mesh-list
154179356|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154179357|NCT05631886|Paclitaxel|paclitaxel|mesh-list
154179358|NCT05631886|Antibodies|antibodies|mesh-list
154179359|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
154179360|NCT05631886|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154179361|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
154179362|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179363|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
154179364|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179375|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
154179376|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
154179377|NCT05601752|Nivolumab|nivolumab|mesh-list
154179378|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179379|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179380|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179381|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179383|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154179384|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179385|NCT05233228|Nicotine|nicotine|mesh-list
154179386|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154179387|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
154179388|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179389|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179390|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154179391|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154179392|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
154179393|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179394|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179395|NCT05119712|Terbinafine|terbinafine|mesh-list
154255116|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154179396|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
154179397|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179398|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179399|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179400|NCT05104047|Lobeline|lobeline|mesh-list
154179401|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154179402|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
154179403|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179404|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179405|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154179406|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154179407|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
154179408|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179409|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179410|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154179411|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
154179412|NCT05101629|Lenvatinib|lenvatinib|mesh-list
154179413|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179414|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179415|NCT05101629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179416|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179417|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154179418|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179419|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154179420|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154179421|NCT04985344|Propranolol|propranolol|mesh-list
154179422|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154179423|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154179424|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
154179425|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179426|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602209|NCT01903057|Azithromycin|azithromycin|mesh-list
154179447|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
154179448|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179449|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179450|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154179451|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
154179452|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154179453|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
154179454|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179455|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179456|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154179457|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
154179458|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
154179459|NCT04920695|Protective Agents|protective agents|mesh-ancestor
154179460|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154179461|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
154179462|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179463|NCT04646707|Lidocaine|lidocaine|mesh-list
154179464|NCT04646707|Bupivacaine|bupivacaine|mesh-list
154179465|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
154179466|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
154179467|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179468|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179469|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
154179470|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179471|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154179472|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154179473|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154179474|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154179475|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179476|NCT04646694|Ketamine|ketamine|mesh-list
154179477|NCT04646694|Analgesics|analgesics|mesh-ancestor
154179478|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
154179479|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179520|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179522|NCT04361708|Protective Agents|protective agents|mesh-ancestor
154179523|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
154179524|NCT04361708|Vitamins|vitamins|mesh-ancestor
154179525|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
154179526|NCT04345146|Bevacizumab|bevacizumab|mesh-list
154179527|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154861042|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255117|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
154164580|NCT00398086|Paclitaxel|paclitaxel|mesh-list
154179528|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179529|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154179530|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154179531|NCT04345146|Growth Substances|growth substances|mesh-ancestor
154179532|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179533|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
154179535|NCT04336098|Gemcitabine|gemcitabine|mesh-list
154179536|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
154179537|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154179538|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154179539|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179540|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
154179541|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
154179542|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
154179543|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179544|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154179545|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
154179546|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179547|NCT04336098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179548|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
154179549|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
154179550|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154179551|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154179552|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179553|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179554|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179555|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154179556|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
154179557|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154179558|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
154179559|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179560|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179561|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154179562|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
154179563|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154179564|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
154179565|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179566|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179567|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154179568|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
154179569|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
154179570|NCT04069052|Protective Agents|protective agents|mesh-ancestor
154179571|NCT03963414|Carboplatin|carboplatin|mesh-list
154179572|NCT03963414|Etoposide|etoposide|mesh-list
154179573|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
154179574|NCT03963414|Durvalumab|durvalumab|mesh-list
154179575|NCT03963414|Tremelimumab|tremelimumab|mesh-list
154179576|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154179577|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179588|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
154179589|NCT03861390|Hormones|hormones|mesh-ancestor
154179590|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179591|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179592|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179593|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179594|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
154179595|NCT03829683|Vitamins|vitamins|mesh-ancestor
154179596|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
154179597|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179598|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
154179599|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179600|NCT03829683|Protective Agents|protective agents|mesh-ancestor
154179601|NCT03530696|Palbociclib|palbociclib|mesh-list
154179602|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179603|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154179604|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179605|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179607|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154179608|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179609|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154179623|NCT03198351|Teriflunomide|teriflunomide|mesh-list
154179624|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154861043|NCT01074463|Protective Agents|protective agents|mesh-ancestor
154861044|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164631|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154179625|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154179626|NCT03198351|Analgesics|analgesics|mesh-ancestor
154179627|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
154179628|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179629|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179630|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179631|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154179632|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179633|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
154179634|NCT03160040|Minocycline|minocycline|mesh-list
154179635|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154179636|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179637|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
154179638|NCT03107182|Promethazine|promethazine|mesh-list
154179639|NCT03107182|Dexamethasone|dexamethasone|mesh-list
154179640|NCT03107182|Paclitaxel|paclitaxel|mesh-list
154179641|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154179642|NCT03107182|Carboplatin|carboplatin|mesh-list
154179643|NCT03107182|Nivolumab|nivolumab|mesh-list
154179649|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
154179650|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
154179651|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179652|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179653|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
154179654|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
154179655|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179656|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179657|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154179658|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
154179659|NCT03107182|Hormones|hormones|mesh-ancestor
154179660|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179661|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179662|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179663|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179664|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
154179665|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179666|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154179667|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154179668|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154179669|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179670|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
154179671|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
154179672|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
154179673|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154179674|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
154179675|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
154179676|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179677|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154179679|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
154179680|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154179681|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154179682|NCT02833701|Vitamins|vitamins|mesh-list
154179683|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
154179684|NCT02833701|Bevacizumab|bevacizumab|mesh-list
154179685|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154179686|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
154179687|NCT02833701|Antibodies|antibodies|mesh-list
154179688|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
154179689|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154179690|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
154179691|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179692|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154179693|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154179694|NCT02833701|Growth Substances|growth substances|mesh-ancestor
154179695|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179696|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
154179697|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
154179698|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
154179699|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
154179700|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179701|NCT02833701|Protective Agents|protective agents|mesh-ancestor
154179702|NCT02767999|Fluoxetine|fluoxetine|mesh-list
154179703|NCT02767999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154179704|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154179705|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154861045|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154179706|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179707|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179708|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
154179709|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179710|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154179711|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
154179712|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154179713|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153602484|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
154179730|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
154179732|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179733|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179734|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179735|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179736|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154179737|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
154179738|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179739|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
154179740|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179741|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179742|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
154179743|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154179744|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
154179745|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
154179746|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
154179747|NCT02658890|Nivolumab|nivolumab|mesh-list
154179748|NCT02658890|Ipilimumab|ipilimumab|mesh-list
154179749|NCT02658890|Linrodostat|linrodostat|mesh-list
154179750|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179751|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179752|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179753|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179754|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179755|NCT02597062|Dexamethasone|dexamethasone|mesh-list
154179756|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
154179757|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179758|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
154179759|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179760|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154179761|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154179762|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
154179763|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179764|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179765|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154179766|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179767|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
154179768|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
154179769|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179770|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154179771|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
154179772|NCT02597062|Hormones|hormones|mesh-ancestor
153602558|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
154179777|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
154179778|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179779|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179780|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154179781|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154179782|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
154179783|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179784|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179785|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154179786|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179787|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179788|NCT02122185|Metformin|metformin|mesh-list
154179789|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154179790|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179791|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
154179792|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154179793|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154179794|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179795|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
154179796|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154179797|NCT01248585|Dexamethasone|dexamethasone|mesh-list
154179798|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179799|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
154179800|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
154179801|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179802|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179803|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154179804|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
154179805|NCT01248585|Hormones|hormones|mesh-ancestor
154179806|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179807|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179808|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179809|NCT00993655|Paclitaxel|paclitaxel|mesh-list
154179810|NCT00993655|Carboplatin|carboplatin|mesh-list
154179811|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154179812|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179813|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
154179814|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
154179815|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
154179816|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179817|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154179818|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
154179819|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179820|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
154179821|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179822|NCT05316493|Megestrol|megestrol|mesh-list
154179823|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
154179824|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
154179825|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
154179826|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153926840|NCT04164823|Analgesics|analgesics|mesh-list
154179827|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179828|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154179829|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154179830|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154179831|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154179832|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154179833|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179834|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179835|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
154179836|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154179837|NCT05316467|Megestrol|megestrol|mesh-list
154179838|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
154179839|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154179840|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154179841|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154179842|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
154179852|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154179853|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154179854|NCT05304949|Growth Substances|growth substances|mesh-ancestor
154179855|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179856|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
154179857|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179858|NCT05294341|Norethindrone|norethindrone|mesh-list
154179859|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
154179860|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154179861|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154179862|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154179863|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
154179864|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154179865|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179866|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154179867|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154179868|NCT05293964|Everolimus|everolimus|mesh-list
154179869|NCT05293964|Palbociclib|palbociclib|mesh-list
154179870|NCT05293964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154179871|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154179872|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179873|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179874|NCT05293964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179875|NCT05293964|Immunologic Factors|immunologic factors|mesh-ancestor
154179876|NCT05293964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179877|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179878|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154179879|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179880|NCT05271240|Bevacizumab|bevacizumab|mesh-list
154179881|NCT05271240|Temozolomide|temozolomide|mesh-list
154164860|NCT00992576|Hydromorphone|hydromorphone|mesh-list
154179882|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179883|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179884|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154179885|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154179886|NCT05271240|Growth Substances|growth substances|mesh-ancestor
154179887|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179888|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
154179889|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154179890|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
154179891|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179892|NCT05264883|Azacitidine|azacitidine|mesh-list
154179894|NCT05264883|Venetoclax|venetoclax|mesh-list
154179895|NCT05264883|Aclarubicin|aclarubicin|mesh-list
154179896|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154179897|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
154179898|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179899|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179900|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926908|NCT03734770|Progesterone|progesterone|mesh-list
154179902|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154179903|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154179904|NCT05263453|Vemurafenib|vemurafenib|mesh-list
154179905|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179906|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154179907|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179914|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154179915|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179916|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179917|NCT05232084|Fentanyl|fentanyl|mesh-list
154179918|NCT05232084|Bupivacaine|bupivacaine|mesh-list
154179919|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
154179920|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
154179921|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179922|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179923|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
154179924|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179925|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154179926|NCT05232084|Narcotics|narcotics|mesh-ancestor
154179927|NCT05232084|Analgesics|analgesics|mesh-ancestor
154179928|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154179929|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154179930|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
154179931|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
154179932|NCT05195619|Vaccines|vaccines|mesh-list
154179933|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
154179934|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179935|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179936|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154179937|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154179938|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
154179939|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179940|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179941|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154179942|NCT05158517|Vedolizumab|vedolizumab|mesh-list
154179943|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154179944|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
154179945|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154179946|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179947|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154179948|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179949|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154179950|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154179951|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154179952|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179953|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179954|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154179955|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154179956|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179957|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
154179958|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179959|NCT05132231|Brodalumab|brodalumab|mesh-list
154179960|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
154179961|NCT05099107|Albuterol|albuterol|mesh-list
154179962|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154179963|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
154179964|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179965|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179966|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154179967|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
154179968|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
154179969|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154179970|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154179971|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154179972|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154179973|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
154179974|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179975|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180001|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180003|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180004|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180005|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154180006|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
154180007|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154180008|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
154180009|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
154180010|NCT04924374|Atezolizumab|atezolizumab|mesh-list
154180011|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154180012|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180013|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180014|NCT04924374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154180015|NCT04924374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180016|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
154180017|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180018|NCT04918147|Acetaminophen|acetaminophen|mesh-list
154180019|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
154180020|NCT04918147|Promethazine|promethazine|mesh-list
154180021|NCT04918147|Prednisone|prednisone|mesh-list
154180022|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
154180023|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154180024|NCT04918147|Elotuzumab|elotuzumab|mesh-list
154180049|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
154180050|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
154180051|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180052|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180053|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154180054|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
154180055|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
154180056|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154180057|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154180058|NCT04902625|Naltrexone|naltrexone|mesh-list
154180059|NCT04902625|Bupropion|bupropion|mesh-list
154180060|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154180061|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154180062|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180063|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
154180064|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180065|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154180066|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
154180067|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154180068|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154180069|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154180070|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154180071|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180072|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
154180073|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180074|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154180075|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154180095|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180096|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154180097|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
154180098|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154180100|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180101|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180102|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154180103|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
154165007|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154180104|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
154180105|NCT04755647|Protective Agents|protective agents|mesh-ancestor
154180106|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
154180107|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180108|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
154180109|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180110|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180111|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154180112|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
154180113|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180114|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180115|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154180117|NCT04648020|Analgesics|analgesics|mesh-ancestor
154180118|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
154180119|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180120|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180121|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154180122|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
154180123|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
154180124|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154180125|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154180126|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154180127|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
154180128|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180129|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602940|NCT01908075|Hormones|hormones|mesh-ancestor
154180139|NCT04614194|Letrozole|letrozole|mesh-list
154180140|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180141|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154180142|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154180143|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180144|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180145|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154180146|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
154180147|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180148|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180149|NCT04593654|Dalteparin|dalteparin|mesh-list
154180150|NCT04593654|Tinzaparin|tinzaparin|mesh-list
154180151|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154180152|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
154180153|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154180154|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154180155|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180156|NCT04585893|Rituximab|rituximab|mesh-list
154180157|NCT04585893|Etoposide|etoposide|mesh-list
154180158|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180159|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180160|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
154180161|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180162|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180163|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154180164|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154180165|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154180166|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180167|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180168|NCT04547946|Trametinib|trametinib|mesh-list
154180169|NCT04547946|Dabrafenib|dabrafenib|mesh-list
154180170|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180171|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180172|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180173|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180174|NCT04535700|Pioglitazone|pioglitazone|mesh-list
154180175|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154180176|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180177|NCT04437225|Glycolic acid|glycolic acid|mesh-list
154180178|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
154180179|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
154180180|NCT04429555|Ibudilast|ibudilast|mesh-list
154180181|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154180182|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
154180183|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180184|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861046|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154255118|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180185|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154180186|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
154180187|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154180188|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180189|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180190|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154180191|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
154180192|NCT04400474|Atezolizumab|atezolizumab|mesh-list
154180193|NCT04400474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154180215|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180217|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180218|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180219|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
154180220|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
154180221|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180222|NCT04261036|Protective Agents|protective agents|mesh-ancestor
154180223|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180224|NCT04261036|Vitamins|vitamins|mesh-ancestor
154180225|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
154180226|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154180227|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
154180228|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154180229|NCT04095832|Anesthetics|anesthetics|mesh-list
154180230|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180231|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180232|NCT04083365|Capecitabine|capecitabine|mesh-list
154180233|NCT04083365|Durvalumab|durvalumab|mesh-list
154180234|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154180235|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
154180236|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180237|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180238|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180239|NCT04072068|Edoxaban|edoxaban|mesh-list
154180240|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154180241|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
154180242|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154180257|NCT03970655|Epinephrine|epinephrine|mesh-list
154180258|NCT03970655|Racepinephrine|racepinephrine|mesh-list
154180259|NCT03970655|Bupivacaine|bupivacaine|mesh-list
154180260|NCT03970655|Ropivacaine|ropivacaine|mesh-list
154180261|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
154180263|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180264|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
154180265|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
154180266|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180267|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180268|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154180269|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
154180270|NCT03970655|Hormones|hormones|mesh-ancestor
154180271|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027383|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
154180272|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154180273|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180274|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
154180275|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180276|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180277|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
154180278|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
154180279|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180280|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
154180281|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154180282|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154180283|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
154180284|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180285|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154180286|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154180287|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154180288|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
154180289|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
154180290|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
154180291|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154180292|NCT03916627|Cemiplimab|cemiplimab|mesh-list
154861047|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
154861048|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
154180293|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180294|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180295|NCT03912064|Ipilimumab|ipilimumab|mesh-list
154180296|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180297|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180298|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154180299|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180300|NCT03911453|Rucaparib|rucaparib|mesh-list
154180301|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153603098|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
154180311|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
154180312|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
154180313|NCT03865290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154180314|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154180315|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
154180316|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180317|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180318|NCT03840291|Edoxaban|edoxaban|mesh-list
154180319|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154180320|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
154180321|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154180322|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
154180323|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180324|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180325|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
154180326|NCT03837626|Amiloride|amiloride|mesh-list
154180327|NCT03837626|Diuretics|diuretics|mesh-ancestor
154180328|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
154180329|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180330|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154180331|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154180332|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154180333|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180334|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154180335|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154180336|NCT03781219|Vemurafenib|vemurafenib|mesh-list
154180337|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180338|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180339|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180340|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180341|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154180342|NCT03773237|SMOFlipid|smoflipid|mesh-list
154180343|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154180344|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154027384|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
154180345|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154180346|NCT03694808|Vaccines|vaccines|mesh-list
154180347|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
154180348|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180349|NCT03659539|Propofol|propofol|mesh-list
154180350|NCT03659539|Desflurane|desflurane|mesh-list
154180351|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154180352|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180353|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180354|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154180355|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
154180356|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
154180357|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154180358|NCT03659136|Everolimus|everolimus|mesh-list
154180359|NCT03659136|Exemestane|exemestane|mesh-list
154180360|NCT03659136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154180361|NCT03659136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180362|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180363|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180364|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180365|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
153603159|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180372|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180373|NCT03629418|Phenylephrine|phenylephrine|mesh-list
154180374|NCT03629418|Norepinephrine|norepinephrine|mesh-list
154180375|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154180376|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
154180377|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
154180378|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180379|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781826|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
154180380|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
154180381|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154180382|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
154180383|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
154180384|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154180385|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154180386|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154180387|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154180388|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180389|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180390|NCT03629418|Protective Agents|protective agents|mesh-ancestor
154180391|NCT03606213|Vaccines|vaccines|mesh-list
154180392|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
154180393|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180394|NCT03514108|Metformin|metformin|mesh-list
154180395|NCT03514108|Hydralazine|hydralazine|mesh-list
154180396|NCT03514108|Isosorbide|isosorbide|mesh-list
154180397|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154180398|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154180399|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154180400|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180401|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154180402|NCT03514108|Diuretics|diuretics|mesh-ancestor
154180403|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
154180404|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
154180405|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154180406|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180407|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154180408|NCT03390036|Triamcinolone|triamcinolone|mesh-list
154180409|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154180410|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154180411|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154180412|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180413|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
154180414|NCT03390036|Hormones|hormones|mesh-ancestor
154180415|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180416|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180417|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153927441|NCT02848612|Heparin|heparin|mesh-list
154180418|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
154180419|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180420|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180421|NCT03379506|Grazoprevir|grazoprevir|mesh-list
154180422|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
154180423|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154180424|NCT03375788|Hormones|hormones|mesh-list
154180425|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154180426|NCT03375788|Tesamorelin|tesamorelin|mesh-list
154180427|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180428|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180429|NCT03375788|Growth Substances|growth substances|mesh-ancestor
154180430|NCT03341936|Nivolumab|nivolumab|mesh-list
154180431|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180432|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180433|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153603221|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154180442|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180443|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180444|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180445|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180447|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154180448|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
154180449|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
154180450|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180451|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180452|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154180453|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154180454|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154180455|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
154180456|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180457|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180458|NCT03289728|Protective Agents|protective agents|mesh-ancestor
154180459|NCT03275415|Budesonide|budesonide|mesh-list
154180460|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255119|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180461|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154180463|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180464|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180465|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154180466|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
154180467|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
154180468|NCT03275415|Hormones|hormones|mesh-ancestor
154180469|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180470|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
154180471|NCT03233724|Decitabine|decitabine|mesh-list
154180472|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
154180473|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180474|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180475|NCT03233724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154180476|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180477|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154180478|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
154180479|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180480|NCT03230734|Docetaxel|docetaxel|mesh-list
154180481|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180482|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
154180483|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
154180484|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154180485|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180486|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154180487|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154180488|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154180489|NCT03229408|Analgesics|analgesics|mesh-ancestor
154180490|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
154180491|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180492|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927508|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180493|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180494|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180496|NCT03146962|Vitamins|vitamins|mesh-ancestor
154180497|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
154180498|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180499|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
153603290|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154180513|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180514|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180515|NCT02998268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154180516|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
154180517|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154180518|NCT02824276|Morphine|morphine|mesh-list
154180519|NCT02824276|Oxycodone|oxycodone|mesh-list
154180520|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154180521|NCT02824276|Narcotics|narcotics|mesh-ancestor
154180522|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180523|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180524|NCT02824276|Analgesics|analgesics|mesh-ancestor
154180525|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
154180526|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180527|NCT02813135|Cytarabine|cytarabine|mesh-list
154180528|NCT02813135|Dexamethasone|dexamethasone|mesh-list
154180529|NCT02813135|Cyclophosphamide|cyclophosphamide|mesh-list
154180530|NCT02813135|Temozolomide|temozolomide|mesh-list
154180531|NCT02813135|Carboplatin|carboplatin|mesh-list
154180532|NCT02813135|Nivolumab|nivolumab|mesh-list
154180533|NCT02813135|Irinotecan|irinotecan|mesh-list
154180534|NCT02813135|Everolimus|everolimus|mesh-list
154180535|NCT02813135|Topotecan|topotecan|mesh-list
154180536|NCT02813135|Olaparib|olaparib|mesh-list
154180537|NCT02813135|Futibatinib|futibatinib|mesh-list
154180538|NCT02813135|Adavosertib|adavosertib|mesh-list
154180539|NCT02813135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180540|NCT02813135|Immunologic Factors|immunologic factors|mesh-ancestor
154180541|NCT02813135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180542|NCT02813135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180543|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154180544|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
154180545|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180546|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180547|NCT02813135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154180548|NCT02813135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180550|NCT02813135|Autonomic Agents|autonomic agents|mesh-ancestor
154180551|NCT02813135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180552|NCT02813135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154180553|NCT02813135|Glucocorticoids|glucocorticoids|mesh-ancestor
154180554|NCT02813135|Hormones|hormones|mesh-ancestor
154180555|NCT02813135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180556|NCT02813135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154180557|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180558|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154180559|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154180560|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154180561|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180562|NCT02813135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154180563|NCT02813135|Antimetabolites|antimetabolites|mesh-ancestor
154180564|NCT02813135|Antiviral Agents|antiviral agents|mesh-ancestor
154180590|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154180591|NCT02476279|Analgesics|analgesics|mesh-ancestor
154180592|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
154180593|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180594|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180595|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180596|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180597|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
154180598|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
154180599|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154180600|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154180601|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180602|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180603|NCT02425865|Golimumab|golimumab|mesh-list
154180604|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154180605|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180606|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180607|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
154180608|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180609|NCT02425852|Prednisolone|prednisolone|mesh-list
154180610|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
154180611|NCT02425852|Infliximab|infliximab|mesh-list
154180612|NCT02425852|Azathioprine|azathioprine|mesh-list
154180613|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180614|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
154180624|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
154180625|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180626|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154180627|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180628|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
154180629|NCT02333188|Leucovorin|leucovorin|mesh-list
154180630|NCT02333188|Paclitaxel|paclitaxel|mesh-list
154180631|NCT02333188|Fluorouracil|fluorouracil|mesh-list
154180632|NCT02333188|Irinotecan|irinotecan|mesh-list
154180633|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154180634|NCT02333188|Calcium|calcium|mesh-list
154180635|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
154180636|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154180637|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180638|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
154180639|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
154180640|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
154180641|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180642|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154180643|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180644|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
154180645|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154180646|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180647|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
154180648|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154180649|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154180650|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180651|NCT02333188|Antidotes|antidotes|mesh-ancestor
154180652|NCT02333188|Protective Agents|protective agents|mesh-ancestor
154180653|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
154180655|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
154180656|NCT02177578|Temozolomide|temozolomide|mesh-list
154180657|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154180658|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
154180659|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180660|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180662|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154180663|NCT01892709|Narcotics|narcotics|mesh-ancestor
154180664|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180665|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180666|NCT01892709|Analgesics|analgesics|mesh-ancestor
154180667|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
154180668|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180669|NCT01806571|Cytarabine|cytarabine|mesh-list
154180670|NCT01806571|Daunorubicin|daunorubicin|mesh-list
154180671|NCT01806571|Nilotinib|nilotinib|mesh-list
154180672|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154180673|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
154180674|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180675|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180676|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
154180677|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154180678|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180679|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
154180680|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180681|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154180689|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
154180690|NCT01633177|Vitamins|vitamins|mesh-list
154180691|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
154180692|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180693|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154180694|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154180695|NCT01517451|Androgens|androgens|mesh-list
154180696|NCT01517451|Hormones|hormones|mesh-ancestor
154180697|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180698|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180699|NCT01204216|Biotin|biotin|mesh-list
154180700|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
154180701|NCT01204216|Vitamins|vitamins|mesh-ancestor
154180702|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
154180703|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180704|NCT01104350|Gemcitabine|gemcitabine|mesh-list
154180705|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154180706|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
154180707|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180708|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180709|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
154180710|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154180711|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180712|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
154180713|NCT01025089|Doxorubicin|doxorubicin|mesh-list
154180714|NCT01025089|Cetuximab|cetuximab|mesh-list
154180715|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180716|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
154180717|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180718|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180719|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154180720|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
154180721|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180722|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180723|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153927737|NCT02845024|Doxycycline|doxycycline|mesh-list
154180724|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154180725|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154180726|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154180727|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180728|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180729|NCT00999037|Sevelamer|sevelamer|mesh-list
154180730|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
154180731|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
154180732|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180733|NCT00921856|Acetylcholine|acetylcholine|mesh-list
154180734|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
154180735|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154180736|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
154180737|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180738|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180739|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180740|NCT00833664|Terbinafine|terbinafine|mesh-list
154180741|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
154180742|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154180743|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180744|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180745|NCT00696111|Leuprolide|leuprolide|mesh-list
154180746|NCT00696111|Progesterone|progesterone|mesh-list
154180747|NCT00696111|Estrogens|estrogens|mesh-list
154180748|NCT00696111|Progestins|progestins|mesh-ancestor
154180749|NCT00696111|Hormones|hormones|mesh-ancestor
154180750|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180763|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180764|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180765|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180766|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154180767|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180768|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
154180769|NCT00199862|Antibodies|antibodies|mesh-list
154180770|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
154180771|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180772|NCT00128310|Gemcitabine|gemcitabine|mesh-list
154180773|NCT00128310|Vinorelbine|vinorelbine|mesh-list
154180774|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154180775|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
154180776|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180777|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180778|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154180779|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
154180780|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
154180781|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
154180782|NCT00885443|Propofol|propofol|mesh-list
154180783|NCT00885443|Sevoflurane|sevoflurane|mesh-list
154180784|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154180785|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180786|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180787|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154180788|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
154180789|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
154180790|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154180791|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154180792|NCT00882869|Sorafenib|sorafenib|mesh-list
154180793|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180794|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180795|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180796|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180797|NCT00882947|Iloprost|iloprost|mesh-list
154180798|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154180799|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
154180800|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154180801|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154180802|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
154180803|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180804|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180805|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154180806|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
154180807|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154180808|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154180809|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154180810|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
154180811|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180812|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180813|NCT00530348|Interferons|interferons|mesh-list
154180838|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
154180839|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180840|NCT01008020|Protective Agents|protective agents|mesh-ancestor
154180841|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180842|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154180843|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154180844|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180845|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154180846|NCT01008098|Escitalopram|escitalopram|mesh-list
154180847|NCT01008098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154180848|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154180849|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154180850|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180851|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180852|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
154180853|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180854|NCT00530270|Dexamethasone|dexamethasone|mesh-list
154180855|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180856|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
154180857|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
154180858|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180859|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180860|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154180861|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
154180862|NCT00530270|Hormones|hormones|mesh-ancestor
154180863|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180864|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154180865|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180881|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154180882|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
154180883|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180884|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180885|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154180886|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180887|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154180888|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180889|NCT01008566|Sorafenib|sorafenib|mesh-list
154180890|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154180891|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180892|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180893|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180894|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180895|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
154180896|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180897|NCT01001936|Bosutinib|bosutinib|mesh-list
154180898|NCT01001936|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154180899|NCT01001936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180900|NCT01001936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180901|NCT01001936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180902|NCT03885596|Acetaminophen|acetaminophen|mesh-list
154180903|NCT03885596|Celecoxib|celecoxib|mesh-list
154180904|NCT03885596|Ketorolac|ketorolac|mesh-list
154180905|NCT03885596|Lidocaine|lidocaine|mesh-list
154180906|NCT03885596|Fentanyl|fentanyl|mesh-list
154180907|NCT03885596|Bupivacaine|bupivacaine|mesh-list
154180908|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
154180909|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
154180910|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180911|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180912|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
154180913|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180914|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154180915|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154180916|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154180917|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154180918|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180919|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154180920|NCT03885596|Narcotics|narcotics|mesh-ancestor
154180921|NCT03885596|Analgesics|analgesics|mesh-ancestor
154180922|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154180923|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154180924|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
154180934|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154180935|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154180936|NCT01002092|Growth Substances|growth substances|mesh-ancestor
154180937|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180938|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
154180939|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180941|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
154180942|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
154180943|NCT00529100|Cisplatin|cisplatin|mesh-list
154180944|NCT00529100|Pemetrexed|pemetrexed|mesh-list
154180945|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180946|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180947|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180948|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154180949|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154180950|NCT00529802|Everolimus|everolimus|mesh-list
153927964|NCT00656773|Sufentanil|sufentanil|mesh-list
154180951|NCT00529802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154180952|NCT00529802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180953|NCT00529802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180954|NCT00529802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180955|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180956|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
154180957|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180958|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180960|NCT00528866|Bicalutamide|bicalutamide|mesh-list
154180961|NCT00528866|Flutamide|flutamide|mesh-list
154180962|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180963|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
154180964|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
154180965|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
154180966|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180967|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
154180968|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
154180969|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180970|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180971|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154180972|NCT03999008|Budesonide|budesonide|mesh-list
154180973|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180974|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154180975|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
154180976|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180977|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180978|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154180979|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
154180980|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
154180981|NCT03999008|Hormones|hormones|mesh-ancestor
154180982|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180983|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
154180984|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154180985|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180986|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180987|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154180988|NCT04932746|Analgesics|analgesics|mesh-ancestor
153603775|NCT01913834|Teriparatide|teriparatide|mesh-list
154181012|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181013|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181014|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
154181015|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181016|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154181017|NCT00880529|Narcotics|narcotics|mesh-ancestor
154181018|NCT00880529|Analgesics|analgesics|mesh-ancestor
154181019|NCT00880841|Buprenorphine|buprenorphine|mesh-list
154181020|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154181021|NCT00880841|Naloxone|naloxone|mesh-list
154181022|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154181023|NCT00880841|Narcotics|narcotics|mesh-ancestor
154181024|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928032|NCT00653341|Insulin|insulin|mesh-list
154181025|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181026|NCT00880841|Analgesics|analgesics|mesh-ancestor
154181027|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
154181028|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181029|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154181030|NCT00883259|Metformin|metformin|mesh-list
154181031|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154181032|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181033|NCT00885599|Listerine|listerine|mesh-list
154181034|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154181035|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181036|NCT04366115|Dexamethasone|dexamethasone|mesh-list
154181037|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
154181038|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154181039|NCT04366115|BB 1101|bb 1101|mesh-list
154181040|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181052|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181053|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181054|NCT04038125|Dexamethasone|dexamethasone|mesh-list
154181055|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181056|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
154181057|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
154181058|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181059|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181060|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154002059|NCT00871039|Midazolam|midazolam|mesh-list
154181061|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
154181062|NCT04038125|Hormones|hormones|mesh-ancestor
154181063|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181064|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154181065|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181066|NCT00881153|Cefprozil|cefprozil|mesh-list
154181067|NCT00881153|Cephalosporins|cephalosporins|mesh-list
154181068|NCT00881153|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154181069|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154181070|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181071|NCT00885833|Fludarabine|fludarabine|mesh-list
154181072|NCT00885833|Busulfan|busulfan|mesh-list
154181073|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
154181074|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181075|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181076|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181077|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
154181078|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181079|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
154181080|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154181081|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154181082|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
154181083|NCT00612677|Pemetrexed|pemetrexed|mesh-list
154181084|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181085|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181086|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181087|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154181088|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154181089|NCT04038749|Cabergoline|cabergoline|mesh-list
154181090|NCT04038749|Bromocriptine|bromocriptine|mesh-list
154181091|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154181092|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154181093|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
154181094|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
154181095|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181096|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181097|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181098|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
154181099|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181100|NCT00881231|Cilostazol|cilostazol|mesh-list
154181101|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154181103|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181104|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181109|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181110|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154181112|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154181113|NCT00881231|Protective Agents|protective agents|mesh-ancestor
154181114|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154181115|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154181116|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181117|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
154181118|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154181119|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154181120|NCT00881387|Rituximab|rituximab|mesh-list
154181121|NCT00881387|Gemcitabine|gemcitabine|mesh-list
154181122|NCT00881387|Vinorelbine|vinorelbine|mesh-list
153489109|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181123|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154181124|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181125|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
154181126|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181127|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181128|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154181129|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
154181130|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181131|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154181132|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154181133|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154181134|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154181135|NCT00883883|Cefdinir|cefdinir|mesh-list
154181136|NCT00883883|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154181137|NCT00883883|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154181138|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154181139|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861049|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181140|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154181141|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154181142|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154181143|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181144|NCT00881543|Incretins|incretins|mesh-ancestor
154181145|NCT00881543|Hormones|hormones|mesh-ancestor
154181146|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181147|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
154181148|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181149|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181150|NCT00881855|Cefprozil|cefprozil|mesh-list
154181151|NCT00881855|Cephalosporins|cephalosporins|mesh-list
154181152|NCT00881855|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154181153|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154181154|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181155|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
154181156|NCT04015115|Narcotics|narcotics|mesh-ancestor
154181157|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181158|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181159|NCT04015115|Analgesics|analgesics|mesh-ancestor
154181160|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
154181161|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181162|NCT02543645|Atezolizumab|atezolizumab|mesh-list
154181163|NCT02543645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154181164|NCT02543645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181165|NCT02543645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154181166|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181167|NCT02543411|Lidocaine|lidocaine|mesh-list
154181168|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
154181169|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
154181170|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181171|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181172|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
154181173|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603962|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
154181178|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181181|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
154181182|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181183|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
154181184|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181185|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181186|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154181187|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
154181188|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181189|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181190|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154181191|NCT00882401|Vitamin D|vitamin d|mesh-list
154181192|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
154181193|NCT00882401|Vitamins|vitamins|mesh-ancestor
154181194|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
154181195|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181196|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154181197|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154181198|NCT00886457|Interferons|interferons|mesh-list
154181199|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
154181200|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
154181201|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154181202|NCT00886457|Decitabine|decitabine|mesh-list
154181203|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181204|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
154181205|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181206|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
154181207|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181208|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154181209|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
154181210|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181211|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181212|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
154181213|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154181214|NCT04038671|Charcoal|charcoal|mesh-list
154181215|NCT04038671|Antidotes|antidotes|mesh-ancestor
154181216|NCT04038671|Protective Agents|protective agents|mesh-ancestor
154181217|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181218|NCT02543099|Policosanol|policosanol|mesh-list
154861050|NCT01075087|Ropivacaine|ropivacaine|mesh-list
154861051|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
154165903|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
154181219|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154181220|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154181221|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
154181222|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181223|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154181224|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154181225|NCT00882635|Heparin|heparin|mesh-list
154181226|NCT00882635|Enoxaparin|enoxaparin|mesh-list
154181227|NCT00882635|Calcium heparin|calcium heparin|mesh-list
154181228|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
154181229|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154181230|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154181231|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181232|NCT00609869|Rituximab|rituximab|mesh-list
154181233|NCT00609869|Lenalidomide|lenalidomide|mesh-list
154181234|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154181235|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181236|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
154181237|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181238|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181239|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154181240|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154181241|NCT00609869|Growth Substances|growth substances|mesh-ancestor
154181242|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
154181243|NCT00888797|Etodolac|etodolac|mesh-list
154181244|NCT00888797|Propranolol|propranolol|mesh-list
154181245|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154181267|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154181268|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154181269|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
154181270|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181271|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181272|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181273|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154181274|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154181275|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
154181276|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154181277|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154181278|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
154181279|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154181280|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154181281|NCT00887003|Prednisolone|prednisolone|mesh-list
154181282|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
154181283|NCT00887003|Bupivacaine|bupivacaine|mesh-list
154181284|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154181285|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
154181286|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
154181287|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
154181288|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181289|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181290|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
154181291|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181292|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181293|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
154181294|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
154181295|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154181296|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
154181297|NCT00887003|Hormones|hormones|mesh-ancestor
154181298|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181314|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646708|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646709|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153646710|NCT02909322|Narcotics|narcotics|mesh-ancestor
154181315|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181317|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181318|NCT00611975|Bupropion|bupropion|mesh-list
154181319|NCT00611975|Fluoxetine|fluoxetine|mesh-list
154181320|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154181321|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
154181322|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154181323|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154181324|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154181325|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154181326|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181327|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
154181328|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861052|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
154181329|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181330|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154181331|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154181332|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181333|NCT00611975|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154181334|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
154181335|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
154181336|NCT04895306|Testosterone|testosterone|mesh-list
154181337|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
154181338|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
154181339|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154181340|NCT04895306|Androgens|androgens|mesh-ancestor
154181341|NCT04895306|Hormones|hormones|mesh-ancestor
154181342|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181343|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181344|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154181345|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181346|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
154181347|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154181348|NCT00889343|Leucovorin|leucovorin|mesh-list
154181349|NCT00889343|Fluorouracil|fluorouracil|mesh-list
154181350|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
154181351|NCT00889343|Irinotecan|irinotecan|mesh-list
154181352|NCT00889343|Sorafenib|sorafenib|mesh-list
154181353|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
154181354|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181355|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154181356|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181357|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181358|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
154181359|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181371|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
154181372|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181373|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154181375|NCT00573131|Cisplatin|cisplatin|mesh-list
154181376|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154181377|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181378|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
154181379|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
154181380|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
154181381|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181382|NCT01565018|Rotigotine|rotigotine|mesh-list
154181383|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
154181384|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
154181385|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181386|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181387|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181388|NCT01565096|Metformin|metformin|mesh-list
154181389|NCT01565096|Glimepiride|glimepiride|mesh-list
154181390|NCT01565096|Vildagliptin|vildagliptin|mesh-list
154181391|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154181392|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181393|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154181394|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181395|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
154181396|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154181397|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
154181398|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181399|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181400|NCT00889499|Tropisetron|tropisetron|mesh-list
154181401|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
154181402|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
154181403|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181404|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181405|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154181406|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154181407|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154181408|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
154181409|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181410|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181411|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154181412|NCT00889655|Laxatives|laxatives|mesh-ancestor
154181413|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154181414|NCT05002946|Naltrexone|naltrexone|mesh-list
154181415|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154181416|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154181417|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181418|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
154181419|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181420|NCT00521144|Topotecan|topotecan|mesh-list
154181421|NCT00521144|Obatoclax|obatoclax|mesh-list
154181422|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154181423|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154181424|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181425|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181439|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154181440|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181441|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
154181442|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181443|NCT00885287|Lumefantrine|lumefantrine|mesh-list
154181444|NCT00885287|Artemether|artemether|mesh-list
154181445|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154181446|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
154181447|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154181448|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154181449|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181450|NCT02542007|Sirolimus|sirolimus|mesh-list
154181451|NCT02542007|Temsirolimus|temsirolimus|mesh-list
154181452|NCT02542007|MTOR Inhibitors|mtor inhibitors|mesh-list
154181453|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154181454|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181455|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154181456|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181457|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
154181458|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181459|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
154181460|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181461|NCT02542007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154181462|NCT02542007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181463|NCT02542007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181464|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154181465|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154181466|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154181467|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181468|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181469|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154181470|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154181471|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154181472|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
154181473|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181474|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181475|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154181476|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154181477|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
154181478|NCT00890279|Imidapril|imidapril|mesh-list
154181479|NCT00890279|Cilnidipine|cilnidipine|mesh-list
154181480|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154181481|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154181482|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181483|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154181484|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181485|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154181486|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
154181487|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181500|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154181501|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154181502|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
154181503|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154181504|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154181505|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154181506|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154181507|NCT02541383|Thalidomide|thalidomide|mesh-list
154181508|NCT02541383|Dexamethasone|dexamethasone|mesh-list
154181509|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
154181510|NCT02541383|Bortezomib|bortezomib|mesh-list
154181511|NCT02541383|Daratumumab|daratumumab|mesh-list
154181512|NCT02541383|BB 1101|bb 1101|mesh-list
154181513|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154181514|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181515|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
154181516|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
154181517|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181518|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181519|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154181520|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
154181521|NCT02541383|Hormones|hormones|mesh-ancestor
154181522|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181523|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154181524|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181525|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
154181526|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181527|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181528|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181529|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
154181530|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
154181531|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153489110|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646711|NCT02909322|Analgesics|analgesics|mesh-ancestor
154181532|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181533|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154181534|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154181535|NCT02541383|Growth Substances|growth substances|mesh-ancestor
154181536|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
154181537|NCT04036487|Propofol|propofol|mesh-list
154181538|NCT04036487|Desflurane|desflurane|mesh-list
154181539|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154181540|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181541|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181542|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154181543|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
154181544|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
154181545|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154181546|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
154181547|NCT05278793|Trace Elements|trace elements|mesh-ancestor
154181548|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
154181549|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181550|NCT04037657|Propofol|propofol|mesh-list
154181551|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154181581|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181583|NCT04017845|Lidocaine|lidocaine|mesh-list
154181584|NCT04017845|Diltiazem|diltiazem|mesh-list
154181585|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
154181586|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
154181587|NCT04017845|Bisacodyl|bisacodyl|mesh-list
154181588|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
154181589|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
154181590|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181591|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181592|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
154181593|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181594|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153604395|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154181603|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154181604|NCT04017845|Laxatives|laxatives|mesh-ancestor
154181605|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154181606|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153781828|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154181607|NCT04017845|Analgesics|analgesics|mesh-ancestor
154181608|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181609|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181610|NCT00520130|Cytarabine|cytarabine|mesh-list
154181611|NCT00520130|Cyclosporine|cyclosporine|mesh-list
154181612|NCT00520130|Rituximab|rituximab|mesh-list
154181613|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
154181614|NCT00520130|Fludarabine|fludarabine|mesh-list
154181615|NCT00520130|Cyclosporins|cyclosporins|mesh-list
154181616|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154181617|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181618|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
154181619|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181620|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181621|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154181622|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
154181623|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181624|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181625|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
154181626|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181627|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181628|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
154181629|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
154181630|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154181631|NCT00519896|Sunitinib|sunitinib|mesh-list
154166206|NCT00385684|Hydrocodone|hydrocodone|mesh-list
154181632|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181633|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154181634|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154181635|NCT00519896|Growth Substances|growth substances|mesh-ancestor
154181636|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181637|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
154181638|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154181639|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181640|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181641|NCT00527618|Valacyclovir|valacyclovir|mesh-list
154181643|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
154181644|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181645|NCT00527072|Infliximab|infliximab|mesh-list
154181646|NCT00527072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154181647|NCT00527072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181648|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
154181649|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489111|NCT04916886|Vaccines|vaccines|mesh-list
154181650|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181651|NCT00519428|Dexetimide|dexetimide|mesh-list
154181652|NCT00519428|Citalopram|citalopram|mesh-list
154181653|NCT00519428|Bupropion|bupropion|mesh-list
154181654|NCT00519428|Escitalopram|escitalopram|mesh-list
154181655|NCT00519428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154181656|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154181657|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154181658|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181659|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181660|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
154181661|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181685|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181687|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
154181688|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154181689|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
154181690|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
154181691|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181692|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181693|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154181694|NCT00430989|Analgesics|analgesics|mesh-ancestor
154181695|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
154181696|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181697|NCT00518882|Liraglutide|liraglutide|mesh-list
154181698|NCT00518882|Exenatide|exenatide|mesh-list
154181699|NCT00518882|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154181700|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154181701|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181702|NCT00518882|Incretins|incretins|mesh-ancestor
154181703|NCT00518882|Hormones|hormones|mesh-ancestor
154181704|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181705|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153928702|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181707|NCT00518180|Vaccines|vaccines|mesh-list
154181708|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
154181709|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181710|NCT00518180|Cathartics|cathartics|mesh-ancestor
154181711|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154181722|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181724|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154181725|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181726|NCT00525590|Carmustine|carmustine|mesh-list
154181727|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154181728|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
154181729|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181730|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181731|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
154181732|NCT00430677|Prednisone|prednisone|mesh-list
154181733|NCT00430677|Prednisolone|prednisolone|mesh-list
154181734|NCT00430677|Abatacept|abatacept|mesh-list
154181735|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181736|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
154181737|NCT00430677|Hormones|hormones|mesh-ancestor
154181738|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181739|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181740|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154255120|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154181741|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181742|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154181743|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154181744|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
154181745|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154181746|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181747|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181748|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181749|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154181750|NCT00430677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154181751|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181752|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
154181753|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181754|NCT02631759|Levetiracetam|levetiracetam|mesh-list
154181755|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
154181756|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
154181757|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
154181758|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154181759|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181760|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
154181761|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154181762|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
154181763|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181764|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181765|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154181766|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
154181767|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
154181768|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154181769|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
154181770|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181771|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181775|NCT03656666|Thalidomide|thalidomide|mesh-list
154181776|NCT03656666|Apremilast|apremilast|mesh-list
154181777|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154181778|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154181779|NCT03656666|Analgesics|analgesics|mesh-ancestor
154181780|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
154181798|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181799|NCT00430521|Vaccines|vaccines|mesh-list
154181800|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
154181801|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181802|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154181803|NCT01036035|Pilocarpine|pilocarpine|mesh-list
154181804|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154181805|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154181806|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
154181807|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181808|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181809|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181810|NCT01036035|Urological Agents|urological agents|mesh-ancestor
154181811|NCT01036035|Miotics|miotics|mesh-ancestor
154181812|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
154181813|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181814|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154181815|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154181816|NCT01036659|Ecallantide|ecallantide|mesh-list
154181817|NCT01036659|Bradykinin|bradykinin|mesh-list
154181818|NCT01036659|Kallikreins|kallikreins|mesh-list
154181819|NCT01036659|Kininogens|kininogens|mesh-list
154181820|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
154181821|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154181822|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
154181823|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181824|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181825|NCT01036659|Analgesics|analgesics|mesh-ancestor
154181826|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
154181827|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181828|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181829|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154181830|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153489115|NCT04907682|Favipiravir|favipiravir|mesh-list
154181831|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181832|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181833|NCT01036659|Coagulants|coagulants|mesh-ancestor
154181834|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154861053|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181835|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
154181836|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154181838|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154181850|NCT06051344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154181851|NCT06051344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181852|NCT06051240|Lithium Carbonate|lithium carbonate|mesh-list
154181853|NCT06051240|Antidepressive Agents|antidepressive agents|mesh-ancestor
153928852|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154181854|NCT06051240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154181855|NCT06051240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181856|NCT06051240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181857|NCT06051240|Antimanic Agents|antimanic agents|mesh-ancestor
154181858|NCT06051240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154181859|NCT06051240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181860|NCT06051240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181861|NCT06050863|Chlorhexidine|chlorhexidine|mesh-list
154181862|NCT06050863|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154181863|NCT06050863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154181864|NCT06050863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181865|NCT06050863|Disinfectants|disinfectants|mesh-ancestor
154181866|NCT06050863|Dermatologic Agents|dermatologic agents|mesh-ancestor
154181867|NCT06050577|Semaglutide|semaglutide|mesh-list
154181868|NCT06050577|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154181869|NCT06050577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154181870|NCT06050577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181872|NCT06180759|Analgesics|analgesics|mesh-ancestor
154181873|NCT06180759|Sensory System Agents|sensory system agents|mesh-ancestor
154181874|NCT06180759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181875|NCT06180759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181876|NCT06180759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154181877|NCT06180759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154181878|NCT06180759|Anesthetics, General|anesthetics, general|mesh-ancestor
154181879|NCT06180759|Anesthetics|anesthetics|mesh-ancestor
154181880|NCT06180759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181881|NCT06180759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154181882|NCT06180759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154181883|NCT06180759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181884|NCT06180759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181885|NCT06180733|Pembrolizumab|pembrolizumab|mesh-list
154181886|NCT06180733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154181887|NCT06180733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181888|NCT06180733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154181889|NCT06180733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181890|NCT06180720|Levodopa|levodopa|mesh-list
154181891|NCT06180720|Carbidopa|carbidopa|mesh-list
154181892|NCT06180720|Entacapone|entacapone|mesh-list
154181893|NCT06180720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154181894|NCT06180720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154181895|NCT06180720|Dopamine Agents|dopamine agents|mesh-ancestor
154181896|NCT06180720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181897|NCT06180720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181898|NCT06180720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181899|NCT06180720|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154181900|NCT06180720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181912|NCT06180707|Anticonvulsants|anticonvulsants|mesh-ancestor
154181913|NCT06180707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154181914|NCT06180707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154181915|NCT06180707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181916|NCT06180707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154181917|NCT06180707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154181918|NCT06180707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154181919|NCT06180707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181920|NCT06180707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154181921|NCT06180707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154181922|NCT06180707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181923|NCT06180447|Vaccines|vaccines|mesh-list
154181924|NCT06180447|Immunologic Factors|immunologic factors|mesh-ancestor
154181925|NCT06180447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181926|NCT06180226|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154181927|NCT06180226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154181928|NCT06180226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181929|NCT06180109|Empagliflozin|empagliflozin|mesh-list
154181930|NCT06180109|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154181931|NCT06180109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181932|NCT06180109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154181933|NCT06180109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181934|NCT06180070|Acetaminophen|acetaminophen|mesh-list
154181935|NCT06180070|Ibuprofen|ibuprofen|mesh-list
154181936|NCT06180070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154181937|NCT06180070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154181938|NCT06180070|Analgesics|analgesics|mesh-ancestor
154181939|NCT06180070|Sensory System Agents|sensory system agents|mesh-ancestor
154181940|NCT06180070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181941|NCT06180070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181942|NCT06180070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489209|NCT02756364|Fulvestrant|fulvestrant|mesh-list
154181943|NCT06180070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181944|NCT06180070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154181945|NCT06180070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181946|NCT06180070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181947|NCT06180070|Antipyretics|antipyretics|mesh-ancestor
154181948|NCT06180031|Magnesium Sulfate|magnesium sulfate|mesh-list
154181949|NCT06180031|Bupivacaine|bupivacaine|mesh-list
154181950|NCT06180031|Anesthetics, Local|anesthetics, local|mesh-ancestor
154181951|NCT06180031|Anesthetics|anesthetics|mesh-ancestor
154181952|NCT06180031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181953|NCT06180031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181954|NCT06180031|Sensory System Agents|sensory system agents|mesh-ancestor
154181955|NCT06180031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181956|NCT06180031|Analgesics|analgesics|mesh-ancestor
154181957|NCT06180031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154181958|NCT06180031|Anticonvulsants|anticonvulsants|mesh-ancestor
154181959|NCT06180031|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154181960|NCT06180031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154181961|NCT06180031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181962|NCT06180031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154181963|NCT06180031|Tocolytic Agents|tocolytic agents|mesh-ancestor
153604746|NCT01919424|Miotics|miotics|mesh-ancestor
154181973|NCT06179485|Etomidate|etomidate|mesh-list
154181974|NCT06179485|Analgesics|analgesics|mesh-ancestor
154181975|NCT06179485|Sensory System Agents|sensory system agents|mesh-ancestor
154181976|NCT06179485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181977|NCT06179485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181978|NCT06179485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154181979|NCT06179485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154181980|NCT06179485|Anesthetics, General|anesthetics, general|mesh-ancestor
154181981|NCT06179485|Anesthetics|anesthetics|mesh-ancestor
154181982|NCT06179485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181983|NCT06179485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154181984|NCT06179485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154181985|NCT06179485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181986|NCT06179485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181987|NCT06179485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154181988|NCT06175494|Vaccines|vaccines|mesh-list
154181989|NCT06175494|Immunologic Factors|immunologic factors|mesh-ancestor
154181990|NCT06175494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181991|NCT06173219|Immunomodulating Agents|immunomodulating agents|mesh-list
154181992|NCT06173219|Immunologic Factors|immunologic factors|mesh-ancestor
154181993|NCT06173219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181994|NCT06169280|Acetylcysteine|acetylcysteine|mesh-list
154181995|NCT06169280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154181996|NCT06169280|Antiviral Agents|antiviral agents|mesh-ancestor
154181997|NCT06169280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181998|NCT06169280|Expectorants|expectorants|mesh-ancestor
154181999|NCT06169280|Respiratory System Agents|respiratory system agents|mesh-ancestor
154182000|NCT06169280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154182001|NCT06169280|Antioxidants|antioxidants|mesh-ancestor
154182002|NCT06169280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182003|NCT06169280|Protective Agents|protective agents|mesh-ancestor
154182004|NCT06169280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929007|NCT00667303|Antibodies|antibodies|mesh-list
154182015|NCT06158841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182016|NCT06158841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182017|NCT06158841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182018|NCT06158841|Glucocorticoids|glucocorticoids|mesh-ancestor
154182019|NCT06158841|Hormones|hormones|mesh-ancestor
154182020|NCT06158841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182021|NCT06158841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154182022|NCT06158841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182023|NCT06158841|Immunologic Factors|immunologic factors|mesh-ancestor
154182024|NCT06158841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182025|NCT06158841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182026|NCT06158841|Growth Substances|growth substances|mesh-ancestor
154182027|NCT06158841|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182037|NCT06131593|Dexamethasone|dexamethasone|mesh-list
154182038|NCT06131593|Methylprednisolone|methylprednisolone|mesh-list
154182039|NCT06131593|Anesthetics|anesthetics|mesh-list
154182040|NCT06131593|Anesthetics, Local|anesthetics, local|mesh-list
154182041|NCT06131593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182042|NCT06131593|Antiemetics|antiemetics|mesh-ancestor
154182043|NCT06131593|Autonomic Agents|autonomic agents|mesh-ancestor
154182044|NCT06131593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182045|NCT06131593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182046|NCT06131593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182047|NCT06131593|Glucocorticoids|glucocorticoids|mesh-ancestor
154182048|NCT06131593|Hormones|hormones|mesh-ancestor
153604811|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
154182060|NCT06107738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182062|NCT06095973|Anesthetics, Local|anesthetics, local|mesh-ancestor
154182063|NCT06095973|Anesthetics|anesthetics|mesh-ancestor
154182064|NCT06095973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154182065|NCT06095973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182066|NCT06095973|Sensory System Agents|sensory system agents|mesh-ancestor
154182067|NCT06095973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182068|NCT06083571|Diphenhydramine|diphenhydramine|mesh-list
154182069|NCT06083571|Promethazine|promethazine|mesh-list
154182070|NCT06083571|Ketorolac|ketorolac|mesh-list
154182071|NCT06083571|Prochlorperazine|prochlorperazine|mesh-list
154182072|NCT06083571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154182073|NCT06083571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154182074|NCT06083571|Analgesics|analgesics|mesh-ancestor
154182075|NCT06083571|Sensory System Agents|sensory system agents|mesh-ancestor
154182076|NCT06083571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182077|NCT06083571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182078|NCT06083571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182079|NCT06083571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154182080|NCT06083571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154182081|NCT06083571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182082|NCT06083571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182083|NCT06083571|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154182084|NCT06083571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154182085|NCT06083571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154182086|NCT06083571|Anesthetics, Local|anesthetics, local|mesh-ancestor
154182087|NCT06083571|Anesthetics|anesthetics|mesh-ancestor
154182088|NCT06083571|Antiemetics|antiemetics|mesh-ancestor
154182089|NCT06083571|Autonomic Agents|autonomic agents|mesh-ancestor
154182090|NCT06083571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182091|NCT06083571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154182092|NCT06083571|Histamine Antagonists|histamine antagonists|mesh-ancestor
154182093|NCT06083571|Histamine Agents|histamine agents|mesh-ancestor
154182094|NCT06083571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182095|NCT06083571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154182096|NCT06083571|Antipruritics|antipruritics|mesh-ancestor
154182097|NCT06083571|Dermatologic Agents|dermatologic agents|mesh-ancestor
154182098|NCT06083571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154182099|NCT06083571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154182100|NCT06083571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154182101|NCT06083571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154182102|NCT06083571|Dopamine Agents|dopamine agents|mesh-ancestor
154182103|NCT06061536|Lamivudine|lamivudine|mesh-list
154182104|NCT06061536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154182105|NCT06061536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154182106|NCT06061536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182107|NCT06061536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182108|NCT06061536|Antiviral Agents|antiviral agents|mesh-ancestor
154182109|NCT06061536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182110|NCT06061536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154182111|NCT06061536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154182134|NCT06017297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182135|NCT05976230|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154182136|NCT05976230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154182137|NCT05976230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182138|NCT05968326|Atezolizumab|atezolizumab|mesh-list
154166606|NCT00798395|Zopiclone|zopiclone|mesh-list
154182139|NCT05968326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182140|NCT05968326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182141|NCT05968326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182142|NCT05968326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182143|NCT05966584|Fulvestrant|fulvestrant|mesh-list
154182144|NCT05966584|Benralizumab|benralizumab|mesh-list
154182145|NCT05966584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154182146|NCT05966584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182147|NCT05966584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154182148|NCT05966584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154182149|NCT05966584|Hormone Antagonists|hormone antagonists|mesh-ancestor
154182150|NCT05966584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182151|NCT05966584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182152|NCT05966584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154182153|NCT05966584|Respiratory System Agents|respiratory system agents|mesh-ancestor
154182154|NCT05904886|Bevacizumab|bevacizumab|mesh-list
154182155|NCT05904886|Atezolizumab|atezolizumab|mesh-list
154182156|NCT05904886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489358|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
154182157|NCT05904886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182158|NCT05904886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182159|NCT05904886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182160|NCT05904886|Growth Substances|growth substances|mesh-ancestor
154182161|NCT05904886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182162|NCT05904886|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182163|NCT05904886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263566|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
154263567|NCT05198934|Trifluridine|trifluridine|mesh-list
154263568|NCT05198934|Panitumumab|panitumumab|mesh-list
154263569|NCT05198934|Sotorasib|sotorasib|mesh-list
154263570|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263571|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263572|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
154263573|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263574|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
154263575|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263576|NCT05198934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263577|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
154263578|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
154263579|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263580|NCT05171777|Atezolizumab|atezolizumab|mesh-list
154263581|NCT05171777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263582|NCT05171777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263583|NCT05171777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263584|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263585|NCT05170464|Caffeine|caffeine|mesh-list
154263586|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154263587|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263588|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154263589|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263590|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263591|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154263592|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154263593|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
154263594|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263595|NCT05147662|Factor VIII|factor viii|mesh-list
154263596|NCT05147662|Coagulants|coagulants|mesh-ancestor
154263597|NCT05131646|Axitinib|axitinib|mesh-list
154263598|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263599|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154263600|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263601|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263602|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
154263603|NCT05119140|Mesalamine|mesalamine|mesh-list
154263604|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
154263605|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154263606|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154263607|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263608|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263609|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263610|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263611|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154263612|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154861054|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263613|NCT05119140|Analgesics|analgesics|mesh-ancestor
154263614|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
154263615|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263616|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263617|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154263618|NCT05116202|Nivolumab|nivolumab|mesh-list
154263619|NCT05116202|Ipilimumab|ipilimumab|mesh-list
154263620|NCT05116202|Atezolizumab|atezolizumab|mesh-list
154182179|NCT05888532|Micronutrients|micronutrients|mesh-ancestor
154263641|NCT05112965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263642|NCT05112965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154263643|NCT05112965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154263644|NCT05112965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263645|NCT05101018|Denosumab|denosumab|mesh-list
154263646|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154263647|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263648|NCT05062044|Folic Acid|folic acid|mesh-list
154263649|NCT05062044|Hematinics|hematinics|mesh-ancestor
154263650|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
154263651|NCT05062044|Vitamins|vitamins|mesh-ancestor
154263652|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
154263653|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263654|NCT05058755|Etoposide|etoposide|mesh-list
154263655|NCT05058755|Lenalidomide|lenalidomide|mesh-list
154263656|NCT05058755|Azacitidine|azacitidine|mesh-list
154263657|NCT05058755|Tislelizumab|tislelizumab|mesh-list
154263658|NCT05058755|Pegaspargase|pegaspargase|mesh-list
154263659|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154263660|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263661|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154263662|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154263663|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263664|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263665|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
154263666|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263667|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154263668|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263669|NCT05058755|Growth Substances|growth substances|mesh-ancestor
154263670|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263671|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263672|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
154263673|NCT05058755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263675|NCT05047250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263690|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
154263691|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154263692|NCT05009342|Calpastatin|calpastatin|mesh-list
154263693|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154263694|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
154263695|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263696|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263697|NCT04929223|Bevacizumab|bevacizumab|mesh-list
154263699|NCT04929223|Atezolizumab|atezolizumab|mesh-list
154263700|NCT04929223|Inavolisib|inavolisib|mesh-list
154263701|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263702|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263703|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154263704|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263705|NCT04929223|Growth Substances|growth substances|mesh-ancestor
154263706|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263707|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263708|NCT04929223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263709|NCT04929223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263710|NCT04929223|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154263711|NCT04929223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263712|NCT04895358|Paclitaxel|paclitaxel|mesh-list
154263713|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154263714|NCT04895358|Doxorubicin|doxorubicin|mesh-list
154263715|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154263716|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
154263717|NCT04895358|Capecitabine|capecitabine|mesh-list
154263718|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154263719|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263720|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
154263721|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
154263722|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
154263723|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263724|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154263725|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154263726|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154263727|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263728|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263729|NCT04895358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263730|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263731|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
154263732|NCT04867343|Fentanyl|fentanyl|mesh-list
154263733|NCT04867343|Remifentanil|remifentanil|mesh-list
154263734|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154263735|NCT04867343|Narcotics|narcotics|mesh-ancestor
153605131|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
154263748|NCT04865289|Lenvatinib|lenvatinib|mesh-list
154263749|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154263750|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263751|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
154263752|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
154263753|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
154263754|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263755|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263756|NCT04865289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263757|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154263758|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263759|NCT04858854|Sulforaphane|sulforaphane|mesh-list
154263760|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154263761|NCT04858854|Protective Agents|protective agents|mesh-ancestor
154263762|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263763|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263764|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154263765|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
154263766|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263767|NCT04829760|Psyllium|psyllium|mesh-list
154263768|NCT04829760|Cathartics|cathartics|mesh-ancestor
154263769|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263770|NCT04795336|Melatonin|melatonin|mesh-list
154263771|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
154263772|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263773|NCT04795336|Protective Agents|protective agents|mesh-ancestor
154263774|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489540|NCT03937986|Cocaine|cocaine|mesh-list
154263775|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154263776|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154263777|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154263778|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
154263779|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263780|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154263781|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263782|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154263783|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263784|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
154263785|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263786|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263787|NCT04752826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263788|NCT04752826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263789|NCT04732910|Ivacaftor|ivacaftor|mesh-list
154263790|NCT04732910|Elexacaftor|elexacaftor|mesh-list
154263791|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154263792|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154263793|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263794|NCT04680052|Rituximab|rituximab|mesh-list
154263795|NCT04680052|Lenalidomide|lenalidomide|mesh-list
154263796|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263797|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263798|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
154263803|NCT04680052|Growth Substances|growth substances|mesh-ancestor
154263804|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263806|NCT04622007|Pemetrexed|pemetrexed|mesh-list
154263807|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263808|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263809|NCT04622007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263810|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263811|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263812|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154263813|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154255121|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154263814|NCT04613492|Durvalumab|durvalumab|mesh-list
154263815|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263816|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263817|NCT04603183|Paclitaxel|paclitaxel|mesh-list
154263818|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154263819|NCT04603183|Letrozole|letrozole|mesh-list
154263820|NCT04603183|Fulvestrant|fulvestrant|mesh-list
154263821|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154263822|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263823|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
154263824|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
154263825|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
154263826|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263827|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154263828|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154263829|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263830|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154263831|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
154263832|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263833|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263834|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154263835|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154263836|NCT04587778|Ketamine|ketamine|mesh-list
154263837|NCT04587778|Esketamine|esketamine|mesh-list
154263838|NCT04587778|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154263839|NCT04587778|Analgesics|analgesics|mesh-ancestor
154263840|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
154263841|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263842|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263843|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154263844|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154263845|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
154263846|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
154263847|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154263848|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154263849|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154263850|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263851|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263852|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
154263853|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154263854|NCT04545736|Metformin|metformin|mesh-list
154263855|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154263856|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263857|NCT04539548|Prednisolone|prednisolone|mesh-list
154263858|NCT04539548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154263859|NCT04539548|Methylprednisolone|methylprednisolone|mesh-list
154263860|NCT04539548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154263861|NCT04539548|Prednisolone acetate|prednisolone acetate|mesh-list
154263862|NCT04539548|Dexamethasone|dexamethasone|mesh-list
154263863|NCT04539548|Dexamethasone acetate|dexamethasone acetate|mesh-list
154263864|NCT04539548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154263865|NCT04539548|Prednisolone phosphate|prednisolone phosphate|mesh-list
154263866|NCT04539548|BB 1101|bb 1101|mesh-list
154263867|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154263868|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
154263869|NCT04539548|Hormones|hormones|mesh-ancestor
154263903|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263904|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263905|NCT04501614|Ponatinib|ponatinib|mesh-list
154263906|NCT04501614|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154263907|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154263926|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154263927|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154263928|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154263930|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154263931|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154263932|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263933|NCT04464980|Naltrexone|naltrexone|mesh-list
154263934|NCT04464980|Buprenorphine|buprenorphine|mesh-list
154263935|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154263936|NCT04464980|Narcotics|narcotics|mesh-ancestor
154263937|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154263938|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263939|NCT04464980|Analgesics|analgesics|mesh-ancestor
154861055|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
154255122|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154255123|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154263940|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
154263941|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263942|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154263943|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154263944|NCT04456699|Leucovorin|leucovorin|mesh-list
154263945|NCT04456699|Bevacizumab|bevacizumab|mesh-list
154263946|NCT04456699|Capecitabine|capecitabine|mesh-list
154263947|NCT04456699|Fluorouracil|fluorouracil|mesh-list
154263948|NCT04456699|Olaparib|olaparib|mesh-list
154263949|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
154263950|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263951|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263952|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154263953|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263954|NCT04456699|Growth Substances|growth substances|mesh-ancestor
154263955|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263956|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263957|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263958|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
154263959|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263960|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154010884|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
154263961|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
154263962|NCT04456699|Antidotes|antidotes|mesh-ancestor
154263963|NCT04456699|Protective Agents|protective agents|mesh-ancestor
154264002|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154264061|NCT04205786|Hematinics|hematinics|mesh-ancestor
154264062|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154264063|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264064|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264065|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154264066|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
154264067|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264068|NCT04181333|Trastuzumab|trastuzumab|mesh-list
154264069|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264070|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264071|NCT04175834|Diphenhydramine|diphenhydramine|mesh-list
154264072|NCT04175834|Promethazine|promethazine|mesh-list
154264073|NCT04175834|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154264074|NCT04175834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154264075|NCT04175834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154264076|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264077|NCT04175834|Anesthetics, Local|anesthetics, local|mesh-ancestor
154264078|NCT04175834|Anesthetics|anesthetics|mesh-ancestor
154264079|NCT04175834|Sensory System Agents|sensory system agents|mesh-ancestor
154264080|NCT04175834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264081|NCT04175834|Antiemetics|antiemetics|mesh-ancestor
154264082|NCT04175834|Autonomic Agents|autonomic agents|mesh-ancestor
154264083|NCT04175834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154264084|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154264085|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-ancestor
154264086|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
154264094|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264095|NCT04152863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264096|NCT04152863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264097|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
154264098|NCT04145349|Vinorelbine|vinorelbine|mesh-list
154264099|NCT04145349|Ramucirumab|ramucirumab|mesh-list
154264100|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264101|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
154264102|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264103|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154264104|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154264105|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
154264106|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264107|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264108|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154264109|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154264110|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
154264111|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
154264112|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
154264113|NCT04145349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154861056|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861057|NCT01075399|Imidazole|imidazole|mesh-list
154264114|NCT04145349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154264115|NCT04145349|Growth Substances|growth substances|mesh-ancestor
154264116|NCT04145349|Growth Inhibitors|growth inhibitors|mesh-ancestor
154264118|NCT04134325|Nivolumab|nivolumab|mesh-list
154264119|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264120|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264121|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264122|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264123|NCT04098666|Metformin|metformin|mesh-list
154264124|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154264125|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264126|NCT04084496|Folfirinox|folfirinox|mesh-list
154264127|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264128|NCT04075526|Vancomycin|vancomycin|mesh-list
154264129|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
154264130|NCT04075526|Povidone|povidone|mesh-list
154264131|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154264132|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264133|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
154264134|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
154264135|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154264136|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
154264137|NCT04046094|Vitamins|vitamins|mesh-ancestor
154264138|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
154264139|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264140|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
154264141|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264142|NCT04046094|Protective Agents|protective agents|mesh-ancestor
154264143|NCT04036188|Vitamin D|vitamin d|mesh-list
154264144|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
154264145|NCT04036188|Triamcinolone|triamcinolone|mesh-list
154264146|NCT04036188|Vitamins|vitamins|mesh-ancestor
154264147|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
154264148|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264149|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154264150|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154264151|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264152|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
154264153|NCT04036188|Hormones|hormones|mesh-ancestor
154264154|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264155|NCT04031027|Apremilast|apremilast|mesh-list
154264164|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154264165|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154264166|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264167|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011102|NCT04260269|Fluorouracil|fluorouracil|mesh-list
154264189|NCT04025879|Paclitaxel|paclitaxel|mesh-list
154264190|NCT04025879|Docetaxel|docetaxel|mesh-list
154264191|NCT04025879|Carboplatin|carboplatin|mesh-list
154264192|NCT04025879|Nivolumab|nivolumab|mesh-list
154264193|NCT04025879|Pemetrexed|pemetrexed|mesh-list
154264194|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154264195|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264196|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
154264197|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
154264198|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
154264199|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264200|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264201|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264202|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264203|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154264204|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154264205|NCT03981523|Benzonidazole|benzonidazole|mesh-list
154264206|NCT03981523|Nifurtimox|nifurtimox|mesh-list
154264207|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264208|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
154264209|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264210|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154264211|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154264212|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154264213|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264214|NCT03969212|Baloxavir|baloxavir|mesh-list
154264215|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
154264216|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264217|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264218|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264219|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154255124|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264220|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154264221|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605609|NCT01933945|Sorafenib|sorafenib|mesh-list
154264242|NCT03878524|Vitamins|vitamins|mesh-list
154264243|NCT03878524|Leucovorin|leucovorin|mesh-list
154264244|NCT03878524|Vitamin A|vitamin a|mesh-list
154264245|NCT03878524|Sirolimus|sirolimus|mesh-list
154264246|NCT03878524|Celecoxib|celecoxib|mesh-list
154264247|NCT03878524|Paclitaxel|paclitaxel|mesh-list
154264248|NCT03878524|Maytansine|maytansine|mesh-list
154264249|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154264250|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154264251|NCT03878524|Bevacizumab|bevacizumab|mesh-list
154264252|NCT03878524|Carboplatin|carboplatin|mesh-list
154264253|NCT03878524|Doxorubicin|doxorubicin|mesh-list
154264254|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154264255|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
154264256|NCT03878524|Capecitabine|capecitabine|mesh-list
154264257|NCT03878524|Fluorouracil|fluorouracil|mesh-list
154264258|NCT03878524|Nivolumab|nivolumab|mesh-list
154264259|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
154264260|NCT03878524|Trastuzumab|trastuzumab|mesh-list
154264261|NCT03878524|Everolimus|everolimus|mesh-list
154264262|NCT03878524|Bortezomib|bortezomib|mesh-list
154264263|NCT03878524|Ipilimumab|ipilimumab|mesh-list
154264264|NCT03878524|Sorafenib|sorafenib|mesh-list
154264265|NCT03878524|Temsirolimus|temsirolimus|mesh-list
154264266|NCT03878524|Durvalumab|durvalumab|mesh-list
154264267|NCT03878524|Sunitinib|sunitinib|mesh-list
154264268|NCT03878524|Daunorubicin|daunorubicin|mesh-list
154264269|NCT03878524|Venetoclax|venetoclax|mesh-list
154264270|NCT03878524|Lenvatinib|lenvatinib|mesh-list
154264271|NCT03878524|Dasatinib|dasatinib|mesh-list
154264272|NCT03878524|Olaparib|olaparib|mesh-list
154264273|NCT03878524|Palbociclib|palbociclib|mesh-list
154264275|NCT03878524|Vorinostat|vorinostat|mesh-list
154264276|NCT03878524|Trametinib|trametinib|mesh-list
154264277|NCT03878524|Tretinoin|tretinoin|mesh-list
154264278|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
154264279|NCT03878524|Bicalutamide|bicalutamide|mesh-list
154264280|NCT03878524|Afatinib|afatinib|mesh-list
154264281|NCT03878524|Dabrafenib|dabrafenib|mesh-list
154264282|NCT03878524|Vemurafenib|vemurafenib|mesh-list
154264283|NCT03878524|Panobinostat|panobinostat|mesh-list
154264284|NCT03878524|Ponatinib|ponatinib|mesh-list
154264285|NCT03878524|Idelalisib|idelalisib|mesh-list
154264286|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154264287|NCT03878524|MTOR Inhibitors|mtor inhibitors|mesh-list
154264288|NCT03878524|Losartan|losartan|mesh-list
154264289|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
154264300|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264301|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
154264302|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
154264303|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489870|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
154264304|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264305|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154264306|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154264307|NCT03878524|Growth Substances|growth substances|mesh-ancestor
154264308|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264309|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
154264311|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
154264312|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154264313|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154264314|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154264315|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264316|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264317|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154264318|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
154264319|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264320|NCT03878524|Antidotes|antidotes|mesh-ancestor
154264321|NCT03878524|Protective Agents|protective agents|mesh-ancestor
154264322|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
154264323|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264324|NCT03878524|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264325|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154264326|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264327|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
154264328|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154264329|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154264330|NCT03878524|Analgesics|analgesics|mesh-ancestor
154264331|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
154264332|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264333|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861058|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264334|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154264335|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154264336|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154264337|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154264338|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154264339|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154264340|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154264341|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154264342|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154264343|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
154264344|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
154264345|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
154264346|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154264347|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
154264348|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
154264349|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264350|NCT03878524|Immunotoxins|immunotoxins|mesh-ancestor
154264351|NCT03875378|Estrogens|estrogens|mesh-list
154264352|NCT03875378|Hormones|hormones|mesh-ancestor
154264353|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264354|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264355|NCT03869190|Gemcitabine|gemcitabine|mesh-list
154264370|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264371|NCT03863288|Oxytocin|oxytocin|mesh-list
154264372|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
154264373|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154264374|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264375|NCT03833154|Durvalumab|durvalumab|mesh-list
154264376|NCT03833154|Osimertinib|osimertinib|mesh-list
154264377|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264378|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264379|NCT03833154|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264380|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264381|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264382|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264383|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
154264384|NCT03820986|Lenvatinib|lenvatinib|mesh-list
154264385|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264386|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264387|NCT03820986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264388|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264389|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264390|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264391|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
154264392|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154264393|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
154264394|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264395|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264396|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154264397|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
154264398|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154264399|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
154264400|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264401|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154264402|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154264403|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
154264404|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
154264405|NCT03773991|Protective Agents|protective agents|mesh-ancestor
154264406|NCT03757910|Corticosterone|corticosterone|mesh-list
154264407|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264408|NCT03747042|Letrozole|letrozole|mesh-list
154264409|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264410|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154264411|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154264412|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264413|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264414|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154264415|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
154182180|NCT05888532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264424|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264425|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264426|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264427|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154264429|NCT03737981|Venetoclax|venetoclax|mesh-list
154264430|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
154264431|NCT03737981|Ibrutinib|ibrutinib|mesh-list
154264432|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264433|NCT03737981|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264434|NCT03737981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264435|NCT03737981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264436|NCT03737981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264437|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264438|NCT03710772|Cytarabine|cytarabine|mesh-list
154264439|NCT03710772|Dexamethasone|dexamethasone|mesh-list
154264440|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
154264441|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
154264442|NCT03710772|Rituximab|rituximab|mesh-list
154264443|NCT03710772|Doxorubicin|doxorubicin|mesh-list
154264444|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154264445|NCT03710772|Methotrexate|methotrexate|mesh-list
154264446|NCT03710772|Vincristine|vincristine|mesh-list
154264447|NCT03710772|Venetoclax|venetoclax|mesh-list
154264448|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154264449|NCT03710772|Antibodies|antibodies|mesh-list
154264450|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
154264451|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154264452|NCT03710772|BB 1101|bb 1101|mesh-list
154264453|NCT03710772|Ibrutinib|ibrutinib|mesh-list
154264454|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264455|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
154264456|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264457|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154264458|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154264459|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
154264460|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264461|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264462|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154264463|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264464|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
154264465|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
154264466|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264467|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154264468|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
154264469|NCT03710772|Hormones|hormones|mesh-ancestor
154264470|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264471|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154264472|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
154264473|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264474|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154264475|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154264476|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154264477|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154264478|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
154264479|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154264480|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154264481|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
154264482|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
154264483|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154264503|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264504|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154264505|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154264506|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264507|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264508|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154264509|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
154264510|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264511|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264512|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154264513|NCT03478514|Palbociclib|palbociclib|mesh-list
154264514|NCT03478514|Ibrutinib|ibrutinib|mesh-list
154264515|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264516|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264517|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264518|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264519|NCT03478514|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264520|NCT03434730|Cyclosporine|cyclosporine|mesh-list
154264521|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
154264522|NCT03434730|Lenograstim|lenograstim|mesh-list
154264523|NCT03434730|Cyclosporins|cyclosporins|mesh-list
154264524|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154264525|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
154264526|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264527|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264528|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264529|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264530|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
154264531|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264532|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
154264533|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154264534|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154264535|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154264536|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264537|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154264538|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
154264544|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264545|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264546|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154264547|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154264548|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
154264549|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154264551|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
154264552|NCT03399539|Venetoclax|venetoclax|mesh-list
154264553|NCT03399539|Ixazomib|ixazomib|mesh-list
154264554|NCT03399539|Ichthammol|ichthammol|mesh-list
154264555|NCT03399539|BB 1101|bb 1101|mesh-list
154264556|NCT03399539|Glycine|glycine|mesh-list
154264557|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264558|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
154264559|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
154264560|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264561|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264562|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154264563|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
154264564|NCT03399539|Hormones|hormones|mesh-ancestor
154264565|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264566|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154264567|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264568|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264569|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
154264570|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264571|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
154264572|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
154264573|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154264574|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154264575|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
154264576|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264577|NCT03377361|Nivolumab|nivolumab|mesh-list
154264578|NCT03377361|Ipilimumab|ipilimumab|mesh-list
154264580|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264581|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264582|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264583|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264584|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264585|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264586|NCT03360721|Prednisone|prednisone|mesh-list
154264587|NCT03360721|Cortisone|cortisone|mesh-list
154264588|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
154264589|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264590|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
154264591|NCT03360721|Hormones|hormones|mesh-ancestor
154264592|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264593|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264594|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154264595|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264596|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154264597|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264598|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264599|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
154264600|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154264601|NCT03330847|Olaparib|olaparib|mesh-list
154264603|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154264604|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264605|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264606|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264607|NCT03319537|Pemetrexed|pemetrexed|mesh-list
154264608|NCT03319537|Pevonedistat|pevonedistat|mesh-list
154182181|NCT05868525|Aspirin|aspirin|mesh-list
154264624|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
154264625|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264626|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264627|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154264628|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
154264629|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154264630|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154264631|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
154264632|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264633|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
154264634|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264635|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154264636|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264637|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154264638|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154264639|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
154264640|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264641|NCT03263572|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264642|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264643|NCT03195478|Nivolumab|nivolumab|mesh-list
154264644|NCT03195478|Ipilimumab|ipilimumab|mesh-list
154264645|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264646|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264647|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264648|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264649|NCT03155061|Nivolumab|nivolumab|mesh-list
154264650|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264651|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264652|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264653|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264654|NCT03078010|Tazobactam|tazobactam|mesh-list
154264655|NCT03078010|Piperacillin|piperacillin|mesh-list
154264656|NCT03078010|Cefepime|cefepime|mesh-list
154264657|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154264658|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154264659|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264660|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154264661|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264662|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264663|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
154264664|NCT03070327|Lenalidomide|lenalidomide|mesh-list
154264665|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264666|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
154264667|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264668|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606055|NCT01936090|Bortezomib|bortezomib|mesh-list
154264682|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
154264683|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154264684|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264685|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154264686|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154264687|NCT03069326|Growth Substances|growth substances|mesh-ancestor
154264688|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
154264689|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264690|NCT03008408|Everolimus|everolimus|mesh-list
154264691|NCT03008408|Letrozole|letrozole|mesh-list
154264692|NCT03008408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154264693|NCT03008408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264694|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264695|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264696|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264697|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
154264698|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264699|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264700|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154264701|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154264702|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154264703|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
154264704|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264705|NCT02997501|Osimertinib|osimertinib|mesh-list
154264706|NCT02997501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153490226|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
154264707|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264708|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264709|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264710|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264711|NCT02992015|Gemcitabine|gemcitabine|mesh-list
154264712|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154264713|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
154264714|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264715|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264716|NCT02983578|Durvalumab|durvalumab|mesh-list
154264717|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
154264718|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154264719|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
154264720|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264721|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264722|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
154264723|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264724|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
154264725|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154264726|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264727|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154264728|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264747|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154264748|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154264749|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154264750|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154264751|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
154264752|NCT02697383|Dexamethasone|dexamethasone|mesh-list
154264753|NCT02697383|Ixazomib|ixazomib|mesh-list
154264754|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264755|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
154264756|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
154264757|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264758|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264759|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154264760|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
154264761|NCT02697383|Hormones|hormones|mesh-ancestor
154264762|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264763|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153490282|NCT02572752|Nintedanib|nintedanib|mesh-list
154264764|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264765|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
154264766|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264767|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264768|NCT02687906|Meropenem|meropenem|mesh-list
154264769|NCT02687906|Vaborbactam|vaborbactam|mesh-list
154264770|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
154264771|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154264772|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264773|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264774|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264775|NCT02570672|Metformin|metformin|mesh-list
154264776|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154264777|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264778|NCT02540330|Fulvestrant|fulvestrant|mesh-list
154264779|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154264780|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264781|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154264782|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154264783|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
154264784|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606174|NCT06070753|Nootropic Agents|nootropic agents|mesh-ancestor
154264796|NCT02475681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264797|NCT02475681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264798|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264799|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154264800|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
154264801|NCT02473497|Crizotinib|crizotinib|mesh-list
154264802|NCT02473497|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264803|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264804|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264805|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264806|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264807|NCT02441686|Dexamethasone|dexamethasone|mesh-list
154264808|NCT02441686|Lenalidomide|lenalidomide|mesh-list
154264809|NCT02441686|Bortezomib|bortezomib|mesh-list
154264810|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264811|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
154264812|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
154264813|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264814|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264815|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154264816|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
154264817|NCT02441686|Hormones|hormones|mesh-ancestor
154264818|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264819|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154264820|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264821|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
154264822|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154264823|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154264824|NCT02441686|Growth Substances|growth substances|mesh-ancestor
154264825|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
154264826|NCT02428205|Propranolol|propranolol|mesh-list
154264827|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154264828|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154264829|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
154264830|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154264831|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264832|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264833|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154264834|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154264835|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
154264836|NCT02415712|Fomepizole|fomepizole|mesh-list
154264837|NCT02415712|Antidotes|antidotes|mesh-ancestor
154264838|NCT02415712|Protective Agents|protective agents|mesh-ancestor
154264839|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264840|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264841|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264842|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
154264843|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154264844|NCT02308982|Antibodies|antibodies|mesh-list
154264845|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
154264846|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154264847|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
154264848|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264849|NCT02187354|Blinatumomab|blinatumomab|mesh-list
154264866|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264867|NCT02102789|Leucovorin|leucovorin|mesh-list
154264868|NCT02102789|Dexamethasone|dexamethasone|mesh-list
154264869|NCT02102789|Fluorouracil|fluorouracil|mesh-list
154264870|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
154264871|NCT02102789|Floxuridine|floxuridine|mesh-list
154264872|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264873|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
154264874|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
154011780|NCT04352205|Growth Substances|growth substances|mesh-ancestor
154264875|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264876|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264877|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154264878|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
154264879|NCT02102789|Hormones|hormones|mesh-ancestor
154264880|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264881|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154264882|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264883|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264884|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
154264885|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154264886|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264887|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
154264888|NCT02102789|Antidotes|antidotes|mesh-ancestor
154264889|NCT02102789|Protective Agents|protective agents|mesh-ancestor
154264890|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
154264891|NCT02102789|Vitamins|vitamins|mesh-ancestor
154264892|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
154264893|NCT01149850|Bevacizumab|bevacizumab|mesh-list
154255125|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154264894|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154264895|NCT01149850|Temozolomide|temozolomide|mesh-list
154264896|NCT01149850|Antibodies|antibodies|mesh-list
154264897|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
154264898|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154264899|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264900|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154264901|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154264902|NCT01149850|Growth Substances|growth substances|mesh-ancestor
154264903|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264904|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
154264905|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
154264906|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154264907|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
154264908|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264921|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264922|NCT01120184|Immunotoxins|immunotoxins|mesh-ancestor
154264923|NCT01120184|Immunoconjugates|immunoconjugates|mesh-ancestor
153490377|NCT03907176|Acetaminophen|acetaminophen|mesh-list
154264924|NCT01120184|Immunologic Factors|immunologic factors|mesh-ancestor
154264925|NCT01120184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264926|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154264927|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
154264928|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264929|NCT00567580|Leuprolide|leuprolide|mesh-list
154264930|NCT00567580|Goserelin|goserelin|mesh-list
154264931|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154264932|NCT00567580|Flutamide|flutamide|mesh-list
154264933|NCT00567580|Bicalutamide|bicalutamide|mesh-list
154264934|NCT00567580|Buserelin|buserelin|mesh-list
154264935|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154264936|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
154264937|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154264938|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264939|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154264940|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264941|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
154264942|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
154264943|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264944|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
154264945|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154264946|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
154264947|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154264948|NCT00407654|Aflibercept|aflibercept|mesh-list
154264949|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
154264950|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154264951|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154264952|NCT00407654|Growth Substances|growth substances|mesh-ancestor
154264953|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264954|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
154264955|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264956|NCT00020475|Interleukin-2|interleukin-2|mesh-list
154264958|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264959|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154264960|NCT00020475|Analgesics|analgesics|mesh-ancestor
154264961|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
154264962|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264963|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264964|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154264965|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
154264966|NCT00020371|Lenograstim|lenograstim|mesh-list
154264967|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154264968|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
154264969|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264970|NCT00020267|Interleukin-2|interleukin-2|mesh-list
154264971|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154264972|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264973|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154264974|NCT00020267|Analgesics|analgesics|mesh-ancestor
154264975|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
153606371|NCT05824767|Angiotensin II|angiotensin ii|mesh-list
154264986|NCT00019890|Sargramostim|sargramostim|mesh-list
154264987|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
154264988|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264989|NCT00019695|Alendronate|alendronate|mesh-list
154264990|NCT00019695|Ketoconazole|ketoconazole|mesh-list
154861059|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255126|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
154264991|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
154264992|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264993|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154264994|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154264995|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264996|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264997|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154264998|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
154264999|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265000|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265001|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154265002|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154265003|NCT00019630|Doxorubicin|doxorubicin|mesh-list
154265004|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154265005|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154265006|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265007|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154265008|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154265009|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265010|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265011|NCT00019539|Thalidomide|thalidomide|mesh-list
154265012|NCT00019539|Bevacizumab|bevacizumab|mesh-list
154265013|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154265014|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265015|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265016|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265017|NCT00019539|Growth Substances|growth substances|mesh-ancestor
154265018|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265019|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265020|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265021|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
154265022|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
154265023|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154265024|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265025|NCT00019448|Interleukin-2|interleukin-2|mesh-list
154265026|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265027|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154265028|NCT00019448|Analgesics|analgesics|mesh-ancestor
154265029|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
154265030|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265032|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154265033|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
154265034|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154265035|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
154265036|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265037|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154265038|NCT00019396|Protective Agents|protective agents|mesh-ancestor
154265039|NCT00019188|Interleukin-12|interleukin-12|mesh-list
154265050|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154265051|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154265052|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
154265053|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265054|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265055|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154265056|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265057|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
154265058|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265059|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154265060|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
154265061|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154265062|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
154265063|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265064|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
154265065|NCT00003552|Fludarabine|fludarabine|mesh-list
154265066|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154265067|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265068|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
154265069|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265070|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154265071|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154265072|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
154861060|NCT03358576|Amoxicillin|amoxicillin|mesh-list
154861061|NCT03358576|Metronidazole|metronidazole|mesh-list
154255127|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
154265073|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265074|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265075|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154265076|NCT00274469|Fulvestrant|fulvestrant|mesh-list
154265077|NCT00274469|Anastrozole|anastrozole|mesh-list
154265078|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154265079|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265080|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154265081|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154265082|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
154265083|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265084|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265085|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154265086|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154265087|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265088|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265089|NCT01556776|Lenalidomide|lenalidomide|mesh-list
154265090|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
154265091|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265092|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265093|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265094|NCT01556776|Growth Substances|growth substances|mesh-ancestor
154265095|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265096|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265097|NCT01314976|Metronidazole|metronidazole|mesh-list
154265098|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265099|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154265100|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154265101|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154265102|NCT04504942|Leronlimab|leronlimab|mesh-list
154265103|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154265104|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154265113|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154265114|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154265115|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265116|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265117|NCT00272987|Paclitaxel|paclitaxel|mesh-list
154265118|NCT00272987|Trastuzumab|trastuzumab|mesh-list
154265119|NCT00272987|Lapatinib|lapatinib|mesh-list
154265120|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154265121|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265122|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
154265123|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
154265124|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
154265125|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265126|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154265127|NCT00272987|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154265128|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154265129|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265130|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154265131|NCT01069757|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154265132|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154265133|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265134|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265135|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265136|NCT01070927|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154265137|NCT01070927|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154265138|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265139|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265140|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154265141|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265142|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154265143|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
154265144|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265145|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
154265146|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265147|NCT01730950|Bevacizumab|bevacizumab|mesh-list
154265148|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154265149|NCT01730950|Antibodies|antibodies|mesh-list
154265150|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
154861062|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
154255128|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
154255129|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
154265151|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154265152|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265153|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265154|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265155|NCT01730950|Growth Substances|growth substances|mesh-ancestor
154265156|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265157|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265158|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
154265159|NCT00271505|Bevacizumab|bevacizumab|mesh-list
154265160|NCT00271505|Carboplatin|carboplatin|mesh-list
154265161|NCT00271505|Docetaxel|docetaxel|mesh-list
154265162|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154265163|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265164|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153490629|NCT02960646|Tacrolimus|tacrolimus|mesh-list
154265165|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265166|NCT00271505|Growth Substances|growth substances|mesh-ancestor
154265167|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265168|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265169|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
154265199|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265200|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265201|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154265203|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265204|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154265205|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265206|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154265207|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
154265208|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154265209|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265210|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154265211|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
154265212|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153606628|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265225|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154265226|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265227|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265228|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154265229|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
154265230|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265231|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265232|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154265233|NCT00270413|Sunitinib|sunitinib|mesh-list
154265234|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265235|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265236|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265237|NCT00270413|Growth Substances|growth substances|mesh-ancestor
154265238|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265239|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265240|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154265241|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265242|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265243|NCT00270257|Buprenorphine|buprenorphine|mesh-list
154265244|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154265245|NCT00270257|Naloxone|naloxone|mesh-list
154265246|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154265247|NCT00270257|Narcotics|narcotics|mesh-ancestor
154265248|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154265249|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265250|NCT00270257|Analgesics|analgesics|mesh-ancestor
154265251|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
154012153|NCT02192359|Irinotecan|irinotecan|mesh-list
154265252|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265253|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154265255|NCT00269399|Rifaximin|rifaximin|mesh-list
154265256|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154265257|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265258|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154265259|NCT00269087|Fluticasone|fluticasone|mesh-list
154265260|NCT00269087|Xhance|xhance|mesh-list
154265261|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154265262|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861063|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
154861064|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
154265263|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154265264|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
154265265|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265266|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265267|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154265268|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
154265269|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
154265270|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154265271|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154265272|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154265273|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154265274|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
154265275|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154265276|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265291|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154265292|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154265293|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154265294|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154265295|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265296|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
154265297|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154265298|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265299|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154265300|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265301|NCT01071005|Leuprolide|leuprolide|mesh-list
154265302|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154265303|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
154265304|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154265305|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265306|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154265307|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265308|NCT03976037|Misoprostol|misoprostol|mesh-list
154265309|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154265310|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
154265311|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154265312|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265313|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154265314|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154265315|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
154265316|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
154265317|NCT00265889|Melphalan|melphalan|mesh-list
154265318|NCT00265889|Busulfan|busulfan|mesh-list
154265319|NCT00265889|Etoposide|etoposide|mesh-list
154265320|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265321|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
154265322|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265323|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154265324|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154265325|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
154265326|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265327|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265328|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154265329|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153490723|NCT02634684|Amphetamine|amphetamine|mesh-list
154265330|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154265331|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154265332|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265333|NCT01333696|Pemetrexed|pemetrexed|mesh-list
154265334|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265335|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265336|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606733|NCT04853004|Antibodies|antibodies|mesh-list
154265347|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154265348|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265349|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
154265350|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
154265351|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
154265352|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265353|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265354|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265355|NCT03206788|Losartan|losartan|mesh-list
154265356|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154265357|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154265358|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154265359|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154265360|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265361|NCT03205150|Licogliflozin|licogliflozin|mesh-list
154265362|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154265363|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265364|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265365|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265366|NCT04936984|Abaloparatide|abaloparatide|mesh-list
154265367|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
154265368|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154265369|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265370|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154265371|NCT02931838|Deucravacitinib|deucravacitinib|mesh-list
154265372|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154265373|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154265374|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265375|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265376|NCT03201562|Tropicamide|tropicamide|mesh-list
154265377|NCT03201562|Aceclidine|aceclidine|mesh-list
154265378|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
154265379|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
154265380|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265381|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265382|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154265383|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154265384|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
154265385|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154265386|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265387|NCT03201562|Miotics|miotics|mesh-ancestor
154265388|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154265389|NCT03200860|Empagliflozin|empagliflozin|mesh-list
154265390|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154265391|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265392|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265393|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265394|NCT01314508|Mecasermin|mecasermin|mesh-list
154265395|NCT01314508|Growth Substances|growth substances|mesh-ancestor
153490778|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
153490838|NCT02653560|Diuretics|diuretics|mesh-ancestor
154265396|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265397|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
154265398|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
154012306|NCT00060398|Hormones|hormones|mesh-ancestor
154265404|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
154265405|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265406|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
154265407|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265408|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154265409|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154265410|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
154265411|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265412|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265413|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154265414|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
154265415|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154265416|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265417|NCT03184558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154265418|NCT03184558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265419|NCT03180736|Dexamethasone|dexamethasone|mesh-list
154265420|NCT03180736|Daratumumab|daratumumab|mesh-list
154265421|NCT03180736|Pomalidomide|pomalidomide|mesh-list
154265422|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154265423|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
154265424|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
154265425|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265426|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265427|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154265428|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
154265429|NCT03180736|Hormones|hormones|mesh-ancestor
154265430|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265431|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154265432|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265433|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
154265434|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265435|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265436|NCT03180736|Growth Substances|growth substances|mesh-ancestor
154265437|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265438|NCT03178942|Permethrin|permethrin|mesh-list
154265439|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265440|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265441|NCT03175198|Dabigatran|dabigatran|mesh-list
154265442|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
154265443|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154265444|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
154265445|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265446|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265447|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
154265448|NCT03087448|Trametinib|trametinib|mesh-list
154265449|NCT03087448|Ceritinib|ceritinib|mesh-list
154265450|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265451|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154265452|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265453|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265454|NCT03087448|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154265455|NCT03175120|Insulin|insulin|mesh-list
154265456|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154265457|NCT03175120|Liraglutide|liraglutide|mesh-list
154265458|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
154265459|NCT03175120|Xultophy|xultophy|mesh-list
154265460|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265461|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265462|NCT03175120|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154265463|NCT03175120|Incretins|incretins|mesh-ancestor
154265464|NCT03175120|Hormones|hormones|mesh-ancestor
154265502|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154265503|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154265504|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
154265505|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
154265506|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265507|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265508|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154265509|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154265510|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154265511|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
154265512|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154265513|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265514|NCT01330810|Curcumin|curcumin|mesh-list
154265515|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154265516|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154265517|NCT01330810|Analgesics|analgesics|mesh-ancestor
154265518|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
154265519|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265520|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265521|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154265522|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154265523|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265524|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265525|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265526|NCT01331122|Droxidopa|droxidopa|mesh-list
154265527|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154265528|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154265529|NCT01320280|Afatinib|afatinib|mesh-list
154265530|NCT01320280|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154265531|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154265532|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265533|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265534|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265535|NCT01331434|Exemestane|exemestane|mesh-list
154265536|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265537|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154265538|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154265539|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265540|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265541|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154265542|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
154265543|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265544|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265545|NCT01331590|Dexamethasone|dexamethasone|mesh-list
154012456|NCT00004860|Vitamins|vitamins|mesh-ancestor
154265546|NCT01331590|Etoposide|etoposide|mesh-list
154255131|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
154255132|NCT03908528|Vitamins|vitamins|mesh-ancestor
154265547|NCT01331590|Ifosfamide|ifosfamide|mesh-list
154265548|NCT01331590|Lenograstim|lenograstim|mesh-list
154265549|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154265550|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
154265551|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
154265552|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265558|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154265559|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265560|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154265561|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154265562|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154265563|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265564|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265565|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154265566|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
154265567|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154265568|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
154265570|NCT01331902|Adenosine|adenosine|mesh-list
154265571|NCT01331902|Analgesics|analgesics|mesh-ancestor
154265572|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
154265573|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265574|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265575|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154265576|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
154265577|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154265578|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
154265579|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
154265580|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154265581|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265582|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154265583|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
154265584|NCT01331902|Vitamins|vitamins|mesh-ancestor
154265585|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
154265586|NCT01332370|Metformin|metformin|mesh-list
154265587|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154265588|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
154265589|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265590|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265591|NCT01332370|Incretins|incretins|mesh-ancestor
154265592|NCT01332370|Hormones|hormones|mesh-ancestor
154265593|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265594|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154265595|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
154265596|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265597|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265598|NCT01332448|Orlistat|orlistat|mesh-list
154265599|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265600|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265601|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154265602|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154265603|NCT04484428|Menthol|menthol|mesh-list
154265604|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
154265605|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
154265606|NCT01332604|Bevacizumab|bevacizumab|mesh-list
154265607|NCT01332604|Capecitabine|capecitabine|mesh-list
154265608|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154265609|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265610|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265611|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265612|NCT01332604|Growth Substances|growth substances|mesh-ancestor
154265613|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265614|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265615|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154265616|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
154265617|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265618|NCT01333150|Propranolol|propranolol|mesh-list
154265619|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154265620|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154265621|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
154265636|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154265637|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265638|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154861065|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154168159|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265639|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154265640|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265641|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
154265642|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154265643|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154265644|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154265645|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154265646|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
154265647|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265648|NCT02818582|Remdesivir|remdesivir|mesh-list
154265649|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
154265650|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265651|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
154265652|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265653|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154265654|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154265655|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265656|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265657|NCT01337440|Incretins|incretins|mesh-ancestor
154265658|NCT01337440|Hormones|hormones|mesh-ancestor
154265659|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491062|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265660|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154265661|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
154265662|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265663|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265664|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154265665|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154265666|NCT01337518|Androgens|androgens|mesh-list
154265667|NCT01337518|Hormones|hormones|mesh-ancestor
154265668|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265669|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265670|NCT05186194|Vitamin D|vitamin d|mesh-list
154265671|NCT05186194|Calcium|calcium|mesh-list
154265672|NCT05186194|Vitamins|vitamins|mesh-ancestor
154265673|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
154265674|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265675|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154265676|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154265677|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
154265678|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154265679|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154265680|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265681|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
154265682|NCT01338454|Coagulants|coagulants|mesh-ancestor
154265683|NCT02882152|Morphine|morphine|mesh-list
154265684|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154265685|NCT02882152|Narcotics|narcotics|mesh-ancestor
154265694|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154012608|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154265695|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154265696|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265697|NCT01338844|Inositol|inositol|mesh-list
154265698|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
154265699|NCT01338844|Vitamins|vitamins|mesh-ancestor
154265700|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
154265701|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265702|NCT01338922|Insulin|insulin|mesh-list
154265703|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265704|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265705|NCT01339312|Vaccines|vaccines|mesh-list
154265706|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
154265707|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265708|NCT01339468|Tacrolimus|tacrolimus|mesh-list
154265709|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265710|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
154265711|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265712|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154265713|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265714|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265715|NCT01339624|Ketorolac|ketorolac|mesh-list
154265716|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154265717|NCT01339624|Fentanyl|fentanyl|mesh-list
154265718|NCT01339624|Morphine|morphine|mesh-list
154265719|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154265720|NCT01339624|Narcotics|narcotics|mesh-ancestor
154861066|NCT03358576|Ertapenem|ertapenem|mesh-list
154168242|NCT06334172|Oxytocin|oxytocin|mesh-list
154168243|NCT06334172|Oxytocics|oxytocics|mesh-ancestor
154168244|NCT06334172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154168245|NCT06334172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168246|NCT06334094|Ozanimod|ozanimod|mesh-list
154168247|NCT06334094|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154168249|NCT06334094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265721|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154265722|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265723|NCT01339624|Analgesics|analgesics|mesh-ancestor
154265724|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
154265725|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265726|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154265727|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154265728|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
154265729|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
154265730|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154265731|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154265732|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154265733|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154265734|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154265735|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265736|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265737|NCT01340248|Carvedilol|carvedilol|mesh-list
154265738|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154265739|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154265740|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
154265741|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154265742|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265743|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265744|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154265745|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
154265746|NCT01340248|Protective Agents|protective agents|mesh-ancestor
154265747|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154265748|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154265749|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154265750|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
154265751|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154265752|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154265762|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154265763|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265764|NCT01340950|Tenofovir|tenofovir|mesh-list
154265765|NCT01340950|Lamivudine|lamivudine|mesh-list
154265766|NCT01340950|Zidovudine|zidovudine|mesh-list
154265767|NCT01340950|Efavirenz|efavirenz|mesh-list
154265768|NCT01340950|Nevirapine|nevirapine|mesh-list
154265769|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154265770|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
154265771|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265772|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154265773|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154265774|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265775|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265776|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154265777|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154265778|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
154265779|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154265780|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154265781|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154265782|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154265783|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154265784|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154265785|NCT01341106|Entecavir|entecavir|mesh-list
154265786|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
154265787|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265788|NCT01341184|Rifampin|rifampin|mesh-list
154265789|NCT01341184|Rifabutin|rifabutin|mesh-list
154861067|NCT03358576|Lactams|lactams|mesh-list
154861068|NCT03358576|Probenecid|probenecid|mesh-list
154861069|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861070|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861071|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154861072|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154861073|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154861074|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154255133|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
154265790|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154265791|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
154265792|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154265793|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265794|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
154265795|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154265796|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265797|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265798|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154265799|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154265800|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154265801|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154265802|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154265803|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154265804|NCT00285857|Lovastatin|lovastatin|mesh-list
154265805|NCT00285857|L 647318|l 647318|mesh-list
154265806|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
154265807|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154265808|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
154265809|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265810|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154265811|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154265812|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154265813|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265814|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
154265815|NCT01341262|Thalidomide|thalidomide|mesh-list
154265816|NCT01341262|Dexamethasone|dexamethasone|mesh-list
154265829|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
154265830|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
154265831|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265832|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154265833|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
154265834|NCT01341262|Hormones|hormones|mesh-ancestor
154265835|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265836|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154265837|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
154265838|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154265839|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265840|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265841|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265842|NCT01341262|Growth Substances|growth substances|mesh-ancestor
154265843|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265844|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154265845|NCT01341340|Everolimus|everolimus|mesh-list
154265846|NCT01341340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154265847|NCT01341340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154265848|NCT01341340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265849|NCT01341340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265850|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265851|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
154265852|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265853|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265854|NCT01341496|Celecoxib|celecoxib|mesh-list
154265855|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
154265856|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265857|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
154265858|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265859|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154265860|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154265861|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
154265862|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265863|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265864|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154265865|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154265866|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154265867|NCT01341496|Analgesics|analgesics|mesh-ancestor
154265868|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
154265869|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265870|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154265871|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154265872|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154265873|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861075|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168385|NCT06333262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168386|NCT06333262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168393|NCT06333210|Adalimumab|adalimumab|mesh-list
154168394|NCT06333210|Antibodies|antibodies|mesh-list
154168395|NCT06333210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154168396|NCT06333210|Immunologic Factors|immunologic factors|mesh-ancestor
154168397|NCT06333210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168398|NCT06333210|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154168399|NCT06333210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168400|NCT06333210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154168401|NCT06333171|4-Aminopyridine|4-aminopyridine|mesh-list
154168402|NCT06333171|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154168403|NCT06333171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154168404|NCT06333171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168407|NCT06332950|Irinotecan|irinotecan|mesh-list
154265874|NCT00284141|Aflibercept|aflibercept|mesh-list
154265875|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265876|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265877|NCT00284141|Growth Substances|growth substances|mesh-ancestor
153607276|NCT03605719|Nivolumab|nivolumab|mesh-list
154265890|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
154265891|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
154265892|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265893|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265894|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154265895|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154265896|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154265897|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154265898|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154265899|NCT00265343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154265900|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154265901|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154265902|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265903|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154265904|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
154265906|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265907|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265908|NCT00283595|Hormones|hormones|mesh-list
154265909|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265910|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265911|NCT00265109|Levetiracetam|levetiracetam|mesh-list
154265912|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
154265913|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
154265914|NCT01342198|Erythromycin|erythromycin|mesh-list
154265915|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
154265916|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154265917|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
154265918|NCT01342198|Pregabalin|pregabalin|mesh-list
154265919|NCT01342198|Analgesics|analgesics|mesh-ancestor
154265920|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
154012828|NCT02732262|Oxycodone|oxycodone|mesh-list
154265921|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265922|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265923|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
154265924|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154265925|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154265926|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265927|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154265928|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154861076|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861077|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861078|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154861079|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154861080|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154861081|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
154861082|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
154861083|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861084|NCT03822013|Miglustat|miglustat|mesh-list
154861085|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861086|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861087|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154861088|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154861089|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
154861090|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265929|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154265930|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154265931|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154265932|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154265933|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265934|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154265935|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154265936|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265937|NCT01342744|Metformin|metformin|mesh-list
154265938|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265939|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265940|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
154265941|NCT05150782|Curcumin|curcumin|mesh-list
154265951|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
154265952|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265953|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154265954|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154265955|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265956|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265957|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154265958|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
154265959|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154265960|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
154265961|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265962|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154265963|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154265964|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154265965|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265966|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265967|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154265968|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154265969|NCT00283049|Insulin|insulin|mesh-list
154265970|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154265971|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
154265972|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
154265973|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265974|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265975|NCT00264875|Pregabalin|pregabalin|mesh-list
154265976|NCT00264875|Analgesics|analgesics|mesh-ancestor
154265977|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
154265978|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265979|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265980|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
154265981|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154265982|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154265983|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265984|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154265985|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154265986|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154265987|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154265988|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154265989|NCT03635398|Midazolam|midazolam|mesh-list
154265990|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154265991|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154265992|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154265993|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265994|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154265995|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154265996|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154265997|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154265998|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
154265999|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
154266000|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
154266001|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
154266002|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266003|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266004|NCT03151408|Azacitidine|azacitidine|mesh-list
154266005|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154266006|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
154266007|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266030|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266032|NCT01316848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266033|NCT01316848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266034|NCT01316848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266035|NCT02121184|Oxytocin|oxytocin|mesh-list
154266036|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
154168535|NCT06332079|Capecitabine|capecitabine|mesh-list
154266037|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154266038|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266039|NCT01485874|Doxorubicin|doxorubicin|mesh-list
154266040|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154266041|NCT01485874|Nintedanib|nintedanib|mesh-list
154266042|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154266043|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266044|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154266045|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154266046|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266047|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266048|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266049|NCT04786756|Bupivacaine|bupivacaine|mesh-list
154266050|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
154266051|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
154266052|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266053|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266054|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
154266055|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266056|NCT00546754|Losartan|losartan|mesh-list
154266057|NCT00546754|Valsartan|valsartan|mesh-list
154266058|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154266059|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153607472|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154266069|NCT04768426|Capecitabine|capecitabine|mesh-list
154266070|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154266071|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
154266072|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266073|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266074|NCT04473508|Ropivacaine|ropivacaine|mesh-list
154266075|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
154266076|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
154266077|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266078|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266079|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
154266080|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491454|NCT02773758|Fluorides|fluorides|mesh-list
154266081|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
154266082|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154266083|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266084|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266085|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266086|NCT04471402|Analgesics|analgesics|mesh-ancestor
154266087|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
154266088|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266089|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154266090|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154266091|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154266092|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
154266093|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266094|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266095|NCT00282347|Acetaminophen|acetaminophen|mesh-list
154266096|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
154266097|NCT00282347|Promethazine|promethazine|mesh-list
154266098|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
154266099|NCT00282347|Prednisone|prednisone|mesh-list
154266100|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
154266101|NCT00282347|Rituximab|rituximab|mesh-list
154266102|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266103|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266104|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
154266105|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266106|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266107|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266108|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
154266109|NCT00282347|Hormones|hormones|mesh-ancestor
154266110|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154266111|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154266112|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266113|NCT00282347|Analgesics|analgesics|mesh-ancestor
154266114|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
154266115|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266116|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
154861091|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154266117|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154266118|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154168608|NCT06329830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168609|NCT06329830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153622043|NCT02002403|Danazol|danazol|mesh-list
154168611|NCT06329830|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154168612|NCT06329830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168613|NCT06329830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168614|NCT06329830|Hormone Antagonists|hormone antagonists|mesh-ancestor
154168615|NCT06329830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154168616|NCT06329830|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154168617|NCT06329830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154168618|NCT06329401|Pirfenidone|pirfenidone|mesh-list
154168619|NCT06329401|Analgesics|analgesics|mesh-ancestor
154168650|NCT06324851|Dienogest|dienogest|mesh-list
154266119|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
154266120|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266121|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266122|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607526|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
154266145|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266146|NCT01334632|Analgesics|analgesics|mesh-ancestor
154266147|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
154266148|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266149|NCT00405964|Desloratadine|desloratadine|mesh-list
154266150|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154266151|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
154266152|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266153|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266154|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266155|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154266156|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154266157|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
154266158|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
154266159|NCT00264797|Methylphenidate|methylphenidate|mesh-list
154266160|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154266161|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266162|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154266163|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154266164|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154266165|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266166|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
154266167|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266168|NCT03148756|Dalbavancin|dalbavancin|mesh-list
154266169|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266170|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266171|NCT01343680|Heparin|heparin|mesh-list
154266172|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
154266173|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154266174|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154266175|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266183|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582961|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154266184|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266185|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266186|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
154266187|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266188|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266189|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266190|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154266191|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
154861092|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154861093|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861094|NCT00376324|Tigecycline|tigecycline|mesh-list
154861095|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861096|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861097|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154861098|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861099|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861100|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
154861101|NCT00376480|Fludarabine|fludarabine|mesh-list
154861102|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
154861103|NCT00376480|Thiotepa|thiotepa|mesh-list
154861104|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154861105|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255134|NCT03903458|Nivolumab|nivolumab|mesh-list
154255135|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255136|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255137|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154255138|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255139|NCT00086502|Metformin|metformin|mesh-list
154255140|NCT00086502|Pioglitazone|pioglitazone|mesh-list
154255141|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154255142|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154255143|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255144|NCT00086502|Incretins|incretins|mesh-ancestor
154255145|NCT00086502|Hormones|hormones|mesh-ancestor
154255146|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154255147|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154255148|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
154255149|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255150|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255151|NCT03903302|Valproic Acid|valproic acid|mesh-list
154266193|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266194|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266195|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
154266196|NCT01070225|Propranolol|propranolol|mesh-list
154266197|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266198|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154266199|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154266200|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
154266201|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266202|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266203|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266204|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154266205|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154266206|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
154266207|NCT01070615|Prucalopride|prucalopride|mesh-list
154266208|NCT01070615|Laxatives|laxatives|mesh-ancestor
154266209|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266210|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154266211|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154266212|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
154266213|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266214|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582962|NCT05653492|Protective Agents|protective agents|mesh-ancestor
154266215|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266216|NCT00262925|Leucovorin|leucovorin|mesh-list
154266217|NCT00262925|Dexamethasone|dexamethasone|mesh-list
154266218|NCT00262925|Methotrexate|methotrexate|mesh-list
154266219|NCT00262925|Vincristine|vincristine|mesh-list
154266220|NCT00262925|Asparaginase|asparaginase|mesh-list
154266221|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
154266222|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
154266223|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154266224|NCT00262925|Antibodies|antibodies|mesh-list
154266225|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
154266226|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154266227|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
154266228|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
154266229|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266230|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266231|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
154266232|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
154861106|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154861107|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
154861108|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861109|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154861110|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
154861111|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861112|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861113|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
154861114|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
154861115|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861116|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154861117|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
154861118|NCT00376480|Hormones|hormones|mesh-ancestor
154861119|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861120|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154861121|NCT00376480|Protective Agents|protective agents|mesh-ancestor
154861122|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154861123|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
153622184|NCT02003313|Vaccines|vaccines|mesh-list
154168765|NCT06238921|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154168766|NCT06238921|Immunoconjugates|immunoconjugates|mesh-ancestor
154168767|NCT06238921|Immunologic Factors|immunologic factors|mesh-ancestor
154168768|NCT06238921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168769|NCT06237062|Erenumab|erenumab|mesh-list
154168770|NCT06237062|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154168771|NCT06237062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168772|NCT06237062|Analgesics|analgesics|mesh-ancestor
154168776|NCT06236815|Dronabinol|dronabinol|mesh-list
154266233|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266234|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266235|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
154266236|NCT00262925|Hormones|hormones|mesh-ancestor
154266237|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154266238|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154266239|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266240|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154266241|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
154266242|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153491713|NCT06083688|Artenimol|artenimol|mesh-list
154266243|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154266244|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
154266245|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607650|NCT01177683|Bortezomib|bortezomib|mesh-list
154266268|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266270|NCT03720470|Abrocitinib|abrocitinib|mesh-list
154266271|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266272|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266273|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266274|NCT00262847|Paclitaxel|paclitaxel|mesh-list
154266275|NCT00262847|Bevacizumab|bevacizumab|mesh-list
154266276|NCT00262847|Carboplatin|carboplatin|mesh-list
154266277|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154266278|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154266279|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
154266280|NCT00262847|Antibodies|antibodies|mesh-list
154266281|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
154266282|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154266283|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
154266284|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154266285|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266286|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
154266287|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
154266288|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
154266289|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266290|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154266291|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154266292|NCT00262847|Growth Substances|growth substances|mesh-ancestor
154266293|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266294|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
154266295|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
154266296|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
154266297|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266298|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607713|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
154266309|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266310|NCT03817268|Capecitabine|capecitabine|mesh-list
154266311|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154266312|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
154266313|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266314|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266315|NCT00280397|Lenvatinib|lenvatinib|mesh-list
154266316|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266317|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266318|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861124|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154861125|NCT03016039|Curcumin|curcumin|mesh-list
154861126|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154861127|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154861128|NCT03016039|Analgesics|analgesics|mesh-ancestor
154861129|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
154861130|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861131|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861132|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861133|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154168835|NCT06222437|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154168836|NCT06222437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154168837|NCT06222437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168838|NCT06193863|Rivaroxaban|rivaroxaban|mesh-list
154168839|NCT06193863|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154168840|NCT06193863|Antithrombins|antithrombins|mesh-ancestor
154168841|NCT06193863|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154168842|NCT06193863|Protease Inhibitors|protease inhibitors|mesh-ancestor
154168843|NCT06193863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168844|NCT06193863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168845|NCT06193863|Anticoagulants|anticoagulants|mesh-ancestor
154168855|NCT06171555|Betamethasone|betamethasone|mesh-list
154168856|NCT06171555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266319|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266320|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
154266321|NCT03817112|Propofol|propofol|mesh-list
154266322|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154266323|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266324|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266325|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266326|NCT03817112|Analgesics|analgesics|mesh-ancestor
154266327|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
154266328|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266329|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154266330|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154266331|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154266332|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
154266333|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266334|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266335|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154266336|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
154266337|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
154266338|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154266339|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154266340|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266341|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
154266342|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266343|NCT03814148|Indapamide|indapamide|mesh-list
154266344|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154266345|NCT03814148|Diuretics|diuretics|mesh-ancestor
154266346|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
154266347|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266348|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154266349|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154266350|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266351|NCT00279305|Rituximab|rituximab|mesh-list
153491816|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154266352|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266353|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266354|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
154266355|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266356|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266357|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
154266358|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154266359|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
154266360|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266361|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
154266374|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154266376|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154266377|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266378|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
154861134|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861135|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861136|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861137|NCT03498196|Avelumab|avelumab|mesh-list
154861138|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154861139|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861140|NCT03500302|Evolocumab|evolocumab|mesh-list
154861141|NCT03500302|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154861142|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154861143|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154861144|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
154861145|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861146|NCT03500302|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154255153|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255154|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255155|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
154255156|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255157|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255158|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
154255159|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154255160|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255161|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154255162|NCT03636542|Bupivacaine|bupivacaine|mesh-list
154255163|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154255164|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
154255165|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255166|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255167|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
154255168|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255169|NCT00086190|Paroxetine|paroxetine|mesh-list
154255170|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154255171|NCT00086190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154255172|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154255173|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255174|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255175|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255176|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
154255177|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255178|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154255179|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
154255180|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153491877|NCT05476796|Nivolumab|nivolumab|mesh-list
154255181|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154255182|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154255183|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622334|NCT02004860|Ciclopirox|ciclopirox|mesh-list
154266379|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
154266380|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266381|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266382|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154266383|NCT03974867|Protective Agents|protective agents|mesh-ancestor
154266384|NCT03799406|Vitamin D|vitamin d|mesh-list
154266385|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
154266386|NCT03799406|Vitamins|vitamins|mesh-ancestor
154861147|NCT03500302|Protease Inhibitors|protease inhibitors|mesh-ancestor
154861148|NCT03500302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861149|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154861150|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154861151|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
154861152|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861153|NCT03503578|Ketamine|ketamine|mesh-list
154861154|NCT03503578|Sevoflurane|sevoflurane|mesh-list
154861155|NCT03503578|Analgesics|analgesics|mesh-ancestor
154861156|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
154861157|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861158|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861159|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154861160|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154861161|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
154861162|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
154861163|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861164|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154861165|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154861166|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861167|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861168|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154861169|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154861170|NCT03270514|Bupivacaine|bupivacaine|mesh-list
154861171|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
154861172|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
154861173|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861174|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861175|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
154861176|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861177|NCT02178241|Gemcitabine|gemcitabine|mesh-list
154861178|NCT02178241|Halichondrin B|halichondrin b|mesh-list
154266387|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
154266388|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266389|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154266390|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154266392|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
154861179|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154861180|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
154861181|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861182|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861183|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
154861184|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
154861185|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
154861186|NCT03015727|Docetaxel|docetaxel|mesh-list
154861187|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266393|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266394|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
154266395|NCT03799094|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154266396|NCT03799094|Vitamins|vitamins|mesh-ancestor
154266397|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
154266398|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266399|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
154266400|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266401|NCT03799094|Protective Agents|protective agents|mesh-ancestor
154266402|NCT03799094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266403|NCT03799094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266404|NCT00277355|Minocycline|minocycline|mesh-list
154266405|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266406|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266407|NCT00262223|Sertraline|sertraline|mesh-list
154266408|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
154266409|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154266410|NCT00262223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154266411|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154266412|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154266413|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266414|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266415|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
154266416|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266417|NCT05575700|Ibuprofen|ibuprofen|mesh-list
154266418|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154266419|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266420|NCT05575700|Analgesics|analgesics|mesh-ancestor
154266421|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
154266422|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266423|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266424|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266425|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266434|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266435|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266436|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266437|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266438|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154266439|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266440|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266441|NCT03798392|Anesthetics|anesthetics|mesh-list
154266442|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266443|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266444|NCT03816020|Niacinamide|niacinamide|mesh-list
154266445|NCT03816020|Niacin|niacin|mesh-list
154266446|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
154266447|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
154266448|NCT03816020|Vitamins|vitamins|mesh-ancestor
154266449|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
154266450|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266451|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154266452|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
154266453|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266454|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154266455|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
154266456|NCT03815864|Antibodies|antibodies|mesh-list
154266457|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
154266458|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
154266459|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266460|NCT03815942|Nivolumab|nivolumab|mesh-list
154169019|NCT06067269|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154169020|NCT06067269|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154266461|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266462|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266463|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154861188|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
154861189|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
154861190|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
154861191|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861192|NCT01077973|Ibuprofen|ibuprofen|mesh-list
154266464|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266465|NCT01303874|Etanercept|etanercept|mesh-list
154266466|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154266467|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266468|NCT01303874|Analgesics|analgesics|mesh-ancestor
154266469|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
154266470|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266471|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266472|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266473|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266474|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266475|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266476|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
154266477|NCT01301612|Cisplatin|cisplatin|mesh-list
154266478|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
154266479|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266480|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266481|NCT01303952|Eculizumab|eculizumab|mesh-list
154266482|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154266483|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266484|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
154266485|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266486|NCT03970616|Durvalumab|durvalumab|mesh-list
154266487|NCT03970616|Tivozanib|tivozanib|mesh-list
154266488|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266489|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266490|NCT03970616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266491|NCT03970616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266492|NCT03970616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266504|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
154266505|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154266506|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154266507|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266508|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266509|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
154266510|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154266511|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266512|NCT01302236|Eplerenone|eplerenone|mesh-list
154266513|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154266514|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
154266515|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154266516|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266517|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154266518|NCT01302236|Diuretics|diuretics|mesh-ancestor
154266519|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
154266520|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154266521|NCT01304264|Maleic acid|maleic acid|mesh-list
154266522|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013429|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266523|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266524|NCT01304342|Fentanyl|fentanyl|mesh-list
154266525|NCT01304342|Remifentanil|remifentanil|mesh-list
154266526|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154266527|NCT01304342|Narcotics|narcotics|mesh-ancestor
154266528|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266529|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266530|NCT01304342|Analgesics|analgesics|mesh-ancestor
154266531|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
154266532|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266533|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154266534|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154266535|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
154861193|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154266536|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
154169094|NCT06045754|Ustekinumab|ustekinumab|mesh-list
154169095|NCT06045754|Vedolizumab|vedolizumab|mesh-list
154169096|NCT06045754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154169097|NCT06045754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169098|NCT06045754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154169099|NCT06045754|Dermatologic Agents|dermatologic agents|mesh-ancestor
154169100|NCT06045754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169101|NCT06042725|Dexamethasone|dexamethasone|mesh-list
154169102|NCT06042725|Dexamethasone acetate|dexamethasone acetate|mesh-list
154169103|NCT06042725|Lenalidomide|lenalidomide|mesh-list
154266537|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154266538|NCT03653546|Gefitinib|gefitinib|mesh-list
154266539|NCT03653546|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154266540|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266541|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266542|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266543|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266544|NCT03812354|Nicotine|nicotine|mesh-list
154266545|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154266546|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
154266547|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266548|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266549|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154266550|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154266551|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
154266552|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266553|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266554|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154266555|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
154266584|NCT03792620|Daratumumab|daratumumab|mesh-list
154266585|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266586|NCT03811418|Docetaxel|docetaxel|mesh-list
154266587|NCT03811418|Trastuzumab|trastuzumab|mesh-list
154266588|NCT03811418|Vinorelbine|vinorelbine|mesh-list
154266589|NCT03811418|Pertuzumab|pertuzumab|mesh-list
154266590|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266591|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
154266592|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
154266593|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
154266594|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266595|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266596|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154266597|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
154266598|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
154266599|NCT03794492|Prednisolone|prednisolone|mesh-list
154266600|NCT03794492|Tacrolimus|tacrolimus|mesh-list
154266601|NCT03794492|Basiliximab|basiliximab|mesh-list
154266617|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266619|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
154266620|NCT03794492|Hormones|hormones|mesh-ancestor
154266621|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154266622|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154266623|NCT03794492|Protective Agents|protective agents|mesh-ancestor
154266624|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154266625|NCT03792152|Warfarin|warfarin|mesh-list
154266626|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
154266627|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
154266628|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154266629|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
154266630|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154266631|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
154266632|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492141|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
154266633|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266634|NCT00262067|Bevacizumab|bevacizumab|mesh-list
154266635|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154861194|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154861195|NCT01077973|Analgesics|analgesics|mesh-ancestor
154861196|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
154861197|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861198|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861199|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861200|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861201|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154861202|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266636|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266637|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169170|NCT05981534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169171|NCT05981534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154169172|NCT05966194|Cisplatin|cisplatin|mesh-list
154169173|NCT05966194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169174|NCT05947500|Avelumab|avelumab|mesh-list
154169175|NCT05947500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154169176|NCT05947500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169177|NCT05947500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169178|NCT05947500|Immunologic Factors|immunologic factors|mesh-ancestor
154169179|NCT05947500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169180|NCT05923970|Vaccines|vaccines|mesh-list
154169181|NCT05923970|Antibodies|antibodies|mesh-list
154169182|NCT05923970|Immunoglobulins|immunoglobulins|mesh-list
154169183|NCT05923970|Immunologic Factors|immunologic factors|mesh-ancestor
154169184|NCT05923970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266638|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154266639|NCT00262067|Growth Substances|growth substances|mesh-ancestor
154266640|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266641|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
154266642|NCT00275561|Fluticasone|fluticasone|mesh-list
154266643|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266644|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154266645|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
154266646|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266647|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266648|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154266649|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
154266650|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
154266651|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154266652|NCT03810872|Paclitaxel|paclitaxel|mesh-list
154266653|NCT03810872|Afatinib|afatinib|mesh-list
154266654|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154266655|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266656|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
154266657|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
153492234|NCT03992456|Trifluridine|trifluridine|mesh-list
154266658|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
154266659|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608076|NCT01938781|Entecavir|entecavir|mesh-list
154266685|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
154266686|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
154266687|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266688|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266689|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154266690|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154266691|NCT03792074|Growth Substances|growth substances|mesh-ancestor
154266692|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266693|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
154266694|NCT00251693|Lansoprazole|lansoprazole|mesh-list
154266695|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
154266696|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154266697|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266698|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154266699|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266700|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266701|NCT03791918|Lenvatinib|lenvatinib|mesh-list
154266702|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
154266703|NCT03791918|Antibodies|antibodies|mesh-list
154266704|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
154266705|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
154266706|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266707|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266708|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154861203|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861204|NCT02973646|Tenofovir|tenofovir|mesh-list
154861205|NCT02973646|Entecavir|entecavir|mesh-list
154861206|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154861207|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
154861208|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861209|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154861210|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154861211|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861212|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861213|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154861214|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154861215|NCT01078363|Ramipril|ramipril|mesh-list
154861216|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154169248|NCT05895955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169250|NCT05884398|Hormones|hormones|mesh-ancestor
154169251|NCT05884398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169252|NCT05884398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169258|NCT05864534|Doxorubicin|doxorubicin|mesh-list
154169259|NCT05864534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154169260|NCT05864534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154169261|NCT05864534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169262|NCT05864534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154169263|NCT05864534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154169264|NCT05864534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169265|NCT05864534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169266|NCT05852691|Paclitaxel|paclitaxel|mesh-list
154169267|NCT05852691|Pembrolizumab|pembrolizumab|mesh-list
154266709|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266710|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266711|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154266712|NCT03791918|Estrogens|estrogens|mesh-ancestor
154266713|NCT03791918|Hormones|hormones|mesh-ancestor
154266724|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266726|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
154266727|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266728|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266729|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266730|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266731|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154266732|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154266733|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266734|NCT01303094|Trabectedin|trabectedin|mesh-list
154266735|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154266736|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
154266737|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266738|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266739|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154266740|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
154266741|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154266742|NCT03791762|Protective Agents|protective agents|mesh-ancestor
154266743|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266744|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
154266745|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154266746|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
154266747|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154266748|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266749|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154266750|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154266751|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154266753|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154266754|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266755|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154266756|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266757|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266758|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
154266759|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154266760|NCT01306370|Hemostatics|hemostatics|mesh-list
154266761|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154266762|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154266763|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861217|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
154266764|NCT01306370|Coagulants|coagulants|mesh-ancestor
154861218|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861219|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861220|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154861221|NCT03371836|Clobazam|clobazam|mesh-list
154861222|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
154861223|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154861224|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154861225|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861226|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861227|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153492346|NCT03348670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861228|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153492415|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154861229|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
154861230|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
154861231|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154169321|NCT05807360|Protective Agents|protective agents|mesh-ancestor
154169322|NCT05807035|Vaccines|vaccines|mesh-list
154169323|NCT05807035|Immunologic Factors|immunologic factors|mesh-ancestor
154169324|NCT05807035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169325|NCT05779943|Furosemide|furosemide|mesh-list
154169326|NCT05779943|Fluorides|fluorides|mesh-list
154169327|NCT05779943|Diuretics|diuretics|mesh-ancestor
154169328|NCT05779943|Natriuretic Agents|natriuretic agents|mesh-ancestor
154169329|NCT05779943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169330|NCT05779943|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154266765|NCT03716024|Linezolid|linezolid|mesh-list
154266766|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266767|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266768|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154266769|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266770|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266771|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
154266772|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154266773|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
154266774|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266775|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266776|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154266806|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154266807|NCT01308242|Sevelamer|sevelamer|mesh-list
154266808|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
154266809|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
154266810|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266811|NCT01308320|Fentanyl|fentanyl|mesh-list
154266812|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154266813|NCT01308320|Narcotics|narcotics|mesh-ancestor
154266814|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266815|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266816|NCT01308320|Analgesics|analgesics|mesh-ancestor
154266817|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
154266818|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266819|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154266820|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154266821|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
154013728|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154266833|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266834|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154266835|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154266836|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154266837|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266838|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266839|NCT03787940|Isoniazid|isoniazid|mesh-list
154266840|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
154266841|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266842|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266843|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154266844|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154266845|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
154266846|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266847|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154266848|NCT03788018|Lidocaine|lidocaine|mesh-list
154266849|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
154266850|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
154266851|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
154266852|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266853|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266854|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
154266855|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266856|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154266857|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154266858|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154861232|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861233|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154861234|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
154861235|NCT01078753|Coagulants|coagulants|mesh-ancestor
154861236|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154861237|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
154861238|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861239|NCT03372382|Acetaminophen|acetaminophen|mesh-list
154861240|NCT03372382|Ibuprofen|ibuprofen|mesh-list
154861241|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154169399|NCT05712356|Paclitaxel|paclitaxel|mesh-list
154169400|NCT05712356|Gemcitabine|gemcitabine|mesh-list
154169401|NCT05712356|Durvalumab|durvalumab|mesh-list
154169402|NCT05712356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154266859|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154266860|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266861|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154266862|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266863|NCT03788018|Analgesics|analgesics|mesh-ancestor
154266864|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154266865|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154266866|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154266867|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
154266868|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266869|NCT03785756|Ibuprofen|ibuprofen|mesh-list
154266870|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154266871|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266872|NCT03785756|Analgesics|analgesics|mesh-ancestor
154266873|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
154266874|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266875|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266876|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266877|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266878|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154266879|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266880|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266881|NCT03788174|Apatinib|apatinib|mesh-list
154266882|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266883|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266884|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266885|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266895|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
154266896|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266897|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153492470|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
154266898|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154266899|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266900|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266901|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154266902|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
154266903|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154266904|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266905|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154266907|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
154266908|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
154266909|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266910|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266911|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
154266912|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266913|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
154266914|NCT05693402|Anesthetics|anesthetics|mesh-list
154266915|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266916|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266917|NCT05693402|Narcotics|narcotics|mesh-ancestor
154266918|NCT05693402|Analgesics|analgesics|mesh-ancestor
154266919|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
154266920|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266921|NCT05694728|Vaccines|vaccines|mesh-list
154266922|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
154266923|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266924|NCT01308632|Irinotecan|irinotecan|mesh-list
154266925|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154266926|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154266927|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266928|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266929|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266930|NCT03789578|Semaglutide|semaglutide|mesh-list
154266931|NCT03789578|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154266932|NCT03789578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154266933|NCT03789578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266934|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
154861242|NCT03372382|Analgesics|analgesics|mesh-ancestor
154861243|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
154861244|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169471|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154169472|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154169473|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154169474|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169502|NCT05623020|Dexamethasone|dexamethasone|mesh-list
154169503|NCT05623020|Lenalidomide|lenalidomide|mesh-list
154169504|NCT05623020|Daratumumab|daratumumab|mesh-list
154169505|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169506|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
154169507|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
154169508|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169509|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266935|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154266936|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266937|NCT03785522|Insulin|insulin|mesh-list
154266938|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154266939|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266940|NCT05694416|Etoposide|etoposide|mesh-list
154266941|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266942|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154266943|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154266944|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154266945|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266946|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266947|NCT03789422|Cetirizine|cetirizine|mesh-list
154266948|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
154266949|NCT03789422|Levocetirizine|levocetirizine|mesh-list
153608362|NCT01940224|Analgesics|analgesics|mesh-ancestor
154266971|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
154013897|NCT00942487|Nebivolol|nebivolol|mesh-list
154266972|NCT05690048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154266973|NCT05690048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266974|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266975|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266976|NCT01308086|Leucovorin|leucovorin|mesh-list
154266977|NCT01308086|Capecitabine|capecitabine|mesh-list
154266978|NCT01308086|Fluorouracil|fluorouracil|mesh-list
154266979|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
154266980|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
154266981|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154266982|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
154266983|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266984|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266985|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266986|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
154266987|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266988|NCT01308086|Antidotes|antidotes|mesh-ancestor
154266989|NCT01308086|Protective Agents|protective agents|mesh-ancestor
154266990|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
154266991|NCT01308086|Vitamins|vitamins|mesh-ancestor
154266992|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
154266993|NCT05443802|Insulin|insulin|mesh-list
154266994|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154266995|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154266996|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266997|NCT01308944|Propranolol|propranolol|mesh-list
154266998|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154266999|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154267000|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267001|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267002|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608429|NCT01940653|Progestins|progestins|mesh-ancestor
154267013|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
154267014|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154861245|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861246|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
154861247|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154861248|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861249|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861250|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154861251|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492582|NCT00577122|Hormones|hormones|mesh-ancestor
154861252|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861253|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154861254|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154861255|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154861256|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267015|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154267016|NCT03777254|Growth Substances|growth substances|mesh-ancestor
154267017|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267018|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
154267019|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267020|NCT01312298|Bupivacaine|bupivacaine|mesh-list
154267021|NCT01312298|Anesthetics|anesthetics|mesh-list
154267022|NCT01312298|Propofol|propofol|mesh-list
154267023|NCT01312298|Succinylcholine|succinylcholine|mesh-list
154267024|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
154267025|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267026|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267027|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
154267028|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267029|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154267030|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154267031|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
154267032|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154267033|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154267034|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154267035|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
154267036|NCT01309022|Sirolimus|sirolimus|mesh-list
154267037|NCT01309022|Tacrolimus|tacrolimus|mesh-list
154267038|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154267039|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
154267040|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267041|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154267042|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267043|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267044|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154267045|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267046|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154267047|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
154267048|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267049|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267050|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
154267051|NCT01560962|Azithromycin|azithromycin|mesh-list
154267052|NCT01560962|Tobramycin|tobramycin|mesh-list
154267053|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
154267054|NCT01560962|Povidone|povidone|mesh-list
154267055|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267056|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267057|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
154267058|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
154267059|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154267060|NCT05401058|Droperidol|droperidol|mesh-list
154267061|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154267062|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
154267063|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
154267064|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267065|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267066|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154267067|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154267068|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154267069|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267102|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154582963|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267104|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267105|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267106|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267107|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154267108|NCT01309178|Diuretics|diuretics|mesh-ancestor
154267109|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
154267110|NCT01335334|Metronidazole|metronidazole|mesh-list
154267119|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154267120|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154267121|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154267122|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267123|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267124|NCT01335334|Antacids|antacids|mesh-ancestor
154267125|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154267126|NCT01344304|Aprepitant|aprepitant|mesh-list
154267127|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
154267128|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
154267129|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
154267130|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267131|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267132|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169624|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169625|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
154169631|NCT05552222|Dexamethasone|dexamethasone|mesh-list
154169632|NCT05552222|Lenalidomide|lenalidomide|mesh-list
154169633|NCT05552222|Daratumumab|daratumumab|mesh-list
154169634|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169635|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
154169636|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
154169637|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169638|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169639|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169640|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
154169641|NCT05552222|Hormones|hormones|mesh-ancestor
154169642|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169643|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169644|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169645|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
154169646|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169647|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169648|NCT05552222|Growth Substances|growth substances|mesh-ancestor
154169649|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169650|NCT05550532|Aticaprant|aticaprant|mesh-list
154169651|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154169652|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169653|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
154267133|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154267134|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267135|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267136|NCT01320020|Catumaxomab|catumaxomab|mesh-list
154267137|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154267138|NCT00379288|Fluticasone|fluticasone|mesh-list
154267140|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
154267141|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154267142|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154267143|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154267144|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154267145|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
154267146|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267147|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267148|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154267149|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154267150|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154267151|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154267152|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154267153|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154267154|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154267155|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267156|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861257|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861258|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154267157|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861259|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154861260|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861261|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
154861262|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861263|NCT03374176|Amoxicillin|amoxicillin|mesh-list
154861264|NCT03374176|Metronidazole|metronidazole|mesh-list
154861265|NCT03374176|Clindamycin|clindamycin|mesh-list
154861266|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
154861267|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
154861268|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861269|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861270|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154861271|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154861272|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154861273|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861274|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861275|NCT03281200|Nintedanib|nintedanib|mesh-list
154861276|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
154861277|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
154861278|NCT03281200|Immunomodulating Agents|immunomodulating agents|mesh-list
154861279|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861280|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169699|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154267159|NCT00379288|Hormones|hormones|mesh-ancestor
154267160|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154267161|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
154267162|NCT03784040|Nivolumab|nivolumab|mesh-list
154267163|NCT03784040|Ipilimumab|ipilimumab|mesh-list
154267164|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267165|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267166|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154267167|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267168|NCT00243503|Trastuzumab|trastuzumab|mesh-list
154267169|NCT00243503|Sunitinib|sunitinib|mesh-list
154267170|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267171|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267172|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154267173|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154267174|NCT00243503|Growth Substances|growth substances|mesh-ancestor
154267175|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267176|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
154267177|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154267178|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492772|NCT02845752|Bromides|bromides|mesh-list
153608589|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154267188|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
154267189|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
154267190|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267191|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154267192|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154267193|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
154267194|NCT03780686|Protective Agents|protective agents|mesh-ancestor
154267195|NCT00338260|Atenolol|atenolol|mesh-list
154267196|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267197|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267198|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267199|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267200|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
154014107|NCT00768651|Pantoprazole|pantoprazole|mesh-list
154267201|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267202|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154267203|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154267204|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
154267205|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154267206|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154267207|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154267208|NCT03775928|Capecitabine|capecitabine|mesh-list
154267209|NCT03775928|Apatinib|apatinib|mesh-list
154267210|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154267211|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
154267212|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267213|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267214|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154267215|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267216|NCT03775538|Dopamine|dopamine|mesh-list
154267217|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154267218|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
154267219|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
154267220|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267221|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267222|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
154267223|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267224|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267225|NCT03775538|Protective Agents|protective agents|mesh-ancestor
154267226|NCT00259649|Eletriptan|eletriptan|mesh-list
154267227|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154267228|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
154267229|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267230|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267231|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267232|NCT01320176|Vaccines|vaccines|mesh-list
154267233|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
154267234|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267235|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154267236|NCT01335646|Analgesics|analgesics|mesh-list
154861281|NCT03281200|Immunologic Factors|immunologic factors|mesh-ancestor
154267237|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
154169774|NCT05464030|Capecitabine|capecitabine|mesh-list
154169775|NCT05464030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169776|NCT05464030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169777|NCT05464030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169778|NCT05464030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169779|NCT05464030|Growth Substances|growth substances|mesh-ancestor
154169780|NCT05464030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169781|NCT05464030|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169782|NCT05464030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169783|NCT05464030|Antimetabolites|antimetabolites|mesh-ancestor
154169784|NCT05464030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267238|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267239|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267241|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267242|NCT00307060|Losartan|losartan|mesh-list
154267243|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154267252|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154267253|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154267254|NCT01320254|Cisplatin|cisplatin|mesh-list
154267255|NCT01320254|Gemcitabine|gemcitabine|mesh-list
154267256|NCT01320254|Panitumumab|panitumumab|mesh-list
154267257|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154267258|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267259|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154267260|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
154267261|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267262|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267263|NCT00092638|Ezetimibe|ezetimibe|mesh-list
154267264|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154267265|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267266|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
154267267|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267268|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267269|NCT03783728|Pyridoxine|pyridoxine|mesh-list
154267270|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
154267271|NCT03783728|Isoniazid|isoniazid|mesh-list
154267272|NCT03783728|Rifapentine|rifapentine|mesh-list
154267273|NCT03783728|Vitamins|vitamins|mesh-ancestor
154267274|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
154267275|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267276|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
154267277|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
154267278|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267279|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267280|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154267281|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267282|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
154267283|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267284|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267285|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154267286|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
154267287|NCT03620422|Mannitol|mannitol|mesh-list
154267288|NCT03620422|Albuterol|albuterol|mesh-list
154267289|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154267290|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
154267291|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267292|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267293|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154267294|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
154267295|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
154267296|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154267297|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154267298|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154861282|NCT03281200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861283|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
154861284|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
154861285|NCT03520348|Vitamins|vitamins|mesh-ancestor
154861286|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
154861287|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861288|NCT03380026|Triamcinolone|triamcinolone|mesh-list
154861289|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154861290|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154861291|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
154861292|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154861293|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255184|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154255185|NCT03275350|Naltrexone|naltrexone|mesh-list
154255186|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154255187|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154255188|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255189|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
154255190|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255191|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154255192|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
154002127|NCT00867295|Cefazolin|cefazolin|mesh-list
154255193|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255194|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154255195|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
154255196|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255197|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255198|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154255199|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154255200|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255201|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
154255202|NCT03557242|Aspirin|aspirin|mesh-list
154267299|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154267300|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267301|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267302|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267303|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154267304|NCT03620422|Diuretics|diuretics|mesh-ancestor
154267305|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
154267306|NCT04228354|Semaglutide|semaglutide|mesh-list
154267307|NCT04228354|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154267308|NCT04228354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154267309|NCT04228354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267310|NCT01309490|Ribavirin|ribavirin|mesh-list
154267319|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267320|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267321|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154267323|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
154267324|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267325|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267326|NCT03780140|Cefiderocol|cefiderocol|mesh-list
154267327|NCT03780140|Siderophores|siderophores|mesh-ancestor
154267328|NCT03780140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154267329|NCT03780140|Chelating Agents|chelating agents|mesh-ancestor
154267330|NCT03780140|Sequestering Agents|sequestering agents|mesh-ancestor
154267331|NCT03780140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267332|NCT03780140|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154267333|NCT03780140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267334|NCT03780140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267335|NCT03774836|Morphine|morphine|mesh-list
154267336|NCT03774836|Tramadol|tramadol|mesh-list
154267337|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154267338|NCT03774836|Narcotics|narcotics|mesh-ancestor
154267339|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267340|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267341|NCT03774836|Analgesics|analgesics|mesh-ancestor
154861294|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
154861295|NCT03380026|Hormones|hormones|mesh-ancestor
154861296|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861297|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861298|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154861299|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
154861300|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861301|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861302|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
154861303|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154861304|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861305|NCT01079143|Cyclosporine|cyclosporine|mesh-list
154861306|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
154861307|NCT01079143|Everolimus|everolimus|mesh-list
154861308|NCT01079143|Cyclosporins|cyclosporins|mesh-list
154861309|NCT01079143|Basiliximab|basiliximab|mesh-list
154861310|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861311|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861312|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154861313|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
154255204|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154169909|NCT05379595|Antidotes|antidotes|mesh-ancestor
154267342|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
154267343|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267344|NCT03774680|Cetuximab|cetuximab|mesh-list
154267345|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267346|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267347|NCT03783338|Vitamin D|vitamin d|mesh-list
154267348|NCT03783338|Vitamins|vitamins|mesh-ancestor
154267349|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
154267350|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267351|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154267352|NCT03774524|Misoprostol|misoprostol|mesh-list
154267353|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154267354|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
154267355|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154267356|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267357|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153492982|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
154267358|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154267359|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
154267360|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
154267361|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
154267362|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154267363|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
154267364|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267365|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154267366|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154267367|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
154267368|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267369|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267370|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154267371|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267372|NCT03773744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154267373|NCT03779516|Lidocaine|lidocaine|mesh-list
154267374|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
154267375|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
154267376|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267377|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267383|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154267384|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267385|NCT03779594|Acetazolamide|acetazolamide|mesh-list
154267386|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
154267387|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154267388|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267389|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267390|NCT03779594|Diuretics|diuretics|mesh-ancestor
154267391|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
154267392|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267393|NCT03779672|Memantine|memantine|mesh-list
154267394|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154267395|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154267396|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
154267397|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267398|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267399|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267400|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154267401|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154267402|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
154267403|NCT03779282|Ketamine|ketamine|mesh-list
154267404|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154267405|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267406|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267407|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153493092|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267408|NCT03779282|Analgesics|analgesics|mesh-ancestor
154267409|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
154267410|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267411|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154267412|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154267413|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154267414|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267415|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861314|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861315|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
154267416|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267417|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154267418|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154267419|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
154267421|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154267422|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154267423|NCT03773588|Propofol|propofol|mesh-list
154267424|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154014332|NCT06004882|Glucocorticoids|glucocorticoids|mesh-ancestor
154267425|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267426|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267427|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154267428|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
154267429|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
154267430|NCT03773510|Trabectedin|trabectedin|mesh-list
154267431|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154267432|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
154267433|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267434|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267435|NCT03779360|Clindamycin|clindamycin|mesh-list
154267436|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
154267437|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
154267438|NCT03779360|Erythromycin|erythromycin|mesh-list
154267439|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
154267440|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154267441|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
154267442|NCT03779360|Prednisolone|prednisolone|mesh-list
154267443|NCT03779360|Clobetasol|clobetasol|mesh-list
154267444|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154267445|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
154267458|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154267459|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154267461|NCT01321034|Niacin|niacin|mesh-list
154267462|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267463|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
154267464|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267465|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267466|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
154267467|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
154267468|NCT01321034|Vitamins|vitamins|mesh-ancestor
154267469|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
153493153|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267470|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267471|NCT03773042|Propofol|propofol|mesh-list
154267472|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154267473|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267474|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267475|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154267476|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
154267477|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
154267478|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154267479|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154267480|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
154267481|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267482|NCT03712280|Rifaximin|rifaximin|mesh-list
154267483|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
154267484|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267485|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267486|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154267487|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154267488|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
154267489|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267490|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267491|NCT01561508|Butyric Acid|butyric acid|mesh-list
154267492|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
154267493|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
154267494|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267495|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267496|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267497|NCT03772262|Metformin|metformin|mesh-list
154267498|NCT03772262|Furosemide|furosemide|mesh-list
154267499|NCT03772262|Midazolam|midazolam|mesh-list
154267500|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154267501|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154267502|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267503|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154267504|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154267505|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267506|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154267507|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154267515|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267516|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154267517|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267518|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
154267519|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267520|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154267521|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267522|NCT03772262|Diuretics|diuretics|mesh-ancestor
154267523|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
154267524|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154267525|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154267526|NCT03772106|Propofol|propofol|mesh-list
154267527|NCT03772106|Sevoflurane|sevoflurane|mesh-list
154267528|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154267529|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267530|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267531|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154267532|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
154267533|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
154267534|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154267535|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154267536|NCT01345240|Vaccines|vaccines|mesh-list
154267537|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
154267538|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267539|NCT03771638|Tenofovir|tenofovir|mesh-list
154267540|NCT03771638|Emtricitabine|emtricitabine|mesh-list
154267541|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
154267542|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267543|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154267544|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154267545|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267546|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267547|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154267548|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154267549|NCT00092560|Ezetimibe|ezetimibe|mesh-list
154267550|NCT00092560|Fenofibrate|fenofibrate|mesh-list
154267551|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154267552|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267553|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
154267554|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267555|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267556|NCT03769064|Methylphenidate|methylphenidate|mesh-list
154267557|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154267558|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267559|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154267560|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154267561|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154267562|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267563|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
154267564|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267565|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154267566|NCT00090298|Simvastatin|simvastatin|mesh-list
154267567|NCT00090298|Ezetimibe|ezetimibe|mesh-list
154267568|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154267569|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267570|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
154267571|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267572|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267573|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154267574|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267575|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
154267576|NCT03771092|Hematinics|hematinics|mesh-ancestor
154267598|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267599|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267600|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154267601|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267602|NCT01321268|Beta Carotene|beta carotene|mesh-list
154267603|NCT01321268|Lycopene|lycopene|mesh-list
154267604|NCT01321268|Resveratrol|resveratrol|mesh-list
154267605|NCT01321268|Carotenoids|carotenoids|mesh-list
154267606|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
154861316|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267607|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267608|NCT01321268|Protective Agents|protective agents|mesh-ancestor
154267609|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267610|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267611|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154267612|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154267613|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154267614|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154267615|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267616|NCT01321268|Provitamins|provitamins|mesh-ancestor
154267617|NCT01321268|Vitamins|vitamins|mesh-ancestor
154267618|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
154267619|NCT01335958|DMUC5754A|dmuc5754a|mesh-list
154267620|NCT01335958|Immunoconjugates|immunoconjugates|mesh-ancestor
154267621|NCT01335958|Immunologic Factors|immunologic factors|mesh-ancestor
154267622|NCT01335958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267623|NCT01561274|Bupivacaine|bupivacaine|mesh-list
154267624|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
154267625|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
154267626|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267627|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267628|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
154267629|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267630|NCT02882854|Guanfacine|guanfacine|mesh-list
154267631|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154267632|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154267633|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154267634|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154267635|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267636|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267646|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154267647|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
154267648|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267649|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
154267650|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267651|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267652|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154267653|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154267654|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267655|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267656|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267657|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154267658|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154267659|NCT01321346|Cytarabine|cytarabine|mesh-list
154267660|NCT01321346|Panobinostat|panobinostat|mesh-list
154267661|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154267662|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
154267663|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267664|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267665|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
154267666|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267667|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154267668|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
154267669|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267670|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154267671|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267672|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
154267673|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154267674|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154267675|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154267676|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493297|NCT03070470|Ritonavir|ritonavir|mesh-list
154267677|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267678|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154267679|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267680|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154267681|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154267682|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267683|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154267684|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154267685|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
154267686|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267687|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267688|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154267689|NCT02118610|Analgesics|analgesics|mesh-ancestor
154861317|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
154267690|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
154267691|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267693|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267694|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267695|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154267696|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267697|NCT01345708|Prednisone|prednisone|mesh-list
154267698|NCT01345708|Rituximab|rituximab|mesh-list
154267699|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267730|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154267731|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154267732|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
154267733|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267734|NCT03948022|Progesterone|progesterone|mesh-list
154267735|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
154267736|NCT03948022|Progestins|progestins|mesh-ancestor
154267737|NCT03948022|Hormones|hormones|mesh-ancestor
154267738|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154267739|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267740|NCT03777644|Morphine|morphine|mesh-list
154267741|NCT03777644|Ropivacaine|ropivacaine|mesh-list
154267742|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154267743|NCT03777644|Narcotics|narcotics|mesh-ancestor
154267744|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267756|NCT04345666|Androgens|androgens|mesh-ancestor
154267757|NCT04345666|Hormones|hormones|mesh-ancestor
154267758|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154267759|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267760|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154267761|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267762|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
154267763|NCT01336192|Gemcitabine|gemcitabine|mesh-list
153493388|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267764|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154267765|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
154267766|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267767|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267768|NCT01336348|Tirofiban|tirofiban|mesh-list
154267769|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154267770|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154267771|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154267772|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154267773|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267774|NCT01346254|Pioglitazone|pioglitazone|mesh-list
154267775|NCT01346254|Vildagliptin|vildagliptin|mesh-list
154267776|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154267777|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267778|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154267779|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
154267780|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267781|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267782|NCT04592536|Alprazolam|alprazolam|mesh-list
154267783|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154267784|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267785|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267786|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154267787|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154267788|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154267789|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
154267790|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
154267791|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267792|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267793|NCT01336582|Docetaxel|docetaxel|mesh-list
154267794|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267795|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
154267796|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
154267797|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
154267798|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267799|NCT03149848|Cabotegravir|cabotegravir|mesh-list
154267800|NCT03149848|Rifabutin|rifabutin|mesh-list
154267801|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154267802|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154267803|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267804|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267805|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154170283|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170284|NCT04923893|Dexamethasone|dexamethasone|mesh-list
154170285|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
154170286|NCT04923893|Fludarabine|fludarabine|mesh-list
154170287|NCT04923893|Lenalidomide|lenalidomide|mesh-list
154170288|NCT04923893|Bortezomib|bortezomib|mesh-list
154170289|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170290|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
154267806|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154267807|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
154267808|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609215|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
154267821|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
154267822|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267823|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154267824|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154267825|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154267827|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
154267828|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
154267829|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154267830|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267831|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
154267832|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267833|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154267834|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154267835|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154267836|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154267837|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267838|NCT01336660|Antivenins|antivenins|mesh-list
154267839|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
154267840|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267841|NCT03768518|Exenatide|exenatide|mesh-list
154267842|NCT03768518|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154267843|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154267844|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267845|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154267846|NCT03768518|Incretins|incretins|mesh-ancestor
154267847|NCT03768518|Hormones|hormones|mesh-ancestor
154267848|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154267849|NCT03770000|Romidepsin|romidepsin|mesh-list
154267850|NCT03770000|Tenalisib|tenalisib|mesh-list
154267851|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154267852|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267853|NCT03770000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154267854|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267855|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267856|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154267857|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154267858|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154267859|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267860|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
154267861|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267862|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267863|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267864|NCT03158272|Nivolumab|nivolumab|mesh-list
154267865|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154267866|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267867|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154267868|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267885|NCT01347424|Paclitaxel|paclitaxel|mesh-list
154267886|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154267887|NCT01347424|Carboplatin|carboplatin|mesh-list
154267888|NCT01347424|Endostatins|endostatins|mesh-list
154267889|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154267890|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267891|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
154861318|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861319|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154861320|NCT01079143|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154861321|NCT01079143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154861322|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861323|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154861324|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154267892|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
154267893|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
154267894|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267895|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154267896|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154267897|NCT01347424|Growth Substances|growth substances|mesh-ancestor
154267898|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267899|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
154267901|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154267902|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
154267903|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267904|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267905|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
154267906|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154267907|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267908|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267909|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154267910|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154267911|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154267912|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154267913|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154267914|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154267915|NCT00654628|Simvastatin|simvastatin|mesh-list
154267916|NCT00654628|Ezetimibe|ezetimibe|mesh-list
154267917|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154267918|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267919|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
154267920|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267921|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154267931|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154267933|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
154267934|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
154267935|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
154267936|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
154267937|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154267938|NCT01337362|Insulin|insulin|mesh-list
154267939|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154267940|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154267941|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267942|NCT03762824|Vaccines|vaccines|mesh-list
154267943|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154267944|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
154267945|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267946|NCT00496834|Losartan|losartan|mesh-list
154267947|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154267948|NCT00496834|Carvedilol|carvedilol|mesh-list
154267949|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154267950|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154267951|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154267952|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154267953|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267954|NCT00496834|Diuretics|diuretics|mesh-ancestor
154267955|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
154267956|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267957|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154267958|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154267959|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154267960|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154267961|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267962|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267963|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
154267964|NCT00496834|Protective Agents|protective agents|mesh-ancestor
154267965|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154267966|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154267967|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
154267968|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154267969|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154267970|NCT00189280|Imiquimod|imiquimod|mesh-list
154267971|NCT00189280|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154267972|NCT00189280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267973|NCT00189280|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154267974|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
154267975|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267976|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154267977|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267978|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
154267979|NCT01352494|Gemcitabine|gemcitabine|mesh-list
154267981|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154267982|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
154267983|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267984|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267985|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
154267997|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267998|NCT01348126|Docetaxel|docetaxel|mesh-list
154267999|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268000|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
154268001|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
154268002|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
154268003|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268004|NCT01348204|Quercetin|quercetin|mesh-list
154268005|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
154268006|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268007|NCT01348204|Protective Agents|protective agents|mesh-ancestor
154268008|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268009|NCT00166504|Atorvastatin|atorvastatin|mesh-list
154268010|NCT00166504|Simvastatin|simvastatin|mesh-list
154268011|NCT00166504|Ezetimibe|ezetimibe|mesh-list
154268012|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154268013|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154268014|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
154268015|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268016|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154268017|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154268018|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268019|NCT01348282|Rivastigmine|rivastigmine|mesh-list
154268020|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268021|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268022|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268023|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154268024|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
154268025|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268026|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154268027|NCT01348282|Protective Agents|protective agents|mesh-ancestor
154268028|NCT03137992|Bromides|bromides|mesh-list
154268029|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
154268030|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154268031|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
154268032|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268033|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268034|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154268035|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
154268036|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
154268037|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154268038|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
154268039|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268040|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268041|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
154268042|NCT04470778|Famotidine|famotidine|mesh-list
154268043|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154268044|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154268045|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154268046|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
154268047|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
154268048|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268049|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268050|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268058|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
154268059|NCT01352572|Nortriptyline|nortriptyline|mesh-list
154268060|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154268061|NCT01352572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154268062|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154268063|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268064|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268065|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268066|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
154170511|NCT04644237|Trastuzumab|trastuzumab|mesh-list
154268067|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268068|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154268069|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154268070|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154268071|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268072|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154268073|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154268074|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
154268075|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
154268076|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154268077|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154268078|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268079|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154268080|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153493688|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
154268081|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154268082|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
154268083|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154268084|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154268085|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154268086|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154268087|NCT01352572|Analgesics|analgesics|mesh-ancestor
154268088|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
154268089|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268090|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154268091|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154268093|NCT01352650|Decitabine|decitabine|mesh-list
154268094|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154268095|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
154268096|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268097|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015007|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154268099|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154268100|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154268101|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
154268102|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268103|NCT01352728|Axitinib|axitinib|mesh-list
154268104|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268105|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268106|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268107|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268108|NCT03767660|Sirolimus|sirolimus|mesh-list
154268109|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154268110|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268111|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154268112|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268113|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
154268114|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268115|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
154268116|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268117|NCT03767504|Thymol|thymol|mesh-list
154268118|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268119|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154268133|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154268134|NCT03761264|Protective Agents|protective agents|mesh-ancestor
154268135|NCT05096312|Zinc|zinc|mesh-list
154268136|NCT05096312|Adapalene|adapalene|mesh-list
154268137|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154268138|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153493691|NCT03340350|Minocycline|minocycline|mesh-list
154268139|NCT05096312|Trace Elements|trace elements|mesh-ancestor
154268140|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
154268141|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268142|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
154268143|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154268144|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154268145|NCT05096312|Analgesics|analgesics|mesh-ancestor
154268146|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
154268147|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268148|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268149|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268150|NCT03767036|Ketorolac|ketorolac|mesh-list
154268151|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154268152|NCT03767036|Tramadol|tramadol|mesh-list
154861325|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
154268153|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154268155|NCT03767036|Analgesics|analgesics|mesh-ancestor
154268156|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
154268157|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268158|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268159|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268160|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268161|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154268162|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268163|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268164|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154268165|NCT03767036|Narcotics|narcotics|mesh-ancestor
154268166|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268167|NCT03758144|Rifaximin|rifaximin|mesh-list
154268168|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154268169|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268170|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154268171|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
154268172|NCT03766724|Empagliflozin|empagliflozin|mesh-list
154268173|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154268174|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268175|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154268176|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268177|NCT04860518|Dexamethasone|dexamethasone|mesh-list
154268178|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268179|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
154268180|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
154268181|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609593|NCT05303038|Bevacizumab|bevacizumab|mesh-list
154268191|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154268192|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154268193|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268194|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268195|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154268196|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154268197|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
154268198|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268199|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154268200|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268201|NCT01322204|Codeine|codeine|mesh-list
154268202|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154268203|NCT01322204|Narcotics|narcotics|mesh-ancestor
154268204|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268205|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268206|NCT01322204|Analgesics|analgesics|mesh-ancestor
154268207|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
154268208|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268209|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
154268210|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
154268211|NCT03766490|Gefitinib|gefitinib|mesh-list
154268212|NCT03766490|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154268213|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268214|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268215|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268216|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268217|NCT01348984|Fentanyl|fentanyl|mesh-list
154268218|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154268219|NCT01348984|Narcotics|narcotics|mesh-ancestor
154268220|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268221|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268222|NCT01348984|Analgesics|analgesics|mesh-ancestor
154268223|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
154268224|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268225|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154268226|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154268227|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
154268228|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
154268229|NCT01567670|Naloxone|naloxone|mesh-list
154268230|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154268231|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268232|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
154268233|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268234|NCT01349062|Immunomodulating Agents|immunomodulating agents|mesh-list
154268235|NCT01349062|Immunologic Factors|immunologic factors|mesh-ancestor
154255205|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154255206|NCT03557242|Analgesics|analgesics|mesh-ancestor
154255207|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
154255208|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255209|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255210|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255211|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255212|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154255213|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154255214|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255215|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154255216|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154170658|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170659|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154170660|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170661|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170662|NCT04497844|Prednisone|prednisone|mesh-list
154170663|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
154170664|NCT04497844|Niraparib|niraparib|mesh-list
154170665|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170666|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
154170667|NCT04497844|Hormones|hormones|mesh-ancestor
154170668|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170669|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170670|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154170671|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170672|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154170673|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170674|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170675|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
154170676|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154170677|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154170678|NCT04487080|Osimertinib|osimertinib|mesh-list
154170679|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154170680|NCT04487080|Lazertinib|lazertinib|mesh-list
154170681|NCT04487080|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154861326|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861327|NCT03381742|Clopidogrel|clopidogrel|mesh-list
154861328|NCT03381742|Ticagrelor|ticagrelor|mesh-list
154861329|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154861330|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154861331|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154861332|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154861333|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
154861334|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861335|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861336|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861337|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
154861338|NCT04735042|Empagliflozin|empagliflozin|mesh-list
154861339|NCT04735042|Linagliptin|linagliptin|mesh-list
154861340|NCT04735042|Saxagliptin|saxagliptin|mesh-list
154861341|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154861342|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861343|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154861344|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861345|NCT04735042|Incretins|incretins|mesh-ancestor
154861346|NCT04735042|Hormones|hormones|mesh-ancestor
154861347|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861348|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154861349|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
154861350|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861351|NCT00376012|Rifampin|rifampin|mesh-list
154861352|NCT00376012|Isoniazid|isoniazid|mesh-list
154861353|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
154861354|NCT00376012|Ethambutol|ethambutol|mesh-list
154861355|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154861356|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
154861357|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861358|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861359|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
154861360|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154861361|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861362|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255217|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255218|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
154255219|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
154255220|NCT04774666|Antibodies|antibodies|mesh-list
154255221|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
154255222|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255223|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154255224|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154255225|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154255226|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255227|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255228|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154255229|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154255230|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154255231|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
154255232|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255233|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255234|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154255235|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154255236|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
154255237|NCT03898466|Fluticasone|fluticasone|mesh-list
154255238|NCT03898466|Xhance|xhance|mesh-list
154255239|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255240|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154255241|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
154170731|NCT04313634|Dasatinib|dasatinib|mesh-list
154170732|NCT04313634|Quercetin|quercetin|mesh-list
154170733|NCT04313634|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154170734|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170738|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
154268236|NCT01349062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268237|NCT04848662|Budesonide|budesonide|mesh-list
154268238|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268239|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154268240|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
154268241|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268242|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268243|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154268244|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
154268245|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
154015162|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268246|NCT04848662|Hormones|hormones|mesh-ancestor
154268263|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268264|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268265|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268266|NCT03757364|Methotrexate|methotrexate|mesh-list
154268267|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154861363|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154861364|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154861365|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154861366|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154861367|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154861368|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154861369|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154861370|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154861371|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
154861372|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154861373|NCT02171611|Dabigatran|dabigatran|mesh-list
154861374|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
154861375|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154861376|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
154861377|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861378|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861379|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
154861380|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
154861381|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
154861382|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154861383|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154861384|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861385|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154861386|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861387|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861388|NCT00942305|Brincidofovir|brincidofovir|mesh-list
154861389|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
154861390|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170811|NCT04192136|Niacin|niacin|mesh-list
154170812|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
154170813|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
154170814|NCT04192136|Vitamins|vitamins|mesh-ancestor
154268268|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
154268269|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153493923|NCT03630198|Lidocaine|lidocaine|mesh-list
153493979|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
154268270|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268271|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154268272|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
154268273|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268274|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268275|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
154268276|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268277|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154268278|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268279|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
154268280|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268281|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268282|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
154268283|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154268284|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268285|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
154268287|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
154268288|NCT04737278|Vitamins|vitamins|mesh-ancestor
154268289|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
154268290|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268291|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154268292|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
154268293|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268294|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154268295|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
154268296|NCT03759860|Ranibizumab|ranibizumab|mesh-list
154268297|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154268298|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154268299|NCT03759860|Growth Substances|growth substances|mesh-ancestor
154268300|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268301|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
154268302|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268303|NCT03759782|Tenofovir|tenofovir|mesh-list
154268304|NCT03759782|Ribavirin|ribavirin|mesh-list
153609725|NCT03539055|Dabigatran|dabigatran|mesh-list
154268311|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154268312|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154268313|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
154268314|NCT03757052|Amoxicillin|amoxicillin|mesh-list
154268315|NCT03757052|Penicillins|penicillins|mesh-list
154268316|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154268317|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268318|NCT03765944|Sirolimus|sirolimus|mesh-list
154268319|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154268320|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268321|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154268322|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268323|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
154268324|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268325|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
154268326|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268327|NCT04684394|Aflibercept|aflibercept|mesh-list
154268328|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154268329|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154268330|NCT04684394|Growth Substances|growth substances|mesh-ancestor
154268331|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268332|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
154268333|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268334|NCT03765554|PF-06700841|pf-06700841|mesh-list
154268335|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268336|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268337|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268338|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
154268339|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154268340|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154268341|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861391|NCT01084759|Etoposide|etoposide|mesh-list
154861392|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
154861393|NCT01084759|Testosterone|testosterone|mesh-list
154861394|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
154268342|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268343|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154268344|NCT04668950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154268345|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154268346|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268347|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268348|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268350|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154268351|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
154268352|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154268353|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154268354|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268355|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154268356|NCT03078478|Insulin|insulin|mesh-list
154268357|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154268358|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
154268359|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154268360|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268361|NCT01349296|Everolimus|everolimus|mesh-list
154268362|NCT01349296|Nintedanib|nintedanib|mesh-list
154268363|NCT01349296|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154268364|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268365|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268366|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268367|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268368|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
154268369|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268370|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268371|NCT03522844|Escitalopram|escitalopram|mesh-list
153609785|NCT02625610|Leucovorin|leucovorin|mesh-list
154268380|NCT00045942|Midostaurin|midostaurin|mesh-list
154268381|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
154268382|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268383|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154268384|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154268385|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268386|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268387|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154268388|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
154268389|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154268390|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268391|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154268392|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268393|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268394|NCT04386616|Astegolimab|astegolimab|mesh-list
154015312|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
154268395|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154268396|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268397|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
154268398|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268399|NCT00045708|Epothilones|epothilones|mesh-list
154268400|NCT00045708|Epothilone B|epothilone b|mesh-list
154268401|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
154268402|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154268403|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154268404|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154268405|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268406|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268407|NCT01349452|Ganciclovir|ganciclovir|mesh-list
154268408|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154268409|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
154268410|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154268411|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154268412|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
154268413|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268414|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268415|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268416|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268417|NCT00045630|Paclitaxel|paclitaxel|mesh-list
154268418|NCT00045630|Carboplatin|carboplatin|mesh-list
154268419|NCT00045630|Gemcitabine|gemcitabine|mesh-list
154268420|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154268421|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268422|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
154268423|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
154268424|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
154268425|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268426|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154268427|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
154268428|NCT01357252|Vildagliptin|vildagliptin|mesh-list
154268429|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154268430|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268431|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154268432|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
154268433|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268434|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268441|NCT03465280|Celecoxib|celecoxib|mesh-list
154268442|NCT03465280|Methotrexate|methotrexate|mesh-list
154268443|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
154268444|NCT03465280|Isotretinoin|isotretinoin|mesh-list
154268445|NCT03465280|Cimetidine|cimetidine|mesh-list
154268446|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268447|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268448|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154268449|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
154268450|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154268451|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154268452|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
154268453|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268454|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
154268455|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268456|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154268457|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268458|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
154268459|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268460|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268461|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
154268462|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268463|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154268464|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154268465|NCT03465280|Analgesics|analgesics|mesh-ancestor
154268466|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
154268467|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268468|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268469|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154268470|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154268471|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154268472|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154268473|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154268474|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
154268475|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
154268476|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268477|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154268478|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154268479|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
154268480|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154268481|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154268482|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154268483|NCT03465280|Protective Agents|protective agents|mesh-ancestor
154268484|NCT01349764|Vitamin D|vitamin d|mesh-list
154268485|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
154268486|NCT01349764|Vitamins|vitamins|mesh-ancestor
154268487|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
154268488|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268489|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154268490|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154268491|NCT02924272|Ixazomib|ixazomib|mesh-list
154268492|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268493|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
154268494|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268495|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268496|NCT01353742|Lamivudine|lamivudine|mesh-list
154268497|NCT01353742|Adefovir|adefovir|mesh-list
154268498|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154268499|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154268500|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268501|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268502|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171037|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
154171038|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171039|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
154171040|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171041|NCT04042376|Ibrutinib|ibrutinib|mesh-list
154171042|NCT04042376|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154171043|NCT04042376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171044|NCT04042376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171045|NCT04042376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171046|NCT04034095|Prednisolone|prednisolone|mesh-list
154171047|NCT04034095|Docetaxel|docetaxel|mesh-list
154171048|NCT04034095|Bicalutamide|bicalutamide|mesh-list
154171049|NCT04034095|Androgens|androgens|mesh-list
154171050|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171051|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
154171052|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
154171053|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
154171054|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171055|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171056|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
154171057|NCT04034095|Hormones|hormones|mesh-ancestor
154268503|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
154268504|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268505|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154268506|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154268507|NCT00003702|Dactinomycin|dactinomycin|mesh-list
154268537|NCT00031590|Lomustine|lomustine|mesh-list
154268538|NCT00031590|Etoposide|etoposide|mesh-list
154268539|NCT00031590|Vincristine|vincristine|mesh-list
154268540|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268541|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
154268542|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268543|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268544|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154268545|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
154268546|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268547|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268548|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154268549|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154268550|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154268551|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154268582|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154268583|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154268584|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
154268585|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268586|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154268587|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154268588|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268589|NCT00238433|Melphalan|melphalan|mesh-list
154268590|NCT00238433|Busulfan|busulfan|mesh-list
154268591|NCT00238433|Thiotepa|thiotepa|mesh-list
154268592|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
154268593|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268594|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154861395|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
154861396|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154861397|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154861398|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861399|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154861400|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154861401|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861402|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861403|NCT01084759|Androgens|androgens|mesh-ancestor
154861404|NCT01084759|Hormones|hormones|mesh-ancestor
154861405|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861406|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861407|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154861408|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
154861409|NCT01110187|Lacosamide|lacosamide|mesh-list
154861410|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
154861411|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
154861412|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154861413|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154861414|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268595|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
154171112|NCT03980483|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154171113|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171114|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171115|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171116|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
154171117|NCT03939637|Antibodies|antibodies|mesh-list
154171118|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
154171119|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154171120|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154171121|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
154171122|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171139|NCT03923725|Artesunate|artesunate|mesh-list
154171140|NCT03923725|Lumefantrine|lumefantrine|mesh-list
154171141|NCT03923725|Artemether|artemether|mesh-list
154171142|NCT03923725|Piperaquine|piperaquine|mesh-list
154171143|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154171145|NCT03923725|Mefloquine|mefloquine|mesh-list
154268596|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268618|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268619|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268620|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154268621|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
154268622|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268623|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268624|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154268625|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
154268626|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
154268627|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
154268628|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154268629|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154268630|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154268631|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268632|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154268634|NCT00045162|Irinotecan|irinotecan|mesh-list
154268635|NCT00045162|Etoposide|etoposide|mesh-list
154268636|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268637|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154268638|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154268639|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268640|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268641|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154268642|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154268643|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154268644|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154268645|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154268646|NCT00238121|Sorafenib|sorafenib|mesh-list
154268647|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268648|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268649|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610078|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
154268659|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268661|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154268662|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268663|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268664|NCT01096212|Sevoflurane|sevoflurane|mesh-list
154268665|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154268666|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154268667|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
154268668|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
154861415|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861416|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154861417|NCT01110421|Amoxicillin|amoxicillin|mesh-list
154861418|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
154861419|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
154861420|NCT01110421|Cefepime|cefepime|mesh-list
154861421|NCT01110421|Doripenem|doripenem|mesh-list
154861422|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154861423|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861424|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861425|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154861426|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861427|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861428|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
154861429|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154861430|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154171190|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154171191|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171198|NCT03767244|Androgens|androgens|mesh-list
154171199|NCT03767244|Hormones|hormones|mesh-ancestor
154171200|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154268669|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268670|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268671|NCT03139240|Oxycodone|oxycodone|mesh-list
154268672|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154268673|NCT03139240|Narcotics|narcotics|mesh-ancestor
154268674|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268675|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268676|NCT03139240|Analgesics|analgesics|mesh-ancestor
154268677|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
154268678|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268679|NCT01350856|Artesunate|artesunate|mesh-list
154268680|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
154268681|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154268682|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154268683|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268684|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268685|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
154268686|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
154268687|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154268688|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
154268689|NCT03973775|Permethrin|permethrin|mesh-list
154268690|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268691|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268692|NCT01351168|Levodopa|levodopa|mesh-list
154268693|NCT01351168|Zolpidem|zolpidem|mesh-list
154268694|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154268695|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154268696|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
154268697|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268698|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268699|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268700|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154268701|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154268702|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268703|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154268704|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
154268705|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
154268706|NCT01351636|Arotinolol|arotinolol|mesh-list
154268707|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154268708|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154268709|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
154268710|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268711|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268712|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268713|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153610190|NCT02900560|Cc-486|cc-486|mesh-list
154268730|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
154268731|NCT03136198|Diuretics|diuretics|mesh-list
154268732|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154268733|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
154268734|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268735|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268736|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268737|NCT01357486|Sorafenib|sorafenib|mesh-list
154268738|NCT01357486|Pravastatin|pravastatin|mesh-list
154268739|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268740|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268741|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268742|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268743|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154268744|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154268745|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
154268746|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154268747|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154861431|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861432|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154861433|NCT04358627|Analgesics|analgesics|mesh-ancestor
154861434|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
154861435|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268748|NCT01318564|Metformin|metformin|mesh-list
154268749|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154268750|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268751|NCT00042432|Cinacalcet|cinacalcet|mesh-list
154268752|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154268753|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268754|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154268755|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
154268756|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154268757|NCT01352338|Prednisone|prednisone|mesh-list
154268758|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
154268759|NCT01352338|Lenalidomide|lenalidomide|mesh-list
154268760|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268761|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
154268762|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268763|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268764|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154268765|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
154268766|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268767|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268768|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154268769|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268770|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
154268801|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
154268802|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268803|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268804|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268805|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
154268806|NCT03950700|Epinephrine|epinephrine|mesh-list
154268807|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154268808|NCT03950700|Bupivacaine|bupivacaine|mesh-list
154268809|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154268810|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
154268811|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
154268812|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268813|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268824|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154268825|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494483|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268827|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
154268828|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
154268829|NCT00237185|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154268830|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268831|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268832|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268833|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268834|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
154268835|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154268836|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154268837|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154268838|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268839|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268840|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
154268841|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268842|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268843|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154268844|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268845|NCT00003222|Aldesleukin|aldesleukin|mesh-list
154268846|NCT00003222|Interleukin-2|interleukin-2|mesh-list
154268847|NCT00003222|Sargramostim|sargramostim|mesh-list
154268848|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
154268849|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268850|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154268851|NCT00003222|Analgesics|analgesics|mesh-ancestor
154268852|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
154268853|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268854|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268855|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
154268856|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154268857|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154268858|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
154268859|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268860|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154268861|NCT01357876|Metformin|metformin|mesh-list
154268862|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154268863|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268864|NCT02877082|Bortezomib|bortezomib|mesh-list
154268865|NCT02877082|Tacrolimus|tacrolimus|mesh-list
154268866|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
154268867|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154268868|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268869|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
154268870|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268871|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154268872|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268873|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268874|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268875|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154268876|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154268877|NCT03951558|Diuretics|diuretics|mesh-ancestor
154268878|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
154268891|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268892|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
154268893|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
154268894|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
154268895|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268896|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
154268897|NCT00002850|Ofloxacin|ofloxacin|mesh-list
154268898|NCT00002850|Trimethoprim|trimethoprim|mesh-list
154268899|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
154268900|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154268901|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268902|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154268903|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154268904|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268905|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268906|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268907|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154268908|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154268909|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154268910|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
154268911|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154268912|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154268913|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154268914|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154268915|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154268916|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
154268917|NCT04234906|Amiodarone|amiodarone|mesh-list
154268918|NCT04234906|Procainamide|procainamide|mesh-list
154268919|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
154268920|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154268921|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268922|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268923|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154268925|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
154268926|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268927|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154268928|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154268929|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154268930|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
154268931|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268932|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268933|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
154268934|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154268935|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
154268936|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154268937|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268938|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154268939|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
154268940|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154268977|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154268978|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268979|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268980|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
154268981|NCT00002766|Hormones|hormones|mesh-ancestor
154269017|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269018|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269019|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154269020|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269021|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154269022|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154269023|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269024|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269025|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269026|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269027|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269028|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
154269029|NCT01584492|Hormones|hormones|mesh-ancestor
154269030|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269031|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
154269032|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154269033|NCT00001962|Daclizumab|daclizumab|mesh-list
154269034|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154269035|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
154269036|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269037|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154269038|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154269039|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
154269040|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154269041|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
154269042|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269043|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
154269044|NCT01101984|Protective Agents|protective agents|mesh-ancestor
154269045|NCT01103154|Nadolol|nadolol|mesh-list
154269046|NCT01103154|Carvedilol|carvedilol|mesh-list
154269047|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154269048|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154269049|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269050|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269051|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269052|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269053|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154269054|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
154269055|NCT01103154|Protective Agents|protective agents|mesh-ancestor
154269056|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153610481|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154269071|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154269073|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
154269074|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269075|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154269077|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154269078|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154269079|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269080|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
154269081|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269082|NCT03950544|Meropenem|meropenem|mesh-list
154269083|NCT03950544|Fosfomycin|fosfomycin|mesh-list
154269084|NCT03950544|Tigecycline|tigecycline|mesh-list
154269085|NCT03950544|Polymyxins|polymyxins|mesh-list
154269086|NCT03950544|Polymyxin B|polymyxin b|mesh-list
154269087|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154269088|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269089|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154269090|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269091|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494662|NCT01115244|Dapsone|dapsone|mesh-list
154269092|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
154269093|NCT00028002|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154269094|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154269095|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269096|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269097|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269098|NCT00256997|Risperidone|risperidone|mesh-list
154269099|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
154269100|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154269101|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
154269102|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269103|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269104|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269105|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154269106|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269107|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154269108|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154269109|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
154269110|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
154269111|NCT00027846|Carboplatin|carboplatin|mesh-list
154269112|NCT00027846|Etoposide|etoposide|mesh-list
154269113|NCT00027846|Vincristine|vincristine|mesh-list
154269114|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
154269115|NCT00027846|Lenograstim|lenograstim|mesh-list
154269116|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153610550|NCT01947790|Metformin|metformin|mesh-list
154269125|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154269126|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154269127|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154269128|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269129|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154269130|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
154269131|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
154269132|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
154269133|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
154269134|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
154269135|NCT00027378|Fluoxetine|fluoxetine|mesh-list
154269136|NCT00027378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154269137|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154269138|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154269139|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269140|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269141|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
154269142|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269143|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154269144|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
154269145|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154269146|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154269147|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154269148|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269149|NCT03949062|Rituximab|rituximab|mesh-list
154269150|NCT03949062|Lenalidomide|lenalidomide|mesh-list
154269151|NCT03949062|Ibrutinib|ibrutinib|mesh-list
154269152|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154269153|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269154|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
154269155|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269156|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154269157|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154269158|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154269159|NCT03949062|Growth Substances|growth substances|mesh-ancestor
154269160|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
154269161|NCT03949062|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154269162|NCT03949062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154269163|NCT03949062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269164|NCT03949062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269165|NCT00235391|Deferasirox|deferasirox|mesh-list
154269166|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154269167|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
154269168|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
154269169|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269170|NCT01103622|Digoxin|digoxin|mesh-list
154269171|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269172|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154269173|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269174|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269175|NCT01103622|Protective Agents|protective agents|mesh-ancestor
154269176|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269177|NCT01072955|Heparin|heparin|mesh-list
154269178|NCT01072955|Calcium heparin|calcium heparin|mesh-list
154269179|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
154269180|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154269181|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154269193|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
154269194|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269195|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154269196|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154269197|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
154269198|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269199|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269200|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154269201|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154269202|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154269203|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154269204|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269205|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269206|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
154582964|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269208|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269209|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154269210|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154269211|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
154269212|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
154269213|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
154269214|NCT00025662|Interleukin-2|interleukin-2|mesh-list
154269215|NCT00025662|Immunotoxins|immunotoxins|mesh-list
154269216|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269217|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154269218|NCT00025662|Analgesics|analgesics|mesh-ancestor
154269219|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
154269220|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269221|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269222|NCT00025662|Immunoconjugates|immunoconjugates|mesh-ancestor
154269223|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
154269224|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
154269225|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154269226|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
154269227|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269228|NCT03759158|Expectorants|expectorants|mesh-ancestor
154269229|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269230|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154269231|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
154269232|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269233|NCT03759158|Protective Agents|protective agents|mesh-ancestor
154269234|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269235|NCT03759158|Antidotes|antidotes|mesh-ancestor
154269236|NCT00025506|Thalidomide|thalidomide|mesh-list
154269237|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154269238|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
154269239|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269240|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
154269241|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154269242|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269243|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154269244|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154269245|NCT00025506|Growth Substances|growth substances|mesh-ancestor
154269246|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
154269247|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610668|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
154269269|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154269270|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269271|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
154269272|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
154269273|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154269274|NCT00023712|Bortezomib|bortezomib|mesh-list
154269275|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269276|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154269277|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
154269278|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269279|NCT04640168|Remdesivir|remdesivir|mesh-list
154269280|NCT04640168|Dexamethasone|dexamethasone|mesh-list
154269281|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269282|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
154269283|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
154269284|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269285|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269286|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154269287|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
154269288|NCT04640168|Hormones|hormones|mesh-ancestor
154269289|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269290|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154269291|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269292|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
154269293|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269294|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
154269295|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269296|NCT00022698|Capecitabine|capecitabine|mesh-list
154269297|NCT00022698|Irinotecan|irinotecan|mesh-list
154269298|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154269299|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
154269300|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269301|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269309|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269310|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154861436|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154861437|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154861438|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154861439|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154861440|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861441|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861442|NCT04356677|Ribavirin|ribavirin|mesh-list
154171626|NCT03090165|Bicalutamide|bicalutamide|mesh-list
154171627|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
154171628|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
154171629|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171630|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171631|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171632|NCT03076554|Avelumab|avelumab|mesh-list
154171633|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171634|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171635|NCT03056755|Letrozole|letrozole|mesh-list
154171636|NCT03056755|Fulvestrant|fulvestrant|mesh-list
154171637|NCT03056755|Leuprolide|leuprolide|mesh-list
154171638|NCT03056755|Goserelin|goserelin|mesh-list
154171639|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171640|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154171641|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154171642|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171643|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171644|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154269311|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154269312|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269313|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269314|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269315|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154269316|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
154269317|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154269318|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269319|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154269320|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154269321|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154269322|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154269323|NCT03951402|Narcotics|narcotics|mesh-ancestor
154269324|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269325|NCT03951402|Analgesics|analgesics|mesh-ancestor
154269326|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
154269327|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269328|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154269329|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154269330|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154269331|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269332|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269333|NCT01100736|Bosentan|bosentan|mesh-list
154269334|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
153494829|NCT00619242|Sorafenib|sorafenib|mesh-list
154269335|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154269336|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154269337|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269338|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
154269339|NCT01584726|Analgesics|analgesics|mesh-ancestor
154861443|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
154861444|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861445|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
154861446|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861447|NCT04356833|Plasminogen|plasminogen|mesh-list
154861448|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154861449|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154861450|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154861451|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861452|NCT05620277|Tocopherols|tocopherols|mesh-list
154861453|NCT05620277|Vitamin E|vitamin e|mesh-list
154861454|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
154861455|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
154861456|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861457|NCT05620277|Protective Agents|protective agents|mesh-ancestor
154861458|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861459|NCT05620277|Vitamins|vitamins|mesh-ancestor
154861460|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
154861461|NCT01110499|Bimatoprost|bimatoprost|mesh-list
154861462|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154269340|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
154269341|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269342|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269343|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
154269344|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269345|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269346|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
154269347|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154269348|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154269349|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269350|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154269351|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
154269352|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154269353|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
154269354|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269355|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
154269356|NCT01105494|Hematinics|hematinics|mesh-ancestor
154269357|NCT06159504|Sofosbuvir|sofosbuvir|mesh-list
154269358|NCT06159504|Velpatasvir|velpatasvir|mesh-list
154269359|NCT06159504|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154269360|NCT06159504|Antiviral Agents|antiviral agents|mesh-ancestor
154269361|NCT06159504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269362|NCT06159491|Azacitidine|azacitidine|mesh-list
154269363|NCT06159491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154269364|NCT06159491|Antimetabolites|antimetabolites|mesh-ancestor
154269365|NCT06159491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269366|NCT06159491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269367|NCT06159491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269368|NCT06159348|Chrysarobin|chrysarobin|mesh-list
154269382|NCT06159322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269383|NCT06159322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154269384|NCT06159322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154269385|NCT06159322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154269386|NCT06159322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269387|NCT06159322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154269388|NCT06159322|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154269389|NCT06159322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154269390|NCT06159322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582965|NCT05435729|Levodopa|levodopa|mesh-list
153494956|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154269391|NCT06159322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269392|NCT06159322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269393|NCT06159322|Serotonin Agents|serotonin agents|mesh-ancestor
154269394|NCT06159322|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154269395|NCT06159322|GABA Antagonists|gaba antagonists|mesh-ancestor
154269396|NCT06159322|GABA Agents|gaba agents|mesh-ancestor
154269397|NCT06159114|Celecoxib|celecoxib|mesh-list
154269398|NCT06159114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154269399|NCT06159114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154269400|NCT06159114|Analgesics|analgesics|mesh-ancestor
154269401|NCT06159114|Sensory System Agents|sensory system agents|mesh-ancestor
154269402|NCT06159114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269403|NCT06159114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269404|NCT06159114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269405|NCT06159114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154269406|NCT06159114|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154269407|NCT06159114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154269408|NCT06159114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269409|NCT06159114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269410|NCT06159101|Ipilimumab|ipilimumab|mesh-list
154269411|NCT06159101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154269412|NCT06159101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269413|NCT06159101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154269414|NCT06159101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269415|NCT06158932|Vitamin D|vitamin d|mesh-list
154269416|NCT06158932|Inositol|inositol|mesh-list
154269417|NCT06158932|Vitamins|vitamins|mesh-ancestor
154269418|NCT06158932|Micronutrients|micronutrients|mesh-ancestor
154269419|NCT06158932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269420|NCT06158932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154269421|NCT06158932|Vitamin B Complex|vitamin b complex|mesh-ancestor
154269422|NCT06158919|Capecitabine|capecitabine|mesh-list
154269423|NCT06158919|Nivolumab|nivolumab|mesh-list
154269424|NCT06158919|Oxaliplatin|oxaliplatin|mesh-list
154269425|NCT06158919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154255243|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269426|NCT06158919|Antimetabolites|antimetabolites|mesh-ancestor
154269427|NCT06158919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269428|NCT06158919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269429|NCT06158919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154269430|NCT06158919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154269431|NCT06158893|Budesonide|budesonide|mesh-list
154269432|NCT06158893|Albuterol|albuterol|mesh-list
154269439|NCT06158893|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269441|NCT06158893|Hormones|hormones|mesh-ancestor
154269442|NCT06158893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269443|NCT06158893|Tocolytic Agents|tocolytic agents|mesh-ancestor
154269444|NCT06158893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154269445|NCT06158893|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154269446|NCT06158893|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154269447|NCT06158893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269448|NCT06158893|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269449|NCT06158893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269450|NCT06158893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269451|NCT06158828|Plerixafor|plerixafor|mesh-list
154269452|NCT06158828|Fludarabine|fludarabine|mesh-list
154269453|NCT06158828|Melphalan|melphalan|mesh-list
154269454|NCT06158828|Busulfan|busulfan|mesh-list
154269455|NCT06158828|Thiotepa|thiotepa|mesh-list
154269456|NCT06158828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154269457|NCT06158828|Thymoglobulin|thymoglobulin|mesh-list
154269458|NCT06158828|Lenograstim|lenograstim|mesh-list
154269459|NCT06158828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269460|NCT06158828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269461|NCT06158828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154269462|NCT06158828|Immunologic Factors|immunologic factors|mesh-ancestor
154269463|NCT06158828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269464|NCT06158828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154269465|NCT06158828|Alkylating Agents|alkylating agents|mesh-ancestor
154269466|NCT06158828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154269467|NCT06158828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154269468|NCT06158828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154269469|NCT06158828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154269470|NCT06158828|Antiviral Agents|antiviral agents|mesh-ancestor
154269471|NCT06158828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269472|NCT06158334|Hemostatics|hemostatics|mesh-list
154269473|NCT06158334|Coagulants|coagulants|mesh-ancestor
154269474|NCT06158230|Propranolol|propranolol|mesh-list
154269475|NCT06158230|Amitriptyline|amitriptyline|mesh-list
154269476|NCT06158230|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154269477|NCT06158230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154269478|NCT06158230|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269479|NCT06158230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269480|NCT06158230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269481|NCT06158230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269482|NCT06158230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269483|NCT06158230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154269484|NCT06158230|Vasodilator Agents|vasodilator agents|mesh-ancestor
154269485|NCT06158230|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154269486|NCT06158230|Antidepressive Agents|antidepressive agents|mesh-ancestor
154269487|NCT06158230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154269488|NCT06158230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154269489|NCT06158230|Analgesics|analgesics|mesh-ancestor
154269490|NCT06158230|Sensory System Agents|sensory system agents|mesh-ancestor
154269491|NCT06158230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269492|NCT06158230|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154269493|NCT06158230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154269494|NCT06158230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154269495|NCT06158048|Phenylephrine|phenylephrine|mesh-list
154269496|NCT06158048|Oxymetazoline|oxymetazoline|mesh-list
154269497|NCT06158048|Norepinephrine|norepinephrine|mesh-list
154269498|NCT06158048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154269499|NCT06158048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154269500|NCT06158048|Mydriatics|mydriatics|mesh-ancestor
154269501|NCT06158048|Autonomic Agents|autonomic agents|mesh-ancestor
154269502|NCT06158048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269521|NCT06158035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269522|NCT06158035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016429|NCT05301205|Analgesics|analgesics|mesh-ancestor
154269523|NCT06158035|Sympathomimetics|sympathomimetics|mesh-ancestor
154269524|NCT06158035|Nasal Decongestants|nasal decongestants|mesh-ancestor
154861463|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154171844|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154171846|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154171847|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154171848|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
154171849|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171850|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
154171851|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171852|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154171853|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171854|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154171855|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
154171856|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171857|NCT02203526|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154171858|NCT02203526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171859|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
154171884|NCT02123758|Prednisone|prednisone|mesh-list
154171885|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
154171886|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171887|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
154171888|NCT02123758|Hormones|hormones|mesh-ancestor
154171890|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269525|NCT06158035|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269526|NCT06158035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154269528|NCT06158035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269529|NCT06158035|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269530|NCT06158035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269531|NCT06158035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269532|NCT06158035|Protective Agents|protective agents|mesh-ancestor
154269533|NCT06158022|Phenylephrine|phenylephrine|mesh-list
154269534|NCT06158022|Oxymetazoline|oxymetazoline|mesh-list
154269535|NCT06158022|Norepinephrine|norepinephrine|mesh-list
154269536|NCT06158022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154269537|NCT06158022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154269538|NCT06158022|Mydriatics|mydriatics|mesh-ancestor
154269539|NCT06158022|Autonomic Agents|autonomic agents|mesh-ancestor
154269540|NCT06158022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269541|NCT06158022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269542|NCT06158022|Sympathomimetics|sympathomimetics|mesh-ancestor
154269543|NCT06158022|Nasal Decongestants|nasal decongestants|mesh-ancestor
154269544|NCT06158022|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269545|NCT06158022|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154269546|NCT06158022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154269547|NCT06158022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269548|NCT06158022|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269549|NCT06158022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269550|NCT06158022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269551|NCT06158022|Protective Agents|protective agents|mesh-ancestor
154269552|NCT06158009|Phenylephrine|phenylephrine|mesh-list
154269553|NCT06158009|Oxymetazoline|oxymetazoline|mesh-list
154269554|NCT06158009|Norepinephrine|norepinephrine|mesh-list
154269555|NCT06158009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154269556|NCT06158009|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154861464|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154861465|NCT02174419|Nalbuphine|nalbuphine|mesh-list
154861466|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154861467|NCT02174419|Narcotics|narcotics|mesh-ancestor
154861468|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861469|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861470|NCT02174419|Analgesics|analgesics|mesh-ancestor
154861471|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
154861472|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861473|NCT05620589|Amoxicillin|amoxicillin|mesh-list
154861474|NCT05620589|Tetracycline|tetracycline|mesh-list
154861475|NCT05620589|Esomeprazole|esomeprazole|mesh-list
154861476|NCT05620589|Bismuth|bismuth|mesh-list
154861477|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861478|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861479|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154861480|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154861481|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154861482|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861483|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861484|NCT05620589|Antacids|antacids|mesh-ancestor
154861485|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154861486|NCT01086475|Cycloserine|cycloserine|mesh-list
154255244|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154269557|NCT06158009|Mydriatics|mydriatics|mesh-ancestor
154269558|NCT06158009|Autonomic Agents|autonomic agents|mesh-ancestor
154269559|NCT06158009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269560|NCT06158009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269561|NCT06158009|Sympathomimetics|sympathomimetics|mesh-ancestor
154269581|NCT06157905|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154269582|NCT06157905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154269584|NCT06157853|Sunscreening Agents|sunscreening agents|mesh-list
154269585|NCT06157853|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154269586|NCT06157853|Protective Agents|protective agents|mesh-ancestor
154269587|NCT06157853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269588|NCT06157853|Dermatologic Agents|dermatologic agents|mesh-ancestor
154269589|NCT06157580|Compound 21|compound 21|mesh-list
154269590|NCT06157580|Angiotensin II|angiotensin ii|mesh-list
154269591|NCT06157580|Giapreza|giapreza|mesh-list
154269592|NCT06157580|Angiotensinogen|angiotensinogen|mesh-list
154269593|NCT06157580|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154269594|NCT06157580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154269595|NCT06157580|Protease Inhibitors|protease inhibitors|mesh-ancestor
154269596|NCT06157580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269597|NCT06157580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269598|NCT06157580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269599|NCT06152861|Timolol|timolol|mesh-list
154269600|NCT06152861|Travoprost|travoprost|mesh-list
154269601|NCT06152861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154269602|NCT06152861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154269603|NCT06152861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269604|NCT06152861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154269605|NCT06152861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154269606|NCT06152861|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269607|NCT06152861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269608|NCT06152861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269609|NCT06152861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269610|NCT06152861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154269612|NCT06132880|Coagulants|coagulants|mesh-ancestor
154269613|NCT06132880|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154269614|NCT06132880|Fertility Agents|fertility agents|mesh-ancestor
154269615|NCT06132880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154269616|NCT06132880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269630|NCT06085573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269631|NCT06085573|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269632|NCT06085573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269633|NCT06085573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269634|NCT06066996|Nicotine|nicotine|mesh-list
154269635|NCT06066996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154269636|NCT06066996|Autonomic Agents|autonomic agents|mesh-ancestor
154269637|NCT06066996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269638|NCT06066996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269639|NCT06066996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154269640|NCT06066996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154269641|NCT06066996|Cholinergic Agents|cholinergic agents|mesh-ancestor
154269642|NCT06066996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269643|NCT06066996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269644|NCT06035081|Prednisolone|prednisolone|mesh-list
154269645|NCT06035081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269646|NCT06035081|Glucocorticoids|glucocorticoids|mesh-ancestor
154269647|NCT06035081|Hormones|hormones|mesh-ancestor
154269648|NCT06035081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269649|NCT06035081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269650|NCT06035081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154269651|NCT06035081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269652|NCT06034925|Valganciclovir|valganciclovir|mesh-list
154269653|NCT06034925|Maribavir|maribavir|mesh-list
154269654|NCT06034925|Antiviral Agents|antiviral agents|mesh-ancestor
154269655|NCT06034925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269656|NCT06031454|Rifampin|rifampin|mesh-list
154269657|NCT06031454|Verapamil|verapamil|mesh-list
154269658|NCT06031454|Midazolam|midazolam|mesh-list
154269659|NCT06031454|Omeprazole|omeprazole|mesh-list
154269660|NCT06031454|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154269661|NCT06031454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154269662|NCT06031454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154269663|NCT06031454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269664|NCT06031454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269665|NCT06031454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154861487|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154269666|NCT06031454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154269667|NCT06031454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154269668|NCT06031454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154269669|NCT06031454|Anesthetics, General|anesthetics, general|mesh-ancestor
154269670|NCT06031454|Anesthetics|anesthetics|mesh-ancestor
154269671|NCT06031454|GABA Modulators|gaba modulators|mesh-ancestor
154269672|NCT06031454|GABA Agents|gaba agents|mesh-ancestor
154269673|NCT06031454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269674|NCT06031454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269675|NCT06031454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154269676|NCT06031454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154269677|NCT06031454|Antimetabolites|antimetabolites|mesh-ancestor
154016579|NCT00612144|Metformin|metformin|mesh-list
154269678|NCT06031454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154269708|NCT06018883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269709|NCT06018883|Tubulin Modulators|tubulin modulators|mesh-ancestor
153495230|NCT00000264|Ethanol|ethanol|mesh-list
154269710|NCT06018883|Antimitotic Agents|antimitotic agents|mesh-ancestor
154269711|NCT06018883|Mitosis Modulators|mitosis modulators|mesh-ancestor
154269712|NCT06018883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269713|NCT06018883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154269715|NCT06006884|Dimercaprol|dimercaprol|mesh-list
154269716|NCT06006884|Chelating Agents|chelating agents|mesh-ancestor
154269717|NCT06006884|Sequestering Agents|sequestering agents|mesh-ancestor
154269718|NCT06006884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269719|NCT06003166|4-Aminopyridine|4-aminopyridine|mesh-list
153611156|NCT01951560|Valproic Acid|valproic acid|mesh-list
154269729|NCT05980117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154269730|NCT05980117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154269731|NCT05980117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154269732|NCT05980117|Anesthetics, General|anesthetics, general|mesh-ancestor
154269733|NCT05980117|Anesthetics|anesthetics|mesh-ancestor
154269734|NCT05980117|GABA Modulators|gaba modulators|mesh-ancestor
154269735|NCT05980117|GABA Agents|gaba agents|mesh-ancestor
154269736|NCT05980117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269737|NCT05980117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269738|NCT05951023|Eszopiclone|eszopiclone|mesh-list
154269739|NCT05951023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154269740|NCT05951023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269741|NCT05951023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269742|NCT05949203|Cabotegravir|cabotegravir|mesh-list
154269743|NCT05949203|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154269744|NCT05949203|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154269745|NCT05949203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269746|NCT05949203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269747|NCT05949203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154269748|NCT05949203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154269749|NCT05949203|Antiviral Agents|antiviral agents|mesh-ancestor
154269750|NCT05949203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269751|NCT05938712|Dapagliflozin|dapagliflozin|mesh-list
154269752|NCT05938712|Semaglutide|semaglutide|mesh-list
154269753|NCT05938712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154269754|NCT05938712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269755|NCT05938712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154269756|NCT05938712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269757|NCT05938712|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154269758|NCT05923060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154269759|NCT05923060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154269760|NCT05923060|Dermatologic Agents|dermatologic agents|mesh-ancestor
154269761|NCT05870761|Niraparib|niraparib|mesh-list
154269762|NCT05870761|Dostarlimab|dostarlimab|mesh-list
154269763|NCT05870761|Immunoglobulins|immunoglobulins|mesh-list
154269764|NCT05870761|Immunoglobulin G|immunoglobulin g|mesh-list
154269765|NCT05870761|Immunologic Factors|immunologic factors|mesh-ancestor
154269766|NCT05870761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269767|NCT05870761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154269768|NCT05870761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269769|NCT05870761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269770|NCT05870761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269771|NCT05850455|Lidocaine|lidocaine|mesh-list
154269772|NCT05850455|Dexmedetomidine|dexmedetomidine|mesh-list
154269773|NCT05850455|Bupivacaine|bupivacaine|mesh-list
154269774|NCT05850455|Anesthetics, Local|anesthetics, local|mesh-ancestor
154269775|NCT05850455|Anesthetics|anesthetics|mesh-ancestor
154269776|NCT05850455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269777|NCT05850455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255245|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269778|NCT05850455|Sensory System Agents|sensory system agents|mesh-ancestor
154269779|NCT05850455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269780|NCT05850455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269781|NCT05850455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154269782|NCT05850455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154269783|NCT05850455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153611196|NCT01951846|Nintedanib|nintedanib|mesh-list
154269792|NCT05850455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269793|NCT05798390|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154269794|NCT05798390|Ezetimibe|ezetimibe|mesh-list
154269795|NCT05798390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154269796|NCT05798390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154269797|NCT05798390|Antimetabolites|antimetabolites|mesh-ancestor
154269798|NCT05798390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269799|NCT05798390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154269800|NCT05798390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269801|NCT05798390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154269802|NCT05798390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269803|NCT05796388|Linaclotide|linaclotide|mesh-list
154269804|NCT05796388|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154269805|NCT05796388|Enzyme Activators|enzyme activators|mesh-ancestor
154269806|NCT05796388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269807|NCT05796388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154269808|NCT05755997|Cerebrolysin|cerebrolysin|mesh-list
154269809|NCT05755997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154269810|NCT05755997|Protective Agents|protective agents|mesh-ancestor
154269811|NCT05755997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269812|NCT05755997|Nootropic Agents|nootropic agents|mesh-ancestor
154269813|NCT05754593|Hormones|hormones|mesh-list
154269814|NCT05754593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269815|NCT05754593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269816|NCT05752305|Dexamethasone|dexamethasone|mesh-list
154269817|NCT05752305|Methylprednisolone|methylprednisolone|mesh-list
154269818|NCT05752305|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154269819|NCT05752305|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154269820|NCT05752305|Prednisolone|prednisolone|mesh-list
154269821|NCT05752305|Prednisolone acetate|prednisolone acetate|mesh-list
154269822|NCT05752305|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154269823|NCT05752305|Prednisolone phosphate|prednisolone phosphate|mesh-list
154269824|NCT05752305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269825|NCT05752305|Antiemetics|antiemetics|mesh-ancestor
154269826|NCT05752305|Autonomic Agents|autonomic agents|mesh-ancestor
154269827|NCT05752305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269828|NCT05752305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269829|NCT05752305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153495315|NCT00000336|Selegiline|selegiline|mesh-list
154269830|NCT05752305|Glucocorticoids|glucocorticoids|mesh-ancestor
154269831|NCT05752305|Hormones|hormones|mesh-ancestor
154269832|NCT05752305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269833|NCT05752305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154269834|NCT05752305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269835|NCT05752305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154269836|NCT05752305|Protective Agents|protective agents|mesh-ancestor
154269837|NCT05752110|Ketamine|ketamine|mesh-list
154269838|NCT05752110|Analgesics|analgesics|mesh-ancestor
154269839|NCT05752110|Sensory System Agents|sensory system agents|mesh-ancestor
154269840|NCT05752110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269841|NCT05752110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269842|NCT05752110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154269843|NCT05752110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154269844|NCT05752110|Anesthetics, General|anesthetics, general|mesh-ancestor
154269845|NCT05752110|Anesthetics|anesthetics|mesh-ancestor
154269846|NCT05752110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269847|NCT05752110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154269848|NCT05752110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154269849|NCT05752110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269857|NCT05702879|Ustekinumab|ustekinumab|mesh-list
154269858|NCT05702879|Vedolizumab|vedolizumab|mesh-list
154269859|NCT05702879|Ozanimod|ozanimod|mesh-list
154269860|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269861|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
154269862|NCT05702879|Hormones|hormones|mesh-ancestor
154269863|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861488|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861489|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154255246|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
154172162|NCT00001481|Estradiol|estradiol|mesh-list
154269864|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269865|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154269866|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269867|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269868|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154269869|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154269870|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
154269871|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154269872|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154269873|NCT05702879|Analgesics|analgesics|mesh-ancestor
154269874|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
154269875|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154269876|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
154269877|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154269878|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269879|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154269880|NCT05576194|Taurolidine|taurolidine|mesh-list
154269881|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154269882|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269883|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269884|NCT05489406|Dolutegravir|dolutegravir|mesh-list
154269885|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154269886|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154269887|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269888|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269889|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154269890|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154269891|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
154269892|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269893|NCT05470881|Atropine|atropine|mesh-list
154269894|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154269895|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269896|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154269897|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
154269898|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269899|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269900|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154269901|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269903|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
154269904|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154269905|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154269906|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
154269907|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269908|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269909|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
154269910|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154269911|NCT05394493|Avelumab|avelumab|mesh-list
154269912|NCT05394493|Axitinib|axitinib|mesh-list
154269913|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154269914|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269915|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154269916|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269917|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269918|NCT05364099|Triamcinolone|triamcinolone|mesh-list
154269919|NCT05364099|Lidocaine|lidocaine|mesh-list
154269920|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
154269937|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
154269938|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269940|NCT05217680|Ranibizumab|ranibizumab|mesh-list
154269941|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154269942|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269943|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154269944|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154269945|NCT05217680|Growth Substances|growth substances|mesh-ancestor
154269946|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269947|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
154269948|NCT05210374|Copper|copper|mesh-list
154269949|NCT05210374|Doxorubicin|doxorubicin|mesh-list
154269950|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154269951|NCT05210374|Disulfiram|disulfiram|mesh-list
154269952|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154269953|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861490|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
154861491|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154255247|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154269954|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154269955|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154269956|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269957|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269958|NCT05210374|Trace Elements|trace elements|mesh-ancestor
154269959|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
153495423|NCT00000510|Aspirin|aspirin|mesh-list
153495474|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
154269960|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269961|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154269962|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154269963|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
154269964|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154269965|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
154269966|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154269967|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269968|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154269969|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154269970|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154269971|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
154269972|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154269973|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
154269974|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269975|NCT05172934|Tenecteplase|tenecteplase|mesh-list
154269976|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154269977|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154269994|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154269995|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
154269996|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269997|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154269998|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154269999|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270000|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270001|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154270002|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154270003|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154270004|NCT05105633|Tenecteplase|tenecteplase|mesh-list
154270005|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154270006|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154270007|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270008|NCT05090033|Ofatumumab|ofatumumab|mesh-list
154270009|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270010|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
154270011|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
154270012|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270013|NCT05070260|Glenzocimab|glenzocimab|mesh-list
154270014|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
154270015|NCT05012865|Avelumab|avelumab|mesh-list
154270016|NCT05012865|Axitinib|axitinib|mesh-list
154270017|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270018|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270019|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270020|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270021|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270022|NCT04877275|Dexamethasone|dexamethasone|mesh-list
154270023|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
154270024|NCT04877275|Doxorubicin|doxorubicin|mesh-list
154270025|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154270026|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154270027|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
154270028|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270029|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270030|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154270031|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
154270032|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270033|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611462|NCT05874700|Sivelestat|sivelestat|mesh-list
154270047|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270048|NCT04765111|Rituximab|rituximab|mesh-list
154270049|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154270050|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
154270051|NCT04765111|Antibodies|antibodies|mesh-list
154270052|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
154270053|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154270054|NCT04765111|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154270055|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
154861492|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
154270056|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270057|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270058|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270059|NCT04765111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270060|NCT04765111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270061|NCT04765111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270062|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
154270063|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154270064|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
154270065|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270066|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
154270067|NCT04704518|Protective Agents|protective agents|mesh-ancestor
154270068|NCT04617015|Bromides|bromides|mesh-list
154270069|NCT04617015|Ipratropium|ipratropium|mesh-list
154270070|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
154270071|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154270072|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
154270073|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270074|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270075|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154270076|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
154270077|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154270078|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
154270079|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582966|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154270080|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270081|NCT04616547|Edetic Acid|edetic acid|mesh-list
154270082|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
154270083|NCT04616547|Antidotes|antidotes|mesh-ancestor
154270084|NCT04616547|Protective Agents|protective agents|mesh-ancestor
154270085|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270086|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
154270087|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
154270088|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270089|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154270090|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
154270091|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154270092|NCT04616248|Poly I-C|poly i-c|mesh-list
154270093|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154270094|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154270095|NCT04616248|Antibodies|antibodies|mesh-list
154270096|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
154270115|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
154270116|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270117|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270118|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270119|NCT04597372|Urological Agents|urological agents|mesh-ancestor
154270120|NCT04585815|Axitinib|axitinib|mesh-list
154270121|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270122|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270123|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270124|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270125|NCT04570436|Diazepam|diazepam|mesh-list
154270126|NCT04570436|Gabapentin|gabapentin|mesh-list
154270127|NCT04570436|Analgesics|analgesics|mesh-ancestor
154270128|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
154270129|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270130|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270132|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154270133|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154270134|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154270135|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154270136|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154270137|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154270138|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270139|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270140|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
154270141|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154270142|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
154270143|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
154270144|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154270145|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154270146|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154270147|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154270148|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154270149|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
154270150|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
154270151|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
154270152|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
154270153|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
154270154|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270155|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270156|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154270166|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270167|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270168|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270169|NCT04551040|Urological Agents|urological agents|mesh-ancestor
154270178|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154270179|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
154270180|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270181|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270182|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154270183|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154270184|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
154270185|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270186|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270187|NCT04382326|Vaccines|vaccines|mesh-list
154270188|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154270189|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
154270190|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270191|NCT04379739|Apatinib|apatinib|mesh-list
154270192|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270193|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270194|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270195|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270196|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154270197|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
154270198|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
154270199|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154270200|NCT04349826|Azithromycin|azithromycin|mesh-list
154270201|NCT04349826|Cefixime|cefixime|mesh-list
154270202|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270203|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270204|NCT04349826|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154270205|NCT04349826|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154270206|NCT04324229|Liraglutide|liraglutide|mesh-list
154270207|NCT04324229|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154270208|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154270209|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270210|NCT04324229|Incretins|incretins|mesh-ancestor
154270211|NCT04324229|Hormones|hormones|mesh-ancestor
154270212|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270213|NCT04251585|Insulin|insulin|mesh-list
154270214|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154270215|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270216|NCT04224272|Fulvestrant|fulvestrant|mesh-list
154270217|NCT04224272|Palbociclib|palbociclib|mesh-list
154270218|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154270219|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270220|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154270221|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154270233|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
154270234|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270235|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270236|NCT04223856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270237|NCT04080739|Ropivacaine|ropivacaine|mesh-list
154270238|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
154270239|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
154270240|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306789|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
154270241|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270242|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
154270243|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270244|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
154270245|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270246|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270247|NCT04074096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270248|NCT04074096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270249|NCT04046575|Paclitaxel|paclitaxel|mesh-list
154270250|NCT04046575|Carboplatin|carboplatin|mesh-list
154270251|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154255248|NCT02527772|Leucovorin|leucovorin|mesh-list
154255249|NCT02527772|Gemcitabine|gemcitabine|mesh-list
154270252|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270253|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
154270254|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
154270255|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
154270256|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270257|NCT03953898|Olaparib|olaparib|mesh-list
154270258|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154270259|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270260|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270261|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270262|NCT03799835|Atezolizumab|atezolizumab|mesh-list
154270263|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
154270264|NCT03799835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270265|NCT03799835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270266|NCT03799835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270267|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270268|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154270269|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
154270270|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270271|NCT03778554|Metoprolol|metoprolol|mesh-list
154270272|NCT03778554|Carvedilol|carvedilol|mesh-list
154270273|NCT03778554|Nebivolol|nebivolol|mesh-list
154270274|NCT03778554|Bisoprolol|bisoprolol|mesh-list
154270275|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154270276|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154270277|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
154270278|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
154270279|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270280|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270281|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154270282|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153611694|NCT04966546|Memantine|memantine|mesh-list
154270288|NCT03778554|Protective Agents|protective agents|mesh-ancestor
154270289|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154270290|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154270291|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154270292|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
154270293|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154270294|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154270295|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154270296|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154270297|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154270298|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
154270299|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270300|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270301|NCT03752333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270302|NCT03752333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270303|NCT03742921|Romidepsin|romidepsin|mesh-list
154270304|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154270305|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270306|NCT03742921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154270307|NCT03742921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270308|NCT03742921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270309|NCT03738553|Trastuzumab|trastuzumab|mesh-list
154270310|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270311|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270312|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
154270313|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154270314|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
154270315|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
154270316|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154270317|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270318|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154270319|NCT03736538|Analgesics|analgesics|mesh-ancestor
154270320|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
154270321|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270322|NCT03656081|Itraconazole|itraconazole|mesh-list
154270323|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154270324|NCT03656081|Amphotericin B|amphotericin b|mesh-list
154270325|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
154270326|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861493|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861494|NCT01112683|Memantine|memantine|mesh-list
154270327|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154270328|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154270329|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270330|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270331|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154270332|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
154270333|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270334|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270335|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154270336|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154270337|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154270338|NCT03656081|Amebicides|amebicides|mesh-ancestor
154270339|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270340|NCT03620032|Vinorelbine|vinorelbine|mesh-list
154270341|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
154270342|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154270343|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270344|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
154270345|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
154270346|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
153495790|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495852|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270347|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270348|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270349|NCT03600350|Nivolumab|nivolumab|mesh-list
154270350|NCT03600350|Sargramostim|sargramostim|mesh-list
154270360|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
154270361|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
154270362|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270363|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270364|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154270365|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
154270366|NCT03582033|Hormones|hormones|mesh-ancestor
154270367|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270368|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154270369|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270370|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
154270371|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154270372|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154270373|NCT03582033|Growth Substances|growth substances|mesh-ancestor
154270374|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
154270375|NCT03513952|Atezolizumab|atezolizumab|mesh-list
154270376|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154270377|NCT03513952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270378|NCT03513952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270379|NCT03513952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270380|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270381|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
154270382|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270383|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154270384|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154270385|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
154270386|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270387|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270388|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270389|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154270390|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154270391|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154270392|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
154270393|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270394|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270395|NCT03385226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270396|NCT03385226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270397|NCT03252808|Paclitaxel|paclitaxel|mesh-list
154270398|NCT03252808|Gemcitabine|gemcitabine|mesh-list
154270399|NCT03252808|Tegafur|tegafur|mesh-list
154270400|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154270401|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270402|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
154270403|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
154270404|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
154270405|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270406|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154255251|NCT02527772|Doxorubicin|doxorubicin|mesh-list
154270407|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
154270408|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
154270409|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154270410|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
154270411|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270412|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270413|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154270414|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
153611827|NCT04084210|Nicotine|nicotine|mesh-list
154270428|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270430|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154270431|NCT03193333|Dorzolamide|dorzolamide|mesh-list
154270432|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154270433|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154270434|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154270435|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154270436|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
154270437|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270438|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270439|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270440|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154270441|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154270442|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154270443|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154270444|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154270445|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154270446|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270447|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154270448|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270449|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
154270450|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154270451|NCT03112044|Velpatasvir|velpatasvir|mesh-list
154270452|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
154270453|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270454|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
154270455|NCT03015974|Prednisone|prednisone|mesh-list
154270456|NCT03015974|Prednisolone|prednisolone|mesh-list
154270457|NCT03015974|Deflazacort|deflazacort|mesh-list
154270458|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
154270459|NCT03015974|Dipyridamole|dipyridamole|mesh-list
154270460|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154270461|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154270462|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154270463|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
154270464|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270465|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270466|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154270467|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
154270468|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270469|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270470|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154270471|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270472|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
154270473|NCT03015974|Hormones|hormones|mesh-ancestor
154270474|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270475|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154270487|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270488|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270489|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270490|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270491|NCT02834637|Vaccines|vaccines|mesh-list
154270492|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
154270493|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270494|NCT02773407|Azithromycin|azithromycin|mesh-list
154270495|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154270496|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270497|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270498|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154270499|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
154270500|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154270501|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154270502|NCT02642042|Docetaxel|docetaxel|mesh-list
154270503|NCT02642042|Trametinib|trametinib|mesh-list
154861495|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153924038|NCT01172639|Analgesics|analgesics|mesh-ancestor
154270504|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270505|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
154270506|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
154270507|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
154270508|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270509|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270510|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270511|NCT02608268|Decitabine|decitabine|mesh-list
154270512|NCT02608268|Spartalizumab|spartalizumab|mesh-list
154270513|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154270514|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
154270515|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270516|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270517|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270518|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270519|NCT02608268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270520|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
154270521|NCT02595879|Cisplatin|cisplatin|mesh-list
154270522|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154270523|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270524|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154270525|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270526|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
154270527|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
154270528|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270529|NCT02506192|Prednisone|prednisone|mesh-list
154270530|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270531|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
154270532|NCT02506192|Hormones|hormones|mesh-ancestor
154270533|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270534|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270535|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154270536|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270537|NCT02476825|Fluticasone|fluticasone|mesh-list
154270538|NCT02476825|Xhance|xhance|mesh-list
154270539|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270540|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154270562|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
154270563|NCT02245321|Hematinics|hematinics|mesh-ancestor
154270565|NCT02223819|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154270566|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270567|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270568|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270569|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270570|NCT02027935|Aldesleukin|aldesleukin|mesh-list
154270571|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
154270572|NCT02027935|Ipilimumab|ipilimumab|mesh-list
154270573|NCT02027935|Interleukin-2|interleukin-2|mesh-list
154270574|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154270575|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
154270576|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270577|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270578|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154270579|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
154270580|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270581|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270582|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154270583|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270584|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270585|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154270586|NCT02027935|Analgesics|analgesics|mesh-ancestor
154270587|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
154270588|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270589|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154270590|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154270591|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
154270592|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270610|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
154270611|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270612|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154270613|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
154270614|NCT01788020|Hormones|hormones|mesh-ancestor
154270615|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270616|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154861496|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154270617|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
154270618|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270619|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270621|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
154270622|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
154270623|NCT01708941|Ipilimumab|ipilimumab|mesh-list
153496018|NCT00001842|Hormones|hormones|mesh-ancestor
154270624|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270625|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
154270626|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270627|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270628|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270629|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270630|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
154270631|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270632|NCT01495676|Cisplatin|cisplatin|mesh-list
154270633|NCT01495676|Gemcitabine|gemcitabine|mesh-list
154270634|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270635|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154270636|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
154270637|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270638|NCT00762645|Travoprost|travoprost|mesh-list
154270639|NCT00762645|Pilocarpine|pilocarpine|mesh-list
154270640|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154270641|NCT00762645|Miotics|miotics|mesh-ancestor
154270642|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
154270643|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270644|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270645|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154270646|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154270647|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
154270648|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270649|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270650|NCT00274599|Telmisartan|telmisartan|mesh-list
154270652|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153612076|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
154270679|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154270680|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270681|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270682|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154270683|NCT01102608|Ifosfamide|ifosfamide|mesh-list
154270684|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154270685|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
154270686|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270687|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270688|NCT01102686|Leucovorin|leucovorin|mesh-list
154270689|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
154270690|NCT01102686|Antidotes|antidotes|mesh-ancestor
154270691|NCT01102686|Protective Agents|protective agents|mesh-ancestor
154270692|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270693|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
154270694|NCT01102686|Vitamins|vitamins|mesh-ancestor
154270695|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
154270696|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
154270697|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154270698|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154270699|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270700|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153612143|NCT00499291|Paclitaxel|paclitaxel|mesh-list
154270718|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270719|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270720|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270721|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270722|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154270723|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270724|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270725|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
154270726|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154270727|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154270728|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154270729|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154270730|NCT05626140|Narcotics|narcotics|mesh-ancestor
154270731|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154270732|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
154270733|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
154270734|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154255252|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154270735|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154270736|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270738|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
154270739|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
154270740|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154270741|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270742|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
154270743|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270744|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154270745|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154270746|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154270747|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154270748|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270749|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154270750|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
154270751|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154270752|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154270753|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270754|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270755|NCT01106118|Urological Agents|urological agents|mesh-ancestor
154270771|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270772|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
154270773|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154270774|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
154270775|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154270776|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
154270777|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
154270778|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154270779|NCT00234065|Protective Agents|protective agents|mesh-ancestor
154270780|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154270781|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154270782|NCT01108848|Complement C1s|complement c1s|mesh-list
154270783|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154270784|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154270785|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
154270786|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270787|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154270788|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154270789|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
154270790|NCT00233987|Melphalan|melphalan|mesh-list
154270791|NCT00233987|Carmustine|carmustine|mesh-list
154270792|NCT00233987|Etoposide|etoposide|mesh-list
154270793|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154270794|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
154270795|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270796|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270797|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154270798|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
154270799|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270800|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270801|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154270802|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154270803|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154270804|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154270805|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270806|NCT01108926|Tenofovir|tenofovir|mesh-list
154270807|NCT01108926|Emtricitabine|emtricitabine|mesh-list
154270808|NCT01108926|Efavirenz|efavirenz|mesh-list
154270809|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154270810|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
154270811|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270812|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154270813|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153612244|NCT01953536|Vitamins|vitamins|mesh-ancestor
154270826|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270827|NCT00233363|Rebamipide|rebamipide|mesh-list
154270828|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154270829|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154270830|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
154270831|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270832|NCT00233363|Protective Agents|protective agents|mesh-ancestor
154270833|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861497|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
154255253|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
154270834|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270835|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
154270836|NCT01147666|Hematinics|hematinics|mesh-ancestor
154270837|NCT01073111|Sirolimus|sirolimus|mesh-list
154270838|NCT01073111|Everolimus|everolimus|mesh-list
154270839|NCT01073111|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154270840|NCT01073111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270841|NCT01073111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270842|NCT01073111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270843|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154270844|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
154270845|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270846|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270847|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270848|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270849|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154270850|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
154270851|NCT01325987|Vitamin D|vitamin d|mesh-list
154270852|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
154270853|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
154270854|NCT01325987|Vitamins|vitamins|mesh-list
154270855|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
154270856|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270857|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153496158|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270858|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154270859|NCT00256295|Gemcitabine|gemcitabine|mesh-list
154270860|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
154270861|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154270862|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
154270863|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270864|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270865|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
154270866|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
154270867|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154270868|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154270869|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270870|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270871|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270872|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270873|NCT01109160|Azithromycin|azithromycin|mesh-list
154270874|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270875|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270885|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
154270886|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154270887|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
154270888|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270889|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
154270890|NCT01363414|Protective Agents|protective agents|mesh-ancestor
154270891|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
154270892|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154270893|NCT02223520|Mupirocin|mupirocin|mesh-list
154270894|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154270895|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270896|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
154270897|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
154270898|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270899|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154270900|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270901|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270902|NCT01356472|Imipenem|imipenem|mesh-list
154270903|NCT01356472|Cilastatin|cilastatin|mesh-list
154270904|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270905|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270906|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
154270907|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270908|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270909|NCT02122198|Leuprolide|leuprolide|mesh-list
154270910|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154270911|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
154270912|NCT02122198|Estradiol|estradiol|mesh-list
154270913|NCT02122198|Estrogens|estrogens|mesh-ancestor
154270914|NCT02122198|Hormones|hormones|mesh-ancestor
154270915|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270916|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270917|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154270918|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
154861498|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270919|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154270920|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154270921|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154270922|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
154270923|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154270924|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270925|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154270926|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154270927|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154270928|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154270929|NCT01363570|Ranibizumab|ranibizumab|mesh-list
154270930|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154270931|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154270932|NCT01363570|Growth Substances|growth substances|mesh-ancestor
154270933|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270934|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
154270935|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270936|NCT04608500|Minocycline|minocycline|mesh-list
154270937|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270938|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270939|NCT01363648|Choline|choline|mesh-list
154270940|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
154270941|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154270957|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154270958|NCT03944070|Growth Substances|growth substances|mesh-ancestor
154270959|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270960|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
154270961|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270962|NCT01363804|Tivozanib|tivozanib|mesh-list
154270963|NCT01363804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270964|NCT01363804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270965|NCT01363804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270966|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154270967|NCT03764462|AD 101|ad 101|mesh-list
154270968|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154270969|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
154270970|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270971|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270972|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154270973|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154270974|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154270975|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154270976|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270977|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154270978|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154270979|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
154270980|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270981|NCT05460416|Aspirin|aspirin|mesh-list
154270982|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154270983|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154270984|NCT05460416|Analgesics|analgesics|mesh-ancestor
154270985|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
154270986|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270987|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270988|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270989|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270990|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154270991|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154270992|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270993|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154270994|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154270995|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270996|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
154270997|NCT01364194|Bupivacaine|bupivacaine|mesh-list
154270998|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
154270999|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
153612440|NCT01954186|Oxytocin|oxytocin|mesh-list
154271020|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154271021|NCT03066622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154271022|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154017929|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154271023|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271024|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271025|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271026|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
154271027|NCT01364974|Peficitinib|peficitinib|mesh-list
154271028|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271029|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271030|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271031|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
154271032|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271033|NCT05323214|Fentanyl|fentanyl|mesh-list
154271034|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
154271035|NCT05323214|Analgesics|analgesics|mesh-list
154271036|NCT05323214|Bupivacaine|bupivacaine|mesh-list
154271037|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
154271038|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
154271039|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271040|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271041|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
154271042|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271043|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154271044|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154271045|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154271046|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154271047|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154271048|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
154271049|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271050|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612488|NCT01954732|Metformin|metformin|mesh-list
154271070|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
154271071|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
154271072|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271073|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271074|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271075|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
154271077|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271078|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154271079|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271080|NCT04501952|Remdesivir|remdesivir|mesh-list
154271081|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
154271082|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271083|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
154271084|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271085|NCT00321100|Bevacizumab|bevacizumab|mesh-list
154271086|NCT00321100|Cetuximab|cetuximab|mesh-list
154271087|NCT00321100|Capecitabine|capecitabine|mesh-list
154271088|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
154271089|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154271090|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271091|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154271092|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154271093|NCT00321100|Growth Substances|growth substances|mesh-ancestor
153496402|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
154271094|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271095|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
154018005|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154271096|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154271097|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
154271098|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271099|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154271100|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154271101|NCT01365598|Primaquine|primaquine|mesh-list
154271102|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
154271103|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154271104|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154271105|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271120|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
154271121|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271122|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154271123|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154271124|NCT01318954|Immunomodulating Agents|immunomodulating agents|mesh-list
154271125|NCT01318954|Immunologic Factors|immunologic factors|mesh-ancestor
154271126|NCT01318954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271127|NCT00070018|Prednisone|prednisone|mesh-list
154271128|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
154271129|NCT00070018|Rituximab|rituximab|mesh-list
154271130|NCT00070018|Doxorubicin|doxorubicin|mesh-list
154271131|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154271132|NCT00070018|Vincristine|vincristine|mesh-list
154271133|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154271134|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271135|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
154271136|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271137|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154271138|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154271139|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
154271140|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271141|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271142|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154271143|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154271144|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154271145|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154271146|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154271147|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271148|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271149|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
154271150|NCT00070018|Hormones|hormones|mesh-ancestor
154271151|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271152|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154271153|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154271154|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154271155|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
154271156|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154271157|NCT01073189|Fenoldopam|fenoldopam|mesh-list
154271158|NCT01073189|Furosemide|furosemide|mesh-list
154271159|NCT01073189|Diuretics|diuretics|mesh-ancestor
154271160|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
154271161|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271162|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154271163|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271164|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271165|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154271166|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
154271167|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
154271188|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154271189|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
154271191|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
154271192|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154271193|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154271194|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
154271195|NCT03752294|Dabigatran|dabigatran|mesh-list
154271196|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
154271197|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154271198|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
154271199|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271200|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271201|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
154271202|NCT03135028|Cytarabine|cytarabine|mesh-list
154271203|NCT03135028|Daunorubicin|daunorubicin|mesh-list
154271204|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154271205|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
154271206|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271207|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271208|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
154271209|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271210|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271211|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
154271212|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271213|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154271214|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154271215|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154271216|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271217|NCT03752138|Decitabine|decitabine|mesh-list
154271218|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154271219|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
154271220|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612663|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
154271235|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154271236|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271237|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271238|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271239|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154271240|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154271241|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154271242|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154271243|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
154271244|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
154271245|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
154271246|NCT05190952|Dexamethasone|dexamethasone|mesh-list
154271247|NCT05190952|Ketamine|ketamine|mesh-list
154271248|NCT05190952|Bupivacaine|bupivacaine|mesh-list
154271249|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271250|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
154271251|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
154271252|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271253|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271254|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271255|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
154271256|NCT05190952|Hormones|hormones|mesh-ancestor
154271257|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271258|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154271259|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271260|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
154271261|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
154271262|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271263|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
154271264|NCT05190952|Analgesics|analgesics|mesh-ancestor
154271265|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154271266|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154271267|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
154271268|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154271269|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154271270|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271271|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271272|NCT03972683|Atropine|atropine|mesh-list
154271273|NCT03972683|Adenosine|adenosine|mesh-list
154271274|NCT03972683|Nitroprusside|nitroprusside|mesh-list
154271275|NCT03972683|Phenylephrine|phenylephrine|mesh-list
154271276|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
154271277|NCT03972683|Acetylcholine|acetylcholine|mesh-list
154271278|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154271279|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
154271280|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
154271281|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271282|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271291|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271292|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271293|NCT03972683|Protective Agents|protective agents|mesh-ancestor
154271294|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154271295|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154271296|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154271297|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154271298|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
154271299|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154271300|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154271301|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
154271302|NCT03972683|Analgesics|analgesics|mesh-ancestor
154271303|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
154271304|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
154271305|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154271306|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
154271307|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
154271308|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154271309|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154271310|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154271311|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
154271312|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
154271313|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271314|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
154271315|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154271316|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
154271317|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271318|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
154271319|NCT03754010|Protective Agents|protective agents|mesh-ancestor
154271320|NCT00227591|Prednisone|prednisone|mesh-list
154271321|NCT00227591|Lenalidomide|lenalidomide|mesh-list
154271322|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271323|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
154271324|NCT00227591|Hormones|hormones|mesh-ancestor
154271325|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271326|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271327|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154271328|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271329|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
154271330|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154271331|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154271332|NCT00227591|Growth Substances|growth substances|mesh-ancestor
154271333|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
154271334|NCT01358344|Pantoprazole|pantoprazole|mesh-list
154271335|NCT01358344|Vorapaxar|vorapaxar|mesh-list
154271336|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154271337|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271338|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154271339|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271340|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271341|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154271342|NCT01366300|Lidocaine|lidocaine|mesh-list
154271343|NCT01366300|Propofol|propofol|mesh-list
154271344|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
154271345|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
154271346|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271347|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271348|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
154271349|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271350|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153612767|NCT01956474|Riboflavin|riboflavin|mesh-list
154271359|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271360|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154271361|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154271362|NCT00226811|Growth Substances|growth substances|mesh-ancestor
154271363|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271364|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
154271365|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154271366|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271367|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271368|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
154271369|NCT05261516|Analgesics|analgesics|mesh-ancestor
154271370|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
154271371|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271372|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271373|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
154271374|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271375|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154271376|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
154271377|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154271378|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271379|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271380|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154271381|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
154271382|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154271383|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
154271384|NCT00226655|Hormones|hormones|mesh-ancestor
154271385|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271386|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271387|NCT01371058|Clopidogrel|clopidogrel|mesh-list
154271388|NCT01371058|Policosanol|policosanol|mesh-list
154271389|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154271390|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154271391|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154271392|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154271393|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
154271394|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271395|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271396|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018298|NCT00648219|Olmesartan|olmesartan|mesh-list
154018304|NCT00648297|Nadolol|nadolol|mesh-list
154271397|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154271398|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154271399|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
154271400|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154271401|NCT01105338|Lycopene|lycopene|mesh-list
154271402|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271403|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
154271404|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271405|NCT01105338|Protective Agents|protective agents|mesh-ancestor
154271406|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271407|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154271408|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154271409|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271410|NCT03747614|Fluorometholone|fluorometholone|mesh-list
154271411|NCT03747614|Tacrolimus|tacrolimus|mesh-list
154271412|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271413|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
154271421|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271423|NCT05347004|BI 425809|bi 425809|mesh-list
154271424|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
154271425|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154271426|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154271427|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
154271428|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271429|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271430|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
154271431|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154271432|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271433|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
154271434|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271435|NCT03747536|Bromides|bromides|mesh-list
154271436|NCT03747536|Ipratropium|ipratropium|mesh-list
154271437|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
154271438|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154271439|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
154271440|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271441|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271442|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154271443|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
154271444|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154271445|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
154271446|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271447|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271448|NCT01358500|Fentanyl|fentanyl|mesh-list
154271449|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154271450|NCT01358500|Narcotics|narcotics|mesh-ancestor
154271451|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271452|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271453|NCT01358500|Analgesics|analgesics|mesh-ancestor
154271454|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
154271455|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271456|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154271457|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154271458|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
154271459|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
154271460|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
154271461|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
154271462|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271463|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271464|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271465|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
154271466|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
154271467|NCT03751514|Azithromycin|azithromycin|mesh-list
154271468|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154271469|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271470|NCT03615664|Dexamethasone|dexamethasone|mesh-list
154271471|NCT03615664|Gemcitabine|gemcitabine|mesh-list
154271472|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154271473|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271474|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
154271475|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
154271476|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271477|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271478|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271479|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
154271481|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271494|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271495|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271496|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271497|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
154271498|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154271499|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
154271500|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271501|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271502|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154271503|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
154271504|NCT01358812|Panitumumab|panitumumab|mesh-list
154271505|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153496713|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
154271506|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271507|NCT01371448|Paroxetine|paroxetine|mesh-list
154271508|NCT01371448|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154271509|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154271510|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271511|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271512|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271513|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
154271514|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271515|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154271516|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
154271517|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154271518|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154271519|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154271520|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271521|NCT01371526|Cosyntropin|cosyntropin|mesh-list
154271522|NCT01371526|Hormones|hormones|mesh-ancestor
154271523|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271524|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271525|NCT03943992|Esomeprazole|esomeprazole|mesh-list
154271526|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154271527|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271528|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154271529|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271530|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271531|NCT01371604|Ribavirin|ribavirin|mesh-list
154271532|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154271533|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
154271534|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271535|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
154271536|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271537|NCT01371682|Ropinirole|ropinirole|mesh-list
154271538|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154271539|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154271540|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
154271541|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
154271542|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271552|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271553|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271554|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
154271555|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271556|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154271557|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154271558|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154271559|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271560|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271561|NCT01111656|Interferons|interferons|mesh-list
154271562|NCT01111656|Interferon-beta|interferon-beta|mesh-list
154271563|NCT01111656|Atorvastatin|atorvastatin|mesh-list
154271564|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
154271565|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271566|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
154271567|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271568|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154271569|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154271570|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
154271571|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271572|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154271573|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154271574|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271575|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
154271576|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271577|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154271578|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
154271579|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154271580|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271581|NCT02819752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154271582|NCT02819752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271583|NCT02567578|YH12852|yh12852|mesh-list
154271584|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154271585|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154271586|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
154271587|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271588|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271589|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271590|NCT02523274|Resveratrol|resveratrol|mesh-list
154271591|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
154271592|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271593|NCT02523274|Protective Agents|protective agents|mesh-ancestor
154271594|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271595|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271596|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154271597|NCT02432560|Sirolimus|sirolimus|mesh-list
154271598|NCT02432560|Everolimus|everolimus|mesh-list
154271599|NCT02432560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154271600|NCT02432560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154271601|NCT02432560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271602|NCT02432560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271603|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271604|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
154271605|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271617|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154271618|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154271619|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
154271620|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271621|NCT01111734|Protective Agents|protective agents|mesh-ancestor
154271622|NCT01111734|Antidotes|antidotes|mesh-ancestor
154271623|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154271624|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154271625|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154271626|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271627|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271628|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154271629|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271630|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271631|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
154271632|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271633|NCT01111890|Timolol|timolol|mesh-list
154271634|NCT01111890|Dorzolamide|dorzolamide|mesh-list
154271635|NCT01111890|Brinzolamide|brinzolamide|mesh-list
154271636|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154271637|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154271638|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
154271639|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271640|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271641|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271642|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154271643|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154271644|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154271645|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271646|NCT01111968|Vaccines|vaccines|mesh-list
154271647|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
154271648|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271649|NCT04398134|Entecavir|entecavir|mesh-list
154271650|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
154271651|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271652|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
154271653|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154271654|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271655|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154271656|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154271657|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271658|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271659|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271660|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
154271661|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154271662|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153924934|NCT04032691|Clonidine|clonidine|mesh-list
154271663|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154271664|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271665|NCT01108302|Oxytocin|oxytocin|mesh-list
154271666|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
154271667|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154271668|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271676|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
154271677|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271679|NCT05167084|Metyrapone|metyrapone|mesh-list
154271680|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271681|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
154271682|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271683|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271684|NCT00867178|Vitamin A|vitamin a|mesh-list
154271685|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
154271686|NCT00867178|Thiotepa|thiotepa|mesh-list
154271687|NCT00867178|Cisplatin|cisplatin|mesh-list
154271688|NCT00867178|Carboplatin|carboplatin|mesh-list
154271689|NCT00867178|Etoposide|etoposide|mesh-list
154271690|NCT00867178|Vincristine|vincristine|mesh-list
154271691|NCT00867178|Vorinostat|vorinostat|mesh-list
154271692|NCT00867178|Tretinoin|tretinoin|mesh-list
154271693|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
154271694|NCT00867178|Isotretinoin|isotretinoin|mesh-list
154271695|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271696|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
154271697|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271698|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154271699|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154271700|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
154271701|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271702|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271703|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154271704|NCT00867178|Vitamins|vitamins|mesh-ancestor
154271705|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
154271706|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154271707|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154271708|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154271709|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271710|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
154271711|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
154271712|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
154271713|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154271714|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
154271715|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
154271716|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
154271717|NCT03945396|Antacids|antacids|mesh-ancestor
154271718|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271719|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271720|NCT01109784|Clopidogrel|clopidogrel|mesh-list
154271721|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154271722|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154271723|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154271724|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154271725|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154271726|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
154271727|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271728|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271729|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271730|NCT01328340|Methamphetamine|methamphetamine|mesh-list
154271731|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154271732|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271733|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
154271734|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
154271735|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271736|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
154271737|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613155|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154271751|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154271752|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154271753|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154271754|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271755|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271756|NCT01328106|Trametinib|trametinib|mesh-list
154271757|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271758|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154271759|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271760|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271761|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
154271762|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154271763|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271764|NCT03122548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154271765|NCT03122548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271766|NCT03749642|Gabapentin|gabapentin|mesh-list
154271767|NCT03749642|Trazodone|trazodone|mesh-list
154271768|NCT03749642|Analgesics|analgesics|mesh-ancestor
154271769|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
154271770|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271771|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271772|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
154271773|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154271774|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154271775|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271776|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154271777|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154271778|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154271779|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271780|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271781|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
154271782|NCT03749642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153496947|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
154271783|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154271784|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271785|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
154271786|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154271787|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
154271788|NCT03751358|Anesthetics|anesthetics|mesh-list
154271789|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
154271790|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271791|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271792|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
154271793|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271794|NCT05193292|Trastuzumab|trastuzumab|mesh-list
153613223|NCT01959971|Alirocumab|alirocumab|mesh-list
154271812|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271813|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271814|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271816|NCT02529774|Hormones|hormones|mesh-ancestor
154271817|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271818|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154271819|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271820|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154271821|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
154271822|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271823|NCT02529774|Antidotes|antidotes|mesh-ancestor
154271824|NCT02529774|Protective Agents|protective agents|mesh-ancestor
154271825|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
154271826|NCT02529774|Vitamins|vitamins|mesh-ancestor
154271827|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
154271828|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271829|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
154271830|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
154271831|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154271832|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154271833|NCT04459598|Efavirenz|efavirenz|mesh-list
154271834|NCT04459598|Quizartinib|quizartinib|mesh-list
154271835|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154271836|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154271837|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271838|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271839|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
154271840|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496994|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
154271841|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154271842|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154271843|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154271844|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154271845|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154271846|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154255256|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271847|NCT04459598|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154271848|NCT04459598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154271850|NCT03942354|Linezolid|linezolid|mesh-list
154271851|NCT03942354|Bedaquiline|bedaquiline|mesh-list
154271852|NCT03942354|Clofazimine|clofazimine|mesh-list
154271853|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154271854|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271855|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154271856|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154271857|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271867|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271868|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271869|NCT05165992|Analgesics|analgesics|mesh-ancestor
154271870|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
154271871|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271872|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154271873|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154271874|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
154271875|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
154271876|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154271877|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
154271878|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154271879|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271880|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
154271881|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271882|NCT01367626|Letrozole|letrozole|mesh-list
154271883|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271884|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154271885|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154271886|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271887|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271888|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154271889|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
154271890|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271891|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271892|NCT01112748|Lidocaine|lidocaine|mesh-list
154271893|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
154271894|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
154271895|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271896|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271897|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
154271898|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271899|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154271900|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154271901|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154271902|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271903|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271904|NCT05192902|Anesthetics|anesthetics|mesh-list
154271905|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271906|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271907|NCT01211808|Diltiazem|diltiazem|mesh-list
154271908|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154271909|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154271910|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271911|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271912|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154271913|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271914|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
154271915|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154271916|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154271917|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154271918|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
154271919|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154271920|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271930|NCT05191888|Metronidazole|metronidazole|mesh-list
154271931|NCT05191888|Clarithromycin|clarithromycin|mesh-list
154271932|NCT05191888|Rabeprazole|rabeprazole|mesh-list
154271933|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154271934|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861499|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271935|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154271936|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154271937|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154271938|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271939|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271940|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154271941|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154271942|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154271943|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271944|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154271945|NCT01112826|Capecitabine|capecitabine|mesh-list
154271946|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154271947|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
154271948|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271949|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271950|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
154271951|NCT01210014|Astringents|astringents|mesh-ancestor
154271952|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271953|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
154271954|NCT05118256|Pirfenidone|pirfenidone|mesh-list
154271955|NCT05118256|Analgesics|analgesics|mesh-ancestor
154271956|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
154271957|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271958|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271959|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154271960|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154271961|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271962|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154271963|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271965|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154271966|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
154271967|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154271968|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271969|NCT02529540|Methamphetamine|methamphetamine|mesh-list
154271970|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154271971|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271972|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
154271973|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
154271974|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271975|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
154271976|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271977|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271978|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
154271979|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154271980|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154271981|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271982|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154271983|NCT01359436|Antibodies|antibodies|mesh-list
154271984|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
154271999|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272000|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154272001|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154272002|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154272003|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272004|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
154272005|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
154272007|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154272008|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
154272009|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272010|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272011|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154272012|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154272013|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
154272014|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272015|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272016|NCT01208454|Vitamin A|vitamin a|mesh-list
154272017|NCT01208454|Vorinostat|vorinostat|mesh-list
154272018|NCT01208454|Tretinoin|tretinoin|mesh-list
154272019|NCT01208454|Isotretinoin|isotretinoin|mesh-list
154272020|NCT01208454|Vitamins|vitamins|mesh-ancestor
154272021|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
154272022|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272023|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272024|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154272025|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272026|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272027|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
154272028|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
154272029|NCT01110486|Carboplatin|carboplatin|mesh-list
154272030|NCT01110486|Docetaxel|docetaxel|mesh-list
154272031|NCT01110486|Ilorasertib|ilorasertib|mesh-list
154272032|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272033|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
154272034|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272035|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272036|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272037|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154272038|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272039|NCT01372306|Galantamine|galantamine|mesh-list
154272040|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154272041|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272042|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272043|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
154272044|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272060|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272061|NCT01359670|Urological Agents|urological agents|mesh-ancestor
154272062|NCT05188768|Mitogens|mitogens|mesh-list
154272063|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272064|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272065|NCT01368328|Chromium|chromium|mesh-list
154272066|NCT01368328|Niacin|niacin|mesh-list
154272067|NCT01368328|Trace Elements|trace elements|mesh-ancestor
154272068|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
154272069|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272070|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154272071|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
154272072|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272073|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154272074|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272075|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
154272076|NCT01368328|Vitamins|vitamins|mesh-ancestor
154272077|NCT01110642|Lovastatin|lovastatin|mesh-list
154272078|NCT01110642|L 647318|l 647318|mesh-list
154272079|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
154272080|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154272081|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154272082|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
154272083|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272084|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154272085|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154272086|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272087|NCT02929498|Azacitidine|azacitidine|mesh-list
154272088|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154272089|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
154272090|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272091|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272092|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272093|NCT01359826|Milnacipran|milnacipran|mesh-list
154272094|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
154272095|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154272096|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154272097|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272098|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272099|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272100|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272101|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154272102|NCT01359826|Analgesics|analgesics|mesh-ancestor
154272103|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
154272104|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613534|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154272125|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272126|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
154272127|NCT01113138|Analgesics|analgesics|mesh-ancestor
154272128|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
154272129|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272130|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272131|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
154272132|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272133|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154272134|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
154272135|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154272136|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272137|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272138|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154272139|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
154272140|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154272141|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
154272142|NCT01115322|Tazarotene|tazarotene|mesh-list
154272143|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
154272144|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
154272145|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
154272146|NCT01115322|Vitamins|vitamins|mesh-ancestor
154272147|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
154272148|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272149|NCT01111188|Bortezomib|bortezomib|mesh-list
154272150|NCT01111188|Palbociclib|palbociclib|mesh-list
154272151|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272152|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154272153|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272154|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272155|NCT01210482|Sirolimus|sirolimus|mesh-list
154272156|NCT01210482|Temsirolimus|temsirolimus|mesh-list
154272157|NCT01210482|MTOR Inhibitors|mtor inhibitors|mesh-list
154272158|NCT01210482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154272159|NCT01210482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272174|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
154272175|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272176|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154272177|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
154272178|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154272179|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582967|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154272180|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272181|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154272182|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
154272183|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154272184|NCT01210638|Oxymorphone|oxymorphone|mesh-list
154272185|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154272186|NCT01210638|Narcotics|narcotics|mesh-ancestor
154272187|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272188|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272189|NCT01210638|Analgesics|analgesics|mesh-ancestor
154272190|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
154272191|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272192|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154272193|NCT03120676|Atezolizumab|atezolizumab|mesh-list
154272194|NCT03120676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154272195|NCT03120676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272196|NCT03120676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272197|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272198|NCT01115478|Vitamin A|vitamin a|mesh-list
154272199|NCT01115478|Vitamins|vitamins|mesh-ancestor
154272200|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
154272201|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272202|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
154272203|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154272204|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
154272205|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272206|NCT01111422|Expectorants|expectorants|mesh-ancestor
154272207|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
154272208|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154272209|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
154272210|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272211|NCT01111422|Protective Agents|protective agents|mesh-ancestor
154272212|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272213|NCT01111422|Antidotes|antidotes|mesh-ancestor
154272214|NCT01212432|Daptomycin|daptomycin|mesh-list
154272215|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154272216|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272217|NCT01213368|Dronedarone|dronedarone|mesh-list
154272218|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154272219|NCT01369186|Morphine|morphine|mesh-list
154272220|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154272233|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
154272234|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272235|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154272236|NCT01319266|Hydrocodone|hydrocodone|mesh-list
154272237|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154272238|NCT01319266|Narcotics|narcotics|mesh-ancestor
154272239|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272240|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272241|NCT01319266|Analgesics|analgesics|mesh-ancestor
154272242|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
154272243|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272244|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
154272245|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
154272246|NCT01115790|Prexasertib|prexasertib|mesh-list
154272247|NCT01115790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154272248|NCT01115790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272249|NCT01115790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272250|NCT01115946|Enalapril|enalapril|mesh-list
154272251|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154272252|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
154272253|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272254|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272255|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154272256|NCT01113372|Clopidogrel|clopidogrel|mesh-list
154272257|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154272258|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154272259|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154272260|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154272261|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
154272262|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272263|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272264|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272265|NCT03120520|Plecanatide|plecanatide|mesh-list
154272266|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154272267|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
154272268|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272269|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154272270|NCT03941340|Aflutinib|aflutinib|mesh-list
154272271|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154272272|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272273|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272274|NCT01372930|Etanercept|etanercept|mesh-list
154272275|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154272276|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154272277|NCT01372930|Analgesics|analgesics|mesh-ancestor
154272278|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
154272279|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272280|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272281|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154272282|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154272283|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154272298|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272299|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154272300|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
154272301|NCT01116180|Candesartan|candesartan|mesh-list
154272302|NCT01116180|Candesartan cilexetil|candesartan cilexetil|mesh-list
154272303|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
154272304|NCT01116180|Giapreza|giapreza|mesh-list
154272305|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154272306|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
154272307|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154272308|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154272309|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272310|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154272311|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154272312|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
154272313|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272314|NCT01113528|Aspirin|aspirin|mesh-list
154272315|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154272316|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153497439|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
154272317|NCT01113528|Analgesics|analgesics|mesh-ancestor
154272318|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
154272319|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272320|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272321|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154272322|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154272323|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154272324|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154272325|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272326|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154272327|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154272328|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272329|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
154272330|NCT01369576|Zopiclone|zopiclone|mesh-list
154272331|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154272332|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272333|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272334|NCT01113762|Cimetidine|cimetidine|mesh-list
154272335|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154272336|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154272337|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154272338|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
154272339|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
154272340|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272341|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272342|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272343|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153613774|NCT01964287|Leucovorin|leucovorin|mesh-list
154272344|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154272346|NCT01212666|Ropivacaine|ropivacaine|mesh-list
154272347|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
154272348|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
154272349|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272350|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272351|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
154272352|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272353|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154272354|NCT01116336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154272355|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154272356|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272357|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272358|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272359|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
154272360|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154272361|NCT01213680|Hematinics|hematinics|mesh-ancestor
154272362|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
154272363|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154272364|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272365|NCT01211496|Methamphetamine|methamphetamine|mesh-list
154272366|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154272367|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272368|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
154272369|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
154272370|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272371|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
154272372|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272373|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272374|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
154272375|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154272376|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154272377|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272378|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154272379|NCT01118286|Nifedipine|nifedipine|mesh-list
154272380|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154272381|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272382|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272383|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154272384|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272385|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272386|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
154272387|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154272388|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154272389|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
154272390|NCT01585350|Poly ICLC|poly iclc|mesh-list
154272391|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154272392|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
154272393|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272394|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
153925502|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154272395|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
154272397|NCT01118598|Niacinamide|niacinamide|mesh-list
154272398|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
154272399|NCT01118598|Vitamins|vitamins|mesh-ancestor
154272400|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
154272401|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272402|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154272403|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
154272404|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272405|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154272406|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272407|NCT01216020|Cisplatin|cisplatin|mesh-list
154272408|NCT01216020|Cetuximab|cetuximab|mesh-list
154272409|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272410|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272411|NCT01121796|Vitamin D|vitamin d|mesh-list
154272412|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
154272413|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
154272414|NCT01121796|Vitamins|vitamins|mesh-list
154272415|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
154272416|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272417|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154272418|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154272441|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154019340|NCT05412056|Metformin|metformin|mesh-list
154272443|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
154272444|NCT01119534|Expectorants|expectorants|mesh-ancestor
154272445|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
154272446|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154272447|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154272448|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
154272449|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272450|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272451|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272452|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
154272453|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154272454|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
154272455|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
154272456|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272457|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
154272458|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154272459|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154272460|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272461|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
154272462|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
154272463|NCT01119534|Protective Agents|protective agents|mesh-ancestor
154272464|NCT01117116|Fluticasone|fluticasone|mesh-list
154272465|NCT01117116|Xhance|xhance|mesh-list
154272466|NCT01117116|Budesonide|budesonide|mesh-list
154272467|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
154272468|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154272469|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154272470|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154272471|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
154272483|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154272484|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
154272485|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272486|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272487|NCT01216488|Lidocaine|lidocaine|mesh-list
154272488|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
154272489|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
154272490|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272491|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272492|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
154272493|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272494|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154272495|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154272496|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154272497|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272498|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272499|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
154861500|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272500|NCT01122342|Testosterone|testosterone|mesh-list
154272501|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
154272502|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
154272503|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154272504|NCT01122342|Androgens|androgens|mesh-ancestor
154272505|NCT01122342|Hormones|hormones|mesh-ancestor
154272506|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272507|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272508|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154272509|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272510|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
154272511|NCT01213992|Iron|iron|mesh-list
154272512|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154272513|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
154272514|NCT01213992|Trace Elements|trace elements|mesh-ancestor
154272515|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
154272516|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272517|NCT01213992|Hematinics|hematinics|mesh-ancestor
154272518|NCT01216644|Leucovorin|leucovorin|mesh-list
154272519|NCT01216644|Docetaxel|docetaxel|mesh-list
154272520|NCT01216644|Fluorouracil|fluorouracil|mesh-list
154272521|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
154272522|NCT01216644|Epirubicin|epirubicin|mesh-list
154272523|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272524|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
154272525|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272526|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272527|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272528|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
154272529|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154272530|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154272531|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
154272532|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272533|NCT01216644|Antidotes|antidotes|mesh-ancestor
154272534|NCT01216644|Protective Agents|protective agents|mesh-ancestor
154272535|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
154272545|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
154272546|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272548|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154272549|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272550|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272551|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154272552|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154272553|NCT01214226|Protective Agents|protective agents|mesh-ancestor
154272554|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272555|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272556|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154272557|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
154272558|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
154272559|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154272560|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272561|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
154272562|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272563|NCT01219062|Morphine|morphine|mesh-list
154272564|NCT01219062|Bupivacaine|bupivacaine|mesh-list
154272565|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
154272566|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
154272567|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272568|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272569|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
154272570|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272571|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154272572|NCT01219062|Narcotics|narcotics|mesh-ancestor
154272573|NCT01219062|Analgesics|analgesics|mesh-ancestor
154272574|NCT01120158|Paclitaxel|paclitaxel|mesh-list
154272575|NCT01120158|Bevacizumab|bevacizumab|mesh-list
154272576|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154272577|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272578|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
154272579|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272580|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272581|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272582|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272583|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154272584|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154272585|NCT01120158|Growth Substances|growth substances|mesh-ancestor
154272586|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272587|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
154272588|NCT01373398|Apaziquone|apaziquone|mesh-list
153925655|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
154272589|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272590|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
154272591|NCT01124526|Rituximab|rituximab|mesh-list
154272592|NCT01124526|Fludarabine|fludarabine|mesh-list
154272593|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154272594|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
153497640|NCT05749614|Lidocaine|lidocaine|mesh-list
154272595|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272596|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154272597|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154272598|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
154272599|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272600|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272601|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154272602|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272603|NCT01120314|Otamixaban|otamixaban|mesh-list
154272621|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154272622|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154272623|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154272624|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154272625|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272626|NCT04624984|Gemcitabine|gemcitabine|mesh-list
154272627|NCT04624984|Doxorubicin|doxorubicin|mesh-list
154272628|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154272629|NCT04624984|Vinorelbine|vinorelbine|mesh-list
154272630|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154272631|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154272632|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
154272633|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272634|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272635|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154272636|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154272637|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154272638|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272639|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154272640|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
154272641|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272642|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272643|NCT04624984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272644|NCT01214382|Sertraline|sertraline|mesh-list
154272645|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
154272646|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154272647|NCT01214382|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154272648|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154272649|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272650|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272651|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272652|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
154272653|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272654|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
154272655|NCT01216956|Niacin|niacin|mesh-list
154272656|NCT01216956|Niacinamide|niacinamide|mesh-list
154272657|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
154272658|NCT01216956|Vitamins|vitamins|mesh-ancestor
154272659|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
154272660|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272661|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154272662|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
154272677|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154272679|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
154272680|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272681|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
154272682|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154272683|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
154272684|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154272685|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154272686|NCT01373554|Protective Agents|protective agents|mesh-ancestor
154272687|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497746|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
154272688|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272689|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154272690|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154272691|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272692|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272693|NCT01319344|Eplerenone|eplerenone|mesh-list
154861501|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154272694|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154272695|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
154272696|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272697|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272698|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154272699|NCT01319344|Diuretics|diuretics|mesh-ancestor
154272700|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
154272701|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154272702|NCT01373632|Sirolimus|sirolimus|mesh-list
154272703|NCT01373632|Temsirolimus|temsirolimus|mesh-list
154272704|NCT01373632|MTOR Inhibitors|mtor inhibitors|mesh-list
154272705|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154272706|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272707|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154272708|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272709|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
154272710|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154272711|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
154272712|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272713|NCT01373632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154272714|NCT01373632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272715|NCT01373632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272716|NCT01124760|Ketoconazole|ketoconazole|mesh-list
154272717|NCT01124760|Diltiazem|diltiazem|mesh-list
154272718|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
154272719|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272720|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153614155|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
154272740|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154272741|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272742|NCT01217736|Aliskiren|aliskiren|mesh-list
154272743|NCT01217736|Renin Inhibitors|renin inhibitors|mesh-ancestor
154272744|NCT01217736|Protease Inhibitors|protease inhibitors|mesh-ancestor
154272745|NCT01217736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272746|NCT01217736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272748|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272749|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272750|NCT03869866|Vaccines|vaccines|mesh-list
154272751|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
154272752|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272753|NCT03783702|Acetaminophen|acetaminophen|mesh-list
154272754|NCT03783702|Ibuprofen|ibuprofen|mesh-list
154272755|NCT03783702|Oxycodone|oxycodone|mesh-list
154272756|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154272757|NCT03783702|Analgesics|analgesics|mesh-ancestor
154272758|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
154272759|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272760|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272761|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
154272762|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154272763|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154272764|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154272765|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154272766|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272767|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272768|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154272769|NCT03783702|Narcotics|narcotics|mesh-ancestor
154272770|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272771|NCT01319734|Glyburide|glyburide|mesh-list
154272772|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272773|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154272774|NCT01121016|Montelukast|montelukast|mesh-list
154272790|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272791|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272792|NCT01214928|Vitamin D|vitamin d|mesh-list
154272793|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
154272794|NCT01214928|Vitamins|vitamins|mesh-ancestor
154272795|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
154272796|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272797|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154272798|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154272799|NCT01122966|Bevacizumab|bevacizumab|mesh-list
154272800|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272801|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272802|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154272803|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154272804|NCT01122966|Growth Substances|growth substances|mesh-ancestor
154272805|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272806|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
154272807|NCT01219686|Pindolol|pindolol|mesh-list
154272808|NCT01219686|Dexetimide|dexetimide|mesh-list
154272809|NCT01219686|Citalopram|citalopram|mesh-list
154272810|NCT01219686|Escitalopram|escitalopram|mesh-list
154272811|NCT01219686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154272812|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154272813|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272814|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272815|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272816|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
154272817|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272818|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154272819|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154272820|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
154272821|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
154272822|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272823|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154272824|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154272825|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
154272826|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154272827|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
154272828|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154272829|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154272830|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154272831|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
154272832|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154272848|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154272849|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154272850|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154272852|NCT03936426|Trace Elements|trace elements|mesh-ancestor
154272853|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
154272854|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272855|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
154272856|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154272857|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272858|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272859|NCT01125696|Ritonavir|ritonavir|mesh-list
154272860|NCT01125696|Lopinavir|lopinavir|mesh-list
154272861|NCT01125696|Tenofovir|tenofovir|mesh-list
154272862|NCT01125696|Lamivudine|lamivudine|mesh-list
154272863|NCT01125696|Zidovudine|zidovudine|mesh-list
154272864|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154272865|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154272866|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
154272867|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272868|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272869|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154272870|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154272871|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
154272872|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272873|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154272874|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154272875|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154272876|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154272877|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
154272878|NCT03932916|Donepezil|donepezil|mesh-list
154272879|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154272880|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272881|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272882|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
154272883|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153497839|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
154272884|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272885|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
154272886|NCT03116152|Paclitaxel|paclitaxel|mesh-list
154272887|NCT03116152|Irinotecan|irinotecan|mesh-list
154272888|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154272889|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272890|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
154272891|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272892|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272893|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614322|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
154272925|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154255258|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154272926|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272927|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154272928|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154272929|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154272930|NCT01220154|Paclitaxel|paclitaxel|mesh-list
154272931|NCT01220154|Bevacizumab|bevacizumab|mesh-list
154272932|NCT01220154|Carboplatin|carboplatin|mesh-list
154272933|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154272934|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272935|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
154272936|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272937|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272938|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614380|NCT01967979|Fluoxetine|fluoxetine|mesh-list
154272950|NCT01220232|Abacavir|abacavir|mesh-list
154272951|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
154272952|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154272953|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154272954|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272955|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272956|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
154272957|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272958|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154272959|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154272960|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
154272961|NCT01126008|Docetaxel|docetaxel|mesh-list
154272962|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272963|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
154272964|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272965|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272966|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497895|NCT00002832|Decitabine|decitabine|mesh-list
154272967|NCT01123824|Clopidogrel|clopidogrel|mesh-list
154272968|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154272969|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154272970|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154272971|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154272972|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
154272973|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272974|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272975|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272977|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154272978|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
154272979|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154272980|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
154272981|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272982|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272983|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
154272984|NCT03009838|Letrozole|letrozole|mesh-list
154272985|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272986|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154272987|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154272988|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272989|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272990|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154272991|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
154272992|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272993|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272994|NCT01124058|Heparin|heparin|mesh-list
154272995|NCT01124058|Calcium heparin|calcium heparin|mesh-list
154272996|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154272997|NCT01124058|Tinzaparin|tinzaparin|mesh-list
154272998|NCT01124058|Dalteparin|dalteparin|mesh-list
154272999|NCT01124058|Warfarin|warfarin|mesh-list
154273000|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
154273001|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154273002|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154273003|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273014|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154273015|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154273016|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273017|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273018|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154861502|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154273019|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273020|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
154273021|NCT05123170|Lidocaine|lidocaine|mesh-list
154273022|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
154273023|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
154273024|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
154273025|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273026|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273027|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
154273028|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273029|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154273030|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154273031|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154273032|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273033|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497957|NCT00002898|Etoposide|etoposide|mesh-list
154273034|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154273035|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154273036|NCT05123170|Analgesics|analgesics|mesh-ancestor
154273037|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154273038|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154273039|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154273040|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
154273041|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273042|NCT01215708|Tamsulosin|tamsulosin|mesh-list
154273043|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154273044|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154273045|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154273046|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
154273047|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273048|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273049|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273050|NCT01215708|Urological Agents|urological agents|mesh-ancestor
154273052|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
154273053|NCT01222026|Vitamins|vitamins|mesh-ancestor
154273054|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
154273055|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273056|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154273057|NCT00225251|Bupropion|bupropion|mesh-list
154273058|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154273059|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
154273060|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154273061|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154273062|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154273063|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273064|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273065|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
154273066|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273067|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614491|NCT01968616|Ranibizumab|ranibizumab|mesh-list
154273089|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273090|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273091|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154273092|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
154273093|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
154273094|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154273096|NCT01073501|Analgesics|analgesics|mesh-ancestor
154273097|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
154273098|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273099|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273100|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
154273101|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154273102|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273103|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273104|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154273105|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154273106|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154273107|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273108|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154273109|NCT01222182|Atorvastatin|atorvastatin|mesh-list
154273110|NCT01222182|Simvastatin|simvastatin|mesh-list
154273111|NCT01222182|Pravastatin|pravastatin|mesh-list
154273112|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154273113|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154273114|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
154273115|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273116|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153614552|NCT01969019|Prednisolone|prednisolone|mesh-list
154273125|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273126|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
154273127|NCT01376284|Dutasteride|dutasteride|mesh-list
154273128|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154273129|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154273130|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273131|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273132|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
154273133|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273134|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273135|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154273136|NCT01376440|Eusol|eusol|mesh-list
154273137|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
154273138|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273139|NCT01329042|Citric Acid|citric acid|mesh-list
154273140|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
154273141|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
154273142|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154273143|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
154273144|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
154273145|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273146|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154273147|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
154273148|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273149|NCT00253643|Protective Agents|protective agents|mesh-ancestor
154273150|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273151|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154273152|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154273153|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273154|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154273155|NCT01222650|Silodosin|silodosin|mesh-list
154273156|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154273157|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154273158|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154273159|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
153498066|NCT00002988|Irinotecan|irinotecan|mesh-list
154273160|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273161|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273162|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273163|NCT01222650|Urological Agents|urological agents|mesh-ancestor
154273164|NCT01073579|Vigabatrin|vigabatrin|mesh-list
154273165|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
154273166|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273167|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273168|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
154273169|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273170|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273171|NCT00221195|Thrombin|thrombin|mesh-list
154273172|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
154273173|NCT00221195|Coagulants|coagulants|mesh-ancestor
154273174|NCT04646590|Vaccines|vaccines|mesh-list
154273175|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
154273176|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273177|NCT03931668|Maleic acid|maleic acid|mesh-list
154273178|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273179|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273180|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
154273181|NCT00220805|Antibodies|antibodies|mesh-list
154273198|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154273199|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
154273200|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273201|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154273202|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154273203|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273206|NCT05760430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154273207|NCT05760430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273208|NCT05760430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154273209|NCT05760430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154273210|NCT05760430|Growth Substances|growth substances|mesh-ancestor
154273211|NCT05760430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273212|NCT05760430|Growth Inhibitors|growth inhibitors|mesh-ancestor
154273213|NCT05760430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154273214|NCT05760430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273215|NCT05760430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273217|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154273218|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
154273219|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273220|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154273221|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
154273222|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
154273223|NCT01221402|Vitamins|vitamins|mesh-ancestor
154273224|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
154273225|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273226|NCT04214860|Azacitidine|azacitidine|mesh-list
154273227|NCT04214860|Venetoclax|venetoclax|mesh-list
154273228|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154273229|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
154273230|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273231|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273232|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273233|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154273234|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154273235|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154273236|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273237|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273238|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273239|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273240|NCT01127490|Analgesics|analgesics|mesh-ancestor
154273241|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
154273264|NCT00252239|Tenecteplase|tenecteplase|mesh-list
154273265|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154273266|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154273267|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273268|NCT01127022|Choline|choline|mesh-list
154273269|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
154273270|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154273271|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
154273272|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273273|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154273274|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154273275|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
154273276|NCT01221558|Lycopene|lycopene|mesh-list
154273277|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273278|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
154273279|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273280|NCT01221558|Protective Agents|protective agents|mesh-ancestor
154273281|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273282|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154273283|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154273284|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273285|NCT01221636|Abatacept|abatacept|mesh-list
154273286|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154273287|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273288|NCT01221636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154273289|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273290|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154273291|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
154273292|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273293|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273294|NCT05731804|Ritonavir|ritonavir|mesh-list
154273312|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273313|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154273314|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154273315|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
154273317|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154273318|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273319|NCT01127100|Fentanyl|fentanyl|mesh-list
154273320|NCT01127100|Gabapentin|gabapentin|mesh-list
154273321|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154273322|NCT01127100|Narcotics|narcotics|mesh-ancestor
154273323|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273324|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273325|NCT01127100|Analgesics|analgesics|mesh-ancestor
154273326|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
154273327|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273328|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153926185|NCT02646709|Ketamine|ketamine|mesh-list
154273329|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154273330|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
154273331|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
154273332|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
154273333|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154273334|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154273335|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154273336|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154273337|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154273338|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273339|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273340|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
154273341|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
154020237|NCT02733380|Hormones|hormones|mesh-ancestor
154273342|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154273343|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273344|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273345|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273346|NCT01221792|Carvedilol|carvedilol|mesh-list
154273347|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154273348|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154273360|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154273361|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154273363|NCT03932526|Vinorelbine|vinorelbine|mesh-list
154273364|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273365|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154273366|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273367|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273368|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154273369|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
154273370|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
154273371|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
154273372|NCT01127724|Vitamins|vitamins|mesh-list
154273373|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
154273374|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
154273375|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
154273376|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
154273377|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273378|NCT01127724|Hematinics|hematinics|mesh-ancestor
154273379|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
154273380|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154273381|NCT03103906|Protective Agents|protective agents|mesh-ancestor
154273382|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273383|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
154273384|NCT05675098|Methylphenidate|methylphenidate|mesh-list
154273385|NCT05675098|Modafinil|modafinil|mesh-list
154273386|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154273387|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273388|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154273389|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154273390|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273391|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273392|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
154273393|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273394|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154273395|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154273396|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154273397|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
154273398|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
154273399|NCT01223742|Vitamins|vitamins|mesh-ancestor
154273400|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
154273401|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273402|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
154273403|NCT01129518|Vaccines|vaccines|mesh-list
154273404|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
154273405|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273406|NCT01223820|Capsaicin|capsaicin|mesh-list
154273407|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
154273408|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
154273409|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
154273410|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614835|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154273426|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
154273427|NCT01223898|Nilotinib|nilotinib|mesh-list
154861503|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
154255259|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153926259|NCT00910975|Ribavirin|ribavirin|mesh-list
154273428|NCT01223898|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154273429|NCT01223898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154273430|NCT01223898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273431|NCT01223898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273432|NCT01127880|Clindamycin|clindamycin|mesh-list
154273433|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
154273434|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
154273435|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154273436|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273437|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154273438|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273439|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273440|NCT01228344|Lumefantrine|lumefantrine|mesh-list
154273441|NCT01228344|Artemether|artemether|mesh-list
154273442|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154273443|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
154273444|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154273445|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154273446|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273447|NCT03927456|Fulvestrant|fulvestrant|mesh-list
154273448|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154273449|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273450|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154273451|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154273452|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
154273453|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273454|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498277|NCT00003150|Prednisone|prednisone|mesh-list
153498324|NCT00003018|Calcium|calcium|mesh-list
154273455|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154273456|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154273457|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
154273458|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273459|NCT01228422|Interferons|interferons|mesh-list
154273460|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
154273461|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
154273462|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273463|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
154273464|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273483|NCT03924492|Brexanolone|brexanolone|mesh-list
154273484|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
154273485|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273486|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273487|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273488|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
154273489|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
154273490|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
154273491|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273492|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154273493|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154273494|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
154273495|NCT01224366|Vildagliptin|vildagliptin|mesh-list
154273496|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154273497|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273498|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154273499|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
154273500|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273501|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273502|NCT05415826|Dexamethasone|dexamethasone|mesh-list
154273503|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273504|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
154273505|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
154273506|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273507|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273508|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154273509|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
154273510|NCT05415826|Hormones|hormones|mesh-ancestor
153498325|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
154273511|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273512|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154273513|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273514|NCT05415748|Tamsulosin|tamsulosin|mesh-list
154273515|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154273516|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154861504|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154861505|NCT04355273|Heparin|heparin|mesh-list
154273517|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154273518|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
154273519|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273520|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614965|NCT01971684|Sirolimus|sirolimus|mesh-list
154273562|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154273563|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154273564|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273565|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154273566|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
154273567|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154273568|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
154273569|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154273570|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
154273571|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154273572|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154273574|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
154273575|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
154273576|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273577|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273578|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154273579|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154273580|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154273581|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273582|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154273583|NCT02927938|Cytarabine|cytarabine|mesh-list
154273584|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154273585|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
154273586|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273587|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273588|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
154273589|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273590|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154273591|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
154273592|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273593|NCT03863860|Fluzoparib|fluzoparib|mesh-list
154273594|NCT03863860|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154273595|NCT03863860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273596|NCT03863860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273597|NCT03863860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273598|NCT03923166|Capecitabine|capecitabine|mesh-list
154273599|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498373|NCT00003204|Hormones|hormones|mesh-ancestor
154273600|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
154273601|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273602|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273603|NCT01224756|Tinoridine|tinoridine|mesh-list
154273604|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154273605|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154273606|NCT01224756|Analgesics|analgesics|mesh-ancestor
154273607|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
154273608|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273609|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273610|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273611|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273612|NCT03392428|Pluvicto|pluvicto|mesh-list
154273613|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153615050|NCT01972373|Growth Substances|growth substances|mesh-ancestor
154273631|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154273632|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
154273633|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273634|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273635|NCT03175978|Methotrexate|methotrexate|mesh-list
154273636|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273637|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154273638|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
154273639|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154273640|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154273641|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
154273642|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273643|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273644|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
154273645|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273646|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154273647|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153926400|NCT04167007|Gemcitabine|gemcitabine|mesh-list
154273648|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
154273649|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273650|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154273651|NCT03923010|Itraconazole|itraconazole|mesh-list
154273652|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
154273653|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273654|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154273655|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154273656|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273657|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273658|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154273659|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
154273660|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273661|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273662|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154273663|NCT01227798|Interferons|interferons|mesh-list
154273664|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
154273665|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273666|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
154273667|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273693|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154273695|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273696|NCT01131468|Expectorants|expectorants|mesh-ancestor
154273697|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
153498424|NCT00003252|Amifostine|amifostine|mesh-list
154273698|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154273699|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
154273700|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273701|NCT01131468|Protective Agents|protective agents|mesh-ancestor
154273702|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273703|NCT01131468|Antidotes|antidotes|mesh-ancestor
153498504|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
154273704|NCT01225224|Peficitinib|peficitinib|mesh-list
154273705|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273706|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273707|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154273708|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
154273709|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273710|NCT01131546|Amlodipine|amlodipine|mesh-list
154273711|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154273712|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154273713|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273714|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273715|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154273716|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615181|NCT01973660|Tamoxifen|tamoxifen|mesh-list
154273744|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154273746|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154273747|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273748|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
154273749|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
154273750|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
154273751|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273752|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154273753|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
154273754|NCT01131702|Ranitidine|ranitidine|mesh-list
154273755|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154273756|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154273757|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154273758|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154273759|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
154273760|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
154273761|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273762|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273763|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273787|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273788|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154273789|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273790|NCT01130688|Zileuton|zileuton|mesh-list
154273791|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154273792|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154273793|NCT01130688|Analgesics|analgesics|mesh-ancestor
154273794|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
154861506|NCT04355273|Calcium heparin|calcium heparin|mesh-list
154861507|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
154273795|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273796|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273797|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273798|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273799|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154273800|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273801|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273802|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154273803|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
154273804|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273805|NCT03925662|Mebendazole|mebendazole|mesh-list
154273806|NCT03925662|Piperazine|piperazine|mesh-list
154273807|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
154273808|NCT03925662|Bevacizumab|bevacizumab|mesh-list
154273809|NCT03925662|DMP 777|dmp 777|mesh-list
154273810|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154273811|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273812|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154273813|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154273814|NCT03925662|Growth Substances|growth substances|mesh-ancestor
154273815|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273816|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
154273817|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
154273818|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
153615266|NCT01973933|Metformin|metformin|mesh-list
154273842|NCT01131780|Ibuprofen|ibuprofen|mesh-list
154273843|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
154273844|NCT01131780|Ephedrine|ephedrine|mesh-list
154273845|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154273846|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154273847|NCT01131780|Analgesics|analgesics|mesh-ancestor
154273848|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
154273849|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273850|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273851|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273852|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273853|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154273854|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273855|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273856|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154273857|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
154273858|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154273859|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
154273860|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
154273861|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154273862|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154273863|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
154273864|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
154273865|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273866|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
154273867|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154273868|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153615319|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
154273877|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153498577|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
154273878|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273879|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154273880|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154273881|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154273883|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154273884|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154273885|NCT01131000|Analgesics|analgesics|mesh-ancestor
154273886|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
154273887|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273888|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273889|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273890|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273891|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154273892|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273893|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273894|NCT01132170|Valproic Acid|valproic acid|mesh-list
154273895|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
154273896|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273897|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273898|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
154273899|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273900|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273901|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
154273902|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154273903|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273904|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154273905|NCT03925428|Entinostat|entinostat|mesh-list
154273906|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154273907|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273908|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273909|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273910|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154273911|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154273912|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273913|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
154273914|NCT03919812|Vitamin D|vitamin d|mesh-list
154273915|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154273916|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273917|NCT03919812|Vitamins|vitamins|mesh-ancestor
154273918|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
154273919|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154273920|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
154273921|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154273922|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273923|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154273924|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273925|NCT01132248|Mefloquine|mefloquine|mesh-list
154273926|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
154273927|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154273928|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154273929|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273930|NCT01229592|Ethanol|ethanol|mesh-list
154273931|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154273932|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615369|NCT01974648|Narcotics|narcotics|mesh-ancestor
154273943|NCT01132404|Leuprolide|leuprolide|mesh-list
154273944|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154273945|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
154273946|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154273947|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273948|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154273949|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273950|NCT01231854|Cyclosporine|cyclosporine|mesh-list
154273951|NCT01231854|Alitretinoin|alitretinoin|mesh-list
154273952|NCT01231854|Cyclosporins|cyclosporins|mesh-list
154273953|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582968|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
154273954|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273955|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154273956|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
154273957|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273958|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
154273959|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273960|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
154273961|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273962|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154273963|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273964|NCT01132638|Esomeprazole|esomeprazole|mesh-list
154273965|NCT01132638|Pantoprazole|pantoprazole|mesh-list
154273966|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154273967|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154273968|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154273969|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273970|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273971|NCT05402124|Aspirin|aspirin|mesh-list
154273972|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154273973|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154273974|NCT05402124|Analgesics|analgesics|mesh-ancestor
154273975|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
154273976|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273977|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273978|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273979|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273980|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154273981|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154273982|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273983|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154273984|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154273985|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273986|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
154273987|NCT01134432|Prednisolone|prednisolone|mesh-list
154273988|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154273989|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
154273990|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154273991|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
154273992|NCT01134432|Rituximab|rituximab|mesh-list
154273993|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154273994|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
154273995|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153615433|NCT01975259|Incretins|incretins|mesh-ancestor
154274002|NCT01134432|Hormones|hormones|mesh-ancestor
154274003|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274004|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154274005|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
154274006|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
154274007|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274008|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274009|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154274010|NCT01134432|Protective Agents|protective agents|mesh-ancestor
154274011|NCT01232010|Mirodenafil|mirodenafil|mesh-list
154274012|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154274013|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154274014|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274015|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274016|NCT01132716|Valacyclovir|valacyclovir|mesh-list
154274017|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
154274018|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274019|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
154274020|NCT05401812|Hormones|hormones|mesh-ancestor
154274021|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274022|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274023|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
154274024|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154274025|NCT01137708|Tofacitinib|tofacitinib|mesh-list
154274026|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154274027|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
154274028|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154274029|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274030|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154274031|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154274032|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154274033|NCT01137708|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154274034|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274035|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274036|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274037|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154274038|NCT01137708|Estrogens|estrogens|mesh-ancestor
154274039|NCT01137708|Hormones|hormones|mesh-ancestor
154274040|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274041|NCT03765138|Pramipexole|pramipexole|mesh-list
154274042|NCT03765138|Dexpramipexole|dexpramipexole|mesh-list
154274043|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
154274044|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274045|NCT03765138|Protective Agents|protective agents|mesh-ancestor
154274046|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274047|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154274048|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154274049|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
154274050|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
154274051|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274052|NCT01134666|Cetuximab|cetuximab|mesh-list
154274053|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154274054|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274055|NCT03739788|Deucravacitinib|deucravacitinib|mesh-list
154274056|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
154274057|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274058|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274059|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274060|NCT01137942|Metronidazole|metronidazole|mesh-list
154274061|NCT01137942|Clarithromycin|clarithromycin|mesh-list
154274062|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154274063|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274064|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153498747|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154274084|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274085|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274086|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154274087|NCT01132794|Analgesics|analgesics|mesh-ancestor
154274088|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
154274089|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274090|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154274091|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154274092|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154274093|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
154274094|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274095|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274096|NCT01135212|Candesartan|candesartan|mesh-list
154274097|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
154274098|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154274099|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154274100|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154274101|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274102|NCT01233570|Tacrolimus|tacrolimus|mesh-list
154274103|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154274104|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
154274105|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274106|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154274107|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274108|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274109|NCT01135290|Petrolatum|petrolatum|mesh-list
154274110|NCT01135290|Emollients|emollients|mesh-ancestor
154274111|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
154274112|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
154274113|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154274114|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274115|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154274116|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274117|NCT01135602|Topiramate|topiramate|mesh-list
154274118|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
154274183|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274185|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274186|NCT01138956|Antidotes|antidotes|mesh-ancestor
154274187|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154274188|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274189|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274190|NCT01232244|Glucagon|glucagon|mesh-list
154274191|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154274192|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274193|NCT01232244|Hormones|hormones|mesh-ancestor
154274206|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274207|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274208|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274209|NCT01133496|Alendronate|alendronate|mesh-list
154274210|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154274211|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274212|NCT01233882|Bosutinib|bosutinib|mesh-list
154274213|NCT01233882|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154274214|NCT01233882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274215|NCT01233882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274216|NCT01233882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274217|NCT01232400|Esmolol|esmolol|mesh-list
154274218|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154274219|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154274220|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154274221|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
154274222|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274223|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274224|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274225|NCT02528760|Erythromycin|erythromycin|mesh-list
154274226|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
154274227|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154274228|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
154274229|NCT02528760|Metoclopramide|metoclopramide|mesh-list
154274230|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
154274231|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
154274232|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274233|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926771|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
154274234|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274235|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154274236|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154274237|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
154274238|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274239|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274240|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274241|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274242|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154274243|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274245|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274246|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274247|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154274248|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274249|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274250|NCT01136538|Valacyclovir|valacyclovir|mesh-list
154274251|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
154274252|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274254|NCT03917628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154274255|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274268|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154274269|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
154274270|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154274271|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154274272|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274273|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274274|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154274276|NCT01234116|Emtricitabine|emtricitabine|mesh-list
154274277|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154274278|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
154274279|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274280|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154274281|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154274282|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274283|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274284|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154274285|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154274286|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
154274287|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
154274288|NCT01230996|Cisplatin|cisplatin|mesh-list
154274289|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274290|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
154274291|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154274292|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154274293|NCT01137084|Prednisolone|prednisolone|mesh-list
154274294|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
153498860|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
154274295|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154274296|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
154274297|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274298|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
154274299|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
154274300|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274301|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274302|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274303|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
154274304|NCT01137084|Hormones|hormones|mesh-ancestor
154274305|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274306|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154274307|NCT01137084|Protective Agents|protective agents|mesh-ancestor
154274308|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154274309|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274310|NCT01133886|Decitabine|decitabine|mesh-list
154021208|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154274311|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154274312|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
154274313|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274314|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274315|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274316|NCT01140126|UB-421|ub-421|mesh-list
154274317|NCT01140126|Antibodies|antibodies|mesh-list
154274318|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
154274319|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861508|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154274345|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274346|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274348|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
154274349|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274350|NCT04913922|Nivolumab|nivolumab|mesh-list
154274351|NCT04913922|Relatlimab|relatlimab|mesh-list
154274352|NCT04913922|Azacitidine|azacitidine|mesh-list
154274353|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154274354|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274355|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154274356|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274357|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154274358|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
154274359|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274360|NCT01234272|Morphine|morphine|mesh-list
154274361|NCT01234272|Ropivacaine|ropivacaine|mesh-list
154274362|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154274363|NCT01234272|Narcotics|narcotics|mesh-ancestor
154274364|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274365|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274366|NCT01234272|Analgesics|analgesics|mesh-ancestor
154274367|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
154274368|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274369|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
154274370|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
154274371|NCT01140438|Metformin|metformin|mesh-list
154274372|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154274373|NCT01140438|Repaglinide|repaglinide|mesh-list
154274399|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
154274400|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
154274401|NCT04751604|Vitamins|vitamins|mesh-ancestor
154274402|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
154274403|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274404|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154274405|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
154274406|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274407|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154274408|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
154274409|NCT01231542|Rifampin|rifampin|mesh-list
154274410|NCT01231542|Rifabutin|rifabutin|mesh-list
154274411|NCT01231542|Dolutegravir|dolutegravir|mesh-list
154274412|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154274413|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
154274414|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274415|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274416|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
154274417|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154274418|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274419|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274420|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154274421|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154274422|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154274423|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153615877|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
154274432|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154274433|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154274434|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154274435|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
154274436|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274437|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274438|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274439|NCT01142778|Bevacizumab|bevacizumab|mesh-list
154274440|NCT01142778|Trastuzumab|trastuzumab|mesh-list
154274441|NCT01142778|Docetaxel|docetaxel|mesh-list
154274442|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154274443|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274444|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154274445|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154274446|NCT01142778|Growth Substances|growth substances|mesh-ancestor
154274447|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274448|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
154274449|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
154274450|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154274451|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154274452|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274453|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
154274454|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154274455|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154274456|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274457|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
154274458|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154274459|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154274460|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
154274461|NCT04722978|Carboplatin|carboplatin|mesh-list
154274462|NCT04722978|Gemcitabine|gemcitabine|mesh-list
154274463|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154021364|NCT02707328|Paclitaxel|paclitaxel|mesh-list
154274464|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274465|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154274466|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
154274467|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274468|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274469|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154274470|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154274471|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274472|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154274473|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
154274474|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154274475|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274476|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154274477|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154274478|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154274479|NCT01140828|Rabeprazole|rabeprazole|mesh-list
154274480|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154274481|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274482|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154274483|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274484|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274485|NCT01234740|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154274486|NCT01234740|Bafetinib|bafetinib|mesh-list
154274487|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274488|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615923|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154274507|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154274508|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
154274509|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274510|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
154274511|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154274512|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154274513|NCT04624776|Prednisolone|prednisolone|mesh-list
154274514|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
154274515|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154274516|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
154274517|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274518|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
154274519|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
153499019|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
154274520|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274521|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274522|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274523|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
154274524|NCT04624776|Hormones|hormones|mesh-ancestor
154274525|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274526|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154274527|NCT04624776|Protective Agents|protective agents|mesh-ancestor
154274528|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154274529|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274530|NCT01234896|Nicotine|nicotine|mesh-list
154274531|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154274532|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
154274533|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274534|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274535|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154274536|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154274537|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
154274538|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274539|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274540|NCT01238094|Simvastatin|simvastatin|mesh-list
154274541|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154274542|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154274543|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
154274560|NCT03633630|Antacids|antacids|mesh-ancestor
154274561|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274562|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274563|NCT01234974|Everolimus|everolimus|mesh-list
154274564|NCT01234974|Pasireotide|pasireotide|mesh-list
154274565|NCT01234974|Somatostatin|somatostatin|mesh-list
154274566|NCT01234974|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154274567|NCT01234974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274568|NCT01234974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274569|NCT01234974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274570|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154274571|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
154274572|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274573|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274574|NCT01234974|Hormones|hormones|mesh-ancestor
154274575|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274576|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
154274577|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154274578|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154274579|NCT01140984|Prednisolone|prednisolone|mesh-list
154274580|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
154274581|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154274582|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
154274583|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274584|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
154274585|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
154274586|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274587|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274588|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274589|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
154274590|NCT01140984|Hormones|hormones|mesh-ancestor
154274591|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274592|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154274593|NCT01140984|Protective Agents|protective agents|mesh-ancestor
154274594|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154274595|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274596|NCT01145430|Doxorubicin|doxorubicin|mesh-list
154274597|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154274598|NCT01145430|Veliparib|veliparib|mesh-list
154274599|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154274600|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274601|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154274602|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154274613|NCT01586052|Hematinics|hematinics|mesh-ancestor
154274614|NCT05796635|Allantoin|allantoin|mesh-list
154274615|NCT05796635|Dermatologic Agents|dermatologic agents|mesh-ancestor
154274617|NCT05796362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274618|NCT05796362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274619|NCT05796115|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154274620|NCT05796115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154274621|NCT05796115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274622|NCT05796115|Antitubercular Agents|antitubercular agents|mesh-ancestor
154274623|NCT05795946|Vitamin D|vitamin d|mesh-list
154274624|NCT05795946|Vitamins|vitamins|mesh-ancestor
154274625|NCT05795946|Micronutrients|micronutrients|mesh-ancestor
154274626|NCT05795946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274627|NCT05795946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154274628|NCT05795920|Gemcitabine|gemcitabine|mesh-list
154274629|NCT05795920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154274630|NCT05795920|Antimetabolites|antimetabolites|mesh-ancestor
154274631|NCT05795920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274632|NCT05795920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274633|NCT05849246|Cisplatin|cisplatin|mesh-list
154274634|NCT05849246|Carboplatin|carboplatin|mesh-list
154274635|NCT05849246|Pemetrexed|pemetrexed|mesh-list
154274636|NCT05849246|Maytansine|maytansine|mesh-list
154274637|NCT05849246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274638|NCT05849246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274639|NCT05849246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274640|NCT05849246|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154274641|NCT05849246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154274642|NCT05849246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154274643|NCT05849246|Tubulin Modulators|tubulin modulators|mesh-ancestor
154274644|NCT05849246|Antimitotic Agents|antimitotic agents|mesh-ancestor
154274645|NCT05849246|Mitosis Modulators|mitosis modulators|mesh-ancestor
154274646|NCT05849220|Dapagliflozin|dapagliflozin|mesh-list
154274647|NCT05849220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154861509|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154274648|NCT05849220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274649|NCT05849220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154274650|NCT05849220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274651|NCT05848635|Morphine|morphine|mesh-list
154274652|NCT05848635|Hydromorphone|hydromorphone|mesh-list
154274653|NCT05848635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154274654|NCT05848635|Narcotics|narcotics|mesh-ancestor
154274655|NCT05848635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274656|NCT05848635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274657|NCT05848635|Analgesics|analgesics|mesh-ancestor
154274658|NCT05848635|Sensory System Agents|sensory system agents|mesh-ancestor
154274659|NCT05848635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274660|NCT05848531|Clonidine|clonidine|mesh-list
154274661|NCT05848531|Analgesics|analgesics|mesh-ancestor
154274662|NCT05848531|Sensory System Agents|sensory system agents|mesh-ancestor
154274663|NCT05848531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274664|NCT05848531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274665|NCT05848531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154274666|NCT05848531|Sympatholytics|sympatholytics|mesh-ancestor
154274667|NCT05848531|Autonomic Agents|autonomic agents|mesh-ancestor
154274668|NCT05848531|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154274682|NCT05848505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154274683|NCT05848505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154274684|NCT05848505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154274685|NCT05848505|Adrenergic Agents|adrenergic agents|mesh-ancestor
154274686|NCT05848505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274687|NCT05848505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274688|NCT05848492|Fluconazole|fluconazole|mesh-list
154274689|NCT05848492|Antifungal Agents|antifungal agents|mesh-ancestor
154274690|NCT05848492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274691|NCT05848492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154274692|NCT05848492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154274693|NCT05848492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274694|NCT05848492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274695|NCT05848492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154274696|NCT05848492|Hormone Antagonists|hormone antagonists|mesh-ancestor
154274697|NCT05848492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274698|NCT05848492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274699|NCT05848492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154274700|NCT05848492|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154274701|NCT05848336|Caseins|caseins|mesh-list
154274702|NCT05848336|Chelating Agents|chelating agents|mesh-ancestor
154274703|NCT05848336|Sequestering Agents|sequestering agents|mesh-ancestor
154274704|NCT05848336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274705|NCT05848102|Dapagliflozin|dapagliflozin|mesh-list
154274706|NCT05848102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154274707|NCT05848102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274708|NCT05848102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154274709|NCT05848102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274710|NCT05847764|Carboplatin|carboplatin|mesh-list
154274711|NCT05847764|Tislelizumab|tislelizumab|mesh-list
154274712|NCT05847764|Aflutinib|aflutinib|mesh-list
154274713|NCT05847764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274714|NCT05847764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154274715|NCT05847764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274716|NCT05847764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274717|NCT05847764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274718|NCT05846373|Niacin|niacin|mesh-list
154274719|NCT05846373|Niacinamide|niacinamide|mesh-list
154274720|NCT05846373|Nicotinic Acids|nicotinic acids|mesh-list
154274721|NCT05846373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154274722|NCT05846373|Antimetabolites|antimetabolites|mesh-ancestor
154274723|NCT05846373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274724|NCT05846373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154274725|NCT05846373|Vasodilator Agents|vasodilator agents|mesh-ancestor
154274726|NCT05846373|Vitamin B Complex|vitamin b complex|mesh-ancestor
154274727|NCT05846373|Vitamins|vitamins|mesh-ancestor
154274746|NCT05845723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274747|NCT05845723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154274748|NCT05845723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154274749|NCT05845723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274750|NCT05845723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274751|NCT05845424|Ezetimibe|ezetimibe|mesh-list
154274752|NCT05845424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154274753|NCT05845424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154274754|NCT05845424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154274755|NCT05845424|Antimetabolites|antimetabolites|mesh-ancestor
154274756|NCT05845424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274757|NCT05845424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154274758|NCT05845424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274759|NCT05845385|Analgesics|analgesics|mesh-list
154274760|NCT05845385|Sensory System Agents|sensory system agents|mesh-ancestor
154274761|NCT05845385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274762|NCT05845385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274763|NCT05845268|Tislelizumab|tislelizumab|mesh-list
154274764|NCT05845268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154274765|NCT05845268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154274766|NCT05845268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274767|NCT05845268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274768|NCT05845125|Triamcinolone|triamcinolone|mesh-list
154274769|NCT05845125|Bupivacaine|bupivacaine|mesh-list
154274770|NCT05845125|Anesthetics, Local|anesthetics, local|mesh-ancestor
154274771|NCT05845125|Anesthetics|anesthetics|mesh-ancestor
154274772|NCT05845125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274773|NCT05845125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274774|NCT05845125|Sensory System Agents|sensory system agents|mesh-ancestor
154274775|NCT05845125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274776|NCT05845125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274777|NCT05845125|Glucocorticoids|glucocorticoids|mesh-ancestor
154274778|NCT05845125|Hormones|hormones|mesh-ancestor
154274779|NCT05845125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274780|NCT05844930|Triamcinolone|triamcinolone|mesh-list
154274781|NCT05844930|Lidocaine|lidocaine|mesh-list
154274782|NCT05844930|Anesthetics, Local|anesthetics, local|mesh-ancestor
154274783|NCT05844930|Anesthetics|anesthetics|mesh-ancestor
154274784|NCT05844930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274798|NCT05844800|Anesthetics, Local|anesthetics, local|mesh-ancestor
154274799|NCT05844800|Anesthetics|anesthetics|mesh-ancestor
154274800|NCT05844800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274801|NCT05844800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274802|NCT05844800|Sensory System Agents|sensory system agents|mesh-ancestor
154274803|NCT05844800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274804|NCT05844683|Chlorhexidine|chlorhexidine|mesh-list
154274805|NCT05844683|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154274806|NCT05844683|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154274807|NCT05844683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274808|NCT05844683|Disinfectants|disinfectants|mesh-ancestor
154274809|NCT05844683|Dermatologic Agents|dermatologic agents|mesh-ancestor
154274810|NCT05844670|Vincristine|vincristine|mesh-list
154274811|NCT05844670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154274812|NCT05844670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274813|NCT05844670|Tubulin Modulators|tubulin modulators|mesh-ancestor
154274814|NCT05844670|Antimitotic Agents|antimitotic agents|mesh-ancestor
154274815|NCT05844670|Mitosis Modulators|mitosis modulators|mesh-ancestor
154274816|NCT05844670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274817|NCT05844553|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154274818|NCT05844553|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153499258|NCT00004068|Irinotecan|irinotecan|mesh-list
154274819|NCT05844553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274820|NCT05844371|Oxaliplatin|oxaliplatin|mesh-list
154274821|NCT05844371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274822|NCT05844306|Deoxyglucose|deoxyglucose|mesh-list
154274823|NCT05844306|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154274824|NCT05844306|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154274825|NCT05844306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274826|NCT05844306|Antimetabolites|antimetabolites|mesh-ancestor
154274827|NCT05844306|Antiviral Agents|antiviral agents|mesh-ancestor
154274828|NCT05844306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274829|NCT05843812|Magnesium Sulfate|magnesium sulfate|mesh-list
154274830|NCT05843812|Analgesics|analgesics|mesh-ancestor
154274831|NCT05843812|Sensory System Agents|sensory system agents|mesh-ancestor
154274832|NCT05843812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274833|NCT05843812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274834|NCT05843812|Anesthetics|anesthetics|mesh-ancestor
154274835|NCT05843812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274836|NCT05843812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154021730|NCT00657423|Cisplatin|cisplatin|mesh-list
154274837|NCT05843812|Anticonvulsants|anticonvulsants|mesh-ancestor
154274838|NCT05843812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154274839|NCT05843812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154274840|NCT05843812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274841|NCT05843812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154274842|NCT05843812|Tocolytic Agents|tocolytic agents|mesh-ancestor
153616315|NCT06327581|Glucocorticoids|glucocorticoids|mesh-ancestor
154274848|NCT05843617|Antioxidants|antioxidants|mesh-ancestor
154274849|NCT05843617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274850|NCT05843617|Protective Agents|protective agents|mesh-ancestor
154274851|NCT05843344|Dexmedetomidine|dexmedetomidine|mesh-list
154274852|NCT05843344|Morphine|morphine|mesh-list
154274853|NCT05843344|Ropivacaine|ropivacaine|mesh-list
154274854|NCT05843344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154274855|NCT05843344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274856|NCT05843344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274857|NCT05843344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154274858|NCT05843344|Analgesics|analgesics|mesh-ancestor
154274859|NCT05843344|Sensory System Agents|sensory system agents|mesh-ancestor
154274860|NCT05843344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274861|NCT05843344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154274862|NCT05843344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154274863|NCT05843344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154274864|NCT05843344|Adrenergic Agents|adrenergic agents|mesh-ancestor
154274865|NCT05843344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274866|NCT05843344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274867|NCT05843344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154274868|NCT05843344|Narcotics|narcotics|mesh-ancestor
154274869|NCT05843344|Anesthetics, Local|anesthetics, local|mesh-ancestor
154274870|NCT05843344|Anesthetics|anesthetics|mesh-ancestor
154274871|NCT05843292|Carboplatin|carboplatin|mesh-list
154274872|NCT05843292|Taxane|taxane|mesh-list
154274873|NCT05843292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274874|NCT05843162|Losartan|losartan|mesh-list
154274875|NCT05843162|Telmisartan|telmisartan|mesh-list
154274876|NCT05843162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154274877|NCT05843162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154274878|NCT05843162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154274879|NCT05843162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154274880|NCT05843162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274881|NCT05842681|Azithromycin|azithromycin|mesh-list
154274882|NCT05842681|Methylprednisolone|methylprednisolone|mesh-list
154274883|NCT05842681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154274884|NCT05842681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154274885|NCT05842681|Prednisolone|prednisolone|mesh-list
154274886|NCT05842681|Prednisolone acetate|prednisolone acetate|mesh-list
154274887|NCT05842681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154274888|NCT05842681|Prednisolone phosphate|prednisolone phosphate|mesh-list
154274889|NCT05842681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274890|NCT05842681|Antiemetics|antiemetics|mesh-ancestor
154274891|NCT05842681|Autonomic Agents|autonomic agents|mesh-ancestor
154274892|NCT05842681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274893|NCT05842681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274894|NCT05842681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274895|NCT05842681|Glucocorticoids|glucocorticoids|mesh-ancestor
154274896|NCT05842681|Hormones|hormones|mesh-ancestor
154274897|NCT05842681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274898|NCT05842681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154274899|NCT05842681|Protective Agents|protective agents|mesh-ancestor
154274900|NCT05842681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154274901|NCT05842681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274902|NCT05842681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274903|NCT05842681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274904|NCT05842486|Antibodies|antibodies|mesh-list
154274905|NCT05842486|Immunologic Factors|immunologic factors|mesh-ancestor
154274906|NCT05842486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274907|NCT05840848|Beta Carotene|beta carotene|mesh-list
154274929|NCT05840562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274930|NCT05840562|Antidepressive Agents|antidepressive agents|mesh-ancestor
154274931|NCT05840562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154274932|NCT05840562|Dopamine Agents|dopamine agents|mesh-ancestor
154274933|NCT05840562|Antipruritics|antipruritics|mesh-ancestor
154274934|NCT05840562|Dermatologic Agents|dermatologic agents|mesh-ancestor
154274936|NCT05840289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154274937|NCT05840289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274938|NCT05840289|Immunologic Factors|immunologic factors|mesh-ancestor
154274939|NCT05840289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274940|NCT05840289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154274941|NCT05839938|Vitamin D|vitamin d|mesh-list
154274942|NCT05839938|Vitamins|vitamins|mesh-ancestor
154274944|NCT05839938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274945|NCT05839938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154274946|NCT05829499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154274947|NCT05829499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154274948|NCT05825573|Vitamin K|vitamin k|mesh-list
154274949|NCT05825573|Anticoagulants|anticoagulants|mesh-list
154274950|NCT05825573|Vitamins|vitamins|mesh-ancestor
154274951|NCT05825573|Micronutrients|micronutrients|mesh-ancestor
154274952|NCT05825573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274953|NCT05825573|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154274954|NCT05825573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154274955|NCT05825573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274956|NCT05825573|Hemostatics|hemostatics|mesh-ancestor
154274957|NCT05825573|Coagulants|coagulants|mesh-ancestor
154274958|NCT05825352|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154274959|NCT05825352|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154274960|NCT05824494|Paclitaxel|paclitaxel|mesh-list
154274961|NCT05824494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154274962|NCT05824494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274963|NCT05824494|Tubulin Modulators|tubulin modulators|mesh-ancestor
154274977|NCT05822817|Sevoflurane|sevoflurane|mesh-list
154274978|NCT05822817|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154274979|NCT05822817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274980|NCT05822817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274981|NCT05822817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154274982|NCT05822817|Anesthetics, General|anesthetics, general|mesh-ancestor
154274983|NCT05822817|Anesthetics|anesthetics|mesh-ancestor
154274984|NCT05822817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154274985|NCT05822817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154274986|NCT05817903|Nivolumab|nivolumab|mesh-list
154274987|NCT05817903|Axitinib|axitinib|mesh-list
154274988|NCT05817903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154021881|NCT00911313|Metformin|metformin|mesh-list
154274989|NCT05817903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274990|NCT05817903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154274991|NCT05817903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274992|NCT05817903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274993|NCT05817903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274994|NCT05805605|Mycophenolic Acid|mycophenolic acid|mesh-list
154274995|NCT05805605|Sirolimus|sirolimus|mesh-list
154274996|NCT05805605|Cyclophosphamide|cyclophosphamide|mesh-list
154274997|NCT05805605|Fludarabine|fludarabine|mesh-list
154274998|NCT05805605|Allopurinol|allopurinol|mesh-list
154274999|NCT05805605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154275000|NCT05805605|Immunologic Factors|immunologic factors|mesh-ancestor
154275001|NCT05805605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275002|NCT05805605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154275003|NCT05805605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154275004|NCT05805605|Alkylating Agents|alkylating agents|mesh-ancestor
154275005|NCT05805605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275006|NCT05805605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275007|NCT05805605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154275008|NCT05805605|Antimetabolites|antimetabolites|mesh-ancestor
154275009|NCT05805605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154275010|NCT05805605|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154275011|NCT05805605|Antitubercular Agents|antitubercular agents|mesh-ancestor
154275012|NCT05805605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154275013|NCT05805605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275014|NCT05805605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275015|NCT05805605|Antifungal Agents|antifungal agents|mesh-ancestor
154275016|NCT05805605|Gout Suppressants|gout suppressants|mesh-ancestor
154275017|NCT05805605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154275018|NCT05805605|Antioxidants|antioxidants|mesh-ancestor
154275019|NCT05805605|Protective Agents|protective agents|mesh-ancestor
154275020|NCT05805072|Cytarabine|cytarabine|mesh-list
154275021|NCT05805072|Azacitidine|azacitidine|mesh-list
154275022|NCT05805072|Decitabine|decitabine|mesh-list
154275023|NCT05805072|Homoharringtonine|homoharringtonine|mesh-list
154275024|NCT05805072|Aclacinomycins|aclacinomycins|mesh-list
154275025|NCT05805072|Lenograstim|lenograstim|mesh-list
154275026|NCT05805072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154275038|NCT05805072|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154275039|NCT05805072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154275040|NCT05797090|Cardioplegic Solutions|cardioplegic solutions|mesh-list
154275041|NCT05797090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154275042|NCT05772364|Calcium|calcium|mesh-list
154275043|NCT05772364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154275044|NCT05772364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275046|NCT05770180|Immunologic Factors|immunologic factors|mesh-ancestor
154275047|NCT05770180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275048|NCT05765682|Bupivacaine|bupivacaine|mesh-list
154275049|NCT05765682|Mepivacaine|mepivacaine|mesh-list
154275050|NCT05765682|Anesthetics, Local|anesthetics, local|mesh-ancestor
154275051|NCT05765682|Anesthetics|anesthetics|mesh-ancestor
154275052|NCT05765682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275053|NCT05765682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275054|NCT05765682|Sensory System Agents|sensory system agents|mesh-ancestor
154275055|NCT05765682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275056|NCT05765604|Vaccines|vaccines|mesh-list
154275057|NCT05765604|Immunologic Factors|immunologic factors|mesh-ancestor
154275058|NCT05765604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275059|NCT05704673|Morphine|morphine|mesh-list
154275060|NCT05704673|Nalbuphine|nalbuphine|mesh-list
154275061|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154275062|NCT05704673|Narcotics|narcotics|mesh-ancestor
154275063|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275064|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275065|NCT05704673|Analgesics|analgesics|mesh-ancestor
154275066|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
154275067|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275068|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
154275069|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154275071|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
154275072|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275073|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
154275074|NCT05678205|Fludarabine|fludarabine|mesh-list
154275075|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154275076|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
154275077|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275078|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154275079|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154275080|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
154275081|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275082|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275083|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154275084|NCT05671562|Lycopene|lycopene|mesh-list
154275085|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275086|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
154275087|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275088|NCT05671562|Protective Agents|protective agents|mesh-ancestor
154275089|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275090|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154275091|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154275114|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275115|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154275116|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
154275117|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154275118|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
154275119|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275120|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275121|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154275122|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
154275123|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
154275124|NCT05505617|Protective Agents|protective agents|mesh-ancestor
154275125|NCT05484466|Entecavir|entecavir|mesh-list
154275126|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
154275127|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275128|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
154275129|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154275130|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275131|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275132|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154275133|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154275134|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154275135|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
154275136|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275137|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
154275138|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275139|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154275140|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275141|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275142|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
154022021|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
153616681|NCT06186141|Analgesics|analgesics|mesh-ancestor
154275156|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
154275157|NCT05358938|Nivolumab|nivolumab|mesh-list
154275158|NCT05358938|Ipilimumab|ipilimumab|mesh-list
154275159|NCT05358938|Avelumab|avelumab|mesh-list
154275160|NCT05358938|Cemiplimab|cemiplimab|mesh-list
154275161|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154275162|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154275163|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275164|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275165|NCT05349474|Metformin|metformin|mesh-list
154275166|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154275167|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275168|NCT05343481|Nivolumab|nivolumab|mesh-list
154275169|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154275170|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275171|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154275172|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275173|NCT05340764|Infliximab|infliximab|mesh-list
154275174|NCT05340764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154275175|NCT05340764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275176|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
154275177|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154275178|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154275179|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
154275180|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154275181|NCT05327361|Protective Agents|protective agents|mesh-ancestor
154275182|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275183|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
154275184|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154275185|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154275186|NCT05300451|Daratumumab|daratumumab|mesh-list
154275187|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275188|NCT05285904|Ofatumumab|ofatumumab|mesh-list
154275189|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275190|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
154275191|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154275192|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275193|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275194|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154275195|NCT05283083|Analgesics|analgesics|mesh-ancestor
154275196|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
154275197|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275198|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154275199|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154275200|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154275201|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275202|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275203|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275213|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275214|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275215|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
154275216|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275217|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154275218|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
154275219|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275221|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154275222|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275223|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154275224|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275225|NCT05229991|Ritonavir|ritonavir|mesh-list
154275226|NCT05229991|Lonafarnib|lonafarnib|mesh-list
154275227|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154275228|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154275229|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154275230|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275231|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275232|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154275233|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154275234|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
154275235|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275236|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154275237|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154275238|NCT05213884|Cisplatin|cisplatin|mesh-list
154275239|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275240|NCT05211024|Penicillins|penicillins|mesh-list
154275241|NCT05211024|Penicillin G|penicillin g|mesh-list
154275242|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154275243|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
154275244|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154275245|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275246|NCT05176080|Fulvestrant|fulvestrant|mesh-list
154275247|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154275248|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275249|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154275250|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154275251|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
154275252|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275253|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275254|NCT05165082|Timolol|timolol|mesh-list
154275255|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154275256|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154275257|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275258|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154275259|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154275260|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275261|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275262|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275263|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154275264|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154275265|NCT05159531|Tenofovir|tenofovir|mesh-list
154275266|NCT05159531|Emtricitabine|emtricitabine|mesh-list
153499801|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154275267|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
154275268|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275269|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154275298|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275299|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275300|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154275301|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
154275302|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154275304|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275305|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275306|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154275307|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
154275308|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
154275309|NCT05109611|Protective Agents|protective agents|mesh-ancestor
154275310|NCT05106153|Zolpidem|zolpidem|mesh-list
154275311|NCT05106153|Suvorexant|suvorexant|mesh-list
154275312|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154275313|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154275314|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275315|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275347|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154275348|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154275349|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
154275350|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275351|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275352|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154275353|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154275354|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
154275355|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275356|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154275357|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154275372|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154275373|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154275374|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154275375|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154275376|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
154275377|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154275378|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154275379|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154275380|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275382|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154275383|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154275384|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275385|NCT04998669|Rituximab|rituximab|mesh-list
154861510|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927598|NCT05012644|Palbociclib|palbociclib|mesh-list
154275386|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154275387|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154275388|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275389|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
154275390|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275391|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154275392|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
154275393|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154275394|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275395|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
154275396|NCT04958811|Bevacizumab|bevacizumab|mesh-list
154275397|NCT04958811|Atezolizumab|atezolizumab|mesh-list
154275398|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154275399|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275400|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154275401|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154275402|NCT04958811|Growth Substances|growth substances|mesh-ancestor
154275403|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275404|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
154275405|NCT04958811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154275406|NCT04958811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275407|NCT04950530|Emtricitabine|emtricitabine|mesh-list
154275408|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
154275409|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275410|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154275411|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154275412|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275413|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275414|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154275415|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154275416|NCT04937699|Aspirin|aspirin|mesh-list
154275417|NCT04937699|Clopidogrel|clopidogrel|mesh-list
154275418|NCT04937699|Ticagrelor|ticagrelor|mesh-list
154275425|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275426|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154275427|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154275428|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154275429|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275430|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154275431|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154275432|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275433|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
154275434|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154275435|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154275436|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154275437|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
154275438|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275439|NCT04891068|Azacitidine|azacitidine|mesh-list
154275440|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154275442|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275443|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275444|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275445|NCT04880499|Folic Acid|folic acid|mesh-list
154275446|NCT04880499|Riboflavin|riboflavin|mesh-list
154275447|NCT04880499|Vitamins|vitamins|mesh-ancestor
154275448|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
154275449|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275450|NCT04880499|Hematinics|hematinics|mesh-ancestor
154275451|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
154275452|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154275453|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
154275454|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
154275455|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275456|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275457|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154275458|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
154275459|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154275460|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
154275461|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
154275462|NCT04852484|Ketamine|ketamine|mesh-list
154275463|NCT04852484|Morphine|morphine|mesh-list
154275464|NCT04852484|Anesthetics|anesthetics|mesh-list
154275465|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
154275466|NCT04852484|Analgesics|analgesics|mesh-ancestor
154275467|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
154275468|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275469|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275470|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154275471|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154275472|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
154275473|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275474|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154275475|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154275476|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275477|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275478|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154275479|NCT04852484|Narcotics|narcotics|mesh-ancestor
154275480|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
154275481|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
154275482|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
154275483|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275484|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275495|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275496|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275497|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154275498|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154275499|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154275500|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154275501|NCT04786873|Clonidine|clonidine|mesh-list
154275502|NCT04786873|Analgesics|analgesics|mesh-ancestor
154275503|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
154275504|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275505|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275506|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154275507|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
154275508|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
154275509|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154275510|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154275511|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154275512|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275513|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275514|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022391|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
154275515|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154275516|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154275517|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275518|NCT04771728|Metronidazole|metronidazole|mesh-list
154275519|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275520|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154275521|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154275522|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154275523|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
154275524|NCT04767074|Guaifenesin|guaifenesin|mesh-list
154275525|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154275526|NCT04767074|Expectorants|expectorants|mesh-ancestor
154275527|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
154275528|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154275529|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154275530|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275531|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275532|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275533|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275534|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
154275535|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154275536|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
154275537|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
154275538|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275539|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
154275540|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154275541|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
154275542|NCT04761614|Leucovorin|leucovorin|mesh-list
154275543|NCT04761614|Folic Acid|folic acid|mesh-list
154275544|NCT04761614|Bevacizumab|bevacizumab|mesh-list
154275545|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154275546|NCT04761614|Fluorouracil|fluorouracil|mesh-list
154275547|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
154275558|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154275559|NCT04761614|Growth Substances|growth substances|mesh-ancestor
154861511|NCT04355429|Captopril|captopril|mesh-list
153500227|NCT00005598|Protective Agents|protective agents|mesh-ancestor
153500330|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154255260|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154275560|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275561|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
154275562|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
154275563|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154275564|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154275565|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
154275566|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275567|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154275568|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154275569|NCT04761614|Antidotes|antidotes|mesh-ancestor
154275570|NCT04761614|Protective Agents|protective agents|mesh-ancestor
154275571|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
154275572|NCT04761614|Vitamins|vitamins|mesh-ancestor
154275573|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
154275574|NCT04761614|Hematinics|hematinics|mesh-ancestor
154275575|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
154275576|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154275577|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154275578|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275579|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154275580|NCT04760860|Prazosin|prazosin|mesh-list
154275581|NCT04760860|Terazosin|terazosin|mesh-list
154275582|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154275583|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154275584|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154275585|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275586|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275587|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275588|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275589|NCT04760860|Urological Agents|urological agents|mesh-ancestor
154275590|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154022467|NCT03687554|Venglustat|venglustat|mesh-list
154275591|NCT04710199|Maraviroc|maraviroc|mesh-list
154275592|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154275593|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154275594|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275595|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154275596|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154275597|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
154275598|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275599|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154275600|NCT04699240|Clotrimazole|clotrimazole|mesh-list
154275601|NCT04699240|Miconazole|miconazole|mesh-list
154275602|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154275603|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275604|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
154275605|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154275606|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154275607|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275608|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275609|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154275610|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
154275611|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275612|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275613|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154275630|NCT04657640|Micronutrients|micronutrients|mesh-list
154275631|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
154275632|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275633|NCT04657640|Hematinics|hematinics|mesh-ancestor
154275634|NCT04657640|Vitamins|vitamins|mesh-ancestor
154275635|NCT04622813|Acetaminophen|acetaminophen|mesh-list
154275636|NCT04622813|Ketoprofen|ketoprofen|mesh-list
154275637|NCT04622813|Nefopam|nefopam|mesh-list
154275638|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154275639|NCT04622813|Analgesics|analgesics|mesh-ancestor
154275640|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
154275641|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275642|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275643|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
154275644|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154275645|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275646|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154275647|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154861512|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153927824|NCT04073290|Rifaximin|rifaximin|mesh-list
154275648|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275649|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275650|NCT04616963|Tenofovir|tenofovir|mesh-list
154275651|NCT04616963|Emtricitabine|emtricitabine|mesh-list
154275652|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154275653|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
154275654|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275655|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154275656|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154275657|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275658|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275659|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154275660|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154275661|NCT04606394|Albuterol|albuterol|mesh-list
154275662|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154275663|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
154275664|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275665|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275666|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154275667|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
154275668|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
154275669|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154275670|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154275671|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154275672|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154275673|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275674|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275707|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
154275709|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
154275710|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
154275711|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275712|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154275713|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154275714|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275728|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154275729|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
154275730|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
154275731|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
154275732|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275733|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
154275734|NCT04445714|Saxagliptin|saxagliptin|mesh-list
154275735|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154275736|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275737|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154275738|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275739|NCT04445714|Incretins|incretins|mesh-ancestor
154275740|NCT04445714|Hormones|hormones|mesh-ancestor
154275741|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275742|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154275743|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
154275744|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275745|NCT04435704|Oxytocin|oxytocin|mesh-list
154275746|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
154275747|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154275748|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275749|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154275750|NCT04427709|Oxytocin|oxytocin|mesh-list
154275751|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
154275752|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154275753|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275754|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
154275755|NCT04415476|Sirolimus|sirolimus|mesh-list
154275756|NCT04415476|Prednisone|prednisone|mesh-list
154275757|NCT04415476|Tacrolimus|tacrolimus|mesh-list
154275758|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275759|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
154275760|NCT04415476|Hormones|hormones|mesh-ancestor
154275761|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275762|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275763|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154275764|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275765|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154275766|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
154275767|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154275768|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861513|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
154255262|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154275769|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275770|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153500644|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
153500789|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275771|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154275772|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
154275773|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154275774|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275775|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
154275776|NCT04389567|Famotidine|famotidine|mesh-list
154275777|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154275798|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275800|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154275801|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154275802|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154275803|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154275804|NCT04341259|Ipatasertib|ipatasertib|mesh-list
154275805|NCT04341259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275806|NCT04341259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154275807|NCT04341259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275808|NCT04341259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275809|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
154275810|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275811|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
154275812|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275813|NCT04335006|Paclitaxel|paclitaxel|mesh-list
154275814|NCT04335006|Apatinib|apatinib|mesh-list
154275815|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154275816|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275817|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
154275818|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
154275819|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
154275820|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275821|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154275822|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275823|NCT04313088|Eluxadoline|eluxadoline|mesh-list
154275824|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154275825|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
154275826|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154275827|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
154275828|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
154275829|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275844|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275845|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275846|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
154275847|NCT04233190|Hormones|hormones|mesh-ancestor
154275848|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275849|NCT04161118|Tisagenlecleucel|tisagenlecleucel|mesh-list
154275850|NCT04161118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154275851|NCT04161118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275852|NCT04119037|Morphine|morphine|mesh-list
154275853|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154275854|NCT04119037|Narcotics|narcotics|mesh-ancestor
154275855|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275856|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275857|NCT04119037|Analgesics|analgesics|mesh-ancestor
154275858|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
154275859|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275860|NCT04071769|Xenon|xenon|mesh-list
154275861|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154275862|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
154275863|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
154275864|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275865|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275866|NCT04052568|Psilocybin|psilocybin|mesh-list
154275867|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
154275868|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275869|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154275870|NCT04050670|Tirzepatide|tirzepatide|mesh-list
154275871|NCT04050670|Incretins|incretins|mesh-ancestor
154275872|NCT04050670|Hormones|hormones|mesh-ancestor
154275873|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275874|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275875|NCT04049084|Adenosine|adenosine|mesh-list
154861514|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275876|NCT04049084|Analgesics|analgesics|mesh-ancestor
154275877|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
154275878|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275879|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275880|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154275881|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
154275882|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154275883|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
154275884|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
154275885|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275886|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275887|NCT04016714|Vaccines|vaccines|mesh-list
154275888|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154275889|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
154275890|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275900|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154275901|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
154275902|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275903|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275904|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154275905|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
154275906|NCT03948243|Tolbutamide|tolbutamide|mesh-list
154275907|NCT03948243|Levomethorphan|levomethorphan|mesh-list
154275908|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
154275909|NCT03948243|Alprazolam|alprazolam|mesh-list
154275910|NCT03948243|Caffeine|caffeine|mesh-list
154275911|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154275912|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275913|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154275914|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275915|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275916|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154275917|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154275918|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
154275919|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275920|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
154275921|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
154275922|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154275923|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154275924|NCT03948243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154275925|NCT03948243|Narcotics|narcotics|mesh-ancestor
154275926|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275927|NCT03948243|Analgesics|analgesics|mesh-ancestor
154275928|NCT03948243|Sensory System Agents|sensory system agents|mesh-ancestor
153501003|NCT00368862|Memantine|memantine|mesh-list
154275929|NCT03948243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275930|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154275931|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154275932|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154275933|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154275934|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
154275935|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
154275936|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154275937|NCT03948035|Dexamethasone|dexamethasone|mesh-list
154275938|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
154275939|NCT03948035|Lenalidomide|lenalidomide|mesh-list
154275940|NCT03948035|Elotuzumab|elotuzumab|mesh-list
154275941|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275942|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
154275943|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
154275944|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275945|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275946|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154275947|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
154275948|NCT03948035|Hormones|hormones|mesh-ancestor
154275949|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275950|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154275951|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275952|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
154275953|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154275954|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154275955|NCT03948035|Growth Substances|growth substances|mesh-ancestor
154275956|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
154275957|NCT03946124|Fesoterodine|fesoterodine|mesh-list
154275958|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154275965|NCT03942224|Dexamethasone|dexamethasone|mesh-list
154275966|NCT03942224|Bortezomib|bortezomib|mesh-list
154275967|NCT03942224|Daratumumab|daratumumab|mesh-list
154275968|NCT03942224|Ixazomib|ixazomib|mesh-list
154275969|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275970|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
154275971|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
154275972|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275973|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275974|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154275975|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
154275976|NCT03942224|Hormones|hormones|mesh-ancestor
154275977|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275978|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154275979|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275980|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
154275981|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275982|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275983|NCT03938701|Adalimumab|adalimumab|mesh-list
154275984|NCT03938701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154275985|NCT03938701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275986|NCT03938701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154275987|NCT03879798|Irinotecan|irinotecan|mesh-list
154275988|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154275989|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154275990|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275991|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275992|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275993|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
154275994|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153501258|NCT00376038|Metformin|metformin|mesh-list
154275995|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154275996|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275997|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
154275998|NCT03801122|Coagulants|coagulants|mesh-ancestor
154275999|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154276000|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
154276001|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276002|NCT03771677|Interferons|interferons|mesh-list
154276003|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
154276004|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
154276005|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276006|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
154276007|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276008|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
154276009|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276010|NCT03770767|Insulin|insulin|mesh-list
154276011|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154276012|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
154276013|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154276014|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276015|NCT03747575|Astegolimab|astegolimab|mesh-list
154276016|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154276017|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276018|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
154276019|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276020|NCT03747419|Avelumab|avelumab|mesh-list
154276021|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276022|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276023|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
154276024|NCT03733145|Giapreza|giapreza|mesh-list
154276025|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
154276026|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154276027|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154276028|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
154276029|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276035|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276036|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276037|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154276038|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
154276039|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154276040|NCT03715972|Diuretics|diuretics|mesh-ancestor
154276041|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
154276042|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276043|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
154276044|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276045|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
154276046|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276047|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276048|NCT03634540|Belzutifan|belzutifan|mesh-list
154276049|NCT03634540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276050|NCT03619876|Adalimumab|adalimumab|mesh-list
154276051|NCT03619876|Abatacept|abatacept|mesh-list
154276052|NCT03619876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154276053|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276054|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276055|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154276056|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276057|NCT03619876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276058|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276059|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154276060|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
154276061|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276062|NCT03605901|Methadone|methadone|mesh-list
154276063|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154276064|NCT03605901|Narcotics|narcotics|mesh-ancestor
154276065|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154276066|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276067|NCT03605901|Analgesics|analgesics|mesh-ancestor
154276068|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
154276069|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276070|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
154276071|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
154276072|NCT03579771|Paclitaxel|paclitaxel|mesh-list
154276073|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154276074|NCT03579771|Gemcitabine|gemcitabine|mesh-list
154276075|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154276076|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276077|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
154276078|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276079|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
154276080|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276081|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154276082|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
154276083|NCT03578081|Dexamethasone|dexamethasone|mesh-list
154276084|NCT03578081|Ondansetron|ondansetron|mesh-list
154276085|NCT03578081|Olanzapine|olanzapine|mesh-list
154276086|NCT03578081|Palonosetron|palonosetron|mesh-list
154276087|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
154276088|NCT03578081|Aprepitant|aprepitant|mesh-list
154276089|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276090|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
154276108|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154276109|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154276110|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154276111|NCT03578081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154276112|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154276113|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276114|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154276115|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
154276117|NCT03510884|Niacinamide|niacinamide|mesh-list
154276118|NCT03510884|Atorvastatin|atorvastatin|mesh-list
154276119|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154276120|NCT03510884|Simvastatin|simvastatin|mesh-list
154276121|NCT03510884|Ezetimibe|ezetimibe|mesh-list
154276122|NCT03510884|Pravastatin|pravastatin|mesh-list
154276123|NCT03510884|Alirocumab|alirocumab|mesh-list
154276124|NCT03510884|Lovastatin|lovastatin|mesh-list
154276125|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
154276126|NCT03510884|Fenofibrate|fenofibrate|mesh-list
154276127|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154276128|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154276129|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
154276130|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276131|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154276132|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154276133|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276134|NCT03510884|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154276135|NCT03510884|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154276136|NCT03510884|Protease Inhibitors|protease inhibitors|mesh-ancestor
154276137|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
154276138|NCT03510884|Vitamins|vitamins|mesh-ancestor
154276139|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
154276140|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276141|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
154276142|NCT03497975|Nalbuphine|nalbuphine|mesh-list
154276143|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154276144|NCT03497975|Narcotics|narcotics|mesh-ancestor
154276145|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154276146|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276147|NCT03497975|Analgesics|analgesics|mesh-ancestor
154276148|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
154276149|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276166|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154276167|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154276168|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154276169|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154276170|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154276171|NCT03455829|Osimertinib|osimertinib|mesh-list
154276172|NCT03455829|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154276173|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276174|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276175|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276176|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276177|NCT03453489|Tryptophan|tryptophan|mesh-list
154276178|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154276179|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
154276180|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154276181|NCT03440190|Methylphenidate|methylphenidate|mesh-list
154276182|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154276183|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276184|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154276185|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154276186|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276187|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276188|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
154276189|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276190|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154276191|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154276192|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276193|NCT03408587|Ipilimumab|ipilimumab|mesh-list
154276194|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276195|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276196|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154276197|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276198|NCT03314636|Dexamethasone|dexamethasone|mesh-list
154276199|NCT03314636|Lenalidomide|lenalidomide|mesh-list
154276200|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276201|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
154276202|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
154276203|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276215|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
154276216|NCT03310541|Fulvestrant|fulvestrant|mesh-list
154276217|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154276218|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276219|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154276220|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154276221|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
154276222|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276223|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276224|NCT03279861|Valsartan|valsartan|mesh-list
154276225|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154276226|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154276227|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154276228|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154276229|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276230|NCT03250117|Ropinirole|ropinirole|mesh-list
154276231|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154276232|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154276233|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
154276234|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
154276235|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276236|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276237|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276238|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
154276239|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154276240|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276241|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276242|NCT03236935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154276243|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276244|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276245|NCT03230838|Meropenem|meropenem|mesh-list
154276246|NCT03230838|Tazobactam|tazobactam|mesh-list
154276247|NCT03230838|Ceftolozane|ceftolozane|mesh-list
154276248|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154276249|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276250|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276251|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154276252|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276253|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276254|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154276255|NCT03217136|Metronidazole|metronidazole|mesh-list
154276256|NCT03217136|Meropenem|meropenem|mesh-list
154276257|NCT03217136|Tazobactam|tazobactam|mesh-list
154276258|NCT03217136|Ceftolozane|ceftolozane|mesh-list
154276259|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154276260|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276261|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276262|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154276263|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154276264|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154276265|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276294|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
154276295|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154276296|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154276297|NCT03022773|Carotenoids|carotenoids|mesh-list
154276298|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
154276299|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276300|NCT03022773|Protective Agents|protective agents|mesh-ancestor
154276301|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276302|NCT02946463|Eculizumab|eculizumab|mesh-list
154276303|NCT02946463|Ravulizumab|ravulizumab|mesh-list
154276304|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154276305|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154276306|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
154276307|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276308|NCT02819024|Alovudine|alovudine|mesh-list
154276309|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
154276310|NCT02819024|Dexamethasone|dexamethasone|mesh-list
154276311|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
154276327|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276328|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
154276329|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
154276330|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276331|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
154276332|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154276333|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154276334|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
154276335|NCT02800785|Metronidazole|metronidazole|mesh-list
154276336|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
154276337|NCT02800785|Levofloxacin|levofloxacin|mesh-list
154276338|NCT02800785|Cefazolin|cefazolin|mesh-list
154276339|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
154276340|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
154276341|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
154023215|NCT00637104|Chromium|chromium|mesh-list
154276342|NCT02800785|Ertapenem|ertapenem|mesh-list
154276343|NCT02800785|Cefuroxime|cefuroxime|mesh-list
154276344|NCT02800785|Tigecycline|tigecycline|mesh-list
154276345|NCT02800785|Cefotaxime|cefotaxime|mesh-list
154276346|NCT02800785|Cefoxitin|cefoxitin|mesh-list
154276347|NCT02800785|Ticarcillin|ticarcillin|mesh-list
154276348|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
154276349|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276350|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276351|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154276352|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154276353|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276354|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276355|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276356|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154276357|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154276358|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154276359|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154276360|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154276361|NCT02800785|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154276362|NCT02800785|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154276363|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154276364|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154276366|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154276367|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276368|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276369|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276370|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276371|NCT02765854|Dexamethasone|dexamethasone|mesh-list
154276372|NCT02765854|Lenalidomide|lenalidomide|mesh-list
154276373|NCT02765854|Ixazomib|ixazomib|mesh-list
154276374|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276403|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154276404|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
154276405|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276406|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276407|NCT02760030|Fulvestrant|fulvestrant|mesh-list
154276408|NCT02760030|Palbociclib|palbociclib|mesh-list
154276409|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154276410|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154276411|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276412|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154276413|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154276414|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
154276415|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276416|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276417|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276418|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276443|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276444|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154276445|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154276446|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276447|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276448|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
154276449|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276450|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
154276451|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154276452|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
154276453|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154276454|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276455|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154276456|NCT02368665|Amlodipine|amlodipine|mesh-list
154276457|NCT02368665|Candesartan|candesartan|mesh-list
154276458|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
154276459|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154276460|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154276461|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276462|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276463|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154276464|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276465|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
154276466|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154276467|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154276468|NCT02368652|Amlodipine|amlodipine|mesh-list
154276469|NCT02368652|Candesartan|candesartan|mesh-list
154276470|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
154276484|NCT02330926|Ibuprofen|ibuprofen|mesh-list
154276485|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154276486|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154276487|NCT02330926|Analgesics|analgesics|mesh-ancestor
154276488|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
154276489|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276490|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276491|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276492|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276493|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154276494|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276495|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276497|NCT02312245|Bevacizumab|bevacizumab|mesh-list
154276498|NCT02312245|Gemcitabine|gemcitabine|mesh-list
154276499|NCT02312245|Doxorubicin|doxorubicin|mesh-list
154276500|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154276501|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154276503|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154276504|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
154276505|NCT02312245|Antibodies|antibodies|mesh-list
154276506|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
154276507|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154276508|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
154276509|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154276510|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276511|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
154276512|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276513|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
154276514|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276515|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154276516|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154276517|NCT02312245|Growth Substances|growth substances|mesh-ancestor
154276518|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276519|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
154276520|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
154276521|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154276522|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
154276523|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154276524|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154276525|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154276526|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276527|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154276528|NCT02297438|Letrozole|letrozole|mesh-list
154276529|NCT02297438|Palbociclib|palbociclib|mesh-list
154276530|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276531|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154276532|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154276541|NCT02297139|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154276542|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276543|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276544|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276545|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276547|NCT02137759|Belinostat|belinostat|mesh-list
154276548|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154276549|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
154276550|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276551|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276552|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154276553|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276554|NCT02090998|Lidocaine|lidocaine|mesh-list
154276555|NCT02090998|Amitriptyline|amitriptyline|mesh-list
154276556|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
154276557|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
154276558|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154276559|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276560|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
154276561|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276562|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154276563|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154276564|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154276565|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276566|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276567|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154276568|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
154276569|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154276570|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153502402|NCT00245856|Tinzaparin|tinzaparin|mesh-list
154276571|NCT02090998|Analgesics|analgesics|mesh-ancestor
154276572|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154276573|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154276574|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
154276575|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276576|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
154276577|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276578|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276579|NCT02043665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154276580|NCT02043665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276581|NCT01912651|Cephalexin|cephalexin|mesh-list
154255264|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255265|NCT02527772|Antidotes|antidotes|mesh-ancestor
154276582|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276583|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276584|NCT01912625|Paclitaxel|paclitaxel|mesh-list
154276585|NCT01912625|Carboplatin|carboplatin|mesh-list
154276586|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154276587|NCT01912625|Trametinib|trametinib|mesh-list
154276588|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154276589|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276590|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
154276591|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276592|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
154276593|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276594|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276595|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276596|NCT01814813|Bevacizumab|bevacizumab|mesh-list
154276606|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
154276607|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276608|NCT01667120|Ketorolac|ketorolac|mesh-list
154276609|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154276610|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154276611|NCT01667120|Analgesics|analgesics|mesh-ancestor
154276612|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
154276613|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276614|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276615|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276616|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276617|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154276618|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276619|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276620|NCT01642251|Cisplatin|cisplatin|mesh-list
154276621|NCT01642251|Etoposide|etoposide|mesh-list
154276622|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
154276623|NCT01642251|Veliparib|veliparib|mesh-list
154276624|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
154276625|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276626|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154276627|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154276628|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154276629|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276630|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276631|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154276632|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
154276633|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
154276634|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154276635|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276636|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154276637|NCT01606137|Nabiximols|nabiximols|mesh-list
154276638|NCT01606137|Analgesics|analgesics|mesh-ancestor
154276639|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
154276640|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276641|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276642|NCT01532518|MEN 11420|men 11420|mesh-list
154276643|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154276644|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
154276645|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276646|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276647|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154276648|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
154276650|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154276651|NCT01489813|Protective Agents|protective agents|mesh-ancestor
154276652|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276653|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276654|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276655|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276656|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276657|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
154276658|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154276659|NCT01489813|Estrogens|estrogens|mesh-ancestor
154276660|NCT01489813|Hormones|hormones|mesh-ancestor
154276661|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276662|NCT01420874|Leucovorin|leucovorin|mesh-list
154276663|NCT01420874|Fluorouracil|fluorouracil|mesh-list
154861515|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861516|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154276686|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
154276687|NCT01027000|Tacrolimus|tacrolimus|mesh-list
154276688|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154276689|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
154276690|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276691|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276692|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154276693|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
154276694|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276695|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276696|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154276697|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276698|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154276699|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
154276700|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154276701|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154276702|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
154276703|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
154276704|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276705|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154276706|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154276707|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154276708|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276709|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276710|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154276711|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
154276712|NCT00861068|Lacosamide|lacosamide|mesh-list
154276713|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
154276714|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154276715|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154276716|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276717|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276718|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
153618612|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154276739|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
154276740|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276741|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276742|NCT00702468|Nabiximols|nabiximols|mesh-list
154276743|NCT00702468|Analgesics|analgesics|mesh-ancestor
154276744|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
154276745|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276746|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276747|NCT00681538|Nabiximols|nabiximols|mesh-list
154276748|NCT00681538|Analgesics|analgesics|mesh-ancestor
154276749|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
154276750|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276751|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276752|NCT00497029|Fluorides|fluorides|mesh-list
154276753|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
154276754|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
154276755|NCT00497029|Protective Agents|protective agents|mesh-ancestor
154276756|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276757|NCT00455351|Vorinostat|vorinostat|mesh-list
154276758|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276759|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154276760|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276761|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276762|NCT00379340|Dactinomycin|dactinomycin|mesh-list
154276763|NCT00379340|Cactinomycin|cactinomycin|mesh-list
154276764|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
154276765|NCT00379340|Doxorubicin|doxorubicin|mesh-list
154276766|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154276767|NCT00379340|Etoposide|etoposide|mesh-list
154276768|NCT00379340|Vincristine|vincristine|mesh-list
154276769|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
154276770|NCT00379340|Podophyllotoxin|podophyllotoxin|mesh-list
154276771|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154276772|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
154276773|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276774|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276794|NCT00301808|Docetaxel|docetaxel|mesh-list
154276795|NCT00301808|Pemetrexed|pemetrexed|mesh-list
154276796|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276797|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
154861517|NCT01114555|Bevacizumab|bevacizumab|mesh-list
154255267|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
154276798|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276799|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
154276800|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276801|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276802|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154276803|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154276805|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154276806|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154276807|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276808|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
154276809|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276810|NCT00138801|Doxycycline|doxycycline|mesh-list
154276811|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
154276812|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276813|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276814|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
154276815|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154276816|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154276817|NCT00138801|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154276818|NCT00138801|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154276820|NCT05795478|Oxycodone|oxycodone|mesh-list
154276821|NCT05795478|Analgesics|analgesics|mesh-ancestor
154276822|NCT05795478|Sensory System Agents|sensory system agents|mesh-ancestor
154276823|NCT05795478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276824|NCT05795478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276825|NCT05795478|Anticonvulsants|anticonvulsants|mesh-ancestor
154276826|NCT05795478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154276827|NCT05795478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276828|NCT05795478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276829|NCT05795478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154276840|NCT05795400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276842|NCT05795283|Citalopram|citalopram|mesh-list
154276843|NCT05795283|Escitalopram|escitalopram|mesh-list
154276844|NCT05795283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154276845|NCT05795283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154276846|NCT05795283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276847|NCT05795283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276848|NCT05795283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276849|NCT05795283|Serotonin Agents|serotonin agents|mesh-ancestor
154276850|NCT05795283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276851|NCT05795283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154276852|NCT05795283|Antidepressive Agents|antidepressive agents|mesh-ancestor
154276853|NCT05795283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154276854|NCT05795283|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154276855|NCT05795283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154276856|NCT05795283|Parasympatholytics|parasympatholytics|mesh-ancestor
154276857|NCT05795283|Autonomic Agents|autonomic agents|mesh-ancestor
154276858|NCT05795283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276859|NCT05795283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154276860|NCT05795283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154276861|NCT05795283|Cholinergic Agents|cholinergic agents|mesh-ancestor
154276862|NCT05794919|Calcium, Dietary|calcium, dietary|mesh-list
154276863|NCT05794919|Phenol|phenol|mesh-list
154276864|NCT05794919|Calcium|calcium|mesh-list
154276865|NCT05794919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154276866|NCT05794919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276867|NCT05794919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154276868|NCT05794919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154276869|NCT05794919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276870|NCT05794919|Disinfectants|disinfectants|mesh-ancestor
154276871|NCT05794919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154023743|NCT00621816|Nitroprusside|nitroprusside|mesh-list
154276872|NCT05794919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154276874|NCT05712343|Antiviral Agents|antiviral agents|mesh-ancestor
154276875|NCT05712343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276876|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
154276877|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276878|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154276879|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154276880|NCT05703425|Analgesics|analgesics|mesh-ancestor
154276881|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
154276882|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861518|NCT01114555|Irinotecan|irinotecan|mesh-list
154276885|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276886|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154276887|NCT05690503|Ketamine|ketamine|mesh-list
154276888|NCT05690503|Analgesics|analgesics|mesh-ancestor
154276889|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
154276890|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276891|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276892|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154276893|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154276929|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276930|NCT05399290|Doxycycline|doxycycline|mesh-list
154276931|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276982|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154276983|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154276984|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
154276986|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154276987|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154276988|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154276989|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276990|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276991|NCT05163041|Nivolumab|nivolumab|mesh-list
154276992|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276993|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276994|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154276995|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276996|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
154276997|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154276998|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
154276999|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277000|NCT05122559|Expectorants|expectorants|mesh-ancestor
154277001|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
154277002|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154277003|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
154277004|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277005|NCT05122559|Protective Agents|protective agents|mesh-ancestor
154277006|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277007|NCT05122559|Antidotes|antidotes|mesh-ancestor
154277008|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
154277009|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154277010|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
154277011|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154277012|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
154277013|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277032|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154277033|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
154277034|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277035|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154277036|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154277037|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277038|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277040|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277041|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
154277042|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277043|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277044|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154277045|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154277046|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277047|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277048|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277049|NCT04915482|Antibodies|antibodies|mesh-list
154277050|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
154277051|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277052|NCT04897971|Antibodies|antibodies|mesh-list
154277053|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
154277054|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277055|NCT04857827|Timolol|timolol|mesh-list
154277056|NCT04857827|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154277057|NCT04857827|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154277058|NCT04857827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277059|NCT04857827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154277060|NCT04857827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154277061|NCT04857827|Adrenergic Agents|adrenergic agents|mesh-ancestor
154277062|NCT04857827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277063|NCT04857827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277064|NCT04857827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154277065|NCT04857827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154277066|NCT04796584|Antibodies|antibodies|mesh-list
153369959|NCT04658849|Pioglitazone|pioglitazone|mesh-list
154277093|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154277094|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277095|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277097|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154277098|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154277099|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154277100|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
154277101|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
154277102|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
154277103|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
154277104|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277105|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277106|NCT04477512|Prednisone|prednisone|mesh-list
154277107|NCT04477512|Nivolumab|nivolumab|mesh-list
154277108|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
154277109|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154277110|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
154277111|NCT04477512|Hormones|hormones|mesh-ancestor
154277112|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277113|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277114|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154277120|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277121|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
154277122|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154277123|NCT04349124|Nifedipine|nifedipine|mesh-list
154277124|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154277125|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154277126|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277127|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154277128|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277129|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
154277130|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
154277131|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154277132|NCT04348292|Sirolimus|sirolimus|mesh-list
154277133|NCT04348292|Durvalumab|durvalumab|mesh-list
154277134|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
154277135|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154277136|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
154277137|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277138|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277139|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154277140|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277141|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
154277142|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277143|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
154277144|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277145|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277146|NCT03991403|Paclitaxel|paclitaxel|mesh-list
154277147|NCT03991403|Bevacizumab|bevacizumab|mesh-list
154277148|NCT03991403|Carboplatin|carboplatin|mesh-list
154277149|NCT03991403|Pemetrexed|pemetrexed|mesh-list
154277150|NCT03991403|Atezolizumab|atezolizumab|mesh-list
154277151|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154277152|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277153|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
154277154|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
154277155|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
154277156|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277157|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277158|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154277159|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154277160|NCT03991403|Growth Substances|growth substances|mesh-ancestor
154277161|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277162|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
154277163|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277164|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154277165|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154277166|NCT03991403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154277168|NCT03930680|Razoxane|razoxane|mesh-list
154277169|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277170|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154277171|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154277172|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154277173|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277174|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277175|NCT03930680|Protective Agents|protective agents|mesh-ancestor
154277176|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277177|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
154277178|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
154277179|NCT03897439|Bupropion|bupropion|mesh-list
154277180|NCT03897439|Nicotine|nicotine|mesh-list
154277181|NCT03897439|Varenicline|varenicline|mesh-list
154277182|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154277183|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
154277191|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154277192|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
154277194|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154277195|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154277196|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154277197|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
154277198|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154277199|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154277200|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277201|NCT03773302|Gemcitabine|gemcitabine|mesh-list
154277202|NCT03773302|Infigratinib|infigratinib|mesh-list
154277203|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277204|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154277205|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
154277206|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277207|NCT03592992|Morphine|morphine|mesh-list
154277208|NCT03592992|Hydromorphone|hydromorphone|mesh-list
154277209|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154277210|NCT03592992|Narcotics|narcotics|mesh-ancestor
154277211|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277212|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277213|NCT03592992|Analgesics|analgesics|mesh-ancestor
154277214|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
154277215|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277216|NCT03447808|Daratumumab|daratumumab|mesh-list
154277217|NCT03447808|Ibrutinib|ibrutinib|mesh-list
154277218|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277219|NCT03447808|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154277220|NCT03447808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277221|NCT03447808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277222|NCT03447808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277223|NCT03366766|Cisplatin|cisplatin|mesh-list
154277224|NCT03366766|Gemcitabine|gemcitabine|mesh-list
154277225|NCT03366766|Nivolumab|nivolumab|mesh-list
154277226|NCT03366766|Pemetrexed|pemetrexed|mesh-list
154277227|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277228|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154277229|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
154277230|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277231|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277232|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154277233|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277234|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154277235|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154277236|NCT03299309|Vaccines|vaccines|mesh-list
154277237|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
154277238|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277239|NCT03254927|Cetuximab|cetuximab|mesh-list
154277240|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277241|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277242|NCT03039036|Misoprostol|misoprostol|mesh-list
154277243|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154277244|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
154277245|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154024113|NCT00639522|Paclitaxel|paclitaxel|mesh-list
154277246|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277247|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154277248|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154277249|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
154277258|NCT02962297|Vitamin E|vitamin e|mesh-list
154277259|NCT02962297|Vitamins|vitamins|mesh-ancestor
154277260|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
154277261|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277262|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
154277263|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277264|NCT02962297|Protective Agents|protective agents|mesh-ancestor
154277265|NCT02827617|Ibrutinib|ibrutinib|mesh-list
154277266|NCT02827617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154277267|NCT02827617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277268|NCT02827617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277269|NCT02827617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277270|NCT02518555|Vaccines|vaccines|mesh-list
154277271|NCT02518555|Ibrutinib|ibrutinib|mesh-list
154277272|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
154277273|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277274|NCT02518555|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154277275|NCT02518555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277276|NCT02518555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277277|NCT02518555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277278|NCT02027376|Docetaxel|docetaxel|mesh-list
154277279|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277280|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
154277281|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
154277282|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
154277283|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277284|NCT02005289|Lenalidomide|lenalidomide|mesh-list
154277285|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
154277286|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277287|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154277288|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154277289|NCT02005289|Growth Substances|growth substances|mesh-ancestor
154277290|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
154277291|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277292|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
154277293|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154277294|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154277295|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277296|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
154277297|NCT01683955|Coagulants|coagulants|mesh-ancestor
154277298|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
154277299|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277300|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277301|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154277302|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154277303|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503744|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154277304|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277305|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277306|NCT01453088|Bortezomib|bortezomib|mesh-list
154277307|NCT01453088|Melphalan|melphalan|mesh-list
154277308|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277309|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154277310|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
154277311|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277312|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154277313|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277314|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
154277315|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277316|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154277333|NCT01141296|Fenofibrate|fenofibrate|mesh-list
154277334|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154277335|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
154277336|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277337|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154277338|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
154277339|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154277340|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277341|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
154277342|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277343|NCT01238406|Pancrelipase|pancrelipase|mesh-list
154277344|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154277345|NCT03724890|Avelumab|avelumab|mesh-list
154277346|NCT03724890|Peposertib|peposertib|mesh-list
154277347|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277348|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861519|NCT01114555|Temozolomide|temozolomide|mesh-list
154277349|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277350|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277351|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277352|NCT01141452|Fluticasone|fluticasone|mesh-list
154277354|NCT01141452|Beclomethasone|beclomethasone|mesh-list
154277355|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154277356|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154277357|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
154277358|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277359|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277360|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154277361|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
154277362|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
154277363|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154277364|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
154277365|NCT01141452|Hormones|hormones|mesh-ancestor
154277366|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277367|NCT00219557|Gemcitabine|gemcitabine|mesh-list
153504087|NCT00550680|Hematinics|hematinics|mesh-ancestor
154277368|NCT00219557|Axitinib|axitinib|mesh-list
154277369|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154277370|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
154277371|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277372|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277373|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277374|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277375|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
154277376|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154277377|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154277398|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277400|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
154277401|NCT01329666|Vitamins|vitamins|mesh-ancestor
154277402|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
154277403|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277404|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154277405|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154277406|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
154277407|NCT01141998|Vitamin D|vitamin d|mesh-list
154277408|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
154277409|NCT01141998|Calcium|calcium|mesh-list
154277410|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154277411|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277412|NCT01141998|Vitamins|vitamins|mesh-ancestor
154277413|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
154277414|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154277415|NCT01238718|Lidocaine|lidocaine|mesh-list
154277416|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
154277417|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
154277418|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277419|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277420|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
154277421|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277422|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154277423|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154277424|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154277425|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154277426|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277427|NCT01238796|Telavancin|telavancin|mesh-list
154277428|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277429|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277443|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
154277444|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277445|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277446|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154277447|NCT01238952|Carboplatin|carboplatin|mesh-list
154277448|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277449|NCT05158998|Propofol|propofol|mesh-list
154277450|NCT05158998|Sevoflurane|sevoflurane|mesh-list
154277451|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154277452|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277453|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277454|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154277455|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
154277456|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
154277457|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154277458|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154277459|NCT01144260|Bafetinib|bafetinib|mesh-list
154277460|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277461|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277462|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277463|NCT01239498|Lidocaine|lidocaine|mesh-list
154277464|NCT01239498|Epinephrine|epinephrine|mesh-list
154277465|NCT01239498|Racepinephrine|racepinephrine|mesh-list
154277466|NCT01239498|Anesthetics|anesthetics|mesh-list
154277467|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
154277468|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
154277469|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277470|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277471|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
154024347|NCT00619346|Pafuramidine|pafuramidine|mesh-list
154277472|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277473|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154277474|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154277475|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154277476|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154277477|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277478|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154277479|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154277480|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
154277481|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277482|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154277483|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154277484|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
154277485|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154277486|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
154277487|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
154277488|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
154277489|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154277490|NCT00251927|Esomeprazole|esomeprazole|mesh-list
154277491|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154277492|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154277518|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
154277519|NCT03971279|Hormones|hormones|mesh-ancestor
154277520|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277521|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154277522|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277523|NCT01329744|Mecasermin|mecasermin|mesh-list
154277524|NCT01329744|Growth Substances|growth substances|mesh-ancestor
154277525|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277526|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
154277527|NCT00165503|Pemetrexed|pemetrexed|mesh-list
154277528|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277529|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277530|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277531|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154277532|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154277533|NCT00165503|Antidotes|antidotes|mesh-ancestor
154277534|NCT00165503|Protective Agents|protective agents|mesh-ancestor
154277535|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277536|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
154277537|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
154277538|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277539|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277540|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
154277541|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
154277542|NCT01144650|Dapsone|dapsone|mesh-list
154277543|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277544|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
154277553|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154277554|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154277555|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
154277556|NCT03970577|Prednisone|prednisone|mesh-list
154277557|NCT03970577|Rituximab|rituximab|mesh-list
154277558|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277559|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277560|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
154277561|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277562|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154277563|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154277564|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
154277565|NCT03970577|Hormones|hormones|mesh-ancestor
154277566|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277567|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154277568|NCT01073813|Minocycline|minocycline|mesh-list
154277569|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277570|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277571|NCT03823391|Adalimumab|adalimumab|mesh-list
154277572|NCT03823391|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154277573|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154277574|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154277575|NCT01075529|Fluoxetine|fluoxetine|mesh-list
154277576|NCT01075529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154277577|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154277578|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154277579|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277580|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277581|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
154277582|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277583|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154277584|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
154277585|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154277586|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154277587|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153504431|NCT05767255|Insulin|insulin|mesh-list
154277588|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277589|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
154277590|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154277591|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277592|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277593|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154277594|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154277595|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277596|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277597|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277598|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154277599|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
154277600|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154277601|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277602|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154277603|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154277604|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154277605|NCT00209027|Aripiprazole|aripiprazole|mesh-list
154277606|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
154277607|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154277608|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154277629|NCT00160199|Progestins|progestins|mesh-ancestor
154277630|NCT00160199|Hormones|hormones|mesh-ancestor
154277631|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277632|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277633|NCT00157157|Factor VIII|factor viii|mesh-list
154277634|NCT00157157|Coagulants|coagulants|mesh-ancestor
154277635|NCT00203411|Bevacizumab|bevacizumab|mesh-list
154277636|NCT00203411|Capecitabine|capecitabine|mesh-list
154277637|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277638|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277639|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154277640|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154277641|NCT00203411|Growth Substances|growth substances|mesh-ancestor
154277642|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277643|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
154277644|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154277645|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
154277646|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277647|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
154277648|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
154277649|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154277650|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
154277651|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277652|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277653|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154277654|NCT00201851|Tamoxifen|tamoxifen|mesh-list
154277655|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154277656|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
154277658|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277659|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154277660|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277672|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154277673|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
154277674|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154277675|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154277676|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154277677|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154277678|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277679|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
154277680|NCT03129100|Ixekizumab|ixekizumab|mesh-list
154277681|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
154277682|NCT03100006|Nivolumab|nivolumab|mesh-list
154277683|NCT03100006|Oregovomab|oregovomab|mesh-list
154277684|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277685|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277686|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154277687|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277688|NCT03099538|Ixekizumab|ixekizumab|mesh-list
154277689|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
154277690|NCT00883480|Gemcitabine|gemcitabine|mesh-list
154277691|NCT00883480|Docetaxel|docetaxel|mesh-list
154277692|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154277693|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277694|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154277695|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
154277696|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277697|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
154024565|NCT02681562|Olaparib|olaparib|mesh-list
154277699|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
154277700|NCT00883480|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154277701|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277702|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277703|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
154277704|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154277705|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277706|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154277707|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277708|NCT03097588|Palonosetron|palonosetron|mesh-list
154277709|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
154277710|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
154277711|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277712|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277713|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154277714|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154277715|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154277716|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
154277717|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277718|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277719|NCT05418166|Evolocumab|evolocumab|mesh-list
154277720|NCT05418166|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153504624|NCT05057819|Empagliflozin|empagliflozin|mesh-list
154277721|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154277722|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154277723|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
154277734|NCT01567774|Atorvastatin|atorvastatin|mesh-list
154277735|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154277736|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154277737|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154277738|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
154277739|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277740|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154277741|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154277742|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277743|NCT01567930|Sirolimus|sirolimus|mesh-list
154277744|NCT01567930|Temsirolimus|temsirolimus|mesh-list
154277745|NCT01567930|MTOR Inhibitors|mtor inhibitors|mesh-list
154277746|NCT01567930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277747|NCT01567930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277748|NCT01567930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277749|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277750|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
154277751|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277752|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277753|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277754|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277755|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154277756|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
154277758|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
154277759|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
154277760|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277761|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277762|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
154277763|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277764|NCT01142700|Ribavirin|ribavirin|mesh-list
154277765|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154277766|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
154277767|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277768|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
154277769|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277770|NCT01144728|Metformin|metformin|mesh-list
154277771|NCT01144728|Glimepiride|glimepiride|mesh-list
154277772|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154277773|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277774|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154277775|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277776|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
154277777|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
154277778|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154277779|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
154277780|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277781|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
154277782|NCT01239810|Protective Agents|protective agents|mesh-ancestor
154277783|NCT01239888|Tibolone|tibolone|mesh-list
154277784|NCT01239888|Oxytocin|oxytocin|mesh-list
154277785|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
154277786|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154277787|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277788|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
154277789|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
154277804|NCT03436108|Estrogens|estrogens|mesh-ancestor
154277805|NCT03436108|Hormones|hormones|mesh-ancestor
154277806|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277807|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277808|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154277809|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
154277810|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277811|NCT03436108|Protective Agents|protective agents|mesh-ancestor
154277812|NCT02870218|Nicotine|nicotine|mesh-list
154277813|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154277814|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
154277815|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277816|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277817|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154277818|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154277819|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
154277820|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277821|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277822|NCT02614690|Calpastatin|calpastatin|mesh-list
154277823|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154277824|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
154277825|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277826|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277827|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154277828|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154277829|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277830|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277831|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
154277832|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277833|NCT00468130|Aripiprazole|aripiprazole|mesh-list
154277834|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
154277835|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154277836|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154277837|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154277838|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277839|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255270|NCT03273946|Fluticasone|fluticasone|mesh-list
154277840|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
154277841|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
154277842|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277843|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277844|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154277845|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154277846|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
154277847|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154277856|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277858|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
154277859|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277860|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154277861|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154277862|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
154277863|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
154277864|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
154277865|NCT01375348|Remifentanil|remifentanil|mesh-list
154277866|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154277867|NCT01375348|Narcotics|narcotics|mesh-ancestor
154277868|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277869|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277870|NCT01375348|Analgesics|analgesics|mesh-ancestor
154277871|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
154277872|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277873|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
154277874|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
154277875|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277876|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
154277877|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277878|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154277879|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154277880|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
154277881|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277882|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277883|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154277884|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154277885|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154277886|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
154277887|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277888|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277889|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277890|NCT05194852|Anesthetics|anesthetics|mesh-list
154277891|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
154277892|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277893|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277894|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
154277895|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277896|NCT01375426|Amoxicillin|amoxicillin|mesh-list
154277897|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277898|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277899|NCT05193838|Allopurinol|allopurinol|mesh-list
154277900|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
154277901|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277902|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277903|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
154277904|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154277905|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154277906|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
154277907|NCT05193838|Protective Agents|protective agents|mesh-ancestor
154277908|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277909|NCT01375816|Leucovorin|leucovorin|mesh-list
154277910|NCT01375816|Bevacizumab|bevacizumab|mesh-list
154277911|NCT01375816|Fluorouracil|fluorouracil|mesh-list
154277912|NCT01375816|Irinotecan|irinotecan|mesh-list
154277913|NCT01375816|Calcium|calcium|mesh-list
154277914|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
154277915|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277916|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277968|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154277969|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
154277970|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277971|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861520|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255271|NCT03273946|Xhance|xhance|mesh-list
153929461|NCT00893464|Ixazomib|ixazomib|mesh-list
154277972|NCT01244880|Ketamine|ketamine|mesh-list
154277973|NCT01244880|Analgesics|analgesics|mesh-ancestor
154277974|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
154277975|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277976|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277977|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154277978|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154277979|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
154277980|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
154277981|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277982|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154277983|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154277984|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277985|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277986|NCT01244958|Rituximab|rituximab|mesh-list
154277987|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277988|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277989|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
154277990|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277991|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154277992|NCT00246324|Interferons|interferons|mesh-list
154277993|NCT00246324|Interferon-beta|interferon-beta|mesh-list
154277994|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
154277995|NCT00246324|Doxycycline|doxycycline|mesh-list
154277996|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277997|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
154277998|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024862|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277999|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154278000|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
154278001|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154278002|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154278003|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
154278004|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278005|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154278006|NCT01237782|Propolis|propolis|mesh-list
154278007|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154278017|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154278018|NCT03913806|Bevacizumab|bevacizumab|mesh-list
154278019|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278020|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278021|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278022|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278023|NCT03913806|Growth Substances|growth substances|mesh-ancestor
154278024|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278025|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278026|NCT01250808|Dexamethasone|dexamethasone|mesh-list
154278027|NCT01250808|Bortezomib|bortezomib|mesh-list
154278028|NCT01250808|Melphalan|melphalan|mesh-list
154278029|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278030|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
154278031|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
154278032|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278033|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278034|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154278035|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
154278036|NCT01250808|Hormones|hormones|mesh-ancestor
154278037|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278038|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154278039|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278040|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154278041|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
154278042|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278043|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154278044|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154278045|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
154278046|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
154278047|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154278048|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278049|NCT05429866|Nivolumab|nivolumab|mesh-list
154278050|NCT05429866|Atezolizumab|atezolizumab|mesh-list
154278051|NCT05429866|Durvalumab|durvalumab|mesh-list
154278052|NCT05429866|Avelumab|avelumab|mesh-list
154278053|NCT05429866|Cemiplimab|cemiplimab|mesh-list
154278054|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154861521|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255272|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278055|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278056|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278057|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278058|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154278059|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
154278060|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
154278061|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
154278062|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278063|NCT03632590|Analgesics|analgesics|mesh-ancestor
154278064|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
154278065|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278066|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278067|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
154278068|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278069|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154278070|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
154278071|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154278072|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154278073|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154278090|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278091|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278093|NCT01243086|Ranibizumab|ranibizumab|mesh-list
154278094|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278095|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
154278096|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
154278097|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278098|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278099|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154278100|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
154278101|NCT01243086|Hormones|hormones|mesh-ancestor
154278102|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278103|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154278104|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278105|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278106|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278107|NCT01243086|Growth Substances|growth substances|mesh-ancestor
154278108|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278109|NCT03908814|Antibodies|antibodies|mesh-list
154278110|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
154278111|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278112|NCT01253382|Ecallantide|ecallantide|mesh-list
154278113|NCT01253382|Analgesics|analgesics|mesh-ancestor
154278114|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
154278115|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278116|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278117|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154278118|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154278119|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278120|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154278121|NCT01148160|Voriconazole|voriconazole|mesh-list
154278122|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
154278123|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278124|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154278125|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154278126|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278127|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278128|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154278129|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
154278130|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278131|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278132|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154278142|NCT01147692|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154278143|NCT01147692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154278144|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278145|NCT03913182|Apatinib|apatinib|mesh-list
154278146|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278147|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154025038|NCT00644982|Sertraline|sertraline|mesh-list
154278148|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278149|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861522|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154255273|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154255274|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
154278150|NCT02713386|Paclitaxel|paclitaxel|mesh-list
154278151|NCT02713386|Carboplatin|carboplatin|mesh-list
154278152|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154278153|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154278154|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278155|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
154278156|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
154278157|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
154278158|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278159|NCT01967238|Vaccines|vaccines|mesh-list
154278160|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
154278161|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278162|NCT05616000|Folic Acid|folic acid|mesh-list
154278163|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
154278164|NCT05616000|Hematinics|hematinics|mesh-ancestor
154278165|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
154278166|NCT05616000|Vitamins|vitamins|mesh-ancestor
154278167|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
154278168|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278169|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
154278170|NCT03912402|Paclitaxel|paclitaxel|mesh-list
154278171|NCT03912402|Bevacizumab|bevacizumab|mesh-list
154278172|NCT03912402|Carboplatin|carboplatin|mesh-list
154278173|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154278174|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278175|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
154278176|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
154278177|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
154278178|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278179|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278180|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278181|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278182|NCT03912402|Growth Substances|growth substances|mesh-ancestor
154278183|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278184|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278185|NCT01147770|Progesterone|progesterone|mesh-list
154278186|NCT01147770|Progestins|progestins|mesh-ancestor
154278187|NCT01147770|Hormones|hormones|mesh-ancestor
153505252|NCT01384578|Vitamins|vitamins|mesh-list
154278188|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278189|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278190|NCT01148316|Fluoxetine|fluoxetine|mesh-list
154278191|NCT01148316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154278192|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154278193|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154278194|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278195|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278196|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
154278197|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278210|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278211|NCT01249638|Growth Substances|growth substances|mesh-ancestor
154278212|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278213|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278214|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154278215|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
154278216|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278217|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154278218|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154278219|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278220|NCT03907098|Endostar protein|endostar protein|mesh-list
154278221|NCT03907098|Endostatins|endostatins|mesh-list
154278222|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278223|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278224|NCT03907098|Growth Substances|growth substances|mesh-ancestor
154278225|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278226|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278227|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278228|NCT01251822|Prucalopride|prucalopride|mesh-list
154278229|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154278230|NCT01251822|Laxatives|laxatives|mesh-ancestor
154278231|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154278232|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154278233|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154861523|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154861524|NCT01114555|Growth Substances|growth substances|mesh-ancestor
154278234|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
154278235|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278236|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278237|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278238|NCT01253694|Ranibizumab|ranibizumab|mesh-list
154278239|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278240|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278241|NCT01253694|Growth Substances|growth substances|mesh-ancestor
154278242|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278243|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278244|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278245|NCT01148004|Ritonavir|ritonavir|mesh-list
154278246|NCT01148004|Lopinavir|lopinavir|mesh-list
154278247|NCT01148004|Fenofibrate|fenofibrate|mesh-list
154278248|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154278249|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154278250|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
154278251|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278252|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278253|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154278254|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154278255|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
154278256|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278257|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154278258|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154278259|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154278268|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154278269|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
154278270|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154278271|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154278272|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278273|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154278274|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
154278275|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154278276|NCT01252056|Protective Agents|protective agents|mesh-ancestor
154278277|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154278278|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154278279|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278280|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154278281|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154278282|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
154278283|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154278284|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
154278285|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
154278286|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154278287|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154278288|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154278289|NCT01148472|Escitalopram|escitalopram|mesh-list
154278290|NCT01148472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154278291|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154278292|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154278293|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278294|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278295|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
154278296|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278297|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278298|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
154278299|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154278300|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154278302|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
154278303|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
154278304|NCT01147146|Midazolam|midazolam|mesh-list
154278305|NCT01147146|Fentanyl|fentanyl|mesh-list
154278306|NCT01147146|Bupivacaine|bupivacaine|mesh-list
154278307|NCT01147146|Propofol|propofol|mesh-list
154278308|NCT01147146|Atracurium|atracurium|mesh-list
154278309|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
154278310|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
154278311|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278312|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278313|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
154278314|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278315|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154278316|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154278317|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
154278318|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154278320|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154278321|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154278322|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
154278323|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
154278324|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278325|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278326|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154278327|NCT01147146|Narcotics|narcotics|mesh-ancestor
154278328|NCT01147146|Analgesics|analgesics|mesh-ancestor
154278329|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154278342|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278343|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154278344|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154278345|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154278346|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278347|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154278348|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154278349|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278350|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
154278351|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
154278352|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278353|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278354|NCT01250652|Cetirizine|cetirizine|mesh-list
154278355|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
154278356|NCT01250652|Levocetirizine|levocetirizine|mesh-list
154278357|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154278358|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154278359|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
154278360|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
154278361|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278362|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278363|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278364|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154278365|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
154278366|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
154278367|NCT01253928|Pioglitazone|pioglitazone|mesh-list
154278368|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154278369|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278370|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
154278371|NCT01252524|Psyllium|psyllium|mesh-list
154278372|NCT01252524|Calcium|calcium|mesh-list
154278373|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154278374|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278375|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
154278377|NCT01252524|Cathartics|cathartics|mesh-ancestor
154278378|NCT03914352|Antibodies|antibodies|mesh-list
154278379|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
154278380|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278381|NCT01254006|Thiamine|thiamine|mesh-list
154278382|NCT01254006|Vitamins|vitamins|mesh-ancestor
154278383|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
154278384|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278385|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
154278386|NCT02528136|Oxytocin|oxytocin|mesh-list
154278387|NCT02528136|Carbetocin|carbetocin|mesh-list
154278388|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
154278389|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278390|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278391|NCT01252680|Vaccines|vaccines|mesh-list
154278392|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
154278393|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278394|NCT01252758|Albuterol|albuterol|mesh-list
154278395|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154278396|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
154278419|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
154278420|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
154278421|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278422|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278423|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
154278424|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278425|NCT01149174|Mitomycins|mitomycins|mesh-list
154278426|NCT01149174|Mitomycin|mitomycin|mesh-list
154278427|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154278428|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278429|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
154278430|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255275|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278431|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154278432|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278433|NCT01148628|Everolimus|everolimus|mesh-list
154278434|NCT01148628|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154278435|NCT01148628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154278436|NCT01148628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278437|NCT01148628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278438|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154278439|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
154278440|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278441|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278442|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154278443|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
154278444|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278445|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154278446|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154278447|NCT03909594|Ketamine|ketamine|mesh-list
154278458|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
154278459|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154278460|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154278461|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278462|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278463|NCT04492072|Misoprostol|misoprostol|mesh-list
154278464|NCT04492072|Oxytocin|oxytocin|mesh-list
154278465|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
154278466|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278467|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278468|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154278469|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
154278470|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154278471|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154278472|NCT04181008|Amiloride|amiloride|mesh-list
154278473|NCT04181008|Diuretics|diuretics|mesh-ancestor
154278474|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
154278475|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278476|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154278477|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154278478|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154278479|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278480|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154278481|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154278482|NCT03904836|Tobramycin|tobramycin|mesh-list
154278483|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154278484|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278485|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154278486|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154278487|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278488|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278489|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154278490|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154278491|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278492|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
154278493|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278494|NCT03904680|Vitamin D|vitamin d|mesh-list
154278495|NCT03904680|Methotrexate|methotrexate|mesh-list
154278496|NCT03904680|Vitamins|vitamins|mesh-ancestor
154278497|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
154278498|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278499|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154278500|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154278501|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
154278502|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278503|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154278504|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
154278505|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278506|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278507|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
154278508|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278509|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154278510|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154278511|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
154278512|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861525|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255276|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278531|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154278532|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
154278534|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278535|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154278536|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154278537|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154278538|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
154278539|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278540|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278542|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
154278543|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278544|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278545|NCT01149330|Adapalene|adapalene|mesh-list
154278546|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154278547|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154278548|NCT01149330|Analgesics|analgesics|mesh-ancestor
154278549|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
154278550|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278551|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278552|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278553|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154278554|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
154278555|NCT01150344|Artemether|artemether|mesh-list
154278556|NCT01150344|Atovaquone|atovaquone|mesh-list
154278557|NCT01150344|Proguanil|proguanil|mesh-list
154278558|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154278559|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
154278560|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154278561|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154278562|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278563|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278564|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278565|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
154278566|NCT01256580|Dexamethasone|dexamethasone|mesh-list
154278567|NCT01256580|Bevacizumab|bevacizumab|mesh-list
154278568|NCT01256580|Verteporfin|verteporfin|mesh-list
154278576|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278578|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
154278579|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278580|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154278581|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
154278582|NCT01256580|Hormones|hormones|mesh-ancestor
154278583|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278584|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154278585|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154278586|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
154278587|NCT03901716|Midazolam|midazolam|mesh-list
154278588|NCT03901716|Fentanyl|fentanyl|mesh-list
154278589|NCT03901716|Sufentanil|sufentanil|mesh-list
154278590|NCT03901716|Remifentanil|remifentanil|mesh-list
154278591|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154278592|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154278593|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278594|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278595|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154278596|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154278597|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154278598|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154025463|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278599|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
154278600|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
154278601|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
154278602|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
154278603|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278604|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278605|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154278606|NCT03901716|Narcotics|narcotics|mesh-ancestor
154278607|NCT03901716|Analgesics|analgesics|mesh-ancestor
154278608|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
154278609|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278610|NCT04113538|Aflibercept|aflibercept|mesh-list
154278611|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278612|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278613|NCT04113538|Growth Substances|growth substances|mesh-ancestor
154861526|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
154255277|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154278614|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278615|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278616|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278617|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154278618|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278619|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278620|NCT03922750|Insulin|insulin|mesh-list
154278621|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154278622|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
154278623|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154278624|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278625|NCT03898128|Immunotoxins|immunotoxins|mesh-list
154278626|NCT03898128|Immunoconjugates|immunoconjugates|mesh-ancestor
154278627|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
154278628|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278629|NCT01149408|Decitabine|decitabine|mesh-list
154278630|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154278631|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
154278632|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278633|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278634|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278635|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154278636|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154278646|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154278647|NCT01149018|Analgesics|analgesics|mesh-ancestor
154278648|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
154278649|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278650|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154278651|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154278652|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278653|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278654|NCT01149018|Hormones|hormones|mesh-ancestor
154278655|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278656|NCT03904056|Ranibizumab|ranibizumab|mesh-list
154278657|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278658|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278659|NCT03904056|Growth Substances|growth substances|mesh-ancestor
154278660|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278661|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278662|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278663|NCT03897660|Vitamins|vitamins|mesh-list
154278664|NCT03897660|Vitamin K|vitamin k|mesh-list
154278665|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
154278666|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
154278667|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278668|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154278669|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154278670|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278671|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
154278672|NCT03897660|Coagulants|coagulants|mesh-ancestor
154278673|NCT03901170|Letrozole|letrozole|mesh-list
154278674|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278675|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154278676|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154278678|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278679|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154278680|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154278681|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278682|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278683|NCT03900858|Isoniazid|isoniazid|mesh-list
154278684|NCT03900858|Rifapentine|rifapentine|mesh-list
154278685|NCT03900858|Rifampin|rifampin|mesh-list
154278686|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
154278687|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154278688|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278689|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154278690|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154278691|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
154278692|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278693|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154278694|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154278695|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
154278696|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154861527|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153930053|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
154278697|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278698|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154278699|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154278700|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154278701|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154278709|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278710|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278711|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278712|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154278713|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154278714|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278715|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278716|NCT01586286|Nifedipine|nifedipine|mesh-list
154278717|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154278718|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154278719|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278720|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154278721|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278722|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
154278723|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
154278724|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278725|NCT01257048|Budesonide|budesonide|mesh-list
154278726|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
153506105|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
154278727|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278728|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154278729|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
154278730|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278731|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278732|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154278733|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
154278734|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
154278735|NCT01257048|Hormones|hormones|mesh-ancestor
154278736|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278737|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154278738|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154278739|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154278740|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
154278741|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278742|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278743|NCT01257126|Diclofenac|diclofenac|mesh-list
154278744|NCT01257126|Nimesulide|nimesulide|mesh-list
154278745|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154278746|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154278747|NCT01257126|Analgesics|analgesics|mesh-ancestor
154278748|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
154278749|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278750|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278751|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154278752|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154278753|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154278754|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278755|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278756|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
154278757|NCT02527824|Irinotecan|irinotecan|mesh-list
154278758|NCT02527824|Tegafur|tegafur|mesh-list
154278759|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278760|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154278761|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154278762|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278763|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278764|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154278765|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
154278766|NCT01586208|Phenytoin|phenytoin|mesh-list
154278767|NCT01586208|Valproic Acid|valproic acid|mesh-list
154278768|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
154278784|NCT03893526|Valsartan|valsartan|mesh-list
154278785|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154278786|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154278787|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278788|NCT03893526|Incretins|incretins|mesh-ancestor
154278789|NCT03893526|Hormones|hormones|mesh-ancestor
154861528|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154861529|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278791|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154278792|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
154278793|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278794|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278795|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154278796|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154278797|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154278798|NCT01149798|Cisplatin|cisplatin|mesh-list
154278799|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154278800|NCT01149798|Paclitaxel|paclitaxel|mesh-list
154278801|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278802|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154278803|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
154278804|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
154278805|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
154278806|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278807|NCT01257360|Panitumumab|panitumumab|mesh-list
154278808|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278809|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278810|NCT01258452|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
154278811|NCT01258452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154278812|NCT01258452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278813|NCT01258452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278814|NCT05943028|Esketamine|esketamine|mesh-list
154278815|NCT05943028|Antidepressive Agents|antidepressive agents|mesh-ancestor
154278816|NCT05943028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154278817|NCT05942963|Metformin|metformin|mesh-list
154278818|NCT05942963|Pioglitazone|pioglitazone|mesh-list
154278819|NCT05942963|Empagliflozin|empagliflozin|mesh-list
154278820|NCT05942963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154278821|NCT05942963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278822|NCT05942963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154278823|NCT05942963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278844|NCT05942573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278845|NCT05942573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278846|NCT05942573|Growth Substances|growth substances|mesh-ancestor
153506299|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
154278847|NCT05942573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278848|NCT05942573|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278849|NCT05942573|Immunologic Factors|immunologic factors|mesh-ancestor
154278850|NCT05942378|Vaccines|vaccines|mesh-list
154278851|NCT05942378|Immunologic Factors|immunologic factors|mesh-ancestor
154278852|NCT05942378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278853|NCT05942053|Vitamin K|vitamin k|mesh-list
154278854|NCT05942053|Vitamin K 2|vitamin k 2|mesh-list
154278855|NCT05942053|Menaquinone 7|menaquinone 7|mesh-list
154278856|NCT05942053|Vitamins|vitamins|mesh-ancestor
154278857|NCT05942053|Micronutrients|micronutrients|mesh-ancestor
154278858|NCT05942053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278859|NCT05942053|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154278860|NCT05942053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154278861|NCT05942053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278862|NCT05942053|Hemostatics|hemostatics|mesh-ancestor
154278863|NCT05942053|Coagulants|coagulants|mesh-ancestor
154278864|NCT05942027|Ubiquinone|ubiquinone|mesh-list
154278865|NCT05942027|Coenzyme Q10|coenzyme q10|mesh-list
154278866|NCT05942027|Micronutrients|micronutrients|mesh-ancestor
154278867|NCT05942027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278868|NCT05942027|Vitamins|vitamins|mesh-ancestor
154278869|NCT05941845|Interferons|interferons|mesh-list
154278870|NCT05941845|Interferon-alpha|interferon-alpha|mesh-list
154278871|NCT05941845|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154278872|NCT05941845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278873|NCT05941845|Antiviral Agents|antiviral agents|mesh-ancestor
154278874|NCT05941845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278875|NCT05941845|Immunologic Factors|immunologic factors|mesh-ancestor
154278876|NCT05941845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278877|NCT05941806|Tamsulosin|tamsulosin|mesh-list
154278878|NCT05941806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154278879|NCT05941806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154278899|NCT05941429|Protective Agents|protective agents|mesh-ancestor
154278900|NCT05941429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278901|NCT05941338|Paclitaxel|paclitaxel|mesh-list
154278902|NCT05941338|Carboplatin|carboplatin|mesh-list
154278904|NCT05941338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154278906|NCT05941338|Tubulin Modulators|tubulin modulators|mesh-ancestor
154278907|NCT05941338|Antimitotic Agents|antimitotic agents|mesh-ancestor
154278908|NCT05941338|Mitosis Modulators|mitosis modulators|mesh-ancestor
154278909|NCT05941338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278910|NCT05941130|Ibuprofen|ibuprofen|mesh-list
154278911|NCT05941130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154278912|NCT05941130|Methylprednisolone|methylprednisolone|mesh-list
154278913|NCT05941130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154278914|NCT05941130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154278915|NCT05941130|Analgesics|analgesics|mesh-ancestor
154278916|NCT05941130|Sensory System Agents|sensory system agents|mesh-ancestor
154278917|NCT05941130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278918|NCT05941130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278919|NCT05941130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154278920|NCT05941130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154278921|NCT05941130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278922|NCT05941130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278923|NCT05941130|Antiemetics|antiemetics|mesh-ancestor
154278924|NCT05941130|Autonomic Agents|autonomic agents|mesh-ancestor
154278925|NCT05941130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154278926|NCT05941130|Glucocorticoids|glucocorticoids|mesh-ancestor
154278927|NCT05941130|Hormones|hormones|mesh-ancestor
154278928|NCT05941130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278929|NCT05941130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154278930|NCT05941130|Protective Agents|protective agents|mesh-ancestor
154278931|NCT05939921|Metformin|metformin|mesh-list
154278932|NCT05939921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154278933|NCT05939921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278934|NCT05939219|Vaccines|vaccines|mesh-list
154278955|NCT05935657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154278956|NCT05935657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278957|NCT05935657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278958|NCT05935657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154278959|NCT05935657|Analgesics|analgesics|mesh-ancestor
154278960|NCT05935657|Sensory System Agents|sensory system agents|mesh-ancestor
154278961|NCT05935657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278962|NCT05935657|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154278963|NCT05935657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154278964|NCT05935657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154278965|NCT05935657|Adrenergic Agents|adrenergic agents|mesh-ancestor
154278966|NCT05935657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278967|NCT05935657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278968|NCT05922982|Norepinephrine|norepinephrine|mesh-list
154278969|NCT05922982|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154278970|NCT05922982|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154278971|NCT05922982|Adrenergic Agents|adrenergic agents|mesh-ancestor
154278972|NCT05922982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278973|NCT05922982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278974|NCT05922982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278976|NCT05922982|Autonomic Agents|autonomic agents|mesh-ancestor
154278977|NCT05922982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278978|NCT05922982|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154278979|NCT05907850|Riboflavin|riboflavin|mesh-list
154278980|NCT05907850|Vitamin B Complex|vitamin b complex|mesh-ancestor
154278981|NCT05907850|Vitamins|vitamins|mesh-ancestor
154278982|NCT05907850|Micronutrients|micronutrients|mesh-ancestor
154278983|NCT05907850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278984|NCT05907850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154278985|NCT05907850|Dermatologic Agents|dermatologic agents|mesh-ancestor
154278986|NCT05904730|Axitinib|axitinib|mesh-list
154278987|NCT05904730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278988|NCT05904730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154278989|NCT05904730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278993|NCT05860270|Vitamins|vitamins|mesh-ancestor
154278994|NCT05860270|Micronutrients|micronutrients|mesh-ancestor
154278995|NCT05860270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278996|NCT05860270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154278997|NCT05860270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154278998|NCT05855395|Dexamethasone|dexamethasone|mesh-list
154278999|NCT05855395|Prednisone|prednisone|mesh-list
153506588|NCT01392833|Prednisolone|prednisolone|mesh-list
154279000|NCT05855395|Methylprednisolone|methylprednisolone|mesh-list
154279001|NCT05855395|Glucocorticoids|glucocorticoids|mesh-list
154279002|NCT05855395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154279003|NCT05855395|Antiemetics|antiemetics|mesh-ancestor
154279004|NCT05855395|Autonomic Agents|autonomic agents|mesh-ancestor
154279005|NCT05855395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279006|NCT05855395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279007|NCT05855395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279008|NCT05855395|Hormones|hormones|mesh-ancestor
154279009|NCT05855395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279010|NCT05855395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154279011|NCT05855395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279012|NCT05855395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154279013|NCT05855395|Protective Agents|protective agents|mesh-ancestor
154279014|NCT05853354|Denosumab|denosumab|mesh-list
154279015|NCT05853354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154279016|NCT05853354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279017|NCT05808881|Naloxone|naloxone|mesh-list
154279018|NCT05808881|Nalmefene|nalmefene|mesh-list
154279019|NCT05808881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154279020|NCT05808881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279021|NCT05808881|Sensory System Agents|sensory system agents|mesh-ancestor
154279022|NCT05808881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279023|NCT05802628|Cetylpyridinium|cetylpyridinium|mesh-list
154279024|NCT05802628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154279025|NCT05802628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279026|NCT05751187|Folic Acid|folic acid|mesh-list
154279027|NCT05751187|Vitamin B 12|vitamin b 12|mesh-list
154279028|NCT05751187|Dexamethasone|dexamethasone|mesh-list
154279029|NCT05751187|Bevacizumab|bevacizumab|mesh-list
154279030|NCT05751187|Pembrolizumab|pembrolizumab|mesh-list
154279031|NCT05751187|Carboplatin|carboplatin|mesh-list
154279032|NCT05751187|Pemetrexed|pemetrexed|mesh-list
154279033|NCT05751187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279034|NCT05751187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279035|NCT05751187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154279036|NCT05751187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154279037|NCT05751187|Growth Substances|growth substances|mesh-ancestor
154279038|NCT05751187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279039|NCT05751187|Growth Inhibitors|growth inhibitors|mesh-ancestor
154279040|NCT05751187|Vitamins|vitamins|mesh-ancestor
154279041|NCT05751187|Micronutrients|micronutrients|mesh-ancestor
154279042|NCT05751187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154279043|NCT05751187|Antiemetics|antiemetics|mesh-ancestor
154279044|NCT05751187|Autonomic Agents|autonomic agents|mesh-ancestor
154279045|NCT05751187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279046|NCT05751187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279047|NCT05751187|Glucocorticoids|glucocorticoids|mesh-ancestor
154279048|NCT05751187|Hormones|hormones|mesh-ancestor
154279049|NCT05751187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279050|NCT05751187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154279051|NCT05751187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154279052|NCT05751187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279053|NCT05751187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279054|NCT05751187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154279055|NCT05751187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154279056|NCT05751187|Hematinics|hematinics|mesh-ancestor
154279057|NCT05751187|Vitamin B Complex|vitamin b complex|mesh-ancestor
154279058|NCT05701241|Octreotide|octreotide|mesh-list
154279059|NCT05701241|Lanreotide|lanreotide|mesh-list
154279060|NCT05701241|Somatostatin|somatostatin|mesh-list
154279061|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279062|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154279063|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279064|NCT05701241|Hormones|hormones|mesh-ancestor
154279078|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279079|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279081|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
154279082|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
154279083|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279084|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
154279085|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
154279086|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279087|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154279088|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
154279089|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
154279090|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279091|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279092|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154279094|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
154279095|NCT05571592|Cannabidiol|cannabidiol|mesh-list
154279096|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
154279097|NCT05559905|Molnupiravir|molnupiravir|mesh-list
154279098|NCT05559905|Antiviral Agents|antiviral agents|mesh-ancestor
154279099|NCT05559905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279100|NCT05536791|Dabigatran|dabigatran|mesh-list
154279101|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
154279102|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154279103|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
154279104|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279105|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279106|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
154279107|NCT05522231|Everolimus|everolimus|mesh-list
154279108|NCT05522231|Axitinib|axitinib|mesh-list
154279109|NCT05522231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154279110|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154279111|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279112|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279113|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154279114|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
154279115|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279116|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279117|NCT05484154|Protein C|protein c|mesh-list
154279118|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
154279119|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154279120|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154279121|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279122|NCT05377424|Istradefylline|istradefylline|mesh-list
154279123|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154279124|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154279150|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
154279151|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279152|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154279153|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154279154|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154279155|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
154279156|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279157|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279158|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154279159|NCT05119920|Pilocarpine|pilocarpine|mesh-list
154279160|NCT05119920|Miotics|miotics|mesh-ancestor
154279161|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
154279162|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279163|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279164|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154279165|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154279166|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
154279167|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279168|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279169|NCT05054868|Ketorolac|ketorolac|mesh-list
154279170|NCT05054868|Oxycodone|oxycodone|mesh-list
154279171|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154279172|NCT05054868|Narcotics|narcotics|mesh-ancestor
154279173|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279194|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279195|NCT04922827|Infliximab|infliximab|mesh-list
154279196|NCT04922827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154279197|NCT04922827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154279198|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
154279199|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279200|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154279201|NCT04921930|Artesunate|artesunate|mesh-list
154279202|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
154279203|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154279204|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154279205|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279206|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279207|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
154279208|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
154279209|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154279210|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
154279211|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
154279212|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279213|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279214|NCT04909684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154279215|NCT04909684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279216|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
154279217|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
154279218|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279219|NCT04631510|Gabapentin|gabapentin|mesh-list
154279220|NCT04631510|Analgesics|analgesics|mesh-ancestor
154279221|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
154279222|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279223|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279224|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
154279225|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154279226|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154279227|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279239|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154279240|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279241|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506889|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154279242|NCT04522050|Gemcitabine|gemcitabine|mesh-list
154279243|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279244|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154279245|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
154279246|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279247|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
154279248|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154279249|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
154279250|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279251|NCT04481048|Expectorants|expectorants|mesh-ancestor
154279252|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
154279253|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154279254|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
154279255|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279256|NCT04481048|Protective Agents|protective agents|mesh-ancestor
154279257|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279258|NCT04481048|Antidotes|antidotes|mesh-ancestor
154279259|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
154279260|NCT04357587|Capecitabine|capecitabine|mesh-list
154279261|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279262|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279263|NCT04357587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154279264|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279265|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154279266|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
154279267|NCT04269408|Nicardipine|nicardipine|mesh-list
154279268|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154279269|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154279270|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154279271|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279272|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154279273|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279274|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
154279275|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154026141|NCT00649974|Valacyclovir|valacyclovir|mesh-list
154279276|NCT04122170|Aspirin|aspirin|mesh-list
154279277|NCT04122170|Ticagrelor|ticagrelor|mesh-list
154279278|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154279279|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279280|NCT04122170|Analgesics|analgesics|mesh-ancestor
154279281|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
154279282|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279283|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279284|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154279285|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154279286|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154279287|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154279288|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279302|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154279303|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506979|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
154279304|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279305|NCT03959293|Durvalumab|durvalumab|mesh-list
154861530|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279306|NCT03959293|Tremelimumab|tremelimumab|mesh-list
154279307|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279308|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279309|NCT03782987|Itraconazole|itraconazole|mesh-list
154279310|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
154279311|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279312|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154279313|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154279314|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279315|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279316|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154279317|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
154279318|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279319|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279320|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154279321|NCT03755102|Osimertinib|osimertinib|mesh-list
154279322|NCT03755102|Dacomitinib|dacomitinib|mesh-list
154279323|NCT03755102|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154279324|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154279325|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279326|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279327|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279328|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154279329|NCT03575403|Methylphenidate|methylphenidate|mesh-list
154279330|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154279331|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279332|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154279333|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154279334|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154279335|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279336|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
154279337|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279338|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154279339|NCT03575403|Analgesics|analgesics|mesh-ancestor
154279340|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
154279341|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279342|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
154279343|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154279344|NCT03474029|Rifampin|rifampin|mesh-list
154279345|NCT03474029|Rifapentine|rifapentine|mesh-list
154279346|NCT03474029|Isoniazid|isoniazid|mesh-list
154279347|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154279348|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
154279364|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154279365|NCT03395080|Paclitaxel|paclitaxel|mesh-list
154279366|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154279367|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279368|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
154279369|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
154279370|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
154279371|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279372|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154279373|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279374|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279375|NCT03217643|Immunotoxins|immunotoxins|mesh-ancestor
154279376|NCT03217643|Immunoconjugates|immunoconjugates|mesh-ancestor
154279377|NCT03217643|Immunologic Factors|immunologic factors|mesh-ancestor
154279378|NCT03217643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279379|NCT03006432|Leucovorin|leucovorin|mesh-list
154279380|NCT03006432|Folic Acid|folic acid|mesh-list
154279381|NCT03006432|Docetaxel|docetaxel|mesh-list
154279382|NCT03006432|Fluorouracil|fluorouracil|mesh-list
154279383|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
154279384|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
154279385|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279386|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
154279387|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
154279388|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
154279389|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279390|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
154279391|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154279392|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154279393|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
154279394|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279395|NCT03006432|Antidotes|antidotes|mesh-ancestor
154279397|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
154279398|NCT03006432|Vitamins|vitamins|mesh-ancestor
154279399|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
154279400|NCT03006432|Hematinics|hematinics|mesh-ancestor
154279401|NCT02759185|Dronabinol|dronabinol|mesh-list
154279402|NCT02759185|Cannabidiol|cannabidiol|mesh-list
154279403|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
154279404|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
154279405|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279406|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154279407|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279408|NCT02759185|Analgesics|analgesics|mesh-ancestor
154279450|NCT01951339|Incretins|incretins|mesh-ancestor
154279451|NCT01951339|Hormones|hormones|mesh-ancestor
154279452|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279453|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154279454|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
154279455|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279456|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279457|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154279458|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154279459|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
154279460|NCT01844518|Abatacept|abatacept|mesh-list
154279461|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154279462|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279463|NCT01844518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279464|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279465|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154279466|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
154279467|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279468|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154279469|NCT01835041|Leucovorin|leucovorin|mesh-list
154279470|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
154279471|NCT01835041|Fluorouracil|fluorouracil|mesh-list
154279472|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
154279473|NCT01835041|Irinotecan|irinotecan|mesh-list
154279474|NCT01835041|Calcium|calcium|mesh-list
154279475|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
154279476|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154279477|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279478|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
154279479|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279480|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154279481|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279482|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154279483|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
154279484|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154279485|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154279486|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279487|NCT01835041|Antidotes|antidotes|mesh-ancestor
154279488|NCT01835041|Protective Agents|protective agents|mesh-ancestor
154279489|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
154279490|NCT01835041|Vitamins|vitamins|mesh-ancestor
154279491|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
154279492|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
154279493|NCT01833572|Gefitinib|gefitinib|mesh-list
154279494|NCT01833572|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154279495|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154279496|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279514|NCT01591577|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154279515|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154279516|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279518|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154279519|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
154279520|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279521|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279522|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154279523|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154279524|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
154279525|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279526|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279527|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
154279528|NCT01364584|Exenatide|exenatide|mesh-list
154279529|NCT01364584|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154279530|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154279531|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279532|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154279533|NCT01364584|Incretins|incretins|mesh-ancestor
154279534|NCT01364584|Hormones|hormones|mesh-ancestor
154279535|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279536|NCT01163383|Iodine|iodine|mesh-list
154279537|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
154279538|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154279539|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154279540|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279541|NCT01163383|Trace Elements|trace elements|mesh-ancestor
154279542|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
154279543|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279544|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279545|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279546|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279547|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154279548|NCT01044264|Clindamycin|clindamycin|mesh-list
154279549|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
154279550|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
154279551|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154279552|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154279553|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279570|NCT00786019|Vitamins|vitamins|mesh-list
154279571|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
154279572|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
154279573|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279574|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
154026446|NCT00650598|Diclofenac|diclofenac|mesh-list
154279575|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279577|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
154279578|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154279579|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
154279580|NCT00692484|Povidone|povidone|mesh-list
154279581|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154279582|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279583|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
154279584|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
154279585|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
154279586|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
154279587|NCT00679783|Olaparib|olaparib|mesh-list
154279588|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154279589|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279590|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279591|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279592|NCT00152698|Irbesartan|irbesartan|mesh-list
154279593|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154279594|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154279595|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154279596|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279597|NCT01257516|Pregabalin|pregabalin|mesh-list
154279598|NCT01257516|Analgesics|analgesics|mesh-ancestor
154279599|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
154279600|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279601|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279602|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
154279603|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154279604|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154279605|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279606|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154279607|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154279608|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154279609|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279610|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154279611|NCT01149954|Ibuprofen|ibuprofen|mesh-list
154279620|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154279621|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279622|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279624|NCT03899610|Tremelimumab|tremelimumab|mesh-list
154279625|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279626|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861531|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154279627|NCT02527668|Vitamin D|vitamin d|mesh-list
154279628|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
154279629|NCT02527668|Calcifediol|calcifediol|mesh-list
154279630|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154279632|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
154279633|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279634|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154279635|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154279636|NCT03896256|Ketamine|ketamine|mesh-list
154279637|NCT03896256|Analgesics|analgesics|mesh-ancestor
154279638|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
154279639|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279640|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279641|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154279642|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154279643|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
154279644|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
154279645|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279646|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154279647|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154026511|NCT06096181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154279648|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507474|NCT05092698|Vitamin D|vitamin d|mesh-list
154279649|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279650|NCT03893136|Leflunomide|leflunomide|mesh-list
154279651|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279652|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279653|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154279654|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
154279655|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279656|NCT01258530|Oseltamivir|oseltamivir|mesh-list
154279657|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
154279658|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279659|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279660|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279661|NCT01255410|Vaccines|vaccines|mesh-list
154279662|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
154279663|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279664|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
154279665|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279666|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
154279667|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
154279668|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
154279669|NCT01257672|Ondansetron|ondansetron|mesh-list
154279670|NCT01257672|Domperidone|domperidone|mesh-list
154279671|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
154279672|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
154279673|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279674|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279675|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279676|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
154279737|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154279738|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154279739|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154279740|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279741|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279742|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154279743|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154279744|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154279745|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
154279746|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279747|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279748|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154279749|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154279750|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
154279751|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
154279753|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
154279770|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279771|NCT03892512|Analgesics|analgesics|mesh-ancestor
154279772|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
154279773|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279774|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154279775|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154279776|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154279777|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
154279778|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279779|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279780|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154279781|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154279782|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154279783|NCT01255878|Gabapentin|gabapentin|mesh-list
154279784|NCT01255878|Analgesics|analgesics|mesh-ancestor
154279785|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
154279786|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279787|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279788|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
154279789|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154279790|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154279791|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279792|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154279793|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154279794|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154279795|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279796|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279797|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
154279799|NCT01255956|Paclitaxel|paclitaxel|mesh-list
154279800|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154279801|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279802|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
154279803|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
154279804|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
154279805|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279806|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154279807|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279808|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154279809|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
154279810|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154279811|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
154279812|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279813|NCT03892434|Dexamethasone|dexamethasone|mesh-list
154280335|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154280336|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
154280337|NCT01156740|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
154280338|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280340|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154280602|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280603|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280604|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154280605|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
154280606|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
154280607|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280608|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154280609|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154280610|NCT01158846|Bivalirudin|bivalirudin|mesh-list
154280611|NCT01158846|Abciximab|abciximab|mesh-list
154280612|NCT01158846|Clopidogrel|clopidogrel|mesh-list
154280613|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154280677|NCT01159158|Nateglinide|nateglinide|mesh-list
154280678|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154280679|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280680|NCT01161108|Melatonin|melatonin|mesh-list
154280681|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
154280682|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280683|NCT01161108|Protective Agents|protective agents|mesh-ancestor
154280870|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154280871|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154280872|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154280873|NCT01280214|Triamcinolone|triamcinolone|mesh-list
154280874|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154280875|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
154280876|NCT01280214|Hormones|hormones|mesh-ancestor
154280877|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280878|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280879|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154280880|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154280881|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154280882|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154280883|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154280884|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
154861532|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
154861533|NCT01115101|Pirinitramide|pirinitramide|mesh-list
154280906|NCT01280526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280908|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154280909|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
154280910|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280911|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280912|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154027386|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154280914|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
154280915|NCT01269138|Coagulants|coagulants|mesh-ancestor
154280916|NCT02526810|Insulin|insulin|mesh-list
154280917|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154280918|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
154280919|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
154280920|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154280921|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280922|NCT01269216|Leucovorin|leucovorin|mesh-list
154280923|NCT01269216|Irinotecan|irinotecan|mesh-list
154280924|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154280925|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154280926|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280927|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280928|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280929|NCT01269216|Antidotes|antidotes|mesh-ancestor
154280930|NCT01269216|Protective Agents|protective agents|mesh-ancestor
154280931|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280932|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
154280933|NCT01269216|Vitamins|vitamins|mesh-ancestor
154280934|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
154280935|NCT03874806|Ropivacaine|ropivacaine|mesh-list
154280936|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154280937|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
154280938|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
154281071|NCT05835713|Anesthetics|anesthetics|mesh-ancestor
154281081|NCT05835089|Estradiol|estradiol|mesh-list
154281082|NCT05835089|Testosterone|testosterone|mesh-list
154281083|NCT05835089|Estrogens|estrogens|mesh-ancestor
154281084|NCT05835089|Hormones|hormones|mesh-ancestor
154281085|NCT05835089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281086|NCT05835089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281087|NCT05835089|Androgens|androgens|mesh-ancestor
154281088|NCT05834868|Insulin Lispro|insulin lispro|mesh-list
154281089|NCT05834868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154281090|NCT05834868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281091|NCT05834855|Rituximab|rituximab|mesh-list
154281092|NCT05834855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281093|NCT05834855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281094|NCT05834855|Immunologic Factors|immunologic factors|mesh-ancestor
154281334|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154281335|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154281336|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
154281337|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154281338|NCT05594680|Protective Agents|protective agents|mesh-ancestor
154281339|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154281340|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154281341|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154281342|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
154281343|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281344|NCT05557643|Psilocybin|psilocybin|mesh-list
154281345|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
154281346|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281347|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154281348|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
154281349|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
154281350|NCT05281614|Etanercept|etanercept|mesh-list
154281402|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281404|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281405|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154281406|NCT04801849|Vitamin E|vitamin e|mesh-list
154281407|NCT04801849|Tocopherols|tocopherols|mesh-list
154281408|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
154281409|NCT04801849|Vitamins|vitamins|mesh-ancestor
154281410|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
154281411|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281412|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
154861534|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154861535|NCT01115101|Narcotics|narcotics|mesh-ancestor
154281413|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281414|NCT04801849|Protective Agents|protective agents|mesh-ancestor
154281415|NCT04635839|Heparin|heparin|mesh-list
154281416|NCT04635839|Calcium heparin|calcium heparin|mesh-list
154281417|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
154281418|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154281419|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154281420|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281421|NCT04560179|Tobramycin|tobramycin|mesh-list
154281422|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154281423|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154281424|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281516|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154281517|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154281518|NCT03729804|Growth Substances|growth substances|mesh-ancestor
154281519|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
154281520|NCT03697564|Gemcitabine|gemcitabine|mesh-list
154281521|NCT03697564|Nivolumab|nivolumab|mesh-list
154281522|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154281523|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
154281524|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281525|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281526|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281527|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154281528|NCT03500445|Dexamethasone|dexamethasone|mesh-list
154281529|NCT03500445|Lenalidomide|lenalidomide|mesh-list
154281530|NCT03500445|Daratumumab|daratumumab|mesh-list
154281531|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281532|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
154281533|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
154281534|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281535|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281806|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
154281807|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
154281808|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281809|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281810|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281811|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
154281812|NCT01665794|Hormones|hormones|mesh-ancestor
154281813|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281814|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281815|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281816|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
154281817|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154281818|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154281819|NCT01665794|Growth Substances|growth substances|mesh-ancestor
154281820|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
154281822|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154281823|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
154281824|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281825|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154281826|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154281827|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281828|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281829|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154281955|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154281956|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154281957|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281958|NCT03870828|Dimercaprol|dimercaprol|mesh-list
154281959|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
154281960|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
154281961|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281962|NCT01168050|Nilotinib|nilotinib|mesh-list
154281963|NCT01168050|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154281964|NCT01168050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154281965|NCT01168050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282003|NCT01281852|Paclitaxel|paclitaxel|mesh-list
154282116|NCT01169142|Vitamins|vitamins|mesh-list
154282117|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
154282118|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282119|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154282120|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154282121|NCT01169298|Lenalidomide|lenalidomide|mesh-list
154282122|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
154255281|NCT00660218|Paclitaxel|paclitaxel|mesh-list
154282123|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282124|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154282125|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154282126|NCT01169298|Growth Substances|growth substances|mesh-ancestor
154282127|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
154282128|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282130|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154282131|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
154282132|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282133|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282134|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282135|NCT01282632|Olanzapine|olanzapine|mesh-list
154282136|NCT01282632|Risperidone|risperidone|mesh-list
154282137|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154282138|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
154282139|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282140|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282141|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282142|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154282143|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154282144|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282145|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154282246|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282247|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282248|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
154282249|NCT01172964|Flucytosine|flucytosine|mesh-list
154282250|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
154282251|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282252|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
154282253|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282254|NCT03866928|Stiripentol|stiripentol|mesh-list
154282255|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
154282256|NCT01172496|Treprostinil|treprostinil|mesh-list
154282285|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282286|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282287|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
154282288|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282289|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154282290|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154282291|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154282292|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154282293|NCT03435640|Nivolumab|nivolumab|mesh-list
154282294|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282295|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282296|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154282297|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282298|NCT01175772|Celecoxib|celecoxib|mesh-list
154282299|NCT01175772|Methotrexate|methotrexate|mesh-list
154282300|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
154282329|NCT01536964|Narcotics|narcotics|mesh-ancestor
154282330|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282331|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282332|NCT01536964|Analgesics|analgesics|mesh-ancestor
154282333|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
154282334|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282335|NCT01288404|Fluorometholone|fluorometholone|mesh-list
154282336|NCT01288404|Bevacizumab|bevacizumab|mesh-list
154282337|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282338|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282339|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154282340|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154282341|NCT01288404|Growth Substances|growth substances|mesh-ancestor
154282342|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282343|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
154282344|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282379|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154282380|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154282381|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282382|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154282383|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282404|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154282405|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282406|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861536|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282407|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154282408|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
154282409|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154282410|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282411|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
154282412|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154282413|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154282415|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154282416|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282417|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
154282418|NCT01174290|Haloperidol|haloperidol|mesh-list
154282419|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
154282420|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
154282421|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
154282422|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282423|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282424|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154282425|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154282426|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154282427|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282428|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154282429|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154282430|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
154282431|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282432|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282433|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154282434|NCT03862404|Epinephrine|epinephrine|mesh-list
154282435|NCT03862404|Bupivacaine|bupivacaine|mesh-list
154282436|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
154282437|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
154282769|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154282770|NCT01177176|Bupropion|bupropion|mesh-list
154282771|NCT01177176|Nicotine|nicotine|mesh-list
154282772|NCT01177176|Varenicline|varenicline|mesh-list
154282773|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154282774|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
154282775|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282776|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282777|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154282778|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154282779|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
154282780|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282781|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282782|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154282783|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
154282784|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154282785|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154282786|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154282787|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154282788|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
154282789|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154282790|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154282791|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282793|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154282794|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282795|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154282796|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282797|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282798|NCT01179828|Oxycodone|oxycodone|mesh-list
154282799|NCT01179828|Clobazam|clobazam|mesh-list
154282800|NCT01179828|Imipramine|imipramine|mesh-list
154282801|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154282802|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154282803|NCT01179828|Narcotics|narcotics|mesh-ancestor
154282804|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282805|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282806|NCT01179828|Analgesics|analgesics|mesh-ancestor
154282807|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
154282808|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282809|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154282810|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154282811|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
154282812|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861537|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282813|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282814|NCT01179828|Urological Agents|urological agents|mesh-ancestor
154282815|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154282816|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
154282817|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154282916|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282917|NCT01290744|Clofazimine|clofazimine|mesh-list
154282918|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282919|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
154282920|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154282921|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283038|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154283039|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154283040|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154283041|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
154283042|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283043|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154283044|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154283045|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154283046|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154283047|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154283048|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154283049|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
154283050|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
154283103|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154283104|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154283105|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154283106|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154283107|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
154283108|NCT01291212|Testosterone|testosterone|mesh-list
154283109|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
154283110|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
154283111|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154283112|NCT01291212|Androgens|androgens|mesh-ancestor
154283113|NCT01291212|Hormones|hormones|mesh-ancestor
154283177|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154283178|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154283297|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154283298|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154283747|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283749|NCT01295502|Cisplatin|cisplatin|mesh-list
154283750|NCT01295502|Carboplatin|carboplatin|mesh-list
154283751|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154283752|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154283753|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283754|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283809|NCT01195428|Simvastatin|simvastatin|mesh-list
154283810|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154283811|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154283812|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
154283813|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283814|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154283815|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154283816|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283817|NCT01193166|Olanzapine|olanzapine|mesh-list
154283818|NCT01193166|Risperidone|risperidone|mesh-list
154283819|NCT01193166|Aripiprazole|aripiprazole|mesh-list
154283820|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154283821|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154283822|NCT01193166|Perphenazine|perphenazine|mesh-list
154283823|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154283824|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
154283825|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283826|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283827|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283828|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154283829|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154283830|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283831|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154283832|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154283833|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
154861538|NCT01115101|Analgesics|analgesics|mesh-ancestor
154283836|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283837|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154283838|NCT01193166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154283917|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154283918|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154283919|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154283920|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283921|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283922|NCT01192854|Adefovir|adefovir|mesh-list
154283923|NCT01192854|Clevudine|clevudine|mesh-list
154283924|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
154283925|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283926|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154283927|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154283928|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283929|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283930|NCT03846180|Octreotide|octreotide|mesh-list
154283931|NCT03846180|Terlipressin|terlipressin|mesh-list
154283932|NCT03846180|Somatostatin|somatostatin|mesh-list
154283933|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154283934|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154283935|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283936|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154283937|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154283938|NCT03846180|Hormones|hormones|mesh-ancestor
154283995|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154283996|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030841|NCT00690417|Vitamin D|vitamin d|mesh-list
154283997|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283998|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154283999|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154284000|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284001|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154284002|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284003|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284004|NCT01202058|Sirolimus|sirolimus|mesh-list
154284005|NCT01202058|Everolimus|everolimus|mesh-list
154284006|NCT01202058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154284007|NCT01202058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154284008|NCT01202058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284009|NCT01202058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284010|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284046|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154284047|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284048|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284049|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154284050|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
154284085|NCT03882970|Tirzepatide|tirzepatide|mesh-list
154284086|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284087|NCT03882970|Incretins|incretins|mesh-ancestor
154284088|NCT03882970|Hormones|hormones|mesh-ancestor
154284238|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154284239|NCT03844776|Analgesics|analgesics|mesh-ancestor
154284240|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
154284241|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284272|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284273|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284274|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154284275|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154284276|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284277|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154284278|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154284279|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284280|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
154284281|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154284282|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154284283|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154284284|NCT02982954|Nivolumab|nivolumab|mesh-list
154284285|NCT02982954|Ipilimumab|ipilimumab|mesh-list
154284286|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154284506|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284507|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284508|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
154284509|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284510|NCT01382134|Aspirin|aspirin|mesh-list
154284511|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154284512|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154284513|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154284514|NCT01382134|Analgesics|analgesics|mesh-ancestor
154284515|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
154284516|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284517|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284518|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284519|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284520|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154284521|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154284522|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284523|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154284524|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154284525|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284526|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
154284527|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
154284528|NCT01382134|Coagulants|coagulants|mesh-ancestor
154284529|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154284530|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
154284531|NCT05077488|Lidocaine|lidocaine|mesh-list
154284532|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
154284533|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
154284534|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284535|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284536|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
154284537|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284538|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154284539|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154284540|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154284541|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284542|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284543|NCT05668572|Vaccines|vaccines|mesh-list
154284544|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
154284545|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284546|NCT02410980|Tretinoin|tretinoin|mesh-list
154284547|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284548|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
154284725|NCT01205256|Narcotics|narcotics|mesh-ancestor
154284726|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284727|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284728|NCT01205256|Analgesics|analgesics|mesh-ancestor
154284729|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
154284730|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284731|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
154284732|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
154284734|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
154284735|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
154284869|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
154284870|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284871|NCT01298076|Dexamethasone|dexamethasone|mesh-list
154284872|NCT01298076|Bevacizumab|bevacizumab|mesh-list
154284873|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154284874|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284875|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154284876|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154284877|NCT01298076|Growth Substances|growth substances|mesh-ancestor
154284878|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284879|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
154284880|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284881|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
154284882|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
154284883|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284884|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154284885|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
154284886|NCT01298076|Hormones|hormones|mesh-ancestor
154284887|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284888|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154284889|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
154284890|NCT03819348|Clotrimazole|clotrimazole|mesh-list
154284891|NCT03819348|Miconazole|miconazole|mesh-list
154284892|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284893|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154284894|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154284923|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284924|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154284925|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154284926|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284927|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154284928|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
154284929|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
154284930|NCT01304472|Clopidogrel|clopidogrel|mesh-list
154284931|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154284932|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154284933|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154284934|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154284935|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154285434|NCT03083470|Paclitaxel|paclitaxel|mesh-list
154285435|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154285436|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285437|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154285438|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154285439|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154285440|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285441|NCT01377610|Naltrexone|naltrexone|mesh-list
154285442|NCT01377610|Buprenorphine|buprenorphine|mesh-list
154285443|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154285444|NCT01377610|Narcotics|narcotics|mesh-ancestor
154285445|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285446|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285447|NCT01377610|Analgesics|analgesics|mesh-ancestor
154285448|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
154285449|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285450|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154285451|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154285452|NCT03811080|Fexuprazan|fexuprazan|mesh-list
154285453|NCT03811080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154285454|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154285455|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285515|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
154285516|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154285517|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285518|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
154285519|NCT01379482|Paclitaxel|paclitaxel|mesh-list
154285520|NCT01379482|Docetaxel|docetaxel|mesh-list
154285521|NCT01379482|Cisplatin|cisplatin|mesh-list
154285522|NCT01379482|Doxorubicin|doxorubicin|mesh-list
154285523|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
154286022|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286023|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
154286024|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154286025|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154286027|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
154286028|NCT01309854|Pioglitazone|pioglitazone|mesh-list
154286029|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154286030|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286031|NCT03780192|Sirolimus|sirolimus|mesh-list
154286032|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286033|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286034|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154286035|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286036|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
154286303|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154286304|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154286305|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
154286306|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154286308|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154286309|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
154286310|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154286311|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286312|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154286313|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154286314|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
154286315|NCT04581148|Antibodies|antibodies|mesh-list
154286316|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
154861539|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
154861540|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286354|NCT02575144|Hormones|hormones|mesh-ancestor
154286355|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286356|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154286357|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286358|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
154286359|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154286459|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154286460|NCT03771066|Estrogens|estrogens|mesh-ancestor
154286461|NCT03771066|Hormones|hormones|mesh-ancestor
154286462|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286463|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286464|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154286465|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
154286466|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286467|NCT03771066|Protective Agents|protective agents|mesh-ancestor
154286468|NCT03768024|Hydromorphone|hydromorphone|mesh-list
154286469|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154286470|NCT03768024|Narcotics|narcotics|mesh-ancestor
154286471|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033326|NCT02697448|Propofol|propofol|mesh-list
154286472|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286473|NCT03768024|Analgesics|analgesics|mesh-ancestor
154286474|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
154286475|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286476|NCT03999684|Tretinoin|tretinoin|mesh-list
154286477|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286550|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154286551|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286552|NCT03760848|Midazolam|midazolam|mesh-list
154286553|NCT03760848|Atorvastatin|atorvastatin|mesh-list
154286554|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154286555|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154286591|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154286592|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
154286593|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
154286594|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286595|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286619|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
154286620|NCT00112840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286621|NCT00112840|Immunologic Factors|immunologic factors|mesh-ancestor
154286622|NCT00112840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154286623|NCT00112840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154286624|NCT00112840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286625|NCT00112840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286626|NCT03769818|Dexamethasone|dexamethasone|mesh-list
154286627|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
154286628|NCT03769818|Bupivacaine|bupivacaine|mesh-list
154286629|NCT03769818|BB 1101|bb 1101|mesh-list
154286630|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286631|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
154286632|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
154286633|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286634|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286635|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154286636|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
154286637|NCT03769818|Hormones|hormones|mesh-ancestor
154286638|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286639|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154286640|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286641|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
154286642|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286643|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286644|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
154286645|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
154286674|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286675|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286677|NCT03766074|Vitamins|vitamins|mesh-ancestor
154286678|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
154286679|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286680|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154286681|NCT05219656|Cyclosporine|cyclosporine|mesh-list
154286684|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286686|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
154286687|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286688|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
154286689|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286690|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
154286691|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154286723|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154286724|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154286725|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154286726|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
154286727|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286728|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286729|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286730|NCT04920838|Acetaminophen|acetaminophen|mesh-list
154286731|NCT04920838|Ciclesonide|ciclesonide|mesh-list
154286732|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
154286733|NCT04920838|Budesonide|budesonide|mesh-list
154286734|NCT04920838|Telmisartan|telmisartan|mesh-list
154286735|NCT04920838|Fluoxetine|fluoxetine|mesh-list
154286736|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154286737|NCT04920838|Analgesics|analgesics|mesh-ancestor
154286738|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
154286739|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286767|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154286768|NCT03764280|Insulin|insulin|mesh-list
154286769|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
154286770|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154286771|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286772|NCT03764202|Sufentanil|sufentanil|mesh-list
154286773|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154286774|NCT03764202|Narcotics|narcotics|mesh-ancestor
154286775|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286776|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286777|NCT03764202|Analgesics|analgesics|mesh-ancestor
154286778|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
154286779|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286780|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154286781|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154286782|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
154286783|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
154286819|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154286820|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
154286821|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286822|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286823|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154286824|NCT05091528|Immunoconjugates|immunoconjugates|mesh-ancestor
154286825|NCT05091528|Immunologic Factors|immunologic factors|mesh-ancestor
154286896|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286897|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154286898|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154286920|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154286921|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154286922|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286924|NCT04621058|Vitamins|vitamins|mesh-list
154286925|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
154286926|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286927|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154286928|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
154286929|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
154286930|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154286931|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154286932|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286933|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286934|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286935|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154286936|NCT04451330|Doxycycline|doxycycline|mesh-list
154286937|NCT04451330|Trifarotene|trifarotene|mesh-list
154286938|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286939|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286940|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
154286943|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
154286944|NCT02493426|Oxytocin|oxytocin|mesh-list
154286945|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
154286946|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154286947|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286948|NCT03763734|Dexamethasone|dexamethasone|mesh-list
154286949|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286950|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
154286971|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286972|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154286973|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
154286974|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286975|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286976|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154286977|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
154286978|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
154286979|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154286980|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154286981|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154286982|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154286983|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
154286984|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286985|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286986|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
154286988|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286989|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
154286990|NCT03749408|Mannitol|mannitol|mesh-list
154286991|NCT03749408|Bupivacaine|bupivacaine|mesh-list
154286992|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
154286993|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
154286994|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286995|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286996|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
154286997|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286998|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154286999|NCT03749408|Diuretics|diuretics|mesh-ancestor
154287000|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
154287001|NCT04387136|Sufentanil|sufentanil|mesh-list
154287002|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154287003|NCT04387136|Narcotics|narcotics|mesh-ancestor
154287004|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287041|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
154287042|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287043|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
154287044|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154287073|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
154287074|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287075|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287076|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
154287077|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287078|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287079|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154287080|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
154287081|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154287082|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154287083|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154287084|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287085|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287086|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154287087|NCT04605588|Ribavirin|ribavirin|mesh-list
154287088|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
154287089|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
154287090|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
154287126|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154287127|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287160|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287161|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
154287162|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287163|NCT03755700|Protective Agents|protective agents|mesh-ancestor
154287164|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
154287165|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287166|NCT03755700|Expectorants|expectorants|mesh-ancestor
154287168|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154287203|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287204|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287205|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154287206|NCT03693404|Narcotics|narcotics|mesh-ancestor
154287207|NCT04219358|Imiquimod|imiquimod|mesh-list
154287208|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
154287209|NCT04219358|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154287210|NCT04219358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287211|NCT04219358|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154287247|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154287248|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509548|NCT02535650|Tipifarnib|tipifarnib|mesh-list
154287249|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287250|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
154287280|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
154287281|NCT04497948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154287282|NCT04497948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154287283|NCT04497948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287284|NCT04497948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287285|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287286|NCT04495374|Pregabalin|pregabalin|mesh-list
154287287|NCT04495374|Analgesics|analgesics|mesh-ancestor
154287288|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
154287289|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287290|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287291|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
154287292|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154287293|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154287294|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287307|NCT03752112|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154287308|NCT03752112|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154287309|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154287310|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154287311|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287312|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287313|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
154287314|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287315|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
154287316|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154287318|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154287319|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
154287320|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287321|NCT03501940|Fluorides|fluorides|mesh-list
154287322|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
154287323|NCT03501940|Protective Agents|protective agents|mesh-ancestor
154287324|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287325|NCT03754842|Niacinamide|niacinamide|mesh-list
154287326|NCT03754842|Niacin|niacin|mesh-list
154287327|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
154287328|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
154287329|NCT03754842|Vitamins|vitamins|mesh-ancestor
154287330|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
154287331|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287332|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154287333|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
154287334|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287335|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154287336|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
154287337|NCT01562210|Olaparib|olaparib|mesh-list
154287338|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287339|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154287340|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287341|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287342|NCT04189952|Rituximab|rituximab|mesh-list
154287343|NCT04189952|Carboplatin|carboplatin|mesh-list
154287344|NCT04189952|Etoposide|etoposide|mesh-list
154287345|NCT04189952|Ifosfamide|ifosfamide|mesh-list
154287346|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
154287347|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287348|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287349|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
154861541|NCT02245529|Tamsulosin|tamsulosin|mesh-list
154287351|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287352|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154287353|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154287354|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287355|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287356|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287357|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154287381|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287383|NCT03754686|Oseltamivir|oseltamivir|mesh-list
154287384|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154287385|NCT03754686|Analgesics|analgesics|mesh-ancestor
154287386|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
154287387|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287388|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287389|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
154287390|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
154287391|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287392|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287393|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287394|NCT05200884|Lidocaine|lidocaine|mesh-list
154287395|NCT05200884|Carticaine|carticaine|mesh-list
154287396|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
154287397|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
154287398|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287399|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287400|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
154287401|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287402|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154287403|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154287404|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154287405|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154287440|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
154287441|NCT03746366|Corticosterone|corticosterone|mesh-list
154287442|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154287443|NCT04157738|Insulin|insulin|mesh-list
154287444|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154287445|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
154287446|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
154287447|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154287469|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287470|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154287471|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154287472|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
154287473|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154287474|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287475|NCT04537806|Pregnanolone|pregnanolone|mesh-list
154287476|NCT04537806|Brexanolone|brexanolone|mesh-list
154287477|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
154287478|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287479|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287480|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
154287481|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287482|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287483|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
154287484|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
154287485|NCT03744806|Bevacizumab|bevacizumab|mesh-list
154287486|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287487|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287488|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154287489|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154287490|NCT03744806|Growth Substances|growth substances|mesh-ancestor
154287491|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287492|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
154287493|NCT04531098|Vaccines|vaccines|mesh-list
154287494|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
154287495|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287496|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
154287497|NCT04529850|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154287498|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
154287499|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287523|NCT05206318|Cysteamine|cysteamine|mesh-list
154287524|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154287525|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287529|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287531|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287532|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154287533|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287534|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287535|NCT04425252|Brequinar|brequinar|mesh-list
154287536|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287537|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287538|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287539|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287540|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
154287541|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287542|NCT04003610|Carboplatin|carboplatin|mesh-list
154287543|NCT04003610|Gemcitabine|gemcitabine|mesh-list
154287544|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
154287545|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287546|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154287547|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
154287548|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287579|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287580|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154287581|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
154287582|NCT05280626|Hormones|hormones|mesh-ancestor
154287583|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154287584|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154287585|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
154287586|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
154287587|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287588|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154287589|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154287590|NCT05280626|Protective Agents|protective agents|mesh-ancestor
154287591|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154287592|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
154287625|NCT03751176|Protective Agents|protective agents|mesh-ancestor
154287626|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
154287627|NCT03751176|Vitamins|vitamins|mesh-ancestor
154287628|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
154287629|NCT03751176|Hematinics|hematinics|mesh-ancestor
154287630|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287631|NCT04377308|Fluoxetine|fluoxetine|mesh-list
154287632|NCT04377308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154287633|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154287634|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154287635|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287636|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287637|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
154287669|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154287670|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287671|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287673|NCT05204056|Morphine|morphine|mesh-list
154287674|NCT05204056|Ropivacaine|ropivacaine|mesh-list
154287675|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
154287676|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154287677|NCT05204056|Narcotics|narcotics|mesh-ancestor
154287678|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287679|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287712|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287713|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287714|NCT05761366|PSMA-BCH|psma-bch|mesh-list
154287715|NCT05761366|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154287716|NCT05761366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287717|NCT05302466|Silicon|silicon|mesh-list
154287718|NCT05302466|Trace Elements|trace elements|mesh-ancestor
154287719|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
154287720|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287721|NCT05203588|Vitamin D|vitamin d|mesh-list
154287722|NCT05203588|Denosumab|denosumab|mesh-list
154287723|NCT05203588|Calcium|calcium|mesh-list
154287724|NCT05203588|Vitamins|vitamins|mesh-ancestor
153453223|NCT01762800|Xhance|xhance|mesh-list
154287725|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
154287749|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
154287750|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255284|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154287751|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287753|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
154287754|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
154287755|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154287756|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287757|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154287758|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154287759|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154287760|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287761|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287762|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287763|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287764|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
154287765|NCT05761132|Pembrolizumab|pembrolizumab|mesh-list
154287766|NCT05761132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287767|NCT05761132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287768|NCT05761132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154287769|NCT05761132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287770|NCT04411680|Sargramostim|sargramostim|mesh-list
154287771|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
154287772|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287773|NCT05760976|Cisatracurium|cisatracurium|mesh-list
154287774|NCT05760976|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154287775|NCT05760976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154287776|NCT05760976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287805|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287807|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154287808|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154287809|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154287810|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154287811|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287812|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
154287813|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287814|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287815|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154287816|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287817|NCT04578106|Trastuzumab|trastuzumab|mesh-list
154287818|NCT04578106|Pertuzumab|pertuzumab|mesh-list
154287819|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287820|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287854|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154287855|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287856|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287857|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
154287858|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154287859|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510227|NCT01400009|Vitamin D|vitamin d|mesh-list
154287860|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287861|NCT04161144|Sirolimus|sirolimus|mesh-list
154287893|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154287894|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
154287895|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154287896|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
154287897|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154287898|NCT04153188|Protective Agents|protective agents|mesh-ancestor
154287899|NCT03611010|Atorvastatin|atorvastatin|mesh-list
154287900|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154287901|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154287902|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
154287932|NCT04400682|Favipiravir|favipiravir|mesh-list
154287933|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
154287934|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287935|NCT03066778|Carboplatin|carboplatin|mesh-list
154287936|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
154287937|NCT03066778|Etoposide|etoposide|mesh-list
154287938|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287939|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287940|NCT03066778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154287941|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287942|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154861542|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154861543|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154287943|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154287944|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287945|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287946|NCT04136548|Fentanyl|fentanyl|mesh-list
154287947|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154287980|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
154287981|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034833|NCT00647192|Eplerenone|eplerenone|mesh-list
154287982|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287983|NCT03979820|Phenelzine|phenelzine|mesh-list
154287984|NCT03979820|Tyramine|tyramine|mesh-list
154287985|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
154287986|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154287987|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154287988|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287989|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287990|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
154287991|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
154288027|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154288028|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
154288029|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288030|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
154288031|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
154288063|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
154288064|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
154288065|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154288066|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
154288067|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288068|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288069|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154288070|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
154288071|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
154288107|NCT02909452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154288108|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288109|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154288110|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288143|NCT00826462|Triamcinolone|triamcinolone|mesh-list
154288144|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154288145|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154288146|NCT00826462|Naproxen|naproxen|mesh-list
154288147|NCT00826462|Lidocaine|lidocaine|mesh-list
154288148|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154288149|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
154288150|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
154288151|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288152|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288153|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
154288154|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288174|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154288175|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288176|NCT04398732|Analgesics|analgesics|mesh-ancestor
154288177|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
154288178|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288179|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288180|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288181|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288182|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288183|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154288184|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
154288185|NCT04322682|Colchicine|colchicine|mesh-list
154288186|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
154288187|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288188|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
154288189|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
154288190|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
154288191|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288192|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288193|NCT04322526|Naltrexone|naltrexone|mesh-list
154288194|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154288195|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154288196|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288197|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
154288198|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288199|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
154861544|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154288200|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154288201|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
154288202|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288203|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
154288204|NCT04115358|Protective Agents|protective agents|mesh-ancestor
154288205|NCT05668884|Gemcitabine|gemcitabine|mesh-list
154288206|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
154288207|NCT05668884|Tislelizumab|tislelizumab|mesh-list
154288208|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154288209|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
154288245|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288246|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288247|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
154288248|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
154288249|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154288277|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288279|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154288280|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154288281|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288282|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154288283|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154288284|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154288285|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288286|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288287|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
154035128|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288288|NCT04389840|Heparin|heparin|mesh-list
154288289|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
154288290|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154288291|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154288292|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288293|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
154288294|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288295|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
154288296|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154288323|NCT02717416|Coagulants|coagulants|mesh-ancestor
154288324|NCT02054104|Celecoxib|celecoxib|mesh-list
154288325|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
154288326|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154288327|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
154288328|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288329|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288330|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154288331|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
154288332|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288333|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288334|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154288335|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154288336|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288337|NCT02054104|Analgesics|analgesics|mesh-ancestor
154288338|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
154288339|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288340|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288341|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154288342|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153510645|NCT01402622|Propofol|propofol|mesh-list
154288343|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288344|NCT04229290|Dolutegravir|dolutegravir|mesh-list
154288376|NCT04382586|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154288377|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154288378|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288379|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288380|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288381|NCT02728648|Oxycodone|oxycodone|mesh-list
154288382|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154288383|NCT02728648|Narcotics|narcotics|mesh-ancestor
154288384|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288385|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288386|NCT02728648|Analgesics|analgesics|mesh-ancestor
154288387|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
154288420|NCT03673670|Olodaterol|olodaterol|mesh-list
154288421|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154288422|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
154861545|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154861546|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288423|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288424|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288425|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154288426|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
154288427|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
154288428|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154288429|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
154288430|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288431|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288432|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
154288457|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
154288459|NCT05215366|Coagulants|coagulants|mesh-ancestor
154288460|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154288461|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154288462|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
154288463|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288464|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154288465|NCT03891524|Enoxaparin|enoxaparin|mesh-list
154288466|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
154288467|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154288468|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154288469|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288470|NCT04695652|Somatomedin B|somatomedin b|mesh-list
154288471|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154288472|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154288473|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
154288474|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288475|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288476|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
154288477|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154288478|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154288479|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288480|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
154288481|NCT04489108|Coagulants|coagulants|mesh-ancestor
154288482|NCT03771586|Ketamine|ketamine|mesh-list
154288483|NCT03771586|Analgesics|analgesics|mesh-ancestor
154288513|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
154288514|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288515|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154288516|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154288517|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288519|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288521|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288522|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
154288523|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288524|NCT04075604|Nivolumab|nivolumab|mesh-list
154288525|NCT04075604|Palbociclib|palbociclib|mesh-list
154288526|NCT04075604|Anastrozole|anastrozole|mesh-list
154288527|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154288528|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288558|NCT05052970|Bortezomib|bortezomib|mesh-list
154288559|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
154288560|NCT05052970|BB 1101|bb 1101|mesh-list
154288561|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288562|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
154288563|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
154288564|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288565|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288566|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288567|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
154288568|NCT05052970|Hormones|hormones|mesh-ancestor
154288569|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288570|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154288571|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288572|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
154288573|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288607|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288609|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
154288610|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288611|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154288612|NCT04496362|Heparin|heparin|mesh-list
154288613|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
154288614|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154288615|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154288616|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288617|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
154288638|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154288639|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288640|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154288641|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154288642|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288643|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154288644|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154288645|NCT04963816|Dexamethasone|dexamethasone|mesh-list
154288646|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
154288647|NCT04963816|Bupivacaine|bupivacaine|mesh-list
154288648|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154288649|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154288651|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288652|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
154288653|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
154288654|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288655|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288656|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288657|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
154288658|NCT04963816|Hormones|hormones|mesh-ancestor
154288659|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288660|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154288661|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035509|NCT00693849|Sertraline|sertraline|mesh-list
154288662|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
154288663|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288664|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288665|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
154288666|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
154288667|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288668|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
154288669|NCT04933240|Tamoxifen|tamoxifen|mesh-list
154288670|NCT04933240|Estradiol|estradiol|mesh-list
154288698|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154288699|NCT05706688|Anesthetics|anesthetics|mesh-list
154288700|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511009|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288701|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288702|NCT05706454|Ramatroban|ramatroban|mesh-list
154288703|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154288704|NCT01317550|Minocycline|minocycline|mesh-list
154288705|NCT01317550|Modafinil|modafinil|mesh-list
154288706|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154288707|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288708|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154288709|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288710|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154288711|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154288712|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154288713|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288714|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
154288715|NCT01317472|Lansoprazole|lansoprazole|mesh-list
154288716|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154288717|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288741|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154288742|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154288743|NCT03693612|Paclitaxel|paclitaxel|mesh-list
154288744|NCT03693612|Docetaxel|docetaxel|mesh-list
154288745|NCT03693612|Cetuximab|cetuximab|mesh-list
154288746|NCT03693612|Tremelimumab|tremelimumab|mesh-list
154288747|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154288748|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288749|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
154288750|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
154288751|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
154288752|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288753|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154288754|NCT03746652|Dexamethasone|dexamethasone|mesh-list
154288755|NCT03746652|Daratumumab|daratumumab|mesh-list
154288756|NCT03746652|Ixazomib|ixazomib|mesh-list
154288757|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288758|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
154288759|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
154288760|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288761|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288762|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288763|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
154288764|NCT03746652|Hormones|hormones|mesh-ancestor
154288765|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288766|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154288779|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
154288780|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288781|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288782|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154288783|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154288784|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
154288785|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154288786|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154288787|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154288788|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154288789|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
154288790|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154288791|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
154288792|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288794|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154288795|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288796|NCT04067492|Analgesics|analgesics|mesh-ancestor
154288797|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
154288798|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288799|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288800|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288801|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288802|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154288803|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288804|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288805|NCT04186806|Muramidase|muramidase|mesh-list
154288806|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288807|NCT03748446|Xenon|xenon|mesh-list
154288808|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154288809|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
154288810|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
154288811|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288812|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288813|NCT04036110|Vitamins|vitamins|mesh-list
154288814|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
154288815|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
154288816|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288817|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
154288818|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288819|NCT04036110|Protective Agents|protective agents|mesh-ancestor
154288820|NCT03053050|Selonsertib|selonsertib|mesh-list
154288821|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154288822|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288823|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288824|NCT04369950|Lidocaine|lidocaine|mesh-list
154288825|NCT04369950|Epinephrine|epinephrine|mesh-list
154288826|NCT04369950|Morphine|morphine|mesh-list
154288827|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
154288828|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
154288829|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
154288861|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
154288862|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288863|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288864|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
154288865|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154288866|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154288867|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288868|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154288869|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154288870|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154288871|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288907|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288908|NCT05598424|Hormones|hormones|mesh-ancestor
154288909|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288910|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154288928|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154288929|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153932372|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154288930|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
154288931|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288932|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154288933|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154288934|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288935|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154288936|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288937|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154288938|NCT05280028|Tibolone|tibolone|mesh-list
154288939|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154288940|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154288941|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
154288942|NCT05280028|Estradiol|estradiol|mesh-list
154288943|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154288944|NCT05280028|Estrogens|estrogens|mesh-ancestor
154288945|NCT05280028|Hormones|hormones|mesh-ancestor
154288946|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288947|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288948|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154288949|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
154288950|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154288951|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154288952|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154288953|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154288954|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154288955|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154288956|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154288957|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288958|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
154288959|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
154288960|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154288961|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154288963|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154288964|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288965|NCT01343368|Leuprolide|leuprolide|mesh-list
154288966|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154288967|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
154288968|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154289001|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154289002|NCT03626506|Diuretics|diuretics|mesh-ancestor
154289003|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
154289004|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154289005|NCT03737708|Adalimumab|adalimumab|mesh-list
154289006|NCT03737708|Methotrexate|methotrexate|mesh-list
154289033|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154289034|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289035|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289036|NCT04050722|Listerine|listerine|mesh-list
154289037|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
154289038|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
154289039|NCT04050722|Protective Agents|protective agents|mesh-ancestor
154289040|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289041|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154289042|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289043|NCT04049552|Sirolimus|sirolimus|mesh-list
154289044|NCT04049552|Temsirolimus|temsirolimus|mesh-list
154289045|NCT04049552|MTOR Inhibitors|mtor inhibitors|mesh-list
154289046|NCT04049552|Petrolatum|petrolatum|mesh-list
154289047|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289048|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289049|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154289050|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289051|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
154289052|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154289053|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
154289054|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289083|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
154289084|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289086|NCT03876028|Ibrutinib|ibrutinib|mesh-list
154289087|NCT03876028|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154289088|NCT03876028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154861547|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289089|NCT03876028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289090|NCT03876028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289091|NCT03876028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154289092|NCT03876028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289093|NCT03732482|Temozolomide|temozolomide|mesh-list
154289094|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154289095|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
154289096|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289097|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289098|NCT04047446|Dexamethasone|dexamethasone|mesh-list
154289124|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289125|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154289126|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
154289127|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289128|NCT03045328|Venetoclax|venetoclax|mesh-list
154289129|NCT03045328|Ibrutinib|ibrutinib|mesh-list
154289130|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289131|NCT03045328|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154289132|NCT03045328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289133|NCT03045328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289134|NCT03045328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289135|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154289136|NCT02154490|Nivolumab|nivolumab|mesh-list
154289137|NCT02154490|Ipilimumab|ipilimumab|mesh-list
154289138|NCT02154490|Durvalumab|durvalumab|mesh-list
154289139|NCT02154490|Rilotumumab|rilotumumab|mesh-list
154289140|NCT02154490|Docetaxel|docetaxel|mesh-list
154289141|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154289142|NCT02154490|Palbociclib|palbociclib|mesh-list
154289143|NCT02154490|Tremelimumab|tremelimumab|mesh-list
154289144|NCT02154490|Talazoparib|talazoparib|mesh-list
154289145|NCT02154490|Antibodies|antibodies|mesh-list
154289146|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
154289147|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154289148|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
154289149|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
154289150|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289151|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289152|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
154289187|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
154289188|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289189|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154289190|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154289191|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289228|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
154289229|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289230|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154289292|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
154289293|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289294|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154289295|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154289296|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
154289297|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289298|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289299|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154289300|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154289301|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
154289302|NCT05244460|Promethazine|promethazine|mesh-list
154289303|NCT05244460|Droperidol|droperidol|mesh-list
154289304|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154289305|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154289306|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289307|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289308|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
154289309|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
154289310|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
154289311|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289312|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
154289313|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
154289314|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289342|NCT03040024|Ketamine|ketamine|mesh-list
154289343|NCT03040024|Analgesics|analgesics|mesh-ancestor
154289344|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
154289345|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289346|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289347|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154289348|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154289349|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
154289350|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
154289351|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289352|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154289353|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154289354|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289355|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289356|NCT03038620|Liraglutide|liraglutide|mesh-list
154289357|NCT03038620|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154289358|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154289376|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289378|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
154289379|NCT01350934|Alendronate|alendronate|mesh-list
154289380|NCT01350934|Calcitriol|calcitriol|mesh-list
154289381|NCT01350934|Calcium|calcium|mesh-list
154289382|NCT01350934|Vitamins|vitamins|mesh-ancestor
154289383|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
154289384|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289385|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154289386|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154289387|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154289388|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289389|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289390|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154289391|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154289392|NCT01146418|Hormones|hormones|mesh-ancestor
154289393|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289394|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289395|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
154289396|NCT05654896|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154289397|NCT05654896|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154289398|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289399|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289400|NCT00745108|Tibolone|tibolone|mesh-list
154289401|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289402|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154289403|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289404|NCT00745108|Hormones|hormones|mesh-ancestor
154289405|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289406|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
154289407|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
154289408|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154289409|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154289410|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
154289411|NCT00725374|Tibolone|tibolone|mesh-list
154289412|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
154289413|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
154289414|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289437|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154289438|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154289439|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289440|NCT00446056|Ketotifen|ketotifen|mesh-list
154289441|NCT00446056|Montelukast|montelukast|mesh-list
154289442|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289443|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289444|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289445|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289446|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154289447|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154289448|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
154289449|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289450|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153511692|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
153511791|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289451|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154289452|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
154289453|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
154289454|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154289455|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
154289456|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
154289457|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154861548|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289460|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154289461|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
154289462|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289463|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154289494|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289495|NCT00090142|Montelukast|montelukast|mesh-list
154289496|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154289497|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289498|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154289499|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
154289500|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289501|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289502|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154289503|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154289504|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289538|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289539|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289540|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154289542|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
154289543|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154289544|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289570|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
154289571|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289572|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289573|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154289574|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154289575|NCT03735368|Analgesics|analgesics|mesh-ancestor
154289576|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
154289577|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289578|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154289579|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154289580|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154289581|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
154289582|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289583|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289584|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
154289585|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154289586|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289587|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154289588|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154289589|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154289590|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289591|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
154289592|NCT00071799|Cytarabine|cytarabine|mesh-list
154289593|NCT00071799|Azacitidine|azacitidine|mesh-list
154289594|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154289595|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
154289625|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289626|NCT03730064|Antidotes|antidotes|mesh-ancestor
154289627|NCT03580382|Trametinib|trametinib|mesh-list
154289628|NCT03580382|Antibodies|antibodies|mesh-list
154289629|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
154289630|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289631|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289632|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289633|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289634|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289635|NCT03611582|Semaglutide|semaglutide|mesh-list
154289636|NCT03611582|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154289637|NCT03611582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154289638|NCT03611582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289639|NCT03577730|Caffeine|caffeine|mesh-list
154289640|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
154289641|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289712|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289713|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154289714|NCT03639896|Analgesics|analgesics|mesh-ancestor
154289715|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
154289716|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289717|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154289718|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154289719|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154289751|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154289752|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
154289753|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289754|NCT03729128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154289755|NCT03729128|Narcotics|narcotics|mesh-ancestor
154289756|NCT03729128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289757|NCT03729128|Analgesics|analgesics|mesh-ancestor
154289758|NCT03729128|Sensory System Agents|sensory system agents|mesh-ancestor
154289790|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154289791|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154289792|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289793|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154289794|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289796|NCT03730766|Diuretics|diuretics|mesh-ancestor
154289797|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
154289798|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289799|NCT03730766|Expectorants|expectorants|mesh-ancestor
154289800|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289801|NCT00071487|Belimumab|belimumab|mesh-list
154289802|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154289803|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
154289804|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289805|NCT03962283|Rifaximin|rifaximin|mesh-list
154289806|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289839|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289840|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
154289841|NCT00070707|Albuterol|albuterol|mesh-list
154289842|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154289843|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
154289869|NCT01086345|Bevacizumab|bevacizumab|mesh-list
154289870|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154289871|NCT01086345|Irinotecan|irinotecan|mesh-list
154289872|NCT01086345|Camptothecin|camptothecin|mesh-list
154289873|NCT01086345|Antibodies|antibodies|mesh-list
154289874|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
154289875|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154289876|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289877|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154289878|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154289879|NCT01086345|Growth Substances|growth substances|mesh-ancestor
154289880|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289881|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
153511925|NCT01409616|Aspirin|aspirin|mesh-list
154289882|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
154289883|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154289884|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154289885|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289886|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289887|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154289888|NCT03960411|Doxycycline|doxycycline|mesh-list
154289889|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289890|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289920|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154289921|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154289923|NCT03733652|Interferons|interferons|mesh-list
154289924|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
154289925|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
154289926|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289927|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
154289928|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289929|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
154289930|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289931|NCT03586544|Albuterol|albuterol|mesh-list
154289932|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154289933|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
154289966|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
154289967|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289968|NCT03589768|Antacids|antacids|mesh-ancestor
154289969|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289970|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154861549|NCT02245529|Urological Agents|urological agents|mesh-ancestor
154861550|NCT00947765|Prednisolone|prednisolone|mesh-list
154289994|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289995|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154289996|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289997|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154289998|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154290000|NCT00089505|Lopinavir|lopinavir|mesh-list
154290001|NCT00089505|Tenofovir|tenofovir|mesh-list
154290002|NCT00089505|Emtricitabine|emtricitabine|mesh-list
154290003|NCT00089505|Nevirapine|nevirapine|mesh-list
154290004|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154290005|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154290006|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154290007|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
154290008|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290009|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290010|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154290011|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154290012|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
154290013|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290014|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154290015|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154290016|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154290017|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154290018|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154290019|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154290020|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154290021|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154290022|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154290085|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290086|NCT05462548|Luspatercept|luspatercept|mesh-list
154290087|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154290088|NCT05462548|Hematinics|hematinics|mesh-ancestor
154290089|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
154290090|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290091|NCT03408340|Fentanyl|fentanyl|mesh-list
154290092|NCT03408340|Ketamine|ketamine|mesh-list
154290093|NCT03408340|Propofol|propofol|mesh-list
154290094|NCT03408340|Sevoflurane|sevoflurane|mesh-list
154290095|NCT03408340|Rocuronium|rocuronium|mesh-list
154290096|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
154290097|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290098|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290099|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
154290100|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290101|NCT03408340|Analgesics|analgesics|mesh-ancestor
154290102|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154290103|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154290104|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
154290105|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154290106|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154290107|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290108|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290109|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154290110|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154290111|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154290112|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154290113|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154290138|NCT04004208|Growth Substances|growth substances|mesh-ancestor
154290139|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290140|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
154290141|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290142|NCT03727412|Naproxen|naproxen|mesh-list
154290143|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154290144|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154290145|NCT03727412|Analgesics|analgesics|mesh-ancestor
154290146|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
154290147|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290148|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290149|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512176|NCT01411670|Protein C|protein c|mesh-list
154290150|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154290151|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
154290152|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154290153|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290154|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290155|NCT03643952|Daptomycin|daptomycin|mesh-list
154290158|NCT03035032|Leuprolide|leuprolide|mesh-list
154290159|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154290160|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
154290161|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154290162|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290163|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154290164|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290165|NCT03629184|Oseltamivir|oseltamivir|mesh-list
154290166|NCT03629184|Baloxavir|baloxavir|mesh-list
154290191|NCT03724838|Esomeprazole|esomeprazole|mesh-list
154290192|NCT03724838|Citric Acid|citric acid|mesh-list
154290193|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
154290194|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
154290195|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154290196|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
154290197|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
154290198|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290199|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
154290200|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154290201|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154290202|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290203|NCT03724838|Urological Agents|urological agents|mesh-ancestor
154290204|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154290205|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290206|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154290207|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
154290208|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290209|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
154290210|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154290211|NCT03358030|Riboflavin|riboflavin|mesh-list
154290212|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
154290213|NCT03358030|Vitamins|vitamins|mesh-ancestor
154290214|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
154290215|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290216|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154290217|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
154290280|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290281|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154290282|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154290283|NCT05093608|Growth Substances|growth substances|mesh-ancestor
154290284|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290285|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
154290286|NCT05093608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154290287|NCT05093608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290288|NCT03991494|Pamiparib|pamiparib|mesh-list
154290289|NCT03991494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154290290|NCT03991494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290291|NCT03991494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290292|NCT03991494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290293|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154290294|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290295|NCT03383770|Anesthetics|anesthetics|mesh-list
154290296|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290297|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290298|NCT00086307|Pramipexole|pramipexole|mesh-list
154290299|NCT00086307|Escitalopram|escitalopram|mesh-list
154290335|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
154290336|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154290337|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154290338|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290339|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154290340|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
154290373|NCT04112589|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154290374|NCT04112589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154290376|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
154037219|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
154290377|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
154290378|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154290379|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290380|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
154290381|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290480|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290481|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290482|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153932892|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154290483|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154290484|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154290485|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290486|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154290487|NCT03723824|Grazoprevir|grazoprevir|mesh-list
154290488|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154290489|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
154290490|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290491|NCT00620464|Etonogestrel|etonogestrel|mesh-list
154290492|NCT00620464|Desogestrel|desogestrel|mesh-list
154290493|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154290494|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
154290495|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154290496|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290522|NCT00413764|Hormones|hormones|mesh-ancestor
154290523|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290524|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290525|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154290526|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
154290527|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154290528|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154290529|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154290531|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154290532|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
154290533|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
154290534|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154290535|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154290536|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290537|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154290538|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
154290539|NCT03726788|Triamcinolone|triamcinolone|mesh-list
154290540|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154290541|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154290542|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
154290543|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154290544|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154290545|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154290546|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154290581|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154290582|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154290583|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290584|NCT03615924|Ticagrelor|ticagrelor|mesh-list
154290613|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290615|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
154290616|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
154290617|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290618|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290619|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
154290620|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290621|NCT03981822|Cantharidin|cantharidin|mesh-list
154290622|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290623|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290624|NCT05506930|Morphine|morphine|mesh-list
154290625|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154290626|NCT05506930|Narcotics|narcotics|mesh-ancestor
154290627|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290628|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290629|NCT05506930|Analgesics|analgesics|mesh-ancestor
154290630|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
154290664|NCT03682302|Bupivacaine|bupivacaine|mesh-list
154290665|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
154290666|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
154290667|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290668|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290669|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
154290670|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290671|NCT03522506|Modafinil|modafinil|mesh-list
154290672|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154290673|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290702|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154290703|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290707|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290708|NCT00055497|Adalimumab|adalimumab|mesh-list
154290709|NCT00055497|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154290710|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290711|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154290712|NCT03726398|Macitentan|macitentan|mesh-list
154290713|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154290714|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154290715|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290716|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154290717|NCT04050592|Estradiol|estradiol|mesh-list
154290718|NCT04050592|Estrogens|estrogens|mesh-ancestor
154290719|NCT04050592|Hormones|hormones|mesh-ancestor
154290742|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154290743|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154290744|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290745|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290746|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154290747|NCT01094457|Aspirin|aspirin|mesh-list
154290748|NCT01094457|Cilostazol|cilostazol|mesh-list
154290749|NCT01094457|Clopidogrel|clopidogrel|mesh-list
154290750|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154290751|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037592|NCT02575924|Imidacloprid|imidacloprid|mesh-list
154290752|NCT01094457|Analgesics|analgesics|mesh-ancestor
154290753|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
154290754|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290755|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290756|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290757|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154290758|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154290759|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154290760|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290761|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154290762|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154290763|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290764|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
154290765|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154290766|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154290767|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154290768|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
154290769|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290798|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290799|NCT03734562|Amiodarone|amiodarone|mesh-list
154290800|NCT03734562|Sotalol|sotalol|mesh-list
154290801|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154290802|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
154290803|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154290804|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290805|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290806|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154290807|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154290808|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154290809|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290810|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154290811|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154290812|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154290813|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154290814|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154290815|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
154290847|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290849|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154290850|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154290851|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154290852|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
154582969|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290853|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290854|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
154290855|NCT03678870|Narcotics|narcotics|mesh-ancestor
154290887|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290888|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290890|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290891|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154290892|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154290893|NCT03479216|Analgesics|analgesics|mesh-ancestor
154290894|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154290895|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154290896|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154290897|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
154290898|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290899|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290900|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154290932|NCT03677934|Ranibizumab|ranibizumab|mesh-list
154290933|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154290934|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154290935|NCT03677934|Growth Substances|growth substances|mesh-ancestor
154290936|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290937|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
154290938|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290939|NCT03435692|Acetaminophen|acetaminophen|mesh-list
154290940|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
154290941|NCT03435692|Promethazine|promethazine|mesh-list
154290942|NCT03435692|Fentanyl|fentanyl|mesh-list
154290943|NCT03435692|Morphine|morphine|mesh-list
154290973|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154290974|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154290975|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
154290976|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
154290977|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154290978|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
154290979|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154290980|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154290981|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154290982|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
154290983|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
154290985|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
154290986|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290987|NCT03673956|Vancomycin|vancomycin|mesh-list
154290988|NCT03673956|Levofloxacin|levofloxacin|mesh-list
154290989|NCT03673956|Tobramycin|tobramycin|mesh-list
154290990|NCT03673956|Mupirocin|mupirocin|mesh-list
154290991|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154290992|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290993|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154291011|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291012|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291013|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291014|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154291015|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154291016|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154291017|NCT03716804|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154291018|NCT03716804|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154291019|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154291020|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154291021|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291022|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154291023|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
154291024|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291025|NCT03733860|Alprostadil|alprostadil|mesh-list
154291026|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154291027|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
154291028|NCT03733860|Urological Agents|urological agents|mesh-ancestor
154291029|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
154291030|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154291031|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291032|NCT01310244|Paclitaxel|paclitaxel|mesh-list
154291033|NCT01310244|Carboplatin|carboplatin|mesh-list
154291034|NCT01310244|Belinostat|belinostat|mesh-list
154291035|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154291036|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291037|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
154291038|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
154291039|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
154291040|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291041|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154255289|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255290|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255292|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
153933132|NCT03641326|Sunitinib|sunitinib|mesh-list
154291042|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291043|NCT03672006|Heparin|heparin|mesh-list
154291044|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154291045|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
154291046|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154291047|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154291048|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291049|NCT03621072|Fluconazole|fluconazole|mesh-list
154291050|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
154291079|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154291080|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154291081|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291082|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
154291083|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154291084|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
154291085|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291086|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291087|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154291088|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
154291089|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291090|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291091|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154291092|NCT03702946|Oxytocin|oxytocin|mesh-list
154291128|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
154291129|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
154291161|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
154291162|NCT03644550|LMB-100|lmb-100|mesh-list
154291163|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154291164|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291165|NCT03644550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618887|NCT01980667|Cisplatin|cisplatin|mesh-list
154291166|NCT03644550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291167|NCT03644550|Immunoconjugates|immunoconjugates|mesh-ancestor
154291168|NCT03644550|Immunologic Factors|immunologic factors|mesh-ancestor
154291169|NCT03644550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291170|NCT00054717|Ritonavir|ritonavir|mesh-list
154291171|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154291172|NCT00054717|Tipranavir|tipranavir|mesh-list
154291173|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
154291203|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291206|NCT00066807|Exemestane|exemestane|mesh-list
154291207|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154291208|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154291209|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291210|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154291211|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154291212|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291213|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291214|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154291215|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
154291216|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154291237|NCT03619330|Incretins|incretins|mesh-ancestor
154291239|NCT00054639|Oblimersen|oblimersen|mesh-list
154291240|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154291241|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291242|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
154291243|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291244|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291245|NCT02530359|Pirfenidone|pirfenidone|mesh-list
154291246|NCT02530359|Analgesics|analgesics|mesh-ancestor
154291247|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
154291248|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291249|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291250|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154291251|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154291252|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861552|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
154861553|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154861554|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
154861555|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154861556|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
153933198|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291253|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291254|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291255|NCT03428360|Diazepam|diazepam|mesh-list
154291256|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154291257|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
154291258|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
154291259|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
154291260|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291261|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291262|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154291263|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154291264|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291265|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154291266|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154291267|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154291268|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154291269|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154291296|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154291297|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
154291298|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154291299|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154291300|NCT03698734|Analgesics|analgesics|mesh-ancestor
154291301|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
154291302|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291303|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291304|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291305|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291306|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154291307|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
154291308|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291309|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154291310|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
154291311|NCT04070157|Lofexidine|lofexidine|mesh-list
154291312|NCT04070157|Clonidine|clonidine|mesh-list
154291313|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154291314|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154291315|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291316|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
154291317|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291318|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154291319|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154291320|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154291353|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038183|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
154291354|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154291355|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154291356|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291357|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291359|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
154291360|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291361|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154291395|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291396|NCT00032487|Metformin|metformin|mesh-list
154291397|NCT00032487|Glimepiride|glimepiride|mesh-list
154291398|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
154291399|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154291400|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291401|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154291402|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154291425|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154291426|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154038268|NCT00987493|Rituximab|rituximab|mesh-list
154291428|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291429|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
154291430|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291431|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154291432|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154291433|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
154291434|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291435|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154291436|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154291437|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154861557|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291440|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291441|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154291442|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154291443|NCT03692416|Protective Agents|protective agents|mesh-ancestor
154291444|NCT03594552|Baclofen|baclofen|mesh-list
154291445|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154291446|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291447|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154291448|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291449|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154291450|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
154291451|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
154291452|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291453|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291481|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291482|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154291483|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154291484|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
154291485|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291486|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154291487|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154291488|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
154291489|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154291490|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154291491|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154291492|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154291493|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291494|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
154291495|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291496|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291497|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154291498|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291499|NCT03421730|Budesonide|budesonide|mesh-list
154291500|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291532|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
154291534|NCT00054327|Etoposide|etoposide|mesh-list
154291535|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
154291536|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154291537|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
154291538|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291539|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291540|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154291541|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
154291542|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291570|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
154291571|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291572|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
154291573|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154291574|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
154291575|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291576|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154291577|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
154291579|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
154291580|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
154291581|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291582|NCT03692026|Protective Agents|protective agents|mesh-ancestor
154291583|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291584|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291585|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154291586|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
154291587|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
154291588|NCT03624322|Olanzapine|olanzapine|mesh-list
154291589|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
154291590|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
154291609|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154291610|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291611|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154291612|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154291613|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291614|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291615|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
154291616|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154291618|NCT03957291|Povidone|povidone|mesh-list
154291619|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154291620|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291621|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
154291622|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
154291623|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
154291624|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
154291625|NCT04044976|Caffeine|caffeine|mesh-list
154291626|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
154291627|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291628|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154291629|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291630|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154291631|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291632|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154291633|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154291634|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
154291635|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291636|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154291637|NCT03691636|Lifitegrast|lifitegrast|mesh-list
154291638|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154291639|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
154291640|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
154291641|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
154291642|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
154291643|NCT03956121|Analgesics|analgesics|mesh-ancestor
154291644|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
154291645|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291646|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291674|NCT01098201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154291675|NCT01098201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291676|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154291677|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
154291678|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291679|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291680|NCT01092039|Lactoferrin|lactoferrin|mesh-list
154291681|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291682|NCT03663582|Teduglutide|teduglutide|mesh-list
154291683|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154291684|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154291685|NCT03663582|Protective Agents|protective agents|mesh-ancestor
154291686|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291687|NCT01098357|Becaplermin|becaplermin|mesh-list
154291688|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
154291689|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154291690|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154291691|NCT01098357|Growth Substances|growth substances|mesh-ancestor
154291692|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291693|NCT03730740|Lenalidomide|lenalidomide|mesh-list
154291694|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
154291729|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291730|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291731|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
154291732|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291733|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154291734|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154291758|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154291759|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291760|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
154291761|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
154291762|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291763|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
154291764|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154291765|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154291766|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154291767|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154291768|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291769|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154291770|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154291771|NCT03028012|Analgesics|analgesics|mesh-ancestor
154291772|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291773|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154291774|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255293|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154291775|NCT03634800|Nivolumab|nivolumab|mesh-list
154291776|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154291777|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291778|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154291779|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291780|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
154291781|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154291782|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291783|NCT02955186|Saracatinib|saracatinib|mesh-list
154291784|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291785|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291813|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154291814|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291815|NCT03715556|Amiodarone|amiodarone|mesh-list
154291816|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154291817|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
154291818|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154291819|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154291820|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291821|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154291822|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154291823|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154291824|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291825|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154291826|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154291827|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154291859|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153513277|NCT01419340|Donepezil|donepezil|mesh-list
154291860|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154291862|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
154291863|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291864|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291865|NCT03715322|Tobramycin|tobramycin|mesh-list
154291866|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154291867|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291868|NCT03687268|Naloxone|naloxone|mesh-list
154291896|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154291897|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291898|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
154291899|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154291900|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154291902|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
154291903|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291904|NCT03689998|Protective Agents|protective agents|mesh-ancestor
154291905|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291906|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291907|NCT03948178|Simendan|simendan|mesh-list
154291908|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154291909|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
154291910|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154291911|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154291912|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291913|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291914|NCT03948178|Protective Agents|protective agents|mesh-ancestor
154291915|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291946|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154291947|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154291948|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154291949|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
154291950|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291951|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291952|NCT03682198|Protective Agents|protective agents|mesh-ancestor
154291953|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
154291954|NCT02953340|Docetaxel|docetaxel|mesh-list
154291955|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154291956|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
154291957|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291958|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291959|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154291960|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
154291988|NCT03624010|Protective Agents|protective agents|mesh-ancestor
154861558|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
154291989|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291991|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154291992|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291993|NCT04629976|Tenofovir|tenofovir|mesh-list
154291994|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
154291995|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291996|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154291997|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154291998|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291999|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292000|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154292001|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154292002|NCT03728946|Bupivacaine|bupivacaine|mesh-list
154292003|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
154292004|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
154292005|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292041|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154292042|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154292072|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292073|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292074|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
154292075|NCT03518112|Leucovorin|leucovorin|mesh-list
154292076|NCT03518112|Folic Acid|folic acid|mesh-list
154292077|NCT03518112|Cytarabine|cytarabine|mesh-list
154292078|NCT03518112|Dexamethasone|dexamethasone|mesh-list
154292079|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
154292080|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
154292081|NCT03518112|Rituximab|rituximab|mesh-list
154292082|NCT03518112|Methotrexate|methotrexate|mesh-list
154292083|NCT03518112|Vincristine|vincristine|mesh-list
154292084|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
154292085|NCT03518112|Blinatumomab|blinatumomab|mesh-list
154292086|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154292087|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
154292123|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
154292124|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154292125|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154292126|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
154292127|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292163|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
154292164|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292165|NCT03680638|Allopurinol|allopurinol|mesh-list
154292166|NCT03680638|Tempol|tempol|mesh-list
154292167|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
154292168|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292195|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154292196|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
154292197|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292198|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154292199|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292200|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
154292201|NCT03680404|Allopurinol|allopurinol|mesh-list
154292202|NCT03680404|Phenylephrine|phenylephrine|mesh-list
154292203|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
154292204|NCT03680404|Tempol|tempol|mesh-list
154292205|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154292206|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
154292207|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
154292208|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292209|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292210|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
154292211|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154292212|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
154292213|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
154292214|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154292215|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154292216|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154292241|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292242|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154292243|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
154292244|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292245|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154292246|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154861559|NCT00947765|Hormones|hormones|mesh-ancestor
154292249|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154292250|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
154292251|NCT02954406|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154292252|NCT02954406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154292253|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292254|NCT01310478|Endostatins|endostatins|mesh-list
154292255|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154292256|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154292257|NCT01310478|Growth Substances|growth substances|mesh-ancestor
154292258|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292259|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
154292260|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292261|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
154292262|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154292263|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
154292264|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292265|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
154292266|NCT03728244|Protective Agents|protective agents|mesh-ancestor
154292267|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154292268|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154292295|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154292296|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292297|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292298|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154292299|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
154292301|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154292302|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154292303|NCT03508830|Bupivacaine|bupivacaine|mesh-list
154292304|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
154292305|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
154292306|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292307|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292308|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
154292309|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292310|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154292311|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154292312|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
154292313|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154292314|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
154292315|NCT03724578|Fluorides|fluorides|mesh-list
154292316|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
154292317|NCT03724578|Protective Agents|protective agents|mesh-ancestor
154292318|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292319|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292344|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292346|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154292347|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
154292348|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
154292349|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
154292350|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292351|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292352|NCT03568500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154292353|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154292354|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154292355|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
154292356|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
154292357|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154292358|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154292359|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154292360|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154292361|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154292362|NCT03685084|Piperacillin|piperacillin|mesh-list
154292363|NCT03685084|Cefepime|cefepime|mesh-list
154292364|NCT03685084|Lactams|lactams|mesh-list
154292365|NCT03685084|beta-Lactams|beta-lactams|mesh-list
154292366|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
154292367|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154292368|NCT03685084|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
154292399|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292400|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292401|NCT03684772|Digoxin|digoxin|mesh-list
154292402|NCT03684772|Furosemide|furosemide|mesh-list
154292403|NCT03684772|Diuretics|diuretics|mesh-ancestor
154292404|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
154292405|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292406|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154292407|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154292408|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292409|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154292410|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154292411|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292412|NCT03684772|Protective Agents|protective agents|mesh-ancestor
154292442|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154292443|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
154292444|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154292445|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292446|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154292447|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292448|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
154292449|NCT03678610|Ionomycin|ionomycin|mesh-list
154292450|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
154292451|NCT03678610|Ionophores|ionophores|mesh-ancestor
154292452|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154292453|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292454|NCT03675646|Morphine|morphine|mesh-list
154292455|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154292456|NCT03675646|Narcotics|narcotics|mesh-ancestor
154292490|NCT03623776|Carboplatin|carboplatin|mesh-list
154292491|NCT03623776|Pemetrexed|pemetrexed|mesh-list
154292492|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292493|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292494|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292495|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154292496|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154292497|NCT03683914|Dinoprostone|dinoprostone|mesh-list
154292498|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
154292499|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154292500|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292536|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292537|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154292538|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
154292539|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154292540|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154292541|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292577|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154292578|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
154292579|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292580|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292581|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154292582|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
154292583|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
154292584|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154292620|NCT03023722|Immunologic Factors|immunologic factors|mesh-ancestor
154292621|NCT03023722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292622|NCT03623230|Bupivacaine|bupivacaine|mesh-list
154292623|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154292624|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
154292655|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154292656|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292657|NCT03668860|Dexamethasone|dexamethasone|mesh-list
154292658|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
154292659|NCT03668860|Betamethasone|betamethasone|mesh-list
154292660|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
154292661|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154292662|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
154292663|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
154292664|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154292665|NCT03668860|BB 1101|bb 1101|mesh-list
154292666|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292667|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
154292668|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
154292669|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292670|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292671|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292672|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
154292697|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292700|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292701|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154292702|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
154292703|NCT00945724|Cytarabine|cytarabine|mesh-list
154292704|NCT00945724|Prednisolone|prednisolone|mesh-list
154292705|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
154292706|NCT00945724|Rituximab|rituximab|mesh-list
154292707|NCT00945724|Doxorubicin|doxorubicin|mesh-list
154292708|NCT00945724|Methotrexate|methotrexate|mesh-list
154292709|NCT00945724|Vincristine|vincristine|mesh-list
154292710|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292711|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
154292712|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292713|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292714|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154292715|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
154292716|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292717|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292718|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154292719|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154292720|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154292721|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154292755|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292756|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154292757|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154292759|NCT01099059|Amantadine|amantadine|mesh-list
154292760|NCT01099059|Methylphenidate|methylphenidate|mesh-list
154292793|NCT00031551|Analgesics|analgesics|mesh-ancestor
154292794|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
154292795|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292796|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292797|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292798|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292799|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292833|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292834|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154292835|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
154292836|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292837|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292838|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154292839|NCT00049257|Paclitaxel|paclitaxel|mesh-list
154292864|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292865|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
154292866|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
154292867|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292868|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
154292869|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292870|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292871|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
153514221|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
154292872|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154292873|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154292874|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154292875|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154292876|NCT03018340|Pimavanserin|pimavanserin|mesh-list
154292877|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154292878|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154292879|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154292880|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154292881|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292882|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292883|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154292884|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154292885|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154292886|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
154292887|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292888|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292917|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154292918|NCT00048165|Protective Agents|protective agents|mesh-ancestor
154292919|NCT01099527|Capecitabine|capecitabine|mesh-list
154292920|NCT01099527|Everolimus|everolimus|mesh-list
154292921|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154292922|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
154292923|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292924|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292925|NCT01099527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154292926|NCT01099527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154292927|NCT01099527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292928|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292929|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
154292930|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292931|NCT01093365|Varenicline|varenicline|mesh-list
154292932|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154292933|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154292934|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
154292935|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292936|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292966|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292967|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154292968|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292969|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292970|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154292971|NCT00058539|Pertuzumab|pertuzumab|mesh-list
154292972|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154292973|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292974|NCT03956823|Amlodipine|amlodipine|mesh-list
154292975|NCT03956823|Telmisartan|telmisartan|mesh-list
154292976|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154292977|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154292978|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154292979|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292980|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154292981|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293003|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293004|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293005|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
154293006|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293007|NCT01095939|Benazepril|benazepril|mesh-list
154293008|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154293009|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
154293010|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293011|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293012|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154293013|NCT03015220|Semaglutide|semaglutide|mesh-list
154293014|NCT03015220|Dulaglutide|dulaglutide|mesh-list
154293015|NCT03015220|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154293016|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154293017|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293018|NCT00022659|Bevacizumab|bevacizumab|mesh-list
154293019|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154293020|NCT00022659|Antibodies|antibodies|mesh-list
154293021|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
154293022|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154293023|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293024|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154293025|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154293026|NCT00022659|Growth Substances|growth substances|mesh-ancestor
154293027|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293028|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
154293029|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
154293030|NCT03018106|Estrogens|estrogens|mesh-list
154293031|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154293032|NCT03018106|Hormones|hormones|mesh-ancestor
154293033|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293034|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293035|NCT03018028|Liraglutide|liraglutide|mesh-list
154293069|NCT00021255|Trastuzumab|trastuzumab|mesh-list
154293070|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154293071|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
154293072|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293073|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293074|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154293075|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
154293112|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293113|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293145|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
154293146|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293147|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154293148|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154039950|NCT05023018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293149|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
154293150|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293151|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293152|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154293153|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154293154|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
154293155|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154293156|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
154293157|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
154293158|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
154293159|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154293184|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
154293185|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154293186|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293187|NCT03540030|Acetaminophen|acetaminophen|mesh-list
154293188|NCT03540030|Celecoxib|celecoxib|mesh-list
154293189|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154293190|NCT03540030|Lidocaine|lidocaine|mesh-list
154293191|NCT03540030|Gabapentin|gabapentin|mesh-list
154293192|NCT03540030|Propofol|propofol|mesh-list
154293193|NCT03540030|Sevoflurane|sevoflurane|mesh-list
154293194|NCT03540030|Desflurane|desflurane|mesh-list
154293195|NCT03540030|Rocuronium|rocuronium|mesh-list
154293196|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
154293197|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293198|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
154293199|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293200|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293201|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
154293202|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293203|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154293204|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154293205|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154293206|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154293207|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293208|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154293209|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154293210|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
154293239|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
154293240|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293241|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293242|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154293243|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
154293244|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293245|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293246|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154293247|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293248|NCT03003676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154293249|NCT03665740|Resveratrol|resveratrol|mesh-list
154293250|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
154293251|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293252|NCT03665740|Protective Agents|protective agents|mesh-ancestor
154293253|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293254|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293255|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154293256|NCT03665350|Insulin|insulin|mesh-list
154293288|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293290|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154293291|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
154293292|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154293293|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293294|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293295|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154293296|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154293297|NCT03664414|Protective Agents|protective agents|mesh-ancestor
154293329|NCT03487666|Capecitabine|capecitabine|mesh-list
154293330|NCT03487666|Nivolumab|nivolumab|mesh-list
154293332|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
154293333|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293334|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293335|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293336|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154293337|NCT00027027|Pertuzumab|pertuzumab|mesh-list
154293367|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154293368|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
154293369|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293370|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293371|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154293372|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293373|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
154293374|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293375|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293376|NCT01101009|Amlodipine|amlodipine|mesh-list
154293377|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154293378|NCT01101009|Olmesartan|olmesartan|mesh-list
154293379|NCT01101009|Perindopril|perindopril|mesh-list
154293380|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154293381|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154293405|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293407|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293408|NCT03720756|Nickel|nickel|mesh-list
154293409|NCT03720756|Trace Elements|trace elements|mesh-ancestor
154293410|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
154293411|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293412|NCT00025233|Bevacizumab|bevacizumab|mesh-list
154293413|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154293414|NCT00025233|Antibodies|antibodies|mesh-list
154293415|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
154293416|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154293417|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293418|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154293419|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154293420|NCT00025233|Growth Substances|growth substances|mesh-ancestor
154293421|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293422|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
154293423|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
154293424|NCT00025155|Epothilones|epothilones|mesh-list
154293425|NCT00025155|Epothilone B|epothilone b|mesh-list
154293426|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
154293427|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
154293428|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
154293429|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293430|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293455|NCT01063270|Clindamycin|clindamycin|mesh-list
154293456|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
154293457|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
154293458|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154293459|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
154293460|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154293461|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154293462|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
154293463|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154293464|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293465|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293466|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154293467|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154293468|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154293469|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154293470|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154293471|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154293472|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154293473|NCT00023673|Paclitaxel|paclitaxel|mesh-list
154293474|NCT00023673|Carboplatin|carboplatin|mesh-list
154293475|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154293476|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293477|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154293478|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154293479|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154293513|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293514|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293515|NCT00006237|Analgesics|analgesics|mesh-ancestor
154293516|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
154293517|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293518|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154293519|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154293520|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154293521|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
154293522|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293543|NCT02993926|Leuprolide|leuprolide|mesh-list
154293544|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154293545|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
154293546|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154293547|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293548|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154293549|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293550|NCT04055506|Ritonavir|ritonavir|mesh-list
154293551|NCT04055506|Deucravacitinib|deucravacitinib|mesh-list
154293552|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154293553|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154293554|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
154293555|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293556|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293557|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154293558|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154293559|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
154293560|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154293561|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154293562|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154293563|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
154293564|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154293565|NCT02993224|Deferasirox|deferasirox|mesh-list
154293566|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154293567|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
154293568|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
154293569|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293570|NCT02992132|Pimavanserin|pimavanserin|mesh-list
154293571|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154293572|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154293573|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154293574|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154293610|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293646|NCT05975346|Ketamine|ketamine|mesh-list
154293647|NCT05975346|Analgesics|analgesics|mesh-ancestor
154293648|NCT05975346|Sensory System Agents|sensory system agents|mesh-ancestor
154293679|NCT05975294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154293680|NCT05975294|Glucocorticoids|glucocorticoids|mesh-ancestor
154293681|NCT05975294|Hormones|hormones|mesh-ancestor
154293682|NCT05975294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293683|NCT05975294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154293684|NCT05975294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293685|NCT05975294|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293686|NCT05975294|Anesthetics|anesthetics|mesh-ancestor
154293687|NCT05975294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293688|NCT05975294|Sensory System Agents|sensory system agents|mesh-ancestor
154293689|NCT05975294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154293690|NCT05975294|Narcotics|narcotics|mesh-ancestor
154293691|NCT05975294|Analgesics|analgesics|mesh-ancestor
154293692|NCT05975294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154293693|NCT05975294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154293721|NCT05974527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293722|NCT05974527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154293724|NCT05974527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154293725|NCT05974527|Adrenergic Agents|adrenergic agents|mesh-ancestor
154293726|NCT05974527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293727|NCT05974527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293728|NCT05974501|Acetaminophen|acetaminophen|mesh-list
154293729|NCT05974501|Dexamethasone|dexamethasone|mesh-list
154293730|NCT05974501|Celecoxib|celecoxib|mesh-list
154293731|NCT05974501|Meloxicam|meloxicam|mesh-list
154293732|NCT05974501|Oxycodone|oxycodone|mesh-list
154293733|NCT05974501|Ropivacaine|ropivacaine|mesh-list
154293734|NCT05974501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154293736|NCT05974501|Autonomic Agents|autonomic agents|mesh-ancestor
154293737|NCT05974501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293738|NCT05974501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293770|NCT05974423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293771|NCT05974423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293772|NCT05974423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154293773|NCT05974423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293774|NCT05974423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154293775|NCT05974423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293776|NCT05974423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293777|NCT05974423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154293778|NCT05974423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293780|NCT05974410|Hydrocortisone|hydrocortisone|mesh-list
154293883|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
154293884|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293885|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293886|NCT05595044|Vitamin D|vitamin d|mesh-list
154293887|NCT05595044|Vitamins|vitamins|mesh-ancestor
154293888|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
154293889|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293890|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154293891|NCT05372133|Morphine|morphine|mesh-list
154293892|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154293893|NCT05372133|Narcotics|narcotics|mesh-ancestor
154293894|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293895|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293896|NCT05372133|Analgesics|analgesics|mesh-ancestor
154293897|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
154293898|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293899|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
154293900|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154293901|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
154293922|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293923|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293924|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293925|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154293926|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154293927|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
154293928|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154293929|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154293930|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293931|NCT04884412|Anesthetics|anesthetics|mesh-list
154293932|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293933|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293934|NCT04863950|Lomustine|lomustine|mesh-list
154293935|NCT04863950|Imipramine|imipramine|mesh-list
154293936|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154293937|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
154293938|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293939|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293940|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154293941|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
154293942|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154293943|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154293944|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154293945|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154293946|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
154293947|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293948|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293949|NCT04826393|Cemiplimab|cemiplimab|mesh-list
154293950|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293951|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293952|NCT04824391|Vaccines|vaccines|mesh-list
154293953|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
154293954|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293955|NCT04822597|Lidocaine|lidocaine|mesh-list
154293956|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293957|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
154293958|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293959|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293990|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293992|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154293993|NCT04639245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293994|NCT04599465|Ivacaftor|ivacaftor|mesh-list
154293995|NCT04599465|Elexacaftor|elexacaftor|mesh-list
154293996|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154293997|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154293998|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293999|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
154294000|NCT04589130|Naltrexone|naltrexone|mesh-list
154294001|NCT04589130|Bupropion|bupropion|mesh-list
154294002|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154294003|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154294004|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294005|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
154294024|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154294025|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294026|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
154294027|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294028|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154294029|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
154294030|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154294031|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154294032|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154294033|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154294034|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294035|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
154294036|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154294037|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154294038|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154294039|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294040|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154294041|NCT04562441|Avelumab|avelumab|mesh-list
154294042|NCT04562441|Axitinib|axitinib|mesh-list
154294043|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515174|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
154294044|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294045|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154294046|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294047|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294048|NCT04433780|Tenofovir|tenofovir|mesh-list
154294049|NCT04433780|Lamivudine|lamivudine|mesh-list
154294050|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
154294051|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294052|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154294053|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294054|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294055|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294056|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154294057|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154294079|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294080|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
154294081|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294082|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294083|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154294084|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154294085|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294086|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154294087|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
154294088|NCT04362293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154294089|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294090|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294091|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
154294092|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294093|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
154294094|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154294095|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154294096|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154294097|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
154294100|NCT04332367|Ramucirumab|ramucirumab|mesh-list
154294101|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294102|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294103|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294104|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294105|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294106|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294107|NCT04332367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154294108|NCT04332367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154294109|NCT04332367|Growth Substances|growth substances|mesh-ancestor
154294110|NCT04332367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294111|NCT04332367|Growth Inhibitors|growth inhibitors|mesh-ancestor
154294112|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
154294113|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154294114|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294144|NCT03497676|Rilpivirine|rilpivirine|mesh-list
154294145|NCT03497676|Cabotegravir|cabotegravir|mesh-list
154294146|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
154294147|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294148|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154294149|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294150|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515347|NCT01428817|Carbetocin|carbetocin|mesh-list
154294151|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294152|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154294153|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154294154|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154294155|NCT03366142|Ustekinumab|ustekinumab|mesh-list
154294156|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
154294157|NCT03300947|Lorazepam|lorazepam|mesh-list
154294158|NCT03300947|Psilocybin|psilocybin|mesh-list
154294159|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
154294193|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154294195|NCT03003325|Analgesics|analgesics|mesh-ancestor
154294196|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
154294197|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294198|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294199|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294232|NCT02748564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294233|NCT02748564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294234|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154294236|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
154294237|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294238|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294268|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294269|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294270|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294271|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
154294272|NCT01936532|Hormones|hormones|mesh-ancestor
154294273|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154294274|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154294275|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294276|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
154294277|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154294278|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154294279|NCT01936532|Growth Substances|growth substances|mesh-ancestor
154294280|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
154294281|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
154294282|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294283|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294284|NCT01054625|Zalutumumab|zalutumumab|mesh-list
154294285|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294286|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294287|NCT00707655|Zalutumumab|zalutumumab|mesh-list
154294321|NCT00488605|Vitamins|vitamins|mesh-ancestor
154294322|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
154294323|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294324|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294325|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294326|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294327|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
154294330|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154294331|NCT00006734|Etoposide|etoposide|mesh-list
154294357|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294358|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294359|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294360|NCT02991040|Lidocaine|lidocaine|mesh-list
154294361|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
154294362|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
154294363|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294364|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294365|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
154294366|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294367|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154294368|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154294369|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154294370|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154294371|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294372|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
154294373|NCT03660436|Deucravacitinib|deucravacitinib|mesh-list
154294374|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154294375|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294376|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154294377|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
154294410|NCT03415178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154294411|NCT03415178|Protease Inhibitors|protease inhibitors|mesh-ancestor
154294413|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294414|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294415|NCT01068652|Insulin|insulin|mesh-list
154294416|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154294417|NCT01068652|Metformin|metformin|mesh-list
154294418|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
154294448|NCT06324357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294450|NCT06324357|Immunoconjugates|immunoconjugates|mesh-ancestor
154294451|NCT06324357|Immunologic Factors|immunologic factors|mesh-ancestor
154294452|NCT06324357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294453|NCT06324279|Misoprostol|misoprostol|mesh-list
154294454|NCT06324279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154294455|NCT06324279|Abortifacient Agents|abortifacient agents|mesh-ancestor
154294456|NCT06324279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154294457|NCT06324279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294458|NCT06324279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154294459|NCT06324279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294489|NCT06324240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294490|NCT06324240|Immunologic Factors|immunologic factors|mesh-ancestor
154294491|NCT06324240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294492|NCT06323837|Mirtazapine|mirtazapine|mesh-list
153515630|NCT01430689|Vaccines|vaccines|mesh-list
154294493|NCT06323837|Antidepressive Agents|antidepressive agents|mesh-ancestor
154294494|NCT06323837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154294495|NCT06323837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154294496|NCT06323837|Histamine Antagonists|histamine antagonists|mesh-ancestor
154294497|NCT06323837|Histamine Agents|histamine agents|mesh-ancestor
154294498|NCT06323837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154294499|NCT06323837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294500|NCT06323837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294501|NCT06323837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154294502|NCT06323837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154294503|NCT06323837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294504|NCT06323837|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154294536|NCT06323525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294537|NCT06323525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154294538|NCT06323525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154294539|NCT06323525|Antimetabolites|antimetabolites|mesh-ancestor
154294541|NCT06323460|Cisplatin|cisplatin|mesh-list
154294542|NCT06323460|Carboplatin|carboplatin|mesh-list
154294543|NCT06323460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154294544|NCT06323460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294545|NCT06323460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294546|NCT06323460|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294547|NCT06323460|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294548|NCT06323460|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294574|NCT06323369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154041380|NCT04069858|Entecavir|entecavir|mesh-list
154294575|NCT06323239|Gemcitabine|gemcitabine|mesh-list
154294576|NCT06323239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294577|NCT06323239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154294578|NCT06323239|Antimetabolites|antimetabolites|mesh-ancestor
154294579|NCT06323239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294580|NCT06323174|Semaglutide|semaglutide|mesh-list
154294581|NCT06323174|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154294582|NCT06323174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294583|NCT06323174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294588|NCT06323148|Osimertinib|osimertinib|mesh-list
154294589|NCT06323148|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154294590|NCT06323148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154294591|NCT06323148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294592|NCT06323148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294593|NCT06323148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294594|NCT06322745|Hemostatics|hemostatics|mesh-list
154294595|NCT06322745|Coagulants|coagulants|mesh-ancestor
154294596|NCT06322719|Pyrithione zinc|pyrithione zinc|mesh-list
154294629|NCT06322407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294630|NCT06322407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154294631|NCT06322407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294632|NCT06322407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294633|NCT06322407|Anticonvulsants|anticonvulsants|mesh-ancestor
154294634|NCT06322407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294635|NCT06319378|Psilocybin|psilocybin|mesh-list
154294636|NCT06319378|Hallucinogens|hallucinogens|mesh-ancestor
154294637|NCT06319378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294638|NCT06319378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154294639|NCT06319131|Nadroparin|nadroparin|mesh-list
154294640|NCT06319131|Anticoagulants|anticoagulants|mesh-ancestor
154294641|NCT06319131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154294667|NCT06307548|Dermatologic Agents|dermatologic agents|mesh-ancestor
154294668|NCT06307548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294669|NCT06307548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294670|NCT06304857|Dapagliflozin|dapagliflozin|mesh-list
154294671|NCT06304857|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154294672|NCT06304857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294673|NCT06304857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294674|NCT06304857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294675|NCT06301178|Cholecalciferol|cholecalciferol|mesh-list
154294676|NCT06301178|Vitamin D|vitamin d|mesh-list
154294677|NCT06301178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154294678|NCT06301178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294679|NCT06301178|Vitamins|vitamins|mesh-ancestor
154294680|NCT06301178|Micronutrients|micronutrients|mesh-ancestor
154294681|NCT06301178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154294682|NCT06299813|Betamethasone|betamethasone|mesh-list
154294683|NCT06299813|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154294684|NCT06299813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294685|NCT06299813|Glucocorticoids|glucocorticoids|mesh-ancestor
154294686|NCT06299813|Hormones|hormones|mesh-ancestor
154294717|NCT06297096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294718|NCT06297096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154294719|NCT06284902|Fexofenadine|fexofenadine|mesh-list
154294720|NCT06284902|Terfenadine|terfenadine|mesh-list
154294721|NCT06284902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154294722|NCT06284902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154294723|NCT06284902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154294724|NCT06284902|Histamine Antagonists|histamine antagonists|mesh-ancestor
154294725|NCT06284902|Histamine Agents|histamine agents|mesh-ancestor
154294726|NCT06284902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154294727|NCT06284902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294755|NCT06247917|Busulfan|busulfan|mesh-list
154294756|NCT06247917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294757|NCT06247917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294758|NCT06247917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294759|NCT06247917|Immunologic Factors|immunologic factors|mesh-ancestor
154294760|NCT06247917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294761|NCT06247917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294762|NCT06247917|Alkylating Agents|alkylating agents|mesh-ancestor
154294763|NCT06247917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154294764|NCT06239272|Doxorubicin|doxorubicin|mesh-list
154294765|NCT06239272|Ifosfamide|ifosfamide|mesh-list
154294766|NCT06239272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153934468|NCT01194440|Letrozole|letrozole|mesh-list
154294767|NCT06239272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294768|NCT06239272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154294769|NCT06239272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154294770|NCT06239272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294771|NCT06239272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294772|NCT06239272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294808|NCT06230224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294809|NCT06230224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154294810|NCT06230224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154294811|NCT06230224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294812|NCT06230224|Antiviral Agents|antiviral agents|mesh-ancestor
154294813|NCT06230224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294841|NCT06212752|Pembrolizumab|pembrolizumab|mesh-list
154294842|NCT06212752|Pemetrexed|pemetrexed|mesh-list
154294843|NCT06212752|Lenograstim|lenograstim|mesh-list
154294844|NCT06212752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294845|NCT06212752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294846|NCT06212752|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294847|NCT06212752|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294848|NCT06212752|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294849|NCT06212752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294850|NCT06212752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294851|NCT06212752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294852|NCT06212752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154294853|NCT06212752|Immunologic Factors|immunologic factors|mesh-ancestor
154294854|NCT06212752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294855|NCT06212752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294856|NCT06212752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153515895|NCT01432223|Paclitaxel|paclitaxel|mesh-list
154294857|NCT06212752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294904|NCT06196788|Gemcitabine|gemcitabine|mesh-list
154294905|NCT06196788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294906|NCT06196788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294907|NCT06196788|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294908|NCT06196788|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294938|NCT06145308|Hormone Antagonists|hormone antagonists|mesh-ancestor
154294939|NCT06145308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154294940|NCT06145308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294941|NCT06145308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294942|NCT06143306|Bupivacaine|bupivacaine|mesh-list
154294943|NCT06143306|Anesthetics, Local|anesthetics, local|mesh-ancestor
154294944|NCT06143306|Anesthetics|anesthetics|mesh-ancestor
154294945|NCT06143306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294946|NCT06143306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041748|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
154294947|NCT06143306|Sensory System Agents|sensory system agents|mesh-ancestor
154294948|NCT06143306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294949|NCT06132958|Paclitaxel|paclitaxel|mesh-list
154294950|NCT06132958|Doxorubicin|doxorubicin|mesh-list
154294951|NCT06132958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294984|NCT06074588|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294985|NCT06074588|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294986|NCT06074588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294987|NCT06074588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294988|NCT06074588|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154294989|NCT06074588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294990|NCT06068855|Botulinum Toxins|botulinum toxins|mesh-list
154294991|NCT06068855|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154294992|NCT06068855|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154295028|NCT06052267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295029|NCT06052267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295030|NCT06049212|Carboplatin|carboplatin|mesh-list
154295055|NCT06034561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295056|NCT06034561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154295057|NCT06034561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154295058|NCT06034561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154295059|NCT06034561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154295060|NCT06034561|Abortifacient Agents|abortifacient agents|mesh-ancestor
154295061|NCT06034561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154861560|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861561|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295063|NCT06034561|Antimetabolites|antimetabolites|mesh-ancestor
154295064|NCT06034561|Dermatologic Agents|dermatologic agents|mesh-ancestor
154295065|NCT06034561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154295066|NCT06034561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295067|NCT06034561|Immunologic Factors|immunologic factors|mesh-ancestor
154295068|NCT06034561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295069|NCT06034561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154295070|NCT06034561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154295071|NCT06034561|Tubulin Modulators|tubulin modulators|mesh-ancestor
154295072|NCT06034561|Antimitotic Agents|antimitotic agents|mesh-ancestor
154295073|NCT06034561|Mitosis Modulators|mitosis modulators|mesh-ancestor
154295074|NCT06016985|Caffeine|caffeine|mesh-list
154295075|NCT06016985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154295076|NCT06016985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295077|NCT06016985|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154295078|NCT06016985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295079|NCT06016985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295080|NCT06016985|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154295081|NCT06016985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154295116|NCT05990465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295118|NCT05984277|Carboplatin|carboplatin|mesh-list
154295119|NCT05984277|Pembrolizumab|pembrolizumab|mesh-list
154295120|NCT05984277|Pemetrexed|pemetrexed|mesh-list
154295121|NCT05984277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154295122|NCT05984277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295158|NCT05969223|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154295159|NCT05969223|Immunologic Factors|immunologic factors|mesh-ancestor
154295186|NCT05959356|Vitamins|vitamins|mesh-ancestor
154295187|NCT05959356|Micronutrients|micronutrients|mesh-ancestor
154295188|NCT05959356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295189|NCT05956509|Botulinum Toxins|botulinum toxins|mesh-list
154295190|NCT05956509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154295191|NCT05956509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154295192|NCT05956509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154295193|NCT05956509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154295194|NCT05956509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295195|NCT05956509|Cholinergic Agents|cholinergic agents|mesh-ancestor
154295196|NCT05956509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295197|NCT05956509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295198|NCT05956509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154295199|NCT05956509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295200|NCT05949632|Axitinib|axitinib|mesh-list
154295201|NCT05949632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295202|NCT05949632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295203|NCT05949632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295204|NCT05949632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295205|NCT05935748|Palbociclib|palbociclib|mesh-list
154295206|NCT05935748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295207|NCT05935748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295208|NCT05935748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295225|NCT05836571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295226|NCT05836571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295227|NCT05836571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295228|NCT05806931|Bevacizumab|bevacizumab|mesh-list
154295229|NCT05806931|Oxaliplatin|oxaliplatin|mesh-list
154295231|NCT05806931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295232|NCT05806931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295233|NCT05806931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154295234|NCT05806931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154295235|NCT05806931|Growth Substances|growth substances|mesh-ancestor
154295236|NCT05806931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295237|NCT05806931|Growth Inhibitors|growth inhibitors|mesh-ancestor
154295238|NCT05806931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154295239|NCT05806931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154295240|NCT05806931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295241|NCT05806931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295242|NCT05786547|Varenicline|varenicline|mesh-list
154295243|NCT05786547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154295244|NCT05786547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154295245|NCT05786547|Cholinergic Agents|cholinergic agents|mesh-ancestor
154295247|NCT05786547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295249|NCT05775900|Capecitabine|capecitabine|mesh-list
154295250|NCT05775900|Cetuximab|cetuximab|mesh-list
154295251|NCT05775900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295252|NCT05775900|Antimetabolites|antimetabolites|mesh-ancestor
154295253|NCT05775900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295254|NCT05775900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295255|NCT05775900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295256|NCT05773274|Everolimus|everolimus|mesh-list
154295257|NCT05773274|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154295258|NCT05773274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154295259|NCT05773274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295260|NCT05773274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295261|NCT05773274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295262|NCT05773274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295263|NCT05773274|Immunologic Factors|immunologic factors|mesh-ancestor
154295264|NCT05773274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295296|NCT05732532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295297|NCT05732532|Anesthetics, Local|anesthetics, local|mesh-ancestor
154295298|NCT05732532|Anesthetics|anesthetics|mesh-ancestor
154295299|NCT05732532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295300|NCT05732532|Sensory System Agents|sensory system agents|mesh-ancestor
154295301|NCT05732532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154295302|NCT05732532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154295303|NCT05732532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154295304|NCT05732532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154295305|NCT05732532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295306|NCT05711940|Psilocybin|psilocybin|mesh-list
154295307|NCT05711940|Hallucinogens|hallucinogens|mesh-ancestor
154295339|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295340|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154295341|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154295342|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
154295343|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
154295344|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295345|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154295346|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154295347|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295348|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295349|NCT05696548|Nivolumab|nivolumab|mesh-list
154295350|NCT05696548|Lenvatinib|lenvatinib|mesh-list
154295351|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295352|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295353|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295354|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295355|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295356|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295357|NCT05688670|Ropivacaine|ropivacaine|mesh-list
154295358|NCT05688670|Anesthetics|anesthetics|mesh-ancestor
154295359|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295391|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154295392|NCT05662228|Antibodies|antibodies|mesh-list
154295393|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
154295394|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154295395|NCT05662228|Tofacitinib|tofacitinib|mesh-list
154295396|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
154295397|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295398|NCT05662228|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154295399|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295400|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295401|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295402|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
154295429|NCT05632133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154295430|NCT05632133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295431|NCT05632133|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154295432|NCT05632133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295433|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295435|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154295436|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154295437|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154295439|NCT05628363|Hormones|hormones|mesh-ancestor
154295440|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295441|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295442|NCT05624268|Psilocybin|psilocybin|mesh-list
154295443|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
154295444|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295445|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154295446|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154295447|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295448|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
154295449|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154295450|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295451|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295477|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295478|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295479|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154295480|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
154295481|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
154295482|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154295483|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154295484|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154295485|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
154295486|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295487|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295489|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154295490|NCT05554380|Ipatasertib|ipatasertib|mesh-list
154295491|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154295492|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295493|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
154295494|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
154295495|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
154295496|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295497|NCT05554380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295498|NCT05554380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295499|NCT05554354|Fulvestrant|fulvestrant|mesh-list
154295500|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154295517|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
154295518|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154295519|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295520|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154295521|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295523|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154295524|NCT05447286|Narcotics|narcotics|mesh-ancestor
154295525|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295526|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295527|NCT05447286|Analgesics|analgesics|mesh-ancestor
154295528|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
154295529|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295530|NCT05406401|Prednisone|prednisone|mesh-list
154295531|NCT05406401|Prednisolone|prednisolone|mesh-list
154295532|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
154295533|NCT05406401|Rituximab|rituximab|mesh-list
154295534|NCT05406401|Doxorubicin|doxorubicin|mesh-list
154295535|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295536|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
154295537|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295538|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295539|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154295540|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
154295541|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295542|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295543|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154295544|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295545|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154295546|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154295547|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154295548|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295549|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154295550|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
154295552|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516604|NCT01437046|Doxazosin|doxazosin|mesh-list
154295553|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154295556|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295557|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295589|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
154295590|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
154295591|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295592|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295593|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
154295594|NCT05344469|Interferons|interferons|mesh-list
154295595|NCT05344469|Interferon-beta|interferon-beta|mesh-list
154295596|NCT05344469|Ofatumumab|ofatumumab|mesh-list
154295597|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
154295598|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
154295599|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295600|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
154295601|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295602|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154295603|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
154295674|NCT05239741|Leucovorin|leucovorin|mesh-list
154295675|NCT05239741|Bevacizumab|bevacizumab|mesh-list
154295676|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
154295677|NCT05239741|Cetuximab|cetuximab|mesh-list
154295704|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295705|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295706|NCT05217446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295707|NCT05217446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295708|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
154295709|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154295710|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154295711|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154295712|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154295713|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295714|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
154295715|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295716|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295717|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154295718|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295719|NCT05211323|Bevacizumab|bevacizumab|mesh-list
154295720|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154295721|NCT05211323|Atezolizumab|atezolizumab|mesh-list
154295722|NCT05211323|Cisplatin|cisplatin|mesh-list
154295723|NCT05211323|Gemcitabine|gemcitabine|mesh-list
154295724|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
154295725|NCT05211323|Antibodies|antibodies|mesh-list
154295726|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
154295758|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295759|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
154295760|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154295761|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154295762|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295763|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154295764|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154295765|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154295766|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295767|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295798|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
154295799|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295800|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295801|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295802|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
154295803|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295804|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154295805|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
154295806|NCT05136196|Nivolumab|nivolumab|mesh-list
154295807|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295808|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295809|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295826|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295827|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295829|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
154295830|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
154295831|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295833|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
154295834|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295835|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154295836|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154295837|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154295838|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154295839|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295840|NCT05083975|Epinephrine|epinephrine|mesh-list
154295841|NCT05083975|Anesthetics|anesthetics|mesh-list
154295842|NCT05083975|Carticaine|carticaine|mesh-list
154042651|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
154295843|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
154295844|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295845|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295846|NCT05083975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154295847|NCT05083975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154295848|NCT05083975|Adrenergic Agents|adrenergic agents|mesh-ancestor
154295849|NCT05083975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295850|NCT05083975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295851|NCT05083975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154295852|NCT05083975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154295853|NCT05083975|Autonomic Agents|autonomic agents|mesh-ancestor
154295854|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295855|NCT05083975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154295856|NCT05083975|Respiratory System Agents|respiratory system agents|mesh-ancestor
154295857|NCT05083975|Mydriatics|mydriatics|mesh-ancestor
154295858|NCT05083975|Sympathomimetics|sympathomimetics|mesh-ancestor
154295859|NCT05083975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154295860|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
154295861|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
154295862|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154295863|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
154295864|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295865|NCT05081479|Expectorants|expectorants|mesh-ancestor
154295866|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
154295895|NCT05067283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154295896|NCT05067283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154295897|NCT05047172|Aspirin|aspirin|mesh-list
154295898|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
154295899|NCT05047172|Clopidogrel|clopidogrel|mesh-list
154295900|NCT05047172|Ticagrelor|ticagrelor|mesh-list
154295901|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154295902|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154295903|NCT05047172|Analgesics|analgesics|mesh-ancestor
154295904|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
154295905|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295906|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295907|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154295908|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295909|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153517058|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295910|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154295911|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295912|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154295913|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154295914|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295915|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
154295951|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295953|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154295954|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
154295955|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295988|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295989|NCT04858334|Olaparib|olaparib|mesh-list
154295990|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154295991|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295992|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295993|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295994|NCT04832100|Pregabalin|pregabalin|mesh-list
154295995|NCT04832100|Imipramine|imipramine|mesh-list
154295996|NCT04832100|Analgesics|analgesics|mesh-ancestor
154295997|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
154296024|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296025|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255302|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255303|NCT01149278|Benzocaine|benzocaine|mesh-list
153934924|NCT02771704|Iodine|iodine|mesh-list
154296027|NCT04770896|Atezolizumab|atezolizumab|mesh-list
154296028|NCT04770896|Lenvatinib|lenvatinib|mesh-list
154296029|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296030|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296031|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296032|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296033|NCT04770896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296034|NCT04770896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296035|NCT04743934|Androgens|androgens|mesh-list
154296036|NCT04743934|Hormones|hormones|mesh-ancestor
154296037|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154296038|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296039|NCT04740697|Tamoxifen|tamoxifen|mesh-list
154296040|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154296041|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
154296042|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154296062|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
154296063|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154296064|NCT04729959|Atezolizumab|atezolizumab|mesh-list
154296065|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
154296066|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154296067|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
154296068|NCT04729959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296069|NCT04729959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296070|NCT04729959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296071|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296072|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
154296073|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296074|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
154296075|NCT04701918|Avelumab|avelumab|mesh-list
154296076|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296077|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296078|NCT04701918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296079|NCT04701918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296080|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
154296081|NCT04675710|Trametinib|trametinib|mesh-list
154296082|NCT04675710|Dabrafenib|dabrafenib|mesh-list
154296083|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296084|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296085|NCT04675710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296086|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296087|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296088|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296089|NCT04665739|Deoxyglucose|deoxyglucose|mesh-list
154296090|NCT04665739|Everolimus|everolimus|mesh-list
154296091|NCT04665739|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154296092|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154296093|NCT04665739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154296094|NCT04665739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296095|NCT04665739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296096|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296097|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296098|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
154296127|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296128|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296129|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296130|NCT04579224|Paclitaxel|paclitaxel|mesh-list
154296131|NCT04579224|Camptothecin|camptothecin|mesh-list
154296132|NCT04579224|Docetaxel|docetaxel|mesh-list
154296133|NCT04579224|Halichondrin B|halichondrin b|mesh-list
154296134|NCT04579224|Gemcitabine|gemcitabine|mesh-list
154296135|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154296136|NCT04579224|Irinotecan|irinotecan|mesh-list
154296137|NCT04579224|Immunoconjugates|immunoconjugates|mesh-list
154296138|NCT04579224|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154296139|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154296140|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296141|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
154296142|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
154861562|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154861563|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861564|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
154296143|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
154296144|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296145|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296179|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
154296180|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
154296181|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
154296182|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296183|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154296184|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154296185|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154296196|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154296197|NCT04550481|Protective Agents|protective agents|mesh-ancestor
154296198|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296199|NCT04542837|Lenvatinib|lenvatinib|mesh-list
154296200|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296201|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296202|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296203|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296204|NCT04515472|Hormones|hormones|mesh-list
154296205|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296206|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154296207|NCT04509700|Ibrutinib|ibrutinib|mesh-list
154296208|NCT04509700|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154296209|NCT04509700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296210|NCT04509700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296211|NCT04509700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296212|NCT04500275|Vancomycin|vancomycin|mesh-list
154296213|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154296214|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296215|NCT04442022|Dexamethasone|dexamethasone|mesh-list
154296216|NCT04442022|Rituximab|rituximab|mesh-list
154296217|NCT04442022|Gemcitabine|gemcitabine|mesh-list
154296218|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296219|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027391|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296220|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
154296221|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
154296222|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296223|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296224|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154296225|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
154296226|NCT04442022|Hormones|hormones|mesh-ancestor
154296227|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154296228|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154296229|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296230|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
154296231|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296232|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296233|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
154296262|NCT04411654|Protective Agents|protective agents|mesh-ancestor
154296263|NCT04344873|Abatacept|abatacept|mesh-list
154296264|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296265|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296266|NCT04344873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296267|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296268|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296269|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
154296270|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296271|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296277|NCT04313881|Azacitidine|azacitidine|mesh-list
154296278|NCT04313881|Magrolimab|magrolimab|mesh-list
154296279|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296280|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
154296315|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154296316|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296318|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296319|NCT04143724|Luspatercept|luspatercept|mesh-list
154296320|NCT04143724|Hematinics|hematinics|mesh-ancestor
154296321|NCT04115059|Dasatinib|dasatinib|mesh-list
154296322|NCT04115059|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154296391|NCT03885037|Infliximab|infliximab|mesh-list
154296392|NCT03885037|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154296393|NCT03885037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154296394|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
154296395|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154296396|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296397|NCT03872180|Venetoclax|venetoclax|mesh-list
154296398|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154296399|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
154296400|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296401|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153517391|NCT01439230|Donepezil|donepezil|mesh-list
153517471|NCT01440114|Fentanyl|fentanyl|mesh-list
154296402|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
154296403|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296404|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296405|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
154296441|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296442|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154296443|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154296444|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
154296465|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154296466|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296467|NCT03738228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296468|NCT03738228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296469|NCT03738228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296470|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
154296471|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296472|NCT03724747|BAY 2315497|bay 2315497|mesh-list
154296473|NCT03724747|Immunoconjugates|immunoconjugates|mesh-ancestor
154296474|NCT03724747|Immunologic Factors|immunologic factors|mesh-ancestor
154296475|NCT03724747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296476|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
154296477|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296478|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296479|NCT03711032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296480|NCT03711032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296481|NCT03614949|Atezolizumab|atezolizumab|mesh-list
154296482|NCT03614949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296483|NCT03614949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296484|NCT03614949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296485|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296486|NCT03610724|Tisagenlecleucel|tisagenlecleucel|mesh-list
154296487|NCT03610724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296488|NCT03610724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296489|NCT03560882|Atorvastatin|atorvastatin|mesh-list
154296490|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154296491|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154296492|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
153517472|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154296493|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296494|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154296495|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154296496|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296497|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
154296498|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296531|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296532|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296533|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296534|NCT03326921|Vidarabine|vidarabine|mesh-list
154296535|NCT03326921|Fludarabine|fludarabine|mesh-list
154296536|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
154296537|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296538|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296576|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296577|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296578|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296607|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154296608|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296609|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154296610|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
154296611|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296612|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296613|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296614|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296615|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
154861565|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
154861566|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296617|NCT02912559|Protective Agents|protective agents|mesh-ancestor
154296618|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
154296619|NCT02912559|Vitamins|vitamins|mesh-ancestor
154296620|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
154296621|NCT02912559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296622|NCT02912559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296623|NCT02912559|Hematinics|hematinics|mesh-ancestor
154296624|NCT02890329|Ipilimumab|ipilimumab|mesh-list
154296625|NCT02890329|Decitabine|decitabine|mesh-list
154296626|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517535|NCT01440582|Hormones|hormones|mesh-ancestor
153517603|NCT01440842|Insulin|insulin|mesh-list
154296627|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296655|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
154296656|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296657|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154296658|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154296659|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154296660|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154296661|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154296662|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
154296663|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
154296664|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
154296666|NCT02689440|Dasatinib|dasatinib|mesh-list
154296667|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296668|NCT02689440|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154296669|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296670|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296671|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043473|NCT00536263|Interferons|interferons|mesh-list
154296672|NCT02631733|Irinotecan|irinotecan|mesh-list
154296673|NCT02631733|Camptothecin|camptothecin|mesh-list
154296674|NCT02631733|Veliparib|veliparib|mesh-list
154296675|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154296710|NCT02567435|MTOR Inhibitors|mtor inhibitors|mesh-list
154296711|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296712|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
154296713|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296714|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296715|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154296716|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
154296717|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296718|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296754|NCT02400216|Cholic Acids|cholic acids|mesh-list
154296755|NCT02400216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154296756|NCT02394769|Aspirin|aspirin|mesh-list
154296785|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296786|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296787|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154296788|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154296789|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
154296790|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296791|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154296792|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154296793|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154296794|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154296795|NCT02188264|Cyclosporine|cyclosporine|mesh-list
154296796|NCT02188264|Cyclosporins|cyclosporins|mesh-list
154296797|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296798|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296799|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296800|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
154296830|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296831|NCT01303341|Sorafenib|sorafenib|mesh-list
154296832|NCT01303341|Riluzole|riluzole|mesh-list
154296833|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296834|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296835|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296836|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296837|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
154296838|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154296839|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154296840|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154296841|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296842|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154296843|NCT01303341|Protective Agents|protective agents|mesh-ancestor
154296871|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296872|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154296873|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296874|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154296875|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
154296876|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154296877|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
154296878|NCT00594958|Vaccines|vaccines|mesh-list
154296879|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
154296880|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296881|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
154296882|NCT00588185|Testosterone|testosterone|mesh-list
154296883|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
154296884|NCT00588185|Androgens|androgens|mesh-ancestor
154296885|NCT00588185|Hormones|hormones|mesh-ancestor
154296886|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154296887|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296888|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
154296889|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296890|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
154296891|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296892|NCT00092222|Interferons|interferons|mesh-list
154296893|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
154296894|NCT00092222|Zidovudine|zidovudine|mesh-list
154296895|NCT00092222|Valganciclovir|valganciclovir|mesh-list
154296930|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154296931|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
154296932|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
153517686|NCT01441284|Protective Agents|protective agents|mesh-ancestor
154296933|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154296934|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154296935|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154296936|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154297017|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297018|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
154297019|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
154297020|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
154297021|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297022|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154297023|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297056|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297057|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297059|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154297060|NCT03657472|Atorvastatin|atorvastatin|mesh-list
154297061|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154297062|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154297063|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
154297064|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297091|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297092|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154297093|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
154297094|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297095|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
154297096|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297097|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
154297098|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297099|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154297100|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
154297101|NCT01096329|Testosterone|testosterone|mesh-list
154297102|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
154297103|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
154297104|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154297105|NCT01096329|Androgens|androgens|mesh-ancestor
154297107|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297108|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297109|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154297110|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297111|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
154297112|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
154297113|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154297131|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935276|NCT01706692|Adalimumab|adalimumab|mesh-list
154297132|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154297133|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
153517889|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154297134|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297135|NCT02906644|Nicotine|nicotine|mesh-list
154297136|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154297137|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
154297138|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297139|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297140|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154297141|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154297142|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
154297143|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297144|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297145|NCT02982772|Nicotine|nicotine|mesh-list
154297146|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154297147|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
154297148|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297149|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297150|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154297151|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154297152|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
154297153|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297154|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297155|NCT03713216|Morphine|morphine|mesh-list
154297156|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154297157|NCT03713216|Narcotics|narcotics|mesh-ancestor
154297158|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297159|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297160|NCT03713216|Analgesics|analgesics|mesh-ancestor
154297161|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
154297162|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297163|NCT03655834|Pemetrexed|pemetrexed|mesh-list
154297164|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297165|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297166|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297167|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154297168|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154297169|NCT03488108|Minoxidil|minoxidil|mesh-list
154297170|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154297171|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
154297172|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
154297244|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154297245|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154297246|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154297247|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154297248|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154297249|NCT02975206|Serlopitant|serlopitant|mesh-list
154297250|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154297275|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297276|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044074|NCT02725541|Immunotoxins|immunotoxins|mesh-ancestor
154297277|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154297278|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154297279|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
154297280|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297281|NCT00004635|Thalidomide|thalidomide|mesh-list
154297282|NCT00004635|Leuprolide|leuprolide|mesh-list
154297283|NCT00004635|Goserelin|goserelin|mesh-list
154297284|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154297285|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
154297286|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297287|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
154297288|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154297289|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297290|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154297291|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154297292|NCT00004635|Growth Substances|growth substances|mesh-ancestor
154297293|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
154297294|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297295|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154297296|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
154297297|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154297298|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154861567|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154297299|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
154297332|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
154297333|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297334|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297335|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154297336|NCT01103193|Narcotics|narcotics|mesh-ancestor
154297337|NCT01103193|Analgesics|analgesics|mesh-ancestor
154297338|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
154297339|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297340|NCT03949101|Atropine|atropine|mesh-list
154297341|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154297342|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154297343|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154297344|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154297345|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154297376|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
154297377|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
154297378|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297379|NCT02918968|Flutamide|flutamide|mesh-list
154297380|NCT02918968|Androgens|androgens|mesh-list
154297381|NCT02918968|Hormones|hormones|mesh-ancestor
154297382|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297383|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297384|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
154297385|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
154297386|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154297387|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297388|NCT01065766|Metformin|metformin|mesh-list
154297389|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154297421|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297422|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
154297423|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154297424|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153518203|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154297425|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297426|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
154297428|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
154297458|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154297459|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297460|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154297461|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154297462|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
154297463|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297464|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154297465|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
154297466|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297467|NCT01103739|Simvastatin|simvastatin|mesh-list
154297468|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154297469|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154297470|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
154297471|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297472|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154297505|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297506|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
154297507|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154297509|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
154297510|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297511|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154297512|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
154297513|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154297533|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297534|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154297535|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154297536|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
154297537|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154297538|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154297539|NCT03652480|Prednisolone|prednisolone|mesh-list
154297540|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
154297541|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154297542|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
154297543|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154297544|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
154297545|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
154297546|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255306|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297547|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518264|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
154297548|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154297550|NCT03652480|Hormones|hormones|mesh-ancestor
154297551|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297552|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154297553|NCT03652480|Protective Agents|protective agents|mesh-ancestor
154297554|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154297555|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297556|NCT03622060|Nicardipine|nicardipine|mesh-list
154297557|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
154297558|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
154297559|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154297560|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154297561|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154297562|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297563|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154297564|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297565|NCT00040365|Amifostine|amifostine|mesh-list
154297566|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154297567|NCT00040365|Protective Agents|protective agents|mesh-ancestor
154297568|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297569|NCT02974114|Acetaminophen|acetaminophen|mesh-list
154297570|NCT02974114|Caffeine|caffeine|mesh-list
154297571|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154297602|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154297603|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
154297604|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297605|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297606|NCT00001941|Daclizumab|daclizumab|mesh-list
154297607|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154297608|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
154297609|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297610|NCT01061866|Thalidomide|thalidomide|mesh-list
154297611|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154297612|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
154297613|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297646|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297647|NCT01102101|Analgesics|analgesics|mesh-ancestor
153518308|NCT01444846|Ebselen|ebselen|mesh-list
154297648|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
154297649|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297650|NCT01102335|Telbivudine|telbivudine|mesh-list
154297651|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
154297652|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297653|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154297655|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297656|NCT02973100|Dulaglutide|dulaglutide|mesh-list
154297657|NCT02973100|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154297691|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
154297692|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154297693|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154297694|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154297695|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297696|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297697|NCT02972632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154297698|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154297699|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154297729|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297730|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154297731|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
154297732|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297733|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
154297734|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154297735|NCT01104519|Niacin|niacin|mesh-list
154297736|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
154297737|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154297738|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
154297739|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297740|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154297741|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
154861568|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154861569|NCT00947765|Protective Agents|protective agents|mesh-ancestor
154297742|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
154297743|NCT01104519|Vitamins|vitamins|mesh-ancestor
154297744|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
154297745|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297746|NCT03944733|Iron|iron|mesh-list
154297774|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297775|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297776|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154297777|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154297778|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154297779|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
154297780|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297781|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297783|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297784|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297785|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154297786|NCT05276895|Quercetin|quercetin|mesh-list
154297787|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
154297788|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297789|NCT05276895|Protective Agents|protective agents|mesh-ancestor
154297790|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297791|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154297792|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
154297826|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154297827|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
154297828|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297829|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297830|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154297831|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154297832|NCT01106235|Analgesics|analgesics|mesh-ancestor
154297833|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
154297834|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297866|NCT04053400|Ketamine|ketamine|mesh-list
154297867|NCT04053400|Analgesics|analgesics|mesh-ancestor
154297868|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
154297869|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297870|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297871|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154297872|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154297873|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
154297874|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
154297875|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297876|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154297877|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154297878|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297879|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297902|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
154297903|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297904|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154297905|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
154297906|NCT01109121|Protective Agents|protective agents|mesh-ancestor
154297907|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297908|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
154297909|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154297910|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154297911|NCT01106547|Prednisolone|prednisolone|mesh-list
154297912|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
154297913|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154297914|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
154297915|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154297916|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
154297917|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
154297918|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297919|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297920|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154297921|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
154297922|NCT01106547|Hormones|hormones|mesh-ancestor
153518368|NCT01445223|Ritonavir|ritonavir|mesh-list
154297923|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153518422|NCT01445392|Pemetrexed|pemetrexed|mesh-list
154297924|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154297925|NCT01106547|Protective Agents|protective agents|mesh-ancestor
154297926|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154297927|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861570|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154297930|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297962|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154297963|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297964|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154297965|NCT01118793|Clopidogrel|clopidogrel|mesh-list
154297966|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154297967|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154297968|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154297969|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154297970|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
154297999|NCT01328301|Methamphetamine|methamphetamine|mesh-list
154298000|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154298001|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298002|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
154298003|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
154298004|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298005|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
154298006|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298007|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298008|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
154298009|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154298010|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154298011|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154298012|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154298014|NCT01328457|Neomycin|neomycin|mesh-list
154298042|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298043|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298044|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298045|NCT03943407|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154298046|NCT03943407|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154298047|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
154298048|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154298049|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298050|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
154298051|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154298052|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154298053|NCT03943407|Protective Agents|protective agents|mesh-ancestor
154298054|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154298055|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154298056|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298057|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154298058|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
154298059|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154298060|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
154298061|NCT01209351|Teduglutide|teduglutide|mesh-list
154298062|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154298085|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298087|NCT01107639|Docetaxel|docetaxel|mesh-list
154298088|NCT01107639|Cetuximab|cetuximab|mesh-list
154298089|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298090|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
154298091|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
154298092|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
154298093|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298094|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154298095|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
154298096|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154298097|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154298098|NCT03942861|Prednisolone|prednisolone|mesh-list
154298099|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
154298100|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154298101|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
154298102|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154298103|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
154298104|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
154298105|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298106|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298107|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154298108|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
154298109|NCT03942861|Hormones|hormones|mesh-ancestor
154298110|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153518482|NCT01445743|Vaccines|vaccines|mesh-list
154298112|NCT03942861|Protective Agents|protective agents|mesh-ancestor
154298145|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154298146|NCT01110603|Niraparib|niraparib|mesh-list
154298147|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154298148|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298149|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
154298150|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
154298151|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
154298152|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298153|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154298154|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154298155|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154298156|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298192|NCT01208649|Hormones|hormones|mesh-ancestor
154298193|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298194|NCT01211847|Diazoxide|diazoxide|mesh-list
154298195|NCT01211847|Choline|choline|mesh-list
154298196|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
154298218|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
154298219|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298220|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298221|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154298222|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154298223|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154298224|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154298225|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298226|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154298227|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154298228|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298229|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
154298230|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154298231|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
154298232|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154298233|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154298234|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298235|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298236|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
154298237|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298238|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154298239|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154298240|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154298241|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154298242|NCT01328145|Aspirin|aspirin|mesh-list
154298243|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154298244|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154298245|NCT01328145|Analgesics|analgesics|mesh-ancestor
154298246|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
154298247|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298248|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298276|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298278|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154298279|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518600|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154298280|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
154298281|NCT01210755|Dabigatran|dabigatran|mesh-list
154298282|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154298283|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
154298284|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154298285|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
154298286|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298287|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298288|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
154298289|NCT01210911|Metformin|metformin|mesh-list
154298290|NCT01210911|Gemcitabine|gemcitabine|mesh-list
154298291|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154298292|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154298293|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
154298294|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298295|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298325|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
154298326|NCT01211223|Amoxicillin|amoxicillin|mesh-list
154298327|NCT01211223|Metronidazole|metronidazole|mesh-list
154298329|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298330|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154298331|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154298332|NCT01113489|Beclomethasone|beclomethasone|mesh-list
154298333|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154298334|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
154298335|NCT01113489|Hormones|hormones|mesh-ancestor
154298336|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298337|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298338|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154298339|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
154298340|NCT01115439|Artesunate|artesunate|mesh-list
154298341|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
154298342|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
154298343|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154298344|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
154298371|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
154298372|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298373|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154298374|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154298375|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
154298376|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
154298377|NCT03939663|Misoprostol|misoprostol|mesh-list
154298378|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154298379|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
154298380|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154298381|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298382|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154298383|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154298384|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
154298385|NCT01213407|Temozolomide|temozolomide|mesh-list
154298386|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154298387|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
154298388|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298389|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298390|NCT01211457|Venetoclax|venetoclax|mesh-list
154298391|NCT01211457|Decitabine|decitabine|mesh-list
154298392|NCT01211457|Sapacitabine|sapacitabine|mesh-list
154298393|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298394|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154298426|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298427|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154298428|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154298429|NCT01116219|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154298430|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298432|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154298433|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
154298434|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154298435|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
154298463|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298464|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298465|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
154298466|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154298467|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154298468|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298469|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154298470|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154298471|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154298472|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298473|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154298474|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154298476|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154298477|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154298478|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298479|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
154045279|NCT02617290|Ticagrelor|ticagrelor|mesh-list
154298506|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153518655|NCT01446523|Lactulose|lactulose|mesh-list
154298507|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298508|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154298509|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298510|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298512|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154298515|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154298516|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298517|NCT01116843|Dacomitinib|dacomitinib|mesh-list
154298518|NCT01116843|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154298519|NCT01116843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298520|NCT01116843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298521|NCT01116843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298522|NCT03788967|Ertapenem|ertapenem|mesh-list
154298523|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298524|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298525|NCT01118559|Darexaban|darexaban|mesh-list
154298526|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154298527|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
154298528|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154298529|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
154298560|NCT01216449|Citalopram|citalopram|mesh-list
154298561|NCT01216449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154298562|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154298563|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154298564|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298565|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298566|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
154298567|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298568|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154298569|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
154298597|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154298598|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
154298599|NCT01213017|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154298600|NCT01213017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154298601|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154298602|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
154298603|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298604|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154298605|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
154298606|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154298607|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154298608|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298609|NCT01216605|Oxytocin|oxytocin|mesh-list
154298610|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
154298611|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154298612|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298613|NCT01213095|Rituximab|rituximab|mesh-list
154298614|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154298615|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518736|NCT01447212|Heroin|heroin|mesh-list
153518774|NCT01447550|Bosentan|bosentan|mesh-list
154298652|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154298653|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
154298654|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
154298655|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
154298656|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298685|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154298686|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
154298687|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298688|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298689|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154298691|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154298692|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154298693|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154298694|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154298695|NCT01217619|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154298696|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298697|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298698|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298699|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298700|NCT01122615|Sirolimus|sirolimus|mesh-list
154298701|NCT01122615|Sunitinib|sunitinib|mesh-list
154298702|NCT01122615|Temsirolimus|temsirolimus|mesh-list
154298703|NCT01122615|MTOR Inhibitors|mtor inhibitors|mesh-list
154298762|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154298763|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154298764|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
154298766|NCT01219413|Aliskiren|aliskiren|mesh-list
153935871|NCT04582942|Lactulose|lactulose|mesh-list
154298767|NCT01219413|Renin Inhibitors|renin inhibitors|mesh-ancestor
154298768|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
154298769|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298770|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298771|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154298772|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154298773|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
154298774|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
154298775|NCT03783039|Coagulants|coagulants|mesh-ancestor
154298776|NCT03933501|Amoxicillin|amoxicillin|mesh-list
154298777|NCT03933501|Metronidazole|metronidazole|mesh-list
154045583|NCT00731224|Protective Agents|protective agents|mesh-ancestor
154298778|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298779|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298781|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154298782|NCT01122771|Amphotericin B|amphotericin b|mesh-list
154298783|NCT01122771|Paromomycin|paromomycin|mesh-list
154298784|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154298785|NCT01122771|Miltefosine|miltefosine|mesh-list
154298786|NCT01122771|Amebicides|amebicides|mesh-ancestor
154298787|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154298788|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154298789|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298790|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298791|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
154298792|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298793|NCT01125033|Vitamins|vitamins|mesh-list
154298816|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
154298817|NCT01120821|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154298818|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298819|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298820|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298821|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298823|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
154298824|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154298825|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154298826|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154298827|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298828|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298829|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298830|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154298831|NCT01125423|Analgesics|analgesics|mesh-ancestor
154298832|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
154298833|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298834|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
154298835|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154298836|NCT01219569|Propofol|propofol|mesh-list
154298837|NCT01219569|Sevoflurane|sevoflurane|mesh-list
154298838|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154298839|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298840|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298841|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154298842|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
154298843|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
154298844|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154298845|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154298846|NCT03933345|Naloxone|naloxone|mesh-list
154298879|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154298880|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154298881|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153518839|NCT01448070|Insulin|insulin|mesh-list
154298882|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154298884|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
154298885|NCT01214889|Vaccines|vaccines|mesh-list
154298886|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
154298887|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298917|NCT01123551|Analgesics|analgesics|mesh-ancestor
154298918|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
154298919|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298920|NCT01125657|Darexaban|darexaban|mesh-list
154298921|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154298922|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
154298923|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154298924|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
154298925|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298926|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861571|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154255307|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298928|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
154298929|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154298930|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154298931|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298933|NCT03934047|Coagulants|coagulants|mesh-ancestor
154298934|NCT01218711|Losartan|losartan|mesh-list
154298935|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154298961|NCT01215669|Vaccines|vaccines|mesh-list
154298962|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
154298963|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298964|NCT01222143|Nilotinib|nilotinib|mesh-list
154298965|NCT01222143|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154298966|NCT01222143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298967|NCT01222143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298968|NCT01222143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298969|NCT01222221|Temozolomide|temozolomide|mesh-list
154298970|NCT01222221|Sargramostim|sargramostim|mesh-list
154298971|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154298972|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
154298973|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298974|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298975|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
154298976|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298977|NCT01220661|Cefotetan|cefotetan|mesh-list
154298978|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298979|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298980|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
154298981|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154298982|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299016|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299017|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154299018|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154299019|NCT01226355|Sirolimus|sirolimus|mesh-list
154299040|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299041|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299042|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154299044|NCT01221129|Trace Elements|trace elements|mesh-ancestor
153518933|NCT01448395|Avibactam|avibactam|mesh-list
154299045|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
154299046|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299047|NCT01222923|Risperidone|risperidone|mesh-list
154299048|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154299049|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
154299050|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299051|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299052|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299053|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154299054|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154299055|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299056|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154299057|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154299058|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
154299059|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154299060|NCT01223079|Hormones|hormones|mesh-ancestor
154299061|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299062|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299063|NCT03648970|Pravastatin|pravastatin|mesh-list
154299064|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154299065|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154299066|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
154299067|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299068|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154299069|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154299070|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299071|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
154299072|NCT03927963|Propofol|propofol|mesh-list
154299073|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154299074|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299096|NCT01226667|Analgesics|analgesics|mesh-ancestor
154299097|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
154861572|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861573|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
154861574|NCT01089595|Nilotinib|nilotinib|mesh-list
154299100|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
154299101|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154299102|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299103|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299104|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154299105|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154299106|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154299107|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299108|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154299109|NCT03927807|Misoprostol|misoprostol|mesh-list
154299110|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154299111|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
154299112|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154299113|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299114|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154299115|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154299116|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
154299117|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
154299118|NCT05284942|Prednisone|prednisone|mesh-list
154299119|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299120|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
154299121|NCT05284942|Hormones|hormones|mesh-ancestor
154299122|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299123|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299124|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154299125|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299126|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154299127|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154299149|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299150|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
154299152|NCT03647956|Atezolizumab|atezolizumab|mesh-list
154299153|NCT03647956|Carboplatin|carboplatin|mesh-list
154299154|NCT03647956|Pemetrexed|pemetrexed|mesh-list
154299155|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154299156|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299157|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154299158|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154299159|NCT03647956|Growth Substances|growth substances|mesh-ancestor
154299160|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299161|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
154299162|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299163|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299164|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154299165|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154299166|NCT03647956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154299167|NCT01221675|Antibodies|antibodies|mesh-list
154299168|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
154299169|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299170|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
154299171|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154299172|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
154299173|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
154299174|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299175|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299176|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154299177|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154299178|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154299179|NCT02968576|Tenofovir|tenofovir|mesh-list
154299199|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154299200|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154299201|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154299202|NCT01226901|Niraparib|niraparib|mesh-list
154299203|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154299204|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299205|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299206|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299207|NCT03648658|Acetaminophen|acetaminophen|mesh-list
154299208|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154299209|NCT03648658|Analgesics|analgesics|mesh-ancestor
154299210|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
154299212|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299213|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
154299214|NCT03931239|Vaccines|vaccines|mesh-list
154299215|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
154299216|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299217|NCT03927495|Paclitaxel|paclitaxel|mesh-list
154299218|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154299219|NCT03927495|Cisplatin|cisplatin|mesh-list
154299220|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154299221|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299222|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
154299223|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
154299224|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
154299225|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046041|NCT01000441|Analgesics|analgesics|mesh-ancestor
154299226|NCT02966002|Aspirin|aspirin|mesh-list
154299227|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154299228|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154299229|NCT02966002|Analgesics|analgesics|mesh-ancestor
154299230|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
154299231|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299253|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299254|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299255|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154299256|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154299257|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154299258|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154299260|NCT01129713|Omeprazole|omeprazole|mesh-list
154299261|NCT01129713|Lansoprazole|lansoprazole|mesh-list
154299262|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154299263|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154299264|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154299265|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299266|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299267|NCT01221831|Dienogest|dienogest|mesh-list
154299268|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154299269|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154299270|NCT01221831|Estradiol|estradiol|mesh-list
154299271|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154299272|NCT01221831|Estrogens|estrogens|mesh-ancestor
154299273|NCT01221831|Hormones|hormones|mesh-ancestor
154299274|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299275|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299276|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154299277|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
154299278|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154299279|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154299280|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154299281|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154299282|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154299283|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
154299284|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154299317|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299318|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
154299319|NCT03925155|Trace Elements|trace elements|mesh-ancestor
154299320|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
154299321|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299323|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
154299324|NCT01131195|Bevacizumab|bevacizumab|mesh-list
154299325|NCT01131195|Capecitabine|capecitabine|mesh-list
154299326|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154299327|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299328|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
154299356|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299358|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154299359|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154299360|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154299361|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
154299362|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299363|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154299364|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154299365|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299366|NCT01228227|Atorvastatin|atorvastatin|mesh-list
154255309|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255310|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154255311|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
154255312|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154255313|NCT03902522|Leronlimab|leronlimab|mesh-list
154255314|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154255315|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154255316|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255317|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154255318|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153936169|NCT02756104|Vitamin D|vitamin d|mesh-list
154299367|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154299368|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154299369|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154299370|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
154299371|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299372|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154299404|NCT01228305|Acetaminophen|acetaminophen|mesh-list
154299405|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154299406|NCT01228305|Analgesics|analgesics|mesh-ancestor
154299407|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
154299408|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299409|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299410|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
154299411|NCT02902120|Grazoprevir|grazoprevir|mesh-list
154299412|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
154299413|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299414|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
154299415|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
154299416|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299449|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299450|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299451|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
154299452|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299453|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154299454|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154299455|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154299456|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299457|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299458|NCT01127841|Rituximab|rituximab|mesh-list
154299459|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154299479|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
154299480|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
154299481|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154299482|NCT01130259|Iniparib|iniparib|mesh-list
154299483|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154299484|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299485|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299486|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299487|NCT01585623|Metoprolol|metoprolol|mesh-list
154299488|NCT01585623|Midazolam|midazolam|mesh-list
154299489|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154299490|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154299491|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299492|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299493|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154299494|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154299495|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154299496|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154299497|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
154299498|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
154299499|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
154861575|NCT01089595|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154861576|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154861577|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861578|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861579|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861580|NCT01089751|Trospium chloride|trospium chloride|mesh-list
154861581|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
154861582|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
154861583|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861584|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861585|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154299500|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
154299501|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299502|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299503|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154299504|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154299505|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
154299506|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
154299507|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299508|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154299509|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154299510|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154299511|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
154299542|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154299543|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
154299544|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299545|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299547|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299548|NCT03923751|Anesthetics|anesthetics|mesh-list
154299549|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299550|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299551|NCT03923361|Propofol|propofol|mesh-list
154299552|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154299553|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299554|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299555|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154299556|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
154299557|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
154299558|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154299588|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299589|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154299590|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
154299591|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
154299592|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154299593|NCT03922815|Narcotics|narcotics|mesh-ancestor
154299594|NCT03922815|Analgesics|analgesics|mesh-ancestor
154299595|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
154299596|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299597|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153519268|NCT01451320|Plasminogen|plasminogen|mesh-list
153519294|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299598|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154299599|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299600|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154299601|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299602|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
154299603|NCT01227915|Hormones|hormones|mesh-ancestor
154299635|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
154299636|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299637|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299638|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
154299639|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299640|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154299641|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
154299642|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
154299643|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299644|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
154299645|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154299646|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154299667|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299669|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299670|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154299671|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154299672|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154299673|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299674|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299675|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154046493|NCT02713763|Sunitinib|sunitinib|mesh-list
154299676|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299677|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
154299678|NCT03609424|Spartalizumab|spartalizumab|mesh-list
154299679|NCT03609424|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154299680|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154299681|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299682|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299683|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299684|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154299686|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154299687|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154299688|NCT03644446|Bisoprolol|bisoprolol|mesh-list
154299689|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154299690|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
154299691|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
154299692|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299693|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299694|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154299695|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154299696|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154299697|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
154299719|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153519365|NCT05964387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154299721|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154299722|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154299723|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299724|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299725|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154299726|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
154299727|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
154299728|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154299729|NCT03925779|Narcotics|narcotics|mesh-ancestor
154299730|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154299731|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
154299732|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299733|NCT03925701|Metformin|metformin|mesh-list
154299734|NCT03925701|Vildagliptin|vildagliptin|mesh-list
154299735|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154299736|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299737|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154299738|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
154299739|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299740|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299741|NCT01224717|Teriparatide|teriparatide|mesh-list
154299742|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154299743|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299744|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154299745|NCT03925233|Tamoxifen|tamoxifen|mesh-list
154299746|NCT03925233|Toremifene|toremifene|mesh-list
154299747|NCT03925233|Vinorelbine|vinorelbine|mesh-list
154046566|NCT04219865|Edaravone|edaravone|mesh-list
154299748|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
154299749|NCT03925233|Bevacizumab|bevacizumab|mesh-list
154299750|NCT03925233|Carboplatin|carboplatin|mesh-list
154299778|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299779|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154299780|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
154299781|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154299782|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154299783|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154299784|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154299785|NCT03925233|Growth Substances|growth substances|mesh-ancestor
154299786|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
154299787|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154299788|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
154299789|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154299790|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154299791|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154299792|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299793|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154299794|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
154299795|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154299796|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
154299797|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154299798|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154299799|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
154299800|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154299801|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
154299802|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
154299803|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154299804|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154299829|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299830|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299831|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299833|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299834|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299835|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154299837|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299838|NCT01131039|Bevacizumab|bevacizumab|mesh-list
154299839|NCT01131039|Gemcitabine|gemcitabine|mesh-list
154299840|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154299841|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299842|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154299843|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154299844|NCT01131039|Growth Substances|growth substances|mesh-ancestor
154299845|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299846|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154299847|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154299848|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
154299849|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299850|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
154299851|NCT01229085|Salicylates|salicylates|mesh-list
154299878|NCT03643666|Hormones|hormones|mesh-ancestor
154299879|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299880|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154299881|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299882|NCT03643666|Analgesics|analgesics|mesh-ancestor
154299883|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
154299884|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
154299885|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299886|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154299887|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
153519475|NCT05962216|Dopamine Agents|dopamine agents|mesh-ancestor
154299888|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154299889|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299890|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299891|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154299892|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
154299893|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154299894|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
154299895|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154299896|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
154299897|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299898|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
154299918|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299919|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299920|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154299921|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154299922|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
154299923|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299924|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154299925|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
154299926|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
154299927|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
154299928|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154299929|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154299930|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299931|NCT03921567|Lidocaine|lidocaine|mesh-list
154299932|NCT03921567|Ketamine|ketamine|mesh-list
154299933|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
154299934|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
154299935|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299936|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299937|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
154299938|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299939|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154299940|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154299941|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154299942|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299943|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519517|NCT05960721|Aspirin|aspirin|mesh-list
154299944|NCT03921567|Analgesics|analgesics|mesh-ancestor
154299945|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154299946|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154299947|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
154299948|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154299949|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154299950|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299951|NCT01229241|Anesthetics|anesthetics|mesh-list
154299952|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
154299953|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299979|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
154299980|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299981|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154299982|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299983|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
154299984|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
154299985|NCT03921099|Vitamins|vitamins|mesh-ancestor
154299986|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
154299987|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299988|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
154299989|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299990|NCT03921099|Protective Agents|protective agents|mesh-ancestor
154299991|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154299992|NCT02962648|Hematinics|hematinics|mesh-ancestor
154299993|NCT03920631|Nivolumab|nivolumab|mesh-list
154299994|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154299995|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299996|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154299997|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299998|NCT03930069|Vasopressins|vasopressins|mesh-list
154299999|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
154300000|NCT03930069|Misoprostol|misoprostol|mesh-list
154300001|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154300002|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
154300003|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154300034|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300035|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154300036|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
154300037|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
154300038|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154300039|NCT03929835|Protective Agents|protective agents|mesh-ancestor
154300040|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300041|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
154300042|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154300043|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154300044|NCT01132677|Prednisolone|prednisolone|mesh-list
154300045|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
154300046|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154300047|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
154300048|NCT01132677|Hylan|hylan|mesh-list
154300049|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300050|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
154300051|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
154300082|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154300083|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300084|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300085|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
154300086|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300087|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
154300088|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154300089|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
154300090|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300091|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
154300092|NCT03920553|Protective Agents|protective agents|mesh-ancestor
154300093|NCT03643900|Indomethacin|indomethacin|mesh-list
154300122|NCT03919461|Propranolol|propranolol|mesh-list
154300123|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154300124|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154300125|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
154300126|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300127|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300128|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300129|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154300130|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154300131|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
154300132|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154300133|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154300134|NCT03919461|Analgesics|analgesics|mesh-ancestor
154300135|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
154300136|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300137|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300138|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154300139|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154300140|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154300168|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154300169|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300170|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300171|NCT03918993|Urological Agents|urological agents|mesh-ancestor
154300173|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154300174|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
154300175|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154300176|NCT03920475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154300177|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154300178|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300179|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300180|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300181|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
154300182|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300183|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154300184|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154300185|NCT03920319|Bupropion|bupropion|mesh-list
154300186|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154300187|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
154300216|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154300217|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154300218|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
154300219|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300220|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300221|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154300222|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154300223|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300224|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300225|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300226|NCT01128699|Bevacizumab|bevacizumab|mesh-list
154300227|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154300228|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300229|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154300254|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154300255|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300256|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
154300257|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
154300258|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154300259|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154300260|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300261|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300262|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300263|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154300264|NCT01132911|Bortezomib|bortezomib|mesh-list
154300265|NCT01132911|Vorinostat|vorinostat|mesh-list
154300266|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300267|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154300268|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300269|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300270|NCT01132989|Lenalidomide|lenalidomide|mesh-list
154300271|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
154300272|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300273|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154300274|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154300275|NCT01132989|Growth Substances|growth substances|mesh-ancestor
154300276|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
154300277|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300278|NCT01225653|Latanoprost|latanoprost|mesh-list
154300279|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154300280|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154300293|NCT01133223|Plasminogen|plasminogen|mesh-list
154300294|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154300295|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154300296|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154300297|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300298|NCT01233219|Morphine|morphine|mesh-list
154300299|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154300300|NCT01233219|Narcotics|narcotics|mesh-ancestor
154300301|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300302|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861586|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154255319|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
154255320|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300304|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
154300305|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300306|NCT02960854|Nivolumab|nivolumab|mesh-list
154300307|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154300308|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300309|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154300310|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300311|NCT01133301|Naltrexone|naltrexone|mesh-list
154300312|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154300313|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154300314|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300315|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
154300316|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300317|NCT03918135|Acetaminophen|acetaminophen|mesh-list
154300318|NCT03918135|Ibuprofen|ibuprofen|mesh-list
154300319|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154300320|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154300321|NCT03918135|Analgesics|analgesics|mesh-ancestor
154300322|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
154300323|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300324|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300325|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300326|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154300327|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154300328|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300329|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300330|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
154300331|NCT05480475|Dabigatran|dabigatran|mesh-list
154300332|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154300333|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154300334|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154300335|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
154300336|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300337|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154300338|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154300339|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300340|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
154300341|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154300342|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
154300343|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
154300344|NCT03642184|Empagliflozin|empagliflozin|mesh-list
154300375|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300376|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300377|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
154300378|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300379|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300380|NCT01133457|Urological Agents|urological agents|mesh-ancestor
154300381|NCT01135563|Sirolimus|sirolimus|mesh-list
154300382|NCT01135563|Vinblastine|vinblastine|mesh-list
154300383|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300384|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300385|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154300386|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300387|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
154300414|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300416|NCT01135641|Rituximab|rituximab|mesh-list
154300417|NCT01135641|Cyclosporins|cyclosporins|mesh-list
154300418|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154300419|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300420|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
154300421|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300422|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154300423|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300424|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300425|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300426|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
154300427|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300428|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
154300429|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154300430|NCT03640156|Oxytocin|oxytocin|mesh-list
154861587|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
154861588|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300432|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154300452|NCT01136031|Irinotecan|irinotecan|mesh-list
154300453|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154300454|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300455|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
154300456|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
154300457|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
154300458|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300459|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154300460|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154300461|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300462|NCT01137903|Amoxicillin|amoxicillin|mesh-list
154300463|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
154300464|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
154300465|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
154300466|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154300467|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154300468|NCT01137903|Trimethoprim|trimethoprim|mesh-list
154300469|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
154300470|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300471|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300472|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154300473|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154300474|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300475|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300476|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300477|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154300478|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154300479|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154300480|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
154300481|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154300482|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154300483|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154300484|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154300485|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154300486|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154300514|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300515|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300516|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154300518|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300519|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
154300520|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300521|NCT01232439|Aticaprant|aticaprant|mesh-list
154300522|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300523|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
154300524|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300525|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154300526|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
154300527|NCT01138137|Paclitaxel|paclitaxel|mesh-list
154300528|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154300529|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154300530|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300531|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
154300532|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
154300533|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
154300534|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300535|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
154300536|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300569|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300570|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300571|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154300572|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
154300573|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154300574|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154300575|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
154300576|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154300577|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
154300578|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154300579|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
154300580|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047393|NCT05730673|Leronlimab|leronlimab|mesh-list
154300581|NCT01136499|Panobinostat|panobinostat|mesh-list
154300582|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255322|NCT01092858|Testosterone|testosterone|mesh-list
154300583|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154300609|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
154300610|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300611|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154300612|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154300613|NCT01138683|Diuretics|diuretics|mesh-list
154300614|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
154300615|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300616|NCT04767243|Methamphetamine|methamphetamine|mesh-list
154300617|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154300618|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300619|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
154300620|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
154300621|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300622|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
154300623|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300624|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300625|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154300626|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154300627|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154300628|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300629|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154300630|NCT01138839|Dexamethasone|dexamethasone|mesh-list
154300631|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300632|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
154300633|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
154300634|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300661|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300662|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300664|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154300665|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
154300666|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300667|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300668|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
154300669|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300670|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300671|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
154300672|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300673|NCT01234857|Sirolimus|sirolimus|mesh-list
154300674|NCT01234857|Exemestane|exemestane|mesh-list
154300675|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154300676|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300677|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154300678|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154300679|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300680|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300681|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154300682|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154300716|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300717|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300719|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154300720|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154300740|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300741|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300742|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
154300743|NCT01143129|Hormones|hormones|mesh-ancestor
154300744|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300745|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154300746|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300747|NCT01139463|Haloperidol|haloperidol|mesh-list
154300748|NCT01139463|Olanzapine|olanzapine|mesh-list
154300749|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
154300750|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
154300751|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
154300752|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300753|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300754|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300755|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154861589|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861590|NCT01089751|Urological Agents|urological agents|mesh-ancestor
154861591|NCT03032315|Amlodipine|amlodipine|mesh-list
153936837|NCT00636298|Growth Substances|growth substances|mesh-ancestor
154300756|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154300757|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300758|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154300759|NCT01139463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154300760|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154300761|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300762|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300763|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300764|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
154300765|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154300766|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
154300767|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154300768|NCT03640468|Lidocaine|lidocaine|mesh-list
154300769|NCT03640468|Midazolam|midazolam|mesh-list
154300770|NCT03640468|Ketamine|ketamine|mesh-list
154300771|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
154300772|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
154300773|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300774|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300775|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
154300776|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300806|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154047612|NCT00734890|Growth Substances|growth substances|mesh-ancestor
154300807|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154300808|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
154300809|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300810|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300811|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
154300812|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154300813|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
154300814|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154300815|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300816|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154300817|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
154300818|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154300819|NCT03618472|Metformin|metformin|mesh-list
154300848|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154300849|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
154300850|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
154300851|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300852|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300854|NCT01236651|Meperidine|meperidine|mesh-list
154300855|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154300856|NCT01236651|Narcotics|narcotics|mesh-ancestor
154300857|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300858|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300859|NCT01236651|Analgesics|analgesics|mesh-ancestor
154300860|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
154300861|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300862|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154300863|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
154300891|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300892|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154300893|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300894|NCT03616288|Thiamine|thiamine|mesh-list
154300895|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
154300896|NCT03616288|Vitamins|vitamins|mesh-ancestor
154300897|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
154300898|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300899|NCT03616132|Sirolimus|sirolimus|mesh-list
154300900|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300901|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300902|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154300903|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300904|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
154300905|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300906|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
154300907|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300908|NCT02872012|Lidocaine|lidocaine|mesh-list
154300909|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
154300910|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
154300942|NCT02869438|Benralizumab|benralizumab|mesh-list
154300943|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154300944|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
154300946|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300947|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300948|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300949|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154300965|NCT03613168|Trastuzumab|trastuzumab|mesh-list
154300966|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154300967|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300968|NCT01141881|Bevacizumab|bevacizumab|mesh-list
154300969|NCT01141881|Plasminogen|plasminogen|mesh-list
154300970|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154300971|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154300972|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300973|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154300974|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154300975|NCT01141881|Growth Substances|growth substances|mesh-ancestor
154300976|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300977|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
154300978|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154300979|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154300980|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300981|NCT04707430|Progesterone|progesterone|mesh-list
154300982|NCT04707430|Progestins|progestins|mesh-ancestor
154300983|NCT04707430|Hormones|hormones|mesh-ancestor
154300984|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300985|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300986|NCT03611920|Tetracycline|tetracycline|mesh-list
154300987|NCT03611920|Dexamethasone|dexamethasone|mesh-list
154300988|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300989|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
154300990|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
154300991|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300992|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300993|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300994|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
154300995|NCT03611920|Hormones|hormones|mesh-ancestor
154300996|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300997|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154300998|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300999|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154301000|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301001|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154301002|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301003|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301004|NCT05383534|Propofol|propofol|mesh-list
154301005|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154301006|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301039|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
154301040|NCT01143831|Menatetrenone|menatetrenone|mesh-list
154301041|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
154301042|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301043|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154301044|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154301045|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301046|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
154301047|NCT01143831|Coagulants|coagulants|mesh-ancestor
154301048|NCT01143987|Cinacalcet|cinacalcet|mesh-list
154301049|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154301050|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301051|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154301052|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
154301053|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301054|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
154301055|NCT01144065|Testosterone|testosterone|mesh-list
154301056|NCT01144065|Androgens|androgens|mesh-ancestor
154301087|NCT02572167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301088|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
154301089|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154301090|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
154301091|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154301092|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301093|NCT01336738|Incretins|incretins|mesh-ancestor
154301094|NCT01336738|Hormones|hormones|mesh-ancestor
154861593|NCT03032315|Telmisartan|telmisartan|mesh-list
154255323|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
154301095|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301096|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154301097|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
154301127|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
154301129|NCT01237119|Liraglutide|liraglutide|mesh-list
154301130|NCT01237119|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154301131|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154301132|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301133|NCT01237119|Incretins|incretins|mesh-ancestor
154301134|NCT01237119|Hormones|hormones|mesh-ancestor
154301135|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301136|NCT01237275|Sertraline|sertraline|mesh-list
154301137|NCT01237275|Fluoxetine|fluoxetine|mesh-list
154301138|NCT01237275|Paroxetine|paroxetine|mesh-list
154301139|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
154301140|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154301141|NCT01237275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154301142|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154301143|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301144|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301145|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301177|NCT02033512|Hormones|hormones|mesh-list
154047989|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
154301178|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301179|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301180|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
154301181|NCT02712112|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154301182|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154301183|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301202|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
154301203|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154301204|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
154301205|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301206|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
154301207|NCT01144533|Protective Agents|protective agents|mesh-ancestor
154301208|NCT01238055|Docetaxel|docetaxel|mesh-list
154301209|NCT01238055|Sunitinib|sunitinib|mesh-list
154301210|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301211|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
154301212|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
154301213|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
154301214|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301215|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154301216|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154301217|NCT01238055|Growth Substances|growth substances|mesh-ancestor
154301218|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301219|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
154301220|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154301221|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301222|NCT01144923|Gabapentin|gabapentin|mesh-list
154301223|NCT01144923|Nortriptyline|nortriptyline|mesh-list
154301224|NCT01144923|Analgesics|analgesics|mesh-ancestor
154301225|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
154301226|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301227|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301228|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
154301229|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154301230|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154301231|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301232|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154301233|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154301234|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154301235|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301236|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301237|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
154301238|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154301239|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
154301263|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301265|NCT01145079|Sirolimus|sirolimus|mesh-list
154301266|NCT01145079|Everolimus|everolimus|mesh-list
154301267|NCT01145079|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154861594|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154255324|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
154301268|NCT01145079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154301269|NCT01145079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301270|NCT01145079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301271|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154301272|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
154301273|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301274|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301275|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154301276|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301277|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154301278|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
154301279|NCT01146483|Pantoprazole|pantoprazole|mesh-list
153520288|NCT06245564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301280|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154301281|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154301282|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154301283|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
154301284|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301311|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154301312|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301313|NCT03485222|Empagliflozin|empagliflozin|mesh-list
154301314|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154301315|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301316|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154301317|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301318|NCT01347554|Everolimus|everolimus|mesh-list
154301319|NCT01347554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154301320|NCT01347554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154301321|NCT01347554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301322|NCT01347554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301323|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154301324|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
154301325|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301326|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301327|NCT05567354|Oxycodone|oxycodone|mesh-list
154301328|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154301329|NCT05567354|Narcotics|narcotics|mesh-ancestor
154301330|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301331|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301332|NCT05567354|Analgesics|analgesics|mesh-ancestor
154301333|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
154301368|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154301369|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154301370|NCT03386474|Growth Substances|growth substances|mesh-ancestor
154301371|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301372|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
154301373|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301398|NCT02863354|Aflibercept|aflibercept|mesh-list
154301399|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154301400|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154301401|NCT02863354|Growth Substances|growth substances|mesh-ancestor
154301402|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301403|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
154301404|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301405|NCT02859454|Avelumab|avelumab|mesh-list
154301406|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154301407|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301408|NCT02862730|Pancrelipase|pancrelipase|mesh-list
154301409|NCT02862730|Pancreatin|pancreatin|mesh-list
154301410|NCT02862730|Hormones|hormones|mesh-list
154301411|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301412|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301413|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301414|NCT03609970|Vitamin D|vitamin d|mesh-list
154301415|NCT03609970|Vitamins|vitamins|mesh-ancestor
154301416|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
154301417|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301418|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154301419|NCT03610282|Propofol|propofol|mesh-list
154301420|NCT03610282|Methylphenidate|methylphenidate|mesh-list
154301421|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154301422|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301423|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301424|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154861595|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153937133|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301425|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
154301426|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
154301444|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
154301445|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301446|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154301447|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154301448|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
154301449|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154301450|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154301451|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154301452|NCT05383300|Oxytocin|oxytocin|mesh-list
154301453|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
154301454|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154301455|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301456|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154301457|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154301458|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301459|NCT02862106|Vaccines|vaccines|mesh-list
154301460|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
154301461|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301462|NCT03609892|Amoxicillin|amoxicillin|mesh-list
154301463|NCT03609892|Tetracycline|tetracycline|mesh-list
154301464|NCT03609892|Furazolidone|furazolidone|mesh-list
154301465|NCT03609892|Esomeprazole|esomeprazole|mesh-list
154301466|NCT03609892|Bismuth|bismuth|mesh-list
154301467|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154301468|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301469|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154301470|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301471|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154301472|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301473|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301474|NCT03609892|Antacids|antacids|mesh-ancestor
153520415|NCT06057519|Rifampin|rifampin|mesh-list
154301475|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154301476|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154301477|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154301478|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154301479|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154301480|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154301481|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154301482|NCT03609814|Fludarabine|fludarabine|mesh-list
154301501|NCT03351608|Neostigmine|neostigmine|mesh-list
154301502|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154301503|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154301504|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154301505|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
154301506|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301507|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301508|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154301509|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
154301510|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
154301511|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
154301512|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154301513|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154301514|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
154301515|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301516|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301517|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154301518|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301519|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154301520|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154301521|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154301522|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
154301523|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301524|NCT03382418|Antacids|antacids|mesh-ancestor
154301525|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301526|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301527|NCT02236936|Cetuximab|cetuximab|mesh-list
154301528|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301529|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154861596|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154301530|NCT03638960|Bupivacaine|bupivacaine|mesh-list
154301531|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
154301532|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
154301533|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301534|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301535|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
154301536|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301537|NCT02259790|Amlodipine|amlodipine|mesh-list
154301538|NCT02259790|Telmisartan|telmisartan|mesh-list
154301539|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154301540|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154301576|NCT03609190|Analgesics|analgesics|mesh-ancestor
154301577|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
154301578|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301579|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301580|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154301593|NCT02856802|Sumatriptan|sumatriptan|mesh-list
154301594|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154301595|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154301596|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154301597|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
154301598|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301599|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301600|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301601|NCT02024230|Warfarin|warfarin|mesh-list
154301602|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
154301603|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
154301604|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154301605|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
154301606|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154301607|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
154301608|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301609|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301610|NCT03380390|Phenylephrine|phenylephrine|mesh-list
154301611|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
154301612|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154301613|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154301614|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301615|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301616|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301617|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301618|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
154301619|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
154301620|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301621|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
154301622|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154301623|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
154301624|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154301625|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
154301626|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154048432|NCT04229615|Fluzoparib|fluzoparib|mesh-list
154301627|NCT03380390|Protective Agents|protective agents|mesh-ancestor
154301628|NCT02034292|Aspirin|aspirin|mesh-list
154301629|NCT02034292|Clopidogrel|clopidogrel|mesh-list
154301630|NCT02034292|APD791|apd791|mesh-list
154301631|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154301632|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154301633|NCT02034292|Analgesics|analgesics|mesh-ancestor
154301634|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
154301635|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301636|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301637|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154301638|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154301639|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154301640|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153520463|NCT05982093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301641|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301642|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154301664|NCT02237326|Acetic Acid|acetic acid|mesh-list
154301665|NCT02237326|Retinol acetate|retinol acetate|mesh-list
154301666|NCT02237326|Lugol's solution|lugol's solution|mesh-list
154301667|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154301668|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301669|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154301670|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
154301671|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301672|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154301673|NCT02237326|Protective Agents|protective agents|mesh-ancestor
154301674|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301675|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
154301676|NCT02237326|Coagulants|coagulants|mesh-ancestor
154301678|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154301680|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154301681|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301682|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301683|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301684|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301685|NCT02034604|Urological Agents|urological agents|mesh-ancestor
154301686|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
154301687|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154301688|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154301689|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301690|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301691|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301692|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301693|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
154301694|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
154301695|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301725|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
154301726|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154301727|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301728|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154301729|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
154301730|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154301731|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301732|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301733|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301735|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
154301736|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301737|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154301738|NCT03604354|Pregabalin|pregabalin|mesh-list
154301739|NCT03604354|Tapentadol|tapentadol|mesh-list
154301740|NCT03604354|Analgesics|analgesics|mesh-ancestor
154301741|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
154301770|NCT03603418|Hormones|hormones|mesh-ancestor
154301771|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301772|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154027394|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154301773|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301774|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
154301775|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301776|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301777|NCT02034838|Ritonavir|ritonavir|mesh-list
154301778|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154301779|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154301780|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154301781|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
154301782|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301783|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301784|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154301785|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154301804|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
154301805|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301806|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
154301807|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
154301808|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
154301809|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301810|NCT03606928|Antidotes|antidotes|mesh-ancestor
154301811|NCT03606928|Protective Agents|protective agents|mesh-ancestor
154301812|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301813|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
154301814|NCT03606928|Vitamins|vitamins|mesh-ancestor
154301815|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
154301816|NCT03602248|Methamphetamine|methamphetamine|mesh-list
154301817|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154301818|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301819|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
154301820|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
154301821|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301822|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
154301823|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301824|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301825|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301826|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154301827|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154301828|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301829|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154301830|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154301831|NCT03602638|Acarbose|acarbose|mesh-list
154301832|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154301833|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301834|NCT03602638|Incretins|incretins|mesh-ancestor
154301835|NCT03602638|Hormones|hormones|mesh-ancestor
154301836|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301837|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154301838|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
154301839|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301840|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301864|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154301865|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
154301866|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301867|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154301868|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154301869|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
154301870|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301871|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301872|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154301873|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154301874|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
154301875|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
154301876|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301877|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301878|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
154301879|NCT03601624|Hormones|hormones|mesh-ancestor
154301880|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301881|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154301882|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154301883|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154301884|NCT03601624|Growth Substances|growth substances|mesh-ancestor
154301885|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
154301886|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
154301887|NCT02238418|Vitamin D|vitamin d|mesh-list
154301888|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154301889|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301890|NCT02238418|Vitamins|vitamins|mesh-ancestor
154301891|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
154301892|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154301893|NCT02850016|Romidepsin|romidepsin|mesh-list
154301914|NCT03594604|Norethindrone|norethindrone|mesh-list
154301915|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
154301916|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
154301917|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154301918|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153520703|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
154301919|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301920|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154301921|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154301922|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154301923|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154301924|NCT02238184|Ipratropium|ipratropium|mesh-list
154301925|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154301926|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
154301927|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301928|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301929|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154301930|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
154301931|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154301932|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
154301933|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301934|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301935|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
154301936|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154301937|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154301938|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301939|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154301940|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154301941|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
154301943|NCT03600064|Misoprostol|misoprostol|mesh-list
154301944|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154301970|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154301971|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301972|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301973|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301974|NCT03577912|Anesthetics|anesthetics|mesh-list
154301975|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301976|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301977|NCT02238262|Telmisartan|telmisartan|mesh-list
154301978|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154301979|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154301980|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154301981|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301982|NCT03577834|Acetic Acid|acetic acid|mesh-list
154301983|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154301984|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301985|NCT03707678|Albuterol|albuterol|mesh-list
154301986|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154301987|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
154301988|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301989|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301990|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154301991|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
154301992|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
154302048|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302049|NCT02238340|Analgesics|analgesics|mesh-ancestor
154302050|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
154302051|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302052|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154302053|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154302054|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302055|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302056|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154302057|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302058|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302059|NCT03577132|Atezolizumab|atezolizumab|mesh-list
154302060|NCT03577132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154302061|NCT03577132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302062|NCT03577132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154302063|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302064|NCT02250664|Nicotine|nicotine|mesh-list
154302065|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154302066|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
154302067|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302068|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302069|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154302070|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154302071|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
154302072|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302073|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302074|NCT02239276|Stiripentol|stiripentol|mesh-list
154302075|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
154302077|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154302078|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
154302079|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
154302080|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302081|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302082|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
154302083|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302099|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
154302100|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
154302101|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154302102|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302104|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154302105|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154302106|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
153520943|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302107|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302108|NCT03576508|Lidocaine|lidocaine|mesh-list
154302109|NCT03576508|Epinephrine|epinephrine|mesh-list
154302110|NCT03576508|Capsaicin|capsaicin|mesh-list
154302111|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
154302113|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302114|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302116|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302117|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154302118|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154302119|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154302120|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302121|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302122|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154302123|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154302124|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
154302125|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302126|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154302127|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154302128|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
154302129|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154302130|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
154302131|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
154302132|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
154302133|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154302134|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
154302135|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
154302136|NCT02646982|Candesartan|candesartan|mesh-list
154302137|NCT02646982|Candesartan cilexetil|candesartan cilexetil|mesh-list
154302138|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154302139|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154302140|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154302159|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154302160|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302161|NCT03573934|Hormones|hormones|mesh-ancestor
154302162|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302163|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302164|NCT03573934|Incretins|incretins|mesh-ancestor
154302165|NCT02229136|Prednisolone|prednisolone|mesh-list
154302166|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
154302167|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302168|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
154302169|NCT02229136|Hormones|hormones|mesh-ancestor
154302170|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302171|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302172|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154302173|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302174|NCT02523898|Metformin|metformin|mesh-list
154302175|NCT02523898|Clomiphene|clomiphene|mesh-list
154302176|NCT02523898|Enclomiphene|enclomiphene|mesh-list
154302177|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
154302178|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154302179|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302180|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154302181|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
154302182|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302183|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154302184|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
154302185|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154302186|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154302187|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154302188|NCT02845336|Celecoxib|celecoxib|mesh-list
154302189|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
154302190|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154302191|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154302192|NCT02845336|Analgesics|analgesics|mesh-ancestor
154302193|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
154302194|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302195|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302220|NCT02951156|Rituximab|rituximab|mesh-list
154302222|NCT02951156|Gemcitabine|gemcitabine|mesh-list
154302223|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
154302224|NCT02951156|Azacitidine|azacitidine|mesh-list
154302225|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154302226|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154302227|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302228|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
154302230|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302231|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154302232|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
154302233|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302234|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302235|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154302236|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
154302237|NCT03571594|Octreotide|octreotide|mesh-list
154302238|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302239|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154302240|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302241|NCT03571438|Sirolimus|sirolimus|mesh-list
154302242|NCT03571438|Sunitinib|sunitinib|mesh-list
154302243|NCT03571438|Temsirolimus|temsirolimus|mesh-list
154302244|NCT03571438|MTOR Inhibitors|mtor inhibitors|mesh-list
154302245|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302246|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154302276|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
154302277|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154302278|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154302279|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
154302280|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
154302281|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302282|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302283|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302284|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
154302285|NCT01874860|Hormones|hormones|mesh-ancestor
154302286|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302287|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154302288|NCT01874860|Protective Agents|protective agents|mesh-ancestor
154302289|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154302290|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302291|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154302292|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302323|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
154302324|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
154302325|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302326|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302327|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302328|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
154302329|NCT03572686|Hormones|hormones|mesh-ancestor
154302330|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302331|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154302332|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302333|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
154302334|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302335|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302368|NCT05332496|Growth Substances|growth substances|mesh-ancestor
154302369|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302370|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
154302371|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302372|NCT03567304|Rilpivirine|rilpivirine|mesh-list
154302373|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154302374|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154302375|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302376|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302392|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302393|NCT03566914|Urological Agents|urological agents|mesh-ancestor
154302394|NCT03366428|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154302395|NCT03366428|Immunoconjugates|immunoconjugates|mesh-ancestor
154302396|NCT03366428|Immunologic Factors|immunologic factors|mesh-ancestor
154302397|NCT03366428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302398|NCT02839876|Acetaminophen|acetaminophen|mesh-list
154302399|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154302400|NCT02839876|Analgesics|analgesics|mesh-ancestor
154302401|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
154302402|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302403|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302404|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
154302405|NCT01312064|Rituximab|rituximab|mesh-list
154302406|NCT01312064|Everolimus|everolimus|mesh-list
154302407|NCT01312064|Tacrolimus|tacrolimus|mesh-list
154302409|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154302410|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302411|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
154302412|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302413|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302414|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154302415|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154302416|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302417|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302418|NCT01312064|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154302419|NCT01312064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154302420|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
154302421|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
154302422|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
154302423|NCT03566134|DA-8010|da-8010|mesh-list
154302424|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154302425|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154302426|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
154302427|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302428|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302429|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302430|NCT03566134|Urological Agents|urological agents|mesh-ancestor
154302431|NCT03101722|Huperzine A|huperzine a|mesh-list
154302432|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154302433|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302434|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302435|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
154302436|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302507|NCT03708848|Expectorants|expectorants|mesh-ancestor
154302508|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
154302509|NCT03564652|Azithromycin|azithromycin|mesh-list
154302510|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154302545|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154302546|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302548|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302549|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
154302550|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
153521263|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153521366|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
154302551|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
154302570|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302571|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
154302572|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302573|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
154302574|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
154302575|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
154302576|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
154302577|NCT00093015|Hematinics|hematinics|mesh-ancestor
154302578|NCT01145703|Vitamin D|vitamin d|mesh-list
154302579|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
154302580|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
154302581|NCT01145703|Vitamins|vitamins|mesh-list
154302582|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
154302583|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302584|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154302585|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154302586|NCT05137587|Ketamine|ketamine|mesh-list
154302587|NCT05137587|Propofol|propofol|mesh-list
154302588|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154302589|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302590|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302591|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154302592|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
154302593|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
154302594|NCT05137587|Analgesics|analgesics|mesh-ancestor
154302595|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
154302596|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302597|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154302598|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154302599|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154302600|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302601|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302603|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154302604|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
154302605|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154302606|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
154302607|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302609|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
154302625|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302626|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154302627|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154302628|NCT03708536|Growth Substances|growth substances|mesh-ancestor
154302629|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521524|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
154302630|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
154302631|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154302632|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
154302633|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302634|NCT03705728|Remifentanil|remifentanil|mesh-list
154302636|NCT03705728|Sevoflurane|sevoflurane|mesh-list
154302637|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154302638|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302639|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302640|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154302641|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
154302642|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
154302643|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154302644|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154302645|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154302646|NCT03705728|Narcotics|narcotics|mesh-ancestor
154302647|NCT03705728|Analgesics|analgesics|mesh-ancestor
154302648|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
154302649|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302650|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
154302651|NCT05177666|Trastuzumab|trastuzumab|mesh-list
154302652|NCT05177666|Pertuzumab|pertuzumab|mesh-list
154302653|NCT05177666|Vemurafenib|vemurafenib|mesh-list
154302654|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154302655|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302656|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154302657|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302658|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302659|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
154302660|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154302661|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
154302662|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
154302663|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154302664|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
154302665|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302666|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302667|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154302668|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
154302687|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302688|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154302689|NCT01246323|Narcotics|narcotics|mesh-ancestor
154302690|NCT01246323|Analgesics|analgesics|mesh-ancestor
154302691|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
154302692|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302693|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154302694|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154302695|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
154302696|NCT05160363|Piperaquine|piperaquine|mesh-list
154302697|NCT05160363|Pyronaridine|pyronaridine|mesh-list
154302698|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
154302699|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154302700|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154302701|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302703|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154302704|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154302705|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302706|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302707|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302708|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
154302709|NCT03708458|Indomethacin|indomethacin|mesh-list
154302710|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154302711|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
154302712|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302713|NCT03708458|Expectorants|expectorants|mesh-ancestor
154302714|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
154302715|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154302716|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
154302718|NCT03708458|Protective Agents|protective agents|mesh-ancestor
154302719|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302720|NCT03708458|Antidotes|antidotes|mesh-ancestor
154302721|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154302722|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154302723|NCT03708458|Analgesics|analgesics|mesh-ancestor
154302724|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
154302725|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302726|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302760|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302761|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302763|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154302764|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
154302765|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302766|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
154302767|NCT01147731|Warfarin|warfarin|mesh-list
154302768|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
154302802|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154302803|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302804|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302836|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
154302837|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154302838|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154302839|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302840|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302841|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302842|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302843|NCT04865835|Metformin|metformin|mesh-list
153521745|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302844|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154302845|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302846|NCT01248195|Olanzapine|olanzapine|mesh-list
154302847|NCT01248195|Clozapine|clozapine|mesh-list
154302877|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302878|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302879|NCT03709940|Methylphenidate|methylphenidate|mesh-list
154302880|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154302881|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302882|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154302883|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154302884|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302885|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302886|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
154302887|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302888|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
154302889|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154302890|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302891|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154302913|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154302914|NCT03915561|Parecoxib|parecoxib|mesh-list
154302915|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154302916|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154302917|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302918|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302919|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154302920|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154302921|NCT03915561|Analgesics|analgesics|mesh-ancestor
154302922|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
154302923|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302924|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302925|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302926|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302927|NCT01148277|Midazolam|midazolam|mesh-list
154302928|NCT01148277|Fentanyl|fentanyl|mesh-list
154302929|NCT01148277|Propofol|propofol|mesh-list
154302930|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154302931|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302932|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302933|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154302934|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
154302935|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
154302936|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154302937|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154302938|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154302939|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154302940|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
154302941|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
154302942|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302943|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302944|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154302945|NCT01148277|Narcotics|narcotics|mesh-ancestor
154302946|NCT01148277|Analgesics|analgesics|mesh-ancestor
154302947|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
154302962|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154302963|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302964|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302965|NCT01358734|Lenalidomide|lenalidomide|mesh-list
154302966|NCT01358734|Azacitidine|azacitidine|mesh-list
154302967|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
154302968|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302969|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154302970|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154302971|NCT01358734|Growth Substances|growth substances|mesh-ancestor
154302972|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
154302973|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302974|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154302975|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
154302976|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302978|NCT03907215|Citalopram|citalopram|mesh-list
154302979|NCT03907215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154302980|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154302981|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302982|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302983|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302984|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
154302985|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302986|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154302987|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
154302988|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154302989|NCT01250457|Timolol|timolol|mesh-list
154302990|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154302991|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154302992|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
154302993|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302994|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302995|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302996|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154302997|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154302998|NCT03902925|Lidocaine|lidocaine|mesh-list
154302999|NCT03902925|Ropivacaine|ropivacaine|mesh-list
154303000|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
154303001|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
154303002|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303003|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303004|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
153522023|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153522024|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154303005|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303006|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154303007|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154303008|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154303040|NCT01341652|Molgramostim|molgramostim|mesh-list
154303041|NCT01341652|Sargramostim|sargramostim|mesh-list
154303042|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
154303043|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303044|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303045|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
154303046|NCT03563794|Vildagliptin|vildagliptin|mesh-list
154303047|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154303048|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049844|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
154303050|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
154303051|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303052|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303076|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303077|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303078|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
154303079|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303080|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153937986|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303081|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154303082|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154303083|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154303084|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303085|NCT01148667|Caseins|caseins|mesh-list
154303086|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
154303087|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
154303088|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303089|NCT01254123|Exenatide|exenatide|mesh-list
154303090|NCT01254123|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154303091|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154303092|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303093|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154303094|NCT01254123|Incretins|incretins|mesh-ancestor
154303095|NCT01254123|Hormones|hormones|mesh-ancestor
154303096|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154303097|NCT03898635|Linezolid|linezolid|mesh-list
154303098|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303099|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303100|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154303101|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303136|NCT02527863|Tolvaptan|tolvaptan|mesh-list
154303137|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154303138|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303139|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
154303140|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303141|NCT01256541|Lactulose|lactulose|mesh-list
154303166|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154303167|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154303169|NCT01256619|Hormones|hormones|mesh-ancestor
154303170|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154303171|NCT03898011|Lamotrigine|lamotrigine|mesh-list
154303172|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
154303173|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154303174|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154303175|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303176|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154303177|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303178|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154303179|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154303180|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303181|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154303182|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154303183|NCT01254513|Prednisone|prednisone|mesh-list
154303184|NCT01254513|Docetaxel|docetaxel|mesh-list
154303185|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303186|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
154303187|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
154303188|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
154303189|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303190|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303191|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
154303192|NCT01254513|Hormones|hormones|mesh-ancestor
154303218|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303219|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303220|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154303221|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154303222|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
154303223|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303224|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154303225|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154303226|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
154303227|NCT03903783|Cefotaxime|cefotaxime|mesh-list
154303228|NCT03903783|Cefoxitin|cefoxitin|mesh-list
154303229|NCT03903783|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154303230|NCT03903783|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154303231|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303232|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303233|NCT03899337|Prednisolone|prednisolone|mesh-list
154303234|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
154303235|NCT03899337|Rituximab|rituximab|mesh-list
154303236|NCT03899337|Doxorubicin|doxorubicin|mesh-list
154303237|NCT03899337|Vincristine|vincristine|mesh-list
154861597|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154303238|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
154303239|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303240|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
154303241|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303259|NCT03899337|Hormones|hormones|mesh-ancestor
153522148|NCT04793529|Vitamin D|vitamin d|mesh-list
154303260|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522214|NCT06039592|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153522215|NCT06039592|Diuretics|diuretics|mesh-ancestor
154303261|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154303262|NCT03899337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154303263|NCT03899337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303264|NCT01586169|Azithromycin|azithromycin|mesh-list
154303265|NCT01586169|Ivermectin|ivermectin|mesh-list
154303266|NCT01586169|Albendazole|albendazole|mesh-list
154303267|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303268|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303269|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154303270|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
154303271|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
154303272|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154303273|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154303274|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
154303275|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
154303276|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
154303277|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303278|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303279|NCT01256775|Aspirin|aspirin|mesh-list
154303280|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
154303281|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154303282|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154303283|NCT01256775|Analgesics|analgesics|mesh-ancestor
154303284|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
154303285|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303286|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303287|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303288|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303289|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154303290|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154303291|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303292|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154303293|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154303294|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
154303295|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303296|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153522300|NCT06039202|Antiviral Agents|antiviral agents|mesh-ancestor
154303297|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
154303325|NCT01151787|Analgesics|analgesics|mesh-ancestor
154303326|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
154303327|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154303328|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154303329|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154303330|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303331|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
154303332|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303333|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
154303334|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154303335|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303336|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303337|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154303338|NCT01151865|Analgesics|analgesics|mesh-ancestor
154303339|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
154303340|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303341|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154303342|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154050153|NCT00669344|Rivastigmine|rivastigmine|mesh-list
154303369|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154303370|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
154303371|NCT01257165|Ethanol|ethanol|mesh-list
154303372|NCT01257165|Zopiclone|zopiclone|mesh-list
154303373|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154303374|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303375|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303376|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303377|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154303378|NCT01151943|Anesthetics|anesthetics|mesh-list
154303379|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
154303380|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303381|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303382|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
154303383|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303384|NCT01256151|Alprazolam|alprazolam|mesh-list
154303385|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154303386|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303387|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303388|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154303389|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154303390|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154303391|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
154303392|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
154303393|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303394|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303395|NCT01259973|Haloperidol|haloperidol|mesh-list
154303430|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303431|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
154303432|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154303433|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
154303434|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522441|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522443|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
154303435|NCT01258569|Alvimopan|alvimopan|mesh-list
154303436|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154303437|NCT01257399|Mesalamine|mesalamine|mesh-list
154303467|NCT01260129|Urological Agents|urological agents|mesh-ancestor
154303468|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154303469|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
154303470|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154303471|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154303472|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303473|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303474|NCT01260285|Urological Agents|urological agents|mesh-ancestor
154303476|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
154303477|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303478|NCT01151241|Anesthetics|anesthetics|mesh-list
154303479|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
154303480|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303503|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154303504|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
154303505|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303506|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
154303507|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154303508|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154303509|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154303510|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154303511|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154303512|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154303513|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154303515|NCT01154361|Icatibant|icatibant|mesh-list
154303516|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303517|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154303518|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154303519|NCT01154361|Analgesics|analgesics|mesh-ancestor
154303520|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
154303521|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303522|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303523|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303524|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154303525|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154303526|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303527|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153522568|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
153522569|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
154303528|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303529|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
154303530|NCT01260519|Heparin|heparin|mesh-list
154303531|NCT01260519|Calcium heparin|calcium heparin|mesh-list
154303549|NCT02947022|Edetic Acid|edetic acid|mesh-list
154303550|NCT02947022|Calcium|calcium|mesh-list
154303551|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
154303552|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154303553|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303554|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154303555|NCT02947022|Trace Elements|trace elements|mesh-ancestor
154303556|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
154303557|NCT02947022|Antidotes|antidotes|mesh-ancestor
154861598|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938205|NCT02710552|Indapamide|indapamide|mesh-list
154303558|NCT02947022|Protective Agents|protective agents|mesh-ancestor
154303559|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
154303560|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
154303561|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303562|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154303563|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
154303564|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154303565|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
154303566|NCT01259193|Sorafenib|sorafenib|mesh-list
154303567|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303568|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303569|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050382|NCT00669890|Busulfan|busulfan|mesh-list
154303570|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303571|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154303572|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303573|NCT05182892|Dopamine|dopamine|mesh-list
154303574|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
154303575|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154303576|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
154303577|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
154303578|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303579|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303580|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
154303581|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303582|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522697|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303583|NCT05182892|Protective Agents|protective agents|mesh-ancestor
154303584|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
154303585|NCT01312376|Bevacizumab|bevacizumab|mesh-list
154303586|NCT01312376|Fludarabine|fludarabine|mesh-list
154303587|NCT01312376|Vaccines|vaccines|mesh-list
154303588|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
154303589|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303610|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303612|NCT03887871|Tamsulosin|tamsulosin|mesh-list
154303613|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154303614|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154303615|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154303616|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
154303617|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303618|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303619|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303620|NCT03887871|Urological Agents|urological agents|mesh-ancestor
154303621|NCT03708146|Zamicastat|zamicastat|mesh-list
154303622|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303623|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303624|NCT01260753|Fluticasone|fluticasone|mesh-list
154303626|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303627|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154303628|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
154303629|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303630|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303631|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154303632|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
154303633|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
154303634|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154303635|NCT03895671|Azacitidine|azacitidine|mesh-list
154303636|NCT03895671|Ponatinib|ponatinib|mesh-list
154303637|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154303638|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
154303639|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303640|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303641|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303642|NCT03895671|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154050463|NCT00673088|Ropinirole|ropinirole|mesh-list
153522960|NCT02807207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153522961|NCT02807116|Rifampin|rifampin|mesh-list
154303664|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154303665|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154303666|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154861599|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154303667|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
154303668|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154303669|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154303670|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
154303671|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
154303672|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154303673|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303674|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303675|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
154303676|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154303677|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303678|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303679|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
154303680|NCT03338972|Fludarabine|fludarabine|mesh-list
154303681|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303682|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
154303683|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303684|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303685|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154303686|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
154303687|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303688|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303689|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154303690|NCT01151397|Vitamin D|vitamin d|mesh-list
154303691|NCT01151397|Ribavirin|ribavirin|mesh-list
154303692|NCT01151397|Vitamins|vitamins|mesh-ancestor
154303693|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
154303694|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303695|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154303720|NCT03886779|Analgesics|analgesics|mesh-ancestor
154303721|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
154303722|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303723|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303724|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303725|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153522976|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
154303726|NCT03887013|Trimetazidine|trimetazidine|mesh-list
154303727|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
154303728|NCT01261299|Carboplatin|carboplatin|mesh-list
154303729|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303730|NCT01154829|Aripiprazole|aripiprazole|mesh-list
154303731|NCT01154829|Amisulpride|amisulpride|mesh-list
154303732|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
154303733|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154303734|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154303735|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154303736|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303737|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303738|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
154303739|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
154303740|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303741|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303742|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154303743|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154303744|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
154303745|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154303746|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154303747|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154303748|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154303768|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303769|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303770|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303771|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303772|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154303773|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154303774|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303775|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154303776|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154303777|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303778|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
154303779|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
154303780|NCT01261689|Sufentanil|sufentanil|mesh-list
154303781|NCT01261689|Dsuvia|dsuvia|mesh-list
154303782|NCT01261689|Ropivacaine|ropivacaine|mesh-list
154303783|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
154303784|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
154303785|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303786|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303787|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
154303788|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303790|NCT01261689|Narcotics|narcotics|mesh-ancestor
154303791|NCT01261689|Analgesics|analgesics|mesh-ancestor
154303792|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154303793|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154303794|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
154303795|NCT01154907|Praziquantel|praziquantel|mesh-list
154303796|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
154303797|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154303798|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303799|NCT01261923|Alitretinoin|alitretinoin|mesh-list
154303800|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303801|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
154303802|NCT01157247|Fentanyl|fentanyl|mesh-list
154303803|NCT01157247|Anesthetics|anesthetics|mesh-list
154303804|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
154303805|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154303806|NCT01157247|Narcotics|narcotics|mesh-ancestor
154303807|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303841|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303843|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154303844|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154303845|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
154303846|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303863|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
154303864|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303865|NCT03885219|Paclitaxel|paclitaxel|mesh-list
154303866|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154303867|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303868|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
154303869|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
154303870|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
154303871|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303872|NCT01157559|Ziprasidone|ziprasidone|mesh-list
154303873|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154303874|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
154303875|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303876|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303877|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303878|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154303879|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154303880|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303881|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154303882|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154303883|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
154303884|NCT01263951|Everolimus|everolimus|mesh-list
154303885|NCT01263951|Sorafenib|sorafenib|mesh-list
154303886|NCT01263951|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154303887|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303888|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303889|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303890|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303891|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
154303892|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303893|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303894|NCT01265433|Molgramostim|molgramostim|mesh-list
154303895|NCT01265433|Sargramostim|sargramostim|mesh-list
154303896|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154303897|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
154303898|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303899|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303900|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154303901|NCT01265589|Vitamin A|vitamin a|mesh-list
154303902|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154303903|NCT01265589|Vitamins|vitamins|mesh-ancestor
154303904|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
154303928|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154303930|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
154303931|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
154303932|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154303933|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303934|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154303935|NCT03885141|Zolpidem|zolpidem|mesh-list
154303936|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154303937|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154303938|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303939|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303940|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154303941|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
154303942|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
154303943|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303944|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303945|NCT03879057|Antibodies|antibodies|mesh-list
154303946|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154050756|NCT04061824|Olmesartan|olmesartan|mesh-list
154303948|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303949|NCT01266057|Sirolimus|sirolimus|mesh-list
154303950|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
154303951|NCT01266057|Vorinostat|vorinostat|mesh-list
154303952|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303973|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154303974|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
154303975|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154303976|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303977|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154303978|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154303979|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303980|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303981|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
154303982|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154303983|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154303984|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
154303985|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523493|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303986|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303987|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303988|NCT01262391|Urological Agents|urological agents|mesh-ancestor
154303989|NCT03880695|Doxorubicin|doxorubicin|mesh-list
154303990|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154303991|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154303992|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303993|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154303994|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154303995|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303996|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303997|NCT01155765|Clopidogrel|clopidogrel|mesh-list
154303998|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154303999|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154304000|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154304001|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154304002|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154304003|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
154304004|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304005|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304030|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
154304031|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
154304032|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304033|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304034|NCT01262469|Capecitabine|capecitabine|mesh-list
154304036|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154304037|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
154304038|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304039|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304040|NCT01262469|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154304041|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154304042|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304043|NCT01155921|Risperidone|risperidone|mesh-list
154304044|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154304045|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
154304046|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304047|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304048|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304049|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154304050|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154304051|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304052|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304053|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154861600|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938508|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154304055|NCT03884127|Orlistat|orlistat|mesh-list
154304056|NCT03884127|Ezetimibe|ezetimibe|mesh-list
154304088|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154304089|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154304090|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
154304091|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304092|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304093|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154304094|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154304095|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
154304096|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154304097|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
154304099|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
154304100|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154304101|NCT01266681|Amiodarone|amiodarone|mesh-list
154304102|NCT01266681|Dronedarone|dronedarone|mesh-list
154304103|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154304135|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
154304136|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
154304137|NCT03878667|Calcium|calcium|mesh-list
154304138|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154304139|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304140|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154304141|NCT03878667|Antacids|antacids|mesh-ancestor
154304167|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304168|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304169|NCT01264731|Imiquimod|imiquimod|mesh-list
154304170|NCT01264731|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154304171|NCT01264731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304172|NCT01264731|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154304173|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
154304174|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523624|NCT03219047|Ibrutinib|ibrutinib|mesh-list
154304175|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154304176|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304177|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
154304178|NCT03879837|Fluticasone|fluticasone|mesh-list
154304179|NCT03879837|Xhance|xhance|mesh-list
154304180|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304181|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154304182|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
154304183|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304184|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304185|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154304186|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
154304187|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
154304188|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154304189|NCT05308628|Complement C3|complement c3|mesh-list
154304190|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
154304214|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154304215|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304216|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304217|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154304218|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
154304219|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
154304220|NCT02527083|Analgesics|analgesics|mesh-ancestor
154304221|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
154304222|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304223|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154304224|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154304225|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154304226|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304227|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304228|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154304229|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154304230|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154304231|NCT02527083|Narcotics|narcotics|mesh-ancestor
154304232|NCT05156684|Zinc|zinc|mesh-list
154304233|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
154304234|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
154861601|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
154304235|NCT05156684|Trace Elements|trace elements|mesh-ancestor
154304236|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
154304237|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304238|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154861602|NCT03032315|Diuretics|diuretics|mesh-ancestor
153938582|NCT02937766|Progestins|progestins|mesh-ancestor
154304239|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304240|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304241|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154304242|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154304243|NCT05156684|Protective Agents|protective agents|mesh-ancestor
154304262|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304263|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304264|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154304265|NCT03883347|Narcotics|narcotics|mesh-ancestor
154304266|NCT01159275|Lopinavir|lopinavir|mesh-list
154304267|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154304268|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154304269|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
154304270|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304271|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304272|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154304273|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154304274|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
154304275|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304276|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154304277|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154304278|NCT01159353|Insulin|insulin|mesh-list
154304279|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154304280|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
154304281|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
154304282|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154304283|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304284|NCT02943668|Deferasirox|deferasirox|mesh-list
154304285|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154304286|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
154304287|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
154304288|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304289|NCT01265199|Cytarabine|cytarabine|mesh-list
154304290|NCT01265199|Daunorubicin|daunorubicin|mesh-list
154304291|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154304292|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
154304293|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304294|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304295|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
154304296|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304297|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304298|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
154304299|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523796|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
154304300|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154304301|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154304330|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
154304331|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154304332|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
154304333|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154304334|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304335|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304336|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304337|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154304338|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154304339|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304340|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304341|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154304342|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
154304343|NCT01267305|PENTA|penta|mesh-list
154304344|NCT01267305|Nadroparin|nadroparin|mesh-list
154304345|NCT01267305|Fondaparinux|fondaparinux|mesh-list
154304346|NCT01267305|Calcium|calcium|mesh-list
154304347|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154304348|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304349|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154304350|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154304351|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
154304352|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154304378|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154304379|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154304380|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304381|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304382|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
154861603|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
154304383|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154304384|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
154304385|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154304386|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
154304387|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
154304388|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154304389|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154304390|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304391|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304393|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154304394|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154304396|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
154304397|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051196|NCT06156761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304398|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304422|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
154304423|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304424|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
154304425|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154304426|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
154304427|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
154304428|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304429|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304430|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154304431|NCT03283670|Analgesics|analgesics|mesh-ancestor
154304432|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
154304433|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304434|NCT03205358|Vaccines|vaccines|mesh-list
154304435|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
154304436|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304437|NCT01358578|Etanercept|etanercept|mesh-list
154304438|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154304439|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154304440|NCT01358578|Analgesics|analgesics|mesh-ancestor
154304441|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
154304442|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304443|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304444|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304445|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154304446|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154304447|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304474|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154304476|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304477|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154304478|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154304479|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154304480|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304482|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
154304483|NCT04745780|Vitamins|vitamins|mesh-ancestor
154304484|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
154304485|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304486|NCT02833948|Aspirin|aspirin|mesh-list
154304487|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
154304488|NCT02833948|Clopidogrel|clopidogrel|mesh-list
154304489|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154304490|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154304491|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154304492|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154304493|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
154304494|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304495|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304496|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304525|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304527|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
154304528|NCT01267695|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154304529|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154304530|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304531|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304532|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304534|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304535|NCT01162941|Prednisolone|prednisolone|mesh-list
154304536|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304537|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
154304538|NCT01162941|Hormones|hormones|mesh-ancestor
154304539|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304540|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304541|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154304542|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304543|NCT00161044|Galantamine|galantamine|mesh-list
154304580|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304581|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304603|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304604|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304605|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154304606|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154304607|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
154304608|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154304609|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304610|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
154304611|NCT05433272|Vaccines|vaccines|mesh-list
154304612|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
154304613|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304614|NCT01268631|Pregabalin|pregabalin|mesh-list
154304615|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154304616|NCT01268631|Analgesics|analgesics|mesh-ancestor
154304617|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
153524015|NCT01455636|Trace Elements|trace elements|mesh-list
154304618|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304619|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304620|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
154304621|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154304622|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154304623|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304624|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154304625|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154304626|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154304627|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304644|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304645|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304646|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154304647|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154304648|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304649|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
154304650|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
154304651|NCT02827708|Semaglutide|semaglutide|mesh-list
154304652|NCT02827708|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154304653|NCT02827708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154304654|NCT02827708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304655|NCT03881943|Aspirin|aspirin|mesh-list
154304656|NCT03881943|Ticagrelor|ticagrelor|mesh-list
154304657|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154304658|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154304659|NCT03881943|Analgesics|analgesics|mesh-ancestor
154304660|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
154304661|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304662|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304663|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304664|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154304665|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154304666|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154304667|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304668|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154304669|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154304670|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304671|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
153524066|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304672|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154304673|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154304674|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154304675|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
154304676|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304677|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154304678|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154304679|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154304680|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154304681|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154304682|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
154304683|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304702|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154304704|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
154304706|NCT05363384|Alogliptin|alogliptin|mesh-list
154304707|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154304708|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304709|NCT05363384|Incretins|incretins|mesh-ancestor
154304710|NCT05363384|Hormones|hormones|mesh-ancestor
154304711|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304712|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154304713|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
154304714|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304715|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304716|NCT01165125|Ketoconazole|ketoconazole|mesh-list
154304717|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
154304718|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304719|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154304720|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154304721|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304722|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304723|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154304724|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
154304725|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304726|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304727|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154304728|NCT01163799|Alefacept|alefacept|mesh-list
154304729|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
154304730|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
154304731|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304732|NCT02274662|Cyclosporine|cyclosporine|mesh-list
154304733|NCT02274662|Tacrolimus|tacrolimus|mesh-list
154304734|NCT02274662|Cyclosporins|cyclosporins|mesh-list
154304735|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154304736|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
153524126|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154304760|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304761|NCT03876015|Semaglutide|semaglutide|mesh-list
154304762|NCT03876015|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154304763|NCT03876015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154304764|NCT03876015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304765|NCT01280175|Charcoal|charcoal|mesh-list
154304766|NCT01280175|Antidotes|antidotes|mesh-ancestor
154304767|NCT01280175|Protective Agents|protective agents|mesh-ancestor
154304768|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304769|NCT01583283|Dexamethasone|dexamethasone|mesh-list
154304770|NCT01583283|Lenalidomide|lenalidomide|mesh-list
154304771|NCT01583283|Ricolinostat|ricolinostat|mesh-list
154304772|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154304773|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304774|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
154304775|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
154304776|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304777|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304778|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154304779|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
154304780|NCT01583283|Hormones|hormones|mesh-ancestor
154304781|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304782|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154304783|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304784|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
154304785|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154304786|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154304787|NCT01583283|Growth Substances|growth substances|mesh-ancestor
154304819|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154304820|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154304821|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
154304822|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304823|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154304824|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304827|NCT03330236|Anesthetics|anesthetics|mesh-list
154304859|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
154304860|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
154304861|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
154304862|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154304863|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154304864|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
154304865|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154304866|NCT03638726|Protective Agents|protective agents|mesh-ancestor
154304867|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153524217|NCT01460979|Sirolimus|sirolimus|mesh-list
154304868|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154304869|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
154304870|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154304871|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154304872|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
154304873|NCT01164189|Bevacizumab|bevacizumab|mesh-list
154304874|NCT01164189|Temozolomide|temozolomide|mesh-list
154304900|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154304901|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154304902|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154304903|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154304904|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
154304905|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304906|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304907|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304908|NCT02259868|Ritonavir|ritonavir|mesh-list
154304909|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154304910|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154304911|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
154304912|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304913|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304914|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154304915|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154304916|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
154304917|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304918|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154304919|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154304921|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154304922|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304945|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304946|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154304947|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304948|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154304949|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154304950|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
154304951|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154304952|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304953|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304954|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304956|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154304957|NCT01269099|Narcotics|narcotics|mesh-ancestor
154304958|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304959|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304960|NCT01269099|Analgesics|analgesics|mesh-ancestor
154304961|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
154304962|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524218|NCT01460979|Temsirolimus|temsirolimus|mesh-list
153524279|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154304963|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154304964|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154304965|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
154304966|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
154304967|NCT01164813|Nabumetone|nabumetone|mesh-list
154304968|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154304969|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154304970|NCT01164813|Analgesics|analgesics|mesh-ancestor
154304971|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
154304972|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305002|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154305003|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305004|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
154305005|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
154305006|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
153938951|NCT04558216|Rifampin|rifampin|mesh-list
154305007|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305008|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305009|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
154305010|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305011|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154305012|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154305013|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
154305014|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154305015|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154305016|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
154305017|NCT03563170|Antidotes|antidotes|mesh-ancestor
154305018|NCT03563170|Protective Agents|protective agents|mesh-ancestor
154305019|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
154305020|NCT03563170|Vitamins|vitamins|mesh-ancestor
154305038|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154305039|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154305041|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
154305042|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
154305043|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305044|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
154305045|NCT03869931|Fenofibrate|fenofibrate|mesh-list
154305046|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154305047|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
154305048|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305049|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154305050|NCT04876066|Ketamine|ketamine|mesh-list
154305051|NCT04876066|Analgesics|analgesics|mesh-ancestor
154305052|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
154305053|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305054|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305055|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154305056|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154305057|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
154305058|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
154305059|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305060|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154305061|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154305062|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305063|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305064|NCT01169805|Ondansetron|ondansetron|mesh-list
154305065|NCT01169805|Palonosetron|palonosetron|mesh-list
154305066|NCT01169805|Ramosetron|ramosetron|mesh-list
154305067|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
154305068|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
154305069|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305070|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305071|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154305072|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
154305073|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
154305074|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154305075|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154305076|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
154305077|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305100|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305102|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154305103|NCT01276431|Narcotics|narcotics|mesh-ancestor
154305104|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305105|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305106|NCT01276431|Analgesics|analgesics|mesh-ancestor
154305107|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
154305108|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305109|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154305110|NCT01281579|Canagliflozin|canagliflozin|mesh-list
154305111|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154305112|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305113|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154305114|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305115|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154305116|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154305117|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305118|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305119|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
154861604|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154305120|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305122|NCT01166451|Trace Elements|trace elements|mesh-ancestor
154305123|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
154305124|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305126|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
154305127|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154305128|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305158|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305159|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154305160|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154305161|NCT01167699|Oxycodone|oxycodone|mesh-list
154305162|NCT01167699|Naloxone|naloxone|mesh-list
154305163|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154305164|NCT01167699|Narcotics|narcotics|mesh-ancestor
154305165|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305166|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305167|NCT01167699|Analgesics|analgesics|mesh-ancestor
154305168|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
154305169|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305170|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154305171|NCT02526303|Nadroparin|nadroparin|mesh-list
154305172|NCT02526303|Warfarin|warfarin|mesh-list
154305173|NCT02526303|Calcium|calcium|mesh-list
154305174|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154305175|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305194|NCT01170351|Cyclosporins|cyclosporins|mesh-list
154305195|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305196|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305197|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305198|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
154305199|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305200|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
154305201|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305202|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
154305203|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154305204|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154305205|NCT01170429|Procaterol|procaterol|mesh-list
154305206|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154305207|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
154305208|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305209|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524495|NCT01464008|Ribavirin|ribavirin|mesh-list
154305210|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305211|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305212|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
154305213|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154305214|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154305215|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154305216|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
154305217|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305218|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305219|NCT01170507|Vitamin D|vitamin d|mesh-list
154305220|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
154305221|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
154305222|NCT01170507|Vitamins|vitamins|mesh-list
154305223|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
154305224|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305225|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154305226|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154305227|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154305228|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154305229|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154305230|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
154305231|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305232|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154305263|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154305265|NCT01168011|ON 01910|on 01910|mesh-list
154305266|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305267|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305268|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305269|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305270|NCT01171209|Interferons|interferons|mesh-list
154305271|NCT01171209|Interferon-beta|interferon-beta|mesh-list
154305272|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
154305273|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
154305274|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305276|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305277|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
154305278|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305279|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154305280|NCT01166685|Everolimus|everolimus|mesh-list
154305281|NCT01166685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154305282|NCT01166685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305283|NCT01166685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305284|NCT01166685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305285|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305286|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
154305287|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305288|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305289|NCT03870711|Lidocaine|lidocaine|mesh-list
154305290|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
154052099|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154305291|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
154305292|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305293|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305294|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
154305295|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305296|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154305297|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154305298|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154305299|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154305300|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305301|NCT03872505|Paclitaxel|paclitaxel|mesh-list
154305302|NCT03872505|Carboplatin|carboplatin|mesh-list
154305303|NCT03872505|Durvalumab|durvalumab|mesh-list
154305304|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154305305|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305306|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
154305307|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
154305308|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
154305309|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305310|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154305311|NCT01171365|Ciclesonide|ciclesonide|mesh-list
154305312|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
154305313|NCT01171365|Hormones|hormones|mesh-ancestor
154305314|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154305315|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305316|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154305317|NCT01281891|Morphine|morphine|mesh-list
154305318|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154305319|NCT01281891|Narcotics|narcotics|mesh-ancestor
154305320|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305321|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305322|NCT01281891|Analgesics|analgesics|mesh-ancestor
154305323|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
154305324|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305325|NCT01282047|Lenalidomide|lenalidomide|mesh-list
154305326|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
154305327|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305328|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154305329|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154305330|NCT01282047|Growth Substances|growth substances|mesh-ancestor
153524607|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305331|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
154305332|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305333|NCT02525991|Loxapine|loxapine|mesh-list
154305334|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154305335|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154305336|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305337|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305338|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154305339|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154305340|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
154305341|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305342|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305343|NCT01171755|Gemcitabine|gemcitabine|mesh-list
154305344|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154305345|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
154305346|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305347|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305350|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
154305351|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305352|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305353|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305354|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305355|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154305356|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
154305357|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305358|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305359|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154305360|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
154305361|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
154305362|NCT01172691|Protective Agents|protective agents|mesh-ancestor
154305363|NCT01171833|Sevoflurane|sevoflurane|mesh-list
154305364|NCT01171833|Desflurane|desflurane|mesh-list
154305365|NCT01171833|Isoflurane|isoflurane|mesh-list
154305366|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154305367|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154305368|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
154305369|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
154305370|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305371|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305372|NCT01172769|Sirolimus|sirolimus|mesh-list
154305373|NCT01172769|Temsirolimus|temsirolimus|mesh-list
154305374|NCT01172769|MTOR Inhibitors|mtor inhibitors|mesh-list
154305375|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
154305376|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305377|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305378|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305379|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
154305380|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305381|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305382|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154305383|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305384|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154305385|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
154305386|NCT01584531|ON 01910|on 01910|mesh-list
154305387|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305388|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305389|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305390|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305391|NCT01171911|Nicardipine|nicardipine|mesh-list
154305392|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
154305393|NCT01171911|Esmolol|esmolol|mesh-list
154305394|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154305395|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305396|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154305397|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154305398|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154305399|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
154305400|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305401|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305402|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154305403|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154305404|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
154305405|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
154305406|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154305407|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
154305408|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305409|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305410|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305411|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305412|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
154305413|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154305414|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
154305415|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305416|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305417|NCT01173003|Misoprostol|misoprostol|mesh-list
154305418|NCT01173003|Mifepristone|mifepristone|mesh-list
154305419|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154305420|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
154305422|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305424|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154305426|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154305427|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154305428|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154305429|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154305430|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
154305431|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154305432|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154305433|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
154305434|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154305435|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
154305436|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154305437|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154305438|NCT01172223|Paclitaxel|paclitaxel|mesh-list
154305439|NCT01172223|Doxorubicin|doxorubicin|mesh-list
154305441|NCT01172223|Lapatinib|lapatinib|mesh-list
154305442|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154305443|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305444|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
154305445|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
154305446|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
154305447|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305448|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154305449|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154305450|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154305451|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305452|NCT01172223|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154305453|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305454|NCT01173081|Teriparatide|teriparatide|mesh-list
154305455|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154305456|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305457|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154305458|NCT03866733|Narcotics|narcotics|mesh-list
154305459|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305460|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305461|NCT03866733|Analgesics|analgesics|mesh-ancestor
154305462|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
154305463|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305464|NCT01168791|Doxorubicin|doxorubicin|mesh-list
154305465|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154305466|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
154305467|NCT01168791|Ifosfamide|ifosfamide|mesh-list
154305468|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154305469|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305470|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153524776|NCT01467531|Cabotegravir|cabotegravir|mesh-list
153524844|NCT01468025|Analgesics|analgesics|mesh-ancestor
154305471|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154305472|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305473|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305474|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154305475|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
154305476|NCT01284309|Mirabegron|mirabegron|mesh-list
154305477|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154305478|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154305479|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154305480|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
154305481|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305482|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305483|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305484|NCT01284309|Urological Agents|urological agents|mesh-ancestor
154305485|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154305486|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305487|NCT01169025|Fentanyl|fentanyl|mesh-list
154305488|NCT01169025|Ketamine|ketamine|mesh-list
154305489|NCT01169025|Analgesics|analgesics|mesh-ancestor
154305490|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
154305491|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305492|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305493|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154305494|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154305495|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
154305496|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
153939313|NCT04310579|Paroxetine|paroxetine|mesh-list
154305497|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305498|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154305499|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154305500|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305501|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305502|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154305503|NCT01169025|Narcotics|narcotics|mesh-ancestor
154305504|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154305505|NCT01582347|Buprenorphine|buprenorphine|mesh-list
154305506|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154305507|NCT01582347|Naloxone|naloxone|mesh-list
154305508|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154305509|NCT01582347|Narcotics|narcotics|mesh-ancestor
154305510|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305511|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305512|NCT01582347|Analgesics|analgesics|mesh-ancestor
154305513|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
154305514|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305515|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154305517|NCT01336634|Dabrafenib|dabrafenib|mesh-list
154305518|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305519|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305520|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305521|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305522|NCT01284855|Antivenins|antivenins|mesh-list
154305523|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
154305524|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305525|NCT00785798|Doxorubicin|doxorubicin|mesh-list
154305526|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154305527|NCT00785798|Vorinostat|vorinostat|mesh-list
154305528|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154305529|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305530|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154305531|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154305532|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305533|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305534|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154305535|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
154305536|NCT01175109|Panobinostat|panobinostat|mesh-list
154305537|NCT01175109|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154305538|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305539|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305540|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305541|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305542|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154305543|NCT01282515|Clobetasol|clobetasol|mesh-list
154305544|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154305545|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
154305546|NCT01282515|Hormones|hormones|mesh-ancestor
154305547|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154305548|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305549|NCT03329846|Nivolumab|nivolumab|mesh-list
154305550|NCT03329846|Linrodostat|linrodostat|mesh-list
154305551|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154305552|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305553|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154305554|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305555|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305556|NCT04020848|Melatonin|melatonin|mesh-list
154305557|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
154305558|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305559|NCT04020848|Protective Agents|protective agents|mesh-ancestor
154305560|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305561|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305562|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154305563|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154305564|NCT01355302|Capecitabine|capecitabine|mesh-list
154305565|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305566|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154305567|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
154305568|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305569|NCT01355068|Phenytoin|phenytoin|mesh-list
154861605|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154305571|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154305573|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154305574|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305575|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154305576|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154305577|NCT03562780|Acetaminophen|acetaminophen|mesh-list
154305578|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154305579|NCT03562780|Analgesics|analgesics|mesh-ancestor
154305580|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
154305581|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305582|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305583|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
154305584|NCT02259946|Bromides|bromides|mesh-list
154305585|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
154305586|NCT02259946|Olodaterol|olodaterol|mesh-list
154305587|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154052427|NCT03131765|Poly I-C|poly i-c|mesh-list
154305588|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
154305589|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305590|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305591|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305592|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305593|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
154305594|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154305595|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
154305596|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305597|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305598|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
154305599|NCT03756129|Ketamine|ketamine|mesh-list
154305600|NCT03756129|Analgesics|analgesics|mesh-ancestor
154305601|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
154305602|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305603|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305604|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154305605|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154305606|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
154305607|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
154305608|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305609|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154305610|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154305611|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305612|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305613|NCT03863691|Amisulpride|amisulpride|mesh-list
154305614|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154305615|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154305616|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305617|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305618|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154305619|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154305620|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
154305621|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305622|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305623|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154305624|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
154305625|NCT02822794|Ribavirin|ribavirin|mesh-list
154305626|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
154305627|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154305628|NCT02822794|Velpatasvir|velpatasvir|mesh-list
154305629|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
154305630|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305631|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
154305632|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305633|NCT01173315|Vitamins|vitamins|mesh-list
154305634|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
154305635|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305636|NCT01173549|Canagliflozin|canagliflozin|mesh-list
154305637|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154305638|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305639|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154305640|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305641|NCT01338298|Aripiprazole|aripiprazole|mesh-list
154305644|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154305645|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154305646|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305647|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305648|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
154305649|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
154305650|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305651|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305652|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154305653|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154305654|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
154305655|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154305656|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154305657|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154305658|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154305659|NCT01169415|Dexamethasone|dexamethasone|mesh-list
154305660|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
154305661|NCT01169415|BB 1101|bb 1101|mesh-list
154305662|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154305663|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
154305664|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
154305665|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305666|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305667|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154305668|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
154305670|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154305671|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154305672|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305673|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
154305674|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305675|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305676|NCT01173627|Fentanyl|fentanyl|mesh-list
154305677|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154305678|NCT01173627|Narcotics|narcotics|mesh-ancestor
154305679|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305680|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305681|NCT01173627|Analgesics|analgesics|mesh-ancestor
154305682|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
154305683|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305684|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154305685|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154305686|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
154305687|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
154305688|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
154305689|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154305690|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305691|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305692|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154305693|NCT01169571|Analgesics|analgesics|mesh-ancestor
154305694|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
154305695|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305696|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154305697|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154305698|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154305699|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525117|NCT06077019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305700|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305701|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305702|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
154305703|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154305704|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
154305705|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305706|NCT01354132|Expectorants|expectorants|mesh-ancestor
154305707|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305708|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154305709|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
154305710|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305711|NCT01354132|Protective Agents|protective agents|mesh-ancestor
154305712|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305713|NCT01354132|Antidotes|antidotes|mesh-ancestor
154305714|NCT05707936|Heparin|heparin|mesh-list
154305715|NCT05707936|Anticoagulants|anticoagulants|mesh-ancestor
154305717|NCT05707936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154305718|NCT05707936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305720|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154305721|NCT01372150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154305722|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154305723|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154305724|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305725|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305726|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
154305727|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305728|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154305729|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
154305730|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154305731|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154305732|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154305733|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305734|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154305735|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154305736|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154305737|NCT01175577|Carotenoids|carotenoids|mesh-list
154305738|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
153525119|NCT06077019|Dermatologic Agents|dermatologic agents|mesh-ancestor
154305739|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305740|NCT01175577|Protective Agents|protective agents|mesh-ancestor
154305741|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305742|NCT01175733|Panitumumab|panitumumab|mesh-list
154305743|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154305744|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305745|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
154305746|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154305747|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305748|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305749|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154305750|NCT02035930|Analgesics|analgesics|mesh-ancestor
154305751|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
154305752|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305753|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154305754|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154305755|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154305756|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
154305757|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305758|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305759|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154305760|NCT01173939|Pravastatin|pravastatin|mesh-list
154305761|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154305762|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154305763|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
154305764|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305765|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154305766|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154305767|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305768|NCT01174017|Iodine|iodine|mesh-list
154305769|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
154305770|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154305771|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305772|NCT01174017|Trace Elements|trace elements|mesh-ancestor
154305773|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
154305774|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305775|NCT01288131|Cyclosporine|cyclosporine|mesh-list
154305776|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
153525242|NCT06072898|Antimetabolites|antimetabolites|mesh-ancestor
153525243|NCT06072898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305777|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
154305778|NCT01288131|Cyclosporins|cyclosporins|mesh-list
154305779|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305780|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
154305781|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305782|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154305783|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154305784|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
154305785|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305786|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305788|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305789|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
154305790|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305791|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
154305792|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154305793|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154305794|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154305795|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
153939607|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
154305796|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154305797|NCT02525211|Ropivacaine|ropivacaine|mesh-list
154305798|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
154305799|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
154305800|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305801|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305802|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
154305803|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305804|NCT03865563|Gemcitabine|gemcitabine|mesh-list
154305805|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
154305806|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154305807|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
154305808|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052626|NCT01897454|Antidotes|antidotes|mesh-ancestor
154305809|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305810|NCT01178151|Everolimus|everolimus|mesh-list
154305811|NCT01178151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154305812|NCT01178151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305813|NCT01178151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305814|NCT01178151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305815|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305816|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
154305817|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305818|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305819|NCT03862287|Lidocaine|lidocaine|mesh-list
154305820|NCT03862287|Bupivacaine|bupivacaine|mesh-list
154305821|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
154305822|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
154305823|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305824|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305825|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
154305826|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305827|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154305828|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154305829|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154305830|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154305831|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305832|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154305833|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154305834|NCT01287351|Fluticasone|fluticasone|mesh-list
154305835|NCT01287351|Xhance|xhance|mesh-list
154305836|NCT01287351|Beclomethasone|beclomethasone|mesh-list
154305837|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154305838|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154305839|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
154305840|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305841|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305842|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305843|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305844|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
154305845|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154305846|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
154305847|NCT01287351|Hormones|hormones|mesh-ancestor
154305848|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154305849|NCT03864783|Curcumin|curcumin|mesh-list
154305850|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154305851|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154305852|NCT03864783|Analgesics|analgesics|mesh-ancestor
154305853|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
154305854|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305855|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305856|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154305857|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154305858|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305859|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305860|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305861|NCT01287507|Lactoferrin|lactoferrin|mesh-list
154305862|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305863|NCT03864705|Metformin|metformin|mesh-list
154305864|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154305865|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305866|NCT01287663|Permethrin|permethrin|mesh-list
154305867|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305868|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305870|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305871|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305872|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305873|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305874|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
154305875|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154305876|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
154305877|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305878|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305879|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305880|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305881|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154305882|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154305883|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154305884|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
154305885|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305886|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305888|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154305889|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154305890|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305891|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305892|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
154305893|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154305894|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305895|NCT01174953|Urological Agents|urological agents|mesh-ancestor
154305896|NCT01286103|Canagliflozin|canagliflozin|mesh-list
154305897|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154305898|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305899|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154305900|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305901|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
154305902|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
154305903|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154305904|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
154305905|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305906|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305907|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305908|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305909|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
154305910|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154305911|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
153525454|NCT05939674|GABA Agents|gaba agents|mesh-ancestor
154305912|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154305913|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305914|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154305915|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154305916|NCT03863925|Propofol|propofol|mesh-list
154305917|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154305918|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305919|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305920|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154305921|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
154305922|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
154305923|NCT01178697|Triamcinolone|triamcinolone|mesh-list
154305924|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154305925|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154305926|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154305927|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154305928|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
154305929|NCT01178697|Hormones|hormones|mesh-ancestor
154305930|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154305931|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305932|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154305933|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
154305936|NCT03329690|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154305937|NCT03329690|Immunoconjugates|immunoconjugates|mesh-ancestor
154305938|NCT03329690|Immunologic Factors|immunologic factors|mesh-ancestor
154305939|NCT03329690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305940|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
154305941|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
154305942|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
154305943|NCT03328832|Thrombin|thrombin|mesh-list
154305944|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154305945|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154305946|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305947|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
154305948|NCT03328832|Coagulants|coagulants|mesh-ancestor
154305949|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154305950|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
154305951|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154305952|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
154305953|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305954|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
154305955|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
154305956|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154305957|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154305958|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154305959|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154305960|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154305961|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305962|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154305963|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305964|NCT02942576|Warfarin|warfarin|mesh-list
154305965|NCT02942576|Edoxaban|edoxaban|mesh-list
154305966|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
154305967|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
154305968|NCT02942576|Fluindione|fluindione|mesh-list
154305969|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
154305970|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153525565|NCT05742295|Vitamin K|vitamin k|mesh-list
154305971|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
154305972|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154305973|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
154305974|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305975|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305976|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
154305977|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154305978|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305979|NCT02036008|Liver Extracts|liver extracts|mesh-list
154305980|NCT02036008|Hematinics|hematinics|mesh-ancestor
154305981|NCT02819440|Tadalafil|tadalafil|mesh-list
154305982|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
154305983|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154305984|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154305985|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305986|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305987|NCT02819440|Urological Agents|urological agents|mesh-ancestor
154305988|NCT03562468|Niacinamide|niacinamide|mesh-list
154305989|NCT03562468|Niacin|niacin|mesh-list
154305990|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
154305991|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
154305992|NCT03562468|Vitamins|vitamins|mesh-ancestor
154305993|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
154305994|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305995|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154305996|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
154305997|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305998|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154305999|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
154306000|NCT02036164|Paclitaxel|paclitaxel|mesh-list
154306001|NCT02036164|Cisplatin|cisplatin|mesh-list
154306002|NCT02036164|Carboplatin|carboplatin|mesh-list
154306003|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154306004|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306005|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
154306006|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
154306007|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
154306008|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306009|NCT02818036|Naltrexone|naltrexone|mesh-list
154306010|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154306012|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525611|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
154306013|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
154306014|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306016|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
154306017|NCT01287741|Rituximab|rituximab|mesh-list
154306018|NCT01287741|Doxorubicin|doxorubicin|mesh-list
154306019|NCT01287741|Vincristine|vincristine|mesh-list
154306020|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
154306021|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306022|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
154306023|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306024|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306025|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154255328|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154255329|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255330|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154255331|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255332|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
154255333|NCT00314327|Risperidone|risperidone|mesh-list
154255334|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154255335|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
154255336|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255337|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255338|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255339|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154255340|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153939830|NCT02703064|Fenugreek seed meal|fenugreek seed meal|mesh-list
154306026|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
154306027|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306028|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306029|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154306030|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306031|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154306032|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154306033|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154306034|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306035|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306036|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
154306037|NCT01287741|Hormones|hormones|mesh-ancestor
154306038|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306039|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154306040|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154861607|NCT01090921|Bortezomib|bortezomib|mesh-list
154306041|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
154306042|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
154306043|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
154306044|NCT01180959|Bevacizumab|bevacizumab|mesh-list
154306045|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154306046|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306047|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306048|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154306049|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154306050|NCT01180959|Growth Substances|growth substances|mesh-ancestor
154306051|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306052|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
154306053|NCT01180959|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154306054|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154306055|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306056|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306057|NCT01177371|Cyclosporine|cyclosporine|mesh-list
154306058|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
154306059|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154306060|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154306061|NCT01177371|Prednisolone|prednisolone|mesh-list
154306062|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
154306063|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
154306064|NCT01177371|Busulfan|busulfan|mesh-list
154306065|NCT01177371|Methotrexate|methotrexate|mesh-list
154306066|NCT01177371|Cyclosporins|cyclosporins|mesh-list
154306067|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154306068|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
154306069|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306070|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
154861608|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861609|NCT03537274|Interferons|interferons|mesh-list
154861610|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
154861611|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
154861612|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154861613|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861614|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
154861615|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861616|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
154861617|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861618|NCT00939653|Cytarabine|cytarabine|mesh-list
154861619|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
154861620|NCT00939653|Etoposide|etoposide|mesh-list
154861621|NCT00939653|Clofarabine|clofarabine|mesh-list
154861622|NCT00939653|Lenograstim|lenograstim|mesh-list
154861623|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306071|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306072|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306073|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154306074|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
154306075|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306076|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306077|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154306078|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154306079|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
153525675|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306080|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154306081|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154306082|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
154306083|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
154306084|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306087|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
154306088|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306089|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154306090|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306091|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
154306092|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
154306093|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306094|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306095|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
154306096|NCT01177371|Hormones|hormones|mesh-ancestor
154306097|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306098|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154306099|NCT01177371|Protective Agents|protective agents|mesh-ancestor
154306100|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154306101|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
154306102|NCT01178931|Progesterone|progesterone|mesh-list
154306103|NCT01178931|Progestins|progestins|mesh-ancestor
154306104|NCT01178931|Hormones|hormones|mesh-ancestor
154306105|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306106|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306107|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
154306108|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154306109|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
154306110|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306111|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306112|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
154306113|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306114|NCT01181193|Vitamin D|vitamin d|mesh-list
154306115|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
154306116|NCT01181193|Temozolomide|temozolomide|mesh-list
154306117|NCT01181193|Vitamins|vitamins|mesh-ancestor
154306118|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
154306119|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306120|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154306121|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154306122|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
154306123|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306124|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306125|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154306126|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
153525871|NCT05081674|Nivolumab|nivolumab|mesh-list
154306127|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306128|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306129|NCT03855579|Simendan|simendan|mesh-list
154306130|NCT03855579|Milrinone|milrinone|mesh-list
154306131|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154306132|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
154306133|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154306134|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154306135|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306136|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306137|NCT03855579|Protective Agents|protective agents|mesh-ancestor
154306138|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306139|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154306140|NCT03855423|Tocotrienols|tocotrienols|mesh-list
154306141|NCT03855423|Vitamin E|vitamin e|mesh-list
154306142|NCT03855423|Tocopherols|tocopherols|mesh-list
154306143|NCT03855423|Tocovid|tocovid|mesh-list
154306144|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
154306145|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306146|NCT03855423|Protective Agents|protective agents|mesh-ancestor
153939966|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
154306147|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306148|NCT03855423|Vitamins|vitamins|mesh-ancestor
154306149|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
154306150|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154306151|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154306152|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154306153|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
154306154|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306155|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306156|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306157|NCT01181505|Urological Agents|urological agents|mesh-ancestor
154306158|NCT01290783|Irinotecan|irinotecan|mesh-list
154306160|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154306161|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306162|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306163|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306164|NCT03857763|Paclitaxel|paclitaxel|mesh-list
154306165|NCT03857763|Apatinib|apatinib|mesh-list
154306166|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154306167|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306168|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
154306169|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
154306170|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
154306171|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306172|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153525873|NCT05081674|Alectinib|alectinib|mesh-list
154306173|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306174|NCT06008327|Tretinoin|tretinoin|mesh-list
154306175|NCT06008327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306176|NCT06008327|Keratolytic Agents|keratolytic agents|mesh-ancestor
154306177|NCT06008327|Dermatologic Agents|dermatologic agents|mesh-ancestor
154306178|NCT06008249|Lithium Carbonate|lithium carbonate|mesh-list
154306179|NCT06008249|Antidepressive Agents|antidepressive agents|mesh-ancestor
154306180|NCT06008249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154306181|NCT06008249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306182|NCT06008249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306183|NCT06008249|Antimanic Agents|antimanic agents|mesh-ancestor
154306184|NCT06008249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154306185|NCT06008249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306186|NCT06008249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306187|NCT06008223|Vitamin B 6|vitamin b 6|mesh-list
154306189|NCT06008223|Pyridoxine|pyridoxine|mesh-list
154306190|NCT06008223|Vitamins|vitamins|mesh-ancestor
154306191|NCT06008223|Micronutrients|micronutrients|mesh-ancestor
154306192|NCT06008223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306193|NCT06008223|Vitamin B Complex|vitamin b complex|mesh-ancestor
154306194|NCT06008119|Bevacizumab|bevacizumab|mesh-list
154306195|NCT06008119|Cetuximab|cetuximab|mesh-list
154306196|NCT06008119|Vemurafenib|vemurafenib|mesh-list
154306197|NCT06008119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306198|NCT06008119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306199|NCT06008119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154306200|NCT06008119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154306201|NCT06008119|Growth Substances|growth substances|mesh-ancestor
154306202|NCT06008119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306203|NCT06008119|Growth Inhibitors|growth inhibitors|mesh-ancestor
154306204|NCT06008119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154306205|NCT06008119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306206|NCT06008119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306207|NCT06008106|Paclitaxel|paclitaxel|mesh-list
154306208|NCT06008106|Cisplatin|cisplatin|mesh-list
154306209|NCT06008106|Carboplatin|carboplatin|mesh-list
154306210|NCT06008106|Temozolomide|temozolomide|mesh-list
154306211|NCT06008106|Dacarbazine|dacarbazine|mesh-list
154306212|NCT06008106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154306213|NCT06008106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306214|NCT06008106|Tubulin Modulators|tubulin modulators|mesh-ancestor
154306215|NCT06008106|Antimitotic Agents|antimitotic agents|mesh-ancestor
154306216|NCT06008106|Mitosis Modulators|mitosis modulators|mesh-ancestor
154306217|NCT06008106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306218|NCT06008106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154306219|NCT06008106|Alkylating Agents|alkylating agents|mesh-ancestor
154306220|NCT06007937|Ramucirumab|ramucirumab|mesh-list
154861624|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
154306221|NCT06007937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154306222|NCT06007937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154306223|NCT06007937|Growth Substances|growth substances|mesh-ancestor
154255341|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306224|NCT06007937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306225|NCT06007937|Growth Inhibitors|growth inhibitors|mesh-ancestor
154306226|NCT06007937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306227|NCT06007573|Nimodipine|nimodipine|mesh-list
154306228|NCT06007573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154306229|NCT06007573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154306230|NCT06007573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154306231|NCT06007573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306232|NCT06007573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154306233|NCT06007573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306234|NCT06007573|Vasodilator Agents|vasodilator agents|mesh-ancestor
154306236|NCT06007222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154306237|NCT06007222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154306238|NCT06007222|Analgesics|analgesics|mesh-ancestor
154306239|NCT06007222|Sensory System Agents|sensory system agents|mesh-ancestor
154306240|NCT06007222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306241|NCT06007222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306242|NCT06007222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306243|NCT06007222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306244|NCT06007222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154306245|NCT06007222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154306246|NCT06007222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306247|NCT06007222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154306248|NCT06007222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154306249|NCT06007222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306250|NCT06007222|Antipyretics|antipyretics|mesh-ancestor
154306251|NCT06006949|Luspatercept|luspatercept|mesh-list
154306252|NCT06006949|Hematinics|hematinics|mesh-ancestor
154306253|NCT06006923|Pembrolizumab|pembrolizumab|mesh-list
154306254|NCT06006923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306255|NCT06006923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306256|NCT06006923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154306257|NCT06006923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306258|NCT06006663|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154306259|NCT06006663|Metronidazole|metronidazole|mesh-list
154306260|NCT06006663|Ciprofloxacin|ciprofloxacin|mesh-list
154306261|NCT06006663|Clindamycin|clindamycin|mesh-list
154306262|NCT06006663|Ibuprofen|ibuprofen|mesh-list
154306263|NCT06006663|Curcumin|curcumin|mesh-list
154053084|NCT00680654|Riociguat|riociguat|mesh-list
154306264|NCT06006663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306265|NCT06006663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154306266|NCT06006663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154306267|NCT06006663|Analgesics|analgesics|mesh-ancestor
154306268|NCT06006663|Sensory System Agents|sensory system agents|mesh-ancestor
154306269|NCT06006663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306270|NCT06006663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306271|NCT06006663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306272|NCT06006663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306273|NCT06006663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154306274|NCT06006663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306275|NCT06006663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306276|NCT06006663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154306277|NCT06006663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154306278|NCT06006663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154306279|NCT06006663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154306280|NCT06006663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306281|NCT06006663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154306282|NCT06006663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154306283|NCT06006663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154306284|NCT06006650|Paclitaxel|paclitaxel|mesh-list
154306285|NCT06006650|Pembrolizumab|pembrolizumab|mesh-list
154306286|NCT06006650|Fluorouracil|fluorouracil|mesh-list
154306287|NCT06006650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154306288|NCT06006650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306289|NCT06006650|Tubulin Modulators|tubulin modulators|mesh-ancestor
154306290|NCT06006650|Antimitotic Agents|antimitotic agents|mesh-ancestor
154306291|NCT06006650|Mitosis Modulators|mitosis modulators|mesh-ancestor
154306292|NCT06006650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306293|NCT06006650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306294|NCT06006650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154306295|NCT06006650|Antimetabolites|antimetabolites|mesh-ancestor
154861625|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306296|NCT06006650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154306297|NCT06006650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306298|NCT06006650|Immunologic Factors|immunologic factors|mesh-ancestor
154306299|NCT06006650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306300|NCT06006624|Dexamethasone|dexamethasone|mesh-list
154306301|NCT06006624|Bupivacaine|bupivacaine|mesh-list
154306302|NCT06006624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306303|NCT06006624|Antiemetics|antiemetics|mesh-ancestor
154306304|NCT06006624|Autonomic Agents|autonomic agents|mesh-ancestor
154306305|NCT06006624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306306|NCT06006624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306307|NCT06006624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306308|NCT06006624|Glucocorticoids|glucocorticoids|mesh-ancestor
154306310|NCT06006624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306311|NCT06006624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154306312|NCT06006624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306314|NCT06006624|Anesthetics|anesthetics|mesh-ancestor
154306315|NCT06006624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306316|NCT06006624|Sensory System Agents|sensory system agents|mesh-ancestor
154306317|NCT06006143|Varenicline|varenicline|mesh-list
154306318|NCT06006143|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154306319|NCT06006143|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154306320|NCT06006143|Cholinergic Agents|cholinergic agents|mesh-ancestor
154306321|NCT06006143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306322|NCT06006143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306323|NCT06006143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306324|NCT06006091|Letrozole|letrozole|mesh-list
154306325|NCT06006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306326|NCT06006091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154306327|NCT06006091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154306328|NCT06006091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306329|NCT06006091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306330|NCT06006091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154306331|NCT06006091|Hormone Antagonists|hormone antagonists|mesh-ancestor
154306332|NCT06006091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306333|NCT06006091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306334|NCT06005870|Zanubrutinib|zanubrutinib|mesh-list
154306335|NCT06005870|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154306336|NCT06005870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154306337|NCT06005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306338|NCT06005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306339|NCT06005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306340|NCT06002295|Chlorhexidine|chlorhexidine|mesh-list
154306341|NCT06002295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154306342|NCT06002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306343|NCT06002295|Disinfectants|disinfectants|mesh-ancestor
154306344|NCT05995457|Haloperidol|haloperidol|mesh-list
154306345|NCT05995457|Haloperidol decanoate|haloperidol decanoate|mesh-list
154306346|NCT05995457|Antiemetics|antiemetics|mesh-ancestor
154306347|NCT05995457|Autonomic Agents|autonomic agents|mesh-ancestor
154306348|NCT05995457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306349|NCT05995457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306350|NCT05995457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306351|NCT05995457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154306352|NCT05995457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154306353|NCT05995457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306354|NCT05995457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154306355|NCT05995457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154306356|NCT05995457|Dopamine Agents|dopamine agents|mesh-ancestor
154306357|NCT05995457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306358|NCT05995457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306359|NCT05995457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154306360|NCT05988528|Nifuroxazide|nifuroxazide|mesh-list
154306361|NCT05988528|Mesalamine|mesalamine|mesh-list
154306362|NCT05988528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154306363|NCT05988528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154306364|NCT05988528|Analgesics|analgesics|mesh-ancestor
154306365|NCT05988528|Sensory System Agents|sensory system agents|mesh-ancestor
154306366|NCT05988528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306367|NCT05988528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306368|NCT05988528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306369|NCT05988528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306370|NCT05988528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306371|NCT05962957|Pentoxifylline|pentoxifylline|mesh-list
154306372|NCT05962957|Levodopa|levodopa|mesh-list
154306373|NCT05962957|Carbidopa|carbidopa|mesh-list
154306374|NCT05962957|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154306375|NCT05962957|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154306376|NCT05962957|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154306377|NCT05962957|Dopamine Agents|dopamine agents|mesh-ancestor
154306378|NCT05962957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306379|NCT05962957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306380|NCT05962957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306381|NCT05962957|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154306384|NCT05962957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154306385|NCT05962957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154306386|NCT05962957|Protective Agents|protective agents|mesh-ancestor
154306387|NCT05962957|Vasodilator Agents|vasodilator agents|mesh-ancestor
154306388|NCT05962957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154306389|NCT05962957|Antioxidants|antioxidants|mesh-ancestor
154306390|NCT05962957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154306391|NCT05962957|Immunologic Factors|immunologic factors|mesh-ancestor
154306392|NCT05962957|Dopamine Agonists|dopamine agonists|mesh-ancestor
154306393|NCT05957848|Guanfacine|guanfacine|mesh-list
154306394|NCT05957848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154306395|NCT05957848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154306396|NCT05957848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154306397|NCT05957848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154306398|NCT05957848|Adrenergic Agents|adrenergic agents|mesh-ancestor
153526168|NCT04527003|Cannabidiol|cannabidiol|mesh-list
154306399|NCT05957848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306400|NCT05957848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306401|NCT05957848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306402|NCT05928871|Misoprostol|misoprostol|mesh-list
154306403|NCT05928871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154306404|NCT05928871|Abortifacient Agents|abortifacient agents|mesh-ancestor
154306405|NCT05928871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154306406|NCT05928871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306407|NCT05928871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154306408|NCT05928871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306409|NCT05928871|Oxytocics|oxytocics|mesh-ancestor
154306410|NCT05892237|Immunomodulating Agents|immunomodulating agents|mesh-list
154306411|NCT05892237|Immunologic Factors|immunologic factors|mesh-ancestor
154306412|NCT05892237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306413|NCT05840016|Carboplatin|carboplatin|mesh-list
154306414|NCT05840016|Tislelizumab|tislelizumab|mesh-list
154306415|NCT05840016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306416|NCT05840016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306417|NCT05797870|Ethiodized Oil|ethiodized oil|mesh-list
154306418|NCT05797870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306419|NCT05790213|Androgens|androgens|mesh-list
154306420|NCT05790213|Hormones|hormones|mesh-ancestor
154306421|NCT05790213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306422|NCT05790213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306423|NCT05777733|Acetylcysteine|acetylcysteine|mesh-list
154306424|NCT05777733|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154306425|NCT05777733|Antidotes|antidotes|mesh-ancestor
154306426|NCT05777733|Protective Agents|protective agents|mesh-ancestor
154306427|NCT05777733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306428|NCT05777733|Antioxidants|antioxidants|mesh-ancestor
154306429|NCT05777733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306430|NCT05777733|Antiviral Agents|antiviral agents|mesh-ancestor
154306431|NCT05777733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306432|NCT05777733|Expectorants|expectorants|mesh-ancestor
154306433|NCT05777733|Respiratory System Agents|respiratory system agents|mesh-ancestor
154306434|NCT05777733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154306435|NCT05777109|Denosumab|denosumab|mesh-list
154306436|NCT05777109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154306437|NCT05777109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306438|NCT05773365|Anesthetics|anesthetics|mesh-list
154306439|NCT05773365|Anesthetics, Local|anesthetics, local|mesh-list
154306440|NCT05773365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306441|NCT05773365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306442|NCT05773365|Sensory System Agents|sensory system agents|mesh-ancestor
154306443|NCT05773365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306444|NCT05683223|Sertraline|sertraline|mesh-list
154306445|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
154306446|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154306447|NCT05683223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154306448|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154306449|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154306450|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306451|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306452|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
154306453|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306454|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154306457|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306458|NCT05525455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306459|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306461|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
154306462|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306463|NCT05383482|Paclitaxel|paclitaxel|mesh-list
154306464|NCT05383482|Docetaxel|docetaxel|mesh-list
154306465|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154306466|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306467|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
154306468|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
154306469|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
154306470|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306471|NCT05372315|Dexamethasone|dexamethasone|mesh-list
154306472|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
154306473|NCT05372315|BB 1101|bb 1101|mesh-list
154306474|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306475|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
154306476|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
154306477|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306478|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306479|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306480|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
154306481|NCT05372315|Hormones|hormones|mesh-ancestor
154306482|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306483|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154306484|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306485|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
154306486|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306487|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306488|NCT05121883|Edaravone|edaravone|mesh-list
153526342|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526353|NCT03995641|Bupivacaine|bupivacaine|mesh-list
154306489|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154306490|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
154306491|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306492|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154306493|NCT05121883|Protective Agents|protective agents|mesh-ancestor
154306494|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306495|NCT05104983|Sirolimus|sirolimus|mesh-list
154306496|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154306497|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306498|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154306499|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306500|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
154306501|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306502|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
154306503|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306504|NCT04914741|Prednisolone|prednisolone|mesh-list
154306505|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
154306506|NCT04914741|Rituximab|rituximab|mesh-list
154306507|NCT04914741|Doxorubicin|doxorubicin|mesh-list
154306508|NCT04914741|Vincristine|vincristine|mesh-list
154306509|NCT04914741|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154306510|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306511|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
154306512|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306513|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306514|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154306515|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
154306516|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306517|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306518|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154306519|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306520|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154306521|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154306522|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154306523|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306524|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154306525|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
154306526|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
154306527|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
154306532|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154306533|NCT04914741|Immunoconjugates|immunoconjugates|mesh-ancestor
154306535|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154306536|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154306537|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306538|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
154306539|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306540|NCT04677569|Azithromycin|azithromycin|mesh-list
153526408|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306541|NCT04677569|Amikacin|amikacin|mesh-list
154306542|NCT04677569|Ethambutol|ethambutol|mesh-list
154306543|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154306544|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306545|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
154306546|NCT04648930|Omalizumab|omalizumab|mesh-list
154306547|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154306548|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154306549|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154306550|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
154306551|NCT04633148|Fludarabine|fludarabine|mesh-list
154306552|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306553|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
154306554|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306555|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306556|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154306557|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
154306558|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306559|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306560|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154306561|NCT04494529|Betamethasone|betamethasone|mesh-list
154306562|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
154306563|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154306564|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
154306565|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154306566|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306567|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
154306568|NCT04494529|Hormones|hormones|mesh-ancestor
154306569|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306570|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306571|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154306572|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
154306573|NCT04356209|Pravastatin|pravastatin|mesh-list
154306574|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154306575|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154306576|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
154306577|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306578|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154306579|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154306580|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306581|NCT04346394|Yohimbine|yohimbine|mesh-list
154306582|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
154306583|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
154306584|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306585|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306586|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154306587|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154306588|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154306589|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
154306590|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306591|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306592|NCT04346394|Urological Agents|urological agents|mesh-ancestor
154306593|NCT04299438|Propranolol|propranolol|mesh-list
154306594|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154306595|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154306596|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
154306597|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306612|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306613|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
154306614|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154306615|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154306616|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
154306617|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306618|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154861626|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306619|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154306620|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
154306621|NCT04214678|Hormones|hormones|mesh-ancestor
154306622|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306623|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306624|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306625|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306626|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154306627|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306628|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
154306629|NCT04196491|Fludarabine|fludarabine|mesh-list
154306630|NCT04196491|Lenalidomide|lenalidomide|mesh-list
154306631|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306632|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
154306633|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306634|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306635|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154306636|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
154053459|NCT00742690|Terlipressin|terlipressin|mesh-list
154306637|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306638|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306639|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154306640|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154306641|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154306642|NCT04196491|Growth Substances|growth substances|mesh-ancestor
154306643|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
154306644|NCT04165967|Nivolumab|nivolumab|mesh-list
153526531|NCT03190967|Temozolomide|temozolomide|mesh-list
154306645|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306646|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306647|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154306648|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306649|NCT04044859|Pembrolizumab|pembrolizumab|mesh-list
154306650|NCT04044859|Nivolumab|nivolumab|mesh-list
154306651|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306652|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306653|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154306654|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306658|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306659|NCT03995628|Dexamethasone|dexamethasone|mesh-list
154306660|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306661|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
154306662|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
154306663|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306664|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306665|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306666|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
154306667|NCT03995628|Hormones|hormones|mesh-ancestor
154306668|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306669|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154306670|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306671|NCT03923556|Neostigmine|neostigmine|mesh-list
154306672|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154306673|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306674|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306675|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
154306676|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306677|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306678|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154306679|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
154306680|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306681|NCT03913247|Metronidazole|metronidazole|mesh-list
154306682|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306683|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154306684|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154306685|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154306686|NCT03816982|Bupivacaine|bupivacaine|mesh-list
154306687|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
154306688|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
154306689|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306690|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306691|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
154306692|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306693|NCT03736629|Azithromycin|azithromycin|mesh-list
154306694|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154306695|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306696|NCT03681639|Cobalt|cobalt|mesh-list
154306697|NCT03681639|Chromium|chromium|mesh-list
154306698|NCT03681639|Trace Elements|trace elements|mesh-ancestor
154306699|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
154306700|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306701|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154306702|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306703|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154306704|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154306705|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154306706|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306707|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
154306708|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306709|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306710|NCT03217201|Methamphetamine|methamphetamine|mesh-list
154053532|NCT04808531|Analgesics|analgesics|mesh-ancestor
154306711|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154306712|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306713|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
154306714|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
154306715|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306716|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
154306717|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306718|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306719|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
154306720|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154306721|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154306722|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154306723|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154306724|NCT03029429|Theophylline|theophylline|mesh-list
154306725|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154306726|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
154306737|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
154306738|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306739|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
154306740|NCT02754765|Levofloxacin|levofloxacin|mesh-list
154306741|NCT02754765|Linezolid|linezolid|mesh-list
154306742|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
154306743|NCT02754765|Bedaquiline|bedaquiline|mesh-list
154306744|NCT02754765|Clofazimine|clofazimine|mesh-list
154306745|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154306746|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306747|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154306748|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154306749|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526633|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
154306750|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306751|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306752|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154306753|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154306754|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154306755|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154306756|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
154306757|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306758|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
154306759|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
154306760|NCT02620007|Rifaximin|rifaximin|mesh-list
154306761|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154306762|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306763|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154306764|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154306765|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306766|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306767|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306768|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154306769|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154306770|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306771|NCT02586623|Droxidopa|droxidopa|mesh-list
154306772|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154306773|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154306774|NCT01622543|Leucovorin|leucovorin|mesh-list
154306775|NCT01622543|Bevacizumab|bevacizumab|mesh-list
154306776|NCT01622543|Fluorouracil|fluorouracil|mesh-list
154306777|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
154306778|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306780|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154306781|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154306782|NCT01622543|Growth Substances|growth substances|mesh-ancestor
154306783|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306784|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
154306785|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
154306786|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306787|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154306788|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306790|NCT01622543|Antidotes|antidotes|mesh-ancestor
154306792|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
154306794|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
154306795|NCT01618357|Veliparib|veliparib|mesh-list
154306796|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154306797|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306798|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306799|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306800|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
154306801|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154306802|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154306803|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
154306804|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306805|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306806|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154306807|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
154306808|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
154306809|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154306810|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
153526710|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
153526711|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306811|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306812|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306813|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154306814|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154306815|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154306816|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
154306817|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
154306818|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154306819|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154306820|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154306821|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
154306822|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306823|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306824|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306825|NCT00233662|Alefacept|alefacept|mesh-list
154306826|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
154306827|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
154306828|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306829|NCT00078949|Cytarabine|cytarabine|mesh-list
154306830|NCT00078949|Dexamethasone|dexamethasone|mesh-list
154306831|NCT00078949|Rituximab|rituximab|mesh-list
154306832|NCT00078949|Gemcitabine|gemcitabine|mesh-list
154306833|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306834|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306835|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
154306836|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
154306837|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306838|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306839|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306840|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
154306841|NCT00078949|Hormones|hormones|mesh-ancestor
154306842|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306843|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154306844|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306845|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
154306846|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306847|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154306848|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
154306849|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306850|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
154306851|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306852|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154306853|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
154306854|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154306855|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306856|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306857|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154306858|NCT01289769|Analgesics|analgesics|mesh-ancestor
154306860|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306861|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154306862|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154306863|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154306866|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306867|NCT01185015|Nicorandil|nicorandil|mesh-list
154306868|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154306869|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154306870|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
154306871|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
154306872|NCT01185015|Vitamins|vitamins|mesh-ancestor
154306873|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
154306874|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306875|NCT01289925|Selenium|selenium|mesh-list
154306876|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
154306877|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306878|NCT01289925|Protective Agents|protective agents|mesh-ancestor
154306879|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306880|NCT01289925|Trace Elements|trace elements|mesh-ancestor
154306881|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
154306882|NCT01290939|Bevacizumab|bevacizumab|mesh-list
154306883|NCT01290939|Lomustine|lomustine|mesh-list
154306884|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154306885|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306886|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154306887|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154306888|NCT01290939|Growth Substances|growth substances|mesh-ancestor
154306889|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306890|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
154306891|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154306892|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
154306893|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306894|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
154306895|NCT01288755|Rilpivirine|rilpivirine|mesh-list
154306896|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153526800|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154306897|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154306898|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
154306899|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306900|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154306901|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154306902|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306903|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306904|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154306905|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154306906|NCT01290003|Tazobactam|tazobactam|mesh-list
154306907|NCT01290003|Piperacillin|piperacillin|mesh-list
154306908|NCT01290003|Amikacin|amikacin|mesh-list
154306909|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154306910|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154306911|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306912|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154306913|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306914|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306915|NCT01291095|Cisplatin|cisplatin|mesh-list
154306916|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154306917|NCT03739203|Cariprazine|cariprazine|mesh-list
154306918|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
154306919|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154306920|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154306921|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154306922|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306923|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306924|NCT01185405|Voriconazole|voriconazole|mesh-list
154306925|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
154306926|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306927|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154306928|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154306929|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306930|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306931|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154255342|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154306932|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
154306933|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306934|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306935|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154306936|NCT01182129|Nicotine|nicotine|mesh-list
154306939|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306940|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306941|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154306942|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154306943|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
154306944|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306945|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306946|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
154306947|NCT01587729|Serotonin|serotonin|mesh-list
154306948|NCT01587729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154306949|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154306950|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154306951|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
154306952|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306953|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306954|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306955|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154306956|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154306957|NCT03855267|Propofol|propofol|mesh-list
154306958|NCT03855267|Etomidate|etomidate|mesh-list
154306959|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154306960|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154306961|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306962|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154306963|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
154306964|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
154306965|NCT01185873|Ritonavir|ritonavir|mesh-list
154306966|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154306967|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154306968|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
154306969|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526846|NCT02227823|Bromides|bromides|mesh-list
154306970|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306971|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154306972|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154306973|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
154306974|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154306975|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154306976|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154306977|NCT01182597|Pantoprazole|pantoprazole|mesh-list
154306978|NCT01182597|Lansoprazole|lansoprazole|mesh-list
154306979|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
154306980|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154306981|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306982|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154306983|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306984|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306985|NCT01185951|Polidocanol|polidocanol|mesh-list
154306986|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154306987|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154306988|NCT01587807|Dimercaprol|dimercaprol|mesh-list
154306989|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
154306990|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
154306991|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306992|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
154306993|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306994|NCT01180179|Lansoprazole|lansoprazole|mesh-list
154306995|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
154306996|NCT01180179|Famotidine|famotidine|mesh-list
154306997|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154306998|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154306999|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154307000|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307001|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307002|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154307003|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
154307004|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
154307005|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307006|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861627|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154307007|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154307008|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154307009|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
154307010|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307011|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307013|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154307014|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526895|NCT01730937|Sorafenib|sorafenib|mesh-list
153526900|NCT01560416|Fulvestrant|fulvestrant|mesh-list
154307015|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154307016|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307017|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307018|NCT03854409|Aripiprazole|aripiprazole|mesh-list
154307019|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
154307020|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307021|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154307022|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154307023|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307024|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307025|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
154307026|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
154307027|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307028|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307029|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154307030|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154307031|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
154307032|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154307033|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154307034|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154307035|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154307036|NCT01186653|Fluticasone|fluticasone|mesh-list
154307037|NCT01186653|Budesonide|budesonide|mesh-list
154307038|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
154307039|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154307040|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154307041|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154307042|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154307043|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
154307044|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307045|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307046|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154307047|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
154307048|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
154307049|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154307050|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
154307051|NCT01186653|Hormones|hormones|mesh-ancestor
154307052|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154307053|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154307054|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154307055|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154307056|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
154307057|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307058|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307059|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
154307060|NCT01186731|Docetaxel|docetaxel|mesh-list
154307061|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307062|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
154307063|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
154307064|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
154307065|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307066|NCT01186887|Celecoxib|celecoxib|mesh-list
154307067|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154307068|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154307069|NCT01186887|Analgesics|analgesics|mesh-ancestor
154307070|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
154307071|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307072|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307073|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154307074|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154307075|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154307076|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154307077|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307078|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861628|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
154307079|NCT01180413|Losartan|losartan|mesh-list
154307080|NCT01180413|Amlodipine|amlodipine|mesh-list
154307081|NCT01180413|Ramipril|ramipril|mesh-list
154307082|NCT01180413|Lercanidipine|lercanidipine|mesh-list
154307083|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154307085|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154307086|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307087|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154307088|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307089|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
154307090|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154307091|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154307092|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154307093|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154307094|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
154307095|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307096|NCT03858387|Meropenem|meropenem|mesh-list
154307097|NCT03858387|Imipenem|imipenem|mesh-list
154307098|NCT03858387|Cilastatin|cilastatin|mesh-list
154307099|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154307100|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307101|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
154307102|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307103|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307104|NCT01289301|Cyclosporine|cyclosporine|mesh-list
154307105|NCT01289301|Sirolimus|sirolimus|mesh-list
154307106|NCT01289301|Everolimus|everolimus|mesh-list
154307107|NCT01289301|MTOR Inhibitors|mtor inhibitors|mesh-list
154307108|NCT01289301|Temsirolimus|temsirolimus|mesh-list
154307109|NCT01289301|Tacrolimus|tacrolimus|mesh-list
154307110|NCT01289301|Cyclosporins|cyclosporins|mesh-list
154307111|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154307112|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154307113|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
154307114|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307115|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307116|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307117|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
154307118|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307119|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
154307120|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154307121|NCT01289301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154307122|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307123|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154307124|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154307125|NCT02524899|Guanfacine|guanfacine|mesh-list
154307126|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154307127|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154307128|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154307129|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154307130|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
154307131|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307132|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307133|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307134|NCT02524821|Metformin|metformin|mesh-list
154307135|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154307136|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307137|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
154307138|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154307139|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307140|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307141|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154307142|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154307143|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
154307144|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154307145|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154307146|NCT03854175|Estradiol|estradiol|mesh-list
154307147|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154307148|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307149|NCT03854175|Estrogens|estrogens|mesh-ancestor
154307150|NCT03854175|Hormones|hormones|mesh-ancestor
154307151|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154307152|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307153|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154307154|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
154307155|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154307156|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154307157|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
154307158|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154307159|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154307160|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307161|NCT03854175|Urological Agents|urological agents|mesh-ancestor
154307162|NCT01183611|Vaccines|vaccines|mesh-list
154307163|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
154307164|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307165|NCT01180569|Lenalidomide|lenalidomide|mesh-list
154307166|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
154307167|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307168|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154307169|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154307170|NCT01180569|Growth Substances|growth substances|mesh-ancestor
154307171|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
154307172|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307173|NCT02942264|Temozolomide|temozolomide|mesh-list
154307174|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154307175|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
154307176|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307177|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307178|NCT01180725|Psyllium|psyllium|mesh-list
154307179|NCT01180725|Cathartics|cathartics|mesh-ancestor
154307180|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154307181|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154307182|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
154307183|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307184|NCT01183767|Protective Agents|protective agents|mesh-ancestor
154307185|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307186|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154307187|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154307188|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307189|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154307190|NCT03853785|Podophyllin|podophyllin|mesh-list
154307191|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154307192|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307193|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
154307194|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154307195|NCT01290471|U3-1565|u3-1565|mesh-list
154307196|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154307197|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307198|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
154307199|NCT01291563|Bedaquiline|bedaquiline|mesh-list
154307200|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
154307201|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154307202|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154307203|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307204|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154307205|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154307206|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307207|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307208|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307209|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154307210|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
154307211|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154307212|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307213|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154307214|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154307215|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154307216|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
154307217|NCT01187589|Albuterol|albuterol|mesh-list
154307218|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154307219|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
154307220|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307221|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307222|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154307223|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
154307224|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
154307225|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154307226|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154307227|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154307228|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154307229|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
154307230|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307231|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307232|NCT01290549|Rituximab|rituximab|mesh-list
154307235|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307236|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
154307237|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307238|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154307239|NCT01290549|Immunoconjugates|immunoconjugates|mesh-ancestor
153527175|NCT01469884|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153527231|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
154307240|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
154307241|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
154307242|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307243|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154307244|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307245|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307246|NCT01184391|Valproic Acid|valproic acid|mesh-list
154307247|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
154307248|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307249|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307250|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
154307251|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307252|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307253|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
154307254|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154307255|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307256|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307257|NCT02524743|Acetaminophen|acetaminophen|mesh-list
154307258|NCT02524743|Lidocaine|lidocaine|mesh-list
154307259|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
154307260|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
154307261|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307262|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307263|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
154307264|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307265|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154307266|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154307267|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154307268|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154307269|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307270|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154307271|NCT02524743|Analgesics|analgesics|mesh-ancestor
154307272|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
154307273|NCT01188057|Alprazolam|alprazolam|mesh-list
154307274|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154307275|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307276|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307277|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154307278|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154307279|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307280|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
154307281|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
154307282|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307283|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307284|NCT01291641|Cilostazol|cilostazol|mesh-list
153527279|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307285|NCT01291641|Probucol|probucol|mesh-list
154307286|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154307287|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154307288|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
154307289|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307290|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307291|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154307292|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
154307293|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154307294|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154307295|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307296|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154307297|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
154307298|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154307299|NCT01291641|Protective Agents|protective agents|mesh-ancestor
154307300|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154307301|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154307302|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307303|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154307304|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154307305|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
154307308|NCT03855501|Calcium|calcium|mesh-list
154307309|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154307310|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307311|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154307312|NCT01588587|Vildagliptin|vildagliptin|mesh-list
154307313|NCT01588587|Alogliptin|alogliptin|mesh-list
154307314|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154307315|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307316|NCT01588587|Incretins|incretins|mesh-ancestor
154307317|NCT01588587|Hormones|hormones|mesh-ancestor
154307318|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154307319|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154307320|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
154307321|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307322|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307323|NCT03325712|Midazolam|midazolam|mesh-list
154307324|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154307325|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154307326|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307327|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307328|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154307329|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154307330|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307331|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154307332|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
154307333|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
154307334|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
154307335|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
154307336|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307337|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307338|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154307339|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154307340|NCT01293747|Estradiol|estradiol|mesh-list
154307341|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154307342|NCT01293747|Progesterone|progesterone|mesh-list
154307343|NCT01293747|Estrogens|estrogens|mesh-ancestor
154307344|NCT01293747|Hormones|hormones|mesh-ancestor
154307345|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154307346|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307347|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154307348|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
154307349|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154307350|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154307351|NCT01293747|Progestins|progestins|mesh-ancestor
154307352|NCT03849729|Phentermine|phentermine|mesh-list
154307353|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154307354|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307355|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
154307356|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154307357|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
154307358|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
154307359|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307360|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
154307361|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307362|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307363|NCT03325556|Pimavanserin|pimavanserin|mesh-list
154307364|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154307365|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154307366|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154307367|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154307368|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307369|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307370|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307371|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154307372|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154307373|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
154307374|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307375|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307376|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
154307377|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154307378|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154307379|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154307381|NCT03852303|Ivermectin|ivermectin|mesh-list
154307382|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
154307383|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154307384|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307385|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
154307386|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154307387|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154307388|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307389|NCT03325166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154307390|NCT03325166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307391|NCT03325166|Hematinics|hematinics|mesh-ancestor
154307392|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154307393|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154307394|NCT03847623|Curcumin|curcumin|mesh-list
154307395|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154307396|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154307397|NCT03847623|Analgesics|analgesics|mesh-ancestor
154307398|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
154307399|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307400|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307401|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154307402|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154307403|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307404|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307405|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307406|NCT01294059|Milnacipran|milnacipran|mesh-list
154307407|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
154307408|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154307409|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154307410|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154307411|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307412|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307413|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307414|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154307415|NCT01294059|Analgesics|analgesics|mesh-ancestor
154307416|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
154307417|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307418|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
154307419|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307420|NCT03847155|Nicotine|nicotine|mesh-list
154307421|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154307422|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
154307423|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307424|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307425|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154307426|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154307427|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
154307428|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307429|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307430|NCT01294215|Nifedipine|nifedipine|mesh-list
154307431|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154307432|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154307433|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307434|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154307435|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307436|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
154307437|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
154307438|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154307439|NCT01296555|Letrozole|letrozole|mesh-list
154307440|NCT01296555|Fulvestrant|fulvestrant|mesh-list
154307441|NCT01296555|Midazolam|midazolam|mesh-list
154307442|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154307443|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154307444|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307445|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307446|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154307447|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154307448|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307449|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154307450|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
154307451|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
154307452|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
154307454|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307455|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054286|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
154307456|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527620|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255345|NCT03897452|Fentanyl|fentanyl|mesh-list
154307457|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154307458|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154307459|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527622|NCT01472666|Caseins|caseins|mesh-list
154307460|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154307461|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
154307462|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154307463|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154307464|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154307465|NCT01294293|Paclitaxel|paclitaxel|mesh-list
154307466|NCT01294293|Doxorubicin|doxorubicin|mesh-list
154307467|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154307468|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154307469|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307470|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
154307471|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
154307472|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
154307473|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307474|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154307475|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154307476|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154307477|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307478|NCT01294605|Edetic Acid|edetic acid|mesh-list
154307479|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
154307480|NCT01294605|Antidotes|antidotes|mesh-ancestor
154307481|NCT01294605|Protective Agents|protective agents|mesh-ancestor
154307482|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307483|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
154307484|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
154307485|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307486|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154307487|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
154307488|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154307489|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
154307490|NCT01294761|Darunavir|darunavir|mesh-list
154307491|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154307492|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154307493|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
154307494|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307495|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154307496|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154307497|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307498|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307499|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154307500|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154307501|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
154307502|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
154307503|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
154307504|NCT03305666|Bupivacaine|bupivacaine|mesh-list
154307505|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
154307506|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
154307507|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307508|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307509|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
154307510|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307511|NCT01194843|Ropivacaine|ropivacaine|mesh-list
154307512|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
154307513|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
154307514|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307515|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307516|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
154307517|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307518|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
154307519|NCT01297023|Vitamin D|vitamin d|mesh-list
154307520|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
154307521|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
154307522|NCT01297023|Vitamins|vitamins|mesh-list
154307523|NCT01297023|Calcium|calcium|mesh-list
154307524|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
154307525|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307526|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154027395|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307538|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307539|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307541|NCT04781426|Lamivudine|lamivudine|mesh-list
154307542|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
154861629|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307544|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154307545|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154307546|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307547|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307548|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154307549|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154307550|NCT01292031|Meropenem|meropenem|mesh-list
154307551|NCT01292031|Colistin|colistin|mesh-list
154307552|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154307553|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307554|NCT04633226|Vaccines|vaccines|mesh-list
154307555|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
154307556|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307557|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
154307558|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154307559|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
154307560|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
154307561|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307562|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307563|NCT01188759|Voriconazole|voriconazole|mesh-list
154307564|NCT01188759|Anidulafungin|anidulafungin|mesh-list
154307565|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
154307566|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307567|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154307568|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154307569|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307570|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307571|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154307572|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
154307573|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154307574|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307575|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154307576|NCT01295073|Trientine|trientine|mesh-list
154307577|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
154307578|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
154307579|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307580|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
154307581|NCT01292109|Cathartics|cathartics|mesh-ancestor
154307582|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154307583|NCT01191645|Remifentanil|remifentanil|mesh-list
154307584|NCT01191645|Metoclopramide|metoclopramide|mesh-list
154307585|NCT01191645|Naloxone|naloxone|mesh-list
154307586|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154307587|NCT01191645|Narcotics|narcotics|mesh-ancestor
154307588|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307591|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
154307592|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307593|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154307594|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
154307595|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
154307596|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154307597|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153527835|NCT01474382|Phentolamine|phentolamine|mesh-list
154307598|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154307599|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
154307600|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307601|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307602|NCT03736785|Insulin|insulin|mesh-list
154307603|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154307604|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307605|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
154307606|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
154307607|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307608|NCT01295151|Adalimumab|adalimumab|mesh-list
154307609|NCT01295151|Infliximab|infliximab|mesh-list
154307610|NCT01295151|Golimumab|golimumab|mesh-list
154307611|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
154307612|NCT01295151|Etanercept|etanercept|mesh-list
154307613|NCT01295151|Rituximab|rituximab|mesh-list
154307614|NCT01295151|Abatacept|abatacept|mesh-list
154307615|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154307616|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307617|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
154307618|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307619|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154307620|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154307621|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255346|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154255347|NCT03897452|Narcotics|narcotics|mesh-ancestor
154255348|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255349|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255350|NCT03897452|Analgesics|analgesics|mesh-ancestor
154255351|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
154255352|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255353|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154255354|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154255355|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
154255356|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
154255357|NCT01151072|Insulin|insulin|mesh-list
154255358|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154307622|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154307623|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154307624|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154307625|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154307626|NCT01295151|Analgesics|analgesics|mesh-ancestor
154307627|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
154307628|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307629|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154307630|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154307631|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307632|NCT01295307|Clofarabine|clofarabine|mesh-list
154307633|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154307634|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
154307635|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307636|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307637|NCT01292343|Listerine|listerine|mesh-list
154307638|NCT01292343|Triclosan|triclosan|mesh-list
154307639|NCT01292343|Fluorides|fluorides|mesh-list
154307640|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
154307641|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
154307642|NCT01292343|Protective Agents|protective agents|mesh-ancestor
154307643|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307644|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154307645|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307646|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154307647|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154307648|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
154307649|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307650|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154307651|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
154307652|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
154307653|NCT01192113|Vitamins|vitamins|mesh-ancestor
154307654|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
154307655|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307656|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154307657|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
154307658|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307659|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154307660|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
154307661|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307662|NCT01192503|Rasagiline|rasagiline|mesh-list
154307663|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154307664|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307665|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307666|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154307668|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307669|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154307670|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
154307671|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
154307672|NCT03851289|Calcium|calcium|mesh-list
154861630|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861631|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154861632|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154861633|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154861634|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154861635|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861636|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154861637|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
154861638|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
154861639|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861640|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154861641|NCT04355039|Dexamethasone|dexamethasone|mesh-list
154861642|NCT04355039|Pomalidomide|pomalidomide|mesh-list
154307674|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307675|NCT03733899|Anesthetics|anesthetics|mesh-list
154307676|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307677|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307678|NCT01196013|Clofarabine|clofarabine|mesh-list
154307679|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154307680|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
154307681|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307682|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307683|NCT01196169|Vancomycin|vancomycin|mesh-list
154307684|NCT01196169|Daptomycin|daptomycin|mesh-list
154307685|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154307686|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307687|NCT01196481|Carvedilol|carvedilol|mesh-list
154307688|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154307689|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154307690|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
154307691|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307692|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307693|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307694|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154307695|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
154307696|NCT01196481|Protective Agents|protective agents|mesh-ancestor
154307697|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154307698|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154307699|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154307700|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
154307701|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154307702|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154307703|NCT05283057|Empagliflozin|empagliflozin|mesh-list
154307704|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154307705|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307706|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154307707|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307708|NCT01193595|Bevacizumab|bevacizumab|mesh-list
154307709|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154307710|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307711|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154307712|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153528101|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528181|NCT01477034|Vitamin D|vitamin d|mesh-list
154307713|NCT01193595|Growth Substances|growth substances|mesh-ancestor
154307714|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307715|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
154307716|NCT01196559|Gemcitabine|gemcitabine|mesh-list
154307717|NCT01196559|Vinorelbine|vinorelbine|mesh-list
154307718|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154307719|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
154307720|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307721|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307722|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154307723|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
154307724|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
154307725|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
154307726|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154307727|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
154307728|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154307729|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
154307730|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307731|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154307732|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154307733|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154307734|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154307735|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307736|NCT01581177|Albuterol|albuterol|mesh-list
154307739|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307740|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307741|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154307742|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
154307743|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
154307744|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154307745|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154307746|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154307747|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154307748|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
154307749|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307750|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307751|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
154307752|NCT01580007|Vitamin D|vitamin d|mesh-list
154307753|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154307754|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154307755|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307756|NCT01580007|Vitamins|vitamins|mesh-ancestor
154054581|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528294|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307757|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
154307758|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154307759|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307760|NCT01189695|Ritonavir|ritonavir|mesh-list
154307761|NCT01189695|Lopinavir|lopinavir|mesh-list
154307762|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154307763|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154307764|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
154307765|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307766|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307767|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154307768|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154307769|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
154307770|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307771|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154307772|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154307773|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
154307774|NCT01196715|Hematinics|hematinics|mesh-ancestor
154307775|NCT01189773|Ibuprofen|ibuprofen|mesh-list
154307776|NCT01189773|Codeine|codeine|mesh-list
154307777|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154307778|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154307779|NCT01189773|Analgesics|analgesics|mesh-ancestor
154307780|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
154307781|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307782|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307783|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154307784|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154307785|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154307786|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307787|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307788|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154307789|NCT01189773|Narcotics|narcotics|mesh-ancestor
154307790|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307791|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
154307792|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
154307793|NCT01189929|Gemcitabine|gemcitabine|mesh-list
154307794|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154307795|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154307796|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
154307797|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307798|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307799|NCT03845673|Psyllium|psyllium|mesh-list
154307800|NCT03845673|Cathartics|cathartics|mesh-ancestor
154307801|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154307802|NCT01190163|Oxytocin|oxytocin|mesh-list
154307803|NCT01190163|Dinoprostone|dinoprostone|mesh-list
154307804|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
154307805|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154307806|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307807|NCT01199445|Vitamin A|vitamin a|mesh-list
154307808|NCT01199445|Vitamins|vitamins|mesh-ancestor
154307809|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
154307810|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307813|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154307814|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307815|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154307816|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154307817|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307818|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307819|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307820|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307821|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154307822|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154307823|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154307824|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
154307825|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307826|NCT01199523|Urological Agents|urological agents|mesh-ancestor
154307827|NCT01190241|Everolimus|everolimus|mesh-list
154307828|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154307829|NCT01190241|Sorafenib|sorafenib|mesh-list
154054658|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
154307830|NCT01190241|Sunitinib|sunitinib|mesh-list
154307831|NCT01190241|Lapatinib|lapatinib|mesh-list
154307832|NCT01190241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154307833|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154307834|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307835|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307836|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154307837|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
154307838|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307839|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307840|NCT01190241|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154307841|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154307842|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154307843|NCT01190241|Growth Substances|growth substances|mesh-ancestor
154307844|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
154307845|NCT01197261|Oxycodone|oxycodone|mesh-list
154307846|NCT01197261|Naloxone|naloxone|mesh-list
154307847|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154307848|NCT01197261|Narcotics|narcotics|mesh-ancestor
154307849|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307850|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307851|NCT01197261|Analgesics|analgesics|mesh-ancestor
154307852|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
154307853|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307854|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154307855|NCT01190553|Amantadine|amantadine|mesh-list
154307856|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154307857|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154307858|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
154307859|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154307860|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
154307861|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307862|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307863|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307864|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154307865|NCT01190553|Analgesics|analgesics|mesh-ancestor
154307866|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
154307867|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307868|NCT01199757|Fluticasone|fluticasone|mesh-list
154307870|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
154307871|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154307872|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154307873|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
153528360|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
154307874|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307875|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307876|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154307877|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
154307878|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
154307879|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154307880|NCT03843879|Lidocaine|lidocaine|mesh-list
154307881|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
154307882|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
154307883|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307884|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307885|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
154307886|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307888|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154307889|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154307890|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154307891|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307892|NCT03850587|Celecoxib|celecoxib|mesh-list
154307893|NCT03850587|Tramadol|tramadol|mesh-list
154307894|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154307895|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154307896|NCT03850587|Analgesics|analgesics|mesh-ancestor
154307897|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
154307898|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307899|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307900|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154307901|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255359|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307902|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154307903|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154307904|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307905|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307906|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154307907|NCT03850587|Narcotics|narcotics|mesh-ancestor
154307908|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307910|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154307911|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307912|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
154307913|NCT05671497|Cilostazol|cilostazol|mesh-list
154307914|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154307915|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
154307916|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307917|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307918|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154307919|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
154307920|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154307921|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154307922|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307923|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154307924|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
154307925|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154307926|NCT05671497|Protective Agents|protective agents|mesh-ancestor
154307927|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154307928|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154307929|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307930|NCT03915626|Rivastigmine|rivastigmine|mesh-list
154307931|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154307932|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307933|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307934|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
154307935|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307936|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307937|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154307938|NCT03915626|Protective Agents|protective agents|mesh-ancestor
154307939|NCT04491968|Methadone|methadone|mesh-list
154307940|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154307941|NCT04491968|Narcotics|narcotics|mesh-ancestor
154307942|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307943|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307944|NCT04491968|Analgesics|analgesics|mesh-ancestor
154307945|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
154307946|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154307947|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
154307948|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
154307949|NCT03313076|Vitamin D|vitamin d|mesh-list
154307950|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
154307951|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
154307952|NCT03313076|Vitamins|vitamins|mesh-list
154307953|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
154307954|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307955|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154307956|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154307957|NCT01191021|Propofol|propofol|mesh-list
154307958|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
154307959|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307960|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307962|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154307963|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
154307965|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
154307966|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
154307967|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154307968|NCT01200537|Estradiol|estradiol|mesh-list
154307969|NCT01200537|Estrogens|estrogens|mesh-ancestor
154307970|NCT01200537|Hormones|hormones|mesh-ancestor
154307971|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154307972|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307973|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154307974|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154307975|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154307976|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154861643|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255360|NCT01257386|Mesalamine|mesalamine|mesh-list
153941752|NCT00621400|Hormones|hormones|mesh-ancestor
154307977|NCT01198353|Ziprasidone|ziprasidone|mesh-list
154307978|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154307979|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
154307980|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307981|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307982|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307983|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154307984|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154307985|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154307986|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154307987|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154307989|NCT01200693|Sirolimus|sirolimus|mesh-list
154307990|NCT01200693|Everolimus|everolimus|mesh-list
154307991|NCT01200693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154307992|NCT01200693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154307993|NCT01200693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307994|NCT01200693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307995|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154307996|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
154307997|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307998|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307999|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154308000|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308001|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154308002|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
154308003|NCT03844581|Propiverine|propiverine|mesh-list
154308004|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
154308005|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
154308006|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308007|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308008|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154308009|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154308010|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
154308011|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528576|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153528577|NCT01479114|Lenograstim|lenograstim|mesh-list
154308012|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308013|NCT03844581|Urological Agents|urological agents|mesh-ancestor
154308014|NCT01202097|Fluticasone|fluticasone|mesh-list
154308015|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154308016|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154308017|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308018|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154308019|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
154308020|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308021|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308022|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154308023|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
154308024|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
154308025|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154308026|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154308027|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154308028|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154308029|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308030|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308031|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308032|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
154308033|NCT01202097|Hormones|hormones|mesh-ancestor
154308034|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154308035|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
154308036|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154308037|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154308038|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
154308039|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
154308040|NCT01201005|Hematinics|hematinics|mesh-ancestor
154308041|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
154308042|NCT01201005|Vitamins|vitamins|mesh-ancestor
154308043|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
154308044|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308045|NCT01198665|Prednisolone|prednisolone|mesh-list
154308046|NCT01198665|Doxorubicin|doxorubicin|mesh-list
154308047|NCT01198665|Vincristine|vincristine|mesh-list
154308048|NCT01198665|Everolimus|everolimus|mesh-list
154308049|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154308050|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308051|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154861644|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
154308052|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154308053|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308054|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308055|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154308056|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
154308057|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
154308058|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
154308059|NCT01198665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154308060|NCT01198665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154308061|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154308062|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
153528669|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154308063|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308064|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308065|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
154308067|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154308068|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154308069|NCT01198821|Gemcitabine|gemcitabine|mesh-list
154308070|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154308071|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
154308072|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308073|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308074|NCT05013801|Hydroquinone|hydroquinone|mesh-list
154308075|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
154308076|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308077|NCT05013801|Protective Agents|protective agents|mesh-ancestor
154308078|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308079|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154308080|NCT01566669|Parecoxib|parecoxib|mesh-list
154308081|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154308082|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154308083|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308084|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308085|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154308086|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154308087|NCT01566669|Analgesics|analgesics|mesh-ancestor
154308088|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
154308089|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308090|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308091|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308092|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154308093|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
154308094|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154308095|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
154308096|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154308097|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154308098|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308099|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154308100|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308101|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153528677|NCT01479881|Cyclosporine|cyclosporine|mesh-list
154308102|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308103|NCT01201161|Ranibizumab|ranibizumab|mesh-list
154308104|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154308105|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154308106|NCT01201161|Growth Substances|growth substances|mesh-ancestor
154308107|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308108|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
154308109|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308110|NCT03841383|Dipyridamole|dipyridamole|mesh-list
154308114|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154308115|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
154308117|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
154308118|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
154308119|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308120|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308121|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
154308122|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308123|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154308124|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154308125|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154308126|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154308127|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308129|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154308130|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154308131|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
154308132|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308133|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154308135|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308136|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308137|NCT01199367|Letrozole|letrozole|mesh-list
154308138|NCT01199367|Lapatinib|lapatinib|mesh-list
154308139|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308140|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154308141|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154308142|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308143|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308144|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154308145|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
154308146|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154308147|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308148|NCT01199367|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154308149|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154308150|NCT01203735|Valproic Acid|valproic acid|mesh-list
154308151|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
154308152|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308153|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308154|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
154308155|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308156|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308157|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
154308158|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154308159|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528734|NCT01480141|Afatinib|afatinib|mesh-list
153528779|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308160|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154308161|NCT03842631|Timolol|timolol|mesh-list
154308162|NCT03842631|Maleic acid|maleic acid|mesh-list
154308163|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308164|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308165|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154308166|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154308167|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308168|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308169|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308170|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154308171|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154308172|NCT05669781|Metoclopramide|metoclopramide|mesh-list
154308173|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
154308174|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
154308175|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308176|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308177|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154308178|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154308179|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154308180|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
154308182|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308184|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154308185|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308186|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154308187|NCT01201551|Latanoprost|latanoprost|mesh-list
154308188|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154308189|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154308190|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154308191|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154308192|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154308193|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154308194|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308195|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308196|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308197|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308198|NCT01204125|Paclitaxel|paclitaxel|mesh-list
154308199|NCT01204125|Iniparib|iniparib|mesh-list
154308200|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154308201|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308202|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
154308203|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154308204|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154308205|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055029|NCT00912392|Carboplatin|carboplatin|mesh-list
154308206|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154308207|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308208|NCT03074240|Anesthetics|anesthetics|mesh-list
154308209|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
154308210|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308211|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308212|NCT03725085|Guaifenesin|guaifenesin|mesh-list
154308213|NCT03725085|Expectorants|expectorants|mesh-ancestor
154308214|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
154308215|NCT01566825|Amitriptyline|amitriptyline|mesh-list
154308216|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154308217|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
154308218|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154308219|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154308220|NCT01566825|Analgesics|analgesics|mesh-ancestor
154308221|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
154308222|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308223|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308224|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154308225|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154308226|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154308227|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308228|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308229|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308230|NCT03559010|Norgestrel|norgestrel|mesh-list
154308231|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154308232|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154308233|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154308234|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
154308235|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154308236|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308237|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154308238|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154308239|NCT03298412|Blinatumomab|blinatumomab|mesh-list
154308240|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528865|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528866|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308241|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
154308242|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
154308243|NCT03297398|Androgens|androgens|mesh-list
154308244|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154308245|NCT03297398|Hormones|hormones|mesh-ancestor
154308246|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154308247|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308248|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
154308249|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308250|NCT03297398|Protective Agents|protective agents|mesh-ancestor
154308251|NCT03297398|Vitamins|vitamins|mesh-ancestor
154308252|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
154308253|NCT03297398|Estrogens|estrogens|mesh-ancestor
154308254|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154308255|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308256|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
154308257|NCT03293654|Bevacizumab|bevacizumab|mesh-list
154308258|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154308259|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308260|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154308261|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154308262|NCT03293654|Growth Substances|growth substances|mesh-ancestor
154308263|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308264|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
154308265|NCT03930615|Letermovir|letermovir|mesh-list
154308266|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154308267|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308268|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308269|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308270|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
154308271|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308272|NCT03838029|Etodolac|etodolac|mesh-list
154308273|NCT03838029|Propranolol|propranolol|mesh-list
154308274|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154308275|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154308276|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154861645|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
154308277|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308278|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308279|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308280|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154308281|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154308282|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
154308283|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154308284|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154308285|NCT03838029|Analgesics|analgesics|mesh-ancestor
154308286|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
154308287|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308288|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308289|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154308290|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154308291|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154308292|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308293|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
154308294|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308295|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
154308296|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308297|NCT04708340|Protective Agents|protective agents|mesh-ancestor
154308298|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308299|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
154308300|NCT03292640|Tazarotene|tazarotene|mesh-list
154308301|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
154308302|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
154308303|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
154308304|NCT03292640|Vitamins|vitamins|mesh-ancestor
154308305|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
154308306|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308307|NCT01567215|Ethanol|ethanol|mesh-list
154308308|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
154308309|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154308310|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308311|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308312|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308313|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
154308314|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154308315|NCT01202487|Lidocaine|lidocaine|mesh-list
154308316|NCT01202487|Epinephrine|epinephrine|mesh-list
154308317|NCT01202487|Tetracaine|tetracaine|mesh-list
154308318|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
154308319|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
154308320|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308321|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308322|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
154308323|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308324|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154308325|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154308327|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154308328|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308329|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154308330|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154308331|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308332|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308333|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154308334|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154308335|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
154308336|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154308337|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
154308339|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
154308340|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154308341|NCT01204437|Paclitaxel|paclitaxel|mesh-list
154308342|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
154308343|NCT01204437|Capecitabine|capecitabine|mesh-list
154308344|NCT01204437|Methotrexate|methotrexate|mesh-list
154308345|NCT01204437|Epirubicin|epirubicin|mesh-list
153528924|NCT01481311|Bromides|bromides|mesh-list
154308346|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154308347|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308348|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
154308349|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
154308350|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
154308351|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255361|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154308352|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154308353|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
154308354|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308355|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154308356|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154308357|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
154308358|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154308359|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154308360|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
154308361|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154308362|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
154308363|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154308364|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
154308365|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308366|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154308367|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154308368|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154308369|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154308370|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154308371|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
154308372|NCT02633241|Propofol|propofol|mesh-list
154308373|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154308374|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308375|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308376|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154308377|NCT02633241|Analgesics|analgesics|mesh-ancestor
154308378|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
154308379|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308380|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154308381|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154308382|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154308383|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308384|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308385|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308386|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154308387|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
154308388|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
154308389|NCT03292016|Apomorphine|apomorphine|mesh-list
154308390|NCT03292016|Emetics|emetics|mesh-ancestor
154308391|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308392|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
154308393|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308394|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154308395|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
154308396|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
154308397|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308398|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308399|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
153529044|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
154308402|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154308403|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154308404|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
154308405|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308406|NCT03289676|Nicotine|nicotine|mesh-list
154308407|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154308408|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
154308409|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308410|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308411|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154308412|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154308413|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
154308414|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308415|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308416|NCT03834831|Selenium|selenium|mesh-list
154308417|NCT03834831|Ubiquinone|ubiquinone|mesh-list
154308418|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
154308419|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
154308420|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308421|NCT03834831|Protective Agents|protective agents|mesh-ancestor
154308422|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308423|NCT03834831|Trace Elements|trace elements|mesh-ancestor
154308424|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
154308425|NCT03834831|Vitamins|vitamins|mesh-ancestor
154308426|NCT01206153|Metformin|metformin|mesh-list
154308427|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154861646|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308428|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055256|NCT00488683|Vaccines|vaccines|mesh-list
154308429|NCT01298271|Propranolol|propranolol|mesh-list
154308430|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154308431|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154308432|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308433|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308434|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308435|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308436|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154308437|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154308438|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
154308439|NCT05281965|Tretinoin|tretinoin|mesh-list
154308440|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308441|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
154308442|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
154308443|NCT04251884|Ropivacaine|ropivacaine|mesh-list
154308444|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
154308445|NCT04251884|Anesthetics|anesthetics|mesh-list
154308446|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308447|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308448|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
154308449|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308450|NCT01202799|Diclofenac|diclofenac|mesh-list
154308451|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154308452|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154308453|NCT01202799|Analgesics|analgesics|mesh-ancestor
154308454|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
153529105|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153529106|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
154308455|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308456|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308457|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308458|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154308459|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154308460|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308461|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308462|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
154308463|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
154308464|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308465|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308466|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308467|NCT01298505|Fexofenadine|fexofenadine|mesh-list
154308468|NCT01298505|Terfenadine|terfenadine|mesh-list
154308469|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154308470|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154308471|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154308472|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
154308473|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
154308474|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308477|NCT01204593|Insulin|insulin|mesh-list
154308478|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154308479|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
154308480|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
154308481|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154308482|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308483|NCT03310970|Lidocaine|lidocaine|mesh-list
154308484|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
154308485|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
154308486|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308487|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308488|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
154308489|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308490|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154308491|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154308492|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154308493|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154308494|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308495|NCT05281419|Triamcinolone|triamcinolone|mesh-list
154308496|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154308497|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154308498|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154308499|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308500|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
154308501|NCT05281419|Hormones|hormones|mesh-ancestor
154308502|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154308503|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255362|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154055331|NCT00498433|Amlodipine|amlodipine|mesh-list
154308504|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154308505|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
154308506|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308507|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308509|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154308510|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
154308511|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
154308512|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154308513|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308514|NCT02722941|Panobinostat|panobinostat|mesh-list
154308515|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308516|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154308517|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308518|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308519|NCT03420339|Adderall|adderall|mesh-list
154308520|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154308521|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308522|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
154308523|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154308524|NCT01297179|Mirabegron|mirabegron|mesh-list
154308525|NCT01297179|Estradiol|estradiol|mesh-list
154308526|NCT01297179|Estrogens|estrogens|mesh-ancestor
154308527|NCT01297179|Hormones|hormones|mesh-ancestor
154308528|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154308529|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308530|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154308531|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
154308532|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154308533|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154308534|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154308535|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154308536|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153529143|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
153529195|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
154308537|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154308538|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154308539|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154308540|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308541|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308542|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308543|NCT01297179|Urological Agents|urological agents|mesh-ancestor
154308544|NCT01205139|Simeprevir|simeprevir|mesh-list
154308545|NCT01205139|Rilpivirine|rilpivirine|mesh-list
154308546|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
154308549|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308550|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308551|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154308552|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154308553|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154308554|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154308555|NCT01205217|Paclitaxel|paclitaxel|mesh-list
154308556|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
154308557|NCT01205217|Trastuzumab|trastuzumab|mesh-list
154308558|NCT01205217|Epirubicin|epirubicin|mesh-list
154308559|NCT01205217|Lapatinib|lapatinib|mesh-list
154308560|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154308561|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308562|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
154308563|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
154308564|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
154308565|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308566|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154308567|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
154308568|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308569|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154308570|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154308571|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
154308572|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154308573|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154308574|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154308575|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154308576|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153529244|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308577|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308578|NCT01205217|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154861647|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942349|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
154308579|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154308580|NCT01203267|Paclitaxel|paclitaxel|mesh-list
154308581|NCT01203267|Carboplatin|carboplatin|mesh-list
154308582|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154308583|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308584|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
154308585|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
154308586|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
154308587|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308588|NCT01207245|Tobramycin|tobramycin|mesh-list
154308589|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154308590|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308591|NCT01297569|Ranibizumab|ranibizumab|mesh-list
154308592|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154308593|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154308594|NCT01297569|Growth Substances|growth substances|mesh-ancestor
154308595|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308596|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
154308597|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308598|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154308599|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
154308600|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308601|NCT01299597|Atorvastatin|atorvastatin|mesh-list
154308602|NCT01299597|Simvastatin|simvastatin|mesh-list
154308603|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154308604|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154308605|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
154308606|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308607|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154308608|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154308609|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308610|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
154308611|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154308612|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308613|NCT03723915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154308614|NCT03723915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308615|NCT03840057|Azithromycin|azithromycin|mesh-list
154308616|NCT03840057|Metoclopramide|metoclopramide|mesh-list
154308617|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154308618|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308619|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
154308628|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308631|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154308632|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308633|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
154308634|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308635|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154308636|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308637|NCT03824691|Durvalumab|durvalumab|mesh-list
154308638|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154308639|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308640|NCT01299831|Hormones|hormones|mesh-list
154308641|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154308642|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308643|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
154308644|NCT01205997|Fentanyl|fentanyl|mesh-list
154308645|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154308646|NCT01205997|Narcotics|narcotics|mesh-ancestor
154308647|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308648|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308649|NCT01205997|Analgesics|analgesics|mesh-ancestor
154308650|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
154308651|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308652|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154308653|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154308654|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
154308656|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154308657|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
154308658|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154308659|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154308660|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308661|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154861648|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154308662|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
154308663|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154308664|NCT03818997|Paclitaxel|paclitaxel|mesh-list
154308665|NCT03818997|Atezolizumab|atezolizumab|mesh-list
154308666|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154308667|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308668|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
154308669|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
154308670|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
154308671|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308672|NCT03818997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154308673|NCT03818997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154308674|NCT03818919|Acetaminophen|acetaminophen|mesh-list
154308675|NCT03818919|Celecoxib|celecoxib|mesh-list
154308676|NCT03818919|Ketorolac|ketorolac|mesh-list
154308677|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154308678|NCT03818919|Diazepam|diazepam|mesh-list
154308679|NCT03818919|Gabapentin|gabapentin|mesh-list
154308680|NCT03818919|Hydrocodone|hydrocodone|mesh-list
154308681|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154308682|NCT03818919|Analgesics|analgesics|mesh-ancestor
154308683|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
154308684|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308685|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308689|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154308690|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154308691|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154308692|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308693|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308694|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
154308695|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154308696|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154308697|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308698|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154308699|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154308700|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154308701|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308702|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
154308703|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154308704|NCT03818919|Narcotics|narcotics|mesh-ancestor
154308705|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
154308706|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
154308707|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154308708|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
154308709|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
154308710|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154308711|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154308712|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154308713|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154308714|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154308715|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
154308716|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
154308717|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
154308718|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
154308719|NCT03821493|Itraconazole|itraconazole|mesh-list
154308720|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154308721|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
154308722|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308723|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154308724|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154308725|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308726|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308727|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154308728|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
154055587|NCT02685059|Paclitaxel|paclitaxel|mesh-list
154308729|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154308730|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308731|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154308732|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154308733|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154308734|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154308735|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308736|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
154308737|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154861649|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
153942499|NCT00638326|Clopidogrel|clopidogrel|mesh-list
154308738|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308739|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154308740|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308741|NCT03814629|Vitamins|vitamins|mesh-list
154308742|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
154308743|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308744|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154308745|NCT01585935|SMOFlipid|smoflipid|mesh-list
154308746|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154308747|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154308748|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154308749|NCT01300377|Lidocaine|lidocaine|mesh-list
154308750|NCT01300377|Bupivacaine|bupivacaine|mesh-list
154308751|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
154308752|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
154308753|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308754|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308755|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
154308756|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308759|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154308760|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154308761|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308762|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
154308763|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154308764|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
154308765|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308766|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
154308767|NCT03814707|Protective Agents|protective agents|mesh-ancestor
154308768|NCT03818295|Praliciguat|praliciguat|mesh-list
154308769|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154308770|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
154308771|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308772|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154308773|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154308774|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154308775|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
154308776|NCT01301313|Simendan|simendan|mesh-list
154308777|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154308778|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
154308779|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154308780|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154308781|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308782|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308783|NCT01301313|Protective Agents|protective agents|mesh-ancestor
154308784|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308785|NCT03817359|Remifentanil|remifentanil|mesh-list
154308786|NCT03817359|Propofol|propofol|mesh-list
154308787|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154308788|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308789|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308790|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154308791|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
154308792|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
154308793|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154308794|NCT03817359|Narcotics|narcotics|mesh-ancestor
154308795|NCT03817359|Analgesics|analgesics|mesh-ancestor
154308796|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
154308797|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308798|NCT03813927|Vitamin D|vitamin d|mesh-list
154308799|NCT03813927|Vitamins|vitamins|mesh-ancestor
154308800|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
154308801|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308802|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154055637|NCT00639587|Cetirizine|cetirizine|mesh-list
154308803|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154308804|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154308806|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
154308807|NCT03813771|Etanercept|etanercept|mesh-list
154308808|NCT03813771|Methotrexate|methotrexate|mesh-list
154308809|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154308810|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
154308811|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154308812|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308813|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154308814|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
154861650|NCT04355039|Hormones|hormones|mesh-ancestor
154308815|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308817|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
154308818|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308819|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154308820|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154308821|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
154308822|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154308823|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154308824|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
154308825|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154308826|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154308827|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308828|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154308829|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154308834|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154308835|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
154308836|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154308837|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154308838|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308839|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
154308840|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
154308841|NCT02036242|Sufentanil|sufentanil|mesh-list
154308842|NCT02036242|Ropivacaine|ropivacaine|mesh-list
154308843|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
154308844|NCT02036242|Anesthetics|anesthetics|mesh-list
154308845|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308846|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308847|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
154308848|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308849|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154308850|NCT02036242|Narcotics|narcotics|mesh-ancestor
154308851|NCT02036242|Analgesics|analgesics|mesh-ancestor
154308852|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154308853|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154308854|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
154308855|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
154308856|NCT05281107|Vitamin D|vitamin d|mesh-list
154308857|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
154308858|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
154308859|NCT05281107|Vitamins|vitamins|mesh-list
154308860|NCT05281107|Calcium|calcium|mesh-list
154308861|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
154308862|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308863|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154308864|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154308865|NCT02812186|Rocuronium|rocuronium|mesh-list
154308866|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154308867|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154308868|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154308869|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308870|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308871|NCT03310268|Listerine|listerine|mesh-list
154308872|NCT03310268|Fluorides|fluorides|mesh-list
154308873|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
154308874|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
154308875|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
154308876|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
154308877|NCT03310268|Protective Agents|protective agents|mesh-ancestor
154308878|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308879|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154308880|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308881|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154308882|NCT02810392|Insulin|insulin|mesh-list
154308883|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154308884|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154308885|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308886|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
154308887|NCT03805035|Maleic acid|maleic acid|mesh-list
154308888|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
154308889|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154308890|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154308891|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308892|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308893|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
154308894|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308896|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
154308897|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
154308898|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154308899|NCT02815540|Cannabidiol|cannabidiol|mesh-list
154308900|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
154308901|NCT03816267|Albuterol|albuterol|mesh-list
154308902|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154308903|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
154308904|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308908|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
154308909|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154308910|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154308911|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154308912|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154308913|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308914|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308915|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308917|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154308918|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154308919|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
154308920|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
154308921|NCT02036554|Everolimus|everolimus|mesh-list
154308922|NCT02036554|Tacrolimus|tacrolimus|mesh-list
154308923|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154308924|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
154308925|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308926|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154308927|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308928|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308929|NCT02036554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154308930|NCT02036554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154308931|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154308932|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154308933|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154308934|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
154308935|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154308936|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308937|NCT05577117|Fentanyl|fentanyl|mesh-list
154308938|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
154308939|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154308940|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308941|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308942|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154308943|NCT05577117|Analgesics|analgesics|mesh-ancestor
154308944|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
154308945|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308946|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154308947|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154308948|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154308949|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
154308950|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308951|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308952|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154308953|NCT05577117|Narcotics|narcotics|mesh-ancestor
154308954|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154308955|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154308956|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
154308957|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
154308958|NCT03813303|Midazolam|midazolam|mesh-list
154308959|NCT03813303|Fentanyl|fentanyl|mesh-list
154308960|NCT03813303|Propofol|propofol|mesh-list
154308961|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154308962|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154308963|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308964|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154308965|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
154308966|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
154308967|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154308968|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154308969|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154308970|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154308971|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
154308972|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
154308973|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308974|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308975|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154308977|NCT03813303|Analgesics|analgesics|mesh-ancestor
154308979|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308980|NCT03637790|Rifampin|rifampin|mesh-list
154308981|NCT03637790|Abrocitinib|abrocitinib|mesh-list
154308982|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154308983|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
154308984|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154308985|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308986|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
154308987|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154308988|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308989|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308990|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154308991|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154308992|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154308993|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154308994|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154308995|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154308996|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154308997|NCT03813069|Permethrin|permethrin|mesh-list
154308998|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308999|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309000|NCT03276026|Neostigmine|neostigmine|mesh-list
154309001|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154309002|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309003|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309004|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
154309005|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309006|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309007|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154309008|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
154309009|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309010|NCT01303497|Paclitaxel|paclitaxel|mesh-list
154309011|NCT01303497|Bevacizumab|bevacizumab|mesh-list
154309012|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154309013|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309014|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
154309015|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
154309016|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
154309017|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309018|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154309019|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154309020|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154309021|NCT01303497|Growth Substances|growth substances|mesh-ancestor
154309022|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309023|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
154309024|NCT01589523|Cholic Acids|cholic acids|mesh-list
154309025|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
154309026|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309027|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154309028|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
154309029|NCT03804177|Melatonin|melatonin|mesh-list
154309030|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
154309031|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
154309032|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055855|NCT00593606|Rotigotine|rotigotine|mesh-list
154309033|NCT03804177|Protective Agents|protective agents|mesh-ancestor
154309034|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309035|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309036|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154309037|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
154309038|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
154309039|NCT03804177|Vitamins|vitamins|mesh-ancestor
154309040|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
154309041|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
154309042|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154309043|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309044|NCT03277352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154309045|NCT03277352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309046|NCT01302093|Racecadotril|racecadotril|mesh-list
154309047|NCT01302093|Thiorphan|thiorphan|mesh-list
154309048|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
153529771|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154309049|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309050|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
154309052|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309054|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
154309055|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
154309056|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154309057|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
154309058|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154309059|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309060|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154309061|NCT02047552|Iron|iron|mesh-list
154309062|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154309063|NCT02047552|Oxandrolone|oxandrolone|mesh-list
154309064|NCT02047552|Trace Elements|trace elements|mesh-ancestor
154309065|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
154309066|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309067|NCT02047552|Hematinics|hematinics|mesh-ancestor
154309068|NCT02047552|Androgens|androgens|mesh-ancestor
154309069|NCT02047552|Hormones|hormones|mesh-ancestor
154309070|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309071|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
154309072|NCT01303731|Fentanyl|fentanyl|mesh-list
154309073|NCT01303731|Bupivacaine|bupivacaine|mesh-list
154309074|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309075|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
154309076|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309077|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309078|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
154309079|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309080|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154309081|NCT01303731|Narcotics|narcotics|mesh-ancestor
154309082|NCT01303731|Analgesics|analgesics|mesh-ancestor
154309083|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154309084|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154309085|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
154309086|NCT03815487|Insulin|insulin|mesh-list
154309087|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154309088|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154309089|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309090|NCT03815422|Anesthetics|anesthetics|mesh-list
154309091|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309092|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309093|NCT02260024|Pramipexole|pramipexole|mesh-list
154309094|NCT02260024|Dexpramipexole|dexpramipexole|mesh-list
154309095|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
154309096|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309097|NCT02260024|Protective Agents|protective agents|mesh-ancestor
154309098|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309099|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154309100|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154309101|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
154309102|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
153529829|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309103|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309104|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
154309105|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
154309106|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309107|NCT03800667|Protective Agents|protective agents|mesh-ancestor
154309108|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309109|NCT03800667|Vitamins|vitamins|mesh-ancestor
154309110|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
154309111|NCT01302171|Lenograstim|lenograstim|mesh-list
154309112|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154309113|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
154309114|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309115|NCT02047630|Latanoprost|latanoprost|mesh-list
154309116|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154309117|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154309118|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154309119|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154309120|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
154309121|NCT03799809|Voriconazole|voriconazole|mesh-list
154309122|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
154309123|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309124|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154309125|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154309126|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861651|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309137|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309138|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309139|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309140|NCT03812523|Analgesics|analgesics|mesh-ancestor
154309141|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
154309142|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309143|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
154309144|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154309145|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
154309146|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
154309147|NCT02049970|Bupivacaine|bupivacaine|mesh-list
154309148|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309149|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
154309150|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309151|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309152|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
154309153|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309154|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154309155|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154309156|NCT02049970|Analgesics|analgesics|mesh-ancestor
154309157|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154309158|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154309159|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154309160|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
154309161|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309162|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309163|NCT02048020|Paclitaxel|paclitaxel|mesh-list
154309164|NCT02048020|Carboplatin|carboplatin|mesh-list
154309165|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154309166|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309167|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
154309168|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
154309169|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
154309170|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309171|NCT03562390|Irinotecan|irinotecan|mesh-list
154309172|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154309173|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154309174|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309175|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309176|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309177|NCT02048098|Misoprostol|misoprostol|mesh-list
154309178|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154309179|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
154309180|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154309181|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309182|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154309183|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309184|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
154309185|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
154309186|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
154309188|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154309189|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309190|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309191|NCT02050360|Urological Agents|urological agents|mesh-ancestor
154309192|NCT02940860|Iron|iron|mesh-list
154309193|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154309194|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154309195|NCT02940860|Trace Elements|trace elements|mesh-ancestor
154309196|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
154309197|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309198|NCT02940860|Hematinics|hematinics|mesh-ancestor
154309199|NCT01303887|Prednisolone|prednisolone|mesh-list
154309200|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
154309201|NCT01303887|Rituximab|rituximab|mesh-list
154309202|NCT01303887|Fludarabine|fludarabine|mesh-list
154309203|NCT01303887|Vincristine|vincristine|mesh-list
154309204|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154309205|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
154309206|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309207|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154309208|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154309209|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
154309210|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309211|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309212|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154309213|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942950|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
154309214|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154309215|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
154309216|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
154309217|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
154309218|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154309220|NCT01303887|Hormones|hormones|mesh-ancestor
154309221|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309222|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154309223|NCT02050594|Ipilimumab|ipilimumab|mesh-list
154309224|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154309225|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309226|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154309227|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309228|NCT02806960|Glucagon|glucagon|mesh-list
154309229|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309230|NCT02806960|Hormones|hormones|mesh-ancestor
154309231|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309232|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309233|NCT03718143|Adavosertib|adavosertib|mesh-list
154309234|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309235|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309236|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
154309237|NCT02955134|Antacids|antacids|mesh-ancestor
154309238|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309239|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309240|NCT02048488|Belizatinib|belizatinib|mesh-list
154309241|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529941|NCT01488266|Fluoxetine|fluoxetine|mesh-list
154309242|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309243|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309244|NCT02050672|Inositol|inositol|mesh-list
154309245|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
154309246|NCT02050672|Vitamins|vitamins|mesh-ancestor
154309247|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
154309248|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309249|NCT03811366|Prednisone|prednisone|mesh-list
154309250|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154309251|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
154309252|NCT03811366|Hormones|hormones|mesh-ancestor
154309253|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309254|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309255|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154309256|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309257|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154309258|NCT03274466|Laxatives|laxatives|mesh-ancestor
154056074|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
154309259|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309263|NCT02037802|Propofol|propofol|mesh-list
154309264|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309265|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
154309266|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309267|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309268|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
154309269|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309270|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154309271|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154309272|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
154309273|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154309274|NCT02037802|Narcotics|narcotics|mesh-ancestor
154309275|NCT02037802|Analgesics|analgesics|mesh-ancestor
154309276|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154309277|NCT02051530|Tryptophan|tryptophan|mesh-list
154309278|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154309279|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
154309280|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154309281|NCT03797703|Lidocaine|lidocaine|mesh-list
154309282|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309283|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
154309284|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309285|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309286|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
154309287|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309288|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154861652|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154309289|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154309290|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154309291|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154309292|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309294|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
154309295|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154309296|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
154309297|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529993|NCT01488396|Cyclosporine|cyclosporine|mesh-list
154309298|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309299|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154309300|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
154309301|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154309302|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154309303|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154309304|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
154309305|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309306|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309307|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154309308|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
154309309|NCT02048644|Hormones|hormones|mesh-ancestor
154309310|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309311|NCT02048800|Treosulfan|treosulfan|mesh-list
154309312|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154309313|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
154309314|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309315|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309316|NCT03797625|Cisplatin|cisplatin|mesh-list
154309317|NCT03797625|Irinotecan|irinotecan|mesh-list
154309318|NCT03797625|Endostar protein|endostar protein|mesh-list
154309319|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309320|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154309321|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154309322|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309323|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309324|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154309325|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154309326|NCT03797625|Growth Substances|growth substances|mesh-ancestor
154309327|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309328|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
154309329|NCT02051842|Metadoxine|metadoxine|mesh-list
154309330|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154309331|NCT02806414|Ivermectin|ivermectin|mesh-list
154309332|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154309333|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309334|NCT02049190|Onapristone|onapristone|mesh-list
154056153|NCT04119752|Curcumin|curcumin|mesh-list
154309336|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154309337|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
154309338|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154309339|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309340|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
154309341|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309343|NCT03811509|Diphosphonates|diphosphonates|mesh-list
154309344|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154309345|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309346|NCT02037412|Clopidogrel|clopidogrel|mesh-list
154309347|NCT02037412|Ticagrelor|ticagrelor|mesh-list
154309348|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154309349|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154309350|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154309351|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154309352|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
154309353|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309354|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309355|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309356|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154309357|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
154309358|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309359|NCT03797079|Bupivacaine|bupivacaine|mesh-list
154309360|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309361|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
154309362|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309363|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309365|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309366|NCT02049268|Ethanol|ethanol|mesh-list
154309367|NCT02049268|Nicotine|nicotine|mesh-list
154309368|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154309369|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
154309370|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309371|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309372|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154309373|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154309374|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
154309375|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309376|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309377|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154309378|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309379|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309380|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
154309381|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
154309382|NCT02049346|Hematinics|hematinics|mesh-ancestor
154309383|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
154309384|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154309385|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154309386|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309387|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
154309388|NCT02806024|Coagulants|coagulants|mesh-ancestor
154309389|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154309390|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309391|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309392|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
154309393|NCT02049580|Thiotepa|thiotepa|mesh-list
154309394|NCT02049580|Fludarabine|fludarabine|mesh-list
154309395|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154309396|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
154309397|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309398|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154309399|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154309400|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
154309401|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309402|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309403|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154309404|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
154309405|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154309406|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309407|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154309408|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154309409|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309410|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309411|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309412|NCT03796533|Posaconazole|posaconazole|mesh-list
154309413|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
154309414|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309415|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154309416|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154309417|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154309418|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154309419|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153530138|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
154309420|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309421|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309422|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154309423|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
154309424|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309425|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309426|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
154309427|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154309428|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
154309429|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154309430|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
154309431|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309432|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309433|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
154309434|NCT02049736|Telbivudine|telbivudine|mesh-list
154309435|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
154309436|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309437|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154309438|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309439|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309440|NCT01303029|Gemcitabine|gemcitabine|mesh-list
154309441|NCT01303029|Capecitabine|capecitabine|mesh-list
154309442|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154309443|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154309444|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
154309445|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309446|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309447|NCT01303029|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154309448|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154309449|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309451|NCT02052388|Brilacidin|brilacidin|mesh-list
154309452|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154309453|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309454|NCT01303107|Bupivacaine|bupivacaine|mesh-list
154309455|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309456|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
154309457|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309458|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309459|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
154309460|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309461|NCT03795909|Dexamethasone|dexamethasone|mesh-list
154309462|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154309463|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
154309464|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
154309465|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309466|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309467|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309468|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
154309469|NCT03795909|Hormones|hormones|mesh-ancestor
154309470|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309471|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154309472|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309473|NCT03795597|Melphalan|melphalan|mesh-list
154309474|NCT03795597|Busulfan|busulfan|mesh-list
154309475|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154309476|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
153530244|NCT01489696|Mirabegron|mirabegron|mesh-list
154309477|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309478|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309479|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154309480|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154309481|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
154309482|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309483|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
154309484|NCT02802592|Hematinics|hematinics|mesh-ancestor
154309485|NCT03637972|Nicotine|nicotine|mesh-list
154309486|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154309487|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
154309488|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309489|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309490|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154309491|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154309492|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
154309493|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309494|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309495|NCT03383679|Capecitabine|capecitabine|mesh-list
154309496|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154309497|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
154309498|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309499|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309500|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
154309501|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154309502|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309503|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
154309504|NCT02053402|Vitamin D|vitamin d|mesh-list
154309505|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
154309506|NCT02053402|Vitamins|vitamins|mesh-ancestor
154309507|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
154309508|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309509|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154309510|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154309511|NCT04639011|Norepinephrine|norepinephrine|mesh-list
154309512|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154309513|NCT04639011|Serotonin|serotonin|mesh-list
154255365|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309514|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154309515|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154309516|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154309517|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309518|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309519|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309520|NCT04639011|Analgesics|analgesics|mesh-ancestor
154309521|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
154309522|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309523|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
154309524|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154309525|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
154309526|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154309527|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154309528|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
154309529|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
154309530|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
154309531|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153530318|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
154309532|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154309533|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
154309534|NCT02053558|Lidocaine|lidocaine|mesh-list
154309535|NCT02053558|Ropivacaine|ropivacaine|mesh-list
154309536|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309537|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
154309538|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309539|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309540|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
154309541|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309542|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154309543|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154309544|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154309545|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154309546|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309547|NCT03809949|Fentanyl|fentanyl|mesh-list
154309548|NCT03809949|Anesthetics|anesthetics|mesh-list
154309549|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309550|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309551|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154309552|NCT03809949|Narcotics|narcotics|mesh-ancestor
154309553|NCT03809949|Analgesics|analgesics|mesh-ancestor
154309554|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
154309555|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309556|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154309557|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154056374|NCT00699296|Panobinostat|panobinostat|mesh-list
154309558|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
154309576|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309577|NCT01569633|Erythromycin|erythromycin|mesh-list
154309578|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
154309579|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154309580|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
154309581|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154309582|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309583|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309584|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154309585|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309586|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309587|NCT02054182|Vitamin D|vitamin d|mesh-list
154309588|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
154309589|NCT02054182|Vitamins|vitamins|mesh-ancestor
154309590|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
154309591|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309592|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154309593|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154309594|NCT02803138|Ritonavir|ritonavir|mesh-list
154309595|NCT02803138|Ribavirin|ribavirin|mesh-list
154309596|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154309597|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154309598|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
154309599|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309600|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309601|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154861653|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861654|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
153943324|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
154309602|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154309603|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
154309604|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309605|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154309606|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154309607|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
154309609|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154309610|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309611|NCT02056210|Plerixafor|plerixafor|mesh-list
154309612|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154309613|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154309614|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
154309615|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309616|NCT02801578|Ibrutinib|ibrutinib|mesh-list
154309617|NCT02801578|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154309618|NCT02801578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154309619|NCT02801578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309633|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309634|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
154309635|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309636|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154309637|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154309638|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154309639|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154309640|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309641|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154309643|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
154309644|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309645|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
154309647|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309648|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154309649|NCT03794505|Protective Agents|protective agents|mesh-ancestor
154309650|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154309651|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309652|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154309653|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
154309654|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154309655|NCT05625243|Protective Agents|protective agents|mesh-ancestor
154309656|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309657|NCT03023007|Anesthetics|anesthetics|mesh-list
154309658|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309659|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309660|NCT01304901|Montelukast|montelukast|mesh-list
154309661|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154309662|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
154309663|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154309664|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
154309665|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309666|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309667|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154309668|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154309669|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309670|NCT03794271|Anesthetics|anesthetics|mesh-list
154309671|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309672|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309673|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
154309674|NCT03792321|Testosterone|testosterone|mesh-list
154309675|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
154309676|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
154309677|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154309678|NCT03792321|Androgens|androgens|mesh-ancestor
154309679|NCT03792321|Hormones|hormones|mesh-ancestor
153530470|NCT01490476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153530549|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309680|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309683|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309684|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
154309685|NCT01305057|Pyridoxine|pyridoxine|mesh-list
154309686|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
154309687|NCT01305057|Vitamins|vitamins|mesh-ancestor
154309688|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
154309689|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309690|NCT03792009|Bupivacaine|bupivacaine|mesh-list
154861655|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154309691|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309692|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
154309693|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309694|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309695|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
154309696|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309697|NCT01305135|Azacitidine|azacitidine|mesh-list
154309698|NCT01305135|Idarubicin|idarubicin|mesh-list
154309699|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154309700|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
154309701|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309702|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309703|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309704|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154309705|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154309706|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154309707|NCT01305603|Bupivacaine|bupivacaine|mesh-list
154309708|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
154309709|NCT01305603|Anesthetics|anesthetics|mesh-list
154309710|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309711|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309712|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
154309713|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309715|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309716|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154309717|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309718|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309719|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154309720|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154309721|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
154309722|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
154309723|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309724|NCT02056366|Protective Agents|protective agents|mesh-ancestor
154309725|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309726|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
154309727|NCT02056366|Vitamins|vitamins|mesh-ancestor
154309728|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
154309729|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
154309730|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154309731|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154309732|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309733|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
154309734|NCT02056444|Coagulants|coagulants|mesh-ancestor
154309735|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154309736|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154309737|NCT05624229|Esomeprazole|esomeprazole|mesh-list
154309738|NCT05624229|Omeprazole|omeprazole|mesh-list
154309739|NCT05624229|Rabeprazole|rabeprazole|mesh-list
154309740|NCT05624229|Pantoprazole|pantoprazole|mesh-list
154309741|NCT05624229|Lansoprazole|lansoprazole|mesh-list
154309742|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154309743|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154309744|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309745|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530625|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154309746|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309747|NCT05622370|Brivaracetam|brivaracetam|mesh-list
154309748|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
154309749|NCT03791775|Polidocanol|polidocanol|mesh-list
154309750|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154309751|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154309752|NCT03789123|Dienogest|dienogest|mesh-list
154309753|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154309754|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154309755|NCT03789123|Estradiol|estradiol|mesh-list
154309756|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154309757|NCT03789123|Nandrolone|nandrolone|mesh-list
154309759|NCT03789123|Hormones|hormones|mesh-ancestor
154309760|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309761|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309762|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154309763|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
154309764|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154309765|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154309766|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154309767|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154309768|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154309769|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
154255366|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309770|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154309771|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309773|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
154309774|NCT05471817|Dabigatran|dabigatran|mesh-list
154309775|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
154309776|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154309777|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
154309778|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309779|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309780|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
154309781|NCT03788889|Ketamine|ketamine|mesh-list
154309782|NCT03788889|Lorazepam|lorazepam|mesh-list
154309783|NCT03788889|Phenobarbital|phenobarbital|mesh-list
154309784|NCT03788889|Analgesics|analgesics|mesh-ancestor
154027396|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154309785|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
154309786|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309787|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309788|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154309789|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154309790|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
154309791|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
154309792|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309793|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154309794|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154309795|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309796|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309797|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
154309798|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
154309799|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
154309800|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309801|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154309802|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154309803|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154309804|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154309805|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
154309806|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
154309807|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154309808|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154309809|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154309810|NCT03788733|Melatonin|melatonin|mesh-list
154309811|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
154309812|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309813|NCT03788733|Protective Agents|protective agents|mesh-ancestor
154309814|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309815|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309816|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
154309817|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309818|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309819|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309820|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154309821|NCT04753515|Midazolam|midazolam|mesh-list
154309822|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
154309823|NCT04753515|Remifentanil|remifentanil|mesh-list
154309824|NCT04753515|Propofol|propofol|mesh-list
154309825|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154309826|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309827|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309828|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154309829|NCT04753515|Analgesics|analgesics|mesh-ancestor
154309830|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
154309831|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309834|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154309835|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
154309836|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309837|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309838|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154309839|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
154309840|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
154309841|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154309842|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154309843|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154309844|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154861656|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154309845|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
154309846|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
154309847|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154309848|NCT04753515|Narcotics|narcotics|mesh-ancestor
154309849|NCT01306461|Timolol|timolol|mesh-list
154309850|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154309851|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154309852|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
154309853|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309854|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309855|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309856|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154309857|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154309858|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
154309859|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154309860|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154309861|NCT01305837|Prednisolone|prednisolone|mesh-list
154309862|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
154309863|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154309864|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
154309865|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154309866|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
154309867|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
154309868|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309869|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309870|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309871|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
154309872|NCT01305837|Hormones|hormones|mesh-ancestor
154309873|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309874|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154309875|NCT01305837|Protective Agents|protective agents|mesh-ancestor
154309876|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154309877|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309878|NCT01306773|Oseltamivir|oseltamivir|mesh-list
154309879|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
154309880|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309881|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309882|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309883|NCT03790605|Curcumin|curcumin|mesh-list
154309884|NCT03790605|Iproplatin|iproplatin|mesh-list
154309885|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154309886|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154309887|NCT03790605|Analgesics|analgesics|mesh-ancestor
154309888|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
154309889|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309890|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309891|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154309892|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154309893|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309894|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309895|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309896|NCT03787953|Antibodies|antibodies|mesh-list
154309897|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
154309898|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309899|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154309900|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
154309901|NCT01306851|Coagulants|coagulants|mesh-ancestor
154309902|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
154309903|NCT03790215|Progestins|progestins|mesh-ancestor
154309904|NCT03790215|Hormones|hormones|mesh-ancestor
154309905|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309906|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309908|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154309909|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
154309910|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154309911|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309912|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154309913|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309914|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
154309915|NCT01307475|Adenosine|adenosine|mesh-list
154309916|NCT01307475|Analgesics|analgesics|mesh-ancestor
154309917|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
154309918|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154309919|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309920|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154309921|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
154861657|NCT04355039|Growth Substances|growth substances|mesh-ancestor
154309922|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154309923|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
154309924|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
154309925|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309926|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309928|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
154309929|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309930|NCT03787641|Coagulants|coagulants|mesh-ancestor
154309931|NCT03790293|Rituximab|rituximab|mesh-list
154309932|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154309933|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309934|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
154309935|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309936|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154309937|NCT03245450|Irinotecan|irinotecan|mesh-list
154309938|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154309939|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154309940|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530769|NCT01492712|Propofol|propofol|mesh-list
154309941|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309942|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309943|NCT05694585|Esmolol|esmolol|mesh-list
154309944|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154309945|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154309946|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154309947|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
154309948|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309949|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309950|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309951|NCT03712917|Topiramate|topiramate|mesh-list
154309952|NCT03712917|Flunarizine|flunarizine|mesh-list
154309953|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
154309954|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154309955|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309956|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154309957|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154309958|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309959|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154309960|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154309961|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
154309962|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
154309963|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309964|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
154309965|NCT03787017|Metformin|metformin|mesh-list
154309966|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154309967|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309968|NCT01307865|Mannitol|mannitol|mesh-list
154309969|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154309970|NCT01307865|Diuretics|diuretics|mesh-ancestor
154309971|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
154309972|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309973|NCT01308177|Ecabet|ecabet|mesh-list
154309974|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154309975|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154309976|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154309977|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
154309978|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309979|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489205|NCT02834052|Laxatives|laxatives|mesh-ancestor
154309981|NCT01308177|Protective Agents|protective agents|mesh-ancestor
154309982|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309983|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309985|NCT01308255|Folic Acid|folic acid|mesh-list
154309986|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
154309987|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154309988|NCT01308255|Infliximab|infliximab|mesh-list
154309989|NCT01308255|Methotrexate|methotrexate|mesh-list
154309990|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
154309991|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309992|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154309993|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
154309994|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154309995|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154309996|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
154309997|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309998|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309999|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
154310000|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310001|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154310002|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154310003|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
154310004|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310005|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154310006|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154310007|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
154310008|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
154310009|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310010|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154310011|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
154310012|NCT01308255|Hormones|hormones|mesh-ancestor
154310013|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154056833|NCT00921700|Narcotics|narcotics|mesh-ancestor
154310014|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154310015|NCT01308255|Protective Agents|protective agents|mesh-ancestor
154310016|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154310017|NCT01308255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154310018|NCT01308255|Hematinics|hematinics|mesh-ancestor
154310019|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
154310020|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
154310021|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154310022|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154310023|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310024|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
154310025|NCT03782025|Coagulants|coagulants|mesh-ancestor
154310026|NCT03782025|Vitamins|vitamins|mesh-ancestor
154310027|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
154310028|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310029|NCT03781947|Antarelix|antarelix|mesh-list
154310030|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
154310031|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154310032|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310033|NCT03781869|Cisplatin|cisplatin|mesh-list
154310034|NCT03781869|Etoposide|etoposide|mesh-list
154310035|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
154310036|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310037|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154310038|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154310039|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154310040|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310041|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310042|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154310043|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310044|NCT03781635|Ketamine|ketamine|mesh-list
154310045|NCT03781635|Analgesics|analgesics|mesh-ancestor
154310046|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
154310047|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310048|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310049|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154310050|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154310051|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
154310052|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
154310053|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310056|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310057|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310058|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
154310059|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154310060|NCT03785613|Buprenorphine|buprenorphine|mesh-list
154310061|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154310062|NCT03785613|Narcotics|narcotics|mesh-ancestor
154310063|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310064|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310065|NCT03785613|Analgesics|analgesics|mesh-ancestor
154310066|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
154310067|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310068|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154310069|NCT01308723|Sorafenib|sorafenib|mesh-list
154310070|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154310071|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310072|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310073|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310074|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310075|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
154310076|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310077|NCT01561131|Calcium|calcium|mesh-list
154310078|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310079|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310080|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
154310081|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154310082|NCT03780621|Andrographolide|andrographolide|mesh-list
154310083|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154310084|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154310085|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154310086|NCT03780621|Analgesics|analgesics|mesh-ancestor
154310087|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
154310088|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310089|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310090|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310091|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154310092|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154310093|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310094|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
154310095|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154310096|NCT03785067|Amlodipine|amlodipine|mesh-list
154310097|NCT03785067|Telmisartan|telmisartan|mesh-list
154310098|NCT03785067|Indapamide|indapamide|mesh-list
154310099|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154310100|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154310101|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154310102|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310103|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310104|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310105|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
154310106|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154310107|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154310108|NCT03785067|Diuretics|diuretics|mesh-ancestor
154310109|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
154310110|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154310111|NCT02059018|Diclofenac|diclofenac|mesh-list
154310112|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
154310113|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
154310114|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154310115|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154310116|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154310117|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154310118|NCT02059018|Analgesics|analgesics|mesh-ancestor
154310119|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
154310120|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310121|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310122|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530997|NCT01494259|Epinephrine|epinephrine|mesh-list
154310123|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310124|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310125|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310131|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154310132|NCT01561209|Analgesics|analgesics|mesh-ancestor
154310133|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
154310134|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310135|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310136|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154310137|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154310138|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154310139|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310140|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310141|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310142|NCT02800642|Aflibercept|aflibercept|mesh-list
154310143|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154310144|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154310145|NCT02800642|Growth Substances|growth substances|mesh-ancestor
154310146|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310147|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
154310148|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310149|NCT02056600|Metformin|metformin|mesh-list
154310150|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154310151|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310152|NCT02056678|Acetaminophen|acetaminophen|mesh-list
154310153|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154255367|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943865|NCT00645892|Adalimumab|adalimumab|mesh-list
154310154|NCT02056678|Analgesics|analgesics|mesh-ancestor
154310155|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
154310156|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310157|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310158|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
154310159|NCT04662567|Acetaminophen|acetaminophen|mesh-list
154310160|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154310161|NCT04662567|Analgesics|analgesics|mesh-ancestor
154310162|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
154310163|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310164|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310165|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
154310166|NCT02799784|Albuterol|albuterol|mesh-list
154310167|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154310168|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
154310169|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310170|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310171|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154310172|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
154310173|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
154310174|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154310175|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154310176|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154310177|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154310178|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310179|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310180|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310181|NCT03779685|Anesthetics|anesthetics|mesh-list
154310182|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310183|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310184|NCT03779451|Progesterone|progesterone|mesh-list
154310185|NCT03779451|Progestins|progestins|mesh-ancestor
154310186|NCT03779451|Hormones|hormones|mesh-ancestor
154310187|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154310188|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310189|NCT02059330|Palbociclib|palbociclib|mesh-list
154310190|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310191|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310192|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310193|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310194|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
154310195|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154310208|NCT01333072|Aripiprazole|aripiprazole|mesh-list
154310209|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154310210|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
154310211|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310212|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310213|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310214|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154310215|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154310216|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310217|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154310218|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154310219|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
154310220|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
154310221|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
154310222|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154310223|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154310224|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154310225|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154310226|NCT02059564|Liraglutide|liraglutide|mesh-list
154310227|NCT02059564|Exenatide|exenatide|mesh-list
154310228|NCT02059564|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154310229|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154310230|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310231|NCT02059564|Incretins|incretins|mesh-ancestor
154310232|NCT02059564|Hormones|hormones|mesh-ancestor
154310233|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154310234|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154310235|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
154310236|NCT05622058|Docetaxel|docetaxel|mesh-list
154310237|NCT05622058|Doxorubicin|doxorubicin|mesh-list
154861658|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154861659|NCT02524405|Corticosterone|corticosterone|mesh-list
154310238|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154310239|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
154310240|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310241|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310242|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154310243|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
153531153|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
153531218|NCT01495208|Growth Substances|growth substances|mesh-ancestor
154310244|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310245|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310246|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154310247|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
154310248|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
154310249|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
154310250|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154310251|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154310252|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154310253|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310254|NCT02055196|Irinotecan|irinotecan|mesh-list
154310255|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154310256|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154310257|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310263|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310264|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310265|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310266|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154310267|NCT03783897|Norgestimate|norgestimate|mesh-list
154310268|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
154310269|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
154310271|NCT03783897|Estrogens|estrogens|mesh-ancestor
154310272|NCT03783897|Hormones|hormones|mesh-ancestor
154310273|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154310274|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310275|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154310276|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154310277|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154310278|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154310279|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154310280|NCT03779061|Propofol|propofol|mesh-list
154310281|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154310282|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310283|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310284|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154310285|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
154310286|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
154310287|NCT01316445|Midazolam|midazolam|mesh-list
154310288|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154310289|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154310290|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310291|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310292|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154310293|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154310294|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154310295|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154310296|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
154310297|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
154310298|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
154310299|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
154310300|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310301|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310302|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
154310303|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154310304|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310305|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154310306|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154310307|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
154310308|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310309|NCT03778359|Leuprolide|leuprolide|mesh-list
154310310|NCT03778359|Dienogest|dienogest|mesh-list
154310311|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
154310312|NCT03778359|Progestins|progestins|mesh-list
154310313|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154310315|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154310316|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310317|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154310318|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154310319|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154310320|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154310321|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
154310322|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154310323|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310324|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154310325|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154310326|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
154310327|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154310328|NCT03778359|Hormones|hormones|mesh-ancestor
154310335|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
154310336|NCT02057770|Busulfan|busulfan|mesh-list
154310337|NCT02057770|Fludarabine|fludarabine|mesh-list
154310338|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
154310339|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154310340|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
154310341|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310342|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310343|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154310344|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
154310345|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310346|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310347|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154310348|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154310349|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
154310350|NCT03778281|Baclofen|baclofen|mesh-list
154310351|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154310352|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310353|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154310354|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310355|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154310356|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
154310357|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
154310358|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310359|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310360|NCT02055586|Alovudine|alovudine|mesh-list
154310361|NCT02055586|Fluorides|fluorides|mesh-list
154310362|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
154310363|NCT02055586|Protective Agents|protective agents|mesh-ancestor
154310364|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310365|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
154310366|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310367|NCT03778593|Leucovorin|leucovorin|mesh-list
154310368|NCT03778593|Fluorouracil|fluorouracil|mesh-list
154310369|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
154310370|NCT03778593|Irinotecan|irinotecan|mesh-list
154310371|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
154310372|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310373|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154310374|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310375|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154310376|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
154310377|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310378|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154310379|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154310380|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310381|NCT03778593|Antidotes|antidotes|mesh-ancestor
154310382|NCT03778593|Protective Agents|protective agents|mesh-ancestor
154310383|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
154310384|NCT03778593|Vitamins|vitamins|mesh-ancestor
154310385|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
154310386|NCT02055664|Ropivacaine|ropivacaine|mesh-list
154310387|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
154310388|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
154310389|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310390|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310391|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
154310392|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310394|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154310395|NCT01309425|Narcotics|narcotics|mesh-ancestor
154310396|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310397|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310398|NCT01309425|Analgesics|analgesics|mesh-ancestor
154310399|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
153489619|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310404|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310406|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310408|NCT03561298|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154310409|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310410|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310411|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310412|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310413|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
154310414|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154310415|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310416|NCT02057926|Tetracycline|tetracycline|mesh-list
154310417|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154310418|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310419|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154310420|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310421|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310422|NCT03777579|Paclitaxel|paclitaxel|mesh-list
154310423|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154310424|NCT03777579|Antibodies|antibodies|mesh-list
154310425|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
154310426|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154310427|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310428|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
154310429|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
154310430|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
154310431|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310432|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
154310433|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310434|NCT02059876|Paclitaxel|paclitaxel|mesh-list
154310435|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154310436|NCT02059876|Carboplatin|carboplatin|mesh-list
154310437|NCT02059876|Trastuzumab|trastuzumab|mesh-list
154310438|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154310439|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310440|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
154310441|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
154310442|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
154310443|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310444|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154310445|NCT03777423|Cobalt|cobalt|mesh-list
154310446|NCT03777423|Chromium|chromium|mesh-list
154310447|NCT03777423|Trace Elements|trace elements|mesh-ancestor
154310448|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
154310449|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310450|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
154310451|NCT03777033|Calcium|calcium|mesh-list
154310452|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310453|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310454|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154310455|NCT02060032|Atorvastatin|atorvastatin|mesh-list
154310456|NCT02060032|Simvastatin|simvastatin|mesh-list
154310457|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154310458|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154310459|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
154310460|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310461|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154310462|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154310463|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310464|NCT03783273|Vitamin D|vitamin d|mesh-list
154310465|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
154310466|NCT03783273|Vitamins|vitamins|mesh-ancestor
154310467|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
154310468|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310469|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154310480|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
154310481|NCT01318005|Norinyl|norinyl|mesh-list
154310482|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
153531516|NCT01497093|Pomalidomide|pomalidomide|mesh-list
154310483|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154310484|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310485|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154310486|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154310487|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154310488|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154310489|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154310490|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154310491|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
154310492|NCT03710889|Abaloparatide|abaloparatide|mesh-list
153944155|NCT00645424|Atorvastatin|atorvastatin|mesh-list
154310493|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154310494|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310495|NCT02061124|Sevelamer|sevelamer|mesh-list
154310496|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
154310497|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
154310498|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310499|NCT01318941|Ranibizumab|ranibizumab|mesh-list
154310500|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154310501|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154310502|NCT01318941|Growth Substances|growth substances|mesh-ancestor
154310503|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310504|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
154310505|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310506|NCT03560440|Vancomycin|vancomycin|mesh-list
154310507|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154310508|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310509|NCT03776955|Carvedilol|carvedilol|mesh-list
154310510|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154310511|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154310512|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310513|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310514|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310515|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310516|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154310517|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
154310518|NCT03776955|Protective Agents|protective agents|mesh-ancestor
154310519|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154310520|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154310521|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310522|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
154310523|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154310524|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154310525|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154310526|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154310527|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
154310528|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310529|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310530|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154310531|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
154310532|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154310533|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154310534|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154310550|NCT03776409|Vancomycin|vancomycin|mesh-list
154310551|NCT03776409|Tazobactam|tazobactam|mesh-list
154310552|NCT03776409|Piperacillin|piperacillin|mesh-list
154310553|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154310554|NCT03776409|Lactams|lactams|mesh-list
154310555|NCT03776409|beta-Lactams|beta-lactams|mesh-list
154310556|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154310557|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310558|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154310559|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310560|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310561|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
154310562|NCT03782805|Vitamin D|vitamin d|mesh-list
154310563|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310564|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310565|NCT03782805|Vitamins|vitamins|mesh-ancestor
154310566|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
154310567|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154310568|NCT03775863|Liver Extracts|liver extracts|mesh-list
154310569|NCT03775863|Hematinics|hematinics|mesh-ancestor
154310570|NCT03274076|Tofacitinib|tofacitinib|mesh-list
154310571|NCT03274076|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154310572|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310573|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310574|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310575|NCT03775707|Lenvatinib|lenvatinib|mesh-list
154310576|NCT03775707|Antibodies|antibodies|mesh-list
154310577|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
154310578|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310579|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310580|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310581|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861660|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255368|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944224|NCT02660008|Incretins|incretins|mesh-ancestor
154310582|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310583|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154310584|NCT01320501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154310585|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310586|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310587|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310588|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310589|NCT02764268|Apatinib|apatinib|mesh-list
154310590|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310591|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310592|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310593|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310594|NCT01320111|Paclitaxel|paclitaxel|mesh-list
154310595|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154310596|NCT01320111|Sorafenib|sorafenib|mesh-list
153489822|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
154310600|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
154310601|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
154310602|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310603|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531648|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310604|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310605|NCT01320579|Tacrolimus|tacrolimus|mesh-list
154310606|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154310607|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
154310608|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310609|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154310610|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310611|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310612|NCT03775395|Sorafenib|sorafenib|mesh-list
154310613|NCT03775395|Lenvatinib|lenvatinib|mesh-list
154310614|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310615|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310616|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310617|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310618|NCT02797522|Acetaminophen|acetaminophen|mesh-list
154310619|NCT02797522|Tenofovir|tenofovir|mesh-list
154310620|NCT02797522|Entecavir|entecavir|mesh-list
154310621|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
154310622|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154310623|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154310624|NCT02797522|Analgesics|analgesics|mesh-ancestor
154310625|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
154310626|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310627|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310628|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
154310629|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
154310630|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310631|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154310632|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154310633|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310634|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310635|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154310636|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154310637|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
154310638|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310639|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
154310640|NCT02060656|Rituximab|rituximab|mesh-list
154310641|NCT02060656|Gemcitabine|gemcitabine|mesh-list
154310642|NCT02060656|Lenalidomide|lenalidomide|mesh-list
154310643|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310644|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154310645|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
154310646|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310647|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310648|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154310649|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
154310650|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310651|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154310652|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154310653|NCT02060656|Growth Substances|growth substances|mesh-ancestor
154310654|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
154310655|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861661|NCT03014323|Galantamine|galantamine|mesh-list
154861662|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154310656|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
154310657|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
154310658|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310659|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154310660|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
154310661|NCT02060656|Hormones|hormones|mesh-ancestor
154310662|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154310663|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154310664|NCT02060656|Protective Agents|protective agents|mesh-ancestor
154310665|NCT03774771|Cinacalcet|cinacalcet|mesh-list
154310666|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310667|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310668|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154310669|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
154310672|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
154310673|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310674|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310675|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154310676|NCT03774693|Narcotics|narcotics|mesh-ancestor
154310677|NCT03774693|Analgesics|analgesics|mesh-ancestor
154310678|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
154310679|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310680|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154310681|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154310682|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
154310683|NCT03774615|Ferric maltol|ferric maltol|mesh-list
154310684|NCT03774615|Hematinics|hematinics|mesh-ancestor
154310685|NCT01321047|Propofol|propofol|mesh-list
154310686|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154310687|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310688|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310689|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154310690|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
154310691|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
154310692|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
154310693|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154310694|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
154310695|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154310697|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310698|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
154310699|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
154310700|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
154310701|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
154310702|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
154310703|NCT05435313|Irinotecan|irinotecan|mesh-list
154310704|NCT05435313|Tislelizumab|tislelizumab|mesh-list
154310705|NCT05435313|Raltitrexed|raltitrexed|mesh-list
154310706|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310707|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154310708|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154310709|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531740|NCT01498562|Gefitinib|gefitinib|mesh-list
153531781|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310710|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310711|NCT05435313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154310712|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154310713|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
154310714|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154310715|NCT05472675|Bupivacaine|bupivacaine|mesh-list
154310716|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
154310717|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
154310718|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
154310719|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310720|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310721|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
154310722|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310723|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154310724|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154310725|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310726|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
154310727|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310728|NCT01321905|Vitamin D|vitamin d|mesh-list
154310729|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
154310730|NCT01321905|Vitamins|vitamins|mesh-ancestor
154310731|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
154310732|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310733|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154310734|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310735|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153944373|NCT00648934|Topiramate|topiramate|mesh-list
154310736|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
154310737|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154310738|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
154310739|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310740|NCT03763227|Ranibizumab|ranibizumab|mesh-list
154310741|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
154310742|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154310743|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154310744|NCT03763227|Growth Substances|growth substances|mesh-ancestor
153489958|NCT02491944|Osimertinib|osimertinib|mesh-list
154310750|NCT04929548|Maleic acid|maleic acid|mesh-list
154310751|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531783|NCT01498835|Sunitinib|sunitinib|mesh-list
153531821|NCT01498926|Insulin|insulin|mesh-list
154310752|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310753|NCT02060734|Lidocaine|lidocaine|mesh-list
154310754|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
154310755|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
154310756|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310757|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310758|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
154310759|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310760|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154310761|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154310762|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154310763|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154310764|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310765|NCT03270644|Propranolol|propranolol|mesh-list
154310766|NCT03270644|Lasmiditan|lasmiditan|mesh-list
154310767|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154310768|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154310769|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310770|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310771|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310772|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310773|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154310774|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154310775|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
154310776|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154310778|NCT04535102|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154310779|NCT04535102|Immunoconjugates|immunoconjugates|mesh-ancestor
154310780|NCT04535102|Immunologic Factors|immunologic factors|mesh-ancestor
154310781|NCT04535102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310782|NCT04529720|Vaccines|vaccines|mesh-list
154310783|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
154310784|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310785|NCT03768609|Cyclosporine|cyclosporine|mesh-list
154310786|NCT03768609|Cyclosporins|cyclosporins|mesh-list
154310787|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310788|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310789|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154310790|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
154310791|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310792|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
154310793|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310794|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
154310795|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310796|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154310797|NCT03269552|Rituximab|rituximab|mesh-list
154310798|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154310799|NCT03269552|Antibodies|antibodies|mesh-list
154310800|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
154310801|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154310802|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
154310803|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310804|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310805|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154310806|NCT03771729|Valsartan|valsartan|mesh-list
154310807|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154310808|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154310809|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154310810|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154310811|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310812|NCT03560362|Epinephrine|epinephrine|mesh-list
154310813|NCT03560362|Bupivacaine|bupivacaine|mesh-list
154861663|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310814|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
154310818|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
154310819|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310820|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154310821|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154310822|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310823|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310824|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310825|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154310826|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154310827|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
154310828|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154310829|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
154310830|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
154310831|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
154310832|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154310833|NCT03768531|Nivolumab|nivolumab|mesh-list
154310834|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154310835|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310836|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154310837|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310838|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
154310839|NCT01322061|Vitamins|vitamins|mesh-ancestor
154310840|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
154310841|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310842|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
154310843|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310844|NCT01322061|Protective Agents|protective agents|mesh-ancestor
154310845|NCT02062996|Phenylephrine|phenylephrine|mesh-list
154310846|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
153531879|NCT01499407|Abciximab|abciximab|mesh-list
154310847|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154310848|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154310849|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310850|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310851|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310852|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310853|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
154310854|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
154310855|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310856|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
154310857|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154310858|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
154310859|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154310860|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
154310861|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154310862|NCT02062996|Protective Agents|protective agents|mesh-ancestor
154310863|NCT03762369|Latanoprost|latanoprost|mesh-list
154310864|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154310865|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154310866|NCT01321515|Famciclovir|famciclovir|mesh-list
154310867|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
154310868|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310869|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154310870|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310871|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310872|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
154310873|NCT02065414|Listerine|listerine|mesh-list
154310874|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154310875|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310876|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
154310877|NCT04233879|Tenofovir|tenofovir|mesh-list
154310878|NCT04233879|Emtricitabine|emtricitabine|mesh-list
154310879|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154310880|NCT04233879|Islatravir|islatravir|mesh-list
154310881|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
154310882|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310883|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154310884|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154310885|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310886|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310887|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154310890|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154310891|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154310892|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
154310893|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310894|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310895|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310896|NCT03792334|Anesthetics|anesthetics|mesh-list
154310897|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310898|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310899|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
154310900|NCT04545411|Volagidemab|volagidemab|mesh-list
154310901|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154310902|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310903|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154310904|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310905|NCT02065492|Amlodipine|amlodipine|mesh-list
154310906|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
154310907|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310908|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310909|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154310910|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154310911|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310912|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
154310913|NCT02063620|Ketamine|ketamine|mesh-list
154310914|NCT02063620|Analgesics|analgesics|mesh-ancestor
154057745|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
154310915|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
154310916|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310917|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310918|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154310919|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154310920|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
154310921|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
154310922|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310923|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154310924|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154310925|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310926|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310927|NCT03767439|Nivolumab|nivolumab|mesh-list
154310928|NCT03767439|Ipilimumab|ipilimumab|mesh-list
154310929|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154310930|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310931|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154310932|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310933|NCT04539405|Sevoflurane|sevoflurane|mesh-list
154310934|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154310935|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154310936|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
153532053|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154310937|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
154310938|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310939|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310940|NCT02065804|Bupivacaine|bupivacaine|mesh-list
154310941|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
154310942|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
154310943|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310944|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310945|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
154310946|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310947|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
154310948|NCT02064010|Acamprosate|acamprosate|mesh-list
154310949|NCT02064010|Calcium|calcium|mesh-list
154310950|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310951|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310952|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154310953|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154310954|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
154310955|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
154310956|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
154310957|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490173|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154310960|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310961|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154310962|NCT02066038|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154310963|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310964|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310965|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310966|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310967|NCT03766893|Naltrexone|naltrexone|mesh-list
154310968|NCT03766893|Buprenorphine|buprenorphine|mesh-list
154310969|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154310970|NCT03766893|Naloxone|naloxone|mesh-list
154310971|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154310972|NCT03766893|Narcotics|narcotics|mesh-ancestor
154310973|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310974|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310975|NCT03766893|Analgesics|analgesics|mesh-ancestor
154310976|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
154310977|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310978|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154310979|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154310980|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
154310981|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154310982|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310983|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310984|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154310985|NCT03760809|Analgesics|analgesics|mesh-ancestor
154310986|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
154310987|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310988|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154310989|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154057805|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
154310991|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310992|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310993|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310994|NCT01370590|Atorvastatin|atorvastatin|mesh-list
154310995|NCT01370590|Ezetimibe|ezetimibe|mesh-list
154310996|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154310997|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154310998|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
154310999|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311000|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154311001|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154311002|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311003|NCT01567683|Imiquimod|imiquimod|mesh-list
154311004|NCT01567683|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154311005|NCT01567683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311006|NCT01567683|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154311007|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
154311008|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311009|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154311010|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311011|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
154311012|NCT01561911|Antibodies|antibodies|mesh-list
154311013|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154311014|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
154311015|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311016|NCT03770637|Glucagon|glucagon|mesh-list
154311017|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154311018|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311019|NCT03770637|Hormones|hormones|mesh-ancestor
153532113|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
154311020|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311021|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311022|NCT03770637|Incretins|incretins|mesh-ancestor
154311023|NCT03766269|Dronabinol|dronabinol|mesh-list
154311024|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
154311025|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311026|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154311027|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154311028|NCT03766269|Analgesics|analgesics|mesh-ancestor
154311029|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
154311030|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311032|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154311033|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311034|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311035|NCT03766269|Hormones|hormones|mesh-ancestor
154311036|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311037|NCT03765645|Tazobactam|tazobactam|mesh-list
154311038|NCT03765645|Piperacillin|piperacillin|mesh-list
154311039|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154311040|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154311041|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311042|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154311043|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311044|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311046|NCT01321671|Analgesics|analgesics|mesh-ancestor
154311047|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
154311048|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311049|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311050|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
154311051|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154311052|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311053|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311054|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311055|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154311056|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154311057|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311058|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154311059|NCT03770013|Clonidine|clonidine|mesh-list
153532167|NCT01501084|Exenatide|exenatide|mesh-list
153532202|NCT01501136|Cisplatin|cisplatin|mesh-list
154311060|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
154311061|NCT03770013|Bupivacaine|bupivacaine|mesh-list
154311062|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
154311063|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
154311064|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311066|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
154311067|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311068|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154311069|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154311070|NCT03770013|Analgesics|analgesics|mesh-ancestor
154311071|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154311072|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154311073|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154311074|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
154311075|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311076|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311077|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154311078|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
154311079|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
154311080|NCT03769935|Etoposide|etoposide|mesh-list
154311081|NCT03769935|Cisplatin|cisplatin|mesh-list
154311082|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154311083|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311084|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154311085|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154311086|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311087|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311088|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
154311089|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154311090|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154311091|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311092|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
154311093|NCT03765021|Coagulants|coagulants|mesh-ancestor
154311094|NCT05418699|Insulin|insulin|mesh-list
154311095|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154311096|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311097|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154311098|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
154311099|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154311100|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
154311101|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311102|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
154311103|NCT03758859|Protective Agents|protective agents|mesh-ancestor
154311104|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154311105|NCT03764241|Vitamin K|vitamin k|mesh-list
154311108|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
154311109|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311110|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154311111|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
154311112|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154311113|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
154311114|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311115|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311116|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
154311117|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154311118|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154311119|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
154311120|NCT03764241|Coagulants|coagulants|mesh-ancestor
154311122|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154311123|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
154311124|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
154311125|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311126|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311127|NCT01321827|Itraconazole|itraconazole|mesh-list
154311128|NCT01321827|Prednisolone|prednisolone|mesh-list
154311129|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
154311130|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154311131|NCT01321827|Hormones|hormones|mesh-ancestor
154311132|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311133|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311134|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154311135|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311136|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
154311137|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057952|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154311138|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154311139|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154311140|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311141|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311142|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154311143|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
154311144|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154311145|NCT03753477|Amlodipine|amlodipine|mesh-list
154311146|NCT03753477|Olmesartan|olmesartan|mesh-list
154311147|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154311148|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
154311149|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154311150|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154311151|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154311152|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311153|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311154|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311155|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311156|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
154311157|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154311158|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154311159|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
154311160|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154311161|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154311162|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311163|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154311164|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154311165|NCT03758469|Rifampin|rifampin|mesh-list
154311166|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154311167|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
154311168|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154311169|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311170|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
154311171|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154311172|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311173|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311174|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154311175|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154311176|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154311178|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154311179|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154311181|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
154311182|NCT04646109|Ivermectin|ivermectin|mesh-list
154311183|NCT04646109|Favipiravir|favipiravir|mesh-list
154311184|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154311185|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311186|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
154311187|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154311188|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154311189|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311190|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311191|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311192|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
154311193|NCT05320107|Ketamine|ketamine|mesh-list
154311194|NCT05320107|Analgesics|analgesics|mesh-ancestor
154311195|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
154311196|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311197|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311198|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154311199|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154311200|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
154311201|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
154311202|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311203|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154311204|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154311205|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311206|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311207|NCT03752931|Celiprolol|celiprolol|mesh-list
153532409|NCT01501708|Voriconazole|voriconazole|mesh-list
154311208|NCT03752931|Diltiazem|diltiazem|mesh-list
154311209|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154311210|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154311211|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311212|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311213|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311214|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311215|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
154311216|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154311217|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
154311218|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
154311219|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311220|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154311221|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154311222|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154311223|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
154311224|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311225|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154311226|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154311227|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154311228|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154311229|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311230|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311231|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154311232|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311233|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311234|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
154311235|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311236|NCT02066350|Pancrelipase|pancrelipase|mesh-list
154311237|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311238|NCT02064946|Vitamin D|vitamin d|mesh-list
154311239|NCT02064946|Vitamins|vitamins|mesh-ancestor
154311240|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
154311241|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311242|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154311243|NCT02064556|Amlodipine|amlodipine|mesh-list
154311244|NCT02064556|Candesartan|candesartan|mesh-list
154311245|NCT02064556|Candesartan cilexetil|candesartan cilexetil|mesh-list
154311246|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154311247|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154311248|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490471|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154311251|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311252|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
154311253|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154311254|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154311255|NCT03752229|Diazepam|diazepam|mesh-list
154311256|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154311257|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
154311258|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
154311259|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
154311260|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311261|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311262|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311263|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154311264|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311265|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154311266|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154311267|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154311268|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154311269|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154311270|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154311271|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
154311272|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
154311273|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
154311274|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
154311275|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311276|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311277|NCT03695367|Acetaminophen|acetaminophen|mesh-list
154311278|NCT03695367|Ibuprofen|ibuprofen|mesh-list
154311279|NCT03695367|Ketorolac|ketorolac|mesh-list
154311280|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154311281|NCT03695367|Analgesics|analgesics|mesh-ancestor
154311282|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
154058097|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311283|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311284|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311285|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
154311286|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154311287|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154311288|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311289|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154311290|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311291|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311292|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154311293|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154311294|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
154311295|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311296|NCT03755427|Antacids|antacids|mesh-ancestor
154311297|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311298|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311299|NCT03758079|Gabapentin|gabapentin|mesh-list
154311300|NCT03758079|Doxepin|doxepin|mesh-list
154311301|NCT03758079|Analgesics|analgesics|mesh-ancestor
154311302|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
154311303|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311304|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311305|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
154311306|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154311307|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154311308|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532539|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154311309|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154311310|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154311311|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154311312|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311313|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311314|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
154311315|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154311316|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154311317|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154311318|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
153490546|NCT05419674|Antacids|antacids|mesh-ancestor
154311320|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
154311321|NCT02067910|Abatacept|abatacept|mesh-list
154311322|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154311323|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311324|NCT02067910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154311325|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311326|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154311327|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
154311328|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311329|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311330|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
154311331|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
154311332|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154311333|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
154311334|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154311335|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
154311336|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311337|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311338|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
154311339|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
154311340|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154311341|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154311342|NCT05280873|Prednisolone|prednisolone|mesh-list
154311343|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
154311344|NCT05280873|Pirfenidone|pirfenidone|mesh-list
154311345|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154311346|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
154311347|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154311348|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
154311349|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
154311350|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311351|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311352|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311353|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
154311354|NCT05280873|Hormones|hormones|mesh-ancestor
154311355|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311356|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154311357|NCT05280873|Protective Agents|protective agents|mesh-ancestor
154311358|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154311359|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311360|NCT05280873|Analgesics|analgesics|mesh-ancestor
154311361|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
154311362|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154311363|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154311364|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311365|NCT02066818|Lidocaine|lidocaine|mesh-list
154311366|NCT02066818|Tetracaine|tetracaine|mesh-list
154311367|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
154311368|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
154311369|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311370|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311371|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
154311372|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311373|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154311374|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154311375|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154311376|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311377|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311378|NCT04558125|Heparin|heparin|mesh-list
154311379|NCT04558125|Calcium heparin|calcium heparin|mesh-list
154311380|NCT04558125|Enoxaparin|enoxaparin|mesh-list
154311381|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154311382|NCT04558125|Tinzaparin|tinzaparin|mesh-list
154311383|NCT04558125|Dalteparin|dalteparin|mesh-list
154311384|NCT04558125|Tenecteplase|tenecteplase|mesh-list
154311385|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
154311386|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
154311387|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154311388|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154311389|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311390|NCT05460195|Immunomodulating Agents|immunomodulating agents|mesh-list
154311391|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
154311392|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311393|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
154311394|NCT02793622|Piperaquine|piperaquine|mesh-list
154311397|NCT02793622|Artenimol|artenimol|mesh-list
154311398|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
154311399|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154311400|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154311401|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311402|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154311403|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311404|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311405|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154311406|NCT04493931|Rifampin|rifampin|mesh-list
154311407|NCT04493931|Gepotidacin|gepotidacin|mesh-list
154311408|NCT04493931|Digoxin|digoxin|mesh-list
154311409|NCT04493931|Midazolam|midazolam|mesh-list
154311410|NCT04493931|Cimetidine|cimetidine|mesh-list
154311411|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154311412|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154311413|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311414|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311415|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154311416|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154311417|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154311418|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154311419|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
154311420|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
154311421|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
154311422|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
154311423|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311424|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311425|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154311426|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
154311427|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154311428|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311429|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
154311430|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154311431|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311432|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154311433|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154311434|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154311435|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154311436|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154311437|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154311438|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154311439|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154311440|NCT04493931|Protective Agents|protective agents|mesh-ancestor
154311441|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154311442|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311443|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154311444|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
154311445|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
154311446|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154311447|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154311448|NCT04493931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154311449|NCT04493931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311450|NCT06264284|Anesthetics|anesthetics|mesh-list
154311451|NCT06264284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311452|NCT06264284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311453|NCT06264206|Immunoglobulins|immunoglobulins|mesh-list
154311454|NCT06264206|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154311455|NCT06264206|Antibodies|antibodies|mesh-list
154311456|NCT06264206|Immunologic Factors|immunologic factors|mesh-ancestor
154311457|NCT06264206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311458|NCT06264180|Pembrolizumab|pembrolizumab|mesh-list
154311459|NCT06264180|Nivolumab|nivolumab|mesh-list
154311460|NCT06264180|Relatlimab|relatlimab|mesh-list
154311461|NCT06264180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154311462|NCT06264180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311463|NCT06264180|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154311464|NCT06264180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311465|NCT06264141|Nitric Oxide|nitric oxide|mesh-list
154311466|NCT06264141|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154311467|NCT06264141|Autonomic Agents|autonomic agents|mesh-ancestor
154311468|NCT06264141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311469|NCT06264141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311471|NCT06264141|Respiratory System Agents|respiratory system agents|mesh-ancestor
154311472|NCT06264141|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154311473|NCT06264141|Antioxidants|antioxidants|mesh-ancestor
154311474|NCT06264141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311475|NCT06264141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311476|NCT06264141|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154311477|NCT06264141|Vasodilator Agents|vasodilator agents|mesh-ancestor
154311478|NCT06264141|Gasotransmitters|gasotransmitters|mesh-ancestor
154311479|NCT06264141|Protective Agents|protective agents|mesh-ancestor
154311480|NCT06263673|Dapagliflozin|dapagliflozin|mesh-list
154311481|NCT06263673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154311482|NCT06263673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154311483|NCT06263673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154311484|NCT06263673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311485|NCT06263673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154311486|NCT06263673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311487|NCT06263673|Incretins|incretins|mesh-ancestor
154311488|NCT06263673|Hormones|hormones|mesh-ancestor
154311489|NCT06263673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311490|NCT06263673|Protease Inhibitors|protease inhibitors|mesh-ancestor
154311491|NCT06263673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311492|NCT06263543|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154311493|NCT06263543|Immunoconjugates|immunoconjugates|mesh-ancestor
154311494|NCT06263543|Immunologic Factors|immunologic factors|mesh-ancestor
154311495|NCT06263543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311496|NCT06263517|Clodronic Acid|clodronic acid|mesh-list
154311497|NCT06263517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154311498|NCT06263517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311499|NCT06263270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154311500|NCT06263270|Protease Inhibitors|protease inhibitors|mesh-list
154311501|NCT06263270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311502|NCT06263270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311503|NCT06263270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154311504|NCT06263270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154311505|NCT06263270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154311506|NCT06263270|Antiviral Agents|antiviral agents|mesh-ancestor
154311507|NCT06263270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311508|NCT06263231|Trabectedin|trabectedin|mesh-list
154311509|NCT06263231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154311510|NCT06263231|Alkylating Agents|alkylating agents|mesh-ancestor
154311511|NCT06263231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311512|NCT06263231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311514|NCT06262945|Penicillins|penicillins|mesh-list
154311515|NCT06262945|Analgesics|analgesics|mesh-list
154311516|NCT06262945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311517|NCT06262945|Sensory System Agents|sensory system agents|mesh-ancestor
154311518|NCT06262945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311519|NCT06262945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532808|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154311520|NCT06262854|Calcium|calcium|mesh-list
154311521|NCT06262854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311522|NCT06262854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311523|NCT06262685|Atorvastatin|atorvastatin|mesh-list
154311524|NCT06262685|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154311525|NCT06262685|Simvastatin|simvastatin|mesh-list
154311526|NCT06262685|Pravastatin|pravastatin|mesh-list
154311527|NCT06262685|Pitavastatin|pitavastatin|mesh-list
154311528|NCT06262685|Lovastatin|lovastatin|mesh-list
154311529|NCT06262685|L 647318|l 647318|mesh-list
154311530|NCT06262685|Dihydromevinolin|dihydromevinolin|mesh-list
154311531|NCT06262685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154311532|NCT06262685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154311533|NCT06262685|Antimetabolites|antimetabolites|mesh-ancestor
154311534|NCT06262685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311535|NCT06262685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154311536|NCT06262685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154311537|NCT06262685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311538|NCT06262594|Lemborexant|lemborexant|mesh-list
154311539|NCT06262594|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154311540|NCT06262594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311541|NCT06262594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311542|NCT06262594|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154311543|NCT06262594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154311544|NCT06262594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311545|NCT06262594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311547|NCT06262581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154311548|NCT06262581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311549|NCT06262438|Cytarabine|cytarabine|mesh-list
154311550|NCT06262438|Methotrexate|methotrexate|mesh-list
154311551|NCT06262438|Fludarabine|fludarabine|mesh-list
154311552|NCT06262438|Etoposide|etoposide|mesh-list
154311553|NCT06262438|Daunorubicin|daunorubicin|mesh-list
154311554|NCT06262438|Mitoxantrone|mitoxantrone|mesh-list
154311555|NCT06262438|Dexrazoxane|dexrazoxane|mesh-list
154311556|NCT06262438|Razoxane|razoxane|mesh-list
154311557|NCT06262438|Quizartinib|quizartinib|mesh-list
154311558|NCT06262438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154311559|NCT06262438|Abortifacient Agents|abortifacient agents|mesh-ancestor
154311560|NCT06262438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154311561|NCT06262438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311562|NCT06262438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154311563|NCT06262438|Antimetabolites|antimetabolites|mesh-ancestor
154311564|NCT06262438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311565|NCT06262438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311566|NCT06262438|Dermatologic Agents|dermatologic agents|mesh-ancestor
154311567|NCT06262438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311568|NCT06262438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154311569|NCT06262438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154311570|NCT06262438|Immunologic Factors|immunologic factors|mesh-ancestor
154311571|NCT06262438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311572|NCT06262438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154311573|NCT06262438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154311574|NCT06262438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154311575|NCT06262438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154311576|NCT06262438|Antiviral Agents|antiviral agents|mesh-ancestor
154311577|NCT06262438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311578|NCT06262438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154311579|NCT06262438|Analgesics|analgesics|mesh-ancestor
154311580|NCT06262438|Sensory System Agents|sensory system agents|mesh-ancestor
154311581|NCT06262438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311582|NCT06262438|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154311583|NCT06262438|Protective Agents|protective agents|mesh-ancestor
154311584|NCT06262438|Antimitotic Agents|antimitotic agents|mesh-ancestor
154311585|NCT06262438|Mitosis Modulators|mitosis modulators|mesh-ancestor
154311586|NCT06262438|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154311587|NCT06262438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154311588|NCT06262386|Cisplatin|cisplatin|mesh-list
154311589|NCT06262386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311590|NCT06260072|Riboflavin|riboflavin|mesh-list
154311591|NCT06260072|Vitamin B Complex|vitamin b complex|mesh-ancestor
154311592|NCT06260072|Vitamins|vitamins|mesh-ancestor
154311593|NCT06260072|Micronutrients|micronutrients|mesh-ancestor
154311594|NCT06260072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311595|NCT06260072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154311596|NCT06260072|Dermatologic Agents|dermatologic agents|mesh-ancestor
154311597|NCT06259747|Pyridoxine|pyridoxine|mesh-list
154311598|NCT06259747|Doxylamine|doxylamine|mesh-list
154311599|NCT06259747|Vitamin B Complex|vitamin b complex|mesh-ancestor
154311600|NCT06259747|Vitamins|vitamins|mesh-ancestor
154311601|NCT06259747|Micronutrients|micronutrients|mesh-ancestor
154311602|NCT06259747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311603|NCT06259747|Antiemetics|antiemetics|mesh-ancestor
154311604|NCT06259747|Autonomic Agents|autonomic agents|mesh-ancestor
154311605|NCT06259747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311606|NCT06259747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311607|NCT06259747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154311608|NCT06259747|Histamine Antagonists|histamine antagonists|mesh-ancestor
154311609|NCT06259747|Histamine Agents|histamine agents|mesh-ancestor
154311610|NCT06259747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311611|NCT06259747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311612|NCT06258525|Oxaliplatin|oxaliplatin|mesh-list
154311613|NCT06258525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311614|NCT06257875|Adalimumab|adalimumab|mesh-list
154311615|NCT06257875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154311616|NCT06257875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532900|NCT01503918|Valganciclovir|valganciclovir|mesh-list
154311617|NCT06257875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311618|NCT06256601|Calcium, Dietary|calcium, dietary|mesh-list
154311619|NCT06256601|Calcium|calcium|mesh-list
154311620|NCT06256601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311621|NCT06256601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311624|NCT06255626|Immunologic Factors|immunologic factors|mesh-ancestor
154311625|NCT06255626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311626|NCT06249113|Lidocaine|lidocaine|mesh-list
154311627|NCT06249113|Anesthetics, Local|anesthetics, local|mesh-ancestor
154311628|NCT06249113|Anesthetics|anesthetics|mesh-ancestor
154311629|NCT06249113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311630|NCT06249113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311631|NCT06249113|Sensory System Agents|sensory system agents|mesh-ancestor
154311632|NCT06249113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311633|NCT06249113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154311634|NCT06249113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154311635|NCT06249113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154311636|NCT06249113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311637|NCT06249113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311638|NCT06244745|Letrozole|letrozole|mesh-list
154311639|NCT06244745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311640|NCT06244745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154311641|NCT06244745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154311642|NCT06244745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311643|NCT06244745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311644|NCT06244745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154311645|NCT06244745|Hormone Antagonists|hormone antagonists|mesh-ancestor
154311646|NCT06244745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311647|NCT06244745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311648|NCT06232707|Dexamethasone|dexamethasone|mesh-list
154311649|NCT06232707|Daratumumab|daratumumab|mesh-list
154311650|NCT06232707|Pomalidomide|pomalidomide|mesh-list
154311651|NCT06232707|Elotuzumab|elotuzumab|mesh-list
154311652|NCT06232707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154311653|NCT06232707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154311654|NCT06232707|Antiemetics|antiemetics|mesh-ancestor
154311655|NCT06232707|Autonomic Agents|autonomic agents|mesh-ancestor
154311656|NCT06232707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311657|NCT06232707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311658|NCT06232707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311659|NCT06232707|Glucocorticoids|glucocorticoids|mesh-ancestor
153532922|NCT01504074|Hormones|hormones|mesh-ancestor
153532960|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311660|NCT06232707|Hormones|hormones|mesh-ancestor
154311661|NCT06232707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311662|NCT06232707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153532961|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311663|NCT06232707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311664|NCT06232707|Immunologic Factors|immunologic factors|mesh-ancestor
154058464|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
154311665|NCT06232707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154311666|NCT06232707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154311667|NCT06232707|Growth Substances|growth substances|mesh-ancestor
154311668|NCT06232707|Growth Inhibitors|growth inhibitors|mesh-ancestor
154311669|NCT06177483|Curcumin|curcumin|mesh-list
154311670|NCT06177483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154311671|NCT06177483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154311672|NCT06177483|Analgesics|analgesics|mesh-ancestor
154311673|NCT06177483|Sensory System Agents|sensory system agents|mesh-ancestor
154311674|NCT06177483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311675|NCT06177483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311676|NCT06177483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154311677|NCT06177483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311678|NCT06177483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311679|NCT06177483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311680|NCT06177483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311681|NCT06138509|Serotonin|serotonin|mesh-list
154311682|NCT06138509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154311683|NCT06138509|Serotonin Agents|serotonin agents|mesh-ancestor
154311684|NCT06138509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311685|NCT06138509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311686|NCT06138509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311687|NCT06137690|Antifungal Agents|antifungal agents|mesh-list
154311688|NCT06137690|Clotrimazole|clotrimazole|mesh-list
154311689|NCT06137690|Miconazole|miconazole|mesh-list
154311690|NCT06137690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311691|NCT06137690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154311692|NCT06137690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153490910|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154311699|NCT06137690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311700|NCT06137690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154311701|NCT06137690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154311702|NCT06130826|Immunomodulating Agents|immunomodulating agents|mesh-list
154311703|NCT06130826|Immunologic Factors|immunologic factors|mesh-ancestor
154311704|NCT06130826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311705|NCT06129773|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154311706|NCT06129773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311707|NCT06128070|Methotrexate|methotrexate|mesh-list
154311708|NCT06128070|Tacrolimus|tacrolimus|mesh-list
154311709|NCT06128070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154311710|NCT06128070|Abortifacient Agents|abortifacient agents|mesh-ancestor
154311711|NCT06128070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154311712|NCT06128070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311713|NCT06128070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154311714|NCT06128070|Antimetabolites|antimetabolites|mesh-ancestor
154311715|NCT06128070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311716|NCT06128070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311717|NCT06128070|Dermatologic Agents|dermatologic agents|mesh-ancestor
154311718|NCT06128070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311719|NCT06128070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154311720|NCT06128070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154311721|NCT06128070|Immunologic Factors|immunologic factors|mesh-ancestor
154311722|NCT06128070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311723|NCT06128070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154311724|NCT06128070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154311725|NCT06125691|Vaccines|vaccines|mesh-list
153945348|NCT02649478|Fluticasone|fluticasone|mesh-list
154311726|NCT06125691|Immunologic Factors|immunologic factors|mesh-ancestor
154311727|NCT06125691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311728|NCT06088862|Nicotine|nicotine|mesh-list
154311729|NCT06088862|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154311730|NCT06088862|Autonomic Agents|autonomic agents|mesh-ancestor
154311731|NCT06088862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311732|NCT06088862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311733|NCT06088862|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154311734|NCT06088862|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154311735|NCT06088862|Cholinergic Agents|cholinergic agents|mesh-ancestor
154311736|NCT06088862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311737|NCT06088862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311738|NCT06024889|Furosemide|furosemide|mesh-list
154311739|NCT06024889|Diuretics|diuretics|mesh-ancestor
154311740|NCT06024889|Natriuretic Agents|natriuretic agents|mesh-ancestor
154311741|NCT06024889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311742|NCT06024889|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154311743|NCT06024889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311744|NCT06024889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311745|NCT06016270|Paclitaxel|paclitaxel|mesh-list
154311746|NCT06016270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154311747|NCT06016270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154311748|NCT06016270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311749|NCT06016270|Tubulin Modulators|tubulin modulators|mesh-ancestor
154311750|NCT06016270|Antimitotic Agents|antimitotic agents|mesh-ancestor
154311751|NCT06016270|Mitosis Modulators|mitosis modulators|mesh-ancestor
154311752|NCT06016270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311753|NCT05993611|Immunoglobulins|immunoglobulins|mesh-list
154311754|NCT05993611|Immunologic Factors|immunologic factors|mesh-ancestor
154311755|NCT05993611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311756|NCT05959629|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154311757|NCT05959629|Eusol|eusol|mesh-list
154311758|NCT05959629|Disinfectants|disinfectants|mesh-ancestor
154311770|NCT05890664|Colchicine|colchicine|mesh-list
154311771|NCT05890664|Gout Suppressants|gout suppressants|mesh-ancestor
153533029|NCT01504490|Bexarotene|bexarotene|mesh-list
153533083|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
154311772|NCT05890664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311773|NCT05890664|Tubulin Modulators|tubulin modulators|mesh-ancestor
154311774|NCT05890664|Antimitotic Agents|antimitotic agents|mesh-ancestor
154311775|NCT05890664|Mitosis Modulators|mitosis modulators|mesh-ancestor
154311776|NCT05890664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311777|NCT05890664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311778|NCT05865990|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154311779|NCT05865990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154311780|NCT05865990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311781|NCT05856305|Copper|copper|mesh-list
154311782|NCT05856305|Chlorophyllin|chlorophyllin|mesh-list
154311783|NCT05856305|Trace Elements|trace elements|mesh-ancestor
154311784|NCT05856305|Micronutrients|micronutrients|mesh-ancestor
154311785|NCT05856305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311786|NCT05856305|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154311787|NCT05856305|Protective Agents|protective agents|mesh-ancestor
154311788|NCT05826119|Magnesium Sulfate|magnesium sulfate|mesh-list
154311789|NCT05826119|Analgesics|analgesics|mesh-ancestor
154311790|NCT05826119|Sensory System Agents|sensory system agents|mesh-ancestor
154311791|NCT05826119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311792|NCT05826119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311793|NCT05826119|Anesthetics|anesthetics|mesh-ancestor
154311794|NCT05826119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311795|NCT05826119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154311796|NCT05826119|Anticonvulsants|anticonvulsants|mesh-ancestor
154311797|NCT05826119|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154311798|NCT05826119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311799|NCT05826119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311800|NCT05826119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311801|NCT05826119|Tocolytic Agents|tocolytic agents|mesh-ancestor
154311802|NCT05826119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154311803|NCT05797740|Cladribine|cladribine|mesh-list
154311804|NCT05797740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311805|NCT05797740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154311806|NCT05797740|Immunologic Factors|immunologic factors|mesh-ancestor
154311807|NCT05797740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311808|NCT05763771|Nicotine|nicotine|mesh-list
154311809|NCT05763771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154311810|NCT05763771|Autonomic Agents|autonomic agents|mesh-ancestor
154861664|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311811|NCT05763771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311812|NCT05763771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311813|NCT05763771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153533138|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154311814|NCT05763771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154311815|NCT05763771|Cholinergic Agents|cholinergic agents|mesh-ancestor
154311816|NCT05763771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311817|NCT05763771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311818|NCT05759000|Dapagliflozin|dapagliflozin|mesh-list
154311819|NCT05759000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154311820|NCT05759000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311821|NCT05759000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154311842|NCT05722067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311844|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
154311845|NCT05673785|Doxorubicin|doxorubicin|mesh-list
154311846|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154311847|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154311848|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
154311849|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311850|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154311851|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154311852|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
154311853|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311854|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311855|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154311856|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154311857|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154311858|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154311859|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311860|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154311861|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
154311862|NCT05673785|Hormones|hormones|mesh-ancestor
154311863|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311864|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154311865|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154311866|NCT05673785|Immunotoxins|immunotoxins|mesh-ancestor
154311867|NCT05673785|Immunoconjugates|immunoconjugates|mesh-ancestor
154311868|NCT05664191|Simendan|simendan|mesh-list
154311869|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154311870|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
154311871|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154311872|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154311873|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491116|NCT02733588|Glucagon|glucagon|mesh-list
154311891|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311892|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154311893|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
154311894|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154311895|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311896|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311897|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311898|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
154311899|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154311900|NCT05642182|Vitamin D|vitamin d|mesh-list
154311901|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
154311902|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
154311903|NCT05642182|Vitamins|vitamins|mesh-list
154311904|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
154311905|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311906|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154311907|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311908|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154311909|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
154311910|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
154311911|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311912|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311913|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154311914|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154311915|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
154311916|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311917|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311918|NCT05562089|Paclitaxel|paclitaxel|mesh-list
154311919|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154255370|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154311920|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311921|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
154311922|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
154311923|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
154311924|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311925|NCT05556044|Empagliflozin|empagliflozin|mesh-list
154311926|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154311927|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311928|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154311929|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311931|NCT05548023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154311932|NCT05548023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311933|NCT05548023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154311934|NCT05548023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311935|NCT05548023|Antifungal Agents|antifungal agents|mesh-ancestor
154311936|NCT05548023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154311937|NCT05548023|Immunologic Factors|immunologic factors|mesh-ancestor
154311938|NCT05548023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311939|NCT05520723|Loperamide|loperamide|mesh-list
154311940|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
154311941|NCT05520723|Lenograstim|lenograstim|mesh-list
154311942|NCT05520723|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154311943|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154311944|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
153533244|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
154311945|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533245|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
154311946|NCT05520723|Immunoconjugates|immunoconjugates|mesh-ancestor
154311947|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154311948|NCT05403229|Topiramate|topiramate|mesh-list
154311949|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
154311950|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154311951|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311952|NCT05382104|Maribavir|maribavir|mesh-list
154311953|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
154311954|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311955|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154311956|NCT05376878|Trastuzumab|trastuzumab|mesh-list
154311957|NCT05376878|Camptothecin|camptothecin|mesh-list
154311958|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154311959|NCT05376878|Antibodies|antibodies|mesh-list
154311960|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
154311961|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154311962|NCT05376878|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154311963|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
154311964|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
154311965|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311966|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311967|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311968|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154311969|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154311970|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154311971|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311972|NCT05375084|Nivolumab|nivolumab|mesh-list
154311973|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154311974|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311975|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154311976|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311977|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154311978|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154311979|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311980|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311981|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154311982|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311983|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311984|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
154311985|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311986|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154311987|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154311988|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311989|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311990|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154311991|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311992|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861665|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
154311993|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
154311994|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154311995|NCT05231460|Narcotics|narcotics|mesh-list
154311996|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154311997|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311998|NCT05231460|Analgesics|analgesics|mesh-ancestor
154311999|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
154312000|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312001|NCT05215405|Venetoclax|venetoclax|mesh-list
154312002|NCT05215405|Navitoclax|navitoclax|mesh-list
154312003|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312004|NCT05197270|Aflibercept|aflibercept|mesh-list
154312008|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312009|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
154312010|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312011|NCT05153915|Tacrolimus|tacrolimus|mesh-list
154312012|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312013|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
154312014|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312015|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154312016|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312017|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312018|NCT05152628|Tacrolimus|tacrolimus|mesh-list
154312019|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312020|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
154312021|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312022|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154312023|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312024|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312025|NCT05141708|Talazoparib|talazoparib|mesh-list
154312026|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154312027|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312028|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312029|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312030|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
154312031|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
154312032|NCT05115630|Melphalan|melphalan|mesh-list
154312033|NCT05115630|Fludarabine|fludarabine|mesh-list
154312034|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
154312035|NCT05115630|Tacrolimus|tacrolimus|mesh-list
154312036|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154058850|NCT02650427|Incretins|incretins|mesh-ancestor
154312037|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
154312038|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312039|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154312040|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154312041|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
154312042|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312043|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312044|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154312045|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154312046|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
154312047|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154312048|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312049|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154312050|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154312051|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
154312052|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154312053|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312054|NCT05105035|Meropenem|meropenem|mesh-list
154312055|NCT05105035|Ceftazidime|ceftazidime|mesh-list
154312056|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154312057|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312058|NCT05105035|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154312059|NCT05105035|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154312060|NCT05028140|Pioglitazone|pioglitazone|mesh-list
154312061|NCT05028140|Empagliflozin|empagliflozin|mesh-list
154312062|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154312063|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312064|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154312065|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312066|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
154312067|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154312068|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
154861666|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312069|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312070|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
154312071|NCT05027581|Protective Agents|protective agents|mesh-ancestor
154312072|NCT04999761|Bevacizumab|bevacizumab|mesh-list
154312073|NCT04999761|Ramucirumab|ramucirumab|mesh-list
154312074|NCT04999761|Futibatinib|futibatinib|mesh-list
154312075|NCT04999761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312076|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312108|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
154312109|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312110|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154312111|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154312112|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154312113|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312114|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154312115|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154312116|NCT04802161|Growth Substances|growth substances|mesh-ancestor
154312117|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
154312118|NCT04802161|Leprostatic Agents|leprostatic agents|mesh-ancestor
154312119|NCT04802161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154312120|NCT04690322|Factor VIII|factor viii|mesh-list
154312121|NCT04690322|BAX 855|bax 855|mesh-list
154312122|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154312123|NCT04690322|Coagulants|coagulants|mesh-ancestor
154312124|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
154312125|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312126|NCT04670666|Metformin|metformin|mesh-list
154312127|NCT04670666|Empagliflozin|empagliflozin|mesh-list
154312128|NCT04670666|Linagliptin|linagliptin|mesh-list
154312129|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154312130|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312131|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154312132|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312133|NCT04670666|Incretins|incretins|mesh-ancestor
154312134|NCT04670666|Hormones|hormones|mesh-ancestor
154312135|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312146|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312147|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312148|NCT04666714|Pregabalin|pregabalin|mesh-list
154312149|NCT04666714|Analgesics|analgesics|mesh-ancestor
154312150|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
154312151|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312152|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312153|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
154312154|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154312155|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154312156|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312157|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154312158|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154312159|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154312160|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312161|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154312162|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
154312163|NCT04602754|Empagliflozin|empagliflozin|mesh-list
154312164|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154312165|NCT04602754|Calcium|calcium|mesh-list
154312166|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154312167|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312168|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154312169|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154312170|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154312171|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
154312172|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312173|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154312174|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154312175|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312176|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154312177|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154312178|NCT04594018|Minoxidil|minoxidil|mesh-list
154312179|NCT04594018|Finasteride|finasteride|mesh-list
154312180|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154312181|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
154312182|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154312183|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154312184|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312185|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312186|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
154312187|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312188|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312189|NCT04594018|Urological Agents|urological agents|mesh-ancestor
154312190|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154312191|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154312192|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312193|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
154312194|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312195|NCT04522336|Docetaxel|docetaxel|mesh-list
154312196|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
154312197|NCT04522336|Fluorouracil|fluorouracil|mesh-list
154312212|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312213|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312214|NCT04435197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154312215|NCT04435197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312217|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154312218|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312219|NCT04263792|Trimethoprim|trimethoprim|mesh-list
154312220|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154312221|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312222|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
154312223|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154312224|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154312225|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154312226|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312227|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312228|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154312229|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154312230|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154312231|NCT04258852|Nicotine|nicotine|mesh-list
154312232|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154312233|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
154312234|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312235|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312236|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154312237|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154312238|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
154312239|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312240|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312241|NCT04240106|Niraparib|niraparib|mesh-list
154312242|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154312243|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154312244|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312245|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312246|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312247|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154312248|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154312249|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
154312250|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312251|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312252|NCT04226365|Nortriptyline|nortriptyline|mesh-list
154312253|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154312254|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
154312255|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154312267|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154312268|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154312269|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312270|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312271|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312272|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154312273|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
154312274|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
154312275|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312277|NCT04188405|Decitabine|decitabine|mesh-list
154312278|NCT04188405|Ponatinib|ponatinib|mesh-list
154312279|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312280|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154312281|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
154312282|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312283|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312284|NCT04188405|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154312285|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154312286|NCT04125472|Lumasiran|lumasiran|mesh-list
154312287|NCT04125472|Renal Agents|renal agents|mesh-ancestor
154312288|NCT04085237|Ropivacaine|ropivacaine|mesh-list
154312289|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
154312290|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
154312291|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312292|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312293|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
154312294|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312295|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
154312296|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154312297|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312298|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312299|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154312300|NCT04040439|Analgesics|analgesics|mesh-ancestor
154312301|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
154312302|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312303|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154312304|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154312305|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154312306|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
154312307|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312308|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312309|NCT04017962|Letermovir|letermovir|mesh-list
154312310|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154312311|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312312|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312313|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312314|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
154312315|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312316|NCT03997786|Etanercept|etanercept|mesh-list
154312317|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153491549|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154312332|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
154059143|NCT02642939|Mifepristone|mifepristone|mesh-list
154312333|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
154312334|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312335|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312336|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
154312337|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312338|NCT03954483|Triazolam|triazolam|mesh-list
154312339|NCT03954483|Buspirone|buspirone|mesh-list
154312340|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154312341|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154312342|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312343|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312344|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154312345|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154312346|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
154312347|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312348|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312349|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154312350|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
154312351|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
154312352|NCT03954327|Tenofovir|tenofovir|mesh-list
154312353|NCT03954327|Emtricitabine|emtricitabine|mesh-list
154312354|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
154312355|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
154312356|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312357|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154312358|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154312359|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533603|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153533683|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
154312360|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312361|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154312362|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154312363|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154312364|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154312365|NCT03940690|Bevacizumab|bevacizumab|mesh-list
154312366|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312367|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312368|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154312369|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154312370|NCT03940690|Growth Substances|growth substances|mesh-ancestor
154312371|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312372|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
154312374|NCT03934372|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154312375|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154312376|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312377|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312378|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312384|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312385|NCT03861702|Irinotecan|irinotecan|mesh-list
154312386|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154312387|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154312388|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312389|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312390|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312391|NCT03815643|Avelumab|avelumab|mesh-list
154312392|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312393|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312394|NCT03746769|Gastrins|gastrins|mesh-list
154312395|NCT03746769|Hormones|hormones|mesh-ancestor
154312396|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312397|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312398|NCT03681184|Lumasiran|lumasiran|mesh-list
154312399|NCT03681184|Renal Agents|renal agents|mesh-ancestor
154312400|NCT03661645|Dexamethasone|dexamethasone|mesh-list
154312401|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
154312402|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
154312403|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154312404|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154312405|NCT03661645|BB 1101|bb 1101|mesh-list
154312406|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154312407|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
154312408|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
154059212|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312409|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312410|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533684|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
154312411|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154312412|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
154312413|NCT03661645|Hormones|hormones|mesh-ancestor
154312414|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312415|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154312416|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312417|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
154312418|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312419|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312420|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154312421|NCT03661645|Protective Agents|protective agents|mesh-ancestor
154312422|NCT03583957|Caffeine|caffeine|mesh-list
154312423|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154312424|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312425|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154312426|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312427|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312428|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154312429|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154312430|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
154312431|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312432|NCT03575793|Nivolumab|nivolumab|mesh-list
154312433|NCT03575793|Ipilimumab|ipilimumab|mesh-list
154312434|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312435|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312436|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154312437|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312438|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154312439|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154312440|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
154312441|NCT03559868|Digoxin|digoxin|mesh-list
154312442|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154312443|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154312444|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312445|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312446|NCT03559868|Protective Agents|protective agents|mesh-ancestor
154312447|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312451|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154312452|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312453|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154312454|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154312455|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154312456|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
154312457|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312458|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154312459|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154312460|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312461|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
154312462|NCT03467386|Tacrolimus|tacrolimus|mesh-list
154312463|NCT03467386|Lenograstim|lenograstim|mesh-list
154312464|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312465|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
154312466|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312467|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154312468|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154312469|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
154312470|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312471|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312472|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154312473|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154312474|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154312475|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312476|NCT03343431|Tenofovir|tenofovir|mesh-list
154312477|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
154312478|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312479|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154312480|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154312481|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059298|NCT00654173|Atorvastatin|atorvastatin|mesh-list
154312482|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312483|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154312484|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154312485|NCT03326102|Paclitaxel|paclitaxel|mesh-list
154312486|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154312487|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154312488|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312489|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
154312490|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
154312491|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
154312492|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312493|NCT03321019|Capsaicin|capsaicin|mesh-list
154312494|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
154312495|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
154312496|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
154312497|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312498|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312499|NCT03317405|Tamoxifen|tamoxifen|mesh-list
154312500|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154312501|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
154312502|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312503|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312504|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154312505|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312506|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154312507|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154312508|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154312509|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
154312510|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312511|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312512|NCT03316573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154312513|NCT03316573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312514|NCT03285321|Nivolumab|nivolumab|mesh-list
154312515|NCT03285321|Ipilimumab|ipilimumab|mesh-list
154312516|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312517|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312518|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154312519|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312521|NCT03247972|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154312522|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154255371|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154312523|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154312525|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312526|NCT03247972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154312527|NCT03247972|Protease Inhibitors|protease inhibitors|mesh-ancestor
154312528|NCT03247972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312529|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154312530|NCT03161353|Tamoxifen|tamoxifen|mesh-list
154312531|NCT03161353|Carboplatin|carboplatin|mesh-list
154312532|NCT03161353|Docetaxel|docetaxel|mesh-list
154312533|NCT03161353|Trastuzumab|trastuzumab|mesh-list
154312534|NCT03161353|Letrozole|letrozole|mesh-list
154312535|NCT03161353|Pertuzumab|pertuzumab|mesh-list
154312536|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312537|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
154312538|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
154312539|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
154312540|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312541|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312542|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154312543|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154312544|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312545|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154312546|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
154312547|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312548|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312549|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154312550|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154312551|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154312552|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154312553|NCT02901184|Spironolactone|spironolactone|mesh-list
154312554|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154312555|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
154312556|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312557|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312558|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154312560|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
154312561|NCT02879136|Methylphenidate|methylphenidate|mesh-list
154312562|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154312563|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154312564|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312565|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154312566|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154312567|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154312568|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312569|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
154312570|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312571|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154312572|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
154312573|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154312574|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154312575|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312576|NCT02788981|Paclitaxel|paclitaxel|mesh-list
154312577|NCT02788981|Mifepristone|mifepristone|mesh-list
154312578|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154312579|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312580|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
154312581|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
154312582|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
154312583|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312584|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154312585|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
154312586|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154312587|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312588|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154312589|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154312590|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154312591|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
154312593|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154312594|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
154861667|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946104|NCT01148810|Siponimod|siponimod|mesh-list
154312595|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312596|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
154312597|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154312598|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154312599|NCT02767661|Capecitabine|capecitabine|mesh-list
154312600|NCT02767661|Letrozole|letrozole|mesh-list
154312601|NCT02767661|Anastrozole|anastrozole|mesh-list
154312602|NCT02767661|Exemestane|exemestane|mesh-list
154312603|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154312604|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154312605|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
154312606|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312607|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312608|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154312609|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312610|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154312611|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
154312612|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312613|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312614|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154312615|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154312616|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154312617|NCT02744612|Antibodies|antibodies|mesh-list
154312618|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
154312619|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154312620|NCT02744612|Ibrutinib|ibrutinib|mesh-list
154312621|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
154312622|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
154312623|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312624|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312625|NCT02744612|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154312626|NCT02744612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154312627|NCT02744612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312628|NCT02744612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312630|NCT02711826|Acetaminophen|acetaminophen|mesh-list
154312631|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
154312632|NCT02711826|Promethazine|promethazine|mesh-list
154312633|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
154312634|NCT02711826|Everolimus|everolimus|mesh-list
154312635|NCT02711826|Tacrolimus|tacrolimus|mesh-list
154312636|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312637|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
154312638|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312639|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154312640|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312641|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312642|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154312643|NCT02711826|Analgesics|analgesics|mesh-ancestor
154312644|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
154312645|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312646|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
154312647|NCT02711826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154312648|NCT02711826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154312649|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312650|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154312651|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154312652|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
154312653|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154312654|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312655|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154312656|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154312657|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312658|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
154312659|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
154312660|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
154312661|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
154312662|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154312663|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154312664|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
154312665|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
154312666|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312667|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154312671|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
154312672|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312673|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861668|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154312674|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154312675|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154312676|NCT02681549|Growth Substances|growth substances|mesh-ancestor
154312677|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312678|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
154312679|NCT02681549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154312680|NCT02681549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312681|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154312682|NCT02493322|Olmesartan|olmesartan|mesh-list
154312683|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154312684|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
154312685|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154312686|NCT02493322|Diuretics|diuretics|mesh-ancestor
154312687|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
154312688|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312689|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154312690|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154312691|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312692|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154312693|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154312694|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154312695|NCT02483936|Olmesartan|olmesartan|mesh-list
154312696|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154312697|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
154312698|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154312699|NCT02483936|Diuretics|diuretics|mesh-ancestor
154312700|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
154312701|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312702|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154312703|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154312704|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312705|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154312706|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154312708|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
154312709|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312710|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312711|NCT02362035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154312712|NCT02362035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312713|NCT02362035|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154312714|NCT02362035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154312715|NCT02362035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312716|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154312717|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154312718|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
154312719|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312720|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312721|NCT02293954|Antibodies|antibodies|mesh-list
154312722|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154312723|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
154312724|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312726|NCT01939275|Trastuzumab|trastuzumab|mesh-list
154312727|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312728|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312729|NCT01939275|Trace Elements|trace elements|mesh-ancestor
154312730|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
154312731|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312732|NCT01318317|Plerixafor|plerixafor|mesh-list
154312733|NCT01318317|Rituximab|rituximab|mesh-list
154312734|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154312735|NCT01318317|Antibodies|antibodies|mesh-list
154312736|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
154312737|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154312738|NCT01318317|Lenograstim|lenograstim|mesh-list
154312739|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
154312740|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312749|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154312750|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
154312751|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
154312752|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312753|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312754|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154312755|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154312756|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154312757|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
154312758|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312759|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312760|NCT00580437|Protective Agents|protective agents|mesh-ancestor
154312761|NCT00577278|Sirolimus|sirolimus|mesh-list
154312762|NCT00577278|Rituximab|rituximab|mesh-list
154312763|NCT00577278|Fludarabine|fludarabine|mesh-list
154312764|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
154312765|NCT00577278|Melphalan|melphalan|mesh-list
154312766|NCT00577278|Tacrolimus|tacrolimus|mesh-list
154312767|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154312768|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312769|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312770|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
154312771|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312772|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154312773|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154312774|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
154312775|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312776|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312777|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154312778|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312779|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154312780|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312781|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154312782|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
154312783|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154312784|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
154312785|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154312786|NCT00544466|Fludarabine|fludarabine|mesh-list
154312787|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
154312788|NCT00544466|Melphalan|melphalan|mesh-list
154312789|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312790|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154312791|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
154312792|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312793|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312794|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
154312795|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312796|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154312797|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
154312798|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154312799|NCT00493298|Natalizumab|natalizumab|mesh-list
154312800|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
154312801|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312802|NCT02260336|Celecoxib|celecoxib|mesh-list
154312803|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154312804|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154312805|NCT02260336|Analgesics|analgesics|mesh-ancestor
154312806|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
154312807|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312808|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312809|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154312811|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154312812|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154312813|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312814|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312815|NCT03755193|Diphosphonates|diphosphonates|mesh-list
154312816|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154312817|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312818|NCT03755115|Epirubicin|epirubicin|mesh-list
154312819|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154312820|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312821|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154312822|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154312823|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312824|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312825|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154312826|NCT03755037|Estradiol|estradiol|mesh-list
154312827|NCT03755037|Estrogens|estrogens|mesh-ancestor
154312828|NCT03755037|Hormones|hormones|mesh-ancestor
154312829|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312830|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312831|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154312832|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
153946319|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154312833|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154312834|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154312835|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154312836|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154312838|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312839|NCT04490499|Vaccines|vaccines|mesh-list
154312840|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
154312841|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312842|NCT01332994|Rituximab|rituximab|mesh-list
154312843|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312844|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312845|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
154312846|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312847|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154312848|NCT03754959|Midazolam|midazolam|mesh-list
154312849|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154312850|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154312851|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312852|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312853|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154312854|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154312855|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154312856|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154312857|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
154312858|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
154312859|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
154312860|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
154312861|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312862|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312863|NCT02068690|BI 425809|bi 425809|mesh-list
154312864|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
154312865|NCT02067442|Acetaminophen|acetaminophen|mesh-list
154312866|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154312867|NCT02067442|Analgesics|analgesics|mesh-ancestor
154312868|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
154312869|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312870|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312871|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
154312872|NCT02067520|Hydromorphone|hydromorphone|mesh-list
154312873|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154312874|NCT02067520|Narcotics|narcotics|mesh-ancestor
154312875|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312876|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312877|NCT02067520|Analgesics|analgesics|mesh-ancestor
154312878|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
154312879|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312880|NCT03757923|Metformin|metformin|mesh-list
154312881|NCT03757923|Pioglitazone|pioglitazone|mesh-list
154312882|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154312883|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312884|NCT02071888|Dexamethasone|dexamethasone|mesh-list
154312885|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
154312889|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
154312890|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
154312891|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312892|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312893|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154312894|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
154312895|NCT02071888|Hormones|hormones|mesh-ancestor
154312896|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312897|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154312898|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312899|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154312900|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312901|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312902|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
154312903|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154312904|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154312905|NCT02071888|Growth Substances|growth substances|mesh-ancestor
154312906|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
154312907|NCT02071966|Clopidogrel|clopidogrel|mesh-list
154312908|NCT02071966|Ticagrelor|ticagrelor|mesh-list
154312909|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154312910|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154861669|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
154312911|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154312912|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154312913|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
154312914|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312915|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312916|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312917|NCT02072278|Vortioxetine|vortioxetine|mesh-list
154312918|NCT02072278|Escitalopram|escitalopram|mesh-list
154312919|NCT02072278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154312920|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154312921|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154312922|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312923|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312924|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
154312925|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312926|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
154312927|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154312928|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154312929|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154312930|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154312931|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154312932|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154312933|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154312934|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154312935|NCT02072512|Fulvestrant|fulvestrant|mesh-list
154312936|NCT02072512|Anastrozole|anastrozole|mesh-list
154312937|NCT02072512|Goserelin|goserelin|mesh-list
154312938|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154312939|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312940|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154312941|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154312942|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
154312943|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312944|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312945|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154312946|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154312947|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534392|NCT01511263|Amiodarone|amiodarone|mesh-list
153534434|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154312948|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312949|NCT04534491|Oxybutynin|oxybutynin|mesh-list
154312950|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
154312951|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
154312952|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312953|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312954|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154312955|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154312956|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
154312963|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
154312964|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312965|NCT02077348|Hormones|hormones|mesh-list
154312966|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312967|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312968|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
154312969|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154312970|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154312971|NCT03694821|Prednisolone|prednisolone|mesh-list
154312972|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
154312973|NCT03694821|Ketorolac|ketorolac|mesh-list
154312974|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154312975|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154312976|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
154312977|NCT03694821|Hylan|hylan|mesh-list
154312978|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154312979|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
154312980|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
154312981|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312982|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312983|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154312984|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
154312985|NCT03694821|Hormones|hormones|mesh-ancestor
154312986|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154312987|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154312988|NCT03694821|Protective Agents|protective agents|mesh-ancestor
154312989|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154312990|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312991|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154312992|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154312993|NCT03694821|Analgesics|analgesics|mesh-ancestor
154312994|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
154312995|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154312996|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154312997|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312998|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312999|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
154313000|NCT02069158|Paclitaxel|paclitaxel|mesh-list
154313001|NCT02069158|Carboplatin|carboplatin|mesh-list
154313002|NCT02069158|Gedatolisib|gedatolisib|mesh-list
154313003|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154313004|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313005|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
154059815|NCT00911261|Oxymorphone|oxymorphone|mesh-list
154313006|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
154313007|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
154313008|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313009|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313010|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313011|NCT04531527|Butenafine|butenafine|mesh-list
154313012|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
154313013|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313014|NCT02078440|Bromocriptine|bromocriptine|mesh-list
154313015|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154313016|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154313017|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
154313018|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313019|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313020|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
154313021|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
154313022|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313023|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313024|NCT02070406|Aldesleukin|aldesleukin|mesh-list
154313025|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
154313034|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313035|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154313036|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
154313037|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313038|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313039|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154313040|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154313041|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
154313042|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154313043|NCT02070406|Analgesics|analgesics|mesh-ancestor
154313044|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
154313045|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313046|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154313047|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154313048|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
154313049|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313050|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154313051|NCT02078596|Valproic Acid|valproic acid|mesh-list
154313052|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
154313053|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313054|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313055|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
154313056|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313057|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313058|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
154313059|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154313060|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313061|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154313062|NCT02070718|Pentazocine|pentazocine|mesh-list
154313063|NCT02070718|Naloxone|naloxone|mesh-list
154313064|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154313065|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313066|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
154313067|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313068|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154313069|NCT02070718|Narcotics|narcotics|mesh-ancestor
154313070|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313071|NCT02070718|Analgesics|analgesics|mesh-ancestor
154313072|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154313073|NCT02070796|Rotigotine|rotigotine|mesh-list
154313074|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
154313075|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
153534552|NCT01511822|Drospirenone|drospirenone|mesh-list
154313076|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313077|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313078|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313079|NCT02079064|Propofol|propofol|mesh-list
154313080|NCT02079064|Desflurane|desflurane|mesh-list
154313081|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154313082|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313083|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313084|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154313085|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
154313086|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
154313087|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154313088|NCT02079220|Capecitabine|capecitabine|mesh-list
154313089|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
154313090|NCT02079220|Aflibercept|aflibercept|mesh-list
154313091|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154313092|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
154313093|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313094|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492332|NCT03350516|Antacids|antacids|mesh-ancestor
154313105|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
154313106|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313107|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313108|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313110|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154313111|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313112|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313113|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
154313114|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313115|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154313116|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154313117|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154313118|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
154313119|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313120|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154313121|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154313122|NCT02071342|Everolimus|everolimus|mesh-list
154313123|NCT02071342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154313124|NCT02071342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313125|NCT02071342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313126|NCT02071342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313127|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313128|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
154313129|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313130|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313131|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154313132|NCT02080078|Theophylline|theophylline|mesh-list
154313133|NCT02080078|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154313134|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313135|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313136|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313137|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313138|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154313139|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
154313140|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313141|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313142|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154313143|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
154313144|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154313145|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
154313146|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154313147|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154313148|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
154313149|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313150|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
154313151|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154313152|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313153|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313154|NCT03559504|Sevoflurane|sevoflurane|mesh-list
154313155|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153492399|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
154313156|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154313157|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
154313159|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313160|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313161|NCT02080234|Gemcitabine|gemcitabine|mesh-list
154313162|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
154313163|NCT02080234|Asparaginase|asparaginase|mesh-list
154313164|NCT02080234|Pegaspargase|pegaspargase|mesh-list
154313165|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154313166|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
154313167|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313168|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313169|NCT05070039|Antibodies|antibodies|mesh-list
154313170|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
154313171|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313172|NCT05459649|Cyclosporine|cyclosporine|mesh-list
154313173|NCT05459649|Prednisone|prednisone|mesh-list
154313174|NCT05459649|Cyclosporins|cyclosporins|mesh-list
154313175|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313176|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
154313177|NCT05459649|Hormones|hormones|mesh-ancestor
154313178|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313179|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313180|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154313181|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313182|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313183|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313184|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313185|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
154313186|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
154313187|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313188|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313189|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313190|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154313191|NCT04461795|Erenumab|erenumab|mesh-list
154313192|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154313193|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
154313194|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313195|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154313196|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313197|NCT04461795|Analgesics|analgesics|mesh-ancestor
154313198|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
154313199|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313200|NCT04461015|Insulin|insulin|mesh-list
154313201|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154313202|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154313203|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313204|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
154313205|NCT03754179|Trametinib|trametinib|mesh-list
154313206|NCT03754179|Dabrafenib|dabrafenib|mesh-list
154313207|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
154313208|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154313209|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154313210|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313211|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313212|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313213|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313214|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313215|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313216|NCT03753867|Acitretin|acitretin|mesh-list
154313217|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
154313218|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313219|NCT03750669|Folic Acid|folic acid|mesh-list
154313220|NCT03750669|Paclitaxel|paclitaxel|mesh-list
154313221|NCT03750669|Gemcitabine|gemcitabine|mesh-list
154313222|NCT03750669|Fluorouracil|fluorouracil|mesh-list
154313223|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
154313224|NCT03750669|Irinotecan|irinotecan|mesh-list
154313225|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154313226|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313227|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
154313228|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
154060038|NCT00880607|Morphine|morphine|mesh-list
154313229|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
154313230|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313231|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153492473|NCT02416128|Hormones|hormones|mesh-ancestor
154313233|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313234|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
153946697|NCT02635282|Narcotics|narcotics|mesh-ancestor
154313235|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313236|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154313237|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154313238|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313239|NCT03750669|Hematinics|hematinics|mesh-ancestor
154313240|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
154313241|NCT03750669|Vitamins|vitamins|mesh-ancestor
154313242|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
154313243|NCT03757221|Daratumumab|daratumumab|mesh-list
154313244|NCT03757221|Ixazomib|ixazomib|mesh-list
154313245|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313246|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
154313247|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313248|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313249|NCT03757143|Ethanol|ethanol|mesh-list
154313250|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
154313251|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
154313252|NCT03757143|Povidone|povidone|mesh-list
154313253|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154313254|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313255|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534812|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313256|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313257|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
154313258|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
154313259|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
154313260|NCT04428411|Etanercept|etanercept|mesh-list
154313261|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154313262|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154313263|NCT04428411|Analgesics|analgesics|mesh-ancestor
154313264|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
154313265|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313266|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313267|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313268|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313269|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154313270|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313271|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
154313272|NCT03751059|Dexamethasone|dexamethasone|mesh-list
154313273|NCT03751059|Bromfenac|bromfenac|mesh-list
154313274|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313275|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
154313276|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
154313277|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313278|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313279|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154313280|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
154313281|NCT03751059|Hormones|hormones|mesh-ancestor
154313282|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313283|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154313284|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313285|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154313286|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154313287|NCT03751059|Analgesics|analgesics|mesh-ancestor
154313288|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
154313289|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313290|NCT04422561|Ivermectin|ivermectin|mesh-list
154313291|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154313292|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313293|NCT03756987|Ropivacaine|ropivacaine|mesh-list
154313294|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
154313295|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
154313296|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313297|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313298|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
154313299|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313300|NCT02072746|Zinc|zinc|mesh-list
154313301|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
154313302|NCT02072746|Trace Elements|trace elements|mesh-ancestor
154313303|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
154313304|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313305|NCT02072746|Astringents|astringents|mesh-ancestor
154313306|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
154060111|NCT02632331|Gabapentin|gabapentin|mesh-list
154861670|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313307|NCT04940338|Dexamethasone|dexamethasone|mesh-list
154313308|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
154313309|NCT04940338|Bromfenac|bromfenac|mesh-list
154313311|NCT04940338|BB 1101|bb 1101|mesh-list
154313312|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255372|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313313|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
154313314|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
154313315|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313316|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313317|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154313318|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
154313319|NCT04940338|Hormones|hormones|mesh-ancestor
154313320|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313321|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154313322|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313323|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
154313324|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313325|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313326|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154313327|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154313328|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154313329|NCT04940338|Analgesics|analgesics|mesh-ancestor
154313330|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
154313331|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313332|NCT02083510|Colchicine|colchicine|mesh-list
154313333|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
154313334|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313335|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
154313336|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
154313337|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
154313338|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313339|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313340|NCT04407507|Ivermectin|ivermectin|mesh-list
154313341|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154313342|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313343|NCT02080624|Sirolimus|sirolimus|mesh-list
154313344|NCT02080624|Temsirolimus|temsirolimus|mesh-list
154313345|NCT02080624|MTOR Inhibitors|mtor inhibitors|mesh-list
154313346|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313347|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313348|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154313349|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313350|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
154313351|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313352|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
154313353|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313354|NCT02080624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313355|NCT02080624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313356|NCT02080624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313357|NCT02080858|Apixaban|apixaban|mesh-list
154313358|NCT02080858|Ticagrelor|ticagrelor|mesh-list
154313359|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154313360|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154313361|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154313362|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154313363|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
154313364|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313365|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313366|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313367|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154313368|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
154313369|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154313370|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
154313371|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313372|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
154313373|NCT02073526|Adalimumab|adalimumab|mesh-list
154313374|NCT02073526|Infliximab|infliximab|mesh-list
154313375|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
154313376|NCT02073526|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154313377|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313378|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313379|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313380|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154313381|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313382|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
154313383|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313384|NCT02073916|Paclitaxel|paclitaxel|mesh-list
154313385|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154060182|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
154861671|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
154861672|NCT03393208|Metformin|metformin|mesh-list
154313387|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154313389|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154313390|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313391|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
154313392|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
154313393|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
154313394|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313395|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154313396|NCT02073916|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154313397|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313398|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313399|NCT02073916|Immunotoxins|immunotoxins|mesh-ancestor
154313400|NCT02073916|Immunoconjugates|immunoconjugates|mesh-ancestor
154313401|NCT02073916|Immunologic Factors|immunologic factors|mesh-ancestor
154313402|NCT02073916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313403|NCT02084368|Bupivacaine|bupivacaine|mesh-list
154313404|NCT02084368|Ropivacaine|ropivacaine|mesh-list
154313405|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
154313406|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
154313407|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313408|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313409|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
154313410|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313411|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
154313412|NCT02084446|Prednisone|prednisone|mesh-list
154313413|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
154313414|NCT02084446|Everolimus|everolimus|mesh-list
154313415|NCT02084446|Tacrolimus|tacrolimus|mesh-list
154313416|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
154313417|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154313418|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313419|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
154313420|NCT02084446|Hormones|hormones|mesh-ancestor
154313421|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313422|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313423|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154313424|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313425|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313426|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
154313427|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154313428|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313429|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313430|NCT02084446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154313431|NCT02084446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313432|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154313433|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154313434|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
154313435|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313436|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313437|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
154313438|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
154313439|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313440|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154313441|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154313442|NCT02084446|Protective Agents|protective agents|mesh-ancestor
154313443|NCT02801656|Vancomycin|vancomycin|mesh-list
154313444|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313445|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313446|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154313447|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154313448|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313449|NCT02084602|Artesunate|artesunate|mesh-list
154313450|NCT02084602|Mefloquine|mefloquine|mesh-list
154313451|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
154313452|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154313453|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154313454|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313455|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313456|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
154313457|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
154313458|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154313459|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
154313460|NCT02081560|Colistin|colistin|mesh-list
153535005|NCT01514188|Doxorubicin|doxorubicin|mesh-list
154313461|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313467|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313468|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154313469|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255373|NCT01257464|Incretins|incretins|mesh-ancestor
154255374|NCT01257464|Hormones|hormones|mesh-ancestor
154313470|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313472|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313473|NCT02074228|Methylphenidate|methylphenidate|mesh-list
154313474|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154313475|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313476|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154313477|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154313478|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154313479|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313480|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
154313481|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313482|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
154313483|NCT04346199|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154313484|NCT04346199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313485|NCT04346199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313486|NCT04346199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313487|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313488|NCT03558490|Immunomodulating Agents|immunomodulating agents|mesh-list
154313489|NCT03558490|Immunologic Factors|immunologic factors|mesh-ancestor
154313490|NCT03558490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313491|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
154313492|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
154313493|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154313494|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154313495|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313496|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313497|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313498|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313499|NCT02085304|Temozolomide|temozolomide|mesh-list
154313500|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154313501|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
154313502|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313503|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313504|NCT02260414|Tinzaparin|tinzaparin|mesh-list
154313505|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154313506|NCT02260414|Dalteparin|dalteparin|mesh-list
154313507|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
154313508|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154313509|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154313510|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313511|NCT02085538|Palbociclib|palbociclib|mesh-list
154313512|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313513|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313514|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313515|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313516|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154313517|NCT04169061|Hormones|hormones|mesh-ancestor
153535048|NCT01514487|Incretins|incretins|mesh-ancestor
154313518|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313519|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313520|NCT01562691|Petrolatum|petrolatum|mesh-list
154313521|NCT01562691|Emollients|emollients|mesh-ancestor
154313522|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313523|NCT02792218|Teriflunomide|teriflunomide|mesh-list
154313524|NCT02792218|Ofatumumab|ofatumumab|mesh-list
154313525|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154313526|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313527|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
154313528|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313529|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154313530|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154313533|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313534|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313535|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313536|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313537|NCT02075086|Bevacizumab|bevacizumab|mesh-list
154060337|NCT05861648|Folic Acid|folic acid|mesh-list
154313538|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154313539|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313540|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154313541|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154313542|NCT02075086|Growth Substances|growth substances|mesh-ancestor
154861673|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154313543|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313544|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
154313545|NCT02082418|Caseins|caseins|mesh-list
154313546|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
154313547|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
154313548|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313549|NCT02082496|Liraglutide|liraglutide|mesh-list
154313550|NCT02082496|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154313551|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154313552|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313553|NCT02082496|Incretins|incretins|mesh-ancestor
154313554|NCT02082496|Hormones|hormones|mesh-ancestor
154313555|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313556|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
154313557|NCT02075242|Tacrolimus|tacrolimus|mesh-list
154313558|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313559|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
154313560|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313561|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154313562|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313563|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313564|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154313565|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313566|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154313567|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
154313568|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313569|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313570|NCT02082652|Etonogestrel|etonogestrel|mesh-list
154313571|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154313572|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
154313573|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154313574|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313575|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154313576|NCT00153101|Telmisartan|telmisartan|mesh-list
154313577|NCT00153101|Ramipril|ramipril|mesh-list
154313578|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154313579|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154313580|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154313581|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313582|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154313583|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
154313584|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313585|NCT03558412|Decitabine|decitabine|mesh-list
154313586|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154313587|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
154313588|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313589|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313590|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313591|NCT04401579|Remdesivir|remdesivir|mesh-list
154313592|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
154313593|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313594|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
154313595|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313596|NCT03558880|Anesthetics|anesthetics|mesh-list
154313597|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313598|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313599|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154313600|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154313601|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
154313602|NCT03749733|Megestrol|megestrol|mesh-list
154313609|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313611|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154313613|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154313614|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154313615|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154313616|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154313617|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154313618|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154313619|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313620|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
154313621|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154313622|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313623|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
154313624|NCT01582607|Fentanyl|fentanyl|mesh-list
154313625|NCT01582607|Bupivacaine|bupivacaine|mesh-list
154313626|NCT01582607|Ropivacaine|ropivacaine|mesh-list
154313627|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
154313628|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
154313629|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
154313630|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313631|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313632|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
154313633|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313634|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154313635|NCT01582607|Narcotics|narcotics|mesh-ancestor
154313636|NCT01582607|Analgesics|analgesics|mesh-ancestor
154313637|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154313638|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154313639|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
154313640|NCT00149825|Dexetimide|dexetimide|mesh-list
154313641|NCT00149825|Citalopram|citalopram|mesh-list
154313642|NCT00149825|Escitalopram|escitalopram|mesh-list
154313643|NCT00149825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154313644|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154313645|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154313646|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313647|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313648|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
154313649|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313650|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154313651|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154313652|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
154313653|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
154313654|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313655|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154313656|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154313657|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
154313658|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154313659|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
154313660|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154313661|NCT02792062|Relugolix|relugolix|mesh-list
154313662|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
154313663|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
154313664|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313665|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313666|NCT05027295|Riboflavin|riboflavin|mesh-list
154313667|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154313668|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154313669|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
154313670|NCT05027295|Vitamins|vitamins|mesh-ancestor
154313671|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
154313672|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313673|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154313677|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154313678|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313679|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154313680|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313681|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
154313682|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
154313683|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154313684|NCT02086474|Bupivacaine|bupivacaine|mesh-list
154313685|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
154313686|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
154313687|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
154313688|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313689|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313690|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
154313691|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313692|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154313693|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
154313695|NCT02086474|Protective Agents|protective agents|mesh-ancestor
154313696|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
154313697|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313698|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313699|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154313700|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154313701|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313702|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313703|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313704|NCT04397445|Ranitidine|ranitidine|mesh-list
154313705|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154313706|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153535407|NCT01516567|Doxorubicin|doxorubicin|mesh-list
154313707|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154313708|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154313709|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
154313710|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
154313711|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313712|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313713|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313714|NCT02091388|Risperidone|risperidone|mesh-list
154313715|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154313716|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
154313717|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313718|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313719|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313720|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154313721|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154313722|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313723|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154313724|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154313725|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
154313726|NCT02086942|Dexamethasone|dexamethasone|mesh-list
154313727|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
154313728|NCT02086942|Bortezomib|bortezomib|mesh-list
154313729|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313730|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
154313731|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313732|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313733|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154313734|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
154313735|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313736|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313737|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154313738|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313739|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
154313740|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
154313741|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313742|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154313743|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
154313744|NCT02086942|Hormones|hormones|mesh-ancestor
154313745|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154313746|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154313752|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154313753|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154313754|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313755|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154313756|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313757|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313758|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154313759|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313760|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
154313761|NCT02088502|Theophylline|theophylline|mesh-list
154313762|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154313763|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
153535486|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
154313764|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313766|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
154313767|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154313768|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
154313769|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313770|NCT02088502|Protective Agents|protective agents|mesh-ancestor
154313771|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313772|NCT02088502|Antidotes|antidotes|mesh-ancestor
154313773|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154313774|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
154313775|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313776|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154313777|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154313778|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313779|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
154313780|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154313781|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154313782|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
154313783|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313784|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
154313785|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154313786|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154313787|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
154313788|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313789|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313790|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313791|NCT02087098|Urological Agents|urological agents|mesh-ancestor
154313792|NCT01369342|Ustekinumab|ustekinumab|mesh-list
154313793|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313794|NCT00191477|Gemcitabine|gemcitabine|mesh-list
154313795|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154313796|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
154313797|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313798|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313799|NCT02087332|Torsemide|torsemide|mesh-list
154313800|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154313801|NCT02087332|Diuretics|diuretics|mesh-ancestor
154313802|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
154313803|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313804|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154313805|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154313806|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313807|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154313808|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
154313809|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154313810|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313811|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313812|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154313813|NCT02092012|Analgesics|analgesics|mesh-ancestor
154313814|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
154313815|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313816|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154313828|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535487|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153535543|NCT01517165|Pioglitazone|pioglitazone|mesh-list
154313829|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313830|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154313831|NCT00187889|Diuretics|diuretics|mesh-ancestor
154313832|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
154313833|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154313834|NCT02087488|Eszopiclone|eszopiclone|mesh-list
154313835|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154313836|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313837|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313838|NCT02087566|Linezolid|linezolid|mesh-list
154313839|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313840|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313841|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154313842|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313843|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313844|NCT00148109|Cetuximab|cetuximab|mesh-list
154313845|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154313846|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313847|NCT03746223|Rituximab|rituximab|mesh-list
154313848|NCT03746223|Methotrexate|methotrexate|mesh-list
154313849|NCT03746223|Lenalidomide|lenalidomide|mesh-list
154313850|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154313851|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313852|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
154313853|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313854|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313855|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154313856|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
154313857|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154313858|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154313859|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
154313860|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313861|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313862|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313863|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154313864|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313865|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154313866|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154313867|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154313868|NCT03746223|Growth Substances|growth substances|mesh-ancestor
154313869|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
154313870|NCT03969017|Interferons|interferons|mesh-list
154313871|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313872|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
154313873|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313874|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
154313875|NCT04596033|Fludarabine|fludarabine|mesh-list
154313876|NCT04596033|Interleukin-2|interleukin-2|mesh-list
154313877|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313878|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
153493116|NCT02970552|Progesterone|progesterone|mesh-list
154313882|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
154313883|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313884|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313885|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154313886|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154313887|NCT04596033|Analgesics|analgesics|mesh-ancestor
154313888|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
154313889|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313890|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
153535638|NCT01517568|Liraglutide|liraglutide|mesh-list
154313891|NCT02092558|Cephalosporins|cephalosporins|mesh-list
154313892|NCT02092558|Second Generation Cephalosporins|second generation cephalosporins|mesh-list
154313893|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154313894|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313895|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154313896|NCT02092558|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154313897|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
154313898|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
154313899|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154313900|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
154313901|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313902|NCT01074359|Protective Agents|protective agents|mesh-ancestor
154313903|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313904|NCT02087722|Melatonin|melatonin|mesh-list
154313905|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
154313906|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313907|NCT02087722|Protective Agents|protective agents|mesh-ancestor
154313908|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313909|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313910|NCT01326221|Tenofovir|tenofovir|mesh-list
154313911|NCT01326221|Emtricitabine|emtricitabine|mesh-list
154313912|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
154313913|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313914|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154313915|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154313916|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313917|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313918|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154313919|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154313920|NCT04311177|Losartan|losartan|mesh-list
154313921|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154313922|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154313923|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154313924|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154313925|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313926|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
154313927|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154313928|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
154313929|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313930|NCT01074593|Interferons|interferons|mesh-list
154313931|NCT01074593|Interferon-beta|interferon-beta|mesh-list
154313932|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
154313933|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313934|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
154313935|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313936|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
154313937|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313938|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154313939|NCT02088970|Riboflavin|riboflavin|mesh-list
154313940|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154313941|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313942|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
154313943|NCT02088970|Vitamins|vitamins|mesh-ancestor
153535643|NCT01517568|Hormones|hormones|mesh-ancestor
153535708|NCT01517997|Paclitaxel|paclitaxel|mesh-list
154313944|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
154313945|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313946|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154313947|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313949|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154313950|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
154313951|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
154313963|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
154313964|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154313965|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
154313966|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154313967|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
154313968|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313969|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313971|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154313972|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313973|NCT01313390|Docetaxel|docetaxel|mesh-list
154313974|NCT01313390|Everolimus|everolimus|mesh-list
154313975|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154313976|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
154313977|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
154313978|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
154313979|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313980|NCT01313390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154313981|NCT01313390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154313982|NCT01313390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154313983|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313984|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
154313985|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313986|NCT05571332|Cyclosporine|cyclosporine|mesh-list
154313987|NCT05571332|Cyclosporins|cyclosporins|mesh-list
154313989|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313990|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313991|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
154313992|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313993|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
154313994|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313995|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313996|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313997|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154313998|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154313999|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154314000|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154314001|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314002|NCT02089048|Auranofin|auranofin|mesh-list
154314003|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314004|NCT02089126|Glimepiride|glimepiride|mesh-list
154314005|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154314006|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314007|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314008|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154314009|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
154314010|NCT05571176|Ketamine|ketamine|mesh-list
154314011|NCT05571176|Esketamine|esketamine|mesh-list
154314012|NCT05571176|Analgesics|analgesics|mesh-ancestor
154314013|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
154314014|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314015|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314016|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154314017|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154314020|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314021|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154314022|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154314023|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314024|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314025|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
154314026|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154314027|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154314028|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154314029|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314030|NCT02095834|Dexamethasone|dexamethasone|mesh-list
154314031|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
154314032|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154314034|NCT02095834|BB 1101|bb 1101|mesh-list
154314035|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314036|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
154314037|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
154314038|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947446|NCT00629382|Polymyxin B|polymyxin b|mesh-list
153947447|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153947448|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947449|NCT06200220|Venetoclax|venetoclax|mesh-list
153947450|NCT06200220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947451|NCT06200181|Olanzapine|olanzapine|mesh-list
153947452|NCT06200181|Antiemetics|antiemetics|mesh-ancestor
153947453|NCT06200181|Autonomic Agents|autonomic agents|mesh-ancestor
153947454|NCT06200181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947455|NCT06200181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314039|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314040|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314041|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
154314042|NCT02095834|Hormones|hormones|mesh-ancestor
154314043|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314044|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153535750|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314045|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314046|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154314047|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
154314048|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314049|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
154314050|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314051|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
154314052|NCT03556852|Misoprostol|misoprostol|mesh-list
154314053|NCT03556852|Carbetocin|carbetocin|mesh-list
154314054|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154314055|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
154314056|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154314057|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314058|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154314059|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314060|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
154314061|NCT02808572|Mitogens|mitogens|mesh-list
154314062|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
154314063|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314064|NCT02093728|Itraconazole|itraconazole|mesh-list
154314065|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154314066|NCT02093728|Fluconazole|fluconazole|mesh-list
154314067|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
154314068|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314069|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154314070|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154314071|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314072|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314073|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154314074|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
154314075|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314076|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314077|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154314078|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154314079|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154314080|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
154314081|NCT02089204|Fluorides|fluorides|mesh-list
154314082|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
154314083|NCT02089204|Protective Agents|protective agents|mesh-ancestor
154314084|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314085|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
154314086|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314087|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
154314088|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314089|NCT02095990|Hydroquinone|hydroquinone|mesh-list
154314092|NCT02095990|Protective Agents|protective agents|mesh-ancestor
154314093|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314094|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154861674|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861675|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
154861676|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154861677|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
154861678|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861679|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861680|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154861681|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
154861682|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154314095|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
154255375|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535814|NCT01518465|Hormones|hormones|mesh-ancestor
153535890|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
154255376|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
154255377|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255378|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255380|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154255381|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255382|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314096|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154314097|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314098|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314099|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314100|NCT02096068|Analgesics|analgesics|mesh-ancestor
154314101|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
154314102|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314103|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154314104|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154314105|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154314106|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
154314107|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314108|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314109|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154314110|NCT02089438|Vildagliptin|vildagliptin|mesh-list
154314111|NCT02089438|Saxagliptin|saxagliptin|mesh-list
154314112|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314113|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314114|NCT02089438|Incretins|incretins|mesh-ancestor
154314116|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314117|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154314118|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
154314119|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314120|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314121|NCT05471674|Nivolumab|nivolumab|mesh-list
154314122|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154314123|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314124|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154314125|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314126|NCT02096224|Sevoflurane|sevoflurane|mesh-list
154314127|NCT02096224|Desflurane|desflurane|mesh-list
154314128|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154314129|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154314130|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
154314131|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
154314132|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314133|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314134|NCT02096380|Cisplatin|cisplatin|mesh-list
154314135|NCT02096380|Docetaxel|docetaxel|mesh-list
154314136|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314137|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
154314138|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
154314139|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
154314140|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314141|NCT02250118|Bevacizumab|bevacizumab|mesh-list
154314142|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154314143|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314144|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154314145|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154314146|NCT02250118|Growth Substances|growth substances|mesh-ancestor
154314147|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314148|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154314149|NCT03060772|Pioglitazone|pioglitazone|mesh-list
154314150|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314151|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314152|NCT02096536|Vancomycin|vancomycin|mesh-list
154861683|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
154861684|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861685|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861686|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154861687|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
154861688|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
154861689|NCT01092559|Protective Agents|protective agents|mesh-ancestor
154861690|NCT03587428|Zinc|zinc|mesh-list
154861691|NCT03587428|Trace Elements|trace elements|mesh-ancestor
153947587|NCT06199076|Oxytocin|oxytocin|mesh-list
154314153|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314154|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314155|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
154314156|NCT02096614|Fludarabine|fludarabine|mesh-list
154314157|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154314158|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
154314159|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314160|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314161|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154314171|NCT02094274|Fluticasone|fluticasone|mesh-list
154314173|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154314174|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314175|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154314176|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
154314177|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314178|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314179|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154314180|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
154314181|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
154314182|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154314183|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154314184|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154314185|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154314186|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
154314187|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314188|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314189|NCT02096926|Ibuprofen|ibuprofen|mesh-list
154314190|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154314191|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314192|NCT02096926|Analgesics|analgesics|mesh-ancestor
154314193|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
154314194|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314195|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314196|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314197|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314198|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154314199|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314200|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314201|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154314202|NCT02097004|Entecavir|entecavir|mesh-list
154314203|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
154314204|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314205|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
154314206|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314207|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
154314208|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314209|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314210|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154314211|NCT03691779|Ivacaftor|ivacaftor|mesh-list
154314212|NCT03691779|Elexacaftor|elexacaftor|mesh-list
154314213|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154314214|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154314215|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314216|NCT02095054|Cetuximab|cetuximab|mesh-list
154314217|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154314218|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314219|NCT03555994|Liraglutide|liraglutide|mesh-list
154314220|NCT03555994|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154314221|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314222|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314223|NCT03555994|Incretins|incretins|mesh-ancestor
154314224|NCT03555994|Hormones|hormones|mesh-ancestor
154314225|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314235|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314236|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154314237|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154314239|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
154314240|NCT02097082|Paclitaxel|paclitaxel|mesh-list
154314241|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154314242|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314243|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
154314244|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
154314245|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
154861692|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
154314246|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314248|NCT02097160|Vitamins|vitamins|mesh-ancestor
154314249|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
154314250|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314251|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154314252|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
154314253|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314254|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154314255|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
154314256|NCT02097316|Insulin|insulin|mesh-list
154314257|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314258|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314259|NCT02095522|Colchicine|colchicine|mesh-list
154314260|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
154314261|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314262|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
154314263|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
154314264|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
154314265|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314266|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314267|NCT02097394|Pancreatin|pancreatin|mesh-list
154314268|NCT02097394|Pancrelipase|pancrelipase|mesh-list
154314269|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314270|NCT04123665|Fluorides|fluorides|mesh-list
154314271|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
153536125|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
154314272|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
154314273|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
154314274|NCT04123665|Protective Agents|protective agents|mesh-ancestor
154314275|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314276|NCT02250508|Factor VIII|factor viii|mesh-list
154314277|NCT02250508|Coagulants|coagulants|mesh-ancestor
154314278|NCT03555526|Amoxicillin|amoxicillin|mesh-list
154314279|NCT03555526|Metronidazole|metronidazole|mesh-list
154314280|NCT03555526|Clarithromycin|clarithromycin|mesh-list
154314281|NCT03555526|Levofloxacin|levofloxacin|mesh-list
154314282|NCT03555526|Tetracycline|tetracycline|mesh-list
154314283|NCT03555526|Esomeprazole|esomeprazole|mesh-list
154314284|NCT03555526|Bismuth|bismuth|mesh-list
154314285|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314286|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314287|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154314288|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154314289|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154314290|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314291|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154314292|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314293|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314294|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154314295|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153493521|NCT00151398|Donepezil|donepezil|mesh-list
154314297|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154314298|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154314299|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154314300|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314301|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154314302|NCT03555526|Antacids|antacids|mesh-ancestor
154314303|NCT02102620|Lidocaine|lidocaine|mesh-list
154314304|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154314305|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
154314306|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314307|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314308|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
154314309|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314310|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154314311|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154314312|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154314313|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154314314|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314315|NCT02102698|Ecopipam|ecopipam|mesh-list
154314316|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154314317|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154314318|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314319|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536126|NCT01520350|Aripiprazole|aripiprazole|mesh-list
154314320|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154314321|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154314322|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
154314323|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314324|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314326|NCT02102776|Mitomycin|mitomycin|mesh-list
154314327|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154314328|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314329|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
154314330|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314331|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154314332|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314333|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
154314334|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154314335|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
154314336|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314337|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154314338|NCT02670044|Venetoclax|venetoclax|mesh-list
154314339|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314340|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154314341|NCT02307656|Cobicistat|cobicistat|mesh-list
154314342|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154314343|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154314344|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
154314345|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314346|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314347|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154314348|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154314349|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
154314350|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314351|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154314352|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154314353|NCT04232943|Vaccines|vaccines|mesh-list
154314354|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
154314355|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314356|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
154314357|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154314358|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154314359|NCT02098330|Prednisolone|prednisolone|mesh-list
154314360|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
154314361|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154314362|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
154314363|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314364|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
154314365|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
154314366|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314367|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314368|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536186|NCT01520584|Vitamins|vitamins|mesh-list
154314369|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
154314372|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154314374|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154314375|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314376|NCT02103166|Scopolamine|scopolamine|mesh-list
154314377|NCT02103166|Bromides|bromides|mesh-list
154314378|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
154314379|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154314380|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
154314381|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
154314382|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314383|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314384|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314385|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
154314386|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154314387|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
154314388|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314389|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314390|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154314391|NCT02103244|Carboplatin|carboplatin|mesh-list
154314392|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314393|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
154314394|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
154314395|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314396|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314397|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154314398|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154314399|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314400|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314401|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314402|NCT02098486|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154314403|NCT02098486|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154314404|NCT02250820|Pentobarbital|pentobarbital|mesh-list
154314405|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
154314406|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154314407|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314408|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314409|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314410|NCT02250820|Analgesics|analgesics|mesh-ancestor
154314411|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
154314412|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536297|NCT01521455|Hormones|hormones|mesh-ancestor
154314413|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154314414|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154314415|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154314416|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
154314417|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314418|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314419|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154314420|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
154314421|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
154314422|NCT02100046|Ethosuximide|ethosuximide|mesh-list
154314423|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
154314424|NCT02100202|Turmeric extract|turmeric extract|mesh-list
154314425|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
154314426|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314427|NCT02100202|Protective Agents|protective agents|mesh-ancestor
154314428|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314430|NCT05423392|Carticaine|carticaine|mesh-list
154314431|NCT05423392|Anesthetics|anesthetics|mesh-list
154314432|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
154314433|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314434|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314435|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
154314436|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314437|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154314438|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154314439|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154314440|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154314441|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314442|NCT02103556|Mineral Oil|mineral oil|mesh-list
154314443|NCT02103556|Emollients|emollients|mesh-ancestor
154314445|NCT02099890|Curcumin|curcumin|mesh-list
154314446|NCT02099890|Antioxidants|antioxidants|mesh-list
154314447|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154314448|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314449|NCT02099890|Analgesics|analgesics|mesh-ancestor
154314450|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
153536385|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
153536386|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314451|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314452|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314453|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314454|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314455|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314456|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314457|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314458|NCT02099890|Protective Agents|protective agents|mesh-ancestor
154314459|NCT03555136|Vortioxetine|vortioxetine|mesh-list
154314460|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
154314461|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154314462|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154314463|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154314464|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314465|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314466|NCT03555136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154314467|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154314468|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154314469|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314470|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314471|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
154314472|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154314473|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154314474|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154314475|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154314476|NCT03554980|Listerine|listerine|mesh-list
154314477|NCT03554980|Fluorides|fluorides|mesh-list
154314478|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
154314479|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
154314480|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
154314481|NCT03554980|Protective Agents|protective agents|mesh-ancestor
154314482|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314483|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154314484|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314486|NCT04230213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154314487|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314488|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314489|NCT03746691|Citalopram|citalopram|mesh-list
154314490|NCT03746691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154314491|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154314492|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154314493|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314494|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314495|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
154314496|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314497|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154314498|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
154314499|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154314500|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154314501|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154314502|NCT03745911|Paclitaxel|paclitaxel|mesh-list
154314503|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154314504|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314505|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
154314506|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
154314507|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
154314508|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314509|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154314510|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154314511|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314512|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314513|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314515|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314517|NCT02106286|Bisoprolol|bisoprolol|mesh-list
154314518|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154314519|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
154314520|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
154314521|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314522|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314523|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154314524|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154314525|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154314526|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
154314527|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314528|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314529|NCT04109391|Trastuzumab|trastuzumab|mesh-list
154314530|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154314531|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314532|NCT02106364|Insulin|insulin|mesh-list
154314533|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154314534|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
154314535|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314536|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314537|NCT04077866|Temozolomide|temozolomide|mesh-list
154314538|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154314539|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
154314540|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314541|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314542|NCT02101138|Pramipexole|pramipexole|mesh-list
154314543|NCT02101138|Dexpramipexole|dexpramipexole|mesh-list
154314544|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
154314545|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314546|NCT02101138|Protective Agents|protective agents|mesh-ancestor
154314547|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314548|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
154314549|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314550|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154314551|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154255383|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
154314552|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
154314553|NCT02106520|Bevacizumab|bevacizumab|mesh-list
154314554|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154314555|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314556|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154314557|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154314558|NCT02106520|Growth Substances|growth substances|mesh-ancestor
154314559|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314560|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
154314561|NCT02101216|Abacavir|abacavir|mesh-list
154314562|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
154314563|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154314564|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154314565|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314566|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314567|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
154314568|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314569|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154314570|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154314571|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
154314572|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154314573|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
154314574|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314575|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154314576|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154314577|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314578|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314579|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154314580|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154314581|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
154314582|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154314583|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314584|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314585|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154314586|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154314587|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314588|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314592|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154314593|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314594|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154314595|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154314596|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154314597|NCT01562301|Carboplatin|carboplatin|mesh-list
154314598|NCT01562301|Docetaxel|docetaxel|mesh-list
154314599|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314600|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
154314601|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
154314602|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
154314603|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314604|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
154314605|NCT04094883|Vaccines|vaccines|mesh-list
154314606|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
154314607|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314608|NCT02101606|Tenecteplase|tenecteplase|mesh-list
154314609|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154314610|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154314611|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314612|NCT02101840|Oxycodone|oxycodone|mesh-list
154314613|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154314614|NCT02101840|Narcotics|narcotics|mesh-ancestor
154314615|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314616|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314617|NCT02101840|Analgesics|analgesics|mesh-ancestor
154314618|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
154314619|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314620|NCT02107378|Paclitaxel|paclitaxel|mesh-list
154314621|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154314622|NCT02107378|Doxorubicin|doxorubicin|mesh-list
154314623|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154314624|NCT02107378|Topotecan|topotecan|mesh-list
154314625|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154314626|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314627|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
154861693|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314628|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
154314629|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
154314630|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314631|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154314632|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154314633|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154314634|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314635|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154314636|NCT02105350|Gemcitabine|gemcitabine|mesh-list
154314637|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
154314638|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154314639|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
154314640|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314641|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314642|NCT02102152|Tobramycin|tobramycin|mesh-list
154314643|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314644|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314645|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
154314646|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154314647|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314648|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
154314649|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314650|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154314651|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154314652|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314653|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314654|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314655|NCT02107690|Lidocaine|lidocaine|mesh-list
154314656|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
154314657|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
154314658|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314659|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314660|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
154314661|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314662|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154314663|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154314664|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154314665|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154314666|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314668|NCT05568836|Vitamins|vitamins|mesh-ancestor
154314669|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
154314670|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314671|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154314672|NCT03259490|Metformin|metformin|mesh-list
154314673|NCT03259490|Empagliflozin|empagliflozin|mesh-list
154314674|NCT03259490|Linagliptin|linagliptin|mesh-list
154314675|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154314676|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314677|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154314678|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314679|NCT03259490|Incretins|incretins|mesh-ancestor
154314680|NCT03259490|Hormones|hormones|mesh-ancestor
154314681|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314682|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154314683|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
154314684|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314685|NCT02106130|Rebamipide|rebamipide|mesh-list
154314686|NCT02106130|Mosapride|mosapride|mesh-list
154314687|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314688|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154314689|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314690|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
154314691|NCT02106130|Protective Agents|protective agents|mesh-ancestor
154314692|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314693|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314694|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154314695|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
154314696|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314697|NCT02251132|Ritonavir|ritonavir|mesh-list
154314698|NCT02251132|Erythromycin|erythromycin|mesh-list
154314699|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
154314700|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154314701|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
153948118|NCT04760275|Fluoxetine|fluoxetine|mesh-list
154314702|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154314703|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154314704|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
154314705|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314706|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314707|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154314708|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154314709|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
154314710|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314711|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154314712|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154314713|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314714|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314715|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154314716|NCT01331824|Amrubicin|amrubicin|mesh-list
154314717|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314718|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
154314719|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154314720|NCT05571722|Vancomycin|vancomycin|mesh-list
154314721|NCT05571722|Linezolid|linezolid|mesh-list
154314722|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314723|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314724|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154314725|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314726|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314727|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
154314728|NCT02110654|Montelukast|montelukast|mesh-list
154314729|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154314730|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
154314731|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154314732|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
154314733|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314734|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314735|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154314736|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154314737|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314738|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314739|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
154314740|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154314742|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
154314743|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314744|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154314745|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154314746|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314747|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314748|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154314749|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154314750|NCT02110810|Indomethacin|indomethacin|mesh-list
154314751|NCT02110810|Glycerol|glycerol|mesh-list
154314752|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154314753|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314754|NCT02110810|Analgesics|analgesics|mesh-ancestor
154314755|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
154314756|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314757|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314758|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314759|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314760|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
154314761|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
154314762|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154314763|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154314764|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314765|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314766|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154314767|NCT02110810|Protective Agents|protective agents|mesh-ancestor
154314768|NCT02107924|Vancomycin|vancomycin|mesh-list
154314769|NCT02107924|Tobramycin|tobramycin|mesh-list
154314770|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314771|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314772|NCT02108002|Vorinostat|vorinostat|mesh-list
154314773|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314774|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154314775|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861694|NCT03398278|Oxycodone|oxycodone|mesh-list
154255384|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536790|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
153536823|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314776|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314777|NCT02114476|Progestins|progestins|mesh-list
154314778|NCT02114476|Hormones|hormones|mesh-ancestor
154314779|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314780|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314781|NCT02110966|Tramadol|tramadol|mesh-list
154314782|NCT02110966|Mepivacaine|mepivacaine|mesh-list
154314783|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154314784|NCT02110966|Narcotics|narcotics|mesh-ancestor
154314785|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314786|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314787|NCT02110966|Analgesics|analgesics|mesh-ancestor
154314788|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
154314789|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314790|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
154314791|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
154314792|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
154314793|NCT02937740|Testosterone|testosterone|mesh-list
154314794|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
154314795|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
154314796|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154314797|NCT02937740|Androgens|androgens|mesh-ancestor
154314798|NCT02937740|Hormones|hormones|mesh-ancestor
154314799|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314800|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314801|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154314802|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314803|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
154314804|NCT02111044|Octreotide|octreotide|mesh-list
154314805|NCT02111044|Somatostatin|somatostatin|mesh-list
154061621|NCT00670787|Losartan|losartan|mesh-list
154314806|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314808|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314809|NCT02111044|Hormones|hormones|mesh-ancestor
154314810|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314811|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314812|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
154314813|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314814|NCT02108548|Naproxen|naproxen|mesh-list
154314815|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154314816|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314817|NCT02108548|Analgesics|analgesics|mesh-ancestor
154314818|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
154314819|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314820|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314821|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314822|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154314823|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
154314824|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154314825|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314826|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314827|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
154314828|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154314829|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154314830|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
154314831|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
154314832|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314833|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314834|NCT02108626|Nicotine|nicotine|mesh-list
154314835|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154314836|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
154314837|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314838|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314839|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154314840|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154314841|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
154314842|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314843|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314844|NCT03745599|Diclofenac|diclofenac|mesh-list
154314845|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
154314846|NCT03745599|Benzydamine|benzydamine|mesh-list
154314847|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154314848|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314849|NCT03745599|Analgesics|analgesics|mesh-ancestor
154861695|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154861696|NCT03398278|Narcotics|narcotics|mesh-ancestor
154314850|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
154314851|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314852|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314853|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314855|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154314856|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314857|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314858|NCT02108782|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154314859|NCT02108782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154314860|NCT02108782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314861|NCT02108782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314862|NCT02111434|Testosterone|testosterone|mesh-list
154314863|NCT02111434|Androgens|androgens|mesh-ancestor
154314864|NCT02111434|Hormones|hormones|mesh-ancestor
154314865|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314866|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314867|NCT03230864|Olanzapine|olanzapine|mesh-list
154314868|NCT03230864|Risperidone|risperidone|mesh-list
154314869|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154314870|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
154314871|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536918|NCT01524757|Pantoprazole|pantoprazole|mesh-list
154314872|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314873|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314874|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154314875|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154314876|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314877|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154314878|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154314879|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
154314889|NCT02111590|Antibodies|antibodies|mesh-list
154314890|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
154314891|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314892|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154314893|NCT02937350|Calcifediol|calcifediol|mesh-list
154314894|NCT02937350|Vitamins|vitamins|mesh-ancestor
154314895|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
154314896|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314897|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154314898|NCT02109328|Paclitaxel|paclitaxel|mesh-list
154314899|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154314900|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314901|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
154314902|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
154314903|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
154314904|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314905|NCT02115490|Diphosphonates|diphosphonates|mesh-list
154314906|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154314907|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314908|NCT02251288|Vaccines|vaccines|mesh-list
154314909|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
154314910|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314911|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
154314912|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154314913|NCT02109718|Petrolatum|petrolatum|mesh-list
154314914|NCT02109718|Emollients|emollients|mesh-ancestor
154314915|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
154314916|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154314917|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314918|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154314919|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154314920|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
154314921|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154314922|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154314923|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314924|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314925|NCT02112292|Dronabinol|dronabinol|mesh-list
154314926|NCT02112292|Cannabidiol|cannabidiol|mesh-list
154314927|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
154314928|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
154314929|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314930|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154314931|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154314932|NCT02112292|Analgesics|analgesics|mesh-ancestor
154314933|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
154314934|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314935|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154314936|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154314937|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314938|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314940|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314941|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
154314942|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154314943|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
154314944|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154314945|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
154314946|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154314958|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
154314959|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314960|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314962|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154314963|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154314964|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154314965|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314966|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314967|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
154314968|NCT02116348|Mitogens|mitogens|mesh-list
154314969|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
154314970|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314971|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154314972|NCT02116348|Protective Agents|protective agents|mesh-ancestor
154314973|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314974|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
154314975|NCT02119000|Bisacodyl|bisacodyl|mesh-list
154314976|NCT02119000|Cathartics|cathartics|mesh-ancestor
154314977|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314978|NCT02119000|Laxatives|laxatives|mesh-ancestor
154314979|NCT02119234|Beclomethasone|beclomethasone|mesh-list
154314980|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
154314981|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
154314982|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154314983|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
154314984|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314985|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314986|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154314987|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
154314988|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154314989|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154314990|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154314991|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
154314992|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154314993|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314994|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154314995|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154314996|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154314997|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
154314998|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154314999|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
154315000|NCT02119234|Hormones|hormones|mesh-ancestor
154315001|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315002|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154315003|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315004|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315005|NCT03694197|Alirocumab|alirocumab|mesh-list
154315006|NCT03694197|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154315007|NCT03694197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154315008|NCT03694197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154315009|NCT03694197|Antimetabolites|antimetabolites|mesh-ancestor
153494243|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154315011|NCT03694197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154315013|NCT03694197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315014|NCT03694197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154315015|NCT01562847|Nilotinib|nilotinib|mesh-list
154315016|NCT01562847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154315017|NCT01562847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154315018|NCT01562847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315019|NCT01562847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315020|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154315021|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
154315022|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315023|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
154315024|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
154315025|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315026|NCT03919617|Volagidemab|volagidemab|mesh-list
154315027|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154315028|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315029|NCT03748173|Calfactant|calfactant|mesh-list
154315030|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154315031|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
154315032|NCT03848403|Ixekizumab|ixekizumab|mesh-list
154315033|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154315034|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
154315035|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154315036|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154315038|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154315039|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154315040|NCT03743883|Analgesics|analgesics|mesh-ancestor
154315041|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
154315042|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315043|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315044|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315045|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154315046|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154315047|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154315048|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315049|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154315050|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154315051|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315052|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
154315053|NCT03988803|Memantine|memantine|mesh-list
154315054|NCT03988803|BI 425809|bi 425809|mesh-list
154315055|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154315056|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154315057|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
154315058|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315059|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315060|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315061|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154315062|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154315063|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
154315064|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154315065|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
154315066|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154315067|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154315068|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154315069|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315070|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315071|NCT00180713|Simvastatin|simvastatin|mesh-list
154315072|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154315073|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153537190|NCT05470400|Vaccines|vaccines|mesh-list
154315074|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
154315075|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315076|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154315077|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154315078|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315079|NCT02531477|Propofol|propofol|mesh-list
154315080|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154315081|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315082|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315084|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
154315085|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
154315086|NCT04052139|Naltrexone|naltrexone|mesh-list
154315087|NCT04052139|Gabapentin|gabapentin|mesh-list
154315088|NCT04052139|Analgesics|analgesics|mesh-ancestor
154315089|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
154315090|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315091|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315092|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
154315093|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154315094|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154315095|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315096|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154315097|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154315098|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154315099|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315100|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315101|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
154315102|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154315103|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154315104|NCT03743805|Naloxone|naloxone|mesh-list
154315105|NCT03743805|Flumazenil|flumazenil|mesh-list
154315106|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154315107|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315108|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
154315109|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315110|NCT03743805|Antidotes|antidotes|mesh-ancestor
154315111|NCT03743805|Protective Agents|protective agents|mesh-ancestor
154315112|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
154315113|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
154315114|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315115|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315116|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
154315117|NCT03743727|Ledipasvir|ledipasvir|mesh-list
154315118|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154315119|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
154315120|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315121|NCT03981861|Metformin|metformin|mesh-list
154315122|NCT03981861|Spironolactone|spironolactone|mesh-list
154315123|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154315124|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315125|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154315126|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
154315127|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315128|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154315129|NCT03981861|Diuretics|diuretics|mesh-ancestor
154315130|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
154315131|NCT01332266|Cetuximab|cetuximab|mesh-list
154315132|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154315133|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315134|NCT03255824|Midazolam|midazolam|mesh-list
154315135|NCT03255824|Fentanyl|fentanyl|mesh-list
154315136|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
154315137|NCT03255824|Propofol|propofol|mesh-list
154315138|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154315139|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315140|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315141|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154315142|NCT03255824|Analgesics|analgesics|mesh-ancestor
154315143|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
154315144|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315145|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154315146|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154315147|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154315148|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
154315149|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315150|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315151|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154315152|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
154315153|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
154315154|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154315155|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154315156|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154315157|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154315158|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
154315159|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
154315161|NCT03255824|Narcotics|narcotics|mesh-ancestor
154315162|NCT03238352|Listerine|listerine|mesh-list
154315163|NCT03238352|Fluorides|fluorides|mesh-list
154315164|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
154315165|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
154315166|NCT03238352|Protective Agents|protective agents|mesh-ancestor
154315167|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315168|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154315169|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315170|NCT01222754|Lenalidomide|lenalidomide|mesh-list
154315171|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
154315172|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315173|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154315174|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154315175|NCT01222754|Growth Substances|growth substances|mesh-ancestor
154315176|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
154315177|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315178|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
154315179|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154315180|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315181|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
154315182|NCT00180479|Paclitaxel|paclitaxel|mesh-list
154315183|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154315184|NCT00180479|Everolimus|everolimus|mesh-list
154315185|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154315186|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061980|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
154315187|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
154315188|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
154315189|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
154315190|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315192|NCT00180479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154315193|NCT00180479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315194|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315195|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
154315196|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315197|NCT05169944|Magrolimab|magrolimab|mesh-list
154315198|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154315199|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315200|NCT02955069|Spartalizumab|spartalizumab|mesh-list
154315201|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154315202|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315203|NCT02955069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154315204|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315205|NCT03254108|Tolvaptan|tolvaptan|mesh-list
154315206|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154315207|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315208|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
154315209|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315210|NCT02585895|Evolocumab|evolocumab|mesh-list
154315211|NCT02585895|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154315212|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154315213|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154315214|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
154315215|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315216|NCT02585895|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154315217|NCT02585895|Protease Inhibitors|protease inhibitors|mesh-ancestor
154315218|NCT02585895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315219|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154315220|NCT03736161|Methotrexate|methotrexate|mesh-list
154315221|NCT03736161|Tofacitinib|tofacitinib|mesh-list
154315222|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154315223|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
154315224|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154315225|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315226|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154315227|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
154315228|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315229|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315230|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
154315231|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315232|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154315233|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315234|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
154315236|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154315237|NCT03736161|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154315238|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154315239|NCT02956005|Tacrolimus|tacrolimus|mesh-list
154315240|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315241|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
154315242|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315243|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154315244|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315245|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315246|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154315247|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154315248|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154315249|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
154315250|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315251|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255385|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315252|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154315253|NCT03253094|Fluconazole|fluconazole|mesh-list
154315254|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
154315255|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
154315256|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315257|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154315258|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154315259|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062055|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315260|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315261|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154315262|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
154315263|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315264|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315265|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154315266|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154315267|NCT05179070|Carvedilol|carvedilol|mesh-list
154315268|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154315269|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154315270|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
154315271|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315272|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315273|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315274|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154315275|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
154315276|NCT05179070|Protective Agents|protective agents|mesh-ancestor
154315277|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154315278|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315279|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154315280|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
154315281|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154315282|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154315283|NCT00179621|Lenalidomide|lenalidomide|mesh-list
154315284|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
154315285|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315286|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154315287|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154315288|NCT00179621|Growth Substances|growth substances|mesh-ancestor
154315289|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
154315290|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315291|NCT00179309|Docetaxel|docetaxel|mesh-list
154315292|NCT00179309|Sargramostim|sargramostim|mesh-list
154315293|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315294|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
154315295|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
154315296|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
154315297|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315298|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
154315299|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315300|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154315301|NCT00177671|Donepezil|donepezil|mesh-list
154315302|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154315303|NCT00177671|Escitalopram|escitalopram|mesh-list
154315304|NCT00177671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154315305|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154315310|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315311|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315312|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
154315313|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154315314|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
154315315|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154315316|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154315317|NCT00177671|Analgesics|analgesics|mesh-ancestor
154315318|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
153537547|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153537548|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154315319|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
154315320|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154315321|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315322|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
154315323|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
154315324|NCT03235154|Velpatasvir|velpatasvir|mesh-list
154315325|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154861697|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315326|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
154315327|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315328|NCT03233438|Dalbavancin|dalbavancin|mesh-list
154315329|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315330|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315331|NCT02251600|Deflazacort|deflazacort|mesh-list
154315332|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315333|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315334|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
154315335|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315336|NCT02113072|Beclomethasone|beclomethasone|mesh-list
154315337|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315338|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
154315339|NCT02113072|Hormones|hormones|mesh-ancestor
154315340|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315341|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315342|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154315343|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
154315344|NCT02113150|Ketamine|ketamine|mesh-list
154315345|NCT02113150|Remifentanil|remifentanil|mesh-list
154315346|NCT02113150|Analgesics|analgesics|mesh-ancestor
154315347|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
154315348|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315349|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315350|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154315351|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154315352|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
154315353|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
154315354|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315355|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154315356|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154315357|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315358|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315359|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154315360|NCT02113150|Narcotics|narcotics|mesh-ancestor
154315361|NCT04647500|Methylphenidate|methylphenidate|mesh-list
154315362|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154315363|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315364|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154315365|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154315366|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315367|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315368|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
154315369|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315370|NCT03553108|Olaparib|olaparib|mesh-list
154315371|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154315372|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315373|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315374|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315386|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
154315387|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315388|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154315389|NCT02117362|Ipilimumab|ipilimumab|mesh-list
154315390|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154315391|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315392|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154315393|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315394|NCT02113540|Atorvastatin|atorvastatin|mesh-list
154315395|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154315396|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154315397|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
154315398|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315399|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154315400|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154315401|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315402|NCT02123056|Metoprolol|metoprolol|mesh-list
154315403|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154315404|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154315405|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
154315406|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
154315407|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315408|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948806|NCT02330952|Hormones|hormones|mesh-ancestor
154315409|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154315410|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153537597|NCT03186638|Ibuprofen|ibuprofen|mesh-list
154315411|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154315412|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
154315413|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315414|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315415|NCT02120092|Clopidogrel|clopidogrel|mesh-list
154315416|NCT02120092|Ticagrelor|ticagrelor|mesh-list
154315417|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154315418|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154315419|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154315420|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154315421|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
154315422|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315423|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315424|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315425|NCT02117596|Sirolimus|sirolimus|mesh-list
154315426|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315427|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315428|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154315429|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315430|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
154315431|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315432|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
154315433|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315434|NCT02117752|Dapsone|dapsone|mesh-list
154315435|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315436|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
154315437|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154315445|NCT02117830|Enclomiphene|enclomiphene|mesh-list
154315446|NCT02117830|Clomiphene|clomiphene|mesh-list
154315447|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
154315448|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315449|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315450|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154315451|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154315452|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315453|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315454|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315455|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154315456|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315457|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154315458|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
154315459|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315460|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154315461|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
154315462|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154315463|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154315464|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
154315465|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
154315466|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315467|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315468|NCT03552406|Cetuximab|cetuximab|mesh-list
154315469|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154315470|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315471|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
154315472|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154315473|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
154315474|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315475|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
154315476|NCT02123368|Protective Agents|protective agents|mesh-ancestor
154315477|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
154315478|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154315479|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
154315480|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154315481|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
154315482|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315483|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315484|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
154315485|NCT02117986|Colistin|colistin|mesh-list
154315486|NCT02117986|Polymyxins|polymyxins|mesh-list
154315487|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315488|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315489|NCT02118064|Irinotecan|irinotecan|mesh-list
154861698|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315490|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154315491|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154315492|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315493|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315494|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315495|NCT02120872|Simvastatin|simvastatin|mesh-list
154315496|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154315497|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154315498|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
154315499|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315500|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154315501|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154315502|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315503|NCT03552016|Riboflavin|riboflavin|mesh-list
154315504|NCT03552016|Vitamins|vitamins|mesh-ancestor
154315505|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
154315506|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315509|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
154315510|NCT02118142|Betaine|betaine|mesh-list
154315511|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154315512|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
154315513|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154315514|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
154315515|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315516|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154315517|NCT02118376|Exenatide|exenatide|mesh-list
154315518|NCT02118376|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154315519|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154315520|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315521|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154315522|NCT02118376|Incretins|incretins|mesh-ancestor
154315523|NCT02118376|Hormones|hormones|mesh-ancestor
154315524|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315525|NCT02124070|Hormones|hormones|mesh-list
154315526|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315527|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315528|NCT02118532|Paclitaxel|paclitaxel|mesh-list
154315529|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154315530|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315531|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
154315532|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
154315533|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
154315534|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315535|NCT02118688|Risperidone|risperidone|mesh-list
154315536|NCT02118688|Trazodone|trazodone|mesh-list
153537722|NCT00667121|Tamoxifen|tamoxifen|mesh-list
154315537|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154315538|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
154315539|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315540|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315541|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315542|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154315543|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154315544|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315545|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154315546|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154315547|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
154315548|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154315549|NCT02118688|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154315550|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154315551|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315552|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154315553|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
154062357|NCT00683644|Zinc|zinc|mesh-list
154315554|NCT02126956|Ponesimod|ponesimod|mesh-list
154315555|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154315556|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315557|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315558|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
154315559|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315560|NCT02124148|Leucovorin|leucovorin|mesh-list
154315561|NCT02124148|Fluorouracil|fluorouracil|mesh-list
154315562|NCT02124148|Pemetrexed|pemetrexed|mesh-list
154315563|NCT02124148|Cetuximab|cetuximab|mesh-list
154315564|NCT02124148|Prexasertib|prexasertib|mesh-list
154315565|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948980|NCT01950390|Bevacizumab|bevacizumab|mesh-list
154315566|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
154315567|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315568|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154315569|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315570|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
154315571|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315572|NCT02124148|Antidotes|antidotes|mesh-ancestor
154315573|NCT02124148|Protective Agents|protective agents|mesh-ancestor
154315574|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
154315575|NCT02124148|Vitamins|vitamins|mesh-ancestor
154315576|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
154315577|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315578|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153494797|NCT00676026|Hormones|hormones|mesh-ancestor
154315581|NCT02124148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154315582|NCT02124226|Methotrexate|methotrexate|mesh-list
154315583|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154315584|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
154315585|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154315586|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315587|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154315588|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
154315589|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315590|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315591|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
154315592|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315593|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154315594|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315595|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
154315596|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154315597|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154315598|NCT02127034|Digoxin|digoxin|mesh-list
154315599|NCT02127034|Mirabegron|mirabegron|mesh-list
154315600|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
154315601|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154315602|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154315603|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315604|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315605|NCT02127034|Protective Agents|protective agents|mesh-ancestor
154315606|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315607|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154315608|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154315609|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154315610|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
154315611|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315612|NCT02127034|Urological Agents|urological agents|mesh-ancestor
154315613|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154315614|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154315615|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
154315616|NCT02787304|Volixibat|volixibat|mesh-list
154315617|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154315618|NCT02127190|CXA-10|cxa-10|mesh-list
154315619|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315620|NCT02932904|Vortioxetine|vortioxetine|mesh-list
154315621|NCT02932904|Paroxetine|paroxetine|mesh-list
154315622|NCT02932904|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154315623|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154315624|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315625|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315626|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315627|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
154315628|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315629|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154315630|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
154315631|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154315632|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154315633|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154315634|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315635|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154315636|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154315637|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315638|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154315639|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154861699|NCT03398278|Analgesics|analgesics|mesh-ancestor
154315640|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154315641|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154315642|NCT02127736|Amitriptyline|amitriptyline|mesh-list
154315643|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154315644|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
154315645|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154315646|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154315647|NCT02127736|Analgesics|analgesics|mesh-ancestor
154315648|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
154315649|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315651|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154315652|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154315653|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315654|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315655|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
154315656|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315658|NCT02124850|Cetuximab|cetuximab|mesh-list
154315659|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154315660|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315661|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154315662|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315663|NCT02125084|Everolimus|everolimus|mesh-list
154315664|NCT02125084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154315665|NCT02125084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154315666|NCT02125084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315667|NCT02125084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315668|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315669|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
154315670|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315671|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315672|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
154315673|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154315674|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315675|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315676|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154315677|NCT02122510|Analgesics|analgesics|mesh-ancestor
154315678|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
154315679|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315680|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154315681|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154315682|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154315683|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154315684|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315685|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315686|NCT02125318|Anagrelide|anagrelide|mesh-list
154315687|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154315688|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154315689|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315690|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154315691|NCT02128126|Vaccines|vaccines|mesh-list
154315692|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
154315693|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315694|NCT02128204|Lidocaine|lidocaine|mesh-list
154315695|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
154315696|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
154315697|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315698|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315699|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
154315700|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315701|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154315702|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154315703|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154315704|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315705|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315706|NCT02128282|Gemcitabine|gemcitabine|mesh-list
154315707|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315708|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154315709|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
154315710|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315711|NCT02125630|Hormones|hormones|mesh-list
154861700|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
154255388|NCT01149356|Goserelin|goserelin|mesh-list
154315712|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315713|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315714|NCT03551548|Spironolactone|spironolactone|mesh-list
154315715|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154315716|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
154315717|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315718|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315719|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154315720|NCT03551548|Diuretics|diuretics|mesh-ancestor
154315724|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154315725|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154315726|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315727|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315728|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154315729|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
154315730|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315731|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315732|NCT02126020|Infliximab|infliximab|mesh-list
154315733|NCT02126020|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154315734|NCT02126020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315735|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
154315736|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154315737|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154315738|NCT00688376|Donepezil|donepezil|mesh-list
154315739|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154315740|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315741|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315742|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
154315743|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315744|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315745|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
154315746|NCT02126332|Acetaminophen|acetaminophen|mesh-list
154315747|NCT02126332|Sufentanil|sufentanil|mesh-list
154315748|NCT02126332|Nefopam|nefopam|mesh-list
154315749|NCT02126332|Tramadol|tramadol|mesh-list
154315750|NCT02126332|Ropivacaine|ropivacaine|mesh-list
154315751|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
154315752|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
154315753|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315754|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315755|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
154315756|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315757|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154315758|NCT02126332|Analgesics|analgesics|mesh-ancestor
154315759|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
154315760|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154315761|NCT02126332|Narcotics|narcotics|mesh-ancestor
154315762|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154315763|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154315764|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
154315765|NCT02131246|Insulin|insulin|mesh-list
154315766|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154315767|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
154315768|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
154315769|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154315770|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154315771|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315772|NCT02126644|Glycolic acid|glycolic acid|mesh-list
154315773|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
154315774|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
154315775|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
154315776|NCT03550534|Calcium|calcium|mesh-list
154315777|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154315778|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315779|NCT03550534|Antacids|antacids|mesh-ancestor
154315780|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315781|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154315782|NCT02131480|Doxorubicin|doxorubicin|mesh-list
154315783|NCT02131480|Trabectedin|trabectedin|mesh-list
154315784|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154315785|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315786|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154315787|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154315788|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861701|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315789|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315790|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154315791|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
154315792|NCT02128984|Antioxidants|antioxidants|mesh-list
154315793|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315794|NCT02128984|Protective Agents|protective agents|mesh-ancestor
154315797|NCT06149117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315798|NCT06149117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315799|NCT06149091|Tranexamic Acid|tranexamic acid|mesh-list
154315800|NCT06149091|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154315801|NCT06149091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154315802|NCT06149091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315803|NCT06149091|Hemostatics|hemostatics|mesh-ancestor
154315804|NCT06149091|Coagulants|coagulants|mesh-ancestor
154315805|NCT06149078|Uric Acid|uric acid|mesh-list
154315806|NCT06149078|Antioxidants|antioxidants|mesh-ancestor
154315807|NCT06149078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315808|NCT06149078|Protective Agents|protective agents|mesh-ancestor
154315809|NCT06149078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315810|NCT06149065|Testosterone|testosterone|mesh-list
154315811|NCT06149065|Androgens|androgens|mesh-ancestor
154315812|NCT06149065|Hormones|hormones|mesh-ancestor
154315813|NCT06149065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315814|NCT06149065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315815|NCT06148740|Propolis|propolis|mesh-list
154315816|NCT06148740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315817|NCT06148649|Dulaglutide|dulaglutide|mesh-list
154315818|NCT06148649|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154315819|NCT06148649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154315820|NCT06148649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315821|NCT06148558|Sunscreening Agents|sunscreening agents|mesh-list
154315822|NCT06148558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154315823|NCT06148558|Protective Agents|protective agents|mesh-ancestor
154315824|NCT06148558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315825|NCT06148558|Dermatologic Agents|dermatologic agents|mesh-ancestor
154315826|NCT06148545|Vitamin D|vitamin d|mesh-list
154315828|NCT06148545|Vitamins|vitamins|mesh-ancestor
154315829|NCT06148545|Micronutrients|micronutrients|mesh-ancestor
153538091|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
154315830|NCT06148545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315831|NCT06148545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154315832|NCT06148545|Trace Elements|trace elements|mesh-ancestor
154315833|NCT06148402|Capecitabine|capecitabine|mesh-list
154315834|NCT06148402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154315835|NCT06148402|Antimetabolites|antimetabolites|mesh-ancestor
154315836|NCT06148402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315837|NCT06148402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315838|NCT06148259|Chrysarobin|chrysarobin|mesh-list
154315839|NCT06148259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154315840|NCT06148259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154315841|NCT06148259|Analgesics|analgesics|mesh-ancestor
154315842|NCT06148259|Sensory System Agents|sensory system agents|mesh-ancestor
154315843|NCT06148259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315844|NCT06148259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315845|NCT06148259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315846|NCT06148259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154315847|NCT06148168|Bupivacaine|bupivacaine|mesh-list
154315848|NCT06148168|Anesthetics, Local|anesthetics, local|mesh-ancestor
154315849|NCT06148168|Anesthetics|anesthetics|mesh-ancestor
154315850|NCT06148168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315851|NCT06148168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315852|NCT06148168|Sensory System Agents|sensory system agents|mesh-ancestor
154315853|NCT06148168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315854|NCT06148103|Fentanyl|fentanyl|mesh-list
154315855|NCT06148103|Propofol|propofol|mesh-list
154315856|NCT06148103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154315857|NCT06148103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315858|NCT06148103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315859|NCT06148103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154315860|NCT06148103|Anesthetics, General|anesthetics, general|mesh-ancestor
154315861|NCT06148103|Anesthetics|anesthetics|mesh-ancestor
154315862|NCT06148103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154315863|NCT06148103|Narcotics|narcotics|mesh-ancestor
154315864|NCT06148103|Analgesics|analgesics|mesh-ancestor
154315865|NCT06148103|Sensory System Agents|sensory system agents|mesh-ancestor
154315866|NCT06148103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949279|NCT00972478|Prednisone|prednisone|mesh-list
154315867|NCT06148103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154315869|NCT06148025|Neomycin|neomycin|mesh-list
154315870|NCT06148025|Vaccines|vaccines|mesh-list
154315871|NCT06148025|BCG Vaccine|bcg vaccine|mesh-list
154315873|NCT06148025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315874|NCT06148025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315875|NCT06148025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315876|NCT06148025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154315877|NCT06148025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154315878|NCT06148025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315879|NCT06148025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315880|NCT06145945|Ropivacaine|ropivacaine|mesh-list
154315881|NCT06145945|Anesthetics, Local|anesthetics, local|mesh-ancestor
154315882|NCT06145945|Anesthetics|anesthetics|mesh-ancestor
154315883|NCT06145945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315884|NCT06145945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315885|NCT06145945|Sensory System Agents|sensory system agents|mesh-ancestor
154315886|NCT06145945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315887|NCT06144866|Rivaroxaban|rivaroxaban|mesh-list
154315888|NCT06144866|Apixaban|apixaban|mesh-list
154315889|NCT06144866|Edoxaban|edoxaban|mesh-list
154315890|NCT06144866|Dabigatran|dabigatran|mesh-list
154315891|NCT06144866|Anticoagulants|anticoagulants|mesh-list
154315892|NCT06144866|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154315893|NCT06144866|Antithrombins|antithrombins|mesh-ancestor
154315894|NCT06144866|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154315895|NCT06144866|Protease Inhibitors|protease inhibitors|mesh-ancestor
154315896|NCT06144866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315897|NCT06144866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315898|NCT06136728|4-Aminopyridine|4-aminopyridine|mesh-list
154315899|NCT06136728|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154315900|NCT06136728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315901|NCT06136728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315902|NCT06134284|Rituximab|rituximab|mesh-list
154315903|NCT06134284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154315904|NCT06134284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315905|NCT06134284|Immunologic Factors|immunologic factors|mesh-ancestor
154315906|NCT06134284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315907|NCT06134284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154315908|NCT06130527|Nicardipine|nicardipine|mesh-list
154315909|NCT06130527|Remifentanil|remifentanil|mesh-list
154315910|NCT06130527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154315911|NCT06130527|Narcotics|narcotics|mesh-ancestor
154315912|NCT06130527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154315913|NCT06130527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315914|NCT06130527|Analgesics|analgesics|mesh-ancestor
154315915|NCT06130527|Sensory System Agents|sensory system agents|mesh-ancestor
154315916|NCT06130527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315917|NCT06130527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154315918|NCT06130527|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154315919|NCT06130527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315920|NCT06130527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315921|NCT06130527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154315922|NCT06130527|Vasodilator Agents|vasodilator agents|mesh-ancestor
154315923|NCT06119490|Methylprednisolone|methylprednisolone|mesh-list
154315924|NCT06119490|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154315925|NCT06119490|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154315926|NCT06119490|Prednisolone|prednisolone|mesh-list
154315927|NCT06119490|Prednisolone acetate|prednisolone acetate|mesh-list
154315928|NCT06119490|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154315929|NCT06119490|Prednisolone phosphate|prednisolone phosphate|mesh-list
154315930|NCT06119490|Tofacitinib|tofacitinib|mesh-list
154315931|NCT06119490|Abrocitinib|abrocitinib|mesh-list
154315932|NCT06119490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315933|NCT06119490|Antiemetics|antiemetics|mesh-ancestor
154315934|NCT06119490|Autonomic Agents|autonomic agents|mesh-ancestor
154315935|NCT06119490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315936|NCT06119490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315937|NCT06119490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154315938|NCT06119490|Glucocorticoids|glucocorticoids|mesh-ancestor
154315939|NCT06119490|Hormones|hormones|mesh-ancestor
154315940|NCT06119490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315941|NCT06119490|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154315942|NCT06119490|Protective Agents|protective agents|mesh-ancestor
154315943|NCT06119490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154861702|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
154315944|NCT06119490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315945|NCT06119490|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154315946|NCT06119490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154315962|NCT06116201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154315965|NCT06115538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154315966|NCT06115538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154315967|NCT06115538|Dopamine Agents|dopamine agents|mesh-ancestor
154315968|NCT06115538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315969|NCT06115538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315970|NCT06115538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315971|NCT06102915|Bromides|bromides|mesh-list
154315972|NCT06102915|Rocuronium|rocuronium|mesh-list
154315973|NCT06102915|Atracurium|atracurium|mesh-list
154315974|NCT06102915|Cisatracurium|cisatracurium|mesh-list
154315975|NCT06102915|Anticonvulsants|anticonvulsants|mesh-ancestor
154315976|NCT06102915|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154315977|NCT06102915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154315978|NCT06102915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154315979|NCT06102915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315980|NCT06102915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315981|NCT06102915|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154315982|NCT06102915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154315983|NCT06102915|Cholinergic Agents|cholinergic agents|mesh-ancestor
154315984|NCT06102915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315985|NCT06102915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315986|NCT06084754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154315987|NCT06084754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154315988|NCT06077786|Ibuprofen|ibuprofen|mesh-list
154315989|NCT06077786|Pregabalin|pregabalin|mesh-list
154315990|NCT06077786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154315991|NCT06077786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154315992|NCT06077786|Analgesics|analgesics|mesh-ancestor
154315993|NCT06077786|Sensory System Agents|sensory system agents|mesh-ancestor
154315994|NCT06077786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154315995|NCT06077786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315996|NCT06077786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315997|NCT06077786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154315998|NCT06077786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154315999|NCT06077786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316000|NCT06077786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316001|NCT06077786|Anticonvulsants|anticonvulsants|mesh-ancestor
154316002|NCT06077786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154316003|NCT06077786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154316004|NCT06077786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154316005|NCT06077786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154316019|NCT06056583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316020|NCT06056583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316021|NCT06056583|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154316022|NCT06056583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154316023|NCT06056583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316024|NCT06043414|Triclosan|triclosan|mesh-list
154316025|NCT06043414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153538268|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
154316026|NCT06043414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316027|NCT06043414|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154316028|NCT06043414|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154316029|NCT06043414|Antimetabolites|antimetabolites|mesh-ancestor
154316030|NCT06043414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316031|NCT06043414|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154316032|NCT06041438|Itraconazole|itraconazole|mesh-list
154316033|NCT06041438|Antifungal Agents|antifungal agents|mesh-ancestor
154316034|NCT06041438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316035|NCT06041438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154316036|NCT06041438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154316037|NCT06041438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316038|NCT06041438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316039|NCT06041438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154316040|NCT06041438|Hormone Antagonists|hormone antagonists|mesh-ancestor
154316041|NCT06041438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316042|NCT06041438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316043|NCT06041438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154316044|NCT06022302|Laxatives|laxatives|mesh-list
153949421|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
154316045|NCT06022302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316046|NCT06014801|Dialysis Solutions|dialysis solutions|mesh-list
154316047|NCT06014801|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154316048|NCT06013345|Propofol|propofol|mesh-list
154316049|NCT06013345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154316050|NCT06013345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316051|NCT06013345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316052|NCT06013345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154316053|NCT06013345|Anesthetics, General|anesthetics, general|mesh-ancestor
154316054|NCT06013345|Anesthetics|anesthetics|mesh-ancestor
154316055|NCT05999604|Ocrelizumab|ocrelizumab|mesh-list
154316056|NCT05999604|Immunologic Factors|immunologic factors|mesh-ancestor
154316057|NCT05999604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316058|NCT05986773|Metolazone|metolazone|mesh-list
154316059|NCT05986773|Furosemide|furosemide|mesh-list
154316060|NCT05986773|Acetazolamide|acetazolamide|mesh-list
154316061|NCT05986773|Diuretics|diuretics|mesh-ancestor
154316062|NCT05986773|Natriuretic Agents|natriuretic agents|mesh-ancestor
154316063|NCT05986773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316064|NCT05986773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153538339|NCT01527669|Lovastatin|lovastatin|mesh-list
153538390|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316065|NCT05986773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154316066|NCT05986773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316067|NCT05986773|Anticonvulsants|anticonvulsants|mesh-ancestor
154316068|NCT05986773|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154316073|NCT05962424|Analgesics|analgesics|mesh-ancestor
154316074|NCT05962424|Sensory System Agents|sensory system agents|mesh-ancestor
154316075|NCT05962424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316076|NCT05962424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316077|NCT05962424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154316078|NCT05962424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154316079|NCT05962424|Anesthetics, General|anesthetics, general|mesh-ancestor
154316080|NCT05962424|Anesthetics|anesthetics|mesh-ancestor
154062879|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154316081|NCT05962424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316082|NCT05962424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154316083|NCT05962424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154316084|NCT05962424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316085|NCT05962424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316086|NCT05934409|Niacin|niacin|mesh-list
154316087|NCT05934409|Nicotinic Acids|nicotinic acids|mesh-list
154316088|NCT05934409|Niacinamide|niacinamide|mesh-list
154316089|NCT05934409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154316090|NCT05934409|Antimetabolites|antimetabolites|mesh-ancestor
154316091|NCT05934409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316092|NCT05934409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154316093|NCT05934409|Vasodilator Agents|vasodilator agents|mesh-ancestor
154316094|NCT05934409|Vitamin B Complex|vitamin b complex|mesh-ancestor
154316095|NCT05934409|Vitamins|vitamins|mesh-ancestor
154316096|NCT05934409|Micronutrients|micronutrients|mesh-ancestor
154316097|NCT05934409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316098|NCT05830136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154316099|NCT05824559|Bevacizumab|bevacizumab|mesh-list
154316100|NCT05824559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316101|NCT05824559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316102|NCT05824559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154316103|NCT05824559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154316104|NCT05824559|Growth Substances|growth substances|mesh-ancestor
154316105|NCT05824559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316106|NCT05824559|Growth Inhibitors|growth inhibitors|mesh-ancestor
154316107|NCT05774691|Heparin|heparin|mesh-list
154316108|NCT05774691|Calcium heparin|calcium heparin|mesh-list
154316109|NCT05774691|Protamines|protamines|mesh-list
154316110|NCT05774691|Anticoagulants|anticoagulants|mesh-ancestor
154316111|NCT05774691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154316112|NCT05774691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154316113|NCT05774691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316114|NCT05774691|Heparin Antagonists|heparin antagonists|mesh-ancestor
154316115|NCT05774691|Coagulants|coagulants|mesh-ancestor
154316116|NCT05754996|Nifuroxazide|nifuroxazide|mesh-list
154316117|NCT05754996|Lactulose|lactulose|mesh-list
154316118|NCT05754996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316119|NCT05754996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316120|NCT05695508|Dexamethasone|dexamethasone|mesh-list
154316121|NCT05695508|Lenalidomide|lenalidomide|mesh-list
154316122|NCT05695508|Bortezomib|bortezomib|mesh-list
154316123|NCT05695508|Daratumumab|daratumumab|mesh-list
154861703|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154316124|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154316125|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
154316126|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
154316127|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316128|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316129|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316130|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
154316131|NCT05695508|Hormones|hormones|mesh-ancestor
154316132|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316133|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154316134|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316135|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
154316136|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154316137|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154316138|NCT05695508|Growth Substances|growth substances|mesh-ancestor
154316139|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
154316140|NCT05665140|Dexamethasone|dexamethasone|mesh-list
154316141|NCT05665140|Lenalidomide|lenalidomide|mesh-list
154316146|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316147|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316148|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316149|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
154316150|NCT05665140|Hormones|hormones|mesh-ancestor
154316151|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316152|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154316153|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316154|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
154316155|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154062955|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
154316156|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154316157|NCT05665140|Growth Substances|growth substances|mesh-ancestor
154316158|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
154316159|NCT05656170|Bupivacaine|bupivacaine|mesh-list
154316160|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
154316161|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
154316162|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316163|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316164|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
154316165|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316166|NCT05619328|Vitamins|vitamins|mesh-list
154316167|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
154316168|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
154316169|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316170|NCT05589766|Niacinamide|niacinamide|mesh-list
154316171|NCT05589766|Niacin|niacin|mesh-list
154316172|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
154316173|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
154316174|NCT05589766|Vitamins|vitamins|mesh-ancestor
154316175|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
154316176|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316177|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154316178|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
154316179|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316180|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154316181|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
154316182|NCT05587374|Gemcitabine|gemcitabine|mesh-list
154316183|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154316184|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316185|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154316186|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
154316187|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316188|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
154316189|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316190|NCT05583175|Venetoclax|venetoclax|mesh-list
154316191|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316192|NCT05553184|Niacin|niacin|mesh-list
154316193|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
154316194|NCT05553184|Niacinamide|niacinamide|mesh-list
154316195|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
154316196|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154316197|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
154316198|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316199|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316200|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154316201|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
154316202|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154316203|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154316204|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154316205|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
154316206|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538549|NCT01528865|Tenofovir|tenofovir|mesh-list
153538550|NCT01528865|Lamivudine|lamivudine|mesh-list
154316207|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316208|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154316209|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
154316210|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154316211|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
154316212|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
154316213|NCT05553184|Vitamins|vitamins|mesh-ancestor
154316214|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
154316215|NCT05544721|Ropivacaine|ropivacaine|mesh-list
154316226|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316227|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316228|NCT05514899|Dronabinol|dronabinol|mesh-list
154316229|NCT05514899|Cannabidiol|cannabidiol|mesh-list
154316230|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
154316231|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
154316232|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316233|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154027397|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316234|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154316235|NCT05514899|Analgesics|analgesics|mesh-ancestor
154316236|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
154316237|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316238|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154316239|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154316240|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316241|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316242|NCT05514899|Hormones|hormones|mesh-ancestor
154316243|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316244|NCT05487807|Nicotine|nicotine|mesh-list
154316245|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154316246|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
154316247|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316248|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316249|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154316250|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154316251|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
154316252|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316253|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316254|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
154316255|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154316256|NCT05440942|Trametinib|trametinib|mesh-list
154316257|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316258|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154316259|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316260|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316261|NCT05437575|Fentanyl|fentanyl|mesh-list
154316262|NCT05437575|Ketamine|ketamine|mesh-list
154316263|NCT05437575|Analgesics|analgesics|mesh-ancestor
154316264|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
154316265|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316266|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316267|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154316268|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154316269|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
154316270|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
154316271|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316272|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154316273|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154316274|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316275|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316276|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154316277|NCT05437575|Narcotics|narcotics|mesh-ancestor
154316278|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154316310|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316311|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154316312|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316313|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154316314|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154316315|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
154316316|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316317|NCT05363514|Naltrexone|naltrexone|mesh-list
154316318|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154316319|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154316320|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316327|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316328|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
154316329|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316330|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
154316331|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
154316332|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154316333|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154316334|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316335|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316336|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316337|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154316338|NCT05284812|Vaccines|vaccines|mesh-list
154316339|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
154316340|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316341|NCT05283382|Cannabidiol|cannabidiol|mesh-list
154316342|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
154316343|NCT05262335|Paclitaxel|paclitaxel|mesh-list
154316344|NCT05262335|Docetaxel|docetaxel|mesh-list
154316345|NCT05262335|Capecitabine|capecitabine|mesh-list
154316346|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
154316347|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154316348|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316349|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
154316350|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
154316351|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
154316352|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316353|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154316354|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
154316359|NCT05092945|Niacin|niacin|mesh-list
154316360|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
154316361|NCT05092945|Niacinamide|niacinamide|mesh-list
154316362|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154316363|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
154316364|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316365|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154316366|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
154316367|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
154316368|NCT05092945|Vitamins|vitamins|mesh-ancestor
154316369|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
154316370|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316371|NCT05088889|Nivolumab|nivolumab|mesh-list
154316372|NCT05088889|Ipilimumab|ipilimumab|mesh-list
154316373|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316374|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316375|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316376|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316377|NCT05065567|Droperidol|droperidol|mesh-list
154316378|NCT05065567|Haloperidol|haloperidol|mesh-list
154316379|NCT05065567|Ondansetron|ondansetron|mesh-list
154316380|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
154316381|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
154316382|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
154316383|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316384|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316385|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316386|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
154316387|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
154316388|NCT05065567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154316389|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154316390|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
154316391|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316392|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316393|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154316394|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154316395|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316396|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154316400|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154316401|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154316403|NCT05060731|Trace Elements|trace elements|mesh-ancestor
154316404|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
154316405|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316406|NCT04989335|Fludarabine|fludarabine|mesh-list
154316407|NCT04989335|Clofarabine|clofarabine|mesh-list
154316408|NCT04989335|Bisantrene|bisantrene|mesh-list
154316409|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316410|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154316411|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
154316412|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316413|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154316414|NCT04986631|Topiramate|topiramate|mesh-list
154316415|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
154316416|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154316417|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316418|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154316419|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316420|NCT04946864|Palbociclib|palbociclib|mesh-list
154316421|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316422|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154316423|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316424|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316425|NCT04940572|Valproic Acid|valproic acid|mesh-list
154316426|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
154316427|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316428|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316429|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
154316430|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316431|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316432|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
154316433|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154316434|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316435|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154316436|NCT04904536|Atorvastatin|atorvastatin|mesh-list
154316437|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154316438|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154316439|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
154316440|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316441|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154316442|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154316443|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316444|NCT04895280|Triamcinolone|triamcinolone|mesh-list
154316445|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154316446|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154316447|NCT04895280|Ketorolac|ketorolac|mesh-list
154316448|NCT04895280|Bupivacaine|bupivacaine|mesh-list
154316449|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154316450|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154316451|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
154316452|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316453|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316454|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
154316455|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316456|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154316457|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
154316458|NCT04895280|Hormones|hormones|mesh-ancestor
154316459|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316460|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154316461|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
154316462|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063259|NCT00756184|Travoprost|travoprost|mesh-list
154316463|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316464|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154316465|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154316466|NCT04895280|Analgesics|analgesics|mesh-ancestor
154316467|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154316468|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154316469|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154316481|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316482|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316483|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316484|NCT04802746|Alprazolam|alprazolam|mesh-list
154316485|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154316486|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316487|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316488|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154316489|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154316490|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154316491|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
154316492|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
153949789|NCT05739929|Colchicine|colchicine|mesh-list
154316493|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316494|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316495|NCT04800822|Cetuximab|cetuximab|mesh-list
154316496|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316497|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316498|NCT04779697|Semaglutide|semaglutide|mesh-list
154316499|NCT04779697|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154316500|NCT04779697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154316501|NCT04779697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316502|NCT04746183|Ritonavir|ritonavir|mesh-list
154316503|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
154316504|NCT04746183|Favipiravir|favipiravir|mesh-list
154316505|NCT04746183|Nirmatrelvir|nirmatrelvir|mesh-list
154316506|NCT04746183|Sotrovimab|sotrovimab|mesh-list
154316507|NCT04746183|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154316508|NCT04746183|Molnupiravir|molnupiravir|mesh-list
154316509|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154316510|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154316511|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
154316512|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316513|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316514|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154316515|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154316516|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
154316517|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316518|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154316519|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154316520|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154316521|NCT04718220|Antibodies|antibodies|mesh-list
154316522|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
154316523|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316524|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
154316525|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
154316526|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
154316527|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154316528|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
154316529|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
154316530|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316531|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316532|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316533|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154316534|NCT04685616|Doxorubicin|doxorubicin|mesh-list
154316538|NCT04685616|Vinblastine|vinblastine|mesh-list
154316540|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154316541|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316542|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154316543|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154316544|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316545|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316546|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
154316547|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154316548|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
154316549|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316550|NCT04685616|Immunotoxins|immunotoxins|mesh-ancestor
154316551|NCT04685616|Immunoconjugates|immunoconjugates|mesh-ancestor
154316552|NCT04685616|Immunologic Factors|immunologic factors|mesh-ancestor
154316553|NCT04685616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316554|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154316555|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
154316556|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
154316557|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154316558|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154316559|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154316560|NCT04681417|Carboplatin|carboplatin|mesh-list
154316561|NCT04681417|Etoposide|etoposide|mesh-list
154316562|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
154316563|NCT04681417|Vincristine|vincristine|mesh-list
154316564|NCT04681417|Melphalan|melphalan|mesh-list
154316565|NCT04681417|Topotecan|topotecan|mesh-list
154316566|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316567|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154316568|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154316569|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154316570|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861704|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154861705|NCT03593902|Prednisolone|prednisolone|mesh-list
154316571|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316572|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
154316573|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
153538854|NCT01530217|Analgesics|analgesics|mesh-ancestor
154316574|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
154316575|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154316576|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
154316577|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154316578|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154316579|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
154316580|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316581|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154316582|NCT04676958|Vitamin K|vitamin k|mesh-list
154316583|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
154316584|NCT04676958|Vitamins|vitamins|mesh-ancestor
154316585|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
154316586|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316587|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154316588|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154316589|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316590|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
154316591|NCT04676958|Coagulants|coagulants|mesh-ancestor
154316592|NCT04672941|Bromides|bromides|mesh-list
154316593|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
154316594|NCT04672941|Olodaterol|olodaterol|mesh-list
154316595|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154316596|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
154316597|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316598|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316599|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154316600|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
154316601|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
154316602|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154316603|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
154316604|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316605|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316606|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
154316607|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
154316608|NCT04670679|Cetuximab|cetuximab|mesh-list
154316609|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316610|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316612|NCT04670679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316614|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154316615|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316617|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316618|NCT04599972|Pilocarpine|pilocarpine|mesh-list
154316619|NCT04599972|Miotics|miotics|mesh-ancestor
154316620|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
154316621|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316622|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316623|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154316624|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154316625|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
154316626|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316627|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316628|NCT04599933|Pilocarpine|pilocarpine|mesh-list
154316629|NCT04599933|Miotics|miotics|mesh-ancestor
154316630|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
154316631|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316632|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316633|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154316634|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154316635|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
154316636|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316637|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316638|NCT04570475|Vitamin D|vitamin d|mesh-list
154316639|NCT04570475|Vitamins|vitamins|mesh-ancestor
154316640|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
154316641|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316642|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154316643|NCT04558918|Eculizumab|eculizumab|mesh-list
154316644|NCT04558918|Ravulizumab|ravulizumab|mesh-list
154316645|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154316646|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154316647|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
154316648|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316649|NCT04501939|Venetoclax|venetoclax|mesh-list
154316650|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316651|NCT04439110|Trastuzumab|trastuzumab|mesh-list
154316652|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154316653|NCT04439110|Maytansine|maytansine|mesh-list
154316654|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
154316655|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316656|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316657|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154316658|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154316659|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154316660|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154316661|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316662|NCT04439110|Immunotoxins|immunotoxins|mesh-ancestor
154316663|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
154316664|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316665|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
154316666|NCT04422184|Diuretics|diuretics|mesh-ancestor
154316667|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
154316668|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316669|NCT04422184|Expectorants|expectorants|mesh-ancestor
154316670|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
154316671|NCT04416568|Nivolumab|nivolumab|mesh-list
154316672|NCT04416568|Ipilimumab|ipilimumab|mesh-list
154316673|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316674|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063489|NCT00758134|Trastuzumab|trastuzumab|mesh-list
154316675|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316676|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316677|NCT04260022|Blinatumomab|blinatumomab|mesh-list
154316678|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316679|NCT04227678|Heparin|heparin|mesh-list
154316680|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
154316681|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154316682|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154316683|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316684|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
154316685|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154316686|NCT04223765|Fludarabine|fludarabine|mesh-list
154316689|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316691|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154316692|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
154316693|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316694|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316695|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154316696|NCT04203056|Aripiprazole|aripiprazole|mesh-list
154316697|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
154316698|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
154316699|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154316700|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154316701|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153539086|NCT01531361|Sorafenib|sorafenib|mesh-list
154316702|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316703|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316704|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
154316705|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
154316706|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316707|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316708|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154316709|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154316710|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
154316711|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154316712|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154316713|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154316714|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154316715|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
154316716|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154316717|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316718|NCT04158141|Cisplatin|cisplatin|mesh-list
154316719|NCT04158141|Carboplatin|carboplatin|mesh-list
154316720|NCT04158141|Pemetrexed|pemetrexed|mesh-list
154316721|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316722|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316723|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316724|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154316725|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154316726|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
154316727|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154861706|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
154316728|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154316729|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
154316730|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316731|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316732|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154316733|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
154316734|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316735|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316736|NCT04090528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316737|NCT04090528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316738|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
154316739|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154316740|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
154316741|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154316742|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
154316743|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316744|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316745|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
154316746|NCT03829501|Atezolizumab|atezolizumab|mesh-list
154316747|NCT03829501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316748|NCT03829501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316749|NCT03829501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316750|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316751|NCT03805932|Aspirin|aspirin|mesh-list
154316752|NCT03805932|Acetaminophen|acetaminophen|mesh-list
154316753|NCT03805932|Diphenhydramine|diphenhydramine|mesh-list
154316754|NCT03805932|Promethazine|promethazine|mesh-list
154316755|NCT03805932|Dexamethasone|dexamethasone|mesh-list
154316756|NCT03805932|Rituximab|rituximab|mesh-list
154316757|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
154316758|NCT03805932|Famotidine|famotidine|mesh-list
154316760|NCT03805932|Antiemetics|antiemetics|mesh-ancestor
154316761|NCT03805932|Autonomic Agents|autonomic agents|mesh-ancestor
154316762|NCT03805932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316763|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316764|NCT03805932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316765|NCT03805932|Glucocorticoids|glucocorticoids|mesh-ancestor
154316767|NCT03805932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316768|NCT03805932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154316769|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316770|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316771|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
154316772|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154316773|NCT03805932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154316774|NCT03805932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154316775|NCT03805932|Analgesics|analgesics|mesh-ancestor
154316776|NCT03805932|Sensory System Agents|sensory system agents|mesh-ancestor
154316777|NCT03805932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154316778|NCT03805932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154316779|NCT03805932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316780|NCT03805932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154316781|NCT03805932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154316782|NCT03805932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316783|NCT03805932|Antipyretics|antipyretics|mesh-ancestor
154316784|NCT03805932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154316785|NCT03805932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154316786|NCT03805932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316787|NCT03805932|Anesthetics, Local|anesthetics, local|mesh-ancestor
154316788|NCT03805932|Anesthetics|anesthetics|mesh-ancestor
154316789|NCT03805932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154316790|NCT03805932|Histamine Antagonists|histamine antagonists|mesh-ancestor
154316791|NCT03805932|Histamine Agents|histamine agents|mesh-ancestor
154316792|NCT03805932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316793|NCT03805932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154316794|NCT03805932|Antipruritics|antipruritics|mesh-ancestor
154316795|NCT03805932|Dermatologic Agents|dermatologic agents|mesh-ancestor
154316796|NCT03805932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154316797|NCT03805932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154316798|NCT03805932|Immunotoxins|immunotoxins|mesh-ancestor
154316799|NCT03805932|Immunoconjugates|immunoconjugates|mesh-ancestor
154316800|NCT03803787|Budesonide|budesonide|mesh-list
154316801|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154316802|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154316803|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
154316804|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861707|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
154316805|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316806|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154316807|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
154316808|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
154316809|NCT03803787|Hormones|hormones|mesh-ancestor
154316810|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316811|NCT03774186|Pancrelipase|pancrelipase|mesh-list
154316812|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316813|NCT03724409|Octreotide|octreotide|mesh-list
154316814|NCT03724409|Edotreotide|edotreotide|mesh-list
154316815|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316816|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154316817|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316818|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154316819|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316820|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
154316821|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316822|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316823|NCT03694834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153539269|NCT01532804|Growth Substances|growth substances|mesh-ancestor
154316824|NCT03694834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316825|NCT03689894|Rituximab|rituximab|mesh-list
154316826|NCT03689894|Ibrutinib|ibrutinib|mesh-list
154316827|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316828|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316829|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
154316830|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316831|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154316832|NCT03689894|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154316833|NCT03689894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154316834|NCT03689894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316835|NCT03689894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316837|NCT03681275|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154316838|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154316839|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316840|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316842|NCT03537742|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154316843|NCT03537742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154316844|NCT03537742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154316845|NCT03537742|Antimetabolites|antimetabolites|mesh-ancestor
154316846|NCT03537742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316847|NCT03537742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154316848|NCT03537742|Protease Inhibitors|protease inhibitors|mesh-ancestor
154316849|NCT03537742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316850|NCT03537742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154316851|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
154316852|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
154316853|NCT03516279|Dasatinib|dasatinib|mesh-list
154316854|NCT03516279|Nilotinib|nilotinib|mesh-list
154316855|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316856|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316857|NCT03516279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316858|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316859|NCT03516279|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154316860|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154316861|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316862|NCT03511846|Capsaicin|capsaicin|mesh-list
154316863|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
154316864|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
154316865|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
154316866|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316867|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316868|NCT03507751|Meropenem|meropenem|mesh-list
154316869|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154316870|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316871|NCT03466502|Vancomycin|vancomycin|mesh-list
154316872|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154316873|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316874|NCT03415555|Acetaminophen|acetaminophen|mesh-list
154316875|NCT03415555|Oxycodone|oxycodone|mesh-list
154316876|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316877|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316878|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154316879|NCT03415555|Analgesics|analgesics|mesh-ancestor
154316880|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
154316881|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950184|NCT03544736|Paclitaxel|paclitaxel|mesh-list
154316882|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
154316883|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154316884|NCT03415555|Narcotics|narcotics|mesh-ancestor
154316885|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
154316886|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154316887|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
154316888|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154316889|NCT03357159|Antibodies|antibodies|mesh-list
154316890|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154316891|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
154316892|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316893|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154316894|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154316895|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
154316896|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316897|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316898|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154316899|NCT03346096|Thiotepa|thiotepa|mesh-list
154316900|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154316901|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
154316902|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316903|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316904|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154316905|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154316906|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
154316907|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316908|NCT03332316|Dexamethasone|dexamethasone|mesh-list
154316909|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
154316910|NCT03332316|Ropivacaine|ropivacaine|mesh-list
154316912|NCT03332316|BB 1101|bb 1101|mesh-list
154316913|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154316914|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
154316915|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
154316916|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316917|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316918|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316920|NCT03332316|Hormones|hormones|mesh-ancestor
154316921|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154316922|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154316923|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316924|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
154316925|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
154316926|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539439|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
154316927|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
154316928|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
154316929|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316930|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316931|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
154316932|NCT03292861|Sirolimus|sirolimus|mesh-list
154316933|NCT03292861|Tacrolimus|tacrolimus|mesh-list
154316934|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
154316935|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154316936|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
154316937|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316938|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154316939|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316940|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316941|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154316942|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316943|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154316944|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
154316945|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154316946|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316947|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
154316948|NCT03283930|Fluoxetine|fluoxetine|mesh-list
154316949|NCT03283930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154316950|NCT03283930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154316951|NCT03283930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154316952|NCT03283930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316953|NCT03283930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316954|NCT03283930|Serotonin Agents|serotonin agents|mesh-ancestor
154316955|NCT03283930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316956|NCT03283930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154861708|NCT03593902|Rituximab|rituximab|mesh-list
154861709|NCT03593902|Fludarabine|fludarabine|mesh-list
154255912|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316957|NCT03283930|Antidepressive Agents|antidepressive agents|mesh-ancestor
154316958|NCT03283930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154316959|NCT03283930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154316960|NCT03283930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154316961|NCT03283930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316962|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
154316963|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316964|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316965|NCT03255018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316966|NCT03255018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316967|NCT03246750|Cisplatin|cisplatin|mesh-list
154316968|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316969|NCT03216733|Sirolimus|sirolimus|mesh-list
154316970|NCT03216733|Temsirolimus|temsirolimus|mesh-list
154316971|NCT03216733|MTOR Inhibitors|mtor inhibitors|mesh-list
154316972|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154316973|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154316974|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154316975|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316976|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
154316977|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154316978|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
154316979|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316980|NCT03216733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154316981|NCT03216733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316982|NCT03216733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316983|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
154316984|NCT03204188|Fludarabine|fludarabine|mesh-list
154316985|NCT03204188|Ibrutinib|ibrutinib|mesh-list
154316987|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316988|NCT03204188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316989|NCT03204188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316990|NCT03204188|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154316991|NCT03204188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154316992|NCT03204188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316994|NCT03179930|Entinostat|entinostat|mesh-list
154316995|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316996|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154316997|NCT03179930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316998|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316999|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154317000|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317001|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154317002|NCT03159754|Metronidazole|metronidazole|mesh-list
154317003|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
154317004|NCT03159754|Tazobactam|tazobactam|mesh-list
154317005|NCT03159754|Piperacillin|piperacillin|mesh-list
154317006|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154317007|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317008|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154317009|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154317010|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154317011|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154317012|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317013|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317014|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317015|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154317016|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154317017|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154317018|NCT03072771|Cytarabine|cytarabine|mesh-list
154317019|NCT03072771|Etoposide|etoposide|mesh-list
154317020|NCT03072771|Melphalan|melphalan|mesh-list
154317021|NCT03072771|Carmustine|carmustine|mesh-list
154317022|NCT03072771|Blinatumomab|blinatumomab|mesh-list
154317023|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154317024|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317025|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154317026|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154317027|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317028|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317029|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317030|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
154861710|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
154861711|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154317032|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317033|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317034|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
154317035|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317036|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154317037|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
154317038|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154317039|NCT03000530|Zuranolone|zuranolone|mesh-list
154317040|NCT03000530|Antidepressive Agents|antidepressive agents|mesh-ancestor
154317041|NCT03000530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154317042|NCT02978781|Zuranolone|zuranolone|mesh-list
154317043|NCT02978781|Antidepressive Agents|antidepressive agents|mesh-ancestor
154317044|NCT02978781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154317045|NCT02943057|Ganciclovir|ganciclovir|mesh-list
154317046|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154317047|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
154317048|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317049|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154317050|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317051|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317052|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
154317053|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154317054|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154317055|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317056|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
154317057|NCT02918201|Coagulants|coagulants|mesh-ancestor
154317058|NCT02804126|Acetaminophen|acetaminophen|mesh-list
154317059|NCT02804126|Dipyrone|dipyrone|mesh-list
154317060|NCT02804126|Ketoprofen|ketoprofen|mesh-list
154317061|NCT02804126|Morphine|morphine|mesh-list
154317072|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317073|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
154317074|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154317075|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317076|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317077|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154317078|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317079|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317084|NCT02726711|Trimethaphan|trimethaphan|mesh-list
154317085|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
154317086|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154317087|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154317088|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154317089|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
154317090|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317091|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317092|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154317093|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154317094|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
154317095|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317096|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317097|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
154317098|NCT02549092|Levodopa|levodopa|mesh-list
154317099|NCT02549092|Carbidopa|carbidopa|mesh-list
154317100|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154317101|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154317102|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154317103|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
154317104|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317105|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317106|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317107|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154317108|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317109|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154317110|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
154317111|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
154317112|NCT02287129|Paclitaxel|paclitaxel|mesh-list
154317113|NCT02287129|Carboplatin|carboplatin|mesh-list
154317114|NCT02287129|Capecitabine|capecitabine|mesh-list
154317115|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
154317116|NCT02287129|Epirubicin|epirubicin|mesh-list
154317117|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154317118|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317119|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
154317120|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
154317121|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
154255389|NCT01149356|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154255390|NCT01149356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154255392|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154255393|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154255394|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950389|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317122|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317123|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317124|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
154317125|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154317126|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154317127|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154317128|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317129|NCT02237183|Iloprost|iloprost|mesh-list
154317130|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154317131|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
154317132|NCT02232386|Rituximab|rituximab|mesh-list
154317133|NCT02232386|Ibrutinib|ibrutinib|mesh-list
154317134|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317137|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317138|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317139|NCT02232386|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154317140|NCT02232386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154317141|NCT02232386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317142|NCT02232386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317144|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317145|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317146|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154317147|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317149|NCT02181738|Nivolumab|nivolumab|mesh-list
154317150|NCT02181738|Dacarbazine|dacarbazine|mesh-list
154317151|NCT02181738|Vinblastine|vinblastine|mesh-list
154317152|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154317153|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317154|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154317155|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154317156|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317157|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317158|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317159|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154317160|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154317161|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
154317162|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154317163|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154317164|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154317165|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154861712|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154317166|NCT01848951|Anesthetics|anesthetics|mesh-list
154317167|NCT01848951|Anesthetics, Local|anesthetics, local|mesh-list
154317168|NCT01848951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317169|NCT01848951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317170|NCT01848951|Sensory System Agents|sensory system agents|mesh-ancestor
154317171|NCT01848951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317172|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154317173|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154317174|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
154317175|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154317176|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317177|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154317178|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154317179|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154317180|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
154861713|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
154861714|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154861715|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
154861716|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861717|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861718|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154861719|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
154317181|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317182|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
154317183|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317184|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317185|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154317186|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
154317187|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317188|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317189|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154317190|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
154317191|NCT01145209|Fludarabine|fludarabine|mesh-list
154317192|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
154317193|NCT01145209|Ofatumumab|ofatumumab|mesh-list
154317194|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317195|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
154317196|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317197|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317198|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154317199|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
154317200|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317201|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317202|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154317203|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317204|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
153496397|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154317205|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154317206|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
154317207|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154317208|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154317209|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154317210|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154317211|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
154317212|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317213|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182219|NCT05717738|Bevacizumab|bevacizumab|mesh-list
154317214|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317215|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154317216|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154317217|NCT00977691|Sirolimus|sirolimus|mesh-list
154317218|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
154317219|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
154317220|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317221|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
154317222|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317223|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317224|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154317225|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
154317226|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317227|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317228|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154317229|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154317230|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317231|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154317232|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
154317233|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317234|NCT00823563|Adenosine|adenosine|mesh-list
154317235|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
154317236|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
154317237|NCT00823563|Analgesics|analgesics|mesh-ancestor
154317238|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
154317239|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317240|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317241|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154317242|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154317243|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
154317244|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
154317245|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317246|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317247|NCT00697684|Clofarabine|clofarabine|mesh-list
154317248|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154317249|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317250|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
154317251|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317252|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317253|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
153950547|NCT01128842|Capecitabine|capecitabine|mesh-list
154317254|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317255|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317256|NCT02252302|Albuterol|albuterol|mesh-list
154317257|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154317258|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
154317259|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317260|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317261|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154317262|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
154317263|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
154317264|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154317265|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154317266|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154317267|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154317268|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
154317269|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317270|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317271|NCT02252614|Acetaminophen|acetaminophen|mesh-list
154317272|NCT02252614|Naproxen|naproxen|mesh-list
154317273|NCT02252614|Codeine|codeine|mesh-list
154317274|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317275|NCT02252614|Analgesics|analgesics|mesh-ancestor
154317276|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
154317277|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317278|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317279|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
154317285|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317286|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317287|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154317289|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317290|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
154317291|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
154317292|NCT02260570|Tolcapone|tolcapone|mesh-list
154317293|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154317294|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154317295|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154317296|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317297|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317298|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
154317299|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317300|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317301|NCT03681951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154317302|NCT03681951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317303|NCT02131948|Insulin|insulin|mesh-list
154317304|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
154317305|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154317306|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317307|NCT02132026|Denosumab|denosumab|mesh-list
154317308|NCT02132026|Alendronate|alendronate|mesh-list
154317309|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154317310|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317311|NCT03735771|Bupivacaine|bupivacaine|mesh-list
154317312|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
154317313|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
154317314|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317315|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317316|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
154317317|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317318|NCT02132104|Hormones|hormones|mesh-list
154317319|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154317320|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317321|NCT00174785|Dronedarone|dronedarone|mesh-list
154317322|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154317323|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
154317324|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154317325|NCT03681093|Growth Substances|growth substances|mesh-ancestor
154317326|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317327|NCT00166439|Cytarabine|cytarabine|mesh-list
154317328|NCT00166439|Dexamethasone|dexamethasone|mesh-list
154317329|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
154317330|NCT00166439|Rituximab|rituximab|mesh-list
154317331|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317332|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
154317333|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
154861720|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317334|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317335|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317336|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154317337|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
154317338|NCT00166439|Hormones|hormones|mesh-ancestor
154317339|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154317340|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154317341|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317342|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317343|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
154317344|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317345|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317346|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
154317347|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496551|NCT00002334|Zidovudine|zidovudine|mesh-list
154317358|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317359|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317360|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
154317361|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
154317362|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154317363|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
154317364|NCT01074905|Amebicides|amebicides|mesh-ancestor
154317365|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317366|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154317367|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317369|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
154317370|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317371|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317372|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317373|NCT01074905|Filaricides|filaricides|mesh-ancestor
154317374|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
154317375|NCT03968237|Buprenorphine|buprenorphine|mesh-list
154317376|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154317377|NCT03968237|Naloxone|naloxone|mesh-list
154317378|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154317379|NCT03968237|Narcotics|narcotics|mesh-ancestor
154317380|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317381|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317382|NCT03968237|Analgesics|analgesics|mesh-ancestor
154317383|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
154317384|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317385|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154317386|NCT00138671|Insulin|insulin|mesh-list
154317387|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154317388|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154317389|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317390|NCT01367158|Vaccines|vaccines|mesh-list
154317391|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
154317392|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317393|NCT00130637|Daclizumab|daclizumab|mesh-list
154317394|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317395|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
154317396|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317397|NCT01077479|Metformin|metformin|mesh-list
154317398|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154317399|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317400|NCT02136784|Morphine|morphine|mesh-list
154317401|NCT02136784|Oxycodone|oxycodone|mesh-list
154317402|NCT02136784|Buprenorphine|buprenorphine|mesh-list
154317403|NCT02136784|Hydromorphone|hydromorphone|mesh-list
154317404|NCT02136784|Hydrocodone|hydrocodone|mesh-list
154317405|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154317406|NCT02136784|Narcotics|narcotics|mesh-ancestor
154317407|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317408|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317409|NCT02136784|Analgesics|analgesics|mesh-ancestor
154317410|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
154317411|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317412|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154317413|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
154317414|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
154317415|NCT02129764|Prednisone|prednisone|mesh-list
154317416|NCT02129764|Allopurinol|allopurinol|mesh-list
154317417|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317418|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
154317419|NCT02129764|Hormones|hormones|mesh-ancestor
153496621|NCT00002376|Zidovudine|zidovudine|mesh-list
154317421|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317422|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154317424|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
154317425|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317426|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317427|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
154317428|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317429|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154317430|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
154317431|NCT02129764|Protective Agents|protective agents|mesh-ancestor
154317432|NCT00130247|Rifampin|rifampin|mesh-list
154317433|NCT00130247|Isoniazid|isoniazid|mesh-list
154317434|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
154317435|NCT00130247|Ethambutol|ethambutol|mesh-list
154317436|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154317437|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
154317438|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154317439|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317440|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
154317441|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154317442|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317443|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317444|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154317445|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154317446|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154317447|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154317448|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154317449|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154317450|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154317451|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154317452|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
154317453|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154317454|NCT02252926|Acetaminophen|acetaminophen|mesh-list
154317455|NCT02252926|Lidocaine|lidocaine|mesh-list
154317456|NCT02252926|Morphine|morphine|mesh-list
154317457|NCT02252926|Gabapentin|gabapentin|mesh-list
154317458|NCT02252926|Bupivacaine|bupivacaine|mesh-list
154317459|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
154317460|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
154317461|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317462|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317463|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
154317464|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317465|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154317466|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154317467|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154317468|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154317469|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317470|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154317471|NCT02252926|Narcotics|narcotics|mesh-ancestor
154317472|NCT02252926|Analgesics|analgesics|mesh-ancestor
154317473|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317474|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
154317475|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
154317476|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154317477|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154317478|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154317479|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154317480|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154317481|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317482|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
154317483|NCT02253004|Cilostazol|cilostazol|mesh-list
154317484|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154317485|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
154317486|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317487|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317488|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154317489|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
154317490|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154317491|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153496681|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154317493|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154317494|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
154317495|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154317496|NCT02253004|Protective Agents|protective agents|mesh-ancestor
154317497|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154255395|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317498|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154317499|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317501|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154317502|NCT02252458|Narcotics|narcotics|mesh-ancestor
154317503|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317504|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317505|NCT02252458|Analgesics|analgesics|mesh-ancestor
154317506|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
154317507|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317508|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154317509|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154317510|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
154317511|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
154317512|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
154317513|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154317514|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
154317515|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317516|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317517|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
154064286|NCT00775294|Maraviroc|maraviroc|mesh-list
154317518|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317520|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154317521|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317522|NCT02132260|Naftifine|naftifine|mesh-list
154317523|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
154317524|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317525|NCT02137564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154317526|NCT02137564|Nirogacestat|nirogacestat|mesh-list
154317527|NCT02137564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317528|NCT02137564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317529|NCT02132416|Acetaminophen|acetaminophen|mesh-list
154317530|NCT02132416|Ibuprofen|ibuprofen|mesh-list
154317531|NCT02132416|Diclofenac|diclofenac|mesh-list
154317532|NCT02132416|Morphine|morphine|mesh-list
154317533|NCT02132416|Oxycodone|oxycodone|mesh-list
154317534|NCT02132416|Tramadol|tramadol|mesh-list
154317535|NCT02132416|Anesthetics|anesthetics|mesh-list
154317536|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317537|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317538|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154317539|NCT02132416|Narcotics|narcotics|mesh-ancestor
154317540|NCT02132416|Analgesics|analgesics|mesh-ancestor
154317541|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
154317542|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317543|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154317544|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317545|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317546|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317547|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154317548|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317549|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317550|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
154317551|NCT00137423|Sunitinib|sunitinib|mesh-list
154317552|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317553|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154317554|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154317555|NCT00137423|Growth Substances|growth substances|mesh-ancestor
154317556|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317557|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
154317558|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154317559|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317560|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317561|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154317562|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
154317563|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317564|NCT02130700|Seviteronel|seviteronel|mesh-list
154317565|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496758|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317568|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317569|NCT02137954|Lidocaine|lidocaine|mesh-list
154317570|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
154317571|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
154317572|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317573|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861721|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861722|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153950824|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154317574|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
154317575|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317576|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154317577|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154317578|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154317579|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154317580|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317581|NCT02131012|Celecoxib|celecoxib|mesh-list
154317582|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154317583|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317584|NCT02131012|Analgesics|analgesics|mesh-ancestor
154317585|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
154317586|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317587|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317588|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317589|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317590|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154317591|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154317592|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317593|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317594|NCT02138500|PF-06372865|pf-06372865|mesh-list
154317595|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
154317596|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
154317597|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317598|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317599|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317600|NCT01561768|Vaccines|vaccines|mesh-list
154317601|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
154182578|NCT04792385|Diuretics|diuretics|mesh-ancestor
154317602|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317603|NCT00137111|Cytarabine|cytarabine|mesh-list
154317604|NCT00137111|Dexamethasone|dexamethasone|mesh-list
154317605|NCT00137111|Prednisone|prednisone|mesh-list
154317606|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
154317607|NCT00137111|Doxorubicin|doxorubicin|mesh-list
154317608|NCT00137111|Methotrexate|methotrexate|mesh-list
154317609|NCT00137111|Etoposide|etoposide|mesh-list
154317610|NCT00137111|Vincristine|vincristine|mesh-list
154317611|NCT00137111|Daunorubicin|daunorubicin|mesh-list
154317612|NCT00137111|Asparaginase|asparaginase|mesh-list
154317613|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
154317614|NCT00137111|Pegaspargase|pegaspargase|mesh-list
154317615|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317616|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
154317617|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317618|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317619|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154317620|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
154317621|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317622|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317623|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154317624|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317625|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
154317626|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
154317627|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317628|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154317629|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
154317630|NCT00137111|Hormones|hormones|mesh-ancestor
154317631|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154317632|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154317633|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154317634|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154317635|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154317636|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317637|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154317638|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
154317639|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154317640|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317641|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
154317642|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
154317643|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154317644|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154861723|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317645|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154317646|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
154317647|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317648|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
154317649|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
154317650|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
154317651|NCT02133118|Pioglitazone|pioglitazone|mesh-list
154317652|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154317653|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317655|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154317656|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317657|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154317658|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
154317659|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
154317660|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317661|NCT00136955|Irinotecan|irinotecan|mesh-list
154317662|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154317663|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154317664|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317665|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317666|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317667|NCT00135707|Vitamins|vitamins|mesh-list
154317668|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
154317669|NCT00135707|Vitamin E|vitamin e|mesh-list
154317670|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
154317671|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
154317672|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317673|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
154317674|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317675|NCT00135707|Protective Agents|protective agents|mesh-ancestor
154317676|NCT03548818|Interferons|interferons|mesh-list
154317677|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
154317678|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317679|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
154317680|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317681|NCT02252692|Enalapril|enalapril|mesh-list
154317682|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154317683|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
154317684|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317685|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317686|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154317687|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
154317688|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154317689|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
154317690|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317691|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
154317692|NCT03548662|Protective Agents|protective agents|mesh-ancestor
154317693|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154317694|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317695|NCT03966209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317696|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317697|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
154317698|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154317699|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
154317700|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317701|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317702|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154317703|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
154317704|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154317705|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
154317706|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317707|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317708|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154317709|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
154317710|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
154317711|NCT02252770|Protective Agents|protective agents|mesh-ancestor
154317712|NCT05578456|Aspirin|aspirin|mesh-list
154317713|NCT05578456|Prednisone|prednisone|mesh-list
154317714|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317717|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154317718|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317719|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154317720|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317721|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154317722|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317723|NCT05578456|Analgesics|analgesics|mesh-ancestor
154317724|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
154317725|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317726|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317727|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154317728|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154317729|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317730|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154317731|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154317732|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317733|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
154317734|NCT02133820|Analgesics|analgesics|mesh-list
154317735|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
154317736|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317737|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317738|NCT05578378|Cytarabine|cytarabine|mesh-list
154317739|NCT05578378|Methotrexate|methotrexate|mesh-list
154317740|NCT05578378|Fludarabine|fludarabine|mesh-list
154317741|NCT05578378|Cladribine|cladribine|mesh-list
154317742|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154317743|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
154317744|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154317745|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317746|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317747|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
154317748|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317749|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317750|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
154317751|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317752|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154317753|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317754|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
154317755|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317756|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154317757|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
154317758|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317759|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
154317760|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154317761|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317762|NCT02139904|Vinorelbine|vinorelbine|mesh-list
154317763|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154317764|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317765|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154317766|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
154317767|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
154317768|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317769|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
154317770|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317771|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317772|NCT05578222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154317773|NCT05578222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317774|NCT00129545|Warfarin|warfarin|mesh-list
154317775|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
154317776|NCT02134288|Everolimus|everolimus|mesh-list
154317777|NCT02134288|Abatacept|abatacept|mesh-list
154317778|NCT02134288|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154317779|NCT02134288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154317780|NCT02134288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317781|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317782|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317783|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
154317784|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317785|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317786|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154317787|NCT02134288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317790|NCT00129467|Serotonin|serotonin|mesh-list
154317791|NCT00129467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154317792|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154317793|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317794|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154317795|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154317796|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154317797|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317798|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
154317799|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255396|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154317800|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154317801|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
154317802|NCT00129311|Selegiline|selegiline|mesh-list
154317803|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
154317804|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154317805|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154317806|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154317807|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154317808|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317809|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317810|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154317811|NCT00129311|Protective Agents|protective agents|mesh-ancestor
154317812|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317813|NCT01076621|Norethindrone|norethindrone|mesh-list
154317814|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
154317815|NCT01076621|Estradiol|estradiol|mesh-list
154317816|NCT01076621|Estrogens|estrogens|mesh-ancestor
154317817|NCT01076621|Hormones|hormones|mesh-ancestor
154582970|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317818|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027398|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
154317819|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317820|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154317822|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154317823|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154317824|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154317825|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154317826|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154317827|NCT03965819|Acetaminophen|acetaminophen|mesh-list
154317828|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154317829|NCT03965819|Analgesics|analgesics|mesh-ancestor
154317830|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
154317831|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317832|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317833|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
154317834|NCT02134366|Lorazepam|lorazepam|mesh-list
154317835|NCT02134366|Clonazepam|clonazepam|mesh-list
154317836|NCT02134366|Clobazam|clobazam|mesh-list
154317837|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
154317838|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
154317839|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
154317840|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317841|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317842|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154317843|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154317844|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317845|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154317846|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154317847|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154317848|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
154317849|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
154317850|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317851|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317852|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154317853|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
154317854|NCT01077947|Anesthetics|anesthetics|mesh-list
154317855|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317856|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317857|NCT00133991|Leucovorin|leucovorin|mesh-list
154317858|NCT00133991|Cytarabine|cytarabine|mesh-list
154317859|NCT00133991|Prednisone|prednisone|mesh-list
154317860|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
154317861|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
154317862|NCT00133991|Rituximab|rituximab|mesh-list
154317863|NCT00133991|Methotrexate|methotrexate|mesh-list
154317879|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154317880|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154317881|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
154317882|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154317883|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317884|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
154317885|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
154317886|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317887|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154317888|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154317889|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
154317890|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861724|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317892|NCT00133991|Protective Agents|protective agents|mesh-ancestor
154317893|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
154317894|NCT00133991|Vitamins|vitamins|mesh-ancestor
154317895|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
154317896|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154317897|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154317898|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154317899|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154317900|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154317901|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
154317902|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317903|NCT02140450|Timolol|timolol|mesh-list
154317904|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154317905|NCT02140450|Mannitol|mannitol|mesh-list
154317906|NCT02140450|Acetazolamide|acetazolamide|mesh-list
154317907|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154317908|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154317909|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
154317910|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317911|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317912|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317913|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154317914|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154317915|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154317916|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154317917|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154317918|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154317919|NCT02140450|Diuretics|diuretics|mesh-ancestor
154317920|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
154317921|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
154317922|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154317928|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154317929|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154317930|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
154317931|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317932|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317933|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154317934|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154317935|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
154317936|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317937|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154317938|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154317939|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
154317940|NCT02134990|Docetaxel|docetaxel|mesh-list
154317941|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317942|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
154317943|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
154317944|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
154317945|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317946|NCT02135224|Fentanyl|fentanyl|mesh-list
154317947|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154317948|NCT02135224|Narcotics|narcotics|mesh-ancestor
154317949|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317950|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317951|NCT02135224|Analgesics|analgesics|mesh-ancestor
154317952|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
154317953|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317954|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154317955|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154317956|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
154317957|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
154317958|NCT02785900|Azacitidine|azacitidine|mesh-list
154317959|NCT02785900|Decitabine|decitabine|mesh-list
154317960|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154317961|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
154317962|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317963|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317964|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317965|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
154317966|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
154317967|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
154317968|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154317969|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317970|NCT02135770|Heparin|heparin|mesh-list
154317971|NCT02135770|Calcium heparin|calcium heparin|mesh-list
154317972|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
153708775|NCT05190471|Decitabine|decitabine|mesh-list
154317973|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154317974|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154317975|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317976|NCT05478850|Anesthetics|anesthetics|mesh-list
154317977|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317978|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317979|NCT01560754|Nicotine|nicotine|mesh-list
154317980|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154317981|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
154317982|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317983|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317984|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154317985|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154317986|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
154317987|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154317988|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317989|NCT03547804|Apatinib|apatinib|mesh-list
154317990|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317991|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154317992|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317993|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317994|NCT02217267|Lidocaine|lidocaine|mesh-list
154317995|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
154317996|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
154317998|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318000|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318001|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154318002|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154318003|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154318004|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318005|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318006|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
154318007|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
154318008|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154318009|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318010|NCT03546400|Methylphenidate|methylphenidate|mesh-list
154318011|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154318012|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318013|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154318014|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154318015|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318016|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318017|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
154318018|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318019|NCT03669861|Abatacept|abatacept|mesh-list
154318020|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154318021|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318022|NCT03669861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154318023|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318024|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154318025|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
154318026|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318027|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318028|NCT00127127|Vorinostat|vorinostat|mesh-list
154318029|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318030|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154318031|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318032|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318033|NCT00126659|Sorafenib|sorafenib|mesh-list
154318034|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318035|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318036|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318037|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318038|NCT03669081|Ketorolac|ketorolac|mesh-list
154318039|NCT03669081|Pregabalin|pregabalin|mesh-list
154318040|NCT03669081|Analgesics|analgesics|mesh-ancestor
154318041|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
154318042|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318043|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318044|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
154861725|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
154318045|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154861726|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
154318046|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318047|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318048|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154318049|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154318050|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154318051|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318052|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154318053|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154318054|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154318055|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318056|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318057|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154318058|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318059|NCT02253940|Ritonavir|ritonavir|mesh-list
154318060|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154318061|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154318062|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
154318063|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318064|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318065|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154318066|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154318072|NCT02253550|Simeprevir|simeprevir|mesh-list
154318073|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
154318074|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318075|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
154318076|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318077|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318078|NCT05203432|Atropine|atropine|mesh-list
154318079|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154318080|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154318081|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154318082|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
154318083|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318084|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318085|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154318086|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318087|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
154318088|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
154318089|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154318090|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154318091|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
154318092|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318093|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318094|NCT03667053|Glucagon|glucagon|mesh-list
154318095|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318096|NCT03667053|Hormones|hormones|mesh-ancestor
154318097|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154318098|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318099|NCT04589728|Venetoclax|venetoclax|mesh-list
154318100|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318101|NCT05557240|Poly I-C|poly i-c|mesh-list
154318102|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154318103|NCT05557240|Vaccines|vaccines|mesh-list
154318104|NCT05557240|Poly ICLC|poly iclc|mesh-list
154318105|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
154318106|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318107|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
154318108|NCT05557240|Laxatives|laxatives|mesh-ancestor
154318109|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318110|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
154318111|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318112|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
154318113|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154318114|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318115|NCT03631407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154318116|NCT03631407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318117|NCT03547024|Midazolam|midazolam|mesh-list
154318118|NCT03547024|Levomethorphan|levomethorphan|mesh-list
154318119|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
154318120|NCT03547024|Omeprazole|omeprazole|mesh-list
154064879|NCT00876395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318121|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
154318122|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154318123|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154318124|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
154318125|NCT03547024|Estradiol|estradiol|mesh-list
154318126|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154318127|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154318128|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318129|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318130|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154318131|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154318132|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154318133|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154318134|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
154318135|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
154318136|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
154318137|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
154318138|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318140|NCT03547024|Estrogens|estrogens|mesh-ancestor
154318142|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154318143|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154318144|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
154318145|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154318146|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154318147|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154318148|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318149|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154318150|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318151|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154318152|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154318153|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154318154|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
154318155|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318156|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154318157|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154318158|NCT03547024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154318159|NCT03547024|Narcotics|narcotics|mesh-ancestor
154318160|NCT03547024|Analgesics|analgesics|mesh-ancestor
154318161|NCT03547024|Sensory System Agents|sensory system agents|mesh-ancestor
154318162|NCT03547024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318163|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154318164|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
154318165|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154318166|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154318167|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
154318168|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
154318169|NCT04012996|Meloxicam|meloxicam|mesh-list
154318170|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154318171|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154318172|NCT04012996|Analgesics|analgesics|mesh-ancestor
154318173|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
154318174|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318175|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183136|NCT02162810|Prednisolone|prednisolone|mesh-list
154318176|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318177|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318178|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154318179|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154318180|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318181|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318182|NCT02253784|Dexamethasone|dexamethasone|mesh-list
154318183|NCT02253784|Bupivacaine|bupivacaine|mesh-list
154318184|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318185|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
154318186|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
154318187|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318188|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318189|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318190|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
154318191|NCT02253784|Hormones|hormones|mesh-ancestor
154318192|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154318193|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154318194|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318195|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
154318196|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
154064970|NCT00685607|Loperamide|loperamide|mesh-list
154318197|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318198|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
154318199|NCT03734445|Vitamins|vitamins|mesh-list
154318200|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
154318201|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951423|NCT02819856|Ebselen|ebselen|mesh-list
154318202|NCT03546088|Anesthetics|anesthetics|mesh-list
154318203|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318204|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318205|NCT03866980|Carboplatin|carboplatin|mesh-list
154318206|NCT03866980|Pemetrexed|pemetrexed|mesh-list
154318207|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318208|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318209|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318210|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154318225|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154318227|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154318228|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154318229|NCT02253862|Urological Agents|urological agents|mesh-ancestor
154318230|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154318231|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154318232|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154318233|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318234|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318235|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154318236|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154318237|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154318238|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154318239|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
154318240|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318241|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318242|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154318243|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154318244|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
154318245|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154318246|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154318247|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
154318248|NCT03776656|Allopurinol|allopurinol|mesh-list
154318249|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
154318250|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318251|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318252|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
154318253|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318254|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154318255|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
154318256|NCT03776656|Protective Agents|protective agents|mesh-ancestor
154318257|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318258|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
154318259|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154318260|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
154318261|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318262|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318263|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154318264|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
154318265|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318266|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318267|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154318268|NCT00126581|Paclitaxel|paclitaxel|mesh-list
154318269|NCT00126581|Carboplatin|carboplatin|mesh-list
154318270|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154318271|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154318272|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154318273|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318274|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
154318275|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
154318276|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
154318277|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318278|NCT00126581|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154318279|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318280|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318281|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
154318282|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154318283|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154318284|NCT03704584|Prednisolone|prednisolone|mesh-list
154318285|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
154318286|NCT03704584|Lidocaine|lidocaine|mesh-list
154318287|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154318288|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
154318289|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
154861727|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951508|NCT00911625|Insulin|insulin|mesh-list
154318290|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
154318291|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318292|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318293|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
154318294|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318295|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154318296|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154318297|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154318298|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318299|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318300|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183245|NCT06049966|Etoposide|etoposide|mesh-list
154318301|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
154318302|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
154318303|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318304|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
154318305|NCT03704584|Hormones|hormones|mesh-ancestor
154318306|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154318307|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154318308|NCT03704584|Protective Agents|protective agents|mesh-ancestor
154318309|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154318310|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318311|NCT03737721|Avelumab|avelumab|mesh-list
154318312|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154318313|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318314|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
154318315|NCT03647709|Narcotics|narcotics|mesh-ancestor
154318316|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318317|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318318|NCT03647709|Analgesics|analgesics|mesh-ancestor
154318319|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
154318320|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318321|NCT03546634|Vaccines|vaccines|mesh-list
154318322|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
154318323|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318324|NCT03661983|Aripiprazole|aripiprazole|mesh-list
154318325|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
154318326|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154318327|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154318328|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154318329|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318330|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318331|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
154318332|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
154318333|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318334|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318335|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154318336|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154318337|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
154318338|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154318339|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154318340|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154318341|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154318342|NCT02783170|Vaccines|vaccines|mesh-list
154318343|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
154318346|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
154318347|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154318348|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318349|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154318350|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
154318351|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154318352|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318353|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154318355|NCT02254018|Immunoconjugates|immunoconjugates|mesh-ancestor
154318356|NCT02254018|Immunologic Factors|immunologic factors|mesh-ancestor
154318357|NCT02254018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318358|NCT03396952|Aspirin|aspirin|mesh-list
154318359|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
154318360|NCT03396952|Ipilimumab|ipilimumab|mesh-list
154318361|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154318362|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318363|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154318364|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861728|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318365|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154318366|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154318368|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
154318369|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318370|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318371|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318372|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318373|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154318374|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154318375|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154318376|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154318377|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318378|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
154318379|NCT03378934|Aspirin|aspirin|mesh-list
154318380|NCT03378934|Clopidogrel|clopidogrel|mesh-list
154318381|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154318382|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154318383|NCT03378934|Analgesics|analgesics|mesh-ancestor
154318384|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
154318385|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318386|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318387|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318388|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318389|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154318390|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154318391|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318392|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154318393|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154318394|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318395|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
154318396|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154318397|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154318398|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154318399|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
154318400|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318401|NCT00126503|Bevacizumab|bevacizumab|mesh-list
154318402|NCT00126503|Sorafenib|sorafenib|mesh-list
154318403|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154318404|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318405|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154318406|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154318407|NCT00126503|Growth Substances|growth substances|mesh-ancestor
154318408|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318409|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
154318410|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318411|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318412|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318413|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154318414|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318415|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318417|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154318418|NCT00126191|Leucovorin|leucovorin|mesh-list
154318419|NCT00126191|Cytarabine|cytarabine|mesh-list
154318420|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
154318422|NCT00126191|Rituximab|rituximab|mesh-list
154318423|NCT00126191|Doxorubicin|doxorubicin|mesh-list
154318424|NCT00126191|Methotrexate|methotrexate|mesh-list
154318425|NCT00126191|Etoposide|etoposide|mesh-list
154318426|NCT00126191|Vincristine|vincristine|mesh-list
154318427|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154318428|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
154318429|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318430|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318431|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154318432|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
154318433|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318434|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318435|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154318436|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154318437|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154318438|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154318439|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154318440|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318441|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154318442|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
154318443|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154318444|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154318445|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
154318446|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
154318447|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154318448|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154318449|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154318450|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
154318451|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318452|NCT00126191|Antidotes|antidotes|mesh-ancestor
154318453|NCT00126191|Protective Agents|protective agents|mesh-ancestor
154318454|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
154318455|NCT00126191|Vitamins|vitamins|mesh-ancestor
154318456|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
154318457|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
154318458|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
154318459|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
154318460|NCT00124943|Paclitaxel|paclitaxel|mesh-list
154318461|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154318462|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154318463|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318464|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
154318465|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
154318466|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
154318467|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318468|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
154318469|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154318470|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154318471|NCT00124709|Analgesics|analgesics|mesh-ancestor
154318472|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
154318473|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318474|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318475|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318476|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318477|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
154318478|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154318479|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
154318480|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154318481|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318482|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318483|NCT04139434|Azacitidine|azacitidine|mesh-list
154318484|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154318485|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
154318486|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318487|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318488|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318489|NCT03058354|Propofol|propofol|mesh-list
154318490|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
154318491|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318494|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154318495|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
154318497|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154318498|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154318499|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
154318500|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318501|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318502|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318503|NCT02143570|Urological Agents|urological agents|mesh-ancestor
154318504|NCT02143804|Molgramostim|molgramostim|mesh-list
154318505|NCT02143804|Sargramostim|sargramostim|mesh-list
154318506|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
154318507|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318508|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318509|NCT03544996|Insulin|insulin|mesh-list
154318510|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154318511|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318512|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154318513|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
154318514|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154318515|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
154318516|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154318517|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318518|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154318519|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154318520|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255397|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
154318521|NCT02144194|Docetaxel|docetaxel|mesh-list
154318522|NCT02144194|Vinorelbine|vinorelbine|mesh-list
154318523|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318524|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
154318525|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
154318526|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
154318527|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318528|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154318529|NCT02140840|Trametinib|trametinib|mesh-list
154318530|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318531|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318532|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183481|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154318533|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318534|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
154318535|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318536|NCT00108160|Mupirocin|mupirocin|mesh-list
154318537|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154318538|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318539|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154318540|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318541|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318542|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
154318543|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154318544|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154318545|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
154318546|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318547|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318548|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154318549|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318550|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
154318551|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154318552|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
154318553|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318554|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318555|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154318556|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154318557|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154318558|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
154318559|NCT03545308|Rocuronium|rocuronium|mesh-list
154318560|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154318561|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154318562|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154318563|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318564|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318566|NCT00108082|Carvedilol|carvedilol|mesh-list
154318567|NCT00108082|Lisinopril|lisinopril|mesh-list
154318568|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154318569|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154318570|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
154318571|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318572|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318573|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318574|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154318576|NCT00108082|Protective Agents|protective agents|mesh-ancestor
154318577|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154318578|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318579|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154318580|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
154318581|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154318582|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154318583|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154318584|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
154318585|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318586|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154318587|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154318588|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
154318589|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
154318590|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318591|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154318592|NCT02144662|Ranibizumab|ranibizumab|mesh-list
154318593|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154318594|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154861729|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
154318595|NCT02144662|Growth Substances|growth substances|mesh-ancestor
154318596|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318597|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
154318598|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318599|NCT02141698|Esomeprazole|esomeprazole|mesh-list
154318600|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154318601|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318602|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154318603|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318604|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318605|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154318606|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
154318607|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154318608|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
154318609|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154318610|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318611|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154318612|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154318613|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318614|NCT02147938|Tacrolimus|tacrolimus|mesh-list
154318615|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154318616|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
154318617|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318618|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154318619|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318620|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318621|NCT02148016|Levofloxacin|levofloxacin|mesh-list
154318622|NCT02148016|Betamethasone|betamethasone|mesh-list
154318623|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154318624|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318625|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154318626|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154318627|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154318628|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318629|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318630|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318631|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154318632|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154318633|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318634|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
154318635|NCT02148016|Hormones|hormones|mesh-ancestor
154318636|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497853|NCT00002802|Cobalt|cobalt|mesh-list
154318639|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318641|NCT02148094|Emtricitabine|emtricitabine|mesh-list
154318642|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154318643|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
154318644|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318645|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154318646|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154318647|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318648|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318649|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154318650|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154318651|NCT02148328|Vaccines|vaccines|mesh-list
154318652|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
154318653|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318654|NCT02142010|Paclitaxel|paclitaxel|mesh-list
154318655|NCT02142010|Cisplatin|cisplatin|mesh-list
154318656|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154318657|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318658|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
154318659|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154318660|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154318661|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318662|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
154318663|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154318664|NCT03543826|Rocuronium|rocuronium|mesh-list
154318665|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154318666|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154318667|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154318668|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318669|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318670|NCT02148640|Infliximab|infliximab|mesh-list
154318671|NCT02148640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154318672|NCT02148640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318673|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
154318674|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318675|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154318676|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154318677|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
154318678|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154318679|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154318680|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154318681|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318682|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318683|NCT02142634|Budesonide|budesonide|mesh-list
154318684|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318685|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154318686|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
154318687|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318688|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318689|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154318690|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318691|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
154318692|NCT02142634|Hormones|hormones|mesh-ancestor
154318693|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154318694|NCT02142790|Paclitaxel|paclitaxel|mesh-list
154318695|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154318696|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318697|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
154318698|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
154318699|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
154318700|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318701|NCT02142868|Letrozole|letrozole|mesh-list
154318702|NCT02142868|Palbociclib|palbociclib|mesh-list
154318703|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318704|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154318705|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154318706|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318707|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318708|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154318711|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318712|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318713|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
154318714|NCT02145520|Analgesics|analgesics|mesh-ancestor
154318715|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
154318716|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318717|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318718|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
154318719|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318720|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154318721|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
154318722|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154318723|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318724|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318725|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154318726|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
154318727|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154318728|NCT02145598|Lenalidomide|lenalidomide|mesh-list
154318729|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
154318730|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318731|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154318732|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154318733|NCT02145598|Growth Substances|growth substances|mesh-ancestor
154318734|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
154318735|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318736|NCT02145832|Fluconazole|fluconazole|mesh-list
154318737|NCT02145832|Micafungin|micafungin|mesh-list
154318738|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
154318739|NCT02145832|Clotrimazole|clotrimazole|mesh-list
154318740|NCT02145832|Miconazole|miconazole|mesh-list
154318741|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318742|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154318743|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154318744|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318745|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318746|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154318747|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
154318748|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154318749|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318750|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154318751|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154318752|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154318753|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154318754|NCT00104728|Gefitinib|gefitinib|mesh-list
154318755|NCT00104728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154318756|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318757|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318758|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318759|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318760|NCT02145910|Vemurafenib|vemurafenib|mesh-list
154318761|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318762|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318763|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318764|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318765|NCT02146222|Docetaxel|docetaxel|mesh-list
154318766|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318767|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
154318768|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
154318769|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
154318770|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318771|NCT02146300|Xylometazoline|xylometazoline|mesh-list
154318772|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
154318773|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154318774|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318775|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
154318776|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154318777|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154318778|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318780|NCT02146456|Coagulants|coagulants|mesh-ancestor
154318781|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
154318782|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154318783|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318784|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318785|NCT02151916|Fluorides|fluorides|mesh-list
154318786|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
154318787|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
154318788|NCT02151916|Protective Agents|protective agents|mesh-ancestor
154318789|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318790|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
154318791|NCT02146846|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154065552|NCT00769210|Simvastatin|simvastatin|mesh-list
154318792|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318793|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318794|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318795|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318796|NCT02152228|Teriparatide|teriparatide|mesh-list
154318797|NCT02152228|Hormones|hormones|mesh-list
154318798|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
154318799|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154318800|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318801|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154318802|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154318803|NCT02152306|Amlodipine|amlodipine|mesh-list
154318804|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154318805|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154318806|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318807|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318808|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154318809|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318810|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
154318811|NCT02261116|Telmisartan|telmisartan|mesh-list
154318812|NCT02261116|Candesartan|candesartan|mesh-list
154318813|NCT02261116|Candesartan cilexetil|candesartan cilexetil|mesh-list
154318814|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154318815|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154318816|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154318817|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318818|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154318819|NCT02147548|Lorazepam|lorazepam|mesh-list
154255913|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154318821|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
154318822|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
154318823|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
154318824|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318825|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318826|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154318827|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154318828|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318829|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154318830|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154318831|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154318832|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
154318833|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
154318834|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318835|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318836|NCT00122681|Vaccines|vaccines|mesh-list
154318837|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
154318838|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318839|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154318840|NCT02774278|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154318841|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318842|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318843|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318844|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318845|NCT03733275|Lidocaine|lidocaine|mesh-list
154318846|NCT03733275|Bupivacaine|bupivacaine|mesh-list
154318847|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
154318848|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
154318849|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318850|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318851|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
154318853|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154318854|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154318855|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154318856|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154318857|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318858|NCT03542422|Apatinib|apatinib|mesh-list
154318859|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318860|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318861|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318862|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318863|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154065641|NCT04136639|Fluorides|fluorides|mesh-list
154318864|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
154318865|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154318867|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
154318868|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318869|NCT03645057|Tacrolimus|tacrolimus|mesh-list
154318870|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154318871|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
154318872|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318873|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154318874|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318875|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318876|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
154318877|NCT04863430|Apatinib|apatinib|mesh-list
154318878|NCT04863430|Tegafur|tegafur|mesh-list
154318879|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318880|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318881|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318882|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318883|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154318884|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
154318885|NCT05665881|Phenylephrine|phenylephrine|mesh-list
154318886|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
154318887|NCT05665881|Norepinephrine|norepinephrine|mesh-list
154318888|NCT05665881|Ephedrine|ephedrine|mesh-list
154318889|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154318890|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
154318891|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
154318892|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318893|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318894|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
154861730|NCT03593902|Hormones|hormones|mesh-ancestor
154318896|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
154318897|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318898|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154318899|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154318900|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154318901|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
154318902|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318903|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318904|NCT05665881|Protective Agents|protective agents|mesh-ancestor
154318905|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154318906|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
154318907|NCT03643575|Guaifenesin|guaifenesin|mesh-list
154318908|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154318909|NCT03643575|Expectorants|expectorants|mesh-ancestor
154318910|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318911|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154318912|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154318913|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
154318914|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318915|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318916|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318917|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
154318918|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154318919|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
154318920|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
154318921|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318922|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
154318923|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154318924|NCT02768194|Fluorides|fluorides|mesh-list
154318925|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
154318927|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
154318928|NCT02768194|Protective Agents|protective agents|mesh-ancestor
154318929|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318931|NCT02254954|Macitentan|macitentan|mesh-list
154318932|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154318933|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
154318934|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318935|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318936|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154318937|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154318938|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154318939|NCT00130793|Vaccines|vaccines|mesh-list
154318940|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
154318941|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318942|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
154318943|NCT02154334|Phenylephrine|phenylephrine|mesh-list
154318944|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
154318945|NCT02154334|Esketamine|esketamine|mesh-list
154318946|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154318947|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
154318948|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154318949|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
154318950|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154318951|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154318952|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154318953|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
154318954|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154318955|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318956|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318957|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
154318958|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
154318959|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318960|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
154318961|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154318962|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
154318963|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154318964|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
154318965|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154318966|NCT02154334|Protective Agents|protective agents|mesh-ancestor
154318967|NCT01078961|Bortezomib|bortezomib|mesh-list
154318968|NCT01078961|Sorafenib|sorafenib|mesh-list
154318969|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318970|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318971|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318972|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318974|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154318975|NCT03818399|Narcotics|narcotics|mesh-ancestor
154318976|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318977|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318978|NCT03818399|Analgesics|analgesics|mesh-ancestor
154318979|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
154318980|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318981|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154318982|NCT02154646|Gemcitabine|gemcitabine|mesh-list
154318983|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154318984|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
154318985|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318986|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154318987|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
154318988|NCT03642873|Hydrocodone|hydrocodone|mesh-list
154318989|NCT03642873|Guaifenesin|guaifenesin|mesh-list
154318990|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154318991|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154318992|NCT03642873|Narcotics|narcotics|mesh-ancestor
154318993|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154318994|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318995|NCT03642873|Analgesics|analgesics|mesh-ancestor
154318996|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
154318997|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318998|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
154318999|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
154319000|NCT03642873|Expectorants|expectorants|mesh-ancestor
154319004|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154319005|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319006|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
154319007|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154319008|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
154319009|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
154319010|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
154319011|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154319012|NCT01079819|BMS 708163|bms 708163|mesh-list
154183958|NCT06082388|Mydriatics|mydriatics|mesh-ancestor
154319013|NCT01079819|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154319014|NCT01079819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319015|NCT01079819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319016|NCT02156596|Ketoprofen|ketoprofen|mesh-list
154319017|NCT02156596|Morphine|morphine|mesh-list
154319018|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154319019|NCT02156596|Narcotics|narcotics|mesh-ancestor
154319020|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319021|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319022|NCT02156596|Analgesics|analgesics|mesh-ancestor
154319023|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
154319024|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319025|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154319026|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319027|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319028|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319029|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154319030|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319031|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319032|NCT01079117|Morphine|morphine|mesh-list
154319033|NCT01079117|Methadone|methadone|mesh-list
154319034|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154319035|NCT01079117|Narcotics|narcotics|mesh-ancestor
154319036|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319037|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319038|NCT01079117|Analgesics|analgesics|mesh-ancestor
154319039|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
154319040|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319041|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
154319042|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
154319043|NCT03732963|Melatonin|melatonin|mesh-list
154319044|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
154319045|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319046|NCT03732963|Protective Agents|protective agents|mesh-ancestor
154319047|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319048|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319050|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
154319051|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
154319052|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154319053|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319054|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319055|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
154319056|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319057|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319058|NCT04996719|Sirolimus|sirolimus|mesh-list
154319059|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319060|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319061|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154319062|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319063|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
154319064|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319065|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
154319066|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319067|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
154319068|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319069|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319070|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
154319071|NCT02770612|Narcotics|narcotics|mesh-ancestor
154319072|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319073|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319079|NCT03542110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154319080|NCT03542110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154319081|NCT03542110|Antimetabolites|antimetabolites|mesh-ancestor
154319082|NCT03542110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319083|NCT03542110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154319084|NCT03542110|Protease Inhibitors|protease inhibitors|mesh-ancestor
154319085|NCT03542110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319086|NCT03542110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154319087|NCT03575871|Abrocitinib|abrocitinib|mesh-list
154319088|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319089|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319090|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319091|NCT02155504|Itraconazole|itraconazole|mesh-list
154319092|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
154319094|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154319095|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154319096|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319097|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319098|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154319099|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
154319100|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319101|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319102|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154319103|NCT03642717|Empagliflozin|empagliflozin|mesh-list
154319104|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154319105|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319106|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319107|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319108|NCT02766478|Genistein|genistein|mesh-list
154319109|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154319110|NCT02766478|Protective Agents|protective agents|mesh-ancestor
154319111|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319112|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319113|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319114|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319115|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319116|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
154319117|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154319118|NCT02766478|Estrogens|estrogens|mesh-ancestor
154319119|NCT02766478|Hormones|hormones|mesh-ancestor
154319120|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319121|NCT03729375|Bupivacaine|bupivacaine|mesh-list
154319122|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
154319123|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
154319124|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319125|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319126|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
153952332|NCT00805285|Budesonide|budesonide|mesh-list
154319127|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319128|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154319129|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154319130|NCT02159326|Riociguat|riociguat|mesh-list
154319131|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
154319132|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319133|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154319134|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
154319135|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154319136|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319137|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154319138|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154319139|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154319140|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153498356|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
154319158|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319159|NCT00104416|Lamotrigine|lamotrigine|mesh-list
154319160|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
154319161|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154319162|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154319163|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319164|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154319166|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154319167|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154319168|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319169|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154319170|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154319172|NCT02149888|Emtricitabine|emtricitabine|mesh-list
154319173|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
154319174|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319175|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154319176|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154319177|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319178|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319179|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154319180|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154319181|NCT03639675|Aflibercept|aflibercept|mesh-list
154319182|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154319183|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154319184|NCT03639675|Growth Substances|growth substances|mesh-ancestor
154319185|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319186|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
154319187|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319188|NCT03543436|Meropenem|meropenem|mesh-list
154319189|NCT03543436|Imipenem|imipenem|mesh-list
154319190|NCT03543436|Temocillin|temocillin|mesh-list
154319191|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319192|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319193|NCT02149966|Mitapivat|mitapivat|mesh-list
154319194|NCT02149966|Enzyme Activators|enzyme activators|mesh-ancestor
154319195|NCT02149966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319196|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
154319197|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
153498426|NCT00003252|Protective Agents|protective agents|mesh-ancestor
154319207|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319208|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319209|NCT03541798|Anesthetics|anesthetics|mesh-list
154319210|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319211|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319212|NCT02150122|Vitamin D|vitamin d|mesh-list
154319213|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
154319214|NCT02150122|Vitamins|vitamins|mesh-ancestor
154319215|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
154319216|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319217|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154319218|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154319219|NCT03728829|Carboplatin|carboplatin|mesh-list
154319220|NCT03728829|Docetaxel|docetaxel|mesh-list
154319221|NCT03728829|Trastuzumab|trastuzumab|mesh-list
154319222|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319223|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
154319224|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
154319225|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
154861731|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319226|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319227|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154319229|NCT00121667|Pioglitazone|pioglitazone|mesh-list
154319230|NCT00121667|Saxagliptin|saxagliptin|mesh-list
154319231|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154184164|NCT06012175|Melatonin|melatonin|mesh-list
154319232|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319233|NCT00121667|Incretins|incretins|mesh-ancestor
154319234|NCT00121667|Hormones|hormones|mesh-ancestor
154319235|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319236|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154319237|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
154319238|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319239|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319241|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154319242|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319243|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319244|NCT00121199|Prednisone|prednisone|mesh-list
154319245|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
154319246|NCT00121199|Bevacizumab|bevacizumab|mesh-list
154319247|NCT00121199|Rituximab|rituximab|mesh-list
154319248|NCT00121199|Doxorubicin|doxorubicin|mesh-list
154319249|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154319250|NCT00121199|Vincristine|vincristine|mesh-list
154319251|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154319252|NCT00121199|Antibodies|antibodies|mesh-list
154319253|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
154319254|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154319255|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319256|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
154319257|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319258|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319259|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154319260|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
154319261|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319262|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319263|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154319264|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154319265|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153498486|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
154319282|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319284|NCT00119015|Xhance|xhance|mesh-list
154319285|NCT00119015|Montelukast|montelukast|mesh-list
154319286|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319287|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154319288|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
154319289|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319290|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319291|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154319292|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
154319293|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
154319294|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154319295|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154319296|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
154319297|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319298|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154319299|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154319300|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319301|NCT03557307|Benralizumab|benralizumab|mesh-list
154319302|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154319303|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
154319304|NCT01079351|Carbamazepine|carbamazepine|mesh-list
154319305|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
154319306|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
154319307|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154319308|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319309|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319310|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154319311|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319312|NCT01079351|Analgesics|analgesics|mesh-ancestor
154319313|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
154066074|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
154319314|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319315|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154319316|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952468|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
154319317|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319318|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154319319|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154319320|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
154319321|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154319323|NCT02158624|Ranibizumab|ranibizumab|mesh-list
154319324|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154319325|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154319326|NCT02158624|Growth Substances|growth substances|mesh-ancestor
154319327|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319328|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
154319329|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319330|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
154319331|NCT00115739|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154319332|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319333|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319334|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319335|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319336|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
154319337|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
154319338|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319339|NCT03639519|Protective Agents|protective agents|mesh-ancestor
154319340|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319341|NCT03639519|Vitamins|vitamins|mesh-ancestor
154319342|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
154319343|NCT02158702|Dexamethasone|dexamethasone|mesh-list
154319344|NCT02158702|Pomalidomide|pomalidomide|mesh-list
154319345|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319346|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
154319347|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
154319348|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319349|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319350|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154319351|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
154319352|NCT02158702|Hormones|hormones|mesh-ancestor
154319353|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319354|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154319355|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319356|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
154319357|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154319358|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154319359|NCT02158702|Growth Substances|growth substances|mesh-ancestor
154319360|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
154319361|NCT03725709|Anesthetics|anesthetics|mesh-list
154319362|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319363|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319364|NCT01761890|Dasatinib|dasatinib|mesh-list
154319365|NCT01761890|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154319366|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319367|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319368|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319369|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319370|NCT02160028|Anesthetics|anesthetics|mesh-list
154319371|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319372|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319373|NCT03246152|Bevacizumab|bevacizumab|mesh-list
154319374|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154319375|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319376|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154319377|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154319378|NCT03246152|Growth Substances|growth substances|mesh-ancestor
154319379|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319380|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
154319381|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
154319382|NCT03541564|Deucravacitinib|deucravacitinib|mesh-list
154319383|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319384|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319385|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154319386|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154319387|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319388|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319389|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861732|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154319390|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
154319391|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319392|NCT00115349|Deferiprone|deferiprone|mesh-list
154319393|NCT00115349|Deferoxamine|deferoxamine|mesh-list
154319394|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154319395|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
154319397|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319398|NCT00115349|Siderophores|siderophores|mesh-ancestor
154319399|NCT04804696|Paclitaxel|paclitaxel|mesh-list
154319400|NCT04804696|Cisplatin|cisplatin|mesh-list
154319401|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154319402|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319403|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
154319404|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
154319405|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
154319406|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319407|NCT00115037|Naltrexone|naltrexone|mesh-list
154319408|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154319409|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154319410|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319411|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
154319412|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319413|NCT02160106|Vactosertib|vactosertib|mesh-list
154319414|NCT02160106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319415|NCT02160106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319416|NCT02160106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319417|NCT02160184|Pancrelipase|pancrelipase|mesh-list
154319418|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154319419|NCT03725553|Vasopressins|vasopressins|mesh-list
154319420|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
154319421|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
154319422|NCT03725553|Coagulants|coagulants|mesh-ancestor
154319423|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154319424|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154319425|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
154319426|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319427|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154319428|NCT03213626|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154319429|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319430|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319431|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319432|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319433|NCT03604341|Dronabinol|dronabinol|mesh-list
154319434|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
154319435|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319436|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154319437|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319438|NCT03604341|Analgesics|analgesics|mesh-ancestor
154319439|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
154319440|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319441|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154319442|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154319443|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154319444|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319445|NCT03604341|Hormones|hormones|mesh-ancestor
154319446|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319447|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
154319448|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154319449|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154319450|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319451|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
154319452|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
154319453|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
154319454|NCT01186640|Fludarabine|fludarabine|mesh-list
154319455|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
154319456|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
154319457|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
154319458|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319459|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
154319460|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319461|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319462|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154319463|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
154319464|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319465|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319466|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154184392|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154319467|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154319468|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
154319469|NCT01186640|Analgesics|analgesics|mesh-ancestor
154319470|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
154319472|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154319473|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154319474|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319475|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154319477|NCT04949516|Colchicine|colchicine|mesh-list
154319478|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154319479|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319480|NCT04949516|Analgesics|analgesics|mesh-ancestor
154319481|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
154319482|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319483|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319484|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319485|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319486|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154319487|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154319488|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319489|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154319490|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154319491|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319492|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
154319493|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
154319494|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
154319495|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
154319496|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
154319497|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319498|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
154319499|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
154319500|NCT00114959|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154319501|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319502|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319503|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319504|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319505|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154319506|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154319507|NCT02778100|Phenylephrine|phenylephrine|mesh-list
154319508|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
154319509|NCT02778100|Glucagon|glucagon|mesh-list
154319510|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154319511|NCT02778100|Hormones|hormones|mesh-ancestor
154319512|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319513|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319514|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154319515|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154319516|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
154319517|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154319518|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319519|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
154319520|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
154319521|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319522|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
154319523|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154319524|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
154319525|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154319526|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
154319527|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154319528|NCT02778100|Protective Agents|protective agents|mesh-ancestor
154319529|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
154319530|NCT02159248|Gemcitabine|gemcitabine|mesh-list
154319531|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154319532|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
154319533|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319534|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319535|NCT02159248|Analgesics|analgesics|mesh-ancestor
154319536|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
154319537|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609104|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
154319538|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319539|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154319540|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319541|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319542|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952695|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154319544|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154319545|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154319546|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
154319547|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
154319548|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319549|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154319550|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
154319551|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154319552|NCT00118157|Tamoxifen|tamoxifen|mesh-list
154319553|NCT00118157|Lapatinib|lapatinib|mesh-list
154319554|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319555|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154319556|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
154319557|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319558|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319559|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154319560|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319561|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154319562|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154319563|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154319564|NCT00118157|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154319565|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319566|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319567|NCT03543202|Anesthetics|anesthetics|mesh-list
154319568|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319569|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319570|NCT03552549|Interferons|interferons|mesh-list
154319571|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
154319572|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
154319573|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154319574|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319575|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
154319576|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319577|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
154319578|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319579|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
154319580|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319581|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
154319582|NCT02761642|Hematinics|hematinics|mesh-ancestor
154319583|NCT03731403|Fluorides|fluorides|mesh-list
154319584|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
154319585|NCT03731403|Protective Agents|protective agents|mesh-ancestor
154319586|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319587|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
154319588|NCT03189524|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154319589|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319590|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319591|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319592|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319593|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
154319594|NCT03600909|Busulfan|busulfan|mesh-list
154319595|NCT03600909|Fludarabine|fludarabine|mesh-list
154319596|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154319597|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
154319598|NCT03600909|Lenograstim|lenograstim|mesh-list
154319599|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319600|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
154319601|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319602|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319603|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154319604|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
154319605|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319606|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319607|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154319608|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154319609|NCT01314482|Minocycline|minocycline|mesh-list
154319610|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319611|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319612|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
154319613|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154319614|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
154319615|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319616|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861733|NCT03593902|Protective Agents|protective agents|mesh-ancestor
154319619|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
154319620|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154319621|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
154319622|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154319623|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319624|NCT02895945|Factor VIII|factor viii|mesh-list
154319625|NCT02895945|Coagulants|coagulants|mesh-ancestor
154319626|NCT02777554|Thalidomide|thalidomide|mesh-list
154319627|NCT02777554|Apremilast|apremilast|mesh-list
154319628|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154319629|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319630|NCT02777554|Analgesics|analgesics|mesh-ancestor
154319631|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
154319632|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319633|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319634|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319635|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319636|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154319637|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154319638|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319639|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319640|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319641|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
154319642|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
154319643|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319644|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319645|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154319646|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154319647|NCT02777554|Growth Substances|growth substances|mesh-ancestor
154319648|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
154319649|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319650|NCT03220178|Letrozole|letrozole|mesh-list
154319651|NCT03220178|Fulvestrant|fulvestrant|mesh-list
154319652|NCT03220178|Palbociclib|palbociclib|mesh-list
154319653|NCT03220178|Anastrozole|anastrozole|mesh-list
154319654|NCT03220178|Exemestane|exemestane|mesh-list
154319655|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319656|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154319657|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154319658|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319659|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319660|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154319661|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
154319662|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319663|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319664|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154319665|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154319666|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319667|NCT03032510|Levofloxacin|levofloxacin|mesh-list
154319668|NCT03032510|Ertapenem|ertapenem|mesh-list
154319669|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154319670|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319671|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319672|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154319673|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154319674|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319675|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319676|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319677|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154319678|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154319679|NCT03022292|Aflibercept|aflibercept|mesh-list
154319680|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154319681|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154319682|NCT03022292|Growth Substances|growth substances|mesh-ancestor
154319683|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319684|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
154319685|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319686|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
154066451|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
154319688|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
154319689|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
154319691|NCT03599193|Vitamins|vitamins|mesh-ancestor
154319692|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
154319693|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319694|NCT02161354|Buprenorphine|buprenorphine|mesh-list
154319695|NCT02161354|Naloxone|naloxone|mesh-list
154319696|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154319697|NCT02161354|Narcotics|narcotics|mesh-ancestor
154319698|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319699|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319700|NCT02161354|Analgesics|analgesics|mesh-ancestor
154319701|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
154319702|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319703|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154319704|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
154319705|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319706|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319707|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
154319708|NCT02777242|Testosterone|testosterone|mesh-list
154319709|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
154319710|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
154319711|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154319712|NCT02777242|Androgens|androgens|mesh-ancestor
154319713|NCT02777242|Hormones|hormones|mesh-ancestor
154319714|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319715|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319716|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154319717|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319718|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
154319719|NCT02163070|Vitamins|vitamins|mesh-list
154319720|NCT02163070|Vitamin E|vitamin e|mesh-list
154319721|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
154319722|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319723|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
154319724|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319725|NCT02163070|Protective Agents|protective agents|mesh-ancestor
154319726|NCT03484520|Venetoclax|venetoclax|mesh-list
154319727|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319728|NCT03566979|Naproxen|naproxen|mesh-list
154319729|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154319730|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319731|NCT03566979|Analgesics|analgesics|mesh-ancestor
154319732|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
154319733|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319734|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319735|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319736|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319737|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
154319738|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154319739|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319740|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319741|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
154319742|NCT00116831|Glipizide|glipizide|mesh-list
154319743|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319744|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319745|NCT02161588|Semaglutide|semaglutide|mesh-list
154319746|NCT02161588|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154319747|NCT02161588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319748|NCT02161588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319749|NCT02784704|Meropenem|meropenem|mesh-list
154319750|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319751|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319752|NCT03540472|Tacrolimus|tacrolimus|mesh-list
154319753|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319754|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
154319755|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319756|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154319757|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319758|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319759|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154319760|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154319761|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154319762|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
154319763|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319765|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154319766|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319773|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154319775|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
154319776|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319777|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154319778|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153952921|NCT00876460|Docetaxel|docetaxel|mesh-list
154319779|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319780|NCT03183908|Vaccines|vaccines|mesh-list
154319781|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
154319782|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319783|NCT03724851|Vactosertib|vactosertib|mesh-list
154319784|NCT03724851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154319785|NCT03724851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319786|NCT03724851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319787|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154319788|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154319789|NCT00113399|Paclitaxel|paclitaxel|mesh-list
154319790|NCT00113399|Docetaxel|docetaxel|mesh-list
154319791|NCT00113399|Fluorouracil|fluorouracil|mesh-list
154319792|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154319793|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319794|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
154319795|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
154319796|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
154319797|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319798|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
154319799|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154319800|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319801|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
154319802|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319803|NCT01326611|Clarithromycin|clarithromycin|mesh-list
154319804|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319805|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319806|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154319807|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319808|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319809|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154319810|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154319811|NCT00113087|Enalapril|enalapril|mesh-list
154319812|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154319813|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
154319814|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319815|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319816|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154319817|NCT00112463|Romidepsin|romidepsin|mesh-list
154319818|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154319819|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319820|NCT00112463|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154319821|NCT00112463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319822|NCT00112463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319823|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
154319824|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
154319825|NCT01083017|Diuretics|diuretics|mesh-ancestor
154319826|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
154319827|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319828|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154319829|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154319830|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319831|NCT00112385|Etanercept|etanercept|mesh-list
154319832|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154319833|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319834|NCT00112385|Analgesics|analgesics|mesh-ancestor
154319836|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319837|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319838|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319839|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319840|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154319841|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319842|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
154319843|NCT03731169|Voriconazole|voriconazole|mesh-list
154319844|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
154319845|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319846|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154319847|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154319848|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319849|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319850|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154319851|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
154861734|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154319852|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319853|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319854|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154319856|NCT03731091|Betamethasone|betamethasone|mesh-list
154319857|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
154319858|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154319859|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
154319860|NCT03731091|Calcipotriene|calcipotriene|mesh-list
154319861|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154319862|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319863|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
154319864|NCT03731091|Hormones|hormones|mesh-ancestor
154319865|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319866|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319867|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154319868|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
154319869|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
154319870|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154319871|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154319872|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154319873|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319874|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154319875|NCT03731091|Vitamins|vitamins|mesh-ancestor
154319876|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
154319877|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154319878|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154319879|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
154319880|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319881|NCT03560739|Ofatumumab|ofatumumab|mesh-list
154319882|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154319883|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319884|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
154319885|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319886|NCT01310673|Allopurinol|allopurinol|mesh-list
154319887|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
154319888|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319889|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319890|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
154319891|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319892|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154319893|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
154319894|NCT01310673|Protective Agents|protective agents|mesh-ancestor
154319895|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319896|NCT00101686|Bevacizumab|bevacizumab|mesh-list
154319897|NCT00101686|Capecitabine|capecitabine|mesh-list
154319898|NCT00101686|Irinotecan|irinotecan|mesh-list
154319899|NCT00101686|Fluorouracil|fluorouracil|mesh-list
154319900|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154319901|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319902|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154319903|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154319904|NCT00101686|Growth Substances|growth substances|mesh-ancestor
154319905|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319906|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
154319907|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154319908|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
154319909|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319910|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154319911|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154319912|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319913|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154319914|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
154319915|NCT02163616|Misoprostol|misoprostol|mesh-list
154319916|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154319917|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
154319918|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154319919|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319920|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154319921|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154319922|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
154319923|NCT00101452|Escitalopram|escitalopram|mesh-list
154319924|NCT00101452|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154319925|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154255915|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154319926|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154319927|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319928|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154319929|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
154319930|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319931|NCT02162134|Cefuroxime|cefuroxime|mesh-list
154319932|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
154319933|NCT02162134|Ketorolac|ketorolac|mesh-list
154319934|NCT02162134|Midazolam|midazolam|mesh-list
154319935|NCT02162134|Propofol|propofol|mesh-list
154319936|NCT02162134|Sevoflurane|sevoflurane|mesh-list
154319937|NCT02162134|Atracurium|atracurium|mesh-list
154319938|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154319939|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319940|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319941|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154319942|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
154319943|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
154319944|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154319945|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154319946|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154319947|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154319948|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
154319949|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
154319950|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154319951|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319952|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154319953|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154319954|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154319955|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154319956|NCT02162134|Analgesics|analgesics|mesh-ancestor
154319957|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
154319958|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319959|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319960|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154319961|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154319962|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319963|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154319964|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154319965|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154319966|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154319967|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154319968|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154319969|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154319970|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
154319971|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154319972|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154319973|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154319974|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319975|NCT02164006|Immunotoxins|immunotoxins|mesh-ancestor
154319976|NCT02164006|Immunoconjugates|immunoconjugates|mesh-ancestor
154319977|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
154319978|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319979|NCT02167360|Tisagenlecleucel|tisagenlecleucel|mesh-list
154319980|NCT02167360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154319981|NCT02167360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154319982|NCT03546621|Tenofovir|tenofovir|mesh-list
154319983|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
154319985|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154319986|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154319987|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319988|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319989|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154319990|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154319991|NCT02761330|Ketamine|ketamine|mesh-list
154319992|NCT02761330|Analgesics|analgesics|mesh-ancestor
154319993|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
154319994|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319995|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319996|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154319997|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154319998|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
154319999|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
154320000|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861735|NCT00948935|Gemcitabine|gemcitabine|mesh-list
154861736|NCT00948935|Irinotecan|irinotecan|mesh-list
154320001|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154320002|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154320003|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320004|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320005|NCT03730857|Olanzapine|olanzapine|mesh-list
154320006|NCT03730857|Risperidone|risperidone|mesh-list
154320007|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154320008|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
154320009|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154320010|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
154320011|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320012|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320013|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320014|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154320015|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320016|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154320017|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154320018|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
154320019|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
154320020|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
154320021|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320022|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154320023|NCT03730857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154320024|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154320025|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154320026|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154320027|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154320028|NCT03726177|Aspirin|aspirin|mesh-list
154320029|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154320030|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154320031|NCT03726177|Analgesics|analgesics|mesh-ancestor
154320032|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
154320033|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320034|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320035|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154320036|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154320037|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154320038|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154320039|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320040|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154320041|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154320042|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320043|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
154320044|NCT03726099|Amoxicillin|amoxicillin|mesh-list
154320045|NCT03726099|Tetracycline|tetracycline|mesh-list
154320046|NCT03726099|Furazolidone|furazolidone|mesh-list
154320047|NCT03726099|Esomeprazole|esomeprazole|mesh-list
154320048|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154320049|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320050|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154320051|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154320052|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154320053|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320054|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320055|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154320056|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154320059|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154320060|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154320061|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154320063|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
154320064|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154320065|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320066|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320067|NCT03558555|Acetaminophen|acetaminophen|mesh-list
154320068|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154320069|NCT03558555|Analgesics|analgesics|mesh-ancestor
154320070|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
154320071|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320072|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320073|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
154320074|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
154320075|NCT03726021|Irinotecan|irinotecan|mesh-list
154320076|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320077|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154320078|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154255916|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154320079|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320080|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320081|NCT05665023|Bevacizumab|bevacizumab|mesh-list
154320082|NCT05665023|Folfirinox|folfirinox|mesh-list
154320083|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154320084|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320085|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154320086|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154320087|NCT05665023|Growth Substances|growth substances|mesh-ancestor
154320088|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320089|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
154320090|NCT03557931|Olanzapine|olanzapine|mesh-list
154320091|NCT03557931|Risperidone|risperidone|mesh-list
154320092|NCT03557931|Aripiprazole|aripiprazole|mesh-list
154320093|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154320094|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154320095|NCT03557931|Ziprasidone|ziprasidone|mesh-list
154320096|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154320097|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
154320098|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154320099|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
154320100|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320101|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320102|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320103|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154320104|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154320105|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320106|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154320107|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154184987|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
154320108|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
154320109|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
154320110|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
154320111|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320112|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154320113|NCT03557931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154320114|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154320115|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154320116|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
154320117|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
154320118|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154320119|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154320120|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154320121|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154320122|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154320123|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154320124|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154320125|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
154320126|NCT03977675|Ketamine|ketamine|mesh-list
154320127|NCT03977675|Analgesics|analgesics|mesh-ancestor
154320128|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
154320129|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320130|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320136|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154320137|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154320139|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320140|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154320141|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
154320142|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154320143|NCT01066559|Protective Agents|protective agents|mesh-ancestor
154320144|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320145|NCT00293813|Denosumab|denosumab|mesh-list
154320146|NCT00293813|Alendronate|alendronate|mesh-list
154320147|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154320148|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320149|NCT00293579|Pemetrexed|pemetrexed|mesh-list
154320150|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320151|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320152|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320153|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154320154|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154320155|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
154320156|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154320157|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
154861737|NCT00948935|Panitumumab|panitumumab|mesh-list
154320158|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320159|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154320160|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320161|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
154320162|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320163|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
154185051|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320164|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154320165|NCT00293423|Protective Agents|protective agents|mesh-ancestor
154320166|NCT03521817|Ethanol|ethanol|mesh-list
154320167|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154320168|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320169|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320170|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320171|NCT03538431|Buspirone|buspirone|mesh-list
154320172|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154320173|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154320174|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320175|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320176|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154320177|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154320178|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
154320179|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320180|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320181|NCT03521193|Aspirin|aspirin|mesh-list
154320182|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154320183|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154320184|NCT03521193|Analgesics|analgesics|mesh-ancestor
154320185|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
154320186|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320187|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320188|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154320189|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154320190|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154320191|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154320192|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320193|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154320194|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154320195|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320196|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
154320197|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
154320198|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154320199|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154320200|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
154320219|NCT01080365|Bosutinib|bosutinib|mesh-list
154320220|NCT01080365|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154320221|NCT01080365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154320222|NCT01080365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320223|NCT01080365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320224|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154320225|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154320226|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
154320227|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154320228|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320229|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154320230|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
154320231|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154320232|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320233|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320234|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320235|NCT00111917|Infliximab|infliximab|mesh-list
154320236|NCT00111917|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154320237|NCT00111917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154320238|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
154320239|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154320240|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154320241|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
154320242|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
154320243|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154320244|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154320245|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320246|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320247|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320248|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154320249|NCT03520569|Octreotide|octreotide|mesh-list
154320250|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154320251|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154320252|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320253|NCT00111839|Pemetrexed|pemetrexed|mesh-list
154320254|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320255|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320287|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154320288|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154320289|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320290|NCT00111761|Antidotes|antidotes|mesh-ancestor
154320291|NCT00111761|Protective Agents|protective agents|mesh-ancestor
154320292|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
154320294|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
154320295|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154320296|NCT03519867|Bromides|bromides|mesh-list
154320297|NCT03519867|Rocuronium|rocuronium|mesh-list
154320298|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
154320299|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154320300|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154320301|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154320302|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320311|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
154320312|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320313|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154320314|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
154320315|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320316|NCT02164552|Vitamin D|vitamin d|mesh-list
154320317|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
154320318|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
154320319|NCT02164552|Vitamins|vitamins|mesh-list
154320320|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
154320321|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320322|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154320323|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154320324|NCT03723135|Azacitidine|azacitidine|mesh-list
154320325|NCT03723135|Cc-486|cc-486|mesh-list
154320326|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154320327|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
154320328|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320329|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320330|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320331|NCT02762578|Insulin|insulin|mesh-list
154320332|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154320333|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
154320334|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
154320335|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154320336|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
154320337|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320338|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320339|NCT03540628|Thiamine|thiamine|mesh-list
154320340|NCT03540628|Vitamins|vitamins|mesh-ancestor
154320341|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
154320342|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320343|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
154320344|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
154320345|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154320346|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320347|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320348|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154320349|NCT02170948|Analgesics|analgesics|mesh-ancestor
154320350|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
154320351|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320352|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154320353|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154320354|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154320355|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
154320356|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320357|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320358|NCT02171026|Amiodarone|amiodarone|mesh-list
154320359|NCT02171026|Dabigatran|dabigatran|mesh-list
154320360|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
154320361|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154320362|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
154320363|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320364|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320365|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
154320366|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154320367|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
154320368|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154255917|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154320369|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154320370|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154320371|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154320395|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154320396|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154320397|NCT02171182|Capsaicin|capsaicin|mesh-list
154320398|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
154320399|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
154320400|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
154320401|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320402|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320403|NCT00100828|Irinotecan|irinotecan|mesh-list
154320404|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154320405|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154320406|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320407|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320408|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320409|NCT02165098|Cariprazine|cariprazine|mesh-list
154320410|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154320411|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154320412|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320413|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320414|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154320415|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154320416|NCT02171338|Azithromycin|azithromycin|mesh-list
154320417|NCT02171338|Clarithromycin|clarithromycin|mesh-list
154320418|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
154320419|NCT02171338|Tazobactam|tazobactam|mesh-list
154320420|NCT02171338|Piperacillin|piperacillin|mesh-list
154320421|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154320422|NCT02171338|Penicillin G|penicillin g|mesh-list
154320423|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320446|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320447|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154320448|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
154320449|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154320450|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320451|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154320452|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154320453|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154320454|NCT02171572|Dabigatran|dabigatran|mesh-list
154320455|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
154320456|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154320457|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
154320458|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320459|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320460|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
154320461|NCT02255578|Clomiphene|clomiphene|mesh-list
154320462|NCT02255578|Enclomiphene|enclomiphene|mesh-list
154320463|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
154320464|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154320465|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
154320466|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154320467|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320468|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154320469|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
154320470|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154320471|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154320472|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154320473|NCT02169154|Diclofenac|diclofenac|mesh-list
154320504|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154320505|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154320506|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154320507|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154320508|NCT02171650|Afatinib|afatinib|mesh-list
154320509|NCT02171650|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154320510|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154320511|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320512|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320513|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320515|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154320516|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
154320517|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320590|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154861738|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153953511|NCT01106690|Pioglitazone|pioglitazone|mesh-list
154320621|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154320622|NCT02172274|Empagliflozin|empagliflozin|mesh-list
154320623|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154320624|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320625|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320626|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320627|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
154320628|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154320629|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
154320630|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320631|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499878|NCT00004758|Carbamazepine|carbamazepine|mesh-list
154320659|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
154320660|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
154320661|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154320662|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
154320663|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320664|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320665|NCT02172586|Losartan|losartan|mesh-list
154320666|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154320667|NCT02172586|Telmisartan|telmisartan|mesh-list
154320668|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154320669|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154320670|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154320671|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154320672|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320673|NCT02172586|Diuretics|diuretics|mesh-ancestor
154320674|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
154320675|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320676|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154320677|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154320705|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
154320706|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320708|NCT02172976|Gemcitabine|gemcitabine|mesh-list
154320709|NCT02172976|Fluorouracil|fluorouracil|mesh-list
154320710|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
154320711|NCT02172976|Irinotecan|irinotecan|mesh-list
154320712|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154320713|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
154320714|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320715|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320716|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154320717|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
154320718|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320719|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154320720|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154320721|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320722|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
154320723|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
154320724|NCT02173132|Vitamins|vitamins|mesh-ancestor
154320725|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
154320726|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320727|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
154320728|NCT02173288|Furosemide|furosemide|mesh-list
154320754|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154320755|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320756|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320757|NCT02175394|Incretins|incretins|mesh-ancestor
154320758|NCT02175394|Hormones|hormones|mesh-ancestor
154320759|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154320760|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154320761|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
154320762|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320763|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320764|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154320765|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
154320766|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154320767|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154320768|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154320769|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154320770|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154320771|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154861739|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
154320793|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
154320794|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320795|NCT00102466|Metformin|metformin|mesh-list
154320796|NCT00102466|Vildagliptin|vildagliptin|mesh-list
154320797|NCT00102466|Gliclazide|gliclazide|mesh-list
154320798|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320799|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320800|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154320801|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
154320802|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320803|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320804|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154320805|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154320806|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154320807|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320808|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320809|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320810|NCT02173912|Amlodipine|amlodipine|mesh-list
154320811|NCT02173912|Candesartan|candesartan|mesh-list
154320812|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
154320813|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154320814|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154320815|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154320816|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320817|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154320818|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320819|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
154320820|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154320821|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154320822|NCT02173990|Aflibercept|aflibercept|mesh-list
153500067|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
154320856|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320857|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
154320858|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320859|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320860|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154320861|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
154320862|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320863|NCT02174068|Acetaminophen|acetaminophen|mesh-list
154320864|NCT02174068|Nefopam|nefopam|mesh-list
154320893|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
154320895|NCT02182102|Nintedanib|nintedanib|mesh-list
154320896|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320897|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320898|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320899|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154320900|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154320901|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154320902|NCT02176720|Fluorides|fluorides|mesh-list
154320903|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154320904|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
154320905|NCT02176720|Protective Agents|protective agents|mesh-ancestor
154320906|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320907|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
154320908|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320909|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320910|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154320911|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
154320912|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320937|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
154320938|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
154320939|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
154320940|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320941|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320942|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
154320943|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154320944|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154320945|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320946|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154320947|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154320948|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
154320949|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154185409|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
154320950|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153953664|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953666|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
153953667|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153953669|NCT02848443|Bevacizumab|bevacizumab|mesh-list
153953670|NCT02848443|Nivolumab|nivolumab|mesh-list
154320951|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154320952|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154320953|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154320954|NCT02182336|Protective Agents|protective agents|mesh-ancestor
154320955|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154320956|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154320957|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
154320958|NCT02182336|Coagulants|coagulants|mesh-ancestor
154320959|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
154320960|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
154320961|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154320962|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154320963|NCT02182336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154320964|NCT02182336|Narcotics|narcotics|mesh-ancestor
154320965|NCT02182336|Analgesics|analgesics|mesh-ancestor
154320966|NCT02182336|Sensory System Agents|sensory system agents|mesh-ancestor
154320967|NCT02182336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320968|NCT02182570|Epinastine|epinastine|mesh-list
154320996|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154320997|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
154320998|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154320999|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
154321000|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321001|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321002|NCT03536494|Mirabegron|mirabegron|mesh-list
154321003|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154321004|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154321005|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154321006|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
154321007|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321008|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321009|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321010|NCT03536494|Urological Agents|urological agents|mesh-ancestor
154321011|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154321012|NCT02177422|Telmisartan|telmisartan|mesh-list
154321013|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154321014|NCT02177422|Diuretics|diuretics|mesh-ancestor
154321015|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
154321016|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321017|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154321041|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154321042|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154321043|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321044|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321045|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321046|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154321047|NCT02183038|Naproxen|naproxen|mesh-list
154321048|NCT02183038|Meloxicam|meloxicam|mesh-list
154321049|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321050|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321051|NCT02183038|Analgesics|analgesics|mesh-ancestor
154321052|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
154321053|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321054|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321055|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321056|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321057|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
154321058|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154321059|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321060|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321061|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154321062|NCT02752906|Vaccines|vaccines|mesh-list
154321063|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
154861740|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861741|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861742|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154861743|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154861744|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321064|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321065|NCT00293033|Fentanyl|fentanyl|mesh-list
154321066|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154321067|NCT00293033|Narcotics|narcotics|mesh-ancestor
154321068|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321069|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321099|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
154321100|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321101|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321102|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154321103|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154321104|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
154321105|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
154321106|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321107|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154321108|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154321109|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321110|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321111|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154321112|NCT02177500|Telmisartan|telmisartan|mesh-list
154321113|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154321142|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321143|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154321144|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
154321145|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321146|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321148|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
154321149|NCT01080911|Narcotics|narcotics|mesh-ancestor
154321150|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321151|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321152|NCT01080911|Analgesics|analgesics|mesh-ancestor
154321153|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
154321154|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321155|NCT02183506|Metformin|metformin|mesh-list
154321156|NCT02183506|Linagliptin|linagliptin|mesh-list
154321157|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153500401|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154321193|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321227|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321229|NCT01083329|Niacin|niacin|mesh-list
154321230|NCT01083329|Niacinamide|niacinamide|mesh-list
154321231|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
154321232|NCT01083329|Vitamins|vitamins|mesh-ancestor
154321233|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
154321234|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321235|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154321236|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
154321271|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154321272|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154321273|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
154321274|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154321275|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154321276|NCT02178124|Donepezil|donepezil|mesh-list
154321305|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321307|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154321308|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
154321309|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321310|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321311|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154321312|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154321313|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
154321314|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321315|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
154321316|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321317|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
154321318|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154321319|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154321320|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153500564|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154321348|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154321349|NCT03536806|Diuretics|diuretics|mesh-ancestor
154321350|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
153953823|NCT00652431|Vitamins|vitamins|mesh-ancestor
154321351|NCT00108485|Niacin|niacin|mesh-list
154321352|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154321353|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
154321354|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321355|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154321356|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
154321357|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
154321358|NCT00108485|Vitamins|vitamins|mesh-ancestor
154321359|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
154321360|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321361|NCT02181946|Fluconazole|fluconazole|mesh-list
154321362|NCT02181946|Nevirapine|nevirapine|mesh-list
154321363|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
154321364|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321365|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154321366|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153443611|NCT01946412|Ivacaftor|ivacaftor|mesh-list
154321395|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
154321396|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321397|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321399|NCT02185846|Dirithromycin|dirithromycin|mesh-list
154321400|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154321401|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321402|NCT02184832|Metformin|metformin|mesh-list
154321403|NCT02184832|Tryptophan|tryptophan|mesh-list
154321404|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321405|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321406|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154321407|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
154321408|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154321439|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321441|NCT02185924|Ropivacaine|ropivacaine|mesh-list
154321442|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
154321443|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
154321444|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321445|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185602|NCT01057186|Vitamins|vitamins|mesh-ancestor
154321446|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
154321447|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321448|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154321449|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154321450|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321451|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500698|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
154068242|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
154321481|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321482|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321483|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154321484|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321485|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321486|NCT01083953|Sevoflurane|sevoflurane|mesh-list
154321487|NCT01083953|Desflurane|desflurane|mesh-list
154321488|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154321489|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154321490|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
154321491|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
154321492|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321493|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321494|NCT02190526|Mesalamine|mesalamine|mesh-list
154321495|NCT02190526|Amitriptyline|amitriptyline|mesh-list
154321496|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154321497|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
154321533|NCT01084187|Urological Agents|urological agents|mesh-ancestor
154321534|NCT02185300|Dolutegravir|dolutegravir|mesh-list
154321568|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321569|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154321570|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
154321571|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321572|NCT02185456|Metronidazole|metronidazole|mesh-list
154321574|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321575|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154321576|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154321577|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154321578|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
153500850|NCT00365040|Mitomycins|mitomycins|mesh-list
154321610|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861745|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255919|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
153953895|NCT03708549|Metformin|metformin|mesh-list
154321611|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154321612|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
154321613|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321614|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321615|NCT02186782|Citric Acid|citric acid|mesh-list
154321616|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
154321617|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154321618|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154321619|NCT02186782|Clomiphene|clomiphene|mesh-list
154321644|NCT02187250|Liraglutide|liraglutide|mesh-list
154321645|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321646|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321647|NCT02187250|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154321648|NCT02187250|Incretins|incretins|mesh-ancestor
154321649|NCT02187250|Hormones|hormones|mesh-ancestor
154321650|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321651|NCT03535480|Lenograstim|lenograstim|mesh-list
154321652|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154321653|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
154321654|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321655|NCT02187484|Telmisartan|telmisartan|mesh-list
154321656|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154321657|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154321658|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154321659|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321660|NCT02256748|Midazolam|midazolam|mesh-list
154321661|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154321662|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154321663|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321664|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321665|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154321666|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154321667|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154321668|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154321669|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
154321670|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
154321700|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321701|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154321702|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154321703|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154321704|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154321705|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
154321706|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
154321707|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
154321708|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
154321709|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321710|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321711|NCT02192320|Dexamethasone|dexamethasone|mesh-list
154321712|NCT02192320|Atorvastatin|atorvastatin|mesh-list
154321713|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321714|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
154321715|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
153500962|NCT00368160|Eszopiclone|eszopiclone|mesh-list
154321739|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321740|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154321741|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154321742|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321743|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321744|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321745|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154321746|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154321747|NCT04870138|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154321748|NCT04870138|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154321749|NCT02188186|Metformin|metformin|mesh-list
154321750|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154321751|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321752|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321753|NCT02188186|Incretins|incretins|mesh-ancestor
154321754|NCT02188186|Hormones|hormones|mesh-ancestor
154321755|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321756|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154321757|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
154861746|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
154861747|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
153953961|NCT02852382|Morphine|morphine|mesh-list
154321758|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321759|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321760|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154321761|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321762|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321763|NCT02192632|Analgesics|analgesics|mesh-ancestor
154321764|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
154321797|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321798|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321799|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154321800|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
154321802|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154321803|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154321804|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154321805|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154321806|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
154321807|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321808|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321846|NCT02188810|Vaccines|vaccines|mesh-list
154321847|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
154321848|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321849|NCT02188888|Esmolol|esmolol|mesh-list
153501097|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
154321882|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154321883|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
154321884|NCT02193256|Prazosin|prazosin|mesh-list
154321885|NCT02193256|Varenicline|varenicline|mesh-list
154321886|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154321887|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154321888|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
154321889|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321890|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321891|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321892|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154321893|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154321930|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501180|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
154321958|NCT02197000|Protective Agents|protective agents|mesh-ancestor
154321959|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321960|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321962|NCT02196142|Mannitol|mannitol|mesh-list
154321963|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154321964|NCT02196142|Diuretics|diuretics|mesh-ancestor
154321965|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
154321966|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321967|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321968|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154321969|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154321970|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154321971|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321972|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154321973|NCT03534388|Eusol|eusol|mesh-list
154321974|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
154321975|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322010|NCT02031016|Remifentanil|remifentanil|mesh-list
154322011|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154322012|NCT02031016|Narcotics|narcotics|mesh-ancestor
154322013|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322014|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322015|NCT02031016|Analgesics|analgesics|mesh-ancestor
154322016|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
154322017|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322018|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154322043|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154322044|NCT00095147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154322045|NCT02198170|Ketoconazole|ketoconazole|mesh-list
154322046|NCT02198170|Lenvatinib|lenvatinib|mesh-list
154322047|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
154322048|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322049|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154322050|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154322051|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322052|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861748|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
153954038|NCT02852070|Dimercaprol|dimercaprol|mesh-list
154322053|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154322054|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154322055|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154322056|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322057|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154322058|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322059|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154322060|NCT02198248|Prednisolone|prednisolone|mesh-list
154322061|NCT02198248|Rituximab|rituximab|mesh-list
154322062|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
154322063|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154322064|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322065|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
154322066|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322067|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322068|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322096|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154322097|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154322098|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322099|NCT02198482|Analgesics|analgesics|mesh-ancestor
154322100|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
154322101|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322102|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
154322103|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322104|NCT02201134|Sevoflurane|sevoflurane|mesh-list
154322105|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154322106|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154322107|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
154322108|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
154322109|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322110|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322111|NCT02201602|Gliclazide|gliclazide|mesh-list
154322112|NCT02201602|Glyburide|glyburide|mesh-list
154322113|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154322114|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322115|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154322146|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154322147|NCT02202304|Thymol|thymol|mesh-list
154322148|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154322149|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322150|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
154322151|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
154322152|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
154322153|NCT02207452|Albuterol|albuterol|mesh-list
154322154|NCT02207452|Ipratropium|ipratropium|mesh-list
154322155|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154322156|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
154322157|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322158|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322160|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
154322191|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
154322192|NCT03532906|Bupivacaine|bupivacaine|mesh-list
154322193|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
154322194|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
154322195|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322196|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322197|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
154322198|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322199|NCT02199418|Paclitaxel|paclitaxel|mesh-list
154322200|NCT02199418|Cisplatin|cisplatin|mesh-list
154322201|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154322202|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322203|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
154322204|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
154322235|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
154322236|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322237|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154322238|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154322239|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
154322240|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
154322241|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154322242|NCT02203552|Minocycline|minocycline|mesh-list
154322243|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154322244|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322245|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154322246|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154861749|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954113|NCT00604578|Pioglitazone|pioglitazone|mesh-list
154322247|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
154322248|NCT02200354|Bevacizumab|bevacizumab|mesh-list
154322270|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322271|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322272|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322274|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154322275|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154322276|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
154322277|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
154322278|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322279|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322280|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322281|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
154322283|NCT02204644|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154322284|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154322285|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322286|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322287|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322288|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
154322289|NCT02204722|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154322290|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154322291|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322292|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322293|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322294|NCT02204878|Parecoxib|parecoxib|mesh-list
154322295|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154322296|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154322297|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322298|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501527|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
154322318|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322319|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
154322320|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
154322321|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322322|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
154322323|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154322324|NCT02220868|Ribavirin|ribavirin|mesh-list
154322325|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
154322326|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154322327|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
154322328|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322329|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
154322330|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322331|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154322332|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154322333|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154322334|NCT02221102|Aspirin|aspirin|mesh-list
154322335|NCT02221102|Edoxaban|edoxaban|mesh-list
154322336|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154322337|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322338|NCT02221102|Analgesics|analgesics|mesh-ancestor
154322339|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
154322340|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322341|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322342|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322343|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322344|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154322345|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154322346|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322347|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154322348|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154322349|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322350|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
154322381|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154322382|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154322383|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154322385|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322386|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322387|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154861750|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255920|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322388|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154322389|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154322390|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154322391|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154322392|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
154322393|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322394|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154322422|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
154322423|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322424|NCT05164978|Antibodies|antibodies|mesh-list
154322425|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
154322426|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322427|NCT02221570|Baclofen|baclofen|mesh-list
154322428|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154322429|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322430|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154322431|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322432|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154322433|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
154322434|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
154322435|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322436|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322437|NCT02205502|Lidocaine|lidocaine|mesh-list
154322438|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
154322439|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
154322440|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322441|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322464|NCT02205580|Dsuvia|dsuvia|mesh-list
154322465|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154322466|NCT02205580|Narcotics|narcotics|mesh-ancestor
154322467|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322468|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322469|NCT02205580|Analgesics|analgesics|mesh-ancestor
154322470|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
154322471|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322472|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154322473|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154322474|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
154322475|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
154322476|NCT02221960|Durvalumab|durvalumab|mesh-list
154322477|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154322478|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322479|NCT02220088|Leucovorin|leucovorin|mesh-list
154322480|NCT02220088|Fluorouracil|fluorouracil|mesh-list
154322481|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
154322482|NCT02220088|Sorafenib|sorafenib|mesh-list
154322483|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
154322484|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322485|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154322486|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322487|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322488|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
154322489|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322490|NCT02220088|Antidotes|antidotes|mesh-ancestor
154322491|NCT02220088|Protective Agents|protective agents|mesh-ancestor
154322492|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
154322493|NCT02220088|Vitamins|vitamins|mesh-ancestor
154322494|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
154322495|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154322496|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069289|NCT02604966|Artesunate|artesunate|mesh-list
154322527|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154322528|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154322529|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
154322530|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322531|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322532|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
154322533|NCT02206204|Selexipag|selexipag|mesh-list
153932970|NCT02789332|Epirubicin|epirubicin|mesh-list
154322534|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154322535|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154322536|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322537|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154322573|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322575|NCT02225548|Selegiline|selegiline|mesh-list
154861751|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154861752|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154322608|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322609|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
154322610|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154322611|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154322613|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154322649|NCT02226328|Midazolam|midazolam|mesh-list
154322650|NCT02226328|Fentanyl|fentanyl|mesh-list
154322651|NCT02226328|Propofol|propofol|mesh-list
154322652|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154322653|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501902|NCT02992938|Diuretics|diuretics|mesh-ancestor
154322690|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154322691|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
154322692|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322727|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
154322728|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322729|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322730|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
154322731|NCT00082433|Capecitabine|capecitabine|mesh-list
154322765|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154322766|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322767|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322768|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322769|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154322770|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322771|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322831|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322832|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322834|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154322835|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322836|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154322837|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154322838|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
154322839|NCT00099359|Lamivudine|lamivudine|mesh-list
154322840|NCT00099359|Zidovudine|zidovudine|mesh-list
154322841|NCT00099359|Nevirapine|nevirapine|mesh-list
154322842|NCT00099359|Nelfinavir|nelfinavir|mesh-list
154322843|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154322844|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154322845|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322846|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322847|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
154322848|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322849|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154322850|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154322851|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
154322852|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154322853|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154322854|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154322855|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154322856|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
154322857|NCT00092417|Vaccines|vaccines|mesh-list
154322858|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
153502098|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
154322892|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154322893|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154322894|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322895|NCT04772248|Adalimumab|adalimumab|mesh-list
154322896|NCT04772248|Infliximab|infliximab|mesh-list
154322897|NCT04772248|Golimumab|golimumab|mesh-list
154322898|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
154322932|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154322933|NCT01775644|Growth Substances|growth substances|mesh-ancestor
154322934|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322935|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
154322936|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154322937|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154322960|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154322961|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154322962|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154322963|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154322964|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154322965|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
154322966|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322968|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154322969|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
154322970|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154322971|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
154322972|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322973|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154322974|NCT01081847|Diuretics|diuretics|mesh-ancestor
154322975|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
154322976|NCT02224456|Tenofovir|tenofovir|mesh-list
154322977|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
154322978|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322979|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154322980|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154322981|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322982|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322983|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154322984|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154322985|NCT02224534|Clopidogrel|clopidogrel|mesh-list
154322986|NCT02224534|Ticagrelor|ticagrelor|mesh-list
154322987|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154322988|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154323016|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154323017|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154323018|NCT01082003|Protective Agents|protective agents|mesh-ancestor
154323019|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323020|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
154323021|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154323022|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
154323023|NCT01082237|Escitalopram|escitalopram|mesh-list
154323024|NCT01082237|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154323025|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154323026|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323027|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323028|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323029|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
154323030|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323031|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154323032|NCT02228122|Laxatives|laxatives|mesh-ancestor
153502280|NCT01270464|Reslizumab|reslizumab|mesh-list
154323059|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154323060|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323061|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
154323062|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154323063|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154323064|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154323065|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582971|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323066|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323067|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
154323068|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323069|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323070|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154323071|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323072|NCT00096941|Pertuzumab|pertuzumab|mesh-list
154323073|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154323074|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323075|NCT00096785|Entecavir|entecavir|mesh-list
154323076|NCT00096785|Adefovir|adefovir|mesh-list
154323077|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
154323078|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323079|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154323080|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154323081|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502333|NCT00249834|Hormones|hormones|mesh-ancestor
154323107|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323109|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154323110|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
154323111|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323112|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323113|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154323114|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154323115|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154323116|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154323117|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154323118|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323119|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154323120|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
154323121|NCT02228512|Hormones|hormones|mesh-ancestor
154323122|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323123|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154323124|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154323125|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
154323126|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
154323127|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
154323128|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154323129|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154323130|NCT02228512|Growth Substances|growth substances|mesh-ancestor
154323131|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
154323132|NCT01082627|Somatostatin|somatostatin|mesh-list
154323134|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323155|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323157|NCT01085981|Niacinamide|niacinamide|mesh-list
154323158|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
154323159|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154323160|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
154323161|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323162|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154323163|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
154323164|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
154323165|NCT01085981|Vitamins|vitamins|mesh-ancestor
154323166|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
154323167|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323168|NCT03345082|Ranibizumab|ranibizumab|mesh-list
154323169|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154323170|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154323171|NCT03345082|Growth Substances|growth substances|mesh-ancestor
154323172|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323173|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
154323174|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323175|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
154323176|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
154323177|NCT02228902|Trace Elements|trace elements|mesh-ancestor
154323178|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
154323179|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323180|NCT02228902|Hematinics|hematinics|mesh-ancestor
154323181|NCT03288454|Apixaban|apixaban|mesh-list
154323182|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154323183|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
154323184|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154323185|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
154323186|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323187|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323188|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
154323189|NCT00090545|Sorafenib|sorafenib|mesh-list
154323190|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323191|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154323192|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502424|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
154323263|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323264|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323265|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154323266|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323267|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
154323268|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154323269|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323270|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323305|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
154323306|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154323308|NCT05563480|Gemcitabine|gemcitabine|mesh-list
154323309|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323310|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154323348|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
153502596|NCT03215940|Hormones|hormones|mesh-ancestor
154323374|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154323375|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154323376|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154323377|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154323378|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323380|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
154323381|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323382|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154323383|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323384|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
154323385|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154323386|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323387|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323388|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154323389|NCT03723538|Analgesics|analgesics|mesh-ancestor
154323390|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
154323391|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323392|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154323393|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154323394|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154323395|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
154323396|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323430|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323431|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154323433|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154323434|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323435|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323461|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323462|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154323463|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
154323464|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154323465|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
154323466|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323467|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323468|NCT02233972|Midazolam|midazolam|mesh-list
154323469|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154323470|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154323471|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323472|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323473|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154323474|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154323475|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154323476|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154323477|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
154323478|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
154323479|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
154323480|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
154323481|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323482|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323483|NCT02234050|Trabectedin|trabectedin|mesh-list
153502727|NCT03211572|Tamoxifen|tamoxifen|mesh-list
154323519|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
154323520|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323521|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323522|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154323523|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154323524|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
154323525|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323559|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323560|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323561|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
154323562|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323598|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
154323599|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323628|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
154323629|NCT01327079|Methadone|methadone|mesh-list
154323630|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154323631|NCT01327079|Narcotics|narcotics|mesh-ancestor
154323632|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323633|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323634|NCT01327079|Analgesics|analgesics|mesh-ancestor
154323635|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
154323636|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323637|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
154323638|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
154323639|NCT01091207|Sorafenib|sorafenib|mesh-list
154323640|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323641|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154323642|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323643|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323644|NCT00054275|Docetaxel|docetaxel|mesh-list
154323645|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154323646|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323647|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
154323648|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
154323649|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
154323679|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323680|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154323681|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
154323682|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323683|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323684|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154323685|NCT00051311|Cyclosporine|cyclosporine|mesh-list
154323686|NCT00051311|Prednisone|prednisone|mesh-list
154323687|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
154323688|NCT00051311|Doxorubicin|doxorubicin|mesh-list
154323689|NCT00051311|Methotrexate|methotrexate|mesh-list
154323690|NCT00051311|Fludarabine|fludarabine|mesh-list
154323691|NCT00051311|Etoposide|etoposide|mesh-list
154323692|NCT00051311|Vincristine|vincristine|mesh-list
154323693|NCT00051311|Cyclosporins|cyclosporins|mesh-list
154323718|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154323719|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154323720|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154323721|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
154323722|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
154323723|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
154323724|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
154323725|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323726|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154323728|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154323729|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154323730|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323731|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323732|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154323733|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323734|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
154323735|NCT00049673|Thalidomide|thalidomide|mesh-list
154323736|NCT00049673|Prednisone|prednisone|mesh-list
154323737|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154323738|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
154323739|NCT00049673|Hormones|hormones|mesh-ancestor
154323740|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323741|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323766|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323768|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323769|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323770|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
154323771|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323772|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323773|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
154323774|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154323775|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
154323776|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323777|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323778|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
154323779|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323780|NCT03957629|Interferons|interferons|mesh-list
154323781|NCT03957629|Tenofovir|tenofovir|mesh-list
154323782|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
154323783|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
154323784|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154323785|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323786|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
154323787|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323788|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154323789|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154323790|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502984|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
154323816|NCT00065429|Immunoconjugates|immunoconjugates|mesh-ancestor
154323817|NCT00065429|Immunologic Factors|immunologic factors|mesh-ancestor
154323818|NCT00065429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323819|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154323820|NCT01095731|Acetic Acid|acetic acid|mesh-list
154323821|NCT01095731|Retinol acetate|retinol acetate|mesh-list
154323822|NCT01095731|Glycine|glycine|mesh-list
154861753|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154323823|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
154323824|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323825|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323826|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323827|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154323828|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323829|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154323831|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154323832|NCT01095731|Protective Agents|protective agents|mesh-ancestor
154323833|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323834|NCT01095809|Triamcinolone|triamcinolone|mesh-list
154323835|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154323836|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154323837|NCT01095809|Bevacizumab|bevacizumab|mesh-list
154323838|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154323839|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154323840|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323869|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154323870|NCT00047879|Thalidomide|thalidomide|mesh-list
154323871|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323872|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
154323873|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323874|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
154323875|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323876|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323877|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
154323878|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154323879|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154323880|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154323881|NCT00047879|Growth Substances|growth substances|mesh-ancestor
154323882|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
154323883|NCT00064337|Thalidomide|thalidomide|mesh-list
154323884|NCT00064337|Dexamethasone|dexamethasone|mesh-list
154323885|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
154323886|NCT00064337|Melphalan|melphalan|mesh-list
154323887|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323888|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
154323889|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323920|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323921|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
154323922|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323923|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154323924|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323925|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
154323926|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323928|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323929|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323930|NCT00044213|Vitamins|vitamins|mesh-list
154323931|NCT00044213|Edetic Acid|edetic acid|mesh-list
154323932|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
154323960|NCT01096199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154323961|NCT01096199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323962|NCT01096199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323963|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323964|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
154323965|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323966|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154323967|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154323968|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323969|NCT01096277|Incretins|incretins|mesh-ancestor
154323970|NCT01096277|Hormones|hormones|mesh-ancestor
154323971|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323972|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154323973|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
154323974|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323975|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323976|NCT01096355|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154323977|NCT01096355|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154324005|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324006|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
154324007|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154324008|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324009|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154324010|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324011|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154324012|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
154324014|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324015|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324016|NCT00043979|Cyclosporine|cyclosporine|mesh-list
154324017|NCT00043979|Sirolimus|sirolimus|mesh-list
154324018|NCT00043979|Prednisone|prednisone|mesh-list
154324019|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
154324020|NCT00043979|Melphalan|melphalan|mesh-list
154324021|NCT00043979|Doxorubicin|doxorubicin|mesh-list
154324022|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154324051|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154324052|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
154324053|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
154324054|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
154324055|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
154324056|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324057|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
154324058|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324059|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154324060|NCT01436032|Ketorolac|ketorolac|mesh-list
154324061|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154324062|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154324063|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154324064|NCT01436032|Analgesics|analgesics|mesh-ancestor
154324065|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
154324066|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324067|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324068|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324069|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324070|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153503265|NCT01729260|Mebendazole|mebendazole|mesh-list
154324092|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
154324093|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324094|NCT01425970|Interferons|interferons|mesh-list
154324095|NCT01425970|Ribavirin|ribavirin|mesh-list
154324096|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
154324097|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
154324098|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154324099|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324100|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
154324101|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324102|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
154324103|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324105|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324106|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154324107|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154324108|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324109|NCT01619332|Incretins|incretins|mesh-ancestor
154324110|NCT01619332|Hormones|hormones|mesh-ancestor
154324111|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324112|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154324113|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
154324114|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324115|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324116|NCT01616524|Interferons|interferons|mesh-list
154324117|NCT01616524|Ribavirin|ribavirin|mesh-list
154324118|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
154324119|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
154324120|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154324121|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324122|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
154324123|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324124|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
153503313|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324159|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
154324160|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324192|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324193|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
154324194|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
154324195|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324196|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154324197|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154324198|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
154324199|NCT01399684|Antidotes|antidotes|mesh-ancestor
154324200|NCT01399684|Protective Agents|protective agents|mesh-ancestor
154324201|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
153954781|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324202|NCT01399684|Vitamins|vitamins|mesh-ancestor
154324203|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
154324204|NCT01399684|Hematinics|hematinics|mesh-ancestor
154324205|NCT01397968|Cenobamate|cenobamate|mesh-list
154324232|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324233|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154324234|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154324235|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324236|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
154324237|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154324238|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
154324239|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154324240|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
154324241|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
154324242|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154324243|NCT02266030|Protective Agents|protective agents|mesh-ancestor
154324244|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154324245|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154324246|NCT01527916|Donepezil|donepezil|mesh-list
154324247|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154324248|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324249|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324250|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
154324251|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503442|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
154324287|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154324288|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154186587|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324289|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154324290|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
154324291|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324324|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154324325|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
154324326|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324327|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324328|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324329|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154324330|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153503532|NCT03400722|Clomiphene|clomiphene|mesh-list
154324359|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
154324360|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324362|NCT01476904|Racepinephrine|racepinephrine|mesh-list
154324363|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
154324364|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154324365|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154324366|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
154324367|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324368|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324369|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324370|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154324371|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154324372|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
154324373|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324374|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154324375|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
154324376|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
154324377|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
153503574|NCT02241096|Lidocaine|lidocaine|mesh-list
154324411|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
154324412|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324413|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324415|NCT02265484|Bromocriptine|bromocriptine|mesh-list
154324416|NCT02265484|Lactulose|lactulose|mesh-list
154324417|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324418|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324444|NCT02267122|Mupirocin|mupirocin|mesh-list
154324445|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324446|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324447|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154324448|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324449|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324450|NCT01261312|Guadecitabine|guadecitabine|mesh-list
154324451|NCT01261312|Azacitidine|azacitidine|mesh-list
154324452|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324453|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154861754|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324454|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
154324455|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324456|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324457|NCT01254370|Travoprost|travoprost|mesh-list
154324458|NCT01254370|Latanoprost|latanoprost|mesh-list
154324459|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154324460|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154324461|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154324462|NCT01254136|Trastuzumab|trastuzumab|mesh-list
154324463|NCT01254136|Vinorelbine|vinorelbine|mesh-list
154324464|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154324465|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324466|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154324467|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
154324493|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324494|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324495|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154324496|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154324497|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
154324498|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154324499|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154324500|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
154324501|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
154324502|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324503|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154324504|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154324505|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154324506|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154324507|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154324508|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
154324509|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324510|NCT00039377|Antidotes|antidotes|mesh-ancestor
154324511|NCT00039377|Protective Agents|protective agents|mesh-ancestor
154324512|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
154324514|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
154324515|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154324516|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
154324517|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
154324518|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
154324548|NCT00154102|Cetuximab|cetuximab|mesh-list
154324549|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
154324550|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
154324551|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324552|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154324553|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324554|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154324555|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
154324556|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324557|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154324558|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154324559|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324560|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154324561|NCT00154102|Antidotes|antidotes|mesh-ancestor
154324562|NCT00154102|Protective Agents|protective agents|mesh-ancestor
154186678|NCT00892307|Adenosine|adenosine|mesh-list
154324563|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
154324564|NCT00154102|Vitamins|vitamins|mesh-ancestor
154324565|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
154324599|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324600|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324602|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
154324603|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324604|NCT02236078|Isoniazid|isoniazid|mesh-list
154324605|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
154324606|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324607|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324608|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154324646|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324667|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
154324668|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
154324669|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154324670|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154324671|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154324672|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154324673|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
154324674|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861755|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154324675|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324676|NCT01076764|Heparin|heparin|mesh-list
154324677|NCT01076764|Calcium heparin|calcium heparin|mesh-list
154324678|NCT01076764|Otamixaban|otamixaban|mesh-list
154324679|NCT01076764|Eptifibatide|eptifibatide|mesh-list
154324680|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
154324681|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154324682|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154324683|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324684|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154324685|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154324686|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
154324687|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154324688|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
154324689|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324690|NCT02269072|Anastrozole|anastrozole|mesh-list
154324691|NCT02269072|Leuprolide|leuprolide|mesh-list
154582972|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
154324692|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154324693|NCT02269072|Testosterone|testosterone|mesh-list
154324694|NCT02269072|Androgens|androgens|mesh-ancestor
154324695|NCT02269072|Hormones|hormones|mesh-ancestor
154324696|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324697|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324698|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154324699|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071451|NCT04110288|Paclitaxel|paclitaxel|mesh-list
153503883|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
154324736|NCT01030432|Asunaprevir|asunaprevir|mesh-list
154324737|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
154324763|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324764|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
154324766|NCT02269540|Sertraline|sertraline|mesh-list
154324767|NCT02269540|Citalopram|citalopram|mesh-list
154324768|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154324769|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
154324770|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324771|NCT02269540|Expectorants|expectorants|mesh-ancestor
154324772|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
154324773|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153570061|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
154324774|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
154324775|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324776|NCT02269540|Protective Agents|protective agents|mesh-ancestor
154324777|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324778|NCT02269540|Antidotes|antidotes|mesh-ancestor
154324779|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
154324780|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154324781|NCT02269540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154324782|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154324783|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154324820|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324850|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324851|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
154324852|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324853|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154324854|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154324855|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324856|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154324857|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
154324858|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324859|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154324860|NCT00035555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154324862|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154324863|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324864|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324865|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
154324891|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154324892|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324893|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
154324894|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154324895|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324896|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154324897|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324899|NCT01088009|Adefovir|adefovir|mesh-list
154324900|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154861756|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154324901|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154324902|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324903|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324904|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
154324905|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324906|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154324907|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154324908|NCT03894046|Imipenem|imipenem|mesh-list
154324909|NCT03894046|Colistin|colistin|mesh-list
154324910|NCT03894046|Sulbactam|sulbactam|mesh-list
154324911|NCT03894046|Durlobactam|durlobactam|mesh-list
154324912|NCT03894046|Cilastatin|cilastatin|mesh-list
154324913|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324914|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324915|NCT03894046|Protease Inhibitors|protease inhibitors|mesh-ancestor
153504104|NCT00552708|Lisinopril|lisinopril|mesh-list
154324949|NCT01001338|Lesinurad|lesinurad|mesh-list
154324950|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
154324951|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324952|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324953|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
154324954|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324955|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154324956|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
154324957|NCT01001338|Protective Agents|protective agents|mesh-ancestor
153504145|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154324985|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324987|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154324988|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154324989|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324990|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154324991|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154324992|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154324993|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
154324994|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154324995|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154324996|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154324997|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324998|NCT05628610|Paclitaxel|paclitaxel|mesh-list
154324999|NCT05628610|Carboplatin|carboplatin|mesh-list
154325034|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154325035|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
154325036|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325037|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325038|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504235|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154325070|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
154325071|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154325072|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154325073|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
154325074|NCT01129648|Protective Agents|protective agents|mesh-ancestor
154325075|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325076|NCT04438720|Nifedipine|nifedipine|mesh-list
154325077|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154325078|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325079|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325080|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154325081|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325113|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325114|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154325115|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
154325116|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325117|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325119|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
154325120|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325121|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
154325122|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325123|NCT01088165|Adalimumab|adalimumab|mesh-list
154325124|NCT01088165|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154325125|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325126|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154325127|NCT00892762|Travoprost|travoprost|mesh-list
154325128|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154861757|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
154325158|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325159|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154325160|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
154325161|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154325162|NCT00890890|BMS 708163|bms 708163|mesh-list
154325163|NCT00890890|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154325164|NCT00890890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325165|NCT00890890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325166|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
154325167|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154325168|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325169|NCT03175172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154325170|NCT03175172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325171|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154325172|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154325173|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
153504362|NCT05767827|Lidocaine|lidocaine|mesh-list
154325187|NCT01088555|Antidotes|antidotes|mesh-ancestor
154325188|NCT01088555|Protective Agents|protective agents|mesh-ancestor
154325189|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325190|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
154325191|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325192|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
154325193|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325194|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325195|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
154325196|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
154325197|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
154325198|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
154325199|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325201|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
154325202|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325203|NCT00078767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154325204|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154325205|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325206|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325207|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325208|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
154325209|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325210|NCT04474288|Antibodies|antibodies|mesh-list
154325211|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
154325212|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325213|NCT00078377|Modafinil|modafinil|mesh-list
154325214|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154325215|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325216|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154325217|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154325218|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154325219|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325220|NCT01107496|Viloxazine|viloxazine|mesh-list
154325221|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154325222|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
154325223|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325224|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154325225|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154325226|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325227|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325228|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
154325229|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325230|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325231|NCT00886600|Losartan|losartan|mesh-list
154325232|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154325233|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154325294|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
154325295|NCT00945802|Dexamethasone|dexamethasone|mesh-list
154325296|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
154325297|NCT00945802|BB 1101|bb 1101|mesh-list
154325298|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325299|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
154325300|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
154325301|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325302|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325303|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325304|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
154325306|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325307|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325308|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325309|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
154325310|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325311|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325312|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325313|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325314|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154325315|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154325316|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154325317|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154325318|NCT01105624|Azithromycin|azithromycin|mesh-list
154325319|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154325320|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153504509|NCT05631028|Analgesics|analgesics|mesh-ancestor
154325356|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325377|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325378|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
154325379|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154325380|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325381|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325382|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154325383|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154325384|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154325385|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154325386|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325387|NCT05096962|Antibodies|antibodies|mesh-list
154325388|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
154325389|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325390|NCT00869128|Melatonin|melatonin|mesh-list
154325391|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
154325392|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325393|NCT00869128|Protective Agents|protective agents|mesh-ancestor
154325394|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325395|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154325396|NCT00945646|Dexamethasone|dexamethasone|mesh-list
154325397|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325398|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
154325399|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
154325400|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325401|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325402|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072196|NCT00831376|Albuterol|albuterol|mesh-list
154325403|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
154325405|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325406|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325407|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325408|NCT00077675|Vancomycin|vancomycin|mesh-list
154325409|NCT00077675|Penicillins|penicillins|mesh-list
154325410|NCT00077675|Telavancin|telavancin|mesh-list
154325411|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325444|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154325445|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325447|NCT04945616|Clopidogrel|clopidogrel|mesh-list
154325448|NCT04945616|Ticagrelor|ticagrelor|mesh-list
154325449|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154325450|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154325451|NCT04945616|Analgesics|analgesics|mesh-ancestor
154325452|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
154325453|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504640|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
154325474|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154325475|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325476|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325477|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154325478|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154325479|NCT00849862|Levetiracetam|levetiracetam|mesh-list
154325480|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
154325481|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
154325482|NCT00077207|Carboplatin|carboplatin|mesh-list
154325483|NCT00077207|Vincristine|vincristine|mesh-list
154325484|NCT00077207|Temozolomide|temozolomide|mesh-list
154325485|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325486|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154325487|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
154325488|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
154325489|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
154325490|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325491|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154325492|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
154325493|NCT01099085|Simvastatin|simvastatin|mesh-list
154325494|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154325495|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154325496|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
154325497|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325498|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154325499|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154325500|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325501|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
154325502|NCT03206918|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154325503|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154325504|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325505|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325526|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
154325527|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325528|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325529|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154325530|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154325531|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325532|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154325533|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154325534|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154187041|NCT00900887|Ketorolac|ketorolac|mesh-list
154325535|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154325536|NCT00920764|Atrasentan|atrasentan|mesh-list
154325537|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325538|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154325539|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154325540|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325541|NCT05376046|Thrombin|thrombin|mesh-list
154325542|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
154325543|NCT05376046|Coagulants|coagulants|mesh-ancestor
154325544|NCT03034304|Carboplatin|carboplatin|mesh-list
154325545|NCT03034304|Gemcitabine|gemcitabine|mesh-list
154325546|NCT03034304|Doxorubicin|doxorubicin|mesh-list
154325547|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154325548|NCT03034304|Ifosfamide|ifosfamide|mesh-list
154325549|NCT03034304|Antibodies|antibodies|mesh-list
154325550|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
154325551|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325552|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325553|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154325554|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
154325555|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325556|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154325557|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154325558|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154325579|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154325580|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325581|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154325583|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
154325584|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325585|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325586|NCT00057941|Fulvestrant|fulvestrant|mesh-list
154325587|NCT00057941|Anastrozole|anastrozole|mesh-list
154325588|NCT00057941|Gefitinib|gefitinib|mesh-list
154325589|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325590|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325591|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154325592|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154325593|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
154325594|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325595|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325596|NCT00057941|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154325597|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154325598|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325599|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325600|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154325601|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154325602|NCT03005522|Dexamethasone|dexamethasone|mesh-list
154325603|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325604|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
154325605|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
154325606|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325607|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325608|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325609|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
154325610|NCT03005522|Hormones|hormones|mesh-ancestor
154325611|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325642|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154325643|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325644|NCT02996474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154325645|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325646|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154325647|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
154325648|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325649|NCT00821002|Latanoprost|latanoprost|mesh-list
154325650|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154325651|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154325652|NCT00820924|Lapatinib|lapatinib|mesh-list
154325653|NCT00820924|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154325654|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153504850|NCT03786783|Vitamins|vitamins|mesh-ancestor
154325683|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154325684|NCT04855526|Analgesics|analgesics|mesh-ancestor
154325685|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
154325686|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325687|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154325688|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154325689|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325690|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325691|NCT04855526|Hormones|hormones|mesh-ancestor
154325692|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325693|NCT02339090|Hormones|hormones|mesh-list
154325694|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325695|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325696|NCT05442008|Erenumab|erenumab|mesh-list
154325697|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154325698|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325721|NCT02038634|Hormones|hormones|mesh-ancestor
154325722|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325723|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325724|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154325725|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
154325726|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154325727|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154325728|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
154325729|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187136|NCT00909077|Rituximab|rituximab|mesh-list
154325730|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325731|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154325732|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154325733|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154325734|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154325735|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154325736|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
154325737|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325738|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325739|NCT03636308|Paclitaxel|paclitaxel|mesh-list
154325740|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154325741|NCT03636308|Gemcitabine|gemcitabine|mesh-list
154325742|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154325743|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325744|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
154325745|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
154325746|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
154861758|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325747|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325748|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154325749|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
154325762|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325763|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
154325764|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325765|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325766|NCT00835666|Urological Agents|urological agents|mesh-ancestor
154325767|NCT00835588|Pantoprazole|pantoprazole|mesh-list
154325768|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154325769|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325770|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154325771|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325772|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325773|NCT00713518|Ranibizumab|ranibizumab|mesh-list
154325774|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154325775|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154325776|NCT00713518|Growth Substances|growth substances|mesh-ancestor
154325777|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325778|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
154325779|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325780|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
154325781|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154325782|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
154325783|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325784|NCT00708292|Dexamethasone|dexamethasone|mesh-list
154325786|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325787|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
154325788|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
154325789|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325790|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325791|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325792|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
154325793|NCT00708292|Hormones|hormones|mesh-ancestor
154325794|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325795|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325796|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325797|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
154325798|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154325799|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325800|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154325801|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325802|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
154325803|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
154325804|NCT00835354|Cefprozil|cefprozil|mesh-list
154325805|NCT00835354|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154325806|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325807|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325808|NCT00698230|Metformin|metformin|mesh-list
154325809|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154325810|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325811|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
154325832|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325833|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325835|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325836|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325837|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154325838|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154325839|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
154325840|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325841|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325842|NCT01759238|Bevacizumab|bevacizumab|mesh-list
154325843|NCT01759238|Capecitabine|capecitabine|mesh-list
154325844|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154325845|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325846|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154072659|NCT00840112|Vitamin E|vitamin e|mesh-list
154325847|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154325848|NCT01759238|Growth Substances|growth substances|mesh-ancestor
154325849|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325850|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
154325851|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154325852|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
154325853|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325854|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154325855|NCT00835042|Moexipril|moexipril|mesh-list
154325856|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154325857|NCT00835042|Diuretics|diuretics|mesh-ancestor
154325858|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
154325859|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325860|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154325861|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325862|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325880|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325881|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325882|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325883|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325884|NCT00834574|Cefdinir|cefdinir|mesh-list
154325885|NCT00834574|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154325886|NCT00834574|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154325887|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325888|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325889|NCT04879966|Infliximab|infliximab|mesh-list
154325890|NCT04879966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154325891|NCT04879966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325892|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
154325893|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325894|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154325895|NCT00834418|Leflunomide|leflunomide|mesh-list
154325896|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325897|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325898|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154325899|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
154325900|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325901|NCT04621318|Denosumab|denosumab|mesh-list
154325902|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154325903|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325904|NCT00834340|Glimepiride|glimepiride|mesh-list
154325905|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154325906|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154325907|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325908|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154325909|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
154325910|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
154325911|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325912|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
154325913|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325914|NCT04473274|Pioglitazone|pioglitazone|mesh-list
154325915|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154325916|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325917|NCT00679588|Enoxaparin|enoxaparin|mesh-list
154325918|NCT00679588|Semuloparin|semuloparin|mesh-list
154325941|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154325942|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154325944|NCT00830206|Azithromycin|azithromycin|mesh-list
154325945|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325946|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325947|NCT00829504|Ropinirole|ropinirole|mesh-list
154325948|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154325949|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154325950|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
154325951|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
154325952|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325953|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325954|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325955|NCT00829426|Alprazolam|alprazolam|mesh-list
154325956|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154325957|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154325958|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325959|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154325960|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154325961|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325962|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
154325963|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
154325964|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325965|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325966|NCT00152464|Levocetirizine|levocetirizine|mesh-list
154325967|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154325968|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154325969|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
154325990|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154325991|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154325992|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325994|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
154325996|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154325997|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325998|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
154325999|NCT00770848|Hormones|hormones|mesh-ancestor
154326000|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326001|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326002|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154326003|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326004|NCT00770848|Analgesics|analgesics|mesh-ancestor
154326005|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
154326006|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326007|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154326008|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154326009|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326010|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326011|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154326012|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
154326013|NCT00672412|Lamivudine|lamivudine|mesh-list
154326014|NCT00672412|Zidovudine|zidovudine|mesh-list
154326015|NCT00672412|Nevirapine|nevirapine|mesh-list
154326016|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154326017|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154326018|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326019|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326020|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
154326021|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326022|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153505222|NCT04823442|Bisoprolol|bisoprolol|mesh-list
154326048|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
154326049|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326050|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154326051|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326052|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326054|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154326055|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154326056|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154326057|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
154326058|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
154326059|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326060|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326061|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326062|NCT01642004|Docetaxel|docetaxel|mesh-list
154326063|NCT01642004|Nivolumab|nivolumab|mesh-list
154326064|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326065|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
154326066|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
154326067|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154326068|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326069|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154326070|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154326072|NCT00042289|Lopinavir|lopinavir|mesh-list
154326119|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154326135|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154326136|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154326137|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326138|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154326139|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154326140|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154326141|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154326142|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154326143|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154326144|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154326145|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154326146|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154326147|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
154326148|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
154326149|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154326150|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154326151|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154326152|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154326153|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154326154|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154326155|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
154326156|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154326157|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154326158|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154326159|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154326160|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154326161|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154326162|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326163|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154326165|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154326166|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
154326167|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
154326168|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326169|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
154326170|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326171|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
154326172|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326173|NCT01096693|Substance P|substance p|mesh-list
154326174|NCT01096693|Neurokinin A|neurokinin a|mesh-list
153505363|NCT01385631|Ezetimibe|ezetimibe|mesh-list
154326197|NCT03191396|Semaglutide|semaglutide|mesh-list
154326198|NCT03191396|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154326199|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154326200|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326201|NCT03191396|Incretins|incretins|mesh-ancestor
154326202|NCT03191396|Hormones|hormones|mesh-ancestor
154326203|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326204|NCT03509636|Fluzoparib|fluzoparib|mesh-list
154326205|NCT03509636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154326206|NCT03509636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326207|NCT03509636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326208|NCT03509636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326209|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154326210|NCT00007345|Romidepsin|romidepsin|mesh-list
154326211|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154326212|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326213|NCT00007345|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154326214|NCT00007345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326215|NCT00007345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326216|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154326217|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
154326218|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326219|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154326220|NCT00031447|Acyclovir|acyclovir|mesh-list
154326221|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
154326222|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326223|NCT00006289|Neurotropin|neurotropin|mesh-list
154073016|NCT00912899|Noscapine|noscapine|mesh-list
154326258|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154326259|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154326260|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154326261|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326262|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154326263|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154326264|NCT00005047|Doxorubicin|doxorubicin|mesh-list
154326265|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154326277|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326278|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154326279|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
154326280|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
154326281|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154326282|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154326283|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
154326284|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154326285|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154326286|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153955683|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
154326287|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
154326288|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
154326289|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
154326290|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154326292|NCT01103635|Tremelimumab|tremelimumab|mesh-list
154326293|NCT01103635|Antibodies|antibodies|mesh-list
154326294|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
154326295|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154326296|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
154326297|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326298|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326299|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154073086|NCT00765063|Dalteparin|dalteparin|mesh-list
154326300|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326301|NCT03949075|Enalapril|enalapril|mesh-list
154326302|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154326303|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
154326304|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326305|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326306|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154326307|NCT01101529|Aprepitant|aprepitant|mesh-list
154326308|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
154326309|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
154326310|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326311|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326312|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154326313|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154326314|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326315|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326316|NCT01100125|Insulin|insulin|mesh-list
154326317|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154326318|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154326319|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
154326320|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154326321|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326322|NCT01100125|Incretins|incretins|mesh-ancestor
154326323|NCT01100125|Hormones|hormones|mesh-ancestor
154326324|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326325|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154326326|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
154326327|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326359|NCT01103791|Docetaxel|docetaxel|mesh-list
154326360|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326361|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
154326362|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
154326363|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
154326364|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326365|NCT03800173|Galidesivir|galidesivir|mesh-list
154326366|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
154326367|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326368|NCT00003631|Cytarabine|cytarabine|mesh-list
154326369|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
154326404|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326405|NCT00030901|Trace Elements|trace elements|mesh-ancestor
154326406|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
154326407|NCT01104259|Vinorelbine|vinorelbine|mesh-list
154326409|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326410|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153505617|NCT01386671|Metformin|metformin|mesh-list
154326445|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154326446|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
154326447|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326448|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154326449|NCT00003199|Analgesics|analgesics|mesh-ancestor
154326450|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
154326476|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326478|NCT03951415|Olaparib|olaparib|mesh-list
154326479|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154326480|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154326481|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326482|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326483|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326484|NCT00001849|Edetic Acid|edetic acid|mesh-list
154326485|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
154861759|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955760|NCT00931710|Diuretics|diuretics|mesh-ancestor
154326486|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326487|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326488|NCT00001849|Antidotes|antidotes|mesh-ancestor
154326489|NCT00001849|Protective Agents|protective agents|mesh-ancestor
154326490|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
154326491|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
154326492|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154326493|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
154326494|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154326495|NCT01104571|Trastuzumab|trastuzumab|mesh-list
154326496|NCT01104571|Lapatinib|lapatinib|mesh-list
154326497|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505693|NCT01387373|Capecitabine|capecitabine|mesh-list
154326526|NCT01104883|Trace Elements|trace elements|mesh-ancestor
154326527|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
154326528|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326529|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154326530|NCT04371380|Rilpivirine|rilpivirine|mesh-list
154326531|NCT04371380|Cabotegravir|cabotegravir|mesh-list
154326532|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154326533|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154326534|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326535|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326536|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
154326537|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326538|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154326539|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154326540|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154326541|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154326542|NCT01341080|Varenicline|varenicline|mesh-list
154326543|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154326544|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153505739|NCT01387997|Antibodies|antibodies|mesh-list
154326563|NCT01332344|Fluticasone|fluticasone|mesh-list
154326564|NCT01332344|Xhance|xhance|mesh-list
154326565|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154326566|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326567|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154326568|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
154326569|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326570|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326571|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154326572|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
154326573|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
154326574|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154326575|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154326576|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154326577|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154326578|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
154326579|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326580|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326581|NCT01332422|Fluticasone|fluticasone|mesh-list
154326582|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154326583|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154326584|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326585|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154326586|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
154326587|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326588|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326589|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154326590|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
154326591|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
154326592|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154326593|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154326594|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154326595|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154326596|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
154326597|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326598|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326599|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
154326600|NCT01332422|Hormones|hormones|mesh-ancestor
153505784|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
154326622|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154326623|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
154326624|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154861760|NCT03944681|Droperidol|droperidol|mesh-list
154326625|NCT03326492|Antivenins|antivenins|mesh-list
154326626|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
154326627|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326628|NCT01524536|Prednisone|prednisone|mesh-list
154326629|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326630|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
154326631|NCT01524536|Hormones|hormones|mesh-ancestor
154326632|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326633|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326634|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154326635|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326636|NCT00533468|Lidocaine|lidocaine|mesh-list
154326637|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
154326638|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
154326639|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154326640|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326641|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
154326642|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326643|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154326644|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154326645|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154326646|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326647|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326648|NCT01333124|Gemcitabine|gemcitabine|mesh-list
154326649|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154326650|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
154326651|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326663|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326664|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154326665|NCT00004124|Prednisone|prednisone|mesh-list
154326666|NCT00004124|Goserelin|goserelin|mesh-list
154326667|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
154326668|NCT00004124|Bicalutamide|bicalutamide|mesh-list
154326669|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326670|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
154326671|NCT00004124|Hormones|hormones|mesh-ancestor
154326672|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326673|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326674|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154326675|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326676|NCT00004124|Analgesics|analgesics|mesh-ancestor
154326677|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
154326678|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326679|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154326680|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154326681|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326682|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326683|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
154326684|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
154326685|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
154326686|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154326687|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326689|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154326690|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326691|NCT01334762|Letrozole|letrozole|mesh-list
154326692|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326693|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154326694|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154326695|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326696|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326697|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154326698|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
154326699|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326700|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326701|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
154326702|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
154326703|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154326704|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
154326705|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326706|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326707|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154326708|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
154326709|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154255921|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154326710|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154326711|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154326712|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
154326713|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326714|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326715|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326747|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154326748|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326749|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326751|NCT01776424|Pantoprazole|pantoprazole|mesh-list
154326752|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
154326753|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154326754|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154326755|NCT01776424|Analgesics|analgesics|mesh-ancestor
154326756|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
154326757|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326758|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326759|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505957|NCT01389206|Bosentan|bosentan|mesh-list
154326779|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326780|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326781|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154326782|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
154326783|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
154326785|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326786|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
154326787|NCT00629980|Azithromycin|azithromycin|mesh-list
154326788|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154326789|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326790|NCT00629590|Azithromycin|azithromycin|mesh-list
154326791|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154326792|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326793|NCT00626704|Doxorubicin|doxorubicin|mesh-list
154326794|NCT00626704|Conatumumab|conatumumab|mesh-list
154326795|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154326796|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326797|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154326798|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154326799|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326800|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326801|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154326802|NCT00765700|Ketoprofen|ketoprofen|mesh-list
154326803|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154326804|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154326805|NCT00765700|Analgesics|analgesics|mesh-ancestor
154326806|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
154326807|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326808|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326809|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326810|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154326811|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154326812|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326813|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326814|NCT02280694|Celecoxib|celecoxib|mesh-list
154326834|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154326835|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154326836|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154326837|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154326839|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
154326840|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326841|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326842|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154326843|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154326844|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154326845|NCT02280772|Cathartics|cathartics|mesh-ancestor
154326846|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154326847|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
154326848|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
154326849|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
154326850|NCT02281006|Antidotes|antidotes|mesh-ancestor
154326851|NCT02281006|Protective Agents|protective agents|mesh-ancestor
154326852|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861761|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153955978|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
154326853|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
154326854|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326855|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
154326856|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154326857|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326858|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
154326859|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
154326860|NCT00758290|Triclosan|triclosan|mesh-list
154326861|NCT00758290|Fluorides|fluorides|mesh-list
154326862|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
154326863|NCT00758290|Protective Agents|protective agents|mesh-ancestor
154326864|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326865|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154326866|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326867|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154326868|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154326869|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
154326870|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326871|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154326892|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154326893|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
154326894|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154326895|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154326896|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154326897|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326898|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326899|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
154326900|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326901|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326902|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154326903|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326904|NCT02276014|Beta Carotene|beta carotene|mesh-list
154326905|NCT02276014|Carotenoids|carotenoids|mesh-list
154326906|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
154326907|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326908|NCT02276014|Protective Agents|protective agents|mesh-ancestor
154326909|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326910|NCT02276014|Provitamins|provitamins|mesh-ancestor
154326911|NCT02276014|Vitamins|vitamins|mesh-ancestor
154326912|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
154326913|NCT01102387|Octenidine|octenidine|mesh-list
154326914|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326915|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154326916|NCT02277808|Amikacin|amikacin|mesh-list
154326917|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154326918|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326919|NCT02281240|Oprelvekin|oprelvekin|mesh-list
154326920|NCT02281240|Heparin|heparin|mesh-list
154326921|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
154326922|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154326923|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154326924|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326925|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326926|NCT01102465|Losartan|losartan|mesh-list
154326961|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326962|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154326963|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154326964|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
154326965|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326994|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326996|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154326997|NCT03947125|Narcotics|narcotics|mesh-ancestor
154326998|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154326999|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327000|NCT03947125|Analgesics|analgesics|mesh-ancestor
154327001|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
154327002|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327003|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154327004|NCT00658762|Paroxetine|paroxetine|mesh-list
154327005|NCT00658762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154327006|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154327007|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327008|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861762|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
154861763|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
153956059|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
154327009|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327010|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
154327011|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327012|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154327013|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
153506207|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
154327032|NCT03946657|Anesthetics|anesthetics|mesh-list
154327033|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
154327034|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327035|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327036|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
154327037|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
154327038|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154327039|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327040|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327041|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154327042|NCT01106053|Pramipexole|pramipexole|mesh-list
154327043|NCT01106053|Dexpramipexole|dexpramipexole|mesh-list
154327044|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
154327045|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327046|NCT01106053|Protective Agents|protective agents|mesh-ancestor
154327047|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327048|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154327049|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154327050|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
154327051|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
154327052|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327053|NCT00616330|Clindamycin|clindamycin|mesh-list
154327054|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
154327055|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
154327056|NCT00616330|Butoconazole|butoconazole|mesh-list
154327057|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154327058|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327059|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154327060|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327061|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327062|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
154327063|NCT00612820|Fluticasone|fluticasone|mesh-list
154327064|NCT00612820|Xhance|xhance|mesh-list
154327065|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
153506257|NCT01390792|Zanamivir|zanamivir|mesh-list
154327088|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
154327091|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327092|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327093|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154327094|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
154327095|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154327096|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327097|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327098|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154327099|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154327100|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154327101|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
154327102|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
154327103|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327104|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154327105|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154327107|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327108|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327109|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154327110|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327111|NCT01102699|Lenograstim|lenograstim|mesh-list
154327112|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153506306|NCT01390961|Naphazoline|naphazoline|mesh-list
154327143|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327144|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154327145|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154327146|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
154327147|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
154327148|NCT02743780|MGV354|mgv354|mesh-list
154327149|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
154861764|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327150|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327151|NCT02280148|Propofol|propofol|mesh-list
154327152|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
154327153|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327154|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327155|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154327156|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154327157|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
154327158|NCT00602602|Bevacizumab|bevacizumab|mesh-list
154327159|NCT00602602|Gemcitabine|gemcitabine|mesh-list
154327160|NCT00602602|Fluorouracil|fluorouracil|mesh-list
153506370|NCT01391377|Niacin|niacin|mesh-list
154073829|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
154327192|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154327193|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327194|NCT04471480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154327195|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327197|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
154327198|NCT01111513|Analgesics|analgesics|mesh-list
154327199|NCT01111513|Ropivacaine|ropivacaine|mesh-list
154327200|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
154327201|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
154327202|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327203|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327204|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
154327237|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154327238|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154327239|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154327240|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327241|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327242|NCT03944473|Neostigmine|neostigmine|mesh-list
154327243|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154327244|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327245|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327246|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
154327268|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327269|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
154327270|NCT02280538|Protective Agents|protective agents|mesh-ancestor
154327271|NCT01111747|Mitogens|mitogens|mesh-list
154327272|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
154327273|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327274|NCT02281708|Cisplatin|cisplatin|mesh-list
154327275|NCT02281708|Vinorelbine|vinorelbine|mesh-list
154327276|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327277|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154327278|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154327279|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154327280|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154327281|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327282|NCT01111903|Lenalidomide|lenalidomide|mesh-list
154327283|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
154327284|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327285|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154327286|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154327287|NCT01111903|Growth Substances|growth substances|mesh-ancestor
154327288|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
154327289|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327290|NCT02280616|Budesonide|budesonide|mesh-list
154327291|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327292|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154327293|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
154327294|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327295|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327296|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154327297|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
154327298|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
154327299|NCT02280616|Hormones|hormones|mesh-ancestor
154327300|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327318|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
154327319|NCT03942601|Temsirolimus|temsirolimus|mesh-list
154327320|NCT03942601|MTOR Inhibitors|mtor inhibitors|mesh-list
154327321|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154327322|NCT03942601|BB 1101|bb 1101|mesh-list
154327323|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327324|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
153956204|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327325|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
154327326|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327327|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327328|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154327329|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
154327330|NCT03942601|Hormones|hormones|mesh-ancestor
154327331|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187986|NCT04015661|Paclitaxel|paclitaxel|mesh-list
154327332|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154327333|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327334|NCT03942601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154327335|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327336|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327337|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154327338|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
154327339|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154327340|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327341|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154327342|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
154327343|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
154327344|NCT00598312|Leuprolide|leuprolide|mesh-list
154327345|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154073959|NCT00833261|Paclitaxel|paclitaxel|mesh-list
154327346|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
154327347|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154327348|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327349|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154327350|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327351|NCT00595426|Warfarin|warfarin|mesh-list
154327352|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
154327353|NCT01112137|Clopidogrel|clopidogrel|mesh-list
154327354|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154327355|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154327356|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154327357|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154327358|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
154327359|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506537|NCT01392716|Rituximab|rituximab|mesh-list
154327379|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327380|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154327381|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154327382|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154327383|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327384|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327385|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327386|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327387|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154327388|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
154327389|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154327391|NCT01107067|Androgens|androgens|mesh-ancestor
154327392|NCT01107067|Hormones|hormones|mesh-ancestor
154327393|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327394|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327395|NCT02282176|Azithromycin|azithromycin|mesh-list
154327396|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154327397|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327399|NCT00580216|Warfarin|warfarin|mesh-list
154327400|NCT00580216|Idraparinux|idraparinux|mesh-list
154327401|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
154327402|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
154327403|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154327404|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
154327405|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154327406|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
154327407|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327408|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327409|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
154327410|NCT00580216|Vitamins|vitamins|mesh-ancestor
154327411|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
154327412|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327413|NCT01107145|Artesunate|artesunate|mesh-list
154327414|NCT01107145|Chloroquine|chloroquine|mesh-list
153506600|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
154327448|NCT01112215|Azathioprine|azathioprine|mesh-list
154861765|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327449|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154327450|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327451|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154327452|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
154327453|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154327454|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327455|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327456|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327457|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
154327475|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154327477|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154327478|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327479|NCT00384904|Ritonavir|ritonavir|mesh-list
154327480|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154327481|NCT00384904|Tenofovir|tenofovir|mesh-list
154327482|NCT00384904|Famotidine|famotidine|mesh-list
154327483|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154327484|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154327485|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
154327486|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327487|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327488|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154327489|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154327490|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
154327491|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327492|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154327493|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154327494|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154327495|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154327496|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154327497|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154327498|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154327499|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
154327500|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
154327501|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327502|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327503|NCT01335386|Glycerol|glycerol|mesh-list
154327504|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154327505|NCT01335386|Protective Agents|protective agents|mesh-ancestor
154327506|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327507|NCT00383578|Metformin|metformin|mesh-list
154327508|NCT00383578|Vildagliptin|vildagliptin|mesh-list
154327509|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327510|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327511|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154327512|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
154327513|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449778|NCT00004373|Alprazolam|alprazolam|mesh-list
154327543|NCT00092690|Atorvastatin|atorvastatin|mesh-list
154327544|NCT00092690|Simvastatin|simvastatin|mesh-list
154327545|NCT00092690|Ezetimibe|ezetimibe|mesh-list
154327546|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154327547|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154327548|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
154327549|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327550|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154327551|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154327552|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327553|NCT02286700|Desonide|desonide|mesh-list
154327554|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327555|NCT01338896|Rotigotine|rotigotine|mesh-list
154327556|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
154327578|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327579|NCT00379990|Prednisolone|prednisolone|mesh-list
154327580|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327581|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
154327582|NCT00379990|Hormones|hormones|mesh-ancestor
154327583|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327584|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327585|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154327586|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327587|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154327588|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
154327589|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327590|NCT01341938|Nicotine|nicotine|mesh-list
153956365|NCT02605915|Immunotoxins|immunotoxins|mesh-ancestor
154327591|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154327592|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
154327593|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327594|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327595|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154327596|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154327597|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
154327598|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327599|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327600|NCT02284048|Ticagrelor|ticagrelor|mesh-list
154327601|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154327602|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154327603|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154327604|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154327605|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
154327606|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506789|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154327628|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154327629|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154327630|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327631|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327632|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
154327633|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327634|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327635|NCT00468442|Sirolimus|sirolimus|mesh-list
154327636|NCT00468442|Rituximab|rituximab|mesh-list
154327637|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154327638|NCT00468442|Daclizumab|daclizumab|mesh-list
154327639|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154327640|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327641|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
154327642|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327643|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154327644|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154327645|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327646|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154327647|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
154327649|NCT01339442|Fulvestrant|fulvestrant|mesh-list
154327650|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188145|NCT00931229|Entecavir|entecavir|mesh-list
154327651|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327652|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154327653|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154327654|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
154327655|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327656|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327657|NCT02286934|Carvedilol|carvedilol|mesh-list
154327658|NCT02286934|Isoproterenol|isoproterenol|mesh-list
154327659|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154327660|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154327677|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
154327678|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327679|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154327680|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
154327681|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154327682|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
154327683|NCT02282410|Factor VIII|factor viii|mesh-list
154327684|NCT02282410|Coagulants|coagulants|mesh-ancestor
154327685|NCT00092612|Ezetimibe|ezetimibe|mesh-list
154327686|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154327687|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154327688|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
154327689|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327690|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154327691|NCT00540358|Carboplatin|carboplatin|mesh-list
154327692|NCT00540358|Gemcitabine|gemcitabine|mesh-list
154327693|NCT00540358|Iniparib|iniparib|mesh-list
154327694|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327695|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154327696|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
154327697|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327698|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154327699|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327700|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154861766|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154327701|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
154327702|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154327703|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
154327704|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327705|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154327706|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154327707|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154327708|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327709|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327710|NCT02287246|Bupivacaine|bupivacaine|mesh-list
154327711|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
154327712|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
154327713|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327714|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327715|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
154327716|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327717|NCT04470544|Camostat|camostat|mesh-list
154327718|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
154327741|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154327742|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154327743|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154327744|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
154327745|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
154327747|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327748|NCT00369070|Paclitaxel|paclitaxel|mesh-list
154327749|NCT00369070|Bevacizumab|bevacizumab|mesh-list
154327750|NCT00369070|Carboplatin|carboplatin|mesh-list
154327751|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
154327752|NCT00369070|Imetelstat|imetelstat|mesh-list
154327753|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154327754|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327755|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
154327756|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
154327757|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
154327758|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327759|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154327760|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154327761|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154327762|NCT00369070|Growth Substances|growth substances|mesh-ancestor
154327763|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327764|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
154327765|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154327766|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327767|NCT02284204|Midazolam|midazolam|mesh-list
154327768|NCT02284204|Ketamine|ketamine|mesh-list
154327769|NCT02284204|Sevoflurane|sevoflurane|mesh-list
154327770|NCT02284204|Analgesics|analgesics|mesh-ancestor
153506952|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154327796|NCT00531622|Escitalopram|escitalopram|mesh-list
154327797|NCT00531622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154327798|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154327799|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327800|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327801|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327802|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
154327803|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327805|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154327806|NCT00364546|Narcotics|narcotics|mesh-ancestor
154327807|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327808|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327809|NCT00364546|Analgesics|analgesics|mesh-ancestor
154327810|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
154327811|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327812|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154327813|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154327814|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327815|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327816|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154327817|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327842|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
154327843|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154327844|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327845|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154327846|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
154861767|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154327847|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327848|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327849|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
154327850|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327851|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154327852|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154327853|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
154327854|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154327855|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154327857|NCT02284282|Morphine|morphine|mesh-list
154327858|NCT02284282|Bupivacaine|bupivacaine|mesh-list
154327859|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
154327860|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
154327861|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327862|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327863|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
154327864|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327865|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154327866|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154327867|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154327894|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154327895|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154327896|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154327897|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154327898|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
154327899|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327900|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327901|NCT02287558|Pomalidomide|pomalidomide|mesh-list
154327902|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
154327903|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327904|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154327905|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154327906|NCT02287558|Growth Substances|growth substances|mesh-ancestor
154327907|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
154327908|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327909|NCT04470076|Carboplatin|carboplatin|mesh-list
154327910|NCT04470076|Gemcitabine|gemcitabine|mesh-list
154327911|NCT04470076|Pemetrexed|pemetrexed|mesh-list
154327912|NCT04470076|Afatinib|afatinib|mesh-list
154327913|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327914|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154327915|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
154327916|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327917|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327918|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154327919|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153507099|NCT01395485|Brodalumab|brodalumab|mesh-list
154327981|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154327982|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327983|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154327984|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154327985|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327986|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327987|NCT05982704|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154327988|NCT05982704|Antiviral Agents|antiviral agents|mesh-ancestor
154327989|NCT05982704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327997|NCT05982587|Calcium Carbonate|calcium carbonate|mesh-list
154327999|NCT05982587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328000|NCT05982587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328001|NCT05982522|Paclitaxel|paclitaxel|mesh-list
154328002|NCT05982522|Tislelizumab|tislelizumab|mesh-list
154328003|NCT05982522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154328004|NCT05982522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328005|NCT05982522|Tubulin Modulators|tubulin modulators|mesh-ancestor
153507199|NCT01395875|Xhance|xhance|mesh-list
154328063|NCT05981742|Metformin|metformin|mesh-list
154328064|NCT05981742|Cabergoline|cabergoline|mesh-list
154328065|NCT05981742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328066|NCT05981742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328067|NCT05981742|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154328068|NCT05981742|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154328069|NCT05981742|Dopamine Agonists|dopamine agonists|mesh-ancestor
154328070|NCT05981742|Dopamine Agents|dopamine agents|mesh-ancestor
154328071|NCT05981742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328072|NCT05981742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328073|NCT05981079|Tazobactam|tazobactam|mesh-list
154328075|NCT05981079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154328076|NCT05981079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154328077|NCT05981079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328078|NCT05981079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154328079|NCT05981079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328080|NCT05981079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328081|NCT05981053|Resveratrol|resveratrol|mesh-list
154328082|NCT05981053|Antioxidants|antioxidants|mesh-ancestor
154328083|NCT05981053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328084|NCT05981053|Protective Agents|protective agents|mesh-ancestor
154328085|NCT05981053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328086|NCT05981053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328087|NCT05981053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154328088|NCT05981014|Paclitaxel|paclitaxel|mesh-list
154328089|NCT05981014|Cyclophosphamide|cyclophosphamide|mesh-list
154328090|NCT05981014|Doxorubicin|doxorubicin|mesh-list
154328091|NCT05981014|Fludarabine|fludarabine|mesh-list
154328092|NCT05981014|Interleukin-2|interleukin-2|mesh-list
154328093|NCT05981014|Epirubicin|epirubicin|mesh-list
154328094|NCT05981014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154328125|NCT05981001|Mitosis Modulators|mitosis modulators|mesh-ancestor
154328126|NCT05981001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328127|NCT05981001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328128|NCT05981001|Immunologic Factors|immunologic factors|mesh-ancestor
154328129|NCT05981001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328130|NCT05981001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328131|NCT05981001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328132|NCT05981001|Alkylating Agents|alkylating agents|mesh-ancestor
154328133|NCT05981001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328134|NCT05981001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328135|NCT05981001|Antimetabolites|antimetabolites|mesh-ancestor
154328136|NCT05981001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154328137|NCT05981001|Analgesics|analgesics|mesh-ancestor
154328138|NCT05981001|Sensory System Agents|sensory system agents|mesh-ancestor
154328139|NCT05981001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328140|NCT05980871|Doxycycline|doxycycline|mesh-list
154328141|NCT05980871|Ceftriaxone|ceftriaxone|mesh-list
154328142|NCT05980871|Penicillins|penicillins|mesh-list
154328175|NCT05978219|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154328176|NCT05978219|Histamine Antagonists|histamine antagonists|mesh-ancestor
154328177|NCT05978219|Histamine Agents|histamine agents|mesh-ancestor
154328178|NCT05978219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328179|NCT05978219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328180|NCT05978219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328181|NCT05978219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154328182|NCT05978219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154328183|NCT05978219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328184|NCT05978219|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154328214|NCT05947201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328216|NCT05914389|Oxaliplatin|oxaliplatin|mesh-list
154328217|NCT05914389|Antibodies|antibodies|mesh-list
154328218|NCT05914389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154328219|NCT05914389|Immunologic Factors|immunologic factors|mesh-ancestor
154328220|NCT05914389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328221|NCT05914389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328222|NCT05914389|Antimetabolites|antimetabolites|mesh-ancestor
154328223|NCT05914389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328224|NCT05914389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328225|NCT05909267|Carbidopa|carbidopa|mesh-list
154328226|NCT05909267|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154328227|NCT05909267|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154328228|NCT05909267|Dopamine Agents|dopamine agents|mesh-ancestor
154328229|NCT05909267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328252|NCT05863364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154328253|NCT05863364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328254|NCT05863364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328255|NCT05816252|Carboplatin|carboplatin|mesh-list
154328256|NCT05816252|Pembrolizumab|pembrolizumab|mesh-list
154328257|NCT05816252|Osimertinib|osimertinib|mesh-list
154328258|NCT05816252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328259|NCT05816252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328260|NCT05816252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154328261|NCT05816252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328262|NCT05816252|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154328263|NCT05816252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154328264|NCT05816252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328265|NCT05801172|Ketoprofen|ketoprofen|mesh-list
154328266|NCT05801172|Lidocaine|lidocaine|mesh-list
154328267|NCT05801172|Anesthetics|anesthetics|mesh-list
154328268|NCT05801172|Anesthetics, Local|anesthetics, local|mesh-ancestor
154328269|NCT05801172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328270|NCT05801172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328271|NCT05801172|Sensory System Agents|sensory system agents|mesh-ancestor
154328272|NCT05801172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328273|NCT05801172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154328274|NCT05801172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154328275|NCT05801172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154328276|NCT05801172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154328277|NCT05801172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328278|NCT05801172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154328279|NCT05801172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154328280|NCT05801172|Analgesics|analgesics|mesh-ancestor
154328293|NCT05757648|Anesthetics|anesthetics|mesh-list
154328294|NCT05757648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328295|NCT05757648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328296|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
154328297|NCT05674877|Ketamine|ketamine|mesh-list
154328298|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
154328299|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154328300|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328301|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328302|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154328303|NCT05674877|Analgesics|analgesics|mesh-ancestor
154328304|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
154328305|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328306|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154328307|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154328308|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154328309|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
154328310|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328311|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328312|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154328313|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154328314|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
154328315|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
154328316|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154328317|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154328318|NCT05674877|Narcotics|narcotics|mesh-ancestor
154328319|NCT06098625|Empagliflozin|empagliflozin|mesh-list
154328320|NCT06098625|Linagliptin|linagliptin|mesh-list
154328321|NCT06098625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154328322|NCT06098625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328323|NCT06098625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328324|NCT06098625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328326|NCT06098625|Hormones|hormones|mesh-ancestor
154328327|NCT06098625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154328328|NCT06098625|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154328329|NCT06098625|Protease Inhibitors|protease inhibitors|mesh-ancestor
154328330|NCT06098625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328331|NCT06098599|Doxorubicin|doxorubicin|mesh-list
154328332|NCT06098599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154328333|NCT06098599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154328334|NCT06098599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328335|NCT06098599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154328336|NCT06098599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154328337|NCT06098599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328338|NCT06098599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328339|NCT06098417|Liver Extracts|liver extracts|mesh-list
154328340|NCT06098417|Hematinics|hematinics|mesh-ancestor
154328341|NCT06098326|Cyclophosphamide|cyclophosphamide|mesh-list
154328342|NCT06098326|Fludarabine|fludarabine|mesh-list
154328343|NCT06098326|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154188462|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
154328364|NCT06098014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328365|NCT06098014|Immunologic Factors|immunologic factors|mesh-ancestor
154328366|NCT06098014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328367|NCT06098014|Leprostatic Agents|leprostatic agents|mesh-ancestor
154328368|NCT06098014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154328369|NCT06098014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328370|NCT06098014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154328371|NCT06098014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154328372|NCT06098014|Growth Substances|growth substances|mesh-ancestor
154328373|NCT06098014|Growth Inhibitors|growth inhibitors|mesh-ancestor
154328374|NCT06098014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328375|NCT06097975|Nivolumab|nivolumab|mesh-list
154328376|NCT06097975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328377|NCT06097975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328378|NCT06097975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154328379|NCT06097975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328380|NCT06097767|Amikacin|amikacin|mesh-list
154328381|NCT06097767|Caffeine|caffeine|mesh-list
154328382|NCT06097767|Caffeine citrate|caffeine citrate|mesh-list
154328383|NCT06097767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328384|NCT06097767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154328385|NCT06097767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328386|NCT06097767|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154328387|NCT06097767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328388|NCT06097767|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154328389|NCT06097767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154328390|NCT06097767|Purinergic Agents|purinergic agents|mesh-ancestor
154328391|NCT06097767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328392|NCT06097767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154328393|NCT06097767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328394|NCT06097585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153507566|NCT06103188|Anesthetics, General|anesthetics, general|mesh-ancestor
154328428|NCT06093464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154328429|NCT06093451|Dexmedetomidine|dexmedetomidine|mesh-list
154328430|NCT06093451|Lorazepam|lorazepam|mesh-list
154328431|NCT06093451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154328432|NCT06093451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328433|NCT06093451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328434|NCT06093451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153507633|NCT05988710|Oxycodone|oxycodone|mesh-list
154328505|NCT06092684|Sensory System Agents|sensory system agents|mesh-ancestor
154328506|NCT06092684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328507|NCT06092684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328508|NCT06092684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154328509|NCT06092684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154328510|NCT06092684|Anesthetics, General|anesthetics, general|mesh-ancestor
154328512|NCT06092684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328513|NCT06092684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154328514|NCT06092684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154328515|NCT06092684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328516|NCT06092684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328517|NCT06092671|Anesthetics|anesthetics|mesh-list
154328548|NCT06092073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328549|NCT06092047|Cyclophosphamide|cyclophosphamide|mesh-list
154328550|NCT06092047|Fludarabine|fludarabine|mesh-list
154328551|NCT06092047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328552|NCT06092047|Immunologic Factors|immunologic factors|mesh-ancestor
154328553|NCT06092047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328554|NCT06092047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328555|NCT06092047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328556|NCT06092047|Alkylating Agents|alkylating agents|mesh-ancestor
154328557|NCT06092047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328558|NCT06092047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328559|NCT06092047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328560|NCT06091267|Decitabine|decitabine|mesh-list
154328561|NCT06091267|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154328562|NCT06091267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328598|NCT06084897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328599|NCT06081348|Sertraline|sertraline|mesh-list
154328600|NCT06081348|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154328601|NCT06081348|Serotonin|serotonin|mesh-list
154328621|NCT06079645|Immunologic Factors|immunologic factors|mesh-ancestor
154328622|NCT06079645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328623|NCT06079645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328625|NCT06075004|Anesthetics, Local|anesthetics, local|mesh-list
154328626|NCT06075004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328627|NCT06075004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328628|NCT06075004|Sensory System Agents|sensory system agents|mesh-ancestor
154861768|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154328629|NCT06075004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328630|NCT06072326|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154328631|NCT06072326|Ambrisentan|ambrisentan|mesh-list
154328632|NCT06072326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154328633|NCT06072326|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154328634|NCT06072326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328635|NCT06072326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328636|NCT06072326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328637|NCT06056752|Cyclophosphamide|cyclophosphamide|mesh-list
154328638|NCT06056752|Fludarabine|fludarabine|mesh-list
154328639|NCT06056752|Fludarabine phosphate|fludarabine phosphate|mesh-list
154328640|NCT06056752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328641|NCT06056752|Immunologic Factors|immunologic factors|mesh-ancestor
154328642|NCT06056752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328643|NCT06056752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328644|NCT06056752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328645|NCT06056752|Alkylating Agents|alkylating agents|mesh-ancestor
154328646|NCT06056752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328647|NCT06056752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328648|NCT06056752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328649|NCT06056752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328650|NCT06056752|Antimetabolites|antimetabolites|mesh-ancestor
154328651|NCT06048627|Fluorides|fluorides|mesh-list
154328652|NCT06048627|Cariostatic Agents|cariostatic agents|mesh-ancestor
154328676|NCT06001320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328677|NCT06001320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328678|NCT06001320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328680|NCT06001320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328681|NCT05992922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154328682|NCT05992922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154328683|NCT05991908|Vidarabine|vidarabine|mesh-list
154328684|NCT05991908|Fludarabine|fludarabine|mesh-list
154328685|NCT05991908|Fludarabine phosphate|fludarabine phosphate|mesh-list
154328686|NCT05991908|Melphalan|melphalan|mesh-list
154328687|NCT05991908|Busulfan|busulfan|mesh-list
154328688|NCT05991908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328689|NCT05991908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328690|NCT05991908|Antimetabolites|antimetabolites|mesh-ancestor
154328691|NCT05991908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328692|NCT05991908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328693|NCT05991908|Immunologic Factors|immunologic factors|mesh-ancestor
154328694|NCT05991908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328695|NCT05991908|Antiviral Agents|antiviral agents|mesh-ancestor
154328696|NCT05991908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328697|NCT05991908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328698|NCT05991908|Alkylating Agents|alkylating agents|mesh-ancestor
154328699|NCT05991908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328700|NCT05988983|Contraceptive Agents|contraceptive agents|mesh-list
154328701|NCT05988983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154328702|NCT05988983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328703|NCT05960656|Empagliflozin|empagliflozin|mesh-list
154328704|NCT05960656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154328739|NCT06217354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154328740|NCT06217354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328741|NCT06217302|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154328742|NCT06217302|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154328743|NCT06217302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328744|NCT06217302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328781|NCT06216886|Cholinergic Agents|cholinergic agents|mesh-ancestor
154328782|NCT06216886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328783|NCT06216535|Escitalopram|escitalopram|mesh-list
153507973|NCT04075149|Spironolactone|spironolactone|mesh-list
154328812|NCT06216210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328813|NCT06216197|Fentanyl|fentanyl|mesh-list
154328814|NCT06216197|Dexmedetomidine|dexmedetomidine|mesh-list
154328815|NCT06216197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154328816|NCT06216197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328817|NCT06216197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328818|NCT06216197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154328819|NCT06216197|Analgesics|analgesics|mesh-ancestor
154328820|NCT06216197|Sensory System Agents|sensory system agents|mesh-ancestor
154328821|NCT06216197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328822|NCT06216197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154328823|NCT06216197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154328824|NCT06216197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154328825|NCT06216197|Adrenergic Agents|adrenergic agents|mesh-ancestor
154328826|NCT06216197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508023|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
154328858|NCT06215989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328859|NCT06215989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328860|NCT06215976|Metformin|metformin|mesh-list
154328861|NCT06215976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328862|NCT06215976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328863|NCT06215768|Midazolam|midazolam|mesh-list
154328864|NCT06215768|Dexmedetomidine|dexmedetomidine|mesh-list
154328865|NCT06215768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154328866|NCT06215768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328867|NCT06215768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328868|NCT06215768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154328869|NCT06215768|Analgesics|analgesics|mesh-ancestor
154328870|NCT06215768|Sensory System Agents|sensory system agents|mesh-ancestor
154328871|NCT06215768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328872|NCT06215768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154328897|NCT06215573|Protective Agents|protective agents|mesh-ancestor
154328898|NCT06215573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328899|NCT06215573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328900|NCT06215521|Moxifloxacin|moxifloxacin|mesh-list
154328901|NCT06215521|Pirtobrutinib|pirtobrutinib|mesh-list
154328902|NCT06215521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154328903|NCT06215521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328904|NCT06215521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154328905|NCT06215521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154328906|NCT06215521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328907|NCT06215521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328908|NCT06215521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328909|NCT06215521|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154328910|NCT06215521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154328911|NCT06215430|Caffeine|caffeine|mesh-list
154328912|NCT06215430|Omeprazole|omeprazole|mesh-list
154328913|NCT06215430|Warfarin|warfarin|mesh-list
154328914|NCT06215430|Pirtobrutinib|pirtobrutinib|mesh-list
154328915|NCT06215430|Anticoagulants|anticoagulants|mesh-ancestor
154328916|NCT06215430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154328917|NCT06215430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328918|NCT06215430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154328919|NCT06215430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328920|NCT06215430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328921|NCT06215430|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154328922|NCT06215430|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154328923|NCT06215430|Purinergic Agents|purinergic agents|mesh-ancestor
153508114|NCT03456063|Paclitaxel|paclitaxel|mesh-list
154328940|NCT06214728|Immunologic Factors|immunologic factors|mesh-ancestor
154328941|NCT06214728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328942|NCT06214728|Viscosupplements|viscosupplements|mesh-ancestor
154328943|NCT06214728|Protective Agents|protective agents|mesh-ancestor
154328944|NCT06213896|Tropicamide|tropicamide|mesh-list
154328945|NCT06213896|Mydriatics|mydriatics|mesh-list
154328946|NCT06213896|Autonomic Agents|autonomic agents|mesh-ancestor
154328947|NCT06213896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328948|NCT06213896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328949|NCT06213896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154328950|NCT06213896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154328951|NCT06213896|Cholinergic Agents|cholinergic agents|mesh-ancestor
154328952|NCT06213896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328953|NCT06213896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328954|NCT06213649|Biguanides|biguanides|mesh-list
154328955|NCT06213649|Polihexanide|polihexanide|mesh-list
154328956|NCT06213649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328957|NCT06213649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328958|NCT06213649|Disinfectants|disinfectants|mesh-ancestor
154328959|NCT06213649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328960|NCT06211283|Valproic Acid|valproic acid|mesh-list
154328961|NCT06211283|Anticonvulsants|anticonvulsants|mesh-ancestor
154328962|NCT06211283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328963|NCT06211283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328964|NCT06211283|GABA Agents|gaba agents|mesh-ancestor
154328965|NCT06211283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328966|NCT06211283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328967|NCT06211283|Antimanic Agents|antimanic agents|mesh-ancestor
154328968|NCT06211283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154328969|NCT06211283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328970|NCT06211283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154328971|NCT06206291|Cannabidiol|cannabidiol|mesh-list
154328972|NCT06206291|Anticonvulsants|anticonvulsants|mesh-ancestor
154328973|NCT06203912|Dexamethasone|dexamethasone|mesh-list
154328974|NCT06203912|Dexamethasone acetate|dexamethasone acetate|mesh-list
154328975|NCT06203912|Cyclophosphamide|cyclophosphamide|mesh-list
154328976|NCT06203912|Ichthammol|ichthammol|mesh-list
154328977|NCT06203912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154328978|NCT06203912|BB 1101|bb 1101|mesh-list
154328979|NCT06203912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328980|NCT06203912|Immunologic Factors|immunologic factors|mesh-ancestor
154328981|NCT06203912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328982|NCT06203912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328983|NCT06203912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328984|NCT06203912|Alkylating Agents|alkylating agents|mesh-ancestor
153508157|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154328997|NCT06203912|Protease Inhibitors|protease inhibitors|mesh-ancestor
154328998|NCT06203912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329000|NCT06192888|Lenalidomide|lenalidomide|mesh-list
154329001|NCT06192888|Obinutuzumab|obinutuzumab|mesh-list
154329002|NCT06192888|Immunologic Factors|immunologic factors|mesh-ancestor
154329003|NCT06192888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329004|NCT06192888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154329005|NCT06192888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154329006|NCT06192888|Growth Substances|growth substances|mesh-ancestor
154329007|NCT06192888|Growth Inhibitors|growth inhibitors|mesh-ancestor
154329008|NCT06192888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329009|NCT06192888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329010|NCT06128590|Epinephrine|epinephrine|mesh-list
154329011|NCT06128590|Anesthetics|anesthetics|mesh-list
154329012|NCT06128590|Mepivacaine|mepivacaine|mesh-list
154329013|NCT06128590|Anesthetics, Local|anesthetics, local|mesh-list
154329014|NCT06128590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329015|NCT06128590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329016|NCT06128590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154329017|NCT06128590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154329018|NCT06128590|Adrenergic Agents|adrenergic agents|mesh-ancestor
154329019|NCT06128590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329020|NCT06128590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329021|NCT06128590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154329022|NCT06128590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154329023|NCT06128590|Autonomic Agents|autonomic agents|mesh-ancestor
154329024|NCT06128590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329025|NCT06128590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154329026|NCT06128590|Respiratory System Agents|respiratory system agents|mesh-ancestor
154329027|NCT06128590|Mydriatics|mydriatics|mesh-ancestor
154329028|NCT06128590|Sympathomimetics|sympathomimetics|mesh-ancestor
154329029|NCT06128590|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154329030|NCT06128590|Sensory System Agents|sensory system agents|mesh-ancestor
154329031|NCT06062420|Dostarlimab|dostarlimab|mesh-list
154329032|NCT06062420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329033|NCT06038539|Carboplatin|carboplatin|mesh-list
154329034|NCT06038539|Docetaxel|docetaxel|mesh-list
154329035|NCT06038539|Trastuzumab|trastuzumab|mesh-list
154329036|NCT06038539|Pertuzumab|pertuzumab|mesh-list
154329037|NCT06038539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329038|NCT06038539|Tubulin Modulators|tubulin modulators|mesh-ancestor
154329039|NCT06038539|Antimitotic Agents|antimitotic agents|mesh-ancestor
154329040|NCT06038539|Mitosis Modulators|mitosis modulators|mesh-ancestor
154329041|NCT06038539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329042|NCT06038539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329043|NCT06023706|Capsaicin|capsaicin|mesh-list
154329044|NCT06023706|Antipruritics|antipruritics|mesh-ancestor
154329045|NCT06023706|Dermatologic Agents|dermatologic agents|mesh-ancestor
154329046|NCT06023706|Sensory System Agents|sensory system agents|mesh-ancestor
154329047|NCT06023706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329048|NCT06023706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508224|NCT02402920|Cisplatin|cisplatin|mesh-list
154329082|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154329083|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154329084|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154329085|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329086|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154329087|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154329088|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329109|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154329111|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329112|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
154329113|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154329114|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
154329115|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329116|NCT05549505|Anastrozole|anastrozole|mesh-list
154329117|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154329118|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329119|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154329120|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154329121|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329122|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329123|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154329124|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
154329125|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154329126|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329127|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154329128|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154329129|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
154329130|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154329131|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154329132|NCT05542147|Fenofibrate|fenofibrate|mesh-list
154329133|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154329134|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
154329135|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329136|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154329137|NCT05501769|Everolimus|everolimus|mesh-list
154329138|NCT05501769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154329139|NCT05501769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329140|NCT05501769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329141|NCT05501769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329142|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329143|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
154329144|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329145|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329174|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154329176|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329177|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329178|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154329179|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329180|NCT05178745|Fluorouracil|fluorouracil|mesh-list
154329181|NCT05178745|Irinotecan|irinotecan|mesh-list
154329182|NCT05178745|Aflibercept|aflibercept|mesh-list
154329183|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
154329184|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329185|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329186|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329187|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329188|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
154329189|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329190|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154329216|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154329217|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154329218|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
154329219|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
154329220|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154329221|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154329222|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329223|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154329224|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154329225|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154329226|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154329227|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154329228|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154329229|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154329230|NCT05079841|Oxytocin|oxytocin|mesh-list
154329231|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
154329232|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154329233|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329234|NCT05074056|Ketorolac|ketorolac|mesh-list
154329235|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154329236|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154329237|NCT05074056|Analgesics|analgesics|mesh-ancestor
154329258|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154329259|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329260|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329261|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329262|NCT04980482|Interferons|interferons|mesh-list
154329263|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
154329264|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
154329265|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154329266|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329267|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
154329268|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329269|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
154329270|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329271|NCT04969263|Vaccines|vaccines|mesh-list
154329272|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
154329273|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329274|NCT04964063|Listerine|listerine|mesh-list
154329275|NCT04964063|Fluorides|fluorides|mesh-list
154329276|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
154329277|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
154329278|NCT04964063|Protective Agents|protective agents|mesh-ancestor
154329279|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329280|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154329281|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329282|NCT04959812|Sufentanil|sufentanil|mesh-list
154329283|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154329284|NCT04959812|Narcotics|narcotics|mesh-ancestor
154329285|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329286|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329287|NCT04959812|Analgesics|analgesics|mesh-ancestor
154329288|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
154329289|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329290|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154329291|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154329307|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329308|NCT04914390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329309|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
154329310|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154329311|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329312|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154329313|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329314|NCT04765059|Cisplatin|cisplatin|mesh-list
154329315|NCT04765059|Carboplatin|carboplatin|mesh-list
154329316|NCT04765059|Pemetrexed|pemetrexed|mesh-list
154329317|NCT04765059|Osimertinib|osimertinib|mesh-list
154329318|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329319|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329320|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329321|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154329322|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154329323|NCT04765059|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154329324|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329325|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
154329326|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154329327|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154329328|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329329|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
154329330|NCT04742205|Coagulants|coagulants|mesh-ancestor
154329331|NCT04724447|Valganciclovir|valganciclovir|mesh-list
154329332|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
154329333|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329334|NCT04678479|Ganaxolone|ganaxolone|mesh-list
154329335|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
154329336|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329337|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329338|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329339|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
154329340|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
154329341|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154329342|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
154329343|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
154329344|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329346|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
154329347|NCT04662710|Capecitabine|capecitabine|mesh-list
154329348|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
154329349|NCT04662710|Lenvatinib|lenvatinib|mesh-list
154329350|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
154329351|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329352|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329353|NCT04662710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508519|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154329384|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154329385|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
154329386|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329387|NCT04587687|Immunotoxins|immunotoxins|mesh-ancestor
154329388|NCT04572451|Nivolumab|nivolumab|mesh-list
154329389|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329390|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329391|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154329392|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329393|NCT04559048|Tacrolimus|tacrolimus|mesh-list
154329394|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329395|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
154329396|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329397|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154329398|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329399|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329425|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329426|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154329427|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329428|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329429|NCT04363801|Leucovorin|leucovorin|mesh-list
154329430|NCT04363801|Capecitabine|capecitabine|mesh-list
154329431|NCT04363801|Fluorouracil|fluorouracil|mesh-list
154329432|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
154329433|NCT04363801|Tislelizumab|tislelizumab|mesh-list
154329434|NCT04363801|Calcium|calcium|mesh-list
154329435|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
154329436|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154329437|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329438|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329439|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
154329440|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329441|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329442|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329443|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
154329444|NCT04363801|Antidotes|antidotes|mesh-ancestor
154329445|NCT04363801|Protective Agents|protective agents|mesh-ancestor
154329446|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
154075785|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154329447|NCT04363801|Vitamins|vitamins|mesh-ancestor
154329448|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
154329449|NCT04363801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329450|NCT04329494|Leucovorin|leucovorin|mesh-list
154329472|NCT04329494|Antidotes|antidotes|mesh-ancestor
154329473|NCT04329494|Protective Agents|protective agents|mesh-ancestor
154329474|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
154329475|NCT04329494|Vitamins|vitamins|mesh-ancestor
154329476|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
154329477|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
154329478|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154329479|NCT04260464|PF-06700841|pf-06700841|mesh-list
154329480|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329481|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329482|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329483|NCT04246372|Tofacitinib|tofacitinib|mesh-list
154329484|NCT04246372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154329485|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329486|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329487|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329488|NCT04204967|Fentanyl|fentanyl|mesh-list
154329489|NCT04204967|Remifentanil|remifentanil|mesh-list
154329490|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154329491|NCT04204967|Narcotics|narcotics|mesh-ancestor
154329492|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329493|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329494|NCT04204967|Analgesics|analgesics|mesh-ancestor
154329495|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
154329496|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329497|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154329498|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154329499|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
154329500|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
154329501|NCT04158362|Paclitaxel|paclitaxel|mesh-list
154329502|NCT04158362|Capecitabine|capecitabine|mesh-list
154329503|NCT04158362|Letrozole|letrozole|mesh-list
154329504|NCT04158362|Fulvestrant|fulvestrant|mesh-list
154329505|NCT04158362|Anastrozole|anastrozole|mesh-list
154329506|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154027403|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154027404|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
153508678|NCT05248724|Ketorolac|ketorolac|mesh-list
154329522|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154329523|NCT04145258|Aspirin|aspirin|mesh-list
154329524|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154329525|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154329526|NCT04145258|Analgesics|analgesics|mesh-ancestor
154329527|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
154329528|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329529|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329530|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154329531|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154329559|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329560|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154329561|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154329562|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
154329563|NCT03952637|Hormones|hormones|mesh-ancestor
154329564|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154329565|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154329566|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154329567|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329568|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154329569|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
154329570|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329571|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
154329572|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
154329573|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329574|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154329575|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154329576|NCT03952637|Protective Agents|protective agents|mesh-ancestor
154329577|NCT03896503|Topotecan|topotecan|mesh-list
154329578|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154329604|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329605|NCT03529110|Immunotoxins|immunotoxins|mesh-ancestor
154329606|NCT03529110|Immunoconjugates|immunoconjugates|mesh-ancestor
154329607|NCT03529110|Immunologic Factors|immunologic factors|mesh-ancestor
154329608|NCT03529110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329609|NCT03500874|Leucovorin|leucovorin|mesh-list
154329610|NCT03500874|Fluorouracil|fluorouracil|mesh-list
154329611|NCT03500874|Floxuridine|floxuridine|mesh-list
154329612|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
154329613|NCT03500874|Irinotecan|irinotecan|mesh-list
154329614|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
154329615|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329616|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329617|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329618|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329619|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
154329620|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329621|NCT03500874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154329622|NCT03500874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154329623|NCT03500874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329624|NCT03500874|Antidotes|antidotes|mesh-ancestor
154329625|NCT03500874|Protective Agents|protective agents|mesh-ancestor
154329626|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
154329627|NCT03500874|Vitamins|vitamins|mesh-ancestor
153508828|NCT05064137|Listerine|listerine|mesh-list
154329658|NCT02939287|Olanzapine|olanzapine|mesh-list
154329659|NCT02939287|Aprepitant|aprepitant|mesh-list
154329660|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
154329661|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
154329662|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
154329663|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329664|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329665|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154329666|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154329667|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153957295|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154329668|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329669|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154329670|NCT02939287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154329671|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154329672|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154329673|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329710|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329711|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329737|NCT05877807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329739|NCT05877807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329741|NCT05877807|GABA Agonists|gaba agonists|mesh-ancestor
154329742|NCT05877807|GABA Agents|gaba agents|mesh-ancestor
154329743|NCT05877807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329744|NCT05877807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329745|NCT05874544|Amoxicillin|amoxicillin|mesh-list
154329746|NCT05874544|Metronidazole|metronidazole|mesh-list
154329747|NCT05874544|Tetracycline|tetracycline|mesh-list
154329749|NCT05874544|Potassium Citrate|potassium citrate|mesh-list
154329750|NCT05874544|Bismuth|bismuth|mesh-list
154329751|NCT05874544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329752|NCT05874544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154329753|NCT05874544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329754|NCT05874544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154329755|NCT05874544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154329756|NCT05874544|Antacids|antacids|mesh-ancestor
154329757|NCT05874544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154329758|NCT05874544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154329759|NCT05874544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329760|NCT05874544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154329761|NCT05874544|Antitubercular Agents|antitubercular agents|mesh-ancestor
154329762|NCT05874544|Diuretics|diuretics|mesh-ancestor
154329763|NCT05874544|Natriuretic Agents|natriuretic agents|mesh-ancestor
154329764|NCT05874544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329765|NCT05874544|Expectorants|expectorants|mesh-ancestor
154329793|NCT05804162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154329794|NCT05804162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154329795|NCT05804162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329796|NCT05804162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329797|NCT05804162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329798|NCT05804162|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154329799|NCT05804162|Contraceptive Agents|contraceptive agents|mesh-ancestor
154329800|NCT05804162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154329801|NCT05804162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329802|NCT05804162|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154329803|NCT05804162|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154329804|NCT05804162|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154329805|NCT05748145|Metronidazole|metronidazole|mesh-list
154329806|NCT05748145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329807|NCT05748145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154329808|NCT05748145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154329809|NCT05748145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154329810|NCT05718869|Zanubrutinib|zanubrutinib|mesh-list
154329811|NCT05718869|Immunoglobulins|immunoglobulins|mesh-list
154329812|NCT05718869|Immunologic Factors|immunologic factors|mesh-ancestor
153452105|NCT04414800|Fentanyl|fentanyl|mesh-list
154329833|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329835|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329836|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329837|NCT05699993|Itraconazole|itraconazole|mesh-list
154329838|NCT05699993|Levomethorphan|levomethorphan|mesh-list
154329839|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
154329840|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
154329841|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329842|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154329843|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154329844|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329845|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329846|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154329847|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
154329848|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861769|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861770|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957367|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154329849|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329850|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154329851|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
154329852|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
154329853|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154329854|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154329855|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329856|NCT05699993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154329857|NCT05699993|Narcotics|narcotics|mesh-ancestor
154329858|NCT05699993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329859|NCT05699993|Analgesics|analgesics|mesh-ancestor
154329860|NCT05699993|Sensory System Agents|sensory system agents|mesh-ancestor
154329861|NCT05699993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329862|NCT05688124|Esomeprazole|esomeprazole|mesh-list
154329891|NCT05631262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329893|NCT05624853|Analgesics|analgesics|mesh-ancestor
154329894|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
154329895|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329896|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329897|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
154329898|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154329899|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154329900|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329901|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154329902|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154329903|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154329904|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329905|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154329906|NCT05594433|Lenograstim|lenograstim|mesh-list
154329907|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154329908|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
154329909|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329910|NCT05589597|Nivolumab|nivolumab|mesh-list
153509099|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
154329936|NCT05573802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329937|NCT05546242|Dolutegravir|dolutegravir|mesh-list
154329938|NCT05546242|Cabotegravir|cabotegravir|mesh-list
154329939|NCT05546242|Rilpivirine|rilpivirine|mesh-list
154329940|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154329941|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154329942|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154329943|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329944|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329945|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154329946|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
154329947|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329948|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154329949|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154329950|NCT05543122|Fluconazole|fluconazole|mesh-list
154329951|NCT05543122|Methotrexate|methotrexate|mesh-list
154329952|NCT05543122|Atenolol|atenolol|mesh-list
154329953|NCT05543122|Lamotrigine|lamotrigine|mesh-list
154329954|NCT05543122|Lacosamide|lacosamide|mesh-list
154329955|NCT05543122|Levetiracetam|levetiracetam|mesh-list
154329956|NCT05543122|Brivaracetam|brivaracetam|mesh-list
154329957|NCT05543122|Bupropion|bupropion|mesh-list
154329958|NCT05543122|Ezetimibe|ezetimibe|mesh-list
154076307|NCT00791258|Amlodipine|amlodipine|mesh-list
154329959|NCT05543122|Escitalopram|escitalopram|mesh-list
153781909|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
154329990|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154329991|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154329992|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
154329993|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
154329994|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
154329995|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329996|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154329997|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154329998|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
154329999|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330000|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153509201|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
154330024|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154330025|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
154330026|NCT05480046|Risperidone|risperidone|mesh-list
154330027|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154330028|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
154330029|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330030|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330031|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076368|NCT00807599|Dexamethasone|dexamethasone|mesh-list
154330032|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154330033|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154330034|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154330035|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154330036|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154330037|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
154330038|NCT05466474|Tislelizumab|tislelizumab|mesh-list
154330039|NCT05466474|Dacarbazine|dacarbazine|mesh-list
154330040|NCT05466474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330041|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330042|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154330043|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
154330044|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330045|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154330046|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154330047|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
154189257|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
154330068|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154330069|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330071|NCT05347134|Capecitabine|capecitabine|mesh-list
154330072|NCT05347134|Vinorelbine|vinorelbine|mesh-list
154330073|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154330074|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
154330075|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330076|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330077|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154330078|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330079|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330080|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
154330081|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
154330082|NCT05331651|Tropisetron|tropisetron|mesh-list
154330083|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154330084|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154330085|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154330086|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
154330087|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330088|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330089|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330090|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
154330091|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
154330092|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330093|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330094|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154330095|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154330096|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
154330097|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
154330098|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154330099|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154330100|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330101|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154330102|NCT05304598|Analgesics|analgesics|mesh-ancestor
154330127|NCT05275010|Trastuzumab|trastuzumab|mesh-list
154330128|NCT05275010|Pertuzumab|pertuzumab|mesh-list
154330129|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330130|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330131|NCT05261321|Dronabinol|dronabinol|mesh-list
154330132|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
154330133|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330134|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154330135|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154330136|NCT05261321|Analgesics|analgesics|mesh-ancestor
154330137|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
154330138|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330139|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154330140|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154330141|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330142|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330143|NCT05261321|Hormones|hormones|mesh-ancestor
154330144|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330145|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154330146|NCT05245292|Antibodies|antibodies|mesh-list
154330147|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
154330148|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154330149|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
154330175|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154330177|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
154330178|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154330179|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
154330180|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154330181|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
154330182|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
154330183|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330184|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330185|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330186|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
154330187|NCT05113901|Hormones|hormones|mesh-ancestor
154330188|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330189|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154330190|NCT05113901|Protective Agents|protective agents|mesh-ancestor
154330191|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330192|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330193|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154330194|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154330195|NCT05085873|Midazolam|midazolam|mesh-list
154330196|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
154330197|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154330198|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154330199|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154330237|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330238|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330274|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154330275|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330277|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
154330278|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330298|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330299|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154330300|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330301|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330302|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154330303|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
154330304|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
154330305|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330306|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154330307|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154330309|NCT04727671|Menotropins|menotropins|mesh-list
154330310|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
154330311|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154330312|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
154330313|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154330314|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330315|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154330316|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330317|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330318|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154330319|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
154330320|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
154330321|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330322|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154330323|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154330324|NCT04724486|Cetrorelix|cetrorelix|mesh-list
154330325|NCT04724486|Menotropins|menotropins|mesh-list
154330326|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
154330327|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154330328|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
154330329|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154330330|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330331|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154330332|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330333|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330368|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330369|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153957594|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
154330370|NCT04682522|Metronidazole|metronidazole|mesh-list
154330371|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330372|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154330373|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154330374|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154330392|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330393|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154330394|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330395|NCT04547985|Naltrexone|naltrexone|mesh-list
154330396|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154330397|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154330398|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330399|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
154330400|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330401|NCT04467957|Xenon|xenon|mesh-list
154330402|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154330403|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
154330404|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
154330405|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076738|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
154330406|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330407|NCT04467905|Etripamil|etripamil|mesh-list
154330408|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154330409|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154330410|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330411|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154330412|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330413|NCT04417621|Trametinib|trametinib|mesh-list
154330414|NCT04417621|Naporafenib|naporafenib|mesh-list
154330415|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330416|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330417|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330418|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330419|NCT04395222|Fludarabine|fludarabine|mesh-list
154330420|NCT04395222|Melphalan|melphalan|mesh-list
154330421|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
154330422|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154330423|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330424|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330425|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154330426|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
154330427|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330428|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154330429|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
154330430|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154330431|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
154330456|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154330457|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
154330458|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
154330459|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330460|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154330461|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154330462|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154330463|NCT04338321|Esketamine|esketamine|mesh-list
154330464|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
154330465|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154330466|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154330467|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154330468|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154330469|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330470|NCT04322955|Nivolumab|nivolumab|mesh-list
154330471|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330472|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330473|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330474|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330475|NCT04303780|Docetaxel|docetaxel|mesh-list
154330476|NCT04303780|Sotorasib|sotorasib|mesh-list
154330477|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330478|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330479|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330480|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
153509673|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154861771|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154330505|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330506|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330507|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330508|NCT04259996|Estradiol|estradiol|mesh-list
154330509|NCT04259996|Progesterone|progesterone|mesh-list
154330510|NCT04259996|Estrogens|estrogens|mesh-ancestor
154330511|NCT04259996|Hormones|hormones|mesh-ancestor
154330512|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330513|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330514|NCT04259996|Progestins|progestins|mesh-ancestor
154330515|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
154330516|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154330517|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
154330518|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330519|NCT04226456|Expectorants|expectorants|mesh-ancestor
154330520|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
154330521|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154330522|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
154330523|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330524|NCT04226456|Protective Agents|protective agents|mesh-ancestor
154330525|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330526|NCT04226456|Antidotes|antidotes|mesh-ancestor
154330527|NCT04174755|Semaglutide|semaglutide|mesh-list
154330528|NCT04174755|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154330529|NCT04174755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154330530|NCT04174755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330560|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330561|NCT04058717|Nicotine|nicotine|mesh-list
154330562|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154330563|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
154330564|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330565|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330566|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154330567|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154330568|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
154330569|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330570|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330571|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
154330572|NCT03970746|Pemetrexed|pemetrexed|mesh-list
154330573|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330574|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509787|NCT01334606|Insulin|insulin|mesh-list
154330607|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154330609|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
154330610|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330611|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330612|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330613|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
154330614|NCT03875690|Hormones|hormones|mesh-ancestor
154330615|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330616|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153509816|NCT00768820|Risperidone|risperidone|mesh-list
154330646|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330648|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154330649|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154330650|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330651|NCT03836209|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154330652|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330653|NCT03829514|Fenofibrate|fenofibrate|mesh-list
154330654|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154330655|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
154330656|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330657|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154330658|NCT03780127|Fenfluramine|fenfluramine|mesh-list
154330659|NCT03780127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154330660|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154330661|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154330662|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330701|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
154330702|NCT03689712|Trace Elements|trace elements|mesh-ancestor
154330774|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330775|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330776|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330777|NCT03206073|Durvalumab|durvalumab|mesh-list
154330778|NCT03206073|Tremelimumab|tremelimumab|mesh-list
154330802|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255922|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154330804|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330805|NCT02962063|Paclitaxel|paclitaxel|mesh-list
154330806|NCT02962063|Carboplatin|carboplatin|mesh-list
154330807|NCT02962063|Durvalumab|durvalumab|mesh-list
154330808|NCT02962063|Tremelimumab|tremelimumab|mesh-list
154330809|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154330810|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330811|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330812|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330813|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
154330814|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330815|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330816|NCT02941926|Letrozole|letrozole|mesh-list
154330817|NCT02941926|Leuprolide|leuprolide|mesh-list
154330818|NCT02941926|Goserelin|goserelin|mesh-list
154330819|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330820|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154330821|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154330822|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330823|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330824|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154330825|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
154330826|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330827|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330828|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154330829|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
154330830|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154330865|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330866|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154330867|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
154330868|NCT02535312|Cisplatin|cisplatin|mesh-list
154330869|NCT02535312|Pemetrexed|pemetrexed|mesh-list
154330870|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330871|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330872|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330873|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154330874|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154330875|NCT02520180|Everolimus|everolimus|mesh-list
154330904|NCT02336074|Vorinostat|vorinostat|mesh-list
154330905|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330906|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154330907|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330908|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330909|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154330910|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
154330911|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330912|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154330913|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154330914|NCT02313272|Bevacizumab|bevacizumab|mesh-list
154330915|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
154330916|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330917|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330918|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154330919|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154330920|NCT02313272|Growth Substances|growth substances|mesh-ancestor
154330921|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330954|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
154330955|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330956|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330957|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154330958|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154330959|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
154330960|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
154330961|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330962|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330963|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
154330964|NCT02303821|Hormones|hormones|mesh-ancestor
154330965|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330966|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154331000|NCT02254005|Maytansine|maytansine|mesh-list
154331001|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
154331002|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154331003|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861772|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154861773|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
154255398|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154255399|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255400|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154255402|NCT01148576|Entecavir|entecavir|mesh-list
154255403|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
154255404|NCT01148576|Vitamins|vitamins|mesh-ancestor
154255405|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
154255406|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255407|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
154255408|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255409|NCT01148576|Protective Agents|protective agents|mesh-ancestor
154331004|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
154331005|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189608|NCT06313801|Leucovorin|leucovorin|mesh-list
154189677|NCT06313268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189678|NCT06313268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189679|NCT06313268|Growth Substances|growth substances|mesh-ancestor
154331006|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153510194|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
154331037|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331039|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331040|NCT02229825|Analgesics|analgesics|mesh-ancestor
154331041|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
154331042|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331043|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
154331044|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154331045|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
154331046|NCT02065765|Ramucirumab|ramucirumab|mesh-list
154331047|NCT02065765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154331069|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
154331070|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331071|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331072|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154331073|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331075|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
154331076|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331077|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154331078|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
154331079|NCT01920737|Hormones|hormones|mesh-ancestor
154331080|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331081|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154331082|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154331083|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
154331084|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154331085|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154331086|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
154331087|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
154331088|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331089|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154331090|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154331091|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
154331092|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154331093|NCT01920737|Antidotes|antidotes|mesh-ancestor
154331094|NCT01920737|Protective Agents|protective agents|mesh-ancestor
154331095|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
154331096|NCT01920737|Vitamins|vitamins|mesh-ancestor
154331097|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
154331098|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154331099|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
154331100|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
154331101|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
154331102|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154331103|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154331104|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154331105|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
154331140|NCT01755975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861774|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861775|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861776|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
154861777|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861778|NCT03031691|Trifluridine|trifluridine|mesh-list
154861779|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
154861780|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861781|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
154861782|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861783|NCT02430103|Goserelin|goserelin|mesh-list
154255410|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
154255411|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255412|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154331141|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
154331142|NCT01752491|Temozolomide|temozolomide|mesh-list
154331143|NCT01752491|Vitamins|vitamins|mesh-ancestor
154331144|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
154331145|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331146|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153510334|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
154331177|NCT01494662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154331178|NCT01494662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331180|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
154331182|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154331183|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331184|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
154331185|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331186|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154331187|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154331188|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154331189|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331223|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
154331224|NCT00736450|Hormones|hormones|mesh-ancestor
154331225|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331226|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154331227|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154331228|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
154331229|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
154331230|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
154331259|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331260|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331262|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154331263|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154331264|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154331265|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154331266|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331267|NCT00571662|Cyclosporine|cyclosporine|mesh-list
154331268|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
154331269|NCT00571662|Pentostatin|pentostatin|mesh-list
154331270|NCT00571662|Cyclosporins|cyclosporins|mesh-list
154331271|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331272|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331273|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331274|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
154331275|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331276|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
154331277|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154331278|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
154331279|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331316|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331347|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154331348|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154331349|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331350|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154331351|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
154331352|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331353|NCT05374057|Ibuprofen|ibuprofen|mesh-list
154331354|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154331355|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154331356|NCT05374057|Analgesics|analgesics|mesh-ancestor
154331357|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
154331358|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331384|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154331385|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
154331386|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
154331387|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
154331388|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154331389|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
154331390|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154331391|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
154331392|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861784|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154861785|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861786|NCT03031535|Octreotide|octreotide|mesh-list
153958008|NCT02831205|Cobalt|cobalt|mesh-list
154331393|NCT05139043|Dexamethasone|dexamethasone|mesh-list
154331394|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
154331395|NCT05139043|Ichthammol|ichthammol|mesh-list
154331396|NCT05139043|BB 1101|bb 1101|mesh-list
154331397|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331398|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
154331399|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
154331400|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331401|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331402|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154331403|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
154331404|NCT05139043|Hormones|hormones|mesh-ancestor
154331405|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331406|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153510585|NCT01402245|Vaccines|vaccines|mesh-list
154331423|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154331424|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331425|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
154331426|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331427|NCT04976387|Acetaminophen|acetaminophen|mesh-list
154331428|NCT04976387|Ibuprofen|ibuprofen|mesh-list
154331429|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154331430|NCT04976387|Hydrocodone|hydrocodone|mesh-list
154331431|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154331432|NCT04976387|Analgesics|analgesics|mesh-ancestor
154331433|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
154331434|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331435|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331436|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
154331437|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154331438|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331439|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331440|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154331441|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582973|NCT05430750|Sevoflurane|sevoflurane|mesh-list
154331442|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331443|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154331444|NCT04976387|Narcotics|narcotics|mesh-ancestor
154331445|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154331446|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
154331447|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
154331448|NCT04941872|FAPI-46|fapi-46|mesh-list
154331449|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154331450|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331451|NCT04915755|Niraparib|niraparib|mesh-list
154331452|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154331453|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331454|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331455|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331456|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
154331457|NCT04897321|Fludarabine|fludarabine|mesh-list
154331458|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331460|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331461|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331462|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154331463|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
154331464|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331465|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331492|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331493|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331494|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
154331495|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331496|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331497|NCT04844918|Tirzepatide|tirzepatide|mesh-list
154331498|NCT04844918|Incretins|incretins|mesh-ancestor
154331499|NCT04844918|Hormones|hormones|mesh-ancestor
154331500|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331501|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331502|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154331503|NCT04826354|Ezetimibe|ezetimibe|mesh-list
154331504|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154331505|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154331506|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
154331507|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861787|NCT03031535|Hormones|hormones|mesh-list
154331508|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154331509|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154331510|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331511|NCT04781998|Liraglutide|liraglutide|mesh-list
154331512|NCT04781998|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154331513|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154331545|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154331546|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331547|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154331548|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
154331549|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154331550|NCT04418427|Aflibercept|aflibercept|mesh-list
154331551|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154331552|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154331553|NCT04418427|Growth Substances|growth substances|mesh-ancestor
154331554|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331555|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
154331556|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331583|NCT04310930|Amikacin|amikacin|mesh-list
154331584|NCT04310930|Ethambutol|ethambutol|mesh-list
154331585|NCT04310930|Rifabutin|rifabutin|mesh-list
154331586|NCT04310930|Tigecycline|tigecycline|mesh-list
154331587|NCT04310930|Bedaquiline|bedaquiline|mesh-list
154331588|NCT04310930|Clofazimine|clofazimine|mesh-list
154331589|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154331590|NCT04310930|Cefoxitin|cefoxitin|mesh-list
154331591|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154331592|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154331593|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154331594|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154331595|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331596|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331597|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331598|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154331599|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154331600|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154331601|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
154331602|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154331603|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154331604|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
154331605|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154331624|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331625|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
154331626|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331628|NCT04196413|Fludarabine|fludarabine|mesh-list
154331629|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331630|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
154331631|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331632|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331633|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154331634|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
154331635|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331636|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331637|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154331638|NCT04164732|Valsartan|valsartan|mesh-list
154331639|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154331640|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154331641|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154331642|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154331643|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331644|NCT04117932|Ustekinumab|ustekinumab|mesh-list
154331645|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
154331646|NCT04033354|Paclitaxel|paclitaxel|mesh-list
154331647|NCT04033354|Carboplatin|carboplatin|mesh-list
154331648|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154331649|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331650|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
154331651|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
154331652|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
154331653|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331654|NCT03952403|Bevacizumab|bevacizumab|mesh-list
154331655|NCT03952403|Carboplatin|carboplatin|mesh-list
154331656|NCT03952403|Pemetrexed|pemetrexed|mesh-list
154331657|NCT03952403|Antibodies|antibodies|mesh-list
154331658|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154331659|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331660|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154331661|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154331727|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331728|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
154331729|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331730|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
154331731|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331732|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331733|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154331734|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
154331735|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331736|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331737|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154331738|NCT03083704|Enoxaparin|enoxaparin|mesh-list
154331739|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
154331740|NCT03083704|Apixaban|apixaban|mesh-list
154331741|NCT03083704|Edoxaban|edoxaban|mesh-list
154331764|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331765|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
154331766|NCT01782352|Vitamin D|vitamin d|mesh-list
154331767|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
154331768|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
154331769|NCT01782352|Vitamins|vitamins|mesh-list
154331770|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
154331771|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331772|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154331773|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154331774|NCT01765868|Betrixaban|betrixaban|mesh-list
154331775|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154331776|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
154331777|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154331778|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
154331779|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331780|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331781|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
154331782|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154331783|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
154331784|NCT01641718|Coagulants|coagulants|mesh-ancestor
154331785|NCT00968799|Cisplatin|cisplatin|mesh-list
154331786|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331787|NCT00751231|Clopidogrel|clopidogrel|mesh-list
154331788|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154331789|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154331790|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154331791|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154331792|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
154331793|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331794|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331795|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331796|NCT00332956|Vaccines|vaccines|mesh-list
154331825|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
154331826|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331828|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154331829|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
154331830|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331831|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
154331832|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154331833|NCT02207504|Crizotinib|crizotinib|mesh-list
154331834|NCT02207504|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154331835|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154331836|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331837|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331838|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331839|NCT01342016|Prednisone|prednisone|mesh-list
154331840|NCT01342016|Tacrolimus|tacrolimus|mesh-list
154331868|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154331869|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
154331870|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331871|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331873|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
154331874|NCT02083250|Busulfan|busulfan|mesh-list
154331875|NCT02083250|Vorinostat|vorinostat|mesh-list
154331876|NCT02083250|Clofarabine|clofarabine|mesh-list
154331877|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
154331878|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154331879|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331880|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154331881|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
154331882|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331883|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331884|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
154331885|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331886|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
154331887|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153511084|NCT01404715|Metformin|metformin|mesh-list
154331918|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154331919|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
154331920|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331921|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331922|NCT01339676|Vitamin D|vitamin d|mesh-list
154331923|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
154331924|NCT01339676|Vitamins|vitamins|mesh-ancestor
154331925|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
154331926|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331927|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154331928|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154331929|NCT01339754|Trabectedin|trabectedin|mesh-list
154331930|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154331931|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
154331932|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331933|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331963|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154331964|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
154331965|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331966|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331967|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331968|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
154331969|NCT01342328|Propofol|propofol|mesh-list
154331970|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154331971|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154331972|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331973|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154331974|NCT01342328|Analgesics|analgesics|mesh-ancestor
154331975|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
154331976|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331977|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154331978|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154332001|NCT05184374|Hormones|hormones|mesh-ancestor
154332002|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332003|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332004|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154332005|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
154332006|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
154332007|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332008|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332009|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
154332010|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332011|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154332012|NCT01342562|Anesthetics|anesthetics|mesh-list
154332013|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332014|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332015|NCT00116116|Lamivudine|lamivudine|mesh-list
154332016|NCT00116116|Efavirenz|efavirenz|mesh-list
154332017|NCT00116116|Stavudine|stavudine|mesh-list
154332018|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154332019|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154332020|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332021|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332022|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
154332023|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332024|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154332025|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154332026|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154332027|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154332028|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153958250|NCT04669782|Teriparatide|teriparatide|mesh-list
153511197|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332058|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154332059|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154332060|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154332061|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154332062|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154332063|NCT00110422|Irbesartan|irbesartan|mesh-list
154332064|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154332065|NCT00110422|Diuretics|diuretics|mesh-ancestor
154332066|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
154332067|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332068|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154332069|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154332070|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332104|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
154332105|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332106|NCT00297310|Tacrolimus|tacrolimus|mesh-list
154332107|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154332108|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
154332109|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332110|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154332111|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332112|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332113|NCT00095290|Ramipril|ramipril|mesh-list
154332146|NCT01342874|Vitamins|vitamins|mesh-ancestor
154332147|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
154332148|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332149|NCT01337258|Dutasteride|dutasteride|mesh-list
154332150|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154332151|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154332152|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332179|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
154332180|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
154332181|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154332182|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154332183|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154332184|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154332185|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
154332186|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332187|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332189|NCT02285374|Emtricitabine|emtricitabine|mesh-list
154332190|NCT02285374|Efavirenz|efavirenz|mesh-list
154332191|NCT02285374|Dolutegravir|dolutegravir|mesh-list
154332192|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154332193|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
154332194|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332195|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154332196|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154332197|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332198|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332231|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332232|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154332234|NCT03943459|Atorvastatin|atorvastatin|mesh-list
154332235|NCT03943459|Quercetin|quercetin|mesh-list
154332236|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154332237|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154332238|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
154332239|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332268|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
154332269|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332270|NCT00064714|Exenatide|exenatide|mesh-list
154332271|NCT00064714|Daclizumab|daclizumab|mesh-list
154332272|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154332273|NCT00064714|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154332274|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154332275|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332276|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154332278|NCT00064714|Hormones|hormones|mesh-ancestor
154332279|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332280|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
154332281|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154332282|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154861788|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154332283|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154332284|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154190147|NCT06304870|Lidocaine|lidocaine|mesh-list
154332285|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154332286|NCT01109485|Analgesics|analgesics|mesh-ancestor
154332287|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
154332288|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332305|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154332306|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
154332307|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332308|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332309|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332310|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
154332311|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
154332312|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332313|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154332314|NCT00284128|Losartan|losartan|mesh-list
154332315|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154332316|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154332317|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154332318|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154332319|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332320|NCT00035542|Metformin|metformin|mesh-list
154332321|NCT00035542|Glyburide|glyburide|mesh-list
154332322|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154332323|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332324|NCT01209715|Fluticasone|fluticasone|mesh-list
154332325|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154332326|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154332327|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332328|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154332329|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
154332330|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332331|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332332|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154332333|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
154332334|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
154332335|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154332336|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154332337|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154332338|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154332339|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
154332340|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332341|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332342|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
154332343|NCT01209715|Hormones|hormones|mesh-ancestor
154332344|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332345|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
154332383|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154332384|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
154332385|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511578|NCT01407848|Furosemide|furosemide|mesh-list
154332407|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154332408|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154332409|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
154332410|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154332411|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332412|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154332413|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154332414|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154332415|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332416|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
154332417|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154332418|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
154332420|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154332421|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154332422|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154332423|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332424|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332426|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154332427|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
154332428|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332429|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332430|NCT00267280|Atorvastatin|atorvastatin|mesh-list
154332431|NCT00267280|Simvastatin|simvastatin|mesh-list
154332432|NCT00267280|Torcetrapib|torcetrapib|mesh-list
154332433|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154332434|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154332435|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
154332436|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332437|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153511609|NCT01408056|Timolol|timolol|mesh-list
154332466|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154332467|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
154332468|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332469|NCT01210339|Esomeprazole|esomeprazole|mesh-list
154332470|NCT01210339|Clopidogrel|clopidogrel|mesh-list
154332471|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154332472|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154332473|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154332474|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154332475|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
154332476|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332477|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332478|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332479|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154332480|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154332481|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153511666|NCT01408199|Lenalidomide|lenalidomide|mesh-list
154332508|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
154332509|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332510|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332512|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154332513|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
154332514|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332515|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
154332516|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154332517|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154332518|NCT01207921|Lenalidomide|lenalidomide|mesh-list
154332519|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
154332520|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332521|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154332522|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154332523|NCT01207921|Growth Substances|growth substances|mesh-ancestor
154332524|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
154332525|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332526|NCT01108393|Agomelatine|agomelatine|mesh-list
154332527|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154332528|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332529|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332530|NCT01113229|Misoprostol|misoprostol|mesh-list
154332531|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154332555|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332556|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332557|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
154332558|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154332559|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332560|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332561|NCT02288962|Cabergoline|cabergoline|mesh-list
154332562|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154332563|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154332564|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
154332565|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
154332566|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332567|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332568|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332569|NCT03942991|Mepivacaine|mepivacaine|mesh-list
154332570|NCT03942991|Carticaine|carticaine|mesh-list
154332571|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
154332572|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
154332573|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332574|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332575|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
154332576|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332577|NCT00162292|Methotrexate|methotrexate|mesh-list
154332578|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154332579|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
154332580|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154332581|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332582|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154332583|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
153511756|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154332607|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
154332609|NCT03531970|Epinephrine|epinephrine|mesh-list
154332610|NCT03531970|BB 1101|bb 1101|mesh-list
154332611|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332612|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
154332613|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
154332614|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332615|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332616|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154332617|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
154332618|NCT03531970|Hormones|hormones|mesh-ancestor
154332619|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332620|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154332621|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332622|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
154332623|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332624|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332625|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
154332626|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
154332627|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332628|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
154332629|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154332630|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154332631|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154332667|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154332668|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154332669|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332685|NCT01211275|Axitinib|axitinib|mesh-list
154332686|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332687|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332688|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332689|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154332690|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154332691|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154332692|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154332693|NCT03529084|Gefitinib|gefitinib|mesh-list
154332694|NCT03529084|Nazartinib|nazartinib|mesh-list
154332695|NCT03529084|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154332696|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154332697|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332698|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332699|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332700|NCT03942757|Bilirubin|bilirubin|mesh-list
154332701|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
154332702|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332703|NCT03942757|Protective Agents|protective agents|mesh-ancestor
154332704|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332705|NCT01208701|Atorvastatin|atorvastatin|mesh-list
154332706|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154332707|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154332708|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
154332709|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332710|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154332711|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154332712|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332713|NCT03528772|Minoxidil|minoxidil|mesh-list
154332714|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
154332715|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154332716|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
154332717|NCT01316744|Ketamine|ketamine|mesh-list
154332718|NCT01316744|Analgesics|analgesics|mesh-ancestor
154332719|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
154332720|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079072|NCT00777296|Amikacin|amikacin|mesh-list
154332721|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332722|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154332723|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154332724|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
154332725|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
154332726|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332727|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154332728|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154332755|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154332756|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332757|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154332758|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332760|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154332761|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
154332762|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154332763|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
154332764|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332765|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332766|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154332767|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154332768|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332769|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
154332770|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154332771|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154332772|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332773|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332799|NCT01344512|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154332800|NCT01344512|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154332803|NCT05064488|Sumatriptan|sumatriptan|mesh-list
154332804|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154332805|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154332806|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332807|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154332808|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154332809|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
154332810|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332811|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154332812|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154332813|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332814|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154332815|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154332816|NCT05064488|Protective Agents|protective agents|mesh-ancestor
154332817|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154332818|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154332819|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154332820|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
153512004|NCT01410201|Hormones|hormones|mesh-ancestor
154332851|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
154332852|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332853|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332855|NCT03528616|Digoxin|digoxin|mesh-list
154332856|NCT03528616|Adenosine|adenosine|mesh-list
154332857|NCT03528616|Amiodarone|amiodarone|mesh-list
154332858|NCT03528616|Flecainide|flecainide|mesh-list
154332859|NCT03528616|Procainamide|procainamide|mesh-list
154332860|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154332861|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154332862|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
154332863|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512053|NCT01410916|Eculizumab|eculizumab|mesh-list
154332885|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154332886|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154332887|NCT02529631|Orlistat|orlistat|mesh-list
154332888|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332889|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332890|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154332891|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154332892|NCT04469062|Mirikizumab|mirikizumab|mesh-list
154332893|NCT04469062|Vedolizumab|vedolizumab|mesh-list
154332894|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154332895|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154332896|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154332897|NCT04469062|Analgesics|analgesics|mesh-ancestor
154332898|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
154332899|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332900|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332901|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332902|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154332903|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154332904|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
154332905|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154332906|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332907|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
154332908|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154332910|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
154332911|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332912|NCT01115179|Propofol|propofol|mesh-list
154332913|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153512094|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
154332941|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332942|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332943|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
154332944|NCT03145064|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154332945|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154332946|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332947|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332948|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332949|NCT03527134|Amantadine|amantadine|mesh-list
154332950|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154332951|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154332952|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
154332953|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332954|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
154332955|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332956|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332957|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332958|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154332959|NCT03527134|Analgesics|analgesics|mesh-ancestor
154332960|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
153512148|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
154332987|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
154332988|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154332989|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154332990|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
154332991|NCT01121809|Etravirine|etravirine|mesh-list
154332992|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154332993|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154332994|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
154332995|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332996|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154332997|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154332998|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332999|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333000|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154333001|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154333002|NCT03937687|Caffeine|caffeine|mesh-list
154333003|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154333004|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333005|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154333006|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333007|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333008|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154333031|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
154333032|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
154333033|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154333034|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333035|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
154333036|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333037|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
154333038|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333039|NCT01216111|Paclitaxel|paclitaxel|mesh-list
154333040|NCT01216111|Docetaxel|docetaxel|mesh-list
154333041|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
154333042|NCT01216111|Fluorouracil|fluorouracil|mesh-list
154333043|NCT01216111|Epirubicin|epirubicin|mesh-list
154333044|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154333045|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333046|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
154333047|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
154333048|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
154333049|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333050|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154333051|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
154255416|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
154333052|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333053|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154333054|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154333055|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
154333056|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154333057|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
154333058|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154333059|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154333060|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154333085|NCT01212523|Isoflurane|isoflurane|mesh-list
154333086|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154333087|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079444|NCT03326193|Niraparib|niraparib|mesh-list
154333088|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333089|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154333090|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
154333091|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
154333092|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154333093|NCT01122121|Leuprolide|leuprolide|mesh-list
154333094|NCT01122121|Flutamide|flutamide|mesh-list
154333095|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154333096|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
154333097|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154333098|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333099|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154333100|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333101|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
154333102|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
154333103|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333104|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154333105|NCT01115725|Hormones|hormones|mesh-ancestor
154333106|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333107|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333108|NCT01122199|Everolimus|everolimus|mesh-list
154333109|NCT01122199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154333110|NCT01122199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154333111|NCT01122199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512293|NCT01412567|Vaccines|vaccines|mesh-list
154333145|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333146|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154333147|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154333148|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
154333149|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
154333150|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333151|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154333152|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154333180|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333181|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333182|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
154333183|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333184|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333185|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
154333186|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154333187|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333188|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154333189|NCT03936907|Nabiximols|nabiximols|mesh-list
154333190|NCT03936907|Analgesics|analgesics|mesh-ancestor
154333191|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
154333192|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333193|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333194|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
154333195|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333196|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333197|NCT01217203|Lenalidomide|lenalidomide|mesh-list
154333198|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
153512388|NCT01413230|Vitamin D|vitamin d|mesh-list
154333214|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333216|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154333217|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154333218|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154333219|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154333220|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333221|NCT01116193|Dexamethasone|dexamethasone|mesh-list
154333223|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333224|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
154333225|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
154333226|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333227|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333228|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154333229|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
154333230|NCT01116193|Hormones|hormones|mesh-ancestor
154333231|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333232|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154333233|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333234|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
154333235|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154333236|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154333237|NCT01116193|Growth Substances|growth substances|mesh-ancestor
154333238|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
154333239|NCT01120327|Amlodipine|amlodipine|mesh-list
154333240|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154333241|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154333242|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154333243|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333244|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154190594|NCT06176339|Antioxidants|antioxidants|mesh-ancestor
154333245|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333246|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
154333247|NCT01116271|Irinotecan|irinotecan|mesh-list
154333248|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154333249|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154333250|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333251|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333252|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333253|NCT01217359|Interferons|interferons|mesh-list
154333254|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
154333255|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
154333256|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333257|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
154333283|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333284|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154333285|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154333286|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154333287|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333288|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333289|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
154333290|NCT03935347|Vidarabine|vidarabine|mesh-list
154333291|NCT03935347|Aldesleukin|aldesleukin|mesh-list
154333292|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
154333293|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
154333294|NCT03935347|Fludarabine|fludarabine|mesh-list
154333295|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
154333296|NCT03935347|Interleukin-2|interleukin-2|mesh-list
154333297|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
154333298|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
154333299|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154333300|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
154333301|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333302|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154333303|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154333304|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
154333305|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333306|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333323|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333324|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333325|NCT03939871|Vinorelbine|vinorelbine|mesh-list
154333326|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154333327|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333328|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
154333329|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
154333330|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
154333331|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333332|NCT01122667|Anacetrapib|anacetrapib|mesh-list
154333333|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154333334|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154333335|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
154333336|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190650|NCT06151236|Nivolumab|nivolumab|mesh-list
154333337|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154333338|NCT01120561|Trastuzumab|trastuzumab|mesh-list
154333339|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154333340|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154333341|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333342|NCT01120561|Immunotoxins|immunotoxins|mesh-ancestor
154333343|NCT01120561|Immunoconjugates|immunoconjugates|mesh-ancestor
154333344|NCT01120561|Immunologic Factors|immunologic factors|mesh-ancestor
154333345|NCT01120561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333346|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
154333347|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
154333348|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
154333349|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333350|NCT01217125|Sirolimus|sirolimus|mesh-list
154333351|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154333352|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333353|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154333354|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333355|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
154333356|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154333357|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
154333358|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333359|NCT03635372|Sucralfate|sucralfate|mesh-list
154333360|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
154333361|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154333362|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154333363|NCT03635372|Antacids|antacids|mesh-ancestor
153512541|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154333383|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154333384|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
154333385|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333386|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
154333387|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
154333388|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333389|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079744|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
154333390|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154333391|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
154333392|NCT04467892|Hormones|hormones|mesh-ancestor
154333393|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333394|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154333395|NCT04467892|Protective Agents|protective agents|mesh-ancestor
154333396|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154333397|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333398|NCT01122979|Insulin|insulin|mesh-list
154333399|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154333400|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
154333401|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
154333402|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
154333403|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
154333404|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
154333405|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154333406|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333407|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
154333408|NCT04179110|Ramucirumab|ramucirumab|mesh-list
154333409|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154333410|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333411|NCT04179110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154333412|NCT04179110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333413|NCT04179110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154333414|NCT04179110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154333415|NCT04179110|Growth Substances|growth substances|mesh-ancestor
154333416|NCT04179110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333417|NCT04179110|Growth Inhibitors|growth inhibitors|mesh-ancestor
154333418|NCT01123057|Riboflavin|riboflavin|mesh-list
154333436|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
154333437|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333438|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333439|NCT03524872|Analgesics|analgesics|mesh-list
154333440|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333441|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
154333442|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333443|NCT01345370|Temozolomide|temozolomide|mesh-list
154333444|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154333445|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
154333446|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333447|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333448|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
154333449|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154333450|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
154333451|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333452|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
154333453|NCT04702802|Protective Agents|protective agents|mesh-ancestor
154333454|NCT01214941|Itraconazole|itraconazole|mesh-list
154333455|NCT01214941|Ticlopidine|ticlopidine|mesh-list
154333456|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
154333457|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333458|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154333459|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154333460|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333461|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333462|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154333463|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
154333464|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079818|NCT00436345|Propofol|propofol|mesh-list
154333465|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333466|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154333467|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154333468|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154333469|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154333470|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154333471|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154333472|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154333473|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
154333496|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154333497|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154333498|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154333499|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
154333500|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333501|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333502|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333503|NCT04001894|Clopidogrel|clopidogrel|mesh-list
154333504|NCT04001894|Ticagrelor|ticagrelor|mesh-list
154333505|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154333506|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154333507|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154333508|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154333509|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
154333510|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333511|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333512|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333513|NCT01212913|Insulin|insulin|mesh-list
154333514|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154333515|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
154333516|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
154333517|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
154333518|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154333519|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154333520|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333521|NCT01345604|Ropivacaine|ropivacaine|mesh-list
154333522|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
154333523|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
154333524|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333525|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333558|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154333559|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333560|NCT03526276|Fluorides|fluorides|mesh-list
154333561|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
154333562|NCT03526276|Protective Agents|protective agents|mesh-ancestor
154333563|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333564|NCT04466254|Cetuximab|cetuximab|mesh-list
154333565|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154333566|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333567|NCT04466176|Fluticasone|fluticasone|mesh-list
154333568|NCT04466176|Xhance|xhance|mesh-list
154333569|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154333570|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154333600|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333603|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
154333604|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333605|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154333606|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154333607|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154333608|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
154333609|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333610|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333611|NCT04674020|Erenumab|erenumab|mesh-list
153512804|NCT01416350|Azithromycin|azithromycin|mesh-list
154333636|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
154333637|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154333638|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333639|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333640|NCT01121497|Physostigmine|physostigmine|mesh-list
154333641|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154333642|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333643|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333644|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
154333645|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333646|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333648|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
154333649|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333650|NCT01213147|Clomiphene|clomiphene|mesh-list
154333651|NCT01213147|Enclomiphene|enclomiphene|mesh-list
154333652|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
154333653|NCT01213147|Buserelin|buserelin|mesh-list
154333654|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154333655|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
154333656|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333657|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333658|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154333659|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
154333687|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154333688|NCT03934411|Narcotics|narcotics|mesh-ancestor
154333689|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333690|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333691|NCT03934411|Analgesics|analgesics|mesh-ancestor
154333692|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
154333693|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333694|NCT01218451|Vaccines|vaccines|mesh-list
154190821|NCT06111872|Anesthetics|anesthetics|mesh-ancestor
154333695|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
154333696|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333697|NCT01346930|Macitentan|macitentan|mesh-list
154333698|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154333699|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154333700|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333701|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154333702|NCT01219153|Letrozole|letrozole|mesh-list
154333703|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
153512896|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154333729|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154333730|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154333731|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333732|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333734|NCT03781375|Methotrexate|methotrexate|mesh-list
154333735|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154333736|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
154333737|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154333738|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333739|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154333740|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
154333741|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333742|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333743|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
154333744|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333745|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154333746|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154333747|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
154333748|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512946|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
154333768|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333769|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333770|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154333771|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333773|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154333774|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154333775|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333776|NCT03933787|Saxagliptin|saxagliptin|mesh-list
154333777|NCT03933787|Incretins|incretins|mesh-ancestor
154333778|NCT03933787|Hormones|hormones|mesh-ancestor
154333779|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333780|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333781|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154333782|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
154333783|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333784|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333785|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154333786|NCT03934333|Budesonide|budesonide|mesh-list
154333787|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333788|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154333789|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
154190892|NCT06086340|Letrozole|letrozole|mesh-list
154333790|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333791|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333792|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154333793|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
154333794|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
154333795|NCT03934333|Hormones|hormones|mesh-ancestor
154333796|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333797|NCT01124227|Icodextrin|icodextrin|mesh-list
154333798|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
154333799|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154333800|NCT03931915|Leuprolide|leuprolide|mesh-list
154333801|NCT03931915|Relugolix|relugolix|mesh-list
154333802|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154333803|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
154333826|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
154333827|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333828|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154333829|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154333830|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154333831|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154333832|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333833|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154333834|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154333836|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154333837|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154333838|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154333839|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154333840|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
154333841|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
154333842|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333843|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154333844|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154333845|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154333846|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154333847|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154333848|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154333849|NCT01124383|Narcotics|narcotics|mesh-ancestor
154333850|NCT01124383|Analgesics|analgesics|mesh-ancestor
154333851|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154333852|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
154333853|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
154333854|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154333855|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
154333856|NCT01226017|Oxytocin|oxytocin|mesh-list
154333857|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
154333858|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154333859|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333880|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154333881|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
154333882|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333883|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333884|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333885|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154333886|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154333887|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333888|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154333889|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154333890|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
154333891|NCT01129063|Clopidogrel|clopidogrel|mesh-list
154333892|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154333893|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154333894|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154333895|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154333896|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
154333897|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333898|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333899|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333900|NCT01317368|Ropivacaine|ropivacaine|mesh-list
154333901|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
154333902|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
154333903|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333904|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333905|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
154333906|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333907|NCT01219699|Fulvestrant|fulvestrant|mesh-list
154333908|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154333909|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333910|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154333911|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154333912|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
154333934|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333936|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154333937|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
154333938|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
154333939|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
154333940|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
154333941|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154333942|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333943|NCT01125553|Insulin|insulin|mesh-list
154333944|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
154333945|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154333946|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333947|NCT02640664|Ranibizumab|ranibizumab|mesh-list
154333948|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154333949|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154333950|NCT02640664|Growth Substances|growth substances|mesh-ancestor
154333951|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333952|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
154333953|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333954|NCT01317446|Fluorides|fluorides|mesh-list
154333955|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
154333956|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
154333957|NCT01317446|Protective Agents|protective agents|mesh-ancestor
154333958|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333959|NCT02529241|Delpazolid|delpazolid|mesh-list
154333960|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
154333961|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154333962|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333963|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154191009|NCT06053580|Valsartan|valsartan|mesh-list
154333964|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513155|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
154333992|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333993|NCT03132038|Nivolumab|nivolumab|mesh-list
154333994|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154333995|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333996|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154333997|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333998|NCT01129375|Omeprazole|omeprazole|mesh-list
154333999|NCT01129375|Clopidogrel|clopidogrel|mesh-list
154334000|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154334001|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154334002|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154334003|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154334004|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
154334005|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334006|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334007|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334008|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154334009|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154334027|NCT06130007|Mitosis Modulators|mitosis modulators|mesh-ancestor
154334028|NCT06130007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334029|NCT06130007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334031|NCT06129955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334032|NCT06129955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334033|NCT06129955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334034|NCT06129955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334035|NCT06129851|Relugolix|relugolix|mesh-list
154334036|NCT06129851|Androgen Antagonists|androgen antagonists|mesh-ancestor
154334037|NCT06129851|Hormone Antagonists|hormone antagonists|mesh-ancestor
154334038|NCT06129851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334039|NCT06129851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334040|NCT06129734|Venetoclax|venetoclax|mesh-list
154334041|NCT06129734|Decitabine|decitabine|mesh-list
154334042|NCT06129734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334043|NCT06129734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154334044|NCT06129734|Antimetabolites|antimetabolites|mesh-ancestor
154334045|NCT06129734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334046|NCT06129734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334047|NCT06129474|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154334048|NCT06129474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334049|NCT06129474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334050|NCT06129162|Anesthetics|anesthetics|mesh-list
154334051|NCT06129162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334052|NCT06129162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334053|NCT06128967|Metformin|metformin|mesh-list
154334054|NCT06128967|Fluvoxamine|fluvoxamine|mesh-list
154334055|NCT06128967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154334056|NCT06128967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334057|NCT06128967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334058|NCT06128967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334059|NCT06128967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154334060|NCT06128967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154334061|NCT06128967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334062|NCT06128967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154334063|NCT06128967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154334064|NCT06128967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154334065|NCT06128967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154334066|NCT06128967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334067|NCT06128967|Serotonin Agents|serotonin agents|mesh-ancestor
154334100|NCT06128408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154191046|NCT06034860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154334101|NCT06128408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154334102|NCT06128408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154334103|NCT06128408|Antidepressive Agents|antidepressive agents|mesh-ancestor
154334104|NCT06128408|Dopamine Agonists|dopamine agonists|mesh-ancestor
154334105|NCT06128408|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154334106|NCT06128408|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154334107|NCT06128408|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154334108|NCT06128408|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154334109|NCT06128278|Equol|equol|mesh-list
154334143|NCT06126068|Sensory System Agents|sensory system agents|mesh-ancestor
154334144|NCT06126068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334145|NCT06126068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334146|NCT06126068|Anesthetics|anesthetics|mesh-ancestor
154334147|NCT06126068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334148|NCT06126068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154334149|NCT06126068|Anticonvulsants|anticonvulsants|mesh-ancestor
154334150|NCT06126068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154334151|NCT06126068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154334178|NCT06086171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334179|NCT06086171|Analgesics|analgesics|mesh-ancestor
154334180|NCT06086171|Sensory System Agents|sensory system agents|mesh-ancestor
154334181|NCT06086171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334182|NCT06086171|Antitussive Agents|antitussive agents|mesh-ancestor
154334183|NCT06086171|Respiratory System Agents|respiratory system agents|mesh-ancestor
154334184|NCT06064500|AMG 757|amg 757|mesh-list
154334185|NCT06064500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334186|NCT06058650|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154334187|NCT06058650|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154334188|NCT06058650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334189|NCT06054113|Blinatumomab|blinatumomab|mesh-list
154334190|NCT06054113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334191|NCT06022146|Rifampin|rifampin|mesh-list
154334192|NCT06022146|Rifapentine|rifapentine|mesh-list
154334193|NCT06022146|Isoniazid|isoniazid|mesh-list
154334194|NCT06022146|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154334195|NCT06022146|Antitubercular Agents|antitubercular agents|mesh-ancestor
154334196|NCT06022146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154334197|NCT06022146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513395|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
154334230|NCT05968937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334232|NCT05968937|GABA Agonists|gaba agonists|mesh-ancestor
154334233|NCT05968937|GABA Agents|gaba agents|mesh-ancestor
154334234|NCT05968937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513441|NCT01420523|Maraviroc|maraviroc|mesh-list
154334250|NCT05867329|Glucocorticoids|glucocorticoids|mesh-ancestor
154334252|NCT05867329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334253|NCT05867329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334254|NCT05867329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334255|NCT05867329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334256|NCT05867329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191116|NCT06001372|Anesthetics|anesthetics|mesh-ancestor
154334257|NCT05867329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334258|NCT05867329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334259|NCT05867329|Immunologic Factors|immunologic factors|mesh-ancestor
154334260|NCT05867329|Antifungal Agents|antifungal agents|mesh-ancestor
154334261|NCT05867329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334262|NCT05867329|Dermatologic Agents|dermatologic agents|mesh-ancestor
154334263|NCT05867329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154334264|NCT05867329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154334265|NCT05867329|Antiemetics|antiemetics|mesh-ancestor
154334266|NCT05867329|Autonomic Agents|autonomic agents|mesh-ancestor
154334267|NCT05867329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334268|NCT05867329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154334269|NCT05867329|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154334270|NCT05867329|Protective Agents|protective agents|mesh-ancestor
154334271|NCT05867329|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154334272|NCT05867329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334273|NCT05694715|Irinotecan|irinotecan|mesh-list
154334274|NCT05694715|Niraparib|niraparib|mesh-list
154334275|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154334276|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154334277|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334278|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334279|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334280|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154334281|NCT05623995|Evolocumab|evolocumab|mesh-list
154334282|NCT05623995|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154334283|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154334284|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154334285|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154334286|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
154334287|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334288|NCT05623995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154334289|NCT05623995|Protease Inhibitors|protease inhibitors|mesh-ancestor
154334290|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334291|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154334292|NCT05608252|Fulvestrant|fulvestrant|mesh-list
154334293|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334294|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334357|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
154334358|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
154334359|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334360|NCT05153564|Semaglutide|semaglutide|mesh-list
154334361|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154334362|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154334363|NCT05153564|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154334364|NCT05153564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154334365|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334366|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154334367|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
154334368|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154334369|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154334370|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154334371|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154334372|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154334373|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154334400|NCT05016609|Velpatasvir|velpatasvir|mesh-list
154334401|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154334402|NCT05016609|Antibodies|antibodies|mesh-list
154334403|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
154334404|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
154191164|NCT05945615|Mydriatics|mydriatics|mesh-ancestor
154334405|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334406|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
154334407|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334408|NCT04988308|Adalimumab|adalimumab|mesh-list
154334409|NCT04988308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154334410|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334411|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154334412|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
154334413|NCT04904562|Giapreza|giapreza|mesh-list
154334414|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
154334415|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154334416|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154334417|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
154334418|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334419|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334420|NCT04849364|Pembrolizumab|pembrolizumab|mesh-list
154334421|NCT04849364|Capecitabine|capecitabine|mesh-list
154334422|NCT04849364|Talazoparib|talazoparib|mesh-list
154334423|NCT04849364|Inavolisib|inavolisib|mesh-list
154334424|NCT04849364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334447|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334448|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
154334449|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
154334450|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334452|NCT04737109|Androgens|androgens|mesh-list
154334453|NCT04737109|Hormones|hormones|mesh-ancestor
154334454|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334455|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334456|NCT04737109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334457|NCT04737109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334458|NCT04737109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334459|NCT04737109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334460|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
154334461|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334462|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
154334463|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334464|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334465|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154334466|NCT04589325|Ixekizumab|ixekizumab|mesh-list
154334467|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
154334468|NCT04582669|Triamcinolone|triamcinolone|mesh-list
154334469|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154334470|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154334471|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154334472|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334473|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
154334474|NCT04582669|Hormones|hormones|mesh-ancestor
154334475|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513681|NCT01422018|Bevacizumab|bevacizumab|mesh-list
154334507|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154334508|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154334509|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
154334510|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
154334511|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334512|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154334513|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154334514|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334515|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334516|NCT04019873|Lamivudine|lamivudine|mesh-list
154334517|NCT04019873|Rilpivirine|rilpivirine|mesh-list
154334518|NCT04019873|Dolutegravir|dolutegravir|mesh-list
154334519|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154334520|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154334556|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154334557|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334558|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154334559|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154334560|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154334597|NCT03753919|Tremelimumab|tremelimumab|mesh-list
154334598|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334628|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
154334629|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334630|NCT03237611|Dexamethasone|dexamethasone|mesh-list
154334631|NCT03237611|Ondansetron|ondansetron|mesh-list
154334633|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
154334634|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334635|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
154334636|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
154334637|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334638|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334639|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154334640|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
154334641|NCT03237611|Hormones|hormones|mesh-ancestor
154334642|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334643|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334644|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334673|NCT03054363|Tucatinib|tucatinib|mesh-list
154334674|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334675|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154334676|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154334677|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334678|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334679|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154334680|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
154334681|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334682|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334683|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334684|NCT03043313|Trastuzumab|trastuzumab|mesh-list
154334685|NCT03043313|Tucatinib|tucatinib|mesh-list
154334686|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153513901|NCT01423175|Clofarabine|clofarabine|mesh-list
154334721|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154334722|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334723|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154334725|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
154334726|NCT01787409|Vitamins|vitamins|mesh-ancestor
154334727|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
153513942|NCT01423305|Hormones|hormones|mesh-ancestor
154334754|NCT03525730|Valproic Acid|valproic acid|mesh-list
154334755|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
154334756|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154334757|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154334758|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334759|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154334760|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334761|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334762|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
154334763|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
154334764|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334765|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334766|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
154334767|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154334768|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334769|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154334770|NCT01223443|Paclitaxel|paclitaxel|mesh-list
154334771|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154334772|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334773|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
154334774|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
154334775|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
154334776|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334839|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334840|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
154334841|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154334842|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
154334843|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154334844|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334845|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154334846|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
154334847|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334848|NCT01223755|Sirolimus|sirolimus|mesh-list
154334849|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154334850|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334851|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154334852|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334853|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
154334854|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334855|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
154334856|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334857|NCT01126177|Interferons|interferons|mesh-list
154334858|NCT01126177|Interferon-beta|interferon-beta|mesh-list
154334859|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
154334860|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334861|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
154334862|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334863|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
154334864|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334865|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154334866|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
154334867|NCT03680092|Methotrexate|methotrexate|mesh-list
154334868|NCT03680092|Abatacept|abatacept|mesh-list
154334869|NCT03680092|Tacrolimus|tacrolimus|mesh-list
154334906|NCT05789680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334933|NCT05789030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334934|NCT05789030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334935|NCT05789030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334937|NCT05789030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334938|NCT05789030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334939|NCT05789030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334940|NCT05789030|Immunologic Factors|immunologic factors|mesh-ancestor
154334941|NCT05789030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154334942|NCT05789030|Respiratory System Agents|respiratory system agents|mesh-ancestor
154334943|NCT05789017|Mycophenolic Acid|mycophenolic acid|mesh-list
154334944|NCT05789017|Prednisone|prednisone|mesh-list
154334945|NCT05789017|Leflunomide|leflunomide|mesh-list
154334946|NCT05789017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334947|NCT05789017|Glucocorticoids|glucocorticoids|mesh-ancestor
154334948|NCT05789017|Hormones|hormones|mesh-ancestor
154334949|NCT05789017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334950|NCT05789017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334969|NCT05788913|Heparin|heparin|mesh-list
154334970|NCT05788913|Anticoagulants|anticoagulants|mesh-ancestor
154334971|NCT05788913|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154334972|NCT05788913|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154334973|NCT05788913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334974|NCT05788900|Heparin|heparin|mesh-list
154334975|NCT05788900|Anticoagulants|anticoagulants|mesh-ancestor
154334976|NCT05788900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154334977|NCT05788900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154334978|NCT05788900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334979|NCT05788835|Chlorotrianisene|chlorotrianisene|mesh-list
154334980|NCT05788835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154334981|NCT05788835|Estrogens|estrogens|mesh-ancestor
154334982|NCT05788835|Hormones|hormones|mesh-ancestor
154334983|NCT05788835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334984|NCT05788835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334985|NCT05788835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334986|NCT05788835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334987|NCT05788705|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154334988|NCT05788705|Boswellic acid|boswellic acid|mesh-list
154334989|NCT05788705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334990|NCT05788705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154334991|NCT05788705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154334992|NCT05788705|Analgesics|analgesics|mesh-ancestor
154334993|NCT05788705|Sensory System Agents|sensory system agents|mesh-ancestor
154334994|NCT05788705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334995|NCT05788705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334996|NCT05788705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154334997|NCT05755282|Hand Sanitizers|hand sanitizers|mesh-list
154334998|NCT05755282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154334999|NCT05755282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335000|NCT05755282|Disinfectants|disinfectants|mesh-ancestor
154335001|NCT05697471|Dienogest|dienogest|mesh-list
154335002|NCT05697471|Danazol|danazol|mesh-list
154335003|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154335004|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
154335005|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154335006|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335007|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154335026|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154335029|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
154335030|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154335031|NCT05635877|Esmolol|esmolol|mesh-list
154335032|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154335033|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154335034|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154335035|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
154335036|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335037|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335038|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335039|NCT05596006|Domperidone|domperidone|mesh-list
154335040|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
154335041|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
154335042|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335043|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335044|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154335045|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154335046|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
154335047|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335048|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335049|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
154335050|NCT05586529|Vitamin D|vitamin d|mesh-list
154335051|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154335052|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335053|NCT05586529|Vitamins|vitamins|mesh-ancestor
154335054|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
154335055|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154335056|NCT05555303|Amikacin|amikacin|mesh-list
154335057|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335058|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335059|NCT05549752|Amiodarone|amiodarone|mesh-list
154335060|NCT05549752|Flecainide|flecainide|mesh-list
154335061|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154335062|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154335063|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
153514261|NCT01425099|Dolutegravir|dolutegravir|mesh-list
154335088|NCT05441930|Levofloxacin|levofloxacin|mesh-list
154335089|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154335090|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335091|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335092|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154335093|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154335094|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335095|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335096|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335097|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154335098|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154335099|NCT05394727|Insulin|insulin|mesh-list
154335100|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154335101|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154335102|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335103|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
154335104|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154335105|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335106|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153514312|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
154335138|NCT05112263|Cyclosporins|cyclosporins|mesh-list
154335139|NCT05112263|Tofacitinib|tofacitinib|mesh-list
154335140|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335141|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335142|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154335143|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
154335144|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335145|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
154335146|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514357|NCT01425476|Vitamin D|vitamin d|mesh-list
154335177|NCT05040984|Urological Agents|urological agents|mesh-ancestor
154335178|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154335179|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154335180|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
154335182|NCT05017272|Narcotics|narcotics|mesh-ancestor
154335183|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154335184|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335185|NCT05017272|Analgesics|analgesics|mesh-ancestor
154335186|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
154335187|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335188|NCT04981912|Rituximab|rituximab|mesh-list
154335189|NCT04981912|Venetoclax|venetoclax|mesh-list
153514397|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
154335221|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335222|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
154335223|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
154335224|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
154335225|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335226|NCT04880395|Lamivudine|lamivudine|mesh-list
154335227|NCT04880395|Emtricitabine|emtricitabine|mesh-list
154335228|NCT04880395|Dolutegravir|dolutegravir|mesh-list
154335229|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154335230|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154335231|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335232|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335233|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
154335260|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335262|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
154335263|NCT04790513|Evolocumab|evolocumab|mesh-list
154335264|NCT04790513|Alirocumab|alirocumab|mesh-list
154335265|NCT04790513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154335266|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154335267|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154335268|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
154335269|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335270|NCT04790513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154335271|NCT04790513|Protease Inhibitors|protease inhibitors|mesh-ancestor
154335272|NCT04790513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335273|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154335274|NCT04777071|Edetic Acid|edetic acid|mesh-list
154335275|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154335276|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
154335277|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
154335278|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335279|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
154335280|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154335281|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154335282|NCT04646837|Paclitaxel|paclitaxel|mesh-list
154335312|NCT04522284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335313|NCT04489888|Paclitaxel|paclitaxel|mesh-list
154335314|NCT04489888|Carboplatin|carboplatin|mesh-list
154335315|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
154335316|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154335317|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335318|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
154335319|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
154335320|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
154335321|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335322|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335323|NCT04489888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154335325|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335326|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335327|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514533|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
154335384|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
154335385|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335386|NCT04193553|Lenvatinib|lenvatinib|mesh-list
154335387|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335388|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335389|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335390|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335391|NCT04183101|Enalapril|enalapril|mesh-list
154335392|NCT04183101|Enalaprilat|enalaprilat|mesh-list
154335393|NCT04183101|Aliskiren|aliskiren|mesh-list
154335394|NCT04183101|Renin Inhibitors|renin inhibitors|mesh-ancestor
154335395|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
154335396|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335397|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335398|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154335399|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154335401|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154335402|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
154335403|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335404|NCT04155632|Expectorants|expectorants|mesh-ancestor
154335405|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
154335406|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154335407|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
154335408|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335409|NCT04155632|Protective Agents|protective agents|mesh-ancestor
154335410|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335411|NCT04155632|Antidotes|antidotes|mesh-ancestor
154335412|NCT04073134|Evolocumab|evolocumab|mesh-list
154335413|NCT04073134|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154335414|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154335415|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154335416|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
154335417|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335418|NCT04073134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154335454|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335455|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154335456|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154335457|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
154335491|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154335492|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154335493|NCT03529396|Analgesics|analgesics|mesh-ancestor
154335494|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
154335495|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335496|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335497|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335498|NCT03529396|Filaricides|filaricides|mesh-ancestor
154335499|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
154335531|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154335532|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
154335533|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335534|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335535|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
154335536|NCT03358017|Atorvastatin|atorvastatin|mesh-list
154335537|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154335538|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154335539|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
154335540|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335541|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154335542|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154335570|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335571|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154335572|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154335573|NCT03251300|Mirabegron|mirabegron|mesh-list
154335574|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154335575|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154335576|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154335577|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
154335578|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335579|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335580|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335581|NCT03251300|Urological Agents|urological agents|mesh-ancestor
154335582|NCT03228693|Triamcinolone|triamcinolone|mesh-list
154335583|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335584|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
154335585|NCT03228693|Hormones|hormones|mesh-ancestor
154335586|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335587|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335588|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154335617|NCT03103152|Analgesics|analgesics|mesh-ancestor
154335618|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
154335619|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335620|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335621|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081952|NCT02520778|Osimertinib|osimertinib|mesh-list
154335622|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154335623|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154335624|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335625|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154335626|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154335627|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335628|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
154335629|NCT02937285|Interferons|interferons|mesh-list
154335630|NCT02937285|Interferon-beta|interferon-beta|mesh-list
154335631|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
154335632|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
154335633|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335634|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
154335635|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335636|NCT02937285|Analgesics|analgesics|mesh-ancestor
154335637|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
154335638|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514836|NCT01425827|Analgesics|analgesics|mesh-ancestor
154335672|NCT02315196|Carboplatin|carboplatin|mesh-list
154335673|NCT02315196|Doxorubicin|doxorubicin|mesh-list
154335674|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154335675|NCT02315196|Epirubicin|epirubicin|mesh-list
154335676|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154335677|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335678|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
154335679|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
154335680|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
154335731|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335732|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
154335733|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335734|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
154335735|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154335736|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
154335737|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154335738|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335739|NCT03721328|Vancomycin|vancomycin|mesh-list
154335740|NCT03721328|Tobramycin|tobramycin|mesh-list
154335741|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335742|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335743|NCT01220791|Progesterone|progesterone|mesh-list
154335744|NCT01220791|Progestins|progestins|mesh-ancestor
154335745|NCT01220791|Hormones|hormones|mesh-ancestor
154335746|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335747|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335748|NCT01353482|Pemetrexed|pemetrexed|mesh-list
154335749|NCT01353482|Vorinostat|vorinostat|mesh-list
154335750|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335751|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335752|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335753|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154335754|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154335755|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154335756|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
154335757|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154335758|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154335759|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154335760|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154335761|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335762|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
154335763|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335764|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335765|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154335766|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335767|NCT01353716|Dolutegravir|dolutegravir|mesh-list
154335768|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154335769|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154335770|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335771|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335772|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154335773|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154335774|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
154335775|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335776|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
154335777|NCT04481672|Analgesics|analgesics|mesh-ancestor
153514962|NCT01426737|Vildagliptin|vildagliptin|mesh-list
154335795|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154335796|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154335797|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335798|NCT04465942|Paclitaxel|paclitaxel|mesh-list
154335799|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
154335800|NCT04465942|Nivolumab|nivolumab|mesh-list
154335801|NCT04465942|Pemetrexed|pemetrexed|mesh-list
154335802|NCT04465942|Atezolizumab|atezolizumab|mesh-list
154335803|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154335804|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335805|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
154335806|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
154335807|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
154335808|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335809|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335810|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154335811|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335812|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154335813|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154335815|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335816|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335817|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335818|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335819|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154335820|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
154335821|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
154335822|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335823|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
154335824|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335825|NCT01329289|Dexamethasone|dexamethasone|mesh-list
154335826|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
154335827|NCT01329289|Bortezomib|bortezomib|mesh-list
154335828|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154335829|NCT01329289|Pasireotide|pasireotide|mesh-list
154335830|NCT01329289|BB 1101|bb 1101|mesh-list
154335831|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335832|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
154335833|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
154335834|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335835|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335864|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335865|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335866|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154335867|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
154335868|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154335869|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335870|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335871|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154335872|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
154335873|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
154335874|NCT01348412|Raltitrexed|raltitrexed|mesh-list
154335875|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335876|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154335877|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
154335878|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335898|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335899|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335900|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335901|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154335902|NCT01221103|Dexamethasone|dexamethasone|mesh-list
154335903|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154335904|NCT01221103|Ofatumumab|ofatumumab|mesh-list
154335905|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154335906|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335907|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
154335908|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
154335909|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335910|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335911|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154335912|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
154335913|NCT01221103|Hormones|hormones|mesh-ancestor
154335914|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335915|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154335916|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335917|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154335918|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
154335919|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335920|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
154335921|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
154082236|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
154335923|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
154335924|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
154335925|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335926|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154335927|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154335929|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335930|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154335931|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154335932|NCT03927313|Aspirin|aspirin|mesh-list
154335933|NCT03927313|Rifampin|rifampin|mesh-list
154335934|NCT03927313|Linezolid|linezolid|mesh-list
154335935|NCT03927313|Dexamethasone|dexamethasone|mesh-list
154335960|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
154335961|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335962|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335963|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
154335964|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154335965|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154335966|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154335967|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154335968|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154335969|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154335970|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154335971|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154335973|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
154335974|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154335975|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154335976|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335977|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154191798|NCT05477953|Nifurtimox|nifurtimox|mesh-list
154335978|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154335979|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335980|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335981|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
154335982|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
154336056|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336057|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336058|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154336059|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154336060|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153515268|NCT01428414|Paclitaxel|paclitaxel|mesh-list
154336084|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336085|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
154336086|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336087|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154336088|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154336089|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
154336090|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336091|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154336092|NCT02289430|Ezetimibe|ezetimibe|mesh-list
154336093|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154336094|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154336095|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
154336096|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336097|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154336098|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154336099|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336100|NCT01224847|Lidocaine|lidocaine|mesh-list
154336101|NCT01224847|Cocaine|cocaine|mesh-list
154336102|NCT01224847|Tetracaine|tetracaine|mesh-list
154336103|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
154336104|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
154336105|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336106|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336107|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
154336108|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336109|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154336110|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154336111|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154336134|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336136|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
154336137|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336138|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336139|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154336140|NCT02289586|Narcotics|narcotics|mesh-ancestor
154336141|NCT02289586|Analgesics|analgesics|mesh-ancestor
154336142|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
154336143|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336144|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154336145|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154336147|NCT03740581|Insulin|insulin|mesh-list
154336148|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154082462|NCT00709449|Papaverine|papaverine|mesh-list
154336149|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336150|NCT03874897|Antibodies|antibodies|mesh-list
154336151|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154336152|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
154336153|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336154|NCT01127035|Immunomodulating Agents|immunomodulating agents|mesh-list
154336155|NCT01127035|Immunologic Factors|immunologic factors|mesh-ancestor
154336156|NCT01127035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336157|NCT02294266|Ethanol|ethanol|mesh-list
154336158|NCT02294266|Methamphetamine|methamphetamine|mesh-list
154336159|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154336160|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336161|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336162|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336163|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154336164|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
154336165|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
154336189|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336190|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154336191|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154336193|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154336194|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
154336195|NCT03926377|Hormones|hormones|mesh-ancestor
154336196|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336197|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336198|NCT03132688|Propofol|propofol|mesh-list
154336199|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154336200|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336201|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336202|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154336203|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
154336204|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
154336205|NCT01227811|Darifenacin|darifenacin|mesh-list
154336206|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154336207|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
154336208|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154336209|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336210|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336211|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336212|NCT01227811|Urological Agents|urological agents|mesh-ancestor
154336213|NCT01225081|Pioglitazone|pioglitazone|mesh-list
154336214|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
153515424|NCT01429415|Analgesics|analgesics|mesh-ancestor
154336249|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336250|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154336251|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154336252|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154336253|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154336254|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336290|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336292|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
154336293|NCT03517930|Ephedrine|ephedrine|mesh-list
154336294|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
154336324|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154336325|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336327|NCT02295046|Atorvastatin|atorvastatin|mesh-list
154336328|NCT02295046|Calcium|calcium|mesh-list
154336329|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154336330|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336331|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154336332|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154336333|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
154336334|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336335|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153515535|NCT01429844|Tacrolimus|tacrolimus|mesh-list
154336357|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336358|NCT03925051|Denosumab|denosumab|mesh-list
154336359|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153960146|NCT06074185|Dexamethasone|dexamethasone|mesh-list
154336360|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336361|NCT03514576|Pasireotide|pasireotide|mesh-list
154336362|NCT03514576|Hormones|hormones|mesh-ancestor
154336363|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336364|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336365|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
154336366|NCT02299024|Narcotics|narcotics|mesh-ancestor
154336367|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336368|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336369|NCT02299024|Analgesics|analgesics|mesh-ancestor
154336370|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
154336371|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082689|NCT02589678|Vaccines|vaccines|mesh-list
154336372|NCT03929419|Insulin|insulin|mesh-list
154336373|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154336374|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336375|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154336376|NCT01228279|Icodextrin|icodextrin|mesh-list
154336377|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
154336378|NCT03514342|Ropivacaine|ropivacaine|mesh-list
154336379|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
154336380|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
154336381|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336382|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336383|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
154336384|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336385|NCT01228045|Trastuzumab|trastuzumab|mesh-list
154336386|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336387|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336388|NCT03514030|Antibodies|antibodies|mesh-list
154336389|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
154336390|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336391|NCT03517462|Ivermectin|ivermectin|mesh-list
154336425|NCT06142591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336426|NCT06142474|Dapagliflozin|dapagliflozin|mesh-list
154336427|NCT06142474|Empagliflozin|empagliflozin|mesh-list
154336428|NCT06142474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154336429|NCT06142474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336459|NCT06141330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154336461|NCT06141330|Sensory System Agents|sensory system agents|mesh-ancestor
154336462|NCT06141330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336463|NCT06141330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336464|NCT06141330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154336465|NCT06141330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154336466|NCT06141330|Dermatologic Agents|dermatologic agents|mesh-ancestor
154336467|NCT06141304|Plerixafor|plerixafor|mesh-list
154336468|NCT06141304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154336469|NCT06141304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154336470|NCT06141304|Antiviral Agents|antiviral agents|mesh-ancestor
154336471|NCT06141304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336472|NCT06141265|Niraparib|niraparib|mesh-list
154336473|NCT06141265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154336474|NCT06141265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336475|NCT06141265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515678|NCT01431092|Melatonin|melatonin|mesh-list
154336503|NCT06141018|Viscosupplements|viscosupplements|mesh-ancestor
154336504|NCT06141018|Protective Agents|protective agents|mesh-ancestor
154336506|NCT06140953|Nicotinic Acids|nicotinic acids|mesh-list
154336507|NCT06140953|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154336508|NCT06140953|Furosemide|furosemide|mesh-list
154336509|NCT06140953|Trimetazidine|trimetazidine|mesh-list
154336510|NCT06140953|Diuretics|diuretics|mesh-ancestor
154336511|NCT06140953|Natriuretic Agents|natriuretic agents|mesh-ancestor
154336512|NCT06140953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336513|NCT06140953|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154336514|NCT06140953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336515|NCT06140953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336516|NCT06140953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154336517|NCT06140953|Antimetabolites|antimetabolites|mesh-ancestor
154336518|NCT06140953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154336519|NCT06140953|Vasodilator Agents|vasodilator agents|mesh-ancestor
154336520|NCT06140953|Vitamin B Complex|vitamin b complex|mesh-ancestor
154336521|NCT06140953|Vitamins|vitamins|mesh-ancestor
154336522|NCT06140953|Micronutrients|micronutrients|mesh-ancestor
154336523|NCT06140914|Calcium|calcium|mesh-list
154861789|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336547|NCT06139029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336548|NCT06139029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154336549|NCT06139029|Glucocorticoids|glucocorticoids|mesh-ancestor
154336550|NCT06139029|Hormones|hormones|mesh-ancestor
154336551|NCT06139029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336552|NCT06137378|Pembrolizumab|pembrolizumab|mesh-list
154336553|NCT06137378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336554|NCT06137378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336555|NCT06137378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154582974|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154336556|NCT06137378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336557|NCT06134726|Rheumatoid Factor|rheumatoid factor|mesh-list
154336558|NCT06134726|Immunologic Factors|immunologic factors|mesh-ancestor
154336559|NCT06134726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336560|NCT06134037|Aminophylline|aminophylline|mesh-list
154336561|NCT06134037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154336562|NCT06134037|Autonomic Agents|autonomic agents|mesh-ancestor
154336563|NCT06134037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336564|NCT06134037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336565|NCT06134037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154336566|NCT06134037|Respiratory System Agents|respiratory system agents|mesh-ancestor
154336567|NCT06134037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154336568|NCT06134037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154336569|NCT06134037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336570|NCT06134037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336571|NCT06134037|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154336572|NCT06134037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154336573|NCT06134037|Purinergic Agents|purinergic agents|mesh-ancestor
154336608|NCT06030258|Etoposide|etoposide|mesh-list
154336609|NCT06030258|Tislelizumab|tislelizumab|mesh-list
154336610|NCT06030258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336611|NCT06030258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154336612|NCT06030258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154336613|NCT06030258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154336614|NCT06030258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336615|NCT06030258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336641|NCT05914467|Teicoplanin|teicoplanin|mesh-list
154336642|NCT05914467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154336643|NCT05914467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336644|NCT05891613|Bupivacaine|bupivacaine|mesh-list
154336645|NCT05891613|Anesthetics, Local|anesthetics, local|mesh-ancestor
154336646|NCT05891613|Anesthetics|anesthetics|mesh-ancestor
154336647|NCT05891613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336648|NCT05891613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336649|NCT05891613|Sensory System Agents|sensory system agents|mesh-ancestor
154336650|NCT05891613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336651|NCT05883150|Midazolam|midazolam|mesh-list
154192076|NCT05320627|Edoxaban|edoxaban|mesh-list
154336652|NCT05883150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154336653|NCT05883150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154336654|NCT05883150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336655|NCT05883150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336656|NCT05883150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154336657|NCT05883150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154336658|NCT05883150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336659|NCT05883150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154336660|NCT05883150|Anesthetics, General|anesthetics, general|mesh-ancestor
154336661|NCT05883150|Anesthetics|anesthetics|mesh-ancestor
154336662|NCT05883150|GABA Modulators|gaba modulators|mesh-ancestor
154336663|NCT05883150|GABA Agents|gaba agents|mesh-ancestor
154336664|NCT05883150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336701|NCT05825924|Nicotine|nicotine|mesh-list
153515905|NCT01432249|Analgesics|analgesics|mesh-ancestor
154336737|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
154336738|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336768|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154336769|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
154336770|NCT05669339|Irinotecan|irinotecan|mesh-list
154336771|NCT05669339|Sorafenib|sorafenib|mesh-list
154336772|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154336773|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154336774|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336775|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336776|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336777|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154336778|NCT05658861|Caseins|caseins|mesh-list
154336779|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
154336780|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
153960276|NCT05903131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154336781|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336799|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336800|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336802|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154336803|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154336804|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336805|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336806|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154336807|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154336808|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336809|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154336810|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
154336811|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
154336812|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
154336813|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
154336814|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336815|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336816|NCT05518903|FAPI-46|fapi-46|mesh-list
154336817|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154336818|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336819|NCT05509933|Budesonide|budesonide|mesh-list
154336820|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154336821|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154336822|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
154336823|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336824|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336825|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154336826|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
154336827|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
154336828|NCT05509933|Hormones|hormones|mesh-ancestor
154336829|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336830|NCT05500326|Ivermectin|ivermectin|mesh-list
154336831|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154336832|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336833|NCT05478174|Propofol|propofol|mesh-list
154336834|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154336835|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336836|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336837|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154336838|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
154336839|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
154336840|NCT05461573|Drospirenone|drospirenone|mesh-list
153516025|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154336874|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336875|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336876|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154336877|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
154336878|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336879|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336880|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154336881|NCT05369234|Sucralfate|sucralfate|mesh-list
154336914|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336915|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
154336916|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154336917|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336918|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
154336919|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
154336920|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336921|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336953|NCT05026736|Antibodies|antibodies|mesh-list
154336954|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
154336955|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154336956|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
154336957|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336958|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336959|NCT05014581|Norepinephrine|norepinephrine|mesh-list
154336960|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154336961|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153516166|NCT01434147|Bevacizumab|bevacizumab|mesh-list
154336986|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154336987|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861790|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336989|NCT05000710|Tremelimumab|tremelimumab|mesh-list
154336990|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336991|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336992|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
154336993|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154336994|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
154336995|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336996|NCT04992052|Bone wax|bone wax|mesh-list
154336997|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
154336998|NCT04992052|Coagulants|coagulants|mesh-ancestor
154336999|NCT04977908|Insulin|insulin|mesh-list
154337000|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154337001|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337002|NCT04924322|Enoxaparin|enoxaparin|mesh-list
154337003|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
154337004|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154337005|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154337006|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337007|NCT04807517|Buspirone|buspirone|mesh-list
154337008|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154337009|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154337010|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337036|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
154337037|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337038|NCT04677972|Protective Agents|protective agents|mesh-ancestor
154337039|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154337040|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337041|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154337043|NCT04634877|Docetaxel|docetaxel|mesh-list
154337044|NCT04634877|Cisplatin|cisplatin|mesh-list
154337045|NCT04634877|Carboplatin|carboplatin|mesh-list
154337046|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
154337047|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154337048|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337049|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
154337050|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
154337051|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
154337052|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337053|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337054|NCT04634877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154337055|NCT04625972|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154337056|NCT04625972|Antiviral Agents|antiviral agents|mesh-ancestor
154337057|NCT04625972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337058|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
154337059|NCT04555603|Avelumab|avelumab|mesh-list
154337082|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337083|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337084|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154337085|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
154337087|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337088|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337089|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337090|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
154337091|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
154337092|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337093|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
154337094|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
154337095|NCT04464005|Analgesics|analgesics|mesh-ancestor
154337096|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
154337097|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337098|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337099|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
154337100|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337101|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154337102|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
154337103|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154337104|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154337105|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337106|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154337107|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
154337108|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154337109|NCT04429503|Aflibercept|aflibercept|mesh-list
154337110|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154337111|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154337143|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154337144|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337145|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154337146|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154337147|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
154337148|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154337149|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
154337150|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
154337151|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154337152|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337153|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154337154|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337155|NCT04332393|Metformin|metformin|mesh-list
154337156|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154337157|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337158|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
154337159|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153516360|NCT01435252|Cetuximab|cetuximab|mesh-list
153516399|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337227|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337228|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337229|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154337230|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154337231|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154337232|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
154337233|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337234|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
154337235|NCT03600649|Topotecan|topotecan|mesh-list
154337236|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337237|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
154337238|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337239|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337240|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337241|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
154337242|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337270|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337272|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
154337273|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337274|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337275|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337276|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154337277|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
154337278|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337279|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337280|NCT03366844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154337281|NCT03366844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337282|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154337283|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337284|NCT03196180|Fluorouracil|fluorouracil|mesh-list
154337285|NCT03196180|Imiquimod|imiquimod|mesh-list
154337286|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
154337287|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516483|NCT01435980|Exenatide|exenatide|mesh-list
154337312|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337313|NCT03093155|Bevacizumab|bevacizumab|mesh-list
154337314|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337315|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337316|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154337317|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154337318|NCT03093155|Growth Substances|growth substances|mesh-ancestor
154337319|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337320|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
154337321|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
154337322|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154337323|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337324|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337325|NCT03069378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154337326|NCT03069378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337327|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
154337328|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337329|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
154861791|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153960496|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154337330|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337331|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337332|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
154337333|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153516523|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
154337347|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337348|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
154337349|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154337350|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154337351|NCT02937571|Growth Substances|growth substances|mesh-ancestor
154337352|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
154337353|NCT02919072|Ropivacaine|ropivacaine|mesh-list
154337354|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
154337355|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
154337356|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
154337357|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337358|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337359|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
154337360|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337361|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
154337362|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
154337363|NCT02880293|Melphalan|melphalan|mesh-list
154337364|NCT02880293|Thiotepa|thiotepa|mesh-list
154337365|NCT02880293|Fludarabine|fludarabine|mesh-list
154337366|NCT02880293|Tacrolimus|tacrolimus|mesh-list
154337367|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337368|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
154337369|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337370|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337371|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337372|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
154337373|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337374|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337375|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154337376|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154337377|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337378|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154337379|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154337380|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
154337381|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154337382|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337383|NCT02739035|Dexamethasone|dexamethasone|mesh-list
154337384|NCT02739035|Celecoxib|celecoxib|mesh-list
154337385|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337386|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
154337387|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
154337388|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337389|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337390|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154337391|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
154337392|NCT02739035|Hormones|hormones|mesh-ancestor
154337393|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337394|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337413|NCT02657434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154337414|NCT02657434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337415|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
154083745|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337416|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337417|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337418|NCT02557321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154337419|NCT02557321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337420|NCT02555839|Thalidomide|thalidomide|mesh-list
154337421|NCT02555839|Dexamethasone|dexamethasone|mesh-list
154337422|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
154337423|NCT02555839|Bortezomib|bortezomib|mesh-list
154337424|NCT02555839|Pomalidomide|pomalidomide|mesh-list
154337425|NCT02555839|BB 1101|bb 1101|mesh-list
154337426|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337427|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
154337428|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
154337429|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861792|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337430|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337431|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154337432|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
154337433|NCT02555839|Hormones|hormones|mesh-ancestor
154337434|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337435|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337436|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337437|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
154337438|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337439|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337440|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
154337441|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154337442|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154337443|NCT02555839|Growth Substances|growth substances|mesh-ancestor
154337444|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
154337445|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337446|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
154337447|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154337448|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337478|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
154337479|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154337480|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
154337481|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154337482|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
154337483|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337484|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337485|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
154337486|NCT02112734|Vitamin D|vitamin d|mesh-list
154337487|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
154337488|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
154337489|NCT02112734|Vitamins|vitamins|mesh-list
154337490|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
154337491|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337492|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154337493|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154337494|NCT01990352|Doxorubicin|doxorubicin|mesh-list
154337495|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154337496|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154337497|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337498|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154337499|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154337538|NCT01193842|Etoposide|etoposide|mesh-list
154337539|NCT01193842|Vincristine|vincristine|mesh-list
154337540|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
154337541|NCT01193842|Vorinostat|vorinostat|mesh-list
154337542|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
153516734|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
154337565|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154337566|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
154337567|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
154337568|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
154337569|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154027425|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337570|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
154337571|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
154337572|NCT00855465|Riociguat|riociguat|mesh-list
154337573|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
154337574|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337575|NCT00098475|Thalidomide|thalidomide|mesh-list
154337576|NCT00098475|Dexamethasone|dexamethasone|mesh-list
154337577|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
154337578|NCT00098475|Lenalidomide|lenalidomide|mesh-list
154337579|NCT00098475|Ichthammol|ichthammol|mesh-list
154337580|NCT00098475|BB 1101|bb 1101|mesh-list
154337581|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337582|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
154337583|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
154337584|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337585|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337586|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154337587|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
154337588|NCT00098475|Hormones|hormones|mesh-ancestor
154337589|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337590|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337591|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337592|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
154337593|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337619|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154337621|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154337622|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154861793|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960644|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337623|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
154337624|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337625|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337626|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
154337627|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337628|NCT03513874|Metformin|metformin|mesh-list
154337629|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154337630|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337631|NCT01228357|Milnacipran|milnacipran|mesh-list
154337632|NCT01228357|Mirtazapine|mirtazapine|mesh-list
154337633|NCT01228357|Sertraline|sertraline|mesh-list
154337634|NCT01228357|Fluoxetine|fluoxetine|mesh-list
154337635|NCT01228357|Paroxetine|paroxetine|mesh-list
154337636|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154337637|NCT01228357|Nortriptyline|nortriptyline|mesh-list
154337638|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
154337639|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154192448|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
154337640|NCT01228357|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154337641|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154337707|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337708|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337709|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
154337710|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337711|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337712|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154337713|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
154337714|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337715|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
153516907|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
154337747|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337748|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337749|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
154337750|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337751|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337752|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
154337753|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154337787|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337788|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
154337789|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
154337790|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154337791|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
154337792|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
154337793|NCT01348724|Naloxegol|naloxegol|mesh-list
154337794|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153516993|NCT04234061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337818|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
154337819|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337821|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
154337822|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
154337823|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337824|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337825|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
154337826|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337827|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154337828|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
154337829|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154337830|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154337831|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337832|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337833|NCT01348880|Urological Agents|urological agents|mesh-ancestor
154337834|NCT03923179|Etoposide|etoposide|mesh-list
154337835|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154337836|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337837|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154337838|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154337839|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337840|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337841|NCT01318460|Simendan|simendan|mesh-list
153517035|NCT03512496|Caffeine|caffeine|mesh-list
154337872|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
154337873|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337874|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337875|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
154337876|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960744|NCT04635241|Heparin|heparin|mesh-list
154337877|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154337878|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154337879|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154337880|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154337907|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337909|NCT02589860|Melphalan|melphalan|mesh-list
154337910|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337911|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
154337912|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337913|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337914|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154337915|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337916|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
154337917|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337918|NCT01355354|Digoxin|digoxin|mesh-list
154337919|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154337920|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154337921|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337922|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337923|NCT01355354|Protective Agents|protective agents|mesh-ancestor
154337924|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337925|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154337926|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154337927|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154337928|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154337929|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154337964|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154337966|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337967|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337968|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153517168|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
154337993|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
154337994|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154337995|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337996|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154337997|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
154337998|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154337999|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338000|NCT02296762|Sirolimus|sirolimus|mesh-list
154338001|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154338002|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338003|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154338004|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338005|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
154338006|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154338007|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
154338008|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338009|NCT01132573|Clofarabine|clofarabine|mesh-list
154338010|NCT01132573|Entinostat|entinostat|mesh-list
154338011|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154338012|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154338013|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
154338014|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338015|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338016|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338017|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154338018|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154338019|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338020|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154338021|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154338048|NCT02300350|Protective Agents|protective agents|mesh-ancestor
154338049|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338050|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154338051|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154338053|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154338054|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338055|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
154338056|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338057|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
154338058|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
154338059|NCT02300428|Trace Elements|trace elements|mesh-ancestor
154861794|NCT01093417|Vitamin D|vitamin d|mesh-list
154338060|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
154338061|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338062|NCT02300428|Hematinics|hematinics|mesh-ancestor
154338063|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154338064|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154338065|NCT02296996|Trametinib|trametinib|mesh-list
154338087|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338088|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154338089|NCT03515668|Methylphenidate|methylphenidate|mesh-list
154338090|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154338091|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338092|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154338093|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154338094|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154338095|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338096|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
154338097|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338098|NCT01356212|Ketorolac|ketorolac|mesh-list
154338099|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154338100|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154338101|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338102|NCT01356212|Analgesics|analgesics|mesh-ancestor
154338103|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
154338104|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338105|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338106|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338107|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338108|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154338109|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338110|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338111|NCT02302378|Bupivacaine|bupivacaine|mesh-list
154338112|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
154338113|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
154338114|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517312|NCT01438736|Hormones|hormones|mesh-ancestor
154338145|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338146|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338147|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338148|NCT02300740|Niacinamide|niacinamide|mesh-list
154338149|NCT02300740|Niacin|niacin|mesh-list
154338150|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
154338151|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
154338152|NCT02300740|Vitamins|vitamins|mesh-ancestor
154338153|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
154338154|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338155|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154338156|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
154338157|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338158|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154192652|NCT04793958|Cetuximab|cetuximab|mesh-list
154338187|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338189|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154338190|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338191|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
154338192|NCT01356680|Hormones|hormones|mesh-ancestor
154338193|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338194|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154338195|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154338196|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154338197|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154338198|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338199|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
154338200|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
154338201|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
154338202|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154338203|NCT04464850|Iron|iron|mesh-list
154338204|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
154338205|NCT04464850|Folic Acid|folic acid|mesh-list
154338206|NCT04464850|Trace Elements|trace elements|mesh-ancestor
154338207|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
154338208|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338229|NCT01134523|Paclitaxel|paclitaxel|mesh-list
154338230|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154338231|NCT01134523|Epirubicin|epirubicin|mesh-list
154338232|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154338233|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338234|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
154338235|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
154338236|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
154338237|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338238|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154338239|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154338240|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154338241|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338242|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154338243|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
154338244|NCT01349738|Levofloxacin|levofloxacin|mesh-list
154338246|NCT01349738|Gentamicins|gentamicins|mesh-list
154338247|NCT01349738|Cefazolin|cefazolin|mesh-list
154338248|NCT01349738|Tobramycin|tobramycin|mesh-list
154338249|NCT01349738|Ampicillin|ampicillin|mesh-list
154338250|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154338251|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
154338252|NCT01349738|Sulbactam|sulbactam|mesh-list
154338253|NCT01349738|Trimethoprim|trimethoprim|mesh-list
154338254|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
154338255|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338256|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154338257|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154338258|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338259|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338260|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338261|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154338262|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154338263|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154338264|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154338265|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
154338266|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154338267|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153517453|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
154338291|NCT01350050|Carticaine|carticaine|mesh-list
154338292|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
154338293|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
154338294|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338295|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338296|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
154338297|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338298|NCT03918889|Midazolam|midazolam|mesh-list
154338299|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
154338300|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154338301|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338302|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338303|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338304|NCT03918889|Analgesics|analgesics|mesh-ancestor
154338305|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
154338306|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338307|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154338308|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154338309|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154338310|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
154338311|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338312|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338313|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154084688|NCT00710385|Heroin|heroin|mesh-list
154338314|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154338315|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154338316|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154338317|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154338318|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
154338346|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154338347|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338348|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
154338349|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338350|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338351|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154338352|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338354|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
154338355|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338356|NCT03511768|Octreotide|octreotide|mesh-list
154338357|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
154338358|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154338359|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154338360|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338361|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154338362|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338363|NCT01134991|Minocycline|minocycline|mesh-list
154338364|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154338365|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338366|NCT03515200|Cytarabine|cytarabine|mesh-list
154338367|NCT03515200|Dexamethasone|dexamethasone|mesh-list
154338395|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
154338396|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154338397|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154338398|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
154338399|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338400|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154338402|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338403|NCT03515200|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154338404|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154338405|NCT03918265|Tacrolimus|tacrolimus|mesh-list
154338406|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154338407|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
154338408|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338409|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154338410|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338411|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338412|NCT03920839|Paclitaxel|paclitaxel|mesh-list
154338413|NCT03920839|Carboplatin|carboplatin|mesh-list
154338414|NCT03920839|Gemcitabine|gemcitabine|mesh-list
154338415|NCT03920839|Pemetrexed|pemetrexed|mesh-list
153517622|NCT01440985|Nicotine|nicotine|mesh-list
154338441|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154338442|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338443|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338444|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154338445|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154338446|NCT02301208|Nedaplatin|nedaplatin|mesh-list
154338447|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338448|NCT02298010|Capecitabine|capecitabine|mesh-list
154338449|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
154338450|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154338451|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
154338452|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338453|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338454|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
154338455|NCT01229605|Docetaxel|docetaxel|mesh-list
154338456|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154338457|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
154338458|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338459|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338460|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154338461|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
154338462|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338463|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338464|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154338465|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
154338487|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154338488|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338489|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154338490|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338491|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154338492|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154338493|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338494|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154338495|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154338496|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
154338497|NCT03511222|Nivolumab|nivolumab|mesh-list
154338498|NCT03511222|Vorolanib|vorolanib|mesh-list
154338499|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154338500|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338501|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154338502|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338503|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154338504|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338505|NCT01230463|Ketorolac|ketorolac|mesh-list
154338506|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154338507|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154338508|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338509|NCT01230463|Analgesics|analgesics|mesh-ancestor
153961032|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
154338510|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
154338511|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338512|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338513|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338514|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338515|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153517701|NCT01441388|Axitinib|axitinib|mesh-list
154338538|NCT03920137|Nicotine|nicotine|mesh-list
154338539|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154338540|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
154338541|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338542|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338543|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154338544|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154338545|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
154338546|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338547|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338548|NCT03132610|Andrographolide|andrographolide|mesh-list
154338549|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338550|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154338551|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338552|NCT03132610|Analgesics|analgesics|mesh-ancestor
154338553|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
154338554|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338555|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338556|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338557|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154338558|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154338559|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338560|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
154338561|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154338562|NCT02298088|Clopidogrel|clopidogrel|mesh-list
154338563|NCT02298088|Ticagrelor|ticagrelor|mesh-list
154338564|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154338565|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154338566|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154338596|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154338597|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154338598|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154338600|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
154338601|NCT03514810|Ketoprofen|ketoprofen|mesh-list
154338602|NCT03514810|Sertraline|sertraline|mesh-list
154338603|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
154338604|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154338605|NCT03514810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154338606|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154338607|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153517806|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154338637|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154338638|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
154338639|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
154338640|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154338641|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154338642|NCT01135771|Insulin|insulin|mesh-list
154338643|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154338644|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338645|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
154338646|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154338647|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154338648|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154338649|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338650|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
154338680|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338681|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338683|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154338684|NCT03509740|Narcotics|narcotics|mesh-ancestor
154338685|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338686|NCT03918187|Midazolam|midazolam|mesh-list
154338687|NCT03918187|Nalbuphine|nalbuphine|mesh-list
154338688|NCT03918187|Bupivacaine|bupivacaine|mesh-list
154338689|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
154338690|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
154192884|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
154338691|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861795|NCT01093417|Vitamins|vitamins|mesh-ancestor
154861796|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
154338692|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338693|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
154338694|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338695|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154338696|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154338697|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154338698|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154338735|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154338736|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
154338737|NCT03507556|Metronidazole|metronidazole|mesh-list
154338738|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
154338766|NCT01232257|Protective Agents|protective agents|mesh-ancestor
154338767|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338768|NCT01232257|Antidotes|antidotes|mesh-ancestor
154338769|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
154338771|NCT03509662|Vitamins|vitamins|mesh-ancestor
154338772|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
154338773|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338774|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
154338775|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338776|NCT03509662|Protective Agents|protective agents|mesh-ancestor
154338777|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
154338778|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
154338779|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154338780|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338781|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154338782|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154338783|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338784|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338785|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517978|NCT01442935|Leucovorin|leucovorin|mesh-list
154338819|NCT01233505|Veliparib|veliparib|mesh-list
154338820|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154338821|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
154338822|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338823|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338824|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154338825|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338826|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
154338848|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338850|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
154338851|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154338852|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
154338853|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338854|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338855|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154338856|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
154338857|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154338858|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154338859|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154338860|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
154338861|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338862|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338863|NCT01230775|Anagrelide|anagrelide|mesh-list
154338864|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154338865|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154338866|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338867|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154338868|NCT01136317|Omeprazole|omeprazole|mesh-list
154338869|NCT01136317|Rabeprazole|rabeprazole|mesh-list
154338870|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154338871|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154338872|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154338873|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338874|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338875|NCT03507244|Dexamethasone|dexamethasone|mesh-list
154338876|NCT03507244|Pemetrexed|pemetrexed|mesh-list
153518072|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
154338913|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338914|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154338945|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154338946|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
154338947|NCT02304250|Hormones|hormones|mesh-ancestor
154338948|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338949|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154338950|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338951|NCT01136551|Huperzine A|huperzine a|mesh-list
154338952|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154338953|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338954|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338955|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
154338956|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338957|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338958|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154338959|NCT01136551|Protective Agents|protective agents|mesh-ancestor
154338960|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
154338961|NCT03132142|Capsaicin|capsaicin|mesh-list
154338962|NCT03132142|Menthol|menthol|mesh-list
154338979|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154338980|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154338981|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338982|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
154338983|NCT01232647|Coagulants|coagulants|mesh-ancestor
154338984|NCT03917095|Mesalamine|mesalamine|mesh-list
154338985|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154338986|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338987|NCT03917095|Analgesics|analgesics|mesh-ancestor
154338988|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
154338989|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338990|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338991|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338992|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338993|NCT01133743|Thalidomide|thalidomide|mesh-list
154338994|NCT01133743|Dexamethasone|dexamethasone|mesh-list
154338995|NCT01133743|Lenalidomide|lenalidomide|mesh-list
154338996|NCT01133743|Immunomodulating Agents|immunomodulating agents|mesh-list
154338997|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338998|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
154338999|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
154339000|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339001|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339002|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154339003|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
154339004|NCT01133743|Hormones|hormones|mesh-ancestor
154193064|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339005|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339006|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154339007|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339008|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
154339009|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154339010|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154339011|NCT01133743|Growth Substances|growth substances|mesh-ancestor
154339012|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
154339013|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154339014|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
154339015|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154339016|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339017|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154339018|NCT01138423|Moxonidine|moxonidine|mesh-list
154339019|NCT01138423|Aliskiren|aliskiren|mesh-list
154339020|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154339021|NCT01138423|Diuretics|diuretics|mesh-ancestor
154339022|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
154339023|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339024|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154339037|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339038|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
154339039|NCT03961516|Pancrelipase|pancrelipase|mesh-list
154339040|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154339041|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
154339042|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154339043|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154339044|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154339045|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339046|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339047|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
154339048|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339049|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339050|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154339051|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339052|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
154339053|NCT03504280|Vitamin D|vitamin d|mesh-list
154339054|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154339055|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339056|NCT03504280|Vitamins|vitamins|mesh-ancestor
154339057|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
154339058|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154339059|NCT03504202|Trimetazidine|trimetazidine|mesh-list
154339060|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
154339061|NCT01136941|Zileuton|zileuton|mesh-list
154339062|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339063|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339064|NCT01136941|Analgesics|analgesics|mesh-ancestor
154339065|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
154339066|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339067|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339068|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339069|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339070|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154339071|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339072|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339073|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154339074|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
154339075|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339076|NCT01232803|Tenofovir|tenofovir|mesh-list
154339077|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
154339078|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339079|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154339080|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154339081|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339082|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339083|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153518265|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154339093|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339095|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339096|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154339097|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154339098|NCT05187715|Simvastatin|simvastatin|mesh-list
154339099|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154339100|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154339101|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
154339102|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339103|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154339104|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154339105|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339106|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
154339107|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154339108|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154339109|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339110|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
154339111|NCT02312440|Coagulants|coagulants|mesh-ancestor
154339112|NCT01137019|Everolimus|everolimus|mesh-list
154339113|NCT01137019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154339114|NCT01137019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154339115|NCT01137019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339116|NCT01137019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339117|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154339118|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
154339119|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339120|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339121|NCT03508804|Lidocaine|lidocaine|mesh-list
154339122|NCT03508804|Prilocaine|prilocaine|mesh-list
154339123|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154339124|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
154339125|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
154339126|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339127|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339128|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
154339129|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339130|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154339131|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154339132|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154339133|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339134|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339135|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154339136|NCT01231165|Aspirin|aspirin|mesh-list
154339137|NCT01231165|Amiloride|amiloride|mesh-list
153961322|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961323|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961324|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
153961325|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
153961326|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961330|NCT02876510|Analgesics|analgesics|mesh-ancestor
154339138|NCT01231165|Clopidogrel|clopidogrel|mesh-list
154339139|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154339140|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339141|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339142|NCT01231165|Analgesics|analgesics|mesh-ancestor
154339143|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
154339144|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085479|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
154339145|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339146|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339147|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518325|NCT01444885|Amlodipine|amlodipine|mesh-list
154339158|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
154339159|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339160|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154339161|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154339162|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
154339163|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154339164|NCT01231165|Diuretics|diuretics|mesh-ancestor
154339165|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
154339166|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154339167|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154339168|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339169|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154339170|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154339171|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154339172|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154339173|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339174|NCT03503890|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154339175|NCT03503890|Immunoconjugates|immunoconjugates|mesh-ancestor
154339176|NCT03503890|Immunologic Factors|immunologic factors|mesh-ancestor
154339177|NCT03503890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339179|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339180|NCT03506620|Ropivacaine|ropivacaine|mesh-list
154339181|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154339182|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
154339183|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339184|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339185|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
154339186|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339187|NCT02305030|Opicapone|opicapone|mesh-list
154339188|NCT02305030|Warfarin|warfarin|mesh-list
154339189|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
154339190|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154339191|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339192|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339193|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154339194|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154339195|NCT01139437|Vaccines|vaccines|mesh-list
154339196|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
154339197|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339198|NCT01137253|Trimethaphan|trimethaphan|mesh-list
154339199|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
154339200|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154339201|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154339202|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154339203|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
154339204|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339205|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339206|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154339207|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154339208|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
154861797|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861798|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154861799|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154861800|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154861801|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339209|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339210|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861802|NCT01093651|Incretins|incretins|mesh-ancestor
154339211|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153518390|NCT01445236|Cyclosporine|cyclosporine|mesh-list
154339231|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
154193197|NCT04210115|Antidotes|antidotes|mesh-ancestor
154339232|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339233|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339234|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339236|NCT02308930|Vitamins|vitamins|mesh-list
154339237|NCT02308930|Vitamin A|vitamin a|mesh-list
154339238|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
154339239|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
154339240|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339241|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
154339242|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339243|NCT02308930|Protective Agents|protective agents|mesh-ancestor
154339244|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154339245|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339246|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154339247|NCT01139671|Remifentanil|remifentanil|mesh-list
154339248|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154339249|NCT01139671|Narcotics|narcotics|mesh-ancestor
154339250|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339251|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339252|NCT01139671|Analgesics|analgesics|mesh-ancestor
154339253|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
154339254|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339256|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339257|NCT01234051|Docetaxel|docetaxel|mesh-list
154339258|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
154339259|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339260|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
154339261|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
154339262|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
154339263|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339264|NCT03341962|Calcium|calcium|mesh-list
154339265|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154339266|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339267|NCT01234597|Insulin|insulin|mesh-list
154339288|NCT01139749|Ciclopirox|ciclopirox|mesh-list
154339289|NCT01139749|Salicylates|salicylates|mesh-list
154339290|NCT01139749|Isotretinoin|isotretinoin|mesh-list
154339291|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154339292|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339293|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
154339294|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
154339295|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339296|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339297|NCT01139749|Analgesics|analgesics|mesh-ancestor
154339298|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
154339299|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339300|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339301|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339302|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339303|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339304|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339305|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339306|NCT02305810|Everolimus|everolimus|mesh-list
154339307|NCT02305810|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154339308|NCT02305810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154339309|NCT02305810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339310|NCT02305810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339311|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154339312|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
154339313|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339314|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339315|NCT01142869|Cetuximab|cetuximab|mesh-list
154339316|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154339317|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339318|NCT01139905|Ritonavir|ritonavir|mesh-list
154339319|NCT01139905|Lopinavir|lopinavir|mesh-list
154339320|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154339321|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154339322|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
154339323|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339334|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339335|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154339336|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
154339337|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154339338|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154339340|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
154339341|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
154339342|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339343|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339344|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
154339345|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339346|NCT03502642|Morphine|morphine|mesh-list
154339347|NCT03502642|Ropivacaine|ropivacaine|mesh-list
154339348|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
154339349|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339350|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339351|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154339352|NCT03502642|Narcotics|narcotics|mesh-ancestor
154339353|NCT03502642|Analgesics|analgesics|mesh-ancestor
154339354|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
154339355|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339356|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
154339357|NCT02306278|Gabapentin|gabapentin|mesh-list
154339358|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339359|NCT02306278|Analgesics|analgesics|mesh-ancestor
154339360|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
154339361|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339362|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
154339363|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154339364|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154193314|NCT03941730|Estradiol|estradiol|mesh-list
154339365|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339366|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154339367|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154339368|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154339369|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339370|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339371|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
154085708|NCT03980925|Nivolumab|nivolumab|mesh-list
154339372|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
154339373|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154339374|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339375|NCT02313922|Etanercept|etanercept|mesh-list
154339376|NCT02313922|Methotrexate|methotrexate|mesh-list
154339377|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154339378|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
154339379|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154339380|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339381|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154339382|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
154339383|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339384|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339385|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
154339386|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339387|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154339397|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339398|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154339399|NCT03508102|Remifentanil|remifentanil|mesh-list
154339400|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154339401|NCT03508102|Narcotics|narcotics|mesh-ancestor
154339402|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339403|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339404|NCT03508102|Analgesics|analgesics|mesh-ancestor
154339405|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
154339406|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339407|NCT03505528|Paclitaxel|paclitaxel|mesh-list
154339408|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154339409|NCT03505528|Phenelzine|phenelzine|mesh-list
154339410|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154339411|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339412|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
154339413|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
154339414|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
154339415|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193355|NCT03907826|Antibodies|antibodies|mesh-list
154339416|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
154339417|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154339418|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154339419|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339420|NCT01234285|Heparin|heparin|mesh-list
154339421|NCT01234285|Calcium heparin|calcium heparin|mesh-list
154339422|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
154339423|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154339424|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154339425|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339426|NCT02314312|Cyclosporine|cyclosporine|mesh-list
154339427|NCT02314312|Prednisolone|prednisolone|mesh-list
154339428|NCT02314312|Everolimus|everolimus|mesh-list
154339429|NCT02314312|Cyclosporins|cyclosporins|mesh-list
154339430|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339431|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339432|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154339433|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
154339434|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339435|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
154339436|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339437|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
154339438|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339439|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154339440|NCT02314312|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154339441|NCT02314312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154339442|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339443|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339444|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
154339445|NCT02314312|Hormones|hormones|mesh-ancestor
154339446|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339447|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154339448|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154339449|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154339450|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
154339451|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339453|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154339454|NCT02310490|Diuretics|diuretics|mesh-ancestor
154339455|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
154339474|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339475|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154339476|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154339477|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154339478|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154339479|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339480|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339481|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
154339482|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
154339483|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154339484|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154339485|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154339486|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154339487|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154339488|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
154339489|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154339490|NCT01141153|Aspirin|aspirin|mesh-list
154339491|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
154339492|NCT01141153|Clopidogrel|clopidogrel|mesh-list
154193400|NCT03807778|Mobocertinib|mobocertinib|mesh-list
154339493|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154339494|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154339495|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154339496|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154339497|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
154339498|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339499|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339500|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339501|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339502|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339503|NCT01141153|Analgesics|analgesics|mesh-ancestor
154339504|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
154339505|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339506|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339507|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339508|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154339509|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154339510|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339511|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339521|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339523|NCT01238029|Vinorelbine|vinorelbine|mesh-list
154339524|NCT01238029|Lapatinib|lapatinib|mesh-list
154339525|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961632|NCT00792948|Dasatinib|dasatinib|mesh-list
154339526|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
154339527|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339528|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339529|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154339530|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
154339531|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
154339532|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
154339533|NCT01238029|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154339534|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154339535|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339536|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
154339537|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154339538|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339539|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339540|NCT03139604|Prednisone|prednisone|mesh-list
154339541|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
154339542|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154339543|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154339544|NCT03139604|Prednisolone|prednisolone|mesh-list
154339545|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
154339546|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154339547|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
154339548|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339549|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
154339550|NCT03139604|Hormones|hormones|mesh-ancestor
154339551|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339552|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339553|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154339554|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339555|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
154339556|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
154339557|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339558|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154339559|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154339560|NCT03139604|Protective Agents|protective agents|mesh-ancestor
154339561|NCT01350596|Ibuprofen|ibuprofen|mesh-list
154193510|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154339562|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339563|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339564|NCT01350596|Analgesics|analgesics|mesh-ancestor
154339565|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
154339566|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339567|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339568|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339569|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339570|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339571|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339572|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339573|NCT04462822|Fluticasone|fluticasone|mesh-list
154339574|NCT04462822|Xhance|xhance|mesh-list
154339575|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154339576|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154339577|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339578|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154339589|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
154339590|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339591|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339592|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
154339593|NCT04462822|Hormones|hormones|mesh-ancestor
154339594|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339595|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
154339596|NCT01362218|Aspirin|aspirin|mesh-list
154339597|NCT01362218|Ramipril|ramipril|mesh-list
154339598|NCT01362218|Simvastatin|simvastatin|mesh-list
154339599|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154339600|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154339601|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
154339602|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339603|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154339604|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154339605|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339606|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339607|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339608|NCT01362218|Analgesics|analgesics|mesh-ancestor
154861803|NCT01093651|Hormones|hormones|mesh-ancestor
154339610|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339611|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339612|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339613|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339614|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154339615|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154339616|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154339617|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339618|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
154339619|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154339620|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
154339621|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154339622|NCT02316964|Aldesleukin|aldesleukin|mesh-list
154339623|NCT02316964|Decitabine|decitabine|mesh-list
154339624|NCT02316964|Azacitidine|azacitidine|mesh-list
154339625|NCT02316964|Interleukin-2|interleukin-2|mesh-list
154339626|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154339627|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
154339628|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339629|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339630|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339631|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339632|NCT02316964|Analgesics|analgesics|mesh-ancestor
154339633|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
154339634|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339635|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339636|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154339637|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154339638|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
154339639|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339640|NCT02875340|Risperidone|risperidone|mesh-list
154339641|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154339642|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
154339643|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339651|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
154339653|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339654|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339655|NCT04462666|Analgesics|analgesics|mesh-ancestor
154339656|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
154339657|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339658|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339659|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339660|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339661|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154339662|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339663|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339664|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339665|NCT01359020|Acetaminophen|acetaminophen|mesh-list
154339666|NCT01359020|Dipyrone|dipyrone|mesh-list
154339667|NCT01359020|Ibuprofen|ibuprofen|mesh-list
154339668|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339669|NCT01359020|Analgesics|analgesics|mesh-ancestor
154339670|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
154339671|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339672|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339673|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
154339674|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339675|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339676|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339677|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339678|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339679|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339680|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
154339681|NCT01359098|Dexamethasone|dexamethasone|mesh-list
154339682|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339683|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
154339684|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
154339685|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339686|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339687|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154339688|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
154339689|NCT01359098|Hormones|hormones|mesh-ancestor
154339690|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339691|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154339692|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339693|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339694|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339695|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154339696|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339697|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154339698|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154339699|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154339700|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154339701|NCT01319240|Insulin|insulin|mesh-list
154339702|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154339703|NCT01319240|Liraglutide|liraglutide|mesh-list
154339704|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
154339705|NCT01319240|Xultophy|xultophy|mesh-list
154339706|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154339707|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339708|NCT01319240|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154339709|NCT01319240|Incretins|incretins|mesh-ancestor
154339710|NCT01319240|Hormones|hormones|mesh-ancestor
154339728|NCT02316028|Decitabine|decitabine|mesh-list
154339729|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154339730|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
154339731|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339732|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339733|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339734|NCT01359488|Hormones|hormones|mesh-list
154339735|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154339736|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339737|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339738|NCT01141465|Fluticasone|fluticasone|mesh-list
154339740|NCT01141465|Budesonide|budesonide|mesh-list
154339741|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
154339742|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154339743|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154339744|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154339745|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339746|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154339747|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
154339748|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339749|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339750|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154339751|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
154339752|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154339753|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154339754|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
154339755|NCT01141465|Hormones|hormones|mesh-ancestor
154339756|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339757|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154339758|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154339759|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154339760|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
154339761|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339762|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339763|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
154339764|NCT01141543|Plerixafor|plerixafor|mesh-list
154339765|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154339777|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339779|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154339780|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
154339781|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154339782|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154339783|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
154339784|NCT02317198|Clopidogrel|clopidogrel|mesh-list
154339785|NCT02317198|Ticagrelor|ticagrelor|mesh-list
154339786|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154339787|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154339788|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154339789|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154339790|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154339791|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
154339792|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339793|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339794|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339795|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
154339796|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154339797|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
154339798|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339799|NCT01359722|Expectorants|expectorants|mesh-ancestor
154339800|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
154339801|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154339802|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
154339803|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339804|NCT01359722|Protective Agents|protective agents|mesh-ancestor
154339805|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339806|NCT01359722|Antidotes|antidotes|mesh-ancestor
154339807|NCT01238185|Aspirin|aspirin|mesh-list
154339808|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339809|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339810|NCT01238185|Analgesics|analgesics|mesh-ancestor
154339811|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
154339812|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339813|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339814|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339815|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339816|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154339817|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154339818|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339819|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154339820|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339821|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339822|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
154339823|NCT01143805|Tofacitinib|tofacitinib|mesh-list
154339824|NCT01143805|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154339825|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154339826|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339827|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339828|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
154339829|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339837|NCT03498118|Bupivacaine|bupivacaine|mesh-list
154339838|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
154339839|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
154339840|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339841|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339842|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
154339843|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339844|NCT05188742|Mirabegron|mirabegron|mesh-list
154339845|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154339846|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154339847|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154339848|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
154339849|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339850|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339851|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339852|NCT05188742|Urological Agents|urological agents|mesh-ancestor
154339853|NCT02324452|Capecitabine|capecitabine|mesh-list
154339854|NCT02324452|Fluorouracil|fluorouracil|mesh-list
154339855|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154339856|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
154339857|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339858|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339859|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154339860|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
154339861|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339862|NCT02321176|Resveratrol|resveratrol|mesh-list
154339863|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
154339864|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339865|NCT02321176|Protective Agents|protective agents|mesh-ancestor
154339866|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339867|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339868|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154339869|NCT01351298|Lidocaine|lidocaine|mesh-list
154339870|NCT01351298|Xylometazoline|xylometazoline|mesh-list
154339871|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
154339872|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
154339873|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339874|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339875|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
154339876|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339877|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154339878|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154339879|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154339880|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339881|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339882|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
154339883|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154339884|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
154339885|NCT02324686|Vitamin K|vitamin k|mesh-list
154339886|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
154339887|NCT02324686|Vitamins|vitamins|mesh-ancestor
154339888|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
154339889|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339890|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154339891|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154339892|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339893|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
154339894|NCT02324686|Coagulants|coagulants|mesh-ancestor
154339906|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339907|NCT01360034|Analgesics|analgesics|mesh-ancestor
154339908|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
154339909|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339910|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154339911|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339912|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
154339913|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339914|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339915|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154339916|NCT01363310|Escitalopram|escitalopram|mesh-list
154339917|NCT01363310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154339918|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154339919|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339920|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339921|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339922|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
154339923|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339924|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
154339925|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154339926|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154339927|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154339928|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339929|NCT01363544|Methylphenidate|methylphenidate|mesh-list
154339930|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154339931|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339932|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154339933|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154339934|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339935|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339936|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
154339937|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339938|NCT03257618|Temozolomide|temozolomide|mesh-list
154339939|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154339940|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
154339941|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339942|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339943|NCT01363778|Tivozanib|tivozanib|mesh-list
154339944|NCT01363778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154339945|NCT01363778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339946|NCT01363778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339947|NCT02324998|Olaparib|olaparib|mesh-list
154339948|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154339949|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339950|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339951|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339952|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
154339953|NCT03500848|Sirolimus|sirolimus|mesh-list
154339954|NCT03500848|Tacrolimus|tacrolimus|mesh-list
153519141|NCT01449448|Triamcinolone|triamcinolone|mesh-list
154339974|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
154339975|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339976|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154339977|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
154339978|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154339979|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154339980|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154339981|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339982|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
154339984|NCT03132376|Caseins|caseins|mesh-list
154339985|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
154339986|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
154339987|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339988|NCT01364012|Paclitaxel|paclitaxel|mesh-list
154339989|NCT01364012|Bevacizumab|bevacizumab|mesh-list
154339990|NCT01364012|Carboplatin|carboplatin|mesh-list
154339991|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154339992|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339993|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
154339994|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
154339995|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
154339996|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339997|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154339998|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154339999|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154340000|NCT01364012|Growth Substances|growth substances|mesh-ancestor
154340001|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340002|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
154340003|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154340004|NCT02318056|Bacitracin|bacitracin|mesh-list
153519198|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
154340007|NCT02318056|Laxatives|laxatives|mesh-ancestor
154340008|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154340009|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154340010|NCT01360424|Teriparatide|teriparatide|mesh-list
154340011|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154340012|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340013|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154340014|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
154340015|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154340016|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340017|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
154340018|NCT01364402|Hematinics|hematinics|mesh-ancestor
154340019|NCT03552380|Nivolumab|nivolumab|mesh-list
154340020|NCT03552380|Ipilimumab|ipilimumab|mesh-list
154340021|NCT03552380|Entinostat|entinostat|mesh-list
154340022|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154340023|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340024|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154340025|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340026|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154340027|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340028|NCT02318290|Analgesics|analgesics|mesh-list
154340029|NCT02318290|Narcotics|narcotics|mesh-list
154340030|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
154340031|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340032|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340033|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340034|NCT03452072|Timolol|timolol|mesh-list
154340035|NCT03452072|Petrolatum|petrolatum|mesh-list
154340036|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154340037|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154340038|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
154340039|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340040|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340041|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340042|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154086389|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
154340043|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154340045|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
154340046|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154340047|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154340048|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154340049|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
154340050|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340051|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340052|NCT03433040|Progestins|progestins|mesh-ancestor
153962079|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340054|NCT02318446|Folic Acid|folic acid|mesh-list
154340055|NCT02318446|Hematinics|hematinics|mesh-ancestor
154340056|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
154340057|NCT02318446|Vitamins|vitamins|mesh-ancestor
154340058|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
154340059|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340060|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154340061|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154340062|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154340063|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
154340064|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340065|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
154340066|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154340067|NCT01360658|Antibodies|antibodies|mesh-list
154340068|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
154340069|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154340070|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
154340071|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340072|NCT02318758|Ethanol|ethanol|mesh-list
154340073|NCT02318758|Treprostinil|treprostinil|mesh-list
154340074|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154340075|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340076|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340077|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519250|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
154340096|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154340097|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154340098|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340099|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
154340100|NCT01364792|Valacyclovir|valacyclovir|mesh-list
154340101|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
154340102|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340103|NCT02318836|Lofexidine|lofexidine|mesh-list
154340104|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154340105|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154340106|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340107|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
154340108|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340109|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154340110|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154340111|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154340112|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
154340113|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340114|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340115|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154340116|NCT01352312|Ofatumumab|ofatumumab|mesh-list
154340117|NCT01352312|Pentostatin|pentostatin|mesh-list
154340118|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154340119|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
154340120|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340121|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340122|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154340123|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340124|NCT02939209|Hydromorphone|hydromorphone|mesh-list
154340125|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154340126|NCT02939209|Narcotics|narcotics|mesh-ancestor
154340127|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340128|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340129|NCT02939209|Analgesics|analgesics|mesh-ancestor
154340130|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
154340131|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340132|NCT01141855|Varenicline|varenicline|mesh-list
154340142|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340143|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340145|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154340146|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154340147|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340148|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154340149|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154340150|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154340151|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340152|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340153|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
154340155|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340156|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340157|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
154340158|NCT01365104|Deferoxamine|deferoxamine|mesh-list
154340159|NCT01365104|Siderophores|siderophores|mesh-ancestor
154340160|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154340161|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
154340162|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
154340163|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340164|NCT03492970|Melatonin|melatonin|mesh-list
154340165|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
154340166|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340167|NCT03492970|Protective Agents|protective agents|mesh-ancestor
154340168|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340169|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340170|NCT01362374|Leucovorin|leucovorin|mesh-list
154340171|NCT01362374|Paclitaxel|paclitaxel|mesh-list
154340172|NCT01362374|Docetaxel|docetaxel|mesh-list
154340173|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
154340174|NCT01362374|Ipatasertib|ipatasertib|mesh-list
154340175|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154340176|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340177|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
154340178|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
154340179|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
154340180|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340181|NCT01362374|Antidotes|antidotes|mesh-ancestor
154340182|NCT01362374|Protective Agents|protective agents|mesh-ancestor
154340183|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340184|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
154340185|NCT01362374|Vitamins|vitamins|mesh-ancestor
154340186|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
154340187|NCT01362374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154340188|NCT01362374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340189|NCT01142011|Belimumab|belimumab|mesh-list
154340190|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340191|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
154340192|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340193|NCT02319460|Thrombin|thrombin|mesh-list
154340194|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
154340195|NCT02319460|Coagulants|coagulants|mesh-ancestor
154340196|NCT04722952|Cytarabine|cytarabine|mesh-list
154340197|NCT04722952|Azacitidine|azacitidine|mesh-list
154340198|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
154340199|NCT04722952|Visilizumab|visilizumab|mesh-list
154340200|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154340217|NCT01365260|Protective Agents|protective agents|mesh-ancestor
154340219|NCT01235455|Interferon-beta|interferon-beta|mesh-list
154340220|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
154340221|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340222|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
154340223|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340224|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
154340225|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340226|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154340227|NCT01145677|Topiramate|topiramate|mesh-list
154340228|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
154340229|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154340230|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340231|NCT02319616|Clobetasol|clobetasol|mesh-list
154340232|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340233|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
154340234|NCT02319616|Hormones|hormones|mesh-ancestor
154340235|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340236|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340237|NCT01142245|Esomeprazole|esomeprazole|mesh-list
154340238|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154340239|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154340240|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154340241|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340242|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340243|NCT02319772|Galidesivir|galidesivir|mesh-list
154340244|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
154340245|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340246|NCT03499132|Anesthetics|anesthetics|mesh-list
154340247|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340248|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340249|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
154340250|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340251|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340252|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340254|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154340255|NCT03498820|Narcotics|narcotics|mesh-ancestor
154340256|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340257|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340258|NCT03498820|Analgesics|analgesics|mesh-ancestor
153519440|NCT05962671|Anesthetics|anesthetics|mesh-list
154340269|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340270|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154340271|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
154340273|NCT02320240|Fluoxetine|fluoxetine|mesh-list
154340274|NCT02320240|Paroxetine|paroxetine|mesh-list
154340275|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154340276|NCT02320240|Sertraline|sertraline|mesh-list
154340277|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154340278|NCT02320240|Escitalopram|escitalopram|mesh-list
154340279|NCT02320240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154340280|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154340281|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154340282|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340283|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340284|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
154340285|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340286|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340287|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154340288|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
154340289|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154340290|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154340291|NCT02320240|Analgesics|analgesics|mesh-ancestor
154340292|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
154340293|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
154340294|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154340295|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154340296|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340297|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154340298|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154340299|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340300|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154340301|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154340302|NCT03492736|Melatonin|melatonin|mesh-list
154340303|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
154340304|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340305|NCT03492736|Protective Agents|protective agents|mesh-ancestor
154340306|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340307|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340308|NCT02320474|Aflibercept|aflibercept|mesh-list
154340309|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154340310|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154340311|NCT02320474|Growth Substances|growth substances|mesh-ancestor
154340312|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340313|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
154340314|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340315|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
154340316|NCT03492580|Empagliflozin|empagliflozin|mesh-list
154340317|NCT03492580|Canagliflozin|canagliflozin|mesh-list
154340318|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154340319|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154340320|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154340321|NCT03492580|Glucagon|glucagon|mesh-list
154340322|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153519496|NCT05961202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340328|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340330|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
154340331|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340332|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
154340334|NCT01238965|Fluorouracil|fluorouracil|mesh-list
154340335|NCT01238965|Panobinostat|panobinostat|mesh-list
154340336|NCT01238965|Calcium|calcium|mesh-list
154340337|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
154340338|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154340339|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154340340|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340341|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154340342|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
154340343|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340344|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154340345|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340346|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340347|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
154340349|NCT01238965|Protective Agents|protective agents|mesh-ancestor
154340350|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
154340351|NCT01238965|Vitamins|vitamins|mesh-ancestor
154340352|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
154340353|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340354|NCT01142557|Interferons|interferons|mesh-list
154340355|NCT01142557|Interferon-beta|interferon-beta|mesh-list
154340356|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
154340357|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340358|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
154340359|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340360|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
154340361|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340362|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154340363|NCT04496908|Misoprostol|misoprostol|mesh-list
154340364|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154340365|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
154340366|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154340367|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340368|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154340369|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154340370|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
154340371|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
154340372|NCT01144117|Hematinics|hematinics|mesh-ancestor
154340373|NCT04371640|Sirolimus|sirolimus|mesh-list
154340374|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154340375|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340376|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154340377|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340378|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
154340379|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340380|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
154340381|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340382|NCT04356196|Verapamil|verapamil|mesh-list
154340383|NCT04356196|Bisoprolol|bisoprolol|mesh-list
154340384|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154340385|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154340386|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154340387|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340388|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154340389|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340390|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
154340391|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154340392|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
153519560|NCT05928611|Hormones|hormones|mesh-ancestor
154340405|NCT02047981|Azithromycin|azithromycin|mesh-list
154340406|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154340407|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340408|NCT04802356|Dexamethasone|dexamethasone|mesh-list
154340409|NCT04802356|Lenalidomide|lenalidomide|mesh-list
154340411|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340412|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
154340413|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
154340414|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340415|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340416|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154340417|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
154340418|NCT04802356|Hormones|hormones|mesh-ancestor
154340419|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340420|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154340421|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340422|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
154340423|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154340424|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154340425|NCT04802356|Growth Substances|growth substances|mesh-ancestor
154340426|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
154255418|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153962384|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
154340427|NCT01142635|Bromides|bromides|mesh-list
154340428|NCT01142635|Rocuronium|rocuronium|mesh-list
154340429|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
154340430|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154340431|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154340432|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154340433|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340434|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340435|NCT01144195|Panitumumab|panitumumab|mesh-list
154340436|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154340437|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340438|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154340439|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154340440|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154340441|NCT02528383|Estradiol|estradiol|mesh-list
154340442|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154340443|NCT02528383|Estrogens|estrogens|mesh-ancestor
154340444|NCT02528383|Hormones|hormones|mesh-ancestor
154340445|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340446|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340447|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154340448|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
154340449|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154340450|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154340451|NCT01146067|Rivastigmine|rivastigmine|mesh-list
154340452|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154340453|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519636|NCT05867550|Cathartics|cathartics|mesh-ancestor
154340464|NCT01237249|Bortezomib|bortezomib|mesh-list
154340465|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340466|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
154340467|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
154340468|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340469|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340470|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154340471|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
154340472|NCT01237249|Hormones|hormones|mesh-ancestor
154582975|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154340473|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340474|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154340475|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340476|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154340477|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
154340478|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340479|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154340480|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340481|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
154340482|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154340483|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154340484|NCT01237249|Growth Substances|growth substances|mesh-ancestor
154340485|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
154340486|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
154340487|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154340488|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
154340489|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340490|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340491|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154340492|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
154340493|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154340494|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154340495|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154340496|NCT01244347|Folic Acid|folic acid|mesh-list
154340497|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
154340498|NCT01244347|Hematinics|hematinics|mesh-ancestor
154086835|NCT00683787|Docetaxel|docetaxel|mesh-list
154340499|NCT01244347|Vitamins|vitamins|mesh-ancestor
154340500|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
154340501|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340502|NCT01763827|Ezetimibe|ezetimibe|mesh-list
154340503|NCT01763827|Evolocumab|evolocumab|mesh-list
154340504|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154340505|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154340506|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154340507|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
154861804|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340508|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340509|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154340510|NCT01763827|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154340511|NCT01763827|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154340512|NCT01763827|Protease Inhibitors|protease inhibitors|mesh-ancestor
154340513|NCT01763827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340514|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
154340515|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340516|NCT01146145|Ketamine|ketamine|mesh-list
154340517|NCT01146145|Morphine|morphine|mesh-list
154340518|NCT01146145|Analgesics|analgesics|mesh-ancestor
154194269|NCT01017744|Anesthetics|anesthetics|mesh-list
154340519|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
153519687|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
154340527|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154340528|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154340529|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340530|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340531|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154340532|NCT01146145|Narcotics|narcotics|mesh-ancestor
154340533|NCT01146535|Interferons|interferons|mesh-list
154340534|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
154340535|NCT01146535|Oseltamivir|oseltamivir|mesh-list
154340536|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340537|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
154340538|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340539|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
154340540|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340541|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340542|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340543|NCT01732783|Panitumumab|panitumumab|mesh-list
154340544|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154340545|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340546|NCT04355728|Heparin|heparin|mesh-list
154340547|NCT04355728|Calcium heparin|calcium heparin|mesh-list
154340548|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
154340549|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154340550|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154340551|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340552|NCT01693783|Ipilimumab|ipilimumab|mesh-list
154340553|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154340554|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340555|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154340556|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340557|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
154340558|NCT02528461|Liver Extracts|liver extracts|mesh-list
154340559|NCT02528461|Hematinics|hematinics|mesh-ancestor
154340560|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
154340561|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340562|NCT01237483|Cetuximab|cetuximab|mesh-list
154340563|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154340564|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340565|NCT01240213|Vitamin D|vitamin d|mesh-list
154340566|NCT01240213|Vitamins|vitamins|mesh-ancestor
154340567|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
154340568|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340569|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154340570|NCT01375777|Ezetimibe|ezetimibe|mesh-list
154340571|NCT01375777|Evolocumab|evolocumab|mesh-list
154340572|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154340573|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154340574|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154340575|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
154340576|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340577|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154340578|NCT01375777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154340579|NCT01375777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154340580|NCT01375777|Protease Inhibitors|protease inhibitors|mesh-ancestor
154340581|NCT01375777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340582|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
154340583|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340584|NCT02431702|Haloperidol|haloperidol|mesh-list
154340585|NCT02431702|Olanzapine|olanzapine|mesh-list
154340586|NCT02431702|Risperidone|risperidone|mesh-list
154340587|NCT02431702|Aripiprazole|aripiprazole|mesh-list
154340588|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153519757|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
154194300|NCT00414609|Aliskiren|aliskiren|mesh-list
154340597|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154340598|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154340599|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340600|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154340601|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154340602|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
154340603|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
154340604|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
154340605|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340606|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154340607|NCT02431702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154340608|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154340609|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154340610|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
154340611|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
154340612|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154340613|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154340614|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154340615|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154340616|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154340617|NCT02086552|Lenalidomide|lenalidomide|mesh-list
154340618|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
154340619|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340620|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154340621|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154340622|NCT02086552|Growth Substances|growth substances|mesh-ancestor
154340623|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
154340624|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340625|NCT02321878|Liraglutide|liraglutide|mesh-list
154340626|NCT02321878|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154340627|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154340628|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340629|NCT02321878|Incretins|incretins|mesh-ancestor
154340631|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340632|NCT03491410|Aspirin|aspirin|mesh-list
154340633|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154340634|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154340635|NCT03491410|Analgesics|analgesics|mesh-ancestor
154340636|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
154340637|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340638|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340639|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340640|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154340641|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154340642|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154340643|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340644|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154340645|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154340646|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340647|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
154340648|NCT00876031|Etoposide|etoposide|mesh-list
154340649|NCT00876031|Idarubicin|idarubicin|mesh-list
154340650|NCT00876031|Trofosfamide|trofosfamide|mesh-list
154086981|NCT04056039|Colchicine|colchicine|mesh-list
154340651|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154340652|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519819|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
154340658|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340659|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
154340660|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340661|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154340662|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
154340663|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
154340664|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
154340665|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
154340666|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340667|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340668|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
154340669|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340670|NCT01146301|Clopidogrel|clopidogrel|mesh-list
154340671|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154340672|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154340673|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154340674|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154340675|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
154340676|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340677|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962599|NCT02797041|Bortezomib|bortezomib|mesh-list
153962601|NCT02794779|Oxytocin|oxytocin|mesh-list
154340678|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340679|NCT00807859|Paclitaxel|paclitaxel|mesh-list
154340680|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154340681|NCT00807859|Capecitabine|capecitabine|mesh-list
154340682|NCT00807859|Trastuzumab|trastuzumab|mesh-list
154340683|NCT00807859|Lapatinib|lapatinib|mesh-list
154340684|NCT00807859|Trebananib|trebananib|mesh-list
154340685|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154340686|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340687|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
154340688|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
154340689|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
154340690|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340691|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154340692|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
154340693|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154340694|NCT00807859|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154340695|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154340696|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340697|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154340698|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154340699|NCT00807859|Growth Substances|growth substances|mesh-ancestor
154340700|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340701|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
154340702|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154340703|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154340704|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154340705|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340706|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
154340707|NCT03491098|Prednisolone|prednisolone|mesh-list
154340708|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154340709|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
154340710|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154340711|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
154194428|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
154340712|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154340713|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
154340714|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340715|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
154340716|NCT03491098|Hormones|hormones|mesh-ancestor
154340717|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340718|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340719|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154340720|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340728|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154340730|NCT02322502|Sevoflurane|sevoflurane|mesh-list
154340731|NCT02322502|Desflurane|desflurane|mesh-list
154340732|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154340733|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340734|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340735|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154340736|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
154340737|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
154340738|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154340739|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154340740|NCT02322580|Etanercept|etanercept|mesh-list
154340741|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154340742|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154340743|NCT02322580|Analgesics|analgesics|mesh-ancestor
154340744|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
154340745|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340746|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340747|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340748|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154340749|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154340750|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340751|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
154340752|NCT03190174|Sirolimus|sirolimus|mesh-list
154340753|NCT03190174|Nivolumab|nivolumab|mesh-list
154340754|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154340755|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340756|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154340757|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861805|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154340758|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154340759|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340760|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154340761|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
154340762|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340763|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
154340764|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340765|NCT03490708|Tranilast|tranilast|mesh-list
154340766|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154340767|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154340768|NCT03490708|Analgesics|analgesics|mesh-ancestor
154340769|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
154340770|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340771|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340772|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340773|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154340774|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154340775|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154340776|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340777|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154340778|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154340779|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
154340780|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
154340781|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340782|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154340783|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154340784|NCT00924326|Vidarabine|vidarabine|mesh-list
154340785|NCT00924326|Aldesleukin|aldesleukin|mesh-list
154340786|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
154340787|NCT00924326|Fludarabine|fludarabine|mesh-list
154340806|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340807|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154340808|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154340809|NCT03496870|Levodopa|levodopa|mesh-list
154340810|NCT03496870|Carbidopa|carbidopa|mesh-list
154340811|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154340812|NCT03496870|Opicapone|opicapone|mesh-list
154340813|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154340814|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154340815|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
154340816|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340817|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340818|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340819|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154340820|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340821|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154340822|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
154340823|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
154340824|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154340825|NCT01370096|Epoprostenol|epoprostenol|mesh-list
154340826|NCT01370096|Vasopressins|vasopressins|mesh-list
154340827|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
154340828|NCT01370096|Tezosentan|tezosentan|mesh-list
154340829|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
154340830|NCT01370096|Coagulants|coagulants|mesh-ancestor
154340831|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154340832|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154340833|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
154340834|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340835|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154340836|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154340837|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
154340838|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154340839|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
154340840|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340841|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
154340842|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340843|NCT02875028|Vorapaxar|vorapaxar|mesh-list
154340844|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154340845|NCT01371344|Tacrolimus|tacrolimus|mesh-list
154340846|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340847|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
154340851|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340853|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
154340854|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
154340855|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340856|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340857|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729881|NCT00131768|Hylan|hylan|mesh-list
154340858|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154340859|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154340860|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340861|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154340862|NCT03631004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154340863|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154340864|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154340865|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340866|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340867|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
154340868|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
154340869|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340870|NCT00943618|Bupropion|bupropion|mesh-list
154340871|NCT00943618|Varenicline|varenicline|mesh-list
154340872|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154340873|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
154340874|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154340875|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154340876|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154340877|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154340878|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340879|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
154340880|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340881|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340882|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154340883|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154340884|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340885|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154340886|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154340887|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
154340888|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
154340889|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
154340890|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
154340891|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154340892|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
154340893|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
154340894|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340895|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340896|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340897|NCT02322658|Eszopiclone|eszopiclone|mesh-list
154340898|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154340899|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340900|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340901|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
154340902|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154340903|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
154340904|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154340905|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
154340906|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340907|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340942|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
154340943|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340944|NCT03490396|Povidone|povidone|mesh-list
154340945|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
154340946|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154340947|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
153520139|NCT06255886|Caseins|caseins|mesh-list
154340979|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340980|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154340981|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154340982|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
154340983|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340984|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340985|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154340986|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154340987|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
154340988|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154340989|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154340990|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
154340991|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
154340992|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340993|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154861806|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
154340994|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154340995|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154340996|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154341007|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341008|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154341009|NCT01956110|Hormones|hormones|mesh-ancestor
154341010|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341011|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341012|NCT03489928|Misoprostol|misoprostol|mesh-list
154341013|NCT03489928|Dinoprostone|dinoprostone|mesh-list
154341014|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154341015|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
154341016|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154341017|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341018|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154341019|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154341020|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
154341021|NCT02323282|Ropivacaine|ropivacaine|mesh-list
154341022|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
154341023|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
154341024|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341025|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341026|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
154087353|NCT00758199|Analgesics|analgesics|mesh-ancestor
154341027|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341028|NCT01802086|Lidocaine|lidocaine|mesh-list
154341029|NCT01802086|Prilocaine|prilocaine|mesh-list
154341030|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154341031|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
154341032|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
154341033|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341034|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341035|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
154341036|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341037|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154341038|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154341039|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154341040|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341041|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341042|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154341043|NCT05347316|Colchicine|colchicine|mesh-list
154341044|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
154341045|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341046|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
154341047|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
154341048|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
154341049|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341050|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341051|NCT03495466|Anesthetics|anesthetics|mesh-list
154341052|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341053|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341054|NCT01372826|Naloxegol|naloxegol|mesh-list
154341055|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154341056|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341057|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
154341058|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341059|NCT01371968|Alfentanil|alfentanil|mesh-list
154341060|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154341072|NCT04989322|Pemetrexed|pemetrexed|mesh-list
154341073|NCT04989322|Lenvatinib|lenvatinib|mesh-list
154341074|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341075|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154341076|NCT04989322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154341077|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341078|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341079|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154341080|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154341081|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154341082|NCT01367054|Metformin|metformin|mesh-list
154341083|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154341084|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341085|NCT03634514|Hormones|hormones|mesh-list
154341086|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341087|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341088|NCT02323438|Menthol|menthol|mesh-list
154341089|NCT02323438|Nicotine|nicotine|mesh-list
154341090|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154341091|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
154341092|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341093|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341094|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154341095|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154341096|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
154341097|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341098|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341099|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
154341100|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
154341101|NCT01372904|Dexamethasone|dexamethasone|mesh-list
154341102|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
154341103|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154341104|NCT01372904|BB 1101|bb 1101|mesh-list
154341105|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341106|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
154341107|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
154341108|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341109|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341110|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154341111|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
154341112|NCT01372904|Hormones|hormones|mesh-ancestor
154341113|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341114|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154341115|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341116|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
154341117|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341118|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341119|NCT01372982|Letrozole|letrozole|mesh-list
154341120|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341121|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154341122|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154341123|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341124|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341125|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154341132|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154341134|NCT02323516|Analgesics|analgesics|mesh-ancestor
154341135|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
154341136|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341137|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341138|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341139|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341140|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154341141|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154341142|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341143|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154341144|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154341145|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341146|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
154341147|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154341148|NCT01367210|Maraviroc|maraviroc|mesh-list
154341149|NCT01367210|Darunavir|darunavir|mesh-list
154341150|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154341151|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154341152|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154194756|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
154341153|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341154|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154341155|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
154341156|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341157|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154341158|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154341159|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154341160|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
154341161|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341162|NCT02323594|Asunaprevir|asunaprevir|mesh-list
154341163|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
154341164|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341165|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341166|NCT01372280|Galantamine|galantamine|mesh-list
154341167|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154341168|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341169|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341170|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
154341171|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341172|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341173|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154341174|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
154341175|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341176|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
154087513|NCT00919880|Paclitaxel|paclitaxel|mesh-list
154341177|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
154341178|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154341179|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341180|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154341181|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341182|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
154341183|NCT04742140|Analgesics|analgesics|mesh-ancestor
154341184|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
154341185|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341186|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341187|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
154341188|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341189|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154341190|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
154341191|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154341192|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341199|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154341200|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154341201|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341202|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341204|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
154341205|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154341206|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341207|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
154341208|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154341209|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154341210|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582976|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
154341211|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341212|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341213|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
154341214|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154341215|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341216|NCT04455178|Indapamide|indapamide|mesh-list
154341217|NCT04455178|Spironolactone|spironolactone|mesh-list
154341218|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154341219|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
154341220|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341221|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341222|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154341223|NCT04455178|Diuretics|diuretics|mesh-ancestor
154341224|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
154341225|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341226|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154341227|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341228|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341229|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
154341230|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154341231|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341232|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
154341233|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341234|NCT02446834|Metformin|metformin|mesh-list
154341235|NCT02446834|Acarbose|acarbose|mesh-list
154341236|NCT02446834|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154341237|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154341238|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341239|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154341240|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341241|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341242|NCT03489616|Pemetrexed|pemetrexed|mesh-list
154341243|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341244|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341245|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341246|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154341247|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154341248|NCT02323906|Sorafenib|sorafenib|mesh-list
154341249|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341250|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154341251|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341252|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341253|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154341254|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
154341255|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154341256|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154341257|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341269|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341270|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341271|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341272|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154341273|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154341274|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
154341276|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154341277|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
154341278|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341279|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154341280|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
154341281|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
154341282|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154582977|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
154341283|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154341284|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
154341285|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341286|NCT01373216|Exenatide|exenatide|mesh-list
154341287|NCT01373216|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154341288|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154341289|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341290|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154341291|NCT01373216|Incretins|incretins|mesh-ancestor
154341292|NCT01373216|Hormones|hormones|mesh-ancestor
154341293|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341294|NCT03487354|Misoprostol|misoprostol|mesh-list
154341295|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154341296|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
154341297|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154341298|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341299|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154341300|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154341301|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
154341302|NCT04461340|Sirolimus|sirolimus|mesh-list
154341303|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154341304|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341305|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154341306|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341307|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
154341308|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154341309|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
154341310|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341311|NCT05154968|Mannitol|mannitol|mesh-list
154341312|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154341313|NCT05154968|Diuretics|diuretics|mesh-ancestor
154341314|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
154341315|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341316|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
154341317|NCT01373372|Hormones|hormones|mesh-ancestor
154341318|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341319|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341320|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154341334|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341335|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341337|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
154341338|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341339|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341340|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341341|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
154341342|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
154341343|NCT03881020|Fluorides|fluorides|mesh-list
154341344|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
154341345|NCT03881020|Protective Agents|protective agents|mesh-ancestor
154341346|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341347|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
154341348|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154341349|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341350|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
154341351|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341352|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
154341353|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154341354|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341355|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
154341356|NCT03487042|Bimatoprost|bimatoprost|mesh-list
154341357|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154341358|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154341359|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341360|NCT03115294|Theophylline|theophylline|mesh-list
154341361|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154341362|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
154341363|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341364|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341365|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154341366|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
154341367|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154341368|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341369|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341370|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
154341371|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154341372|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154341373|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
154341374|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341375|NCT01367756|Citalopram|citalopram|mesh-list
154341376|NCT01367756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154341377|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154341378|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341379|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341380|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341381|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
154341391|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341392|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341393|NCT04624958|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154341394|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154341395|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341396|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341398|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341399|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
154341400|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
154341401|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341402|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341403|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154341404|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154341405|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154341406|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341407|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341408|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341409|NCT02946424|Simvastatin|simvastatin|mesh-list
154341410|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154341411|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154341412|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
154341413|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341414|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154341415|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154341416|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341418|NCT00783536|Methotrexate|methotrexate|mesh-list
154341419|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154341420|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
154341421|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154341422|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341423|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154341424|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
154341425|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341426|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341427|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
154341428|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341429|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154341430|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154341431|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
154341432|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341433|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154341434|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154341435|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154341436|NCT00783536|Analgesics|analgesics|mesh-ancestor
154341437|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
154341438|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341439|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341440|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154341441|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154341442|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154341443|NCT01367912|Estradiol|estradiol|mesh-list
154341444|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154341445|NCT01367912|Estrogens|estrogens|mesh-ancestor
154341446|NCT01367912|Hormones|hormones|mesh-ancestor
154341466|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154341468|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341469|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341470|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154341471|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
154341473|NCT01373528|Hormones|hormones|mesh-ancestor
154341474|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341475|NCT03634202|Capecitabine|capecitabine|mesh-list
154341476|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154341477|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
154341478|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341479|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341480|NCT05019560|Sevoflurane|sevoflurane|mesh-list
154341481|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154341482|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154341483|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
154341484|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
154341485|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341486|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341487|NCT01373606|Terlipressin|terlipressin|mesh-list
154341488|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341489|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154341490|NCT01367990|Norepinephrine|norepinephrine|mesh-list
154341491|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154341492|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154341493|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341494|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341495|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341496|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341497|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
154341498|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
154341499|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341531|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341532|NCT01368068|Tibolone|tibolone|mesh-list
154341533|NCT01368068|Escitalopram|escitalopram|mesh-list
154341534|NCT01368068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154341535|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154341536|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341537|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341538|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341539|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
154341540|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341541|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
154341542|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
154341543|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341582|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
154341612|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341614|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
154341615|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341616|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341617|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154341618|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
154341619|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154341620|NCT01374698|Aspirin|aspirin|mesh-list
154341621|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154341623|NCT01374698|Analgesics|analgesics|mesh-ancestor
154341624|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
154341625|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341626|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341627|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341628|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341629|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154341654|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154341655|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341656|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154341657|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154341658|NCT01368848|Growth Substances|growth substances|mesh-ancestor
154341659|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341660|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
154341661|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
154341662|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
154341663|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
154341664|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341666|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
154341667|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154341668|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341669|NCT01369082|Cyclosporine|cyclosporine|mesh-list
154341670|NCT01369082|Sirolimus|sirolimus|mesh-list
154341671|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
154341672|NCT01369082|Tacrolimus|tacrolimus|mesh-list
154341673|NCT01369082|Cyclosporins|cyclosporins|mesh-list
154341674|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154341675|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
154341676|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341677|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154341678|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341679|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341713|NCT01375322|Valsartan|valsartan|mesh-list
154341714|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154341715|NCT01375322|Benazepril|benazepril|mesh-list
154341716|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341717|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154341718|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341719|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341720|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154341721|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341722|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
154341750|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154341751|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341752|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341754|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154341755|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154341756|NCT03535194|Analgesics|analgesics|mesh-ancestor
154341757|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
154341758|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341759|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341760|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341761|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341762|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154341763|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154341764|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154341765|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154341766|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341767|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341768|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341769|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341770|NCT05194904|Ketorolac|ketorolac|mesh-list
154341794|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
154341795|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341796|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341797|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341798|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341799|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154341800|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154341801|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341802|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154341803|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154341804|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341805|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
154341806|NCT01319864|Plerixafor|plerixafor|mesh-list
154341807|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154341808|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154341809|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
154341810|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341811|NCT05194046|Amoxicillin|amoxicillin|mesh-list
154341812|NCT05194046|Clarithromycin|clarithromycin|mesh-list
154341813|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154341814|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341815|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154341816|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341817|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341818|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154341819|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154341820|NCT01369472|Carvedilol|carvedilol|mesh-list
154341844|NCT05193578|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154341845|NCT05193578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154341846|NCT05193578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341848|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154341849|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341850|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341851|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341852|NCT03486496|Gefitinib|gefitinib|mesh-list
154341853|NCT03486496|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154341854|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154341855|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341856|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341857|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341858|NCT02091934|Dipivefrin|dipivefrin|mesh-list
154341859|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154341860|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341861|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341862|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341863|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341864|NCT01375634|Midazolam|midazolam|mesh-list
154341865|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154341866|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154341867|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341868|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341869|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154341870|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154341894|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154341895|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154341896|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154341897|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154341898|NCT05108740|Everolimus|everolimus|mesh-list
154341899|NCT05108740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154341900|NCT05108740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154341901|NCT05108740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341902|NCT05108740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341903|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154341904|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
154341905|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341906|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341907|NCT05105750|Aspirin|aspirin|mesh-list
154341908|NCT05105750|Indobufen|indobufen|mesh-list
154341909|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154341910|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154341911|NCT05105750|Analgesics|analgesics|mesh-ancestor
154341912|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
154341913|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341914|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341915|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341916|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341917|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154341918|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154088248|NCT00767091|Protective Agents|protective agents|mesh-ancestor
154341919|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341920|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154088323|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
154341991|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341992|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154341993|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341994|NCT03531840|Olaparib|olaparib|mesh-list
154341995|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154341996|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341997|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341998|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341999|NCT05151796|Aspirin|aspirin|mesh-list
154342000|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154342001|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154342002|NCT05151796|Analgesics|analgesics|mesh-ancestor
154342003|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
154342028|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154342029|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154342030|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342031|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154342032|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154342033|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
154342034|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342035|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342036|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154342037|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
154342038|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154342039|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154342040|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
154342041|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
154342042|NCT03486184|Cystatins|cystatins|mesh-list
154342043|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154342044|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
154342045|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342046|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342047|NCT03109756|Gaboxadol|gaboxadol|mesh-list
154342048|NCT03109756|Analgesics|analgesics|mesh-ancestor
154342049|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
154342050|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342051|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342052|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
154342053|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
154342054|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
154342055|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521230|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342080|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
154342081|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342082|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154342083|NCT04871360|Laxatives|laxatives|mesh-ancestor
154342084|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342085|NCT05153200|Adalimumab|adalimumab|mesh-list
154342086|NCT05153200|Upadacitinib|upadacitinib|mesh-list
154342087|NCT05153200|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154342088|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342089|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342090|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154342091|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154342092|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342093|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342094|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
154342095|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342096|NCT03477136|Vitamin D|vitamin d|mesh-list
154342097|NCT03477136|Vitamins|vitamins|mesh-ancestor
154342098|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
154342099|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342100|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154342101|NCT03552068|Clonidine|clonidine|mesh-list
154342102|NCT03552068|Analgesics|analgesics|mesh-ancestor
154342103|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
153521279|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154342137|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
154342138|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342139|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
154342140|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
154342141|NCT03480958|Morphine|morphine|mesh-list
154342142|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154342143|NCT03480958|Narcotics|narcotics|mesh-ancestor
154342144|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342145|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342146|NCT03480958|Analgesics|analgesics|mesh-ancestor
154342180|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154342181|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
153521370|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
154342213|NCT04720976|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154342214|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154342215|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088550|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154342218|NCT03480568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154342219|NCT03480568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154342220|NCT03480568|Antimetabolites|antimetabolites|mesh-ancestor
154342221|NCT03480568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342222|NCT03480568|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154342223|NCT03480568|Protease Inhibitors|protease inhibitors|mesh-ancestor
154342224|NCT03480568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342225|NCT03480568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154342226|NCT04707326|Lamivudine|lamivudine|mesh-list
154342255|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342256|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342257|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154342258|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154342259|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342261|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154342262|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342263|NCT03482752|Molgramostim|molgramostim|mesh-list
154342264|NCT03482752|Sargramostim|sargramostim|mesh-list
154342265|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342266|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
154342267|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342268|NCT01310712|Oxybutynin|oxybutynin|mesh-list
154342269|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
154342270|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
154342271|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342272|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342300|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
154342301|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342302|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342303|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154342304|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
154342305|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342306|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154342307|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154342308|NCT03723096|Pomalidomide|pomalidomide|mesh-list
154342309|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
154342310|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342311|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154342312|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154342313|NCT03723096|Growth Substances|growth substances|mesh-ancestor
154342314|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
154342315|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342316|NCT02534012|Anesthetics|anesthetics|mesh-list
154342348|NCT03722940|Analgesics|analgesics|mesh-ancestor
154342349|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
154342350|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342351|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342352|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
154342353|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342354|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154342355|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
154342356|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154342357|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342358|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342383|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342384|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342386|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154342387|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154342388|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342389|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342390|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154342391|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154342392|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154342393|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154342394|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
154342395|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
154342396|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
154342397|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
154342398|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342399|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342400|NCT01148173|Ifosfamide|ifosfamide|mesh-list
154342401|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154342402|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
154861807|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255419|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
154255420|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154255421|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154255422|NCT03905486|Pregabalin|pregabalin|mesh-list
154255423|NCT03905486|Analgesics|analgesics|mesh-ancestor
154255424|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
154255425|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582978|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342403|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342404|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342405|NCT01898312|Mifepristone|mifepristone|mesh-list
154342406|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154342407|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
154342408|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153521577|NCT03623373|Cytarabine|cytarabine|mesh-list
154088763|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
154342439|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342440|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154342441|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
154342442|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342443|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342444|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154342445|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
154342446|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
154342448|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342449|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154342450|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154342451|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154342477|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
154342479|NCT02348203|Zileuton|zileuton|mesh-list
154342480|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154342481|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154342482|NCT02348203|Analgesics|analgesics|mesh-ancestor
154342483|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
154342484|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342485|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342486|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342487|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342488|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154342489|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154342490|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342491|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154342492|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154342493|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342494|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
154342495|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154342496|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154342497|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
154342498|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342520|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342521|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342522|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342523|NCT01366898|Methotrexate|methotrexate|mesh-list
154342524|NCT01366898|Idarubicin|idarubicin|mesh-list
154342525|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154342526|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
154342527|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342528|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342529|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154342530|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
154342531|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342532|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342533|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
154342534|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342535|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154342536|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154342537|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
154195422|NCT00508274|Capecitabine|capecitabine|mesh-list
154861808|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861809|NCT00362895|Tobramycin|tobramycin|mesh-list
154861810|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154861811|NCT00362895|Dexamethasone|dexamethasone|mesh-list
154861812|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
154861813|NCT00362895|BB 1101|bb 1101|mesh-list
154861814|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963646|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
154342538|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342539|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154342540|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154342541|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154342542|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154342543|NCT01248871|Sufentanil|sufentanil|mesh-list
154342544|NCT01248871|Remifentanil|remifentanil|mesh-list
154342546|NCT01248871|Propofol|propofol|mesh-list
154342547|NCT01248871|Sevoflurane|sevoflurane|mesh-list
154342548|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154342549|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342550|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521717|NCT02995330|Androgens|androgens|mesh-ancestor
154342579|NCT03916393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342580|NCT03907813|Bupivacaine|bupivacaine|mesh-list
154342581|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
154342582|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
154342583|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342584|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342585|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
154342586|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342587|NCT00938912|Lacosamide|lacosamide|mesh-list
154342589|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154342590|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154342591|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342592|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342593|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
154342594|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154342595|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154342596|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154342597|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153521770|NCT02480803|Levodopa|levodopa|mesh-list
154342629|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154342631|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
154342632|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
154342633|NCT03907111|Coagulants|coagulants|mesh-ancestor
154342634|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
154342635|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
154342636|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342637|NCT03912727|Protective Agents|protective agents|mesh-ancestor
154342638|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342639|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
154342640|NCT03912727|Vitamins|vitamins|mesh-ancestor
154342673|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342674|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154342675|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154342676|NCT03472014|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154195495|NCT00490646|Docetaxel|docetaxel|mesh-list
154342677|NCT03472014|Antiviral Agents|antiviral agents|mesh-ancestor
154342678|NCT03472014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342679|NCT04182100|Aspirin|aspirin|mesh-list
154342680|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154342681|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154342709|NCT03912415|Carboplatin|carboplatin|mesh-list
154342710|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154342711|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342712|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
154342713|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
154342714|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
154342715|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342716|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154342717|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154342718|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154342719|NCT03912415|Growth Substances|growth substances|mesh-ancestor
154342720|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342721|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
154342723|NCT03525834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154342724|NCT03525834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154342725|NCT03525834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342726|NCT03525834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342759|NCT00481052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154342760|NCT00481052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342761|NCT00481052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861815|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
154342762|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
154342763|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154342764|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342765|NCT03954106|Defibrotide|defibrotide|mesh-list
154342766|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154342798|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154342799|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342800|NCT03632876|Vitamins|vitamins|mesh-ancestor
154342801|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
154342802|NCT03914755|Tucatinib|tucatinib|mesh-list
154342803|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342804|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154342805|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342806|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342834|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154342835|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154342836|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
154342837|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342838|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342840|NCT03479086|Naltrexone|naltrexone|mesh-list
154342841|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154342842|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154342843|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342844|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
154342845|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342846|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
154342847|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154342848|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
154342849|NCT01252069|Progestins|progestins|mesh-list
154342850|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154342851|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
154342852|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342853|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342854|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154342855|NCT01252069|Hormones|hormones|mesh-ancestor
153522025|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342883|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154342884|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154342885|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
154342886|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154342887|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154342888|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342889|NCT03574792|Oxycodone|oxycodone|mesh-list
154342890|NCT03574792|Methadone|methadone|mesh-list
154342891|NCT03574792|Gabapentin|gabapentin|mesh-list
154342892|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154342893|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154342894|NCT03574792|Narcotics|narcotics|mesh-ancestor
154342895|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342896|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342897|NCT03574792|Analgesics|analgesics|mesh-ancestor
154342898|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
154342899|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342900|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
154342923|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342925|NCT01254175|Vaccines|vaccines|mesh-list
154342926|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
154342927|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342928|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154342929|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154342930|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342931|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342932|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154342933|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
154342934|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342935|NCT03903367|Fentanyl|fentanyl|mesh-list
154342936|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154342937|NCT03903367|Narcotics|narcotics|mesh-ancestor
154342938|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342939|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342940|NCT03903367|Analgesics|analgesics|mesh-ancestor
154342941|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
154342942|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342943|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154342944|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154342945|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
154342946|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
154342947|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
153963793|NCT02610712|Ketamine|ketamine|mesh-list
154342948|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342949|NCT03717168|Hormones|hormones|mesh-list
154342950|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342951|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342967|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342969|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
154342970|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342971|NCT03478306|Protective Agents|protective agents|mesh-ancestor
154342972|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342973|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342974|NCT03103100|Lidocaine|lidocaine|mesh-list
154342975|NCT03103100|Bupivacaine|bupivacaine|mesh-list
154342976|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
154342977|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
154342978|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342979|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342980|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
154342981|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342982|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154342983|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154342984|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154342985|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342986|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342987|NCT03639168|Cisplatin|cisplatin|mesh-list
154342988|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342989|NCT03131050|Scopolamine|scopolamine|mesh-list
154342990|NCT03131050|Escitalopram|escitalopram|mesh-list
154342991|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154342992|NCT03131050|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154342993|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154342994|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342995|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342996|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342997|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
154342998|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342999|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
154343000|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
154343001|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343002|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154343003|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154343004|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
154343005|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154343006|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
154343007|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154343008|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
153522178|NCT06040112|Lidocaine|lidocaine|mesh-list
154343032|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
154343033|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154343034|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154343035|NCT03718806|Zoliflodacin|zoliflodacin|mesh-list
154343036|NCT03718806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154343037|NCT03718806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154343038|NCT03718806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343039|NCT03718806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343040|NCT03718806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343041|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
154343042|NCT03716856|Fludarabine|fludarabine|mesh-list
154343043|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154343044|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
154343045|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343046|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343047|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154343048|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
154343049|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195656|NCT00386607|Aliskiren|aliskiren|mesh-list
154343050|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343051|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154343052|NCT03910543|Tofacitinib|tofacitinib|mesh-list
154343053|NCT03910543|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154343054|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154343055|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343056|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343057|NCT03101462|Vaccines|vaccines|mesh-list
154861816|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
154255426|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343058|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
154343087|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343089|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
154343090|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343091|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343092|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
154343093|NCT01256359|Docetaxel|docetaxel|mesh-list
154343094|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343095|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154343096|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154343097|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154343098|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343099|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154343100|NCT02527993|Liraglutide|liraglutide|mesh-list
154343101|NCT02527993|Acarbose|acarbose|mesh-list
154343102|NCT02527993|Verapamil|verapamil|mesh-list
154343103|NCT02527993|Pasireotide|pasireotide|mesh-list
154343104|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154343137|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343138|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
154343139|NCT01149577|Olanzapine|olanzapine|mesh-list
154343140|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
154343141|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
153522316|NCT06038552|Imatinib Mesylate|imatinib mesylate|mesh-list
154343171|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
154343172|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343173|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343174|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154343175|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
154343176|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154343177|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154343178|NCT03894007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154343179|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154343180|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154343181|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154343182|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343183|NCT03894007|Immunotoxins|immunotoxins|mesh-ancestor
154343184|NCT03894007|Immunoconjugates|immunoconjugates|mesh-ancestor
154343185|NCT01150747|Azithromycin|azithromycin|mesh-list
154343186|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
154343187|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343218|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154343219|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343220|NCT01586299|Acetaminophen|acetaminophen|mesh-list
154343221|NCT01586299|Ibuprofen|ibuprofen|mesh-list
154343222|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343223|NCT01586299|Analgesics|analgesics|mesh-ancestor
154343224|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
154343225|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195708|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
154343226|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343227|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
154343228|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343229|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343252|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343253|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154343254|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154089593|NCT00664521|Rituximab|rituximab|mesh-list
154343255|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154343256|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343257|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343258|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
154343259|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
154343260|NCT01149967|Dexetimide|dexetimide|mesh-list
154343261|NCT01149967|Citalopram|citalopram|mesh-list
154343262|NCT01149967|Escitalopram|escitalopram|mesh-list
154343263|NCT01149967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154343264|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154343265|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343266|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343267|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522474|NCT05435053|Nivolumab|nivolumab|mesh-list
154343299|NCT04770740|Vitamins|vitamins|mesh-ancestor
154343300|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
154343301|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343302|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154861817|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255427|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
153963946|NCT04302584|Vasopressins|vasopressins|mesh-list
154343303|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154343304|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343305|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
154343306|NCT04770740|Coagulants|coagulants|mesh-ancestor
154343307|NCT03896971|Cyclosporine|cyclosporine|mesh-list
154343308|NCT03896971|Cyclosporins|cyclosporins|mesh-list
154343309|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343310|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343311|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154343312|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
154343342|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154343343|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154343344|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343345|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
154343346|NCT03899233|Coagulants|coagulants|mesh-ancestor
154343347|NCT03101150|Vitamin D|vitamin d|mesh-list
154343348|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
154343349|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
154343350|NCT03101150|Vitamins|vitamins|mesh-list
154343351|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
154343352|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343353|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154343354|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154343355|NCT01255579|Fluticasone|fluticasone|mesh-list
154343356|NCT01255579|Beclomethasone|beclomethasone|mesh-list
154343357|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
154343358|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154343359|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154343360|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343361|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154343362|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
154343391|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154343392|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154343394|NCT05415254|Calcitriol|calcitriol|mesh-list
154343395|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154343396|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343397|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154343398|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153522582|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
154343421|NCT01257529|Pregabalin|pregabalin|mesh-list
154343422|NCT01257529|Analgesics|analgesics|mesh-ancestor
154343423|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
154343424|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343425|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343426|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
154343427|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154343428|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343429|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343430|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154343431|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154343432|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154343433|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154343434|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154343435|NCT03896113|Celecoxib|celecoxib|mesh-list
154343436|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343437|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343438|NCT03896113|Analgesics|analgesics|mesh-ancestor
154343439|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
154343440|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343441|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343442|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153522617|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343468|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343469|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
154343470|NCT03892525|Atezolizumab|atezolizumab|mesh-list
154343471|NCT03892525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154343472|NCT03892525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343473|NCT03892525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154343474|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343475|NCT05418452|Metformin|metformin|mesh-list
154343476|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154861818|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861819|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154343477|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343478|NCT01260103|Temozolomide|temozolomide|mesh-list
154089819|NCT02576288|Incretins|incretins|mesh-ancestor
154343479|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154343480|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
154343481|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343482|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343483|NCT03480750|Carboplatin|carboplatin|mesh-list
154343484|NCT03480750|Doxorubicin|doxorubicin|mesh-list
154343485|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154343486|NCT03480750|Trientine|trientine|mesh-list
154343487|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343488|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154343489|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154343563|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195830|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
154343564|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
154343565|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343598|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154343599|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
154343600|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343601|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154343602|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154343603|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343605|NCT03891433|Tazobactam|tazobactam|mesh-list
154343606|NCT03891433|Piperacillin|piperacillin|mesh-list
154343607|NCT03891433|Ertapenem|ertapenem|mesh-list
154343608|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343609|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343645|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154343646|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
154343647|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154343682|NCT03891043|Protective Agents|protective agents|mesh-ancestor
154343683|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343684|NCT03891043|Trace Elements|trace elements|mesh-ancestor
154343685|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
154343686|NCT03890341|Drospirenone|drospirenone|mesh-list
154343687|NCT03890341|Midazolam|midazolam|mesh-list
154343720|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
154343721|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154343722|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154343723|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154343724|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343725|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343726|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
154343727|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343728|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343755|NCT01152931|Vitamin A|vitamin a|mesh-list
154343756|NCT01152931|Zinc|zinc|mesh-list
154343757|NCT01152931|Selenium|selenium|mesh-list
154343758|NCT01152931|Artesunate|artesunate|mesh-list
154343759|NCT01152931|Lumefantrine|lumefantrine|mesh-list
154343760|NCT01152931|Artemether|artemether|mesh-list
154343761|NCT01152931|Amodiaquine|amodiaquine|mesh-list
154343762|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
154343763|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
154343764|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343765|NCT01152931|Trace Elements|trace elements|mesh-ancestor
154343766|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
154343767|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343768|NCT01152931|Protective Agents|protective agents|mesh-ancestor
154343769|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
154343770|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154343771|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154343772|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343773|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343774|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
154343775|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
154343776|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154343777|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
153522941|NCT02828761|Calcium|calcium|mesh-list
154343810|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154343811|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
154343812|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154343813|NCT01153165|Citalopram|citalopram|mesh-list
154343814|NCT01153165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154343815|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154343816|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153522979|NCT02265770|Methotrexate|methotrexate|mesh-list
154343853|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
154343854|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195881|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
154343855|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343882|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343883|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343884|NCT03716388|Analgesics|analgesics|mesh-ancestor
154343885|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
154343886|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343887|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343888|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343889|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343890|NCT01311336|Loratadine|loratadine|mesh-list
154343891|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
154343892|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
154343893|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154343894|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154343895|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154343896|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
154343897|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
154343898|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343899|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523059|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
154343934|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343935|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154343936|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154343937|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343938|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154344011|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154344012|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154344013|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154344014|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154344034|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154344036|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154344037|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
154344038|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154344039|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344040|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344041|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
154344042|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154344043|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
154344044|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344045|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344046|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154344047|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
154344048|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154344049|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
154344050|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344051|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344052|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154344053|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
154344054|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
154344055|NCT01155115|Protective Agents|protective agents|mesh-ancestor
154344056|NCT03713190|Empagliflozin|empagliflozin|mesh-list
154344057|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154344058|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344059|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154344060|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344061|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
154344062|NCT03718182|Vitamin D|vitamin d|mesh-list
154344063|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154344064|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344065|NCT03718182|Vitamins|vitamins|mesh-ancestor
154344066|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
154344067|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154344068|NCT03881449|Aripiprazole|aripiprazole|mesh-list
153523218|NCT04518410|Camostat|camostat|mesh-list
154344092|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344093|NCT03884491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154344094|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154344095|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154344096|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344097|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344099|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154344100|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154344101|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154344102|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154344103|NCT01155817|Nilotinib|nilotinib|mesh-list
154344104|NCT01155817|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154344105|NCT01155817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154344106|NCT01155817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344107|NCT01155817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344108|NCT03880981|Acetaminophen|acetaminophen|mesh-list
154344109|NCT03880981|Ibuprofen|ibuprofen|mesh-list
154344110|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154344111|NCT03880981|Analgesics|analgesics|mesh-ancestor
154344112|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
154344113|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344114|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344115|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
154344149|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344150|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154344151|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344153|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153523322|NCT04169347|Leucovorin|leucovorin|mesh-list
154344186|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154344187|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344188|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344190|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154344191|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344192|NCT01159639|Clopidogrel|clopidogrel|mesh-list
154344193|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154344194|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154344195|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153523360|NCT04126070|Docetaxel|docetaxel|mesh-list
154344229|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
154344230|NCT03880045|Coagulants|coagulants|mesh-ancestor
154344231|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154344232|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154344233|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
154344234|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344235|NCT03879889|Nicotine|nicotine|mesh-list
154344236|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154344253|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154344254|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154344255|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
154344256|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344257|NCT01266187|Antidotes|antidotes|mesh-ancestor
154344258|NCT01266187|Protective Agents|protective agents|mesh-ancestor
154344259|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
154344260|NCT01266187|Vitamins|vitamins|mesh-ancestor
154344261|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
154344262|NCT01586533|Mesalamine|mesalamine|mesh-list
154344263|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154344264|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154344265|NCT01586533|Analgesics|analgesics|mesh-ancestor
154344266|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
154344267|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344268|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344269|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344270|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154344271|NCT03880123|Ixazomib|ixazomib|mesh-list
154344272|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344273|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
154344274|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344275|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344276|NCT01266499|Colistin|colistin|mesh-list
154344277|NCT01266499|Polymyxins|polymyxins|mesh-list
154344278|NCT01266499|Gentamicins|gentamicins|mesh-list
154344279|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154344280|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344281|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154344282|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344283|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344284|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
154344285|NCT00075725|Leucovorin|leucovorin|mesh-list
154344286|NCT00075725|Folic Acid|folic acid|mesh-list
154344287|NCT00075725|Cytarabine|cytarabine|mesh-list
154344288|NCT00075725|Dexamethasone|dexamethasone|mesh-list
154344289|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
154344290|NCT00075725|Prednisone|prednisone|mesh-list
154344291|NCT00075725|Cortisone|cortisone|mesh-list
154344292|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
154344293|NCT00075725|Doxorubicin|doxorubicin|mesh-list
154344294|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154344295|NCT00075725|Methotrexate|methotrexate|mesh-list
154344296|NCT00075725|Vincristine|vincristine|mesh-list
154344297|NCT00075725|Daunorubicin|daunorubicin|mesh-list
154344298|NCT00075725|Asparaginase|asparaginase|mesh-list
154344299|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
154090632|NCT02577068|Propacetamol|propacetamol|mesh-list
154344333|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154344334|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154344335|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
154344336|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
154344337|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154344338|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154344339|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
154344340|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344341|NCT00075725|Antidotes|antidotes|mesh-ancestor
154344342|NCT00075725|Protective Agents|protective agents|mesh-ancestor
154344343|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
154344379|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154344380|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090708|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154196054|NCT00490022|Androgens|androgens|mesh-ancestor
154344381|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154344382|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
154344383|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
154344384|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344402|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154344404|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
154344405|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
154344406|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
154344407|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344408|NCT03717558|Ivermectin|ivermectin|mesh-list
154344409|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154344410|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344411|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
154344412|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
154344413|NCT00074711|Calcium|calcium|mesh-list
154344414|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154344415|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344416|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154344417|NCT00074711|Antacids|antacids|mesh-ancestor
154344418|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344419|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154344420|NCT01156207|Aliskiren|aliskiren|mesh-list
154344421|NCT01156207|Renin Inhibitors|renin inhibitors|mesh-ancestor
154344422|NCT01156207|Protease Inhibitors|protease inhibitors|mesh-ancestor
154344423|NCT01156207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344424|NCT01156207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344425|NCT03960905|Meropenem|meropenem|mesh-list
154344426|NCT03960905|Ceftazidime|ceftazidime|mesh-list
154344427|NCT03960905|Cefepime|cefepime|mesh-list
154344428|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
154344429|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154344430|NCT03960905|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154344431|NCT03960905|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154344432|NCT05619120|Mexiletine|mexiletine|mesh-list
154344433|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154344434|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154344435|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154344436|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154344437|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344438|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
154344439|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154344440|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154344441|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154344442|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154344452|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154344453|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
154344454|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154344455|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154344456|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344457|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154344458|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154344459|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154344460|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154344461|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154344462|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344463|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154344464|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
154344465|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344467|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154344468|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344469|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154344470|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344471|NCT01158859|Pregabalin|pregabalin|mesh-list
154344472|NCT01158859|Analgesics|analgesics|mesh-ancestor
154344473|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
154344474|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344475|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344476|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
154344477|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154344478|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154344479|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344480|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154344481|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154344482|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154344483|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344484|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344485|NCT01100021|Doxazosin|doxazosin|mesh-list
154344486|NCT01100021|Tamsulosin|tamsulosin|mesh-list
154344487|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154344488|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154344489|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154344490|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
154344491|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344492|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344493|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344494|NCT01100021|Urological Agents|urological agents|mesh-ancestor
154344495|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154344496|NCT03407430|Pregabalin|pregabalin|mesh-list
154344497|NCT03407430|Analgesics|analgesics|mesh-ancestor
154344498|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
154344499|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344500|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344501|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
154344502|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154344503|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154344504|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344505|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153523638|NCT03170960|Atezolizumab|atezolizumab|mesh-list
154344528|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344530|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154344531|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344533|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154344534|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344535|NCT01100177|Sunitinib|sunitinib|mesh-list
154344536|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344537|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154344538|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154344539|NCT01100177|Growth Substances|growth substances|mesh-ancestor
154344540|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344541|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
154344542|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154344543|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344544|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344545|NCT01100333|Hormones|hormones|mesh-list
154344546|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154344547|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344548|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344549|NCT01327235|Cisplatin|cisplatin|mesh-list
154344550|NCT01327235|Endostar protein|endostar protein|mesh-list
154344551|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344552|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154344553|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154344554|NCT01327235|Growth Substances|growth substances|mesh-ancestor
154344555|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255428|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153964398|NCT02848794|Irinotecan|irinotecan|mesh-list
154344556|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
154344557|NCT03406260|Lasmiditan|lasmiditan|mesh-list
154344558|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154344559|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
154344560|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344586|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344588|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
154344589|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
154344590|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
154344591|NCT01265173|Cefotaxime|cefotaxime|mesh-list
154344592|NCT01265173|Cefoxitin|cefoxitin|mesh-list
154344593|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154344594|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344595|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154344596|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154344597|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344598|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344599|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344600|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154344601|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154344602|NCT01265173|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154344603|NCT01265173|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154344604|NCT01159327|Sorafenib|sorafenib|mesh-list
154344605|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090940|NCT00794235|Sorafenib|sorafenib|mesh-list
154344606|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154344607|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344608|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344609|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
154344610|NCT01160341|Testosterone|testosterone|mesh-list
154344632|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
154344633|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154344634|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344635|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
154344636|NCT03877705|Protective Agents|protective agents|mesh-ancestor
154344637|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344638|NCT01160419|Leucovorin|leucovorin|mesh-list
154344639|NCT01160419|Folic Acid|folic acid|mesh-list
154344640|NCT01160419|Docetaxel|docetaxel|mesh-list
154344641|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
154344642|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
154344643|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344644|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
154344645|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
154344646|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
154344647|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344648|NCT01160419|Antidotes|antidotes|mesh-ancestor
154344649|NCT01160419|Protective Agents|protective agents|mesh-ancestor
154344650|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344651|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
154344652|NCT01160419|Vitamins|vitamins|mesh-ancestor
154344653|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
154344654|NCT01160419|Hematinics|hematinics|mesh-ancestor
154344655|NCT02954172|Paclitaxel|paclitaxel|mesh-list
154344656|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154344657|NCT02954172|Bevacizumab|bevacizumab|mesh-list
154344658|NCT02954172|Carboplatin|carboplatin|mesh-list
154344659|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154344660|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344661|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
154344662|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
154344663|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
154344664|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344665|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154344666|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523826|NCT01614197|Cytarabine|cytarabine|mesh-list
154344702|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154344703|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154344704|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344705|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154344718|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154344719|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344720|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
154344721|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154344722|NCT01161979|Zonisamide|zonisamide|mesh-list
154344723|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
154861820|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
154861821|NCT00362895|Hormones|hormones|mesh-ancestor
154344724|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154344725|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154344726|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344727|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154344728|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344729|NCT01160731|Etoposide|etoposide|mesh-list
154344730|NCT01160731|Panobinostat|panobinostat|mesh-list
154344731|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
154344732|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344733|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154344734|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154344735|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154344736|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344737|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344738|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154344739|NCT01160965|Ropivacaine|ropivacaine|mesh-list
154344740|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
154344741|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
154344742|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
154344743|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344744|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344745|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
154344746|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344747|NCT01156909|Rituximab|rituximab|mesh-list
154344748|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154344749|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344750|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
154344751|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344752|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154344753|NCT01162603|Latanoprost|latanoprost|mesh-list
154344754|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154344755|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154344756|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
154344757|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154344758|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344759|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
154344760|NCT02527213|Antidotes|antidotes|mesh-ancestor
154344761|NCT02527213|Protective Agents|protective agents|mesh-ancestor
154344762|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344763|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
154344764|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344765|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
154344766|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154344767|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344768|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
154344769|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
154344770|NCT01161277|Haloperidol|haloperidol|mesh-list
154344771|NCT01161277|Aripiprazole|aripiprazole|mesh-list
154344792|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344793|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154344794|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154344795|NCT01268215|Budesonide|budesonide|mesh-list
154344796|NCT01268215|Calfactant|calfactant|mesh-list
154344797|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344798|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154344799|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
154344800|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344801|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344802|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154344803|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
154344804|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
154344805|NCT01268215|Hormones|hormones|mesh-ancestor
154344806|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344807|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154344808|NCT01269307|Ketamine|ketamine|mesh-list
154344809|NCT01269307|Propofol|propofol|mesh-list
154344810|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154344811|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344812|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344813|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154344814|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
154344815|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
154344816|NCT01269307|Analgesics|analgesics|mesh-ancestor
154344817|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
154344818|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344819|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154344820|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154344821|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154344822|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344823|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344824|NCT03874585|Nicotine|nicotine|mesh-list
154344825|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154344838|NCT01268371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344839|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154344840|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
154196349|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154344841|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344842|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344843|NCT01267669|Somatostatin|somatostatin|mesh-list
154344844|NCT01267669|Hormones|hormones|mesh-ancestor
154344845|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344846|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344847|NCT05666869|Esketamine|esketamine|mesh-list
154344848|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
154344849|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344850|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154344851|NCT01164943|Hormones|hormones|mesh-ancestor
154344852|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344853|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344854|NCT01269541|Rifampin|rifampin|mesh-list
154344855|NCT01269541|Mupirocin|mupirocin|mesh-list
154344856|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154344857|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
154344858|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154344859|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344860|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
154344861|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154344862|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344863|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344864|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154344865|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154344866|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154344867|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154344868|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154344869|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154344870|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154344871|NCT03877003|Choline|choline|mesh-list
154344872|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
154344873|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154344874|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
154344875|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344876|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154344877|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154344878|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
154344879|NCT01280149|Substance P|substance p|mesh-list
154344880|NCT01280149|Neurokinin A|neurokinin a|mesh-list
154344881|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344882|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344883|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344884|NCT01165255|Bupropion|bupropion|mesh-list
154344885|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
154344886|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154344903|NCT01311414|Urapidil|urapidil|mesh-list
154344904|NCT01311414|Theodrenaline|theodrenaline|mesh-list
154344905|NCT01311414|Cafedrine|cafedrine|mesh-list
154344906|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154344907|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
154344908|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154344910|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344911|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344912|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344913|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154344914|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154344915|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154344916|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
154344917|NCT03715296|Lenalidomide|lenalidomide|mesh-list
154344918|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
154344919|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344920|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154344921|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154344922|NCT03715296|Growth Substances|growth substances|mesh-ancestor
154344923|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
154344924|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344925|NCT01347762|Nabilone|nabilone|mesh-list
154344926|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
154344927|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
154344928|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344929|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344930|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154344931|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154344932|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154344933|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344934|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344935|NCT03874273|Crizotinib|crizotinib|mesh-list
154344936|NCT03874273|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154344937|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154344938|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344939|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344940|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344941|NCT01167127|Oxycodone|oxycodone|mesh-list
154344942|NCT01167127|Naloxone|naloxone|mesh-list
154344943|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154344944|NCT01167127|Narcotics|narcotics|mesh-ancestor
154344973|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
154344974|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154344975|NCT01163929|Paclitaxel|paclitaxel|mesh-list
154344976|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154344977|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344978|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
154344979|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
154344980|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
154344981|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091311|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
154344982|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
154344983|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154344985|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
154344986|NCT00073307|Sorafenib|sorafenib|mesh-list
154344987|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344988|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154344989|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524137|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345009|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345010|NCT01271179|Insulin|insulin|mesh-list
154345011|NCT01271179|Allopurinol|allopurinol|mesh-list
154345012|NCT01271179|Adenosine|adenosine|mesh-list
154345013|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154345014|NCT01271179|Analgesics|analgesics|mesh-ancestor
154345015|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
154345016|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345017|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345018|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154345019|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
154345020|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154345021|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
154345022|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
154345023|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345024|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345025|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
154345026|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345027|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
154345028|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345029|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154345030|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
154345031|NCT01271179|Protective Agents|protective agents|mesh-ancestor
154345032|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154345033|NCT03388164|Dexetimide|dexetimide|mesh-list
154345034|NCT03388164|Citalopram|citalopram|mesh-list
154345035|NCT03388164|Escitalopram|escitalopram|mesh-list
154345036|NCT03388164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154345037|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154345038|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154345039|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345040|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345041|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
154345042|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345043|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153524186|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
154345059|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
154345060|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345061|NCT01268839|Efavirenz|efavirenz|mesh-list
154345062|NCT01268839|Rilpivirine|rilpivirine|mesh-list
154345063|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154345064|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154345065|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345066|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345067|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
154345068|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345069|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154345070|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154345071|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154345072|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154345073|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154345074|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154345075|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154345076|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154345077|NCT03403374|Evolocumab|evolocumab|mesh-list
154345078|NCT03403374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154345079|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154345080|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154345081|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
154345082|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345083|NCT03403374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154345084|NCT03403374|Protease Inhibitors|protease inhibitors|mesh-ancestor
154345085|NCT03403374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345086|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154345087|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
154345088|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154345089|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154345090|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345091|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154345092|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154345093|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
154345094|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345095|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345096|NCT03387462|Tenofovir|tenofovir|mesh-list
154345097|NCT03387462|Emtricitabine|emtricitabine|mesh-list
154345098|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
154345099|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345100|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154345101|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153524238|NCT01461031|Nefopam|nefopam|mesh-list
154345112|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
154345113|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345114|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345115|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154345116|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
154345117|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
154345118|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154345119|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154345120|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154345121|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154345122|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
154345123|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345124|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345125|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
154345126|NCT03756883|Hormones|hormones|mesh-ancestor
154345127|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345128|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
154345129|NCT01586611|Leucovorin|leucovorin|mesh-list
154345130|NCT01586611|Gemcitabine|gemcitabine|mesh-list
154345131|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
154345132|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154345133|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
154345134|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345135|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345136|NCT01586611|Antidotes|antidotes|mesh-ancestor
154345137|NCT01586611|Protective Agents|protective agents|mesh-ancestor
154345138|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345139|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
154345140|NCT01586611|Vitamins|vitamins|mesh-ancestor
154345141|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
154345142|NCT03386448|Scopolamine|scopolamine|mesh-list
154345143|NCT03386448|Naltrexone|naltrexone|mesh-list
154345144|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154345145|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154345146|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154345147|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345148|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
154345149|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345150|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154345151|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
154345152|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
154345153|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345154|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
154345155|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154345156|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
154345157|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345158|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345159|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154345160|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
154345161|NCT01280929|Ranibizumab|ranibizumab|mesh-list
154345162|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154345163|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154345164|NCT01280929|Growth Substances|growth substances|mesh-ancestor
154345165|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345166|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
154345167|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345200|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345201|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
154345202|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345203|NCT00009737|Leucovorin|leucovorin|mesh-list
154345204|NCT00009737|Capecitabine|capecitabine|mesh-list
154345205|NCT00009737|Fluorouracil|fluorouracil|mesh-list
154345206|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154345207|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
154345208|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345209|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345248|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154345249|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345262|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345264|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154345265|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
154345266|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345267|NCT03960671|Midazolam|midazolam|mesh-list
154345268|NCT03960671|Diazepam|diazepam|mesh-list
154345269|NCT03960671|Propofol|propofol|mesh-list
154345270|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154345271|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345272|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345273|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154345274|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
154345275|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
154345276|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154345277|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154345278|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154345279|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154345280|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
154345281|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
154345282|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345283|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345284|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
154345285|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
154345286|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
154345287|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345288|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345289|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154345290|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154345291|NCT01281553|Cisapride|cisapride|mesh-list
154345292|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154345293|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345294|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154345295|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
154345296|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345297|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345298|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345299|NCT01164787|Trandolapril|trandolapril|mesh-list
154345300|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154345301|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
154345302|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345303|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345304|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154345305|NCT01269151|Ranibizumab|ranibizumab|mesh-list
154345306|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154345307|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154345308|NCT01269151|Growth Substances|growth substances|mesh-ancestor
154345309|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345310|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
154345311|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345312|NCT00028769|Paclitaxel|paclitaxel|mesh-list
154345313|NCT00028769|Etoposide|etoposide|mesh-list
154345314|NCT00028769|Leuprolide|leuprolide|mesh-list
154345315|NCT00028769|Goserelin|goserelin|mesh-list
154345326|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154345327|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154345329|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154345330|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
154345331|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154196649|NCT00551135|Pregabalin|pregabalin|mesh-list
154345332|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345333|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154345334|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
154345335|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
154345336|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345337|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154345338|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
154345339|NCT01281787|Losartan|losartan|mesh-list
154345340|NCT01281787|Metoprolol|metoprolol|mesh-list
154345341|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154345342|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154345343|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154345344|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154345345|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345346|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
154345347|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
154345348|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345349|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345350|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154345351|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154345352|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154345353|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
154345354|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345355|NCT02953314|Ivacaftor|ivacaftor|mesh-list
154345356|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154345357|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154345358|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345359|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
154345360|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091678|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
154345362|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345363|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345364|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154345365|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
154345366|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345367|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345368|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154345369|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
154345370|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154345371|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154345372|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345373|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
154345374|NCT03714360|Coagulants|coagulants|mesh-ancestor
154345375|NCT01169857|Bortezomib|bortezomib|mesh-list
154345376|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
154345377|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345378|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
154345379|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345393|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154345394|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154345395|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345396|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345397|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154345398|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154345399|NCT01166035|Lenalidomide|lenalidomide|mesh-list
154345400|NCT01166035|Cetuximab|cetuximab|mesh-list
154345401|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
154345402|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345403|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154345404|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154345405|NCT01166035|Growth Substances|growth substances|mesh-ancestor
154345406|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
154345407|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345408|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154345409|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154345410|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154345411|NCT03869281|Pancrelipase|pancrelipase|mesh-list
154345412|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345413|NCT01281943|Sirolimus|sirolimus|mesh-list
154345414|NCT01281943|Doxorubicin|doxorubicin|mesh-list
154345415|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154345416|NCT01281943|Temsirolimus|temsirolimus|mesh-list
154345417|NCT01281943|MTOR Inhibitors|mtor inhibitors|mesh-list
154345418|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154345419|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345420|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154345421|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154345422|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345423|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345424|NCT01281943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154345425|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154345426|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
154345427|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345428|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154345429|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345430|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
154345431|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
154345432|NCT03869047|Bupivacaine|bupivacaine|mesh-list
154345433|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
154345434|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
154345435|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345436|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345437|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
154345438|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345439|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154345440|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154345441|NCT03869047|Analgesics|analgesics|mesh-ancestor
154345442|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153524577|NCT01464476|Azimilide|azimilide|mesh-list
154345457|NCT01168531|Hormones|hormones|mesh-ancestor
154345458|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345459|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154345460|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345461|NCT01168531|Analgesics|analgesics|mesh-ancestor
154345462|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
154345463|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
154345464|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154345465|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154345466|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345467|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154345468|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154345469|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154345470|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345471|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154345472|NCT01170169|Omeprazole|omeprazole|mesh-list
154345473|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154345474|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345475|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154345476|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345477|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345478|NCT01587313|Hydralazine|hydralazine|mesh-list
154345479|NCT01587313|Isosorbide|isosorbide|mesh-list
154345480|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154345481|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154345482|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154345483|NCT01587313|Diuretics|diuretics|mesh-ancestor
154345484|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
154345485|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345486|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
154345487|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154345488|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345489|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154345490|NCT01282333|Gemcitabine|gemcitabine|mesh-list
154345491|NCT01282333|Veliparib|veliparib|mesh-list
154345492|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345493|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154345494|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
154345495|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345496|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154345497|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345498|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
154345499|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
154345500|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154345501|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345502|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345503|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
154345540|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
154345541|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345542|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345557|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345558|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
154345559|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154345560|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345561|NCT03873025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154345562|NCT03873025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345563|NCT02526745|Vaccines|vaccines|mesh-list
154345564|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
154345565|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345566|NCT01169389|Bupivacaine|bupivacaine|mesh-list
154345567|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
154345568|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
154345569|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345570|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345571|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
154345572|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345573|NCT01170871|Pemetrexed|pemetrexed|mesh-list
154345574|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345575|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345576|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345577|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154345578|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154345579|NCT03868111|Sufentanil|sufentanil|mesh-list
154345580|NCT03868111|Remifentanil|remifentanil|mesh-list
154345581|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154345582|NCT03868111|Narcotics|narcotics|mesh-ancestor
154345583|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345584|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345585|NCT03868111|Analgesics|analgesics|mesh-ancestor
154345586|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
154345587|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345588|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154345589|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154345590|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
154345591|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
154345592|NCT01282879|Itraconazole|itraconazole|mesh-list
154345593|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
154345594|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345595|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154345596|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154345597|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345598|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345599|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154345600|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
154345601|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345621|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345623|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
154345624|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154345625|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345626|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345627|NCT00025259|Cytarabine|cytarabine|mesh-list
154345628|NCT00025259|Dexamethasone|dexamethasone|mesh-list
154345629|NCT00025259|Prednisone|prednisone|mesh-list
154345630|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
154345631|NCT00025259|Cortisone|cortisone|mesh-list
154345632|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
154345633|NCT00025259|Cisplatin|cisplatin|mesh-list
154345634|NCT00025259|Doxorubicin|doxorubicin|mesh-list
154345635|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154345636|NCT00025259|Etoposide|etoposide|mesh-list
154345637|NCT00025259|Vincristine|vincristine|mesh-list
154345638|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
154345639|NCT00025259|Bleomycin|bleomycin|mesh-list
154345640|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
154345641|NCT00025259|Lenograstim|lenograstim|mesh-list
154345642|NCT00025259|BB 1101|bb 1101|mesh-list
154345643|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154345644|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
154345645|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345646|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345647|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154345648|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
154345649|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345650|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345651|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154345652|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345653|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
154345654|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
154345655|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345656|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345657|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
154345658|NCT00025259|Hormones|hormones|mesh-ancestor
154345659|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345660|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154345670|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154345671|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
154345672|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
154345673|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
154345674|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
154345675|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
154345676|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
154345678|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345679|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154345680|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345681|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345682|NCT03866629|Lifitegrast|lifitegrast|mesh-list
154345683|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154345684|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154345685|NCT01280071|Aminophylline|aminophylline|mesh-list
154345686|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154345687|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
154345688|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345689|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345690|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154345691|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
154345692|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154345693|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154345694|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345695|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196901|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
154345696|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154345697|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154345698|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
154345699|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345700|NCT01280071|Protective Agents|protective agents|mesh-ancestor
154345701|NCT02526199|Dexamethasone|dexamethasone|mesh-list
154345702|NCT02526199|Epinephrine|epinephrine|mesh-list
154345703|NCT02526199|Bupivacaine|bupivacaine|mesh-list
154345704|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345705|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
154345706|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
154345707|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345708|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345709|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345710|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
154345711|NCT02526199|Hormones|hormones|mesh-ancestor
154345712|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345713|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154345714|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345715|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
154345716|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
154345717|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345718|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
153965150|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
154345719|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154345720|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154345721|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
154345722|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345723|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345724|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154345747|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345748|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154345750|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
154345751|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345752|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345753|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
154345754|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
154345755|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345756|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
154345757|NCT01171807|Dexamethasone|dexamethasone|mesh-list
154345758|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154345759|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345760|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
154345761|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
154345762|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345763|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345764|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345765|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
154345767|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345768|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154345769|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345770|NCT05445648|Tislelizumab|tislelizumab|mesh-list
154345771|NCT05445648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154345772|NCT05445648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345773|NCT01171885|Ropivacaine|ropivacaine|mesh-list
154345774|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
154345775|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
153524915|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345787|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154345788|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154345789|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345790|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
154345791|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154345792|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
154345793|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345794|NCT00024167|Ketoconazole|ketoconazole|mesh-list
154345795|NCT00024167|Dexamethasone|dexamethasone|mesh-list
154345796|NCT00024167|Prednisone|prednisone|mesh-list
154345797|NCT00024167|Estramustine|estramustine|mesh-list
154345798|NCT00024167|Docetaxel|docetaxel|mesh-list
154345799|NCT00024167|Doxorubicin|doxorubicin|mesh-list
154196969|NCT01566474|Melatonin|melatonin|mesh-list
154345800|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154345801|NCT00024167|Vinblastine|vinblastine|mesh-list
154345802|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345803|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
154345804|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
154345805|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345806|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345807|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345808|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
154345809|NCT00024167|Hormones|hormones|mesh-ancestor
154345810|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345811|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154345812|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345813|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
154345814|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
154345815|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
154345816|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345817|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154345818|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154345819|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154345820|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345821|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
154345822|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345823|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154345824|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154345825|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154345827|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154345828|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154345829|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154345830|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
154345831|NCT03867097|Iloprost|iloprost|mesh-list
154345832|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154345833|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
154345834|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
154345835|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154345836|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154345837|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345838|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154345839|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154345840|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
154345850|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
154345851|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154345852|NCT01285141|Protective Agents|protective agents|mesh-ancestor
154345854|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154345855|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
154345856|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345857|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
154345858|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154345859|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
154345860|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345861|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
154345862|NCT01284439|Protective Agents|protective agents|mesh-ancestor
154345863|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154345864|NCT01172431|Indapamide|indapamide|mesh-list
154345865|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154345866|NCT01172431|Diuretics|diuretics|mesh-ancestor
154345867|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
154345868|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345869|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154345870|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154345871|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345872|NCT01172509|Baclofen|baclofen|mesh-list
154345873|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154345874|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345875|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154345876|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345877|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154345878|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
154345879|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
154345880|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345881|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345882|NCT01089959|Esomeprazole|esomeprazole|mesh-list
154345883|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154345884|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345885|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154345886|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345887|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345888|NCT01090037|Epoprostenol|epoprostenol|mesh-list
154345889|NCT01090037|Beraprost|beraprost|mesh-list
154345890|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154345891|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
154345892|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154345893|NCT01285375|Curcumin|curcumin|mesh-list
154345894|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154345895|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154345896|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154345897|NCT01285375|Analgesics|analgesics|mesh-ancestor
154345898|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
154345899|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345900|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345901|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345902|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345903|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345904|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345905|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345906|NCT05625893|Bevacizumab|bevacizumab|mesh-list
154345925|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154345926|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345928|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
154345929|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154345930|NCT01288261|Paclitaxel|paclitaxel|mesh-list
154345931|NCT01288261|Bavituximab|bavituximab|mesh-list
154345932|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154345933|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345934|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
154345935|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
154345936|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
154345937|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345938|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154345939|NCT01174303|Insulin|insulin|mesh-list
154345940|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154345941|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
154345942|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
154345943|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154345944|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
154345945|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154345946|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154345947|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345948|NCT01285453|Vadimezan|vadimezan|mesh-list
154345949|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345950|NCT01288339|Leucovorin|leucovorin|mesh-list
154345951|NCT01288339|Fluorouracil|fluorouracil|mesh-list
154345952|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
154345953|NCT01288339|Panitumumab|panitumumab|mesh-list
154345954|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
154345955|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345956|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154345957|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345958|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154345959|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
154345960|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345981|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345982|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154345983|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
154345985|NCT01178203|Tramadol|tramadol|mesh-list
154345986|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154345987|NCT01178203|Narcotics|narcotics|mesh-ancestor
154345988|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345989|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345990|NCT01178203|Analgesics|analgesics|mesh-ancestor
154345991|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
154345992|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345993|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154345994|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154345995|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345996|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345997|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
154345998|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154345999|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346000|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346001|NCT01286701|Terbinafine|terbinafine|mesh-list
154346002|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
154346003|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346004|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346005|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346006|NCT00006305|Biguanides|biguanides|mesh-list
154346007|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154346008|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
154346009|NCT00006305|Calcium|calcium|mesh-list
154346010|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154346011|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154346012|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154346013|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154346014|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346015|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154346040|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154346041|NCT01101269|Protective Agents|protective agents|mesh-ancestor
154346042|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346043|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154346044|NCT01103375|Isotretinoin|isotretinoin|mesh-list
154346045|NCT01103375|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154346046|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154346047|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346048|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346049|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346050|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
154346051|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154346052|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
154346053|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
154346054|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154346055|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154346056|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
154346057|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346058|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154346059|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154346060|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346061|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346062|NCT01285765|Rituximab|rituximab|mesh-list
154346063|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154346064|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346065|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
153525203|NCT06074367|Antioxidants|antioxidants|mesh-ancestor
154346094|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154346096|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154346097|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346098|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154346099|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346100|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
154346101|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154346102|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154346103|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
154346104|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346105|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154346106|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154346107|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
154346108|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154346109|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
154346110|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
154346111|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
154346112|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154346127|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346128|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346129|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346130|NCT03349710|Nivolumab|nivolumab|mesh-list
154346131|NCT03349710|Cetuximab|cetuximab|mesh-list
154346132|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346133|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154346134|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154346135|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346136|NCT01288495|Psyllium|psyllium|mesh-list
154346137|NCT01288495|Cathartics|cathartics|mesh-ancestor
154346138|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154346139|NCT01105793|Danazol|danazol|mesh-list
154346140|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154346141|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
154346142|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154346143|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346144|NCT04934579|Rituximab|rituximab|mesh-list
154346145|NCT04934579|Methotrexate|methotrexate|mesh-list
154346146|NCT04934579|Lenalidomide|lenalidomide|mesh-list
154346147|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154346148|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346149|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
154346150|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346151|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346152|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154346153|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
154346154|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154346155|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154346156|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
154346157|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346158|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
154346159|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346160|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154346161|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346162|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154346163|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154346164|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154346165|NCT04934579|Growth Substances|growth substances|mesh-ancestor
154346166|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
154346167|NCT03134131|TIC10 compound|tic10 compound|mesh-list
154346168|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346169|NCT01103609|Warfarin|warfarin|mesh-list
154346170|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
154346171|NCT01288573|Plerixafor|plerixafor|mesh-list
154346172|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154346183|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346184|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346185|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346186|NCT00006011|Paclitaxel|paclitaxel|mesh-list
154346187|NCT00006011|Doxorubicin|doxorubicin|mesh-list
154346188|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154346189|NCT00006011|Lenograstim|lenograstim|mesh-list
154346190|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154346191|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346192|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
154346193|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
154346194|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
154346195|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346196|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154346197|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154346198|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154346199|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346200|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154346201|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
154346202|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346204|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154346205|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346206|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
154346207|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346208|NCT03377556|Talazoparib|talazoparib|mesh-list
154346209|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154346210|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346211|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346212|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346213|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
154346214|NCT05625581|Tofacitinib|tofacitinib|mesh-list
154346215|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346216|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
154346217|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346218|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346219|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154346220|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
154346221|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346222|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346223|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154346224|NCT05625581|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154346225|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154346226|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346227|NCT01176175|Progesterone|progesterone|mesh-list
154346228|NCT01176175|Progestins|progestins|mesh-ancestor
154346229|NCT01176175|Hormones|hormones|mesh-ancestor
154346230|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154346231|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346232|NCT05624099|Paclitaxel|paclitaxel|mesh-list
154346233|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154346234|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346235|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
154346236|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
154346237|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
154346266|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
154346267|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346268|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
154346269|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154346270|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346271|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154346272|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154346273|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346274|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346275|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346276|NCT03948737|Tocopherols|tocopherols|mesh-list
154346277|NCT03948737|Vitamin E|vitamin e|mesh-list
154346278|NCT03948737|Tocotrienols|tocotrienols|mesh-list
154346279|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
154346280|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
154346281|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346282|NCT03948737|Protective Agents|protective agents|mesh-ancestor
154346283|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346284|NCT03948737|Vitamins|vitamins|mesh-ancestor
154346285|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
154346286|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
154346306|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346307|NCT03480009|Oxycodone|oxycodone|mesh-list
154346308|NCT03480009|Levomethorphan|levomethorphan|mesh-list
154346309|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
154346310|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154346311|NCT03480009|Narcotics|narcotics|mesh-ancestor
154346312|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346313|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346314|NCT03480009|Analgesics|analgesics|mesh-ancestor
154346315|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
154346316|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346317|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
154346318|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
154346319|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154346320|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154346321|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346322|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346323|NCT03859375|Disinfectants|disinfectants|mesh-list
154346324|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346325|NCT01310751|Iloprost|iloprost|mesh-list
154346326|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154346327|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
154346328|NCT01180933|Folic Acid|folic acid|mesh-list
154346329|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
154346330|NCT01180933|Hematinics|hematinics|mesh-ancestor
154346331|NCT01180933|Vitamins|vitamins|mesh-ancestor
154346332|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
154346333|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346334|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
154346335|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154346336|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154346337|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346338|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
154346339|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
154346340|NCT03859141|Vaccines|vaccines|mesh-list
154346341|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
154346342|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346374|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346375|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
154346376|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
154346377|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
154346378|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346379|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346380|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
154346381|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346382|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
154346383|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154346384|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346385|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154346398|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346399|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346400|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
154346401|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346402|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154346403|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154346404|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154346405|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154346406|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346408|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154346409|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346410|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154346411|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346412|NCT03478683|Budesonide|budesonide|mesh-list
154346413|NCT03478683|Albuterol|albuterol|mesh-list
154346414|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
154346415|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
154346416|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154346417|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154346418|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154346420|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346421|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346422|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154346423|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
154346424|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
154346425|NCT03478683|Hormones|hormones|mesh-ancestor
154346426|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154346427|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154346428|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154346429|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154346430|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
154346431|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346432|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346433|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
154346434|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154346435|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
154346436|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
154346437|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154346438|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
154346439|NCT01176799|Doxorubicin|doxorubicin|mesh-list
154346440|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154346441|NCT01176799|Sunitinib|sunitinib|mesh-list
154346442|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346443|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
154346444|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346445|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346446|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154346447|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
154346474|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
154346475|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154346476|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
154346477|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
154346478|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346480|NCT01181401|Docetaxel|docetaxel|mesh-list
154346481|NCT01181401|Cetuximab|cetuximab|mesh-list
154346482|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346483|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
154346484|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
154346485|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
154346486|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346487|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154346488|NCT01287715|Etanercept|etanercept|mesh-list
154346489|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154346490|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154346491|NCT01287715|Analgesics|analgesics|mesh-ancestor
154346492|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
154346493|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346494|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346495|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154346560|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154346561|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
154346562|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346563|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154346564|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154346565|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154346566|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154346567|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154346568|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154346569|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154346570|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154346571|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154346573|NCT01311882|Suvorexant|suvorexant|mesh-list
154346574|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154346575|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346576|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346577|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154346578|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154346604|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
154346605|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346606|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346607|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346608|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
154346609|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
154346610|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346611|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154346612|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154346614|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154346615|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154346616|NCT01289743|Analgesics|analgesics|mesh-ancestor
154346617|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
154346618|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346619|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346620|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154346621|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346622|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154346623|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346624|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
154346625|NCT03390426|Anesthetics|anesthetics|mesh-list
154346626|NCT03390426|Mepivacaine|mepivacaine|mesh-list
154346627|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
154346628|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154197465|NCT01062802|Atorvastatin|atorvastatin|mesh-list
154346639|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154346640|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346641|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154346642|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154346643|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154346644|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346645|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346646|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
154346647|NCT02906020|Venglustat|venglustat|mesh-list
154346648|NCT02906020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346649|NCT02906020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346650|NCT01177423|Anesthetics|anesthetics|mesh-list
154346651|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346652|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346653|NCT01180231|Moxonidine|moxonidine|mesh-list
154346654|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154346655|NCT01177501|Topotecan|topotecan|mesh-list
154346656|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154346657|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154346658|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346659|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346660|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346661|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
154346662|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
154346663|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
154346664|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154346665|NCT03478150|Protective Agents|protective agents|mesh-ancestor
154346666|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346667|NCT03499353|Talazoparib|talazoparib|mesh-list
154346668|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154346669|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346670|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346671|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346672|NCT00004259|Carmustine|carmustine|mesh-list
154346673|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154346674|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
154346675|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346676|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346678|NCT01177579|Trace Elements|trace elements|mesh-ancestor
154346679|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
154346680|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346681|NCT03722355|Carmustine|carmustine|mesh-list
154346682|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154346683|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
154346684|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346685|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346686|NCT03857815|Antibodies|antibodies|mesh-list
154346687|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
154346688|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346689|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154346690|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346691|NCT03477994|Clonidine|clonidine|mesh-list
154346692|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
154346693|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154346699|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346700|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154346701|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154346702|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154346703|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
154346704|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346705|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346706|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154346707|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
154346708|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
154197534|NCT00548717|Sirolimus|sirolimus|mesh-list
154346709|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154346710|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
154346711|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
154346712|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154346713|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154346714|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
154346715|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346716|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
154346717|NCT04668131|Protective Agents|protective agents|mesh-ancestor
154346719|NCT03857581|Clozapine|clozapine|mesh-list
154346720|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
154346721|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
154346722|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346723|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346724|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154346725|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154346726|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154346727|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346728|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154346729|NCT03857581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154346730|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154346731|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154346732|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346733|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346734|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
154346735|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154346736|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
154346737|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
154346738|NCT01103843|Clopidogrel|clopidogrel|mesh-list
154346739|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154346740|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154346741|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154346742|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154346743|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154346744|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
154346745|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346746|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346747|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346749|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154346750|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154346751|NCT03738865|Hormones|hormones|mesh-ancestor
154346752|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154346753|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346754|NCT03738865|Incretins|incretins|mesh-ancestor
154346755|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154346756|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154346757|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
154346758|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154346759|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
154346760|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346761|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
154346762|NCT03524157|Protective Agents|protective agents|mesh-ancestor
154346763|NCT03719391|Nicotine|nicotine|mesh-list
154346768|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154346769|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154346770|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
154346771|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346772|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346773|NCT03468543|Memantine|memantine|mesh-list
154346774|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154346775|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154346776|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
154346777|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346778|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346779|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346780|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154346781|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154346782|NCT03467763|Metformin|metformin|mesh-list
154346783|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154346784|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346785|NCT00004031|Prednisone|prednisone|mesh-list
154346786|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
154346787|NCT00004031|Carmustine|carmustine|mesh-list
154346788|NCT00004031|Rituximab|rituximab|mesh-list
154346789|NCT00004031|Doxorubicin|doxorubicin|mesh-list
154346790|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154346791|NCT00004031|Etoposide|etoposide|mesh-list
154346792|NCT00004031|Vincristine|vincristine|mesh-list
154346793|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346794|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
154346795|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346796|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346797|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154346798|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
154346799|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346800|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346801|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154346802|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154346803|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154346804|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154346805|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154346806|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346807|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154346808|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
154346809|NCT00004031|Hormones|hormones|mesh-ancestor
154346810|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154346811|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154346812|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154346813|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
154346814|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
154346815|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
154346816|NCT01184443|Olanzapine|olanzapine|mesh-list
154346817|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
154346818|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
154346819|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346820|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346821|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154346822|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154346823|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154346824|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346825|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154346826|NCT01184443|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154346827|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154346828|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154346829|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346830|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346831|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
154346832|NCT01180621|Vaccines|vaccines|mesh-list
154346833|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
154346858|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154346859|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154346860|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197650|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
154346861|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346862|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
154346863|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346864|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
154346865|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346866|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154346867|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154346868|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154346869|NCT00003875|Analgesics|analgesics|mesh-ancestor
154346870|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
154346871|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346872|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154346873|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154346874|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
154346875|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346876|NCT01327625|Azithromycin|azithromycin|mesh-list
154346877|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154346878|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346880|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
154346881|NCT01290211|Maraviroc|maraviroc|mesh-list
154346882|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154346883|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154346900|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346901|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346902|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346903|NCT01311960|Bevacizumab|bevacizumab|mesh-list
154346904|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154346905|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154346906|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346907|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154346908|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154346909|NCT01311960|Growth Substances|growth substances|mesh-ancestor
154346910|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346911|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
154346912|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154346913|NCT03709056|Propofol|propofol|mesh-list
154346914|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154346915|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346916|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346917|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154346918|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
154346919|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
154346920|NCT05663307|Aspirin|aspirin|mesh-list
154346921|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154346922|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154346923|NCT05663307|Analgesics|analgesics|mesh-ancestor
154346924|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
154346925|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346926|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346927|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154346928|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346929|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154346930|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154346931|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346932|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154346933|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154346934|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346935|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
154346936|NCT01106495|Simvastatin|simvastatin|mesh-list
154346937|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154346938|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154346939|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
154346940|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346947|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346949|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346950|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
154346951|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346952|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154346953|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
154346954|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
154346955|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154346956|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
154346957|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154346958|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154346959|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346960|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154346961|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346962|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346963|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154346964|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
154346965|NCT01185067|Resveratrol|resveratrol|mesh-list
154346966|NCT01185067|Antioxidants|antioxidants|mesh-list
154346967|NCT01185067|Quercetin|quercetin|mesh-list
154346968|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346969|NCT01185067|Protective Agents|protective agents|mesh-ancestor
154346970|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965971|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154346971|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346972|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154346973|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154346974|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346976|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
154346977|NCT03364686|Vitamins|vitamins|mesh-ancestor
154346978|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
154346979|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346980|NCT03437577|Tacrolimus|tacrolimus|mesh-list
154346981|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346982|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
154346983|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346984|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154346985|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346986|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346987|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
154346988|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
154346989|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154346990|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346991|NCT03364608|Albuterol|albuterol|mesh-list
154346992|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154346993|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
154346994|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346995|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346996|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154346997|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
154346998|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
154346999|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154347000|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154347001|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154347002|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154347003|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
154347004|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347005|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347006|NCT03719157|Anesthetics|anesthetics|mesh-list
154347007|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
154347008|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347009|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347010|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
154347011|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347026|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
154347027|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347028|NCT01188031|Alprazolam|alprazolam|mesh-list
154347029|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154347030|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347031|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347032|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154347033|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154347034|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154347035|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
154347036|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
154347037|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347038|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347039|NCT01182883|Sirolimus|sirolimus|mesh-list
154347040|NCT01182883|Temsirolimus|temsirolimus|mesh-list
154347041|NCT01182883|MTOR Inhibitors|mtor inhibitors|mesh-list
154347042|NCT01182883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154347043|NCT01182883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347044|NCT01182883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347045|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154347046|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
154347047|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347048|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347049|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154347050|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347051|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154347052|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
154347053|NCT01188265|Levomethorphan|levomethorphan|mesh-list
154347054|NCT01188265|Valproic Acid|valproic acid|mesh-list
154347055|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
154347056|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
154347057|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861822|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347058|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347059|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
154347060|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347061|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347062|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
154347063|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154347064|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347065|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154347066|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
154347067|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
154347068|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154347069|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154347070|NCT01188265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154347071|NCT01188265|Narcotics|narcotics|mesh-ancestor
154347072|NCT01188265|Analgesics|analgesics|mesh-ancestor
154347073|NCT01188265|Sensory System Agents|sensory system agents|mesh-ancestor
154347094|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154347095|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197832|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
154347096|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154347097|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347099|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154347100|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
154347101|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347102|NCT01185535|Anesthetics|anesthetics|mesh-list
154347103|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347104|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347105|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
154347106|NCT00003659|Rituximab|rituximab|mesh-list
154347107|NCT00003659|Fludarabine|fludarabine|mesh-list
154347108|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
154347109|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154347110|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
154347111|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347112|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154347113|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154347114|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
154347115|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347116|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347117|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154347118|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347119|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154347120|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
154347121|NCT01101581|Epratuzumab|epratuzumab|mesh-list
154347122|NCT01101581|Veltuzumab|veltuzumab|mesh-list
154347123|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153526254|NCT04332341|Vitamins|vitamins|mesh-ancestor
154347149|NCT01185847|Pemetrexed|pemetrexed|mesh-list
154347150|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347151|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154347152|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
154347153|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347154|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347155|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154347156|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154347157|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
154347158|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154347159|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
154347160|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347161|NCT03720483|Expectorants|expectorants|mesh-ancestor
154347162|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
154347163|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154347164|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
154347165|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347166|NCT03720483|Protective Agents|protective agents|mesh-ancestor
154347167|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347168|NCT03720483|Antidotes|antidotes|mesh-ancestor
154347169|NCT01183663|Leucovorin|leucovorin|mesh-list
154347170|NCT01183663|Sirolimus|sirolimus|mesh-list
154347171|NCT01183663|Bevacizumab|bevacizumab|mesh-list
154347172|NCT01183663|Lenalidomide|lenalidomide|mesh-list
154347173|NCT01183663|Fluorouracil|fluorouracil|mesh-list
154347174|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
154347175|NCT01183663|Sorafenib|sorafenib|mesh-list
154347190|NCT01183663|Antidotes|antidotes|mesh-ancestor
154347191|NCT01183663|Protective Agents|protective agents|mesh-ancestor
154347192|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
154347193|NCT01183663|Vitamins|vitamins|mesh-ancestor
154347194|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
154347195|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154347196|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347197|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154347198|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347199|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154347200|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
154347201|NCT01291927|Pancrelipase|pancrelipase|mesh-list
154347202|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347203|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
154347204|NCT03344172|Paclitaxel|paclitaxel|mesh-list
154347205|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154347206|NCT03344172|Gemcitabine|gemcitabine|mesh-list
154347207|NCT03344172|Avelumab|avelumab|mesh-list
154347208|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154347209|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347210|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
154347211|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
154347212|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
154347213|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347214|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154347215|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
154347216|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
154347217|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154347218|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154347219|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347220|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347221|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154347222|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347223|NCT01188733|Octreotide|octreotide|mesh-list
154347224|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347225|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154347226|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347227|NCT01101659|Ketamine|ketamine|mesh-list
154347228|NCT01101659|Analgesics|analgesics|mesh-ancestor
154347229|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
154347230|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347231|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347232|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154347233|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154347234|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
154347235|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
154347236|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347237|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154347247|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347248|NCT03855865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154347249|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154347250|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154347251|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347252|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347253|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
154347254|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154347255|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154347256|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154347257|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154347258|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
154347259|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154347260|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
154347261|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347262|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
154347263|NCT01290367|Protective Agents|protective agents|mesh-ancestor
154347264|NCT03465891|Atezolizumab|atezolizumab|mesh-list
154347265|NCT03465891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154347266|NCT03465891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347267|NCT03465891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347268|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347269|NCT03363906|Dulaglutide|dulaglutide|mesh-list
154347270|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154347271|NCT03363906|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154347272|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154347273|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347274|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
154347275|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
154347276|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
154347277|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154347278|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154347279|NCT03948191|Prednisolone|prednisolone|mesh-list
154347280|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
154347281|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154347282|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
154347283|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
154347284|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154347285|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
154347286|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
154347287|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347288|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347289|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347290|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
154347291|NCT03948191|Hormones|hormones|mesh-ancestor
154347292|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347293|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154347294|NCT03948191|Protective Agents|protective agents|mesh-ancestor
154347295|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154347296|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347297|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154347298|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154347299|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347300|NCT01292083|Azacitidine|azacitidine|mesh-list
154347318|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154347319|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347320|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347321|NCT01185925|Urological Agents|urological agents|mesh-ancestor
154347322|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
154347323|NCT01188889|Everolimus|everolimus|mesh-list
154347324|NCT01188889|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154347325|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154347326|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347327|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347328|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347329|NCT01188889|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154347330|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154347331|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
154347332|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347333|NCT01184287|Ranpirnase|ranpirnase|mesh-list
154347334|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347335|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154347336|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347337|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347338|NCT01107431|Chromium|chromium|mesh-list
154347339|NCT01107431|Trace Elements|trace elements|mesh-ancestor
154347340|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
154347341|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347342|NCT01186159|Parecoxib|parecoxib|mesh-list
154347343|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154347344|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154347345|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347346|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347347|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154347348|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154347349|NCT01186159|Analgesics|analgesics|mesh-ancestor
154347350|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
154347351|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347352|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347353|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154347354|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154347355|NCT01107509|Everolimus|everolimus|mesh-list
154347361|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
154347362|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347363|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347364|NCT01101815|Naltrexone|naltrexone|mesh-list
154347365|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154347366|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154347367|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347368|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
154347369|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347370|NCT01104935|Trastuzumab|trastuzumab|mesh-list
154347371|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347372|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347373|NCT01293643|Clindamycin|clindamycin|mesh-list
154347375|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
154347376|NCT01293643|Amphotericin B|amphotericin b|mesh-list
154347377|NCT01293643|Tetracycline|tetracycline|mesh-list
154347378|NCT01293643|Ketoconazole|ketoconazole|mesh-list
154347379|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154347380|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154347381|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347382|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154347383|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347384|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347385|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
154347386|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154347387|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154347388|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154347389|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
154347390|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347391|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347392|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154347393|NCT01293643|Amebicides|amebicides|mesh-ancestor
154347394|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154347395|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154347396|NCT01105013|Clotrimazole|clotrimazole|mesh-list
154347397|NCT01105013|Miconazole|miconazole|mesh-list
154347398|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154347399|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347400|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
154347401|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154347402|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154347403|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347404|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347405|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154347406|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
154347407|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347408|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347409|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154347410|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154347411|NCT03851731|Naltrexone|naltrexone|mesh-list
154347412|NCT03851731|Naloxone|naloxone|mesh-list
154347413|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154347414|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154347415|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347416|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
154347417|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347418|NCT03707652|Vitamins|vitamins|mesh-list
154347419|NCT03707652|Niacinamide|niacinamide|mesh-list
154347421|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
154347422|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
154347423|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
154347424|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526548|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
154347431|NCT01588093|Growth Substances|growth substances|mesh-ancestor
154347432|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347433|NCT01186471|Nicotine|nicotine|mesh-list
154347434|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154347435|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
154347436|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347437|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347438|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154347439|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154347440|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
154347441|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347442|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347443|NCT01292551|Bosentan|bosentan|mesh-list
154347444|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154347445|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154347446|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347447|NCT03854383|Isosorbide|isosorbide|mesh-list
154347448|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154347449|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154347450|NCT03854383|Misoprostol|misoprostol|mesh-list
154347451|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154347452|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
154347453|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154347454|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347455|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154347456|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347457|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
154347458|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154347459|NCT03854383|Diuretics|diuretics|mesh-ancestor
154347460|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
154347461|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
154347462|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154347463|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347464|NCT03854617|Vinorelbine|vinorelbine|mesh-list
154347465|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154347466|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347467|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
154347468|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
154347469|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
154347470|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347471|NCT01186549|Lidocaine|lidocaine|mesh-list
154347472|NCT01186549|Ephedrine|ephedrine|mesh-list
154347473|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
154347474|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
154347475|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
154347476|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347477|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347478|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
154347479|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347480|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154347481|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154347482|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154347483|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154347484|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347485|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154347486|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
154347487|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
154347488|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154347489|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
154347490|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347491|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154347492|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154347493|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
154347513|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154347514|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347515|NCT01291459|Tenofovir|tenofovir|mesh-list
154347516|NCT01291459|Emtricitabine|emtricitabine|mesh-list
154347517|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
154347518|NCT01291459|Maraviroc|maraviroc|mesh-list
154347519|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
154347520|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347521|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154347522|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154347523|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347524|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347525|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154347526|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154347527|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154347528|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154347529|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154347530|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154347531|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154347532|NCT00003377|Paclitaxel|paclitaxel|mesh-list
154347533|NCT00003377|Cisplatin|cisplatin|mesh-list
154347534|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154347535|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347536|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
154347537|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
154347538|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
154347539|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347540|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154347541|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154347542|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
154347543|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347544|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154347545|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154347546|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
154347547|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
154347548|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347557|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
154347558|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347559|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347560|NCT01328015|Urological Agents|urological agents|mesh-ancestor
154347561|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
154347563|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154347564|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
154347565|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347566|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154347567|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154347568|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582979|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347569|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347570|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154347571|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
154347572|NCT00002651|Goserelin|goserelin|mesh-list
154347573|NCT00002651|Bicalutamide|bicalutamide|mesh-list
154347574|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154347575|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347576|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
154347577|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
154347578|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347579|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347580|NCT03853993|Vaccines|vaccines|mesh-list
154347581|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
154347582|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347583|NCT03473626|Alicaforsen|alicaforsen|mesh-list
154347584|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347585|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154347586|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
154347587|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347588|NCT05154682|Acetaminophen|acetaminophen|mesh-list
154347589|NCT05154682|Naproxen|naproxen|mesh-list
154347590|NCT05154682|Oxycodone|oxycodone|mesh-list
154347591|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154347592|NCT05154682|Analgesics|analgesics|mesh-ancestor
154347593|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
154347594|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347595|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347596|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
154347597|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154347598|NCT05154682|Narcotics|narcotics|mesh-ancestor
154347599|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347600|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154347601|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154347602|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154347603|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
154347604|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154347605|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347606|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347607|NCT01294735|Temozolomide|temozolomide|mesh-list
154347608|NCT01294735|Niraparib|niraparib|mesh-list
154347609|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154347610|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
154347611|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347612|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347613|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154347614|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347615|NCT03851263|Evolocumab|evolocumab|mesh-list
154347625|NCT03849235|Glucagon|glucagon|mesh-list
154347626|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347627|NCT03849235|Hormones|hormones|mesh-ancestor
154347628|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347629|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347630|NCT03477448|Bleomycin|bleomycin|mesh-list
154347631|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154347632|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347633|NCT00002597|Leuprolide|leuprolide|mesh-list
154347634|NCT00002597|Goserelin|goserelin|mesh-list
154347635|NCT00002597|Flutamide|flutamide|mesh-list
154198271|NCT00967421|Ethanol|ethanol|mesh-list
154347636|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154347637|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
154347638|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154347639|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347640|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153966502|NCT04218981|Paroxetine|paroxetine|mesh-list
154347641|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347642|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
154347643|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
154347644|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347645|NCT03853525|Petrolatum|petrolatum|mesh-list
154347646|NCT03853525|Emollients|emollients|mesh-ancestor
154347647|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
154347648|NCT03716583|Melatonin|melatonin|mesh-list
154347649|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154347650|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
154347651|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347652|NCT03716583|Protective Agents|protective agents|mesh-ancestor
154347653|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347654|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347655|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154347656|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154347657|NCT02738008|Tenofovir|tenofovir|mesh-list
154347658|NCT02738008|Entecavir|entecavir|mesh-list
154347659|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
154347660|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154347661|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
154347662|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347663|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154347664|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154347665|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347666|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347667|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154347668|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154347669|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
154347670|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347671|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347672|NCT03720249|Vitamins|vitamins|mesh-list
154347673|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
154347674|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
154347675|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
154347676|NCT03720249|Betaine|betaine|mesh-list
154347677|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
154347678|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347679|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347680|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
154347681|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154347682|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
154347696|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154347697|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
154347699|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347700|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347701|NCT03850561|Ubiquinone|ubiquinone|mesh-list
154347702|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
154347703|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
154347704|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347705|NCT03850561|Vitamins|vitamins|mesh-ancestor
154347706|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
154347707|NCT01190137|Vitamin D|vitamin d|mesh-list
154347708|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
154347709|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154347710|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347711|NCT01190137|Vitamins|vitamins|mesh-ancestor
154347712|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
154347713|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154347714|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
154347715|NCT02529839|Fludarabine|fludarabine|mesh-list
154347716|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
154347717|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154347718|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
154347719|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347720|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154347721|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154347722|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
154347723|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347724|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347725|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154347726|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347727|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
154347728|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154347729|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
154347730|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861823|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154347731|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347732|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154347733|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
154347734|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154347735|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
154347736|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347737|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347738|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154347739|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
154347740|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
154347741|NCT03473314|Protective Agents|protective agents|mesh-ancestor
154347742|NCT03945539|Itraconazole|itraconazole|mesh-list
154347754|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154347756|NCT01190293|Efavirenz|efavirenz|mesh-list
154347757|NCT01190293|Maraviroc|maraviroc|mesh-list
154347758|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154347759|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154347760|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347761|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347762|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
154347763|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347764|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154347765|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154347766|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154347767|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154094092|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
154347768|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154347769|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154347770|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154198373|NCT00311584|Irinotecan|irinotecan|mesh-list
154347771|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154347772|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154347773|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154347774|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154347775|NCT03945227|Spartalizumab|spartalizumab|mesh-list
154347776|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154347777|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347778|NCT03945227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347779|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347780|NCT01108133|Dexamethasone|dexamethasone|mesh-list
154347781|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154347782|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
154347783|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
154347784|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347785|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347786|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347787|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
154347788|NCT01108133|Hormones|hormones|mesh-ancestor
154347789|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347790|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154347791|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347792|NCT01108289|Oxytocin|oxytocin|mesh-list
154347793|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
154347794|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154347795|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347796|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
154347797|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154347798|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154347799|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347800|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154347813|NCT01327469|Albendazole|albendazole|mesh-list
154347814|NCT01327469|Mebendazole|mebendazole|mesh-list
154347816|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
154347817|NCT01327469|Pyrantel|pyrantel|mesh-list
154347818|NCT01327469|Oxantel|oxantel|mesh-list
154347819|NCT01327469|DMP 777|dmp 777|mesh-list
154347820|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
154347821|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154347822|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347823|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
154347824|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154347825|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154347826|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
154347827|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
154347828|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
154347829|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347830|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347831|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
154347832|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347833|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154347834|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154347835|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154347836|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347837|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347838|NCT03950141|Apatinib|apatinib|mesh-list
154347839|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347840|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154347841|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347842|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347843|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
154347844|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154347845|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347846|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154347847|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154347848|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347849|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347850|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347851|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154347852|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154347854|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154347855|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
154347856|NCT03084718|Hormones|hormones|mesh-ancestor
154347857|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347858|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347859|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154347860|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
154347861|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
154347862|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347863|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347864|NCT02938624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154347877|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347879|NCT01102439|Clopidogrel|clopidogrel|mesh-list
154347880|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154347881|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154347882|NCT01102439|Analgesics|analgesics|mesh-ancestor
154347883|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
154347884|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347885|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347886|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154347887|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154347888|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154347889|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154347890|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347891|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154347892|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154347893|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347894|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
154347895|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154347896|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154347897|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154347898|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
154347899|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347900|NCT03949985|Hemostatics|hemostatics|mesh-list
154347901|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
154347902|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154347903|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347904|NCT03949985|Coagulants|coagulants|mesh-ancestor
154347905|NCT01584791|Aspirin|aspirin|mesh-list
154347906|NCT01584791|Clopidogrel|clopidogrel|mesh-list
154198488|NCT00974441|Valproic Acid|valproic acid|mesh-list
154347907|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154347908|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154347909|NCT01584791|Analgesics|analgesics|mesh-ancestor
154347910|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
154347911|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347912|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347913|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154347914|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154347915|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154255429|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154094247|NCT02545972|Tacrolimus|tacrolimus|mesh-list
154347916|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154347917|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347918|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154347919|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154347920|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347921|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
154347922|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154347923|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154347932|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154347933|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154347934|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
154347935|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
154347936|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347937|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154347938|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154347939|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347940|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347941|NCT01310985|Capecitabine|capecitabine|mesh-list
154347942|NCT01310985|Cetuximab|cetuximab|mesh-list
154347943|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154347944|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
154347945|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347946|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347947|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347948|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
154347949|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154347950|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347951|NCT02492711|Trastuzumab|trastuzumab|mesh-list
154347952|NCT02492711|Margetuximab|margetuximab|mesh-list
154347953|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347954|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347955|NCT03716427|Tolbutamide|tolbutamide|mesh-list
154347956|NCT03716427|Midazolam|midazolam|mesh-list
154347957|NCT03716427|Levomethorphan|levomethorphan|mesh-list
154347958|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
154347959|NCT03716427|Omeprazole|omeprazole|mesh-list
154347960|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154347961|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154347962|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347963|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347964|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154347965|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154347966|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154347967|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154347968|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
154347969|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
154347970|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
154347971|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
154347972|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347973|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347974|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154347975|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154347976|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154347977|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347978|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
154347979|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
154347980|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154347981|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154347982|NCT03716427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154347983|NCT03716427|Narcotics|narcotics|mesh-ancestor
154347984|NCT03716427|Analgesics|analgesics|mesh-ancestor
154347985|NCT03716427|Sensory System Agents|sensory system agents|mesh-ancestor
154347986|NCT03716427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347987|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154347988|NCT01147822|Sunitinib|sunitinib|mesh-list
154347989|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347990|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154094325|NCT02545738|Hormones|hormones|mesh-ancestor
154347991|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154348010|NCT03516292|Mitogens|mitogens|mesh-list
154348011|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
154348012|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348013|NCT01291615|Gemcitabine|gemcitabine|mesh-list
154861824|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966794|NCT00813748|Omalizumab|omalizumab|mesh-list
154348014|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154348015|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
154348016|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348017|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348018|NCT01295047|Atenolol|atenolol|mesh-list
154348019|NCT01295047|Verapamil|verapamil|mesh-list
154348020|NCT01295047|Perindopril|perindopril|mesh-list
154348021|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154348022|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154348023|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
154348024|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
154348025|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348026|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348027|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154348028|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154348029|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154348030|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154348031|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348032|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348033|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154348034|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348035|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348036|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
154348037|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154348038|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154348039|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348040|NCT03472846|Teriparatide|teriparatide|mesh-list
154348041|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348042|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348043|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154348044|NCT01190371|Artesunate|artesunate|mesh-list
154348045|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
154348046|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154348047|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154348048|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348059|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
154348060|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
154348061|NCT03853369|Nifekalant|nifekalant|mesh-list
154348062|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154348063|NCT05158348|Lidocaine|lidocaine|mesh-list
154348064|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
154027427|NCT02869633|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154348066|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
154348067|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348068|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348069|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
154348070|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198598|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
154348071|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154348072|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154348073|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154348074|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348075|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348076|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154348077|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154348078|NCT05158348|Analgesics|analgesics|mesh-ancestor
154348079|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154348080|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154348081|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154348082|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
154348083|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348084|NCT01187719|Phenytoin|phenytoin|mesh-list
154348085|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
154348086|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154348087|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154348088|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348089|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348090|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154348091|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154348092|NCT01102595|Bevacizumab|bevacizumab|mesh-list
154348093|NCT01102595|Temozolomide|temozolomide|mesh-list
154348094|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154348095|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861825|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
154348096|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154348097|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154348098|NCT01102595|Growth Substances|growth substances|mesh-ancestor
154348099|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348100|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
154348101|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154348102|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
154348103|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348104|NCT03848611|Vorolanib|vorolanib|mesh-list
154348105|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348106|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348107|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348108|NCT01584947|Bupivacaine|bupivacaine|mesh-list
154348109|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
154348110|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
154348111|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348112|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348133|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348134|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348135|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154348136|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154348137|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
154348138|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348139|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154348140|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154348141|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154348142|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154348143|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
154348144|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154348145|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348146|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348147|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
154348148|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348149|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348150|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
154348151|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348152|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348153|NCT03481725|Coal Tar|coal tar|mesh-list
154348154|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
154348155|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
154348156|NCT03472456|Eugenol|eugenol|mesh-list
154348157|NCT03472456|Carticaine|carticaine|mesh-list
154348158|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
154348159|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
154348160|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348161|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348162|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
154348163|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348164|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348165|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154182182|NCT05868525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154348200|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348201|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348202|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348230|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348232|NCT01190761|Galantamine|galantamine|mesh-list
154348233|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154348234|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348235|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348236|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
154348237|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348238|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348239|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154348240|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
154348241|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348242|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
154348243|NCT01209455|Acetaminophen|acetaminophen|mesh-list
154348244|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
154348245|NCT01209455|Ranitidine|ranitidine|mesh-list
154348246|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154348247|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154348248|NCT01209455|Analgesics|analgesics|mesh-ancestor
154348249|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
154348250|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348251|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348282|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348284|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348285|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154348286|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154348287|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154348288|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154348289|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154348290|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
154348291|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154348292|NCT03847207|Pasireotide|pasireotide|mesh-list
154348293|NCT03847207|Hormones|hormones|mesh-ancestor
154348294|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154348295|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348296|NCT01192087|Cetuximab|cetuximab|mesh-list
154348297|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153527449|NCT01471704|Verapamil|verapamil|mesh-list
154348323|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348324|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
154348325|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
154348326|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
154348327|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348328|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348329|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154348330|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154348331|NCT01192165|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154348332|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348334|NCT01192243|Pemetrexed|pemetrexed|mesh-list
154348335|NCT01192243|Gefitinib|gefitinib|mesh-list
154348336|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348337|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348338|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348339|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154348340|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154348341|NCT01192243|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154348342|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348343|NCT01209845|Ketamine|ketamine|mesh-list
154348344|NCT01209845|Analgesics|analgesics|mesh-ancestor
154348345|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
154348361|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348362|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
154348363|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348364|NCT03451773|Gemcitabine|gemcitabine|mesh-list
154348365|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154348366|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
154348367|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348368|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348369|NCT01112891|Vitamin D|vitamin d|mesh-list
154348370|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
154348371|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
154348372|NCT01112891|Vitamins|vitamins|mesh-list
154348373|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
154348374|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348375|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154348376|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348377|NCT03847441|Vitamin D|vitamin d|mesh-list
154348378|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
154348379|NCT03847441|Calcipotriene|calcipotriene|mesh-list
154348380|NCT03847441|Vitamins|vitamins|mesh-ancestor
154348381|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
154348382|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348383|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154348384|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348385|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
154348386|NCT02529683|NuvaRing|nuvaring|mesh-list
154348387|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154348388|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
154348389|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154348390|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348391|NCT05406895|Lidocaine|lidocaine|mesh-list
154348392|NCT05406895|Epinephrine|epinephrine|mesh-list
154348393|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
154348394|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
154861826|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861827|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967022|NCT06077877|Niraparib|niraparib|mesh-list
154348395|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348396|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348397|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
154348398|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348399|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154348400|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154348401|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154348402|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348403|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198790|NCT00273052|Metoprolol|metoprolol|mesh-list
154348424|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154348426|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348427|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348428|NCT03941561|Tegafur|tegafur|mesh-list
154348429|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154348430|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
154348431|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348432|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348433|NCT03424239|Vitamin D|vitamin d|mesh-list
154348434|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
154094741|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
154348435|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
154348436|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
154348437|NCT03424239|Vitamins|vitamins|mesh-list
154348438|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
154348439|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348440|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348441|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154348442|NCT03941795|Axitinib|axitinib|mesh-list
154348443|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348444|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348445|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348446|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348447|NCT01197001|Losartan|losartan|mesh-list
154348448|NCT01197001|Amlodipine|amlodipine|mesh-list
154348449|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154348450|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154348451|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348452|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348453|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348454|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348455|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
154348456|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154348490|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348491|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348492|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154348493|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
154348494|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
154348496|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527668|NCT01473043|Axitinib|axitinib|mesh-list
154348509|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348510|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348511|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
154348512|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154348513|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348514|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154348515|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348516|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154348517|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
154348518|NCT03845881|Oxycodone|oxycodone|mesh-list
154348519|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154348520|NCT03845881|Narcotics|narcotics|mesh-ancestor
154348521|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348522|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348523|NCT03845881|Analgesics|analgesics|mesh-ancestor
154348524|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
154348525|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348526|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
154348527|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154348528|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348529|NCT01296997|Calcium|calcium|mesh-list
154348530|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348531|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348532|NCT01114841|Tazarotene|tazarotene|mesh-list
154348533|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
154348534|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
154348535|NCT01113437|Omalizumab|omalizumab|mesh-list
154348536|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154348537|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154348538|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
154348539|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
154348540|NCT01197235|Hematinics|hematinics|mesh-ancestor
154348541|NCT01192789|Amoxicillin|amoxicillin|mesh-list
154348542|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154348543|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348544|NCT01211171|Telmisartan|telmisartan|mesh-list
154348545|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154348546|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154348547|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154348548|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348549|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
154348550|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154348551|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154348552|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348553|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
154348554|NCT03846973|Coagulants|coagulants|mesh-ancestor
154348555|NCT01113515|Esmolol|esmolol|mesh-list
154348556|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154348557|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154348558|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154348559|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
154348560|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348590|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348592|NCT01113671|Tocopherols|tocopherols|mesh-list
154348593|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
154348594|NCT01113671|Vitamins|vitamins|mesh-ancestor
154348595|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
154348596|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348597|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
154348598|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348599|NCT01113671|Protective Agents|protective agents|mesh-ancestor
154348600|NCT03943043|Paclitaxel|paclitaxel|mesh-list
154348601|NCT03943043|Gemcitabine|gemcitabine|mesh-list
154348602|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
154348603|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154348604|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348605|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
154348606|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
154348622|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154348623|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154348624|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348625|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348626|NCT01193491|Geldanamycin|geldanamycin|mesh-list
154348627|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154348628|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348629|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
154348630|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348631|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348632|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348633|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154348634|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
154348635|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154348636|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154348637|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154348638|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348639|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348640|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154348641|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154348642|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154348643|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
154348644|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198916|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
154348645|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348646|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154348647|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154348648|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
154348649|NCT01208285|Ivacaftor|ivacaftor|mesh-list
154348650|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154348651|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255430|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348652|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348654|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154348655|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
154348656|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
154348657|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348658|NCT01208441|Letrozole|letrozole|mesh-list
154348659|NCT01208441|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154348660|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348661|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154348662|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154348663|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348694|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348695|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348696|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
154348697|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154348698|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
154348699|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
154348700|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348701|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154348702|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
154348703|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154348704|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153527858|NCT01474499|Sorbitol|sorbitol|mesh-list
154348723|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154348724|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154348725|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348726|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348727|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154348728|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154348729|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154348730|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154348731|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
154348732|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
154348733|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
154348734|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
154348735|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348736|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348737|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
154348738|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
154348739|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154348740|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
154348741|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
154348742|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154348743|NCT03715881|Prednisolone|prednisolone|mesh-list
154348744|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
154348745|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154348746|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
154348747|NCT03715881|Hormones|hormones|mesh-ancestor
154348748|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154348749|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348750|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154348751|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348752|NCT03715881|Hematinics|hematinics|mesh-ancestor
154348753|NCT01197781|Verapamil|verapamil|mesh-list
154348754|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154348755|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154348756|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348757|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348758|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348759|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348760|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
154348761|NCT01110551|Vaccines|vaccines|mesh-list
154348792|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348794|NCT01110785|Simvastatin|simvastatin|mesh-list
154348795|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154348796|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154348797|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
154348798|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348799|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154348800|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154861828|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154255924|NCT01259804|Immunomodulating Agents|immunomodulating agents|mesh-list
154348801|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348802|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154348803|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348804|NCT03846271|Oxytocin|oxytocin|mesh-list
154348822|NCT01118039|Sunitinib|sunitinib|mesh-list
154348823|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348824|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154348825|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154348826|NCT01118039|Growth Substances|growth substances|mesh-ancestor
154348827|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348828|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154348829|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348830|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348831|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348832|NCT01213433|Artesunate|artesunate|mesh-list
154348833|NCT01213433|Amodiaquine|amodiaquine|mesh-list
154348834|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
154348835|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154199033|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154348836|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154348837|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348838|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348839|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
154348840|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
154348841|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154348842|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
154348843|NCT06107894|Aldesleukin|aldesleukin|mesh-list
154348844|NCT06107894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348845|NCT06107894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154348846|NCT06107894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154348847|NCT06107894|Antiviral Agents|antiviral agents|mesh-ancestor
154348848|NCT06107894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348849|NCT06107790|Trastuzumab|trastuzumab|mesh-list
154348850|NCT06107790|Vinorelbine|vinorelbine|mesh-list
154348851|NCT06107790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154348852|NCT06107790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348853|NCT06107790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154348854|NCT06107790|Tubulin Modulators|tubulin modulators|mesh-ancestor
154348855|NCT06107790|Antimitotic Agents|antimitotic agents|mesh-ancestor
154348856|NCT06107790|Mitosis Modulators|mitosis modulators|mesh-ancestor
154348857|NCT06107790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348858|NCT06107673|Cyclophosphamide|cyclophosphamide|mesh-list
154348859|NCT06107673|Docetaxel|docetaxel|mesh-list
154348860|NCT06107673|Epirubicin|epirubicin|mesh-list
154348861|NCT06107673|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154348862|NCT06107673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154348863|NCT06107673|Immunologic Factors|immunologic factors|mesh-ancestor
154348864|NCT06107673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348865|NCT06107673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154348894|NCT06106932|Leuprolide|leuprolide|mesh-list
154348895|NCT06106932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154348896|NCT06106932|Fertility Agents|fertility agents|mesh-ancestor
154348897|NCT06106932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154348898|NCT06106932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348899|NCT06106932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154348900|NCT06106932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348901|NCT06106802|Tepotinib|tepotinib|mesh-list
154348902|NCT06106802|Lazertinib|lazertinib|mesh-list
154348903|NCT06106802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348904|NCT06106802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348905|NCT06106802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348906|NCT06106802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348907|NCT06106789|Tobramycin|tobramycin|mesh-list
154348908|NCT06106789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348909|NCT06106789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154348910|NCT06105840|Turmeric extract|turmeric extract|mesh-list
154348946|NCT06105671|Adrenergic Agents|adrenergic agents|mesh-ancestor
154348947|NCT06105671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528111|NCT01476488|Tacrolimus|tacrolimus|mesh-list
154348980|NCT06102603|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154348981|NCT06102603|Protease Inhibitors|protease inhibitors|mesh-ancestor
154348982|NCT06102603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348983|NCT06102603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348984|NCT06102395|Paclitaxel|paclitaxel|mesh-list
154348985|NCT06102395|Docetaxel|docetaxel|mesh-list
154348986|NCT06102395|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154348987|NCT06102395|Carboplatin|carboplatin|mesh-list
154348988|NCT06102395|Pembrolizumab|pembrolizumab|mesh-list
154861829|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967317|NCT04989946|Cemiplimab|cemiplimab|mesh-list
154348989|NCT06102395|Fluorouracil|fluorouracil|mesh-list
154348990|NCT06102395|Nedaplatin|nedaplatin|mesh-list
154349017|NCT06100367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349019|NCT06086197|Rituximab|rituximab|mesh-list
154349020|NCT06086197|Gemcitabine|gemcitabine|mesh-list
154349021|NCT06086197|Oxaliplatin|oxaliplatin|mesh-list
154349022|NCT06086197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154349023|NCT06086197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349024|NCT06086197|Immunologic Factors|immunologic factors|mesh-ancestor
154349025|NCT06086197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349026|NCT06086197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349027|NCT06086197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154349028|NCT06086197|Antimetabolites|antimetabolites|mesh-ancestor
154349029|NCT06086197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349030|NCT06080165|Sirolimus|sirolimus|mesh-list
154349031|NCT06080165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154349032|NCT06080165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349033|NCT06080165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154349034|NCT06080165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349035|NCT06080165|Antifungal Agents|antifungal agents|mesh-ancestor
154349036|NCT06080165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349072|NCT06027983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349073|NCT05999344|Ethanol|ethanol|mesh-list
154349074|NCT05999344|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154349075|NCT05999344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528232|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
154349100|NCT05932303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154349101|NCT05932303|Hormone Antagonists|hormone antagonists|mesh-ancestor
154349102|NCT05932303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349103|NCT05932303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349104|NCT05932303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154349105|NCT05932303|Anticonvulsants|anticonvulsants|mesh-ancestor
154349106|NCT05932303|Antimanic Agents|antimanic agents|mesh-ancestor
154349107|NCT05932303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154349108|NCT05932303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349109|NCT05932303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154349110|NCT05932303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154349112|NCT05932303|Sensory System Agents|sensory system agents|mesh-ancestor
154349113|NCT05932303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349114|NCT05932303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154349115|NCT05932303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154349116|NCT05932303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154349117|NCT05932303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154349118|NCT05932303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154349119|NCT05932303|Antimetabolites|antimetabolites|mesh-ancestor
154349120|NCT05932303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154349121|NCT05932303|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154349122|NCT05922605|Ketamine|ketamine|mesh-list
154349123|NCT05922605|Ropivacaine|ropivacaine|mesh-list
154349124|NCT05922605|Esketamine|esketamine|mesh-list
154349125|NCT05922605|Analgesics|analgesics|mesh-ancestor
154349126|NCT05922605|Sensory System Agents|sensory system agents|mesh-ancestor
154349136|NCT05922605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349137|NCT05922605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349138|NCT05922605|Anesthetics, Local|anesthetics, local|mesh-ancestor
154349139|NCT05922605|Antidepressive Agents|antidepressive agents|mesh-ancestor
154349140|NCT05922605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154349142|NCT05872854|Antidepressive Agents|antidepressive agents|mesh-ancestor
154349143|NCT05872854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154349144|NCT05872854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349145|NCT05872854|Antiviral Agents|antiviral agents|mesh-ancestor
154349146|NCT05872854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349147|NCT05872854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349148|NCT05872854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349149|NCT05872854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349150|NCT05872854|Immunologic Factors|immunologic factors|mesh-ancestor
154349151|NCT05872854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349152|NCT05732727|Antihypertensive Agents|antihypertensive agents|mesh-list
154349153|NCT05696782|Durvalumab|durvalumab|mesh-list
154349154|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154349155|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349156|NCT05691699|Itraconazole|itraconazole|mesh-list
154349157|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
154861830|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154349158|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349159|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154349160|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154349161|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349162|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349163|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154349164|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
154349165|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349166|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349167|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154349168|NCT05653193|Interferons|interferons|mesh-list
154349169|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
154349170|NCT05653193|Clotrimazole|clotrimazole|mesh-list
154349171|NCT05653193|Miconazole|miconazole|mesh-list
154349172|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
154349173|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349174|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
154349175|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349176|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154349177|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154349178|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154349179|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349180|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349181|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154349182|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
154349183|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349184|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349185|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154349186|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154349188|NCT05618236|Neostigmine|neostigmine|mesh-list
154349189|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154349194|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349195|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154349196|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
154349198|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
154349199|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154349200|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154349201|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
154349202|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349203|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349204|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154349205|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349206|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154349207|NCT05618210|Anesthetics|anesthetics|mesh-list
154349208|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349209|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349210|NCT05598255|Dexamethasone|dexamethasone|mesh-list
154349211|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
154349212|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154349213|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
154349214|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
154349215|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349216|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349217|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154349218|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
154349219|NCT05598255|Hormones|hormones|mesh-ancestor
154349220|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349221|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349222|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349223|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
154349224|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
154349225|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349226|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
154349227|NCT05587894|Ritonavir|ritonavir|mesh-list
154349228|NCT05587894|Remdesivir|remdesivir|mesh-list
154349229|NCT05587894|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154349230|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154349231|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154349232|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
154349233|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349234|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349235|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154349236|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154349237|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
154349238|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349239|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154349240|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154349241|NCT05587894|Antimetabolites|antimetabolites|mesh-ancestor
154349242|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
154349243|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349244|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154349245|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154349246|NCT05580861|Analgesics|analgesics|mesh-ancestor
154349247|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
154349248|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349249|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349250|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154349251|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349252|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154349253|NCT05572476|Carboplatin|carboplatin|mesh-list
154349254|NCT05572476|Etoposide|etoposide|mesh-list
154349255|NCT05572476|Durvalumab|durvalumab|mesh-list
154095565|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
154349256|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349257|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349258|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154349260|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349277|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349278|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349279|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154349280|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154349281|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
154349283|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349284|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349285|NCT05198960|Aspirin|aspirin|mesh-list
154349286|NCT05198960|Anticoagulants|anticoagulants|mesh-list
154349287|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154349288|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154349289|NCT05198960|Analgesics|analgesics|mesh-ancestor
154349290|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
154349291|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349292|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349293|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154349294|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349295|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154349296|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154349297|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349298|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154349299|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154349300|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349301|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
154349302|NCT05151471|Edaravone|edaravone|mesh-list
154349303|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154349304|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
154349305|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349306|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154349307|NCT05151471|Protective Agents|protective agents|mesh-ancestor
154349308|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349309|NCT05054374|Fulvestrant|fulvestrant|mesh-list
154349310|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349311|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349312|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154349313|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154349314|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
154349315|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349316|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349322|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349323|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349324|NCT05051436|Urological Agents|urological agents|mesh-ancestor
154349325|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154199308|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349326|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154349327|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154349328|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
154349329|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095663|NCT00854776|Antacids|antacids|mesh-ancestor
154349330|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349331|NCT05045066|Vitamin D|vitamin d|mesh-list
154349332|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
154349333|NCT05045066|Vitamins|vitamins|mesh-ancestor
154349334|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
154349335|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349336|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154349337|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154349338|NCT05037500|Decitabine|decitabine|mesh-list
154349339|NCT05037500|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154349340|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154349341|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
154349342|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349343|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349344|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349345|NCT05035836|Tamoxifen|tamoxifen|mesh-list
154349346|NCT05035836|Letrozole|letrozole|mesh-list
154349347|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349348|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154349349|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154349350|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349351|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349352|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154349353|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
154349354|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349355|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349356|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349357|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154349358|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154349359|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154349360|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
154349361|NCT05030155|Azathioprine|azathioprine|mesh-list
154349362|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349363|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
154349364|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349365|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349366|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154349367|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
154349368|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349369|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349370|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154349371|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
154349372|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154349373|NCT04999020|Ravulizumab|ravulizumab|mesh-list
154349374|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154349375|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349376|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
154349377|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349378|NCT04986839|Acetaminophen|acetaminophen|mesh-list
154349379|NCT04986839|Ibuprofen|ibuprofen|mesh-list
154349380|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154349381|NCT04986839|Analgesics|analgesics|mesh-ancestor
154349382|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
154349383|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349384|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349385|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
154349416|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349417|NCT04816214|Carboplatin|carboplatin|mesh-list
154349418|NCT04816214|Pemetrexed|pemetrexed|mesh-list
154349419|NCT04816214|Osimertinib|osimertinib|mesh-list
154349420|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349421|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349422|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349423|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154349424|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154349425|NCT04816214|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154349426|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154349427|NCT04767594|Palbociclib|palbociclib|mesh-list
154349428|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349440|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154349441|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154349442|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154349443|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349444|NCT04686279|Tenofovir|tenofovir|mesh-list
154349445|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
154349446|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349447|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154255925|NCT01259804|Immunologic Factors|immunologic factors|mesh-ancestor
154255926|NCT01259804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255927|NCT01153880|Mupirocin|mupirocin|mesh-list
154255928|NCT01153880|Retapamulin|retapamulin|mesh-list
154255929|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154255930|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967624|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
154349448|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154349449|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349450|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349451|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154349452|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154349453|NCT04671615|Palbociclib|palbociclib|mesh-list
154349454|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349455|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154349456|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349457|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349458|NCT04639986|Gemcitabine|gemcitabine|mesh-list
154349459|NCT04639986|Capecitabine|capecitabine|mesh-list
154349460|NCT04639986|Vinorelbine|vinorelbine|mesh-list
154349461|NCT04639986|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154349462|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154349463|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
154349464|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349465|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349466|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349467|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
154349468|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
154349469|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
154349470|NCT04639986|Immunoconjugates|immunoconjugates|mesh-ancestor
154349471|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
154349472|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349473|NCT04594187|Immunomodulating Agents|immunomodulating agents|mesh-list
154349474|NCT04594187|Immunologic Factors|immunologic factors|mesh-ancestor
154349475|NCT04594187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349476|NCT04569084|Edaravone|edaravone|mesh-list
154349477|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154349478|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
154349479|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349480|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154349481|NCT04569084|Protective Agents|protective agents|mesh-ancestor
154349482|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349483|NCT04493138|Azacitidine|azacitidine|mesh-list
154349484|NCT04493138|Quizartinib|quizartinib|mesh-list
154349485|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154349486|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
154349487|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349488|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349489|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349490|NCT04493138|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154349503|NCT04323956|Vincristine|vincristine|mesh-list
154349504|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154349505|NCT04323956|Antibodies|antibodies|mesh-list
154349506|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
154349507|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154349508|NCT04323956|Lenograstim|lenograstim|mesh-list
154349509|NCT04323956|Immunoconjugates|immunoconjugates|mesh-list
154349510|NCT04323956|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154349511|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349512|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
154349513|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349514|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349515|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154349516|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
154349517|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349518|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349519|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154349520|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154349521|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154861831|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154861832|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
154861833|NCT04744623|Dapsone|dapsone|mesh-list
154861834|NCT04744623|Prednisolone|prednisolone|mesh-list
154861835|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154861836|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
154861837|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154255931|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154349522|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154349523|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349524|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154349525|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
154349526|NCT04323956|Hormones|hormones|mesh-ancestor
154349527|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349528|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349529|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154349530|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349531|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
154349532|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
154349533|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
154349534|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
154349535|NCT04303000|Naloxone|naloxone|mesh-list
154349536|NCT04303000|Narcotics|narcotics|mesh-ancestor
154349537|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349538|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349539|NCT04303000|Analgesics|analgesics|mesh-ancestor
154349540|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
154349541|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349542|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154349543|NCT04300140|Nivolumab|nivolumab|mesh-list
154349544|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154349545|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349546|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154349547|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349548|NCT04259749|Menthol|menthol|mesh-list
154349549|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
154349550|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154349551|NCT04245280|Ropivacaine|ropivacaine|mesh-list
154349552|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154349553|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154349554|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
154349555|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349557|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
154349558|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349559|NCT04212650|Losartan|losartan|mesh-list
154349569|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154349570|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154349571|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154349572|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154349573|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154349574|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154349575|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
154349576|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
154349577|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
154349578|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349579|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349580|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
154349581|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154349582|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349583|NCT04129515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154349584|NCT04129515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349585|NCT04095715|Hemostatics|hemostatics|mesh-list
154349586|NCT04095715|Coagulants|coagulants|mesh-ancestor
154349587|NCT04016090|Folic Acid|folic acid|mesh-list
154349588|NCT04016090|Hematinics|hematinics|mesh-ancestor
154349589|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
154349590|NCT04016090|Vitamins|vitamins|mesh-ancestor
154349591|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
154349592|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349593|NCT03998319|Tenecteplase|tenecteplase|mesh-list
154349594|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154349595|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154349596|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349597|NCT03992196|Rotigotine|rotigotine|mesh-list
154349598|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
154349599|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
154349600|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349601|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349602|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349603|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154349604|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349605|NCT03866772|Misoprostol|misoprostol|mesh-list
154349606|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154861838|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
154349607|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
154349608|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154349609|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349610|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154349611|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154349612|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
154349613|NCT03840200|Rucaparib|rucaparib|mesh-list
154349614|NCT03840200|Ipatasertib|ipatasertib|mesh-list
154349615|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154349616|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349617|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349618|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349619|NCT03840200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154349620|NCT03836105|Cemiplimab|cemiplimab|mesh-list
154349621|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154349622|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349623|NCT03595059|Paclitaxel|paclitaxel|mesh-list
154349624|NCT03595059|Docetaxel|docetaxel|mesh-list
153528756|NCT01480336|Amiodarone|amiodarone|mesh-list
154349634|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
154349635|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349636|NCT03564678|Hematinics|hematinics|mesh-ancestor
154349637|NCT03416153|Paclitaxel|paclitaxel|mesh-list
154349638|NCT03416153|Carboplatin|carboplatin|mesh-list
154349639|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349640|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349641|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
154349642|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
154349643|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
154349644|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349645|NCT03263650|Prednisone|prednisone|mesh-list
154349646|NCT03263650|Carboplatin|carboplatin|mesh-list
154349647|NCT03263650|Olaparib|olaparib|mesh-list
154349648|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349649|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154349650|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
154349651|NCT03263650|Hormones|hormones|mesh-ancestor
154349652|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349653|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349654|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349655|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154349656|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349657|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349658|NCT03172299|Aflibercept|aflibercept|mesh-list
154349659|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154349660|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154349661|NCT03172299|Growth Substances|growth substances|mesh-ancestor
154349662|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349663|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
154349664|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349665|NCT03150914|Sirolimus|sirolimus|mesh-list
154349666|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154349667|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349668|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154349669|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349670|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
154349671|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349672|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
154349673|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349674|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
154349675|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
154349676|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349677|NCT02924857|Paclitaxel|paclitaxel|mesh-list
154349678|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349679|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349680|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
154349681|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
154349682|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
154349683|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349684|NCT02885311|Naltrexone|naltrexone|mesh-list
154349685|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154349686|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154349687|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349688|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
154349689|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349690|NCT02740192|Bupivacaine|bupivacaine|mesh-list
154349691|NCT02740192|Ropivacaine|ropivacaine|mesh-list
153967847|NCT02166463|Bleomycin|bleomycin|mesh-list
154349692|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
154349701|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
154349702|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349703|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349704|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349705|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154349706|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
154349707|NCT02717507|Protective Agents|protective agents|mesh-ancestor
154349708|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154349709|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154349710|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154349711|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
154349712|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154349713|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154349714|NCT02699437|Antibodies|antibodies|mesh-list
154349715|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
154349716|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
154349717|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349718|NCT02547662|Dexamethasone|dexamethasone|mesh-list
154349719|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
154349720|NCT02547662|Pomalidomide|pomalidomide|mesh-list
154349721|NCT02547662|Ixazomib|ixazomib|mesh-list
154349722|NCT02547662|Ichthammol|ichthammol|mesh-list
154349723|NCT02547662|BB 1101|bb 1101|mesh-list
154349724|NCT02547662|Glycine|glycine|mesh-list
154349725|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154349726|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
154349727|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
154349728|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349729|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349730|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154349731|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
154349732|NCT02547662|Hormones|hormones|mesh-ancestor
154349733|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349734|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349735|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349736|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349737|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
154349738|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349739|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
154349740|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154349741|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154349742|NCT02547662|Growth Substances|growth substances|mesh-ancestor
154349743|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
154349744|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
154349745|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
154349746|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349747|NCT02470585|Paclitaxel|paclitaxel|mesh-list
154349748|NCT02470585|Carboplatin|carboplatin|mesh-list
154349749|NCT02470585|Veliparib|veliparib|mesh-list
154349750|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349751|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349752|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
154349753|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
154349754|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
154349755|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349756|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154349757|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349758|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
154349759|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154349760|NCT02425306|Poly ICLC|poly iclc|mesh-list
154349767|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349768|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349769|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154349770|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154349771|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
154349772|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154349773|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154349774|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
154349775|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154349776|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
154349777|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154349778|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349779|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154861839|NCT04744623|Triamcinolone|triamcinolone|mesh-list
154861840|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153967924|NCT02000622|Olaparib|olaparib|mesh-list
154349780|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349781|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349782|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154349783|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154349785|NCT02330757|Enclomiphene|enclomiphene|mesh-list
154349786|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
154349787|NCT02330757|Estradiol|estradiol|mesh-list
154349788|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154349789|NCT02330757|Estrogens|estrogens|mesh-ancestor
154349790|NCT02330757|Hormones|hormones|mesh-ancestor
154349791|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349792|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349793|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154349794|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
154349795|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154349796|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154349797|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154349798|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
154349799|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154349800|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
154349801|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154349802|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154349803|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154349804|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
154349805|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154349806|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
154349807|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154349808|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349809|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154349810|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349811|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349812|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154349813|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
154349814|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154349815|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
154349816|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154349817|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349818|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154349819|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349820|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349821|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
154349822|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154349823|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154349824|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349825|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
154349826|NCT02199080|Coagulants|coagulants|mesh-ancestor
154349827|NCT02134925|Poly ICLC|poly iclc|mesh-list
154349828|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
153528945|NCT01481519|Dexamethasone|dexamethasone|mesh-list
154349832|NCT01849263|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154349833|NCT01849263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154349834|NCT01849263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349835|NCT01849263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349836|NCT01841723|Ibrutinib|ibrutinib|mesh-list
154349837|NCT01841723|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154349838|NCT01841723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154349839|NCT01841723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349840|NCT01841723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349841|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154349842|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154349843|NCT01771107|Doxorubicin|doxorubicin|mesh-list
154349844|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154349845|NCT01771107|Dacarbazine|dacarbazine|mesh-list
154349846|NCT01771107|Vinblastine|vinblastine|mesh-list
154349847|NCT01771107|Antibodies|antibodies|mesh-list
154349848|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
154349849|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154349850|NCT01771107|Imidazole|imidazole|mesh-list
154349851|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
154349852|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
154349853|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349854|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349855|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154349856|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154861841|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154349857|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154349858|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349859|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349860|NCT01771107|Immunotoxins|immunotoxins|mesh-ancestor
154349861|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154349862|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
154349863|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349864|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154349865|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154349866|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154349867|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
154349868|NCT00950846|Busulfan|busulfan|mesh-list
154349869|NCT00950846|Fludarabine|fludarabine|mesh-list
154349870|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349871|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
154349872|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349873|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349874|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154349875|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
154349876|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349877|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349878|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154349879|NCT00007735|Doxycycline|doxycycline|mesh-list
154349880|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154349881|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199792|NCT00377403|Acetaminophen|acetaminophen|mesh-list
154349882|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
154349883|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154349884|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154349885|NCT00007670|Lamotrigine|lamotrigine|mesh-list
154349886|NCT00007670|Carbamazepine|carbamazepine|mesh-list
154349887|NCT00007670|Gabapentin|gabapentin|mesh-list
154349888|NCT00007670|Analgesics|analgesics|mesh-ancestor
154349889|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
154349890|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349891|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349892|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
154349893|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154349894|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154349895|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349896|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154349897|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154349898|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154349899|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349900|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349901|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
153529017|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154349913|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349914|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
154349915|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349916|NCT03848533|Protective Agents|protective agents|mesh-ancestor
154349917|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349918|NCT01111253|Amoxicillin|amoxicillin|mesh-list
154349919|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
154349920|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
154349921|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154349922|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154349923|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349924|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154349925|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349926|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349927|NCT01213667|Ranibizumab|ranibizumab|mesh-list
154349928|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154349929|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154349930|NCT01213667|Growth Substances|growth substances|mesh-ancestor
154349931|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349932|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
154349933|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349935|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154349936|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154349937|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
154349938|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349939|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349940|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968067|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154349941|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154349942|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154349943|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154349944|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154349945|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154349946|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349948|NCT03845179|Hormones|hormones|mesh-ancestor
154349949|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349950|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
154349951|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349952|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349953|NCT01121705|Interferons|interferons|mesh-list
154349954|NCT01121705|Ribavirin|ribavirin|mesh-list
154349955|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
154349956|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
154349957|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154349958|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349959|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
154349960|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349961|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
154349962|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349963|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
154349964|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349965|NCT01196455|Capecitabine|capecitabine|mesh-list
154349975|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349976|NCT03846583|Trastuzumab|trastuzumab|mesh-list
154349977|NCT03846583|Tucatinib|tucatinib|mesh-list
154349978|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154349979|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154349980|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349981|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154349982|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349983|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349984|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154349985|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
154349986|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154349987|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349988|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154349989|NCT01115543|Calcitriol|calcitriol|mesh-list
154349990|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
154349991|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154349992|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154349993|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349994|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154349995|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154349996|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349997|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154349998|NCT01115543|Vitamins|vitamins|mesh-ancestor
154349999|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
154350000|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154350001|NCT01216007|Propofol|propofol|mesh-list
154350002|NCT01216007|Sevoflurane|sevoflurane|mesh-list
154350003|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154350004|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350005|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096321|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
154350006|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154350007|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
154350008|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
154350009|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154350010|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154350011|NCT01198249|Losartan|losartan|mesh-list
154350012|NCT01198249|Amlodipine|amlodipine|mesh-list
154350013|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154350014|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154350015|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154350016|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154350017|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350018|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154861842|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154350019|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350020|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
154350021|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154350022|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154350023|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154350024|NCT01198249|Diuretics|diuretics|mesh-ancestor
154350025|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
154350026|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154350027|NCT02529761|Sorafenib|sorafenib|mesh-list
154350028|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529151|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
154350040|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350041|NCT01119209|Ropivacaine|ropivacaine|mesh-list
154350042|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
154350043|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
154350044|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350045|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350046|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
154350047|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350048|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
154350049|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154350050|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350051|NCT01116167|Letrozole|letrozole|mesh-list
154350052|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350053|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154350054|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154350055|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350056|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350057|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154350058|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
154350059|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350060|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350061|NCT01119521|Isoniazid|isoniazid|mesh-list
154350062|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
154350063|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154350064|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350065|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154350066|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154350067|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
154350068|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350069|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154350070|NCT01119599|Temozolomide|temozolomide|mesh-list
154350071|NCT01119599|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154350072|NCT01119599|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154350073|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154350074|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
154350075|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350076|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350077|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350078|NCT03419403|Temozolomide|temozolomide|mesh-list
154350079|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154350080|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154350081|NCT03419403|ABT-414|abt-414|mesh-list
154350082|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154350083|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
154350084|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350085|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350086|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154350087|NCT03419403|Immunoconjugates|immunoconjugates|mesh-ancestor
154350088|NCT03419403|Immunologic Factors|immunologic factors|mesh-ancestor
154199972|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
154350089|NCT03419403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350103|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154350104|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350105|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154350106|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154350107|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154350108|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350109|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350110|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350111|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154350112|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154350113|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154350114|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
154350115|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
154350116|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154350117|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154350118|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154350119|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154350120|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154350121|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154350122|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154350123|NCT05156437|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154350124|NCT05156437|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154350125|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154350126|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
154350127|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154350128|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
154350129|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350130|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350131|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
154350132|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350134|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
154350135|NCT03715725|Dabigatran|dabigatran|mesh-list
154350136|NCT03715725|Apixaban|apixaban|mesh-list
154350137|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
154350138|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154350139|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
154350140|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154350141|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
154350142|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350143|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350144|NCT01212653|Golimumab|golimumab|mesh-list
154350145|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154350146|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350147|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350148|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
154350149|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350150|NCT01213979|Iron|iron|mesh-list
154350151|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154350152|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
154350153|NCT01213979|Trace Elements|trace elements|mesh-ancestor
154350154|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
154350155|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350156|NCT01213979|Hematinics|hematinics|mesh-ancestor
154350157|NCT05282719|Azacitidine|azacitidine|mesh-list
154350158|NCT05282719|Venetoclax|venetoclax|mesh-list
154350162|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350163|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350164|NCT01118429|Oxybutynin|oxybutynin|mesh-list
154350165|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
154200030|NCT00266032|Drospirenone|drospirenone|mesh-list
154350166|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
154350167|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350168|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350169|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154350170|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154350171|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
154350172|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350173|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350174|NCT01118429|Urological Agents|urological agents|mesh-ancestor
154350175|NCT03447249|Ivacaftor|ivacaftor|mesh-list
154350177|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154350178|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154350179|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350180|NCT04156555|Amoxicillin|amoxicillin|mesh-list
154350181|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
154350182|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
154350183|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154350184|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154350185|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350186|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154350187|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350188|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350189|NCT01200121|Bevacizumab|bevacizumab|mesh-list
154350190|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154350191|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350192|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154350193|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154350194|NCT01200121|Growth Substances|growth substances|mesh-ancestor
154350195|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350196|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
154350197|NCT01214291|Toremifene|toremifene|mesh-list
154350198|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154350199|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350200|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154350201|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154350202|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
154350203|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350204|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350205|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154350206|NCT01116635|Doxorubicin|doxorubicin|mesh-list
154350207|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154350208|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350209|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154350210|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154350211|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350212|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350213|NCT01566799|Metformin|metformin|mesh-list
154350214|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154350215|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350216|NCT04642807|Calpastatin|calpastatin|mesh-list
154350217|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154350218|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
154350219|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350220|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350221|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
154350222|NCT01216085|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154350223|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154350224|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350225|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350226|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350227|NCT01198639|Remifentanil|remifentanil|mesh-list
154350248|NCT01116713|Hormones|hormones|mesh-ancestor
154350249|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350250|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154350251|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350252|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
154350253|NCT01202149|Emollients|emollients|mesh-list
154350254|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154350255|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154350256|NCT01202149|Analgesics|analgesics|mesh-ancestor
154350257|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
154350258|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350259|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350260|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350261|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154350262|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
154350263|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350264|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
154350265|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154350266|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350267|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350268|NCT01116791|Cisplatin|cisplatin|mesh-list
154350269|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350270|NCT03940001|Paclitaxel|paclitaxel|mesh-list
154350271|NCT03940001|Carboplatin|carboplatin|mesh-list
154350272|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154350273|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350274|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
154350275|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
154350276|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
154350277|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350278|NCT01120769|Acetaminophen|acetaminophen|mesh-list
154350279|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154350280|NCT01120769|Analgesics|analgesics|mesh-ancestor
154350281|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
154350282|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350297|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154350298|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154350299|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154350300|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350301|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154350302|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968369|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350303|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154350304|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350305|NCT04600999|Favipiravir|favipiravir|mesh-list
154350306|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
154350307|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350309|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350310|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
154350311|NCT01199029|Hormones|hormones|mesh-ancestor
154350312|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350313|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350314|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154350315|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350316|NCT01200745|Capsaicin|capsaicin|mesh-list
154350317|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
154350318|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
154350319|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
154200156|NCT00265330|Ziprasidone|ziprasidone|mesh-list
154350320|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350321|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350322|NCT01585415|Aldesleukin|aldesleukin|mesh-list
154350323|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
154350324|NCT01585415|Fludarabine|fludarabine|mesh-list
154350325|NCT01585415|Vemurafenib|vemurafenib|mesh-list
154350326|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350327|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
154350328|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350329|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154350330|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154350331|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
154350332|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350333|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350334|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154350335|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154350336|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154350337|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
154350338|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350339|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154350340|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350341|NCT01566643|Metronidazole|metronidazole|mesh-list
154350342|NCT01566643|Rabeprazole|rabeprazole|mesh-list
154350356|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350357|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154350358|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
154350359|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154350360|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154350361|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154350362|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350363|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350364|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
154350365|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154350366|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
154350367|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350368|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
154350369|NCT01212809|Protective Agents|protective agents|mesh-ancestor
154350371|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154350372|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154350373|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350374|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350375|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154350376|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154096685|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
154200216|NCT05586113|Bismuth|bismuth|mesh-list
154350377|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
154350378|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350379|NCT03843229|Bufanolides|bufanolides|mesh-list
154350380|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154350381|NCT03843229|Protective Agents|protective agents|mesh-ancestor
154350382|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350383|NCT01212887|Aldesleukin|aldesleukin|mesh-list
154350384|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
154350385|NCT01212887|Fludarabine|fludarabine|mesh-list
154350386|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
154350387|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350388|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
154350389|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350390|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861843|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154350391|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154350392|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
154350393|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350394|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350395|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154350396|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154350397|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
154350398|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154350399|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154350400|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
154350401|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350403|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
154350404|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350405|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
154350416|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350417|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154350418|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154350419|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154350420|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
154350421|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350422|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350423|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350425|NCT04961281|Hormones|hormones|mesh-ancestor
154350426|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350427|NCT01212965|Selenium|selenium|mesh-list
154350428|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
154350429|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350430|NCT01212965|Protective Agents|protective agents|mesh-ancestor
154350431|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350432|NCT01212965|Trace Elements|trace elements|mesh-ancestor
154350433|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
154350434|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
154350435|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154350436|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350437|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154350438|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350439|NCT01216709|Iron|iron|mesh-list
154350440|NCT01216709|Trace Elements|trace elements|mesh-ancestor
154350441|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
154350442|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350443|NCT01216787|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154350444|NCT01216787|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154350445|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350446|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350447|NCT05282251|Bupivacaine|bupivacaine|mesh-list
154350448|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
154350449|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
154350450|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350451|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350452|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
154350453|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350454|NCT01199341|Warfarin|warfarin|mesh-list
154350455|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
154350456|NCT01215539|Panitumumab|panitumumab|mesh-list
154350457|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154350458|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350459|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
154350460|NCT01203709|Tacrolimus|tacrolimus|mesh-list
154350461|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350462|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
154350463|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350464|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154350465|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350466|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350467|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154350480|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350481|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350482|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154350483|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154350484|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
154350485|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350486|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
154350487|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154350488|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
154350489|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154350490|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154350491|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154350492|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350493|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350494|NCT01124435|Celecoxib|celecoxib|mesh-list
154350495|NCT01124435|Carboplatin|carboplatin|mesh-list
154350496|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350497|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154350498|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154350499|NCT01124435|Analgesics|analgesics|mesh-ancestor
154350500|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
154350501|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350502|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350503|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350504|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154350505|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154350506|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154350507|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350508|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350509|NCT03294304|Gemcitabine|gemcitabine|mesh-list
154350510|NCT03294304|Nivolumab|nivolumab|mesh-list
154350511|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350512|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154350513|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
154350514|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350515|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154350516|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154350517|NCT01201213|Anesthetics|anesthetics|mesh-list
154350518|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
154350519|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350520|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350521|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
154350522|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350523|NCT03472378|Celecoxib|celecoxib|mesh-list
154350524|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154350525|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154350526|NCT03472378|Analgesics|analgesics|mesh-ancestor
154350527|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
154350528|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529654|NCT01486433|Analgesics|analgesics|mesh-ancestor
154350534|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350535|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350537|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
154350538|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154350539|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154350540|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154350541|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350542|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350543|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
154350544|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
154350545|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350546|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350547|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154350548|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154350549|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
154350550|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154350551|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154350552|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154350553|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154200369|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
154350554|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154350555|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154350556|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154350557|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
154350558|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350559|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154350560|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154350561|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350562|NCT03780959|Etanercept|etanercept|mesh-list
154350563|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154350564|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154350565|NCT03780959|Analgesics|analgesics|mesh-ancestor
154350566|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
154350567|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350568|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350569|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350570|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154350571|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154350572|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350573|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
154350574|NCT03838783|Insulin|insulin|mesh-list
154350575|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154350576|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350577|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
154350578|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
154350579|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
154350580|NCT03408639|Vitamins|vitamins|mesh-ancestor
154350581|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
154350582|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350583|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
154350584|NCT03408639|Hematinics|hematinics|mesh-ancestor
154350585|NCT01219205|Bevacizumab|bevacizumab|mesh-list
154350586|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154350587|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350588|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154350589|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154350590|NCT01219205|Growth Substances|growth substances|mesh-ancestor
154350591|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350592|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
154350593|NCT03810235|Lidocaine|lidocaine|mesh-list
154350594|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
154350595|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
154350596|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350597|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350598|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
154350599|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350609|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
154350610|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350611|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350612|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
154350613|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350614|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154350615|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154350616|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
154350617|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350618|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350619|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154350620|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154350621|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
154350622|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154350623|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
154350624|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
154350625|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
154350626|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154350627|NCT03408483|Narcotics|narcotics|mesh-ancestor
154350628|NCT03408483|Analgesics|analgesics|mesh-ancestor
154350629|NCT03715023|PC-786|pc-786|mesh-list
154350630|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
154350631|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350632|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350633|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350634|NCT03714867|Pregabalin|pregabalin|mesh-list
154350635|NCT03714867|Analgesics|analgesics|mesh-ancestor
154350636|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
154350637|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350638|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350639|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
154350640|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154350641|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154350642|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350643|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154350644|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154350645|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154350646|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350647|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154350648|NCT01204177|Sorafenib|sorafenib|mesh-list
154350649|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350650|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154350651|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350652|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350653|NCT01217099|Azithromycin|azithromycin|mesh-list
154350654|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
154350655|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154350656|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154350657|NCT01217099|Prednisolone|prednisolone|mesh-list
154350658|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
154350659|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154350660|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
154350661|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350662|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
154350663|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
154350664|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350665|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350681|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154350682|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
154350683|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154350685|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350686|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350687|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154350688|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
154350689|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
154350690|NCT04305457|Protective Agents|protective agents|mesh-ancestor
154350691|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
154350692|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154350693|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154350694|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
154350695|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350696|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350697|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350698|NCT01122563|Urological Agents|urological agents|mesh-ancestor
154350699|NCT01217177|Everolimus|everolimus|mesh-list
154350700|NCT01217177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154350701|NCT01217177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154350702|NCT01217177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350703|NCT01217177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350704|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350705|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
154200479|NCT00464672|Vaccines|vaccines|mesh-list
154350706|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350707|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350708|NCT01204333|Heparin|heparin|mesh-list
154350709|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
154350710|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154350711|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154350712|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350713|NCT02529059|Tenofovir|tenofovir|mesh-list
154350714|NCT02529059|Emtricitabine|emtricitabine|mesh-list
154350715|NCT02529059|Rilpivirine|rilpivirine|mesh-list
154350716|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
154350717|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350718|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154350719|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154350720|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350721|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350722|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154350723|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154350724|NCT03932669|Nilotinib|nilotinib|mesh-list
154350725|NCT03932669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154350735|NCT03933761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154350736|NCT03933761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350737|NCT03933761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350738|NCT03933761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350739|NCT03932123|Vancomycin|vancomycin|mesh-list
154350740|NCT03932123|Meropenem|meropenem|mesh-list
154350741|NCT03932123|Tazobactam|tazobactam|mesh-list
154350742|NCT03932123|Piperacillin|piperacillin|mesh-list
154350743|NCT03932123|Cefotaxime|cefotaxime|mesh-list
154350744|NCT03932123|Cefoxitin|cefoxitin|mesh-list
154350745|NCT03932123|Azlocillin|azlocillin|mesh-list
154350746|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154350747|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350748|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154350749|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350750|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861844|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
153968731|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
154350751|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
154350752|NCT02866279|Etonogestrel|etonogestrel|mesh-list
154097059|NCT00870220|Hormones|hormones|mesh-ancestor
154350753|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154350754|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350755|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154350756|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154350757|NCT01222169|Propofol|propofol|mesh-list
154350758|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154350759|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350760|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350761|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154350762|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
154350763|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
154350764|NCT02871778|Ivacaftor|ivacaftor|mesh-list
154350765|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154350766|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154350767|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350768|NCT04947592|Fluconazole|fluconazole|mesh-list
154350769|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
154350770|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350771|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154350772|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154350773|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350774|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350775|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154350776|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
154350777|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200548|NCT00540449|Efavirenz|efavirenz|mesh-list
154350778|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350779|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154350780|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154350781|NCT02735473|Choline|choline|mesh-list
154350782|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
154350783|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154350784|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
154350785|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350786|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154350787|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154350788|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
154350798|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
154350799|NCT01204411|Artesunate|artesunate|mesh-list
154350800|NCT01204411|Amodiaquine|amodiaquine|mesh-list
154350801|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
154350802|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154350803|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154350804|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350805|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350806|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
154350807|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
154350808|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154350809|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
154350810|NCT01471444|Methotrexate|methotrexate|mesh-list
154350811|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
154350812|NCT01471444|Clofarabine|clofarabine|mesh-list
154350813|NCT01471444|Fludarabine|fludarabine|mesh-list
154350814|NCT01471444|Busulfan|busulfan|mesh-list
154350815|NCT01471444|Tacrolimus|tacrolimus|mesh-list
154350816|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
154350817|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154350818|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154350819|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
154350820|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154350821|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350822|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154350823|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
154350824|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350825|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350826|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
154350827|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350828|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154350829|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350830|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
154350831|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154350832|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154861845|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153968803|NCT02727309|Apatinib|apatinib|mesh-list
153968808|NCT05755750|Genipin|genipin|mesh-list
154350833|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154350834|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
154350835|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154350836|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154350837|NCT05282407|Tenofovir|tenofovir|mesh-list
154350838|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
154350839|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350840|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154350841|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154350842|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350843|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350844|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154350845|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154350846|NCT01125215|Capsaicin|capsaicin|mesh-list
154350847|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
154350848|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
154350849|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
154350850|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350851|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350852|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
154350853|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154350854|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
154350855|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350856|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350857|NCT05162872|Niraparib|niraparib|mesh-list
154350877|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154350878|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350879|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350880|NCT03933605|Midazolam|midazolam|mesh-list
154350881|NCT03933605|Palonosetron|palonosetron|mesh-list
154350882|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154350883|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154350884|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350885|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350886|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154350887|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154350888|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154350889|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154350890|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
154350891|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
154200659|NCT01069042|Enalapril|enalapril|mesh-list
154350892|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
154350893|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
154350894|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154350895|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350896|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
154350897|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
154350898|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350899|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154350900|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154350901|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154350902|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
154350903|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
154350904|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154350905|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154350906|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
154350907|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
154350908|NCT01311141|Doripenem|doripenem|mesh-list
154350909|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154350910|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350911|NCT01122641|Vildagliptin|vildagliptin|mesh-list
154350912|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154350913|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350924|NCT01125449|Protective Agents|protective agents|mesh-ancestor
154350925|NCT01206049|Bevacizumab|bevacizumab|mesh-list
154350926|NCT01206049|Panitumumab|panitumumab|mesh-list
154350927|NCT01206049|Gemcitabine|gemcitabine|mesh-list
154350928|NCT01206049|Capecitabine|capecitabine|mesh-list
154350929|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
154350930|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154350931|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350932|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154350933|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154350934|NCT01206049|Growth Substances|growth substances|mesh-ancestor
154350935|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861846|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350936|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
154350937|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154350938|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
154350939|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350940|NCT03931889|Vitamin D|vitamin d|mesh-list
154350941|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
154350942|NCT03931889|Vitamins|vitamins|mesh-ancestor
154350943|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
154350944|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350945|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154350946|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154350947|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154350948|NCT02953821|Hormones|hormones|mesh-ancestor
154350949|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350950|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350951|NCT01206205|Lenalidomide|lenalidomide|mesh-list
154350952|NCT01206205|Bortezomib|bortezomib|mesh-list
154350953|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
154350954|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350955|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154350956|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154350957|NCT01206205|Growth Substances|growth substances|mesh-ancestor
154350958|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
154350959|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350960|NCT03783923|Deflazacort|deflazacort|mesh-list
154350961|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200696|NCT01050621|Protective Agents|protective agents|mesh-ancestor
154350962|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350963|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
154350964|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350965|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154350966|NCT03472144|Levofloxacin|levofloxacin|mesh-list
154350967|NCT03472144|Ofloxacin|ofloxacin|mesh-list
154350968|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154350969|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350970|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
154350971|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154350972|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154350973|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154350974|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350975|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350976|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350977|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154350978|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154351011|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
154351012|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351013|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351014|NCT03931343|Epinephrine|epinephrine|mesh-list
154351015|NCT03931343|Racepinephrine|racepinephrine|mesh-list
154351016|NCT03931343|Bupivacaine|bupivacaine|mesh-list
154351017|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
154351018|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
154351032|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154351033|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
154351034|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
154351035|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
154351036|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154351037|NCT01122953|Phenytoin|phenytoin|mesh-list
154351038|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
154351039|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154351040|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154351041|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351042|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351043|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154351044|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154351045|NCT01125683|Donepezil|donepezil|mesh-list
154351046|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154351047|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351048|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351049|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
154351050|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351051|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351052|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
154351053|NCT01127555|Leucovorin|leucovorin|mesh-list
154351054|NCT01127555|Fluorouracil|fluorouracil|mesh-list
154351055|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
154351056|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
154351057|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351058|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154351059|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351060|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154351061|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
154351062|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351063|NCT01127555|Antidotes|antidotes|mesh-ancestor
154351064|NCT01127555|Protective Agents|protective agents|mesh-ancestor
154351065|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
154351066|NCT01127555|Vitamins|vitamins|mesh-ancestor
154351067|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
154351068|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
154351069|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154351070|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
154351071|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351072|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351073|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154351074|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
154351075|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351076|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351077|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154351078|NCT03471988|Voriconazole|voriconazole|mesh-list
154351079|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
154351097|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
154351098|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154351099|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351100|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154351101|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351102|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351103|NCT01220063|Irinotecan|irinotecan|mesh-list
154351104|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154351105|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154351106|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351107|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351108|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351109|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
154351110|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154351111|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351112|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154351113|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351114|NCT01217879|Telmisartan|telmisartan|mesh-list
154351115|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154351116|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154351117|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154351118|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351119|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
154351120|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154351121|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351122|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
154351123|NCT04249310|Olodaterol|olodaterol|mesh-list
154351124|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154351125|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
154351126|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351127|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351128|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154351129|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
154351130|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
154351131|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154351132|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
154351133|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351149|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
154351150|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351151|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154351152|NCT03714165|Defensins|defensins|mesh-list
154351153|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
154351154|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351155|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
154351156|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154351157|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
154351158|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
154351159|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154351160|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351161|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154351162|NCT03932825|Analgesics|analgesics|mesh-ancestor
154351163|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
154351164|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351165|NCT03932981|Temozolomide|temozolomide|mesh-list
154351166|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154351167|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
154351168|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351169|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351170|NCT01220219|Pregabalin|pregabalin|mesh-list
154351171|NCT01220219|Analgesics|analgesics|mesh-ancestor
154351172|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
154351173|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351174|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351175|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
154351176|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154351177|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351178|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351179|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154351180|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154351181|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154351182|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154351183|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154351184|NCT03441789|Betamethasone|betamethasone|mesh-list
154351185|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
154351186|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154351187|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
154351188|NCT03441789|Calcipotriene|calcipotriene|mesh-list
154351189|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154351190|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154351191|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
154351192|NCT03441789|Hormones|hormones|mesh-ancestor
153530324|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154351203|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
154351204|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
154351205|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351206|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154351207|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
154351209|NCT04321174|Lopinavir|lopinavir|mesh-list
154351210|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154351211|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154351212|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
154351213|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351214|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351215|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154351216|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154351217|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
154351218|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351219|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154351220|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154351221|NCT01123265|Methotrexate|methotrexate|mesh-list
154351222|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154351223|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
154351224|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154351225|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351226|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154351227|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
154351228|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351229|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351230|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
154351231|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351232|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154351233|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154351234|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
154351235|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351236|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154351237|NCT01204723|Aprepitant|aprepitant|mesh-list
154351238|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
154351239|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
154351240|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
154351241|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351242|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351243|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351244|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153969124|NCT00736645|Selenium|selenium|mesh-list
154351245|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351246|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351247|NCT01204801|Doxorubicin|doxorubicin|mesh-list
154351248|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154351249|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154351250|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351251|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154351252|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154351253|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351264|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351265|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154351266|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
154351267|NCT03832621|Nivolumab|nivolumab|mesh-list
154351268|NCT03832621|Ipilimumab|ipilimumab|mesh-list
154351269|NCT03832621|Temozolomide|temozolomide|mesh-list
154351270|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154351271|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351272|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154351273|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351274|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154097586|NCT05704036|Progestins|progestins|mesh-ancestor
154351275|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
154351277|NCT01220375|Vinorelbine|vinorelbine|mesh-list
154351278|NCT01220375|Lenograstim|lenograstim|mesh-list
154351279|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154351280|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
154351281|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351282|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154351283|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351284|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
154351285|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
154351286|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
154351287|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351288|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154351289|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154351290|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
154351291|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351292|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
154351293|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
154351294|NCT01223729|Vitamins|vitamins|mesh-ancestor
154351295|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
154351296|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351297|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
154351298|NCT01126073|Niacin|niacin|mesh-list
154200937|NCT02534337|Leucovorin|leucovorin|mesh-list
154351299|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154351300|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
154351301|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351302|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154351303|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
154351304|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
154351305|NCT01126073|Vitamins|vitamins|mesh-ancestor
154351306|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
154351307|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351308|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
154351309|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154351310|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351311|NCT03287050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154351312|NCT03287050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351313|NCT03130504|Progesterone|progesterone|mesh-list
154351314|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154351315|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154351316|NCT03130504|Progestins|progestins|mesh-ancestor
154351317|NCT03130504|Hormones|hormones|mesh-ancestor
154351318|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351336|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351337|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154351338|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154351339|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351341|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154351342|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154351343|NCT03930875|Analgesics|analgesics|mesh-ancestor
154351344|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
154351345|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861847|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154861848|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
153969176|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154351346|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351347|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154351348|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351349|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154351350|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154351351|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351352|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154351353|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154351354|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351355|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
154351356|NCT01206907|Oxymorphone|oxymorphone|mesh-list
154351357|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154351358|NCT01206907|Narcotics|narcotics|mesh-ancestor
154351359|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154351360|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351361|NCT01206907|Analgesics|analgesics|mesh-ancestor
154351362|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
154351363|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351364|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154351365|NCT03925246|Nivolumab|nivolumab|mesh-list
154351366|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154351367|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351368|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154351369|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351370|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154351371|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154351372|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154351373|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
154351374|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530509|NCT01490762|Insulin|insulin|mesh-list
154351389|NCT01126307|Verapamil|verapamil|mesh-list
154351390|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154351391|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154351392|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351393|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351394|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154351395|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351396|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
154351397|NCT04173338|Pemetrexed|pemetrexed|mesh-list
154351398|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351399|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351400|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351401|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154351402|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154351403|NCT03936491|Methylphenidate|methylphenidate|mesh-list
154351404|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154351405|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154351406|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351407|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154351408|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154351409|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351410|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351411|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
154351412|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351413|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154351414|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
154351415|NCT00890617|Prednisone|prednisone|mesh-list
154351416|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154351417|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
154351418|NCT00890617|Hormones|hormones|mesh-ancestor
154351419|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351420|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351421|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154351422|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351423|NCT03468946|Caffeine|caffeine|mesh-list
154351424|NCT03468946|Citric Acid|citric acid|mesh-list
154351425|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154351426|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351427|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154351428|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861849|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153969249|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351429|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351430|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154351431|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154351432|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
154351441|NCT01218425|Methylphenidate|methylphenidate|mesh-list
154351442|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154351443|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351444|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154351445|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154351446|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351447|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351448|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
154351449|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351450|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154351451|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154351452|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154351453|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351454|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
154351455|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
154351456|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351457|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351458|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154351459|NCT05621005|Rifaximin|rifaximin|mesh-list
154351460|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154351461|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351462|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351463|NCT01224041|Tacrolimus|tacrolimus|mesh-list
154351464|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154351465|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
154351466|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351467|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154351468|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351469|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351470|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
154351471|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351472|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351473|NCT01123811|Cetuximab|cetuximab|mesh-list
154351474|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154351475|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351476|NCT01128101|Spironolactone|spironolactone|mesh-list
154351477|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154351478|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
154351479|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351480|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351481|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154351482|NCT01128101|Diuretics|diuretics|mesh-ancestor
154351483|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
154351484|NCT01299415|Vadimezan|vadimezan|mesh-list
154351485|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351486|NCT01123967|Nicotine|nicotine|mesh-list
154351487|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154351488|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
154351489|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351490|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351491|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154351492|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154351493|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
154351494|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351495|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351496|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
154351497|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351498|NCT01126697|Ubiquinone|ubiquinone|mesh-list
154351499|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
154351500|NCT01126697|Lisinopril|lisinopril|mesh-list
154351501|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154351509|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
154351510|NCT01126697|Vitamins|vitamins|mesh-ancestor
154351511|NCT01220843|Sevelamer|sevelamer|mesh-list
154351512|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
154351513|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
154351514|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351515|NCT02804932|Methamphetamine|methamphetamine|mesh-list
154861850|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861851|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351516|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154351517|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351518|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
154351519|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
154351520|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351521|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
154351522|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351523|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351524|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
154351525|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154351526|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154351527|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351528|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154351529|NCT03468790|Fluticasone|fluticasone|mesh-list
154351531|NCT03468790|Budesonide|budesonide|mesh-list
154351532|NCT03468790|Albuterol|albuterol|mesh-list
154351533|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
154351534|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154351535|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154351536|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154351537|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154351538|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154351539|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
154351540|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351541|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351542|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154351543|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
154351544|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
154351545|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154351546|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
154351547|NCT03468790|Hormones|hormones|mesh-ancestor
154351548|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351549|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154351550|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154351551|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154351552|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
154351553|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351554|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351555|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
154351556|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154351557|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
154351558|NCT01224197|Simeprevir|simeprevir|mesh-list
154351559|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
154351560|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351561|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
154351562|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351563|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351564|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
154351565|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
154351566|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351567|NCT01224353|Protective Agents|protective agents|mesh-ancestor
154351568|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351569|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
154351582|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154351583|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154351584|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351585|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
154351586|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154351587|NCT03720847|Estradiol|estradiol|mesh-list
154351588|NCT03720847|Progesterone|progesterone|mesh-list
154351589|NCT03720847|Estrogens|estrogens|mesh-ancestor
154351590|NCT03720847|Hormones|hormones|mesh-ancestor
154351591|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351592|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351593|NCT03720847|Progestins|progestins|mesh-ancestor
154351594|NCT01128257|Alendronate|alendronate|mesh-list
154351595|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
154351596|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154351597|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351598|NCT01205347|Simvastatin|simvastatin|mesh-list
154351599|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154351600|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154351601|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
154351602|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351603|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154861852|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969399|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351604|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154351605|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351606|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
154351607|NCT01218737|Prednisolone|prednisolone|mesh-list
154201188|NCT01048983|Analgesics|analgesics|mesh-ancestor
154351608|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154351609|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
154351610|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154351611|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
154351612|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154351613|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
154351614|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154351615|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
154351616|NCT01218737|Hormones|hormones|mesh-ancestor
154351617|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351618|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351619|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154351620|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351621|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
154351622|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
154351623|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351624|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351625|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154351626|NCT01218737|Protective Agents|protective agents|mesh-ancestor
154351627|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154351628|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351629|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154351630|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154351631|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154351632|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154351633|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351634|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351635|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
154351641|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351642|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154351643|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154351644|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154351645|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
154351646|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154097960|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154351647|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154351648|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
154351649|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351650|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
154351651|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154351652|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154351654|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154351655|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154351656|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351657|NCT01218581|Letrozole|letrozole|mesh-list
154351658|NCT01218581|Goserelin|goserelin|mesh-list
154351659|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351660|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154351661|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154351662|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351663|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351664|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154351665|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
154351666|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351667|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351668|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154351669|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
154351670|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154351671|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
154351672|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351673|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
154351674|NCT03825133|Protective Agents|protective agents|mesh-ancestor
154351675|NCT03817567|Antibodies|antibodies|mesh-list
154351676|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154351677|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
154351678|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351679|NCT01127009|Cytarabine|cytarabine|mesh-list
154351680|NCT01127009|Etoposide|etoposide|mesh-list
154351681|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
154351682|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
154351683|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
154351684|NCT01127009|Bortezomib|bortezomib|mesh-list
154351685|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154351686|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351687|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154351688|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154351689|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351690|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351691|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154351692|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
154351693|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
154351694|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351695|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154351696|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
154351697|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351698|NCT01127009|Analgesics|analgesics|mesh-ancestor
154351699|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
154351700|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351701|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
154351702|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
154351703|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
154351704|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
154351722|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154351723|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154351724|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351726|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351727|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
154351728|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351730|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154351731|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154351732|NCT03824119|Analgesics|analgesics|mesh-ancestor
154351733|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
154351734|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351735|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351736|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154351737|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351738|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154351739|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351740|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351741|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
154351742|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154351743|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154351744|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351745|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
154351746|NCT03823417|Coagulants|coagulants|mesh-ancestor
154351747|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
154351748|NCT01297777|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154351749|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154351750|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351751|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351752|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351753|NCT01224977|Azithromycin|azithromycin|mesh-list
154351754|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154351755|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351756|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
154351757|NCT01226069|Glycerol|glycerol|mesh-list
154351758|NCT01226069|Analgesics|analgesics|mesh-ancestor
154351759|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
154351760|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351761|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351762|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
154351775|NCT03928691|Analgesics|analgesics|mesh-ancestor
154351776|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
154351777|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351778|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351779|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
154351780|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154351781|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154351782|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
154351783|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154351784|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351785|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351786|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154351787|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
154351788|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154351789|NCT01297855|Rifampin|rifampin|mesh-list
154351790|NCT01297855|Colistin|colistin|mesh-list
154351791|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154351792|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
154351793|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154351794|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351795|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
154351796|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154351797|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351798|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351799|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154351800|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154351801|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154351802|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154351803|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154351804|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154351805|NCT02631070|Luspatercept|luspatercept|mesh-list
154351806|NCT02631070|Hematinics|hematinics|mesh-ancestor
154351807|NCT01298011|Paclitaxel|paclitaxel|mesh-list
154351808|NCT01298011|Gemcitabine|gemcitabine|mesh-list
154351809|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154351810|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154351811|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351812|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
154351813|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
154351814|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
154351815|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351816|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154351817|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
154351818|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154351819|NCT01221935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154351820|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
154351821|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154351829|NCT05137678|Glyburide|glyburide|mesh-list
154351830|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154351831|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351832|NCT01226303|Tretinoin|tretinoin|mesh-list
154351833|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351834|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
154351835|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
154351836|NCT03814759|Cisplatin|cisplatin|mesh-list
154351837|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351838|NCT03929861|Fluconazole|fluconazole|mesh-list
154351839|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
154351840|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351841|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154351842|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154351843|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351844|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351845|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154351846|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
154351847|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351848|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351849|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154351850|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154351851|NCT03821623|Niacinamide|niacinamide|mesh-list
154351852|NCT03821623|Niacin|niacin|mesh-list
154351853|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
154351854|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
154351855|NCT03821623|Vitamins|vitamins|mesh-ancestor
154351856|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
154351857|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351858|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154351859|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
154351860|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351861|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154351862|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
154351863|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154351864|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
154351865|NCT03928145|Amiloride|amiloride|mesh-list
154351866|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154351867|NCT03928145|Diuretics|diuretics|mesh-ancestor
154351868|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
154351869|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351870|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154351871|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351872|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351873|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154351874|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154351875|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154351876|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154351877|NCT01129271|Clopidogrel|clopidogrel|mesh-list
154351878|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154351879|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154351880|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154351881|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154351882|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
154351883|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351884|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351885|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351886|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
153531012|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
154351909|NCT04457050|Ribavirin|ribavirin|mesh-list
154351910|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
154351911|NCT04457050|Ledipasvir|ledipasvir|mesh-list
154351912|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
154351913|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351914|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
154351915|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351916|NCT01228409|Acitretin|acitretin|mesh-list
154351917|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
154351918|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
154351919|NCT03470350|Capecitabine|capecitabine|mesh-list
154351920|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154351921|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
154351922|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351923|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351924|NCT04565392|Famotidine|famotidine|mesh-list
154351925|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154351926|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351927|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154351928|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
154351929|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
154351930|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351931|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351932|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351933|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154351934|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
154351935|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154351936|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
154351937|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351938|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154351956|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351957|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351958|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154351960|NCT01129427|Clopidogrel|clopidogrel|mesh-list
154351961|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154351962|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154351963|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154351964|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154351965|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
154351966|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351967|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351968|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351969|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154351970|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351971|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154351972|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351973|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154351974|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
154351975|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351976|NCT03354429|Ticagrelor|ticagrelor|mesh-list
154351977|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154351978|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154351979|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153969698|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
154351980|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154351981|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
154351982|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351983|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351984|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351985|NCT05164198|Adalimumab|adalimumab|mesh-list
154351986|NCT05164198|Infliximab|infliximab|mesh-list
154351987|NCT05164198|Golimumab|golimumab|mesh-list
154351988|NCT05164198|Etanercept|etanercept|mesh-list
154351989|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154351990|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154351991|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351992|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
154351993|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154351994|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153531129|NCT01494805|Ranibizumab|ranibizumab|mesh-list
154352007|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352008|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154352009|NCT03924245|Olaparib|olaparib|mesh-list
154352010|NCT03924245|Entinostat|entinostat|mesh-list
154352011|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154352012|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352013|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352014|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352015|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154352016|NCT01225445|Ramipril|ramipril|mesh-list
154352017|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154352018|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
154352019|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352020|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352021|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154352022|NCT05555329|Thalidomide|thalidomide|mesh-list
154352023|NCT05555329|Pomalidomide|pomalidomide|mesh-list
154352024|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
154352025|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352026|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154352027|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154352028|NCT05555329|Growth Substances|growth substances|mesh-ancestor
154352029|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
154352030|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352031|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154352032|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
154352033|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154352034|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352035|NCT01228565|Cetuximab|cetuximab|mesh-list
154352036|NCT01228565|OTD70DERM|otd70derm|mesh-list
154352037|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352038|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352039|NCT01228565|Protective Agents|protective agents|mesh-ancestor
154352040|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352041|NCT01226849|Rituximab|rituximab|mesh-list
154352042|NCT01226849|Carboplatin|carboplatin|mesh-list
154352043|NCT01226849|Etoposide|etoposide|mesh-list
154352044|NCT01226849|Bortezomib|bortezomib|mesh-list
154352045|NCT01226849|Ifosfamide|ifosfamide|mesh-list
154352046|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352047|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352048|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
154352049|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352050|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154352051|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154352052|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154352053|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154352054|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352055|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201559|NCT04994561|Dasatinib|dasatinib|mesh-list
154352056|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154352057|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
154352058|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
154352091|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098409|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154352092|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
154352093|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352094|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
154352095|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861853|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861854|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
154255431|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154352097|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154352098|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
154352105|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352106|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
154352107|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154352108|NCT03384693|Defibrotide|defibrotide|mesh-list
154352109|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154352110|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154352111|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352112|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154352113|NCT05533281|Dexamethasone|dexamethasone|mesh-list
154352114|NCT05533281|Metoclopramide|metoclopramide|mesh-list
154352115|NCT05533281|Tropisetron|tropisetron|mesh-list
154352116|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154352117|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
154352118|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
154352119|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352120|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352121|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154352122|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
154352123|NCT05533281|Hormones|hormones|mesh-ancestor
154352124|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154352125|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154352126|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352127|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154352128|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154352129|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
154352130|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352131|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352132|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154352133|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154352134|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
154352135|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
154352136|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154352137|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352138|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352139|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154352140|NCT03923075|Analgesics|analgesics|mesh-ancestor
154352141|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
154352142|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352143|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154352144|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154352145|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154352146|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
154352147|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352148|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352149|NCT03923231|Ritonavir|ritonavir|mesh-list
154352150|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154352151|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154352152|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154352153|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
154352154|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352155|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352156|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154352157|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154352158|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
154352159|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352160|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154352161|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154352162|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
154352163|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352164|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
154352165|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154352198|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
154352199|NCT03815539|Protective Agents|protective agents|mesh-ancestor
154352200|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
154352201|NCT03922919|Cefotaxime|cefotaxime|mesh-list
154352202|NCT03922919|Cefoxitin|cefoxitin|mesh-list
154352203|NCT03922919|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154352204|NCT03922919|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154352205|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861855|NCT04744623|Hormones|hormones|mesh-ancestor
154352206|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352207|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
154352208|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154352209|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352222|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154352223|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352224|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
154352225|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
154352226|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
154352227|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352228|NCT01285102|Irinotecan|irinotecan|mesh-list
154352229|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154352230|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154352231|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352232|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352233|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352234|NCT03740243|Buprenorphine|buprenorphine|mesh-list
154352235|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154352236|NCT03740243|Naloxone|naloxone|mesh-list
154352237|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154352238|NCT03740243|Narcotics|narcotics|mesh-ancestor
154352239|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352240|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352241|NCT03740243|Analgesics|analgesics|mesh-ancestor
154352242|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
154352243|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352244|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154352245|NCT03813043|Midazolam|midazolam|mesh-list
154352246|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154352247|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154352248|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352249|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352250|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154352251|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154352252|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154352253|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154352254|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
154352255|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
154352256|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
154201700|NCT00438672|Hormones|hormones|mesh-ancestor
154352257|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
154352258|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352259|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352260|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
154352261|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352262|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352263|NCT03382899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154352264|NCT03382899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352265|NCT03815305|Petrolatum|petrolatum|mesh-list
154352266|NCT03815305|Emollients|emollients|mesh-ancestor
154352267|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
154352268|NCT01560013|Naltrexone|naltrexone|mesh-list
154352269|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154352270|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154352271|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531398|NCT01496326|Analgesics|analgesics|mesh-ancestor
154352285|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
154352286|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352287|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352288|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352289|NCT01560091|Urological Agents|urological agents|mesh-ancestor
154352290|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
154352291|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154352292|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352293|NCT03807271|Anesthetics|anesthetics|mesh-list
154352294|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352295|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352296|NCT03812731|Fentanyl|fentanyl|mesh-list
154352297|NCT03812731|Ropivacaine|ropivacaine|mesh-list
154352298|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
154352299|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
154352300|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352301|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352302|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
154352303|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352304|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154352305|NCT03812731|Narcotics|narcotics|mesh-ancestor
154352306|NCT03812731|Analgesics|analgesics|mesh-ancestor
154352307|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154352308|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154352309|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
154352310|NCT03351231|Nivolumab|nivolumab|mesh-list
154352311|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352312|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352313|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154352314|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352315|NCT03922373|Benzonatate|benzonatate|mesh-list
154352316|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
154352317|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
154352318|NCT03709719|Blinatumomab|blinatumomab|mesh-list
154352319|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352320|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
154352321|NCT03926663|Bupivacaine|bupivacaine|mesh-list
154352322|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
154352323|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
154352324|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352325|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352326|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
154352327|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352328|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154352329|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154352330|NCT03926663|Analgesics|analgesics|mesh-ancestor
154352331|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154352332|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153531457|NCT01496742|Paclitaxel|paclitaxel|mesh-list
154352339|NCT05481775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352341|NCT05165914|Anesthetics|anesthetics|mesh-list
154352342|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352343|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352344|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154352345|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154352346|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154352347|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154352348|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154352349|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154352350|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
154352351|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
154352352|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
154352353|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352354|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352355|NCT01132157|Propofol|propofol|mesh-list
154352356|NCT01132157|Desflurane|desflurane|mesh-list
154352357|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154352358|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352359|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352360|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154352361|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
154352362|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
154352363|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154352364|NCT05389150|Pregabalin|pregabalin|mesh-list
154352365|NCT05389150|Tramadol|tramadol|mesh-list
154352366|NCT05389150|Analgesics|analgesics|mesh-ancestor
154352367|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
154352368|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352369|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352370|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
154352371|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154352372|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154352373|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352374|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154352375|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154352376|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154352377|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352378|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154352379|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154352380|NCT05389150|Narcotics|narcotics|mesh-ancestor
154352381|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154352382|NCT03806101|Abrocitinib|abrocitinib|mesh-list
154352383|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154352384|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154352385|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
154352386|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352387|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154352388|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154352389|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352390|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154352391|NCT03812419|Esomeprazole|esomeprazole|mesh-list
154352392|NCT03812419|Pantoprazole|pantoprazole|mesh-list
154352393|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154352394|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098714|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
154352395|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154352396|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352397|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352399|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154352400|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154352415|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
154352416|NCT03401229|Benralizumab|benralizumab|mesh-list
154352417|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154352418|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
154352419|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154352420|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154352421|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
154352422|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
154352423|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
154352424|NCT05281081|Morphine|morphine|mesh-list
154352425|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
154352426|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154352427|NCT05281081|Narcotics|narcotics|mesh-ancestor
154352428|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352429|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352430|NCT05281081|Analgesics|analgesics|mesh-ancestor
154352431|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
154352432|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352433|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
154352434|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
154352435|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
154352436|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154352437|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154352438|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154352439|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154352440|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352441|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
154352442|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352443|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352444|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154352445|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352446|NCT01303237|Cetuximab|cetuximab|mesh-list
154352447|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352448|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352449|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
154352450|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154352451|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352452|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154352453|NCT01227941|Doxorubicin|doxorubicin|mesh-list
154352454|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154352455|NCT01227941|Niraparib|niraparib|mesh-list
154352456|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154352457|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352458|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154352459|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154352460|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352461|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352470|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352471|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352472|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154352473|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154352474|NCT03380091|Vitamin D|vitamin d|mesh-list
154352475|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
154352476|NCT03380091|Metformin|metformin|mesh-list
154352477|NCT03380091|Vitamins|vitamins|mesh-ancestor
154352478|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
154352479|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352480|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154352481|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154352482|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154352483|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
154255433|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154352484|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154352485|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352486|NCT03919253|Paclitaxel|paclitaxel|mesh-list
154352487|NCT03919253|Maleic acid|maleic acid|mesh-list
154352488|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154352489|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352490|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
154352491|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
154352492|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
154352493|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352494|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352495|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154352496|NCT05165290|Latanoprost|latanoprost|mesh-list
154352497|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154352498|NCT01132703|Glyburide|glyburide|mesh-list
154352499|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154352500|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352501|NCT01377922|Amifampridine|amifampridine|mesh-list
154352502|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154352503|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352504|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352505|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154352506|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154352507|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352508|NCT03919175|Rituximab|rituximab|mesh-list
154352509|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352510|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352511|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
154352512|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352513|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154352514|NCT01303471|Remifentanil|remifentanil|mesh-list
154352515|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154352516|NCT01303471|Narcotics|narcotics|mesh-ancestor
154352517|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352518|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352519|NCT01303471|Analgesics|analgesics|mesh-ancestor
154352520|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
154352521|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352522|NCT03804541|Ensartinib|ensartinib|mesh-list
154352523|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352524|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154352525|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352526|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352527|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
154352528|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531656|NCT01497652|Rasagiline|rasagiline|mesh-list
154352548|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154352549|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352550|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352551|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352553|NCT01302613|Capecitabine|capecitabine|mesh-list
154352554|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
154352555|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154352556|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
154352557|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352558|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352559|NCT01302613|Antidotes|antidotes|mesh-ancestor
154352560|NCT01302613|Protective Agents|protective agents|mesh-ancestor
154352561|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352562|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
154352563|NCT01302613|Vitamins|vitamins|mesh-ancestor
154352564|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
154352565|NCT03803371|Acetaminophen|acetaminophen|mesh-list
154352566|NCT03803371|Tramadol|tramadol|mesh-list
154352567|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154352568|NCT03803371|Analgesics|analgesics|mesh-ancestor
154352569|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
154352570|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352571|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352572|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
154352573|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154352574|NCT03803371|Narcotics|narcotics|mesh-ancestor
154352575|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352576|NCT01130909|Ketamine|ketamine|mesh-list
154352577|NCT01130909|Analgesics|analgesics|mesh-ancestor
154861856|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154352578|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
154352579|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352580|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352581|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154352582|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154352583|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
154352584|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
154352585|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352586|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154352587|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154352596|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
154352597|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352598|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154352599|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154352600|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352601|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352602|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352603|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154352604|NCT03796507|Temozolomide|temozolomide|mesh-list
154352605|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154352606|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
154352607|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352608|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352609|NCT01132781|Theophylline|theophylline|mesh-list
154352610|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154352611|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
154352612|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352613|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352614|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154352615|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
154352616|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154352617|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352618|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352619|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
154352620|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154352621|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154352622|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
154352623|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352624|NCT03497767|Osimertinib|osimertinib|mesh-list
154352625|NCT03497767|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154352626|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154352627|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352628|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352629|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352630|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
154352631|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154352632|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
154352633|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352634|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154352635|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154352636|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
154352637|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352638|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352639|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154352640|NCT01134341|Vitamins|vitamins|mesh-list
154352641|NCT01134341|Folic Acid|folic acid|mesh-list
154352642|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
154352643|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
154352644|NCT01134341|Bexarotene|bexarotene|mesh-list
154352645|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
154352646|NCT01134341|Aminopterin|aminopterin|mesh-list
154352647|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
154352648|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352649|NCT01134341|Hematinics|hematinics|mesh-ancestor
154352650|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154352651|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352652|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352653|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352654|NCT04308304|Donepezil|donepezil|mesh-list
154352655|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154352669|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352670|NCT01230359|Pyridoxine|pyridoxine|mesh-list
154352671|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
154352672|NCT01230359|Vitamins|vitamins|mesh-ancestor
154352673|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
154352674|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352675|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
154352676|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
154352677|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352678|NCT03795571|Dexamethasone|dexamethasone|mesh-list
154352679|NCT03795571|Rituximab|rituximab|mesh-list
154352680|NCT03795571|Gemcitabine|gemcitabine|mesh-list
154352681|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
154352682|NCT03795571|Lenalidomide|lenalidomide|mesh-list
154352683|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154352684|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
154352685|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
154352686|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352687|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352688|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154352689|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
154352690|NCT03795571|Hormones|hormones|mesh-ancestor
154352691|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154352692|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154352693|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352694|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352695|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
154352696|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154352697|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154352698|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
154352699|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099010|NCT02521493|Analgesics|analgesics|mesh-ancestor
154352700|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154352701|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154352702|NCT03795571|Growth Substances|growth substances|mesh-ancestor
154352703|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
154352704|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
154352705|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154352706|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154352707|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352708|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
154352709|NCT03795649|Coagulants|coagulants|mesh-ancestor
154352710|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
154352711|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154352712|NCT04211272|Macitentan|macitentan|mesh-list
154352713|NCT04211272|Riociguat|riociguat|mesh-list
154352714|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154352715|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154352716|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
154352717|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352730|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154352731|NCT05402189|Narcotics|narcotics|mesh-ancestor
154352732|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352733|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352734|NCT05402189|Analgesics|analgesics|mesh-ancestor
154352735|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
154352736|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352737|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154352738|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154352739|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
154352740|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
154352741|NCT01304563|Vaccines|vaccines|mesh-list
154352742|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
154352743|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352744|NCT01231997|Udenafil|udenafil|mesh-list
154352745|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154352746|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154352747|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352748|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352749|NCT03795805|Lidocaine|lidocaine|mesh-list
154352750|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
154352751|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
154352752|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352753|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352754|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
154352755|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352756|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154352757|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154352758|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154352759|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154352760|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352761|NCT04072042|Apatinib|apatinib|mesh-list
154352762|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352763|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154352764|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352765|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352766|NCT03799315|Nicotine|nicotine|mesh-list
154352767|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154352768|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
154352769|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352770|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352771|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154352772|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154352773|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
154352774|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352775|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352777|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154352778|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352796|NCT03921671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352797|NCT03921671|Growth Inhibitors|growth inhibitors|mesh-ancestor
154352798|NCT03921593|Pancrelipase|pancrelipase|mesh-list
154352799|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154352800|NCT03369951|Minocycline|minocycline|mesh-list
154352801|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154352802|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352803|NCT01131767|Naproxen|naproxen|mesh-list
154352804|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
154352805|NCT01131767|Ephedrine|ephedrine|mesh-list
154352806|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154352807|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154352808|NCT01131767|Analgesics|analgesics|mesh-ancestor
154352809|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
154352810|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352811|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352812|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154352813|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154352814|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
154352815|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154352816|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352817|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352818|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154352819|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
154352820|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154352821|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
154352822|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
154352823|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154352824|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154352825|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
154352826|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
154352827|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352828|NCT03795259|Rocuronium|rocuronium|mesh-list
154352829|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154352830|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154352831|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154352832|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352833|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352834|NCT01229189|Vitamin D|vitamin d|mesh-list
154352835|NCT01229189|Vitamins|vitamins|mesh-ancestor
154352836|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
154352837|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352847|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154352848|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
154352849|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
154352850|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352851|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352852|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352853|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154352854|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
154352855|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352856|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154352857|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
154352858|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
154352859|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154352860|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154352861|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
154352862|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
153970370|NCT00724867|Belimumab|belimumab|mesh-list
154352863|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
154352864|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
154352865|NCT05401721|Coagulants|coagulants|mesh-ancestor
154352866|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154352867|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154352868|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
154352869|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352870|NCT01560481|Metformin|metformin|mesh-list
154352871|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154352872|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352873|NCT05238844|Tenofovir|tenofovir|mesh-list
154352874|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
154352875|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352876|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154352877|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154352878|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352879|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352880|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154352881|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154352882|NCT04785625|Bupivacaine|bupivacaine|mesh-list
154352883|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
154352884|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
154352885|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352886|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352887|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
154352888|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352889|NCT03368859|Leucovorin|leucovorin|mesh-list
154352890|NCT03368859|Bevacizumab|bevacizumab|mesh-list
154352891|NCT03368859|Fluorouracil|fluorouracil|mesh-list
154352892|NCT03368859|Irinotecan|irinotecan|mesh-list
154352893|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352894|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352895|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154352896|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154352897|NCT03368859|Growth Substances|growth substances|mesh-ancestor
154352898|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352899|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
154352900|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
154582980|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154352901|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352902|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154352903|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154352904|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
153532022|NCT01500408|Interferons|interferons|mesh-list
154352922|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154352923|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352924|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352925|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154352926|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
154352927|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
154352928|NCT03810547|Analgesics|analgesics|mesh-ancestor
154352929|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
154352930|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352931|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154352932|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154352933|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154352934|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352935|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352936|NCT03096314|Vitamin D|vitamin d|mesh-list
154352937|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
154352938|NCT03096314|Vitamins|vitamins|mesh-ancestor
154352939|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
154352940|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352941|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154352942|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154352943|NCT03710655|Histamine|histamine|mesh-list
154352944|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
154352945|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
154352946|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352947|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352948|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352949|NCT03917537|Nivolumab|nivolumab|mesh-list
154352950|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352951|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352952|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154861857|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255434|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352953|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352955|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
154352956|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154352957|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352958|NCT04749602|Nivolumab|nivolumab|mesh-list
154352959|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154352960|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352961|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154352962|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352963|NCT03461302|Coal Tar|coal tar|mesh-list
154352974|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
154352975|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
154352976|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352977|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352978|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154352979|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154352980|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352981|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154352982|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
154352983|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154352984|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352985|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154352986|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
154352987|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154352988|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154352989|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154352990|NCT01131845|Treprostinil|treprostinil|mesh-list
154352991|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154352992|NCT03711422|Afatinib|afatinib|mesh-list
154352993|NCT03711422|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154352994|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154352995|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352996|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352997|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352998|NCT03460678|Pemetrexed|pemetrexed|mesh-list
154352999|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154353000|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353001|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353002|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353003|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154353004|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154353005|NCT03460678|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154353006|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154353007|NCT03810391|Butorphanol|butorphanol|mesh-list
154353008|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154353009|NCT03810391|Narcotics|narcotics|mesh-ancestor
154353010|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353011|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353012|NCT03810391|Analgesics|analgesics|mesh-ancestor
154353013|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
154353014|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353015|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
154353016|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
154353017|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154353018|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
154353019|NCT01229579|Astringents|astringents|mesh-ancestor
154353020|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353021|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
154353022|NCT01131923|Amlodipine|amlodipine|mesh-list
154353023|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154353024|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154353025|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154353026|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353027|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154353028|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353029|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
153532145|NCT01500928|Insulin|insulin|mesh-list
154353038|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154353039|NCT01230983|Doxorubicin|doxorubicin|mesh-list
154353040|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154861858|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154353041|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
154353042|NCT01230983|Methotrexate|methotrexate|mesh-list
154353043|NCT01230983|Vincristine|vincristine|mesh-list
154353044|NCT01230983|Asparaginase|asparaginase|mesh-list
154353045|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
154353046|NCT01230983|Razoxane|razoxane|mesh-list
154353047|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
154353048|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154353049|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353050|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154353051|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154353052|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353053|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353054|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353055|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353056|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
154353057|NCT01230983|Hormones|hormones|mesh-ancestor
154353058|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353059|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154353060|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154353061|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
154353062|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154353063|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154353064|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
154353065|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
154353066|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154353067|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353068|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
154353069|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353070|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154353071|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
154353072|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353073|NCT01230983|Antidotes|antidotes|mesh-ancestor
154353074|NCT01230983|Protective Agents|protective agents|mesh-ancestor
154353075|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
154353076|NCT01230983|Vitamins|vitamins|mesh-ancestor
154353077|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
154353078|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154353079|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
154353080|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
154353081|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
154353082|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154353083|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
154353084|NCT01304797|Trastuzumab|trastuzumab|mesh-list
154353085|NCT01304797|Doxorubicin|doxorubicin|mesh-list
154353086|NCT01304797|Gancotamab|gancotamab|mesh-list
154353087|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
154353088|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353089|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
154353090|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353091|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353092|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154353093|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
154353094|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353095|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353096|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154353097|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154353098|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154353099|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154353130|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
154353132|NCT01229813|Capecitabine|capecitabine|mesh-list
154353133|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154353134|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154353135|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353136|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154353137|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154353138|NCT01229813|Growth Substances|growth substances|mesh-ancestor
154353139|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353140|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
154353141|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154353142|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
154353143|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353157|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
154353158|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353159|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154353160|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970588|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
154353161|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353162|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
154353163|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353164|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154353165|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353166|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
154353168|NCT01649947|Bevacizumab|bevacizumab|mesh-list
154353169|NCT01649947|Carboplatin|carboplatin|mesh-list
154353170|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154353171|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353172|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
154353173|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
154353174|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
154353175|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353176|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154353177|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154353178|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154353179|NCT01649947|Growth Substances|growth substances|mesh-ancestor
154353180|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353181|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
154353182|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
154353183|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154353184|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154353185|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353186|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353187|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353188|NCT03793075|Ketamine|ketamine|mesh-list
154353189|NCT03793075|Propofol|propofol|mesh-list
154353190|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154353191|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353192|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353193|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154353194|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
154353195|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
154353196|NCT03793075|Analgesics|analgesics|mesh-ancestor
154353197|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
154353198|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353199|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154353200|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154353201|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154353202|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182183|NCT05868525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154353215|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154353216|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353218|NCT03707457|Ipilimumab|ipilimumab|mesh-list
154353219|NCT03707457|MK-4166|mk-4166|mesh-list
154353220|NCT03707457|Antibodies|antibodies|mesh-list
154353221|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154353222|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
154353223|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353224|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154353225|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353226|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154353227|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353228|NCT01568294|Pomalidomide|pomalidomide|mesh-list
154353229|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
154353230|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353231|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154353232|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154353233|NCT01568294|Growth Substances|growth substances|mesh-ancestor
154353234|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
154353235|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353236|NCT03422666|Teduglutide|teduglutide|mesh-list
154353237|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154353238|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154353239|NCT03422666|Protective Agents|protective agents|mesh-ancestor
154353240|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353241|NCT03453190|Apremilast|apremilast|mesh-list
154353242|NCT03453190|Clobetasol|clobetasol|mesh-list
154353243|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154353244|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154353245|NCT03453190|Analgesics|analgesics|mesh-ancestor
154353246|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
154861859|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
154255435|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154255436|NCT03901118|Paclitaxel|paclitaxel|mesh-list
154255437|NCT03901118|Etoposide|etoposide|mesh-list
154255438|NCT03901118|Chiauranib|chiauranib|mesh-list
154255439|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154255440|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970665|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
154353247|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353248|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353249|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353250|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353251|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154353252|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154353253|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353254|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353255|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
154353256|NCT03453190|Hormones|hormones|mesh-ancestor
154353257|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353258|NCT01231139|Acetaminophen|acetaminophen|mesh-list
154353259|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154353260|NCT01231139|Analgesics|analgesics|mesh-ancestor
154353261|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
154353262|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353274|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
154353275|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353277|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154353278|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154353279|NCT02528825|Remifentanil|remifentanil|mesh-list
154353280|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154353281|NCT02528825|Narcotics|narcotics|mesh-ancestor
154353282|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353283|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353284|NCT02528825|Analgesics|analgesics|mesh-ancestor
154353285|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
154353286|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353287|NCT01233245|Interferons|interferons|mesh-list
154353288|NCT01233245|Interferon-beta|interferon-beta|mesh-list
154353289|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
154353290|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202506|NCT01058577|Hormones|hormones|mesh-ancestor
154353291|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
154353292|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353293|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
154353294|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353295|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154353296|NCT03776812|Paclitaxel|paclitaxel|mesh-list
154353297|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154353298|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154353299|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353300|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154353301|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
154353302|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
154353303|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353304|NCT03361605|Propofol|propofol|mesh-list
154353305|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154353306|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353307|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353308|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154353309|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
154353310|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
154353311|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
154353312|NCT03794167|Melphalan|melphalan|mesh-list
154353313|NCT03794167|Busulfan|busulfan|mesh-list
154353314|NCT03794167|Etoposide|etoposide|mesh-list
154353315|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353316|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
154353317|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353318|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353319|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154353320|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
154353321|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861860|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
154861861|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861862|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154861863|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154861864|NCT04744623|Protective Agents|protective agents|mesh-ancestor
154861865|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154255442|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154255443|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154255444|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255445|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154255446|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154255447|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255448|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154255449|NCT03895892|Caffeine|caffeine|mesh-list
154255450|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154353322|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353323|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154353324|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154353325|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154353326|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154353327|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353349|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154353350|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154353351|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
154353352|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353353|NCT03829046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154353354|NCT03829046|Protease Inhibitors|protease inhibitors|mesh-ancestor
154353355|NCT03829046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353356|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154353357|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
154353358|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154353359|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353360|NCT05320588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154353361|NCT05320588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353362|NCT01231529|Dolutegravir|dolutegravir|mesh-list
154353363|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154353364|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154353365|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353366|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353367|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154353368|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154353369|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
154353370|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353371|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154353372|NCT05306704|Calcifediol|calcifediol|mesh-list
154353373|NCT05306704|Vitamins|vitamins|mesh-ancestor
154353374|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
154353375|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353376|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154353377|NCT01231685|Ritonavir|ritonavir|mesh-list
154353378|NCT01231685|Lopinavir|lopinavir|mesh-list
154353379|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154353380|NCT01231685|Darunavir|darunavir|mesh-list
154353390|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353391|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154353392|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154353393|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154353394|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154353396|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
154353397|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353398|NCT05402735|Protective Agents|protective agents|mesh-ancestor
154353399|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353400|NCT01138085|Trametinib|trametinib|mesh-list
154353401|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353402|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154353403|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353404|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353405|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154353406|NCT03792217|Eusol|eusol|mesh-list
154353407|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
154861866|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
154861867|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
154861868|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154861869|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154861870|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154861871|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
154861872|NCT00939731|Crizotinib|crizotinib|mesh-list
154861873|NCT00939731|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154861874|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154861875|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353408|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353409|NCT03359811|Bupivacaine|bupivacaine|mesh-list
154353410|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
154353411|NCT03359811|Anesthetics|anesthetics|mesh-list
154353412|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353413|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353414|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
154353415|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353416|NCT03728426|Letermovir|letermovir|mesh-list
154353417|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154353418|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353419|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353420|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353421|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
154353422|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353423|NCT01140581|Dronedarone|dronedarone|mesh-list
154353424|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154353425|NCT03792139|Itraconazole|itraconazole|mesh-list
154353426|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
154353427|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353428|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154353429|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154353430|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353431|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353432|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154353433|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
154353434|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353435|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353436|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154353437|NCT03792295|Acetaminophen|acetaminophen|mesh-list
154353438|NCT03792295|Ibuprofen|ibuprofen|mesh-list
154353439|NCT03792295|Oxycodone|oxycodone|mesh-list
154353440|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154353441|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154353442|NCT03792295|Analgesics|analgesics|mesh-ancestor
154353443|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
154353444|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532558|NCT01502241|Temozolomide|temozolomide|mesh-list
154353471|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
154353472|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154353473|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353474|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154353475|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353476|NCT04745273|Ondansetron|ondansetron|mesh-list
154353477|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
154353478|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
154353479|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353480|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353481|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154353482|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
154353483|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
154353484|NCT04745273|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154353485|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154353486|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
154353487|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353488|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353489|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
154353490|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154353491|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
154353505|NCT03448588|Selenium|selenium|mesh-list
154353506|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
154353507|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353508|NCT03448588|Protective Agents|protective agents|mesh-ancestor
154353509|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353510|NCT03448588|Trace Elements|trace elements|mesh-ancestor
154353511|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
154353512|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
154353513|NCT03797443|Paclitaxel|paclitaxel|mesh-list
154353514|NCT03797443|Gemcitabine|gemcitabine|mesh-list
154353515|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154353516|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353517|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
154353518|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
154353519|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582981|NCT05430750|Analgesics|analgesics|mesh-ancestor
154353520|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353521|NCT03797443|Vitamins|vitamins|mesh-ancestor
154353522|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
154353523|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353524|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154353525|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
154353526|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
154353527|NCT03797443|Protective Agents|protective agents|mesh-ancestor
154353528|NCT01135589|Micafungin|micafungin|mesh-list
154353529|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
154353530|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353531|NCT01140737|Axitinib|axitinib|mesh-list
154353532|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353533|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154353534|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353535|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353536|NCT05624671|Fentanyl|fentanyl|mesh-list
154353537|NCT05624671|Bupivacaine|bupivacaine|mesh-list
154353538|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
154353539|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
154353540|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353541|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353542|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
154353543|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353544|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154353545|NCT05624671|Narcotics|narcotics|mesh-ancestor
154353546|NCT05624671|Analgesics|analgesics|mesh-ancestor
154353547|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154353548|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154353549|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
154353550|NCT03578965|Cefazolin|cefazolin|mesh-list
154353551|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154353552|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353553|NCT03791905|Leucovorin|leucovorin|mesh-list
154353554|NCT03791905|Paclitaxel|paclitaxel|mesh-list
154353555|NCT03791905|Fluorouracil|fluorouracil|mesh-list
154353556|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
154353557|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154353558|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353565|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353566|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
154353567|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353568|NCT03791905|Antidotes|antidotes|mesh-ancestor
154353569|NCT03791905|Protective Agents|protective agents|mesh-ancestor
154353570|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
154353571|NCT03791905|Vitamins|vitamins|mesh-ancestor
154353572|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
154353573|NCT01138553|Mifepristone|mifepristone|mesh-list
154353574|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154353575|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
154353576|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154353577|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353578|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154353579|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154353580|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154353581|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
154353582|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154353583|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154353584|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
154353585|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353586|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
154353587|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154353588|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154353589|NCT05171374|Trametinib|trametinib|mesh-list
154353590|NCT05171374|Dabrafenib|dabrafenib|mesh-list
154353591|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353592|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154353593|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353594|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353595|NCT03447184|Androgens|androgens|mesh-list
154353596|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154353597|NCT03447184|Hormones|hormones|mesh-ancestor
154353598|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353599|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353600|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154353601|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353602|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353603|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154353604|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
154353605|NCT03739541|Benzonidazole|benzonidazole|mesh-list
154353606|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353607|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
154099916|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154353609|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154353610|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154353611|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154353612|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353613|NCT01135667|Clopidogrel|clopidogrel|mesh-list
154353614|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154353615|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154353616|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154353617|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154353618|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154353619|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
154353620|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353621|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353622|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353623|NCT03446872|Leucovorin|leucovorin|mesh-list
154353624|NCT03446872|Fluorouracil|fluorouracil|mesh-list
154353625|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
154353626|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353640|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353642|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
154353643|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353644|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353645|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
154353646|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353647|NCT05401019|Pramipexole|pramipexole|mesh-list
154353648|NCT05401019|Risperidone|risperidone|mesh-list
154353649|NCT05401019|Dexpramipexole|dexpramipexole|mesh-list
154353650|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154353651|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
154353652|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353653|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353654|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353655|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154353656|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154353657|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353658|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154353659|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154353660|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
154353661|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
154353662|NCT05401019|Protective Agents|protective agents|mesh-ancestor
154353663|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154353664|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154353665|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
154353666|NCT03788863|Diflucortolone|diflucortolone|mesh-list
154353667|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
154353668|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353669|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
154353670|NCT03788863|Hormones|hormones|mesh-ancestor
154353671|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353672|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353673|NCT03129256|Apatinib|apatinib|mesh-list
154353674|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353675|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154353676|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353677|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353678|NCT05682807|Caffeine|caffeine|mesh-list
154353679|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154353680|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353681|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154353682|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353683|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353684|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154353685|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154353687|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353688|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
154353689|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
154353690|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
154353695|NCT03445702|Metformin|metformin|mesh-list
154353696|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154353697|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353699|NCT03445624|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154353700|NCT03445624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353701|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
154353702|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154353703|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353704|NCT01312077|Morphine|morphine|mesh-list
154353705|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
154353706|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154353707|NCT01312077|Narcotics|narcotics|mesh-ancestor
154353708|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353709|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353710|NCT01312077|Analgesics|analgesics|mesh-ancestor
154353711|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
154353712|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353713|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
154353714|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
154353715|NCT03793309|Vitamin D|vitamin d|mesh-list
154353716|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
154353717|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
154353718|NCT03793309|Vitamins|vitamins|mesh-list
154353719|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
154353720|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353721|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154353722|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154353723|NCT01140893|Exenatide|exenatide|mesh-list
154353724|NCT01140893|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154353725|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154353726|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353727|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154353728|NCT01140893|Incretins|incretins|mesh-ancestor
154353729|NCT01140893|Hormones|hormones|mesh-ancestor
154353730|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353731|NCT03445468|Vaccines|vaccines|mesh-list
154353732|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
154353733|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353734|NCT03791827|Cyclosporine|cyclosporine|mesh-list
154353735|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
154353736|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
154353737|NCT03791827|Prednisone|prednisone|mesh-list
154353738|NCT03791827|Prednisolone|prednisolone|mesh-list
154353739|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
154353740|NCT03791827|Rituximab|rituximab|mesh-list
154353741|NCT03791827|Azathioprine|azathioprine|mesh-list
154353742|NCT03791827|Tacrolimus|tacrolimus|mesh-list
154353743|NCT03791827|Cyclosporins|cyclosporins|mesh-list
154353744|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353745|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
154353746|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353747|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353748|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154353749|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
154353750|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353751|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353752|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154353753|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154353754|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353755|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
154353756|NCT03791827|Hormones|hormones|mesh-ancestor
154353757|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353758|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154100065|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154353759|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154353760|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353761|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
154353762|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353785|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154353786|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154353787|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154353788|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154353789|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154353790|NCT01308229|Paclitaxel|paclitaxel|mesh-list
154353791|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154353792|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353793|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
154353794|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
154353795|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
154353796|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353798|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
154353799|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353800|NCT03445078|Protective Agents|protective agents|mesh-ancestor
154353801|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353802|NCT03445078|Trace Elements|trace elements|mesh-ancestor
154353803|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
154353804|NCT01233791|Diazepam|diazepam|mesh-list
154353805|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154353806|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
154353807|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
154353808|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
154353809|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353810|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353811|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154353812|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154202923|NCT01004237|Valsartan|valsartan|mesh-list
154353813|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353814|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154353815|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154353816|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154353827|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154353828|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
154353829|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154353830|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353831|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154353832|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154353833|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
154353834|NCT03129022|Anesthetics|anesthetics|mesh-list
154353835|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353836|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353837|NCT03342963|Aripiprazole|aripiprazole|mesh-list
154353838|NCT03342963|Sertraline|sertraline|mesh-list
154353839|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
154353840|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154353841|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154353842|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154353843|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353844|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353845|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
154353846|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
154353847|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353848|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353849|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154353850|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154353851|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
154353852|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154353853|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154353854|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154353855|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154353856|NCT03342963|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154353857|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154353858|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154353859|NCT03706755|Norepinephrine|norepinephrine|mesh-list
154353860|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154353861|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154353862|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
154353863|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353864|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353865|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353866|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
154353867|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
154353868|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353869|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154353870|NCT03791515|Calcitonin|calcitonin|mesh-list
154353871|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
154353872|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154353873|NCT03791515|Katacalcin|katacalcin|mesh-list
154353874|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154353875|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353876|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154353877|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
154353878|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
154353879|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
154353880|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353881|NCT04595591|Remifentanil|remifentanil|mesh-list
154353882|NCT04595591|Rocuronium|rocuronium|mesh-list
154353894|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353895|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154353897|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353898|NCT03444142|Exenatide|exenatide|mesh-list
154353899|NCT03444142|Dulaglutide|dulaglutide|mesh-list
154353900|NCT03444142|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154353901|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154353902|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353903|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154353904|NCT03444142|Incretins|incretins|mesh-ancestor
154353905|NCT03444142|Hormones|hormones|mesh-ancestor
154353906|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353907|NCT01305733|Ketorolac|ketorolac|mesh-list
154353908|NCT01305733|Epinephrine|epinephrine|mesh-list
154353909|NCT01305733|Racepinephrine|racepinephrine|mesh-list
154353910|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
154353911|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
154353912|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154353913|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154353914|NCT01305733|Analgesics|analgesics|mesh-ancestor
154353915|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
154353916|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353917|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353918|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353919|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353920|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154353921|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353922|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353923|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
154353924|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
154353925|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353926|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154353927|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154353928|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
154353929|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353930|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154353931|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154353932|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
154353933|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154353934|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
154353935|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
154353936|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
154353937|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154353938|NCT05210153|Sertraline|sertraline|mesh-list
154353939|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
154353940|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154353941|NCT05210153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154353942|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154353943|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154353944|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353945|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203023|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154353960|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353961|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154353962|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
154353963|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154353964|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154353965|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154353966|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353967|NCT03361176|Triamcinolone|triamcinolone|mesh-list
154353968|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154353969|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154353970|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
154353971|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154353972|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353973|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
154353974|NCT03361176|Hormones|hormones|mesh-ancestor
154353975|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154353976|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353977|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353978|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
154353979|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353980|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353981|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154353982|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154353983|NCT03438214|Vancomycin|vancomycin|mesh-list
154353984|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154353985|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353986|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
154353987|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154353988|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154353989|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353990|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
154353991|NCT01141127|Coagulants|coagulants|mesh-ancestor
154353992|NCT05280444|Idarubicin|idarubicin|mesh-list
154353993|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154353994|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353995|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154353996|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154353997|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353998|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353999|NCT01308541|Propofol|propofol|mesh-list
154354000|NCT01308541|Fospropofol|fospropofol|mesh-list
154354001|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154354002|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354003|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354004|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154354012|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
154354013|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
154354014|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354015|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354016|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354017|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
154354019|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354020|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154354021|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354022|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
154354023|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354024|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354025|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354026|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
154354027|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354028|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
154354029|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154354030|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154354031|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154354032|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354033|NCT03437980|Propofol|propofol|mesh-list
154354034|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154354035|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354036|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354037|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154354038|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
154354039|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
154354040|NCT05176119|Ketamine|ketamine|mesh-list
154354041|NCT05176119|Nalbuphine|nalbuphine|mesh-list
154354042|NCT05176119|Analgesics|analgesics|mesh-ancestor
154354043|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
154354044|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354045|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354046|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154354047|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154354048|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
154354049|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
154354050|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354051|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154354052|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154354053|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354054|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354055|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154354056|NCT05176119|Narcotics|narcotics|mesh-ancestor
154100408|NCT00614614|Vaccines|vaccines|mesh-list
154354057|NCT03437902|Vitamins|vitamins|mesh-list
154354058|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
154354059|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
154354060|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354061|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
154354062|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354063|NCT03437902|Protective Agents|protective agents|mesh-ancestor
154354064|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
154354065|NCT05283499|Analgesics|analgesics|mesh-list
154354066|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
154354067|NCT05283499|Narcotics|narcotics|mesh-ancestor
154354068|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354069|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354070|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
154354071|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354072|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
154354073|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
154354074|NCT03437824|Vitamins|vitamins|mesh-ancestor
154354081|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154354082|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154354083|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
154354084|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354085|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354086|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354088|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
154354089|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354090|NCT05632445|Apixaban|apixaban|mesh-list
154354091|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154354092|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
154354093|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154354094|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
154354095|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354096|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203146|NCT01009073|Irinotecan|irinotecan|mesh-list
154354097|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
154354098|NCT01235117|Azacitidine|azacitidine|mesh-list
154354099|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154354100|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
154354101|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354102|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354103|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354104|NCT01306591|Bevacizumab|bevacizumab|mesh-list
154354105|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154354106|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354107|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154354108|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154354109|NCT01306591|Growth Substances|growth substances|mesh-ancestor
154354110|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354111|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
154354112|NCT03098030|Irinotecan|irinotecan|mesh-list
154354113|NCT03098030|Topotecan|topotecan|mesh-list
154354114|NCT03098030|Dinutuximab|dinutuximab|mesh-list
154354115|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154354116|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154354117|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354118|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354119|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354120|NCT01233947|Fulvestrant|fulvestrant|mesh-list
154354121|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154354122|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354123|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154354124|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154354125|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
154354126|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354127|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354128|NCT01139645|Esomeprazole|esomeprazole|mesh-list
154354129|NCT01139645|Rabeprazole|rabeprazole|mesh-list
154354130|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154354131|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354132|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154354133|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354134|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354135|NCT03706287|Cisplatin|cisplatin|mesh-list
154354136|NCT03706287|Carboplatin|carboplatin|mesh-list
154354137|NCT03706287|Pemetrexed|pemetrexed|mesh-list
154354138|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354139|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354140|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354141|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154354142|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154354143|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154354174|NCT04455958|Ritonavir|ritonavir|mesh-list
154354175|NCT04455958|Lopinavir|lopinavir|mesh-list
154354176|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154354177|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154354178|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
154354179|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354180|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354181|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154354182|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154354183|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
154354184|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354185|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154354186|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154354187|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
154354188|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354204|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154354205|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154354206|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
154354207|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354208|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354209|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354210|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
154100510|NCT00874744|Hormones|hormones|mesh-ancestor
154354211|NCT02891850|Tadalafil|tadalafil|mesh-list
154354212|NCT02891850|Riociguat|riociguat|mesh-list
154354213|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
154354214|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154354215|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154354216|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354217|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354218|NCT02891850|Urological Agents|urological agents|mesh-ancestor
154354219|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
154354220|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
154354221|NCT05175027|Povidone|povidone|mesh-list
154354222|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
154354223|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
154354224|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154354225|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354226|NCT03707418|Heparin|heparin|mesh-list
154354227|NCT03707418|Calcium heparin|calcium heparin|mesh-list
154354228|NCT03707418|Bivalirudin|bivalirudin|mesh-list
154354229|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
154354230|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154354231|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154354232|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354233|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
154354234|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154354235|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
154354236|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354237|NCT03785041|Tramadol|tramadol|mesh-list
154354238|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
154354239|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154354240|NCT03785041|Narcotics|narcotics|mesh-ancestor
154354241|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354242|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354243|NCT03785041|Analgesics|analgesics|mesh-ancestor
154354244|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
154354245|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354246|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354247|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
154354248|NCT03710304|Misoprostol|misoprostol|mesh-list
154354255|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154354256|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354257|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
154354258|NCT03710304|Coagulants|coagulants|mesh-ancestor
154354259|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154354260|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
154354261|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154354262|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354263|NCT03790345|Vitamins|vitamins|mesh-list
154354264|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
154354265|NCT03790345|Pyridoxine|pyridoxine|mesh-list
154354266|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
154354267|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
154354268|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
154354269|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354270|NCT05416190|Anticoagulants|anticoagulants|mesh-list
154354271|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
154354272|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
154354273|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354274|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154354275|NCT04454788|Tenecteplase|tenecteplase|mesh-list
154354276|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154354277|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154354278|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354279|NCT05681403|Cytarabine|cytarabine|mesh-list
154354280|NCT05681403|Carmustine|carmustine|mesh-list
154354281|NCT05681403|Melphalan|melphalan|mesh-list
154354282|NCT05681403|Etoposide|etoposide|mesh-list
154354283|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154354284|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
154354285|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354286|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354287|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154354288|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
154354289|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
154354290|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354291|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154354293|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354294|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154354295|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154354296|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154354297|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354298|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154354299|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154354300|NCT01309009|MEN 11420|men 11420|mesh-list
154354301|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154354302|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
154354303|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354304|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354305|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154354306|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
154354307|NCT03339453|Glucagon|glucagon|mesh-list
154354308|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154354309|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354310|NCT03339453|Hormones|hormones|mesh-ancestor
154354311|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354312|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354313|NCT03339453|Incretins|incretins|mesh-ancestor
154354314|NCT05418686|Colchicine|colchicine|mesh-list
154354315|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
154354316|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154354317|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
154354318|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
154354319|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
154354320|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354321|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354335|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
154354336|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354337|NCT03784495|Protective Agents|protective agents|mesh-ancestor
154354338|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354339|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354340|NCT05234697|Remifentanil|remifentanil|mesh-list
154354341|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154354342|NCT05234697|Narcotics|narcotics|mesh-ancestor
154354343|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354344|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354345|NCT05234697|Analgesics|analgesics|mesh-ancestor
154354346|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
154354347|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354348|NCT02133404|Cinacalcet|cinacalcet|mesh-list
154354349|NCT02133404|ASP7991|asp7991|mesh-list
154354350|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154354351|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354352|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154354353|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
154354354|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354355|NCT01307215|Ropivacaine|ropivacaine|mesh-list
154354356|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354357|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
154354358|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354359|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354361|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354362|NCT03420794|Analgesics|analgesics|mesh-list
154354363|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
154354364|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
154354365|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354366|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354367|NCT01568450|Oxycodone|oxycodone|mesh-list
154354368|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154354369|NCT01568450|Narcotics|narcotics|mesh-ancestor
154354370|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354371|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354372|NCT01568450|Analgesics|analgesics|mesh-ancestor
154354373|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
154354374|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354375|NCT03784105|Codeine|codeine|mesh-list
154354376|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154354377|NCT03784105|Narcotics|narcotics|mesh-ancestor
154354378|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354379|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354380|NCT03784105|Analgesics|analgesics|mesh-ancestor
154354381|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
154354382|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354383|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
154354384|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
154354394|NCT02989402|Rivastigmine|rivastigmine|mesh-list
154354395|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154354396|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354397|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354398|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
154354399|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354400|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354401|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154354402|NCT02989402|Protective Agents|protective agents|mesh-ancestor
154354403|NCT02861950|Bupivacaine|bupivacaine|mesh-list
154354404|NCT02861950|Ropivacaine|ropivacaine|mesh-list
154354405|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354406|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
154354407|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354408|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354409|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
154354410|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354411|NCT05681247|Ezetimibe|ezetimibe|mesh-list
154354412|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154354413|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154354414|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
154354415|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354416|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154354417|NCT03787927|Aspirin|aspirin|mesh-list
154354418|NCT03787927|Clopidogrel|clopidogrel|mesh-list
154354419|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154354420|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154354421|NCT03787927|Analgesics|analgesics|mesh-ancestor
154354422|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
154354423|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354424|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354425|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154354426|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154354427|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154354428|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154354429|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354430|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154354431|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154354432|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354433|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
154354434|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154354435|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154354436|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154354437|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
154354438|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354439|NCT00602576|Temozolomide|temozolomide|mesh-list
154100738|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154354440|NCT00602576|Sorafenib|sorafenib|mesh-list
154354441|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154354442|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
154354443|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354444|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354445|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154354446|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354448|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154354477|NCT04752540|Olorofim|olorofim|mesh-list
154354478|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
154354479|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354480|NCT04341454|Fexuprazan|fexuprazan|mesh-list
154354481|NCT04341454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354482|NCT03712345|Vilobelimab|vilobelimab|mesh-list
154354483|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154354484|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154354485|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
154354486|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354487|NCT03130348|Dexamethasone|dexamethasone|mesh-list
154354488|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
154354489|NCT03130348|Bortezomib|bortezomib|mesh-list
154354490|NCT03130348|Ichthammol|ichthammol|mesh-list
154354491|NCT03130348|BB 1101|bb 1101|mesh-list
154354492|NCT03130348|Ibrutinib|ibrutinib|mesh-list
154354493|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154354494|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
154354495|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
154354496|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354497|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354498|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354505|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354506|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354507|NCT03130348|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154354508|NCT03130348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154354509|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
154354510|NCT01307527|Riboflavin|riboflavin|mesh-list
154354511|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
154354512|NCT01307527|Vitamins|vitamins|mesh-ancestor
154354513|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
154354514|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354515|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154354516|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
154354517|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
154354518|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
154354519|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154354520|NCT03789799|Protective Agents|protective agents|mesh-ancestor
154354521|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354522|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
154354523|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154354524|NCT01309399|Teriparatide|teriparatide|mesh-list
154354525|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154354526|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354527|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154354528|NCT01309477|Tacrolimus|tacrolimus|mesh-list
154354529|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154354530|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
154354531|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354532|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154354533|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354534|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354535|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
154354536|NCT03089216|Calcium|calcium|mesh-list
154354537|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154354538|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354539|NCT03089216|Antacids|antacids|mesh-ancestor
154354540|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354541|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354542|NCT03339726|Phenylephrine|phenylephrine|mesh-list
154354543|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
154354544|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154354545|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
154354546|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
154354547|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354548|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354549|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
154354550|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154354551|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
154354552|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
154354553|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154354554|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154354555|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154354556|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
154354557|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354558|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354559|NCT03339726|Protective Agents|protective agents|mesh-ancestor
154354560|NCT03339297|Defibrotide|defibrotide|mesh-list
154354561|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154354562|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154354563|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354564|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154354565|NCT05434624|Midazolam|midazolam|mesh-list
154354566|NCT05434624|Propofol|propofol|mesh-list
153533668|NCT01507389|Hormones|hormones|mesh-ancestor
154354588|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154354590|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354591|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
154354592|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154354593|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
154354594|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354595|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154354596|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354597|NCT05215431|Antioxidants|antioxidants|mesh-list
154354598|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354599|NCT05215431|Protective Agents|protective agents|mesh-ancestor
154354600|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354601|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
154354602|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154354603|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154354604|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
154354605|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354606|NCT01310647|Estradiol|estradiol|mesh-list
154354607|NCT01310647|Testosterone|testosterone|mesh-list
154354608|NCT01310647|Estrogens|estrogens|mesh-ancestor
154354609|NCT01310647|Hormones|hormones|mesh-ancestor
154354610|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354611|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354612|NCT01310647|Androgens|androgens|mesh-ancestor
154354613|NCT02949024|Triamcinolone|triamcinolone|mesh-list
154354614|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154354615|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154354616|NCT02949024|Aflibercept|aflibercept|mesh-list
154354617|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154354618|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154354619|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
154354620|NCT02949024|Hormones|hormones|mesh-ancestor
154354621|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354643|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354644|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154354645|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354646|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154354647|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354648|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154354650|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
154354651|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154354652|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154354653|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154354654|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
154354655|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354656|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354657|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354658|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
154354659|NCT03782935|Choline|choline|mesh-list
154354660|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
154354661|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154354662|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
154354663|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354664|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354665|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154354666|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
154354667|NCT04370847|Ephedrine|ephedrine|mesh-list
154354668|NCT04370847|Fentanyl|fentanyl|mesh-list
154100967|NCT00922311|Aliskiren|aliskiren|mesh-list
154354669|NCT04370847|Bupivacaine|bupivacaine|mesh-list
154354670|NCT04370847|Oxytocin|oxytocin|mesh-list
154354671|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354672|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
154354673|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354674|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354675|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
154354681|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154354682|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
154354683|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
154354684|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154354685|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154354686|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
154354687|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
154354688|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154354689|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
154354690|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354691|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354692|NCT03708120|Insect Repellents|insect repellents|mesh-list
154354693|NCT03708120|Protective Agents|protective agents|mesh-ancestor
154354694|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354695|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
154354696|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154354697|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354698|NCT03093428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154354699|NCT03093428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354700|NCT02735980|Prexasertib|prexasertib|mesh-list
154354701|NCT02735980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154354702|NCT02735980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354703|NCT02735980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354704|NCT01309789|Prednisone|prednisone|mesh-list
154354705|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
154354706|NCT01309789|Doxorubicin|doxorubicin|mesh-list
154354707|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154354708|NCT01309789|Vincristine|vincristine|mesh-list
154354709|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154354710|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154354711|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154354712|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
154354713|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354714|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154354715|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154354716|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
154354717|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354718|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354719|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154354720|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154354721|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154354722|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154354723|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354724|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154354725|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
154354726|NCT01309789|Hormones|hormones|mesh-ancestor
154354727|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354728|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154354729|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154354730|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
154354731|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
154354732|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
154354733|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154354734|NCT01309789|Immunotoxins|immunotoxins|mesh-ancestor
154354735|NCT01309789|Immunoconjugates|immunoconjugates|mesh-ancestor
154354736|NCT03707847|Etoposide|etoposide|mesh-list
154354737|NCT03707847|Crizotinib|crizotinib|mesh-list
154354738|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154354739|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354740|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154354741|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154354742|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354743|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354744|NCT03707847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154354745|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154354770|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354771|NCT02620306|Losartan|losartan|mesh-list
154354772|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154354773|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154354774|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154354775|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154354776|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354777|NCT03781843|Lidocaine|lidocaine|mesh-list
154354778|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354779|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
154354780|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354781|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354782|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
154354783|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354784|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154354785|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154354786|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154354787|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354788|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354789|NCT05205447|Itraconazole|itraconazole|mesh-list
154354790|NCT05205447|Carbamazepine|carbamazepine|mesh-list
154354791|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
154354792|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354793|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153533898|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
154354809|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
154354810|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354811|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154354812|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354813|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154354814|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154354815|NCT03781687|Morphine|morphine|mesh-list
154354816|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154354817|NCT03781687|Narcotics|narcotics|mesh-ancestor
154354818|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354819|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354820|NCT03781687|Analgesics|analgesics|mesh-ancestor
154354821|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
154354822|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354823|NCT03092726|ASP8062|asp8062|mesh-list
154354824|NCT03092726|Analgesics|analgesics|mesh-ancestor
154354825|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
154354826|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354827|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354828|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
154354829|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
154354830|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203681|NCT00433836|Valsartan|valsartan|mesh-list
154354831|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354832|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
154354833|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154354834|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
154354835|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154354836|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
154354837|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354838|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354839|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
154354840|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154354841|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154354842|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
154354843|NCT05126511|Hormones|hormones|mesh-ancestor
154354844|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354845|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354846|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354847|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354848|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154354849|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154354850|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
154354858|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354859|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154354860|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354861|NCT03787069|Lidocaine|lidocaine|mesh-list
154354862|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354863|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
154354864|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354865|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354866|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
154354867|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354868|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154354869|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154354870|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154354871|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354872|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354873|NCT04447118|Docetaxel|docetaxel|mesh-list
154354874|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354875|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154354876|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154354877|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154354878|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354879|NCT01553032|Cetuximab|cetuximab|mesh-list
154354880|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154354881|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354882|NCT05181124|Naproxen|naproxen|mesh-list
154354883|NCT05181124|Meloxicam|meloxicam|mesh-list
154354884|NCT05181124|Aceclofenac|aceclofenac|mesh-list
154354885|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154354886|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154203746|NCT00422292|Vaccines|vaccines|mesh-list
154354887|NCT05181124|Analgesics|analgesics|mesh-ancestor
154354888|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
154354889|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101203|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
154354890|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354891|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154354892|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154354893|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
154354894|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154354895|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354896|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354897|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154354898|NCT02897648|Lactams|lactams|mesh-list
154354899|NCT02897648|beta-Lactams|beta-lactams|mesh-list
154354900|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154354901|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354902|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
154354903|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154354904|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354905|NCT04959591|Acetaminophen|acetaminophen|mesh-list
154354906|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154354907|NCT04959591|Analgesics|analgesics|mesh-ancestor
154354908|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
154354909|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354910|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354911|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
154354912|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
154354913|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154354914|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154354915|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354916|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
154354928|NCT03632408|Zopiclone|zopiclone|mesh-list
154354929|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154354930|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354931|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354932|NCT01307839|Lidocaine|lidocaine|mesh-list
154354933|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354934|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
154354935|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354936|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354937|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
154354938|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354939|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154354940|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154354941|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154354942|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354943|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354944|NCT03777085|Rituximab|rituximab|mesh-list
154354945|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154354946|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354947|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
154354948|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354949|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154354950|NCT01328548|Vaccines|vaccines|mesh-list
154354951|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
154354952|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354953|NCT04453306|Topiramate|topiramate|mesh-list
154354954|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
154354955|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154354956|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354957|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
154354958|NCT03786289|Hematinics|hematinics|mesh-ancestor
154354959|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
154354960|NCT03776851|Hematinics|hematinics|mesh-ancestor
154354961|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154354962|NCT03337308|Ezetimibe|ezetimibe|mesh-list
154354963|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154354964|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154354965|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
154354966|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354967|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154354968|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354969|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154354970|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354972|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354973|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154354974|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354975|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354976|NCT03468010|Paclitaxel|paclitaxel|mesh-list
154354977|NCT03468010|Cisplatin|cisplatin|mesh-list
154354978|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154354979|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354980|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
154354981|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154354982|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154354983|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354984|NCT03337152|Chloroquine|chloroquine|mesh-list
154354995|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154354996|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354997|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
154354998|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
154354999|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355000|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
154355001|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355002|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355003|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
154355004|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154355005|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154355006|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154355007|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154355008|NCT04305249|Nivolumab|nivolumab|mesh-list
154355009|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355010|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355011|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154355012|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355013|NCT03707808|Nivolumab|nivolumab|mesh-list
154355014|NCT03707808|Ipilimumab|ipilimumab|mesh-list
154355015|NCT03707808|Avelumab|avelumab|mesh-list
154355016|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355017|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355018|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154355019|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355020|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154355021|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154355022|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154355023|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154355024|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355025|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
154355026|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355027|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355028|NCT02761070|Bevacizumab|bevacizumab|mesh-list
154355029|NCT02761070|Temozolomide|temozolomide|mesh-list
154355030|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355031|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355032|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154355033|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154355034|NCT02761070|Growth Substances|growth substances|mesh-ancestor
153801715|NCT00321126|Zinc|zinc|mesh-list
154355035|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355036|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
154355037|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154355038|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
154355039|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355040|NCT03090152|Bupivacaine|bupivacaine|mesh-list
154355041|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
154355042|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
154355043|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355044|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355045|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
154355046|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355047|NCT03466528|Thiamine|thiamine|mesh-list
154355048|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
154355049|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
154355050|NCT03466528|Vitamins|vitamins|mesh-ancestor
154355084|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355085|NCT03130114|Azithromycin|azithromycin|mesh-list
154355086|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154355087|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355088|NCT03130270|Apatinib|apatinib|mesh-list
154355089|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355090|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154355091|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355100|NCT02522572|Plerixafor|plerixafor|mesh-list
154355101|NCT02522572|Bortezomib|bortezomib|mesh-list
154355102|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355103|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154355104|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154355105|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
154355106|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355107|NCT04602507|Ivermectin|ivermectin|mesh-list
154355108|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154355109|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355110|NCT03773809|Vitamin D|vitamin d|mesh-list
154355111|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
154355112|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
154355113|NCT03773809|Vitamins|vitamins|mesh-list
154355114|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
154355115|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355116|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154355117|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154355119|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154355120|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355121|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355122|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
154355123|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355124|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154355125|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154355126|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
154355127|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355128|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154355129|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355130|NCT03780049|Leucovorin|leucovorin|mesh-list
154355131|NCT03780049|Fluorouracil|fluorouracil|mesh-list
154355132|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
154355133|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
154355134|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355135|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154355136|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355137|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154355138|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
154355139|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355140|NCT03780049|Antidotes|antidotes|mesh-ancestor
154355141|NCT03780049|Protective Agents|protective agents|mesh-ancestor
154355142|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
154355143|NCT03780049|Vitamins|vitamins|mesh-ancestor
154355144|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
154355145|NCT04252287|Canagliflozin|canagliflozin|mesh-list
154355146|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154355147|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355148|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355149|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355150|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
154355151|NCT05681754|Calcium|calcium|mesh-list
154861876|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731362|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355152|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154355153|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355154|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154355155|NCT03465202|Capecitabine|capecitabine|mesh-list
154355156|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154355157|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
154355158|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355159|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355171|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154355173|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355174|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
154355175|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
154355176|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
154355177|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355178|NCT03464968|Leucovorin|leucovorin|mesh-list
154355179|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
154355180|NCT03464968|Irinotecan|irinotecan|mesh-list
154355181|NCT03464968|Fluorouracil|fluorouracil|mesh-list
154355182|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
154355183|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355184|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154355185|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154355186|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355187|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355188|NCT03464968|Antidotes|antidotes|mesh-ancestor
154355189|NCT03464968|Protective Agents|protective agents|mesh-ancestor
154355190|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355191|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
154355192|NCT03464968|Vitamins|vitamins|mesh-ancestor
154355193|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
154355194|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
154355195|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154355196|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154355197|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
154355198|NCT05073744|Morphine|morphine|mesh-list
154355199|NCT05073744|Nalbuphine|nalbuphine|mesh-list
154203994|NCT00451958|Leuprolide|leuprolide|mesh-list
154355200|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154355201|NCT05073744|Narcotics|narcotics|mesh-ancestor
154355202|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355203|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355204|NCT05073744|Analgesics|analgesics|mesh-ancestor
154355205|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
154355206|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355207|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
154355208|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355209|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
154355210|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355211|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355212|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154355213|NCT01312350|Docetaxel|docetaxel|mesh-list
154355214|NCT01312350|Fluorouracil|fluorouracil|mesh-list
154355215|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355216|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
154355217|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
154355218|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
154355219|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355220|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
154355221|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154355222|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154355223|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
154355224|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355225|NCT03464656|Antioxidants|antioxidants|mesh-list
154355226|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355242|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154355243|NCT03463642|Emollients|emollients|mesh-ancestor
154355244|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
154355245|NCT03463564|Insulin|insulin|mesh-list
154355246|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154355247|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355248|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355249|NCT05092386|Vaccines|vaccines|mesh-list
154355250|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
154355251|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355252|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154861877|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355253|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
154355255|NCT03463252|Progestins|progestins|mesh-ancestor
154355256|NCT03463252|Hormones|hormones|mesh-ancestor
154355257|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355258|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355259|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154355260|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154355261|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154355262|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
154355263|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154355264|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154355265|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154355266|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154355267|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154355268|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355269|NCT05309538|Betahistine|betahistine|mesh-list
154355270|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
154355271|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
154355272|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
154355273|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355274|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355275|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355276|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154355277|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
154355278|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355279|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154355280|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154355281|NCT03011450|Fenofibrate|fenofibrate|mesh-list
154355282|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154355283|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
154355284|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355285|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154355286|NCT03638856|Misoprostol|misoprostol|mesh-list
154355287|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153534378|NCT01511237|Lamivudine|lamivudine|mesh-list
154355296|NCT03705780|Narcotics|narcotics|mesh-ancestor
154355297|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355298|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355299|NCT03705780|Analgesics|analgesics|mesh-ancestor
154355300|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
154355301|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355302|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154355303|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154355304|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
154355305|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
154355306|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
154355307|NCT04976790|Analgesics|analgesics|mesh-ancestor
154355308|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
154355309|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355310|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355311|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154355312|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154355313|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154355314|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154355315|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154355316|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355317|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355318|NCT04452838|Fesoterodine|fesoterodine|mesh-list
154355319|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154355320|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154355321|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
154355322|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355323|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355324|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355325|NCT04452838|Urological Agents|urological agents|mesh-ancestor
154355327|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154355328|NCT04188860|Antibodies|antibodies|mesh-list
154355329|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154355330|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355331|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
154355332|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
154355333|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
154355334|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355336|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355337|NCT01383668|Sirolimus|sirolimus|mesh-list
154355338|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
154204102|NCT00419952|Budesonide|budesonide|mesh-list
154355339|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154355340|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355341|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154355342|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355343|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
154355344|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101637|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
154355345|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
154355346|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355347|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154355349|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154355350|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355351|NCT01381796|Sumatriptan|sumatriptan|mesh-list
154355352|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154355353|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154355354|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154355355|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
154355389|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355391|NCT04483973|Ebselen|ebselen|mesh-list
154355392|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154355393|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154355394|NCT04483973|Analgesics|analgesics|mesh-ancestor
154355395|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
154355406|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355407|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154355408|NCT04283890|Nivolumab|nivolumab|mesh-list
154355409|NCT04283890|Ipilimumab|ipilimumab|mesh-list
154355410|NCT04283890|Melphalan|melphalan|mesh-list
154355411|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355412|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355413|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154355414|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355415|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154355416|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
154355417|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154355418|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154355419|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
154355420|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355421|NCT01139723|Bevacizumab|bevacizumab|mesh-list
154355422|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355423|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355424|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154355425|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154355426|NCT01139723|Growth Substances|growth substances|mesh-ancestor
154355427|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355428|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
154355429|NCT05068037|Antiemetics|antiemetics|mesh-list
154355430|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
154355431|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355432|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355433|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154355435|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
154355436|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355437|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154355438|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154355439|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355440|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355441|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154355442|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154355443|NCT01141439|Fluticasone|fluticasone|mesh-list
154355444|NCT01141439|Xhance|xhance|mesh-list
154355445|NCT01141439|Beclomethasone|beclomethasone|mesh-list
154355446|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154355447|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154355448|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
154355449|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355450|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355451|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154355452|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
154355453|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
154355454|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154355455|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
154355456|NCT01141439|Hormones|hormones|mesh-ancestor
154355457|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355458|NCT05549531|Itraconazole|itraconazole|mesh-list
154355459|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
154355460|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182184|NCT05868525|Analgesics|analgesics|mesh-ancestor
154355467|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355469|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154355470|NCT04452370|Etoposide|etoposide|mesh-list
154355471|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154355472|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355473|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154355474|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154355475|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355476|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355477|NCT01232777|Bevacizumab|bevacizumab|mesh-list
154355478|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355479|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355480|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154355481|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154355482|NCT01232777|Growth Substances|growth substances|mesh-ancestor
154355483|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355484|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
154355485|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
154355486|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355487|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355488|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
154355489|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154355490|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355491|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355492|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355493|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154101794|NCT00818415|Naproxen|naproxen|mesh-list
154355494|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154355495|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355497|NCT04921995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355498|NCT04921995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355499|NCT03129867|Ticagrelor|ticagrelor|mesh-list
154355500|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154355501|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154355502|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154355503|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154355504|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
154355505|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355506|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355507|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355508|NCT01235273|Hormones|hormones|mesh-list
154355509|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355510|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355511|NCT05147896|Semaglutide|semaglutide|mesh-list
154355512|NCT05147896|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154355513|NCT05147896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355514|NCT05147896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355515|NCT01140035|Insulin|insulin|mesh-list
154355516|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355517|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355518|NCT03086330|Semaglutide|semaglutide|mesh-list
154355519|NCT03086330|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154355520|NCT03086330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355521|NCT03086330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355522|NCT00872950|Amifampridine|amifampridine|mesh-list
153534609|NCT01511991|Sevoflurane|sevoflurane|mesh-list
154355532|NCT01568996|Sulforaphane|sulforaphane|mesh-list
154355533|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154355534|NCT01568996|Protective Agents|protective agents|mesh-ancestor
154355535|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355536|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355537|NCT02943993|Edoxaban|edoxaban|mesh-list
154355538|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154355539|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
154355540|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153730776|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
154355541|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
154355542|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355543|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355544|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
154355545|NCT02620150|Escitalopram|escitalopram|mesh-list
154355546|NCT02620150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154355547|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154355548|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154355549|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355550|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355551|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
154355552|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355553|NCT04098302|Dutasteride|dutasteride|mesh-list
154355554|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154355555|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154355556|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204243|NCT00451178|Hormones|hormones|mesh-ancestor
154355557|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355558|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
154355559|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355560|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355561|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154355562|NCT05488613|Midostaurin|midostaurin|mesh-list
154355563|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355564|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154355565|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355566|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355567|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154355568|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355569|NCT01137383|Interferons|interferons|mesh-list
154355570|NCT01137383|Ribavirin|ribavirin|mesh-list
154355571|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
154355572|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
154355573|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154355574|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355575|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
154355576|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355577|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
154355578|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355579|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
154355580|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355581|NCT03449836|Fluticasone|fluticasone|mesh-list
154355582|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
154355583|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154355584|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154355585|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
154355586|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355603|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355604|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355605|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154355606|NCT03443518|Narcotics|narcotics|mesh-ancestor
154355607|NCT03443518|Analgesics|analgesics|mesh-ancestor
154355608|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
154355609|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355610|NCT01142063|Neratinib|neratinib|mesh-list
154355611|NCT01142063|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154355612|NCT01142063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154355613|NCT01142063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355614|NCT01142063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355615|NCT01142843|Propolis|propolis|mesh-list
154355616|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355617|NCT04330625|Volagidemab|volagidemab|mesh-list
154355618|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355619|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355620|NCT03747497|Linezolid|linezolid|mesh-list
154355621|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154355622|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355623|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154355624|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355625|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355626|NCT03109600|Vaccines|vaccines|mesh-list
154355627|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154861879|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
154861880|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355628|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
154355629|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355630|NCT03679013|Acetaminophen|acetaminophen|mesh-list
154355631|NCT03679013|Gabapentin|gabapentin|mesh-list
154355632|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154355633|NCT03679013|Analgesics|analgesics|mesh-ancestor
154355634|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
154355635|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355636|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355637|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
154355638|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
154355639|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154355640|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154355641|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355642|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154355643|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154355644|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154355645|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534741|NCT01512862|Vitamins|vitamins|mesh-ancestor
154355661|NCT03991013|Dolutegravir|dolutegravir|mesh-list
154355662|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154355663|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154355664|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355665|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355666|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154355667|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154355668|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
154355669|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355670|NCT03441412|Metoprolol|metoprolol|mesh-list
154355671|NCT03441412|Epinephrine|epinephrine|mesh-list
154355672|NCT03441412|Ticagrelor|ticagrelor|mesh-list
154355673|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154355674|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154355675|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
154355676|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355677|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355678|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355679|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154355680|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154355681|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
154355682|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355683|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154355684|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
154355685|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
154355686|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
154355687|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154355688|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154355689|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154355690|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154355691|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154355692|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
154355693|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154355694|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154355695|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
154355696|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154355697|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154355698|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154355699|NCT01235819|Insulin|insulin|mesh-list
154355700|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154355701|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154355702|NCT01235819|Exenatide|exenatide|mesh-list
154355703|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154355704|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355705|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355724|NCT03440788|Immunologic Factors|immunologic factors|mesh-ancestor
154355725|NCT03440788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355726|NCT02824575|Paclitaxel|paclitaxel|mesh-list
154355727|NCT02824575|Rebastinib|rebastinib|mesh-list
154355728|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154355729|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355730|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
154355731|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
154355732|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
154355733|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355734|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154255454|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255455|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154255456|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154355735|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355736|NCT03780608|Durvalumab|durvalumab|mesh-list
154355737|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355738|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355739|NCT03631316|Valganciclovir|valganciclovir|mesh-list
154355740|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
154355741|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355742|NCT03608865|Durvalumab|durvalumab|mesh-list
154355743|NCT03608865|Tremelimumab|tremelimumab|mesh-list
154355744|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355745|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355746|NCT03532451|Nivolumab|nivolumab|mesh-list
154355747|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355748|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355749|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154355750|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355751|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
154355752|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154355753|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
154355754|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355755|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
154355756|NCT04704531|Protective Agents|protective agents|mesh-ancestor
154355757|NCT02637531|Nivolumab|nivolumab|mesh-list
154355758|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355759|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355760|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154355761|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355762|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
154355763|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154355776|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
154355777|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355778|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154355779|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
154355781|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154355782|NCT01313247|Analgesics|analgesics|mesh-ancestor
154204417|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
154355783|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
154355784|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355785|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355786|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
154355787|NCT01142453|Interferons|interferons|mesh-list
154355788|NCT01142453|Interferon-beta|interferon-beta|mesh-list
154355789|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
154355790|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355791|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
154355792|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355793|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
154355794|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355795|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154355796|NCT04701424|Insulin|insulin|mesh-list
154355797|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355798|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355799|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
154355800|NCT03560193|Ethanol|ethanol|mesh-list
154355801|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
154355802|NCT03560193|Povidone|povidone|mesh-list
154355803|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154355804|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355805|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
154355806|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355807|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355808|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
154355809|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
154355810|NCT04451200|Busulfan|busulfan|mesh-list
154355811|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
154355812|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355813|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154355814|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
154355815|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355816|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154355817|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861881|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154861882|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154861883|NCT00633945|Growth Substances|growth substances|mesh-ancestor
154255457|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
154355818|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154355819|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154355820|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154355821|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
154355822|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
154355823|NCT02251821|Melphalan|melphalan|mesh-list
154355824|NCT02251821|Busulfan|busulfan|mesh-list
154355825|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
154355826|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154355827|NCT02251821|Methotrexate|methotrexate|mesh-list
154355828|NCT02251821|Fludarabine|fludarabine|mesh-list
154355829|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
154355830|NCT02251821|Tacrolimus|tacrolimus|mesh-list
154355835|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154355836|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
154355837|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355838|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355839|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154355840|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154355841|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
154355842|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154355843|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154355845|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
154355846|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355847|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154355848|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154355849|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154355850|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154355851|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154355852|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
154355853|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154355854|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355855|NCT03784781|Dimercaprol|dimercaprol|mesh-list
154355856|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
154355857|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
154355858|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355859|NCT03438604|Donepezil|donepezil|mesh-list
154355860|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154355861|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355862|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355863|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
154355864|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355865|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355866|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
154355867|NCT03433378|Tretinoin|tretinoin|mesh-list
154355868|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355869|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
154355870|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
154355872|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
154355873|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
154355874|NCT05016076|Dexamethasone|dexamethasone|mesh-list
154355875|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154355876|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
154355877|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
154355878|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355879|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355880|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154355881|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
154355882|NCT05016076|Hormones|hormones|mesh-ancestor
154355883|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355884|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154355885|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355886|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
154355887|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154355888|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355889|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355890|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154355891|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
154355892|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154355893|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154355894|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355895|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
154355896|NCT03433144|Coagulants|coagulants|mesh-ancestor
154355897|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
154355898|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154861884|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
153731036|NCT00136175|Carboplatin|carboplatin|mesh-list
154355899|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154355900|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154355901|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154355908|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154355910|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154355911|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
154355912|NCT02927834|Hormones|hormones|mesh-ancestor
154355913|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355914|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355915|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154355916|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355917|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154355918|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355919|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154355920|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355921|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355922|NCT03170180|Sunitinib|sunitinib|mesh-list
154355923|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
154355924|NCT03170180|Gefitinib|gefitinib|mesh-list
154355925|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355926|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154355927|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154355928|NCT03170180|Growth Substances|growth substances|mesh-ancestor
154355929|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355930|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
154355931|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154355932|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355933|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355934|NCT03170180|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154355935|NCT03319667|Dexamethasone|dexamethasone|mesh-list
154355936|NCT03319667|Lenalidomide|lenalidomide|mesh-list
154355937|NCT03319667|Bortezomib|bortezomib|mesh-list
154355938|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154355939|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
154355940|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
154355941|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355942|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355943|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154355944|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
154355945|NCT03319667|Hormones|hormones|mesh-ancestor
154355946|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355947|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154355948|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355949|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
154355950|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154355951|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154355952|NCT03319667|Growth Substances|growth substances|mesh-ancestor
154355953|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
154355954|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
154355955|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355956|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355957|NCT03432676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154355958|NCT03432676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355959|NCT03432598|Paclitaxel|paclitaxel|mesh-list
154355960|NCT03432598|Etoposide|etoposide|mesh-list
154355961|NCT03432598|Carboplatin|carboplatin|mesh-list
154355962|NCT03432598|Gemcitabine|gemcitabine|mesh-list
154355963|NCT03432598|Pemetrexed|pemetrexed|mesh-list
154355964|NCT03432598|Tislelizumab|tislelizumab|mesh-list
154355965|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154355966|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355967|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
154355968|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
154355969|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
154356001|NCT03110510|Leucovorin|leucovorin|mesh-list
154356002|NCT03110510|Fluorouracil|fluorouracil|mesh-list
154356003|NCT03110510|Irinotecan|irinotecan|mesh-list
154356004|NCT03110510|Calcium|calcium|mesh-list
154356005|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
154356006|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154356007|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356008|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
154356009|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356010|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154861885|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255458|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255459|NCT01151306|Simvastatin|simvastatin|mesh-list
154356011|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356012|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154356038|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154356039|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
154356040|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
154356041|NCT03319719|Protective Agents|protective agents|mesh-ancestor
154356042|NCT03128242|Oxytocin|oxytocin|mesh-list
154356043|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
154356044|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154356045|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356046|NCT01313689|Ofatumumab|ofatumumab|mesh-list
154356047|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356048|NCT03431272|Lifitegrast|lifitegrast|mesh-list
154356049|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154356050|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154356051|NCT02528513|Midazolam|midazolam|mesh-list
154356052|NCT02528513|Fentanyl|fentanyl|mesh-list
154356053|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
154356054|NCT02528513|Propofol|propofol|mesh-list
154356055|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154356056|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356057|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356058|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154356059|NCT02528513|Analgesics|analgesics|mesh-ancestor
154356060|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
154356061|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356062|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154356089|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
154356090|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154356091|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
154356092|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356093|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356094|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154356095|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
154356096|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154356097|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
154356098|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356099|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356100|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154356101|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
154356102|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
154356103|NCT04460183|Protective Agents|protective agents|mesh-ancestor
154356104|NCT01243697|Desogestrel|desogestrel|mesh-list
154356105|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154356106|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154356107|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154356108|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
154356109|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154356110|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356111|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154356129|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356130|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356132|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154356133|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154356134|NCT01238393|Growth Substances|growth substances|mesh-ancestor
154356135|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356136|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
154356137|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356138|NCT03776305|Imipenem|imipenem|mesh-list
154356139|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154356140|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356141|NCT01146509|Donepezil|donepezil|mesh-list
154356142|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154356143|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356144|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356145|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
154356146|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356147|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356148|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
154356149|NCT03775993|Hormones|hormones|mesh-list
154356150|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154356151|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861886|NCT01118845|Rituximab|rituximab|mesh-list
154861887|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154255460|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154255461|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154356152|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
154356153|NCT03316131|Febuxostat|febuxostat|mesh-list
154356154|NCT03316131|Verinurad|verinurad|mesh-list
154356155|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154356156|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356157|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154356158|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356159|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
154356160|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154356161|NCT03779659|Anesthetics|anesthetics|mesh-list
154356162|NCT03779659|Benzocaine|benzocaine|mesh-list
154356163|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
154356164|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356165|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356166|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
154356167|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356189|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154356190|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154356191|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356192|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154356193|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356194|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
154356195|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
154356196|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154356197|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
154356198|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154356199|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154356200|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
154356201|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154356202|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154356203|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356204|NCT01238627|Nicotine|nicotine|mesh-list
154356205|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154356206|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
154356207|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356208|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356209|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154356210|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154356211|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
154356212|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356213|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356214|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
154356215|NCT01321021|Promethazine|promethazine|mesh-list
154356216|NCT01321021|Losartan|losartan|mesh-list
154356217|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154356218|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154356219|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153535304|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
154356228|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
154356229|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356231|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
154356232|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154356233|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154356234|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
154356235|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
154356236|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356237|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154356238|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
154356239|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
154356240|NCT01238705|Metoprolol|metoprolol|mesh-list
154356241|NCT01238705|Felodipine|felodipine|mesh-list
154356242|NCT01238705|Irbesartan|irbesartan|mesh-list
154356243|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154356244|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154356245|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
154356246|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
154356247|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356248|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356249|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154356250|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154356251|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154861888|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154861889|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255462|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
154356252|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
154356253|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356254|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356255|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154356256|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154356257|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154356258|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204769|NCT00405756|Analgesics|analgesics|mesh-ancestor
154356259|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154356260|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
154356261|NCT03779347|Praziquantel|praziquantel|mesh-list
154356262|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
154356263|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154356264|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356265|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
154356266|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356267|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154356268|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
154356269|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
154356270|NCT01245725|Tirofiban|tirofiban|mesh-list
154356271|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154356272|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154356273|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356274|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154356275|NCT01143545|Celecoxib|celecoxib|mesh-list
154356276|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
154356277|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154356278|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
154356279|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356280|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154356281|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154356282|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
154356283|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356284|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356304|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356305|NCT03301415|Valganciclovir|valganciclovir|mesh-list
154356306|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
154356307|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356308|NCT05449015|Atropine|atropine|mesh-list
154356309|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154356310|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154356311|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154356312|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
154356313|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356314|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356315|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154356316|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
154356317|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
154356318|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
154356319|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154356320|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154356321|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
154356322|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356323|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356324|NCT01239017|Fasinumab|fasinumab|mesh-list
154356325|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154356326|NCT01239017|Analgesics|analgesics|mesh-ancestor
154356327|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
154356328|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356329|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356330|NCT02732938|Paclitaxel|paclitaxel|mesh-list
154356331|NCT02732938|Gemcitabine|gemcitabine|mesh-list
154356332|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154356333|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356334|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
154356335|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
154356336|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
154356337|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356338|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154356339|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
154356340|NCT03778723|Fentanyl|fentanyl|mesh-list
154356347|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
154356348|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356349|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154861890|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
153357814|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154356350|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154356352|NCT01245959|Cisplatin|cisplatin|mesh-list
154356353|NCT01245959|Docetaxel|docetaxel|mesh-list
154356354|NCT01245959|Fluorouracil|fluorouracil|mesh-list
154356355|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356356|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
154356357|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
154356358|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
154356359|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356360|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
154356361|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154356362|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154356363|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
154356364|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356365|NCT03778645|Epinephrine|epinephrine|mesh-list
154356366|NCT03778645|Racepinephrine|racepinephrine|mesh-list
154356367|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
154356368|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154356369|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154356370|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
154356371|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356372|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356373|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356374|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154356375|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154356376|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
154356377|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356378|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154356379|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
154356380|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
154356381|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
154356382|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154356383|NCT04326478|Azithromycin|azithromycin|mesh-list
154356384|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154356385|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356386|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
154356387|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356388|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154356389|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
154356390|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
154356391|NCT04647721|Protective Agents|protective agents|mesh-ancestor
154356392|NCT03470038|Mitogens|mitogens|mesh-list
154356393|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
154356394|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102680|NCT05324904|Acyclovir|acyclovir|mesh-list
154356395|NCT03778567|Lamivudine|lamivudine|mesh-list
154356396|NCT03778567|Telbivudine|telbivudine|mesh-list
154356397|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154356398|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154356399|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356400|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356401|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
154356402|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356403|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154356404|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154356406|NCT03784066|Tremelimumab|tremelimumab|mesh-list
154356407|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154356408|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356409|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356410|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
153535479|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
154356437|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
154356438|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356439|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356440|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356441|NCT01239173|Propranolol|propranolol|mesh-list
154356442|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154356443|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154356444|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
154356445|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356446|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356447|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356448|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154356449|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154861891|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356451|NCT03063203|Decitabine|decitabine|mesh-list
154356452|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154356453|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
154356454|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356455|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356456|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356457|NCT03435094|Alendronate|alendronate|mesh-list
154356458|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154356467|NCT03772561|Olaparib|olaparib|mesh-list
154356468|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356469|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356470|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154356471|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356472|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356474|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154356475|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154356476|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356477|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356478|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356479|NCT01146041|Rivastigmine|rivastigmine|mesh-list
154204942|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
154356480|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154356481|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356482|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356483|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
154356484|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356485|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356486|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154356487|NCT01146041|Protective Agents|protective agents|mesh-ancestor
154356488|NCT04450576|Chrysarobin|chrysarobin|mesh-list
154356489|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154356490|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154356491|NCT04450576|Analgesics|analgesics|mesh-ancestor
154356492|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
154356493|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356494|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356495|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154356496|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154356497|NCT03430180|Naloxone|naloxone|mesh-list
154356498|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154356499|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356500|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
154356501|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356502|NCT03777787|Denatonium|denatonium|mesh-list
154356503|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
154356504|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356505|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
154356506|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356507|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
154356508|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356509|NCT03430024|Estrogens|estrogens|mesh-list
154356510|NCT03430024|Hormones|hormones|mesh-ancestor
154356511|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154356512|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356513|NCT03434782|Listerine|listerine|mesh-list
154356514|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154356515|NCT03434782|Fluorides|fluorides|mesh-list
154356516|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
154356517|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
154356518|NCT03434782|Protective Agents|protective agents|mesh-ancestor
154356519|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356520|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154356521|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356522|NCT01320397|Losartan|losartan|mesh-list
154356523|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154356524|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154356525|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154356545|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154356547|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154356548|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
154356549|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861892|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255463|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356550|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154356551|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154356552|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154356553|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356555|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154356556|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154356557|NCT02891226|Analgesics|analgesics|mesh-ancestor
154356558|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
154356559|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356560|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356561|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154356562|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154356563|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154356564|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154356565|NCT03771781|Empagliflozin|empagliflozin|mesh-list
154356566|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154356567|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356568|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154356569|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356570|NCT03224104|Temozolomide|temozolomide|mesh-list
154356571|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154356572|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
154356573|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356574|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356575|NCT01320475|Sufentanil|sufentanil|mesh-list
154356576|NCT01320475|Ketamine|ketamine|mesh-list
154356577|NCT01320475|Analgesics|analgesics|mesh-ancestor
154356578|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
153535665|NCT01517828|Midazolam|midazolam|mesh-list
154356584|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
154356585|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356586|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154356587|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154356588|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356589|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356590|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154356591|NCT01320475|Narcotics|narcotics|mesh-ancestor
154356592|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154356593|NCT05177406|Erenumab|erenumab|mesh-list
154356594|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154356595|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356596|NCT05177406|Analgesics|analgesics|mesh-ancestor
154356597|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
154356598|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356599|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356600|NCT02521246|Losartan|losartan|mesh-list
154356601|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154356602|NCT02521246|Candesartan|candesartan|mesh-list
154356603|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
154356604|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
154356605|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154356606|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154356607|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154356608|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154356609|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356610|NCT02521246|Diuretics|diuretics|mesh-ancestor
154356611|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
154356612|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356613|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154356614|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154356615|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
154356616|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154356617|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
154102904|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
154356619|NCT05309070|Expectorants|expectorants|mesh-ancestor
154356620|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
154356621|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154356622|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
154356623|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356624|NCT05309070|Protective Agents|protective agents|mesh-ancestor
154861893|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154356625|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356626|NCT05309070|Antidotes|antidotes|mesh-ancestor
154356627|NCT04763928|Venetoclax|venetoclax|mesh-list
154356628|NCT04763928|Decitabine|decitabine|mesh-list
154356629|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356630|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154356631|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
154356632|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356633|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356634|NCT01567501|Cetirizine|cetirizine|mesh-list
154356635|NCT01567501|Levocetirizine|levocetirizine|mesh-list
154356636|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154356637|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154356638|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
154356639|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
154356640|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356641|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356642|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356643|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154356644|NCT01321957|Bevacizumab|bevacizumab|mesh-list
154356645|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
154356646|NCT01321957|Irinotecan|irinotecan|mesh-list
154356647|NCT01321957|Fluorouracil|fluorouracil|mesh-list
153535719|NCT01518101|Metformin|metformin|mesh-list
154356654|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
154356655|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154356656|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154356657|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356658|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356660|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154356661|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154356662|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
154356663|NCT05363592|Metformin|metformin|mesh-list
154356664|NCT05363592|Alogliptin|alogliptin|mesh-list
154356665|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154356666|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356667|NCT05363592|Incretins|incretins|mesh-ancestor
154356668|NCT05363592|Hormones|hormones|mesh-ancestor
154356669|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154356670|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154356671|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
154356672|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356673|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356674|NCT03708211|Esomeprazole|esomeprazole|mesh-list
154356675|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154356676|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154356677|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154356678|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356679|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356680|NCT03770923|Montelukast|montelukast|mesh-list
154356681|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154356682|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
154356683|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154356684|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
154356685|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154356686|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356687|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154356688|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154356689|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356690|NCT03433534|Nivolumab|nivolumab|mesh-list
154102988|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
154356691|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356692|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356693|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154356694|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356695|NCT05445895|Clopidogrel|clopidogrel|mesh-list
154356696|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154356697|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154356698|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154356699|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154356700|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
154356701|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356702|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356703|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356704|NCT03367299|Blinatumomab|blinatumomab|mesh-list
154356705|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356706|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
154356707|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154356708|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
154356709|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154356710|NCT04449718|Vitamin D|vitamin d|mesh-list
154356711|NCT04449718|Vitamins|vitamins|mesh-ancestor
153535791|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
154356733|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
154356734|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
154356735|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356736|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154356737|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154356738|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356740|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154356741|NCT03429400|Narcotics|narcotics|mesh-ancestor
154356742|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356743|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356744|NCT03429400|Analgesics|analgesics|mesh-ancestor
154356745|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
154356746|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356747|NCT03429010|Anesthetics|anesthetics|mesh-list
154356748|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356749|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356750|NCT02944656|Gabapentin|gabapentin|mesh-list
154356751|NCT02944656|Analgesics|analgesics|mesh-ancestor
154356752|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
154356753|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356754|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356755|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
154356756|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154356757|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154356758|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356759|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154356760|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154356761|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154356762|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356763|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356764|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
154356765|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
154356793|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356794|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356795|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154356796|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154356797|NCT01146977|Cytarabine|cytarabine|mesh-list
154356798|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154356799|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
154356800|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356801|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356802|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
154356803|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356804|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154356805|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
154356806|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356807|NCT03762967|Hormones|hormones|mesh-list
154356808|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154356809|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356824|NCT01236989|Hematinics|hematinics|mesh-ancestor
154356825|NCT03423472|Vitamin A|vitamin a|mesh-list
154356826|NCT03423472|Vitamins|vitamins|mesh-ancestor
154356827|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
154356828|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356829|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
154356830|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154356831|NCT01239563|Basiliximab|basiliximab|mesh-list
154356832|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
154356833|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356834|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154356835|NCT01321255|Aspirin|aspirin|mesh-list
154356836|NCT01321255|Ramipril|ramipril|mesh-list
154356837|NCT01321255|Simvastatin|simvastatin|mesh-list
154356838|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154356839|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154356840|NCT01321255|Analgesics|analgesics|mesh-ancestor
154356842|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356843|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356845|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154356846|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154356847|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154356848|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356849|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154356850|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154356851|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356852|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
154356853|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154356854|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154356855|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
154356856|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154356857|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154356858|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154356859|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
154356860|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154356861|NCT03638778|Semaglutide|semaglutide|mesh-list
154356862|NCT03638778|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154356863|NCT03638778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154356864|NCT03638778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356865|NCT04546581|Remdesivir|remdesivir|mesh-list
154356866|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
154356867|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154356868|NCT04546581|Antibodies|antibodies|mesh-list
154356869|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
154356870|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356871|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
153535949|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154356883|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356884|NCT03164655|Leucovorin|leucovorin|mesh-list
154356885|NCT03164655|Bevacizumab|bevacizumab|mesh-list
154356886|NCT03164655|Cetuximab|cetuximab|mesh-list
154356887|NCT03164655|Panitumumab|panitumumab|mesh-list
154356888|NCT03164655|Fluorouracil|fluorouracil|mesh-list
154356889|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
154356890|NCT03164655|Irinotecan|irinotecan|mesh-list
154356891|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356892|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356893|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154356894|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154356895|NCT03164655|Growth Substances|growth substances|mesh-ancestor
154356896|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356897|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
154356898|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
154356899|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356900|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154356901|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154356902|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
154356903|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154356904|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154356905|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356906|NCT03164655|Antidotes|antidotes|mesh-ancestor
154356907|NCT03164655|Protective Agents|protective agents|mesh-ancestor
154356908|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
154356909|NCT03164655|Vitamins|vitamins|mesh-ancestor
154356910|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
154356911|NCT02521012|Vitamin D|vitamin d|mesh-list
153952239|NCT02626936|Insulin|insulin|mesh-list
154356912|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
154356913|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
154356914|NCT02521012|Vitamins|vitamins|mesh-list
154356915|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
154356916|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356917|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154356918|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154356919|NCT04756128|Colchicine|colchicine|mesh-list
154356920|NCT04756128|Naltrexone|naltrexone|mesh-list
154356921|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154356922|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154356923|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356924|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
154356925|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356926|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
154356927|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154356928|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
154356929|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
154356930|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
154255464|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154356931|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356932|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356934|NCT03427216|Baclofen|baclofen|mesh-list
154356935|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154356936|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356937|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154356938|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356939|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154356952|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154356953|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154356954|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154356955|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
154356956|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
154356957|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
154356958|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
154356959|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154356960|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356961|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356962|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154356963|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154356964|NCT01144091|Protective Agents|protective agents|mesh-ancestor
154356965|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356966|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
154356967|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154356968|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
154356969|NCT02392559|Evolocumab|evolocumab|mesh-list
154356970|NCT02392559|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154356971|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154356972|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154356973|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
154356974|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356975|NCT02392559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154356976|NCT02392559|Protease Inhibitors|protease inhibitors|mesh-ancestor
154356977|NCT02392559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356978|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154356979|NCT03332589|Dabrafenib|dabrafenib|mesh-list
154356980|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356981|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154356982|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356983|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356984|NCT03767569|Folic Acid|folic acid|mesh-list
154356985|NCT03767569|Inositol|inositol|mesh-list
154356986|NCT03767569|Hematinics|hematinics|mesh-ancestor
154356987|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
154356988|NCT03767569|Vitamins|vitamins|mesh-ancestor
154356989|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
154356990|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356991|NCT03620916|Morphine|morphine|mesh-list
154356992|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154356993|NCT03620916|Narcotics|narcotics|mesh-ancestor
154356994|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356995|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356996|NCT03620916|Analgesics|analgesics|mesh-ancestor
154356997|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
154356998|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356999|NCT01237067|Carboplatin|carboplatin|mesh-list
154357000|NCT01237067|Olaparib|olaparib|mesh-list
154357001|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357002|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154357003|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357004|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357005|NCT03426982|Heparin|heparin|mesh-list
154357026|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
154357027|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
154357028|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357029|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357030|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
154357031|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154357032|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
154357033|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
154357034|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154357035|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154357036|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154357037|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
154861894|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
154357039|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357041|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154357042|NCT03008616|Digoxin|digoxin|mesh-list
154357043|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154357044|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154357045|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357046|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357047|NCT03008616|Protective Agents|protective agents|mesh-ancestor
154357048|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357049|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
154357050|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154357051|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357052|NCT03426592|Vitamin D|vitamin d|mesh-list
154357053|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
154357054|NCT03426592|Vitamins|vitamins|mesh-ancestor
154357055|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
154357056|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357057|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154357058|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154357059|NCT01567657|Midazolam|midazolam|mesh-list
154357060|NCT01567657|Meperidine|meperidine|mesh-list
154357061|NCT01567657|Propofol|propofol|mesh-list
154357062|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154357063|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357080|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357082|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
154357083|NCT03416062|Vitamins|vitamins|mesh-ancestor
154357084|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
154357085|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357086|NCT03761485|Fluorides|fluorides|mesh-list
154357087|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
154357088|NCT03761485|Protective Agents|protective agents|mesh-ancestor
154357089|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357090|NCT03766867|Vortioxetine|vortioxetine|mesh-list
154357091|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
154357092|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154357093|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154357094|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154357095|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357096|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357097|NCT03766867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154357098|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154357099|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154357100|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357101|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357102|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
154357103|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154357104|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154357105|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154357106|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154357107|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
154357108|NCT02061293|Promethazine|promethazine|mesh-list
154357109|NCT02061293|Psilocybin|psilocybin|mesh-list
154357110|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154357111|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154357112|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357113|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357114|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
154357115|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
154357116|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
154357117|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357118|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
154357119|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
154357120|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154357121|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154357122|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
153536191|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
154357158|NCT03415750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154357159|NCT03415750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357172|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
154205424|NCT00276016|Phenylephrine|phenylephrine|mesh-list
154357173|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357174|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357175|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154357176|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
154357178|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154357179|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154357180|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357181|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
154357182|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357183|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357184|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
154357185|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154357186|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154357187|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
154357188|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
154357189|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357190|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154357191|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
154357192|NCT03916679|Fludarabine|fludarabine|mesh-list
154357193|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357194|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
154357195|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357196|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357197|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154357198|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
154357199|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357200|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357201|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154357202|NCT03421990|Anesthetics|anesthetics|mesh-list
154357203|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357204|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357205|NCT03426202|Modafinil|modafinil|mesh-list
154357206|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154357207|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357208|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154357209|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154357210|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154357211|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357212|NCT01248299|Cisplatin|cisplatin|mesh-list
154357213|NCT01248299|Docetaxel|docetaxel|mesh-list
154357214|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
154357215|NCT01248299|Fluorouracil|fluorouracil|mesh-list
154357216|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357217|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
154357218|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
154357219|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
154357220|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357221|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
154357222|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154357223|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357235|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357237|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
154357238|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
154357239|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154357240|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154357241|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357242|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357243|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357244|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357245|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
154357246|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
154357247|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154357248|NCT03620838|Progesterone|progesterone|mesh-list
154357249|NCT03620838|Progestins|progestins|mesh-ancestor
154357250|NCT03620838|Hormones|hormones|mesh-ancestor
154357251|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154357252|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357253|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154357254|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154357255|NCT01239953|Paclitaxel|paclitaxel|mesh-list
154357256|NCT01239953|Everolimus|everolimus|mesh-list
154357257|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154357258|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357259|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154861895|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357260|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154357261|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154357262|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357263|NCT01239953|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154357264|NCT01239953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357265|NCT01239953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357266|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357267|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
154357268|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357269|NCT01322191|Morphine|morphine|mesh-list
154357270|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154357271|NCT01322191|Narcotics|narcotics|mesh-ancestor
154357272|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357273|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357274|NCT01322191|Analgesics|analgesics|mesh-ancestor
154357275|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
154357276|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357277|NCT03620760|Aspirin|aspirin|mesh-list
154357278|NCT03620760|Ticagrelor|ticagrelor|mesh-list
154357279|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154357280|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357281|NCT03620760|Analgesics|analgesics|mesh-ancestor
154357282|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
154357283|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357284|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357285|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357286|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153536353|NCT01521936|Vitamin D|vitamin d|mesh-list
154357314|NCT03638076|Ritonavir|ritonavir|mesh-list
154357315|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154357316|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154357317|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
154357318|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357319|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357320|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154357321|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154357322|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
154357323|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357324|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154357325|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154357326|NCT01329731|Olaflur|olaflur|mesh-list
154357327|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
154357328|NCT01329731|Protective Agents|protective agents|mesh-ancestor
154357329|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357330|NCT03765697|Lidocaine|lidocaine|mesh-list
154357331|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
154357332|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
154357333|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357334|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357357|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
154357358|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
154357359|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
154357360|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
154357361|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357362|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357363|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154357364|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154357365|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
154357366|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154357367|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154357368|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103658|NCT00621777|Varenicline|varenicline|mesh-list
154357369|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
154357370|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154357371|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
154357372|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
154357373|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154357374|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
154357375|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154357376|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357377|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
154357378|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154357379|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154357380|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154357381|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154357382|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154357384|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154357385|NCT01249937|Triamcinolone|triamcinolone|mesh-list
153536460|NCT01522612|Antidotes|antidotes|mesh-ancestor
154357399|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154357401|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
154357402|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357403|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357404|NCT02528201|Celecoxib|celecoxib|mesh-list
154357405|NCT02528201|Diclofenac|diclofenac|mesh-list
154357406|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154357407|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357408|NCT02528201|Analgesics|analgesics|mesh-ancestor
154357409|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
154357410|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357411|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357412|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357413|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357414|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154357415|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154357416|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357417|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357418|NCT03758677|Gemcitabine|gemcitabine|mesh-list
154357419|NCT03758677|Docetaxel|docetaxel|mesh-list
154357420|NCT03758677|Pemetrexed|pemetrexed|mesh-list
154357421|NCT03758677|Apatinib|apatinib|mesh-list
154357422|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154357423|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
154357424|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357425|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357426|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
154357427|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
154357428|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
154357429|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357430|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154357431|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154357432|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357433|NCT03764683|Suvorexant|suvorexant|mesh-list
154357434|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154357435|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154357436|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357437|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357438|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154357439|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357440|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357441|NCT03414892|Globalagliatin|globalagliatin|mesh-list
154357442|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
154357443|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357444|NCT01242605|Gemcitabine|gemcitabine|mesh-list
154357445|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027429|NCT02869633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357456|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
154357457|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357458|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154357459|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154357460|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154357461|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154357462|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154357463|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357464|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357465|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154357466|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
154357467|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154357468|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357469|NCT03764605|Metformin|metformin|mesh-list
154357470|NCT03764605|Tolvaptan|tolvaptan|mesh-list
154357471|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154357472|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357473|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154357474|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357475|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
154861896|NCT03162731|Nivolumab|nivolumab|mesh-list
154357478|NCT03764527|Artemether|artemether|mesh-list
154357479|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154357480|NCT03764527|Amodiaquine|amodiaquine|mesh-list
154357481|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
154357482|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154357483|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154357484|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357485|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357486|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
154357487|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
154357488|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154357489|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
154357490|NCT01321801|Pregabalin|pregabalin|mesh-list
154357491|NCT01321801|Analgesics|analgesics|mesh-ancestor
154357492|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
154357493|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357494|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357495|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
154357496|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154357497|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154357498|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357499|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154357500|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154357501|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154357502|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357503|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154357504|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
154357505|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154357506|NCT01155375|Hematinics|hematinics|mesh-ancestor
154357507|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154357508|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154357509|NCT01155375|Trace Elements|trace elements|mesh-ancestor
154357529|NCT02260102|Temocillin|temocillin|mesh-list
154357530|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154357531|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357532|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
154357533|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154357534|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357535|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357536|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357537|NCT03425734|Analgesics|analgesics|mesh-ancestor
154357538|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
154357539|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357540|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154357541|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154357542|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154357543|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
154357544|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357545|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357546|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
154357547|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154357548|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
154357549|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
154357550|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357551|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357552|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357553|NCT03420586|Analgesics|analgesics|mesh-ancestor
154357554|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
154357555|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357556|NCT03759067|Clopidogrel|clopidogrel|mesh-list
154357557|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154357558|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154357559|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154357560|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154357561|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
154357562|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536639|NCT01523327|Protective Agents|protective agents|mesh-ancestor
154357570|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
154357571|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357572|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357573|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154357574|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
154861897|NCT03162731|Ipilimumab|ipilimumab|mesh-list
154357575|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357577|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154357578|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
154357579|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
154357580|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
154357581|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154357582|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154357583|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154357584|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357585|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357587|NCT03413722|Tacrolimus|tacrolimus|mesh-list
154357588|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357589|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
154357590|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357591|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154357592|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357593|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357594|NCT03413722|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154357596|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357597|NCT04843462|Esketamine|esketamine|mesh-list
154357598|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
154357599|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154357600|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
154357601|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154357602|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357603|NCT03413410|Metoprolol|metoprolol|mesh-list
154357604|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154357605|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154357606|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
154357607|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
154357608|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357609|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357610|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154357611|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154357612|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154357613|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
154357614|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357615|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357616|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154357617|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154357618|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
154357619|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357620|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154357621|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154357622|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
154357623|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
154357624|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357625|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357626|NCT03424876|Sunitinib|sunitinib|mesh-list
154357627|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
154357628|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357629|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154357630|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153536695|NCT01523574|Calcium|calcium|mesh-list
154357640|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357641|NCT03476577|Analgesics|analgesics|mesh-ancestor
154357642|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
154357643|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357644|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357645|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357646|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357647|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154357648|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357649|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357650|NCT03720561|Ibrutinib|ibrutinib|mesh-list
154357651|NCT03720561|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154357652|NCT03720561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357653|NCT03720561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357654|NCT03720561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357655|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154357656|NCT03419650|Hormones|hormones|mesh-ancestor
154861898|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357657|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154357658|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357659|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
154357660|NCT04893915|Fludarabine|fludarabine|mesh-list
154357661|NCT04893915|Interleukin-2|interleukin-2|mesh-list
154357662|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357663|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
154357664|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357665|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357666|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154357667|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
154357668|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357669|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357670|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154357671|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357672|NCT04893915|Analgesics|analgesics|mesh-ancestor
154357673|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
154357674|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357675|NCT03419494|Doxorubicin|doxorubicin|mesh-list
154357676|NCT03419494|Daunorubicin|daunorubicin|mesh-list
154357677|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154357678|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154357679|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357680|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154357681|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154357682|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357683|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357684|NCT03413020|Amoxicillin|amoxicillin|mesh-list
154357685|NCT03413020|Metronidazole|metronidazole|mesh-list
154357686|NCT03413020|Clarithromycin|clarithromycin|mesh-list
154357687|NCT03413020|Levofloxacin|levofloxacin|mesh-list
154357688|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
154357689|NCT03413020|Esomeprazole|esomeprazole|mesh-list
154357690|NCT03413020|Bismuth|bismuth|mesh-list
154357691|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357692|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154357693|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357694|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154357695|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154357740|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357741|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154357743|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357744|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357745|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154357746|NCT03305055|Narcotics|narcotics|mesh-ancestor
154357747|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154357748|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
154357749|NCT03412552|Analgesics|analgesics|mesh-ancestor
154357750|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
154357751|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357752|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357753|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
154357754|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357755|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154357756|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
154357757|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154357758|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154357759|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357760|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154357761|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
154357762|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154357763|NCT03412474|Acetaminophen|acetaminophen|mesh-list
154357764|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
154357765|NCT03412474|Bupivacaine|bupivacaine|mesh-list
154357766|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
154357767|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
154357768|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357769|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357770|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
154357771|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357772|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154357773|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357774|NCT03412474|Analgesics|analgesics|mesh-ancestor
154357775|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154357776|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153357822|NCT01213199|Adapalene|adapalene|mesh-list
154357777|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154357778|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
154357779|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357780|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357781|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
154357782|NCT03273387|Trimetazidine|trimetazidine|mesh-list
154357783|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
154357784|NCT04447612|Gemcitabine|gemcitabine|mesh-list
154357786|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357787|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154357788|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
154357789|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357790|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357791|NCT03418558|Trastuzumab|trastuzumab|mesh-list
154357792|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154357793|NCT03418558|Maytansine|maytansine|mesh-list
154357794|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357795|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357796|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154357797|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
154357798|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
154357799|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
154357800|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357801|NCT03418558|Immunotoxins|immunotoxins|mesh-ancestor
154357825|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154357827|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357828|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
154357829|NCT05170594|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154357830|NCT05170594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357831|NCT05170594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357832|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
154357833|NCT03273153|Atezolizumab|atezolizumab|mesh-list
154357834|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357835|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357836|NCT03273153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154357837|NCT03273153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357838|NCT03418090|Xenon|xenon|mesh-list
154357839|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154357840|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
154357841|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
154357842|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357843|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357844|NCT02520934|Miglustat|miglustat|mesh-list
154357845|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357846|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357847|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154357848|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154357849|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
154357850|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357851|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154357852|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154357868|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357869|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154357870|NCT03410524|Simethicone|simethicone|mesh-list
154357871|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
154357872|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357873|NCT03410524|Emollients|emollients|mesh-ancestor
154357874|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
154357875|NCT02713776|Pasireotide|pasireotide|mesh-list
154357876|NCT02713776|Somatostatin|somatostatin|mesh-list
154357877|NCT02713776|Hormones|hormones|mesh-ancestor
154357878|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154357879|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357880|NCT05215990|Metformin|metformin|mesh-list
154357881|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154357882|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357883|NCT03268941|Metoclopramide|metoclopramide|mesh-list
154357884|NCT03268941|Maleic acid|maleic acid|mesh-list
154357885|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357886|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357887|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
154357888|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
154357889|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154861899|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205942|NCT01581814|Hormones|hormones|mesh-ancestor
154357890|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104169|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
154357891|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154357892|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154357893|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154357894|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
154357895|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357896|NCT05215834|Remifentanil|remifentanil|mesh-list
154357897|NCT05215834|Propofol|propofol|mesh-list
154357898|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154357899|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357900|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357901|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154357902|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
154357903|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
154357904|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154357905|NCT05215834|Narcotics|narcotics|mesh-ancestor
154357906|NCT05215834|Analgesics|analgesics|mesh-ancestor
154357907|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
154357908|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357909|NCT03394144|Durvalumab|durvalumab|mesh-list
154357910|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357911|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357912|NCT05011149|Ibuprofen|ibuprofen|mesh-list
154357913|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154357930|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357931|NCT03393988|Analgesics|analgesics|mesh-ancestor
154357932|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
154357933|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357934|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154357935|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154357936|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154357937|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
154357938|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357939|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357940|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154357941|NCT03393988|Narcotics|narcotics|mesh-ancestor
154357942|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154357943|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154357944|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
154357945|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
154357946|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
154357947|NCT03410212|Ketorolac|ketorolac|mesh-list
154357948|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154357949|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154357950|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357951|NCT03410212|Analgesics|analgesics|mesh-ancestor
154357952|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
154357953|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357954|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357955|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357956|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357957|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154357958|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357959|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357960|NCT03397264|Aflibercept|aflibercept|mesh-list
154357961|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154357962|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154357963|NCT03397264|Growth Substances|growth substances|mesh-ancestor
154357964|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357965|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
154357966|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357967|NCT03397186|Trabectedin|trabectedin|mesh-list
154357968|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154357969|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
154357970|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357971|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357997|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357998|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357999|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154358000|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154358001|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
154358002|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358003|NCT04539730|Bupivacaine|bupivacaine|mesh-list
154358004|NCT04539730|Ropivacaine|ropivacaine|mesh-list
154358005|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
154358006|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
154358007|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358008|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358009|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
154358010|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358011|NCT03396484|Methyldopa|methyldopa|mesh-list
154358012|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154358013|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
154358014|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
154358015|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358016|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358017|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154358018|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154358019|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154358020|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
154358021|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358022|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358036|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358037|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358038|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
154358039|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154358040|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154358042|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
154358043|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
154358044|NCT01974609|Acetaminophen|acetaminophen|mesh-list
154206053|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358046|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154358047|NCT01974609|Hydrocodone|hydrocodone|mesh-list
154358048|NCT01974609|Narcotics|narcotics|mesh-list
154358049|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358050|NCT01974609|Analgesics|analgesics|mesh-ancestor
154358051|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
154358052|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358053|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358054|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
154358055|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154358056|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358057|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358058|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154358059|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358060|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358061|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154358062|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358063|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
154358064|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358065|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
154358066|NCT02593123|Molgramostim|molgramostim|mesh-list
154358067|NCT02593123|Lenograstim|lenograstim|mesh-list
154358068|NCT02593123|Sargramostim|sargramostim|mesh-list
154358069|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154358070|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
154358071|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358072|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154358073|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358074|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154358075|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
154358076|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154358077|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358078|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358079|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358080|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
154358081|NCT03396250|Promethazine|promethazine|mesh-list
154358082|NCT03396250|Naproxen|naproxen|mesh-list
153537147|NCT05874570|Natriuretic Agents|natriuretic agents|mesh-ancestor
154358099|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
154358100|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
154358101|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
154358102|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154358103|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154358104|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
154358105|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
154358106|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358107|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154358108|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
154358109|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
154358111|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
154358112|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
154358113|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154358114|NCT03302559|Protective Agents|protective agents|mesh-ancestor
154358115|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358116|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
154358117|NCT03302559|Vitamins|vitamins|mesh-ancestor
154358118|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
154358119|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
154358120|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358121|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154358122|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358123|NCT03763669|Folic Acid|folic acid|mesh-list
154358124|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
154358125|NCT03763669|Inositol|inositol|mesh-list
154358126|NCT03763669|Hematinics|hematinics|mesh-ancestor
154358127|NCT03763669|Vitamins|vitamins|mesh-ancestor
154358128|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
154358129|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358130|NCT03302247|Gemcitabine|gemcitabine|mesh-list
154358131|NCT03302247|Nivolumab|nivolumab|mesh-list
154358132|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154358133|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
154358134|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358135|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358136|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154358137|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154358138|NCT04363840|Aspirin|aspirin|mesh-list
154358139|NCT04363840|Vitamin D|vitamin d|mesh-list
154358140|NCT04363840|Vitamins|vitamins|mesh-ancestor
154358141|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
154358142|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358158|NCT04981665|Tislelizumab|tislelizumab|mesh-list
154358159|NCT04981665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154358160|NCT04981665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358161|NCT03392740|Lisinopril|lisinopril|mesh-list
154358162|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154358163|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
154358164|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358165|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358166|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154358167|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154358168|NCT03392740|Protective Agents|protective agents|mesh-ancestor
154358169|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358170|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
154358171|NCT02818023|Vemurafenib|vemurafenib|mesh-list
154358172|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154358173|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358174|NCT02818023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154358175|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358176|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154358177|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358178|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154358179|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154358180|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358181|NCT04631536|Folic Acid|folic acid|mesh-list
154358182|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
154358183|NCT04631536|Nicorandil|nicorandil|mesh-list
154358184|NCT04631536|Nebivolol|nebivolol|mesh-list
154358185|NCT04631536|Atorvastatin|atorvastatin|mesh-list
154358186|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154358187|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154358188|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
154358189|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358190|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154104462|NCT00392665|Growth Substances|growth substances|mesh-ancestor
154358191|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154358192|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358193|NCT04631536|Hematinics|hematinics|mesh-ancestor
154358194|NCT04631536|Vitamins|vitamins|mesh-ancestor
154358195|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
154358196|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358197|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154358198|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
154358199|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153537266|NCT05290025|Nicotine|nicotine|mesh-list
154358213|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358214|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358215|NCT05166538|Clopidogrel|clopidogrel|mesh-list
154358216|NCT05166538|Ticagrelor|ticagrelor|mesh-list
154358217|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154358218|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154358219|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154358220|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154358221|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
154358222|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358223|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358224|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358225|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154358226|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154358227|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358228|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154358229|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154358230|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358231|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358232|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
154358233|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358234|NCT04666441|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154358235|NCT04666441|Antiviral Agents|antiviral agents|mesh-ancestor
154358236|NCT04666441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358237|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
154358238|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154358239|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154358240|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154358241|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358242|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358243|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
154358244|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358245|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358246|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154358247|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358248|NCT04447378|PENTA|penta|mesh-list
154358249|NCT04447378|Fondaparinux|fondaparinux|mesh-list
154358250|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154358251|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
154358252|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154358253|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
154358254|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358255|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358256|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
154358257|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154358258|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154358259|NCT03125980|Capecitabine|capecitabine|mesh-list
154358260|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
154358266|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154104536|NCT00366301|Metformin|metformin|mesh-list
154358267|NCT03399526|Calcitriol|calcitriol|mesh-list
154358268|NCT03399526|Betamethasone|betamethasone|mesh-list
154358269|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
154358270|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154358271|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
154358272|NCT03399526|Clobetasol|clobetasol|mesh-list
154358273|NCT03399526|Prednicarbate|prednicarbate|mesh-list
154358274|NCT03399526|Calcipotriene|calcipotriene|mesh-list
154358275|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154358276|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358277|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
154358278|NCT03399526|Hormones|hormones|mesh-ancestor
154358279|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358280|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358281|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154358282|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358283|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
154358284|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154358285|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154358286|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358287|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358288|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154358289|NCT03399526|Vitamins|vitamins|mesh-ancestor
154358290|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
154358291|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154358292|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154358293|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
154358294|NCT03392272|Coagulants|coagulants|mesh-ancestor
154358295|NCT03905902|Vaccines|vaccines|mesh-list
154358296|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
154358297|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358298|NCT03638310|Gentamicins|gentamicins|mesh-list
154358299|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154358300|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358301|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154358302|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358303|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358304|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
154358305|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
154358306|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358307|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
154358308|NCT03399448|Fludarabine|fludarabine|mesh-list
154358309|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154358310|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
154358311|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358312|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358313|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154358314|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
154358315|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358316|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358317|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154358318|NCT03755947|Venetoclax|venetoclax|mesh-list
154358319|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
154358320|NCT03755947|Ibrutinib|ibrutinib|mesh-list
154358321|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358322|NCT03755947|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154358323|NCT03755947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154358324|NCT03755947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358325|NCT03755947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358326|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154358327|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154358328|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154358329|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154358330|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
154358344|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
154358345|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358346|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358347|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
154358348|NCT04632459|Ramucirumab|ramucirumab|mesh-list
154358349|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154358350|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358351|NCT04632459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154358352|NCT04632459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358353|NCT04632459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154358354|NCT04632459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154358355|NCT04632459|Growth Substances|growth substances|mesh-ancestor
154358356|NCT04632459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358357|NCT04632459|Growth Inhibitors|growth inhibitors|mesh-ancestor
154358358|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154358359|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154358360|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
154358361|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154358362|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358363|NCT03316872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154358364|NCT03316872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358365|NCT03256695|Albuterol|albuterol|mesh-list
154358366|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154358367|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
154358368|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358369|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358370|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154358371|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358372|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
154358373|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154358374|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154358375|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154358376|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154358377|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
154358378|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358379|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358380|NCT04623684|Phenylephrine|phenylephrine|mesh-list
154358381|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
154358383|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154358384|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
154358385|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
154358386|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358387|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358388|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
153537456|NCT04074746|Vidarabine|vidarabine|mesh-list
154358399|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154358400|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154358401|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
154358403|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
154358404|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
154358405|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358406|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358407|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154358408|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
154358409|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
154358410|NCT03297021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154358411|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154358412|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
154358413|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358414|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358415|NCT03752749|Prednisolone|prednisolone|mesh-list
154358416|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358417|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
154358418|NCT03752749|Hormones|hormones|mesh-ancestor
154358419|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358420|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358421|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154358422|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358423|NCT01988571|Atorvastatin|atorvastatin|mesh-list
154358424|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154358425|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154358426|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
154358427|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358428|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154358429|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154358430|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358431|NCT03755557|Budesonide|budesonide|mesh-list
154358432|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358433|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154358434|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
154358435|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358436|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358437|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154358438|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358439|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
154358440|NCT03755557|Hormones|hormones|mesh-ancestor
154206384|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154358441|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358442|NCT03511599|Cycloserine|cycloserine|mesh-list
154358443|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154358444|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358445|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154358446|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
154358447|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154358448|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
154358449|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358450|NCT01140867|Zonisamide|zonisamide|mesh-list
154358451|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
154358466|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154358467|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154358468|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358469|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358470|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154358471|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154358472|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358473|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154358474|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358475|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154358476|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
154358477|NCT02891070|Coagulants|coagulants|mesh-ancestor
154358478|NCT00381381|Donepezil|donepezil|mesh-list
154358479|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154358480|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358481|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358482|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
154358483|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358484|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358485|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
154358486|NCT03637335|Carboplatin|carboplatin|mesh-list
154358487|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358488|NCT02939937|Phenytoin|phenytoin|mesh-list
154358489|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
154358490|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154358491|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154358492|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358493|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358494|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154358495|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154358496|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154358497|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154358498|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358499|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154358500|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
154358501|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358502|NCT02774265|Aspirin|aspirin|mesh-list
154358503|NCT02774265|Heparin|heparin|mesh-list
154358504|NCT02774265|Enoxaparin|enoxaparin|mesh-list
154358505|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154358506|NCT02774265|Tinzaparin|tinzaparin|mesh-list
154358507|NCT02774265|Dalteparin|dalteparin|mesh-list
154358518|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358519|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154358520|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154358521|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358522|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
154358523|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
154358524|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154358525|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154358526|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154358527|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358528|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358529|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154358530|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358531|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358532|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
154358533|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358534|NCT03755479|Insulin|insulin|mesh-list
154358535|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154358536|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358537|NCT05239390|Dronabinol|dronabinol|mesh-list
154358538|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
154358539|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358540|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154358541|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358542|NCT05239390|Analgesics|analgesics|mesh-ancestor
154358543|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
154358544|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358545|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154358546|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154358547|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358548|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358549|NCT05239390|Hormones|hormones|mesh-ancestor
154358550|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358551|NCT03752437|Heparin|heparin|mesh-list
154358552|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
154358553|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154358554|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154358555|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358556|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
154358557|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154358558|NCT04748341|Benzocaine|benzocaine|mesh-list
154358559|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
154358560|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
154358561|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358562|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358564|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358566|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
154358567|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154358568|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154358569|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358570|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358586|NCT02579265|SMOFlipid|smoflipid|mesh-list
154358587|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
154358588|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154358589|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154358590|NCT05238220|Valganciclovir|valganciclovir|mesh-list
154358591|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
154358592|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358593|NCT04446598|Tadalafil|tadalafil|mesh-list
154358594|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
154358595|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154358596|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154358597|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358598|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358599|NCT04446598|Urological Agents|urological agents|mesh-ancestor
154358600|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154358601|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154358602|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358603|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358604|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154358605|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358606|NCT03391570|Analgesics|analgesics|mesh-ancestor
154358607|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
154358608|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358609|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358610|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358611|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358612|NCT03755089|Lidocaine|lidocaine|mesh-list
154358613|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
154358614|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
154358615|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358616|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358617|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
154358618|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358619|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154358620|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154358621|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154358622|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358623|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358624|NCT03757117|Hormones|hormones|mesh-list
154358625|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358626|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358627|NCT03752125|Caffeine|caffeine|mesh-list
153537697|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
154358640|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358641|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154358642|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358643|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358644|NCT03395002|Fluticasone|fluticasone|mesh-list
154358645|NCT03395002|Xhance|xhance|mesh-list
154358646|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
154358647|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154358648|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358649|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154358650|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
154206531|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
154358651|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358652|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358653|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154358654|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358655|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
154358656|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154358657|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
154358658|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154358659|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
154358660|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358661|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358662|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154358663|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154358664|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154358665|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
154358667|NCT05238064|Doxorubicin|doxorubicin|mesh-list
154358668|NCT05238064|Vincristine|vincristine|mesh-list
154358669|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154358670|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
154358671|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358672|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358673|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154358674|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
154358675|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358676|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358677|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154358678|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154358679|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154358680|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154358681|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358682|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154358683|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
154358684|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
154358685|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
154358686|NCT03390790|Lidocaine|lidocaine|mesh-list
154358687|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
154358688|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
154358689|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358690|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358691|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
154358707|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358708|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154358709|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154358712|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
154358713|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154358714|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154358715|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
154358716|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358717|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358718|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154358719|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358720|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
154358721|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154358722|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358723|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358724|NCT03390712|Risperidone|risperidone|mesh-list
154358725|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154358726|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
154358727|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154358728|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
154358729|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358730|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358731|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358732|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154358733|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358734|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154358735|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154358736|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
154358737|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154358738|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154358739|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
154358740|NCT03756727|Vitamins|vitamins|mesh-ancestor
154358741|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
154358742|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358743|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
154358744|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358745|NCT03756727|Protective Agents|protective agents|mesh-ancestor
154358746|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154358747|NCT03398434|Apixaban|apixaban|mesh-list
154358748|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154358749|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
154358769|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154358770|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358771|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
154358772|NCT03394222|Hormones|hormones|mesh-ancestor
154358773|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358774|NCT03398044|Dexamethasone|dexamethasone|mesh-list
154358775|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358776|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
154358777|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
154358778|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358779|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105062|NCT00574275|Gemcitabine|gemcitabine|mesh-list
154358780|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154358781|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
154358782|NCT03398044|Hormones|hormones|mesh-ancestor
154358783|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358784|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154358785|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358787|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358788|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358789|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
154358790|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154358791|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154358792|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
154358793|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358794|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358795|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154358796|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358797|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
154358798|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154358799|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
154358800|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358801|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358802|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
154358803|NCT02813200|Hormones|hormones|mesh-ancestor
154358804|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358819|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154358820|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154358821|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154358822|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154358823|NCT01481272|Leucovorin|leucovorin|mesh-list
154358824|NCT01481272|Cytarabine|cytarabine|mesh-list
154358825|NCT01481272|Methotrexate|methotrexate|mesh-list
154358826|NCT01481272|Etoposide|etoposide|mesh-list
154358827|NCT01481272|Ofatumumab|ofatumumab|mesh-list
154358828|NCT01481272|Lenograstim|lenograstim|mesh-list
154358829|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154358830|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
154358831|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154358832|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358833|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154358834|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
154358835|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358836|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358837|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
154358838|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358839|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154358840|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154358841|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
154358842|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358843|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154358844|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154358845|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154358846|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154358847|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
154358848|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358849|NCT01481272|Antidotes|antidotes|mesh-ancestor
154358850|NCT01481272|Protective Agents|protective agents|mesh-ancestor
154358851|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
154358852|NCT01481272|Vitamins|vitamins|mesh-ancestor
154358853|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
154358854|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154358855|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
154358856|NCT02687386|Analgesics|analgesics|mesh-ancestor
154358858|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358859|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358860|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358861|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154358862|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154358863|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358864|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358865|NCT04531813|Butenafine|butenafine|mesh-list
154358866|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
154358877|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154358878|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
154358879|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358880|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358881|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358882|NCT03754543|Iron|iron|mesh-list
154358883|NCT03754543|Trace Elements|trace elements|mesh-ancestor
154358884|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
154358885|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358886|NCT01199302|Brodalumab|brodalumab|mesh-list
154358887|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
154358888|NCT03754387|Ceftazidime|ceftazidime|mesh-list
154358889|NCT03754387|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154358890|NCT03754387|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154358891|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154358892|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358893|NCT03171480|Isosorbide|isosorbide|mesh-list
154358894|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154358895|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154358896|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154358897|NCT03171480|Diuretics|diuretics|mesh-ancestor
154358898|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
154358899|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358900|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
154358901|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154358902|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358903|NCT04465357|Erenumab|erenumab|mesh-list
154358904|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154358905|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358906|NCT04465357|Analgesics|analgesics|mesh-ancestor
154358907|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
154358908|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358909|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358910|NCT05396690|Sevoflurane|sevoflurane|mesh-list
154358911|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154358912|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154358913|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
154358914|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
154358915|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358916|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358917|NCT01384058|Simvastatin|simvastatin|mesh-list
154358918|NCT01384058|Ezetimibe|ezetimibe|mesh-list
154358919|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154358920|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154358921|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
154358922|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358923|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154358924|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154358925|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358926|NCT04401384|Pyridoxine|pyridoxine|mesh-list
154358927|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
154358928|NCT04401384|Doxylamine|doxylamine|mesh-list
154358929|NCT04401384|Dicyclomine|dicyclomine|mesh-list
154358930|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
154358931|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
154358932|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358939|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358941|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154358942|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154358943|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
154358944|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
154358945|NCT04401384|Vitamins|vitamins|mesh-ancestor
154358946|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
154358947|NCT03312114|Avelumab|avelumab|mesh-list
154358948|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154358949|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358950|NCT04239222|Ibuprofen|ibuprofen|mesh-list
154358951|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154358952|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358953|NCT04239222|Analgesics|analgesics|mesh-ancestor
154358954|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
154358955|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358956|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358957|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358958|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358959|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154358960|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358961|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358963|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154358964|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358965|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358966|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358967|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
154358968|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358969|NCT03084536|Acetaminophen|acetaminophen|mesh-list
154358970|NCT03084536|Celecoxib|celecoxib|mesh-list
154358971|NCT03084536|Midazolam|midazolam|mesh-list
154358972|NCT03084536|Fentanyl|fentanyl|mesh-list
154358973|NCT03084536|Gabapentin|gabapentin|mesh-list
154358974|NCT03084536|Bupivacaine|bupivacaine|mesh-list
154358975|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
154358976|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
154358977|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358978|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358979|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
154358980|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358981|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154358982|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154358983|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154358984|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154358985|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154358986|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154358987|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
154358988|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
154358989|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
154358990|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358991|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358992|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154358993|NCT03084536|Narcotics|narcotics|mesh-ancestor
154358994|NCT03084536|Analgesics|analgesics|mesh-ancestor
154358995|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358996|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
154358997|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154358998|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358999|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359000|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154359001|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153538056|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
154359015|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154359016|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359017|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
154359018|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
154359019|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
154359020|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359021|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
154359022|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154359023|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154359024|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
154359025|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359026|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154359027|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154359028|NCT03311646|Nicotine|nicotine|mesh-list
154359029|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154359030|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
154359031|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359032|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359033|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154359034|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154359035|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
154359036|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359037|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359038|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
154359039|NCT03680274|Vitamins|vitamins|mesh-ancestor
154359040|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
154359041|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359042|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
154359043|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359044|NCT03680274|Protective Agents|protective agents|mesh-ancestor
154359046|NCT03288987|Bevacizumab|bevacizumab|mesh-list
154359047|NCT03288987|Fluorouracil|fluorouracil|mesh-list
154359048|NCT03288987|Irinotecan|irinotecan|mesh-list
154359049|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154359050|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359051|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154359052|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154359053|NCT03288987|Growth Substances|growth substances|mesh-ancestor
154359054|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359055|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
154359056|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
154359057|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359058|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154359059|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154359060|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
154359061|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154359062|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154359063|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359075|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
154359076|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154359077|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
154359078|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359079|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359080|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
154359081|NCT03682224|Epinephrine|epinephrine|mesh-list
154359082|NCT03682224|Bupivacaine|bupivacaine|mesh-list
154359083|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
154359084|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
154359085|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359086|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359088|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359089|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154359090|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154359091|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
154359092|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359093|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359094|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154359095|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154359096|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
154359097|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154359098|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
154359099|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
154359100|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
154359101|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154359102|NCT01383044|Carvedilol|carvedilol|mesh-list
154359103|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154206888|NCT00429026|Melphalan|melphalan|mesh-list
154359104|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154359105|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
154359106|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359107|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359108|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359109|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154359110|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
154359111|NCT01383044|Protective Agents|protective agents|mesh-ancestor
154359112|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154359113|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154359114|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154359115|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
154359116|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154359117|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154359118|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
154359119|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154359120|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
154359121|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359122|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359123|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154359124|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
154359125|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154359126|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154359127|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154359128|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
154359129|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359130|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359141|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
154359142|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359143|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359144|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359145|NCT01314027|Gemcitabine|gemcitabine|mesh-list
154359146|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
154359147|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154359148|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
154359149|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359150|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359151|NCT03708003|Venetoclax|venetoclax|mesh-list
154359152|NCT03708003|Ibrutinib|ibrutinib|mesh-list
154359153|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359154|NCT03708003|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154359155|NCT03708003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359156|NCT03708003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359157|NCT03708003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359158|NCT03083132|Modafinil|modafinil|mesh-list
154359159|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154359160|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359161|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154359162|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154359163|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154359164|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359165|NCT04121468|Metformin|metformin|mesh-list
154359166|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154359167|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359168|NCT03648489|Paclitaxel|paclitaxel|mesh-list
154359169|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154359170|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359171|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154359172|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154359173|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154359174|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359175|NCT01382888|Heparin|heparin|mesh-list
154359176|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
154359177|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154359178|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154359179|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359180|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154359181|NCT03249909|Laxatives|laxatives|mesh-ancestor
154359182|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154359183|NCT04809116|Pimavanserin|pimavanserin|mesh-list
154359184|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154359185|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154359186|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154359187|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154359188|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359189|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359190|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154359191|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154359192|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154359193|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
154359194|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359207|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359208|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359209|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359210|NCT03076970|Sumatriptan|sumatriptan|mesh-list
154359211|NCT03076970|Lasmiditan|lasmiditan|mesh-list
154359212|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154359213|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154359214|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154359215|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
154359216|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359217|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359218|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359219|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
154359220|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
154359221|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154359222|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154359223|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359224|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812319|NCT00429234|Gemcitabine|gemcitabine|mesh-list
154359225|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359226|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359227|NCT04897880|Panobinostat|panobinostat|mesh-list
154359228|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359229|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154359230|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359231|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359232|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
154359233|NCT02890992|Niacin|niacin|mesh-list
154359234|NCT02890992|Niacinamide|niacinamide|mesh-list
154359235|NCT02890992|Ezetimibe|ezetimibe|mesh-list
154359236|NCT02890992|Alirocumab|alirocumab|mesh-list
154359237|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
154359238|NCT02890992|Fenofibrate|fenofibrate|mesh-list
154359239|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154359240|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154359241|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
154359242|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359243|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154359244|NCT02890992|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154359245|NCT02890992|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154359246|NCT02890992|Protease Inhibitors|protease inhibitors|mesh-ancestor
154359247|NCT02890992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359248|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
154359249|NCT02890992|Vitamins|vitamins|mesh-ancestor
154359250|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
154359251|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359252|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
154359253|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154359254|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154359255|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154359256|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359257|NCT05274984|Lidocaine|lidocaine|mesh-list
154359258|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
154359259|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
153538314|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
154359273|NCT05274672|Trimethoprim|trimethoprim|mesh-list
154359274|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
154359275|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154359276|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359277|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154359278|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154359279|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359280|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359281|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359282|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154359283|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154359284|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154359285|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
154359286|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154359287|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154359288|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154359289|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154359290|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154359291|NCT01379144|Latanoprost|latanoprost|mesh-list
154359292|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154207040|NCT01325571|Tacrolimus|tacrolimus|mesh-list
154359293|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154359294|NCT01376882|Caffeine|caffeine|mesh-list
154359295|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154359296|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359297|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154359298|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359299|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359300|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154359301|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154359302|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
154359303|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359304|NCT04656002|Vactosertib|vactosertib|mesh-list
154359305|NCT04656002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359306|NCT04656002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359307|NCT04656002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105579|NCT02547597|Atenolol|atenolol|mesh-list
154359308|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
154359310|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154861900|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154359311|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359312|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
154359313|NCT01382498|Coagulants|coagulants|mesh-ancestor
154359314|NCT03476538|Gabapentin|gabapentin|mesh-list
154359315|NCT03476538|Analgesics|analgesics|mesh-ancestor
154359316|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
154359317|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359318|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359331|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154359332|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154359333|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154359334|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359335|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
154359336|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359337|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359338|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154359339|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359340|NCT00000116|Vitamin A|vitamin a|mesh-list
154359341|NCT00000116|Vitamins|vitamins|mesh-ancestor
154359342|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
154359343|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359344|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154359345|NCT05232396|Antibodies|antibodies|mesh-list
154359346|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
154359347|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154359348|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
154359349|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359350|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359351|NCT05222724|Ibuprofen|ibuprofen|mesh-list
154359352|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154359353|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154359354|NCT05222724|Analgesics|analgesics|mesh-ancestor
154359355|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
154359356|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359357|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359358|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359359|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359360|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154359361|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359362|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359363|NCT01382342|Rasagiline|rasagiline|mesh-list
154359364|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154359365|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359366|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359367|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154359368|NCT01382342|Protective Agents|protective agents|mesh-ancestor
154359369|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359370|NCT03471728|Linaclotide|linaclotide|mesh-list
154359371|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154359372|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
154359373|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359374|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154359375|NCT03630614|Nicotine|nicotine|mesh-list
154359376|NCT03630614|Varenicline|varenicline|mesh-list
154359377|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154359378|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
154359379|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359380|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359393|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154359394|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
154359395|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
154359396|NCT05764304|Sinomenine|sinomenine|mesh-list
154359397|NCT05764304|Glucocorticoids|glucocorticoids|mesh-list
154359398|NCT05764304|Hormones|hormones|mesh-ancestor
154359399|NCT05764304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359400|NCT05764304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359401|NCT05764304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359402|NCT03075410|GSK656|gsk656|mesh-list
154359403|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154359404|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359405|NCT05764226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154359406|NCT02826512|Niraparib|niraparib|mesh-list
154359407|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154359408|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359409|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359410|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812464|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359411|NCT02731352|Apatinib|apatinib|mesh-list
154359412|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359413|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359414|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359415|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359416|NCT05132660|Levodopa|levodopa|mesh-list
154359417|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154359418|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154359419|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154359420|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
154359421|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359422|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359423|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359424|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154359425|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
154359426|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
154359427|NCT05762744|Exenatide|exenatide|mesh-list
154207156|NCT01044810|Efavirenz|efavirenz|mesh-list
154359428|NCT05762744|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154359429|NCT05762744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154359430|NCT05762744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359431|NCT05762744|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154359432|NCT05762744|Incretins|incretins|mesh-ancestor
154359433|NCT05762744|Hormones|hormones|mesh-ancestor
154359434|NCT05762744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359435|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
154359436|NCT02257424|Trametinib|trametinib|mesh-list
154359437|NCT02257424|Dabrafenib|dabrafenib|mesh-list
154359438|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
154359439|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154359440|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154359441|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359442|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359451|NCT01858922|Cisplatin|cisplatin|mesh-list
154359452|NCT01858922|Doxorubicin|doxorubicin|mesh-list
154359453|NCT01858922|Etoposide|etoposide|mesh-list
154359454|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
154359455|NCT01858922|Vincristine|vincristine|mesh-list
154359456|NCT01858922|Bleomycin|bleomycin|mesh-list
154359457|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154359458|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
154359459|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359460|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359461|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154359462|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
154359463|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359464|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359465|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154359466|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359468|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
154359469|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359470|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154359471|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
154359472|NCT01858922|Hormones|hormones|mesh-ancestor
154359473|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359474|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154359475|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359476|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154359477|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154359478|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154359479|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154359480|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154359481|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
154359482|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
154359483|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359484|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
154359485|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
154359486|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
154359487|NCT01378286|Artesunate|artesunate|mesh-list
154359488|NCT01378286|Chloroquine|chloroquine|mesh-list
154359489|NCT01378286|Amodiaquine|amodiaquine|mesh-list
154359490|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
154861901|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359491|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154359492|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154359493|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359494|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812546|NCT00434031|Docetaxel|docetaxel|mesh-list
154359495|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
154359496|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
154359497|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154359498|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
154359499|NCT01378286|Amebicides|amebicides|mesh-ancestor
154359500|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359501|NCT01377974|Miltefosine|miltefosine|mesh-list
154359502|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154359503|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
154359504|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359505|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359506|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154359507|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154359508|NCT03071276|Cytarabine|cytarabine|mesh-list
154359509|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
154359510|NCT03071276|Methotrexate|methotrexate|mesh-list
154359511|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
154359512|NCT03071276|Fludarabine|fludarabine|mesh-list
154359513|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154359514|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
153538557|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154359523|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154359524|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154359525|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
154359526|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359527|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154359528|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
154359529|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359530|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359531|NCT03629600|Indomethacin|indomethacin|mesh-list
154359532|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154359533|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154359534|NCT03629600|Analgesics|analgesics|mesh-ancestor
154359535|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
154359536|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359537|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359538|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359539|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359540|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
154359541|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
154359542|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154359543|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154359544|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359545|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359546|NCT03074162|Diclofenac|diclofenac|mesh-list
154359547|NCT03074162|Capsaicin|capsaicin|mesh-list
154359548|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154359549|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154359550|NCT03074162|Analgesics|analgesics|mesh-ancestor
154359551|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
154359552|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359553|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359554|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359555|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359556|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154359557|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359558|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359559|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
154359560|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
154359561|NCT05069012|Morphine|morphine|mesh-list
154359562|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154359563|NCT05069012|Narcotics|narcotics|mesh-ancestor
154359564|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359565|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359566|NCT05069012|Analgesics|analgesics|mesh-ancestor
154359567|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
154359568|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359569|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
154359570|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154359571|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359572|NCT02888106|Tenofovir|tenofovir|mesh-list
154359573|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154359574|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
154359575|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
154861902|NCT03030911|Midazolam|midazolam|mesh-list
154359576|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359577|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154861903|NCT03030911|Fentanyl|fentanyl|mesh-list
153812598|NCT00329459|Naproxen|naproxen|mesh-list
154359578|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154359579|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359580|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359587|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154359588|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
154359589|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359590|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359591|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
154359592|NCT03304626|Prednisone|prednisone|mesh-list
154359593|NCT03304626|Budesonide|budesonide|mesh-list
154359594|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359595|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
154359596|NCT03304626|Hormones|hormones|mesh-ancestor
154359597|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359598|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359599|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154359600|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359601|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154359602|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
154359603|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359604|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154359605|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
154359606|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
154359607|NCT05121714|Caffeine|caffeine|mesh-list
154207329|NCT00282243|Tacrolimus|tacrolimus|mesh-list
154359608|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154359609|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105872|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154359610|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154359611|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359612|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359613|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154359614|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154359615|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
154359616|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359617|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154359618|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154359619|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359620|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154359621|NCT05121714|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154359622|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154359623|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154359624|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
154359625|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154359626|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
154359627|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154359628|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154359629|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154359630|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
154359631|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154359632|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359633|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359634|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154359635|NCT02958150|Analgesics|analgesics|mesh-ancestor
154359636|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
154359637|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359638|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154359639|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154359640|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154359641|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
154359642|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359643|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359644|NCT04250142|Methamphetamine|methamphetamine|mesh-list
154359645|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154359646|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359664|NCT03267576|Canagliflozin|canagliflozin|mesh-list
154359665|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154359666|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359667|NCT03267576|Incretins|incretins|mesh-ancestor
154359668|NCT03267576|Hormones|hormones|mesh-ancestor
154359669|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861904|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
154359670|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154359671|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
154359672|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359673|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359674|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154359675|NCT02472912|Adalimumab|adalimumab|mesh-list
154359676|NCT02472912|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154359677|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359678|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359679|NCT02356458|Bortezomib|bortezomib|mesh-list
154359680|NCT02356458|Ibrutinib|ibrutinib|mesh-list
154359681|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359682|NCT02356458|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154359683|NCT02356458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359684|NCT02356458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359685|NCT02356458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359686|NCT03243630|Menthol|menthol|mesh-list
154359687|NCT03243630|Nicotine|nicotine|mesh-list
154359688|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154359689|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
154359690|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359691|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359692|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154359693|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154359694|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
154359695|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359696|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359697|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
154359698|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
154359699|NCT03753685|Ensartinib|ensartinib|mesh-list
154359700|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359701|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359702|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359703|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359704|NCT02787044|Vaccines|vaccines|mesh-list
154359738|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359739|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359740|NCT05763836|Ibuprofen|ibuprofen|mesh-list
154359741|NCT05763836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154359742|NCT05763836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154359743|NCT05763836|Analgesics|analgesics|mesh-ancestor
154359744|NCT05763836|Sensory System Agents|sensory system agents|mesh-ancestor
154359745|NCT05763836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538825|NCT01530022|Analgesics|analgesics|mesh-ancestor
154359782|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154359783|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359784|NCT01147133|Clopidogrel|clopidogrel|mesh-list
154359785|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154359816|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
154359817|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359818|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154359819|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154359820|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154359821|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
154359822|NCT03914963|Coagulants|coagulants|mesh-ancestor
154359823|NCT04162795|Loratadine|loratadine|mesh-list
154359824|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
154359825|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
154359826|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154359827|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154359828|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154359829|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
153538920|NCT01530503|Mitomycins|mitomycins|mesh-list
154359844|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154359845|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154359846|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
154359847|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359848|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359849|NCT01250405|Cinacalcet|cinacalcet|mesh-list
154359850|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154359851|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359852|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154359853|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
154359854|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359855|NCT05083910|Misoprostol|misoprostol|mesh-list
154359856|NCT05083910|Oxytocin|oxytocin|mesh-list
154359858|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
154359859|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154359860|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359861|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154359862|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
154359863|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154359864|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154359865|NCT01250561|Valacyclovir|valacyclovir|mesh-list
154359866|NCT01250561|Gabapentin|gabapentin|mesh-list
154359867|NCT01250561|Analgesics|analgesics|mesh-ancestor
154359868|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
154359869|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359870|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359871|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
154359872|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154359873|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154359874|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359875|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154359876|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154359877|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154359878|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359879|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359880|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
154359881|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
154359882|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359883|NCT05055908|Atezolizumab|atezolizumab|mesh-list
154359884|NCT05055908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154359885|NCT05055908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359886|NCT05055908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154359887|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359888|NCT01147523|Vitamin E|vitamin e|mesh-list
154359889|NCT01147523|Spironolactone|spironolactone|mesh-list
154359907|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
154359908|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154359909|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
154359910|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359911|NCT01251029|Protective Agents|protective agents|mesh-ancestor
154359912|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359913|NCT01251029|Antidotes|antidotes|mesh-ancestor
154359914|NCT01251107|Prednisone|prednisone|mesh-list
154359915|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
154359916|NCT01251107|Dacarbazine|dacarbazine|mesh-list
154359917|NCT01251107|Doxorubicin|doxorubicin|mesh-list
154359918|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154359919|NCT01251107|Etoposide|etoposide|mesh-list
154359920|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
154359921|NCT01251107|Vincristine|vincristine|mesh-list
154359922|NCT01251107|Bleomycin|bleomycin|mesh-list
154359923|NCT01251107|Vinblastine|vinblastine|mesh-list
154359924|NCT01251107|Procarbazine|procarbazine|mesh-list
154359925|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154359926|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
154359927|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359928|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359929|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154359930|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
154359931|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359932|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359933|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154359934|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154359935|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154359936|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154359937|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359938|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359939|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
154359940|NCT01251107|Hormones|hormones|mesh-ancestor
154359941|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359942|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154359943|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154359944|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154359945|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154359946|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154359964|NCT00882050|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154359965|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154359966|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359967|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154359968|NCT00882050|Incretins|incretins|mesh-ancestor
154359969|NCT00882050|Hormones|hormones|mesh-ancestor
154359970|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359971|NCT03912857|Apatinib|apatinib|mesh-list
154359972|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359973|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359974|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359975|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359976|NCT04892420|Dexamethasone|dexamethasone|mesh-list
154359977|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
154359978|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
154359979|NCT04892420|Bupivacaine|bupivacaine|mesh-list
154359980|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359981|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
154359982|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
154359983|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359984|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359985|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154359986|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
154359988|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359989|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154359990|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359991|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
154359992|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
154359993|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359994|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
154359995|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154359996|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154359997|NCT04892420|Analgesics|analgesics|mesh-ancestor
154359998|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154359999|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154360000|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154360001|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
154360002|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360003|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360004|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154360005|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
154360006|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154360056|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
154360057|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154360059|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
154106317|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360060|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360061|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360063|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154360064|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154360065|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360066|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154360067|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154360068|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154360069|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360070|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360071|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
154360072|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360073|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
154360074|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154360075|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154360076|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
154360077|NCT04166942|Belumosudil|belumosudil|mesh-list
154360078|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154360079|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360080|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360081|NCT04349917|Methylphenidate|methylphenidate|mesh-list
154360082|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154360083|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360084|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154360085|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154360086|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360087|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360088|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
154360089|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360090|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154360091|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154360092|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154360093|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
154360094|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360095|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154360096|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154360097|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360099|NCT04691856|Ibuprofen|ibuprofen|mesh-list
154360100|NCT04691856|Morphine|morphine|mesh-list
154360101|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154360102|NCT04691856|Narcotics|narcotics|mesh-ancestor
154360103|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360104|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360105|NCT04691856|Analgesics|analgesics|mesh-ancestor
154360106|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
154360107|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360120|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360122|NCT03300570|Dolcanatide|dolcanatide|mesh-list
154360123|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154360124|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
154360125|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360126|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360127|NCT03853694|Morphine|morphine|mesh-list
154360128|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154360129|NCT03853694|Narcotics|narcotics|mesh-ancestor
154360130|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360131|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360132|NCT03853694|Analgesics|analgesics|mesh-ancestor
154360133|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
154360134|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360135|NCT04154293|Isotretinoin|isotretinoin|mesh-list
154360136|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
154360137|NCT01148147|Adenosine|adenosine|mesh-list
154360138|NCT01148147|Analgesics|analgesics|mesh-ancestor
154360139|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
154360140|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360141|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360142|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154360143|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
154360144|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154360145|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
154360146|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
154360147|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360148|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360149|NCT03902249|Dexamethasone|dexamethasone|mesh-list
154360150|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360151|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
154360152|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
154360153|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360154|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360155|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360156|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
154360157|NCT03902249|Hormones|hormones|mesh-ancestor
154360158|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360159|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154360160|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360161|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
154360162|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
154360163|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360164|NCT03908489|Protective Agents|protective agents|mesh-ancestor
154360165|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360166|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154360167|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360168|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154360177|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154360178|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
154360179|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360180|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360181|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154360182|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
154360183|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360184|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360186|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154360187|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
154360188|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154360189|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360190|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
154360192|NCT03908333|Gemcitabine|gemcitabine|mesh-list
154360193|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154360194|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154360195|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360196|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
154360197|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
154360198|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
154360199|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360200|NCT03908333|Vitamins|vitamins|mesh-ancestor
154360201|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
154360202|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360203|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154360204|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
154360205|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
154360206|NCT03908333|Protective Agents|protective agents|mesh-ancestor
154360207|NCT04340557|Losartan|losartan|mesh-list
154360208|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154360209|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154360210|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154360211|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154360212|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360214|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
154360215|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
154360216|NCT04549376|Povidone|povidone|mesh-list
154360217|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154360218|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360219|NCT04549376|Trace Elements|trace elements|mesh-ancestor
154360220|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
154360221|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360222|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
154360223|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
154360224|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
154360225|NCT01149395|Lansoprazole|lansoprazole|mesh-list
154360226|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154360227|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360228|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154360229|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360230|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360231|NCT02527733|Ranibizumab|ranibizumab|mesh-list
154360232|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154360233|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154360234|NCT02527733|Growth Substances|growth substances|mesh-ancestor
154360235|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360236|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
154360237|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360238|NCT04135495|Ivacaftor|ivacaftor|mesh-list
154360239|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154360258|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360259|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154360260|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360262|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154360263|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154360264|NCT05205122|Mitomycins|mitomycins|mesh-list
154360265|NCT05205122|Mitomycin|mitomycin|mesh-list
154360266|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154360267|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360268|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
154360269|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360270|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154360271|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360272|NCT03907163|Dronabinol|dronabinol|mesh-list
154360273|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
154360274|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360275|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154360276|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154360277|NCT03907163|Analgesics|analgesics|mesh-ancestor
154360278|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
154360279|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360280|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154360281|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154360282|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360283|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360285|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360286|NCT01253681|Paclitaxel|paclitaxel|mesh-list
154360287|NCT01253681|Carboplatin|carboplatin|mesh-list
154360288|NCT01253681|Trebananib|trebananib|mesh-list
154360289|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154360290|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360291|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
154360318|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360320|NCT01589549|Hormones|hormones|mesh-ancestor
154360321|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360322|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154360323|NCT01589549|Protective Agents|protective agents|mesh-ancestor
154360324|NCT03899675|Caffeine|caffeine|mesh-list
154360325|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154360326|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360327|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154360328|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360329|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360330|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154360331|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154360332|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
154360333|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360334|NCT01562197|Axitinib|axitinib|mesh-list
154360335|NCT01562197|Lomustine|lomustine|mesh-list
154360336|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360337|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154360353|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154360354|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360355|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360356|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154360357|NCT03905837|Narcotics|narcotics|mesh-ancestor
154360358|NCT03905837|Analgesics|analgesics|mesh-ancestor
154360359|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154360360|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154360361|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
154360362|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
154360363|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154360364|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154360365|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360366|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360367|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360368|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360369|NCT01148615|Docetaxel|docetaxel|mesh-list
154360370|NCT01148615|Aflibercept|aflibercept|mesh-list
154360371|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360372|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
154360373|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
154360374|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
154360375|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360376|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154360377|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154360378|NCT01148615|Growth Substances|growth substances|mesh-ancestor
154360379|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360380|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
154360381|NCT03905759|Colchicine|colchicine|mesh-list
154360382|NCT03905759|Amiodarone|amiodarone|mesh-list
154360383|NCT03905759|Dronedarone|dronedarone|mesh-list
154360384|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
154360385|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360386|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
154360387|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
154360388|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
154360389|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360390|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360391|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154360392|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
154360393|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154360394|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360395|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154360396|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153539457|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
154861905|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154360425|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360428|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
154360429|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
154360430|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360431|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360432|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360433|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
154360434|NCT03629210|Hormones|hormones|mesh-ancestor
154360435|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360436|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154360437|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360438|NCT03899285|Citalopram|citalopram|mesh-list
154360439|NCT03899285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154360440|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154360451|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154360452|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154360453|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154360454|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
154360455|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360456|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360457|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360458|NCT01254071|Urological Agents|urological agents|mesh-ancestor
154360459|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154360460|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154360461|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360462|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
154360463|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360464|NCT05761418|Misoprostol|misoprostol|mesh-list
154360465|NCT05761418|Dinoprostone|dinoprostone|mesh-list
154360466|NCT05761418|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154360467|NCT05761418|Abortifacient Agents|abortifacient agents|mesh-ancestor
154360468|NCT05761418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154360469|NCT05761418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360470|NCT05761418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154360471|NCT05761418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360472|NCT05761418|Oxytocics|oxytocics|mesh-ancestor
154360473|NCT05207774|Oxytocin|oxytocin|mesh-list
154360474|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
154360475|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154360476|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360477|NCT02528123|Tobramycin|tobramycin|mesh-list
154360478|NCT02528123|Ofloxacin|ofloxacin|mesh-list
154360479|NCT02528123|Dexamethasone|dexamethasone|mesh-list
154360480|NCT02528123|Benoxinate|benoxinate|mesh-list
154360481|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
154360482|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360483|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
154360484|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
154360485|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360486|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360487|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360488|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
154360489|NCT02528123|Hormones|hormones|mesh-ancestor
154360490|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360491|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154360492|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360493|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154360494|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360495|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154360496|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154360497|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154360498|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360499|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360500|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154360501|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154360502|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
154360503|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
154360504|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360530|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154360531|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154360532|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154360533|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255465|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154360534|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360535|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
154360536|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360537|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360538|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154360539|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360541|NCT04320745|Androgens|androgens|mesh-ancestor
154360542|NCT04320745|Hormones|hormones|mesh-ancestor
154360543|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360544|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360545|NCT01254461|Pravastatin|pravastatin|mesh-list
154360546|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154360547|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154360548|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
154360549|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360550|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154360551|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154360552|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360570|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360571|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154360572|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
154360573|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360574|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360575|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154360576|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
154360577|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
154360578|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154360579|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154360580|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154360581|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154360582|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
154360583|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360584|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360585|NCT03904745|Atosiban|atosiban|mesh-list
154360586|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
154360587|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360588|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360589|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
154360590|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154360591|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
154360592|NCT05187338|Ipilimumab|ipilimumab|mesh-list
154360593|NCT05187338|Durvalumab|durvalumab|mesh-list
154360594|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154360595|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360596|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154360597|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360598|NCT03898583|Calcitriol|calcitriol|mesh-list
154360599|NCT03898583|Betamethasone|betamethasone|mesh-list
154360600|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
154360601|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154360602|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
154360603|NCT03898583|Calcipotriene|calcipotriene|mesh-list
154360604|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154360605|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360606|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
154360607|NCT03898583|Hormones|hormones|mesh-ancestor
154360608|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360609|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360610|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154360627|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360628|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154360629|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154360630|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360632|NCT03321188|Carboplatin|carboplatin|mesh-list
154360633|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154360634|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360635|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
154360636|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
154360637|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
154861906|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255466|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360638|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360639|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154360640|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154360641|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360642|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154360643|NCT01254617|Cetuximab|cetuximab|mesh-list
154360644|NCT01254617|Lenalidomide|lenalidomide|mesh-list
154360645|NCT01254617|Antibodies|antibodies|mesh-list
154360646|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
154360647|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154360648|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
154360649|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360650|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360651|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154360652|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154360653|NCT01254617|Growth Substances|growth substances|mesh-ancestor
154360654|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
154360655|NCT01150331|Levetiracetam|levetiracetam|mesh-list
154360656|NCT01150331|Clonazepam|clonazepam|mesh-list
154360657|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
154360658|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
154360659|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
154360660|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
154360661|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360662|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360663|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360664|NCT01256489|Infliximab|infliximab|mesh-list
154360665|NCT01256489|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154360666|NCT01256489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539735|NCT01535391|Nilotinib|nilotinib|mesh-list
154360699|NCT02898506|Liraglutide|liraglutide|mesh-list
154360700|NCT02898506|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154360701|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154360702|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360703|NCT02898506|Incretins|incretins|mesh-ancestor
154360704|NCT02898506|Hormones|hormones|mesh-ancestor
154360705|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360706|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
154360707|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154360708|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
154360709|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360710|NCT04123405|Expectorants|expectorants|mesh-ancestor
154360723|NCT02611232|Hormones|hormones|mesh-ancestor
154360724|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360725|NCT01150877|Vitamin D|vitamin d|mesh-list
154360726|NCT01150877|Vitamins|vitamins|mesh-ancestor
154360727|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
154360728|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360729|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154360730|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154360732|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
154360733|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154360734|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154360735|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360736|NCT01256801|Interleukin-2|interleukin-2|mesh-list
154360737|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360738|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154360739|NCT01256801|Analgesics|analgesics|mesh-ancestor
154360740|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
154360741|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360742|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360743|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
154360744|NCT02519738|Triamcinolone|triamcinolone|mesh-list
154360745|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154360746|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360747|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
154360748|NCT02519738|Hormones|hormones|mesh-ancestor
154360749|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360750|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360751|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154360752|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
154360753|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154360754|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360755|NCT03893747|Vaccines|vaccines|mesh-list
154360756|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
154861907|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360757|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360758|NCT02343224|Interferons|interferons|mesh-list
154360759|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
154360760|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
154360761|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154360762|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360763|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
154360764|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360765|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
154360766|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360767|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154360768|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154360769|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360770|NCT04314037|Praziquantel|praziquantel|mesh-list
154360771|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
154360772|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154360773|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360774|NCT05737862|Folic Acid|folic acid|mesh-list
154360775|NCT05737862|Hematinics|hematinics|mesh-ancestor
154360793|NCT01150955|Protective Agents|protective agents|mesh-ancestor
154360794|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360795|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360796|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154360797|NCT03897413|Antacids|antacids|mesh-list
154360798|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
154360799|NCT03897413|Calcium|calcium|mesh-list
154360800|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154360801|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360802|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360803|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360804|NCT01258439|Ritonavir|ritonavir|mesh-list
154360805|NCT01258439|Darunavir|darunavir|mesh-list
154360806|NCT01258439|Tenofovir|tenofovir|mesh-list
154360807|NCT01258439|Emtricitabine|emtricitabine|mesh-list
154360808|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154360809|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
154360810|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154360811|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154360812|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
154360813|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360814|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360815|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154360816|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154360817|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
154360818|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360819|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154360820|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154360821|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154360822|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154360823|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154360824|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154360825|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
154360826|NCT01560572|Prednisolone|prednisolone|mesh-list
154360827|NCT01560572|Tacrolimus|tacrolimus|mesh-list
154360828|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154360829|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
154360830|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360831|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154360832|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360858|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360859|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360860|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154360861|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154360862|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
154360863|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360864|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154360865|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
154360866|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
154360867|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
154360868|NCT03892499|Itraconazole|itraconazole|mesh-list
154360869|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
154360870|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360871|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154360872|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154360873|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861908|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154360874|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360875|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154360876|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
154360877|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360878|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360904|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154360905|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154360906|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154360907|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360908|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360909|NCT01152203|Bevacizumab|bevacizumab|mesh-list
154360910|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154360911|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154360912|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360913|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154360914|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154360915|NCT01152203|Growth Substances|growth substances|mesh-ancestor
154360916|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360917|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
154360918|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154360919|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
154360920|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360921|NCT01257815|Ranibizumab|ranibizumab|mesh-list
154360922|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154360923|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154360924|NCT01257815|Growth Substances|growth substances|mesh-ancestor
154360925|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360926|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
154360927|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360928|NCT03892421|Cytarabine|cytarabine|mesh-list
154360947|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
154360948|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360949|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
154360950|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360951|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154360952|NCT05546567|Niacinamide|niacinamide|mesh-list
154360953|NCT05546567|Niacin|niacin|mesh-list
154107228|NCT00865605|Clobetasol|clobetasol|mesh-list
154360954|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
154360955|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
154360956|NCT05546567|Vitamins|vitamins|mesh-ancestor
154360957|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
154360958|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360959|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154360960|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
154360961|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360962|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154360963|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
154360964|NCT03895229|Empagliflozin|empagliflozin|mesh-list
154360965|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154360966|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360967|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154360968|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360969|NCT01257893|Aspirin|aspirin|mesh-list
154360970|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154360971|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154360972|NCT01257893|Analgesics|analgesics|mesh-ancestor
154360973|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
154360974|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360975|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360976|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360977|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360978|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154360979|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154360980|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208196|NCT00395304|Hormones|hormones|mesh-ancestor
154360981|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154360982|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154360983|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360984|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
154360985|NCT01152593|Mupirocin|mupirocin|mesh-list
154361015|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154361016|NCT03894839|Glutaral|glutaral|mesh-list
154361017|NCT03894839|Eusol|eusol|mesh-list
154361018|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154361020|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
154361021|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
154361022|NCT01152749|Nicotine|nicotine|mesh-list
154361023|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154361024|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
154361025|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361026|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107298|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361027|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154361028|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154361029|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
154361030|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361031|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361062|NCT01152827|Everolimus|everolimus|mesh-list
154361063|NCT01152827|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154361064|NCT01152827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154361065|NCT01152827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361066|NCT01152827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361067|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361068|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
154361069|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361070|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361071|NCT01153373|Ethanol|ethanol|mesh-list
154361072|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154361073|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540150|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
154361084|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361085|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
154361086|NCT03889145|Diuretics|diuretics|mesh-ancestor
154361087|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
154361088|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154361089|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154361090|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154361091|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
154361092|NCT03888677|Epirubicin|epirubicin|mesh-list
154361093|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361094|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
154361095|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361096|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154361097|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154361098|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
154361099|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361100|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361101|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154361102|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154361103|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154361104|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154361105|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361107|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361108|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361109|NCT01260233|Nicotine|nicotine|mesh-list
154361110|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154361111|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
154361112|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361113|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361114|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154361115|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154361116|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
154361117|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361118|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361119|NCT04435964|Immunomodulating Agents|immunomodulating agents|mesh-list
154361120|NCT04435964|Immunologic Factors|immunologic factors|mesh-ancestor
154361121|NCT04435964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361122|NCT01153919|Interferons|interferons|mesh-list
154361123|NCT01153919|Ribavirin|ribavirin|mesh-list
154361124|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
154361125|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
154361126|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154361127|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361128|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
154361129|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361130|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
154861909|NCT03030911|Analgesics|analgesics|mesh-ancestor
154361131|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361133|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361135|NCT03912389|Pemetrexed|pemetrexed|mesh-list
154361136|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361137|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182185|NCT05868525|Sensory System Agents|sensory system agents|mesh-ancestor
154361152|NCT01154387|Tacrolimus|tacrolimus|mesh-list
154361153|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
154361154|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154361155|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361156|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
154361157|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361158|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154361159|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361160|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361161|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154361162|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361163|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154361164|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
154361165|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154361166|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361167|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
154361168|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154361169|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361170|NCT01260623|Prednisone|prednisone|mesh-list
154361171|NCT01260623|Prednisolone|prednisolone|mesh-list
154361172|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361173|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
154361174|NCT01260623|Hormones|hormones|mesh-ancestor
154361175|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361176|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361177|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361178|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361179|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154361180|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
154361181|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154361182|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
154361183|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154361184|NCT01260857|Diuretics|diuretics|mesh-ancestor
154361185|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
154361186|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361187|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154361188|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154361189|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361190|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
154361191|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361192|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361193|NCT01153217|Tenofovir|tenofovir|mesh-list
154361194|NCT01153217|Abacavir|abacavir|mesh-list
154361195|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
154361196|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361197|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154361198|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154361202|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154361204|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154361205|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361206|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154361207|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
154361208|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154361209|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361210|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361211|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361212|NCT03889379|Albuterol|albuterol|mesh-list
154361213|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154361214|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
154361215|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361216|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361217|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154361218|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
154361219|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
154361220|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154361221|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154361222|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154361223|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154361224|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
154361225|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361226|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361227|NCT01586507|Tramadol|tramadol|mesh-list
154361228|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154361229|NCT01586507|Narcotics|narcotics|mesh-ancestor
154361230|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361231|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361232|NCT01586507|Analgesics|analgesics|mesh-ancestor
154361233|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
154361234|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361235|NCT03910361|Pioglitazone|pioglitazone|mesh-list
154361236|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361237|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361238|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154361239|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
154361240|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154361241|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154361242|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154361243|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
154361244|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154361245|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361246|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154361247|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154361248|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154361249|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361250|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361251|NCT03885947|Fludarabine|fludarabine|mesh-list
154361252|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
154361253|NCT03885947|Thiotepa|thiotepa|mesh-list
154361254|NCT03885947|Valproic Acid|valproic acid|mesh-list
154361255|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361256|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361257|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361258|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
154361259|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361260|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154361261|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154361262|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
154361263|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154361264|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
154361265|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361266|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
154361267|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361268|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
154361269|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154361300|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361302|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154361303|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
154361304|NCT01155635|Protective Agents|protective agents|mesh-ancestor
154361305|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154361306|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154361307|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154361308|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
154361309|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153540393|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
154361341|NCT01155791|Hormones|hormones|mesh-ancestor
154361342|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361343|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361344|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361345|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154361346|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154361347|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154361348|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361349|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361350|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154361360|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154361361|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361362|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361363|NCT03884465|Treprostinil|treprostinil|mesh-list
154361364|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154361365|NCT01155947|Anastrozole|anastrozole|mesh-list
154361366|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361367|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361368|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154361369|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154361370|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361371|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361372|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154361373|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
154361374|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361375|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361376|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154361377|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154361378|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154361379|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361380|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361381|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154361382|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154361383|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154361384|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
154361385|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361386|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361387|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154361388|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154361389|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
154361390|NCT01264133|Adefovir|adefovir|mesh-list
154361391|NCT01264133|Clevudine|clevudine|mesh-list
154361392|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
154361393|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361394|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154361395|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154361396|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361397|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361398|NCT02527577|Ropivacaine|ropivacaine|mesh-list
154361399|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
154361401|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361402|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361403|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
154361404|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361405|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154361406|NCT03883841|Hematinics|hematinics|mesh-ancestor
154361407|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
154361408|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361409|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361410|NCT03881111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154361411|NCT03881111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361412|NCT01264211|Diacerein|diacerein|mesh-list
154361413|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361414|NCT03880877|Leucovorin|leucovorin|mesh-list
154361415|NCT03880877|Antidotes|antidotes|mesh-ancestor
153540484|NCT01539330|Voriconazole|voriconazole|mesh-list
154361431|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154361432|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154361433|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361434|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361435|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
154361436|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361437|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361438|NCT01264289|Urological Agents|urological agents|mesh-ancestor
154361439|NCT03880487|Oxycodone|oxycodone|mesh-list
154361440|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154361441|NCT03880487|Narcotics|narcotics|mesh-ancestor
154361442|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361443|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361444|NCT03880487|Analgesics|analgesics|mesh-ancestor
154361445|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
154361446|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361447|NCT03880409|Lidocaine|lidocaine|mesh-list
154361448|NCT03880409|Epinephrine|epinephrine|mesh-list
154361449|NCT03880409|Racepinephrine|racepinephrine|mesh-list
154361450|NCT03880409|Carticaine|carticaine|mesh-list
154361451|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
154361452|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
154361453|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
154361454|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361455|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361456|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
154361457|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361458|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154361459|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154361460|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154361461|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154361462|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361463|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154361464|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154361465|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
154361466|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361467|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154361468|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154361470|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154107748|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154361471|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
154361472|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
154361473|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
154361474|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154361476|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154361477|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361489|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361491|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361492|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154361493|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361494|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361495|NCT01264445|Vaccines|vaccines|mesh-list
154361496|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
154361497|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361498|NCT01157975|Pioglitazone|pioglitazone|mesh-list
154361499|NCT01157975|Prednisone|prednisone|mesh-list
154361500|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361501|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
154361502|NCT01157975|Hormones|hormones|mesh-ancestor
154361503|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361504|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361505|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361506|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361507|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361508|NCT03060512|Naloxegol|naloxegol|mesh-list
154361509|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154361510|NCT03060512|Laxatives|laxatives|mesh-ancestor
154361511|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361512|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154361513|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361514|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
154361515|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361516|NCT01263353|Everolimus|everolimus|mesh-list
154361517|NCT01263353|Pasireotide|pasireotide|mesh-list
154361518|NCT01263353|Somatostatin|somatostatin|mesh-list
154361519|NCT01263353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154361520|NCT01263353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154361521|NCT01263353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208514|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154361522|NCT01263353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361523|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361524|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
154361525|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361526|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361527|NCT01263353|Hormones|hormones|mesh-ancestor
154361528|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361529|NCT01158287|Sorafenib|sorafenib|mesh-list
154361530|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361531|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154361532|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361533|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361534|NCT01158365|Glycerol|glycerol|mesh-list
154361535|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154361536|NCT01158365|Protective Agents|protective agents|mesh-ancestor
154361537|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361538|NCT01156649|Acetaminophen|acetaminophen|mesh-list
154361539|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154361540|NCT01156649|Analgesics|analgesics|mesh-ancestor
154361541|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
154361555|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361556|NCT03879707|Protective Agents|protective agents|mesh-ancestor
154361557|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361558|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361559|NCT01265147|Nedaplatin|nedaplatin|mesh-list
154361560|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361561|NCT01159145|Omeprazole|omeprazole|mesh-list
154361562|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154361563|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361564|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154361565|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361566|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361567|NCT01156883|Cytarabine|cytarabine|mesh-list
154361568|NCT01156883|Dexamethasone|dexamethasone|mesh-list
154361569|NCT01156883|Prednisone|prednisone|mesh-list
154361570|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
154361571|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
154361572|NCT01156883|Ifosfamide|ifosfamide|mesh-list
154361573|NCT01156883|Doxorubicin|doxorubicin|mesh-list
154361574|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154361575|NCT01156883|Methotrexate|methotrexate|mesh-list
154361576|NCT01156883|Vincristine|vincristine|mesh-list
154361577|NCT01156883|Daunorubicin|daunorubicin|mesh-list
154361578|NCT01156883|Asparaginase|asparaginase|mesh-list
154361579|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
154361580|NCT01156883|Thioguanine|thioguanine|mesh-list
154361581|NCT01156883|Vindesine|vindesine|mesh-list
154361582|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361583|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
154361584|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208574|NCT00375518|Atorvastatin|atorvastatin|mesh-list
154361585|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154361586|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154361587|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
154361588|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361589|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361590|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154361591|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361592|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
154361593|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
154361594|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361595|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361596|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
154361597|NCT01156883|Hormones|hormones|mesh-ancestor
154361598|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361599|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361600|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154361601|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154361602|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154361603|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540662|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154361611|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154361612|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
154361613|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361614|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154361615|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
154361616|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
154361617|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
154361618|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154361619|NCT01156883|Protective Agents|protective agents|mesh-ancestor
154361620|NCT01156961|Paclitaxel|paclitaxel|mesh-list
154361621|NCT01156961|Bevacizumab|bevacizumab|mesh-list
154361622|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154361623|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361624|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
154107897|NCT00949624|Docetaxel|docetaxel|mesh-list
154361625|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
154361626|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582982|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
154361627|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361628|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361629|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154361630|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154361631|NCT01156961|Growth Substances|growth substances|mesh-ancestor
154361632|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361633|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
154361634|NCT01159301|Sorafenib|sorafenib|mesh-list
154361635|NCT01159301|Entinostat|entinostat|mesh-list
154361636|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154361637|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361638|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154361639|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361640|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361641|NCT01159379|Ertapenem|ertapenem|mesh-list
154361642|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154361643|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361644|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154361645|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361646|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361647|NCT01159847|Incretins|incretins|mesh-ancestor
154361648|NCT01159847|Hormones|hormones|mesh-ancestor
154361649|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361650|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154361651|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
154361652|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361653|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361654|NCT02539160|Ticagrelor|ticagrelor|mesh-list
154361655|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154361656|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154361657|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154361658|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154361659|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
154361660|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361661|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361662|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361663|NCT01265927|Trastuzumab|trastuzumab|mesh-list
154361664|NCT01265927|Imetelstat|imetelstat|mesh-list
154361665|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361666|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361667|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361668|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361669|NCT01266005|Entecavir|entecavir|mesh-list
154361693|NCT03241173|Ipilimumab|ipilimumab|mesh-list
154361694|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361695|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361696|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154361697|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361698|NCT03264066|Atezolizumab|atezolizumab|mesh-list
154107973|NCT00742976|Insulin|insulin|mesh-list
154361699|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154361700|NCT03264066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154361701|NCT03264066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361702|NCT03264066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361703|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361704|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
154361705|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361706|NCT03759041|Vancomycin|vancomycin|mesh-list
154361707|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154361708|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361709|NCT04110145|Linaclotide|linaclotide|mesh-list
154361710|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154361711|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
154361712|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361713|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361714|NCT02477618|Brexanolone|brexanolone|mesh-list
154361715|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
154361716|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361717|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361718|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361719|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
153540797|NCT01541124|Morphine|morphine|mesh-list
154361740|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361742|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
154361743|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154361744|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154361745|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
154361746|NCT05158491|Irinotecan|irinotecan|mesh-list
154361747|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154361748|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154361749|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361750|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361751|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361752|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
154361753|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361754|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361755|NCT03876587|Docetaxel|docetaxel|mesh-list
154361756|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361757|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
154361758|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
154361759|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
154361760|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361761|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154361762|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
154361763|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361764|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
154361765|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361766|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154361767|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
154361768|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
154361769|NCT03282357|Protective Agents|protective agents|mesh-ancestor
154361770|NCT01162967|Posaconazole|posaconazole|mesh-list
154361771|NCT01162967|Benzonidazole|benzonidazole|mesh-list
154361772|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
154361773|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361774|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154361775|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154361784|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361785|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361786|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
154361787|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154361788|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
154361789|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154361790|NCT04272775|Dexamethasone|dexamethasone|mesh-list
154361791|NCT04272775|Lenalidomide|lenalidomide|mesh-list
154361792|NCT04272775|Ixazomib|ixazomib|mesh-list
154361793|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361794|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
154361795|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
154361796|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361797|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361798|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361799|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
154361800|NCT04272775|Hormones|hormones|mesh-ancestor
154361801|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361802|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361803|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361804|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
154361805|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154361806|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154361807|NCT04272775|Growth Substances|growth substances|mesh-ancestor
154361808|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
154361809|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
154361810|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361811|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361812|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
154361813|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361814|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361815|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
154361816|NCT01163201|Fludarabine|fludarabine|mesh-list
154361817|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361818|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
154361819|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361820|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154361821|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154361822|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
154361823|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361824|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361825|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154361826|NCT03876041|Dexamethasone|dexamethasone|mesh-list
154361827|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
154361828|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
154361829|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154361830|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154361831|NCT03876041|BB 1101|bb 1101|mesh-list
154361832|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361833|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
154361834|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
154361835|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361836|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361837|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361838|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
154361839|NCT03876041|Hormones|hormones|mesh-ancestor
154361840|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361847|NCT03876041|Protective Agents|protective agents|mesh-ancestor
154361848|NCT04102345|Zolpidem|zolpidem|mesh-list
154361849|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154361851|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361852|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361853|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154361854|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
154361855|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
154361856|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361857|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361858|NCT01163435|Clarithromycin|clarithromycin|mesh-list
154361859|NCT01163435|Levofloxacin|levofloxacin|mesh-list
154361860|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154361861|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361862|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154361863|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361864|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361865|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154361866|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154361867|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154361868|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154361869|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154361870|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361871|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154361872|NCT03299244|Cinacalcet|cinacalcet|mesh-list
154361873|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154361874|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361875|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154361876|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
154361877|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361878|NCT03757715|Dexamethasone|dexamethasone|mesh-list
154361879|NCT03757715|Bupivacaine|bupivacaine|mesh-list
154361880|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361881|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
154361882|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
154361883|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361884|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361885|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361886|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
154361887|NCT03757715|Hormones|hormones|mesh-ancestor
154361888|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361889|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361890|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361891|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
154361892|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
154361893|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361894|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
154361895|NCT01163825|Mitogens|mitogens|mesh-list
154361896|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154361897|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361898|NCT01163903|Doxorubicin|doxorubicin|mesh-list
154361899|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154361900|NCT01163903|Pantoprazole|pantoprazole|mesh-list
154361901|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154361902|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361903|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154361904|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154361905|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208848|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
154361906|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361907|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154361908|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361921|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154361922|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
154361923|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
154361924|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361925|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361926|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361928|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154361929|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361930|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154861910|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
154255467|NCT05570786|Gestrinone|gestrinone|mesh-list
154361931|NCT01164059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154361932|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154361933|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154361934|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361935|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361936|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
154361937|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
154361938|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
154361939|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
154361940|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154361941|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154361942|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154361943|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154361944|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154361945|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154361946|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154361947|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
154361948|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154361949|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361950|NCT03878771|Clobetasol|clobetasol|mesh-list
154361951|NCT03878771|Benzocaine|benzocaine|mesh-list
154361952|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361953|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
154361954|NCT03878771|Hormones|hormones|mesh-ancestor
154361955|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361956|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361957|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
154361958|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
154361959|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361960|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
154361961|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361962|NCT02959918|Sirolimus|sirolimus|mesh-list
154361963|NCT02959918|Temsirolimus|temsirolimus|mesh-list
154361964|NCT02959918|MTOR Inhibitors|mtor inhibitors|mesh-list
154361965|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154361966|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361967|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154361968|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361969|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
154361970|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361971|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
154361972|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361979|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361980|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154361981|NCT01266707|Growth Substances|growth substances|mesh-ancestor
154361982|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
154361983|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361984|NCT03263442|Thiamine|thiamine|mesh-list
154361985|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
154361986|NCT03263442|Vitamins|vitamins|mesh-ancestor
154361987|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
154361988|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361989|NCT01164215|Leucovorin|leucovorin|mesh-list
154361990|NCT01164215|Fluorouracil|fluorouracil|mesh-list
154361991|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
154361992|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
154361993|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361994|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
154361995|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361996|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154361997|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361998|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154361999|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
154362000|NCT01164215|Antidotes|antidotes|mesh-ancestor
154362001|NCT01164215|Protective Agents|protective agents|mesh-ancestor
154362002|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
154362003|NCT01164215|Vitamins|vitamins|mesh-ancestor
154362004|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
154362005|NCT04245709|Clenbuterol|clenbuterol|mesh-list
154362006|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154362007|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154362008|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
154362009|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362010|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861911|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255468|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154362011|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362012|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154362013|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
154362014|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362015|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154362016|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
154362017|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
154362018|NCT03878693|Fomepizole|fomepizole|mesh-list
154362019|NCT03878693|Antidotes|antidotes|mesh-ancestor
154362020|NCT03878693|Protective Agents|protective agents|mesh-ancestor
154362021|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362022|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362023|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362024|NCT05305495|Empagliflozin|empagliflozin|mesh-list
154362025|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154362026|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362027|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154362028|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362029|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
154362030|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154362031|NCT02527109|Nifedipine|nifedipine|mesh-list
154362032|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154362033|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362034|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362035|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154362036|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362037|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
154362038|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
154362039|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154362040|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154362041|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153541096|NCT01542723|Nadroparin|nadroparin|mesh-list
154362066|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362067|NCT03746821|Biotin|biotin|mesh-list
154362068|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
154362069|NCT03746821|Vitamins|vitamins|mesh-ancestor
154362070|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
154362071|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362072|NCT02472964|Paclitaxel|paclitaxel|mesh-list
154362073|NCT02472964|Docetaxel|docetaxel|mesh-list
154362074|NCT02472964|Trastuzumab|trastuzumab|mesh-list
154362075|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154362076|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362077|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
154362078|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
154362079|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
154362080|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362081|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362082|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154362083|NCT01160315|Norethindrone|norethindrone|mesh-list
154362084|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
154362085|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
154362086|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154362087|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
154362088|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154362089|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362090|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154362091|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154362092|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541164|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362106|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362107|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154362108|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154362109|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362110|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362112|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
154362113|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362114|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154362115|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154362116|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154362117|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861912|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154861913|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154362118|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362120|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362121|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362122|NCT01164761|Ramipril|ramipril|mesh-list
154362123|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154362124|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
154362125|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362126|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362127|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154362128|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
154362129|NCT03385096|Melphalan|melphalan|mesh-list
154362130|NCT03385096|Busulfan|busulfan|mesh-list
154362131|NCT03385096|Etoposide|etoposide|mesh-list
154362132|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154362133|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
154362134|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362135|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154362136|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154362137|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
154362138|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362139|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362140|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154362141|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154362142|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154362143|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154362144|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362145|NCT02526875|Amlodipine|amlodipine|mesh-list
154362146|NCT02526875|Telmisartan|telmisartan|mesh-list
154362147|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154362148|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154362149|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362150|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362151|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154362152|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362153|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
154362172|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
154362173|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362174|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362175|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154362176|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154362177|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362178|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362179|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362180|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
154362181|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154362182|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
154362183|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362184|NCT01160627|Expectorants|expectorants|mesh-ancestor
154362185|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
154362186|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154362187|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
154362188|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362189|NCT01160627|Protective Agents|protective agents|mesh-ancestor
154362190|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362191|NCT01160627|Antidotes|antidotes|mesh-ancestor
154362192|NCT04075513|Insulin|insulin|mesh-list
154362193|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154362194|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
154362195|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
154362196|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154362197|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362198|NCT03877679|Triamcinolone|triamcinolone|mesh-list
154362199|NCT03877679|Curcumin|curcumin|mesh-list
154362200|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154362201|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
154362202|NCT03877679|Hormones|hormones|mesh-ancestor
154362203|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362204|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362205|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362206|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362207|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154362208|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154362209|NCT03877679|Analgesics|analgesics|mesh-ancestor
153761961|NCT00188669|Vitamins|vitamins|mesh-ancestor
154362242|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154362244|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362245|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
154362246|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
154362247|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
154362248|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362249|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154362250|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
154362269|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362270|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154362271|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154362272|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362273|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362274|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154362275|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
154362276|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362277|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154362278|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154362279|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362280|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154362282|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
154362283|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
154362284|NCT03384862|Vitamins|vitamins|mesh-ancestor
154362285|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
154362286|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362287|NCT03384862|Hematinics|hematinics|mesh-ancestor
154362288|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
154362289|NCT01269437|Budesonide|budesonide|mesh-list
154362290|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154362291|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154362292|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
154362293|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362294|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362295|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154362296|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
154108570|NCT04039815|Thiamine|thiamine|mesh-list
154362297|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
154362298|NCT01269437|Hormones|hormones|mesh-ancestor
154362299|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362300|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
154362301|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
154362302|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362303|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
154362304|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362305|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362306|NCT00462748|Atorvastatin|atorvastatin|mesh-list
154362320|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154362321|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362322|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154362323|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
154362324|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154362325|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154362326|NCT01161017|Analgesics|analgesics|mesh-ancestor
154362327|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
154362328|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362329|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154362330|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154209121|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
154362331|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362332|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362333|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
154362334|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362335|NCT03935685|Mirtazapine|mirtazapine|mesh-list
154362336|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
154362337|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154362338|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154362339|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
154362340|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
154362341|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362342|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362343|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362344|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154362345|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154861914|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154362346|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362347|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154362348|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154362349|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154362350|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
154362351|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154362352|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154362353|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
154362354|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154362355|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154362356|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
154362357|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362358|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154362359|NCT03238911|Hematinics|hematinics|mesh-ancestor
154362360|NCT01269515|Etoricoxib|etoricoxib|mesh-list
154362361|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154362362|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154362363|NCT01269515|Analgesics|analgesics|mesh-ancestor
154362364|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
154362365|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362366|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362367|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154362368|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154362387|NCT01269671|Protective Agents|protective agents|mesh-ancestor
154362388|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362389|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362390|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
154362391|NCT01269671|Emollients|emollients|mesh-ancestor
154362392|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
154362393|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
154362394|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
154362395|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362396|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154362397|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
154362398|NCT04407286|Vitamin D|vitamin d|mesh-list
154362399|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
154362400|NCT04407286|Vitamins|vitamins|mesh-ancestor
154362401|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
154362402|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362403|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154362404|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154362405|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154362406|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
154362407|NCT03276975|Coagulants|coagulants|mesh-ancestor
154362408|NCT03125746|Exemestane|exemestane|mesh-list
154362409|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362410|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154362411|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154362412|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362413|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362414|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154362415|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
154362416|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362417|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362418|NCT03877601|Bevacizumab|bevacizumab|mesh-list
154362419|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362420|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362421|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154362422|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154362423|NCT03877601|Growth Substances|growth substances|mesh-ancestor
154362424|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362425|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
154362447|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154362448|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154362449|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362450|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
154362451|NCT01267487|Coagulants|coagulants|mesh-ancestor
154362452|NCT01267643|Alefacept|alefacept|mesh-list
154362453|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
154362454|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
154362455|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362456|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
154362457|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154362458|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362459|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362460|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154362461|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154362462|NCT01269827|Protective Agents|protective agents|mesh-ancestor
154362463|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362464|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
154362465|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154362466|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
154362467|NCT03388372|Temozolomide|temozolomide|mesh-list
154362468|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
154362469|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154362470|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
154362471|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362472|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362473|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362474|NCT05173246|Paclitaxel|paclitaxel|mesh-list
154362475|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154362476|NCT05173246|Cisplatin|cisplatin|mesh-list
154362477|NCT05173246|Carboplatin|carboplatin|mesh-list
154362478|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154362479|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362480|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
154362481|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
154362494|NCT05173090|Ropivacaine|ropivacaine|mesh-list
154362495|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
154362496|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
154362497|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362498|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362499|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
154362500|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362501|NCT02526953|Paclitaxel|paclitaxel|mesh-list
154362502|NCT02526953|Capecitabine|capecitabine|mesh-list
154362503|NCT02526953|Mitomycins|mitomycins|mesh-list
154362504|NCT02526953|Mitomycin|mitomycin|mesh-list
154362505|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154362506|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362507|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154362508|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154362509|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154362510|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362511|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154362512|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
154362513|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154362514|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
154362515|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154362516|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362517|NCT03258762|Leucovorin|leucovorin|mesh-list
154362518|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
154362519|NCT03258762|Calcium|calcium|mesh-list
154362520|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
154362521|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154362522|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108783|NCT00383149|Cetuximab|cetuximab|mesh-list
154362523|NCT03258762|Antidotes|antidotes|mesh-ancestor
154362524|NCT03258762|Protective Agents|protective agents|mesh-ancestor
154362525|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
154362526|NCT03258762|Vitamins|vitamins|mesh-ancestor
154362527|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
154362528|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
154362529|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154362530|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154362531|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362532|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154362533|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362534|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362535|NCT05427669|Leucovorin|leucovorin|mesh-list
154362536|NCT05427669|Fluorouracil|fluorouracil|mesh-list
154362537|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
154362538|NCT05427669|Irinotecan|irinotecan|mesh-list
154362539|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
154362540|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
154362541|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362542|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154362543|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362544|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154362545|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
154362546|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362555|NCT01270373|Docetaxel|docetaxel|mesh-list
154362556|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362557|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
153762246|NCT00220233|Amlodipine|amlodipine|mesh-list
154362558|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
154362559|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
154362560|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362561|NCT03713086|Vaccines|vaccines|mesh-list
154362562|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
154362563|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362564|NCT01271231|Azithromycin|azithromycin|mesh-list
154362565|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154362566|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362567|NCT03379558|Alirocumab|alirocumab|mesh-list
154362568|NCT03379558|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154362569|NCT03379558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154362570|NCT03379558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154362571|NCT03379558|Antimetabolites|antimetabolites|mesh-ancestor
154362572|NCT03379558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362573|NCT03379558|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154362574|NCT03379558|Protease Inhibitors|protease inhibitors|mesh-ancestor
154362575|NCT03379558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362576|NCT03379558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154362577|NCT01169909|Ranibizumab|ranibizumab|mesh-list
154362578|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154362579|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154362580|NCT01169909|Growth Substances|growth substances|mesh-ancestor
154362581|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362582|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
154362583|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362584|NCT04502589|Disulfiram|disulfiram|mesh-list
154362585|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154362586|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154362587|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362588|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362589|NCT03387904|Irinotecan|irinotecan|mesh-list
154362590|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154362591|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154362592|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362593|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362594|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362595|NCT03291288|Tolbutamide|tolbutamide|mesh-list
154362596|NCT03291288|Midazolam|midazolam|mesh-list
154362597|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154362598|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154362599|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362600|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362601|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154362602|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154362603|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154362604|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154362605|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
154362606|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
154362607|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
154362608|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
154362609|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362610|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362611|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154362612|NCT05172310|FAPI-46|fapi-46|mesh-list
154362613|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154362614|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362615|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154362616|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362630|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154362631|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154362632|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
154362633|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362634|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362635|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362636|NCT03871517|Aspirin|aspirin|mesh-list
154362637|NCT03871517|Indobufen|indobufen|mesh-list
154362638|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154362639|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154362640|NCT03871517|Analgesics|analgesics|mesh-ancestor
154362641|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
154362642|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362643|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362644|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154861915|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
154362646|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154362647|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154362648|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362649|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154362650|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154362651|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362652|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
154362653|NCT03387592|Leucovorin|leucovorin|mesh-list
154362654|NCT03387592|Capecitabine|capecitabine|mesh-list
154362655|NCT03387592|Fluorouracil|fluorouracil|mesh-list
154362656|NCT03387592|Temozolomide|temozolomide|mesh-list
154362657|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
154362658|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154362659|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
154362660|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362661|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362662|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154362663|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
154362664|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362665|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154362666|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
154362667|NCT03387592|Antidotes|antidotes|mesh-ancestor
154362668|NCT03387592|Protective Agents|protective agents|mesh-ancestor
154362669|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
154362670|NCT03387592|Vitamins|vitamins|mesh-ancestor
154362671|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
154362672|NCT04445506|Dexamethasone|dexamethasone|mesh-list
154362673|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154362674|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
154362675|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
154362676|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108938|NCT00369655|Aflibercept|aflibercept|mesh-list
154362677|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362679|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
154362680|NCT04445506|Hormones|hormones|mesh-ancestor
154362697|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154362698|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154362699|NCT03379012|Growth Substances|growth substances|mesh-ancestor
154362700|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
154362701|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154362702|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362703|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362704|NCT03383302|Nivolumab|nivolumab|mesh-list
154362705|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362706|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362707|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154362708|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362709|NCT03493126|Estradiol|estradiol|mesh-list
154362710|NCT03493126|Estrogens|estrogens|mesh-ancestor
154362711|NCT03493126|Hormones|hormones|mesh-ancestor
154362712|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209417|NCT00361842|Irinotecan|irinotecan|mesh-list
154362713|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362714|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154362715|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154362716|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362717|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154362718|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
154362719|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362720|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
154362721|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154362722|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154362723|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362724|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
154362725|NCT03386656|Coagulants|coagulants|mesh-ancestor
154362726|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154362727|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154362728|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154362729|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362730|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362731|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154362732|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154362733|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154362734|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
154362735|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362736|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362746|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362747|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362749|NCT05171530|Taxane|taxane|mesh-list
154362750|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109009|NCT00873951|Caseins|caseins|mesh-list
154362751|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154362752|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362753|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362754|NCT02936037|Biotin|biotin|mesh-list
154362755|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
154362756|NCT02936037|Vitamins|vitamins|mesh-ancestor
154362757|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
154362758|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362759|NCT01283789|Everolimus|everolimus|mesh-list
154362760|NCT01283789|Lapatinib|lapatinib|mesh-list
154362761|NCT01283789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154362762|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154362763|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362764|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362765|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154362766|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
154362767|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362768|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362769|NCT01283789|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154362770|NCT03383068|Metformin|metformin|mesh-list
154362771|NCT03383068|Exenatide|exenatide|mesh-list
154362772|NCT03383068|Acarbose|acarbose|mesh-list
154362773|NCT03383068|Orlistat|orlistat|mesh-list
154362774|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154362775|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362776|NCT03383068|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154362777|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154362778|NCT03383068|Incretins|incretins|mesh-ancestor
154362779|NCT03383068|Hormones|hormones|mesh-ancestor
154362780|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362781|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154362782|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362783|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362784|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154362785|NCT03378310|Linrodostat|linrodostat|mesh-list
154362786|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362787|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362788|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
154362789|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154362790|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362791|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154362792|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
154362793|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154362794|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362795|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362796|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362797|NCT04194151|Propofol|propofol|mesh-list
154362798|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154362799|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362800|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362801|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154362802|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
154362803|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
154362817|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154362819|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362820|NCT03748147|Misoprostol|misoprostol|mesh-list
154362821|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154362822|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
154362823|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154362824|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362825|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154362826|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154362828|NCT01580813|Acipimox|acipimox|mesh-list
154362829|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154362830|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
154362831|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362832|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154362833|NCT04446364|Disinfectants|disinfectants|mesh-list
154362834|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362835|NCT01588535|Benzocaine|benzocaine|mesh-list
154362836|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
154362837|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
154362838|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362839|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362840|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
154362841|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362842|NCT01165931|Riociguat|riociguat|mesh-list
154362843|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
154362844|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362845|NCT01274273|Interferons|interferons|mesh-list
154362846|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
154362847|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
154362848|NCT01274273|Aldesleukin|aldesleukin|mesh-list
154362849|NCT01274273|Bevacizumab|bevacizumab|mesh-list
154362850|NCT01274273|Interleukin-2|interleukin-2|mesh-list
154362851|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362852|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362853|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154362854|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154362855|NCT01274273|Growth Substances|growth substances|mesh-ancestor
154362856|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362857|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
154362858|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
154362859|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362860|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
154362861|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154362862|NCT01274273|Analgesics|analgesics|mesh-ancestor
154362863|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
154362864|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362865|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154362866|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154362867|NCT04058353|Ivacaftor|ivacaftor|mesh-list
154362878|NCT01167725|Irinotecan|irinotecan|mesh-list
154362879|NCT01167725|Mitomycins|mitomycins|mesh-list
154362880|NCT01167725|Mitomycin|mitomycin|mesh-list
154362881|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
154362882|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362883|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362884|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154362885|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154362886|NCT01167725|Growth Substances|growth substances|mesh-ancestor
154362887|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362888|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
154362889|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154362890|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
154362891|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362892|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154362893|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
154362894|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154362895|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154362896|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362897|NCT01167725|Antidotes|antidotes|mesh-ancestor
154362898|NCT01167725|Protective Agents|protective agents|mesh-ancestor
154362899|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
154362900|NCT01167725|Vitamins|vitamins|mesh-ancestor
154362901|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
154362902|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154362903|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
154362904|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154362905|NCT04446130|Decitabine|decitabine|mesh-list
154362906|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154362907|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
154362908|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362909|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362910|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362911|NCT03226275|Amlodipine|amlodipine|mesh-list
154362912|NCT03226275|Bisoprolol|bisoprolol|mesh-list
154362913|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154362914|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154362915|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362916|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362917|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154362918|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362919|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
154362920|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
154362921|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
154255469|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154362922|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362923|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154362924|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154362925|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154362926|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
154362927|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362928|NCT03382756|Choline|choline|mesh-list
154362929|NCT03382756|Atorvastatin|atorvastatin|mesh-list
154362930|NCT03382756|Fenofibrate|fenofibrate|mesh-list
154362931|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154362932|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154362933|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
154362934|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362935|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154362955|NCT01170767|Bevacizumab|bevacizumab|mesh-list
154362956|NCT01170767|Ranibizumab|ranibizumab|mesh-list
154362957|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362958|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362959|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154362960|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154362961|NCT01170767|Growth Substances|growth substances|mesh-ancestor
154362962|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362963|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
154362964|NCT01170845|Sivelestat|sivelestat|mesh-list
154362965|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154362966|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
154362967|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362968|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362969|NCT01150890|Brodalumab|brodalumab|mesh-list
154362970|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
154362971|NCT01167803|Desflurane|desflurane|mesh-list
154362972|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154362973|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
154362974|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
154362975|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362976|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362977|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154362978|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154362979|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362980|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362981|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154362982|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362983|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362984|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
154362985|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362986|NCT01275911|Remifentanil|remifentanil|mesh-list
154362987|NCT01275911|Esmolol|esmolol|mesh-list
153542042|NCT01548950|Bosentan|bosentan|mesh-list
154362996|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154362997|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154362998|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
154362999|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363000|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363001|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
154363002|NCT01166165|Vitamin D|vitamin d|mesh-list
154363003|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154363004|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363005|NCT01166165|Vitamins|vitamins|mesh-ancestor
154363006|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
154363007|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154363008|NCT03286218|Alprazolam|alprazolam|mesh-list
154363009|NCT03286218|Lasmiditan|lasmiditan|mesh-list
154363010|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154363011|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363012|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363013|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154363014|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154363015|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154363016|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
154363017|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
154363018|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363019|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363020|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154363021|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
154861916|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363022|NCT03745261|Fluticasone|fluticasone|mesh-list
154363023|NCT03745261|Xhance|xhance|mesh-list
154363024|NCT03745261|Bromides|bromides|mesh-list
154363025|NCT03745261|Albuterol|albuterol|mesh-list
154363026|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
154363027|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154363028|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154363029|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363030|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154363031|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
154363032|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363033|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363034|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154363035|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
154363036|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
154363037|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154363038|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
154363039|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154363040|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
154363041|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363042|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363043|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154363044|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154363045|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154363046|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
154363047|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
154363048|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
154363049|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154363050|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
154363051|NCT03745261|Hormones|hormones|mesh-ancestor
154363052|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154363053|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
154363054|NCT03744949|Remifentanil|remifentanil|mesh-list
154363055|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154363067|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154363068|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154363069|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154363070|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154363071|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363072|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154363073|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363074|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363075|NCT03870503|Misoprostol|misoprostol|mesh-list
154363076|NCT03870503|Oxytocin|oxytocin|mesh-list
154363077|NCT03870503|Carbetocin|carbetocin|mesh-list
154363078|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
154363079|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154363080|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363081|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154363082|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
154363083|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154363084|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154363085|NCT02857426|Nivolumab|nivolumab|mesh-list
154363086|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154363087|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363088|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154363089|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363090|NCT05181033|Letrozole|letrozole|mesh-list
154363091|NCT05181033|Lenvatinib|lenvatinib|mesh-list
154363092|NCT05181033|Fulvestrant|fulvestrant|mesh-list
154363093|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363094|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154363095|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154363096|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363097|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363098|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154363099|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
154363100|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154363101|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363102|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154363103|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154363104|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154363105|NCT05666765|Isotretinoin|isotretinoin|mesh-list
154363106|NCT05666765|Silymarin|silymarin|mesh-list
154363107|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
154363108|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
154363109|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363110|NCT05666765|Protective Agents|protective agents|mesh-ancestor
154363111|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363112|NCT01127256|Carbamazepine|carbamazepine|mesh-list
154363113|NCT01127256|Zonisamide|zonisamide|mesh-list
154363114|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
154363115|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
154363116|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154363117|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363118|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363119|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153542167|NCT01549743|Celecoxib|celecoxib|mesh-list
154363149|NCT01277705|Vaccines|vaccines|mesh-list
154363150|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
154363151|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363152|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
154363153|NCT04757337|Doxorubicin|doxorubicin|mesh-list
154363154|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363155|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
154363156|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363157|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363158|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154363159|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
154363160|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363161|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363162|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154363163|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154363178|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154363179|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154363180|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154363181|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
154363182|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154363183|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363184|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154363185|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154363186|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154363187|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363188|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154363189|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154363190|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154363191|NCT01282073|Cyclosporine|cyclosporine|mesh-list
154363192|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
154363193|NCT01282073|Cyclosporins|cyclosporins|mesh-list
154363194|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363195|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363196|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363197|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
154363198|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363199|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
154363200|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363201|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
154363202|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363203|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154363204|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154363205|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363206|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154363207|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
154363208|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363209|NCT01166477|Ritonavir|ritonavir|mesh-list
154363210|NCT01166477|Lopinavir|lopinavir|mesh-list
154363211|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154363212|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154363213|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
154363214|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363215|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363216|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154363217|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154363218|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
154363219|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363220|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154363221|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154363222|NCT01282151|Cisplatin|cisplatin|mesh-list
154363223|NCT01282151|Pemetrexed|pemetrexed|mesh-list
154363224|NCT01282151|Docetaxel|docetaxel|mesh-list
154363242|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363243|NCT03377218|Protective Agents|protective agents|mesh-ancestor
154363244|NCT01168505|Teferrol|teferrol|mesh-list
154363245|NCT01168505|Hematinics|hematinics|mesh-ancestor
154363246|NCT04013191|Padsevonil|padsevonil|mesh-list
154363247|NCT04013191|Anticonvulsants|anticonvulsants|mesh-ancestor
154363248|NCT03867929|Vitamin D|vitamin d|mesh-list
154363249|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154363250|NCT03867929|Calcifediol|calcifediol|mesh-list
154363251|NCT03867929|Vitamins|vitamins|mesh-ancestor
154363252|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
154363253|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363254|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154363255|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
154363256|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154363257|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154363258|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363259|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154363260|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363261|NCT01171469|Imiquimod|imiquimod|mesh-list
154363262|NCT01171469|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154363263|NCT01171469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363264|NCT01171469|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154363265|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
154363266|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363267|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154363268|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363269|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
154363270|NCT02695992|Metoprolol|metoprolol|mesh-list
154363271|NCT02695992|Diltiazem|diltiazem|mesh-list
154363272|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154363273|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154363274|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
154363275|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
154363276|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363277|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363278|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154363279|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154109531|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
154363280|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154363281|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
154363282|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363291|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
154363292|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363293|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363294|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154363295|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
154363297|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209862|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154363298|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154363299|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363300|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
154363301|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
154363302|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154363303|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154363304|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363305|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363306|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363307|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363308|NCT01171547|Daptomycin|daptomycin|mesh-list
154363309|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363310|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363311|NCT04048681|Cocaine|cocaine|mesh-list
154363312|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
154363313|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
154363314|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363315|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363316|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
154363317|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363318|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154363319|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154363320|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154363321|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154363322|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363323|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
153762965|NCT06318897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153762975|NCT06318546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153762976|NCT06318546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153762982|NCT06318546|Narcotics|narcotics|mesh-ancestor
154363324|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363325|NCT01282385|Simvastatin|simvastatin|mesh-list
154363326|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154363327|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154363328|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
154363329|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363330|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154363331|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154363332|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363333|NCT04007107|Semaglutide|semaglutide|mesh-list
154363334|NCT04007107|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154363335|NCT04007107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154363336|NCT04007107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363337|NCT01166711|Chromium|chromium|mesh-list
154363338|NCT01166711|Paclitaxel|paclitaxel|mesh-list
154363339|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154363340|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154363341|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363342|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
154363343|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
154363344|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
154363345|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363346|NCT01166711|Trace Elements|trace elements|mesh-ancestor
154363347|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
154363348|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363366|NCT02652468|Rituximab|rituximab|mesh-list
154363367|NCT02652468|Fludarabine|fludarabine|mesh-list
154363368|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
154363369|NCT02652468|Tacrolimus|tacrolimus|mesh-list
154363370|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363371|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
154363372|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363373|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363374|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154363375|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
154363376|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363377|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363378|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154363379|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154363380|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154363381|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
154363382|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154363383|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363384|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154363385|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154363386|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
154363387|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363388|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363389|NCT04673877|Vancomycin|vancomycin|mesh-list
154363390|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363391|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363392|NCT01166789|Lubiprostone|lubiprostone|mesh-list
154363393|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154363394|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154363395|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363396|NCT01314339|Desloratadine|desloratadine|mesh-list
154363397|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154363398|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
154363399|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363400|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363401|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363402|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154363403|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154363404|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
154363405|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
154363406|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154861917|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861918|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154861919|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154861920|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154363407|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
153542459|NCT01551667|Antibodies|antibodies|mesh-list
154363432|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154363433|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363434|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363435|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363436|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154363437|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154363439|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
154363440|NCT03745105|Piroxicam|piroxicam|mesh-list
154363441|NCT03745105|Mepivacaine|mepivacaine|mesh-list
154363442|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154363443|NCT03745105|BB 1101|bb 1101|mesh-list
154363444|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363445|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
154363446|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
154363447|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363448|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363449|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154363450|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
154363451|NCT03745105|Hormones|hormones|mesh-ancestor
154363452|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154363453|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154363454|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363455|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
154363456|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
154363457|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363458|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
153542521|NCT01552122|Vitamin D|vitamin d|mesh-list
154363473|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
154363474|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363475|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363476|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154363477|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363478|NCT03744247|Lenvatinib|lenvatinib|mesh-list
154363479|NCT03744247|Antibodies|antibodies|mesh-list
154363480|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
154363481|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
154363482|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363483|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363484|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154363485|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363486|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363487|NCT01282619|Huperzine A|huperzine a|mesh-list
154363488|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154363489|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363490|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363491|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
154363492|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363493|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210049|NCT01046006|Rituximab|rituximab|mesh-list
154363494|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154363495|NCT01282619|Protective Agents|protective agents|mesh-ancestor
154363496|NCT01282697|Sirolimus|sirolimus|mesh-list
154363497|NCT01282697|Irinotecan|irinotecan|mesh-list
154363498|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154363499|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154363500|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363501|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363502|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363503|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363504|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363505|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154363506|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
154363507|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363508|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
154363509|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363510|NCT01169597|Prednisone|prednisone|mesh-list
154363511|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363512|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
154363513|NCT01169597|Hormones|hormones|mesh-ancestor
154363514|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154363515|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363516|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154363517|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363539|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
154363540|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255471|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
154363541|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363542|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154363543|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154363544|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
154363545|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363546|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363547|NCT01172717|Panitumumab|panitumumab|mesh-list
154363548|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154363549|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363550|NCT03209973|Tislelizumab|tislelizumab|mesh-list
154363551|NCT03209973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154363552|NCT03209973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363553|NCT03751631|Phenylephrine|phenylephrine|mesh-list
154363554|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
154363555|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154363556|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154363557|NCT03751631|Tropicamide|tropicamide|mesh-list
154363558|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154363559|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
154363560|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
154363561|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363562|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363563|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
154363564|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154363565|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
154363566|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
154363567|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154363568|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154363569|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154363570|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
154363571|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542627|NCT01552993|Analgesics|analgesics|mesh-ancestor
154363580|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363581|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154363582|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363583|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
154363584|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363585|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
154363586|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363587|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
154363588|NCT03736369|Esomeprazole|esomeprazole|mesh-list
154363590|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154363591|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154363592|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154363593|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363594|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363595|NCT03867695|Ropivacaine|ropivacaine|mesh-list
154363596|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
154363597|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
154363598|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363599|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363600|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
154363601|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363602|NCT01172171|Melatonin|melatonin|mesh-list
154363603|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
154363604|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363605|NCT01172171|Protective Agents|protective agents|mesh-ancestor
154363606|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363607|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363608|NCT03655717|Ethanol|ethanol|mesh-list
154363609|NCT03655717|Dronabinol|dronabinol|mesh-list
154363610|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154363611|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363612|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363613|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363614|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
154363615|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154363616|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154363617|NCT03655717|Analgesics|analgesics|mesh-ancestor
154363618|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
154363619|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363620|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154363621|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154861921|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154363622|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363623|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363624|NCT03655717|Hormones|hormones|mesh-ancestor
154363625|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154363626|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
154363627|NCT03867071|Hematinics|hematinics|mesh-ancestor
154363628|NCT01284413|Cisplatin|cisplatin|mesh-list
154363629|NCT01284413|Gemcitabine|gemcitabine|mesh-list
154363630|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363631|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154363632|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
154363633|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363634|NCT05152017|Vaccines|vaccines|mesh-list
154363635|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
154363636|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363637|NCT03866993|Paclitaxel|paclitaxel|mesh-list
154363638|NCT03866993|Carboplatin|carboplatin|mesh-list
154363639|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154363650|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
154363651|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363652|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363653|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154109906|NCT05895201|Hormones|hormones|mesh-ancestor
154363654|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363655|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154363656|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363657|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363658|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154363659|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154363660|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154363661|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154363662|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
154363663|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363664|NCT04000165|Mitapivat|mitapivat|mesh-list
154363665|NCT04000165|Enzyme Activators|enzyme activators|mesh-ancestor
154363666|NCT04000165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363667|NCT03375424|Vedolizumab|vedolizumab|mesh-list
154363668|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154363669|NCT03187197|Dabigatran|dabigatran|mesh-list
154363670|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
154363671|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154363672|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
154363673|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363674|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363675|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
154363676|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
154363677|NCT01284647|Sucralfate|sucralfate|mesh-list
154363678|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154363679|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154363680|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363681|NCT04000009|Pimavanserin|pimavanserin|mesh-list
154363682|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154363683|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154363684|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154363685|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154363686|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363687|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363688|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154363689|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154363690|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154363691|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
154363692|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363693|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363694|NCT03282240|Vaccines|vaccines|mesh-list
154363695|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
154363696|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363697|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
154363698|NCT01284725|Azathioprine|azathioprine|mesh-list
154363699|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154363700|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154363701|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363702|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154363703|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
153542749|NCT01554124|Meropenem|meropenem|mesh-list
154363740|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
154363761|NCT03381664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363763|NCT03381664|Sensory System Agents|sensory system agents|mesh-ancestor
154363764|NCT03381664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363765|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154363766|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154363767|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
154363768|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154363769|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
154363770|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154363771|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154363772|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363773|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363774|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154363775|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154363776|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
154363777|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154363778|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154363779|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154363780|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154363781|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154363782|NCT04060758|Latanoprost|latanoprost|mesh-list
154363783|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154363784|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154363785|NCT03863405|Metformin|metformin|mesh-list
154363786|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154363787|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363788|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
154363789|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363790|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363791|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154363792|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154363793|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363811|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154363812|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363813|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
154363814|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363815|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154363816|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154363817|NCT01178021|Analgesics|analgesics|mesh-ancestor
154363818|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
154363819|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363820|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363821|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363822|NCT01178021|Filaricides|filaricides|mesh-ancestor
154363823|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
154363824|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
154363825|NCT03250182|Budesonide|budesonide|mesh-list
154363826|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
154363827|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
154363828|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363829|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154363830|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
154363831|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363832|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363833|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154363834|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
154363835|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
154363836|NCT03250182|Hormones|hormones|mesh-ancestor
154363837|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154363838|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154363839|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154363840|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154363841|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
154363842|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363843|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363844|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154363845|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154363846|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154363847|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
154363848|NCT01173263|Propofol|propofol|mesh-list
154363849|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154363850|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861922|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153542903|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
154363861|NCT01288157|Golimumab|golimumab|mesh-list
154363862|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154363863|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154363864|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363865|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363866|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
154363867|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363868|NCT03993379|Ipilimumab|ipilimumab|mesh-list
154363869|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154363870|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363871|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154363872|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363873|NCT03866447|Vitamin D|vitamin d|mesh-list
154363874|NCT03866447|Adapalene|adapalene|mesh-list
154363875|NCT03866447|Vitamins|vitamins|mesh-ancestor
154363876|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
154363877|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363878|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154363879|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154363880|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154363881|NCT03866447|Analgesics|analgesics|mesh-ancestor
154363882|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
154363883|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363884|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363885|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363886|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
154363887|NCT03370120|Padsevonil|padsevonil|mesh-list
154363888|NCT03370120|Anticonvulsants|anticonvulsants|mesh-ancestor
154363889|NCT01175291|Leucovorin|leucovorin|mesh-list
154363890|NCT01175291|Bevacizumab|bevacizumab|mesh-list
154363891|NCT01175291|Fluorouracil|fluorouracil|mesh-list
154363892|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
154363893|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
154363894|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154363895|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363896|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154363897|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154363898|NCT01175291|Growth Substances|growth substances|mesh-ancestor
154363899|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363900|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
154363901|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
154363902|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363903|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154363904|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363905|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
154363906|NCT01175291|Antidotes|antidotes|mesh-ancestor
154363907|NCT01175291|Protective Agents|protective agents|mesh-ancestor
154363908|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
154363909|NCT01175291|Vitamins|vitamins|mesh-ancestor
154363910|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
154363911|NCT03230266|Insulin|insulin|mesh-list
154363912|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154363913|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363914|NCT03732469|Acetaminophen|acetaminophen|mesh-list
154363915|NCT03732469|Fentanyl|fentanyl|mesh-list
154363916|NCT03732469|Propofol|propofol|mesh-list
154363917|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154363918|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363934|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154363935|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
154363936|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363937|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363938|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154363939|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
154363940|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154363941|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363942|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
154363943|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154363944|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
154363945|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363946|NCT01175525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154363947|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363948|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154363949|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
154363950|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154363951|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363952|NCT03381118|Cytarabine|cytarabine|mesh-list
154363953|NCT03381118|Nivolumab|nivolumab|mesh-list
154363954|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154363955|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363956|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154363957|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363958|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154363959|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
154363960|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
154363961|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363962|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363963|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
154363964|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363966|NCT02954575|Coagulants|coagulants|mesh-ancestor
154363967|NCT02997358|Doxorubicin|doxorubicin|mesh-list
154363968|NCT02997358|Trabectedin|trabectedin|mesh-list
154363969|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154363970|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363971|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154363972|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154363973|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363974|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363975|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154363976|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
154363977|NCT03375034|Clonazepam|clonazepam|mesh-list
154363978|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
154363979|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
154363980|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
154363981|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363982|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364017|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364018|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154364019|NCT03732391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154364020|NCT03732391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364021|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
154364022|NCT03374722|Narcotics|narcotics|mesh-ancestor
153543093|NCT05847257|Vitamins|vitamins|mesh-ancestor
154364055|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364056|NCT03219723|Amoxicillin|amoxicillin|mesh-list
154364057|NCT03219723|Metronidazole|metronidazole|mesh-list
154364058|NCT03219723|Clarithromycin|clarithromycin|mesh-list
154364059|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154364060|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364061|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154364062|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154364063|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154364064|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543129|NCT05847049|Natriuretic Agents|natriuretic agents|mesh-ancestor
154364076|NCT03369964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154364077|NCT03369964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364078|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154364080|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
154364081|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154364082|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364083|NCT01173809|Amiodarone|amiodarone|mesh-list
154364084|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154364085|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
154364086|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154364087|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154364088|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364089|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154364090|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154364091|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154364092|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364093|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154364094|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154364095|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154364096|NCT03375580|Metformin|metformin|mesh-list
154364097|NCT03375580|Simvastatin|simvastatin|mesh-list
154364098|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154364099|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364100|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154364101|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154364102|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
154210411|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154364103|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364104|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154861923|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
154364105|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154364106|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110357|NCT04199325|Uric Acid|uric acid|mesh-list
154364107|NCT01286909|Lycopene|lycopene|mesh-list
154364108|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154364109|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
154364110|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364111|NCT01286909|Protective Agents|protective agents|mesh-ancestor
154364112|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364113|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154364114|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154364115|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364116|NCT02954887|Cannabidiol|cannabidiol|mesh-list
154364117|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
154364118|NCT03860129|Sevoflurane|sevoflurane|mesh-list
154364119|NCT03860129|Desflurane|desflurane|mesh-list
154364120|NCT03860129|Isoflurane|isoflurane|mesh-list
154364121|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154364122|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154364123|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
154364124|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
153543186|NCT05840536|Furosemide|furosemide|mesh-list
154364143|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154364144|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
154364145|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154364146|NCT02651740|Rifaximin|rifaximin|mesh-list
154364147|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154364148|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364149|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154364150|NCT03862391|Analgesics|analgesics|mesh-list
154364151|NCT03862391|Antiemetics|antiemetics|mesh-list
154364152|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
154364153|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364154|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364155|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
154364156|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154364157|NCT03859583|Capsaicin|capsaicin|mesh-list
154364158|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
154364159|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
154364160|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
154364161|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364162|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364163|NCT03369262|Atosiban|atosiban|mesh-list
154364164|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
154364165|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154364166|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364167|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
154364168|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154364169|NCT03276078|Bromides|bromides|mesh-list
154364170|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
154364171|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154364172|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
154364173|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364174|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364175|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154364176|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
154364177|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154364178|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154364179|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154110437|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
154364180|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
154364181|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364207|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154364208|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154364209|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364210|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364211|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154364212|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154364213|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154364214|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154364215|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
154364217|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
154364218|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
154364219|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364220|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364221|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154364222|NCT04597320|Narcotics|narcotics|mesh-ancestor
154364223|NCT04597320|Analgesics|analgesics|mesh-ancestor
154364224|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
154364225|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364226|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
154364227|NCT03373708|Tamoxifen|tamoxifen|mesh-list
154364228|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
154364229|NCT03373708|Docetaxel|docetaxel|mesh-list
154364230|NCT03373708|Letrozole|letrozole|mesh-list
154364231|NCT03373708|Epirubicin|epirubicin|mesh-list
154364232|NCT03373708|Goserelin|goserelin|mesh-list
154364259|NCT03123952|Immunoconjugates|immunoconjugates|mesh-ancestor
154364260|NCT03123952|Immunologic Factors|immunologic factors|mesh-ancestor
154364261|NCT03123952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364262|NCT02519608|Aspirin|aspirin|mesh-list
154364263|NCT02519608|Clopidogrel|clopidogrel|mesh-list
154364264|NCT02519608|Ticagrelor|ticagrelor|mesh-list
154364265|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154364266|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364267|NCT02519608|Analgesics|analgesics|mesh-ancestor
154364268|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
154364269|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364270|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364271|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154364272|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364273|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154364274|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154364275|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543338|NCT05813158|Sensory System Agents|sensory system agents|mesh-ancestor
154364300|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154364301|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154364302|NCT03124420|Amoxicillin|amoxicillin|mesh-list
154364303|NCT03124420|Clarithromycin|clarithromycin|mesh-list
154364304|NCT03124420|Lansoprazole|lansoprazole|mesh-list
154364305|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
154364306|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154364307|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364308|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154364309|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364310|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364311|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154364312|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154364313|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154364314|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154364315|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154364316|NCT03231228|Cefazolin|cefazolin|mesh-list
154364317|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154364318|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364319|NCT01178645|Cytarabine|cytarabine|mesh-list
154364320|NCT01178645|Etoposide|etoposide|mesh-list
154364321|NCT01178645|Melphalan|melphalan|mesh-list
154364322|NCT01178645|Busulfan|busulfan|mesh-list
154364323|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154364324|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364325|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154364333|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154364334|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
154364335|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364336|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154364337|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
154364338|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154364339|NCT01285505|Alprazolam|alprazolam|mesh-list
154364340|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154364341|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364342|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364343|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154364344|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154364345|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154364346|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
154364347|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
154364348|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364349|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364350|NCT03372850|Esomeprazole|esomeprazole|mesh-list
154364351|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154364352|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154364353|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154364354|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364355|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364356|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
154364357|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154364358|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
154364359|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364360|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
154364361|NCT04525066|Protective Agents|protective agents|mesh-ancestor
154364362|NCT03362788|Vitamin K|vitamin k|mesh-list
154364363|NCT03362788|Anticoagulants|anticoagulants|mesh-list
154364364|NCT03362788|Vitamins|vitamins|mesh-ancestor
154364365|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
154364366|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364367|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154364368|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154364369|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364370|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
154364371|NCT03362788|Coagulants|coagulants|mesh-ancestor
154364372|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
154364373|NCT03368794|Narcotics|narcotics|mesh-ancestor
154364374|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364375|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364376|NCT03368794|Analgesics|analgesics|mesh-ancestor
154364377|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
154364378|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364379|NCT03862079|Tazobactam|tazobactam|mesh-list
154364380|NCT03862079|Piperacillin|piperacillin|mesh-list
154210587|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
154364381|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154364382|NCT03862079|Nystatin|nystatin|mesh-list
154364383|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154364384|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364385|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154364386|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364387|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364388|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
154364389|NCT03862079|Ionophores|ionophores|mesh-ancestor
154364390|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154364391|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154364392|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364393|NCT01179269|Paclitaxel|paclitaxel|mesh-list
153543433|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154364419|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364420|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364421|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
154364422|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154364423|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364424|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154364425|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154364426|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
154364427|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154364428|NCT01287689|Antibodies|antibodies|mesh-list
154364429|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
154364430|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
154364431|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364432|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
154364433|NCT01179503|Vitamin D|vitamin d|mesh-list
154364434|NCT01179503|Calcium|calcium|mesh-list
154364435|NCT01179503|Vitamins|vitamins|mesh-ancestor
154364436|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
154364437|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364438|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154364439|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154364440|NCT03372304|Ropivacaine|ropivacaine|mesh-list
154364441|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
154364442|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
154364443|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364459|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
154364460|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
154364461|NCT02525003|Vitamins|vitamins|mesh-list
154364462|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
154364463|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364464|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154364465|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154364466|NCT03464448|Teriflunomide|teriflunomide|mesh-list
154364467|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154364468|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364469|NCT03464448|Analgesics|analgesics|mesh-ancestor
154364470|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
154364471|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364472|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364473|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154364474|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364475|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154364476|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
154364477|NCT03362008|Varenicline|varenicline|mesh-list
154364478|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154364479|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154364480|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
154364481|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364482|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364483|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364484|NCT03123406|Cinacalcet|cinacalcet|mesh-list
154364485|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154364486|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364487|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154364488|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
154364489|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154364490|NCT01179659|Pantoprazole|pantoprazole|mesh-list
154364491|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154364492|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154364493|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154364494|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364495|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364497|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
154364498|NCT03361774|Protective Agents|protective agents|mesh-ancestor
154364499|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364500|NCT04523740|Acetaminophen|acetaminophen|mesh-list
154364501|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364502|NCT04523740|Analgesics|analgesics|mesh-ancestor
154364503|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
154364513|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364514|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
154364516|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364517|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154364518|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364519|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364520|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
154364521|NCT03371992|Nivolumab|nivolumab|mesh-list
154364522|NCT03371992|Atezolizumab|atezolizumab|mesh-list
154364523|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154364524|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364525|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154364526|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364527|NCT03682705|Upadacitinib|upadacitinib|mesh-list
154364528|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154364529|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154210697|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
154364530|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364531|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364532|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364533|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
154364534|NCT03361618|Astringents|astringents|mesh-ancestor
154364535|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364536|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
154364537|NCT01314495|Abatacept|abatacept|mesh-list
154364538|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154364539|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364540|NCT01314495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154364541|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364542|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154364543|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
154364544|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364545|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364546|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154364547|NCT03123484|Gefitinib|gefitinib|mesh-list
154364548|NCT03123484|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154364549|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154364550|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364551|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364552|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364553|NCT03179787|Aripiprazole|aripiprazole|mesh-list
154364554|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
154364555|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154364556|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154364557|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154364558|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364559|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364560|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
154364561|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
154364563|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364564|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154364565|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154364566|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
154364567|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154364568|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154364569|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154364578|NCT02956057|Vitamins|vitamins|mesh-ancestor
154364579|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
154364580|NCT02956057|Cathartics|cathartics|mesh-ancestor
154364581|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154364582|NCT04526470|Paclitaxel|paclitaxel|mesh-list
154364583|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154210751|NCT01049672|Alfentanil|alfentanil|mesh-list
154364584|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364585|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154364586|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154364587|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154364588|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364589|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
154364590|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154364591|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364592|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
154364593|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154364594|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154364595|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154364596|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
154364597|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364598|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364599|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364600|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
154364601|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154364602|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364603|NCT01179971|Analgesics|analgesics|mesh-ancestor
154364604|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
154364605|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364606|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364607|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154364608|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364609|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154364610|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
154364611|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364612|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154364613|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
154364614|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154364615|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364616|NCT03681691|Estradiol|estradiol|mesh-list
154364617|NCT03681691|Estrogens|estrogens|mesh-ancestor
154364618|NCT03681691|Hormones|hormones|mesh-ancestor
154364619|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154364620|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364621|NCT03360760|Doxorubicin|doxorubicin|mesh-list
154364622|NCT03360760|Methotrexate|methotrexate|mesh-list
154364623|NCT03360760|Ifosfamide|ifosfamide|mesh-list
154364624|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
154364625|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364626|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154364627|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154364628|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154364629|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364630|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364631|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154364632|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
154364633|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154364634|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110882|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
154364635|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153543682|NCT04149899|Timolol|timolol|mesh-list
154364663|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154364664|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154364666|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364667|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154364668|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154364669|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154364670|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154364671|NCT01180205|Amlodipine|amlodipine|mesh-list
154364672|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154364673|NCT01180205|Telmisartan|telmisartan|mesh-list
154364674|NCT01180205|Olmesartan|olmesartan|mesh-list
154364675|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154364676|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154364677|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154364678|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154364679|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364680|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154364681|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364682|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
154364683|NCT01180205|Diuretics|diuretics|mesh-ancestor
154364684|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
154364685|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154364686|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154364687|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154364688|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
154364702|NCT03860831|Analgesics|analgesics|mesh-ancestor
154364703|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
154364704|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364705|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364706|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154364707|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154364708|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
154110959|NCT00960232|Vitamin D|vitamin d|mesh-list
154364709|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
154364710|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364711|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154364713|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364714|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364715|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154364716|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154364717|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154364718|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154364719|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154364720|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
154364721|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
154364722|NCT03667326|Aspirin|aspirin|mesh-list
154364723|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154364724|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364725|NCT03667326|Analgesics|analgesics|mesh-ancestor
154364726|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
154364727|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364728|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364729|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154364730|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364731|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154364732|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154364733|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364734|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154364735|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154364736|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364737|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
154364738|NCT04525300|Liraglutide|liraglutide|mesh-list
154364739|NCT04525300|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154364740|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154364741|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364742|NCT04525300|Incretins|incretins|mesh-ancestor
154364743|NCT04525300|Hormones|hormones|mesh-ancestor
154364744|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154364745|NCT03865121|Nicotine|nicotine|mesh-list
154364746|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154364747|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
154364748|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364762|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
154364763|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364764|NCT03680911|Protective Agents|protective agents|mesh-ancestor
154364765|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364766|NCT03680911|Antidotes|antidotes|mesh-ancestor
154364767|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
154364768|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154364769|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764363|NCT05346484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764364|NCT05327556|Epinephrine|epinephrine|mesh-list
153764365|NCT05327556|Racepinephrine|racepinephrine|mesh-list
153764366|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
153764367|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153764368|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153764369|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
153764370|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153764371|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764372|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764373|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153764374|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154364770|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364771|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364772|NCT03370588|Analgesics|analgesics|mesh-ancestor
154364773|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
154364774|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364775|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154210890|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154364776|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154364777|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154364778|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
154364779|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364780|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364781|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
154364782|NCT05156814|Progestins|progestins|mesh-ancestor
154364784|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154364785|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364786|NCT01289483|Fospropofol|fospropofol|mesh-list
154364787|NCT01289483|Propofol|propofol|mesh-list
154364788|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154364789|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364790|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364791|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154364792|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
154364793|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
154364794|NCT01289327|Midazolam|midazolam|mesh-list
154364795|NCT01289327|Alfentanil|alfentanil|mesh-list
154364796|NCT01289327|Propofol|propofol|mesh-list
154364797|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154364798|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364799|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364800|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154364801|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
154364802|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
154364803|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154364804|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154364805|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154364806|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154364807|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
154364808|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
154364809|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364810|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364811|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154364830|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154364831|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
154364832|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364833|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364834|NCT02596997|Brincidofovir|brincidofovir|mesh-list
154364835|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
154364836|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364837|NCT03649477|Carbetocin|carbetocin|mesh-list
154364838|NCT03649477|Oxytocin|oxytocin|mesh-list
154861924|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
154861925|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
154861926|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
154861927|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154861928|NCT03030911|Narcotics|narcotics|mesh-ancestor
154861929|NCT01120405|Sevoflurane|sevoflurane|mesh-list
154861930|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154210952|NCT00129220|Haloperidol|haloperidol|mesh-list
154861931|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154861932|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
154861933|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
154861934|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154861935|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364839|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
154861936|NCT03013387|Octreotide|octreotide|mesh-list
154364840|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154364841|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364843|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154364844|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
154364845|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364846|NCT01310101|Dexamethasone|dexamethasone|mesh-list
154364847|NCT01310101|Ofatumumab|ofatumumab|mesh-list
154364848|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154364849|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
154364850|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
154364851|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364852|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364853|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154364854|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
154364855|NCT01310101|Hormones|hormones|mesh-ancestor
154364856|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111112|NCT00889161|Curcumin|curcumin|mesh-list
154364857|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154364858|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364859|NCT03639727|Mannitol|mannitol|mesh-list
154364860|NCT03639727|Citric Acid|citric acid|mesh-list
154364862|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154364863|NCT03639727|Diuretics|diuretics|mesh-ancestor
154364864|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
154364865|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364866|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
154364867|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154364868|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
154364869|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
154364870|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364894|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364895|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154364896|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154364897|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
154364898|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364899|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
154364900|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154364901|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154364902|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154364903|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154364904|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210998|NCT01074892|Progestins|progestins|mesh-list
154364905|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364906|NCT01289561|Analgesics|analgesics|mesh-ancestor
154364907|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
154364908|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
154364909|NCT03855527|Fluorides|fluorides|mesh-list
154364910|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
154364911|NCT03855527|Protective Agents|protective agents|mesh-ancestor
154364912|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364913|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154364914|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364915|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
154364916|NCT03366064|Pemetrexed|pemetrexed|mesh-list
154364917|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364918|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364919|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364920|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154364954|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154182186|NCT05868525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364985|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154364986|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364987|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364988|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364989|NCT03357718|Analgesics|analgesics|mesh-ancestor
154364990|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
154364991|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364992|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154364993|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154364994|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154364995|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
154364996|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544051|NCT02641028|Aticaprant|aticaprant|mesh-list
154365011|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
154365012|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365013|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
153764583|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764584|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153764595|NCT04931342|Maytansine|maytansine|mesh-list
153764596|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153764597|NCT04931342|Cyclophosphamide|cyclophosphamide|mesh-list
153764625|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
153764626|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764627|NCT04931342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764628|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154365014|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365015|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154365016|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154365017|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
154365018|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365019|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365020|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154365021|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154365022|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154365023|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154365024|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
154365025|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365026|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154365027|NCT03864185|Rituximab|rituximab|mesh-list
154365028|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154365029|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365030|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
154365031|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365032|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365033|NCT01185119|Glucagon|glucagon|mesh-list
154365034|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154365035|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154365036|NCT01185119|Hormones|hormones|mesh-ancestor
154365037|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365038|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365039|NCT01185119|Incretins|incretins|mesh-ancestor
154365040|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
154365041|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
154365042|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154365043|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154365044|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365045|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154365046|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
154365047|NCT01185197|Prednisolone|prednisolone|mesh-list
154365048|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154365049|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365050|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154365051|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
154365052|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154365053|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365054|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365055|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365056|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365057|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
154365058|NCT01185197|Hormones|hormones|mesh-ancestor
154365059|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365090|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365092|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154365093|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365094|NCT04522882|Insulin|insulin|mesh-list
154365095|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154365096|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365097|NCT03123718|Methotrexate|methotrexate|mesh-list
154365098|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154365099|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
154861937|NCT03013387|Edotreotide|edotreotide|mesh-list
154861938|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154861939|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154861940|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861941|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154861942|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861943|NCT01782989|Doxycycline|doxycycline|mesh-list
154861944|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154861945|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861946|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
153764770|NCT04607421|Antidotes|antidotes|mesh-ancestor
154365100|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154365101|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365102|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154365103|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
154365104|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365168|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154365169|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365170|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
154365172|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365173|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365174|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154365175|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
154365176|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
154365177|NCT03733327|Busulfan|busulfan|mesh-list
154365178|NCT03733327|Etoposide|etoposide|mesh-list
154365179|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365180|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
154365181|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365182|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365183|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154365184|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
154365185|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365186|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365187|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154365188|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154365189|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154365190|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154365191|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365192|NCT03733171|Epinephrine|epinephrine|mesh-list
154365219|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365220|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
154365221|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365222|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154365223|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
154365224|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154365225|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154365226|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154365227|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365228|NCT03857399|Caspofungin|caspofungin|mesh-list
154365229|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
154365230|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365231|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365232|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365233|NCT04520620|Enoxaparin|enoxaparin|mesh-list
154365234|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
154365235|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154365236|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154365237|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365238|NCT03857711|Amiodarone|amiodarone|mesh-list
154365239|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154365269|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154365270|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
154365271|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365272|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365273|NCT01186289|Atorvastatin|atorvastatin|mesh-list
154365274|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154365275|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154365276|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
154365277|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365278|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154365279|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154365280|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365317|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365318|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153544414|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365421|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365422|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365423|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154365424|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154861947|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154861948|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154365426|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154365427|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154365428|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154365429|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154365430|NCT03205566|Lamivudine|lamivudine|mesh-list
154365431|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
154365432|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154365433|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154365434|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365435|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365436|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
154365437|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365438|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153544491|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
154365464|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365466|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
154365467|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154365468|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154365469|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
154365470|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365471|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154365472|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154365473|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365474|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365475|NCT01182077|Midazolam|midazolam|mesh-list
154365476|NCT01182077|Peficitinib|peficitinib|mesh-list
154365477|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154365478|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154365479|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365480|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365481|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154365482|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154365483|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154365484|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154365485|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
154365486|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
153544541|NCT01558869|Capecitabine|capecitabine|mesh-list
154365516|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365517|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365518|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365519|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154365521|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154365522|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365523|NCT03356080|Cytarabine|cytarabine|mesh-list
154365524|NCT03356080|Decitabine|decitabine|mesh-list
154365525|NCT03356080|Tretinoin|tretinoin|mesh-list
154365526|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154365527|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
154365528|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365529|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365531|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365532|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365533|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
154365549|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
154365550|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
154365551|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365552|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365553|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
154365554|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365555|NCT03205488|Nilotinib|nilotinib|mesh-list
154365556|NCT03205488|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154365557|NCT03205488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154365558|NCT03205488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365559|NCT03205488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365560|NCT02518516|Atorvastatin|atorvastatin|mesh-list
154365561|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154365562|NCT02518516|Simvastatin|simvastatin|mesh-list
154365563|NCT02518516|Pravastatin|pravastatin|mesh-list
154365564|NCT02518516|Lovastatin|lovastatin|mesh-list
154365565|NCT02518516|L 647318|l 647318|mesh-list
154365566|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
154365567|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154365568|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154365569|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
154365570|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365571|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154365572|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154365573|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365574|NCT04508686|Capecitabine|capecitabine|mesh-list
154365575|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154365576|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
154365577|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365578|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365579|NCT02518438|Tramadol|tramadol|mesh-list
154365580|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154365581|NCT02518438|Narcotics|narcotics|mesh-ancestor
154365582|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365583|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365584|NCT02518438|Analgesics|analgesics|mesh-ancestor
154365585|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
154365586|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365587|NCT04521556|Morphine|morphine|mesh-list
154365588|NCT04521556|Tramadol|tramadol|mesh-list
154365589|NCT04521556|Anesthetics|anesthetics|mesh-list
154365590|NCT04521556|Ropivacaine|ropivacaine|mesh-list
154365591|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365592|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365593|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154365594|NCT04521556|Narcotics|narcotics|mesh-ancestor
154365595|NCT04521556|Analgesics|analgesics|mesh-ancestor
154365596|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
154365597|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365616|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154365617|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154365618|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365620|NCT03122782|Coagulants|coagulants|mesh-ancestor
154365621|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
154365622|NCT01291433|Tocopherols|tocopherols|mesh-list
154365623|NCT01291433|Vitamin E|vitamin e|mesh-list
154365624|NCT01291433|Tocotrienols|tocotrienols|mesh-list
154365625|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
154365626|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
154365627|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154365628|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365629|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365630|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154365631|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154365632|NCT01291433|Protective Agents|protective agents|mesh-ancestor
154365633|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365634|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
154365635|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154365636|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
154365637|NCT01291433|Vitamins|vitamins|mesh-ancestor
154365638|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
154365639|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154365640|NCT01314144|Bupivacaine|bupivacaine|mesh-list
154365641|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
154365642|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
154365643|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365644|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365645|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
154365646|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365647|NCT02954653|Cytarabine|cytarabine|mesh-list
154365648|NCT02954653|Azacitidine|azacitidine|mesh-list
154365649|NCT02954653|Decitabine|decitabine|mesh-list
154365650|NCT02954653|Daunorubicin|daunorubicin|mesh-list
154365651|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154365652|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
154365653|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365654|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365655|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
154365693|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
154365695|NCT03732703|Daratumumab|daratumumab|mesh-list
154365729|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365730|NCT03123016|Apremilast|apremilast|mesh-list
154365731|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154365732|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154365733|NCT03123016|Analgesics|analgesics|mesh-ancestor
154365734|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
154365735|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365736|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365737|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365738|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544790|NCT05564741|Norepinephrine|norepinephrine|mesh-list
154255473|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365750|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
154365751|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
154365752|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
154365753|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365755|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154365756|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154365757|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
154365758|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154365759|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154112008|NCT00975988|Lapatinib|lapatinib|mesh-list
154365760|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365761|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
154365762|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365763|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365764|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154365765|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
154365766|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
154365767|NCT01186835|Protective Agents|protective agents|mesh-ancestor
154365768|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154365769|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365770|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
154365771|NCT04812951|Cyclosporine|cyclosporine|mesh-list
154365772|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154365773|NCT04812951|Cyclosporins|cyclosporins|mesh-list
154365774|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365775|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365776|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365777|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
154365778|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365779|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
154365780|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365781|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
154365782|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365783|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154365784|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154365785|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
154365787|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154365788|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154365789|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365790|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
154365791|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365792|NCT05666089|Expectorants|expectorants|mesh-ancestor
154365793|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
154365794|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154365795|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
154365796|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365797|NCT05666089|Protective Agents|protective agents|mesh-ancestor
154365798|NCT05666089|Antidotes|antidotes|mesh-ancestor
154365799|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
154365800|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154365801|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154365813|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154365814|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154365815|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211371|NCT00138424|Cidofovir|cidofovir|mesh-list
154365816|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154365817|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365818|NCT02730208|Ivacaftor|ivacaftor|mesh-list
154365819|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154365820|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154365821|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365822|NCT01291511|Iloperidone|iloperidone|mesh-list
154365823|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154365824|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154365825|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365826|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365827|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154365828|NCT01292213|Dimercaprol|dimercaprol|mesh-list
154365829|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
154365830|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
154365831|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861949|NCT01120639|Temozolomide|temozolomide|mesh-list
154365832|NCT03122938|Lactoferrin|lactoferrin|mesh-list
154112078|NCT00969904|Expectorants|expectorants|mesh-ancestor
154365833|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365834|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
154365835|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
154365836|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154365837|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365838|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
154365839|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365840|NCT03782532|Prednisone|prednisone|mesh-list
154365841|NCT03782532|Prednisolone|prednisolone|mesh-list
154365842|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365843|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
154365844|NCT03782532|Hormones|hormones|mesh-ancestor
154365845|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365846|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365847|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154365848|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365849|NCT03355768|Romidepsin|romidepsin|mesh-list
154365850|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154365851|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365852|NCT03355768|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154365853|NCT03355768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365854|NCT03355768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365855|NCT03349840|Insulin|insulin|mesh-list
154365856|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154365857|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
154365858|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154365859|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365860|NCT03170271|Benralizumab|benralizumab|mesh-list
154365861|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154365862|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
154365863|NCT03355612|Capecitabine|capecitabine|mesh-list
154365877|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365878|NCT04503850|Mirabegron|mirabegron|mesh-list
154365879|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154365880|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154365881|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154365882|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154365883|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
154365884|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365885|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365886|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365887|NCT04503850|Urological Agents|urological agents|mesh-ancestor
154365888|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154365889|NCT03349684|Metformin|metformin|mesh-list
154365890|NCT03349684|Acarbose|acarbose|mesh-list
154365891|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154365892|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365893|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154365894|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365895|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365896|NCT03856697|Gefitinib|gefitinib|mesh-list
154365897|NCT03856697|Maleic acid|maleic acid|mesh-list
154365898|NCT03856697|Abivertinib|abivertinib|mesh-list
154365899|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365900|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365901|NCT03856697|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154365902|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154365903|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365904|NCT03349606|Amphetamine|amphetamine|mesh-list
154365905|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
154365906|NCT03349606|FLB 457|flb 457|mesh-list
154365907|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154365908|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365909|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
154365910|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
154365911|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365912|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
154365913|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365914|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365915|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
154365916|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154365917|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154365918|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154365919|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154365920|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154365921|NCT02843451|Silymarin|silymarin|mesh-list
154365922|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
154365923|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365924|NCT02843451|Protective Agents|protective agents|mesh-ancestor
154365925|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365926|NCT01292525|Tacrolimus|tacrolimus|mesh-list
154365940|NCT01183247|Sirolimus|sirolimus|mesh-list
154365941|NCT01183247|Prednisone|prednisone|mesh-list
154365942|NCT01183247|Everolimus|everolimus|mesh-list
154365943|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365944|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
154365945|NCT01183247|Hormones|hormones|mesh-ancestor
154365946|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365947|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365948|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154365949|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365950|NCT01183247|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154365951|NCT01183247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154365952|NCT01183247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365953|NCT01183247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365954|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365955|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
154365956|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154365957|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365958|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154365959|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
154365960|NCT03349216|Anesthetics|anesthetics|mesh-list
154365961|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365962|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365963|NCT04507750|Apatinib|apatinib|mesh-list
154365964|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365965|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154365966|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365967|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365968|NCT03633331|Letrozole|letrozole|mesh-list
154365969|NCT03633331|Fulvestrant|fulvestrant|mesh-list
154365970|NCT03633331|Palbociclib|palbociclib|mesh-list
154365971|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365972|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154365973|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154365974|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365975|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365976|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154365977|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
154365978|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365979|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365980|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154365981|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154365982|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154365983|NCT01189097|Levomethorphan|levomethorphan|mesh-list
154365984|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
154365985|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
154365986|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
153545006|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154365994|NCT01189097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365995|NCT01189097|Analgesics|analgesics|mesh-ancestor
154365996|NCT01189097|Sensory System Agents|sensory system agents|mesh-ancestor
154365997|NCT01189097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365998|NCT01187303|Ofatumumab|ofatumumab|mesh-list
154365999|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366000|NCT01187459|Vitamin D|vitamin d|mesh-list
154366001|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
154366002|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
154366003|NCT01187459|Vitamins|vitamins|mesh-list
154366004|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
154211537|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
154366005|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366006|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154366007|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154366008|NCT01187537|Bupivacaine|bupivacaine|mesh-list
154366009|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366010|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
154366011|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366012|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366013|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
154366014|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366015|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154366016|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154366017|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154366018|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154366019|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366020|NCT01290419|Vaccines|vaccines|mesh-list
154366021|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
154366022|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366023|NCT03737773|Methamphetamine|methamphetamine|mesh-list
154366024|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154366025|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366026|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
154366027|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
154366028|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366029|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
154366030|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366031|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366032|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
154366033|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154366034|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154366035|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154366036|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154366037|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154366038|NCT01060579|Latanoprost|latanoprost|mesh-list
154366039|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154366040|NCT04443946|Sufentanil|sufentanil|mesh-list
154366041|NCT04443946|Propofol|propofol|mesh-list
154366042|NCT04443946|Sevoflurane|sevoflurane|mesh-list
154366043|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154366044|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366045|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366046|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154366047|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
154366048|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
154366049|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154366050|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154366051|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154366052|NCT04443946|Narcotics|narcotics|mesh-ancestor
154366053|NCT04443946|Analgesics|analgesics|mesh-ancestor
154366054|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
154366068|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154366069|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154366070|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154366071|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366072|NCT03729973|Analgesics|analgesics|mesh-ancestor
154366073|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154366074|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154366075|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
154211598|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
154366076|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154366077|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154366078|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366079|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
154366080|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154366081|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154366082|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
154366083|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154366084|NCT01189253|Doxorubicin|doxorubicin|mesh-list
154366085|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154366086|NCT01189253|Trabectedin|trabectedin|mesh-list
154366087|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154366088|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366089|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154366090|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154366091|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366092|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366093|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154366094|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
154366095|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
154366096|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154366097|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
154366098|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366099|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366100|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154366101|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
154366102|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154366103|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
154366104|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366105|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366106|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154366107|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
154366108|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
154366109|NCT04443868|Protective Agents|protective agents|mesh-ancestor
154366110|NCT03851393|Citric Acid|citric acid|mesh-list
154366111|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
154366112|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
154366113|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154366114|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
154366121|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366123|NCT04443556|Narcotics|narcotics|mesh-ancestor
154366124|NCT04443556|Analgesics|analgesics|mesh-ancestor
154366125|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
154366126|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366127|NCT01187615|Cisplatin|cisplatin|mesh-list
154366128|NCT01187615|Pemetrexed|pemetrexed|mesh-list
154366129|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366130|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366131|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366132|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154366133|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154366134|NCT05375097|Erenumab|erenumab|mesh-list
154366135|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154366136|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366137|NCT05375097|Analgesics|analgesics|mesh-ancestor
154366138|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
154366139|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366140|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366141|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154366142|NCT02752191|Hematinics|hematinics|mesh-ancestor
154366143|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154366144|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154366145|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
154366146|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154366147|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
154366148|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366149|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
154366150|NCT01290497|Protective Agents|protective agents|mesh-ancestor
154366151|NCT03738215|Cariprazine|cariprazine|mesh-list
154366152|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154366153|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154366154|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366155|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366156|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154366157|NCT05352321|Gemcitabine|gemcitabine|mesh-list
154366158|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366159|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154366160|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
154366161|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366162|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154366163|NCT03199911|Erythromycin|erythromycin|mesh-list
154366164|NCT03199911|Bacitracin|bacitracin|mesh-list
154366165|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366166|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366167|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154366168|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366169|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366170|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154366171|NCT02517814|Vitamin D|vitamin d|mesh-list
154366172|NCT02517814|Vitamins|vitamins|mesh-ancestor
154366173|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
154366174|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366175|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154366176|NCT05349201|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154366177|NCT05349201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154366178|NCT05349201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366179|NCT05303727|Cyclosporine|cyclosporine|mesh-list
154366180|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
154366181|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
154366182|NCT05303727|Melphalan|melphalan|mesh-list
154366183|NCT05303727|Busulfan|busulfan|mesh-list
154366184|NCT05303727|Thiotepa|thiotepa|mesh-list
154366197|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366198|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366199|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154366200|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154366201|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
154366202|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154366203|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211727|NCT01259648|Remifentanil|remifentanil|mesh-list
154366205|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
154366206|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366207|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154366208|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154366209|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154366210|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
154366212|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154366213|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154366214|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
154366215|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154366216|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154366217|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154366218|NCT04502368|Dimercaprol|dimercaprol|mesh-list
154366219|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
154366220|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
154366221|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366222|NCT04984083|Vitamin K|vitamin k|mesh-list
154366223|NCT04984083|Vitamins|vitamins|mesh-ancestor
154366224|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
154366225|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366226|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154366227|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154366228|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366229|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
154366230|NCT04984083|Coagulants|coagulants|mesh-ancestor
154366231|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154366232|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
154366233|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366234|NCT01581203|Interferons|interferons|mesh-list
154366235|NCT01581203|Ribavirin|ribavirin|mesh-list
154366236|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
154366237|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
154366238|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154366239|NCT01581203|Asunaprevir|asunaprevir|mesh-list
154366240|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366241|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
154366242|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366243|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
154366244|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366245|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
154366246|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366247|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
154366248|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366249|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154366250|NCT03168555|Cathartics|cathartics|mesh-ancestor
154366251|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366252|NCT03235050|Liraglutide|liraglutide|mesh-list
154366266|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
154366267|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
154366268|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366269|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154366270|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154366271|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366272|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366273|NCT01189721|Propofol|propofol|mesh-list
154366274|NCT01189721|Sevoflurane|sevoflurane|mesh-list
154366275|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154366276|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366277|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366278|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154366279|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
154366280|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
154366281|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154366282|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154366283|NCT03167619|Durvalumab|durvalumab|mesh-list
154366284|NCT03167619|Olaparib|olaparib|mesh-list
154366285|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154366286|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366287|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154366289|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366291|NCT03198507|Rifabutin|rifabutin|mesh-list
154366292|NCT03198507|Omeprazole|omeprazole|mesh-list
154366293|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154366294|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366295|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154366296|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366297|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154366298|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366299|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366300|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154366301|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
154366302|NCT03850769|Paclitaxel|paclitaxel|mesh-list
154366303|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154366304|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366305|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
154366306|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
154366307|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
154366308|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366309|NCT04663464|Abaloparatide|abaloparatide|mesh-list
154366310|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
154366311|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154211813|NCT00525161|Sorafenib|sorafenib|mesh-list
154366312|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366313|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154366330|NCT03167151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154366331|NCT03167151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366333|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154366334|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
154366335|NCT01191203|Trace Elements|trace elements|mesh-ancestor
154366336|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
154366337|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366338|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154366339|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154366340|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154366341|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
154366342|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154366343|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154366344|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154366345|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154366346|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154366347|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366348|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
154366349|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154366350|NCT03197883|Protective Agents|protective agents|mesh-ancestor
154366351|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366352|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
154366353|NCT03729505|Lidocaine|lidocaine|mesh-list
154366354|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
154366355|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366356|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
154366357|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112618|NCT00984724|Nicotine|nicotine|mesh-list
154366358|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366359|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
154366360|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366361|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154366362|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154366363|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154366364|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154366365|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366366|NCT03729505|Analgesics|analgesics|mesh-ancestor
154366378|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211861|NCT00124072|Folic Acid|folic acid|mesh-list
154366380|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154366381|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
154366382|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366383|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154366384|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154366385|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
154366386|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154366387|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154366388|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366389|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
154366390|NCT03606109|Coagulants|coagulants|mesh-ancestor
154366391|NCT01191359|Immunomodulating Agents|immunomodulating agents|mesh-list
154366392|NCT01191359|Immunologic Factors|immunologic factors|mesh-ancestor
154366393|NCT01191359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366394|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154366395|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154366396|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366397|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
154366398|NCT01193855|Dutasteride|dutasteride|mesh-list
154366399|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154366400|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154366401|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366402|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366403|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
154366404|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154366405|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366406|NCT01190345|Bevacizumab|bevacizumab|mesh-list
154366407|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154366408|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366409|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154366410|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154366411|NCT01190345|Growth Substances|growth substances|mesh-ancestor
154366412|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366413|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
154366414|NCT02729896|Rituximab|rituximab|mesh-list
154366415|NCT02729896|Atezolizumab|atezolizumab|mesh-list
154366416|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
154366417|NCT02729896|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154366418|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154366419|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366420|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
154366421|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366422|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154366423|NCT02729896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154366424|NCT02729896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366425|NCT02729896|Immunoconjugates|immunoconjugates|mesh-ancestor
154366426|NCT04506034|Lidocaine|lidocaine|mesh-list
154366427|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366428|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
153545438|NCT06308367|Lipotropic Agents|lipotropic agents|mesh-ancestor
154366437|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366438|NCT01294631|Canagliflozin|canagliflozin|mesh-list
154366439|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154366440|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366441|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154366442|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366443|NCT03849209|Pancrelipase|pancrelipase|mesh-list
154366444|NCT03849209|Pancreatin|pancreatin|mesh-list
154366445|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366446|NCT05342662|Methamphetamine|methamphetamine|mesh-list
154366447|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154366448|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366449|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
154366450|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
154366451|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366452|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
154366453|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366454|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366455|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
154366456|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154366457|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154366458|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154366459|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154366460|NCT03847571|Acetazolamide|acetazolamide|mesh-list
154366461|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
154366462|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154366463|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366464|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366465|NCT03847571|Diuretics|diuretics|mesh-ancestor
154366466|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
154366467|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366468|NCT01293149|Clonidine|clonidine|mesh-list
154255474|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154255475|NCT05570786|Progestins|progestins|mesh-ancestor
154366469|NCT01293149|Ropivacaine|ropivacaine|mesh-list
154366470|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366471|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
154366472|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366473|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366474|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
154366475|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366476|NCT01293149|Analgesics|analgesics|mesh-ancestor
154366477|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154366478|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
154366479|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
154366480|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154366481|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154366482|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154366483|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
154366484|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366485|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366486|NCT03575065|Pamiparib|pamiparib|mesh-list
154366487|NCT03575065|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154366488|NCT03575065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366489|NCT03575065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366490|NCT03575065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366510|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366511|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154366512|NCT04505644|Lidocaine|lidocaine|mesh-list
154366513|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366514|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
154366515|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366516|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366517|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
154366518|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366519|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154366520|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154366521|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154366522|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154366523|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366524|NCT04505800|Tryptophan|tryptophan|mesh-list
154366525|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154366526|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
154366527|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154366528|NCT05200156|Choline|choline|mesh-list
154366529|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
154366530|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154366531|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
154366532|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366533|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366534|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154366535|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
154366536|NCT03347968|Warfarin|warfarin|mesh-list
154366537|NCT03347968|Esmolol|esmolol|mesh-list
154366538|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
154366539|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154366540|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154366541|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154366542|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
154366543|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366544|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366545|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366546|NCT01191593|Ropivacaine|ropivacaine|mesh-list
153545582|NCT06304896|Antioxidants|antioxidants|mesh-ancestor
154366555|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154366556|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366557|NCT03347890|Incretins|incretins|mesh-ancestor
154366558|NCT03347890|Hormones|hormones|mesh-ancestor
154366559|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154366560|NCT01296503|Thalidomide|thalidomide|mesh-list
154366561|NCT01296503|Dexamethasone|dexamethasone|mesh-list
154366562|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
154366563|NCT01296503|BB 1101|bb 1101|mesh-list
154366564|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366565|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
154366566|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
154861950|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154861951|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
154366567|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366568|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366569|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366570|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
154366571|NCT01296503|Hormones|hormones|mesh-ancestor
154366572|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154366573|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154366574|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366575|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
154366576|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366577|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112825|NCT00982540|Caspofungin|caspofungin|mesh-list
154366578|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154366579|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
154366580|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
154366581|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154366582|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366583|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154366584|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154366585|NCT01296503|Growth Substances|growth substances|mesh-ancestor
154366586|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
154366587|NCT01295099|Triamcinolone|triamcinolone|mesh-list
154366588|NCT01295099|Fluorouracil|fluorouracil|mesh-list
154366589|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
154366590|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366591|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154366592|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212030|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
154366593|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154366594|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
154366595|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366596|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366597|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
154366599|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154366600|NCT01426529|Norepinephrine|norepinephrine|mesh-list
154366601|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
154366602|NCT01426529|Giapreza|giapreza|mesh-list
154366603|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
154366604|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154366605|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154366606|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154366607|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366608|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366609|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366610|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
154366611|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
154366612|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366613|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154366622|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366624|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366625|NCT01190735|Caffeine|caffeine|mesh-list
154366626|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154366627|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366628|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154366629|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366630|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366631|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154366632|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154366633|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
154366634|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366635|NCT05097118|Ketamine|ketamine|mesh-list
154366636|NCT05097118|Bupivacaine|bupivacaine|mesh-list
154366637|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366638|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
154366639|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366640|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366641|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
154366642|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366643|NCT05097118|Analgesics|analgesics|mesh-ancestor
154366644|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154366645|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154366646|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
154366647|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154366648|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154366649|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366650|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366652|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
154366653|NCT01194791|Lenalidomide|lenalidomide|mesh-list
154366654|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154366655|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
154366656|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366657|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154366658|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154366659|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
154366660|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366661|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366662|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154366663|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366664|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
154366665|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
154366666|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366667|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366668|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
154366669|NCT01194791|Hormones|hormones|mesh-ancestor
154366670|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154366671|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154366672|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154366673|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154366674|NCT01194791|Growth Substances|growth substances|mesh-ancestor
154366675|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
154366676|NCT03351322|Minoxidil|minoxidil|mesh-list
154366677|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154366689|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366690|NCT01197053|Immunomodulating Agents|immunomodulating agents|mesh-list
154366691|NCT01197053|Immunologic Factors|immunologic factors|mesh-ancestor
154366692|NCT01197053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366693|NCT03845699|Fentanyl|fentanyl|mesh-list
154366694|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154366695|NCT03845699|Narcotics|narcotics|mesh-ancestor
154366696|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366697|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366698|NCT03845699|Analgesics|analgesics|mesh-ancestor
154366699|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
154366700|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366701|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154366702|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154366703|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
154366704|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
154366705|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154366706|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366707|NCT00709618|Vinorelbine|vinorelbine|mesh-list
154366708|NCT00709618|Lapatinib|lapatinib|mesh-list
154366709|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154366710|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366711|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
154366712|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
154366713|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
154366714|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366715|NCT00709618|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154366716|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154366717|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366718|NCT01195259|Metformin|metformin|mesh-list
154366719|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
154366720|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154366721|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366722|NCT05584228|Infliximab|infliximab|mesh-list
154366723|NCT05584228|Azathioprine|azathioprine|mesh-list
154366724|NCT05584228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154366725|NCT05584228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366726|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
154366727|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366728|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154366729|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
154366730|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366731|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154366732|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366733|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154366734|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
154366735|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366736|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154366737|NCT03193047|Evolocumab|evolocumab|mesh-list
154366738|NCT03193047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154366739|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154366740|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154366741|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
154366742|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545759|NCT06301724|Anesthetics|anesthetics|mesh-ancestor
154366749|NCT04504552|Avelumab|avelumab|mesh-list
154366750|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154366751|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366752|NCT03845387|Pramipexole|pramipexole|mesh-list
154366753|NCT03845387|Dexpramipexole|dexpramipexole|mesh-list
154366754|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
154366755|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366756|NCT03845387|Protective Agents|protective agents|mesh-ancestor
154366757|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366758|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154366759|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154366760|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
154366761|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
154366762|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366763|NCT01295177|Insulin|insulin|mesh-list
154366764|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154366765|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154366766|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366767|NCT02918019|Astegolimab|astegolimab|mesh-list
154366768|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154366769|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366770|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
154366771|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366772|NCT04848454|Vinorelbine|vinorelbine|mesh-list
154366773|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366774|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154366775|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
154366776|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
154366777|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
154366778|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366779|NCT04842292|Heparin|heparin|mesh-list
154366780|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
154366781|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154366782|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154366783|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366784|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
154366785|NCT01191983|Hematinics|hematinics|mesh-ancestor
154366786|NCT03055988|Fluticasone|fluticasone|mesh-list
154366787|NCT03055988|Xhance|xhance|mesh-list
154366788|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
154366789|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154366790|NCT03055988|Olodaterol|olodaterol|mesh-list
154366791|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366792|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154366793|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
154366794|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366795|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366796|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154366797|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
154366798|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
154366799|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154366800|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
154366801|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154366802|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
154366803|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366804|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366805|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154366806|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154366808|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
154366809|NCT03346642|Decitabine|decitabine|mesh-list
154366810|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154366811|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154366812|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
154366813|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366814|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366824|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366825|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154366826|NCT04780724|Nitrox|nitrox|mesh-list
154366827|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154366828|NCT04780724|Protective Agents|protective agents|mesh-ancestor
154366829|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366830|NCT05583214|Dexamethasone|dexamethasone|mesh-list
154366831|NCT05583214|Ondansetron|ondansetron|mesh-list
154366832|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366833|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
154366834|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
154366835|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366836|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366837|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154366838|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
154366839|NCT05583214|Hormones|hormones|mesh-ancestor
154366840|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154366841|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154366842|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366843|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
154366844|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
154366845|NCT05583214|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154366846|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154366847|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
154366848|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366849|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366850|NCT02871297|Vortioxetine|vortioxetine|mesh-list
154366851|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
154366852|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154366853|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154366854|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154366855|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366856|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366857|NCT02871297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154366858|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154366859|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154366860|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366861|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366862|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
154366863|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154366864|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154366865|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154366866|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154366867|NCT03628430|Lidocaine|lidocaine|mesh-list
154366868|NCT03628430|Epinephrine|epinephrine|mesh-list
154366869|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366870|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
154366871|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366872|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366873|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
154366874|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366875|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154366876|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154366877|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154366878|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153619041|NCT01981889|Prednisone|prednisone|mesh-list
154366884|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154366885|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154366886|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
154366887|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154366888|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
154366889|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
154366890|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
154366891|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154366893|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366894|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154366895|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366896|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366897|NCT03122314|Acetaminophen|acetaminophen|mesh-list
154366898|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154366899|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154366900|NCT03122314|Analgesics|analgesics|mesh-ancestor
154366901|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
154366902|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366903|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366904|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
154366905|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154366906|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366907|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154366908|NCT03554005|Acetaminophen|acetaminophen|mesh-list
154366909|NCT03554005|Interferons|interferons|mesh-list
154366910|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
154366911|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
154366912|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154366913|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366914|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
154366915|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366916|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154366917|NCT03554005|Analgesics|analgesics|mesh-ancestor
154366918|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
154366919|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366920|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366921|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
154366922|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
154366924|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154366925|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
154366926|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366927|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
154366928|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366930|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154366931|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366932|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
154366933|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366934|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154366935|NCT05214872|Calcium|calcium|mesh-list
154366936|NCT05214872|Mitogens|mitogens|mesh-list
154366937|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154366938|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366939|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
154366940|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366941|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
154366942|NCT01195571|Vaccines|vaccines|mesh-list
154366943|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
154366944|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366945|NCT03219372|Pravastatin|pravastatin|mesh-list
154366946|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154366947|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154366948|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
154366949|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366962|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154366963|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154366964|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366966|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154366967|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
154366968|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366969|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366970|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154366971|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
154366972|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154366973|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
154366974|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366975|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366976|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154366977|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
154366978|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
154366979|NCT04338828|Protective Agents|protective agents|mesh-ancestor
154366980|NCT01295567|Dipyridamole|dipyridamole|mesh-list
154366981|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154366982|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366983|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366984|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154366985|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
154366986|NCT01192529|Phentermine|phentermine|mesh-list
154366987|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154366988|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366989|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
154366990|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154366991|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
154366992|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
154366993|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366994|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154366995|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366996|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366997|NCT01195649|Sorafenib|sorafenib|mesh-list
154366998|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366999|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154367000|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367001|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367002|NCT01195727|Apixaban|apixaban|mesh-list
154367003|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154367004|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
154367005|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154367006|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
154367007|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367008|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367009|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
154367010|NCT04958876|Naltrexone|naltrexone|mesh-list
154367045|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154367046|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367048|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154367049|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154367050|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367064|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367065|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154367066|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154367067|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367068|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367069|NCT02352753|Denosumab|denosumab|mesh-list
154367070|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154367071|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367072|NCT02517736|Sorafenib|sorafenib|mesh-list
154367073|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367074|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154367075|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367076|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367077|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
154367078|NCT03844841|Propofol|propofol|mesh-list
154367079|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154367080|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367081|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367082|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367083|NCT03844841|Analgesics|analgesics|mesh-ancestor
154367084|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
154367085|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367086|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154367087|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154367088|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154367089|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
154367090|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367091|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367092|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154367093|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
154367094|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
154367095|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
154367096|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
154113341|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
154367097|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367099|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154367100|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154367101|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154367102|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154367103|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
154367104|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367105|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367118|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154367119|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367120|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
154367121|NCT01198223|Ionophores|ionophores|mesh-ancestor
154861952|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367122|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367123|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367124|NCT01193465|Anesthetics|anesthetics|mesh-list
154367125|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367126|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367127|NCT03347344|Riluzole|riluzole|mesh-list
154367128|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
154367129|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154367130|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154367131|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367132|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367133|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367134|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154367135|NCT03347344|Protective Agents|protective agents|mesh-ancestor
154367136|NCT03173456|Acetaminophen|acetaminophen|mesh-list
154367137|NCT03173456|Ibuprofen|ibuprofen|mesh-list
154367138|NCT03173456|Oxycodone|oxycodone|mesh-list
154367139|NCT03173456|Hydrocodone|hydrocodone|mesh-list
154367140|NCT03173456|Codeine|codeine|mesh-list
154367141|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154367142|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367143|NCT03173456|Analgesics|analgesics|mesh-ancestor
154367144|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
154367145|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367146|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367147|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367148|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367149|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154367150|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367151|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367152|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154367153|NCT03173456|Narcotics|narcotics|mesh-ancestor
154367154|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367155|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
154367156|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
154367157|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
154367158|NCT01193621|Haloperidol|haloperidol|mesh-list
154367159|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
154367160|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
154367161|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
154367162|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367163|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367164|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367165|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154367166|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154212494|NCT06142396|Dexamethasone|dexamethasone|mesh-list
154367167|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367168|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154367169|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154367181|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367182|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154367183|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154367184|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367185|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367187|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367188|NCT01567904|Semuloparin|semuloparin|mesh-list
154367189|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154367190|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154367191|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367192|NCT01196507|Carvedilol|carvedilol|mesh-list
154367193|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154367194|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154367195|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
154367196|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367197|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367198|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367199|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154367200|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
154367201|NCT01196507|Protective Agents|protective agents|mesh-ancestor
154367202|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154367203|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367204|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154367205|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
154367206|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154367207|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154367208|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
154367209|NCT05282771|Clobetasol|clobetasol|mesh-list
154367210|NCT05282771|Halobetasol|halobetasol|mesh-list
154367211|NCT05282771|Tazarotene|tazarotene|mesh-list
154367212|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
154367213|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
154367214|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
154367215|NCT05282771|Vitamins|vitamins|mesh-ancestor
154367216|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
154367217|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367218|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154367219|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367220|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
154367221|NCT05282771|Hormones|hormones|mesh-ancestor
154212554|NCT06083844|Cyclophosphamide|cyclophosphamide|mesh-list
154367222|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367223|NCT05487833|Insulin|insulin|mesh-list
154367224|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154367225|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367226|NCT03600805|Prednisone|prednisone|mesh-list
154367227|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367228|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
154367229|NCT03600805|Hormones|hormones|mesh-ancestor
154367230|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367231|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367245|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367246|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154367247|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154367248|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367249|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
154367250|NCT03848039|Vaccines|vaccines|mesh-list
154367251|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
154367252|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367253|NCT01296269|Vasopressins|vasopressins|mesh-list
154367254|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
154367255|NCT01296269|Oxytocin|oxytocin|mesh-list
154367256|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
154367257|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154367258|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367259|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
154367260|NCT01296269|Coagulants|coagulants|mesh-ancestor
154367261|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154367262|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154367263|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
154367264|NCT05595772|Mitogens|mitogens|mesh-list
154367265|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
154367266|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367267|NCT03844451|Epinephrine|epinephrine|mesh-list
154367268|NCT03844451|Bupivacaine|bupivacaine|mesh-list
154367269|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
154367270|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
154367271|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367272|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367273|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
154367274|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367275|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154367276|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154367277|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
154367278|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367279|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367280|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154367281|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154367282|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
154367283|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154367284|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
154367285|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
154367286|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
154367287|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154367288|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
154367289|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154367290|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367291|NCT03386214|Pevonedistat|pevonedistat|mesh-list
154367292|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619469|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
154367310|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367311|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367312|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154367313|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
154367314|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367315|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367316|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154113568|NCT04034589|Fulvestrant|fulvestrant|mesh-list
154367317|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154367318|NCT01198925|Piperacillin|piperacillin|mesh-list
154367319|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154367320|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367321|NCT03844139|Glycerol|glycerol|mesh-list
154367322|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154367323|NCT03844139|Protective Agents|protective agents|mesh-ancestor
154367324|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367325|NCT04500496|Isoniazid|isoniazid|mesh-list
154367326|NCT04500496|Dinoprostone|dinoprostone|mesh-list
154367327|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
154367328|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154367329|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367330|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
154367331|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154367332|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367333|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154367334|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154367335|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
154367336|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367337|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154367338|NCT01199081|Dronedarone|dronedarone|mesh-list
154367339|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154367340|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154367341|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154367342|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154367343|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367344|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154367345|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
154367362|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154367363|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367364|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
154367365|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
154367366|NCT05669963|Lactoferrin|lactoferrin|mesh-list
154367367|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367368|NCT02507440|Lidocaine|lidocaine|mesh-list
154367369|NCT02507440|Propofol|propofol|mesh-list
154367370|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
154367371|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
154367372|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367373|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367374|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
154367375|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367376|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154367377|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154367378|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154367379|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367380|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367381|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154367382|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154367383|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
154367384|NCT02507362|Riboflavin|riboflavin|mesh-list
154367385|NCT02507362|Dextrans|dextrans|mesh-list
154367386|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
154367387|NCT02507362|Vitamins|vitamins|mesh-ancestor
154367388|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
154367389|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367390|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154367391|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
154367392|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
154367393|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
154113642|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367394|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
154367395|NCT05640830|Paclitaxel|paclitaxel|mesh-list
154367396|NCT05640830|Bevacizumab|bevacizumab|mesh-list
154367397|NCT05640830|Trastuzumab|trastuzumab|mesh-list
154367398|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154367399|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367400|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
154367401|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
154367402|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
153731527|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154367403|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367404|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154367405|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153619593|NCT01985789|Promethazine|promethazine|mesh-list
154367420|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367421|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
154367422|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
154367423|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367424|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367425|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367426|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
154367427|NCT01078454|Hormones|hormones|mesh-ancestor
154367428|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367429|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154367430|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367431|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154367432|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
154367433|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367434|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154367435|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154367436|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
154367437|NCT02968602|Minocycline|minocycline|mesh-list
154367438|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154367439|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367440|NCT03345004|Vitamin D|vitamin d|mesh-list
154367441|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
154367442|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
154367443|NCT03345004|Vitamins|vitamins|mesh-list
154367444|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
154367445|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367446|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154367447|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154367448|NCT03552757|Semaglutide|semaglutide|mesh-list
154367449|NCT03552757|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154367450|NCT03552757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154367451|NCT03552757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367452|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
154367453|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154367454|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367455|NCT03003468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154367456|NCT03003468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367457|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154367458|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367459|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367460|NCT03552523|Pancrelipase|pancrelipase|mesh-list
154367461|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367462|NCT03728101|Dabigatran|dabigatran|mesh-list
154367463|NCT03728101|Simvastatin|simvastatin|mesh-list
154367464|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154367465|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154367466|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
154367482|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
154367483|NCT02515864|Dotinurad|dotinurad|mesh-list
154367484|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154367485|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154367486|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367487|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154367488|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154367489|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367490|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367491|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367492|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154367493|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
154367494|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154367495|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367496|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154367497|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154367498|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154367499|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
154367500|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
154367501|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367502|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
154861953|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367503|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
154367504|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
154367505|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367506|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367507|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367508|NCT02892409|Amoxicillin|amoxicillin|mesh-list
154367509|NCT02892409|Clarithromycin|clarithromycin|mesh-list
154367510|NCT02892409|Lansoprazole|lansoprazole|mesh-list
154367511|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
154367512|NCT02892409|Bismuth|bismuth|mesh-list
154367513|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154367514|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367515|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154367516|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367517|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367518|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154367519|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154367520|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154367521|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367522|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154367523|NCT02892409|Antacids|antacids|mesh-ancestor
154367524|NCT02507128|Liraglutide|liraglutide|mesh-list
154367525|NCT02507128|Glucagon|glucagon|mesh-list
154367526|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154367527|NCT02507128|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154367540|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367541|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154367542|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154367543|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154367544|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367545|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367546|NCT02292758|Bevacizumab|bevacizumab|mesh-list
154367547|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154367548|NCT02292758|Cetuximab|cetuximab|mesh-list
154367549|NCT02292758|Irinotecan|irinotecan|mesh-list
154367550|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
154367551|NCT02292758|Antibodies|antibodies|mesh-list
154367552|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
154367553|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154367554|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
154367555|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367556|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154367557|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154367558|NCT02292758|Growth Substances|growth substances|mesh-ancestor
154367559|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367560|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
154367561|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
154367562|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154367563|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154367564|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367565|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367566|NCT03727867|Mitogens|mitogens|mesh-list
154367567|NCT03727867|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154367568|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
154367569|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367570|NCT03727867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154367571|NCT03727867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367572|NCT02832648|Selenium|selenium|mesh-list
154367573|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
154367574|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367575|NCT02832648|Protective Agents|protective agents|mesh-ancestor
154367576|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367577|NCT02832648|Trace Elements|trace elements|mesh-ancestor
154367578|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
154367579|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
154367580|NCT04497766|Analgesics|analgesics|mesh-ancestor
154367581|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
154367582|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367583|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367584|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
154367585|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367586|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154367587|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
154367588|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154861954|NCT01095757|Plerixafor|plerixafor|mesh-list
154367589|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367596|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367597|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154367598|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367599|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367600|NCT03620526|Iloprost|iloprost|mesh-list
154367601|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154367602|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
154367603|NCT03843749|Trastuzumab|trastuzumab|mesh-list
154367604|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154367605|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367606|NCT03192306|Ethanol|ethanol|mesh-list
154367607|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154367608|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367609|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367610|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367611|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
154367612|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154367613|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
154367614|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367615|NCT03216954|Expectorants|expectorants|mesh-ancestor
154367616|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
154367617|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154367618|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
154367619|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113867|NCT00769548|Goserelin|goserelin|mesh-list
154367620|NCT03216954|Protective Agents|protective agents|mesh-ancestor
154367621|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367622|NCT03216954|Antidotes|antidotes|mesh-ancestor
154367623|NCT05669807|Paclitaxel|paclitaxel|mesh-list
154367624|NCT05669807|Irinotecan|irinotecan|mesh-list
154367625|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154367626|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154367627|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367628|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
154367629|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
154367630|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
154367631|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367632|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154367633|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154367634|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367635|NCT03599089|Acetaminophen|acetaminophen|mesh-list
154367636|NCT03599089|Ketorolac|ketorolac|mesh-list
154367637|NCT03599089|Oxycodone|oxycodone|mesh-list
154367638|NCT03599089|Bupivacaine|bupivacaine|mesh-list
154367639|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
154367640|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
154367641|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367642|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367643|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
154367644|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367645|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367646|NCT03599089|Analgesics|analgesics|mesh-ancestor
154367647|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
154367648|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154367649|NCT03599089|Narcotics|narcotics|mesh-ancestor
154367650|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154367651|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367652|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367653|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154367654|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367655|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367656|NCT03597529|Melatonin|melatonin|mesh-list
154367657|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
154367658|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367671|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367673|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
154367674|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
154367675|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367676|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154367677|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
154367678|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367679|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367680|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154367681|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
154367682|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154367683|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154367684|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154367685|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154367686|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154367687|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367689|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
154367690|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367691|NCT04667507|Dexamethasone|dexamethasone|mesh-list
154367692|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367693|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
154113941|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367694|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
154367695|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367696|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367697|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367699|NCT04667507|Hormones|hormones|mesh-ancestor
154367700|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367701|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154367702|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367703|NCT01200251|Bimatoprost|bimatoprost|mesh-list
154367704|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154367705|NCT03597139|Cyclosporine|cyclosporine|mesh-list
154367706|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154367707|NCT03597139|Cyclosporins|cyclosporins|mesh-list
154367708|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367709|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367710|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154367711|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
154367712|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367713|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
154367714|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367715|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
154367716|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367717|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154367718|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154367719|NCT01202435|Pregabalin|pregabalin|mesh-list
154367720|NCT01202435|Analgesics|analgesics|mesh-ancestor
154367721|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
154367722|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367723|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367733|NCT05406102|Propofol|propofol|mesh-list
154367734|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154367735|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367736|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367737|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154367738|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
154367739|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
154367740|NCT01204307|Cisplatin|cisplatin|mesh-list
154367741|NCT01204307|Docetaxel|docetaxel|mesh-list
154367742|NCT01204307|Pemetrexed|pemetrexed|mesh-list
154367743|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367744|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
154367745|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
154367746|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
154367747|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367748|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367749|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154367750|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154367751|NCT00708214|Letrozole|letrozole|mesh-list
154367752|NCT00708214|Afatinib|afatinib|mesh-list
154367753|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367754|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154367755|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154367756|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367757|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367758|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154367759|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
154367760|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367761|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367762|NCT00708214|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154367763|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154367764|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
154367765|NCT02506894|Analgesics|analgesics|mesh-ancestor
154367766|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
154367767|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367768|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367769|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
154367770|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367771|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154367772|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
154367773|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154367774|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367775|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367776|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154367777|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
154367778|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154367779|NCT04891250|Ivermectin|ivermectin|mesh-list
154367780|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154367781|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367782|NCT03570697|Evolocumab|evolocumab|mesh-list
154367783|NCT03570697|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154367784|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154367785|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154367786|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
154367787|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367803|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
154367804|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154367805|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154367806|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367807|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154367808|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154367809|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154367810|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367811|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367812|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
154367813|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
154367814|NCT01200641|Protective Agents|protective agents|mesh-ancestor
154367815|NCT01856270|Amitriptyline|amitriptyline|mesh-list
154367816|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154367817|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
154367818|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154367819|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367820|NCT01856270|Analgesics|analgesics|mesh-ancestor
154367821|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
154367822|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367823|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367824|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154367825|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154367826|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367827|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367828|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
154367829|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367830|NCT02511340|Flumatinib|flumatinib|mesh-list
154367831|NCT02511340|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154367832|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154367833|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367834|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367835|NCT02506348|Diclofenac|diclofenac|mesh-list
154367836|NCT02506348|Nepafenac|nepafenac|mesh-list
154367837|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154367838|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367839|NCT02506348|Analgesics|analgesics|mesh-ancestor
154367840|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
154367841|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367842|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367843|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367844|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367845|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154367846|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367847|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367854|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367856|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
154367857|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367858|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367859|NCT01202513|Bimatoprost|bimatoprost|mesh-list
154367860|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153604529|NCT01918150|Cobalt|cobalt|mesh-list
154367861|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154367862|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154367863|NCT03835715|Vortioxetine|vortioxetine|mesh-list
154367864|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
154367865|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154367866|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154367867|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154367868|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367869|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367870|NCT03835715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154367871|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154367872|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367873|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367874|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367875|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
154213050|NCT04561375|Sufentanil|sufentanil|mesh-list
154367876|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154367877|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154367878|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154367879|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154367880|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
154367881|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154367882|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154367883|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367884|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367885|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
154367886|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367887|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367888|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154367889|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367890|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154367891|NCT03843281|Acetaminophen|acetaminophen|mesh-list
154367892|NCT03843281|Morphine|morphine|mesh-list
154367893|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154367894|NCT03843281|Narcotics|narcotics|mesh-ancestor
154367895|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367896|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367897|NCT03843281|Analgesics|analgesics|mesh-ancestor
154367898|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
154367899|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367900|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367901|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
154367902|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154367903|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
154367904|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367905|NCT03843515|Nivolumab|nivolumab|mesh-list
154367906|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154367907|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367908|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154367909|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367910|NCT00245960|Etanercept|etanercept|mesh-list
154367911|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154367912|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367913|NCT00245960|Analgesics|analgesics|mesh-ancestor
154367914|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
154367924|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154367925|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154367926|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367927|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
154367928|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367929|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154367930|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367931|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367932|NCT01202825|Simeprevir|simeprevir|mesh-list
154367933|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
154367934|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367935|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
154367936|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367937|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367938|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154367939|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154367940|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861955|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154367942|NCT05222204|Gemcitabine|gemcitabine|mesh-list
154367943|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154367944|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367945|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
154367946|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
154367947|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
154367948|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367949|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154367950|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
154367951|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
154367952|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154367953|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
154367954|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154367955|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
154367956|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367957|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367958|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
154367959|NCT05218616|Sunitinib|sunitinib|mesh-list
154367960|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367961|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154367962|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154367963|NCT05218616|Growth Substances|growth substances|mesh-ancestor
154367964|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367965|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
154367966|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154367967|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367968|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367969|NCT02505880|Anesthetics|anesthetics|mesh-list
154367970|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
154367971|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367972|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367973|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
154367974|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367975|NCT02510950|Temozolomide|temozolomide|mesh-list
154367976|NCT02510950|Poly ICLC|poly iclc|mesh-list
154367977|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154367978|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
154367979|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367980|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367985|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154367986|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367987|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367988|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367989|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
154367990|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154367991|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367992|NCT02505568|Infliximab|infliximab|mesh-list
154114243|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154367993|NCT02505568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154367994|NCT02505568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367995|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
154367996|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367997|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367998|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154367999|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154368001|NCT05217836|Chrysarobin|chrysarobin|mesh-list
154368002|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154368003|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368004|NCT05217836|Analgesics|analgesics|mesh-ancestor
154368005|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
154368006|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368007|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368008|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368009|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368010|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368011|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
154368012|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368013|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368014|NCT02514538|Acetaminophen|acetaminophen|mesh-list
154368015|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368016|NCT02514538|Analgesics|analgesics|mesh-ancestor
154368017|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
154368019|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368020|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
154368021|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
154368022|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154368023|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368024|NCT03832673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154368025|NCT03832673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368026|NCT03548935|Semaglutide|semaglutide|mesh-list
154368027|NCT03548935|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154368028|NCT03548935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154368029|NCT03548935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368030|NCT02504944|Propranolol|propranolol|mesh-list
154368031|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154368032|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154368033|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154368034|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154368035|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
154368036|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368037|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368038|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368039|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154368040|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154368041|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
154368042|NCT01201499|Morphine|morphine|mesh-list
154368043|NCT01201499|Remifentanil|remifentanil|mesh-list
154368044|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154368045|NCT01201499|Narcotics|narcotics|mesh-ancestor
154368046|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368047|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368048|NCT01201499|Analgesics|analgesics|mesh-ancestor
154368049|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
153620221|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
154368058|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368059|NCT03121690|Prednisone|prednisone|mesh-list
154368060|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368061|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
154368062|NCT03121690|Hormones|hormones|mesh-ancestor
154368063|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368064|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114325|NCT00987844|Prucalopride|prucalopride|mesh-list
154368065|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154368066|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368067|NCT03831269|Azithromycin|azithromycin|mesh-list
154368068|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154213227|NCT03971409|Avelumab|avelumab|mesh-list
154368069|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368070|NCT02504476|Midazolam|midazolam|mesh-list
154368071|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154368072|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154368073|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368074|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368075|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154368076|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154368077|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154368078|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154368079|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
154368080|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
154368081|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
154368082|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
154368083|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368084|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368085|NCT02504398|Methamphetamine|methamphetamine|mesh-list
154368086|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154368087|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368088|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
154368089|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
154368090|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368091|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
154368092|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368093|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368094|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
154368095|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154861956|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154368096|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154255933|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368097|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154368098|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154368099|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154368100|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154368101|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368102|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
154368103|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
154582983|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368104|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368105|NCT03830489|Protective Agents|protective agents|mesh-ancestor
154368106|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368107|NCT03830489|Vitamins|vitamins|mesh-ancestor
154368108|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
154368109|NCT02509468|Sirolimus|sirolimus|mesh-list
154368110|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154368111|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368112|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154368113|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368114|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
154368115|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368128|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154368129|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154368130|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154368131|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368132|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368133|NCT01205243|Abacavir|abacavir|mesh-list
154368134|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154368135|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154368136|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368137|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368138|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
154368139|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368140|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154368141|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154368143|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154368144|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154368145|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368146|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368147|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154368148|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154368149|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154368150|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154368151|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
154368152|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
154368153|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
154368154|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
154368155|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368156|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368157|NCT02509234|Irinotecan|irinotecan|mesh-list
154368158|NCT02509234|Trabectedin|trabectedin|mesh-list
154368159|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154368160|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154368161|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368162|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368163|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368164|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154368165|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
154368166|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
154368167|NCT01205321|Bombesin|bombesin|mesh-list
154368168|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368169|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368170|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368171|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154368172|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
154368173|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154368174|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368175|NCT03566485|Atezolizumab|atezolizumab|mesh-list
154368176|NCT03566485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154368177|NCT03566485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368178|NCT03566485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154368210|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368212|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154861957|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
154861958|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368213|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154368214|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
154368215|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368216|NCT01957332|Trastuzumab|trastuzumab|mesh-list
154368217|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154368218|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368219|NCT01205711|Leucovorin|leucovorin|mesh-list
154368220|NCT01205711|Fluorouracil|fluorouracil|mesh-list
154368221|NCT01205711|Irinotecan|irinotecan|mesh-list
154368222|NCT01205711|Calcium|calcium|mesh-list
154368232|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154368233|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154368234|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368235|NCT01205711|Antidotes|antidotes|mesh-ancestor
154368236|NCT01205711|Protective Agents|protective agents|mesh-ancestor
154368237|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
154368238|NCT01205711|Vitamins|vitamins|mesh-ancestor
154368239|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
154368240|NCT02508922|Vitamin D|vitamin d|mesh-list
154368241|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
154368242|NCT02508922|Vitamins|vitamins|mesh-ancestor
154368243|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
154368244|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368245|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154368246|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154368247|NCT03730675|Sorafenib|sorafenib|mesh-list
154368248|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368249|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154368250|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368251|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368252|NCT01345682|Methotrexate|methotrexate|mesh-list
154368253|NCT01345682|Afatinib|afatinib|mesh-list
154368254|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154368255|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
154368256|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154368257|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368258|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154368259|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
154368260|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368261|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368262|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
154368263|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368264|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154368265|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368266|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
154368267|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368268|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154368269|NCT01345682|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154368270|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154368271|NCT03562117|Gepotidacin|gepotidacin|mesh-list
154368272|NCT03562117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154368273|NCT03562117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368274|NCT03562117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368275|NCT03562117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368276|NCT02503462|Ritonavir|ritonavir|mesh-list
154368277|NCT02503462|Darunavir|darunavir|mesh-list
154368278|NCT02503462|Cobicistat|cobicistat|mesh-list
154368279|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154368280|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154368281|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
154368282|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368283|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368284|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154368285|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154368286|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
154368287|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620465|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
154368302|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154368304|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
154368305|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368306|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154368307|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
154368308|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154368309|NCT03627260|Protective Agents|protective agents|mesh-ancestor
154368310|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368311|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
154368312|NCT05706038|Adalimumab|adalimumab|mesh-list
154861959|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154368313|NCT05706038|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154368314|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368315|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368316|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
154368317|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
154368318|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368319|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368320|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368321|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154368322|NCT05126264|Ibuprofen|ibuprofen|mesh-list
154368323|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154368324|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368325|NCT05126264|Analgesics|analgesics|mesh-ancestor
154368326|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
154368327|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368328|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368329|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368330|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368331|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154368332|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368333|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368334|NCT03001817|Fenofibrate|fenofibrate|mesh-list
154368335|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154368336|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
154368337|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368338|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154368339|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
154368340|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154368341|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154368342|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368343|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
154368344|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
154368345|NCT03590743|Apixaban|apixaban|mesh-list
154368346|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154368347|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
154368348|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154368349|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
154368350|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368365|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368366|NCT03121222|Expectorants|expectorants|mesh-ancestor
154368367|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
154368368|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154368369|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
154368370|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368371|NCT03121222|Protective Agents|protective agents|mesh-ancestor
154368372|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368373|NCT03121222|Antidotes|antidotes|mesh-ancestor
154368374|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154368375|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154368376|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154368377|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154368378|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
154368379|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368380|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154368381|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154368382|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368383|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154368384|NCT03344302|Oxytocin|oxytocin|mesh-list
154368385|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
154368386|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154368387|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368388|NCT03545503|Ketamine|ketamine|mesh-list
154368389|NCT03545503|Etomidate|etomidate|mesh-list
154368390|NCT03545503|Analgesics|analgesics|mesh-ancestor
154368391|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
154368392|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368393|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368394|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154368395|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154368396|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
154368397|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
154368398|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368399|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154368400|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154368401|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768008|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
154368402|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368403|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154368404|NCT01297829|Ibuprofen|ibuprofen|mesh-list
154368405|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154368406|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368407|NCT01297829|Analgesics|analgesics|mesh-ancestor
154368408|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
154368409|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620591|NCT01993212|Androgens|androgens|mesh-ancestor
154368425|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
154368426|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368427|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368428|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154368429|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
154368430|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154368431|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
154368432|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368433|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368434|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154368435|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
154368436|NCT02508220|Oxytocin|oxytocin|mesh-list
154368437|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
154368438|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154368439|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368440|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
154368441|NCT01297907|Miotics|miotics|mesh-ancestor
154368442|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
154368443|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368444|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368445|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154368446|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154368447|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
154368448|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154368449|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154368450|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
154368451|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368452|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368453|NCT02508064|Fostemsavir|fostemsavir|mesh-list
154368454|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154368455|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154368456|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
154368457|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213545|NCT02506959|Gemcitabine|gemcitabine|mesh-list
154368458|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154368459|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154368460|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368461|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
154368462|NCT05705570|Fludarabine|fludarabine|mesh-list
154368463|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368464|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
154368465|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368466|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368467|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154368468|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
154368469|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368478|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154368479|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368480|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368481|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
154368482|NCT03343444|Ledipasvir|ledipasvir|mesh-list
154368483|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
154368484|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368485|NCT03819101|Aspirin|aspirin|mesh-list
154368486|NCT03819101|Atorvastatin|atorvastatin|mesh-list
154368487|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154368488|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154368489|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
154368490|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368491|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154368492|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154368493|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368494|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154368495|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368496|NCT03819101|Analgesics|analgesics|mesh-ancestor
154861960|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154368497|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
154368498|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368499|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368500|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368501|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368502|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154368503|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154368504|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154368505|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154368507|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154368508|NCT03343366|Metronidazole|metronidazole|mesh-list
154368509|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368510|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154368511|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154368512|NCT01298297|Morphine|morphine|mesh-list
154368513|NCT01298297|Buprenorphine|buprenorphine|mesh-list
154368514|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154368515|NCT01298297|Narcotics|narcotics|mesh-ancestor
154368516|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368517|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368518|NCT01298297|Analgesics|analgesics|mesh-ancestor
154368519|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
154368520|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368521|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154368522|NCT05525338|Alectinib|alectinib|mesh-list
154368523|NCT05525338|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154368524|NCT05525338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154368525|NCT05525338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368526|NCT05525338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368527|NCT03818945|Listerine|listerine|mesh-list
154368528|NCT03818945|Fluorides|fluorides|mesh-list
154368529|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
154368530|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
154368531|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
154368532|NCT03818945|Protective Agents|protective agents|mesh-ancestor
154368533|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368534|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154368535|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368536|NCT03842423|Anesthetics|anesthetics|mesh-list
154368537|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368538|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368539|NCT03172026|Maraviroc|maraviroc|mesh-list
154368549|NCT01201577|Sulfalene|sulfalene|mesh-list
154368550|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154368551|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368552|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154368553|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
154368554|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154368555|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154368556|NCT04496050|Alprostadil|alprostadil|mesh-list
154368557|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154368558|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
154368559|NCT04496050|Urological Agents|urological agents|mesh-ancestor
154368560|NCT01300793|Rituximab|rituximab|mesh-list
154368561|NCT01300793|Carboplatin|carboplatin|mesh-list
154368562|NCT01300793|Etoposide|etoposide|mesh-list
154368563|NCT01300793|Bortezomib|bortezomib|mesh-list
154368564|NCT01300793|Ifosfamide|ifosfamide|mesh-list
154368565|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
154368566|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154368567|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368568|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
154368569|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368570|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368571|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154368572|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154368573|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154368574|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368575|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368576|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154368577|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
154368578|NCT03342040|Bupivacaine|bupivacaine|mesh-list
154368579|NCT03342040|Ropivacaine|ropivacaine|mesh-list
154861961|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368580|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
153731528|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368581|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
154368582|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368583|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368584|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
154368585|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368586|NCT01298843|Ceftaroline|ceftaroline|mesh-list
154368587|NCT01298843|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154368588|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154368589|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368590|NCT03336970|Calcium|calcium|mesh-list
154368591|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154114871|NCT00776724|Docetaxel|docetaxel|mesh-list
154368592|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368593|NCT03336814|Terlipressin|terlipressin|mesh-list
154368594|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154368595|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154368596|NCT02495584|Vitamin D|vitamin d|mesh-list
154368597|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
154368598|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
154368599|NCT02495584|Vitamins|vitamins|mesh-list
154368600|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
154368601|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368602|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154368603|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154368604|NCT02495818|Lidocaine|lidocaine|mesh-list
154368605|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
154368606|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
153620779|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
154368623|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368624|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
154368625|NCT02495662|Hormones|hormones|mesh-ancestor
154368626|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368627|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368628|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154368629|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368630|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
154368631|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
154368632|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368633|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154368634|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154368635|NCT02495662|Protective Agents|protective agents|mesh-ancestor
154368636|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154368637|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154368638|NCT02496052|Estradiol|estradiol|mesh-list
154368639|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154368640|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
154368641|NCT02496052|Estrogens|estrogens|mesh-ancestor
154368642|NCT02496052|Hormones|hormones|mesh-ancestor
154368643|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368644|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368645|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154368646|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
154368647|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154368648|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154368649|NCT02496052|Progestins|progestins|mesh-ancestor
154368650|NCT01206569|Tacrolimus|tacrolimus|mesh-list
154368651|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368652|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
154368653|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368654|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154368655|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368656|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368657|NCT01206647|Metformin|metformin|mesh-list
154368658|NCT01206647|Saxagliptin|saxagliptin|mesh-list
154368659|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154368660|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368661|NCT01206647|Incretins|incretins|mesh-ancestor
154368662|NCT01206647|Hormones|hormones|mesh-ancestor
154182187|NCT05868525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368669|NCT03341884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368670|NCT03341884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154368671|NCT03341884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368672|NCT03341884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368674|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154368675|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
154861962|NCT02245451|Ritonavir|ritonavir|mesh-list
154861963|NCT02245451|Tipranavir|tipranavir|mesh-list
153731529|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
153768316|NCT00225264|Pioglitazone|pioglitazone|mesh-list
154368676|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368677|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368679|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
154368680|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154368681|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368682|NCT03336346|Efavirenz|efavirenz|mesh-list
154368683|NCT03336346|Dolutegravir|dolutegravir|mesh-list
154368684|NCT03336346|Etonogestrel|etonogestrel|mesh-list
154368685|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154368686|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154368687|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368688|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368689|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
154368690|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368691|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154368692|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154368693|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154368694|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154368695|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154368696|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154368697|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154368698|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154368699|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154368700|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154368701|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154368702|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
154368703|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154368704|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368705|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154368706|NCT03841292|Varenicline|varenicline|mesh-list
154368707|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154368708|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154368709|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
154368710|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368711|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368712|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368713|NCT03814577|Antioxidants|antioxidants|mesh-list
154368714|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368715|NCT03814577|Protective Agents|protective agents|mesh-ancestor
154368716|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368717|NCT03730363|Pentamidine|pentamidine|mesh-list
154368718|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
154368719|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368720|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154368721|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154368722|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154368723|NCT01206803|Ganirelix|ganirelix|mesh-list
154368724|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
154368725|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368726|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368742|NCT01206881|Trastuzumab|trastuzumab|mesh-list
154115036|NCT00744224|Exenatide|exenatide|mesh-list
154368743|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368744|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
154582984|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
154368745|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368746|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368747|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154368748|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
154368749|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368750|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368751|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154368752|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
154368753|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
154368754|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
154368755|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154368756|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154368757|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154368758|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368759|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154368760|NCT02494804|Temozolomide|temozolomide|mesh-list
154861964|NCT02245451|Methadone|methadone|mesh-list
154861965|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154255935|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154368761|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154368762|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
154368763|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368764|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368765|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154368766|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
154368767|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368768|NCT03814343|Amphotericin B|amphotericin b|mesh-list
154368769|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154368770|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154368771|NCT03814343|Amebicides|amebicides|mesh-ancestor
154368772|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154368773|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154368774|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368775|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154368776|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
154368777|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154368778|NCT03814343|Protective Agents|protective agents|mesh-ancestor
154368779|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368780|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154368781|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
154368782|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368783|NCT03817541|Propofol|propofol|mesh-list
154368784|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154368785|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368786|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620973|NCT01996085|Amlodipine|amlodipine|mesh-list
154368802|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154368803|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
154368804|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368806|NCT03725995|Midazolam|midazolam|mesh-list
154368807|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
154368808|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
154368809|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368810|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368811|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
154368812|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368813|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154368814|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154213826|NCT00110890|Cinacalcet|cinacalcet|mesh-list
154368815|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154368816|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115078|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
154368817|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368819|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154368820|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154368821|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154368822|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154368823|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154368824|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
154368825|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
154368826|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
154368827|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368828|NCT03341260|Diclofenac|diclofenac|mesh-list
154368829|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154368830|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368831|NCT03341260|Analgesics|analgesics|mesh-ancestor
154368832|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
154368833|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368834|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368835|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368836|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368837|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154368838|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368839|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368840|NCT03052400|Mifepristone|mifepristone|mesh-list
154368841|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154368842|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
154368843|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154368844|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368845|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154368846|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154368854|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154861966|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154368855|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154368856|NCT03341104|Bupivacaine|bupivacaine|mesh-list
154368857|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
154368858|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
154368859|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368860|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368861|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
154368862|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368863|NCT03335098|Thalidomide|thalidomide|mesh-list
154368864|NCT03335098|Dexamethasone|dexamethasone|mesh-list
154368865|NCT03335098|Bortezomib|bortezomib|mesh-list
154368866|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368867|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
154368868|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
154368869|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368870|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368871|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154368872|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
154368873|NCT03335098|Hormones|hormones|mesh-ancestor
154368874|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213901|NCT00322374|Epirubicin|epirubicin|mesh-list
154368875|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154368876|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368877|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368878|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
154368879|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
154368880|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154368881|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368882|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154368883|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154368884|NCT03335098|Growth Substances|growth substances|mesh-ancestor
154368885|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
154368886|NCT03639571|Ibuprofen|ibuprofen|mesh-list
154368887|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154368888|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368889|NCT03639571|Analgesics|analgesics|mesh-ancestor
154368890|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
154368891|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368892|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368893|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368894|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368895|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154368896|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368897|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368898|NCT03052322|Adalimumab|adalimumab|mesh-list
154368899|NCT03052322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154368900|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368901|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368902|NCT03521791|Bromfenac|bromfenac|mesh-list
154368903|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154368904|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368905|NCT03521791|Analgesics|analgesics|mesh-ancestor
154368906|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
154368907|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368908|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368909|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368910|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368911|NCT03521635|Pramipexole|pramipexole|mesh-list
154368912|NCT03521635|Dexpramipexole|dexpramipexole|mesh-list
154368913|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
154368927|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154368928|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
154368929|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368930|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368931|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154368932|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368934|NCT03340558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154368935|NCT03340558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368936|NCT03340558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154368937|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368938|NCT04905108|Riboflavin|riboflavin|mesh-list
154368939|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
154368940|NCT04905108|Vitamins|vitamins|mesh-ancestor
154368941|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
154368942|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368943|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154368944|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
154368945|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
154368946|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154368947|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
154368948|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368949|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
154368950|NCT04443166|Protective Agents|protective agents|mesh-ancestor
154368951|NCT01560221|Buprenorphine|buprenorphine|mesh-list
154368952|NCT01560221|Methadone|methadone|mesh-list
154368953|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154368954|NCT01560221|Narcotics|narcotics|mesh-ancestor
154368955|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368956|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368957|NCT01560221|Analgesics|analgesics|mesh-ancestor
154368958|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
154368959|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368960|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154368961|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
154368962|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
154368963|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
154368964|NCT03813329|Calcium|calcium|mesh-list
154368965|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154368966|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368967|NCT03813329|Antacids|antacids|mesh-ancestor
154368968|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368969|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154368970|NCT03639415|Oxycodone|oxycodone|mesh-list
154368971|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154368972|NCT03639415|Narcotics|narcotics|mesh-ancestor
154368973|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368974|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368975|NCT03639415|Analgesics|analgesics|mesh-ancestor
154368976|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
154368985|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368986|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368987|NCT03340168|Bisphenol A|bisphenol a|mesh-list
154368988|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154368989|NCT03340168|Estrogens|estrogens|mesh-ancestor
154368990|NCT03340168|Hormones|hormones|mesh-ancestor
154368991|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368992|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368993|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154368994|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
154368995|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368996|NCT03340168|Protective Agents|protective agents|mesh-ancestor
154368997|NCT01299701|Vadimezan|vadimezan|mesh-list
154368998|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368999|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154369000|NCT01299779|Laxatives|laxatives|mesh-ancestor
154369001|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154369002|NCT03812939|Octreotide|octreotide|mesh-list
154369003|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154369004|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369005|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369006|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
154369007|NCT03339700|Busulfan|busulfan|mesh-list
154369008|NCT03339700|Gemcitabine|gemcitabine|mesh-list
154369009|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369010|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
154369011|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369012|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369013|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369014|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
154369015|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369016|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369017|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154369018|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154369019|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
154369020|NCT01299857|Rituximab|rituximab|mesh-list
154369021|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369022|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369023|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
154369024|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369025|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369026|NCT03478969|Insulin|insulin|mesh-list
154369027|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154369028|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369029|NCT03812783|Sorafenib|sorafenib|mesh-list
154369030|NCT03812783|Folfirinox|folfirinox|mesh-list
154369031|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369032|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154369033|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369034|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369035|NCT02500498|Abatacept|abatacept|mesh-list
154369036|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369037|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369038|NCT02500498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369039|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369040|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369041|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
154369042|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369043|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369055|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369057|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154369058|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
154369059|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154369060|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154369061|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154369062|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154369063|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154369064|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154369065|NCT02492308|Basiliximab|basiliximab|mesh-list
154369066|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369067|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
154369068|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369069|NCT05865470|Dronabinol|dronabinol|mesh-list
154369070|NCT05865470|Hallucinogens|hallucinogens|mesh-ancestor
154369071|NCT05865470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369072|NCT05865470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154369073|NCT05865470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154369074|NCT05865470|Analgesics|analgesics|mesh-ancestor
154369075|NCT05865470|Sensory System Agents|sensory system agents|mesh-ancestor
154369076|NCT05865470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369077|NCT05865470|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154369078|NCT05865470|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154369079|NCT05865470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154369080|NCT05865470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369081|NCT05865470|Hormones|hormones|mesh-ancestor
154369082|NCT05865470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369083|NCT05865431|Zinc Oxide|zinc oxide|mesh-list
154369084|NCT05865431|Avobenzone|avobenzone|mesh-list
154369085|NCT05865431|Dermatologic Agents|dermatologic agents|mesh-ancestor
154369086|NCT05865431|Sunscreening Agents|sunscreening agents|mesh-ancestor
154369087|NCT05865431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154369088|NCT05865431|Protective Agents|protective agents|mesh-ancestor
154369089|NCT05865431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369090|NCT05865288|Oxytocin|oxytocin|mesh-list
154369091|NCT05865288|Oxytocics|oxytocics|mesh-ancestor
154369092|NCT05865288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154369093|NCT05865288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369094|NCT05865132|Palbociclib|palbociclib|mesh-list
154369095|NCT05865132|Afatinib|afatinib|mesh-list
154369096|NCT05865132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369097|NCT05865132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154369098|NCT05865132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369099|NCT05865132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369100|NCT05865132|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154369101|NCT05864885|Minoxidil|minoxidil|mesh-list
154369102|NCT05864885|Latanoprost|latanoprost|mesh-list
154369103|NCT05864885|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154369104|NCT05864885|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154369105|NCT05864885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154369106|NCT05864885|Vasodilator Agents|vasodilator agents|mesh-ancestor
154369107|NCT05864664|Anesthetics|anesthetics|mesh-list
154369108|NCT05864664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369109|NCT05864664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369119|NCT05864053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154369120|NCT05864053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154369121|NCT05864053|Anesthetics, General|anesthetics, general|mesh-ancestor
154369122|NCT05864053|Anesthetics|anesthetics|mesh-ancestor
154369123|NCT05864053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369124|NCT05864053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154369125|NCT05864053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154255936|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154861967|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
154369126|NCT05864053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154369127|NCT05864053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369128|NCT05863975|Interferons|interferons|mesh-list
154369129|NCT05863975|Interferon-alpha|interferon-alpha|mesh-list
154369130|NCT05863975|Interferon alpha-2|interferon alpha-2|mesh-list
154369131|NCT05863975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369132|NCT05863975|Antiviral Agents|antiviral agents|mesh-ancestor
154369133|NCT05863975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369134|NCT05863975|Immunologic Factors|immunologic factors|mesh-ancestor
154369135|NCT05863975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369136|NCT05863949|Vitamin D|vitamin d|mesh-list
154369137|NCT05863949|Calcium|calcium|mesh-list
154369138|NCT05863949|Vitamins|vitamins|mesh-ancestor
154369139|NCT05863949|Micronutrients|micronutrients|mesh-ancestor
154369140|NCT05863949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369141|NCT05863949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154369142|NCT05863949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154369143|NCT05863936|Methylprednisolone|methylprednisolone|mesh-list
154369144|NCT05863936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154369145|NCT05863936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154369146|NCT05863936|Prednisolone|prednisolone|mesh-list
154369147|NCT05863936|Prednisolone acetate|prednisolone acetate|mesh-list
154369148|NCT05863936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154369149|NCT05863936|Prednisolone phosphate|prednisolone phosphate|mesh-list
154369150|NCT05863936|Belimumab|belimumab|mesh-list
154369151|NCT05863936|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154369152|NCT05863936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369153|NCT05863936|Antiemetics|antiemetics|mesh-ancestor
154369154|NCT05863936|Autonomic Agents|autonomic agents|mesh-ancestor
154369155|NCT05863936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369156|NCT05863936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369157|NCT05863936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154369158|NCT05863936|Glucocorticoids|glucocorticoids|mesh-ancestor
154369159|NCT05863936|Hormones|hormones|mesh-ancestor
154369160|NCT05863936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369161|NCT05863936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154369162|NCT05863936|Protective Agents|protective agents|mesh-ancestor
154369163|NCT05863936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369164|NCT05863936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369165|NCT05863936|Immunologic Factors|immunologic factors|mesh-ancestor
154369166|NCT05863858|Amoxicillin|amoxicillin|mesh-list
154369167|NCT05863858|Moxifloxacin|moxifloxacin|mesh-list
154369168|NCT05863858|Levofloxacin|levofloxacin|mesh-list
154369169|NCT05863858|Ofloxacin|ofloxacin|mesh-list
154369170|NCT05863858|Tinidazole|tinidazole|mesh-list
154369171|NCT05863858|Omeprazole|omeprazole|mesh-list
154369172|NCT05863858|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154369173|NCT05863858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154369174|NCT05863858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369175|NCT05863858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154369182|NCT05863858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154369183|NCT05863858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369184|NCT05863858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154369185|NCT05863858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154369186|NCT05863858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154369187|NCT05863858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154369188|NCT05863858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154369189|NCT05863858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154369190|NCT05863858|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154369191|NCT05863858|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154369192|NCT05863858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154369193|NCT05863858|Alkylating Agents|alkylating agents|mesh-ancestor
154369194|NCT05863858|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154369196|NCT05863858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154369198|NCT05863845|Etoposide|etoposide|mesh-list
154369199|NCT05863845|Melphalan|melphalan|mesh-list
154369200|NCT05863845|Venetoclax|venetoclax|mesh-list
154369201|NCT05863845|Carmustine|carmustine|mesh-list
154369202|NCT05863845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154369203|NCT05863845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369204|NCT05863845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154369205|NCT05863845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154369206|NCT05863845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861968|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154861969|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369207|NCT05863845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369208|NCT05863845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154369210|NCT05863845|Antiviral Agents|antiviral agents|mesh-ancestor
154369211|NCT05863845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369212|NCT05863845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369213|NCT05863845|Immunologic Factors|immunologic factors|mesh-ancestor
154369214|NCT05863845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369215|NCT05863845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369216|NCT05863845|Alkylating Agents|alkylating agents|mesh-ancestor
154369217|NCT05863845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154369218|NCT05863832|Metronidazole|metronidazole|mesh-list
154369219|NCT05863832|Ciprofloxacin|ciprofloxacin|mesh-list
154369220|NCT05863832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369221|NCT05863832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154369222|NCT05863832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154369223|NCT05863832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154369224|NCT05863832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154369225|NCT05863832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154369226|NCT05863832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369227|NCT05863832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369228|NCT05863832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369229|NCT05863832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154369230|NCT05863832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154369231|NCT05863585|MEDI9197|medi9197|mesh-list
154369232|NCT05863585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154369233|NCT05863585|Immunologic Factors|immunologic factors|mesh-ancestor
154369234|NCT05863585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369235|NCT05863455|Midazolam|midazolam|mesh-list
154369236|NCT05863455|Sufentanil|sufentanil|mesh-list
154369237|NCT05863455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154369238|NCT05863455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154369239|NCT05863455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369240|NCT05863455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369241|NCT05863455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154369242|NCT05863455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154369243|NCT05863455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154369244|NCT05863455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154369255|NCT05863455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369256|NCT05863416|Dexmedetomidine|dexmedetomidine|mesh-list
154369257|NCT05863416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154369258|NCT05863416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369259|NCT05863416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369260|NCT05863416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154369261|NCT05863416|Analgesics|analgesics|mesh-ancestor
154369262|NCT05863416|Sensory System Agents|sensory system agents|mesh-ancestor
154369263|NCT05863416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369264|NCT05863416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154369265|NCT05863416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154369266|NCT05863416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154369267|NCT05863416|Adrenergic Agents|adrenergic agents|mesh-ancestor
154369268|NCT05863416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154369269|NCT05863416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369270|NCT05863273|Apremilast|apremilast|mesh-list
154369271|NCT05863273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154369272|NCT05863273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154369273|NCT05863273|Analgesics|analgesics|mesh-ancestor
154369274|NCT05863273|Sensory System Agents|sensory system agents|mesh-ancestor
154369275|NCT05863273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369276|NCT05863273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369277|NCT05863273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369278|NCT05863273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369279|NCT05863273|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154369280|NCT05863273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154369281|NCT05863273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369282|NCT05863273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369284|NCT05860998|Immunoglobulin G|immunoglobulin g|mesh-list
154369285|NCT05860998|Immunologic Factors|immunologic factors|mesh-ancestor
154369286|NCT05860998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369287|NCT05856500|Curcumin|curcumin|mesh-list
154369288|NCT05856500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154369289|NCT05856500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154861970|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154255477|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154255478|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
154255479|NCT03895970|Lenvatinib|lenvatinib|mesh-list
154255480|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255481|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255482|NCT03895970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369290|NCT05856500|Analgesics|analgesics|mesh-ancestor
154369291|NCT05856500|Sensory System Agents|sensory system agents|mesh-ancestor
154369292|NCT05856500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369293|NCT05856500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369294|NCT05856500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369295|NCT05856500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369296|NCT05856500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369297|NCT05856500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369298|NCT05856500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369299|NCT05828303|Metformin|metformin|mesh-list
154369300|NCT05828303|Digoxin|digoxin|mesh-list
154369301|NCT05828303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154369302|NCT05828303|Calcium|calcium|mesh-list
154369303|NCT05828303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154369304|NCT05828303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369305|NCT05828303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154369306|NCT05828303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154369307|NCT05828303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154369308|NCT05828303|Antimetabolites|antimetabolites|mesh-ancestor
154369309|NCT05828303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369310|NCT05828303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154369331|NCT05801705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369332|NCT05778617|Ambroxol|ambroxol|mesh-list
154369333|NCT05778617|Expectorants|expectorants|mesh-ancestor
154369334|NCT05778617|Respiratory System Agents|respiratory system agents|mesh-ancestor
154369335|NCT05743777|Pembrolizumab|pembrolizumab|mesh-list
154369336|NCT05743777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369337|NCT05743777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369338|NCT05743777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369339|NCT05743777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369340|NCT05489796|Ketorolac|ketorolac|mesh-list
154369341|NCT05489796|Fentanyl|fentanyl|mesh-list
154369342|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154369343|NCT05489796|Narcotics|narcotics|mesh-ancestor
154582985|NCT05429593|Semaglutide|semaglutide|mesh-list
154369344|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369345|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369346|NCT05489796|Analgesics|analgesics|mesh-ancestor
154369347|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
154369348|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369349|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154369350|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154369351|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
154369352|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
154369353|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154369354|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154369355|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369356|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369357|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154369358|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369359|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369360|NCT05422131|Clozapine|clozapine|mesh-list
154369361|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154369362|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
154369363|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182188|NCT05868525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369375|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
154369376|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369377|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
154369378|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154369379|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154369380|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
154369381|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154861971|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154861972|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
154861973|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154861974|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154861975|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154861976|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154861977|NCT02245451|Narcotics|narcotics|mesh-ancestor
154255483|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369382|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154369383|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369384|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
154369385|NCT05357079|Coagulants|coagulants|mesh-ancestor
154369386|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
154369387|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154369388|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154369389|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369390|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
154369391|NCT05326997|Coagulants|coagulants|mesh-ancestor
154369392|NCT05309629|Carboplatin|carboplatin|mesh-list
154369393|NCT05309629|Etoposide|etoposide|mesh-list
154369394|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369395|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154369396|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154369397|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154369398|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369399|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369400|NCT05209620|Pemetrexed|pemetrexed|mesh-list
154369401|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369402|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369403|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369404|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154369405|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154369406|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
154369407|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154369408|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369409|NCT05184062|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154369410|NCT05184062|Antiviral Agents|antiviral agents|mesh-ancestor
154369411|NCT05184062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369412|NCT05153304|Nivolumab|nivolumab|mesh-list
154369413|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369414|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369415|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369416|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369417|NCT04967495|Lenvatinib|lenvatinib|mesh-list
154369418|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
154369419|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369420|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154369421|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369422|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369423|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154369425|NCT04967495|Hormones|hormones|mesh-ancestor
154369426|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369427|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369437|NCT04828135|Xenon|xenon|mesh-list
154369438|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154369439|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
154369440|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
154369441|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369442|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369443|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
154369444|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369445|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369446|NCT04815720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369447|NCT04815720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369448|NCT04737889|Rituximab|rituximab|mesh-list
154369449|NCT04737889|Methotrexate|methotrexate|mesh-list
154369450|NCT04737889|Lenalidomide|lenalidomide|mesh-list
154369451|NCT04737889|Temozolomide|temozolomide|mesh-list
154369452|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369453|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369454|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
154369455|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369456|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369457|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154369458|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
154369459|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154369460|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154369461|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
154369462|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154861978|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369463|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
154369464|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369465|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154369466|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369467|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154369468|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154369469|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154369470|NCT04737889|Growth Substances|growth substances|mesh-ancestor
154369471|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154369472|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369473|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
154369474|NCT04735354|Valsartan|valsartan|mesh-list
154369475|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154369476|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154369477|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154369478|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154369479|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369480|NCT04679740|Sirolimus|sirolimus|mesh-list
154369481|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154369482|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369483|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154369484|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369485|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
154369486|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369487|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
154369488|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369489|NCT04672291|Poly I-C|poly i-c|mesh-list
154369490|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154369491|NCT04672291|Poly ICLC|poly iclc|mesh-list
154369503|NCT04668365|Epirubicin|epirubicin|mesh-list
154369504|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
154369505|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369506|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
154369507|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369508|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369509|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369510|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
154369511|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369512|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369513|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154369514|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369515|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369516|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
154369517|NCT04668365|Hormones|hormones|mesh-ancestor
154369518|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369519|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369520|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154369521|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
154369522|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
154369523|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
154369524|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154369525|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154369526|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154369527|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214453|NCT00510887|Analgesics|analgesics|mesh-ancestor
154369528|NCT04668365|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154369529|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154369530|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154369531|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
154369532|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154369533|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
154369534|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154369535|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369536|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154369537|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369538|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369539|NCT04496401|Tacrolimus|tacrolimus|mesh-list
154369540|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369541|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
154369542|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369543|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154369544|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369545|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369546|NCT04433156|Prednisone|prednisone|mesh-list
154369547|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
154255484|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154369548|NCT04433156|Rituximab|rituximab|mesh-list
154369549|NCT04433156|Bortezomib|bortezomib|mesh-list
154369550|NCT04433156|Epirubicin|epirubicin|mesh-list
154369551|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369552|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
154369553|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369554|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369555|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369556|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
154369557|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369564|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369565|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369567|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154369568|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154369570|NCT04388176|Compound 21|compound 21|mesh-list
154369571|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369572|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
154369573|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
154369574|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369575|NCT04311489|Ularitide|ularitide|mesh-list
154369576|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154369577|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
154369578|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369579|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369580|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154369581|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
154369582|NCT04311489|Diuretics|diuretics|mesh-ancestor
154369583|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
154369584|NCT04305405|Benralizumab|benralizumab|mesh-list
154369585|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154369586|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
154369587|NCT04255134|Adalimumab|adalimumab|mesh-list
154369588|NCT04255134|Abatacept|abatacept|mesh-list
154369589|NCT04255134|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154369590|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369591|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369592|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369593|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369594|NCT04255134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369595|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369596|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369597|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
154369598|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369599|NCT04192370|Cannabidiol|cannabidiol|mesh-list
154369600|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
154369601|NCT04180371|Nivolumab|nivolumab|mesh-list
154369602|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369603|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369604|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369605|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369606|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
154369607|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154369608|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
154369609|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154369610|NCT04067037|Vincristine|vincristine|mesh-list
154369611|NCT04067037|Epirubicin|epirubicin|mesh-list
154369612|NCT04067037|Dacarbazine|dacarbazine|mesh-list
154369613|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154369614|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369615|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
154369616|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
154369617|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
154369618|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369619|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154369620|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154369621|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154369622|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369623|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369624|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
154369625|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
154369626|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369647|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154861979|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861980|NCT02245451|Analgesics|analgesics|mesh-ancestor
154255485|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369648|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154369649|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
154369650|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154369651|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154369652|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
154369653|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369654|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
154369655|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369656|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154369657|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369658|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154369659|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154369660|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154369661|NCT03495960|Growth Substances|growth substances|mesh-ancestor
154369662|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
154369663|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369664|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
154369665|NCT03491683|Temozolomide|temozolomide|mesh-list
154369666|NCT03491683|Cemiplimab|cemiplimab|mesh-list
154369667|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369668|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
154369669|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369670|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369671|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369672|NCT03345823|Upadacitinib|upadacitinib|mesh-list
154369673|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154369674|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154369675|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369676|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369677|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369678|NCT03138161|Nivolumab|nivolumab|mesh-list
154369679|NCT03138161|Ipilimumab|ipilimumab|mesh-list
154369690|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
154369691|NCT02329080|Cytarabine|cytarabine|mesh-list
154369692|NCT02329080|Rituximab|rituximab|mesh-list
154369693|NCT02329080|Methotrexate|methotrexate|mesh-list
154369694|NCT02329080|Etoposide|etoposide|mesh-list
154369695|NCT02329080|Ifosfamide|ifosfamide|mesh-list
154369696|NCT02329080|Thiotepa|thiotepa|mesh-list
154369697|NCT02329080|Carmustine|carmustine|mesh-list
154369698|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369699|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369700|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
154369701|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369702|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369703|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154369704|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
154369705|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154369706|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154369707|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
154369708|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369709|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
154369710|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369711|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154369712|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369713|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154369714|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154369715|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154369716|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154115976|NCT00565773|Sirolimus|sirolimus|mesh-list
154214605|NCT00383708|Lanreotide|lanreotide|mesh-list
154369717|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
154369718|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369719|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369720|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
154369721|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154369722|NCT02227927|Domperidone|domperidone|mesh-list
154369723|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
154369724|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
154369725|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369726|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369727|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154369728|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154369729|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
154369730|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154861981|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
154369731|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369732|NCT01820910|Doxycycline|doxycycline|mesh-list
154369733|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154369734|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369735|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
154369736|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154369737|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154369739|NCT01808599|Chlorambucil|chlorambucil|mesh-list
154369740|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369741|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369742|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
154369743|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369744|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154182189|NCT05868525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369760|NCT05465278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154369761|NCT05465278|Protease Inhibitors|protease inhibitors|mesh-ancestor
154369762|NCT05465278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369763|NCT05465278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154369764|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
154369765|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
154369766|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154369767|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154369768|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154369769|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369770|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154369771|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154369772|NCT03339544|Celecoxib|celecoxib|mesh-list
154369773|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154369774|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154369775|NCT03339544|Analgesics|analgesics|mesh-ancestor
154369776|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
154369777|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369778|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369779|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369780|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369781|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154369782|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154369783|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369784|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369785|NCT03332602|Vitamins|vitamins|mesh-list
154369786|NCT03332602|Folic Acid|folic acid|mesh-list
154369787|NCT03332602|Vitamin A|vitamin a|mesh-list
154369788|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
154369789|NCT03332602|Fesoterodine|fesoterodine|mesh-list
154116053|NCT03489525|Antibodies|antibodies|mesh-list
154369790|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
154369791|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
154369792|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369794|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
154369795|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154369796|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
154369797|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
154369798|NCT03332602|Protective Agents|protective agents|mesh-ancestor
154369799|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
154369800|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369801|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154369802|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369803|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153621999|NCT02002260|Estradiol|estradiol|mesh-list
154369818|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154369819|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154369820|NCT03332524|Analgesics|analgesics|mesh-ancestor
154369821|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
154369822|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369823|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369824|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369825|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154369826|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154369827|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369828|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369829|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
154369830|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
154369831|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154369832|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
154369833|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
154369834|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255487|NCT00336479|Ribavirin|ribavirin|mesh-list
154369835|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154369836|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
154369837|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
154369838|NCT03812003|Remifentanil|remifentanil|mesh-list
154369839|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154369840|NCT03812003|Narcotics|narcotics|mesh-ancestor
154369841|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369842|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369843|NCT03812003|Analgesics|analgesics|mesh-ancestor
154369844|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
154369845|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369846|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
154369847|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154369848|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154369849|NCT04874610|Prednisolone|prednisolone|mesh-list
154369850|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
154369851|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154369852|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
154369853|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369854|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
154369855|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
154369856|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369857|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369858|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154369859|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
154369860|NCT04874610|Hormones|hormones|mesh-ancestor
154369861|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369862|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154369863|NCT04874610|Protective Agents|protective agents|mesh-ancestor
154369864|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369865|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369866|NCT03518125|Vaccines|vaccines|mesh-list
154116124|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
154369876|NCT02440230|Anastrozole|anastrozole|mesh-list
154369877|NCT02440230|Exemestane|exemestane|mesh-list
154369878|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369879|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369880|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154369881|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154369882|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369883|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369884|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154369885|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
154369886|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369887|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369888|NCT03478891|Ansuvimab|ansuvimab|mesh-list
154369889|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
154369890|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369891|NCT00706966|Dutasteride|dutasteride|mesh-list
154369892|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154369893|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154369894|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369895|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369896|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
154369897|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369898|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369899|NCT01330524|Triamcinolone|triamcinolone|mesh-list
154369900|NCT01330524|Bevacizumab|bevacizumab|mesh-list
154369901|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369902|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369903|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154369904|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154369905|NCT01330524|Growth Substances|growth substances|mesh-ancestor
154369906|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369907|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
154369908|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369909|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
154369910|NCT01330524|Hormones|hormones|mesh-ancestor
154369911|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369912|NCT01560065|Folic Acid|folic acid|mesh-list
154369913|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
154369914|NCT01560065|Inositol|inositol|mesh-list
154369915|NCT01560065|Hematinics|hematinics|mesh-ancestor
154861982|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369916|NCT01560065|Vitamins|vitamins|mesh-ancestor
154369917|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
154369918|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369919|NCT01302587|Albuterol|albuterol|mesh-list
154369920|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154369921|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
154369922|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369923|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369924|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154369925|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
154369926|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
154369927|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154369928|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154369929|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154369930|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154369931|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
154369932|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182190|NCT05868525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154369940|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369941|NCT03018288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369942|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369943|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369944|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
154369945|NCT03515941|Leucovorin|leucovorin|mesh-list
154369946|NCT03515941|Capecitabine|capecitabine|mesh-list
154369947|NCT03515941|Fluorouracil|fluorouracil|mesh-list
154369948|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
154369949|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154369950|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
154369951|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369952|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369953|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154369954|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
154369955|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369956|NCT03515941|Antidotes|antidotes|mesh-ancestor
154369957|NCT03515941|Protective Agents|protective agents|mesh-ancestor
154369958|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
154369959|NCT03515941|Vitamins|vitamins|mesh-ancestor
154369960|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
154369961|NCT03819647|Stiripentol|stiripentol|mesh-list
154369962|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
154369963|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
154369964|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369965|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369966|NCT02498860|Pemetrexed|pemetrexed|mesh-list
154369967|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369968|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369969|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369970|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154369971|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154369972|NCT03011034|Daratumumab|daratumumab|mesh-list
154369973|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369974|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
154369975|NCT03515629|Cemiplimab|cemiplimab|mesh-list
154369976|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369977|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369978|NCT03515629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369979|NCT03515629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369980|NCT01302821|Tryptophan|tryptophan|mesh-list
154369981|NCT01302821|Vaccines|vaccines|mesh-list
154369982|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
154369983|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369984|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154369985|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
154369986|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154369987|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154369988|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
154369989|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369990|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154369991|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154369992|NCT03512353|Dexamethasone|dexamethasone|mesh-list
154369993|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369994|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
154369995|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
154369996|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369997|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369998|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154255488|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
154369999|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
154370000|NCT03512353|Hormones|hormones|mesh-ancestor
154182191|NCT05868525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154370010|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370011|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154370013|NCT04851522|Petrolatum|petrolatum|mesh-list
154370014|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
154370015|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370016|NCT04851522|Emollients|emollients|mesh-ancestor
154370017|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
154370018|NCT03512275|Antibodies|antibodies|mesh-list
154370019|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154370020|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
154370021|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370022|NCT03809897|Nicotine|nicotine|mesh-list
154370023|NCT03809897|Varenicline|varenicline|mesh-list
154370024|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154370025|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
154370026|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370027|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370028|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154370029|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154370030|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
154370031|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370032|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370033|NCT03473197|Diacerein|diacerein|mesh-list
154370034|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370035|NCT01560299|Methimazole|methimazole|mesh-list
154370036|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
154370037|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
154370038|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370039|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370040|NCT03337828|Ethanol|ethanol|mesh-list
154370041|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154370042|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370043|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370044|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370045|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
154370047|NCT03510715|Niacinamide|niacinamide|mesh-list
154370048|NCT03510715|Atorvastatin|atorvastatin|mesh-list
154370049|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154370050|NCT03510715|Simvastatin|simvastatin|mesh-list
154370051|NCT03510715|Ezetimibe|ezetimibe|mesh-list
154370052|NCT03510715|Pravastatin|pravastatin|mesh-list
154370053|NCT03510715|Alirocumab|alirocumab|mesh-list
154370054|NCT03510715|Lovastatin|lovastatin|mesh-list
154370055|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
154370056|NCT03510715|Fenofibrate|fenofibrate|mesh-list
154370057|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154370058|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154370059|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
154370060|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370061|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154370062|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154370063|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370064|NCT03510715|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154370065|NCT03510715|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154370066|NCT03510715|Protease Inhibitors|protease inhibitors|mesh-ancestor
154370067|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
154370068|NCT03510715|Vitamins|vitamins|mesh-ancestor
154370086|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154370087|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154370088|NCT03815279|Growth Substances|growth substances|mesh-ancestor
153961862|NCT05631249|Sotorasib|sotorasib|mesh-list
154370089|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
154370091|NCT03814733|Alprazolam|alprazolam|mesh-list
154370092|NCT03814733|Analgesics|analgesics|mesh-ancestor
154370093|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
154370094|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370095|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370096|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154370097|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154370098|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
154370099|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
154370100|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370101|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154370102|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154861983|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
154370103|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370104|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370105|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154370107|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154370108|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154370109|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
154370110|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
154370111|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
154370112|NCT03721627|Ledipasvir|ledipasvir|mesh-list
154370113|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154370114|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
154370115|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370116|NCT03811223|Evolocumab|evolocumab|mesh-list
154370117|NCT03811223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154370118|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154370119|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154370120|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
154370121|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370122|NCT03811223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154370123|NCT03811223|Protease Inhibitors|protease inhibitors|mesh-ancestor
154370124|NCT03811223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370125|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154370126|NCT03723031|Misoprostol|misoprostol|mesh-list
154370127|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154370128|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
154370140|NCT03528577|Procaterol|procaterol|mesh-list
154370141|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154370142|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
154370143|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370144|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370145|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154370146|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
154370147|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
154370148|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154370149|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154370150|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154370151|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154370152|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
154370153|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370154|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370155|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
154370156|NCT05432414|Dexamethasone|dexamethasone|mesh-list
154370157|NCT05432414|Bortezomib|bortezomib|mesh-list
154370158|NCT05432414|Pomalidomide|pomalidomide|mesh-list
154370159|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370160|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
154370161|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
154370162|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370163|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370164|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154370165|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
154370166|NCT05432414|Hormones|hormones|mesh-ancestor
154370167|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370168|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154370169|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370170|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
154370171|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154370172|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154370173|NCT05432414|Growth Substances|growth substances|mesh-ancestor
154370174|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
154370175|NCT03796403|Diclofenac|diclofenac|mesh-list
154370176|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154370177|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154370179|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
154370180|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370181|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370182|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370183|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154370184|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154370185|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370186|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370187|NCT00706654|Aripiprazole|aripiprazole|mesh-list
154370188|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
154370189|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154370190|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154370191|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154370192|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622366|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370227|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
154370228|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370229|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370249|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370252|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370253|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154370254|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
154370255|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370256|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370257|NCT03636048|Bupivacaine|bupivacaine|mesh-list
154370258|NCT03636048|Anesthetics|anesthetics|mesh-list
154370259|NCT03636048|Propofol|propofol|mesh-list
154370260|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
154370261|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370262|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370263|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
154370264|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370265|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154370266|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154370267|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
154370268|NCT03527173|Vaccines|vaccines|mesh-list
154370269|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
154370270|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370271|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
154370272|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154370273|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154370274|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370275|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
154370276|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
154370277|NCT01303601|Olanzapine|olanzapine|mesh-list
154370278|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
154370279|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
154370280|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370281|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370282|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154370283|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154370284|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154370285|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370286|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153622472|NCT02005757|Analgesics|analgesics|mesh-ancestor
154370304|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370305|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
154370306|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154370307|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154370308|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154370309|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154370310|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154370311|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
154370312|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154370313|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154370314|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
154370315|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370316|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370318|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154370319|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370320|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
154116570|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154370321|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154370322|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
154370323|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370324|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
154370325|NCT02861183|Protective Agents|protective agents|mesh-ancestor
154370326|NCT02498002|Lidocaine|lidocaine|mesh-list
154370327|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
154370328|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
154370329|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370330|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370331|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
154370332|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370333|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154370334|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153607284|NCT03605719|Hormones|hormones|mesh-ancestor
154370335|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154370336|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154370337|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370360|NCT03801707|Velpatasvir|velpatasvir|mesh-list
154370361|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
154370362|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370363|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
154370364|NCT04239872|Calcium|calcium|mesh-list
154370365|NCT04239872|Fluorides|fluorides|mesh-list
154370366|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154370367|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370368|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154370369|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
154370370|NCT04239872|Protective Agents|protective agents|mesh-ancestor
154370371|NCT03164772|Durvalumab|durvalumab|mesh-list
154370372|NCT03164772|Tremelimumab|tremelimumab|mesh-list
154370373|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370374|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370375|NCT03801317|Micronutrients|micronutrients|mesh-list
154370376|NCT03801317|Trace Elements|trace elements|mesh-list
154370377|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370378|NCT03337126|Metronidazole|metronidazole|mesh-list
154370379|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370380|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154370381|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154370382|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154370383|NCT04710732|Enoxaparin|enoxaparin|mesh-list
154370384|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
154370385|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
154370386|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154370387|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154370388|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370389|NCT05014334|Amoxicillin|amoxicillin|mesh-list
154370390|NCT05014334|Clarithromycin|clarithromycin|mesh-list
154370407|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370408|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
154370409|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
154370410|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370411|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370412|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154370413|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
154370414|NCT02497378|Hormones|hormones|mesh-ancestor
154370415|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370416|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154370417|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370418|NCT02497222|RNS60|rns60|mesh-list
154370419|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154370420|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154370421|NCT02497222|Analgesics|analgesics|mesh-ancestor
154370422|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
154370423|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370424|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370425|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370426|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154370427|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154370428|NCT02491606|Tafenoquine|tafenoquine|mesh-list
154215131|NCT01053806|Azacitidine|azacitidine|mesh-list
154370429|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
154370430|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154370431|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154370432|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370433|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154370434|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154370435|NCT03050450|Lenalidomide|lenalidomide|mesh-list
154370436|NCT03050450|Vorinostat|vorinostat|mesh-list
154370437|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
154370438|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370439|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154370440|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154370441|NCT03050450|Growth Substances|growth substances|mesh-ancestor
154370442|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
154370443|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370444|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154370445|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370446|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370447|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
154370448|NCT03505021|Simendan|simendan|mesh-list
154861984|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
154255490|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154255491|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255492|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
154255493|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255494|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
154002419|NCT02792400|Incretins|incretins|mesh-ancestor
154255495|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255496|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
154255497|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255498|NCT03905564|Pyridoxine|pyridoxine|mesh-list
154255499|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
154370449|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154370450|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
154370469|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370470|NCT03329248|Leucovorin|leucovorin|mesh-list
154116715|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370471|NCT03329248|Paclitaxel|paclitaxel|mesh-list
154370472|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
154370473|NCT03329248|Bevacizumab|bevacizumab|mesh-list
154370474|NCT03329248|Capecitabine|capecitabine|mesh-list
154370475|NCT03329248|Fluorouracil|fluorouracil|mesh-list
154370476|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
154370477|NCT03329248|Avelumab|avelumab|mesh-list
154370478|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154370479|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370480|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
154370481|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
154370482|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
154370483|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370484|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154370485|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
154370486|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370487|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154370488|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154370489|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
154370490|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154370491|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370492|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154370493|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154370494|NCT03329248|Growth Substances|growth substances|mesh-ancestor
154370495|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
154370496|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154370497|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
154370498|NCT03329248|Antidotes|antidotes|mesh-ancestor
154370499|NCT03329248|Protective Agents|protective agents|mesh-ancestor
154370500|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
154370501|NCT03329248|Vitamins|vitamins|mesh-ancestor
154370502|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
154370503|NCT03792971|Levomethorphan|levomethorphan|mesh-list
154370504|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
154370505|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
154370506|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
154370507|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
154370523|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154370524|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
154370525|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370526|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370527|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154370528|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154370529|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
154370530|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370531|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154370532|NCT02496754|Hormones|hormones|mesh-ancestor
154370533|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154861985|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154861986|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154861987|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154861988|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154861989|NCT00951899|Metformin|metformin|mesh-list
154861990|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154861991|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154861992|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154861993|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154861994|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154861995|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
154370534|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370536|NCT02496910|Telmisartan|telmisartan|mesh-list
154370537|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
154370538|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154370539|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154370540|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154370541|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154370542|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370543|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154370544|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370545|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
154370546|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154370547|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154370548|NCT02496910|Diuretics|diuretics|mesh-ancestor
154370549|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
154370550|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154370551|NCT03342352|Carboplatin|carboplatin|mesh-list
154370552|NCT03342352|Fluorouracil|fluorouracil|mesh-list
154370553|NCT03342352|Nivolumab|nivolumab|mesh-list
154370554|NCT03342352|Cetuximab|cetuximab|mesh-list
154370555|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370556|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
154370557|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370558|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154370559|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154370560|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
154370561|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370562|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370563|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154370564|NCT03120442|Fentanyl|fentanyl|mesh-list
154370565|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
154370589|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154370590|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
154370591|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370592|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370593|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370594|NCT00852696|Urological Agents|urological agents|mesh-ancestor
154370595|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154370596|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154370597|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370598|NCT03324490|Fentanyl|fentanyl|mesh-list
154370599|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
154370600|NCT03324490|Bupivacaine|bupivacaine|mesh-list
154370601|NCT03324490|Anesthetics|anesthetics|mesh-list
154370602|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154370603|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370604|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370605|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
154370606|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370607|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154370608|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154370609|NCT03324490|Analgesics|analgesics|mesh-ancestor
154370610|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154370611|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154370612|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154370613|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
154370614|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370615|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622809|NCT05967377|Vitamins|vitamins|mesh-ancestor
154370623|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
154370624|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
154370625|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370626|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370627|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
154370628|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370629|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370630|NCT03274661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154370631|NCT03274661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370632|NCT03798821|Sulfalene|sulfalene|mesh-list
154370633|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215296|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
154370634|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154370635|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
154370636|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154370637|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154370638|NCT03324334|Antibodies|antibodies|mesh-list
154370639|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
154370640|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370641|NCT03792815|Etoposide|etoposide|mesh-list
154370642|NCT03792815|Melphalan|melphalan|mesh-list
154370643|NCT03792815|Busulfan|busulfan|mesh-list
154370644|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154370645|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370646|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154370647|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154370648|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370649|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370650|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154370651|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
154370652|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154370653|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154370654|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
154370655|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370656|NCT04381364|Ciclesonide|ciclesonide|mesh-list
154370657|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
154370658|NCT04381364|Hormones|hormones|mesh-ancestor
154370659|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370660|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370661|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154370662|NCT01331382|Resveratrol|resveratrol|mesh-list
154370663|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
154370664|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370665|NCT01331382|Protective Agents|protective agents|mesh-ancestor
154370666|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370667|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370668|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154370669|NCT03794765|Metronidazole|metronidazole|mesh-list
154370670|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
154370671|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370672|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154370673|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154370674|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154370675|NCT03794765|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154370676|NCT03794765|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154370677|NCT02496286|Bevacizumab|bevacizumab|mesh-list
154370678|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370679|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370680|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154370681|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154370682|NCT02496286|Growth Substances|growth substances|mesh-ancestor
154370683|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370684|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
154370685|NCT01489176|Regadenoson|regadenoson|mesh-list
154370696|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370697|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370699|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154370700|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154370701|NCT03794843|Nimodipine|nimodipine|mesh-list
154370702|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154370703|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154370704|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154370705|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370706|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154370707|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370708|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
154370709|NCT01333800|Ciclesonide|ciclesonide|mesh-list
154370710|NCT01333800|Beclomethasone|beclomethasone|mesh-list
154370711|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370712|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
154370713|NCT01333800|Hormones|hormones|mesh-ancestor
154370714|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370715|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370716|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154370717|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
154370718|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154370719|NCT04494100|Lidocaine|lidocaine|mesh-list
154370720|NCT04494100|Epinephrine|epinephrine|mesh-list
154370721|NCT04494100|Ropivacaine|ropivacaine|mesh-list
154370722|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
154370723|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
154370724|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370725|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370726|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
154370727|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370728|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154370729|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154370730|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154370731|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154370732|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370733|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154370734|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154370735|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
154370736|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370737|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154370738|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154370739|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
154370740|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154370741|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
154370742|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
154370743|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
154370744|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154370745|NCT01333878|Abatacept|abatacept|mesh-list
154370746|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154370747|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370748|NCT01333878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370749|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370785|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154370786|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154370787|NCT03323710|Growth Substances|growth substances|mesh-ancestor
153622988|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154370821|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370822|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154370823|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154370824|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154370825|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370826|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370828|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154370829|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
153623052|NCT05474560|Febuxostat|febuxostat|mesh-list
154370846|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370847|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215388|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
154370848|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154370849|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154370850|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154370851|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154370852|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154370853|NCT04697186|Antacids|antacids|mesh-ancestor
154370854|NCT02488642|Isosorbide|isosorbide|mesh-list
154370855|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154370856|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154370857|NCT02488642|Misoprostol|misoprostol|mesh-list
154370858|NCT02488642|Oxytocin|oxytocin|mesh-list
154370859|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
154370860|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154370861|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370862|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154370863|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
154370864|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154370865|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154370866|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154370867|NCT02488642|Diuretics|diuretics|mesh-ancestor
154370868|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
154370869|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
154370870|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154370871|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370872|NCT02488486|Remifentanil|remifentanil|mesh-list
154370873|NCT02488486|Propofol|propofol|mesh-list
154370874|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154370875|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370876|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370877|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154370878|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
154370879|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
154370880|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154370881|NCT02488486|Narcotics|narcotics|mesh-ancestor
154370882|NCT02488486|Analgesics|analgesics|mesh-ancestor
154370883|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
154370884|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370885|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
154370886|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370887|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
154370888|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370889|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370890|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154370891|NCT03327766|Calcifediol|calcifediol|mesh-list
154370911|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370912|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370913|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154370914|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
154215463|NCT00377858|Insulin|insulin|mesh-list
154370915|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154370916|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370917|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370918|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
154370919|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154370920|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370921|NCT03050060|Nelfinavir|nelfinavir|mesh-list
154370922|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
154370923|NCT03050060|Nivolumab|nivolumab|mesh-list
154370924|NCT03050060|Atezolizumab|atezolizumab|mesh-list
154370925|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154370926|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370927|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370928|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154370929|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370931|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370932|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154370933|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154370934|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
154370935|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370936|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154370937|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154370938|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
154370939|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370940|NCT01334112|Axitinib|axitinib|mesh-list
154370941|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370942|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154370943|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370944|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370945|NCT03791957|Chrysarobin|chrysarobin|mesh-list
154370946|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154370947|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154370948|NCT03791957|Analgesics|analgesics|mesh-ancestor
154370959|NCT03792113|Coagulants|coagulants|mesh-ancestor
154370960|NCT01304927|Vitamin D|vitamin d|mesh-list
154370961|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
154370962|NCT01304927|Calcium|calcium|mesh-list
154370963|NCT01304927|Vitamins|vitamins|mesh-ancestor
154370964|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
154370965|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370966|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154370967|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154370968|NCT05464940|Caffeine|caffeine|mesh-list
154370969|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154370970|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370971|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154370972|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370973|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370974|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154370975|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154370976|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
154370977|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370978|NCT01305551|Metformin|metformin|mesh-list
154370979|NCT01305551|Saxagliptin|saxagliptin|mesh-list
154370980|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154370981|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370982|NCT01305551|Incretins|incretins|mesh-ancestor
154370983|NCT01305551|Hormones|hormones|mesh-ancestor
154370984|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370985|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154370986|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
154370987|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370988|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370989|NCT03799757|Bupivacaine|bupivacaine|mesh-list
154370990|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
154370991|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
154370992|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370993|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370994|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
154370995|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370996|NCT03327454|Etanercept|etanercept|mesh-list
154370997|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154370998|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154370999|NCT03327454|Analgesics|analgesics|mesh-ancestor
154371000|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
154371001|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371002|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371003|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371004|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371005|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154371006|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371007|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
154371008|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
154371010|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371011|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
154371012|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371013|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371014|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154371015|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
154371026|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371027|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371028|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154371029|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154371030|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371031|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371032|NCT03799601|Carboplatin|carboplatin|mesh-list
154371033|NCT03799601|Docetaxel|docetaxel|mesh-list
154371034|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371035|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
154371036|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
154371037|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
154371038|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371039|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
154371040|NCT03791801|Rocuronium|rocuronium|mesh-list
154371041|NCT03791801|Neostigmine|neostigmine|mesh-list
154215561|NCT00376688|Sirolimus|sirolimus|mesh-list
154371042|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154371043|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154371044|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154371045|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371046|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371047|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154371048|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371049|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371050|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
154371051|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371052|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154371053|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
154371054|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154371055|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154371056|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154371057|NCT01305083|Udenafil|udenafil|mesh-list
154371058|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154371059|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154371060|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371061|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371062|NCT03791723|Valsartan|valsartan|mesh-list
154371063|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154371064|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154371065|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154371066|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154371067|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371068|NCT05452070|Lidocaine|lidocaine|mesh-list
154371069|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
154371070|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
154371071|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371072|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371073|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
154371074|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371075|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154371076|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154371077|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154371095|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154371096|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
154371097|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371098|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371100|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154371101|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154371102|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371103|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154371104|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154371105|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154371106|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154371107|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154371108|NCT02487706|Dolutegravir|dolutegravir|mesh-list
154371109|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154371110|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154371111|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371112|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371113|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154371114|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154371115|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
154371116|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371117|NCT03326752|Nivolumab|nivolumab|mesh-list
154371118|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154371119|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154371120|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371121|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371122|NCT03326674|Capecitabine|capecitabine|mesh-list
154371123|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154371124|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
154371125|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371126|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371127|NCT01316900|Bromides|bromides|mesh-list
154371128|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
154371129|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154371130|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
154371131|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623311|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371143|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154371144|NCT02490982|Analgesics|analgesics|mesh-ancestor
154371145|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
154117393|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154371146|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371147|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371148|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371149|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371150|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371151|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
154371153|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
154371154|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154371155|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154371156|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154371157|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
154371158|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371159|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371160|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154371161|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
154371162|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
154371163|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
154371164|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154371165|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154371166|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
154371167|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371168|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371169|NCT03499873|Nepafenac|nepafenac|mesh-list
154371170|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154371171|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154371172|NCT03499873|Analgesics|analgesics|mesh-ancestor
154371173|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
154371174|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371175|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371176|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371177|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371178|NCT01305707|Diazepam|diazepam|mesh-list
154371179|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154371180|NCT01305707|Lorazepam|lorazepam|mesh-list
154371181|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
154371182|NCT01305707|Dexetimide|dexetimide|mesh-list
154371183|NCT01305707|Olanzapine|olanzapine|mesh-list
154371184|NCT01305707|Risperidone|risperidone|mesh-list
154371185|NCT01305707|Aripiprazole|aripiprazole|mesh-list
154371186|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154371187|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
154371188|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
154371189|NCT01305707|Mirtazapine|mirtazapine|mesh-list
154371190|NCT01305707|Citalopram|citalopram|mesh-list
154371191|NCT01305707|Sertraline|sertraline|mesh-list
154371192|NCT01305707|Fluoxetine|fluoxetine|mesh-list
154371193|NCT01305707|Paroxetine|paroxetine|mesh-list
154371194|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154371195|NCT01305707|Nortriptyline|nortriptyline|mesh-list
154371196|NCT01305707|Imipramine|imipramine|mesh-list
154371197|NCT01305707|Clomipramine|clomipramine|mesh-list
154371210|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
154371211|NCT01305707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154371212|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154371213|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371214|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154371215|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154371216|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
154371217|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
154371218|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371219|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154371220|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154371221|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
154371222|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154371223|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
154371224|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154371225|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
154371226|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154371227|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154371228|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154371229|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154371230|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154371232|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
154371233|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154371234|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154371235|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371236|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
154371237|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
154371238|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154371239|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154371240|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
154371241|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
154371242|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154371243|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
154371244|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
154371245|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154215708|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
154371246|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154371247|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154371248|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
154371249|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154371250|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154371251|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154371252|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154371253|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154371254|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
154371255|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
154371256|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154371257|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154371258|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154371259|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
154371260|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371280|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154371281|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371282|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154371283|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154371284|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154371287|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154371288|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371289|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154371290|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371291|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371292|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154371293|NCT03794297|Protective Agents|protective agents|mesh-ancestor
154371294|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371295|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154371296|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
154371297|NCT03048500|Metformin|metformin|mesh-list
154371298|NCT03048500|Nivolumab|nivolumab|mesh-list
154371299|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154371300|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371301|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154371302|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371303|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154371304|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371305|NCT03790787|Empagliflozin|empagliflozin|mesh-list
154371306|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154371307|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371308|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154371309|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371310|NCT01334268|Paclitaxel|paclitaxel|mesh-list
154371311|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154371312|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371313|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154371314|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154371315|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154371316|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371317|NCT04493398|Erythritol|erythritol|mesh-list
154371325|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154371326|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
154371327|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371328|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154371329|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154371330|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371331|NCT02613416|Denosumab|denosumab|mesh-list
154371332|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154371333|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371334|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
154371335|NCT03326050|Rifampin|rifampin|mesh-list
154371336|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
154371337|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154371338|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371339|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154371340|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154371341|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371342|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371343|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371344|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154371345|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154371346|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154371347|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
154371348|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
154371349|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154371350|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154371351|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154371352|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154371353|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154371354|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154371355|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154371356|NCT01334424|Propofol|propofol|mesh-list
154371357|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154371358|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371359|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371360|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154371361|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
154371362|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
154371363|NCT05664685|Bismuth|bismuth|mesh-list
154371364|NCT05664685|Antacids|antacids|mesh-ancestor
154371365|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371366|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154371367|NCT03793517|Decitabine|decitabine|mesh-list
154371368|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154371369|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
154371370|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371371|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371372|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371373|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
154371374|NCT02886702|Tazarotene|tazarotene|mesh-list
154371375|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
154371376|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
154371377|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
154371378|NCT02886702|Vitamins|vitamins|mesh-ancestor
154371379|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
154371380|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371381|NCT03498313|Estradiol|estradiol|mesh-list
154371382|NCT03498313|Progesterone|progesterone|mesh-list
154371383|NCT03498313|Estrogens|estrogens|mesh-ancestor
154371384|NCT03498313|Hormones|hormones|mesh-ancestor
153623548|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154371396|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154371397|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154371398|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371399|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371400|NCT04493554|Vasopressins|vasopressins|mesh-list
154371401|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
154371402|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
154371403|NCT04493554|Coagulants|coagulants|mesh-ancestor
154371404|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154371405|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154371406|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
154371407|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371408|NCT02601014|Nivolumab|nivolumab|mesh-list
154371409|NCT02601014|Ipilimumab|ipilimumab|mesh-list
154371410|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154371411|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371412|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154371413|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371414|NCT01307046|Losartan|losartan|mesh-list
154371415|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154371416|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154371417|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154371418|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154371419|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371420|NCT05419115|Furosemide|furosemide|mesh-list
154371421|NCT05419115|Diuretics|diuretics|mesh-ancestor
154371422|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
154371423|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371424|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154371425|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371426|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371427|NCT02490592|Fluorides|fluorides|mesh-list
154371428|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
154371429|NCT02490592|Protective Agents|protective agents|mesh-ancestor
154371430|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371431|NCT03075462|Apatinib|apatinib|mesh-list
154371432|NCT03075462|Fluzoparib|fluzoparib|mesh-list
154371433|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371434|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154371435|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371436|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371437|NCT03075462|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154371438|NCT01305395|Sirolimus|sirolimus|mesh-list
154371439|NCT01305395|Temsirolimus|temsirolimus|mesh-list
154371440|NCT01305395|MTOR Inhibitors|mtor inhibitors|mesh-list
154371441|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154371442|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371443|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154371444|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371445|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
154371446|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371465|NCT03318718|Rocuronium|rocuronium|mesh-list
154371466|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371467|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154371468|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154371469|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154215896|NCT03989024|Hormones|hormones|mesh-ancestor
154371470|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371471|NCT03325348|Labetalol|labetalol|mesh-list
154371472|NCT03325348|Nifedipine|nifedipine|mesh-list
154371473|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154371474|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371475|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371476|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154371477|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371478|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
154371479|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
154371480|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154371481|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154371482|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154371483|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
154371484|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371485|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154371486|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
154371487|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
154371488|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371489|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154371490|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154371491|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
154371492|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
154371493|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
154371494|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371495|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371496|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
154371497|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371498|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
154371499|NCT03325270|Trace Elements|trace elements|mesh-ancestor
154371500|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
154371501|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371513|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371515|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371516|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371517|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154371518|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
154371519|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371520|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371521|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154371522|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154371523|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154371524|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154371525|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154371526|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371527|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371528|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
154371529|NCT01334502|Hormones|hormones|mesh-ancestor
154371530|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154371531|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154371532|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154371533|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
154371534|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
154371535|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
154371536|NCT01334502|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154371537|NCT01334502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154371538|NCT02487082|Melatonin|melatonin|mesh-list
154371539|NCT02487082|Donepezil|donepezil|mesh-list
154371540|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
154371541|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371542|NCT02487082|Protective Agents|protective agents|mesh-ancestor
154371543|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371544|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371545|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154371546|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371547|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
154371548|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371549|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
154371551|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154371552|NCT03788681|Estradiol|estradiol|mesh-list
154371553|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154371554|NCT03788681|Estrogens|estrogens|mesh-ancestor
154371555|NCT03788681|Hormones|hormones|mesh-ancestor
154371556|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154371557|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371558|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154371559|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
154371560|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154371561|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154371562|NCT03790085|Olanzapine|olanzapine|mesh-list
154371563|NCT03790085|Risperidone|risperidone|mesh-list
154371564|NCT03790085|Aripiprazole|aripiprazole|mesh-list
154371565|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154371566|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
154371567|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371581|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154371582|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371583|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
154371584|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
154371585|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154371586|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154371587|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154371588|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154371590|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
154371591|NCT01306097|Trace Elements|trace elements|mesh-ancestor
154371592|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
154371593|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371594|NCT01306097|Astringents|astringents|mesh-ancestor
154371595|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
154371596|NCT03790007|Bupivacaine|bupivacaine|mesh-list
154371597|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
154371598|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
154371599|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371600|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371601|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
154371602|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371603|NCT03789695|Dabigatran|dabigatran|mesh-list
154371604|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
154371605|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154371606|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
154371607|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371608|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371609|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
154371610|NCT00739674|Losartan|losartan|mesh-list
154371611|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154371612|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
154371613|NCT00739674|Calcium|calcium|mesh-list
154371614|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154371615|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371616|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154371617|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154371618|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154371619|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154371620|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371621|NCT00739674|Diuretics|diuretics|mesh-ancestor
154371622|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
154371623|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154371624|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371625|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
154371626|NCT01306409|Hematinics|hematinics|mesh-ancestor
154371627|NCT01331928|Docetaxel|docetaxel|mesh-list
154371628|NCT01331928|Capecitabine|capecitabine|mesh-list
154371657|NCT00400218|Losartan|losartan|mesh-list
154371658|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154371659|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154371660|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154371661|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154371662|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154371663|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371664|NCT00400218|Diuretics|diuretics|mesh-ancestor
154371665|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
154371666|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371667|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154371668|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371669|NCT02486848|Minoxidil|minoxidil|mesh-list
154371670|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154371671|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154371672|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
154371673|NCT01306565|Atorvastatin|atorvastatin|mesh-list
154371674|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154371675|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154371677|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371694|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154371695|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371696|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371697|NCT01334892|Cyclosporine|cyclosporine|mesh-list
154371698|NCT01334892|Cyclosporins|cyclosporins|mesh-list
154371699|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371700|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371701|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371702|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
154371703|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371704|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
154371705|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371706|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
154371707|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371708|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154371709|NCT04730219|Paclitaxel|paclitaxel|mesh-list
154371710|NCT04730219|Tislelizumab|tislelizumab|mesh-list
154371711|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154371712|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371713|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
154371714|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
154371715|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
154371716|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371717|NCT04730219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154371718|NCT04492774|Dexamethasone|dexamethasone|mesh-list
154371719|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371720|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
154371721|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
154371722|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371723|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371724|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154371725|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
154371726|NCT04492774|Hormones|hormones|mesh-ancestor
154371727|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154371728|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154371729|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371730|NCT03321292|Aspirin|aspirin|mesh-list
154371731|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154371732|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154371733|NCT03321292|Analgesics|analgesics|mesh-ancestor
154371734|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
154371735|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371736|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371756|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371758|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154371759|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
154371760|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371761|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154371762|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
154371763|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
154371764|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154371765|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154371766|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
154371767|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
154371768|NCT01337466|Fialuridine|fialuridine|mesh-list
154371769|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
154371770|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371771|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154371772|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371773|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371774|NCT02486926|Remifentanil|remifentanil|mesh-list
154861996|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371775|NCT02486926|Alfentanil|alfentanil|mesh-list
154371776|NCT02486926|Thiopental|thiopental|mesh-list
154371777|NCT02486926|Sevoflurane|sevoflurane|mesh-list
154371778|NCT02486926|Rocuronium|rocuronium|mesh-list
154371779|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154371780|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154371781|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
154371782|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
154371783|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371784|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371785|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154371786|NCT02486926|Narcotics|narcotics|mesh-ancestor
154371787|NCT02486926|Analgesics|analgesics|mesh-ancestor
154371788|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
154371789|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371790|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154371791|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153623964|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
154371795|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154371796|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
154371797|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
154371798|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371799|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371800|NCT01335048|Clopidogrel|clopidogrel|mesh-list
154371801|NCT01335048|Atorvastatin|atorvastatin|mesh-list
154371802|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154371803|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154371804|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
154371805|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371806|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154371807|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154371808|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371809|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154371810|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154371811|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154371812|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154371813|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
154371814|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371815|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371816|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
154371817|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154371818|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154371819|NCT01567475|Rituximab|rituximab|mesh-list
154371820|NCT01567475|Everolimus|everolimus|mesh-list
154371821|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154371822|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371823|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
154371824|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371825|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371826|NCT01567475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154371827|NCT01567475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154371828|NCT01567475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371829|NCT01567475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371830|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371831|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
154371832|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154371833|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
154371834|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
154371835|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371836|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371837|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154371838|NCT03435055|Analgesics|analgesics|mesh-ancestor
154371839|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
154371840|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371841|NCT03316066|Ropivacaine|ropivacaine|mesh-list
154371842|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
154371843|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
154371844|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371845|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371846|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
154371847|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371848|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
154371849|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371850|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
154371851|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371852|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731547|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
154371853|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154371854|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
154371855|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371856|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371857|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154371858|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154371859|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154371860|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154371861|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371862|NCT01335360|Nevirapine|nevirapine|mesh-list
154371872|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154371873|NCT02489266|Aldesleukin|aldesleukin|mesh-list
154371874|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
154371875|NCT02489266|Fludarabine|fludarabine|mesh-list
154371876|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371877|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
154371878|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371879|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371880|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154371881|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
154371882|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371883|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371884|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154371885|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154371886|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154371887|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
154371888|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371889|NCT03434119|Insulin|insulin|mesh-list
154371890|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154371891|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
154371892|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154371893|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371894|NCT02484352|Oxycodone|oxycodone|mesh-list
154371895|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154371896|NCT02484352|Narcotics|narcotics|mesh-ancestor
154371897|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371898|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371899|NCT02484352|Analgesics|analgesics|mesh-ancestor
154371900|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
154371901|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371902|NCT01308671|Varenicline|varenicline|mesh-list
154371903|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154371904|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154371905|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
154371906|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371907|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371908|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371909|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
154371910|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371911|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
154371912|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154371913|NCT03315676|Esomeprazole|esomeprazole|mesh-list
154371914|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154371915|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154371916|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154371917|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371918|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371919|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
154371920|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154371921|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
154371922|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371923|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371924|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154371925|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
154371926|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
154371927|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154371928|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
154371937|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371938|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154371939|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371941|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154371942|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154371943|NCT05694923|Empagliflozin|empagliflozin|mesh-list
154861997|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154255501|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
154371944|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154371945|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371946|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154371947|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371948|NCT01332396|Lapatinib|lapatinib|mesh-list
154371949|NCT01332396|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154371950|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154371951|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371952|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371953|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371954|NCT03719053|Tenofovir|tenofovir|mesh-list
154371955|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
154371956|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371957|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154371958|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154371959|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371960|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371961|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154371962|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154371963|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154371964|NCT03526848|Antibodies|antibodies|mesh-list
154371965|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
154371966|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154371967|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
154371968|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371969|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371970|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154371971|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
154371972|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371973|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154371974|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154371975|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
154371976|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371977|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371978|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154371979|NCT01332552|Ritonavir|ritonavir|mesh-list
154371980|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154371981|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154371982|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
154371983|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216292|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
154371984|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371985|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154371986|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154371987|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
154371988|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371989|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154371990|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154371991|NCT03720223|Bupivacaine|bupivacaine|mesh-list
154371992|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
154371993|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
154371994|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371995|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371996|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
154372013|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154372014|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
154372015|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372016|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154372017|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154372018|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372020|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372021|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372022|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372023|NCT03317548|Progesterone|progesterone|mesh-list
154372024|NCT03317548|Progestins|progestins|mesh-ancestor
154372025|NCT03317548|Hormones|hormones|mesh-ancestor
154372026|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372027|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372028|NCT00092586|Ezetimibe|ezetimibe|mesh-list
154372029|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154372030|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154861998|NCT01097395|Ribavirin|ribavirin|mesh-list
154861999|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
154255502|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
154372031|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
154372032|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372033|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154372035|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154372036|NCT03786887|Narcotics|narcotics|mesh-ancestor
154372037|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372038|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372039|NCT03786887|Analgesics|analgesics|mesh-ancestor
154372040|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
154216365|NCT00346034|Pregabalin|pregabalin|mesh-list
154372041|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372042|NCT03787043|Metformin|metformin|mesh-list
154372043|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154372044|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372045|NCT00090168|Atorvastatin|atorvastatin|mesh-list
154372046|NCT00090168|Simvastatin|simvastatin|mesh-list
154372047|NCT00090168|Ezetimibe|ezetimibe|mesh-list
154372048|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154372049|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154372050|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
154372051|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372052|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154372053|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154372070|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
154372071|NCT01338090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154372072|NCT01338090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154372073|NCT01338090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372074|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372075|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372076|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
154372077|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154372078|NCT01307969|Lidocaine|lidocaine|mesh-list
154372079|NCT01307969|Epinephrine|epinephrine|mesh-list
154372080|NCT01307969|Racepinephrine|racepinephrine|mesh-list
154372081|NCT01307969|Ropivacaine|ropivacaine|mesh-list
154372082|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
154372083|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
154372084|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
154372085|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372086|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372087|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
154372088|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372089|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154372090|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154372091|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154372092|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372093|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372094|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154372095|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154372096|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
154372097|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372098|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154372099|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154372100|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
154372101|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154372102|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
154372103|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
154372104|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
154372105|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154372106|NCT03786419|Atezolizumab|atezolizumab|mesh-list
154372107|NCT03786419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154372108|NCT03786419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372109|NCT03786419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154372110|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372111|NCT01338324|Simvastatin|simvastatin|mesh-list
154372112|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154372119|NCT01336062|Paclitaxel|paclitaxel|mesh-list
154372120|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154372121|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154372122|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372123|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
154372124|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154372125|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
154862000|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372126|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372127|NCT05694221|Metformin|metformin|mesh-list
154372128|NCT05694221|Digoxin|digoxin|mesh-list
154372129|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154372130|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372131|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154372132|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154372133|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372134|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372135|NCT05694221|Protective Agents|protective agents|mesh-ancestor
154372136|NCT01308047|Bupivacaine|bupivacaine|mesh-list
154372137|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
154372138|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
154372139|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372140|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372141|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
154372142|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372143|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
154372144|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
154372145|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
154372146|NCT03777761|Tucatinib|tucatinib|mesh-list
154372147|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154372148|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372149|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154372150|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154372151|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372152|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372153|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372154|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154372155|NCT01316861|Acarbose|acarbose|mesh-list
154372156|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154372157|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372158|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372159|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154372160|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372161|NCT01336218|Rifampin|rifampin|mesh-list
154372162|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154372163|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
154372164|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154372165|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372166|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
154372167|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154372168|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372169|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372170|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154372171|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154372172|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154372173|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154372174|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154372175|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154372176|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154372177|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372178|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154372192|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372193|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372194|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372195|NCT03775655|Analgesics|analgesics|mesh-ancestor
154372196|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
154372197|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372198|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154372199|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154372200|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154372201|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
154372202|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372203|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372204|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
154372205|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154372206|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372207|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
154372208|NCT03781895|Vitamin D|vitamin d|mesh-list
154372209|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154372210|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255503|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
154255504|NCT03905564|Vitamins|vitamins|mesh-ancestor
154372211|NCT03781895|Vitamins|vitamins|mesh-ancestor
154372212|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
154372213|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154372214|NCT00706030|Vinorelbine|vinorelbine|mesh-list
154372215|NCT00706030|Neratinib|neratinib|mesh-list
154372216|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154372217|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372218|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154372219|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154372220|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154372221|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372222|NCT00706030|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154372223|NCT00706030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154372224|NCT00706030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372225|NCT03781505|Acetaminophen|acetaminophen|mesh-list
154372226|NCT03781505|Ropivacaine|ropivacaine|mesh-list
154372227|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
154372228|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
154372229|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372230|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372231|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
154372232|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372233|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372234|NCT03781505|Analgesics|analgesics|mesh-ancestor
154372235|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
154372236|NCT03781115|Olanzapine|olanzapine|mesh-list
154372237|NCT03781115|Ziprasidone|ziprasidone|mesh-list
154372238|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
154372239|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
154372240|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372260|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154372261|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372262|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372263|NCT01313429|Celecoxib|celecoxib|mesh-list
154372264|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
154372265|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372266|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
154372267|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372268|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372269|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154372270|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
154372271|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372272|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372273|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154372274|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154372275|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372277|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
154372278|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372279|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372280|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154372281|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154372282|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372283|NCT03488251|Gemcitabine|gemcitabine|mesh-list
154372284|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
154372285|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154372286|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
154372287|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372288|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372289|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
154372290|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154372291|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372292|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154372293|NCT03315520|Cytarabine|cytarabine|mesh-list
154372294|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
154372295|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154372332|NCT03487549|Cantharidin|cantharidin|mesh-list
154372333|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372338|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
154372339|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372340|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372341|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154372342|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
154372343|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
154862001|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
154862002|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372344|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154372345|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154372346|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154372347|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154372348|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
154372349|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372350|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372351|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372352|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
154372353|NCT01313585|Hormones|hormones|mesh-ancestor
154372354|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372355|NCT01561235|Hormones|hormones|mesh-list
154372356|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372357|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372358|NCT02485990|Olaparib|olaparib|mesh-list
154372359|NCT02485990|Tremelimumab|tremelimumab|mesh-list
154372360|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154372361|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372362|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372363|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372364|NCT01313819|Amantadine|amantadine|mesh-list
154372365|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154372366|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154372367|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
154372368|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372369|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
154372370|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372371|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372372|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372373|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372374|NCT01313819|Analgesics|analgesics|mesh-ancestor
154372375|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
154372376|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372377|NCT03315442|Caffeine|caffeine|mesh-list
154372378|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154372379|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372380|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154372381|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372382|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372383|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154372384|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154372385|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
154372386|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372387|NCT03464383|Escitalopram|escitalopram|mesh-list
154372388|NCT03464383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154372389|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154372390|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372391|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372392|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372393|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
154372394|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372395|NCT03779633|Estradiol|estradiol|mesh-list
154372396|NCT03779633|Estrogens|estrogens|mesh-ancestor
154372397|NCT03779633|Hormones|hormones|mesh-ancestor
154372398|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372399|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372400|NCT03720067|Propranolol|propranolol|mesh-list
154372401|NCT03720067|Carvedilol|carvedilol|mesh-list
153624562|NCT02008019|Everolimus|everolimus|mesh-list
154372420|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154372421|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372422|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154216608|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154372423|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154372424|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154372426|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372427|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154372428|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
154372429|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372430|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372431|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154372432|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
154372433|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
154372434|NCT01444092|Hormones|hormones|mesh-ancestor
154255505|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
154372435|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372436|NCT03719989|Azacitidine|azacitidine|mesh-list
154372437|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154372438|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
154372439|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372440|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372441|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372442|NCT05462470|Liver Extracts|liver extracts|mesh-list
154372443|NCT05462470|Hematinics|hematinics|mesh-ancestor
154372444|NCT01265784|Ertapenem|ertapenem|mesh-list
154372445|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154372446|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372447|NCT03774953|Vitamins|vitamins|mesh-list
154372448|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
154372449|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372450|NCT02483026|Vitamin D|vitamin d|mesh-list
154372451|NCT02483026|Vitamins|vitamins|mesh-list
154372452|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
154372453|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372454|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154372455|NCT02483104|Paclitaxel|paclitaxel|mesh-list
154372456|NCT02483104|Carboplatin|carboplatin|mesh-list
154372481|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372482|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372483|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154372484|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154372485|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372486|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154372487|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154372488|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372489|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
154372490|NCT05185518|Insulin|insulin|mesh-list
154372491|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154372492|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372493|NCT03316690|Metformin|metformin|mesh-list
154372494|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154372495|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372496|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
154372497|NCT03315052|Prednisone|prednisone|mesh-list
154372498|NCT03315052|Budesonide|budesonide|mesh-list
154372499|NCT03315052|Tacrolimus|tacrolimus|mesh-list
154372500|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372501|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
154372502|NCT03315052|Hormones|hormones|mesh-ancestor
154372503|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372504|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372505|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153624696|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
154372512|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154372513|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154372515|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154372516|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372517|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154372518|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
154372519|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372520|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154372521|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
154372522|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
154372523|NCT03778619|Rituximab|rituximab|mesh-list
154372524|NCT03778619|Fludarabine|fludarabine|mesh-list
154372525|NCT03778619|Interleukin-2|interleukin-2|mesh-list
154372526|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372527|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
154372528|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372529|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372530|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154372531|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
154372532|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372533|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372534|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154372535|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154372536|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372537|NCT03778619|Analgesics|analgesics|mesh-ancestor
154372538|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
154372539|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372540|NCT05714176|Lactoferrin|lactoferrin|mesh-list
154862003|NCT00467987|Testosterone|testosterone|mesh-list
154372541|NCT05714176|Dextrans|dextrans|mesh-list
154372542|NCT05714176|Iron-Dextran Complex|iron-dextran complex|mesh-list
154372543|NCT05714176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372544|NCT05714176|Anticoagulants|anticoagulants|mesh-ancestor
154372545|NCT05714176|Plasma Substitutes|plasma substitutes|mesh-ancestor
154372546|NCT05714176|Blood Substitutes|blood substitutes|mesh-ancestor
154372547|NCT05714176|Hematinics|hematinics|mesh-ancestor
154372548|NCT03156504|Ketamine|ketamine|mesh-list
154372549|NCT03156504|Analgesics|analgesics|mesh-ancestor
154372550|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
154372551|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372552|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372553|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154372554|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154372555|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
154372556|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
154372557|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372558|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154372559|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154372560|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372561|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372562|NCT01333332|Capecitabine|capecitabine|mesh-list
154372563|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154372564|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
154372565|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372566|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372567|NCT03316534|Aspirin|aspirin|mesh-list
154372568|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154372569|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372570|NCT03316534|Analgesics|analgesics|mesh-ancestor
154372571|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
154372572|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372573|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372590|NCT04476420|Hormones|hormones|mesh-ancestor
154372591|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372592|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372593|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154372594|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
154372595|NCT03778541|Temozolomide|temozolomide|mesh-list
154372596|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154372597|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
154372598|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372599|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372600|NCT02479828|Ropivacaine|ropivacaine|mesh-list
154372601|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
154372602|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
154372603|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372604|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372605|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
154372606|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372607|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
154372608|NCT01320449|Hematinics|hematinics|mesh-ancestor
154372609|NCT03430063|Ipilimumab|ipilimumab|mesh-list
154372610|NCT03430063|Cemiplimab|cemiplimab|mesh-list
154372611|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154372612|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372613|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154372614|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372615|NCT03158220|Vaccines|vaccines|mesh-list
154372616|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
154372617|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372618|NCT01308983|Amiloride|amiloride|mesh-list
154372619|NCT01308983|Diuretics|diuretics|mesh-ancestor
154372620|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
154372621|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372622|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154372623|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154372624|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372625|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372626|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154372627|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154372628|NCT01336842|Pemetrexed|pemetrexed|mesh-list
154372629|NCT01336842|Panobinostat|panobinostat|mesh-list
154372630|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372631|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772522|NCT00222573|Metoprolol|metoprolol|mesh-list
154372632|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372633|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154372647|NCT03314740|Olaparib|olaparib|mesh-list
154372648|NCT03314740|Cediranib|cediranib|mesh-list
154372649|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154372650|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372651|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
154372652|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
154372653|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
154372654|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372655|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154372656|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372657|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154372658|NCT02482636|Vaccines|vaccines|mesh-list
154372659|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154372660|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
154372661|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372662|NCT02482402|Iloprost|iloprost|mesh-list
154372663|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154372664|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
154372665|NCT03774095|Pycnogenols|pycnogenols|mesh-list
154372666|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154372667|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
154372668|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372669|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
154372670|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372671|NCT03774095|Protective Agents|protective agents|mesh-ancestor
154372672|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154372673|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
154372674|NCT01333410|Tacrolimus|tacrolimus|mesh-list
154372675|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372676|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
154372677|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372678|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154372679|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372680|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372681|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372682|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
154372683|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154372684|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
154372685|NCT02482090|Fludarabine|fludarabine|mesh-list
154372686|NCT02482090|Interleukin-2|interleukin-2|mesh-list
154372687|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372688|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
154372689|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372690|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372691|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154372692|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
154372708|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372709|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154372710|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372711|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372712|NCT05185284|Remdesivir|remdesivir|mesh-list
154372713|NCT05185284|Favipiravir|favipiravir|mesh-list
154372714|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
154372715|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372716|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
154372717|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372718|NCT03784703|Atorvastatin|atorvastatin|mesh-list
154372719|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154372720|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154216835|NCT06251180|Glucocorticoids|glucocorticoids|mesh-ancestor
154372721|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154372722|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
154372723|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372724|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154372725|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154372726|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372727|NCT02724592|Fluorides|fluorides|mesh-list
154372728|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
154372729|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
154372730|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
154372731|NCT02724592|Protective Agents|protective agents|mesh-ancestor
154372732|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372733|NCT02476864|Macitentan|macitentan|mesh-list
154862004|NCT00467987|Androgens|androgens|mesh-ancestor
154372734|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154372735|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154372736|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372737|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154372738|NCT05451550|Anesthetics|anesthetics|mesh-list
154372739|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372740|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372741|NCT02476708|Curcumin|curcumin|mesh-list
154372742|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154372743|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372744|NCT02476708|Analgesics|analgesics|mesh-ancestor
154372745|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
154372746|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372747|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372748|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372749|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624952|NCT04364984|Renin Inhibitors|renin inhibitors|mesh-list
154372757|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
154372758|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
154372759|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372760|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372761|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154372762|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154372763|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154372764|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
154372765|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372766|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372767|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154372768|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372769|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154372770|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
154372771|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
154372772|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
154372773|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372774|NCT01339572|Plerixafor|plerixafor|mesh-list
154372775|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154372776|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154372777|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
154372778|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372779|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
154372780|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154372781|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
154372782|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372783|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372784|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154372785|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
154372786|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
154372787|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154372788|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
154372789|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372790|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372791|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
154372792|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
154372793|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154372794|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154372795|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372796|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372797|NCT03154476|Urological Agents|urological agents|mesh-ancestor
154372798|NCT03784391|Nifurtimox|nifurtimox|mesh-list
154372799|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154372800|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154372801|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154372802|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372803|NCT02476552|Niraparib|niraparib|mesh-list
154372804|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154372805|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372806|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372807|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372808|NCT01316718|Mesalamine|mesalamine|mesh-list
154372809|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154372810|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372811|NCT01316718|Analgesics|analgesics|mesh-ancestor
154372812|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
154862005|NCT00467987|Hormones|hormones|mesh-ancestor
154372813|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372814|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372815|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372816|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372817|NCT01316952|Carvedilol|carvedilol|mesh-list
154372831|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154372832|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154372833|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154372834|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154372835|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372836|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
154372837|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
154372838|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154372839|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
154372840|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154372841|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372842|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154372843|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154372844|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154372845|NCT03768713|Suvorexant|suvorexant|mesh-list
154372846|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154372847|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154372848|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372849|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372850|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154372851|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372852|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372853|NCT02481076|Monensin|monensin|mesh-list
154372854|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
154372855|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372856|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154372857|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154372858|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
154372859|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
154372860|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
154372861|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372862|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372863|NCT02481076|Ionophores|ionophores|mesh-ancestor
154372864|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372865|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
154372866|NCT05713396|Losartan|losartan|mesh-list
154372867|NCT05713396|Quinapril|quinapril|mesh-list
154372868|NCT05713396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154372869|NCT05713396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154372870|NCT05713396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154372871|NCT05713396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154372872|NCT05713396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372873|NCT05713396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154372874|NCT05713396|Protease Inhibitors|protease inhibitors|mesh-ancestor
154372875|NCT05713396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372876|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
154372877|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
154372893|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154372894|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
154372895|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372896|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
154372897|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372898|NCT02478424|Cyclosporine|cyclosporine|mesh-list
154372899|NCT02478424|Methotrexate|methotrexate|mesh-list
154372900|NCT02478424|Cannabidiol|cannabidiol|mesh-list
154372901|NCT02478424|Cyclosporins|cyclosporins|mesh-list
154372902|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154372903|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
154372904|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154372905|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372906|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154372907|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
154372908|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372909|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372910|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
154372911|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372912|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154372913|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372914|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
154372915|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372918|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372919|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154372920|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
154372921|NCT03712787|Tilavonemab|tilavonemab|mesh-list
154372922|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
154372923|NCT02478268|Xenon|xenon|mesh-list
154372924|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154372925|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
154372926|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
154372927|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372928|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372929|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
154372930|NCT04053881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154372931|NCT04053881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372932|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372933|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
154372934|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372935|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372936|NCT03768557|Minocycline|minocycline|mesh-list
154372937|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154372964|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154372965|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154372966|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372967|NCT03769103|Osimertinib|osimertinib|mesh-list
154372968|NCT03769103|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154372969|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154372970|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372971|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372972|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372973|NCT04998214|Thrombin|thrombin|mesh-list
154372974|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
154372975|NCT04998214|Coagulants|coagulants|mesh-ancestor
154372976|NCT01309607|Paclitaxel|paclitaxel|mesh-list
154372977|NCT01309607|Carboplatin|carboplatin|mesh-list
154372978|NCT01309607|Lapatinib|lapatinib|mesh-list
154372979|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154372980|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372981|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
154372982|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
154372983|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
154372984|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372985|NCT01309607|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154372986|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154372987|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373006|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373007|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373009|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373010|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
154373011|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154373012|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154373013|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373014|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373015|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
154373016|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373017|NCT02477956|Vitamin D|vitamin d|mesh-list
154373018|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
154373019|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
154373020|NCT02477956|Vitamins|vitamins|mesh-list
154373021|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
154373022|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373023|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154373024|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154373025|NCT02472574|Plasminogen|plasminogen|mesh-list
154373026|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154373027|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154373028|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154373029|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373030|NCT05708248|Pentoxifylline|pentoxifylline|mesh-list
154373031|NCT05708248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154373032|NCT05708248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373033|NCT05708248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373034|NCT05708248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154373035|NCT05708248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154373036|NCT05708248|Protective Agents|protective agents|mesh-ancestor
154373037|NCT05708248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373038|NCT05708248|Vasodilator Agents|vasodilator agents|mesh-ancestor
154373039|NCT05708248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154373040|NCT05708248|Antioxidants|antioxidants|mesh-ancestor
154373041|NCT03772223|Budesonide|budesonide|mesh-list
154373042|NCT03772223|Albuterol|albuterol|mesh-list
154373043|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373044|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154373045|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
154373046|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373078|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373080|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154373081|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373082|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373083|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154373084|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
154373085|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154373086|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
154373087|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154373088|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625311|NCT01163357|Sirolimus|sirolimus|mesh-list
154373108|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373109|NCT03772067|Insulin|insulin|mesh-list
154373110|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154373111|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154373112|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154373113|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373114|NCT03772067|Incretins|incretins|mesh-ancestor
154373115|NCT03772067|Hormones|hormones|mesh-ancestor
154373116|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373117|NCT03783065|Propranolol|propranolol|mesh-list
154373118|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154373119|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154373120|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
154373121|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373122|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373123|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373124|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154373125|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154373126|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
154373127|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
154373128|NCT03766997|Betamethasone|betamethasone|mesh-list
154373129|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
154373130|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373131|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
154373132|NCT03766997|Hormones|hormones|mesh-ancestor
154373133|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373134|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373135|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154373136|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
154373137|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
154373138|NCT03782831|Antibodies|antibodies|mesh-list
154373139|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
154373140|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373141|NCT03766607|Paclitaxel|paclitaxel|mesh-list
154373142|NCT03766607|Trastuzumab|trastuzumab|mesh-list
154373143|NCT03766607|Ramucirumab|ramucirumab|mesh-list
154373155|NCT03766607|Growth Inhibitors|growth inhibitors|mesh-ancestor
154373156|NCT01567709|Vorinostat|vorinostat|mesh-list
154373157|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373158|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154373159|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373160|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373161|NCT03765827|Vitamins|vitamins|mesh-list
154373162|NCT03765827|Vitamin E|vitamin e|mesh-list
154373163|NCT03765827|Tocopherols|tocopherols|mesh-list
154373164|NCT03765827|Tocotrienols|tocotrienols|mesh-list
154373165|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
154373166|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
154373167|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373168|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
154373169|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373170|NCT03765827|Protective Agents|protective agents|mesh-ancestor
154373171|NCT03771053|Simvastatin|simvastatin|mesh-list
154373172|NCT03771053|Ezetimibe|ezetimibe|mesh-list
154373173|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154373174|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154373175|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
154373176|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373177|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154373178|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154373179|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373180|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
154373181|NCT03770663|Azathioprine|azathioprine|mesh-list
154373182|NCT03770663|Tacrolimus|tacrolimus|mesh-list
154373183|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373184|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
154373185|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373186|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373187|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154373188|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
154373189|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373190|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373191|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154373192|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154373193|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373194|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
154373195|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154373196|NCT03048422|Tenofovir|tenofovir|mesh-list
154373197|NCT03048422|Emtricitabine|emtricitabine|mesh-list
154373198|NCT03048422|Efavirenz|efavirenz|mesh-list
154373199|NCT03048422|Dolutegravir|dolutegravir|mesh-list
154373200|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154373201|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154373202|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154373203|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
154373204|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373205|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154373225|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373226|NCT03770039|PF-06700841|pf-06700841|mesh-list
154373227|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154373228|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373229|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373230|NCT01321775|Paclitaxel|paclitaxel|mesh-list
154373231|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
154373232|NCT01321775|Bevacizumab|bevacizumab|mesh-list
154373233|NCT01321775|Trastuzumab|trastuzumab|mesh-list
154373234|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154373235|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373236|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
154373237|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
154373238|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
154373239|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373240|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373241|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
154373242|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373243|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373244|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154373245|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
154373246|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154373247|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154373248|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154373249|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154373250|NCT01321775|Growth Substances|growth substances|mesh-ancestor
154373251|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
154373252|NCT03764267|Lidocaine|lidocaine|mesh-list
154373253|NCT03764267|Remifentanil|remifentanil|mesh-list
154373254|NCT03764267|Anesthetics|anesthetics|mesh-list
154373255|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
154373256|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
154373257|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373258|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373287|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373288|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
154373289|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154373290|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373291|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373292|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154373293|NCT03762785|Analgesics|analgesics|mesh-ancestor
154373294|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
154373295|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373296|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154373297|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154373298|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154373299|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
154373300|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625529|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154373307|NCT03756623|Metformin|metformin|mesh-list
154373308|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154373309|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373310|NCT03756233|Remifentanil|remifentanil|mesh-list
154373311|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154373312|NCT03756233|Narcotics|narcotics|mesh-ancestor
154373313|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373314|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119558|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
154373315|NCT03756233|Analgesics|analgesics|mesh-ancestor
154373316|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
154373317|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373318|NCT03758339|Tucatinib|tucatinib|mesh-list
154373319|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373320|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154373321|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373322|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373323|NCT05085665|Ivermectin|ivermectin|mesh-list
154373324|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154373325|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373326|NCT03755609|Fentanyl|fentanyl|mesh-list
154373327|NCT03755609|Oxycodone|oxycodone|mesh-list
154373328|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154373329|NCT03755609|Narcotics|narcotics|mesh-ancestor
154373330|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373331|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373332|NCT03755609|Analgesics|analgesics|mesh-ancestor
154373333|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
154373334|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373335|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154373336|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154373337|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
154373338|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
154373339|NCT03760445|Cytarabine|cytarabine|mesh-list
154373340|NCT03760445|Posaconazole|posaconazole|mesh-list
154373341|NCT03760445|Daunorubicin|daunorubicin|mesh-list
154373342|NCT03760445|Idarubicin|idarubicin|mesh-list
154373343|NCT03760445|Midostaurin|midostaurin|mesh-list
154373344|NCT03760445|Midazolam|midazolam|mesh-list
154373345|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154373346|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
154373347|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373348|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373349|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
154373350|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373351|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373352|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
154373353|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217301|NCT05563220|Everolimus|everolimus|mesh-list
154373354|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154373355|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154373356|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373357|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154373358|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154373359|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154373360|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154373361|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
154373362|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
154373363|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
154373364|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
154373365|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373366|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154373367|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154373368|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154373369|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625577|NCT02011126|Imetelstat|imetelstat|mesh-list
154373392|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373393|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154373394|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
154373395|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
154373396|NCT03755531|Oxytocin|oxytocin|mesh-list
154373397|NCT03755531|Carbetocin|carbetocin|mesh-list
154373398|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
154373399|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154373400|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373401|NCT04854707|Menotropins|menotropins|mesh-list
154373402|NCT04854707|Hormones|hormones|mesh-list
154373403|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154373404|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373405|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373406|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154373407|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
154373408|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154373409|NCT03215069|Empagliflozin|empagliflozin|mesh-list
154373410|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154373411|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373412|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154373413|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373414|NCT03759353|Lactoferrin|lactoferrin|mesh-list
154373415|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373416|NCT03757559|Hydromorphone|hydromorphone|mesh-list
154373417|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154373418|NCT03757559|Narcotics|narcotics|mesh-ancestor
154373419|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373428|NCT04784897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373429|NCT01322711|Atorvastatin|atorvastatin|mesh-list
154373430|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154373431|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154373432|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
154373433|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217339|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
154373434|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154373435|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154373436|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373437|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154373438|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154373439|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373440|NCT03041792|Liraglutide|liraglutide|mesh-list
154373441|NCT03041792|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154373442|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154373443|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373444|NCT03041792|Incretins|incretins|mesh-ancestor
154373445|NCT03041792|Hormones|hormones|mesh-ancestor
154373446|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373447|NCT03753581|Cytarabine|cytarabine|mesh-list
154373448|NCT03753581|Methotrexate|methotrexate|mesh-list
154373449|NCT03753581|Etoposide|etoposide|mesh-list
154373450|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154373451|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
154373452|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373453|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373454|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
154373455|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373456|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373457|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
154373458|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373459|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154373460|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154373461|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154373462|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373463|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154373464|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
154373465|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154373466|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
154373467|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154373468|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373469|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154373470|NCT04507763|Etanercept|etanercept|mesh-list
154373471|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154373472|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154373473|NCT04507763|Analgesics|analgesics|mesh-ancestor
154373474|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
154373475|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373476|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373477|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373478|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373479|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154373480|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373481|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
154373482|NCT00705484|Infliximab|infliximab|mesh-list
154373483|NCT00705484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154373484|NCT00705484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373485|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
154373486|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154373497|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154373498|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373500|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154373501|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373502|NCT05459441|Pemetrexed|pemetrexed|mesh-list
154373503|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373504|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373505|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373506|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154373507|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154373508|NCT04523831|Doxycycline|doxycycline|mesh-list
154373509|NCT04523831|Ivermectin|ivermectin|mesh-list
154373510|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154373511|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373512|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
154373513|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154373514|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154373515|NCT05691764|Cyclosporine|cyclosporine|mesh-list
154373516|NCT05691764|Cyclosporins|cyclosporins|mesh-list
154373517|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373518|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373519|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373520|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
154373521|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373522|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
154373523|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373524|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
154373525|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373526|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154373527|NCT04707664|Sargramostim|sargramostim|mesh-list
154373528|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
154373529|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373530|NCT01316276|Amikacin|amikacin|mesh-list
154373531|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154373532|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373533|NCT02474290|Sorafenib|sorafenib|mesh-list
154373534|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373535|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154373536|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373537|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373538|NCT02474212|Enoxaparin|enoxaparin|mesh-list
154373539|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
154373540|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154373541|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154373542|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373543|NCT05200286|Olorofim|olorofim|mesh-list
154373544|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
154373545|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373546|NCT02474446|Vitamin D|vitamin d|mesh-list
154373547|NCT02474446|Vitamins|vitamins|mesh-ancestor
154373548|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
154373549|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373550|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154373551|NCT05199818|Palonosetron|palonosetron|mesh-list
154373552|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
154373553|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
154373575|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373577|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154373578|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
154373579|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
154373580|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373581|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862006|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373582|NCT01322867|Alprazolam|alprazolam|mesh-list
154373583|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154255508|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
154373584|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373585|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373586|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154373587|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154373588|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154373589|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
154373590|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
154373591|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373592|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373593|NCT04624828|Androgens|androgens|mesh-list
154373594|NCT04624828|Hormones|hormones|mesh-ancestor
154373595|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373596|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373597|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154373598|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
154373599|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373600|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
154373601|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373602|NCT02477488|Allopurinol|allopurinol|mesh-list
154373603|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
154373604|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373605|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373606|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
154373633|NCT02473354|Narcotics|narcotics|mesh-ancestor
154373634|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373635|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373636|NCT02473354|Analgesics|analgesics|mesh-ancestor
154373637|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
154373638|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373639|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
154373640|NCT02470858|Asunaprevir|asunaprevir|mesh-list
154373641|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
154373642|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373643|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
154373644|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373645|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373646|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154373647|NCT02473198|Morphine|morphine|mesh-list
154373648|NCT02473198|Bupivacaine|bupivacaine|mesh-list
154373649|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
154373650|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
154373651|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373652|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373653|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
154373654|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373655|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154373674|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154373675|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
154373676|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373677|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373678|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373679|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154373681|NCT05180292|Protective Agents|protective agents|mesh-ancestor
154373682|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154373683|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154373684|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154373685|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
154373686|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154373687|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154373688|NCT01315938|Abatacept|abatacept|mesh-list
154373689|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154373690|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373691|NCT01315938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154373692|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373693|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119932|NCT03041740|Perflubron|perflubron|mesh-list
154373695|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373696|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373697|NCT01339884|Resveratrol|resveratrol|mesh-list
154373698|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
154373699|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373700|NCT01339884|Protective Agents|protective agents|mesh-ancestor
154862007|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862008|NCT00433589|Tamoxifen|tamoxifen|mesh-list
153773522|NCT00241254|Protective Agents|protective agents|mesh-ancestor
154373701|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373702|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373703|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154373704|NCT04736394|Epirubicin|epirubicin|mesh-list
154373705|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154373706|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373707|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154373708|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154373709|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625922|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
154373729|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
154373730|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
154373731|NCT01340118|Hormones|hormones|mesh-ancestor
154373732|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373733|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
154373734|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154373735|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154373736|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154373737|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373738|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154373739|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
154373740|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154373741|NCT04409964|Lidocaine|lidocaine|mesh-list
154373742|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
154373743|NCT04409964|Remifentanil|remifentanil|mesh-list
154373744|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
154373745|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
154373746|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373747|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373748|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
154373749|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373750|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154373751|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154373752|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154373753|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154373754|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373755|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154373756|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154373757|NCT04409964|Analgesics|analgesics|mesh-ancestor
154373758|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154373759|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154373760|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154373761|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
154373762|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373763|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154373764|NCT04409964|Narcotics|narcotics|mesh-ancestor
154373797|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373798|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154373800|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373801|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373802|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
154373803|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154373817|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154373818|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373820|NCT03310762|Trace Elements|trace elements|mesh-ancestor
154373821|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
154373822|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373823|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154373824|NCT03310606|Lactams|lactams|mesh-list
154373825|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373826|NCT01315704|Vitamin D|vitamin d|mesh-list
154373827|NCT01315704|Vitamins|vitamins|mesh-ancestor
154373828|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
154373829|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373830|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154373831|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
154373832|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373833|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
154373834|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373835|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373836|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154373837|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
154373838|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862009|NCT00433589|Docetaxel|docetaxel|mesh-list
154373839|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373840|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154373841|NCT03310372|Temozolomide|temozolomide|mesh-list
154373842|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154373843|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
154373844|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373845|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373846|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154373847|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154373848|NCT01342614|Metformin|metformin|mesh-list
154373849|NCT01342614|Fosinopril|fosinopril|mesh-list
154373850|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154373851|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373852|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154373853|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
154373854|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373855|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373856|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154373857|NCT01342692|Lenalidomide|lenalidomide|mesh-list
154373858|NCT01342692|Azacitidine|azacitidine|mesh-list
154373859|NCT01342692|Idarubicin|idarubicin|mesh-list
154373860|NCT01342692|Valproic Acid|valproic acid|mesh-list
154373861|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
154373862|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373863|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154373864|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154373865|NCT01342692|Growth Substances|growth substances|mesh-ancestor
154373866|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
154373867|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373878|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154373879|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154373880|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154373881|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154373882|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
154373883|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154373884|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154373885|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154373886|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373887|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
154373888|NCT03310060|Coagulants|coagulants|mesh-ancestor
154373889|NCT03740958|Argatroban|argatroban|mesh-list
154373890|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
154373891|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154373892|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
154373893|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373894|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373895|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
154373896|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154373897|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
154373898|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154373899|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
154373900|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373901|NCT05251584|Gentamicins|gentamicins|mesh-list
154373902|NCT05251584|Mupirocin|mupirocin|mesh-list
154373903|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154373904|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373905|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154373906|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373907|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373908|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
154373909|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154373910|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154373911|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154373912|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
154373913|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373914|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373915|NCT03309592|Ambrisentan|ambrisentan|mesh-list
154373916|NCT03309592|Tadalafil|tadalafil|mesh-list
154373917|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
154373918|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154373919|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154373920|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373921|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373922|NCT03309592|Urological Agents|urological agents|mesh-ancestor
154373923|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154373924|NCT04641312|Dulaglutide|dulaglutide|mesh-list
154373926|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154373927|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373928|NCT06209567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154373929|NCT06209567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154373930|NCT06209567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373931|NCT06209398|Vaccines|vaccines|mesh-list
154373932|NCT06209398|Immunologic Factors|immunologic factors|mesh-ancestor
154373952|NCT06209294|Paclitaxel|paclitaxel|mesh-list
154373953|NCT06209294|Carboplatin|carboplatin|mesh-list
154373954|NCT06209294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154373955|NCT06209294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373956|NCT06209294|Tubulin Modulators|tubulin modulators|mesh-ancestor
154373957|NCT06209294|Antimitotic Agents|antimitotic agents|mesh-ancestor
154373958|NCT06209294|Mitosis Modulators|mitosis modulators|mesh-ancestor
154373959|NCT06209294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373960|NCT06209281|Atropine|atropine|mesh-list
154373961|NCT06209281|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154373962|NCT06209281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154373963|NCT06209281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154373964|NCT06209281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154373965|NCT06209281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154373966|NCT06209281|Autonomic Agents|autonomic agents|mesh-ancestor
154373967|NCT06209281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373968|NCT06209281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373969|NCT06209281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154373970|NCT06209281|Respiratory System Agents|respiratory system agents|mesh-ancestor
154373971|NCT06209281|Mydriatics|mydriatics|mesh-ancestor
154373972|NCT06209281|Parasympatholytics|parasympatholytics|mesh-ancestor
154373973|NCT06209281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154373974|NCT06209281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154373975|NCT06209281|Cholinergic Agents|cholinergic agents|mesh-ancestor
154373976|NCT06209281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373977|NCT06209281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373978|NCT06209229|Cholecalciferol|cholecalciferol|mesh-list
154373979|NCT06209229|Pyridoxine|pyridoxine|mesh-list
154373980|NCT06209229|Vitamin B 6|vitamin b 6|mesh-list
154373981|NCT06209229|Sodium nucleinate|sodium nucleinate|mesh-list
154373982|NCT06209229|Quercetin|quercetin|mesh-list
154373983|NCT06209229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154373984|NCT06209229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373985|NCT06209229|Vitamins|vitamins|mesh-ancestor
154373986|NCT06209229|Micronutrients|micronutrients|mesh-ancestor
154373987|NCT06209229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154373988|NCT06209229|Vitamin B Complex|vitamin b complex|mesh-ancestor
154373989|NCT06209229|Antioxidants|antioxidants|mesh-ancestor
154374024|NCT06208956|Sensory System Agents|sensory system agents|mesh-ancestor
154374025|NCT06208956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374026|NCT06208956|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154374027|NCT06208956|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154374028|NCT06208956|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154374029|NCT06208956|Adrenergic Agents|adrenergic agents|mesh-ancestor
154374030|NCT06208956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626269|NCT02015507|Ivacaftor|ivacaftor|mesh-list
154374056|NCT06208917|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154374057|NCT06208917|Serotonin Agents|serotonin agents|mesh-ancestor
154374058|NCT06208917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374059|NCT06208839|Ethanol|ethanol|mesh-list
154374060|NCT06208839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154374061|NCT06208839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374062|NCT06208839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374063|NCT06208839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374064|NCT06208826|Cisplatin|cisplatin|mesh-list
154374065|NCT06208826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374066|NCT06208748|Sunitinib|sunitinib|mesh-list
154374067|NCT06208748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120306|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154374068|NCT06208748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154374069|NCT06208748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154374070|NCT06208748|Growth Substances|growth substances|mesh-ancestor
154374071|NCT06208748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374072|NCT06208748|Growth Inhibitors|growth inhibitors|mesh-ancestor
154374073|NCT06208748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154374074|NCT06208748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374075|NCT06208748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359882|NCT03323463|Carboplatin|carboplatin|mesh-list
154374077|NCT06208683|Immunologic Factors|immunologic factors|mesh-ancestor
154374078|NCT06208683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374079|NCT06208657|Irinotecan|irinotecan|mesh-list
154374080|NCT06208657|Temozolomide|temozolomide|mesh-list
154374100|NCT06208527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154374101|NCT06208527|Antimetabolites|antimetabolites|mesh-ancestor
154374102|NCT06208527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374103|NCT06208527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154374104|NCT06208527|Vasodilator Agents|vasodilator agents|mesh-ancestor
154374105|NCT06208384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154374106|NCT06208384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154374107|NCT06208280|Cyclophosphamide|cyclophosphamide|mesh-list
154374108|NCT06208280|Fludarabine|fludarabine|mesh-list
154374109|NCT06208280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154374110|NCT06208280|Immunologic Factors|immunologic factors|mesh-ancestor
154374111|NCT06208280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374112|NCT06208280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154374113|NCT06208280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154374114|NCT06208280|Alkylating Agents|alkylating agents|mesh-ancestor
154374115|NCT06208280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374116|NCT06208280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374117|NCT06208280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154374118|NCT06208267|Tranexamic Acid|tranexamic acid|mesh-list
154374119|NCT06208267|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154374120|NCT06208267|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154374121|NCT06208267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374122|NCT06208267|Hemostatics|hemostatics|mesh-ancestor
154374123|NCT06208267|Coagulants|coagulants|mesh-ancestor
154374124|NCT06208098|Hydrocortisone|hydrocortisone|mesh-list
154374125|NCT06208098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154374126|NCT06208072|Irbesartan|irbesartan|mesh-list
154374127|NCT06208072|Eplerenone|eplerenone|mesh-list
154374128|NCT06208072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154374129|NCT06208072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154374130|NCT06208072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154374131|NCT06208072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374132|NCT06208072|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154374133|NCT06208072|Hormone Antagonists|hormone antagonists|mesh-ancestor
154374134|NCT06208072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374135|NCT06208072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374136|NCT06208072|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154374166|NCT06207760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374167|NCT06207682|Simvastatin|simvastatin|mesh-list
154374168|NCT06207682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154374169|NCT06207682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154374170|NCT06207682|Antimetabolites|antimetabolites|mesh-ancestor
154374171|NCT06207682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374172|NCT06207682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154374173|NCT06207682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154374174|NCT06207682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374175|NCT06207539|Scopolamine|scopolamine|mesh-list
154374176|NCT06207539|Bromides|bromides|mesh-list
154374177|NCT06207539|Misoprostol|misoprostol|mesh-list
154374178|NCT06207539|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154374179|NCT06207539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154374180|NCT06207539|Abortifacient Agents|abortifacient agents|mesh-ancestor
154374181|NCT06207539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154374182|NCT06207539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374183|NCT06207539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154374210|NCT06207253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154374211|NCT06207253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154374212|NCT06207253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154374213|NCT06207253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374214|NCT06207253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374215|NCT06207123|Dexamethasone|dexamethasone|mesh-list
154374216|NCT06207123|Methotrexate|methotrexate|mesh-list
154374217|NCT06207123|Vincristine|vincristine|mesh-list
154374218|NCT06207123|Ponatinib|ponatinib|mesh-list
154374219|NCT06207123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154374220|NCT06207123|Antiemetics|antiemetics|mesh-ancestor
154374222|NCT06207123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374223|NCT06207123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374224|NCT06207123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154862010|NCT00433589|Capecitabine|capecitabine|mesh-list
154862011|NCT00433589|Letrozole|letrozole|mesh-list
154255509|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374225|NCT06207123|Glucocorticoids|glucocorticoids|mesh-ancestor
154374226|NCT06207123|Hormones|hormones|mesh-ancestor
154374227|NCT06207123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374228|NCT06207123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154374229|NCT06207123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374230|NCT06207123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154374231|NCT06207123|Abortifacient Agents|abortifacient agents|mesh-ancestor
154374232|NCT06207123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154374233|NCT06207123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154374251|NCT06206564|Artemisinins|artemisinins|mesh-list
154374252|NCT06206564|Artemisinin|artemisinin|mesh-list
154374253|NCT06206564|Antimalarials|antimalarials|mesh-ancestor
154374254|NCT06206564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154374255|NCT06206564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154374256|NCT06206564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374257|NCT06206564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374258|NCT06206564|Antiviral Agents|antiviral agents|mesh-ancestor
154374259|NCT06206564|Schistosomicides|schistosomicides|mesh-ancestor
154374260|NCT06206564|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154374261|NCT06206564|Anthelmintics|anthelmintics|mesh-ancestor
154374262|NCT06206278|Infigratinib|infigratinib|mesh-list
154374263|NCT06206278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374264|NCT06206096|Bevacizumab|bevacizumab|mesh-list
154374265|NCT06206096|Capecitabine|capecitabine|mesh-list
154374266|NCT06206096|Oxaliplatin|oxaliplatin|mesh-list
154374267|NCT06206096|Antibodies|antibodies|mesh-list
154374268|NCT06206096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374269|NCT06206096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374270|NCT06206096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154374271|NCT06206096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154374272|NCT06206096|Growth Substances|growth substances|mesh-ancestor
154374273|NCT06206096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374274|NCT06206096|Growth Inhibitors|growth inhibitors|mesh-ancestor
154374275|NCT06206096|Immunologic Factors|immunologic factors|mesh-ancestor
154374276|NCT06206096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154374277|NCT06206096|Antimetabolites|antimetabolites|mesh-ancestor
154374278|NCT06206096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374279|NCT06205979|Ranibizumab|ranibizumab|mesh-list
154374280|NCT06205979|Aflibercept|aflibercept|mesh-list
154374281|NCT06205979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154374282|NCT06205979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154374283|NCT06205979|Growth Substances|growth substances|mesh-ancestor
154374284|NCT06205979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374285|NCT06205979|Growth Inhibitors|growth inhibitors|mesh-ancestor
154374286|NCT06205979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374287|NCT06205888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154374288|NCT06205888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154374289|NCT06205888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374290|NCT06205849|Antibodies|antibodies|mesh-list
154374291|NCT06205849|Immunologic Factors|immunologic factors|mesh-ancestor
154374292|NCT06205849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374293|NCT06205836|Cemiplimab|cemiplimab|mesh-list
154374323|NCT06205719|GABA Agents|gaba agents|mesh-ancestor
154374324|NCT06205719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374325|NCT06205719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374326|NCT06205706|Pembrolizumab|pembrolizumab|mesh-list
154374327|NCT06205706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374328|NCT06205706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374329|NCT06205706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154374330|NCT06205706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374331|NCT06205680|Anesthetics|anesthetics|mesh-list
154374332|NCT06205680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374333|NCT06205680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374334|NCT06205641|Baloxavir|baloxavir|mesh-list
154374335|NCT06205641|Antiviral Agents|antiviral agents|mesh-ancestor
154374336|NCT06205641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374337|NCT06205641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374338|NCT06205641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374339|NCT06205589|Vaccines|vaccines|mesh-list
154374565|NCT06106295|Antimetabolites|antimetabolites|mesh-ancestor
154374566|NCT06106295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374567|NCT06106295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374568|NCT06100705|Methyltestosterone|methyltestosterone|mesh-list
154374569|NCT06100705|Testosterone|testosterone|mesh-list
154862012|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374570|NCT06100705|Testosterone undecanoate|testosterone undecanoate|mesh-list
154374571|NCT06100705|Testosterone enanthate|testosterone enanthate|mesh-list
154374572|NCT06100705|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154374573|NCT06100705|Androgens|androgens|mesh-ancestor
154374574|NCT06100705|Hormones|hormones|mesh-ancestor
154374575|NCT06100705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374576|NCT06100705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374577|NCT06100705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154374578|NCT06100705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374579|NCT06100705|Anabolic Agents|anabolic agents|mesh-ancestor
154374580|NCT06091189|Ethanol|ethanol|mesh-list
154374581|NCT06091189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154374582|NCT06091189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374583|NCT06091189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374584|NCT06091189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374585|NCT06089434|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154374586|NCT06089434|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154374587|NCT06089434|beta-Endorphin|beta-endorphin|mesh-list
154374588|NCT06089434|Hormones|hormones|mesh-ancestor
154374589|NCT06089434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374590|NCT06089434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374591|NCT06089434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374592|NCT06089434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374593|NCT06080178|Norepinephrine|norepinephrine|mesh-list
154374594|NCT06080178|Plasma-lyte 148|plasma-lyte 148|mesh-list
154374595|NCT06080178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154374597|NCT06080178|Adrenergic Agents|adrenergic agents|mesh-ancestor
154374598|NCT06080178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374599|NCT06080178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374600|NCT06080178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374601|NCT06080178|Sympathomimetics|sympathomimetics|mesh-ancestor
154374602|NCT06080178|Autonomic Agents|autonomic agents|mesh-ancestor
154374603|NCT06080178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374604|NCT06080178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154374605|NCT06080178|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154374606|NCT06080178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154374607|NCT06068530|Piperaquine|piperaquine|mesh-list
154374608|NCT06068530|Antimalarials|antimalarials|mesh-ancestor
154374609|NCT06068530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154374610|NCT06068530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154374611|NCT06068530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374612|NCT06064929|Felzartamab|felzartamab|mesh-list
154374613|NCT06064929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374614|NCT06064929|Immunologic Factors|immunologic factors|mesh-ancestor
154374615|NCT06064929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374616|NCT06064877|Cetuximab|cetuximab|mesh-list
154374617|NCT06064877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374618|NCT06064877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374619|NCT06056141|Misoprostol|misoprostol|mesh-list
154374620|NCT06056141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154374644|NCT06053398|Nasal Decongestants|nasal decongestants|mesh-ancestor
154374645|NCT06053398|Respiratory System Agents|respiratory system agents|mesh-ancestor
154374646|NCT06053398|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154374647|NCT06053398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154374648|NCT06053398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154374649|NCT06053398|Adrenergic Agents|adrenergic agents|mesh-ancestor
154374650|NCT06053398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374651|NCT06053398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374652|NCT06053398|Protective Agents|protective agents|mesh-ancestor
154374653|NCT06051227|Fentanyl|fentanyl|mesh-list
154374654|NCT06051227|Esketamine|esketamine|mesh-list
154374655|NCT06051227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154374656|NCT06051227|Narcotics|narcotics|mesh-ancestor
154374657|NCT06051227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374658|NCT06051227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374659|NCT06051227|Analgesics|analgesics|mesh-ancestor
154374660|NCT06051227|Sensory System Agents|sensory system agents|mesh-ancestor
154374661|NCT06051227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374662|NCT06051227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154374663|NCT06051227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154374664|NCT06051227|Anesthetics, General|anesthetics, general|mesh-ancestor
154374665|NCT06051227|Anesthetics|anesthetics|mesh-ancestor
154374666|NCT06051227|Antidepressive Agents|antidepressive agents|mesh-ancestor
154374667|NCT06051227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154374668|NCT06042517|Liver Extracts|liver extracts|mesh-list
154374669|NCT06042517|Hematinics|hematinics|mesh-ancestor
154374671|NCT06041217|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154374672|NCT06041217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154374673|NCT06041217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374674|NCT06040320|Rituximab|rituximab|mesh-list
153736550|NCT01665144|Siponimod|siponimod|mesh-list
154374686|NCT06038578|Tubulin Modulators|tubulin modulators|mesh-ancestor
154374687|NCT06038578|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374688|NCT06038578|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374689|NCT06038578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374690|NCT06038578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154374691|NCT06038578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154374692|NCT06038578|Growth Substances|growth substances|mesh-ancestor
154374693|NCT06038578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374694|NCT06038578|Growth Inhibitors|growth inhibitors|mesh-ancestor
154374695|NCT06029894|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154374696|NCT06029894|Nootropic Agents|nootropic agents|mesh-ancestor
154374697|NCT06029673|Cabergoline|cabergoline|mesh-list
154374698|NCT06029673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154374699|NCT06029673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154374700|NCT06029673|Dopamine Agonists|dopamine agonists|mesh-ancestor
154374701|NCT06029673|Dopamine Agents|dopamine agents|mesh-ancestor
154374702|NCT06029673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374703|NCT06029673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374704|NCT06029673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374705|NCT06016387|Capecitabine|capecitabine|mesh-list
154374706|NCT06016387|Trastuzumab|trastuzumab|mesh-list
154374707|NCT06016387|Tucatinib|tucatinib|mesh-list
154374708|NCT06016387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154374709|NCT06016387|Antimetabolites|antimetabolites|mesh-ancestor
154374710|NCT06016387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374711|NCT06016387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374712|NCT06016387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374713|NCT06016387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154374714|NCT06016387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374715|NCT06005688|Carbamazepine|carbamazepine|mesh-list
154374716|NCT06005688|Anticonvulsants|anticonvulsants|mesh-ancestor
154374717|NCT06005688|Antimanic Agents|antimanic agents|mesh-ancestor
154374718|NCT06005688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154374719|NCT06005688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374720|NCT06005688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374721|NCT06005688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154374722|NCT06005688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154374723|NCT06005688|Analgesics|analgesics|mesh-ancestor
154374724|NCT06005688|Sensory System Agents|sensory system agents|mesh-ancestor
154374725|NCT06005688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374726|NCT06005688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154374727|NCT06005688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374728|NCT06005688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374729|NCT06005688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154374730|NCT06005688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154374731|NCT06003621|Atezolizumab|atezolizumab|mesh-list
154374732|NCT06003621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154374733|NCT06003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374734|NCT06003621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374735|NCT06003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374736|NCT05985681|Vaccines|vaccines|mesh-list
154374737|NCT05985681|Immunologic Factors|immunologic factors|mesh-ancestor
153736596|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
154374748|NCT05972681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154374749|NCT05972681|Adrenergic Agents|adrenergic agents|mesh-ancestor
154374750|NCT05972681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374751|NCT05972681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374752|NCT05972681|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154374753|NCT05972681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154374754|NCT05972681|Autonomic Agents|autonomic agents|mesh-ancestor
154374755|NCT05972681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154374756|NCT05972681|Respiratory System Agents|respiratory system agents|mesh-ancestor
154374757|NCT05972681|Mydriatics|mydriatics|mesh-ancestor
154374758|NCT05972681|Sympathomimetics|sympathomimetics|mesh-ancestor
154374759|NCT05972681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154374760|NCT05969236|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154374761|NCT05969236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154374762|NCT05954442|Everolimus|everolimus|mesh-list
154862013|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
154374764|NCT05954442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154374765|NCT05954442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374766|NCT05954442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374767|NCT05954442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154374768|NCT05954442|Immunologic Factors|immunologic factors|mesh-ancestor
154374769|NCT05954442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218061|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
154374770|NCT05954442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374771|NCT05944458|Acetylcysteine|acetylcysteine|mesh-list
154374772|NCT05944458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154374773|NCT05944458|Antiviral Agents|antiviral agents|mesh-ancestor
154374774|NCT05944458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374775|NCT05944458|Expectorants|expectorants|mesh-ancestor
154374776|NCT05944458|Respiratory System Agents|respiratory system agents|mesh-ancestor
154374777|NCT05944458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154374778|NCT05944458|Antioxidants|antioxidants|mesh-ancestor
154374779|NCT05944458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374780|NCT05944458|Protective Agents|protective agents|mesh-ancestor
154374781|NCT05944458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374782|NCT05944458|Antidotes|antidotes|mesh-ancestor
154374783|NCT05932199|Carboplatin|carboplatin|mesh-list
154374784|NCT05932199|Pemetrexed|pemetrexed|mesh-list
154374785|NCT05932199|Durvalumab|durvalumab|mesh-list
154374786|NCT05932199|Tremelimumab|tremelimumab|mesh-list
154374787|NCT05932199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154374788|NCT05932199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374789|NCT05932199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374790|NCT05932199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374791|NCT05932199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154374792|NCT05932199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154374793|NCT05932199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374794|NCT05932199|Immunologic Factors|immunologic factors|mesh-ancestor
154374795|NCT05932199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374796|NCT05930782|Piperaquine|piperaquine|mesh-list
154374797|NCT05930782|Antimalarials|antimalarials|mesh-ancestor
154374798|NCT05930782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154374799|NCT05930782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154374800|NCT05930782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374801|NCT05905367|Fentanyl|fentanyl|mesh-list
154374802|NCT05905367|Morphine|morphine|mesh-list
154374803|NCT05905367|Methadone|methadone|mesh-list
154374804|NCT05905367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154374811|NCT05905367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154374812|NCT05905367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154374813|NCT05905367|Anesthetics, General|anesthetics, general|mesh-ancestor
154374814|NCT05905367|Anesthetics|anesthetics|mesh-ancestor
154374815|NCT05905367|Antitussive Agents|antitussive agents|mesh-ancestor
154374816|NCT05905367|Respiratory System Agents|respiratory system agents|mesh-ancestor
154374817|NCT05898646|Daratumumab|daratumumab|mesh-list
154374818|NCT05898646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154374819|NCT05898646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374820|NCT05898646|Immunologic Factors|immunologic factors|mesh-ancestor
154374821|NCT05898646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121068|NCT01062139|Cetirizine|cetirizine|mesh-list
154374822|NCT05875727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154374823|NCT05875727|Immunologic Factors|immunologic factors|mesh-ancestor
154374824|NCT05875727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374825|NCT05872685|Oxaliplatin|oxaliplatin|mesh-list
154374826|NCT05872685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374827|NCT05867654|Amoxicillin|amoxicillin|mesh-list
154374828|NCT05867654|Levofloxacin|levofloxacin|mesh-list
154374829|NCT05867654|Clindamycin|clindamycin|mesh-list
154374830|NCT05867654|Clindamycin palmitate|clindamycin palmitate|mesh-list
154374831|NCT05867654|Clindamycin phosphate|clindamycin phosphate|mesh-list
154374832|NCT05867654|Clavulanic Acid|clavulanic acid|mesh-list
154374833|NCT05867654|Clavulanic Acids|clavulanic acids|mesh-list
154374834|NCT05867654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154374835|NCT05867654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154374836|NCT05867654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374837|NCT05867654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154374838|NCT05867654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154374839|NCT05867654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154862014|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374840|NCT05867654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374841|NCT05867654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374842|NCT05867654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374843|NCT05867654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154255510|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374844|NCT05867654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154374845|NCT05867654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154374846|NCT05867654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154374847|NCT05858957|Magnesium Sulfate|magnesium sulfate|mesh-list
154374849|NCT05858957|Sensory System Agents|sensory system agents|mesh-ancestor
154374850|NCT05858957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374851|NCT05858957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374852|NCT05858957|Anesthetics|anesthetics|mesh-ancestor
154374853|NCT05858957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374854|NCT05858957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154374855|NCT05858957|Anticonvulsants|anticonvulsants|mesh-ancestor
154374856|NCT05858957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154374857|NCT05858957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374858|NCT05858957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374859|NCT05858957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154374860|NCT05858957|Tocolytic Agents|tocolytic agents|mesh-ancestor
154374861|NCT05858957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154374862|NCT05852002|Hyaluronic Acid|hyaluronic acid|mesh-list
154374863|NCT05852002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154374864|NCT05852002|Immunologic Factors|immunologic factors|mesh-ancestor
154374865|NCT05852002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374866|NCT05852002|Viscosupplements|viscosupplements|mesh-ancestor
154374867|NCT05852002|Protective Agents|protective agents|mesh-ancestor
154374868|NCT05845099|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154374869|NCT05845099|Vasodilator Agents|vasodilator agents|mesh-ancestor
154374870|NCT05845099|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154374871|NCT05845099|Protective Agents|protective agents|mesh-ancestor
154374872|NCT05845099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374885|NCT05834023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154374886|NCT05834023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154374887|NCT05834023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374888|NCT05834023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374890|NCT05826015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154374891|NCT05826015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374892|NCT05826015|Tubulin Modulators|tubulin modulators|mesh-ancestor
154374893|NCT05826015|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374894|NCT05826015|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374895|NCT05826015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374896|NCT05819892|Paclitaxel|paclitaxel|mesh-list
154374897|NCT05819892|Cisplatin|cisplatin|mesh-list
154374898|NCT05819892|Carboplatin|carboplatin|mesh-list
154374899|NCT05819892|Dostarlimab|dostarlimab|mesh-list
154374900|NCT05819892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154374901|NCT05819892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374902|NCT05819892|Tubulin Modulators|tubulin modulators|mesh-ancestor
154374903|NCT05819892|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374904|NCT05819892|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374905|NCT05819892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374906|NCT05801978|Vaccines|vaccines|mesh-list
154374907|NCT05801978|Immunologic Factors|immunologic factors|mesh-ancestor
154374908|NCT05801978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374909|NCT05801146|Botulinum Toxins|botulinum toxins|mesh-list
154374910|NCT05801146|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154374911|NCT05801146|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154374912|NCT05801146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154374913|NCT05801146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374914|NCT05801146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374915|NCT05801146|Cholinergic Agents|cholinergic agents|mesh-ancestor
154374916|NCT05801146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374917|NCT05801146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374918|NCT05801146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154374919|NCT05801146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374920|NCT05786417|Calcium Channel Blockers|calcium channel blockers|mesh-list
154374921|NCT05786417|Calcium|calcium|mesh-list
154374922|NCT05786417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154374923|NCT05786417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154374924|NCT05786417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374925|NCT05786417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154374926|NCT05786417|Adrenergic Agents|adrenergic agents|mesh-ancestor
154374927|NCT05786417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154862015|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374928|NCT05786417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218214|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374929|NCT05786417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374930|NCT05780801|Glycerol|glycerol|mesh-list
154374931|NCT05780801|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154374932|NCT05780801|Protective Agents|protective agents|mesh-ancestor
154374933|NCT05780801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374934|NCT05775939|Deoxyglucose|deoxyglucose|mesh-list
154374959|NCT05715229|Ipilimumab|ipilimumab|mesh-list
154374960|NCT05715229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154374961|NCT05715229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374962|NCT05715229|Tubulin Modulators|tubulin modulators|mesh-ancestor
154374963|NCT05715229|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374964|NCT05715229|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374965|NCT05715229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374966|NCT05715229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374967|NCT05715229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154374968|NCT05715229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374969|NCT05715229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154374970|NCT05715229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154374971|NCT05704049|Dexamethasone|dexamethasone|mesh-list
154374972|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
154374973|NCT05704049|BB 1101|bb 1101|mesh-list
154374974|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154374975|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
154374976|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
154374977|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374978|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374979|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374980|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
154374982|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374983|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154374984|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374985|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
154374986|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374987|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374988|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154374989|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154374990|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375004|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375005|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375006|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154375007|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
154375008|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375009|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375010|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154375011|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375012|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
154375014|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375015|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375016|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154375017|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375018|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154375019|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154375020|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
154375021|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154375022|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375023|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
154375024|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
154375025|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375026|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375027|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154375028|NCT05666336|Protective Agents|protective agents|mesh-ancestor
154375029|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
154375030|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154375031|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154375032|NCT05660382|Miconazole|miconazole|mesh-list
154375033|NCT05660382|Clotrimazole|clotrimazole|mesh-list
154375034|NCT05660382|Mineral Oil|mineral oil|mesh-list
154375035|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
154375036|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375037|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154375038|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154375039|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375040|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774633|NCT00220064|Leucovorin|leucovorin|mesh-list
154375041|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154375042|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
154375043|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375044|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375045|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154375046|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154375047|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154375048|NCT05660382|Emollients|emollients|mesh-ancestor
154121283|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
154375049|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
154375050|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
154375104|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154375105|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375106|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154375107|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154375109|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
154375110|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154375111|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154375112|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154375113|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
154375114|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154375115|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154375116|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
154375117|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154375118|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
154375119|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
154375131|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375132|NCT05629429|Olaparib|olaparib|mesh-list
154375133|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154375134|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375135|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375136|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375137|NCT05605535|Paclitaxel|paclitaxel|mesh-list
154375138|NCT05605535|Carboplatin|carboplatin|mesh-list
154375139|NCT05605535|Oregovomab|oregovomab|mesh-list
154375140|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154375141|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375142|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
154375143|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
154375144|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
154375145|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375146|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375147|NCT05593328|Bevacizumab|bevacizumab|mesh-list
154375148|NCT05593328|Onvansertib|onvansertib|mesh-list
154375149|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375150|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375151|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154375152|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154375153|NCT05593328|Growth Substances|growth substances|mesh-ancestor
154375154|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375155|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
154375156|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375157|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375158|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375159|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
154375160|NCT05582590|Fludarabine|fludarabine|mesh-list
154375161|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375162|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
154375163|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375164|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375165|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154375166|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
154375167|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375168|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375169|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154375170|NCT05573724|Itraconazole|itraconazole|mesh-list
154375171|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
154375172|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375173|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154375174|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154375175|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862016|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774737|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
154375176|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375177|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154375178|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
154375179|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375180|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737041|NCT06171152|Liraglutide|liraglutide|mesh-list
154375192|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375194|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375195|NCT05555121|Progesterone|progesterone|mesh-list
154375196|NCT05555121|Progestins|progestins|mesh-ancestor
154375197|NCT05555121|Hormones|hormones|mesh-ancestor
154121436|NCT00999700|Cisplatin|cisplatin|mesh-list
154375198|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375199|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375200|NCT05547386|Edetic Acid|edetic acid|mesh-list
154375201|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154375202|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
154375203|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
154375204|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375205|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
154375206|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154375207|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154375208|NCT05541016|Cisplatin|cisplatin|mesh-list
154375209|NCT05541016|Docetaxel|docetaxel|mesh-list
154375210|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375211|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
154375212|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
154375213|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
154375214|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375215|NCT05524246|Pravastatin|pravastatin|mesh-list
154375216|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154375217|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154375218|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
154375219|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375220|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154375221|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154375222|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375223|NCT05487859|Acarbose|acarbose|mesh-list
154375224|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154375225|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375226|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375227|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154375228|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375229|NCT05486481|Dexamethasone|dexamethasone|mesh-list
154375230|NCT05486481|Venetoclax|venetoclax|mesh-list
154375231|NCT05486481|Daratumumab|daratumumab|mesh-list
154375232|NCT05486481|Immunoglobulins|immunoglobulins|mesh-list
154375233|NCT05486481|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154375234|NCT05486481|Antibodies|antibodies|mesh-list
154375235|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154375236|NCT05486481|Immunoglobulin Heavy Chains|immunoglobulin heavy chains|mesh-list
154375237|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375238|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
154375239|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
154375240|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375241|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375242|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375243|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
154375244|NCT05486481|Hormones|hormones|mesh-ancestor
153737103|NCT06059456|Vaccines|vaccines|mesh-list
154375252|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
154375253|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375254|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375255|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154375256|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
154375257|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375258|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375259|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154375260|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154375261|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154375262|NCT05450978|Lamotrigine|lamotrigine|mesh-list
154375263|NCT05450978|Levetiracetam|levetiracetam|mesh-list
154375264|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
154375265|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
154862017|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154375267|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154375268|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375269|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154375270|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375271|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154375272|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154375273|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375274|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154375275|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154375276|NCT05450562|Atezolizumab|atezolizumab|mesh-list
154375277|NCT05450562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375278|NCT05450562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375279|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375280|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375281|NCT05428969|Azacitidine|azacitidine|mesh-list
154375282|NCT05428969|Venetoclax|venetoclax|mesh-list
154375283|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154375284|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
154375285|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375286|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375287|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375288|NCT05425420|Methadone|methadone|mesh-list
154375289|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154375290|NCT05425420|Narcotics|narcotics|mesh-ancestor
154375291|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375292|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375293|NCT05425420|Analgesics|analgesics|mesh-ancestor
154375294|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
154375295|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375296|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
154375297|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
154582986|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154375298|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
154375299|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154375300|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
154375301|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154375302|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375303|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375304|NCT05392452|Insulin|insulin|mesh-list
154375305|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154375306|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375307|NCT05389046|Dexetimide|dexetimide|mesh-list
154375308|NCT05389046|Aripiprazole|aripiprazole|mesh-list
154375309|NCT05389046|Citalopram|citalopram|mesh-list
154375310|NCT05389046|Escitalopram|escitalopram|mesh-list
154375326|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154375327|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
154375328|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154375329|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154375330|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154375331|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375332|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
154375333|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
154375334|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154375335|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154375336|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154375337|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154375338|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154375339|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154375340|NCT05388487|Complement Factor H|complement factor h|mesh-list
154375341|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154375342|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375343|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
154375344|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121584|NCT00816426|Kanamycin|kanamycin|mesh-list
154375345|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
154375346|NCT05385042|Thiamine|thiamine|mesh-list
154375347|NCT05385042|Vitamins|vitamins|mesh-ancestor
154375348|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
154375349|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375350|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
154375351|NCT05365035|Cytarabine|cytarabine|mesh-list
154375352|NCT05365035|Azacitidine|azacitidine|mesh-list
154375353|NCT05365035|Venetoclax|venetoclax|mesh-list
154375354|NCT05365035|Cladribine|cladribine|mesh-list
154375355|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154375356|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
154375357|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375358|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375359|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
154375360|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375361|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375362|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
154375363|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375364|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375365|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
154375366|NCT05360511|Hematinics|hematinics|mesh-ancestor
154375367|NCT05357846|Paclitaxel|paclitaxel|mesh-list
154375368|NCT05357846|Cisplatin|cisplatin|mesh-list
154375369|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154375392|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154375393|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154375394|NCT05319834|Aspirin|aspirin|mesh-list
154375395|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154375396|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154375397|NCT05319834|Analgesics|analgesics|mesh-ancestor
154375398|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
154375399|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375400|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375401|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375402|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375403|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154375404|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154375405|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375406|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154375407|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154375408|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375409|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
154375410|NCT05319574|Tislelizumab|tislelizumab|mesh-list
154375411|NCT05319574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375412|NCT05319574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375413|NCT05291325|Linaclotide|linaclotide|mesh-list
154375414|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154375415|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
154375416|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375417|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375418|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154375419|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
154375420|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375431|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
154375432|NCT05267600|Hormones|hormones|mesh-ancestor
154375433|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375434|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375435|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375436|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375437|NCT05262270|Naltrexone|naltrexone|mesh-list
154375438|NCT05262270|Buprenorphine|buprenorphine|mesh-list
154375439|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154375440|NCT05262270|Narcotics|narcotics|mesh-ancestor
154375441|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375442|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375443|NCT05262270|Analgesics|analgesics|mesh-ancestor
154375444|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
154375445|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375446|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154375447|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154375448|NCT05252754|Indomethacin|indomethacin|mesh-list
154375449|NCT05252754|Tacrolimus|tacrolimus|mesh-list
154375450|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375451|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
154375452|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375453|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154375454|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375455|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375456|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154375457|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154375458|NCT05252754|Analgesics|analgesics|mesh-ancestor
154375459|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
154862018|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
154375461|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375462|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375463|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
154375464|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
154375465|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154375466|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154375467|NCT05249101|Capecitabine|capecitabine|mesh-list
154375468|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154375469|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
154375470|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375471|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375472|NCT05241873|Carboplatin|carboplatin|mesh-list
154375473|NCT05241873|Pemetrexed|pemetrexed|mesh-list
154375474|NCT05241873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375475|NCT05241873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375476|NCT05241873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375477|NCT05241873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154375478|NCT05241873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154375479|NCT05241275|Xenon|xenon|mesh-list
154375480|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154375481|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
154375482|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
154375483|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375484|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375485|NCT05222971|Durvalumab|durvalumab|mesh-list
154375506|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375508|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375509|NCT05166304|Protective Agents|protective agents|mesh-ancestor
154375510|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375511|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375512|NCT05127044|Bilirubin|bilirubin|mesh-list
154375513|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
154375514|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375515|NCT05127044|Protective Agents|protective agents|mesh-ancestor
154375516|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375517|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
154375518|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
154375519|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154375520|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154375521|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375522|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375523|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375524|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375525|NCT05118399|Bupivacaine|bupivacaine|mesh-list
154375526|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
154375527|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
154375528|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375529|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375530|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
154375531|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375532|NCT05115903|Adalimumab|adalimumab|mesh-list
154375533|NCT05115903|Infliximab|infliximab|mesh-list
154375534|NCT05115903|Golimumab|golimumab|mesh-list
154375535|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
154375536|NCT05115903|Etanercept|etanercept|mesh-list
154375537|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154375538|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154375539|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375563|NCT05084430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375564|NCT05072236|Lidocaine|lidocaine|mesh-list
154375565|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
154375566|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
154375567|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375568|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375569|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
154375570|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121808|NCT00530920|Tipranavir|tipranavir|mesh-list
154375571|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154375572|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154862019|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154375573|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154375574|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154375575|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375576|NCT05065021|Paclitaxel|paclitaxel|mesh-list
154375577|NCT05065021|Bevacizumab|bevacizumab|mesh-list
154375578|NCT05065021|Niraparib|niraparib|mesh-list
154375579|NCT05065021|Dostarlimab|dostarlimab|mesh-list
154375580|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154375581|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375582|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
154375583|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
154375584|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
154218671|NCT01064232|Risperidone|risperidone|mesh-list
154375585|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375586|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375587|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154375588|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154375597|NCT05064735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375598|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154375599|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375600|NCT05035316|Aspirin|aspirin|mesh-list
154375601|NCT05035316|Calcium|calcium|mesh-list
154375602|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154375603|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375604|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154375605|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154375606|NCT05035316|Analgesics|analgesics|mesh-ancestor
154375607|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
154375608|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375609|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375610|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375611|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154375612|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154375613|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375614|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154375615|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154375616|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375617|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
154375618|NCT05020860|Paclitaxel|paclitaxel|mesh-list
154375619|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
154375620|NCT05020860|Carboplatin|carboplatin|mesh-list
154375621|NCT05020860|Doxorubicin|doxorubicin|mesh-list
154375622|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
154375623|NCT05020860|Trastuzumab|trastuzumab|mesh-list
154375624|NCT05020860|Pertuzumab|pertuzumab|mesh-list
154375625|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154375626|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375627|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
154375628|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
154375629|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
154375630|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375631|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375632|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
154375633|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375634|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375635|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154375636|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
154375637|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154375638|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154375639|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154375640|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154375641|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375642|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375643|NCT05020860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375644|NCT05011487|Pemetrexed|pemetrexed|mesh-list
154375645|NCT05011487|Osimertinib|osimertinib|mesh-list
154375646|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375647|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375648|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375649|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154375650|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154218712|NCT01016795|Lenograstim|lenograstim|mesh-list
154375651|NCT05011487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154375652|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375653|NCT04987203|Nivolumab|nivolumab|mesh-list
154375654|NCT04987203|Tivozanib|tivozanib|mesh-list
154375655|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375679|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375680|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375681|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375682|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154375683|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154375684|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375686|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375687|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375688|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375689|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375690|NCT04930562|Belumosudil|belumosudil|mesh-list
154375691|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375692|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375693|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375694|NCT04908787|Paclitaxel|paclitaxel|mesh-list
154375695|NCT04908787|Doxorubicin|doxorubicin|mesh-list
154375696|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154375697|NCT04908787|Topotecan|topotecan|mesh-list
154375698|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154375699|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375700|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
154375701|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
154375702|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
154375726|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375727|NCT04887506|Prednisone|prednisone|mesh-list
154375728|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
154375729|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375730|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
154375731|NCT04887506|Hormones|hormones|mesh-ancestor
154375732|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375733|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375734|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375735|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375736|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154375737|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375738|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375739|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
154375740|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154375741|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
154375742|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154375743|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
154375744|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375745|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
154375746|NCT04872595|Melphalan|melphalan|mesh-list
154375747|NCT04872595|Busulfan|busulfan|mesh-list
154375748|NCT04872595|Thiotepa|thiotepa|mesh-list
154375749|NCT04872595|Fludarabine|fludarabine|mesh-list
154375750|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375751|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
154375752|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375753|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375754|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154375766|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375767|NCT04848337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154218767|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154375768|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375769|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375770|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375771|NCT04844606|Mirikizumab|mirikizumab|mesh-list
154375772|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154375773|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154375774|NCT04844606|Analgesics|analgesics|mesh-ancestor
154375775|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
154375776|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375777|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375778|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375779|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375780|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154375781|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375782|NCT04839328|Hemay005|hemay005|mesh-list
154375783|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
154375784|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154375785|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154375786|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375787|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375788|NCT04822337|Dexamethasone|dexamethasone|mesh-list
154375789|NCT04822337|Lenalidomide|lenalidomide|mesh-list
154375790|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375791|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
154375792|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
154375793|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375794|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375795|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375796|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
154375797|NCT04822337|Hormones|hormones|mesh-ancestor
154375798|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375799|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375800|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375801|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
154375802|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154375803|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154375804|NCT04822337|Growth Substances|growth substances|mesh-ancestor
154375805|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
154375806|NCT04799249|Carboplatin|carboplatin|mesh-list
154375807|NCT04799249|Gemcitabine|gemcitabine|mesh-list
154375808|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375809|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154375810|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
154375811|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375812|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154375813|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375814|NCT04791761|Acetaminophen|acetaminophen|mesh-list
154375815|NCT04791761|Ibuprofen|ibuprofen|mesh-list
154375816|NCT04791761|Oxycodone|oxycodone|mesh-list
154375817|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
154375837|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154375838|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375839|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154375840|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154375841|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154375842|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375843|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154375844|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
154375845|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375846|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375847|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
154375848|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154375849|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154375850|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375851|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375852|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375853|NCT04785547|Blinatumomab|blinatumomab|mesh-list
154375854|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375855|NCT04781322|Alirocumab|alirocumab|mesh-list
154375856|NCT04781322|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154375857|NCT04781322|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154375858|NCT04781322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154375859|NCT04781322|Antimetabolites|antimetabolites|mesh-ancestor
154375860|NCT04781322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375861|NCT04781322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154375862|NCT04781322|Protease Inhibitors|protease inhibitors|mesh-ancestor
154375863|NCT04781322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375864|NCT04781322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154375865|NCT04773184|Capsaicin|capsaicin|mesh-list
154375866|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
154375867|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
154375868|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
154375869|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375870|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375871|NCT04764942|Dexamethasone|dexamethasone|mesh-list
154375872|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
154375873|NCT04764942|Pomalidomide|pomalidomide|mesh-list
154375874|NCT04764942|Ichthammol|ichthammol|mesh-list
154375875|NCT04764942|BB 1101|bb 1101|mesh-list
154375876|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375905|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375906|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375907|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375908|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375909|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375910|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154375911|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154375912|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154375913|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154375914|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375915|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
154375916|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154255511|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154375917|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375918|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375919|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154375920|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154375922|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154375923|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154375924|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375927|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154375928|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375929|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
154375930|NCT04704219|Lenvatinib|lenvatinib|mesh-list
154375931|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375932|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375933|NCT04704219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375934|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375935|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375936|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375937|NCT04703920|Talazoparib|talazoparib|mesh-list
154375938|NCT04703920|Belinostat|belinostat|mesh-list
154375939|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154375940|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375941|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375942|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375943|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154375944|NCT04676477|Osimertinib|osimertinib|mesh-list
154375945|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154375946|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154375947|NCT04676477|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154375948|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375949|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375950|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375951|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375952|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
154375953|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375954|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375955|NCT04664361|Niacinamide|niacinamide|mesh-list
154375956|NCT04664361|Niacin|niacin|mesh-list
154375957|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
154375958|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
154375959|NCT04664361|Vitamins|vitamins|mesh-ancestor
154375960|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
154375961|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375962|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154375963|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
154375964|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375965|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154375966|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
154375967|NCT04656652|Docetaxel|docetaxel|mesh-list
154375968|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375969|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
154375970|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
154375971|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
154375972|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375973|NCT04611529|Ibuprofen|ibuprofen|mesh-list
154375984|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375985|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375986|NCT04610580|Choline|choline|mesh-list
154375987|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
154375988|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154375989|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
154375990|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375991|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375992|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154375993|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
154375994|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154375995|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375996|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154375997|NCT04601350|Midazolam|midazolam|mesh-list
154375998|NCT04601350|Anesthetics|anesthetics|mesh-ancestor
154375999|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154376000|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862020|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154376001|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154376002|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154376003|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154376004|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154376005|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154376006|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154376007|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
154376008|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
154376009|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
154376010|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154376011|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376012|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154376013|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376014|NCT04584853|Tamoxifen|tamoxifen|mesh-list
154376015|NCT04584853|Letrozole|letrozole|mesh-list
154376016|NCT04584853|Anastrozole|anastrozole|mesh-list
154376017|NCT04584853|Exemestane|exemestane|mesh-list
154376018|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376019|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154376020|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154376021|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376022|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376023|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154376024|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
154376025|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376026|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376027|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376028|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154376029|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154376030|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154376031|NCT04574856|Temozolomide|temozolomide|mesh-list
154376032|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154376033|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
154376034|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376035|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376036|NCT04573478|Atrasentan|atrasentan|mesh-list
153737900|NCT04375605|Leucovorin|leucovorin|mesh-list
154376046|NCT04569461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376048|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376049|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376050|NCT04565236|Factor VIII|factor viii|mesh-list
154376051|NCT04565236|Coagulants|coagulants|mesh-ancestor
154376052|NCT04554459|Ponatinib|ponatinib|mesh-list
154376053|NCT04554459|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154376054|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376055|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376056|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376057|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376058|NCT04552613|Carboplatin|carboplatin|mesh-list
154376059|NCT04552613|Pemetrexed|pemetrexed|mesh-list
154376060|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376061|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376062|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376063|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154376064|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154376065|NCT04474600|Propofol|propofol|mesh-list
154376066|NCT04474600|Desflurane|desflurane|mesh-list
154376067|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154376068|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154376069|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376070|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154376071|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
154376072|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
154376073|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154376074|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
154376075|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154376076|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154376077|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376078|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154376079|NCT04454515|Analgesics|analgesics|mesh-ancestor
154376080|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
154376081|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376082|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154376083|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154376084|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154376085|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
154376086|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154376087|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376088|NCT04408625|Sirolimus|sirolimus|mesh-list
154376089|NCT04408625|Prednisone|prednisone|mesh-list
154376090|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
154376091|NCT04408625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154376092|NCT04408625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154122336|NCT05774028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376093|NCT04408625|Prednisolone|prednisolone|mesh-list
154376094|NCT04408625|Prednisolone acetate|prednisolone acetate|mesh-list
154376095|NCT04408625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154376096|NCT04408625|Prednisolone phosphate|prednisolone phosphate|mesh-list
154376097|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376098|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
154376099|NCT04408625|Hormones|hormones|mesh-ancestor
154376111|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
154376112|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376113|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154376114|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154376115|NCT04408625|Protective Agents|protective agents|mesh-ancestor
154376116|NCT04398524|Cemiplimab|cemiplimab|mesh-list
154376117|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376118|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376119|NCT04398316|Lidocaine|lidocaine|mesh-list
154376120|NCT04398316|Hydromorphone|hydromorphone|mesh-list
154376121|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
154376122|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
154376123|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154376124|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376125|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
154376126|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376127|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154376128|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154376129|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154376130|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154376131|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376132|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154376133|NCT04398316|Narcotics|narcotics|mesh-ancestor
154376134|NCT04398316|Analgesics|analgesics|mesh-ancestor
154376135|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
154376136|NCT04350021|Capecitabine|capecitabine|mesh-list
154376137|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154376138|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
154376139|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376140|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154376141|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154376142|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
154376143|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376144|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376145|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154376146|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154376147|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
154376148|NCT04308174|Durvalumab|durvalumab|mesh-list
154376149|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376150|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376151|NCT04290546|Cetuximab|cetuximab|mesh-list
154376152|NCT04290546|Ipilimumab|ipilimumab|mesh-list
154376153|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154376154|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376155|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376156|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376157|NCT04274426|Paclitaxel|paclitaxel|mesh-list
154376158|NCT04274426|Maytansine|maytansine|mesh-list
154376159|NCT04274426|Carboplatin|carboplatin|mesh-list
154376160|NCT04274426|Gemcitabine|gemcitabine|mesh-list
154376161|NCT04274426|Doxorubicin|doxorubicin|mesh-list
154376162|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153738034|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
154376172|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154376173|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154376174|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154376175|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376177|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
154376178|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376179|NCT04272801|Tamoxifen|tamoxifen|mesh-list
154376180|NCT04272801|Letrozole|letrozole|mesh-list
154376181|NCT04272801|Anastrozole|anastrozole|mesh-list
154376182|NCT04272801|Exemestane|exemestane|mesh-list
154376183|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376184|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154376185|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154376186|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376187|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376188|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154376189|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
154376190|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376191|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376192|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376193|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154376194|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154376195|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154376196|NCT04261439|Tislelizumab|tislelizumab|mesh-list
154376197|NCT04261439|Spartalizumab|spartalizumab|mesh-list
154376198|NCT04261439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376199|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376200|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376201|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376202|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154376203|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376204|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154376205|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
154376206|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154376207|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
154376208|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154376209|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154376210|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376211|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
154376212|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
154376213|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154376214|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154376215|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376216|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376217|NCT04213209|Immunotoxins|immunotoxins|mesh-ancestor
154376218|NCT04213209|Immunoconjugates|immunoconjugates|mesh-ancestor
154376219|NCT04213209|Immunologic Factors|immunologic factors|mesh-ancestor
154376220|NCT04213209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376221|NCT04186871|Abatacept|abatacept|mesh-list
154376222|NCT04186871|Branebrutinib|branebrutinib|mesh-list
154376223|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376224|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376225|NCT04186871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376226|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376239|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376241|NCT04100018|Docetaxel|docetaxel|mesh-list
154376242|NCT04100018|Nivolumab|nivolumab|mesh-list
154376243|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376244|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376245|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376246|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376247|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376248|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376249|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
154376251|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376252|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376253|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376254|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376255|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376256|NCT04058366|Ivacaftor|ivacaftor|mesh-list
154376257|NCT04058366|Elexacaftor|elexacaftor|mesh-list
154376258|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154376259|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154376260|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376261|NCT04030455|Cisplatin|cisplatin|mesh-list
154376262|NCT04030455|Carboplatin|carboplatin|mesh-list
154376263|NCT04030455|Docetaxel|docetaxel|mesh-list
154376264|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
154376265|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376266|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376268|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376269|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376270|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376271|NCT04030455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376272|NCT04022980|Nivolumab|nivolumab|mesh-list
154376273|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376274|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376275|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376276|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376277|NCT04021108|Nivolumab|nivolumab|mesh-list
154376278|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376279|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376280|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376281|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376282|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
154376283|NCT04008706|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154376284|NCT04008706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376285|NCT04008706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376286|NCT04008706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376300|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154376302|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376303|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376304|NCT03946878|Venetoclax|venetoclax|mesh-list
154376305|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
154376306|NCT03946878|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154376307|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376308|NCT03946878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376309|NCT03946878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376310|NCT03946878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376311|NCT03903835|Prednisone|prednisone|mesh-list
154376312|NCT03903835|Carboplatin|carboplatin|mesh-list
154376313|NCT03903835|Docetaxel|docetaxel|mesh-list
154376314|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
154376315|NCT03903835|Niraparib|niraparib|mesh-list
154376316|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154376317|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154376318|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376319|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376320|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376321|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376322|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376323|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376324|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
154376325|NCT03903835|Hormones|hormones|mesh-ancestor
154376326|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376327|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376328|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376329|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154376330|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376331|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
154376332|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154376333|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154376334|NCT03875144|Cisplatin|cisplatin|mesh-list
154376335|NCT03875144|Doxorubicin|doxorubicin|mesh-list
154376336|NCT03875144|Pemetrexed|pemetrexed|mesh-list
154376337|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376338|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154376339|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154376340|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154376341|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376342|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376343|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154376344|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154376345|NCT03850691|Aldesleukin|aldesleukin|mesh-list
154376346|NCT03850691|Nivolumab|nivolumab|mesh-list
154376347|NCT03850691|Ipilimumab|ipilimumab|mesh-list
153738224|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376352|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154376353|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154376354|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
154376355|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154376356|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154376358|NCT03847857|Coagulants|coagulants|mesh-ancestor
154376360|NCT03840902|Etoposide|etoposide|mesh-list
154376361|NCT03840902|Carboplatin|carboplatin|mesh-list
154376362|NCT03840902|Pemetrexed|pemetrexed|mesh-list
154376363|NCT03840902|Durvalumab|durvalumab|mesh-list
154376364|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376365|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376366|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376367|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376368|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376369|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376370|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154376371|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154376372|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376373|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154376374|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154376375|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376376|NCT03839446|Etoposide|etoposide|mesh-list
154376377|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
154376378|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
154376379|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376380|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376381|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154376382|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154376383|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376384|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376385|NCT03839446|Analgesics|analgesics|mesh-ancestor
154376386|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
154376387|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219278|NCT02532114|Niclosamide|niclosamide|mesh-list
154376388|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376389|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376390|NCT03839446|Immunotoxins|immunotoxins|mesh-ancestor
154376391|NCT03839446|Immunoconjugates|immunoconjugates|mesh-ancestor
154376392|NCT03839446|Immunologic Factors|immunologic factors|mesh-ancestor
154376393|NCT03819088|Zinc|zinc|mesh-list
154376394|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
154376395|NCT03819088|Trace Elements|trace elements|mesh-ancestor
154376396|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
154376397|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376398|NCT03819088|Astringents|astringents|mesh-ancestor
154376399|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
154376400|NCT03778957|Bevacizumab|bevacizumab|mesh-list
154376401|NCT03778957|Durvalumab|durvalumab|mesh-list
154376402|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376403|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376404|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154376405|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154376406|NCT03778957|Growth Substances|growth substances|mesh-ancestor
154376407|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376408|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
154376409|NCT03775486|Paclitaxel|paclitaxel|mesh-list
154376410|NCT03775486|Cisplatin|cisplatin|mesh-list
154376411|NCT03775486|Carboplatin|carboplatin|mesh-list
154376412|NCT03775486|Gemcitabine|gemcitabine|mesh-list
154376413|NCT03775486|Pemetrexed|pemetrexed|mesh-list
154376414|NCT03775486|Durvalumab|durvalumab|mesh-list
154376415|NCT03775486|Olaparib|olaparib|mesh-list
154376416|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154376417|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376418|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376419|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376420|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376421|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376429|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
154376430|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376431|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154376432|NCT03742102|Paclitaxel|paclitaxel|mesh-list
154376433|NCT03742102|Trastuzumab|trastuzumab|mesh-list
154376434|NCT03742102|Durvalumab|durvalumab|mesh-list
154376435|NCT03742102|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154376436|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376437|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376438|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376439|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376440|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376441|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376442|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376443|NCT03742102|Immunoconjugates|immunoconjugates|mesh-ancestor
154376444|NCT03742102|Immunologic Factors|immunologic factors|mesh-ancestor
154376445|NCT03742102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376446|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154376447|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376448|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376449|NCT03729609|Immunotoxins|immunotoxins|mesh-ancestor
154376450|NCT03729609|Immunoconjugates|immunoconjugates|mesh-ancestor
154376451|NCT03729609|Immunologic Factors|immunologic factors|mesh-ancestor
154376452|NCT03729609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376453|NCT03729401|Aspirin|aspirin|mesh-list
154376454|NCT03729401|Clopidogrel|clopidogrel|mesh-list
154376455|NCT03729401|Ticagrelor|ticagrelor|mesh-list
154376456|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154219328|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376457|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154376458|NCT03729401|Analgesics|analgesics|mesh-ancestor
154376459|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
154376460|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376461|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376462|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376463|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154376464|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154376465|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154376466|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376467|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154376468|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154376469|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376470|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
154376471|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154376472|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154376473|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154376474|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
154376475|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154376476|NCT03729011|Propofol|propofol|mesh-list
154376477|NCT03729011|Sevoflurane|sevoflurane|mesh-list
154376478|NCT03729011|Desflurane|desflurane|mesh-list
154376479|NCT03729011|Isoflurane|isoflurane|mesh-list
154376480|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154376481|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154376482|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376483|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154376484|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
154376485|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
154376486|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154376487|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154376488|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
154376535|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
154376536|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376537|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376538|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376539|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376540|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376541|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376542|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376543|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154376544|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154376545|NCT03635567|Growth Substances|growth substances|mesh-ancestor
154376546|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376547|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
154376548|NCT03635567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376549|NCT03620669|Durvalumab|durvalumab|mesh-list
154376550|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376551|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376552|NCT03610711|Nivolumab|nivolumab|mesh-list
154376553|NCT03610711|Relatlimab|relatlimab|mesh-list
154376554|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376555|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376556|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376557|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376558|NCT03576547|Dexamethasone|dexamethasone|mesh-list
154219386|NCT03978156|Dronabinol|dronabinol|mesh-list
154376559|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
154376560|NCT03576547|Rituximab|rituximab|mesh-list
154376561|NCT03576547|Venetoclax|venetoclax|mesh-list
154376562|NCT03576547|Ponatinib|ponatinib|mesh-list
154376563|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154376564|NCT03576547|Antibodies|antibodies|mesh-list
154376565|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
154376566|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154376567|NCT03576547|BB 1101|bb 1101|mesh-list
154376568|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
154376569|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376570|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376571|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
154376572|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
154376573|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376574|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154376575|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
154376576|NCT03576547|Hormones|hormones|mesh-ancestor
154376577|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376578|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376579|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376580|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154376581|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
154376582|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376583|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376584|NCT03576547|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154376585|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376586|NCT03564340|Cemiplimab|cemiplimab|mesh-list
154376587|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376588|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376589|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154376590|NCT03515837|Carboplatin|carboplatin|mesh-list
154376591|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
154376592|NCT03515837|Pemetrexed|pemetrexed|mesh-list
154376593|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154376594|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376595|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738463|NCT01756456|Mitogens|mitogens|mesh-list
154376610|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376612|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154376613|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376614|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154376615|NCT03384238|Panitumumab|panitumumab|mesh-list
154376616|NCT03384238|Antibodies|antibodies|mesh-list
154376617|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
154376618|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154376619|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
154376620|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376621|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376622|NCT03375242|Crizotinib|crizotinib|mesh-list
154376623|NCT03375242|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154376625|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376626|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376627|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376628|NCT03368963|Trifluridine|trifluridine|mesh-list
154376629|NCT03368963|Irinotecan|irinotecan|mesh-list
154376630|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154376631|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154376632|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376633|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376634|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376635|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
154376636|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
154376637|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154376638|NCT03365622|Acetaminophen|acetaminophen|mesh-list
154376639|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154376640|NCT03365622|Analgesics|analgesics|mesh-ancestor
154376641|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
154376642|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376643|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376644|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
154376645|NCT03361306|Elotuzumab|elotuzumab|mesh-list
154376646|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376647|NCT03325439|Brivaracetam|brivaracetam|mesh-list
154376648|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
154376649|NCT03324425|Simvastatin|simvastatin|mesh-list
154376650|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154376651|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154376652|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
154376653|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376654|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154376655|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154376674|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376675|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376676|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376677|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154376678|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154376679|NCT03141177|Growth Substances|growth substances|mesh-ancestor
154376680|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376681|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
154376682|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376683|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376685|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376686|NCT03098836|Prednisone|prednisone|mesh-list
154376687|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
154219486|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
154376688|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376689|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
154376690|NCT03098836|Hormones|hormones|mesh-ancestor
154376691|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376692|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376693|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376694|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376695|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154376696|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376697|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376698|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
154376699|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154376701|NCT03083691|Ipilimumab|ipilimumab|mesh-list
154376702|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376703|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376704|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376705|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376706|NCT03071536|Furosemide|furosemide|mesh-list
154376707|NCT03071536|Diuretics|diuretics|mesh-ancestor
154376708|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
154376709|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376710|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154376711|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154376712|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376713|NCT03069937|Docetaxel|docetaxel|mesh-list
154376743|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376744|NCT02942355|Palbociclib|palbociclib|mesh-list
154376745|NCT02942355|Anastrozole|anastrozole|mesh-list
154376746|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376747|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376748|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376749|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376750|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376751|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154376752|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154376753|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154376754|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
154376755|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376756|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376757|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154376758|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153738648|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154376809|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154376810|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376811|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376812|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154376813|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154376814|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
154376815|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376816|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154376817|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
154376818|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
154376819|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
154376820|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154376821|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
154376822|NCT02785224|Coagulants|coagulants|mesh-ancestor
154376823|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154376824|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
154376825|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
154376826|NCT02784171|Pemetrexed|pemetrexed|mesh-list
154376827|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376828|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376829|NCT02784171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376830|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376831|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376832|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154376833|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154376835|NCT02759107|Tirzepatide|tirzepatide|mesh-list
154376836|NCT02759107|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154376837|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154376838|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376839|NCT02759107|Incretins|incretins|mesh-ancestor
154376840|NCT02759107|Hormones|hormones|mesh-ancestor
154376841|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376842|NCT02733133|Testosterone|testosterone|mesh-list
154376843|NCT02733133|Androgens|androgens|mesh-ancestor
154376844|NCT02733133|Hormones|hormones|mesh-ancestor
154376845|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376846|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376847|NCT02697227|Nicotine|nicotine|mesh-list
154376848|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154376849|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
154376850|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376851|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376852|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154376853|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154376854|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
154376855|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154376877|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154376878|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376879|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376880|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154376881|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154376882|NCT02530697|Protective Agents|protective agents|mesh-ancestor
154376883|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376884|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
154376885|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154376886|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
154376887|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
154376888|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154376889|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376890|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154376891|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154376892|NCT02489006|Olaparib|olaparib|mesh-list
154376893|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154376894|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376895|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376896|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376897|NCT02467582|Aspirin|aspirin|mesh-list
154376898|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154376899|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154376900|NCT02467582|Analgesics|analgesics|mesh-ancestor
154376901|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
154219598|NCT01067430|Diclofenac|diclofenac|mesh-list
154376902|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376903|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376904|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376905|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154376906|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154376907|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154376944|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376945|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154376946|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
154376947|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154376961|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376963|NCT02143830|Busulfan|busulfan|mesh-list
154376964|NCT02143830|Fludarabine|fludarabine|mesh-list
154376965|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
154376966|NCT02143830|Lenograstim|lenograstim|mesh-list
154376967|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154376968|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
154376969|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376970|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154376971|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154862021|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376973|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376974|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376975|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154376976|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154376977|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
154376978|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154376979|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154376980|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
154376981|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154376982|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376983|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376984|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
154376985|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
154376986|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376987|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
154376988|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154376989|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
154376990|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
154376991|NCT01949129|Busulfan|busulfan|mesh-list
154376992|NCT01949129|Thiotepa|thiotepa|mesh-list
154376993|NCT01949129|Treosulfan|treosulfan|mesh-list
154376994|NCT01949129|Fludarabine|fludarabine|mesh-list
154376995|NCT01949129|Etoposide|etoposide|mesh-list
154376996|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
154376997|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154376998|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
154376999|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377000|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
154377001|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377002|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377003|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154377004|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
154377005|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377006|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377007|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154377008|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154377062|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154377063|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154377064|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154377065|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154377066|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377067|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154377068|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
154377069|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
154377070|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
154377071|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154377072|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154377073|NCT01857934|Analgesics|analgesics|mesh-ancestor
154377074|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
154377075|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377077|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154377078|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
154377079|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377080|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154377081|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
154377082|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
154377083|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154377085|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154377086|NCT01748149|Vemurafenib|vemurafenib|mesh-list
154377087|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377088|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154377089|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377090|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377091|NCT01589081|Nicotine|nicotine|mesh-list
154377092|NCT01589081|Progesterone|progesterone|mesh-list
154377093|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154377094|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
154377095|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377096|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377097|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154377098|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154377099|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
154377100|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154862022|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154862023|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
154377101|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377102|NCT01589081|Progestins|progestins|mesh-ancestor
154377103|NCT01589081|Hormones|hormones|mesh-ancestor
154377104|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377105|NCT01589068|Nicotine|nicotine|mesh-list
154377106|NCT01589068|Progesterone|progesterone|mesh-list
154377107|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154377108|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
154377109|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377110|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377111|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154377112|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153738987|NCT00471952|Caffeine|caffeine|mesh-list
154377138|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377140|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377141|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377142|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154377143|NCT01501513|Laxatives|laxatives|mesh-ancestor
154377144|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154377145|NCT01410942|Methylphenidate|methylphenidate|mesh-list
154377146|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154377147|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377148|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154123386|NCT04840888|Itraconazole|itraconazole|mesh-list
154377149|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154377150|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154377151|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377153|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377155|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154377156|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
154377157|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
154377158|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377159|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377160|NCT01217931|Bevacizumab|bevacizumab|mesh-list
154377161|NCT01217931|Everolimus|everolimus|mesh-list
154377183|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377184|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377185|NCT01192568|Urological Agents|urological agents|mesh-ancestor
154377186|NCT00680901|Capecitabine|capecitabine|mesh-list
154377187|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
154377188|NCT00680901|Lapatinib|lapatinib|mesh-list
154377189|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154377190|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
154377191|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377192|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377193|NCT00680901|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154377194|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154377195|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377196|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
154377197|NCT00557193|Leucovorin|leucovorin|mesh-list
154377198|NCT00557193|Folic Acid|folic acid|mesh-list
154377199|NCT00557193|Cytarabine|cytarabine|mesh-list
154377200|NCT00557193|Dexamethasone|dexamethasone|mesh-list
154377201|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
154377202|NCT00557193|Prednisone|prednisone|mesh-list
154377203|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
154377204|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154377205|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154377206|NCT00557193|Prednisolone|prednisolone|mesh-list
154377207|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
154377208|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
154377209|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154377210|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154377211|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154377212|NCT00557193|Cortisone|cortisone|mesh-list
154377213|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
154377214|NCT00557193|Methotrexate|methotrexate|mesh-list
154377215|NCT00557193|Etoposide|etoposide|mesh-list
154377216|NCT00557193|Vincristine|vincristine|mesh-list
154377217|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
154377244|NCT00557193|Hormones|hormones|mesh-ancestor
154377245|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377246|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154377247|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
154377248|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377249|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154377250|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154377251|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154377252|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
154377253|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154377254|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154377255|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
154377256|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
154377257|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154377258|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154377259|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154377260|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154377261|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154377262|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
154377263|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377264|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154377265|NCT00557193|Antidotes|antidotes|mesh-ancestor
154377266|NCT00557193|Protective Agents|protective agents|mesh-ancestor
154377267|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
154377268|NCT00557193|Vitamins|vitamins|mesh-ancestor
154377269|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
154377303|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377304|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
154377305|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123528|NCT00527332|Fentanyl|fentanyl|mesh-list
154377306|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377307|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154377308|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
154377309|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219793|NCT00298740|Insulin|insulin|mesh-list
154377310|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377311|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154377312|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154377313|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154377341|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
154377342|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154377343|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
154377344|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377345|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377346|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154377347|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
154377348|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154377349|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154377350|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154377351|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
154377352|NCT05183334|Tramadol|tramadol|mesh-list
154377353|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
154377354|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154377355|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154377356|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377357|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377358|NCT05183334|Urological Agents|urological agents|mesh-ancestor
154377359|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154377360|NCT05183334|Narcotics|narcotics|mesh-ancestor
154377396|NCT06065137|Propofol|propofol|mesh-list
154377397|NCT06065137|Etomidate|etomidate|mesh-list
154377398|NCT06065137|Atracurium|atracurium|mesh-list
154377399|NCT06065137|Rocuronium|rocuronium|mesh-list
154377400|NCT06065137|Cisatracurium|cisatracurium|mesh-list
154377401|NCT06065137|Succinylcholine|succinylcholine|mesh-list
154377402|NCT06065137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153739285|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154377439|NCT06064539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377440|NCT06064539|Leprostatic Agents|leprostatic agents|mesh-ancestor
154377467|NCT06064331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377468|NCT06064331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154377469|NCT06064331|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154377470|NCT06064331|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154377471|NCT06064331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154377472|NCT06064331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377473|NCT06064175|Ibuprofen|ibuprofen|mesh-list
154377474|NCT06064175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154377475|NCT06064175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154377476|NCT06064175|Analgesics|analgesics|mesh-ancestor
154377477|NCT06064175|Sensory System Agents|sensory system agents|mesh-ancestor
154377478|NCT06064175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377480|NCT06064175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154377482|NCT06064175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154377483|NCT06064175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377484|NCT06064175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377501|NCT06063798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377502|NCT06063772|Clevidipine|clevidipine|mesh-list
154377503|NCT06063772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154377504|NCT06063772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154377505|NCT06063772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219844|NCT00284856|Fluticasone|fluticasone|mesh-list
154377506|NCT06063772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154377507|NCT06063772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377508|NCT06062134|Ropivacaine|ropivacaine|mesh-list
154377509|NCT06062134|Anesthetics, Local|anesthetics, local|mesh-ancestor
154377510|NCT06062134|Anesthetics|anesthetics|mesh-ancestor
154377511|NCT06062134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377512|NCT06062134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377513|NCT06062134|Sensory System Agents|sensory system agents|mesh-ancestor
154377514|NCT06062134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377515|NCT06059911|Caffeine|caffeine|mesh-list
154377516|NCT06059911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154377517|NCT06059911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377518|NCT06059911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154377519|NCT06059911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377520|NCT06059911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377521|NCT06059911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154377522|NCT06059911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154377523|NCT06059911|Purinergic Agents|purinergic agents|mesh-ancestor
154377524|NCT06059911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377525|NCT06059339|Analgesics, Opioid|analgesics, opioid|mesh-list
154377526|NCT06059339|Narcotics|narcotics|mesh-ancestor
154377527|NCT06059339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377528|NCT06059339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377529|NCT06059339|Analgesics|analgesics|mesh-ancestor
154377530|NCT06059339|Sensory System Agents|sensory system agents|mesh-ancestor
154377531|NCT06059339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377533|NCT06041932|Pentoxifylline|pentoxifylline|mesh-list
154377534|NCT06041932|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154377535|NCT06041932|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154377536|NCT06041932|Adrenergic Agents|adrenergic agents|mesh-ancestor
154377537|NCT06041932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377538|NCT06041932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377539|NCT06041932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377540|NCT06041932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154377541|NCT06041932|Antioxidants|antioxidants|mesh-ancestor
154377561|NCT06040424|Respiratory System Agents|respiratory system agents|mesh-ancestor
154377563|NCT06040424|Cholinergic Agents|cholinergic agents|mesh-ancestor
154377564|NCT06040424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377565|NCT06040424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377566|NCT06040424|Tocolytic Agents|tocolytic agents|mesh-ancestor
154377567|NCT06040424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154377568|NCT06040424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154377569|NCT06040424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154377570|NCT06040424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154377571|NCT06040424|Adrenergic Agents|adrenergic agents|mesh-ancestor
154377572|NCT06036823|Insulin|insulin|mesh-list
154377573|NCT06036823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154377574|NCT06036823|Albuterol|albuterol|mesh-list
154377575|NCT06036823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154377576|NCT06036823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377577|NCT06036823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154377578|NCT06036823|Autonomic Agents|autonomic agents|mesh-ancestor
154377579|NCT06036823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377580|NCT06036823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154377581|NCT06036823|Respiratory System Agents|respiratory system agents|mesh-ancestor
154377582|NCT06036823|Tocolytic Agents|tocolytic agents|mesh-ancestor
154377583|NCT06036823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154377584|NCT06036823|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154377585|NCT06036823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154377586|NCT06036823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154377587|NCT06036823|Adrenergic Agents|adrenergic agents|mesh-ancestor
154377588|NCT06036823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377589|NCT06036823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377590|NCT06021990|Clopidogrel|clopidogrel|mesh-list
154377591|NCT06021990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154377592|NCT06021990|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154377593|NCT06021990|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154377594|NCT06021990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154377625|NCT05907993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377626|NCT05907993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154377627|NCT05907993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377628|NCT05907993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154377629|NCT05907993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377630|NCT05907993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377631|NCT05890898|Nitrous Oxide|nitrous oxide|mesh-list
154377632|NCT05890898|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154377633|NCT05890898|Anesthetics, General|anesthetics, general|mesh-ancestor
154377634|NCT05890898|Anesthetics|anesthetics|mesh-ancestor
154377635|NCT05890898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377636|NCT05890898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377637|NCT05890898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154377638|NCT05890898|Analgesics|analgesics|mesh-ancestor
154377664|NCT05735717|Nootropic Agents|nootropic agents|mesh-ancestor
154377665|NCT05723276|Psilocybin|psilocybin|mesh-list
154377666|NCT05723276|Hallucinogens|hallucinogens|mesh-ancestor
154377667|NCT05723276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377668|NCT05723276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154377669|NCT05681195|Pemetrexed|pemetrexed|mesh-list
154377670|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
154377671|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377672|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377673|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377674|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154377675|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154377676|NCT05681195|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154377677|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154377678|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
154377679|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154377680|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154377681|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
154377682|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377683|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377684|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377685|NCT05635201|Anesthetics|anesthetics|mesh-list
154377686|NCT05635201|Propofol|propofol|mesh-list
154377687|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377688|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377689|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154377717|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377718|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154377719|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377720|NCT05506969|Vaccines|vaccines|mesh-list
154377721|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
154377722|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
154377723|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377724|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154377725|NCT05501483|Pioglitazone|pioglitazone|mesh-list
154377726|NCT05501483|Semaglutide|semaglutide|mesh-list
154377727|NCT05501483|Empagliflozin|empagliflozin|mesh-list
154377728|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154377729|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377730|NCT05501483|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154377731|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154377732|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377733|NCT05500599|Midazolam|midazolam|mesh-list
154377734|NCT05500599|Fentanyl|fentanyl|mesh-list
154377769|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
154377770|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377771|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377772|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154862024|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377773|NCT05451173|Durvalumab|durvalumab|mesh-list
154377774|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154377775|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739667|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154377809|NCT05360732|Folfirinox|folfirinox|mesh-list
154377810|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377811|NCT05320757|Olaparib|olaparib|mesh-list
154377812|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154377813|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377814|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377815|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377847|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154377848|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154377849|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
154377850|NCT05147220|Teriflunomide|teriflunomide|mesh-list
154377851|NCT05147220|Remibrutinib|remibrutinib|mesh-list
154377852|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154377853|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154377854|NCT05147220|Analgesics|analgesics|mesh-ancestor
154377855|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
154377856|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377857|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377858|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154377859|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377860|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377861|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
154377862|NCT05147220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154377863|NCT05147220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377896|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377897|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377898|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
154377899|NCT05020522|Phenobarbital|phenobarbital|mesh-list
154377900|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
154124115|NCT00827580|Eniluracil|eniluracil|mesh-list
153739790|NCT00150657|Bevacizumab|bevacizumab|mesh-list
154377928|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377929|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154377930|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154377931|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154377932|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154377933|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
154377934|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154377935|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154377936|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154377937|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154377938|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154377939|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377940|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154377941|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
154377942|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377943|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154377944|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
154377945|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154377946|NCT04970069|Analgesics|analgesics|mesh-list
154378014|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
154378015|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154378016|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
154378017|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378018|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378019|NCT04680923|Bupivacaine|bupivacaine|mesh-list
154378020|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
154378021|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
154378022|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378023|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378024|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
154378025|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378026|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154220058|NCT01068444|Pioglitazone|pioglitazone|mesh-list
154378027|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154378028|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378060|NCT04591431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154378061|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154378062|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378063|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378065|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378066|NCT04591431|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154378067|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154378068|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
154378069|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
154378070|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
154378072|NCT04591431|Immunoconjugates|immunoconjugates|mesh-ancestor
154378073|NCT04591431|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154378074|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
154378075|NCT04588311|Hematinics|hematinics|mesh-ancestor
154378076|NCT04551677|Vaccines|vaccines|mesh-list
154378077|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
154378078|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378079|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
154378112|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154378114|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378115|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
154378116|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378117|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154378118|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154378119|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378120|NCT04481204|Antidotes|antidotes|mesh-ancestor
154378121|NCT04481204|Protective Agents|protective agents|mesh-ancestor
154378122|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
154378123|NCT04481204|Vitamins|vitamins|mesh-ancestor
153740013|NCT00513058|Vinorelbine|vinorelbine|mesh-list
154378139|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
154378140|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
154378141|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378142|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378143|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
154378144|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378146|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154378147|NCT04296396|Narcotics|narcotics|mesh-ancestor
154378148|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378149|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378150|NCT04296396|Analgesics|analgesics|mesh-ancestor
154378151|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
154378152|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378153|NCT04259658|Calcium|calcium|mesh-list
154378154|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154378155|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378156|NCT04220021|Metformin|metformin|mesh-list
154378157|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154378158|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378159|NCT04193306|Alirocumab|alirocumab|mesh-list
154378160|NCT04193306|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154378161|NCT04193306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154378162|NCT04193306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154378163|NCT04193306|Antimetabolites|antimetabolites|mesh-ancestor
154378164|NCT04193306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378165|NCT04193306|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154378166|NCT04193306|Protease Inhibitors|protease inhibitors|mesh-ancestor
154378167|NCT04193306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378168|NCT04193306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154378169|NCT04141995|Leucovorin|leucovorin|mesh-list
154378170|NCT04141995|Fluorouracil|fluorouracil|mesh-list
154378171|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
154378172|NCT04141995|Irinotecan|irinotecan|mesh-list
154378173|NCT04141995|Camptothecin|camptothecin|mesh-list
154378174|NCT04141995|Digoxin|digoxin|mesh-list
154378175|NCT04141995|Calcium|calcium|mesh-list
154378176|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
154378177|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154378178|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378179|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
154378180|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378181|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154378182|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378183|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378184|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
154378185|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154378186|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154378224|NCT03826589|Avelumab|avelumab|mesh-list
154378245|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378246|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378247|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154378248|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
154378249|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378250|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
154378251|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378252|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378253|NCT03611556|Antidotes|antidotes|mesh-ancestor
154378254|NCT03611556|Protective Agents|protective agents|mesh-ancestor
154378255|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
154378256|NCT03611556|Vitamins|vitamins|mesh-ancestor
154378257|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
154378258|NCT03611556|Hematinics|hematinics|mesh-ancestor
154378259|NCT03608657|Apremilast|apremilast|mesh-list
154378260|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154378261|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154378262|NCT03608657|Analgesics|analgesics|mesh-ancestor
154378263|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
154378264|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378265|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378266|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378267|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378268|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154378269|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154378270|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378271|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378272|NCT03600857|Misoprostol|misoprostol|mesh-list
154378273|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154378274|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
154378275|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154378276|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378277|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154378278|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154378279|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
154378280|NCT03477162|Metformin|metformin|mesh-list
154378281|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154378298|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378299|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378300|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154378301|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154378302|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378303|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378305|NCT03248479|Magrolimab|magrolimab|mesh-list
154378306|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154378307|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
154378308|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220189|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
154378309|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378310|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378311|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378312|NCT03194126|Misoprostol|misoprostol|mesh-list
154378313|NCT03194126|Mifepristone|mifepristone|mesh-list
154378314|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154378315|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
154378316|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154378317|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378318|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154378319|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154378320|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
154378321|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154378322|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154378323|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154378324|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154378325|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
154378326|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154378327|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154378328|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
154378329|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154378330|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
154378331|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154378332|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154378333|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
154378334|NCT03061565|Hematinics|hematinics|mesh-ancestor
154378335|NCT02910414|Ethanol|ethanol|mesh-list
154378336|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154378337|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378338|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378339|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378341|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154378342|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
154378343|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378349|NCT02744092|Enoxaparin|enoxaparin|mesh-list
154378350|NCT02744092|Dalteparin|dalteparin|mesh-list
154378351|NCT02744092|PENTA|penta|mesh-list
154378352|NCT02744092|Warfarin|warfarin|mesh-list
154378353|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
154378354|NCT02744092|Dabigatran|dabigatran|mesh-list
154378355|NCT02744092|Apixaban|apixaban|mesh-list
154378356|NCT02744092|Edoxaban|edoxaban|mesh-list
154378357|NCT02744092|Fondaparinux|fondaparinux|mesh-list
154378358|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
154378359|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154378360|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
154378361|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154378362|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
154378363|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378364|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378365|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154378366|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154378368|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154378369|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378370|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
154378371|NCT02605421|Melphalan|melphalan|mesh-list
154378372|NCT02605421|Thiotepa|thiotepa|mesh-list
154378373|NCT02605421|Carboplatin|carboplatin|mesh-list
154378374|NCT02605421|Etoposide|etoposide|mesh-list
154378375|NCT02605421|Lenograstim|lenograstim|mesh-list
154378376|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378377|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
154378378|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378379|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378380|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154378381|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
154378382|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378383|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378384|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154378385|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154378386|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154378387|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154378388|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378389|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154378390|NCT02582905|Choline|choline|mesh-list
154378391|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154378392|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
154378393|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154378394|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
154378395|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378396|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154378397|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154378398|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
154378399|NCT02548364|Vitamin D|vitamin d|mesh-list
154378400|NCT02548364|Calcifediol|calcifediol|mesh-list
154378401|NCT02548364|Vitamins|vitamins|mesh-ancestor
154378402|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
154378403|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378404|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154378405|NCT02546375|Bosutinib|bosutinib|mesh-list
154378406|NCT02546375|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154378407|NCT02546375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154378408|NCT02546375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378409|NCT02546375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378410|NCT02504333|Paclitaxel|paclitaxel|mesh-list
154378411|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154378412|NCT02504333|Gemcitabine|gemcitabine|mesh-list
154378413|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154378414|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378415|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
154378416|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
154862025|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378417|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
154378418|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378437|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
154378438|NCT02473042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154378439|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154378441|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378442|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378443|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154378444|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154378445|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
154378446|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
154378447|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154378448|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154378449|NCT02305173|Dexamethasone|dexamethasone|mesh-list
154378450|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378451|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
154378452|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
154378453|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378454|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378455|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154378456|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
154378457|NCT02305173|Hormones|hormones|mesh-ancestor
154378458|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154378459|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154378460|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378461|NCT02272790|Paclitaxel|paclitaxel|mesh-list
154378462|NCT02272790|Carboplatin|carboplatin|mesh-list
154378463|NCT02272790|Gemcitabine|gemcitabine|mesh-list
154378464|NCT02272790|Adavosertib|adavosertib|mesh-list
154378465|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154378466|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378467|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
154378468|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
154378469|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
154378470|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378471|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154378472|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
154378473|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378474|NCT02100956|Oxytocin|oxytocin|mesh-list
154378475|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
154378476|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154378477|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378515|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378516|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378517|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
153740390|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
154378531|NCT03304288|Rituximab|rituximab|mesh-list
154378532|NCT03304288|Tretinoin|tretinoin|mesh-list
154378533|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378534|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378535|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
154378536|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378537|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378538|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
154378539|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154378540|NCT03313960|Insulin|insulin|mesh-list
154378541|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154378542|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378543|NCT03308890|Entecavir|entecavir|mesh-list
154378544|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
154378545|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378546|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154378547|NCT03313726|Hormones|hormones|mesh-ancestor
154378548|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154378549|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378550|NCT03303976|Vaccines|vaccines|mesh-list
154378551|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154378552|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
154378553|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378554|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
154378555|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154378556|NCT03313414|Velpatasvir|velpatasvir|mesh-list
154378557|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
154378558|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378559|NCT02468518|Vitamin E|vitamin e|mesh-list
154378560|NCT02468518|Vitamins|vitamins|mesh-ancestor
154378561|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
154378562|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378563|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
154378564|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378565|NCT02468518|Protective Agents|protective agents|mesh-ancestor
154255514|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378566|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154378567|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
154378568|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
154378569|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378570|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378571|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
154378572|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378573|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154378574|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
154378575|NCT05262322|Apixaban|apixaban|mesh-list
154378576|NCT05262322|Edoxaban|edoxaban|mesh-list
154378577|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154378578|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
154378579|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154378580|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
154378581|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740429|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
154378608|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
154378609|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378610|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378611|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378612|NCT01314872|Urological Agents|urological agents|mesh-ancestor
154378613|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154378614|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154378615|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154378616|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154378617|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378618|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
154378619|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378620|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378621|NCT00703924|Paromomycin|paromomycin|mesh-list
154378622|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154378623|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378624|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154378625|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154378626|NCT03302650|Norepinephrine|norepinephrine|mesh-list
154378627|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
154378628|NCT03302650|Giapreza|giapreza|mesh-list
154378651|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378653|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378654|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378655|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
154378656|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154378657|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154378658|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154378659|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154378660|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378661|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
154378662|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378663|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378664|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154378665|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378666|NCT00739050|Simvastatin|simvastatin|mesh-list
154378667|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154378668|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154378669|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
154124863|NCT00957411|Cetuximab|cetuximab|mesh-list
154378670|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378671|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154378672|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154378673|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378675|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154378676|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154378677|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
154378678|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378679|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378691|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154378692|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
154378693|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378694|NCT03311932|Hydrocortisone|hydrocortisone|mesh-list
154378695|NCT03311932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378696|NCT00604812|Rizatriptan|rizatriptan|mesh-list
154862026|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154255937|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154378697|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154378698|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
154378699|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378700|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378701|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378702|NCT04347408|Antibodies|antibodies|mesh-list
154378703|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
154378704|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378705|NCT03306550|Aspirin|aspirin|mesh-list
154378706|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154378707|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154378708|NCT03306550|Analgesics|analgesics|mesh-ancestor
154378709|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
154378710|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378711|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378712|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378713|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378714|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154378715|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154378716|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378717|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154378718|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154378719|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378720|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
154378721|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
154378722|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378723|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378724|NCT03311542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154378725|NCT03311542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378726|NCT03311464|Adalimumab|adalimumab|mesh-list
154378727|NCT03311464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154378728|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378729|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378730|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
154378731|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
154378732|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378733|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378734|NCT02468206|Polidocanol|polidocanol|mesh-list
154378735|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154378736|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154378737|NCT01344174|Lamivudine|lamivudine|mesh-list
154378738|NCT01344174|Dexamethasone|dexamethasone|mesh-list
154378739|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378740|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
154378741|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
154378742|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378743|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378748|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154378749|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378750|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154378751|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154378752|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378753|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378754|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
154378755|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378756|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154378757|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154378758|NCT05162274|Lazertinib|lazertinib|mesh-list
154378759|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154378760|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378761|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378762|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154378763|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
154378764|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
154378765|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378766|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154378767|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154378768|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154378769|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378770|NCT02468908|Molgramostim|molgramostim|mesh-list
154378771|NCT02468908|Sargramostim|sargramostim|mesh-list
154862027|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154255515|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378772|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
154378773|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378774|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378775|NCT02468128|Nalbuphine|nalbuphine|mesh-list
154378776|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154378777|NCT02468128|Narcotics|narcotics|mesh-ancestor
154378778|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378779|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378780|NCT02468128|Analgesics|analgesics|mesh-ancestor
154378781|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
154378782|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378783|NCT03305536|Vitamin D|vitamin d|mesh-list
154378784|NCT03305536|Vitamins|vitamins|mesh-list
154378785|NCT03305536|Vitamin K|vitamin k|mesh-list
154378786|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
154378787|NCT03305536|Menaquinone 7|menaquinone 7|mesh-list
154378788|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
154378789|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378790|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154378791|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154378792|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154378793|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378794|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
154378795|NCT03305536|Coagulants|coagulants|mesh-ancestor
154378796|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
154378797|NCT02467426|Analgesics|analgesics|mesh-ancestor
154378798|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
154378799|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378800|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378801|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378802|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154378803|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154378804|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378805|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378806|NCT04296942|Trastuzumab|trastuzumab|mesh-list
154378807|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154378808|NCT04296942|Maytansine|maytansine|mesh-list
154378809|NCT04296942|Entinostat|entinostat|mesh-list
154378810|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378811|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378812|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154378813|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
153740661|NCT05731596|Vitamins|vitamins|mesh-ancestor
154378825|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
154378826|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154378827|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378828|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154378829|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378831|NCT01344720|Oxycodone|oxycodone|mesh-list
154378832|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154378833|NCT01344720|Narcotics|narcotics|mesh-ancestor
154378834|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378835|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378836|NCT01344720|Analgesics|analgesics|mesh-ancestor
154378837|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
154378838|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378839|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154378840|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154378841|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378842|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378843|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154378844|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154378845|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378846|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378847|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154378848|NCT03220854|Antibodies|antibodies|mesh-list
154378849|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
154378850|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154378851|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
154378852|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378853|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378854|NCT03305068|Celecoxib|celecoxib|mesh-list
154378855|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154378856|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154862028|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154378857|NCT03305068|Analgesics|analgesics|mesh-ancestor
154378858|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
154378859|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378860|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378861|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378862|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378863|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154378864|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154378865|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378866|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378867|NCT04490590|Etoposide|etoposide|mesh-list
154378868|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154378869|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378870|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154378871|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154378872|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378873|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378874|NCT03299998|Anesthetics|anesthetics|mesh-list
154378875|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378876|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378877|NCT05468632|Semaglutide|semaglutide|mesh-list
153740733|NCT05457582|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154378895|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378896|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378897|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154378898|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378899|NCT03168438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154378900|NCT03299296|Enoxaparin|enoxaparin|mesh-list
154378901|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
154378902|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154378903|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
154378904|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154378905|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
154378906|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378907|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378908|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
154378909|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154378910|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154378911|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
154378912|NCT03137784|Bromides|bromides|mesh-list
154378913|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
154378914|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154378915|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154378916|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154378917|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
154378918|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378919|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378920|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378921|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
154378922|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154378923|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154378924|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
154378925|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154378926|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
154378927|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378928|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378929|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
154378930|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
154378931|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378932|NCT01347996|Interleukin-2|interleukin-2|mesh-list
154378933|NCT01347996|Histamine|histamine|mesh-list
154378934|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
154378935|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740797|NCT04971499|Dapansutrile|dapansutrile|mesh-list
154378948|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
154378949|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378950|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
154378951|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378952|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
154378953|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154378954|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154378955|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378956|NCT02466802|Urological Agents|urological agents|mesh-ancestor
154378958|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154378960|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378961|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154378962|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154378963|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
154378964|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378965|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154378966|NCT04074174|Acetaminophen|acetaminophen|mesh-list
154378967|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
154378968|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
154378969|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154378970|NCT04074174|Analgesics|analgesics|mesh-ancestor
154378971|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
154378972|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378973|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378974|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
154378975|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154378976|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154378977|NCT03620292|Bevacizumab|bevacizumab|mesh-list
154378978|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378979|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378980|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154378981|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154378982|NCT03620292|Growth Substances|growth substances|mesh-ancestor
154378983|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378984|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
154378985|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
154378986|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154378987|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378988|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378989|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154378990|NCT01353378|Analgesics|analgesics|mesh-ancestor
154378991|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
154378992|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378993|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154378994|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154378995|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154378996|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
153740859|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
154379023|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154379025|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379026|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379027|NCT05549726|Cabotegravir|cabotegravir|mesh-list
154379028|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154379029|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154379030|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379031|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379032|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154379033|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154379034|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
154379035|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379036|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
154379037|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154379038|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379039|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379040|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154379041|NCT01353456|Analgesics|analgesics|mesh-ancestor
154379042|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
154125243|NCT00949455|Lapatinib|lapatinib|mesh-list
153740918|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154379060|NCT05726734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379062|NCT05726734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379063|NCT05726734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154379064|NCT05726734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154379065|NCT05726734|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154379066|NCT05726734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154379067|NCT05726734|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154379068|NCT05726734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379069|NCT05726734|Antacids|antacids|mesh-ancestor
154379070|NCT05726734|Diuretics|diuretics|mesh-ancestor
154379071|NCT05726734|Natriuretic Agents|natriuretic agents|mesh-ancestor
154379072|NCT05726734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379073|NCT05726734|Expectorants|expectorants|mesh-ancestor
154379074|NCT05726734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154255517|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379075|NCT01317966|Rituximab|rituximab|mesh-list
154379076|NCT01317966|Oprelvekin|oprelvekin|mesh-list
154379077|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379078|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379079|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
154379080|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379081|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154379082|NCT01345734|Liraglutide|liraglutide|mesh-list
154379083|NCT01345734|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154379084|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154379085|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379086|NCT01345734|Incretins|incretins|mesh-ancestor
154379087|NCT01345734|Hormones|hormones|mesh-ancestor
154379088|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379089|NCT01318044|Thiopental|thiopental|mesh-list
154379090|NCT01318044|Propofol|propofol|mesh-list
154379091|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154379092|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379093|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379094|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154379095|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
154379096|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
154379097|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
154379098|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
154379099|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
154379100|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379101|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379102|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154379115|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154379117|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
154379118|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154379119|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379120|NCT01349010|Probucol|probucol|mesh-list
154379121|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154379122|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154379123|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
154379124|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379125|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154379126|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
154379127|NCT01349010|Protective Agents|protective agents|mesh-ancestor
154379128|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379129|NCT05232370|Losartan|losartan|mesh-list
154379130|NCT05232370|Enalapril|enalapril|mesh-list
154379131|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154379132|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154379133|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154379134|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154379135|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154379136|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154220766|NCT00293384|BB 1101|bb 1101|mesh-list
154379137|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379138|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
154379139|NCT01349088|Niacinamide|niacinamide|mesh-list
154379140|NCT01349088|Capecitabine|capecitabine|mesh-list
154379141|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
154379142|NCT01349088|Imetelstat|imetelstat|mesh-list
154379143|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154379144|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
154379145|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379146|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379147|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154379148|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379149|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
154379150|NCT01349088|Vitamins|vitamins|mesh-ancestor
154379151|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
154379152|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379153|NCT04490434|Celecoxib|celecoxib|mesh-list
154379154|NCT04490434|Naproxen|naproxen|mesh-list
154379155|NCT04490434|Meloxicam|meloxicam|mesh-list
154379156|NCT04490434|Fexuprazan|fexuprazan|mesh-list
154379157|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154379158|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154379159|NCT04490434|Analgesics|analgesics|mesh-ancestor
154379160|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
154379161|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379162|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862029|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154255518|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
153777894|NCT00566683|Meperidine|meperidine|mesh-list
154379163|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154379164|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154379165|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154379166|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154379198|NCT02879994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379199|NCT02466022|Midazolam|midazolam|mesh-list
154379200|NCT02466022|Fentanyl|fentanyl|mesh-list
154379201|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
154379202|NCT02466022|Bupivacaine|bupivacaine|mesh-list
154379203|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
154379204|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
154379205|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379206|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379207|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
154379208|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379220|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154379221|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154379222|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154379223|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
154379224|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
154379225|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
154379226|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154379227|NCT02466022|Narcotics|narcotics|mesh-ancestor
154379228|NCT03937596|Cycloserine|cycloserine|mesh-list
154379229|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154379230|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379231|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154379232|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
154379233|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154379234|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
154379235|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379236|NCT03578172|Menotropins|menotropins|mesh-list
154379237|NCT03578172|Hormones|hormones|mesh-list
154379238|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379239|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220825|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154379240|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154379241|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
154379242|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154379243|NCT03928158|Valsartan|valsartan|mesh-list
154379244|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154379245|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154379246|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154379247|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154379248|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379249|NCT01354158|Droxidopa|droxidopa|mesh-list
154379250|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154379251|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154379252|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154379253|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154379254|NCT02466490|Diuretics|diuretics|mesh-ancestor
154379255|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
154379256|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379257|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154379258|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154379259|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379260|NCT04547842|Dexamethasone|dexamethasone|mesh-list
154379261|NCT04547842|Mirtazapine|mirtazapine|mesh-list
154379262|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154379263|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
154379264|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
154379265|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379266|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379267|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154379268|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
154379269|NCT04547842|Hormones|hormones|mesh-ancestor
154379270|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125474|NCT00839280|Vitamins|vitamins|mesh-ancestor
154379276|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
154379277|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
154379278|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379279|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862030|NCT03013075|Morphine|morphine|mesh-list
154862031|NCT03013075|Bupivacaine|bupivacaine|mesh-list
154862032|NCT03013075|Anesthetics|anesthetics|mesh-list
154379280|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154379281|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154379282|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379283|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154379284|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154379285|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154379286|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
154379287|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154379288|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154379290|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154379291|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
154379292|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
154379293|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379294|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
154379295|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379296|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379298|NCT00702052|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154379299|NCT00702052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154379300|NCT00702052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379301|NCT00702052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379302|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154379303|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
154379304|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379305|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379306|NCT01354470|Modafinil|modafinil|mesh-list
154379307|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154379308|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379309|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154379310|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154379311|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154379312|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379313|NCT01349556|Tretinoin|tretinoin|mesh-list
154379314|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379315|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
154379316|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154379317|NCT01354704|Enoxaparin|enoxaparin|mesh-list
154379318|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
154379319|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154379320|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154379321|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379322|NCT01346670|Lovastatin|lovastatin|mesh-list
154379323|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154379324|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154379325|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
154379326|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379327|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154379328|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154379329|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379330|NCT03136068|Digoxin|digoxin|mesh-list
154379331|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154379332|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154379333|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379334|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379335|NCT03136068|Protective Agents|protective agents|mesh-ancestor
154379336|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379337|NCT01350024|Lidocaine|lidocaine|mesh-list
153741184|NCT02144857|Etanercept|etanercept|mesh-list
154379357|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154379358|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
154379359|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154379360|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
154379362|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
154379363|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154379364|NCT01318590|Triamcinolone|triamcinolone|mesh-list
154379365|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154379366|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154379367|NCT01318590|Bupivacaine|bupivacaine|mesh-list
154379368|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154379369|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
154379370|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
154379371|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379372|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379373|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
154379374|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379375|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154379376|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
154379378|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379379|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154379380|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
154379381|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379382|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379383|NCT01346826|Infliximab|infliximab|mesh-list
154379384|NCT01346826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154379385|NCT01346826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154379386|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
154379387|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154379388|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154379389|NCT01354860|Lobeline|lobeline|mesh-list
154379390|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154379391|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
154379392|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379397|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379398|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379399|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
154379400|NCT02556606|Midazolam|midazolam|mesh-list
154379401|NCT02556606|Ketamine|ketamine|mesh-list
154379402|NCT02556606|Analgesics|analgesics|mesh-ancestor
154379403|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
154379404|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379405|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379406|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154379407|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154379408|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
154379409|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
154379410|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379411|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154379412|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154379413|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379414|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379415|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154379416|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154379417|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154379418|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154379419|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154379420|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
154379421|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
154379422|NCT01355562|Interleukin-2|interleukin-2|mesh-list
154379423|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379424|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154379425|NCT01355562|Analgesics|analgesics|mesh-ancestor
154379426|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
154379427|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379428|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379429|NCT01350570|Loperamide|loperamide|mesh-list
154379430|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
154379431|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154379432|NCT01355718|Repaglinide|repaglinide|mesh-list
154379433|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154379434|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379435|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154379436|NCT03377790|Cantharidin|cantharidin|mesh-list
154379437|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379438|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379439|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
154379440|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154379441|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154379442|NCT02422368|Prednisolone|prednisolone|mesh-list
154379443|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
154379444|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154379445|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
154379446|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154379447|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
154379448|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
154862033|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
154379449|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379450|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379451|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154379452|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
154379453|NCT02422368|Hormones|hormones|mesh-ancestor
154379454|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379455|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154379456|NCT02422368|Protective Agents|protective agents|mesh-ancestor
154221024|NCT00093808|Capecitabine|capecitabine|mesh-list
154379457|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154379458|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379459|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
154379460|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
154379461|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379462|NCT01355952|Protective Agents|protective agents|mesh-ancestor
154379463|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379464|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
154379470|NCT05720572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154379472|NCT05720572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154379473|NCT05720572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379474|NCT05720572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154379475|NCT05720572|Histamine Antagonists|histamine antagonists|mesh-ancestor
154379476|NCT05720572|Histamine Agents|histamine agents|mesh-ancestor
154379477|NCT05720572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379478|NCT05720572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379479|NCT05720572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154379480|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
154379481|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
154379482|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154379483|NCT05716750|Vitamin D|vitamin d|mesh-list
154379484|NCT05716750|Vitamins|vitamins|mesh-ancestor
154379485|NCT05716750|Micronutrients|micronutrients|mesh-ancestor
154379486|NCT05716750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379487|NCT05716750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154379488|NCT01350882|Rituximab|rituximab|mesh-list
154379489|NCT01350882|Citric Acid|citric acid|mesh-list
154379490|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
154379491|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379492|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379493|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
154379494|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379495|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154379496|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
154125691|NCT00840606|Buspirone|buspirone|mesh-list
154379497|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154379498|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
154379499|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
154379500|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379501|NCT01844856|Ertapenem|ertapenem|mesh-list
154379502|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154379503|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379504|NCT00618098|Thrombin|thrombin|mesh-list
154379505|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
154379506|NCT00618098|Coagulants|coagulants|mesh-ancestor
154379507|NCT02464228|Tipifarnib|tipifarnib|mesh-list
154379508|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379509|NCT01351038|Capecitabine|capecitabine|mesh-list
154379510|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
154379511|NCT01351038|Panitumumab|panitumumab|mesh-list
154379512|NCT01351038|Epirubicin|epirubicin|mesh-list
154379513|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154379514|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
154379515|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379516|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379517|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379518|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154379519|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154379520|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154379521|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379522|NCT02464462|Vitamin D|vitamin d|mesh-list
154379523|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
154379524|NCT02464462|Calcium|calcium|mesh-list
154379525|NCT02464462|Vitamins|vitamins|mesh-ancestor
154379526|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
154379527|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379528|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154379529|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154379530|NCT04270864|Nivolumab|nivolumab|mesh-list
154379531|NCT04270864|Ipilimumab|ipilimumab|mesh-list
154379532|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379533|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379534|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154862034|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
154379535|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379536|NCT01318668|Vaccines|vaccines|mesh-list
154379537|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
154379549|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154379550|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154379551|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379552|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154379553|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379554|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
154379555|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
154379556|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154379557|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154379558|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154379559|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379560|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
154379561|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
154379562|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379563|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
154379564|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154379565|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379566|NCT01351818|Hormones|hormones|mesh-list
154379567|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379568|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379569|NCT02463994|Atezolizumab|atezolizumab|mesh-list
154379570|NCT02463994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154379571|NCT02463994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379572|NCT02463994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379573|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379574|NCT02079948|Folic Acid|folic acid|mesh-list
154379575|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
154379576|NCT02079948|Methotrexate|methotrexate|mesh-list
154379577|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154379578|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
154379579|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154379580|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379581|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154379582|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
154379583|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379584|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379585|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
154379586|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379587|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154379588|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154379589|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
154379590|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154379591|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154379592|NCT02079948|Hematinics|hematinics|mesh-ancestor
154379593|NCT02079948|Vitamins|vitamins|mesh-ancestor
154379594|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
154379595|NCT01357902|Lamotrigine|lamotrigine|mesh-list
154379596|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
154379597|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154379598|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154379608|NCT04634409|Sotrovimab|sotrovimab|mesh-list
154379609|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
154379610|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379611|NCT01352130|Ondansetron|ondansetron|mesh-list
154379612|NCT01352130|Granisetron|granisetron|mesh-list
154379613|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
154379614|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
154379615|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
154379616|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379617|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379618|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154379619|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
154379620|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
154379621|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154379622|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
154379623|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379624|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379625|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154379626|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154379627|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379628|NCT00005780|Prednisone|prednisone|mesh-list
154379629|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
154379630|NCT00005780|Doxorubicin|doxorubicin|mesh-list
154379631|NCT00005780|Etoposide|etoposide|mesh-list
154379632|NCT00005780|Vincristine|vincristine|mesh-list
154379633|NCT00005780|Sargramostim|sargramostim|mesh-list
154379634|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154379635|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
154379636|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379637|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154379638|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154379639|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
154379640|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379641|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379642|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154379643|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154379644|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154379645|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154125868|NCT00845598|Xhance|xhance|mesh-list
154379646|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379647|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154379648|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
154379650|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379651|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154379652|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154379653|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
154379654|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
154379655|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
154379656|NCT01356732|Sufentanil|sufentanil|mesh-list
154379657|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154379658|NCT01356732|Narcotics|narcotics|mesh-ancestor
154379659|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379660|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379661|NCT01356732|Analgesics|analgesics|mesh-ancestor
154379662|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
154379663|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379664|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154379677|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379678|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379679|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379680|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154379681|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154379682|NCT02465320|Lidocaine|lidocaine|mesh-list
154379683|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
154379684|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
154379685|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379686|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379687|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
154379688|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379689|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154379690|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154379691|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154379692|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154379693|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379694|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
154379695|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
154379696|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
154379697|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379698|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379699|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
154379700|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379701|NCT04105114|Buspirone|buspirone|mesh-list
154379702|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154379703|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154379704|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379705|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379706|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154379707|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154379708|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
154379709|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379710|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379711|NCT05573230|Cyclosporine|cyclosporine|mesh-list
154379712|NCT05573230|Midazolam|midazolam|mesh-list
154379713|NCT05573230|Cyclosporins|cyclosporins|mesh-list
154379714|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154379715|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154379716|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379717|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379718|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154379719|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154379720|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154379721|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154379722|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
154379723|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
154379724|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
154379725|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
154379726|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379727|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379765|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154379766|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379767|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379768|NCT01757782|Urological Agents|urological agents|mesh-ancestor
154379776|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
154379777|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379778|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379779|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154379780|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
154379781|NCT01330563|Ketoconazole|ketoconazole|mesh-list
154379782|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
154379783|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379784|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154379785|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154379786|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379787|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379788|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154379789|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
154379790|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379791|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379792|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154379793|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
154379794|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
154379795|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379796|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379797|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379798|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
154379799|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
154379801|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
154379802|NCT04897503|Vitamins|vitamins|mesh-ancestor
154379803|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
154379804|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379805|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154379806|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
154379807|NCT01333917|Curcumin|curcumin|mesh-list
154379808|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154379809|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154379810|NCT01333917|Analgesics|analgesics|mesh-ancestor
154379811|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
154379812|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379813|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379814|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154379815|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154379816|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379817|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379818|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379819|NCT03129360|Levetiracetam|levetiracetam|mesh-list
154379820|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
154379821|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
154379822|NCT01315275|Ranibizumab|ranibizumab|mesh-list
154379823|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154379824|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154379825|NCT01315275|Growth Substances|growth substances|mesh-ancestor
154379826|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379827|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
154379828|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379829|NCT01319448|Artesunate|artesunate|mesh-list
154379830|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
154379831|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
154379832|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154379835|NCT01319448|Proguanil|proguanil|mesh-list
154379836|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
153741676|NCT00520000|Carboplatin|carboplatin|mesh-list
154379855|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379857|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
154379858|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379859|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379860|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154379861|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154379862|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379863|NCT01928199|Incretins|incretins|mesh-ancestor
154379864|NCT01928199|Hormones|hormones|mesh-ancestor
154379865|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379866|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154379867|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
154379868|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379869|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379870|NCT01845441|Midazolam|midazolam|mesh-list
154379871|NCT01845441|Fentanyl|fentanyl|mesh-list
154126070|NCT00849264|Fluorouracil|fluorouracil|mesh-list
154379872|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
154379873|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154379874|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379875|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379876|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154379878|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
154379879|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379880|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154379881|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154379882|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154379883|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
154379884|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379885|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379886|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154379887|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154379888|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154379889|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154379890|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154379891|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
154379892|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
154379893|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
154379905|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379906|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154379907|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154379908|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
154379909|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
154379910|NCT01365936|Menotropins|menotropins|mesh-list
154379911|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154379912|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
154379913|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154379914|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379915|NCT01334151|Insulin|insulin|mesh-list
154379916|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154379917|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
154379918|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154379919|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379920|NCT03296410|Vaccines|vaccines|mesh-list
154379921|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
154379922|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379923|NCT05189184|Paclitaxel|paclitaxel|mesh-list
154379924|NCT05189184|Apatinib|apatinib|mesh-list
154379925|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154379926|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154379927|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379928|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
154379929|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
154379930|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
154379931|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379932|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154379933|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379934|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154379935|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154379936|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
154379937|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154379938|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379939|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
154379940|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379941|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379942|NCT03735290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154379943|NCT03735290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379944|NCT03619538|Nefopam|nefopam|mesh-list
154379945|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154379946|NCT03619538|Analgesics|analgesics|mesh-ancestor
154379947|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
154379948|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379949|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379950|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
154379951|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154379953|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154379954|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379955|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154379956|NCT01366326|Bromides|bromides|mesh-list
154379957|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
154379958|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
154379959|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154379960|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379961|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
153741793|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
154379973|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379974|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154379975|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
154379976|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379977|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379978|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
154379979|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154379980|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154379981|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154379982|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154379983|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
154379984|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154379985|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379986|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154379987|NCT01656434|Estrogens|estrogens|mesh-ancestor
154379988|NCT01656434|Hormones|hormones|mesh-ancestor
154379989|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379990|NCT01656434|Trace Elements|trace elements|mesh-ancestor
154379991|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
154379992|NCT01319214|Propranolol|propranolol|mesh-list
154379993|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154379994|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154379995|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
154379996|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379997|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379998|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379999|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154380000|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154380001|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
154380002|NCT01359228|Rifaximin|rifaximin|mesh-list
154380003|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154380004|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380005|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154380006|NCT02461030|Listerine|listerine|mesh-list
154380007|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
154380008|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
154380009|NCT02461030|Protective Agents|protective agents|mesh-ancestor
154380010|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380011|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154380012|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380013|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154380014|NCT01599494|Progesterone|progesterone|mesh-list
154380015|NCT01599494|Ganirelix|ganirelix|mesh-list
154380016|NCT01599494|Progestins|progestins|mesh-ancestor
154380017|NCT01599494|Hormones|hormones|mesh-ancestor
154380018|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380019|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380020|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154380021|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380022|NCT03295786|Dopamine|dopamine|mesh-list
154380023|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154380024|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
154380025|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
154380036|NCT03194932|Venetoclax|venetoclax|mesh-list
154380037|NCT03194932|Idarubicin|idarubicin|mesh-list
154380038|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154380039|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
154380040|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154380041|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380042|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154380043|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
154380044|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380045|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380046|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
154380047|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380048|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154380049|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380050|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
154380051|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380052|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154380053|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
154380054|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380055|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380056|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154380057|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154380058|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154380059|NCT03037580|Treprostinil|treprostinil|mesh-list
154380060|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154380061|NCT05154734|Belimumab|belimumab|mesh-list
154380062|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380063|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
154380064|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380065|NCT02978404|Nivolumab|nivolumab|mesh-list
154380066|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380067|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380068|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154380069|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380070|NCT04441918|Antibodies|antibodies|mesh-list
154380071|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154380072|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
154380073|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380074|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
154380075|NCT01331655|Drospirenone|drospirenone|mesh-list
154380076|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154380077|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380078|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380079|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380080|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154380081|NCT01331655|Diuretics|diuretics|mesh-ancestor
154380082|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
154380083|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
154380084|NCT01331655|Vitamins|vitamins|mesh-ancestor
154380085|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
154380086|NCT03289390|Acetaminophen|acetaminophen|mesh-list
154380087|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154380088|NCT03289390|Analgesics|analgesics|mesh-ancestor
154380089|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
154380090|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380091|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380110|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380111|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380112|NCT03295084|Capecitabine|capecitabine|mesh-list
154380113|NCT03295084|Irinotecan|irinotecan|mesh-list
154380114|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154380115|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
154380116|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380117|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380118|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154380119|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154380120|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380121|NCT01339689|Ganaxolone|ganaxolone|mesh-list
154380122|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
154380123|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221527|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380124|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380125|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380126|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
154380127|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
154380128|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153615972|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
154380129|NCT00702806|Ganirelix|ganirelix|mesh-list
154380130|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380131|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380132|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380133|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154380134|NCT03635931|Mitogens|mitogens|mesh-list
154380135|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154380136|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380137|NCT01331967|Pioglitazone|pioglitazone|mesh-list
154380138|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154380139|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380140|NCT00696878|Progesterone|progesterone|mesh-list
154380141|NCT00696878|Progestins|progestins|mesh-ancestor
154380142|NCT00696878|Hormones|hormones|mesh-ancestor
154380143|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380144|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380145|NCT00731757|Adalimumab|adalimumab|mesh-list
154380146|NCT00731757|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153741987|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
154380156|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154380157|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154380158|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154380159|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154380160|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
154380161|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
154380162|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
154380163|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
154380164|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380165|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380166|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154380167|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380168|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154380169|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
154380170|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154380171|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380172|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380173|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154380174|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154380175|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154380176|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
154380178|NCT02278588|Rasagiline|rasagiline|mesh-list
154380179|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154380180|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380181|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380182|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154380183|NCT02278588|Protective Agents|protective agents|mesh-ancestor
154380184|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380185|NCT03288610|Vasopressins|vasopressins|mesh-list
154380186|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
154380187|NCT03288610|Coagulants|coagulants|mesh-ancestor
154380188|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154380189|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154380190|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
154380191|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380192|NCT00696800|Progesterone|progesterone|mesh-list
154380193|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154380194|NCT00696800|Ganirelix|ganirelix|mesh-list
154380195|NCT00696800|Progestins|progestins|mesh-ancestor
154380196|NCT00696800|Hormones|hormones|mesh-ancestor
154380197|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380198|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380199|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380200|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
154380201|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154380202|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380203|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
154380204|NCT03288532|Durvalumab|durvalumab|mesh-list
154380205|NCT03288532|Tremelimumab|tremelimumab|mesh-list
154380206|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380207|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380208|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154380209|NCT00598208|Hormones|hormones|mesh-ancestor
154380210|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380211|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862035|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380213|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154380214|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380221|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154380223|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154380224|NCT00395408|Beclomethasone|beclomethasone|mesh-list
154380225|NCT00395408|Montelukast|montelukast|mesh-list
154380226|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380227|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380228|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
154380229|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154380230|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154380231|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380232|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380233|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154380234|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154380235|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380236|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
154380237|NCT00395408|Hormones|hormones|mesh-ancestor
154380238|NCT02462044|Iodine|iodine|mesh-list
154380239|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
154380240|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154380241|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380242|NCT02462044|Trace Elements|trace elements|mesh-ancestor
154380243|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
154380244|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380245|NCT00289874|Montelukast|montelukast|mesh-list
154380246|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154380247|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
154380248|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154380249|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380250|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126443|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380251|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380252|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154380253|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154380254|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380256|NCT00245570|Montelukast|montelukast|mesh-list
154380257|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154380258|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
154380259|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380260|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380261|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154380262|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
154380263|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154380264|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154380265|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154380266|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380267|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380268|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380269|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154380270|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380271|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380272|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154380273|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154380274|NCT02461888|Dexamethasone|dexamethasone|mesh-list
154380275|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
154380276|NCT02461888|Ixazomib|ixazomib|mesh-list
154380277|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380278|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
154380279|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380280|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380281|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153742107|NCT00523666|Galantamine|galantamine|mesh-list
154380291|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
154380292|NCT02461888|Hormones|hormones|mesh-ancestor
154380293|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380294|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154380295|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154380296|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380297|NCT00229970|Montelukast|montelukast|mesh-list
154380298|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154380299|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
154380300|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154380302|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380303|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380304|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154380305|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154380306|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380307|NCT00111722|Rizatriptan|rizatriptan|mesh-list
154380308|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380309|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380310|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380311|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154380312|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
154380313|NCT05235100|Apatinib|apatinib|mesh-list
154380314|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380315|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154380316|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380317|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380318|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
154380319|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154380320|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154380321|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154380322|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154380323|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380324|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
154380325|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380326|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380327|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154380328|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380329|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
154380330|NCT00092066|Vitamin D|vitamin d|mesh-list
154380331|NCT00092066|Alendronate|alendronate|mesh-list
154380332|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154380333|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380334|NCT00092066|Vitamins|vitamins|mesh-ancestor
154380335|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
154380336|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154380337|NCT01334619|Ropivacaine|ropivacaine|mesh-list
154380338|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
154380339|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
154380340|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380341|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380342|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
154380343|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380344|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
154380345|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380360|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154380361|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380362|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154380363|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380365|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
154380366|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
154380367|NCT04479566|Calcium|calcium|mesh-list
154380368|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154380369|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380370|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
154380371|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154380372|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380373|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380374|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
154380375|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154380376|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380377|NCT04479566|Antacids|antacids|mesh-ancestor
154380378|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154380379|NCT06030219|Moxifloxacin|moxifloxacin|mesh-list
154380380|NCT06030219|Vancomycin|vancomycin|mesh-list
154380381|NCT06030219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154380382|NCT06030219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380383|NCT06030219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154862036|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380384|NCT06030219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154380385|NCT06030219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380386|NCT06030219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380387|NCT06030219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380389|NCT06029933|Immunologic Factors|immunologic factors|mesh-ancestor
154380390|NCT06029933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380391|NCT06029816|Neratinib|neratinib|mesh-list
154380392|NCT06029816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154380393|NCT06029816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154380394|NCT06029816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380395|NCT06029816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380396|NCT06029803|Epinephrine|epinephrine|mesh-list
154380397|NCT06029803|Racepinephrine|racepinephrine|mesh-list
154380398|NCT06029803|Epinephryl borate|epinephryl borate|mesh-list
154380399|NCT06029803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154380400|NCT06029803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154380401|NCT06029803|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380402|NCT06029803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380403|NCT06029803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380404|NCT06029803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380405|NCT06029803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153742244|NCT00512824|Antacids|antacids|mesh-ancestor
154380422|NCT06029569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154380423|NCT06029569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380424|NCT06029569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154380425|NCT06029569|Antifungal Agents|antifungal agents|mesh-ancestor
154380426|NCT06029569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380427|NCT06029569|Immunologic Factors|immunologic factors|mesh-ancestor
154380428|NCT06029569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380430|NCT06028737|Docetaxel|docetaxel|mesh-list
154380431|NCT06028737|Fluorouracil|fluorouracil|mesh-list
154380432|NCT06028737|Oxaliplatin|oxaliplatin|mesh-list
154380433|NCT06028737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380434|NCT06028737|Tubulin Modulators|tubulin modulators|mesh-ancestor
154380435|NCT06028737|Antimitotic Agents|antimitotic agents|mesh-ancestor
154380436|NCT06028737|Mitosis Modulators|mitosis modulators|mesh-ancestor
154380437|NCT06028737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380438|NCT06028737|Antimetabolites|antimetabolites|mesh-ancestor
154380439|NCT06028737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154380440|NCT06028737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380441|NCT06028737|Immunologic Factors|immunologic factors|mesh-ancestor
154380442|NCT06028737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380443|NCT06028737|Antidotes|antidotes|mesh-ancestor
154380444|NCT06028737|Protective Agents|protective agents|mesh-ancestor
154380445|NCT06028737|Vitamin B Complex|vitamin b complex|mesh-ancestor
154380446|NCT06028737|Vitamins|vitamins|mesh-ancestor
154380447|NCT06028737|Micronutrients|micronutrients|mesh-ancestor
154380448|NCT06028633|Paclitaxel|paclitaxel|mesh-list
154380449|NCT06028633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154380450|NCT06028633|Pembrolizumab|pembrolizumab|mesh-list
154380451|NCT06028633|Lenvatinib|lenvatinib|mesh-list
154380452|NCT06028633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154380453|NCT06028633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380454|NCT06028633|Tubulin Modulators|tubulin modulators|mesh-ancestor
154380455|NCT06028633|Antimitotic Agents|antimitotic agents|mesh-ancestor
154380456|NCT06028633|Mitosis Modulators|mitosis modulators|mesh-ancestor
154380457|NCT06028633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380458|NCT06028633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380459|NCT06028633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154380460|NCT06028633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154380461|NCT06028633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380462|NCT06028256|Norepinephrine|norepinephrine|mesh-list
154380463|NCT06028256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154380464|NCT06028256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154380465|NCT06028256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380466|NCT06028256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380474|NCT05959720|Prednisone|prednisone|mesh-list
154380475|NCT05959720|Cyclophosphamide|cyclophosphamide|mesh-list
154380476|NCT05959720|Doxorubicin|doxorubicin|mesh-list
154380477|NCT05959720|Methotrexate|methotrexate|mesh-list
154380478|NCT05959720|Daunorubicin|daunorubicin|mesh-list
154380479|NCT05959720|Asparaginase|asparaginase|mesh-list
154380480|NCT05959720|Mercaptopurine|mercaptopurine|mesh-list
154380481|NCT05959720|Pegaspargase|pegaspargase|mesh-list
154380482|NCT05959720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380483|NCT05959720|Immunologic Factors|immunologic factors|mesh-ancestor
154380484|NCT05959720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380485|NCT05959720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380486|NCT05959720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154380487|NCT05959720|Alkylating Agents|alkylating agents|mesh-ancestor
154380488|NCT05959720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380489|NCT05959720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380490|NCT05959720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154380491|NCT05959720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154380492|NCT05959720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154380493|NCT05959720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154380494|NCT05959720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380495|NCT05959720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380496|NCT05959720|Glucocorticoids|glucocorticoids|mesh-ancestor
154380497|NCT05959720|Hormones|hormones|mesh-ancestor
154380498|NCT05959720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380499|NCT05959720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154380500|NCT05959720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154380501|NCT05959720|Abortifacient Agents|abortifacient agents|mesh-ancestor
154380502|NCT05959720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154380503|NCT05959720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154380504|NCT05959720|Antimetabolites|antimetabolites|mesh-ancestor
154380505|NCT05959720|Dermatologic Agents|dermatologic agents|mesh-ancestor
154221856|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
154380506|NCT05959720|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154380507|NCT05959720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154380508|NCT05959720|Antiviral Agents|antiviral agents|mesh-ancestor
154380509|NCT05959720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380510|NCT05926180|Digoxin|digoxin|mesh-list
154380511|NCT05926180|Midazolam|midazolam|mesh-list
154380512|NCT05926180|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154380513|NCT05926180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154380514|NCT05926180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154380515|NCT05926180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380516|NCT05926180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380517|NCT05926180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154380518|NCT05926180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154380519|NCT05926180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154380520|NCT05926180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154380521|NCT05926180|Anesthetics, General|anesthetics, general|mesh-ancestor
154380522|NCT05926180|Anesthetics|anesthetics|mesh-ancestor
154380523|NCT05926180|GABA Modulators|gaba modulators|mesh-ancestor
154380524|NCT05926180|GABA Agents|gaba agents|mesh-ancestor
154380525|NCT05926180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380526|NCT05926180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380527|NCT05926180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154380528|NCT05926180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154380529|NCT05926180|Antimetabolites|antimetabolites|mesh-ancestor
154380530|NCT05926180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154380531|NCT05926180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154380532|NCT05926180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380533|NCT05926180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154380534|NCT05926180|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154380535|NCT05926180|Protective Agents|protective agents|mesh-ancestor
154380558|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380559|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380560|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154380561|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380562|NCT05638932|Tofacitinib|tofacitinib|mesh-list
154380563|NCT05638932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154380564|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154380565|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380566|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380567|NCT05600127|Avelumab|avelumab|mesh-list
154380568|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380569|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380570|NCT05568160|Vasopressins|vasopressins|mesh-list
154380571|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
154380572|NCT05568160|Norepinephrine|norepinephrine|mesh-list
154380573|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154380574|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154380575|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380576|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380577|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380578|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380579|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
154380580|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
154255938|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154380581|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380583|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
154380584|NCT05568160|Coagulants|coagulants|mesh-ancestor
154380585|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154380586|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
154380587|NCT05552287|Infliximab|infliximab|mesh-list
154380588|NCT05552287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154380606|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154380607|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380608|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380609|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154380610|NCT05436964|Analgesics|analgesics|mesh-ancestor
154380611|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
154380612|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380613|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154380614|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154380615|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154380616|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380617|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380618|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380619|NCT05412706|Niraparib|niraparib|mesh-list
154380620|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154380621|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380622|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380623|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380624|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154380625|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154380626|NCT05338398|Benzydamine|benzydamine|mesh-list
154380627|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380628|NCT05306548|Triamcinolone|triamcinolone|mesh-list
154380629|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154380630|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154380631|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154380632|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380633|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
154380634|NCT05306548|Hormones|hormones|mesh-ancestor
154380635|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380636|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380637|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380638|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
154380639|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380640|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380641|NCT05283109|Vaccines|vaccines|mesh-list
154380642|NCT05283109|Poly ICLC|poly iclc|mesh-list
154380643|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
154380644|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380645|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
154380664|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154380665|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154380666|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380667|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380668|NCT05142254|Urological Agents|urological agents|mesh-ancestor
154380669|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380670|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
154380671|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154380672|NCT05125978|Dipyrone|dipyrone|mesh-list
154380673|NCT05125978|Tramadol|tramadol|mesh-list
154380674|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154380675|NCT05125978|Narcotics|narcotics|mesh-ancestor
154380676|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380677|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380678|NCT05125978|Analgesics|analgesics|mesh-ancestor
154380679|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
154380680|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380681|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154380682|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154380683|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380684|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380685|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
154380686|NCT05098574|Drospirenone|drospirenone|mesh-list
154380687|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154380688|NCT05098574|Estradiol|estradiol|mesh-list
154380689|NCT05098574|Estrogens|estrogens|mesh-ancestor
154255939|NCT01260506|Growth Substances|growth substances|mesh-ancestor
154380690|NCT05098574|Hormones|hormones|mesh-ancestor
154380691|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154380692|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380693|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154380694|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
154380695|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154380696|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154380697|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154380698|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154380699|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154380700|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
154380701|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154380702|NCT05098574|Diuretics|diuretics|mesh-ancestor
154380703|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
154380713|NCT04968015|Cytarabine|cytarabine|mesh-list
154380714|NCT04968015|Venetoclax|venetoclax|mesh-list
154380715|NCT04968015|Idarubicin|idarubicin|mesh-list
154380716|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154380717|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
154380718|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380719|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380720|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
154380721|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380722|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380723|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
154380724|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380725|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154380726|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154380727|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154380728|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380729|NCT04955366|Abatacept|abatacept|mesh-list
154380730|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154380731|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380732|NCT04955366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380733|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380734|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380735|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
154380736|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380737|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380738|NCT04864743|Factor VIII|factor viii|mesh-list
154380739|NCT04864743|Coagulants|coagulants|mesh-ancestor
154380740|NCT04767061|Propranolol|propranolol|mesh-list
154380741|NCT04767061|Metoprolol|metoprolol|mesh-list
154380742|NCT04767061|Atenolol|atenolol|mesh-list
154380743|NCT04767061|Sotalol|sotalol|mesh-list
154380744|NCT04767061|Nadolol|nadolol|mesh-list
154380745|NCT04767061|Acebutolol|acebutolol|mesh-list
154380746|NCT04767061|Carvedilol|carvedilol|mesh-list
154380747|NCT04767061|Nebivolol|nebivolol|mesh-list
154380748|NCT04767061|Bisoprolol|bisoprolol|mesh-list
154380749|NCT04767061|Labetalol|labetalol|mesh-list
154380750|NCT04767061|Pindolol|pindolol|mesh-list
154380751|NCT04767061|Betaxolol|betaxolol|mesh-list
154380752|NCT04767061|Penbutolol|penbutolol|mesh-list
154380753|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154380754|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154380755|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380756|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380757|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380758|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380759|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154380760|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154380761|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
154380762|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
154380763|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
154380764|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380765|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154380766|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
154380767|NCT04767061|Protective Agents|protective agents|mesh-ancestor
154380768|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154380769|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154380770|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153742609|NCT00407277|Nicotine|nicotine|mesh-list
154380779|NCT04753294|Diazepam|diazepam|mesh-list
154380780|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154380781|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
154380782|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
154862037|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
154255940|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380783|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
154380784|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380785|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380786|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154380787|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154222065|NCT00288626|Carmustine|carmustine|mesh-list
154380788|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380789|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154380790|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154380791|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154380792|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154380793|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154380794|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154380795|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
154380796|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
154380797|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
154380798|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
154380799|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380800|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380801|NCT04750967|Lidocaine|lidocaine|mesh-list
154380802|NCT04750967|Amitriptyline|amitriptyline|mesh-list
154380803|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
154380804|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
154380805|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380806|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380807|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
154380808|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380809|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154380810|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154380811|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154380812|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154380813|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380814|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154380815|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
154380816|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154380817|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154380818|NCT04750967|Analgesics|analgesics|mesh-ancestor
154380819|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154380820|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154380821|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380822|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380823|NCT04742075|Durvalumab|durvalumab|mesh-list
154380824|NCT04742075|Olaparib|olaparib|mesh-list
154380825|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154380826|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380827|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380828|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
154380829|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380830|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154380831|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380832|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380833|NCT04729517|Azelastine|azelastine|mesh-list
154380834|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154380835|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
154380852|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380853|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154380854|NCT04720963|Analgesics|analgesics|mesh-ancestor
154380855|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
154380856|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380857|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154380858|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154380859|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154380860|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380861|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380862|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380863|NCT04666701|Ketorolac|ketorolac|mesh-list
154380864|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154380865|NCT04666701|Scopolamine|scopolamine|mesh-list
154380866|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154380867|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154380868|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154380869|NCT04666701|Analgesics|analgesics|mesh-ancestor
154380870|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
154862038|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779620|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
154380871|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380872|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380873|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380874|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380875|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154380876|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380877|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380878|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154380879|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
154380880|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
154380881|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154380882|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
154380883|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154380884|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
154380885|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380886|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154380887|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
154380898|NCT04638660|Phentolamine|phentolamine|mesh-list
154380899|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154380900|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154380901|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154380902|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154380921|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
154380922|NCT04448392|Valacyclovir|valacyclovir|mesh-list
154380923|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
154380924|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380926|NCT04388904|Emtricitabine|emtricitabine|mesh-list
154380927|NCT04388904|Darunavir|darunavir|mesh-list
154380928|NCT04388904|Cobicistat|cobicistat|mesh-list
154380929|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154380930|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154380932|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380933|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154380934|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154380935|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380936|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380937|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154380938|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154380939|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154380940|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154380941|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
154380942|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154380943|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154380944|NCT04373941|Lenograstim|lenograstim|mesh-list
154380945|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154380946|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
154380947|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380948|NCT04281706|Propofol|propofol|mesh-list
154380949|NCT04281706|Etomidate|etomidate|mesh-list
154380950|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154380951|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380952|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380953|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154380954|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
154380955|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
154380956|NCT04263415|Semaglutide|semaglutide|mesh-list
154380957|NCT04263415|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154380958|NCT04263415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154380959|NCT04263415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380960|NCT04246437|Carbidopa|carbidopa|mesh-list
154380975|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380976|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380977|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
154380978|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380979|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380980|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
154380981|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380982|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154380983|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154380984|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154380985|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380987|NCT03976323|Carboplatin|carboplatin|mesh-list
154380988|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
154380989|NCT03976323|Pemetrexed|pemetrexed|mesh-list
154380990|NCT03976323|Olaparib|olaparib|mesh-list
154862039|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154380991|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380992|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380993|NCT03976323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154380994|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380995|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380996|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154380997|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154380998|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154380999|NCT03826628|Sirolimus|sirolimus|mesh-list
154381000|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154381001|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381002|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154381003|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381005|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381006|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
154381007|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381008|NCT03772028|Cisplatin|cisplatin|mesh-list
154381009|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381010|NCT03740165|Paclitaxel|paclitaxel|mesh-list
154381011|NCT03740165|Docetaxel|docetaxel|mesh-list
154381012|NCT03740165|Bevacizumab|bevacizumab|mesh-list
154381013|NCT03740165|Carboplatin|carboplatin|mesh-list
154381014|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
154381015|NCT03740165|Olaparib|olaparib|mesh-list
154381016|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154381017|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381018|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
154381019|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
154222230|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
154381020|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
154381021|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381022|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381035|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
154381036|NCT03737240|Xultophy|xultophy|mesh-list
154381037|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154381038|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381039|NCT03737240|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154381040|NCT03737240|Incretins|incretins|mesh-ancestor
154381041|NCT03737240|Hormones|hormones|mesh-ancestor
154381042|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381043|NCT03632044|Ropivacaine|ropivacaine|mesh-list
154381044|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
154381045|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
154381046|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381047|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381048|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
154381049|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381050|NCT03553875|Memantine|memantine|mesh-list
154381051|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154381052|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154381053|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
154381054|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381055|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381056|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381057|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154381058|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154381059|NCT03532178|Rocuronium|rocuronium|mesh-list
154381060|NCT03532178|Succinylcholine|succinylcholine|mesh-list
154381061|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154381062|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154381063|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154381064|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381065|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381066|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154381067|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
154381068|NCT03519997|Bavituximab|bavituximab|mesh-list
154381069|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381070|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381071|NCT03519997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154381072|NCT03519997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381073|NCT03511976|Methylphenidate|methylphenidate|mesh-list
154381074|NCT03511976|Amphetamine|amphetamine|mesh-list
154381075|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154381076|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381077|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154255941|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
154381078|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154381079|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154381080|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381082|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381083|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
154381084|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
154381085|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381118|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154381119|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381120|NCT03328078|Ibrutinib|ibrutinib|mesh-list
154381121|NCT03328078|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154381122|NCT03328078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154381123|NCT03328078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381124|NCT03328078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381125|NCT03204812|Durvalumab|durvalumab|mesh-list
154381126|NCT03204812|Ipilimumab|ipilimumab|mesh-list
154381127|NCT03204812|Tremelimumab|tremelimumab|mesh-list
154381128|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
154381129|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153742989|NCT00531115|Cetuximab|cetuximab|mesh-list
154381142|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381143|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154381144|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
154381145|NCT03201250|Hormones|hormones|mesh-ancestor
154381146|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381147|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154381148|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381149|NCT02853305|Carboplatin|carboplatin|mesh-list
154381150|NCT02853305|Gemcitabine|gemcitabine|mesh-list
154381151|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
154381152|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127349|NCT00863460|Hormones|hormones|mesh-ancestor
154381153|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381154|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
154381155|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381156|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381157|NCT02853305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154381158|NCT02815995|Durvalumab|durvalumab|mesh-list
154381159|NCT02815995|Tremelimumab|tremelimumab|mesh-list
154381160|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381161|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381162|NCT02735902|Aspirin|aspirin|mesh-list
154381163|NCT02735902|Vitamin K|vitamin k|mesh-list
154381164|NCT02735902|Anticoagulants|anticoagulants|mesh-list
154381165|NCT02735902|Vitamins|vitamins|mesh-ancestor
154381166|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
154381167|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381168|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154381169|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154381170|NCT02735902|Analgesics|analgesics|mesh-ancestor
154381171|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
154381172|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381173|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381174|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154381175|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154381176|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154381177|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381178|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154381179|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154381180|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381181|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
154381182|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154381183|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
154381184|NCT02735902|Coagulants|coagulants|mesh-ancestor
154381185|NCT02524275|Docetaxel|docetaxel|mesh-list
154381186|NCT02524275|Capecitabine|capecitabine|mesh-list
154381187|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381188|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
154381189|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
154381190|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
154381191|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381192|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381205|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
154381206|NCT01871766|Ifosfamide|ifosfamide|mesh-list
154381207|NCT01871766|Bevacizumab|bevacizumab|mesh-list
154381208|NCT01871766|Doxorubicin|doxorubicin|mesh-list
154862040|NCT03013075|Narcotics|narcotics|mesh-ancestor
154381209|NCT01871766|Irinotecan|irinotecan|mesh-list
154381210|NCT01871766|Etoposide|etoposide|mesh-list
154381211|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
154381212|NCT01871766|Vincristine|vincristine|mesh-list
154381213|NCT01871766|Sorafenib|sorafenib|mesh-list
154381214|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
154381215|NCT01871766|Razoxane|razoxane|mesh-list
154381216|NCT01871766|Mitogens|mitogens|mesh-list
154381217|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381218|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
154381219|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381220|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154381221|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154381222|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
154381223|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381224|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381225|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154381226|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381227|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154127425|NCT02555696|Paclitaxel|paclitaxel|mesh-list
154381228|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154381229|NCT01871766|Growth Substances|growth substances|mesh-ancestor
154381230|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
154381231|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154381232|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154381233|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154381234|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381235|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154381236|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154381237|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
154381238|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
154381239|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
154381240|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154381241|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154381242|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381243|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154381244|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154381245|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154381246|NCT01871766|Protective Agents|protective agents|mesh-ancestor
154381247|NCT01628029|Melatonin|melatonin|mesh-list
154381248|NCT01628029|Methylphenidate|methylphenidate|mesh-list
154381249|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
154381250|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381251|NCT01628029|Protective Agents|protective agents|mesh-ancestor
154381252|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381253|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381254|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154381255|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154381256|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153743075|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381269|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381270|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154381271|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381272|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
154381273|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
154381274|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381275|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154381276|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
154381277|NCT01346787|Hormones|hormones|mesh-ancestor
154222400|NCT01026701|Bortezomib|bortezomib|mesh-list
154381278|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381279|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154381280|NCT01033565|Melatonin|melatonin|mesh-list
154381281|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
154381282|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381283|NCT01033565|Protective Agents|protective agents|mesh-ancestor
154381284|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381285|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381286|NCT00981656|Fluorouracil|fluorouracil|mesh-list
154381287|NCT00981656|Mitomycins|mitomycins|mesh-list
154381288|NCT00981656|Mitomycin|mitomycin|mesh-list
154381289|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381290|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
154381291|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381292|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381293|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381294|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
154255942|NCT01154114|Darapladib|darapladib|mesh-list
153779984|NCT00227084|Hemostatics|hemostatics|mesh-list
154381295|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381296|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154381297|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
154381298|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154381299|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381300|NCT00742157|Hormones|hormones|mesh-list
154381301|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381302|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381303|NCT00539591|Interferons|interferons|mesh-list
154381304|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
154381305|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
154381306|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154381307|NCT00539591|Temozolomide|temozolomide|mesh-list
154381308|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381309|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
154381310|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381311|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154381312|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
154381313|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381314|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
154381315|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381316|NCT03293992|Latanoprost|latanoprost|mesh-list
154381317|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154381318|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154381334|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381335|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381336|NCT01332279|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154381337|NCT03298906|Ticlopidine|ticlopidine|mesh-list
154381338|NCT03298906|Esketamine|esketamine|mesh-list
154381339|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
154381340|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154381341|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154381342|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154381343|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381344|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154381345|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154381346|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154381347|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154381348|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
154381349|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381350|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381351|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154381352|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154381353|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222472|NCT00063934|Docetaxel|docetaxel|mesh-list
154381354|NCT03697629|Daratumumab|daratumumab|mesh-list
154381355|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381356|NCT00398541|Losartan|losartan|mesh-list
154381357|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154381358|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154381359|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154381360|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154381361|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154381362|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381363|NCT00398541|Diuretics|diuretics|mesh-ancestor
154381364|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
154381365|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381366|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154381367|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154381368|NCT03286582|Clobetasol|clobetasol|mesh-list
154381369|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381370|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
154381371|NCT03286582|Hormones|hormones|mesh-ancestor
154381372|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381373|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381374|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154381375|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154381376|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
154381387|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381389|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
154381390|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862041|NCT03013075|Analgesics|analgesics|mesh-ancestor
154862042|NCT03030677|Lidocaine|lidocaine|mesh-list
154255521|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381391|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
154381392|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
154381393|NCT03298516|Azacitidine|azacitidine|mesh-list
154381394|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381395|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
154222535|NCT00458705|Growth Substances|growth substances|mesh-ancestor
154381396|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381397|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381398|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381399|NCT03285802|Everolimus|everolimus|mesh-list
154381400|NCT03285802|Letrozole|letrozole|mesh-list
154381401|NCT03285802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154381402|NCT03285802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154381403|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381404|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381405|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381406|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
154381407|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381408|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381409|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154381410|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154381411|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154381412|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
154381413|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381414|NCT05130086|Islatravir|islatravir|mesh-list
154381415|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
154381416|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381417|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381418|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381419|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154381420|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154381421|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154381422|NCT02461186|Piperaquine|piperaquine|mesh-list
154381423|NCT02461186|Artenimol|artenimol|mesh-list
154381424|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
154381425|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154381426|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154381427|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381428|NCT04921670|Infliximab|infliximab|mesh-list
154381429|NCT04921670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154381430|NCT04921670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381431|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
154381432|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154381433|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154381434|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
154381435|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154381436|NCT03512210|Velpatasvir|velpatasvir|mesh-list
154381437|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
154381438|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381439|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
154381440|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
153743263|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
154381444|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381446|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
154381447|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154381448|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154381449|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154381450|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
154381451|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381452|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381453|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381454|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
154381455|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154381456|NCT03292822|Paclitaxel|paclitaxel|mesh-list
154381457|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154381458|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381459|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
154381460|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
154381461|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
154381462|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381463|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
154381464|NCT03297502|Tacrolimus|tacrolimus|mesh-list
154381465|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154381466|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154862043|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
154862044|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
154381467|NCT03297502|Analgesics|analgesics|mesh-ancestor
154381468|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
154381469|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381470|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381471|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381472|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154381473|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
154381474|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381475|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
154381476|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154381477|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381478|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381479|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
154381480|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
154381481|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154381482|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154381483|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381484|NCT03292744|Vitamins|vitamins|mesh-ancestor
154381485|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
154381486|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154381487|NCT03035942|Dexamethasone|dexamethasone|mesh-list
154381488|NCT03035942|Ondansetron|ondansetron|mesh-list
154381489|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381490|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
154381491|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
154381492|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381493|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381494|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154381495|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
154381496|NCT03035942|Hormones|hormones|mesh-ancestor
154381497|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381498|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154381499|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381500|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
154381501|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
154381502|NCT03035942|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154381503|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154381504|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
154381505|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381506|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381507|NCT02820519|Loxapine|loxapine|mesh-list
154381508|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154381509|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154381510|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381511|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381521|NCT02616146|Etonogestrel|etonogestrel|mesh-list
154381522|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154381523|NCT02616146|Estradiol|estradiol|mesh-list
154381524|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154381525|NCT02616146|Estrogens|estrogens|mesh-ancestor
154127734|NCT00286429|Insulin|insulin|mesh-list
154381526|NCT02616146|Hormones|hormones|mesh-ancestor
154381527|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381528|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381529|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154381530|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
154381531|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154381532|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154381533|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154381534|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154381535|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154381536|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154381537|NCT01332747|Atorvastatin|atorvastatin|mesh-list
154381538|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154381539|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154381540|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
154381541|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381542|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154381543|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154381544|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381545|NCT01337427|Interferons|interferons|mesh-list
154381546|NCT01337427|Interferon-beta|interferon-beta|mesh-list
154381547|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
154381548|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381549|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
154255522|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
154255523|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154381550|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381551|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
154381552|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381553|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154381554|NCT02459938|Glucagon|glucagon|mesh-list
154381555|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154381556|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154381557|NCT02459938|Hormones|hormones|mesh-ancestor
154381558|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381559|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381560|NCT02459938|Incretins|incretins|mesh-ancestor
154381561|NCT03284164|Tenofovir|tenofovir|mesh-list
154381562|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
154381563|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381564|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154381565|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154381566|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381567|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381568|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154381569|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154381570|NCT01337583|Dapivirine|dapivirine|mesh-list
154381571|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154381572|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154381573|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
154381574|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381575|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
154381576|NCT03107962|Antibodies|antibodies|mesh-list
154381577|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
154381597|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381599|NCT01335321|Hormones|hormones|mesh-ancestor
154381600|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381601|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381602|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
154381603|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
154381605|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154381606|NCT01333137|Carboplatin|carboplatin|mesh-list
154381607|NCT01333137|Gemcitabine|gemcitabine|mesh-list
154381608|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381609|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381610|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
154381611|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381612|NCT03282838|Celecoxib|celecoxib|mesh-list
154381613|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154381614|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154381615|NCT03282838|Analgesics|analgesics|mesh-ancestor
154381616|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
154381617|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381618|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381619|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381620|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154381621|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154381622|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154381623|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381624|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381625|NCT04431466|Ivermectin|ivermectin|mesh-list
154381626|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154381627|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381628|NCT03291418|Naproxen|naproxen|mesh-list
154381629|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154381630|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154381631|NCT03291418|Analgesics|analgesics|mesh-ancestor
154381632|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
154381633|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743462|NCT00169065|Olanzapine|olanzapine|mesh-list
154381647|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
154381648|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381649|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381650|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
154381651|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381652|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154381653|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381654|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
154862045|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154862046|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381655|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154381656|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154381657|NCT02459782|Anesthetics|anesthetics|mesh-list
154381658|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381659|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381660|NCT02884089|Metformin|metformin|mesh-list
154381661|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154381662|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381663|NCT01315431|Capecitabine|capecitabine|mesh-list
154381664|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381665|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
154381666|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381667|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381668|NCT00092625|Ezetimibe|ezetimibe|mesh-list
154381669|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154381670|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154381671|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
154381672|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381673|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154381674|NCT01333449|Decitabine|decitabine|mesh-list
154127863|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
154381675|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381676|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
154381677|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381679|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381680|NCT01341717|Metformin|metformin|mesh-list
154381681|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154381682|NCT01341717|Glimepiride|glimepiride|mesh-list
154381683|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154381684|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381685|NCT01341717|Incretins|incretins|mesh-ancestor
154381686|NCT01341717|Hormones|hormones|mesh-ancestor
154381687|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381688|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154381689|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
154381690|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381691|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381692|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153743515|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
154381702|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154381703|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381704|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
154381705|NCT01338129|Vitamins|vitamins|mesh-ancestor
154381706|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
154381707|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381708|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
154381709|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381710|NCT01338129|Protective Agents|protective agents|mesh-ancestor
154381711|NCT05181969|Dextrans|dextrans|mesh-list
154381712|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
154381713|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
154381714|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
154381715|NCT00092157|Simvastatin|simvastatin|mesh-list
154381716|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154381717|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154381718|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
154381719|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381720|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154381721|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154381722|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381723|NCT00089895|Eptifibatide|eptifibatide|mesh-list
154381724|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154381725|NCT05166291|Anesthetics|anesthetics|mesh-list
154381726|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381727|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381728|NCT01338441|Erythromycin|erythromycin|mesh-list
154381729|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
154381730|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154381731|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
154381732|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154381733|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381734|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154381735|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154381736|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381737|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381738|NCT01341951|Lenograstim|lenograstim|mesh-list
154381739|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154222811|NCT06200584|Antioxidants|antioxidants|mesh-ancestor
154381741|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381742|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154381743|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381744|NCT02714218|Nivolumab|nivolumab|mesh-list
154381745|NCT02714218|Ipilimumab|ipilimumab|mesh-list
154381746|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381747|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381748|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154381749|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381750|NCT05185869|Paclitaxel|paclitaxel|mesh-list
154381751|NCT05185869|Gemcitabine|gemcitabine|mesh-list
154381752|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154381753|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381754|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
154381755|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
154381756|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
154381757|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381758|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381775|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154381776|NCT01338753|Growth Substances|growth substances|mesh-ancestor
154381777|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381778|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
154381779|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
154381780|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
154381781|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
154381782|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381783|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154381784|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154381785|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154381786|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381787|NCT02457286|Metformin|metformin|mesh-list
154381788|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154381789|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381790|NCT01338909|Clopidogrel|clopidogrel|mesh-list
154381791|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154381792|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154381793|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154381794|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154381795|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154381796|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
154381797|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381798|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381799|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381800|NCT03282136|Incretins|incretins|mesh-list
154381801|NCT03282136|Hormones|hormones|mesh-ancestor
154381802|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381803|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381804|NCT03156621|Alirocumab|alirocumab|mesh-list
154381805|NCT03156621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154381806|NCT03156621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154381807|NCT03156621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154381808|NCT03156621|Antimetabolites|antimetabolites|mesh-ancestor
154381809|NCT03156621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381810|NCT03156621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154381811|NCT03156621|Protease Inhibitors|protease inhibitors|mesh-ancestor
154381812|NCT03156621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381813|NCT03156621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154381814|NCT03264586|Lidocaine|lidocaine|mesh-list
154381815|NCT03264586|Prilocaine|prilocaine|mesh-list
154381816|NCT03264586|Mepivacaine|mepivacaine|mesh-list
154381817|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154381828|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381829|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154381830|NCT01342731|Tigecycline|tigecycline|mesh-list
154381831|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154381832|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381833|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154381834|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381835|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381836|NCT01339065|Ketamine|ketamine|mesh-list
154381837|NCT01339065|Analgesics|analgesics|mesh-ancestor
154381838|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
154381839|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381840|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381841|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154381842|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154381843|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
154381844|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
154381845|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381846|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154381847|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154381848|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381849|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381850|NCT02460016|Ziresovir|ziresovir|mesh-list
154381851|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
154381852|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381853|NCT05187507|Theobromine|theobromine|mesh-list
154381854|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154381855|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
154381856|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381857|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381858|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154381859|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
154381860|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
154381861|NCT01339143|Pioglitazone|pioglitazone|mesh-list
154381862|NCT01339143|Vildagliptin|vildagliptin|mesh-list
154381863|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154381864|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381865|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154381866|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
154381867|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381868|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381869|NCT03264430|Ketamine|ketamine|mesh-list
154381870|NCT03264430|Bupivacaine|bupivacaine|mesh-list
154381871|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
154381872|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
154381873|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381874|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381875|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
154381876|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381877|NCT03264430|Analgesics|analgesics|mesh-ancestor
154381878|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154381879|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154381880|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
154381906|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154381907|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154381908|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154381909|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154381910|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154381912|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
154381913|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154381914|NCT02457130|Clopidogrel|clopidogrel|mesh-list
154381915|NCT02457130|Ticagrelor|ticagrelor|mesh-list
154381916|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154381917|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154381918|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154381919|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154381920|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
154381921|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381922|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381923|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381924|NCT01340235|Erythromycin|erythromycin|mesh-list
154381925|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
154381926|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154381927|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
154381943|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
154381944|NCT05184465|Anesthetics|anesthetics|mesh-list
154381945|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381946|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381947|NCT03152019|Tacrolimus|tacrolimus|mesh-list
154381948|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381949|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
154381950|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381951|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154381952|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381953|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381955|NCT04813107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381956|NCT04813107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381957|NCT02714062|Topiramate|topiramate|mesh-list
154381958|NCT02714062|Phentermine|phentermine|mesh-list
154381959|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
154381960|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154381961|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381962|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154381963|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
154381964|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154381965|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
154381966|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
154381967|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381968|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154381969|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381970|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381971|NCT03280342|Topiramate|topiramate|mesh-list
154381972|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
154128163|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381973|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154381974|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381975|NCT03279796|Betamethasone|betamethasone|mesh-list
154222986|NCT05829226|Decitabine|decitabine|mesh-list
154381976|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381977|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
154381978|NCT03279796|Hormones|hormones|mesh-ancestor
154381979|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381980|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381981|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154381982|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
154381983|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154381984|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154381985|NCT02713828|Immunoconjugates|immunoconjugates|mesh-ancestor
154381997|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381999|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
154382000|NCT05183997|Coagulants|coagulants|mesh-ancestor
154382001|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
154382002|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382003|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382004|NCT05119101|Analgesics|analgesics|mesh-ancestor
154382005|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
154382006|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382007|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382008|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
154382009|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154382010|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
154382011|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154382012|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154382013|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154382014|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
154382015|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154382016|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
154382017|NCT01340547|Ifosfamide|ifosfamide|mesh-list
154382018|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154382019|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
154382020|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382021|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382022|NCT03277222|Insulin|insulin|mesh-list
154382023|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154382024|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382025|NCT04931667|Lorecivivint|lorecivivint|mesh-list
154382026|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382027|NCT03262948|Paclitaxel|paclitaxel|mesh-list
154382028|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154382029|NCT03262948|Carboplatin|carboplatin|mesh-list
154382030|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154382031|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382032|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
154382033|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
154382034|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
154382035|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382036|NCT03276598|Losartan|losartan|mesh-list
154382037|NCT03276598|Amlodipine|amlodipine|mesh-list
154382038|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154382039|NCT03276598|Bisoprolol|bisoprolol|mesh-list
154382040|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154382041|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154382042|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154382043|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382044|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154382045|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382046|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
154382047|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154382060|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382061|NCT03262792|Andrographolide|andrographolide|mesh-list
154382062|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382063|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154382064|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382066|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
154382067|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382068|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382069|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154382070|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154382071|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154382072|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154382073|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
154382074|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154382075|NCT01359462|Tolvaptan|tolvaptan|mesh-list
154382076|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154382077|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382078|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
154382079|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382080|NCT02875392|Fucoidan|fucoidan|mesh-list
154382081|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154382082|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154382083|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
154382084|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382085|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
154382086|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154382087|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154382088|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154382089|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154382090|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154382091|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382092|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382093|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382094|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154382095|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
154382096|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154382097|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382098|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154382099|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154382100|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154382101|NCT03267628|Morphine|morphine|mesh-list
154382102|NCT03267628|Anesthetics|anesthetics|mesh-list
154382103|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
154382104|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154382105|NCT03267628|Narcotics|narcotics|mesh-ancestor
154382106|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382107|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382108|NCT03267628|Analgesics|analgesics|mesh-ancestor
154382123|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382124|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382125|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154382126|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154382128|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382129|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382130|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154382131|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154382132|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
154382133|NCT01367028|Bevacizumab|bevacizumab|mesh-list
154382134|NCT01367028|Trastuzumab|trastuzumab|mesh-list
154382135|NCT01367028|Docetaxel|docetaxel|mesh-list
154382136|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154382137|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382138|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154382139|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154255524|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154382140|NCT01367028|Growth Substances|growth substances|mesh-ancestor
154382141|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382142|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
154382143|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
154382144|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
154382145|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
154382146|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382147|NCT03965962|Vaccines|vaccines|mesh-list
154382148|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
154382149|NCT03965962|Antibodies|antibodies|mesh-list
154382150|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
154382151|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154382152|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154382153|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
154382154|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382155|NCT03273088|Etanercept|etanercept|mesh-list
154382156|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154382157|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382158|NCT03273088|Analgesics|analgesics|mesh-ancestor
154382159|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
154382160|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382161|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382162|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382163|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154382164|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154382165|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382166|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
154382167|NCT04235634|Alprostadil|alprostadil|mesh-list
154382168|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154382169|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
154382178|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382179|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154382180|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154382181|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154382182|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
154382183|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382184|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382185|NCT03151551|Adalimumab|adalimumab|mesh-list
154382186|NCT03151551|Ixekizumab|ixekizumab|mesh-list
154382187|NCT03151551|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154382188|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382189|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154382190|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
154382191|NCT01359930|Naltrexone|naltrexone|mesh-list
154382192|NCT01359930|Bupropion|bupropion|mesh-list
154382193|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154382194|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154382195|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128394|NCT00870714|Docetaxel|docetaxel|mesh-list
154382196|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
154382197|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382198|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154382199|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
154382200|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382201|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154382202|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154382203|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154382204|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382205|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
154382206|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382207|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154382208|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154382209|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382210|NCT05075512|Fulvestrant|fulvestrant|mesh-list
154382211|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154382212|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382213|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154382214|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154382215|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
154382216|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382217|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382218|NCT01316757|Paclitaxel|paclitaxel|mesh-list
154382219|NCT01316757|Carboplatin|carboplatin|mesh-list
154862047|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
154255525|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382220|NCT01316757|Cetuximab|cetuximab|mesh-list
154382221|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154382222|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154382223|NCT01316757|Antibodies|antibodies|mesh-list
154382224|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
154382225|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154382226|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154382227|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382228|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
154382229|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
154382230|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
154382231|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382232|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
154382233|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382234|NCT01316757|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154382268|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
154382269|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
154382270|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382271|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382272|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
154382273|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382274|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154382276|NCT01367418|Analgesics|analgesics|mesh-ancestor
154382277|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154382287|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382288|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
154382289|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382290|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154382291|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382292|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
154382293|NCT01360086|Antidotes|antidotes|mesh-ancestor
154382294|NCT01360086|Protective Agents|protective agents|mesh-ancestor
154382295|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
154382296|NCT01360086|Vitamins|vitamins|mesh-ancestor
154382297|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
154382298|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154382300|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154382301|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
154382302|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382303|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154382304|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
154382305|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
154382306|NCT02458924|Vitamins|vitamins|mesh-ancestor
154382307|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
154382308|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382309|NCT01367496|Naltrexone|naltrexone|mesh-list
154382310|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
154382311|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154382312|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382313|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
154382314|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382315|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154382316|NCT02459158|Arbekacin|arbekacin|mesh-list
154382317|NCT02459158|Dibekacin|dibekacin|mesh-list
154382318|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154382319|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154382320|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154382321|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
154382322|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154382323|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382324|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
154382325|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382326|NCT04693689|Vaccines|vaccines|mesh-list
154382327|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
154382328|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382329|NCT03126786|Triamcinolone|triamcinolone|mesh-list
154382330|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154382331|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154382332|NCT03126786|Aflibercept|aflibercept|mesh-list
154382333|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154382334|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382335|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
154382336|NCT03126786|Hormones|hormones|mesh-ancestor
154862048|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862049|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154382337|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382338|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382339|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382340|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
154382341|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382342|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382343|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154382344|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154382345|NCT03126786|Growth Substances|growth substances|mesh-ancestor
154382346|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
154382347|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382368|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154382369|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154382370|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154382372|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
154382373|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382374|NCT01360476|Vitamin D|vitamin d|mesh-list
154382375|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
154382376|NCT01360476|Vitamins|vitamins|mesh-ancestor
154382377|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
154382378|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382379|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154382380|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154382381|NCT01317069|Fluorouracil|fluorouracil|mesh-list
154382382|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
154382383|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382384|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154382385|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382386|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382387|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
154382388|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382389|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154382390|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154382391|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154382392|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
154382393|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382394|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382395|NCT01317225|Progestins|progestins|mesh-ancestor
154382396|NCT01317225|Hormones|hormones|mesh-ancestor
154382397|NCT01363206|Ipilimumab|ipilimumab|mesh-list
154382398|NCT01363206|Molgramostim|molgramostim|mesh-list
153744255|NCT02941198|Copper|copper|mesh-list
154382408|NCT01344213|Analgesics|analgesics|mesh-ancestor
154382409|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
154382410|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382411|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382412|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
154382413|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154382414|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154382415|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382416|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154382417|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154382418|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154382419|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382420|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382421|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154382422|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382423|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382424|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154382425|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154382426|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154382427|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382428|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
154382429|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154382430|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
154382431|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154382432|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
154382433|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382434|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382435|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
154382436|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154223328|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382437|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154382438|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154255526|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
154255527|NCT01258010|Coagulants|coagulants|mesh-ancestor
154382439|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154382440|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382441|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382442|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382443|NCT01363284|Analgesics|analgesics|mesh-ancestor
154382444|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
154382445|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382446|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
154382447|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382448|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
154382449|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154382450|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154382451|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154382452|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
154382453|NCT01344291|Curcumin|curcumin|mesh-list
154382454|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154382455|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382456|NCT01344291|Analgesics|analgesics|mesh-ancestor
154382457|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
154382458|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382459|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382460|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382461|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154382462|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382482|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
154382483|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382484|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382485|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
154382486|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382487|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
154382488|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154382489|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
154382490|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382491|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382492|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154382493|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
154382494|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154382495|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
154382496|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382497|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382498|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154382499|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
154382500|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
154382501|NCT01347957|Protective Agents|protective agents|mesh-ancestor
154382502|NCT04735965|Meperidine|meperidine|mesh-list
154382503|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
154382504|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154382505|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382506|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382507|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382508|NCT04735965|Analgesics|analgesics|mesh-ancestor
154382509|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
154382510|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382511|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154382512|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154382513|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154382514|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
153744340|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223396|NCT04627064|Belzutifan|belzutifan|mesh-list
154382542|NCT02456428|Troglitazone|troglitazone|mesh-list
154382543|NCT02456428|Meglitinide|meglitinide|mesh-list
154382544|NCT02456428|Acetohexamide|acetohexamide|mesh-list
154382545|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
154382546|NCT02456428|Phenformin|phenformin|mesh-list
154382547|NCT02456428|Buformin|buformin|mesh-list
154382548|NCT02456428|Glibornuride|glibornuride|mesh-list
154382549|NCT02456428|Tolazamide|tolazamide|mesh-list
154382550|NCT02456428|Carbutamide|carbutamide|mesh-list
154382551|NCT02456428|Gliquidone|gliquidone|mesh-list
154382552|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154382553|NCT02456428|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154382554|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
154382555|NCT02456428|Incretins|incretins|mesh-list
154382556|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382557|NCT02456428|Hormones|hormones|mesh-ancestor
154862050|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153567584|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567585|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567603|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153567604|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153567622|NCT05225545|Iron|iron|mesh-list
153567623|NCT05225545|Trace Elements|trace elements|mesh-ancestor
153567624|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
153567625|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567626|NCT05195775|Tadalafil|tadalafil|mesh-list
153567627|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
154382558|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382559|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
154382560|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382561|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382562|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154382563|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154382564|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382565|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
154382566|NCT03259516|Cytarabine|cytarabine|mesh-list
154382567|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
154382568|NCT03259516|Melphalan|melphalan|mesh-list
154382569|NCT03259516|Nivolumab|nivolumab|mesh-list
154382570|NCT03259516|Fludarabine|fludarabine|mesh-list
154128764|NCT00797030|Cyclosporine|cyclosporine|mesh-list
154382571|NCT03259516|Azacitidine|azacitidine|mesh-list
154382572|NCT03259516|Tretinoin|tretinoin|mesh-list
154382573|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
154382574|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382580|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382581|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382582|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154382583|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154382584|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154382585|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154382586|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
154382587|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
154382588|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154382589|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382590|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
154382591|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154382592|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154382593|NCT03259516|Urological Agents|urological agents|mesh-ancestor
154382594|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
154382595|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
154382596|NCT01344681|Itraconazole|itraconazole|mesh-list
154382597|NCT01344681|Micafungin|micafungin|mesh-list
154382598|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
154382599|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154382600|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154382601|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154223466|NCT04375631|Analgesics|analgesics|mesh-ancestor
154382602|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382603|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382604|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154382605|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
154382606|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382607|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382608|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154382609|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
154382610|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154382611|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382612|NCT03259672|Sevoflurane|sevoflurane|mesh-list
154382613|NCT03259672|Desflurane|desflurane|mesh-list
154382614|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154382615|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154862051|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154862052|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154862053|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862054|NCT01122901|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154862055|NCT01122901|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154862056|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862057|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382616|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
154382618|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382619|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382620|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
154382621|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154382622|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154382623|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
154382624|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382625|NCT03265288|Fenretinide|fenretinide|mesh-list
154382626|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382627|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154382628|NCT03265288|Protective Agents|protective agents|mesh-ancestor
154382629|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382630|NCT03261310|Acetaminophen|acetaminophen|mesh-list
154382631|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382632|NCT03261310|Analgesics|analgesics|mesh-ancestor
154382633|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
154382634|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382635|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382636|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
154382637|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
154382638|NCT02456350|Fludarabine|fludarabine|mesh-list
154382639|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382640|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
154382641|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382642|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154382643|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154382656|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382657|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154382658|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382659|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382660|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154382661|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382662|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154382663|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
154382664|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154382665|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154382666|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
154382667|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154382668|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
154382669|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154382671|NCT01360710|Moxonidine|moxonidine|mesh-list
154382672|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154382673|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154382674|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154382675|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382676|NCT01360788|Albuterol|albuterol|mesh-list
154382677|NCT01360788|Ipratropium|ipratropium|mesh-list
154382678|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154382679|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
154382680|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382681|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382682|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154382683|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
154382684|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
154382685|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154382686|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154382687|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154382688|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154382689|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
154382690|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382691|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382692|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154382693|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
154382694|NCT01361022|Brotizolam|brotizolam|mesh-list
154382695|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154382696|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382697|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382698|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154382699|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154382700|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154382701|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
154382702|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382703|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154382704|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154382705|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382706|NCT02713204|Aflibercept|aflibercept|mesh-list
154382716|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382717|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382718|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
154382719|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382720|NCT01364376|Leucovorin|leucovorin|mesh-list
154382721|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
154382722|NCT01364376|Calcium|calcium|mesh-list
154382723|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
154382724|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154382725|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382726|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382727|NCT01364376|Antidotes|antidotes|mesh-ancestor
154382729|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
154382730|NCT01364376|Vitamins|vitamins|mesh-ancestor
154382731|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
154382732|NCT01348503|Lenalidomide|lenalidomide|mesh-list
154382733|NCT01348503|Sorafenib|sorafenib|mesh-list
154382734|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
154382735|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382736|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154382737|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154382738|NCT01348503|Growth Substances|growth substances|mesh-ancestor
154382739|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
154382740|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382741|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154382742|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382743|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382744|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154382745|NCT01369290|Bupropion|bupropion|mesh-list
154382746|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154382747|NCT01369290|Escitalopram|escitalopram|mesh-list
154382748|NCT01369290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154382749|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154382750|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154382751|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382752|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382753|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
154382754|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382755|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382756|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154382757|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
154382758|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382759|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154382760|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
154382761|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154382762|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154382763|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382764|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154382765|NCT01369290|Analgesics|analgesics|mesh-ancestor
154382766|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
154382767|NCT03533452|Ropivacaine|ropivacaine|mesh-list
154382768|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
154382769|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
154382770|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382771|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382772|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
154382773|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382789|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382791|NCT01369368|Azacitidine|azacitidine|mesh-list
154382792|NCT01369368|Valproic Acid|valproic acid|mesh-list
154382793|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154382794|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
154382795|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128987|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
154382796|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382797|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382798|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
154382799|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
154382800|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382801|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382802|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
154382803|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154382804|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382805|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382806|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
154382807|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
154382808|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382809|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382810|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
154382811|NCT01369602|Vitamins|vitamins|mesh-ancestor
154382812|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
154382813|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382814|NCT03252496|Ephedrine|ephedrine|mesh-list
154382815|NCT03252496|Fentanyl|fentanyl|mesh-list
154382816|NCT03252496|Bupivacaine|bupivacaine|mesh-list
154382817|NCT03252496|Oxytocin|oxytocin|mesh-list
154382818|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
154382819|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
154382820|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382821|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382822|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
154382823|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382824|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154382825|NCT03252496|Narcotics|narcotics|mesh-ancestor
154382826|NCT03252496|Analgesics|analgesics|mesh-ancestor
154382827|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154382828|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154382829|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
154382830|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
154382831|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153744646|NCT02928679|Incretins|incretins|mesh-ancestor
154382842|NCT03252418|Protective Agents|protective agents|mesh-ancestor
154382843|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382844|NCT03252418|Vitamins|vitamins|mesh-ancestor
154382845|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
154382846|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
154382847|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154382848|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154382849|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382850|NCT01364688|Vitamins|vitamins|mesh-ancestor
154382851|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
154382852|NCT01370148|Conivaptan|conivaptan|mesh-list
154382853|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154382854|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382855|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
154382856|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382857|NCT04684953|Hormones|hormones|mesh-list
154382858|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382859|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382860|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
154382861|NCT01349127|Vitamin D|vitamin d|mesh-list
154382862|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
154382863|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
154382864|NCT01349127|Vitamins|vitamins|mesh-list
154382865|NCT01349127|Calcium|calcium|mesh-list
154382866|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
154382867|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382868|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154382869|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154382870|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154382871|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
154382872|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382873|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382874|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154382875|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382876|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
154382877|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
154382878|NCT01349205|Caffeine|caffeine|mesh-list
154382879|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154382880|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382881|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154382882|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382883|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382884|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154382885|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154382886|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
154382887|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382888|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
154382889|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154382890|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154382891|NCT01349205|Protective Agents|protective agents|mesh-ancestor
154382892|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382893|NCT01349205|Analgesics|analgesics|mesh-ancestor
154382894|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
154382895|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382913|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382914|NCT03160521|Risperidone|risperidone|mesh-list
154382915|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154382916|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
154382917|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382918|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382919|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382920|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154382921|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154382922|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382923|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382924|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154382925|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
154382926|NCT01365000|Naloxegol|naloxegol|mesh-list
154382927|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154382928|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382929|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
154382930|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382931|NCT03147040|Carboplatin|carboplatin|mesh-list
154382932|NCT03147040|Atezolizumab|atezolizumab|mesh-list
154382933|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382934|NCT03147040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154382935|NCT03147040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382936|NCT03147040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154382937|NCT03251170|Midazolam|midazolam|mesh-list
154382938|NCT03251170|Fentanyl|fentanyl|mesh-list
154382939|NCT03251170|Ketamine|ketamine|mesh-list
154382940|NCT03251170|Analgesics|analgesics|mesh-ancestor
154382941|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
154382942|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382943|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382944|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154382945|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154382946|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
154382947|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
154382948|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382965|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382966|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154382967|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382968|NCT03539601|Analgesics|analgesics|mesh-ancestor
154382969|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
154382970|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382971|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382972|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154382973|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
154382974|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382975|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
154382976|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154382977|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382978|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382979|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
154382980|NCT02455180|Vitamins|vitamins|mesh-ancestor
154382981|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
154382982|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382983|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
154382984|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382985|NCT02455180|Protective Agents|protective agents|mesh-ancestor
154382986|NCT03514719|Avelumab|avelumab|mesh-list
154382987|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154382988|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154382989|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382990|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
154382991|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382992|NCT01349439|Propranolol|propranolol|mesh-list
154382993|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154382994|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154382995|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
154382996|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382997|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382998|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382999|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154383000|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154383001|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
154383002|NCT03245554|Propranolol|propranolol|mesh-list
154383003|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154383004|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154383005|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
154383006|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383016|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
154383017|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
154383018|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
154383019|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383020|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383021|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
154383022|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383023|NCT03004131|Fluticasone|fluticasone|mesh-list
154383025|NCT03004131|Loratadine|loratadine|mesh-list
154383026|NCT03004131|Azelastine|azelastine|mesh-list
154383027|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383028|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154383029|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
154383030|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383031|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383032|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154383033|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
154383034|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
154383035|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154383036|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
154383037|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154383038|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154383039|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
154383040|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
154383041|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383042|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383043|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154383044|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383045|NCT01350063|Troclosene|troclosene|mesh-list
154383046|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
154383047|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383048|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
154383049|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
154383050|NCT03421041|Dexamethasone|dexamethasone|mesh-list
154383051|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383052|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
154383053|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
154383054|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383055|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383056|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154383057|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
154383058|NCT03421041|Hormones|hormones|mesh-ancestor
154383059|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383060|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154383061|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383062|NCT03244774|Paclitaxel|paclitaxel|mesh-list
154383063|NCT03244774|Fluorouracil|fluorouracil|mesh-list
154383064|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
154383065|NCT03244774|Apatinib|apatinib|mesh-list
154383066|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154383067|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383068|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
154383069|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
154383070|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
154383071|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383072|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
154383073|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154383098|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383099|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383100|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154383102|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154383103|NCT03894501|Narcotics|narcotics|mesh-ancestor
154383104|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383105|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255529|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
154383106|NCT03894501|Analgesics|analgesics|mesh-ancestor
154383107|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
154383108|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383109|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
154383110|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
154383112|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154383113|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
154383114|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383115|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383116|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154383117|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
154383118|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154383119|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154383120|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383121|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154383122|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
154383123|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154383124|NCT01346865|Protective Agents|protective agents|mesh-ancestor
154383135|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383137|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
154383138|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383139|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154383140|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154383141|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
154383142|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154383143|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154383144|NCT03244540|Acetaminophen|acetaminophen|mesh-list
154383145|NCT03244540|Dipyrone|dipyrone|mesh-list
154383146|NCT03244540|Ketoprofen|ketoprofen|mesh-list
154383147|NCT03244540|Bupivacaine|bupivacaine|mesh-list
154383148|NCT03244540|Ropivacaine|ropivacaine|mesh-list
154383149|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
154383150|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
154383151|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383152|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383153|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
154383154|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383155|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383156|NCT03244540|Analgesics|analgesics|mesh-ancestor
154383157|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
154383158|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154383159|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383160|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154383161|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154383162|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383163|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383164|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154383165|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
154383166|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
154383167|NCT02454868|Remifentanil|remifentanil|mesh-list
154383168|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154383169|NCT02454868|Narcotics|narcotics|mesh-ancestor
154383170|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383171|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383172|NCT02454868|Analgesics|analgesics|mesh-ancestor
154383173|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
154383174|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383175|NCT03753087|Empagliflozin|empagliflozin|mesh-list
154383176|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154383177|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383178|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154383179|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383181|NCT02454712|Oxycodone|oxycodone|mesh-list
154383182|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154383183|NCT02454712|Narcotics|narcotics|mesh-ancestor
154383184|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383185|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383186|NCT02454712|Analgesics|analgesics|mesh-ancestor
154383187|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
154383188|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383189|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154383220|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862058|NCT01097785|Simvastatin|simvastatin|mesh-list
153568934|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
154383221|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154383222|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154383223|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383224|NCT03243604|Hormones|hormones|mesh-list
154383225|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383226|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383227|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154383228|NCT02454556|Hormones|hormones|mesh-ancestor
154383229|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383244|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383246|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383247|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154383248|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154383249|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154383250|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383251|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154383252|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154383253|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
154383254|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
154383255|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154383256|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154383257|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383258|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154383259|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154383260|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154383261|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
154383262|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154383263|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154383264|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154383265|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383266|NCT01352559|Analgesics|analgesics|mesh-ancestor
154383267|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
154383268|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383269|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154383270|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154383271|NCT01350609|Candesartan|candesartan|mesh-list
154383272|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
154383273|NCT01350609|Nifedipine|nifedipine|mesh-list
154383274|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154383275|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154383276|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154383277|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383278|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154383279|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154383280|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154383281|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383282|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
154383283|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
154383284|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154383285|NCT03269409|Coal Tar|coal tar|mesh-list
154383286|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
154383287|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
154383288|NCT03778372|Methadone|methadone|mesh-list
154383315|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383316|NCT03257722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154383317|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383318|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383320|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154383321|NCT03268005|Metformin|metformin|mesh-list
154383322|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
154383323|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
154383324|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154383325|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154383326|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383327|NCT03239314|Dexamethasone|dexamethasone|mesh-list
154383328|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154383329|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383330|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
154383331|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
154383332|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862059|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154255943|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154383333|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383334|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154383335|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
153745158|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154383353|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
154383354|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154383356|NCT02454088|Triamcinolone|triamcinolone|mesh-list
154383357|NCT02454088|Calcium|calcium|mesh-list
154383358|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154383359|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383360|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154383361|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383362|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
154383363|NCT02454088|Hormones|hormones|mesh-ancestor
154383364|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224027|NCT00456599|Gemcitabine|gemcitabine|mesh-list
154383365|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154383366|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383367|NCT02456116|Analgesics|analgesics|mesh-ancestor
154383368|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
154383369|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383370|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383371|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383372|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154383373|NCT03239236|Anesthetics|anesthetics|mesh-list
154383374|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383375|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383376|NCT03257800|Ketamine|ketamine|mesh-list
154383377|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
154383378|NCT03257800|Sevoflurane|sevoflurane|mesh-list
154383379|NCT03257800|Analgesics|analgesics|mesh-ancestor
154383380|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
154383381|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383382|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383383|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154383384|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154383385|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
154383386|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
154383387|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383388|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154383389|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154383390|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383391|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745223|NCT05292339|Ketorolac|ketorolac|mesh-list
154383403|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383405|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154383406|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154383407|NCT03239080|Denosumab|denosumab|mesh-list
154383408|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154383409|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383410|NCT03149055|Isavuconazole|isavuconazole|mesh-list
154383411|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
154383412|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383413|NCT01352091|Goserelin|goserelin|mesh-list
154383414|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154383415|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383416|NCT02954523|Dasatinib|dasatinib|mesh-list
154383417|NCT02954523|Osimertinib|osimertinib|mesh-list
154383418|NCT02954523|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154383419|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154383420|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383421|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224083|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
154383422|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383423|NCT04486612|Anesthetics|anesthetics|mesh-list
154383424|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383425|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383426|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
154383427|NCT01353729|Zanamivir|zanamivir|mesh-list
154383428|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154383429|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154383430|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383431|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154862060|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154862061|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
154558149|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558150|NCT02761057|Sunitinib|sunitinib|mesh-list
154558151|NCT02761057|Crizotinib|crizotinib|mesh-list
154558152|NCT02761057|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154558153|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558154|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154558155|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154558156|NCT02761057|Growth Substances|growth substances|mesh-ancestor
154558157|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558158|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
154558159|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154558160|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558161|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558162|NCT02407821|Escitalopram|escitalopram|mesh-list
154558163|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154558164|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154558165|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558166|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558167|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558168|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
154558169|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558170|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154558171|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154558172|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558173|NCT02417337|Acetaminophen|acetaminophen|mesh-list
154558174|NCT02417337|Ibuprofen|ibuprofen|mesh-list
154558175|NCT02417337|Diclofenac|diclofenac|mesh-list
154558176|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
154558177|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154558178|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558179|NCT02417337|Analgesics|analgesics|mesh-ancestor
154558180|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
154558181|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558182|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558183|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558184|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558185|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154558186|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558187|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558188|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
154558189|NCT02167321|Leucovorin|leucovorin|mesh-list
154558190|NCT02167321|Fluorouracil|fluorouracil|mesh-list
154558191|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
154558192|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
154558193|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558194|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154558195|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558196|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154558197|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
154558198|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558199|NCT02167321|Antidotes|antidotes|mesh-ancestor
154558200|NCT02167321|Protective Agents|protective agents|mesh-ancestor
154558201|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
154558202|NCT02167321|Vitamins|vitamins|mesh-ancestor
154558203|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
154558205|NCT02162797|Trace Elements|trace elements|mesh-ancestor
154558206|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
154558207|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558208|NCT02162875|Praziquantel|praziquantel|mesh-list
154558209|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
154558210|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154558211|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558212|NCT02167633|Pantoprazole|pantoprazole|mesh-list
154558213|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154558214|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
154558215|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154558216|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154558217|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558218|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558219|NCT02167633|Hormones|hormones|mesh-ancestor
154558220|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558221|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558222|NCT02413281|Buprenorphine|buprenorphine|mesh-list
154558223|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154558224|NCT02413281|Narcotics|narcotics|mesh-ancestor
154558225|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558226|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558227|NCT02413281|Analgesics|analgesics|mesh-ancestor
154558228|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
154558229|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558230|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154558232|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
154558233|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154558234|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
154558235|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558236|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558237|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
154558239|NCT02164825|Ropivacaine|ropivacaine|mesh-list
154558240|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154558241|NCT02164825|Narcotics|narcotics|mesh-ancestor
154558242|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558243|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558244|NCT02164825|Analgesics|analgesics|mesh-ancestor
154558245|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
154558246|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558247|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558248|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
154558249|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
154558250|NCT02170987|Dabigatran|dabigatran|mesh-list
154558251|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154558252|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558253|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154558254|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154558255|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224187|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154558256|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558257|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558258|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
154558259|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154558260|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
154558261|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
154558262|NCT03176121|Oxycodone|oxycodone|mesh-list
154558263|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154558264|NCT03176121|Narcotics|narcotics|mesh-ancestor
154558265|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558266|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558267|NCT03176121|Analgesics|analgesics|mesh-ancestor
154558268|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
154558269|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558270|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154558271|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558272|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558273|NCT02171143|ASP2409|asp2409|mesh-list
154558274|NCT02171143|Immunoconjugates|immunoconjugates|mesh-ancestor
154558275|NCT02171143|Immunologic Factors|immunologic factors|mesh-ancestor
154558276|NCT02171143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558277|NCT03176199|Oxycodone|oxycodone|mesh-list
154558278|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154558279|NCT03176199|Narcotics|narcotics|mesh-ancestor
154558280|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558281|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558282|NCT03176199|Analgesics|analgesics|mesh-ancestor
154558283|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
154558284|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558285|NCT05697614|Lamotrigine|lamotrigine|mesh-list
154558286|NCT05697614|Carbamazepine|carbamazepine|mesh-list
154558287|NCT05697614|Phenytoin|phenytoin|mesh-list
154558288|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
154558289|NCT05697614|Valproic Acid|valproic acid|mesh-list
154558290|NCT05697614|Clobazam|clobazam|mesh-list
154558291|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
154558292|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154558293|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558294|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558295|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154558296|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558297|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154558298|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154558299|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558300|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154558301|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154558302|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282129|NCT01277484|Decitabine|decitabine|mesh-list
154558304|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558305|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
154558307|NCT05697614|Analgesics|analgesics|mesh-ancestor
154558308|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
154558309|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558310|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154558311|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154558312|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154558313|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154558314|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154558315|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154558316|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
154558317|NCT02171221|DFP-11207|dfp-11207|mesh-list
154558318|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154558319|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
154558320|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558321|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558322|NCT02413515|Nifedipine|nifedipine|mesh-list
154558323|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154558324|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558325|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558326|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154558327|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558328|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
154558329|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
154558330|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154558331|NCT03194906|Memantine|memantine|mesh-list
154558332|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154558333|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154558334|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
154558335|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558336|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558337|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558338|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154558339|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154558340|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
154558341|NCT03171987|Lidocaine|lidocaine|mesh-list
154558342|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558343|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
154558344|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558345|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558346|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
154558347|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558348|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154558349|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154558350|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154558351|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558352|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558353|NCT03171987|Analgesics|analgesics|mesh-ancestor
154558354|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154558355|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558356|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558357|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558358|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154558359|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558360|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
154558361|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154558362|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558363|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558364|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558365|NCT03172065|Analgesics|analgesics|mesh-ancestor
154558366|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
154558367|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558368|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154558369|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154558370|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154558371|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558372|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558373|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558374|NCT06110546|Methadone|methadone|mesh-list
153569829|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
154558375|NCT06110546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154558376|NCT06110546|Narcotics|narcotics|mesh-ancestor
154558377|NCT06110546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558378|NCT06110546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558379|NCT06110546|Analgesics|analgesics|mesh-ancestor
154558380|NCT06110546|Sensory System Agents|sensory system agents|mesh-ancestor
154558381|NCT06110546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558382|NCT06110546|Antitussive Agents|antitussive agents|mesh-ancestor
154558383|NCT06110546|Respiratory System Agents|respiratory system agents|mesh-ancestor
154558384|NCT06110494|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154558386|NCT06110494|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154558387|NCT06110494|Hematinics|hematinics|mesh-ancestor
154558388|NCT06110494|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154558389|NCT06110494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154558390|NCT06110494|Disinfectants|disinfectants|mesh-ancestor
154558391|NCT06110494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558393|NCT06110195|Carboplatin|carboplatin|mesh-list
154558394|NCT06110195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154558395|NCT06110195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558396|NCT06110195|Tubulin Modulators|tubulin modulators|mesh-ancestor
154558397|NCT06110195|Antimitotic Agents|antimitotic agents|mesh-ancestor
154558398|NCT06110195|Mitosis Modulators|mitosis modulators|mesh-ancestor
154558399|NCT06110195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558400|NCT06110078|Acetazolamide|acetazolamide|mesh-list
154558401|NCT06110078|Anticonvulsants|anticonvulsants|mesh-ancestor
154558402|NCT06110078|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154558403|NCT06110078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558404|NCT06110078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558405|NCT06110078|Diuretics|diuretics|mesh-ancestor
154558406|NCT06110078|Natriuretic Agents|natriuretic agents|mesh-ancestor
154558407|NCT06110078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558408|NCT06109688|Lactoferrin|lactoferrin|mesh-list
154558409|NCT06109688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558410|NCT06109649|Afamelanotide|afamelanotide|mesh-list
154558411|NCT06109649|Dermatologic Agents|dermatologic agents|mesh-ancestor
154558412|NCT06109623|Hormones|hormones|mesh-list
154558413|NCT06109623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558414|NCT06109623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558415|NCT06109428|Acetaminophen|acetaminophen|mesh-list
154558416|NCT06109428|Ibuprofen|ibuprofen|mesh-list
154558417|NCT06109428|Bupivacaine|bupivacaine|mesh-list
154558418|NCT06109428|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558419|NCT06109428|Anesthetics|anesthetics|mesh-ancestor
154558420|NCT06109428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558421|NCT06109428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558422|NCT06109428|Sensory System Agents|sensory system agents|mesh-ancestor
154558423|NCT06109428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558424|NCT06109428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558425|NCT06109428|Analgesics|analgesics|mesh-ancestor
154558426|NCT06109428|Antipyretics|antipyretics|mesh-ancestor
154558427|NCT06109428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154558428|NCT06109428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558429|NCT06109428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558430|NCT06109428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154558431|NCT06109428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558432|NCT06109428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558433|NCT06109415|Acetaminophen|acetaminophen|mesh-list
154558434|NCT06109415|Ibuprofen|ibuprofen|mesh-list
154558435|NCT06109415|Bupivacaine|bupivacaine|mesh-list
154558436|NCT06109415|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558437|NCT06109415|Anesthetics|anesthetics|mesh-ancestor
154558438|NCT06109415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558439|NCT06109415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558440|NCT06109415|Sensory System Agents|sensory system agents|mesh-ancestor
154558441|NCT06109415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558442|NCT06109415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558443|NCT06109415|Analgesics|analgesics|mesh-ancestor
154558444|NCT06109415|Antipyretics|antipyretics|mesh-ancestor
154558445|NCT06109415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154558446|NCT06109415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558447|NCT06109415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558448|NCT06109415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154558449|NCT06109415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253743|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
154224362|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154558450|NCT06109415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558452|NCT06109389|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558453|NCT06109389|Anesthetics|anesthetics|mesh-ancestor
154558454|NCT06109389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558455|NCT06109389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558456|NCT06109389|Sensory System Agents|sensory system agents|mesh-ancestor
154558457|NCT06109389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558458|NCT06109389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154558459|NCT06109389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154558460|NCT06109389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154558461|NCT06109389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558462|NCT06109389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558463|NCT06109064|Azacitidine|azacitidine|mesh-list
154558464|NCT06109064|Venetoclax|venetoclax|mesh-list
154558465|NCT06109064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154558466|NCT06109064|Antimetabolites|antimetabolites|mesh-ancestor
154558467|NCT06109064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558468|NCT06109064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558469|NCT06109064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558470|NCT06108518|Carvedilol|carvedilol|mesh-list
154558471|NCT06108518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154558472|NCT06108518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154558473|NCT06108518|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558474|NCT06108518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558475|NCT06108518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558476|NCT06108518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558477|NCT06108518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154558478|NCT06108518|Antioxidants|antioxidants|mesh-ancestor
154558479|NCT06108518|Protective Agents|protective agents|mesh-ancestor
154558480|NCT06108518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154558481|NCT06108518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558482|NCT06108518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154558483|NCT06108518|Vasodilator Agents|vasodilator agents|mesh-ancestor
154558484|NCT06108518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154558485|NCT06108518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154558486|NCT06108453|Rifampin|rifampin|mesh-list
154558487|NCT06108453|Methotrexate|methotrexate|mesh-list
154558488|NCT06108453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154558489|NCT06108453|Abortifacient Agents|abortifacient agents|mesh-ancestor
154558490|NCT06108453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154558491|NCT06108453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558492|NCT06108453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154558493|NCT06108453|Antimetabolites|antimetabolites|mesh-ancestor
154558494|NCT06108453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558495|NCT06108453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558496|NCT06108453|Dermatologic Agents|dermatologic agents|mesh-ancestor
154558497|NCT06108453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558498|NCT06108453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154558499|NCT06108453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154558500|NCT06108453|Immunologic Factors|immunologic factors|mesh-ancestor
154558501|NCT06108453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558502|NCT06108453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154558503|NCT06108453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154558504|NCT06108453|Antitubercular Agents|antitubercular agents|mesh-ancestor
154558505|NCT06108453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154558506|NCT06108453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558507|NCT06108453|Leprostatic Agents|leprostatic agents|mesh-ancestor
154558508|NCT06108453|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154558509|NCT06108453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154558510|NCT06108453|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154558511|NCT06108453|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154558512|NCT06108453|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154558513|NCT06108453|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154558514|NCT06108414|Rivaroxaban|rivaroxaban|mesh-list
154558515|NCT06108414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154558516|NCT06108414|Antithrombins|antithrombins|mesh-ancestor
154558517|NCT06108414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154558518|NCT06108414|Protease Inhibitors|protease inhibitors|mesh-ancestor
154558519|NCT06108414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558520|NCT06108414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558521|NCT06108414|Anticoagulants|anticoagulants|mesh-ancestor
154862062|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558522|NCT06108362|Terlipressin|terlipressin|mesh-list
154558523|NCT06108362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154558524|NCT06108362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154558525|NCT06108349|Cannabidiol|cannabidiol|mesh-list
154282345|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
154558526|NCT06108349|Anticonvulsants|anticonvulsants|mesh-ancestor
154558527|NCT06107569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154558528|NCT06107569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558529|NCT06107504|Sucralfate|sucralfate|mesh-list
154558530|NCT06107504|Tranexamic Acid|tranexamic acid|mesh-list
154558531|NCT06107504|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154558532|NCT06107504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154558533|NCT06107504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558534|NCT06107504|Hemostatics|hemostatics|mesh-ancestor
154558535|NCT06107504|Coagulants|coagulants|mesh-ancestor
154558536|NCT06107504|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154558537|NCT06107504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154558538|NCT06105619|Etoposide|etoposide|mesh-list
154558539|NCT06105619|Temozolomide|temozolomide|mesh-list
154558540|NCT06105619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558541|NCT06105619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154558542|NCT06105619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154558543|NCT06105619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154558544|NCT06105619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558545|NCT06105619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558546|NCT06105619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154558547|NCT06105619|Alkylating Agents|alkylating agents|mesh-ancestor
154558548|NCT06105060|Acetylcysteine|acetylcysteine|mesh-list
154558549|NCT06105060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154558550|NCT06105060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154558551|NCT06105060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154558552|NCT06105060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154558553|NCT06105060|Antimetabolites|antimetabolites|mesh-ancestor
154558554|NCT06105060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558555|NCT06105060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154558556|NCT06105060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154558557|NCT06105060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558558|NCT06105060|Antiviral Agents|antiviral agents|mesh-ancestor
154558559|NCT06105060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558560|NCT06105060|Expectorants|expectorants|mesh-ancestor
154558561|NCT06105060|Respiratory System Agents|respiratory system agents|mesh-ancestor
154558562|NCT06105060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154558563|NCT06105060|Antioxidants|antioxidants|mesh-ancestor
154558564|NCT06105060|Protective Agents|protective agents|mesh-ancestor
154558565|NCT06105060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558566|NCT06105060|Antidotes|antidotes|mesh-ancestor
154558567|NCT06101147|Vitamin D|vitamin d|mesh-list
154558568|NCT06101147|Cholecalciferol|cholecalciferol|mesh-list
154558569|NCT06101147|Vitamins|vitamins|mesh-ancestor
154558570|NCT06101147|Micronutrients|micronutrients|mesh-ancestor
154558571|NCT06101147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558572|NCT06101147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154558573|NCT06101147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154558574|NCT06095128|Vedolizumab|vedolizumab|mesh-list
154558575|NCT06095128|Tofacitinib|tofacitinib|mesh-list
154558576|NCT06095128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154558577|NCT06095128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224498|NCT00250718|Hormones|hormones|mesh-ancestor
154558578|NCT06095128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558579|NCT06095128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558580|NCT06095128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154558581|NCT06074692|Fluzoparib|fluzoparib|mesh-list
154558582|NCT06074692|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154558583|NCT06074692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558584|NCT06074692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558585|NCT06074692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558586|NCT06043830|Acetazolamide|acetazolamide|mesh-list
154558587|NCT06043830|Anticonvulsants|anticonvulsants|mesh-ancestor
154558588|NCT06043830|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154558589|NCT06043830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558590|NCT06043830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558591|NCT06043830|Diuretics|diuretics|mesh-ancestor
154558592|NCT06043830|Natriuretic Agents|natriuretic agents|mesh-ancestor
154558593|NCT06043830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558594|NCT06003829|Denatonium|denatonium|mesh-list
154558595|NCT06003829|Aversive Agents|aversive agents|mesh-ancestor
154255531|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154862063|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154558596|NCT06003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558598|NCT06003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558599|NCT06003829|Sensory System Agents|sensory system agents|mesh-ancestor
154558600|NCT06003829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558601|NCT05993975|Dexmedetomidine|dexmedetomidine|mesh-list
154558603|NCT05993975|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558604|NCT05993975|Anesthetics|anesthetics|mesh-ancestor
154558605|NCT05993975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558606|NCT05993975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558607|NCT05993975|Sensory System Agents|sensory system agents|mesh-ancestor
154558608|NCT05993975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558609|NCT05993975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154558610|NCT05993975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558611|NCT05993975|Analgesics|analgesics|mesh-ancestor
154558612|NCT05993975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154558613|NCT05993975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154558614|NCT05993975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154558615|NCT05993975|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558616|NCT05993975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558617|NCT05993975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558618|NCT05966025|Antihypertensive Agents|antihypertensive agents|mesh-list
154558619|NCT05966025|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154558620|NCT05966025|Antimetabolites|antimetabolites|mesh-ancestor
154558621|NCT05966025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558622|NCT05966025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154558623|NCT05965531|Trifluridine|trifluridine|mesh-list
154558624|NCT05965531|Antimetabolites|antimetabolites|mesh-ancestor
154558625|NCT05965531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558626|NCT05965531|Antiviral Agents|antiviral agents|mesh-ancestor
154558627|NCT05965531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558628|NCT05960942|Sufentanil|sufentanil|mesh-list
154558629|NCT05960942|Propofol|propofol|mesh-list
154558630|NCT05960942|Esketamine|esketamine|mesh-list
154558631|NCT05960942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154558632|NCT05960942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558633|NCT05960942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558634|NCT05960942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154558635|NCT05960942|Anesthetics, General|anesthetics, general|mesh-ancestor
154558636|NCT05960942|Anesthetics|anesthetics|mesh-ancestor
154558637|NCT05960942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154558638|NCT05960942|Narcotics|narcotics|mesh-ancestor
154558639|NCT05960942|Analgesics|analgesics|mesh-ancestor
154558640|NCT05960942|Sensory System Agents|sensory system agents|mesh-ancestor
154558641|NCT05960942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558642|NCT05960942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154558643|NCT05960942|Antidepressive Agents|antidepressive agents|mesh-ancestor
154558644|NCT05960942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154558645|NCT05833958|Metformin|metformin|mesh-list
154558646|NCT05833958|Dapagliflozin|dapagliflozin|mesh-list
154558647|NCT05833958|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154558648|NCT05833958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154558649|NCT05833958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558650|NCT05833958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154558651|NCT05833958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558652|NCT05833958|Incretins|incretins|mesh-ancestor
154558653|NCT05833958|Hormones|hormones|mesh-ancestor
154558654|NCT05833958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558655|NCT05833958|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154558656|NCT05833958|Protease Inhibitors|protease inhibitors|mesh-ancestor
154558657|NCT05833958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558658|NCT05830071|Moxifloxacin|moxifloxacin|mesh-list
154558659|NCT05830071|Beclomethasone|beclomethasone|mesh-list
154558660|NCT05830071|Glycopyrrolate|glycopyrrolate|mesh-list
154558661|NCT05830071|Bromides|bromides|mesh-list
154558662|NCT05830071|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154558663|NCT05830071|Formoterol Fumarate|formoterol fumarate|mesh-list
154558664|NCT05830071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154558665|NCT05830071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558666|NCT05830071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154558667|NCT05830071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154558668|NCT05830071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558669|NCT05830071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558670|NCT05830071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862064|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154862065|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862066|NCT03030287|Paclitaxel|paclitaxel|mesh-list
154862067|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154862068|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154862069|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862070|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
154862071|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
154558671|NCT05830071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154558672|NCT05830071|Contraceptive Agents|contraceptive agents|mesh-ancestor
154558673|NCT05830071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154558674|NCT05830071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558675|NCT05830071|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154282491|NCT01176318|Expectorants|expectorants|mesh-ancestor
154558676|NCT05830071|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154558677|NCT05830071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154558678|NCT05830071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154558679|NCT05830071|Autonomic Agents|autonomic agents|mesh-ancestor
154558680|NCT05830071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558681|NCT05830071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154558682|NCT05830071|Respiratory System Agents|respiratory system agents|mesh-ancestor
154224623|NCT06185621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558683|NCT05830071|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154558684|NCT05830071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154558685|NCT05830071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154558686|NCT05830071|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558687|NCT05830071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558688|NCT05830071|Anticonvulsants|anticonvulsants|mesh-ancestor
154558689|NCT05830071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154558690|NCT05830071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154558691|NCT05830071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154558692|NCT05830071|Cholinergic Agents|cholinergic agents|mesh-ancestor
154558693|NCT05830071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558694|NCT05830071|Glucocorticoids|glucocorticoids|mesh-ancestor
154558695|NCT05830071|Hormones|hormones|mesh-ancestor
154558696|NCT05830071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558697|NCT05828836|Allopurinol|allopurinol|mesh-list
154558698|NCT05828836|Antimetabolites|antimetabolites|mesh-ancestor
154558699|NCT05828836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558700|NCT05828836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558701|NCT05828836|Gout Suppressants|gout suppressants|mesh-ancestor
154558702|NCT05828836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558703|NCT05828836|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154558704|NCT05828836|Antioxidants|antioxidants|mesh-ancestor
154558705|NCT05828836|Protective Agents|protective agents|mesh-ancestor
154558706|NCT05828836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558707|NCT05821075|Prednisolone|prednisolone|mesh-list
154558708|NCT05821075|Cerebrolysin|cerebrolysin|mesh-list
154558709|NCT05821075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558710|NCT05821075|Glucocorticoids|glucocorticoids|mesh-ancestor
154558711|NCT05821075|Hormones|hormones|mesh-ancestor
154558712|NCT05821075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558713|NCT05821075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558714|NCT05821075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154558715|NCT05821075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558716|NCT05821075|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154558717|NCT05821075|Protective Agents|protective agents|mesh-ancestor
154558718|NCT05821075|Nootropic Agents|nootropic agents|mesh-ancestor
154558719|NCT05785325|Bevacizumab|bevacizumab|mesh-list
154558720|NCT05785325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154558721|NCT05785325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558722|NCT05785325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154558723|NCT05785325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154558724|NCT05785325|Growth Substances|growth substances|mesh-ancestor
154558725|NCT05785325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558726|NCT05785325|Growth Inhibitors|growth inhibitors|mesh-ancestor
154558727|NCT05765513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154558728|NCT05719831|Amoxicillin|amoxicillin|mesh-list
154558729|NCT05719831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154558730|NCT05719831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558731|NCT05704400|Rituximab|rituximab|mesh-list
154558732|NCT05704400|Daratumumab|daratumumab|mesh-list
154558733|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154558734|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558735|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
154558736|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558737|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558738|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
154558739|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154558740|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558741|NCT05629546|Nivolumab|nivolumab|mesh-list
154558742|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154558743|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558744|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154558745|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558746|NCT05624866|Triamcinolone|triamcinolone|mesh-list
154558747|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
154558748|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154282571|NCT03182166|Golimumab|golimumab|mesh-list
154558749|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558750|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558751|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558752|NCT05624866|Analgesics|analgesics|mesh-ancestor
154558753|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
154558754|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558755|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154558756|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154558757|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154558758|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558759|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558760|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558761|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558762|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
154558763|NCT05624866|Hormones|hormones|mesh-ancestor
154558764|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558765|NCT05613361|Colistin|colistin|mesh-list
154558766|NCT05613361|Curcumin|curcumin|mesh-list
154558767|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154558768|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558769|NCT05613361|Analgesics|analgesics|mesh-ancestor
154558770|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
154558771|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558772|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558773|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558774|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558775|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558776|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558777|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558778|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154558779|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558780|NCT05591092|Iodine|iodine|mesh-list
154558781|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
154558782|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154558783|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558784|NCT05591092|Trace Elements|trace elements|mesh-ancestor
154558785|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
154558786|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558787|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
154558788|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154558789|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
154558790|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558791|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
154558792|NCT05579665|Protective Agents|protective agents|mesh-ancestor
154558793|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
154558794|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154558795|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558796|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154558797|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558798|NCT05510115|Empagliflozin|empagliflozin|mesh-list
154558799|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154558800|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558801|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154558802|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558803|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
154558804|NCT05501548|Olaparib|olaparib|mesh-list
154558805|NCT05501548|Vitamins|vitamins|mesh-ancestor
154558806|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
154558807|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558808|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
154558809|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558810|NCT05501548|Protective Agents|protective agents|mesh-ancestor
154862072|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
154558811|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154558813|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558814|NCT05407233|Insulin|insulin|mesh-list
154558815|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154558816|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154558817|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558818|NCT05391893|Diltiazem|diltiazem|mesh-list
154558819|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154558820|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154558821|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558822|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558823|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154253744|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558824|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558825|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
154558827|NCT05367336|Morphine|morphine|mesh-list
154558828|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154558829|NCT05367336|Narcotics|narcotics|mesh-ancestor
154558830|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558831|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558832|NCT05367336|Analgesics|analgesics|mesh-ancestor
154558833|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
154558834|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558835|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154558836|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154558837|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
154558838|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
154558839|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
154558840|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558841|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
154558842|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224792|NCT06030804|Analgesics|analgesics|mesh-ancestor
154558843|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558844|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
154558845|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558846|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154558847|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558848|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558849|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
154558850|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154558851|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
154558852|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558853|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558854|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154558855|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
154558856|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154558857|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
154558858|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558859|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558860|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154558861|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
154558862|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
154558863|NCT05351502|Protective Agents|protective agents|mesh-ancestor
154558864|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
154558865|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154558866|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558867|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558868|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558869|NCT05280223|Analgesics|analgesics|mesh-ancestor
154558870|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
154558871|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558872|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154558873|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154558874|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154558875|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558876|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558877|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558878|NCT05238506|Lidocaine|lidocaine|mesh-list
154558879|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558880|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
154558881|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558882|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558883|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
154558885|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154558886|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154558887|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154558888|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154558889|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558890|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154558891|NCT05216328|Antacids|antacids|mesh-ancestor
154558892|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558893|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154558894|NCT05177991|Bupivacaine|bupivacaine|mesh-list
154558895|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558896|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
154253745|NCT01136642|Nicotine|nicotine|mesh-list
154558897|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558898|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558899|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
154558900|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558901|NCT05141877|Anesthetics|anesthetics|mesh-list
154558902|NCT05141877|Propofol|propofol|mesh-list
154558903|NCT05141877|Sevoflurane|sevoflurane|mesh-list
154558904|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558905|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558906|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154558907|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154558908|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
154558909|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154558910|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154558911|NCT05120622|Tremelimumab|tremelimumab|mesh-list
154558912|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558913|NCT05099666|Doxorubicin|doxorubicin|mesh-list
154558914|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154558915|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558916|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154558917|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154558918|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558919|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558920|NCT05090124|Adalimumab|adalimumab|mesh-list
154558921|NCT05090124|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154558922|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558923|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558924|NCT05036577|Dexamethasone|dexamethasone|mesh-list
154558925|NCT05036577|Rituximab|rituximab|mesh-list
154558926|NCT05036577|Methotrexate|methotrexate|mesh-list
154558927|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154558928|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558929|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
154558930|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558931|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154558932|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154558933|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
154558934|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
154558935|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558936|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154558937|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
154558938|NCT05036577|Hormones|hormones|mesh-ancestor
154558939|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558940|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154558941|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154558942|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
154558943|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154558944|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154558945|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
154558946|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558947|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
154558948|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154558949|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154558950|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154558951|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154558952|NCT05017116|Entecavir|entecavir|mesh-list
154558953|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
154558954|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558955|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154558956|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558957|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
154558958|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154558959|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558960|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558961|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154558962|NCT04946396|Analgesics|analgesics|mesh-ancestor
154558963|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
154558964|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558965|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154558966|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154558967|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154558968|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
154558969|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154558970|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282792|NCT01287780|Gentamicins|gentamicins|mesh-list
154558972|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154558973|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558974|NCT04892875|Cisplatin|cisplatin|mesh-list
154558975|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558976|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
154558977|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154558978|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154558979|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154558980|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
154558981|NCT04818866|Coagulants|coagulants|mesh-ancestor
154558982|NCT04817826|Durvalumab|durvalumab|mesh-list
154558983|NCT04817826|Tremelimumab|tremelimumab|mesh-list
154558984|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154558985|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154558986|NCT04794842|Phenol|phenol|mesh-list
154558987|NCT04794842|Tetracaine|tetracaine|mesh-list
154558988|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
154558989|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
154558990|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154558991|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154558992|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
154558993|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154558994|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154558995|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154558996|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
154558997|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154558998|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154558999|NCT04770155|Bosentan|bosentan|mesh-list
154559000|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
154559001|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
154559002|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154559003|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154559004|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559005|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559006|NCT04770155|Urological Agents|urological agents|mesh-ancestor
154559007|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154559008|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154559009|NCT04753203|Capecitabine|capecitabine|mesh-list
154559010|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154559011|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
154559012|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559013|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559014|NCT04751955|Capecitabine|capecitabine|mesh-list
154559015|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154559016|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
154559017|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559018|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559019|NCT04734080|Dronabinol|dronabinol|mesh-list
154559020|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
154559021|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559022|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154559023|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154559024|NCT04734080|Analgesics|analgesics|mesh-ancestor
154559025|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
154559026|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559027|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154559028|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154559029|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154559030|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559031|NCT04734080|Hormones|hormones|mesh-ancestor
154559032|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559033|NCT04709276|Carboplatin|carboplatin|mesh-list
154559035|NCT04709276|Ipilimumab|ipilimumab|mesh-list
154559036|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559037|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559038|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154559039|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559040|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
154559041|NCT04696731|Fludarabine|fludarabine|mesh-list
154559042|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559043|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
154559044|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282866|NCT01289496|Interferons|interferons|mesh-list
154559045|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559046|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154559047|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
154559048|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559049|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559050|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154559051|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154559052|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154559053|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559054|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
154559055|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
154559056|NCT04645719|Analgesics|analgesics|mesh-ancestor
154559057|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
154559058|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559059|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559060|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
154559061|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559062|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154559063|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
154559064|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154559065|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154559066|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559067|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154559068|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
154559069|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154559070|NCT04601324|Fluticasone|fluticasone|mesh-list
154559071|NCT04601324|Xhance|xhance|mesh-list
154559072|NCT04601324|Azelastine|azelastine|mesh-list
154559073|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559074|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154559075|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
154559076|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559077|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559078|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154559079|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
154559080|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
154559081|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154559082|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154559083|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559084|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559085|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154559086|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154559087|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
154559088|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
154559089|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154559090|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154559091|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154138187|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
154559092|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559093|NCT04561739|Sirolimus|sirolimus|mesh-list
154559094|NCT04561739|Paclitaxel|paclitaxel|mesh-list
154559095|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154559096|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559097|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
154559098|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
154559099|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
154559100|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559101|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154559102|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559103|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154559104|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
154559106|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
154559107|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559108|NCT04547439|Melatonin|melatonin|mesh-list
154559109|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
154559110|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559111|NCT04547439|Protective Agents|protective agents|mesh-ancestor
154559112|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559113|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559114|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
154559115|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154559116|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154559117|NCT04519476|Prednisolone|prednisolone|mesh-list
154282943|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154559118|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
154559120|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154559121|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
154559122|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
154559123|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559124|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154559125|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154559126|NCT04519476|Growth Substances|growth substances|mesh-ancestor
154559127|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
154559128|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559129|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559130|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
154559131|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
154559132|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559133|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154559134|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
154559135|NCT04519476|Hormones|hormones|mesh-ancestor
154559136|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559137|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154559138|NCT04519476|Protective Agents|protective agents|mesh-ancestor
154559139|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154559140|NCT04498234|Bupivacaine|bupivacaine|mesh-list
154559141|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
154559142|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
154559143|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559144|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559145|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
154559146|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559147|NCT04446351|Dostarlimab|dostarlimab|mesh-list
154559148|NCT04446351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559149|NCT04367233|Anesthetics|anesthetics|mesh-list
154559150|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559151|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559152|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
154559153|NCT04363164|Testosterone|testosterone|mesh-list
154559154|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
154559155|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
154559156|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154559157|NCT04363164|Androgens|androgens|mesh-ancestor
154559158|NCT04363164|Hormones|hormones|mesh-ancestor
154559159|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559160|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559161|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154559162|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559163|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
154559164|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
154559165|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154559166|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559167|NCT04156347|Topotecan|topotecan|mesh-list
154559168|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154559169|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154559170|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559171|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559172|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559173|NCT04044534|Insulin|insulin|mesh-list
154559174|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154559175|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559176|NCT04039464|Bosentan|bosentan|mesh-list
154559177|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
154559178|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
154559179|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154559181|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559182|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559183|NCT04039464|Urological Agents|urological agents|mesh-ancestor
154559184|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154559185|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154559186|NCT03974139|Metformin|metformin|mesh-list
154559187|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154559188|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559189|NCT03968822|Lidocaine|lidocaine|mesh-list
154559190|NCT03968822|Bupivacaine|bupivacaine|mesh-list
154559191|NCT03968822|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154559192|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
154559193|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
154559194|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559195|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559196|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
154559197|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559198|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154559199|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154559200|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154559201|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154559202|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559203|NCT03968822|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154559204|NCT03968822|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154559205|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154559206|NCT03946800|Durvalumab|durvalumab|mesh-list
154138296|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
154559207|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559208|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559209|NCT03932136|Sulforaphane|sulforaphane|mesh-list
154559210|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154559211|NCT03932136|Protective Agents|protective agents|mesh-ancestor
154559212|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559213|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559214|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154559215|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154559216|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154559217|NCT03804229|Protective Agents|protective agents|mesh-ancestor
154559218|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559219|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
154559220|NCT03797326|Lenvatinib|lenvatinib|mesh-list
154559221|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559222|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559223|NCT03797326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154559224|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559225|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154559226|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559227|NCT03781700|Prednisolone|prednisolone|mesh-list
154559228|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559229|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
154559230|NCT03781700|Hormones|hormones|mesh-ancestor
154559231|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559232|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559233|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154559234|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559235|NCT03749018|Prednisone|prednisone|mesh-list
154559236|NCT03749018|Cortisone|cortisone|mesh-list
154559237|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
154559238|NCT03749018|Rituximab|rituximab|mesh-list
154559239|NCT03749018|Doxorubicin|doxorubicin|mesh-list
154559240|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154559241|NCT03749018|Nivolumab|nivolumab|mesh-list
154559242|NCT03749018|Etoposide|etoposide|mesh-list
154559243|NCT03749018|Vincristine|vincristine|mesh-list
154559244|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
154559245|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
154559246|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154559247|NCT03749018|Antibodies|antibodies|mesh-list
154559248|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
154559249|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154559250|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559251|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
154138355|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
154559252|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559253|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559254|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154559256|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559257|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559258|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154559259|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154559260|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154559261|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154559262|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559263|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559264|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
154559265|NCT03749018|Hormones|hormones|mesh-ancestor
154559266|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559267|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154559268|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154559269|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154559270|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154559271|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
154559272|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154559273|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
154559274|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
154559275|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154559276|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154559277|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154559278|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559279|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559280|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154559281|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154559282|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559283|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
154559284|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154559285|NCT03637400|Doxycycline|doxycycline|mesh-list
154559286|NCT03637400|Trimethoprim|trimethoprim|mesh-list
154559287|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
154559288|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154559289|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559290|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
154559291|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154559292|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154559293|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154559294|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154559295|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559296|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559297|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154559298|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154559299|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154559300|NCT03586453|Osimertinib|osimertinib|mesh-list
154559301|NCT03586453|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154559302|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154559303|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559304|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559305|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559306|NCT03583255|Dexamethasone|dexamethasone|mesh-list
154559307|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
154559308|NCT03583255|Ichthammol|ichthammol|mesh-list
154559309|NCT03583255|BB 1101|bb 1101|mesh-list
154559310|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559311|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
154559312|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
154559313|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559314|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559315|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154559316|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
154559317|NCT03583255|Hormones|hormones|mesh-ancestor
154559318|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559319|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154559320|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559321|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
154559322|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559323|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559324|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
154559325|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154559326|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154559327|NCT03409432|Lenalidomide|lenalidomide|mesh-list
154559328|NCT03409432|Antibodies|antibodies|mesh-list
154559329|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
154559330|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154559331|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
154559332|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
154559333|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559334|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559335|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154559336|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154559337|NCT03409432|Growth Substances|growth substances|mesh-ancestor
154559338|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
154559339|NCT03409432|Immunotoxins|immunotoxins|mesh-ancestor
154559340|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
154559341|NCT03323476|Prednisone|prednisone|mesh-list
154559342|NCT03323476|Rituximab|rituximab|mesh-list
154559343|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154559344|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559345|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559346|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
154559347|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559348|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559349|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154559350|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154559351|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
154559352|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154559353|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559354|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559355|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559356|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559357|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
154559359|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559360|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154559361|NCT03315312|Fluorides|fluorides|mesh-list
154559362|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
154559363|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
154559364|NCT03315312|Protective Agents|protective agents|mesh-ancestor
154559365|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559366|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
154559367|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154559368|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559369|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559370|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154559371|NCT03289325|Analgesics|analgesics|mesh-ancestor
154559372|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
154559373|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559374|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154559375|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154559376|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154559377|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
154559378|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154559379|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559380|NCT03190954|Raclopride|raclopride|mesh-list
154559381|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154559382|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154559383|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559384|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559385|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154559386|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154559387|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
154559388|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154559389|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559390|NCT03122717|Gefitinib|gefitinib|mesh-list
154559391|NCT03122717|Osimertinib|osimertinib|mesh-list
154559392|NCT03122717|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154559393|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154559394|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559395|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559396|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559397|NCT03006068|Upadacitinib|upadacitinib|mesh-list
154559398|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154559399|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154559400|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559401|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559402|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559403|NCT02965703|Aspirin|aspirin|mesh-list
154559404|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154559405|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154559406|NCT02965703|Analgesics|analgesics|mesh-ancestor
154559407|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
154559408|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559409|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559410|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559411|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559412|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154559413|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154559414|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559415|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154559416|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154283246|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
154559418|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
154559419|NCT02772003|Interleukin-12|interleukin-12|mesh-list
154559420|NCT02772003|Vaccines|vaccines|mesh-list
154559421|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
154559422|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559423|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154559424|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154559425|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154559426|NCT02772003|Growth Substances|growth substances|mesh-ancestor
154559427|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
154559428|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559429|NCT02708394|Olanzapine|olanzapine|mesh-list
154559430|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
154559431|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
154559432|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559433|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559434|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154559435|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154559436|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154559437|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559438|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154559439|NCT02708394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154559440|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154559441|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154559442|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559443|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154559444|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
154559445|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
154559446|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559447|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559448|NCT02662062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154559449|NCT02662062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559450|NCT02649855|Docetaxel|docetaxel|mesh-list
154559451|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559452|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
154559453|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
154559454|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
154559455|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559456|NCT02619682|Lenalidomide|lenalidomide|mesh-list
154559457|NCT02619682|Ixazomib|ixazomib|mesh-list
154559458|NCT02619682|Glycine|glycine|mesh-list
154559459|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
154559460|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559461|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154559462|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154559463|NCT02619682|Growth Substances|growth substances|mesh-ancestor
154559464|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
154559465|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559466|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559467|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
154559468|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559469|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
154559470|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154559471|NCT02613507|Docetaxel|docetaxel|mesh-list
154559472|NCT02613507|Nivolumab|nivolumab|mesh-list
154559473|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559474|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
154559475|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
154559476|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
154559477|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559478|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559480|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
154559482|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559483|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559484|NCT02538510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154559485|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559486|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154559487|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559488|NCT02521285|Aspirin|aspirin|mesh-list
154559489|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154559490|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154559491|NCT02521285|Analgesics|analgesics|mesh-ancestor
154559492|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
154559493|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559494|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559495|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559496|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559497|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154559498|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154559499|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559500|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154559501|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154559502|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559503|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
154559504|NCT02436226|Citric Acid|citric acid|mesh-list
154559505|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
154559506|NCT02436226|Clomiphene|clomiphene|mesh-list
154559507|NCT02436226|Enclomiphene|enclomiphene|mesh-list
154559508|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
154559509|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154559510|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
154559511|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154559512|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
154559513|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
154559514|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559515|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154559516|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
154559517|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559518|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559519|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154559520|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
154559521|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154559522|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154559523|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154559524|NCT02419040|Lidocaine|lidocaine|mesh-list
154559525|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
154559526|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
154559527|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559528|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559529|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
154559530|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559531|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154559532|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154559533|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154559534|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154559535|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559536|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
154559537|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559538|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559539|NCT02407171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154559540|NCT02407171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559541|NCT02381535|Cisplatin|cisplatin|mesh-list
154559542|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559543|NCT02331134|Lenograstim|lenograstim|mesh-list
154559544|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154559545|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
154559546|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559547|NCT02303171|Enoxaparin|enoxaparin|mesh-list
154559548|NCT02303171|Warfarin|warfarin|mesh-list
154559549|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
154559550|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154559551|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154559552|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559553|NCT02135042|Paclitaxel|paclitaxel|mesh-list
154559554|NCT02135042|Cisplatin|cisplatin|mesh-list
154559555|NCT02135042|Gemcitabine|gemcitabine|mesh-list
154559556|NCT02135042|Fluorouracil|fluorouracil|mesh-list
154559557|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154559558|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154559559|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559560|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
154559561|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
154559562|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
154559563|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559564|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154559565|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
154283394|NCT01191060|Bortezomib|bortezomib|mesh-list
154559566|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559567|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
154559568|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559569|NCT01693601|Panobinostat|panobinostat|mesh-list
154559570|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559571|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154559572|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559573|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559574|NCT01671982|Tenofovir|tenofovir|mesh-list
154559575|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
154559576|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559577|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154559578|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154559579|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559580|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559581|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154559582|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154559583|NCT00082706|Leucovorin|leucovorin|mesh-list
154559584|NCT00082706|Cisplatin|cisplatin|mesh-list
154559585|NCT00082706|Gemcitabine|gemcitabine|mesh-list
154559586|NCT00082706|Fluorouracil|fluorouracil|mesh-list
154559587|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559588|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154559589|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
154559590|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559591|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559592|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
154559593|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559594|NCT00082706|Antidotes|antidotes|mesh-ancestor
154559595|NCT00082706|Protective Agents|protective agents|mesh-ancestor
154559596|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
154559597|NCT00082706|Vitamins|vitamins|mesh-ancestor
154559598|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
154559599|NCT00020345|Gemcitabine|gemcitabine|mesh-list
154559600|NCT00020345|Fluorouracil|fluorouracil|mesh-list
154559601|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154559602|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
154559603|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559604|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559605|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559606|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
154559607|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559608|NCT00020046|Thalidomide|thalidomide|mesh-list
154559609|NCT00020046|Docetaxel|docetaxel|mesh-list
154559610|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559611|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
154559612|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
154559613|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
154559614|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559615|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559616|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
154559617|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559618|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
154559619|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154559620|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559621|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154559622|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154559623|NCT00020046|Growth Substances|growth substances|mesh-ancestor
154559624|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
154559625|NCT00019968|Melphalan|melphalan|mesh-list
154559626|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154559627|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
154559628|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559629|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559630|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154559631|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559633|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559634|NCT00019760|Leucovorin|leucovorin|mesh-list
154559635|NCT00019760|Melphalan|melphalan|mesh-list
154559636|NCT00019760|Floxuridine|floxuridine|mesh-list
154559637|NCT00019760|Calcium|calcium|mesh-list
154559638|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
154559639|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154559640|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559641|NCT00019760|Antidotes|antidotes|mesh-ancestor
154559642|NCT00019760|Protective Agents|protective agents|mesh-ancestor
154559643|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
154559644|NCT00019760|Vitamins|vitamins|mesh-ancestor
154559645|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
154559646|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154559647|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
154559648|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559649|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559650|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154559651|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559652|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
154559653|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154559654|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
154559655|NCT02171299|Ropivacaine|ropivacaine|mesh-list
154559656|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
154559657|NCT02171299|Anesthetics|anesthetics|mesh-list
154559658|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559659|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559660|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
154559661|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559662|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
154559663|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
154559664|NCT03171831|Busulfan|busulfan|mesh-list
154559665|NCT03171831|Methotrexate|methotrexate|mesh-list
154559666|NCT03171831|Fludarabine|fludarabine|mesh-list
154559667|NCT03171831|Tacrolimus|tacrolimus|mesh-list
154559668|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
154559669|NCT03171831|Basiliximab|basiliximab|mesh-list
154559670|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559671|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
154559672|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559673|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559674|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154559675|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
154559676|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559677|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559678|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154559679|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154559680|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
154559681|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154559682|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154559683|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
154559684|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
154559685|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559686|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154559687|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154559688|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154559689|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154559690|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154559691|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
154559692|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154559693|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559694|NCT02171455|Dabigatran|dabigatran|mesh-list
154559695|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
154559696|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154559697|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
154559698|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559699|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559700|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
154559701|NCT02171533|Verapamil|verapamil|mesh-list
154559702|NCT02171533|Dabigatran|dabigatran|mesh-list
154559703|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
154559704|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154559705|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
154559706|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559707|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559708|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
154559709|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154559710|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154559711|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154559712|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154559713|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559714|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
154559715|NCT04482543|Methotrexate|methotrexate|mesh-list
154559716|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154559717|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
154559718|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154559719|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559720|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154559721|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
154559722|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559723|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559724|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
154559725|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559726|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154559727|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559728|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
154559729|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559730|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154559731|NCT02406183|Ipilimumab|ipilimumab|mesh-list
154559732|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154559733|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559734|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154559735|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559736|NCT04723472|Cefuroxime|cefuroxime|mesh-list
154559737|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
154559738|NCT04723472|Bismuth|bismuth|mesh-list
154559739|NCT04723472|Antacids|antacids|mesh-ancestor
154559740|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559741|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154559742|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154559743|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559744|NCT02412813|Cobalt|cobalt|mesh-list
154559745|NCT02412813|Trace Elements|trace elements|mesh-ancestor
154559746|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
154559747|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559748|NCT02013128|Ibrutinib|ibrutinib|mesh-list
154559749|NCT02013128|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154559750|NCT02013128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154559751|NCT02013128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559752|NCT02013128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559753|NCT03116295|Opicapone|opicapone|mesh-list
154559754|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154559755|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559756|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559757|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154559758|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154559759|NCT02405715|Oxytocin|oxytocin|mesh-list
154559760|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
154559761|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154559762|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559763|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
154559764|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559765|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
154559766|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559767|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559768|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154559769|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
154559770|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559771|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559772|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154559773|NCT02412345|Alprostadil|alprostadil|mesh-list
154559774|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154559775|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
154559776|NCT02412345|Urological Agents|urological agents|mesh-ancestor
154559777|NCT05679050|Folfirinox|folfirinox|mesh-list
154559778|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559779|NCT02412267|Carboplatin|carboplatin|mesh-list
154559781|NCT02412267|Ifosfamide|ifosfamide|mesh-list
154559782|NCT02412267|Ofatumumab|ofatumumab|mesh-list
154559783|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559784|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154559785|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154559786|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154559787|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559788|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559789|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154559790|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
154559791|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154559792|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154559793|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154559794|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
154559795|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138892|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154559796|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559797|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
154559798|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154559799|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
154559801|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
154559802|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154559803|NCT05539118|Interferons|interferons|mesh-list
154559804|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559805|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
154559806|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559807|NCT02405793|Meloxicam|meloxicam|mesh-list
154559808|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154559809|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154559810|NCT02405793|Analgesics|analgesics|mesh-ancestor
154559811|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
154559812|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559813|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559814|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559815|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559816|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154559817|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154559818|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559819|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559820|NCT05695664|Ibuprofen|ibuprofen|mesh-list
154559821|NCT05695664|Ketorolac|ketorolac|mesh-list
154559822|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154559823|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154559824|NCT05695664|Analgesics|analgesics|mesh-ancestor
154559825|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
154559826|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559827|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559828|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559829|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559830|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154559831|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559832|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559833|NCT02412189|Norepinephrine|norepinephrine|mesh-list
154559834|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154559835|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154559836|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
154559837|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154559838|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559839|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559840|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
154559841|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
154559842|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559843|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154559844|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
154559845|NCT02411955|Tazarotene|tazarotene|mesh-list
154559846|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
154559847|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
154559848|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
154559849|NCT02411955|Vitamins|vitamins|mesh-ancestor
154559850|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
154559851|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559852|NCT03172533|Dienogest|dienogest|mesh-list
154559853|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154559854|NCT03172533|Estradiol|estradiol|mesh-list
154559855|NCT03172533|Estrogens|estrogens|mesh-ancestor
154559856|NCT03172533|Hormones|hormones|mesh-ancestor
154559857|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559858|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559859|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154559860|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
154559861|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154559862|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154559863|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154559864|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154559865|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154283699|NCT05416840|Amlodipine|amlodipine|mesh-list
154559866|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
154559867|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154559868|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559869|NCT02412033|Misoprostol|misoprostol|mesh-list
154559870|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154559871|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
154559872|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154559873|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559874|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154559875|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154559876|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
154559877|NCT02401971|Thalidomide|thalidomide|mesh-list
154559878|NCT02401971|Irinotecan|irinotecan|mesh-list
154559879|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154559880|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154559881|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559882|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559883|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559884|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154559885|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
154559886|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559887|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
154559888|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154559889|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559890|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154559891|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154559892|NCT02401971|Growth Substances|growth substances|mesh-ancestor
154559893|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
154559894|NCT00701883|Atorvastatin|atorvastatin|mesh-list
154559895|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154559896|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154559897|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
154559898|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559899|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154559900|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154559901|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559902|NCT05678738|Antioxidants|antioxidants|mesh-list
154559903|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559904|NCT05678738|Protective Agents|protective agents|mesh-ancestor
154559905|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559906|NCT03175653|Oxycodone|oxycodone|mesh-list
154559907|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154559908|NCT03175653|Narcotics|narcotics|mesh-ancestor
154559909|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154559910|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559911|NCT03175653|Analgesics|analgesics|mesh-ancestor
154559912|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
154559913|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559914|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154559915|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
154559916|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559917|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
154559918|NCT03175341|Vitamins|vitamins|mesh-ancestor
154559919|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
154559920|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559921|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
154559922|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559923|NCT03175341|Protective Agents|protective agents|mesh-ancestor
154559924|NCT05538026|Mesalamine|mesalamine|mesh-list
154559925|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154559926|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154559927|NCT05538026|Analgesics|analgesics|mesh-ancestor
154559928|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
154559929|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559930|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559932|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559934|NCT02401425|Misoprostol|misoprostol|mesh-list
154559935|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154559936|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154559937|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154559938|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559939|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559940|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154559941|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
154559942|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559943|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283774|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
154559944|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154559945|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
154559946|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154559947|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154559948|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154559949|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
154559950|NCT02401269|Aspirin|aspirin|mesh-list
154559951|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154559952|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154559953|NCT02401269|Analgesics|analgesics|mesh-ancestor
154559954|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
154559955|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154559956|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559957|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154559958|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154559959|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154559960|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154559961|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559962|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154559963|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154559964|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559965|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
154559966|NCT04480827|Cholic Acids|cholic acids|mesh-list
154559967|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154559968|NCT02582684|Lamivudine|lamivudine|mesh-list
154559969|NCT02582684|Dolutegravir|dolutegravir|mesh-list
154559970|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154559971|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154559972|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559973|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559974|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
154559975|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559976|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154559977|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154559978|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154559979|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154559980|NCT02411877|Clotrimazole|clotrimazole|mesh-list
154559981|NCT02411877|Miconazole|miconazole|mesh-list
154559982|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154559983|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154559984|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
154559985|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154559986|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154559987|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154559988|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154559989|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154559990|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
154559991|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154559992|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154559993|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154559994|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154559995|NCT03169569|Hemostatics|hemostatics|mesh-list
154559996|NCT03169569|Coagulants|coagulants|mesh-ancestor
154559997|NCT02585960|Factor VIII|factor viii|mesh-list
154559998|NCT02585960|BAX 855|bax 855|mesh-list
154559999|NCT02585960|Coagulants|coagulants|mesh-ancestor
154560000|NCT03169413|Adenosine|adenosine|mesh-list
154560001|NCT03169413|Analgesics|analgesics|mesh-ancestor
154560002|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
154560003|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560004|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560005|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154560007|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154560008|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
154560009|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
154560010|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560011|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560012|NCT03169335|Paclitaxel|paclitaxel|mesh-list
154560013|NCT03169335|Bevacizumab|bevacizumab|mesh-list
154560014|NCT03169335|Carboplatin|carboplatin|mesh-list
154560015|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154560016|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560017|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
154560018|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
154560019|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
154560020|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560021|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154560022|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154560023|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154560024|NCT03169335|Growth Substances|growth substances|mesh-ancestor
154560025|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560026|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
154560027|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
154560029|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154560030|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154560031|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
154560032|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560033|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560034|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560035|NCT03106623|Urological Agents|urological agents|mesh-ancestor
154560036|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154560037|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154560038|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154560039|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
154560040|NCT02411175|Ethanol|ethanol|mesh-list
154560041|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154560042|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560043|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560044|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560045|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
154560046|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154560047|NCT02411331|Ethanol|ethanol|mesh-list
154560048|NCT02411331|Enoxaparin|enoxaparin|mesh-list
154560049|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
154560050|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154560051|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154560052|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560053|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154560054|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560055|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560056|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560057|NCT00100789|Paclitaxel|paclitaxel|mesh-list
154560058|NCT00100789|Gemcitabine|gemcitabine|mesh-list
154560059|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154560060|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560061|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
154560062|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
154560063|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
154560064|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560065|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154560066|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
154560067|NCT02410863|Trametinib|trametinib|mesh-list
154560068|NCT02410863|Dabrafenib|dabrafenib|mesh-list
154560069|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560070|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154560071|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560072|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560073|NCT05678192|Hormones|hormones|mesh-list
154560074|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560075|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560076|NCT00708123|Listerine|listerine|mesh-list
154560077|NCT00708123|Fluorides|fluorides|mesh-list
154560078|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
154560079|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
154560080|NCT00708123|Protective Agents|protective agents|mesh-ancestor
154560081|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560082|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154560083|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560085|NCT05678036|Narcotics|narcotics|mesh-ancestor
154560086|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560087|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560088|NCT05678036|Analgesics|analgesics|mesh-ancestor
154560089|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
154560090|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560091|NCT02400879|Sufentanil|sufentanil|mesh-list
154560092|NCT02400879|Remifentanil|remifentanil|mesh-list
154560093|NCT02400879|Sevoflurane|sevoflurane|mesh-list
154560094|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154560095|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154560096|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
154560097|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
154560098|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560099|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560100|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154560101|NCT02400879|Narcotics|narcotics|mesh-ancestor
154560102|NCT02400879|Analgesics|analgesics|mesh-ancestor
154560103|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
154560104|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560105|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154560106|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154560107|NCT04133480|Cannabidiol|cannabidiol|mesh-list
154560108|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
154560109|NCT02400645|Ketorolac|ketorolac|mesh-list
154560110|NCT02400645|Bupivacaine|bupivacaine|mesh-list
154560111|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
154560112|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
154560113|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560114|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560115|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
154560116|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560117|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154560118|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154560119|NCT02400645|Analgesics|analgesics|mesh-ancestor
154560120|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154560121|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154560122|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154560123|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139194|NCT01017640|Veliparib|veliparib|mesh-list
154560124|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560125|NCT02165215|Etrolizumab|etrolizumab|mesh-list
154560126|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154560127|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
154560128|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560129|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154560130|NCT02400801|Dienogest|dienogest|mesh-list
154560131|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154560132|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
154560133|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154560134|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
154560135|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154560136|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560137|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154560138|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154560139|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560140|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154560141|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154560142|NCT02400801|Estrogens|estrogens|mesh-ancestor
154560143|NCT02400801|Hormones|hormones|mesh-ancestor
154560144|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560145|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154560146|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
154560147|NCT02168569|Artesunate|artesunate|mesh-list
154560148|NCT02168569|Lumefantrine|lumefantrine|mesh-list
154560149|NCT02168569|Artemether|artemether|mesh-list
154560150|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154560151|NCT02168569|Amodiaquine|amodiaquine|mesh-list
154560152|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
154560153|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154560154|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154560155|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560156|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560157|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
154560158|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
154560159|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154560160|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
154560162|NCT02171689|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154560163|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154560164|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560165|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560166|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560167|NCT02171767|Afatinib|afatinib|mesh-list
154560168|NCT02171767|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154560169|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154560170|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560171|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560172|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560173|NCT02400021|Progesterone|progesterone|mesh-list
154560174|NCT02400021|Progestins|progestins|mesh-ancestor
154560175|NCT02400021|Hormones|hormones|mesh-ancestor
154560176|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560177|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560178|NCT02165449|Ketamine|ketamine|mesh-list
154560179|NCT02165449|Analgesics|analgesics|mesh-ancestor
154560180|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
154560181|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560182|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560183|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154560184|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154560185|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
154560186|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
154560187|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560188|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154560189|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154560190|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560191|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560192|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154560193|NCT02172001|Hematinics|hematinics|mesh-ancestor
154560194|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
154560195|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154560196|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154560197|NCT05535998|Estrogens|estrogens|mesh-ancestor
154560198|NCT05535998|Hormones|hormones|mesh-ancestor
154560199|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560200|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560201|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154560202|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560203|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560204|NCT05535998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154560205|NCT03540199|Antibodies|antibodies|mesh-list
154560206|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154560207|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
154560208|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560209|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
154560210|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154560211|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
154560212|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560213|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
154560214|NCT02165917|Protective Agents|protective agents|mesh-ancestor
154560215|NCT02168881|Misoprostol|misoprostol|mesh-list
154560216|NCT02168881|Dinoprostone|dinoprostone|mesh-list
154560217|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154560218|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
154560219|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154560220|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560221|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154560222|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154560223|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
154560224|NCT02168959|Bupivacaine|bupivacaine|mesh-list
154560225|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
154560226|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
154560227|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560228|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560229|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
153579491|NCT01739985|BB 1101|bb 1101|mesh-list
154560231|NCT05450822|Lamotrigine|lamotrigine|mesh-list
154560232|NCT05450822|Levetiracetam|levetiracetam|mesh-list
154560233|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
154560234|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
154560235|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154560236|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154560237|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560238|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154560239|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560240|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154560241|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154560242|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560243|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154560244|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154560245|NCT02172157|Olodaterol|olodaterol|mesh-list
154253746|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154560246|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154560247|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
154560248|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560249|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560250|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154560251|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
154560252|NCT02172235|Pioglitazone|pioglitazone|mesh-list
154560253|NCT02172235|Empagliflozin|empagliflozin|mesh-list
154560254|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154560255|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560256|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154560257|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560258|NCT02166229|Valproic Acid|valproic acid|mesh-list
154560259|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
154560260|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560261|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560262|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
154560263|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560264|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560265|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
154560266|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154560267|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560268|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154560269|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
154560270|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154560271|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560272|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560273|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154560274|NCT02757625|Analgesics|analgesics|mesh-ancestor
154560275|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
154560276|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560277|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154560278|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154560279|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154560280|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
154560281|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560282|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560283|NCT05691920|Fentanyl|fentanyl|mesh-list
154560284|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154560285|NCT05691920|Narcotics|narcotics|mesh-ancestor
154560286|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560287|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560288|NCT05691920|Analgesics|analgesics|mesh-ancestor
154560289|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
154560290|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560291|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154560292|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154560293|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
154560294|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
154560295|NCT02172313|Semaglutide|semaglutide|mesh-list
154560296|NCT02172313|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154560297|NCT02172313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154560298|NCT02172313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560299|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154560300|NCT05696366|Volagidemab|volagidemab|mesh-list
154560301|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154560302|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560303|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154560304|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560305|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154560306|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
154560307|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154560308|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
154560309|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560310|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560311|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154560312|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
154560313|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
154560314|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154560315|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
154560316|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560317|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560318|NCT00109681|Iloprost|iloprost|mesh-list
154560319|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154560320|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
154560321|NCT02172469|Bromides|bromides|mesh-list
154560322|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
154560323|NCT02172469|Ipratropium|ipratropium|mesh-list
154560324|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154560325|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
154560326|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560327|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560328|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154560329|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
154560330|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
154560331|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154560332|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
154560333|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560334|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560335|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
154560336|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
154560337|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154560338|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
154560339|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560340|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560341|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154139419|NCT00888758|Umirolimus|umirolimus|mesh-list
154560342|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
154560343|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
154560344|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154560345|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
154560346|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560347|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560348|NCT02174887|Paclitaxel|paclitaxel|mesh-list
154560349|NCT02174887|Gemcitabine|gemcitabine|mesh-list
154560350|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154560351|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560352|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
154560353|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
154560354|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
154560355|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560356|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154560357|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
154560358|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154560359|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
154560360|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
154560361|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560362|NCT05142319|Vaccines|vaccines|mesh-list
154560363|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
154560364|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560365|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
154560366|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560367|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560368|NCT04298528|Dronabinol|dronabinol|mesh-list
154560369|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
154560370|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560371|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154560372|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154862073|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560373|NCT04298528|Analgesics|analgesics|mesh-ancestor
154560374|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
154560375|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560376|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154560377|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154560378|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560379|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560380|NCT04298528|Hormones|hormones|mesh-ancestor
154560381|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560382|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
154560383|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560384|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154560385|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
154560386|NCT02581202|Ritonavir|ritonavir|mesh-list
154560387|NCT02581202|Lopinavir|lopinavir|mesh-list
154560388|NCT02581202|Lamivudine|lamivudine|mesh-list
154560389|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154560390|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154560391|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
154284220|NCT05281926|Nivolumab|nivolumab|mesh-list
154560393|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560394|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154560395|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154560396|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
154560397|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560398|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154560399|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154560400|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154560401|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154560402|NCT02758171|Empagliflozin|empagliflozin|mesh-list
154560403|NCT02758171|Linagliptin|linagliptin|mesh-list
154560404|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154560405|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560406|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154560407|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560408|NCT02758171|Incretins|incretins|mesh-ancestor
154560409|NCT02758171|Hormones|hormones|mesh-ancestor
154560410|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560411|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154560412|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560413|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560414|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
154560415|NCT02172781|Ipratropium|ipratropium|mesh-list
154560416|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154560417|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
154560418|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560419|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560420|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154560421|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
154560422|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
154560423|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154560424|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
154560425|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560426|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560427|NCT02173093|Aldesleukin|aldesleukin|mesh-list
154560428|NCT02173093|Interleukin-2|interleukin-2|mesh-list
154560429|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560430|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154560431|NCT02173093|Analgesics|analgesics|mesh-ancestor
154560432|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
154560433|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560434|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560435|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154560436|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154560437|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
154560438|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560439|NCT05142085|Mineral Oil|mineral oil|mesh-list
154560440|NCT05142085|Emollients|emollients|mesh-ancestor
154560441|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
154560442|NCT00103831|Taxane|taxane|mesh-list
154560443|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560444|NCT03538483|Bupivacaine|bupivacaine|mesh-list
154560445|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
154560446|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
154560447|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560448|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560449|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
154560450|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560452|NCT02175355|Telmisartan|telmisartan|mesh-list
154560453|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154560454|NCT02175355|Diuretics|diuretics|mesh-ancestor
154560455|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
154560456|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560457|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154560458|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154560459|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560460|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154560461|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154560462|NCT03538327|Silybin|silybin|mesh-list
154560463|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154560464|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560465|NCT03538327|Protective Agents|protective agents|mesh-ancestor
154560466|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560467|NCT02170597|Dabigatran|dabigatran|mesh-list
154560468|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
154560469|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154560470|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560471|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560472|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560473|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
154560474|NCT02170675|Ketoconazole|ketoconazole|mesh-list
154560475|NCT02170675|Dabigatran|dabigatran|mesh-list
154560476|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
154560477|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154560478|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560479|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560480|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560481|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
154560482|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
154560483|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560484|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154560485|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154560486|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154560487|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
154560488|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560489|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560490|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154560491|NCT02175433|AGS67E|ags67e|mesh-list
154560492|NCT02175433|Immunoconjugates|immunoconjugates|mesh-ancestor
154560493|NCT02175433|Immunologic Factors|immunologic factors|mesh-ancestor
154560494|NCT02175433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560495|NCT04154150|Ketamine|ketamine|mesh-list
154560496|NCT04154150|Analgesics|analgesics|mesh-ancestor
154560497|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
154560498|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560499|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560500|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154560501|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154560502|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
154560503|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
154560504|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560505|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154560506|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154560507|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560508|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560509|NCT02170831|Dabigatran|dabigatran|mesh-list
154560510|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
154560511|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154560512|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560513|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560514|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560515|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
154560516|NCT02175589|Colchicine|colchicine|mesh-list
154560517|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
154560518|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154560519|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
154560520|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
154560521|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
154862074|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
154560522|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560523|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560524|NCT05438186|Liraglutide|liraglutide|mesh-list
154560525|NCT05438186|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154560526|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154560527|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560528|NCT05438186|Incretins|incretins|mesh-ancestor
154560529|NCT05438186|Hormones|hormones|mesh-ancestor
154560530|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560531|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154560532|NCT02178397|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154560533|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154560534|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560535|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560536|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560537|NCT02173639|Metformin|metformin|mesh-list
154560538|NCT02173639|Linagliptin|linagliptin|mesh-list
154560539|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154284368|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
154560540|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560541|NCT02173639|Incretins|incretins|mesh-ancestor
154560542|NCT02173639|Hormones|hormones|mesh-ancestor
154560543|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560544|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154560545|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560546|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560547|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560548|NCT02173717|Rifampin|rifampin|mesh-list
154560549|NCT02173717|Dabigatran|dabigatran|mesh-list
154560550|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
154560551|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154560552|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560553|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560554|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560555|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
154560556|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154560557|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
154560558|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154560559|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560560|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
154560561|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154560562|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154560563|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154560564|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154560565|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154560566|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154560567|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154560568|NCT04067648|Sufentanil|sufentanil|mesh-list
154560569|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154560570|NCT04067648|Narcotics|narcotics|mesh-ancestor
154560571|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560572|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560573|NCT04067648|Analgesics|analgesics|mesh-ancestor
154560574|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
154560575|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560576|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154560577|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154560578|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
154560579|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
154560580|NCT02173795|Fenoterol|fenoterol|mesh-list
154560581|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154560582|NCT02173795|Ipratropium|ipratropium|mesh-list
154560583|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154560584|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
154560585|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560586|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560587|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154560588|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
154560589|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
154560590|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
154560591|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154139676|NCT04074317|Insulin|insulin|mesh-list
154560592|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154560593|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154560594|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154560595|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
154560596|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560597|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560598|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154560599|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
154560600|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154560601|NCT02175901|Amoxicillin|amoxicillin|mesh-list
154560602|NCT02175901|Metronidazole|metronidazole|mesh-list
154560603|NCT02175901|Clarithromycin|clarithromycin|mesh-list
154560604|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154560605|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
154560606|NCT02175901|Lansoprazole|lansoprazole|mesh-list
154560607|NCT02175901|Bismuth|bismuth|mesh-list
154560608|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154560609|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560610|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
154560611|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560612|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154560613|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154560614|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154560615|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560616|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154560617|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154560618|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154560619|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154560621|NCT02175901|Diuretics|diuretics|mesh-ancestor
154560622|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
154560623|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560624|NCT02175901|Expectorants|expectorants|mesh-ancestor
154560625|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
154560626|NCT02173873|Aflibercept|aflibercept|mesh-list
154560627|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154560628|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154560629|NCT02173873|Growth Substances|growth substances|mesh-ancestor
154560630|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560631|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
154560632|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560633|NCT02176057|Azithromycin|azithromycin|mesh-list
154560634|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154560635|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560636|NCT02173951|Deferiprone|deferiprone|mesh-list
154560637|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154560638|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
154560639|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
154560640|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560641|NCT02176135|Auranofin|auranofin|mesh-list
154560642|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154560643|NCT02176213|Dexamethasone|dexamethasone|mesh-list
154560644|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
154560645|NCT02176213|Pomalidomide|pomalidomide|mesh-list
154560646|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154560647|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
154560648|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560649|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154560650|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154560651|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
154560652|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560653|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560654|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154560655|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154560656|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
154560657|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
154560658|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560659|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154560660|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
154560661|NCT02176213|Hormones|hormones|mesh-ancestor
154560662|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560663|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154560664|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154560665|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154560666|NCT02176213|Growth Substances|growth substances|mesh-ancestor
154560667|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
154560668|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
154560669|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
154560670|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
154560671|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154560672|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560673|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560674|NCT04305002|Exenatide|exenatide|mesh-list
154560675|NCT04305002|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154560676|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154560677|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560678|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154560679|NCT04305002|Incretins|incretins|mesh-ancestor
154560680|NCT04305002|Hormones|hormones|mesh-ancestor
154560681|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560682|NCT02253797|Ritonavir|ritonavir|mesh-list
154560683|NCT02253797|Tipranavir|tipranavir|mesh-list
154560684|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154560685|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154560686|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560687|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560688|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560689|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154560690|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154560691|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
154560692|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560693|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154560694|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154560695|NCT02253875|Ritonavir|ritonavir|mesh-list
154560696|NCT02253875|Tipranavir|tipranavir|mesh-list
154560697|NCT02253875|Omeprazole|omeprazole|mesh-list
154139791|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
154560698|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154560699|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154560700|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560701|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560702|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560703|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154560704|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154560705|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
154560706|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560707|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154560708|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154560709|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154560710|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154560711|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154560712|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154560713|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154560714|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560715|NCT04597268|Midazolam|midazolam|mesh-list
154560716|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
154560717|NCT04597268|Ketamine|ketamine|mesh-list
154560718|NCT04597268|Propofol|propofol|mesh-list
154560719|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154560720|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560721|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560722|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154560723|NCT04597268|Analgesics|analgesics|mesh-ancestor
154560724|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
154560725|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560726|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154560727|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154560728|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154560729|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
154560730|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560731|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560732|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154560733|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
154560734|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
154560735|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154560736|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154560737|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154560738|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154560739|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154560740|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154560741|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154560742|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
154560743|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
154560744|NCT04976543|Nadroparin|nadroparin|mesh-list
154560745|NCT04976543|Warfarin|warfarin|mesh-list
154560746|NCT04976543|Calcium|calcium|mesh-list
154560747|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154560748|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560749|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
154560750|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154560751|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154560752|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560753|NCT02924441|Lidocaine|lidocaine|mesh-list
154560754|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
154560755|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
154560756|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560757|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560758|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
154560759|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560760|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154560761|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154560762|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154560763|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154560764|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560765|NCT00109967|Sirolimus|sirolimus|mesh-list
154560766|NCT00109967|Rituximab|rituximab|mesh-list
154560767|NCT00109967|Temsirolimus|temsirolimus|mesh-list
154560768|NCT00109967|MTOR Inhibitors|mtor inhibitors|mesh-list
154560769|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154560770|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560771|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
154560772|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560773|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154560774|NCT00109967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154560775|NCT00109967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560776|NCT00109967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560777|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154560778|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154560779|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154560780|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154560781|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
154560782|NCT02579096|Allopurinol|allopurinol|mesh-list
154560783|NCT02579096|Febuxostat|febuxostat|mesh-list
154560784|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
154560785|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560786|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560787|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
154560788|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154560789|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154560790|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
154560791|NCT02579096|Protective Agents|protective agents|mesh-ancestor
154560792|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560793|NCT02578862|Propofol|propofol|mesh-list
154560794|NCT02578862|Sevoflurane|sevoflurane|mesh-list
154560795|NCT02578862|Isoflurane|isoflurane|mesh-list
154560796|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154560797|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154560798|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560799|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154560800|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
154560801|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
154560802|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154560803|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154560804|NCT02578706|Aspirin|aspirin|mesh-list
154560805|NCT02578706|Clopidogrel|clopidogrel|mesh-list
154560806|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154560807|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154560808|NCT02578706|Analgesics|analgesics|mesh-ancestor
154560809|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
154560810|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560811|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560812|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154560813|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154560814|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154560815|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154560816|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560817|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154560818|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154560819|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560820|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
154560821|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154560822|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154560823|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154560824|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
154560825|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560827|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560828|NCT00108953|Doxorubicin|doxorubicin|mesh-list
154560829|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154560830|NCT00108953|Sorafenib|sorafenib|mesh-list
154560831|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154560832|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560833|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154560834|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154560835|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560836|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560837|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154560838|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154560839|NCT02578316|Lenvatinib|lenvatinib|mesh-list
154560840|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560841|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154284674|NCT03719586|Remdesivir|remdesivir|mesh-list
154560842|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560843|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560844|NCT05532878|Apixaban|apixaban|mesh-list
154560845|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154560846|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
154560847|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154560848|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560849|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560850|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560851|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
154560852|NCT02576678|Apremilast|apremilast|mesh-list
154560853|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154560854|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154560855|NCT02576678|Analgesics|analgesics|mesh-ancestor
154560856|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
154560857|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560858|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560859|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154560860|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154560861|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154560862|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154560863|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560864|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560865|NCT05532332|Fluoxetine|fluoxetine|mesh-list
154560866|NCT05532332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154560867|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154560868|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154560869|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560870|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560871|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
154560872|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560873|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154560874|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
154560875|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154560876|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154560877|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154560878|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560879|NCT05532254|Aripiprazole|aripiprazole|mesh-list
154560880|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
154560881|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154560882|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154560883|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154560884|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139995|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154560885|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560886|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
154560887|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
154560888|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154560889|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560890|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154560891|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154560892|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
154560893|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154560894|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154560895|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154560896|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154560897|NCT05471648|Pertuzumab|pertuzumab|mesh-list
154560898|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154560899|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560900|NCT00108745|Paclitaxel|paclitaxel|mesh-list
154560901|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154560902|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
154560903|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154560904|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560905|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
154560906|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
154560907|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
154560908|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560909|NCT05532020|Diazoxide|diazoxide|mesh-list
154560910|NCT05532020|Choline|choline|mesh-list
154560911|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
154560912|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154560913|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
154560914|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560915|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154560916|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154560917|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
154560918|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154560919|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
154560920|NCT02098343|Carboplatin|carboplatin|mesh-list
154560921|NCT02098343|Doxorubicin|doxorubicin|mesh-list
154560922|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154560923|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560924|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154560925|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154560926|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154560927|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560928|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560929|NCT02176369|Vinorelbine|vinorelbine|mesh-list
154560930|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154560931|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560932|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
154560933|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
154560934|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
154560935|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560936|NCT02716805|Melphalan|melphalan|mesh-list
154560937|NCT02716805|Durvalumab|durvalumab|mesh-list
154560938|NCT02716805|Tremelimumab|tremelimumab|mesh-list
154560939|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154560940|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
154560941|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560942|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560943|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154560944|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154560945|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
154560946|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560947|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154560948|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
154560949|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
154560950|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
154560951|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560952|NCT04152473|Proglumide|proglumide|mesh-list
154560953|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154560954|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154560955|NCT02581982|Paclitaxel|paclitaxel|mesh-list
154560956|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
154560957|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154560958|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154560959|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154560960|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
154560961|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
154560962|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
154560963|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560964|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154560965|NCT02581982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154560966|NCT03751397|Cystatins|cystatins|mesh-list
154560967|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154560968|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560969|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560970|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862075|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560971|NCT02176681|Vildagliptin|vildagliptin|mesh-list
154560972|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154560973|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560974|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154560975|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
154560976|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154560977|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560978|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
154560979|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154560980|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154560981|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154560982|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154560983|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
154560984|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140078|NCT00528879|Metformin|metformin|mesh-list
154560985|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560986|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154560987|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154560988|NCT02254577|Progesterone|progesterone|mesh-list
154284831|NCT01297686|Hormones|hormones|mesh-ancestor
154560989|NCT02254577|Progestins|progestins|mesh-ancestor
154560990|NCT02254577|Hormones|hormones|mesh-ancestor
154560991|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154560992|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154560993|NCT02176759|Citric Acid|citric acid|mesh-list
154560994|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
154560995|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
154560996|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154560997|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
154560998|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
154560999|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561000|NCT06010602|Analgesics|analgesics|mesh-list
154561001|NCT06010602|Sensory System Agents|sensory system agents|mesh-ancestor
154561002|NCT06010602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561003|NCT06010602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561004|NCT06010290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154561005|NCT06010290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154561006|NCT06010290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561007|NCT06010277|Leucovorin|leucovorin|mesh-list
154561008|NCT06010277|Folic Acid|folic acid|mesh-list
154561009|NCT06010277|Levoleucovorin|levoleucovorin|mesh-list
154561010|NCT06010277|Antidotes|antidotes|mesh-ancestor
154561011|NCT06010277|Protective Agents|protective agents|mesh-ancestor
154561012|NCT06010277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561013|NCT06010277|Vitamin B Complex|vitamin b complex|mesh-ancestor
154561014|NCT06010277|Vitamins|vitamins|mesh-ancestor
154561015|NCT06010277|Micronutrients|micronutrients|mesh-ancestor
154561016|NCT06010277|Hematinics|hematinics|mesh-ancestor
154561017|NCT06010212|Paclitaxel|paclitaxel|mesh-list
154561018|NCT06010212|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154561019|NCT06010212|Nedaplatin|nedaplatin|mesh-list
154561020|NCT06010212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154561021|NCT06010212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561022|NCT06010212|Tubulin Modulators|tubulin modulators|mesh-ancestor
154561023|NCT06010212|Antimitotic Agents|antimitotic agents|mesh-ancestor
154561024|NCT06010212|Mitosis Modulators|mitosis modulators|mesh-ancestor
154561025|NCT06010212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561026|NCT06010056|Ketamine|ketamine|mesh-list
154561027|NCT06010056|Morphine|morphine|mesh-list
154561028|NCT06010056|Analgesics|analgesics|mesh-ancestor
154561029|NCT06010056|Sensory System Agents|sensory system agents|mesh-ancestor
154561030|NCT06010056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561031|NCT06010056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561032|NCT06010056|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154561033|NCT06010056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154561034|NCT06010056|Anesthetics, General|anesthetics, general|mesh-ancestor
154561035|NCT06010056|Anesthetics|anesthetics|mesh-ancestor
154561036|NCT06010056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561037|NCT06010056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154561038|NCT06010056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154561039|NCT06010056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561040|NCT06010056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561041|NCT06010056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154561042|NCT06010056|Narcotics|narcotics|mesh-ancestor
154561043|NCT06009900|Celecoxib|celecoxib|mesh-list
154561044|NCT06009900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154561045|NCT06009900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561046|NCT06009900|Analgesics|analgesics|mesh-ancestor
154561047|NCT06009900|Sensory System Agents|sensory system agents|mesh-ancestor
154561048|NCT06009900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561049|NCT06009900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561050|NCT06009900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154561051|NCT06009900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561052|NCT06009900|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154561053|NCT06009900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154561054|NCT06009900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561055|NCT06009900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561056|NCT06009874|Dapagliflozin|dapagliflozin|mesh-list
154561057|NCT06009874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154561058|NCT06009874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561059|NCT06009874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154561060|NCT06009874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561061|NCT06009861|Paclitaxel|paclitaxel|mesh-list
154561062|NCT06009861|Tislelizumab|tislelizumab|mesh-list
154561063|NCT06009861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154561064|NCT06009861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154561065|NCT06009861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561066|NCT06009861|Tubulin Modulators|tubulin modulators|mesh-ancestor
154561067|NCT06009861|Antimitotic Agents|antimitotic agents|mesh-ancestor
154561068|NCT06009861|Mitosis Modulators|mitosis modulators|mesh-ancestor
154561069|NCT06009861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561070|NCT06009861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561071|NCT06009744|Vitamins|vitamins|mesh-list
154561072|NCT06009744|Ascorbic Acid|ascorbic acid|mesh-list
154561074|NCT06009744|Micronutrients|micronutrients|mesh-ancestor
154561075|NCT06009744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561076|NCT06009744|Trace Elements|trace elements|mesh-ancestor
154561077|NCT06009744|Antioxidants|antioxidants|mesh-ancestor
154561078|NCT06009744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561079|NCT06009744|Protective Agents|protective agents|mesh-ancestor
154561080|NCT06009679|Misoprostol|misoprostol|mesh-list
154561081|NCT06009679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154561082|NCT06009679|Abortifacient Agents|abortifacient agents|mesh-ancestor
154561083|NCT06009679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154561084|NCT06009679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561085|NCT06009679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154561086|NCT06009679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154561087|NCT06009679|Oxytocics|oxytocics|mesh-ancestor
154561088|NCT06009627|Cyclophosphamide|cyclophosphamide|mesh-list
154561089|NCT06009627|Docetaxel|docetaxel|mesh-list
154561090|NCT06009627|Epirubicin|epirubicin|mesh-list
154561091|NCT06009627|Exemestane|exemestane|mesh-list
154561092|NCT06009627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154561093|NCT06009627|Immunologic Factors|immunologic factors|mesh-ancestor
154561094|NCT06009627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561095|NCT06009627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561096|NCT06009627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154561097|NCT06009627|Alkylating Agents|alkylating agents|mesh-ancestor
154561098|NCT06009627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561099|NCT06009627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561100|NCT06009627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154561101|NCT06009627|Tubulin Modulators|tubulin modulators|mesh-ancestor
154561102|NCT06009627|Antimitotic Agents|antimitotic agents|mesh-ancestor
154561103|NCT06009627|Mitosis Modulators|mitosis modulators|mesh-ancestor
154561104|NCT06009627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154561105|NCT06009627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154561106|NCT06009627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154561107|NCT06009627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561108|NCT06009627|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154561109|NCT06009627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154561110|NCT06009627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154561111|NCT06009627|Hormone Antagonists|hormone antagonists|mesh-ancestor
154561112|NCT06009627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561113|NCT06009497|Cyclosporine|cyclosporine|mesh-list
154561114|NCT06009497|Cyclosporins|cyclosporins|mesh-list
154561115|NCT06009497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561116|NCT06009497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862076|NCT03035357|Daratumumab|daratumumab|mesh-list
154561117|NCT06009497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154561118|NCT06009497|Immunologic Factors|immunologic factors|mesh-ancestor
154561119|NCT06009497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561120|NCT06009497|Antifungal Agents|antifungal agents|mesh-ancestor
154561121|NCT06009497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561122|NCT06009497|Dermatologic Agents|dermatologic agents|mesh-ancestor
154561123|NCT06009497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561124|NCT06009497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154561125|NCT06009042|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154561126|NCT06009042|gamma-Globulins|gamma-globulins|mesh-list
154561127|NCT06009042|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154561128|NCT06009042|Immunologic Factors|immunologic factors|mesh-ancestor
154561129|NCT06009042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561130|NCT06009029|Immunomodulating Agents|immunomodulating agents|mesh-list
154561131|NCT06009029|Immunologic Factors|immunologic factors|mesh-ancestor
154561132|NCT06009029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561134|NCT06008925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561135|NCT06008925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561136|NCT06008925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154561137|NCT06008925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561138|NCT05981352|Hyaluronic Acid|hyaluronic acid|mesh-list
154561139|NCT05981352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154561140|NCT05981352|Immunologic Factors|immunologic factors|mesh-ancestor
154561141|NCT05981352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561143|NCT05981352|Protective Agents|protective agents|mesh-ancestor
154561144|NCT05969327|Vitamin D|vitamin d|mesh-list
154561145|NCT05969327|Vitamins|vitamins|mesh-ancestor
154561146|NCT05969327|Micronutrients|micronutrients|mesh-ancestor
154561147|NCT05969327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561148|NCT05969327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154561149|NCT05945901|Bevacizumab|bevacizumab|mesh-list
154561150|NCT05945901|Oxaliplatin|oxaliplatin|mesh-list
154561151|NCT05945901|Fluorouracil|fluorouracil|mesh-list
154561152|NCT05945901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561153|NCT05945901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561154|NCT05945901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154561155|NCT05945901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154561156|NCT05945901|Growth Substances|growth substances|mesh-ancestor
154561157|NCT05945901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561158|NCT05945901|Growth Inhibitors|growth inhibitors|mesh-ancestor
154561159|NCT05945901|Antimetabolites|antimetabolites|mesh-ancestor
154561160|NCT05945901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561161|NCT05945901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154561162|NCT05945901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154561163|NCT05945901|Immunologic Factors|immunologic factors|mesh-ancestor
154561164|NCT05920642|Morphine|morphine|mesh-list
154561165|NCT05920642|Analgesics|analgesics|mesh-list
154561166|NCT05920642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154561167|NCT05920642|Narcotics|narcotics|mesh-ancestor
154561168|NCT05920642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561169|NCT05920642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561170|NCT05920642|Sensory System Agents|sensory system agents|mesh-ancestor
154561171|NCT05920642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561172|NCT05920005|Amlodipine|amlodipine|mesh-list
154561173|NCT05920005|Valsartan|valsartan|mesh-list
154561174|NCT05920005|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154561175|NCT05920005|Candesartan|candesartan|mesh-list
154561176|NCT05920005|Candesartan cilexetil|candesartan cilexetil|mesh-list
154561177|NCT05920005|Chlorthalidone|chlorthalidone|mesh-list
154561178|NCT05920005|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154561179|NCT05920005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154561180|NCT05920005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154561181|NCT05920005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154561182|NCT05920005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561183|NCT05920005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154561184|NCT05920005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561185|NCT05920005|Vasodilator Agents|vasodilator agents|mesh-ancestor
154561186|NCT05920005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154561187|NCT05920005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154561188|NCT05920005|Diuretics|diuretics|mesh-ancestor
154561189|NCT05920005|Natriuretic Agents|natriuretic agents|mesh-ancestor
154561190|NCT05920005|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154561191|NCT05918796|Dexamethasone|dexamethasone|mesh-list
154561192|NCT05918796|Bupivacaine|bupivacaine|mesh-list
154561193|NCT05918796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154561194|NCT05918796|Antiemetics|antiemetics|mesh-ancestor
154561195|NCT05918796|Autonomic Agents|autonomic agents|mesh-ancestor
154561196|NCT05918796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580738|NCT01747590|Zolpidem|zolpidem|mesh-list
154561197|NCT05918796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561198|NCT05918796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154561199|NCT05918796|Glucocorticoids|glucocorticoids|mesh-ancestor
154561200|NCT05918796|Hormones|hormones|mesh-ancestor
154561201|NCT05918796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561202|NCT05918796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154561203|NCT05918796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561204|NCT05918796|Anesthetics, Local|anesthetics, local|mesh-ancestor
154561205|NCT05918796|Anesthetics|anesthetics|mesh-ancestor
154561206|NCT05918796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561207|NCT05918796|Sensory System Agents|sensory system agents|mesh-ancestor
154561208|NCT05846698|Tibolone|tibolone|mesh-list
154561209|NCT05846698|Androgen Antagonists|androgen antagonists|mesh-ancestor
154561210|NCT05846698|Hormone Antagonists|hormone antagonists|mesh-ancestor
154561211|NCT05846698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561212|NCT05846698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561213|NCT05846698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154561214|NCT05846698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154561215|NCT05846698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561216|NCT05846698|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154561218|NCT05846698|Hormones|hormones|mesh-ancestor
154561219|NCT05800600|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154561220|NCT05800600|Hematinics|hematinics|mesh-ancestor
154561221|NCT05774704|Curcumin|curcumin|mesh-list
154561222|NCT05774704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154561223|NCT05774704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561224|NCT05774704|Analgesics|analgesics|mesh-ancestor
154561225|NCT05774704|Sensory System Agents|sensory system agents|mesh-ancestor
154561226|NCT05774704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561227|NCT05774704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561228|NCT05774704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154561229|NCT05774704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561230|NCT05774704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561231|NCT05774704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561232|NCT05774704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561233|NCT05745233|Pembrolizumab|pembrolizumab|mesh-list
154561234|NCT05745233|Nivolumab|nivolumab|mesh-list
154561235|NCT05745233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561236|NCT05745233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561237|NCT05745233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154561238|NCT05745233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561239|NCT05725382|Remifentanil|remifentanil|mesh-list
154561240|NCT05725382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154561241|NCT05725382|Narcotics|narcotics|mesh-ancestor
154140344|NCT00896558|Midazolam|midazolam|mesh-list
154561242|NCT05725382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561243|NCT05725382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561244|NCT05725382|Analgesics|analgesics|mesh-ancestor
154561245|NCT05725382|Sensory System Agents|sensory system agents|mesh-ancestor
154561246|NCT05725382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561247|NCT05721404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154561248|NCT05721404|Icodextrin|icodextrin|mesh-list
154561249|NCT05721404|Dialysis Solutions|dialysis solutions|mesh-list
154561250|NCT05710874|Fluorides|fluorides|mesh-list
154561251|NCT05710874|Cariostatic Agents|cariostatic agents|mesh-ancestor
154561252|NCT05710874|Protective Agents|protective agents|mesh-ancestor
154561253|NCT05710874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561254|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
154561255|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
154561256|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154561257|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154561258|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561259|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561260|NCT05684289|Urological Agents|urological agents|mesh-ancestor
154561261|NCT05677126|Copper|copper|mesh-list
154561262|NCT05677126|Trace Elements|trace elements|mesh-list
154561263|NCT05677126|Selenious Acid|selenious acid|mesh-list
154561264|NCT05677126|Micronutrients|micronutrients|mesh-list
154561265|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561266|NCT05661682|Zinc|zinc|mesh-list
154561267|NCT05661682|Copper|copper|mesh-list
154561268|NCT05661682|Manganese|manganese|mesh-list
154561269|NCT05661682|Trace Elements|trace elements|mesh-list
154561270|NCT05661682|Selenious Acid|selenious acid|mesh-list
154561271|NCT05661682|Micronutrients|micronutrients|mesh-list
154561272|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
154561273|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
154561274|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561275|NCT05661682|Astringents|astringents|mesh-ancestor
154561276|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
154561277|NCT05661682|Antidotes|antidotes|mesh-ancestor
154561278|NCT05661682|Protective Agents|protective agents|mesh-ancestor
154561279|NCT05661682|Emetics|emetics|mesh-ancestor
154561280|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
154561281|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561282|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154561283|NCT05607147|Antibodies|antibodies|mesh-list
154561284|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
154561285|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561286|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
154561287|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154561288|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561289|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561290|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561291|NCT05579964|Analgesics|analgesics|mesh-ancestor
154561292|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
154561293|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561294|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154561295|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154561296|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154561297|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
154561298|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561299|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561300|NCT05567770|Androgens|androgens|mesh-list
154561301|NCT05567770|Hormones|hormones|mesh-ancestor
154561302|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561303|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561304|NCT05550337|Trifarotene|trifarotene|mesh-list
154561305|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
154561306|NCT05549180|Emtricitabine|emtricitabine|mesh-list
154561307|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
154561308|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561309|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154561310|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154561311|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561312|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561313|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154561314|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154561315|NCT05514119|Fenofibrate|fenofibrate|mesh-list
154561316|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154561317|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
154561318|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561319|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154561320|NCT05416229|Psilocybin|psilocybin|mesh-list
154561321|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
154561322|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561323|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154561324|NCT05414877|Phenylephrine|phenylephrine|mesh-list
154561325|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
154561326|NCT05414877|Norepinephrine|norepinephrine|mesh-list
154561327|NCT05414877|Ephedrine|ephedrine|mesh-list
154561328|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154561329|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
154561330|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
154561331|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561332|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561333|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
154561334|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154561335|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
154561336|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
154561337|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154561338|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154561339|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154561340|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
154561341|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561342|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561343|NCT05414877|Protective Agents|protective agents|mesh-ancestor
154561344|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154561345|NCT05345327|Metformin|metformin|mesh-list
154561346|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
154561347|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154561348|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561349|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154561350|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561351|NCT05305287|Pioglitazone|pioglitazone|mesh-list
154561353|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561354|NCT05188677|Vaccines|vaccines|mesh-list
154561355|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
154561356|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561357|NCT05170009|Oseltamivir|oseltamivir|mesh-list
154561358|NCT05170009|Baloxavir|baloxavir|mesh-list
154561359|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
154561360|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561361|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561362|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561363|NCT05159427|Glipizide|glipizide|mesh-list
154561364|NCT05159427|Rifaximin|rifaximin|mesh-list
154140446|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
154561365|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154561366|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561367|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154561368|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154561369|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561370|NCT05132699|Cannabidiol|cannabidiol|mesh-list
154561371|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154561372|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
154561374|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
154561375|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
154561376|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561377|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561378|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
154561379|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561380|NCT04919629|Bevacizumab|bevacizumab|mesh-list
154561381|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154561382|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
154561383|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
154561384|NCT04919629|Antibodies|antibodies|mesh-list
154561385|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
154561386|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154561387|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
154561388|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561389|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154561390|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154561391|NCT04919629|Growth Substances|growth substances|mesh-ancestor
154561392|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561393|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
154561394|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
154561395|NCT04919629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154561396|NCT04919629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561397|NCT04701307|Niraparib|niraparib|mesh-list
154561398|NCT04701307|Dostarlimab|dostarlimab|mesh-list
154561399|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
154561400|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
154561401|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
154561402|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561403|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154561404|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561405|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561406|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561407|NCT04673461|Xylometazoline|xylometazoline|mesh-list
154561408|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
154561409|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154561410|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
154561411|NCT04673175|Tazobactam|tazobactam|mesh-list
154561412|NCT04673175|Ceftolozane|ceftolozane|mesh-list
154561413|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154561414|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154561415|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561416|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154561417|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561418|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561419|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154561420|NCT04666649|Venetoclax|venetoclax|mesh-list
154561421|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561422|NCT04534725|Interferons|interferons|mesh-list
154561423|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
154561424|NCT04534725|Lenzilumab|lenzilumab|mesh-list
154561425|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561426|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
154561427|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561428|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
154561429|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561430|NCT04534725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154561431|NCT04463498|Methamphetamine|methamphetamine|mesh-list
154561432|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154561433|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561434|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
154561435|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
154561436|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561437|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
154561438|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561439|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561440|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
154561441|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154561442|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154561443|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154561444|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154561445|NCT04385433|Pravastatin|pravastatin|mesh-list
154561446|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154285273|NCT03084796|Bromides|bromides|mesh-list
154561447|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154561448|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
154561449|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561450|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154561451|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154561452|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561453|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154561454|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561455|NCT04284761|Bicalutamide|bicalutamide|mesh-list
154561456|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
154561457|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
154561458|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561459|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561460|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561461|NCT04275024|Calcipotriene|calcipotriene|mesh-list
154561462|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
154561463|NCT04259255|Edaravone|edaravone|mesh-list
154561464|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154561465|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
154561466|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561467|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154561468|NCT04259255|Protective Agents|protective agents|mesh-ancestor
154561469|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561470|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154561471|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
154561472|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561473|NCT04011345|Folic Acid|folic acid|mesh-list
154561474|NCT04011345|Hematinics|hematinics|mesh-ancestor
154561475|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
154561476|NCT04011345|Vitamins|vitamins|mesh-ancestor
154561477|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
154561478|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561479|NCT03970837|Tofacitinib|tofacitinib|mesh-list
154561480|NCT03970837|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154561481|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154561482|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561483|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561484|NCT03945357|Clindamycin|clindamycin|mesh-list
154561485|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
154561486|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
154561487|NCT03945357|Gemcitabine|gemcitabine|mesh-list
154561488|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154561489|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
154561490|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561491|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561492|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154561493|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561494|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154561495|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561496|NCT03896009|Meloxicam|meloxicam|mesh-list
154561497|NCT03896009|Rizatriptan|rizatriptan|mesh-list
154561498|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154561499|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561500|NCT03896009|Analgesics|analgesics|mesh-ancestor
154561501|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
154561502|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561503|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862077|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561504|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154561505|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561506|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154561507|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154561508|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561509|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561510|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154561511|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
154561512|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561513|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154561514|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154561515|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561516|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
154561517|NCT03606174|Nivolumab|nivolumab|mesh-list
154561518|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561519|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561520|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154561521|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561523|NCT03450707|Vitamins|vitamins|mesh-ancestor
154561524|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
154561525|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561526|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
154561527|NCT03392311|Calcipotriene|calcipotriene|mesh-list
154561528|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
154561529|NCT03337009|Naloxone|naloxone|mesh-list
154561530|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154561531|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561532|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
154561533|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561534|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
154561535|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561536|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561537|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154561538|NCT03296527|Hormones|hormones|mesh-ancestor
154561539|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561540|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561541|NCT03267498|Nivolumab|nivolumab|mesh-list
154561542|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561543|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561544|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154140629|NCT06088082|Bupivacaine|bupivacaine|mesh-list
154561545|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561546|NCT03241771|Naloxone|naloxone|mesh-list
154561547|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154561548|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561549|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
154561550|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561551|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154561552|NCT03228680|Hormones|hormones|mesh-ancestor
154561553|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561554|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561555|NCT03194542|Luspatercept|luspatercept|mesh-list
154561556|NCT03194542|Hematinics|hematinics|mesh-ancestor
154561557|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
154561558|NCT03160079|Blinatumomab|blinatumomab|mesh-list
154561559|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561560|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561561|NCT03160079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154561562|NCT03160079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561563|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
154561564|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561565|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561566|NCT03083808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154561567|NCT03083808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561568|NCT03047330|Leuprolide|leuprolide|mesh-list
154561569|NCT03047330|Estradiol|estradiol|mesh-list
154561570|NCT03047330|Estrogens|estrogens|mesh-ancestor
154561571|NCT03047330|Hormones|hormones|mesh-ancestor
154561572|NCT03047330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561573|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561574|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154561575|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154561576|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
154862078|NCT00940589|Melatonin|melatonin|mesh-list
154561577|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154561578|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561579|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
154561580|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154561581|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
154561582|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561583|NCT02608216|Paclitaxel|paclitaxel|mesh-list
154561584|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154561585|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561586|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
154561587|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
154561588|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
154561589|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561590|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
154561591|NCT02328014|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154561592|NCT02328014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154561593|NCT02328014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253747|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
154561594|NCT02328014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561595|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561596|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
154561597|NCT02213926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154561598|NCT02213926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154561599|NCT02213926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561600|NCT02213926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561601|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561602|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154561603|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154561604|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561605|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
154561606|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154561607|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
154561608|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561609|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561610|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154561611|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
154561612|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561613|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561614|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154561615|NCT00265798|Sorafenib|sorafenib|mesh-list
154561616|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561617|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154561618|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561619|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561620|NCT03538171|Exemestane|exemestane|mesh-list
154561621|NCT03538171|Entinostat|entinostat|mesh-list
154561622|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561623|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154561624|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154561625|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561626|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561627|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154561628|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
154561629|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561630|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561631|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154561632|NCT05312216|Durvalumab|durvalumab|mesh-list
154561633|NCT05312216|Lenvatinib|lenvatinib|mesh-list
154561634|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561635|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561636|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154561637|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561638|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561639|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
154561640|NCT02256319|Propofol|propofol|mesh-list
154561641|NCT02256319|Imidazole|imidazole|mesh-list
154561642|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154561643|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561644|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561645|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561646|NCT02256319|Analgesics|analgesics|mesh-ancestor
154561647|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
154561648|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561649|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154561650|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154561651|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154561652|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
154561653|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561654|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561655|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154561656|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
154561658|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561659|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
154561660|NCT04510285|Trastuzumab|trastuzumab|mesh-list
154561661|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561662|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561663|NCT04510285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154561664|NCT04510285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561665|NCT05450432|Ketamine|ketamine|mesh-list
154561666|NCT05450432|Esketamine|esketamine|mesh-list
154561667|NCT05450432|Analgesics|analgesics|mesh-ancestor
154561668|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
154561669|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561670|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561671|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154561672|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154561673|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
154561674|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
154561675|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561676|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154561677|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154561678|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561679|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561680|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
154561681|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154561682|NCT02179255|Hormones|hormones|mesh-list
154561683|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154561684|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561685|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561686|NCT02182063|Nintedanib|nintedanib|mesh-list
154561687|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561688|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154561689|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561690|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561691|NCT02182141|Nintedanib|nintedanib|mesh-list
154561692|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561693|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154561694|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561695|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561696|NCT02182219|Nintedanib|nintedanib|mesh-list
154561697|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561698|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154561699|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561700|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561701|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
154561702|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
154561703|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561704|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154561705|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561706|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
154561707|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154561708|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154561709|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
154561710|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561711|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154561712|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154561713|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561714|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561715|NCT02179567|Bevacizumab|bevacizumab|mesh-list
154561716|NCT02179567|Docetaxel|docetaxel|mesh-list
154561717|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154561718|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561719|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154561720|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154561721|NCT02179567|Growth Substances|growth substances|mesh-ancestor
154561722|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561723|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
154561724|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
154561725|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
154561726|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
154561727|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561728|NCT02182453|Empagliflozin|empagliflozin|mesh-list
154561729|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154561730|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561731|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154561732|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561733|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
154561735|NCT02182531|Epinastine|epinastine|mesh-list
154561736|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154561737|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
154561738|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561739|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561740|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154561741|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
154561743|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154561744|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154561745|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
154561746|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
154561747|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561748|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561749|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154561750|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
154561751|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
154561752|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154561753|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
154561754|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154561755|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
154561756|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561757|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561758|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154561759|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
154561760|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
154561761|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154561762|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
154561763|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561764|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561765|NCT02182765|Nevirapine|nevirapine|mesh-list
154561766|NCT02182765|Abacavir|abacavir|mesh-list
154561767|NCT02182765|Amprenavir|amprenavir|mesh-list
154561768|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154561769|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154561770|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561771|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561772|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
154561773|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561774|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154561775|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154561776|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154561777|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154561778|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154561779|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
154561780|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154561781|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154561782|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154561783|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
154561784|NCT02179645|Celecoxib|celecoxib|mesh-list
154561785|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154561786|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561787|NCT02179645|Analgesics|analgesics|mesh-ancestor
154561788|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
154561789|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561790|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561791|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154561792|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561793|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154561794|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154561795|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581432|NCT06174883|Folic Acid|folic acid|mesh-list
154561796|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561798|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154561799|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154561800|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154561801|NCT01606202|Nabiximols|nabiximols|mesh-list
154561802|NCT01606202|Analgesics|analgesics|mesh-ancestor
154561803|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
154561804|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561805|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561806|NCT03536611|Warfarin|warfarin|mesh-list
154561807|NCT03536611|Dabigatran|dabigatran|mesh-list
154561808|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
154561809|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
154561810|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154561811|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
154561812|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561813|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561814|NCT02630459|Erenumab|erenumab|mesh-list
154561815|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154561816|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154561817|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561819|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
154561820|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561821|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561822|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
154561823|NCT02183077|Meloxicam|meloxicam|mesh-list
154561824|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154561825|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561826|NCT02183077|Analgesics|analgesics|mesh-ancestor
154561827|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
154561828|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561829|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561830|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154561831|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561832|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154561833|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154561834|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561835|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561836|NCT02183155|Indomethacin|indomethacin|mesh-list
154561837|NCT02183155|Meloxicam|meloxicam|mesh-list
154561838|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154561839|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561840|NCT02183155|Analgesics|analgesics|mesh-ancestor
154561841|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
154561842|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561843|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561844|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154561845|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561846|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
154561847|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
154561848|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154561849|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154561850|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561851|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561852|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154561853|NCT02177461|Telmisartan|telmisartan|mesh-list
154561854|NCT02177461|Clonidine|clonidine|mesh-list
154561855|NCT02177461|Enalapril|enalapril|mesh-list
154561856|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154561857|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154561858|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154561859|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561860|NCT02177461|Analgesics|analgesics|mesh-ancestor
154561861|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
154561862|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561863|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561864|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
154561865|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
154561866|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154561867|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154561868|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154561869|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
154561870|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561871|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154561873|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561874|NCT03545243|Pantoprazole|pantoprazole|mesh-list
154561875|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154561876|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154561877|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154561878|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561879|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561880|NCT02183311|Linagliptin|linagliptin|mesh-list
154561881|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154561882|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561883|NCT02183311|Incretins|incretins|mesh-ancestor
154561884|NCT02183311|Hormones|hormones|mesh-ancestor
154561885|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561886|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154561887|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
154561888|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561889|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561890|NCT05518526|Annamycin|annamycin|mesh-list
154561891|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154561892|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561893|NCT01464593|Doxorubicin|doxorubicin|mesh-list
154561894|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154561895|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154561896|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561897|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154561898|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154561899|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561900|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561901|NCT02183389|Linagliptin|linagliptin|mesh-list
154561902|NCT02183389|Warfarin|warfarin|mesh-list
154561903|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
154561904|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154561905|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561906|NCT02183389|Incretins|incretins|mesh-ancestor
154561907|NCT02183389|Hormones|hormones|mesh-ancestor
154561908|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154561909|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154561910|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
154561911|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561912|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561913|NCT02177539|Phenylephrine|phenylephrine|mesh-list
154561914|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
154561915|NCT02177539|Tropicamide|tropicamide|mesh-list
154561916|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
154561917|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154561918|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
154561919|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
154561920|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561921|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561922|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
154561923|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154561924|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
154561925|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
154561926|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154561927|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154561928|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154561929|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
154561930|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154561931|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561932|NCT02177539|Protective Agents|protective agents|mesh-ancestor
154561933|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154561934|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154561935|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
154561936|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
154561937|NCT06220279|Diclofenac|diclofenac|mesh-list
154561938|NCT06220279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154561939|NCT06220279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561940|NCT06220279|Analgesics|analgesics|mesh-ancestor
154561941|NCT06220279|Sensory System Agents|sensory system agents|mesh-ancestor
154561942|NCT06220279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561943|NCT06220279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561944|NCT06220279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862079|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
154561945|NCT06220279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154561946|NCT06220279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154561947|NCT06220279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561948|NCT06220279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561949|NCT06220175|Lidocaine|lidocaine|mesh-list
154561950|NCT06220175|Anesthetics, Local|anesthetics, local|mesh-ancestor
154561951|NCT06220175|Anesthetics|anesthetics|mesh-ancestor
154561952|NCT06220175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561953|NCT06220175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561954|NCT06220175|Sensory System Agents|sensory system agents|mesh-ancestor
154561955|NCT06220175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561956|NCT06220175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154561957|NCT06220175|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154561958|NCT06220175|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154561959|NCT06220175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154561960|NCT06220175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561961|NCT06220123|Enoxaparin|enoxaparin|mesh-list
154561962|NCT06220123|Rivaroxaban|rivaroxaban|mesh-list
154561963|NCT06220123|Enoxaparin sodium|enoxaparin sodium|mesh-list
154561964|NCT06220123|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154561965|NCT06220123|Antithrombins|antithrombins|mesh-ancestor
154561966|NCT06220123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154561967|NCT06220123|Protease Inhibitors|protease inhibitors|mesh-ancestor
154561968|NCT06220123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561969|NCT06220123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561970|NCT06220123|Anticoagulants|anticoagulants|mesh-ancestor
154561971|NCT06220123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154561972|NCT06220123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154561973|NCT06220097|Fludarabine|fludarabine|mesh-list
154561974|NCT06220097|Mitoxantrone|mitoxantrone|mesh-list
154561975|NCT06220097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154561976|NCT06220097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154561977|NCT06220097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561978|NCT06220097|Analgesics|analgesics|mesh-ancestor
154561979|NCT06220097|Sensory System Agents|sensory system agents|mesh-ancestor
154561980|NCT06220097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154561981|NCT06220097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154561982|NCT06220097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154561983|NCT06220097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154561984|NCT06220045|Fluorides|fluorides|mesh-list
154561985|NCT06220045|Cariostatic Agents|cariostatic agents|mesh-ancestor
154561986|NCT06220045|Protective Agents|protective agents|mesh-ancestor
154561987|NCT06220045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561988|NCT06219967|Charcoal|charcoal|mesh-list
154561989|NCT06219967|Antidotes|antidotes|mesh-ancestor
154561990|NCT06219967|Protective Agents|protective agents|mesh-ancestor
154561991|NCT06219967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561992|NCT06219928|Dexmedetomidine|dexmedetomidine|mesh-list
154561993|NCT06219928|Ketamine|ketamine|mesh-list
154561994|NCT06219928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154561995|NCT06219928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154561996|NCT06219928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154561997|NCT06219928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154561998|NCT06219928|Analgesics|analgesics|mesh-ancestor
154561999|NCT06219928|Sensory System Agents|sensory system agents|mesh-ancestor
154562000|NCT06219928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562001|NCT06219928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154562002|NCT06219928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154562003|NCT06219928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154562004|NCT06219928|Adrenergic Agents|adrenergic agents|mesh-ancestor
154562005|NCT06219928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562006|NCT06219928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562007|NCT06219928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154562008|NCT06219928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154562009|NCT06219928|Anesthetics, General|anesthetics, general|mesh-ancestor
154562010|NCT06219928|Anesthetics|anesthetics|mesh-ancestor
154562011|NCT06219928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154562012|NCT06219928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154562013|NCT06219837|Bupivacaine|bupivacaine|mesh-list
154562014|NCT06219837|Anesthetics, Local|anesthetics, local|mesh-ancestor
154562015|NCT06219837|Anesthetics|anesthetics|mesh-ancestor
154562016|NCT06219837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562017|NCT06219837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562018|NCT06219837|Sensory System Agents|sensory system agents|mesh-ancestor
154562019|NCT06219837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562020|NCT06219733|Imatinib Mesylate|imatinib mesylate|mesh-list
154562022|NCT06219733|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154562023|NCT06219733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562024|NCT06219733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562025|NCT06219733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562026|NCT06219733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562027|NCT06219590|Acetylcholine|acetylcholine|mesh-list
154562028|NCT06219590|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562029|NCT06219590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154562030|NCT06219590|Cholinergic Agents|cholinergic agents|mesh-ancestor
154562031|NCT06219590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562032|NCT06219590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562033|NCT06219590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562034|NCT06219525|Zinc|zinc|mesh-list
154285872|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562035|NCT06219525|Trace Elements|trace elements|mesh-ancestor
154562036|NCT06219525|Micronutrients|micronutrients|mesh-ancestor
154562037|NCT06219525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562038|NCT06219486|Fibrin fragment D|fibrin fragment d|mesh-list
154562039|NCT06219486|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154562040|NCT06219486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154562041|NCT06219486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562043|NCT06219486|Coagulants|coagulants|mesh-ancestor
154562044|NCT06219317|Cemiplimab|cemiplimab|mesh-list
154562045|NCT06219317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562046|NCT06219317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562047|NCT06219096|Liver Extracts|liver extracts|mesh-list
154562048|NCT06219096|Hematinics|hematinics|mesh-ancestor
154562049|NCT06218979|Risperidone|risperidone|mesh-list
154562050|NCT06218979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154562051|NCT06218979|Serotonin Agents|serotonin agents|mesh-ancestor
154562052|NCT06218979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562053|NCT06218979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562054|NCT06218979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562055|NCT06218979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154562056|NCT06218979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154562057|NCT06218979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562058|NCT06218979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154562059|NCT06218979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154562060|NCT06218979|Dopamine Agents|dopamine agents|mesh-ancestor
154562061|NCT06218901|Immunomodulating Agents|immunomodulating agents|mesh-list
154562062|NCT06218901|Immunologic Factors|immunologic factors|mesh-ancestor
154562063|NCT06218901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562064|NCT06218888|Tislelizumab|tislelizumab|mesh-list
154562065|NCT06218888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562066|NCT06218888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562067|NCT06218862|Antiviral Agents|antiviral agents|mesh-list
154562068|NCT06218862|Sivelestat|sivelestat|mesh-list
154562069|NCT06218862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562070|NCT06218862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154562071|NCT06218862|Protease Inhibitors|protease inhibitors|mesh-ancestor
154562072|NCT06218862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562073|NCT06218862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562074|NCT06218810|Bevacizumab|bevacizumab|mesh-list
154562075|NCT06218810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562076|NCT06218810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562077|NCT06218810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154562078|NCT06218810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154562079|NCT06218810|Growth Substances|growth substances|mesh-ancestor
154562080|NCT06218810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562081|NCT06218810|Growth Inhibitors|growth inhibitors|mesh-ancestor
154562082|NCT06218680|Propofol|propofol|mesh-list
154562083|NCT06218680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154562084|NCT06218680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562085|NCT06218680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562086|NCT06218680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154562087|NCT06218680|Anesthetics, General|anesthetics, general|mesh-ancestor
154562088|NCT06218680|Anesthetics|anesthetics|mesh-ancestor
154562089|NCT06218550|Dronabinol|dronabinol|mesh-list
154562090|NCT06218550|Hallucinogens|hallucinogens|mesh-ancestor
154562091|NCT06218550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562092|NCT06218550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154562093|NCT06218550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154562094|NCT06218550|Analgesics|analgesics|mesh-ancestor
154562095|NCT06218550|Sensory System Agents|sensory system agents|mesh-ancestor
154562096|NCT06218550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562097|NCT06218550|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154562098|NCT06218550|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154562100|NCT06218550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562101|NCT06218550|Hormones|hormones|mesh-ancestor
154562102|NCT06218550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562103|NCT06218524|Temozolomide|temozolomide|mesh-list
154562104|NCT06218524|Haloperidol|haloperidol|mesh-list
154141200|NCT04940299|Ipilimumab|ipilimumab|mesh-list
154562105|NCT06218524|Haloperidol decanoate|haloperidol decanoate|mesh-list
154562106|NCT06218524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154562107|NCT06218524|Alkylating Agents|alkylating agents|mesh-ancestor
154562108|NCT06218524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562109|NCT06218524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562110|NCT06218524|Antiemetics|antiemetics|mesh-ancestor
154562111|NCT06218524|Autonomic Agents|autonomic agents|mesh-ancestor
154562112|NCT06218524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285952|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
154562113|NCT06218524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562114|NCT06218524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562115|NCT06218524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154562116|NCT06218524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154562117|NCT06218524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562118|NCT06218524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154562119|NCT06218524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154562121|NCT06218524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562122|NCT06218524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154562123|NCT06218498|Minoxidil|minoxidil|mesh-list
154562124|NCT06218498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154562125|NCT06218498|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562126|NCT06218407|Caryophyllene|caryophyllene|mesh-list
154562127|NCT06218407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154562128|NCT06218407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154562129|NCT06218407|Analgesics|analgesics|mesh-ancestor
154562130|NCT06218407|Sensory System Agents|sensory system agents|mesh-ancestor
154562131|NCT06218407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562132|NCT06218407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562133|NCT06218407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562134|NCT06218407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154562135|NCT06218394|Minoxidil|minoxidil|mesh-list
154562136|NCT06218394|Mitogens|mitogens|mesh-list
154562137|NCT06218394|Mitosis Modulators|mitosis modulators|mesh-ancestor
154562138|NCT06218394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562139|NCT06218394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154562140|NCT06218394|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562141|NCT06218316|Botulinum Toxins|botulinum toxins|mesh-list
154562142|NCT06218316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154562143|NCT06218316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154562144|NCT06218316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154562145|NCT06218316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154562146|NCT06218316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562147|NCT06218316|Cholinergic Agents|cholinergic agents|mesh-ancestor
154562148|NCT06218316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562149|NCT06218316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562150|NCT06218316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154562151|NCT06218316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562152|NCT06218199|Valsartan|valsartan|mesh-list
154562153|NCT06218199|Hydralazine|hydralazine|mesh-list
154562154|NCT06218199|Torsemide|torsemide|mesh-list
154562155|NCT06218199|Furosemide|furosemide|mesh-list
154562156|NCT06218199|Isosorbide|isosorbide|mesh-list
154562157|NCT06218199|Bumetanide|bumetanide|mesh-list
154562158|NCT06218199|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154562159|NCT06218199|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154562160|NCT06218199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154562161|NCT06218199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154562162|NCT06218199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154562163|NCT06218199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154562164|NCT06218199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562165|NCT06218199|Diuretics|diuretics|mesh-ancestor
154562166|NCT06218199|Natriuretic Agents|natriuretic agents|mesh-ancestor
154562167|NCT06218199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562168|NCT06218199|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153581987|NCT04944888|Eliglustat|eliglustat|mesh-list
154562169|NCT06218199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154562170|NCT06218199|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154562171|NCT06218199|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562172|NCT06218199|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154562173|NCT06218160|Hydromorphone|hydromorphone|mesh-list
154562174|NCT06218160|Ropivacaine|ropivacaine|mesh-list
154562175|NCT06218160|Anesthetics, Local|anesthetics, local|mesh-ancestor
154562176|NCT06218160|Anesthetics|anesthetics|mesh-ancestor
154562177|NCT06218160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562178|NCT06218160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562179|NCT06218160|Sensory System Agents|sensory system agents|mesh-ancestor
154562180|NCT06218160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562181|NCT06218160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154562182|NCT06218160|Narcotics|narcotics|mesh-ancestor
154562183|NCT06218160|Analgesics|analgesics|mesh-ancestor
154562184|NCT06218056|Cannabidiol|cannabidiol|mesh-list
154562185|NCT06218056|Anticonvulsants|anticonvulsants|mesh-ancestor
154562186|NCT06217939|Hydrocortisone|hydrocortisone|mesh-list
154562187|NCT06217939|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154562188|NCT06217939|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154562189|NCT06217939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154562190|NCT06217939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562192|NCT06217887|Gliclazide|gliclazide|mesh-list
154562193|NCT06217887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154562194|NCT06217887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562195|NCT06217848|Liraglutide|liraglutide|mesh-list
154562196|NCT06217848|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154562197|NCT06217848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154562198|NCT06217848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562199|NCT06217848|Incretins|incretins|mesh-ancestor
154562200|NCT06217848|Hormones|hormones|mesh-ancestor
154562201|NCT06217848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562202|NCT06214273|Miconazole|miconazole|mesh-list
154562203|NCT06214273|Clotrimazole|clotrimazole|mesh-list
154562204|NCT06214273|Antifungal Agents|antifungal agents|mesh-list
154562205|NCT06214273|Ibuprofen|ibuprofen|mesh-list
154562206|NCT06214273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154562207|NCT06214273|Analgesics|analgesics|mesh-list
154562208|NCT06214273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154562209|NCT06214273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154562210|NCT06214273|Sensory System Agents|sensory system agents|mesh-ancestor
154562211|NCT06214273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562212|NCT06214273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562213|NCT06214273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154562214|NCT06214273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154562215|NCT06214273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562216|NCT06214273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562217|NCT06214273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562218|NCT06214273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154562219|NCT06214273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154141322|NCT04218968|Carvedilol|carvedilol|mesh-list
154562220|NCT06214273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154562221|NCT06214273|Hormone Antagonists|hormone antagonists|mesh-ancestor
154562222|NCT06214273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562223|NCT06214273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154562224|NCT06214273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154562225|NCT06214273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154562226|NCT06214130|Valproic Acid|valproic acid|mesh-list
154562227|NCT06214130|Anticonvulsants|anticonvulsants|mesh-ancestor
154562228|NCT06214130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562229|NCT06214130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562230|NCT06214130|GABA Agents|gaba agents|mesh-ancestor
154562231|NCT06214130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562232|NCT06214130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562233|NCT06214130|Antimanic Agents|antimanic agents|mesh-ancestor
154562234|NCT06214130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154562235|NCT06214130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562236|NCT06214130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154562237|NCT06212102|Progestins|progestins|mesh-list
154562238|NCT06212102|Hormones|hormones|mesh-ancestor
154562239|NCT06212102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562240|NCT06212102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562241|NCT06209554|Erythritol|erythritol|mesh-list
154562242|NCT06209554|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562243|NCT06207175|Vaccines|vaccines|mesh-list
153582079|NCT04518306|Amlodipine|amlodipine|mesh-list
154562244|NCT06207175|Immunologic Factors|immunologic factors|mesh-ancestor
154562245|NCT06207175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562246|NCT06206850|Osimertinib|osimertinib|mesh-list
154562247|NCT06206850|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154562248|NCT06206850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562249|NCT06206850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562250|NCT06206850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562251|NCT06206850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562252|NCT06205316|Ascorbic Acid|ascorbic acid|mesh-list
154562253|NCT06205316|Methyltestosterone|methyltestosterone|mesh-list
154562254|NCT06205316|Hormones|hormones|mesh-list
154562255|NCT06205316|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154562256|NCT06205316|Androgens|androgens|mesh-list
154562257|NCT06205316|Androgen Antagonists|androgen antagonists|mesh-list
154562258|NCT06205316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562259|NCT06205316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562260|NCT06205316|Antioxidants|antioxidants|mesh-ancestor
154562261|NCT06205316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562262|NCT06205316|Protective Agents|protective agents|mesh-ancestor
154562263|NCT06205316|Vitamins|vitamins|mesh-ancestor
154562264|NCT06205316|Micronutrients|micronutrients|mesh-ancestor
154562265|NCT06205316|Estrogens|estrogens|mesh-ancestor
154562266|NCT06205316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154562267|NCT06205316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562268|NCT06205316|Anabolic Agents|anabolic agents|mesh-ancestor
154562269|NCT06205316|Hormone Antagonists|hormone antagonists|mesh-ancestor
154562270|NCT06197269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154562271|NCT06197269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154562272|NCT06197269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562273|NCT06197269|Antitubercular Agents|antitubercular agents|mesh-ancestor
154562274|NCT06186401|Cyclophosphamide|cyclophosphamide|mesh-list
154562275|NCT06186401|Fludarabine|fludarabine|mesh-list
154562276|NCT06186401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154562277|NCT06186401|Immunologic Factors|immunologic factors|mesh-ancestor
154141392|NCT03714555|Copper|copper|mesh-list
154562278|NCT06186401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562279|NCT06186401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154562280|NCT06186401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154562281|NCT06186401|Alkylating Agents|alkylating agents|mesh-ancestor
154562282|NCT06186401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562283|NCT06186401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562284|NCT06186401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154562285|NCT06175923|Edetic Acid|edetic acid|mesh-list
154562286|NCT06175923|Pentetic Acid|pentetic acid|mesh-list
154562287|NCT06175923|Anticoagulants|anticoagulants|mesh-ancestor
154562288|NCT06175923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154562289|NCT06175923|Chelating Agents|chelating agents|mesh-ancestor
154562290|NCT06175923|Sequestering Agents|sequestering agents|mesh-ancestor
154562291|NCT06175923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562292|NCT06175923|Antidotes|antidotes|mesh-ancestor
154562293|NCT06175923|Protective Agents|protective agents|mesh-ancestor
154562294|NCT06175923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562295|NCT06175923|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154562296|NCT06169410|Paclitaxel|paclitaxel|mesh-list
154562297|NCT06169410|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154562298|NCT06169410|Ramucirumab|ramucirumab|mesh-list
154562299|NCT06169410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154562300|NCT06169410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562301|NCT06169410|Tubulin Modulators|tubulin modulators|mesh-ancestor
154562302|NCT06169410|Antimitotic Agents|antimitotic agents|mesh-ancestor
154562303|NCT06169410|Mitosis Modulators|mitosis modulators|mesh-ancestor
154562304|NCT06169410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562305|NCT06169410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154562306|NCT06169410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154562307|NCT06169410|Growth Substances|growth substances|mesh-ancestor
154562308|NCT06169410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562309|NCT06169410|Growth Inhibitors|growth inhibitors|mesh-ancestor
154562310|NCT06155435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154562311|NCT06123117|Ropivacaine|ropivacaine|mesh-list
154562312|NCT06123117|Anesthetics, Local|anesthetics, local|mesh-ancestor
154562313|NCT06123117|Anesthetics|anesthetics|mesh-ancestor
154562314|NCT06123117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562315|NCT06123117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562316|NCT06123117|Sensory System Agents|sensory system agents|mesh-ancestor
154562317|NCT06123117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562318|NCT06120816|Nitric Oxide|nitric oxide|mesh-list
154862080|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862081|NCT00940589|Protective Agents|protective agents|mesh-ancestor
154562319|NCT06120816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154562320|NCT06120816|Autonomic Agents|autonomic agents|mesh-ancestor
154562321|NCT06120816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562322|NCT06120816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562323|NCT06120816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154562324|NCT06120816|Respiratory System Agents|respiratory system agents|mesh-ancestor
154562325|NCT06120816|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154562326|NCT06120816|Antioxidants|antioxidants|mesh-ancestor
154562327|NCT06120816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562328|NCT06120816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562329|NCT06120816|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154562330|NCT06120816|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562331|NCT06120816|Gasotransmitters|gasotransmitters|mesh-ancestor
154562332|NCT06120816|Protective Agents|protective agents|mesh-ancestor
154562333|NCT06096038|Cyclophosphamide|cyclophosphamide|mesh-list
154562334|NCT06096038|Fludarabine|fludarabine|mesh-list
154562335|NCT06096038|Fludarabine phosphate|fludarabine phosphate|mesh-list
154562336|NCT06096038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154562337|NCT06096038|Immunologic Factors|immunologic factors|mesh-ancestor
154562338|NCT06096038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286180|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
154562339|NCT06096038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154562340|NCT06096038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154562341|NCT06096038|Alkylating Agents|alkylating agents|mesh-ancestor
154562342|NCT06096038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562343|NCT06096038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562344|NCT06096038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154562345|NCT06096038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154562346|NCT06096038|Antimetabolites|antimetabolites|mesh-ancestor
154562348|NCT06090227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154562349|NCT06090227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562350|NCT06086444|Tranexamic Acid|tranexamic acid|mesh-list
154562351|NCT06086444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154562352|NCT06086444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154562353|NCT06086444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562354|NCT06086444|Hemostatics|hemostatics|mesh-ancestor
154562355|NCT06086444|Coagulants|coagulants|mesh-ancestor
154562356|NCT06086431|Dexamethasone|dexamethasone|mesh-list
154562357|NCT06086431|Dexmedetomidine|dexmedetomidine|mesh-list
154562358|NCT06086431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562359|NCT06086431|Antiemetics|antiemetics|mesh-ancestor
154562360|NCT06086431|Autonomic Agents|autonomic agents|mesh-ancestor
154562361|NCT06086431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562362|NCT06086431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562363|NCT06086431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562364|NCT06086431|Glucocorticoids|glucocorticoids|mesh-ancestor
154562365|NCT06086431|Hormones|hormones|mesh-ancestor
154562366|NCT06086431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562367|NCT06086431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154562368|NCT06086431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562369|NCT06086431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154562370|NCT06086431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562371|NCT06086431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154562372|NCT06086431|Analgesics|analgesics|mesh-ancestor
154562373|NCT06086431|Sensory System Agents|sensory system agents|mesh-ancestor
154562374|NCT06086431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154141487|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
154562375|NCT06086431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154562376|NCT06086431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154562377|NCT06086431|Adrenergic Agents|adrenergic agents|mesh-ancestor
154562378|NCT06086431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562379|NCT06086431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562380|NCT06086418|Dexamethasone|dexamethasone|mesh-list
154562381|NCT06086418|Dexamethasone acetate|dexamethasone acetate|mesh-list
154562382|NCT06086418|BB 1101|bb 1101|mesh-list
154562383|NCT06086418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562384|NCT06086418|Antiemetics|antiemetics|mesh-ancestor
154562385|NCT06086418|Autonomic Agents|autonomic agents|mesh-ancestor
154562386|NCT06086418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562387|NCT06086418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562388|NCT06086418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562389|NCT06086418|Glucocorticoids|glucocorticoids|mesh-ancestor
154562390|NCT06086418|Hormones|hormones|mesh-ancestor
154562391|NCT06086418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562392|NCT06086418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154562393|NCT06086418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562394|NCT06086418|Protease Inhibitors|protease inhibitors|mesh-ancestor
154562395|NCT06086418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562396|NCT06086418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562398|NCT06086392|Dexamethasone acetate|dexamethasone acetate|mesh-list
154562399|NCT06086392|BB 1101|bb 1101|mesh-list
154562400|NCT06086392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562401|NCT06086392|Antiemetics|antiemetics|mesh-ancestor
154562402|NCT06086392|Autonomic Agents|autonomic agents|mesh-ancestor
154562403|NCT06086392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562404|NCT06086392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562405|NCT06086392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562406|NCT06086392|Glucocorticoids|glucocorticoids|mesh-ancestor
154562407|NCT06086392|Hormones|hormones|mesh-ancestor
154562408|NCT06086392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562409|NCT06086392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154562410|NCT06086392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562411|NCT06086392|Protease Inhibitors|protease inhibitors|mesh-ancestor
154562412|NCT06086392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562413|NCT06086392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562414|NCT06051409|Imatinib Mesylate|imatinib mesylate|mesh-list
154562415|NCT06051409|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154562416|NCT06051409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562417|NCT06051409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562418|NCT06051409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562419|NCT06051409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562420|NCT06013839|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154562421|NCT06013839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154562422|NCT06013839|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562423|NCT06004674|Enoxaparin|enoxaparin|mesh-list
154562424|NCT06004674|Anticoagulants|anticoagulants|mesh-ancestor
154562425|NCT06004674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154562426|NCT06004674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154562427|NCT06004674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562428|NCT05977920|Caffeine|caffeine|mesh-list
154562429|NCT05977920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154562430|NCT05977920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562431|NCT05977920|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154562432|NCT05977920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562433|NCT05977920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562434|NCT05977920|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154562435|NCT05977920|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154562436|NCT05977920|Purinergic Agents|purinergic agents|mesh-ancestor
154562437|NCT05977920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562438|NCT05951452|Oxytocin|oxytocin|mesh-list
154562439|NCT05951452|Testosterone|testosterone|mesh-list
154562440|NCT05951452|Oxytocics|oxytocics|mesh-ancestor
154562441|NCT05951452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154562442|NCT05951452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562443|NCT05951452|Androgens|androgens|mesh-ancestor
154562444|NCT05951452|Hormones|hormones|mesh-ancestor
154562445|NCT05951452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562446|NCT05938387|Vaccines|vaccines|mesh-list
154562447|NCT05938387|Immunologic Factors|immunologic factors|mesh-ancestor
154562448|NCT05938387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562449|NCT05925478|Bupivacaine|bupivacaine|mesh-list
154562450|NCT05925478|Anesthetics, Local|anesthetics, local|mesh-ancestor
154562451|NCT05925478|Anesthetics|anesthetics|mesh-ancestor
154562452|NCT05925478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562453|NCT05925478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562454|NCT05925478|Sensory System Agents|sensory system agents|mesh-ancestor
154562455|NCT05925478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562456|NCT05924594|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154562457|NCT05924594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154562458|NCT05924594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562459|NCT05924594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154562460|NCT05924594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154562461|NCT05924594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154562462|NCT05924594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562463|NCT05924594|Dopamine Agents|dopamine agents|mesh-ancestor
153582344|NCT03736720|Antidotes|antidotes|mesh-ancestor
154562464|NCT05924594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562466|NCT05916586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562467|NCT05916586|Glucocorticoids|glucocorticoids|mesh-ancestor
154562468|NCT05916586|Hormones|hormones|mesh-ancestor
154562469|NCT05916586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562470|NCT05916586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562471|NCT05916586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154562472|NCT05916586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562473|NCT05910970|Lenvatinib|lenvatinib|mesh-list
154562474|NCT05910970|Tislelizumab|tislelizumab|mesh-list
154562475|NCT05910970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562476|NCT05910970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562477|NCT05910970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562478|NCT05910970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562479|NCT05910970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562480|NCT05906732|Dofetilide|dofetilide|mesh-list
154562481|NCT05906732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154562482|NCT05906732|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154562483|NCT05906732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154562484|NCT05906732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562485|NCT05906511|Dronabinol|dronabinol|mesh-list
154562486|NCT05906511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154562487|NCT05906511|Hallucinogens|hallucinogens|mesh-ancestor
154562488|NCT05906511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562489|NCT05906511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154562490|NCT05906511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154562491|NCT05906511|Analgesics|analgesics|mesh-ancestor
154562492|NCT05906511|Sensory System Agents|sensory system agents|mesh-ancestor
154562493|NCT05906511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562494|NCT05906511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154562495|NCT05906511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154562496|NCT05906511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562497|NCT05906511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562498|NCT05906511|Hormones|hormones|mesh-ancestor
154562499|NCT05906511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562500|NCT05898841|Tenofovir|tenofovir|mesh-list
154562501|NCT05898841|Emtricitabine|emtricitabine|mesh-list
154562502|NCT05898841|Dolutegravir|dolutegravir|mesh-list
154562503|NCT05898841|Rilpivirine|rilpivirine|mesh-list
154562504|NCT05898841|Antiviral Agents|antiviral agents|mesh-ancestor
154562505|NCT05898841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562506|NCT05898841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154562507|NCT05898841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154562508|NCT05898841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562509|NCT05898841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562510|NCT05898841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154562511|NCT05898841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154562512|NCT05898841|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154562513|NCT05898841|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154562514|NCT05879029|Rabeprazole|rabeprazole|mesh-list
154562515|NCT05879029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154562516|NCT05879029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562517|NCT05879029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154562518|NCT05879029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562519|NCT05879029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562520|NCT05878353|Doxycycline|doxycycline|mesh-list
154562521|NCT05878353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154562522|NCT05878353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562523|NCT05878353|Antimalarials|antimalarials|mesh-ancestor
154562524|NCT05878353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154562525|NCT05878353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154562526|NCT05863104|Glycopyrrolate|glycopyrrolate|mesh-list
154562527|NCT05863104|Bromides|bromides|mesh-list
154562528|NCT05863104|Anticonvulsants|anticonvulsants|mesh-ancestor
154562529|NCT05863104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154562530|NCT05863104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154562531|NCT05863104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154562532|NCT05863104|Cholinergic Agents|cholinergic agents|mesh-ancestor
154562533|NCT05863104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562534|NCT05863104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562535|NCT05863104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562536|NCT05848843|Durvalumab|durvalumab|mesh-list
154562537|NCT05848843|Adagrasib|adagrasib|mesh-list
154562538|NCT05848843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562540|NCT05828810|Chlorhexidine|chlorhexidine|mesh-list
154562541|NCT05828810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154562542|NCT05828810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562543|NCT05828810|Disinfectants|disinfectants|mesh-ancestor
154562544|NCT05811676|Tranexamic Acid|tranexamic acid|mesh-list
154562545|NCT05811676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154562546|NCT05811676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154562547|NCT05811676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562548|NCT05811676|Hemostatics|hemostatics|mesh-ancestor
154562549|NCT05811676|Coagulants|coagulants|mesh-ancestor
154562550|NCT05806749|Belumosudil|belumosudil|mesh-list
154562551|NCT05806749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562552|NCT05806749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562553|NCT05806749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562554|NCT05795244|Nivolumab|nivolumab|mesh-list
154562555|NCT05795244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562556|NCT05795244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562557|NCT05795244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154562558|NCT05795244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562559|NCT05761756|Caffeine|caffeine|mesh-list
154562560|NCT05761756|Methylphenidate|methylphenidate|mesh-list
154562561|NCT05761756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154562562|NCT05761756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286397|NCT03771846|Gemcitabine|gemcitabine|mesh-list
154562563|NCT05761756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154562564|NCT05761756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562565|NCT05761756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562566|NCT05761756|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154562567|NCT05761756|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154562568|NCT05761756|Purinergic Agents|purinergic agents|mesh-ancestor
154562569|NCT05761756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562570|NCT05761756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154562571|NCT05761756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154562572|NCT05761756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154562573|NCT05761756|Dopamine Agents|dopamine agents|mesh-ancestor
154562574|NCT05758389|Paclitaxel|paclitaxel|mesh-list
154562575|NCT05758389|Tislelizumab|tislelizumab|mesh-list
154562576|NCT05758389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154562577|NCT05758389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562578|NCT05758389|Tubulin Modulators|tubulin modulators|mesh-ancestor
154562579|NCT05758389|Antimitotic Agents|antimitotic agents|mesh-ancestor
154562580|NCT05758389|Mitosis Modulators|mitosis modulators|mesh-ancestor
154562581|NCT05758389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562582|NCT05758389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562583|NCT05741385|Metoprolol|metoprolol|mesh-list
154562584|NCT05741385|Midazolam|midazolam|mesh-list
154562585|NCT05741385|Caffeine|caffeine|mesh-list
154562586|NCT05741385|Omeprazole|omeprazole|mesh-list
154562587|NCT05741385|Warfarin|warfarin|mesh-list
154562588|NCT05741385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154562589|NCT05741385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154562590|NCT05741385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562591|NCT05741385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562592|NCT05741385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154562593|NCT05741385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154562594|NCT05741385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154562595|NCT05741385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154562596|NCT05741385|Anesthetics, General|anesthetics, general|mesh-ancestor
154562597|NCT05741385|Anesthetics|anesthetics|mesh-ancestor
154562598|NCT05741385|GABA Modulators|gaba modulators|mesh-ancestor
154562599|NCT05741385|GABA Agents|gaba agents|mesh-ancestor
154562600|NCT05741385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562601|NCT05741385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562602|NCT05741385|Anticoagulants|anticoagulants|mesh-ancestor
154562603|NCT05741385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154562604|NCT05741385|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154562605|NCT05741385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562606|NCT05741385|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154562607|NCT05741385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154562608|NCT05741385|Purinergic Agents|purinergic agents|mesh-ancestor
154562609|NCT05741385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154562610|NCT05741385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562611|NCT05741385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154562612|NCT05741385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154562613|NCT05741385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154562614|NCT05741385|Sympatholytics|sympatholytics|mesh-ancestor
154562615|NCT05741385|Autonomic Agents|autonomic agents|mesh-ancestor
154562616|NCT05741385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562617|NCT05741385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154562618|NCT05741385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154562619|NCT05741385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154562620|NCT05741385|Adrenergic Agents|adrenergic agents|mesh-ancestor
154562621|NCT05737563|Capecitabine|capecitabine|mesh-list
154562622|NCT05737563|Irinotecan|irinotecan|mesh-list
154562623|NCT05737563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154562624|NCT05737563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154562625|NCT05737563|Antimetabolites|antimetabolites|mesh-ancestor
154562626|NCT05737563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562627|NCT05737563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562628|NCT05737563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154562629|NCT05737563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154562630|NCT05737563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562631|NCT05737563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141744|NCT00241098|Valsartan|valsartan|mesh-list
154562632|NCT05711823|Dexamethasone|dexamethasone|mesh-list
154562633|NCT05711823|Dexamethasone acetate|dexamethasone acetate|mesh-list
154562634|NCT05711823|Aprepitant|aprepitant|mesh-list
154562635|NCT05711823|Granisetron|granisetron|mesh-list
154562636|NCT05711823|BB 1101|bb 1101|mesh-list
154562637|NCT05711823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562638|NCT05711823|Antiemetics|antiemetics|mesh-ancestor
154562639|NCT05711823|Autonomic Agents|autonomic agents|mesh-ancestor
154562640|NCT05711823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562641|NCT05711823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562642|NCT05711823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562643|NCT05711823|Glucocorticoids|glucocorticoids|mesh-ancestor
154562644|NCT05711823|Hormones|hormones|mesh-ancestor
154562645|NCT05711823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562646|NCT05711823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154562647|NCT05711823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562648|NCT05711823|Protease Inhibitors|protease inhibitors|mesh-ancestor
154562649|NCT05711823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562650|NCT05711823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562651|NCT05711823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154562652|NCT05711823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562653|NCT05711823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154562654|NCT05711823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154562655|NCT05711823|Serotonin Agents|serotonin agents|mesh-ancestor
154562656|NCT05706506|Tirzepatide|tirzepatide|mesh-list
154562657|NCT05706506|Incretins|incretins|mesh-ancestor
154562658|NCT05706506|Hormones|hormones|mesh-ancestor
154562659|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562660|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562661|NCT05664958|Bupivacaine|bupivacaine|mesh-list
154562662|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
154562663|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
154562664|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562665|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562666|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
154562667|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562668|NCT05660785|Cyclosporine|cyclosporine|mesh-list
154562669|NCT05660785|Cyclosporins|cyclosporins|mesh-list
154562670|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562671|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562672|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154562673|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
154562674|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562675|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
154562676|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562677|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154562678|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154562679|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154562680|NCT05655130|Dexamethasone|dexamethasone|mesh-list
154562681|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
154562682|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154562683|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154562684|NCT05655130|Prednisolone|prednisolone|mesh-list
154562685|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
154562686|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154562687|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
154862082|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562688|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562690|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
154562691|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562692|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562693|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562694|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
154562695|NCT05655130|Hormones|hormones|mesh-ancestor
154562696|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562697|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154562698|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562699|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154562700|NCT05655130|Protective Agents|protective agents|mesh-ancestor
154562701|NCT05635929|Betaine|betaine|mesh-list
154562702|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562703|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
154562704|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154562705|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
154562706|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562707|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154562708|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
154562709|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154562710|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
154562711|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562712|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562713|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154562714|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
154562715|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154562716|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
154562717|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562718|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562719|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154562720|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562721|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
154562722|NCT05616910|Protective Agents|protective agents|mesh-ancestor
154562723|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
154562724|NCT05571072|Narcotics|narcotics|mesh-ancestor
154562725|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562726|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562727|NCT05571072|Analgesics|analgesics|mesh-ancestor
154562728|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
154562729|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562730|NCT05543278|Amiodarone|amiodarone|mesh-list
154562731|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154562732|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562733|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154562734|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154562735|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562736|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154562737|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154141837|NCT00940836|Acetaminophen|acetaminophen|mesh-list
154562738|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154562739|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562740|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154562741|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154562742|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154562743|NCT05532319|Lenvatinib|lenvatinib|mesh-list
154562744|NCT05532319|Tislelizumab|tislelizumab|mesh-list
154562745|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562746|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562747|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562748|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562749|NCT05532319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562750|NCT05516862|Camphor|camphor|mesh-list
154562751|NCT05516862|Salicylates|salicylates|mesh-list
154562752|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
154562753|NCT05516862|Menthol|menthol|mesh-list
154562754|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154562755|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562756|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
154562757|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
154562758|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154562759|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154562760|NCT05516862|Analgesics|analgesics|mesh-ancestor
154562761|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
154562762|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562763|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562764|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154562765|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154562766|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154562767|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562768|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562769|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
154562770|NCT05495464|Rituximab|rituximab|mesh-list
154562771|NCT05495464|Fludarabine|fludarabine|mesh-list
154562772|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
154562773|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
154562774|NCT05495464|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154562775|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154562776|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
154562777|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562778|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154562779|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154562780|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
154562781|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562782|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562783|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154562784|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562785|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154562786|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
154562787|NCT05495464|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154562788|NCT05495464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562789|NCT05495464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562791|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
154562792|NCT05432388|Remibrutinib|remibrutinib|mesh-list
154562793|NCT05432388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562794|NCT05432388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562795|NCT05432388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562796|NCT05429489|Morphine|morphine|mesh-list
154562797|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154562798|NCT05429489|Narcotics|narcotics|mesh-ancestor
154141883|NCT00944502|Dexamethasone|dexamethasone|mesh-list
154562799|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562800|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562801|NCT05429489|Analgesics|analgesics|mesh-ancestor
154562802|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
154562803|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562804|NCT05413369|Metformin|metformin|mesh-list
154562805|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
154562806|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154562807|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154562808|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562809|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562810|NCT05411107|Iloprost|iloprost|mesh-list
154562811|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154562812|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562813|NCT05362994|Sirolimus|sirolimus|mesh-list
154562814|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154562815|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154562816|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154562817|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562818|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
154562819|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154562820|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
154562821|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562822|NCT05342467|Dinoprostone|dinoprostone|mesh-list
154562823|NCT05342467|Gemeprost|gemeprost|mesh-list
154562824|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
154562825|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154562826|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562827|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154562828|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
154562829|NCT05329155|Heparin|heparin|mesh-list
154562830|NCT05329155|Calcium heparin|calcium heparin|mesh-list
154562831|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
154562832|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154862083|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154862084|NCT02574078|Paclitaxel|paclitaxel|mesh-list
154562833|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154562834|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562835|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153360003|NCT01853748|Immunotoxins|immunotoxins|mesh-ancestor
154562836|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154562837|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562838|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154562839|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154562840|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154562841|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562842|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
154562843|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562844|NCT05280704|Lidocaine|lidocaine|mesh-list
154562845|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
154562846|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
154562847|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154562848|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562849|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
154562850|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562851|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154562852|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154141949|NCT00521001|Everolimus|everolimus|mesh-list
154562853|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154562854|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154562855|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562856|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
154562857|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562858|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562859|NCT05275374|Trametinib|trametinib|mesh-list
154562860|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562861|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562862|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562863|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562864|NCT05269706|Cannabidiol|cannabidiol|mesh-list
154562865|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
154562866|NCT05251233|Pantoprazole|pantoprazole|mesh-list
154562867|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154562868|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154562869|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154562870|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562871|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562872|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
154562873|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154562874|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562875|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154562876|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562877|NCT05242965|Vaccines|vaccines|mesh-list
154562878|NCT05242965|Sargramostim|sargramostim|mesh-list
154562879|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
154562880|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562881|NCT05241288|Albuterol|albuterol|mesh-list
154562882|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154562883|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
154562884|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154562885|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562886|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154562887|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154562888|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
154562889|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154562890|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154562891|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154562892|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154562893|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
154562894|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562895|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562896|NCT05239169|Capecitabine|capecitabine|mesh-list
154562897|NCT05239169|Durvalumab|durvalumab|mesh-list
154562898|NCT05239169|Tremelimumab|tremelimumab|mesh-list
154562899|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154562900|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
154562901|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562902|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562903|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154562904|NCT05238831|Paclitaxel|paclitaxel|mesh-list
154562905|NCT05238831|Vinorelbine|vinorelbine|mesh-list
154562906|NCT05238831|Maytansine|maytansine|mesh-list
154562907|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154862085|NCT02574078|Docetaxel|docetaxel|mesh-list
154862086|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154562909|NCT05238831|Bevacizumab|bevacizumab|mesh-list
154562910|NCT05238831|Carboplatin|carboplatin|mesh-list
154562911|NCT05238831|Capecitabine|capecitabine|mesh-list
154562912|NCT05238831|Trastuzumab|trastuzumab|mesh-list
154562913|NCT05238831|Irinotecan|irinotecan|mesh-list
154562914|NCT05238831|Atezolizumab|atezolizumab|mesh-list
154562915|NCT05238831|Letrozole|letrozole|mesh-list
154562916|NCT05238831|Fulvestrant|fulvestrant|mesh-list
154562917|NCT05238831|Olaparib|olaparib|mesh-list
154562918|NCT05238831|Palbociclib|palbociclib|mesh-list
154562919|NCT05238831|Pertuzumab|pertuzumab|mesh-list
154562920|NCT05238831|Anastrozole|anastrozole|mesh-list
154562921|NCT05238831|Niraparib|niraparib|mesh-list
154562922|NCT05238831|Vemurafenib|vemurafenib|mesh-list
154562923|NCT05238831|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154562924|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154562925|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
154562926|NCT05238831|Antibodies|antibodies|mesh-list
154562927|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
154562928|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154562929|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
154562930|NCT05238831|Alectinib|alectinib|mesh-list
154562931|NCT05238831|Entrectinib|entrectinib|mesh-list
154562932|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
154562933|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
154562934|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154562935|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562936|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
154562937|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
154562938|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
154562939|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562940|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154562941|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154562942|NCT05238831|Growth Substances|growth substances|mesh-ancestor
154562943|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562944|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
154562945|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
154562946|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154562947|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
154562948|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154562949|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154562950|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562951|NCT05238831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154562952|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154562953|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154562954|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154562955|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
154562956|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154562957|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154562958|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154562959|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154562960|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154562961|NCT05238831|Immunotoxins|immunotoxins|mesh-ancestor
154562962|NCT05238831|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154562963|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
154562964|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
154142058|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
154562965|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562966|NCT05189977|Propranolol|propranolol|mesh-list
154562967|NCT05189977|Prazosin|prazosin|mesh-list
154562968|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154562969|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154562970|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
154562971|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154562972|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562973|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562974|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154562975|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154562976|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562977|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154562978|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154562979|NCT05189535|Paclitaxel|paclitaxel|mesh-list
154562980|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
154562981|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154562982|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562983|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
154562984|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
154562985|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
154562986|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154562987|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154562988|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154562989|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154562990|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154562991|NCT05189535|Protective Agents|protective agents|mesh-ancestor
154562992|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154562993|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
154562994|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154562995|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
154562996|NCT05183828|Letrozole|letrozole|mesh-list
154562997|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154562998|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154562999|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154563000|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563001|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563002|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154563003|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
154563004|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563005|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563006|NCT05178407|Micronutrients|micronutrients|mesh-list
154563007|NCT05178407|Trace Elements|trace elements|mesh-list
154563008|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563009|NCT05100472|Androgens|androgens|mesh-list
154563010|NCT05100472|Hormones|hormones|mesh-ancestor
154563011|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563012|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563013|NCT05062837|Apatinib|apatinib|mesh-list
154563014|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286853|NCT05536102|Capecitabine|capecitabine|mesh-list
154142116|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
154563015|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154563016|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563017|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563019|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
154563020|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
154563021|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563022|NCT04998006|Ethanol|ethanol|mesh-list
154563023|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154563024|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563025|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563026|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563027|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
154563028|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563029|NCT04970355|Erenumab|erenumab|mesh-list
154563030|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154563031|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563032|NCT04970355|Analgesics|analgesics|mesh-ancestor
154563033|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
154563034|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563035|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563036|NCT04950660|Caffeine|caffeine|mesh-list
154563037|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154563038|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563039|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154563040|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563041|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563042|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154563043|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154563044|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
154563045|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563046|NCT04928339|Bupivacaine|bupivacaine|mesh-list
154563047|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
154563048|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
154563049|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563050|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563051|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
154563052|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563053|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154563054|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154563055|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
154563056|NCT04912765|Nivolumab|nivolumab|mesh-list
154563057|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563058|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563059|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154563060|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563061|NCT04835506|Infliximab|infliximab|mesh-list
154563062|NCT04835506|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154563063|NCT04835506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563064|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
154563065|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154563066|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154563067|NCT04779645|Volagidemab|volagidemab|mesh-list
154563068|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563069|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563070|NCT04760717|Spironolactone|spironolactone|mesh-list
154563071|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154563072|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
154563073|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563074|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563075|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154563076|NCT04760717|Diuretics|diuretics|mesh-ancestor
154563077|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
154563078|NCT04731480|Propofol|propofol|mesh-list
154563079|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154563080|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563081|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563082|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154563083|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
154563084|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
154563085|NCT04711161|Paclitaxel|paclitaxel|mesh-list
154563086|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154563087|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563088|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
154563089|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
154563090|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
154563091|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563092|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
154563093|NCT04700696|Narcotics|narcotics|mesh-ancestor
154563094|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563095|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563096|NCT04700696|Analgesics|analgesics|mesh-ancestor
154563097|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
154563098|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563099|NCT04698746|Anesthetics|anesthetics|mesh-list
154563100|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
154563101|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563102|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563103|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
154563104|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563105|NCT04685876|Bupivacaine|bupivacaine|mesh-list
154563106|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
154563107|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
154563108|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563109|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563110|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
154563111|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563112|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154563113|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
154563114|NCT04669678|Etonogestrel|etonogestrel|mesh-list
154563115|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154563116|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154563117|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154563118|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
154563119|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154563120|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563121|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154142229|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
154563122|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154563123|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154563124|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154563125|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563126|NCT04638517|Danazol|danazol|mesh-list
154563127|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154563128|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
154563129|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563130|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862087|NCT02574078|Bevacizumab|bevacizumab|mesh-list
154563131|NCT04638400|Simvastatin|simvastatin|mesh-list
154563132|NCT04638400|Ezetimibe|ezetimibe|mesh-list
154563133|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154563134|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154563135|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
154563136|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563137|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154563138|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154563139|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563140|NCT04595994|Gemcitabine|gemcitabine|mesh-list
154563141|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154563142|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
154563143|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563144|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563145|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154563146|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154563147|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154563148|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
154563149|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563150|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154563151|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154563152|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563153|NCT04465487|Cemiplimab|cemiplimab|mesh-list
154563154|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563155|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563156|NCT04434040|Atezolizumab|atezolizumab|mesh-list
154563157|NCT04434040|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154563158|NCT04434040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154563159|NCT04434040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563160|NCT04434040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563161|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563162|NCT04434040|Immunoconjugates|immunoconjugates|mesh-ancestor
154563163|NCT04434040|Immunologic Factors|immunologic factors|mesh-ancestor
154563164|NCT04434040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563165|NCT04385940|Vitamin D|vitamin d|mesh-list
154563166|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
154563167|NCT04385940|Vitamins|vitamins|mesh-ancestor
154563168|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
154563169|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563170|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154563171|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154563172|NCT04379635|Paclitaxel|paclitaxel|mesh-list
154563173|NCT04379635|Carboplatin|carboplatin|mesh-list
154563174|NCT04379635|Pemetrexed|pemetrexed|mesh-list
154563175|NCT04379635|Tislelizumab|tislelizumab|mesh-list
154563176|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154563177|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563178|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
154563179|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
154563180|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
154563181|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563182|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563183|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154563184|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154563185|NCT04379635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563186|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154563187|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154563188|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154563189|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154563190|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563191|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
154563192|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563193|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563194|NCT04342585|Progesterone|progesterone|mesh-list
154563195|NCT04342585|Progestins|progestins|mesh-ancestor
154563196|NCT04342585|Hormones|hormones|mesh-ancestor
154563197|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563198|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563199|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
154563200|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
154563201|NCT04339777|Busulfan|busulfan|mesh-list
154563202|NCT04339777|Fludarabine|fludarabine|mesh-list
154563203|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
154563204|NCT04339777|Tacrolimus|tacrolimus|mesh-list
154862088|NCT02574078|Carboplatin|carboplatin|mesh-list
154563205|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563206|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
154563207|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563208|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154563209|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154563210|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
154563211|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563212|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563213|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154563214|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154563215|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563216|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154563217|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154563218|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
154563219|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154563220|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563221|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563222|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
154563223|NCT04245423|Narcotics|narcotics|mesh-ancestor
154142329|NCT06026553|Ketorolac|ketorolac|mesh-list
154563224|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563225|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563226|NCT04245423|Analgesics|analgesics|mesh-ancestor
154563227|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
154563228|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563230|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
154563231|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563232|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154563233|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154563234|NCT04226690|Analgesics|analgesics|mesh-ancestor
154563235|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
154563236|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563237|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154563238|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154563239|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563240|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563241|NCT04226690|Hormones|hormones|mesh-ancestor
154563242|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563243|NCT04221477|Acetaminophen|acetaminophen|mesh-list
154563244|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
154563245|NCT04221477|Promethazine|promethazine|mesh-list
154563246|NCT04221477|Prednisone|prednisone|mesh-list
154563247|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
154563248|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
154563249|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563250|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
154563251|NCT04221477|Hormones|hormones|mesh-ancestor
154563252|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563253|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563254|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154563255|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563256|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154563257|NCT04221477|Analgesics|analgesics|mesh-ancestor
154563258|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
154563259|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563260|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
154563261|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
154563262|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
154563263|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154563264|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154563265|NCT04221477|Protective Agents|protective agents|mesh-ancestor
154563266|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563267|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154563268|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154563269|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563270|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
154563271|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
154563272|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154563273|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
154563274|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
154563275|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563276|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563277|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154563278|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
153583459|NCT01755923|Gefitinib|gefitinib|mesh-list
154563279|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
154563280|NCT04183205|Sertraline|sertraline|mesh-list
154563281|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
154563282|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154563283|NCT04183205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154563284|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154563285|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154563286|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563287|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563288|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
154563289|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563290|NCT04138706|Vancomycin|vancomycin|mesh-list
154563291|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154563292|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563293|NCT04098718|Prednisolone|prednisolone|mesh-list
154563294|NCT04098718|Benralizumab|benralizumab|mesh-list
154563295|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563296|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
154563297|NCT04098718|Hormones|hormones|mesh-ancestor
154563298|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563299|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563300|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154563301|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563302|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154563303|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
154563304|NCT04024696|Abexinostat|abexinostat|mesh-list
154563305|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154563306|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563307|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563308|NCT03940352|Venetoclax|venetoclax|mesh-list
154563309|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563310|NCT03936153|Abexinostat|abexinostat|mesh-list
154563311|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154563312|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563313|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563314|NCT03934567|Abexinostat|abexinostat|mesh-list
154563315|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154563316|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563317|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563318|NCT03877809|Sirolimus|sirolimus|mesh-list
154563319|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154563320|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563321|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154563322|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563323|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
154563324|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563325|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
154563326|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563327|NCT03834688|Rituximab|rituximab|mesh-list
154563328|NCT03834688|Venetoclax|venetoclax|mesh-list
154563329|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154563330|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563331|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563332|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
154563333|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563334|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154563335|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154563336|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
154563337|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563338|NCT03808961|Vitamins|vitamins|mesh-list
154563339|NCT03808961|Niacin|niacin|mesh-list
154563340|NCT03808961|Niacinamide|niacinamide|mesh-list
154563341|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
154563342|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
154563343|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
154563344|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563345|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154563346|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
154563347|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563348|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154563349|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
154563350|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
154563351|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154563352|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563353|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563354|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563356|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
154563357|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154563358|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154563359|NCT03703778|Androgens|androgens|mesh-list
154563360|NCT03703778|Hormones|hormones|mesh-ancestor
154563361|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563362|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563363|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
154563364|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563365|NCT03703778|Protective Agents|protective agents|mesh-ancestor
154563366|NCT03703778|Vitamins|vitamins|mesh-ancestor
154563367|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
154563368|NCT03703778|Estrogens|estrogens|mesh-ancestor
154563369|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154563370|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563371|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
154563372|NCT03637543|Nivolumab|nivolumab|mesh-list
154563373|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563374|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563375|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154563376|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563377|NCT03600441|Abexinostat|abexinostat|mesh-list
154563378|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154563379|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563380|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563381|NCT03592472|Abexinostat|abexinostat|mesh-list
154563382|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154563383|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563384|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563385|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154563386|NCT03583528|Edotreotide|edotreotide|mesh-list
154563387|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154563388|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563389|NCT03551964|Ticagrelor|ticagrelor|mesh-list
154563390|NCT03551964|Cangrelor|cangrelor|mesh-list
154142500|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154563391|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154563392|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154563393|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154563394|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154563395|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
154563396|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563397|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563398|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563399|NCT03543813|CX-2029|cx-2029|mesh-list
154563400|NCT03543813|Immunoconjugates|immunoconjugates|mesh-ancestor
154563401|NCT03543813|Immunologic Factors|immunologic factors|mesh-ancestor
154563402|NCT03543813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563403|NCT03527537|Insulin|insulin|mesh-list
154563404|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563405|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563406|NCT03520790|Paclitaxel|paclitaxel|mesh-list
154563407|NCT03520790|Gemcitabine|gemcitabine|mesh-list
154563408|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154563409|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563410|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
154563411|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
154563412|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
154563413|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563414|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154563415|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
154563416|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
154563417|NCT03511391|Nivolumab|nivolumab|mesh-list
154563418|NCT03511391|Atezolizumab|atezolizumab|mesh-list
154563419|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154563420|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563421|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563422|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563423|NCT03486834|Vaccines|vaccines|mesh-list
154563424|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
154563425|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563426|NCT03482167|Niacinamide|niacinamide|mesh-list
154563427|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
154563428|NCT03482167|Vitamins|vitamins|mesh-ancestor
154563429|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
154563430|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563431|NCT03312738|Everolimus|everolimus|mesh-list
154563432|NCT03312738|Exemestane|exemestane|mesh-list
154563433|NCT03312738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154563434|NCT03312738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154563435|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563436|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563437|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563438|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
154563439|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563440|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563441|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154563442|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154563443|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154563444|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
154563445|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563446|NCT03297359|Dalteparin|dalteparin|mesh-list
154563447|NCT03297359|Tinzaparin|tinzaparin|mesh-list
154563448|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154563449|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
154563450|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154563451|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154563452|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563453|NCT03284866|Vaccines|vaccines|mesh-list
154563454|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
154563455|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563456|NCT03268954|Azacitidine|azacitidine|mesh-list
154563457|NCT03268954|Pevonedistat|pevonedistat|mesh-list
154563458|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154563459|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
154563460|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563461|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563462|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563463|NCT03242382|Palbociclib|palbociclib|mesh-list
154563464|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563465|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154563466|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563467|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563468|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
154563469|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563470|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563471|NCT03196232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154563472|NCT03196232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563473|NCT03120624|Iodine|iodine|mesh-list
154563474|NCT03120624|Interferons|interferons|mesh-list
154563475|NCT03120624|Interferon-beta|interferon-beta|mesh-list
154563476|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
154563477|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563478|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
154563479|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563480|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
154563481|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563482|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154563483|NCT03120624|Trace Elements|trace elements|mesh-ancestor
154563484|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
154563485|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154563486|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563487|NCT03117933|Paclitaxel|paclitaxel|mesh-list
154563488|NCT03117933|Olaparib|olaparib|mesh-list
154563489|NCT03117933|Cediranib|cediranib|mesh-list
154563490|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154563491|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563492|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
154563493|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
154563494|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
154563495|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563496|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154563497|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563498|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154563499|NCT03114527|Everolimus|everolimus|mesh-list
154563500|NCT03114527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154862089|NCT02574078|Gemcitabine|gemcitabine|mesh-list
154563501|NCT03114527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154563502|NCT03114527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563503|NCT03114527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563504|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563505|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
154563506|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563507|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563508|NCT03094663|Cefazolin|cefazolin|mesh-list
154563509|NCT03094663|Cephalosporins|cephalosporins|mesh-list
154563510|NCT03094663|Dexamethasone|dexamethasone|mesh-list
154563511|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
154563512|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
154563513|NCT03094663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154563514|NCT03094663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154563515|NCT03094663|Epinephrine|epinephrine|mesh-list
154563516|NCT03094663|Racepinephrine|racepinephrine|mesh-list
154563517|NCT03094663|Bupivacaine|bupivacaine|mesh-list
154563518|NCT03094663|Epinephryl borate|epinephryl borate|mesh-list
154563519|NCT03094663|BB 1101|bb 1101|mesh-list
154563520|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563521|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
154563522|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
154563523|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563524|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563525|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154563526|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
154563527|NCT03094663|Hormones|hormones|mesh-ancestor
154563528|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563529|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154563530|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563531|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
154563532|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563533|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563534|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
154563535|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
154563536|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563537|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
154563538|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154563539|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563540|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154563541|NCT03094663|Protective Agents|protective agents|mesh-ancestor
154563542|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154563543|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154563544|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
154563545|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563546|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154563547|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154563548|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154563549|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
154563551|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
154563552|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154563553|NCT02663622|Methotrexate|methotrexate|mesh-list
154563554|NCT02663622|Tacrolimus|tacrolimus|mesh-list
154563555|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154563556|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
154563557|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154563558|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563559|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154563560|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
154563561|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563562|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563563|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
154563564|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563565|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154563566|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563567|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
154563568|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154563569|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154563570|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154563571|NCT02650271|Tenofovir|tenofovir|mesh-list
154563572|NCT02650271|Entecavir|entecavir|mesh-list
154563573|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
154563574|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563575|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154563576|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154563577|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563578|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563579|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154563580|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154563581|NCT02649387|Ibrutinib|ibrutinib|mesh-list
154563582|NCT02649387|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154563583|NCT02649387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154563584|NCT02649387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563585|NCT02649387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563586|NCT02553473|Doxycycline|doxycycline|mesh-list
154563587|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154563588|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563589|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
154563590|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154563591|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154563592|NCT02169310|Raclopride|raclopride|mesh-list
154563593|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154563594|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154563595|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563596|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563597|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154563598|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154563599|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
154563600|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563601|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563602|NCT01722240|Liraglutide|liraglutide|mesh-list
154563603|NCT01722240|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154563604|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563605|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563606|NCT01722240|Incretins|incretins|mesh-ancestor
154563607|NCT01722240|Hormones|hormones|mesh-ancestor
154563608|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563609|NCT01190787|Prednisone|prednisone|mesh-list
154563610|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
154563611|NCT01190787|Melphalan|melphalan|mesh-list
154563612|NCT01190787|Bortezomib|bortezomib|mesh-list
154563613|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563614|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
154563615|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563616|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154563617|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154563618|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
154142725|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563619|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563620|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563621|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154563622|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563623|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
154563624|NCT01190787|Hormones|hormones|mesh-ancestor
154563625|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563626|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154563627|NCT01107717|Metformin|metformin|mesh-list
154563628|NCT01107717|Pioglitazone|pioglitazone|mesh-list
154563629|NCT01107717|Exenatide|exenatide|mesh-list
154563630|NCT01107717|Glyburide|glyburide|mesh-list
154563631|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563632|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563633|NCT01107717|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154563634|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154563635|NCT01107717|Incretins|incretins|mesh-ancestor
154563636|NCT01107717|Hormones|hormones|mesh-ancestor
154563637|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563638|NCT00978458|Temozolomide|temozolomide|mesh-list
154563639|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154563640|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
154563641|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563642|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563643|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
154563644|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
154563645|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154563646|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154563647|NCT00882895|Prednisolone|prednisolone|mesh-list
154563648|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
154563649|NCT00882895|Tacrolimus|tacrolimus|mesh-list
154563650|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
154563651|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154563652|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154563653|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
154563654|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563655|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
154563656|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862090|NCT02574078|Nivolumab|nivolumab|mesh-list
154862091|NCT02574078|Pemetrexed|pemetrexed|mesh-list
154563657|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154563658|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563659|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563660|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154563661|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563662|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154563663|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
154563664|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154563665|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563666|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563667|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
154563668|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
154563669|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563670|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142786|NCT04675151|Miotics|miotics|mesh-ancestor
154563671|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
154563672|NCT00882895|Hormones|hormones|mesh-ancestor
154563673|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563674|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154563675|NCT00882895|Protective Agents|protective agents|mesh-ancestor
154563676|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154563677|NCT00819546|Everolimus|everolimus|mesh-list
154563678|NCT00819546|Midostaurin|midostaurin|mesh-list
154563679|NCT00819546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154563680|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154563681|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563682|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563683|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563684|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
154563685|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563686|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563687|NCT04141904|Tofacitinib|tofacitinib|mesh-list
154563688|NCT04141904|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154563689|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154287530|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
154563690|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563691|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563693|NCT05527340|Dexamethasone|dexamethasone|mesh-list
154563694|NCT05527340|Daratumumab|daratumumab|mesh-list
154563695|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563696|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
154563697|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
154563698|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563699|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563700|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154563701|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
154563702|NCT05527340|Hormones|hormones|mesh-ancestor
154563703|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563704|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154563705|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563706|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
154563707|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154563708|NCT05527106|Vitamins|vitamins|mesh-ancestor
154563709|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
154563710|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563711|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
154563712|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563713|NCT05527106|Protective Agents|protective agents|mesh-ancestor
154563714|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
154563715|NCT05526794|Analgesics|analgesics|mesh-list
154563716|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
154563717|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563718|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563719|NCT05522894|Paclitaxel|paclitaxel|mesh-list
154563720|NCT05522894|Cisplatin|cisplatin|mesh-list
154563721|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154563722|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563723|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
154563724|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
154563725|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
154563726|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563727|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
154563728|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563729|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563730|NCT02573870|Fluticasone|fluticasone|mesh-list
154862092|NCT02574078|Crizotinib|crizotinib|mesh-list
154563733|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563734|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154563735|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
154563736|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563737|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563738|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154563739|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
154563740|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
154563741|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154563742|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
154563743|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154563744|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154563745|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154563746|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154563747|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
154563748|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563749|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563750|NCT05148026|Heparin|heparin|mesh-list
154563751|NCT05148026|Calcium heparin|calcium heparin|mesh-list
154563752|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
154563753|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
154563754|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154563755|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154563756|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563757|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154563758|NCT05522270|Mitogens|mitogens|mesh-list
154563759|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
154563760|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563761|NCT05522192|Venetoclax|venetoclax|mesh-list
154563762|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
154563763|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563764|NCT05522192|Analgesics|analgesics|mesh-ancestor
154563765|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
154563766|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563767|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563768|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154563769|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154563770|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563771|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563772|NCT05525234|Thalidomide|thalidomide|mesh-list
154563773|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563774|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
154563775|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563776|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
154563777|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154563778|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563779|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154563780|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154563781|NCT05525234|Growth Substances|growth substances|mesh-ancestor
154563782|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
154563783|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563784|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154563785|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154563786|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563787|NCT04295330|Lidocaine|lidocaine|mesh-list
154563788|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
154563789|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
154563790|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563791|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563792|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
154563793|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563794|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154563795|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154563796|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154563797|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154563798|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563799|NCT05525156|Aspirin|aspirin|mesh-list
154563800|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154563801|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154563802|NCT05525156|Analgesics|analgesics|mesh-ancestor
154563803|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
154563804|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862093|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154563805|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563806|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563807|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154563808|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154563809|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154563810|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563811|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154563812|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154563813|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563814|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
154563815|NCT05512130|Empagliflozin|empagliflozin|mesh-list
154563816|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154563817|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563818|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563819|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563820|NCT02180425|Adapalene|adapalene|mesh-list
154563821|NCT02180425|Tretinoin|tretinoin|mesh-list
154563822|NCT02180425|Isotretinoin|isotretinoin|mesh-list
154563823|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
154563824|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154563825|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154563826|NCT02180425|Analgesics|analgesics|mesh-ancestor
154563827|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
154563828|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563829|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563830|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563831|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154563832|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563833|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
154563834|NCT02183467|Linagliptin|linagliptin|mesh-list
154563835|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
154563836|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154563837|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563838|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154563839|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154563840|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563841|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563842|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154563843|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563844|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563845|NCT02183467|Incretins|incretins|mesh-ancestor
154563846|NCT02183467|Hormones|hormones|mesh-ancestor
154563847|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563848|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154563849|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
154563850|NCT02180503|Linagliptin|linagliptin|mesh-list
154563851|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563852|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563853|NCT02180503|Incretins|incretins|mesh-ancestor
154563854|NCT02180503|Hormones|hormones|mesh-ancestor
154563855|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563856|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154563857|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
154563858|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563859|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563861|NCT02177851|Trace Elements|trace elements|mesh-ancestor
154563862|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
154563863|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563864|NCT05075876|Granisetron|granisetron|mesh-list
154563865|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
154563866|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
154142974|NCT04198363|Antacids|antacids|mesh-ancestor
154563867|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563868|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563869|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154563870|NCT05075876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154563871|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154563872|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
154563873|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563874|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563875|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
154563876|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154563877|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563878|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563879|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154563880|NCT02180737|Analgesics|analgesics|mesh-ancestor
154563881|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
154563882|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563883|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154563884|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154563885|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154563886|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
154563887|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563888|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563889|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
154563890|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
154563891|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
154563892|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154563893|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
154563894|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
154563895|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563896|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563897|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563898|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154563899|NCT02183623|Linagliptin|linagliptin|mesh-list
154563900|NCT02183623|Simvastatin|simvastatin|mesh-list
154563901|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154563902|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154563903|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
154563904|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563905|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154143039|NCT03815929|Estradiol|estradiol|mesh-list
154563906|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154563907|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563908|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154563909|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563910|NCT02183623|Incretins|incretins|mesh-ancestor
154563911|NCT02183623|Hormones|hormones|mesh-ancestor
154563912|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563913|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154563914|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
154563915|NCT02183701|Losartan|losartan|mesh-list
154563916|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154563917|NCT02183701|Telmisartan|telmisartan|mesh-list
154563918|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154563919|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154563920|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154563921|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154563922|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563923|NCT02183701|Diuretics|diuretics|mesh-ancestor
154563924|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
154563925|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563926|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154563927|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154563928|NCT02183779|Fluconazole|fluconazole|mesh-list
154563929|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
154563930|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563931|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154563932|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154563933|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563934|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563935|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154563936|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
154563937|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563938|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563939|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154563940|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154563941|NCT02184091|Nevirapine|nevirapine|mesh-list
154563942|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154563943|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154563944|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563945|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563946|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
154563947|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154563948|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154563949|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154563950|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154563951|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154563952|NCT02184247|Theophylline|theophylline|mesh-list
154563953|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154563954|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
154563955|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563956|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563957|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154563958|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
154563959|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154563960|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563961|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563962|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
154563963|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154563964|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154563965|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
154563966|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154563967|NCT04292756|Triamcinolone|triamcinolone|mesh-list
154563968|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154563969|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154563970|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154563971|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154563972|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
154563973|NCT04292756|Hormones|hormones|mesh-ancestor
154563974|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154563975|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563976|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154563977|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
154563978|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154563979|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154563980|NCT05074706|Antibodies|antibodies|mesh-list
154563981|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
154563982|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
154563983|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563984|NCT02181205|Bupivacaine|bupivacaine|mesh-list
154563985|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
154563986|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
154563987|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563988|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563989|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
154563990|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563991|NCT02184559|Ropivacaine|ropivacaine|mesh-list
154563992|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
154563993|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
154563994|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154563995|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154563996|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
154563997|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154563999|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564000|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564001|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154564002|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154564003|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
154564004|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564005|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154564006|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154564007|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564008|NCT02181361|Aspirin|aspirin|mesh-list
154564009|NCT02181361|Hirudins|hirudins|mesh-list
154564010|NCT02181361|Warfarin|warfarin|mesh-list
154564011|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564012|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564013|NCT02181361|Analgesics|analgesics|mesh-ancestor
154564014|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
154564015|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564016|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564017|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564018|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564019|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154564020|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154564021|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564022|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154564023|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154564024|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564025|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
154564026|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
154564028|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154564029|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
154564030|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
154564031|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
154564032|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564033|NCT02184637|Lumefantrine|lumefantrine|mesh-list
154564034|NCT02184637|Artemether|artemether|mesh-list
154564035|NCT02184637|Piperaquine|piperaquine|mesh-list
154564036|NCT02184637|Artenimol|artenimol|mesh-list
154564037|NCT02184637|Tafenoquine|tafenoquine|mesh-list
154564038|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154564039|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
154564040|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154564041|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154564042|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564043|NCT04870424|Colchicine|colchicine|mesh-list
154564044|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
154564045|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564046|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
154564047|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
154564048|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
154564049|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564050|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564051|NCT03536845|Vitamin D|vitamin d|mesh-list
154564052|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
154564053|NCT03536845|Vitamins|vitamins|mesh-ancestor
154564054|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
154564055|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564056|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154564057|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154564058|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154564059|NCT02181985|Heparin|heparin|mesh-list
154564060|NCT02181985|Enoxaparin|enoxaparin|mesh-list
154564061|NCT02181985|Tenecteplase|tenecteplase|mesh-list
154564062|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154564063|NCT02181985|Abciximab|abciximab|mesh-list
154564064|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
154564065|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154564066|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154564067|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564068|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154564069|NCT05514080|Insulin|insulin|mesh-list
154564070|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154564071|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564072|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154564073|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154564074|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154564075|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
154564076|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564077|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154564078|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154564079|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564080|NCT02186119|Ranibizumab|ranibizumab|mesh-list
154564081|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154564082|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154564083|NCT02186119|Growth Substances|growth substances|mesh-ancestor
154564084|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564085|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
154564086|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564087|NCT02185261|Interferons|interferons|mesh-list
154564088|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
154564089|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
154143194|NCT02809690|Clevudine|clevudine|mesh-list
154564090|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564091|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
154564092|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564093|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
154564094|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564095|NCT02573012|Prednisone|prednisone|mesh-list
154564096|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564097|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
154564098|NCT02573012|Hormones|hormones|mesh-ancestor
154564099|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154564100|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564101|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154564102|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564103|NCT04128176|Omalizumab|omalizumab|mesh-list
154564104|NCT04128176|Rituximab|rituximab|mesh-list
154564105|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154564106|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564107|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
154564108|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564109|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564110|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154564111|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154564112|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
154564113|NCT02186275|Vitamin D|vitamin d|mesh-list
154564114|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
154564115|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
154564116|NCT02186275|Vitamins|vitamins|mesh-list
154564117|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
154564118|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564119|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154564120|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154564121|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
154564122|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
154564123|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
154564124|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564125|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564126|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
154564127|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564128|NCT04411706|Capecitabine|capecitabine|mesh-list
154564129|NCT04411706|Apatinib|apatinib|mesh-list
154564130|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154564131|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
154564132|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564133|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564134|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154564135|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564136|NCT05518994|Bevacizumab|bevacizumab|mesh-list
154564137|NCT05518994|Tislelizumab|tislelizumab|mesh-list
154564138|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154564139|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564140|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154564141|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154564142|NCT05518994|Growth Substances|growth substances|mesh-ancestor
154564143|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564144|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
154564146|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154564147|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154564148|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
154564149|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154564150|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564151|NCT02256943|Analgesics|analgesics|mesh-ancestor
154564152|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
154564153|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143252|NCT01797523|Letrozole|letrozole|mesh-list
154564154|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564155|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154564156|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154564157|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564158|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564159|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
154564160|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564161|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154564162|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154564163|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
154564164|NCT02256943|Urological Agents|urological agents|mesh-ancestor
154564165|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154564166|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564167|NCT05059951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154564168|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564169|NCT02186899|Anesthetics|anesthetics|mesh-list
154564170|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564171|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564172|NCT05510024|Immunomodulating Agents|immunomodulating agents|mesh-list
154564173|NCT05510024|Immunologic Factors|immunologic factors|mesh-ancestor
154564174|NCT05510024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564175|NCT02752633|Allopurinol|allopurinol|mesh-list
154564176|NCT02752633|Febuxostat|febuxostat|mesh-list
154564177|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
154564178|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564179|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564180|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
154564181|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564182|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154564183|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
154564184|NCT02752633|Protective Agents|protective agents|mesh-ancestor
154564185|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564186|NCT02191189|Nevirapine|nevirapine|mesh-list
154564187|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154564188|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154564189|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564190|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564191|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
154564192|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564193|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154564194|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154564195|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154564196|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154564197|NCT02187133|Rituximab|rituximab|mesh-list
154564198|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154564199|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154564200|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564201|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
154564202|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564203|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564204|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154564205|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
154564206|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564207|NCT04411862|Choline|choline|mesh-list
154564208|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
154564209|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154564210|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
154564211|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564212|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564213|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154564214|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
154564215|NCT02187211|Minocycline|minocycline|mesh-list
154564216|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154564217|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564218|NCT04766996|Aspirin|aspirin|mesh-list
154564219|NCT04766996|Acetaminophen|acetaminophen|mesh-list
154564220|NCT04766996|Prednisone|prednisone|mesh-list
154564221|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154564222|NCT04766996|Meloxicam|meloxicam|mesh-list
154564223|NCT04766996|Diclofenac|diclofenac|mesh-list
154564224|NCT04766996|Lidocaine|lidocaine|mesh-list
154564225|NCT04766996|Pregabalin|pregabalin|mesh-list
154564226|NCT04766996|Tramadol|tramadol|mesh-list
154564227|NCT04766996|Bupivacaine|bupivacaine|mesh-list
154564228|NCT04766996|Propofol|propofol|mesh-list
154564229|NCT04766996|Omeprazole|omeprazole|mesh-list
154564230|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
154564231|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
154564232|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
154564233|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564234|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564235|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
154564236|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564237|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154564238|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154564239|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154564240|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564241|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564242|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564243|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
154564244|NCT04766996|Hormones|hormones|mesh-ancestor
154564245|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154564246|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154564247|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564248|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154564249|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154564250|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
154564251|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564252|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564253|NCT04766996|Analgesics|analgesics|mesh-ancestor
154564254|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564255|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154564256|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154564257|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154564258|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154564259|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564260|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
154564261|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564262|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
154564263|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154564264|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154564265|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154564266|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154564267|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154564268|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154564269|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
154564270|NCT04766996|Coagulants|coagulants|mesh-ancestor
154564271|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154564272|NCT04766996|Narcotics|narcotics|mesh-ancestor
154564273|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154564274|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154564275|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154564276|NCT02191423|Oxytocin|oxytocin|mesh-list
154564277|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
154564278|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154564279|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564280|NCT05509946|Celecoxib|celecoxib|mesh-list
154564281|NCT05509946|Pregabalin|pregabalin|mesh-list
154564282|NCT05509946|Analgesics|analgesics|mesh-ancestor
154564283|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
154564284|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564285|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564286|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
154564287|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154564288|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564289|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564290|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154564291|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154564292|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154564293|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564294|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154564295|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564296|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564297|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564298|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564299|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154564300|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154564301|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564302|NCT04304209|Capecitabine|capecitabine|mesh-list
154564303|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
154564304|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154564305|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
154564306|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564307|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564308|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
154564309|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154564310|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
154564311|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564312|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564313|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154564314|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
154564315|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564316|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564317|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154564318|NCT02187445|Budesonide|budesonide|mesh-list
154564319|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564320|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154564321|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
154564322|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564323|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564324|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154564325|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
154564326|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
154564327|NCT02187445|Hormones|hormones|mesh-ancestor
154564328|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154564329|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154564330|NCT02187523|Telmisartan|telmisartan|mesh-list
154564331|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154564332|NCT02187523|Diuretics|diuretics|mesh-ancestor
154564333|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
154564334|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564335|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154564336|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564337|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564338|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154564339|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154564340|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154564341|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154564342|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154564343|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564344|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564345|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
154564346|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564347|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564348|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154564349|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564350|NCT05507606|Bevacizumab|bevacizumab|mesh-list
154564351|NCT05507606|Carboplatin|carboplatin|mesh-list
154564352|NCT05507606|Pemetrexed|pemetrexed|mesh-list
154564353|NCT05507606|Osimertinib|osimertinib|mesh-list
154564354|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154564355|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564356|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154564357|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154564358|NCT05507606|Growth Substances|growth substances|mesh-ancestor
154564359|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564360|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
154564361|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564362|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564363|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154564364|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154564365|NCT05507606|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154564366|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154564368|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154564369|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
154564370|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
154564371|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564372|NCT02191891|Afatinib|afatinib|mesh-list
154564373|NCT02191891|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154564374|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154564375|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564376|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564377|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564378|NCT05507372|Pimozide|pimozide|mesh-list
154564379|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154564380|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154564381|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564382|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564383|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154564384|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154564385|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
154564386|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564387|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564388|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154564389|NCT02192203|Diclofenac|diclofenac|mesh-list
154564390|NCT02192203|Menthol|menthol|mesh-list
154564391|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564392|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564393|NCT02192203|Analgesics|analgesics|mesh-ancestor
154564394|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
154564395|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564396|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564397|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564398|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564399|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154564400|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564401|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564402|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
154564403|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
154564404|NCT02257021|Ritonavir|ritonavir|mesh-list
154564405|NCT02257021|Tipranavir|tipranavir|mesh-list
154862094|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564406|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154564407|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154564408|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
154564409|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564410|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564411|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154564412|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154564413|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
154564414|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564415|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154564416|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154564417|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
154564419|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564420|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564421|NCT03536065|Analgesics|analgesics|mesh-ancestor
154564422|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
154564423|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564424|NCT02192827|Dexamethasone|dexamethasone|mesh-list
154564425|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
154564426|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154564427|NCT02192827|BB 1101|bb 1101|mesh-list
154564428|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564429|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
154564430|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
154564431|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143541|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
154564432|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564433|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564434|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
154564435|NCT02192827|Hormones|hormones|mesh-ancestor
154564436|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154564437|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154564438|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564439|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
154564440|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564441|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564443|NCT02188225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154564444|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154564445|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564446|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564447|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564448|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
154564449|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564450|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154564451|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
154564452|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154564453|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154564454|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154564455|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564456|NCT04535089|Lidocaine|lidocaine|mesh-list
154564457|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
154564458|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
154564459|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
154564460|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564461|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564462|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
154564463|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564464|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154564465|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154564466|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154564467|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564468|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564469|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154564470|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564471|NCT04535089|Analgesics|analgesics|mesh-ancestor
154564472|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154564473|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154564474|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154564475|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
154564476|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564477|NCT02188537|Nelfinavir|nelfinavir|mesh-list
154564478|NCT02188537|Dexamethasone|dexamethasone|mesh-list
154564479|NCT02188537|Bortezomib|bortezomib|mesh-list
154862095|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
154564480|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862096|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
154564481|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
154564482|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
154564483|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564484|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564485|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564486|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
154564487|NCT02188537|Hormones|hormones|mesh-ancestor
154564488|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154564489|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154564490|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564491|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154564492|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154564493|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
154564494|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564495|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564496|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154564497|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154564498|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
154564499|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564500|NCT03535051|Tacrolimus|tacrolimus|mesh-list
154564501|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154564502|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
154564503|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564504|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154564505|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564506|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564507|NCT02188615|Vinorelbine|vinorelbine|mesh-list
154564508|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564509|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154564510|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
154564511|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
154564512|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
154288367|NCT04292730|Remdesivir|remdesivir|mesh-list
154564513|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564514|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
154564515|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154564516|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
154564517|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564518|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
154564519|NCT02188771|Protective Agents|protective agents|mesh-ancestor
154564520|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
154564521|NCT02194075|Methylphenidate|methylphenidate|mesh-list
154564522|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154564523|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564524|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154564525|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154564526|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564527|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564528|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
154564529|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564530|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154564531|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154564532|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564533|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154564534|NCT02194075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154564535|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
154564536|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154564537|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
154564538|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154564539|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154564540|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564541|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154564542|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154564543|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154564544|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564545|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154564546|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
154564547|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564548|NCT03534973|Caffeine|caffeine|mesh-list
154564549|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154564550|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564551|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154564552|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143667|NCT02224391|Nicotine|nicotine|mesh-list
154564553|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564554|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154564555|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154564556|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
154564557|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564558|NCT03534895|Midazolam|midazolam|mesh-list
154564559|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
154564560|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564561|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564562|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154564563|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154564564|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154564565|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154564566|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154564567|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154564568|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
154564569|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
154564570|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
154564571|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564572|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564573|NCT03535753|Decitabine|decitabine|mesh-list
154564574|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154564575|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
154564576|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564577|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564578|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564579|NCT02189395|Insulin|insulin|mesh-list
154564580|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
154564581|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154564582|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154564583|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564584|NCT03535519|Methotrexate|methotrexate|mesh-list
154288438|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154564585|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154564586|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
154564587|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154564588|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564589|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154564590|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
154564591|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564592|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564593|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
154564594|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564595|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154564596|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154564597|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
154564598|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564599|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154564600|NCT02194153|Tenecteplase|tenecteplase|mesh-list
154564601|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154564602|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154564603|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564604|NCT02194231|Trabectedin|trabectedin|mesh-list
154564605|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154564606|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
154564607|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564608|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564609|NCT02933671|Ropivacaine|ropivacaine|mesh-list
154564610|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
154564611|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
154564612|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564613|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564614|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
154564615|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564617|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154564618|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564619|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154564620|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564621|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564622|NCT05509478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154564623|NCT02194309|Amlodipine|amlodipine|mesh-list
154564625|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154564626|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154564627|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154564628|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564629|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154564630|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564631|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
154564632|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154564633|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154564634|NCT04392505|Durvalumab|durvalumab|mesh-list
154564635|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154564636|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564637|NCT05502458|Propofol|propofol|mesh-list
154564638|NCT05502458|Desflurane|desflurane|mesh-list
154564639|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154564640|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564641|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564642|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154564643|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
154564644|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
154564645|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154564646|NCT03534037|Febuxostat|febuxostat|mesh-list
154564647|NCT03534037|Benzbromarone|benzbromarone|mesh-list
154564648|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
154564649|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564650|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
154564651|NCT03533959|Alirocumab|alirocumab|mesh-list
154564652|NCT03533959|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154564653|NCT03533959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154564654|NCT03533959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154564655|NCT03533959|Antimetabolites|antimetabolites|mesh-ancestor
154564656|NCT03533959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564657|NCT03533959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154288518|NCT02335060|Hormones|hormones|mesh-ancestor
154564658|NCT03533959|Protease Inhibitors|protease inhibitors|mesh-ancestor
154564659|NCT03533959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564660|NCT03533959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154564661|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154564662|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564663|NCT02567708|Nemiralisib|nemiralisib|mesh-list
154564664|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154564665|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564666|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564667|NCT05509244|Acetaminophen|acetaminophen|mesh-list
154564668|NCT05509244|Ibuprofen|ibuprofen|mesh-list
154143788|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
154564669|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564670|NCT05509244|Analgesics|analgesics|mesh-ancestor
154564671|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
154564672|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564673|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564674|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
154564675|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564676|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564677|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564678|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154564679|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564680|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564681|NCT05502068|Vitamin D|vitamin d|mesh-list
154564682|NCT05502068|Vitamins|vitamins|mesh-ancestor
154564683|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
154564684|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564685|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154564686|NCT02194777|Olcegepant|olcegepant|mesh-list
154564687|NCT02194777|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154564688|NCT02194777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564689|NCT02194777|Analgesics|analgesics|mesh-ancestor
154564690|NCT02194777|Sensory System Agents|sensory system agents|mesh-ancestor
154564691|NCT02194777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564692|NCT02194777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564693|NCT02030977|Resveratrol|resveratrol|mesh-list
154564694|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
154564695|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564696|NCT02030977|Protective Agents|protective agents|mesh-ancestor
154564697|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564698|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564699|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154564700|NCT02194855|Rocuronium|rocuronium|mesh-list
154564701|NCT02194855|Cisatracurium|cisatracurium|mesh-list
154564702|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154564703|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154564704|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154564705|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564706|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564707|NCT03534661|Teduglutide|teduglutide|mesh-list
154564708|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154564709|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564710|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564711|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564712|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154564713|NCT03534661|Protective Agents|protective agents|mesh-ancestor
154564714|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564715|NCT02562716|Paclitaxel|paclitaxel|mesh-list
154564716|NCT02562716|Camptothecin|camptothecin|mesh-list
154564717|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154564718|NCT02562716|Gemcitabine|gemcitabine|mesh-list
154564719|NCT02562716|Fluorouracil|fluorouracil|mesh-list
154564720|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
154564721|NCT02562716|Irinotecan|irinotecan|mesh-list
154564722|NCT02562716|Pancrelipase|pancrelipase|mesh-list
154564723|NCT02562716|Pancreatin|pancreatin|mesh-list
154564724|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154564725|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564726|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
154564727|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
154564728|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
154564729|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564730|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154564731|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
154564732|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154288591|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
154564733|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
154564734|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564735|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154564736|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154564737|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564738|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564739|NCT02031211|Etanercept|etanercept|mesh-list
154564740|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564741|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564742|NCT02031211|Analgesics|analgesics|mesh-ancestor
154564743|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
154564744|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564745|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564746|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564747|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564748|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564749|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154564750|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
154564751|NCT02195089|Vaccines|vaccines|mesh-list
154564752|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
154564753|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564754|NCT02031289|Folic Acid|folic acid|mesh-list
154564755|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
154564756|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
154564757|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
154564758|NCT02031289|Vitamins|vitamins|mesh-ancestor
154564759|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
154564760|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564761|NCT02031289|Hematinics|hematinics|mesh-ancestor
154564762|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
154564763|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
154564764|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154564765|NCT02197741|Narcotics|narcotics|mesh-ancestor
154564766|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564767|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564768|NCT02197741|Analgesics|analgesics|mesh-ancestor
154564769|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
154564770|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564771|NCT02196493|Azithromycin|azithromycin|mesh-list
154564772|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154564773|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564774|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
154564775|NCT03533803|Indomethacin|indomethacin|mesh-list
154564776|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564777|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564778|NCT03533803|Analgesics|analgesics|mesh-ancestor
154564779|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
154564780|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143898|NCT00519285|Prednisone|prednisone|mesh-list
154564781|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564782|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564783|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564784|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
154564785|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
154564786|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154564787|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154564788|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564789|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564790|NCT02198209|Liraglutide|liraglutide|mesh-list
154564791|NCT02198209|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154564792|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154564793|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564794|NCT02198209|Incretins|incretins|mesh-ancestor
154564796|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154564797|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154564798|NCT02195557|Hylan|hylan|mesh-list
154564799|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
154564800|NCT02195557|Protective Agents|protective agents|mesh-ancestor
154564801|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564802|NCT02195635|Octreotide|octreotide|mesh-list
154564803|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564804|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154564805|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564806|NCT03534505|Ketorolac|ketorolac|mesh-list
154564807|NCT03534505|Bupivacaine|bupivacaine|mesh-list
154564808|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
154564809|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
154564810|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564811|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564812|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
154564813|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564814|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564815|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564816|NCT03534505|Analgesics|analgesics|mesh-ancestor
154564817|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564818|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564819|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154564820|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564821|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564822|NCT02195791|Pioglitazone|pioglitazone|mesh-list
154564823|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154564824|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564826|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154564827|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154564828|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
154564829|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564830|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154564831|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
154564832|NCT02196805|Protective Agents|protective agents|mesh-ancestor
154564833|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564834|NCT02198443|Ritonavir|ritonavir|mesh-list
154564835|NCT02198443|Lopinavir|lopinavir|mesh-list
154564836|NCT02198443|Tenofovir|tenofovir|mesh-list
154564837|NCT02198443|Emtricitabine|emtricitabine|mesh-list
154564838|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154564839|NCT02198443|Cobicistat|cobicistat|mesh-list
154564840|NCT02198443|Elvitegravir|elvitegravir|mesh-list
154564841|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154564842|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154564843|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
154564844|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564845|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564846|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154564847|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154564848|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
154564849|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564850|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154564851|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154564852|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154564853|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154564854|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154564855|NCT03533179|Glucagon|glucagon|mesh-list
154564856|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154564857|NCT03533179|Esmolol|esmolol|mesh-list
154564858|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564859|NCT03533179|Hormones|hormones|mesh-ancestor
154564860|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154564861|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564862|NCT03533179|Incretins|incretins|mesh-ancestor
154564863|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154564864|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154564865|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154564866|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
154564867|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564868|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564869|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154564870|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
154564871|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564872|NCT05261971|Etodolac|etodolac|mesh-list
154564873|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154564874|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154564875|NCT05261971|Analgesics|analgesics|mesh-ancestor
154564876|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
154564877|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564878|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564879|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564880|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564881|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154564882|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154144025|NCT00453310|Sunitinib|sunitinib|mesh-list
154564883|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564884|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564885|NCT02201563|Minocycline|minocycline|mesh-list
154564886|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154564887|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564888|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154564889|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154564890|NCT02206477|Protective Agents|protective agents|mesh-ancestor
154564891|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564892|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154564893|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
154564894|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564895|NCT02201641|Calcium|calcium|mesh-list
154564896|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154564897|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564898|NCT02206555|Tenofovir|tenofovir|mesh-list
154564899|NCT02206555|Emtricitabine|emtricitabine|mesh-list
154564900|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154564901|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
154564902|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564903|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154564904|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154564905|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564906|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564907|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154564908|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154564909|NCT02206711|BMS-955176|bms-955176|mesh-list
154564910|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154564911|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154564912|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
154564913|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564914|NCT02202187|Gepotidacin|gepotidacin|mesh-list
154564915|NCT02202187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154564916|NCT02202187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564917|NCT02202187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564918|NCT02202187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564919|NCT02206789|Cyclosporine|cyclosporine|mesh-list
154564920|NCT02206789|Prednisolone|prednisolone|mesh-list
154564921|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154564922|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
154564923|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154564924|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
154564925|NCT02206789|Cyclosporins|cyclosporins|mesh-list
154862097|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
154564926|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154564927|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
154564928|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564929|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564930|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154564931|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
154564932|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564933|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
154564934|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564935|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
154564936|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564937|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154564938|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564939|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
154564940|NCT02206789|Hormones|hormones|mesh-ancestor
154564941|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154564942|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154564943|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564944|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
154564945|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
154144056|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154564946|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564947|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154564948|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154564949|NCT02206789|Protective Agents|protective agents|mesh-ancestor
154564950|NCT03892369|Ethanol|ethanol|mesh-list
154564951|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154564952|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154564953|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154564954|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564955|NCT02206867|Adalimumab|adalimumab|mesh-list
154564956|NCT02206867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154564957|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154564958|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154564959|NCT02751931|Mirabegron|mirabegron|mesh-list
154564960|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154564961|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154564962|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154564963|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
154564964|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154564965|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564966|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564967|NCT02751931|Urological Agents|urological agents|mesh-ancestor
154564968|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154564970|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
154564971|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154564972|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564973|NCT02199223|Panitumumab|panitumumab|mesh-list
154564974|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154564975|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564976|NCT02207335|Carboplatin|carboplatin|mesh-list
154564977|NCT02207335|Gemcitabine|gemcitabine|mesh-list
154564978|NCT02207335|Capecitabine|capecitabine|mesh-list
154564979|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154564980|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154564981|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
154564982|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564983|NCT02561078|Insulin|insulin|mesh-list
154564984|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154564985|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154564986|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564987|NCT02202889|Calcium|calcium|mesh-list
154564988|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154564989|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154564990|NCT04058197|Deferoxamine|deferoxamine|mesh-list
154564991|NCT04058197|Siderophores|siderophores|mesh-ancestor
154564992|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154564993|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
154564994|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
154564995|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154564996|NCT02202967|Misoprostol|misoprostol|mesh-list
154564997|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154564998|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
154564999|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154565000|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565001|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154565002|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565003|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
154565004|NCT05977647|Tamsulosin|tamsulosin|mesh-list
154565005|NCT05977647|Silodosin|silodosin|mesh-list
154565006|NCT05977647|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154565007|NCT05977647|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153524452|NCT01463735|Vitamin E|vitamin e|mesh-list
154565008|NCT05977647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154565009|NCT05977647|Adrenergic Agents|adrenergic agents|mesh-ancestor
154565010|NCT05977647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565011|NCT05977647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565012|NCT05977647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565013|NCT05977647|Urological Agents|urological agents|mesh-ancestor
154565014|NCT05977400|Gentamicins|gentamicins|mesh-list
154565015|NCT05977400|Ampicillin|ampicillin|mesh-list
154565016|NCT05977400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154565017|NCT05977400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565018|NCT05977400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154565019|NCT05977400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565020|NCT05977400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565021|NCT05977101|Antibodies|antibodies|mesh-list
154565022|NCT05977101|Immunoglobulins|immunoglobulins|mesh-list
154565023|NCT05977101|Antibodies, Blocking|antibodies, blocking|mesh-list
154565024|NCT05977101|Immunologic Factors|immunologic factors|mesh-ancestor
154565025|NCT05977101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565026|NCT05976932|Doxorubicin|doxorubicin|mesh-list
154565027|NCT05976932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154565028|NCT05976932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154565029|NCT05976932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565030|NCT05976932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154565031|NCT05976932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154565032|NCT05976932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565033|NCT05976932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288892|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
154565034|NCT05976893|Evolocumab|evolocumab|mesh-list
154565035|NCT05976893|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154565036|NCT05976893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154565037|NCT05976893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154565038|NCT05976893|Antimetabolites|antimetabolites|mesh-ancestor
154565039|NCT05976893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565040|NCT05976893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154565041|NCT05976893|Protease Inhibitors|protease inhibitors|mesh-ancestor
154565042|NCT05976893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565043|NCT05976893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154565044|NCT05976802|Budesonide|budesonide|mesh-list
154565045|NCT05976802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565046|NCT05976802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154565047|NCT05976802|Autonomic Agents|autonomic agents|mesh-ancestor
154565048|NCT05976802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565049|NCT05976802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565050|NCT05976802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154565051|NCT05976802|Respiratory System Agents|respiratory system agents|mesh-ancestor
154565052|NCT05976802|Glucocorticoids|glucocorticoids|mesh-ancestor
154565053|NCT05976802|Hormones|hormones|mesh-ancestor
154565054|NCT05976802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565055|NCT05976737|Levodopa|levodopa|mesh-list
154565056|NCT05976737|Carbidopa|carbidopa|mesh-list
154565057|NCT05976737|Entacapone|entacapone|mesh-list
154565058|NCT05976737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154565059|NCT05976737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154565060|NCT05976737|Dopamine Agents|dopamine agents|mesh-ancestor
154565061|NCT05976737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565062|NCT05976737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565063|NCT05976737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565064|NCT05976737|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154565065|NCT05976737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565066|NCT05976737|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154565067|NCT05976568|Bevacizumab|bevacizumab|mesh-list
154565068|NCT05976568|Capecitabine|capecitabine|mesh-list
154565069|NCT05976568|Oxaliplatin|oxaliplatin|mesh-list
154565070|NCT05976568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565071|NCT05976568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565072|NCT05976568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154565073|NCT05976568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154565074|NCT05976568|Growth Substances|growth substances|mesh-ancestor
154565075|NCT05976568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565076|NCT05976568|Growth Inhibitors|growth inhibitors|mesh-ancestor
154565077|NCT05976568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565078|NCT05976568|Antimetabolites|antimetabolites|mesh-ancestor
154565079|NCT05976568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565080|NCT05976438|Amlodipine|amlodipine|mesh-list
154565081|NCT05976438|Chlorthalidone|chlorthalidone|mesh-list
154565082|NCT05976438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154565083|NCT05976438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154565084|NCT05976438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154565085|NCT05976438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565086|NCT05976438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154565087|NCT05976438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565088|NCT05976438|Vasodilator Agents|vasodilator agents|mesh-ancestor
154565089|NCT05976438|Diuretics|diuretics|mesh-ancestor
154565090|NCT05976438|Natriuretic Agents|natriuretic agents|mesh-ancestor
154565091|NCT05976438|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154565092|NCT05976360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154565093|NCT05976360|Immunologic Factors|immunologic factors|mesh-ancestor
154565094|NCT05976360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565095|NCT05976152|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154565096|NCT05976152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154565097|NCT05976152|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154565098|NCT05976152|Protective Agents|protective agents|mesh-ancestor
154565099|NCT05976152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565100|NCT05976126|Trace Elements|trace elements|mesh-list
154565101|NCT05976126|Micronutrients|micronutrients|mesh-list
154565102|NCT05976126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565103|NCT05975996|Cyclophosphamide|cyclophosphamide|mesh-list
154565104|NCT05975996|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154565105|NCT05975996|Immunologic Factors|immunologic factors|mesh-ancestor
154565106|NCT05975996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565107|NCT05975996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288962|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
154565108|NCT05975996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154565109|NCT05975996|Alkylating Agents|alkylating agents|mesh-ancestor
154565110|NCT05975996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565111|NCT05975996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565112|NCT05975996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154565113|NCT05975944|Olaparib|olaparib|mesh-list
154565114|NCT05975944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154565115|NCT05975944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565116|NCT05975944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565117|NCT05975944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565118|NCT05975879|Vitamin D|vitamin d|mesh-list
154565119|NCT05975879|Cholecalciferol|cholecalciferol|mesh-list
154565120|NCT05975879|Vitamins|vitamins|mesh-list
154565121|NCT05975879|Dimethyl sulfone|dimethyl sulfone|mesh-list
154565122|NCT05975879|Micronutrients|micronutrients|mesh-ancestor
154565123|NCT05975879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565124|NCT05975879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154565125|NCT05975879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154565126|NCT05975879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565127|NCT05975866|Curcumin|curcumin|mesh-list
154565128|NCT05975866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154565129|NCT05975866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154565130|NCT05975866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154565131|NCT05975866|Analgesics|analgesics|mesh-ancestor
154565132|NCT05975866|Sensory System Agents|sensory system agents|mesh-ancestor
154565133|NCT05975866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565134|NCT05975866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565135|NCT05975866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565136|NCT05975866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565137|NCT05975866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565138|NCT05975866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565139|NCT05975528|Glimepiride|glimepiride|mesh-list
154565140|NCT05975528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154565141|NCT05975528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154565142|NCT05975528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154565143|NCT05975528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565144|NCT05975528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565145|NCT05975528|Immunologic Factors|immunologic factors|mesh-ancestor
154565146|NCT05975528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565147|NCT05974124|Chlorhexidine|chlorhexidine|mesh-list
154565148|NCT05974124|Povidone-Iodine|povidone-iodine|mesh-list
154565149|NCT05974124|Povidone|povidone|mesh-list
154565150|NCT05974124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154565151|NCT05974124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565152|NCT05974124|Disinfectants|disinfectants|mesh-ancestor
154565153|NCT05974124|Plasma Substitutes|plasma substitutes|mesh-ancestor
154565154|NCT05974124|Blood Substitutes|blood substitutes|mesh-ancestor
154565155|NCT05969054|Lacosamide|lacosamide|mesh-list
154565156|NCT05969054|Levetiracetam|levetiracetam|mesh-list
154565157|NCT05969054|Anticonvulsants|anticonvulsants|mesh-ancestor
154565158|NCT05969054|Nootropic Agents|nootropic agents|mesh-ancestor
154565159|NCT05969054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154565160|NCT05969054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154565161|NCT05969054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154565162|NCT05969054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565163|NCT05957107|Antibodies|antibodies|mesh-list
154565164|NCT05957107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154565165|NCT05957107|Immunologic Factors|immunologic factors|mesh-ancestor
154565166|NCT05957107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565167|NCT05866536|BCG Vaccine|bcg vaccine|mesh-list
154565168|NCT05866536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154565169|NCT05866536|Immunologic Factors|immunologic factors|mesh-ancestor
154565170|NCT05866536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565171|NCT05790525|Bismuth|bismuth|mesh-list
154565172|NCT05790525|Antacids|antacids|mesh-ancestor
154565173|NCT05790525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565174|NCT05790525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565175|NCT05667285|Sirolimus|sirolimus|mesh-list
154565176|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154565177|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565178|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154565179|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565180|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
154565181|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565182|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
154565183|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565184|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
154565185|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565186|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565187|NCT05642780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154565188|NCT05642780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565189|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
154565190|NCT05627635|Leucovorin|leucovorin|mesh-list
154565191|NCT05627635|Folic Acid|folic acid|mesh-list
154565192|NCT05627635|Bevacizumab|bevacizumab|mesh-list
154565193|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154565194|NCT05627635|Fluorouracil|fluorouracil|mesh-list
154565195|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
154565196|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
154565197|NCT05627635|Antibodies|antibodies|mesh-list
154565198|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
154565199|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154565200|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
154565201|NCT05627635|Calcium|calcium|mesh-list
154565202|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
154565203|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565204|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154565205|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154565206|NCT05627635|Growth Substances|growth substances|mesh-ancestor
154565207|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565208|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
154565209|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
154565210|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154565211|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154565212|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
154565213|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565214|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565215|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565216|NCT05627635|Antidotes|antidotes|mesh-ancestor
154565217|NCT05627635|Protective Agents|protective agents|mesh-ancestor
154565218|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
154565219|NCT05627635|Vitamins|vitamins|mesh-ancestor
154565220|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
154565221|NCT05627635|Hematinics|hematinics|mesh-ancestor
154565222|NCT05590598|Azelastine|azelastine|mesh-list
154565223|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154565224|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
154565225|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565226|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565227|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154565228|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
154565229|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154565230|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565231|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565232|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154565233|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154565234|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154565235|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
154565236|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
154565237|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565238|NCT05507775|Digoxin|digoxin|mesh-list
154565239|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154565240|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154565241|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565242|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565243|NCT05507775|Protective Agents|protective agents|mesh-ancestor
154565244|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565245|NCT05495945|Propofol|propofol|mesh-list
154565246|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154565247|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154565248|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565249|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154565250|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
154565251|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
154565252|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
154565253|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154565254|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154565255|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565256|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
154565257|NCT05441592|Coagulants|coagulants|mesh-ancestor
154565258|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
154565259|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154565260|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565261|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154289115|NCT03629054|Metformin|metformin|mesh-list
154565262|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565263|NCT05398094|Sotorasib|sotorasib|mesh-list
154565264|NCT05398094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154565265|NCT05398094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565266|NCT05398094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565267|NCT05398094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565268|NCT05331183|Ivacaftor|ivacaftor|mesh-list
154565269|NCT05331183|Elexacaftor|elexacaftor|mesh-list
154565270|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154565271|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154565272|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565273|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
154565274|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154565275|NCT05215236|Narcotics|narcotics|mesh-ancestor
154565276|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154565277|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565278|NCT05215236|Analgesics|analgesics|mesh-ancestor
154565279|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
154565280|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565281|NCT05157971|Cytarabine|cytarabine|mesh-list
154565282|NCT05157971|Prednisone|prednisone|mesh-list
154565283|NCT05157971|Cortisone|cortisone|mesh-list
154565284|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
154565285|NCT05157971|Methotrexate|methotrexate|mesh-list
154565286|NCT05157971|Vincristine|vincristine|mesh-list
154565287|NCT05157971|Daunorubicin|daunorubicin|mesh-list
154565288|NCT05157971|Venetoclax|venetoclax|mesh-list
154565289|NCT05157971|Asparaginase|asparaginase|mesh-list
154565290|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
154565291|NCT05157971|Pegaspargase|pegaspargase|mesh-list
154565292|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565293|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
154565294|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565295|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565296|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154565297|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
154565298|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565299|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565300|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154565301|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565302|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
154565303|NCT05157971|Hormones|hormones|mesh-ancestor
154565304|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565306|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154565307|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
154565308|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154565309|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565310|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
154565311|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
154565312|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565313|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154565314|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154565315|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
154565316|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565317|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565318|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565319|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565320|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565321|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154565322|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154565323|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154565324|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
154565325|NCT04972968|Hormones|hormones|mesh-ancestor
154565326|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565327|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565328|NCT04928651|Clonidine|clonidine|mesh-list
154565329|NCT04928651|Analgesics|analgesics|mesh-ancestor
154565330|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
154565331|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565332|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565333|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154565334|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
154565335|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
154565336|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154565337|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154565338|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154565339|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
154565340|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565341|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565342|NCT04916327|Antioxidants|antioxidants|mesh-list
154565343|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565344|NCT04916327|Protective Agents|protective agents|mesh-ancestor
154565345|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565346|NCT04875364|Eszopiclone|eszopiclone|mesh-list
154565347|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154565348|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154565349|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565350|NCT04848116|Nivolumab|nivolumab|mesh-list
154565351|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565352|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565353|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154565354|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565355|NCT04846829|Citalopram|citalopram|mesh-list
154565356|NCT04846829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154565357|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154565358|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154565359|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565360|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565361|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
154565362|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565363|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154565364|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
154565365|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154565366|NCT04825704|Bupivacaine|bupivacaine|mesh-list
154565367|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
154565368|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
154565369|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154565370|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565371|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
154565372|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565373|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154565374|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154565376|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
154565377|NCT04798469|Testosterone|testosterone|mesh-list
154565378|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
154565379|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
154565380|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154565381|NCT04798469|Androgens|androgens|mesh-ancestor
154565382|NCT04798469|Hormones|hormones|mesh-ancestor
154565383|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565384|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565385|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565386|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565387|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
154565388|NCT04758000|Metformin|metformin|mesh-list
154565389|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154565390|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565391|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154565392|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154565393|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154565394|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565395|NCT04659616|Cytarabine|cytarabine|mesh-list
154565396|NCT04659616|Daunorubicin|daunorubicin|mesh-list
154565397|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565398|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
154565399|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565400|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565401|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
154565402|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565403|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565404|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
154565405|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565406|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154565407|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154565408|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154565409|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289263|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
154565410|NCT04627870|Paclitaxel|paclitaxel|mesh-list
154565411|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565412|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565413|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565414|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565415|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565416|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565417|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
154565418|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154565419|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565420|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154565421|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565422|NCT04508790|Dexamethasone|dexamethasone|mesh-list
154565423|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
154565424|NCT04508790|Pomalidomide|pomalidomide|mesh-list
154565425|NCT04508790|Ichthammol|ichthammol|mesh-list
154565426|NCT04508790|BB 1101|bb 1101|mesh-list
154565427|NCT04508790|Leflunomide|leflunomide|mesh-list
154565428|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565429|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
154565430|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
154565431|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565432|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565433|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565434|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
154565435|NCT04508790|Hormones|hormones|mesh-ancestor
154565436|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565437|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565438|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565439|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
154565440|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565441|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565442|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
154565443|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154565444|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154565445|NCT04508790|Growth Substances|growth substances|mesh-ancestor
154565446|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
154565447|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
154255542|NCT03905018|Tadalafil|tadalafil|mesh-list
154565448|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565449|NCT04492566|Pancrelipase|pancrelipase|mesh-list
154565450|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565451|NCT04393389|Paclitaxel|paclitaxel|mesh-list
154565452|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565453|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565454|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565455|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565456|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565457|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565458|NCT04273061|Atezolizumab|atezolizumab|mesh-list
154565459|NCT04273061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154565460|NCT04273061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565461|NCT04273061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565462|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565463|NCT04140266|Tenofovir|tenofovir|mesh-list
154565464|NCT04140266|Emtricitabine|emtricitabine|mesh-list
154565465|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154565466|NCT04140266|Dapivirine|dapivirine|mesh-list
154565467|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
154565468|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565469|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154565470|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154565471|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565472|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565473|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154565474|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154565475|NCT04120415|Vedolizumab|vedolizumab|mesh-list
154565476|NCT04120415|Vaccines|vaccines|mesh-list
154565477|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
154565478|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565479|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565480|NCT04093570|Decitabine|decitabine|mesh-list
154565481|NCT04093570|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154565482|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565483|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
154565484|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565485|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565486|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565487|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154565488|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154565489|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565490|NCT03939520|Pirfenidone|pirfenidone|mesh-list
154565491|NCT03939520|Nintedanib|nintedanib|mesh-list
154565492|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565493|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154565494|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565495|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565496|NCT03939520|Analgesics|analgesics|mesh-ancestor
154565497|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
154565498|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565499|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565500|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154565501|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154565502|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565503|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565504|NCT03926143|Maytansine|maytansine|mesh-list
154565505|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
154565506|NCT03926143|Anetumab ravtansine|anetumab ravtansine|mesh-list
154565507|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565508|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565509|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565510|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565511|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565512|NCT03926143|Immunoconjugates|immunoconjugates|mesh-ancestor
154565513|NCT03926143|Immunologic Factors|immunologic factors|mesh-ancestor
154565514|NCT03926143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565515|NCT03876262|Ivermectin|ivermectin|mesh-list
154565516|NCT03876262|Moxidectin|moxidectin|mesh-list
154565517|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154565518|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565519|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
154565520|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
154565521|NCT03867682|Venetoclax|venetoclax|mesh-list
154565522|NCT03867682|Lintuzumab|lintuzumab|mesh-list
154565523|NCT03867682|Spironolactone|spironolactone|mesh-list
154565524|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565525|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154565526|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
154565527|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565528|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565529|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154565530|NCT03867682|Diuretics|diuretics|mesh-ancestor
154565531|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
154565532|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565533|NCT03846505|Oxytocin|oxytocin|mesh-list
154565534|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
154565535|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154565536|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565537|NCT03768570|Durvalumab|durvalumab|mesh-list
154565538|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565539|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565540|NCT03617445|Vancomycin|vancomycin|mesh-list
154565541|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154565542|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565543|NCT03421652|Nivolumab|nivolumab|mesh-list
154565544|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565545|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565546|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154565547|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565548|NCT03215524|Thalidomide|thalidomide|mesh-list
154565549|NCT03215524|Dexamethasone|dexamethasone|mesh-list
154565550|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
154565551|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
154565552|NCT03215524|Daratumumab|daratumumab|mesh-list
154565553|NCT03215524|Pomalidomide|pomalidomide|mesh-list
154565554|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154565555|NCT03215524|BB 1101|bb 1101|mesh-list
154565556|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565557|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
154565558|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565559|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565560|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154565561|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
154565562|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565563|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565564|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154565565|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565566|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
154565567|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
154565568|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565569|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565570|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
154565571|NCT03215524|Hormones|hormones|mesh-ancestor
154565572|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565573|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565574|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
154565575|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565576|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154565577|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154565578|NCT03215524|Growth Substances|growth substances|mesh-ancestor
154565579|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
154565580|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
154565581|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154565582|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565583|NCT03045029|Treprostinil|treprostinil|mesh-list
154565584|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154565585|NCT03018080|Paclitaxel|paclitaxel|mesh-list
154565586|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
154565587|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565588|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565589|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565590|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565591|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565592|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565593|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565594|NCT03018080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154565595|NCT02799641|Lidocaine|lidocaine|mesh-list
154565596|NCT02799641|Diazepam|diazepam|mesh-list
154565597|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
154565598|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
154565599|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154565601|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
154565602|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565603|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154565604|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154565605|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154565606|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154144720|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154565607|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565608|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154565609|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
154565610|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
154565611|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
154565612|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565613|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154565614|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154565615|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154565616|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154565617|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154565618|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154565619|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154565620|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
154565621|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
154565622|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
154565623|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565624|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
154565625|NCT02782546|Tacrolimus|tacrolimus|mesh-list
154565626|NCT02782546|Lenograstim|lenograstim|mesh-list
154565627|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565628|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
154565629|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565630|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154565631|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565632|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565633|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154565634|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565635|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154565636|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
154565637|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154565638|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565639|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154565640|NCT02781090|Nicotine|nicotine|mesh-list
154565641|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154565642|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
154565643|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565644|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565645|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154565646|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154565647|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
154565648|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565649|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565650|NCT02774291|Aldesleukin|aldesleukin|mesh-list
154565651|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
154565652|NCT02774291|Fludarabine|fludarabine|mesh-list
154565653|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
154565654|NCT02774291|Interleukin-2|interleukin-2|mesh-list
154565655|NCT02774291|Lenograstim|lenograstim|mesh-list
154565656|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565657|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
154565658|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565659|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565660|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154565661|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
154565662|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565663|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565664|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154565665|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565666|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
154565667|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154565668|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154565669|NCT02774291|Analgesics|analgesics|mesh-ancestor
154565670|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
154565671|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565672|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154565673|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154565674|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
154565675|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565676|NCT02734771|Prednisone|prednisone|mesh-list
154565677|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
154565678|NCT02734771|Rituximab|rituximab|mesh-list
154565679|NCT02734771|Doxorubicin|doxorubicin|mesh-list
154565680|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154565681|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565682|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
154565683|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565684|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565685|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154565686|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
154565687|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565688|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565689|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154565690|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565691|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154565692|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154565693|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154565694|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565695|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565696|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
154565697|NCT02734771|Hormones|hormones|mesh-ancestor
154565698|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565699|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565700|NCT02734771|Immunotoxins|immunotoxins|mesh-ancestor
154565701|NCT02734771|Immunoconjugates|immunoconjugates|mesh-ancestor
154565702|NCT02689024|Acetaminophen|acetaminophen|mesh-list
154565703|NCT02689024|Dipyrone|dipyrone|mesh-list
154565704|NCT02689024|Ibuprofen|ibuprofen|mesh-list
154565705|NCT02689024|Diclofenac|diclofenac|mesh-list
154565706|NCT02689024|Naproxen|naproxen|mesh-list
154565707|NCT02689024|Fentanyl|fentanyl|mesh-list
154565708|NCT02689024|Morphine|morphine|mesh-list
154565709|NCT02689024|Bupivacaine|bupivacaine|mesh-list
154565710|NCT02689024|Ropivacaine|ropivacaine|mesh-list
154565711|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
154565712|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
154565713|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
154565714|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154565715|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565716|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
154565717|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565718|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154565719|NCT02689024|Narcotics|narcotics|mesh-ancestor
154565720|NCT02689024|Analgesics|analgesics|mesh-ancestor
154144846|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154565721|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154565722|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154565723|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
154565724|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154565725|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
154565726|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154565727|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565728|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565729|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154565730|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565731|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565732|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
154565733|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
154565734|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565735|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565736|NCT02658279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154565737|NCT02658279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565738|NCT02649686|Trastuzumab|trastuzumab|mesh-list
154565739|NCT02649686|Durvalumab|durvalumab|mesh-list
154565740|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565741|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565742|NCT02144584|Memantine|memantine|mesh-list
154565743|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154565744|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154565745|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
154565746|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565747|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565748|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565749|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154565750|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154565751|NCT01846390|Dexamethasone|dexamethasone|mesh-list
154565752|NCT01846390|Gemcitabine|gemcitabine|mesh-list
154565754|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565755|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565756|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
154565757|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
154565758|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565759|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565760|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565761|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
154565762|NCT01846390|Hormones|hormones|mesh-ancestor
154565763|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565764|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565765|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565766|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
154565767|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565768|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154565769|NCT01846390|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154565770|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565771|NCT01783197|Paclitaxel|paclitaxel|mesh-list
154565772|NCT01783197|Carboplatin|carboplatin|mesh-list
154565773|NCT01783197|Pemetrexed|pemetrexed|mesh-list
154565774|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565775|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565776|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565777|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565778|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
154144890|NCT00719693|Calcium|calcium|mesh-list
154565779|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565780|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565781|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154565782|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154565783|NCT01765855|Betrixaban|betrixaban|mesh-list
154565784|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154565785|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
154565786|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154565787|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
154565788|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565789|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565790|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
154565791|NCT01708993|Docetaxel|docetaxel|mesh-list
154565792|NCT01708993|Pemetrexed|pemetrexed|mesh-list
154565793|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565794|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565795|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565796|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565797|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565798|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565799|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154565800|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154565801|NCT01656538|Paclitaxel|paclitaxel|mesh-list
154565802|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565803|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565804|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565805|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565806|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565807|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565808|NCT01619813|Prednisone|prednisone|mesh-list
154565809|NCT01619813|Docetaxel|docetaxel|mesh-list
154565810|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565811|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565812|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565813|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565814|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565815|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565816|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
154565817|NCT01619813|Hormones|hormones|mesh-ancestor
154565818|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565819|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565820|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565821|NCT01591421|Panitumumab|panitumumab|mesh-list
154565822|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565823|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565824|NCT01419834|Antibodies|antibodies|mesh-list
154565825|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154565826|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
154255543|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
154565827|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565828|NCT01138384|Lapatinib|lapatinib|mesh-list
154565829|NCT01138384|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154565830|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154565831|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565832|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565833|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565834|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154565835|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565836|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565837|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154144948|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565838|NCT01068587|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154565839|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154565840|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565841|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565842|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565843|NCT00869752|Etoposide|etoposide|mesh-list
154565844|NCT00869752|Antibodies|antibodies|mesh-list
154565845|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154565846|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
154565847|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565848|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565849|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565850|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154565851|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154565852|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565853|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565854|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154565855|NCT00836485|Ketotifen|ketotifen|mesh-list
154565856|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
154565857|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154565858|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154565859|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154565860|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154565861|NCT00836485|Analgesics|analgesics|mesh-ancestor
154565862|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
154565863|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154565864|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565865|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565866|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565867|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154565868|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154565869|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154565870|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
154565871|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
154565872|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154565873|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565874|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
154565875|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
154565876|NCT00658593|Gemcitabine|gemcitabine|mesh-list
154565877|NCT00658593|Capecitabine|capecitabine|mesh-list
154565878|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565879|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
154565880|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565881|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565882|NCT00651326|Docetaxel|docetaxel|mesh-list
154565883|NCT00651326|Leuprolide|leuprolide|mesh-list
154565884|NCT00651326|Goserelin|goserelin|mesh-list
154565885|NCT00651326|Bicalutamide|bicalutamide|mesh-list
154565886|NCT00651326|Flutamide|flutamide|mesh-list
154565887|NCT00651326|Buserelin|buserelin|mesh-list
154565888|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565889|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565890|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565891|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565892|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565893|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154565894|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
154565895|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154565896|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565897|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565898|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
154565899|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
154565900|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565901|NCT00640471|Cetuximab|cetuximab|mesh-list
154565902|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565903|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565905|NCT00535353|Olaparib|olaparib|mesh-list
154565906|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154565907|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154565908|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565909|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565910|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565911|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154565912|NCT00516828|Cytarabine|cytarabine|mesh-list
154565913|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565914|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
154565915|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565916|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565917|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
154565918|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154565919|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565920|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
154565921|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565922|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154565923|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565924|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565925|NCT00471432|Docetaxel|docetaxel|mesh-list
154565926|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565927|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565928|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565929|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565930|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565931|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
154565932|NCT00470353|Vitamin D|vitamin d|mesh-list
154565933|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
154565934|NCT00470353|Calcium|calcium|mesh-list
154565935|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154565936|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565937|NCT00470353|Vitamins|vitamins|mesh-ancestor
154565938|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
154565939|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154289781|NCT03730766|Amoxicillin|amoxicillin|mesh-list
154565940|NCT00470353|Antacids|antacids|mesh-ancestor
154565941|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565942|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154565943|NCT00428142|Prednisone|prednisone|mesh-list
154565944|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
154565945|NCT00428142|Rituximab|rituximab|mesh-list
154565946|NCT00428142|Vincristine|vincristine|mesh-list
154565947|NCT00428142|Bortezomib|bortezomib|mesh-list
154565948|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565949|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
154565950|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565951|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154565952|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154565953|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
154565954|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565955|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565956|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154565957|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154565958|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154565959|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
154565960|NCT00428142|Hormones|hormones|mesh-ancestor
154565961|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154565962|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154565963|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154565964|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565965|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565966|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565967|NCT00387400|Everolimus|everolimus|mesh-list
154565968|NCT00387400|Temozolomide|temozolomide|mesh-list
154565969|NCT00387400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154565970|NCT00387400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154565971|NCT00387400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154565972|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565973|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154565974|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
154565975|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154565977|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154565978|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
154565979|NCT00377052|Gemcitabine|gemcitabine|mesh-list
154565980|NCT00377052|Bortezomib|bortezomib|mesh-list
154565981|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154565982|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
154565983|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565984|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565985|NCT00372736|Docetaxel|docetaxel|mesh-list
154565986|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565987|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565988|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565989|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565990|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565991|NCT00357747|Docetaxel|docetaxel|mesh-list
154565992|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154565993|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
154565994|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
154565995|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
154565996|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154565997|NCT00352079|Gefitinib|gefitinib|mesh-list
154565998|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
154565999|NCT00352079|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154566000|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566001|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566002|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566003|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566004|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154566005|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
154566006|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566007|NCT00343408|Leucovorin|leucovorin|mesh-list
154566008|NCT00343408|Gemcitabine|gemcitabine|mesh-list
154566009|NCT00343408|Fluorouracil|fluorouracil|mesh-list
154566010|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
154566011|NCT00343408|Cediranib|cediranib|mesh-list
154566012|NCT00343408|Calcium|calcium|mesh-list
154566013|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
154566014|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566015|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154566016|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
154566017|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566018|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154566019|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566020|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154566021|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
154566022|NCT00343408|Antidotes|antidotes|mesh-ancestor
154566023|NCT00343408|Protective Agents|protective agents|mesh-ancestor
154566024|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
154566026|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
154566027|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566028|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566029|NCT00305812|Dexamethasone|dexamethasone|mesh-list
154566030|NCT00305812|Lenalidomide|lenalidomide|mesh-list
154566031|NCT00305812|Melphalan|melphalan|mesh-list
154566032|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566033|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
154566034|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
154566035|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566036|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566037|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154566038|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
154566039|NCT00305812|Hormones|hormones|mesh-ancestor
154566040|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566041|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154566042|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566043|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
154566044|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154566045|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154566046|NCT00305812|Growth Substances|growth substances|mesh-ancestor
154566047|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
154566048|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154566049|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
154566050|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566051|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154566052|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154566053|NCT00265876|Gemcitabine|gemcitabine|mesh-list
154566054|NCT00265876|Saracatinib|saracatinib|mesh-list
154566055|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154566056|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
154566057|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566058|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566059|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566060|NCT00258388|Prednisone|prednisone|mesh-list
154566061|NCT00258388|Docetaxel|docetaxel|mesh-list
154145188|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
154566062|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566063|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
154566064|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
154566065|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
154566066|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566067|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566068|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
154566069|NCT00258388|Hormones|hormones|mesh-ancestor
154566070|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566071|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566072|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154566073|NCT00258375|Docetaxel|docetaxel|mesh-list
154566074|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566075|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
154566076|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
154566077|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
154566078|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566079|NCT00255788|Everolimus|everolimus|mesh-list
154566080|NCT00255788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154566081|NCT00255788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566082|NCT00255788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566083|NCT00255788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566084|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154566085|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
154566086|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566087|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566088|NCT00245154|Paclitaxel|paclitaxel|mesh-list
154566089|NCT00245154|Carboplatin|carboplatin|mesh-list
154566090|NCT00245154|Cediranib|cediranib|mesh-list
154566091|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154566092|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566093|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
154566094|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
154566095|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
154566096|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566097|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566098|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566099|NCT00093457|Sorafenib|sorafenib|mesh-list
154566100|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566101|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566102|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566103|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566104|NCT00084734|Docetaxel|docetaxel|mesh-list
154566105|NCT00084734|Capecitabine|capecitabine|mesh-list
154566106|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566107|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
154566108|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
154566109|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154566110|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566111|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154566112|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
154566113|NCT00079079|Carboplatin|carboplatin|mesh-list
154566114|NCT00079079|Gemcitabine|gemcitabine|mesh-list
154566115|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566116|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154566117|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
154566118|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566119|NCT00079066|Cetuximab|cetuximab|mesh-list
154566120|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154566121|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566122|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154566123|NCT00079053|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154566124|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566125|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566126|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566127|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566128|NCT00066443|Docetaxel|docetaxel|mesh-list
154566129|NCT00066443|Epirubicin|epirubicin|mesh-list
154566130|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566131|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
154566132|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
154566133|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
154566134|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566135|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154566136|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154566137|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154566138|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566139|NCT00054106|Flutamide|flutamide|mesh-list
154566140|NCT00054106|Buserelin|buserelin|mesh-list
154566141|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
154566142|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
154566143|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566144|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566145|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154566146|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566147|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154566148|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
154566149|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154566150|NCT00030875|Bortezomib|bortezomib|mesh-list
154566151|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566152|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
154566153|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
154566154|NCT03532867|Protective Agents|protective agents|mesh-ancestor
154566155|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566156|NCT02207959|Proflavine|proflavine|mesh-list
154566157|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154566158|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566159|NCT02567552|Progesterone|progesterone|mesh-list
154566160|NCT02567552|Progestins|progestins|mesh-ancestor
154566161|NCT02567552|Hormones|hormones|mesh-ancestor
154566162|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566163|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566164|NCT02208427|Isoniazid|isoniazid|mesh-list
154566165|NCT02208427|Rifapentine|rifapentine|mesh-list
154566166|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
154566167|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154566168|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566169|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154566170|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154566171|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
154566172|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566173|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154566174|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154566175|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
154566176|NCT05508620|Sirolimus|sirolimus|mesh-list
154566177|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154566178|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566179|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154566180|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566181|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
154566182|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154566183|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
154566184|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566185|NCT03803605|Vorinostat|vorinostat|mesh-list
154566186|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566187|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154566188|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566189|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566190|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
154566191|NCT02208505|Remifentanil|remifentanil|mesh-list
154566192|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154566193|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566194|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566195|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566196|NCT02208505|Analgesics|analgesics|mesh-ancestor
154566197|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
154566198|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566199|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154566200|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154566201|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154566202|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
154566203|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383432|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154566204|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566205|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154566206|NCT02208505|Narcotics|narcotics|mesh-ancestor
154566207|NCT02208583|Prednisone|prednisone|mesh-list
154566208|NCT02208583|Cisplatin|cisplatin|mesh-list
154566209|NCT02208583|Docetaxel|docetaxel|mesh-list
154566210|NCT02208583|Etoposide|etoposide|mesh-list
154566211|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
154566212|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566213|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
154566214|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
154566215|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
154566216|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566217|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566218|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
154566219|NCT02208583|Hormones|hormones|mesh-ancestor
154566220|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566221|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566222|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154566223|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154566224|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154566225|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154566226|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566227|NCT05501288|Pholcodine|pholcodine|mesh-list
154566228|NCT05501288|Analgesics|analgesics|mesh-ancestor
154566229|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
154566230|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566231|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566232|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
154566233|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154566234|NCT02199379|Lenvatinib|lenvatinib|mesh-list
154566235|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566236|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566237|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566238|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566239|NCT03532711|Leucovorin|leucovorin|mesh-list
154566240|NCT03532711|Capecitabine|capecitabine|mesh-list
154566241|NCT03532711|Fluorouracil|fluorouracil|mesh-list
154566242|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
154566243|NCT03532711|Irinotecan|irinotecan|mesh-list
154566244|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
154566245|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566246|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154566247|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
154566248|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566249|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566250|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154566251|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
154566252|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154566253|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154566254|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566255|NCT03532711|Antidotes|antidotes|mesh-ancestor
154566256|NCT03532711|Protective Agents|protective agents|mesh-ancestor
154566257|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
154566258|NCT03532711|Vitamins|vitamins|mesh-ancestor
154566259|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
154566260|NCT04714112|Dexamethasone|dexamethasone|mesh-list
154566261|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
154566262|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154566263|NCT04714112|BB 1101|bb 1101|mesh-list
154566264|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566265|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
154566266|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
154566267|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566268|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566269|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154566270|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
154566271|NCT04714112|Hormones|hormones|mesh-ancestor
154566272|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566273|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154566274|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566275|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
154566276|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566277|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566278|NCT02199613|Darunavir|darunavir|mesh-list
154566279|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154566280|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154566281|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
154566282|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566283|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566285|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154566286|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
154566287|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566288|NCT02209441|Sorafenib|sorafenib|mesh-list
154566289|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566290|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566291|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566292|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566293|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
154566294|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154566295|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154566296|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
154566297|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566298|NCT03338647|Doxorubicin|doxorubicin|mesh-list
154566299|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154566300|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566301|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154566302|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154566303|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566304|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566305|NCT05500742|Selenium|selenium|mesh-list
154566306|NCT05500742|Ubiquinone|ubiquinone|mesh-list
154566307|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
154566308|NCT05500742|Resveratrol|resveratrol|mesh-list
154566309|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
154566310|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566311|NCT05500742|Protective Agents|protective agents|mesh-ancestor
154566312|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566313|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566314|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154566315|NCT05500742|Trace Elements|trace elements|mesh-ancestor
154566316|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
154566317|NCT05500742|Vitamins|vitamins|mesh-ancestor
154566318|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
154566319|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
154566320|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154290156|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154566321|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566322|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
154566323|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
154566324|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
154566325|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154566326|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566327|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566328|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566329|NCT02200159|Analgesics|analgesics|mesh-ancestor
154566330|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
154566331|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566332|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154566333|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154566334|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154566335|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
154566336|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566337|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566338|NCT02204527|Vitamin D|vitamin d|mesh-list
154566339|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
154566340|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
154566341|NCT02204527|Vitamins|vitamins|mesh-list
154566342|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
154566343|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566344|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154566345|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154566346|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
154566347|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154566348|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
154566349|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566350|NCT02200237|Antacids|antacids|mesh-ancestor
154566351|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145478|NCT00894608|Letrozole|letrozole|mesh-list
154566352|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154566353|NCT02209831|Pantoprazole|pantoprazole|mesh-list
154566354|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154566355|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154566356|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154566357|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566358|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566359|NCT01663532|Aripiprazole|aripiprazole|mesh-list
154566360|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
154566361|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154566362|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154566363|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154566364|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566365|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566366|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
154566367|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
154566368|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566369|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566370|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154566371|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154566372|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
154566373|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154566374|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154566375|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154566376|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154566377|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
154566378|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154566379|NCT02204839|Insulin|insulin|mesh-list
154566380|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
154566381|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
154566382|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154566383|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566384|NCT02209909|Aspirin|aspirin|mesh-list
154566385|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154566386|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566387|NCT02209909|Analgesics|analgesics|mesh-ancestor
154566388|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
154566389|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566390|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566391|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566392|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154566393|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154290252|NCT00086385|Bupropion|bupropion|mesh-list
154566394|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154566395|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566396|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154566397|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154566398|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566400|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154566401|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
154566402|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566403|NCT02205151|Amlodipine|amlodipine|mesh-list
154566404|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154566405|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154566406|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154566407|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566408|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154566409|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566410|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
154566411|NCT05262985|Durvalumab|durvalumab|mesh-list
154566412|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154566413|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566414|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
154566415|NCT05504720|Trastuzumab|trastuzumab|mesh-list
154566416|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154566417|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566418|NCT05504720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154566419|NCT05504720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566420|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
154566421|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154566422|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
154566423|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566424|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566425|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154566426|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
154566427|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154566428|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
154566429|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566430|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566431|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154566432|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
154566433|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
154566434|NCT04476992|Protective Agents|protective agents|mesh-ancestor
154566435|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
154566437|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566438|NCT02220673|Protective Agents|protective agents|mesh-ancestor
154566439|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566440|NCT02220751|Doxycycline|doxycycline|mesh-list
154566441|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154566442|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566443|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
154566444|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154566445|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154566446|NCT02205541|Eculizumab|eculizumab|mesh-list
154566447|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154566448|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154566449|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
154566450|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566451|NCT02205619|Glycine|glycine|mesh-list
154566452|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
154566453|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566454|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566455|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566456|NCT05504330|Aspirin|aspirin|mesh-list
154566457|NCT05504330|Clopidogrel|clopidogrel|mesh-list
154566458|NCT05504330|Atorvastatin|atorvastatin|mesh-list
154566459|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154566460|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566461|NCT05504330|Analgesics|analgesics|mesh-ancestor
154566462|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
154566463|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566464|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566465|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566466|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154566467|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154566468|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154566469|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566470|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154566471|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154566472|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566473|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
154566474|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154566475|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154566476|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
154566477|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154566478|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154566479|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154566480|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154566481|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154566482|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
154566483|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566484|NCT02220829|Silodosin|silodosin|mesh-list
154566485|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154566486|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154566487|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154566488|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
154566489|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566490|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566491|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566492|NCT02220829|Urological Agents|urological agents|mesh-ancestor
154566493|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
154566494|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154566495|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154566496|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
154566497|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566498|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154566499|NCT02215213|Vitamin D|vitamin d|mesh-list
154566500|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
154566501|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
154566502|NCT02215213|Vitamins|vitamins|mesh-list
154566503|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
154566504|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465391|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
154566505|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154566506|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154566508|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154566509|NCT02205775|Ezetimibe|ezetimibe|mesh-list
154566510|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154566511|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154566512|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
154566513|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566514|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154566515|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154566516|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566517|NCT02217787|PF-06372865|pf-06372865|mesh-list
154566518|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
154566519|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
154566520|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566521|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566522|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566523|NCT02205931|Topiramate|topiramate|mesh-list
154566524|NCT02205931|Lamotrigine|lamotrigine|mesh-list
154566525|NCT02205931|Zonisamide|zonisamide|mesh-list
154566526|NCT02205931|Carbamazepine|carbamazepine|mesh-list
154566527|NCT02205931|Phenytoin|phenytoin|mesh-list
154566528|NCT02205931|Rufinamide|rufinamide|mesh-list
154566529|NCT02205931|Levetiracetam|levetiracetam|mesh-list
154566530|NCT02205931|Valproic Acid|valproic acid|mesh-list
154566531|NCT02205931|Clonazepam|clonazepam|mesh-list
154566532|NCT02205931|Vigabatrin|vigabatrin|mesh-list
154566533|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
154566534|NCT02205931|Clobazam|clobazam|mesh-list
154566535|NCT02205931|Ethosuximide|ethosuximide|mesh-list
154566536|NCT02205931|Stiripentol|stiripentol|mesh-list
154566537|NCT02205931|Nitrazepam|nitrazepam|mesh-list
154566538|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154566539|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566540|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
154566541|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154566542|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154566543|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566544|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154566545|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154566546|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154566547|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566548|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154566549|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154566550|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566551|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
154566552|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566553|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
154566554|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566555|NCT02205931|Analgesics|analgesics|mesh-ancestor
154566556|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
154566557|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566558|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154566559|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154566560|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154566561|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154566562|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
154566563|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154566564|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154566565|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
154566566|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154566568|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
154566569|NCT02221063|Vitamins|vitamins|mesh-ancestor
154566570|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
154566571|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566572|NCT02220049|Bortezomib|bortezomib|mesh-list
154566573|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566574|NCT01351805|Vitamin D|vitamin d|mesh-list
154566575|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
154566576|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
154566577|NCT01351805|Vitamins|vitamins|mesh-list
154566578|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
154566579|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566580|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154566581|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154566582|NCT02206165|Amlodipine|amlodipine|mesh-list
154566583|NCT02206165|Candesartan|candesartan|mesh-list
154566584|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
154566585|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154566586|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154566587|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154566588|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566589|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154566590|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566591|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
154566592|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154566593|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154566594|NCT04356950|Thrombin|thrombin|mesh-list
154566595|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
154566596|NCT04356950|Coagulants|coagulants|mesh-ancestor
154566597|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154566598|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154566599|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
154566600|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566601|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566602|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154566603|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
154566604|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154566605|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154566606|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154566607|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
154566608|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566609|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566610|NCT05563610|Amoxicillin|amoxicillin|mesh-list
154566611|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154566612|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566613|NCT05503706|Selenium|selenium|mesh-list
154566614|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
154566615|NCT05503706|Salicylates|salicylates|mesh-list
154566616|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
154566617|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
154566618|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566619|NCT05503706|Protective Agents|protective agents|mesh-ancestor
154566620|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566621|NCT05503706|Trace Elements|trace elements|mesh-ancestor
154566622|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
154566623|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566624|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
154566625|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
154566626|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
154566627|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154566628|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566629|NCT05503706|Analgesics|analgesics|mesh-ancestor
154566630|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
154566631|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566632|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566633|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154566634|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154566635|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566636|NCT02174861|Erenumab|erenumab|mesh-list
154566637|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154566638|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566639|NCT02174861|Analgesics|analgesics|mesh-ancestor
154566640|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
154566641|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566642|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566643|NCT02221375|Ciclesonide|ciclesonide|mesh-list
154566644|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
154566645|NCT02221375|Hormones|hormones|mesh-ancestor
154566646|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566647|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566648|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154566649|NCT02399709|Simvastatin|simvastatin|mesh-list
154566650|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154566651|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154566652|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
154566653|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566654|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154566655|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154566656|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566657|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
154566658|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154566660|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566661|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566662|NCT02220361|Analgesics|analgesics|mesh-ancestor
154566663|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
154566664|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566665|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154566666|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154566667|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154566668|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
154566669|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566670|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566671|NCT05175001|Betamethasone|betamethasone|mesh-list
154566672|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154566673|NCT05175001|Ropivacaine|ropivacaine|mesh-list
154566674|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
154566675|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
154566676|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566677|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566678|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
154566679|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566680|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566681|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
154566682|NCT05175001|Hormones|hormones|mesh-ancestor
154566683|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566684|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154566685|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
154566686|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154566687|NCT00140855|Ipilimumab|ipilimumab|mesh-list
154566688|NCT00140855|Antibodies|antibodies|mesh-list
154566689|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
154566690|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154566691|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
154566692|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566693|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566694|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154566695|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566696|NCT02399397|Midazolam|midazolam|mesh-list
154290530|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154566698|NCT02399397|Anesthetics|anesthetics|mesh-list
154566699|NCT02399397|Propofol|propofol|mesh-list
154566700|NCT02399397|Rocuronium|rocuronium|mesh-list
154566701|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566702|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566703|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154566704|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154566705|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
154566706|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154566707|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154566708|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154566709|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154566710|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
154566711|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
154566712|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566713|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566714|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154566715|NCT02399397|Narcotics|narcotics|mesh-ancestor
154566716|NCT02399397|Analgesics|analgesics|mesh-ancestor
154566717|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
154566718|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566719|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154566720|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154566721|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154566722|NCT02221453|Triamcinolone|triamcinolone|mesh-list
154566723|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154566724|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154566725|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154566726|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566727|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
154566728|NCT02221453|Hormones|hormones|mesh-ancestor
154566729|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566730|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566731|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154566732|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
154566733|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566734|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566735|NCT03106545|Bupivacaine|bupivacaine|mesh-list
154566736|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
154566737|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
154566738|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566739|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566740|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
154566741|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566742|NCT02221531|Carbetocin|carbetocin|mesh-list
154566743|NCT02221531|Oxytocin|oxytocin|mesh-list
154566744|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
154566745|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154566746|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566747|NCT02231125|Losartan|losartan|mesh-list
154566748|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154566749|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154566750|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154566751|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154566752|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566753|NCT02396433|Carboplatin|carboplatin|mesh-list
154566754|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154566755|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566756|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566757|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566758|NCT02231203|Tocopherols|tocopherols|mesh-list
154566759|NCT02231203|Antioxidants|antioxidants|mesh-list
154566760|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566761|NCT02231203|Protective Agents|protective agents|mesh-ancestor
154566762|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566763|NCT02231203|Vitamins|vitamins|mesh-ancestor
154566764|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
154566765|NCT02231281|Ritonavir|ritonavir|mesh-list
154566766|NCT02231281|Lopinavir|lopinavir|mesh-list
154566767|NCT02231281|Tenofovir|tenofovir|mesh-list
154566768|NCT02231281|Lamivudine|lamivudine|mesh-list
154566769|NCT02231281|Zidovudine|zidovudine|mesh-list
154566770|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154566771|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154566772|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
154566773|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566774|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566775|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154566776|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154566777|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
154566778|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566779|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154145910|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
154566780|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154566781|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154566782|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154566783|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
154566784|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154566785|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154566786|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
154566787|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566788|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566789|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154566790|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
154566791|NCT02780687|Afatinib|afatinib|mesh-list
154566792|NCT02780687|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154566793|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154566794|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566795|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566796|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566797|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154566798|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154566799|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
154566800|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566801|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566802|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154566803|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
154566804|NCT02147873|Azacitidine|azacitidine|mesh-list
154566805|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154566806|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
154566807|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566808|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566809|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566810|NCT02398929|Bisoprolol|bisoprolol|mesh-list
154566811|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154566812|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
154566813|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
154566814|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566815|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566816|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154566817|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154566818|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154566819|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
154566820|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566821|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566822|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
154566823|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154566824|NCT02221765|Hormones|hormones|mesh-ancestor
154566825|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566826|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566827|NCT05069129|Vaccines|vaccines|mesh-list
154566828|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
154566829|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566830|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154566831|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154566832|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566833|NCT03544073|Leuprolide|leuprolide|mesh-list
154566834|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154566835|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
154566836|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154566837|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566838|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154566839|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566840|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154566841|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566842|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
154566843|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154566844|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154566845|NCT02781311|Finasteride|finasteride|mesh-list
154290680|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
154566846|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154566847|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154566848|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566849|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566850|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
154566851|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566852|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566853|NCT02781311|Urological Agents|urological agents|mesh-ancestor
154566854|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
154566855|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154566856|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566857|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154566858|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154566859|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566860|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154566861|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
154566862|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566863|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154566864|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
154566865|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566866|NCT02564198|Ramucirumab|ramucirumab|mesh-list
154566867|NCT02564198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154566868|NCT02564198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154566869|NCT02564198|Growth Substances|growth substances|mesh-ancestor
154566870|NCT02564198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566871|NCT02564198|Growth Inhibitors|growth inhibitors|mesh-ancestor
154566872|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566873|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
154566874|NCT02398539|Triamcinolone|triamcinolone|mesh-list
154566875|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566876|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
154566877|NCT02398539|Hormones|hormones|mesh-ancestor
154566878|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154566879|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566880|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154566881|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566883|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
154566884|NCT02144753|Cathartics|cathartics|mesh-ancestor
154566885|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154566886|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
154566887|NCT02231905|Pramipexole|pramipexole|mesh-list
154566888|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
154566889|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566890|NCT02231905|Protective Agents|protective agents|mesh-ancestor
154566891|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566892|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154566893|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154566894|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
154566895|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
154566896|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566897|NCT02141087|Pirfenidone|pirfenidone|mesh-list
154566898|NCT02141087|Analgesics|analgesics|mesh-ancestor
154566899|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
154566900|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566901|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566902|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154566903|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566904|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154566905|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154566906|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566907|NCT02698293|Vitamin D|vitamin d|mesh-list
154566908|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
154566909|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
154566910|NCT02698293|Vitamins|vitamins|mesh-list
154566911|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
154566912|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566913|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154566914|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154566915|NCT02226289|Bevacizumab|bevacizumab|mesh-list
154566916|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154566917|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566918|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154566919|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154566920|NCT02226289|Growth Substances|growth substances|mesh-ancestor
154566921|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566922|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
154566923|NCT04480593|Propolis|propolis|mesh-list
154566924|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154566925|NCT05079217|Vaccines|vaccines|mesh-list
154566926|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
154566927|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566928|NCT02141321|Alprostadil|alprostadil|mesh-list
154566929|NCT02141321|Misoprostol|misoprostol|mesh-list
154566930|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154566931|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
154566932|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154566933|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566934|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154566935|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154566936|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
154566937|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154566938|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
154566939|NCT02141321|Urological Agents|urological agents|mesh-ancestor
154566940|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154566941|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154566942|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154566943|NCT02141477|Decitabine|decitabine|mesh-list
154566944|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
154566945|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154566946|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
154566947|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566948|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566949|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154566950|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154566951|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154566952|NCT02232139|Midazolam|midazolam|mesh-list
154566953|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154566954|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153588600|NCT01789294|Mesalamine|mesalamine|mesh-list
154566955|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566956|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566958|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154566959|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154566960|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154566961|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
154566962|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
154566963|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
154566964|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
154566965|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566966|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566967|NCT02226601|Aprepitant|aprepitant|mesh-list
154566968|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
154566969|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
154566970|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566971|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566972|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154566973|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154566974|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566975|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566976|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
154566977|NCT02397603|Bupivacaine|bupivacaine|mesh-list
154566978|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
154566979|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
154566980|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154566981|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154566982|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
154566983|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154566984|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154566985|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154566986|NCT02397603|Analgesics|analgesics|mesh-ancestor
154566987|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154566988|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154566989|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154566990|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
154566991|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154566992|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154566993|NCT02145065|Paclitaxel|paclitaxel|mesh-list
154566994|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154566995|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154566996|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
154566997|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
154566998|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
154566999|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567000|NCT02226757|Paclitaxel|paclitaxel|mesh-list
154567001|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154567002|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567003|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
154567004|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
154567005|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
154567006|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567007|NCT04616924|Clarithromycin|clarithromycin|mesh-list
154567008|NCT04616924|Rifabutin|rifabutin|mesh-list
154567009|NCT04616924|Clofazimine|clofazimine|mesh-list
154567010|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154567011|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567012|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154567013|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567014|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567015|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154567016|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154567017|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154567018|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
154567019|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567020|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
154567021|NCT02226913|Lidocaine|lidocaine|mesh-list
154567022|NCT02226913|Epinephrine|epinephrine|mesh-list
154567023|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
154567024|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
154567025|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567026|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567027|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
154567028|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567030|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154567031|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154567032|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567033|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567034|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154567035|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154567036|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
154567037|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567038|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154567039|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154567040|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
154567041|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154567042|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
154567043|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
154567044|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
154567045|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154567046|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
154567047|NCT02254655|Puerarin|puerarin|mesh-list
154567048|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
154567049|NCT02226991|Ritonavir|ritonavir|mesh-list
154567050|NCT02226991|Tipranavir|tipranavir|mesh-list
154567051|NCT02226991|Efavirenz|efavirenz|mesh-list
154567052|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154567053|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154567054|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154567055|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567056|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567057|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154567058|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154567059|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
154567060|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567061|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154567062|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154567063|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154567064|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154567065|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154567066|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154567067|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154567068|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154567069|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154567070|NCT00705783|Aripiprazole|aripiprazole|mesh-list
154567071|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
154567072|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154567073|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154567074|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154567075|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567076|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567077|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
154567078|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
154567079|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567080|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567081|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154567082|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154567083|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
154567084|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154567085|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154567086|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154567087|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154567088|NCT02145611|Vildagliptin|vildagliptin|mesh-list
154567089|NCT02145611|Glyburide|glyburide|mesh-list
154567090|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154567091|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567092|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154567093|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
154567094|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567095|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567096|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
154567097|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154567098|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567099|NCT03543683|Aspirin|aspirin|mesh-list
154567100|NCT03543683|Osimertinib|osimertinib|mesh-list
154567101|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154567102|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154567103|NCT03543683|Analgesics|analgesics|mesh-ancestor
154567104|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
154567105|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567106|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567107|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567108|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567109|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154567110|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154567111|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567112|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154567113|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154567114|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567115|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
154567116|NCT03543683|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154567117|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154567118|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567119|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
154567120|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154567121|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154567122|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154567123|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567124|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567125|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
154567126|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567127|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567128|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154567129|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567130|NCT02145767|Progesterone|progesterone|mesh-list
154567131|NCT02145767|Progestins|progestins|mesh-ancestor
154567132|NCT02145767|Hormones|hormones|mesh-ancestor
154567133|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154146250|NCT00509067|Olanzapine|olanzapine|mesh-list
154567134|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567135|NCT02031523|Analgesics|analgesics|mesh-list
154567136|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
154567137|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567138|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567139|NCT02397213|Cyclosporine|cyclosporine|mesh-list
154567140|NCT02397213|Cyclosporins|cyclosporins|mesh-list
154567141|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567142|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567143|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154567144|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
154567145|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567146|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
154567147|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567148|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
154567149|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567150|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154567151|NCT04480281|Lidocaine|lidocaine|mesh-list
154567152|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
154567153|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
154567154|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567155|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567156|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
154567157|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567158|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154567159|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154567160|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154567161|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567162|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567163|NCT03544775|Anesthetics|anesthetics|mesh-list
154567164|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567165|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567166|NCT02258815|Dinutuximab|dinutuximab|mesh-list
154567167|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567168|NCT02149433|Prednisone|prednisone|mesh-list
154567169|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567170|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
154567171|NCT02149433|Hormones|hormones|mesh-ancestor
154567172|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567173|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567174|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154383433|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567175|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567177|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
154567178|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154567179|NCT02228005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154567180|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154567181|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567182|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567183|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567184|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
154567185|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567186|NCT02146079|Semaglutide|semaglutide|mesh-list
154567187|NCT02146079|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154567188|NCT02146079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154567189|NCT02146079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567190|NCT02228083|Lidocaine|lidocaine|mesh-list
154567191|NCT02228083|Epinephrine|epinephrine|mesh-list
154567192|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
154567193|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
154567194|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567195|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567196|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
154567197|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567198|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154567199|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154567200|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154567201|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567202|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567203|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154567204|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154567205|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154567206|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567207|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154567208|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154567209|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
154567210|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154567211|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
154567212|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
154567213|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
154567214|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154567215|NCT02394483|Olorofim|olorofim|mesh-list
154567216|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
154567217|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567218|NCT02142335|Rituximab|rituximab|mesh-list
154567219|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154567220|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567221|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
154567222|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567223|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567224|NCT02228239|Mirtazapine|mirtazapine|mesh-list
154567225|NCT02228239|Esketamine|esketamine|mesh-list
154567226|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
154567227|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154567228|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154567229|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
154567230|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
154567231|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567232|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567233|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567234|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154567235|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154567236|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567237|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154567238|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154146354|NCT02570243|Heparin|heparin|mesh-list
154567239|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154567240|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
154567241|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154567242|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154567243|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
154567244|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154567245|NCT03167385|Apatinib|apatinib|mesh-list
154567246|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567247|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154567248|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862098|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567249|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567250|NCT02142569|Tocotrienols|tocotrienols|mesh-list
154567251|NCT02142569|Vitamin E|vitamin e|mesh-list
154567252|NCT02142569|Tocopherols|tocopherols|mesh-list
154567253|NCT02142569|Red yeast rice|red yeast rice|mesh-list
154567254|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
154567255|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567256|NCT02142569|Protective Agents|protective agents|mesh-ancestor
154567257|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567258|NCT02142569|Vitamins|vitamins|mesh-ancestor
154567259|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
154567260|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154567261|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154567262|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154567263|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
154567264|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567265|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154567266|NCT02228473|Atropine|atropine|mesh-list
154567267|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
154567268|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154567269|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154567270|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154567271|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
154567272|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567273|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567274|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154567275|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
154567276|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
154567277|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
154567278|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154567279|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154567280|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
154567281|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567282|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567283|NCT02394093|Aspirin|aspirin|mesh-list
154567284|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154567285|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154567286|NCT02394093|Analgesics|analgesics|mesh-ancestor
154567287|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
154567288|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567289|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567290|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567291|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567292|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154567293|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154567294|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567295|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154567296|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154567297|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567298|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
154567299|NCT02146391|Enclomiphene|enclomiphene|mesh-list
154567300|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154567301|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
154146401|NCT00728273|Micronutrients|micronutrients|mesh-list
154146404|NCT00927602|PENTA|penta|mesh-list
154567302|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567303|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567304|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154567305|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
154567306|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154567307|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154567308|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154567309|NCT04225273|Lidocaine|lidocaine|mesh-list
154567310|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
154567311|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
154567312|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567313|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567314|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
154567315|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567316|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154567317|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154567318|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154567319|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567320|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567321|NCT02146547|Aripiprazole|aripiprazole|mesh-list
154567322|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154567323|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
154567324|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154567325|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154567326|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154567327|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567328|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567329|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
154567330|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
154567331|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567332|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567333|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154567334|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154567335|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
154567336|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154567337|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154567338|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154567339|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154567340|NCT02394015|Doxorubicin|doxorubicin|mesh-list
154567341|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154567342|NCT02394015|Trabectedin|trabectedin|mesh-list
154567343|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154567344|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567345|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154567346|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154567347|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567348|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567349|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154567350|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
154567351|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
154567352|NCT02146703|Gemcitabine|gemcitabine|mesh-list
154567353|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154567354|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
154567355|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567356|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567357|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154567358|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154567359|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154567360|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567361|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567362|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154567363|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146466|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
154567364|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291205|NCT00066807|Epirubicin|epirubicin|mesh-list
154567365|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
154567366|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567367|NCT02782169|Pregabalin|pregabalin|mesh-list
154567368|NCT02782169|Analgesics|analgesics|mesh-ancestor
154567369|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
154567370|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567371|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567372|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
154567373|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154567374|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567375|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567376|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154567377|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154567378|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154567379|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567380|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154567381|NCT04163185|Meloxicam|meloxicam|mesh-list
154567382|NCT04163185|Rizatriptan|rizatriptan|mesh-list
154567383|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154567384|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154567385|NCT04163185|Analgesics|analgesics|mesh-ancestor
154567386|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
154567387|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567388|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567389|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567390|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567391|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154567392|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154862099|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154567393|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567394|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567395|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154567396|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
154567397|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567398|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
154567400|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154567401|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
154567402|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567403|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567404|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154567405|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
154567406|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
154567407|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154567408|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154567409|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
154567410|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
154567411|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567412|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567413|NCT04440267|Dexamethasone|dexamethasone|mesh-list
154567414|NCT04440267|Prednisone|prednisone|mesh-list
154567415|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
154567416|NCT04440267|Methotrexate|methotrexate|mesh-list
154567417|NCT04440267|Vincristine|vincristine|mesh-list
154567418|NCT04440267|Daunorubicin|daunorubicin|mesh-list
154567419|NCT04440267|Asparaginase|asparaginase|mesh-list
154567420|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
154567421|NCT04440267|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154567422|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154567423|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
154146536|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
154567424|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567425|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567426|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154567427|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
154567428|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567429|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567430|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154567431|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567432|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
154567433|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
154567434|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567435|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154567436|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
154567437|NCT04440267|Hormones|hormones|mesh-ancestor
154567438|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567439|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154291283|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
154567440|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154567441|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
154567442|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154567443|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154567444|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
154567445|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154567446|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567447|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154567448|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154567449|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154567450|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
154567451|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
154567452|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
154567453|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154567454|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154567455|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154567456|NCT04440267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154567457|NCT02043847|Melphalan|melphalan|mesh-list
154567458|NCT02043847|Lenograstim|lenograstim|mesh-list
154567459|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154567460|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
154567461|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567462|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154567463|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
154567464|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567465|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567466|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154567467|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154567469|NCT02146937|Finasteride|finasteride|mesh-list
154567470|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
154567471|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
154567472|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567473|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567474|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567475|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154567476|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154567477|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567478|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567479|NCT02146937|Urological Agents|urological agents|mesh-ancestor
154567480|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154567481|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
154567482|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
154567483|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
154567484|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154567485|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567486|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567487|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
154567488|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
154567489|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567490|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567491|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154567492|NCT02147015|Hormones|hormones|mesh-ancestor
154567493|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567494|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154567495|NCT02147015|Protective Agents|protective agents|mesh-ancestor
154567496|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567497|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567498|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154567499|NCT02229175|Bevacizumab|bevacizumab|mesh-list
154567500|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154567501|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567502|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154567503|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154567504|NCT02229175|Growth Substances|growth substances|mesh-ancestor
154567505|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567506|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
154567507|NCT04947007|Bupivacaine|bupivacaine|mesh-list
154567508|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
154567509|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
154567510|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567511|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567512|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
154567513|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567514|NCT04104685|Minocycline|minocycline|mesh-list
154567515|NCT04104685|Adapalene|adapalene|mesh-list
154567516|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154567517|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567518|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154567519|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154567520|NCT04104685|Analgesics|analgesics|mesh-ancestor
154567521|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
154567522|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567523|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567524|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567525|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567526|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
154567527|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154567528|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567529|NCT02392845|Docetaxel|docetaxel|mesh-list
154567530|NCT02392845|Epirubicin|epirubicin|mesh-list
154567531|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567532|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
154567533|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
154567534|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
154567535|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567536|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154567537|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154567538|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154567539|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567540|NCT03166605|Simethicone|simethicone|mesh-list
154567541|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
154567542|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567543|NCT03166605|Emollients|emollients|mesh-ancestor
154567544|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
154567545|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
154567546|NCT03166527|Antibodies|antibodies|mesh-list
154567547|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
154567548|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154567549|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154567550|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
154567551|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567552|NCT02695719|Lubiprostone|lubiprostone|mesh-list
154567553|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154567554|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567555|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567556|NCT05498012|Cannabidiol|cannabidiol|mesh-list
154567557|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
154567558|NCT02150291|Folic Acid|folic acid|mesh-list
154567559|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
154567560|NCT02150291|Hematinics|hematinics|mesh-ancestor
154567561|NCT02150291|Vitamins|vitamins|mesh-ancestor
154567562|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
154567563|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567564|NCT04907071|Coal Tar|coal tar|mesh-list
154567565|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
154567566|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
154567567|NCT02155517|Propofol|propofol|mesh-list
154567568|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154567569|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567570|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567571|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154567572|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
154567573|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
154567574|NCT05497934|Glycerol|glycerol|mesh-list
154567575|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154567576|NCT05497934|Protective Agents|protective agents|mesh-ancestor
154567577|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567578|NCT02229721|Oxytocin|oxytocin|mesh-list
154567579|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
154567580|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154567581|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567582|NCT05497700|Norepinephrine|norepinephrine|mesh-list
154567583|NCT05497700|Ephedrine|ephedrine|mesh-list
154567584|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154567585|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154567586|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
154291438|NCT03692416|Analgesics|analgesics|mesh-ancestor
154567587|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567588|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567589|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567590|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
154567591|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
154567592|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567593|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154567594|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154567595|NCT03106389|Misoprostol|misoprostol|mesh-list
154567596|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154567597|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
154567598|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154567599|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567600|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154567601|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154567602|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
154567603|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154567604|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154567605|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567606|NCT02255045|Diclofenac|diclofenac|mesh-list
154567607|NCT02255045|Meloxicam|meloxicam|mesh-list
154567608|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154567609|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154567610|NCT02255045|Analgesics|analgesics|mesh-ancestor
154567611|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
154567612|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567613|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567614|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567615|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567616|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154567617|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567618|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567619|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154567620|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154567622|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154146744|NCT00732407|Aliskiren|aliskiren|mesh-list
154567623|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567624|NCT02150447|Lansoprazole|lansoprazole|mesh-list
154567625|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154567626|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154567627|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154567628|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567629|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567630|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154567631|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567632|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567633|NCT02229955|Cyclosporine|cyclosporine|mesh-list
154567634|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154567635|NCT02229955|Cyclosporins|cyclosporins|mesh-list
154567636|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567637|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567638|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154567639|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
154567640|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567641|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
154567642|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567643|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
154567644|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567645|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154567646|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154567647|NCT02230033|Itraconazole|itraconazole|mesh-list
154567648|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
154567649|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
154567650|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567651|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154567652|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154567653|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567654|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567655|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154567656|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
154567657|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567658|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567659|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154567660|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154567661|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
154567662|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154567663|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154291502|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
154567664|NCT02223949|Alprostadil|alprostadil|mesh-list
154567665|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154567666|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
154567667|NCT02223949|Urological Agents|urological agents|mesh-ancestor
154567668|NCT02691507|Decanoic acid|decanoic acid|mesh-list
154567669|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
154567670|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567671|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
154567672|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154567673|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567674|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567675|NCT02151695|Aflibercept|aflibercept|mesh-list
154567676|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154567677|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154567678|NCT02151695|Growth Substances|growth substances|mesh-ancestor
154567679|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567680|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
154567681|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567682|NCT02151929|Everolimus|everolimus|mesh-list
154567683|NCT02151929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154567684|NCT02151929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154567685|NCT02151929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567686|NCT02151929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567687|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154567688|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
154567689|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567690|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567692|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
154567693|NCT03542357|Sumatriptan|sumatriptan|mesh-list
154567694|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154567695|NCT03542357|Katacalcin|katacalcin|mesh-list
154567696|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154567697|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154567698|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154567699|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
154567700|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567701|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567702|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567703|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154567704|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154567705|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
154567706|NCT04811001|Osimertinib|osimertinib|mesh-list
154567707|NCT04811001|Dacomitinib|dacomitinib|mesh-list
154567708|NCT04811001|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154567709|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154567710|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567711|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567712|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567713|NCT02150993|Ritonavir|ritonavir|mesh-list
154567714|NCT02150993|Lopinavir|lopinavir|mesh-list
154567715|NCT02150993|Tenofovir|tenofovir|mesh-list
154567716|NCT02150993|Lamivudine|lamivudine|mesh-list
154567717|NCT02150993|Emtricitabine|emtricitabine|mesh-list
154567718|NCT02150993|Zidovudine|zidovudine|mesh-list
154567719|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
154567720|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154567721|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154567722|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154567723|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
154567724|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567725|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567726|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154567727|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154567728|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
154567729|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567730|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154567731|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154567732|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154567733|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154567734|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
154567735|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154567736|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154567737|NCT02690727|Tenalisib|tenalisib|mesh-list
154567738|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154567739|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567740|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567742|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154567743|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
154567744|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154567745|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
154567746|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154567747|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
154567748|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567749|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
154567750|NCT02224105|Hormones|hormones|mesh-ancestor
154567751|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567752|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567753|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154567754|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567755|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
154567756|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
154567757|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567758|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154567759|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154567760|NCT02224105|Protective Agents|protective agents|mesh-ancestor
154567761|NCT02156375|Ustekinumab|ustekinumab|mesh-list
154567762|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
154567763|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
154567764|NCT03542279|Hormones|hormones|mesh-ancestor
154567765|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567766|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567767|NCT02230735|Epinephrine|epinephrine|mesh-list
154567768|NCT02230735|Racepinephrine|racepinephrine|mesh-list
154567769|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
154567770|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154567771|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154567772|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
154567773|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567774|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567775|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567776|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154567777|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154567778|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
154567779|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567780|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154567781|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
154567782|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
154567783|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
154567784|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154567785|NCT02258581|Tenofovir|tenofovir|mesh-list
154567786|NCT02258581|Vesatolimod|vesatolimod|mesh-list
154567787|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
154567788|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567789|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154567790|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154567791|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567792|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567793|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154567794|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154567795|NCT03165825|Dexamethasone|dexamethasone|mesh-list
154567796|NCT03165825|Betamethasone|betamethasone|mesh-list
154567797|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567798|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
154567799|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
154567800|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567801|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567802|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154567803|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
154567804|NCT03165825|Hormones|hormones|mesh-ancestor
154567805|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567806|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154567807|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567808|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154567809|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
154567810|NCT03167853|Antibodies|antibodies|mesh-list
154567811|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154567812|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
154567813|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567814|NCT05746143|Zolpidem|zolpidem|mesh-list
154291657|NCT03636906|Vaccines|vaccines|mesh-list
154567815|NCT05746143|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154567816|NCT05746143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154567817|NCT05746143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567818|NCT05746143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567819|NCT05746143|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154567820|NCT05746143|GABA Agonists|gaba agonists|mesh-ancestor
154567821|NCT05746143|GABA Agents|gaba agents|mesh-ancestor
154567822|NCT05746143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567823|NCT05746143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567824|NCT03165591|Vaccines|vaccines|mesh-list
154567825|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
154567826|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567827|NCT03114813|Carvedilol|carvedilol|mesh-list
154567828|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154567829|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154567830|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
154567831|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567832|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567833|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567834|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154567835|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
154567836|NCT03114813|Protective Agents|protective agents|mesh-ancestor
154567837|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154567838|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567839|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154567840|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
154567841|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154567842|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154567844|NCT01358864|Ribavirin|ribavirin|mesh-list
154567845|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
154567846|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567847|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
154567848|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567849|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
154567850|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567851|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
154567852|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567853|NCT02750761|Tedizolid|tedizolid|mesh-list
154567854|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
154567855|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
154567856|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154567857|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567858|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154567859|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567860|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567861|NCT02814019|Idebenone|idebenone|mesh-list
154567862|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
154567863|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567864|NCT02814019|Protective Agents|protective agents|mesh-ancestor
154567865|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567866|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
154567867|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
154567868|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154567869|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154567870|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567871|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567872|NCT03364244|Urological Agents|urological agents|mesh-ancestor
154567873|NCT03165123|Azithromycin|azithromycin|mesh-list
154567874|NCT03165123|Dexamethasone|dexamethasone|mesh-list
154567875|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567876|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
154567877|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
154567878|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567879|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567880|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154567881|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
154567882|NCT03165123|Hormones|hormones|mesh-ancestor
154567883|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567884|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154567885|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567886|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154567887|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567888|NCT01131169|Vidarabine|vidarabine|mesh-list
154567889|NCT01131169|Fludarabine|fludarabine|mesh-list
154567891|NCT01131169|Melphalan|melphalan|mesh-list
154567892|NCT01131169|Busulfan|busulfan|mesh-list
154567893|NCT01131169|Lenograstim|lenograstim|mesh-list
154567894|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567895|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154567896|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
154567897|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567898|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154567899|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
154567900|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567901|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
154567902|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154567903|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154567904|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154567905|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
154567906|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154567907|NCT02688933|Insulin|insulin|mesh-list
154567908|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154567909|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
154567910|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154567911|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567912|NCT00882505|Vitamin D|vitamin d|mesh-list
154567913|NCT00882505|Vitamins|vitamins|mesh-ancestor
154567914|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
154567915|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567916|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154567917|NCT04480359|Meloxicam|meloxicam|mesh-list
154567918|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154567919|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154567921|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
154567922|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567923|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567924|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154567925|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154567926|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154567927|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154567928|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567929|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567930|NCT03724825|Testosterone|testosterone|mesh-list
154567931|NCT03724825|Androgens|androgens|mesh-ancestor
154567932|NCT03724825|Hormones|hormones|mesh-ancestor
154567933|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154567934|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567935|NCT04227704|Ketamine|ketamine|mesh-list
154567936|NCT04227704|Analgesics|analgesics|mesh-ancestor
154147043|NCT00507429|Paclitaxel|paclitaxel|mesh-list
154567937|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
154567938|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567939|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567940|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154567941|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154567942|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
154567943|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
154567944|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154567945|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154567946|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154567947|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567948|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567949|NCT03720613|Naloxegol|naloxegol|mesh-list
154567950|NCT03720613|Lubiprostone|lubiprostone|mesh-list
154567951|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154567952|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567953|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567954|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154567955|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567956|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
154567957|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567958|NCT02709512|Cisplatin|cisplatin|mesh-list
154567959|NCT02709512|Carboplatin|carboplatin|mesh-list
154567960|NCT02709512|Pemetrexed|pemetrexed|mesh-list
154567961|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154567962|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154567963|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567964|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154567965|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154567966|NCT03659929|Amphetamine|amphetamine|mesh-list
154567967|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154567968|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567969|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
154567970|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
154567971|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154567972|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
154567973|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154567974|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567975|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
154567976|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154567977|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154567978|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567979|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154567980|NCT03448081|Calcipotriene|calcipotriene|mesh-list
154567981|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
154567982|NCT02232607|Lacidipine|lacidipine|mesh-list
154567983|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154567984|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154567985|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154567986|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567987|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154567988|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154567989|NCT02232685|Choline|choline|mesh-list
154567990|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
154567991|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154567992|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
154567993|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154567994|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154567995|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154567996|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
154567997|NCT02232763|Losartan|losartan|mesh-list
154567998|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154567999|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154568000|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154568001|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154568002|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568003|NCT04294784|Paclitaxel|paclitaxel|mesh-list
154568004|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154568005|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154568006|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154568007|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568008|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
154568009|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
154568010|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
154568011|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568012|NCT04294784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568013|NCT02262559|Telmisartan|telmisartan|mesh-list
154568014|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154568015|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154568016|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154568017|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568018|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
154568019|NCT05491460|Apixaban|apixaban|mesh-list
154568020|NCT05491460|Edoxaban|edoxaban|mesh-list
154568021|NCT05491460|Dabigatran|dabigatran|mesh-list
154568022|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154568023|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
154568024|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154568025|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
154568026|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568027|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568028|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
154568029|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
154568030|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154568031|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154568032|NCT02762929|Bupivacaine|bupivacaine|mesh-list
154568033|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
154568034|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
154568035|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154568036|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568037|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
154291873|NCT03576066|Tenofovir|tenofovir|mesh-list
154568039|NCT02262637|Telmisartan|telmisartan|mesh-list
154568040|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154568041|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154568042|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154568043|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154568044|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568045|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154568046|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154568047|NCT02262637|Diuretics|diuretics|mesh-ancestor
154568048|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
154568049|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568050|NCT01662986|Bromides|bromides|mesh-list
154568051|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
154568052|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154568053|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
154568054|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568055|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568056|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154568057|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
154568058|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
154568059|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154568060|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
154568061|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568062|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568063|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
154568064|NCT05497232|Pancrelipase|pancrelipase|mesh-list
154568065|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568066|NCT00054158|Thalidomide|thalidomide|mesh-list
154568068|NCT00054158|Doxorubicin|doxorubicin|mesh-list
154568069|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154568070|NCT00054158|Vincristine|vincristine|mesh-list
154568071|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568072|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
154568073|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
154568074|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568075|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568076|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568077|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
154568078|NCT00054158|Hormones|hormones|mesh-ancestor
154568079|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568080|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154568081|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568082|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154568083|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154568084|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154568085|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568086|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568087|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154568088|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
154568089|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
154568090|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
154568091|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568092|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
154568093|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
154568094|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568095|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568096|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154862100|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154568097|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154568098|NCT00054158|Growth Substances|growth substances|mesh-ancestor
154568099|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
154568100|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154568101|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
154568102|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568103|NCT05496764|Dexamethasone|dexamethasone|mesh-list
154568104|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568105|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
154568106|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
154568107|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568108|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568109|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568110|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
154568111|NCT05496764|Hormones|hormones|mesh-ancestor
154568112|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568113|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154568114|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568115|NCT05496530|Triamcinolone|triamcinolone|mesh-list
154568116|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154568117|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154568118|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154568119|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568120|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
154568121|NCT05496530|Hormones|hormones|mesh-ancestor
154568122|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568123|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568124|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568125|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
154568126|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568127|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568128|NCT02744833|Enoxaparin|enoxaparin|mesh-list
154568129|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
154568130|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
154568131|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154568132|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154568133|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568134|NCT02234869|Interferons|interferons|mesh-list
154568135|NCT02234869|Interferon-beta|interferon-beta|mesh-list
154568136|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
154568137|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
154568138|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568139|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
154568140|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568142|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568143|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154568144|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154568145|NCT05499026|Cathartics|cathartics|mesh-ancestor
154568146|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568147|NCT05498714|Lactulose|lactulose|mesh-list
154568148|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568149|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
154568150|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
154568151|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154568152|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
154568153|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568154|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
154568155|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568156|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568157|NCT01338025|Lamivudine|lamivudine|mesh-list
154568158|NCT01338025|Emtricitabine|emtricitabine|mesh-list
154568159|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154568160|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154568161|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568162|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568163|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
154568164|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568165|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154568166|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154568167|NCT05498636|Prednisone|prednisone|mesh-list
154568168|NCT05498636|Etoposide|etoposide|mesh-list
154568169|NCT05498636|Lenalidomide|lenalidomide|mesh-list
154568170|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568171|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
154568172|NCT05498636|Hormones|hormones|mesh-ancestor
154568173|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568174|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568175|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154568176|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568177|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154568178|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154568179|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154568180|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568181|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568182|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
154568183|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154568184|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154568185|NCT05498636|Growth Substances|growth substances|mesh-ancestor
154568186|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
154568187|NCT02262715|Oseltamivir|oseltamivir|mesh-list
154568188|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
154568189|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568190|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568191|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568192|NCT04424420|Acetaminophen|acetaminophen|mesh-list
154568193|NCT04424420|Ibuprofen|ibuprofen|mesh-list
154568194|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154568195|NCT04424420|Analgesics|analgesics|mesh-ancestor
154568196|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
154568197|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568198|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568199|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
154568200|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154568201|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568202|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568203|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154568204|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568205|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568206|NCT02233075|Interferons|interferons|mesh-list
154568207|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
154568208|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
154568209|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154568210|NCT02233075|REP 2139|rep 2139|mesh-list
154568211|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568212|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
154568213|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568214|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
154568215|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568216|NCT04300244|Nivolumab|nivolumab|mesh-list
154568217|NCT04300244|Ipilimumab|ipilimumab|mesh-list
154862101|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154568218|NCT04300244|Sargramostim|sargramostim|mesh-list
154568219|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568220|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568221|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154568222|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568223|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
154568224|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568225|NCT02578771|Methylene Blue|methylene blue|mesh-list
154568226|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568227|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568228|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
154568229|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154568230|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
154568231|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
154568232|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568233|NCT02259595|Expectorants|expectorants|mesh-ancestor
154568234|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
154568235|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154568236|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
154568237|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568238|NCT02259595|Protective Agents|protective agents|mesh-ancestor
154568239|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568240|NCT02259595|Antidotes|antidotes|mesh-ancestor
154568241|NCT02804035|Furosemide|furosemide|mesh-list
154568242|NCT02804035|Diuretics|diuretics|mesh-ancestor
154568243|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
154568244|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568245|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154568246|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154568247|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568248|NCT02262793|Telmisartan|telmisartan|mesh-list
154568249|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154147376|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
154568250|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154568251|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154568252|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568253|NCT02559206|Linaclotide|linaclotide|mesh-list
154568254|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154568255|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
154568256|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568257|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568258|NCT04402723|Cytarabine|cytarabine|mesh-list
154568259|NCT04402723|Daunorubicin|daunorubicin|mesh-list
154568260|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568261|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
154568262|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568263|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568264|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
154568265|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568266|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568267|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
154568268|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568269|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154568270|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154568271|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154568272|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568273|NCT02235337|Riboflavin|riboflavin|mesh-list
154568274|NCT02235337|Vitamins|vitamins|mesh-ancestor
154568275|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
154568276|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568277|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
154568278|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154568279|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
154568280|NCT02233231|Varenicline|varenicline|mesh-list
154568281|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154568282|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154568283|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
154568284|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568285|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568286|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568287|NCT02263027|Vaccines|vaccines|mesh-list
154568288|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
154568289|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568290|NCT02263105|Temozolomide|temozolomide|mesh-list
153370260|NCT02484885|Xenon|xenon|mesh-list
154568291|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154568292|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
154568293|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568294|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568295|NCT05485064|Fentanyl|fentanyl|mesh-list
154568296|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154568297|NCT05485064|Narcotics|narcotics|mesh-ancestor
154568298|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154568299|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568300|NCT05485064|Analgesics|analgesics|mesh-ancestor
154568301|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
154568302|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568303|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154568304|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154568305|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
154568306|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
154568307|NCT05626153|Anesthetics|anesthetics|mesh-list
154568308|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154568309|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568310|NCT02553343|Vaccines|vaccines|mesh-list
154568311|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
154568312|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568313|NCT02235415|Lacidipine|lacidipine|mesh-list
154568314|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154568315|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154568316|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154568317|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568318|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154568319|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568320|NCT03995017|Nivolumab|nivolumab|mesh-list
154568321|NCT03995017|Ramucirumab|ramucirumab|mesh-list
154568322|NCT03995017|Rucaparib|rucaparib|mesh-list
154568323|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568324|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568325|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154568326|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568327|NCT03995017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154568328|NCT03995017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154568329|NCT03995017|Growth Substances|growth substances|mesh-ancestor
154568330|NCT03995017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568331|NCT03995017|Growth Inhibitors|growth inhibitors|mesh-ancestor
154568332|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154568333|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568334|NCT02558894|Durvalumab|durvalumab|mesh-list
154568335|NCT02558894|Tremelimumab|tremelimumab|mesh-list
154568336|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154568337|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568338|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568339|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
154568340|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568341|NCT02233387|Imidazole|imidazole|mesh-list
154568342|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568343|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568344|NCT02510599|Solithromycin|solithromycin|mesh-list
154568345|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568346|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568347|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
154568348|NCT02235805|Cathartics|cathartics|mesh-ancestor
154568349|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568350|NCT02688387|Ambrisentan|ambrisentan|mesh-list
154568351|NCT02688387|Tadalafil|tadalafil|mesh-list
154568352|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
154147486|NCT06137924|Clonidine|clonidine|mesh-list
154568353|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154568354|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154568355|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568356|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568357|NCT02688387|Urological Agents|urological agents|mesh-ancestor
154568358|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154568359|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
154568360|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154568361|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154862102|NCT02574078|Growth Substances|growth substances|mesh-ancestor
154862103|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568362|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568363|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154568364|NCT05489900|Analgesics|analgesics|mesh-ancestor
154568365|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
154568366|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568367|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154568368|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154568369|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154568370|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
154568371|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568372|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568374|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
154568375|NCT05489666|Vitamins|vitamins|mesh-ancestor
154568376|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
154568377|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568378|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154568379|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154568380|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154568381|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568382|NCT05483894|Atorvastatin|atorvastatin|mesh-list
154568383|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154568384|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154568385|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
154568386|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568387|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154568388|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154568389|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568390|NCT01621243|Paclitaxel|paclitaxel|mesh-list
154568391|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154568392|NCT01621243|Gemcitabine|gemcitabine|mesh-list
154568393|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154568394|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568395|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
154568396|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
154568397|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154568398|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568399|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568400|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
154568401|NCT04076761|Trifluridine|trifluridine|mesh-list
154568402|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
154568403|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568404|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
154568405|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568406|NCT02235961|Liraglutide|liraglutide|mesh-list
154568407|NCT02235961|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154568408|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154568409|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568410|NCT02235961|Incretins|incretins|mesh-ancestor
154568411|NCT02235961|Hormones|hormones|mesh-ancestor
154568412|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568413|NCT01610245|Oseltamivir|oseltamivir|mesh-list
154568414|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
154568415|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
154568416|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568417|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568418|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568419|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154568420|NCT04138628|Atezolizumab|atezolizumab|mesh-list
154568421|NCT04138628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154568422|NCT04138628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568423|NCT04138628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568424|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568425|NCT02741791|Bupropion|bupropion|mesh-list
154568426|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154568427|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
154568428|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154568429|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154568430|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154568431|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154568432|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568433|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
154568434|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568435|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568436|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154568437|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154568438|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568439|NCT04275518|Cytarabine|cytarabine|mesh-list
154568440|NCT04275518|Azacitidine|azacitidine|mesh-list
154568441|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568442|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
154568443|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568444|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568445|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
154568446|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568447|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568448|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
154568449|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568450|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568451|NCT02263495|Paclitaxel|paclitaxel|mesh-list
154568452|NCT02263495|Gemcitabine|gemcitabine|mesh-list
154568453|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154568454|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568455|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
154568456|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
154568457|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
154568458|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568459|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568460|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
154568461|NCT02687451|Oxymorphone|oxymorphone|mesh-list
154568462|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154568463|NCT02687451|Narcotics|narcotics|mesh-ancestor
154568464|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154568465|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568466|NCT02687451|Analgesics|analgesics|mesh-ancestor
154568467|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
154568468|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568469|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154568470|NCT02557646|Ribavirin|ribavirin|mesh-list
154568471|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154568472|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
154568473|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568474|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
154568475|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568476|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
154568477|NCT02679573|Linezolid|linezolid|mesh-list
154568478|NCT02679573|Delafloxacin|delafloxacin|mesh-list
154568479|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568480|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568481|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154568482|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154568483|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568484|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568485|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568486|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154568487|NCT05493332|Leucovorin|leucovorin|mesh-list
154568488|NCT05493332|Fluorouracil|fluorouracil|mesh-list
154568490|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
154568491|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568492|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568493|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568494|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568495|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
154568496|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568497|NCT05493332|Antidotes|antidotes|mesh-ancestor
154568498|NCT05493332|Protective Agents|protective agents|mesh-ancestor
154568499|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
154568500|NCT05493332|Vitamins|vitamins|mesh-ancestor
154568501|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
154568502|NCT01591447|Solithromycin|solithromycin|mesh-list
154568503|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568504|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568505|NCT01578655|Prednisone|prednisone|mesh-list
154568506|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568507|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
154568508|NCT01578655|Hormones|hormones|mesh-ancestor
154568509|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568510|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568511|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154568512|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568513|NCT01577173|Cetuximab|cetuximab|mesh-list
154568514|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568515|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568516|NCT01573351|Interferons|interferons|mesh-list
154568517|NCT01573351|Ribavirin|ribavirin|mesh-list
154568518|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
154568519|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
154568520|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154568521|NCT01573351|Asunaprevir|asunaprevir|mesh-list
154568522|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568523|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
154568524|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568525|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
154568526|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568527|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
154568528|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568529|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
154568530|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568531|NCT02685033|Dalbavancin|dalbavancin|mesh-list
154568532|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568533|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568534|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
154568535|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
154568536|NCT00258427|Busulfan|busulfan|mesh-list
154568537|NCT00258427|Fludarabine|fludarabine|mesh-list
154568538|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
154568539|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154568540|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568541|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
154568542|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568543|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568544|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154568545|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
154568546|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568547|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568548|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154568549|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568550|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
154568551|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568552|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
154568553|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
154568554|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568555|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568556|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
154568557|NCT00258427|Hormones|hormones|mesh-ancestor
154568558|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568559|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154568560|NCT00258427|Protective Agents|protective agents|mesh-ancestor
154568561|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
154568562|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154253748|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568563|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154568564|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568565|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154568566|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154568568|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154568569|NCT02233621|Estrogens|estrogens|mesh-ancestor
154568570|NCT02233621|Hormones|hormones|mesh-ancestor
154568571|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568572|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568573|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154568574|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
154568575|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154568576|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154568577|NCT02557100|Adalimumab|adalimumab|mesh-list
154568578|NCT02557100|Methotrexate|methotrexate|mesh-list
154568579|NCT02557100|Abatacept|abatacept|mesh-list
154568580|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154568581|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
154568582|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154568583|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568584|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568585|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
154568586|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568587|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568588|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
154862104|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
154568589|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568590|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154568591|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568592|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
154568593|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568594|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154568595|NCT02557100|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154568596|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568597|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154568598|NCT02557100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568599|NCT02233777|Pregabalin|pregabalin|mesh-list
154568600|NCT02233777|Analgesics|analgesics|mesh-ancestor
154568601|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
154568602|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568603|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568604|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
154568605|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154568606|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154568607|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568608|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154568609|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154568610|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154568611|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154568612|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154568613|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154568614|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154568615|NCT01520545|Baclofen|baclofen|mesh-list
154568616|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154568617|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568618|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154568619|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568620|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154568621|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
154568622|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
154568623|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568624|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568625|NCT05488106|Riboflavin|riboflavin|mesh-list
154568626|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
154568627|NCT05488106|Vitamins|vitamins|mesh-ancestor
154568628|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
154568629|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568630|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154568631|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
154568632|NCT05492318|Clarithromycin|clarithromycin|mesh-list
154568633|NCT05492318|Midazolam|midazolam|mesh-list
154568634|NCT05492318|Dabigatran|dabigatran|mesh-list
154568635|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154568636|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154568637|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154568638|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154568639|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568640|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154568641|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154568642|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154568643|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154568644|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
154568645|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
154568646|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
154568647|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
154568648|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568649|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568650|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568651|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568652|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154568653|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568654|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153471298|NCT05764811|Canagliflozin|canagliflozin|mesh-list
154568655|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154568656|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
154568657|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154568658|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
154568659|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
154568660|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154568662|NCT01337635|Vitamins|vitamins|mesh-ancestor
154568663|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
154568664|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568665|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154568666|NCT02264041|Itraconazole|itraconazole|mesh-list
154568667|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
154568669|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154568670|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154568671|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568672|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568673|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154568674|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
154568675|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568676|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568677|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154568678|NCT02261779|Tretinoin|tretinoin|mesh-list
154568679|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
154568680|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568681|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
154568682|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
154568683|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
154568684|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154568685|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154568686|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568687|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568688|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154568689|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154568690|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154568691|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568692|NCT05157685|Azithromycin|azithromycin|mesh-list
154568693|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568694|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568695|NCT02556632|Curcumin|curcumin|mesh-list
154568696|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154568697|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154568698|NCT02556632|Analgesics|analgesics|mesh-ancestor
154568699|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
154568700|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568701|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568702|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568703|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568704|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568705|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568706|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568707|NCT05491928|Tempol|tempol|mesh-list
154568708|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
154568709|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568710|NCT05491928|Protective Agents|protective agents|mesh-ancestor
154568711|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568712|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154568713|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568714|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154568715|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154568716|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
154568717|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568718|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568719|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154568720|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154568721|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568722|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568723|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568724|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154568725|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154568726|NCT02262169|Omeprazole|omeprazole|mesh-list
154568727|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154568728|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568729|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154568730|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568731|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568732|NCT05491694|Paclitaxel|paclitaxel|mesh-list
154568733|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
154568734|NCT05491694|Carboplatin|carboplatin|mesh-list
154568735|NCT05491694|Epirubicin|epirubicin|mesh-list
154568736|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154568737|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568738|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
154568739|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
154568740|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
154568741|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568742|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568743|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
154568744|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568745|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568746|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154568747|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
154568748|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154568749|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154568750|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154568751|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154568752|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568754|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154568755|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
154568756|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568757|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568758|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568759|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154568760|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154568761|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154568762|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154568763|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154568764|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
154568765|NCT03922880|Nivolumab|nivolumab|mesh-list
154568766|NCT03922880|Ipilimumab|ipilimumab|mesh-list
154568767|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568768|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568769|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154568770|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568771|NCT02264119|Pantoprazole|pantoprazole|mesh-list
154568772|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154568773|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568774|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154568775|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568776|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568777|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
154568778|NCT02262481|Progestins|progestins|mesh-ancestor
154568779|NCT02262481|Hormones|hormones|mesh-ancestor
154568780|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568781|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568782|NCT01435369|Pidilizumab|pidilizumab|mesh-list
154568783|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154568784|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568785|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154568786|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154568787|NCT01252693|Goserelin|goserelin|mesh-list
154568788|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154568789|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568790|NCT01486849|Riluzole|riluzole|mesh-list
154568791|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
154568792|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154568793|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154568794|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568795|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568796|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568797|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154568798|NCT01486849|Protective Agents|protective agents|mesh-ancestor
154568799|NCT01484119|Cetirizine|cetirizine|mesh-list
154568800|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154568801|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154568802|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154568803|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
154568804|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
154568805|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568806|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568807|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568808|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154568809|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
154568810|NCT01482403|Ribavirin|ribavirin|mesh-list
154568811|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
154568812|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568813|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
154568814|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568815|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
154568816|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568817|NCT01481077|Latanoprost|latanoprost|mesh-list
154568818|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154568819|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154568820|NCT02268409|Luspatercept|luspatercept|mesh-list
154568821|NCT02268409|Hematinics|hematinics|mesh-ancestor
154568822|NCT02268487|Sertraline|sertraline|mesh-list
154568823|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
154568824|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154568825|NCT02268487|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154568826|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154568827|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154568828|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568829|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568830|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
154568831|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568832|NCT02265289|Clopidogrel|clopidogrel|mesh-list
154568833|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154568834|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154568835|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154568836|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154568837|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
154568838|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568839|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568840|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568841|NCT02265445|beta-Lactams|beta-lactams|mesh-list
154568842|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568843|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568844|NCT04476121|Aspirin|aspirin|mesh-list
154568845|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154568846|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154568847|NCT04476121|Analgesics|analgesics|mesh-ancestor
154568848|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
154568849|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568850|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568851|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568852|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568853|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154568854|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154568855|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568856|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154568857|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154568858|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568859|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
154568860|NCT01234519|Doxorubicin|doxorubicin|mesh-list
154568861|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154253749|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568862|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568863|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154568864|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154568865|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568866|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568867|NCT01474135|Travoprost|travoprost|mesh-list
154568868|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154568869|NCT02268565|Aspirin|aspirin|mesh-list
154568870|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154568871|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154568872|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154568873|NCT02268565|Analgesics|analgesics|mesh-ancestor
154568874|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
154568875|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568876|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568877|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568878|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154568879|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154568880|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568881|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154568882|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154568883|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568884|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
154568885|NCT05479448|Prednisone|prednisone|mesh-list
154568886|NCT05479448|Hormones|hormones|mesh-list
154862105|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568887|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568888|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
154568889|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568890|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568891|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154568892|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568893|NCT02264587|Domperidone|domperidone|mesh-list
154568894|NCT02264587|Mosapride|mosapride|mesh-list
154568895|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
154568896|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
154568897|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154568898|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568899|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154568900|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154568901|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
154568902|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154568903|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568904|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154568905|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
154568906|NCT05475080|Anticoagulants|anticoagulants|mesh-list
154568907|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154568908|NCT02683941|Lanreotide|lanreotide|mesh-list
154568909|NCT02683941|Somatostatin|somatostatin|mesh-list
154568910|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568911|NCT02683941|Hormones|hormones|mesh-ancestor
154568912|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568913|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568914|NCT01225393|Adalimumab|adalimumab|mesh-list
154568915|NCT01225393|Methotrexate|methotrexate|mesh-list
154568916|NCT01225393|Leflunomide|leflunomide|mesh-list
154568917|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154568918|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
154568919|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154568920|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568921|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568922|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
154568923|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568924|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568925|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
154568926|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568927|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154568928|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568929|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
154568930|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568931|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154568932|NCT01225393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154568933|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568934|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154253750|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154568935|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154568936|NCT02264743|Estradiol|estradiol|mesh-list
154568937|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154568938|NCT02264743|Estrogens|estrogens|mesh-ancestor
154568939|NCT02264743|Hormones|hormones|mesh-ancestor
154568940|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568941|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568942|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154568943|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
154568944|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154568945|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154568946|NCT01220947|Ritonavir|ritonavir|mesh-list
154568947|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154568948|NCT01220947|Lactams|lactams|mesh-list
154568949|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154568950|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154568951|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
154568952|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568953|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568954|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154568955|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154568956|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
154568957|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568958|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154862106|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
154568959|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154568960|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568961|NCT01393639|Prednisone|prednisone|mesh-list
154568962|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154568963|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
154568964|NCT01393639|Hormones|hormones|mesh-ancestor
154568965|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154568966|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568967|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154568968|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568969|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
154568970|NCT01379209|Sirolimus|sirolimus|mesh-list
154568971|NCT01379209|Methotrexate|methotrexate|mesh-list
154568972|NCT01379209|KRN 7000|krn 7000|mesh-list
154568973|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154568974|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154568975|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
154568976|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154568977|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154568978|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154568979|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
154568980|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154568981|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568982|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
154568983|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154568984|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154568985|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154568986|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
154568987|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154568988|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154568989|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154568990|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154568991|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
154568992|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154568993|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154568994|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
154568995|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154568996|NCT01204099|Docetaxel|docetaxel|mesh-list
154568997|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154568998|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
154568999|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
154569000|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
154569001|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569002|NCT01188187|Dexamethasone|dexamethasone|mesh-list
154569003|NCT01188187|Prednisone|prednisone|mesh-list
154569004|NCT01188187|Docetaxel|docetaxel|mesh-list
154569005|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569006|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
154569007|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
154569008|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569009|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569010|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154569011|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
154569012|NCT01188187|Hormones|hormones|mesh-ancestor
154569013|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154569014|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154569016|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
154569017|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
154569018|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
154569019|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569020|NCT05478356|Atropine|atropine|mesh-list
154569021|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154569022|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154569023|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154569024|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154569025|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154569026|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
154569027|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569028|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569029|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154569030|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
154569031|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
154569032|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
154569033|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154569034|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154569035|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
154862107|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154569036|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569037|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569038|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154569039|NCT01186861|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154569040|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154569041|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569042|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569043|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569044|NCT01175785|Cyclosporine|cyclosporine|mesh-list
154569045|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
154569046|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
154569047|NCT01175785|Fludarabine|fludarabine|mesh-list
154569048|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
154569049|NCT01175785|Cyclosporins|cyclosporins|mesh-list
154569050|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154569051|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
154569052|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569053|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569054|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154569055|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
154569056|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569057|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569058|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154569059|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154569060|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
154569061|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569062|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
154569063|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569064|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154569065|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154569066|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154569067|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154569068|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
154569069|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569070|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
154569071|NCT05478044|Vitamins|vitamins|mesh-ancestor
154569072|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
154569073|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569074|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
154569075|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569076|NCT05478044|Protective Agents|protective agents|mesh-ancestor
154569077|NCT01445899|Ranibizumab|ranibizumab|mesh-list
154569078|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154569079|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154569080|NCT01445899|Growth Substances|growth substances|mesh-ancestor
154569081|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569082|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
154569083|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569084|NCT03649724|Leuprolide|leuprolide|mesh-list
154569085|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154569086|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
154039813|NCT05589896|Mesna|mesna|mesh-list
154569087|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154569088|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569089|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154569090|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569091|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
154569092|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154569093|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154569094|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154569095|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154569096|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569097|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
154569098|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569099|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569100|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154569101|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569102|NCT02266303|Insulin|insulin|mesh-list
154569103|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154569104|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569105|NCT02551874|Metformin|metformin|mesh-list
154569106|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
154569107|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
154569108|NCT02551874|Saxagliptin|saxagliptin|mesh-list
154569109|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154255552|NCT03894800|Fentanyl|fentanyl|mesh-list
154862108|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862109|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154569110|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569111|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154569112|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569113|NCT02551874|Incretins|incretins|mesh-ancestor
154569114|NCT02551874|Hormones|hormones|mesh-ancestor
154569115|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154569116|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154569117|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
154569118|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569119|NCT03646604|Upadacitinib|upadacitinib|mesh-list
154569120|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154569121|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154569122|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569123|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569124|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569125|NCT01354717|Fluorouracil|fluorouracil|mesh-list
154569126|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
154569127|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569128|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154569129|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569130|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154569131|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
154569132|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569133|NCT01072981|Gemcitabine|gemcitabine|mesh-list
154569134|NCT01072981|Fluorouracil|fluorouracil|mesh-list
154569135|NCT01072981|Pancrelipase|pancrelipase|mesh-list
154569136|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
154569137|NCT01072981|Immunomodulating Agents|immunomodulating agents|mesh-list
154569138|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154569139|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
154569140|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569141|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569142|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154569143|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569144|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154569145|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154569146|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
154569147|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154569148|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
154569149|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569150|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
154569151|NCT03347708|Protective Agents|protective agents|mesh-ancestor
154569152|NCT01159249|Vildagliptin|vildagliptin|mesh-list
154569153|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154569154|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569155|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154569156|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
154569157|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569158|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569159|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154569160|NCT01156753|Immunoconjugates|immunoconjugates|mesh-ancestor
154569161|NCT01156753|Immunologic Factors|immunologic factors|mesh-ancestor
154569162|NCT01156753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569163|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154569164|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569165|NCT01345045|Pregabalin|pregabalin|mesh-list
154569166|NCT01345045|Analgesics|analgesics|mesh-ancestor
154569167|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
154569168|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569169|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569170|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
154569171|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154569172|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154569173|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569174|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154569175|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154569176|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154569177|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569178|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154569179|NCT01344187|Riboflavin|riboflavin|mesh-list
154569180|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154569181|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
154569182|NCT01344187|Vitamins|vitamins|mesh-ancestor
154862110|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154569184|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569185|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154569186|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
154569187|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154569189|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
154569190|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154569191|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154569192|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569193|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569194|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
154569195|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569196|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154569197|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154569198|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154569199|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154569200|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154569201|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154569202|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154569203|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154569204|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154569205|NCT05625919|Sirolimus|sirolimus|mesh-list
154569206|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569207|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569208|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154569209|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569210|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
154569211|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154569212|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
154569213|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569214|NCT02266537|Doxazosin|doxazosin|mesh-list
154569215|NCT02266537|Tamsulosin|tamsulosin|mesh-list
154569216|NCT02266537|Alfuzosin|alfuzosin|mesh-list
154569217|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154569218|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154569219|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154569220|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
154569221|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569222|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569223|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569224|NCT02266537|Urological Agents|urological agents|mesh-ancestor
154569225|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154569226|NCT02269735|Insulin|insulin|mesh-list
154569227|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154569228|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
154569229|NCT02269735|MK-2640|mk-2640|mesh-list
154569230|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154569231|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569232|NCT01038739|Mesalamine|mesalamine|mesh-list
154569233|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154569234|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154569235|NCT01038739|Analgesics|analgesics|mesh-ancestor
154569236|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
154569237|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569238|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569239|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569240|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569241|NCT01336465|Etrolizumab|etrolizumab|mesh-list
154569242|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154569243|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
154569244|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569245|NCT02769065|Donepezil|donepezil|mesh-list
154569246|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154569247|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569248|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569249|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
154569250|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569251|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569252|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
154569253|NCT02540954|Aflibercept|aflibercept|mesh-list
154569254|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154569255|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154569256|NCT02540954|Growth Substances|growth substances|mesh-ancestor
154569257|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569258|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
154569259|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569260|NCT05265975|Rituximab|rituximab|mesh-list
154569261|NCT05265975|Lenalidomide|lenalidomide|mesh-list
154569262|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154569263|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569264|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
154569265|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569266|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569267|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154569268|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154569269|NCT05265975|Growth Substances|growth substances|mesh-ancestor
154569270|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
154569271|NCT02151305|Remifentanil|remifentanil|mesh-list
154569272|NCT02151305|Propofol|propofol|mesh-list
154569273|NCT02151305|Sevoflurane|sevoflurane|mesh-list
154569274|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154569275|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569276|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569277|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154569278|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
154569279|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
154569280|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154569281|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154569282|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154569283|NCT02151305|Narcotics|narcotics|mesh-ancestor
154569284|NCT02151305|Analgesics|analgesics|mesh-ancestor
154569285|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
154569286|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569287|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
154569288|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154569289|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
154569290|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569291|NCT03164421|Expectorants|expectorants|mesh-ancestor
154569292|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
154569293|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154569294|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
154569295|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569296|NCT03164421|Protective Agents|protective agents|mesh-ancestor
154569297|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569298|NCT03164421|Antidotes|antidotes|mesh-ancestor
154569299|NCT05228613|Vaccines|vaccines|mesh-list
154569300|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
154569301|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569302|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154569303|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154569304|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569305|NCT02628704|Dexamethasone|dexamethasone|mesh-list
154569306|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569307|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
154569308|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
154569309|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569310|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569311|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154569312|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
154569313|NCT02628704|Hormones|hormones|mesh-ancestor
154569314|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154569315|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154569316|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569318|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154569319|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154569320|NCT02152475|Analgesics|analgesics|mesh-ancestor
154569321|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
154569322|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569323|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569324|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569325|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569326|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569327|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569328|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569329|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
154569330|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154862111|NCT02574078|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154569331|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569332|NCT03161457|Rituximab|rituximab|mesh-list
154569333|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154569334|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569335|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
154569336|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569337|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569338|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154569339|NCT02159573|Natalizumab|natalizumab|mesh-list
154569340|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
154569341|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569342|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
154569343|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154569344|NCT02152709|Vaccines|vaccines|mesh-list
154569345|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
154569346|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569347|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
154569348|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
154569349|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569350|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569351|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154569352|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154569353|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569354|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569355|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569356|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569357|NCT03164109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154569358|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
154569359|NCT03164109|Protective Agents|protective agents|mesh-ancestor
154569360|NCT02152787|Propofol|propofol|mesh-list
154569361|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154569362|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569363|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569364|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154569365|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
154569366|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
154569367|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
154569368|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
154569369|NCT00154375|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154569370|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154569371|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569372|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569373|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569374|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
154569375|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154569376|NCT02765399|Liraglutide|liraglutide|mesh-list
154569377|NCT02765399|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154569378|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154569379|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569380|NCT02765399|Incretins|incretins|mesh-ancestor
154569381|NCT02765399|Hormones|hormones|mesh-ancestor
154569382|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154569383|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154569384|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154569385|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154569386|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154569387|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154569389|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
154569390|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569391|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569392|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569393|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569394|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154569395|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154569396|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154569397|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
154569398|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
154862112|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154862113|NCT03605914|Acetaminophen|acetaminophen|mesh-list
154862114|NCT03605914|Diclofenac|diclofenac|mesh-list
154862115|NCT03605914|Hydrocodone|hydrocodone|mesh-list
154862116|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154862117|NCT03605914|Analgesics|analgesics|mesh-ancestor
154862118|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
154862119|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862120|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569399|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569400|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569401|NCT02269969|Tobramycin|tobramycin|mesh-list
154569402|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569403|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569404|NCT03232424|Temozolomide|temozolomide|mesh-list
154569405|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154569406|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
154569407|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569408|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569409|NCT03163407|Norepinephrine|norepinephrine|mesh-list
154569410|NCT03163407|Ephedrine|ephedrine|mesh-list
154569411|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154569412|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154569413|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
154569414|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569415|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569416|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569417|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
154569418|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
154569419|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569420|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154569421|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154569422|NCT02547974|Vaccines|vaccines|mesh-list
154569423|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
154569424|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569425|NCT00154297|Everolimus|everolimus|mesh-list
154569426|NCT00154297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154569427|NCT00154297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154569428|NCT00154297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569429|NCT00154297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569430|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154569431|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
154569432|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569433|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569434|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
154569435|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154569436|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569437|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569438|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154569439|NCT02270281|Analgesics|analgesics|mesh-ancestor
154569440|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
154569441|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569442|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154569443|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154569444|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154569445|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
154569446|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569447|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569448|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154569449|NCT01033123|Iniparib|iniparib|mesh-list
154569450|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569451|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569452|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569453|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
154569454|NCT03163173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154569455|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
154569456|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569457|NCT03163173|Protective Agents|protective agents|mesh-ancestor
154569458|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569459|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
154569460|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154569461|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569462|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569463|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154569464|NCT03162861|Anesthetics|anesthetics|mesh-list
154569465|NCT03162861|Propofol|propofol|mesh-list
154569466|NCT03162861|Sevoflurane|sevoflurane|mesh-list
154569467|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569468|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569469|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154569470|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154569471|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
154862121|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
154569472|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154569473|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154569475|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154569476|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
154569477|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569478|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569479|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
154569480|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
154569481|NCT02156843|Vitamins|vitamins|mesh-ancestor
154569482|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
154569483|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569484|NCT02675907|Meloxicam|meloxicam|mesh-list
154569485|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154569486|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154569487|NCT02675907|Analgesics|analgesics|mesh-ancestor
154569488|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
154569489|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569490|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569491|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569492|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569493|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154569494|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154569495|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569496|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569497|NCT02152865|Lupeol|lupeol|mesh-list
154569498|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569499|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154569500|NCT02152943|Trastuzumab|trastuzumab|mesh-list
154569501|NCT02152943|Everolimus|everolimus|mesh-list
154569502|NCT02152943|Letrozole|letrozole|mesh-list
154569503|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154569504|NCT02152943|Antibodies|antibodies|mesh-list
154569505|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
154569506|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154569507|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
154569508|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569509|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569510|NCT02152943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154569511|NCT02152943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154569512|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569513|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569514|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154569515|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154569516|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154569517|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154569518|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
154569519|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154569520|NCT02156999|Vitamin D|vitamin d|mesh-list
154569521|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
154569522|NCT02156999|Vitamins|vitamins|mesh-ancestor
154569523|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
154569524|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569525|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154569526|NCT02159651|Tacrolimus|tacrolimus|mesh-list
154569527|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154569528|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
154569529|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569530|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154569531|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569532|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569533|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154569534|NCT02774681|Trastuzumab|trastuzumab|mesh-list
154569535|NCT02774681|Palbociclib|palbociclib|mesh-list
154569536|NCT02774681|Antibodies|antibodies|mesh-list
154569537|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
154569539|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
154569540|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569541|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569542|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154569543|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569544|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569545|NCT02157311|Tenofovir|tenofovir|mesh-list
154569546|NCT02157311|Lamivudine|lamivudine|mesh-list
154569547|NCT02157311|Emtricitabine|emtricitabine|mesh-list
154569548|NCT02157311|Efavirenz|efavirenz|mesh-list
154569549|NCT02157311|Lopinavir|lopinavir|mesh-list
154569551|NCT02157311|Darunavir|darunavir|mesh-list
154569552|NCT02157311|Abacavir|abacavir|mesh-list
154569553|NCT02157311|Rilpivirine|rilpivirine|mesh-list
154569554|NCT02157311|Etravirine|etravirine|mesh-list
154569555|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
154569556|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569557|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154569558|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154569559|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569560|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569561|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154569562|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154569563|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154569564|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154569565|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154569566|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154569567|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154569568|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154569569|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154569570|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154569571|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
154569572|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154569573|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
154569574|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154569575|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154569576|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569577|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
154569578|NCT04784039|Coagulants|coagulants|mesh-ancestor
154569579|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
154569580|NCT02157467|BMS-955176|bms-955176|mesh-list
154569581|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154569582|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569583|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569584|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154569585|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154569586|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569587|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569588|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569589|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154569590|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
154569591|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154569592|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569593|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154569594|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154569595|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154569596|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154569597|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154569598|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
154569599|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154569600|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
154569601|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154569602|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
154569603|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154569604|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569605|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154569606|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154569607|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569608|NCT00152971|Enoxaparin|enoxaparin|mesh-list
154569609|NCT00152971|Dabigatran|dabigatran|mesh-list
154569610|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
154569611|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154569612|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154569613|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569614|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
154569615|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154569616|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
154569617|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569618|NCT02538614|Idelalisib|idelalisib|mesh-list
154569619|NCT02538614|BI 836826|bi 836826|mesh-list
154569620|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569621|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569622|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862122|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154569623|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154569625|NCT03504644|Venetoclax|venetoclax|mesh-list
154569626|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154569627|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569628|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
154569629|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
154569630|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
154569631|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569632|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154569633|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154569634|NCT02160275|Insulin|insulin|mesh-list
154569635|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154569636|NCT02160275|Pancrelipase|pancrelipase|mesh-list
154569637|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154569638|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569639|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154569640|NCT03126968|Epinephrine|epinephrine|mesh-list
154569641|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154569642|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154569643|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
154569644|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569645|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569646|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569647|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154569648|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154569649|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
154569650|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569651|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154569652|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
154569653|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
154569654|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
154569655|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154569656|NCT02266849|Loperamide|loperamide|mesh-list
154569657|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
154569658|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154569659|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154569660|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154569661|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154569662|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154569663|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569664|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569665|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569666|NCT01309945|Analgesics|analgesics|mesh-ancestor
154569667|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
154569668|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569669|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
154569670|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154569671|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
154569672|NCT02153567|Escitalopram|escitalopram|mesh-list
154569673|NCT02153567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154569674|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154569675|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154569676|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569677|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569678|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
154569679|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569680|NCT02441660|Capsaicin|capsaicin|mesh-list
154569681|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
154569682|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
154569683|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
154569684|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569685|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569686|NCT01303783|Candesartan|candesartan|mesh-list
154569687|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
154569688|NCT01303783|Nifedipine|nifedipine|mesh-list
154569689|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154569690|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154569691|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154569692|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569693|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154569694|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154569695|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154569696|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569697|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
154569698|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
154569699|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154569700|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
154569701|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154569702|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154569703|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569704|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
154569705|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154569707|NCT02153879|Fenofibrate|fenofibrate|mesh-list
154569708|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154569709|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
154569710|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569711|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154569712|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
154569713|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
154569714|NCT02153879|Vitamins|vitamins|mesh-ancestor
154569715|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
154569716|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569717|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
154569718|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154569719|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569720|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569721|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154569722|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154569723|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569724|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569725|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569726|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154569727|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
154569728|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154569729|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569730|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154569731|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154569732|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154569733|NCT02160743|Metformin|metformin|mesh-list
154569734|NCT02160743|Atorvastatin|atorvastatin|mesh-list
154569735|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154569736|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569737|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154569738|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154569739|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
154569740|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569741|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154569742|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154569743|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569744|NCT02158013|Diltiazem|diltiazem|mesh-list
154569745|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154569746|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154569747|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154569748|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569749|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154569750|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569751|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
154569752|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
154569753|NCT01023295|Combretastatin|combretastatin|mesh-list
154569754|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154569755|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569756|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
154569757|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
154569758|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
154569759|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569760|NCT05468138|Antibodies|antibodies|mesh-list
154569761|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
154569762|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569763|NCT01140217|Norethindrone|norethindrone|mesh-list
154569764|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
154569765|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154569766|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154255566|NCT03900026|Evolocumab|evolocumab|mesh-list
154862123|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862124|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154862125|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154569767|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154569768|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
154569769|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154569770|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569771|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154569772|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154569773|NCT01297543|Lenograstim|lenograstim|mesh-list
154569774|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154569775|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
154569776|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569777|NCT03541265|Bupivacaine|bupivacaine|mesh-list
154569778|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
154569779|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
154569780|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569781|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569782|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
154569783|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569784|NCT02547038|Amoxicillin|amoxicillin|mesh-list
154569785|NCT02547038|Metronidazole|metronidazole|mesh-list
154569786|NCT02547038|Clarithromycin|clarithromycin|mesh-list
154569787|NCT02547038|Tetracycline|tetracycline|mesh-list
154569788|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154569789|NCT02547038|Pantoprazole|pantoprazole|mesh-list
154569790|NCT02547038|Bismuth|bismuth|mesh-list
154569791|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569792|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569793|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154569794|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154569795|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154569796|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569797|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569798|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154569799|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154569800|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154569801|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154569802|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154569803|NCT02547038|Antacids|antacids|mesh-ancestor
154569804|NCT02161055|Insulin|insulin|mesh-list
154569805|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154569806|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154569807|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569808|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154569809|NCT02764697|Hormones|hormones|mesh-ancestor
154569810|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154569811|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569812|NCT02266927|Fluticasone|fluticasone|mesh-list
154569813|NCT02266927|Xhance|xhance|mesh-list
154569814|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569815|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154569816|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
154569817|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569818|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569819|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154569820|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
154569821|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
154569822|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154569823|NCT02158481|Carotenoids|carotenoids|mesh-list
154569824|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
154569825|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569826|NCT02158481|Protective Agents|protective agents|mesh-ancestor
154569827|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569828|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154569829|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569830|NCT01020565|Entecavir|entecavir|mesh-list
154569831|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
154569832|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569833|NCT01020097|Fluorides|fluorides|mesh-list
154569834|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
154569835|NCT01020097|Protective Agents|protective agents|mesh-ancestor
154569836|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569837|NCT02154269|Lenograstim|lenograstim|mesh-list
154569838|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154569839|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
154569840|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569842|NCT03738683|Piperacillin|piperacillin|mesh-list
154569843|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154862126|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569844|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569845|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569846|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154569847|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569848|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569849|NCT04475887|Iron|iron|mesh-list
154569850|NCT04475887|Trace Elements|trace elements|mesh-ancestor
154569851|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
154569852|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569853|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
154569854|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154569855|NCT02267239|Listerine|listerine|mesh-list
154569856|NCT02267239|Hexetidine|hexetidine|mesh-list
154569857|NCT02267239|Menthol|menthol|mesh-list
154569858|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
154569859|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154569860|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569861|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
154569862|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
154569863|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
154569864|NCT02267239|Protective Agents|protective agents|mesh-ancestor
154569865|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569866|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
154569867|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
154569868|NCT02766023|Metronidazole|metronidazole|mesh-list
154569869|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569870|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569871|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154569872|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154569873|NCT05466500|Dexamethasone|dexamethasone|mesh-list
154569874|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
154569875|NCT05466500|Bupivacaine|bupivacaine|mesh-list
154569876|NCT05466500|BB 1101|bb 1101|mesh-list
154569877|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154569878|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
154569879|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
154569880|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569881|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569882|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154569883|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
154569884|NCT05466500|Hormones|hormones|mesh-ancestor
154569885|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154569886|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154569887|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569888|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
154569889|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154569890|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569891|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
154569892|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
154569893|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569894|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
154569895|NCT04475107|Artesunate|artesunate|mesh-list
154569896|NCT04475107|Pyronaridine|pyronaridine|mesh-list
154569897|NCT04475107|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154569898|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
154569899|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154569900|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154569901|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569902|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569903|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
154569904|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
154569905|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154569906|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
154569907|NCT02254967|Vancomycin|vancomycin|mesh-list
154569908|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
154569909|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154569910|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569911|NCT05444036|Ketamine|ketamine|mesh-list
154569912|NCT05444036|Analgesics|analgesics|mesh-ancestor
154569913|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
154569914|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293807|NCT05973552|Iron|iron|mesh-list
154569915|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569916|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154569917|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154569918|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
154569919|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
154569920|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154569921|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154569922|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154569923|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569924|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569925|NCT02161367|Simethicone|simethicone|mesh-list
154569926|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
154569927|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569928|NCT02161367|Emollients|emollients|mesh-ancestor
154569929|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
154569931|NCT03542825|Lactoferrin|lactoferrin|mesh-list
154569932|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
154569933|NCT03542825|Trace Elements|trace elements|mesh-ancestor
154569934|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
154569935|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569936|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569937|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
154569938|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
154569939|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569940|NCT01001923|Fasinumab|fasinumab|mesh-list
154569941|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154569942|NCT01001923|Analgesics|analgesics|mesh-ancestor
154569943|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
154569944|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154569945|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569946|NCT02154503|Minoxidil|minoxidil|mesh-list
154569947|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154569948|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
154569949|NCT02536976|Mirabegron|mirabegron|mesh-list
154569950|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154569951|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154569952|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154569953|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
154569954|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154569955|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569956|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569957|NCT02536976|Urological Agents|urological agents|mesh-ancestor
154569958|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
154569959|NCT00992563|Ranibizumab|ranibizumab|mesh-list
154569960|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154569961|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154569962|NCT00992563|Growth Substances|growth substances|mesh-ancestor
154569963|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569964|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
154569965|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569966|NCT02267707|Paclitaxel|paclitaxel|mesh-list
154569967|NCT02267707|Gemcitabine|gemcitabine|mesh-list
154569968|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154569969|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569970|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
154569971|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
154569972|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
154569973|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569974|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154569975|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
154569976|NCT01373229|Plerixafor|plerixafor|mesh-list
154569977|NCT01373229|Rituximab|rituximab|mesh-list
154569978|NCT01373229|Lenalidomide|lenalidomide|mesh-list
154569979|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154569980|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154569981|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
154569982|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154569983|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154569984|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154569985|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154569986|NCT01373229|Growth Substances|growth substances|mesh-ancestor
154569987|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
154569988|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154569989|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154569990|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
154569991|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154569992|NCT01112527|Dacomitinib|dacomitinib|mesh-list
154569993|NCT01112527|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154569994|NCT01112527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154569996|NCT01112527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569997|NCT02671461|Aspirin|aspirin|mesh-list
154862127|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154569998|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154569999|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570000|NCT02671461|Analgesics|analgesics|mesh-ancestor
154570001|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
154570002|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570003|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570004|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570005|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570006|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154570007|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154570008|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570009|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154570010|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154570011|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570012|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
154570013|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154570014|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
154570015|NCT05467033|Coagulants|coagulants|mesh-ancestor
154570016|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154570017|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
154570018|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570020|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154570021|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570022|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
154570023|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
154570024|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
154570025|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570026|NCT02268019|Epinephrine|epinephrine|mesh-list
154570027|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154570028|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154570029|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
154570030|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570031|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570032|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570033|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154570034|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154570035|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
154570036|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149180|NCT04191096|Hormones|hormones|mesh-ancestor
154570037|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154570038|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
154570039|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
154570040|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
154570041|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154570042|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154570043|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154570044|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
154570045|NCT01110889|Agomelatine|agomelatine|mesh-list
154570046|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154570047|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570048|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570049|NCT01106989|Lidocaine|lidocaine|mesh-list
154570050|NCT01106989|Tetracaine|tetracaine|mesh-list
154570051|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
154570052|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
154570053|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570054|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570055|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
154570056|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570057|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154570058|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154570059|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154570060|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154570061|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570062|NCT00975091|Entecavir|entecavir|mesh-list
154570063|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
154570064|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570065|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
154570066|NCT02535416|Promethazine|promethazine|mesh-list
154570067|NCT02535416|Cetirizine|cetirizine|mesh-list
154293904|NCT05042440|BAX 855|bax 855|mesh-list
154570068|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154570069|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154570070|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570071|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570072|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
154570074|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
154570075|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570076|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
154570077|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
154570078|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154570079|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154570080|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
154570081|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
154570082|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570083|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570084|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154570085|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
154570086|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
154570087|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154570088|NCT00911443|Interferons|interferons|mesh-list
154570089|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
154570090|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
154570091|NCT00911443|Dacarbazine|dacarbazine|mesh-list
154570092|NCT00911443|Thymalfasin|thymalfasin|mesh-list
154149231|NCT04039750|Clindamycin|clindamycin|mesh-list
154570093|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570094|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
154570095|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570096|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
154570097|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570098|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154570099|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
154570100|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570101|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154570102|NCT03949478|Ibuprofen|ibuprofen|mesh-list
154570103|NCT03949478|Nifedipine|nifedipine|mesh-list
154570104|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154570105|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570106|NCT03949478|Analgesics|analgesics|mesh-ancestor
154570107|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
154570108|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570109|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570110|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570111|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570112|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154570113|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570114|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570115|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154570116|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154570117|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154570118|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
154570119|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
154570120|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154570121|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154570122|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
154570123|NCT00909649|Coagulants|coagulants|mesh-ancestor
154570124|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154570125|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
154570126|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570127|NCT04787965|Opicapone|opicapone|mesh-list
154570128|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154570129|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570130|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570131|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154570132|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154570133|NCT02670915|Insulin|insulin|mesh-list
154570134|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154570135|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
154570136|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
154570137|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154570138|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570139|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293980|NCT04639245|Fludarabine|fludarabine|mesh-list
154570140|NCT00821977|Vildagliptin|vildagliptin|mesh-list
154570141|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570142|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149287|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570143|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154570144|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
154570145|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600449|NCT01884298|Lidocaine|lidocaine|mesh-list
154570146|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570148|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154570149|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
154570150|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154570151|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
154570152|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570153|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570154|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154570155|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154570156|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570157|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
154570158|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
154570159|NCT00961675|Dexamethasone|dexamethasone|mesh-list
154570160|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
154570161|NCT00961675|Povidone|povidone|mesh-list
154570162|NCT00961675|BB 1101|bb 1101|mesh-list
154570163|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570164|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
154570165|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
154570166|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570167|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570168|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154570169|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
154570170|NCT00961675|Hormones|hormones|mesh-ancestor
154570171|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570172|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154570173|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570174|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
154570175|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570176|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570177|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154570178|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570179|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154570180|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154570181|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154570182|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154149336|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
154570183|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
154570184|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
154570185|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154570186|NCT00819169|Conatumumab|conatumumab|mesh-list
154570187|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154570188|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570189|NCT02161679|Carboplatin|carboplatin|mesh-list
154570190|NCT02161679|Camptothecin|camptothecin|mesh-list
154570191|NCT02161679|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154570192|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
154570193|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570194|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
154570195|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570196|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154570197|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154570198|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154570199|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570200|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570201|NCT00955981|Lesinurad|lesinurad|mesh-list
154570202|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
154570203|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570204|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
154570205|NCT03541031|Micronutrients|micronutrients|mesh-list
154570206|NCT03541031|Trace Elements|trace elements|mesh-list
154570207|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570208|NCT02154737|Gemcitabine|gemcitabine|mesh-list
154570209|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154570210|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154570211|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
154570212|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570213|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570214|NCT02154737|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154570215|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154570216|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570217|NCT00813163|Irinotecan|irinotecan|mesh-list
154570218|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154570219|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154570220|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570221|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570222|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570223|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154570224|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154570225|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
154570226|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
154570227|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154570228|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570229|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570230|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
154570231|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154570232|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570233|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570235|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154570236|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154570237|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570238|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154570239|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154570240|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
154570241|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570242|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154570243|NCT02161991|Aprepitant|aprepitant|mesh-list
154570244|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
154570245|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
154570246|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570247|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570248|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154570249|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154570250|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570251|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570252|NCT00948961|Poly I-C|poly i-c|mesh-list
154570253|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154570254|NCT00948961|Poly ICLC|poly iclc|mesh-list
154570255|NCT00948961|Resiquimod|resiquimod|mesh-list
154570256|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
154570257|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
154570258|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570259|NCT00948961|Laxatives|laxatives|mesh-ancestor
154570260|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154570261|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
154570262|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570263|NCT00948961|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154570264|NCT00948961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570265|NCT00948961|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154570266|NCT02159105|Chrysarobin|chrysarobin|mesh-list
154570267|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154570268|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570269|NCT02159105|Analgesics|analgesics|mesh-ancestor
154570270|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
154570271|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570272|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570273|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570274|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570275|NCT00890305|Pidilizumab|pidilizumab|mesh-list
154570276|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154570277|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570278|NCT01661972|Capecitabine|capecitabine|mesh-list
154570279|NCT01661972|Aflibercept|aflibercept|mesh-list
154570280|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154570281|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
154570282|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570283|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570284|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154149427|NCT03810742|Irinotecan|irinotecan|mesh-list
154570285|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154570286|NCT01661972|Growth Substances|growth substances|mesh-ancestor
154570287|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570288|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
154570289|NCT02155049|Bimatoprost|bimatoprost|mesh-list
154570290|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154570291|NCT03540953|Mitomycins|mitomycins|mesh-list
154570292|NCT03540953|Mitomycin|mitomycin|mesh-list
154570293|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154570294|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570295|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
154570296|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570297|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154570298|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570299|NCT00888355|Losartan|losartan|mesh-list
154570300|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154570301|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154570302|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154570303|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154570304|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570305|NCT00794677|Ezetimibe|ezetimibe|mesh-list
154570306|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154570307|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154570308|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
154570309|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570310|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154570311|NCT00792727|Ketoprofen|ketoprofen|mesh-list
154570312|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154570313|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570314|NCT00792727|Analgesics|analgesics|mesh-ancestor
154570315|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
154570316|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570317|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570318|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570319|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570320|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154570321|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570322|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570323|NCT00945763|Ibuprofen|ibuprofen|mesh-list
154570324|NCT00945763|Meloxicam|meloxicam|mesh-list
154570325|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154570326|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570327|NCT00945763|Analgesics|analgesics|mesh-ancestor
154570328|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
154570329|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570330|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570331|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570332|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570333|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154570334|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570335|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570336|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154570337|NCT02770391|Leuprolide|leuprolide|mesh-list
154570338|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154570339|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
154570340|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154570341|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570342|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154570343|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570344|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
154570345|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154570346|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570347|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154570348|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154570349|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570350|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570351|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570352|NCT02162303|Colchicine|colchicine|mesh-list
154570353|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
154570354|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570355|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
154570356|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
154570357|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
154570358|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570359|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570360|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
154570361|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
154570362|NCT05430308|Povidone|povidone|mesh-list
154570363|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154570364|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570365|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
154253751|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154570366|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
154570367|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
154570368|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
154862128|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154570369|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570370|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
154570371|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570372|NCT04707703|Isavuconazole|isavuconazole|mesh-list
154570373|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
154570374|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570375|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
154570376|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154570377|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570378|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154570379|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154570380|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570381|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570382|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570383|NCT00934921|Ondansetron|ondansetron|mesh-list
154570384|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
154570385|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
154570386|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570387|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570388|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154570389|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
154570390|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
154570391|NCT00934921|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154570392|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154570393|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
154570394|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570395|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570396|NCT05429450|Triamcinolone|triamcinolone|mesh-list
154570397|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154570398|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154570399|NCT05429450|Methotrexate|methotrexate|mesh-list
154570400|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154570401|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154570402|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
154570403|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154570404|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570405|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154570406|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
154570407|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570408|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570409|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
154570410|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570411|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154570412|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154570413|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
154570414|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570415|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154570416|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570417|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
154570418|NCT05429450|Hormones|hormones|mesh-ancestor
154570419|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570420|NCT00103259|Irinotecan|irinotecan|mesh-list
154570421|NCT00103259|Bortezomib|bortezomib|mesh-list
154570422|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154570423|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154570424|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570425|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570426|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570427|NCT02162381|Methylphenidate|methylphenidate|mesh-list
154570428|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154570429|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570430|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154570431|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154570432|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154570433|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570434|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
154570435|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570436|NCT00782431|Vaccines|vaccines|mesh-list
154570437|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
154570438|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570439|NCT02155439|Triamcinolone|triamcinolone|mesh-list
154294293|NCT00488605|Leucovorin|leucovorin|mesh-list
154570440|NCT02155439|Fluorouracil|fluorouracil|mesh-list
154570441|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
154862129|NCT03605914|Narcotics|narcotics|mesh-ancestor
154570442|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570443|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154570444|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570445|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154570446|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
154570447|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570448|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570449|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
154570450|NCT02155439|Hormones|hormones|mesh-ancestor
154570451|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570452|NCT02544152|Lubiprostone|lubiprostone|mesh-list
154570453|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154570454|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154570455|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570456|NCT02162537|Bevacizumab|bevacizumab|mesh-list
154570457|NCT02162537|Pemetrexed|pemetrexed|mesh-list
154570458|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154570459|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570460|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154570461|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154570462|NCT02162537|Growth Substances|growth substances|mesh-ancestor
154570463|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570464|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
154570465|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570466|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570467|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154570468|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154570469|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
154570470|NCT00864175|Docetaxel|docetaxel|mesh-list
154570471|NCT00864175|Trastuzumab|trastuzumab|mesh-list
154570472|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570473|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
154570474|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
154570475|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
154570476|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570477|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154570478|NCT02166593|Atorvastatin|atorvastatin|mesh-list
154570479|NCT02166593|Pravastatin|pravastatin|mesh-list
154570480|NCT02166593|Fenofibrate|fenofibrate|mesh-list
154570481|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154570482|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154570483|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
154570484|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570485|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154570486|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154570487|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570488|NCT00858871|Sorafenib|sorafenib|mesh-list
154570489|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570490|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154570491|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570492|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570493|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
154570494|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154570495|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
154570496|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570497|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
154570498|NCT02162693|Protective Agents|protective agents|mesh-ancestor
154570499|NCT02163161|Abrocitinib|abrocitinib|mesh-list
154570500|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154570501|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570502|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570503|NCT00917293|Pyridoxal|pyridoxal|mesh-list
154570504|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
154570505|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
154570506|NCT00917293|Vitamins|vitamins|mesh-ancestor
154570507|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
154570508|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570509|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154570510|NCT00845299|Latanoprost|latanoprost|mesh-list
154570511|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
154570512|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154570513|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154570514|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154570515|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570516|NCT02255591|Lidocaine|lidocaine|mesh-list
154570518|NCT02255591|Racepinephrine|racepinephrine|mesh-list
154570519|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
154570520|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
154570521|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
154570522|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570523|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570524|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
154570525|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570526|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154570527|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154570528|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154570529|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154570530|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570531|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154570532|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154570533|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
154570534|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570535|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154570536|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154570537|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
154570538|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154570539|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
154570540|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
154570541|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
154570542|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154570543|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154570544|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
154570545|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570546|NCT02167061|Metformin|metformin|mesh-list
154570547|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570548|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570549|NCT03715465|Melatonin|melatonin|mesh-list
154570550|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
154570551|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570552|NCT03715465|Protective Agents|protective agents|mesh-ancestor
154570553|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570554|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570555|NCT02171039|Dabigatran|dabigatran|mesh-list
154570556|NCT02171039|Atorvastatin|atorvastatin|mesh-list
154570557|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154570558|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154570559|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
154570560|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570561|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154570562|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154570563|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570564|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
154570565|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154570566|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
154570567|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
154570568|NCT00840073|Trandolapril|trandolapril|mesh-list
154149715|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154570569|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154570570|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
154570571|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570572|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570573|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154570574|NCT02261207|Axitinib|axitinib|mesh-list
154570575|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570576|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154570577|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570578|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570579|NCT00838279|Lamotrigine|lamotrigine|mesh-list
154570580|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
154570581|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154570582|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154570583|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570584|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154570585|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570586|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154570587|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154570588|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294429|NCT03658720|Analgesics|analgesics|mesh-ancestor
154570589|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154570590|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154570592|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
154570593|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570594|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154570595|NCT00769795|Goserelin|goserelin|mesh-list
154570596|NCT00769795|Bicalutamide|bicalutamide|mesh-list
154570597|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154570598|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570599|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
154570600|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
154570601|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570602|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570603|NCT03134677|Bupivacaine|bupivacaine|mesh-list
154570604|NCT03134677|Sevoflurane|sevoflurane|mesh-list
154570605|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
154570606|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
154570607|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570608|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570609|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
154570610|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570611|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154570612|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154570613|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
154570614|NCT00722917|Pioglitazone|pioglitazone|mesh-list
154570615|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570616|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570617|NCT02164097|Heparin|heparin|mesh-list
154570618|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
154570619|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154570620|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154570621|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570622|NCT00717457|Exenatide|exenatide|mesh-list
154570623|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154570624|NCT00717457|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154570625|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570626|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570627|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154570628|NCT00717457|Incretins|incretins|mesh-ancestor
154570629|NCT00717457|Hormones|hormones|mesh-ancestor
154570630|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570631|NCT02171507|Diclofenac|diclofenac|mesh-list
154570632|NCT02171507|Dabigatran|dabigatran|mesh-list
154570633|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154570634|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570635|NCT02171507|Analgesics|analgesics|mesh-ancestor
154570636|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
154570637|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570638|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570639|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570640|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570641|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154570642|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570643|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570644|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
154570645|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154570646|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
154570647|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
154570648|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154570649|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154570650|NCT00758953|Danazol|danazol|mesh-list
154570651|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154570652|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
154570653|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570654|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570655|NCT02167685|Brincidofovir|brincidofovir|mesh-list
154570656|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
154570657|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570658|NCT00758563|Triclosan|triclosan|mesh-list
154570659|NCT00758563|Fluorides|fluorides|mesh-list
154570660|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
154570661|NCT00758563|Protective Agents|protective agents|mesh-ancestor
154570662|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570663|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154862130|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570664|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570665|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154570666|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154570667|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
154570668|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570669|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154570670|NCT02171585|Clarithromycin|clarithromycin|mesh-list
154570672|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154570673|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570674|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154570675|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570676|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570677|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154570678|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154570679|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
154570680|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154570681|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
154570682|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
154570683|NCT03134443|Andrographolide|andrographolide|mesh-list
154570684|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570685|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154570686|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570687|NCT03134443|Analgesics|analgesics|mesh-ancestor
154570688|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
154570689|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570690|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570691|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570692|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154570693|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154570694|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570695|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
154570696|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154570697|NCT02171663|Afatinib|afatinib|mesh-list
154570698|NCT02171663|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154570699|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154570700|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570701|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570702|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570703|NCT02171741|Docetaxel|docetaxel|mesh-list
154570704|NCT02171741|Afatinib|afatinib|mesh-list
154570705|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570706|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
154570707|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
154570708|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
154570709|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570710|NCT02171741|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154570711|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154570712|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570713|NCT00835705|Amoxicillin|amoxicillin|mesh-list
154570714|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154570715|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
154570716|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
154570717|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154570718|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570719|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154570720|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570721|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570722|NCT00713401|Esmolol|esmolol|mesh-list
154570723|NCT00713401|Tecadenoson|tecadenoson|mesh-list
154570724|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154570725|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154570726|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154570727|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
154570728|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570729|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570730|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570731|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154570732|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
154570733|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
154570734|NCT02171975|Anesthetics|anesthetics|mesh-list
154570735|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570736|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570737|NCT00835549|Cefdinir|cefdinir|mesh-list
154570738|NCT00835549|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154570739|NCT00835549|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154570740|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154570741|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570742|NCT02164253|Deferiprone|deferiprone|mesh-list
154570743|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154570744|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
154570745|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
154570746|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570747|NCT00755287|Metformin|metformin|mesh-list
154570748|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
154570749|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154570750|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570751|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570752|NCT00755287|Incretins|incretins|mesh-ancestor
154570753|NCT00755287|Hormones|hormones|mesh-ancestor
154570754|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570755|NCT02168075|Mannitol|mannitol|mesh-list
154570756|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154570757|NCT02168075|Diuretics|diuretics|mesh-ancestor
154570758|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
154570759|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570760|NCT00712699|Adderall|adderall|mesh-list
154570761|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154570762|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570763|NCT03945825|Vaccines|vaccines|mesh-list
154570764|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
154570765|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570766|NCT02759315|Ruzasvir|ruzasvir|mesh-list
154570767|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
154570768|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
154570769|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570770|NCT00697099|Enoxaparin|enoxaparin|mesh-list
154570771|NCT00697099|Semuloparin|semuloparin|mesh-list
154570772|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
154570773|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
154570774|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154570775|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154570776|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570777|NCT02172131|Olodaterol|olodaterol|mesh-list
154570778|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154570779|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
154570780|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570781|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570782|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154570783|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
154570784|NCT05435768|Denosumab|denosumab|mesh-list
154570785|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154570786|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570787|NCT00835081|Cefadroxil|cefadroxil|mesh-list
154570788|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154570789|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570790|NCT02543918|Ixekizumab|ixekizumab|mesh-list
154570791|NCT02543918|Vaccines|vaccines|mesh-list
154570792|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154570793|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
154570794|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570795|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
154570796|NCT03539003|Remifentanil|remifentanil|mesh-list
154570797|NCT03539003|Propofol|propofol|mesh-list
154570798|NCT03539003|Sevoflurane|sevoflurane|mesh-list
154570799|NCT03539003|Desflurane|desflurane|mesh-list
154570800|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154570801|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570802|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570803|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154570804|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
154570805|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
154570806|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154570807|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154570808|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154570809|NCT03539003|Narcotics|narcotics|mesh-ancestor
154570810|NCT03539003|Analgesics|analgesics|mesh-ancestor
154570811|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
154570812|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570813|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
154570814|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154570815|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154570816|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570817|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
154570819|NCT04265534|Folic Acid|folic acid|mesh-list
154570820|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
154570821|NCT04265534|Dexamethasone|dexamethasone|mesh-list
154862131|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
154570822|NCT04265534|Carboplatin|carboplatin|mesh-list
154570823|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
154570824|NCT04265534|Pemetrexed|pemetrexed|mesh-list
154570825|NCT04265534|Vitamins|vitamins|mesh-ancestor
154570826|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
154570827|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570828|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570829|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
154570830|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
154570831|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570832|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154570833|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
154570834|NCT04265534|Hormones|hormones|mesh-ancestor
154570835|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570836|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154570837|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570838|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154570839|NCT04265534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154570840|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570841|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570842|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154570843|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154570844|NCT04265534|Hematinics|hematinics|mesh-ancestor
154570845|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
154570846|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
154570847|NCT00750295|Hematinics|hematinics|mesh-ancestor
154570848|NCT02172209|Empagliflozin|empagliflozin|mesh-list
154570849|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154570850|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570851|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570852|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570853|NCT02168543|Alendronate|alendronate|mesh-list
154570854|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154570855|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570856|NCT01372995|Vitamin D|vitamin d|mesh-list
154570857|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
154570858|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
154570859|NCT01372995|Vitamins|vitamins|mesh-list
154570860|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
154570861|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570862|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154570863|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154570864|NCT04239859|Cyclosporine|cyclosporine|mesh-list
154570865|NCT04239859|Methotrexate|methotrexate|mesh-list
154570866|NCT04239859|Acitretin|acitretin|mesh-list
154570867|NCT04239859|Cyclosporins|cyclosporins|mesh-list
154570868|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154570869|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
154570870|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154570871|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570872|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154570873|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
154570874|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570875|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570876|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
154570877|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570878|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154570879|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154570880|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
154570881|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154570882|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154570883|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
154570884|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570885|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154570886|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
154570887|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
154570888|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154570889|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
154570890|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
154570891|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570892|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570893|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570894|NCT02757521|Analgesics|analgesics|mesh-ancestor
154570895|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
154570896|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570897|NCT00744367|Metformin|metformin|mesh-list
154570898|NCT00744367|Pioglitazone|pioglitazone|mesh-list
154570899|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154570900|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570901|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570902|NCT00744367|Incretins|incretins|mesh-ancestor
154570903|NCT00744367|Hormones|hormones|mesh-ancestor
154570904|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570905|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
154570906|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154570907|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154570908|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
154570909|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570910|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570911|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154570912|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
154570913|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
154570914|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154570915|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
154570916|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570917|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570918|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154570919|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154570920|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154570921|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
154570922|NCT02261129|Telmisartan|telmisartan|mesh-list
154570923|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154570924|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154570925|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154570926|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570927|NCT00694135|Dexamethasone|dexamethasone|mesh-list
154570928|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
154570929|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154570930|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154570931|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154570932|NCT00694135|BB 1101|bb 1101|mesh-list
154570933|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154570934|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
154570935|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
154570936|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570937|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570938|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154570939|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
154570940|NCT00694135|Hormones|hormones|mesh-ancestor
154570941|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154570942|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154570943|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154570944|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
154570945|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570946|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570947|NCT03540095|Bupivacaine|bupivacaine|mesh-list
154570948|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
154570949|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
154570950|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570951|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570952|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
154570953|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570954|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
154570955|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154570956|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154570957|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570958|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154570959|NCT03071185|Analgesics|analgesics|mesh-ancestor
154570960|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
154570961|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570962|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154570963|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154570964|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154570965|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
154570966|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570967|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570968|NCT00741715|Atorvastatin|atorvastatin|mesh-list
154570969|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154570970|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154570972|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570973|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154570974|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154570975|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154570976|NCT02169167|Octenidine|octenidine|mesh-list
154570977|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154570978|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154570979|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
154570980|NCT02172443|Ipratropium|ipratropium|mesh-list
154570981|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154570982|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
154570983|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154570984|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570985|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154570986|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
154570987|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
154570988|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154570989|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
154570990|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154570991|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154570992|NCT00834613|Metformin|metformin|mesh-list
154570993|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154570994|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154570995|NCT02172521|Bromides|bromides|mesh-list
154570996|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
154570997|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154570998|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
154570999|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571000|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571001|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154571002|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
154571003|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
154571004|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154571005|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
154571006|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571007|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571008|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
154571009|NCT00834535|Cefdinir|cefdinir|mesh-list
154571010|NCT00834535|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154571011|NCT00834535|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154571012|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154571013|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571014|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
154571015|NCT00691717|Anecortave|anecortave|mesh-list
154571016|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154571017|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154571018|NCT00691717|Growth Substances|growth substances|mesh-ancestor
154571019|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571020|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
154571021|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571022|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154571023|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154571024|NCT00834067|Moexipril|moexipril|mesh-list
154571025|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154571026|NCT00834067|Diuretics|diuretics|mesh-ancestor
154571027|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
154571028|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571029|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154571030|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154571031|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571032|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154571033|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571034|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571035|NCT00682981|Carboplatin|carboplatin|mesh-list
154571036|NCT00682981|Etoposide|etoposide|mesh-list
154571037|NCT00682981|Obatoclax|obatoclax|mesh-list
154571038|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571039|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154571040|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154571041|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154571042|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294873|NCT06212622|Oxycodone|oxycodone|mesh-list
154571043|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571044|NCT00833521|Zolpidem|zolpidem|mesh-list
154571045|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154571046|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154571047|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571048|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571049|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154571051|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
154571052|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571053|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571054|NCT00832507|Cicletanine|cicletanine|mesh-list
154571055|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154571056|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154571057|NCT00832507|Diuretics|diuretics|mesh-ancestor
154571058|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
154571059|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571060|NCT02802943|Imiquimod|imiquimod|mesh-list
154571061|NCT02802943|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154571062|NCT02802943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571063|NCT02802943|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154571064|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
154571065|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571066|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154571067|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571068|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
154571069|NCT02165033|Budesonide|budesonide|mesh-list
154571070|NCT02165033|Procaterol|procaterol|mesh-list
154571071|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154571072|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154571073|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
154571074|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571075|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571076|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154571077|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
154571078|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
154571079|NCT02165033|Hormones|hormones|mesh-ancestor
154571080|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154571081|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
154571082|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154571083|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154571084|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154571085|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571086|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571087|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571088|NCT00734461|Naltrexone|naltrexone|mesh-list
154571089|NCT00734461|Oxycodone|oxycodone|mesh-list
154571090|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154571091|NCT00734461|Narcotics|narcotics|mesh-ancestor
154571092|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571093|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571094|NCT00734461|Analgesics|analgesics|mesh-ancestor
154571095|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
154571096|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571097|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154571098|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154571099|NCT02169713|Tamsulosin|tamsulosin|mesh-list
154571100|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
154571101|NCT02169713|Mirabegron|mirabegron|mesh-list
154571102|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154571103|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154571104|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154571105|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571106|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571107|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571108|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571109|NCT02169713|Urological Agents|urological agents|mesh-ancestor
154571110|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154571111|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154571112|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
154571113|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154571114|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154571115|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154571116|NCT03980041|Nivolumab|nivolumab|mesh-list
154571117|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154571118|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601637|NCT01899105|Ivacaftor|ivacaftor|mesh-list
154571119|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154571120|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571121|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154571122|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154571123|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154571124|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571125|NCT00829309|Pravastatin|pravastatin|mesh-list
154571126|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154571127|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154571128|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
154571129|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571130|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154571131|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154571132|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571133|NCT02165189|Ribavirin|ribavirin|mesh-list
154571134|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
154571135|NCT02165189|Simeprevir|simeprevir|mesh-list
154571136|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
154571137|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571138|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
154571139|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571140|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571141|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571142|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
154571143|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
154571144|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571145|NCT00725881|Protective Agents|protective agents|mesh-ancestor
154571146|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571147|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154571148|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571149|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
154571150|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154571151|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571152|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
154571153|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154571154|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
154571155|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154571156|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571157|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571158|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571159|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
154571160|NCT01950403|Linaclotide|linaclotide|mesh-list
154571161|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154571162|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
154571163|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571164|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571165|NCT03607539|Pemetrexed|pemetrexed|mesh-list
154571166|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571167|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571168|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571169|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154150307|NCT00936962|Vaccines|vaccines|mesh-list
154571170|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154571171|NCT00629941|Azithromycin|azithromycin|mesh-list
154571172|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154571173|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571174|NCT02404779|Cisatracurium|cisatracurium|mesh-list
154571175|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154571176|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154571177|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571178|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571179|NCT00629551|Paroxetine|paroxetine|mesh-list
154571180|NCT00629551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154571181|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154571182|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154571183|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571184|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571185|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
154571186|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571187|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154295022|NCT06052267|Tocolytic Agents|tocolytic agents|mesh-ancestor
154571188|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
154571189|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154571190|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154571191|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154571192|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571193|NCT00625651|Bevacizumab|bevacizumab|mesh-list
154571194|NCT00625651|Conatumumab|conatumumab|mesh-list
154571195|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154571196|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571197|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154571198|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154571199|NCT00625651|Growth Substances|growth substances|mesh-ancestor
154571200|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571201|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
154571202|NCT00672997|Timolol|timolol|mesh-list
154571203|NCT00672997|Travoprost|travoprost|mesh-list
154571204|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154571205|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154571206|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154571207|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154571208|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571209|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571210|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571211|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571212|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154571213|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154571214|NCT02669043|Ketamine|ketamine|mesh-list
154571215|NCT02669043|Analgesics|analgesics|mesh-ancestor
154571216|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
154571217|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571218|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571219|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154571220|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154571221|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
154571222|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
154571223|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571224|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154571225|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154571226|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571227|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571228|NCT02281045|Citric Acid|citric acid|mesh-list
154571229|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
154571230|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
154571231|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154571232|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
154571233|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
154571234|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571235|NCT04472689|Lidocaine|lidocaine|mesh-list
154571236|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
154571237|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
154571238|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571239|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571240|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
154571241|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571242|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154571243|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154571244|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154571245|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154571246|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571247|NCT02405013|Ribavirin|ribavirin|mesh-list
154571248|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
154571249|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154571250|NCT02405013|Ledipasvir|ledipasvir|mesh-list
154571251|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
154571252|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571253|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
154571254|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571255|NCT02173145|Azithromycin|azithromycin|mesh-list
154571256|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154571257|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571258|NCT00670033|Travoprost|travoprost|mesh-list
154571259|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154571260|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154571261|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154253752|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
154571262|NCT02283775|Dexamethasone|dexamethasone|mesh-list
154571263|NCT02283775|Pomalidomide|pomalidomide|mesh-list
154571264|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154571266|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
154571267|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571268|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571269|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571270|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
154571271|NCT02283775|Hormones|hormones|mesh-ancestor
154571272|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154571273|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154571274|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571275|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
154571276|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154571277|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154571278|NCT02283775|Growth Substances|growth substances|mesh-ancestor
154571279|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
154571280|NCT04479891|Itraconazole|itraconazole|mesh-list
154571281|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
154571282|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571283|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154571284|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154571285|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571286|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571287|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154571288|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
154571289|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154571290|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571291|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154571292|NCT02281201|Thrombin|thrombin|mesh-list
154571293|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
154571294|NCT02281201|Coagulants|coagulants|mesh-ancestor
154571295|NCT02281279|Rituximab|rituximab|mesh-list
154571296|NCT02281279|Lenalidomide|lenalidomide|mesh-list
154571297|NCT02281279|Romidepsin|romidepsin|mesh-list
154571298|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154571299|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571300|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
154571301|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571302|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154571303|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154571304|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154571305|NCT02281279|Growth Substances|growth substances|mesh-ancestor
154571306|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
154571307|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154571308|NCT02281279|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154571309|NCT02281279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571310|NCT02281279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571311|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154571312|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154571313|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571314|NCT02173457|Incretins|incretins|mesh-ancestor
154571315|NCT02173457|Hormones|hormones|mesh-ancestor
154571316|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154571317|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154571318|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571319|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571320|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571321|NCT00805129|Everolimus|everolimus|mesh-list
154571322|NCT00805129|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154571323|NCT00805129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154571324|NCT00805129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571325|NCT00805129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571326|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154571327|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
154571328|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571329|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571330|NCT00501709|Abatacept|abatacept|mesh-list
154571331|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154571332|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154571333|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571334|NCT00501709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154862132|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
154862133|NCT04353479|Decitabine|decitabine|mesh-list
154571335|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571336|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
154571337|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571338|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154571339|NCT02273635|Andrographolide|andrographolide|mesh-list
154571340|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154571341|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154571342|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154571344|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
154571345|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571346|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571347|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154571348|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154571349|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154571350|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571351|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
154571352|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154571353|NCT02170415|Pregabalin|pregabalin|mesh-list
154571354|NCT02170415|Anesthetics|anesthetics|mesh-list
154571355|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
154571356|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571357|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571358|NCT02170415|Analgesics|analgesics|mesh-ancestor
154571359|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
154571360|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571361|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
154571362|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154571363|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154571364|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571365|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154571366|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154571367|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154571368|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154571369|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
154571370|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571371|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154571372|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154571373|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150523|NCT00933920|Aliskiren|aliskiren|mesh-list
154571374|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571375|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
154571376|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
154571377|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154571378|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154571379|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
154571380|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571381|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571382|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154571383|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
154571384|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
154571385|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154571386|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
154571387|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571388|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571389|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154571390|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154571391|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154571392|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571393|NCT02274259|Ranibizumab|ranibizumab|mesh-list
154571394|NCT02274259|Aflibercept|aflibercept|mesh-list
154571395|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154571396|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154571397|NCT02274259|Growth Substances|growth substances|mesh-ancestor
154571398|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571399|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
154571400|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571401|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154571402|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154571403|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571404|NCT02404623|Vitamin D|vitamin d|mesh-list
154571405|NCT02404623|Vitamins|vitamins|mesh-ancestor
154571406|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
154571407|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571408|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154571409|NCT02170571|Dabigatran|dabigatran|mesh-list
154862134|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154571410|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
154571411|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154571412|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571413|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571414|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571415|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
154571417|NCT04481841|Vitamin E|vitamin e|mesh-list
154571418|NCT04481841|Riboflavin|riboflavin|mesh-list
154571419|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
154571420|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571421|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
154571422|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
154571423|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571424|NCT04481841|Protective Agents|protective agents|mesh-ancestor
154571425|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154571426|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
154571427|NCT02388477|Doxycycline|doxycycline|mesh-list
154571428|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154571429|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571430|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
154571431|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154571432|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154571433|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154571434|NCT02166359|Icodextrin|icodextrin|mesh-list
154571435|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
154571436|NCT00488839|Baclofen|baclofen|mesh-list
154571437|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154571438|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571439|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154571440|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571441|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154571442|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
154571443|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
154571444|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571445|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571446|NCT02255747|Lactulose|lactulose|mesh-list
154571447|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571448|NCT01654731|Bezafibrate|bezafibrate|mesh-list
154571449|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154571450|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
154571451|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571452|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154571453|NCT00485563|Folic Acid|folic acid|mesh-list
154571454|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
154571455|NCT00485563|Interferons|interferons|mesh-list
154571456|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
154571457|NCT00485563|Interleukin-2|interleukin-2|mesh-list
154571458|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154571459|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571460|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
154571461|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571462|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
154571463|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571464|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154571465|NCT00485563|Analgesics|analgesics|mesh-ancestor
154571466|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
154571467|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571468|NCT00485563|Hematinics|hematinics|mesh-ancestor
154571469|NCT00485563|Vitamins|vitamins|mesh-ancestor
154571470|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
154571471|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154571472|NCT02170805|Pantoprazole|pantoprazole|mesh-list
154571473|NCT02170805|Dabigatran|dabigatran|mesh-list
154571474|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154571475|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571476|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154571477|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571478|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571479|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
154571480|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154571481|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571482|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
154571483|NCT00606697|Vofopitant|vofopitant|mesh-list
154571484|NCT00606697|Vestipitant|vestipitant|mesh-list
154571485|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154571486|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571487|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571488|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571489|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
154571490|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
154571491|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571492|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571494|NCT02404077|Analgesics|analgesics|mesh-ancestor
154571495|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
154571496|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571497|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571498|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154571499|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
154571500|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
154571501|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154571502|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154571503|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154571504|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571505|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571506|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571507|NCT02174939|Cilostazol|cilostazol|mesh-list
154571508|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154571509|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
154571510|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571511|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571512|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154571513|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
154571514|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154571515|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154571516|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571517|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154571518|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
154571519|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154571520|NCT02174939|Protective Agents|protective agents|mesh-ancestor
154571521|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154571522|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154571523|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571524|NCT02404233|Darunavir|darunavir|mesh-list
154571525|NCT02404233|Cobicistat|cobicistat|mesh-list
154571526|NCT02404233|Rilpivirine|rilpivirine|mesh-list
154571527|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154571528|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154571529|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154150712|NCT00502671|Capecitabine|capecitabine|mesh-list
154571530|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571531|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571532|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571533|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154571534|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154571535|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
154571536|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571537|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154571538|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154571539|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154571540|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154571541|NCT00603577|Xaliproden|xaliproden|mesh-list
154571542|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154571543|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154571544|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
154571545|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571546|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571547|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571548|NCT02178293|Ketoprofen|ketoprofen|mesh-list
154571549|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
154571550|NCT02178293|Benzydamine|benzydamine|mesh-list
154571551|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154571552|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154571553|NCT02178293|Analgesics|analgesics|mesh-ancestor
154571554|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
154571555|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571556|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571557|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154571558|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154571559|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154571560|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571561|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571562|NCT03170895|Sorafenib|sorafenib|mesh-list
154571563|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
154862135|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154571564|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571565|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154571566|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571567|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571568|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154571569|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154571570|NCT02277847|Cytarabine|cytarabine|mesh-list
154571571|NCT02277847|Idarubicin|idarubicin|mesh-list
154571572|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154571573|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
154571574|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571575|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571576|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
154571577|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571578|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154571579|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
154571580|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571581|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154571582|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154571583|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154571584|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571585|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
154571586|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154571587|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
154571588|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571589|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571590|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154571591|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
154571592|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154571593|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
154571594|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571595|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571596|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154571597|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
154571598|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
154571599|NCT01457781|Protective Agents|protective agents|mesh-ancestor
154571600|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
154571601|NCT00468403|Abatacept|abatacept|mesh-list
154571602|NCT00468403|Tacrolimus|tacrolimus|mesh-list
154571603|NCT00468403|Basiliximab|basiliximab|mesh-list
154571604|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154571605|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
154571606|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571607|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154571608|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571609|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571610|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154571611|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571612|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154571613|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
154571614|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154571615|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571616|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154571617|NCT00468403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154571618|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154571619|NCT02175017|Nivolumab|nivolumab|mesh-list
154571620|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154571621|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571622|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154571623|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571624|NCT02178449|Dexamethasone|dexamethasone|mesh-list
154571625|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
154571626|NCT02178449|Ropivacaine|ropivacaine|mesh-list
154571627|NCT02178449|BB 1101|bb 1101|mesh-list
154571628|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154571629|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
154571630|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
154571631|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571632|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571633|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571634|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
154571635|NCT02178449|Hormones|hormones|mesh-ancestor
154571636|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154571637|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154295474|NCT05575219|Clonidine|clonidine|mesh-list
154571638|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571639|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
154571640|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
154571641|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571642|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
154571643|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571644|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571645|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571646|NCT02387931|Vitamin D|vitamin d|mesh-list
154571647|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
154571648|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
154571649|NCT02387931|Vitamins|vitamins|mesh-list
154571650|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
154571651|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571652|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154571653|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154571654|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154571655|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154571656|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154571657|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571658|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
154571659|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154571660|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
154571661|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
154571662|NCT02178683|Tacrolimus|tacrolimus|mesh-list
154571663|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154571664|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
154571665|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571666|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154571667|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571668|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571669|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154571670|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571671|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154571672|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
154571673|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154571674|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571675|NCT03170739|Dopamine|dopamine|mesh-list
154571676|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
154571677|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154571678|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571679|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571680|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154571681|NCT03170739|Analgesics|analgesics|mesh-ancestor
154571682|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
154571683|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571684|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154571685|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154571686|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154571687|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571688|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571689|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571690|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154571691|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
154571692|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
154571693|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
154571694|NCT03170739|Protective Agents|protective agents|mesh-ancestor
154571695|NCT00459745|Fenofibrate|fenofibrate|mesh-list
154571696|NCT00459745|Pravastatin|pravastatin|mesh-list
154571697|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154571698|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
154571699|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571700|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154571701|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154571702|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154571703|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571704|NCT02178761|Chromium|chromium|mesh-list
154571705|NCT02178761|Everolimus|everolimus|mesh-list
154571706|NCT02178761|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154571707|NCT02178761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154571708|NCT02178761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571709|NCT02178761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150859|NCT04013438|Hormones|hormones|mesh-ancestor
154571710|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154571711|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
154571712|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295551|NCT05406401|Hormones|hormones|mesh-ancestor
154571713|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571714|NCT02178761|Trace Elements|trace elements|mesh-ancestor
154571715|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
154571716|NCT02742181|Alvimopan|alvimopan|mesh-list
154571717|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571718|NCT02175407|Itraconazole|itraconazole|mesh-list
154571719|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
154571720|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571721|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154571722|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154571723|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571724|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571725|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154571726|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
154571727|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154571728|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571729|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154571730|NCT02182193|Nintedanib|nintedanib|mesh-list
154571731|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571732|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154571733|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571734|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571735|NCT02175485|Fexofenadine|fexofenadine|mesh-list
154571736|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154571737|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154571738|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154571739|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
154571740|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
154571741|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571742|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571743|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571744|NCT04575779|Cyclosporine|cyclosporine|mesh-list
154571745|NCT04575779|Cyclosporins|cyclosporins|mesh-list
154571746|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571747|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571748|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154571749|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
154571750|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571751|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
154571752|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571753|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
154571754|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154571755|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154571756|NCT02741713|Lidocaine|lidocaine|mesh-list
154571757|NCT02741713|Clonidine|clonidine|mesh-list
154571758|NCT02741713|Epinephrine|epinephrine|mesh-list
154571759|NCT02741713|Racepinephrine|racepinephrine|mesh-list
154571760|NCT02741713|Bupivacaine|bupivacaine|mesh-list
154571761|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154571762|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
154571763|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
154571764|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
154571765|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571766|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571767|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
154571768|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571769|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154571770|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154571771|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154571772|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154571773|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571774|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154571775|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154571776|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571777|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571778|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154571779|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154571780|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
154571781|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154571782|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
154571783|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
154571784|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
154571785|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154571786|NCT02741713|Analgesics|analgesics|mesh-ancestor
154862136|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
154571787|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154571788|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
154571789|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154571790|NCT00459277|Fentanyl|fentanyl|mesh-list
154571791|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154571792|NCT00459277|Narcotics|narcotics|mesh-ancestor
154571793|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154571794|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571795|NCT00459277|Analgesics|analgesics|mesh-ancestor
154571796|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
154571797|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571798|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154571799|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154571800|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
154571801|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
154571802|NCT00602329|Leucovorin|leucovorin|mesh-list
154571803|NCT00602329|Bevacizumab|bevacizumab|mesh-list
154571804|NCT00602329|Fluorouracil|fluorouracil|mesh-list
154571805|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
154571806|NCT00602329|Calcium|calcium|mesh-list
154571807|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
154571808|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154571809|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571810|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154571811|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154571812|NCT00602329|Growth Substances|growth substances|mesh-ancestor
154571813|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571814|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
154571815|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154571816|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
154150988|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571817|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571818|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154571819|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154571820|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
154571821|NCT00602329|Antidotes|antidotes|mesh-ancestor
154571822|NCT00602329|Protective Agents|protective agents|mesh-ancestor
154571823|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
154571824|NCT00602329|Vitamins|vitamins|mesh-ancestor
154571825|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
154571826|NCT02182505|Fenoterol|fenoterol|mesh-list
154571827|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154571828|NCT02182505|Ipratropium|ipratropium|mesh-list
154571829|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154571830|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
154571831|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571832|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571833|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154571834|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
154571835|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
154571836|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
154571837|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154571838|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154571839|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154571840|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154571841|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571842|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571843|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571844|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154571845|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
154571846|NCT02387619|Amlodipine|amlodipine|mesh-list
154571847|NCT02387619|Telmisartan|telmisartan|mesh-list
154571848|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154571849|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154571850|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154571851|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154571852|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154571853|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571854|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154571855|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571856|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
154571857|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154151034|NCT00936182|Fluconazole|fluconazole|mesh-list
154571858|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154571859|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
154571860|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153472413|NCT04356144|Thrombin|thrombin|mesh-list
154862137|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571861|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154253753|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571863|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154571864|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154571865|NCT03537443|Vitamin D|vitamin d|mesh-list
154571866|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
154571867|NCT03537443|Vitamins|vitamins|mesh-ancestor
154571868|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
154571869|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571870|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154571871|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154571872|NCT00595699|Escitalopram|escitalopram|mesh-list
154571873|NCT00595699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154571874|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154571875|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154571876|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571877|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571878|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
154571879|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571880|NCT02256215|Vitamin D|vitamin d|mesh-list
154571881|NCT02256215|Vitamins|vitamins|mesh-ancestor
154571882|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
154571883|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571884|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154571885|NCT02182583|Oxitropium|oxitropium|mesh-list
154571886|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
154571887|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
154571888|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571889|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571890|NCT03133975|Vitamin D|vitamin d|mesh-list
154571891|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
154571892|NCT03133975|Vitamins|vitamins|mesh-ancestor
154571893|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
154571894|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571895|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154571896|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154571897|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154571898|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154571899|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571900|NCT02182661|Oxitropium|oxitropium|mesh-list
154571901|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
154571902|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
154571903|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571904|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571905|NCT02663271|Bevacizumab|bevacizumab|mesh-list
154571906|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154571907|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154571908|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154571909|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154571910|NCT02663271|Growth Substances|growth substances|mesh-ancestor
154571911|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571912|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
154571913|NCT00659191|Cabotegravir|cabotegravir|mesh-list
154571914|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154571915|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154571916|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571917|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571918|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154571919|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154571920|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
154571921|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154571922|NCT02182739|Meloxicam|meloxicam|mesh-list
154571923|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154571924|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154571925|NCT02182739|Analgesics|analgesics|mesh-ancestor
154571926|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
154571927|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571928|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571929|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154571930|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154571931|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154571932|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154571933|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571934|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571935|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154571936|NCT00583609|Laxatives|laxatives|mesh-ancestor
154571937|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154571938|NCT03170115|Aspirin|aspirin|mesh-list
154571939|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154571940|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154571941|NCT03170115|Analgesics|analgesics|mesh-ancestor
154571942|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
154571943|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571944|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571945|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154571946|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154571947|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154571948|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154571949|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571950|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154571951|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154571952|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571953|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
154571954|NCT03169959|Metformin|metformin|mesh-list
154571955|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
154571956|NCT03169959|Saxagliptin|saxagliptin|mesh-list
154571957|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154571958|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571959|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154571960|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571961|NCT03169959|Incretins|incretins|mesh-ancestor
154571962|NCT03169959|Hormones|hormones|mesh-ancestor
154571963|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154571964|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154571965|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
154571966|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571967|NCT02176187|Fenoterol|fenoterol|mesh-list
154571968|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154571969|NCT02176187|Ipratropium|ipratropium|mesh-list
154571970|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154571971|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
154571972|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154571973|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571974|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154571975|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
154571976|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
154571977|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
154571978|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154571979|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154571980|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154571981|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154571982|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
154571983|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154571984|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571985|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154571986|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
154571987|NCT02176499|Telmisartan|telmisartan|mesh-list
154571988|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154571989|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154571990|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154571991|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571992|NCT02176733|Cyclosporine|cyclosporine|mesh-list
154571993|NCT02176733|Cyclosporins|cyclosporins|mesh-list
154571994|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154571995|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154571996|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154571997|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
154571998|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154571999|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
154572000|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572001|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
154572002|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572003|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154572004|NCT03536741|Anesthetics|anesthetics|mesh-list
154572005|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
154572006|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154572007|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572008|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
154572009|NCT02403687|Topiramate|topiramate|mesh-list
154572010|NCT02403687|Diclofenac|diclofenac|mesh-list
154572011|NCT02403687|Meloxicam|meloxicam|mesh-list
154572012|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
154572013|NCT02403687|Lidocaine|lidocaine|mesh-list
154572014|NCT02403687|Clonidine|clonidine|mesh-list
154572015|NCT02403687|Sumatriptan|sumatriptan|mesh-list
154572016|NCT02403687|Ketamine|ketamine|mesh-list
154572017|NCT02403687|Gabapentin|gabapentin|mesh-list
154572018|NCT02403687|Amitriptyline|amitriptyline|mesh-list
154572019|NCT02403687|Tizanidine|tizanidine|mesh-list
154572020|NCT02403687|Bupivacaine|bupivacaine|mesh-list
154572021|NCT02403687|Prilocaine|prilocaine|mesh-list
154572022|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
154572023|NCT02403687|Baclofen|baclofen|mesh-list
154572024|NCT02403687|Capsaicin|capsaicin|mesh-list
154572025|NCT02403687|Menthol|menthol|mesh-list
154572026|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
154572027|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
154572028|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154572029|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572030|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
154572031|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572032|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154572033|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154572034|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154572035|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572036|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572037|NCT02403687|Analgesics|analgesics|mesh-ancestor
154572038|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154572039|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154572040|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
154572041|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154572042|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154572043|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572044|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
154572045|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154572046|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154572047|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154572048|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
154572049|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154572050|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154572051|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572052|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572053|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154572054|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572055|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572056|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
154572057|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
154572058|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154572059|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154572060|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154572061|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
154572062|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
154572063|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154572064|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154572065|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154572066|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154572067|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
154572068|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154572069|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
154572070|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154572071|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154572072|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
154572073|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
154572074|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
154572075|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154572076|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154572077|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154572078|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154572079|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
154572080|NCT02742649|Timolol|timolol|mesh-list
154572081|NCT02742649|Bimatoprost|bimatoprost|mesh-list
154572082|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154572083|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154572084|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
154572085|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572086|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572087|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572088|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154572089|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154572090|NCT02183051|Ibuprofen|ibuprofen|mesh-list
154572091|NCT02183051|Meloxicam|meloxicam|mesh-list
154572092|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154572093|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154572094|NCT02183051|Analgesics|analgesics|mesh-ancestor
154572095|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
154572096|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572097|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572098|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572099|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572100|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154572101|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572102|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572103|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154572104|NCT03169725|Vaccines|vaccines|mesh-list
154572105|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
154572106|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572107|NCT02403531|Docetaxel|docetaxel|mesh-list
154572108|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572109|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
154572110|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
154572111|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
154572112|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572113|NCT02279953|Vortioxetine|vortioxetine|mesh-list
154572114|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
154572115|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154572116|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154572117|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154572118|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154572119|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572120|NCT02279953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154572121|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154572122|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572123|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572124|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572125|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
154572126|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154572127|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154572128|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154572129|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154572130|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
154572131|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154572132|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154572133|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572134|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154572135|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154572136|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572137|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572138|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572139|NCT02387307|Interferons|interferons|mesh-list
154572140|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572141|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
154572142|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572143|NCT02183363|Linagliptin|linagliptin|mesh-list
154572144|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572145|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572146|NCT02183363|Incretins|incretins|mesh-ancestor
154572147|NCT02183363|Hormones|hormones|mesh-ancestor
154572148|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572149|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154572150|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
154572151|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572152|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572153|NCT02183441|Linagliptin|linagliptin|mesh-list
154572154|NCT02183441|Ritonavir|ritonavir|mesh-list
154572155|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154572156|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154572157|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
154572158|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572159|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572160|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154572161|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154572162|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
154572163|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572164|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154572165|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154572166|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572167|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572168|NCT02183441|Incretins|incretins|mesh-ancestor
154572169|NCT02183441|Hormones|hormones|mesh-ancestor
154572170|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572171|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154572172|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154572173|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
154572174|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154572175|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154572176|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154572177|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572178|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572179|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
154572180|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572181|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572182|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154572183|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572184|NCT03537287|Progesterone|progesterone|mesh-list
154572185|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
154572186|NCT03537287|Progestins|progestins|mesh-ancestor
154572187|NCT03537287|Hormones|hormones|mesh-ancestor
154572188|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572189|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572190|NCT02280031|Aspirin|aspirin|mesh-list
154572191|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154572192|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154572193|NCT02280031|Analgesics|analgesics|mesh-ancestor
154572194|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
154572195|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572196|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572197|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572198|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572199|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154572200|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154572201|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572202|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154572203|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154572204|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572205|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
154572206|NCT00449605|Metformin|metformin|mesh-list
154572207|NCT00449605|Glimepiride|glimepiride|mesh-list
154572208|NCT00449605|Rimonabant|rimonabant|mesh-list
154572209|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572210|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572211|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154572212|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154572213|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
154572214|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154572215|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154572216|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154572217|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572218|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572219|NCT00449605|Hormones|hormones|mesh-ancestor
154572220|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572221|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
154572222|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154572223|NCT02774239|Antibodies|antibodies|mesh-list
154572224|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
154572225|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
154572226|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572227|NCT02280109|Tenofovir|tenofovir|mesh-list
154572228|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
154572229|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572230|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154572231|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154572232|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572233|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572234|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154572235|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154572236|NCT00576667|Rimonabant|rimonabant|mesh-list
154572237|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154572238|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154572239|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154572240|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572241|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572242|NCT00576667|Hormones|hormones|mesh-ancestor
154572243|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572244|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572245|NCT02403063|Neostigmine|neostigmine|mesh-list
154572246|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154572247|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572248|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572249|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
154572250|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572251|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572252|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154572253|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
154572254|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572255|NCT02177357|Pramipexole|pramipexole|mesh-list
154572256|NCT02177357|Dexpramipexole|dexpramipexole|mesh-list
154572257|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
154572258|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572259|NCT02177357|Protective Agents|protective agents|mesh-ancestor
154572260|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572261|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154572262|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154572263|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
154572264|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
154572265|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572266|NCT02386449|Mannitol|mannitol|mesh-list
154572267|NCT02386449|Bisacodyl|bisacodyl|mesh-list
154572268|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
154572269|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
154572270|NCT02386449|Citric Acid|citric acid|mesh-list
154572271|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
154572272|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154572273|NCT02386449|Diuretics|diuretics|mesh-ancestor
154572274|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
154572275|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572276|NCT02386449|Cathartics|cathartics|mesh-ancestor
154572277|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154572278|NCT02386449|Laxatives|laxatives|mesh-ancestor
154572279|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
154572280|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154572281|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
154572282|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
154572283|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572284|NCT02386449|Antacids|antacids|mesh-ancestor
154572285|NCT00656539|Azithromycin|azithromycin|mesh-list
154572286|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154572287|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572288|NCT02179775|Propranolol|propranolol|mesh-list
154572289|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154572290|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154572291|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
154572292|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572293|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572294|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572295|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154572296|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154572297|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
154572298|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154572299|NCT02177435|Telmisartan|telmisartan|mesh-list
154572300|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154572301|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154572302|NCT02177435|Diuretics|diuretics|mesh-ancestor
154572303|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
154572304|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572305|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154572306|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572307|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572308|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154572309|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154572310|NCT02280265|Factor VIII|factor viii|mesh-list
154572312|NCT02179931|Flupenthixol|flupenthixol|mesh-list
154572313|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154572314|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154572315|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154572316|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154572317|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572318|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154572319|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154572320|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
154572321|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572322|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572323|NCT02184065|Meloxicam|meloxicam|mesh-list
154572324|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154572325|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154572326|NCT02184065|Analgesics|analgesics|mesh-ancestor
154572327|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
154572328|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572329|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572330|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572331|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572332|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154572333|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154572334|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151488|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572335|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572336|NCT00564421|Epinastine|epinastine|mesh-list
154572337|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154572338|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
154572339|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
154572340|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572341|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572342|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572343|NCT02665689|Ranibizumab|ranibizumab|mesh-list
154572344|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154572345|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154572346|NCT02665689|Growth Substances|growth substances|mesh-ancestor
154572347|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572348|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
154572349|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572350|NCT02386293|Irbesartan|irbesartan|mesh-list
154572351|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154572352|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154572353|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154572354|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572355|NCT00563563|Naltrexone|naltrexone|mesh-list
154572356|NCT00563563|Bupropion|bupropion|mesh-list
154572357|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154572358|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154572359|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572360|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
154572361|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572362|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154572363|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
154572364|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154572365|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154572366|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154572367|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572368|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572369|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
154572370|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572371|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154572372|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154572373|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572374|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154572375|NCT05149365|Cyclosporine|cyclosporine|mesh-list
154572376|NCT05149365|Methotrexate|methotrexate|mesh-list
154572377|NCT05149365|Cyclosporins|cyclosporins|mesh-list
154572378|NCT05149365|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154572379|NCT05149365|Abortifacient Agents|abortifacient agents|mesh-ancestor
154572380|NCT05149365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154572381|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572382|NCT05149365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154572383|NCT05149365|Antimetabolites|antimetabolites|mesh-ancestor
154572384|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572385|NCT05149365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572386|NCT05149365|Dermatologic Agents|dermatologic agents|mesh-ancestor
154572387|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572388|NCT05149365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154572389|NCT05149365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154572390|NCT05149365|Immunologic Factors|immunologic factors|mesh-ancestor
154572391|NCT05149365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572392|NCT05149365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154572393|NCT05149365|Antifungal Agents|antifungal agents|mesh-ancestor
154572394|NCT05149365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572395|NCT05149365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154572396|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572397|NCT05149365|Incretins|incretins|mesh-ancestor
154572399|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572400|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154572401|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
154572402|NCT02180087|Ketoprofen|ketoprofen|mesh-list
154572403|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154572404|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154572405|NCT02180087|Analgesics|analgesics|mesh-ancestor
154572406|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
154572407|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572408|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572409|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572410|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572411|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154572412|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572413|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572414|NCT02184299|Nevirapine|nevirapine|mesh-list
154572415|NCT02184299|Prednisone|prednisone|mesh-list
154572416|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572417|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
154572418|NCT02184299|Hormones|hormones|mesh-ancestor
154572419|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572420|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572421|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154572422|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572423|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154572424|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154572425|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572426|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572427|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
154572428|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572429|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154572430|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154572431|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154572432|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154572433|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
154572434|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154572435|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154572436|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572437|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572438|NCT02282371|Cetuximab|cetuximab|mesh-list
154572439|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154572440|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572441|NCT02402595|Itraconazole|itraconazole|mesh-list
154572442|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
154572443|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572444|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154572445|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154572446|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572447|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572448|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154572449|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
154572450|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572451|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572452|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154572453|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
154862138|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572454|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154572455|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154572456|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572457|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
154572458|NCT02180321|Coagulants|coagulants|mesh-ancestor
154572459|NCT00547651|Topotecan|topotecan|mesh-list
154572460|NCT00547651|Amrubicin|amrubicin|mesh-list
154572461|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154572462|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154572463|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572464|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572465|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572466|NCT00546793|Veltuzumab|veltuzumab|mesh-list
154572467|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572468|NCT02402283|Metronidazole|metronidazole|mesh-list
154572469|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572470|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154572471|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154572472|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154572473|NCT02184533|Selenious Acid|selenious acid|mesh-list
154572474|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
154572475|NCT02184533|Trace Elements|trace elements|mesh-ancestor
154572476|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
154572477|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572478|NCT02386059|Dexamethasone|dexamethasone|mesh-list
154572479|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
154572480|NCT02386059|Ondansetron|ondansetron|mesh-list
154572481|NCT02386059|BB 1101|bb 1101|mesh-list
154572482|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572483|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
154572484|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
154572485|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572486|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572487|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154572488|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
154572489|NCT02386059|Hormones|hormones|mesh-ancestor
154572490|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572491|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154572492|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572493|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
154572494|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572495|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572496|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
154572497|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
154572498|NCT02386059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154572499|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154572500|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
154572501|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572502|NCT00443287|Cilostazol|cilostazol|mesh-list
154572503|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
154572504|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154572505|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
154572506|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572507|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572508|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154572509|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
154572510|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154572511|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154572512|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572513|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154572514|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
154572515|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154572516|NCT00443287|Protective Agents|protective agents|mesh-ancestor
154572517|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154572518|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154572519|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572520|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
154572521|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
154572522|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
154572523|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154572524|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572525|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572526|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
154572527|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154572528|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154572529|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572530|NCT02390739|Aldesleukin|aldesleukin|mesh-list
154572531|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
154572532|NCT02390739|Fludarabine|fludarabine|mesh-list
154572533|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154572534|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
154572535|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572536|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572537|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154572538|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
154572539|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572540|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572541|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154572542|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154572543|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154572544|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
154572545|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572547|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
154572548|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572549|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
154572550|NCT02177825|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154572551|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154572552|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572553|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572554|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572555|NCT02390817|Neostigmine|neostigmine|mesh-list
154572556|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154572557|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572558|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572559|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
154572560|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572561|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572562|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154151727|NCT01030510|Rocuronium|rocuronium|mesh-list
154572563|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
154572564|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572565|NCT00537043|Carvedilol|carvedilol|mesh-list
154572566|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154572567|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154572568|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
154572569|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572570|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572571|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572572|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154572573|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
154572574|NCT00537043|Protective Agents|protective agents|mesh-ancestor
154572575|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154572576|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572577|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154572578|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
154572579|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154572580|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154572581|NCT00387907|Trastuzumab|trastuzumab|mesh-list
154572582|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154572583|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572584|NCT02180789|Tamsulosin|tamsulosin|mesh-list
154572585|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154572586|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154572587|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154572588|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154572589|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572590|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572591|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572592|NCT02180789|Urological Agents|urological agents|mesh-ancestor
154572593|NCT02282683|Prednisone|prednisone|mesh-list
154572594|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572595|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
154572596|NCT02282683|Hormones|hormones|mesh-ancestor
154572597|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572598|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572599|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154572600|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572601|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154572602|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154572603|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154296450|NCT03820817|Rifaximin|rifaximin|mesh-list
154572605|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572606|NCT00375193|Amrubicin|amrubicin|mesh-list
154572607|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572608|NCT00151411|Metformin|metformin|mesh-list
154572609|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572610|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572611|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
154572612|NCT04471441|Everolimus|everolimus|mesh-list
154572613|NCT04471441|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154572614|NCT04471441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154572615|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572616|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572617|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154572618|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
154572619|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572620|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572621|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154572622|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154572623|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
154572624|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154572625|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572626|NCT02662569|Atorvastatin|atorvastatin|mesh-list
154572627|NCT02662569|Evolocumab|evolocumab|mesh-list
154572628|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154572629|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154572630|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
154572631|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572632|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154572633|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154572634|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572635|NCT02662569|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154572636|NCT02662569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154572637|NCT02662569|Protease Inhibitors|protease inhibitors|mesh-ancestor
154572638|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
154572639|NCT02178137|Astringents|astringents|mesh-ancestor
154572640|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572641|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
154572642|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
154572643|NCT02181023|Bromides|bromides|mesh-list
154572644|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
154572645|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154572646|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154572647|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154572648|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
154572649|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572650|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572651|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572652|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
154572653|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154572654|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154572655|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572656|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
154572657|NCT02286973|Coagulants|coagulants|mesh-ancestor
154572658|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
154572659|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154572660|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572661|NCT02256683|Dabigatran|dabigatran|mesh-list
154572662|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
154572663|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
154572664|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154572665|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
154572666|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572667|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572668|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
154572669|NCT00411385|Interferons|interferons|mesh-list
154572670|NCT00411385|Ribavirin|ribavirin|mesh-list
154572671|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
154572672|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
154572673|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154572674|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572675|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
154572676|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572677|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
154572678|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572679|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
154572680|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572681|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154572682|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
154572683|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572685|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
154572686|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154572687|NCT02185547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154572688|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154572689|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572690|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572691|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572692|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
154572693|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572694|NCT02030483|Dexamethasone|dexamethasone|mesh-list
154572695|NCT02030483|Lenalidomide|lenalidomide|mesh-list
154572696|NCT02030483|Palbociclib|palbociclib|mesh-list
154572697|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572698|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
154572699|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
154572700|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572701|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572702|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154572703|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
154572704|NCT02030483|Hormones|hormones|mesh-ancestor
154572705|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572706|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154572707|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572708|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
154572709|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154572710|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154572711|NCT02030483|Growth Substances|growth substances|mesh-ancestor
154572712|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
154572713|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154572714|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572715|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572716|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154572717|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154572718|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154572719|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572720|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572721|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
154572722|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572723|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572724|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
154572725|NCT02385435|Bupivacaine|bupivacaine|mesh-list
154572726|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
154572727|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
154572728|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154572729|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572730|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
154572731|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572732|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154572733|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154572734|NCT02385435|Analgesics|analgesics|mesh-ancestor
154572735|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154572736|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154572737|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154572738|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
154572739|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572740|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572741|NCT02753075|Fluorides|fluorides|mesh-list
154572742|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
154572743|NCT02753075|Protective Agents|protective agents|mesh-ancestor
154572744|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572745|NCT03133897|Dexamethasone|dexamethasone|mesh-list
154572746|NCT03133897|Prednisone|prednisone|mesh-list
154572747|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572748|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
154572749|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
154572750|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572751|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572752|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154572753|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
154862139|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572755|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572756|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154572757|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572758|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
154572759|NCT05443425|Leflunomide|leflunomide|mesh-list
154572760|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572761|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572762|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154572763|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
154572764|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572765|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154572766|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154572767|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
154572768|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154572769|NCT02190149|Factor VIII|factor viii|mesh-list
154572770|NCT02190149|Coagulants|coagulants|mesh-ancestor
154572771|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
154572772|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572773|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
154572774|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572775|NCT02185859|Lidocaine|lidocaine|mesh-list
154572776|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
154572777|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
154572778|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
154572779|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154572780|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572781|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
154572782|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572783|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154572784|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154572785|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154572786|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154572787|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572788|NCT02185859|Analgesics|analgesics|mesh-ancestor
154572789|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
154572790|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154572791|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154572792|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
154572793|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154572794|NCT02332720|Ribavirin|ribavirin|mesh-list
154572795|NCT02332720|Grazoprevir|grazoprevir|mesh-list
154572796|NCT02332720|Ruzasvir|ruzasvir|mesh-list
154572797|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
154572798|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
154572799|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572800|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
154572801|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572802|NCT05089175|Aspirin|aspirin|mesh-list
154572803|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154572804|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154572805|NCT05089175|Analgesics|analgesics|mesh-ancestor
154572806|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
154572807|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572808|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572809|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572810|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154572811|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154572812|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154572813|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572814|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154572815|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154572816|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572817|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
154572818|NCT02181335|Budesonide|budesonide|mesh-list
154572819|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572820|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154572821|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
154572822|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572823|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572824|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154572825|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
154572826|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
154572827|NCT02181335|Hormones|hormones|mesh-ancestor
154572828|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572829|NCT00517153|Miglustat|miglustat|mesh-list
154296682|NCT02631733|Hematinics|hematinics|mesh-ancestor
154572830|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572831|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572832|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154572833|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154572834|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
154572835|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572836|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154572837|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572838|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572839|NCT02285101|BCT-100|bct-100|mesh-list
154572840|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572841|NCT00359437|Satavaptan|satavaptan|mesh-list
154572842|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154572843|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572844|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
154572845|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572846|NCT00401011|Dexamethasone|dexamethasone|mesh-list
154572847|NCT00401011|Bortezomib|bortezomib|mesh-list
154572848|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572849|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
154572850|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
154572851|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572852|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572853|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154572854|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
154572855|NCT00401011|Hormones|hormones|mesh-ancestor
154572856|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572857|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154572858|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572859|NCT01645930|Dexamethasone|dexamethasone|mesh-list
154572860|NCT01645930|Lenalidomide|lenalidomide|mesh-list
154572861|NCT01645930|Ixazomib|ixazomib|mesh-list
154572862|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572863|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
154572864|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
154572865|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572866|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572867|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154572868|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
154572869|NCT01645930|Hormones|hormones|mesh-ancestor
154572870|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572871|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154572872|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572873|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
154572874|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154572875|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154572876|NCT01645930|Growth Substances|growth substances|mesh-ancestor
154572877|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
154572878|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
154572879|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572880|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572881|NCT02190695|Carboplatin|carboplatin|mesh-list
154572882|NCT02190695|Decitabine|decitabine|mesh-list
154572883|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
154572884|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572885|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154572886|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
154572887|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572888|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572889|NCT00514267|Prednisone|prednisone|mesh-list
154572890|NCT00514267|Docetaxel|docetaxel|mesh-list
154572891|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572892|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
154572893|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
154572894|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
154572895|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572896|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572897|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
154572898|NCT00514267|Hormones|hormones|mesh-ancestor
154572899|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572900|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572901|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154572902|NCT02384967|Darunavir|darunavir|mesh-list
154572903|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154572904|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154572905|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
154572906|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572907|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572909|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154572910|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
154572911|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572912|NCT02186249|Nivolumab|nivolumab|mesh-list
154572913|NCT02186249|Ipilimumab|ipilimumab|mesh-list
154572914|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154572915|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572916|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154572917|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572918|NCT00511459|Paclitaxel|paclitaxel|mesh-list
154572919|NCT00511459|Bevacizumab|bevacizumab|mesh-list
154572920|NCT00511459|Trebananib|trebananib|mesh-list
154572921|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154572922|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572923|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
154572924|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
154572925|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
154572926|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572927|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154572928|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154572929|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154572930|NCT00511459|Growth Substances|growth substances|mesh-ancestor
154572931|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572932|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
154572933|NCT02384889|Eflornithine|eflornithine|mesh-list
154572934|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572935|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154572936|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154572937|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154572938|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154572939|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154572940|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572941|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572942|NCT02299336|Aflibercept|aflibercept|mesh-list
154572943|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154572944|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154572945|NCT02299336|Growth Substances|growth substances|mesh-ancestor
154572946|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572947|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
154572948|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154572949|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
154572950|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572951|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572952|NCT02186483|Metformin|metformin|mesh-list
154572953|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154572954|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572955|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572956|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154572957|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154572958|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
154572959|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572960|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154572961|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154572962|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154572963|NCT02256605|Vitamin D|vitamin d|mesh-list
154572964|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
154572965|NCT02256605|Vitamins|vitamins|mesh-ancestor
154572966|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
154572967|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572968|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154572969|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154572970|NCT00393991|Fluticasone|fluticasone|mesh-list
154572972|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
154572973|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154572974|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154572975|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
154572976|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154572977|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572978|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154572979|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
154572980|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
154572981|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154572982|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154572983|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154572984|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154572985|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
154572986|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154572987|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154572988|NCT02664441|Exenatide|exenatide|mesh-list
154572989|NCT02664441|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154572990|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154572991|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154572992|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154572993|NCT02664441|Incretins|incretins|mesh-ancestor
154572994|NCT02664441|Hormones|hormones|mesh-ancestor
154572995|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154572996|NCT02191007|Calcitriol|calcitriol|mesh-list
154572997|NCT02191007|Betamethasone|betamethasone|mesh-list
154572998|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
154572999|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154573000|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
154573001|NCT02191007|Calcipotriene|calcipotriene|mesh-list
154573002|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154573003|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154573004|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
154573005|NCT02191007|Hormones|hormones|mesh-ancestor
154573006|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573007|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573008|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154573009|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
154573010|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
154573011|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154573012|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154573013|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154573014|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573015|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154573016|NCT02191007|Vitamins|vitamins|mesh-ancestor
154573017|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
154573018|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154573019|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
154573020|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154573021|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
154573022|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573023|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154573024|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154573025|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
154573026|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573027|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573028|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154573029|NCT04470115|Anesthetics|anesthetics|mesh-list
154573030|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573031|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573032|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
154573033|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154573034|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573035|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573036|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154573037|NCT02384343|Analgesics|analgesics|mesh-ancestor
154573038|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
154573039|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573040|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154573041|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154573042|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154573043|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
154573044|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573045|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573046|NCT05033639|Melatonin|melatonin|mesh-list
154573047|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
154573048|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573049|NCT05033639|Protective Agents|protective agents|mesh-ancestor
154573050|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360193|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
154862140|NCT04353479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154862141|NCT03608488|Vitamin D|vitamin d|mesh-list
154862142|NCT03608488|Vitamins|vitamins|mesh-ancestor
154573051|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573052|NCT02328040|Insulin|insulin|mesh-list
154573053|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154573054|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154573055|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
154573056|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154573057|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573058|NCT02328040|Incretins|incretins|mesh-ancestor
154573059|NCT02328040|Hormones|hormones|mesh-ancestor
154573060|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573061|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154573062|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573063|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573064|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573065|NCT00355849|Insulin|insulin|mesh-list
154573066|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154573067|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
154573068|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154573069|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573070|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154573071|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
154573072|NCT02384499|Coagulants|coagulants|mesh-ancestor
154573073|NCT02186951|Amoxicillin|amoxicillin|mesh-list
154573074|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
154573075|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
154573076|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154573077|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573078|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573079|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573080|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154573081|NCT02285413|Cisplatin|cisplatin|mesh-list
154573082|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573083|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154573084|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
154573085|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573086|NCT02187107|Darunavir|darunavir|mesh-list
154573087|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154573088|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154573089|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573090|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573091|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573092|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154573093|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154573094|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
154573095|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573096|NCT02285491|Bupivacaine|bupivacaine|mesh-list
154573097|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
154573098|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
154573099|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573100|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573101|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
154573102|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573103|NCT02298868|Baclofen|baclofen|mesh-list
154573104|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154573105|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573106|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154573107|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573108|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154573109|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
154573110|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
154573111|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573112|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573113|NCT02389179|Vitamin D|vitamin d|mesh-list
154573114|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
154573115|NCT02389179|Vitamins|vitamins|mesh-ancestor
154573116|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
154573117|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573118|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154573119|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154573120|NCT02285647|Rolapitant|rolapitant|mesh-list
154573121|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154573122|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573123|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573124|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573125|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154862143|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
154573126|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573127|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573128|NCT02187497|Telmisartan|telmisartan|mesh-list
154296980|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154573129|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154573130|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154573131|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154573132|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573133|NCT00099853|Pioglitazone|pioglitazone|mesh-list
154573134|NCT00099853|Vildagliptin|vildagliptin|mesh-list
154573135|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154573136|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573137|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154573138|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573139|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573140|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573141|NCT02381145|Resveratrol|resveratrol|mesh-list
154573142|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
154573143|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573144|NCT02381145|Protective Agents|protective agents|mesh-ancestor
154573145|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573146|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573147|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154573149|NCT00097357|Warfarin|warfarin|mesh-list
154573150|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
154573151|NCT00097357|Apixaban|apixaban|mesh-list
154573152|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
154573153|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154573154|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154573155|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573156|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154573157|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
154573158|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154573159|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573160|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573161|NCT02296840|Acetaminophen|acetaminophen|mesh-list
154573162|NCT02296840|Ibuprofen|ibuprofen|mesh-list
154573163|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154573164|NCT02296840|Hydrocodone|hydrocodone|mesh-list
154573165|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154573166|NCT02296840|Analgesics|analgesics|mesh-ancestor
154573167|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
154573168|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573169|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573170|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
154573171|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154573172|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154573173|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154573174|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154573175|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573176|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573177|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154573178|NCT02296840|Narcotics|narcotics|mesh-ancestor
154573179|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573180|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
154573181|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
154573182|NCT02191319|Nevirapine|nevirapine|mesh-list
154573183|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154573184|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154573185|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573186|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573187|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
154573188|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573189|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154573190|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154573191|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154573192|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154573193|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154573194|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154573195|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573196|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154573197|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573198|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573200|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
154573201|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
154573202|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
154573203|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154573204|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154573205|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573206|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573207|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573208|NCT02191709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154573210|NCT02191709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573211|NCT02191709|Analgesics|analgesics|mesh-ancestor
154573212|NCT02191709|Sensory System Agents|sensory system agents|mesh-ancestor
154573213|NCT02191709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573214|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
154573215|NCT00326287|Linezolid|linezolid|mesh-list
154573216|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
154573217|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154573218|NCT00326287|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154573219|NCT00326287|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154573220|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154573221|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573222|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154573223|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573224|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573225|NCT02191943|Fluorides|fluorides|mesh-list
154573226|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
154573227|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
154573228|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
154573229|NCT02191943|Protective Agents|protective agents|mesh-ancestor
154573230|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573231|NCT02663895|Treprostinil|treprostinil|mesh-list
154573232|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154573233|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
154573234|NCT00320203|Anecortave|anecortave|mesh-list
154573235|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154573236|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154573237|NCT00320203|Growth Substances|growth substances|mesh-ancestor
154573238|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573239|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
154573240|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573241|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154573242|NCT00071461|Bosentan|bosentan|mesh-list
154573243|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154573244|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154573245|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573246|NCT00069745|Prednisone|prednisone|mesh-list
154573247|NCT00069745|Satraplatin|satraplatin|mesh-list
154573248|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154573249|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
154573250|NCT00069745|Hormones|hormones|mesh-ancestor
154573251|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573252|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573253|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154152440|NCT03954834|Hormones|hormones|mesh-ancestor
154573254|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573255|NCT02192411|Lidocaine|lidocaine|mesh-list
154573256|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
154573257|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
154573258|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573259|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573260|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
154573261|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573262|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154573263|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154573264|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154573265|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154573266|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573267|NCT02193893|Coal Tar|coal tar|mesh-list
154573268|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
154573269|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
154573270|NCT02384187|Gabapentin|gabapentin|mesh-list
154573271|NCT02384187|Analgesics|analgesics|mesh-ancestor
154573272|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
154573273|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573274|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573276|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154573277|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154573278|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573279|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154573280|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154573281|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154573282|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573283|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573284|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
154573285|NCT02192723|Olanzapine|olanzapine|mesh-list
154573286|NCT02192723|Risperidone|risperidone|mesh-list
154573287|NCT02192723|Aripiprazole|aripiprazole|mesh-list
154573288|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154573289|NCT02192723|Ziprasidone|ziprasidone|mesh-list
154573290|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
154573291|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154573292|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
154573293|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573294|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573295|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573296|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154573297|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573298|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154573299|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154573300|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
154573301|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
154573302|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
154573303|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573304|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154573305|NCT02192723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154573306|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154573307|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154573308|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
154573309|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
154573310|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154573311|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154573312|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154573313|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154573314|NCT00319969|Topotecan|topotecan|mesh-list
154573315|NCT00319969|Amrubicin|amrubicin|mesh-list
154573316|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154573317|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154573318|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152481|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
154573319|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573320|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573321|NCT00317395|Heparin|heparin|mesh-list
154573322|NCT00317395|Calcium heparin|calcium heparin|mesh-list
154573323|NCT00317395|Otamixaban|otamixaban|mesh-list
154573324|NCT00317395|Eptifibatide|eptifibatide|mesh-list
154573325|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
154573326|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154573327|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154573328|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573329|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154573330|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154573331|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
154573332|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154573333|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573334|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573335|NCT02383563|Metformin|metformin|mesh-list
154573336|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154573337|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573338|NCT03535961|Etoposide|etoposide|mesh-list
154573339|NCT03535961|Apatinib|apatinib|mesh-list
154573340|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154573341|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573342|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154573343|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154573344|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573345|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573346|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154573347|NCT02380755|Clomiphene|clomiphene|mesh-list
154573348|NCT02380755|Enclomiphene|enclomiphene|mesh-list
154573349|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
154573350|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154573351|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154297214|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
154573352|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573353|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573354|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154573355|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
154573356|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154573357|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154573358|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154573359|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
154573360|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154573361|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154573362|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154573363|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154573364|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154573365|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573366|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
154573367|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573368|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573369|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154573370|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573371|NCT02380521|Exenatide|exenatide|mesh-list
154573372|NCT02380521|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154573373|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154573374|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573375|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154573376|NCT02380521|Incretins|incretins|mesh-ancestor
154573377|NCT02380521|Hormones|hormones|mesh-ancestor
154573378|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573379|NCT00315757|Bortezomib|bortezomib|mesh-list
154573380|NCT00315757|Mapatumumab|mapatumumab|mesh-list
154573381|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154573382|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573383|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
154573384|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573385|NCT02377401|Zanamivir|zanamivir|mesh-list
154573386|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
154573387|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573388|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573389|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573390|NCT00312091|Lamivudine|lamivudine|mesh-list
154573391|NCT00312091|Nevirapine|nevirapine|mesh-list
154573392|NCT00312091|Stavudine|stavudine|mesh-list
154573393|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154573394|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154573395|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573396|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573397|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
154573398|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573399|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154573400|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154573401|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154573402|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154573403|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
154573404|NCT00389779|Guanfacine|guanfacine|mesh-list
154573405|NCT00389779|Darusentan|darusentan|mesh-list
154573406|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154573407|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154573408|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154573409|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154573410|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154573411|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573412|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573413|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573414|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154573415|NCT00389155|Gemcitabine|gemcitabine|mesh-list
154573416|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154573417|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
154573418|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573419|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573420|NCT02188511|Nicotine|nicotine|mesh-list
154573421|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154573422|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
154573423|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573424|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573425|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154573426|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154573427|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
154573428|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573429|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573431|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
154573432|NCT02380131|Trastuzumab|trastuzumab|mesh-list
154573433|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154573434|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
154573435|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573436|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152601|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
154573437|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154573438|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154573439|NCT03535103|Hormones|hormones|mesh-ancestor
154573440|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573441|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573442|NCT04551365|Chitosan|chitosan|mesh-list
154573443|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154573444|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154573445|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
154573446|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573447|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154573448|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
154573449|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
154573450|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
154573451|NCT04551365|Coagulants|coagulants|mesh-ancestor
154573452|NCT00028639|Bortezomib|bortezomib|mesh-list
154573453|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573454|NCT00298987|Dasatinib|dasatinib|mesh-list
154573455|NCT00298987|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154573456|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154573457|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573458|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573459|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573460|NCT02380053|Celiprolol|celiprolol|mesh-list
154573461|NCT02380053|Bisoprolol|bisoprolol|mesh-list
154573462|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154573463|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
154573464|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
154573465|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573466|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573467|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154573468|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154573469|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154573470|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
154573471|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573472|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573473|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154573474|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
154573475|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
154573476|NCT02371707|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154573477|NCT02371707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154573478|NCT02371707|Serotonin Agents|serotonin agents|mesh-ancestor
154573479|NCT02371707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573480|NCT02371707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573481|NCT02371707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573482|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154573483|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154573484|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154573485|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154573486|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
154573487|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573488|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573489|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154573490|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154573491|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154573492|NCT03535415|Hormones|hormones|mesh-list
154573493|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154862144|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573494|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573496|NCT02030717|Anesthetics|anesthetics|mesh-list
154152667|NCT00956462|Analgesics|analgesics|mesh-ancestor
154573497|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573498|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573499|NCT02030717|Analgesics|analgesics|mesh-ancestor
154573500|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
154573501|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573502|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154573503|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
154573504|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
154573505|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154573506|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154573507|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154573508|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
154573509|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573510|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573512|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
154573513|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154573514|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573515|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573516|NCT02371473|Diuretics|diuretics|mesh-ancestor
154573517|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
154573518|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573519|NCT04301661|Tenofovir|tenofovir|mesh-list
154573520|NCT04301661|Lamivudine|lamivudine|mesh-list
154573521|NCT04301661|Emtricitabine|emtricitabine|mesh-list
154573522|NCT04301661|Abacavir|abacavir|mesh-list
154573523|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
154573524|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573525|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154573526|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154573527|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573528|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573529|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154573530|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154573531|NCT02194049|Etoposide|etoposide|mesh-list
154573532|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
154573533|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573534|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154573535|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154573536|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154573537|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573538|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573539|NCT02379663|Enoxaparin|enoxaparin|mesh-list
154573540|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
154573541|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154573542|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
154573543|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154573544|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573545|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573546|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573547|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
154573548|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154573549|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154573550|NCT02030639|ON 01910|on 01910|mesh-list
154573551|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573552|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154573553|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573554|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573555|NCT00004897|Leucovorin|leucovorin|mesh-list
154573556|NCT00004897|Interferons|interferons|mesh-list
154573557|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
154573558|NCT00004897|Fluorouracil|fluorouracil|mesh-list
154573559|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
154573560|NCT00004897|Calcium|calcium|mesh-list
154573561|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
154573562|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573563|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154573564|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573565|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
154573566|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573567|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154573568|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154573569|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
154573570|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
154573571|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573572|NCT00004897|Antidotes|antidotes|mesh-ancestor
154573573|NCT00004897|Protective Agents|protective agents|mesh-ancestor
154297427|NCT04055194|Coagulants|coagulants|mesh-ancestor
154573574|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
154573575|NCT00004897|Vitamins|vitamins|mesh-ancestor
154573576|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
154573577|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
154573578|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573579|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154573580|NCT00004231|Leucovorin|leucovorin|mesh-list
154573581|NCT00004231|Interferons|interferons|mesh-list
154573582|NCT00004231|Cytarabine|cytarabine|mesh-list
154573583|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
154573584|NCT00004231|Aldesleukin|aldesleukin|mesh-list
154573585|NCT00004231|Prednisone|prednisone|mesh-list
154573586|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
154573587|NCT00004231|Busulfan|busulfan|mesh-list
154573588|NCT00004231|Doxorubicin|doxorubicin|mesh-list
154573589|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154573590|NCT00004231|Methotrexate|methotrexate|mesh-list
154573591|NCT00004231|Vincristine|vincristine|mesh-list
154573592|NCT00004231|Teniposide|teniposide|mesh-list
154573593|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
154573594|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154573595|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
154573596|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573597|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154573598|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154573599|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
154573600|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573601|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573602|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154573603|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154573604|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154573605|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154573606|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573607|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154573608|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
154573609|NCT00004231|Hormones|hormones|mesh-ancestor
154573610|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573611|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154573612|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154573613|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
154573614|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154573615|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154573616|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
154573617|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
154573618|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154573619|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154573620|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
154573621|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573622|NCT00004231|Antidotes|antidotes|mesh-ancestor
154573623|NCT00004231|Protective Agents|protective agents|mesh-ancestor
154573624|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
154573625|NCT00004231|Vitamins|vitamins|mesh-ancestor
154573626|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
154573627|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154573628|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
154573629|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
154573630|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
154573631|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154573632|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154573633|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
154573634|NCT00004171|Busulfan|busulfan|mesh-list
154573635|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154573636|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
154573637|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573638|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154573639|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154573640|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
154573641|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573642|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573643|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154573644|NCT00004165|Melphalan|melphalan|mesh-list
154573645|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
154573646|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573647|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154573648|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
154573649|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573650|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573651|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154297516|NCT00041067|Docetaxel|docetaxel|mesh-list
154573652|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154573653|NCT00004093|Paclitaxel|paclitaxel|mesh-list
154573654|NCT00004093|Vinorelbine|vinorelbine|mesh-list
154573655|NCT00004093|Carboplatin|carboplatin|mesh-list
154573656|NCT00004093|Gemcitabine|gemcitabine|mesh-list
154573657|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154573658|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573659|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
154573660|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
154573661|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
154573662|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573663|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154573664|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
154573665|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154573666|NCT02193269|Minocycline|minocycline|mesh-list
154573667|NCT02193269|Tetracycline|tetracycline|mesh-list
154573668|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573669|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154573670|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573671|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573672|NCT00002479|Tretinoin|tretinoin|mesh-list
154573673|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573674|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
154573675|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
154573676|NCT00002371|Lamivudine|lamivudine|mesh-list
154573677|NCT00002371|Zidovudine|zidovudine|mesh-list
154573678|NCT00002371|Stavudine|stavudine|mesh-list
154573679|NCT00002371|Indinavir|indinavir|mesh-list
154573680|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154573681|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154573682|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573683|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573684|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
154573685|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573686|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154573687|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154573688|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
154573689|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154573690|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154573691|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573692|NCT02189681|Anesthetics|anesthetics|mesh-list
154573693|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573694|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573695|NCT05715385|Bromfenac|bromfenac|mesh-list
154573696|NCT05715385|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154573697|NCT05715385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154573698|NCT05715385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154573699|NCT05715385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154573700|NCT05715385|Analgesics|analgesics|mesh-ancestor
154573701|NCT05715385|Sensory System Agents|sensory system agents|mesh-ancestor
154573702|NCT05715385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573703|NCT05715385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573704|NCT05715385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154573705|NCT05715385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154573706|NCT02194283|Ambroxol|ambroxol|mesh-list
154573707|NCT02194283|Expectorants|expectorants|mesh-ancestor
154573708|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
154573709|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
154573710|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154573711|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154573712|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573713|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154573714|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154573715|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154573716|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154573717|NCT00263341|Estrogens|estrogens|mesh-ancestor
154573718|NCT00263341|Hormones|hormones|mesh-ancestor
154573719|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573720|NCT03534869|Analgesics|analgesics|mesh-list
154573721|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
154573722|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573723|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605059|NCT01930552|Leucovorin|leucovorin|mesh-list
154573725|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152906|NCT01084291|Vaccines|vaccines|mesh-list
154573726|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154573727|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
154573728|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
154573729|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154573730|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154573731|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573732|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573733|NCT02378649|Urological Agents|urological agents|mesh-ancestor
154573734|NCT02197169|Interferons|interferons|mesh-list
154573735|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
154573736|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573737|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
154573738|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573739|NCT02376309|Nandrolone|nandrolone|mesh-list
154573740|NCT02376309|Androgens|androgens|mesh-ancestor
154573741|NCT02376309|Hormones|hormones|mesh-ancestor
154573742|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573743|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573744|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
154573745|NCT00232141|Pregabalin|pregabalin|mesh-list
154573746|NCT00232141|Analgesics|analgesics|mesh-ancestor
154573747|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
154573748|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573749|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573750|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
154573751|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154573752|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154573753|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573754|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154573755|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154573756|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154573757|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573758|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154573759|NCT02378415|Ketamine|ketamine|mesh-list
154573760|NCT02378415|Analgesics|analgesics|mesh-ancestor
154573761|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
154573762|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573763|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573764|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154573765|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154573766|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
154573767|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
154573768|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573769|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154573770|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154573771|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573772|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573773|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
154573774|NCT02197403|Propofol|propofol|mesh-list
154573775|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154573776|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573777|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573778|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154573779|NCT02197403|Analgesics|analgesics|mesh-ancestor
154573780|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
154573781|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573782|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154573783|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154573784|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154573785|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
154573786|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573787|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573788|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154573789|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
154573790|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
154573791|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154573792|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
154573793|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573794|NCT02376075|Linagliptin|linagliptin|mesh-list
154573795|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154573796|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573797|NCT02376075|Incretins|incretins|mesh-ancestor
154573799|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573800|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154573801|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573802|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297654|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573803|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573804|NCT02197637|Vinorelbine|vinorelbine|mesh-list
154573805|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154573806|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573807|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
154573808|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
154573809|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
154573810|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573811|NCT04469413|Acetaminophen|acetaminophen|mesh-list
154573812|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154573813|NCT04469413|Analgesics|analgesics|mesh-ancestor
154573814|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
154573815|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573816|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573817|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
154573818|NCT03532087|Denosumab|denosumab|mesh-list
154573819|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154573820|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573821|NCT02288923|Acetaminophen|acetaminophen|mesh-list
154573822|NCT02288923|Ibuprofen|ibuprofen|mesh-list
154573823|NCT02288923|Morphine|morphine|mesh-list
154573824|NCT02288923|Antiemetics|antiemetics|mesh-list
154573825|NCT02288923|Anesthetics|anesthetics|mesh-list
154573826|NCT02288923|Emetics|emetics|mesh-list
154573827|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573828|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573829|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154573830|NCT02288923|Narcotics|narcotics|mesh-ancestor
154573831|NCT02288923|Analgesics|analgesics|mesh-ancestor
154573832|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
154573833|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573834|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154573835|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154573836|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154573837|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154573838|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154573839|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573840|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573841|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
154573842|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
154573843|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154573844|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154573845|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154573846|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
154573847|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573848|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573849|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154573850|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
154573851|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
154573852|NCT02195375|Hormones|hormones|mesh-ancestor
154573853|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573854|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
154573855|NCT03531931|Apatinib|apatinib|mesh-list
154573856|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154573857|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154573858|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573859|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573860|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154573861|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154573862|NCT02369133|Acetaminophen|acetaminophen|mesh-list
154573863|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154573864|NCT02369133|Analgesics|analgesics|mesh-ancestor
154573865|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
154573866|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573867|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573868|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
154573869|NCT02377635|Selenious Acid|selenious acid|mesh-list
154573870|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
154573871|NCT02377635|Trace Elements|trace elements|mesh-ancestor
154573872|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
154573873|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573874|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
154573875|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
154573876|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573877|NCT02198027|Bupivacaine|bupivacaine|mesh-list
154573878|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
154573879|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
154573880|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154573881|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573882|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
154573883|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573885|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
154573886|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
154573887|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573888|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573889|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154573890|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
154573891|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573892|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153056|NCT04010318|Anesthetics|anesthetics|mesh-list
154573893|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154573894|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573895|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
154573896|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154573897|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154573898|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
154573899|NCT02198261|Minoxidil|minoxidil|mesh-list
154573900|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154573901|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
154573902|NCT03533699|Propranolol|propranolol|mesh-list
154573903|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154573904|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154573905|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
154573906|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573907|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573908|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573909|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154573910|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154573911|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
154573912|NCT00135421|Escitalopram|escitalopram|mesh-list
154573913|NCT00135421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154573914|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154573915|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154573916|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573917|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573918|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
154573919|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573920|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
154573921|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154573922|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154573923|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573924|NCT02200991|Incretins|incretins|mesh-ancestor
154573925|NCT02200991|Hormones|hormones|mesh-ancestor
154573926|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154573927|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154573928|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573929|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154573930|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573931|NCT02368743|Mesalamine|mesalamine|mesh-list
154573932|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154573933|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154573934|NCT02368743|Analgesics|analgesics|mesh-ancestor
154573935|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
154573936|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573937|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573938|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154573939|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154573940|NCT00135343|Ritonavir|ritonavir|mesh-list
154573941|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154573942|NCT00135343|Efavirenz|efavirenz|mesh-list
154573943|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154573944|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154573945|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
154573946|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862145|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154573947|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573948|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154573949|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154573950|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
154573951|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573952|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154573953|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154573954|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154573955|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154573956|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154573957|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154573958|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154573959|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154573960|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154573961|NCT02201225|Micronutrients|micronutrients|mesh-list
154573962|NCT02201225|Trace Elements|trace elements|mesh-list
154573963|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573964|NCT02365155|Vitamin D|vitamin d|mesh-list
154573965|NCT02365155|Vitamins|vitamins|mesh-ancestor
154573966|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
154573967|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573968|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154573969|NCT05724745|Albuterol|albuterol|mesh-list
154573970|NCT05724745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154573971|NCT05724745|Autonomic Agents|autonomic agents|mesh-ancestor
154573972|NCT05724745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573973|NCT05724745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573974|NCT05724745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154573975|NCT05724745|Respiratory System Agents|respiratory system agents|mesh-ancestor
154573976|NCT05724745|Tocolytic Agents|tocolytic agents|mesh-ancestor
154573977|NCT05724745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154573978|NCT05724745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154573979|NCT05724745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154573980|NCT05724745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154573981|NCT05724745|Adrenergic Agents|adrenergic agents|mesh-ancestor
154573982|NCT05724745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154573983|NCT05724745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573984|NCT02198339|Olcegepant|olcegepant|mesh-list
154573985|NCT02198339|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154573986|NCT02198339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154573987|NCT02198339|Analgesics|analgesics|mesh-ancestor
154573988|NCT02198339|Sensory System Agents|sensory system agents|mesh-ancestor
154573989|NCT02198339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154573990|NCT02198339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154573991|NCT02198807|Piperaquine|piperaquine|mesh-list
154573992|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
154573993|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
154573994|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154573995|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154573996|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154573997|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154573998|NCT02198417|Metformin|metformin|mesh-list
154573999|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154574000|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574001|NCT02201459|Interferons|interferons|mesh-list
154574002|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
154574003|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
154574004|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154574005|NCT02201459|Nilotinib|nilotinib|mesh-list
154574006|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574007|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
154574008|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574009|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
154574010|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574011|NCT02201459|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154574012|NCT02201459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574013|NCT02201459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574014|NCT02201459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574015|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154574016|NCT02198495|Hematinics|hematinics|mesh-ancestor
154574017|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154574018|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154574019|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574020|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
154862146|NCT03035045|Acetaminophen|acetaminophen|mesh-list
154574021|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574023|NCT02375217|Neostigmine|neostigmine|mesh-list
154574024|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154574025|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574026|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574027|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
154574028|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574029|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574030|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154574031|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
154574032|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574033|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154574034|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154574035|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154574037|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154574038|NCT02375139|Metformin|metformin|mesh-list
154574039|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154574040|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574041|NCT02202005|Nevirapine|nevirapine|mesh-list
154574042|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154574043|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154574044|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574045|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574046|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
154574047|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574048|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154574049|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154574050|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154574051|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154574052|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154574053|NCT02741245|Ezetimibe|ezetimibe|mesh-list
154574054|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154574055|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154574056|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
154574057|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574058|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154574059|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154574060|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574061|NCT02202239|Midazolam|midazolam|mesh-list
154574062|NCT02202239|Fentanyl|fentanyl|mesh-list
154574063|NCT02202239|Remifentanil|remifentanil|mesh-list
154574064|NCT02202239|Propofol|propofol|mesh-list
154574065|NCT02202239|Etomidate|etomidate|mesh-list
154574066|NCT02202239|Sevoflurane|sevoflurane|mesh-list
154574067|NCT02202239|Cisatracurium|cisatracurium|mesh-list
154574068|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154574069|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574070|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574071|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154574072|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
154574073|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
154574074|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154574075|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154574076|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154574077|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154574078|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
154574079|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
154574080|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574081|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574082|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154574083|NCT02202239|Narcotics|narcotics|mesh-ancestor
154574084|NCT02202239|Analgesics|analgesics|mesh-ancestor
154574085|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
154574086|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574087|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154574088|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154574089|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154574090|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154574091|NCT02368197|Paclitaxel|paclitaxel|mesh-list
154574092|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154574093|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574094|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
154574095|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
154574096|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
154574097|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574098|NCT02364765|Remifentanil|remifentanil|mesh-list
154574099|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154574100|NCT02364765|Narcotics|narcotics|mesh-ancestor
154574101|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574102|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574103|NCT02364765|Analgesics|analgesics|mesh-ancestor
154574104|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
154574105|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574106|NCT04547049|Cytarabine|cytarabine|mesh-list
154574107|NCT04547049|Cyclosporine|cyclosporine|mesh-list
154574108|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
154574109|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
154574110|NCT04547049|Busulfan|busulfan|mesh-list
154574111|NCT04547049|Cyclosporins|cyclosporins|mesh-list
154574112|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154574113|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
154574114|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574115|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
154574116|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574117|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574118|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154574119|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
154574120|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574121|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574122|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154574123|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574124|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
154574125|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
154574126|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574127|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574128|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
154574129|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
154574130|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154574131|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154574132|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154574133|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
154574134|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154574135|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
154153301|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154574136|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154574137|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
154574138|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
154574139|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574140|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574141|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154574142|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
154574143|NCT05647291|Hormones|hormones|mesh-ancestor
154574144|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574145|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154574146|NCT05647291|Protective Agents|protective agents|mesh-ancestor
154574147|NCT03105765|Ketamine|ketamine|mesh-list
154574148|NCT03105765|Analgesics|analgesics|mesh-ancestor
154574149|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
154574150|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574151|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574152|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154574153|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154574154|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
154574155|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
154574156|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574157|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154574158|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154574159|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574160|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574161|NCT02202473|Lamivudine|lamivudine|mesh-list
154574162|NCT02202473|Oxymatrine|oxymatrine|mesh-list
154574163|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154574164|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154574165|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574166|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574167|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
154574168|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574169|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154574170|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154862147|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154862148|NCT03035045|Analgesics|analgesics|mesh-ancestor
154574171|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154574172|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
154574173|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574174|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154574175|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574176|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574177|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
154574178|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574179|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574180|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154574181|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154574182|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154574183|NCT02206763|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154574184|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574185|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574186|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574187|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574188|NCT02202707|Gabapentin|gabapentin|mesh-list
154574189|NCT02202707|Analgesics|analgesics|mesh-ancestor
154574190|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
154574191|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574192|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574193|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
154574194|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154574195|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154574196|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574197|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154574198|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154574199|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154574200|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574201|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574202|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
154574203|NCT02367807|Tenofovir|tenofovir|mesh-list
154574204|NCT02367807|Emtricitabine|emtricitabine|mesh-list
154574205|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
154574206|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574207|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154574208|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154574209|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574210|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574211|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154574212|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154574213|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
154574214|NCT02364609|Afatinib|afatinib|mesh-list
154574215|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574216|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574217|NCT02364609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154574218|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574219|NCT02364609|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154574220|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574221|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574222|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154574223|NCT02364453|Growth Substances|growth substances|mesh-ancestor
154574224|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574225|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
154574226|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574227|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574228|NCT02258009|Ranibizumab|ranibizumab|mesh-list
154574229|NCT02258009|Aflibercept|aflibercept|mesh-list
154574230|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154574231|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154574232|NCT02258009|Growth Substances|growth substances|mesh-ancestor
154574233|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574234|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
154574235|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574236|NCT02203097|Propofol|propofol|mesh-list
154574237|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154574238|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574239|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574240|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154574241|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
154574242|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
154574243|NCT04439487|Anesthetics|anesthetics|mesh-list
154862149|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
154574244|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574245|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574246|NCT03528967|Aspirin|aspirin|mesh-list
154574247|NCT03528967|Enoxaparin|enoxaparin|mesh-list
154574248|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154574249|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154574250|NCT03528967|Analgesics|analgesics|mesh-ancestor
154574251|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
154574252|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574253|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574254|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154574255|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574256|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154574257|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154574258|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574259|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154574260|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154574261|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574262|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
154574263|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
154574264|NCT02363985|Vitamin A|vitamin a|mesh-list
154574265|NCT02363985|Vitamins|vitamins|mesh-ancestor
154574266|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
154574267|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574268|NCT05723731|Laxatives|laxatives|mesh-list
154574269|NCT05723731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154574270|NCT02363829|Nelfinavir|nelfinavir|mesh-list
154574271|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154574272|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154574273|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
154574274|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574275|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574276|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154574277|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154574278|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
154574279|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574280|NCT03113019|Immunomodulating Agents|immunomodulating agents|mesh-list
154574281|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
154574282|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574283|NCT02363751|Bevacizumab|bevacizumab|mesh-list
154574284|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574285|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574286|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154574287|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154574288|NCT02363751|Growth Substances|growth substances|mesh-ancestor
154574289|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574290|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
154574291|NCT03527251|Ipilimumab|ipilimumab|mesh-list
154574292|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574293|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574294|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154574295|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574296|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
154574297|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
154574298|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574299|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
154574300|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
154574301|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
154574302|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574303|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574304|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
154574305|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574306|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
154574307|NCT02363361|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154574308|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574309|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574310|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574311|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574312|NCT04594915|Edoxaban|edoxaban|mesh-list
154574313|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154574314|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
154574315|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154574316|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
154574317|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862150|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862151|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574318|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574319|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
154574320|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
154574321|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154574322|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
154574323|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154574324|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
154574325|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574326|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574327|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
154574328|NCT02366949|Paclitaxel|paclitaxel|mesh-list
154574329|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154574330|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574331|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
154574332|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
154574333|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
154574334|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574335|NCT03532919|Cystatins|cystatins|mesh-list
154574336|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154574337|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
154574338|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574339|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574340|NCT05503225|Colchicine|colchicine|mesh-list
154574341|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
154574342|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574343|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
154574344|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
154574345|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
154574346|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574347|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574348|NCT02203175|Fentanyl|fentanyl|mesh-list
154574349|NCT02203175|Propofol|propofol|mesh-list
154574350|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154574351|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574352|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574353|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154574354|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
154574355|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
154574356|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154574357|NCT02203175|Narcotics|narcotics|mesh-ancestor
154574358|NCT02203175|Analgesics|analgesics|mesh-ancestor
154574359|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
154574360|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574361|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154574362|NCT05791890|Gilteritinib|gilteritinib|mesh-list
154574363|NCT05791890|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154574364|NCT05791890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574365|NCT05791890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574366|NCT05791890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574367|NCT05791799|Etonogestrel|etonogestrel|mesh-list
154574368|NCT05791799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154574369|NCT05791799|Contraceptive Agents|contraceptive agents|mesh-ancestor
154574370|NCT05791799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154574371|NCT05791799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574372|NCT05791799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154574373|NCT05791721|Dexamethasone|dexamethasone|mesh-list
154574374|NCT05791721|Etoricoxib|etoricoxib|mesh-list
154574375|NCT05791721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154574376|NCT05791721|Antiemetics|antiemetics|mesh-ancestor
154574377|NCT05791721|Autonomic Agents|autonomic agents|mesh-ancestor
154574378|NCT05791721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574379|NCT05791721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574380|NCT05791721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154574381|NCT05791721|Glucocorticoids|glucocorticoids|mesh-ancestor
154574382|NCT05791721|Hormones|hormones|mesh-ancestor
154574383|NCT05791721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574384|NCT05791721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154574385|NCT05791721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574386|NCT05791721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154574387|NCT05791721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154574388|NCT05791721|Analgesics|analgesics|mesh-ancestor
154574389|NCT05791721|Sensory System Agents|sensory system agents|mesh-ancestor
154574390|NCT05791721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574391|NCT05791721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154574392|NCT05791721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154862152|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
154574393|NCT05791721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574394|NCT05791721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574396|NCT05791669|Fluorides|fluorides|mesh-list
154574397|NCT05791669|Sodium Fluoride|sodium fluoride|mesh-list
154574398|NCT05791669|Fluorides, Topical|fluorides, topical|mesh-list
154574399|NCT05791669|Cariostatic Agents|cariostatic agents|mesh-ancestor
154574400|NCT05791669|Protective Agents|protective agents|mesh-ancestor
154574401|NCT05791669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574402|NCT05791669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154574403|NCT05791669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574404|NCT05791487|Budesonide|budesonide|mesh-list
154574406|NCT05791487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154574407|NCT05791487|Autonomic Agents|autonomic agents|mesh-ancestor
154574408|NCT05791487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574409|NCT05791487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574410|NCT05791487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154574411|NCT05791487|Respiratory System Agents|respiratory system agents|mesh-ancestor
154574412|NCT05791487|Glucocorticoids|glucocorticoids|mesh-ancestor
154574413|NCT05791487|Hormones|hormones|mesh-ancestor
154574414|NCT05791487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574415|NCT05791409|Venetoclax|venetoclax|mesh-list
154574416|NCT05791409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574417|NCT05791331|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154574418|NCT05791331|Respiratory System Agents|respiratory system agents|mesh-ancestor
154574419|NCT05791136|Immunomodulating Agents|immunomodulating agents|mesh-list
154574420|NCT05791136|Immunologic Factors|immunologic factors|mesh-ancestor
154574421|NCT05791136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574422|NCT05791058|Anesthetics|anesthetics|mesh-list
154574423|NCT05791058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574424|NCT05791058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574425|NCT05790941|Minoxidil|minoxidil|mesh-list
154574426|NCT05790941|Latanoprost|latanoprost|mesh-list
154574427|NCT05790941|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154574428|NCT05790941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154574429|NCT05790941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154574430|NCT05790941|Vasodilator Agents|vasodilator agents|mesh-ancestor
154574431|NCT05790902|Tamsulosin|tamsulosin|mesh-list
154574432|NCT05790902|Silodosin|silodosin|mesh-list
154574433|NCT05790902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154574434|NCT05790902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154574435|NCT05790902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154574436|NCT05790902|Adrenergic Agents|adrenergic agents|mesh-ancestor
154574437|NCT05790902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574438|NCT05790902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574439|NCT05790902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574440|NCT05790902|Urological Agents|urological agents|mesh-ancestor
154574441|NCT05790629|Calcium, Dietary|calcium, dietary|mesh-list
154574442|NCT05790629|Calcium|calcium|mesh-list
154574443|NCT05790629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154574444|NCT05790629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574445|NCT05790629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154574446|NCT05790603|Hemostatics|hemostatics|mesh-list
154574447|NCT05790603|Coagulants|coagulants|mesh-ancestor
154574448|NCT05790447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154574449|NCT05790447|Thymalfasin|thymalfasin|mesh-list
154574450|NCT05790447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154574451|NCT05790447|Immunologic Factors|immunologic factors|mesh-ancestor
154153623|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
154574452|NCT05790447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574453|NCT05790447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574454|NCT05790447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574455|NCT05790447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574456|NCT05790330|Methotrexate|methotrexate|mesh-list
154574457|NCT05790330|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154574458|NCT05790330|Abortifacient Agents|abortifacient agents|mesh-ancestor
154574459|NCT05790330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154574460|NCT05790330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574461|NCT05790330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574462|NCT05790330|Antimetabolites|antimetabolites|mesh-ancestor
154574463|NCT05790330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574464|NCT05790330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574465|NCT05790330|Dermatologic Agents|dermatologic agents|mesh-ancestor
154574466|NCT05790330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574467|NCT05790330|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154574468|NCT05790330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574469|NCT05790330|Immunologic Factors|immunologic factors|mesh-ancestor
154574470|NCT05790330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574471|NCT05790330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154574473|NCT05790239|Dextroamphetamine|dextroamphetamine|mesh-list
154574474|NCT05790239|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154574475|NCT05790239|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154574476|NCT05790239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574477|NCT05790239|Sympathomimetics|sympathomimetics|mesh-ancestor
154574478|NCT05790239|Autonomic Agents|autonomic agents|mesh-ancestor
154574479|NCT05790239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574480|NCT05790239|Dopamine Agents|dopamine agents|mesh-ancestor
154574481|NCT05790239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574482|NCT05790239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574483|NCT05790239|Adrenergic Agents|adrenergic agents|mesh-ancestor
154574484|NCT05790239|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154574485|NCT05790239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154574486|NCT05790239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154574487|NCT05790239|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154574488|NCT05790239|Hallucinogens|hallucinogens|mesh-ancestor
154574489|NCT05790239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154574490|NCT05790239|Serotonin Agents|serotonin agents|mesh-ancestor
154574491|NCT05683444|Octreotide|octreotide|mesh-list
154574492|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154574493|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154574494|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574495|NCT05669274|Caseins|caseins|mesh-list
154574496|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
154574497|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
154574498|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574499|NCT05667090|Vitamin D|vitamin d|mesh-list
154574500|NCT05667090|Vitamins|vitamins|mesh-ancestor
154574501|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
154574502|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574503|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154574504|NCT05553392|Petrolatum|petrolatum|mesh-list
154574505|NCT05553392|Emollients|emollients|mesh-ancestor
154574506|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
154574507|NCT05518734|Itraconazole|itraconazole|mesh-list
154574508|NCT05518734|Midazolam|midazolam|mesh-list
154574509|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154574510|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154574511|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574512|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574513|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154574514|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154574515|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154574516|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154574517|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
154574518|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
154574519|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
154574520|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
154574521|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574522|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574523|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
154574524|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574525|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154574526|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154574527|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574528|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154574529|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
154574530|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574531|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154574532|NCT05513365|Goserelin|goserelin|mesh-list
154574533|NCT05513365|Bicalutamide|bicalutamide|mesh-list
154574534|NCT05513365|Dutasteride|dutasteride|mesh-list
154574535|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154574536|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574537|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
154574538|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
154574539|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574540|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574541|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154574542|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154574543|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574544|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574545|NCT05442749|Niraparib|niraparib|mesh-list
154574546|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154574547|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574548|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574549|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574550|NCT05361655|Palbociclib|palbociclib|mesh-list
154574551|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154574552|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574553|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574555|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574556|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154574557|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154574558|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
154574559|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574560|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574561|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
154574562|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154574563|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574564|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
154574565|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154574566|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
154574567|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574568|NCT05308056|Anesthetics|anesthetics|mesh-list
154574569|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574570|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574571|NCT05276284|Atezolizumab|atezolizumab|mesh-list
154574572|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
154574573|NCT05276284|Thioguanine|thioguanine|mesh-list
154574574|NCT05276284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154574575|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574576|NCT05276284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574577|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574578|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
154574579|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574580|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574581|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
154574582|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574583|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154574584|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574585|NCT05237960|Metformin|metformin|mesh-list
154574586|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154574587|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574588|NCT05144698|Sirolimus|sirolimus|mesh-list
154574589|NCT05144698|Temsirolimus|temsirolimus|mesh-list
154574590|NCT05144698|MTOR Inhibitors|mtor inhibitors|mesh-list
154574591|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154574592|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574593|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154574594|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574595|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
154574596|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574597|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
154574598|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574599|NCT05144698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574600|NCT05144698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574601|NCT05144698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574602|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
154574603|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
154574604|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
154574605|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574606|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574607|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
154574608|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574609|NCT04910061|Niacinamide|niacinamide|mesh-list
154574610|NCT04910061|Niacin|niacin|mesh-list
154574611|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
154574612|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
154574613|NCT04910061|Vitamins|vitamins|mesh-ancestor
154574614|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
154574615|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574616|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154574617|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
154574618|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574619|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154574620|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
154574621|NCT04887467|Apomorphine|apomorphine|mesh-list
154574622|NCT04887467|Emetics|emetics|mesh-ancestor
154574623|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574624|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
154574625|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574626|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154574627|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
154574628|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
154574629|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574630|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574631|NCT04878393|Semaglutide|semaglutide|mesh-list
154574632|NCT04878393|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154574633|NCT04878393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154574634|NCT04878393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574635|NCT04846335|Doxycycline|doxycycline|mesh-list
154574636|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154574637|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574638|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
154574639|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154574640|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154574641|NCT04796220|Gemcitabine|gemcitabine|mesh-list
154574642|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574643|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
154574644|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574645|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574646|NCT04777045|Diltiazem|diltiazem|mesh-list
154574647|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154574648|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154574649|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154574650|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574651|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154574652|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574653|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
154574654|NCT04517799|Cannabidiol|cannabidiol|mesh-list
154574655|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
154574656|NCT04495296|Paclitaxel|paclitaxel|mesh-list
154574657|NCT04495296|Gemcitabine|gemcitabine|mesh-list
154574658|NCT04495296|Capecitabine|capecitabine|mesh-list
154574659|NCT04495296|Nivolumab|nivolumab|mesh-list
154574660|NCT04495296|Oxaliplatin|oxaliplatin|mesh-list
154574661|NCT04495296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154574662|NCT04495296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574663|NCT04495296|Tubulin Modulators|tubulin modulators|mesh-ancestor
154574664|NCT04495296|Antimitotic Agents|antimitotic agents|mesh-ancestor
154574665|NCT04495296|Mitosis Modulators|mitosis modulators|mesh-ancestor
154574666|NCT04495296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574667|NCT04495296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574668|NCT04495296|Antimetabolites|antimetabolites|mesh-ancestor
154574669|NCT04495296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574670|NCT04495296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154574671|NCT04404062|Antibodies|antibodies|mesh-list
154574672|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
154574673|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
154574674|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574675|NCT04147546|Artenimol|artenimol|mesh-list
154574676|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
154574677|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154574678|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154574679|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574680|NCT04141579|Evolocumab|evolocumab|mesh-list
154574681|NCT04141579|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154574682|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154574683|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154574684|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
154574685|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574686|NCT04141579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154574687|NCT04141579|Protease Inhibitors|protease inhibitors|mesh-ancestor
154574688|NCT04141579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574689|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154574690|NCT03987451|Semaglutide|semaglutide|mesh-list
154574691|NCT03987451|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154574692|NCT03987451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154862153|NCT03034733|Dexamethasone|dexamethasone|mesh-list
154574693|NCT03987451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574694|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154574695|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
154574696|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574697|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
154574698|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574699|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574700|NCT03849469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154574701|NCT03849469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574702|NCT03805607|Ketorolac|ketorolac|mesh-list
154574703|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154574704|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154574705|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154574706|NCT03805607|Analgesics|analgesics|mesh-ancestor
154574707|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
154574708|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574709|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153875|NCT00502203|Paclitaxel|paclitaxel|mesh-list
154574710|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154574711|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574712|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154574713|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574714|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574715|NCT03496766|Tipifarnib|tipifarnib|mesh-list
154574716|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574717|NCT03406715|Nivolumab|nivolumab|mesh-list
154574718|NCT03406715|Ipilimumab|ipilimumab|mesh-list
154574719|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574720|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574721|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154574722|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574723|NCT03363763|Sirolimus|sirolimus|mesh-list
154574724|NCT03363763|Temsirolimus|temsirolimus|mesh-list
154574725|NCT03363763|MTOR Inhibitors|mtor inhibitors|mesh-list
154574726|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154574727|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574728|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154574729|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574730|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
154574731|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574732|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
154574733|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574734|NCT03363763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574735|NCT03363763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574736|NCT03363763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574737|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
154574738|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154574739|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154574740|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574741|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
154574742|NCT03182751|Coagulants|coagulants|mesh-ancestor
154574743|NCT03105245|Thiopental|thiopental|mesh-list
154574744|NCT03105245|Anesthetics|anesthetics|mesh-list
154574745|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574746|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574747|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
154574748|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154574749|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154574750|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
154574751|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
154574752|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
154574753|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574754|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574755|NCT03019588|Paclitaxel|paclitaxel|mesh-list
154574756|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
154574757|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154574758|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574759|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
154574760|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
154574761|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
154574762|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574763|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574764|NCT03019588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154574765|NCT02959944|Prednisone|prednisone|mesh-list
154574766|NCT02959944|Ibrutinib|ibrutinib|mesh-list
154574767|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154574768|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
154862154|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862155|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
154153933|NCT00968240|Bevacizumab|bevacizumab|mesh-list
154574770|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574771|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574772|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154574773|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574774|NCT02959944|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154574775|NCT02959944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574776|NCT02959944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574777|NCT02959944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574778|NCT02806687|Gemcitabine|gemcitabine|mesh-list
154298628|NCT01216839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574779|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574780|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
154574781|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574782|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574783|NCT02559180|Aflibercept|aflibercept|mesh-list
154574784|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154574785|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154574786|NCT02559180|Growth Substances|growth substances|mesh-ancestor
154574787|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574788|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
154574789|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574790|NCT02539966|Sirolimus|sirolimus|mesh-list
154574791|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154574792|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574793|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154574794|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574795|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
154574796|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574797|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
154574798|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574799|NCT02401139|Ketamine|ketamine|mesh-list
154574800|NCT02401139|Analgesics|analgesics|mesh-ancestor
154574801|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
154574802|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574803|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574804|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154574805|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154574806|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
154574807|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
154574808|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154574809|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154574810|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154574811|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154574812|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574813|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
154574814|NCT02367846|NuvaRing|nuvaring|mesh-list
154574815|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
154574816|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154574817|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154574818|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574819|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154574820|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154574821|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
154574822|NCT02195895|Vitamin D|vitamin d|mesh-list
154574823|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
154574824|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
154574825|NCT02195895|Alendronate|alendronate|mesh-list
154574826|NCT02195895|Vitamins|vitamins|mesh-list
154574827|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
154574828|NCT02195895|Antacids|antacids|mesh-list
154574829|NCT02195895|Calcium|calcium|mesh-list
154574830|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
154574831|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574832|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154574833|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154574834|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574835|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154574836|NCT01970722|Paclitaxel|paclitaxel|mesh-list
154574837|NCT01970722|Cisplatin|cisplatin|mesh-list
154574838|NCT01970722|Carboplatin|carboplatin|mesh-list
154574839|NCT01970722|Gemcitabine|gemcitabine|mesh-list
154574840|NCT01970722|Doxorubicin|doxorubicin|mesh-list
154574841|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154574842|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153606570|NCT05517122|Niacin|niacin|mesh-list
154574843|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154574844|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574845|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
154574846|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
154574847|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
154574848|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574849|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574850|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
154574851|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154574852|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154574853|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154574854|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574855|NCT01913951|Azacitidine|azacitidine|mesh-list
154574856|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574857|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
154574858|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574859|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574860|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574861|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
154574862|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154574863|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154574864|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
154574865|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574866|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154574867|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154574868|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574869|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574870|NCT01709136|Sirolimus|sirolimus|mesh-list
154574871|NCT01709136|Temsirolimus|temsirolimus|mesh-list
154574872|NCT01709136|MTOR Inhibitors|mtor inhibitors|mesh-list
154574873|NCT01709136|Tacrolimus|tacrolimus|mesh-list
154574874|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574875|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
154574876|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574877|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154574878|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574879|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574880|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154574881|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574882|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154574883|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574884|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
154574885|NCT01709136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154574886|NCT01565499|Paclitaxel|paclitaxel|mesh-list
154574887|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154574888|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574889|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
154574890|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
154574891|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
154574892|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574893|NCT01036087|Paclitaxel|paclitaxel|mesh-list
154574894|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154574895|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
154574896|NCT01036087|Carboplatin|carboplatin|mesh-list
154574897|NCT01036087|Fluorouracil|fluorouracil|mesh-list
154574898|NCT01036087|Epirubicin|epirubicin|mesh-list
154574899|NCT01036087|Panitumumab|panitumumab|mesh-list
154574900|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154574901|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574902|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
154574903|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
154574904|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
154574905|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574906|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574907|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
154574908|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574909|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574910|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154574911|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
154574912|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154574913|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
154574914|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154574915|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154574916|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154574917|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154574918|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574919|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574921|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
154574922|NCT00783367|Rituximab|rituximab|mesh-list
154574923|NCT00783367|Lenalidomide|lenalidomide|mesh-list
154574924|NCT00783367|BB 1101|bb 1101|mesh-list
154574925|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154574926|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574927|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
154574928|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574929|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574930|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154574931|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
154298780|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154574932|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
154574933|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574934|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154574935|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
154574936|NCT00783367|Hormones|hormones|mesh-ancestor
154574937|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154574938|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154574939|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
154574940|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574941|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574942|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154574943|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154574944|NCT00783367|Growth Substances|growth substances|mesh-ancestor
154574945|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
154574946|NCT00572156|Mecasermin|mecasermin|mesh-list
154574947|NCT00572156|Growth Substances|growth substances|mesh-ancestor
154574948|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574949|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
154574950|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154574951|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154574952|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154574953|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154574954|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574955|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
154574956|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154141|NCT02976909|Cisplatin|cisplatin|mesh-list
154574957|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574958|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154574959|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574960|NCT00255216|Policosanol|policosanol|mesh-list
154574961|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154574962|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154574963|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
154574964|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574965|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154574966|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154574967|NCT02257697|Mizoribine|mizoribine|mesh-list
154574968|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
154574969|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154574970|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
154574971|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574972|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154574973|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154574974|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
154574975|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154574976|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154574977|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154574978|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154574979|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154574980|NCT02257697|Analgesics|analgesics|mesh-ancestor
154574981|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
154574982|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154574983|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154574984|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154574985|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154574986|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154574987|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
154574988|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154574989|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154574990|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154574991|NCT04468711|Vitamin D|vitamin d|mesh-list
154862156|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
154574993|NCT04468711|Vitamins|vitamins|mesh-ancestor
154574994|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
154574995|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154574996|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154574997|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154574998|NCT02207387|Rasagiline|rasagiline|mesh-list
154574999|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154575000|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575001|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575002|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154575003|NCT02207387|Protective Agents|protective agents|mesh-ancestor
154575004|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575005|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
154575006|NCT03528421|Fludarabine|fludarabine|mesh-list
154575007|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154575008|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
154575009|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575010|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154575011|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154575012|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
154575013|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575014|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575015|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154575016|NCT02374047|Atorvastatin|atorvastatin|mesh-list
154575017|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154575018|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154575019|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
154575020|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575021|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154575022|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154575023|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575024|NCT02203253|Thalidomide|thalidomide|mesh-list
154575025|NCT02203253|Dexamethasone|dexamethasone|mesh-list
154575026|NCT02203253|Palonosetron|palonosetron|mesh-list
154575027|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154575028|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
154575029|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
154575030|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575031|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575032|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154575033|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
154575034|NCT02203253|Hormones|hormones|mesh-ancestor
154575035|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154575036|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154575037|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575038|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154575039|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
154575040|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
154575041|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575042|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575043|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154575044|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154862157|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862158|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862159|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154862160|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
154862161|NCT03034733|Hormones|hormones|mesh-ancestor
154862162|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154862163|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154862164|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862165|NCT05512416|Letrozole|letrozole|mesh-list
154862166|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862167|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154862168|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154862169|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862170|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862171|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154862172|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
154862173|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154862174|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862175|NCT03403504|Oxycodone|oxycodone|mesh-list
154862176|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154862177|NCT03403504|Narcotics|narcotics|mesh-ancestor
154575045|NCT02203253|Growth Substances|growth substances|mesh-ancestor
154575046|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
154575047|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154575048|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154575050|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575051|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575052|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
154575053|NCT02207699|Benzonatate|benzonatate|mesh-list
154575054|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575055|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575056|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154575057|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154575058|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575059|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575060|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575061|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
154575062|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575063|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
154575064|NCT02296138|Olodaterol|olodaterol|mesh-list
154575065|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154575066|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
154575067|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575068|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575069|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154575070|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575071|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
154575072|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154575073|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
154575074|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575075|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575076|NCT01306942|Paclitaxel|paclitaxel|mesh-list
154575077|NCT01306942|Trastuzumab|trastuzumab|mesh-list
154575078|NCT01306942|Dasatinib|dasatinib|mesh-list
154298932|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
154575079|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154575080|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575081|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
154575082|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
154575083|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
154575084|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575085|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154575086|NCT01306942|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154575087|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154575088|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575089|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
154575090|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
154575091|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
154575092|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575093|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575094|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
154575095|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575096|NCT03532841|Tramadol|tramadol|mesh-list
154575097|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154575098|NCT03532841|Narcotics|narcotics|mesh-ancestor
154575099|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575100|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575101|NCT03532841|Analgesics|analgesics|mesh-ancestor
154575102|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
154575103|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575104|NCT02199431|Itraconazole|itraconazole|mesh-list
154575105|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
154575106|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575107|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154575108|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154575109|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575110|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575111|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154575112|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
154575113|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154575114|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575115|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154575116|NCT03532763|Tocotrienols|tocotrienols|mesh-list
154575117|NCT03532763|Vitamin E|vitamin e|mesh-list
154575118|NCT03532763|Tocopherols|tocopherols|mesh-list
154575119|NCT03532763|Tocovid|tocovid|mesh-list
154575120|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
154575121|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575122|NCT03532763|Protective Agents|protective agents|mesh-ancestor
154575123|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575124|NCT03532763|Vitamins|vitamins|mesh-ancestor
154575125|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
154575126|NCT02208245|Ropivacaine|ropivacaine|mesh-list
154575127|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
154575128|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
154575129|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575130|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575131|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
154575132|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575133|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
154575134|NCT03514901|Nivolumab|nivolumab|mesh-list
154575135|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154575136|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575137|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154575138|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575139|NCT04441021|Penicillins|penicillins|mesh-list
154575140|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575141|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575142|NCT03533387|Ibudilast|ibudilast|mesh-list
154575143|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154575144|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
154575145|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575146|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575147|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154575148|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575149|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154575150|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575151|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575152|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154575153|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
154575154|NCT02324842|Liraglutide|liraglutide|mesh-list
154575155|NCT02324842|Canagliflozin|canagliflozin|mesh-list
154575156|NCT02324842|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154575157|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154575158|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575159|NCT02324842|Incretins|incretins|mesh-ancestor
154575160|NCT02324842|Hormones|hormones|mesh-ancestor
154575161|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154575162|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154575163|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575164|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
154575165|NCT02295280|Promethazine|promethazine|mesh-list
154575166|NCT02295280|Codeine|codeine|mesh-list
154575167|NCT02295280|Metoclopramide|metoclopramide|mesh-list
154575168|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154575169|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154575170|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575171|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575172|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154575173|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
154575174|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
154575175|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575176|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
154575177|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
154575178|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154575179|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154575180|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
154575181|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
154575182|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575183|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575184|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154575185|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
154575186|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
154575187|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154575188|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154575189|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
154575190|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154575191|NCT02295280|Narcotics|narcotics|mesh-ancestor
154575192|NCT02295280|Analgesics|analgesics|mesh-ancestor
154575193|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
154575194|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575195|NCT05263505|Methotrexate|methotrexate|mesh-list
154575196|NCT05263505|Azathioprine|azathioprine|mesh-list
154575197|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154575198|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
154575199|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154575200|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575201|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154575202|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
154575203|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575204|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575205|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
154575206|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575207|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154575208|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154401|NCT04008888|Fludarabine|fludarabine|mesh-list
154575209|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
154575210|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154575211|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154575212|NCT02204501|Midazolam|midazolam|mesh-list
154575213|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154575214|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154575215|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575216|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575217|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154575218|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154575219|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154575220|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154575221|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
154575222|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
154575223|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
154575224|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
154575225|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575226|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575227|NCT02294734|Nemiralisib|nemiralisib|mesh-list
154575228|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154575229|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299090|NCT01127529|Protein C|protein c|mesh-list
154575230|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575231|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154575233|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
154575234|NCT03533231|Propolis|propolis|mesh-list
154575235|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575236|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154575237|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154575238|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154575239|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154575240|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575241|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575242|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575243|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154575244|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154575245|NCT02200757|Topotecan|topotecan|mesh-list
154575246|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154575247|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154575248|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575249|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575250|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575251|NCT02208791|Sirolimus|sirolimus|mesh-list
154575252|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575253|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575254|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154575255|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575256|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
154575257|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154575258|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
154575259|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575260|NCT05223101|Telmisartan|telmisartan|mesh-list
154575261|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154154456|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575262|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154575263|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154575264|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575265|NCT02852057|Timolol|timolol|mesh-list
154575266|NCT02852057|Dorzolamide|dorzolamide|mesh-list
154575267|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575268|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575269|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154575270|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154575271|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
154575272|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575273|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575274|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154575275|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154575276|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154575277|NCT04020445|Insulin|insulin|mesh-list
154575278|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154575279|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575280|NCT03524833|Amoxicillin|amoxicillin|mesh-list
154575281|NCT03524833|Metronidazole|metronidazole|mesh-list
154575282|NCT03524833|Lansoprazole|lansoprazole|mesh-list
154575283|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
154575284|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575285|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575286|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154575287|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154575288|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154575289|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154575290|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154575291|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575292|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575293|NCT02220647|Metformin|metformin|mesh-list
154575294|NCT02220647|Linagliptin|linagliptin|mesh-list
154575295|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154575296|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575297|NCT02220647|Incretins|incretins|mesh-ancestor
154575298|NCT02220647|Hormones|hormones|mesh-ancestor
154575299|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154575300|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154575301|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
154575302|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575303|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575304|NCT03544567|Paclitaxel|paclitaxel|mesh-list
154575305|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154575306|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575307|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
154575308|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
154575309|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
154575310|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575311|NCT02209025|Theobromine|theobromine|mesh-list
154575312|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154575313|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
154575314|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575315|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575316|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154575317|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575318|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
154575319|NCT02220803|Acetazolamide|acetazolamide|mesh-list
154575320|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
154575321|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154575322|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575323|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575324|NCT02220803|Diuretics|diuretics|mesh-ancestor
154575325|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
154575326|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575327|NCT02322892|Thiamine|thiamine|mesh-list
154575328|NCT02322892|Vitamins|vitamins|mesh-ancestor
154575329|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
154575330|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575331|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
154575332|NCT03274375|Rituximab|rituximab|mesh-list
154575333|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154575334|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575335|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
154575336|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575337|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154575338|NCT02739997|Metronidazole|metronidazole|mesh-list
154575339|NCT02739997|Tazobactam|tazobactam|mesh-list
154575340|NCT02739997|Ceftolozane|ceftolozane|mesh-list
154575341|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575342|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575343|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154575344|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154575345|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154575347|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575348|NCT04467931|Losartan|losartan|mesh-list
154575349|NCT04467931|Timolol|timolol|mesh-list
154575350|NCT04467931|Propranolol|propranolol|mesh-list
154575351|NCT04467931|Metoprolol|metoprolol|mesh-list
154575352|NCT04467931|Atenolol|atenolol|mesh-list
154575353|NCT04467931|Verapamil|verapamil|mesh-list
154575354|NCT04467931|Felodipine|felodipine|mesh-list
154575355|NCT04467931|Nadolol|nadolol|mesh-list
154575356|NCT04467931|Acebutolol|acebutolol|mesh-list
154575357|NCT04467931|Amlodipine|amlodipine|mesh-list
154575358|NCT04467931|Valsartan|valsartan|mesh-list
154575359|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154575360|NCT04467931|Telmisartan|telmisartan|mesh-list
154575361|NCT04467931|Clonidine|clonidine|mesh-list
154575362|NCT04467931|Carvedilol|carvedilol|mesh-list
154575363|NCT04467931|Candesartan|candesartan|mesh-list
154575364|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
154575365|NCT04467931|Ramipril|ramipril|mesh-list
154575366|NCT04467931|Olmesartan|olmesartan|mesh-list
154575367|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154575368|NCT04467931|Enalapril|enalapril|mesh-list
154575369|NCT04467931|Enalaprilat|enalaprilat|mesh-list
154575370|NCT04467931|Lisinopril|lisinopril|mesh-list
154575371|NCT04467931|Irbesartan|irbesartan|mesh-list
154575372|NCT04467931|Eplerenone|eplerenone|mesh-list
154575373|NCT04467931|Nebivolol|nebivolol|mesh-list
154575374|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
154575375|NCT04467931|Bisoprolol|bisoprolol|mesh-list
154575376|NCT04467931|Perindopril|perindopril|mesh-list
154575377|NCT04467931|Diltiazem|diltiazem|mesh-list
154575378|NCT04467931|Minoxidil|minoxidil|mesh-list
154575379|NCT04467931|Guanfacine|guanfacine|mesh-list
154575380|NCT04467931|Prazosin|prazosin|mesh-list
154575381|NCT04467931|Doxazosin|doxazosin|mesh-list
154575382|NCT04467931|Captopril|captopril|mesh-list
154575383|NCT04467931|Labetalol|labetalol|mesh-list
154575384|NCT04467931|Benazepril|benazepril|mesh-list
154575385|NCT04467931|Indapamide|indapamide|mesh-list
154575386|NCT04467931|Hydralazine|hydralazine|mesh-list
154575387|NCT04467931|Nicardipine|nicardipine|mesh-list
154575388|NCT04467931|Torsemide|torsemide|mesh-list
154575389|NCT04467931|Quinapril|quinapril|mesh-list
154575390|NCT04467931|Metolazone|metolazone|mesh-list
154575391|NCT04467931|Trandolapril|trandolapril|mesh-list
154575392|NCT04467931|Methyldopa|methyldopa|mesh-list
154575393|NCT04467931|Fosinopril|fosinopril|mesh-list
154575394|NCT04467931|Isradipine|isradipine|mesh-list
154575395|NCT04467931|Pindolol|pindolol|mesh-list
154575396|NCT04467931|Eprosartan|eprosartan|mesh-list
154575397|NCT04467931|Reserpine|reserpine|mesh-list
154575398|NCT04467931|Betaxolol|betaxolol|mesh-list
154575399|NCT04467931|Moexipril|moexipril|mesh-list
154575400|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
154575401|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
154575402|NCT04467931|Guanabenz|guanabenz|mesh-list
154575403|NCT04467931|Nisoldipine|nisoldipine|mesh-list
154575404|NCT04467931|Penbutolol|penbutolol|mesh-list
154575405|NCT04467931|Nifedipine|nifedipine|mesh-list
154575406|NCT04467931|Amiloride|amiloride|mesh-list
154575407|NCT04467931|Triamterene|triamterene|mesh-list
154575408|NCT04467931|Furosemide|furosemide|mesh-list
154575409|NCT04467931|Spironolactone|spironolactone|mesh-list
154575410|NCT04467931|Bumetanide|bumetanide|mesh-list
154575411|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
154575412|NCT04467931|Terazosin|terazosin|mesh-list
154575413|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154575414|NCT04467931|Aliskiren|aliskiren|mesh-list
154575415|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154575416|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154575417|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154575418|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154575419|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575420|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154575421|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575422|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
154575423|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154575424|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154575425|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154575426|NCT04467931|Diuretics|diuretics|mesh-ancestor
154575427|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
154154597|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154575428|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154575429|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154575430|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154575431|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
154575432|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575433|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154575434|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
154575435|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
154575436|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575437|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154575438|NCT04467931|Analgesics|analgesics|mesh-ancestor
154575439|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
154575440|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154575441|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154575442|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154575443|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154575444|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
154575445|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154575446|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154575447|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
154575448|NCT04467931|Protective Agents|protective agents|mesh-ancestor
154575449|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154575450|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154575451|NCT04467931|Renin Inhibitors|renin inhibitors|mesh-ancestor
154575452|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
154575453|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575454|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
154575455|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154575456|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154575457|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154575458|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154575459|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154575460|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154575461|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154575462|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
154154670|NCT04974996|Prednisone|prednisone|mesh-list
154575463|NCT04467931|Urological Agents|urological agents|mesh-ancestor
154575464|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154575465|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
154575466|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
154575467|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154575468|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154575469|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575470|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154575471|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154575472|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154575474|NCT03522649|Fluorouracil|fluorouracil|mesh-list
154575475|NCT03522649|Irinotecan|irinotecan|mesh-list
154575476|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
154575477|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575478|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154575479|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575480|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154575481|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
154575482|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575483|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154575484|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154575485|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575486|NCT03522649|Antidotes|antidotes|mesh-ancestor
154575487|NCT03522649|Protective Agents|protective agents|mesh-ancestor
154575488|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
154575489|NCT03522649|Vitamins|vitamins|mesh-ancestor
154575490|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
154575491|NCT02366481|Vitamins|vitamins|mesh-list
154575492|NCT02366481|Vitamin K|vitamin k|mesh-list
154575493|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
154575494|NCT02366481|Menaquinone 7|menaquinone 7|mesh-list
154575495|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
154575496|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575497|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154575498|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154575499|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575500|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
154575501|NCT02366481|Coagulants|coagulants|mesh-ancestor
154575502|NCT02366247|Adefovir|adefovir|mesh-list
154575503|NCT02366247|Thymalfasin|thymalfasin|mesh-list
154575504|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
154575505|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575506|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154575507|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154575508|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575509|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575510|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154575511|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
154575512|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575513|NCT02373735|Mannitol|mannitol|mesh-list
154575514|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154575515|NCT02373735|Diuretics|diuretics|mesh-ancestor
154575516|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
154575517|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575518|NCT03526315|Fluorides|fluorides|mesh-list
154575519|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
154575520|NCT03526315|Protective Agents|protective agents|mesh-ancestor
154575521|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575522|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
154575523|NCT03112551|Analgesics|analgesics|mesh-ancestor
154575524|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
154575525|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575526|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575527|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
154575528|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575529|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154575530|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
154575531|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154575532|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154575533|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575534|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154575535|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
154575536|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154575537|NCT05373433|Ritonavir|ritonavir|mesh-list
154575538|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154575539|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154575540|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
154575541|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575542|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575543|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154575544|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154575545|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
154575546|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575547|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154299381|NCT03740373|Budesonide|budesonide|mesh-list
154575548|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154575549|NCT02363127|Progesterone|progesterone|mesh-list
154575550|NCT02363127|Progestins|progestins|mesh-ancestor
154575551|NCT02363127|Hormones|hormones|mesh-ancestor
154575552|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154575553|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575554|NCT03526159|Gentamicins|gentamicins|mesh-list
154575555|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575556|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575557|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154575558|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575559|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575560|NCT03523741|Clozapine|clozapine|mesh-list
154575561|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154575562|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
154575563|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575564|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575565|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575566|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154575567|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154575568|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575569|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154575570|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
154575571|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
154575572|NCT02362581|Factor VIII|factor viii|mesh-list
154575573|NCT02362581|Coagulants|coagulants|mesh-ancestor
154575574|NCT02373579|Methotrexate|methotrexate|mesh-list
154575575|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154575576|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
154575577|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154575578|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575579|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154575580|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
154575581|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575582|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575583|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
154575584|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862178|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575586|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154575587|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
154575588|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154575589|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154575590|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
154575591|NCT02365857|Bupivacaine|bupivacaine|mesh-list
154575592|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
154575593|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
154575594|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575595|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575596|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
154575597|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575598|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154575599|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154575600|NCT02365857|Analgesics|analgesics|mesh-ancestor
154575601|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154575602|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154575603|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154575604|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
154575605|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575606|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575607|NCT02365935|Paclitaxel|paclitaxel|mesh-list
154575608|NCT02365935|Cisplatin|cisplatin|mesh-list
154575609|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154575610|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575611|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
154575612|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
154575613|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
154575614|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575615|NCT02365623|Bedaquiline|bedaquiline|mesh-list
154575616|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
154575617|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
154575618|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575619|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575620|NCT03112707|Aspirin|aspirin|mesh-list
154575621|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154575622|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154575623|NCT03112707|Analgesics|analgesics|mesh-ancestor
154575624|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
154575625|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575626|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575627|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154575628|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154575629|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154575630|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154575631|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575632|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154575633|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154575634|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575635|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
154575637|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575638|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154575639|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575640|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575641|NCT02209649|Telmisartan|telmisartan|mesh-list
154575642|NCT02209649|Lacidipine|lacidipine|mesh-list
154575643|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154575644|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154575645|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154575646|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575647|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154575648|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154575649|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154575650|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575651|NCT02361567|Acetaminophen|acetaminophen|mesh-list
154575652|NCT02361567|Oxycodone|oxycodone|mesh-list
154575653|NCT02361567|Tramadol|tramadol|mesh-list
154575654|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154575655|NCT02361567|Narcotics|narcotics|mesh-ancestor
154575656|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575657|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575658|NCT02361567|Analgesics|analgesics|mesh-ancestor
154575659|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
154575660|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575661|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154575662|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
154575663|NCT03112785|Cimetidine|cimetidine|mesh-list
154575664|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154575665|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154575666|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154575667|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
154575668|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
154575669|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575670|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575671|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575672|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154575673|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154575674|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575675|NCT02361879|Leuprolide|leuprolide|mesh-list
154575676|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
154575677|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154575678|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
154575679|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154575680|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575681|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154575682|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575683|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154575684|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
154575685|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154575686|NCT02361645|Ketorolac|ketorolac|mesh-list
154575687|NCT02361645|Indomethacin|indomethacin|mesh-list
154575688|NCT02361645|Nepafenac|nepafenac|mesh-list
154575689|NCT02361645|Bromfenac|bromfenac|mesh-list
154575690|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154575691|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154575692|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154575693|NCT02361645|Analgesics|analgesics|mesh-ancestor
154575694|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
154575695|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575696|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575697|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154575698|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154575699|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154575700|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575701|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575702|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
154575703|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
154575704|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154575705|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154575706|NCT03522181|Insulin|insulin|mesh-list
154575707|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154575708|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154575709|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575710|NCT02373033|Folic Acid|folic acid|mesh-list
154575711|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
154575712|NCT02373033|Hematinics|hematinics|mesh-ancestor
154575713|NCT02373033|Vitamins|vitamins|mesh-ancestor
154575714|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
154575715|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575716|NCT05186129|Clopidogrel|clopidogrel|mesh-list
154575717|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154575718|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154575719|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154575720|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154575721|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
154575722|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575723|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575724|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575725|NCT02361723|Pamiparib|pamiparib|mesh-list
154575726|NCT02361723|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154575727|NCT02361723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575728|NCT02361723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575729|NCT02361723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575730|NCT03596281|Bevacizumab|bevacizumab|mesh-list
154575731|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
154575732|NCT03596281|Doxorubicin|doxorubicin|mesh-list
154575733|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154575734|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154575735|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575737|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154575738|NCT03596281|Growth Substances|growth substances|mesh-ancestor
154575739|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575740|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
154575741|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154575742|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154575743|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154575744|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575745|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575746|NCT03596281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154575747|NCT05172167|Antibodies|antibodies|mesh-list
154575748|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
154575749|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575750|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
154575751|NCT02359149|Growth Substances|growth substances|mesh-ancestor
154575752|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575753|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
154575754|NCT02221583|Tacrolimus|tacrolimus|mesh-list
154575755|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154575756|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
154575757|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575758|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154575759|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575760|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575761|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154575762|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575763|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154575764|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
154575765|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575766|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575767|NCT02751359|Cannabidiol|cannabidiol|mesh-list
154575768|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
154575769|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
154575770|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
154575771|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
154575772|NCT02358993|Methenamine|methenamine|mesh-list
154575773|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575774|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575775|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154575776|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154575777|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575778|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575779|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575780|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154575781|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154575782|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154575783|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
154575785|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154575786|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575787|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154575788|NCT05092841|Naltrexone|naltrexone|mesh-list
154575789|NCT05092841|Baclofen|baclofen|mesh-list
154575790|NCT05092841|Sorbitol|sorbitol|mesh-list
154575791|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154575792|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154575793|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575794|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
154575795|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575796|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154575797|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154575798|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154575799|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
154575800|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
154575801|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575802|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575803|NCT05092841|Cathartics|cathartics|mesh-ancestor
154575804|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154575805|NCT02224937|Melatonin|melatonin|mesh-list
154575806|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
154575807|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575808|NCT02224937|Protective Agents|protective agents|mesh-ancestor
154575809|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575810|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575811|NCT02290327|Pantoprazole|pantoprazole|mesh-list
154575812|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154575813|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154575814|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154575815|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575816|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575817|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
154575818|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154575819|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575820|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154575821|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575822|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
154575823|NCT02358057|Alfentanil|alfentanil|mesh-list
154575824|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154575825|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575826|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575827|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154575828|NCT02358057|Analgesics|analgesics|mesh-ancestor
154575829|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
154575830|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575831|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154575832|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154575833|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154575834|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
154575835|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575836|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575837|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154575838|NCT02358057|Narcotics|narcotics|mesh-ancestor
154575839|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154155025|NCT00983034|Lansoprazole|lansoprazole|mesh-list
154575840|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
154575841|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
154575842|NCT02225093|Levomethorphan|levomethorphan|mesh-list
154575843|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
154575844|NCT02225093|Caffeine|caffeine|mesh-list
154575845|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154575846|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575847|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154575849|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575850|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154575851|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154575852|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
154575853|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575854|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
154575855|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575856|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154575857|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154575858|NCT02225093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154575859|NCT02225093|Narcotics|narcotics|mesh-ancestor
154575860|NCT02225093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575861|NCT02225093|Analgesics|analgesics|mesh-ancestor
154575862|NCT02225093|Sensory System Agents|sensory system agents|mesh-ancestor
154575863|NCT02225093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575864|NCT02212535|Plerixafor|plerixafor|mesh-list
154575865|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154575866|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154575867|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
154575868|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575869|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
154575870|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575871|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
154575872|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154575873|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154575874|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575875|NCT02372487|Urological Agents|urological agents|mesh-ancestor
154575876|NCT02361177|Oxytocin|oxytocin|mesh-list
154575877|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
154155071|NCT00977964|Caseins|caseins|mesh-list
154575878|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154575879|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575880|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154575881|NCT05055713|Somatostatin|somatostatin|mesh-list
154575882|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154575883|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154575884|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255593|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
154862179|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575885|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575886|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575887|NCT05055713|Hormones|hormones|mesh-ancestor
154575888|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154575889|NCT02360709|Sirolimus|sirolimus|mesh-list
154575890|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154575891|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154575892|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154575893|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575894|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
154575895|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154575896|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
154575897|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575898|NCT05030519|Trastuzumab|trastuzumab|mesh-list
154575899|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154575900|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575901|NCT02357277|Budesonide|budesonide|mesh-list
154575902|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154575903|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154575904|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
154575905|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575906|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575907|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154575908|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575909|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
154575910|NCT02357277|Hormones|hormones|mesh-ancestor
154575911|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154575912|NCT02222441|Pioglitazone|pioglitazone|mesh-list
154575913|NCT02222441|Palbociclib|palbociclib|mesh-list
154575914|NCT02222441|Modafinil|modafinil|mesh-list
154575915|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154575916|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575917|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575918|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154575919|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154575920|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575921|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154575922|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154575923|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154575924|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154575925|NCT02290717|Fluticasone|fluticasone|mesh-list
154575927|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154575928|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154575929|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
154575930|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575931|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575932|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154575933|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575934|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
154575935|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154575936|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
154575937|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154575938|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
154575939|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154575940|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
154575941|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575942|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154575943|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154575944|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
154575945|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575946|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154575947|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154575948|NCT02360007|Buprenorphine|buprenorphine|mesh-list
154575949|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154575950|NCT02360007|Narcotics|narcotics|mesh-ancestor
154575951|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575952|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575953|NCT02360007|Analgesics|analgesics|mesh-ancestor
154575954|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
154575955|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575956|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154575957|NCT02294305|Vortioxetine|vortioxetine|mesh-list
154575958|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
154862180|NCT03403504|Analgesics|analgesics|mesh-ancestor
154575959|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154575960|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154575961|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154575962|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154575963|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575964|NCT02294305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154575965|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154575966|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154575967|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575968|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575969|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
154575970|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154575971|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154575972|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154575973|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154575974|NCT02222519|Bromides|bromides|mesh-list
154575975|NCT02222519|Rocuronium|rocuronium|mesh-list
154575976|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
154575977|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154575978|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154575979|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154575980|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575981|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575982|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
154575983|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154575984|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
154575985|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154575986|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154575987|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154575988|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
154575989|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154575990|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
154575991|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154575992|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154575993|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154575994|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
154575995|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
154575996|NCT02220023|Protective Agents|protective agents|mesh-ancestor
154575997|NCT02356965|Ketamine|ketamine|mesh-list
154575998|NCT02356965|Analgesics|analgesics|mesh-ancestor
154575999|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
154576000|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576001|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576002|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154576003|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154576004|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
154576005|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
154576006|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576007|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154576008|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154576009|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576010|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576011|NCT02359695|Hormones|hormones|mesh-list
154576012|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576013|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576014|NCT02294539|Losartan|losartan|mesh-list
154576015|NCT02294539|Amlodipine|amlodipine|mesh-list
154576016|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154576017|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154576018|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154576019|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576020|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576021|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154576022|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576023|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
154576024|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154576025|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154576026|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154576027|NCT02294539|Diuretics|diuretics|mesh-ancestor
154576028|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
154576029|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154862181|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
154576031|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154576032|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576033|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154576034|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
154576035|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154576036|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154576037|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154576038|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
154576039|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154576040|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576041|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154576042|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154576043|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154576044|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154576045|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576046|NCT02294617|Nicotine|nicotine|mesh-list
154576047|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154576048|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
154576049|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576050|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576051|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154576052|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154576053|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
154576054|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576055|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576056|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154576057|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154576058|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154576059|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576060|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576061|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576062|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576063|NCT02291341|Analgesics|analgesics|mesh-ancestor
154576064|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
154576065|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576066|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
154576067|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154576068|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
154576069|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
154576070|NCT02352987|Salicylates|salicylates|mesh-list
154576071|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576072|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
154576073|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
154576074|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
154576075|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154576076|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154576077|NCT02352987|Analgesics|analgesics|mesh-ancestor
154576078|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
154576079|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576080|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576081|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576082|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154576083|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154576084|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576085|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576086|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
154576087|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154576088|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154576089|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576090|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154576091|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
154576092|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154576093|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576094|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576095|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576096|NCT02226341|Hormones|hormones|mesh-ancestor
154576097|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576098|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576099|NCT02222987|Clopidogrel|clopidogrel|mesh-list
154576100|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154255594|NCT01149902|Docetaxel|docetaxel|mesh-list
154576101|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154576102|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154155301|NCT00987636|Busulfan|busulfan|mesh-list
154576103|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154576105|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576106|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576107|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576108|NCT03521245|Trastuzumab|trastuzumab|mesh-list
154576109|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154576110|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576111|NCT02481245|Bezafibrate|bezafibrate|mesh-list
154576112|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154576113|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
154576114|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576115|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154576116|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154576117|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154576118|NCT02352597|Clomiphene|clomiphene|mesh-list
154576119|NCT02352597|Enclomiphene|enclomiphene|mesh-list
154576120|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
154576121|NCT02352597|Estradiol|estradiol|mesh-list
154576122|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154576123|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
154576124|NCT02352597|Estrogens|estrogens|mesh-ancestor
154576125|NCT02352597|Hormones|hormones|mesh-ancestor
154576126|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576127|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576128|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154576129|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
154576130|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154576131|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154576132|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154576133|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
154576134|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154576135|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
154576136|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154576137|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154576138|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154576139|NCT03521167|Acetaminophen|acetaminophen|mesh-list
154576140|NCT03521167|Lidocaine|lidocaine|mesh-list
154576141|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
154576142|NCT03521167|Ketamine|ketamine|mesh-list
154576144|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
154576145|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
154576146|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576147|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576148|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
154576149|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576150|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154576151|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154576152|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154576153|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576154|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576155|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154576156|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154576157|NCT03521167|Analgesics|analgesics|mesh-ancestor
154576158|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154576159|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154576160|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154576161|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
154576162|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576163|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154576164|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154576165|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
154576166|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154576167|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154576168|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
154576169|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154576170|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154576171|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154576172|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
154576173|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
154576174|NCT02352519|Anesthetics|anesthetics|mesh-list
154576175|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
154576176|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576177|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576178|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
154576179|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576180|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
154576181|NCT02356419|Hematinics|hematinics|mesh-ancestor
154576182|NCT02220335|Digoxin|digoxin|mesh-list
154576183|NCT02220335|Diuretics|diuretics|mesh-list
154576184|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154576185|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154576186|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154576187|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154576188|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576189|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576190|NCT02220335|Protective Agents|protective agents|mesh-ancestor
154576191|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576192|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
154576193|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
154576194|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
154576195|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576196|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154576197|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154576198|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154576199|NCT02223299|Tryptophan|tryptophan|mesh-list
154576200|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154576201|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
154576202|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154576203|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154576204|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154576205|NCT02291887|Ranibizumab|ranibizumab|mesh-list
154576206|NCT02291887|Aflibercept|aflibercept|mesh-list
154576207|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154576208|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154576209|NCT02291887|Growth Substances|growth substances|mesh-ancestor
154576210|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576211|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
154576212|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576213|NCT02352285|Tolvaptan|tolvaptan|mesh-list
154576214|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154576215|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576216|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
154576217|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576218|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
154576219|NCT03521713|Hematinics|hematinics|mesh-ancestor
154576220|NCT02223533|Morphine|morphine|mesh-list
154576221|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154576222|NCT02223533|Narcotics|narcotics|mesh-ancestor
154576223|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576224|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576225|NCT02223533|Analgesics|analgesics|mesh-ancestor
154576226|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
154576227|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576228|NCT02231021|Pioglitazone|pioglitazone|mesh-list
154576229|NCT02231021|Alogliptin|alogliptin|mesh-list
154576230|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154576231|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576232|NCT02231021|Incretins|incretins|mesh-ancestor
154576233|NCT02231021|Hormones|hormones|mesh-ancestor
154576234|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576235|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154576236|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
154576237|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576238|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576239|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154576240|NCT04465123|Spironolactone|spironolactone|mesh-list
154576241|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154576242|NCT04465123|Diuretics|diuretics|mesh-ancestor
154576243|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
154576244|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576245|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154576246|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576247|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576248|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154576249|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
154576250|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576251|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154576252|NCT02401347|Talazoparib|talazoparib|mesh-list
154576253|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154576254|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576255|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576256|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576257|NCT02231255|Pramipexole|pramipexole|mesh-list
154576258|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
154576259|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576260|NCT02231255|Protective Agents|protective agents|mesh-ancestor
154576261|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576262|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154576263|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154576264|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
154576265|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
154576266|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576267|NCT02352051|Methylphenidate|methylphenidate|mesh-list
154576268|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154576269|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154576270|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576271|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154576272|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154576273|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576274|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576275|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
154576276|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576277|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154576278|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
154576279|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154576280|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
154576281|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
154576282|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576283|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576284|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
154576285|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
154576286|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576287|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154576288|NCT02292121|Mannitol|mannitol|mesh-list
154576289|NCT02292121|Lactitol|lactitol|mesh-list
154576290|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154576291|NCT02292121|Diuretics|diuretics|mesh-ancestor
154576292|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
154576293|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576294|NCT02292121|Cathartics|cathartics|mesh-ancestor
154576295|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576296|NCT02223611|Cisplatin|cisplatin|mesh-list
154576297|NCT02223611|Vinorelbine|vinorelbine|mesh-list
154576298|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576299|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154576300|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
154576301|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
154576302|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
154576303|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576304|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
154576305|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154576306|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576307|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576308|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154576309|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154576310|NCT02231333|Protective Agents|protective agents|mesh-ancestor
154576311|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576312|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
154576313|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154576314|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
154576315|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154576316|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154576317|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576318|NCT02227433|Immunotoxins|immunotoxins|mesh-ancestor
154576319|NCT02227433|Immunoconjugates|immunoconjugates|mesh-ancestor
154576320|NCT02227433|Immunologic Factors|immunologic factors|mesh-ancestor
154576321|NCT02227433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576322|NCT02351973|Amiloride|amiloride|mesh-list
154862182|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576323|NCT02351973|Diuretics|diuretics|mesh-ancestor
154576324|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
154576325|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576326|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154576327|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154155515|NCT05919615|Tranexamic Acid|tranexamic acid|mesh-list
154576328|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576329|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576330|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154576331|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154576332|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
154576333|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154576334|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154576335|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576336|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
154576337|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
154576338|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576339|NCT03520543|Clonidine|clonidine|mesh-list
154576340|NCT03520543|Yohimbine|yohimbine|mesh-list
154576341|NCT03520543|Analgesics|analgesics|mesh-ancestor
154576342|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
154576343|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576344|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576345|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154576346|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
154576347|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
154576348|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154576349|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154576350|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154576351|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
154576352|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576353|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576354|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
154576355|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154576356|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154576357|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154576358|NCT03520543|Urological Agents|urological agents|mesh-ancestor
154576359|NCT02355639|Betamethasone|betamethasone|mesh-list
154576360|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
154576361|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154576362|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
154576363|NCT02355639|Clobetasol|clobetasol|mesh-list
154576364|NCT02355639|Petrolatum|petrolatum|mesh-list
154576365|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154576366|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576367|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
154576368|NCT02355639|Hormones|hormones|mesh-ancestor
154576369|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576370|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576371|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154576372|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
154576373|NCT02355639|Emollients|emollients|mesh-ancestor
154576374|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
154576375|NCT02351895|Copper|copper|mesh-list
154576376|NCT02351895|Trace Elements|trace elements|mesh-ancestor
154576377|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
154155564|NCT05918588|Belumosudil|belumosudil|mesh-list
154576378|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576379|NCT00503035|Celecoxib|celecoxib|mesh-list
154576380|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154576381|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154576382|NCT00503035|Analgesics|analgesics|mesh-ancestor
154576383|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
154576384|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576385|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576386|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576387|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154576388|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154576389|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154576390|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576391|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576392|NCT02227745|Dorzolamide|dorzolamide|mesh-list
154576393|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
154576394|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154576395|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
154576396|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576397|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
154576398|NCT02227745|Protective Agents|protective agents|mesh-ancestor
154576399|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154576400|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154576401|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576402|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576403|NCT03517033|Nebivolol|nebivolol|mesh-list
154576404|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154576405|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
154576406|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154576407|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154576408|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154576409|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
154576410|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576411|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576412|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576413|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154576414|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154576415|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154576416|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
154576417|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576418|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154576419|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154576420|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576421|NCT02259179|Naltrexone|naltrexone|mesh-list
154576422|NCT02259179|Bupropion|bupropion|mesh-list
154576423|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154576424|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154576425|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576426|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
154576427|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576428|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154576429|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
154576430|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154576431|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154576432|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154576433|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576434|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576435|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
154576436|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576437|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154576438|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154576439|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576440|NCT02355093|Ropivacaine|ropivacaine|mesh-list
154576441|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
154576442|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
154576443|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576444|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576445|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
154576446|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576447|NCT02227901|Temozolomide|temozolomide|mesh-list
154576448|NCT02227901|Tipifarnib|tipifarnib|mesh-list
154576449|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154576450|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
154576451|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576452|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576453|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
154576454|NCT03146793|Antidotes|antidotes|mesh-ancestor
154576455|NCT03146793|Protective Agents|protective agents|mesh-ancestor
154576456|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576457|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
154576458|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576459|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
154576460|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154576461|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576462|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
154576463|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
154576464|NCT03133195|Vitamin D|vitamin d|mesh-list
154576465|NCT03133195|Teriparatide|teriparatide|mesh-list
154576466|NCT03133195|Calcium|calcium|mesh-list
154576467|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
154576468|NCT03133195|Vitamins|vitamins|mesh-ancestor
154576469|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
154576470|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576471|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154576472|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154862183|NCT05512728|Midazolam|midazolam|mesh-list
154576473|NCT03159741|Glucagon|glucagon|mesh-list
154576474|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154862184|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154576475|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576476|NCT03159741|Hormones|hormones|mesh-ancestor
154576477|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576478|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576479|NCT03159741|Incretins|incretins|mesh-ancestor
154576480|NCT02292277|Ticagrelor|ticagrelor|mesh-list
154576481|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154576482|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154576483|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154576484|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154576485|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
154576486|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576487|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576488|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576489|NCT02228135|Dexamethasone|dexamethasone|mesh-list
154576490|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576491|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
154576492|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
154576493|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576494|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576495|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576496|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
154576497|NCT02228135|Hormones|hormones|mesh-ancestor
154576498|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576499|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154576500|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576501|NCT03152877|Bupivacaine|bupivacaine|mesh-list
154576502|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
154576503|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
154576504|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576505|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576506|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
154576507|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576508|NCT02295709|Dexamethasone|dexamethasone|mesh-list
154576509|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
154576510|NCT02295709|BB 1101|bb 1101|mesh-list
154576511|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576512|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
154576513|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
154576514|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576515|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576516|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576517|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
154576518|NCT02295709|Hormones|hormones|mesh-ancestor
154576519|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576520|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154576521|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576522|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
154576523|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576524|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576525|NCT02354937|Cabotegravir|cabotegravir|mesh-list
154576526|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154576527|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154576528|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576529|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576530|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154576531|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154576532|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
154576533|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576534|NCT02295787|Ketamine|ketamine|mesh-list
154576535|NCT02295787|Analgesics|analgesics|mesh-ancestor
154576536|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
154576537|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576538|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576539|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154576540|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154576541|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
154576542|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
154576543|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576544|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154576545|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154576546|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576547|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576548|NCT04464967|Trastuzumab|trastuzumab|mesh-list
154576550|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154576551|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576552|NCT02228369|Osimertinib|osimertinib|mesh-list
154576553|NCT02228369|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154576554|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154576555|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576556|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576557|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576558|NCT03146871|Azacitidine|azacitidine|mesh-list
154576559|NCT03146871|Decitabine|decitabine|mesh-list
154576560|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154576561|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
154576562|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576563|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576564|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576565|NCT02231957|Vaccines|vaccines|mesh-list
154576566|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
154576567|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576568|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
154576569|NCT02354547|Topotecan|topotecan|mesh-list
154576570|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154576571|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
154576572|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576573|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154576574|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154576575|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
154576576|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576577|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576578|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154576579|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154576580|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154576581|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576582|NCT02232035|Diazepam|diazepam|mesh-list
154576583|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154576584|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
154576585|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
154576586|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
154576587|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576588|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576589|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576590|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154576591|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576592|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154576593|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154576594|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154576595|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154576596|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154576597|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154576598|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
154576599|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
154576600|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
154576601|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
154576602|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576603|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576604|NCT02296021|Amoxicillin|amoxicillin|mesh-list
154576605|NCT02296021|Clarithromycin|clarithromycin|mesh-list
154576606|NCT02296021|Esomeprazole|esomeprazole|mesh-list
154576607|NCT02296021|Bismuth|bismuth|mesh-list
154576608|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154576609|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576610|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154576611|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576612|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154576613|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576614|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576615|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154576616|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154576617|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154576618|NCT02296021|Antacids|antacids|mesh-ancestor
154576619|NCT02289391|Anesthetics|anesthetics|mesh-list
154576620|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576621|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576622|NCT02354313|Lenalidomide|lenalidomide|mesh-list
154576623|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
154576624|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576626|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154576627|NCT02354313|Growth Substances|growth substances|mesh-ancestor
154576628|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
154576629|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576630|NCT02292667|Acetaminophen|acetaminophen|mesh-list
154576631|NCT02292667|Morphine|morphine|mesh-list
154576632|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154576633|NCT02292667|Narcotics|narcotics|mesh-ancestor
154576634|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576635|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576636|NCT02292667|Analgesics|analgesics|mesh-ancestor
154576637|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
154576638|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576639|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154576640|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
154576641|NCT02232269|Felodipine|felodipine|mesh-list
154576642|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154155832|NCT04880785|Lamivudine|lamivudine|mesh-list
154576643|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154576644|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154576645|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576646|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576647|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154576648|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576649|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
154576650|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
154576651|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154576652|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576653|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154576654|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154576655|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
154576656|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576657|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576658|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154576659|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154576660|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154576661|NCT02347839|Gefitinib|gefitinib|mesh-list
154576662|NCT02347839|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154576663|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154576664|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576665|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576666|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576667|NCT02289547|Capecitabine|capecitabine|mesh-list
154300506|NCT01133925|Sirolimus|sirolimus|mesh-list
154576668|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154576669|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
154576670|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576671|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576672|NCT02351427|Bortezomib|bortezomib|mesh-list
154576673|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576674|NCT02232971|Glucagon|glucagon|mesh-list
154576675|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576676|NCT02232971|Hormones|hormones|mesh-ancestor
154576677|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154155888|NCT04678102|PHI-101|phi-101|mesh-list
154576678|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576679|NCT02296333|Ondansetron|ondansetron|mesh-list
154576680|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
154576681|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
154576682|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576683|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576684|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576685|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
154576686|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
154576687|NCT02296333|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154576688|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154576689|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
154576690|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576691|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576692|NCT03149913|Paclitaxel|paclitaxel|mesh-list
154576693|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154576694|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576695|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
154576696|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
154576697|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
154576698|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576700|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154576701|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
154576702|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154576703|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
154576704|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576705|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576706|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
154576707|NCT02232347|Sufentanil|sufentanil|mesh-list
154576708|NCT02232347|Ketamine|ketamine|mesh-list
154576709|NCT02232347|Analgesics|analgesics|mesh-ancestor
154576710|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
154576711|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576712|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576713|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154576714|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154576715|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
154576716|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
154576717|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576718|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154576719|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154576720|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576721|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576722|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154576723|NCT02232347|Narcotics|narcotics|mesh-ancestor
154576724|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154576725|NCT03542669|Doxorubicin|doxorubicin|mesh-list
154576726|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154576727|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576728|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154576729|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154576730|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576731|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576732|NCT03146481|Aceclofenac|aceclofenac|mesh-list
154576733|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154576734|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154576735|NCT03146481|Analgesics|analgesics|mesh-ancestor
154576736|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
154576737|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576738|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576739|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576740|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154576741|NCT03541655|Celecoxib|celecoxib|mesh-list
154576742|NCT03541655|Bupivacaine|bupivacaine|mesh-list
154576743|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
154576744|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
154576745|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576746|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576747|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
154576748|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576749|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154576750|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154576751|NCT03541655|Analgesics|analgesics|mesh-ancestor
154576752|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576753|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154576754|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154576755|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154576756|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576757|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576758|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
154576760|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
154576761|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154576762|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154576763|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154576764|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
154576765|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576766|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576767|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576768|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
154576769|NCT02229617|Testosterone|testosterone|mesh-list
154576770|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
154576771|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
154576772|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154576773|NCT02229617|Androgens|androgens|mesh-ancestor
154576774|NCT02229617|Hormones|hormones|mesh-ancestor
154576775|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576776|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576777|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154576778|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576779|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
154576780|NCT02347059|Dopamine|dopamine|mesh-list
154576781|NCT02347059|Levodopa|levodopa|mesh-list
154576782|NCT02347059|Pramipexole|pramipexole|mesh-list
154576783|NCT02347059|Dexpramipexole|dexpramipexole|mesh-list
154576784|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
154576785|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154576786|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154576787|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
154576788|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576789|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576790|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576791|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
154576792|NCT02347059|Protective Agents|protective agents|mesh-ancestor
154576793|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154576794|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
154576795|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
154576796|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576797|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154576798|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154576799|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576800|NCT02296567|Bevacizumab|bevacizumab|mesh-list
154576801|NCT02296567|Ranibizumab|ranibizumab|mesh-list
154576802|NCT02296567|Aflibercept|aflibercept|mesh-list
154576803|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154576804|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576805|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154576806|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154576807|NCT02296567|Growth Substances|growth substances|mesh-ancestor
154576808|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576809|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
154576810|NCT02296723|Valganciclovir|valganciclovir|mesh-list
154576811|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
154576812|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576813|NCT02289937|Ropivacaine|ropivacaine|mesh-list
154576814|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
154576815|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
154576816|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300663|NCT01139151|Cytarabine|cytarabine|mesh-list
154576817|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576818|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
154576819|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576821|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154576822|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154576823|NCT03519061|Budesonide|budesonide|mesh-list
154576824|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576825|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154576826|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
154576827|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576828|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576829|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154576830|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
154576831|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
154576832|NCT03519061|Hormones|hormones|mesh-ancestor
154576833|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576834|NCT02229773|Pravastatin|pravastatin|mesh-list
154576835|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154576836|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154576837|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
154576838|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576839|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154576840|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154576841|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576842|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
154576843|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
154576844|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154576845|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576846|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576847|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
154576848|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154862185|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154576849|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576850|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576851|NCT03515707|Etoposide|etoposide|mesh-list
154576852|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
154576853|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
154576854|NCT03515707|Busulfan|busulfan|mesh-list
154576855|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154576856|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576857|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154576858|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154576859|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576860|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576861|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
154576862|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154576863|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
154576864|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576865|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154576866|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154576867|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
154576868|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
154576869|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
154576870|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
154576871|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
154576872|NCT02298205|Beclomethasone|beclomethasone|mesh-list
154576873|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576874|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
154576875|NCT02298205|Hormones|hormones|mesh-ancestor
154576876|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576877|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576878|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154576879|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
154576880|NCT03514771|Valacyclovir|valacyclovir|mesh-list
154576881|NCT03514771|Isotretinoin|isotretinoin|mesh-list
154576882|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
154576883|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576884|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
154576885|NCT02298283|Prednisone|prednisone|mesh-list
154576886|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
154576887|NCT02298283|Doxorubicin|doxorubicin|mesh-list
154576888|NCT02298283|Etoposide|etoposide|mesh-list
154576889|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154576890|NCT02298283|Vincristine|vincristine|mesh-list
154576891|NCT02298283|Bleomycin|bleomycin|mesh-list
154576892|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154576893|NCT02298283|Procarbazine|procarbazine|mesh-list
154576894|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154576895|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
154576896|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576897|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154576898|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154576899|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
154576900|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576901|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576902|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154576903|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154576904|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154576905|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154576906|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576907|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576908|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
154576909|NCT02298283|Hormones|hormones|mesh-ancestor
154576910|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154576911|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154576912|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154576913|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
154576914|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
154576915|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
154576916|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154576917|NCT02298283|Immunotoxins|immunotoxins|mesh-ancestor
154576918|NCT02298283|Immunoconjugates|immunoconjugates|mesh-ancestor
154576919|NCT02346357|Ropivacaine|ropivacaine|mesh-list
154576920|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
154576921|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
154576922|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576923|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862186|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576924|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
154576926|NCT03146247|Apremilast|apremilast|mesh-list
154576927|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154576928|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154576929|NCT03146247|Analgesics|analgesics|mesh-ancestor
154576930|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
154576931|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576932|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576933|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154576934|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154576935|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154576936|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154576937|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576938|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576939|NCT03263273|Minocycline|minocycline|mesh-list
154576940|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154576941|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576942|NCT03146325|Metronidazole|metronidazole|mesh-list
154576943|NCT03146325|Tetracycline|tetracycline|mesh-list
154576944|NCT03146325|Omeprazole|omeprazole|mesh-list
154576945|NCT03146325|Bismuth|bismuth|mesh-list
154576946|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154576947|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154576948|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154576949|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154576950|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154576951|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154576952|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154576953|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576954|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576955|NCT03146325|Antacids|antacids|mesh-ancestor
154156153|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154576956|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154576957|NCT02233049|Everolimus|everolimus|mesh-list
154576958|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154576959|NCT02233049|Dasatinib|dasatinib|mesh-list
154576960|NCT02233049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154576961|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154576962|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576963|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576964|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154576965|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
154576966|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576967|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154576968|NCT02233049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154576969|NCT02350725|Furosemide|furosemide|mesh-list
154576970|NCT02350725|Diuretics|diuretics|mesh-ancestor
154576971|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
154576972|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576973|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154576974|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154576975|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576976|NCT02350959|Atorvastatin|atorvastatin|mesh-list
154576977|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154576978|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154576979|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
154576980|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576981|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154576982|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154576983|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154576984|NCT02350335|Nicotine|nicotine|mesh-list
154576985|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154576986|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
154576987|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154576988|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576989|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154576990|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154576991|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
154576992|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154576993|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154576994|NCT02293447|Lidocaine|lidocaine|mesh-list
154576995|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
154576996|NCT02293447|Anesthetics|anesthetics|mesh-list
154576997|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154576998|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154576999|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
154577000|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577001|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154577002|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154577003|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154577004|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154577005|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577007|NCT04464811|Diuretics|diuretics|mesh-ancestor
154577008|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
154577009|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577010|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154577011|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154577012|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577013|NCT02293525|Morphine|morphine|mesh-list
154577014|NCT02293525|Oxycodone|oxycodone|mesh-list
154577015|NCT02293525|Ropivacaine|ropivacaine|mesh-list
154577016|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154577017|NCT02293525|Narcotics|narcotics|mesh-ancestor
154577018|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577019|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577020|NCT02293525|Analgesics|analgesics|mesh-ancestor
154577021|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
154577022|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577023|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
154577024|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
154577025|NCT02298595|Cetuximab|cetuximab|mesh-list
154577026|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577027|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154577028|NCT02345343|Apixaban|apixaban|mesh-list
154577029|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154577030|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
154577031|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154577032|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
154577033|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577034|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577035|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
154577036|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
154577037|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154577038|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154577039|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577040|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
154577041|NCT02350179|Coagulants|coagulants|mesh-ancestor
154577042|NCT02233205|Gemcitabine|gemcitabine|mesh-list
154577043|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577044|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
154577045|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577046|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577047|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154577049|NCT02293681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154577050|NCT02293681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577051|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
154577052|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577053|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577054|NCT02259491|Calcium|calcium|mesh-list
154577055|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154577056|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577057|NCT05255523|Capecitabine|capecitabine|mesh-list
154577058|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577059|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
154577060|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577061|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577062|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
154577063|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154577064|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
154577065|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577066|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577067|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154577068|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
154577069|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577070|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577071|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154577072|NCT02298985|Curcumin|curcumin|mesh-list
154577073|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
154577074|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154577075|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154577076|NCT02298985|Analgesics|analgesics|mesh-ancestor
154577077|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
154577078|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577079|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577080|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577081|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577082|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577083|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577084|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577085|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154577086|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577087|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154577088|NCT02345187|Micronutrients|micronutrients|mesh-list
154577089|NCT02345187|Trace Elements|trace elements|mesh-list
154577090|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577091|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
154577092|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154577093|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577094|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577095|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154577096|NCT02299063|Analgesics|analgesics|mesh-ancestor
154577097|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
154577098|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577099|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154577100|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154577101|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154577102|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
154577103|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577104|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577105|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
154577106|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577107|NCT03514381|Doxorubicin|doxorubicin|mesh-list
154577108|NCT03514381|Ifosfamide|ifosfamide|mesh-list
154577109|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154577110|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577111|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154577112|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154577113|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577114|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577115|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154577116|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
154577117|NCT02343393|Hydralazine|hydralazine|mesh-list
154577118|NCT02343393|Isosorbide|isosorbide|mesh-list
154577119|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154577120|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154577121|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154577122|NCT02343393|Diuretics|diuretics|mesh-ancestor
154577123|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
154577124|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577125|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
154577126|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154577127|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577128|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154577129|NCT02344875|Dotinurad|dotinurad|mesh-list
154577130|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
154577131|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
154577132|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577133|NCT03145623|Grazoprevir|grazoprevir|mesh-list
154577134|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154577135|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
154577136|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577137|NCT02294071|Acetaminophen|acetaminophen|mesh-list
154577138|NCT02294071|Ibuprofen|ibuprofen|mesh-list
154577139|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154577140|NCT02294071|Analgesics|analgesics|mesh-ancestor
154577141|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
154577142|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577143|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577144|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
154577145|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154577146|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577147|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577148|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154577149|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577150|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577152|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577153|NCT02350023|Betamethasone|betamethasone|mesh-list
154577154|NCT02350023|Latanoprost|latanoprost|mesh-list
154577155|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154577156|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154577157|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577158|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
154577159|NCT02350023|Hormones|hormones|mesh-ancestor
154577160|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577161|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577162|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154577163|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
154577164|NCT02342925|Metformin|metformin|mesh-list
154577165|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154577166|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577167|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154577168|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154577169|NCT02344641|Exenatide|exenatide|mesh-list
154577170|NCT02344641|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154577171|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154577172|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577173|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154577174|NCT02344641|Incretins|incretins|mesh-ancestor
154577175|NCT02344641|Hormones|hormones|mesh-ancestor
154577176|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577177|NCT03798743|Docetaxel|docetaxel|mesh-list
154577178|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577179|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
154577180|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
154577181|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
154577182|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577183|NCT02342769|Dolutegravir|dolutegravir|mesh-list
154577184|NCT02342769|Abacavir|abacavir|mesh-list
154577185|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154577186|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154577187|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156389|NCT06269406|Analgesics|analgesics|mesh-ancestor
154577188|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577189|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154577190|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154577191|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
154577192|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577193|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154577194|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154301036|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
154577195|NCT03766295|Gemcitabine|gemcitabine|mesh-list
154577196|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577197|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
154577198|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577199|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577200|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154577201|NCT02349945|Hormones|hormones|mesh-ancestor
154577202|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577203|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577204|NCT02302495|Prednisone|prednisone|mesh-list
154577205|NCT02302495|Melphalan|melphalan|mesh-list
154577206|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577207|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
154577208|NCT02302495|Hormones|hormones|mesh-ancestor
154577209|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577210|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577211|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154577212|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577213|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154577214|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
154577215|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577216|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154577217|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154577218|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
154577219|NCT02813447|Sertraline|sertraline|mesh-list
154577220|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
154577221|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154577222|NCT02813447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154577223|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154577224|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154577225|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577226|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577227|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
154577228|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577229|NCT02342145|Cyclosporine|cyclosporine|mesh-list
154577230|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
154577231|NCT02342145|Methotrexate|methotrexate|mesh-list
154577232|NCT02342145|Cyclosporins|cyclosporins|mesh-list
154577233|NCT02342145|Basiliximab|basiliximab|mesh-list
154577234|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154577235|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
154577236|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154577237|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577238|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577239|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
154577240|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577241|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577242|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154577243|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577244|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154577245|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154577246|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
154577247|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577248|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154577249|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
154577250|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577251|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154577252|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154577253|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154577254|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
154577255|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154577256|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
154577257|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154577258|NCT02349399|Cyproterone|cyproterone|mesh-list
154577259|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
154577260|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154577261|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154577262|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154577263|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
154577264|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154577265|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577266|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154577267|NCT02349399|Estrogens|estrogens|mesh-ancestor
154301118|NCT02410317|Morphine|morphine|mesh-list
154577268|NCT02349399|Hormones|hormones|mesh-ancestor
154577269|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577270|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
154577271|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
154577272|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577273|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154577274|NCT02306473|Mannitol|mannitol|mesh-list
154577275|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154577276|NCT02306473|Diuretics|diuretics|mesh-ancestor
154577277|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
154577278|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577279|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154577280|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154577281|NCT02344095|Paclitaxel|paclitaxel|mesh-list
154577282|NCT02344095|Cisplatin|cisplatin|mesh-list
154577283|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154577284|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577285|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
154577286|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
154577287|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
154577288|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577289|NCT00157339|Insulin|insulin|mesh-list
154577290|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154577291|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154577292|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577293|NCT02342067|Pioglitazone|pioglitazone|mesh-list
154577294|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
154577295|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154577296|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577297|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154577298|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577300|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154577301|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
154577302|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577303|NCT02344017|Prednisone|prednisone|mesh-list
154577304|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577305|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
154577306|NCT02344017|Hormones|hormones|mesh-ancestor
154577307|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577308|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577309|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154577310|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577311|NCT02343861|Emollients|emollients|mesh-list
154577312|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
154577313|NCT03676751|Azithromycin|azithromycin|mesh-list
154577314|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154577315|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577316|NCT02302729|Micronutrients|micronutrients|mesh-list
154577317|NCT02302729|Trace Elements|trace elements|mesh-list
154577318|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577319|NCT03513601|Rituximab|rituximab|mesh-list
154577320|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154577321|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577322|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
154577323|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156524|NCT06265675|Phenol|phenol|mesh-list
154577324|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577325|NCT03507829|Insulin|insulin|mesh-list
154577326|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154577327|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
154577328|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
154577329|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
154577330|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
154577331|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154577332|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577333|NCT02232581|Alovudine|alovudine|mesh-list
154577334|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
154577335|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
154577336|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577337|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
154577338|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577339|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154577340|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154577341|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577342|NCT02341833|Sevoflurane|sevoflurane|mesh-list
154577343|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154577344|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154577345|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
154577346|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
154577347|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577348|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577349|NCT02337231|Borage oil|borage oil|mesh-list
154577350|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577351|NCT02306629|Epratuzumab|epratuzumab|mesh-list
154577352|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154577353|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577354|NCT03510793|Anesthetics|anesthetics|mesh-list
154577355|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577356|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577358|NCT05230797|Propolis|propolis|mesh-list
154577359|NCT05230797|Eugenol|eugenol|mesh-list
154577360|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
154577361|NCT05230797|Trace Elements|trace elements|mesh-ancestor
154577362|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
154577363|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577364|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577365|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
154577366|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
154577367|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154577368|NCT05230797|Protective Agents|protective agents|mesh-ancestor
154577369|NCT02341365|Vitamin D|vitamin d|mesh-list
154577370|NCT02341365|Vitamins|vitamins|mesh-ancestor
154577371|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
154577372|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577373|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154577374|NCT02299687|Omeprazole|omeprazole|mesh-list
154577375|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154577376|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577377|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154577378|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577379|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577380|NCT02349243|Entacapone|entacapone|mesh-list
154577381|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154577382|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154577383|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154577384|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577385|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577386|NCT02341209|Doxycycline|doxycycline|mesh-list
154577387|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154577388|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577389|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
154577390|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154577391|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154577392|NCT02349165|Riboflavin|riboflavin|mesh-list
154577393|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
154577394|NCT02349165|Vitamins|vitamins|mesh-ancestor
154577395|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
154577396|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577397|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154577398|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
154577399|NCT03112005|Mydriatics|mydriatics|mesh-list
154577400|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
154577401|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577402|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577403|NCT02306785|Mesalamine|mesalamine|mesh-list
154577404|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154577405|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154577406|NCT02306785|Analgesics|analgesics|mesh-ancestor
154577407|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
154577408|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577409|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577410|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577411|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577412|NCT02299765|Carboplatin|carboplatin|mesh-list
154577413|NCT02299765|Gemcitabine|gemcitabine|mesh-list
154577414|NCT02299765|Gefitinib|gefitinib|mesh-list
154577415|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577416|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577417|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
154577418|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577419|NCT02299765|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154577420|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154577421|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577422|NCT04771923|Epinephrine|epinephrine|mesh-list
154577423|NCT04771923|Racepinephrine|racepinephrine|mesh-list
154577424|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
154577425|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
154577426|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154577427|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154577428|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577430|NCT04771923|Coagulants|coagulants|mesh-ancestor
154577431|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154577432|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154577433|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154577434|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577435|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577436|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154577437|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154577438|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
154577439|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577440|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154577441|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
154577442|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
154577443|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
154577444|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154577445|NCT05254899|Gemcitabine|gemcitabine|mesh-list
154577446|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
154577447|NCT05254899|Tislelizumab|tislelizumab|mesh-list
154577448|NCT05254899|Pegaspargase|pegaspargase|mesh-list
154577449|NCT05254899|Antibodies|antibodies|mesh-list
154577450|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154577451|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
154577452|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862187|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577453|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577454|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
154577455|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577456|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577457|NCT05254899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154577458|NCT03148509|Risperidone|risperidone|mesh-list
154577459|NCT03148509|Aripiprazole|aripiprazole|mesh-list
154577460|NCT03148509|Bupropion|bupropion|mesh-list
154577461|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154577462|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
154577463|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577464|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577465|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577466|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154577467|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154577468|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577469|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154577470|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154577471|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
154577472|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154577473|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
154577474|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154577475|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154577476|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154156667|NCT06264778|Dabrafenib|dabrafenib|mesh-list
154577477|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154577478|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154577479|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577480|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
154577481|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154577482|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154577483|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154577484|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154577485|NCT05254665|Docetaxel|docetaxel|mesh-list
154577486|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577487|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
154577488|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
154577489|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
154577490|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577491|NCT03513055|Insulin|insulin|mesh-list
154577492|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154577493|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577494|NCT03510325|Olanzapine|olanzapine|mesh-list
154577495|NCT03510325|Risperidone|risperidone|mesh-list
154577496|NCT03510325|Aripiprazole|aripiprazole|mesh-list
154577497|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154577498|NCT03510325|Amisulpride|amisulpride|mesh-list
154577499|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154577500|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
154577501|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577502|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577503|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577504|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154577505|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154577506|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577507|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154577508|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154577509|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
154577510|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
154577511|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
154577512|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577513|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577514|NCT03510325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154577515|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154577516|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154577517|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
154577518|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
154577519|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154577520|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154577521|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154577522|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154577523|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154577524|NCT03507127|Varenicline|varenicline|mesh-list
154577525|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154577526|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154862188|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154577527|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
154577528|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577529|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577530|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577531|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154577532|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154577533|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577534|NCT02336529|Bupivacaine|bupivacaine|mesh-list
154577535|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
154577536|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
154577537|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577538|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577539|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
154577540|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577541|NCT02307487|Mitomycins|mitomycins|mesh-list
154577542|NCT02307487|Mitomycin|mitomycin|mesh-list
154577543|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154577544|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577545|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
154577546|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577547|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154577548|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577549|NCT02307565|Midodrine|midodrine|mesh-list
154577550|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
154577551|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
154577552|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577553|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577554|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154577555|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154577556|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154577557|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154577558|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
154577559|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577560|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577561|NCT03510013|Anesthetics|anesthetics|mesh-list
154577562|NCT03510013|Sevoflurane|sevoflurane|mesh-list
154577563|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
154577564|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577565|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577566|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154577567|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
154577568|NCT02307721|Remifentanil|remifentanil|mesh-list
154577569|NCT02307721|Naloxone|naloxone|mesh-list
154577570|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154577571|NCT02307721|Narcotics|narcotics|mesh-ancestor
154577572|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577573|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577574|NCT02307721|Analgesics|analgesics|mesh-ancestor
154577575|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
154577576|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577577|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154577578|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
154577579|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154577580|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
154577581|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154577582|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
154577583|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577584|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577585|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
154577586|NCT02348463|Clindamycin|clindamycin|mesh-list
154577587|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
154577588|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
154577589|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154577590|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577591|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154577592|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577593|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577594|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
154577595|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154577596|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154577597|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
154577598|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577599|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577600|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862189|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154862190|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154577601|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
154577602|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
154577603|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577604|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
154577605|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154577606|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
154577609|NCT02300623|Indinavir|indinavir|mesh-list
154577610|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154577611|NCT02300623|Interleukin-2|interleukin-2|mesh-list
154577612|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154577613|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154577614|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577615|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577616|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
154577617|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577618|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154577619|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577620|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154577621|NCT02300623|Analgesics|analgesics|mesh-ancestor
154577622|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
154577623|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577624|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577625|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
154577626|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154577627|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154577628|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
154577629|NCT04463953|Dexamethasone|dexamethasone|mesh-list
154577630|NCT04463953|Ixazomib|ixazomib|mesh-list
154577631|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
154577632|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577633|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
154577634|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
154577635|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577636|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577637|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577638|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
154577639|NCT04463953|Hormones|hormones|mesh-ancestor
154577640|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577641|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154577642|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577643|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
154577644|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577645|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577646|NCT04463953|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154577647|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154577648|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
154577649|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
154577650|NCT02307955|Protective Agents|protective agents|mesh-ancestor
154577651|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577652|NCT03147963|Docetaxel|docetaxel|mesh-list
154577653|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577654|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
154577655|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
154577656|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
154156857|NCT06217796|Protective Agents|protective agents|mesh-ancestor
154577657|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577658|NCT02348307|Dotinurad|dotinurad|mesh-list
154577659|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
154577660|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
154577661|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577662|NCT02340117|Paclitaxel|paclitaxel|mesh-list
154577663|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154577664|NCT02340117|Gemcitabine|gemcitabine|mesh-list
154577665|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154577666|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577667|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
154577668|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
154577669|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
154577670|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577671|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577672|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
154577673|NCT02300701|Omalizumab|omalizumab|mesh-list
154577674|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154577675|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154862191|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154577676|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
154577677|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
154577679|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
154577680|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577681|NCT02340195|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154577682|NCT02340195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154577683|NCT02340195|Serotonin Agents|serotonin agents|mesh-ancestor
154577684|NCT02340195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577685|NCT02340195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577686|NCT02340195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577687|NCT02300935|Paclitaxel|paclitaxel|mesh-list
154577688|NCT02300935|Trametinib|trametinib|mesh-list
154577689|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154577690|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577691|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
154577692|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
154577693|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
154577694|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577695|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154577696|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577697|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154577698|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154577699|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577700|NCT02301091|Mitomycins|mitomycins|mesh-list
154577701|NCT02301091|Mitomycin|mitomycin|mesh-list
154577702|NCT02301091|Pirarubicin|pirarubicin|mesh-list
154577703|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154577704|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577705|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
154577706|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156898|NCT06190249|Analgesics|analgesics|mesh-ancestor
154577707|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154577708|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577709|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
154577710|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
154577711|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154577712|NCT02335593|Hematinics|hematinics|mesh-ancestor
154577713|NCT02335593|Astringents|astringents|mesh-ancestor
154577714|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577715|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
154577716|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154577717|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154577718|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
154577719|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577720|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154577721|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154577722|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
154577723|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577724|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577725|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154301560|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
154577726|NCT02309281|Aflibercept|aflibercept|mesh-list
154577727|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154577728|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154577729|NCT02309281|Growth Substances|growth substances|mesh-ancestor
154577730|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577731|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
154577732|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577733|NCT02335281|Mesalamine|mesalamine|mesh-list
154577734|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154577735|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154577736|NCT02335281|Analgesics|analgesics|mesh-ancestor
154577737|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
154577738|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577739|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577740|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577741|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577742|NCT02309437|Oxycodone|oxycodone|mesh-list
154577743|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154577744|NCT02309437|Narcotics|narcotics|mesh-ancestor
154577745|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154577746|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577747|NCT02309437|Analgesics|analgesics|mesh-ancestor
154577748|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
154577749|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577750|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
154577751|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154577752|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154577753|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577755|NCT02335359|Coagulants|coagulants|mesh-ancestor
154577756|NCT03511261|Curcumin|curcumin|mesh-list
154577757|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154577758|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154577759|NCT03511261|Analgesics|analgesics|mesh-ancestor
154577760|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
154577761|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577762|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577763|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577764|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577765|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577766|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577767|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577768|NCT03509701|Antibodies|antibodies|mesh-list
154577769|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
154577770|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577771|NCT03511183|Bevacizumab|bevacizumab|mesh-list
154577772|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154577773|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577774|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154577775|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154577776|NCT03511183|Growth Substances|growth substances|mesh-ancestor
154577777|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577778|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
154577779|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
154577780|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154577781|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154577782|NCT02303587|Prednisolone|prednisolone|mesh-list
154577783|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
154577784|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154577785|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
154577786|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577787|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
154577788|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
154577789|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577790|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577791|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577792|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
154577793|NCT02303587|Hormones|hormones|mesh-ancestor
154577794|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577795|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154577796|NCT02303587|Protective Agents|protective agents|mesh-ancestor
154577797|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154577798|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577799|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
154577800|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577801|NCT03107871|Valganciclovir|valganciclovir|mesh-list
154577802|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
154577803|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577804|NCT03064113|Ipratropium|ipratropium|mesh-list
154577805|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154577806|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
154577807|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577808|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577809|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154577810|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
154577811|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154577812|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
154577813|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577814|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577815|NCT02301715|Oxytocin|oxytocin|mesh-list
154577816|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
154577817|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154577818|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577819|NCT03509545|Torsemide|torsemide|mesh-list
154577820|NCT03509545|Furosemide|furosemide|mesh-list
154577821|NCT03509545|Diuretics|diuretics|mesh-ancestor
154577822|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
154577823|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577824|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154577825|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154577826|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577827|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154577828|NCT02301949|Thalidomide|thalidomide|mesh-list
154577829|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154577830|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
154577831|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577832|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
154577833|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154577834|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577835|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154577836|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154577837|NCT02301949|Growth Substances|growth substances|mesh-ancestor
154577838|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
154577839|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577840|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154577841|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
154577842|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154577843|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154577844|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154577845|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
154577846|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154577847|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577848|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154577849|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154577850|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154577851|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154577852|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577853|NCT02303899|Gemcitabine|gemcitabine|mesh-list
154577854|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
154577855|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577856|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
154577857|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577858|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577859|NCT02303899|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154157053|NCT06067737|Hallucinogens|hallucinogens|mesh-ancestor
154577860|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154577861|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577862|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154577863|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154577864|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577865|NCT03510871|Nivolumab|nivolumab|mesh-list
154577866|NCT03510871|Ipilimumab|ipilimumab|mesh-list
154577867|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154577868|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577869|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154577870|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577871|NCT02331771|Donepezil|donepezil|mesh-list
154577872|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154577873|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577874|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301702|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
154577875|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
154577876|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577877|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577878|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
154577879|NCT02334501|Lansoprazole|lansoprazole|mesh-list
154577880|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
154577881|NCT02334501|Neratinib|neratinib|mesh-list
154577882|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154577883|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577884|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154577885|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577886|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577887|NCT02334501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154577888|NCT02334501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154577889|NCT02331927|Aflibercept|aflibercept|mesh-list
154577890|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154577891|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154577892|NCT02331927|Growth Substances|growth substances|mesh-ancestor
154577893|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577894|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
154577895|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577896|NCT02322190|Methoxsalen|methoxsalen|mesh-list
154577897|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154577898|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
154577899|NCT02304055|Oxytocin|oxytocin|mesh-list
154577900|NCT02304055|Carbetocin|carbetocin|mesh-list
154577901|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
154577902|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154577903|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577905|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
154577906|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154577907|NCT03505489|Diuretics|diuretics|mesh-ancestor
154577908|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
154577909|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577910|NCT03505489|Miotics|miotics|mesh-ancestor
154577911|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
154577912|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577913|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154577914|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154577915|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
154577916|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154577917|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154577918|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
154577919|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577920|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577921|NCT02310373|Nicotine|nicotine|mesh-list
154577922|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154577923|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
154577924|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577925|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577926|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154577927|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154577928|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
154577929|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154577930|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577931|NCT02338323|Febuxostat|febuxostat|mesh-list
154577932|NCT02338323|Benzbromarone|benzbromarone|mesh-list
154577933|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
154577934|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154577935|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
154577936|NCT02321800|Imipenem|imipenem|mesh-list
154577937|NCT02321800|Cefiderocol|cefiderocol|mesh-list
154577938|NCT02321800|Cilastatin|cilastatin|mesh-list
154577939|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154577940|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154577941|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
154577942|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577943|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577944|NCT02321800|Siderophores|siderophores|mesh-ancestor
154577945|NCT02321800|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154577946|NCT02321800|Chelating Agents|chelating agents|mesh-ancestor
154577947|NCT02321800|Sequestering Agents|sequestering agents|mesh-ancestor
154577948|NCT02321800|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154577949|NCT02310295|Triamcinolone|triamcinolone|mesh-list
154577950|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154577951|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154577952|NCT02310295|Bevacizumab|bevacizumab|mesh-list
154577953|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154577954|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154577955|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577956|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154577957|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154577958|NCT02310295|Growth Substances|growth substances|mesh-ancestor
154577959|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577960|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
154577961|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154577962|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
154577963|NCT02310295|Hormones|hormones|mesh-ancestor
154577964|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154577965|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154577966|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
154577967|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577968|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577969|NCT02338089|Oxytocin|oxytocin|mesh-list
154577970|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
154577971|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154577972|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577973|NCT02338245|Capecitabine|capecitabine|mesh-list
154577974|NCT02338245|Lapatinib|lapatinib|mesh-list
154577975|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154577976|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
154577977|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610717|NCT01948804|Hormones|hormones|mesh-ancestor
154577978|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154577979|NCT02338245|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154577980|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154577981|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154577982|NCT02332005|Choline|choline|mesh-list
154577983|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
154577984|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154577985|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
154577986|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154577987|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154577988|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154577989|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
154577990|NCT02304211|Insulin|insulin|mesh-list
154577991|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154577992|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577993|NCT02311777|Pregabalin|pregabalin|mesh-list
154577994|NCT02311777|Ketamine|ketamine|mesh-list
154577995|NCT02311777|Analgesics|analgesics|mesh-ancestor
154577996|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
154577997|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154577998|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154577999|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154578000|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154578001|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
154578002|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
154578003|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578004|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154578005|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154578006|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578007|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578008|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
154578009|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154578010|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154578011|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154578012|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154578013|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154578014|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154578015|NCT03504865|Bupivacaine|bupivacaine|mesh-list
154578016|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
154578017|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
154578018|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578019|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578020|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
154578021|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578022|NCT02304289|Artesunate|artesunate|mesh-list
154578023|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
154578024|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154578025|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154578026|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578027|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578028|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
154578029|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
154578030|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154578031|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
154578032|NCT02292784|Atosiban|atosiban|mesh-list
154578033|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
154578034|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578035|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578036|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
154578037|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154578038|NCT02338011|Gefitinib|gefitinib|mesh-list
154578039|NCT02338011|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154578040|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578041|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578042|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578043|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578044|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154578045|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154578046|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
154578047|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578048|NCT02337855|Antacids|antacids|mesh-ancestor
154578049|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578050|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578051|NCT02320396|Desloratadine|desloratadine|mesh-list
154578052|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154862192|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
154578053|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
154578054|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157248|NCT05965544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578055|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578056|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578057|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154578058|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154578059|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
154578060|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
154578061|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
154578062|NCT02310997|Melphalan|melphalan|mesh-list
154578063|NCT02310997|Busulfan|busulfan|mesh-list
154578064|NCT02310997|Fludarabine|fludarabine|mesh-list
154578065|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154578066|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
154578067|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578068|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578069|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154578070|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
154578071|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578072|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578073|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154578074|NCT03505411|Melatonin|melatonin|mesh-list
154578075|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
154578076|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578077|NCT03505411|Protective Agents|protective agents|mesh-ancestor
154578078|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578079|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578080|NCT02292238|Benphothiamine|benphothiamine|mesh-list
154578081|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154578082|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
154578083|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578084|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
154578085|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
154578086|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578087|NCT03867123|Temozolomide|temozolomide|mesh-list
154578088|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154578089|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
154578090|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578091|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578092|NCT03504475|Paroxetine|paroxetine|mesh-list
154578093|NCT03504475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154578094|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154578095|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154578096|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578097|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578098|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
154578099|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578100|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154578101|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
154578102|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154578103|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154578104|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154578106|NCT02327247|Felodipine|felodipine|mesh-list
154578107|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154578108|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154578109|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154578110|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154578111|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578112|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154578113|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578114|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
154578115|NCT03505255|Neostigmine|neostigmine|mesh-list
154578116|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154578117|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578118|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578119|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
154578120|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578121|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578122|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154578123|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
154578124|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862193|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
154578125|NCT02333799|Linezolid|linezolid|mesh-list
154578126|NCT02333799|Bedaquiline|bedaquiline|mesh-list
154578127|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154578128|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578129|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154578130|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578131|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578132|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
154578133|NCT02311231|Heparin|heparin|mesh-list
154578134|NCT02311231|Calcium heparin|calcium heparin|mesh-list
154578135|NCT02311231|Bivalirudin|bivalirudin|mesh-list
154578136|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
154578137|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154578138|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154578139|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578140|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
154578141|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154578142|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
154578143|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578144|NCT03508999|Metronidazole|metronidazole|mesh-list
154578145|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578146|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154578147|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154578148|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154578149|NCT03105375|Omeprazole|omeprazole|mesh-list
154578150|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154578151|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578152|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154578153|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578154|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578155|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
154578156|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154578157|NCT02304445|Estrogens|estrogens|mesh-ancestor
154578158|NCT02304445|Hormones|hormones|mesh-ancestor
154578159|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578160|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578161|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154578162|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578163|NCT02316301|Misoprostol|misoprostol|mesh-list
154578164|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154578165|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
154578166|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154578167|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578168|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154578169|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578170|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
154578171|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
154578172|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154578173|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154578174|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578175|NCT02327091|Vitamins|vitamins|mesh-ancestor
154578176|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
154578177|NCT02316535|Capecitabine|capecitabine|mesh-list
154578178|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154578179|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
154578180|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578181|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578182|NCT02333253|Cetrorelix|cetrorelix|mesh-list
154578183|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154578184|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
154578185|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154578186|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578187|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
154578188|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578189|NCT02039661|Lidocaine|lidocaine|mesh-list
154578190|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
154578191|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
154578192|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578193|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578194|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
154578195|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578196|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154578197|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154578198|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154578199|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154862194|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
154578200|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578201|NCT02326779|Aspirin|aspirin|mesh-list
154578202|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154578203|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578204|NCT02326779|Analgesics|analgesics|mesh-ancestor
154578205|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
154578206|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578207|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578208|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578209|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578210|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154578211|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154578212|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578213|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154578214|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154578215|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578216|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
154578217|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154578218|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578219|NCT02312635|Cycloserine|cycloserine|mesh-list
154578220|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154578221|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578222|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154578223|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
154578224|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154578225|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
154578226|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578227|NCT03144453|Atropine|atropine|mesh-list
154578228|NCT03144453|Neostigmine|neostigmine|mesh-list
154578229|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154578230|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154578231|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154578232|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
154578233|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578234|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578235|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154578236|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
154578237|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
154578238|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
154578239|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154578240|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154578241|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
154578242|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578243|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578244|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154578245|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578246|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154578247|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
154578248|NCT02317159|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154578249|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578250|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302076|NCT03576820|Lidocaine|lidocaine|mesh-list
154157444|NCT05784844|Micafungin|micafungin|mesh-list
154578251|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578252|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578253|NCT02332941|Rituximab|rituximab|mesh-list
154578254|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154578255|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578256|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
154578257|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578258|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578259|NCT03503227|Aspirin|aspirin|mesh-list
154578260|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
154578261|NCT03503227|Prednisolone|prednisolone|mesh-list
154578262|NCT03503227|Salicylates|salicylates|mesh-list
154578263|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578264|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
154578265|NCT03503227|Hormones|hormones|mesh-ancestor
154578266|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578267|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578268|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154578269|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578270|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578271|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578272|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
154578273|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
154578274|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
154578275|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154578276|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578277|NCT03503227|Analgesics|analgesics|mesh-ancestor
154578278|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
154578279|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578280|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154578281|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578282|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578283|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154578284|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154578285|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154578286|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
154578287|NCT02305069|Pioglitazone|pioglitazone|mesh-list
154578288|NCT02305069|Octreotide|octreotide|mesh-list
154578289|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154578290|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578291|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578292|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154578293|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157503|NCT05647447|SR 142801|sr 142801|mesh-list
154578294|NCT02317237|Anesthetics|anesthetics|mesh-list
154578295|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578296|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578297|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154578298|NCT02332473|Molgramostim|molgramostim|mesh-list
154578299|NCT02332473|Sargramostim|sargramostim|mesh-list
154578300|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
154578301|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578302|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
154578303|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578304|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578305|NCT03501433|Niacinamide|niacinamide|mesh-list
154578306|NCT03501433|Niacin|niacin|mesh-list
154578307|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
154578308|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
154578309|NCT03501433|Vitamins|vitamins|mesh-ancestor
154578310|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
154578311|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578312|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154578313|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
154578314|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578315|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154578316|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
154578317|NCT02313103|Lofexidine|lofexidine|mesh-list
154578318|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154578319|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154578320|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578321|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
154578322|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578323|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154578324|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154578325|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154578326|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
154578327|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578328|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578329|NCT01959633|Interferons|interferons|mesh-list
154578330|NCT01959633|Vemurafenib|vemurafenib|mesh-list
154578331|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578332|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
154578333|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578334|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578335|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578336|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578337|NCT02326623|Anesthetics|anesthetics|mesh-list
154578338|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
154578339|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578340|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578341|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
154578342|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578343|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
154578344|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578345|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
154578346|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154578347|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154578348|NCT02332629|Prednisolone|prednisolone|mesh-list
154578349|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
154578350|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154578351|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
154578352|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578353|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
154578354|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
154578355|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578356|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578357|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578358|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
154578359|NCT02332629|Hormones|hormones|mesh-ancestor
154578360|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578361|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154578362|NCT02332629|Protective Agents|protective agents|mesh-ancestor
154578363|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154578364|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578365|NCT02313337|Midazolam|midazolam|mesh-list
154578366|NCT02313337|Fentanyl|fentanyl|mesh-list
154578367|NCT02313337|Anesthetics|anesthetics|mesh-list
154578368|NCT02313337|Propofol|propofol|mesh-list
154578369|NCT02313337|Atracurium|atracurium|mesh-list
154578370|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578371|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578372|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154578373|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154578374|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
154578375|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154578376|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154578377|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154578378|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154578379|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
154578380|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
154578381|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578382|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578383|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154578384|NCT02313337|Narcotics|narcotics|mesh-ancestor
154578385|NCT02313337|Analgesics|analgesics|mesh-ancestor
154578386|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
154578387|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578388|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154578389|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154578390|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154578391|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154578392|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154578393|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
154578394|NCT02305615|Bevacizumab|bevacizumab|mesh-list
154578395|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154578396|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578397|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154578398|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154578399|NCT02305615|Growth Substances|growth substances|mesh-ancestor
154578400|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578401|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
154578402|NCT02305693|Letrozole|letrozole|mesh-list
154578403|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302221|NCT02951156|Avelumab|avelumab|mesh-list
154578404|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154578405|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154578406|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578407|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578408|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154578409|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
154578410|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578411|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578413|NCT02317861|Verinurad|verinurad|mesh-list
154578414|NCT02317861|Benzbromarone|benzbromarone|mesh-list
154578415|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
154578416|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578417|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
154578418|NCT02318017|Methylphenidate|methylphenidate|mesh-list
154578419|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154578420|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578421|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154578422|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154578423|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154578424|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578425|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
154578426|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578428|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154578429|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578430|NCT02313805|Insulin|insulin|mesh-list
154578431|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154578432|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578433|NCT03132493|Nivolumab|nivolumab|mesh-list
154578434|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154578435|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578436|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154578437|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578438|NCT02313883|Taurolidine|taurolidine|mesh-list
154578439|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578440|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154578441|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578442|NCT03500653|Curcumin|curcumin|mesh-list
154578443|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154578444|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578445|NCT03500653|Analgesics|analgesics|mesh-ancestor
154578446|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
154578447|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578448|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578449|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578450|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578451|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578452|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578453|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578454|NCT02305927|Vitamin D|vitamin d|mesh-list
154578455|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
154578456|NCT02305927|Vitamins|vitamins|mesh-ancestor
154578457|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
154578458|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578459|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154578460|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154578461|NCT02440009|Itraconazole|itraconazole|mesh-list
154578462|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
154578463|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
154578464|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578465|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154578466|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154578467|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578468|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578469|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154578470|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
154578471|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578472|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578473|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154578474|NCT02440009|Hormones|hormones|mesh-ancestor
154578475|NCT02318563|Cannabidiol|cannabidiol|mesh-list
154578476|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154578477|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
154578478|NCT02314195|Serotonin|serotonin|mesh-list
154578479|NCT02314195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154578480|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154578481|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
154578482|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578483|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578484|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578485|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154578486|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154578487|NCT02314273|Oprelvekin|oprelvekin|mesh-list
154578488|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578489|NCT02314351|Fentanyl|fentanyl|mesh-list
154578490|NCT02314351|Metoclopramide|metoclopramide|mesh-list
154578491|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154578492|NCT02314351|Narcotics|narcotics|mesh-ancestor
154578493|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157696|NCT05477875|Dronabinol|dronabinol|mesh-list
154578494|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578495|NCT02314351|Analgesics|analgesics|mesh-ancestor
154578496|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
154578497|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578498|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154578499|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154862195|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
154578500|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
154578501|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
154578502|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
154578503|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
154578504|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578505|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154578506|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154578507|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
154578508|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578509|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578510|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
154578511|NCT04463875|Riboflavin|riboflavin|mesh-list
154578512|NCT04463875|Ubiquinone|ubiquinone|mesh-list
154578513|NCT04463875|Andrographolide|andrographolide|mesh-list
154578514|NCT04463875|Vitamins|vitamins|mesh-ancestor
154578515|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
154578516|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578517|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
154578518|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154578519|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154578520|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578521|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154578522|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578523|NCT04463875|Analgesics|analgesics|mesh-ancestor
154578524|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
154578525|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578526|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578527|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154578528|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154578529|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578530|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
154578531|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154578532|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
154578533|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154578534|NCT04462939|Micronutrients|micronutrients|mesh-list
154578535|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578536|NCT02306239|Terlipressin|terlipressin|mesh-list
154578537|NCT02306239|Norepinephrine|norepinephrine|mesh-list
154578538|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154578539|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154578540|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
154578541|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578542|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578543|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578544|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
154578545|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
154578546|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578547|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154578548|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154578549|NCT02319187|Irinotecan|irinotecan|mesh-list
154578550|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154578551|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154578552|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578553|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578554|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578555|NCT02319265|Melatonin|melatonin|mesh-list
154578556|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
154578557|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578558|NCT02319265|Protective Agents|protective agents|mesh-ancestor
154578559|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578560|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578561|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
154578562|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154578563|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154578564|NCT02319343|Prednisolone|prednisolone|mesh-list
154578565|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
154578566|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154578567|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
154578568|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578569|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
154578570|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
154578571|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578572|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578573|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578574|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
154578575|NCT02319343|Hormones|hormones|mesh-ancestor
154578576|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578577|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154578578|NCT02319343|Protective Agents|protective agents|mesh-ancestor
154578579|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154578580|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578582|NCT02319499|Iron|iron|mesh-list
154578583|NCT02319499|Zinc|zinc|mesh-list
154578584|NCT02319499|Vitamins|vitamins|mesh-ancestor
154578585|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
154578586|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578587|NCT02319499|Trace Elements|trace elements|mesh-ancestor
154578588|NCT03499639|Ritonavir|ritonavir|mesh-list
154578589|NCT03499639|Ribavirin|ribavirin|mesh-list
154578590|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154578591|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154578592|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
154578593|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578594|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578595|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154578596|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154578597|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
154578598|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578599|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154578600|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154578601|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
154578602|NCT03502135|Phenylephrine|phenylephrine|mesh-list
154578603|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
154578604|NCT03502135|Tetracaine|tetracaine|mesh-list
154578605|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
154578606|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
154578607|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578608|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578609|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
154578610|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578611|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154578612|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154578613|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
154578614|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578615|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578616|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
154578617|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
154578618|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
154578619|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154578620|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
154578621|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154578622|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
154578623|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154578624|NCT03502135|Protective Agents|protective agents|mesh-ancestor
154578625|NCT02315287|Pioglitazone|pioglitazone|mesh-list
154578626|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154578627|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578628|NCT02319577|Vinorelbine|vinorelbine|mesh-list
154578629|NCT02319577|Gefitinib|gefitinib|mesh-list
154578630|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154578631|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578632|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
154578633|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
154157836|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
154578634|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
154578635|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578636|NCT02319577|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154578637|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578638|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578639|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154578640|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578641|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
154578642|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154578643|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578644|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578645|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578646|NCT03132259|Analgesics|analgesics|mesh-ancestor
154578647|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
154578648|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578649|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154578650|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154578651|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154578652|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
154578653|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578654|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578656|NCT03499171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154578657|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154578658|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154578659|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578660|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578661|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
154578662|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578663|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154578664|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
154578665|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154578666|NCT02447419|Gefitinib|gefitinib|mesh-list
154578667|NCT02447419|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154578668|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578669|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578670|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578671|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578672|NCT02319889|Paclitaxel|paclitaxel|mesh-list
154578673|NCT02319889|Carboplatin|carboplatin|mesh-list
154578674|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154578675|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154578676|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578677|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
154578678|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
154578679|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
154578680|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578681|NCT02324413|Clonidine|clonidine|mesh-list
154578682|NCT02324413|Analgesics|analgesics|mesh-ancestor
154578683|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
154578684|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578685|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578686|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154578687|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
154578688|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
154578689|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154578690|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154578691|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154578692|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
154578693|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578694|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578695|NCT03498703|Azathioprine|azathioprine|mesh-list
154578696|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
154578697|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578698|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154578699|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578700|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154578701|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
154578702|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578703|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302522|NCT03710252|Ritonavir|ritonavir|mesh-list
154578705|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154578706|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154578707|NCT02324491|Growth Substances|growth substances|mesh-ancestor
154578708|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578709|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
154578710|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578711|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154578712|NCT03494257|Brinzolamide|brinzolamide|mesh-list
154578713|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154578714|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154578715|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154578716|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154578717|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
154578718|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578719|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578720|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578721|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154578722|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578723|NCT03132181|Empagliflozin|empagliflozin|mesh-list
154578724|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154578725|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578726|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154578727|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578728|NCT02320045|Exenatide|exenatide|mesh-list
154578729|NCT02320045|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154578730|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154578731|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578732|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154578733|NCT02320045|Incretins|incretins|mesh-ancestor
154578734|NCT02320045|Hormones|hormones|mesh-ancestor
154578735|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578736|NCT02320357|Clopidogrel|clopidogrel|mesh-list
154578737|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154578738|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154578739|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154578740|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154578741|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
154578742|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578743|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578744|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578745|NCT03498235|Propofol|propofol|mesh-list
154578746|NCT03498235|Sevoflurane|sevoflurane|mesh-list
154578747|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154578748|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578749|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578750|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154578751|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
154578752|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
154578753|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154578754|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154578755|NCT03132103|Vitamin D|vitamin d|mesh-list
154578756|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
154578757|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
154578758|NCT03132103|Vitamins|vitamins|mesh-list
154578759|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
154578760|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578761|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154578762|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154578763|NCT04635943|Ivermectin|ivermectin|mesh-list
154578764|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154578765|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578766|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154578767|NCT04461925|Azithromycin|azithromycin|mesh-list
154578768|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
154578769|NCT04461925|Dexamethasone|dexamethasone|mesh-list
154578770|NCT04461925|Enoxaparin|enoxaparin|mesh-list
154578771|NCT04461925|Anticoagulants|anticoagulants|mesh-list
154578772|NCT04461925|Hormones|hormones|mesh-list
154578773|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578774|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
154578775|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
154578776|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578777|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578778|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302602|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
154578779|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
154578780|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578781|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154578782|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578783|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578784|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578785|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154578786|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154578787|NCT04461925|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154578788|NCT04461925|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154578789|NCT02325583|Midazolam|midazolam|mesh-list
154578790|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154578791|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154578792|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578793|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578794|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154578795|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154578796|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154578797|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154578798|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
154578799|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
154578800|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
154578801|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
154578803|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578804|NCT02321293|Curcumin|curcumin|mesh-list
154578805|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154578806|NCT02321293|Gefitinib|gefitinib|mesh-list
154578807|NCT02321293|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154578808|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578809|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578810|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578811|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578812|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154578813|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578814|NCT02321293|Analgesics|analgesics|mesh-ancestor
154578815|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
154578816|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578817|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578818|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578819|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578820|NCT02321371|Rifaximin|rifaximin|mesh-list
154578821|NCT02321371|Lactulose|lactulose|mesh-list
154578822|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154578823|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578824|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578825|NCT03491371|Apatinib|apatinib|mesh-list
154578826|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578827|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578828|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578829|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578830|NCT03546829|Vancomycin|vancomycin|mesh-list
154578831|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154578832|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578833|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
154578834|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154578835|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154578836|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154578837|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154578838|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578839|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
154578840|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578841|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578842|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154578843|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578844|NCT03493087|Vitamin K|vitamin k|mesh-list
154578845|NCT03493087|Vitamins|vitamins|mesh-ancestor
154578846|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
154578847|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578848|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154578849|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154578850|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578851|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
154578852|NCT03493087|Coagulants|coagulants|mesh-ancestor
154578853|NCT03136627|Nivolumab|nivolumab|mesh-list
154578854|NCT03136627|Tivozanib|tivozanib|mesh-list
154578855|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154578856|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578857|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154578858|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578859|NCT03136627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578860|NCT03136627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578861|NCT02922985|Acetaminophen|acetaminophen|mesh-list
154578862|NCT02922985|Ketorolac|ketorolac|mesh-list
154578863|NCT02922985|Bupivacaine|bupivacaine|mesh-list
154578864|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
154578865|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
154578866|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578867|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578868|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
154578869|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578870|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154578871|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578872|NCT02922985|Analgesics|analgesics|mesh-ancestor
154578873|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154578874|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578875|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154578876|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578877|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578878|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
154578879|NCT04881955|Ecopipam|ecopipam|mesh-list
154578880|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154578881|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154578882|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578883|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578884|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154578885|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154578886|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
154578887|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578888|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578889|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
154578890|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154578891|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
154578892|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154578893|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
154578894|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578895|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578896|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
154578897|NCT03492931|Ticagrelor|ticagrelor|mesh-list
154578898|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154578899|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154578900|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154578901|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154578902|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
154578903|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578904|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578905|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578906|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
154578907|NCT02234921|Imiquimod|imiquimod|mesh-list
154578908|NCT02234921|Vaccines|vaccines|mesh-list
154578909|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
154578910|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578911|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154578912|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154578913|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154578914|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
154578915|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578916|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578917|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154578918|NCT02234921|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154578919|NCT02234921|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154578920|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154578921|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
154578922|NCT02321761|Amantadine|amantadine|mesh-list
154578923|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154578924|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154578925|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
154578926|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578927|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
154578928|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578929|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578930|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578931|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578932|NCT02321761|Analgesics|analgesics|mesh-ancestor
154578933|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
154578934|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578935|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
154578936|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154578937|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154578938|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578939|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154578940|NCT04674241|Analgesics|analgesics|mesh-ancestor
154578941|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
154578942|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154578943|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154578944|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154578945|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154578946|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
154578947|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154578948|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578949|NCT02259647|Sorafenib|sorafenib|mesh-list
154578950|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578951|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154578952|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578953|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578954|NCT02321839|Ranibizumab|ranibizumab|mesh-list
154578955|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154578956|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154578957|NCT02321839|Growth Substances|growth substances|mesh-ancestor
154578958|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578959|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
154578960|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154578961|NCT03490279|Lactoferrin|lactoferrin|mesh-list
154578962|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578963|NCT02750345|Nitisinone|nitisinone|mesh-list
154578964|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154578965|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578966|NCT01329263|Menthol|menthol|mesh-list
154578967|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
154578968|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
154578969|NCT03490123|Azithromycin|azithromycin|mesh-list
154578970|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154578971|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154578972|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
154578973|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154578974|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578975|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154578976|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154578977|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154578978|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154578979|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154578980|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154578981|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154578982|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154578983|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154578984|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154578985|NCT01388491|Desogestrel|desogestrel|mesh-list
154578986|NCT01388491|Estradiol|estradiol|mesh-list
154578987|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154578988|NCT01388491|Estrogens|estrogens|mesh-ancestor
154578989|NCT01388491|Hormones|hormones|mesh-ancestor
154578990|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154578991|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154578992|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154578993|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
154578994|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154578995|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154578996|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154578997|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154578998|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154578999|NCT01388491|Progestins|progestins|mesh-ancestor
154579000|NCT02236169|Bromides|bromides|mesh-list
154579001|NCT02236169|Norflurane|norflurane|mesh-list
154579002|NCT02236169|Ipratropium|ipratropium|mesh-list
154579003|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
154579004|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154579005|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
154579006|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579007|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579008|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154579009|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
154579010|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154579011|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
154579012|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579013|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579014|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
154579015|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579016|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154579017|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154579018|NCT03492385|Ticagrelor|ticagrelor|mesh-list
154579019|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154579020|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154579021|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154579022|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154579023|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
154579024|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579025|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579026|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579027|NCT03736265|Carvedilol|carvedilol|mesh-list
154579028|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154579029|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154579030|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
154579031|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579032|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579033|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579034|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154579035|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
154579036|NCT03736265|Protective Agents|protective agents|mesh-ancestor
154579037|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154579038|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154158297|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
154579039|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154579040|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
154579041|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154579042|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154579043|NCT04939363|Venetoclax|venetoclax|mesh-list
154579044|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
154579045|NCT04939363|Ibrutinib|ibrutinib|mesh-list
154579046|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579047|NCT04939363|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154579048|NCT04939363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154579049|NCT04939363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579050|NCT04939363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579051|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579052|NCT02236403|Metronidazole|metronidazole|mesh-list
154579053|NCT02236403|Ivermectin|ivermectin|mesh-list
154579054|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579055|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154579056|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154579057|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154579058|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154579059|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579060|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
154579061|NCT03491527|Pemetrexed|pemetrexed|mesh-list
154579062|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579063|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579064|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579065|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154579066|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154579067|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579068|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
154579069|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
154579070|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
154579071|NCT02638805|Metformin|metformin|mesh-list
154579072|NCT02638805|Liraglutide|liraglutide|mesh-list
154579073|NCT02638805|Exenatide|exenatide|mesh-list
154579074|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154579075|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579076|NCT02638805|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154158364|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
154302900|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579077|NCT02638805|Incretins|incretins|mesh-ancestor
154579078|NCT02638805|Hormones|hormones|mesh-ancestor
154579079|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154579080|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154579081|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
154579082|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154579083|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579084|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579085|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579086|NCT02261675|Analgesics|analgesics|mesh-ancestor
154579087|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
154579088|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579089|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154579090|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154579091|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154579092|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
154579093|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579094|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579095|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154579096|NCT02262143|Fenofibrate|fenofibrate|mesh-list
154862196|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579097|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154579098|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154579099|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
154579100|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579101|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154579102|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154579103|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579105|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154579106|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154579107|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579108|NCT02262299|Pirfenidone|pirfenidone|mesh-list
154579109|NCT02262299|Analgesics|analgesics|mesh-ancestor
154579110|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
154579111|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579112|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579113|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154579114|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579115|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579116|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579117|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579118|NCT02608697|Atorvastatin|atorvastatin|mesh-list
154579119|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154579120|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154579121|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
154579122|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579123|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154579124|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154579125|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579126|NCT02262455|Doxorubicin|doxorubicin|mesh-list
154579127|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154579128|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154579129|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579130|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154579131|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154579132|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579133|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579134|NCT02262533|Atenolol|atenolol|mesh-list
154579135|NCT02262533|Apixaban|apixaban|mesh-list
154579136|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154579137|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
154579138|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154579139|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
154579140|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579141|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579142|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
154579143|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154579144|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154579145|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
154579146|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
154579147|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579148|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579149|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154302977|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579150|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154579151|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154579152|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154579153|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579155|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154579156|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154579157|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154579158|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154579159|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579160|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154579161|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154579162|NCT02262611|Diuretics|diuretics|mesh-ancestor
154579163|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
154579164|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579165|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
154579166|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
154579167|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
154579168|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579169|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579170|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153612287|NCT01953757|Vitamins|vitamins|mesh-list
154579172|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154579173|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
154579174|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154579175|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154579176|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579177|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154579178|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579179|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154579180|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579181|NCT02515175|Vaccines|vaccines|mesh-list
154579182|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
154579183|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579184|NCT02513303|Sirolimus|sirolimus|mesh-list
154579185|NCT02513303|Temsirolimus|temsirolimus|mesh-list
154579186|NCT02513303|MTOR Inhibitors|mtor inhibitors|mesh-list
154579187|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154579188|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579189|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154579190|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579191|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
154579192|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154579193|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
154579194|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579195|NCT02513303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154579196|NCT02513303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579197|NCT02513303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579198|NCT01616303|Paclitaxel|paclitaxel|mesh-list
154579199|NCT01616303|Carboplatin|carboplatin|mesh-list
154579200|NCT01616303|Oregovomab|oregovomab|mesh-list
154579201|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154579202|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579203|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
154579204|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
154579205|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
154579206|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579207|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579208|NCT01590719|Leucovorin|leucovorin|mesh-list
154579209|NCT01590719|Folic Acid|folic acid|mesh-list
154579210|NCT01590719|Fluorouracil|fluorouracil|mesh-list
154579211|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
154579212|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
154579213|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
154158481|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154579214|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579215|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154579216|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579217|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154579218|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
154579219|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303049|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154579220|NCT01590719|Antidotes|antidotes|mesh-ancestor
154579221|NCT01590719|Protective Agents|protective agents|mesh-ancestor
154579222|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
154579223|NCT01590719|Vitamins|vitamins|mesh-ancestor
154579224|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
154579225|NCT01590719|Hematinics|hematinics|mesh-ancestor
154579226|NCT01536041|Montelukast|montelukast|mesh-list
154579227|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154579228|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
154579229|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154579230|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
154579231|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154579232|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579233|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154579234|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154579235|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579236|NCT01534403|Epratuzumab|epratuzumab|mesh-list
154579237|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579238|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579239|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
154579240|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154579241|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579242|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154579243|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154579244|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579245|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579246|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579247|NCT02264093|Propranolol|propranolol|mesh-list
154579248|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154579249|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154579250|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
154579251|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579252|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579253|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579254|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154579255|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154579256|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
154579257|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
154579258|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154579259|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154579260|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
154579261|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579262|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154579263|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
154579264|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158539|NCT04384692|Tacrolimus|tacrolimus|mesh-list
154579265|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
154579266|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579267|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579268|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154579269|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
154579270|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579271|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579272|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154579273|NCT01516073|Fluticasone|fluticasone|mesh-list
154579275|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579276|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154579277|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
154579278|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579279|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579280|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154579281|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
154579282|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
154579283|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154579284|NCT01495247|Paclitaxel|paclitaxel|mesh-list
154579285|NCT01495247|Dactolisib|dactolisib|mesh-list
154579286|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154579287|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579288|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
154579289|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
154579290|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
154579291|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579292|NCT01495013|Glimepiride|glimepiride|mesh-list
154579293|NCT01495013|Atorvastatin|atorvastatin|mesh-list
154579294|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154579295|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154579296|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
154303121|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579297|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579298|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154579299|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154579300|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579301|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154579302|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154579303|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579304|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154579305|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
154579306|NCT02264171|Ketoconazole|ketoconazole|mesh-list
154579307|NCT02264171|Tamsulosin|tamsulosin|mesh-list
154579308|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154579309|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154579310|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154579311|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
154579312|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579313|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579314|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579315|NCT02264171|Urological Agents|urological agents|mesh-ancestor
154579316|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
154579317|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579318|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154579319|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154579320|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579321|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154579322|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
154579323|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154579324|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154579325|NCT01481051|Latanoprost|latanoprost|mesh-list
154579326|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154579327|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154579329|NCT01480583|Trastuzumab|trastuzumab|mesh-list
154579330|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579331|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579332|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
154579333|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579334|NCT01470131|Dexamethasone|dexamethasone|mesh-list
154579335|NCT01470131|Bortezomib|bortezomib|mesh-list
154579336|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579337|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
154579338|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
154579339|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579340|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579341|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154579342|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
154579343|NCT01470131|Hormones|hormones|mesh-ancestor
154579344|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154579345|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154579346|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579347|NCT02264561|Caffeine|caffeine|mesh-list
154579348|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154579349|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579350|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154579351|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579352|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579353|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154579354|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154579355|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
154579356|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579357|NCT01464437|Metformin|metformin|mesh-list
154579358|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154579359|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579360|NCT01461317|Etrolizumab|etrolizumab|mesh-list
154579361|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154579362|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
154579363|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579364|NCT01449071|Epratuzumab|epratuzumab|mesh-list
154579365|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579366|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579367|NCT01445795|Ribavirin|ribavirin|mesh-list
154579368|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
154579369|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579370|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
154579371|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579372|NCT02264795|Lidocaine|lidocaine|mesh-list
154579373|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
154579374|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
154579375|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579376|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579377|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
154579378|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579379|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154579380|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154579381|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154579382|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154579383|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579384|NCT02264873|Decitabine|decitabine|mesh-list
154158673|NCT04047797|Glycine|glycine|mesh-list
154579385|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154579386|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
154579387|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579388|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579389|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579390|NCT00156533|Zolpidem|zolpidem|mesh-list
154579391|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154579392|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154579393|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579394|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579395|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154579396|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
154579397|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
154579398|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579399|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579400|NCT01410695|Methotrexate|methotrexate|mesh-list
154579401|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154579402|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
154579403|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154579404|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579405|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154579406|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
154579407|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579408|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579409|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
154579410|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579411|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154579412|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154579413|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
154579414|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579415|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154579416|NCT01660022|Piperaquine|piperaquine|mesh-list
154579417|NCT01660022|Artefenomel|artefenomel|mesh-list
154579418|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
154579419|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154579420|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154579421|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579422|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
154579423|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154579424|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
154579425|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579426|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
154579427|NCT02265575|Protective Agents|protective agents|mesh-ancestor
154579428|NCT02265731|Rituximab|rituximab|mesh-list
154579429|NCT02265731|Venetoclax|venetoclax|mesh-list
154579430|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579431|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579432|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
154579433|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579434|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579435|NCT02265809|Aldesleukin|aldesleukin|mesh-list
154579436|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579437|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154579438|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154579439|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
154579440|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579441|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
154579442|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154579443|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
154579444|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579445|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
154579446|NCT01372475|Protective Agents|protective agents|mesh-ancestor
154579447|NCT00156065|Haloperidol|haloperidol|mesh-list
154579448|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
154579449|NCT00156065|Asenapine|asenapine|mesh-list
154579450|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
154579451|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
154579452|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579453|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579454|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154579455|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154579456|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154579457|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579458|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154579459|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154579460|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
154579461|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579462|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579463|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154579464|NCT01554956|Plasminogen|plasminogen|mesh-list
154579465|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154579466|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154579467|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579468|NCT01360853|Gemcitabine|gemcitabine|mesh-list
154579469|NCT01360853|ON 01910|on 01910|mesh-list
154579470|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154579471|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
154579472|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579473|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579474|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154579475|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579476|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154579477|NCT01355393|Sargramostim|sargramostim|mesh-list
154579478|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
154579479|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579480|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
154579481|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579482|NCT02266355|Omalizumab|omalizumab|mesh-list
154579483|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154579484|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154579485|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
154579486|NCT02266511|Tamsulosin|tamsulosin|mesh-list
154158763|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579487|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154579488|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154579489|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154579490|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
154579491|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579492|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579493|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579494|NCT02266511|Urological Agents|urological agents|mesh-ancestor
154579495|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
154579496|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579497|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154579498|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154579499|NCT01298687|Travoprost|travoprost|mesh-list
154579500|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154579501|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154579502|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154579503|NCT02267057|Acetaminophen|acetaminophen|mesh-list
154579504|NCT02267057|Buprenorphine|buprenorphine|mesh-list
154579505|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579506|NCT02267057|Analgesics|analgesics|mesh-ancestor
154579507|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
154579508|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579509|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579510|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
154579511|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154579512|NCT02267057|Narcotics|narcotics|mesh-ancestor
154579513|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579514|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154579515|NCT05260541|Pramoxine|pramoxine|mesh-list
154579516|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
154579517|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
154579518|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579519|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579520|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
154579521|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579522|NCT01262261|Buprenorphine|buprenorphine|mesh-list
154579523|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154579524|NCT01262261|Narcotics|narcotics|mesh-ancestor
154579525|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579526|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579527|NCT01262261|Analgesics|analgesics|mesh-ancestor
154579528|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
154579529|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579530|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154579531|NCT02267681|Fentanyl|fentanyl|mesh-list
154579532|NCT02267681|Alfentanil|alfentanil|mesh-list
154579533|NCT02267681|Propofol|propofol|mesh-list
154579534|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154579535|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579536|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579537|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154579538|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
154579539|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
154579540|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154579541|NCT02267681|Narcotics|narcotics|mesh-ancestor
154862197|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579542|NCT02267681|Analgesics|analgesics|mesh-ancestor
154579543|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
154579544|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579545|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154862198|NCT02565810|Adalimumab|adalimumab|mesh-list
154579546|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
154579547|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154579548|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154579549|NCT05177939|Prednisolone|prednisolone|mesh-list
154579550|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
154579551|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154158824|NCT03840967|Niraparib|niraparib|mesh-list
154579552|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
154579553|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
154579554|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154579555|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
154579556|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154579557|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579558|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
154579559|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
154579560|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579561|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579562|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154579563|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
154579564|NCT05177939|Hormones|hormones|mesh-ancestor
154579565|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154579566|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154579567|NCT05177939|Protective Agents|protective agents|mesh-ancestor
154579568|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154579569|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579570|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
154579571|NCT02267915|Rituximab|rituximab|mesh-list
154579572|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579573|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579574|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
154579575|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579576|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579577|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
154579578|NCT02268149|Prednisone|prednisone|mesh-list
154579579|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579580|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
154579581|NCT02268149|Hormones|hormones|mesh-ancestor
154579582|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154579583|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579584|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154579585|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579586|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154579587|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
154579588|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579589|NCT01255709|Epinephrine|epinephrine|mesh-list
154579590|NCT01255709|Racepinephrine|racepinephrine|mesh-list
154579591|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
154579592|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154579593|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154579594|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
154579595|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579596|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579597|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579598|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154303421|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154579599|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154579600|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
154579601|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579602|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154579603|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
154579604|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
154579605|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
154579606|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154579607|NCT02233907|Oxitropium|oxitropium|mesh-list
154579608|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
154579609|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
154158883|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154579610|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579611|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579612|NCT01253603|Fluticasone|fluticasone|mesh-list
154579614|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
154579615|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579616|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154579617|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
154579618|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579619|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579620|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154579622|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154579623|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154579624|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154579625|NCT01253603|Growth Substances|growth substances|mesh-ancestor
154579626|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
154579627|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579628|NCT02268383|Luspatercept|luspatercept|mesh-list
154579629|NCT02268383|Hematinics|hematinics|mesh-ancestor
154579630|NCT01329419|Adefovir|adefovir|mesh-list
154579631|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154579632|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
154579633|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579634|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154579635|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154579636|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579637|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579638|NCT01235039|Insulin|insulin|mesh-list
154579639|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
154579640|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154579641|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154579642|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579643|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154579644|NCT01221077|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154579645|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154579646|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579647|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579648|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579649|NCT01207115|Naproxen|naproxen|mesh-list
154579650|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154579651|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579652|NCT01207115|Analgesics|analgesics|mesh-ancestor
154579653|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
154579654|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579655|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579656|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579657|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579658|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
154579659|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154579660|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579661|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579662|NCT01186991|Paclitaxel|paclitaxel|mesh-list
154579663|NCT01186991|Bevacizumab|bevacizumab|mesh-list
154579664|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154579665|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154579666|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579667|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154579668|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154579669|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154579670|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579671|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579672|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154579673|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154579674|NCT01186991|Growth Substances|growth substances|mesh-ancestor
154158941|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579675|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579676|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
154579677|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
154579678|NCT02268773|Aspirin|aspirin|mesh-list
154579679|NCT02268773|Dipyridamole|dipyridamole|mesh-list
154579680|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
154579681|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154579682|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579683|NCT02268773|Analgesics|analgesics|mesh-ancestor
154579684|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
154579685|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579686|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579687|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579688|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579689|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154579690|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154579691|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579692|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154579693|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154579694|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579696|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154579697|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
154579698|NCT01183949|Bortezomib|bortezomib|mesh-list
154579699|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579700|NCT02269085|Ibrutinib|ibrutinib|mesh-list
154579701|NCT02269085|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154579702|NCT02269085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154579703|NCT02269085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579704|NCT02269085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579705|NCT01092065|Levodopa|levodopa|mesh-list
154579706|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154579707|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154579708|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
154579709|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579710|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579711|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579712|NCT01173497|Irinotecan|irinotecan|mesh-list
154579713|NCT01173497|Iniparib|iniparib|mesh-list
154579714|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154579715|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154579716|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159009|NCT03345095|Temozolomide|temozolomide|mesh-list
154579717|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579718|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579719|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154579720|NCT01171313|Carbidopa|carbidopa|mesh-list
154579721|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154579722|NCT01171313|Levodopa|levodopa|mesh-list
154579723|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154579724|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154579725|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
154579726|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579727|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579728|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579729|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154579730|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579731|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154579732|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
154579733|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
154579734|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
154579735|NCT01071239|Busulfan|busulfan|mesh-list
154579736|NCT01071239|Fludarabine|fludarabine|mesh-list
154579737|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154579738|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
154579739|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579740|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579741|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154579742|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
154579743|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579744|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579745|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154579746|NCT01156415|Agomelatine|agomelatine|mesh-list
154579747|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154579748|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579749|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579750|NCT01057667|Ribavirin|ribavirin|mesh-list
154579751|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154579752|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
154579753|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579754|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
154579755|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579756|NCT01027013|Rebamipide|rebamipide|mesh-list
154579757|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154579758|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154579759|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154579760|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154579761|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
154579762|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579763|NCT01027013|Protective Agents|protective agents|mesh-ancestor
154579764|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579765|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579766|NCT04197076|Immunomodulating Agents|immunomodulating agents|mesh-list
154579767|NCT04197076|Immunologic Factors|immunologic factors|mesh-ancestor
154579768|NCT04197076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579769|NCT01138163|Docetaxel|docetaxel|mesh-list
154579770|NCT01138163|Bavituximab|bavituximab|mesh-list
154579771|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579772|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154579773|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154579774|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154579775|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579776|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154579777|NCT01022801|Entecavir|entecavir|mesh-list
154579778|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
154579779|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579780|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
154579781|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154579782|NCT05628389|Nicotine|nicotine|mesh-list
154579783|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154579784|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
154579785|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579786|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579787|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154579788|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154579789|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
154579790|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579791|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579792|NCT01128335|Tacrolimus|tacrolimus|mesh-list
154579793|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154579794|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
154579795|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579796|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154579797|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579798|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579799|NCT01012895|Interferons|interferons|mesh-list
154579800|NCT01012895|Ribavirin|ribavirin|mesh-list
154579801|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
154579802|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
154579803|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154579804|NCT01012895|Asunaprevir|asunaprevir|mesh-list
154579805|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579806|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
154579807|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579808|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
154579809|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579810|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
154579811|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579812|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
154579813|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579814|NCT01009775|Docetaxel|docetaxel|mesh-list
154579815|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579816|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
154579817|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
154579818|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
154579819|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579820|NCT02319148|Itraconazole|itraconazole|mesh-list
154579821|NCT02319148|Verapamil|verapamil|mesh-list
154579822|NCT02319148|Diltiazem|diltiazem|mesh-list
154579823|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
154579824|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579825|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154579826|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154579827|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579828|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579829|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154579830|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
154579831|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154579832|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579833|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154579834|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154579835|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154579836|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154579837|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154579838|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
154579839|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154579840|NCT02526212|Buprenorphine|buprenorphine|mesh-list
154579841|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154579842|NCT02526212|Narcotics|narcotics|mesh-ancestor
154579843|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579844|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579845|NCT02526212|Analgesics|analgesics|mesh-ancestor
154579846|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
154579847|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579848|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154579849|NCT05627843|Curcumin|curcumin|mesh-list
154579850|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154579851|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579852|NCT05627843|Analgesics|analgesics|mesh-ancestor
154579853|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
154579854|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579855|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579856|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579857|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579858|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579859|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579860|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579861|NCT01004081|Exemestane|exemestane|mesh-list
154579862|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579863|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154579864|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154579865|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579866|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579867|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154579868|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
154579869|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154579870|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579871|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
154579872|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154579873|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
154579874|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579875|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579876|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154579877|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
154579878|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154579879|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154579880|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154579881|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
154579882|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579883|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579884|NCT02532374|Nicotine|nicotine|mesh-list
154579885|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154579886|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
154579887|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579888|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579889|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154579890|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154579891|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
154579892|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154579893|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579894|NCT05398874|Acetaminophen|acetaminophen|mesh-list
154579895|NCT05398874|Diclofenac|diclofenac|mesh-list
154579896|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579897|NCT05398874|Analgesics|analgesics|mesh-ancestor
154579898|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
154579899|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579900|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579901|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
154579902|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154579903|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579904|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579905|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154579906|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579907|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579908|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
154579909|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154579910|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579911|NCT00152477|Paclitaxel|paclitaxel|mesh-list
154579912|NCT00152477|Carboplatin|carboplatin|mesh-list
154579913|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154579914|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579915|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
154579916|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
154579917|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
154579918|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579919|NCT01111955|Metformin|metformin|mesh-list
154579920|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154579921|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579922|NCT01106807|Adapalene|adapalene|mesh-list
154579923|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154579924|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154579925|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
154579926|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154579927|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154579928|NCT01106807|Analgesics|analgesics|mesh-ancestor
154579929|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
154579930|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579931|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579932|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154579933|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154579934|NCT05533229|Fentanyl|fentanyl|mesh-list
154579935|NCT05533229|Morphine|morphine|mesh-list
154579936|NCT05533229|Bupivacaine|bupivacaine|mesh-list
154579937|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
154579938|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
154579939|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154579940|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154579941|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
154579942|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154579943|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154579944|NCT05533229|Narcotics|narcotics|mesh-ancestor
154579945|NCT05533229|Analgesics|analgesics|mesh-ancestor
154579946|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154579947|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154579948|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
154579949|NCT00153179|Acipimox|acipimox|mesh-list
154579950|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154579951|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
154579952|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579953|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154579954|NCT02743949|Esomeprazole|esomeprazole|mesh-list
154579955|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154579956|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154579957|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154579958|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579959|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579960|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
154579961|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154579962|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579963|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154579964|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154579965|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579966|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579967|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579968|NCT02289898|Gemcitabine|gemcitabine|mesh-list
154579969|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154579970|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154579971|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
154579972|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579973|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579974|NCT01659554|Cisplatin|cisplatin|mesh-list
154579975|NCT01659554|Doxorubicin|doxorubicin|mesh-list
154579976|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154579977|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154579978|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154579979|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154579980|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154579981|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579982|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579983|NCT05355350|Meropenem|meropenem|mesh-list
154579984|NCT05355350|Tazobactam|tazobactam|mesh-list
154579985|NCT05355350|Piperacillin|piperacillin|mesh-list
154579986|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154579987|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154579988|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579989|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154579990|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154579991|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154579992|NCT01659320|Minocycline|minocycline|mesh-list
154579993|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154579994|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154862199|NCT02565810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154579996|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154579997|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154579998|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
154579999|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154580000|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154580001|NCT01660334|Voriconazole|voriconazole|mesh-list
154580002|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
154580003|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580004|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154580005|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154580006|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580007|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580008|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154580009|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
154580010|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580011|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580012|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154580013|NCT01660256|Rebamipide|rebamipide|mesh-list
154580014|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154580015|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580016|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
154580017|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580018|NCT01660256|Protective Agents|protective agents|mesh-ancestor
154580019|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580020|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580021|NCT02330367|Abivertinib|abivertinib|mesh-list
154159320|NCT02681302|Ipilimumab|ipilimumab|mesh-list
154580022|NCT02330367|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154580023|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154580024|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580025|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580026|NCT02318602|Cannabidiol|cannabidiol|mesh-list
154580027|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
154580028|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154580029|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154580030|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154580031|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580032|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580033|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580034|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580035|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
154580036|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154580037|NCT05559008|Azacitidine|azacitidine|mesh-list
154580038|NCT05559008|Apatinib|apatinib|mesh-list
154580039|NCT05559008|Dasatinib|dasatinib|mesh-list
154580040|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154580041|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
154580042|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580043|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580044|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580045|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154580046|NCT05559008|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154580047|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154580048|NCT02318368|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154580049|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154580050|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580051|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580052|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580053|NCT05053425|Cytarabine|cytarabine|mesh-list
154580054|NCT05053425|Azacitidine|azacitidine|mesh-list
154580055|NCT05053425|Venetoclax|venetoclax|mesh-list
154580056|NCT05053425|Idarubicin|idarubicin|mesh-list
154580057|NCT05053425|Cladribine|cladribine|mesh-list
154580058|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154580059|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
154580060|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580061|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580062|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
154580063|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580064|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154580065|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
154580066|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580067|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580068|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154580069|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154580070|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154580071|NCT02317510|Anesthetics|anesthetics|mesh-list
154580072|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580073|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580074|NCT05350124|Vitamins|vitamins|mesh-list
154580075|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
154580076|NCT05350124|Vitamin E|vitamin e|mesh-list
154580077|NCT05350124|Tocopherols|tocopherols|mesh-list
154580078|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
154580079|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580080|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
154580081|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580082|NCT05350124|Protective Agents|protective agents|mesh-ancestor
154580083|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
154580084|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154580085|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154580086|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580087|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
154580088|NCT04803591|Coagulants|coagulants|mesh-ancestor
154580089|NCT04735263|Atorvastatin|atorvastatin|mesh-list
154580090|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154580091|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154580092|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
154580093|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580094|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154580095|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154580096|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580097|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154580098|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154580099|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580100|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
154580101|NCT04662723|Empagliflozin|empagliflozin|mesh-list
154580102|NCT04662723|Canagliflozin|canagliflozin|mesh-list
154580103|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154580104|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
154580105|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154580106|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154580107|NCT04662723|Prednisolone|prednisolone|mesh-list
154580108|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
154580109|NCT04662723|Losartan|losartan|mesh-list
154580110|NCT04662723|Ramipril|ramipril|mesh-list
154580111|NCT04662723|Lisinopril|lisinopril|mesh-list
154580112|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154580113|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
154580114|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154580115|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
154580116|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
154580117|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580118|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580119|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580120|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
154580121|NCT04662723|Hormones|hormones|mesh-ancestor
154580122|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580123|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154303947|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
154580124|NCT04662723|Protective Agents|protective agents|mesh-ancestor
154580125|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154580126|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580127|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580128|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580129|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154580130|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154580131|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154580132|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154580133|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154580134|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
154580135|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580136|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154580137|NCT05307926|Lenvatinib|lenvatinib|mesh-list
154580138|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154580139|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580140|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154580141|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580142|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580143|NCT05307926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154862200|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154580144|NCT04026945|Lidocaine|lidocaine|mesh-list
154580145|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
154580146|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
154580147|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580148|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580149|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
154580150|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580151|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154580152|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154580153|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154580154|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580155|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580156|NCT02328729|Epinephrine|epinephrine|mesh-list
154580157|NCT02328729|Racepinephrine|racepinephrine|mesh-list
154580158|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
154580159|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154580160|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154580161|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580162|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580163|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580164|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580165|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154580166|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154580167|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
154580168|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580169|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154580170|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
154580171|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
154580172|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
154580173|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154580174|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
154580175|NCT02328963|Everolimus|everolimus|mesh-list
154580176|NCT02328963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154580177|NCT02328963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154580178|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580179|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580180|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154580181|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
154580182|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580183|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580184|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154580185|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154580186|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
154580187|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154580188|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580189|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
154580190|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154580191|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154580192|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580193|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
154580194|NCT03353259|Coagulants|coagulants|mesh-ancestor
154580195|NCT02328651|Ribavirin|ribavirin|mesh-list
154580196|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
154580197|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580198|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
154580199|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304035|NCT01262469|Lapatinib|lapatinib|mesh-list
154580200|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154580201|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154580202|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154580203|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154580204|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154580205|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580206|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580207|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580208|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580209|NCT02328495|Misoprostol|misoprostol|mesh-list
154580210|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154580211|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
154580212|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154580213|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580214|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154580215|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580216|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
154580217|NCT02287402|Voglibose|voglibose|mesh-list
154580218|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580219|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580220|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154580221|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580222|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580223|NCT02913495|Progesterone|progesterone|mesh-list
154580224|NCT02913495|Progestins|progestins|mesh-ancestor
154580225|NCT02913495|Hormones|hormones|mesh-ancestor
154580226|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580227|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580228|NCT03111069|Doxorubicin|doxorubicin|mesh-list
154580229|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154580230|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154580231|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580232|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154580233|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154580234|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580235|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580236|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154580237|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154580238|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
154580239|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580240|NCT03110757|Antacids|antacids|mesh-ancestor
154580241|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580242|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580243|NCT05080569|Progesterone|progesterone|mesh-list
154580244|NCT05080569|Progestins|progestins|mesh-ancestor
154580245|NCT05080569|Hormones|hormones|mesh-ancestor
154580246|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580247|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580248|NCT03145467|Acetaminophen|acetaminophen|mesh-list
154580249|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
154580250|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154580251|NCT03145467|Analgesics|analgesics|mesh-ancestor
154580252|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
154580253|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580254|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580255|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
154580256|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154580257|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154580258|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
154580259|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580260|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580261|NCT05302856|Antibodies|antibodies|mesh-list
154159557|NCT01712490|Bleomycin|bleomycin|mesh-list
154580262|NCT05302856|Testosterone|testosterone|mesh-list
154580263|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
154580264|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580265|NCT05302856|Androgens|androgens|mesh-ancestor
154580266|NCT05302856|Hormones|hormones|mesh-ancestor
154580267|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580268|NCT02328183|Polymyxins|polymyxins|mesh-list
154580269|NCT02328183|Polymyxin B|polymyxin b|mesh-list
154580270|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154580271|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580272|NCT05610488|Faricimab|faricimab|mesh-list
154580273|NCT05610488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154580274|NCT05610488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154580275|NCT05610488|Growth Substances|growth substances|mesh-ancestor
154580276|NCT05610488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580277|NCT05610488|Growth Inhibitors|growth inhibitors|mesh-ancestor
154580278|NCT05610488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580279|NCT01646398|Vaccines|vaccines|mesh-list
154580280|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154580281|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
154580282|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580283|NCT01646320|Metformin|metformin|mesh-list
154580284|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
154580285|NCT01646320|Saxagliptin|saxagliptin|mesh-list
154580286|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580287|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580288|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154580289|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580290|NCT01646320|Incretins|incretins|mesh-ancestor
154580291|NCT01646320|Hormones|hormones|mesh-ancestor
154255608|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
154862201|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154580292|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580293|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154580294|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
154580295|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580296|NCT03141645|Ondansetron|ondansetron|mesh-list
154580297|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
154580298|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
154580299|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580300|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580301|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580302|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
154580303|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
154580304|NCT03141645|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154580305|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154580306|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
154580307|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580308|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580309|NCT01658150|Isradipine|isradipine|mesh-list
154580310|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154580311|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154580312|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580313|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580314|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154580315|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580316|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
154580317|NCT02285998|Vaccines|vaccines|mesh-list
154580318|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
154580319|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580320|NCT02285920|Spironolactone|spironolactone|mesh-list
154580321|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154580322|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
154580323|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580324|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580325|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154580326|NCT02285920|Diuretics|diuretics|mesh-ancestor
154580327|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
154580328|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154580329|NCT05292872|Cathartics|cathartics|mesh-ancestor
154580330|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580331|NCT02035137|Irinotecan|irinotecan|mesh-list
154580332|NCT02035137|Vincristine|vincristine|mesh-list
154580333|NCT02035137|Vorinostat|vorinostat|mesh-list
154580334|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154580335|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154580336|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154580337|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580338|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580339|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580340|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154580341|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
154580342|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
154580343|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
154580344|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154580345|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154580346|NCT05264870|Norepinephrine|norepinephrine|mesh-list
154580347|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154580348|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154580349|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580350|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580351|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580352|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580353|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
154580354|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
154580355|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580356|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154580357|NCT05079087|Midazolam|midazolam|mesh-list
154580358|NCT05079087|Ketamine|ketamine|mesh-list
154580359|NCT05079087|Analgesics|analgesics|mesh-ancestor
154580360|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
154580361|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580362|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580363|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154580364|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154580365|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
154580366|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
154580367|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580368|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154580369|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154580370|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580371|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580372|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154580373|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154580374|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154580375|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154580376|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154580377|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
154580379|NCT02522780|Mesalamine|mesalamine|mesh-list
154580380|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154580381|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154580382|NCT02522780|Analgesics|analgesics|mesh-ancestor
154580383|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
154580384|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580385|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580386|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154580387|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154580388|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154580389|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154580390|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154580391|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580392|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580393|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580394|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580395|NCT03618225|Analgesics|analgesics|mesh-ancestor
154580396|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
154580397|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580398|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
154580399|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154580400|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
154580401|NCT03566199|Panobinostat|panobinostat|mesh-list
154580402|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580403|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154580404|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580405|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580406|NCT03561831|Propofol|propofol|mesh-list
154580407|NCT03561831|Sevoflurane|sevoflurane|mesh-list
154580408|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154580409|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580410|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580411|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154580412|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
154580413|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
154580414|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154580415|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154580416|NCT03144843|Apatinib|apatinib|mesh-list
154580417|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580418|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154580419|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580420|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580421|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154580422|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154580423|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580424|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580425|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154580426|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
154580427|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580428|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580430|NCT03199755|Artemether|artemether|mesh-list
154580431|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154580432|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
154580433|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154580434|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154580435|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580436|NCT05318066|Norepinephrine|norepinephrine|mesh-list
154580437|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154580438|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154580439|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
154862202|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
154862203|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
154580440|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580441|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580442|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580444|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
154580445|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580446|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154580447|NCT02327793|Labetalol|labetalol|mesh-list
154580448|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
154580449|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
154159754|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
154580450|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154580451|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154580452|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580453|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580454|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580455|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580456|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154580457|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
154580458|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
154580459|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580460|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154580461|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154580462|NCT02327715|Emtricitabine|emtricitabine|mesh-list
154580463|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
154580464|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580465|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154580466|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154580467|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580468|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580469|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154580470|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154580471|NCT02951013|Chrysarobin|chrysarobin|mesh-list
154580472|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154580473|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154580474|NCT02951013|Analgesics|analgesics|mesh-ancestor
154580475|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
154580476|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580477|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580478|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154580479|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154580480|NCT02285062|Prednisone|prednisone|mesh-list
154580481|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
154580482|NCT02285062|Rituximab|rituximab|mesh-list
154580483|NCT02285062|Doxorubicin|doxorubicin|mesh-list
154580484|NCT02285062|Vincristine|vincristine|mesh-list
154580485|NCT02285062|Lenalidomide|lenalidomide|mesh-list
154580486|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154580487|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
154580488|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580489|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159788|NCT01267448|Glipizide|glipizide|mesh-list
154580490|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154580491|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
154580492|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580493|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580494|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154580495|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154580496|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154580497|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154580498|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154580499|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580500|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154580501|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
154580503|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580504|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154580505|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154580506|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
154580507|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154580508|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
154580509|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154580510|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154580511|NCT02285062|Growth Substances|growth substances|mesh-ancestor
154580512|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
154580513|NCT02431767|Interleukin-12|interleukin-12|mesh-list
154580514|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154580515|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
154580516|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580517|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154580518|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154580519|NCT02431767|Growth Substances|growth substances|mesh-ancestor
154580520|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
154580521|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580522|NCT04571697|Methotrexate|methotrexate|mesh-list
154580523|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154580524|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
154580525|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154580526|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580527|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154580528|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
154580529|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580530|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580531|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
154580532|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580533|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154580534|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154580535|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
154580536|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154580537|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154580538|NCT05253794|Colchicine|colchicine|mesh-list
154580539|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
154580540|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154580541|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
154580542|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
154580543|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
154580544|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580545|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580546|NCT03140943|Thalidomide|thalidomide|mesh-list
154580547|NCT03140943|Dexamethasone|dexamethasone|mesh-list
154580548|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154580549|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
154580550|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
154580551|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580552|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580553|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580554|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
154580555|NCT03140943|Hormones|hormones|mesh-ancestor
154580556|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580557|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154580558|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580559|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154580560|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
154580561|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
154580562|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154580563|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580564|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154580565|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154580566|NCT03140943|Growth Substances|growth substances|mesh-ancestor
154580567|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
154580568|NCT02038257|Petrolatum|petrolatum|mesh-list
154580569|NCT02038257|Emollients|emollients|mesh-ancestor
154580570|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
154580572|NCT05311436|Folic Acid|folic acid|mesh-list
154580573|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580574|NCT05311436|Trace Elements|trace elements|mesh-ancestor
154580575|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
154580576|NCT05311436|Hematinics|hematinics|mesh-ancestor
154580577|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
154580578|NCT05311436|Vitamins|vitamins|mesh-ancestor
154580579|NCT01352741|Pregabalin|pregabalin|mesh-list
154580580|NCT01352741|Tapentadol|tapentadol|mesh-list
154580581|NCT01352741|Analgesics|analgesics|mesh-ancestor
154580582|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
154580583|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580584|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580585|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
154580586|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154580587|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580588|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580589|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153614074|NCT01965977|Bortezomib|bortezomib|mesh-list
154580590|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154580591|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154580592|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580593|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154580594|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154580595|NCT01352741|Narcotics|narcotics|mesh-ancestor
154580596|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154580597|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154580598|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580599|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580600|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
154580601|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154580602|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580603|NCT00911963|Ribavirin|ribavirin|mesh-list
154580604|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154580605|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
154580606|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580607|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
154580608|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580609|NCT01657292|Octenidine|octenidine|mesh-list
154580610|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580611|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154580612|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
154580613|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154580614|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580615|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154580616|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
154580617|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154580618|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580619|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580620|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580621|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
154580622|NCT03140553|Carboplatin|carboplatin|mesh-list
154580623|NCT03140553|Docetaxel|docetaxel|mesh-list
154580624|NCT03140553|Trastuzumab|trastuzumab|mesh-list
154580625|NCT03140553|Epirubicin|epirubicin|mesh-list
154580626|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154580627|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
154580628|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580629|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154580630|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154580631|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
154580632|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580633|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580634|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154580635|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
154580636|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
154580637|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
154580638|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154580639|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154580640|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154580641|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154580642|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580643|NCT00905567|Topiramate|topiramate|mesh-list
154580644|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
154580645|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580646|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580647|NCT02282020|Olaparib|olaparib|mesh-list
154580648|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154304475|NCT01268163|Docetaxel|docetaxel|mesh-list
154580649|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580650|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580651|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580653|NCT05249972|Betamethasone|betamethasone|mesh-list
154580654|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
154580655|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154580656|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
154580657|NCT05249972|Calcipotriene|calcipotriene|mesh-list
154580658|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154580659|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154580660|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
154580661|NCT05249972|Hormones|hormones|mesh-ancestor
154580662|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580663|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580664|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154580665|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
154580667|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154580668|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154580669|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580670|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580671|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154580672|NCT05249972|Vitamins|vitamins|mesh-ancestor
154580673|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
154580674|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154580675|NCT00904943|Topiramate|topiramate|mesh-list
154580676|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
154580677|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580678|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580679|NCT00902291|Gemcitabine|gemcitabine|mesh-list
154580680|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154580681|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
154580682|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580683|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580684|NCT02281552|Tofacitinib|tofacitinib|mesh-list
154580685|NCT02281552|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154580686|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154580687|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580688|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580689|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
154580690|NCT03832647|Salicylates|salicylates|mesh-list
154580691|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580692|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
154580693|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
154580694|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
154580695|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154580696|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154580697|NCT03832647|Analgesics|analgesics|mesh-ancestor
154580698|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
154580699|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580700|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580701|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154580702|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154580703|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154580704|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580705|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580706|NCT00901979|Metformin|metformin|mesh-list
154580707|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154580708|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580709|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580710|NCT00901979|Incretins|incretins|mesh-ancestor
154580711|NCT00901979|Hormones|hormones|mesh-ancestor
154580712|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580713|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154580714|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
154580715|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580716|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580717|NCT03778671|Fentanyl|fentanyl|mesh-list
154580718|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
154580719|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
154304548|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580720|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154580721|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580722|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580724|NCT03778671|Analgesics|analgesics|mesh-ancestor
154580725|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
154580726|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580727|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154580728|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154580729|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154580730|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580731|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580732|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580733|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154580734|NCT03778671|Narcotics|narcotics|mesh-ancestor
154580735|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154580736|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154580737|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
154580738|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
154580739|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
154580742|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580743|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
154580744|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580745|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
154580746|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154580747|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580748|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154580749|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154580750|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580751|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580752|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580753|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154580754|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154580755|NCT00890591|Amlodipine|amlodipine|mesh-list
154580756|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154580757|NCT00890591|Olmesartan|olmesartan|mesh-list
154580758|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154580759|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154580760|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154580761|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580762|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580763|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154580764|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580765|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
154580766|NCT00890591|Diuretics|diuretics|mesh-ancestor
154580767|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
154580768|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154580769|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154580770|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154580771|NCT05248334|Ranibizumab|ranibizumab|mesh-list
154580772|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154580773|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154580774|NCT05248334|Growth Substances|growth substances|mesh-ancestor
154580775|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580776|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
154580777|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580778|NCT03140787|Lidocaine|lidocaine|mesh-list
154580779|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
154580780|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
154580781|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580782|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580783|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
154580784|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580785|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154580786|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154580787|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154580788|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580789|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580790|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
154580791|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154580792|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580793|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154580794|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154580795|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580796|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580797|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580798|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154580799|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154580800|NCT03317223|Amoxicillin|amoxicillin|mesh-list
154580801|NCT03317223|Clarithromycin|clarithromycin|mesh-list
154580802|NCT03317223|Lansoprazole|lansoprazole|mesh-list
154580803|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154580804|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580805|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154580806|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580807|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580808|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154580809|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154580810|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154160113|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862204|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154580811|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580812|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154580814|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580815|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580816|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
154580817|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154580818|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580819|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580820|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154580821|NCT02566863|Analgesics|analgesics|mesh-ancestor
154580822|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
154580823|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580824|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154580825|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154580826|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154580827|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580828|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580829|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580830|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
154580831|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154580832|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154580833|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154580834|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580835|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580836|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
154580837|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580838|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580839|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154580840|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580841|NCT04474457|Favipiravir|favipiravir|mesh-list
154580842|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
154580843|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580844|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154580845|NCT00880217|Methylphenidate|methylphenidate|mesh-list
154580846|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154580847|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154580848|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580849|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154580850|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154580851|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580852|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580853|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
154580854|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580855|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154580856|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580858|NCT01657760|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154580859|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154580860|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154580861|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160150|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154580862|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580863|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
154580864|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580865|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154580866|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
154580867|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154580868|NCT00966953|Honokiol|honokiol|mesh-list
154580869|NCT00966953|Triclosan|triclosan|mesh-list
154580870|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154580871|NCT00966953|Fluorides|fluorides|mesh-list
154580872|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
154580873|NCT00966953|Protective Agents|protective agents|mesh-ancestor
154580874|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580875|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154580876|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580877|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154580878|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154580879|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
154580880|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580881|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154580882|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154580883|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154580884|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580885|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580886|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580887|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154580888|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154580889|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154580890|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154580891|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154580892|NCT05084079|Insulin|insulin|mesh-list
154580893|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154580894|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580895|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580896|NCT05084001|Listerine|listerine|mesh-list
154580897|NCT05084001|Fluorides|fluorides|mesh-list
154580898|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
154580899|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
154580900|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
154580901|NCT05084001|Protective Agents|protective agents|mesh-ancestor
154580902|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580903|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154580904|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580905|NCT00875459|Insulin|insulin|mesh-list
154580906|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154580907|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154580908|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580909|NCT03140709|Oxytocin|oxytocin|mesh-list
154580910|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
154580911|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154580912|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580913|NCT02283658|Everolimus|everolimus|mesh-list
154580914|NCT02283658|Letrozole|letrozole|mesh-list
154580915|NCT02283658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154580916|NCT02283658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154580917|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580918|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580919|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154580920|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
154580921|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580922|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580923|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154580924|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154580925|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154580926|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
154580927|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154580928|NCT00872885|Morphine|morphine|mesh-list
154580929|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154580930|NCT00872885|Narcotics|narcotics|mesh-ancestor
154580931|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154580932|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580933|NCT00872885|Analgesics|analgesics|mesh-ancestor
154580934|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
154580935|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580936|NCT00871481|Aldesleukin|aldesleukin|mesh-list
154580937|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
154580938|NCT00871481|Ipilimumab|ipilimumab|mesh-list
154580939|NCT00871481|Interleukin-2|interleukin-2|mesh-list
154580940|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154580941|NCT00871481|Antibodies|antibodies|mesh-list
154580942|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
154580943|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154580944|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154580945|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
154580946|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580947|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154580948|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154580949|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
154580950|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580951|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580952|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154580953|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154580954|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154580955|NCT00871481|Analgesics|analgesics|mesh-ancestor
154580956|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
154580957|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154580958|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154580959|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154580960|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
154862205|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154580961|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154580962|NCT05456165|Ipilimumab|ipilimumab|mesh-list
154580963|NCT05456165|Atezolizumab|atezolizumab|mesh-list
154580964|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154580965|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580966|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154580967|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580968|NCT05083689|Bevacizumab|bevacizumab|mesh-list
154580969|NCT05083689|Timolol|timolol|mesh-list
154580970|NCT05083689|Dorzolamide|dorzolamide|mesh-list
154580971|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
154580972|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154580973|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154580974|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154580975|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154580976|NCT05083689|Growth Substances|growth substances|mesh-ancestor
154580977|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580978|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
154580979|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154580980|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154580981|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
154580982|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154580983|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154580984|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154580985|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154580986|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154580987|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154580988|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154580989|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154580990|NCT05165966|Vaccines|vaccines|mesh-list
154580991|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
154580992|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580993|NCT05165732|Vaccines|vaccines|mesh-list
154580994|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
154580995|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154580996|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
154580997|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
154580998|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154580999|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154581000|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581001|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581002|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581003|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581004|NCT03138759|Probenecid|probenecid|mesh-list
154581005|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
154581006|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
154581007|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581008|NCT03079921|Propranolol|propranolol|mesh-list
154581009|NCT03079921|Phentolamine|phentolamine|mesh-list
154581010|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154581011|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154581012|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
154581013|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581014|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581015|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581016|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154581017|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154581018|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
154581019|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154581020|NCT04473989|Teriparatide|teriparatide|mesh-list
154304840|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
154581021|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154581022|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581023|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154581025|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154581026|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581027|NCT05209490|Trace Elements|trace elements|mesh-ancestor
154581028|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
154581029|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581030|NCT05162222|Itraconazole|itraconazole|mesh-list
154581031|NCT05162222|Diltiazem|diltiazem|mesh-list
154581032|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
154581033|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581034|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154581035|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154581036|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160318|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
154581037|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581038|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154581039|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
154581040|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581041|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581042|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154581043|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154581044|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154581045|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154581046|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154581047|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
154581048|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
154581049|NCT05088057|Docetaxel|docetaxel|mesh-list
154581050|NCT05088057|Doxorubicin|doxorubicin|mesh-list
154581051|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154581052|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
154581053|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581054|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581055|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154581056|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
154581057|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581058|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581059|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154581060|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581061|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581062|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581063|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154581064|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154581065|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154581066|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581067|NCT03132025|Capecitabine|capecitabine|mesh-list
154581068|NCT03132025|Apatinib|apatinib|mesh-list
154581069|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154581070|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
154581071|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581072|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581073|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154581074|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581075|NCT00857285|Losartan|losartan|mesh-list
154581076|NCT00857285|Olmesartan|olmesartan|mesh-list
154581077|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154581078|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154581079|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154581080|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154581081|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154581082|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581083|NCT04461379|Vaccines|vaccines|mesh-list
154581084|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
154581085|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
154581086|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581087|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154581088|NCT00854945|ON 01910|on 01910|mesh-list
154581089|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581090|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154581091|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581092|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581093|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
154304920|NCT01167231|Acarbose|acarbose|mesh-list
154581094|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154581095|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154581096|NCT04876534|Prednisolone|prednisolone|mesh-list
154581097|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
154581098|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154581099|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154581100|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
154581101|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581102|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
154581103|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
154581104|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581105|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581106|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581107|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
154581108|NCT04876534|Hormones|hormones|mesh-ancestor
154862206|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581109|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581111|NCT04876534|Protective Agents|protective agents|mesh-ancestor
154581112|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154581113|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581114|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
154581115|NCT02443831|Fludarabine|fludarabine|mesh-list
154581116|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154581117|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
154581118|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581119|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581120|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154581121|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
154581122|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581123|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581124|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154581125|NCT00851045|Leucovorin|leucovorin|mesh-list
154581126|NCT00851045|Bevacizumab|bevacizumab|mesh-list
154581127|NCT00851045|Fluorouracil|fluorouracil|mesh-list
154581128|NCT00851045|Irinotecan|irinotecan|mesh-list
154581129|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154581130|NCT00851045|Calcium|calcium|mesh-list
154581131|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
154581132|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581133|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581134|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154581135|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154581136|NCT00851045|Growth Substances|growth substances|mesh-ancestor
154581137|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581138|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
154581139|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154581140|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
154581141|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581142|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154581143|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154581144|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
154581145|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154581146|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154581147|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581148|NCT00851045|Antidotes|antidotes|mesh-ancestor
154581149|NCT00851045|Protective Agents|protective agents|mesh-ancestor
154581150|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
154581151|NCT00851045|Vitamins|vitamins|mesh-ancestor
154581152|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
154581153|NCT00850577|Paclitaxel|paclitaxel|mesh-list
154581154|NCT00850577|Bevacizumab|bevacizumab|mesh-list
154581155|NCT00850577|Carboplatin|carboplatin|mesh-list
154581156|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154581157|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154581158|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581159|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581160|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581161|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581162|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581163|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581164|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154581165|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154581166|NCT00850577|Growth Substances|growth substances|mesh-ancestor
154581167|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581168|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
154581169|NCT00838981|Methadone|methadone|mesh-list
154581170|NCT00838981|Modafinil|modafinil|mesh-list
154581171|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154581172|NCT00838981|Narcotics|narcotics|mesh-ancestor
154581173|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581174|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581175|NCT00838981|Analgesics|analgesics|mesh-ancestor
154581176|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
154581177|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581178|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
154581179|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
154581180|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154581181|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154581182|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153614892|NCT01971411|Vitamins|vitamins|mesh-list
154581183|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154581184|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581185|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
154581186|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
154581187|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154581188|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154581189|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154581190|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581191|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154581192|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154581193|NCT05082441|Bupivacaine|bupivacaine|mesh-list
154581194|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
154581195|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
154581196|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581197|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581198|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
154581199|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581200|NCT00950885|Melatonin|melatonin|mesh-list
154581201|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
154581202|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581203|NCT00950885|Protective Agents|protective agents|mesh-ancestor
154581204|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581205|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581206|NCT00849485|Levetiracetam|levetiracetam|mesh-list
154581207|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
154581208|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
154581209|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
154581210|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
154581211|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154581212|NCT03140397|Estrogens|estrogens|mesh-ancestor
154581213|NCT03140397|Hormones|hormones|mesh-ancestor
154581214|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581215|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581216|NCT05047445|Vaccines|vaccines|mesh-list
154581217|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
154581218|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581219|NCT05235542|Paclitaxel|paclitaxel|mesh-list
154581220|NCT05235542|Docetaxel|docetaxel|mesh-list
154581221|NCT05235542|Capecitabine|capecitabine|mesh-list
154581222|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
154581223|NCT05235542|Irinotecan|irinotecan|mesh-list
154581224|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154581225|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581226|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581227|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581228|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581229|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581230|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154581231|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
154581232|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154581233|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154581234|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581235|NCT00840281|Cefprozil|cefprozil|mesh-list
154581236|NCT00840281|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154581237|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154581238|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581239|NCT00840203|Mesalamine|mesalamine|mesh-list
154581240|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154581241|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154581242|NCT00840203|Analgesics|analgesics|mesh-ancestor
154581243|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
154581244|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581245|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581246|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581247|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581249|NCT00838799|Analgesics|analgesics|mesh-ancestor
154581250|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
154581251|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581252|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581253|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
154581254|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154581255|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154581256|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581257|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154581258|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154581260|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581261|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154581262|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
154581263|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154581264|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581265|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581266|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581267|NCT00836069|Paroxetine|paroxetine|mesh-list
154581268|NCT00836069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154581269|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154581270|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154581271|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581272|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581273|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
154581274|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581275|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154581276|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
154581277|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154581278|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154581279|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154581280|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581281|NCT03134729|Ropivacaine|ropivacaine|mesh-list
154581282|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
154581283|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
154160580|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154581284|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581285|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581286|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
154581287|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581288|NCT03134651|Propofol|propofol|mesh-list
154581289|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154581290|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581291|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581292|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154581293|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
154581294|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
154581295|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
154581296|NCT05202782|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154581297|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154581298|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581299|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581300|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581301|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154581302|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154581303|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581304|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581305|NCT05155124|Cetuximab|cetuximab|mesh-list
154581306|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581307|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581308|NCT00927641|Ketoprofen|ketoprofen|mesh-list
154581309|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154581310|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154581311|NCT00927641|Analgesics|analgesics|mesh-ancestor
154581312|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
154581313|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581314|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581315|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154305147|NCT03872661|Bevacizumab|bevacizumab|mesh-list
154581316|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581317|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154581318|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581319|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581321|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581322|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581323|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154581324|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154581325|NCT05200364|Growth Substances|growth substances|mesh-ancestor
154581326|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581327|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
154581328|NCT00835991|Metformin|metformin|mesh-list
154581329|NCT00835991|Glyburide|glyburide|mesh-list
154581330|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581331|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581333|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
154581334|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581335|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581336|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581337|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581338|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581339|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581340|NCT00925535|Rifabutin|rifabutin|mesh-list
154581341|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154581342|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581343|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154581344|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
154581345|NCT02276872|Treprostinil|treprostinil|mesh-list
154581346|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154581347|NCT00835367|Amlodipine|amlodipine|mesh-list
154581348|NCT00835367|Benazepril|benazepril|mesh-list
154581349|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154581350|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154581351|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154581352|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581353|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154581354|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581355|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
154581356|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154581357|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
154581358|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581359|NCT02276560|Paclitaxel|paclitaxel|mesh-list
154581360|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154581361|NCT02276560|Cisplatin|cisplatin|mesh-list
154581362|NCT02276560|Gemcitabine|gemcitabine|mesh-list
154581363|NCT02276560|Pemetrexed|pemetrexed|mesh-list
154581364|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154581365|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581366|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581367|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581368|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581369|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581370|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154581371|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
154581372|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581373|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154581374|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154581375|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154581376|NCT02276482|Metronidazole|metronidazole|mesh-list
154581377|NCT02276482|Vancomycin|vancomycin|mesh-list
154581378|NCT02276482|Clindamycin|clindamycin|mesh-list
154581379|NCT02276482|Cefazolin|cefazolin|mesh-list
154581380|NCT02276482|Linezolid|linezolid|mesh-list
154581381|NCT02276482|Cephalexin|cephalexin|mesh-list
154581382|NCT02276482|Aztreonam|aztreonam|mesh-list
154581383|NCT02276482|Tedizolid|tedizolid|mesh-list
154581384|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581385|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154581386|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154581387|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154581388|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581389|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581390|NCT00924833|Carvedilol|carvedilol|mesh-list
154581391|NCT00924833|Nebivolol|nebivolol|mesh-list
154581392|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154581393|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154581394|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
154581395|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581396|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581397|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581398|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154581399|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
154581400|NCT00924833|Protective Agents|protective agents|mesh-ancestor
154581401|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154581402|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154581403|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154581404|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
154581405|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154581406|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154581407|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154581408|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154581409|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154581410|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154581412|NCT00835211|Coagulants|coagulants|mesh-ancestor
154581413|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154581414|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
154581415|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581416|NCT00834977|Amlodipine|amlodipine|mesh-list
154581417|NCT00834977|Benazepril|benazepril|mesh-list
154581418|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154581419|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154581420|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154581421|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581422|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154581423|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581424|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
154581425|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154581426|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
154581427|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581428|NCT05227664|Paclitaxel|paclitaxel|mesh-list
154581429|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154581430|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154581431|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581432|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581433|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581434|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581435|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581436|NCT00834743|Metformin|metformin|mesh-list
154581437|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581438|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581439|NCT00834587|Metformin|metformin|mesh-list
154581440|NCT00834587|Glipizide|glipizide|mesh-list
154581441|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581442|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581443|NCT00834431|Famciclovir|famciclovir|mesh-list
154581444|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
154581445|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581446|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154581447|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581448|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581449|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154581450|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154581451|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581452|NCT00834275|Cefadroxil|cefadroxil|mesh-list
154581453|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154581454|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581455|NCT00834197|Mirtazapine|mirtazapine|mesh-list
154581456|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
154581457|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154581458|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154581459|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
154581460|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
154581461|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581462|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581463|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581464|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154581465|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154581466|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581467|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154581468|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154581469|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154581470|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
154581471|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154581472|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154581473|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
154581474|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154581475|NCT00833495|Prednisolone|prednisolone|mesh-list
154581476|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154862207|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862208|NCT00940901|Urological Agents|urological agents|mesh-ancestor
154862209|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154862210|NCT04353713|Laxatives|laxatives|mesh-ancestor
154581477|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
154581478|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154581479|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
154581480|NCT00833495|Prednisone|prednisone|mesh-list
154581481|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154581482|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
154581483|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581484|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
154581485|NCT00833495|Hormones|hormones|mesh-ancestor
154581486|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581487|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581488|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154581489|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581490|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
154581491|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
154581492|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581493|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581494|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154581495|NCT00833495|Protective Agents|protective agents|mesh-ancestor
154581496|NCT00830219|Ropinirole|ropinirole|mesh-list
154581497|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154581498|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154581499|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
154581500|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
154581501|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581502|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581503|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581504|NCT02274766|Amantadine|amantadine|mesh-list
154581505|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154581506|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154581507|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
154581508|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581509|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
154581510|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581511|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581512|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581513|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154581514|NCT02274766|Analgesics|analgesics|mesh-ancestor
154581515|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
154581516|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581517|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154581518|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154581519|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581520|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154581521|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154581522|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154581523|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581524|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
154581525|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581526|NCT05221658|Cisplatin|cisplatin|mesh-list
154581527|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581528|NCT05132114|Lugol's solution|lugol's solution|mesh-list
154581529|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
154581530|NCT05132114|Coagulants|coagulants|mesh-ancestor
154581531|NCT02370238|Paclitaxel|paclitaxel|mesh-list
154581532|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154581533|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581534|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581535|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581536|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581537|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581538|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
154581539|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154581540|NCT05109104|Protective Agents|protective agents|mesh-ancestor
154581541|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581542|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
154581543|NCT05126342|Niraparib|niraparib|mesh-list
154581544|NCT05126342|Dostarlimab|dostarlimab|mesh-list
154160840|NCT00496197|Anidulafungin|anidulafungin|mesh-list
154581545|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154581546|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581547|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581548|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581549|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
154581550|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154581551|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581552|NCT05180708|Sirolimus|sirolimus|mesh-list
154581553|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154581554|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581555|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154581556|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581557|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
154581558|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154581559|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
154581560|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581561|NCT02273752|Everolimus|everolimus|mesh-list
154581562|NCT02273752|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154581563|NCT02273752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154581564|NCT02273752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581565|NCT02273752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581566|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154581567|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
154581568|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581569|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581570|NCT05102552|Huperzine A|huperzine a|mesh-list
154581571|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154581572|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581573|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581574|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
154581575|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581576|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581577|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154581578|NCT05102552|Protective Agents|protective agents|mesh-ancestor
154581579|NCT02273050|Metformin|metformin|mesh-list
154581580|NCT02273050|Saxagliptin|saxagliptin|mesh-list
154581581|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581582|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581583|NCT02273050|Incretins|incretins|mesh-ancestor
154581584|NCT02273050|Hormones|hormones|mesh-ancestor
154581585|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581586|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154581587|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
154581588|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581589|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581590|NCT02272816|Carboplatin|carboplatin|mesh-list
154581591|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581592|NCT05170256|Trastuzumab|trastuzumab|mesh-list
154581593|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581594|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581595|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
154581596|NCT05386979|Anesthetics|anesthetics|mesh-list
154581597|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581598|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581599|NCT05386979|Narcotics|narcotics|mesh-ancestor
154581600|NCT05386979|Analgesics|analgesics|mesh-ancestor
154581601|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
154581602|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581603|NCT02367352|Paclitaxel|paclitaxel|mesh-list
154581604|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154581605|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581606|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581607|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581608|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581609|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581610|NCT02270944|Vaccines|vaccines|mesh-list
154581611|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
154581612|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581613|NCT05648734|Pirfenidone|pirfenidone|mesh-list
154581614|NCT05648734|Colchicine|colchicine|mesh-list
154581615|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
154305440|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154581616|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581617|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581618|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581619|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581620|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581621|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581622|NCT05648734|Analgesics|analgesics|mesh-ancestor
154581623|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
154581624|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581625|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581626|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154581627|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154581628|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581630|NCT02365558|Evacetrapib|evacetrapib|mesh-list
154581631|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154581632|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581633|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154581634|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581635|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581636|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154581637|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154581638|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
154581639|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154581640|NCT04875767|Coal Tar|coal tar|mesh-list
154581641|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
154581642|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
154581643|NCT02270242|Aspirin|aspirin|mesh-list
154581644|NCT02270242|Ticagrelor|ticagrelor|mesh-list
154581645|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154581646|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154581647|NCT02270242|Analgesics|analgesics|mesh-ancestor
154581648|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
154581649|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581650|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581651|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581652|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581653|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154581654|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154581655|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581656|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154581657|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154581658|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581659|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
154581660|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154581661|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154581662|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154581663|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
154581664|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581665|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
154581666|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154581667|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581668|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581669|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581670|NCT05648266|Analgesics|analgesics|mesh-list
154581671|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
154581672|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581673|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581674|NCT04992026|Prednisone|prednisone|mesh-list
154581675|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
154581676|NCT04992026|Hormones|hormones|mesh-list
154581677|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154581678|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581679|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
154581680|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581681|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581682|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154581683|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581684|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154581685|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581686|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581687|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
154581688|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154581689|NCT05036798|Lenvatinib|lenvatinib|mesh-list
154581690|NCT05036798|Tislelizumab|tislelizumab|mesh-list
154305516|NCT01336634|Trametinib|trametinib|mesh-list
154581691|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581692|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154581693|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581694|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581695|NCT05036798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581696|NCT05071898|Semaglutide|semaglutide|mesh-list
154581697|NCT05071898|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154581698|NCT05071898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581699|NCT05071898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862211|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581700|NCT04209218|Dexamethasone|dexamethasone|mesh-list
154161001|NCT00419926|Prednisone|prednisone|mesh-list
154581701|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
154581702|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581703|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
154581704|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
154581705|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581706|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581707|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581708|NCT04209218|Hormones|hormones|mesh-ancestor
154581709|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581710|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154581711|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581712|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
154581713|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154581714|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581715|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581716|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581717|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154581718|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
154581719|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154581720|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154581721|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
154581722|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581723|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
154581724|NCT04421300|Protective Agents|protective agents|mesh-ancestor
154581725|NCT02268058|Acetaminophen|acetaminophen|mesh-list
154581726|NCT02268058|Ibuprofen|ibuprofen|mesh-list
154581727|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154581728|NCT02268058|Analgesics|analgesics|mesh-ancestor
154581729|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
154581730|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581731|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581732|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
154581733|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154581734|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581735|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581736|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154581737|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581738|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581739|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
154581740|NCT02267746|Tazarotene|tazarotene|mesh-list
154581741|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
154581742|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
154581743|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
154581744|NCT02267746|Vitamins|vitamins|mesh-ancestor
154581745|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
154581746|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581747|NCT04421534|Lactoferrin|lactoferrin|mesh-list
154581748|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581749|NCT05059028|Oxytocin|oxytocin|mesh-list
154581750|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
154581751|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154581752|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581753|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154581754|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154581755|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154581756|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581757|NCT04215848|Budesonide|budesonide|mesh-list
154581758|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
154581759|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581760|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154581761|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
154581762|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581763|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581764|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154581765|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
154581766|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
154581767|NCT04215848|Hormones|hormones|mesh-ancestor
154581768|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581769|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154581770|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154581771|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154581772|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
154581773|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615814|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
154862212|NCT03565666|Insulin|insulin|mesh-list
154581774|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581776|NCT04215146|Avelumab|avelumab|mesh-list
154581777|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154581778|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581779|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581780|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581781|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581782|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581783|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581784|NCT04959266|Itraconazole|itraconazole|mesh-list
154581785|NCT04959266|Rifampin|rifampin|mesh-list
154581786|NCT04959266|Omeprazole|omeprazole|mesh-list
154581787|NCT04959266|Adavosertib|adavosertib|mesh-list
154581788|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154581789|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581790|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154581791|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581792|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581793|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
154581794|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581795|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154581796|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154581797|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154581798|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
154581799|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581800|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581801|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154581802|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154581803|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
154581804|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154581805|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
154581806|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154581807|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154581808|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154581809|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154581810|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154581811|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154581812|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154581813|NCT04945148|Metformin|metformin|mesh-list
154581814|NCT04945148|Temozolomide|temozolomide|mesh-list
154581815|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581816|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581817|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154581818|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
154581819|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581820|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581821|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154581822|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154581823|NCT05003570|Fentanyl|fentanyl|mesh-list
154581824|NCT05003570|Remifentanil|remifentanil|mesh-list
154581825|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154581826|NCT05003570|Narcotics|narcotics|mesh-ancestor
154581827|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581828|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581829|NCT05003570|Analgesics|analgesics|mesh-ancestor
154581830|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
154581831|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581832|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154581833|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154581834|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
154581835|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
154581836|NCT02483078|Leronlimab|leronlimab|mesh-list
154581837|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154581838|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154305669|NCT01169415|Hormones|hormones|mesh-ancestor
154581839|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581840|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154581841|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154581842|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
154581843|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581844|NCT02452190|Reslizumab|reslizumab|mesh-list
154581845|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153615947|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
154581846|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
154862213|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154862214|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
154862215|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
154862216|NCT03565666|Pancrelipase|pancrelipase|mesh-list
154862217|NCT03565666|Pancreatin|pancreatin|mesh-list
154581847|NCT02514122|Ketamine|ketamine|mesh-list
154581848|NCT02514122|Analgesics|analgesics|mesh-ancestor
154581849|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
154581850|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581851|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581852|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154581853|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154581854|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
154581855|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
154581856|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154581857|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154581858|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154581859|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154581860|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581861|NCT00730639|Nivolumab|nivolumab|mesh-list
154581862|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581863|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581864|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154581865|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581866|NCT04462003|Enoxaparin|enoxaparin|mesh-list
154581867|NCT04462003|Apixaban|apixaban|mesh-list
154581868|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
154581869|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154581870|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154581871|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581872|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154581873|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
154581874|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154581875|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
154581876|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581877|NCT03489265|Eluxadoline|eluxadoline|mesh-list
154581878|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581879|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
154581880|NCT03344341|Acarbose|acarbose|mesh-list
154581881|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154581882|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581883|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581884|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581885|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154581886|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581887|NCT03238495|Metformin|metformin|mesh-list
154581888|NCT03238495|Carboplatin|carboplatin|mesh-list
154581889|NCT03238495|Docetaxel|docetaxel|mesh-list
154581890|NCT03238495|Trastuzumab|trastuzumab|mesh-list
154581891|NCT03238495|Pertuzumab|pertuzumab|mesh-list
154581892|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581893|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581894|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581895|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
154581896|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581897|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581898|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581899|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581900|NCT02536339|Trastuzumab|trastuzumab|mesh-list
154581901|NCT02536339|Pertuzumab|pertuzumab|mesh-list
154581902|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581903|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581904|NCT01869361|Indomethacin|indomethacin|mesh-list
154581905|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154581906|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154581907|NCT01869361|Analgesics|analgesics|mesh-ancestor
154581908|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
154581909|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581910|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581911|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862218|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154862219|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862220|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581912|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581913|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
154581914|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
154581915|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154581916|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154581917|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581918|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581919|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
154581920|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154581921|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581922|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154581923|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154581924|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154581925|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581926|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581927|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154581928|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581929|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581930|NCT01578967|Immunotoxins|immunotoxins|mesh-ancestor
154581931|NCT01578967|Immunoconjugates|immunoconjugates|mesh-ancestor
154581932|NCT01578967|Immunologic Factors|immunologic factors|mesh-ancestor
154581933|NCT01578967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581934|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
154581935|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154581936|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581937|NCT02322853|Tamoxifen|tamoxifen|mesh-list
154581938|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154581939|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
154581940|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581941|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581942|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154581943|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581944|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154581945|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154581946|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154581947|NCT03496831|Adalimumab|adalimumab|mesh-list
154581948|NCT03496831|Infliximab|infliximab|mesh-list
154581949|NCT03496831|Golimumab|golimumab|mesh-list
154581950|NCT03496831|Etanercept|etanercept|mesh-list
154581951|NCT03496831|Abatacept|abatacept|mesh-list
154581952|NCT03496831|Ustekinumab|ustekinumab|mesh-list
154581953|NCT03496831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154581954|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581955|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
154581956|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581957|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154581958|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154581959|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581960|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
154581961|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581962|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154581963|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154581964|NCT03496831|Analgesics|analgesics|mesh-ancestor
154581965|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
154581966|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581967|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154581968|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154581969|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581970|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
154581971|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
154581972|NCT03488485|Ledipasvir|ledipasvir|mesh-list
154581973|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581974|NCT00821249|Dexamethasone|dexamethasone|mesh-list
154581975|NCT00821249|Filanesib|filanesib|mesh-list
154581976|NCT00821249|Lenograstim|lenograstim|mesh-list
154581977|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154581978|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
154581979|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
154581980|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154581981|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154581982|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154581983|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
154581984|NCT00821249|Hormones|hormones|mesh-ancestor
154581985|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154581986|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154581987|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154581988|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154862221|NCT03620890|Protamines|protamines|mesh-list
154581989|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
154581990|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
154581991|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
154581992|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154581993|NCT04472585|Ivermectin|ivermectin|mesh-list
154581994|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154581995|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154581996|NCT03496519|Durvalumab|durvalumab|mesh-list
154581997|NCT03496519|Trabectedin|trabectedin|mesh-list
154581998|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154581999|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582000|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161309|NCT00974012|Valproic Acid|valproic acid|mesh-list
154582001|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
154582002|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582003|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154582004|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
154582005|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582006|NCT00813605|Conatumumab|conatumumab|mesh-list
154582007|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582008|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582009|NCT00724841|Temozolomide|temozolomide|mesh-list
154582010|NCT00724841|Obatoclax|obatoclax|mesh-list
154582011|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154582012|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
154582013|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582014|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582015|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582016|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
154582017|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154582018|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154582019|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154582020|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582021|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582022|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
154582023|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582024|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582025|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154582026|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582027|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154582028|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
154582029|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
154582030|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582031|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582032|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154582033|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154582034|NCT00805805|Growth Substances|growth substances|mesh-ancestor
154582035|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582036|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
154582037|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582038|NCT03488173|Lansoprazole|lansoprazole|mesh-list
154582039|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
154582040|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154582041|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154582042|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154582043|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582044|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582045|NCT04750759|Niclosamide|niclosamide|mesh-list
154582046|NCT04750759|Camostat|camostat|mesh-list
154582047|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
154582048|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582049|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582050|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154582051|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154582052|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
154582053|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154582054|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
154582055|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154582056|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582057|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
154582058|NCT03382925|Triamcinolone|triamcinolone|mesh-list
154582059|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154582060|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154582061|NCT03382925|Lidocaine|lidocaine|mesh-list
154582062|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154582063|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
154582064|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
154305887|NCT01174953|Finasteride|finasteride|mesh-list
154862222|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
154862223|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862224|NCT03620890|Coagulants|coagulants|mesh-ancestor
154862225|NCT05507112|Capecitabine|capecitabine|mesh-list
154862226|NCT05507112|Tislelizumab|tislelizumab|mesh-list
154862227|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154862228|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154582065|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582066|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582067|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
154582068|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582069|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154582070|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154582071|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154582072|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582073|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582074|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582075|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
154862229|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
154862230|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862231|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582076|NCT03382925|Hormones|hormones|mesh-ancestor
154582077|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582078|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154582079|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
154582080|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582081|NCT03487939|Fluorouracil|fluorouracil|mesh-list
154582082|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
154582083|NCT03487939|Irinotecan|irinotecan|mesh-list
154582084|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
154582085|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582086|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154582087|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582088|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154582089|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
154161413|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
154582090|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582091|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154582092|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154582093|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582094|NCT00796289|Citric Acid|citric acid|mesh-list
154582095|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
154582096|NCT00796289|Clomiphene|clomiphene|mesh-list
154582097|NCT00796289|Enclomiphene|enclomiphene|mesh-list
154582098|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
154582099|NCT00796289|Hormones|hormones|mesh-list
154582100|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154582101|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
154582102|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154582103|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
154582104|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
154582105|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582106|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582107|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582108|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154582109|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
154582110|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154582111|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
154582112|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154582113|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154582114|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154582115|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
154582116|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
154582117|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582118|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
154582119|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154582120|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
154582121|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582122|NCT04460521|Expectorants|expectorants|mesh-ancestor
154582123|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
154582124|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154582125|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
154582126|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582127|NCT04460521|Protective Agents|protective agents|mesh-ancestor
154582128|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616363|NCT06327399|Sympathomimetics|sympathomimetics|mesh-ancestor
154582130|NCT00698789|Metformin|metformin|mesh-list
154582131|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154582132|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582133|NCT03487783|Aripiprazole|aripiprazole|mesh-list
154582134|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154582135|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
154582136|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154582137|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154582138|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154582139|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582140|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582141|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
154582142|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
154582143|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582144|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582145|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154582146|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154582147|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
154582148|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154582149|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154582150|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154582151|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154582152|NCT03495739|Dabigatran|dabigatran|mesh-list
154582153|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
154582154|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154582155|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
154582156|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582157|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582158|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
154582159|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154582160|NCT04071613|Plasminogen|plasminogen|mesh-list
154582161|NCT04071613|Tenecteplase|tenecteplase|mesh-list
154582162|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154582163|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154582164|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582165|NCT00678119|Sunitinib|sunitinib|mesh-list
154582166|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582167|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154582168|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154582169|NCT00678119|Growth Substances|growth substances|mesh-ancestor
154582170|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582171|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
154582172|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154582173|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582174|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582175|NCT02812667|Nivolumab|nivolumab|mesh-list
154582176|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582177|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582178|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154582179|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582180|NCT02011321|Clevidipine|clevidipine|mesh-list
154582181|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154582182|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582183|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582184|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154582185|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582186|NCT01352585|Anagrelide|anagrelide|mesh-list
154582187|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154582188|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154582189|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582190|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154582191|NCT02773355|Liraglutide|liraglutide|mesh-list
154582192|NCT02773355|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154582193|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154582194|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582195|NCT02773355|Incretins|incretins|mesh-ancestor
154582196|NCT02773355|Hormones|hormones|mesh-ancestor
154582197|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582198|NCT02744183|Benzocaine|benzocaine|mesh-list
154582199|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
154582200|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
154582201|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582202|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582203|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
154582204|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582206|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
154582207|NCT03484195|Irinotecan|irinotecan|mesh-list
154582208|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
154582209|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582210|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154582211|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582212|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154582213|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
154582214|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582215|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154582216|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154582217|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582218|NCT04526821|Lactoferrin|lactoferrin|mesh-list
154582219|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582220|NCT02323399|Phenylephrine|phenylephrine|mesh-list
154582221|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
154582222|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154582223|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
154582224|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
154582225|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582226|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582227|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
154582228|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154582229|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
154582230|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
154582231|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154582232|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154582233|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154582234|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
154582235|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582236|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582237|NCT02323399|Protective Agents|protective agents|mesh-ancestor
154582238|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
154582239|NCT01352507|Tadalafil|tadalafil|mesh-list
154582240|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
154582241|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154582242|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154582243|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582244|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582245|NCT01352507|Urological Agents|urological agents|mesh-ancestor
154582246|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
154582247|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154582248|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154582249|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
154582250|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582251|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582252|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154582253|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
154582254|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154582255|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
154582256|NCT04460963|Protective Agents|protective agents|mesh-ancestor
154582257|NCT00873275|Leucovorin|leucovorin|mesh-list
154582258|NCT00873275|Bevacizumab|bevacizumab|mesh-list
154582259|NCT00873275|Fluorouracil|fluorouracil|mesh-list
154582260|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
154582261|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154582262|NCT00873275|Calcium|calcium|mesh-list
154582263|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
154582264|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582265|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582266|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154582267|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154582268|NCT00873275|Growth Substances|growth substances|mesh-ancestor
154582269|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582270|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
154582271|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154582272|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
154582273|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582274|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154582275|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154582276|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
154582277|NCT00873275|Antidotes|antidotes|mesh-ancestor
154582278|NCT00873275|Protective Agents|protective agents|mesh-ancestor
154582279|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
154582280|NCT00873275|Vitamins|vitamins|mesh-ancestor
154582281|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
154582282|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154582283|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154582284|NCT04403243|Colchicine|colchicine|mesh-list
154582285|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
154582286|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582287|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
154582288|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
154582289|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582290|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582291|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582292|NCT05648032|Triamcinolone|triamcinolone|mesh-list
154582293|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154582294|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154582295|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154582296|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582297|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
154582298|NCT05648032|Hormones|hormones|mesh-ancestor
154582299|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582300|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582301|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154582302|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
154582303|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582304|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582305|NCT00774761|Fluticasone|fluticasone|mesh-list
154582306|NCT00774761|Xhance|xhance|mesh-list
154161620|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
154582307|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
154582308|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582309|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154582310|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
154582311|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582312|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582313|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154582314|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
154582315|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
154582316|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154582317|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154582318|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154582319|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154582320|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
154582321|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582322|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582323|NCT00772343|Vaccines|vaccines|mesh-list
154582324|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
154582325|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582326|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
154582327|NCT05647954|Temozolomide|temozolomide|mesh-list
154582328|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
154582329|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582330|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582331|NCT05647954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154582332|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582333|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154582334|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
154582335|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154582336|NCT05647954|Estrogens|estrogens|mesh-ancestor
154582337|NCT05647954|Hormones|hormones|mesh-ancestor
154582338|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582339|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582340|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154582341|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154582342|NCT00770081|Vildagliptin|vildagliptin|mesh-list
154582343|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154582344|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582345|NCT00770081|Incretins|incretins|mesh-ancestor
154582346|NCT00770081|Hormones|hormones|mesh-ancestor
154161667|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582347|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582348|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154582349|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
154582350|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582351|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582352|NCT02360098|Anesthetics|anesthetics|mesh-list
154582353|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582354|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582355|NCT02273609|Vitamin K|vitamin k|mesh-list
154582356|NCT02273609|Warfarin|warfarin|mesh-list
154582357|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
154582358|NCT02273609|Vitamins|vitamins|mesh-ancestor
154582359|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
154582360|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582361|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
154582362|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154582363|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154582364|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582365|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
154582366|NCT02273609|Coagulants|coagulants|mesh-ancestor
154306188|NCT06008223|Pyridoxal|pyridoxal|mesh-list
154582367|NCT02273843|Vitamin D|vitamin d|mesh-list
154582368|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
154582369|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
154582370|NCT02273843|Vitamins|vitamins|mesh-list
154582371|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
154582372|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582373|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154582374|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154582375|NCT00666497|Azacitidine|azacitidine|mesh-list
154582376|NCT00666497|Mocetinostat|mocetinostat|mesh-list
154582377|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154582378|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
154582379|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582380|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582381|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582382|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154582383|NCT02274077|Bupivacaine|bupivacaine|mesh-list
154582384|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
154582385|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
154582386|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582387|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582388|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
154582389|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582390|NCT00765323|Octreotide|octreotide|mesh-list
154582391|NCT00765323|Somatostatin|somatostatin|mesh-list
154582392|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154582393|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154582394|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582395|NCT00765323|Hormones|hormones|mesh-ancestor
154582396|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582397|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582398|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
154582399|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154582400|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154582401|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154582402|NCT02277587|Cortisone|cortisone|mesh-list
154582403|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
154582404|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582405|NCT02277587|Hormones|hormones|mesh-ancestor
154582406|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582407|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582408|NCT00663767|Celecoxib|celecoxib|mesh-list
154582409|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154582410|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154582411|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154582412|NCT00663767|Analgesics|analgesics|mesh-ancestor
154582413|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
154582414|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582415|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582416|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582417|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582418|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154582419|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582420|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582421|NCT00662597|Paclitaxel|paclitaxel|mesh-list
154582422|NCT00662597|Carboplatin|carboplatin|mesh-list
154582423|NCT00662597|Vadimezan|vadimezan|mesh-list
154582424|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154862232|NCT05507112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582425|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582426|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
154582427|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
154582428|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582429|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582430|NCT02266888|Rituximab|rituximab|mesh-list
154582431|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582432|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582433|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
154582434|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582435|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582436|NCT01641952|Rituximab|rituximab|mesh-list
154582437|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582438|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582439|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
154582440|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582441|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582442|NCT00660881|Epratuzumab|epratuzumab|mesh-list
154582443|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582444|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582445|NCT02359552|Rasagiline|rasagiline|mesh-list
154582446|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154582447|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582448|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582449|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154582450|NCT02359552|Protective Agents|protective agents|mesh-ancestor
154582451|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582452|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
154582453|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154582454|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154582455|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154582456|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582457|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582458|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
154582459|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582460|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582461|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154582462|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582463|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
154582464|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154582465|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154582466|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154582467|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582468|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582469|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
154582470|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582471|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582472|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154582473|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582474|NCT00656357|Cocaine|cocaine|mesh-list
154582475|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
154582476|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
154582477|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582478|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582479|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
154582480|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582481|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154582482|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154582483|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154582484|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582485|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582486|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
154582487|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582488|NCT02280629|Mesalamine|mesalamine|mesh-list
154582489|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154582490|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154582491|NCT02280629|Analgesics|analgesics|mesh-ancestor
154582492|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
154582493|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582494|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582495|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582496|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582497|NCT03134573|Interferons|interferons|mesh-list
154582498|NCT03134573|Interferon-beta|interferon-beta|mesh-list
154582499|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
154582500|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582501|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
154862234|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
154582502|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582503|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
154582504|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582505|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154582506|NCT00743795|Ribavirin|ribavirin|mesh-list
154582507|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154582508|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
154582509|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582510|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
154582511|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582512|NCT04232033|Mitogens|mitogens|mesh-list
154582513|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582514|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582515|NCT03134417|Vitamin D|vitamin d|mesh-list
154582516|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
154582517|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
154582518|NCT03134417|Vitamins|vitamins|mesh-list
154582519|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
154582520|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582521|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154862235|NCT00952133|Palonosetron|palonosetron|mesh-list
154862236|NCT00952133|BB 1101|bb 1101|mesh-list
154582522|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154582523|NCT00649025|Fluticasone|fluticasone|mesh-list
154582524|NCT00649025|Xhance|xhance|mesh-list
154582525|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582526|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154582527|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
154582528|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582529|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582530|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154582531|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
154582532|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
154582533|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154582534|NCT00647231|Ketoprofen|ketoprofen|mesh-list
154582535|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154582536|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154582537|NCT00647231|Analgesics|analgesics|mesh-ancestor
154582538|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
154582539|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582540|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582541|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582542|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582543|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154582544|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862237|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862238|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
154862239|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
154862240|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862241|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862242|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154862243|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
154862244|NCT00952133|Hormones|hormones|mesh-ancestor
154862245|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154862246|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154862247|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862248|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
154862249|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862250|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582545|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582546|NCT00739349|Cyclosporine|cyclosporine|mesh-list
154582547|NCT00739349|Cyclosporins|cyclosporins|mesh-list
154582548|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582549|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582550|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154582551|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
154582552|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582553|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
154582554|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582555|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
154582556|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582557|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154582558|NCT00152009|Guanfacine|guanfacine|mesh-list
154582559|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154582560|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154582561|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154582562|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154582563|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
154582564|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582565|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582566|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582567|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154582568|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582569|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582570|NCT02280785|Immunotoxins|immunotoxins|mesh-ancestor
154582571|NCT02280785|Immunoconjugates|immunoconjugates|mesh-ancestor
154582572|NCT02280785|Immunologic Factors|immunologic factors|mesh-ancestor
154582573|NCT02280785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582574|NCT00734435|Zonisamide|zonisamide|mesh-list
154582575|NCT00734435|Olanzapine|olanzapine|mesh-list
154582576|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
154582577|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
154582578|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582579|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582580|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154582581|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154582582|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154582583|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582584|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154582585|NCT00734435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154582586|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154582587|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582588|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582589|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582590|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
154582591|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
154582592|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154582593|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154582594|NCT00728351|Metformin|metformin|mesh-list
154582595|NCT00728351|Vildagliptin|vildagliptin|mesh-list
154582596|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154582597|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582598|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154582599|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
154582600|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582601|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582602|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154582603|NCT00616811|Vildagliptin|vildagliptin|mesh-list
154582604|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154582605|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582606|NCT00616811|Incretins|incretins|mesh-ancestor
154582607|NCT00616811|Hormones|hormones|mesh-ancestor
154582608|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582609|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154582610|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
154582611|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582612|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582613|NCT00615251|Progesterone|progesterone|mesh-list
154582614|NCT00615251|Progestins|progestins|mesh-ancestor
154582615|NCT00615251|Hormones|hormones|mesh-ancestor
154582616|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582617|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582618|NCT02265796|Ranolazine|ranolazine|mesh-list
154582619|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154582620|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582621|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582622|NCT05647642|Midazolam|midazolam|mesh-list
154582623|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
154582624|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154582625|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582626|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582627|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154582628|NCT05647642|Analgesics|analgesics|mesh-ancestor
154582629|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
154582630|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582631|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154862251|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154582632|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154582633|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154582634|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
154582635|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582636|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582637|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154582638|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154582639|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154582640|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154582641|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154582642|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
154582643|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
154582644|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
154582645|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
154582646|NCT02357368|Copper|copper|mesh-list
154582647|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154582648|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
154582649|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
154582650|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
154582651|NCT02357368|Etonogestrel|etonogestrel|mesh-list
154582652|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154582653|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582654|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154582655|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154582656|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154582657|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154582658|NCT02357368|Trace Elements|trace elements|mesh-ancestor
154582659|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
154582660|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154582661|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154582662|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154582663|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582664|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
154582665|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154582666|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582667|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154582668|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154582669|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582670|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582671|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582672|NCT05647408|Dexamethasone|dexamethasone|mesh-list
154582673|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582674|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
154582675|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
154582676|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582677|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582678|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154582679|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
154582680|NCT05647408|Hormones|hormones|mesh-ancestor
154582681|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582682|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154582683|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582684|NCT05984953|Evolocumab|evolocumab|mesh-list
154582685|NCT05984953|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154162025|NCT00077857|Docetaxel|docetaxel|mesh-list
154582686|NCT05984953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154582687|NCT05984953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154582688|NCT05984953|Antimetabolites|antimetabolites|mesh-ancestor
154582689|NCT05984953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582690|NCT05984953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154582691|NCT05984953|Protease Inhibitors|protease inhibitors|mesh-ancestor
154582692|NCT05984953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582693|NCT05984953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154582694|NCT05984745|Ubiquinone|ubiquinone|mesh-list
154582695|NCT05984745|Coenzyme Q10|coenzyme q10|mesh-list
154582696|NCT05984745|Micronutrients|micronutrients|mesh-ancestor
154582697|NCT05984745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582698|NCT05984745|Vitamins|vitamins|mesh-ancestor
154582699|NCT05984602|Paclitaxel|paclitaxel|mesh-list
154582700|NCT05984602|Gemcitabine|gemcitabine|mesh-list
154582701|NCT05984602|Tislelizumab|tislelizumab|mesh-list
154582702|NCT05984602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154582703|NCT05984602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582704|NCT05984602|Tubulin Modulators|tubulin modulators|mesh-ancestor
154582705|NCT05984602|Antimitotic Agents|antimitotic agents|mesh-ancestor
154582706|NCT05984602|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582707|NCT05984602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582708|NCT05984602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154862252|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154862253|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
154582709|NCT05984602|Antimetabolites|antimetabolites|mesh-ancestor
154582710|NCT05984602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582711|NCT05984537|Heparin|heparin|mesh-list
154582712|NCT05984537|Calcium heparin|calcium heparin|mesh-list
154582713|NCT05984537|Hirudins|hirudins|mesh-list
154582714|NCT05984537|Bivalirudin|bivalirudin|mesh-list
154582715|NCT05984537|Anticoagulants|anticoagulants|mesh-ancestor
154582716|NCT05984537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154582717|NCT05984537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154582718|NCT05984537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582719|NCT05984537|Antithrombins|antithrombins|mesh-ancestor
154582720|NCT05984537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154582721|NCT05984537|Protease Inhibitors|protease inhibitors|mesh-ancestor
154582722|NCT05984537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582723|NCT05984342|Paclitaxel|paclitaxel|mesh-list
154582724|NCT05984342|Cisplatin|cisplatin|mesh-list
154582725|NCT05984342|Tislelizumab|tislelizumab|mesh-list
154582726|NCT05984342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154582727|NCT05984342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582728|NCT05984342|Tubulin Modulators|tubulin modulators|mesh-ancestor
154582729|NCT05984342|Antimitotic Agents|antimitotic agents|mesh-ancestor
154582730|NCT05984342|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582731|NCT05984342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582732|NCT05984342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582733|NCT05984264|Lidocaine|lidocaine|mesh-list
154582734|NCT05984264|Prilocaine|prilocaine|mesh-list
154582735|NCT05984264|Anesthetics, Local|anesthetics, local|mesh-ancestor
154582736|NCT05984264|Anesthetics|anesthetics|mesh-ancestor
154582737|NCT05984264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582738|NCT05984264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582739|NCT05984264|Sensory System Agents|sensory system agents|mesh-ancestor
154582740|NCT05984264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582741|NCT05984264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154582742|NCT05984264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154162069|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
154582743|NCT05984264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154582744|NCT05984264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154582745|NCT05984264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582746|NCT05984212|Dexmedetomidine|dexmedetomidine|mesh-list
154582747|NCT05984212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154582748|NCT05984212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582749|NCT05984212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582750|NCT05984212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154582751|NCT05984212|Analgesics|analgesics|mesh-ancestor
154582752|NCT05984212|Sensory System Agents|sensory system agents|mesh-ancestor
154582753|NCT05984212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582754|NCT05984212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154582755|NCT05984212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154582756|NCT05984212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154582757|NCT05984212|Adrenergic Agents|adrenergic agents|mesh-ancestor
154582758|NCT05984212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582759|NCT05984212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582761|NCT05984173|Tocopherols|tocopherols|mesh-list
154582762|NCT05984173|Vitamins|vitamins|mesh-ancestor
154582763|NCT05984173|Micronutrients|micronutrients|mesh-ancestor
154582764|NCT05984173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582765|NCT05984173|Antioxidants|antioxidants|mesh-ancestor
154582766|NCT05984173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582767|NCT05984173|Protective Agents|protective agents|mesh-ancestor
154582768|NCT05983874|MEDI9197|medi9197|mesh-list
154582769|NCT05983874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154582770|NCT05983874|Immunologic Factors|immunologic factors|mesh-ancestor
154582771|NCT05983874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582772|NCT05983783|Docetaxel|docetaxel|mesh-list
154582773|NCT05983783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582774|NCT05983783|Tubulin Modulators|tubulin modulators|mesh-ancestor
154582775|NCT05983783|Antimitotic Agents|antimitotic agents|mesh-ancestor
154582776|NCT05983783|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582777|NCT05983783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582778|NCT05983471|Suplatast tosilate|suplatast tosilate|mesh-list
154582779|NCT05983471|Histamine Antagonists|histamine antagonists|mesh-ancestor
154582780|NCT05983471|Histamine Agents|histamine agents|mesh-ancestor
154582781|NCT05983471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582782|NCT05983471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617828|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
154862254|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154862255|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
154862256|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154862257|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582783|NCT05983471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582784|NCT05983471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154582785|NCT05983445|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154582786|NCT05983445|Betamethasone|betamethasone|mesh-list
154582787|NCT05983445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582788|NCT05983445|Glucocorticoids|glucocorticoids|mesh-ancestor
154582789|NCT05983445|Hormones|hormones|mesh-ancestor
154582790|NCT05983445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582791|NCT05983445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582792|NCT05983445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154582793|NCT05983445|Respiratory System Agents|respiratory system agents|mesh-ancestor
154582794|NCT05983263|Capsaicin|capsaicin|mesh-list
154582795|NCT05983263|Antipruritics|antipruritics|mesh-ancestor
154582796|NCT05983263|Dermatologic Agents|dermatologic agents|mesh-ancestor
154582797|NCT05983263|Sensory System Agents|sensory system agents|mesh-ancestor
154582798|NCT05983263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582799|NCT05983263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582800|NCT05983107|Everolimus|everolimus|mesh-list
154582801|NCT05983107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154582802|NCT05983107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154582803|NCT05983107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582804|NCT05983107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582805|NCT05983107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154582806|NCT05983107|Immunologic Factors|immunologic factors|mesh-ancestor
154582807|NCT05983107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582808|NCT05983107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582809|NCT05983094|Carboplatin|carboplatin|mesh-list
154582810|NCT05983094|Trastuzumab|trastuzumab|mesh-list
154582811|NCT05983094|Epirubicin|epirubicin|mesh-list
154582812|NCT05983094|Pertuzumab|pertuzumab|mesh-list
154582813|NCT05983094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582814|NCT05983094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582815|NCT05983094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154582816|NCT05983094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154582817|NCT05983094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154582818|NCT05983094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582819|NCT05983094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582820|NCT05983042|Ibuprofen|ibuprofen|mesh-list
154582821|NCT05983042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154582822|NCT05983042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154582823|NCT05983042|Analgesics|analgesics|mesh-ancestor
154582824|NCT05983042|Sensory System Agents|sensory system agents|mesh-ancestor
154582825|NCT05983042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582826|NCT05983042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582827|NCT05983042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582828|NCT05983042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582829|NCT05983042|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154582830|NCT05983042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582831|NCT05983042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582832|NCT05982834|Tislelizumab|tislelizumab|mesh-list
154582833|NCT05982834|Disitamab vedotin|disitamab vedotin|mesh-list
154582834|NCT05982834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582835|NCT05982834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582836|NCT05982834|Immunoconjugates|immunoconjugates|mesh-ancestor
154582837|NCT05982834|Immunologic Factors|immunologic factors|mesh-ancestor
154582838|NCT05982834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582839|NCT05982756|Bortezomib|bortezomib|mesh-list
154582840|NCT05982756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582841|NCT05969626|Vaccines|vaccines|mesh-list
154582842|NCT05969626|Immunologic Factors|immunologic factors|mesh-ancestor
154582843|NCT05969626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582844|NCT05904106|Azacitidine|azacitidine|mesh-list
154582845|NCT05904106|Venetoclax|venetoclax|mesh-list
154582846|NCT05904106|Gemtuzumab|gemtuzumab|mesh-list
154582847|NCT05904106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154582848|NCT05904106|Antimetabolites|antimetabolites|mesh-ancestor
154582849|NCT05904106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582850|NCT05904106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582851|NCT05904106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582852|NCT05904106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582853|NCT05904106|Immunotoxins|immunotoxins|mesh-ancestor
154582854|NCT05904106|Immunoconjugates|immunoconjugates|mesh-ancestor
154582855|NCT05904106|Immunologic Factors|immunologic factors|mesh-ancestor
154582856|NCT05904106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582857|NCT05831774|Vancomycin|vancomycin|mesh-list
154582858|NCT05831774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154582859|NCT05831774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582860|NCT05824299|Anesthetics|anesthetics|mesh-list
154582861|NCT05824299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154582862|NCT05824299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582863|NCT05817461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154582864|NCT05815173|Sotorasib|sotorasib|mesh-list
154582865|NCT05815173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154582866|NCT05815173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582867|NCT05815173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582868|NCT05815173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582869|NCT05782972|Dapagliflozin|dapagliflozin|mesh-list
154582870|NCT05782972|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154582871|NCT05782972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582872|NCT05782972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154582873|NCT05782972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582874|NCT05736419|Mycophenolic Acid|mycophenolic acid|mesh-list
154582875|NCT05736419|Dexamethasone|dexamethasone|mesh-list
154582876|NCT05736419|Cyclophosphamide|cyclophosphamide|mesh-list
154582877|NCT05736419|Rituximab|rituximab|mesh-list
154582878|NCT05736419|Fludarabine|fludarabine|mesh-list
154582879|NCT05736419|Bortezomib|bortezomib|mesh-list
154582880|NCT05736419|Tacrolimus|tacrolimus|mesh-list
154582881|NCT05736419|Thymoglobulin|thymoglobulin|mesh-list
154582882|NCT05736419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154582883|NCT05736419|Immunologic Factors|immunologic factors|mesh-ancestor
154582884|NCT05736419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582885|NCT05736419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582886|NCT05736419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154582887|NCT05736419|Alkylating Agents|alkylating agents|mesh-ancestor
154582888|NCT05736419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582889|NCT05736419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582890|NCT05736419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154582891|NCT05736419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582892|NCT05736419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154582893|NCT05736419|Antiemetics|antiemetics|mesh-ancestor
154582895|NCT05736419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582896|NCT05736419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154582897|NCT05736419|Glucocorticoids|glucocorticoids|mesh-ancestor
154582898|NCT05736419|Hormones|hormones|mesh-ancestor
154582899|NCT05736419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154582900|NCT05736419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154582901|NCT05736419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154582902|NCT05736419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582903|NCT05736419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154582904|NCT05736419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154582905|NCT05736419|Antitubercular Agents|antitubercular agents|mesh-ancestor
154582906|NCT05736419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154582907|NCT05736419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582908|NCT05729139|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154582909|NCT05729139|Interferon alpha-2|interferon alpha-2|mesh-list
154582910|NCT05729139|Cemiplimab|cemiplimab|mesh-list
154582911|NCT05729139|Antiviral Agents|antiviral agents|mesh-ancestor
154582912|NCT05729139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154582913|NCT05729139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582914|NCT05729139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582915|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154582916|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154582917|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
154582918|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582919|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154582920|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154582921|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154582922|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582923|NCT05688020|Epinephrine|epinephrine|mesh-list
154582924|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
154582925|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154582926|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154582927|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582928|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
154862258|NCT05042375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154862259|NCT05042375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862260|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
154862261|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154862262|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154862263|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862264|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
154582929|NCT05688020|Coagulants|coagulants|mesh-ancestor
154582930|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154582931|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154582932|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
154582933|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154582934|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154582935|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154582936|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154659741|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659742|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154659743|NCT02475369|Pancrelipase|pancrelipase|mesh-list
154659744|NCT02475369|Pancreatin|pancreatin|mesh-list
154659745|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659746|NCT02474589|Tecovirimat|tecovirimat|mesh-list
154659747|NCT02474589|Antiviral Agents|antiviral agents|mesh-ancestor
154659748|NCT02474589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659749|NCT02474355|Osimertinib|osimertinib|mesh-list
154659750|NCT02474355|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154659751|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154659752|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659753|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659754|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659755|NCT02474199|Acetaminophen|acetaminophen|mesh-list
154659756|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
154659757|NCT02474199|Promethazine|promethazine|mesh-list
154659758|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659759|NCT02474199|Analgesics|analgesics|mesh-ancestor
154659760|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
154659761|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659762|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659763|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
154659764|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154659765|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154659766|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659767|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
154659768|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
154659769|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
154659770|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
154659771|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659772|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154659773|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
154659774|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
154659775|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659776|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659777|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154659778|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
154659779|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
154659780|NCT02450487|Piroxicam|piroxicam|mesh-list
154659781|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154659782|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659783|NCT02450487|Analgesics|analgesics|mesh-ancestor
154659784|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
154659785|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659786|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659787|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659788|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659789|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154659790|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659791|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659792|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
154659793|NCT02506881|Hematinics|hematinics|mesh-ancestor
154659794|NCT02506257|Biguanides|biguanides|mesh-list
154659795|NCT02506257|Polihexanide|polihexanide|mesh-list
154411783|NCT01349335|Tolvaptan|tolvaptan|mesh-list
154659796|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154659797|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659798|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
154659799|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659800|NCT02505945|Omeprazole|omeprazole|mesh-list
154659801|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154659802|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659803|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154659804|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659805|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659806|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
154659807|NCT02448771|Palbociclib|palbociclib|mesh-list
154659808|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659809|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154659810|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659811|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659812|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154659813|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154659814|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
154659815|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659816|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659817|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154659818|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
154659819|NCT02504541|Testosterone|testosterone|mesh-list
154659820|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
154659821|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
154659822|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154659823|NCT02504541|Androgens|androgens|mesh-ancestor
154659824|NCT02504541|Hormones|hormones|mesh-ancestor
154659825|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154659826|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659827|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154659828|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659829|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
154659830|NCT04924257|Esketamine|esketamine|mesh-list
154659831|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
154659832|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154659833|NCT04924179|Tislelizumab|tislelizumab|mesh-list
154659834|NCT04924179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154659835|NCT04924179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659836|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
154659837|NCT04975945|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154659838|NCT04975945|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154659839|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154659840|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659841|NCT03063307|Fluorides|fluorides|mesh-list
154162384|NCT00985556|Capecitabine|capecitabine|mesh-list
154659842|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
154659843|NCT03063307|Protective Agents|protective agents|mesh-ancestor
154659844|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659845|NCT04874935|Lansoprazole|lansoprazole|mesh-list
154659846|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
154659847|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154659848|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154659849|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154659850|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659851|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659852|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
154659853|NCT02961361|Ropivacaine|ropivacaine|mesh-list
154659854|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154659855|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154659856|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659857|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659858|NCT02961361|Analgesics|analgesics|mesh-ancestor
154659859|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
154659860|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659861|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154659862|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154659863|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154659864|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
154659865|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659866|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659867|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
154659868|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
154659869|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
154659870|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
154659871|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659872|NCT02426281|Paclitaxel|paclitaxel|mesh-list
154659873|NCT02426281|Gemcitabine|gemcitabine|mesh-list
154659874|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154659875|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659877|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
154659878|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
154659879|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659880|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154659881|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
154659882|NCT02448537|Gemcitabine|gemcitabine|mesh-list
154659883|NCT02448537|Doxorubicin|doxorubicin|mesh-list
154659884|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154659885|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154659886|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
154659887|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659888|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659889|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154659890|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154659891|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154659892|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659893|NCT03060265|Acetaminophen|acetaminophen|mesh-list
154659894|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659895|NCT03060265|Analgesics|analgesics|mesh-ancestor
154659896|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
154659897|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659898|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659899|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
154659900|NCT02504151|Cannabidiol|cannabidiol|mesh-list
154659901|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
154659902|NCT02448381|Hypericin|hypericin|mesh-list
154659903|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
154659904|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154659905|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154659906|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
154659907|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659908|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659909|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659910|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154659911|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
154659912|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659913|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
154659914|NCT02448225|Fluorides|fluorides|mesh-list
154659915|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154659916|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
154659917|NCT02448225|Protective Agents|protective agents|mesh-ancestor
154659918|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659919|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154659920|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659921|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
154659922|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
154659923|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659924|NCT02447991|Rizatriptan|rizatriptan|mesh-list
154659925|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154659926|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
154659927|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659928|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659929|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659930|NCT02586155|Atorvastatin|atorvastatin|mesh-list
154659931|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154659932|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154659933|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154659934|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
154659935|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659936|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154659937|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154659938|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659939|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
154659940|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
154659941|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154659942|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
154659943|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659944|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
154659945|NCT05536661|Protective Agents|protective agents|mesh-ancestor
154659946|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154659947|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154411945|NCT01543633|Propofol|propofol|mesh-list
154659948|NCT05536271|Bisoprolol|bisoprolol|mesh-list
154659949|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154659951|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
154659952|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659953|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659954|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154659955|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154659956|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154659957|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
154659958|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154659959|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659960|NCT05536193|Metformin|metformin|mesh-list
154659961|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
154659962|NCT05536193|Salicylates|salicylates|mesh-list
154659963|NCT05536193|Mitogens|mitogens|mesh-list
154659964|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154659965|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154659966|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
154659967|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659968|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659969|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
154659970|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
154659971|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
154659972|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154659973|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154659974|NCT05536193|Analgesics|analgesics|mesh-ancestor
154659975|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
154659976|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154659977|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154659978|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659979|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154659980|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659981|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
154659982|NCT04425707|Ivermectin|ivermectin|mesh-list
154659983|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
154659984|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154659985|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154659986|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154659987|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659988|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659989|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154659990|NCT05697185|Evolocumab|evolocumab|mesh-list
154659991|NCT05697185|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154659992|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154659993|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154659994|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
154659995|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154659996|NCT05697185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154659997|NCT05697185|Protease Inhibitors|protease inhibitors|mesh-ancestor
154659998|NCT05697185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154659999|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154660000|NCT02581163|Ritonavir|ritonavir|mesh-list
154660001|NCT02581163|Ribavirin|ribavirin|mesh-list
154660002|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154660003|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154660004|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
154660005|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660006|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660007|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154660008|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154660009|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
154660010|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660011|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154660012|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154660013|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
154660014|NCT01938547|Clevidipine|clevidipine|mesh-list
154660015|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154660016|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154660017|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660018|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154660019|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660020|NCT05695625|Anesthetics|anesthetics|mesh-list
154660021|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660022|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660023|NCT05586737|Rituximab|rituximab|mesh-list
154660024|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154660025|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660026|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
154660027|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660028|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660029|NCT05678933|Prednisone|prednisone|mesh-list
154660030|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
154660031|NCT05678933|Vincristine|vincristine|mesh-list
154660032|NCT05678933|Azacitidine|azacitidine|mesh-list
154660033|NCT05678933|Epirubicin|epirubicin|mesh-list
154660034|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154660035|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
154660036|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660037|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660038|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154660039|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
154660040|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660041|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660042|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154660043|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660044|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
154660045|NCT05678933|Hormones|hormones|mesh-ancestor
154660046|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660047|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154660048|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154660049|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
154660050|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
154660051|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
154660052|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154660053|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
154660054|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660055|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154660056|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154660057|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154660058|NCT05678621|Amoxicillin|amoxicillin|mesh-list
154660059|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
154660060|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
154660061|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
154582937|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
154660062|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154660063|NCT05678621|Trimethoprim|trimethoprim|mesh-list
154660064|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
154660065|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
154660066|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154660067|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660068|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
154660069|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660070|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154660071|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154660072|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660073|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660074|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660075|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154660076|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154660077|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154660078|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
154660079|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154660080|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154660081|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154660082|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154660083|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154660084|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154660085|NCT05530577|Semaglutide|semaglutide|mesh-list
154660086|NCT05530577|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154660087|NCT05530577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154660088|NCT05530577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660089|NCT02627677|Ponatinib|ponatinib|mesh-list
154660090|NCT02627677|Nilotinib|nilotinib|mesh-list
154660091|NCT02627677|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154660092|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154660093|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660094|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660095|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660096|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
154660097|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154660098|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660099|NCT04964479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154660100|NCT04964479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660101|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
154660102|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154660103|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154660104|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
154660105|NCT02585999|Ortho Evra|ortho evra|mesh-list
154660106|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154660107|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660108|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154660109|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
154660110|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
154660111|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154660112|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154660113|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660114|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660115|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154660116|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154660117|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660118|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660119|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
154660120|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154660121|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
154660122|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154660123|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660124|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660125|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154660126|NCT05674253|Analgesics|analgesics|mesh-ancestor
154660127|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
154660128|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660129|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154660130|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154660131|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154660132|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
154660133|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660134|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660135|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660136|NCT02500641|Naproxen|naproxen|mesh-list
154660137|NCT02500641|Colchicine|colchicine|mesh-list
154660138|NCT02500641|Allopurinol|allopurinol|mesh-list
154660139|NCT02500641|Febuxostat|febuxostat|mesh-list
154660140|NCT02500641|Omeprazole|omeprazole|mesh-list
154660141|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154660142|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660143|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154660144|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660145|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660146|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154660147|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154660148|NCT02500641|Analgesics|analgesics|mesh-ancestor
154660149|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
154660150|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660151|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660152|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660153|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660154|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
154660155|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154660156|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
154660157|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
154660158|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
154660159|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660160|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
154660161|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154660162|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
154660163|NCT02500641|Protective Agents|protective agents|mesh-ancestor
154660164|NCT04973293|Bevacizumab|bevacizumab|mesh-list
154660165|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154660166|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660167|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154660168|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154660169|NCT04973293|Growth Substances|growth substances|mesh-ancestor
154660170|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660171|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
154660172|NCT04962451|Ticagrelor|ticagrelor|mesh-list
154660173|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154412163|NCT06271772|Hormones|hormones|mesh-ancestor
154660174|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154660175|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154660176|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154660177|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
154660178|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660179|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660180|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660181|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154660182|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660183|NCT03059719|Exenatide|exenatide|mesh-list
154660184|NCT03059719|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154660185|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154660186|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660187|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154660188|NCT03059719|Incretins|incretins|mesh-ancestor
154660189|NCT03059719|Hormones|hormones|mesh-ancestor
154660190|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660191|NCT03060031|Oxytocin|oxytocin|mesh-list
154660192|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
154660193|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154660194|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660195|NCT02499783|Adalimumab|adalimumab|mesh-list
154660196|NCT02499783|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154660197|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660198|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660199|NCT04972045|Curcumin|curcumin|mesh-list
154660200|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154660201|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154660202|NCT04972045|Analgesics|analgesics|mesh-ancestor
154660203|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
154660204|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660205|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660206|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660207|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660208|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660209|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660210|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660211|NCT03059017|Albuterol|albuterol|mesh-list
154660212|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154660213|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
154660214|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660215|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660216|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154660217|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
154660218|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
154660219|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154660220|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154660221|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154660222|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154660223|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
154660224|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660225|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660226|NCT04425655|Fludarabine|fludarabine|mesh-list
154660227|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660228|NCT04970719|Remdesivir|remdesivir|mesh-list
154660229|NCT04970719|Dexamethasone|dexamethasone|mesh-list
154660230|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154660231|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660232|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
154660233|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
154660234|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660235|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660236|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660237|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
154660238|NCT04970719|Hormones|hormones|mesh-ancestor
154660239|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660240|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154660241|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660242|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
154660243|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660244|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
154660245|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660246|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154660247|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660248|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154660249|NCT02466399|Latanoprost|latanoprost|mesh-list
154660250|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154660251|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
154660252|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154660253|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660254|NCT04970251|Aflibercept|aflibercept|mesh-list
154660255|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154660256|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154660257|NCT04970251|Growth Substances|growth substances|mesh-ancestor
154660258|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660259|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
154660260|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660261|NCT04970329|Dextrans|dextrans|mesh-list
154660262|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
154660263|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
154660264|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
154660265|NCT04960657|Glyburide|glyburide|mesh-list
154660266|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154660267|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154660268|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660269|NCT04960657|Growth Substances|growth substances|mesh-ancestor
154660270|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
154660271|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660272|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660273|NCT02464059|Vitamin D|vitamin d|mesh-list
154660274|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
154660275|NCT02464059|Vitamins|vitamins|mesh-ancestor
154660276|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
154660277|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660278|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154660279|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154660280|NCT02463357|Metformin|metformin|mesh-list
154660281|NCT02463357|Nifedipine|nifedipine|mesh-list
154660282|NCT02463357|Methazolamide|methazolamide|mesh-list
154660283|NCT02463357|Quercetin|quercetin|mesh-list
154660284|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154660285|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660286|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154660287|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154660288|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660289|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154660290|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
154660291|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
154660292|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154660293|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
154660294|NCT02463357|Protective Agents|protective agents|mesh-ancestor
154660295|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154660296|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660297|NCT02463357|Diuretics|diuretics|mesh-ancestor
154660298|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
154660299|NCT04959721|Triamcinolone|triamcinolone|mesh-list
154660300|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154660301|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154660302|NCT04959721|Bupivacaine|bupivacaine|mesh-list
154660303|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154660304|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
154660305|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
154660306|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660307|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660308|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
154660309|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660310|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660311|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
154660312|NCT04959721|Hormones|hormones|mesh-ancestor
154660313|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660314|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154660315|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
154660316|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660317|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660318|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
154660319|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660320|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660321|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
154660322|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660323|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660324|NCT04676555|Ofatumumab|ofatumumab|mesh-list
154660325|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
154660326|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660327|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
154660328|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660329|NCT04314167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154660330|NCT04314167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154660331|NCT04314167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154660332|NCT04314167|Antimetabolites|antimetabolites|mesh-ancestor
154660333|NCT04314167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660334|NCT04314167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154660335|NCT04314167|Protease Inhibitors|protease inhibitors|mesh-ancestor
154660336|NCT04314167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660337|NCT04314167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154660338|NCT05575427|Levofloxacin|levofloxacin|mesh-list
154660339|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154660340|NCT05575427|Minocycline|minocycline|mesh-list
154660341|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154660342|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660343|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154660344|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154660345|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154660346|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660347|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660348|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660349|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154660350|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154660351|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
154660352|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154660353|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154660354|NCT04959253|Psilocybin|psilocybin|mesh-list
154660355|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
154660356|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660357|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154660358|NCT02499159|Bupivacaine|bupivacaine|mesh-list
154660359|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
154660360|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
154660361|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660362|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660363|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
154660364|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660365|NCT01664039|Bimatoprost|bimatoprost|mesh-list
154660366|NCT01664039|Travoprost|travoprost|mesh-list
154660367|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154660368|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154660369|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154660370|NCT05645705|Listerine|listerine|mesh-list
154660371|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154660372|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
154660373|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
154660374|NCT05645705|Protective Agents|protective agents|mesh-ancestor
154660375|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660376|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660377|NCT02445339|Naltrexone|naltrexone|mesh-list
154660378|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154660379|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154660380|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660381|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
154660382|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660383|NCT04959409|Tetracaine|tetracaine|mesh-list
154660384|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
154660385|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
154660386|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660387|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660388|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
154660389|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660390|NCT03058939|Tamoxifen|tamoxifen|mesh-list
154660391|NCT03058939|Paclitaxel|paclitaxel|mesh-list
154660392|NCT03058939|Carboplatin|carboplatin|mesh-list
154660393|NCT03058939|Trastuzumab|trastuzumab|mesh-list
154660394|NCT03058939|Letrozole|letrozole|mesh-list
154660395|NCT03058939|Pertuzumab|pertuzumab|mesh-list
154660396|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154660397|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660398|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
154660399|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
154660400|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
154660401|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660402|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154660403|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154660404|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154660405|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660406|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154660407|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
154660408|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660409|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660410|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154660411|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154660412|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154660413|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154660414|NCT03058471|Methotrexate|methotrexate|mesh-list
154660415|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154660416|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
154660417|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154660418|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660419|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154660420|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
154660421|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660422|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660423|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
154660424|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660425|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154660426|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154660427|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
154660428|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660429|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154660430|NCT02579603|Pirfenidone|pirfenidone|mesh-list
154660431|NCT02579603|Nintedanib|nintedanib|mesh-list
154660432|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660433|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154660434|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660435|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660436|NCT02579603|Analgesics|analgesics|mesh-ancestor
154660437|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
154660438|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660439|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660440|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154660441|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154660442|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660443|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660444|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
154660445|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154660446|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154660447|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660448|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
154660449|NCT03060889|Coagulants|coagulants|mesh-ancestor
154660450|NCT05546957|Aspirin|aspirin|mesh-list
154660451|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
154660452|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154660453|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154660454|NCT05546957|Analgesics|analgesics|mesh-ancestor
154660455|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
154660456|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660457|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660458|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660459|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660460|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154660461|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154660462|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660463|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154660464|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154660465|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660466|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
154660467|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154660468|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
154660469|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154660470|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
154660471|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
154660472|NCT04950205|Sevoflurane|sevoflurane|mesh-list
154660473|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154660474|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153987161|NCT00603824|PENTA|penta|mesh-list
154660476|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
154660477|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660478|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660479|NCT02625259|Lansoprazole|lansoprazole|mesh-list
154660480|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
154660481|NCT02625259|Serabelisib|serabelisib|mesh-list
154660482|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154660483|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660484|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154660485|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660486|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660487|NCT02577107|Ranibizumab|ranibizumab|mesh-list
154660488|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154660489|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154660490|NCT02577107|Growth Substances|growth substances|mesh-ancestor
154660491|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660492|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
154660493|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660494|NCT04958473|Axitinib|axitinib|mesh-list
154660495|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660496|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154660497|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660498|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660499|NCT04957927|Fluticasone|fluticasone|mesh-list
154660500|NCT04957927|Xhance|xhance|mesh-list
154660501|NCT04957927|Montelukast|montelukast|mesh-list
154660502|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660503|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154660504|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
154660505|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660506|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660507|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154660508|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
154660509|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
154660510|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154660511|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154660512|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
154660513|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660514|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154660515|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154660516|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660517|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
154660518|NCT04950049|Dexamethasone|dexamethasone|mesh-list
154660519|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
154660520|NCT04950049|BB 1101|bb 1101|mesh-list
154660521|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660522|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
154660523|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
154660524|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660525|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660526|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660527|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
154660528|NCT04950049|Hormones|hormones|mesh-ancestor
154660529|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660530|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154660531|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660532|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
154660533|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660534|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660535|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
154660536|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154660537|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154660538|NCT05587673|Prednisolone|prednisolone|mesh-list
154660539|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
154660540|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154660541|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
154660542|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660543|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
154660544|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
154660545|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660546|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660547|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660548|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
154660549|NCT05587673|Hormones|hormones|mesh-ancestor
154660550|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660551|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154660552|NCT05587673|Protective Agents|protective agents|mesh-ancestor
154660553|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154660554|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660555|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
154660556|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660557|NCT04966429|Maraviroc|maraviroc|mesh-list
154660558|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154660559|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154660560|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660561|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154660562|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154660563|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
154660564|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660565|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154660566|NCT04949347|Glycerol|glycerol|mesh-list
154660567|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154660568|NCT04949347|Protective Agents|protective agents|mesh-ancestor
154660569|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660570|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
154660571|NCT04948957|Esmolol|esmolol|mesh-list
154660572|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
154660573|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154660574|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154660575|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154660576|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
154660577|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660578|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660579|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660580|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
154660581|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154660582|NCT04948801|Velpatasvir|velpatasvir|mesh-list
154660583|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
154660584|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660585|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
154660586|NCT04948567|Analgesics|analgesics|mesh-ancestor
154660587|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
154660588|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660589|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660590|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
154660591|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660592|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154660593|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
154660594|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154660595|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154660596|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660597|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154660598|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
154660599|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154660600|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154660601|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
154660602|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660603|NCT04946929|Heparin|heparin|mesh-list
154660604|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154660605|NCT04946929|Tinzaparin|tinzaparin|mesh-list
154660606|NCT04946929|Dalteparin|dalteparin|mesh-list
154660607|NCT04946929|Ticagrelor|ticagrelor|mesh-list
154660608|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
154660609|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154660610|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154660611|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660612|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154660613|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154660614|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154660615|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154660616|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
154660617|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660618|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660619|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
154660620|NCT03058237|Baclofen|baclofen|mesh-list
154660621|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154660622|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412605|NCT05681182|Amiodarone|amiodarone|mesh-list
154660623|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154660624|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660625|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154660626|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
154660627|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
154660628|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660629|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660630|NCT04947241|Gemcitabine|gemcitabine|mesh-list
154660631|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154660632|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660633|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154660634|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
154660635|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660636|NCT04947241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154660638|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
154660639|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154660640|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660641|NCT04933279|Trace Elements|trace elements|mesh-ancestor
154660642|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
154660643|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660644|NCT02577029|Interferons|interferons|mesh-list
154660645|NCT02577029|Tenofovir|tenofovir|mesh-list
154660646|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
154660647|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
154660648|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154660649|NCT02577029|Entecavir|entecavir|mesh-list
154660650|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
154660651|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154660652|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660653|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
154660654|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660655|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154660656|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154660657|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660658|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660659|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154660660|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154660661|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
154660662|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660663|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
154660664|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660665|NCT04946383|Dasatinib|dasatinib|mesh-list
154660666|NCT04946383|Quercetin|quercetin|mesh-list
154660667|NCT04946383|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154660668|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154660669|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660670|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660671|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660672|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
154660673|NCT04946383|Protective Agents|protective agents|mesh-ancestor
154660674|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660675|NCT04943653|Paclitaxel|paclitaxel|mesh-list
154660676|NCT04943653|Capecitabine|capecitabine|mesh-list
154660677|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
154660678|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154660679|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660680|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
154660681|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
154660682|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
154660683|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660684|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154660685|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
154660686|NCT04943029|Paclitaxel|paclitaxel|mesh-list
154660687|NCT04943029|Carboplatin|carboplatin|mesh-list
154660688|NCT04943029|Pemetrexed|pemetrexed|mesh-list
154660689|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154163233|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
154660690|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660691|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
154660692|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
154660693|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
154660694|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660695|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660696|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154412680|NCT05605899|Hormones|hormones|mesh-ancestor
154660697|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154660698|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
154660699|NCT03660059|Peficitinib|peficitinib|mesh-list
154660700|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660701|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660702|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154660703|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
154660704|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660705|NCT04946227|Paclitaxel|paclitaxel|mesh-list
154660706|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
154660707|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154660708|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660709|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
154660710|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154660711|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154660712|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660713|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154660714|NCT04946227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154660715|NCT04932187|Capecitabine|capecitabine|mesh-list
154660716|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154660717|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
154660718|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660719|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660720|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154660721|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
154660722|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660723|NCT03597347|Molgramostim|molgramostim|mesh-list
154660724|NCT03597347|Sargramostim|sargramostim|mesh-list
154660725|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660726|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
154660727|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660728|NCT04930627|Empagliflozin|empagliflozin|mesh-list
154660729|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154660730|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660731|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154660732|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660733|NCT03057769|Indomethacin|indomethacin|mesh-list
154660734|NCT03057769|Epinephrine|epinephrine|mesh-list
154660735|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154660736|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154660737|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
154660738|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660739|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660740|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660741|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154660742|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154660743|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
154660744|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660745|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154660746|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
154660747|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
154660748|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
154660749|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154660750|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154660751|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154660752|NCT03057769|Analgesics|analgesics|mesh-ancestor
154660753|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
154660754|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660755|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154660756|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
154660757|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
154660758|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154660759|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154660760|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660761|NCT04633577|Lidocaine|lidocaine|mesh-list
154660762|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
154660763|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
154660764|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660765|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660766|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
154660767|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660768|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154660769|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154660770|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154660771|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154660772|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660773|NCT04941625|Cystatins|cystatins|mesh-list
154660774|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154660776|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660777|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660778|NCT04922047|Tislelizumab|tislelizumab|mesh-list
154660779|NCT04922047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154660780|NCT04922047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660781|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154660782|NCT04921657|Simvastatin|simvastatin|mesh-list
154660783|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154660784|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154660785|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
154660786|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660787|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154660788|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154660789|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660790|NCT04930471|Metformin|metformin|mesh-list
154660791|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154660792|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660793|NCT05530811|Dexamethasone|dexamethasone|mesh-list
154660794|NCT05530811|Bupivacaine|bupivacaine|mesh-list
154660795|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660796|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
154660797|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
154660798|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660799|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660800|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660801|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
154660802|NCT05530811|Hormones|hormones|mesh-ancestor
154660803|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660804|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154660805|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660806|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
154660807|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
154660808|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660809|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
154660810|NCT04940845|Denosumab|denosumab|mesh-list
154660811|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154660812|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660813|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
154660814|NCT04921111|Vaccines|vaccines|mesh-list
154660815|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
154660816|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660817|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154660818|NCT04921111|Antacids|antacids|mesh-ancestor
154660819|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660820|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660821|NCT03057145|Olaparib|olaparib|mesh-list
154660822|NCT03057145|Prexasertib|prexasertib|mesh-list
154660823|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154660824|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660825|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660826|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660827|NCT03057145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154660828|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
154660829|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154660830|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154660831|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154660832|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154660833|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660834|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
154660835|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660836|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660837|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154660838|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660839|NCT04939675|Lamotrigine|lamotrigine|mesh-list
154660840|NCT04939675|Zonisamide|zonisamide|mesh-list
154660841|NCT04939675|Levetiracetam|levetiracetam|mesh-list
154660842|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
154660843|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
154660844|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154660845|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154660846|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660847|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154660848|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660849|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154660850|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154660851|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660852|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154660853|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154660854|NCT03055663|Midazolam|midazolam|mesh-list
154660855|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154660856|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154660857|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660858|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660859|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154660860|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154660861|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154660862|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154660863|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
154660864|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
154660865|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
154660866|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
154660867|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660868|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660869|NCT02621047|Alectinib|alectinib|mesh-list
154660870|NCT02621047|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154660871|NCT02621047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154660872|NCT02621047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660873|NCT02621047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660874|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
154660875|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154660876|NCT04928365|Antibodies|antibodies|mesh-list
154660877|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154660878|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
154660879|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660880|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
154660881|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154660882|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154660883|NCT04938037|Prednisolone|prednisolone|mesh-list
154660884|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
154660885|NCT04938037|Bupivacaine|bupivacaine|mesh-list
154660886|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154660887|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
154660888|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
154660889|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
154660890|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660891|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660892|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
154660893|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660894|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660895|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
154660896|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
154660897|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660898|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
154660899|NCT04938037|Hormones|hormones|mesh-ancestor
154660900|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660901|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154660902|NCT04938037|Protective Agents|protective agents|mesh-ancestor
154660903|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154660904|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154660905|NCT04937569|Ivermectin|ivermectin|mesh-list
154660906|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154660907|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154660908|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
154660909|NCT04937101|Codeine|codeine|mesh-list
154660910|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154660911|NCT04937101|Narcotics|narcotics|mesh-ancestor
154660912|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660913|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660914|NCT04937101|Analgesics|analgesics|mesh-ancestor
154660915|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
154660916|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660917|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
154660918|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
154660919|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
154660920|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
154660921|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154660922|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
154660923|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
154660924|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412906|NCT05316935|Hormones|hormones|mesh-ancestor
154660925|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660926|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154660927|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154660928|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154660929|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660930|NCT04936711|Bupivacaine|bupivacaine|mesh-list
154660931|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
154660932|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
154660933|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660934|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660935|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
154660936|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660937|NCT04431349|Clopidogrel|clopidogrel|mesh-list
154660938|NCT04431349|Ticagrelor|ticagrelor|mesh-list
154660939|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154660940|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154660941|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154660942|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154660943|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
154660944|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660945|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660946|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660947|NCT03055741|Donepezil|donepezil|mesh-list
154660948|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154660949|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154660950|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660951|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
154660952|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660953|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660954|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
154660955|NCT04927039|Iloprost|iloprost|mesh-list
154660956|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154660957|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
154660958|NCT02443155|Liraglutide|liraglutide|mesh-list
154660959|NCT02443155|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154660960|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154660961|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660962|NCT02443155|Incretins|incretins|mesh-ancestor
154660963|NCT02443155|Hormones|hormones|mesh-ancestor
154660964|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660965|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
154660966|NCT04935541|Remifentanil|remifentanil|mesh-list
154660967|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154660968|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154660969|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660970|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154660971|NCT04935541|Analgesics|analgesics|mesh-ancestor
154660972|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
154660973|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660974|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154660975|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154660976|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154660977|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
154660978|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154660979|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154660980|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154660981|NCT04935541|Narcotics|narcotics|mesh-ancestor
154660982|NCT04935073|Cetrorelix|cetrorelix|mesh-list
154660983|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154660984|NCT04935073|Hormones|hormones|mesh-ancestor
154660985|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154660986|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660987|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154660988|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
154660989|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154660990|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
154660991|NCT04917757|Dexamethasone|dexamethasone|mesh-list
154660992|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154660993|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
154660994|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
154660995|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154660996|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154660997|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154660998|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
154661000|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661001|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154661002|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661003|NCT04916899|Rifampin|rifampin|mesh-list
154661004|NCT04916899|Isoniazid|isoniazid|mesh-list
154661005|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
154661006|NCT04916899|Ethambutol|ethambutol|mesh-list
154661007|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154661008|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
154661009|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154661010|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661011|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
154661012|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154661013|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661014|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661015|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154661016|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154661017|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154661018|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154661019|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154661020|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154661021|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154661022|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154661023|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
154661024|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154661025|NCT04916821|Propolis|propolis|mesh-list
154661026|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661027|NCT04916665|Teduglutide|teduglutide|mesh-list
154661028|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661029|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154661030|NCT04916665|Protective Agents|protective agents|mesh-ancestor
154661031|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661032|NCT04916353|Triamcinolone|triamcinolone|mesh-list
154661033|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154661034|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154661035|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154661036|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661037|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
154661038|NCT04916353|Hormones|hormones|mesh-ancestor
154661039|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661040|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661041|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154661042|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
154661043|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661044|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661045|NCT03056599|Interferons|interferons|mesh-list
154661046|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
154661047|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
154661048|NCT03056599|Aldesleukin|aldesleukin|mesh-list
154661049|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
154661050|NCT03056599|Gemcitabine|gemcitabine|mesh-list
154661051|NCT03056599|Docetaxel|docetaxel|mesh-list
154661052|NCT03056599|Doxorubicin|doxorubicin|mesh-list
154661053|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
154661054|NCT03056599|Nivolumab|nivolumab|mesh-list
154661055|NCT03056599|Bortezomib|bortezomib|mesh-list
154661056|NCT03056599|Ipilimumab|ipilimumab|mesh-list
154661057|NCT03056599|Atezolizumab|atezolizumab|mesh-list
154661058|NCT03056599|Durvalumab|durvalumab|mesh-list
154661059|NCT03056599|Avelumab|avelumab|mesh-list
154661060|NCT03056599|Trabectedin|trabectedin|mesh-list
154661061|NCT03056599|Olaratumab|olaratumab|mesh-list
154661062|NCT03056599|Entrectinib|entrectinib|mesh-list
154661063|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154661064|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
154661065|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661066|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661067|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
154661068|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
154661069|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
154661070|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154661071|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413058|NCT05089630|Vaccines|vaccines|mesh-list
154661072|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154661073|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661074|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661075|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154661076|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
154661077|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661078|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
154661079|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661080|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154661081|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154661082|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154661083|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
154661084|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154661085|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
154661086|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154661087|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661088|NCT04915963|Vitamin D|vitamin d|mesh-list
154661089|NCT04915963|Vitamins|vitamins|mesh-ancestor
154661090|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
154661091|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661092|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154661093|NCT04915807|Paclitaxel|paclitaxel|mesh-list
154661094|NCT04915807|Irinotecan|irinotecan|mesh-list
154661095|NCT04915807|Ramucirumab|ramucirumab|mesh-list
154661096|NCT04915807|Taxane|taxane|mesh-list
154661097|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154661098|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661099|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
154661100|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
154661101|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
154661102|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661103|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154661104|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154661105|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661106|NCT04915807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154661107|NCT04915807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154661108|NCT04915807|Growth Substances|growth substances|mesh-ancestor
154661109|NCT04915807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661110|NCT04915807|Growth Inhibitors|growth inhibitors|mesh-ancestor
154661111|NCT01360021|Budesonide|budesonide|mesh-list
154661112|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154661113|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661114|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154661115|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
154661116|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661117|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661118|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154661119|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
154661120|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
154661121|NCT01360021|Hormones|hormones|mesh-ancestor
154661122|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661123|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154661124|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
154661125|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661126|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154661127|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154661128|NCT02497287|Sertraline|sertraline|mesh-list
154661129|NCT02497287|Esketamine|esketamine|mesh-list
154661130|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
154661131|NCT02497287|Escitalopram|escitalopram|mesh-list
154661132|NCT02497287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154661133|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154661134|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154661135|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661136|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661137|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
154661138|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661139|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661140|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154661141|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154661142|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154661143|NCT02497287|Analgesics|analgesics|mesh-ancestor
154661144|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
154661145|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
154661146|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154661147|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154661148|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413128|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661149|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
154661150|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661151|NCT02458287|Bococizumab|bococizumab|mesh-list
154661152|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154661153|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154163731|NCT00991796|Paclitaxel|paclitaxel|mesh-list
154661154|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
154661155|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661156|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154661157|NCT03056053|Zolpidem|zolpidem|mesh-list
154661158|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154661159|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154661160|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661161|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661162|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154661163|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
154661164|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
154661165|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661166|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661167|NCT02496039|Quinidine|quinidine|mesh-list
154661168|NCT02496039|Levomethorphan|levomethorphan|mesh-list
154661169|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
154661170|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
154661171|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154661172|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154661173|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154661174|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661175|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661176|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661177|NCT02496039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154661178|NCT02496039|Narcotics|narcotics|mesh-ancestor
154661179|NCT02496039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661180|NCT02496039|Analgesics|analgesics|mesh-ancestor
154661181|NCT02496039|Sensory System Agents|sensory system agents|mesh-ancestor
154661182|NCT02496039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661183|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154661184|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154661185|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
154661186|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154661187|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
154661188|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154661189|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154661190|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661191|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661192|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154661193|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154661194|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
154661195|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154661196|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154661197|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154661198|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154661199|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154661200|NCT04922359|Lidocaine|lidocaine|mesh-list
154661201|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
154661202|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
154661203|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661204|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661205|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
154661206|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661207|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154661208|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154661209|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154661210|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154661211|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661212|NCT02495883|Ethanol|ethanol|mesh-list
154661213|NCT02495883|Propranolol|propranolol|mesh-list
154661214|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154661215|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154661216|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
154661217|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661218|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661219|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661220|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154661221|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154661222|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
154661223|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154661224|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661225|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661226|NCT04910347|Nivolumab|nivolumab|mesh-list
154661227|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661228|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661229|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154661230|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661231|NCT02439957|Valganciclovir|valganciclovir|mesh-list
154661232|NCT02439957|Brincidofovir|brincidofovir|mesh-list
154661233|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
154661234|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661235|NCT02457195|Granisetron|granisetron|mesh-list
154661236|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
154661237|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
154661238|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661239|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661240|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661241|NCT02457195|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154661242|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154661243|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
154661244|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661245|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661246|NCT04913779|Immunomodulating Agents|immunomodulating agents|mesh-list
154661247|NCT04913779|Immunologic Factors|immunologic factors|mesh-ancestor
154661248|NCT04913779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661249|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
154661250|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154661251|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154661252|NCT03054259|Prednisolone|prednisolone|mesh-list
154661253|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
154661254|NCT03054259|Rituximab|rituximab|mesh-list
154661255|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154661256|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
154661257|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661258|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661259|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
154661260|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661261|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154661262|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661263|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
154661264|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
154661265|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661266|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661267|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
154661268|NCT03054259|Hormones|hormones|mesh-ancestor
154661269|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661270|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154661271|NCT03054259|Protective Agents|protective agents|mesh-ancestor
154661272|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154661273|NCT01653327|Ketamine|ketamine|mesh-list
154661274|NCT01653327|Analgesics|analgesics|mesh-ancestor
154661275|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
154661276|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661277|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661278|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154661279|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154661280|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
154661281|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
154661282|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661283|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154661284|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154661285|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661286|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661287|NCT03053869|Diazepam|diazepam|mesh-list
154661288|NCT03053869|Lorazepam|lorazepam|mesh-list
154661289|NCT03053869|Alprazolam|alprazolam|mesh-list
154661290|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
154661291|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
154661292|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
154661293|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661294|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661295|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661296|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154661297|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661298|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154661299|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154661300|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154661301|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
154661302|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
154661303|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661304|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661305|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154661306|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154661307|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154661308|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154661309|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
154661310|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
154661311|NCT03053947|Ketamine|ketamine|mesh-list
154661312|NCT03053947|Analgesics|analgesics|mesh-ancestor
154661313|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
154661314|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661315|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661316|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154661317|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154661318|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
154661319|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
154661320|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661321|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154661322|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154661323|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661324|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661325|NCT04893733|Folic Acid|folic acid|mesh-list
154661326|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
154661327|NCT04893733|Vitamins|vitamins|mesh-ancestor
154661328|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
154661329|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661330|NCT04893733|Hematinics|hematinics|mesh-ancestor
154661331|NCT02493855|Ritonavir|ritonavir|mesh-list
154661332|NCT02493855|Ribavirin|ribavirin|mesh-list
154661333|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154661334|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154661335|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
154661336|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661337|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661338|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154661339|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154661340|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
154661341|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661342|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154661343|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154661344|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
154661345|NCT04892563|Morphine|morphine|mesh-list
154661346|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154661347|NCT04892563|Narcotics|narcotics|mesh-ancestor
154661348|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661349|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661350|NCT04892563|Analgesics|analgesics|mesh-ancestor
154661351|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
154661352|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661353|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
154661354|NCT04909255|Mirabegron|mirabegron|mesh-list
154661355|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154661356|NCT04909255|Oxybutynin|oxybutynin|mesh-list
154661357|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154661358|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154661359|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
154661360|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661361|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661362|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661363|NCT04909255|Urological Agents|urological agents|mesh-ancestor
154661364|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154661365|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154661366|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154661367|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
154661368|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
154661369|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
154661370|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661371|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
154661372|NCT04891861|Apixaban|apixaban|mesh-list
154661373|NCT04891861|Edoxaban|edoxaban|mesh-list
154661374|NCT04891861|Dabigatran|dabigatran|mesh-list
154661375|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154661376|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
154661377|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154661378|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
154661379|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661380|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661382|NCT03053167|Irinotecan|irinotecan|mesh-list
154661383|NCT03053167|Raltitrexed|raltitrexed|mesh-list
154661384|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154661385|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154661386|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661387|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661388|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661389|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154661390|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
154661391|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154661392|NCT04901923|Itraconazole|itraconazole|mesh-list
154661393|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
154661394|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
154661395|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661396|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154661397|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154661398|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661399|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661400|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154661401|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
154661402|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661403|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661404|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154661405|NCT04901923|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154661406|NCT04901923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154661407|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661408|NCT03050905|Ritonavir|ritonavir|mesh-list
154661409|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154661410|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154661411|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
154661412|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661413|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661414|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154661415|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154661416|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
154661417|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661418|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154661419|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154661420|NCT03050827|Oxybutynin|oxybutynin|mesh-list
154661421|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
154661422|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
154661423|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661424|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661425|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154661426|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154661427|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
154661428|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661429|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661430|NCT03050827|Urological Agents|urological agents|mesh-ancestor
154661431|NCT02438787|Golimumab|golimumab|mesh-list
154661432|NCT02438787|Ustekinumab|ustekinumab|mesh-list
154661433|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
154661434|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154661435|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661436|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154661437|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
154661438|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661439|NCT04901065|Lidocaine|lidocaine|mesh-list
154661440|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
154661441|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
154661442|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661443|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661444|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
154661445|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661446|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154661447|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154661448|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154661449|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154661450|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661451|NCT02493777|Methylphenidate|methylphenidate|mesh-list
154661452|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154661453|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661454|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154661455|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154661456|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154661457|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661458|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
154661459|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661460|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154661461|NCT04906915|Ketamine|ketamine|mesh-list
154661462|NCT04906915|Analgesics|analgesics|mesh-ancestor
154661463|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
154661464|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661465|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661466|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154661467|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154661468|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
154661469|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
154661470|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661471|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154661472|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154661473|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661474|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661475|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
154661476|NCT04900129|Diclofenac|diclofenac|mesh-list
154661477|NCT04900129|Salicylates|salicylates|mesh-list
154661478|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
154661479|NCT04900129|Menthol|menthol|mesh-list
154661480|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154661481|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154661482|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154661483|NCT04900129|Analgesics|analgesics|mesh-ancestor
154661484|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
154661485|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661486|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661487|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661488|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154661489|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154661490|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661491|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661492|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
154661493|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
154661494|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
154661495|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661496|NCT04900129|Expectorants|expectorants|mesh-ancestor
154661497|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
154661498|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154661499|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
154661500|NCT04900129|Protective Agents|protective agents|mesh-ancestor
154661501|NCT04900129|Antidotes|antidotes|mesh-ancestor
154661502|NCT02616601|Fluorouracil|fluorouracil|mesh-list
154661503|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
154661504|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661505|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154661506|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661507|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154661508|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
154661509|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661510|NCT02492997|Glycerol|glycerol|mesh-list
154661511|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154661512|NCT02492997|Protective Agents|protective agents|mesh-ancestor
154661513|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661514|NCT04393207|Dexamethasone|dexamethasone|mesh-list
154661515|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
154661516|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
154661517|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154661518|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154661519|NCT04393207|Prednisolone|prednisolone|mesh-list
154661520|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
154661521|NCT04393207|Bupivacaine|bupivacaine|mesh-list
154413502|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154661522|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154661523|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
154661524|NCT04393207|BB 1101|bb 1101|mesh-list
154661525|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661527|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
154661528|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661529|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661530|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661531|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
154661532|NCT04393207|Hormones|hormones|mesh-ancestor
154661533|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661534|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154661535|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661536|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
154661537|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661538|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661539|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
154661540|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
154661541|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661542|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
154661543|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154661544|NCT04393207|Protective Agents|protective agents|mesh-ancestor
154661545|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
154661546|NCT02492841|Calcium|calcium|mesh-list
154661547|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154661548|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661549|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154661550|NCT02492763|Metformin|metformin|mesh-list
154661551|NCT02492763|Liraglutide|liraglutide|mesh-list
154661552|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154661553|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661554|NCT02492763|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154661555|NCT02492763|Incretins|incretins|mesh-ancestor
154661556|NCT02492763|Hormones|hormones|mesh-ancestor
154661557|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661558|NCT04899817|Granisetron|granisetron|mesh-list
154661559|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
154661560|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
154661561|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661562|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661563|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661564|NCT04899817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154661565|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154661566|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
154661567|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661568|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661569|NCT04905667|Trastuzumab|trastuzumab|mesh-list
154661570|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661571|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661572|NCT04397107|Aldesleukin|aldesleukin|mesh-list
154661573|NCT04397107|Interleukin-2|interleukin-2|mesh-list
154661574|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661575|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154661576|NCT04397107|Analgesics|analgesics|mesh-ancestor
154661577|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
154661578|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661579|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661580|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154661581|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154661582|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
154661583|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661584|NCT02453841|Phenylephrine|phenylephrine|mesh-list
154661585|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
154661586|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154661587|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154661588|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
154661589|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661590|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661591|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661592|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
154661593|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
154661594|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661595|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
154661596|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154661597|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
154661598|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154661599|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
154661600|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154661601|NCT02453841|Protective Agents|protective agents|mesh-ancestor
154661603|NCT04888663|Trastuzumab|trastuzumab|mesh-list
154661604|NCT04888663|Ramucirumab|ramucirumab|mesh-list
154661605|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154661606|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661607|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
154661608|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
154661609|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
154661610|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661611|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661612|NCT04888663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154661613|NCT04888663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154661614|NCT04888663|Growth Substances|growth substances|mesh-ancestor
154661615|NCT04888663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661616|NCT04888663|Growth Inhibitors|growth inhibitors|mesh-ancestor
154661617|NCT04899427|Tislelizumab|tislelizumab|mesh-list
154661618|NCT04899427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661619|NCT04899427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661620|NCT02453685|Insulin|insulin|mesh-list
154661621|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154661622|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
154661623|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
154661624|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
154661625|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154661626|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
154661627|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154661628|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154661629|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661630|NCT03051841|Dexamethasone|dexamethasone|mesh-list
154661631|NCT03051841|Bortezomib|bortezomib|mesh-list
154661632|NCT03051841|CKD-581|ckd-581|mesh-list
154661633|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661634|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
154661635|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
154661636|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661637|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661638|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661639|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
154661640|NCT03051841|Hormones|hormones|mesh-ancestor
154661641|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661642|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154661643|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661644|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661645|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661646|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154661647|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
154661648|NCT04905043|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154661649|NCT04905043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154661650|NCT04905043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661651|NCT04905043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661652|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661653|NCT02436759|Phenylephrine|phenylephrine|mesh-list
154661654|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
154661655|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154661656|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154661657|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154661658|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154661659|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
154661660|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661661|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661662|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661663|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
154661664|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
154661665|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661666|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
154661667|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154661668|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
154661669|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154661670|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
154661671|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154661672|NCT02436759|Protective Agents|protective agents|mesh-ancestor
154413670|NCT02945800|Paclitaxel|paclitaxel|mesh-list
154661673|NCT04888819|Fexuprazan|fexuprazan|mesh-list
154661674|NCT04888819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661675|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
154661676|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
154661677|NCT04904185|Fludarabine|fludarabine|mesh-list
154661678|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
154661679|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154661680|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
154661681|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661682|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154661683|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154661684|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
154661685|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661686|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661687|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154661688|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661689|NCT04904185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154661690|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154661691|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
154661692|NCT04887961|Trabectedin|trabectedin|mesh-list
154661693|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154661694|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
154661695|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661696|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661697|NCT04887649|Morphine|morphine|mesh-list
154661698|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154661699|NCT04887649|Narcotics|narcotics|mesh-ancestor
154661700|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661701|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661702|NCT04887649|Analgesics|analgesics|mesh-ancestor
154661703|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
154661704|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661705|NCT03050437|Pemetrexed|pemetrexed|mesh-list
154661706|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661707|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661708|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661709|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154661710|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154661711|NCT02436135|Idelalisib|idelalisib|mesh-list
154661712|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661713|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661714|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661715|NCT02435277|Metformin|metformin|mesh-list
154661716|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154661717|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661718|NCT02420223|Propranolol|propranolol|mesh-list
154661719|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154661720|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154661721|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
154661722|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661723|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661724|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661725|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154661726|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154661727|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
154661728|NCT02433483|Cytarabine|cytarabine|mesh-list
154661729|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
154661730|NCT02433483|Methotrexate|methotrexate|mesh-list
154661731|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154661732|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
154661733|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154661734|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661735|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154661736|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
154661737|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661738|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661739|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
154661740|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661741|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154661742|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154661743|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
154661744|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154661745|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154661746|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
154661747|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661748|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661750|NCT02419755|Dexamethasone|dexamethasone|mesh-list
154661751|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
154661752|NCT02419755|Doxorubicin|doxorubicin|mesh-list
154661753|NCT02419755|Methotrexate|methotrexate|mesh-list
154661754|NCT02419755|Bortezomib|bortezomib|mesh-list
154661755|NCT02419755|Asparaginase|asparaginase|mesh-list
154661756|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
154661757|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
154661758|NCT02419755|Vorinostat|vorinostat|mesh-list
154661759|NCT02419755|Pegaspargase|pegaspargase|mesh-list
154661760|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154661761|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
154661762|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
154661763|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164322|NCT00772499|Olmesartan|olmesartan|mesh-list
154661764|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661765|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661766|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
154661767|NCT02419755|Hormones|hormones|mesh-ancestor
154661768|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661769|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154661770|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661771|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154661772|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154661773|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154661774|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661775|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661776|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154661777|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
154661778|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154661779|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154661780|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
154661781|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
154661782|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154661783|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154661784|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
154661785|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154661786|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154661787|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
154661788|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661789|NCT02419755|Analgesics|analgesics|mesh-ancestor
154661790|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
154661791|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154661792|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
154661793|NCT04913025|Nivolumab|nivolumab|mesh-list
154661794|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661795|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661796|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154661797|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661798|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
154661799|NCT04898101|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154661800|NCT04898101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154661801|NCT04898101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661802|NCT04898101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661803|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661804|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
154661805|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661806|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661807|NCT04887493|Alprostadil|alprostadil|mesh-list
154661808|NCT04887493|Misoprostol|misoprostol|mesh-list
154661809|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154661810|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
154661811|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154661812|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661813|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154661814|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661815|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
154661816|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154661817|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
154661818|NCT04887493|Urological Agents|urological agents|mesh-ancestor
154661819|NCT02486757|Estradiol|estradiol|mesh-list
154661820|NCT02486757|Progesterone|progesterone|mesh-list
154661821|NCT02486757|Estrogens|estrogens|mesh-ancestor
154661822|NCT02486757|Hormones|hormones|mesh-ancestor
154661823|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661824|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661825|NCT02486757|Progestins|progestins|mesh-ancestor
154661826|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154661827|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
154661828|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154661829|NCT03051529|Anesthetics|anesthetics|mesh-list
154661830|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661831|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661832|NCT04886869|Caffeine|caffeine|mesh-list
154661833|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154661834|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661835|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154661836|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661837|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661838|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154661839|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154661840|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
154661841|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661842|NCT04897477|Azacitidine|azacitidine|mesh-list
154661843|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154661844|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154661845|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
154661846|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661847|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661848|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661849|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154661850|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
154661851|NCT02576639|Umibecestat|umibecestat|mesh-list
154661852|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661853|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661854|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154661855|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154661856|NCT02418585|Sertraline|sertraline|mesh-list
154661857|NCT02418585|Esketamine|esketamine|mesh-list
154661858|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
154661859|NCT02418585|Escitalopram|escitalopram|mesh-list
154661860|NCT02418585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154661861|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154661862|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154661863|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661864|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661865|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
154661866|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661867|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661868|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154661869|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154661870|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154661871|NCT02418585|Analgesics|analgesics|mesh-ancestor
154661872|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
154661873|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
154661874|NCT05529875|Propofol|propofol|mesh-list
154661875|NCT05529875|Sevoflurane|sevoflurane|mesh-list
154661876|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154661877|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661878|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661879|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154661880|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
154661881|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
154661882|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154661883|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154661884|NCT03051451|Metformin|metformin|mesh-list
154661885|NCT03051451|Fluoxetine|fluoxetine|mesh-list
154661886|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154661887|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661888|NCT03051451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154661889|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154661890|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154661891|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661892|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661893|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
154661894|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154661895|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
154661896|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154661897|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154661898|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154661900|NCT02417961|Benralizumab|benralizumab|mesh-list
154661901|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154661902|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
154661903|NCT04883125|Pioglitazone|pioglitazone|mesh-list
154661904|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154661905|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661906|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
154661907|NCT05474183|Ketamine|ketamine|mesh-list
154661908|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154661909|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661910|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661911|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154661912|NCT05474183|Analgesics|analgesics|mesh-ancestor
154661913|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
154661914|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661915|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154661916|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154661917|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154661918|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
154661919|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661920|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661921|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154661922|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154661923|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
154661924|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
154661925|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154661926|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154661927|NCT04885777|Lidocaine|lidocaine|mesh-list
154661928|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
154661929|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
154661930|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154661931|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661932|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
154661933|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661934|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154661935|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154661936|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154661937|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154661938|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661939|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
154661940|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
154661941|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661942|NCT05529095|Apomorphine|apomorphine|mesh-list
154661943|NCT05529095|Emetics|emetics|mesh-ancestor
154661944|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661945|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
154661946|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154661947|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661948|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
154661949|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
154164553|NCT04424264|Rifampin|rifampin|mesh-list
154661950|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154661951|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661952|NCT01596127|Rituximab|rituximab|mesh-list
154661953|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154661954|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661955|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
154661956|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661957|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154661958|NCT03051373|Paclitaxel|paclitaxel|mesh-list
154661959|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154661960|NCT03051373|Gemcitabine|gemcitabine|mesh-list
154661961|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154661962|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661963|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
154661964|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
154661965|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
154661966|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661967|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154661968|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
154661969|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154661970|NCT04895059|Ezetimibe|ezetimibe|mesh-list
154661971|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154661972|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154661973|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
154661974|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661975|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154661976|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154661977|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661978|NCT05467475|Esomeprazole|esomeprazole|mesh-list
154661979|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154661980|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154661981|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154661982|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154661983|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154661984|NCT05534165|Tecovirimat|tecovirimat|mesh-list
154661985|NCT05534165|Antiviral Agents|antiviral agents|mesh-ancestor
154661986|NCT05534165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154661987|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
154661988|NCT01595581|Testosterone|testosterone|mesh-list
154661989|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
154661990|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
154661991|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154661992|NCT01595581|Androgens|androgens|mesh-ancestor
154661993|NCT01595581|Hormones|hormones|mesh-ancestor
154661994|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154661995|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154661996|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154661997|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154661998|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
154661999|NCT04885153|Fenofibrate|fenofibrate|mesh-list
154662000|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154662001|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
154662002|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662003|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154662004|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154662005|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662006|NCT04884997|Temozolomide|temozolomide|mesh-list
154164554|NCT04424264|Isoniazid|isoniazid|mesh-list
154662007|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154662008|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
154662009|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662010|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662011|NCT04885075|Midazolam|midazolam|mesh-list
154662012|NCT04885075|Diazepam|diazepam|mesh-list
154662013|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154662014|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154662015|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662016|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662017|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154662018|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154662019|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154662020|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154662021|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
154662022|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
154662023|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
154662024|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
154662025|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662026|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662027|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
154662028|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
154662029|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
154662030|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662031|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154662032|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154662033|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154662034|NCT01610687|Nabiximols|nabiximols|mesh-list
154662035|NCT01610687|Analgesics|analgesics|mesh-ancestor
154662036|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
154662037|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662038|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662039|NCT04884919|Chitosan|chitosan|mesh-list
154662040|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154662041|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154662042|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
154662043|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662044|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154662045|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
154662046|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
154662047|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
154414029|NCT02053922|Misoprostol|misoprostol|mesh-list
154662048|NCT04884919|Coagulants|coagulants|mesh-ancestor
154662049|NCT04878835|Ranibizumab|ranibizumab|mesh-list
154662050|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662051|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662052|NCT04878835|Growth Substances|growth substances|mesh-ancestor
154662053|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662054|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662055|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662056|NCT04872283|Aspirin|aspirin|mesh-list
154662057|NCT04872283|Acetaminophen|acetaminophen|mesh-list
154662058|NCT04872283|Ketorolac|ketorolac|mesh-list
154662059|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154662060|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154662061|NCT04872283|Oxycodone|oxycodone|mesh-list
154662062|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154662063|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662064|NCT04872283|Analgesics|analgesics|mesh-ancestor
154662065|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
154662066|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662067|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662068|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662069|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662070|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154662071|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154662072|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662073|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154662074|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154662075|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662076|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
154662077|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154662078|NCT04872283|Narcotics|narcotics|mesh-ancestor
154662079|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662080|NCT05182385|Venetoclax|venetoclax|mesh-list
154662081|NCT05182385|Blinatumomab|blinatumomab|mesh-list
154662082|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662083|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
154662084|NCT04389073|Bevacizumab|bevacizumab|mesh-list
154662085|NCT04389073|Capecitabine|capecitabine|mesh-list
154662086|NCT04389073|Vinorelbine|vinorelbine|mesh-list
154662087|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154662088|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
154662089|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662090|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662091|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154662092|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
154662093|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662094|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662095|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154662096|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662097|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662098|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662099|NCT04389073|Growth Substances|growth substances|mesh-ancestor
154662100|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662101|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662102|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
154662103|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154662104|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
154662105|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
154662106|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
154662107|NCT04371445|Dexamethasone|dexamethasone|mesh-list
154662108|NCT04371445|Prednisolone|prednisolone|mesh-list
154662109|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154662110|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
154662111|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154662112|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
154662113|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154662114|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
154662115|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662116|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
154662117|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
154662118|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662119|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662120|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154662121|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
154662122|NCT04371445|Hormones|hormones|mesh-ancestor
154662123|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414105|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154662124|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154662125|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662126|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154662128|NCT03049267|Apremilast|apremilast|mesh-list
154662129|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154662130|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662131|NCT03049267|Analgesics|analgesics|mesh-ancestor
154662132|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
154662133|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662134|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662135|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662136|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662137|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154662138|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154662139|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662140|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662141|NCT05524259|Folic Acid|folic acid|mesh-list
154662142|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
154662143|NCT05524259|Inositol|inositol|mesh-list
154662144|NCT05524259|Hematinics|hematinics|mesh-ancestor
154662145|NCT05524259|Vitamins|vitamins|mesh-ancestor
154662146|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
154662147|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662148|NCT04112095|Norgestrel|norgestrel|mesh-list
154662149|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154662150|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154662151|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154662152|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
154662153|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154662154|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662155|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154662156|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154662157|NCT05257993|Paclitaxel|paclitaxel|mesh-list
154662158|NCT05257993|Gemcitabine|gemcitabine|mesh-list
154662159|NCT05257993|Folfirinox|folfirinox|mesh-list
154662160|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154662161|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662162|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154662163|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154662164|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
154662165|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662166|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662167|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
154662168|NCT05533073|Etoricoxib|etoricoxib|mesh-list
154662169|NCT05533073|Tramadol|tramadol|mesh-list
154662170|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154662171|NCT05533073|Narcotics|narcotics|mesh-ancestor
154662172|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662173|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662174|NCT05533073|Analgesics|analgesics|mesh-ancestor
154662175|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
154662176|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662177|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154662178|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662179|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662180|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662181|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154662182|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154662183|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662184|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662185|NCT04050553|Tirzepatide|tirzepatide|mesh-list
154662186|NCT04050553|Incretins|incretins|mesh-ancestor
154662187|NCT04050553|Hormones|hormones|mesh-ancestor
154662188|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154662189|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662190|NCT03946891|Furosemide|furosemide|mesh-list
154662191|NCT03946891|Diuretics|diuretics|mesh-ancestor
154662192|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
154662193|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662194|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154662195|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154662196|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662197|NCT03849625|Aspirin|aspirin|mesh-list
154662198|NCT03849625|Acetaminophen|acetaminophen|mesh-list
154662199|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154662200|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662201|NCT03849625|Analgesics|analgesics|mesh-ancestor
154662202|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
154662203|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662204|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662205|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662206|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662207|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154662208|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154662209|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662210|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154662211|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154662212|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662213|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
154662214|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154662215|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
154662216|NCT03049345|Methylene Blue|methylene blue|mesh-list
154662217|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662218|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662219|NCT05526911|Tenofovir|tenofovir|mesh-list
154662220|NCT05526911|Lamivudine|lamivudine|mesh-list
154662221|NCT05526911|Dolutegravir|dolutegravir|mesh-list
154662222|NCT05526911|Digoxin|digoxin|mesh-list
154662223|NCT05526911|Midazolam|midazolam|mesh-list
154662224|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154662225|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154662226|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662227|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662228|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154662229|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154662230|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154662231|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154662232|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
154662233|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
154662234|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
154662235|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
154662236|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662237|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662238|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
154662239|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662240|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154662241|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154662242|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662243|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154164794|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
154662244|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154662245|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154662246|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154662247|NCT05526911|Protective Agents|protective agents|mesh-ancestor
154662248|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154662249|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154662250|NCT04870489|Isotretinoin|isotretinoin|mesh-list
154662251|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
154662252|NCT05231941|Lidocaine|lidocaine|mesh-list
154662253|NCT05231941|Ropivacaine|ropivacaine|mesh-list
154662254|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
154662255|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
154662256|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662257|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662258|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
154662259|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662260|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154662261|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154662262|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154662263|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154662264|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662265|NCT05216575|Almitrine|almitrine|mesh-list
154662266|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
154662267|NCT04877509|Vitamin D|vitamin d|mesh-list
154662268|NCT04877509|Vitamin A|vitamin a|mesh-list
154662269|NCT04877509|Selenium|selenium|mesh-list
154662270|NCT04877509|Copper|copper|mesh-list
154662271|NCT04877509|Vitamins|vitamins|mesh-ancestor
154662272|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
154662273|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662274|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
154662275|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662276|NCT04877509|Protective Agents|protective agents|mesh-ancestor
154662277|NCT04877509|Trace Elements|trace elements|mesh-ancestor
154662278|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154662279|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
154662280|NCT03044743|Fludarabine|fludarabine|mesh-list
154662281|NCT03044743|Interleukin-2|interleukin-2|mesh-list
154662282|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154662283|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
154662284|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662285|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662286|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154662287|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
154662288|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662289|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662290|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154662291|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662292|NCT03044743|Analgesics|analgesics|mesh-ancestor
154662293|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
154662294|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662295|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154662297|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154662298|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154662299|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
154662300|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662301|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154662302|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154662303|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662304|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
154662305|NCT05525351|Alfentanil|alfentanil|mesh-list
154662306|NCT05525351|Propofol|propofol|mesh-list
154662307|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154662308|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662309|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662310|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662311|NCT05525351|Analgesics|analgesics|mesh-ancestor
154662312|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
154662313|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662314|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154662315|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154662316|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154662317|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
154662318|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662319|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662320|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154662321|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
154662322|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
154662323|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154662324|NCT05525351|Narcotics|narcotics|mesh-ancestor
154662325|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
154164886|NCT00535730|Vaccines|vaccines|mesh-list
154662326|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662327|NCT05521763|Vaccines|vaccines|mesh-list
154662328|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
154662329|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662330|NCT04865185|Ethanol|ethanol|mesh-list
154662331|NCT04865185|Lidocaine|lidocaine|mesh-list
154662332|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154662333|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662334|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662335|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662336|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
154662337|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
154662338|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
154662339|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662340|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154662341|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154662342|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154662343|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154662344|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662345|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
154662346|NCT04876807|Omeprazole|omeprazole|mesh-list
154662347|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154662348|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154662349|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154662350|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662351|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662352|NCT04876807|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154662353|NCT04876807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154662354|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662355|NCT05518409|Donepezil|donepezil|mesh-list
154662356|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154662357|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662358|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662359|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
154662360|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662361|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662362|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
154662363|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
154662364|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
154662365|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
154662366|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154662367|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154662368|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
154662369|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
154662370|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662371|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662372|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662373|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154662374|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
154662375|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154662376|NCT04864717|Doxycycline|doxycycline|mesh-list
154662377|NCT04864717|Isotretinoin|isotretinoin|mesh-list
154662378|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154662379|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662380|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
154662381|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154662382|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154662383|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
154662384|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154662385|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662386|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
154662387|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662388|NCT04876261|Protective Agents|protective agents|mesh-ancestor
154662389|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662390|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154662391|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
154662392|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154662393|NCT02613871|Ledipasvir|ledipasvir|mesh-list
154662394|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
154662395|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662396|NCT04869709|Betamethasone|betamethasone|mesh-list
154662397|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
154662398|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154662399|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
154662400|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154662401|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662402|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
154662403|NCT04869709|Hormones|hormones|mesh-ancestor
154662404|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154662405|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662406|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154662407|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
154662408|NCT02612077|Bevacizumab|bevacizumab|mesh-list
154662409|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662410|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662411|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662412|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662413|NCT02612077|Growth Substances|growth substances|mesh-ancestor
154662414|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662415|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662416|NCT04622735|Acetaminophen|acetaminophen|mesh-list
154662417|NCT04622735|Nefopam|nefopam|mesh-list
154662418|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662419|NCT04622735|Analgesics|analgesics|mesh-ancestor
154662420|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
154662421|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662422|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662423|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
154662424|NCT05048615|Itraconazole|itraconazole|mesh-list
154662425|NCT05048615|Azacitidine|azacitidine|mesh-list
154662426|NCT05048615|Venetoclax|venetoclax|mesh-list
154662427|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662428|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
154662429|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662430|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662431|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662432|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
154662433|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662434|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154662435|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154662436|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154662437|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
154662438|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154662439|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662440|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154662441|NCT05531435|Anesthetics|anesthetics|mesh-list
154662442|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
154662443|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662444|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662445|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
154662446|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662447|NCT05517239|Gemcitabine|gemcitabine|mesh-list
154662448|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
154662449|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662450|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
154662451|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662452|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662453|NCT05519813|Metformin|metformin|mesh-list
154662454|NCT05519813|Pioglitazone|pioglitazone|mesh-list
154662455|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154662456|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662457|NCT02613403|Ribavirin|ribavirin|mesh-list
154662458|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
154662459|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
154662460|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662461|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
154662462|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662463|NCT05002127|Paclitaxel|paclitaxel|mesh-list
154662464|NCT05002127|Trastuzumab|trastuzumab|mesh-list
154662465|NCT05002127|Ramucirumab|ramucirumab|mesh-list
154662466|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154662467|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662468|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
154662469|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
154662470|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
154165028|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154662471|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662472|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662473|NCT05002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662474|NCT05002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662475|NCT05002127|Growth Substances|growth substances|mesh-ancestor
154662476|NCT05002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662477|NCT05002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662478|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
154662479|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
154662480|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154662481|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154662482|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662483|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662484|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662485|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662486|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
154662487|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154662488|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154662489|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662490|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
154662491|NCT03044041|Coagulants|coagulants|mesh-ancestor
154662492|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154662493|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154662494|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662495|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154662496|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154662497|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662498|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154662499|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
154662500|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662501|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
154662502|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662503|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662504|NCT04863079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154662505|NCT04863079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662507|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662508|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662509|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662510|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662511|NCT05512325|Growth Substances|growth substances|mesh-ancestor
154662512|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662513|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662514|NCT04868227|Vitamin D|vitamin d|mesh-list
154662515|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
154662516|NCT04868227|Vitamins|vitamins|mesh-ancestor
154662517|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
154662518|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662519|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154662520|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154662521|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154662522|NCT04873531|Neostigmine|neostigmine|mesh-list
154165071|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
154662523|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154662524|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662525|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662526|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
154662527|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662528|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662529|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154662530|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
154662531|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662532|NCT04862845|Pregabalin|pregabalin|mesh-list
154662533|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154662534|NCT04862845|Analgesics|analgesics|mesh-ancestor
154662535|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
154662536|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662537|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662538|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
154662539|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154662540|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154662541|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662542|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154662543|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154662544|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154662545|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662546|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154662547|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154662548|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154662549|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662550|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
154662551|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
154662552|NCT04862377|Budesonide|budesonide|mesh-list
154662553|NCT04862377|Poractant alfa|poractant alfa|mesh-list
154662554|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662555|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154662556|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
154662557|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662558|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662559|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154662560|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
154662561|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
154662562|NCT04862377|Hormones|hormones|mesh-ancestor
154662563|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154662564|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154662565|NCT04867993|Amikacin|amikacin|mesh-list
154662566|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154662567|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662568|NCT04872985|Paclitaxel|paclitaxel|mesh-list
154662569|NCT04872985|Docetaxel|docetaxel|mesh-list
154662570|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
154662571|NCT04872985|Doxorubicin|doxorubicin|mesh-list
154662572|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154662573|NCT04872985|Epirubicin|epirubicin|mesh-list
154662574|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154662575|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662576|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
154662577|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
154662578|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
154662579|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662580|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154662581|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
154662582|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662583|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662584|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154662585|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
154662586|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154662587|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154662588|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154662589|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154662590|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662591|NCT04872907|Fluorides|fluorides|mesh-list
154662592|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
154662593|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
154662594|NCT04872907|Protective Agents|protective agents|mesh-ancestor
154662595|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662596|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
154662597|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
154662598|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154662599|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
154662600|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662601|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662602|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154662603|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
154662604|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
154662605|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154662606|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
154662607|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662608|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662609|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154662610|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154662611|NCT05507411|Immunomodulating Agents|immunomodulating agents|mesh-list
154662612|NCT05507411|Immunologic Factors|immunologic factors|mesh-ancestor
154662613|NCT05507411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662614|NCT04894643|Paclitaxel|paclitaxel|mesh-list
154662615|NCT04894643|Gemcitabine|gemcitabine|mesh-list
154662616|NCT04894643|Capecitabine|capecitabine|mesh-list
154662617|NCT04894643|Pancrelipase|pancrelipase|mesh-list
154662618|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154662619|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662620|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
154662621|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
154662622|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
154662623|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662624|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662625|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
154662626|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154662627|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
154662628|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154662629|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
154662630|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662631|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662632|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154662633|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
154662634|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
154662635|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154662636|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
154662637|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662638|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662639|NCT05506319|Vasopressins|vasopressins|mesh-list
154662640|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
154662641|NCT05506319|Norepinephrine|norepinephrine|mesh-list
154662642|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154662643|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154662644|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
154662645|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662646|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662647|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662648|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
154662649|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
154662650|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662651|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154662652|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
154662653|NCT05506319|Coagulants|coagulants|mesh-ancestor
154662654|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154662655|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
154662656|NCT05505539|Fluorouracil|fluorouracil|mesh-list
154662657|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
154662658|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662659|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662660|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662661|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154662662|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
154662663|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662665|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
154662666|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488790|NCT02302092|Cefepime|cefepime|mesh-list
154662667|NCT05514275|Capecitabine|capecitabine|mesh-list
154662668|NCT05514275|Endostatins|endostatins|mesh-list
154662669|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662670|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
154662671|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662672|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662673|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662674|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662675|NCT05514275|Growth Substances|growth substances|mesh-ancestor
154662676|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662677|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662678|NCT05514041|Varenicline|varenicline|mesh-list
154662679|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154662680|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154662681|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
154662682|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662683|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662684|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662685|NCT02570711|Paclitaxel|paclitaxel|mesh-list
154662686|NCT02570711|Gemcitabine|gemcitabine|mesh-list
154662687|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
154662688|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154662689|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662690|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
154662691|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
154662692|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
154662693|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662694|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662695|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
154662696|NCT02570711|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154662697|NCT02570711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154662698|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662699|NCT05513729|Pioglitazone|pioglitazone|mesh-list
154662700|NCT05513729|Canagliflozin|canagliflozin|mesh-list
154662701|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154662702|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662703|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154662704|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662705|NCT05504603|Rituximab|rituximab|mesh-list
154662706|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
154662707|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662708|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662709|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
154662710|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662711|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662712|NCT05504603|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154662713|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154662714|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662715|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662716|NCT05504213|Fulvestrant|fulvestrant|mesh-list
154662717|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154662718|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662719|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154662720|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154662721|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
154165264|NCT05343260|Propofol|propofol|mesh-list
154662722|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154662723|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662724|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
154662725|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662726|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662727|NCT02564471|Doxycycline|doxycycline|mesh-list
154662728|NCT02564471|Chloroquine|chloroquine|mesh-list
154662729|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154662731|NCT02564471|Proguanil|proguanil|mesh-list
154662732|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154662733|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662734|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
154662735|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154662736|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154662737|NCT02564471|Amebicides|amebicides|mesh-ancestor
154662738|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662739|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154662740|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662741|NCT02564471|Analgesics|analgesics|mesh-ancestor
154662742|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
154662743|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662744|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662745|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662746|NCT02564471|Filaricides|filaricides|mesh-ancestor
154662747|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
154662748|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
154662749|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662750|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662751|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
154662752|NCT05503667|Bevacizumab|bevacizumab|mesh-list
154662753|NCT05503667|Aflutinib|aflutinib|mesh-list
154662754|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662755|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662756|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662757|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662758|NCT05503667|Growth Substances|growth substances|mesh-ancestor
154662759|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662760|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662761|NCT05503667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154662762|NCT05503667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662763|NCT05503667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662764|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
154662765|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154662766|NCT02563067|Growth Substances|growth substances|mesh-ancestor
154662767|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662768|NCT02568683|Vincristine|vincristine|mesh-list
154662769|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154662770|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662771|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
154662772|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
154662773|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
154662774|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662775|NCT05502731|Adalimumab|adalimumab|mesh-list
154662776|NCT05502731|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154662777|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662778|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662779|NCT05503043|Lidocaine|lidocaine|mesh-list
154662780|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
154662781|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
154662782|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662783|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662784|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
154662785|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662786|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154662787|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154662788|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154662789|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154662790|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662791|NCT02563925|Durvalumab|durvalumab|mesh-list
154662792|NCT02563925|Tremelimumab|tremelimumab|mesh-list
154662793|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662794|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662795|NCT01663727|Paclitaxel|paclitaxel|mesh-list
154662796|NCT01663727|Bevacizumab|bevacizumab|mesh-list
154662797|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154662798|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662799|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
154662800|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
154662801|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
154662802|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662803|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154662804|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662805|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662806|NCT01663727|Growth Substances|growth substances|mesh-ancestor
154662807|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662808|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662809|NCT03042325|Alogliptin|alogliptin|mesh-list
154662810|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154662811|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662812|NCT03042325|Incretins|incretins|mesh-ancestor
154662813|NCT03042325|Hormones|hormones|mesh-ancestor
154662814|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154662815|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154662816|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
154662817|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662818|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662819|NCT01594333|Methotrexate|methotrexate|mesh-list
154662820|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154662821|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
154662822|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154662823|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662824|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154662825|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
154662826|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662827|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662828|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
154662829|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662830|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154662831|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154662832|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
154662833|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662834|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154662835|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
154662836|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
154662837|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154662838|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154662839|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662840|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662841|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662842|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662843|NCT03043495|Dexamethasone|dexamethasone|mesh-list
154662844|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662845|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
154662846|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
154662847|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662848|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662849|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154662850|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
154662851|NCT03043495|Hormones|hormones|mesh-ancestor
154662852|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165400|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
154662853|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154662854|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662855|NCT03043027|Bupivacaine|bupivacaine|mesh-list
154662856|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
154662857|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
154662858|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662859|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662860|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
154662861|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662862|NCT04861207|Cladribine|cladribine|mesh-list
154662863|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662864|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154662865|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
154662866|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662867|NCT04858087|Lumefantrine|lumefantrine|mesh-list
154662868|NCT04858087|Artemether|artemether|mesh-list
154662869|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154662870|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
154662871|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154662872|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154662873|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662874|NCT03041935|Acetaminophen|acetaminophen|mesh-list
154662875|NCT03041935|Dexamethasone|dexamethasone|mesh-list
154662876|NCT03041935|Ketorolac|ketorolac|mesh-list
154662877|NCT03041935|Morphine|morphine|mesh-list
154662878|NCT03041935|Remifentanil|remifentanil|mesh-list
154662879|NCT03041935|Ondansetron|ondansetron|mesh-list
154662880|NCT03041935|Propofol|propofol|mesh-list
154662882|NCT03041935|Sevoflurane|sevoflurane|mesh-list
154662883|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154662884|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
154662885|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
154662886|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662887|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662888|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154662889|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
154662890|NCT03041935|Hormones|hormones|mesh-ancestor
154662891|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154662892|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154662893|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662894|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154662895|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662896|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154662897|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
154662898|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
154662899|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154662900|NCT03041935|Narcotics|narcotics|mesh-ancestor
154662901|NCT03041935|Analgesics|analgesics|mesh-ancestor
154662902|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
154662903|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
154662904|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154662905|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
154662906|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154662907|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154662908|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
154662909|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
154662910|NCT03041935|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154662911|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154662912|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
154662913|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154662914|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662915|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154662916|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154662917|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154662918|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662919|NCT03042013|Naquotinib|naquotinib|mesh-list
154662920|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662921|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154662922|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662923|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662924|NCT03042871|Ranibizumab|ranibizumab|mesh-list
154662925|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154662926|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154662927|NCT03042871|Growth Substances|growth substances|mesh-ancestor
154662928|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662929|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
154662930|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662931|NCT03042637|Tacrolimus|tacrolimus|mesh-list
154662932|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154662933|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
154662934|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662935|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154662936|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662937|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662938|NCT03045133|Morphine|morphine|mesh-list
154662939|NCT03045133|Methadone|methadone|mesh-list
154662940|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154662941|NCT03045133|Narcotics|narcotics|mesh-ancestor
154662942|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662943|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662944|NCT03045133|Analgesics|analgesics|mesh-ancestor
154662945|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
154662946|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154662947|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
154662948|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
154662949|NCT02609659|Ritonavir|ritonavir|mesh-list
154662950|NCT02609659|Ribavirin|ribavirin|mesh-list
154662951|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154662952|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154662953|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
154662954|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662955|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662956|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154662957|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154662958|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
154662959|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662960|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154662961|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154662962|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
154662963|NCT04429711|Ivermectin|ivermectin|mesh-list
154662964|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154662965|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662966|NCT04429633|Candesartan|candesartan|mesh-list
154165508|NCT00790985|Naproxen|naproxen|mesh-list
154662967|NCT04429633|Candesartan cilexetil|candesartan cilexetil|mesh-list
154662968|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154662969|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154662970|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154662971|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662972|NCT03042091|Metronidazole|metronidazole|mesh-list
154662973|NCT03042091|Ethanol|ethanol|mesh-list
154662974|NCT03042091|Neomycin|neomycin|mesh-list
154662975|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154662976|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154662977|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154662978|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154662979|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154662980|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154662981|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662982|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154662983|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662984|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662985|NCT04859569|Denosumab|denosumab|mesh-list
154662986|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154662987|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154662988|NCT04856371|Letrozole|letrozole|mesh-list
154662989|NCT04856371|Fulvestrant|fulvestrant|mesh-list
154662990|NCT04856371|Palbociclib|palbociclib|mesh-list
154662991|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154662992|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154662993|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154662994|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154662995|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154662996|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154662997|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
154662998|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154662999|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663000|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154663001|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154663002|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154663003|NCT03041779|Acetaminophen|acetaminophen|mesh-list
154663004|NCT03041779|Diclofenac|diclofenac|mesh-list
154663005|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663006|NCT03041779|Analgesics|analgesics|mesh-ancestor
154663007|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
154663008|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663009|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663010|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
154663011|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154663012|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663013|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154663014|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154663015|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663016|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663017|NCT02612779|Dexamethasone|dexamethasone|mesh-list
154663018|NCT02612779|Nivolumab|nivolumab|mesh-list
154663019|NCT02612779|Pomalidomide|pomalidomide|mesh-list
154663020|NCT02612779|Elotuzumab|elotuzumab|mesh-list
154663021|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663022|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
154663023|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
154663024|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663025|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663026|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663027|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
154663028|NCT02612779|Hormones|hormones|mesh-ancestor
154663029|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663030|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154663031|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663032|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663033|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154663034|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663036|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154663037|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154663038|NCT02612779|Growth Substances|growth substances|mesh-ancestor
154663039|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
154663040|NCT04866355|Ibuprofen|ibuprofen|mesh-list
154663041|NCT04866355|Scopolamine|scopolamine|mesh-list
154663042|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154663043|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663044|NCT04866355|Analgesics|analgesics|mesh-ancestor
154663045|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
154663046|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663047|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663048|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663049|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154663050|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154663051|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663052|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663053|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154663054|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
154663055|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
154663056|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663057|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
154663058|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154663059|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
154663060|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663061|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154663062|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154663063|NCT02607865|Semaglutide|semaglutide|mesh-list
154663064|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154663065|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663066|NCT02607865|Incretins|incretins|mesh-ancestor
154663067|NCT02607865|Hormones|hormones|mesh-ancestor
154663068|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663069|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154663070|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
154663071|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663072|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663073|NCT02607865|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154663074|NCT04856137|Paclitaxel|paclitaxel|mesh-list
154663075|NCT04856137|Rituximab|rituximab|mesh-list
154663076|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154663077|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663078|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
154663079|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
154663080|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
154663081|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663082|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663083|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
154663084|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663085|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154663086|NCT04855279|Listerine|listerine|mesh-list
154663087|NCT04855279|Fluorides|fluorides|mesh-list
154663088|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
154663089|NCT04855279|Glycerol|glycerol|mesh-list
154663090|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
154663091|NCT04855279|Protective Agents|protective agents|mesh-ancestor
154663092|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663093|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154663094|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663095|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154663096|NCT04848259|Dexamethasone|dexamethasone|mesh-list
154663097|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
154663098|NCT04848259|BB 1101|bb 1101|mesh-list
154663099|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663100|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
154663101|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
154663102|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663103|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663104|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663105|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
154663106|NCT04848259|Hormones|hormones|mesh-ancestor
154415081|NCT02797808|Sertraline|sertraline|mesh-list
154663107|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663108|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154663109|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663110|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
154663111|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663112|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663113|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154663114|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
154663115|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154663116|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
154663117|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154663118|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663119|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154663120|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154663121|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663122|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
154663123|NCT04848181|Finasteride|finasteride|mesh-list
154663124|NCT04848181|Cyproterone|cyproterone|mesh-list
154663125|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154663126|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154663127|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663128|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663129|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
154663130|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663131|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663132|NCT04848181|Urological Agents|urological agents|mesh-ancestor
154663133|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
154663134|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663135|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154663136|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
154663137|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154663138|NCT04847791|Lactoferrin|lactoferrin|mesh-list
154663139|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663140|NCT04375813|Sirolimus|sirolimus|mesh-list
154663141|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154663142|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663143|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154663144|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663145|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
154663146|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154663147|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
154663148|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663149|NCT04847245|Pregabalin|pregabalin|mesh-list
154663150|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154663151|NCT04847245|Esketamine|esketamine|mesh-list
154663152|NCT04847245|Analgesics|analgesics|mesh-ancestor
154663153|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
154663154|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663155|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663156|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
154663157|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154663158|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154663159|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663160|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154663161|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154663162|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154663163|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663164|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154663165|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154663166|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154663167|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663168|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
154663169|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
154663170|NCT04839913|Antibodies|antibodies|mesh-list
154663171|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
154663172|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663173|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
154663174|NCT04846621|Calcium|calcium|mesh-list
154663175|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154663176|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663177|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154663178|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663179|NCT04854577|Anesthetics|anesthetics|mesh-list
154663180|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663181|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663182|NCT04839445|Anesthetics|anesthetics|mesh-list
154663183|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663184|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663185|NCT04845607|Amiodarone|amiodarone|mesh-list
154663186|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154663187|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
154663188|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154663189|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154663190|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663191|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154663192|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154663193|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154663194|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663195|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154663196|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154663197|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154663198|NCT03040531|Vitamin D|vitamin d|mesh-list
154663199|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
154663200|NCT03040531|Alendronate|alendronate|mesh-list
154663201|NCT03040531|Genistein|genistein|mesh-list
154663202|NCT03040531|Calcium|calcium|mesh-list
154663203|NCT03040531|Vitamins|vitamins|mesh-ancestor
154663204|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
154663205|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663206|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154663207|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154663208|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154663209|NCT03040531|Protective Agents|protective agents|mesh-ancestor
154663210|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663211|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154663212|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663213|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663214|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
154663215|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154663216|NCT03040531|Estrogens|estrogens|mesh-ancestor
154663217|NCT03040531|Hormones|hormones|mesh-ancestor
154165761|NCT00408694|Growth Substances|growth substances|mesh-ancestor
154663218|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663219|NCT04838665|Phenylephrine|phenylephrine|mesh-list
154663220|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
154663221|NCT04838665|Tropicamide|tropicamide|mesh-list
154663222|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
154663223|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154663224|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
154663225|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
154663226|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663227|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663228|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
154663229|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154663230|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
154663231|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
154663232|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154663233|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154663234|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154663235|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
154663236|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663237|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663238|NCT04838665|Protective Agents|protective agents|mesh-ancestor
154663239|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154663240|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154663241|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
154663242|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
154663243|NCT04845061|Nebivolol|nebivolol|mesh-list
154663244|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154663245|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
154663246|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154663247|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154663248|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154663249|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
154663250|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663251|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663252|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663253|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
154663254|NCT03040765|Denosumab|denosumab|mesh-list
154663255|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154663256|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663258|NCT01668667|Analgesics|analgesics|mesh-ancestor
154663259|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
154663260|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663261|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663262|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
154663263|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154663264|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154663265|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663266|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154663267|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154663268|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154663269|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663270|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663271|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
154663272|NCT03040219|Folic Acid|folic acid|mesh-list
154663273|NCT03040219|Hematinics|hematinics|mesh-ancestor
154663274|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
154663275|NCT03040219|Vitamins|vitamins|mesh-ancestor
154663276|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
154663277|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663278|NCT03038503|Terlipressin|terlipressin|mesh-list
154663279|NCT03038503|Methylene Blue|methylene blue|mesh-list
154663280|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663281|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663282|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154663283|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154663284|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
154663285|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154663286|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663287|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
154663288|NCT04852315|Caffeine|caffeine|mesh-list
154663289|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154663290|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663291|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154663292|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663293|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663294|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154663295|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154663296|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
154663297|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663298|NCT03038425|Ropivacaine|ropivacaine|mesh-list
154663299|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
154663300|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
154663301|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663302|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663303|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
154663304|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663305|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154663306|NCT04851769|Alirocumab|alirocumab|mesh-list
154663307|NCT04851769|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154663308|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154663309|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154663310|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
154663311|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663312|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663313|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154663314|NCT04851769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154663315|NCT04851769|Protease Inhibitors|protease inhibitors|mesh-ancestor
154663316|NCT04843267|Tislelizumab|tislelizumab|mesh-list
154663317|NCT04843267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663318|NCT04843267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663319|NCT04852081|Tamoxifen|tamoxifen|mesh-list
154663320|NCT04852081|Letrozole|letrozole|mesh-list
154663321|NCT04852081|Fulvestrant|fulvestrant|mesh-list
154663322|NCT04852081|Palbociclib|palbociclib|mesh-list
154663323|NCT04852081|Anastrozole|anastrozole|mesh-list
154663324|NCT04852081|Exemestane|exemestane|mesh-list
154663325|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663326|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154663327|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154663328|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663329|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663330|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154663331|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
154663332|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663333|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663334|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154663335|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154663336|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154663337|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154663338|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154663339|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154663340|NCT02608099|Apixaban|apixaban|mesh-list
154663341|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154663342|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
154663343|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154663344|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
154663345|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663346|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663347|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
154663348|NCT04850755|Nivolumab|nivolumab|mesh-list
154663349|NCT04850755|Ipilimumab|ipilimumab|mesh-list
154663350|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663351|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663352|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154663353|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663354|NCT04842487|Prednisone|prednisone|mesh-list
154663355|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
154663356|NCT04842487|Rituximab|rituximab|mesh-list
154663357|NCT04842487|Vincristine|vincristine|mesh-list
154663358|NCT04842487|Lenalidomide|lenalidomide|mesh-list
154663359|NCT04842487|Doxorubicin|doxorubicin|mesh-list
154663360|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154663361|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154663362|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
154663363|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663364|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154663365|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154663366|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
154663367|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663368|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663369|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154663370|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663371|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663372|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
154663373|NCT04842487|Hormones|hormones|mesh-ancestor
154663374|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663375|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154663376|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154663377|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
154663378|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
154663379|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
154663380|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154663381|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154663382|NCT04842487|Growth Substances|growth substances|mesh-ancestor
154663383|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
154663384|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154663385|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154663386|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154663387|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663388|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154663389|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154663390|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663391|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
154663392|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663393|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663394|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
154663395|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154663396|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
154663397|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663398|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663399|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154663400|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
154663401|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154663402|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
154582938|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663403|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415384|NCT03379428|Trastuzumab|trastuzumab|mesh-list
154663404|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663405|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154663406|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
154663407|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
154663408|NCT04312243|Protective Agents|protective agents|mesh-ancestor
154663409|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
154663410|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154663411|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663412|NCT04837651|Antibodies|antibodies|mesh-list
154663413|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
154663414|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663415|NCT03039205|Clopidogrel|clopidogrel|mesh-list
154663416|NCT03039205|Ticagrelor|ticagrelor|mesh-list
154663417|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154663418|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154663419|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154663420|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154663421|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
154663422|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663423|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663424|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663425|NCT04837261|Propranolol|propranolol|mesh-list
154663426|NCT04837261|Amiodarone|amiodarone|mesh-list
154663427|NCT04837261|Flecainide|flecainide|mesh-list
154663428|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154663429|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154663430|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
154663431|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663432|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663433|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663434|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154663435|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154663436|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
154663437|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154663438|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154663439|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154165997|NCT00072475|Vatalanib|vatalanib|mesh-list
154663440|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154663441|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154663442|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663443|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154663444|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154663445|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154663446|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154663447|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
154663448|NCT04824937|Talazoparib|talazoparib|mesh-list
154663449|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154663450|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663451|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663452|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663453|NCT03036085|Epinephrine|epinephrine|mesh-list
154663454|NCT03036085|Bupivacaine|bupivacaine|mesh-list
154663455|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
154663456|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
154663457|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663458|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663459|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
154663460|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663461|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154663462|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154663463|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
154663464|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663465|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663466|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154663467|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154663468|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
154663469|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154663470|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
154663471|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
154663472|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
154663473|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154663474|NCT04831255|Triamcinolone|triamcinolone|mesh-list
154663475|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154663476|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154663477|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154663478|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663479|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
154663480|NCT04831255|Hormones|hormones|mesh-ancestor
154663481|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663482|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663483|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154663484|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
154663485|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663486|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663487|NCT02431533|Calcium|calcium|mesh-list
154663488|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154663489|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663490|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
154663491|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154663492|NCT02413593|Ledipasvir|ledipasvir|mesh-list
154663493|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
154663494|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663495|NCT01652703|Evolocumab|evolocumab|mesh-list
154663496|NCT01652703|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154663497|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154663498|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154663499|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
154663500|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663501|NCT01652703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154663502|NCT01652703|Protease Inhibitors|protease inhibitors|mesh-ancestor
154663503|NCT01652703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663504|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154663505|NCT01652469|Docetaxel|docetaxel|mesh-list
154663506|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154663507|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663508|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
154663509|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
154663510|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
154663511|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663512|NCT01652469|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154663513|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154663514|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663515|NCT02429427|Celecoxib|celecoxib|mesh-list
154663516|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154663517|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663518|NCT02429427|Analgesics|analgesics|mesh-ancestor
154663519|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
154663520|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663521|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663522|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663523|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154663524|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154663525|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154663526|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663527|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663528|NCT02412657|Dexamethasone|dexamethasone|mesh-list
154663529|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663530|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
154663531|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
154663532|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663533|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663534|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663535|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
154663536|NCT02412657|Hormones|hormones|mesh-ancestor
154663537|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663538|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154663539|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663540|NCT02412111|Ivacaftor|ivacaftor|mesh-list
154663541|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154663542|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154663543|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663544|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
154663545|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154663546|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663547|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154663548|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663549|NCT02484651|Rocuronium|rocuronium|mesh-list
154663550|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154663551|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154663552|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154663553|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663554|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663555|NCT02410551|Fludarabine|fludarabine|mesh-list
154663556|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
154663557|NCT02410551|Busulfan|busulfan|mesh-list
154663558|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663559|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154663560|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
154663561|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663562|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154663563|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
154663564|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663565|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
154663566|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154663567|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154663568|NCT02424591|Ketamine|ketamine|mesh-list
154663569|NCT02424591|Analgesics|analgesics|mesh-ancestor
154663570|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
154663571|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663572|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663573|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154663574|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154663575|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
154663576|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
154663577|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663578|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154663579|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154663580|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663581|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663582|NCT02408523|Lacosamide|lacosamide|mesh-list
154663583|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154663584|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
154663585|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154663586|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154663587|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154663588|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663589|NCT04822909|Thalidomide|thalidomide|mesh-list
154663590|NCT04822909|Apremilast|apremilast|mesh-list
154663591|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154663592|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663593|NCT04822909|Analgesics|analgesics|mesh-ancestor
154663594|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
154663595|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663596|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663597|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663598|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154663599|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154663600|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154663601|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663602|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663603|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154663604|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
154663605|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
154663606|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154663607|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663608|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154663609|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154663610|NCT04822909|Growth Substances|growth substances|mesh-ancestor
154663611|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
154663612|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663613|NCT04831099|Testosterone|testosterone|mesh-list
154663614|NCT04831099|Androgens|androgens|mesh-ancestor
154663615|NCT04831099|Hormones|hormones|mesh-ancestor
154663616|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663617|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663618|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
154663619|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154663620|NCT02603419|Avelumab|avelumab|mesh-list
154663621|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154663622|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663623|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663624|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
154663625|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663627|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154663628|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663629|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663630|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154663631|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154663632|NCT04367935|Protective Agents|protective agents|mesh-ancestor
154663633|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663634|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
154663635|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154663636|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
154663637|NCT04829773|Midazolam|midazolam|mesh-list
154663638|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154663639|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154663640|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663641|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663642|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154663643|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154663644|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154663645|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154663646|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
154663647|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
154663648|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
154663649|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
154663650|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663651|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663652|NCT04829695|Artesunate|artesunate|mesh-list
154663653|NCT04829695|Lumefantrine|lumefantrine|mesh-list
154663654|NCT04829695|Artemether|artemether|mesh-list
154663655|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154663656|NCT04829695|Amodiaquine|amodiaquine|mesh-list
154663657|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
154663658|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154663659|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154663660|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663661|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663662|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
154663663|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
154663664|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154663665|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
154663666|NCT03035695|Hemostatics|hemostatics|mesh-list
154663667|NCT03035695|Coagulants|coagulants|mesh-ancestor
154663668|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
154663669|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663670|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
154663671|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
154663672|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663673|NCT04828525|Dexamethasone|dexamethasone|mesh-list
154663674|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663675|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
154663676|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
154663677|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663678|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663679|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663680|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
154663681|NCT04828525|Hormones|hormones|mesh-ancestor
154663682|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663683|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154663684|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663685|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
154663686|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154663687|NCT04821193|Disinfectants|disinfectants|mesh-list
154663688|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154663689|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154663690|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663691|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
154663692|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
154663693|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154663694|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663695|NCT04827667|Dimercaprol|dimercaprol|mesh-list
154663696|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
154663697|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
154663698|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663699|NCT04360135|Acetaminophen|acetaminophen|mesh-list
154663700|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663701|NCT04360135|Analgesics|analgesics|mesh-ancestor
154663702|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
154663703|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663704|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663705|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
154663706|NCT02605837|Budesonide|budesonide|mesh-list
154663707|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663708|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154663709|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
154663710|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663711|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663712|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154663713|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
154663714|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
154663715|NCT02605837|Hormones|hormones|mesh-ancestor
154663716|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663717|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
154663718|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154663719|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663720|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663721|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663722|NCT04820101|Analgesics|analgesics|mesh-ancestor
154663723|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
154663724|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663725|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154663726|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154663727|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154663728|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
154663729|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663730|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663731|NCT04819867|Propolis|propolis|mesh-list
154663732|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663733|NCT02423343|Nivolumab|nivolumab|mesh-list
154663734|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663735|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663736|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154663737|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663738|NCT04909515|Isotretinoin|isotretinoin|mesh-list
154663739|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
154663740|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
154663741|NCT05617729|Povidone|povidone|mesh-list
154663742|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
154663743|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
154663744|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154663745|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663746|NCT04818931|Cefazolin|cefazolin|mesh-list
154663747|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154663748|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663749|NCT02406261|Midazolam|midazolam|mesh-list
154663750|NCT02406261|Donepezil|donepezil|mesh-list
154663751|NCT02406261|Simvastatin|simvastatin|mesh-list
154663752|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154663753|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154663754|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663755|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663756|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154663757|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154663758|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154663759|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154663760|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
154663761|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
154663762|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
154663763|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
154663764|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663765|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663766|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154663767|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154663768|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
154663769|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154663770|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154663771|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663772|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154663773|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
154663774|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
154663775|NCT02485353|Cytarabine|cytarabine|mesh-list
154663776|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154663777|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
154663778|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663779|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663780|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
154663781|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663782|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154663783|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
154663784|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663785|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154663786|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663787|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663788|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
154663789|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663790|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154663791|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154663792|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154663793|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154663794|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
154663795|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154663796|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
154663797|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663798|NCT04826497|Nicorandil|nicorandil|mesh-list
154663799|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154663800|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154663801|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
154166364|NCT00796211|Nortriptyline|nortriptyline|mesh-list
154663802|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
154663803|NCT04826497|Vitamins|vitamins|mesh-ancestor
154663804|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
154663805|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663806|NCT04819243|Atezolizumab|atezolizumab|mesh-list
154663807|NCT04819243|Talazoparib|talazoparib|mesh-list
154663808|NCT04819243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154663809|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663810|NCT04819243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663811|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663812|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154663813|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663814|NCT02604589|Hydromorphone|hydromorphone|mesh-list
154663815|NCT02604589|Bupivacaine|bupivacaine|mesh-list
154663816|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
154663817|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
154663818|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663819|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663820|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
154663821|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663822|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154663823|NCT02604589|Narcotics|narcotics|mesh-ancestor
154663824|NCT02604589|Analgesics|analgesics|mesh-ancestor
154663825|NCT04818151|Warfarin|warfarin|mesh-list
154663826|NCT04818151|Apixaban|apixaban|mesh-list
154663827|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
154663828|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154663829|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
154663830|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154663831|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
154663832|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663833|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663834|NCT04817527|Edaravone|edaravone|mesh-list
154663835|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154663836|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
154663837|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663838|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154663839|NCT04817527|Protective Agents|protective agents|mesh-ancestor
154663840|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663841|NCT02604199|Tenofovir|tenofovir|mesh-list
154663842|NCT02604199|Entecavir|entecavir|mesh-list
154663843|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
154663844|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154663845|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
154663846|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663847|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154663848|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154663849|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663850|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663851|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154663852|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154663853|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
154663854|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663855|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663856|NCT04807543|Castor Oil|castor oil|mesh-list
154663857|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154663859|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154663860|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
154663861|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663862|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663863|NCT04807543|Progestins|progestins|mesh-ancestor
154663864|NCT04807543|Hormones|hormones|mesh-ancestor
154663865|NCT04807543|Cathartics|cathartics|mesh-ancestor
154663866|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663867|NCT04797949|Aspirin|aspirin|mesh-list
154663868|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154663869|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663870|NCT04797949|Analgesics|analgesics|mesh-ancestor
154663871|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
154663872|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663873|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663874|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663875|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154663876|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154663877|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154663878|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663879|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154663880|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154663881|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663882|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
154663883|NCT04797793|Adapalene|adapalene|mesh-list
154663884|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154663885|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663886|NCT04797793|Analgesics|analgesics|mesh-ancestor
154663887|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
154663888|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663889|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663890|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154663891|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154663892|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
154663893|NCT04796857|Lenalidomide|lenalidomide|mesh-list
154663894|NCT04796857|Tislelizumab|tislelizumab|mesh-list
154663895|NCT04796857|Antibodies|antibodies|mesh-list
154663896|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
154663897|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663898|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154663899|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154663900|NCT04796857|Growth Substances|growth substances|mesh-ancestor
154663901|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
154663902|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663903|NCT04796857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154663904|NCT04796623|Fulvestrant|fulvestrant|mesh-list
154663905|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154166464|NCT00792857|Vitamins|vitamins|mesh-ancestor
154663906|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663907|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154663908|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154663909|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
154663910|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154663911|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663912|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
154663913|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154663914|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663915|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663916|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154663917|NCT04815265|Analgesics|analgesics|mesh-ancestor
154663918|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
154663919|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663920|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154663921|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154663922|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154663923|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
154663924|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663925|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663926|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
154663927|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
154663928|NCT04805827|Gabapentin|gabapentin|mesh-list
154663929|NCT04805827|Analgesics|analgesics|mesh-ancestor
154663930|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
154663931|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663932|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663933|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
154663934|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154663935|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154663936|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663937|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154663938|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154663939|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154663940|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663941|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663942|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
154663943|NCT02596711|Nicotine|nicotine|mesh-list
154663944|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
154663945|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154663946|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
154663947|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154663948|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663949|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154663950|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154663951|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
154663952|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154663953|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663954|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
154663955|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
154663956|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
154663957|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
154663958|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154663959|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154663960|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663961|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
154663962|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154663963|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154663964|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663965|NCT04814485|Paclitaxel|paclitaxel|mesh-list
154663966|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154663967|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154663968|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154663969|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
154663970|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
154663971|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
154663972|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663973|NCT04804423|Listerine|listerine|mesh-list
154663974|NCT04804423|Fluorides|fluorides|mesh-list
154663975|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
154663976|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
154663977|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
154663978|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
154663979|NCT04804423|Protective Agents|protective agents|mesh-ancestor
154663980|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663981|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154663982|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154663983|NCT04794049|Lactulose|lactulose|mesh-list
154663984|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663985|NCT04804267|Linaclotide|linaclotide|mesh-list
154663986|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154663987|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
154166548|NCT00801515|Maraviroc|maraviroc|mesh-list
154663988|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154663989|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154663990|NCT04813471|Folic Acid|folic acid|mesh-list
154663991|NCT04813471|Nicorandil|nicorandil|mesh-list
154663992|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
154663993|NCT04813471|Atorvastatin|atorvastatin|mesh-list
154663994|NCT04813471|Vitamins|vitamins|mesh-ancestor
154663995|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
154663996|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154663997|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154663998|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154663999|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
154664000|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664001|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154664002|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154664003|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664004|NCT04813471|Hematinics|hematinics|mesh-ancestor
154664005|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154664006|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154664008|NCT04803175|Valsartan|valsartan|mesh-list
154664009|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154664010|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154664011|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154664012|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154664013|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664014|NCT04792723|Aspirin|aspirin|mesh-list
154664015|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154664016|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154664017|NCT04792723|Analgesics|analgesics|mesh-ancestor
154664018|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
154664019|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664020|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664021|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154664022|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664023|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154664024|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154664025|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664026|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154664027|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154664028|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664029|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
154664030|NCT04792333|Firibastat|firibastat|mesh-list
154664031|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154664032|NCT04802785|Aspirin|aspirin|mesh-list
154664033|NCT04802785|Domperidone|domperidone|mesh-list
154664034|NCT04802785|Melatonin|melatonin|mesh-list
154664035|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154664036|NCT04802785|Simethicone|simethicone|mesh-list
154664037|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154664038|NCT04802785|Citric Acid|citric acid|mesh-list
154664039|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
154664040|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
154664041|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154664042|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
154664043|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
154664044|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664045|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
154664046|NCT04802785|Protective Agents|protective agents|mesh-ancestor
154664047|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664048|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664049|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154664050|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154664051|NCT04802785|Analgesics|analgesics|mesh-ancestor
154664052|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
154664053|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664054|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154664055|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664056|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154664057|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154664058|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154664059|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154664060|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664061|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
154664062|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
154664063|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
154664064|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154664065|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154664066|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
154664067|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664068|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
154664069|NCT04802785|Emollients|emollients|mesh-ancestor
154664070|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154664071|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
154664072|NCT04802785|Antacids|antacids|mesh-ancestor
154664073|NCT02598193|Pirfenidone|pirfenidone|mesh-list
154664074|NCT02598193|Nintedanib|nintedanib|mesh-list
154664075|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664076|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154664077|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166636|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664078|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664079|NCT02598193|Analgesics|analgesics|mesh-ancestor
154664080|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
154664081|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664082|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664083|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154664084|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154664085|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154664086|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664087|NCT04802083|Eculizumab|eculizumab|mesh-list
154664088|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154664089|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154664090|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
154664091|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664092|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154664093|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
154664094|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154664095|NCT04790383|Protective Agents|protective agents|mesh-ancestor
154664096|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664097|NCT02388165|Vaccines|vaccines|mesh-list
154664098|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
154664099|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664100|NCT04811911|Methotrexate|methotrexate|mesh-list
154664101|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154664102|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
154664103|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154664104|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664105|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154664106|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
154664107|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664108|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664109|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
154664110|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664111|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154664112|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154664113|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
154664114|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664115|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154664116|NCT04788979|Melatonin|melatonin|mesh-list
154664117|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
154664118|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664119|NCT04788979|Protective Agents|protective agents|mesh-ancestor
154664120|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664121|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664122|NCT04811209|Analgesics|analgesics|mesh-list
154664123|NCT04811209|Anesthetics|anesthetics|mesh-list
154664124|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664125|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664126|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
154664127|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664128|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
154664129|NCT04788355|Apixaban|apixaban|mesh-list
154664130|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
154664131|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154664132|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154664133|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664134|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664135|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664136|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664137|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154664138|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
154664139|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154664140|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
154664141|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
154664142|NCT04799743|Resveratrol|resveratrol|mesh-list
154664143|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
154664144|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664145|NCT04799743|Protective Agents|protective agents|mesh-ancestor
154664146|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664147|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664148|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154664149|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
154664150|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154664151|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154664152|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664153|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
154664154|NCT04788121|Coagulants|coagulants|mesh-ancestor
154664155|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
154664156|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154664157|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154664158|NCT04810819|Prednisolone|prednisolone|mesh-list
154664159|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
154664160|NCT04810819|Dyphylline|dyphylline|mesh-list
154664161|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154664162|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
154664163|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154664164|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
154664165|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
154664166|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664167|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664168|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154664169|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
154664170|NCT04810819|Hormones|hormones|mesh-ancestor
154664171|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664172|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154664173|NCT04810819|Protective Agents|protective agents|mesh-ancestor
154664174|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154664175|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664176|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154664177|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154664178|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
154664179|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154664180|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664181|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664182|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
154664183|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154664184|NCT04810507|Anagliptin|anagliptin|mesh-list
154664185|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154664186|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664187|NCT04810507|Incretins|incretins|mesh-ancestor
154664188|NCT04810507|Hormones|hormones|mesh-ancestor
154664189|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664190|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154664191|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
154664192|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664193|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664194|NCT04810585|Aflibercept|aflibercept|mesh-list
154664195|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154664196|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154664197|NCT04810585|Growth Substances|growth substances|mesh-ancestor
154664198|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664199|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
154664200|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664201|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
154664202|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664203|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
154664204|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
154664205|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
154664206|NCT04809649|Itraconazole|itraconazole|mesh-list
154664207|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
154664208|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664209|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154664210|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154664211|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664212|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664213|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154664214|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
154664215|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664216|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664217|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154664218|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154664219|NCT04786795|Pancreatin|pancreatin|mesh-list
154664220|NCT04786795|Pancrelipase|pancrelipase|mesh-list
154664221|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154664222|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154664223|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
154664224|NCT02596945|Hematinics|hematinics|mesh-ancestor
154664225|NCT04786327|Edetic Acid|edetic acid|mesh-list
154664226|NCT04786327|Mitogens|mitogens|mesh-list
154664227|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
154664228|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
154664229|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664230|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
154664231|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154664232|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
154664233|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
154664234|NCT04786327|Antidotes|antidotes|mesh-ancestor
154664235|NCT04786327|Protective Agents|protective agents|mesh-ancestor
154664236|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664237|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154664238|NCT04153435|Calcium|calcium|mesh-list
154664239|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154664240|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664241|NCT01667419|Vemurafenib|vemurafenib|mesh-list
154664242|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664243|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154664244|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664245|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664246|NCT04808791|Trifluridine|trifluridine|mesh-list
154664247|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
154664248|NCT04808791|Irinotecan|irinotecan|mesh-list
154664249|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664250|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154664251|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154664252|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664253|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664254|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
154664255|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
154664256|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664257|NCT03843853|Bevacizumab|bevacizumab|mesh-list
154664258|NCT03843853|Pemetrexed|pemetrexed|mesh-list
154664259|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664260|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664261|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154664262|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154664263|NCT03843853|Growth Substances|growth substances|mesh-ancestor
154664264|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664265|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
154664266|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664267|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664268|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154664269|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154664270|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
154664271|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154664272|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
154664273|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664274|NCT05054179|Ropivacaine|ropivacaine|mesh-list
154664275|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154664276|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
154664277|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
154664278|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664279|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664280|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
154664281|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664282|NCT04789057|Atorvastatin|atorvastatin|mesh-list
154664283|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154664284|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154664285|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
154664286|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664287|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154664288|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154664289|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664290|NCT05611645|Bevacizumab|bevacizumab|mesh-list
154664291|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664292|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664293|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154664294|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154664295|NCT05611645|Growth Substances|growth substances|mesh-ancestor
154664296|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664297|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
154664298|NCT02835079|Tamoxifen|tamoxifen|mesh-list
154664299|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154664300|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
154664301|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664302|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664303|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154664304|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664305|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154664306|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154664307|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154664308|NCT01667107|Posaconazole|posaconazole|mesh-list
154664309|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
154664310|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664311|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154664312|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154664313|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154664314|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154664315|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154664316|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664317|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664318|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154664319|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
154664320|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166877|NCT00656513|Pilocarpine|pilocarpine|mesh-list
154664321|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664322|NCT05240131|Atezolizumab|atezolizumab|mesh-list
154664323|NCT05240131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154664324|NCT05240131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664325|NCT05240131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664326|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664327|NCT05188339|Heparin|heparin|mesh-list
154664328|NCT05188339|Citric Acid|citric acid|mesh-list
154664329|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
154664330|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
154664331|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154664332|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
154664333|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
154664334|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664335|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154664336|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154664337|NCT05614765|Ezetimibe|ezetimibe|mesh-list
154664338|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154664339|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154664340|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
154664341|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664342|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154664343|NCT02590003|Paclitaxel|paclitaxel|mesh-list
154664344|NCT02590003|Carboplatin|carboplatin|mesh-list
154664345|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154664346|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664347|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
154664348|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
154664349|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
154664350|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664351|NCT05474053|Ticagrelor|ticagrelor|mesh-list
154664352|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154664353|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154664354|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154664355|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154664356|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
154664357|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664358|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664359|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664360|NCT05473819|Anesthetics|anesthetics|mesh-list
154664361|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166940|NCT00806663|Sunitinib|sunitinib|mesh-list
154664362|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664363|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
154664364|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
154664365|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664366|NCT04762771|Colchicine|colchicine|mesh-list
154664367|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
154664368|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664369|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
154664370|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
154664371|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
154664372|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664373|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664374|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154664375|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154664376|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154664377|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154664378|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664379|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
154664380|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154664381|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664382|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664383|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154664384|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154664385|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664386|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
154664387|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664389|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154664390|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
154664391|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664392|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
154664393|NCT03032107|Trastuzumab|trastuzumab|mesh-list
154664394|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154664395|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664396|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664397|NCT03032107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154664398|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664399|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154664400|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154664401|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154664402|NCT03032107|Immunotoxins|immunotoxins|mesh-ancestor
154664403|NCT03032107|Immunoconjugates|immunoconjugates|mesh-ancestor
154664404|NCT03032107|Immunologic Factors|immunologic factors|mesh-ancestor
154664405|NCT03032107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664406|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154664407|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
154664408|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
154664409|NCT05700955|Temozolomide|temozolomide|mesh-list
154664410|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664411|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664412|NCT05700955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154664413|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664414|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154664415|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
154664416|NCT01650519|Ibuprofen|ibuprofen|mesh-list
154664417|NCT01650519|Ketorolac|ketorolac|mesh-list
154664418|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154664419|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154664420|NCT01650519|Analgesics|analgesics|mesh-ancestor
154664421|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
154664422|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664423|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664424|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154664425|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664426|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154664427|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664428|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664429|NCT02197039|Esomeprazole|esomeprazole|mesh-list
154664430|NCT02197039|Pantoprazole|pantoprazole|mesh-list
154664431|NCT02197039|Hemostatics|hemostatics|mesh-list
154664432|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154664433|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154664434|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154664435|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664436|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664437|NCT02197039|Coagulants|coagulants|mesh-ancestor
154664438|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154664439|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
154664440|NCT05557903|Antibodies|antibodies|mesh-list
154664441|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
154664442|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154664443|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
154664444|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664445|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664446|NCT02386839|Mecasermin|mecasermin|mesh-list
154664447|NCT02386839|Growth Substances|growth substances|mesh-ancestor
154664448|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664449|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
154664450|NCT05347459|Empagliflozin|empagliflozin|mesh-list
154664451|NCT05347459|Canagliflozin|canagliflozin|mesh-list
154664452|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154664453|NCT05347459|Linagliptin|linagliptin|mesh-list
154664454|NCT05347459|Vildagliptin|vildagliptin|mesh-list
154664455|NCT05347459|Saxagliptin|saxagliptin|mesh-list
154664456|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154416432|NCT03353675|Nivolumab|nivolumab|mesh-list
154664457|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664458|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154664459|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664460|NCT05347459|Incretins|incretins|mesh-ancestor
154664462|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664463|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154664464|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
154664465|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664466|NCT05346445|Fluoxetine|fluoxetine|mesh-list
154664467|NCT05346445|Citalopram|citalopram|mesh-list
154664468|NCT05346445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154664469|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154664470|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154664471|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664472|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664473|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
154664474|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664475|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154664476|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
154664477|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154664478|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154664479|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154664480|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664481|NCT01649271|Trastuzumab|trastuzumab|mesh-list
154664482|NCT01649271|Afatinib|afatinib|mesh-list
154664483|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664484|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664485|NCT01649271|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154664486|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154664487|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664488|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664489|NCT02385669|Ipilimumab|ipilimumab|mesh-list
154664490|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664491|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664492|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154664493|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664494|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
154664495|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154664496|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154664497|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664498|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
154664499|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
154664500|NCT02400333|Ticagrelor|ticagrelor|mesh-list
154664501|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154664502|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154167071|NCT00809939|Progesterone|progesterone|mesh-list
154664503|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154664504|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154664505|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
154664506|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664507|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664508|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664509|NCT02399475|Hormones|hormones|mesh-list
154664510|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
154664511|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664512|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664513|NCT02399163|Fluorides|fluorides|mesh-list
154664514|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
154664515|NCT02399163|Protective Agents|protective agents|mesh-ancestor
154664516|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664517|NCT02397837|Pramipexole|pramipexole|mesh-list
154664518|NCT02397837|Dexpramipexole|dexpramipexole|mesh-list
154664519|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
154664520|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664521|NCT02397837|Protective Agents|protective agents|mesh-ancestor
154664522|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664523|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154664524|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154664525|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
154664526|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
154664527|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664528|NCT05549167|Sirolimus|sirolimus|mesh-list
154664529|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154416506|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
154664530|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664531|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154664532|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664533|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
154664534|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154664535|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
154664536|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664537|NCT05548465|Sufentanil|sufentanil|mesh-list
154664538|NCT05548465|Remifentanil|remifentanil|mesh-list
154664540|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154664541|NCT05548465|Narcotics|narcotics|mesh-ancestor
154664542|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664543|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664544|NCT05548465|Analgesics|analgesics|mesh-ancestor
154664545|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
154664546|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664547|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154664548|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154664549|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
154664550|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
154664551|NCT05554003|Temozolomide|temozolomide|mesh-list
154664552|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154664553|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
154664554|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664555|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664556|NCT05541757|Heparin|heparin|mesh-list
154664557|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
154664558|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154664559|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154664560|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664561|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
154664562|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664563|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664564|NCT05541445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154664565|NCT05541445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664566|NCT05540977|Donepezil|donepezil|mesh-list
154664567|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154664568|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664569|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664570|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
154664571|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664572|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664573|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
154664574|NCT05547685|Methylene Blue|methylene blue|mesh-list
154664575|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664576|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664577|NCT05540587|Warfarin|warfarin|mesh-list
154664578|NCT05540587|Edoxaban|edoxaban|mesh-list
154664579|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
154664580|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154664581|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
154664582|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154664583|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
154664584|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664585|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664586|NCT05540431|Charcoal|charcoal|mesh-list
154664587|NCT05540431|Antidotes|antidotes|mesh-ancestor
154664588|NCT05540431|Protective Agents|protective agents|mesh-ancestor
154664589|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664590|NCT05553067|Antibodies|antibodies|mesh-list
154664591|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
154664592|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664593|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
154664594|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154664595|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154664596|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154664597|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154664598|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664599|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
154664600|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664601|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664602|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154664603|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664604|NCT01666951|Tacrolimus|tacrolimus|mesh-list
154664605|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154664606|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
154664607|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664608|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154664609|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664610|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664611|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154664612|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
154664613|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664615|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154664616|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154664617|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
154664618|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664619|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154664620|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154664621|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664622|NCT05550025|Apatinib|apatinib|mesh-list
154664623|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664624|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154664625|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664626|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664627|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
154664628|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154664629|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
154664630|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664631|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
154664632|NCT05700253|Protective Agents|protective agents|mesh-ancestor
154664633|NCT05544253|Mitomycins|mitomycins|mesh-list
154664634|NCT05544253|Mitomycin|mitomycin|mesh-list
154664635|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154664636|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664637|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
154664638|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664639|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154664640|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664641|NCT05535517|Emollients|emollients|mesh-list
154664642|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
154664643|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
154664644|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154664645|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664646|NCT02580877|Insulin|insulin|mesh-list
154664647|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154664648|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
154664649|NCT02580877|Methamphetamine|methamphetamine|mesh-list
154664650|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154664651|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664652|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154664653|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
154664654|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
154664655|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664656|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
154664657|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664658|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664659|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
154664660|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154664661|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154664662|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154664663|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154664664|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
154664665|NCT01905631|Promethazine|promethazine|mesh-list
154664666|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154664667|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154167247|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
154664668|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664669|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664670|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
154664671|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
154664672|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
154664673|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664674|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
154664675|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
154664676|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154664677|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154664678|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
154664679|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
154664680|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664681|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664682|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154664683|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
154664684|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
154664685|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
154664686|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
154664687|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664688|NCT05679037|Protective Agents|protective agents|mesh-ancestor
154664689|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664690|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
154664691|NCT05679037|Vitamins|vitamins|mesh-ancestor
154664692|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
154664693|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
154664694|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154664695|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154664696|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664697|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154664698|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154664699|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
154664700|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664701|NCT02582749|Bicalutamide|bicalutamide|mesh-list
154664702|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154664703|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
154664704|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
154664705|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167284|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664706|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664707|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664708|NCT05461261|Prednisolone|prednisolone|mesh-list
154664709|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154664710|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
154664711|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154664712|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
154664713|NCT05461261|Docetaxel|docetaxel|mesh-list
154664714|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154664715|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
154664716|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664717|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
154664718|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
154664719|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
154664720|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664721|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154664722|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
154664723|NCT05461261|Hormones|hormones|mesh-ancestor
154664724|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664725|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664726|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154664727|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
154664728|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
154664729|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664730|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154664731|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154664732|NCT05461261|Protective Agents|protective agents|mesh-ancestor
154664733|NCT05678413|Paclitaxel|paclitaxel|mesh-list
154664734|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154664735|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664736|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
154664737|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
154664738|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
154664739|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664740|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
154664741|NCT05678335|Tacrolimus|tacrolimus|mesh-list
154664742|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154664743|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
154664744|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664745|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154664746|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664747|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664748|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
154664749|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154664750|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154664751|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664752|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664753|NCT02582671|Ritonavir|ritonavir|mesh-list
154664754|NCT02582671|Ribavirin|ribavirin|mesh-list
154664755|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154664756|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154664757|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
154664758|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664759|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664760|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154664761|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154664762|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
154664763|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664764|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154664765|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154664766|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
154664767|NCT02585713|Dalteparin|dalteparin|mesh-list
154664768|NCT02585713|Tinzaparin|tinzaparin|mesh-list
154664769|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154664770|NCT02585713|Apixaban|apixaban|mesh-list
154664771|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154664772|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
154664773|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154664774|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
154664775|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664776|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664777|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
154664778|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154664779|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154664780|NCT05078671|Cobicistat|cobicistat|mesh-list
154664781|NCT05078671|Olaparib|olaparib|mesh-list
154664782|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154664783|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664784|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664785|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664786|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154664787|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154664788|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
154664789|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664790|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154664791|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154664792|NCT02579863|Dexamethasone|dexamethasone|mesh-list
154664793|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
154664794|NCT02579863|Lenalidomide|lenalidomide|mesh-list
154664795|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154664796|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
154664797|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
154664798|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664799|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664800|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154664801|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
154664802|NCT02579863|Hormones|hormones|mesh-ancestor
154664803|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664804|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154664805|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664806|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664807|NCT02579863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154664808|NCT02579863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167372|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
154664809|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
154664810|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154664811|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154664812|NCT02579863|Growth Substances|growth substances|mesh-ancestor
154664813|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
154664814|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154664815|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154664816|NCT05677945|Simvastatin|simvastatin|mesh-list
154664817|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664818|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
154664819|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154664820|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154664821|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
154664822|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664823|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154664824|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154664825|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664826|NCT02582515|Cycloserine|cycloserine|mesh-list
154664827|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154664828|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664829|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154664830|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
154664831|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154664832|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
154664833|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664834|NCT02579629|Ropivacaine|ropivacaine|mesh-list
154664835|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
154664836|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
154664837|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664838|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664839|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
154664840|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664841|NCT05677555|Colchicine|colchicine|mesh-list
154664842|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
154664843|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664844|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
154664845|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
154664846|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
154664847|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664848|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664849|NCT02343939|Cytarabine|cytarabine|mesh-list
154167435|NCT00061945|Leucovorin|leucovorin|mesh-list
154664850|NCT02343939|Azacitidine|azacitidine|mesh-list
154664851|NCT02343939|Decitabine|decitabine|mesh-list
154664852|NCT02343939|Daunorubicin|daunorubicin|mesh-list
154664853|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154664854|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
154664855|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664856|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664857|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
154664858|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664859|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154664860|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
154664861|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664862|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664863|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154664864|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154664865|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154664866|NCT02343549|Bevacizumab|bevacizumab|mesh-list
154664867|NCT02343549|Temozolomide|temozolomide|mesh-list
154664868|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154664869|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664870|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154664871|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154664872|NCT02343549|Growth Substances|growth substances|mesh-ancestor
154664873|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664874|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
154664875|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154664876|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
154664877|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664878|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154664879|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
154664880|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154664881|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
154664882|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664883|NCT02395653|Fentanyl|fentanyl|mesh-list
154664884|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154664885|NCT02395653|Narcotics|narcotics|mesh-ancestor
154664886|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664887|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664888|NCT02395653|Analgesics|analgesics|mesh-ancestor
154664889|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
154664890|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664891|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154664892|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154664893|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
154664894|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
154664895|NCT01664923|Bicalutamide|bicalutamide|mesh-list
154664896|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
154664897|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
154664898|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154664899|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664900|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664901|NCT04403347|Losartan|losartan|mesh-list
154664902|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
154664903|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154167471|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
154664904|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154664905|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154664906|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664907|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154664908|NCT01664533|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154664909|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154664910|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664911|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664912|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154664913|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154664914|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154664915|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154664916|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664917|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664918|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154664919|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154664920|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664921|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
154664922|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664923|NCT05692297|Denosumab|denosumab|mesh-list
154664924|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154664925|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664926|NCT05696509|Anesthetics|anesthetics|mesh-list
154664927|NCT05696509|Propofol|propofol|mesh-list
154664928|NCT05696509|Sevoflurane|sevoflurane|mesh-list
154664929|NCT05696509|Isoflurane|isoflurane|mesh-list
154664930|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664931|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664932|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154664933|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154664934|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
154664935|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154664936|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154664937|NCT02584855|Ixekizumab|ixekizumab|mesh-list
154664938|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
154664939|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
154664940|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
154664941|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154664942|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154664943|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664944|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664945|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664946|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664947|NCT02581345|Adalimumab|adalimumab|mesh-list
154664948|NCT02581345|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154664949|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154664950|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154664951|NCT05579509|Midazolam|midazolam|mesh-list
154664952|NCT05579509|Fentanyl|fentanyl|mesh-list
154664953|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154664954|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154664955|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154664956|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664957|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154664958|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154664959|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154167527|NCT00366340|Vaccines|vaccines|mesh-list
154664960|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154664961|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
154664962|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
154664963|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
154664964|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
154664965|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154664966|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664967|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154664968|NCT05579509|Narcotics|narcotics|mesh-ancestor
154664969|NCT05579509|Analgesics|analgesics|mesh-ancestor
154664970|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
154664971|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154664972|NCT05696431|Fluorides|fluorides|mesh-list
154664973|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
154664974|NCT05696431|Protective Agents|protective agents|mesh-ancestor
154664975|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664976|NCT05568745|Misoprostol|misoprostol|mesh-list
154664977|NCT05568745|Oxytocin|oxytocin|mesh-list
154664978|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
154664979|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154664980|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154664981|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154416955|NCT02088398|Ricolinostat|ricolinostat|mesh-list
154664982|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
154664983|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154664984|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154664985|NCT02581189|Ritonavir|ritonavir|mesh-list
154664986|NCT02581189|Ribavirin|ribavirin|mesh-list
154664987|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154664988|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154664989|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
154664990|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154664991|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154664992|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154664993|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154664994|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
154664995|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154664996|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154664997|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154664998|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
154664999|NCT02576977|Dexamethasone|dexamethasone|mesh-list
154665000|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
154665001|NCT02576977|Pomalidomide|pomalidomide|mesh-list
154665002|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665003|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
154665004|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
154167582|NCT01045018|Mesalamine|mesalamine|mesh-list
154665005|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665006|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665007|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154665008|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
154665009|NCT02576977|Hormones|hormones|mesh-ancestor
154665010|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665011|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154665012|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665013|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665014|NCT02576977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665015|NCT02576977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665016|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
154665017|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154665018|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154665019|NCT02576977|Growth Substances|growth substances|mesh-ancestor
154665020|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
154665021|NCT05867212|Cabotegravir|cabotegravir|mesh-list
154665022|NCT05867212|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154665023|NCT05867212|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154665024|NCT05867212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665025|NCT05867212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665026|NCT05867212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154665027|NCT05867212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154665028|NCT05867212|Antiviral Agents|antiviral agents|mesh-ancestor
154665029|NCT05867212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154665030|NCT05866848|Caffeine|caffeine|mesh-list
154665031|NCT05866848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154665032|NCT05866848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665033|NCT05866848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154665034|NCT05866848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665035|NCT05866848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665036|NCT05866848|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154665037|NCT05866848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154665038|NCT05866848|Purinergic Agents|purinergic agents|mesh-ancestor
154665039|NCT05866848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665040|NCT05866614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154665041|NCT05866614|Immunologic Factors|immunologic factors|mesh-ancestor
154665042|NCT05866614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665043|NCT05866588|Coal Tar|coal tar|mesh-list
154665044|NCT05866588|Keratolytic Agents|keratolytic agents|mesh-ancestor
154665045|NCT05866588|Dermatologic Agents|dermatologic agents|mesh-ancestor
154665046|NCT05866575|Vortioxetine|vortioxetine|mesh-list
154665047|NCT05866575|Escitalopram|escitalopram|mesh-list
154665048|NCT05866575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154665049|NCT05866575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154665050|NCT05866575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154665051|NCT05866575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665052|NCT05866575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665053|NCT05866575|Serotonin Agents|serotonin agents|mesh-ancestor
154665054|NCT05866575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665055|NCT05866575|Antidepressive Agents|antidepressive agents|mesh-ancestor
154665056|NCT05866575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154417029|NCT05042947|Hormones|hormones|mesh-ancestor
154665057|NCT05866575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154665058|NCT05866575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154665059|NCT05866575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665060|NCT05866575|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154665061|NCT05866575|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154665062|NCT05866575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154665063|NCT05866575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154665064|NCT05866172|Zoledronic Acid|zoledronic acid|mesh-list
154665065|NCT05866172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154665066|NCT05866172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665067|NCT05866068|Clomiphene|clomiphene|mesh-list
154665068|NCT05866068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154665069|NCT05866068|Hormone Antagonists|hormone antagonists|mesh-ancestor
154665070|NCT05866068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665071|NCT05866068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665072|NCT05866068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154665073|NCT05866068|Fertility Agents|fertility agents|mesh-ancestor
154665074|NCT05866068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154665075|NCT05866068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154665076|NCT05866068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154665077|NCT05865925|Irinotecan|irinotecan|mesh-list
154665078|NCT05865925|Floxuridine|floxuridine|mesh-list
154665079|NCT05865925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154665080|NCT05865925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154665081|NCT05865925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665082|NCT05865925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665083|NCT05865925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665084|NCT05865925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154665085|NCT05865925|Antimetabolites|antimetabolites|mesh-ancestor
154665086|NCT05865548|Aspirin|aspirin|mesh-list
154665087|NCT05865548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154665088|NCT05865548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154665089|NCT05865548|Analgesics|analgesics|mesh-ancestor
154665090|NCT05865548|Sensory System Agents|sensory system agents|mesh-ancestor
154665091|NCT05865548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665092|NCT05865548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665093|NCT05865548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665094|NCT05865548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665095|NCT05865548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154665096|NCT05865548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154665097|NCT05865548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665098|NCT05865548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154665099|NCT05865548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154665100|NCT05865548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665101|NCT05865548|Antipyretics|antipyretics|mesh-ancestor
154665102|NCT05861440|Antitubercular Agents|antitubercular agents|mesh-list
154665103|NCT05861440|Prednisolone|prednisolone|mesh-list
154665104|NCT05861440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665105|NCT05861440|Glucocorticoids|glucocorticoids|mesh-ancestor
154665106|NCT05861440|Hormones|hormones|mesh-ancestor
154665107|NCT05861440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665108|NCT05861440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665109|NCT05861440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154665110|NCT05861440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665111|NCT05861440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154665112|NCT05861440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154665113|NCT05866029|Denosumab|denosumab|mesh-list
154665114|NCT05866029|Teriparatide|teriparatide|mesh-list
154665115|NCT05866029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154665116|NCT05866029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665117|NCT05866029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154665118|NCT05740618|Mannitol|mannitol|mesh-list
154665119|NCT05740618|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154665120|NCT05740618|Diuretics|diuretics|mesh-ancestor
154665121|NCT05740618|Natriuretic Agents|natriuretic agents|mesh-ancestor
154665122|NCT05740618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665123|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154665124|NCT05677295|Imipramine|imipramine|mesh-list
154665125|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154665126|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154665127|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154665128|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665129|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665130|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665131|NCT05677295|Analgesics|analgesics|mesh-ancestor
154665132|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
154665133|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665134|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
154665135|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154665136|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
154665137|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154665138|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154665139|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
154665140|NCT05476991|Aspirin|aspirin|mesh-list
154665141|NCT05476991|Colchicine|colchicine|mesh-list
154665142|NCT05476991|Ticagrelor|ticagrelor|mesh-list
154665143|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154665144|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154665145|NCT05476991|Analgesics|analgesics|mesh-ancestor
154665146|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
154665147|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665148|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665149|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665150|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665151|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154665152|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154665153|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665154|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154665155|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154665156|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665157|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
154665158|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154665159|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154665160|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154665161|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
154665162|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665163|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
154665164|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154665165|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154665166|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154665167|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665168|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
154665169|NCT05465226|Narcotics|narcotics|mesh-ancestor
154665170|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665171|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665172|NCT05465226|Analgesics|analgesics|mesh-ancestor
154665173|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
154665174|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665175|NCT05382806|Flumazenil|flumazenil|mesh-list
154665176|NCT05382806|Antidotes|antidotes|mesh-ancestor
154665177|NCT05382806|Protective Agents|protective agents|mesh-ancestor
154665178|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665179|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
154665180|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
154665181|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665182|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665183|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
154665184|NCT05379972|Olaparib|olaparib|mesh-list
154665185|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665186|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665187|NCT05379972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665188|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665189|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154665190|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665191|NCT05312008|Oxytocin|oxytocin|mesh-list
154665192|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
154665193|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154665194|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665195|NCT05163496|Psilocybin|psilocybin|mesh-list
154665196|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
154665197|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665198|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154665199|NCT05162443|Adagrasib|adagrasib|mesh-list
154665200|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665201|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154665202|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154665203|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154417185|NCT02085902|Ropivacaine|ropivacaine|mesh-list
154167780|NCT00044083|Tolcapone|tolcapone|mesh-list
154665204|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665205|NCT04952402|Vaccines|vaccines|mesh-list
154665206|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
154665207|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665208|NCT04941144|Vaccines|vaccines|mesh-list
154665209|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
154665210|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665211|NCT04842045|Midazolam|midazolam|mesh-list
154665212|NCT04842045|Psilocybin|psilocybin|mesh-list
154665213|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154665214|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154665215|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665216|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665217|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154665218|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154665219|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154665220|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154665221|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
154665222|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
154665223|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
154665224|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
154665225|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665226|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665227|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
154665228|NCT04754945|Dexamethasone|dexamethasone|mesh-list
154665229|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
154665230|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
154665231|NCT04754945|Bortezomib|bortezomib|mesh-list
154665232|NCT04754945|Ichthammol|ichthammol|mesh-list
154665233|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154665234|NCT04754945|BB 1101|bb 1101|mesh-list
154665235|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154665236|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
154665237|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665238|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665239|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154665240|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
154665241|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665242|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665243|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154665244|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665245|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
154665246|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
154665247|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665248|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154665249|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
154665250|NCT04754945|Hormones|hormones|mesh-ancestor
154665251|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665252|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154665253|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
154665254|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665255|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
154665256|NCT04580498|Paclitaxel|paclitaxel|mesh-list
154665257|NCT04580498|Carboplatin|carboplatin|mesh-list
154665258|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154665259|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665260|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
154665261|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
154665262|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
154665263|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665264|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154665265|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154665266|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665267|NCT04428385|Artemisinins|artemisinins|mesh-list
154665268|NCT04428385|Artemisinin|artemisinin|mesh-list
154665269|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
154665270|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154665271|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154665272|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154665273|NCT04074161|Liraglutide|liraglutide|mesh-list
154665274|NCT04074161|Semaglutide|semaglutide|mesh-list
154665275|NCT04074161|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154665276|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154665277|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665278|NCT04074161|Incretins|incretins|mesh-ancestor
154665279|NCT04074161|Hormones|hormones|mesh-ancestor
154665280|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665281|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
154665282|NCT03997903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154665283|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154665284|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665285|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665286|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665287|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
154665288|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
154665289|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154665290|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
154665291|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665292|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154665293|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665294|NCT03843528|Azacitidine|azacitidine|mesh-list
154665295|NCT03843528|Vorinostat|vorinostat|mesh-list
154665296|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154665297|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
154665298|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665299|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665300|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665301|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154665302|NCT03779789|Vortioxetine|vortioxetine|mesh-list
154665303|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
154665304|NCT03779789|Citalopram|citalopram|mesh-list
154665305|NCT03779789|Fluoxetine|fluoxetine|mesh-list
154665306|NCT03779789|Paroxetine|paroxetine|mesh-list
154665307|NCT03779789|Sertraline|sertraline|mesh-list
154665308|NCT03779789|Escitalopram|escitalopram|mesh-list
154665309|NCT03779789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154665310|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154665311|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154665312|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665313|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665314|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
154665315|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665316|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154665317|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
154665318|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154665319|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154665320|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154665321|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665322|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154665323|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154665324|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665325|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154665326|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154665327|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154665328|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154665329|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154665330|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154665331|NCT03733210|Panitumumab|panitumumab|mesh-list
154665332|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665333|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665334|NCT03667820|Osimertinib|osimertinib|mesh-list
154665335|NCT03667820|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154665336|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154665337|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665338|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665339|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665340|NCT03627468|Bromides|bromides|mesh-list
154665341|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
154665342|NCT03588039|Paclitaxel|paclitaxel|mesh-list
154665343|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
154665344|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154665345|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665346|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
154665347|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
154665348|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
154665349|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665350|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665351|NCT03588039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665352|NCT03553004|Niraparib|niraparib|mesh-list
154665353|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154665354|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665355|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665356|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665358|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665359|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665360|NCT03488667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665361|NCT03488667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665362|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154665363|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
154665364|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665365|NCT03317535|Anesthetics|anesthetics|mesh-list
154665366|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665367|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665368|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
154665369|NCT03313206|Lenvatinib|lenvatinib|mesh-list
154665370|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665371|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665372|NCT03313206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665373|NCT03313206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665374|NCT03313206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154665375|NCT03313206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665376|NCT03250377|Brivaracetam|brivaracetam|mesh-list
154665377|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
154665378|NCT03052816|Hydromorphone|hydromorphone|mesh-list
154665379|NCT03052816|Analgesics|analgesics|mesh-ancestor
154665380|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
154665381|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665382|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665383|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154665384|NCT03052816|Narcotics|narcotics|mesh-ancestor
154665385|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665386|NCT02955940|Capecitabine|capecitabine|mesh-list
154665387|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154665388|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
154665389|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665390|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665391|NCT02393625|Nivolumab|nivolumab|mesh-list
154665392|NCT02393625|Ceritinib|ceritinib|mesh-list
154665393|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665394|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665395|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665396|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665397|NCT02393625|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154665398|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154665399|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665400|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154665401|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
154665402|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665403|NCT02168829|Aspirin|aspirin|mesh-list
154665404|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
154665405|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154665406|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154665407|NCT02168829|Analgesics|analgesics|mesh-ancestor
154665408|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
154665409|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665410|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665411|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665412|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665413|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154665414|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154665415|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665416|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154665417|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154665418|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665419|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
154665420|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154665421|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
154665422|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154665423|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
154665424|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
154665425|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154665426|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
154665427|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665428|NCT01433289|Protective Agents|protective agents|mesh-ancestor
154665429|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665430|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154665431|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154665432|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665433|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154665434|NCT00995475|Fluticasone|fluticasone|mesh-list
154665435|NCT00995475|Xhance|xhance|mesh-list
154665436|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665437|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154665438|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
154665439|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665440|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665441|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154665442|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
154665443|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154665444|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154665445|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
154665446|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154665447|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
154665448|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665449|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665450|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154665451|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
154665452|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154665453|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
154665454|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665455|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665456|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154665457|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
154665458|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
154665459|NCT00945529|Protective Agents|protective agents|mesh-ancestor
154665460|NCT00921115|Fulvestrant|fulvestrant|mesh-list
154665461|NCT00921115|Anastrozole|anastrozole|mesh-list
154665462|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154665463|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665464|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154665465|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154665466|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
154665467|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665468|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665469|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154665470|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154665471|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665472|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665473|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
154665474|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154665475|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
154665476|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665477|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665478|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154665479|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
154665480|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154665481|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154665482|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154665483|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
154665484|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665485|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665486|NCT04425187|Bevacizumab|bevacizumab|mesh-list
154665487|NCT04425187|Gefitinib|gefitinib|mesh-list
154665488|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665489|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665490|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154665491|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154665492|NCT04425187|Growth Substances|growth substances|mesh-ancestor
154665493|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665494|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
154168082|NCT01049854|Thiotepa|thiotepa|mesh-list
154665495|NCT04425187|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154665496|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154665497|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665498|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665499|NCT05519839|Vaccines|vaccines|mesh-list
154665500|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
154665501|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665502|NCT05529667|Paclitaxel|paclitaxel|mesh-list
154665503|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154417483|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665504|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665505|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
154665506|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
154665507|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154665508|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665510|NCT03571633|Trastuzumab|trastuzumab|mesh-list
154665511|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154665512|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665513|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
154665514|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
154665515|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
154665516|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665517|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665518|NCT05533255|Z 350|z 350|mesh-list
154665519|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154665520|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154665521|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665522|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665523|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
154665524|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665525|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665526|NCT05529355|Tegafur|tegafur|mesh-list
154665527|NCT05529355|Endostar protein|endostar protein|mesh-list
154665528|NCT05529355|Endostatins|endostatins|mesh-list
154665529|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154665530|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
154665531|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665532|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665533|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154665534|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154665535|NCT05529355|Growth Substances|growth substances|mesh-ancestor
154168118|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665536|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665537|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
154665538|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
154665539|NCT05528887|Fludarabine|fludarabine|mesh-list
154665540|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154665541|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
154665542|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665543|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665544|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154665545|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
154665546|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665547|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665548|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154665549|NCT03009019|Celecoxib|celecoxib|mesh-list
154665550|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154665551|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154665552|NCT03009019|Analgesics|analgesics|mesh-ancestor
154665553|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
154665554|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665555|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665556|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665557|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665558|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154665559|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154665560|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665561|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665562|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
154665563|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665564|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665565|NCT02575807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665566|NCT02575807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665567|NCT02813785|Docetaxel|docetaxel|mesh-list
154665568|NCT02813785|Atezolizumab|atezolizumab|mesh-list
154665569|NCT02813785|Antibodies|antibodies|mesh-list
154665570|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
154665571|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665572|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665573|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
154665574|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
154665575|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
154665576|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665577|NCT02813785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665578|NCT02813785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665579|NCT04302181|Ropivacaine|ropivacaine|mesh-list
154665580|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
154665581|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
154168161|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154665582|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665583|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665584|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
154665585|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665586|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
154665587|NCT05527795|Immunomodulating Agents|immunomodulating agents|mesh-list
154665588|NCT05527795|Immunologic Factors|immunologic factors|mesh-ancestor
154665589|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665590|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154665591|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154665592|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
154665593|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665594|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665595|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
154665596|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
154665597|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665598|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
154665599|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154665600|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
154665601|NCT05532085|Analgesics|analgesics|mesh-list
154665602|NCT05532085|Anesthetics|anesthetics|mesh-list
154665603|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665604|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665605|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
154665606|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665607|NCT02303119|Rituximab|rituximab|mesh-list
154665608|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665609|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665610|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
154665611|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665612|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665613|NCT02575339|Sorafenib|sorafenib|mesh-list
154665614|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665615|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154665616|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665617|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665618|NCT01640587|Artesunate|artesunate|mesh-list
154665619|NCT01640587|Piperaquine|piperaquine|mesh-list
154665620|NCT01640587|Artenimol|artenimol|mesh-list
154665621|NCT01640587|Mefloquine|mefloquine|mesh-list
154665622|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
154665623|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154665624|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154665625|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154665626|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665627|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
154665628|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
154665629|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154665630|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
154665631|NCT01610713|Nabiximols|nabiximols|mesh-list
154665632|NCT01610713|Analgesics|analgesics|mesh-ancestor
154665633|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
154665634|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665635|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665636|NCT01606189|Nabiximols|nabiximols|mesh-list
154665637|NCT01606189|Analgesics|analgesics|mesh-ancestor
154665638|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
154665639|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665640|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665641|NCT01663987|Bromides|bromides|mesh-list
154665642|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
154665643|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154665644|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
154665645|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665646|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665647|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154665648|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
154665649|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
154665650|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154665651|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
154665652|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665653|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665654|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
154665656|NCT05305651|Antiviral Agents|antiviral agents|mesh-ancestor
154665657|NCT05305651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154665658|NCT02380287|Antibodies|antibodies|mesh-list
154665659|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154665660|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
154665661|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665662|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
154665663|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154665664|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
154665665|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665666|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
154665667|NCT02342223|Protective Agents|protective agents|mesh-ancestor
154665668|NCT02393547|Varenicline|varenicline|mesh-list
154665669|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154665670|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154665671|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
154168276|NCT06333951|Pemetrexed|pemetrexed|mesh-list
154665672|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665673|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665674|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665675|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154665676|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
154665677|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665678|NCT05531383|Memantine|memantine|mesh-list
154665679|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154665680|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154665681|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
154665682|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665683|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665684|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665685|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154665686|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154665687|NCT02392611|Fulvestrant|fulvestrant|mesh-list
154665688|NCT02392611|Exemestane|exemestane|mesh-list
154665689|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154665690|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665691|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154665692|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154665693|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
154665694|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665695|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665696|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154665697|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154665698|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665699|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665700|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
154665701|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154665702|NCT02378961|Velpatasvir|velpatasvir|mesh-list
154665703|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
154665704|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154665705|NCT05518513|Bupivacaine|bupivacaine|mesh-list
154665706|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
154665707|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
154665708|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665709|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665710|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
154168312|NCT06333691|Calcium|calcium|mesh-list
154665711|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665712|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
154665713|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154665714|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154665715|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665716|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
154665717|NCT05518279|Coagulants|coagulants|mesh-ancestor
154665718|NCT05523037|Sevoflurane|sevoflurane|mesh-list
154665719|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154665720|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154665721|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
154665722|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
154665723|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665724|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665725|NCT04625647|Sotorasib|sotorasib|mesh-list
154665726|NCT04625647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154665727|NCT04625647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417725|NCT02099240|Cefoperazone|cefoperazone|mesh-list
154665728|NCT04625647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665729|NCT04625647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665730|NCT05122741|Aspirin|aspirin|mesh-list
154665731|NCT05122741|Clopidogrel|clopidogrel|mesh-list
154665732|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154665733|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154665734|NCT05122741|Analgesics|analgesics|mesh-ancestor
154665735|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
154665736|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665737|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665738|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665739|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665740|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154665741|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154665742|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665743|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154665744|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154665745|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665746|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
154665747|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154665748|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154665749|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154665750|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
154665751|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665752|NCT05525767|Bevacizumab|bevacizumab|mesh-list
154665753|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665754|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665755|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154665756|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154665757|NCT05525767|Growth Substances|growth substances|mesh-ancestor
154665758|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665759|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
154665760|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154665761|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665762|NCT05025085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665763|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665764|NCT05522491|Olaparib|olaparib|mesh-list
154665765|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154665766|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665767|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168358|NCT06333418|Methamphetamine|methamphetamine|mesh-list
154665768|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665769|NCT02340975|Durvalumab|durvalumab|mesh-list
154665770|NCT02340975|Tremelimumab|tremelimumab|mesh-list
154665771|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154665772|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665773|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665774|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
154665775|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665776|NCT02392377|Leucovorin|leucovorin|mesh-list
154665777|NCT02392377|Paclitaxel|paclitaxel|mesh-list
154665778|NCT02392377|Carboplatin|carboplatin|mesh-list
154665779|NCT02392377|Fluorouracil|fluorouracil|mesh-list
154665780|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
154665781|NCT02392377|Calcium|calcium|mesh-list
154665782|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
154665783|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154665784|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665785|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
154665786|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
154665787|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
154665788|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665789|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154665790|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665791|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
154665792|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154665793|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154665794|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
154665795|NCT02392377|Antidotes|antidotes|mesh-ancestor
154665796|NCT02392377|Protective Agents|protective agents|mesh-ancestor
154665797|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
154665798|NCT02392377|Vitamins|vitamins|mesh-ancestor
154665799|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
154665800|NCT02340819|Teduglutide|teduglutide|mesh-list
154665801|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154665802|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154665803|NCT02340819|Protective Agents|protective agents|mesh-ancestor
154665804|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665806|NCT04903509|Liraglutide|liraglutide|mesh-list
154665807|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154665808|NCT04903509|Analgesics|analgesics|mesh-ancestor
154665809|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
154665810|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665811|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665812|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
154665813|NCT04903509|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154665814|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154665815|NCT04903509|Incretins|incretins|mesh-ancestor
154665816|NCT04903509|Hormones|hormones|mesh-ancestor
154665817|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665818|NCT05517499|Dexamethasone|dexamethasone|mesh-list
154665819|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
154665820|NCT05517499|BB 1101|bb 1101|mesh-list
154665821|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665822|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
154665823|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
154665824|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665825|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665826|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154665827|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
154665828|NCT05517499|Hormones|hormones|mesh-ancestor
154665829|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665830|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154665831|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665832|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
154665833|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665834|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665835|NCT05512351|Bevacizumab|bevacizumab|mesh-list
154665836|NCT05512351|Tislelizumab|tislelizumab|mesh-list
154665837|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665838|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665839|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154665840|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154665841|NCT05512351|Growth Substances|growth substances|mesh-ancestor
154665842|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665843|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
154665844|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
154665845|NCT02569957|Topotecan|topotecan|mesh-list
154665846|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154665847|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154665848|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154665849|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665850|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665851|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665852|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
154665853|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154665854|NCT02569957|Expectorants|expectorants|mesh-ancestor
154665855|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
154665856|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154665857|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
154665858|NCT02569957|Protective Agents|protective agents|mesh-ancestor
154665859|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665860|NCT02569957|Antidotes|antidotes|mesh-ancestor
154665861|NCT01649427|Tacrolimus|tacrolimus|mesh-list
154665862|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154665863|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
154665864|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665865|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154665866|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665867|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665868|NCT05521633|Metformin|metformin|mesh-list
154665869|NCT05521633|Pioglitazone|pioglitazone|mesh-list
154665870|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154665871|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665872|NCT02336607|Metoprolol|metoprolol|mesh-list
154665873|NCT02336607|Felodipine|felodipine|mesh-list
154665874|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154665875|NCT02336607|Lisinopril|lisinopril|mesh-list
154665876|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154665877|NCT02336607|Diuretics|diuretics|mesh-ancestor
154665878|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
154665879|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417885|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665880|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154665881|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154665882|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665883|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154665884|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
154665885|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
154665886|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665887|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154665888|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154665889|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154665890|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
154665891|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665892|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154665893|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
154665894|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665895|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154665896|NCT02336607|Protective Agents|protective agents|mesh-ancestor
154665897|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154665898|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154665899|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
154665900|NCT02569801|Fulvestrant|fulvestrant|mesh-list
154665901|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154665902|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665903|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154665904|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154665905|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
154665906|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154665907|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665908|NCT02573311|Tamsulosin|tamsulosin|mesh-list
154665909|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154665910|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154665911|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154168532|NCT06332079|Bevacizumab|bevacizumab|mesh-list
154665912|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
154665913|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665914|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665915|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665916|NCT02573311|Urological Agents|urological agents|mesh-ancestor
154665917|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154665918|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665919|NCT05520853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665920|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665921|NCT05516251|Topiramate|topiramate|mesh-list
154665922|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
154665923|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154665924|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665925|NCT02571049|Sumatriptan|sumatriptan|mesh-list
154665926|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154665927|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154665928|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154665929|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
154665930|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665931|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665932|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665933|NCT04295941|Trazodone|trazodone|mesh-list
154665934|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154665935|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154665936|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665937|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665938|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154665939|NCT04295941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154665940|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154665941|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154665942|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665943|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665944|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
154665945|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154665946|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
154665947|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
154665948|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154665949|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
154417966|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
154665950|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665951|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665952|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154665953|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
154665955|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154665956|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
154665957|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154665958|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665959|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154665960|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154665961|NCT05519371|Propofol|propofol|mesh-list
154665962|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154665963|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154665964|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665965|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154665966|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
154665967|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
154665968|NCT04847947|Vitamin D|vitamin d|mesh-list
154665969|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
154665970|NCT04847947|Vitamins|vitamins|mesh-ancestor
154665971|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
154665972|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665973|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154665974|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154665975|NCT05514925|Bevacizumab|bevacizumab|mesh-list
154665976|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154665977|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154665978|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154665979|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154665980|NCT05514925|Growth Substances|growth substances|mesh-ancestor
154665981|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665982|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
154665983|NCT05514847|Aspirin|aspirin|mesh-list
154665984|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154665985|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154665986|NCT05514847|Analgesics|analgesics|mesh-ancestor
154665987|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
154665988|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154665989|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154665990|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154665991|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154665992|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154665993|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154665994|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154665995|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154665996|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154665997|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154665998|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
154665999|NCT05510323|Prednisolone|prednisolone|mesh-list
154666000|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154666001|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
154666002|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154666003|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
154666004|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
154666005|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154666006|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
154666007|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666008|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
154666009|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666010|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666011|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154666012|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
154666013|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666014|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666015|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154666016|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666017|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
154666018|NCT05510323|Hormones|hormones|mesh-ancestor
154666019|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154666020|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154666021|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
154666022|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
154666023|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666024|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666025|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154666026|NCT05510323|Protective Agents|protective agents|mesh-ancestor
154666027|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
154666028|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154666029|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
154666030|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666031|NCT02568397|Dabigatran|dabigatran|mesh-list
154666032|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
154666033|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154666034|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
154666035|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666036|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666037|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
154666038|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
154666039|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154666040|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
154666041|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154666042|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
154666043|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666044|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666045|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
154666046|NCT05513131|Azacitidine|azacitidine|mesh-list
154666047|NCT05513131|Venetoclax|venetoclax|mesh-list
154666048|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
154666049|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154666050|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
154666051|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666052|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666053|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666054|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154666055|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154666056|NCT05506501|Anesthetics|anesthetics|mesh-list
154666057|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666058|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666059|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
154666060|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
154666061|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666062|NCT05509153|Expectorants|expectorants|mesh-ancestor
154666063|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
154666064|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154666065|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
154666066|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666067|NCT05509153|Protective Agents|protective agents|mesh-ancestor
154666068|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666069|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154666070|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154666071|NCT05505877|Tislelizumab|tislelizumab|mesh-list
154666072|NCT05505877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666073|NCT05505877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666074|NCT02336451|Ceritinib|ceritinib|mesh-list
154666075|NCT02336451|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154666076|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154666077|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666078|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666079|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666080|NCT01648101|Ezogabine|ezogabine|mesh-list
154666081|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
154666082|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666083|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666084|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
154666085|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666086|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
154666087|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666088|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666089|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154666090|NCT02372799|Fluoxetine|fluoxetine|mesh-list
154666091|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154666092|NCT02372799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154666093|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154666094|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666095|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666096|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666097|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
154418114|NCT02106338|REP 3123|rep 3123|mesh-list
154666098|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666099|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154666100|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
154666101|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154666102|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154666103|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154666104|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666105|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154666106|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154666107|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
154666108|NCT02566993|Doxorubicin|doxorubicin|mesh-list
154666109|NCT02566993|Vincristine|vincristine|mesh-list
154666110|NCT02566993|Topotecan|topotecan|mesh-list
154666111|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666112|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
154666113|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666114|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666115|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154666116|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
154666117|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666118|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666119|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154666120|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154666121|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154666122|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154666123|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666124|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154666125|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154666126|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154666127|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
154666128|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154666129|NCT02311881|Acetaminophen|acetaminophen|mesh-list
154666130|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154666131|NCT02311881|Analgesics|analgesics|mesh-ancestor
154666132|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
154666133|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666134|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666135|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
154666136|NCT02565511|Umibecestat|umibecestat|mesh-list
154666137|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666138|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666139|NCT02561455|Gilteritinib|gilteritinib|mesh-list
154666140|NCT02561455|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154666141|NCT02561455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154666142|NCT02561455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666143|NCT02561455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666144|NCT04549051|Anesthetics|anesthetics|mesh-list
154666145|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
154666146|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666147|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666148|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
154666149|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666150|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
154666151|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154666152|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154666153|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666154|NCT05505253|Vitamins|vitamins|mesh-ancestor
154666155|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
154666156|NCT02335983|Dexamethasone|dexamethasone|mesh-list
154666157|NCT02335983|Lenalidomide|lenalidomide|mesh-list
154666158|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666159|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
154666160|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
154666161|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666162|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666163|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666164|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
154666165|NCT02335983|Hormones|hormones|mesh-ancestor
154666166|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154666167|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154666168|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666169|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
154666170|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154666171|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154418195|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
154666172|NCT02335983|Growth Substances|growth substances|mesh-ancestor
154666173|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
154666174|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
154666175|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
154666176|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154666177|NCT04578691|Protective Agents|protective agents|mesh-ancestor
154666178|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666179|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
154666180|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154666181|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
154666182|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154666183|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154666184|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154666185|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666186|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666187|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
154666188|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666189|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666190|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154666191|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666192|NCT02310789|Ivacaftor|ivacaftor|mesh-list
154666193|NCT02310789|Pilocarpine|pilocarpine|mesh-list
154666194|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
154666195|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154666196|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666197|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666198|NCT02310789|Miotics|miotics|mesh-ancestor
154666199|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
154666200|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666201|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666202|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154666203|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154666204|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
154666205|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666206|NCT02372253|Verapamil|verapamil|mesh-list
154666207|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154666208|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154666209|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666210|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666211|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154666212|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666213|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
154666214|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
154666215|NCT02371629|Bromides|bromides|mesh-list
154666216|NCT02371629|Albuterol|albuterol|mesh-list
154666217|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
154666218|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154666219|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
154666220|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666221|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666222|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154666223|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
154666224|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
154666225|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154666226|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154666227|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154666228|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154666229|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
154666230|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666231|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666232|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154666233|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154666234|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154666235|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
154666236|NCT02559817|Linaclotide|linaclotide|mesh-list
154666237|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154666238|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
154666239|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666240|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666241|NCT04577443|Adenosine|adenosine|mesh-list
154666242|NCT04577443|Analgesics|analgesics|mesh-ancestor
154666243|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
154666244|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666245|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666246|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154666247|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
154666248|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154666249|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
154666250|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
154666251|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666252|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666253|NCT04411537|Capecitabine|capecitabine|mesh-list
154666254|NCT04411537|Irinotecan|irinotecan|mesh-list
154666255|NCT04411537|Antibodies|antibodies|mesh-list
154666256|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
154666257|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666258|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154666259|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
154666260|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666261|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666262|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154666263|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154666264|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666265|NCT05503147|Nabiximols|nabiximols|mesh-list
154666266|NCT05503147|Analgesics|analgesics|mesh-ancestor
154666267|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
154666268|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666269|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666270|NCT04619095|Psyllium|psyllium|mesh-list
154666271|NCT04619095|Cathartics|cathartics|mesh-ancestor
154666272|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666273|NCT05502991|Bevacizumab|bevacizumab|mesh-list
154666274|NCT05502991|Tislelizumab|tislelizumab|mesh-list
154666275|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666276|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666277|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154666278|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154666279|NCT05502991|Growth Substances|growth substances|mesh-ancestor
154666280|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666281|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
154666282|NCT02563561|Apaziquone|apaziquone|mesh-list
154666283|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666284|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154666285|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666286|NCT04424875|Melatonin|melatonin|mesh-list
154666287|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
154666288|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666289|NCT04424875|Protective Agents|protective agents|mesh-ancestor
154666290|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666291|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666292|NCT04277845|Dexamethasone|dexamethasone|mesh-list
154666293|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
154666294|NCT04277845|Lenalidomide|lenalidomide|mesh-list
154666295|NCT04277845|Bortezomib|bortezomib|mesh-list
154666296|NCT04277845|BB 1101|bb 1101|mesh-list
154666297|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666298|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
154666299|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
154666300|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666301|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666302|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666303|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
154666304|NCT04277845|Hormones|hormones|mesh-ancestor
154666305|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154666306|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154666307|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666308|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
154666309|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666310|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666311|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
154666312|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154666313|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154666314|NCT04277845|Growth Substances|growth substances|mesh-ancestor
154666315|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
154666316|NCT02559505|Vaccines|vaccines|mesh-list
154666317|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
154418341|NCT02103686|Pregabalin|pregabalin|mesh-list
154666318|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666319|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
154666320|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
154666321|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
154666322|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154666323|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154666324|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666325|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154666326|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666327|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666328|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154666329|NCT05560945|Listerine|listerine|mesh-list
154666330|NCT05560945|Fluorides|fluorides|mesh-list
154666331|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
154666332|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
154666333|NCT05560945|Protective Agents|protective agents|mesh-ancestor
154666334|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666335|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154666336|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666337|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
154666338|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154666339|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154666340|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666341|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
154666342|NCT04424563|Coagulants|coagulants|mesh-ancestor
154666343|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
154666344|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
154666345|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666346|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
154666347|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666348|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666349|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154666350|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
154666351|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666352|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666353|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154666354|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154666355|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154666356|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
154666357|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154666358|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666359|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666360|NCT03542461|Nivolumab|nivolumab|mesh-list
154666361|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666362|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666363|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154666364|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666365|NCT02556307|Ribavirin|ribavirin|mesh-list
154666366|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154666367|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
154666368|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666369|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
154666370|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666371|NCT05491057|Neratinib|neratinib|mesh-list
154666372|NCT05491057|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154666373|NCT05491057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154666374|NCT05491057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666375|NCT05491057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666376|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
154666377|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154666378|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666379|NCT05494645|Bupivacaine|bupivacaine|mesh-list
154666380|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
154666381|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
154666382|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666383|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666384|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
154666385|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666386|NCT05494567|Tadalafil|tadalafil|mesh-list
154666387|NCT05494567|Tamsulosin|tamsulosin|mesh-list
154666388|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
154666389|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
154666390|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154666391|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154666392|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666393|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666394|NCT05494567|Urological Agents|urological agents|mesh-ancestor
154666395|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154666396|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154666397|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154666398|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
154666399|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666400|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666401|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154666402|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154666403|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
154666404|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
154666405|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
154666406|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666407|NCT05494411|Mitomycins|mitomycins|mesh-list
154666408|NCT05494411|Mitomycin|mitomycin|mesh-list
154666409|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154666410|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666411|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
154666412|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666413|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154666414|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666415|NCT04251169|Paclitaxel|paclitaxel|mesh-list
154666416|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
154666417|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154666418|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666419|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
154666420|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
154666421|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
154666422|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666423|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666424|NCT04251169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154666425|NCT04279561|Edetic Acid|edetic acid|mesh-list
154666426|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154666427|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
154666428|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
154666429|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666430|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
154666431|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154666432|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154666433|NCT01662895|Deferoxamine|deferoxamine|mesh-list
154666434|NCT01662895|Siderophores|siderophores|mesh-ancestor
154666435|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154666436|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
154666437|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
154666438|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666439|NCT05498857|Ephedrine|ephedrine|mesh-list
154666440|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154666441|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666442|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
154666443|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
154666444|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666445|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154666446|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
154666447|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666448|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666449|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154666450|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666451|NCT04139395|Citric Acid|citric acid|mesh-list
154666452|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
154666453|NCT04139395|Gallium citrate|gallium citrate|mesh-list
154666454|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
154666455|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154666456|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
154666457|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
154666458|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666459|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154666460|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154666461|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
154666462|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666463|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
154666464|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666465|NCT05492305|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154666466|NCT05492305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154666467|NCT05492305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666468|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
154666469|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154666470|NCT02555683|Growth Substances|growth substances|mesh-ancestor
154666471|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418486|NCT04988425|Antibodies|antibodies|mesh-list
154666472|NCT02554981|Cyclosporine|cyclosporine|mesh-list
154666473|NCT02554981|Cyclosporins|cyclosporins|mesh-list
154666474|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666475|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666476|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666477|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
154666478|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666479|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
154666480|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666481|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
154666482|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666483|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154666484|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
154666485|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154666486|NCT02556775|Antibodies|antibodies|mesh-list
154666487|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
154666488|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154666489|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
154666490|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666491|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
154666492|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154666493|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154666494|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154666495|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666496|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666497|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
154666498|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666499|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666500|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154666501|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666502|NCT03879109|Folfirinox|folfirinox|mesh-list
154666503|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666504|NCT05488327|Lenalidomide|lenalidomide|mesh-list
154666505|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
154666506|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666507|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154666508|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154666509|NCT05488327|Growth Substances|growth substances|mesh-ancestor
154666510|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
154666511|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666512|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154666513|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
154666514|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666515|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154666516|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
154666517|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666518|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666519|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154666520|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154666521|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666522|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
154666523|NCT05484817|Hormones|hormones|mesh-list
154666524|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154666525|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666526|NCT05484583|Carboplatin|carboplatin|mesh-list
154666527|NCT05484583|Etoposide|etoposide|mesh-list
154666528|NCT05484583|Durvalumab|durvalumab|mesh-list
154666529|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154666530|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666531|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154666532|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154666533|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154666534|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666535|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169427|NCT05694013|Atezolizumab|atezolizumab|mesh-list
154666536|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666537|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
154666538|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666539|NCT05487469|Thymalfasin|thymalfasin|mesh-list
154666540|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154666541|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
154666542|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666543|NCT05479357|Oxytocin|oxytocin|mesh-list
154666544|NCT05479357|Carbetocin|carbetocin|mesh-list
154666545|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
154666546|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154666547|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666549|NCT05487391|Vinorelbine|vinorelbine|mesh-list
154666550|NCT05487391|Carboplatin|carboplatin|mesh-list
154666551|NCT05487391|Pemetrexed|pemetrexed|mesh-list
154666552|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154666553|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666554|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
154666555|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
154666556|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
154666557|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666558|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666559|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154666560|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154666561|NCT05484193|Progesterone|progesterone|mesh-list
154666562|NCT05484193|Progestins|progestins|mesh-ancestor
154666563|NCT05484193|Hormones|hormones|mesh-ancestor
154666564|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154666565|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666566|NCT03796195|Bupivacaine|bupivacaine|mesh-list
154666567|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
154666568|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
154666569|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666570|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666571|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
154666572|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666573|NCT04268407|Amoxicillin|amoxicillin|mesh-list
154666574|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
154666575|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
154666576|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154666577|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154666578|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666579|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154666580|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666581|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666582|NCT05483647|Anesthetics|anesthetics|mesh-list
154169521|NCT05618808|Enoxaparin|enoxaparin|mesh-list
154666583|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666584|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666585|NCT05475379|Vaccines|vaccines|mesh-list
154666586|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
154666587|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666588|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
154666589|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
154666590|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666591|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
154666592|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666593|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666594|NCT04424017|Antibodies|antibodies|mesh-list
154666595|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
154666596|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666597|NCT05477797|Lenalidomide|lenalidomide|mesh-list
154666598|NCT05477797|Ixazomib|ixazomib|mesh-list
154666599|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
154666600|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666601|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154666602|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154666603|NCT05477797|Growth Substances|growth substances|mesh-ancestor
154666604|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
154666605|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666606|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
154666607|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666608|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666609|NCT05472259|Leucovorin|leucovorin|mesh-list
154666610|NCT05472259|Fluorouracil|fluorouracil|mesh-list
154666611|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
154666612|NCT05472259|Irinotecan|irinotecan|mesh-list
154666613|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
154666614|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666615|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154666616|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666617|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666618|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
154666619|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666620|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154666621|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154666622|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666623|NCT05472259|Antidotes|antidotes|mesh-ancestor
154666624|NCT05472259|Protective Agents|protective agents|mesh-ancestor
154666625|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
154666627|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
154666628|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
154666629|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154666630|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666631|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666632|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154666633|NCT04266145|Analgesics|analgesics|mesh-ancestor
154666634|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
154666635|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666636|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154666637|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154666638|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154666639|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
154666640|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666641|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666642|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154666643|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
154666644|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666645|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154666646|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666647|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154666648|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666649|NCT02554903|Macitentan|macitentan|mesh-list
154666650|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154666651|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154666652|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666653|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154666654|NCT02332707|Ribavirin|ribavirin|mesh-list
154666655|NCT02332707|Grazoprevir|grazoprevir|mesh-list
154666656|NCT02332707|Ruzasvir|ruzasvir|mesh-list
154666657|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
154666658|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
154666659|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666660|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
154666661|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666662|NCT02370615|Itraconazole|itraconazole|mesh-list
154666663|NCT02370615|Digoxin|digoxin|mesh-list
154666664|NCT02370615|Midazolam|midazolam|mesh-list
154666665|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
154666666|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154666667|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154666668|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666669|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666670|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154666671|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154666672|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154666673|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154666674|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
154666675|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
154666676|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
154666677|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
154666678|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666679|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666680|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
154666681|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666682|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154666683|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154666684|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666685|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154666686|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
154666687|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154666688|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154666689|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154666690|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154666691|NCT02370615|Protective Agents|protective agents|mesh-ancestor
154666692|NCT02307513|Apremilast|apremilast|mesh-list
154666693|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154666694|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154666695|NCT02307513|Analgesics|analgesics|mesh-ancestor
154666696|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
154418710|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
154666697|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666698|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666699|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666700|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666701|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154666702|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154666703|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666704|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666705|NCT02328105|Paclitaxel|paclitaxel|mesh-list
154666706|NCT02328105|Carboplatin|carboplatin|mesh-list
154666707|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154666708|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154666709|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666710|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
154666711|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
154666712|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
154666713|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666714|NCT02305797|Lorazepam|lorazepam|mesh-list
154666715|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
154666716|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
154666717|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
154666718|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666719|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666720|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666721|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154666722|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666723|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154666724|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154666725|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154666726|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
154666727|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
154666728|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666729|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666730|NCT01646073|Adalimumab|adalimumab|mesh-list
154666731|NCT01646073|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154666732|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666733|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666734|NCT02551159|Carboplatin|carboplatin|mesh-list
154666735|NCT02551159|Fluorouracil|fluorouracil|mesh-list
154666736|NCT02551159|Cetuximab|cetuximab|mesh-list
154666737|NCT02551159|Durvalumab|durvalumab|mesh-list
154666738|NCT02551159|Tremelimumab|tremelimumab|mesh-list
154666739|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154666740|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666741|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
154666742|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666743|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154666744|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666745|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
154666746|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666747|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666748|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
154666749|NCT04539379|Analgesics|analgesics|mesh-ancestor
154666750|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
154666751|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666752|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666753|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
154666754|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666755|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154666756|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
154666757|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154666758|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666759|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666760|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154666761|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
154666762|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154666763|NCT05470075|Tramadol|tramadol|mesh-list
154666764|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154666765|NCT05470075|Narcotics|narcotics|mesh-ancestor
154666766|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666767|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418819|NCT01376713|Ofatumumab|ofatumumab|mesh-list
154666768|NCT05470075|Analgesics|analgesics|mesh-ancestor
154666769|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
154666770|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666771|NCT05481619|Vedolizumab|vedolizumab|mesh-list
154666772|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666773|NCT02305563|Cytarabine|cytarabine|mesh-list
154666774|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154666775|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
154666776|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666777|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666778|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
154666779|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666780|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666781|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
154666782|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666783|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
154666784|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
154666785|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154666786|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154666787|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666788|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666789|NCT02304705|Urological Agents|urological agents|mesh-ancestor
154666790|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
154666791|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666792|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666793|NCT02553499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154666794|NCT02553499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666795|NCT02553265|Carbidopa|carbidopa|mesh-list
154666796|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154666797|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154666798|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
154666799|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666800|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666801|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666802|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154666803|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666804|NCT01663103|Rilonacept|rilonacept|mesh-list
154666805|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666806|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
154666807|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154666808|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
154666809|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666810|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666811|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154666812|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
154666813|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
154666814|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154666815|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
154169839|NCT05444530|Ipilimumab|ipilimumab|mesh-list
154666816|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154666817|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666818|NCT04532645|Olaparib|olaparib|mesh-list
154666819|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154666820|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666821|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666822|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666823|NCT02560025|Cytarabine|cytarabine|mesh-list
154666824|NCT02560025|Daunorubicin|daunorubicin|mesh-list
154666825|NCT02560025|Idarubicin|idarubicin|mesh-list
154666826|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154666827|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
154666828|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666829|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666830|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
154666831|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666832|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666833|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
154666834|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666835|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154666836|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154666837|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154666838|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666839|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154666840|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154666841|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666842|NCT04524455|Dexamethasone|dexamethasone|mesh-list
154666843|NCT04524455|Blinatumomab|blinatumomab|mesh-list
154666844|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666845|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
154666846|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
154666847|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666848|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666849|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666850|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
154666851|NCT04524455|Hormones|hormones|mesh-ancestor
154666852|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154666853|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154666854|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666855|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
154666856|NCT04411901|Vitamin D|vitamin d|mesh-list
154666857|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154666858|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666859|NCT04411901|Vitamins|vitamins|mesh-ancestor
154666860|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
154666861|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154666862|NCT05508737|Trifluridine|trifluridine|mesh-list
154666863|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
154666864|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666865|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666866|NCT05508737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154666867|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666868|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
154666869|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
154666870|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666871|NCT05508035|Valsartan|valsartan|mesh-list
154666872|NCT05508035|Ramipril|ramipril|mesh-list
154666873|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154666874|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154666875|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154666876|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154666877|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666878|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154666879|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
154666880|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666881|NCT02566889|Infliximab|infliximab|mesh-list
154666882|NCT02566889|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154666883|NCT02566889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666884|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
154666885|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666886|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666887|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
154666888|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154666889|NCT05507957|Ethanol|ethanol|mesh-list
154666890|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
154666891|NCT05507957|Disinfectants|disinfectants|mesh-list
154666892|NCT05507957|Povidone|povidone|mesh-list
154666893|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154666894|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666895|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
154666896|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666897|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666898|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
154666899|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
154666900|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154666901|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
154666902|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154666903|NCT05563571|Prednisolone|prednisolone|mesh-list
154666904|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
154666905|NCT05563571|Lidocaine|lidocaine|mesh-list
154666906|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154666907|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
154666908|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
154666909|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
154666910|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154666911|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666912|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
154666913|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154666914|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154666915|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154169928|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154666916|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154666917|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154666918|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666919|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154666920|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
154666921|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
154666922|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154666923|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
154666924|NCT05563571|Hormones|hormones|mesh-ancestor
154666925|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154666926|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154666927|NCT05563571|Protective Agents|protective agents|mesh-ancestor
154666928|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154666929|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666930|NCT02489903|Paclitaxel|paclitaxel|mesh-list
154666931|NCT02489903|Etoposide|etoposide|mesh-list
154666932|NCT02489903|Vinorelbine|vinorelbine|mesh-list
154666933|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154666934|NCT02489903|Carboplatin|carboplatin|mesh-list
154666935|NCT02489903|Gemcitabine|gemcitabine|mesh-list
154666936|NCT02489903|Irinotecan|irinotecan|mesh-list
154666937|NCT02489903|Pemetrexed|pemetrexed|mesh-list
154666938|NCT02489903|Taxane|taxane|mesh-list
154666939|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154666940|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666941|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
154666942|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
154666943|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
154666944|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666945|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154666946|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
154666947|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154666948|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154666949|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666950|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154666951|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154666952|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154666953|NCT01174199|Sirolimus|sirolimus|mesh-list
154666954|NCT01174199|Vorinostat|vorinostat|mesh-list
154666955|NCT01174199|Temsirolimus|temsirolimus|mesh-list
154666956|NCT01174199|MTOR Inhibitors|mtor inhibitors|mesh-list
154666957|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154666958|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154666959|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154666960|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666961|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
154666962|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666963|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
154666964|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666965|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154666966|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154666967|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666968|NCT01174199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154666969|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154666970|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154666971|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666972|NCT05562869|Abatacept|abatacept|mesh-list
154666973|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154666974|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666975|NCT05562869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154666976|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666977|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154666978|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
154666979|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666980|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154666981|NCT04080869|Vitamin A|vitamin a|mesh-list
154666982|NCT04080869|Tretinoin|tretinoin|mesh-list
154666983|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
154666984|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154666985|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
154666986|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
154666987|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
154666988|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666989|NCT04080869|Protective Agents|protective agents|mesh-ancestor
154666990|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154666991|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154666992|NCT04080869|Vitamins|vitamins|mesh-ancestor
154666993|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
154666994|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154666995|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154666996|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
154666997|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
154666998|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154666999|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667000|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154667001|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154667002|NCT00560495|Growth Substances|growth substances|mesh-ancestor
154667003|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667004|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
154667005|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667006|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154667007|NCT02559713|Vedolizumab|vedolizumab|mesh-list
154667008|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154667009|NCT05499065|Cetuximab|cetuximab|mesh-list
154667010|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154667011|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667012|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
154667013|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
154667014|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154667015|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667016|NCT04038437|Venetoclax|venetoclax|mesh-list
154667017|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667018|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154667019|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
154667020|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154667021|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154667022|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154667023|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
154667024|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154667025|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667026|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154667027|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154667028|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154667029|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154667030|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667031|NCT05485883|Lenvatinib|lenvatinib|mesh-list
154667032|NCT05485883|Tislelizumab|tislelizumab|mesh-list
154667033|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667034|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154667035|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667036|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667037|NCT05485883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154667038|NCT04273607|Heparin|heparin|mesh-list
154667039|NCT04273607|Calcium heparin|calcium heparin|mesh-list
154667040|NCT04273607|Enoxaparin|enoxaparin|mesh-list
154667041|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
154667042|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154667043|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154667044|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667045|NCT05476081|Aspirin|aspirin|mesh-list
154667046|NCT05476081|Clopidogrel|clopidogrel|mesh-list
154667047|NCT05476081|Ticagrelor|ticagrelor|mesh-list
154667048|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667049|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667050|NCT05476081|Analgesics|analgesics|mesh-ancestor
154667051|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
154667052|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667053|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667054|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667055|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667056|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154667057|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154667058|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667059|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154667060|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667061|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667062|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
154667063|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154667064|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154667065|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154667066|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
154667067|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667068|NCT05476003|Midazolam|midazolam|mesh-list
154667069|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154667070|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154667071|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667072|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667073|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154667074|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154667075|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154667076|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154667077|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
154667078|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
154667079|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
154667080|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
154667081|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667082|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170080|NCT05168787|Valsartan|valsartan|mesh-list
154667083|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154667084|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
154667085|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667086|NCT02535715|Insulin|insulin|mesh-list
154667087|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154667088|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154667089|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667090|NCT02336815|Dexamethasone|dexamethasone|mesh-list
154667091|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667092|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
154667093|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
154667094|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667095|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667096|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154667097|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
154667098|NCT02336815|Hormones|hormones|mesh-ancestor
154667099|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667100|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154667101|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667102|NCT05434039|Diclofenac|diclofenac|mesh-list
154667103|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667104|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667105|NCT05434039|Analgesics|analgesics|mesh-ancestor
154667106|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
154667107|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667108|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667109|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667110|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667111|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667112|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667113|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667114|NCT05466175|Prednisone|prednisone|mesh-list
154667115|NCT05466175|Vincristine|vincristine|mesh-list
154667116|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667117|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
154667118|NCT05466175|Hormones|hormones|mesh-ancestor
154667119|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667120|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667121|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154667122|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667123|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154667124|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
154667125|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
154667126|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
154667127|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667128|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154667129|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154667130|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154667131|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
154667132|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667133|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154667134|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154667135|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667136|NCT02545933|Aspirin|aspirin|mesh-list
154667137|NCT02545933|Ticagrelor|ticagrelor|mesh-list
154667138|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154667139|NCT02545933|Vorapaxar|vorapaxar|mesh-list
154667140|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667141|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667142|NCT02545933|Analgesics|analgesics|mesh-ancestor
154667143|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
154667144|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667145|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667146|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667147|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667148|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154667149|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154667150|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667151|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154667152|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667153|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667155|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154667156|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154667157|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154667158|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
154667159|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667160|NCT02545075|Ipilimumab|ipilimumab|mesh-list
154667161|NCT02545075|Dacarbazine|dacarbazine|mesh-list
154667162|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154667163|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667164|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154667165|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667166|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154667167|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
154667168|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
154667169|NCT03007537|Hematinics|hematinics|mesh-ancestor
154667170|NCT02544763|Cannabidiol|cannabidiol|mesh-list
154667171|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
154667172|NCT02556203|Aspirin|aspirin|mesh-list
154667173|NCT02556203|Vitamin K|vitamin k|mesh-list
154667174|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
154667175|NCT02556203|Clopidogrel|clopidogrel|mesh-list
154667176|NCT02556203|Vitamins|vitamins|mesh-ancestor
154667177|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
154667178|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667179|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154667180|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154667181|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154667182|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154667183|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
154667184|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667185|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667186|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154667187|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
154667188|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154667189|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
154667190|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667191|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
154667192|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667193|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667194|NCT02556203|Analgesics|analgesics|mesh-ancestor
154667195|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
154667196|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667197|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667198|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667199|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154667200|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154667201|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667202|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
154667203|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154667204|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
154667205|NCT02556203|Coagulants|coagulants|mesh-ancestor
154667206|NCT05485571|Methotrexate|methotrexate|mesh-list
154667207|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154667208|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
154667209|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154667210|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667211|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154667212|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
154667213|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667214|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667215|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
154667216|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667217|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154667218|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154667219|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
154667220|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667221|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154667222|NCT05496725|Micafungin|micafungin|mesh-list
154667223|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
154667224|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667225|NCT05490719|Cisplatin|cisplatin|mesh-list
154667226|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667227|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
154667228|NCT04424459|Narcotics|narcotics|mesh-ancestor
154667229|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667230|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667231|NCT04424459|Analgesics|analgesics|mesh-ancestor
154667232|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
154667233|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667234|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
154667235|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
154667236|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667237|NCT05485259|Protective Agents|protective agents|mesh-ancestor
154667238|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667239|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
154667240|NCT05485259|Vitamins|vitamins|mesh-ancestor
154667241|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
154667242|NCT05490407|Carboplatin|carboplatin|mesh-list
154667243|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667244|NCT05490095|Everolimus|everolimus|mesh-list
154667245|NCT05490095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154667246|NCT05490095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154667247|NCT05490095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667248|NCT05490095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667249|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154667250|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
154667251|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667252|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667253|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
154667254|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154667255|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
154667256|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154667257|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
154667258|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667259|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667260|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
154667261|NCT05496179|Metoclopramide|metoclopramide|mesh-list
154667262|NCT05496179|Prucalopride|prucalopride|mesh-list
154667263|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
154667264|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
154667265|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667266|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667267|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154667268|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154667269|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154667270|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
154667271|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667272|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667273|NCT05496179|Laxatives|laxatives|mesh-ancestor
154667274|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154667275|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154667276|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
154667277|NCT05489939|Salicylates|salicylates|mesh-list
154667278|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
154667279|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667280|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667281|NCT05489939|Analgesics|analgesics|mesh-ancestor
154667282|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
154667283|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667284|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667285|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667286|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667287|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667288|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667289|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667290|NCT05483543|Pamiparib|pamiparib|mesh-list
154667291|NCT05483543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154667292|NCT05483543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667293|NCT05483543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667294|NCT05483543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667295|NCT04139213|Naltrexone|naltrexone|mesh-list
154667296|NCT04139213|Buprenorphine|buprenorphine|mesh-list
154667297|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154667298|NCT04139213|Naloxone|naloxone|mesh-list
154667299|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154667300|NCT04139213|Narcotics|narcotics|mesh-ancestor
154667301|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154170336|NCT04840602|Venetoclax|venetoclax|mesh-list
154667302|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667303|NCT04139213|Analgesics|analgesics|mesh-ancestor
154667304|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
154667305|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667306|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154667307|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154667308|NCT05494775|Mitogens|mitogens|mesh-list
154667309|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
154667310|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
154667311|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667312|NCT05494775|Growth Substances|growth substances|mesh-ancestor
154667313|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667314|NCT05488925|Vitamin E|vitamin e|mesh-list
154667315|NCT05488925|Diclofenac|diclofenac|mesh-list
154667316|NCT05488925|Piroxicam|piroxicam|mesh-list
154667317|NCT05488925|Tramadol|tramadol|mesh-list
154667318|NCT05488925|Vitamins|vitamins|mesh-ancestor
154667319|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
154667320|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667321|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667322|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667323|NCT05488925|Analgesics|analgesics|mesh-ancestor
154667324|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
154667325|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667326|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667327|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667328|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667329|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667330|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667331|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154667332|NCT05488925|Narcotics|narcotics|mesh-ancestor
154667333|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667334|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
154667335|NCT05488925|Protective Agents|protective agents|mesh-ancestor
154667336|NCT05482763|Itraconazole|itraconazole|mesh-list
154667337|NCT05482763|Terbinafine|terbinafine|mesh-list
154667338|NCT05482763|Ciclopirox|ciclopirox|mesh-list
154667339|NCT05482763|Amorolfine|amorolfine|mesh-list
154667340|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
154667341|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667342|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154170383|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667343|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154667344|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667345|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667346|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154667347|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
154667348|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667349|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667350|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154667351|NCT05482373|Oleuropein|oleuropein|mesh-list
154667352|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667353|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154667354|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
154667355|NCT05482295|Vaccines|vaccines|mesh-list
154667356|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
154667357|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667358|NCT05494307|Terbutaline|terbutaline|mesh-list
154667359|NCT05494307|Danazol|danazol|mesh-list
154667360|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154667361|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
154667362|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667363|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667364|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154667365|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
154667366|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
154667367|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
154667368|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154667369|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154667370|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154667371|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154667372|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
154667373|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667374|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667375|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154667376|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
154667377|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667379|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154667380|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154667381|NCT05487521|Prednisolone|prednisolone|mesh-list
154667382|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
154667383|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154667384|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
154667385|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667386|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
154667387|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
154667388|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667389|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667390|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154667391|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
154667392|NCT05487521|Hormones|hormones|mesh-ancestor
154582939|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154667393|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667394|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154667395|NCT05487521|Protective Agents|protective agents|mesh-ancestor
154667396|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154667397|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667398|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
154667399|NCT05481281|Ketamine|ketamine|mesh-list
154667400|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154667401|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667402|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667403|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667404|NCT05481281|Analgesics|analgesics|mesh-ancestor
154667405|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
154667406|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667407|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154667408|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154667409|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154667410|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
154667411|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667412|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667413|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154667414|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154667415|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
154667416|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
154667417|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154667418|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154667419|NCT05487443|Gemcitabine|gemcitabine|mesh-list
154667420|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154667421|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
154667422|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667423|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667424|NCT02558231|Selexipag|selexipag|mesh-list
154667425|NCT02558231|Tadalafil|tadalafil|mesh-list
154667426|NCT02558231|Macitentan|macitentan|mesh-list
154667427|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
154667428|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154667429|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154667430|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667431|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667432|NCT02558231|Urological Agents|urological agents|mesh-ancestor
154667433|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154667434|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154667435|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154667436|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154667437|NCT05486819|Propofol|propofol|mesh-list
154667438|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154667439|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667440|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667441|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154667442|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
154667443|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
154667444|NCT05492669|Lidocaine|lidocaine|mesh-list
154667445|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
154667446|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
154667447|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667448|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667449|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
154667450|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667451|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154667452|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154667453|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154667454|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154667455|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667457|NCT02554721|Cilostazol|cilostazol|mesh-list
154667458|NCT02554721|Clopidogrel|clopidogrel|mesh-list
154667459|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154667460|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154667461|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154667462|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154667463|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
154667464|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667465|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667466|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667467|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667468|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667469|NCT02554721|Analgesics|analgesics|mesh-ancestor
154667470|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
154667471|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667472|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667473|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667474|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154667475|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154667476|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667477|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667478|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
154667479|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154667480|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
154667481|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154667482|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
154667483|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
154170518|NCT04640623|Gemcitabine|gemcitabine|mesh-list
154170567|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
154667484|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154667485|NCT02554721|Protective Agents|protective agents|mesh-ancestor
154667486|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154667487|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154667488|NCT02552225|Amitriptyline|amitriptyline|mesh-list
154667489|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154667490|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
154667491|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154667492|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667493|NCT02552225|Analgesics|analgesics|mesh-ancestor
154667494|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
154667495|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667496|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667497|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154667498|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154667499|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154667500|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667501|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
154667502|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667503|NCT02552147|Nicotine|nicotine|mesh-list
154667504|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154667505|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
154667506|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667507|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667508|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154667509|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154667510|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
154667511|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667512|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667513|NCT05479487|Apatinib|apatinib|mesh-list
154667514|NCT05479487|Fluzoparib|fluzoparib|mesh-list
154667515|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667516|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154667517|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667518|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667519|NCT05479487|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154667520|NCT05479175|Ibuprofen|ibuprofen|mesh-list
154667521|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667522|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667523|NCT05479175|Analgesics|analgesics|mesh-ancestor
154667524|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
154667525|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667526|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667527|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667528|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154170582|NCT04619251|Itraconazole|itraconazole|mesh-list
154667529|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667530|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667531|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667532|NCT02534935|Vaccines|vaccines|mesh-list
154667533|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
154667534|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667535|NCT02544451|Ivacaftor|ivacaftor|mesh-list
154667536|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154667537|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154667538|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667539|NCT02551991|Leucovorin|leucovorin|mesh-list
154667540|NCT02551991|Fluorouracil|fluorouracil|mesh-list
154667541|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
154667542|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
154667543|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667544|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154667545|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667546|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154667547|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
154667548|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667549|NCT02551991|Antidotes|antidotes|mesh-ancestor
154667550|NCT02551991|Protective Agents|protective agents|mesh-ancestor
154667551|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
154667552|NCT02551991|Vitamins|vitamins|mesh-ancestor
154667553|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
154667554|NCT05491811|Bevacizumab|bevacizumab|mesh-list
154667555|NCT05491811|Ensartinib|ensartinib|mesh-list
154667556|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154667557|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667558|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154667559|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154667560|NCT05491811|Growth Substances|growth substances|mesh-ancestor
154667561|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667562|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
154667563|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154667564|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667565|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667566|NCT05478785|Cisplatin|cisplatin|mesh-list
154667567|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667568|NCT02865551|Anesthetics|anesthetics|mesh-list
154170624|NCT04548752|Olaparib|olaparib|mesh-list
154667569|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667570|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667571|NCT05478083|Leuprolide|leuprolide|mesh-list
154667572|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154667573|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
154667574|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154667575|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667576|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154667577|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667578|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
154667579|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
154667580|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667581|NCT02544217|Protective Agents|protective agents|mesh-ancestor
154667582|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667583|NCT05427565|Caffeine|caffeine|mesh-list
154667584|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154667585|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667586|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154667587|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667588|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667589|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154667590|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154667591|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
154667592|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667593|NCT02533453|Exenatide|exenatide|mesh-list
154667594|NCT02533453|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154667595|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154667596|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667597|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154419612|NCT02404155|Clozapine|clozapine|mesh-list
154667598|NCT02533453|Incretins|incretins|mesh-ancestor
154667599|NCT02533453|Hormones|hormones|mesh-ancestor
154667600|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667601|NCT05424835|Capecitabine|capecitabine|mesh-list
154667602|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154667603|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
154667604|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667605|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667606|NCT02533375|Adalimumab|adalimumab|mesh-list
154667607|NCT02533375|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154667608|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667609|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667610|NCT02551055|Paclitaxel|paclitaxel|mesh-list
154667611|NCT02551055|Docetaxel|docetaxel|mesh-list
154667612|NCT02551055|Serabelisib|serabelisib|mesh-list
154667613|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154667614|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667615|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
154667616|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
154667617|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
154667618|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170648|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154667619|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667620|NCT05470673|Metronidazole|metronidazole|mesh-list
154667621|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667622|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154667623|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154667624|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154667625|NCT05459285|Dulaglutide|dulaglutide|mesh-list
154667626|NCT05459285|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154667627|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154667628|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667629|NCT02542943|Fluorides|fluorides|mesh-list
154667630|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
154667631|NCT02542943|Protective Agents|protective agents|mesh-ancestor
154667632|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667633|NCT03284957|Everolimus|everolimus|mesh-list
154667634|NCT03284957|Palbociclib|palbociclib|mesh-list
154667635|NCT03284957|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154667636|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154667637|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667638|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667639|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154667640|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
154667641|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667642|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667643|NCT02542631|Insulin|insulin|mesh-list
154667644|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154667645|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154667646|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667647|NCT05477615|Carboplatin|carboplatin|mesh-list
154667648|NCT05477615|Pemetrexed|pemetrexed|mesh-list
154667649|NCT05477615|Lazertinib|lazertinib|mesh-list
154667650|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667651|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667652|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667653|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154667654|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154667655|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154667656|NCT02529553|LY3076226|ly3076226|mesh-list
154667657|NCT02529553|Immunoconjugates|immunoconjugates|mesh-ancestor
154667658|NCT02529553|Immunologic Factors|immunologic factors|mesh-ancestor
154667659|NCT02529553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667660|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
154667661|NCT02547935|Saxagliptin|saxagliptin|mesh-list
154667662|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154667663|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667664|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154667665|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667666|NCT02547935|Incretins|incretins|mesh-ancestor
154667667|NCT02547935|Hormones|hormones|mesh-ancestor
154667668|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667669|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154667670|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
154667671|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667672|NCT04258111|Antibodies|antibodies|mesh-list
154667673|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
154419684|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
154170859|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
154667674|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
154667675|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667676|NCT02327169|Paclitaxel|paclitaxel|mesh-list
154667677|NCT02327169|Irinotecan|irinotecan|mesh-list
154667678|NCT02327169|Cetuximab|cetuximab|mesh-list
154667679|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154667680|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667681|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
154667682|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
154667683|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
154667684|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667685|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154667686|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154667687|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667688|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154667689|NCT02327013|Vortioxetine|vortioxetine|mesh-list
154667690|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
154667691|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154667692|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154667693|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154667694|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667695|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667696|NCT02327013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154667697|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154667698|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154667699|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667700|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667701|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
154667702|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154667703|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154667704|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154667705|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154667706|NCT02301975|Fluticasone|fluticasone|mesh-list
154667707|NCT02301975|Xhance|xhance|mesh-list
154667708|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154667709|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667710|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154667711|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
154667712|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667713|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667714|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154667715|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
154667716|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
154667717|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154667718|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154667719|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154667720|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154667721|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
154667722|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667723|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667724|NCT04882839|Psilocybin|psilocybin|mesh-list
154667725|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
154667726|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667727|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154667728|NCT02300259|Itraconazole|itraconazole|mesh-list
154667729|NCT02300259|Diltiazem|diltiazem|mesh-list
154667730|NCT02300259|Tadalafil|tadalafil|mesh-list
154667731|NCT02300259|Simvastatin|simvastatin|mesh-list
154667732|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154667733|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154667734|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
154667735|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667736|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154667737|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154667738|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667739|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
154667740|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667741|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154667742|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154667743|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154667744|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
154667745|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667746|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667747|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154667748|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
154667749|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154667750|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154667751|NCT02300259|Urological Agents|urological agents|mesh-ancestor
154667752|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154667753|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154667754|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154667755|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154667756|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
154667757|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154667758|NCT02300103|Velpatasvir|velpatasvir|mesh-list
154667759|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
154667760|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667761|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
154667762|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154667763|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154667764|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667765|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
154667766|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
154667767|NCT02299635|Nirogacestat|nirogacestat|mesh-list
154667768|NCT02299635|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154667769|NCT02299635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667770|NCT02299635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667771|NCT02366091|Methotrexate|methotrexate|mesh-list
154667772|NCT02366091|Colchicine|colchicine|mesh-list
154667773|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154667774|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
154667775|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154667776|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667777|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154667778|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
154667779|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667780|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667781|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
154667782|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667783|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154667784|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154667785|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
154667786|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667787|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154667788|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
154667789|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
154667790|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
154667791|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
154667792|NCT05476679|Celecoxib|celecoxib|mesh-list
154667793|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667794|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667795|NCT05476679|Analgesics|analgesics|mesh-ancestor
154667796|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
154667797|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667798|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667799|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667800|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667801|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154667802|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667803|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667804|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667805|NCT02546765|Acetaminophen|acetaminophen|mesh-list
154667806|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
154667807|NCT02546765|Propofol|propofol|mesh-list
154667808|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154667809|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667810|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667811|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667812|NCT02546765|Analgesics|analgesics|mesh-ancestor
154667813|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
154667814|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667815|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154667816|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154667817|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154667818|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
154667819|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667820|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667821|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154667822|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
154667824|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
154667825|NCT02553629|Rocuronium|rocuronium|mesh-list
154667826|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154667827|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154667828|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154667829|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667830|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667831|NCT03029351|Exenatide|exenatide|mesh-list
154667832|NCT03029351|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154667833|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154667834|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667835|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154667836|NCT03029351|Incretins|incretins|mesh-ancestor
154667837|NCT03029351|Hormones|hormones|mesh-ancestor
154667838|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667839|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154667840|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
154667841|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667842|NCT02365233|Insulin|insulin|mesh-list
154667843|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154667844|NCT02365233|Pioglitazone|pioglitazone|mesh-list
154667845|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154667846|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
154667847|NCT02365233|Saxagliptin|saxagliptin|mesh-list
154667848|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154667849|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154667850|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667851|NCT02365233|Incretins|incretins|mesh-ancestor
154667852|NCT02365233|Hormones|hormones|mesh-ancestor
154667853|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154667854|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
154667855|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667856|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667857|NCT02364999|Paclitaxel|paclitaxel|mesh-list
154667858|NCT02364999|Bevacizumab|bevacizumab|mesh-list
154667859|NCT02364999|Carboplatin|carboplatin|mesh-list
154667860|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154667861|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667862|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
154667863|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
154667864|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
154667865|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667866|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154667867|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154667868|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154667869|NCT02364999|Growth Substances|growth substances|mesh-ancestor
154667870|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667871|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
154667872|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154667873|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
154667874|NCT02363283|Immunotoxins|immunotoxins|mesh-list
154667875|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154667876|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
154667877|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667878|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154667879|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667880|NCT02321319|Hydromorphone|hydromorphone|mesh-list
154667881|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154667882|NCT02321319|Narcotics|narcotics|mesh-ancestor
154171036|NCT04042740|Ribavirin|ribavirin|mesh-list
154667883|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667884|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667885|NCT02321319|Analgesics|analgesics|mesh-ancestor
154667886|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
154667887|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667888|NCT02088541|Cytarabine|cytarabine|mesh-list
154667889|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
154667890|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154667891|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
154667892|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667893|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667894|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
154667895|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667896|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154667897|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
154667898|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667899|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
154667900|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667901|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154667903|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667904|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667905|NCT02294019|Analgesics|analgesics|mesh-ancestor
154667906|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
154667907|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667908|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667909|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667910|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667911|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667912|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667913|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667914|NCT02320149|Sarecycline|sarecycline|mesh-list
154667915|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154667916|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667917|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
154667918|NCT05405725|Denosumab|denosumab|mesh-list
154667919|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154667920|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667921|NCT02293863|Oseltamivir|oseltamivir|mesh-list
154667922|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
154667923|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154667924|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667925|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667926|NCT02293395|Aspirin|aspirin|mesh-list
154667927|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
154667928|NCT02293395|Clopidogrel|clopidogrel|mesh-list
154667929|NCT02293395|Ticagrelor|ticagrelor|mesh-list
154667930|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667931|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667932|NCT02293395|Analgesics|analgesics|mesh-ancestor
154667933|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
154667934|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667935|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667936|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667937|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667938|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154667939|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154667940|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667941|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154667942|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154667943|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667944|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
154667945|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154667946|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154667947|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154667948|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
154667949|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667950|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154667951|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
154667952|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154667953|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154667954|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
154667955|NCT05447065|Vitamin D|vitamin d|mesh-list
154667956|NCT05447065|Vitamins|vitamins|mesh-ancestor
154667957|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
154667958|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667959|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154667960|NCT05401357|Bimatoprost|bimatoprost|mesh-list
154667961|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154667962|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154667963|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154667964|NCT05401279|Gemcitabine|gemcitabine|mesh-list
154667965|NCT05401279|Tislelizumab|tislelizumab|mesh-list
154667966|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667967|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154667968|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
154667969|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171205|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154667970|NCT05401279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154667971|NCT05451095|Ketamine|ketamine|mesh-list
154667972|NCT05451095|Analgesics|analgesics|mesh-ancestor
154667973|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
154667974|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667975|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667976|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154667977|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154667978|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
154667979|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
154667980|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154667981|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154667982|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154667983|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154667984|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667985|NCT02954081|Apremilast|apremilast|mesh-list
154667986|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154667987|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154667988|NCT02954081|Analgesics|analgesics|mesh-ancestor
154667989|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
154667990|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154667991|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154667992|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154667993|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154667994|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154667995|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154667996|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154667997|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154667998|NCT02532283|Oseltamivir|oseltamivir|mesh-list
154667999|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
154668000|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668001|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668002|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668003|NCT05398705|Cepharanthine|cepharanthine|mesh-list
154668004|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668005|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668006|NCT05398705|Analgesics|analgesics|mesh-ancestor
154668007|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
154668008|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668009|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668010|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668011|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668012|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154668013|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668014|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154668015|NCT05398705|Protective Agents|protective agents|mesh-ancestor
154668016|NCT05415865|Lidocaine|lidocaine|mesh-list
154668017|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
154668018|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
154668019|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668020|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668021|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
154668022|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668023|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154668024|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154668025|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154668026|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154668027|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668028|NCT02552303|Modafinil|modafinil|mesh-list
154668029|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154668030|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668031|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154668032|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154668033|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154668034|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668035|NCT01660711|Leucovorin|leucovorin|mesh-list
154668036|NCT01660711|Fluorouracil|fluorouracil|mesh-list
154668037|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
154668038|NCT01660711|Irinotecan|irinotecan|mesh-list
154668039|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
154668040|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668041|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154668042|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668043|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154668044|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
154668045|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668046|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154668047|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154668048|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668050|NCT01660711|Protective Agents|protective agents|mesh-ancestor
154668051|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
154668052|NCT01660711|Vitamins|vitamins|mesh-ancestor
154668053|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
154668054|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
154668055|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154668056|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
154668057|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668058|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154668059|NCT02538965|Lenalidomide|lenalidomide|mesh-list
154668060|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
154668061|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668062|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154668063|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154668064|NCT02538965|Growth Substances|growth substances|mesh-ancestor
154668065|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
154668066|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668067|NCT02543801|Ketorolac|ketorolac|mesh-list
154668068|NCT02543801|Clonidine|clonidine|mesh-list
154668069|NCT02543801|Epinephrine|epinephrine|mesh-list
154668070|NCT02543801|Bupivacaine|bupivacaine|mesh-list
154668071|NCT02543801|Ropivacaine|ropivacaine|mesh-list
154668072|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
154668073|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
154668074|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668075|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668076|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
154668077|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668078|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154668079|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154668080|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668081|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668082|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668083|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154668084|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154668085|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
154668086|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154668087|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
154668088|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
154668089|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
154668090|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154668091|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668092|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668093|NCT02543801|Analgesics|analgesics|mesh-ancestor
154668094|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668095|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668096|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154668097|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668098|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154668099|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
154668100|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154668101|NCT02481635|Paclitaxel|paclitaxel|mesh-list
154668102|NCT02481635|Gemcitabine|gemcitabine|mesh-list
154668103|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154668104|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668105|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
154668106|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
154668107|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
154668108|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668109|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154668110|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
154668111|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
154668112|NCT05411159|Anesthetics|anesthetics|mesh-list
154668113|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668114|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668115|NCT05411159|Narcotics|narcotics|mesh-ancestor
154668116|NCT05411159|Analgesics|analgesics|mesh-ancestor
154668117|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
154668118|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668119|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
154668120|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154668121|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
154668122|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668123|NCT02362425|Expectorants|expectorants|mesh-ancestor
154668124|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
154668125|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154668126|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
154668127|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668128|NCT02362425|Protective Agents|protective agents|mesh-ancestor
154668129|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668130|NCT02362425|Antidotes|antidotes|mesh-ancestor
154668132|NCT02362269|Vitamins|vitamins|mesh-ancestor
154668133|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
154668134|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668135|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154668136|NCT02529995|Osimertinib|osimertinib|mesh-list
154668137|NCT02529995|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154668138|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668139|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668140|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668141|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668142|NCT02319759|Ustekinumab|ustekinumab|mesh-list
154668143|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
154668144|NCT02318667|Golimumab|golimumab|mesh-list
154668145|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154668146|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668147|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154668148|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
154668149|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668150|NCT02292771|Vasotocin|vasotocin|mesh-list
154668151|NCT02292771|Atosiban|atosiban|mesh-list
154668152|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
154668153|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668154|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668155|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
154668156|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154668157|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
154668158|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154668159|NCT02291913|Tamoxifen|tamoxifen|mesh-list
154668160|NCT02291913|Everolimus|everolimus|mesh-list
154668161|NCT02291913|Letrozole|letrozole|mesh-list
154668162|NCT02291913|Fulvestrant|fulvestrant|mesh-list
154668163|NCT02291913|Anastrozole|anastrozole|mesh-list
154668164|NCT02291913|Exemestane|exemestane|mesh-list
154668165|NCT02291913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154668166|NCT02291913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668167|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668168|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668169|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154668170|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
154668171|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668172|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668173|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154668174|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154668175|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154668176|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
154668177|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668178|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154668179|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154668180|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154668181|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154668182|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154668183|NCT02291679|Linaclotide|linaclotide|mesh-list
154668184|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154668185|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
154668186|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668187|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154668188|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
154668189|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154668190|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154668191|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668192|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
154668193|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
154668194|NCT02360475|Vaccines|vaccines|mesh-list
154668195|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
154668196|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668197|NCT02360397|Ranolazine|ranolazine|mesh-list
154668198|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154668199|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154668200|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668201|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154668203|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668204|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668205|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
154668206|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154668207|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668208|NCT02359851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154668209|NCT02359851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668210|NCT01607905|Acetaminophen|acetaminophen|mesh-list
154668211|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668212|NCT01607905|Analgesics|analgesics|mesh-ancestor
154668213|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
154668214|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668215|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668216|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
154668217|NCT02389543|Dexamethasone|dexamethasone|mesh-list
154668218|NCT02389543|Lenalidomide|lenalidomide|mesh-list
154668219|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668220|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
154668221|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
154668222|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668223|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668224|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154668225|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
154668226|NCT02389543|Hormones|hormones|mesh-ancestor
154668227|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668228|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154668229|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668230|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
154668231|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154668232|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154668233|NCT02389543|Growth Substances|growth substances|mesh-ancestor
154668234|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
154668235|NCT00843037|Sunitinib|sunitinib|mesh-list
154171442|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668236|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668237|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154668238|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154668239|NCT00843037|Growth Substances|growth substances|mesh-ancestor
154668240|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668241|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
154668242|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668243|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668244|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668245|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154668246|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154668247|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668248|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154668249|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668250|NCT05004805|Methylene Blue|methylene blue|mesh-list
154668251|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668252|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668253|NCT04261387|LUT014|lut014|mesh-list
154668254|NCT04261387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668255|NCT04261387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668256|NCT04261387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668257|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
154668258|NCT05411965|Pioglitazone|pioglitazone|mesh-list
154668259|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154668260|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668261|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154668262|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668263|NCT04261075|Durvalumab|durvalumab|mesh-list
154668264|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154668265|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668266|NCT05436769|Clarithromycin|clarithromycin|mesh-list
154668267|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154668268|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668269|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154420273|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668270|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668271|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668272|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154668273|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154668274|NCT01659853|Azelaic acid|azelaic acid|mesh-list
154668275|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154668276|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154668277|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154668278|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154668279|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154668280|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668281|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668282|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668283|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668284|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668285|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
154668286|NCT05576389|Fluzoparib|fluzoparib|mesh-list
154668287|NCT05576389|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154668288|NCT05576389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668289|NCT05576389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668290|NCT05576389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668291|NCT05341609|Ritonavir|ritonavir|mesh-list
154668292|NCT05341609|Nirmatrelvir|nirmatrelvir|mesh-list
154668293|NCT05341609|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154668294|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154668295|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154668296|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
154668297|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668298|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668299|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154668300|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154668301|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
154668302|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668303|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154668304|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154668305|NCT02531113|Ozanimod|ozanimod|mesh-list
154668306|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154668307|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668308|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154668309|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
154668310|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668311|NCT04248595|Azacitidine|azacitidine|mesh-list
154668312|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
154668313|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154668314|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
154668315|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668316|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668317|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668318|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154668319|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154668320|NCT05334277|Bevacizumab|bevacizumab|mesh-list
154668321|NCT05334277|Carboplatin|carboplatin|mesh-list
154668322|NCT05334277|Pemetrexed|pemetrexed|mesh-list
154668323|NCT05334277|Aflutinib|aflutinib|mesh-list
154668324|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154668325|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668326|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154668327|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154668328|NCT05334277|Growth Substances|growth substances|mesh-ancestor
154668329|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668330|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
154668331|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668332|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668333|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154668334|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154668335|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668336|NCT05332717|Melatonin|melatonin|mesh-list
154668337|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668338|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
154668339|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668340|NCT05332717|Protective Agents|protective agents|mesh-ancestor
154668341|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668343|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
154668344|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154668345|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
154668346|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668347|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668348|NCT05353933|Pantoprazole|pantoprazole|mesh-list
154668349|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154668350|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154668351|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154668352|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668353|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668354|NCT05352685|Propofol|propofol|mesh-list
154668355|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154668356|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668357|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668358|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154668359|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
154668360|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
154668361|NCT05321875|Candesartan|candesartan|mesh-list
154668362|NCT05321875|Candesartan cilexetil|candesartan cilexetil|mesh-list
154668363|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154668364|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154668365|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154668366|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668367|NCT02522767|Mesalamine|mesalamine|mesh-list
154668368|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668369|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668370|NCT02522767|Analgesics|analgesics|mesh-ancestor
154668371|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
154668372|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668373|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668374|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668375|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668376|NCT02522377|Midazolam|midazolam|mesh-list
154668377|NCT02522377|Ketamine|ketamine|mesh-list
154668378|NCT02522377|Analgesics|analgesics|mesh-ancestor
154668379|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
154668380|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668381|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668382|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154668383|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154668384|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
154668385|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
154668386|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668387|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154668388|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154668389|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668390|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668391|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154668392|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154668393|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154668394|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154668395|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154668396|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
154668397|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
154668398|NCT05267743|Lansoprazole|lansoprazole|mesh-list
154668399|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
154668400|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154668401|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154668402|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154668403|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668404|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668405|NCT05291845|Vaccines|vaccines|mesh-list
154668406|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
154668407|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668408|NCT05314621|Fluticasone|fluticasone|mesh-list
154668409|NCT05314621|Xhance|xhance|mesh-list
154668410|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154668411|NCT05314621|Dextrans|dextrans|mesh-list
154668412|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154668413|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154668414|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668415|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154668416|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
154420420|NCT04792749|Metformin|metformin|mesh-list
154668417|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668418|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668419|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154668420|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
154668421|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
154668422|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154668423|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668424|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668425|NCT05314621|Analgesics|analgesics|mesh-ancestor
154668426|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
154668427|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668428|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154668429|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154668430|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
154668431|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
154668432|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668433|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668434|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
154668435|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
154668436|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
154668437|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
154668438|NCT05263609|Axitinib|axitinib|mesh-list
154668439|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154668440|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668441|NCT05263609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154668442|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668443|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668444|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668445|NCT05313997|Diclofenac|diclofenac|mesh-list
154668446|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668447|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668448|NCT05313997|Analgesics|analgesics|mesh-ancestor
154668449|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
154668450|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668451|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668452|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668453|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668454|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154668455|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668456|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668457|NCT05259241|Thrombin|thrombin|mesh-list
154668458|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
154668459|NCT05259241|Coagulants|coagulants|mesh-ancestor
154668460|NCT01657903|Listerine|listerine|mesh-list
154668461|NCT01657903|Fluorides|fluorides|mesh-list
154668462|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
154668463|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
154668464|NCT01657903|Protective Agents|protective agents|mesh-ancestor
154668465|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668466|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154668467|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668468|NCT05256823|Celecoxib|celecoxib|mesh-list
154668469|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668470|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668471|NCT05256823|Analgesics|analgesics|mesh-ancestor
154668472|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
154668473|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668474|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668475|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668476|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668477|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154668478|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154668479|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668480|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668481|NCT05253937|Epinephrine|epinephrine|mesh-list
154668482|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154668483|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154668484|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668485|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668486|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668487|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668488|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154668489|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154668490|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
154420496|NCT04546399|Vincristine|vincristine|mesh-list
154668491|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668492|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154668493|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
154668494|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
154668495|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
154668496|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154668497|NCT05218603|Bortezomib|bortezomib|mesh-list
154668498|NCT05218603|Daratumumab|daratumumab|mesh-list
154668499|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668500|NCT05214001|Almotriptan|almotriptan|mesh-list
154668501|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154668502|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
154668503|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668504|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668505|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668506|NCT05249881|Semaglutide|semaglutide|mesh-list
154668507|NCT05249881|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154668508|NCT05249881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154668509|NCT05249881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668510|NCT05248945|Carbamazepine|carbamazepine|mesh-list
154668511|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
154668512|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
154668513|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154668514|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668515|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668516|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154668517|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668518|NCT05248945|Analgesics|analgesics|mesh-ancestor
154668519|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
154668520|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668521|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154668522|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154668523|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668524|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154668525|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154668526|NCT04239313|Vaccines|vaccines|mesh-list
154668527|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
154668528|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668529|NCT05209711|Lidocaine|lidocaine|mesh-list
154668530|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
154668531|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
154668532|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668533|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668534|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
154668535|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668536|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154668537|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154668538|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154668539|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154668540|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668541|NCT05272969|Vitamin D|vitamin d|mesh-list
154668542|NCT05272969|Calcium|calcium|mesh-list
154668543|NCT05272969|Vitamins|vitamins|mesh-ancestor
154668544|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
154668545|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668546|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154668547|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154668548|NCT05206747|Methamphetamine|methamphetamine|mesh-list
154668549|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154668550|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668551|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
154668552|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
154668553|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668554|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
154668555|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668556|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668557|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668558|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154668559|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154668560|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154668561|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154668562|NCT05205811|Zonisamide|zonisamide|mesh-list
154668563|NCT05205811|Bupropion|bupropion|mesh-list
154668564|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154668565|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
154668566|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154668567|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154668568|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154668569|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154668570|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668571|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
154668572|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668573|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668574|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154668575|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154668576|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668577|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
154668578|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154668579|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154668580|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154668581|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
154668582|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668583|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154668584|NCT01656733|Nicotine|nicotine|mesh-list
154668585|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154668586|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
154668587|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668588|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668589|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154668590|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154668591|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
154668592|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668593|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668594|NCT05236543|Itraconazole|itraconazole|mesh-list
154668595|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
154668596|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668597|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154668598|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154668599|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668600|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668601|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154668602|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
154668603|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668604|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668605|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154668606|NCT05157841|Bupivacaine|bupivacaine|mesh-list
154668607|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
154668608|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
154668609|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668610|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668611|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
154668612|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668613|NCT05225155|Enoxaparin|enoxaparin|mesh-list
154668614|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
154668615|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154668616|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154668617|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668618|NCT05190445|Paclitaxel|paclitaxel|mesh-list
154668619|NCT05190445|Ramucirumab|ramucirumab|mesh-list
154668620|NCT05190445|Tucatinib|tucatinib|mesh-list
154668621|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154668622|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668623|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
154668624|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
154668625|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
154582940|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
154668626|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668627|NCT05190445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154668628|NCT05190445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154668629|NCT05190445|Growth Substances|growth substances|mesh-ancestor
154668630|NCT05190445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668631|NCT05190445|Growth Inhibitors|growth inhibitors|mesh-ancestor
154668632|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668633|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668634|NCT05148949|Vaccines|vaccines|mesh-list
154668635|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
154668636|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668637|NCT05107999|Doxepin|doxepin|mesh-list
154668638|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
154668639|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154668640|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154668641|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154668642|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154668643|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668644|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668645|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154668646|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
154668647|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
154668648|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668649|NCT05186545|Fulvestrant|fulvestrant|mesh-list
154668650|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154668651|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668652|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154668653|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154668654|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
154668655|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668656|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668657|NCT05107765|Pioglitazone|pioglitazone|mesh-list
154668658|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154668659|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668660|NCT05094427|Anesthetics|anesthetics|mesh-list
154668661|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
154668662|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668663|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668664|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
154668665|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668666|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
154668667|NCT05175781|Ketamine|ketamine|mesh-list
154668668|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154668669|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668670|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668671|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668672|NCT05175781|Analgesics|analgesics|mesh-ancestor
154668673|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
154668674|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668675|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154668676|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154668677|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154668678|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668679|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668680|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668681|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154668682|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154668683|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
154668684|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
154668685|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154668686|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154668687|NCT04421911|Diclofenac|diclofenac|mesh-list
154668688|NCT04421911|Ketoprofen|ketoprofen|mesh-list
154668689|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668690|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668691|NCT04421911|Analgesics|analgesics|mesh-ancestor
154668692|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
154668693|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668694|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668695|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668696|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668697|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154668698|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668699|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668700|NCT05133817|Norepinephrine|norepinephrine|mesh-list
154668701|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154668702|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154668703|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154668704|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668705|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668706|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668707|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668708|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
154668709|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
154420718|NCT03869268|Analgesics|analgesics|mesh-ancestor
154668710|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668711|NCT05171335|Lenvatinib|lenvatinib|mesh-list
154668712|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668713|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668714|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668715|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668716|NCT02522299|Nemiralisib|nemiralisib|mesh-list
154668717|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668718|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668719|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668720|NCT01365091|Metformin|metformin|mesh-list
154668721|NCT01365091|Saxagliptin|saxagliptin|mesh-list
154668722|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154668723|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668724|NCT01365091|Incretins|incretins|mesh-ancestor
154668725|NCT01365091|Hormones|hormones|mesh-ancestor
154668726|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668727|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154668728|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
154668729|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668730|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668731|NCT05079763|Monolaurin|monolaurin|mesh-list
154668732|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
154668733|NCT05079763|Protective Agents|protective agents|mesh-ancestor
154668734|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668735|NCT05050981|Hormones|hormones|mesh-list
154668736|NCT05050981|Serotonin|serotonin|mesh-list
154668737|NCT05050981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154668738|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668739|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668740|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154668741|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
154668742|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668743|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668744|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154668745|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154668746|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154668747|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
154668748|NCT01364467|Guaifenesin|guaifenesin|mesh-list
154668749|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154668750|NCT01364467|Expectorants|expectorants|mesh-ancestor
154172087|NCT01420250|Hormones|hormones|mesh-list
154668751|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
154668752|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154668753|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154668754|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668755|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668756|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668757|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668758|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
154668759|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154668760|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
154668761|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
154668762|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668763|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
154668764|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154668765|NCT05110417|Bromides|bromides|mesh-list
154668766|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154668767|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
154668768|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154668769|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668770|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668771|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
154668772|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668773|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668774|NCT05031481|Butoconazole|butoconazole|mesh-list
154668775|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
154668776|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668777|NCT05057767|Midazolam|midazolam|mesh-list
154668778|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154668779|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154668780|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668781|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668782|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154668783|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154668784|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154668785|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154668786|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
154668787|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
154668788|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
154668789|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
154668790|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668791|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668792|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154668793|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
154668794|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
154668795|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
154668796|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668797|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154668798|NCT04997239|Vaccines|vaccines|mesh-list
154668799|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
154668800|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668801|NCT04216693|Digoxin|digoxin|mesh-list
154668802|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154668803|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154668804|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668805|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668806|NCT04216693|Protective Agents|protective agents|mesh-ancestor
154668807|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668808|NCT01364389|Prednisone|prednisone|mesh-list
154668809|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668810|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
154668811|NCT01364389|Hormones|hormones|mesh-ancestor
154668812|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668813|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668814|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154668815|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668816|NCT05054881|Iodine|iodine|mesh-list
154668817|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154668818|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668819|NCT05054881|Trace Elements|trace elements|mesh-ancestor
154668820|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
154668821|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668822|NCT04949425|Adavosertib|adavosertib|mesh-list
154668823|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668824|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668825|NCT04421209|Propranolol|propranolol|mesh-list
154668826|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154668827|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154668828|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668829|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668830|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668831|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668832|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154668833|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154668834|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
154668835|NCT04983121|Antibodies|antibodies|mesh-list
154668836|NCT04983121|Mitogens|mitogens|mesh-list
154668837|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
154668838|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
154668839|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668840|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
154668841|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668842|NCT02291289|Bevacizumab|bevacizumab|mesh-list
154668843|NCT02291289|Trastuzumab|trastuzumab|mesh-list
154668844|NCT02291289|Cetuximab|cetuximab|mesh-list
154668845|NCT02291289|Atezolizumab|atezolizumab|mesh-list
154668846|NCT02291289|Pertuzumab|pertuzumab|mesh-list
154668847|NCT02291289|Capecitabine|capecitabine|mesh-list
154668848|NCT02291289|Fluorouracil|fluorouracil|mesh-list
154668849|NCT02291289|Vemurafenib|vemurafenib|mesh-list
154668850|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154668851|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668852|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154668853|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154668854|NCT02291289|Growth Substances|growth substances|mesh-ancestor
154668855|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668856|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
154668857|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154668858|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
154668859|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668860|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154668861|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
154668862|NCT02291289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154668863|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668864|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668865|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
154668866|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154668867|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668868|NCT02289963|Alirocumab|alirocumab|mesh-list
154668869|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154668870|NCT02289963|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154668871|NCT02289963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154668872|NCT02289963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154668873|NCT02289963|Antimetabolites|antimetabolites|mesh-ancestor
154668874|NCT02289963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668875|NCT02289963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154668876|NCT02289963|Protease Inhibitors|protease inhibitors|mesh-ancestor
154668877|NCT02289963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668878|NCT02289963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154668879|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
154668880|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668881|NCT02358369|Timolol|timolol|mesh-list
154668882|NCT02358369|Bimatoprost|bimatoprost|mesh-list
154668883|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154668884|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154668885|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154668886|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154668887|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
154668888|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668889|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668890|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668891|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154668892|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154668893|NCT02316171|Mitomycins|mitomycins|mesh-list
154668894|NCT02316171|Mitomycin|mitomycin|mesh-list
154668895|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154668896|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668897|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
154668898|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668899|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154668900|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668901|NCT02315625|Everolimus|everolimus|mesh-list
154668902|NCT02315625|Sunitinib|sunitinib|mesh-list
154668903|NCT02315625|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154668904|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154668905|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668906|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668907|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154668908|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
154668909|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668910|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668911|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154668912|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154668913|NCT02315625|Growth Substances|growth substances|mesh-ancestor
154668914|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
154668915|NCT02357979|Fluorides|fluorides|mesh-list
154668916|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
154668917|NCT02357979|Protective Agents|protective agents|mesh-ancestor
154668918|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668919|NCT02357901|Buprenorphine|buprenorphine|mesh-list
154668920|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154668921|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154668922|NCT02357901|Narcotics|narcotics|mesh-ancestor
154668923|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154668924|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668925|NCT02357901|Analgesics|analgesics|mesh-ancestor
154668926|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
154668927|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668928|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154668929|NCT01601847|Vitamin D|vitamin d|mesh-list
154668930|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
154668931|NCT01601847|Vitamins|vitamins|mesh-ancestor
154668932|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
154668933|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668934|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154668935|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154668936|NCT02515279|Ribavirin|ribavirin|mesh-list
154668937|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154668938|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
154668939|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668940|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
154668941|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668942|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
154668943|NCT02515045|Prednisolone|prednisolone|mesh-list
154668944|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154668945|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
153657487|NCT06144242|Metronidazole|metronidazole|mesh-list
154668946|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154668947|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
154668948|NCT02515045|Nepafenac|nepafenac|mesh-list
154668949|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154668950|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
154668951|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668952|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
154668953|NCT02515045|Hormones|hormones|mesh-ancestor
154668954|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154668955|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668956|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154668957|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154668958|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
154668959|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
154668960|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668961|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154668962|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154668963|NCT02515045|Protective Agents|protective agents|mesh-ancestor
154668964|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154668965|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154668966|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154668967|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154668968|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668969|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668970|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668971|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668972|NCT02515045|Analgesics|analgesics|mesh-ancestor
154668973|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
154668974|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668975|NCT02513485|Levodopa|levodopa|mesh-list
154668976|NCT02513485|Carbidopa|carbidopa|mesh-list
154668977|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154668978|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154668979|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
154668980|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154668981|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668982|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668983|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154668984|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668985|NCT02289417|Apremilast|apremilast|mesh-list
154668986|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154668987|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154668988|NCT02289417|Analgesics|analgesics|mesh-ancestor
154668989|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
154668990|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154668991|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154668992|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154668993|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154668994|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154668995|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154668996|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154668997|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154668998|NCT02512861|Bupivacaine|bupivacaine|mesh-list
154668999|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
154669000|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
154582941|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
154669001|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669002|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669003|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
154669004|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669005|NCT04979065|Vitamin D|vitamin d|mesh-list
154669006|NCT04979065|Vitamins|vitamins|mesh-ancestor
154669007|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
154669008|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669009|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154669010|NCT02288325|Milnacipran|milnacipran|mesh-list
154669011|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
154421018|NCT02359331|Amoxicillin|amoxicillin|mesh-list
154669012|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154669013|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154669014|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154669015|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669017|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669018|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
154669019|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154669020|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669021|NCT02288325|Analgesics|analgesics|mesh-ancestor
154669022|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
154669023|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669024|NCT04978051|Icatibant|icatibant|mesh-list
154669025|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154669026|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669027|NCT04978051|Analgesics|analgesics|mesh-ancestor
154669028|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
154669029|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669030|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669031|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669032|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154669033|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154669034|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154669035|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669036|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154669037|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154669038|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
154669039|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154669040|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154669041|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669042|NCT05010421|Clobetasol|clobetasol|mesh-list
154669043|NCT05010421|Emollients|emollients|mesh-list
154669044|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669045|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
154669046|NCT05010421|Hormones|hormones|mesh-ancestor
154669047|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669048|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669049|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
154669050|NCT02504827|Ceftazidime|ceftazidime|mesh-list
154669051|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154669052|NCT02504827|Avibactam|avibactam|mesh-list
154669053|NCT02504827|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154669054|NCT02504827|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154669055|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154669056|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669057|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154669058|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669059|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669060|NCT02504671|Folic Acid|folic acid|mesh-list
154669061|NCT02504671|Hematinics|hematinics|mesh-ancestor
154669062|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
154669063|NCT02504671|Vitamins|vitamins|mesh-ancestor
154669064|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
154669065|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669066|NCT02314143|Trametinib|trametinib|mesh-list
154669067|NCT02314143|Dabrafenib|dabrafenib|mesh-list
154669068|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669069|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154669070|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669071|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669072|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
154669073|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154669074|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669075|NCT05007613|Atezolizumab|atezolizumab|mesh-list
154669076|NCT05007613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154669077|NCT05007613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669078|NCT05007613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669079|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669080|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
154669081|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154669082|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154669083|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154669084|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154669085|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154669086|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669087|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
154669088|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669089|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669090|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154669091|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669092|NCT02501629|Reslizumab|reslizumab|mesh-list
154669093|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154669094|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
154669095|NCT02501473|Rituximab|rituximab|mesh-list
154669096|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
154669097|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669098|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669099|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
154669100|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669101|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154669102|NCT02501473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154669103|NCT02501473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669104|NCT02501161|Insulin|insulin|mesh-list
154669105|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154669106|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
154669107|NCT02501161|Liraglutide|liraglutide|mesh-list
154669108|NCT02501161|Xultophy|xultophy|mesh-list
154669109|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154669110|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669111|NCT02501161|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154669112|NCT02501161|Incretins|incretins|mesh-ancestor
154669113|NCT02501161|Hormones|hormones|mesh-ancestor
154669114|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669115|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
154669116|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154669117|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669118|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669119|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669120|NCT04205539|Analgesics|analgesics|mesh-ancestor
154669121|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
154669122|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669123|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154669124|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154669125|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154669126|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
154669127|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669128|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669129|NCT02313909|Aspirin|aspirin|mesh-list
154669130|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
154669131|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154669132|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669133|NCT02313909|Analgesics|analgesics|mesh-ancestor
154669134|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
154669135|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669136|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669137|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669138|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154669139|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154669140|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154669141|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669142|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154669143|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154669144|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669145|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
154669146|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154669147|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
154669148|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154669149|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
154669150|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
154669151|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
154669152|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154669153|NCT02287467|Antibodies|antibodies|mesh-list
154669154|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
154669155|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154669156|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
154669157|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669158|NCT02287233|Cytarabine|cytarabine|mesh-list
154669159|NCT02287233|Venetoclax|venetoclax|mesh-list
154421175|NCT03135301|Metformin|metformin|mesh-list
154669160|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154669161|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
154669162|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669163|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669164|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
154669165|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669166|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154669167|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
154669168|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669169|NCT01646385|Etanercept|etanercept|mesh-list
154669170|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
154669171|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154669172|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669173|NCT01646385|Analgesics|analgesics|mesh-ancestor
154669174|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
154669175|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669176|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669177|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669178|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154669179|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154669180|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
154669181|NCT02286843|Trastuzumab|trastuzumab|mesh-list
154669182|NCT02286843|Pertuzumab|pertuzumab|mesh-list
154669183|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669184|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669185|NCT02281773|BI 409306|bi 409306|mesh-list
154669186|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154669187|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669188|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669189|NCT02354235|Canagliflozin|canagliflozin|mesh-list
154669190|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154669191|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669192|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154669193|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669194|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
154669195|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154669196|NCT02284893|Saxagliptin|saxagliptin|mesh-list
154669197|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154669198|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669199|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154669200|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669201|NCT02284893|Incretins|incretins|mesh-ancestor
154669202|NCT02284893|Hormones|hormones|mesh-ancestor
154669203|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669204|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154669205|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
154669206|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669207|NCT02483611|Lidocaine|lidocaine|mesh-list
154669208|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
154669209|NCT02483611|Cisatracurium|cisatracurium|mesh-list
153923869|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
154669210|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
154669211|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
154669212|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669213|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669214|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
154669215|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669216|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154669217|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154669218|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154669219|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154669220|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669221|NCT02483611|Analgesics|analgesics|mesh-ancestor
154669222|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
154669223|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154669224|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154669225|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
154669226|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154669227|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154669228|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154669229|NCT02482129|Dexamethasone|dexamethasone|mesh-list
154669230|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154669231|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154669232|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669233|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
154669234|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
154669235|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669236|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669237|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154669238|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
154669239|NCT02482129|Hormones|hormones|mesh-ancestor
154669240|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669241|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154669242|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669243|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
154669244|NCT02495857|Viscosupplements|viscosupplements|mesh-list
154669245|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154669246|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
154669247|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669248|NCT02495857|Protective Agents|protective agents|mesh-ancestor
154669249|NCT02495389|Mirabegron|mirabegron|mesh-list
154669250|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154669251|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154669252|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154669253|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
154669254|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669255|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669256|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669257|NCT02495389|Urological Agents|urological agents|mesh-ancestor
154669258|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154669259|NCT02495233|Gilteritinib|gilteritinib|mesh-list
154669260|NCT02495233|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154669261|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154669262|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669263|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669264|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669265|NCT02495077|Acetaminophen|acetaminophen|mesh-list
154669266|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
154669267|NCT02495077|Promethazine|promethazine|mesh-list
154669268|NCT02495077|Loratadine|loratadine|mesh-list
154669269|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
154669270|NCT02495077|Prednisone|prednisone|mesh-list
154669271|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
154669272|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154669273|NCT02495077|Infliximab|infliximab|mesh-list
154669274|NCT02495077|Tacrolimus|tacrolimus|mesh-list
154669275|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
154669276|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154669277|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669278|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
154669279|NCT02495077|Hormones|hormones|mesh-ancestor
154669280|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669281|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669282|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154669283|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669284|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154669285|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
154669286|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154669287|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669288|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669289|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669290|NCT02495077|Analgesics|analgesics|mesh-ancestor
154669291|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
154669292|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669293|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
154669294|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154669295|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154669296|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
154669297|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154669298|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924002|NCT04257838|Meropenem|meropenem|mesh-list
154669299|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
154669300|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
154669301|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154669302|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154669303|NCT02495077|Protective Agents|protective agents|mesh-ancestor
154669304|NCT02495077|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154669305|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
154669306|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154669307|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154669308|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154669309|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669311|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
154669312|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154669313|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
154669314|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
154669315|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669316|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154669317|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
154669318|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154669319|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
154669320|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
154669321|NCT02278341|Hematinics|hematinics|mesh-ancestor
154669322|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
154669323|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154669324|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154669325|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669326|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
154669327|NCT02278263|Coagulants|coagulants|mesh-ancestor
154669328|NCT02494921|Prednisone|prednisone|mesh-list
154669329|NCT02494921|Docetaxel|docetaxel|mesh-list
154669330|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669331|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
154669332|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
154669333|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
154669334|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669335|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669336|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
154669337|NCT02494921|Hormones|hormones|mesh-ancestor
154669338|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669339|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669340|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154669341|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
154669342|NCT01653847|Everolimus|everolimus|mesh-list
154669343|NCT01653847|Tacrolimus|tacrolimus|mesh-list
154669344|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154669345|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
154669346|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669347|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154669348|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669349|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669350|NCT01653847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154669351|NCT01653847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154669352|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669353|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154669354|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154669355|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
154669356|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154669357|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669358|NCT02493751|Avelumab|avelumab|mesh-list
154669359|NCT02493751|Axitinib|axitinib|mesh-list
154669360|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153924017|NCT01172639|Hormones|hormones|mesh-ancestor
153924079|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
154669361|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669362|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154669363|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669364|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669365|NCT02493517|Lanreotide|lanreotide|mesh-list
154669366|NCT02493517|Somatostatin|somatostatin|mesh-list
154669367|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669368|NCT02493517|Hormones|hormones|mesh-ancestor
154669369|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669370|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669371|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
154669372|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669373|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669374|NCT02493361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154669375|NCT02493361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669376|NCT04959799|Dalbavancin|dalbavancin|mesh-list
154669377|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154669378|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669379|NCT02478463|Cabotegravir|cabotegravir|mesh-list
154669380|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154669381|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154669382|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669383|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669384|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154421401|NCT02133326|Ibuprofen|ibuprofen|mesh-list
154669385|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154669386|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
154669387|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669388|NCT02491411|Dexamethasone|dexamethasone|mesh-list
154669389|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
154669390|NCT02491411|Ichthammol|ichthammol|mesh-list
154669391|NCT02491411|BB 1101|bb 1101|mesh-list
154669392|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669393|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
154669394|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
154669395|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669396|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669397|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154669398|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
154669399|NCT02491411|Hormones|hormones|mesh-ancestor
154669400|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669401|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154669402|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669403|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
154669404|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669405|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669406|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
154669407|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
154669408|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154669409|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
154669410|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154669411|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669412|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154669413|NCT02490475|Docetaxel|docetaxel|mesh-list
154669414|NCT02490475|Pertuzumab|pertuzumab|mesh-list
154669415|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669416|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
154669417|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
154669418|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
154669419|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669420|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669421|NCT02477839|Lacosamide|lacosamide|mesh-list
154669422|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
154669423|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154669424|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154669425|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154669426|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669427|NCT04939987|Acetaminophen|acetaminophen|mesh-list
154669428|NCT04939987|Ketorolac|ketorolac|mesh-list
154669429|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154669430|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154669431|NCT04939987|Ketamine|ketamine|mesh-list
154669432|NCT04939987|Oxycodone|oxycodone|mesh-list
154669433|NCT04939987|Gabapentin|gabapentin|mesh-list
154669434|NCT04939987|Tramadol|tramadol|mesh-list
154669435|NCT04939987|Hydrocodone|hydrocodone|mesh-list
154669436|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
154669437|NCT04939987|Analgesics|analgesics|mesh-ancestor
154669438|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
154669439|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669440|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669441|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154669442|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154669443|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
154669444|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
154669445|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669446|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154669447|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154669448|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669449|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669450|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669451|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
154669452|NCT04939987|Narcotics|narcotics|mesh-ancestor
154669453|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
154669454|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154669455|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154669456|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154669457|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
154669458|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154669459|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669460|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421475|NCT02138084|Ritonavir|ritonavir|mesh-list
154669461|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154669462|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669463|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
154669464|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
154669465|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154669466|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154669467|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154669468|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
154669469|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669470|NCT02477215|Dexamethasone|dexamethasone|mesh-list
154669471|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154669472|NCT02477215|Ixazomib|ixazomib|mesh-list
154669473|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669474|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
154669475|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
154669476|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669477|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669478|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154669479|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
154669480|NCT02477215|Hormones|hormones|mesh-ancestor
154669481|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669482|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154669483|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669484|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154669485|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
154669486|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669487|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
154669488|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669489|NCT02487199|Ritonavir|ritonavir|mesh-list
154669490|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154669491|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154669492|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
154669493|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669494|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669495|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154669496|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154669497|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
154669498|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669499|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154669500|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154669501|NCT02475733|Metronidazole|metronidazole|mesh-list
154669502|NCT02475733|Meropenem|meropenem|mesh-list
154669503|NCT02475733|Ceftazidime|ceftazidime|mesh-list
154669504|NCT02475733|Avibactam|avibactam|mesh-list
154669505|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154669506|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669507|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154669508|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154669509|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154669510|NCT02475733|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154669511|NCT02475733|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154669512|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154669513|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669514|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669515|NCT02486653|Tamsulosin|tamsulosin|mesh-list
154669516|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154669517|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154669518|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154669519|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
154669520|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669521|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669522|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669523|NCT02486653|Urological Agents|urological agents|mesh-ancestor
154669524|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
154669525|NCT02475265|Estradiol|estradiol|mesh-list
154669526|NCT02475265|Estrogens|estrogens|mesh-ancestor
154669527|NCT02475265|Hormones|hormones|mesh-ancestor
154669528|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669529|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669530|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154669531|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
154669532|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154669533|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154421552|NCT02138552|Octenidine|octenidine|mesh-list
154669534|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154669535|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154669536|NCT02450539|Docetaxel|docetaxel|mesh-list
154669537|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669538|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
154669539|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
154669540|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
154669541|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669542|NCT02449915|Bupivacaine|bupivacaine|mesh-list
154669543|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
154669544|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
154669545|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669546|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669547|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
154669548|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669549|NCT02472847|Dronabinol|dronabinol|mesh-list
154669550|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
154669551|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669552|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154669553|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669554|NCT02472847|Analgesics|analgesics|mesh-ancestor
154669555|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
154669556|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669557|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154669558|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154669559|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669560|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669561|NCT02472847|Hormones|hormones|mesh-ancestor
154669562|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669563|NCT02472145|Decitabine|decitabine|mesh-list
154669564|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154669565|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
154669566|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669567|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669568|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669569|NCT02448043|Bimatoprost|bimatoprost|mesh-list
154669570|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154669571|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
154669572|NCT02447887|Ixazomib|ixazomib|mesh-list
154669573|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669574|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
154669575|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669576|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669577|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
154669578|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669579|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154669580|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
154669581|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154669582|NCT02417935|Pregabalin|pregabalin|mesh-list
154669583|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154669584|NCT02417935|Analgesics|analgesics|mesh-ancestor
154669585|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
154669586|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154582942|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
154669587|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669588|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
154669589|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154669590|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154669591|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669592|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154669593|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154669594|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154669595|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669596|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154669597|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154669598|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154669599|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669600|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
154669601|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
154669602|NCT02416453|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154669603|NCT02416453|Antiviral Agents|antiviral agents|mesh-ancestor
154669604|NCT02416453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669605|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
154669606|NCT02469961|Propofol|propofol|mesh-list
154669607|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154669608|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669609|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669610|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669611|NCT02469961|Analgesics|analgesics|mesh-ancestor
154669612|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
154669613|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669614|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154669615|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154669616|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154669617|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
154669618|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669619|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669620|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154669621|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
154669622|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
154669623|NCT02415595|BMS-955176|bms-955176|mesh-list
154669624|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154669625|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154669626|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
154669627|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669628|NCT02446717|Ribavirin|ribavirin|mesh-list
154669629|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
154669630|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669631|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
154669632|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669633|NCT02469415|Azacitidine|azacitidine|mesh-list
154669634|NCT02469415|Decitabine|decitabine|mesh-list
154669635|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154669636|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
154669637|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669638|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669639|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669640|NCT02446171|Naloxegol|naloxegol|mesh-list
154669641|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154669642|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669643|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
154669644|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669645|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154669646|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
154669647|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154669648|NCT02415127|Interferons|interferons|mesh-list
154669649|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
154669650|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669651|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
154669652|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669653|NCT02468557|Paclitaxel|paclitaxel|mesh-list
154669654|NCT02468557|Idelalisib|idelalisib|mesh-list
154669655|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154669656|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669657|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
154669658|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
154669659|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
154669660|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669661|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669662|NCT02413489|Daratumumab|daratumumab|mesh-list
154669663|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669664|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
154669665|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154669666|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
154669667|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669668|NCT02444533|Bupivacaine|bupivacaine|mesh-list
154669669|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
154669670|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
154669671|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669672|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669673|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
154669674|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669675|NCT01651039|Dexamethasone|dexamethasone|mesh-list
154669676|NCT01651039|Lenalidomide|lenalidomide|mesh-list
154669677|NCT01651039|Panobinostat|panobinostat|mesh-list
154669678|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669679|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
154669680|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
154669681|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924362|NCT01220024|Bupivacaine|bupivacaine|mesh-list
154669682|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669683|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154669684|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
154669685|NCT01651039|Hormones|hormones|mesh-ancestor
154669686|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669687|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154669688|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669689|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
154669690|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154669691|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154669692|NCT01651039|Growth Substances|growth substances|mesh-ancestor
154669693|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154669694|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154669695|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669696|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669697|NCT02349633|Palbociclib|palbociclib|mesh-list
154669698|NCT02349633|Avelumab|avelumab|mesh-list
154669699|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669700|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154669701|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669702|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669703|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669704|NCT02275611|Oxytocin|oxytocin|mesh-list
154669705|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
154669706|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154669707|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669708|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
154669709|NCT04875585|Lenvatinib|lenvatinib|mesh-list
154669710|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669711|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669712|NCT04875585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154669713|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669714|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154669715|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669716|NCT02273973|Letrozole|letrozole|mesh-list
154669717|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669718|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154669719|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154669720|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669721|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669722|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154669723|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
154669724|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669725|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669726|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154669727|NCT05649111|Difluprednate|difluprednate|mesh-list
154669728|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154669729|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
154669730|NCT05649111|Hormones|hormones|mesh-ancestor
154669731|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669732|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669733|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
154669734|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154669735|NCT02465515|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154669736|NCT02465515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154669737|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669738|NCT02465515|Incretins|incretins|mesh-ancestor
154669739|NCT02465515|Hormones|hormones|mesh-ancestor
154669740|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669741|NCT05561361|Spironolactone|spironolactone|mesh-list
154669742|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154669743|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
154669744|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669745|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669746|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154669747|NCT05561361|Diuretics|diuretics|mesh-ancestor
154669748|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
154669749|NCT02412631|Varenicline|varenicline|mesh-list
154669750|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154669751|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154669752|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
154669753|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669754|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669755|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669756|NCT02272803|Dexamethasone|dexamethasone|mesh-list
154669757|NCT02272803|Lenalidomide|lenalidomide|mesh-list
154669758|NCT02272803|Elotuzumab|elotuzumab|mesh-list
154669759|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669760|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
154669761|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
154669762|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669763|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669764|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154669765|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
154669766|NCT02272803|Hormones|hormones|mesh-ancestor
154669767|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669768|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154669769|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669770|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
154669771|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154669772|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154669773|NCT02272803|Growth Substances|growth substances|mesh-ancestor
154669774|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
154669775|NCT02272725|Ibuprofen|ibuprofen|mesh-list
154669776|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154669777|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669778|NCT02272725|Analgesics|analgesics|mesh-ancestor
154669779|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
154669780|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669781|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669782|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669783|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154669784|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154669785|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669786|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669787|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
154669788|NCT01650805|Ponatinib|ponatinib|mesh-list
154669789|NCT01650805|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154669790|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154669791|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669792|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669793|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669794|NCT02442349|Osimertinib|osimertinib|mesh-list
154669795|NCT02442349|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154669796|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154669797|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669798|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669799|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669800|NCT02442271|Ritonavir|ritonavir|mesh-list
154669801|NCT02442271|Ribavirin|ribavirin|mesh-list
154669802|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154669803|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154669804|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
154669805|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669806|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669807|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154669808|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154669809|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
154669810|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669811|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154669812|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154669813|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
154669814|NCT02463409|Theophylline|theophylline|mesh-list
154669815|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154669816|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
154669817|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669818|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669819|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154669820|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
154669821|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154669822|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669823|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669824|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
154669825|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154669826|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154669827|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
154669828|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669829|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
154669830|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669831|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669832|NCT02528357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154669833|NCT02528357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669834|NCT04910425|Fluorides|fluorides|mesh-list
154669835|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
154669836|NCT04910425|Protective Agents|protective agents|mesh-ancestor
154669837|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669838|NCT02463331|Chloroquine|chloroquine|mesh-list
154669839|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154669840|NCT02463331|Prednisone|prednisone|mesh-list
154669841|NCT02463331|Azathioprine|azathioprine|mesh-list
154669842|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669843|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
154669844|NCT02463331|Hormones|hormones|mesh-ancestor
154669845|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154669846|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669847|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154669848|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669849|NCT02463331|Amebicides|amebicides|mesh-ancestor
154669850|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154669851|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154669852|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669853|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
154669854|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154669855|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154669856|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154669857|NCT02463331|Analgesics|analgesics|mesh-ancestor
154669858|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
154669859|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669860|NCT02463331|Filaricides|filaricides|mesh-ancestor
154669861|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
154669862|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
154669863|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
154669864|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669865|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154669866|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154669867|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
154669868|NCT02463097|Insulin|insulin|mesh-list
154669869|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154669870|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669871|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
154669872|NCT05427149|Analgesics|analgesics|mesh-ancestor
154669873|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
154669874|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669875|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669876|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
154669877|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669878|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154669879|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
154669880|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154669881|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154669882|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924602|NCT02863185|Pitavastatin|pitavastatin|mesh-list
154669883|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154669884|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
154669885|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154669886|NCT02462473|Olanzapine|olanzapine|mesh-list
154669887|NCT02462473|Risperidone|risperidone|mesh-list
154669888|NCT02462473|Aripiprazole|aripiprazole|mesh-list
154669889|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154669890|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154669891|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154669892|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
154669893|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669894|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669895|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669896|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154669897|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154669898|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669899|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154669900|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154669901|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
154669902|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
154669903|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
154669904|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669905|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154669906|NCT02462473|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154669907|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154669908|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154669909|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
154669910|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
154669911|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154669912|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154669913|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154669914|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154669915|NCT02440789|Sirolimus|sirolimus|mesh-list
154669916|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154669917|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669918|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154669919|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669920|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
154669921|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154669922|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
154669923|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669924|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
154669925|NCT02538107|Hematinics|hematinics|mesh-ancestor
154669926|NCT02272413|Bevacizumab|bevacizumab|mesh-list
154669927|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669928|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669929|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154669930|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154669931|NCT02272413|Growth Substances|growth substances|mesh-ancestor
154669932|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669933|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
154669934|NCT05648799|Molnupiravir|molnupiravir|mesh-list
154669935|NCT05648799|Antiviral Agents|antiviral agents|mesh-ancestor
154669936|NCT05648799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154669937|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
154669938|NCT02120807|Pemetrexed|pemetrexed|mesh-list
153924605|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
154669939|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669940|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154669941|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669942|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154669943|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154669944|NCT02120807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154669945|NCT02120807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154669946|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154669947|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
154669948|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669949|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154669950|NCT02532647|Midazolam|midazolam|mesh-list
154669951|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154669952|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154669953|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669954|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669955|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154669956|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154669957|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154669958|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154669959|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
154669960|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
154669961|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
154669962|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
154669963|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154669964|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154669965|NCT02537015|Bimatoprost|bimatoprost|mesh-list
154669966|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154669967|NCT01660763|Sufentanil|sufentanil|mesh-list
154669968|NCT01660763|Dsuvia|dsuvia|mesh-list
154669969|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154669970|NCT01660763|Narcotics|narcotics|mesh-ancestor
154669971|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154669972|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669973|NCT01660763|Analgesics|analgesics|mesh-ancestor
154669974|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
154669975|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154669976|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154669977|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154669978|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
154669979|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
154669980|NCT02268045|Rituximab|rituximab|mesh-list
154669981|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669982|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669983|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
154669984|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669985|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154669987|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924661|NCT03809481|Danaparoid|danaparoid|mesh-list
154669988|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154669989|NCT01641939|Trastuzumab|trastuzumab|mesh-list
154669990|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154669991|NCT01641939|Maytansine|maytansine|mesh-list
154669992|NCT01641939|Taxane|taxane|mesh-list
154669993|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154669994|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154669995|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154669996|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
154669997|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
154669998|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
154669999|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670000|NCT01641939|Immunotoxins|immunotoxins|mesh-ancestor
154670001|NCT01641939|Immunoconjugates|immunoconjugates|mesh-ancestor
154670002|NCT01641939|Immunologic Factors|immunologic factors|mesh-ancestor
154670003|NCT01641939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670004|NCT02409355|Carboplatin|carboplatin|mesh-list
154670005|NCT02409355|Gemcitabine|gemcitabine|mesh-list
154670006|NCT02409355|Atezolizumab|atezolizumab|mesh-list
154670007|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670008|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154670009|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
154670010|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670011|NCT02409355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154670012|NCT02409355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154670013|NCT02438371|Indomethacin|indomethacin|mesh-list
154670014|NCT02438371|Nifedipine|nifedipine|mesh-list
154670015|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154670016|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670017|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670018|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154670019|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670020|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
154670021|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
154670022|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154670023|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154670024|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154670025|NCT02438371|Analgesics|analgesics|mesh-ancestor
154670026|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
154670027|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670028|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670029|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670030|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
154670031|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153924702|NCT00648661|Dexetimide|dexetimide|mesh-list
154670032|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670033|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154670034|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
154670035|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154670036|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
154670037|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670038|NCT04909021|Vaccines|vaccines|mesh-list
154670039|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
154670040|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670041|NCT02460991|Sorafenib|sorafenib|mesh-list
154670042|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670043|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154670044|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670045|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670046|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154670047|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154670048|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670049|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154670050|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670051|NCT02436889|Mirabegron|mirabegron|mesh-list
154670052|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154670053|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154670054|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154670055|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154670056|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
154670057|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422078|NCT02850276|Bromides|bromides|mesh-list
154670058|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670059|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670060|NCT02436889|Urological Agents|urological agents|mesh-ancestor
154670061|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154670062|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154670063|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
154670064|NCT02436577|Ticagrelor|ticagrelor|mesh-list
154670065|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154670066|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154670067|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154670068|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154670069|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
154670070|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670071|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670072|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670073|NCT02459665|Metronidazole|metronidazole|mesh-list
154670074|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670075|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154670076|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154670077|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154670078|NCT02265237|Ritonavir|ritonavir|mesh-list
154670079|NCT02265237|Ribavirin|ribavirin|mesh-list
154670080|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154670081|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154670082|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
154670083|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670084|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670085|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154670086|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154670087|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
154670088|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670089|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154670090|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154670091|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
154670092|NCT04874025|Palbociclib|palbociclib|mesh-list
154670093|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670094|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154670095|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670096|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670097|NCT02263365|Loperamide|loperamide|mesh-list
154670098|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
154670099|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670100|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
154670101|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154670102|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154670103|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154670104|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670105|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670106|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
154670107|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670108|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670109|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154670110|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670111|NCT02260791|Adalimumab|adalimumab|mesh-list
154670112|NCT02260791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154670113|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670114|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670115|NCT02260635|Evacetrapib|evacetrapib|mesh-list
154670116|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154670117|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154670118|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
154670119|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670120|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154670121|NCT02258529|Rituximab|rituximab|mesh-list
154670122|NCT02258529|Idelalisib|idelalisib|mesh-list
154670123|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154670124|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670125|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
154670126|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670127|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670128|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670129|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670130|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
154670131|NCT02256969|Prednisolone|prednisolone|mesh-list
154670132|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154670133|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
153924795|NCT01215032|Metformin|metformin|mesh-list
154670134|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154670135|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
154670136|NCT02256969|Mineral Oil|mineral oil|mesh-list
154670137|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154670138|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
154670139|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670140|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
154670141|NCT02256969|Hormones|hormones|mesh-ancestor
154670142|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670143|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670144|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154670145|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670146|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
154670147|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
154670148|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670149|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670150|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154670151|NCT02256969|Protective Agents|protective agents|mesh-ancestor
154670152|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154670153|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670154|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154670155|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154670156|NCT02256969|Emollients|emollients|mesh-ancestor
154670157|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
154670158|NCT02256267|Rifampin|rifampin|mesh-list
154670159|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154670160|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
154670161|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154670162|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670163|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
154670164|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154670165|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670166|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670167|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154670168|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154670169|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154670170|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154670171|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154670172|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154670173|NCT05429463|Paclitaxel|paclitaxel|mesh-list
154670174|NCT05429463|Carboplatin|carboplatin|mesh-list
154670175|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154670176|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154670177|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670178|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
154670179|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
154670180|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
154670181|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670182|NCT02255565|Methylphenidate|methylphenidate|mesh-list
154670183|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154670184|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670185|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154670186|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154670187|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670188|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670189|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
154670190|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670191|NCT01640301|Aldesleukin|aldesleukin|mesh-list
154670192|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
154670193|NCT01640301|Fludarabine|fludarabine|mesh-list
154670194|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
154670195|NCT01640301|Interleukin-2|interleukin-2|mesh-list
154670196|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154670197|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
154670198|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670199|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670200|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154670201|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
154670202|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670203|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670204|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154670205|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154670206|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
154670207|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154670208|NCT01640301|Analgesics|analgesics|mesh-ancestor
154670209|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
154670210|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670211|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154670212|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154670213|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
154670214|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670215|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
154670216|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
154670217|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154670218|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154670219|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670220|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670221|NCT01642407|Urological Agents|urological agents|mesh-ancestor
154670222|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
154670223|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154670224|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670225|NCT02255097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154670226|NCT02255097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670227|NCT02254551|Bortezomib|bortezomib|mesh-list
154670228|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670229|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
154670230|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154670231|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154670232|NCT05640375|Prednisolone|prednisolone|mesh-list
154670233|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
154670234|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154670235|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
154670236|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670237|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
154670238|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
154670239|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670240|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670241|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670242|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
154670243|NCT05640375|Hormones|hormones|mesh-ancestor
154670244|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670245|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154670246|NCT05640375|Protective Agents|protective agents|mesh-ancestor
154670247|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154670248|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670249|NCT01641237|Listerine|listerine|mesh-list
154670250|NCT01641237|Fluorides|fluorides|mesh-list
154670251|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
154670252|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
154670253|NCT01641237|Protective Agents|protective agents|mesh-ancestor
154670254|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670255|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154670256|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670257|NCT05617209|Thrombin|thrombin|mesh-list
154670258|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
154670259|NCT05617209|Coagulants|coagulants|mesh-ancestor
154670260|NCT01639833|Hemostatics|hemostatics|mesh-list
154670261|NCT01639833|Coagulants|coagulants|mesh-ancestor
154670262|NCT01639131|Gemcitabine|gemcitabine|mesh-list
154670263|NCT01639131|Docetaxel|docetaxel|mesh-list
154670264|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154670265|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
154670266|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670267|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670268|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
154670269|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
154670270|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
154670271|NCT01641159|Buspirone|buspirone|mesh-list
154670272|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154670273|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154670274|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670275|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670276|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154670277|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154670278|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
154670279|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670280|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422309|NCT05417893|Sirolimus|sirolimus|mesh-list
154670281|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
154670282|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154670283|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
154670284|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670285|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670286|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154670287|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
154670288|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154670289|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154670290|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154670291|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154670292|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670293|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670295|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154670296|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154670297|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670298|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
154670299|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
154670300|NCT05369481|Minoxidil|minoxidil|mesh-list
154670301|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
154670302|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
154670303|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154670304|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154670305|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670306|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670307|NCT05369481|Urological Agents|urological agents|mesh-ancestor
154670308|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154670309|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
154670310|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154670311|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
154670312|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670313|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
154670314|NCT04853589|Protective Agents|protective agents|mesh-ancestor
154670315|NCT01638429|Rifaximin|rifaximin|mesh-list
154670316|NCT01638429|Neomycin|neomycin|mesh-list
154670317|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154670318|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670319|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670320|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154670321|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670322|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670323|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154670324|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154670325|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670326|NCT04853355|Spironolactone|spironolactone|mesh-list
154670327|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154670328|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
153924988|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154670329|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670330|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670331|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154670332|NCT04853355|Diuretics|diuretics|mesh-ancestor
154670333|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
154670334|NCT05369091|Simvastatin|simvastatin|mesh-list
154670335|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154670336|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154670337|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
154670338|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670339|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154670340|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154670341|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670342|NCT01601535|Irinotecan|irinotecan|mesh-list
154670343|NCT01601535|Temozolomide|temozolomide|mesh-list
154670344|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154670345|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154670346|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670347|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670348|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670349|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154670350|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
154670351|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154670352|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
154670353|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154670354|NCT05422365|Antibodies|antibodies|mesh-list
154670355|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
154670356|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154422377|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670357|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
154670358|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670359|NCT04641273|Pregabalin|pregabalin|mesh-list
154670360|NCT04641273|Analgesics|analgesics|mesh-ancestor
154670361|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
154670362|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670363|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670364|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
154670365|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154670366|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670367|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670368|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154670369|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154670370|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154670371|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670372|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154670373|NCT04586985|Midazolam|midazolam|mesh-list
154670374|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154670375|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154670376|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670377|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670378|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154670379|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154670380|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154670381|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154670382|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
154670383|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
154670384|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
154670385|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
154670386|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670387|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670388|NCT05408403|Anesthetics|anesthetics|mesh-list
154670389|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670390|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670391|NCT04830735|Dasatinib|dasatinib|mesh-list
154670392|NCT04830735|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154670393|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154670394|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670395|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670396|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670397|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154670398|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670399|NCT04419441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154670400|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670401|NCT05329779|Pregnanolone|pregnanolone|mesh-list
154670402|NCT05329779|Brexanolone|brexanolone|mesh-list
154670403|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
154670404|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670405|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670406|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
154670407|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670408|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670409|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
154670410|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
154670411|NCT04850937|Esketamine|esketamine|mesh-list
154670412|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
154670413|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154670414|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154670415|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154670416|NCT04411329|Dexamethasone|dexamethasone|mesh-list
154670417|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
154670418|NCT04411329|Bupivacaine|bupivacaine|mesh-list
154670419|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670420|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
154670421|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
154670422|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670423|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670424|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670425|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
154670426|NCT04411329|Hormones|hormones|mesh-ancestor
154670427|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670428|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154670429|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670430|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154422459|NCT01364675|Metformin|metformin|mesh-list
154670431|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
154670432|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670433|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
154670434|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154670435|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154670436|NCT04411329|Analgesics|analgesics|mesh-ancestor
154670437|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154670438|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154670439|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154670440|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
154670441|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670442|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670443|NCT05171673|Diclofenac|diclofenac|mesh-list
154670444|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154670445|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154670446|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154670447|NCT05171673|Analgesics|analgesics|mesh-ancestor
154670448|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
154670449|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670450|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670451|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670452|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670453|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154670454|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670455|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670456|NCT05147415|Metoprolol|metoprolol|mesh-list
154670457|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154670458|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154670459|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
154670460|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
154670461|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670462|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670463|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154670464|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154670465|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154670466|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
154670467|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670468|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670469|NCT04390581|Lidocaine|lidocaine|mesh-list
154670470|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
154670471|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
154670472|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670473|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670474|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
154670475|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670476|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154670477|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154670478|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154670479|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670480|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925155|NCT00649441|Quinapril|quinapril|mesh-list
154670481|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154670482|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670483|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670484|NCT04225767|Calcium|calcium|mesh-list
154670485|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154670486|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670487|NCT04820673|Sarecycline|sarecycline|mesh-list
154670488|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154670489|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670490|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
154670491|NCT03256149|Dexamethasone|dexamethasone|mesh-list
154670492|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670493|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
154670494|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
154670495|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670496|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670497|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670498|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
154670499|NCT03256149|Hormones|hormones|mesh-ancestor
154670500|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670501|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154670502|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670503|NCT03253263|Mecasermin|mecasermin|mesh-list
154422530|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
154670504|NCT03253263|Growth Substances|growth substances|mesh-ancestor
154670505|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670507|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
154670508|NCT01636947|Ondansetron|ondansetron|mesh-list
154670509|NCT01636947|Aprepitant|aprepitant|mesh-list
154670510|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
154670511|NCT01636947|Metoclopramide|metoclopramide|mesh-list
154670512|NCT01636947|Granisetron|granisetron|mesh-list
154670513|NCT01636947|Tropisetron|tropisetron|mesh-list
154670514|NCT01636947|Dolasetron|dolasetron|mesh-list
154670515|NCT01636947|Alizapride|alizapride|mesh-list
154670516|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154670517|NCT01636947|BB 1101|bb 1101|mesh-list
154670518|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670519|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
154670520|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
154670521|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670522|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670523|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670524|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
154670525|NCT01636947|Hormones|hormones|mesh-ancestor
154670526|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670527|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154670528|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670529|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
154670530|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670531|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670532|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
154670533|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
154670534|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154670535|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154670536|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
154670537|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670538|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154670539|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154670540|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154670541|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
154670542|NCT03052725|Reslizumab|reslizumab|mesh-list
154670543|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154670544|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
154670545|NCT04793919|Tretinoin|tretinoin|mesh-list
154670546|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
154670547|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
154670548|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670549|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
154670550|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
154670551|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154670552|NCT04793919|Immunotoxins|immunotoxins|mesh-ancestor
154670553|NCT04793919|Immunoconjugates|immunoconjugates|mesh-ancestor
154670554|NCT04793919|Immunologic Factors|immunologic factors|mesh-ancestor
154670555|NCT04793919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670556|NCT02817633|Carboplatin|carboplatin|mesh-list
154670557|NCT02817633|Docetaxel|docetaxel|mesh-list
154670558|NCT02817633|Nivolumab|nivolumab|mesh-list
154670559|NCT02817633|Pemetrexed|pemetrexed|mesh-list
154670560|NCT02817633|Dostarlimab|dostarlimab|mesh-list
154670561|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670562|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
154670563|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
154670564|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
154670565|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670566|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154670567|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154670568|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670569|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154670570|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154670571|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
154670572|NCT05651373|Prednisone|prednisone|mesh-list
154670573|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
154670574|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670575|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
154670576|NCT05651373|Hormones|hormones|mesh-ancestor
154670577|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670578|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422600|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154670579|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154670580|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670581|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
154670582|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154670583|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154670584|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670585|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670586|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670587|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670588|NCT05651373|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154670589|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154670590|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
154670591|NCT03905889|Sunitinib|sunitinib|mesh-list
154670592|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670593|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154670594|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154670595|NCT03905889|Growth Substances|growth substances|mesh-ancestor
154670596|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670597|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154670598|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154670599|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670600|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670601|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154670602|NCT03846765|Phenylephrine|phenylephrine|mesh-list
154670603|NCT03846765|Dobutamine|dobutamine|mesh-list
154670604|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
154670605|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154670606|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
154670607|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
154670608|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670609|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670610|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
154670611|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154670612|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
154670613|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
154670614|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154670615|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154670616|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154670617|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
154670618|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670619|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670620|NCT03846765|Protective Agents|protective agents|mesh-ancestor
154670621|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154670622|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154670623|NCT05163405|Bortezomib|bortezomib|mesh-list
154670624|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670625|NCT01635153|Micronutrients|micronutrients|mesh-list
154670626|NCT01635153|Trace Elements|trace elements|mesh-list
154670627|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670628|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154670629|NCT04446039|Vortioxetine|vortioxetine|mesh-list
154670630|NCT04446039|Mirtazapine|mirtazapine|mesh-list
154670631|NCT04446039|Bupropion|bupropion|mesh-list
154670632|NCT04446039|Fluoxetine|fluoxetine|mesh-list
154670633|NCT04446039|Paroxetine|paroxetine|mesh-list
154670634|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154670635|NCT04446039|Sertraline|sertraline|mesh-list
154670636|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154670637|NCT04446039|Tianeptine|tianeptine|mesh-list
154670638|NCT04446039|Escitalopram|escitalopram|mesh-list
154670639|NCT04446039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154670640|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154670641|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670642|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670643|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670644|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
154670645|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670646|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670647|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154670648|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
153925308|NCT02658409|Vaccines|vaccines|mesh-list
154670649|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154670650|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154670651|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
154670652|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154670653|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154670654|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670655|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154670656|NCT04446039|Analgesics|analgesics|mesh-ancestor
154670657|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
154670658|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154670659|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154670660|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670661|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154670662|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154670663|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154670664|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154670665|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154670666|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
154670667|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
154670668|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154670669|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154670670|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154670671|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
154670672|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154670673|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154670674|NCT03591861|Carmustine|carmustine|mesh-list
154670675|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154670676|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
154670677|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670678|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670679|NCT01600053|Lenalidomide|lenalidomide|mesh-list
154670680|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
154670681|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670682|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154670683|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154670684|NCT01600053|Growth Substances|growth substances|mesh-ancestor
154670685|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
153925362|NCT01169675|Pemetrexed|pemetrexed|mesh-list
154670686|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670687|NCT03569241|Androgens|androgens|mesh-list
154670688|NCT03569241|Hormones|hormones|mesh-ancestor
154670689|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670690|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670691|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
154670692|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
154670693|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154670694|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670695|NCT01068249|Everolimus|everolimus|mesh-list
154670696|NCT01068249|Letrozole|letrozole|mesh-list
154670697|NCT01068249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154670698|NCT01068249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154670699|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670700|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670701|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154670702|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
154670703|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670704|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670705|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154670706|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154670707|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154670708|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
154670709|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670710|NCT01035099|Letrozole|letrozole|mesh-list
154670711|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154670712|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154670713|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154670714|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670715|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670716|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154670717|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
154670718|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670719|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670720|NCT03560349|Lidocaine|lidocaine|mesh-list
154670721|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
154670722|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
154670723|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154670724|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670725|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
154670726|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670727|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154670728|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154670729|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154670730|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154670731|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670732|NCT04435431|Mesdopetam|mesdopetam|mesh-list
154670733|NCT04435431|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154670734|NCT04435431|Dopamine Agents|dopamine agents|mesh-ancestor
154670735|NCT04435431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670736|NCT04435431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670737|NCT04435431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670738|NCT02246673|Febuxostat|febuxostat|mesh-list
154670739|NCT02246673|Verinurad|verinurad|mesh-list
154670740|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
154670741|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154582943|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154670742|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154670743|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154670744|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154670745|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670746|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670747|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
154670748|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670749|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154670750|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154670751|NCT04191447|Budesonide|budesonide|mesh-list
154670752|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
154670753|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154670754|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154670755|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154670756|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
154670757|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670758|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670759|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154670760|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
154670761|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
154670762|NCT04191447|Hormones|hormones|mesh-ancestor
154670763|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154670764|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154670765|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154670766|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154670767|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
154670768|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670769|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670770|NCT02243631|Probenecid|probenecid|mesh-list
154670771|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
154670772|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
154670773|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154670774|NCT02242305|Scopolamine|scopolamine|mesh-list
154670775|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154670776|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154670777|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
154670778|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
154582944|NCT05668455|Dexamethasone|dexamethasone|mesh-list
154670779|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154670780|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154670781|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670782|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
154670783|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154670784|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
154670785|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154670786|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670787|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154670788|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
154670789|NCT02240121|Rifaximin|rifaximin|mesh-list
154670790|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154670791|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670792|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154670793|NCT02238483|AZD7624|azd7624|mesh-list
154670794|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154670795|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670796|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670797|NCT01632891|Ritonavir|ritonavir|mesh-list
154670798|NCT01632891|Lopinavir|lopinavir|mesh-list
154670799|NCT01632891|Tenofovir|tenofovir|mesh-list
154670800|NCT01632891|Emtricitabine|emtricitabine|mesh-list
154670801|NCT01632891|Nevirapine|nevirapine|mesh-list
154670802|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154670803|NCT01632891|Efavirenz|efavirenz|mesh-list
154670804|NCT01632891|Trimethoprim|trimethoprim|mesh-list
154422836|NCT02241018|Antibodies|antibodies|mesh-list
154670805|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
154670806|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154670807|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154670808|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
154670809|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154670810|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154670811|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154670812|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154670813|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
154670814|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154670815|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154670816|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154670817|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154670818|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154670819|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154670820|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154670821|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154670822|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154670823|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154670824|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153782202|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432715|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154432716|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154432717|NCT02591953|Prednisolone|prednisolone|mesh-list
154432718|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
154432719|NCT02591953|Lidocaine|lidocaine|mesh-list
154432720|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154432721|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
154432722|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
154432723|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
154432724|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432725|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432726|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
154432727|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432728|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154432729|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154432730|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154432731|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154432732|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432733|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154432734|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
154432735|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
154432736|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154432737|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
154432738|NCT02591953|Hormones|hormones|mesh-ancestor
154432739|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154432740|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154432741|NCT02591953|Protective Agents|protective agents|mesh-ancestor
154432742|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154432743|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432744|NCT02223884|Carboplatin|carboplatin|mesh-list
154007342|NCT02751528|Vaccines|vaccines|mesh-list
154432745|NCT02223884|Docetaxel|docetaxel|mesh-list
154432746|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432747|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
154432748|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
154432749|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
154432750|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432751|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154432752|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154432753|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
154432754|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432755|NCT02569489|Paclitaxel|paclitaxel|mesh-list
154432756|NCT02569489|Trastuzumab|trastuzumab|mesh-list
154432757|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154432758|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432759|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154432760|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154432761|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154432762|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432763|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432765|NCT02079558|Carbetocin|carbetocin|mesh-list
154432766|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
154432767|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154432768|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432769|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
154432770|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154432771|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154432772|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154432773|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154432774|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432775|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
154432776|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432777|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432778|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154432779|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432780|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154432781|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
154432782|NCT03669003|Coagulants|coagulants|mesh-ancestor
154432783|NCT04313959|Dexamethasone|dexamethasone|mesh-list
154432784|NCT04313959|Ropivacaine|ropivacaine|mesh-list
154432785|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154432786|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
154432787|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
154432788|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432789|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432790|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154432791|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
154432792|NCT04313959|Hormones|hormones|mesh-ancestor
154432793|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154432794|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154432795|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432796|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
154432797|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
154432798|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432799|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
154432800|NCT03073213|Ixekizumab|ixekizumab|mesh-list
154432801|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
154432802|NCT03070483|Vitamin D|vitamin d|mesh-list
154432803|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
154432804|NCT03070483|Vitamins|vitamins|mesh-ancestor
154432805|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
154432806|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432807|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154432808|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154432809|NCT04107727|Cytarabine|cytarabine|mesh-list
154432810|NCT04107727|Idarubicin|idarubicin|mesh-list
154432811|NCT04107727|Quizartinib|quizartinib|mesh-list
154432812|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154432813|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
154432814|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432815|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782206|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782207|NCT00232895|Propofol|propofol|mesh-list
154432816|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
154432817|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432818|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154432819|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
154432820|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432821|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154432822|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154432823|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154007416|NCT02758782|Celecoxib|celecoxib|mesh-list
154432825|NCT04107727|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154432826|NCT04107727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154432827|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154432828|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154432829|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154432830|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154432831|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432832|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432833|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432834|NCT01074151|Analgesics|analgesics|mesh-ancestor
154432835|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
154432836|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432837|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
154432838|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154432839|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
154432840|NCT02786329|Lidocaine|lidocaine|mesh-list
154432841|NCT02786329|Sevoflurane|sevoflurane|mesh-list
154432842|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154432843|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
154432844|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432845|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432846|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
154432847|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432848|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154432849|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154432850|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154432851|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154432852|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432853|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154432854|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154432855|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
154432856|NCT02231762|Temozolomide|temozolomide|mesh-list
154432857|NCT02231762|Lanreotide|lanreotide|mesh-list
154432858|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154432859|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
154432860|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432861|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432862|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
154432863|NCT01191957|Busulfan|busulfan|mesh-list
154432864|NCT01191957|Fludarabine|fludarabine|mesh-list
154432865|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154432866|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
154432867|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432868|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154432869|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154432870|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
154432871|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432872|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432873|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154432874|NCT01050855|Busulfan|busulfan|mesh-list
154432875|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
154432876|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
154432877|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432878|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154432879|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
154432880|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432881|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154432882|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432883|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154432884|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432885|NCT04459286|Ritonavir|ritonavir|mesh-list
154432886|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154432887|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
154432888|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154432889|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154432890|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
154432891|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432892|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432893|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154432894|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154432895|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
154432896|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432897|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154432898|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154432899|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154432900|NCT00744081|Topotecan|topotecan|mesh-list
154432901|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
154432902|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154432903|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154432904|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432905|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432906|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432907|NCT00744081|Analgesics|analgesics|mesh-ancestor
154432908|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
154432909|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432910|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432911|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154432912|NCT02229266|Cytarabine|cytarabine|mesh-list
154432913|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154432914|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
154432915|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432916|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432917|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
154432918|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432919|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154432920|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
154432921|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432922|NCT02224040|Azithromycin|azithromycin|mesh-list
154432923|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
154432924|NCT02224040|Cefixime|cefixime|mesh-list
154432925|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154432926|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432927|NCT02224040|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154432928|NCT02224040|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154432929|NCT04448834|Vincristine|vincristine|mesh-list
154432930|NCT04448834|Blinatumomab|blinatumomab|mesh-list
154432931|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154432932|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432933|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
154432934|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
154432935|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
154432936|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432937|NCT02232308|Lisinopril|lisinopril|mesh-list
154432938|NCT02232308|Nizatidine|nizatidine|mesh-list
154432939|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154432940|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
154432941|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432942|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432943|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154432944|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154432945|NCT02232308|Protective Agents|protective agents|mesh-ancestor
154432946|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432947|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154432948|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154432949|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154432950|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
154432951|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
154432952|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432953|NCT02229734|Androgens|androgens|mesh-list
154432954|NCT02229734|Hormones|hormones|mesh-ancestor
154432955|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154432956|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432958|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
154432959|NCT04333160|Protective Agents|protective agents|mesh-ancestor
154432960|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432961|NCT02258906|Urinastatin|urinastatin|mesh-list
154432962|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154432963|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154432964|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
154432965|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432966|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432967|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153782210|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782211|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153782212|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
154432968|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154432969|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154432970|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432971|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154432972|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154432973|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154432974|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432975|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
154432976|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432977|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154432978|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432979|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432980|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
154432981|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154432982|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432983|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154432984|NCT03068455|Nivolumab|nivolumab|mesh-list
154432985|NCT03068455|Ipilimumab|ipilimumab|mesh-list
154432986|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432987|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432988|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154432989|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432990|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154432991|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154432992|NCT02232932|Capecitabine|capecitabine|mesh-list
154432993|NCT02232932|Liver Extracts|liver extracts|mesh-list
154432994|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154432995|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
154432996|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432997|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432998|NCT02232932|Hematinics|hematinics|mesh-ancestor
154432999|NCT02230358|Anesthetics|anesthetics|mesh-list
154433000|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433001|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433002|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154433003|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154433004|NCT04049864|Lenalidomide|lenalidomide|mesh-list
154433005|NCT04049864|Vaccines|vaccines|mesh-list
154433006|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
153782213|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
154433007|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433008|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154433009|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154433010|NCT04049864|Growth Substances|growth substances|mesh-ancestor
154433011|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
154433012|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433013|NCT03475706|Solabegron|solabegron|mesh-list
154433014|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154433015|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154433016|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154433017|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
154433018|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433019|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433020|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433021|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154433022|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154433023|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154433024|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
154433025|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433026|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154433027|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154433028|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433029|NCT03928184|Lorecivivint|lorecivivint|mesh-list
154433030|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433031|NCT02259374|Ropivacaine|ropivacaine|mesh-list
154433032|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
154433033|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
154433034|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433035|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433036|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
154433037|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433038|NCT04921982|Propranolol|propranolol|mesh-list
154433039|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154433040|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154433041|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
154433042|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433043|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433044|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433045|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154433046|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154433047|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
154433048|NCT04874324|Levonadifloxacin|levonadifloxacin|mesh-list
154433049|NCT04874324|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154433050|NCT04874324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433051|NCT04874324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433052|NCT04874324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154433053|NCT04874324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433054|NCT04866056|Azacitidine|azacitidine|mesh-list
154433055|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154433056|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
154254757|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154433057|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433058|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433059|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433060|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154433061|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154433062|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154433063|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433064|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433065|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154433066|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433067|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433068|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
154433069|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433070|NCT04789148|Oxytocin|oxytocin|mesh-list
154433071|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
154433072|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154433073|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433074|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
154433075|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154433076|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
154433077|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154433078|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
154433079|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433080|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433081|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
154433082|NCT03881852|Reboxetine|reboxetine|mesh-list
154433083|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
154433084|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154433085|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154433086|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154433087|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433088|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433089|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
154433090|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433091|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433092|NCT03818828|Iodine|iodine|mesh-list
153782215|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154433093|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
154433094|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154433095|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433096|NCT03818828|Trace Elements|trace elements|mesh-ancestor
154433097|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
154433098|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433099|NCT02804282|Furosemide|furosemide|mesh-list
154433100|NCT02804282|Diuretics|diuretics|mesh-ancestor
154433101|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
154433102|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433103|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154433104|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433105|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433106|NCT02233244|Midazolam|midazolam|mesh-list
154433107|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154433108|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154433109|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433110|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433111|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154433112|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154433113|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154433114|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154433115|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
154433116|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
154433117|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
154433118|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
154433119|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433120|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433121|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
154433123|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154433124|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154433125|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154433126|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
154433127|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433128|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154433129|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154433130|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433131|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154433132|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154433133|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
154433134|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433135|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154433136|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154433137|NCT03727022|Lorecivivint|lorecivivint|mesh-list
154433138|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433139|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
154433140|NCT02233322|Hematinics|hematinics|mesh-ancestor
154433141|NCT02233400|Acetaminophen|acetaminophen|mesh-list
154433142|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154433143|NCT02233400|Analgesics|analgesics|mesh-ancestor
153782216|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
153782217|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782218|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
153782219|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153782220|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433144|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
154433145|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433146|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433147|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
154433148|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154433149|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154433150|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
154433151|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433152|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154433153|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433154|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154433155|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433156|NCT02235194|Chromium|chromium|mesh-list
154433157|NCT02235194|Picolinic acid|picolinic acid|mesh-list
154433158|NCT02235194|Trace Elements|trace elements|mesh-ancestor
154433159|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
154433160|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433161|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154433162|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
154433163|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
154433164|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433165|NCT03684278|Infliximab|infliximab|mesh-list
154433166|NCT03684278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154433167|NCT03684278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433168|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
154433169|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154433170|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154433171|NCT02726659|Celecoxib|celecoxib|mesh-list
154433172|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154433173|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154433174|NCT02726659|Analgesics|analgesics|mesh-ancestor
154433175|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
154433176|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433177|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433178|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433179|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154433180|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154433181|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154433182|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433183|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433184|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154433185|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154433186|NCT03951961|Midostaurin|midostaurin|mesh-list
154433187|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433188|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154433189|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433190|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433191|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154433192|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154433193|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154433194|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973755|NCT06247956|Cisplatin|cisplatin|mesh-list
154433195|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433196|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433197|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433198|NCT02232542|Analgesics|analgesics|mesh-ancestor
154433199|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
154433200|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433201|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
154433202|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154433203|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
154433204|NCT02600923|Letrozole|letrozole|mesh-list
154433205|NCT02600923|Palbociclib|palbociclib|mesh-list
154433206|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433207|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154433208|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154433209|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433210|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433211|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154433212|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
154433213|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433214|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433215|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154433217|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154433218|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154433219|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154433220|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154433221|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433222|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
154433223|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154433224|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433225|NCT03847519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154433226|NCT03847519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433227|NCT02235428|Bromides|bromides|mesh-list
154433228|NCT02235428|Albuterol|albuterol|mesh-list
154433229|NCT02235428|Ipratropium|ipratropium|mesh-list
154433230|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
154433231|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154433232|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
154433233|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433234|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433235|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154433236|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
154433237|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
154433238|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154433239|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154433240|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154433241|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154433242|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
154433243|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433244|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433245|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154433246|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
154433247|NCT03070171|Dabigatran|dabigatran|mesh-list
154433248|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
154433249|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154433250|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
154433251|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433252|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433253|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
154433254|NCT02262572|Telmisartan|telmisartan|mesh-list
154433255|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154433256|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154433257|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154433258|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154433259|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433260|NCT02262572|Diuretics|diuretics|mesh-ancestor
154433261|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
154433262|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433263|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154433264|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433265|NCT02235584|Dexamethasone|dexamethasone|mesh-list
154433266|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433268|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
154433269|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433270|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433271|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154433272|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
154433273|NCT02235584|Hormones|hormones|mesh-ancestor
154433274|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433275|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154433276|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433277|NCT02235662|Tenofovir|tenofovir|mesh-list
154433278|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
154433279|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
154433280|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433281|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153782223|NCT00232934|Growth Substances|growth substances|mesh-ancestor
154433282|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154433283|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433284|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433285|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154433286|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154433287|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154433288|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
154433289|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154433290|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433291|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154433292|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154433293|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154433294|NCT02262650|Telmisartan|telmisartan|mesh-list
154433295|NCT02262650|Clopidogrel|clopidogrel|mesh-list
154433296|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154433297|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154433298|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154433299|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154433300|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
154433301|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433302|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433303|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433304|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154433305|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154433306|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154433307|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
154433308|NCT02784002|Ridinilazole|ridinilazole|mesh-list
154433309|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154433310|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433311|NCT02233556|Memantine|memantine|mesh-list
154433312|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154433313|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154433314|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
154433315|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433316|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433317|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433318|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154433319|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154433320|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154433321|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154433322|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433323|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
154433324|NCT02236052|Vaccines|vaccines|mesh-list
154433325|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
154433326|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433327|NCT04908592|Dexamethasone|dexamethasone|mesh-list
154433328|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433329|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
154433330|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
154433331|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433332|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433333|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154433334|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
154433335|NCT04908592|Hormones|hormones|mesh-ancestor
154433336|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433337|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154433338|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433339|NCT04759768|Naltrexone|naltrexone|mesh-list
154433340|NCT04759768|Nalmefene|nalmefene|mesh-list
154433341|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154433342|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433343|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
154433344|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433345|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154433346|NCT02564744|Rituximab|rituximab|mesh-list
154433347|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154433348|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433349|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
154433350|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433351|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154433352|NCT05759767|Tamsulosin|tamsulosin|mesh-list
154433353|NCT05759767|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154433354|NCT05759767|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154433355|NCT05759767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154433356|NCT05759767|Adrenergic Agents|adrenergic agents|mesh-ancestor
154433357|NCT05759767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433358|NCT05759767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433359|NCT05759767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433360|NCT05759767|Urological Agents|urological agents|mesh-ancestor
154433361|NCT02750306|Suvorexant|suvorexant|mesh-list
154433362|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154433363|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154433364|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433365|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433366|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154433367|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433368|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433369|NCT01816165|Acipimox|acipimox|mesh-list
154433370|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154433371|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
154433372|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433373|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154433374|NCT04476680|Vitamin D|vitamin d|mesh-list
154433375|NCT04476680|Vitamins|vitamins|mesh-ancestor
154433376|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
154433377|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433378|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154433379|NCT04952350|Atorvastatin|atorvastatin|mesh-list
154433380|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154433381|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154433382|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
154433383|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433384|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154433385|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154433386|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433387|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
154433388|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154433389|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154433390|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
154433391|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433392|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433393|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154433394|NCT04788550|Listerine|listerine|mesh-list
154433395|NCT04788550|Fluorides|fluorides|mesh-list
154433396|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
154433397|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
154433398|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
154433399|NCT04788550|Protective Agents|protective agents|mesh-ancestor
154433400|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433401|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154433402|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433403|NCT01677988|Folfirinox|folfirinox|mesh-list
154433404|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433405|NCT02233790|Clopidogrel|clopidogrel|mesh-list
154433406|NCT02233790|Ticagrelor|ticagrelor|mesh-list
154433407|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154433408|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154433409|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154433410|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154433411|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
154433412|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433413|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433414|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433416|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154433417|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154433418|NCT02547818|Analgesics|analgesics|mesh-ancestor
153782229|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
153782230|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
153782231|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782232|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433419|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
154433420|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433421|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433422|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433423|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154433424|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154433425|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433426|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433427|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154433428|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
154433429|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154433430|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154433431|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
154433432|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433433|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433434|NCT03752918|Niacin|niacin|mesh-list
154433435|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
154433436|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154433437|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154433438|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
154433439|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433440|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154433441|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
154433442|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
154433443|NCT03752918|Vitamins|vitamins|mesh-ancestor
154433444|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
154433445|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433446|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
154433447|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154433448|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
154433449|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433450|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154433451|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154433452|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433453|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
154433454|NCT04259320|Propolis|propolis|mesh-list
154433455|NCT04259320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433456|NCT02263196|Ethanol|ethanol|mesh-list
154433457|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
154433458|NCT02263196|Povidone|povidone|mesh-list
154433459|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154433460|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433461|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433462|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433463|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
154433464|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
154433465|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
154433466|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433467|NCT02926573|Gabapentin|gabapentin|mesh-list
154433468|NCT02926573|Analgesics|analgesics|mesh-ancestor
154433469|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
154433470|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433471|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433472|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
154433473|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154433474|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153973756|NCT06247956|Capecitabine|capecitabine|mesh-list
154433475|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433476|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154433477|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154433478|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154433479|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433480|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433481|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
154433482|NCT04477018|Iron|iron|mesh-list
154433483|NCT04477018|Chelating Agents|chelating agents|mesh-list
154433484|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
154433485|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433486|NCT04477018|Trace Elements|trace elements|mesh-ancestor
154433487|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433488|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
154433489|NCT00158860|Valacyclovir|valacyclovir|mesh-list
154433490|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
154433491|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433493|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154433494|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
154433495|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433496|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433497|NCT02471222|Amantadine|amantadine|mesh-list
154433498|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154433499|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154433500|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
154433501|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433502|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
154433503|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433504|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433505|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433506|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154433507|NCT02471222|Analgesics|analgesics|mesh-ancestor
154433508|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
154433509|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433510|NCT03136120|Bromides|bromides|mesh-list
154433511|NCT03136120|Ipratropium|ipratropium|mesh-list
154433512|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
154433513|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154433514|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
154433515|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433516|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433517|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154433518|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
154433519|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154433520|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
154433521|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433522|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433523|NCT01625234|Ensartinib|ensartinib|mesh-list
154433524|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433525|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154433526|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433527|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433528|NCT02264834|Sufentanil|sufentanil|mesh-list
154433530|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
154433531|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154433532|NCT02264834|Narcotics|narcotics|mesh-ancestor
154433533|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433534|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433535|NCT02264834|Analgesics|analgesics|mesh-ancestor
154433536|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
154433537|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433538|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154433539|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154433540|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
154433541|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
154433542|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
154433543|NCT05762419|Etoposide|etoposide|mesh-list
154433544|NCT05762419|Etoposide phosphate|etoposide phosphate|mesh-list
154433545|NCT05762419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154433546|NCT05762419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433547|NCT05762419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154433548|NCT05762419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154433549|NCT05762419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433550|NCT05762419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433551|NCT02264912|Clopidogrel|clopidogrel|mesh-list
154433552|NCT02264912|Ticagrelor|ticagrelor|mesh-list
154433553|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154433554|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154433555|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154433556|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154433557|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154433558|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
154433559|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433560|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433561|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433562|NCT02263352|Carotenoids|carotenoids|mesh-list
154433563|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
154433564|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433565|NCT02263352|Protective Agents|protective agents|mesh-ancestor
154433566|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433567|NCT01435226|Ribavirin|ribavirin|mesh-list
154433568|NCT01435226|Ledipasvir|ledipasvir|mesh-list
154433569|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
154433570|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433571|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
154433572|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433573|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154433574|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
154433575|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
154433576|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154433577|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154433578|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433579|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433581|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153782238|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153782239|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154433582|NCT04409509|Antibodies|antibodies|mesh-list
154433583|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154433584|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
154433585|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433586|NCT04401865|Riboflavin|riboflavin|mesh-list
154433587|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
154433588|NCT04401865|Vitamins|vitamins|mesh-ancestor
154433589|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
154433590|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433591|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154433592|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
154433593|NCT02609048|Seladelpar|seladelpar|mesh-list
154433594|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154433595|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
154433596|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433597|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154433598|NCT02265068|Ticagrelor|ticagrelor|mesh-list
154433599|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154433600|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154433601|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154433602|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154433603|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
154433604|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433605|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433606|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433607|NCT02262416|Leuprolide|leuprolide|mesh-list
154433608|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154433609|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
154433610|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154433611|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433612|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154433613|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433614|NCT01577654|Folic Acid|folic acid|mesh-list
154433615|NCT01577654|Docetaxel|docetaxel|mesh-list
154433616|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
154433617|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433618|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
154433619|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
154433620|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
154433621|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433622|NCT01577654|Hematinics|hematinics|mesh-ancestor
154433623|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
154433624|NCT01577654|Vitamins|vitamins|mesh-ancestor
154433625|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
154433626|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433627|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154433628|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154433629|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433630|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433631|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
154433632|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154433633|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
154433634|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433635|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433636|NCT01418222|Leucovorin|leucovorin|mesh-list
154433637|NCT01418222|Bevacizumab|bevacizumab|mesh-list
154433638|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154433639|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433640|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154008308|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
154433641|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154433642|NCT01418222|Growth Substances|growth substances|mesh-ancestor
154433643|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433644|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
154433645|NCT01418222|Antidotes|antidotes|mesh-ancestor
154433646|NCT01418222|Protective Agents|protective agents|mesh-ancestor
154433647|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
154433648|NCT01418222|Vitamins|vitamins|mesh-ancestor
154433649|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
154433650|NCT01256762|Paclitaxel|paclitaxel|mesh-list
154433651|NCT01256762|Bevacizumab|bevacizumab|mesh-list
154433652|NCT01256762|Imetelstat|imetelstat|mesh-list
154433653|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
154062241|NCT00808665|Analgesics|analgesics|mesh-ancestor
154433654|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154433655|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433656|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
154433657|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
154433658|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
154433659|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433660|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154433661|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154433662|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154433663|NCT01256762|Growth Substances|growth substances|mesh-ancestor
154433664|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433665|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
154433666|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433667|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154433668|NCT01252628|Cetuximab|cetuximab|mesh-list
154433669|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154433670|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433671|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154433672|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154433673|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433674|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433675|NCT04349371|Chloroquine|chloroquine|mesh-list
154433676|NCT04349371|Amebicides|amebicides|mesh-ancestor
154433677|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154433678|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154433679|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433680|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
154433681|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154433682|NCT01410188|Latanoprost|latanoprost|mesh-list
154433683|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154433684|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154433685|NCT01408082|Azithromycin|azithromycin|mesh-list
154433686|NCT01408082|Dexamethasone|dexamethasone|mesh-list
154433687|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
154433688|NCT01408082|BB 1101|bb 1101|mesh-list
154433689|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433690|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
154433691|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
154433692|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433693|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433694|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154433695|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
154433696|NCT01408082|Hormones|hormones|mesh-ancestor
154433697|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433698|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154433699|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433700|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
154433701|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433702|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433703|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154433704|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433705|NCT03071263|Spironolactone|spironolactone|mesh-list
154433706|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154433707|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
154433708|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433709|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433710|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154433711|NCT03071263|Diuretics|diuretics|mesh-ancestor
154433712|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
154433713|NCT05200663|Tamoxifen|tamoxifen|mesh-list
154433714|NCT05200663|Vitamin E|vitamin e|mesh-list
154433715|NCT05200663|Vitamins|vitamins|mesh-ancestor
154433716|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
154433717|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433718|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154433719|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
154433720|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433721|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154433722|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433723|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154433724|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154433725|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154433726|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
154433727|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433728|NCT05200663|Protective Agents|protective agents|mesh-ancestor
154433729|NCT02268422|Buprenorphine|buprenorphine|mesh-list
154433730|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154433731|NCT02268422|Narcotics|narcotics|mesh-ancestor
154433732|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433733|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433734|NCT02268422|Analgesics|analgesics|mesh-ancestor
154433735|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
154433736|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433737|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154433738|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
154433739|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154433740|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433741|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433742|NCT05049343|Ketamine|ketamine|mesh-list
154433743|NCT05049343|Analgesics|analgesics|mesh-ancestor
154433744|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
154433745|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433746|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433747|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154433748|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154433749|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
154433750|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
154433751|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433752|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154433753|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154433754|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433755|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433756|NCT01569919|Folic Acid|folic acid|mesh-list
154433757|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
154433758|NCT01569919|Dexamethasone|dexamethasone|mesh-list
154433759|NCT01569919|Pemetrexed|pemetrexed|mesh-list
154433760|NCT01569919|Vitamins|vitamins|mesh-ancestor
154433761|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
154433762|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433763|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433764|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433765|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
154433766|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
154433767|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433768|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154433769|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
154433770|NCT01569919|Hormones|hormones|mesh-ancestor
154433771|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433772|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154433773|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433774|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433775|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154433776|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154433777|NCT01569919|Hematinics|hematinics|mesh-ancestor
154433778|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
154433779|NCT01399580|Atrasentan|atrasentan|mesh-list
154433780|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433781|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154433782|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154433783|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433784|NCT04069585|Lidocaine|lidocaine|mesh-list
154433785|NCT04069585|Anesthetics|anesthetics|mesh-list
154433786|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
154433787|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433788|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433789|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
153458015|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458016|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153458017|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153458018|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154433790|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433791|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154433792|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154433793|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154433794|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433795|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433797|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154433798|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
154433799|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433800|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154433801|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154433803|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433804|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433805|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154433806|NCT03066193|Palmidrol|palmidrol|mesh-list
154433807|NCT03066193|Dronabinol|dronabinol|mesh-list
154433808|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
154433809|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433810|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154433811|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154433812|NCT03066193|Analgesics|analgesics|mesh-ancestor
154433813|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
154433814|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433815|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154433816|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154433817|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433818|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433819|NCT03066193|Hormones|hormones|mesh-ancestor
154433820|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154433821|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154433822|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154433823|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154433824|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
154433825|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433826|NCT02263976|Bromides|bromides|mesh-list
154433827|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
154433828|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
154433829|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154433830|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
154433831|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433832|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433833|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154433834|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
154433835|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
154433836|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154433837|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
154433838|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433839|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433840|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
154433841|NCT02263976|Miotics|miotics|mesh-ancestor
154433842|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154433843|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154433844|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154433845|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154433846|NCT01382654|Azelastine|azelastine|mesh-list
154433847|NCT01382654|Epinastine|epinastine|mesh-list
154433848|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154433849|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
154433850|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433851|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433852|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154433853|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
154433854|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154433855|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433856|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433857|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154433858|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154433859|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154433860|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
154433861|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
154433862|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433863|NCT01378676|Riluzole|riluzole|mesh-list
154433864|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
154433865|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154433866|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154433867|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433868|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433869|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433870|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154433871|NCT01378676|Protective Agents|protective agents|mesh-ancestor
154433872|NCT01377662|Methylphenidate|methylphenidate|mesh-list
154433873|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154433875|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154433876|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154433877|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433878|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433879|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
154433880|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433881|NCT01371578|Ribavirin|ribavirin|mesh-list
154433882|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154433883|NCT01371578|Ledipasvir|ledipasvir|mesh-list
154433884|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
154433885|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433886|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
154433887|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433888|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
154433889|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433890|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154433891|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433892|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433893|NCT01498328|Bevacizumab|bevacizumab|mesh-list
154433894|NCT01498328|Rindopepimut|rindopepimut|mesh-list
154433895|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154433896|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433897|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154433898|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154433899|NCT01498328|Growth Substances|growth substances|mesh-ancestor
154433900|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433901|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
154433902|NCT01497704|Apatinib|apatinib|mesh-list
154433903|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433904|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154433905|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433906|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433907|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154433908|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
154433909|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
154433910|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433911|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433912|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
154433913|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433914|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154433915|NCT03911713|Ivacaftor|ivacaftor|mesh-list
154433916|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154433917|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433918|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433919|NCT02264132|Pramipexole|pramipexole|mesh-list
154433920|NCT02264132|Dexpramipexole|dexpramipexole|mesh-list
154433921|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
154433922|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433923|NCT02264132|Protective Agents|protective agents|mesh-ancestor
154433924|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433925|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154433926|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154433927|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
154433928|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
154433929|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154433930|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
154433931|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154433932|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433933|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433934|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154433935|NCT04540744|Tadalafil|tadalafil|mesh-list
154433936|NCT04540744|Macitentan|macitentan|mesh-list
154433937|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
154433938|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154433939|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154433940|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433941|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433942|NCT04540744|Urological Agents|urological agents|mesh-ancestor
154433943|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154433944|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154433945|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154433946|NCT05375734|Tislelizumab|tislelizumab|mesh-list
154433947|NCT05375734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154433949|NCT01489046|Tenofovir|tenofovir|mesh-list
154433950|NCT01489046|Lamivudine|lamivudine|mesh-list
154433951|NCT01489046|Efavirenz|efavirenz|mesh-list
153782253|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154433952|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
154433953|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433954|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154433955|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154433956|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433957|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433958|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154433959|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154433960|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154433961|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154433962|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154433963|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154433964|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154433965|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154433966|NCT01180634|Levofloxacin|levofloxacin|mesh-list
154433967|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154433968|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154433969|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154433970|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154433971|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154433972|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154433973|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433974|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433975|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154433976|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154433977|NCT02268890|Bortezomib|bortezomib|mesh-list
154433978|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154433979|NCT02268968|Lidocaine|lidocaine|mesh-list
154433980|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
154433981|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
154433982|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154433983|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433984|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
154433985|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433986|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154433987|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154433988|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154433989|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154433990|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154433991|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
154433992|NCT01359566|Baclofen|baclofen|mesh-list
154433993|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154433994|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154433995|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154433996|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154433997|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154433998|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
154433999|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
154434000|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434001|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434002|NCT04885816|Sirolimus|sirolimus|mesh-list
154434003|NCT04885816|Everolimus|everolimus|mesh-list
154434004|NCT04885816|MTOR Inhibitors|mtor inhibitors|mesh-list
154434005|NCT04885816|Temsirolimus|temsirolimus|mesh-list
154434006|NCT04885816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434007|NCT04885816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434008|NCT04885816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434009|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154434010|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
154434011|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434012|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434013|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154434014|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434015|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154434017|NCT04865614|Sevoflurane|sevoflurane|mesh-list
154434018|NCT04865614|Etomidate|etomidate|mesh-list
154434019|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154434020|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154434021|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
154434022|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
154434023|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434024|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434025|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154434026|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154434027|NCT02269046|Simvastatin|simvastatin|mesh-list
154434028|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154434029|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154434030|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
154434031|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434032|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154434033|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154434034|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434035|NCT01483742|Ritonavir|ritonavir|mesh-list
154434036|NCT01483742|Ribavirin|ribavirin|mesh-list
154434037|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154434038|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154434039|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154434040|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
154434041|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434042|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434043|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154434044|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154434045|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
154434046|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434047|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154434048|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154434049|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
154434050|NCT04691128|Anesthetics|anesthetics|mesh-list
154434051|NCT04691128|Propofol|propofol|mesh-list
154434052|NCT04691128|Desflurane|desflurane|mesh-list
154434053|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434054|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434055|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154434056|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154434057|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
154434058|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154434059|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
154434060|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434061|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434062|NCT02269202|Midazolam|midazolam|mesh-list
154434063|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154434064|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154434065|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434066|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434067|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154434068|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154434069|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154434070|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154434071|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
154434072|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
154434073|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
154434074|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
154434075|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434076|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434077|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
154434078|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434079|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
154434080|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154434081|NCT01353248|Ribavirin|ribavirin|mesh-list
154434082|NCT01353248|Ledipasvir|ledipasvir|mesh-list
154434083|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
154434084|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008684|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
154434085|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
154434086|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434087|NCT05095636|Apatinib|apatinib|mesh-list
154434088|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434089|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434090|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434091|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434092|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154434093|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
154434094|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434095|NCT05095480|Red yeast rice|red yeast rice|mesh-list
154062678|NCT05626478|Hormones|hormones|mesh-ancestor
154434096|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154434097|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154434098|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154434099|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
154434100|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434101|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434102|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154434103|NCT06091891|Tranexamic Acid|tranexamic acid|mesh-list
154434104|NCT06091891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154434105|NCT06091891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154434106|NCT06091891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434108|NCT06091891|Coagulants|coagulants|mesh-ancestor
154434109|NCT06091852|Caseins|caseins|mesh-list
154434110|NCT06091852|Chelating Agents|chelating agents|mesh-ancestor
154434111|NCT06091852|Sequestering Agents|sequestering agents|mesh-ancestor
154434112|NCT06091852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434113|NCT06091787|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154434114|NCT06091787|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154434115|NCT06091787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154434116|NCT06091748|Edotreotide|edotreotide|mesh-list
154434117|NCT06091748|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154434118|NCT06091748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434119|NCT06091631|Magnesium Sulfate|magnesium sulfate|mesh-list
154434120|NCT06091631|Analgesics|analgesics|mesh-ancestor
154434121|NCT06091631|Sensory System Agents|sensory system agents|mesh-ancestor
154434122|NCT06091631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434123|NCT06091631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434124|NCT06091631|Anesthetics|anesthetics|mesh-ancestor
154434125|NCT06091631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434126|NCT06091631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154434127|NCT06091631|Anticonvulsants|anticonvulsants|mesh-ancestor
154434128|NCT06091631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154434129|NCT06091631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154434130|NCT06091631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434131|NCT06091631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154434132|NCT06091631|Tocolytic Agents|tocolytic agents|mesh-ancestor
154434133|NCT06091631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154434134|NCT06091579|Treprostinil|treprostinil|mesh-list
154434135|NCT06091579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154434136|NCT06091553|Gabapentin|gabapentin|mesh-list
154434137|NCT06091553|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154434138|NCT06091553|Amitriptyline|amitriptyline|mesh-list
154434139|NCT06091553|Analgesics|analgesics|mesh-ancestor
154434140|NCT06091553|Sensory System Agents|sensory system agents|mesh-ancestor
154434141|NCT06091553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434142|NCT06091553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434143|NCT06091553|Anticonvulsants|anticonvulsants|mesh-ancestor
154434144|NCT06091553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154434145|NCT06091553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154434146|NCT06091553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434147|NCT06091553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154434148|NCT06091553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154434149|NCT06091553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154434150|NCT06091553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434151|NCT06091553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434152|NCT06091553|Antimanic Agents|antimanic agents|mesh-ancestor
154434153|NCT06091553|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154434154|NCT06091553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154434155|NCT06091553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154434156|NCT06091553|Antidepressive Agents|antidepressive agents|mesh-ancestor
154434157|NCT06091553|Dopamine Agents|dopamine agents|mesh-ancestor
154434158|NCT06091553|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154434159|NCT06091553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008759|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434160|NCT06091553|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154434161|NCT06091553|Adrenergic Agents|adrenergic agents|mesh-ancestor
154434162|NCT06091475|Dapagliflozin|dapagliflozin|mesh-list
154434163|NCT06091475|Empagliflozin|empagliflozin|mesh-list
154434165|NCT06091475|Spironolactone|spironolactone|mesh-list
154434166|NCT06091475|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154434167|NCT06091475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062793|NCT05256719|Abatacept|abatacept|mesh-list
154434168|NCT06091475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154434169|NCT06091475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434170|NCT06091475|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154434171|NCT06091475|Hormone Antagonists|hormone antagonists|mesh-ancestor
154434172|NCT06091475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434173|NCT06091475|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154434174|NCT06091475|Diuretics|diuretics|mesh-ancestor
154434175|NCT06091475|Natriuretic Agents|natriuretic agents|mesh-ancestor
154434176|NCT06091475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154434177|NCT06091436|Progesterone|progesterone|mesh-list
154434178|NCT06091436|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154434179|NCT06091436|Ganirelix|ganirelix|mesh-list
154434180|NCT06091436|Progestins|progestins|mesh-ancestor
154434181|NCT06091436|Hormones|hormones|mesh-ancestor
154434182|NCT06091436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434183|NCT06091436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434184|NCT06091436|Hormone Antagonists|hormone antagonists|mesh-ancestor
154434185|NCT06091345|Midodrine|midodrine|mesh-list
154434186|NCT06091345|Sympathomimetics|sympathomimetics|mesh-ancestor
154434187|NCT06091345|Autonomic Agents|autonomic agents|mesh-ancestor
154434188|NCT06091345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434189|NCT06091345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434190|NCT06091345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154434191|NCT06091345|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154434192|NCT06091345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154434193|NCT06091345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154434194|NCT06091345|Adrenergic Agents|adrenergic agents|mesh-ancestor
154434195|NCT06091345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434196|NCT06091345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434197|NCT06091332|Sirolimus|sirolimus|mesh-list
154434198|NCT06091332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154434199|NCT06091332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434200|NCT06091332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154434201|NCT06091332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434202|NCT06091332|Antifungal Agents|antifungal agents|mesh-ancestor
154434203|NCT06091332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154434204|NCT06091332|Immunologic Factors|immunologic factors|mesh-ancestor
154434205|NCT06091332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434206|NCT06091241|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154434207|NCT06091241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154434208|NCT06091241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154434209|NCT06091241|Analgesics|analgesics|mesh-ancestor
154434210|NCT06091241|Sensory System Agents|sensory system agents|mesh-ancestor
154434211|NCT06091241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434212|NCT06091241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434213|NCT06091241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434214|NCT06091241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154434215|NCT06090981|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154434216|NCT06090981|Respiratory System Agents|respiratory system agents|mesh-ancestor
154434217|NCT06090955|Lidocaine|lidocaine|mesh-list
154434218|NCT06090955|Dexmedetomidine|dexmedetomidine|mesh-list
154434219|NCT06090955|Anesthetics, Local|anesthetics, local|mesh-ancestor
154434220|NCT06090955|Anesthetics|anesthetics|mesh-ancestor
154434221|NCT06090955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434222|NCT06090955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434223|NCT06090955|Sensory System Agents|sensory system agents|mesh-ancestor
154434224|NCT06090955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434225|NCT06090955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154434226|NCT06090955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154434227|NCT06090955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154434228|NCT06090955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154434229|NCT06090955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434230|NCT06090955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154434231|NCT06090955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008835|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
154434232|NCT06090955|Analgesics|analgesics|mesh-ancestor
154434233|NCT06090955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154434234|NCT06090955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154434235|NCT06090955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154434236|NCT06090955|Adrenergic Agents|adrenergic agents|mesh-ancestor
154434237|NCT06090955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434238|NCT06090890|Aspirin|aspirin|mesh-list
154434239|NCT06090890|Prednisone|prednisone|mesh-list
154434240|NCT06090890|Colchicine|colchicine|mesh-list
154434241|NCT06090890|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154434242|NCT06090890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
154434243|NCT06090890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434244|NCT06090890|Glucocorticoids|glucocorticoids|mesh-ancestor
154434245|NCT06090890|Hormones|hormones|mesh-ancestor
153973758|NCT06247956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153782262|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153782263|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434246|NCT06090890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434247|NCT06090890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434248|NCT06090890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154434249|NCT06090890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434250|NCT06090890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154434251|NCT06090890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154434252|NCT06090890|Analgesics|analgesics|mesh-ancestor
154434253|NCT06090890|Sensory System Agents|sensory system agents|mesh-ancestor
154434254|NCT06090890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434255|NCT06090890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154434256|NCT06090890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154434257|NCT06090890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154434258|NCT06090890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434259|NCT06090890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154434260|NCT06090890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154434261|NCT06090890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434262|NCT06090890|Antipyretics|antipyretics|mesh-ancestor
154434263|NCT06090890|Gout Suppressants|gout suppressants|mesh-ancestor
154434264|NCT06090890|Tubulin Modulators|tubulin modulators|mesh-ancestor
154434265|NCT06090890|Antimitotic Agents|antimitotic agents|mesh-ancestor
154434266|NCT06090890|Mitosis Modulators|mitosis modulators|mesh-ancestor
154434267|NCT06090890|Antimetabolites|antimetabolites|mesh-ancestor
154434268|NCT06090890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154434269|NCT06090890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154434270|NCT06090890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154434271|NCT06090890|Purinergic Agents|purinergic agents|mesh-ancestor
154434272|NCT06090890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434273|NCT06090656|Bevacizumab|bevacizumab|mesh-list
154434274|NCT06090656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434275|NCT06090656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434276|NCT06090656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154434277|NCT06090656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154434278|NCT06090656|Growth Substances|growth substances|mesh-ancestor
154434279|NCT06090656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434280|NCT06090656|Growth Inhibitors|growth inhibitors|mesh-ancestor
154434281|NCT06090422|Midazolam|midazolam|mesh-list
154434282|NCT06090422|Ketamine|ketamine|mesh-list
154434283|NCT06090422|Analgesics|analgesics|mesh-ancestor
154434284|NCT06090422|Sensory System Agents|sensory system agents|mesh-ancestor
154434285|NCT06090422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434286|NCT06090422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434287|NCT06090422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154434288|NCT06090422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154434289|NCT06090422|Anesthetics, General|anesthetics, general|mesh-ancestor
154434290|NCT06090422|Anesthetics|anesthetics|mesh-ancestor
154434291|NCT06090422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782266|NCT00267540|Vitamins|vitamins|mesh-ancestor
154434292|NCT06090422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154434293|NCT06090422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154434294|NCT06090422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434295|NCT06090422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434296|NCT06090422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154434297|NCT06090422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154434298|NCT06090422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154434299|NCT06090422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154434300|NCT06090422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154434301|NCT06090422|GABA Modulators|gaba modulators|mesh-ancestor
154434302|NCT06090422|GABA Agents|gaba agents|mesh-ancestor
154434303|NCT06090318|Atezolizumab|atezolizumab|mesh-list
154434304|NCT06090318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154434305|NCT06090318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434306|NCT06090318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434307|NCT06090318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434308|NCT06090123|Itraconazole|itraconazole|mesh-list
154434309|NCT06090123|Rifampin|rifampin|mesh-list
154434310|NCT06090123|Antifungal Agents|antifungal agents|mesh-ancestor
154434311|NCT06090123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434312|NCT06090123|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154434313|NCT06090123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154434314|NCT06090123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434315|NCT06090123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434316|NCT06090123|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154434317|NCT06090123|Hormone Antagonists|hormone antagonists|mesh-ancestor
154434318|NCT06090123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434319|NCT06090123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434320|NCT06090123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154434321|NCT06090123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154434322|NCT06090123|Antitubercular Agents|antitubercular agents|mesh-ancestor
154434323|NCT06090123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154434324|NCT06090123|Leprostatic Agents|leprostatic agents|mesh-ancestor
154434325|NCT06090123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154434326|NCT06090123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154434327|NCT06090123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154434328|NCT06090123|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154434329|NCT06090123|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154434330|NCT06090123|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154434331|NCT06090123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154434332|NCT06088446|Anesthetics|anesthetics|mesh-list
154434333|NCT06088446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434334|NCT06088446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434335|NCT06087510|Esketamine|esketamine|mesh-list
154434336|NCT06087510|Antidepressive Agents|antidepressive agents|mesh-ancestor
154434337|NCT06087510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154434338|NCT06068153|Lenvatinib|lenvatinib|mesh-list
154434339|NCT06068153|Sotorasib|sotorasib|mesh-list
154434340|NCT06068153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434341|NCT06068153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434342|NCT06068153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434343|NCT06068153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434344|NCT06068153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154434345|NCT06068153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434346|NCT05971849|Hormones|hormones|mesh-list
154434347|NCT05971849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434348|NCT05971849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434349|NCT05962970|Ropivacaine|ropivacaine|mesh-list
154434350|NCT05962970|Anesthetics, Local|anesthetics, local|mesh-ancestor
154434351|NCT05962970|Anesthetics|anesthetics|mesh-ancestor
154434352|NCT05962970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434353|NCT05962970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434354|NCT05962970|Sensory System Agents|sensory system agents|mesh-ancestor
154434355|NCT05962970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434356|NCT05955040|Labetalol|labetalol|mesh-list
154434357|NCT05955040|Nifedipine|nifedipine|mesh-list
154434358|NCT05955040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154434359|NCT05955040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154434360|NCT05955040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434361|NCT05955040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154434362|NCT05955040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434363|NCT05955040|Vasodilator Agents|vasodilator agents|mesh-ancestor
154434364|NCT05955040|Tocolytic Agents|tocolytic agents|mesh-ancestor
154434365|NCT05955040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154434366|NCT05955040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154434367|NCT05955040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154434368|NCT05955040|Adrenergic Agents|adrenergic agents|mesh-ancestor
154434369|NCT05955040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434370|NCT05955040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154434371|NCT05955040|Sympathomimetics|sympathomimetics|mesh-ancestor
154434372|NCT05955040|Autonomic Agents|autonomic agents|mesh-ancestor
154434373|NCT05955040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434374|NCT05955040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154434375|NCT05955040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154434376|NCT05954104|Calcipotriene|calcipotriene|mesh-list
154434377|NCT05954104|Dermatologic Agents|dermatologic agents|mesh-ancestor
154434378|NCT05930405|Sufentanil|sufentanil|mesh-list
154434379|NCT05930405|Ropivacaine|ropivacaine|mesh-list
154434380|NCT05930405|Anesthetics, Local|anesthetics, local|mesh-ancestor
154434381|NCT05930405|Anesthetics|anesthetics|mesh-ancestor
154434382|NCT05930405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434383|NCT05930405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434384|NCT05930405|Sensory System Agents|sensory system agents|mesh-ancestor
154434385|NCT05930405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458020|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458021|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
154434386|NCT05930405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154434387|NCT05930405|Narcotics|narcotics|mesh-ancestor
154434388|NCT05930405|Analgesics|analgesics|mesh-ancestor
154434389|NCT05930405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154434390|NCT05930405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154434391|NCT05930405|Anesthetics, General|anesthetics, general|mesh-ancestor
154434392|NCT05919745|Acetaminophen|acetaminophen|mesh-list
154434393|NCT05919745|Ibuprofen|ibuprofen|mesh-list
154434394|NCT05919745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154434395|NCT05919745|Analgesics|analgesics|mesh-ancestor
154434396|NCT05919745|Sensory System Agents|sensory system agents|mesh-ancestor
154434397|NCT05919745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434398|NCT05919745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434399|NCT05919745|Antipyretics|antipyretics|mesh-ancestor
154434400|NCT05919745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154434401|NCT05919745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434402|NCT05919745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154434403|NCT05919745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154434404|NCT05919745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434405|NCT05919745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434406|NCT05917223|Caseins|caseins|mesh-list
154434407|NCT05917223|Chelating Agents|chelating agents|mesh-ancestor
154434408|NCT05917223|Sequestering Agents|sequestering agents|mesh-ancestor
154434409|NCT05917223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434410|NCT05893797|Insulin Lispro|insulin lispro|mesh-list
154434411|NCT05893797|TEMPO|tempo|mesh-list
154434412|NCT05893797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154434413|NCT05893797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434414|NCT05893797|Antioxidants|antioxidants|mesh-ancestor
154434415|NCT05893797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434416|NCT05893797|Protective Agents|protective agents|mesh-ancestor
154434417|NCT05856084|Vaccines|vaccines|mesh-list
154434418|NCT05856084|Immunologic Factors|immunologic factors|mesh-ancestor
154434419|NCT05856084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434420|NCT05853601|Theophylline|theophylline|mesh-list
154434421|NCT05853601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154434422|NCT05853601|Autonomic Agents|autonomic agents|mesh-ancestor
154434423|NCT05853601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434424|NCT05853601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434425|NCT05853601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154434426|NCT05853601|Respiratory System Agents|respiratory system agents|mesh-ancestor
154434427|NCT05853601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154434428|NCT05853601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434429|NCT05853601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434430|NCT05853601|Vasodilator Agents|vasodilator agents|mesh-ancestor
154434431|NCT05853601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154434432|NCT05853601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154434433|NCT05853601|Purinergic Agents|purinergic agents|mesh-ancestor
154434434|NCT05853601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434435|NCT05853341|Rivastigmine|rivastigmine|mesh-list
154434436|NCT05853341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154434437|NCT05853341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434438|NCT05853341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434439|NCT05853341|Cholinergic Agents|cholinergic agents|mesh-ancestor
154434440|NCT05853341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434441|NCT05853341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434442|NCT05853341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154434443|NCT05853341|Protective Agents|protective agents|mesh-ancestor
154434444|NCT05800288|Propofol|propofol|mesh-list
154434445|NCT05800288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154434446|NCT05800288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434447|NCT05800288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434448|NCT05800288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154434449|NCT05800288|Anesthetics, General|anesthetics, general|mesh-ancestor
154434450|NCT05800288|Anesthetics|anesthetics|mesh-ancestor
154434451|NCT05799729|Ketamine|ketamine|mesh-list
154434452|NCT05799729|Analgesics|analgesics|mesh-ancestor
154434453|NCT05799729|Sensory System Agents|sensory system agents|mesh-ancestor
154434454|NCT05799729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434455|NCT05799729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434456|NCT05799729|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154434457|NCT05799729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154434458|NCT05799729|Anesthetics, General|anesthetics, general|mesh-ancestor
154434460|NCT05799729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434461|NCT05799729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154434462|NCT05799729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154434463|NCT05799729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434464|NCT05799729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434465|NCT05776160|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154434466|NCT05776160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434467|NCT05776160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434468|NCT05773976|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154434469|NCT05773976|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153387583|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434470|NCT05773963|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154434471|NCT05773963|Lubricant Eye Drops|lubricant eye drops|mesh-list
154434472|NCT05773963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154434473|NCT05769010|Bevacizumab|bevacizumab|mesh-list
154434474|NCT05769010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434475|NCT05769010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434476|NCT05769010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154434477|NCT05769010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154434478|NCT05769010|Growth Substances|growth substances|mesh-ancestor
154434479|NCT05769010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434480|NCT05769010|Growth Inhibitors|growth inhibitors|mesh-ancestor
154434481|NCT05762146|Perphenazine|perphenazine|mesh-list
154434482|NCT05762146|Riociguat|riociguat|mesh-list
154434483|NCT05762146|Propylthiouracil|propylthiouracil|mesh-list
154434484|NCT05762146|Enzyme Activators|enzyme activators|mesh-ancestor
154434485|NCT05762146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434486|NCT05762146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154434487|NCT05762146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154434488|NCT05762146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434489|NCT05762146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434490|NCT05762146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154434491|NCT05762146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154434492|NCT05762146|Dopamine Agents|dopamine agents|mesh-ancestor
154434493|NCT05762146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434494|NCT05762146|Antimetabolites|antimetabolites|mesh-ancestor
154434495|NCT05762146|Antithyroid Agents|antithyroid agents|mesh-ancestor
154434496|NCT05762146|Hormone Antagonists|hormone antagonists|mesh-ancestor
154434497|NCT05762146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434498|NCT05737199|Pembrolizumab|pembrolizumab|mesh-list
154434499|NCT05737199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434500|NCT05737199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434501|NCT05737199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154434502|NCT05737199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434503|NCT05702463|Aspirin|aspirin|mesh-list
154434504|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154434505|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154434506|NCT05702463|Analgesics|analgesics|mesh-ancestor
154434507|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
154434508|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434509|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434510|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434511|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154434512|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154434513|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154434514|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434515|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154434516|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154434517|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434518|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
154434519|NCT05681611|Rocuronium|rocuronium|mesh-list
154434520|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154434521|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154434522|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154434523|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434524|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434525|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
154434526|NCT05676684|Spironolactone|spironolactone|mesh-list
154434527|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154434528|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434529|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154434530|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434531|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154434532|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
154434533|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434534|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154434535|NCT05676684|Diuretics|diuretics|mesh-ancestor
154434536|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
154434537|NCT05672680|Bupivacaine|bupivacaine|mesh-list
154434538|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
154434539|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
154434540|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434541|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434542|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
154434543|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434544|NCT05668676|Prednisone|prednisone|mesh-list
154434545|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434546|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
154434547|NCT05668676|Hormones|hormones|mesh-ancestor
154434548|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434549|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434550|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154434551|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434552|NCT05667376|Curcumin|curcumin|mesh-list
154434553|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154434554|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154434555|NCT05667376|Analgesics|analgesics|mesh-ancestor
154434556|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
154434557|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434558|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434559|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434560|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154434561|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434562|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434563|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434564|NCT05624957|Lidocaine|lidocaine|mesh-list
154434565|NCT05624957|Epinephrine|epinephrine|mesh-list
154434566|NCT05624957|Racepinephrine|racepinephrine|mesh-list
154434567|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
154434568|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
154434569|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
154434570|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434571|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434572|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
154434573|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434574|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154434575|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154434576|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154434577|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154434578|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434579|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154434580|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154434581|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
154434582|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434583|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154434584|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154434585|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
154434586|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154434587|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
154434588|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
154434589|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
154434590|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154434591|NCT05619289|Vitamin D|vitamin d|mesh-list
154434592|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
154434593|NCT05619289|Vitamins|vitamins|mesh-ancestor
154434594|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
154434595|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434596|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154434597|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154434598|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
154434599|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
154434601|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434602|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434603|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
154009223|NCT00931645|Hormones|hormones|mesh-ancestor
154434604|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434605|NCT05585580|Paclitaxel|paclitaxel|mesh-list
154434606|NCT05585580|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154434607|NCT05585580|Lenvatinib|lenvatinib|mesh-list
154434608|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154434609|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434610|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
154434611|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
154434612|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
154434613|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434614|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434615|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434616|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
154434617|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154434618|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434619|NCT05559437|Bupivacaine|bupivacaine|mesh-list
154434620|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
154434621|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
154434622|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
154434623|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434624|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434625|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
154434626|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434627|NCT05521048|Doxycycline|doxycycline|mesh-list
154434628|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154434629|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434630|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
154434631|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154434632|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154434633|NCT05500508|Eflornithine|eflornithine|mesh-list
154434634|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434635|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154434636|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154434637|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154434638|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434639|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154434640|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782274|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153782275|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
154434641|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434642|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
154434643|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154434644|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154434645|NCT05462730|Prednisolone|prednisolone|mesh-list
154434646|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
154434647|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154434648|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
154434649|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434650|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
154434651|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
154434652|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434653|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434654|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154434655|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
154434656|NCT05462730|Hormones|hormones|mesh-ancestor
154434657|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434658|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154434659|NCT05462730|Protective Agents|protective agents|mesh-ancestor
154434660|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154434661|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434662|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
154434663|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154434664|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434665|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154434666|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434667|NCT05438953|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154434668|NCT05438953|Antiviral Agents|antiviral agents|mesh-ancestor
154434669|NCT05438953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434670|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154434671|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434673|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
154434674|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434675|NCT05362916|Letermovir|letermovir|mesh-list
154434676|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154434677|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434678|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434679|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434680|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
153387584|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
154434681|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434682|NCT05317000|Nivolumab|nivolumab|mesh-list
154434683|NCT05317000|Azacitidine|azacitidine|mesh-list
154434684|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434685|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434686|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154434687|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434688|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154434689|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
154434690|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434691|NCT05299086|Fluticasone|fluticasone|mesh-list
154434692|NCT05299086|Xhance|xhance|mesh-list
154434693|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434694|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154434695|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
154434696|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434697|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434698|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154434699|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
154434700|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
154434701|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154434702|NCT05262777|Lidocaine|lidocaine|mesh-list
154434703|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
154434704|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
154434705|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154434706|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434707|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
154434708|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434709|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154434710|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154434711|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154434712|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154434713|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434714|NCT05215730|Copper|copper|mesh-list
154434715|NCT05215730|Trace Elements|trace elements|mesh-ancestor
154434716|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
154434717|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434718|NCT05169424|Fluticasone|fluticasone|mesh-list
153782276|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782277|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434719|NCT05169424|Xhance|xhance|mesh-list
154434720|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
154434721|NCT05169424|Olodaterol|olodaterol|mesh-list
154434722|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434723|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154434724|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
154434725|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434726|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434727|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154434728|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
154434729|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
154434730|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154434731|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
154434732|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154434733|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
154434734|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434735|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434736|NCT05150691|Ritonavir|ritonavir|mesh-list
154434737|NCT05150691|Itraconazole|itraconazole|mesh-list
154434738|NCT05150691|Pertuzumab|pertuzumab|mesh-list
154434739|NCT05150691|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154434740|NCT05150691|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154434741|NCT05150691|Protease Inhibitors|protease inhibitors|mesh-ancestor
154434742|NCT05150691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434743|NCT05150691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434744|NCT05150691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154434745|NCT05150691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154434746|NCT05150691|Antiviral Agents|antiviral agents|mesh-ancestor
154434747|NCT05150691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434748|NCT05150691|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154434749|NCT05150691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154434750|NCT05150691|Antifungal Agents|antifungal agents|mesh-ancestor
154434751|NCT05150691|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154434752|NCT05150691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154434753|NCT05150691|Hormone Antagonists|hormone antagonists|mesh-ancestor
154434754|NCT05150691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434755|NCT05150691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434756|NCT05150691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434757|NCT05150691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434759|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154434760|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434761|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
154434762|NCT05092451|Fludarabine|fludarabine|mesh-list
154434763|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
154434764|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154434765|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
153731835|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153731836|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
154434766|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434767|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154434768|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154434769|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
154434770|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434771|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434772|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154434773|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154434774|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
154434775|NCT05068752|Sorafenib|sorafenib|mesh-list
154434776|NCT05068752|Vemurafenib|vemurafenib|mesh-list
154434777|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434778|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434779|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434780|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434781|NCT05051293|Testosterone|testosterone|mesh-list
154434782|NCT05051293|Estrogens|estrogens|mesh-list
154434783|NCT05051293|Androgens|androgens|mesh-ancestor
154434784|NCT05051293|Hormones|hormones|mesh-ancestor
154434785|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434786|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434787|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
154434788|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154434789|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154434790|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434791|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154434792|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434793|NCT05042505|Incretins|incretins|mesh-ancestor
154434794|NCT05042505|Hormones|hormones|mesh-ancestor
154434795|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434796|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154434797|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
154434798|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434799|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
154434800|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154434801|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434802|NCT05010200|Poly ICLC|poly iclc|mesh-list
154434803|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
154434804|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
154434805|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434806|NCT04983615|Midazolam|midazolam|mesh-list
154434807|NCT04983615|Fentanyl|fentanyl|mesh-list
154434808|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154434809|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154434810|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782278|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153782279|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
154434811|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434812|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154434813|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154434814|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154434815|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154434816|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
154434817|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
154434818|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
154434819|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
154434820|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434821|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434822|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154434824|NCT04983615|Analgesics|analgesics|mesh-ancestor
154434825|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
154434826|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434827|NCT04975308|Fulvestrant|fulvestrant|mesh-list
154434828|NCT04975308|Exemestane|exemestane|mesh-list
154434829|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154434830|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434831|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154434832|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154434833|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
154434834|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434835|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434836|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154434837|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154434838|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434839|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434840|NCT04948333|Niacinamide|niacinamide|mesh-list
154434841|NCT04948333|Asciminib|asciminib|mesh-list
154434842|NCT04948333|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154434843|NCT04948333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434844|NCT04948333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434845|NCT04948333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434846|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
154434847|NCT04948333|Vitamins|vitamins|mesh-ancestor
154434848|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
154434849|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434850|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
154434851|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154434852|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154434853|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154434854|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153387585|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
154434855|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434856|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
154434857|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434858|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434859|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154434860|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434861|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
154434862|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
154434863|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154434864|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
154434865|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434866|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434867|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
154434868|NCT04917679|Diacerein|diacerein|mesh-list
154434869|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434870|NCT04905316|Durvalumab|durvalumab|mesh-list
154434871|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434872|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434873|NCT04847921|Dalbavancin|dalbavancin|mesh-list
154434874|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154434875|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434876|NCT04801953|Nimodipine|nimodipine|mesh-list
154434877|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154434878|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154434879|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154434880|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434881|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154434882|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434883|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
154434884|NCT04795427|Asciminib|asciminib|mesh-list
154434885|NCT04795427|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154434886|NCT04795427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434887|NCT04795427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434888|NCT04795427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434889|NCT04771130|Posaconazole|posaconazole|mesh-list
154434890|NCT04771130|Azacitidine|azacitidine|mesh-list
154434891|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154434892|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
154434893|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434894|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434895|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434897|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434898|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154434899|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154434900|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154434901|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154434902|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154009522|NCT00606983|Tamsulosin|tamsulosin|mesh-list
154434903|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154434904|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
154434905|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434906|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434907|NCT04765709|Carboplatin|carboplatin|mesh-list
154434908|NCT04765709|Pemetrexed|pemetrexed|mesh-list
154434909|NCT04765709|Durvalumab|durvalumab|mesh-list
154434910|NCT04765709|Vinorelbine|vinorelbine|mesh-list
154434911|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154434912|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434913|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434914|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434915|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154434916|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154434917|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434918|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
154434919|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434920|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154434921|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
154434922|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
154434923|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
154434924|NCT04738097|Clopidogrel|clopidogrel|mesh-list
154434925|NCT04738097|Ticagrelor|ticagrelor|mesh-list
154434926|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154434927|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154434928|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154434929|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154434930|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
154434931|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434932|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434933|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434934|NCT04666623|Esketamine|esketamine|mesh-list
154434935|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
154434936|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154434937|NCT04649398|Nimodipine|nimodipine|mesh-list
154434938|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154434939|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154434940|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154434941|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434942|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154434943|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434944|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
154434945|NCT04648189|Cetuximab|cetuximab|mesh-list
154434946|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154434947|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434948|NCT04609514|Nicotine|nicotine|mesh-list
154434949|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154434950|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
154434951|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154434952|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434953|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154434954|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154434955|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
154434956|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154434957|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434958|NCT04562532|Sirolimus|sirolimus|mesh-list
154434959|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154434960|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154434961|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154434962|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434963|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
154434964|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154434965|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
154434966|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434967|NCT04533646|Insulin|insulin|mesh-list
154434968|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154434969|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434970|NCT04523064|Empagliflozin|empagliflozin|mesh-list
154434971|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154434972|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434973|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154434974|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434975|NCT04497584|Prednisone|prednisone|mesh-list
154009593|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
154434976|NCT04497584|Afatinib|afatinib|mesh-list
154434977|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154434978|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
154434979|NCT04497584|Hormones|hormones|mesh-ancestor
154434980|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154434981|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154434982|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154434983|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434984|NCT04497584|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154434985|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434986|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434987|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434988|NCT04489771|Belzutifan|belzutifan|mesh-list
154434989|NCT04489771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434990|NCT04452877|Trametinib|trametinib|mesh-list
154434991|NCT04452877|Dabrafenib|dabrafenib|mesh-list
153387586|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
154434992|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434993|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154434994|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154434995|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154434996|NCT04444869|Cisplatin|cisplatin|mesh-list
154434997|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154434998|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154434999|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154435000|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154435001|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435002|NCT04280562|Acetaminophen|acetaminophen|mesh-list
154435003|NCT04280562|Analgesics|analgesics|mesh-list
154435004|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154435005|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
154435006|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435007|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435008|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
154435009|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
154435010|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154435011|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
154435012|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154435013|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
154435014|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435015|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435016|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
154435017|NCT04267926|Ubiquinone|ubiquinone|mesh-list
154435018|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
154435019|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435020|NCT04255433|Dulaglutide|dulaglutide|mesh-list
154435021|NCT04255433|Tirzepatide|tirzepatide|mesh-list
154435022|NCT04255433|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154435023|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154435024|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435025|NCT04255433|Incretins|incretins|mesh-ancestor
154435026|NCT04255433|Hormones|hormones|mesh-ancestor
154435027|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435028|NCT04225819|Vitamin D|vitamin d|mesh-list
154435029|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
154435030|NCT04225819|Vitamins|vitamins|mesh-ancestor
154435031|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
154435032|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435033|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154435034|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154435035|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
154435036|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154435037|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154435038|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435039|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
154435040|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
154435041|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435042|NCT04192773|Lidocaine|lidocaine|mesh-list
154435043|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
154435044|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
154435045|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154435046|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435047|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
154435048|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435049|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154435050|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154435051|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154435052|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154435053|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435054|NCT04158635|Paclitaxel|paclitaxel|mesh-list
154435055|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154435056|NCT04158635|Gemcitabine|gemcitabine|mesh-list
154435057|NCT04158635|Bosentan|bosentan|mesh-list
154435058|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154435059|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435060|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
154435061|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
154435062|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
154435063|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435064|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435065|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
154435066|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154435067|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154435068|NCT04113863|Anastrozole|anastrozole|mesh-list
154435069|NCT04113863|Tretinoin|tretinoin|mesh-list
154435070|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154435071|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435072|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154435073|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154435074|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435075|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435076|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154435077|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
154435078|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435079|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435080|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
154435081|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
154435082|NCT04023110|Carvedilol|carvedilol|mesh-list
154435083|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154435084|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154435085|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
154435086|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435087|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435088|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435089|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154435090|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
154435091|NCT04023110|Protective Agents|protective agents|mesh-ancestor
154435092|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154435093|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154435094|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154435095|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
154435096|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154435097|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154435098|NCT03924791|Dexamethasone|dexamethasone|mesh-list
154435099|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
154435100|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154435101|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154435102|NCT03924791|Prednisolone|prednisolone|mesh-list
154435103|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
154435104|NCT03924791|Lidocaine|lidocaine|mesh-list
154435105|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154435106|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
154435107|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154435108|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
154435109|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
154435110|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435111|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435112|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435113|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
154435114|NCT03924791|Hormones|hormones|mesh-ancestor
154435115|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435116|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154435117|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435118|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
154435120|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154435121|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
154435122|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154435123|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154435124|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154435125|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154435126|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435127|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154435128|NCT03924791|Protective Agents|protective agents|mesh-ancestor
154435129|NCT03854799|Capecitabine|capecitabine|mesh-list
154435130|NCT03854799|Avelumab|avelumab|mesh-list
154435131|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435132|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
154435133|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435134|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435135|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435136|NCT03672643|Crizotinib|crizotinib|mesh-list
154435137|NCT03672643|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154435138|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154435139|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435140|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435141|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435142|NCT03630705|Vaccines|vaccines|mesh-list
154435143|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
153731838|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154435144|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435145|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
154435146|NCT03605654|Tacrolimus|tacrolimus|mesh-list
154435147|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154435148|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
154435149|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435150|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154435151|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435152|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435153|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154435154|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435155|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154435156|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
154435157|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154435158|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435159|NCT03591510|Cytarabine|cytarabine|mesh-list
154435160|NCT03591510|Fludarabine|fludarabine|mesh-list
154435161|NCT03591510|Etoposide|etoposide|mesh-list
154435162|NCT03591510|Daunorubicin|daunorubicin|mesh-list
154435163|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
154435164|NCT03591510|Idarubicin|idarubicin|mesh-list
154435165|NCT03591510|Midostaurin|midostaurin|mesh-list
154435166|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435167|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435168|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
154435169|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435170|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154435171|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
154435172|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435173|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154435174|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154435175|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154435176|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435177|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
154435178|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435179|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154435180|NCT03591510|Analgesics|analgesics|mesh-ancestor
154435181|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
154435182|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435183|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154435184|NCT03543969|Nivolumab|nivolumab|mesh-list
154435185|NCT03543969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435186|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435187|NCT03543969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154435188|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435189|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153782316|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153782317|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153782318|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782319|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782320|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153782321|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153782322|NCT00260325|Analgesics|analgesics|mesh-ancestor
154435190|NCT03534180|Venetoclax|venetoclax|mesh-list
154435192|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435193|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435194|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154435195|NCT03534180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154435196|NCT03534180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435197|NCT03534180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435198|NCT03477539|Lenalidomide|lenalidomide|mesh-list
154435199|NCT03477539|Daratumumab|daratumumab|mesh-list
154435200|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
154435201|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435202|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154435203|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154435204|NCT03477539|Growth Substances|growth substances|mesh-ancestor
154435205|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
154435206|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435207|NCT03476642|Epinephrine|epinephrine|mesh-list
154435208|NCT03476642|Ropivacaine|ropivacaine|mesh-list
154435209|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
154435210|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
154435211|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154435212|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435213|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
154435214|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435215|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154435216|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154435217|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
154435218|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435219|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435220|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154435221|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154435222|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
154435223|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154435224|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
154435225|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
154435226|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
154435227|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154435228|NCT03367156|Dexamethasone|dexamethasone|mesh-list
154435229|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
154435230|NCT03367156|Ichthammol|ichthammol|mesh-list
154435231|NCT03367156|BB 1101|bb 1101|mesh-list
154435232|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154435233|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
154435234|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
154435235|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435236|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435237|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435238|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
154435239|NCT03367156|Hormones|hormones|mesh-ancestor
154435240|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435241|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154435242|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435243|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
154435244|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435245|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435246|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
154435247|NCT03302299|Pyridoxine|pyridoxine|mesh-list
154435248|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
154435249|NCT03302299|Isoniazid|isoniazid|mesh-list
154435250|NCT03302299|Vitamins|vitamins|mesh-ancestor
154435251|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
154435252|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435253|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
154435254|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
154435255|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154435256|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435257|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154435258|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154435259|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
154435260|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435261|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154435262|NCT03262935|Capecitabine|capecitabine|mesh-list
154435263|NCT03262935|Trastuzumab|trastuzumab|mesh-list
154435264|NCT03262935|Vinorelbine|vinorelbine|mesh-list
154435265|NCT03262935|Lapatinib|lapatinib|mesh-list
154435266|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435267|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
154435268|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435270|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435271|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154435272|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
154435273|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
154435274|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
154435275|NCT03262935|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154435276|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154435277|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435278|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
154435279|NCT03200847|Tretinoin|tretinoin|mesh-list
154435280|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435281|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435282|NCT03200847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154435283|NCT03200847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435284|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
154435285|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
154435286|NCT02956447|Hormones|hormones|mesh-list
154435287|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435288|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435289|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
154435290|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
154435291|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435292|NCT02910700|Nivolumab|nivolumab|mesh-list
154435293|NCT02910700|Trametinib|trametinib|mesh-list
154435294|NCT02910700|Dabrafenib|dabrafenib|mesh-list
154435295|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435296|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435297|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153458022|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153458023|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154435298|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435299|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154435300|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435301|NCT02586727|Aflibercept|aflibercept|mesh-list
154435302|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154435303|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154435304|NCT02586727|Growth Substances|growth substances|mesh-ancestor
154435305|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435306|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
154435307|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435308|NCT02555358|Docetaxel|docetaxel|mesh-list
154435309|NCT02555358|Capecitabine|capecitabine|mesh-list
154435310|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
154435311|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435312|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
154435313|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
154435314|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
154435315|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435316|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435317|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
154435318|NCT02532231|Nivolumab|nivolumab|mesh-list
154435319|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435320|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435321|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154435322|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435323|NCT02497365|Cefazolin|cefazolin|mesh-list
154435324|NCT02497365|Tobramycin|tobramycin|mesh-list
154435325|NCT02497365|Besifloxacin|besifloxacin|mesh-list
154435326|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154435327|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435328|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154435329|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154435330|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435331|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435332|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782347|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435333|NCT02458690|Dopamine|dopamine|mesh-list
154435334|NCT02458690|Norepinephrine|norepinephrine|mesh-list
154435335|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
154435336|NCT02458690|Serotonin|serotonin|mesh-list
154435337|NCT02458690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154435338|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
154435339|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154435340|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154435341|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
154435342|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435343|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435344|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435345|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
154435346|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
154435347|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435348|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154435349|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154435350|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154435351|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
154435352|NCT02458690|Protective Agents|protective agents|mesh-ancestor
154009975|NCT04237532|Analgesics|analgesics|mesh-ancestor
154435353|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154435354|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
154435355|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154435356|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154435358|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154435359|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
154435360|NCT02446457|Lenalidomide|lenalidomide|mesh-list
154435361|NCT02446457|Antibodies|antibodies|mesh-list
154435362|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
154435363|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154435364|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
154435365|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435366|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435367|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154435368|NCT02446457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154435369|NCT02446457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435370|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154435371|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154435372|NCT02446457|Growth Substances|growth substances|mesh-ancestor
154435373|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
153782354|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153782360|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782361|NCT00267657|Reserpine|reserpine|mesh-list
154435374|NCT02308280|Bortezomib|bortezomib|mesh-list
154435375|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435376|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
154435377|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154435378|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154435379|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
154435380|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435381|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154435382|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154435383|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435384|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435385|NCT02124421|Paclitaxel|paclitaxel|mesh-list
154435386|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154435387|NCT02124421|Carboplatin|carboplatin|mesh-list
154435388|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154435389|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435390|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
154435391|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
154435392|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
154435393|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435394|NCT01914900|Cisplatin|cisplatin|mesh-list
154435395|NCT01914900|Docetaxel|docetaxel|mesh-list
154435396|NCT01914900|Fluorouracil|fluorouracil|mesh-list
154435397|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435398|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
154435399|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
154435400|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
154435401|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435402|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
154435403|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435404|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154435405|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
154435406|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435407|NCT01703455|Sorafenib|sorafenib|mesh-list
154435408|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435409|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154435410|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435411|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435412|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
154435413|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154435414|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154435415|NCT01496976|Prednisolone|prednisolone|mesh-list
154435416|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
154435417|NCT01496976|Lenalidomide|lenalidomide|mesh-list
154435418|NCT01496976|Ofatumumab|ofatumumab|mesh-list
154435419|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154435420|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
154435421|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
154435422|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435423|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154435424|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154435425|NCT01496976|Growth Substances|growth substances|mesh-ancestor
154435426|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
154435427|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435428|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176578|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
154435429|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
154435430|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
154435431|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435432|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435433|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
154435434|NCT01496976|Hormones|hormones|mesh-ancestor
154435435|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435436|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154435437|NCT01496976|Protective Agents|protective agents|mesh-ancestor
154435438|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154435439|NCT01409161|Vitamins|vitamins|mesh-list
154435440|NCT01409161|Vitamin A|vitamin a|mesh-list
154435441|NCT01409161|Tretinoin|tretinoin|mesh-list
154435442|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
154435443|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
154435444|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
154435445|NCT01409161|Calicheamicins|calicheamicins|mesh-list
154435446|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
154435447|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435448|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435449|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
154435450|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
154435451|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
154435452|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435453|NCT01409161|Protective Agents|protective agents|mesh-ancestor
154435454|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154435455|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435456|NCT01409161|Immunotoxins|immunotoxins|mesh-ancestor
154435457|NCT01409161|Immunoconjugates|immunoconjugates|mesh-ancestor
154435458|NCT01409161|Immunologic Factors|immunologic factors|mesh-ancestor
154435459|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154435460|NCT01140516|Trimethoprim|trimethoprim|mesh-list
154435461|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154435462|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435463|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
154435464|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154435465|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154435466|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154435467|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435468|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435469|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154435470|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154435471|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154435472|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154435473|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154435474|NCT00984399|Estradiol|estradiol|mesh-list
154435475|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154435476|NCT00984399|Estrogens|estrogens|mesh-ancestor
154435477|NCT00984399|Hormones|hormones|mesh-ancestor
154435478|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435479|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435480|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154435481|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
154435482|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154435483|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154435484|NCT02915016|Vaccines|vaccines|mesh-list
154435485|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154435486|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
154435487|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435488|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154435489|NCT01170650|Doxorubicin|doxorubicin|mesh-list
154435490|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154435491|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154435492|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435493|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154435494|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154435496|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435497|NCT01168310|Fluticasone|fluticasone|mesh-list
154435498|NCT01168310|Xhance|xhance|mesh-list
154435499|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
154435500|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154435501|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154435502|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
154435503|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435504|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435505|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154435506|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
154435507|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
154435508|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154435509|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154435510|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154435511|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154435512|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
154435513|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435514|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435515|NCT01472198|Gemcitabine|gemcitabine|mesh-list
154435516|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435517|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
154435518|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435519|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435520|NCT02269358|Methotrexate|methotrexate|mesh-list
154435521|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154435522|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
154435523|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154435524|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435525|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435526|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
154435527|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435528|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435529|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
154435530|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435531|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154435532|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154435533|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
154435534|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154435535|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154435536|NCT04504240|Famotidine|famotidine|mesh-list
154435537|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154435538|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435539|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154435540|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
154435541|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
154435542|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435543|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435544|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435545|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
154435546|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154435547|NCT02269514|Nicotine|nicotine|mesh-list
154435548|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154435549|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
154435550|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435551|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435552|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154435553|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154435554|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
154435555|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435556|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435557|NCT01332812|Dexamethasone|dexamethasone|mesh-list
154435558|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
154435559|NCT01332812|BB 1101|bb 1101|mesh-list
154435560|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154435561|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
154435562|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
154435563|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435564|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435565|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435566|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
154435567|NCT01332812|Hormones|hormones|mesh-ancestor
154435568|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435569|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154435570|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435571|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
154435572|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435573|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435575|NCT03408652|Denosumab|denosumab|mesh-list
154435576|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154435577|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435578|NCT01332656|Paclitaxel|paclitaxel|mesh-list
154435579|NCT01332656|Carboplatin|carboplatin|mesh-list
154435580|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154435581|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010192|NCT05787509|Progesterone|progesterone|mesh-list
154435582|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
154435583|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
154435584|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
154435585|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435587|NCT02084472|Glycerol|glycerol|mesh-list
154435588|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154435589|NCT02084472|Protective Agents|protective agents|mesh-ancestor
154435590|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435591|NCT02084472|Emollients|emollients|mesh-ancestor
154435592|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
154435593|NCT02266784|Nicotine|nicotine|mesh-list
154435594|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154435595|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
154435596|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435597|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435598|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154435599|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154435600|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
154435601|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973759|NCT06247956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435602|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435603|NCT02090790|Dexamethasone|dexamethasone|mesh-list
154435604|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
154435605|NCT02090790|BB 1101|bb 1101|mesh-list
154435606|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154435607|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
154435608|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
154435609|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435610|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435611|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435612|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
154435613|NCT02090790|Hormones|hormones|mesh-ancestor
154435614|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435615|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154435616|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435617|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
154435618|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435619|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435620|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
154435621|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154435622|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154435623|NCT01443728|Vitamin D|vitamin d|mesh-list
154435624|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
154435625|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
154435626|NCT01443728|Vitamins|vitamins|mesh-list
154435627|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
154435628|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435629|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154435630|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154435631|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
154435632|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
154435633|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435634|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435635|NCT01312454|Travoprost|travoprost|mesh-list
154435636|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154435637|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154435638|NCT02084784|Methylene Blue|methylene blue|mesh-list
154435639|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435640|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435641|NCT02091180|Mannitol|mannitol|mesh-list
154435642|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154435643|NCT02091180|Diuretics|diuretics|mesh-ancestor
154435644|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
154435645|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435646|NCT02269748|Analgesics|analgesics|mesh-list
154435647|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
154435648|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435649|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435650|NCT02269904|Fluorouracil|fluorouracil|mesh-list
154435651|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
154435652|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435653|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435654|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435655|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154435656|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
154435657|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435658|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
154435659|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435660|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435662|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154435663|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154435664|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435665|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435666|NCT02085018|Omeprazole|omeprazole|mesh-list
154435667|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154435668|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435669|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154435670|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435671|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435672|NCT02091336|Metformin|metformin|mesh-list
154435673|NCT02091336|Glyburide|glyburide|mesh-list
154435674|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154435675|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435676|NCT01442090|Everolimus|everolimus|mesh-list
154435677|NCT01442090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154435678|NCT01442090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154435679|NCT01442090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435680|NCT01442090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435681|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154435682|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
154435683|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435684|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435685|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
154435686|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154435687|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435688|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154435689|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435690|NCT02088450|Nitrendipine|nitrendipine|mesh-list
154435691|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154435692|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154435693|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154435694|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435695|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154435696|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435697|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
154435698|NCT03688828|Amoxicillin|amoxicillin|mesh-list
154435699|NCT03688828|Clarithromycin|clarithromycin|mesh-list
154435700|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
154435701|NCT03688828|Esomeprazole|esomeprazole|mesh-list
154435702|NCT03688828|Bismuth|bismuth|mesh-list
154435703|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435704|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154435705|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435706|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154435707|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435708|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154435709|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435710|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154435711|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154435712|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154435713|NCT03688828|Antacids|antacids|mesh-ancestor
154435714|NCT03688828|Diuretics|diuretics|mesh-ancestor
154435715|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
154435716|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435717|NCT03688828|Expectorants|expectorants|mesh-ancestor
154435718|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
154435719|NCT02091492|Teriparatide|teriparatide|mesh-list
154435720|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154435721|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435722|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154435723|NCT02266940|DS-1971a|ds-1971a|mesh-list
154435724|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154435725|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154435726|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154435727|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435728|NCT03981952|Vaccines|vaccines|mesh-list
154435729|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
154010339|NCT05403723|Carboplatin|carboplatin|mesh-list
154435730|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435731|NCT04475120|Lactoferrin|lactoferrin|mesh-list
154435732|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435733|NCT02088528|Mitomycins|mitomycins|mesh-list
154435734|NCT02088528|Mitomycin|mitomycin|mesh-list
154435735|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154435736|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435737|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
154435738|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435739|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154435740|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435741|NCT03634150|Doxorubicin|doxorubicin|mesh-list
154435742|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154435743|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435744|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154435745|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154435746|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435747|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435748|NCT02092038|Temozolomide|temozolomide|mesh-list
154435749|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154435750|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
154435751|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435752|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435753|NCT02272166|Propofol|propofol|mesh-list
154435754|NCT02272166|Sevoflurane|sevoflurane|mesh-list
154435755|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154435756|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154435757|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435758|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154435759|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
154435760|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
154435761|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154435762|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154435763|NCT02088684|Fulvestrant|fulvestrant|mesh-list
154435764|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154435765|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435766|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154435767|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154435768|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
154435769|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435770|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435771|NCT01137968|Bevacizumab|bevacizumab|mesh-list
154435772|NCT01137968|Imetelstat|imetelstat|mesh-list
154435773|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
154435774|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435775|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435776|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154435777|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154435778|NCT01137968|Growth Substances|growth substances|mesh-ancestor
154435779|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435780|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
154435781|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435782|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435783|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154435784|NCT02249910|Metformin|metformin|mesh-list
154435785|NCT02249910|Semaglutide|semaglutide|mesh-list
154435786|NCT02249910|Digoxin|digoxin|mesh-list
154435787|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154435788|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435789|NCT02249910|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154435790|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154435791|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154435792|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435793|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435794|NCT02249910|Protective Agents|protective agents|mesh-ancestor
154435795|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154435796|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154435797|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154435798|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435799|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
154435800|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435801|NCT02398396|Lactitol|lactitol|mesh-list
154435802|NCT02398396|Cathartics|cathartics|mesh-ancestor
154435803|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154010414|NCT05077085|Vancomycin|vancomycin|mesh-list
154435804|NCT05628584|Metformin|metformin|mesh-list
154435805|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154435806|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435807|NCT02088918|Metformin|metformin|mesh-list
154435808|NCT02088918|Nateglinide|nateglinide|mesh-list
154435809|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154435810|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435811|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
154435812|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435813|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435814|NCT02092428|Adenosine|adenosine|mesh-list
154435815|NCT02092428|Regadenoson|regadenoson|mesh-list
154435816|NCT02092428|Analgesics|analgesics|mesh-ancestor
154435817|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
154435818|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435819|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435820|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154435821|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
154435822|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154435823|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
154435824|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
154435825|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435826|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435827|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154435828|NCT02783404|Amoxicillin|amoxicillin|mesh-list
154435829|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
154435830|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
154435831|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154435832|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435833|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154435834|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435835|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435836|NCT01097018|Capecitabine|capecitabine|mesh-list
154435837|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435838|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
154435839|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782389|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
154435840|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435841|NCT01096862|Peficitinib|peficitinib|mesh-list
154435842|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435843|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435844|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154435845|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
154435846|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435847|NCT02092506|Amoxicillin|amoxicillin|mesh-list
154435848|NCT02092506|Metronidazole|metronidazole|mesh-list
154435849|NCT02092506|Clarithromycin|clarithromycin|mesh-list
154435850|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154435851|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154435852|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435853|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154435854|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154435855|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154435856|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435857|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435858|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154435859|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154435860|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
154435861|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154435862|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435863|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154435864|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154435865|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
154435866|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435867|NCT01128530|Linezolid|linezolid|mesh-list
154435868|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154435869|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154435870|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154435871|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435872|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435873|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154435874|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154435875|NCT02086032|Estradiol|estradiol|mesh-list
154435876|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154435877|NCT02086032|Estrogens|estrogens|mesh-list
154435878|NCT02086032|Progesterone|progesterone|mesh-list
154435879|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
153368877|NCT02246894|Factor VIII|factor viii|mesh-list
154435880|NCT02086032|Hormones|hormones|mesh-ancestor
154435881|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435882|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435883|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154435884|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
154435885|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154435886|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154435887|NCT02086032|Progestins|progestins|mesh-ancestor
154435888|NCT02092818|Riociguat|riociguat|mesh-list
154435889|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
154435890|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435891|NCT02267408|Warfarin|warfarin|mesh-list
154435892|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
154435893|NCT02092896|Liraglutide|liraglutide|mesh-list
154435894|NCT02092896|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154435895|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154435896|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435897|NCT02092896|Incretins|incretins|mesh-ancestor
154435898|NCT02092896|Hormones|hormones|mesh-ancestor
154435899|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435900|NCT02092974|Citalopram|citalopram|mesh-list
154435901|NCT02092974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154435902|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154435903|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154435904|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435905|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435906|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
154435907|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435908|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154435909|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
154435910|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154435911|NCT05097508|Bromides|bromides|mesh-list
154435912|NCT05097508|Rocuronium|rocuronium|mesh-list
154435913|NCT05097508|Atracurium|atracurium|mesh-list
154435914|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
154435915|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154435916|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154435917|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154435918|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435919|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435920|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154435921|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154435922|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
154435923|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435924|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435925|NCT02089308|Nicotine|nicotine|mesh-list
154435926|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154435927|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
154435928|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154435929|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435930|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154435931|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154435932|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
154435933|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154435934|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435936|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435937|NCT05095714|Liver Extracts|liver extracts|mesh-list
154435938|NCT05095714|Hematinics|hematinics|mesh-ancestor
154435939|NCT02660242|Glucagon|glucagon|mesh-list
154435940|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154435941|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435942|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435943|NCT02660242|Hormones|hormones|mesh-ancestor
154435944|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435945|NCT02660242|Incretins|incretins|mesh-ancestor
154435946|NCT02089386|Tamoxifen|tamoxifen|mesh-list
154435947|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154435948|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
154435949|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154435950|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435951|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154010563|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
154435952|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435953|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154435955|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154435956|NCT03557580|Isosorbide|isosorbide|mesh-list
154435957|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154435958|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154435959|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154435960|NCT03557580|Diuretics|diuretics|mesh-ancestor
154435961|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
154435962|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435963|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
154435964|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154435965|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435966|NCT02089542|Methylene Blue|methylene blue|mesh-list
154435967|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435968|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435969|NCT01295060|Octreotide|octreotide|mesh-list
154435970|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154435971|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154435972|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435973|NCT02086656|Bevacizumab|bevacizumab|mesh-list
154435974|NCT02086656|Capecitabine|capecitabine|mesh-list
154435975|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
154435976|NCT02086656|Irinotecan|irinotecan|mesh-list
154435977|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154435978|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435979|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154435980|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154435981|NCT02086656|Growth Substances|growth substances|mesh-ancestor
154435982|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154435983|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
154435984|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154435985|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
154435986|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435987|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154435988|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154435989|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435990|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
154435991|NCT01294202|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154435992|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154435993|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154435994|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154435995|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154435996|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
154435997|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154435998|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154435999|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436000|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154436001|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154436002|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064572|NCT00829296|Metoprolol|metoprolol|mesh-list
154436003|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436004|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436006|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436007|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436008|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154436009|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154436010|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154436011|NCT03557424|Cathartics|cathartics|mesh-ancestor
154436012|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154436013|NCT05057572|Carvedilol|carvedilol|mesh-list
154436014|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154436015|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154436016|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
154436017|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436018|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436019|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782393|NCT00233714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436020|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154436021|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
154436022|NCT05057572|Protective Agents|protective agents|mesh-ancestor
154436023|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154436024|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436025|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154436026|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
154010636|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
154436027|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154436028|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154436029|NCT02093598|Sirolimus|sirolimus|mesh-list
154436030|NCT02093598|Temsirolimus|temsirolimus|mesh-list
154436031|NCT02093598|MTOR Inhibitors|mtor inhibitors|mesh-list
154436032|NCT02093598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154436033|NCT02093598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436034|NCT02093598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436035|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154436036|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
154436037|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436038|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436039|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154436040|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436041|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154436042|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
154436043|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
154436044|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154436045|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154436046|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154436047|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436048|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436049|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
154436050|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436051|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436052|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154436053|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436054|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
154436055|NCT02087202|Ketamine|ketamine|mesh-list
154436056|NCT02087202|Analgesics|analgesics|mesh-ancestor
154436057|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
154436058|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436059|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436060|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154436061|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154436062|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
154436063|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
154436064|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436065|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154436066|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154436067|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436068|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436069|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154436070|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
154436071|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154436072|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436073|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154436074|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
154436075|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154436076|NCT01283594|Levodopa|levodopa|mesh-list
154436077|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154436078|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154436079|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
154436080|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436081|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436082|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436083|NCT01281254|Trebananib|trebananib|mesh-list
154436084|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154436085|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154436086|NCT01281254|Growth Substances|growth substances|mesh-ancestor
154436087|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436088|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
154436089|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436090|NCT05104138|Eplerenone|eplerenone|mesh-list
154436091|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154436092|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
154436093|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436094|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436095|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154436096|NCT05104138|Diuretics|diuretics|mesh-ancestor
154436097|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
154436098|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154436099|NCT03072043|Azacitidine|azacitidine|mesh-list
154010729|NCT02340169|Hormones|hormones|mesh-ancestor
154436100|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154436101|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
154436102|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436103|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436104|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436105|NCT05626010|Acetaminophen|acetaminophen|mesh-list
154436106|NCT05626010|Ibuprofen|ibuprofen|mesh-list
154436107|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154436108|NCT05626010|Analgesics|analgesics|mesh-ancestor
154436109|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
154436110|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436111|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436112|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
154436113|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154436114|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154436115|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436116|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154436117|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436118|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436119|NCT02089854|Toremifene|toremifene|mesh-list
154436120|NCT02089854|Anastrozole|anastrozole|mesh-list
154436121|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154436122|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436123|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154436124|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154436125|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436126|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436127|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154436128|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
154436129|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436130|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436131|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154436132|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154436133|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154436134|NCT02093910|Dexamethasone|dexamethasone|mesh-list
154436135|NCT02093910|Bortezomib|bortezomib|mesh-list
154436136|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154436137|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
154436138|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
154436139|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436140|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436141|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154436142|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
154436143|NCT02093910|Hormones|hormones|mesh-ancestor
154436144|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436145|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154436146|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436147|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
154436148|NCT04437160|Epirubicin|epirubicin|mesh-list
154436149|NCT04437160|Pirarubicin|pirarubicin|mesh-list
154436150|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154436151|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
154436152|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436153|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436154|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154436155|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
154436156|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436157|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436158|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154436159|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154436160|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154436161|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154436162|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436163|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
154436164|NCT02089932|Bupivacaine|bupivacaine|mesh-list
154436165|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
154436166|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
154436167|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436168|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436169|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
154436170|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436171|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154436172|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154010786|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
154436173|NCT02089932|Analgesics|analgesics|mesh-ancestor
154436175|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154436176|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154436177|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
154436178|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436179|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436180|NCT01037036|Latanoprost|latanoprost|mesh-list
154436181|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154436182|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154436183|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
154436184|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
154436185|NCT03069313|Vitamins|vitamins|mesh-ancestor
154436186|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
154436187|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436188|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
154436189|NCT03069313|Hematinics|hematinics|mesh-ancestor
154436190|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
154436191|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154436192|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154436193|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436194|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
154436195|NCT02094066|Coagulants|coagulants|mesh-ancestor
154436196|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154436197|NCT01033292|Iniparib|iniparib|mesh-list
154436198|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436199|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436200|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436201|NCT03068767|Vitamin D|vitamin d|mesh-list
154436202|NCT03068767|Vitamins|vitamins|mesh-ancestor
153782401|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436203|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
154436204|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436205|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154436206|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
154436207|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436208|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
154436209|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
154436210|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
154436211|NCT01110902|Agomelatine|agomelatine|mesh-list
154436212|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154436213|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436214|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436215|NCT05204173|Paclitaxel|paclitaxel|mesh-list
154436216|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154436217|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436218|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
154436219|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
154436220|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
154436221|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436222|NCT01025648|Epinephrine|epinephrine|mesh-list
154436223|NCT01025648|Racepinephrine|racepinephrine|mesh-list
154436224|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
154436225|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154436226|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154436227|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
154436228|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436229|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436230|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436231|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154436232|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154436233|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
154436234|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436235|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154436236|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
154436237|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
154436238|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
154436239|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154436240|NCT01110746|Insulin|insulin|mesh-list
154436241|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154436242|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436243|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436244|NCT05622968|Dinoprostone|dinoprostone|mesh-list
154436245|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
154436246|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154436247|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436248|NCT02268032|Androgens|androgens|mesh-list
154010855|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
154436249|NCT02268032|Hormones|hormones|mesh-ancestor
154436250|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436251|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436253|NCT03019965|Tazobactam|tazobactam|mesh-list
154436254|NCT03019965|Piperacillin|piperacillin|mesh-list
154436255|NCT03019965|Imipenem|imipenem|mesh-list
153973760|NCT06247956|Tubulin Modulators|tubulin modulators|mesh-ancestor
153782403|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436256|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154436257|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154436258|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436259|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154436260|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436261|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436262|NCT01468831|Minocycline|minocycline|mesh-list
154436263|NCT01468831|Bevacizumab|bevacizumab|mesh-list
154436264|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154436265|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436266|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154436267|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154436268|NCT01468831|Growth Substances|growth substances|mesh-ancestor
154436269|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436270|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
154436271|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154436272|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436273|NCT05627414|Paclitaxel|paclitaxel|mesh-list
154436274|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154436275|NCT05627414|Tegafur|tegafur|mesh-list
154436276|NCT05627414|Disitamab vedotin|disitamab vedotin|mesh-list
154436277|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154436278|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436279|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
154436280|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
154436281|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
154436282|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436283|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154436284|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
154436285|NCT05627414|Immunoconjugates|immunoconjugates|mesh-ancestor
154436286|NCT05627414|Immunologic Factors|immunologic factors|mesh-ancestor
154436287|NCT05627414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436288|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154436289|NCT03018249|Entinostat|entinostat|mesh-list
154436290|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
154436291|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154436292|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154436293|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154436294|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154436295|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
154436296|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154436297|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436298|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154436299|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154436300|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154436301|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154436302|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436303|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436304|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436305|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
154436306|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154436307|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154436308|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154436309|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436310|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436311|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
154436312|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436313|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436314|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154436315|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436316|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154436317|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436318|NCT05374252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154436319|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436320|NCT00905606|Topiramate|topiramate|mesh-list
154436321|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
154436322|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436323|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436325|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
154436326|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
154436327|NCT03017235|Citric Acid|citric acid|mesh-list
154436328|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
154436329|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154436330|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
154436331|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
154436332|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458024|NCT03591744|Growth Substances|growth substances|mesh-ancestor
153458025|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
154436333|NCT03017235|Antacids|antacids|mesh-ancestor
154436334|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154436335|NCT03017235|Cathartics|cathartics|mesh-ancestor
154436336|NCT05048134|Trametinib|trametinib|mesh-list
154436337|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436338|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154436339|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436340|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436341|NCT04438928|Micronutrients|micronutrients|mesh-list
154436342|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436343|NCT03667677|Amlodipine|amlodipine|mesh-list
154436344|NCT03667677|Tandospirone|tandospirone|mesh-list
154436345|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154436346|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154436347|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436348|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436349|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154436350|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436351|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
154436352|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154436353|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154436354|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436355|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154436356|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154436357|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
154436358|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436359|NCT04176718|Dexamethasone|dexamethasone|mesh-list
154436360|NCT04176718|Daratumumab|daratumumab|mesh-list
154436361|NCT04176718|Pomalidomide|pomalidomide|mesh-list
154436362|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154436363|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
154436364|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
154436365|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436366|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436367|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154436368|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
154436369|NCT04176718|Hormones|hormones|mesh-ancestor
154254787|NCT01251458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154436370|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436371|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154436372|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436373|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
154436374|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154436375|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154436376|NCT04176718|Growth Substances|growth substances|mesh-ancestor
154436377|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
154436378|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
154436379|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154436380|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436381|NCT02880371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154436382|NCT02880371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436383|NCT00813956|Carboplatin|carboplatin|mesh-list
154436384|NCT00813956|Gemcitabine|gemcitabine|mesh-list
154436385|NCT00813956|Iniparib|iniparib|mesh-list
154436386|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436387|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154436388|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
154436389|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436390|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154436391|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436392|NCT01002248|Dexamethasone|dexamethasone|mesh-list
154436393|NCT01002248|Bortezomib|bortezomib|mesh-list
154436394|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154436395|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
154436396|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
154436397|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436398|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436399|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154436400|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
154436402|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436403|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154436404|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436405|NCT02837029|Nivolumab|nivolumab|mesh-list
154436406|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154436407|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436408|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154436409|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436410|NCT03667131|Enalapril|enalapril|mesh-list
154436411|NCT03667131|Enalaprilat|enalaprilat|mesh-list
154436412|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154436413|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153973761|NCT06247956|Antimitotic Agents|antimitotic agents|mesh-ancestor
154436414|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436415|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
154436416|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154436417|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154436418|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154436419|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
154436420|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436421|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436422|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
154436423|NCT04976374|Gabapentin|gabapentin|mesh-list
154436424|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154436425|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436426|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436427|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154436428|NCT04976374|Analgesics|analgesics|mesh-ancestor
154436429|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
154436430|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436431|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154436432|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154436433|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154436434|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
154436435|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436436|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436437|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
154436438|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154436439|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154436440|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154254791|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
154436441|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154436442|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154436443|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
154436444|NCT00894530|Azithromycin|azithromycin|mesh-list
154436445|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154436446|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154436447|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154436448|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436449|NCT01376999|Hormones|hormones|mesh-list
154436450|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436451|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436452|NCT00892970|Azithromycin|azithromycin|mesh-list
154436453|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154436454|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154436455|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154436456|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436457|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154436458|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154436459|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436460|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154436461|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436462|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436463|NCT02201381|Metformin|metformin|mesh-list
154436464|NCT02201381|Doxycycline|doxycycline|mesh-list
154436465|NCT02201381|Mebendazole|mebendazole|mesh-list
154436466|NCT02201381|Atorvastatin|atorvastatin|mesh-list
154436467|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436468|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436469|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154436470|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154436471|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
154436472|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436473|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154436474|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154436475|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436476|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154436477|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436478|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
154436479|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154436480|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154436481|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
154436482|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
154436483|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
154436484|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
154436485|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
154436486|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436487|NCT00803114|Morphine|morphine|mesh-list
154436488|NCT00803114|Narcotics|narcotics|mesh-list
154436489|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154436490|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436491|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436492|NCT00803114|Analgesics|analgesics|mesh-ancestor
154436493|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
154436494|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436495|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
154436496|NCT05519384|Fludarabine|fludarabine|mesh-list
154436497|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154436498|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
154436499|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436500|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436501|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154436502|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
154436503|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436504|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436505|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154436506|NCT00799292|Vasopressins|vasopressins|mesh-list
154436507|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
154436508|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
154436509|NCT00799292|Coagulants|coagulants|mesh-ancestor
154436510|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154436511|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154436512|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
154436513|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436514|NCT02914275|Vaccines|vaccines|mesh-list
154436515|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
154436516|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436517|NCT01941875|Progesterone|progesterone|mesh-list
154436518|NCT01941875|Progestins|progestins|mesh-ancestor
154436519|NCT01941875|Hormones|hormones|mesh-ancestor
154436520|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436521|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436522|NCT01814657|Lidocaine|lidocaine|mesh-list
154436523|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
154436524|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
154436525|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436526|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436527|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
154436528|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436529|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154436530|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154436531|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154436532|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436533|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436534|NCT01773395|Methotrexate|methotrexate|mesh-list
154436535|NCT01773395|Fludarabine|fludarabine|mesh-list
154436536|NCT01773395|Busulfan|busulfan|mesh-list
154436537|NCT01773395|Tacrolimus|tacrolimus|mesh-list
154436538|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154436539|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
154436540|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154436541|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436542|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154436543|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
154436544|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436545|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436546|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
154436547|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436548|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154436549|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154436550|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
154436551|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436552|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154436553|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154436554|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
154436555|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154436556|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154436557|NCT01000922|Insulin|insulin|mesh-list
154436558|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154436559|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
154436560|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436561|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436562|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
154436563|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
154436564|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154436565|NCT03666195|Protective Agents|protective agents|mesh-ancestor
154436566|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436567|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
154436568|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154436569|NCT00889382|Paclitaxel|paclitaxel|mesh-list
154436570|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154436571|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436572|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
154436573|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
154436574|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
154436575|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436577|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436578|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
154436579|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154436580|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436581|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436582|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154436583|NCT05375188|Analgesics|analgesics|mesh-ancestor
154436584|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
154436585|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436586|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154436587|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154436588|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154436589|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
154436590|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436591|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436592|NCT00994292|Darexaban|darexaban|mesh-list
154436593|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154436594|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
154436595|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154436596|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
153369203|NCT02581839|BB 1101|bb 1101|mesh-list
154436597|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436598|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436599|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
154436600|NCT02604433|Luspatercept|luspatercept|mesh-list
154436601|NCT02604433|Hematinics|hematinics|mesh-ancestor
154436602|NCT04437004|Fenfluramine|fenfluramine|mesh-list
154436603|NCT04437004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154436604|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154436605|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436606|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436607|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436608|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
154436609|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436610|NCT00992732|Valganciclovir|valganciclovir|mesh-list
154436611|NCT00992732|Ganciclovir|ganciclovir|mesh-list
154436612|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154436613|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
154436614|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
154436615|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436616|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154436617|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436618|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436619|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436620|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
154436621|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154436622|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154436623|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154436624|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436625|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436626|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
154436627|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436628|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436629|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154436630|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436631|NCT03006393|Infliximab|infliximab|mesh-list
154436632|NCT03006393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154436633|NCT03006393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154436634|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
154436635|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154436636|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436637|NCT00991172|Fasinumab|fasinumab|mesh-list
154436638|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154436639|NCT00991172|Analgesics|analgesics|mesh-ancestor
154436640|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
154436641|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436642|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436643|NCT01383109|Pyronaridine|pyronaridine|mesh-list
154436644|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
154436645|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154436646|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154436647|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436648|NCT00882440|Losartan|losartan|mesh-list
154436649|NCT00882440|Enalapril|enalapril|mesh-list
154436650|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154436651|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154436652|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154436653|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154436654|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436655|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154436656|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
154436657|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436658|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
154436659|NCT05214391|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154436660|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154436661|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436662|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436663|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436664|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
154436665|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154436666|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
154436667|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436668|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436669|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154436670|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
154436671|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154436672|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154436673|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154436674|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
154436675|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436676|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436677|NCT05214157|Bupivacaine|bupivacaine|mesh-list
154436678|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
154436679|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
153458026|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
153458027|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153458028|NCT04196946|Fentanyl|fentanyl|mesh-list
154436680|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436681|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436682|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
154436683|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436684|NCT03630341|Clomiphene|clomiphene|mesh-list
154436685|NCT03630341|Enclomiphene|enclomiphene|mesh-list
154436686|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
154436687|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154436688|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
154436689|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436690|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436691|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154436692|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
154436693|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154436694|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154436695|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154436696|NCT02632396|Rituximab|rituximab|mesh-list
154436697|NCT02632396|Ixazomib|ixazomib|mesh-list
154011321|NCT02728518|Amikacin|amikacin|mesh-list
154436698|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154436699|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436700|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
154436701|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436702|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436703|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436704|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
154436705|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436707|NCT05102422|Sevoflurane|sevoflurane|mesh-list
154436708|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154436709|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436710|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436711|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154436712|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
154436713|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
154436714|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153782425|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782427|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154436715|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154436716|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
154436717|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154436718|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
154436719|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436720|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436721|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154436722|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
154436723|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436724|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436725|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154436726|NCT03665181|Bismuth|bismuth|mesh-list
154436727|NCT03665181|Antacids|antacids|mesh-ancestor
154436728|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436729|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154436730|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154436731|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436732|NCT05326906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154436733|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436734|NCT05101954|Mitogens|mitogens|mesh-list
154436735|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
154436736|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436737|NCT00875108|Insulin|insulin|mesh-list
154436738|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154436739|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436740|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436741|NCT04044209|Nivolumab|nivolumab|mesh-list
154436742|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154436743|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436744|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154436745|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436746|NCT03817463|Empagliflozin|empagliflozin|mesh-list
154436747|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154436748|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154436749|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436750|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436751|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436752|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
154436753|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436754|NCT05207683|Antibodies|antibodies|mesh-list
154436755|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
154436756|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
154436757|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436758|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154436759|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
154436760|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436761|NCT05213065|Bupivacaine|bupivacaine|mesh-list
154436762|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
154436763|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
154436764|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436765|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436766|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
154436767|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436768|NCT00969722|Tretinoin|tretinoin|mesh-list
154436769|NCT00969722|Molgramostim|molgramostim|mesh-list
154436770|NCT00969722|Isotretinoin|isotretinoin|mesh-list
154436771|NCT00969722|Sargramostim|sargramostim|mesh-list
154436772|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436773|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
154436774|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
154436775|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
154436776|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436777|NCT05099614|Naloxone|naloxone|mesh-list
154436778|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154436779|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436780|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
154436781|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436782|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
154436783|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154436784|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154436785|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154436786|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436787|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436788|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
154436789|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436790|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436791|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154436792|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436793|NCT00869336|Luliconazole|luliconazole|mesh-list
154436794|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
154436795|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436796|NCT02371889|Topiramate|topiramate|mesh-list
154436797|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
154436798|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436799|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436800|NCT00860288|Metformin|metformin|mesh-list
154436801|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154436802|NCT00860288|Vildagliptin|vildagliptin|mesh-list
154436803|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436804|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436805|NCT00860288|Incretins|incretins|mesh-ancestor
154436806|NCT00860288|Hormones|hormones|mesh-ancestor
154436807|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436808|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153782430|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436809|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
154436810|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436811|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436812|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154436813|NCT03630029|Hematinics|hematinics|mesh-ancestor
154436814|NCT05212597|Losartan|losartan|mesh-list
154436815|NCT05212597|Amlodipine|amlodipine|mesh-list
154436816|NCT05212597|Valsartan|valsartan|mesh-list
154436817|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154436818|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154436819|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154436820|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436821|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436822|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154436823|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436824|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
154436825|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154436826|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154436827|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154436828|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154436829|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436830|NCT03629717|Vitamin D|vitamin d|mesh-list
154436831|NCT03629717|Denosumab|denosumab|mesh-list
154436832|NCT03629717|Calcium|calcium|mesh-list
154436833|NCT03629717|Vitamins|vitamins|mesh-ancestor
154436834|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
154436835|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436836|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154436837|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154436838|NCT05108350|Metformin|metformin|mesh-list
154436839|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436840|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436841|NCT00859430|Levetiracetam|levetiracetam|mesh-list
154436842|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
154436843|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
154436844|NCT00855764|Paclitaxel|paclitaxel|mesh-list
154436845|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154436846|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436847|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
154436849|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
154436850|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436851|NCT00959036|Methotrexate|methotrexate|mesh-list
154436852|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154436853|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
154436854|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154436855|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436856|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154436857|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
154436858|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436859|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436860|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
154436861|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436862|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154436863|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154436864|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
154436865|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436866|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154436867|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
154436868|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
154436869|NCT04129723|Protective Agents|protective agents|mesh-ancestor
154436870|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436871|NCT04474262|Midodrine|midodrine|mesh-list
154436872|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
154436873|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
154436874|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436875|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436876|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154436877|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154436878|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154436879|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154436880|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
154436881|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436882|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436883|NCT05211583|Progesterone|progesterone|mesh-list
154436884|NCT05211583|Progestins|progestins|mesh-ancestor
154436885|NCT05211583|Hormones|hormones|mesh-ancestor
154436886|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436887|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436888|NCT04031599|Hormones|hormones|mesh-list
154436889|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436890|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154436892|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
154436893|NCT04724759|Ketamine|ketamine|mesh-list
154436894|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
154436895|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
154436896|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436897|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436898|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
154436899|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436900|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153973762|NCT06247956|Mitosis Modulators|mitosis modulators|mesh-ancestor
154436901|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154436902|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154436903|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436904|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436905|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154436906|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154436907|NCT04724759|Analgesics|analgesics|mesh-ancestor
154436908|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154436909|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154436910|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154436911|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
154436912|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154436913|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154436914|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154436915|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
154436916|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154436917|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154436918|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
154436919|NCT05186467|Analgesics|analgesics|mesh-ancestor
154436920|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
154436921|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436922|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436924|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436925|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154436926|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
154436927|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154436928|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154436929|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436930|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154436931|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
154436932|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154436933|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154436934|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
154436935|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154436936|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154436937|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154436938|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436939|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436940|NCT00768482|Buprenorphine|buprenorphine|mesh-list
154436941|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154436942|NCT00768482|Narcotics|narcotics|mesh-ancestor
154436943|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154436944|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436945|NCT00768482|Analgesics|analgesics|mesh-ancestor
154436946|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
154436947|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436948|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154436949|NCT00840866|Cefprozil|cefprozil|mesh-list
154436950|NCT00840866|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154436951|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154436952|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154436953|NCT00840632|Trandolapril|trandolapril|mesh-list
154436954|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154436955|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
154436956|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436957|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436958|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154436959|NCT00840476|Meloxicam|meloxicam|mesh-list
154436960|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154436961|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154436962|NCT00840476|Analgesics|analgesics|mesh-ancestor
154436963|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
154436964|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436965|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436966|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154436967|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154436968|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154436969|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154436970|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436971|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436972|NCT00765830|Vildagliptin|vildagliptin|mesh-list
154436973|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154436974|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436975|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154436976|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
154436977|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436978|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436979|NCT03664869|Mitomycins|mitomycins|mesh-list
154436980|NCT03664869|Mitomycin|mitomycin|mesh-list
154436981|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154436982|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154436983|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
154436984|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154436985|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154436986|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154436987|NCT00953420|Dexamethasone|dexamethasone|mesh-list
154436988|NCT00953420|Carboplatin|carboplatin|mesh-list
154436989|NCT00953420|Docetaxel|docetaxel|mesh-list
154436990|NCT00953420|Lenograstim|lenograstim|mesh-list
154436991|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154436992|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
154436993|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
154436994|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154436995|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154436997|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
154436998|NCT00953420|Hormones|hormones|mesh-ancestor
153782432|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154436999|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437000|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154437001|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437002|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
154437003|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
154437004|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
154437005|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437006|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154437007|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
154437008|NCT01602562|Valacyclovir|valacyclovir|mesh-list
154437009|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
154437010|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437011|NCT01945775|Talazoparib|talazoparib|mesh-list
154437012|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154437013|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437014|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437015|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437016|NCT00839930|Cilostazol|cilostazol|mesh-list
154437017|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154437018|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
154437019|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437020|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437021|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154437022|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154437023|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154437024|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154437025|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437026|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154437027|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
154437028|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154437029|NCT00839930|Protective Agents|protective agents|mesh-ancestor
154437030|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154437031|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154437032|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437033|NCT00838136|Lamotrigine|lamotrigine|mesh-list
154437034|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
154437035|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154437036|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437037|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437038|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154437039|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437040|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154437041|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154437042|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437043|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154437044|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154437046|NCT00944294|Binodenoson|binodenoson|mesh-list
154437047|NCT00944294|Analgesics|analgesics|mesh-ancestor
154437048|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
154437049|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437050|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437051|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154437052|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
154437053|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154437054|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
154437055|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
154437056|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437057|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437058|NCT00758966|Naltrexone|naltrexone|mesh-list
154437059|NCT00758966|Fluoxetine|fluoxetine|mesh-list
154437060|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154437061|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154437062|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437063|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
154437064|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437065|NCT00758966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154437066|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154011674|NCT05222984|Navitoclax|navitoclax|mesh-list
154437067|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437068|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437069|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437070|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
154437071|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154437072|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
154437073|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154437074|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154437075|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154437076|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437077|NCT03072719|Fluorides|fluorides|mesh-list
154437078|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
154437079|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
154437080|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
154437081|NCT03072719|Protective Agents|protective agents|mesh-ancestor
154437082|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437083|NCT05106400|Lidocaine|lidocaine|mesh-list
154437084|NCT05106400|Menthol|menthol|mesh-list
154437085|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
154437086|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
154437087|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437088|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437089|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
154437090|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437091|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154437092|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154437093|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154437094|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437095|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437096|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
154437097|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
154437098|NCT00754988|Metformin|metformin|mesh-list
154437099|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154437100|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154437101|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437102|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437103|NCT00754988|Incretins|incretins|mesh-ancestor
154437104|NCT00754988|Hormones|hormones|mesh-ancestor
154437105|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437106|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154437107|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
154437108|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437109|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437110|NCT01416935|Amiodarone|amiodarone|mesh-list
154437111|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154437112|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
154437113|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154437114|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437115|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437116|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154437117|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154437118|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154437119|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437120|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154437121|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154437122|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154437123|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
154437124|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154437125|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
154437126|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154437127|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437128|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437129|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
154437130|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437131|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437132|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154437133|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
154437134|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
153782439|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154437135|NCT05012566|Protective Agents|protective agents|mesh-ancestor
154437136|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154437137|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437138|NCT05202665|Fluorides|fluorides|mesh-list
154011755|NCT04352205|Thalidomide|thalidomide|mesh-list
154437139|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
154437140|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
154437141|NCT05202665|Protective Agents|protective agents|mesh-ancestor
154437142|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437143|NCT04438772|Anesthetics|anesthetics|mesh-list
154437144|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437145|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437146|NCT04560634|Norepinephrine|norepinephrine|mesh-list
154437147|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154437148|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154437149|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
154437150|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437151|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437152|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437153|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
154437154|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
154437155|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437156|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154437157|NCT00927914|Ranirestat|ranirestat|mesh-list
154437158|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437159|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437160|NCT05261464|Metoprolol|metoprolol|mesh-list
154437161|NCT05261464|Diltiazem|diltiazem|mesh-list
154437162|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154437163|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154437164|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
154437165|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
154437166|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437167|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437168|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154437169|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154437170|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154437171|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
154437172|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437173|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437174|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154437175|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437176|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154437177|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
154437178|NCT00835796|Finasteride|finasteride|mesh-list
154437179|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154437180|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154437181|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437182|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437183|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
154437184|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437185|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437186|NCT00835796|Urological Agents|urological agents|mesh-ancestor
154437187|NCT05106712|Vitamin D|vitamin d|mesh-list
154437188|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
154011824|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154011825|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782442|NCT04557007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387590|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154011826|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
154011827|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154011828|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154011829|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154011830|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
154011831|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011832|NCT04195139|Nivolumab|nivolumab|mesh-list
154011833|NCT04195139|Temozolomide|temozolomide|mesh-list
154011834|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011835|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011836|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154011837|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011838|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154011839|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
154011840|NCT04174352|Tamoxifen|tamoxifen|mesh-list
154011841|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154011842|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
154011843|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011844|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011845|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154437189|NCT05106712|Letrozole|letrozole|mesh-list
154437190|NCT05106712|Clomiphene|clomiphene|mesh-list
154437191|NCT05106712|Enclomiphene|enclomiphene|mesh-list
154437192|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
154437193|NCT05106712|Vitamins|vitamins|mesh-ancestor
154437194|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
154437195|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437196|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154437197|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437198|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154437199|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437200|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154437201|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154437202|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437203|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154437204|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
154437205|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782444|NCT00233792|Temsirolimus|temsirolimus|mesh-list
154437206|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154437207|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
154437208|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154437209|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154437210|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154437211|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
154437212|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154437213|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154437214|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437215|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437216|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437217|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
154437218|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437219|NCT00835640|Fexofenadine|fexofenadine|mesh-list
154437220|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154437221|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154437222|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154437223|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
154437224|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
154437225|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437226|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437227|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437228|NCT00752570|Trebananib|trebananib|mesh-list
154437229|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154437230|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154437231|NCT00752570|Growth Substances|growth substances|mesh-ancestor
154437233|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
154437234|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437235|NCT05083000|Topotecan|topotecan|mesh-list
154437236|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154437237|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154437238|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437239|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437240|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437241|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
154437242|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154437243|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154437244|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154437245|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437246|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437247|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
154437248|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437249|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437250|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154437251|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437252|NCT02942017|Brexanolone|brexanolone|mesh-list
154437253|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
154437254|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437255|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437256|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437257|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
154437258|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
154437259|NCT04447781|Citric Acid|citric acid|mesh-list
154437260|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
154437261|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
154437262|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154437264|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
154437265|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437266|NCT00835484|Cefdinir|cefdinir|mesh-list
154437267|NCT00835484|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154437268|NCT00835484|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154437269|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154437270|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437271|NCT00835406|Alendronate|alendronate|mesh-list
154437272|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154437273|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437274|NCT05202275|Olanzapine|olanzapine|mesh-list
154437275|NCT05202275|Aprepitant|aprepitant|mesh-list
154437276|NCT05202275|Palonosetron|palonosetron|mesh-list
154437277|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
154437278|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
154437279|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437280|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437281|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154437282|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154437283|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154437284|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437285|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154437286|NCT05202275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154437287|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154437288|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437289|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437290|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437291|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
154437292|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154437293|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154437294|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154437295|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154437296|NCT00744926|Incretins|incretins|mesh-ancestor
154437297|NCT00744926|Hormones|hormones|mesh-ancestor
154437298|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437299|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437300|NCT03838744|Olaparib|olaparib|mesh-list
154437301|NCT03838744|Trabectedin|trabectedin|mesh-list
154437302|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154437303|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437304|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437305|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437306|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154437307|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
154437309|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
154437310|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437311|NCT05327348|Protective Agents|protective agents|mesh-ancestor
154437312|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437313|NCT05327348|Vitamins|vitamins|mesh-ancestor
154437314|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
154437315|NCT04695106|Aspirin|aspirin|mesh-list
154437316|NCT04695106|Dabigatran|dabigatran|mesh-list
154437317|NCT04695106|Clopidogrel|clopidogrel|mesh-list
154437318|NCT04695106|Ticagrelor|ticagrelor|mesh-list
154437319|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154437320|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154437321|NCT04695106|Analgesics|analgesics|mesh-ancestor
154437322|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
154437323|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437324|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437325|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154437326|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154437327|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154437328|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154437329|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437330|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154437331|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154437332|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437333|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
154437334|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154437335|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154437336|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154437337|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
154437338|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437339|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
154437340|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154437341|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
154437342|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
154437344|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154437345|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
154437346|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154437347|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
154437348|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437349|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437350|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
154437351|NCT03629639|Metformin|metformin|mesh-list
154437352|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437353|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437354|NCT00835172|Glimepiride|glimepiride|mesh-list
154437355|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154437356|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437357|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437358|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154437359|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
154437360|NCT04941755|Famotidine|famotidine|mesh-list
154437361|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154437362|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154437363|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154437364|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
154437365|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
154437366|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437367|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437368|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437369|NCT04921735|Cisatracurium|cisatracurium|mesh-list
154437370|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154437371|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154437372|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437373|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437374|NCT01676116|Liraglutide|liraglutide|mesh-list
154437375|NCT01676116|Exenatide|exenatide|mesh-list
154437376|NCT01676116|Xultophy|xultophy|mesh-list
154437377|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437378|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437379|NCT01676116|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154437380|NCT01676116|Incretins|incretins|mesh-ancestor
154437381|NCT01676116|Hormones|hormones|mesh-ancestor
154437382|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437383|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154437385|NCT05200793|Empagliflozin|empagliflozin|mesh-list
154437386|NCT05200793|Linagliptin|linagliptin|mesh-list
154437387|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437388|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437389|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154437390|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437391|NCT05200793|Incretins|incretins|mesh-ancestor
154437392|NCT05200793|Hormones|hormones|mesh-ancestor
154437393|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437394|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154437395|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
154437396|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437397|NCT03383224|Nicotine|nicotine|mesh-list
154437398|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154437399|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
154437400|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437401|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437402|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154437403|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154437404|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
154437405|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437406|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437407|NCT04699357|Atropine|atropine|mesh-list
154437408|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154437409|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154437410|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154437411|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
154437412|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437413|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437414|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154437415|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
154437416|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
154437417|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
154437418|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154437419|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154437420|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
154437421|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437422|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437423|NCT05198531|Gemcitabine|gemcitabine|mesh-list
154437424|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437425|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154437426|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
154437427|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437428|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
154437429|NCT01869829|Clotrimazole|clotrimazole|mesh-list
154437430|NCT01869829|Miconazole|miconazole|mesh-list
154437431|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437432|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154437433|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154437434|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154437435|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437436|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437437|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154437438|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
154437439|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437440|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437441|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154437442|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154437443|NCT02683018|Dronabinol|dronabinol|mesh-list
154437444|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
154437445|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437446|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154437447|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154437448|NCT02683018|Analgesics|analgesics|mesh-ancestor
154437449|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
154437450|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437451|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154437452|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154437453|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437454|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437455|NCT02683018|Hormones|hormones|mesh-ancestor
154437456|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437457|NCT03982576|Nicotine|nicotine|mesh-list
154437458|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154437459|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
154437460|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437461|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437462|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154437463|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154437464|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
154437465|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437466|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437467|NCT02675842|Dronabinol|dronabinol|mesh-list
154437468|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
154437469|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437470|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154437471|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154437472|NCT02675842|Analgesics|analgesics|mesh-ancestor
154437473|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
154437474|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437475|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154437476|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154437477|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437478|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437479|NCT02675842|Hormones|hormones|mesh-ancestor
154437480|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437481|NCT04528108|Hemostatics|hemostatics|mesh-list
154437482|NCT04528108|Coagulants|coagulants|mesh-ancestor
154437483|NCT04251689|Mannitol|mannitol|mesh-list
154437484|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154437485|NCT04251689|Diuretics|diuretics|mesh-ancestor
154437486|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
154437487|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437488|NCT04232423|Olanzapine|olanzapine|mesh-list
154437489|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
154437490|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
154437491|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437492|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437493|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154437494|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154437495|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154437496|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437497|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154437498|NCT04232423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154437499|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154437500|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437501|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437502|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437503|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
154437504|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154437505|NCT04178993|Methylphenidate|methylphenidate|mesh-list
154437506|NCT04178993|Methamphetamine|methamphetamine|mesh-list
154437507|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154437508|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437509|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154437510|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154437511|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437512|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437513|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
154437514|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437515|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154437516|NCT04178993|Analgesics|analgesics|mesh-ancestor
154437517|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
154437518|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437519|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
154437520|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154437521|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
154437522|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
154437523|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
154437524|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154437525|NCT04436536|Methamphetamine|methamphetamine|mesh-list
154437526|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154437527|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437528|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
154437529|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
154437530|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437531|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
154437532|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437533|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437534|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
154437535|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154437536|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154437537|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437538|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154437539|NCT05762003|Interferons|interferons|mesh-list
154437540|NCT05762003|Teriflunomide|teriflunomide|mesh-list
154437541|NCT05762003|Rituximab|rituximab|mesh-list
154437542|NCT05762003|Alemtuzumab|alemtuzumab|mesh-list
154437543|NCT05762003|Ofatumumab|ofatumumab|mesh-list
154437544|NCT05762003|Cladribine|cladribine|mesh-list
154437545|NCT05762003|Glatiramer Acetate|glatiramer acetate|mesh-list
154437546|NCT05762003|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154437547|NCT05762003|Ocrelizumab|ocrelizumab|mesh-list
154437548|NCT05762003|Natalizumab|natalizumab|mesh-list
154437549|NCT05762003|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153782449|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437550|NCT05762003|(T,G)-A-L|(t,g)-a-l|mesh-list
154437551|NCT05762003|Ponesimod|ponesimod|mesh-list
154437552|NCT05762003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154437553|NCT05762003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437554|NCT05762003|Immunologic Factors|immunologic factors|mesh-ancestor
154437555|NCT05762003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437556|NCT05762003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154437557|NCT05762003|Antiviral Agents|antiviral agents|mesh-ancestor
154437558|NCT05762003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437559|NCT05762003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154437560|NCT05762003|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154012203|NCT01552434|Sirolimus|sirolimus|mesh-list
154437561|NCT05762003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437562|NCT05762003|Dermatologic Agents|dermatologic agents|mesh-ancestor
154437563|NCT05762003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154437564|NCT05762003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154437565|NCT05762003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154437566|NCT05762003|Analgesics|analgesics|mesh-ancestor
154437567|NCT05762003|Sensory System Agents|sensory system agents|mesh-ancestor
154437568|NCT05762003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437569|NCT05762003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154437570|NCT03001557|Lemborexant|lemborexant|mesh-list
154437571|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154437572|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437573|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437574|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154437575|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154437576|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437577|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437579|NCT03134612|Ondansetron|ondansetron|mesh-list
154437580|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
154437581|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
154437582|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437583|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437584|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
154437585|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437586|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154437587|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154437588|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154437589|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437590|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437591|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
154437592|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
154437593|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154437594|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
154437595|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
154437596|NCT03134612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154437597|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154437598|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
154437599|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437600|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154437601|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154437602|NCT04365985|Naltrexone|naltrexone|mesh-list
154437603|NCT04365985|Ketamine|ketamine|mesh-list
154437604|NCT04365985|Analgesics|analgesics|mesh-ancestor
154437605|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
154437606|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437607|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437608|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154437609|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154437610|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
154437611|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
154437612|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437613|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154437614|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154437615|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437616|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437617|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154437618|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154437619|NCT00830336|Azithromycin|azithromycin|mesh-list
154437620|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154437621|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437622|NCT00830258|Pravastatin|pravastatin|mesh-list
154437623|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154437624|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154437625|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
154437626|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437627|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154437628|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154437629|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437630|NCT00830102|Fluticasone|fluticasone|mesh-list
154437632|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
154437633|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154437634|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154437635|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
154437636|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437637|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437638|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154437639|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
154437640|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
154437641|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154437642|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154437643|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154437644|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154437645|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
154437646|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437647|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437648|NCT03349775|Metformin|metformin|mesh-list
154437649|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437650|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437651|NCT00830024|Alprazolam|alprazolam|mesh-list
154437652|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154437653|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437654|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437655|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154437656|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154437657|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154437658|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
154437659|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
154437660|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437661|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437662|NCT00829868|Zaleplon|zaleplon|mesh-list
154437663|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
154437664|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154437665|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437666|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437667|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
154437668|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
154437669|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437670|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437671|NCT00721760|Enoxaparin|enoxaparin|mesh-list
154437672|NCT00721760|Semuloparin|semuloparin|mesh-list
154437673|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
154437674|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
154437675|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154437676|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154437677|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437678|NCT00829790|Doxycycline|doxycycline|mesh-list
154437679|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153369642|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154437680|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437681|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
154437682|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154437683|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154437684|NCT03207815|Prednisone|prednisone|mesh-list
154437685|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154437686|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
154437687|NCT03207815|Hormones|hormones|mesh-ancestor
154437688|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437689|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437690|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154437691|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437692|NCT02911935|Azithromycin|azithromycin|mesh-list
154437693|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154437694|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437695|NCT05193487|Anesthetics|anesthetics|mesh-list
154437696|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437697|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437698|NCT03479762|Liraglutide|liraglutide|mesh-list
154437699|NCT03479762|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154437700|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437701|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437702|NCT03479762|Incretins|incretins|mesh-ancestor
154437703|NCT03479762|Hormones|hormones|mesh-ancestor
154437704|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437705|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154012354|NCT00041314|Gemcitabine|gemcitabine|mesh-list
154437706|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154437707|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437708|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154437709|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154437710|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154437711|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437712|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
154437713|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437714|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154437715|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154437716|NCT05079802|Chitosan|chitosan|mesh-list
154437717|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437718|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
154437719|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154437720|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154437721|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
154437722|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437723|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154437724|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
154437725|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
154437726|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
154437727|NCT05079802|Coagulants|coagulants|mesh-ancestor
154437728|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154437729|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
154437730|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
154437731|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437732|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
154437733|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437734|NCT03899636|Folfirinox|folfirinox|mesh-list
154437735|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437736|NCT03386942|Farletuzumab|farletuzumab|mesh-list
154437737|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437738|NCT04910230|Niacinamide|niacinamide|mesh-list
154437739|NCT04910230|Niacin|niacin|mesh-list
154437740|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
154437741|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
154437742|NCT04910230|Vitamins|vitamins|mesh-ancestor
154437743|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
154437744|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437745|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154437746|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
154437747|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437748|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154437749|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
154437750|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
154437751|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154437752|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437753|NCT04995094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154437754|NCT04995094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437755|NCT05202821|Fluorides|fluorides|mesh-list
154437756|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
154437757|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
154437758|NCT05202821|Protective Agents|protective agents|mesh-ancestor
154437759|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437760|NCT04615936|Methylene Blue|methylene blue|mesh-list
154437761|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437762|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437763|NCT03797222|Vitamin E|vitamin e|mesh-list
154437764|NCT03797222|Tocopherols|tocopherols|mesh-list
154437765|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
154437766|NCT03797222|Vitamins|vitamins|mesh-ancestor
154437767|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
153782450|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
154437768|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437769|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
154437770|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437771|NCT03797222|Protective Agents|protective agents|mesh-ancestor
154437772|NCT04471675|Docetaxel|docetaxel|mesh-list
154437773|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437774|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
154437775|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
154437776|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
154437777|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437778|NCT00716534|Paclitaxel|paclitaxel|mesh-list
154437779|NCT00716534|Carboplatin|carboplatin|mesh-list
154437780|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154437781|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437782|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
154437783|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
154437784|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
154437785|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437786|NCT02283476|Gemcitabine|gemcitabine|mesh-list
154437788|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437789|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154437790|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
154437791|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437792|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154437793|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154437794|NCT02283476|Growth Substances|growth substances|mesh-ancestor
154437795|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437796|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
154437797|NCT05156879|Aspirin|aspirin|mesh-list
154437798|NCT05156879|Drospirenone|drospirenone|mesh-list
154437799|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154437800|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154437801|NCT05156879|Estradiol|estradiol|mesh-list
154437802|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154437803|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154437804|NCT05156879|Analgesics|analgesics|mesh-ancestor
154437805|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
154437806|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437807|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437808|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154437809|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154437810|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154437811|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154437812|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437813|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154437814|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154437815|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437816|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
154437817|NCT05156879|Estrogens|estrogens|mesh-ancestor
154437818|NCT05156879|Hormones|hormones|mesh-ancestor
154437819|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437820|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154437821|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
154437822|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154437823|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154437824|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154437825|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154437826|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154437827|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
154437828|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154437830|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
154437831|NCT02283554|Metformin|metformin|mesh-list
154437832|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154437833|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437834|NCT00641732|Enoxaparin|enoxaparin|mesh-list
154437835|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
154437836|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
154437837|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154437838|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154437839|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437840|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154437841|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
154437842|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154437843|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
154437844|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437845|NCT00790829|Nicotine|nicotine|mesh-list
154437846|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154437847|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
154437848|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437849|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437850|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154437851|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154437852|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154437853|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437854|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437855|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154437856|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154437857|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
154437858|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012508|NCT00003614|Paclitaxel|paclitaxel|mesh-list
154437859|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437860|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154437861|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
154437862|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154437863|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154437864|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154437865|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
154437866|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437867|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437868|NCT03065933|Clonidine|clonidine|mesh-list
154437869|NCT03065933|Analgesics|analgesics|mesh-ancestor
154437870|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
154437871|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154437872|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437873|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154437874|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
154437875|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
154437876|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154437877|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154437878|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154437879|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
154437880|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437881|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437882|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
154437883|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437884|NCT04256629|Allopurinol|allopurinol|mesh-list
154437885|NCT04256629|Verinurad|verinurad|mesh-list
154437886|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
154437887|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437888|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437889|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
154437890|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154437891|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154437892|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
154437893|NCT04256629|Protective Agents|protective agents|mesh-ancestor
154437894|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360250|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
154437896|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154437897|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437898|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
154437899|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
154437900|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154437901|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154437902|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154437903|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437904|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437905|NCT05125523|Sirolimus|sirolimus|mesh-list
154437906|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154437907|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437908|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154437909|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437910|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
154437911|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154437912|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
154437913|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437914|NCT00625664|Gemcitabine|gemcitabine|mesh-list
154437915|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437916|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154437917|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
154437918|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437919|NCT02947165|Spartalizumab|spartalizumab|mesh-list
154437920|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154437921|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437922|NCT02947165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154437923|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437924|NCT03629093|Anesthetics|anesthetics|mesh-list
154437925|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
154437926|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154437927|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437928|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
154437929|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154437930|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437931|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437932|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154437933|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154437935|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437936|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
154437937|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154437938|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
154437939|NCT05055947|Atezolizumab|atezolizumab|mesh-list
154437940|NCT05055947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154437941|NCT05055947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437942|NCT05055947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154437943|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437944|NCT03943342|Venetoclax|venetoclax|mesh-list
154437945|NCT03943342|Ibrutinib|ibrutinib|mesh-list
154437946|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437947|NCT03943342|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154437948|NCT03943342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154437949|NCT03943342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437950|NCT03943342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437951|NCT00694928|Clindamycin|clindamycin|mesh-list
154437952|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
154437953|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
154437954|NCT00694928|Butoconazole|butoconazole|mesh-list
154437955|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154437956|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154437957|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154437958|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437959|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437960|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
154437961|NCT00694382|Semuloparin|semuloparin|mesh-list
154437962|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154437963|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154437964|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154437965|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437966|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
154437967|NCT05116228|Rituximab|rituximab|mesh-list
154437968|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154437969|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437970|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
154437971|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437972|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154437973|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
154437974|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154437975|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437976|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
154437977|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437978|NCT05116150|Protective Agents|protective agents|mesh-ancestor
154437979|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437980|NCT00136903|Cyclosporine|cyclosporine|mesh-list
154437981|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
154437982|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
153782453|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437983|NCT00136903|Prednisone|prednisone|mesh-list
154437984|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
154437985|NCT00136903|Tacrolimus|tacrolimus|mesh-list
154437986|NCT00136903|Cyclosporins|cyclosporins|mesh-list
154437987|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154437988|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
154437989|NCT00136903|Hormones|hormones|mesh-ancestor
154437990|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154437991|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154437992|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154437993|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154437994|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154437995|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
154437996|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154437997|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154437998|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154437999|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
154438000|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438001|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154438002|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438003|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154438004|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154438005|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
154012655|NCT05122481|Protective Agents|protective agents|mesh-ancestor
154438007|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
154438008|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
154438009|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438010|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438011|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154438012|NCT00136903|Protective Agents|protective agents|mesh-ancestor
154438013|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
154438014|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
154438015|NCT04917029|Bupivacaine|bupivacaine|mesh-list
154438016|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
154438017|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
154438018|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438019|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438020|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
154438021|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438022|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154438023|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154438024|NCT04917029|Analgesics|analgesics|mesh-ancestor
154438025|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154438026|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154438027|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154438028|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154438029|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438030|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360252|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438031|NCT04189510|Pancrelipase|pancrelipase|mesh-list
154438032|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438033|NCT03632759|Liraglutide|liraglutide|mesh-list
154438034|NCT03632759|Golimumab|golimumab|mesh-list
154438035|NCT03632759|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154438036|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438037|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438038|NCT03632759|Incretins|incretins|mesh-ancestor
154438039|NCT03632759|Hormones|hormones|mesh-ancestor
154438040|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438041|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154438042|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438043|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438044|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
154438045|NCT02953093|Acarbose|acarbose|mesh-list
154438046|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154438047|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438048|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438049|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438050|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438051|NCT04518280|Capecitabine|capecitabine|mesh-list
154438052|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
154438053|NCT04518280|Antibodies|antibodies|mesh-list
154438054|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
154438055|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438056|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154438057|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
154438058|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438059|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438060|NCT00498836|Sorafenib|sorafenib|mesh-list
154438061|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438062|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154438063|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438064|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438065|NCT02283866|Desflurane|desflurane|mesh-list
154438066|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154438067|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
154438068|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
154438069|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438070|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438071|NCT04517110|Pregabalin|pregabalin|mesh-list
154438072|NCT04517110|Analgesics|analgesics|mesh-ancestor
154438073|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
154438074|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438075|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438076|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
154438077|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154438078|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154012733|NCT02808728|Bupivacaine|bupivacaine|mesh-list
154438079|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438080|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154438081|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154438082|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154438083|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438084|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154438085|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
154438086|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154438087|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
154438088|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438090|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154438091|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438092|NCT02281058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154438093|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438094|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438095|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
154438096|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438097|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438098|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
154438099|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154438100|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154438101|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154438102|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438103|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438104|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
154438105|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438106|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438107|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154438108|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438109|NCT05205317|Metformin|metformin|mesh-list
154438110|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438111|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438112|NCT00691964|Etanercept|etanercept|mesh-list
154438113|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154438114|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154438115|NCT00691964|Analgesics|analgesics|mesh-ancestor
154438116|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
154438117|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782454|NCT00233792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782455|NCT00233792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369811|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
154438118|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438119|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438120|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438121|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438122|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438123|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
154438124|NCT02281292|Ranibizumab|ranibizumab|mesh-list
154438125|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154438126|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154438127|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154438128|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154438129|NCT02281292|Growth Substances|growth substances|mesh-ancestor
154438130|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438131|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
154438132|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438133|NCT02660827|Insulin|insulin|mesh-list
154438134|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438135|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438136|NCT00491738|Bevacizumab|bevacizumab|mesh-list
154438137|NCT00491738|Sunitinib|sunitinib|mesh-list
154438138|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154438139|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438140|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154438141|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154438142|NCT00491738|Growth Substances|growth substances|mesh-ancestor
154438143|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438144|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
154438145|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154438146|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438147|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438148|NCT02281370|Cyclosporine|cyclosporine|mesh-list
154438149|NCT02281370|Cyclosporins|cyclosporins|mesh-list
154438150|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438151|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438152|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438153|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
154438154|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438155|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
154438156|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438157|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
153814406|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154438158|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438159|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154438161|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
154438162|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438163|NCT00680342|Protective Agents|protective agents|mesh-ancestor
154438164|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438165|NCT04057365|Nivolumab|nivolumab|mesh-list
154438166|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154438167|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438168|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154438169|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438170|NCT00616148|Cenobamate|cenobamate|mesh-list
154438171|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
154438172|NCT03622827|Endostar protein|endostar protein|mesh-list
154438173|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154438174|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154438175|NCT03622827|Growth Substances|growth substances|mesh-ancestor
154438176|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438177|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
154438178|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438179|NCT00486512|Aspirin|aspirin|mesh-list
154438180|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
154438181|NCT00486512|Calcitriol|calcitriol|mesh-list
154438182|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154438183|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
154438184|NCT00486512|Calcium|calcium|mesh-list
154438185|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154438186|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438187|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154438188|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154438189|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154438190|NCT00486512|Analgesics|analgesics|mesh-ancestor
154438191|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
154438192|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438193|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438194|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438195|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153782456|NCT00233792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782457|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153731839|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438196|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154438197|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438198|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154438199|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154438200|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438201|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
154438202|NCT00486512|Antacids|antacids|mesh-ancestor
154438203|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438204|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154438205|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438206|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154438207|NCT00486512|Vitamins|vitamins|mesh-ancestor
154438208|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
154438209|NCT04057989|Ketamine|ketamine|mesh-list
154438210|NCT04057989|Analgesics|analgesics|mesh-ancestor
154438211|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
154438212|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438213|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438214|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154438215|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154438216|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
154438217|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
154438218|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438219|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154438220|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154438221|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438222|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438223|NCT00486200|Valacyclovir|valacyclovir|mesh-list
154438224|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
154438225|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438226|NCT00479258|Insulin|insulin|mesh-list
154438227|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154438228|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154012878|NCT00610103|Apomorphine|apomorphine|mesh-list
154438229|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438231|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
154438232|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154438233|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153816661|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154438234|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154438235|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438236|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438237|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
154438238|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438239|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438240|NCT05068336|Anesthetics|anesthetics|mesh-list
154438241|NCT05068336|Sevoflurane|sevoflurane|mesh-list
154438242|NCT05068336|Desflurane|desflurane|mesh-list
154438243|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438244|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438245|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154438246|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154438247|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
154438248|NCT00607256|Reboxetine|reboxetine|mesh-list
154438249|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
154438250|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154438251|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154438252|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154438253|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438254|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438255|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154438256|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438257|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438258|NCT02774590|Timolol|timolol|mesh-list
154438259|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154438260|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154438261|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
154438262|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438263|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438264|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438265|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154438266|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154438267|NCT01069341|Ranibizumab|ranibizumab|mesh-list
154438268|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154438269|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154438270|NCT01069341|Growth Substances|growth substances|mesh-ancestor
154438271|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438272|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
154438273|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438274|NCT00676832|Prednisolone|prednisolone|mesh-list
154438275|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154438276|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
154438277|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154438278|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
154438279|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154438280|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
154438281|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438282|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
154438283|NCT00676832|Hormones|hormones|mesh-ancestor
154438284|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438285|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438286|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154438287|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438288|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
154438289|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
154438290|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438291|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438292|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154438293|NCT00676832|Protective Agents|protective agents|mesh-ancestor
154438294|NCT01909414|Vaccines|vaccines|mesh-list
154438295|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
154438296|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438297|NCT00467402|Agomelatine|agomelatine|mesh-list
154438298|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154438299|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438300|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438301|NCT02996097|Triamcinolone|triamcinolone|mesh-list
154438302|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154438303|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154438304|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154438305|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438307|NCT02996097|Hormones|hormones|mesh-ancestor
154438308|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438309|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438310|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438311|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
154438312|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438313|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438314|NCT04054713|Acetic Acid|acetic acid|mesh-list
154438315|NCT04054713|Retinol acetate|retinol acetate|mesh-list
154438316|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154438317|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438318|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154438319|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
154438320|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438321|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154438322|NCT04054713|Protective Agents|protective agents|mesh-ancestor
154438323|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438324|NCT03314181|Dexamethasone|dexamethasone|mesh-list
154438325|NCT03314181|Bortezomib|bortezomib|mesh-list
154438326|NCT03314181|Venetoclax|venetoclax|mesh-list
154438327|NCT03314181|Daratumumab|daratumumab|mesh-list
154438328|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438329|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
154438330|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
154438331|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438332|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438333|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438334|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
154438335|NCT03314181|Hormones|hormones|mesh-ancestor
154438336|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438337|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154438338|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438339|NCT03133832|Praziquantel|praziquantel|mesh-list
154438340|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
154438341|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154438342|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438343|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
154438344|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154438345|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438346|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438347|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154438348|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154438349|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438350|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438352|NCT04161430|Hormones|hormones|mesh-ancestor
154438353|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438354|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154438355|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
154438356|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438357|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438358|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
154438359|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154438360|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154438361|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
154438362|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438363|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438364|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154438365|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
154438366|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
154438367|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154438368|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
154438369|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438370|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438371|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154438372|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154438373|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154438374|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
154438375|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
154438376|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154438377|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
154438378|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438379|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438380|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154438381|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
154438382|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
154438383|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154438384|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
154438385|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438386|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438387|NCT00672386|Metformin|metformin|mesh-list
154438388|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438389|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438390|NCT04056897|Teriflunomide|teriflunomide|mesh-list
154438391|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154438392|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154438393|NCT04056897|Analgesics|analgesics|mesh-ancestor
154438394|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
154438395|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438396|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438397|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438398|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438399|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438400|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
154438401|NCT02281682|Fluorouracil|fluorouracil|mesh-list
154438402|NCT02281682|Imiquimod|imiquimod|mesh-list
154438403|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154438404|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
154438405|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438406|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153782458|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438407|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438408|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438409|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
154438410|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438411|NCT02281682|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154438412|NCT02281682|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154067020|NCT02619149|Tazobactam|tazobactam|mesh-list
154438413|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154438414|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
154438415|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154438416|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
154438417|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154438418|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154438419|NCT04056975|Antibodies|antibodies|mesh-list
154438420|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
154438421|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438422|NCT02281916|Immunomodulating Agents|immunomodulating agents|mesh-list
154438423|NCT02281916|Immunologic Factors|immunologic factors|mesh-ancestor
154438424|NCT02281916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438425|NCT03662763|Guanfacine|guanfacine|mesh-list
154438426|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154438427|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154438428|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154438429|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154438430|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
154438431|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438432|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438433|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438434|NCT00458978|Cediranib|cediranib|mesh-list
154438435|NCT00458978|Maleic acid|maleic acid|mesh-list
154438436|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438437|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438438|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438439|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154438440|NCT00458276|Tezosentan|tezosentan|mesh-list
154438441|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
154438442|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
154438443|NCT04520074|Carboplatin|carboplatin|mesh-list
154438444|NCT04520074|Etoposide|etoposide|mesh-list
154438445|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438446|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
154438447|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438448|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438449|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154438450|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
154438451|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438452|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438453|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154438454|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154438455|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154438456|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154438458|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154438459|NCT00455156|ST 1435|st 1435|mesh-list
154438460|NCT00455156|Estradiol|estradiol|mesh-list
154438461|NCT00455156|Estrogens|estrogens|mesh-ancestor
154438462|NCT00455156|Hormones|hormones|mesh-ancestor
154438463|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438464|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438465|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154438466|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
154438467|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154438468|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154438469|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154438470|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154438471|NCT03661515|Cytarabine|cytarabine|mesh-list
154438472|NCT03661515|Fludarabine|fludarabine|mesh-list
154438473|NCT03661515|Idarubicin|idarubicin|mesh-list
154438474|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438475|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154438476|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
154438477|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438478|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438479|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
154438480|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438481|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
154438482|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438483|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154438484|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154438485|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154438486|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438487|NCT01624480|Modafinil|modafinil|mesh-list
154438488|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154438489|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438490|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154438491|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154438492|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154438493|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438494|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154438495|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154438496|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154438497|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438498|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438499|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438500|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438501|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154438502|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
154438503|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154438505|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154438506|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438507|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438508|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
154438509|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438510|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438511|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154438512|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
154438513|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438514|NCT02284490|Pemetrexed|pemetrexed|mesh-list
154438515|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438516|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438517|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438518|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154438519|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154438520|NCT02273570|Vitamin D|vitamin d|mesh-list
154438521|NCT02273570|Calcium|calcium|mesh-list
154438522|NCT02273570|Vitamins|vitamins|mesh-ancestor
154438523|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
154438524|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176584|NCT00620555|Analgesics|analgesics|mesh-ancestor
154438525|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154438526|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154438528|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154438529|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154438530|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154438531|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438532|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
154438533|NCT00579020|Dexamethasone|dexamethasone|mesh-list
154438534|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
154438535|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154438536|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154438537|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154438538|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154438539|NCT00579020|BB 1101|bb 1101|mesh-list
154438540|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438541|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
154438542|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
154438543|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438544|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438545|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438546|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
154438547|NCT00579020|Hormones|hormones|mesh-ancestor
154438548|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438549|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154438550|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438551|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
154438552|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438553|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438554|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154438555|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438556|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154438557|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154438558|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154438559|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
154438560|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154254814|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
154438561|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154438562|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154438563|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154438564|NCT04530604|Defibrotide|defibrotide|mesh-list
154438565|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154438566|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154438567|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438568|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154438569|NCT04169698|Denosumab|denosumab|mesh-list
154438570|NCT04169698|Alendronate|alendronate|mesh-list
154438571|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154438572|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438573|NCT04470752|Capsaicin|capsaicin|mesh-list
154438574|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154438575|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
154438576|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
154438577|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
154438578|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438579|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438580|NCT02273804|Topiramate|topiramate|mesh-list
154438581|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
154438582|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438583|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438584|NCT00578474|Ofloxacin|ofloxacin|mesh-list
154438585|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154438586|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154438587|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438588|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154438589|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154438590|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154438591|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438592|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438593|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438594|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154438595|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154438596|NCT00577148|Rimonabant|rimonabant|mesh-list
154013250|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
154438597|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154438598|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154438599|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154438600|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438601|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438602|NCT00577148|Hormones|hormones|mesh-ancestor
154438603|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438604|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438605|NCT03673228|Nicotine|nicotine|mesh-list
154438606|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154438607|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
154438608|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438609|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438610|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154438611|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154438612|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
154438613|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438614|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438615|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
154438616|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154438617|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
154438618|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438619|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
154438620|NCT05116306|Protective Agents|protective agents|mesh-ancestor
154438621|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154438622|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
154438623|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438624|NCT00570752|Atorvastatin|atorvastatin|mesh-list
154438625|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154438626|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154438627|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
154438628|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438629|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154438630|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154438631|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438632|NCT02282384|Oseltamivir|oseltamivir|mesh-list
154438633|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
154438634|NCT02282384|Antacids|antacids|mesh-ancestor
154438635|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438636|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438637|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
154438638|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438639|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438640|NCT02989389|Itraconazole|itraconazole|mesh-list
154438641|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
154438642|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438643|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154438644|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154438645|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438646|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438647|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154438648|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
154438649|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438650|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438651|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154438652|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154438653|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
154438654|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438655|NCT03187509|Torsemide|torsemide|mesh-list
154438656|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154438657|NCT03187509|Diuretics|diuretics|mesh-ancestor
154438658|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
154438659|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438660|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154438661|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438662|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438663|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154438664|NCT00430508|Olmesartan|olmesartan|mesh-list
154438665|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154438666|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154438667|NCT00430508|Diuretics|diuretics|mesh-ancestor
154438668|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
154438669|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438670|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154438671|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438672|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438673|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154438674|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154438675|NCT04221880|Lidocaine|lidocaine|mesh-list
154438676|NCT04221880|Bupivacaine|bupivacaine|mesh-list
154438677|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154438678|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
154438679|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
154438680|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438681|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438682|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
154438683|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438684|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154438685|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154438686|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154438687|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438688|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438689|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
154438690|NCT04055415|Expectorants|expectorants|mesh-list
154438691|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
154438692|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438693|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438694|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154438695|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
154438696|NCT00427856|Rituximab|rituximab|mesh-list
154438697|NCT00427856|Obatoclax|obatoclax|mesh-list
154438698|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154438699|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438700|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
154438701|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438702|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438703|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438704|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438705|NCT00427154|Insulin|insulin|mesh-list
154438707|NCT00427154|Glimepiride|glimepiride|mesh-list
154438708|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
154438709|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154438710|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438711|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438712|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154438713|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438714|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
154438715|NCT02988219|Epinephrine|epinephrine|mesh-list
154438716|NCT02988219|Fentanyl|fentanyl|mesh-list
154438717|NCT02988219|Bupivacaine|bupivacaine|mesh-list
154438718|NCT02988219|Anesthetics|anesthetics|mesh-list
154438719|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
154438720|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438721|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438722|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
154438723|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438724|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154438725|NCT02988219|Narcotics|narcotics|mesh-ancestor
154438726|NCT02988219|Analgesics|analgesics|mesh-ancestor
154438727|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154438728|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154438729|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
154438730|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154438731|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154438732|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
154438733|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438734|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438735|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154438736|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154438737|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
154438738|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154438739|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
154438740|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
154438741|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
154438742|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154438743|NCT01346059|Vancomycin|vancomycin|mesh-list
154438744|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154438745|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438746|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
154438747|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
154438749|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438750|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438751|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
154438752|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154438753|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154438754|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
154438755|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438756|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438757|NCT04548973|Esketamine|esketamine|mesh-list
154438758|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
154438759|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154438760|NCT02277938|Amantadine|amantadine|mesh-list
154438761|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154438762|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154438763|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
154438764|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438765|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
154438766|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438767|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438768|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438769|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154438770|NCT02277938|Analgesics|analgesics|mesh-ancestor
154438771|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
154438772|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438773|NCT00415142|Escitalopram|escitalopram|mesh-list
154438774|NCT00415142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154438775|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154438776|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154438777|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438778|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438779|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
154438780|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438781|NCT03661125|Saracatinib|saracatinib|mesh-list
154438782|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438783|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438784|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438785|NCT00413114|Obatoclax|obatoclax|mesh-list
154438786|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438787|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438788|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
154438789|NCT01318915|Sirolimus|sirolimus|mesh-list
154438790|NCT01318915|Rituximab|rituximab|mesh-list
154438791|NCT01318915|Tacrolimus|tacrolimus|mesh-list
154438792|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
154438793|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154438794|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154438795|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438796|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
154438797|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438798|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438799|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438800|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154438801|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438802|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438803|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154438804|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154438805|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
154438806|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154438807|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438808|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
154438809|NCT04688177|Nicotine|nicotine|mesh-list
154438810|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
154438811|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154438812|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
154438813|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438814|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438815|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154438816|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154438817|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
154438818|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438819|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438820|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
154438821|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
154438822|NCT00411242|Agomelatine|agomelatine|mesh-list
154438823|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154438824|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438825|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438826|NCT00402428|Interferons|interferons|mesh-list
154438827|NCT00402428|Ribavirin|ribavirin|mesh-list
154438828|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
154438829|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
154438830|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154438831|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438832|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
154438833|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438834|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
154438835|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438836|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
154438837|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438838|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
154438839|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154438840|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154438841|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438842|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
154438843|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
154438844|NCT03660267|Caffeine|caffeine|mesh-list
154438845|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154438846|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782461|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438847|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154438848|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438849|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438850|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154438851|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154438852|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
154438853|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438854|NCT03950245|Glucagon|glucagon|mesh-list
154438855|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154438856|NCT03950245|Incretins|incretins|mesh-ancestor
154438857|NCT03950245|Hormones|hormones|mesh-ancestor
154438858|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438859|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438860|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438861|NCT00401570|Gemcitabine|gemcitabine|mesh-list
154438862|NCT00401570|Volociximab|volociximab|mesh-list
154438863|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154438864|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
154438865|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438866|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438867|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154438868|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154438869|NCT00401570|Growth Substances|growth substances|mesh-ancestor
154438870|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438871|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
154438872|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
154438873|NCT05193565|Sirolimus|sirolimus|mesh-list
154438874|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154438875|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438876|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154438877|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
154438878|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154438879|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438880|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438881|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438882|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
154438883|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438884|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
154438885|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438886|NCT04471922|Rabeprazole|rabeprazole|mesh-list
154438887|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154438888|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438889|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154438890|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438891|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438892|NCT04368364|Morphine|morphine|mesh-list
154438893|NCT04368364|Bupivacaine|bupivacaine|mesh-list
154438894|NCT04368364|Ropivacaine|ropivacaine|mesh-list
154438895|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
154438896|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
154438897|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438898|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438899|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
154438900|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438901|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154438902|NCT04368364|Narcotics|narcotics|mesh-ancestor
154438903|NCT04368364|Analgesics|analgesics|mesh-ancestor
154438904|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154438905|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
154438906|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438907|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
154438908|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438909|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
154438910|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154438911|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154438912|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154438913|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438914|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438915|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438916|NCT05229796|Empagliflozin|empagliflozin|mesh-list
154438917|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154438918|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438919|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154438920|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438921|NCT00151892|Mesalamine|mesalamine|mesh-list
154438922|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154438923|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154438924|NCT00151892|Analgesics|analgesics|mesh-ancestor
154438925|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
154438926|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438927|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438928|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438929|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154438930|NCT02740127|Dexamethasone|dexamethasone|mesh-list
154438931|NCT02740127|Clonidine|clonidine|mesh-list
154438932|NCT02740127|Epinephrine|epinephrine|mesh-list
154438933|NCT02740127|Propofol|propofol|mesh-list
153370178|NCT02723500|Xenon|xenon|mesh-list
154438934|NCT02740127|Ropivacaine|ropivacaine|mesh-list
154438935|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154438936|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
154438937|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
154438938|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154438939|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438940|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154438941|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
154438942|NCT02740127|Hormones|hormones|mesh-ancestor
154438943|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154438944|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154438945|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438946|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438947|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154438948|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154438949|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154438950|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
154438951|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
154438952|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
154438953|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
154438954|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154438955|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154438956|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
154438957|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154438958|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154438959|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154438960|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154438961|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
154438962|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
154438963|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
154438964|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154438965|NCT02740127|Analgesics|analgesics|mesh-ancestor
154438966|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154438967|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
154438968|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154438969|NCT04450498|Vaccines|vaccines|mesh-list
154438970|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
154438971|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438972|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
154013638|NCT00941239|Metformin|metformin|mesh-list
154438973|NCT00654992|Hematinics|hematinics|mesh-ancestor
154438974|NCT02921919|Talazoparib|talazoparib|mesh-list
154438975|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154438976|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154438977|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438978|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438979|NCT00393068|Paclitaxel|paclitaxel|mesh-list
154438980|NCT00393068|Bevacizumab|bevacizumab|mesh-list
154438981|NCT00393068|Carboplatin|carboplatin|mesh-list
154438982|NCT00393068|Fluorouracil|fluorouracil|mesh-list
154438983|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154438984|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154438985|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154438986|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
154438987|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
154438988|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
154438989|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154438990|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154438991|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154438992|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154438993|NCT00393068|Growth Substances|growth substances|mesh-ancestor
154438994|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154438995|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
154438996|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
154438997|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154438998|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154438999|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
154439000|NCT00393068|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154439001|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154439002|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439003|NCT02280278|Immunomodulating Agents|immunomodulating agents|mesh-list
154439004|NCT02280278|Immunologic Factors|immunologic factors|mesh-ancestor
154439005|NCT02280278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439007|NCT04769401|Progestins|progestins|mesh-ancestor
154439008|NCT04769401|Hormones|hormones|mesh-ancestor
154439009|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439010|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439011|NCT02094222|Glycerol|glycerol|mesh-list
154439012|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154439013|NCT02094222|Protective Agents|protective agents|mesh-ancestor
154439014|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439015|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154439016|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154439017|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154439018|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
154439019|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439020|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154439021|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154439022|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439023|NCT02090244|Teriparatide|teriparatide|mesh-list
154439024|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154439025|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439026|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154439027|NCT02282774|Lidocaine|lidocaine|mesh-list
154439028|NCT02282774|Bupivacaine|bupivacaine|mesh-list
154439029|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
154439030|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
154439031|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439032|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439033|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
154439034|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439035|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154439036|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154439037|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154439038|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154439039|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439040|NCT02090322|Bevacizumab|bevacizumab|mesh-list
154439041|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154439042|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439043|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154439044|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154439045|NCT02090322|Growth Substances|growth substances|mesh-ancestor
154013706|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
154439047|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
154439048|NCT02095782|Paclitaxel|paclitaxel|mesh-list
154439049|NCT02095782|Carboplatin|carboplatin|mesh-list
154439050|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154439051|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154439052|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439053|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
154439054|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
154439055|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
154439056|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439057|NCT02095782|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154439058|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154439059|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439060|NCT02094378|Esketamine|esketamine|mesh-list
154439061|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
154439062|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154439063|NCT02285738|Aspirin|aspirin|mesh-list
154439064|NCT02285738|Simvastatin|simvastatin|mesh-list
154439065|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154439066|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439067|NCT02285738|Analgesics|analgesics|mesh-ancestor
154439068|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
154439069|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439070|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439071|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439072|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439073|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154439074|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154439075|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439076|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154439077|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154439078|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439079|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
154439080|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154439081|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154439082|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
154439083|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154439084|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154439086|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154439087|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154439088|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
154439089|NCT02090400|Calcium|calcium|mesh-list
154439090|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154439091|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439092|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154439093|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154439094|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
154439095|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439096|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154439097|NCT03134846|Cetuximab|cetuximab|mesh-list
154439098|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154439099|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439100|NCT01068717|Metformin|metformin|mesh-list
154439101|NCT01068717|Saxagliptin|saxagliptin|mesh-list
154439102|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154439103|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439104|NCT01068717|Incretins|incretins|mesh-ancestor
154439105|NCT01068717|Hormones|hormones|mesh-ancestor
154439106|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439107|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154439108|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
154439109|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439110|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439111|NCT02095938|Amisulpride|amisulpride|mesh-list
154439112|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154439113|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154439114|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439115|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439116|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154439117|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154439118|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
154439119|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439120|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439121|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154439122|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
153782463|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782464|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782466|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153782467|NCT00556270|Narcotics|narcotics|mesh-ancestor
153782468|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439123|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154439124|NCT02285972|Tenoxicam|tenoxicam|mesh-list
154439125|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154439126|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439127|NCT02285972|Analgesics|analgesics|mesh-ancestor
154439128|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
154439129|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439130|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439131|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439132|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439133|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154439134|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439135|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439136|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
154439137|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154439138|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439139|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
154439140|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
154439141|NCT02921763|Progestins|progestins|mesh-ancestor
154439142|NCT02921763|Hormones|hormones|mesh-ancestor
154439143|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439144|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439145|NCT03658473|Naproxen|naproxen|mesh-list
154439146|NCT03658473|Rabeprazole|rabeprazole|mesh-list
154439147|NCT03658473|Rebamipide|rebamipide|mesh-list
154439148|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154439149|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439150|NCT03658473|Analgesics|analgesics|mesh-ancestor
154439151|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
154439152|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067769|NCT00702182|Vinorelbine|vinorelbine|mesh-list
154439153|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439154|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439156|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
154439157|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154439158|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439159|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439160|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154439161|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816662|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439162|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154439163|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
154439164|NCT03658473|Protective Agents|protective agents|mesh-ancestor
154439165|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
154439166|NCT02096250|Edetic Acid|edetic acid|mesh-list
154439167|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
154439168|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
154439169|NCT02096250|Trace Elements|trace elements|mesh-ancestor
154439170|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
154439171|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439172|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154439173|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
154439174|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
154439175|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439176|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
154439177|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154439178|NCT02096250|Hematinics|hematinics|mesh-ancestor
154439179|NCT02096328|Murepavadin|murepavadin|mesh-list
154439180|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154439181|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439182|NCT01318135|Metformin|metformin|mesh-list
154439183|NCT01318135|Glimepiride|glimepiride|mesh-list
154439184|NCT01318135|Alogliptin|alogliptin|mesh-list
154439185|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154439186|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439187|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154439188|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154439189|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
154439190|NCT01318135|Incretins|incretins|mesh-ancestor
154439191|NCT01318135|Hormones|hormones|mesh-ancestor
154439192|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439193|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154013852|NCT00637988|Aspirin|aspirin|mesh-list
154439194|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
154439195|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439196|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439197|NCT02094924|Candesartan|candesartan|mesh-list
154439198|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
153782469|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816663|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439199|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154439200|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154439201|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154439202|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439203|NCT02286206|Clozapine|clozapine|mesh-list
154439204|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154439205|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
154439206|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439207|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439208|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439209|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154439210|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154439211|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439212|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154439213|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
154439214|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
154439215|NCT03104283|Apatinib|apatinib|mesh-list
154439216|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439217|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154439218|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439219|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439220|NCT00529178|Pravastatin|pravastatin|mesh-list
154439221|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154439222|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154439223|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
154439224|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439225|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154439226|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154439227|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439228|NCT00382460|Pravastatin|pravastatin|mesh-list
154439229|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154439230|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154439231|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
154439232|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439233|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153370311|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
154439234|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154439235|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439236|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154439237|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154439238|NCT02286596|Heparin|heparin|mesh-list
154439239|NCT02286596|Dextrans|dextrans|mesh-list
154439240|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
154439241|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154439242|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154439243|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439244|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
154439245|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
154439246|NCT02098824|Methylphenidate|methylphenidate|mesh-list
154439247|NCT02098824|Galantamine|galantamine|mesh-list
154439248|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154439249|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439250|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154439251|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154439252|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154439253|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439254|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
154439255|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439256|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154439257|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439258|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
154439259|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154439260|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
154439261|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439262|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
154439263|NCT03658317|Uric Acid|uric acid|mesh-list
154439264|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
154439265|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439266|NCT03658317|Protective Agents|protective agents|mesh-ancestor
154439267|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439268|NCT02286752|Neostigmine|neostigmine|mesh-list
154013928|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154439269|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154439270|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782470|NCT00556270|Analgesics|analgesics|mesh-ancestor
153360253|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439271|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439272|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
154439273|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439274|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439275|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154439276|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
154439277|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439278|NCT02095314|Vaccines|vaccines|mesh-list
154439279|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
154439280|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439281|NCT02098980|Vitamin D|vitamin d|mesh-list
154439282|NCT02098980|Vitamins|vitamins|mesh-ancestor
154439283|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
154439284|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439285|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154439286|NCT00372944|Capecitabine|capecitabine|mesh-list
154439287|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154439288|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
154439289|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439290|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439291|NCT02099136|Celecoxib|celecoxib|mesh-list
154439292|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154439293|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439294|NCT02099136|Analgesics|analgesics|mesh-ancestor
154439295|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
154439296|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439297|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439298|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439299|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439300|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154439301|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154439302|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439303|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439304|NCT00117650|Etoposide|etoposide|mesh-list
154439305|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
154439306|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154439307|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439308|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154439309|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154439310|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439311|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439312|NCT02095548|Lorecivivint|lorecivivint|mesh-list
154439313|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439314|NCT00113438|Paclitaxel|paclitaxel|mesh-list
154439315|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
154439316|NCT00113438|Combretastatin|combretastatin|mesh-list
154439317|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154439318|NCT00113438|Carboplatin|carboplatin|mesh-list
154439319|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154439320|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439321|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
154439322|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
154439323|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
154439324|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439325|NCT04087408|Hormones|hormones|mesh-list
154439326|NCT04087408|Progesterone|progesterone|mesh-list
154439327|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439328|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439329|NCT04087408|Progestins|progestins|mesh-ancestor
154439330|NCT02099292|Rituximab|rituximab|mesh-list
154439331|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154439332|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439333|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
154439334|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439335|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439336|NCT02283242|Galantamine|galantamine|mesh-list
154439337|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154439338|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439339|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439340|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
154439341|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439342|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439343|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154439344|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
154439345|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439346|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
154439348|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439349|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
154439350|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
154439351|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
154439352|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439353|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154439354|NCT03556098|Hormones|hormones|mesh-list
154439355|NCT03556098|Incretins|incretins|mesh-list
154439356|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439357|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439358|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154439359|NCT02286986|Cannabidiol|cannabidiol|mesh-list
154439360|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
154439361|NCT04995874|Micronutrients|micronutrients|mesh-list
154439362|NCT04995874|Trace Elements|trace elements|mesh-list
154439363|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439364|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
154439365|NCT02287064|Antibodies|antibodies|mesh-list
154439366|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
154439367|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154439368|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154439369|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
154439370|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439371|NCT02095704|Acetaminophen|acetaminophen|mesh-list
154439372|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439373|NCT02095704|Analgesics|analgesics|mesh-ancestor
154439374|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
154254819|NCT01144754|Rituximab|rituximab|mesh-list
154439375|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439376|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439378|NCT02099604|Vitamin D|vitamin d|mesh-list
154439379|NCT02099604|Interferons|interferons|mesh-list
154439380|NCT02099604|Ribavirin|ribavirin|mesh-list
154439381|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
154439382|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
154439383|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154439384|NCT02099604|Vitamins|vitamins|mesh-ancestor
154439385|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
154439386|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439387|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154439388|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439389|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
153782472|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439390|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439391|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
154439392|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439393|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
154439394|NCT02099916|Menotropins|menotropins|mesh-list
154439395|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439396|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154439397|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
154439398|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154439399|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154439400|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
154439401|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154439402|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
154439403|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154439404|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439405|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154439406|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154439407|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439408|NCT00366704|Risperidone|risperidone|mesh-list
154439409|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154439410|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
154439411|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439412|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439413|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439414|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154439415|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154439416|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439417|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154439418|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154014111|NCT00768651|Hormones|hormones|mesh-ancestor
154439419|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
154439420|NCT02097264|Adalimumab|adalimumab|mesh-list
154439421|NCT02097264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154439422|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439423|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439425|NCT02097342|Voglibose|voglibose|mesh-list
154439426|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154439427|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439428|NCT02097342|Incretins|incretins|mesh-ancestor
154439429|NCT02097342|Hormones|hormones|mesh-ancestor
154439430|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439431|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154439432|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
154439433|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439434|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439435|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154439436|NCT04294498|Entecavir|entecavir|mesh-list
154439437|NCT04294498|Durvalumab|durvalumab|mesh-list
154439438|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154439439|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439440|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
154439441|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439442|NCT00359450|Taxane|taxane|mesh-list
154439443|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439444|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
154439445|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
154439446|NCT03530462|Rituximab|rituximab|mesh-list
154439447|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
154439448|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154439449|NCT03530462|Antibodies|antibodies|mesh-list
154439450|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
154439451|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154068058|NCT00826280|Caffeine|caffeine|mesh-list
154439453|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
154439454|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439455|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439456|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154439457|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
154439458|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439459|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439460|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154439461|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154439462|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439463|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
154439464|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
154439465|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439466|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154439467|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
154439468|NCT03530462|Hormones|hormones|mesh-ancestor
154439469|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439470|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154439471|NCT03530462|Protective Agents|protective agents|mesh-ancestor
154439472|NCT02103192|Antioxidants|antioxidants|mesh-list
154439473|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439474|NCT02103192|Protective Agents|protective agents|mesh-ancestor
154439475|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439476|NCT02097810|Entrectinib|entrectinib|mesh-list
154439477|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154439478|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439479|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439480|NCT02100462|Aspirin|aspirin|mesh-list
154439481|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154439482|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
154439483|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154439484|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439485|NCT02100462|Analgesics|analgesics|mesh-ancestor
154439486|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
154439487|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439488|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439489|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439490|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439491|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154439492|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154439493|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439494|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154439495|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154439496|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439497|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
154439498|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154439499|NCT02100462|Diuretics|diuretics|mesh-ancestor
154439500|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
154439501|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154439502|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154439503|NCT00150176|Asenapine|asenapine|mesh-list
154439504|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154439505|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154439506|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439507|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439508|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154439509|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
154439510|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439511|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
154439512|NCT02100852|Chlorambucil|chlorambucil|mesh-list
154439513|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153731845|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153731846|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153731847|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154439514|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439515|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154439516|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
154439517|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439518|NCT00057980|Celecoxib|celecoxib|mesh-list
154439519|NCT00057980|Epirubicin|epirubicin|mesh-list
154439520|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154439521|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439522|NCT00057980|Analgesics|analgesics|mesh-ancestor
154439523|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
154439524|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068133|NCT02614937|Squalamine|squalamine|mesh-list
154439525|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439526|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439527|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439528|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154439529|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154439530|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439531|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439532|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154439533|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439534|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154439535|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154439536|NCT02985879|Tilavonemab|tilavonemab|mesh-list
154439537|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
154439539|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
154439540|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
154439541|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439542|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
154439543|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439544|NCT00052598|Aldesleukin|aldesleukin|mesh-list
154439545|NCT00052598|Interleukin-2|interleukin-2|mesh-list
154439546|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439547|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439548|NCT00052598|Analgesics|analgesics|mesh-ancestor
154439549|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
154439550|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439551|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439552|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154439553|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154439554|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
154439555|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439556|NCT05037994|Prednisolone|prednisolone|mesh-list
154439557|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154439558|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
154439559|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154439560|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
154439561|NCT05037994|Gabapentin|gabapentin|mesh-list
154439562|NCT05037994|Bupivacaine|bupivacaine|mesh-list
154439563|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154439564|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
154439565|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439566|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
154439567|NCT05037994|Hormones|hormones|mesh-ancestor
154439568|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439569|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439570|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154439571|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439572|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
154439573|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
154439574|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439575|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154439576|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154439577|NCT05037994|Protective Agents|protective agents|mesh-ancestor
154439578|NCT05037994|Analgesics|analgesics|mesh-ancestor
154439579|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
154439580|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
154439581|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154439582|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154439583|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439584|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154439585|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154439586|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154439587|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439588|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439589|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
154439590|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
154439591|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
154439592|NCT00052520|Aldesleukin|aldesleukin|mesh-list
154439593|NCT00052520|Interleukin-2|interleukin-2|mesh-list
154439594|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439595|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439596|NCT00052520|Analgesics|analgesics|mesh-ancestor
154439597|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
154439598|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439599|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439600|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154439601|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154439603|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439604|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
154439605|NCT05036434|Lenvatinib|lenvatinib|mesh-list
154439606|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154439607|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439608|NCT05036434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154439609|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439610|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154439611|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439612|NCT00051038|Entecavir|entecavir|mesh-list
154439613|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
154439614|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439615|NCT05035186|Amoxicillin|amoxicillin|mesh-list
154439616|NCT05035186|Clarithromycin|clarithromycin|mesh-list
154439617|NCT05035186|Levofloxacin|levofloxacin|mesh-list
154439618|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154439619|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439620|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154439621|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439622|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439623|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154439624|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154439625|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154439626|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154439627|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154439628|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439629|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154439630|NCT01067469|Bevacizumab|bevacizumab|mesh-list
154439631|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154439632|NCT01067469|Lomustine|lomustine|mesh-list
154439633|NCT01067469|Antibodies|antibodies|mesh-list
154439634|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
154439635|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154439636|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439637|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154439638|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154439639|NCT01067469|Growth Substances|growth substances|mesh-ancestor
154439640|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439641|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
154439642|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
154439643|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154439644|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
154439645|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439646|NCT00050102|Ipilimumab|ipilimumab|mesh-list
154439647|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014303|NCT06004947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439648|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439649|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154439650|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439651|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154439652|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
154439653|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
154439654|NCT02103660|Progestins|progestins|mesh-list
154439655|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154439656|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439657|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154439658|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154439659|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154439660|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154439661|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154439662|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154439663|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154439664|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439665|NCT02103660|Hormones|hormones|mesh-ancestor
154439666|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154439667|NCT00358982|Mocetinostat|mocetinostat|mesh-list
154439668|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154439669|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439670|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439671|NCT02101164|Denosumab|denosumab|mesh-list
154439672|NCT02101164|Pamidronate|pamidronate|mesh-list
154439673|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154439674|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439676|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
154439677|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439678|NCT02103738|Ranibizumab|ranibizumab|mesh-list
154439679|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154439680|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154439681|NCT02103738|Growth Substances|growth substances|mesh-ancestor
154439682|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439683|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
154439684|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439685|NCT02985021|Carboplatin|carboplatin|mesh-list
154439686|NCT02985021|Docetaxel|docetaxel|mesh-list
154439687|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439688|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
154439689|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
154439690|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
154439691|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439692|NCT05714540|Magnesium Sulfate|magnesium sulfate|mesh-list
154439693|NCT05714540|Ketamine|ketamine|mesh-list
154439694|NCT05714540|Analgesics|analgesics|mesh-ancestor
154439695|NCT05714540|Sensory System Agents|sensory system agents|mesh-ancestor
154439696|NCT05714540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439697|NCT05714540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439698|NCT05714540|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154439699|NCT05714540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154439700|NCT05714540|Anesthetics, General|anesthetics, general|mesh-ancestor
154439701|NCT05714540|Anesthetics|anesthetics|mesh-ancestor
154439702|NCT05714540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439703|NCT05714540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154439704|NCT05714540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154439705|NCT05714540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439706|NCT05714540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439707|NCT05714540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154439708|NCT05714540|Anticonvulsants|anticonvulsants|mesh-ancestor
154439709|NCT05714540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154439710|NCT05714540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154439711|NCT05714540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154439712|NCT05714540|Tocolytic Agents|tocolytic agents|mesh-ancestor
154439713|NCT05714540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154439714|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
154439715|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154439716|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
154439717|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154439718|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439719|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154439720|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154439721|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154439722|NCT04441424|Azithromycin|azithromycin|mesh-list
154439723|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
154439724|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154439725|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439726|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
154439727|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154439728|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154439729|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439730|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439731|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439732|NCT03530228|Esomeprazole|esomeprazole|mesh-list
154439733|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154439734|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154439735|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154439736|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439737|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439738|NCT01066923|Aspirin|aspirin|mesh-list
154439739|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154439740|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439741|NCT01066923|Analgesics|analgesics|mesh-ancestor
154439742|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
154439743|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439744|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439745|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439746|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439747|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154439748|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154439749|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439750|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154439752|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439753|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
154439754|NCT03530150|Pirfenidone|pirfenidone|mesh-list
154439755|NCT03530150|Analgesics|analgesics|mesh-ancestor
154439756|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
154439757|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439758|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439759|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154439760|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439761|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439762|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439763|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439764|NCT02098590|Chloroquine|chloroquine|mesh-list
154439765|NCT02098590|Atovaquone|atovaquone|mesh-list
154439766|NCT02098590|Proguanil|proguanil|mesh-list
154439767|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154439768|NCT02098590|Amebicides|amebicides|mesh-ancestor
154439769|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154439770|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154439771|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439772|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
154439773|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439774|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439775|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439776|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
154439777|NCT03657381|Antibodies|antibodies|mesh-list
154439778|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154439779|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
154439780|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439781|NCT00005918|Lamivudine|lamivudine|mesh-list
154439782|NCT00005918|Efavirenz|efavirenz|mesh-list
154439783|NCT00005918|Stavudine|stavudine|mesh-list
154439784|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154439785|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154439786|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439787|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439788|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
154439789|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439790|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154439791|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154439792|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154439793|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154439794|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154439795|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154014453|NCT05825417|Selexipag|selexipag|mesh-list
154439796|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154014529|NCT05728645|Plasma Substitutes|plasma substitutes|mesh-ancestor
154439797|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154439798|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
154439799|NCT02656797|Amphotericin B|amphotericin b|mesh-list
154439800|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154439801|NCT02656797|Amebicides|amebicides|mesh-ancestor
154439802|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154439803|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154439804|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154439805|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154439806|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
154439807|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
154439808|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154439809|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154439810|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154439811|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154439812|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439813|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
154439814|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439815|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439816|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154439817|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439818|NCT02101476|Acetaminophen|acetaminophen|mesh-list
154439820|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439821|NCT02101476|Analgesics|analgesics|mesh-ancestor
154439822|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
154068460|NCT00856583|Sertindole|sertindole|mesh-list
154439824|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439825|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
154439826|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154439827|NCT02101476|Narcotics|narcotics|mesh-ancestor
154439828|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439829|NCT02104128|Bupropion|bupropion|mesh-list
154439830|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154439831|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
154439832|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154439833|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154439834|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154439835|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154439836|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439837|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
154439838|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439839|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439840|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154439841|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154439842|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439843|NCT00004916|Paclitaxel|paclitaxel|mesh-list
154439844|NCT00004916|Ifosfamide|ifosfamide|mesh-list
154439845|NCT00004916|Teniposide|teniposide|mesh-list
154439846|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154439847|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439848|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
154439849|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
154439850|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
154439851|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439852|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154439853|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
154439854|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154439855|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154439856|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439857|NCT02101632|Petrolatum|petrolatum|mesh-list
154439858|NCT02101632|Emollients|emollients|mesh-ancestor
154439859|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154439860|NCT02101710|Isosorbide|isosorbide|mesh-list
154439861|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154439862|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154439863|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154439864|NCT02101710|Diuretics|diuretics|mesh-ancestor
154439865|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
154439866|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439867|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
154439868|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154439869|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439870|NCT03878368|Sulforaphane|sulforaphane|mesh-list
154439871|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154439880|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154439881|NCT04441762|Analgesics|analgesics|mesh-ancestor
154439882|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
154439883|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439884|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439885|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439886|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439887|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154439888|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439889|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439890|NCT02104284|Mannitol|mannitol|mesh-list
154439891|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
154439892|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154439893|NCT02104284|Diuretics|diuretics|mesh-ancestor
154439894|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
154439895|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439896|NCT02104284|Miotics|miotics|mesh-ancestor
154439897|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
154439898|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439899|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154439900|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154439901|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
154439902|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154439903|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154439904|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
154439905|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439906|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439907|NCT00337532|Paclitaxel|paclitaxel|mesh-list
154439908|NCT00337532|Cisplatin|cisplatin|mesh-list
154439909|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154439910|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439911|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
154439912|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
154439913|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
154439914|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439915|NCT02625441|Trastuzumab|trastuzumab|mesh-list
154439916|NCT02625441|Pertuzumab|pertuzumab|mesh-list
154439917|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154439918|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439927|NCT02361801|Dobutamine|dobutamine|mesh-list
154439928|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154439929|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
154439930|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
154439931|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154439932|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439933|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154439934|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154439935|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154439936|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
154439937|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439938|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439939|NCT02361801|Protective Agents|protective agents|mesh-ancestor
154439940|NCT03965728|Methotrexate|methotrexate|mesh-list
154439941|NCT03965728|Midazolam|midazolam|mesh-list
154439942|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154439943|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
154439944|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154014598|NCT05407441|Ipilimumab|ipilimumab|mesh-list
154439945|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439946|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154439948|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439949|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439950|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
154439951|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439952|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154439953|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154439954|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
154439955|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439956|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154439957|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154439958|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154439959|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154439960|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154439961|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154439962|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154439963|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154439964|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
154439965|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
154439966|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
154439967|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
154439968|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439969|NCT00337454|Dasatinib|dasatinib|mesh-list
154439970|NCT00337454|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154439971|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154439972|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439973|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439974|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439975|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
154439976|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154439977|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154439978|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439979|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
154439980|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154439981|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439982|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
154439983|NCT00004898|Etoposide|etoposide|mesh-list
154439984|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154439985|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
154439986|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154439987|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154439988|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154439990|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154439991|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154439992|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154439993|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154439994|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154439995|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154439996|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154439997|NCT02106468|Prednisone|prednisone|mesh-list
154439998|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154439999|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
154440000|NCT02106468|Hormones|hormones|mesh-ancestor
154440001|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782478|NCT00260520|Tinzaparin|tinzaparin|mesh-list
154440002|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440003|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154440004|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440005|NCT03956446|Doxycycline|doxycycline|mesh-list
154440006|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154440007|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440008|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
154440009|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154440010|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154440011|NCT00325364|Insulin|insulin|mesh-list
154440012|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154440013|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154440014|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440015|NCT02104674|Montelukast|montelukast|mesh-list
154440016|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154440017|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
154440018|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154440019|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
154440020|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440021|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440022|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154440023|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154440024|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440025|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
154440026|NCT01903330|Bevacizumab|bevacizumab|mesh-list
154440027|NCT01903330|Sargramostim|sargramostim|mesh-list
154440028|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440029|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
154440030|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440031|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440032|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154440033|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
154440034|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440035|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440036|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154440037|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154440038|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154440039|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154440040|NCT01903330|Growth Substances|growth substances|mesh-ancestor
154440041|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
154440042|NCT02907177|Ponesimod|ponesimod|mesh-list
154440043|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154440044|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440045|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440046|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
154440047|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440048|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
154440049|NCT00004172|Ifosfamide|ifosfamide|mesh-list
154440050|NCT00004172|Thiotepa|thiotepa|mesh-list
154440051|NCT00004172|Carboplatin|carboplatin|mesh-list
154440052|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440053|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
154440054|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440055|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440056|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154440057|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
154440058|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440059|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440060|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154440061|NCT04353310|Curcumin|curcumin|mesh-list
154440062|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154440063|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154440064|NCT04353310|Analgesics|analgesics|mesh-ancestor
154440065|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
154440066|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440067|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440068|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154440069|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440070|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440071|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440072|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440073|NCT00004166|Amifostine|amifostine|mesh-list
154440074|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154440075|NCT00004166|Protective Agents|protective agents|mesh-ancestor
154440076|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440077|NCT00004106|Temozolomide|temozolomide|mesh-list
154440078|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154440079|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
154440080|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440081|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440082|NCT00002246|Stavudine|stavudine|mesh-list
154440083|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
154440084|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440085|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154440086|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154440087|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440088|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
154440089|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440090|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154440091|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154440092|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154440093|NCT00002240|Nelfinavir|nelfinavir|mesh-list
154014750|NCT04936126|Amantadine|amantadine|mesh-list
154440094|NCT00002240|Stavudine|stavudine|mesh-list
154440095|NCT00002240|Didanosine|didanosine|mesh-list
154440096|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154440097|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154440098|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
154440099|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440100|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440101|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154440102|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154440103|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
154440104|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440105|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
154440106|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154440107|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154440108|NCT02250924|Caffeine|caffeine|mesh-list
154440109|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154440110|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440111|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154440112|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440113|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440114|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154440115|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154440116|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
154440117|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440118|NCT03645148|Molgramostim|molgramostim|mesh-list
154440119|NCT03645148|Sargramostim|sargramostim|mesh-list
154440120|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
154440121|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440122|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440123|NCT04082728|Dipyrone|dipyrone|mesh-list
154440124|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154440125|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154440126|NCT04082728|Analgesics|analgesics|mesh-ancestor
154440127|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
154440128|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440129|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440130|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154440131|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440132|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
154440133|NCT02906709|Insulin|insulin|mesh-list
154440134|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154440135|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440136|NCT00321308|Pemetrexed|pemetrexed|mesh-list
154440138|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440139|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440140|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154440141|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154440142|NCT02110134|Hydroquinone|hydroquinone|mesh-list
154440143|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
154440144|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440145|NCT02110134|Protective Agents|protective agents|mesh-ancestor
154440146|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440147|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154440148|NCT00318656|Metformin|metformin|mesh-list
154440149|NCT00318656|Glimepiride|glimepiride|mesh-list
154440150|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
154440151|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154440152|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440153|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154440154|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440155|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
154440156|NCT02110524|Paclitaxel|paclitaxel|mesh-list
154440157|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154440158|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440159|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440160|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440161|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440162|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440163|NCT00317486|Bosentan|bosentan|mesh-list
154440164|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154440165|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154440166|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440167|NCT02107170|Remifentanil|remifentanil|mesh-list
154440168|NCT02107170|Propofol|propofol|mesh-list
154440169|NCT02107170|Sevoflurane|sevoflurane|mesh-list
154440170|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154440171|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440172|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440173|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154440174|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
154440175|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
154440176|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154440177|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154440178|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154440179|NCT02107170|Narcotics|narcotics|mesh-ancestor
154440180|NCT02107170|Analgesics|analgesics|mesh-ancestor
154440181|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
154440182|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440183|NCT00313196|Bosentan|bosentan|mesh-list
154440184|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154440185|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154440186|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440187|NCT03656679|Iodine|iodine|mesh-list
154440188|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154440189|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440190|NCT03656679|Trace Elements|trace elements|mesh-ancestor
154440191|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
154440192|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440193|NCT03663166|Nivolumab|nivolumab|mesh-list
154440194|NCT03663166|Ipilimumab|ipilimumab|mesh-list
154440195|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154440196|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440197|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154440198|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440199|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
154440200|NCT03554304|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
154440201|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154440202|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154440203|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731851|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731852|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731853|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153731854|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153731855|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153731856|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
154440204|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154440205|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154440206|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440207|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440208|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440209|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154440210|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
154440211|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154440212|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440213|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154440214|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154440215|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154440217|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
154440218|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
154440219|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440220|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440221|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
154440222|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440223|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154440224|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154440225|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154440226|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154440227|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440228|NCT02110992|Docetaxel|docetaxel|mesh-list
154440229|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440230|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440231|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440232|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440233|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440234|NCT03306394|Trifluridine|trifluridine|mesh-list
154440235|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
154440236|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440237|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
154440238|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440239|NCT00311090|Idraparinux|idraparinux|mesh-list
154440240|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
154440241|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154440242|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
154440243|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154440244|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
154440245|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440246|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440247|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
154440248|NCT02105610|Anesthetics|anesthetics|mesh-list
154440249|NCT02105610|Sevoflurane|sevoflurane|mesh-list
154440250|NCT02105610|Desflurane|desflurane|mesh-list
154440251|NCT02105610|Isoflurane|isoflurane|mesh-list
154440252|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
154440253|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440254|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440255|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154440256|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154440257|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
154440258|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
153370806|NCT01715207|Atenolol|atenolol|mesh-list
154440259|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440260|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
154440261|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154440262|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154440263|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440264|NCT00301262|Urological Agents|urological agents|mesh-ancestor
154440265|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154440266|NCT02254941|Antibodies|antibodies|mesh-list
154440267|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
154440268|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154440269|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
154440270|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440271|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440272|NCT03077620|Suvorexant|suvorexant|mesh-list
154440273|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154440274|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154440275|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440276|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440277|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154440278|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440279|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440280|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
154440281|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154440282|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154440283|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068936|NCT02610920|Iron|iron|mesh-list
154440284|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
154440285|NCT03656445|Coagulants|coagulants|mesh-ancestor
154440286|NCT01903486|Prednisone|prednisone|mesh-list
154440287|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154440288|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
154440289|NCT01903486|Hormones|hormones|mesh-ancestor
154440290|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440291|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440292|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154440293|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440294|NCT03656289|Etonogestrel|etonogestrel|mesh-list
154440295|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154440296|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
154440297|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154440298|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440299|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154440300|NCT00599170|Rituximab|rituximab|mesh-list
154440301|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154440302|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440303|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
154440304|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440305|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440306|NCT04256434|Nalbuphine|nalbuphine|mesh-list
154440307|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154440308|NCT04256434|Narcotics|narcotics|mesh-ancestor
154440309|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440310|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440311|NCT04256434|Analgesics|analgesics|mesh-ancestor
154440312|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
154440313|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440314|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
154440315|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154440316|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
154440317|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154440318|NCT02107950|Carboplatin|carboplatin|mesh-list
154440319|NCT02107950|Gemcitabine|gemcitabine|mesh-list
154440320|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440321|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154440322|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
154440323|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440324|NCT02108106|Mitapivat|mitapivat|mesh-list
154440325|NCT02108106|Enzyme Activators|enzyme activators|mesh-ancestor
154440326|NCT02108106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440327|NCT02113800|Everolimus|everolimus|mesh-list
154440328|NCT02113800|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154440329|NCT02113800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154440330|NCT02113800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440331|NCT02113800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440332|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440333|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
154440334|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440335|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440336|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154440337|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
154440338|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154440339|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154440340|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154440341|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440342|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440343|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154440344|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154440345|NCT02112006|Bupivacaine|bupivacaine|mesh-list
154440346|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
154440347|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
154440348|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440349|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440350|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
154440351|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440352|NCT02251158|Ritonavir|ritonavir|mesh-list
154440353|NCT02251158|Tipranavir|tipranavir|mesh-list
154440354|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154440355|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154440356|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154440357|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
154440358|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440359|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440360|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154440361|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154440362|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
154440363|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440364|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154440365|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154440366|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
154440367|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154440368|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
154440369|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440370|NCT05404516|Cytarabine|cytarabine|mesh-list
154440371|NCT05404516|Sorafenib|sorafenib|mesh-list
154440372|NCT05404516|Idarubicin|idarubicin|mesh-list
154440373|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154440374|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
154440375|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440376|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440377|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
154440378|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440379|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440380|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
154440381|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440382|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154440383|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440384|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154440385|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154440386|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154440387|NCT02114346|Atorvastatin|atorvastatin|mesh-list
154440388|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154440389|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154440390|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
154440391|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440392|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154440393|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154440394|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440395|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
154440396|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154440397|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154440398|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440399|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
154440400|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
154440401|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440402|NCT02108808|Clopidogrel|clopidogrel|mesh-list
154440403|NCT02108808|Ticagrelor|ticagrelor|mesh-list
154440404|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154440405|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154440406|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154440407|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154440408|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154440409|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
154440410|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440411|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440412|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440413|NCT02108886|Montelukast|montelukast|mesh-list
154440414|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154440415|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
154440416|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154440417|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
154440418|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440419|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440420|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154440421|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154440422|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440423|NCT02114502|Pyridoxine|pyridoxine|mesh-list
154440424|NCT02114502|Dexamethasone|dexamethasone|mesh-list
154440425|NCT02114502|Gemcitabine|gemcitabine|mesh-list
154440426|NCT02114502|Melphalan|melphalan|mesh-list
154440427|NCT02114502|Busulfan|busulfan|mesh-list
154440428|NCT02114502|Vorinostat|vorinostat|mesh-list
154440429|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154440430|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
154440431|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
154440432|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440433|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440434|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154440435|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
154440437|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440438|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154440439|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440440|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154440441|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
154440442|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440443|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154440444|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
154440445|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154440446|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440447|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
154440448|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154440449|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440450|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
154440451|NCT02114502|Vitamins|vitamins|mesh-ancestor
154440452|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
154440453|NCT03654027|Docetaxel|docetaxel|mesh-list
154440454|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440455|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440456|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440457|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440458|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440459|NCT02114658|Sorafenib|sorafenib|mesh-list
154440460|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440461|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154440462|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440463|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440464|NCT05126602|Vitamin D|vitamin d|mesh-list
154440465|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
154440466|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
154440467|NCT05126602|Vitamins|vitamins|mesh-list
154440468|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
154440469|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440470|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154440471|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154440472|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
154440473|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154440474|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153731875|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153731876|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731877|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153731878|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
153731879|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731880|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731881|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153731882|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
154440475|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154440476|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440477|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
154440478|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440479|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440480|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154440481|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440482|NCT02112552|Paclitaxel|paclitaxel|mesh-list
154440483|NCT02112552|Carboplatin|carboplatin|mesh-list
154440484|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154440485|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440486|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440487|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440488|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440489|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440490|NCT02109354|Vaccines|vaccines|mesh-list
154440491|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
154440492|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440493|NCT02109510|Lidocaine|lidocaine|mesh-list
154440494|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
154440495|NCT02109510|Ketamine|ketamine|mesh-list
154440496|NCT02109510|Anesthetics|anesthetics|mesh-list
154440497|NCT02109510|Propofol|propofol|mesh-list
154440498|NCT02109510|Sevoflurane|sevoflurane|mesh-list
154440499|NCT02109510|Rocuronium|rocuronium|mesh-list
154440500|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
154440501|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440502|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440503|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
154440504|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440505|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154254825|NCT01144832|Ebastine|ebastine|mesh-list
154440506|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154440508|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154440509|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440510|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154440511|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154440512|NCT02109510|Analgesics|analgesics|mesh-ancestor
154440513|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154440514|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154440515|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154440516|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154440517|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440518|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154440519|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
154440520|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154440521|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154440522|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154440523|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154440524|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153370910|NCT04514393|Methotrexate|methotrexate|mesh-list
154440525|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154440526|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154440527|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154440528|NCT02109666|Abatacept|abatacept|mesh-list
154440529|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154440530|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440531|NCT02109666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154440532|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440533|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440534|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
154440535|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440536|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440537|NCT02109900|Progesterone|progesterone|mesh-list
154440538|NCT02109900|Progestins|progestins|mesh-ancestor
154440539|NCT02109900|Hormones|hormones|mesh-ancestor
154440540|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440541|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440542|NCT02112630|Interferons|interferons|mesh-list
154440543|NCT02112630|Ribavirin|ribavirin|mesh-list
154440544|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
154440545|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
154440546|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154440547|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154440548|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154440549|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440550|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
154440551|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440552|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
154440553|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440554|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
154440555|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440556|NCT04873375|Cemiplimab|cemiplimab|mesh-list
154440557|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154440558|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440559|NCT05125588|Meloxicam|meloxicam|mesh-list
154440560|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154440561|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154440562|NCT05125588|Analgesics|analgesics|mesh-ancestor
154440563|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
154440564|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440565|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440566|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154440567|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440568|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154440569|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154440570|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440571|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440572|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
154440573|NCT02115204|Docetaxel|docetaxel|mesh-list
154440574|NCT02115204|Fluorouracil|fluorouracil|mesh-list
154440575|NCT02115204|Methotrexate|methotrexate|mesh-list
154440576|NCT02115204|Epirubicin|epirubicin|mesh-list
154440577|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440578|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
154440579|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440580|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440581|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154440582|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
154440583|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731890|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731891|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
153731892|NCT00404261|Hormones|hormones|mesh-ancestor
153731893|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440584|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440585|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154440586|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440587|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440588|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440589|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
154440590|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154440591|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154440592|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
154440593|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154440594|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
154440595|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440596|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154440597|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154440598|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154440599|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154440600|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154440601|NCT02115360|Calcitonin|calcitonin|mesh-list
154440602|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
154440603|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154440604|NCT02115360|Fentanyl|fentanyl|mesh-list
154440605|NCT02115360|Katacalcin|katacalcin|mesh-list
154440606|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154440607|NCT02115360|Narcotics|narcotics|mesh-ancestor
154440608|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440609|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440610|NCT02115360|Analgesics|analgesics|mesh-ancestor
154440611|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
154440612|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440613|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154440614|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154440615|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
154440616|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
154440617|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154440618|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154440619|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
154440620|NCT02432404|NuvaRing|nuvaring|mesh-list
154440621|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154440622|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
154440623|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154440624|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440625|NCT02113176|Minocycline|minocycline|mesh-list
154440626|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154440627|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440628|NCT02118870|Aspirin|aspirin|mesh-list
153782486|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440629|NCT02118870|Clopidogrel|clopidogrel|mesh-list
154440630|NCT02118870|Ticagrelor|ticagrelor|mesh-list
154440631|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154440632|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154440633|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154440634|NCT02118870|Analgesics|analgesics|mesh-ancestor
154440635|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
154440636|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440637|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440638|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154440639|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440640|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154440641|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154440642|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440643|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154440644|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154440645|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440646|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
154440647|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154440648|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154440649|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154440650|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
154440651|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440652|NCT03552666|Vitamin D|vitamin d|mesh-list
154440653|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
154440654|NCT03552666|Vitamins|vitamins|mesh-ancestor
154440655|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
154440657|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154440658|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154440659|NCT02115594|Fulvestrant|fulvestrant|mesh-list
154440660|NCT02115594|Entinostat|entinostat|mesh-list
154440661|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154440662|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440663|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154440664|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154440665|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
154440666|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440667|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440668|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154440669|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440670|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731900|NCT00406380|Growth Substances|growth substances|mesh-ancestor
153731901|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731902|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
153731903|NCT00406497|Difluprednate|difluprednate|mesh-list
153731904|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
153731905|NCT00406497|Hormones|hormones|mesh-ancestor
153370954|NCT01721603|Dabrafenib|dabrafenib|mesh-list
154440671|NCT05125042|Amiodarone|amiodarone|mesh-list
154440672|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154440673|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
154440674|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154440675|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154440676|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440677|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154440678|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154440679|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154440680|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440681|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154440682|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154440683|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154440684|NCT02113332|Liraglutide|liraglutide|mesh-list
154440685|NCT02113332|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154440686|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154440687|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440688|NCT02113332|Incretins|incretins|mesh-ancestor
154440689|NCT02113332|Hormones|hormones|mesh-ancestor
154440690|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440691|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154440692|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154440693|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
154440694|NCT02918877|Propofol|propofol|mesh-list
154440695|NCT02918877|Sevoflurane|sevoflurane|mesh-list
154015445|NCT03254654|Apatinib|apatinib|mesh-list
154440696|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154440697|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440698|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440699|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154440700|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
154440701|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
154440702|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154440703|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154440704|NCT03652857|Apatinib|apatinib|mesh-list
154440705|NCT03652857|Vinorelbine|vinorelbine|mesh-list
154440706|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440707|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154440708|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568932|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440709|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440710|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154440711|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440712|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440713|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440714|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
154440715|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154440716|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440717|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154440718|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
154440719|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154440720|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440721|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440722|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440723|NCT02113566|Acetaminophen|acetaminophen|mesh-list
154440724|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154440725|NCT02113566|Analgesics|analgesics|mesh-ancestor
154440726|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
154440727|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440728|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440730|NCT05124730|Metformin|metformin|mesh-list
154440731|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154440732|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440733|NCT02251626|Ubiquinone|ubiquinone|mesh-list
154440734|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
154440735|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
154440736|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440737|NCT02251626|Vitamins|vitamins|mesh-ancestor
154440738|NCT02123004|Clopidogrel|clopidogrel|mesh-list
154440739|NCT02123004|Ticagrelor|ticagrelor|mesh-list
154440740|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154440741|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154440742|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154440743|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154440744|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
154440745|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440746|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440747|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440748|NCT01674712|Simvastatin|simvastatin|mesh-list
154440749|NCT01674712|Fenofibrate|fenofibrate|mesh-list
154440750|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154440751|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153731914|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153731915|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
153731916|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440752|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
154440753|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440754|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154440755|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154440756|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440757|NCT01368432|Escitalopram|escitalopram|mesh-list
154440758|NCT01368432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154440759|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154440760|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154440761|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440762|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440763|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
154440764|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440765|NCT05122780|Acetylcholine|acetylcholine|mesh-list
154440766|NCT05122780|Anticoagulants|anticoagulants|mesh-list
154440767|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154440768|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154440769|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154440771|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440772|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440773|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440774|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
154440775|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154440776|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
154440777|NCT02119806|Midazolam|midazolam|mesh-list
154440778|NCT02119806|Fentanyl|fentanyl|mesh-list
154440779|NCT02119806|Propofol|propofol|mesh-list
154440780|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154440781|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440782|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440783|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154440784|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
154440785|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
154440786|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154440787|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154440788|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154440789|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154440790|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
154440791|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
154440792|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440793|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440794|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154440795|NCT02119806|Narcotics|narcotics|mesh-ancestor
154440796|NCT02119806|Analgesics|analgesics|mesh-ancestor
154440797|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
154440798|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440799|NCT02119884|Octreotide|octreotide|mesh-list
154440800|NCT02119884|Terlipressin|terlipressin|mesh-list
154440801|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154440802|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154069394|NCT00588354|Hormones|hormones|mesh-ancestor
154440804|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154440805|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154440806|NCT05104918|Vortioxetine|vortioxetine|mesh-list
154440807|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154440808|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154440809|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154440810|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154440811|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440812|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440813|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440814|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154440815|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
154440816|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154440817|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154440818|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154440819|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440820|NCT05104918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154440821|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
154440822|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154440823|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154440824|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154440825|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154440826|NCT05089942|Insulin|insulin|mesh-list
154440827|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154440828|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154440829|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440830|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
154440831|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154440832|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440833|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440834|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154440835|NCT04941508|Analgesics|analgesics|mesh-ancestor
154440836|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
154440837|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440838|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154440839|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154440840|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154440841|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
154440842|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015512|NCT02787356|Lidocaine|lidocaine|mesh-list
154440843|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440845|NCT01062555|Sirolimus|sirolimus|mesh-list
154440846|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
154440847|NCT01062555|Tacrolimus|tacrolimus|mesh-list
154440848|NCT01062555|Cyclosporins|cyclosporins|mesh-list
154440849|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440850|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
154440851|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440852|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154440853|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440854|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440855|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
154440856|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440857|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
154440858|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154440859|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154440860|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440861|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154440862|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
154440863|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154440864|NCT03622047|Sufentanil|sufentanil|mesh-list
154440865|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
154440866|NCT03622047|Ropivacaine|ropivacaine|mesh-list
154440867|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154440868|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440869|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440870|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154440871|NCT03622047|Analgesics|analgesics|mesh-ancestor
154440872|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
154440873|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440874|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154069466|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
154440875|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154440876|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154440877|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154440878|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154440879|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440880|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
154440881|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
154440882|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154440883|NCT03622047|Narcotics|narcotics|mesh-ancestor
154440884|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154440885|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154440886|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
154440887|NCT05073562|Folic Acid|folic acid|mesh-list
154440888|NCT05073562|Mebendazole|mebendazole|mesh-list
154440889|NCT05073562|Piperazine|piperazine|mesh-list
154440890|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
154440891|NCT05073562|DMP 777|dmp 777|mesh-list
154440892|NCT05073562|Hematinics|hematinics|mesh-ancestor
154440893|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
154440894|NCT05073562|Vitamins|vitamins|mesh-ancestor
154440895|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
154440896|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440897|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
154440898|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
154440899|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154440900|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440901|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440902|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440903|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440904|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440905|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440906|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440907|NCT01368276|Molgramostim|molgramostim|mesh-list
154440908|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154440909|NCT01368276|Sargramostim|sargramostim|mesh-list
154440910|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
154440911|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440912|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440913|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154440914|NCT02116842|Fentanyl|fentanyl|mesh-list
154440915|NCT02116842|Bupivacaine|bupivacaine|mesh-list
154440916|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
154440917|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
154440918|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440919|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440920|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
154440921|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440922|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154440923|NCT02116842|Narcotics|narcotics|mesh-ancestor
154440924|NCT02116842|Analgesics|analgesics|mesh-ancestor
154440925|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154440926|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154440927|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
154440928|NCT02120118|Docetaxel|docetaxel|mesh-list
154440929|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440930|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440931|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440932|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440933|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440934|NCT04054089|Tenofovir|tenofovir|mesh-list
154440935|NCT04054089|Lamivudine|lamivudine|mesh-list
154440936|NCT04054089|Emtricitabine|emtricitabine|mesh-list
154440937|NCT04054089|Dolutegravir|dolutegravir|mesh-list
154440938|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
154440939|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440940|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154440941|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154440942|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440943|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440944|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154440945|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154440946|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154440947|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154440948|NCT02120196|Rifaximin|rifaximin|mesh-list
154440949|NCT02120196|Norfloxacin|norfloxacin|mesh-list
154440950|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154440951|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154440952|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154440953|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154440954|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153731918|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
154440955|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154440956|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440957|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440958|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154440959|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154440961|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
154440962|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
154440963|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154440964|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440965|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
154440966|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154440967|NCT02120274|Vitamin D|vitamin d|mesh-list
154440968|NCT02120274|Vitamins|vitamins|mesh-list
154440969|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
154440970|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
154440971|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
154440972|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440973|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154440974|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
154440975|NCT02120274|Hematinics|hematinics|mesh-ancestor
154440976|NCT02402842|Docetaxel|docetaxel|mesh-list
154440977|NCT02402842|Fluorouracil|fluorouracil|mesh-list
154440978|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154440979|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
154440980|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
154440981|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
154440982|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154440983|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
154440984|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154440985|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154440986|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
154440987|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440988|NCT01061775|Exenatide|exenatide|mesh-list
154440989|NCT01061775|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154440990|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154440991|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154440992|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154440993|NCT01061775|Incretins|incretins|mesh-ancestor
154440994|NCT01061775|Hormones|hormones|mesh-ancestor
153782490|NCT00233909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782491|NCT00267813|Bupropion|bupropion|mesh-list
154440995|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154440996|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154440997|NCT02123628|Doxycycline|doxycycline|mesh-list
154440998|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
154441000|NCT02123628|Rifampin|rifampin|mesh-list
154441001|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
154441002|NCT02123628|Linezolid|linezolid|mesh-list
154441003|NCT02123628|Cefepime|cefepime|mesh-list
154441004|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154441005|NCT02123628|Cefotaxime|cefotaxime|mesh-list
154441006|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
154441007|NCT02123628|Trimethoprim|trimethoprim|mesh-list
154441008|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
154441009|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441010|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154441011|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
154441012|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
154441013|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154441014|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154441015|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154441016|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154441017|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441018|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441019|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441020|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154441021|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154441022|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154441023|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
154441024|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154441025|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154441026|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154441027|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154441028|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154441029|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154441030|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154441031|NCT02123628|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154441032|NCT02123628|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154441033|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154441034|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154441035|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154441036|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154441037|NCT02651116|Levomethorphan|levomethorphan|mesh-list
154441038|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
154441039|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
154441040|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
154441041|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154441042|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154441043|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441044|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441045|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441046|NCT02651116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154441047|NCT02651116|Narcotics|narcotics|mesh-ancestor
154441048|NCT02651116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441049|NCT02651116|Analgesics|analgesics|mesh-ancestor
154441050|NCT02651116|Sensory System Agents|sensory system agents|mesh-ancestor
154441051|NCT02651116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441052|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
154441053|NCT03652467|Deferoxamine|deferoxamine|mesh-list
154441054|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154441055|NCT03652467|Estrogens|estrogens|mesh-ancestor
154441056|NCT03652467|Hormones|hormones|mesh-ancestor
154441057|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441058|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441059|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154441060|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441061|NCT03652467|Siderophores|siderophores|mesh-ancestor
154441062|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154441063|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
154441064|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
154441065|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441066|NCT03528824|Diclofenac|diclofenac|mesh-list
154441067|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154441068|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154441069|NCT03528824|Analgesics|analgesics|mesh-ancestor
154441070|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
154441071|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015748|NCT05341076|Oxytocin|oxytocin|mesh-list
154441072|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441073|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154441074|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441075|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154441076|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441077|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441079|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441080|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441081|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154441082|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441083|NCT03552432|Alirocumab|alirocumab|mesh-list
154441084|NCT03552432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154441085|NCT03552432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154441086|NCT03552432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154441087|NCT03552432|Antimetabolites|antimetabolites|mesh-ancestor
154441088|NCT03552432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441089|NCT03552432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154441090|NCT03552432|Protease Inhibitors|protease inhibitors|mesh-ancestor
154441091|NCT03552432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441092|NCT03552432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154441093|NCT03765632|Busulfan|busulfan|mesh-list
154441094|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
154441095|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441096|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441097|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
154441098|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441099|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154441100|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441101|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154441102|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
154441103|NCT02973477|Glimepiride|glimepiride|mesh-list
154441104|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154441105|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441107|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441108|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154441109|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441110|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
154441111|NCT03552354|Argatroban|argatroban|mesh-list
154441112|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
154441113|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154441114|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
154441115|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441116|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441117|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
154441118|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154441119|NCT02288000|Memantine|memantine|mesh-list
154441120|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154441121|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154441122|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
154441123|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441124|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441125|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441126|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154441127|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154441128|NCT02788656|Valsartan|valsartan|mesh-list
154441129|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
154441130|NCT02788656|Giapreza|giapreza|mesh-list
154441131|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
154441132|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154441133|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154441134|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154441135|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
154441136|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154441137|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153782492|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153816664|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816665|NCT00458913|Bortezomib|bortezomib|mesh-list
153816666|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441138|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441139|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
154441140|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154441141|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154441142|NCT05258110|Midazolam|midazolam|mesh-list
154441143|NCT05258110|BI 425809|bi 425809|mesh-list
154015811|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154441144|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154441145|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154441146|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441147|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441148|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154441149|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154441150|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154441151|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154441152|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
154441153|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
154441154|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
154441155|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
154441156|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441157|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441158|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
154441159|NCT03652233|Nivolumab|nivolumab|mesh-list
154441160|NCT03652233|Afatinib|afatinib|mesh-list
154441161|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441162|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441163|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154441164|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441165|NCT03652233|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154441166|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154441167|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441168|NCT02117466|Cetuximab|cetuximab|mesh-list
154441169|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441170|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441171|NCT02117622|Insulin|insulin|mesh-list
154441172|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154441173|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441174|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154441175|NCT04529902|Abatacept|abatacept|mesh-list
154441176|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154441177|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441178|NCT04529902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441179|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441180|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441181|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
154441182|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441183|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441184|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154441185|NCT02288078|Dexamethasone|dexamethasone|mesh-list
154441186|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154441187|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154441188|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
154441189|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
154441190|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441191|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441192|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154441193|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
154441194|NCT02288078|Hormones|hormones|mesh-ancestor
154441195|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441196|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154441197|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441198|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441199|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441200|NCT02288234|Telavancin|telavancin|mesh-list
154441201|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154441202|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441203|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154441204|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154441205|NCT04654312|Diuretics|diuretics|mesh-ancestor
154441206|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
154441207|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441208|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154441209|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154441210|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441211|NCT02973087|Factor VIII|factor viii|mesh-list
154441212|NCT02973087|Coagulants|coagulants|mesh-ancestor
154441213|NCT05284656|Folic Acid|folic acid|mesh-list
154441214|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
154441215|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
154441216|NCT05284656|Hematinics|hematinics|mesh-ancestor
154441217|NCT05284656|Vitamins|vitamins|mesh-ancestor
154441218|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
154015888|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154441219|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441220|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154441221|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441222|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441223|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154441224|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154441225|NCT05284656|Protective Agents|protective agents|mesh-ancestor
154441226|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
154441227|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154441228|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
154441229|NCT02124174|Azacitidine|azacitidine|mesh-list
154441230|NCT02124174|Valproic Acid|valproic acid|mesh-list
154441231|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154441232|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
154441233|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441234|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441235|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441236|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
154441237|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
154441238|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441239|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441240|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
154441241|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154441242|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441243|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154441244|NCT03956368|Atorvastatin|atorvastatin|mesh-list
154441245|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154441246|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154441247|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
154441248|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441249|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154441250|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154441251|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441252|NCT02124330|Bentonite|bentonite|mesh-list
154441253|NCT02124330|Antidotes|antidotes|mesh-ancestor
154441254|NCT02124330|Protective Agents|protective agents|mesh-ancestor
154441255|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441256|NCT02118090|Chloroquine|chloroquine|mesh-list
154441257|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154441258|NCT02118090|Amebicides|amebicides|mesh-ancestor
154441259|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154441260|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154441261|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441262|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
154441263|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441264|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154441265|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154441266|NCT02118090|Analgesics|analgesics|mesh-ancestor
154441267|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
154441268|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441269|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441270|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154441271|NCT02118090|Filaricides|filaricides|mesh-ancestor
154441272|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
154441273|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
153545908|NCT06294821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545910|NCT06294704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153545911|NCT06294704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545912|NCT06288035|Dexamethasone|dexamethasone|mesh-list
153545913|NCT06288035|Dexamethasone acetate|dexamethasone acetate|mesh-list
153545914|NCT06288035|BB 1101|bb 1101|mesh-list
153545915|NCT06288035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545916|NCT06288035|Antiemetics|antiemetics|mesh-ancestor
153545917|NCT06288035|Autonomic Agents|autonomic agents|mesh-ancestor
153545918|NCT06288035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545919|NCT06288035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441274|NCT03551808|Ketorolac|ketorolac|mesh-list
154441275|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154441276|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154441277|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154441278|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154441279|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154441280|NCT03551808|Analgesics|analgesics|mesh-ancestor
154441281|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
154441282|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441283|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441284|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154441285|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441286|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154441287|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441288|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441289|NCT04053543|CXA-10|cxa-10|mesh-list
154441290|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154441291|NCT04202458|Tenecteplase|tenecteplase|mesh-list
154441292|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154441293|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154441294|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441295|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
154441296|NCT00273650|Vitamins|vitamins|mesh-ancestor
154441297|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
154441298|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441299|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
154441300|NCT02121288|Clopidogrel|clopidogrel|mesh-list
154441301|NCT02121288|Ticagrelor|ticagrelor|mesh-list
154441302|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154441303|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154441304|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154441305|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154441306|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
154441307|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441308|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441309|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441310|NCT01525329|Fluorouracil|fluorouracil|mesh-list
154441311|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
154441312|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441313|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153545920|NCT06288035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154441314|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441315|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441316|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
154441317|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441318|NCT02121366|Ethanol|ethanol|mesh-list
154441319|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154441320|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441321|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441322|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441323|NCT02121444|Interferons|interferons|mesh-list
154441324|NCT02121444|Interferon-beta|interferon-beta|mesh-list
154441325|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
154441326|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441327|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
154441328|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441329|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
154441330|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441331|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154441332|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
154441333|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154441334|NCT04413526|Estrogens|estrogens|mesh-ancestor
154441335|NCT04413526|Hormones|hormones|mesh-ancestor
154441336|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441337|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441338|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154441339|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441340|NCT03665506|Trifluridine|trifluridine|mesh-list
154441341|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
154441342|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441343|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
154441344|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441345|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
154441346|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154441347|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
154441348|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441349|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
154441350|NCT03318874|Protective Agents|protective agents|mesh-ancestor
154441351|NCT03551652|Rocuronium|rocuronium|mesh-list
154441352|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154441353|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154441354|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154441355|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441356|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441357|NCT00263042|Rimonabant|rimonabant|mesh-list
154441358|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154441359|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154441360|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154441361|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441362|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441363|NCT00263042|Hormones|hormones|mesh-ancestor
154441364|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441365|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441366|NCT05002192|Eucalyptol|eucalyptol|mesh-list
154441367|NCT05002192|Ambroxol|ambroxol|mesh-list
154441368|NCT05002192|Expectorants|expectorants|mesh-list
154016038|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154441369|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
154441371|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
154441372|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
154441373|NCT05002192|Protective Agents|protective agents|mesh-ancestor
154441374|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441375|NCT04973020|Efavirenz|efavirenz|mesh-list
154441376|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154441377|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154441378|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441379|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441380|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
154441381|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441382|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154441383|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154441384|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154441385|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154441386|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154441387|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154441388|NCT05724446|Prednisolone|prednisolone|mesh-list
154441389|NCT05724446|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154441390|NCT05724446|Methylprednisolone|methylprednisolone|mesh-list
154441391|NCT05724446|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154441392|NCT05724446|Prednisolone acetate|prednisolone acetate|mesh-list
154441393|NCT05724446|Clobetasol|clobetasol|mesh-list
154441394|NCT05724446|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154441395|NCT05724446|Prednisolone phosphate|prednisolone phosphate|mesh-list
154441396|NCT05724446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154441397|NCT05724446|Glucocorticoids|glucocorticoids|mesh-ancestor
154441398|NCT05724446|Hormones|hormones|mesh-ancestor
154441399|NCT05724446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441400|NCT05724446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441401|NCT05724446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154441402|NCT05724446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441403|NCT05724446|Antiemetics|antiemetics|mesh-ancestor
154441404|NCT05724446|Autonomic Agents|autonomic agents|mesh-ancestor
154441405|NCT05724446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441406|NCT05724446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154441407|NCT05724446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154441408|NCT05724446|Protective Agents|protective agents|mesh-ancestor
154441409|NCT02124642|Folic Acid|folic acid|mesh-list
154441410|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
154441411|NCT02124642|Hematinics|hematinics|mesh-ancestor
154441412|NCT02124642|Vitamins|vitamins|mesh-ancestor
154441413|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
154441414|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441415|NCT03094234|Propranolol|propranolol|mesh-list
154441416|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154441417|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154441418|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
154441419|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441420|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441421|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441422|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154441423|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154441424|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
154441425|NCT00260156|Vildagliptin|vildagliptin|mesh-list
154441426|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154441427|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441428|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154441429|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
154441430|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441431|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441432|NCT04367103|Phenylephrine|phenylephrine|mesh-list
154441433|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
154441434|NCT04367103|Norepinephrine|norepinephrine|mesh-list
154441435|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154441436|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
154441437|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
154441438|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441439|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441440|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
154441441|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154441442|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
154441443|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
154441444|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154441445|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154441446|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154441447|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
154441448|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441449|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441450|NCT04367103|Protective Agents|protective agents|mesh-ancestor
154441452|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154441453|NCT00260078|Darunavir|darunavir|mesh-list
154441454|NCT00260078|Tenofovir|tenofovir|mesh-list
154441455|NCT00260078|Nevirapine|nevirapine|mesh-list
154441456|NCT00260078|Efavirenz|efavirenz|mesh-list
154441457|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154441458|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154441459|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
154441460|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441461|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441462|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154441463|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154441464|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
154441465|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441466|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154441467|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154441468|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154441469|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154441470|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154441471|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154441472|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154441473|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154441474|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154441475|NCT03034564|Droxidopa|droxidopa|mesh-list
154441476|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154441477|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154441478|NCT05342532|Amoxicillin|amoxicillin|mesh-list
154441479|NCT05342532|Clarithromycin|clarithromycin|mesh-list
154441480|NCT05342532|Omeprazole|omeprazole|mesh-list
154441481|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154441482|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441483|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154441484|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154441485|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154441486|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441487|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441488|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154441489|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154441490|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154441491|NCT04469114|Tofacitinib|tofacitinib|mesh-list
154441492|NCT04469114|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154441493|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154441494|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441495|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441496|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
154441497|NCT02400567|Letrozole|letrozole|mesh-list
154441498|NCT02400567|Epirubicin|epirubicin|mesh-list
154441499|NCT02400567|Palbociclib|palbociclib|mesh-list
154441500|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441501|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
154441502|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441503|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441504|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154441505|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
154441506|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441507|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441508|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154441509|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154441510|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154441511|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441512|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154441513|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
154441514|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441515|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154441516|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154441517|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154441518|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154441519|NCT00228176|Rimonabant|rimonabant|mesh-list
154441520|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154441521|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154441522|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154441523|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441524|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441525|NCT00228176|Hormones|hormones|mesh-ancestor
154441526|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441527|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441528|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
154441529|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
154441530|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441531|NCT01308190|Capecitabine|capecitabine|mesh-list
154441532|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154441533|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
154441534|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441535|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441536|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
154441537|NCT01210768|Doxorubicin|doxorubicin|mesh-list
154441538|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154441539|NCT01210768|Epirubicin|epirubicin|mesh-list
154441540|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441541|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
154441542|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441543|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441544|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154441545|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
154441546|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441547|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441548|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154441549|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154441550|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154441551|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154441552|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441553|NCT02971605|Psilocybin|psilocybin|mesh-list
154441554|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
154441555|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441556|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154441557|NCT02124954|Digoxin|digoxin|mesh-list
154441558|NCT02124954|Midazolam|midazolam|mesh-list
154441559|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154441560|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154441561|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441562|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441563|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154441564|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154441565|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154441566|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154441567|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
154441568|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
154441569|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
154441570|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
154441571|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441572|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441573|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154441574|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154441575|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441576|NCT02124954|Protective Agents|protective agents|mesh-ancestor
154441577|NCT04441112|Triamcinolone|triamcinolone|mesh-list
154441578|NCT04441112|Ketorolac|ketorolac|mesh-list
154441579|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154441580|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
154441581|NCT04441112|Hormones|hormones|mesh-ancestor
154441582|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441583|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441584|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441585|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441586|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154441587|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154441588|NCT04441112|Analgesics|analgesics|mesh-ancestor
154441589|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
154441590|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441591|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441592|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154441594|NCT02121990|Bevacizumab|bevacizumab|mesh-list
154441595|NCT02121990|Olaparib|olaparib|mesh-list
154441596|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154441597|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441598|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
154441599|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
154441600|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
154441601|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441602|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441603|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154441604|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154441605|NCT02121990|Growth Substances|growth substances|mesh-ancestor
154441606|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441607|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
154441608|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154441609|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441610|NCT05724056|Hyaluronic Acid|hyaluronic acid|mesh-list
154441611|NCT05724056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154441612|NCT05724056|Immunologic Factors|immunologic factors|mesh-ancestor
154441613|NCT05724056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441614|NCT05724056|Viscosupplements|viscosupplements|mesh-ancestor
153546211|NCT06193486|Cyclophosphamide|cyclophosphamide|mesh-list
153546262|NCT06172296|Immunologic Factors|immunologic factors|mesh-ancestor
154441615|NCT05724056|Protective Agents|protective agents|mesh-ancestor
154441616|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154441617|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
154441618|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
154441619|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441620|NCT01060059|Exenatide|exenatide|mesh-list
154441621|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154441622|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441623|NCT01060059|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154441624|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154441625|NCT01060059|Incretins|incretins|mesh-ancestor
154441626|NCT01060059|Hormones|hormones|mesh-ancestor
154441627|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441628|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
154441629|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
154441630|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154441631|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154441632|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441633|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441634|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441635|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441637|NCT04307797|Glucagon|glucagon|mesh-list
154441638|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154441639|NCT04307797|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154441640|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154441641|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441642|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154441643|NCT04307797|Incretins|incretins|mesh-ancestor
154441644|NCT04307797|Hormones|hormones|mesh-ancestor
154441645|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441646|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154441647|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154441648|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
154441649|NCT02125188|Coagulants|coagulants|mesh-ancestor
154441650|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154441651|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
154441652|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441653|NCT02125344|Paclitaxel|paclitaxel|mesh-list
154441654|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
154441655|NCT02125344|Carboplatin|carboplatin|mesh-list
154441656|NCT02125344|Doxorubicin|doxorubicin|mesh-list
154441657|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154441658|NCT02125344|Trastuzumab|trastuzumab|mesh-list
154441659|NCT02125344|Epirubicin|epirubicin|mesh-list
154441660|NCT02125344|Pertuzumab|pertuzumab|mesh-list
154441661|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154441662|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441663|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
154441664|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
154441665|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
154441666|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441667|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441668|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
154441669|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441670|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441671|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154441672|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
154441673|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154441674|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154441675|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154441676|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154441677|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441678|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441679|NCT05468840|Ketamine|ketamine|mesh-list
154441680|NCT05468840|Analgesics|analgesics|mesh-ancestor
154441681|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
154441682|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441683|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441684|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154441685|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154441686|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
154441687|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
154441688|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441689|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154441690|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154441691|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441692|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441693|NCT05723900|Castor Oil|castor oil|mesh-list
154441694|NCT05723900|Cathartics|cathartics|mesh-ancestor
154441695|NCT05723900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154441696|NCT02127138|Sirolimus|sirolimus|mesh-list
154441697|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154441698|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441699|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154441700|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441701|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
154441702|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441704|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441705|NCT03651531|Metformin|metformin|mesh-list
154441706|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154441707|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441708|NCT02903511|Metformin|metformin|mesh-list
154441709|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154441710|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441711|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
154441712|NCT05325528|Tislelizumab|tislelizumab|mesh-list
154441713|NCT05325528|Tegafur|tegafur|mesh-list
154441714|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441715|NCT05325528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441716|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154441717|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
154441718|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441719|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
154441720|NCT02125500|Ledipasvir|ledipasvir|mesh-list
154441721|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
154441722|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441723|NCT02125578|Interferons|interferons|mesh-list
154441724|NCT02125578|Interferon-beta|interferon-beta|mesh-list
154441725|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
154441726|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441727|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
154441728|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441729|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
154441730|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441731|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154441732|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154441733|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154441734|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154441735|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154441736|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441737|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441738|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154441739|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154441740|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441741|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
154441742|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441743|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154441744|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154441746|NCT00141284|Zidovudine|zidovudine|mesh-list
154441747|NCT00141284|Nelfinavir|nelfinavir|mesh-list
154441748|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154441749|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154441750|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441751|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441752|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
154441753|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441754|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154441755|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154441756|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
154441757|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154441758|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154441759|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
154441760|NCT04328506|Vorolanib|vorolanib|mesh-list
154441761|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154441762|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441763|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441764|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
154441765|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154441766|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441767|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154441768|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154441769|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441770|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441771|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441772|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
154441773|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154441774|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154441775|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441776|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
154441777|NCT02125890|Coagulants|coagulants|mesh-ancestor
154441778|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
154441779|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154441780|NCT05287984|Rituximab|rituximab|mesh-list
154441781|NCT05287984|Fludarabine|fludarabine|mesh-list
154441782|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
154441783|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154441784|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
154441785|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441786|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154441787|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154441788|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
154441789|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441790|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441791|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154441792|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441793|NCT05287984|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154441794|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154441795|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441796|NCT00134264|Atorvastatin|atorvastatin|mesh-list
153546411|NCT06106412|Calcimycin|calcimycin|mesh-list
154441797|NCT00134264|Torcetrapib|torcetrapib|mesh-list
154441798|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154441799|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154441800|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
154441801|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441802|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154441803|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154441804|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441805|NCT05285800|Bupivacaine|bupivacaine|mesh-list
154441806|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
154441807|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
154441808|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441809|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441810|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
154441811|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441812|NCT02122692|Itraconazole|itraconazole|mesh-list
154441813|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154441814|NCT02122692|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154441815|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
154441816|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441817|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154441818|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154441819|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441820|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441821|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154441822|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
154441823|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441824|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441825|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154441826|NCT02122692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154441827|NCT02122692|Serotonin Agents|serotonin agents|mesh-ancestor
154441828|NCT02122692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441829|NCT00131924|Estrogens|estrogens|mesh-list
154441830|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
154441831|NCT00131924|Hormones|hormones|mesh-ancestor
154441832|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441833|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441834|NCT05284474|Mitogens|mitogens|mesh-list
154441835|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
154441836|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441837|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154441838|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441839|NCT05609695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154441840|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441841|NCT04246060|Cysteamine|cysteamine|mesh-list
154441842|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154441843|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441844|NCT05129176|Metronidazole|metronidazole|mesh-list
154441845|NCT05129176|Levofloxacin|levofloxacin|mesh-list
154441846|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441847|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154441848|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154441849|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154441850|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154441851|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154441852|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154441853|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441854|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441855|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441856|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154441857|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154441858|NCT02127684|Ranibizumab|ranibizumab|mesh-list
154441859|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154441860|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154441861|NCT02127684|Growth Substances|growth substances|mesh-ancestor
154441862|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441863|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
154441864|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441865|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154441866|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154441867|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154441868|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
154441869|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441870|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154441871|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154441872|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441873|NCT02127840|Epinephrine|epinephrine|mesh-list
154441874|NCT02127840|Racepinephrine|racepinephrine|mesh-list
154441875|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
154441876|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154441877|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154441878|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
154441879|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441880|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441881|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441882|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154441883|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154441884|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
154441885|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154441886|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154441887|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
153546535|NCT06065735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441888|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
154441889|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
154441890|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154441891|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
154441892|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
154441893|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
154441894|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154441895|NCT05031442|Protective Agents|protective agents|mesh-ancestor
154441896|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441897|NCT02127918|Clobazam|clobazam|mesh-list
154441898|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
154441899|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154441900|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154441901|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441902|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441903|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154441904|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154441905|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
154441906|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
154441907|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441908|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441909|NCT00127634|Insulin|insulin|mesh-list
154441910|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154441911|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
154441912|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154441913|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441914|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154441915|NCT02127996|Incretins|incretins|mesh-ancestor
154441916|NCT02127996|Hormones|hormones|mesh-ancestor
154441917|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154441918|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441919|NCT02131350|Ranibizumab|ranibizumab|mesh-list
154441920|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154441921|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154441922|NCT02131350|Growth Substances|growth substances|mesh-ancestor
154441923|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441924|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
154441925|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441926|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
154441927|NCT02128308|Levofloxacin|levofloxacin|mesh-list
154441928|NCT02128308|Ofloxacin|ofloxacin|mesh-list
154441929|NCT02128308|Cycloserine|cycloserine|mesh-list
154441930|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
154441931|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154441932|NCT02128308|Streptomycin|streptomycin|mesh-list
154441933|NCT02128308|Kanamycin|kanamycin|mesh-list
154441934|NCT02128308|Prothionamide|prothionamide|mesh-list
154441935|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154441936|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154441937|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154441938|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154441939|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154441940|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441941|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441942|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441943|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154441944|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
154441945|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154441946|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441947|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154441948|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154441949|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154441950|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154441951|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154441952|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154441953|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154441954|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
154441955|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
154441956|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154441957|NCT02131506|Lapatinib|lapatinib|mesh-list
154441958|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154441959|NCT02131506|Doxorubicin|doxorubicin|mesh-list
154441960|NCT02131506|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154441961|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154441962|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441963|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441964|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154441965|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154441966|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154016646|NCT00952159|Tramadol|tramadol|mesh-list
154441967|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154441968|NCT01674010|Inositol|inositol|mesh-list
154441969|NCT01674010|Lamotrigine|lamotrigine|mesh-list
154441970|NCT01674010|Valproic Acid|valproic acid|mesh-list
154441971|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
154441972|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154441973|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154441974|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441975|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154441976|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154441977|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153546581|NCT06037330|Dsuvia|dsuvia|mesh-list
154441978|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154441979|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154441980|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154441981|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154441982|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441983|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
154441984|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154441985|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
154441986|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
154441987|NCT01674010|Vitamins|vitamins|mesh-ancestor
154441988|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
154441989|NCT02252328|Simvastatin|simvastatin|mesh-list
154441990|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154441991|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154441992|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
154441993|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154441994|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154441995|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154441996|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154441997|NCT04656964|Midazolam|midazolam|mesh-list
154441998|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154441999|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154442000|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442001|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442002|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154442003|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154442004|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154442005|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154442006|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
154442008|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
154442009|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
154442010|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442011|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442012|NCT02136030|Amphotericin B|amphotericin b|mesh-list
154442013|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154442014|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
154442015|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
154442016|NCT02136030|Amebicides|amebicides|mesh-ancestor
154442017|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154442018|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154442019|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442020|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442021|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
154442022|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154442023|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442024|NCT02131818|Amoxicillin|amoxicillin|mesh-list
154442025|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442026|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442027|NCT04605796|Bevacizumab|bevacizumab|mesh-list
154442028|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154442029|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442030|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154442031|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154442032|NCT04605796|Growth Substances|growth substances|mesh-ancestor
154016710|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154016711|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
154016712|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
154016713|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154016714|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
154016715|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154016716|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154016717|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154442033|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442034|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
154442035|NCT01345669|Afatinib|afatinib|mesh-list
154442036|NCT01345669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154442037|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442038|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442039|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442040|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442041|NCT01673854|Ipilimumab|ipilimumab|mesh-list
154442042|NCT01673854|Vemurafenib|vemurafenib|mesh-list
154442043|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154442044|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442045|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154442046|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442047|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442048|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442049|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
154442050|NCT03549702|Povidone|povidone|mesh-list
154442051|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
154442052|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
154442053|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154442054|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442055|NCT02529904|Vaccines|vaccines|mesh-list
154442056|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
154442057|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442058|NCT01367886|Fesoterodine|fesoterodine|mesh-list
154442059|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154442060|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154442061|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
154442062|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442063|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442064|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442065|NCT01367886|Urological Agents|urological agents|mesh-ancestor
154442066|NCT05706337|Propofol|propofol|mesh-list
154442067|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154442068|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442069|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442070|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154442071|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
154442072|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
154442073|NCT05222113|Remdesivir|remdesivir|mesh-list
154442074|NCT05222113|Favipiravir|favipiravir|mesh-list
154442075|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
154442076|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442077|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
154442078|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442079|NCT03854578|Citalopram|citalopram|mesh-list
154442080|NCT03854578|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154442081|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154442082|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154442083|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442084|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442085|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
154442086|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442087|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154442088|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
154442089|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154442090|NCT03038594|Hormones|hormones|mesh-list
154442091|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442092|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442093|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
154442094|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154442095|NCT02136888|Ponesimod|ponesimod|mesh-list
154442096|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442097|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442098|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154442099|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154442100|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442101|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442102|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442103|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154442104|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
154442105|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154442106|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442107|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154442108|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154442109|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154442110|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154442111|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154442112|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
154442113|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154442114|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
154442115|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154442116|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154442117|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154442118|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442119|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442121|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
154442122|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
154442123|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154442124|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442125|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154442126|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442127|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442128|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
154442129|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442130|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442131|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154442132|NCT02132442|Vitamin D|vitamin d|mesh-list
154442133|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
154442134|NCT02132442|Vitamins|vitamins|mesh-ancestor
154442135|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
154442136|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442137|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154442138|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154442139|NCT05010148|Lidocaine|lidocaine|mesh-list
154442140|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
154442141|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
153547706|NCT05319353|Maribavir|maribavir|mesh-list
154442142|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442143|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442144|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
154442145|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442146|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154442147|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154442148|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154442149|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154442150|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442151|NCT05138146|Doxorubicin|doxorubicin|mesh-list
154442152|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154442153|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154442154|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442155|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154442156|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154442157|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442158|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442159|NCT05221879|Enoxaparin|enoxaparin|mesh-list
154442160|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
154442161|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154442162|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154442163|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442164|NCT03450772|Pancrelipase|pancrelipase|mesh-list
154442165|NCT03450772|Pancreatin|pancreatin|mesh-list
154442166|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442167|NCT02129088|Esketamine|esketamine|mesh-list
154442168|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
154442169|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154442170|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
154442171|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154442172|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154442173|NCT05137522|Prednisolone|prednisolone|mesh-list
154442174|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
154442175|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154442176|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
154442177|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154442178|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
154442179|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
154442180|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442181|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016859|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442182|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442183|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
154442184|NCT05137522|Hormones|hormones|mesh-ancestor
154442185|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442186|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154442187|NCT05137522|Protective Agents|protective agents|mesh-ancestor
154442188|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154442189|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442190|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
154442191|NCT02129166|Dasatinib|dasatinib|mesh-list
154442192|NCT02129166|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154442193|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442194|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442195|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442196|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442197|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
154442198|NCT02137278|Levodopa|levodopa|mesh-list
154442199|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
154442200|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
154442201|NCT02137278|Diuretics|diuretics|mesh-list
154442202|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154442203|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
154442204|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442205|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
154442206|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442207|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442208|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154442209|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154442210|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154442211|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442212|NCT05705635|Docetaxel|docetaxel|mesh-list
154442213|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442214|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
154442215|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
154442216|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
154442217|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442219|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154442220|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
154442221|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442222|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442223|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154442224|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
154442225|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
154442226|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154442227|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154442228|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154442229|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154442230|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
154442231|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442232|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442233|NCT05193968|Nitroprusside|nitroprusside|mesh-list
154442234|NCT05193968|Norepinephrine|norepinephrine|mesh-list
154442235|NCT05193968|Acetylcholine|acetylcholine|mesh-list
154442236|NCT05193968|Terbutaline|terbutaline|mesh-list
154442237|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154442238|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154442239|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
154442240|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547793|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153547842|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154442241|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442242|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442243|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
154442244|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
154442245|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442246|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154442247|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154442248|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
154442249|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154442250|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154442251|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
154442252|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154442253|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154442254|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
154442255|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
154442256|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154442257|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154442258|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154442260|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154442261|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
154442262|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442263|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442264|NCT05137288|Atropine|atropine|mesh-list
154442265|NCT05137288|Ondansetron|ondansetron|mesh-list
154442266|NCT05137288|Bupivacaine|bupivacaine|mesh-list
154442267|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
154442268|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
154442269|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442270|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442271|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
154442272|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442273|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
154442274|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
154442275|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442276|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
154442277|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154442278|NCT05137288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154442279|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154442280|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
154442281|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442282|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442283|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154442284|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154442285|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154442286|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154442287|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154442288|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
154442289|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
154442290|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154442291|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154442292|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
154442293|NCT05135182|Metronidazole|metronidazole|mesh-list
154442294|NCT05135182|Furazolidone|furazolidone|mesh-list
154442295|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442296|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442297|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154442298|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154442299|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154442300|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154442301|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154442302|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154442303|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442304|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442305|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
154442306|NCT02137434|Calcium|calcium|mesh-list
154442307|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154442308|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442309|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154442310|NCT02137668|Vancomycin|vancomycin|mesh-list
154442311|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442312|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442313|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
154442314|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
154442315|NCT03522428|Vitamins|vitamins|mesh-ancestor
154442316|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
154442317|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442318|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
154442319|NCT03522428|Hematinics|hematinics|mesh-ancestor
154442320|NCT05575999|Ketorolac|ketorolac|mesh-list
154442321|NCT05575999|Ketamine|ketamine|mesh-list
154442322|NCT05575999|Bupivacaine|bupivacaine|mesh-list
154442323|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
154442324|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
154442325|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442326|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442327|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
154442328|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442329|NCT05575999|Analgesics|analgesics|mesh-ancestor
154442330|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154442331|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154442332|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
154442333|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154442334|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154442335|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442336|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442337|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154442338|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154442339|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154442340|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154442341|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154442342|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442343|NCT01062399|Everolimus|everolimus|mesh-list
154442344|NCT01062399|Temozolomide|temozolomide|mesh-list
154442345|NCT01062399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154442346|NCT01062399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442347|NCT01062399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442348|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442349|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154442350|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
154442351|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442352|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442353|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154442354|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
154442355|NCT05136508|Propofol|propofol|mesh-list
154442356|NCT05136508|Sevoflurane|sevoflurane|mesh-list
154442357|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154442358|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442359|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442360|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154442361|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
154442362|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
154442363|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154442364|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154442365|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
154442366|NCT02129322|Sorafenib|sorafenib|mesh-list
154442367|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442368|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442369|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442370|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442371|NCT03767712|Antibodies|antibodies|mesh-list
154442372|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
154442373|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
154442374|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442375|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
154442376|NCT05221411|Tacrolimus|tacrolimus|mesh-list
154442377|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154442378|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
154442379|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442380|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154442381|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442382|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442383|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154442384|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442385|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154442386|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
154442387|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442388|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442389|NCT05306002|Antioxidants|antioxidants|mesh-list
154442390|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442391|NCT05306002|Protective Agents|protective agents|mesh-ancestor
154442392|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442393|NCT04346914|Carboplatin|carboplatin|mesh-list
154442394|NCT04346914|Etoposide|etoposide|mesh-list
154442395|NCT04346914|Antibodies|antibodies|mesh-list
154442396|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154442397|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
154442398|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442399|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442400|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154442401|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154442402|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154442403|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442404|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442405|NCT02129400|Anesthetics|anesthetics|mesh-list
154442406|NCT02129400|Xenon|xenon|mesh-list
154442407|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442408|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442409|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154442410|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
154442411|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154442412|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154442413|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442414|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442415|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154442416|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154442417|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442418|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
154442419|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442420|NCT02133378|Hemostatics|hemostatics|mesh-list
154442421|NCT02133378|Coagulants|coagulants|mesh-ancestor
154442422|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
154442423|NCT04171622|Lenvatinib|lenvatinib|mesh-list
154442424|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154442425|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442426|NCT04171622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154442427|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442428|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442429|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442430|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154442431|NCT02138058|Topiramate|topiramate|mesh-list
154442432|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
154442433|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154442434|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442435|NCT02129634|Paclitaxel|paclitaxel|mesh-list
154442436|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154442437|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442438|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
154442439|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
154442440|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
154442441|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442443|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154442444|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442445|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442446|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442447|NCT02138292|Trametinib|trametinib|mesh-list
154442448|NCT02138292|Digoxin|digoxin|mesh-list
154442449|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442450|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442451|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442452|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442453|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154442454|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154442455|NCT02138292|Protective Agents|protective agents|mesh-ancestor
154442456|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442457|NCT02133612|Paclitaxel|paclitaxel|mesh-list
154442458|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154442459|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154442460|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442461|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
154442462|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
154442463|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
154442464|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442465|NCT03522194|Propofol|propofol|mesh-list
154442466|NCT03522194|Sevoflurane|sevoflurane|mesh-list
154442467|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154442468|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442469|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442470|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154442471|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
154442472|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
154442473|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154442474|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154442475|NCT04820686|Tenofovir|tenofovir|mesh-list
154442476|NCT04820686|Entecavir|entecavir|mesh-list
154442477|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
154442478|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442479|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154442480|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154442481|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442482|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442483|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154442484|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154442485|NCT02260908|Enoxaparin|enoxaparin|mesh-list
154442486|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
154442487|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154442488|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154442489|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442490|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
154442491|NCT02969655|Glycine|glycine|mesh-list
154442492|NCT02969655|Hematinics|hematinics|mesh-ancestor
154442493|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
154442494|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442495|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442496|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442497|NCT04488874|Mannitol|mannitol|mesh-list
154442498|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154442499|NCT04488874|Diuretics|diuretics|mesh-ancestor
154442500|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
154442501|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442502|NCT03651219|Irinotecan|irinotecan|mesh-list
154442503|NCT03651219|Apatinib|apatinib|mesh-list
154442504|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154442505|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154442506|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442507|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442508|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442509|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442510|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154442511|NCT02648698|Levofloxacin|levofloxacin|mesh-list
154442512|NCT02648698|Tinidazole|tinidazole|mesh-list
154442513|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442514|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154254832|NCT01251848|Ritonavir|ritonavir|mesh-list
154442515|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154442516|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154442517|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442518|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442519|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442520|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154442521|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154442522|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
154442523|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154442524|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154442525|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154442526|NCT03524846|Vitamins|vitamins|mesh-list
154442527|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
154442528|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
154442529|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442530|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
154442531|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442532|NCT03524846|Protective Agents|protective agents|mesh-ancestor
154442533|NCT05134558|Xenon|xenon|mesh-list
154442534|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154442535|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
154442536|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
154442537|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442538|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442539|NCT02970669|Valsartan|valsartan|mesh-list
154442540|NCT02970669|Enalapril|enalapril|mesh-list
154442541|NCT02970669|Enalaprilat|enalaprilat|mesh-list
154442542|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154442543|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154442544|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154442545|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154442546|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442547|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154442548|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
154442549|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442550|NCT02134002|Disulfiram|disulfiram|mesh-list
154442551|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154442552|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154442553|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442554|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442555|NCT03650361|Adapalene|adapalene|mesh-list
154442556|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154442557|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154442558|NCT03650361|Analgesics|analgesics|mesh-ancestor
154442559|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
154017232|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154442560|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442561|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442562|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154442563|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153548189|NCT04992013|Niraparib|niraparib|mesh-list
154442564|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
154442565|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154442566|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
154442567|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442568|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154442569|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
154442570|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154442571|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
154442572|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154442573|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
154442574|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442575|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442576|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
154442577|NCT02902965|Dexamethasone|dexamethasone|mesh-list
154442578|NCT02902965|Bortezomib|bortezomib|mesh-list
154442579|NCT02902965|Ibrutinib|ibrutinib|mesh-list
154442580|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154442581|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
154442582|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
154442583|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442584|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442585|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442586|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
154442587|NCT02902965|Hormones|hormones|mesh-ancestor
154442588|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442589|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154442590|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442591|NCT02902965|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154442592|NCT02902965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154442593|NCT02902965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442594|NCT02902965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442595|NCT02130414|Cyclosporine|cyclosporine|mesh-list
154442596|NCT02130414|Cyclosporins|cyclosporins|mesh-list
154442597|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442598|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442599|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154442600|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
154442601|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442602|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
154442603|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442604|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
154442605|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154442606|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154442607|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154442608|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
154442609|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442610|NCT02134470|Testosterone|testosterone|mesh-list
154442611|NCT02134470|Androgens|androgens|mesh-ancestor
154442612|NCT02134470|Hormones|hormones|mesh-ancestor
154442613|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442614|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442615|NCT02134626|Simvastatin|simvastatin|mesh-list
153548221|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
154442616|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154442617|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154442618|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
154442619|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442620|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154442621|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154442622|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442623|NCT02969187|Bupivacaine|bupivacaine|mesh-list
154442624|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
154442625|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
154442626|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442627|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442628|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
154442629|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442630|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154442631|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154442632|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154442633|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
154442634|NCT05285085|Atorvastatin|atorvastatin|mesh-list
154442635|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154442636|NCT05285085|Simvastatin|simvastatin|mesh-list
154442637|NCT05285085|Pravastatin|pravastatin|mesh-list
154442638|NCT05285085|Pitavastatin|pitavastatin|mesh-list
154442639|NCT05285085|Lovastatin|lovastatin|mesh-list
154442640|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154442641|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154442642|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
154442643|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442644|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154442645|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154442646|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442647|NCT02139930|Nicotine|nicotine|mesh-list
154442648|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154442649|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
154442650|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442651|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442652|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154442653|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154442654|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
154442655|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442656|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442657|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154442658|NCT02130804|Salicylates|salicylates|mesh-list
154442659|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154442660|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154442661|NCT02130804|Analgesics|analgesics|mesh-ancestor
154442662|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
154442663|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442664|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442665|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154442666|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154442667|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154442668|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442669|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442670|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
154442672|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154442673|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442674|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154442675|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
154442676|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442677|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442678|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442679|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442680|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154442681|NCT05303272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154442682|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154442683|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
154442684|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442685|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154442686|NCT03549312|Tenofovir|tenofovir|mesh-list
154442687|NCT03549312|Emtricitabine|emtricitabine|mesh-list
154442688|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
154442689|NCT03549312|Cobicistat|cobicistat|mesh-list
154442690|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154442691|NCT03549312|Velpatasvir|velpatasvir|mesh-list
154442692|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154442693|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154442694|NCT03549312|Elvitegravir|elvitegravir|mesh-list
154442695|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
154442696|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442697|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154442698|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154442699|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442700|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442701|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154442702|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154442703|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154442704|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154442705|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154442706|NCT03649269|Bezafibrate|bezafibrate|mesh-list
154442707|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154442708|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
153548365|NCT04821284|Paclitaxel|paclitaxel|mesh-list
154442709|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442710|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154442711|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154442713|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442714|NCT05373446|Ritonavir|ritonavir|mesh-list
154442715|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154442716|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154442717|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
154442718|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442719|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442720|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154442721|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154442722|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
154442723|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442724|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154442725|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154442726|NCT04734028|Clopidogrel|clopidogrel|mesh-list
154442727|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442728|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442729|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154442730|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154442731|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154442732|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154442733|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
154442734|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442735|NCT05285397|Liraglutide|liraglutide|mesh-list
154442736|NCT05285397|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154442738|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442739|NCT05285397|Incretins|incretins|mesh-ancestor
154442740|NCT05285397|Hormones|hormones|mesh-ancestor
154442741|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442742|NCT03050359|Lansoprazole|lansoprazole|mesh-list
154442743|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
154442744|NCT03050359|Bismuth|bismuth|mesh-list
154442745|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154442746|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442747|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154442748|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548419|NCT04802759|Inavolisib|inavolisib|mesh-list
154442749|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442750|NCT03050359|Antacids|antacids|mesh-ancestor
154442751|NCT05302726|Estrogens|estrogens|mesh-list
154442752|NCT05302726|Hormones|hormones|mesh-ancestor
154442753|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442754|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442755|NCT02253264|Rituximab|rituximab|mesh-list
154442756|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154442757|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442758|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
154442759|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442760|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154442761|NCT03648333|Niacin|niacin|mesh-list
154442762|NCT03648333|Amlodipine|amlodipine|mesh-list
154442763|NCT03648333|Valsartan|valsartan|mesh-list
154442764|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154442765|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154442766|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154442767|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154442768|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442769|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154442770|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442771|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
154442772|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154442773|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154442774|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154442775|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
154442776|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154442777|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
154442778|NCT03648333|Vitamins|vitamins|mesh-ancestor
154442779|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
154442780|NCT02252796|Paclitaxel|paclitaxel|mesh-list
154442781|NCT02252796|Carboplatin|carboplatin|mesh-list
154442782|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154442783|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442784|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
154442785|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
154442786|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
154442787|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442788|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
154442789|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442790|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442791|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154442792|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154442793|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548472|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
154442794|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442795|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442796|NCT04660123|Bismuth|bismuth|mesh-list
154442797|NCT04660123|Antacids|antacids|mesh-ancestor
154442798|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442799|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442800|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154442801|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
154442802|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154442803|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154442804|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442805|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
154442806|NCT05579418|Evolocumab|evolocumab|mesh-list
154442807|NCT05579418|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154442808|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154442809|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154442810|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
154071404|NCT00913718|Fluoxetine|fluoxetine|mesh-list
154442811|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442812|NCT05579418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154442813|NCT05579418|Protease Inhibitors|protease inhibitors|mesh-ancestor
154442814|NCT05579418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442815|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154442816|NCT02968173|Palivizumab|palivizumab|mesh-list
154442817|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
154442818|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442819|NCT02135640|Denosumab|denosumab|mesh-list
154442820|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154442821|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442822|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154442823|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
154442824|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154442825|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
154442826|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442827|NCT02253342|Levonadifloxacin|levonadifloxacin|mesh-list
154442828|NCT02253342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154442829|NCT02253342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442830|NCT02253342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442831|NCT02253342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442832|NCT02253342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442833|NCT00495508|Lumefantrine|lumefantrine|mesh-list
154442834|NCT00495508|Artemether|artemether|mesh-list
154442835|NCT00495508|Quinine|quinine|mesh-list
154442836|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154442837|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
154442838|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154442839|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154442840|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442841|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154442842|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442843|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154442844|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442845|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154442846|NCT00495508|Analgesics|analgesics|mesh-ancestor
154442847|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
154442848|NCT05284851|Vaccines|vaccines|mesh-list
154442849|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
154442850|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442851|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154442852|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154442853|NCT03049735|Norethindrone|norethindrone|mesh-list
154442854|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
154442855|NCT03049735|Estradiol|estradiol|mesh-list
154442856|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154442857|NCT03049735|Relugolix|relugolix|mesh-list
154442858|NCT03049735|Estrogens|estrogens|mesh-ancestor
154442859|NCT03049735|Hormones|hormones|mesh-ancestor
154442860|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442861|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442862|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154442863|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
154442864|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154442865|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154442866|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154442867|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154442868|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154442869|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
154442870|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
154442871|NCT04785638|Bupivacaine|bupivacaine|mesh-list
154442872|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
154442873|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
154442874|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442875|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442876|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
154442877|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442878|NCT04762472|Montelukast|montelukast|mesh-list
154442879|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154442880|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
154442881|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154442882|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
154442883|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442884|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442885|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154442886|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154442887|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442888|NCT01295944|Bevacizumab|bevacizumab|mesh-list
154442889|NCT01295944|Carboplatin|carboplatin|mesh-list
154442890|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548588|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
154442891|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442892|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154442893|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154442894|NCT01295944|Growth Substances|growth substances|mesh-ancestor
154442895|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442896|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
154442897|NCT04742348|Levodopa|levodopa|mesh-list
154442898|NCT04742348|Carbidopa|carbidopa|mesh-list
154442899|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154442900|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154442901|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154442902|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
154442903|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442904|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442905|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442906|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154442907|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442908|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154442909|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
154442910|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
154442911|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
154442912|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154442913|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154442914|NCT02140632|Prednisolone|prednisolone|mesh-list
154442915|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
154442916|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154442917|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
154442918|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154442919|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
154442920|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
154442921|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442922|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442923|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442924|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
154442925|NCT02140632|Hormones|hormones|mesh-ancestor
154442926|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442927|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154442928|NCT02140632|Protective Agents|protective agents|mesh-ancestor
154442929|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154442930|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442931|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
154442932|NCT05578404|Vitamin D|vitamin d|mesh-list
154017614|NCT00917579|Atorvastatin|atorvastatin|mesh-list
154442933|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154442934|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442935|NCT05578404|Vitamins|vitamins|mesh-ancestor
154442936|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
154442937|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154442938|NCT03521960|Buspirone|buspirone|mesh-list
154442939|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154442940|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154442941|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442942|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442943|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154442944|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154442945|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
154442946|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154442947|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442948|NCT05479578|Dexamethasone|dexamethasone|mesh-list
154442949|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
154442950|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
154442951|NCT05479578|Ichthammol|ichthammol|mesh-list
154442952|NCT05479578|BB 1101|bb 1101|mesh-list
154442953|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154442954|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
154442955|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442956|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154442957|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154442958|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
154442959|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442960|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442961|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154442962|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154442963|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
154442964|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
154442965|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154442966|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442967|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
154442968|NCT05479578|Hormones|hormones|mesh-ancestor
154442969|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154442970|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154442971|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
154442972|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442973|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
154442974|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154442975|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442976|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
154442977|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
154442978|NCT04853628|Ethanol|ethanol|mesh-list
154442979|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154442980|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442981|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154442982|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154442983|NCT03521726|Amoxicillin|amoxicillin|mesh-list
154442984|NCT03521726|Rabeprazole|rabeprazole|mesh-list
154442985|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154442986|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154442987|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154442988|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154442989|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154442990|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154442991|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442992|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
154442993|NCT03546426|Interleukin-2|interleukin-2|mesh-list
154442994|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154442995|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154442996|NCT03546426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154442997|NCT03546426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154442998|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154442999|NCT03546426|Analgesics|analgesics|mesh-ancestor
154443000|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
154443001|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443002|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443003|NCT02897349|Linagliptin|linagliptin|mesh-list
154443004|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154443005|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443006|NCT02897349|Incretins|incretins|mesh-ancestor
154443007|NCT02897349|Hormones|hormones|mesh-ancestor
154443008|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443009|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154443010|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
154443011|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443012|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443013|NCT03134378|Amoxicillin|amoxicillin|mesh-list
154443014|NCT03134378|Clarithromycin|clarithromycin|mesh-list
154443015|NCT03134378|Rabeprazole|rabeprazole|mesh-list
154443016|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154443017|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443018|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154443019|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443020|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443021|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154443022|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154443023|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154443024|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154443025|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154443026|NCT05434104|Metronidazole|metronidazole|mesh-list
154443027|NCT05434104|Fluconazole|fluconazole|mesh-list
154443028|NCT05434104|Lactoferrin|lactoferrin|mesh-list
154443029|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443030|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154443031|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154443032|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154443033|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
154443034|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154443035|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154443036|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443037|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443038|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154443039|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
154443040|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443041|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443042|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154443043|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154443044|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154443045|NCT03523832|Celecoxib|celecoxib|mesh-list
154443046|NCT03523832|Pregabalin|pregabalin|mesh-list
154443047|NCT03523832|Analgesics|analgesics|mesh-ancestor
154443048|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
154443049|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443050|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443051|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
154443052|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154443053|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154443054|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443055|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154443056|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154443057|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154443058|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443059|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154443060|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154443061|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154443062|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443063|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443064|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154443065|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154443066|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443067|NCT05577624|Rifampin|rifampin|mesh-list
154443068|NCT05577624|Sotorasib|sotorasib|mesh-list
154443069|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154443070|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
154443071|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154443072|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443073|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
154443074|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154443075|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443076|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443077|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154443078|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154443079|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154443080|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154443081|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154443082|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154443083|NCT05577624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154443084|NCT05577624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154443085|NCT05577624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443086|NCT03294694|Fulvestrant|fulvestrant|mesh-list
154443087|NCT03294694|Spartalizumab|spartalizumab|mesh-list
154443088|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154443089|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443090|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154443091|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154443092|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
154443093|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443094|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443095|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154443096|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443097|NCT03294694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154443098|NCT03523754|Isosorbide|isosorbide|mesh-list
154443099|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154443100|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154443101|NCT03523754|Misoprostol|misoprostol|mesh-list
153548837|NCT04551131|Dexamethasone|dexamethasone|mesh-list
153548903|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154443102|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154443103|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
154443104|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154443105|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443106|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154443107|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154443108|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
154443109|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154443110|NCT03523754|Diuretics|diuretics|mesh-ancestor
154443111|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
154443112|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
154443113|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154443114|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443116|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154443117|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443118|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443119|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154443120|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
154443121|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
154443122|NCT03644511|Sorafenib|sorafenib|mesh-list
154443123|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443124|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154443125|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443126|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443127|NCT03290560|Kallikreins|kallikreins|mesh-list
154443128|NCT03290560|Coagulants|coagulants|mesh-ancestor
154443129|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154443130|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
154443131|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154443132|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443133|NCT01316419|Amlodipine|amlodipine|mesh-list
154443134|NCT01316419|Telmisartan|telmisartan|mesh-list
154443135|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154443136|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154443137|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154443138|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443139|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154443140|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443141|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
154443142|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154443143|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154443144|NCT03547362|Caseins|caseins|mesh-list
154443145|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
154443146|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
154443147|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443148|NCT04258150|Nivolumab|nivolumab|mesh-list
154443149|NCT04258150|Ipilimumab|ipilimumab|mesh-list
154443150|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154443151|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443152|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154017832|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
154443153|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443155|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154443156|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443157|NCT02289248|Ketamine|ketamine|mesh-list
154443158|NCT02289248|Analgesics|analgesics|mesh-ancestor
154443159|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
154443160|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443161|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443162|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154443163|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154443164|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
154443165|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
154443166|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443167|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154443168|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154443169|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443170|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443171|NCT02253420|Itraconazole|itraconazole|mesh-list
154443172|NCT02253420|Rifampin|rifampin|mesh-list
154443173|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
154443174|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443175|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154443176|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154443177|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443178|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443179|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154443180|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
154443181|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443182|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443183|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154443184|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154443185|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
154443186|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154443187|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
154443188|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154443189|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154443190|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154443191|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154443192|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154443193|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154443194|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154443196|NCT02028364|Exemestane|exemestane|mesh-list
154443197|NCT02028364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154443198|NCT02028364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154443199|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443200|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443201|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154443202|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
154443203|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443204|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443205|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154443206|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154443207|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154443208|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
154443209|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443210|NCT02897115|Adalimumab|adalimumab|mesh-list
154443211|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154443212|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154443213|NCT02897115|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154443214|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443215|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154443216|NCT02897115|Analgesics|analgesics|mesh-ancestor
154443217|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
154443218|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443219|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443220|NCT02289482|Ritonavir|ritonavir|mesh-list
154443221|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
154443222|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154443223|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154443224|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
154443225|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443226|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443228|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154443229|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
154443230|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443231|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154443232|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154443233|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
154443234|NCT04030195|Fludarabine|fludarabine|mesh-list
154443235|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154443236|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
154443237|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443238|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443239|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154443240|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
154443241|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443242|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443243|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154443244|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154443245|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
154443246|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154443247|NCT02253966|Prednisolone|prednisolone|mesh-list
154443248|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
154443249|NCT02253966|Lidocaine|lidocaine|mesh-list
154443250|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154443251|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
154443252|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
154443253|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
154443254|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443255|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443256|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
154443257|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443258|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154443259|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154443260|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154443261|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154443262|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443263|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443264|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
154443265|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
154443266|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154443267|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
154443268|NCT02253966|Hormones|hormones|mesh-ancestor
154443269|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443270|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154443271|NCT02253966|Protective Agents|protective agents|mesh-ancestor
154443272|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154443273|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443274|NCT01673620|Loratadine|loratadine|mesh-list
154443275|NCT01673620|Montelukast|montelukast|mesh-list
154443276|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154443277|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
154443278|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154443279|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
154443280|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443281|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443282|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154443283|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154443284|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443285|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
154443286|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
154443287|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154443288|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154443289|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154443290|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
154443291|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
154443292|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549100|NCT04400994|Rituximab|rituximab|mesh-list
154443293|NCT04671355|Fluticasone|fluticasone|mesh-list
154443294|NCT04671355|Xhance|xhance|mesh-list
154443295|NCT04671355|Beclomethasone|beclomethasone|mesh-list
154443296|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
154443297|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
154443298|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443299|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154443300|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
154443301|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443302|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443303|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154443304|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
154443305|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
154443306|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154443307|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154443308|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154443309|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154443310|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
154443311|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443312|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443313|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154443314|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154443315|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154443316|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
154443317|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
154443318|NCT04671355|Hormones|hormones|mesh-ancestor
154443319|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443320|NCT03521492|Vitamin D|vitamin d|mesh-list
154443321|NCT03521492|Calcium|calcium|mesh-list
154443322|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
154443323|NCT03521492|Hormones|hormones|mesh-list
154443324|NCT03521492|Vitamins|vitamins|mesh-ancestor
154443325|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
154443326|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071923|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443327|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154443328|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154443329|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443330|NCT03521414|Sevoflurane|sevoflurane|mesh-list
154443331|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154443332|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154443333|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
154443334|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
154443335|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443336|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443337|NCT00432094|Paclitaxel|paclitaxel|mesh-list
154443338|NCT00432094|Etoposide|etoposide|mesh-list
154443339|NCT00432094|Carboplatin|carboplatin|mesh-list
154443340|NCT00432094|Ifosfamide|ifosfamide|mesh-list
154443341|NCT00432094|Thiotepa|thiotepa|mesh-list
154443342|NCT00432094|Mesna|mesna|mesh-list
154443343|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154443344|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443345|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
154443346|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
154443347|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
154443348|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443349|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154443350|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154443351|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443352|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
154443353|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443354|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154443355|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
154443356|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154443357|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154443358|NCT00432094|Protective Agents|protective agents|mesh-ancestor
154443359|NCT04562779|Naltrexone|naltrexone|mesh-list
154443360|NCT04562779|Ketamine|ketamine|mesh-list
154443361|NCT04562779|Analgesics|analgesics|mesh-ancestor
154443362|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
154443363|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443364|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443365|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154443366|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154443367|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
154443368|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
154443369|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443370|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154443371|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154443372|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549196|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
153549236|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154443373|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443374|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154443375|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154443376|NCT03751761|Paclitaxel|paclitaxel|mesh-list
154443377|NCT03751761|Durvalumab|durvalumab|mesh-list
154443378|NCT03751761|Tremelimumab|tremelimumab|mesh-list
154443379|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154443380|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443381|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
154443382|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
154443383|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
154443384|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443385|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154443386|NCT03644823|Atezolizumab|atezolizumab|mesh-list
154443387|NCT03644823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154443388|NCT03644823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443389|NCT03644823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154443390|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443391|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
154443392|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154443393|NCT00072358|Irinotecan|irinotecan|mesh-list
154443394|NCT00072358|Temozolomide|temozolomide|mesh-list
154443395|NCT00072358|Molgramostim|molgramostim|mesh-list
154443396|NCT00072358|Isotretinoin|isotretinoin|mesh-list
154443397|NCT00072358|Antibodies|antibodies|mesh-list
154443398|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
154443399|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154443400|NCT00072358|Sargramostim|sargramostim|mesh-list
154443401|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
154443402|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
154443403|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443404|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443405|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154443406|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154443407|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443408|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443409|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154443410|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
154443411|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
154443412|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154443413|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443414|NCT03104998|Ubiquinone|ubiquinone|mesh-list
154443415|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
154443416|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
154443417|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443418|NCT03104998|Vitamins|vitamins|mesh-ancestor
154443419|NCT03990766|Theophylline|theophylline|mesh-list
154443420|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154443421|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
154443422|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443423|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443424|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154443425|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
154443426|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154443427|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443428|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443429|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
154443430|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154443431|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154443432|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
154443433|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443434|NCT02294162|Ketamine|ketamine|mesh-list
154443435|NCT02294162|Analgesics|analgesics|mesh-ancestor
154443436|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
154443437|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443438|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443439|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154443440|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154443441|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
154443442|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
154443443|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443444|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154443445|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154443446|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443447|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443448|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154443449|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154443450|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154443451|NCT05176158|Analgesics|analgesics|mesh-ancestor
154443452|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
154443453|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443454|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443455|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443456|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443457|NCT02294240|Folic Acid|folic acid|mesh-list
154443458|NCT02294240|Hematinics|hematinics|mesh-ancestor
154443459|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
154443460|NCT02294240|Vitamins|vitamins|mesh-ancestor
154443461|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
154443462|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443463|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
154443464|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154443465|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154443466|NCT04481724|Analgesics|analgesics|mesh-ancestor
154443467|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
154443468|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443469|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443470|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443471|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443472|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154443473|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
154443474|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443475|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154443476|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
154443477|NCT02298218|Meloxicam|meloxicam|mesh-list
154443478|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154443479|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154443480|NCT02298218|Analgesics|analgesics|mesh-ancestor
154443481|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
154443482|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443483|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443484|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443485|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443486|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154443487|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154443488|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443489|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443490|NCT03547830|Plerixafor|plerixafor|mesh-list
154443491|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154443492|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154443493|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
154443494|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443495|NCT04390945|Capecitabine|capecitabine|mesh-list
154443496|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154443497|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
154443498|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443499|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443500|NCT02291666|Tolbutamide|tolbutamide|mesh-list
154443501|NCT02291666|Midazolam|midazolam|mesh-list
153549371|NCT04177433|Hormones|hormones|mesh-ancestor
154443502|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
154443503|NCT02291666|Caffeine|caffeine|mesh-list
154443504|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
154443505|NCT02291666|Bupropion|bupropion|mesh-list
154443506|NCT02291666|Omeprazole|omeprazole|mesh-list
154443507|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154443508|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154443509|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443510|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443511|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154443512|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154443513|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154443514|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154443515|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
154443516|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
154443517|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
154443518|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
154443519|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443520|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443521|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154443522|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154443523|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443524|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154443525|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154443526|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
154443527|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154443528|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154443529|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154443530|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154443531|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
154443532|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154443533|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154443534|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154443535|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
154443536|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154443537|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154443538|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
154443539|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
154443540|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154443541|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154443542|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443543|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154443544|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154443545|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154443546|NCT03102658|Micafungin|micafungin|mesh-list
154443547|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
154443548|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443549|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
154443550|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154443551|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443552|NCT02646748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154443554|NCT03624985|Lidocaine|lidocaine|mesh-list
154443555|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
154443556|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
154443557|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443558|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443559|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
154443560|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443561|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154443562|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154443563|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154443564|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154443565|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443566|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
154443567|NCT03521024|Ether|ether|mesh-list
154443568|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
154443569|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154443570|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443571|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443572|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
154443573|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154443574|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443575|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443576|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154443577|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
154443578|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
154443579|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
154443580|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
154443581|NCT02294552|Busulfan|busulfan|mesh-list
154443582|NCT02294552|Fludarabine|fludarabine|mesh-list
154443583|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
154443584|NCT02294552|Tacrolimus|tacrolimus|mesh-list
154443585|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154443586|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
154443587|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443588|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443589|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154443590|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
154443591|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443592|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443593|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154443594|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154443595|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
154443596|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154443597|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443598|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154018282|NCT00953641|Misoprostol|misoprostol|mesh-list
154443599|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154443600|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
154443601|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154443602|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443603|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
154443604|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154443605|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443606|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154443607|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
154443608|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154443609|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443610|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549456|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154443611|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443613|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154443614|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154443615|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443616|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443617|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
154443618|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443619|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154443620|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154443621|NCT04435522|Maraviroc|maraviroc|mesh-list
154443622|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154443623|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154443624|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443625|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154443627|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
154443628|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443629|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154443630|NCT03843970|Bupivacaine|bupivacaine|mesh-list
154443631|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
154443632|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154443633|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
154443634|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
154443635|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443636|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443637|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
154443638|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443639|NCT03043651|Treprostinil|treprostinil|mesh-list
154443640|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154443641|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154443642|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
154443643|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443644|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154443645|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154443646|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
154443647|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443648|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443649|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154443650|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154443651|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
154443652|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443653|NCT02298530|Caffeine|caffeine|mesh-list
154443654|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154443655|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443656|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154443657|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443658|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443659|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154443660|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154443661|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
154443662|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443663|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
154443664|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
154443665|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
154443666|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443667|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154443668|NCT03644589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154443669|NCT03644589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443670|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
154443671|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443672|NCT03514550|Propofol|propofol|mesh-list
154443673|NCT03514550|Sevoflurane|sevoflurane|mesh-list
154443674|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154443675|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443676|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443677|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154443678|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
154443679|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
154443680|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154443681|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154443682|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
154443683|NCT01344759|Propofol|propofol|mesh-list
154443684|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154443685|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153549556|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549618|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443686|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443687|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154443688|NCT01344759|Analgesics|analgesics|mesh-ancestor
154443689|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
154443690|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443691|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154443692|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154443693|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154443694|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
154443695|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443696|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443697|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154443698|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
154443699|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
154443701|NCT05885386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154443702|NCT05885386|Alkylating Agents|alkylating agents|mesh-ancestor
154443703|NCT05885386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443704|NCT05885386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443705|NCT05885360|Istradefylline|istradefylline|mesh-list
154443706|NCT05885360|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154443707|NCT05885360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154443708|NCT05885360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154443709|NCT05885360|Purinergic Agents|purinergic agents|mesh-ancestor
154443710|NCT05885360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443711|NCT05885360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443712|NCT05885360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443713|NCT05885269|Clobetasol|clobetasol|mesh-list
154443714|NCT05885269|Tacrolimus|tacrolimus|mesh-list
154443715|NCT05885269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154443716|NCT05885269|Immunologic Factors|immunologic factors|mesh-ancestor
154443717|NCT05885269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443718|NCT05885269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154443719|NCT05885269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443720|NCT05885269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443721|NCT05885269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443722|NCT05885269|Glucocorticoids|glucocorticoids|mesh-ancestor
154443723|NCT05885269|Hormones|hormones|mesh-ancestor
154443724|NCT05885269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443725|NCT05885035|Calcium|calcium|mesh-list
154443726|NCT05885035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154443727|NCT05885035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443728|NCT05884983|Vaccines|vaccines|mesh-list
154443729|NCT05884983|Immunologic Factors|immunologic factors|mesh-ancestor
154443730|NCT05884983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443731|NCT05884970|Albuterol|albuterol|mesh-list
154443732|NCT05884970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154443733|NCT05884970|Autonomic Agents|autonomic agents|mesh-ancestor
154443734|NCT05884970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443735|NCT05884970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443736|NCT05884970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154443737|NCT05884970|Respiratory System Agents|respiratory system agents|mesh-ancestor
154443738|NCT05884970|Tocolytic Agents|tocolytic agents|mesh-ancestor
154443739|NCT05884970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154443740|NCT05884970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154443741|NCT05884970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154443742|NCT05884970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154443743|NCT05884970|Adrenergic Agents|adrenergic agents|mesh-ancestor
154443744|NCT05884970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443745|NCT05884970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443746|NCT05884502|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154443747|NCT05884502|Ezetimibe|ezetimibe|mesh-list
154443748|NCT05884502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154443749|NCT05884502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154443750|NCT05884502|Antimetabolites|antimetabolites|mesh-ancestor
154443751|NCT05884502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443752|NCT05884502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154443753|NCT05884502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154443754|NCT05884502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443755|NCT05884463|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154443756|NCT05884463|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154443757|NCT05884463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443758|NCT05884268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154443759|NCT05884268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154443760|NCT05884268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154443761|NCT05884268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154443762|NCT05884268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443763|NCT05884268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443764|NCT05884268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443765|NCT05884268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154443766|NCT05884268|Antidepressive Agents|antidepressive agents|mesh-ancestor
154443767|NCT05884268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154443768|NCT05884255|Octreotide|octreotide|mesh-list
154443769|NCT05884255|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154443770|NCT05884255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154443771|NCT05884255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154443772|NCT05884255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443773|NCT05884255|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154443774|NCT05884255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443776|NCT05884151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154443777|NCT05884151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154443778|NCT05884151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443779|NCT05884151|Hemostatics|hemostatics|mesh-ancestor
154443780|NCT05884151|Coagulants|coagulants|mesh-ancestor
154443781|NCT05883891|Thrombin|thrombin|mesh-list
154443782|NCT05883891|Hemostatics|hemostatics|mesh-ancestor
154443783|NCT05883891|Coagulants|coagulants|mesh-ancestor
154443784|NCT05883865|Fenofibrate|fenofibrate|mesh-list
154443785|NCT05883865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154443786|NCT05883865|Antimetabolites|antimetabolites|mesh-ancestor
154443787|NCT05883865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443788|NCT05883865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154443789|NCT05883709|Lenalidomide|lenalidomide|mesh-list
154443790|NCT05883709|Immunologic Factors|immunologic factors|mesh-ancestor
154443791|NCT05883709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443792|NCT05883709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154443793|NCT05883709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154443794|NCT05883709|Growth Substances|growth substances|mesh-ancestor
154443795|NCT05883709|Growth Inhibitors|growth inhibitors|mesh-ancestor
154443796|NCT05883709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443797|NCT05881720|Valsartan|valsartan|mesh-list
154443798|NCT05881720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154443799|NCT05881720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154443800|NCT05881720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154443801|NCT05881720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154443802|NCT05881720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549836|NCT03858049|Hormones|hormones|mesh-ancestor
154443803|NCT05873725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154443804|NCT05873725|Hormones|hormones|mesh-ancestor
154443805|NCT05873725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443806|NCT05873725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443807|NCT05860530|Olaparib|olaparib|mesh-list
154443808|NCT05860530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154443809|NCT05860530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443810|NCT05860530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443811|NCT05860530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443812|NCT05830799|Tolbutamide|tolbutamide|mesh-list
154443813|NCT05830799|Nintedanib|nintedanib|mesh-list
154443814|NCT05830799|Midazolam|midazolam|mesh-list
154443815|NCT05830799|Caffeine|caffeine|mesh-list
154443816|NCT05830799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154443817|NCT05830799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154443818|NCT05830799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443819|NCT05830799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443820|NCT05830799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154443821|NCT05830799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154443822|NCT05830799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154443823|NCT05830799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154443824|NCT05830799|Anesthetics, General|anesthetics, general|mesh-ancestor
154443825|NCT05830799|Anesthetics|anesthetics|mesh-ancestor
154443826|NCT05830799|GABA Modulators|gaba modulators|mesh-ancestor
154443827|NCT05830799|GABA Agents|gaba agents|mesh-ancestor
154443828|NCT05830799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443829|NCT05830799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443830|NCT05830799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154443831|NCT05830799|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154443832|NCT05830799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443833|NCT05830799|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154443834|NCT05830799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154443835|NCT05830799|Purinergic Agents|purinergic agents|mesh-ancestor
154443836|NCT05830799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443837|NCT05830799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154443838|NCT05830799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154443839|NCT05827523|Cisplatin|cisplatin|mesh-list
154443840|NCT05827523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443841|NCT05731843|Ruzasvir|ruzasvir|mesh-list
154443842|NCT05731843|Antiviral Agents|antiviral agents|mesh-ancestor
154443843|NCT05731843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443844|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154072442|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
154443845|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
154443846|NCT05633563|Trimetazidine|trimetazidine|mesh-list
154443847|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
154443848|NCT05627271|Ofatumumab|ofatumumab|mesh-list
154443849|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
154443850|NCT05627271|Natalizumab|natalizumab|mesh-list
154443851|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443852|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
154443853|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443854|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
154443855|NCT05571514|Calcium|calcium|mesh-list
154443856|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154443857|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443858|NCT05571514|Antacids|antacids|mesh-ancestor
154443859|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443860|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154443861|NCT05556720|Vaccines|vaccines|mesh-list
154443862|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
154443863|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443864|NCT05498389|Osimertinib|osimertinib|mesh-list
154443865|NCT05498389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154443866|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154443867|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443868|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443869|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443870|NCT05334056|Cocaine|cocaine|mesh-list
154443871|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
154443872|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
154443873|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443874|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443875|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
154443876|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443877|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154443878|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154443879|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154443880|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154443881|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443882|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
154443883|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443884|NCT05328414|Prednisolone|prednisolone|mesh-list
154443885|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443886|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
154443887|NCT05328414|Hormones|hormones|mesh-ancestor
154443888|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443889|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443890|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154443891|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443892|NCT05298085|Oxytocin|oxytocin|mesh-list
154443893|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
154018571|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
154443894|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154443895|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443896|NCT05291598|Ketorolac|ketorolac|mesh-list
154443897|NCT05291598|Meloxicam|meloxicam|mesh-list
154443898|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154443899|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154443900|NCT05291598|Analgesics|analgesics|mesh-ancestor
154443901|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
154443902|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443903|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443904|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443905|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443906|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154443907|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443908|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443909|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154443910|NCT05190432|Taxifolin|taxifolin|mesh-list
154443911|NCT05190432|Ergothioneine|ergothioneine|mesh-list
154443912|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
154443913|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443914|NCT05190432|Protective Agents|protective agents|mesh-ancestor
154443915|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443916|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154443917|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154443918|NCT05190432|Analgesics|analgesics|mesh-ancestor
154443919|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
154443920|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443921|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443922|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154443923|NCT05123131|Dexamethasone|dexamethasone|mesh-list
154443924|NCT05123131|Lenalidomide|lenalidomide|mesh-list
154443925|NCT05123131|Bortezomib|bortezomib|mesh-list
154443926|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154443927|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
154443928|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
154443929|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443930|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443931|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154443932|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
154443933|NCT05123131|Hormones|hormones|mesh-ancestor
154443934|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154443935|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154443936|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443937|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
154443938|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154443939|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154443940|NCT05123131|Growth Substances|growth substances|mesh-ancestor
154443941|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
154443942|NCT05101187|Amphotericin B|amphotericin b|mesh-list
154443943|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154443944|NCT05101187|Olorofim|olorofim|mesh-list
154443945|NCT05101187|Amebicides|amebicides|mesh-ancestor
154443946|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154443947|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154443948|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443949|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154443950|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
154443951|NCT05024045|Pirtobrutinib|pirtobrutinib|mesh-list
154443952|NCT05024045|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154443953|NCT05024045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154443954|NCT05024045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443955|NCT05024045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443956|NCT05000047|Silicon|silicon|mesh-list
154443957|NCT05000047|Trace Elements|trace elements|mesh-ancestor
154443958|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
154443959|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443960|NCT04974047|Tislelizumab|tislelizumab|mesh-list
154443961|NCT04974047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154443962|NCT04974047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154443963|NCT04920942|Ivermectin|ivermectin|mesh-list
154443964|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154443965|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154443966|NCT04821687|Opicapone|opicapone|mesh-list
154443967|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
154443968|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154443969|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443970|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
154443971|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443972|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443973|NCT04821687|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154443974|NCT04821687|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154443975|NCT04821687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154443976|NCT04764344|Haloperidol|haloperidol|mesh-list
154443977|NCT04764344|Ondansetron|ondansetron|mesh-list
154443978|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
154443979|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
154443980|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
154443981|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154443982|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154443983|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154443984|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
154443985|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
154443986|NCT04764344|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154443987|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154443988|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
154443989|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154443990|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154443991|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154443992|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154443993|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154443994|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154443995|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154443996|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
154443998|NCT04738981|Basiliximab|basiliximab|mesh-list
154443999|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154444000|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
154444001|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444002|NCT04709185|Dexamethasone|dexamethasone|mesh-list
154444003|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444004|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
154444005|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
154444006|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444007|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444008|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444009|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
154444010|NCT04709185|Hormones|hormones|mesh-ancestor
154444011|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444012|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444013|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444014|NCT04693156|Bupivacaine|bupivacaine|mesh-list
154444015|NCT04693156|Prilocaine|prilocaine|mesh-list
154444016|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
154444017|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
154444018|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444019|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444020|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
154444021|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444022|NCT04504331|Tamoxifen|tamoxifen|mesh-list
154444023|NCT04504331|Infigratinib|infigratinib|mesh-list
154444024|NCT04504331|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154444025|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154444026|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
154444027|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444028|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444029|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444030|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444031|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154444032|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154444033|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154444034|NCT04504331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154444035|NCT04504331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444036|NCT04504331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444037|NCT04447911|Empagliflozin|empagliflozin|mesh-list
154444038|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154444039|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444040|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154444041|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444042|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
154444043|NCT04313985|Immunomodulating Agents|immunomodulating agents|mesh-list
154444044|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444045|NCT04283578|Oxytocin|oxytocin|mesh-list
154444046|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
154018727|NCT02752334|Bupivacaine|bupivacaine|mesh-list
154444047|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154444048|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444049|NCT04123873|Acetaminophen|acetaminophen|mesh-list
154444050|NCT04123873|Dexamethasone|dexamethasone|mesh-list
154444051|NCT04123873|Ibuprofen|ibuprofen|mesh-list
154444052|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444053|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
154444054|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
154444055|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550075|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444056|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444057|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444058|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
154444059|NCT04123873|Hormones|hormones|mesh-ancestor
154444060|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444061|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444062|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444063|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154444064|NCT04123873|Analgesics|analgesics|mesh-ancestor
154444065|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
154444066|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
154444067|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154444068|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444069|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154444071|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444072|NCT04106362|Cisplatin|cisplatin|mesh-list
154444073|NCT04106362|Cetuximab|cetuximab|mesh-list
154444074|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154444075|NCT04106362|Antibodies|antibodies|mesh-list
154444076|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
154444077|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154444078|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
154444079|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444080|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444081|NCT04079088|Interferons|interferons|mesh-list
154444082|NCT04079088|Interferon-beta|interferon-beta|mesh-list
154444083|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
154444084|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
154444085|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
154444086|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444087|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
154444088|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444089|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
154444090|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444091|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154444092|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154444093|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444094|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
154444095|NCT04060030|Leucovorin|leucovorin|mesh-list
154444096|NCT04060030|Calcium|calcium|mesh-list
154444097|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
154444098|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154444099|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444100|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154444101|NCT04060030|Antidotes|antidotes|mesh-ancestor
154444102|NCT04060030|Protective Agents|protective agents|mesh-ancestor
154444103|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
154444104|NCT04060030|Vitamins|vitamins|mesh-ancestor
154444105|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
154444106|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154444107|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
154444108|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444109|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444110|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444111|NCT03819465|Paclitaxel|paclitaxel|mesh-list
154444112|NCT03819465|Carboplatin|carboplatin|mesh-list
154444113|NCT03819465|Gemcitabine|gemcitabine|mesh-list
154444114|NCT03819465|Pemetrexed|pemetrexed|mesh-list
154444115|NCT03819465|Durvalumab|durvalumab|mesh-list
154444116|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154444117|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444118|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444119|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444120|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
154018796|NCT02754362|Bevacizumab|bevacizumab|mesh-list
154444121|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444122|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154444123|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
154444124|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444125|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154444126|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154444127|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444128|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
154444129|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444130|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444131|NCT03637803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444132|NCT03637803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444133|NCT03567720|Paclitaxel|paclitaxel|mesh-list
154444134|NCT03567720|Carboplatin|carboplatin|mesh-list
154444135|NCT03567720|Gemcitabine|gemcitabine|mesh-list
154444136|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
154444137|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154444138|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444139|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444140|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444141|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444142|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444143|NCT03567720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154444144|NCT03567720|Antimetabolites|antimetabolites|mesh-ancestor
154444145|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444148|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154444149|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154444150|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
154444151|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
154444152|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444153|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444154|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154444155|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154444156|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154444157|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
154444158|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444159|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444160|NCT03519893|Losartan|losartan|mesh-list
154444161|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154444162|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154444163|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154444164|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154444165|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444166|NCT03519256|Nivolumab|nivolumab|mesh-list
154444167|NCT03519256|Linrodostat|linrodostat|mesh-list
154444168|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444169|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444170|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444171|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444172|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444173|NCT03507608|Flutamide|flutamide|mesh-list
154444174|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
154444175|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
154444176|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444177|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444178|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444179|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444180|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154444181|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154444182|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444183|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154444184|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154444185|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444186|NCT03215927|Abatacept|abatacept|mesh-list
154444187|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444188|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444189|NCT03215927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444190|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444191|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154444192|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
154444193|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444194|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444195|NCT02999230|Listerine|listerine|mesh-list
154444196|NCT02999230|Fluorides|fluorides|mesh-list
154444197|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
154444198|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
154444199|NCT02999230|Protective Agents|protective agents|mesh-ancestor
154444200|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444201|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154444202|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444203|NCT02941315|Captopril|captopril|mesh-list
154444204|NCT02941315|Spironolactone|spironolactone|mesh-list
154444205|NCT02941315|Furosemide|furosemide|mesh-list
154444206|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154444207|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154444208|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
154444209|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444210|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444211|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154444212|NCT02941315|Diuretics|diuretics|mesh-ancestor
154444213|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
154444214|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154444215|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
154444216|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254837|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444217|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444218|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154444219|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
154444220|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444221|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154444222|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154444223|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154444224|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154444225|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154444226|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444227|NCT02918721|Lidocaine|lidocaine|mesh-list
154444228|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
154444229|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
154444230|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
154444231|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444232|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444233|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
154444234|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444235|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154444236|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154444237|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154444238|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154444239|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444240|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154444241|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
154444242|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
154444243|NCT02918721|Protective Agents|protective agents|mesh-ancestor
154444244|NCT02884180|Dexamethasone|dexamethasone|mesh-list
154444245|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444246|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
154444247|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
154444248|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444249|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444250|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444251|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
154444252|NCT02884180|Hormones|hormones|mesh-ancestor
154444253|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444254|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444255|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444256|NCT02799602|Docetaxel|docetaxel|mesh-list
154444257|NCT02799602|Androgens|androgens|mesh-list
154444258|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444259|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444260|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444261|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444262|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444263|NCT02799602|Hormones|hormones|mesh-ancestor
154444264|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444265|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444266|NCT02770040|Infliximab|infliximab|mesh-list
154444267|NCT02770040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154444268|NCT02770040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444269|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
154444270|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444271|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444272|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154444273|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154444274|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444276|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154444277|NCT02291705|Narcotics|narcotics|mesh-ancestor
154444278|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444279|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444280|NCT02291705|Analgesics|analgesics|mesh-ancestor
154444281|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
154444282|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444283|NCT02243709|Mifepristone|mifepristone|mesh-list
154444284|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154444285|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
154444286|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154444287|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444288|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154444289|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154444290|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154444291|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
154444292|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154444293|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154444294|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
154444295|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444296|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
154444297|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154444298|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154444299|NCT01896011|Teriparatide|teriparatide|mesh-list
154444300|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154444301|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444302|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154444303|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
154444304|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154444305|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
154444306|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444307|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
154444308|NCT01891396|Protective Agents|protective agents|mesh-ancestor
154444309|NCT01746225|Paclitaxel|paclitaxel|mesh-list
154444310|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154444311|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444312|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444313|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444314|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444315|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444316|NCT01716806|Nivolumab|nivolumab|mesh-list
154444317|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154444318|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154444319|NCT01716806|Dacarbazine|dacarbazine|mesh-list
154444320|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444321|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444322|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444323|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444324|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154444325|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
154444326|NCT01716806|Immunotoxins|immunotoxins|mesh-ancestor
154444327|NCT01716806|Immunoconjugates|immunoconjugates|mesh-ancestor
154444328|NCT01716806|Immunologic Factors|immunologic factors|mesh-ancestor
154444329|NCT01716806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444330|NCT01650545|Cyclosporine|cyclosporine|mesh-list
154444331|NCT01650545|Sirolimus|sirolimus|mesh-list
154444332|NCT01650545|Tacrolimus|tacrolimus|mesh-list
154444333|NCT01650545|Cyclosporins|cyclosporins|mesh-list
154444334|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154444335|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
154444336|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444337|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154444338|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444339|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444340|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
154444341|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444342|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
154444343|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444344|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154444345|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154019099|NCT00635960|Hormones|hormones|mesh-list
153550445|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
154444346|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444347|NCT01191008|Timolol|timolol|mesh-list
154444348|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154444349|NCT01191008|Latanoprost|latanoprost|mesh-list
154444350|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154444351|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444352|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154444353|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154444354|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
154444355|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444356|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444357|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154444358|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154444359|NCT01155232|Teriparatide|teriparatide|mesh-list
154444360|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
154444361|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444362|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154444363|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154444364|NCT00821587|Cyclosporine|cyclosporine|mesh-list
154444365|NCT00821587|Tacrolimus|tacrolimus|mesh-list
154444366|NCT00821587|Cyclosporins|cyclosporins|mesh-list
154444367|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154444368|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
154444369|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444370|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154444371|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444372|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444373|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
154444374|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444375|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154444376|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444377|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154444378|NCT00751829|Olmesartan|olmesartan|mesh-list
154444379|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154444380|NCT00751829|Nitrendipine|nitrendipine|mesh-list
154444381|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154444382|NCT00751829|Diuretics|diuretics|mesh-ancestor
154444383|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
154444384|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444385|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154444386|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154444387|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444388|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154444389|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154444390|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154444391|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154444392|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
154444393|NCT00645801|Lubiprostone|lubiprostone|mesh-list
154444394|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154444395|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154444396|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444397|NCT00424099|Methylphenidate|methylphenidate|mesh-list
154444398|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154444399|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444400|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154444401|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154444402|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154444403|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444404|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
154444405|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444406|NCT00382213|Olmesartan|olmesartan|mesh-list
154444407|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154444408|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154444409|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154444410|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154444411|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444412|NCT00176267|Paclitaxel|paclitaxel|mesh-list
154444413|NCT00176267|Carboplatin|carboplatin|mesh-list
154444414|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154444415|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444416|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444417|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444418|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444419|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444420|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
154444421|NCT02298920|Zoliflodacin|zoliflodacin|mesh-list
154444422|NCT02298920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154444423|NCT02298920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154444424|NCT02298920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444425|NCT02298920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444426|NCT02298920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444427|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154444428|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154444429|NCT03517670|Milrinone|milrinone|mesh-list
154444430|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154444431|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154444432|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
154444433|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154444434|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154444435|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444436|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444437|NCT03517670|Protective Agents|protective agents|mesh-ancestor
154444439|NCT00109668|Beclomethasone|beclomethasone|mesh-list
154444440|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444441|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
154444442|NCT00109668|Hormones|hormones|mesh-ancestor
154444443|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444444|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444445|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154444446|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
154444447|NCT03104140|Ketamine|ketamine|mesh-list
154444448|NCT03104140|Thiopental|thiopental|mesh-list
154444449|NCT03104140|Analgesics|analgesics|mesh-ancestor
154444450|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
154444451|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444452|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444453|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154444454|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154444455|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
154444456|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
154444457|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444458|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154444459|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154444460|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444461|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444462|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
154444463|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154444464|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
154444465|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
154444466|NCT03520478|Bicalutamide|bicalutamide|mesh-list
154444467|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
154444468|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
153550691|NCT02636322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154444469|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444470|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444471|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444472|NCT00102648|Temozolomide|temozolomide|mesh-list
154444473|NCT00102648|Lonafarnib|lonafarnib|mesh-list
154444474|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154444475|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
154444476|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444477|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444478|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444479|NCT03290287|Bromides|bromides|mesh-list
154444480|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
154444481|NCT02253888|Ritonavir|ritonavir|mesh-list
154444482|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154444483|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154444484|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154444485|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444486|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444487|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154444488|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154444489|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
154444490|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444491|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154444492|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154444493|NCT05430802|Pemetrexed|pemetrexed|mesh-list
154444494|NCT05430802|Aflutinib|aflutinib|mesh-list
154444495|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444496|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444497|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444498|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154444499|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154444500|NCT05430802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154444501|NCT05524038|Dexamethasone|dexamethasone|mesh-list
154444502|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
154444503|NCT05524038|Bupivacaine|bupivacaine|mesh-list
154444504|NCT05524038|BB 1101|bb 1101|mesh-list
154444505|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444506|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
154444507|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
154444508|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444509|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444510|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444511|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
154444512|NCT05524038|Hormones|hormones|mesh-ancestor
153550790|NCT02436707|Dexamethasone|dexamethasone|mesh-list
154444513|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444515|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444516|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
154444517|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444518|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444519|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
154444520|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
154444521|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444522|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
154444523|NCT03240835|Docetaxel|docetaxel|mesh-list
154444524|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444525|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444526|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444527|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444528|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444529|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
154444530|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444531|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444532|NCT04118868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444533|NCT04118868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444534|NCT04900350|Azacitidine|azacitidine|mesh-list
154444535|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154444536|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
154444537|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444538|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444539|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444540|NCT02292290|Pioglitazone|pioglitazone|mesh-list
154444541|NCT02292290|Liraglutide|liraglutide|mesh-list
154444542|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154444543|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444544|NCT02292290|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154444545|NCT02292290|Incretins|incretins|mesh-ancestor
154444546|NCT02292290|Hormones|hormones|mesh-ancestor
154444547|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444548|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
154444549|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154444550|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444551|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444552|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154444553|NCT02299232|Analgesics|analgesics|mesh-ancestor
154444554|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
154444555|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444556|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154444557|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154444558|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154444559|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
154444560|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550984|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154444561|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444562|NCT02963493|Dexamethasone|dexamethasone|mesh-list
154444563|NCT02963493|Melphalan|melphalan|mesh-list
154444564|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444565|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
154444566|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
154444567|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019281|NCT00913835|Olaratumab|olaratumab|mesh-list
154444568|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444569|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444571|NCT02963493|Hormones|hormones|mesh-ancestor
154444572|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444573|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444574|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444575|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154444576|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
154444577|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444578|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154444579|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154444580|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
154444581|NCT02299310|Valsartan|valsartan|mesh-list
154444582|NCT02299310|Perindopril|perindopril|mesh-list
154444583|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154444584|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154444585|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154444586|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444587|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154444589|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444590|NCT03519776|Progesterone|progesterone|mesh-list
154444591|NCT03519776|Progestins|progestins|mesh-ancestor
154444592|NCT03519776|Hormones|hormones|mesh-ancestor
154444593|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444594|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444595|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
154444596|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154444597|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
154444598|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444599|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444600|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154444601|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
154444602|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154444603|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
154444604|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444605|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444606|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154444607|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
154444608|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
154444609|NCT02295566|Protective Agents|protective agents|mesh-ancestor
154444610|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154444611|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
154444612|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444613|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154444614|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444615|NCT03643497|Meropenem|meropenem|mesh-list
154444616|NCT03643497|Linezolid|linezolid|mesh-list
154444617|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
154444618|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154444619|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154444620|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444621|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444622|NCT03519542|Sunitinib|sunitinib|mesh-list
154444623|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444624|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154444625|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154444626|NCT03519542|Growth Substances|growth substances|mesh-ancestor
154444627|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444628|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
154444629|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154444630|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444631|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444632|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154444633|NCT03516500|Hematinics|hematinics|mesh-ancestor
154444634|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
154444635|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154444636|NCT02293148|Glycine|glycine|mesh-list
154444637|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154444638|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444639|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154444640|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154444641|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444642|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444643|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444644|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154444645|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
154444646|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154444647|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444648|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154444649|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154444650|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154444651|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
154444652|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444653|NCT03519152|Diclofenac|diclofenac|mesh-list
154444654|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154444655|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154444656|NCT03519152|Analgesics|analgesics|mesh-ancestor
154444657|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
154444658|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444659|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444661|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444662|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154444663|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444664|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444665|NCT02959983|Eluxadoline|eluxadoline|mesh-list
154444666|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444667|NCT03516188|Antacids|antacids|mesh-list
154444668|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444669|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444670|NCT03512990|Bupivacaine|bupivacaine|mesh-list
154444671|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
154444672|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
154444673|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444674|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444675|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
154444676|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444677|NCT03512834|Paclitaxel|paclitaxel|mesh-list
154444678|NCT03512834|Avelumab|avelumab|mesh-list
154444679|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154444680|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444681|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444682|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444683|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444684|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444685|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444686|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154444687|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
154444688|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154444689|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
154444690|NCT03640221|Diuretics|diuretics|mesh-ancestor
154444691|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
154444692|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444693|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154444694|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154444695|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444696|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154444697|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154444698|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154444699|NCT03518528|Estradiol|estradiol|mesh-list
154444700|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154444701|NCT03518528|Estrogens|estrogens|mesh-ancestor
154444702|NCT03518528|Hormones|hormones|mesh-ancestor
154444703|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444704|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444705|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154444706|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
154444707|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154444708|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154444709|NCT03515798|Paclitaxel|paclitaxel|mesh-list
154444710|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154444711|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
154444712|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
154444713|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019393|NCT04218734|Metformin|metformin|mesh-list
154444714|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444715|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444716|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444717|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444718|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551302|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154444719|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154444720|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
154444721|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444722|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444723|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154444724|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
154444725|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154444726|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444727|NCT03515798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444728|NCT03041701|Dasatinib|dasatinib|mesh-list
154444729|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444730|NCT03041701|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154444731|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154444733|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444734|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154444735|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
154444736|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154444737|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154444738|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154444739|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
154444740|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154444741|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444742|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154444743|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154444744|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154444745|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444746|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444747|NCT02956629|Ribavirin|ribavirin|mesh-list
154444748|NCT02956629|Ruzasvir|ruzasvir|mesh-list
154444749|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
154444750|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
154444751|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444752|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
154444753|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444754|NCT02297204|Aflibercept|aflibercept|mesh-list
154444755|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154444756|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154444757|NCT02297204|Growth Substances|growth substances|mesh-ancestor
154444758|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444759|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
154444760|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444761|NCT02294006|Metformin|metformin|mesh-list
154444762|NCT02294006|Everolimus|everolimus|mesh-list
154444763|NCT02294006|Octreotide|octreotide|mesh-list
154444764|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154444765|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444766|NCT02294006|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154444767|NCT02294006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154444768|NCT02294006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444769|NCT02294006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444770|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154444771|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
154444772|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444773|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444774|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154444775|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154444776|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154444777|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444778|NCT02294084|Incretins|incretins|mesh-ancestor
154444779|NCT02294084|Hormones|hormones|mesh-ancestor
154444780|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154444781|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154444782|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
154444783|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444784|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444785|NCT01597258|Crizotinib|crizotinib|mesh-list
154444786|NCT01597258|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154019487|NCT04215432|Propolis|propolis|mesh-list
154444787|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154444788|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444789|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444790|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444791|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
154444792|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154444793|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
154444794|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444795|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
154444796|NCT02958267|Protective Agents|protective agents|mesh-ancestor
154444797|NCT02302430|Oxytocin|oxytocin|mesh-list
154444798|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
154444799|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154444800|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444801|NCT02300948|Folic Acid|folic acid|mesh-list
154444802|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
154444804|NCT02300948|Vitamins|vitamins|mesh-ancestor
154444805|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
154444806|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444807|NCT02302508|Clopidogrel|clopidogrel|mesh-list
154444808|NCT02302508|Ticagrelor|ticagrelor|mesh-list
154444809|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154444810|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154444811|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154444812|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154444813|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154444814|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
154444815|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444816|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444817|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444818|NCT02297594|Ziresovir|ziresovir|mesh-list
154444819|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
154444820|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444821|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154444822|NCT02301026|Hematinics|hematinics|mesh-ancestor
154444823|NCT01952574|Erenumab|erenumab|mesh-list
154444824|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154444825|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154444826|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444827|NCT01952574|Analgesics|analgesics|mesh-ancestor
154444828|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
154444829|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444830|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444831|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
154444832|NCT02302586|Morphine|morphine|mesh-list
154444833|NCT02302586|Bupivacaine|bupivacaine|mesh-list
154444834|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
154444835|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
154444836|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444837|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444838|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
154444839|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444840|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154444841|NCT02302586|Narcotics|narcotics|mesh-ancestor
154444842|NCT02302586|Analgesics|analgesics|mesh-ancestor
154444843|NCT01551472|Vitamin E|vitamin e|mesh-list
154444844|NCT01551472|Vitamins|vitamins|mesh-ancestor
154444845|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
154444846|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444847|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
154444848|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444849|NCT01551472|Protective Agents|protective agents|mesh-ancestor
154444850|NCT02254044|Maytansine|maytansine|mesh-list
154444851|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
154444852|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154444853|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444854|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444855|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444856|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444857|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444858|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444859|NCT02254044|Immunotoxins|immunotoxins|mesh-ancestor
154444860|NCT02254044|Immunoconjugates|immunoconjugates|mesh-ancestor
154444861|NCT02254044|Immunologic Factors|immunologic factors|mesh-ancestor
154444862|NCT02254044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444863|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
154444864|NCT02959437|Azacitidine|azacitidine|mesh-list
154444865|NCT02959437|INCB057643|incb057643|mesh-list
154444866|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154444867|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444868|NCT02959437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154444869|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444870|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154444871|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
154444872|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444873|NCT02297906|Ketorolac|ketorolac|mesh-list
154444874|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154444875|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154444876|NCT02297906|Analgesics|analgesics|mesh-ancestor
154444877|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
154444878|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444879|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444880|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444881|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444882|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154444883|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444884|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444885|NCT03511820|Amphotericin B|amphotericin b|mesh-list
154444886|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154444887|NCT03511820|Amebicides|amebicides|mesh-ancestor
154444888|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154444889|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153551566|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
154444890|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154444891|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154444892|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
154444893|NCT02957331|Propranolol|propranolol|mesh-list
154444894|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154444895|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154444896|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
154444897|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444898|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444899|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444900|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154444901|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154444902|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
154444903|NCT02298062|Infliximab|infliximab|mesh-list
154444904|NCT02298062|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154444905|NCT02298062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154444906|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
154444907|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154444908|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154444909|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
154444910|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
154444911|NCT03515018|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154444912|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154444913|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444914|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444915|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444916|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
154444917|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154444918|NCT05891145|Midazolam|midazolam|mesh-list
154444919|NCT05891145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154444920|NCT05891145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154444921|NCT05891145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444922|NCT05891145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444923|NCT05891145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154444924|NCT05891145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154444925|NCT05891145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154444926|NCT05891145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154444927|NCT05891145|Anesthetics, General|anesthetics, general|mesh-ancestor
154444928|NCT05891145|Anesthetics|anesthetics|mesh-ancestor
154444929|NCT05891145|GABA Modulators|gaba modulators|mesh-ancestor
154444930|NCT05891145|GABA Agents|gaba agents|mesh-ancestor
154444931|NCT05891145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444932|NCT05891145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444933|NCT05891080|Paclitaxel|paclitaxel|mesh-list
154444934|NCT05891080|Carboplatin|carboplatin|mesh-list
154444935|NCT05891080|Pemetrexed|pemetrexed|mesh-list
154444936|NCT05891080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154444937|NCT05891080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444938|NCT05891080|Tubulin Modulators|tubulin modulators|mesh-ancestor
154444939|NCT05891080|Antimitotic Agents|antimitotic agents|mesh-ancestor
154444940|NCT05891080|Mitosis Modulators|mitosis modulators|mesh-ancestor
154444941|NCT05891080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444942|NCT05891080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154444943|NCT05891080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154444944|NCT05891080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154444945|NCT05890911|Dopamine|dopamine|mesh-list
154444946|NCT05890911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154444947|NCT05890911|Sympathomimetics|sympathomimetics|mesh-ancestor
154444948|NCT05890911|Autonomic Agents|autonomic agents|mesh-ancestor
154444949|NCT05890911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444950|NCT05890911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444951|NCT05890911|Dopamine Agents|dopamine agents|mesh-ancestor
154444952|NCT05890911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551650|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
154444953|NCT05890911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444954|NCT05890911|Protective Agents|protective agents|mesh-ancestor
154444956|NCT05890768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154444957|NCT05890768|Serotonin Agents|serotonin agents|mesh-ancestor
154444958|NCT05890768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154444959|NCT05890768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444960|NCT05890768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444961|NCT05890768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154444962|NCT05890768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154444963|NCT05890768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444964|NCT05890768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154444965|NCT05890768|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154444966|NCT05890768|Dopamine Agents|dopamine agents|mesh-ancestor
154444967|NCT05890703|Lidocaine|lidocaine|mesh-list
154444968|NCT05890703|Tetracaine|tetracaine|mesh-list
154444969|NCT05890703|Anesthetics, Local|anesthetics, local|mesh-ancestor
154444970|NCT05890703|Anesthetics|anesthetics|mesh-ancestor
154444971|NCT05890703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444972|NCT05890703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444973|NCT05890703|Sensory System Agents|sensory system agents|mesh-ancestor
154444974|NCT05890703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444975|NCT05890703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154444976|NCT05890703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154444977|NCT05890703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154444978|NCT05890703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154444979|NCT05890703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444980|NCT05890495|Lidocaine|lidocaine|mesh-list
154444981|NCT05890495|Anesthetics, Local|anesthetics, local|mesh-ancestor
154444982|NCT05890495|Anesthetics|anesthetics|mesh-ancestor
154444983|NCT05890495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154444984|NCT05890495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444985|NCT05890495|Sensory System Agents|sensory system agents|mesh-ancestor
154444986|NCT05890495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154444987|NCT05890495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154444988|NCT05890495|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154444989|NCT05890495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154444990|NCT05890495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154444991|NCT05890495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154444992|NCT05890287|Tamoxifen|tamoxifen|mesh-list
154444993|NCT05890287|Letrozole|letrozole|mesh-list
154444994|NCT05890287|Fulvestrant|fulvestrant|mesh-list
154444995|NCT05890287|Anastrozole|anastrozole|mesh-list
154444996|NCT05890287|Exemestane|exemestane|mesh-list
154444997|NCT05890287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154444998|NCT05890287|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153551858|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154444999|NCT05890287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154445000|NCT05890287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445001|NCT05890287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445002|NCT05890287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154445003|NCT05890287|Hormone Antagonists|hormone antagonists|mesh-ancestor
154445004|NCT05890287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445005|NCT05890287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445006|NCT05890287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154445007|NCT05890287|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154445008|NCT05890287|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154445009|NCT05890287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154445010|NCT05890287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154445011|NCT05890235|Tamsulosin|tamsulosin|mesh-list
154445012|NCT05890235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154019688|NCT02387099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445013|NCT05890235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154445014|NCT05890235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154445015|NCT05890235|Adrenergic Agents|adrenergic agents|mesh-ancestor
154445016|NCT05890235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445017|NCT05890235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445018|NCT05890235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445019|NCT05890235|Urological Agents|urological agents|mesh-ancestor
154445020|NCT05887505|Vitamin D|vitamin d|mesh-list
154445021|NCT05887505|Vitamins|vitamins|mesh-ancestor
154445022|NCT05887505|Micronutrients|micronutrients|mesh-ancestor
154445023|NCT05887505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445024|NCT05887505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154445025|NCT05882162|Calcium|calcium|mesh-list
154445026|NCT05882162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154445027|NCT05882162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445028|NCT05881486|Ondansetron|ondansetron|mesh-list
154445029|NCT05881486|Fosaprepitant|fosaprepitant|mesh-list
154445030|NCT05881486|Aprepitant|aprepitant|mesh-list
154445031|NCT05881486|Antiemetics|antiemetics|mesh-ancestor
154445032|NCT05881486|Autonomic Agents|autonomic agents|mesh-ancestor
154445033|NCT05881486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445034|NCT05881486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445035|NCT05881486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445036|NCT05881486|Antipruritics|antipruritics|mesh-ancestor
154445037|NCT05881486|Dermatologic Agents|dermatologic agents|mesh-ancestor
154445038|NCT05881486|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154445039|NCT05881486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154445040|NCT05881486|Serotonin Agents|serotonin agents|mesh-ancestor
154445041|NCT05881486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445042|NCT05881486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445043|NCT05881486|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154445044|NCT05770297|Propolis|propolis|mesh-list
154445045|NCT05770297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445046|NCT05744635|Tacrolimus|tacrolimus|mesh-list
154445047|NCT05744635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445048|NCT05744635|Immunologic Factors|immunologic factors|mesh-ancestor
154445049|NCT05744635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445050|NCT05744635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154445051|NCT05744635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445052|NCT05744635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445053|NCT05733689|Paclitaxel|paclitaxel|mesh-list
154445054|NCT05733689|Docetaxel|docetaxel|mesh-list
154445055|NCT05733689|Carboplatin|carboplatin|mesh-list
154445056|NCT05733689|Pembrolizumab|pembrolizumab|mesh-list
154445057|NCT05733689|Nivolumab|nivolumab|mesh-list
154445058|NCT05733689|Irinotecan|irinotecan|mesh-list
154445059|NCT05733689|Folfirinox|folfirinox|mesh-list
154445060|NCT05733689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154445061|NCT05733689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445062|NCT05733689|Tubulin Modulators|tubulin modulators|mesh-ancestor
154445063|NCT05733689|Antimitotic Agents|antimitotic agents|mesh-ancestor
154445064|NCT05733689|Mitosis Modulators|mitosis modulators|mesh-ancestor
154445065|NCT05733689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445066|NCT05733689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445067|NCT05733689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154445068|NCT05733689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154445069|NCT05733689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154445070|NCT05733689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445071|NCT05723874|Bosentan|bosentan|mesh-list
154445072|NCT05723874|BI 425809|bi 425809|mesh-list
154445073|NCT05723874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154445074|NCT05723874|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154445075|NCT05723874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445076|NCT05723874|Nootropic Agents|nootropic agents|mesh-ancestor
154445077|NCT05608837|Dexamethasone|dexamethasone|mesh-list
154445078|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445079|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
154445080|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
154445081|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445082|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445083|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445084|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
154445085|NCT05608837|Hormones|hormones|mesh-ancestor
154019763|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445086|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551950|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
154445087|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154445088|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445089|NCT05489887|Ceritinib|ceritinib|mesh-list
154445090|NCT05489887|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154445091|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445092|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445093|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445094|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445095|NCT05446727|Ropivacaine|ropivacaine|mesh-list
154445096|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
154445097|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
154445098|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154445099|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445100|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
154445101|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445102|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
154445103|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445104|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445105|NCT05349890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154445106|NCT05349890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445108|NCT05301517|Hematinics|hematinics|mesh-ancestor
154445109|NCT05296304|Bexarotene|bexarotene|mesh-list
154445110|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445111|NCT05271448|Losartan|losartan|mesh-list
154445112|NCT05271448|Valsartan|valsartan|mesh-list
154445113|NCT05271448|Candesartan|candesartan|mesh-list
154445114|NCT05271448|Candesartan cilexetil|candesartan cilexetil|mesh-list
154445115|NCT05271448|Ramipril|ramipril|mesh-list
154445116|NCT05271448|Enalapril|enalapril|mesh-list
154445117|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154445118|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154445119|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154445120|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154445121|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445122|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154445123|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
154445124|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445125|NCT05254405|Brexanolone|brexanolone|mesh-list
154445126|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
154445127|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445128|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445129|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445130|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
154445131|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
154445132|NCT05215106|Durvalumab|durvalumab|mesh-list
154445133|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153552117|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445134|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445135|NCT05177731|Cytarabine|cytarabine|mesh-list
154445136|NCT05177731|Decitabine|decitabine|mesh-list
154445137|NCT05177731|Venetoclax|venetoclax|mesh-list
154445138|NCT05177731|Idarubicin|idarubicin|mesh-list
154445139|NCT05177731|Gilteritinib|gilteritinib|mesh-list
154445140|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154445141|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
154445142|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445143|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445144|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
154445145|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445146|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445147|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
154445148|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445149|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445150|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154445151|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154445152|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154445153|NCT05177731|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154445154|NCT05177731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445155|NCT05110482|Oxytocin|oxytocin|mesh-list
154445156|NCT05110482|Carbetocin|carbetocin|mesh-list
154445157|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
154445158|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154445159|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445160|NCT05029960|Brivaracetam|brivaracetam|mesh-list
154445161|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
154445162|NCT05005000|Triamcinolone|triamcinolone|mesh-list
154445163|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154445164|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154445165|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154019837|NCT02741024|Amodiaquine|amodiaquine|mesh-list
154445166|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445167|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
154445169|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445170|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445171|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445172|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
154445173|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445174|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445175|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
154445176|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445177|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445178|NCT04987996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153730015|NCT00132236|Nicotine|nicotine|mesh-list
154445179|NCT04987996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445181|NCT04916509|Palbociclib|palbociclib|mesh-list
154445182|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154445183|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154445184|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445185|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154445186|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154445187|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
154445188|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445189|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445190|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445191|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445192|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445193|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154445194|NCT04882774|Treprostinil|treprostinil|mesh-list
154445195|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154445196|NCT04846920|Belzutifan|belzutifan|mesh-list
154445197|NCT04846920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445198|NCT04774406|Olaparib|olaparib|mesh-list
154445199|NCT04774406|Niraparib|niraparib|mesh-list
154445200|NCT04774406|Talazoparib|talazoparib|mesh-list
154445201|NCT04774406|Veliparib|veliparib|mesh-list
154445202|NCT04774406|Fluzoparib|fluzoparib|mesh-list
154445203|NCT04774406|Rucaparib|rucaparib|mesh-list
154445204|NCT04774406|Pamiparib|pamiparib|mesh-list
154445205|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154445206|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445207|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445208|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445209|NCT04735367|Letrozole|letrozole|mesh-list
154445210|NCT04735367|Palbociclib|palbociclib|mesh-list
154445211|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445212|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154445213|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154445214|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445215|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445216|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153552198|NCT01577043|Racecadotril|racecadotril|mesh-list
154445217|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
154445218|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552266|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154445219|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445220|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445221|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
154445222|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
154445223|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154445224|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154445225|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445226|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445227|NCT04715113|Urological Agents|urological agents|mesh-ancestor
154445228|NCT04713657|Propranolol|propranolol|mesh-list
154445229|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154445230|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154445231|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
154445232|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445233|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445234|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445235|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154445236|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154445237|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
154445238|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
154019914|NCT02735330|Ethanol|ethanol|mesh-list
154445242|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445243|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445244|NCT04706546|Urological Agents|urological agents|mesh-ancestor
154445245|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
154445246|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
154445247|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154445248|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154445249|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445250|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445251|NCT04704440|Urological Agents|urological agents|mesh-ancestor
154445252|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
154445253|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
154445254|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154445255|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154445256|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445257|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445258|NCT04697862|Urological Agents|urological agents|mesh-ancestor
154445259|NCT04696029|Eflornithine|eflornithine|mesh-list
154445260|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445261|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154445262|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154445263|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154445264|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445265|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154445266|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445267|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445268|NCT04625699|Durvalumab|durvalumab|mesh-list
154445269|NCT04625699|Tremelimumab|tremelimumab|mesh-list
154445270|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445271|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445275|NCT04510584|Bevacizumab|bevacizumab|mesh-list
154445276|NCT04510584|Atezolizumab|atezolizumab|mesh-list
154445277|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445278|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445279|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154445280|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154445281|NCT04510584|Growth Substances|growth substances|mesh-ancestor
154445282|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445283|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
154445284|NCT04510584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154445285|NCT04510584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445286|NCT04500847|Emtricitabine|emtricitabine|mesh-list
154445287|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
154445288|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445289|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154445290|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154445291|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445292|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445293|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154445294|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154445295|NCT04484532|Vaccines|vaccines|mesh-list
154445296|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
154445297|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445298|NCT04483583|Clopidogrel|clopidogrel|mesh-list
154445299|NCT04483583|Ticagrelor|ticagrelor|mesh-list
154445300|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154445301|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154445302|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154445303|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154445304|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
154445305|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445306|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445307|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445308|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
154445309|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
154445310|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154445311|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154445312|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445313|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445314|NCT04447989|Urological Agents|urological agents|mesh-ancestor
154445315|NCT04375527|Nivolumab|nivolumab|mesh-list
154445316|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445317|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445318|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154445319|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445320|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
154445321|NCT04218799|Mupirocin|mupirocin|mesh-list
154445322|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154445323|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445324|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
154445325|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154445326|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154445327|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445328|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445329|NCT04189445|Futibatinib|futibatinib|mesh-list
154445330|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445331|NCT04026776|Allopurinol|allopurinol|mesh-list
154445332|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
154445333|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445334|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445335|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
154445336|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445337|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154445338|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
154445339|NCT04026776|Protective Agents|protective agents|mesh-ancestor
154445340|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445341|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
154445342|NCT03846427|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154445343|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445344|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445345|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445346|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445347|NCT03831113|Buprenorphine|buprenorphine|mesh-list
154445348|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154445349|NCT03831113|Narcotics|narcotics|mesh-ancestor
154445350|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154445351|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445352|NCT03831113|Analgesics|analgesics|mesh-ancestor
154445353|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
154445354|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445355|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154445356|NCT03824561|Vedolizumab|vedolizumab|mesh-list
154445357|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445358|NCT03821857|Corticosterone|corticosterone|mesh-list
154445359|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445360|NCT04305236|Fulvestrant|fulvestrant|mesh-list
154445361|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154445362|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445363|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154445364|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154445365|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
154445366|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445367|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445368|NCT03657160|Vedolizumab|vedolizumab|mesh-list
154445369|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445370|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
154445372|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
154445373|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445374|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
154445375|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445376|NCT03508726|Protective Agents|protective agents|mesh-ancestor
154445377|NCT03404661|Secretin|secretin|mesh-list
154445378|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445379|NCT03404661|Hormones|hormones|mesh-ancestor
154445380|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445381|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445382|NCT03370172|Factor VIII|factor viii|mesh-list
154445383|NCT03370172|Coagulants|coagulants|mesh-ancestor
154445384|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
154445385|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445386|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445387|NCT03279692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153552542|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
153552576|NCT01578928|Pasireotide|pasireotide|mesh-list
154445388|NCT03279692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445389|NCT03100786|Dexamethasone|dexamethasone|mesh-list
154445390|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445391|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
154445392|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
154445393|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445394|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445395|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445396|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
154445397|NCT03100786|Hormones|hormones|mesh-ancestor
154445398|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445399|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154445400|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445401|NCT03001882|Nivolumab|nivolumab|mesh-list
154445402|NCT03001882|Ipilimumab|ipilimumab|mesh-list
154445403|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445404|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445405|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154445406|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445407|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
154445408|NCT02932956|Fludarabine|fludarabine|mesh-list
154445409|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
154445410|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445411|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
154445412|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445413|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445414|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154445415|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
154445416|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445417|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445418|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154445419|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154445420|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
154445421|NCT02843165|Immunomodulating Agents|immunomodulating agents|mesh-list
154445422|NCT02843165|Immunologic Factors|immunologic factors|mesh-list
154445423|NCT02843165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445424|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
154445425|NCT02807467|Propofol|propofol|mesh-list
154445426|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154445427|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154445428|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445429|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154445430|NCT02807467|Analgesics|analgesics|mesh-ancestor
153552577|NCT01578928|Hormones|hormones|mesh-ancestor
154445431|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
154445432|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445433|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154445434|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154445435|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154445436|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
154445437|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445438|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445439|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154445440|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
154445441|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
154445442|NCT02794428|Eflornithine|eflornithine|mesh-list
154445443|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445444|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154445445|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154445446|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154445447|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445448|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154445449|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445450|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445451|NCT02740179|Eplerenone|eplerenone|mesh-list
154445452|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154445453|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
154445454|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445455|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445456|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154445457|NCT02740179|Diuretics|diuretics|mesh-ancestor
154445458|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
154445459|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154445460|NCT02679144|Eflornithine|eflornithine|mesh-list
154445461|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445462|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154445463|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154445464|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154445465|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445466|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154445467|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445468|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445469|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
154445470|NCT02650986|Decitabine|decitabine|mesh-list
154445471|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445472|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
154445473|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445474|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445475|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154445476|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
154445477|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445478|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445479|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154445480|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154445481|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
154445482|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445483|NCT02619409|Bupivacaine|bupivacaine|mesh-list
154445484|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
154445485|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
154445486|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154445487|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445488|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
154445489|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445490|NCT02582866|Lacosamide|lacosamide|mesh-list
154445491|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
154445492|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154445493|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154445494|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154445495|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445496|NCT02559778|Eflornithine|eflornithine|mesh-list
154445497|NCT02559778|Sorafenib|sorafenib|mesh-list
154445498|NCT02559778|Dasatinib|dasatinib|mesh-list
154445499|NCT02559778|Vorinostat|vorinostat|mesh-list
154445500|NCT02559778|Ceritinib|ceritinib|mesh-list
154445501|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445502|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445503|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445504|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445505|NCT02559778|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154445506|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154445507|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154445508|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154445509|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154445510|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445511|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154445512|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
154445513|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445514|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
154445515|NCT02453373|Plasminogen|plasminogen|mesh-list
154445516|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154445517|NCT02453373|Propofol|propofol|mesh-list
154445518|NCT02453373|Etomidate|etomidate|mesh-list
154445519|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154445520|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154445521|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445522|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154445523|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
154445524|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
154445525|NCT02453373|Analgesics|analgesics|mesh-ancestor
154445526|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
154445527|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445528|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154445529|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
154445530|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154445531|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154445532|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445533|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154445534|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
154445535|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153674126|NCT00025142|Leucovorin|leucovorin|mesh-list
154445536|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154445537|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154445538|NCT01734928|Thalidomide|thalidomide|mesh-list
154445539|NCT01734928|Dexamethasone|dexamethasone|mesh-list
154445540|NCT01734928|Bortezomib|bortezomib|mesh-list
154445541|NCT01734928|Pomalidomide|pomalidomide|mesh-list
154445542|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445543|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
154445544|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
154445545|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445546|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445547|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445548|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
154445549|NCT01734928|Hormones|hormones|mesh-ancestor
154445550|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445551|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154445552|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445553|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
154445554|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154445555|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154445556|NCT01734928|Growth Substances|growth substances|mesh-ancestor
154445557|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
154445558|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445559|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
154445560|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154445561|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445562|NCT01682616|Rituximab|rituximab|mesh-list
154445563|NCT01682616|Venetoclax|venetoclax|mesh-list
154445564|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445565|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445566|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
154445567|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445568|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445569|NCT01430572|Everolimus|everolimus|mesh-list
154445570|NCT01430572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154445571|NCT01430572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445572|NCT01430572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445573|NCT01430572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445574|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445575|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
154445576|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445577|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445578|NCT00950430|Corticosterone|corticosterone|mesh-list
154445579|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445580|NCT00909051|Acarbose|acarbose|mesh-list
154445581|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154445582|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445583|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445584|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154445585|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445586|NCT05015608|Carboplatin|carboplatin|mesh-list
154445587|NCT05015608|Pemetrexed|pemetrexed|mesh-list
154445588|NCT05015608|Osimertinib|osimertinib|mesh-list
154445589|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445590|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445591|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445592|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154445593|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154445594|NCT05015608|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154445595|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445596|NCT03510416|Apatinib|apatinib|mesh-list
154445597|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445598|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154445599|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445600|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445601|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
154445602|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154445603|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445604|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
154445605|NCT02646124|Naproxen|naproxen|mesh-list
154445606|NCT02646124|Diazepam|diazepam|mesh-list
154445607|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154445608|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154445609|NCT02646124|Analgesics|analgesics|mesh-ancestor
154445610|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
154445611|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445612|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445613|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445614|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445615|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
154445616|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154445617|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445618|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445619|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154445620|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
154445621|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
154445622|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
154445623|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445624|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154445625|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154445626|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154445627|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154445628|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154445629|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154445630|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154445631|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154445632|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
154445633|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
154445634|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
154445635|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
154445636|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445637|NCT02306564|Cabergoline|cabergoline|mesh-list
154445638|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154445639|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154445640|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
154445641|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
154445642|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445643|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445644|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445645|NCT02301494|Fluocinonide|fluocinonide|mesh-list
154445646|NCT02301494|Imiquimod|imiquimod|mesh-list
154445647|NCT02301494|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154445648|NCT02301494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445649|NCT02301494|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154445650|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
154445651|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445652|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154445653|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445654|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
153552916|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
153552969|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154445655|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445656|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
154445657|NCT02301494|Hormones|hormones|mesh-ancestor
154445658|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445659|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154445660|NCT03101800|Azathioprine|azathioprine|mesh-list
154445661|NCT03101800|Allopurinol|allopurinol|mesh-list
154445662|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
154445663|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445664|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445665|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
154445666|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445667|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154445668|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
154445669|NCT03101800|Protective Agents|protective agents|mesh-ancestor
154445670|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445671|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154445672|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445673|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445674|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
154445675|NCT03507842|Cytarabine|cytarabine|mesh-list
154445676|NCT03507842|Daunorubicin|daunorubicin|mesh-list
154445677|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154445678|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
154445679|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445680|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445681|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
154445682|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445683|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445684|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
154445685|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445686|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154445687|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154445688|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154445689|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615217|NCT01973790|Z 338|z 338|mesh-list
154445690|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
154445691|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
154445692|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445693|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
154445694|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445695|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445696|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154445697|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
154445698|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445699|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445700|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154445701|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445702|NCT02301650|Tenofovir|tenofovir|mesh-list
154445703|NCT02301650|Lamivudine|lamivudine|mesh-list
154445704|NCT02301650|Telbivudine|telbivudine|mesh-list
154445705|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
154445706|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445707|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154445708|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154445709|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445710|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445711|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154445712|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154445713|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
154445714|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
154445715|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154445716|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154445717|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445718|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445719|NCT03510338|Urological Agents|urological agents|mesh-ancestor
154445720|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
154445721|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445722|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445723|NCT02303366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154445724|NCT02303366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445725|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154445726|NCT02301806|Glimepiride|glimepiride|mesh-list
154445727|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154445728|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445729|NCT02301806|Incretins|incretins|mesh-ancestor
154445730|NCT02301806|Hormones|hormones|mesh-ancestor
153973763|NCT06247956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445731|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445732|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154445733|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
154445734|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445735|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445736|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154445737|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445738|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
154445739|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
154445740|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154445741|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445742|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
154445743|NCT02301962|Panitumumab|panitumumab|mesh-list
154445744|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445745|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445746|NCT03507374|Alirocumab|alirocumab|mesh-list
154445747|NCT03507374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154445748|NCT03507374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154445749|NCT03507374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154445750|NCT03507374|Antimetabolites|antimetabolites|mesh-ancestor
154445751|NCT03507374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445752|NCT03507374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154445753|NCT03507374|Protease Inhibitors|protease inhibitors|mesh-ancestor
154445754|NCT03507374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445755|NCT03507374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154445756|NCT02639650|Dactinomycin|dactinomycin|mesh-list
154445757|NCT02639650|Paclitaxel|paclitaxel|mesh-list
154445758|NCT02639650|Etoposide|etoposide|mesh-list
154445759|NCT02639650|Vincristine|vincristine|mesh-list
154445760|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
154445761|NCT02639650|Carboplatin|carboplatin|mesh-list
154445762|NCT02639650|Methotrexate|methotrexate|mesh-list
154445763|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154445764|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445765|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
154445766|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
154445767|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
154445768|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445769|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445770|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
154445771|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445772|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445773|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154445774|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
153553065|NCT01590732|Etoposide|etoposide|mesh-list
153553117|NCT01590966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445775|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154445776|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154445777|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
154445778|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154445779|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154445780|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
154445781|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
154445782|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445783|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154445784|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154445785|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154445786|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154445787|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154445788|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445789|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154445790|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154445792|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
154445793|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445794|NCT02306798|Mesalamine|mesalamine|mesh-list
154445795|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154445796|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154445797|NCT02306798|Analgesics|analgesics|mesh-ancestor
154445798|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
154445799|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445800|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445801|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154445802|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154445803|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
154445804|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
154445805|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445806|NCT03509714|Protective Agents|protective agents|mesh-ancestor
154445807|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445808|NCT03509714|Vitamins|vitamins|mesh-ancestor
154445809|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
154445810|NCT02302274|Flecainide|flecainide|mesh-list
154445811|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154445812|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154445813|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154445814|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154445815|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445816|NCT02303600|Montelukast|montelukast|mesh-list
153553122|NCT01591031|Sevoflurane|sevoflurane|mesh-list
154445817|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154445818|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
154445819|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154445820|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
154445821|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154445822|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445823|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154445824|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154445825|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445826|NCT04463342|Methamphetamine|methamphetamine|mesh-list
154445827|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154445828|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445829|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
154445830|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
154445831|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445832|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
154445833|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445834|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445835|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
154445836|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154445837|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154445838|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154445839|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154445840|NCT02303912|Carboplatin|carboplatin|mesh-list
154445841|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445842|NCT01597492|Belimumab|belimumab|mesh-list
154445843|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154445844|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
154445845|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445846|NCT04569994|Insulin|insulin|mesh-list
154445847|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154445848|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445849|NCT00109590|Ritonavir|ritonavir|mesh-list
154445850|NCT00109590|Lopinavir|lopinavir|mesh-list
154445851|NCT00109590|Zidovudine|zidovudine|mesh-list
154445852|NCT00109590|Nevirapine|nevirapine|mesh-list
154445853|NCT00109590|Didanosine|didanosine|mesh-list
154445854|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154445855|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154445857|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445858|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445859|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153553256|NCT01591980|Analgesics|analgesics|mesh-ancestor
154445860|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154445861|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
154445862|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445863|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154445864|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154445865|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
154445866|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154445867|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154445868|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154445869|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154445870|NCT05243446|Losartan|losartan|mesh-list
154445871|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154445872|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154445873|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154445874|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154445875|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445876|NCT02143362|Remifentanil|remifentanil|mesh-list
154445877|NCT02143362|Anesthetics|anesthetics|mesh-list
154445878|NCT02143362|Propofol|propofol|mesh-list
154445879|NCT02143362|Cisatracurium|cisatracurium|mesh-list
154445880|NCT02143362|Atracurium|atracurium|mesh-list
154445881|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154445882|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445883|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154445884|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154445885|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
154445886|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154445887|NCT02143362|Narcotics|narcotics|mesh-ancestor
154445888|NCT02143362|Analgesics|analgesics|mesh-ancestor
154445889|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
154445890|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445891|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154445892|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154445893|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154445894|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154445895|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154445896|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
154445897|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445898|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445899|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
154445900|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154445901|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445902|NCT02143440|Insulin|insulin|mesh-list
154445903|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154445904|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445905|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154445906|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
154445907|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154445908|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
154445909|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445910|NCT02143518|Antacids|antacids|mesh-ancestor
154445911|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445912|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020587|NCT02717780|Fentanyl|fentanyl|mesh-list
154020660|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445914|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154445915|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445916|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
154445917|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154445918|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154445919|NCT00054964|Albuterol|albuterol|mesh-list
154445920|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154445921|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
154445922|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154445923|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445924|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154445925|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
154445926|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
154445927|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154445928|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154445929|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154445930|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154445931|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
154445932|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445933|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445934|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
154445935|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154445936|NCT02781558|Velpatasvir|velpatasvir|mesh-list
154445937|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
154445938|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154445939|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
154445940|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154445941|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445942|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445943|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154445944|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154445945|NCT05073640|Protective Agents|protective agents|mesh-ancestor
154445946|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445947|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
154445948|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154445949|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
154445950|NCT05073094|Esmolol|esmolol|mesh-list
154445951|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154445952|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154445953|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154445954|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
154445955|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445956|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445957|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445958|NCT03509246|Doxorubicin|doxorubicin|mesh-list
154445959|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154445960|NCT03509246|Bortezomib|bortezomib|mesh-list
154445961|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154445962|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445963|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154445964|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154445965|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445966|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445967|NCT03509168|Misoprostol|misoprostol|mesh-list
154445968|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154445969|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
154445970|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154445971|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445972|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154445973|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445974|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
153553435|NCT01593033|Micronutrients|micronutrients|mesh-list
154445975|NCT05072938|Nizatidine|nizatidine|mesh-list
154445976|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154445977|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154445978|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154445979|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
154445980|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
154445981|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154445982|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445983|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154445984|NCT03041311|Carboplatin|carboplatin|mesh-list
154445985|NCT03041311|Etoposide|etoposide|mesh-list
154445986|NCT03041311|Atezolizumab|atezolizumab|mesh-list
154445987|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154445988|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154445989|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154445990|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154445991|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154445992|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445993|NCT03041311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154445994|NCT03041311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154445995|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
154445996|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154445997|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154445998|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154445999|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
154446000|NCT05072860|Coagulants|coagulants|mesh-ancestor
154446001|NCT02311946|Palbociclib|palbociclib|mesh-list
154446002|NCT02311946|Rabeprazole|rabeprazole|mesh-list
154446003|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154446004|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446005|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154446006|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446007|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446008|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154446009|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154446010|NCT04302766|Remdesivir|remdesivir|mesh-list
154446011|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
154446012|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446013|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
154446014|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553487|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154446015|NCT05408221|Lenvatinib|lenvatinib|mesh-list
154446016|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446017|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154446018|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446019|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446020|NCT02307968|Insulin|insulin|mesh-list
154446021|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154446022|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446023|NCT02312180|Plasminogen|plasminogen|mesh-list
154446024|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154446025|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154446026|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446027|NCT03504566|Empagliflozin|empagliflozin|mesh-list
154446028|NCT03504566|Linagliptin|linagliptin|mesh-list
154446029|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154446030|NCT03504566|Telmisartan|telmisartan|mesh-list
154446031|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154446032|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446033|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154446034|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446035|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154446036|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154446037|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154446038|NCT03504566|Incretins|incretins|mesh-ancestor
154446039|NCT03504566|Hormones|hormones|mesh-ancestor
154446040|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446041|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154446042|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
154446043|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446044|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
154446045|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154446046|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
154446047|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154446048|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154446049|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154446050|NCT05070520|Lumefantrine|lumefantrine|mesh-list
154446051|NCT05070520|Artemether|artemether|mesh-list
154446052|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154446053|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
154446054|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154446055|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154446056|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446057|NCT05070598|Paclitaxel|paclitaxel|mesh-list
154446058|NCT05070598|Tegafur|tegafur|mesh-list
154446059|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154446060|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446061|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
154446062|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
154446063|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
154446064|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446065|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154446066|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
154446067|NCT03884452|Atorvastatin|atorvastatin|mesh-list
154446068|NCT03884452|Simvastatin|simvastatin|mesh-list
154446069|NCT03884452|Ezetimibe|ezetimibe|mesh-list
154446070|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154446071|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154446072|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
154446073|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446074|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154446075|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154446076|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446077|NCT03882892|Ezetimibe|ezetimibe|mesh-list
154446078|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154446079|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154446081|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446082|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154446083|NCT02305160|Poractant alfa|poractant alfa|mesh-list
154446084|NCT02305160|Beractant|beractant|mesh-list
154446085|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154446086|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
154446087|NCT02305394|Ketamine|ketamine|mesh-list
154446088|NCT02305394|Propofol|propofol|mesh-list
154446089|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154446090|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446091|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446092|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154446093|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
154446094|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
154446095|NCT02305394|Analgesics|analgesics|mesh-ancestor
154446096|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
154446097|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446098|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154446099|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154446100|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154446101|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446102|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446103|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
154446104|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154446105|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
154446106|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446107|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446108|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154446109|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
154446110|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154446111|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
154446112|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446113|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446114|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154446115|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
154446116|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
154446117|NCT02305550|Protective Agents|protective agents|mesh-ancestor
154446118|NCT03506516|Ethanol|ethanol|mesh-list
154446119|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154446120|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446121|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446122|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446123|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
154446124|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446125|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446126|NCT02643394|Acetaminophen|acetaminophen|mesh-list
154446127|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154446128|NCT02643394|Analgesics|analgesics|mesh-ancestor
154446129|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
154446130|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446131|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446132|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
154446133|NCT03101644|Darunavir|darunavir|mesh-list
154446134|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154446135|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154446136|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
154020807|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153553611|NCT01593774|Melatonin|melatonin|mesh-list
153553662|NCT01594099|Cisplatin|cisplatin|mesh-list
154446137|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446138|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446139|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154446140|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154446141|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
154446142|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446143|NCT03132272|Autoantibodies|autoantibodies|mesh-list
154446144|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
154446145|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446146|NCT05515627|Atezolizumab|atezolizumab|mesh-list
154446147|NCT05515627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154446148|NCT05515627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446149|NCT05515627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154446150|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446151|NCT02144064|Heparin|heparin|mesh-list
154446152|NCT02144064|Calcium heparin|calcium heparin|mesh-list
154446153|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
154446155|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154446156|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446157|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
154446158|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154446159|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154446160|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154446161|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154446162|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
154446163|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446164|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154446165|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154446166|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446167|NCT02305940|Doxycycline|doxycycline|mesh-list
154446168|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154446169|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446170|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
154446171|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154446172|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154446173|NCT02312804|Paclitaxel|paclitaxel|mesh-list
154446174|NCT02312804|Carboplatin|carboplatin|mesh-list
154446175|NCT02312804|Infigratinib|infigratinib|mesh-list
154446176|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154446177|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446178|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
154446179|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
154446180|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
154446181|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446182|NCT03099616|Propofol|propofol|mesh-list
154446183|NCT03099616|Desflurane|desflurane|mesh-list
153553664|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446184|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154446185|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446186|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446187|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154446188|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
154446189|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
154446190|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154446191|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
154446192|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154446193|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154446194|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446195|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
154446196|NCT04463966|Coagulants|coagulants|mesh-ancestor
154446197|NCT00794248|Fexofenadine|fexofenadine|mesh-list
154446198|NCT00794248|Desloratadine|desloratadine|mesh-list
154446199|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154446200|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
154446201|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446202|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446203|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446204|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154446205|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154446206|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
154446207|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
154446208|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154446209|NCT02309450|Asunaprevir|asunaprevir|mesh-list
154446210|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
154446211|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446212|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446213|NCT04475224|Mitogens|mitogens|mesh-list
154446214|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
154446215|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446216|NCT00353496|Lanreotide|lanreotide|mesh-list
154446217|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446218|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
154446219|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153539947|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539976|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154446220|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154446221|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
154446222|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446223|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446224|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446225|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
154446226|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
154446227|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446228|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
154446230|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
154446231|NCT03473977|Benralizumab|benralizumab|mesh-list
154446232|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154446233|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
154446234|NCT01361464|Tipifarnib|tipifarnib|mesh-list
154446235|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446236|NCT04051255|Metronidazole|metronidazole|mesh-list
154446237|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446238|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154446239|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154446240|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154446241|NCT03505736|Adenosine|adenosine|mesh-list
154446242|NCT03505736|Regadenoson|regadenoson|mesh-list
154446243|NCT03505736|Analgesics|analgesics|mesh-ancestor
154446244|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
154446245|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446246|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446247|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154446248|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
154446249|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154446250|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
154446251|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
154446252|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446253|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446254|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154446255|NCT02316626|Progesterone|progesterone|mesh-list
154446256|NCT02316626|Progestins|progestins|mesh-ancestor
154446257|NCT02316626|Hormones|hormones|mesh-ancestor
154446258|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446259|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446260|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
154446261|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154446262|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153540034|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154446263|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446264|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
154446265|NCT03505502|Coagulants|coagulants|mesh-ancestor
154446266|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
154446267|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154446268|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446269|NCT02316704|Tacrine|tacrine|mesh-list
154446270|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154446271|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446272|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446273|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
154446274|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446275|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446276|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154446277|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
154446278|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446279|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
154446280|NCT03501680|Insulin|insulin|mesh-list
154446281|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154446282|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446283|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154446284|NCT02310074|Hormones|hormones|mesh-list
154446285|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154446286|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446287|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446288|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154446289|NCT02313584|Dabigatran|dabigatran|mesh-list
154446290|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
154446291|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154446292|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
154446293|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446294|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446295|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
154446296|NCT05063578|Lidocaine|lidocaine|mesh-list
154446297|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
154446298|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
154446299|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446300|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446301|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
154446302|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446303|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154446304|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154446305|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154446306|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446307|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446308|NCT05063422|Trimethoprim|trimethoprim|mesh-list
154446309|NCT05063422|Polymyxins|polymyxins|mesh-list
154446310|NCT05063422|Polymyxin B|polymyxin b|mesh-list
154446311|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154446312|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154446313|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446314|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
154446315|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154446316|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154446317|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154446318|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446319|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446320|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154446321|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154446322|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154446323|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154446324|NCT05063422|Laxatives|laxatives|mesh-ancestor
154446325|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154446326|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
154446327|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154446328|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154446329|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446330|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
154446331|NCT03782350|Coagulants|coagulants|mesh-ancestor
154446332|NCT03098680|Verapamil|verapamil|mesh-list
154446333|NCT03098680|Nicardipine|nicardipine|mesh-list
154446334|NCT03098680|Phentolamine|phentolamine|mesh-list
154446335|NCT03098680|Phenylephrine|phenylephrine|mesh-list
154446336|NCT03098680|Dobutamine|dobutamine|mesh-list
154446337|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
154446338|NCT03098680|Albuterol|albuterol|mesh-list
154446339|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154446340|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
154446341|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446342|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446343|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154446344|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
154446345|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
154446346|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154446347|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154446348|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154446349|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154446350|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
154446351|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446352|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446353|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154446354|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
154446355|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
154446356|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154446357|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
154446358|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154446359|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154446360|NCT03098680|Protective Agents|protective agents|mesh-ancestor
154446361|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154446362|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154446363|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446364|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154446365|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
154446366|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154446367|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154446368|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154446369|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154446370|NCT03098368|Rotigotine|rotigotine|mesh-list
154446371|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
154446372|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
154446373|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446374|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446375|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446376|NCT05062486|Curcumin|curcumin|mesh-list
154446377|NCT05062486|Resveratrol|resveratrol|mesh-list
154446378|NCT05062486|Quercetin|quercetin|mesh-list
154446379|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154446380|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154446381|NCT05062486|Analgesics|analgesics|mesh-ancestor
154446382|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
154446383|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446384|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446385|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154446386|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154446387|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446388|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446389|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446390|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
154446391|NCT05062486|Protective Agents|protective agents|mesh-ancestor
154446392|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154446393|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154446394|NCT02314208|Resveratrol|resveratrol|mesh-list
154446395|NCT02314208|Atorvastatin|atorvastatin|mesh-list
154446396|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154446397|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154446398|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
154446399|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446400|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154446401|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154446402|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446403|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
154446404|NCT02314208|Protective Agents|protective agents|mesh-ancestor
154446405|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446406|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154446407|NCT02314208|Cathartics|cathartics|mesh-ancestor
154446408|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154446409|NCT03100318|Dotinurad|dotinurad|mesh-list
154446410|NCT03100318|Benzbromarone|benzbromarone|mesh-list
154446411|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
154446412|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
154446413|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154446414|NCT02311010|Tacrolimus|tacrolimus|mesh-list
154446415|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154446416|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
154446417|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446418|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154446419|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446420|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446421|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154446422|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154446423|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154446424|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
153540250|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
154446425|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446426|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154446427|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154446428|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446429|NCT03132194|Dapsone|dapsone|mesh-list
154446430|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446431|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
154446432|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154446433|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154446434|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154446435|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446436|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446437|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
154446438|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154446439|NCT02311088|Caffeine|caffeine|mesh-list
154446440|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154446441|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446442|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154446443|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446444|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446445|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154446446|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154446447|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
154446448|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446449|NCT03501212|Anesthetics|anesthetics|mesh-list
154446450|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
154446451|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446452|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446453|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
154446454|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446455|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154446457|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446458|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154446459|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446460|NCT04435210|Hydralazine|hydralazine|mesh-list
154446461|NCT04435210|Nifedipine|nifedipine|mesh-list
154446462|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154446463|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446464|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446465|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154446466|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446467|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
154446468|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
154446469|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154446470|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154446471|NCT03501056|Antibodies|antibodies|mesh-list
154446472|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154446473|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
154446474|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446475|NCT03292146|Denosumab|denosumab|mesh-list
154446476|NCT03292146|Alendronate|alendronate|mesh-list
154446477|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154446478|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446479|NCT02144376|Psyllium|psyllium|mesh-list
154446480|NCT02144376|Cathartics|cathartics|mesh-ancestor
154446481|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154446482|NCT02314754|Misoprostol|misoprostol|mesh-list
154446483|NCT02314754|Mifepristone|mifepristone|mesh-list
154446484|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154446485|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
154446486|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154446487|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446488|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154446489|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154446490|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
154446491|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154446492|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154446493|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154446494|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154446495|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
154446496|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154446497|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154446498|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
154446499|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446500|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
154446501|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154446502|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154446503|NCT02317640|Testosterone|testosterone|mesh-list
154446504|NCT02317640|Androgens|androgens|mesh-ancestor
154446505|NCT02317640|Hormones|hormones|mesh-ancestor
154446506|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446507|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446508|NCT02716948|Nivolumab|nivolumab|mesh-list
154446509|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154446510|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446511|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154446512|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446513|NCT03500900|Vildagliptin|vildagliptin|mesh-list
154446514|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153540426|NCT01539044|Atropine|atropine|mesh-list
154021189|NCT02641899|Exenatide|exenatide|mesh-list
154446515|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446516|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154446517|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
154446518|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446519|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446520|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154446521|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
154446522|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446523|NCT02141100|Thioguanine|thioguanine|mesh-list
154446524|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154446525|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
154446526|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446527|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446529|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
154446530|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
154446531|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446532|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446533|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
154446534|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446535|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
154446536|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154446537|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446538|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446539|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154446540|NCT02141412|Analgesics|analgesics|mesh-ancestor
154446541|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
154446542|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446543|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154446544|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154446545|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154446546|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
154446547|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446548|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446549|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
154446550|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154446551|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446552|NCT03210558|Testosterone|testosterone|mesh-list
154446553|NCT03210558|Androgens|androgens|mesh-ancestor
154446554|NCT03210558|Hormones|hormones|mesh-ancestor
154446555|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446556|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446557|NCT05046262|Calcium|calcium|mesh-list
154446558|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154446559|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540510|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446560|NCT05036824|Tinzaparin|tinzaparin|mesh-list
154446561|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154446562|NCT05036824|Dalteparin|dalteparin|mesh-list
154446563|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
154446564|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154446565|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154446566|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446567|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
154446568|NCT04462250|Narcotics|narcotics|mesh-ancestor
154446569|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446570|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446571|NCT04462250|Analgesics|analgesics|mesh-ancestor
154446572|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
154446573|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446574|NCT02144766|Ropivacaine|ropivacaine|mesh-list
154446575|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
154446576|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
154446577|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446578|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446579|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
154446580|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446581|NCT05045248|Apraclonidine|apraclonidine|mesh-list
154446582|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154446583|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154446584|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154446585|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
154446586|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446587|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021275|NCT02637375|Paclitaxel|paclitaxel|mesh-list
154446588|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446590|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154446591|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154446592|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154446593|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
154446594|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446595|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446596|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154446597|NCT02261064|Amlodipine|amlodipine|mesh-list
154446598|NCT02261064|Telmisartan|telmisartan|mesh-list
154446599|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154446600|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154446601|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154446602|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540511|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
153540567|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446603|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446604|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154446605|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446606|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
154446607|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154446608|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154446609|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154446610|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154446611|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446612|NCT03498326|Celecoxib|celecoxib|mesh-list
154446613|NCT03498326|Gemcitabine|gemcitabine|mesh-list
154446614|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154446615|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
154446616|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446617|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446618|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154446619|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154446620|NCT03498326|Analgesics|analgesics|mesh-ancestor
154446621|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
154446622|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446623|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446624|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154446625|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154446626|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154446627|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154446628|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446629|NCT03498248|Lenograstim|lenograstim|mesh-list
154446630|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154446631|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
154446632|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446633|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
154446634|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
154446635|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154446636|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446637|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154446638|NCT03498170|Itraconazole|itraconazole|mesh-list
154446639|NCT03498170|Acumapimod|acumapimod|mesh-list
154446640|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
154446641|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446642|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154446643|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154446644|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446645|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446646|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154446647|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154446648|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446649|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446650|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154446651|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154446652|NCT05055544|Fosfomycin|fosfomycin|mesh-list
154446653|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154446654|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540628|NCT01540110|Docetaxel|docetaxel|mesh-list
154446655|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
154446656|NCT03498092|Bupivacaine|bupivacaine|mesh-list
154446657|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
154446658|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
154446659|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446660|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446661|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
154446662|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446663|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154446664|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154446665|NCT03498092|Analgesics|analgesics|mesh-ancestor
154446666|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154446667|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154446668|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154446669|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
154446670|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446671|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446673|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
154446674|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
154446675|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446676|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446677|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
154446678|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446679|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154446680|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154446681|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154446682|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446683|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446684|NCT02315690|Piperaquine|piperaquine|mesh-list
154446685|NCT02315690|Artenimol|artenimol|mesh-list
154446686|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
154446687|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154446688|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154446689|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446690|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
154446691|NCT02639338|Velpatasvir|velpatasvir|mesh-list
153540641|NCT01540136|Nedaplatin|nedaplatin|mesh-list
154446692|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
154446693|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446694|NCT01754857|Rituximab|rituximab|mesh-list
154446695|NCT01754857|Lenalidomide|lenalidomide|mesh-list
154446696|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154446697|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154446698|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446699|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
154446700|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446701|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154446702|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154446703|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154446704|NCT01754857|Growth Substances|growth substances|mesh-ancestor
154446705|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
154446706|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154446707|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
154446708|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446709|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
154446710|NCT03497702|Docetaxel|docetaxel|mesh-list
154446711|NCT03497702|Doxorubicin|doxorubicin|mesh-list
154446712|NCT03497702|Letrozole|letrozole|mesh-list
154446713|NCT03497702|Leuprolide|leuprolide|mesh-list
154446714|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154446715|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
154446716|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446717|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154446718|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154446719|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
154446720|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446721|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446722|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154446723|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
154446724|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
154446725|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
154446726|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154446727|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154446728|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154446729|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446730|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154446731|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154446732|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154446733|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
154446734|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446735|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154446736|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
154446737|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154446738|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154446739|NCT02900352|Zonisamide|zonisamide|mesh-list
154446740|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
154446741|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154446742|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446743|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446744|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153540740|NCT01540812|BB 1101|bb 1101|mesh-list
154446745|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446746|NCT05034406|Lidocaine|lidocaine|mesh-list
154446747|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
154446748|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
154446749|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
154446750|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446751|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446752|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
154446753|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446754|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154446755|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154446756|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154446757|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446758|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446759|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
154446760|NCT02254668|Everolimus|everolimus|mesh-list
154446761|NCT02254668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154446762|NCT02254668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154446763|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446764|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446765|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154446766|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
154446767|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446768|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446769|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154446770|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154446771|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
154446772|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154446773|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446774|NCT03095404|Lidocaine|lidocaine|mesh-list
154446775|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154446776|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
154446777|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
154446778|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446779|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446780|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
154446781|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446782|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154446783|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153540777|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
154446784|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154446785|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446786|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446787|NCT02145546|Amiodarone|amiodarone|mesh-list
154446788|NCT02145546|Sotalol|sotalol|mesh-list
154446789|NCT02145546|Propafenone|propafenone|mesh-list
154446790|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154446791|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
154446792|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154446793|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446794|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446795|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154446796|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154446797|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154446798|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446799|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154446800|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154446801|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154446802|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154446803|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154446804|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154446805|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446806|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446807|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
154446808|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
154446809|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446810|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154446811|NCT03039673|Interleukin-2|interleukin-2|mesh-list
154446812|NCT03039673|Riluzole|riluzole|mesh-list
154446813|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446814|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154446815|NCT03039673|Analgesics|analgesics|mesh-ancestor
154446816|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
154446817|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446818|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446819|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
154446820|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154446821|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154446822|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446823|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446824|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154446825|NCT03039673|Protective Agents|protective agents|mesh-ancestor
154446826|NCT02145624|Vaccines|vaccines|mesh-list
154446827|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
154446828|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446829|NCT02321384|Ritonavir|ritonavir|mesh-list
154446830|NCT02321384|Midazolam|midazolam|mesh-list
154446831|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154446832|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154446833|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446834|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446835|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154446836|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154446837|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154446838|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154446839|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
154446840|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
154446841|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
154446842|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
154446843|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446844|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446845|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154446846|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154446847|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
154446848|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446849|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154446850|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154446851|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
154446852|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446853|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154446854|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154446855|NCT03095326|Zinc|zinc|mesh-list
154446856|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
154446857|NCT03095326|Vaccines|vaccines|mesh-list
154446858|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
154446859|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446860|NCT03095326|Trace Elements|trace elements|mesh-ancestor
154446861|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
154446862|NCT03095326|Astringents|astringents|mesh-ancestor
154446863|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
154446864|NCT02318810|Rocuronium|rocuronium|mesh-list
154446865|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154446866|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154446867|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154446868|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446869|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446870|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
154446871|NCT03500120|Captopril|captopril|mesh-list
154446872|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154446873|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
154446874|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446875|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446876|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154446877|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154446878|NCT02141958|Fenretinide|fenretinide|mesh-list
154446879|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446880|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154446881|NCT02141958|Protective Agents|protective agents|mesh-ancestor
154446882|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446883|NCT02142036|Trastuzumab|trastuzumab|mesh-list
154446885|NCT02142036|Panitumumab|panitumumab|mesh-list
154446886|NCT02142036|Everolimus|everolimus|mesh-list
154446887|NCT02142036|Sunitinib|sunitinib|mesh-list
154446888|NCT02142036|Dasatinib|dasatinib|mesh-list
154446889|NCT02142036|Lapatinib|lapatinib|mesh-list
154446890|NCT02142036|Gefitinib|gefitinib|mesh-list
154446891|NCT02142036|Temsirolimus|temsirolimus|mesh-list
154446892|NCT02142036|Afatinib|afatinib|mesh-list
154446893|NCT02142036|Dabrafenib|dabrafenib|mesh-list
154446894|NCT02142036|Vemurafenib|vemurafenib|mesh-list
154446895|NCT02142036|Crizotinib|crizotinib|mesh-list
154446896|NCT02142036|Nilotinib|nilotinib|mesh-list
154446897|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154446898|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446899|NCT02142036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154446900|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154446901|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446902|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446903|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154446904|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
154446905|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446906|NCT02142036|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154446907|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154446908|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154446909|NCT02142036|Growth Substances|growth substances|mesh-ancestor
154446910|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
154446911|NCT05053594|Neostigmine|neostigmine|mesh-list
154446912|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154446913|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446914|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446915|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
154446916|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154446917|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446918|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154446919|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
154446920|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446921|NCT02318888|Icodextrin|icodextrin|mesh-list
154446922|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
154446923|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154446924|NCT02142192|Natalizumab|natalizumab|mesh-list
154446925|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
154446926|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446927|NCT02321540|Ibrutinib|ibrutinib|mesh-list
153540972|NCT01541956|Metformin|metformin|mesh-list
154446928|NCT02321540|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154446929|NCT02321540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154446930|NCT02321540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154446931|NCT02321540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446932|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
154446933|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154446934|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446935|NCT02324582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154446936|NCT02324582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446937|NCT01255891|Androgens|androgens|mesh-list
154446938|NCT01255891|Hormones|hormones|mesh-ancestor
154446939|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446940|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446941|NCT02777190|Misoprostol|misoprostol|mesh-list
154446942|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154446943|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
154446944|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154446945|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446946|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154446947|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154446948|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
154446949|NCT03494426|Pregabalin|pregabalin|mesh-list
154446950|NCT03494426|Tramadol|tramadol|mesh-list
154446951|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
154446952|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
154446953|NCT03494426|Analgesics|analgesics|mesh-ancestor
154446954|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
154446955|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154446956|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446957|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
154446958|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154446959|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154446960|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446961|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154446962|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154446963|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154446964|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154446965|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154446966|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154446967|NCT03494426|Narcotics|narcotics|mesh-ancestor
154446968|NCT02432209|Orlistat|orlistat|mesh-list
154446969|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254846|NCT01251926|Bevacizumab|bevacizumab|mesh-list
154446970|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154446971|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154446972|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153541017|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154446973|NCT00108732|Metronidazole|metronidazole|mesh-list
154446974|NCT00108732|Goserelin|goserelin|mesh-list
154446975|NCT00108732|Bicalutamide|bicalutamide|mesh-list
154446976|NCT00108732|Vaccines|vaccines|mesh-list
154446977|NCT00108732|Sargramostim|sargramostim|mesh-list
154446978|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
154446979|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446980|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154446981|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154446982|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
154446983|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
154446984|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154446985|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154446986|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154446987|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154446988|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154446989|NCT02319200|Metformin|metformin|mesh-list
154446990|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154446991|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154446992|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154446993|NCT02319278|Hematinics|hematinics|mesh-ancestor
154446994|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154446995|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154446996|NCT02324738|Piperaquine|piperaquine|mesh-list
154446997|NCT02324738|Artenimol|artenimol|mesh-list
154446998|NCT02324738|Mefloquine|mefloquine|mesh-list
154446999|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
154447000|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154447001|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154447002|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447003|NCT02321852|Mannitol|mannitol|mesh-list
154447004|NCT02321852|Triflusal|triflusal|mesh-list
154447005|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154447006|NCT02321852|Diuretics|diuretics|mesh-ancestor
154447007|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
154447008|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447009|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154447010|NCT03499886|Ketamine|ketamine|mesh-list
154447011|NCT03499886|Analgesics|analgesics|mesh-ancestor
154447012|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
154447013|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447014|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447015|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154447016|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154447017|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
154447018|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
154447019|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447020|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154447021|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154447022|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447023|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447024|NCT02325050|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154447025|NCT02325050|Antiviral Agents|antiviral agents|mesh-ancestor
154447026|NCT02325050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447027|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154447028|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447029|NCT02322008|Adalimumab|adalimumab|mesh-list
154447030|NCT02322008|Infliximab|infliximab|mesh-list
154447031|NCT02322008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154447032|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021704|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447033|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154447034|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
154447035|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154447036|NCT02647554|Urinastatin|urinastatin|mesh-list
154447037|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
154447038|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154447040|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447041|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447042|NCT03499730|Midazolam|midazolam|mesh-list
154447043|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154447044|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154447045|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447046|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447047|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154447048|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154447049|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154447050|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154447051|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
154447052|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
154447053|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
154447054|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
154447055|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447056|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447057|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
154447058|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154447059|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447060|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154447061|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447062|NCT02325362|Miglustat|miglustat|mesh-list
154447063|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
154447064|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447065|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447066|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154447067|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154447068|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
154447069|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447070|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154447071|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154447072|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447073|NCT04462094|Ketamine|ketamine|mesh-list
154447074|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
154447075|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447076|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447077|NCT04462094|Analgesics|analgesics|mesh-ancestor
154447078|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
154447079|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447080|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154447081|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154447082|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
154447083|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154447084|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154447085|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447086|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447087|NCT02325440|Natalizumab|natalizumab|mesh-list
154447088|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154447089|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
154447090|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447091|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154447092|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447093|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154447094|NCT03499184|Metronidazole|metronidazole|mesh-list
154447095|NCT03499184|Amoxicillin|amoxicillin|mesh-list
154447096|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447097|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154447098|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154447099|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154447100|NCT00107952|Vancomycin|vancomycin|mesh-list
154447101|NCT00107952|Telavancin|telavancin|mesh-list
154447102|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154447103|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447104|NCT03499106|Itraconazole|itraconazole|mesh-list
154447105|NCT03499106|Praliciguat|praliciguat|mesh-list
154447106|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
154447107|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447108|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154447109|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154447110|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973764|NCT06247956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153541194|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153541195|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154447111|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447112|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154447113|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
154447114|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447115|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447116|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154447117|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154447118|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
154447119|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154447121|NCT02146638|Morphine|morphine|mesh-list
154447122|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154447123|NCT02146638|Narcotics|narcotics|mesh-ancestor
154447124|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447125|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447126|NCT02146638|Analgesics|analgesics|mesh-ancestor
154447127|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
154447128|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447129|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154447130|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154447131|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
154447132|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
154447133|NCT02320448|Cisplatin|cisplatin|mesh-list
154447134|NCT02320448|Doxorubicin|doxorubicin|mesh-list
154447135|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
154447136|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447137|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154447138|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154447139|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154447140|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447141|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447142|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154447143|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
154447144|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447145|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154447146|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154447147|NCT01366638|Ribavirin|ribavirin|mesh-list
154447148|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154447149|NCT01366638|Simeprevir|simeprevir|mesh-list
154447150|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
154447151|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447152|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
154447153|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447154|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
154447155|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447156|NCT02147808|Midazolam|midazolam|mesh-list
154447157|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153541248|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541249|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447158|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154447159|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447160|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447161|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154447162|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154447163|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154447164|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154447165|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
154447166|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
154447167|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
154447168|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
154447169|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447170|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447171|NCT03543072|Diphosphonates|diphosphonates|mesh-list
154447172|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154447173|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447174|NCT02147964|Ketoconazole|ketoconazole|mesh-list
154447175|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
154447176|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154447177|NCT02147964|Testosterone|testosterone|mesh-list
154447178|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
154447179|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
154447180|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154447181|NCT02147964|Dutasteride|dutasteride|mesh-list
154447182|NCT02147964|Acyline|acyline|mesh-list
154447183|NCT02147964|Androgens|androgens|mesh-ancestor
154021853|NCT00880191|Hormones|hormones|mesh-ancestor
154447184|NCT02147964|Hormones|hormones|mesh-ancestor
154447185|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447186|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447187|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154447188|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447189|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
154447190|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
154447191|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447192|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154447193|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154447194|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447195|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447196|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154447198|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154447199|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154447200|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154447201|NCT02780700|Capecitabine|capecitabine|mesh-list
154447202|NCT02780700|Nintedanib|nintedanib|mesh-list
154447203|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154447204|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
154447205|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447206|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447207|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154447208|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447209|NCT02147262|Doxycycline|doxycycline|mesh-list
154447210|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154447211|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447212|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
154447213|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154447214|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154447215|NCT02447276|Fasinumab|fasinumab|mesh-list
154447216|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154447217|NCT02447276|Analgesics|analgesics|mesh-ancestor
154447218|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
154447219|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447220|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447221|NCT02323412|Amoxicillin|amoxicillin|mesh-list
154447222|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154447223|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447224|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
154447225|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
154447226|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447227|NCT03109730|Tenofovir|tenofovir|mesh-list
154447228|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154447229|NCT03109730|Entecavir|entecavir|mesh-list
154447230|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
154447231|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447232|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154447233|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154447234|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447235|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447236|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154447237|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154447238|NCT03495206|Edaravone|edaravone|mesh-list
154447239|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154447240|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
154447241|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447242|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154447243|NCT03495206|Protective Agents|protective agents|mesh-ancestor
154447244|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447245|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
154447246|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154447247|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447248|NCT03491696|Metyrapone|metyrapone|mesh-list
154447249|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
154447250|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447251|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447252|NCT03492866|Gentamicins|gentamicins|mesh-list
154447253|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154447254|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447255|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154447256|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447257|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447258|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
154447259|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154447260|NCT03492710|Antibodies|antibodies|mesh-list
154447261|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
154447262|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447263|NCT03954938|Cocaine|cocaine|mesh-list
154447264|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
154447265|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
154447266|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447267|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447268|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
154447269|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447270|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154447271|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154447272|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154447273|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447274|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447275|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
154447276|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447277|NCT02148120|Beclomethasone|beclomethasone|mesh-list
154447278|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
154447279|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154447280|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
154447281|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447282|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447283|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154447284|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
154447285|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154447286|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154447287|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154447288|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
154447289|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447290|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447291|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154447292|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
154447293|NCT02148120|Hormones|hormones|mesh-ancestor
154447294|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447295|NCT03492632|Hormones|hormones|mesh-list
154447296|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447297|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447298|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
154447299|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154447300|NCT02147730|Anesthetics|anesthetics|mesh-list
154447301|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447302|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447303|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
154447304|NCT02151630|Salicylates|salicylates|mesh-list
154447305|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447306|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
154447307|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
154447308|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
154447309|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154447310|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154447311|NCT02151630|Analgesics|analgesics|mesh-ancestor
154447312|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
154447313|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447314|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447315|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154447316|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154447317|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154447318|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447319|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447320|NCT03494972|Tetracycline|tetracycline|mesh-list
154447321|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154447322|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447323|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154447324|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447325|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447326|NCT02224573|Cannabidiol|cannabidiol|mesh-list
154447327|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
154447328|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154447329|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154447330|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154447331|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447332|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447333|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
154447334|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447335|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154447336|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154447337|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
154447338|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154447339|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447340|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447341|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154447343|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
153541535|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447344|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447345|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154447346|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154447347|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154447348|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
154447349|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447350|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447352|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154447353|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
154447354|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
154447355|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
154447356|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
154447357|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
154447358|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154447359|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447360|NCT03504423|Leucovorin|leucovorin|mesh-list
154447361|NCT03504423|Folic Acid|folic acid|mesh-list
154447362|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
154447363|NCT03504423|Irinotecan|irinotecan|mesh-list
154447364|NCT03504423|Folfirinox|folfirinox|mesh-list
154447365|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
154447366|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447367|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154447368|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154447369|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447370|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447371|NCT03504423|Antidotes|antidotes|mesh-ancestor
154447372|NCT03504423|Protective Agents|protective agents|mesh-ancestor
154447373|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447374|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
154447375|NCT03504423|Vitamins|vitamins|mesh-ancestor
154447376|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
154447377|NCT03504423|Hematinics|hematinics|mesh-ancestor
154447378|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154447379|NCT03097198|Tropicamide|tropicamide|mesh-list
154447380|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154447381|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
154447382|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
154447383|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447384|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447385|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154447386|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154447387|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
153541594|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447388|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447389|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447390|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154447391|NCT02770248|Brinzolamide|brinzolamide|mesh-list
154447392|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154447393|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154447394|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154447395|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154447396|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
154447397|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447398|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447399|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447400|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154447401|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447402|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154447403|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154447404|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
154447405|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447406|NCT02686346|Etoposide|etoposide|mesh-list
154447407|NCT02686346|Ifosfamide|ifosfamide|mesh-list
154447408|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154447409|NCT02686346|Carboplatin|carboplatin|mesh-list
154447410|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154447411|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447412|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154447413|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154447414|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447415|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447416|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154447417|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
154447418|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154447419|NCT02686346|Immunotoxins|immunotoxins|mesh-ancestor
154447420|NCT02686346|Immunoconjugates|immunoconjugates|mesh-ancestor
154075562|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
154447421|NCT02686346|Immunologic Factors|immunologic factors|mesh-ancestor
154447422|NCT02686346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447423|NCT03489044|Levetiracetam|levetiracetam|mesh-list
154447424|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
154447425|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
153541597|NCT01546051|BCI-838|bci-838|mesh-list
153541645|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447426|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154447427|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154447428|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154447429|NCT01344369|Norethindrone|norethindrone|mesh-list
154447430|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
154447431|NCT01344369|Estradiol|estradiol|mesh-list
154447432|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154447433|NCT01344369|Estrogens|estrogens|mesh-ancestor
154447434|NCT01344369|Hormones|hormones|mesh-ancestor
154447435|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447436|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447437|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154447438|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
154447439|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154447440|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154447441|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154447442|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154447443|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154447444|NCT03491072|Fentanyl|fentanyl|mesh-list
154447445|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154447446|NCT03491072|Narcotics|narcotics|mesh-ancestor
154447447|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447448|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447449|NCT03491072|Analgesics|analgesics|mesh-ancestor
154447450|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
154447451|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447452|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154447453|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154447454|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
154447455|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
154447456|NCT03503409|Ivosidenib|ivosidenib|mesh-list
154447457|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447458|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447459|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447460|NCT03490994|Warfarin|warfarin|mesh-list
154447461|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
154447462|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
154447463|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154447464|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
154447465|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154447466|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
154447467|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447468|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447469|NCT01360762|Pentamidine|pentamidine|mesh-list
154447470|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
154447471|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447472|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154447473|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154447474|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154447475|NCT04382924|Ifenprodil|ifenprodil|mesh-list
154447476|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154447477|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154447478|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
154447479|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447480|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447481|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447482|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
154447483|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154447484|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154447485|NCT00002601|Doxorubicin|doxorubicin|mesh-list
154447486|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154447487|NCT00002601|Melphalan|melphalan|mesh-list
154447488|NCT00002601|Ifosfamide|ifosfamide|mesh-list
154447489|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447490|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154447491|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154447492|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154447493|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447494|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447495|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
154447496|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447497|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154447498|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
154447499|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154447500|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154447501|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
154447502|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
154447503|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
154447505|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154447506|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447507|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447508|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154447509|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447510|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
154447511|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
154447512|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154447513|NCT02645474|Ropivacaine|ropivacaine|mesh-list
154447514|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
154447515|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
154447516|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447517|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447518|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
154447519|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447520|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
154447521|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154447522|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
154447523|NCT05052814|Calcium|calcium|mesh-list
154447524|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154447525|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447526|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154447527|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447528|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
154447529|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
154447530|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
154447531|NCT03615417|Anesthetics|anesthetics|mesh-list
154447532|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447533|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447534|NCT02155530|Atorvastatin|atorvastatin|mesh-list
154447535|NCT02155530|Pravastatin|pravastatin|mesh-list
154447536|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154447537|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154447538|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
154447539|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447540|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154447541|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154447542|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447543|NCT05051956|Palbociclib|palbociclib|mesh-list
154447544|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447545|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154447546|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447547|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447548|NCT02769624|Treprostinil|treprostinil|mesh-list
154447549|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154447550|NCT03543774|Simvastatin|simvastatin|mesh-list
154447551|NCT03543774|Ezetimibe|ezetimibe|mesh-list
154447552|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154447553|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154447554|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154447555|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
154447556|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447557|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154447558|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153541811|NCT01547520|Narcotics|narcotics|mesh-ancestor
154447559|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447560|NCT02152176|Morphine|morphine|mesh-list
154447561|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154447562|NCT02152176|Narcotics|narcotics|mesh-ancestor
154447563|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447564|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447565|NCT02152176|Analgesics|analgesics|mesh-ancestor
154447566|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
154447567|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447568|NCT03617055|Cystatins|cystatins|mesh-list
154447569|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154447570|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
154447571|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075730|NCT00806819|Folic Acid|folic acid|mesh-list
154447572|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447573|NCT03488888|Bupivacaine|bupivacaine|mesh-list
154447574|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
154447575|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
154447576|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447577|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447578|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
154447579|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447580|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
154447581|NCT05031676|Anesthetics|anesthetics|mesh-list
154447582|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447583|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447584|NCT05031676|Narcotics|narcotics|mesh-ancestor
154447585|NCT05031676|Analgesics|analgesics|mesh-ancestor
154447586|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
154447587|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447588|NCT03488810|Hormones|hormones|mesh-list
154447589|NCT03488810|Androgens|androgens|mesh-list
154447590|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
154447591|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
154447592|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447593|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447594|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
154447595|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154447596|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447597|NCT03492242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154447598|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447599|NCT03572283|Bethanechol|bethanechol|mesh-list
154447600|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154447601|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
154447602|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447603|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447604|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154447605|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154447606|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
153541814|NCT01547520|Analgesics|analgesics|mesh-ancestor
154447607|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447608|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447609|NCT02254824|Atorvastatin|atorvastatin|mesh-list
154447610|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154447611|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154447612|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
154447613|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447614|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154447615|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154447616|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447617|NCT01525316|Lactoferrin|lactoferrin|mesh-list
154447618|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447619|NCT01673386|Sunitinib|sunitinib|mesh-list
154447620|NCT01673386|Tivozanib|tivozanib|mesh-list
154447621|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447622|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154447623|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154447624|NCT01673386|Growth Substances|growth substances|mesh-ancestor
154447625|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447626|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
154447627|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154447628|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447629|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447630|NCT00103740|Vitamin D|vitamin d|mesh-list
154447631|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
154447632|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
154447633|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
154447634|NCT00103740|Calcium|calcium|mesh-list
154447635|NCT00103740|Vitamins|vitamins|mesh-ancestor
154447636|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
154447637|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447638|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154447639|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154447640|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154447641|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447642|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447643|NCT03616509|Hormones|hormones|mesh-list
154447644|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447645|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447646|NCT02869893|Secretin|secretin|mesh-list
154447647|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154447648|NCT02869893|Hormones|hormones|mesh-ancestor
154447649|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447650|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447651|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
154447652|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154447653|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154447654|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447655|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153541881|NCT01548170|Ketoconazole|ketoconazole|mesh-list
153541930|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154447656|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154447657|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447658|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447659|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447660|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154447661|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
154447662|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154447663|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447664|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154447665|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154447666|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154447667|NCT05118308|Liver Extracts|liver extracts|mesh-list
154447668|NCT05118308|Hematinics|hematinics|mesh-ancestor
154447669|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
154447670|NCT03617289|Analgesics|analgesics|mesh-ancestor
154447671|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
154447672|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447673|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447674|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
154447675|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447676|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154447677|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
154447678|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154447679|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447680|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447681|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154447682|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
154447683|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154447684|NCT02152410|Morphine|morphine|mesh-list
154447685|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154447686|NCT02152410|Narcotics|narcotics|mesh-ancestor
154447687|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447688|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447689|NCT02152410|Analgesics|analgesics|mesh-ancestor
154447690|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
154447691|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447692|NCT05043688|Paclitaxel|paclitaxel|mesh-list
154447693|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153541968|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
153541969|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541970|NCT01548612|Nitroprusside|nitroprusside|mesh-list
154447694|NCT05043688|Carboplatin|carboplatin|mesh-list
154447695|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154447696|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447697|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
154447698|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
154447699|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
154447700|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447701|NCT03614715|Interferons|interferons|mesh-list
154447702|NCT03614715|Interferon-beta|interferon-beta|mesh-list
154447703|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
154447704|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447705|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
154447706|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447707|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
154447708|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447709|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154447710|NCT00363038|Vitamins|vitamins|mesh-list
154447711|NCT00363038|Vitamin K|vitamin k|mesh-list
154447712|NCT00363038|Vitamin A|vitamin a|mesh-list
154447713|NCT00363038|Petrolatum|petrolatum|mesh-list
154447714|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
154447715|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447716|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154447717|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154447718|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447719|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
154447720|NCT00363038|Coagulants|coagulants|mesh-ancestor
154447721|NCT00363038|Emollients|emollients|mesh-ancestor
154447722|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
154447723|NCT03489668|Metformin|metformin|mesh-list
154447724|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154447725|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447726|NCT02872311|Vaccines|vaccines|mesh-list
154447727|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
154447728|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447729|NCT03614403|Vitamin D|vitamin d|mesh-list
154447730|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
154447731|NCT03614403|Vitamins|vitamins|mesh-ancestor
154447732|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
154447733|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447734|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154447735|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153541997|NCT01548807|Everolimus|everolimus|mesh-list
154447736|NCT03488186|Lansoprazole|lansoprazole|mesh-list
154447737|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
154447738|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154447739|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154447740|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154447741|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447742|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447743|NCT05103644|Atorvastatin|atorvastatin|mesh-list
154447744|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154447745|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154447746|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
154447747|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447748|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154447749|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154447750|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447751|NCT03887624|Ethosuximide|ethosuximide|mesh-list
154447752|NCT03887624|Escitalopram|escitalopram|mesh-list
154447753|NCT03887624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154447754|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154447755|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447756|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447757|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447758|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
154447759|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447760|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
154447761|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
154447762|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154447763|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447764|NCT03485846|Ritonavir|ritonavir|mesh-list
154447765|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154447766|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154447767|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
154447768|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447769|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447770|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154447771|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154447772|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
154447773|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447774|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154447775|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154447776|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
154447777|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154447778|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
154447779|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154447780|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
154447781|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447782|NCT03613857|Clopidogrel|clopidogrel|mesh-list
154447783|NCT03613857|Ticagrelor|ticagrelor|mesh-list
154447784|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154447785|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153542073|NCT01549171|Iloprost|iloprost|mesh-list
154447786|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154447787|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154447788|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
154447789|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447790|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447791|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447792|NCT03613389|Vitamin E|vitamin e|mesh-list
154447793|NCT03613389|Vitamins|vitamins|mesh-ancestor
154447794|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
154075940|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154447795|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447796|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
154447797|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447798|NCT03613389|Protective Agents|protective agents|mesh-ancestor
154447799|NCT03614013|Immunomodulating Agents|immunomodulating agents|mesh-list
154447800|NCT03614013|Immunologic Factors|immunologic factors|mesh-ancestor
154447801|NCT03614013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447802|NCT02259777|Amlodipine|amlodipine|mesh-list
154447803|NCT02259777|Telmisartan|telmisartan|mesh-list
154447804|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154447805|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154447806|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154447807|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447808|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447809|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154447810|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447811|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
154447812|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154447813|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154447814|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154447815|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
154447816|NCT03261375|Nifedipine|nifedipine|mesh-list
154447817|NCT03261375|Diuretics|diuretics|mesh-ancestor
154447818|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
154447819|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447820|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154447821|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447822|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447823|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154447824|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154447825|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
154447826|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
154447827|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154447828|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154447829|NCT03613545|Rifaximin|rifaximin|mesh-list
154447830|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
154447831|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447832|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154447833|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154447834|NCT01361308|Paroxetine|paroxetine|mesh-list
154447835|NCT01361308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154447836|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154447837|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447838|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447839|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447840|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
154447841|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447842|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154447843|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
154447844|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154447845|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154447846|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154447847|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447848|NCT05043142|Antibodies|antibodies|mesh-list
154447849|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
154447850|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447851|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154447852|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447853|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
154447854|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154447855|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154447856|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154447857|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
154447858|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447859|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447860|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447861|NCT00103662|Plerixafor|plerixafor|mesh-list
154447862|NCT00103662|Lenograstim|lenograstim|mesh-list
154447863|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154447864|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
154447865|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447866|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154447867|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154447868|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
154447869|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447870|NCT03612219|Apatinib|apatinib|mesh-list
154447871|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447872|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154447873|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447874|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447875|NCT05030116|Domperidone|domperidone|mesh-list
154447876|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
154447877|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
154447878|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447879|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447880|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154447881|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154447882|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
154447883|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447884|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447885|NCT02148978|Saxagliptin|saxagliptin|mesh-list
154447886|NCT02148978|Incretins|incretins|mesh-ancestor
154447887|NCT02148978|Hormones|hormones|mesh-ancestor
154447888|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154447889|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447890|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154447891|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
154447892|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447893|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447894|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154447895|NCT05048914|Acetaminophen|acetaminophen|mesh-list
154447896|NCT05048914|Dipyrone|dipyrone|mesh-list
154447897|NCT05048914|Ibuprofen|ibuprofen|mesh-list
154447898|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154447899|NCT05048914|Analgesics|analgesics|mesh-ancestor
154447900|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
154447901|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447902|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447903|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
154447904|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154447905|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154447906|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154447907|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154447908|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447909|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447910|NCT03046017|Lidocaine|lidocaine|mesh-list
154447911|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
154447912|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
154447913|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154447914|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447915|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
153973765|NCT06247956|Antimetabolites|antimetabolites|mesh-ancestor
153542223|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154447916|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154447917|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154447918|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154447919|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154447920|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154447921|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447922|NCT02149212|Aminaftone|aminaftone|mesh-list
154447923|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
154447924|NCT02149212|Coagulants|coagulants|mesh-ancestor
154447925|NCT03611985|Taxane|taxane|mesh-list
154447926|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447927|NCT03097900|Caffeine|caffeine|mesh-list
154447928|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
154447929|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447930|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154447931|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447932|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154447933|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447934|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154447935|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154447936|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
154447937|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154447938|NCT00354835|Dactinomycin|dactinomycin|mesh-list
154022606|NCT02703194|Prednisone|prednisone|mesh-list
154447939|NCT00354835|Cactinomycin|cactinomycin|mesh-list
154447940|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
154447941|NCT00354835|Irinotecan|irinotecan|mesh-list
154447943|NCT00354835|Camptothecin|camptothecin|mesh-list
154447944|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154447945|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
154447946|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447947|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154447948|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154447949|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
154447950|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447951|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447952|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154447953|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154447954|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154447955|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447956|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154447957|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
154447958|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
154447959|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
154447960|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542309|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154447961|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447962|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154447963|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154447964|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154447965|NCT02768298|Enalapril|enalapril|mesh-list
154447966|NCT02768298|Enalaprilat|enalaprilat|mesh-list
154447967|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154447968|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154447969|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
154447970|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447971|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447972|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154447973|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154447974|NCT05028322|Imiquimod|imiquimod|mesh-list
154447975|NCT05028322|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154447976|NCT05028322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447977|NCT05028322|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154447978|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
154447979|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154447980|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154447981|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447982|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
154447983|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
154447984|NCT03096340|Irinotecan|irinotecan|mesh-list
154447985|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154447986|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154447987|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154447988|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154447989|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154447990|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154447991|NCT02152800|Valacyclovir|valacyclovir|mesh-list
154447992|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
154447993|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154447994|NCT02149758|Etoricoxib|etoricoxib|mesh-list
154447995|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154447996|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154447997|NCT02149758|Analgesics|analgesics|mesh-ancestor
154447998|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
154447999|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448000|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448001|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448002|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154448003|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154448004|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154448005|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448006|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448007|NCT03542214|Calcium|calcium|mesh-list
154448008|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154448009|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448010|NCT03094468|Terbinafine|terbinafine|mesh-list
154448011|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
154448012|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448013|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076168|NCT00798434|Fesoterodine|fesoterodine|mesh-list
154448014|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448016|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
154448017|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
154448018|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
154448019|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154448020|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154448021|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154448022|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448023|NCT03095872|Petrolatum|petrolatum|mesh-list
154448024|NCT03095872|Emollients|emollients|mesh-ancestor
154448025|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
154448026|NCT03096184|Apatinib|apatinib|mesh-list
154448027|NCT03096184|Tegafur|tegafur|mesh-list
154448028|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448029|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154448030|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448031|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448032|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154448033|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
154448034|NCT02157012|Tofacitinib|tofacitinib|mesh-list
154448035|NCT02157012|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154448036|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154448037|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448038|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448039|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
154448040|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
154448041|NCT03096028|Vitamins|vitamins|mesh-ancestor
154448042|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
154448043|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448044|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
154448045|NCT03096028|Hematinics|hematinics|mesh-ancestor
154448046|NCT02149914|Rabeprazole|rabeprazole|mesh-list
154448047|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154448048|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154448049|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154448050|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448051|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448052|NCT02149992|Inositol|inositol|mesh-list
154448053|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
154448054|NCT02149992|Vitamins|vitamins|mesh-ancestor
154448055|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
154448056|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448057|NCT04833582|Gemcitabine|gemcitabine|mesh-list
154448058|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154448059|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
154448060|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448061|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448062|NCT05041582|Citalopram|citalopram|mesh-list
154448063|NCT05041582|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154448064|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154448065|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154448066|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448067|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448068|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
154448069|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448070|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154448071|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
154448072|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154448073|NCT02150070|ASP2408|asp2408|mesh-list
154448074|NCT02150070|Immunoconjugates|immunoconjugates|mesh-ancestor
154448075|NCT02150070|Immunologic Factors|immunologic factors|mesh-ancestor
154448076|NCT02150070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448077|NCT02153424|Apixaban|apixaban|mesh-list
154448078|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154448079|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
154448080|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154448081|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
154448082|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448083|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448084|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
154448085|NCT04434430|Gabapentin|gabapentin|mesh-list
154448086|NCT04434430|Analgesics|analgesics|mesh-ancestor
154448087|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
154448088|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448089|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448092|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154448093|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154448094|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154448095|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154448096|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154448097|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448098|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448099|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
154448100|NCT03094156|Resveratrol|resveratrol|mesh-list
154448101|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
154448102|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
154448103|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448104|NCT03094156|Protective Agents|protective agents|mesh-ancestor
154448105|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448106|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448107|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154448108|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
154448109|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448110|NCT02964273|Tolvaptan|tolvaptan|mesh-list
154448111|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154448112|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448113|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
154448114|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448115|NCT05040724|Ivermectin|ivermectin|mesh-list
154448116|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154448117|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448118|NCT03542058|Carvedilol|carvedilol|mesh-list
154448119|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154448120|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154448121|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
154448122|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448123|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448124|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448125|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154448126|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
154448127|NCT03542058|Protective Agents|protective agents|mesh-ancestor
154448128|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154448129|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154448130|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154448131|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
154448132|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154448133|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154448134|NCT03321513|Bevacizumab|bevacizumab|mesh-list
154448135|NCT03321513|Aflibercept|aflibercept|mesh-list
154448136|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154448137|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448138|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154448139|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154448140|NCT03321513|Growth Substances|growth substances|mesh-ancestor
154448141|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448142|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
154448143|NCT02032797|Progesterone|progesterone|mesh-list
154448144|NCT02032797|Progestins|progestins|mesh-ancestor
154448145|NCT02032797|Hormones|hormones|mesh-ancestor
154448146|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448147|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448148|NCT05024266|Paclitaxel|paclitaxel|mesh-list
154448149|NCT05024266|Carboplatin|carboplatin|mesh-list
154448150|NCT05024266|Tislelizumab|tislelizumab|mesh-list
154448151|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448152|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448153|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
154448154|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
154448155|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
154448156|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448157|NCT05024266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154448158|NCT02773368|Insulin|insulin|mesh-list
154448159|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154448160|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
154448161|NCT02773368|Liraglutide|liraglutide|mesh-list
154448162|NCT02773368|Xultophy|xultophy|mesh-list
154448163|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154448164|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448165|NCT02773368|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154448166|NCT02773368|Incretins|incretins|mesh-ancestor
154448167|NCT02773368|Hormones|hormones|mesh-ancestor
154448168|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448169|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
154448170|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154448171|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448172|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
154448173|NCT02157558|Fexofenadine|fexofenadine|mesh-list
154448174|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154448175|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154448176|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154448177|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
154448178|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
154448179|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448180|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448181|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448182|NCT05018182|Leucovorin|leucovorin|mesh-list
154448183|NCT05018182|Folic Acid|folic acid|mesh-list
154448184|NCT05018182|Capecitabine|capecitabine|mesh-list
154448185|NCT05018182|Fluorouracil|fluorouracil|mesh-list
154448186|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
154448187|NCT05018182|Irinotecan|irinotecan|mesh-list
154448188|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
154448189|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154448190|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
154448191|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448192|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448193|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154448194|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
154448195|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448196|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154448197|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154448198|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448199|NCT05018182|Antidotes|antidotes|mesh-ancestor
154448200|NCT05018182|Protective Agents|protective agents|mesh-ancestor
154448201|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
154448202|NCT05018182|Vitamins|vitamins|mesh-ancestor
154448203|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
154448204|NCT05018182|Hematinics|hematinics|mesh-ancestor
154448205|NCT01336569|Timolol|timolol|mesh-list
154448206|NCT01336569|Travoprost|travoprost|mesh-list
154448207|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448208|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154448209|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154448210|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
154448211|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448212|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448213|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154448214|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154448215|NCT03092986|Paclitaxel|paclitaxel|mesh-list
154448216|NCT03092986|Vinblastine|vinblastine|mesh-list
154448217|NCT03092986|Carboplatin|carboplatin|mesh-list
154448218|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448219|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448220|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
154448221|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
154448222|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
154448223|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448224|NCT03092908|Acetic Acid|acetic acid|mesh-list
154448225|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154448226|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448227|NCT03543306|Trametinib|trametinib|mesh-list
154448228|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448229|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154448230|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448231|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448232|NCT02157792|Carboplatin|carboplatin|mesh-list
154448233|NCT02157792|Gemcitabine|gemcitabine|mesh-list
154448234|NCT02157792|Irinotecan|irinotecan|mesh-list
154448235|NCT02157792|Etoposide|etoposide|mesh-list
154448236|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448237|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154448238|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
154448239|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448240|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154448241|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154448242|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448243|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448244|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154448246|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154448247|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448248|NCT02772978|Tolcapone|tolcapone|mesh-list
153542689|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448249|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154448250|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154448251|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154448252|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448253|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448254|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
154448255|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154448256|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154448257|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448258|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154448259|NCT00104052|Ribavirin|ribavirin|mesh-list
154448260|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154448261|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
154448262|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
154448263|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448264|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
154448265|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448266|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
154448267|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448268|NCT05038072|Triamcinolone|triamcinolone|mesh-list
154448269|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154448270|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154448271|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154448272|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448273|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
154448274|NCT05038072|Hormones|hormones|mesh-ancestor
154448275|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448276|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448277|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154448278|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
154448279|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448280|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448281|NCT02777970|Acetaminophen|acetaminophen|mesh-list
154448282|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154448283|NCT02777970|Tramadol|tramadol|mesh-list
154448284|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154448285|NCT02777970|Analgesics|analgesics|mesh-ancestor
154448286|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
154448287|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448288|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448289|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
154448290|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154448291|NCT02777970|Narcotics|narcotics|mesh-ancestor
154448292|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542730|NCT01553981|Tadalafil|tadalafil|mesh-list
153542737|NCT01554059|Bevacizumab|bevacizumab|mesh-list
154448293|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154448294|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448295|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154448296|NCT02150616|Sevoflurane|sevoflurane|mesh-list
154448297|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154448298|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154448299|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
154448300|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
154448301|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154448302|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448303|NCT01336023|Insulin|insulin|mesh-list
154448304|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154448305|NCT01336023|Liraglutide|liraglutide|mesh-list
154448306|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
154448307|NCT01336023|Xultophy|xultophy|mesh-list
154448308|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154448309|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448310|NCT01336023|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154448311|NCT01336023|Incretins|incretins|mesh-ancestor
154448312|NCT01336023|Hormones|hormones|mesh-ancestor
154448313|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448314|NCT02255292|Cannabidiol|cannabidiol|mesh-list
154448315|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
154448316|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154254851|NCT01251926|Growth Substances|growth substances|mesh-ancestor
154448317|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154448318|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
154448319|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448320|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154448321|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154448322|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448323|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448324|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154448325|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154448326|NCT02254980|Vitamin E|vitamin e|mesh-list
154448327|NCT02254980|Vitamins|vitamins|mesh-ancestor
154448328|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
154448329|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448330|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
154448331|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448332|NCT02254980|Protective Agents|protective agents|mesh-ancestor
154448333|NCT05281003|Paclitaxel|paclitaxel|mesh-list
154448334|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
154448335|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448336|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448337|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
154448338|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
154448339|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
154448340|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448341|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154448342|NCT05281003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154448343|NCT02158182|Rifaximin|rifaximin|mesh-list
154448344|NCT02158182|Lactulose|lactulose|mesh-list
154448345|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
154448346|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154448347|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448348|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154448349|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154448350|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154448351|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448352|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448353|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448354|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
154448355|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154448356|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448357|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
154448358|NCT02154360|Aprepitant|aprepitant|mesh-list
154448359|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
154448360|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
154448361|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448362|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448363|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154448364|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154448365|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448366|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448367|NCT02033031|Bevacizumab|bevacizumab|mesh-list
154448368|NCT02033031|Ranibizumab|ranibizumab|mesh-list
154448369|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154448370|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448371|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154448372|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154448373|NCT02033031|Growth Substances|growth substances|mesh-ancestor
154448374|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448375|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
154448376|NCT05034367|Mannitol|mannitol|mesh-list
154448377|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154448378|NCT05034367|Diuretics|diuretics|mesh-ancestor
153542881|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153542887|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
154448379|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
154448380|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448381|NCT02150928|Asparaginase|asparaginase|mesh-list
154448382|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448383|NCT03611049|Vitamin D|vitamin d|mesh-list
154448384|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
154448385|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
154448386|NCT03611049|Vitamins|vitamins|mesh-list
154448387|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
154448388|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448389|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154448390|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154448391|NCT03610893|Dexamethasone|dexamethasone|mesh-list
154448392|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
154448393|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448394|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
154448395|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
154448396|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448397|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448398|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154448399|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
154448400|NCT03610893|Hormones|hormones|mesh-ancestor
154448401|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448402|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154448403|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448404|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154448405|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154448406|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154448407|NCT03610893|Analgesics|analgesics|mesh-ancestor
154448408|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
154448409|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154448410|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154448411|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154448412|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
154448413|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448414|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448415|NCT02154438|Ketamine|ketamine|mesh-list
154448416|NCT02154438|Analgesics|analgesics|mesh-ancestor
154448417|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
154448418|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448419|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448420|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154448421|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154448422|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
154448423|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
154448424|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154448425|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154448426|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154448427|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448428|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448429|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
154448430|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154448431|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154448432|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448433|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
154448434|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
154448435|NCT03610347|Paclitaxel|paclitaxel|mesh-list
154448436|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448437|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448438|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
154448439|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
154448440|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
154448441|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448442|NCT01518517|Asparaginase|asparaginase|mesh-list
154448443|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448444|NCT02863575|Ibuprofen|ibuprofen|mesh-list
154448445|NCT02863575|Caffeine|caffeine|mesh-list
154448446|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154448447|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154448448|NCT02863575|Analgesics|analgesics|mesh-ancestor
154448449|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
154448450|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448451|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448452|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448453|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154448454|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154448455|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448456|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448457|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154448458|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154448459|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154448460|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154448461|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
154448462|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448463|NCT05021770|Thiotepa|thiotepa|mesh-list
154448464|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154448465|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
154448466|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448467|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448468|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154448469|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154448470|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
154448471|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448472|NCT05230303|Caffeine|caffeine|mesh-list
154448473|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154448474|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448475|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154448476|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448477|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448478|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154448479|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154448480|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
154448481|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448482|NCT04287790|Naltrexone|naltrexone|mesh-list
154448483|NCT04287790|Disulfiram|disulfiram|mesh-list
154448484|NCT04287790|Acamprosate|acamprosate|mesh-list
154448485|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154448486|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154448487|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448488|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
154448489|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448490|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154448491|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448492|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448493|NCT03723967|Paclitaxel|paclitaxel|mesh-list
154448494|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154448495|NCT03723967|Carboplatin|carboplatin|mesh-list
154448496|NCT03723967|Durvalumab|durvalumab|mesh-list
154448497|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154448498|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448499|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448500|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
154448501|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
154448502|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
154448503|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448504|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154448505|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
154448506|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448507|NCT05008666|Azacitidine|azacitidine|mesh-list
154448508|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154448509|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
154448510|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448511|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448512|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448513|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154448514|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154448515|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448516|NCT03659461|Incretins|incretins|mesh-ancestor
154448517|NCT03659461|Hormones|hormones|mesh-ancestor
154448518|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448519|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154448520|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
154448521|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448522|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448523|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
154448524|NCT01227187|Protein C|protein c|mesh-list
154448525|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448526|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
154448527|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154448528|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154448529|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448530|NCT03088072|Aspirin|aspirin|mesh-list
154448531|NCT03088072|Warfarin|warfarin|mesh-list
154448532|NCT03088072|Edoxaban|edoxaban|mesh-list
154448533|NCT03088072|Clopidogrel|clopidogrel|mesh-list
154448534|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154448535|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154448536|NCT03088072|Analgesics|analgesics|mesh-ancestor
154448537|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
154448538|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448539|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448540|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448541|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154448542|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154448543|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154448544|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448545|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154448546|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154448547|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448548|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
154448549|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154448550|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154448551|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154448552|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
154448553|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448554|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
154448555|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154448556|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
154448557|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154448558|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
154448559|NCT01077817|Alendronate|alendronate|mesh-list
154448560|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
154448561|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
154448562|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154448563|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
154448564|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154448565|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448566|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154448567|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154448568|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448569|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154448570|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154448571|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
154448572|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448573|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154448574|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154448575|NCT02638012|Hemostatics|hemostatics|mesh-list
154448576|NCT02638012|Coagulants|coagulants|mesh-ancestor
154448577|NCT05014906|Minocycline|minocycline|mesh-list
153543199|NCT05840406|Tramadol|tramadol|mesh-list
154448578|NCT05014906|Azelaic acid|azelaic acid|mesh-list
154448579|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154448580|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448581|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448582|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
154448583|NCT00103506|Doxorubicin|doxorubicin|mesh-list
154448584|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154448585|NCT00103506|Bortezomib|bortezomib|mesh-list
154448586|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154448587|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448588|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154448589|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154448590|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448591|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448592|NCT02151240|Acyclovir|acyclovir|mesh-list
154448593|NCT02151240|Foscarnet|foscarnet|mesh-list
154448594|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
154448595|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
154448596|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448597|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154448598|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154448599|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448600|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448601|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
154448602|NCT02159196|Albuterol|albuterol|mesh-list
154448603|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154448604|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
154448605|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448606|NCT02159196|Expectorants|expectorants|mesh-ancestor
154448607|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
154448608|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154448609|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
154448610|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448611|NCT02159196|Protective Agents|protective agents|mesh-ancestor
154448612|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023284|NCT00619398|Tacrolimus|tacrolimus|mesh-list
154448613|NCT02159196|Antidotes|antidotes|mesh-ancestor
154448614|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154448615|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
154448616|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448617|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154448618|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
154448619|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154448620|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154448621|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153543261|NCT05839548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448622|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154448623|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
154448624|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448626|NCT02765490|Odalasvir|odalasvir|mesh-list
154448627|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
154448628|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448629|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
154448630|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448631|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448632|NCT02639182|Axitinib|axitinib|mesh-list
154448633|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448634|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154448635|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448636|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448637|NCT02863419|Liraglutide|liraglutide|mesh-list
154448638|NCT02863419|Semaglutide|semaglutide|mesh-list
154448639|NCT02863419|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154448640|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154448641|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448642|NCT02863419|Incretins|incretins|mesh-ancestor
154448643|NCT02863419|Hormones|hormones|mesh-ancestor
154448644|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448645|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154448646|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154448647|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154448648|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448649|NCT02155374|Insulin|insulin|mesh-list
154448650|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154448651|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
154448652|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
154448653|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154448654|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448655|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
154448656|NCT02765100|Minocycline|minocycline|mesh-list
154448657|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154448658|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448659|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
154448660|NCT03091894|Propofol|propofol|mesh-list
154448661|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154448662|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154448663|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448664|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154448665|NCT03091894|Analgesics|analgesics|mesh-ancestor
154448666|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
154448667|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448668|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154448669|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154448670|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154448671|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
154448672|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448673|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448674|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154448675|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
154448676|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
154448677|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
154448678|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154448679|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448680|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154448681|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448682|NCT02761980|Acetaminophen|acetaminophen|mesh-list
154448683|NCT02761980|Ibuprofen|ibuprofen|mesh-list
154448684|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154448685|NCT02761980|Analgesics|analgesics|mesh-ancestor
154448686|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
154448687|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448688|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023341|NCT04209426|Tacrine|tacrine|mesh-list
154448689|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
154448690|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154448691|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448692|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154448693|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154448694|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448695|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448696|NCT05007340|Dimercaprol|dimercaprol|mesh-list
154448697|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
154448698|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
154448699|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448700|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
154448701|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154448702|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448703|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448704|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154448705|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154448706|NCT02163174|Protective Agents|protective agents|mesh-ancestor
154448707|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448708|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
154448709|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154448710|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
154448711|NCT01744912|Lenalidomide|lenalidomide|mesh-list
154448712|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
154448713|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448714|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154448715|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154448716|NCT01744912|Growth Substances|growth substances|mesh-ancestor
154448717|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
154448718|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448719|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
154448720|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
154448721|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154448722|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154448723|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448724|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448725|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448726|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154448727|NCT02159820|Paclitaxel|paclitaxel|mesh-list
154448728|NCT02159820|Carboplatin|carboplatin|mesh-list
154448729|NCT02159820|Decitabine|decitabine|mesh-list
154448730|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448731|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448732|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
154448733|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
154448734|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
154448735|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448736|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154448737|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
154448738|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448739|NCT02862171|Dapivirine|dapivirine|mesh-list
154448740|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154448741|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154448742|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
154448743|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448744|NCT05013112|Metformin|metformin|mesh-list
154448745|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154448746|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154448747|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448748|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448749|NCT05013034|Basiliximab|basiliximab|mesh-list
154448750|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154448751|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
154448752|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448753|NCT02638948|Methotrexate|methotrexate|mesh-list
154448754|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154448755|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
154448756|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154448757|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448758|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154448759|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
154448760|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448761|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973766|NCT06247787|Calcium, Dietary|calcium, dietary|mesh-list
153543485|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
153543486|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154860514|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448762|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
154448763|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023417|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154448764|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154448765|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154448766|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
154448767|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154448768|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154448769|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
154448770|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448771|NCT04465864|Dexamethasone|dexamethasone|mesh-list
154448772|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448773|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
154448774|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
154448775|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448776|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448777|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154448778|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
154448779|NCT04465864|Hormones|hormones|mesh-ancestor
154448780|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448781|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154448782|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448783|NCT03091504|Albuterol|albuterol|mesh-list
154448784|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154448785|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
154448786|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448787|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448788|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154448789|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
154448790|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
154448791|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154448792|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154448793|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154448794|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154448795|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
154448796|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448797|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448798|NCT05019586|Amoxicillin|amoxicillin|mesh-list
154448799|NCT05019586|Clarithromycin|clarithromycin|mesh-list
154448800|NCT05019586|Levofloxacin|levofloxacin|mesh-list
154448801|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154448802|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448803|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154448804|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448805|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448806|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154448807|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154448808|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154448809|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154448810|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154448811|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448812|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154448813|NCT03081676|Glimepiride|glimepiride|mesh-list
154448814|NCT03081676|Glucagon|glucagon|mesh-list
154448815|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154448816|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154448817|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154448818|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154448819|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448820|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154448821|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
154448822|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154448823|NCT03081676|Hormones|hormones|mesh-ancestor
154448824|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448825|NCT03081676|Incretins|incretins|mesh-ancestor
154448826|NCT05013268|Paclitaxel|paclitaxel|mesh-list
154448827|NCT05013268|Docetaxel|docetaxel|mesh-list
154448828|NCT05013268|Carboplatin|carboplatin|mesh-list
154448829|NCT05013268|Tislelizumab|tislelizumab|mesh-list
154448830|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448831|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448832|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154448833|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154448834|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154448835|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543564|NCT04496596|Suramin|suramin|mesh-list
154448836|NCT05013268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154448838|NCT00102960|Lopinavir|lopinavir|mesh-list
154448839|NCT00102960|Lamivudine|lamivudine|mesh-list
154448840|NCT00102960|Zidovudine|zidovudine|mesh-list
154448841|NCT00102960|Nevirapine|nevirapine|mesh-list
154448842|NCT00102960|Abacavir|abacavir|mesh-list
154448843|NCT00102960|Didanosine|didanosine|mesh-list
154448844|NCT00102960|Efavirenz|efavirenz|mesh-list
154448845|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154448846|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154448847|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
154448848|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448849|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448850|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154448851|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154448852|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
154448853|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448854|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154448855|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154448856|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154448857|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154448858|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
154448859|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154448860|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154448861|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154448862|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154448863|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154448864|NCT02858895|Interleukin-4|interleukin-4|mesh-list
154448865|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154448866|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
154448867|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448868|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448869|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154448870|NCT05018962|Paclitaxel|paclitaxel|mesh-list
154448871|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154448872|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448873|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
154448874|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
154448875|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
154448876|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448877|NCT02160054|Tacrolimus|tacrolimus|mesh-list
154448878|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154448879|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
154448880|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448881|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154448882|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448883|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448884|NCT03609489|Capecitabine|capecitabine|mesh-list
154448885|NCT03609489|Apatinib|apatinib|mesh-list
154448886|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154448887|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
154448888|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448889|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448890|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154448891|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448892|NCT02033967|Milrinone|milrinone|mesh-list
154448893|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
154448894|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154448895|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154448896|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154448897|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154448898|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448899|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448900|NCT02033967|Protective Agents|protective agents|mesh-ancestor
154448901|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448902|NCT02163330|Acetazolamide|acetazolamide|mesh-list
154448903|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
154448904|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154448905|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448906|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448907|NCT02163330|Diuretics|diuretics|mesh-ancestor
154448908|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
154448909|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448910|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
154860515|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154448911|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
154448912|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
154448913|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448914|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
154448915|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154448916|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154448917|NCT02160132|Prednisolone|prednisolone|mesh-list
154448918|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
154448919|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154448920|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
154448921|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154448922|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
154448923|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
154448924|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448925|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448926|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154448927|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
154448928|NCT02160132|Hormones|hormones|mesh-ancestor
154448929|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154448930|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154448931|NCT02160132|Protective Agents|protective agents|mesh-ancestor
154448932|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154448933|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448934|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154448935|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154448936|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448937|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154448938|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154448939|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154448940|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448941|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
154448942|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448943|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
154448944|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
154448945|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448946|NCT02858037|Dapivirine|dapivirine|mesh-list
154448947|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154448948|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154448949|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
154448950|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448951|NCT04266340|Midazolam|midazolam|mesh-list
154448952|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
154448953|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154448954|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154448955|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448956|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154448957|NCT04266340|Analgesics|analgesics|mesh-ancestor
154448958|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
154448959|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154448960|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153973767|NCT06247787|Leucovorin|leucovorin|mesh-list
153543737|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154448961|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154448962|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154448963|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
154448964|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154448965|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448966|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154448967|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154448968|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154448969|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154448970|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154448971|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
154448972|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
154448973|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
154448974|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
154448975|NCT02856555|Firsocostat|firsocostat|mesh-list
154448976|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448977|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448978|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
154448979|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154448980|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154448981|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154448982|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154448983|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154448984|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448985|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448986|NCT05000086|Diphosphonates|diphosphonates|mesh-list
154448987|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
154448988|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154448989|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154448990|NCT01242267|Thalidomide|thalidomide|mesh-list
154448991|NCT01242267|Bortezomib|bortezomib|mesh-list
154448992|NCT01242267|Melphalan|melphalan|mesh-list
154448993|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154448994|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154448995|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
154448996|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154448997|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154448998|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154448999|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
154449000|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449001|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
153543814|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154449002|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154449003|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449004|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154449005|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154449006|NCT01242267|Growth Substances|growth substances|mesh-ancestor
154449007|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
154449008|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154449009|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154449010|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154449011|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154449012|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154449013|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
154449014|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449015|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449016|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449017|NCT02635984|Olanzapine|olanzapine|mesh-list
154449018|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
154449019|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
154449020|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449021|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449022|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154449023|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154449024|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154449025|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449026|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154449027|NCT02635984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154449028|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154449029|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449030|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449031|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449032|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
154449033|NCT03073408|Propofol|propofol|mesh-list
154449034|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154449035|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449036|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449037|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154449038|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
154449039|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
154449040|NCT04993222|Amphotericin B|amphotericin b|mesh-list
154449041|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154449042|NCT04993222|Amebicides|amebicides|mesh-ancestor
154449043|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153543867|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154449044|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154449045|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449046|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154449047|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
154449048|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154449049|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154449050|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154449051|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449052|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449053|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154449054|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449055|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449056|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
154449057|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860516|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
154449058|NCT02747043|Rituximab|rituximab|mesh-list
154449059|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449060|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449061|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
154449062|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449063|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449064|NCT05004142|Letrozole|letrozole|mesh-list
154449065|NCT05004142|Fulvestrant|fulvestrant|mesh-list
154449066|NCT05004142|Goserelin|goserelin|mesh-list
154449067|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449068|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154449069|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154449070|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449071|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449072|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154449073|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
154449074|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449075|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449076|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154449077|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154449078|NCT03076684|Allopurinol|allopurinol|mesh-list
154449079|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
154449080|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449081|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449082|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
154449083|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449084|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154449085|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
154449086|NCT03076684|Protective Agents|protective agents|mesh-ancestor
154449087|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449088|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
154449089|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154449090|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
154449091|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449092|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449093|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154449094|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154449095|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
154449096|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154449097|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
154449098|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449099|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449100|NCT03607851|Lacosamide|lacosamide|mesh-list
154449101|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
154449102|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154449103|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154449104|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449105|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449106|NCT04999540|Fulvestrant|fulvestrant|mesh-list
154449107|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154449108|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449109|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154449110|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154449111|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
154449112|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449113|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449114|NCT03608007|Ensartinib|ensartinib|mesh-list
154449115|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449116|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154449117|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449118|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449119|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
154449120|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154449121|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154449122|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
154449123|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
154449124|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449125|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449126|NCT03075358|Lidocaine|lidocaine|mesh-list
154449127|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
154449128|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
154449129|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449130|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077282|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
154860517|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
154449131|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
154449132|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449133|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154449134|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154449135|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154449136|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154023866|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154449137|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449139|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154449140|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154449141|NCT05003596|Prednisolone|prednisolone|mesh-list
154449142|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
154449143|NCT05003596|Narcotics|narcotics|mesh-list
154449144|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154449145|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
154449146|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154449147|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
154449148|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
154449149|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449150|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449151|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154449152|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
154449153|NCT05003596|Hormones|hormones|mesh-ancestor
154449154|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449155|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154449156|NCT05003596|Protective Agents|protective agents|mesh-ancestor
154449157|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154449158|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449159|NCT05003596|Analgesics|analgesics|mesh-ancestor
153544090|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154449160|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
154449161|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449162|NCT04433572|Sirolimus|sirolimus|mesh-list
154449163|NCT04433572|Temsirolimus|temsirolimus|mesh-list
154449164|NCT04433572|MTOR Inhibitors|mtor inhibitors|mesh-list
154449165|NCT04433572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154449166|NCT04433572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449167|NCT04433572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449168|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154449169|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
154449170|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449171|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449172|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154449173|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449174|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154449175|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
154449176|NCT03073018|Fosinopril|fosinopril|mesh-list
154449177|NCT03073018|Pravastatin|pravastatin|mesh-list
154449178|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154449179|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154449180|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
154449181|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449182|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154449183|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154449184|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449185|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154449186|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
154449187|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154449188|NCT06205095|Factor VIII|factor viii|mesh-list
154449189|NCT06205095|Coagulants|coagulants|mesh-ancestor
154449190|NCT06205056|Complement Factor H|complement factor h|mesh-list
154449191|NCT06205056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154449192|NCT06205056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154449193|NCT06205056|Immunologic Factors|immunologic factors|mesh-ancestor
154449194|NCT06205056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449195|NCT06204991|Aldesleukin|aldesleukin|mesh-list
154449196|NCT06204991|Cyclophosphamide|cyclophosphamide|mesh-list
154449197|NCT06204991|Fludarabine|fludarabine|mesh-list
154449198|NCT06204991|Fludarabine phosphate|fludarabine phosphate|mesh-list
154449199|NCT06204991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154449200|NCT06204991|Immunologic Factors|immunologic factors|mesh-ancestor
154449201|NCT06204991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449202|NCT06204991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449203|NCT06204991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154449204|NCT06204991|Alkylating Agents|alkylating agents|mesh-ancestor
154449205|NCT06204991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860518|NCT01921010|Vitamins|vitamins|mesh-ancestor
153544152|NCT00713817|Analgesics|analgesics|mesh-ancestor
154449206|NCT06204991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449207|NCT06204991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154449208|NCT06204991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154449209|NCT06204991|Antimetabolites|antimetabolites|mesh-ancestor
154449210|NCT06204991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154449211|NCT06204991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154449212|NCT06204991|Antiviral Agents|antiviral agents|mesh-ancestor
154449213|NCT06204991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449214|NCT06204796|Vitamin D|vitamin d|mesh-list
154449215|NCT06204796|Prednisone|prednisone|mesh-list
154449216|NCT06204796|Vitamins|vitamins|mesh-ancestor
154449217|NCT06204796|Micronutrients|micronutrients|mesh-ancestor
154449218|NCT06204796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449219|NCT06204796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154449220|NCT06204796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154449221|NCT06204796|Glucocorticoids|glucocorticoids|mesh-ancestor
154449222|NCT06204796|Hormones|hormones|mesh-ancestor
154449223|NCT06204796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449224|NCT06204796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154449225|NCT06204796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449226|NCT06204679|Ruzasvir|ruzasvir|mesh-list
154449227|NCT06204679|Antiviral Agents|antiviral agents|mesh-ancestor
154449228|NCT06204679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449229|NCT06204640|Spironolactone|spironolactone|mesh-list
154449230|NCT06204640|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154449231|NCT06204640|Hormone Antagonists|hormone antagonists|mesh-ancestor
154449232|NCT06204640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449233|NCT06204640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449234|NCT06204640|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154449235|NCT06204640|Diuretics|diuretics|mesh-ancestor
154449236|NCT06204640|Natriuretic Agents|natriuretic agents|mesh-ancestor
154449237|NCT06204614|Paclitaxel|paclitaxel|mesh-list
154449238|NCT06204614|Vinblastine|vinblastine|mesh-list
154449239|NCT06204614|Docetaxel|docetaxel|mesh-list
154449240|NCT06204614|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154449241|NCT06204614|Cisplatin|cisplatin|mesh-list
154449242|NCT06204614|Carboplatin|carboplatin|mesh-list
154449243|NCT06204614|Gemcitabine|gemcitabine|mesh-list
154449244|NCT06204614|Doxorubicin|doxorubicin|mesh-list
154449245|NCT06204614|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154449246|NCT06204614|Pembrolizumab|pembrolizumab|mesh-list
154449247|NCT06204614|Nivolumab|nivolumab|mesh-list
154449248|NCT06204614|Methotrexate|methotrexate|mesh-list
154449249|NCT06204614|Ifosfamide|ifosfamide|mesh-list
154449250|NCT06204614|Avelumab|avelumab|mesh-list
154449251|NCT06204614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154449252|NCT06204614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154449253|NCT06204614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449254|NCT06204614|Tubulin Modulators|tubulin modulators|mesh-ancestor
154449255|NCT06204614|Antimitotic Agents|antimitotic agents|mesh-ancestor
154449256|NCT06204614|Mitosis Modulators|mitosis modulators|mesh-ancestor
154449257|NCT06204614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449258|NCT06204614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154449259|NCT06204614|Antimetabolites|antimetabolites|mesh-ancestor
154449260|NCT06204614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154449261|NCT06204614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154449262|NCT06204614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154449263|NCT06204614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544156|NCT00713323|Nabiximols|nabiximols|mesh-list
153544323|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
154449264|NCT06204614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449265|NCT06204614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154449266|NCT06204614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154449267|NCT06204614|Abortifacient Agents|abortifacient agents|mesh-ancestor
154449268|NCT06204614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154449269|NCT06204614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449270|NCT06204614|Dermatologic Agents|dermatologic agents|mesh-ancestor
154449271|NCT06204614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154449272|NCT06204614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154449273|NCT06204614|Immunologic Factors|immunologic factors|mesh-ancestor
154449274|NCT06204614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449275|NCT06204614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154449276|NCT06204614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154449277|NCT06204614|Alkylating Agents|alkylating agents|mesh-ancestor
154449278|NCT06204432|Citric Acid|citric acid|mesh-list
154449279|NCT06204432|Sodium Citrate|sodium citrate|mesh-list
154449280|NCT06204432|Anticoagulants|anticoagulants|mesh-ancestor
154449281|NCT06204432|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154449282|NCT06204432|Chelating Agents|chelating agents|mesh-ancestor
154449283|NCT06204432|Sequestering Agents|sequestering agents|mesh-ancestor
154449284|NCT06204432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449286|NCT06204185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154449287|NCT06204185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449288|NCT06204120|Morphine|morphine|mesh-list
154449289|NCT06204120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154449290|NCT06204120|Narcotics|narcotics|mesh-ancestor
154449291|NCT06204120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449292|NCT06204120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449293|NCT06204120|Analgesics|analgesics|mesh-ancestor
154449294|NCT06204120|Sensory System Agents|sensory system agents|mesh-ancestor
154449295|NCT06204120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449296|NCT06204107|Metformin|metformin|mesh-list
154449297|NCT06204107|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154449298|NCT06204107|Empagliflozin|empagliflozin|mesh-list
154449299|NCT06204107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154449300|NCT06204107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449301|NCT06204107|Incretins|incretins|mesh-ancestor
154449302|NCT06204107|Hormones|hormones|mesh-ancestor
154449303|NCT06204107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449304|NCT06204107|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154449305|NCT06204107|Protease Inhibitors|protease inhibitors|mesh-ancestor
154449306|NCT06204107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449307|NCT06204107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449308|NCT06204107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154449309|NCT06204094|Capecitabine|capecitabine|mesh-list
153544533|NCT01558713|Analgesics|analgesics|mesh-ancestor
154449310|NCT06204094|Oxaliplatin|oxaliplatin|mesh-list
154449311|NCT06204094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154449312|NCT06204094|Antimetabolites|antimetabolites|mesh-ancestor
154449313|NCT06204094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449314|NCT06204094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449315|NCT06203769|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154449316|NCT06203769|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154449317|NCT06203769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449318|NCT06203769|Antitubercular Agents|antitubercular agents|mesh-ancestor
154449319|NCT06203470|Calcipotriene|calcipotriene|mesh-list
154449320|NCT06203470|Botulinum Toxins|botulinum toxins|mesh-list
154449321|NCT06203470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154449322|NCT06203470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154449323|NCT06203470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154449324|NCT06203470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449325|NCT06203470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449326|NCT06203470|Cholinergic Agents|cholinergic agents|mesh-ancestor
154449327|NCT06203470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449328|NCT06203470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449329|NCT06203470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154449330|NCT06203470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449331|NCT06203470|Dermatologic Agents|dermatologic agents|mesh-ancestor
154449332|NCT06203431|Etomidate|etomidate|mesh-list
154449333|NCT06203431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154449334|NCT06203431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449335|NCT06203431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449336|NCT06203431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154449337|NCT06203431|Anesthetics, General|anesthetics, general|mesh-ancestor
154449338|NCT06203431|Anesthetics|anesthetics|mesh-ancestor
154449339|NCT06203405|Midazolam|midazolam|mesh-list
154449340|NCT06203405|Fentanyl|fentanyl|mesh-list
154449341|NCT06203405|Dexmedetomidine|dexmedetomidine|mesh-list
154449342|NCT06203405|Propofol|propofol|mesh-list
154449343|NCT06203405|Cisatracurium|cisatracurium|mesh-list
154449344|NCT06203405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154449345|NCT06203405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449346|NCT06203405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449347|NCT06203405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154449348|NCT06203405|Analgesics|analgesics|mesh-ancestor
154449349|NCT06203405|Sensory System Agents|sensory system agents|mesh-ancestor
154449350|NCT06203405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449351|NCT06203405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154449352|NCT06203405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154449353|NCT06203405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154449354|NCT06203405|Adrenergic Agents|adrenergic agents|mesh-ancestor
154449355|NCT06203405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449356|NCT06203405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449357|NCT06203405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154077580|NCT03002389|Xhance|xhance|mesh-list
154449358|NCT06203405|Anesthetics, General|anesthetics, general|mesh-ancestor
154449359|NCT06203405|Anesthetics|anesthetics|mesh-ancestor
154449360|NCT06203405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154449361|NCT06203405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154449362|NCT06203405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154449363|NCT06203405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154449364|NCT06203405|GABA Modulators|gaba modulators|mesh-ancestor
154449365|NCT06203405|GABA Agents|gaba agents|mesh-ancestor
154449366|NCT06203405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154449367|NCT06203405|Narcotics|narcotics|mesh-ancestor
154449368|NCT06203405|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154449369|NCT06203405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154449370|NCT06203314|Antibodies|antibodies|mesh-list
154449371|NCT06203314|Immunologic Factors|immunologic factors|mesh-ancestor
154449372|NCT06203314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449373|NCT06203275|Paroxetine|paroxetine|mesh-list
154449374|NCT06203275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154449375|NCT06203275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154449376|NCT06203275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449377|NCT06203275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449378|NCT06203275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449379|NCT06203275|Serotonin Agents|serotonin agents|mesh-ancestor
154449380|NCT06203275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449381|NCT06203275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154449382|NCT06203275|Antidepressive Agents|antidepressive agents|mesh-ancestor
154449383|NCT06203275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154449384|NCT06203275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154449385|NCT06203275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154449386|NCT06203275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449387|NCT06203236|Furosemide|furosemide|mesh-list
154449388|NCT06203236|Diuretics|diuretics|mesh-list
154449389|NCT06203236|Natriuretic Agents|natriuretic agents|mesh-ancestor
154449390|NCT06203236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449391|NCT06203236|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154449392|NCT06203236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449393|NCT06203236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449394|NCT06203210|Topotecan|topotecan|mesh-list
154449395|NCT06203210|Amrubicin|amrubicin|mesh-list
154449396|NCT06203210|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153544652|NCT01559480|Hormones|hormones|mesh-ancestor
153544682|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
154449397|NCT06203210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544704|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
154449398|NCT06203210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449399|NCT06203210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449400|NCT06203210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449401|NCT06203145|Bortezomib|bortezomib|mesh-list
154449402|NCT06203145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449403|NCT06203132|Tenofovir|tenofovir|mesh-list
154449404|NCT06203132|Lamivudine|lamivudine|mesh-list
154449405|NCT06203132|Emtricitabine|emtricitabine|mesh-list
154449406|NCT06203132|Dolutegravir|dolutegravir|mesh-list
154449407|NCT06203132|Antiviral Agents|antiviral agents|mesh-ancestor
154449408|NCT06203132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449409|NCT06203132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154449410|NCT06203132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154449411|NCT06203132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449412|NCT06203132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449413|NCT06203132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154449414|NCT06203132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154449415|NCT06203132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154449416|NCT06203132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154449417|NCT06203080|Nonoxynol|nonoxynol|mesh-list
154449418|NCT06203080|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154449419|NCT06203080|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154449420|NCT06203080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449421|NCT06203080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154449422|NCT06203080|Contraceptive Agents|contraceptive agents|mesh-ancestor
154449423|NCT06203080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154449424|NCT06203080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154449425|NCT06202963|Triamcinolone|triamcinolone|mesh-list
154449426|NCT06202963|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154449427|NCT06202963|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154449428|NCT06202963|Lidocaine|lidocaine|mesh-list
154449429|NCT06202963|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154449430|NCT06202963|Anesthetics, Local|anesthetics, local|mesh-ancestor
154449431|NCT06202963|Anesthetics|anesthetics|mesh-ancestor
154449432|NCT06202963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254857|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
154860519|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
154449433|NCT06202963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449435|NCT06202963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449436|NCT06202963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154449437|NCT06202963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154449438|NCT06202963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154449439|NCT06202963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154024087|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154449440|NCT06202963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449441|NCT06202963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154449442|NCT06202963|Glucocorticoids|glucocorticoids|mesh-ancestor
154449443|NCT06202963|Hormones|hormones|mesh-ancestor
154449444|NCT06202963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449445|NCT06202963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153544812|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449446|NCT06202963|Immunologic Factors|immunologic factors|mesh-ancestor
154449447|NCT06202963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449448|NCT06202911|Acetylcysteine|acetylcysteine|mesh-list
154449449|NCT06202911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154449450|NCT06202911|Antiviral Agents|antiviral agents|mesh-ancestor
154449451|NCT06202911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449452|NCT06202911|Expectorants|expectorants|mesh-ancestor
154449453|NCT06202911|Respiratory System Agents|respiratory system agents|mesh-ancestor
154449454|NCT06202911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154449455|NCT06202911|Antioxidants|antioxidants|mesh-ancestor
154449456|NCT06202911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449457|NCT06202911|Protective Agents|protective agents|mesh-ancestor
154449458|NCT06202911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449459|NCT06202911|Antidotes|antidotes|mesh-ancestor
154449460|NCT06202885|Immunomodulating Agents|immunomodulating agents|mesh-list
154449461|NCT06202885|Immunologic Factors|immunologic factors|mesh-ancestor
154449462|NCT06202885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449463|NCT06202781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154449464|NCT06202781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449465|NCT06202781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449466|NCT06202781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449467|NCT06201871|Lidocaine|lidocaine|mesh-list
154449468|NCT06201871|Anesthetics, Local|anesthetics, local|mesh-ancestor
154449469|NCT06201871|Anesthetics|anesthetics|mesh-ancestor
154449470|NCT06201871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449471|NCT06201871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449472|NCT06201871|Sensory System Agents|sensory system agents|mesh-ancestor
154449473|NCT06201871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449474|NCT06201871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154449475|NCT06201871|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154449476|NCT06201871|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154449477|NCT06201871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449478|NCT06201871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449479|NCT06201507|Rituximab|rituximab|mesh-list
154449480|NCT06201507|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154449481|NCT06201507|Doxorubicin|doxorubicin|mesh-list
154449482|NCT06201507|Vincristine|vincristine|mesh-list
154449483|NCT06201507|Dacarbazine|dacarbazine|mesh-list
154449484|NCT06201507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449485|NCT06201507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449486|NCT06201507|Immunologic Factors|immunologic factors|mesh-ancestor
154449487|NCT06201507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449488|NCT06201507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449489|NCT06201507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154449490|NCT06201507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154449491|NCT06201507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154449492|NCT06201507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449493|NCT06201507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449494|NCT06201507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154449495|NCT06201507|Tubulin Modulators|tubulin modulators|mesh-ancestor
154449496|NCT06201507|Antimitotic Agents|antimitotic agents|mesh-ancestor
154449497|NCT06201507|Mitosis Modulators|mitosis modulators|mesh-ancestor
153544875|NCT04696952|Zopiclone|zopiclone|mesh-list
154449498|NCT06201507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154449499|NCT06201507|Alkylating Agents|alkylating agents|mesh-ancestor
154449500|NCT06201507|Immunotoxins|immunotoxins|mesh-ancestor
154449501|NCT06201507|Immunoconjugates|immunoconjugates|mesh-ancestor
154449502|NCT06201377|Chlorhexidine|chlorhexidine|mesh-list
154449503|NCT06201377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154077661|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154449505|NCT06201377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449506|NCT06201377|Disinfectants|disinfectants|mesh-ancestor
154449507|NCT06201377|Dermatologic Agents|dermatologic agents|mesh-ancestor
154449508|NCT06200233|Apatinib|apatinib|mesh-list
154449509|NCT06200233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449510|NCT06200233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154449511|NCT06200233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449512|NCT06200233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449513|NCT06194981|Capecitabine|capecitabine|mesh-list
154449514|NCT06194981|Oxaliplatin|oxaliplatin|mesh-list
154449515|NCT06194981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154449516|NCT06194981|Antimetabolites|antimetabolites|mesh-ancestor
154449517|NCT06194981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449518|NCT06194981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449519|NCT06191263|Venetoclax|venetoclax|mesh-list
154449520|NCT06191263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449521|NCT06190665|Chlorotrianisene|chlorotrianisene|mesh-list
154449522|NCT06190665|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154449523|NCT06190665|Estrogens|estrogens|mesh-ancestor
154449524|NCT06190665|Hormones|hormones|mesh-ancestor
154449525|NCT06190665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449526|NCT06190665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449527|NCT06190665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154449528|NCT06190665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449529|NCT06162377|Methylnaltrexone|methylnaltrexone|mesh-list
154449530|NCT06162377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154449531|NCT06162377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449532|NCT06162377|Sensory System Agents|sensory system agents|mesh-ancestor
154449533|NCT06162377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449534|NCT06154707|Denosumab|denosumab|mesh-list
154449535|NCT06154707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154449536|NCT06154707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449537|NCT06114628|Moxifloxacin|moxifloxacin|mesh-list
154449538|NCT06114628|Rifampin|rifampin|mesh-list
154449539|NCT06114628|Isoniazid|isoniazid|mesh-list
154449540|NCT06114628|Linezolid|linezolid|mesh-list
154449541|NCT06114628|Pyrazinamide|pyrazinamide|mesh-list
154449542|NCT06114628|Ethambutol|ethambutol|mesh-list
154449543|NCT06114628|Bedaquiline|bedaquiline|mesh-list
154449544|NCT06114628|GSK656|gsk656|mesh-list
154449545|NCT06114628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154449546|NCT06114628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449547|NCT06114628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154449548|NCT06114628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154449549|NCT06114628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449550|NCT06114628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449551|NCT06114628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449552|NCT06114628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154449553|NCT06114628|Antitubercular Agents|antitubercular agents|mesh-ancestor
154449554|NCT06114628|Leprostatic Agents|leprostatic agents|mesh-ancestor
154449555|NCT06114628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154449556|NCT06114628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154449557|NCT06114628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154449558|NCT06114628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154449559|NCT06114628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154449560|NCT06114628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154449561|NCT06114628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154449562|NCT06114628|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154449563|NCT06114628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154449564|NCT06114628|Antimetabolites|antimetabolites|mesh-ancestor
154449565|NCT06114628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154449566|NCT06114628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154449567|NCT06102824|Carboplatin|carboplatin|mesh-list
154449568|NCT06102824|Gemcitabine|gemcitabine|mesh-list
154449569|NCT06102824|Capecitabine|capecitabine|mesh-list
154449570|NCT06102824|Trastuzumab|trastuzumab|mesh-list
154449571|NCT06102824|Vinorelbine|vinorelbine|mesh-list
154449572|NCT06102824|Taxane|taxane|mesh-list
154449573|NCT06102824|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154449574|NCT06102824|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154449575|NCT06102824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449576|NCT06102824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154449577|NCT06102824|Antimetabolites|antimetabolites|mesh-ancestor
154449578|NCT06102824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449579|NCT06102824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449580|NCT06102824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154449581|NCT06102824|Tubulin Modulators|tubulin modulators|mesh-ancestor
154449582|NCT06102824|Antimitotic Agents|antimitotic agents|mesh-ancestor
154449583|NCT06102824|Mitosis Modulators|mitosis modulators|mesh-ancestor
154449584|NCT06102824|Immunoconjugates|immunoconjugates|mesh-ancestor
154449585|NCT06102824|Immunologic Factors|immunologic factors|mesh-ancestor
154449586|NCT06102824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449587|NCT06083454|Durvalumab|durvalumab|mesh-list
154449588|NCT06083454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449589|NCT06083454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449590|NCT06082102|Rituximab|rituximab|mesh-list
154449591|NCT06082102|Lenalidomide|lenalidomide|mesh-list
154449592|NCT06082102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449593|NCT06082102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449594|NCT06082102|Immunologic Factors|immunologic factors|mesh-ancestor
154449595|NCT06082102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449596|NCT06082102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449597|NCT06082102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154449598|NCT06082102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154449599|NCT06082102|Growth Substances|growth substances|mesh-ancestor
154449600|NCT06082102|Growth Inhibitors|growth inhibitors|mesh-ancestor
154449601|NCT06081049|Colchicine|colchicine|mesh-list
154449602|NCT06081049|Gout Suppressants|gout suppressants|mesh-ancestor
154449603|NCT06081049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449604|NCT06081049|Tubulin Modulators|tubulin modulators|mesh-ancestor
154449605|NCT06081049|Antimitotic Agents|antimitotic agents|mesh-ancestor
154449606|NCT06081049|Mitosis Modulators|mitosis modulators|mesh-ancestor
154449607|NCT06081049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449608|NCT06081049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449609|NCT06063317|Blinatumomab|blinatumomab|mesh-list
154449610|NCT06063317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449611|NCT06010758|Listerine|listerine|mesh-list
154449612|NCT06010758|Sodium Fluoride|sodium fluoride|mesh-list
154449613|NCT06010758|Cariostatic Agents|cariostatic agents|mesh-ancestor
154449614|NCT06010758|Protective Agents|protective agents|mesh-ancestor
154449615|NCT06010758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449616|NCT06010758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154449617|NCT06010758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449618|NCT05989074|Fexofenadine|fexofenadine|mesh-list
154449619|NCT05989074|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154449620|NCT05989074|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154449621|NCT05989074|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154449622|NCT05989074|Histamine Antagonists|histamine antagonists|mesh-ancestor
154449623|NCT05989074|Histamine Agents|histamine agents|mesh-ancestor
154449624|NCT05989074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449625|NCT05989074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449626|NCT05989074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449627|NCT05956041|Pembrolizumab|pembrolizumab|mesh-list
154449628|NCT05956041|Mogamulizumab|mogamulizumab|mesh-list
154449629|NCT05956041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449630|NCT05956041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449631|NCT05956041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154449632|NCT05956041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449633|NCT05955365|Aspirin|aspirin|mesh-list
154449634|NCT05955365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154449635|NCT05955365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154449636|NCT05955365|Analgesics|analgesics|mesh-ancestor
154449637|NCT05955365|Sensory System Agents|sensory system agents|mesh-ancestor
154449638|NCT05955365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449639|NCT05955365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449640|NCT05955365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154449641|NCT05955365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449642|NCT05955365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154449643|NCT05955365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154449644|NCT05955365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449645|NCT05955365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154449646|NCT05955365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154449647|NCT05955365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449648|NCT05955365|Antipyretics|antipyretics|mesh-ancestor
154449649|NCT05888870|Daratumumab|daratumumab|mesh-list
154449650|NCT05888870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449651|NCT05826990|Cefepime|cefepime|mesh-list
154449652|NCT05826990|Enmetazobactam|enmetazobactam|mesh-list
154449653|NCT05826990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154449654|NCT05826990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449655|NCT05826990|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154449656|NCT05826990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449657|NCT05826990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449658|NCT05821478|Metronidazole|metronidazole|mesh-list
154449659|NCT05821478|Rifampin|rifampin|mesh-list
154449660|NCT05821478|Ceftriaxone|ceftriaxone|mesh-list
154449661|NCT05821478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449662|NCT05821478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154449663|NCT05821478|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154449664|NCT05821478|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154449665|NCT05821478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154449666|NCT05821478|Antitubercular Agents|antitubercular agents|mesh-ancestor
154449667|NCT05821478|Leprostatic Agents|leprostatic agents|mesh-ancestor
154449668|NCT05821478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154449669|NCT05821478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449670|NCT05821478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449671|NCT05821478|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154449672|NCT05821478|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154449673|NCT05821478|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154449674|NCT05821478|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154449675|NCT05821478|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154449676|NCT05821478|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154449677|NCT05821478|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154449678|NCT05821478|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154449679|NCT05775380|Pioglitazone|pioglitazone|mesh-list
154449680|NCT05775380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154449681|NCT05775380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449682|NCT05717140|Nivolumab|nivolumab|mesh-list
154449683|NCT05717140|Sargramostim|sargramostim|mesh-list
154449684|NCT05717140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449685|NCT05717140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449686|NCT05717140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154449687|NCT05717140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449688|NCT05717140|Immunologic Factors|immunologic factors|mesh-ancestor
154449689|NCT05717140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449690|NCT05714059|Insulin|insulin|mesh-list
154449691|NCT05714059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154449692|NCT05714059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449693|NCT05678673|Nivolumab|nivolumab|mesh-list
154449694|NCT05678673|Sunitinib|sunitinib|mesh-list
154449695|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449696|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449697|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154449698|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449699|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154449700|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154449701|NCT05678673|Growth Substances|growth substances|mesh-ancestor
154449702|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449703|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
154449704|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154449705|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449706|NCT05650554|Vaccines|vaccines|mesh-list
154449707|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
154449708|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449709|NCT05650437|Vitamin D|vitamin d|mesh-list
154449710|NCT05650437|Vitamins|vitamins|mesh-ancestor
154449711|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
154449712|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449713|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154449714|NCT05635227|Dexamethasone|dexamethasone|mesh-list
154449715|NCT05635227|Olanzapine|olanzapine|mesh-list
154449716|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154449717|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545126|NCT01564576|Bromides|bromides|mesh-list
154449718|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
154449719|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
154449720|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449721|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449722|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154449723|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
154449724|NCT05635227|Hormones|hormones|mesh-ancestor
154449725|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449726|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154449727|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449728|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154449729|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154449730|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860520|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449731|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154449732|NCT05635227|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154449733|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154449734|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449735|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449736|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449737|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
154449738|NCT05624281|Nintedanib|nintedanib|mesh-list
154449739|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449740|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154449741|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449746|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154449747|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154449748|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449755|NCT05503875|Methotrexate|methotrexate|mesh-list
154449756|NCT05503875|Ixekizumab|ixekizumab|mesh-list
154449757|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154449758|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154449759|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
154449760|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154449761|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449762|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154449763|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
154449764|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449765|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449766|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154449767|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449768|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154449769|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154449770|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
154449771|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449772|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154449773|NCT05503875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154449774|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154449775|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154449776|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
154449777|NCT05493215|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154449778|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154449779|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449780|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449781|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449782|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
154449783|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
154449784|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154449785|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
154449786|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449787|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449788|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154449789|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
154449790|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449791|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449792|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154449793|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449794|NCT05492682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154449795|NCT05488847|Acetaminophen|acetaminophen|mesh-list
154449796|NCT05488847|Dexamethasone|dexamethasone|mesh-list
154449797|NCT05488847|Ibuprofen|ibuprofen|mesh-list
154449798|NCT05488847|Celecoxib|celecoxib|mesh-list
154449799|NCT05488847|Ketorolac|ketorolac|mesh-list
154449800|NCT05488847|Pregabalin|pregabalin|mesh-list
154449801|NCT05488847|Epinephrine|epinephrine|mesh-list
154449802|NCT05488847|Oxycodone|oxycodone|mesh-list
154449803|NCT05488847|Tramadol|tramadol|mesh-list
154449804|NCT05488847|Tizanidine|tizanidine|mesh-list
154449805|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
154449806|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154449807|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
154449808|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
154449809|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449810|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449811|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154449812|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
154449813|NCT05488847|Hormones|hormones|mesh-ancestor
154449814|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154449815|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154449816|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449817|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153545237|NCT01568684|Citalopram|citalopram|mesh-list
154449818|NCT05488847|Analgesics|analgesics|mesh-ancestor
154449819|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
154449820|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
154449821|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154449822|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154449823|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154449824|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449825|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449826|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
154449827|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154449828|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449829|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154449830|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154449831|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154449832|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449833|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154449834|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154449835|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154449836|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
154449837|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449838|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154449839|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154449840|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154449841|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
154449842|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
154449843|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
154449844|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154449845|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154449846|NCT05488847|Narcotics|narcotics|mesh-ancestor
154449847|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154449848|NCT05488847|Antacids|antacids|mesh-ancestor
154449849|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154449850|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154449851|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
154449852|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154449853|NCT05485662|Listerine|listerine|mesh-list
154449854|NCT05485662|Fluorides|fluorides|mesh-list
154449855|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
154449856|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
154449857|NCT05485662|Protective Agents|protective agents|mesh-ancestor
154449858|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449859|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154449860|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449861|NCT05483400|Atezolizumab|atezolizumab|mesh-list
154449862|NCT05483400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154449863|NCT05483400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449864|NCT05483400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449865|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449866|NCT05430035|Mitomycins|mitomycins|mesh-list
154449867|NCT05430035|Mitomycin|mitomycin|mesh-list
154449868|NCT05430035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154449869|NCT05430035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449870|NCT05430035|Alkylating Agents|alkylating agents|mesh-ancestor
154449871|NCT05430035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449872|NCT05430035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154449873|NCT05430035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449874|NCT05395299|Ethylene|ethylene|mesh-list
154449875|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154449876|NCT05395299|Growth Substances|growth substances|mesh-ancestor
154449877|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449878|NCT05378100|Midazolam|midazolam|mesh-list
154449879|NCT05378100|Ketamine|ketamine|mesh-list
154449880|NCT05378100|Analgesics|analgesics|mesh-ancestor
154449881|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
154449882|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449883|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449884|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154449885|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154449886|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
154449887|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
154449888|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860521|NCT03325816|Nivolumab|nivolumab|mesh-list
154449889|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154449890|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154449891|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449892|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449893|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154449894|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154449895|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154449896|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154449897|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154449898|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
154449899|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
154449900|NCT05351593|Lenalidomide|lenalidomide|mesh-list
154449901|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
154449902|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449903|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154449904|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154449905|NCT05351593|Growth Substances|growth substances|mesh-ancestor
154449906|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
154449907|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449908|NCT05334004|Ritonavir|ritonavir|mesh-list
154449909|NCT05334004|Lopinavir|lopinavir|mesh-list
154449910|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154449911|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154449912|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
154449913|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449914|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449915|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154449916|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154449917|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
154449918|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449919|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154449920|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154449921|NCT05282550|Trazodone|trazodone|mesh-list
154449922|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154449923|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154449924|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449925|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449926|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154449927|NCT05282550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154449928|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154449929|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154449930|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449931|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449932|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
154449933|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154449934|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
154449935|NCT05272878|Irbesartan|irbesartan|mesh-list
154449936|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154449937|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154449938|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154449939|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449940|NCT05268562|Ketamine|ketamine|mesh-list
154449941|NCT05268562|Propofol|propofol|mesh-list
154449942|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154449943|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449944|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449945|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154449946|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
154449947|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
154449948|NCT05268562|Analgesics|analgesics|mesh-ancestor
154449949|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
154449950|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449951|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154449952|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154449953|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154449954|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154449955|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449956|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
154449957|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154449958|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449959|NCT05197621|Vaccines|vaccines|mesh-list
154449960|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
154860522|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154449961|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449962|NCT05191446|Ethanol|ethanol|mesh-list
154449963|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154449964|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154449965|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154449966|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449967|NCT05107674|Paclitaxel|paclitaxel|mesh-list
154449968|NCT05107674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154449969|NCT05107674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449970|NCT05107674|Tubulin Modulators|tubulin modulators|mesh-ancestor
154449971|NCT05107674|Antimitotic Agents|antimitotic agents|mesh-ancestor
154449972|NCT05107674|Mitosis Modulators|mitosis modulators|mesh-ancestor
154449973|NCT05107674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449974|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
154449975|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154449976|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449977|NCT05098132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154449978|NCT05098132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449979|NCT05095116|Fluticasone|fluticasone|mesh-list
154449980|NCT05095116|Xhance|xhance|mesh-list
154449981|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154449982|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154449983|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
154449984|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154449985|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154449986|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154449987|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
154449988|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
154449989|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154449990|NCT05092412|Carboplatin|carboplatin|mesh-list
154449991|NCT05092412|Etoposide|etoposide|mesh-list
154449992|NCT05092412|Durvalumab|durvalumab|mesh-list
154449993|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154449994|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154449995|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154449996|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154449997|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154449998|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154449999|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450000|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
154450001|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
154450002|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154450003|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154450004|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
154450005|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450006|NCT05016310|Vitamin D|vitamin d|mesh-list
154450007|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
154450008|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
154450009|NCT05016310|Vitamins|vitamins|mesh-list
154450010|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
154450011|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450012|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154450013|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154450014|NCT05014828|Lenvatinib|lenvatinib|mesh-list
154450015|NCT05014828|Tislelizumab|tislelizumab|mesh-list
154450016|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450017|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154450018|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450019|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450020|NCT05014828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450021|NCT05011123|Vaccines|vaccines|mesh-list
154450022|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
154450023|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450024|NCT04956640|Carboplatin|carboplatin|mesh-list
154450025|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
154450026|NCT04956640|Pemetrexed|pemetrexed|mesh-list
154450027|NCT04956640|Cetuximab|cetuximab|mesh-list
154450028|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450029|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450030|NCT04956640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153973768|NCT06247787|Folic Acid|folic acid|mesh-list
154450031|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450032|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450033|NCT04956640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154450034|NCT04956640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154860523|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450035|NCT04943536|Bicalutamide|bicalutamide|mesh-list
154450036|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
154450037|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
154450038|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450039|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450040|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450041|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
154450042|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
154024690|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
154450043|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154450044|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154450045|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450046|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450047|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450048|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450050|NCT04864782|Carboplatin|carboplatin|mesh-list
154450051|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154450052|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450053|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
154450054|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
154450055|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
154450056|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450057|NCT04862780|Osimertinib|osimertinib|mesh-list
154450058|NCT04862780|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154450059|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154450060|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450061|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450062|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450063|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
154450064|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154450065|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
154450066|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450067|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450068|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154450069|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
154450070|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154450071|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
154450072|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450073|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154450074|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154450075|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
154450076|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
154450077|NCT04842331|Protective Agents|protective agents|mesh-ancestor
154450078|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
154450079|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450080|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450081|NCT04827862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450082|NCT04827862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450083|NCT04804735|Anesthetics|anesthetics|mesh-list
154450084|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154450085|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450086|NCT04782687|Dexamethasone|dexamethasone|mesh-list
154450087|NCT04782687|Lenalidomide|lenalidomide|mesh-list
154450088|NCT04782687|Daratumumab|daratumumab|mesh-list
154450089|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154450090|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
154450091|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
154450092|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450093|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450094|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154450095|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
154450096|NCT04782687|Hormones|hormones|mesh-ancestor
154450097|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450098|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154450099|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450100|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
154450101|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154450102|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154450103|NCT04782687|Growth Substances|growth substances|mesh-ancestor
154450104|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
154450105|NCT04765137|Atorvastatin|atorvastatin|mesh-list
154450106|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154450107|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154450108|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
154450109|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450110|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154450111|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154450112|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450114|NCT04760691|Emtricitabine|emtricitabine|mesh-list
154450115|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154450116|NCT04760691|Leuprolide|leuprolide|mesh-list
153545594|NCT06304779|Anesthetics|anesthetics|mesh-ancestor
154450117|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154450118|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154450119|NCT04760691|Estradiol|estradiol|mesh-list
154450120|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154450121|NCT04760691|Estrogens|estrogens|mesh-list
154450122|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
154450123|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450124|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154450125|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154450126|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450127|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450128|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154450129|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154450130|NCT04760691|Hormones|hormones|mesh-ancestor
154450131|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450132|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450133|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154450134|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
154450135|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154450136|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154450137|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154450138|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
154450139|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154450140|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450141|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154450142|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
154450143|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450144|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154450145|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154450146|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
154450147|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154450148|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450149|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154450150|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154450151|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154450152|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154450153|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450154|NCT04617457|Leucovorin|leucovorin|mesh-list
154450155|NCT04617457|Folic Acid|folic acid|mesh-list
154450156|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
154450157|NCT04617457|Irinotecan|irinotecan|mesh-list
154450158|NCT04617457|Fluorouracil|fluorouracil|mesh-list
154450159|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
154450160|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450161|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154450162|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450163|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450164|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450165|NCT04617457|Antidotes|antidotes|mesh-ancestor
154450166|NCT04617457|Protective Agents|protective agents|mesh-ancestor
154450167|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450168|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
154450169|NCT04617457|Vitamins|vitamins|mesh-ancestor
154450170|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
154450171|NCT04617457|Hematinics|hematinics|mesh-ancestor
154450172|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
154450173|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154450174|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450175|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
154450176|NCT04599140|Nivolumab|nivolumab|mesh-list
154450177|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450178|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450179|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450180|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450181|NCT04574778|Acetaminophen|acetaminophen|mesh-list
154450182|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154450183|NCT04574778|Analgesics|analgesics|mesh-ancestor
154450184|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
154450185|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450186|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450187|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
154450188|NCT04554485|Blinatumomab|blinatumomab|mesh-list
154450189|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450190|NCT04446962|Lenalidomide|lenalidomide|mesh-list
154450191|NCT04446962|Ibrutinib|ibrutinib|mesh-list
154024898|NCT02676336|Iodine|iodine|mesh-list
154450192|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
154450193|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450194|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154450195|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154450196|NCT04446962|Growth Substances|growth substances|mesh-ancestor
154450197|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
154450198|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450199|NCT04446962|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154450200|NCT04446962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154450201|NCT04446962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450202|NCT04446962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450203|NCT04413123|Nivolumab|nivolumab|mesh-list
154450204|NCT04413123|Ipilimumab|ipilimumab|mesh-list
154450205|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450206|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450207|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450208|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450209|NCT04341350|Analgesics|analgesics|mesh-list
154450210|NCT04341350|Propofol|propofol|mesh-list
154450211|NCT04341350|Isoflurane|isoflurane|mesh-list
154450212|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154450213|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154450214|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450215|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154450216|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
154450217|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
154450218|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
154450219|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450220|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154450221|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
154450222|NCT04305795|Cemiplimab|cemiplimab|mesh-list
154450223|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450224|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450225|NCT04305795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450226|NCT04305795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450227|NCT04296006|Amphetamine|amphetamine|mesh-list
154450228|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
154450229|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154450230|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450231|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
154450232|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
154450233|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450234|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
154450235|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973769|NCT06247787|Cytarabine|cytarabine|mesh-list
154450236|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450237|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
154450238|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154450239|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154450240|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154450241|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154450242|NCT04292054|Cefazolin|cefazolin|mesh-list
154450243|NCT04292054|Tazobactam|tazobactam|mesh-list
154450244|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154450245|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450246|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154450247|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450248|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450249|NCT04279847|INCB057643|incb057643|mesh-list
154450250|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450251|NCT04253262|Rucaparib|rucaparib|mesh-list
154450252|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154450253|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450254|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450255|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450256|NCT04243837|Pirfenidone|pirfenidone|mesh-list
154450257|NCT04243837|Analgesics|analgesics|mesh-ancestor
154450258|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
154450259|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860524|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450260|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450261|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154450262|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154450263|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154450264|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450265|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450266|NCT04215978|Tislelizumab|tislelizumab|mesh-list
154450267|NCT04215978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450268|NCT04215978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450269|NCT04178005|Cladribine|cladribine|mesh-list
154450270|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450271|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450272|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
154450273|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450274|NCT04051619|Oxytocin|oxytocin|mesh-list
154450275|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
154450276|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154450277|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450278|NCT04028765|Misoprostol|misoprostol|mesh-list
154450279|NCT04028765|Oxytocin|oxytocin|mesh-list
154450280|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
154450281|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154450282|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545776|NCT06301711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153545800|NCT06301685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153545805|NCT06300424|Paclitaxel|paclitaxel|mesh-list
154450283|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154450284|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
154450285|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154450286|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154450287|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
154450288|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
154450289|NCT03959241|Methotrexate|methotrexate|mesh-list
154450290|NCT03959241|Tacrolimus|tacrolimus|mesh-list
154450291|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450292|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
154450293|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450294|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450295|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154450296|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
154450297|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450298|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450299|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154450300|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154450301|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
154450302|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154450303|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154450304|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
154450305|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
154450306|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450307|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154450308|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154450309|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154450310|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154450311|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154450312|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
154450313|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154450314|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450315|NCT03958474|Remifentanil|remifentanil|mesh-list
154450316|NCT03958474|Oxycodone|oxycodone|mesh-list
154450317|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154450318|NCT03958474|Narcotics|narcotics|mesh-ancestor
154450319|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154450320|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450321|NCT03958474|Analgesics|analgesics|mesh-ancestor
154450322|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
154450323|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450324|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154450325|NCT03907488|Nivolumab|nivolumab|mesh-list
154450326|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154450327|NCT03907488|Doxorubicin|doxorubicin|mesh-list
154450328|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154450329|NCT03907488|Dacarbazine|dacarbazine|mesh-list
154450330|NCT03907488|Vinblastine|vinblastine|mesh-list
154450331|NCT03907488|Antibodies|antibodies|mesh-list
154450332|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
154450333|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154450334|NCT03907488|Lenograstim|lenograstim|mesh-list
154450335|NCT03907488|Imidazole|imidazole|mesh-list
154450336|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
154450337|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
154450338|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450339|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450340|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154450341|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154450342|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450343|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450344|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450345|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450346|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154450347|NCT03907488|Immunotoxins|immunotoxins|mesh-ancestor
154450348|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154450349|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
154450350|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154450351|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
154450352|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
154450353|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
154450364|NCT03847272|Prednisone|prednisone|mesh-list
154450365|NCT03847272|Ustekinumab|ustekinumab|mesh-list
154450366|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154450367|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
154450368|NCT03847272|Hormones|hormones|mesh-ancestor
154450369|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450370|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450371|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154450372|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450373|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
154450374|NCT03775096|Carvedilol|carvedilol|mesh-list
154450375|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154450376|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154450377|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
154450378|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154450379|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450380|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619071|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450381|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154450382|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
154450383|NCT03775096|Protective Agents|protective agents|mesh-ancestor
154450384|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154450385|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154450386|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154450387|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
154450388|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154450389|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154450390|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
154450391|NCT03734731|Narcotics|narcotics|mesh-ancestor
154450392|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154450393|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450394|NCT03734731|Analgesics|analgesics|mesh-ancestor
154450395|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
154450396|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450397|NCT03720990|Cholic Acids|cholic acids|mesh-list
154450398|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154450399|NCT03687957|Temozolomide|temozolomide|mesh-list
154450400|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154450401|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
154450402|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450403|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450404|NCT03672487|Benzonidazole|benzonidazole|mesh-list
154450405|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450406|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
154450407|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450408|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154450409|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154450410|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154450411|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450412|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
154450413|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450414|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
154450415|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450416|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450417|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154450418|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
154450419|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450420|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450421|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154450423|NCT03519971|Etoposide|etoposide|mesh-list
154450424|NCT03519971|Cisplatin|cisplatin|mesh-list
154450425|NCT03519971|Carboplatin|carboplatin|mesh-list
154450426|NCT03519971|Pemetrexed|pemetrexed|mesh-list
154450427|NCT03519971|Durvalumab|durvalumab|mesh-list
154450428|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154450429|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450430|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
154450431|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
154450432|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
154450433|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450434|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154450435|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450436|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450437|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154450438|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154450439|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450440|NCT03493945|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154450441|NCT03493945|Antiviral Agents|antiviral agents|mesh-ancestor
154450442|NCT03493945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450443|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
154450444|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154450445|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154450446|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450447|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154450448|NCT03480061|Analgesics|analgesics|mesh-ancestor
154450449|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
154450450|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450451|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154450452|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154450453|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154450454|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
154450455|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619152|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450456|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450457|NCT03440450|Gemcitabine|gemcitabine|mesh-list
154450458|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154450459|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
154450460|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450461|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450462|NCT03414684|Carboplatin|carboplatin|mesh-list
154450463|NCT03414684|Nivolumab|nivolumab|mesh-list
154450464|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450465|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450466|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450467|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450468|NCT03346083|Betrixaban|betrixaban|mesh-list
154450469|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154450470|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
154450471|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154450472|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
154450473|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450474|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450475|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
154450476|NCT03298451|Sorafenib|sorafenib|mesh-list
154450477|NCT03298451|Durvalumab|durvalumab|mesh-list
154450478|NCT03298451|Tremelimumab|tremelimumab|mesh-list
154450479|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154450480|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450481|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154450482|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450483|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450484|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450485|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
154450486|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450487|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
154450488|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154450489|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450490|NCT03073967|Cidofovir|cidofovir|mesh-list
154450491|NCT03073967|Foscarnet|foscarnet|mesh-list
154450492|NCT03073967|Pritelivir|pritelivir|mesh-list
154450493|NCT03073967|Imiquimod|imiquimod|mesh-list
154450494|NCT03073967|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154450495|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450497|NCT03073967|Immunologic Factors|immunologic factors|mesh-ancestor
154450498|NCT03073967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450499|NCT03073967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154450500|NCT03073967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450501|NCT03073967|Interferon Inducers|interferon inducers|mesh-ancestor
154450502|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
154450503|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450504|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450505|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154450506|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154450507|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
154450508|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450509|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
154450510|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450511|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450512|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154450513|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
154450514|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450515|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450516|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154450517|NCT02843035|Venglustat|venglustat|mesh-list
154450518|NCT02843035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450519|NCT02843035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450520|NCT02723994|Leucovorin|leucovorin|mesh-list
154450521|NCT02723994|Cytarabine|cytarabine|mesh-list
154450522|NCT02723994|Dexamethasone|dexamethasone|mesh-list
154450523|NCT02723994|Prednisone|prednisone|mesh-list
154450524|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
154450525|NCT02723994|Doxorubicin|doxorubicin|mesh-list
154450526|NCT02723994|Methotrexate|methotrexate|mesh-list
154450527|NCT02723994|Vincristine|vincristine|mesh-list
154450528|NCT02723994|Asparaginase|asparaginase|mesh-list
154450529|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
154450530|NCT02723994|Pegaspargase|pegaspargase|mesh-list
154450531|NCT02723994|Thioguanine|thioguanine|mesh-list
154450532|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
154450533|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450534|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
154450535|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450536|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450537|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154450538|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
154450539|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450540|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450541|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154450542|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154450543|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
154450544|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
154450545|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450546|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154450547|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
154450548|NCT02723994|Hormones|hormones|mesh-ancestor
154450549|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450550|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154450551|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154450552|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154450553|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450554|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450555|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154450556|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
154450557|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154450558|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154450559|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
154450560|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
154450561|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154450562|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154450563|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
154450564|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450565|NCT02723994|Antidotes|antidotes|mesh-ancestor
154450566|NCT02723994|Protective Agents|protective agents|mesh-ancestor
154450567|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
154450568|NCT02723994|Vitamins|vitamins|mesh-ancestor
154450569|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
154450570|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154450572|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
154450573|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
154450574|NCT02685969|Flutemetamol|flutemetamol|mesh-list
154450575|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154450576|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450577|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
154450578|NCT02586857|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154450579|NCT02586857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154450580|NCT02586857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450581|NCT02586857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619302|NCT01983800|Midazolam|midazolam|mesh-list
154450582|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450583|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
154450584|NCT02512926|Etoposide|etoposide|mesh-list
154450585|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450586|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
154450587|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450588|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450589|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154450590|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
154450591|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450592|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450593|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154450594|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154450595|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154450596|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450597|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450598|NCT02427451|Venetoclax|venetoclax|mesh-list
154450599|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
154450600|NCT02427451|Ibrutinib|ibrutinib|mesh-list
154450601|NCT02427451|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154450602|NCT02427451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154450603|NCT02427451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450604|NCT02427451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450605|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450606|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450607|NCT02293980|Nivolumab|nivolumab|mesh-list
154450608|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450609|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450610|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450611|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450612|NCT02255799|Donepezil|donepezil|mesh-list
154450613|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154450614|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450615|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450616|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
154450617|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154450618|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450619|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
154450620|NCT02139397|Eflornithine|eflornithine|mesh-list
154450621|NCT02139397|Bortezomib|bortezomib|mesh-list
154450622|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450623|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154450624|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154450625|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154450626|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450627|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154450628|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450629|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450630|NCT02038777|Cytarabine|cytarabine|mesh-list
154450631|NCT02038777|Azacitidine|azacitidine|mesh-list
154450632|NCT02038777|Daunorubicin|daunorubicin|mesh-list
154450633|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154450634|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
154450635|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450636|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450637|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
154450638|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450639|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450640|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
154450641|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450642|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450643|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154860525|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450644|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154450645|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450646|NCT01991457|Fludarabine|fludarabine|mesh-list
154450647|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450648|NCT01943994|Psilocybin|psilocybin|mesh-list
154450649|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154450650|NCT01943994|Nicotine|nicotine|mesh-list
154450651|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154450652|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
154450653|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450654|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450655|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154450656|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154450657|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
154450658|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154450659|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450660|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
154450661|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154450662|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154450663|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
154450664|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154450665|NCT01899989|Carboplatin|carboplatin|mesh-list
154450666|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450667|NCT01817166|Vitamin D|vitamin d|mesh-list
154450668|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
154450669|NCT01817166|Vitamins|vitamins|mesh-ancestor
154450670|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
154450671|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450672|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154450673|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154450674|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
154450675|NCT00902044|Fludarabine|fludarabine|mesh-list
154450676|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154450677|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
154450678|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450679|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450680|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154450681|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
154450682|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450683|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450684|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154450685|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154450686|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
154450687|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
154450688|NCT03608241|Estradiol|estradiol|mesh-list
154450689|NCT03608241|Estrogens|estrogens|mesh-ancestor
154450690|NCT03608241|Hormones|hormones|mesh-ancestor
154450691|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450692|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450693|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154450694|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154450695|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154450696|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154450697|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
154450698|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154450699|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154450700|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450701|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154450702|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450703|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450704|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450705|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450706|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154450707|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
154450708|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154450709|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450710|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154450711|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154450712|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154450713|NCT03607383|Red yeast rice|red yeast rice|mesh-list
154450714|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154450715|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154450716|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154450717|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
154450718|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025365|NCT02665806|Ciclesonide|ciclesonide|mesh-list
154450720|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154450721|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
154450722|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
154450723|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
154450724|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154450725|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450726|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
154450727|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619556|NCT01985594|Progestins|progestins|mesh-ancestor
154450728|NCT03607149|Pemetrexed|pemetrexed|mesh-list
154450729|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450730|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450731|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450732|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154450733|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154450734|NCT04998838|Tenofovir|tenofovir|mesh-list
154450735|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
154450736|NCT04998838|Antibodies|antibodies|mesh-list
154450737|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
154450738|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154450739|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154450740|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
154450741|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450742|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154450743|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154450744|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450745|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450746|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154450747|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154450748|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
154450749|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450750|NCT03607071|Prednisolone|prednisolone|mesh-list
154450751|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154450752|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
154450753|NCT03607071|Hormones|hormones|mesh-ancestor
154450754|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450755|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450756|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154450757|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450758|NCT02035215|Atorvastatin|atorvastatin|mesh-list
154450759|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154450760|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154450761|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
154450762|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450763|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154450764|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154450765|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450766|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
154450767|NCT03605589|Blinatumomab|blinatumomab|mesh-list
154450768|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154450769|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450770|NCT03605589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154450771|NCT03605589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450772|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154450773|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154450774|NCT03074968|Benzydamine|benzydamine|mesh-list
154450775|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154450776|NCT04991584|Amoxicillin|amoxicillin|mesh-list
154450777|NCT04991584|Levofloxacin|levofloxacin|mesh-list
154450778|NCT04991584|Tetracycline|tetracycline|mesh-list
154450779|NCT04991584|Furazolidone|furazolidone|mesh-list
154450780|NCT04991584|Esomeprazole|esomeprazole|mesh-list
154450781|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154450782|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450783|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154450784|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154450785|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154450786|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450787|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450788|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154450789|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154450790|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450791|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078938|NCT04076865|Lidocaine|lidocaine|mesh-list
154450792|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154450793|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154025441|NCT00647946|Tenofovir|tenofovir|mesh-list
154450794|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154450795|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154450796|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154450797|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154450798|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154450799|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154450800|NCT05001412|Carboplatin|carboplatin|mesh-list
154450801|NCT05001412|Etoposide|etoposide|mesh-list
154450802|NCT05001412|Apatinib|apatinib|mesh-list
154450803|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450804|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154450805|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154450806|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450807|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450808|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450809|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154450810|NCT04991896|Metoprolol|metoprolol|mesh-list
154450811|NCT04991896|Flecainide|flecainide|mesh-list
154450812|NCT04991896|Sotalol|sotalol|mesh-list
154450813|NCT04991896|Bisoprolol|bisoprolol|mesh-list
154450814|NCT04991896|Betaxolol|betaxolol|mesh-list
154450815|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154450816|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154450817|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
154450818|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
154450819|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450820|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450821|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154450822|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154450823|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154450824|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
154450825|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154450826|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450827|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154450828|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154450829|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154450830|NCT03072394|Lidocaine|lidocaine|mesh-list
154450831|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
154450832|NCT03072394|Anesthetics|anesthetics|mesh-list
154450833|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154450834|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450835|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
154450836|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450837|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154450838|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154450839|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154450840|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154450841|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450842|NCT03072082|Aspirin|aspirin|mesh-list
154450843|NCT03072082|Metoprolol|metoprolol|mesh-list
154450844|NCT03072082|Isosorbide|isosorbide|mesh-list
154450845|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154450846|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154450847|NCT03072082|Trimetazidine|trimetazidine|mesh-list
154450848|NCT03072082|Clopidogrel|clopidogrel|mesh-list
154450849|NCT03072082|Atorvastatin|atorvastatin|mesh-list
154450850|NCT03072082|Calcium|calcium|mesh-list
154450851|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154450852|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450853|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154450854|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154450855|NCT03072082|Analgesics|analgesics|mesh-ancestor
154450856|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
154450857|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450858|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154450859|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154450860|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154450861|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154450862|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450863|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154450864|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154450865|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450866|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
154450868|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154025525|NCT00648258|Naproxen|naproxen|mesh-list
154450869|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
154450870|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154450871|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154450872|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154450873|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154450874|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154450875|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
154450876|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154450877|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154450878|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154450879|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
154450880|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
154450881|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154450882|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154450883|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154450884|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
154450885|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154450886|NCT03072082|Diuretics|diuretics|mesh-ancestor
154450887|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
154450888|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
154450889|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154450890|NCT04934020|Metronidazole|metronidazole|mesh-list
154450891|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154450892|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154450893|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154450894|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154450895|NCT04987450|Prednisone|prednisone|mesh-list
154450896|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
154450897|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154450898|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154450899|NCT04987450|Prednisolone|prednisolone|mesh-list
154450900|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
154450901|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154450902|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
154450903|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154450904|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
154450905|NCT04987450|Hormones|hormones|mesh-ancestor
154450906|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450907|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450908|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154450909|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450910|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
154450911|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
154450912|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450913|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154450914|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154450915|NCT04987450|Protective Agents|protective agents|mesh-ancestor
154450916|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154450917|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154450918|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
154450919|NCT03074578|Hormones|hormones|mesh-ancestor
154450920|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154450921|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450922|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154450923|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450924|NCT04991194|Zamicastat|zamicastat|mesh-list
154450925|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450926|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450927|NCT02853435|Gepotidacin|gepotidacin|mesh-list
154450928|NCT02853435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154450929|NCT02853435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450930|NCT02853435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450931|NCT02853435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450932|NCT03071770|Ivosidenib|ivosidenib|mesh-list
154450933|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450934|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450935|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450936|NCT04986982|Opicapone|opicapone|mesh-list
154450937|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154450938|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450939|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450940|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154450941|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154450942|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
154450943|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154450944|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
154450945|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450946|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
154450947|NCT03074344|Protective Agents|protective agents|mesh-ancestor
154450948|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
154450949|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
154450950|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450951|NCT02035371|Insulin|insulin|mesh-list
154450952|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154450953|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
154450954|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
154450955|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154450956|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154450957|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450958|NCT03069820|Docetaxel|docetaxel|mesh-list
154450959|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154450960|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
154450961|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
154450962|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
154450963|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450964|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
154450965|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154450966|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
154450967|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154450968|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
154450969|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450970|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450971|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
154450972|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
154450973|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
154450974|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
154450975|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450976|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450977|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
154450978|NCT03606681|Calcium|calcium|mesh-list
154450979|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154450980|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450981|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154450982|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
154450983|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154450984|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
154450985|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154450986|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
154450987|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154450988|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154450989|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
154450990|NCT03605199|Denosumab|denosumab|mesh-list
154450991|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154450992|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450993|NCT03606369|Ondansetron|ondansetron|mesh-list
154450994|NCT03606369|Palonosetron|palonosetron|mesh-list
154450995|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
154450996|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
154450997|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154450998|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154450999|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451000|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
154451001|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
154451002|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154451003|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154451004|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
154451005|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451006|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451007|NCT02635204|Clobetasol|clobetasol|mesh-list
154451008|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451009|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
154451010|NCT02635204|Hormones|hormones|mesh-ancestor
154451011|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451012|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451013|NCT00102804|Pemetrexed|pemetrexed|mesh-list
154451014|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451015|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619895|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
154451016|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451018|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154451019|NCT03038113|Immunomodulating Agents|immunomodulating agents|mesh-list
154451020|NCT03038113|Immunologic Factors|immunologic factors|mesh-ancestor
154451021|NCT03038113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451022|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154451023|NCT02163720|Doxorubicin|doxorubicin|mesh-list
154451024|NCT02163720|Trabectedin|trabectedin|mesh-list
154451025|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154451026|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451027|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154451028|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154451029|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451030|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451031|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154451032|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
154451033|NCT03487874|Ropivacaine|ropivacaine|mesh-list
154451034|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
154451035|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
154451036|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451037|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451038|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
154451039|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451040|NCT04989400|Misoprostol|misoprostol|mesh-list
154451041|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
154451042|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154451043|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
154451044|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154451045|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451046|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154451047|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451048|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
154451049|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154451050|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
154451051|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154451052|NCT02163954|Clopidogrel|clopidogrel|mesh-list
154451053|NCT02163954|Ticagrelor|ticagrelor|mesh-list
154451054|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153619945|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451055|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154451056|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154451057|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154451058|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
154451059|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451060|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451061|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451062|NCT04985656|Decitabine|decitabine|mesh-list
154451063|NCT04985656|Pevonedistat|pevonedistat|mesh-list
154451064|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154451065|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
154451066|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451067|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451068|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451069|NCT02164032|Insulin|insulin|mesh-list
154451070|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154451071|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154451072|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451073|NCT04682288|Levofloxacin|levofloxacin|mesh-list
154451074|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154451075|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451076|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451077|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154451078|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154451079|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451080|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451081|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451082|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154451083|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154451084|NCT00968149|Montelukast|montelukast|mesh-list
154451085|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154451086|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
154451087|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154451088|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
154451089|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451090|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451091|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154451092|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154451093|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451094|NCT02164110|Vaccines|vaccines|mesh-list
154451095|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
154451096|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451097|NCT02167464|Coal Tar|coal tar|mesh-list
154451098|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154451099|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
154451100|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
154451101|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
154451102|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451103|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451104|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154451105|NCT02167464|Diuretics|diuretics|mesh-ancestor
154451106|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
154451107|NCT03485456|Tobramycin|tobramycin|mesh-list
154451108|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451109|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451110|NCT03487562|Amoxicillin|amoxicillin|mesh-list
154451111|NCT03487562|Clarithromycin|clarithromycin|mesh-list
154451112|NCT03487562|Lansoprazole|lansoprazole|mesh-list
154451113|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
154451114|NCT03487562|Fexuprazan|fexuprazan|mesh-list
154451115|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451116|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451117|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154451118|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451119|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451120|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154451121|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154451122|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154451123|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451124|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154451125|NCT02167620|Metformin|metformin|mesh-list
154451126|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154451127|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451128|NCT03485300|Warfarin|warfarin|mesh-list
154451129|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
154451130|NCT00963469|Loratadine|loratadine|mesh-list
154451131|NCT00963469|Montelukast|montelukast|mesh-list
154451132|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154451133|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
154451134|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154451135|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
154451136|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451137|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451138|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154451139|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154451140|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451141|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
154451142|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
154451143|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154451144|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154451145|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154451146|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
154451147|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
154451148|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451149|NCT00897949|Rizatriptan|rizatriptan|mesh-list
154451150|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154451151|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
154451152|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451153|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451154|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451155|NCT03487406|Aspirin|aspirin|mesh-list
154451156|NCT03487406|Ticagrelor|ticagrelor|mesh-list
154451157|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154451158|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154451159|NCT03487406|Analgesics|analgesics|mesh-ancestor
154451160|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
154451161|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451162|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451163|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451164|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451165|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154451166|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154451167|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451168|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154451169|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154451172|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154451173|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154451174|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154451175|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
154451176|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451177|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154451178|NCT00725491|Ganirelix|ganirelix|mesh-list
154451179|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
154451180|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154451181|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
154451182|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154451183|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451184|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154451185|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154451186|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451187|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
154451188|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451189|NCT00724789|Ganirelix|ganirelix|mesh-list
154451190|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
154451191|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451192|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451193|NCT00711607|Estradiol|estradiol|mesh-list
154451194|NCT00711607|Estrogens|estrogens|mesh-ancestor
154451195|NCT00711607|Hormones|hormones|mesh-ancestor
154451196|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451197|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451198|NCT03893318|Lidocaine|lidocaine|mesh-list
154451199|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
154451200|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
154451201|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451202|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451203|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
154451204|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451205|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154451206|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154451207|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154451208|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154451209|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451210|NCT03625531|Letrozole|letrozole|mesh-list
154451211|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451212|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154451213|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154451214|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451215|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451216|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154451217|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
154451218|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451219|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451220|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
154451221|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154451222|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154451223|NCT02167698|Prednisolone|prednisolone|mesh-list
154451224|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
154451225|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154451226|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
154451227|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451228|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
154451229|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
154451230|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451231|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451232|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451233|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
154451234|NCT02167698|Hormones|hormones|mesh-ancestor
153973770|NCT06247787|Hydrocortisone|hydrocortisone|mesh-list
154451235|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451237|NCT02167698|Protective Agents|protective agents|mesh-ancestor
154025889|NCT00894803|Eptifibatide|eptifibatide|mesh-list
154451240|NCT02634580|Ezetimibe|ezetimibe|mesh-list
154451241|NCT02634580|Evolocumab|evolocumab|mesh-list
154451242|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154451243|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154451244|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154451245|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
154451246|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451247|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154451248|NCT02634580|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154451249|NCT02634580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154451250|NCT02634580|Protease Inhibitors|protease inhibitors|mesh-ancestor
154451251|NCT02634580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451252|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
154451253|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451254|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154451255|NCT00697255|Hormones|hormones|mesh-list
154451256|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154451257|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451258|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451259|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154451260|NCT00548912|Spironolactone|spironolactone|mesh-list
154451261|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154451262|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
154451263|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451264|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451265|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154451266|NCT00548912|Diuretics|diuretics|mesh-ancestor
154451267|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
154451268|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
154451269|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154451270|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451271|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154451272|NCT03071068|Antibodies|antibodies|mesh-list
154451273|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
154451274|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154451275|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
154451276|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451277|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451278|NCT06161441|Paclitaxel|paclitaxel|mesh-list
154451279|NCT06161441|Carboplatin|carboplatin|mesh-list
154451280|NCT06161441|Pemetrexed|pemetrexed|mesh-list
154451281|NCT06161441|Cemiplimab|cemiplimab|mesh-list
154451282|NCT06161441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154451283|NCT06161441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451284|NCT06161441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154451285|NCT06161441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154451286|NCT06161441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154451287|NCT06161441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620213|NCT01990118|Cyclosporins|cyclosporins|mesh-list
154451288|NCT06161441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451289|NCT06161441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154451290|NCT06161441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154451291|NCT06161441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451294|NCT06161272|Apatinib|apatinib|mesh-list
154451295|NCT06161272|Fluzoparib|fluzoparib|mesh-list
154451296|NCT06161272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451297|NCT06161272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154451298|NCT06161272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451299|NCT06161272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451300|NCT06161272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154451301|NCT06161220|Moxifloxacin|moxifloxacin|mesh-list
154451302|NCT06161220|Carbidopa|carbidopa|mesh-list
154451303|NCT06161220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451304|NCT06161220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451305|NCT06161220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154451306|NCT06161220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154451307|NCT06161220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451308|NCT06161220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451309|NCT06161220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451310|NCT06161220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451311|NCT06161220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154451312|NCT06161220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154451313|NCT06161220|Dopamine Agents|dopamine agents|mesh-ancestor
154451314|NCT06161220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451315|NCT06161220|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154451316|NCT06161064|Hyaluronic Acid|hyaluronic acid|mesh-list
154451317|NCT06161064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154451318|NCT06161064|Immunologic Factors|immunologic factors|mesh-ancestor
154451319|NCT06161064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451320|NCT06161064|Viscosupplements|viscosupplements|mesh-ancestor
154451321|NCT06161064|Protective Agents|protective agents|mesh-ancestor
154451322|NCT06160843|Pembrolizumab|pembrolizumab|mesh-list
154451324|NCT06160843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451325|NCT06160843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451326|NCT06160843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154451327|NCT06160843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451328|NCT06160843|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154451329|NCT06160843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451330|NCT06160791|Dexamethasone|dexamethasone|mesh-list
154451331|NCT06160791|Etoposide|etoposide|mesh-list
154451332|NCT06160791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451333|NCT06160791|Antiemetics|antiemetics|mesh-ancestor
154451334|NCT06160791|Autonomic Agents|autonomic agents|mesh-ancestor
154451335|NCT06160791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451336|NCT06160791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451337|NCT06160791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451338|NCT06160791|Glucocorticoids|glucocorticoids|mesh-ancestor
154451339|NCT06160791|Hormones|hormones|mesh-ancestor
154451340|NCT06160791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451341|NCT06160791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154451342|NCT06160791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451343|NCT06160791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154451344|NCT06160791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154451345|NCT06160791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154451346|NCT06160791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451347|NCT06160791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620272|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451348|NCT06160778|Ketorolac|ketorolac|mesh-list
154451349|NCT06160778|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154451350|NCT06160778|Morphine|morphine|mesh-list
154451351|NCT06160778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154451352|NCT06160778|Narcotics|narcotics|mesh-ancestor
154451353|NCT06160778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451354|NCT06160778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451355|NCT06160778|Analgesics|analgesics|mesh-ancestor
154451356|NCT06160778|Sensory System Agents|sensory system agents|mesh-ancestor
154451357|NCT06160778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451358|NCT06160778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154451359|NCT06160778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154451360|NCT06160778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451361|NCT06160778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451362|NCT06160778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154451363|NCT06160778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451364|NCT06160778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451365|NCT06160739|Sirolimus|sirolimus|mesh-list
154451366|NCT06160739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451367|NCT06160739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451368|NCT06160739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154451369|NCT06160739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451370|NCT06160739|Antifungal Agents|antifungal agents|mesh-ancestor
154451371|NCT06160739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154451372|NCT06160739|Immunologic Factors|immunologic factors|mesh-ancestor
154451373|NCT06160739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451374|NCT06160479|Calcium|calcium|mesh-list
154451375|NCT06160479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154451376|NCT06160479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451377|NCT06160362|Cyclophosphamide|cyclophosphamide|mesh-list
154451378|NCT06160362|Fludarabine|fludarabine|mesh-list
154451379|NCT06160362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154451380|NCT06160362|Immunologic Factors|immunologic factors|mesh-ancestor
154451381|NCT06160362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451382|NCT06160362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451383|NCT06160362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154451384|NCT06160362|Alkylating Agents|alkylating agents|mesh-ancestor
154026034|NCT02660346|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154451385|NCT06160362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451386|NCT06160362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451387|NCT06160362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154451389|NCT06160232|Hallucinogens|hallucinogens|mesh-ancestor
154451390|NCT06160232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451391|NCT06160232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154451392|NCT06160219|Hydroxocobalamin|hydroxocobalamin|mesh-list
154451393|NCT06160219|Vitamin B 12|vitamin b 12|mesh-list
154451394|NCT06160219|Hematinics|hematinics|mesh-ancestor
154451395|NCT06160219|Vitamin B Complex|vitamin b complex|mesh-ancestor
154451396|NCT06160219|Vitamins|vitamins|mesh-ancestor
154451397|NCT06160219|Micronutrients|micronutrients|mesh-ancestor
154451398|NCT06160219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451399|NCT06160206|Bevacizumab|bevacizumab|mesh-list
154451400|NCT06160206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154451401|NCT06160206|Endothelial Growth Factors|endothelial growth factors|mesh-list
154451402|NCT06160206|Antibodies|antibodies|mesh-list
154451403|NCT06160206|Immunoglobulins|immunoglobulins|mesh-list
154451404|NCT06160206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154451405|NCT06160206|Immunoglobulin G|immunoglobulin g|mesh-list
154451406|NCT06160206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451407|NCT06160206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154451408|NCT06160206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154451409|NCT06160206|Growth Substances|growth substances|mesh-ancestor
154451410|NCT06160206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451411|NCT06160206|Growth Inhibitors|growth inhibitors|mesh-ancestor
154451412|NCT06160206|Immunologic Factors|immunologic factors|mesh-ancestor
154451413|NCT06160180|Dexamethasone|dexamethasone|mesh-list
154451414|NCT06160180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451415|NCT06160180|Antiemetics|antiemetics|mesh-ancestor
154451416|NCT06160180|Autonomic Agents|autonomic agents|mesh-ancestor
154451417|NCT06160180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451418|NCT06160180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451419|NCT06160180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451420|NCT06160180|Glucocorticoids|glucocorticoids|mesh-ancestor
154451421|NCT06160180|Hormones|hormones|mesh-ancestor
154451422|NCT06160180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451423|NCT06160180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154451424|NCT06160180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451425|NCT06159959|Oxytocin|oxytocin|mesh-list
154451426|NCT06159959|Carbetocin|carbetocin|mesh-list
154451427|NCT06159959|Oxytocics|oxytocics|mesh-ancestor
154451428|NCT06159959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154451429|NCT06159959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451430|NCT06159842|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154451431|NCT06159842|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154451432|NCT06159842|Dermatologic Agents|dermatologic agents|mesh-ancestor
154451433|NCT06159608|Nitric Oxide|nitric oxide|mesh-list
154451434|NCT06159608|Estrogens|estrogens|mesh-list
154451435|NCT06159608|Nitroarginine|nitroarginine|mesh-list
154451436|NCT06159608|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
154451437|NCT06159608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154451438|NCT06159608|Autonomic Agents|autonomic agents|mesh-ancestor
154451439|NCT06159608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451440|NCT06159608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451441|NCT06159608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153620331|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
154451442|NCT06159608|Respiratory System Agents|respiratory system agents|mesh-ancestor
154451443|NCT06159608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154451444|NCT06159608|Antioxidants|antioxidants|mesh-ancestor
154451445|NCT06159608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451446|NCT06159608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451447|NCT06159608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154451448|NCT06159608|Vasodilator Agents|vasodilator agents|mesh-ancestor
154451449|NCT06159608|Gasotransmitters|gasotransmitters|mesh-ancestor
154451450|NCT06159608|Protective Agents|protective agents|mesh-ancestor
154451451|NCT06159608|Hormones|hormones|mesh-ancestor
154451452|NCT06159608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451453|NCT06159608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451454|NCT06153368|Leucovorin|leucovorin|mesh-list
154451455|NCT06153368|Fluorouracil|fluorouracil|mesh-list
154451456|NCT06153368|Oxaliplatin|oxaliplatin|mesh-list
154451457|NCT06153368|Irinotecan|irinotecan|mesh-list
154451458|NCT06153368|Antimetabolites|antimetabolites|mesh-ancestor
154451459|NCT06153368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451460|NCT06153368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154451461|NCT06153368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451462|NCT06153368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154451463|NCT06153368|Immunologic Factors|immunologic factors|mesh-ancestor
154451464|NCT06153368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451465|NCT06153368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154451467|NCT06153368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451469|NCT06153368|Protective Agents|protective agents|mesh-ancestor
154451470|NCT06153368|Vitamin B Complex|vitamin b complex|mesh-ancestor
154451471|NCT06153368|Vitamins|vitamins|mesh-ancestor
154451472|NCT06153368|Micronutrients|micronutrients|mesh-ancestor
154451473|NCT06152874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154451474|NCT06150768|Cobalt|cobalt|mesh-list
154451475|NCT06150768|Chromium|chromium|mesh-list
154451476|NCT06150768|Trace Elements|trace elements|mesh-ancestor
154451477|NCT06150768|Micronutrients|micronutrients|mesh-ancestor
154451478|NCT06150768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451479|NCT06149247|Hypericin|hypericin|mesh-list
154451480|NCT06149247|Mechlorethamine|mechlorethamine|mesh-list
154451481|NCT06149247|Alkylating Agents|alkylating agents|mesh-ancestor
154451482|NCT06149247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451483|NCT06149247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154451484|NCT06149247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451485|NCT06149247|Antidepressive Agents|antidepressive agents|mesh-ancestor
154451486|NCT06149247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154451487|NCT06149247|Antiviral Agents|antiviral agents|mesh-ancestor
154451488|NCT06149247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451489|NCT06149247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451490|NCT06149247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154451491|NCT06149247|Immunologic Factors|immunologic factors|mesh-ancestor
154451492|NCT06149247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451493|NCT06121271|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153620474|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
154451494|NCT06121271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154451495|NCT06121271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451496|NCT06096090|Interleukin-2|interleukin-2|mesh-list
154451497|NCT06096090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451498|NCT06096090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154451499|NCT06096090|Analgesics|analgesics|mesh-ancestor
154451500|NCT06096090|Sensory System Agents|sensory system agents|mesh-ancestor
154451501|NCT06096090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451502|NCT06096090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451503|NCT06095141|Cisplatin|cisplatin|mesh-list
154451504|NCT06095141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451505|NCT06081179|Methylphenidate|methylphenidate|mesh-list
154451506|NCT06081179|Psilocybin|psilocybin|mesh-list
154451507|NCT06081179|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154451508|NCT06081179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154451509|NCT06081179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451510|NCT06081179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154451511|NCT06081179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154451512|NCT06081179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154451513|NCT06081179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451514|NCT06081179|Dopamine Agents|dopamine agents|mesh-ancestor
154451515|NCT06081179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451516|NCT06081179|Hallucinogens|hallucinogens|mesh-ancestor
154451517|NCT06081179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154451518|NCT06081179|Serotonin Agents|serotonin agents|mesh-ancestor
154451519|NCT06081179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154451520|NCT06081179|Adrenergic Agents|adrenergic agents|mesh-ancestor
154451521|NCT06053411|Diclofenac|diclofenac|mesh-list
154451522|NCT06053411|Curcumin|curcumin|mesh-list
154451523|NCT06053411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154451524|NCT06053411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154451525|NCT06053411|Analgesics|analgesics|mesh-ancestor
154451526|NCT06053411|Sensory System Agents|sensory system agents|mesh-ancestor
154451527|NCT06053411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451528|NCT06053411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451529|NCT06053411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451530|NCT06053411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451531|NCT06053411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154451532|NCT06053411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451533|NCT06053411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620512|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154451534|NCT06053411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451535|NCT06021808|Anticoagulants|anticoagulants|mesh-list
154451536|NCT05989932|Upadacitinib|upadacitinib|mesh-list
154451537|NCT05989932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154451538|NCT05989932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154451539|NCT05989932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451540|NCT05989932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451541|NCT05989932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451542|NCT05980091|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154451543|NCT05980091|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154451544|NCT05980091|Estradiol|estradiol|mesh-list
154451545|NCT05980091|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154451546|NCT05980091|Progesterone|progesterone|mesh-list
154451547|NCT05980091|Estrogens|estrogens|mesh-ancestor
154451548|NCT05980091|Hormones|hormones|mesh-ancestor
154451549|NCT05980091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451550|NCT05980091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451551|NCT05980091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154451552|NCT05980091|Contraceptive Agents|contraceptive agents|mesh-ancestor
154451553|NCT05980091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154451554|NCT05980091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154451555|NCT05980091|Progestins|progestins|mesh-ancestor
154451556|NCT05925309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154451557|NCT05925309|Meropenem|meropenem|mesh-list
154451558|NCT05925309|Imipenem|imipenem|mesh-list
154451559|NCT05925309|Cefaclor|cefaclor|mesh-list
154451560|NCT05925309|Sulfamethoxazole|sulfamethoxazole|mesh-list
154451561|NCT05925309|Sulperazone|sulperazone|mesh-list
154451562|NCT05925309|Methylprednisolone|methylprednisolone|mesh-list
154451563|NCT05925309|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154451564|NCT05925309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154451565|NCT05925309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451566|NCT05925309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451567|NCT05925309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451568|NCT05925309|Antiemetics|antiemetics|mesh-ancestor
154451569|NCT05925309|Autonomic Agents|autonomic agents|mesh-ancestor
154451570|NCT05925309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451571|NCT05925309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451572|NCT05925309|Glucocorticoids|glucocorticoids|mesh-ancestor
154451573|NCT05925309|Hormones|hormones|mesh-ancestor
154451574|NCT05925309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451575|NCT05925309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154451576|NCT05925309|Protective Agents|protective agents|mesh-ancestor
154451577|NCT05925309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154451578|NCT05925309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154451579|NCT05897385|Lidocaine|lidocaine|mesh-list
154451580|NCT05897385|Anesthetics, Local|anesthetics, local|mesh-ancestor
154451581|NCT05897385|Anesthetics|anesthetics|mesh-ancestor
154451582|NCT05897385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451583|NCT05897385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451584|NCT05897385|Sensory System Agents|sensory system agents|mesh-ancestor
154451585|NCT05897385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451586|NCT05897385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154451587|NCT05897385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154451588|NCT05897385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154451589|NCT05897385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154451590|NCT05897385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451591|NCT05881811|Probenecid|probenecid|mesh-list
154451592|NCT05881811|Cimetidine|cimetidine|mesh-list
154451593|NCT05881811|Uricosuric Agents|uricosuric agents|mesh-ancestor
154451594|NCT05881811|Gout Suppressants|gout suppressants|mesh-ancestor
154451595|NCT05881811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451596|NCT05881811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154451597|NCT05881811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451598|NCT05881811|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154451599|NCT05881811|Histamine Antagonists|histamine antagonists|mesh-ancestor
154451600|NCT05881811|Histamine Agents|histamine agents|mesh-ancestor
154451601|NCT05881811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451602|NCT05881811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451603|NCT05881811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451604|NCT05881811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154451605|NCT05881811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154451606|NCT05881811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451607|NCT05871177|Hyaluronic Acid|hyaluronic acid|mesh-list
154451608|NCT05871177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154451609|NCT05871177|Immunologic Factors|immunologic factors|mesh-ancestor
154451610|NCT05871177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451611|NCT05871177|Viscosupplements|viscosupplements|mesh-ancestor
154451612|NCT05871177|Protective Agents|protective agents|mesh-ancestor
154451613|NCT05849090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154451614|NCT05849090|Vancomycin|vancomycin|mesh-list
153620619|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620620|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451615|NCT05849090|Clindamycin|clindamycin|mesh-list
154451616|NCT05849090|Clindamycin palmitate|clindamycin palmitate|mesh-list
154451617|NCT05849090|Clindamycin phosphate|clindamycin phosphate|mesh-list
154451618|NCT05849090|Cefazolin|cefazolin|mesh-list
154451619|NCT05849090|Ceftriaxone|ceftriaxone|mesh-list
154451621|NCT05849090|Cephalosporins|cephalosporins|mesh-list
154451622|NCT05849090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154451623|NCT05849090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451624|NCT05849090|Antitubercular Agents|antitubercular agents|mesh-ancestor
154451625|NCT05849090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154451626|NCT05849090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451627|NCT05849090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451628|NCT05849090|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154451629|NCT05849090|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154451630|NCT05846646|Pembrolizumab|pembrolizumab|mesh-list
154451631|NCT05846646|Nivolumab|nivolumab|mesh-list
154451632|NCT05846646|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154451633|NCT05846646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451634|NCT05846646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451635|NCT05846646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451636|NCT05846451|Oxycodone|oxycodone|mesh-list
154451637|NCT05846451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154451638|NCT05846451|Narcotics|narcotics|mesh-ancestor
154451639|NCT05846451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451640|NCT05846451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451641|NCT05846451|Analgesics|analgesics|mesh-ancestor
154451642|NCT05846451|Sensory System Agents|sensory system agents|mesh-ancestor
154451643|NCT05846451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451644|NCT05685719|Itraconazole|itraconazole|mesh-list
154451645|NCT05685719|Rifampin|rifampin|mesh-list
154451646|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
154451647|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451648|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154451649|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154451650|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451651|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451652|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154451653|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
154451654|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451655|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451656|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154451657|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154451658|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
154451659|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451660|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
154451661|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154451662|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154451663|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154451664|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154451665|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154451666|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154451667|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154451668|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154451669|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451670|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451671|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
154451672|NCT05645380|Carboplatin|carboplatin|mesh-list
154451673|NCT05645380|Docetaxel|docetaxel|mesh-list
154451674|NCT05645380|Doxorubicin|doxorubicin|mesh-list
154451675|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
154451676|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154451677|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
154451678|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451679|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451680|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154451681|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
154451682|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451683|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451684|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154451685|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
154451686|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
154451687|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
154451688|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154451689|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154026339|NCT00651300|Parecoxib|parecoxib|mesh-list
154451690|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154451691|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451692|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451693|NCT05645380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154451694|NCT05641142|Anticoagulants|anticoagulants|mesh-list
154451695|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
154451696|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154451697|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451698|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154451699|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
153620726|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154451700|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451701|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451702|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451703|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451704|NCT05601882|Upadacitinib|upadacitinib|mesh-list
154451705|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154451706|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154451707|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451708|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451709|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451711|NCT05590416|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154451712|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451713|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451714|NCT05578287|Celecoxib|celecoxib|mesh-list
154451715|NCT05578287|Tislelizumab|tislelizumab|mesh-list
154451716|NCT05578287|Disitamab vedotin|disitamab vedotin|mesh-list
154451717|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154451718|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154451719|NCT05578287|Analgesics|analgesics|mesh-ancestor
154451720|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
154451721|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451722|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451723|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451724|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451725|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154451726|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154451727|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451728|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451729|NCT05578287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451730|NCT05578287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451731|NCT05578287|Immunoconjugates|immunoconjugates|mesh-ancestor
154451732|NCT05578287|Immunologic Factors|immunologic factors|mesh-ancestor
154451733|NCT05567731|Hormones|hormones|mesh-list
154451734|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451735|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451736|NCT05560230|Clonidine|clonidine|mesh-list
154451737|NCT05560230|Analgesics|analgesics|mesh-ancestor
154451738|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
154451739|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620754|NCT01994642|Hormones|hormones|mesh-ancestor
153620756|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154451740|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451741|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154451742|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
154451743|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
154451744|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154451745|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154451746|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154451747|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
154451748|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451749|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451750|NCT05487040|Ritonavir|ritonavir|mesh-list
154451751|NCT05487040|Nirmatrelvir|nirmatrelvir|mesh-list
154451752|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154451753|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154451754|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
154451755|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451756|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451757|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154451758|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154451759|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
154451760|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451761|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154451762|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154026408|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154451764|NCT05461508|Fucoidan|fucoidan|mesh-list
154451765|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451766|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451767|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154451768|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451769|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
154451770|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451771|NCT05432934|Dexamethasone|dexamethasone|mesh-list
154451772|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451773|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
154451774|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
154451775|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451776|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451777|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451778|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
154451780|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451781|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154451782|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451783|NCT05334485|Bromides|bromides|mesh-list
154451784|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154451785|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
154451786|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154451787|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451788|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451789|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
154451790|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451791|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451792|NCT05315999|Palonosetron|palonosetron|mesh-list
154451793|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
154451794|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
154451795|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451796|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451797|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451798|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154451799|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154451800|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
154451801|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451802|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451803|NCT05252988|Loperamide|loperamide|mesh-list
154451804|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
154451805|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154451806|NCT05252988|Neratinib|neratinib|mesh-list
154451807|NCT05252988|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154451808|NCT05252988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154451809|NCT05252988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451810|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451811|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451812|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154451813|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154451814|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
154451815|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154451816|NCT05243563|Clobetasol|clobetasol|mesh-list
154451817|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451818|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
154451819|NCT05243563|Hormones|hormones|mesh-ancestor
154451820|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451821|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451822|NCT05157672|Letrozole|letrozole|mesh-list
154451823|NCT05157672|Nicotine|nicotine|mesh-list
154451824|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154451825|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
154451826|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451827|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451828|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154451829|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154451830|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
154451831|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154451832|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451833|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451834|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154451835|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154451836|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451837|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154451838|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
154026561|NCT06095362|Bevacizumab|bevacizumab|mesh-list
154451839|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451840|NCT05147090|Empagliflozin|empagliflozin|mesh-list
154079982|NCT00585312|Celecoxib|celecoxib|mesh-list
154451841|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154451842|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451843|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154451844|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451845|NCT05104229|Aspirin|aspirin|mesh-list
154451846|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154451847|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154451848|NCT05104229|Analgesics|analgesics|mesh-ancestor
154451849|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
154451850|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451851|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451852|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451853|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451854|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154451855|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154451856|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451857|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154451858|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154451859|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451860|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
154451861|NCT05057247|Docetaxel|docetaxel|mesh-list
154451862|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451863|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
154451864|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
154451865|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
154451866|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451867|NCT05028075|Cobalt|cobalt|mesh-list
154451868|NCT05028075|Trace Elements|trace elements|mesh-ancestor
154451869|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
154451870|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451871|NCT05018273|Atezolizumab|atezolizumab|mesh-list
154451872|NCT05018273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154451873|NCT05018273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451874|NCT05018273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451875|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451876|NCT05010629|Carboplatin|carboplatin|mesh-list
154451877|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451878|NCT05010304|Amoxicillin|amoxicillin|mesh-list
154451879|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154451880|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451881|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
154451882|NCT05008523|Narcotics|narcotics|mesh-ancestor
154451883|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451884|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451885|NCT05008523|Analgesics|analgesics|mesh-ancestor
154451886|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
154451887|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451888|NCT04969939|Semaglutide|semaglutide|mesh-list
154451889|NCT04969939|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154451890|NCT04969939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154451891|NCT04969939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451892|NCT04967664|Capsaicin|capsaicin|mesh-list
154451893|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
154451894|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
154451895|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
154451896|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451897|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451898|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
154451899|NCT04937907|Benazepril|benazepril|mesh-list
154451900|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
154451901|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154451902|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154451903|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154451904|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451905|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451906|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451907|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154451908|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
154451909|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154451910|NCT04934475|Lenalidomide|lenalidomide|mesh-list
154451911|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
154451912|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620915|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451913|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154451914|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154451915|NCT04934475|Growth Substances|growth substances|mesh-ancestor
154451916|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
154451917|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451918|NCT04904302|Nivolumab|nivolumab|mesh-list
154451919|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451920|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451921|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154451922|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451923|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154451924|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154451925|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451926|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
154451927|NCT04895735|Pemetrexed|pemetrexed|mesh-list
154451928|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154451929|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451930|NCT04895735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154451931|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451932|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451933|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154451934|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154451935|NCT04879225|Menthol|menthol|mesh-list
154451936|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
154451937|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
154451938|NCT04865939|Gemcitabine|gemcitabine|mesh-list
154451939|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154451940|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
154451941|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451942|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451943|NCT04745949|Prednisone|prednisone|mesh-list
154451944|NCT04745949|Cortisone|cortisone|mesh-list
154451945|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
154451946|NCT04745949|Rituximab|rituximab|mesh-list
154451947|NCT04745949|Doxorubicin|doxorubicin|mesh-list
154451948|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154451949|NCT04745949|Nivolumab|nivolumab|mesh-list
154451950|NCT04745949|Daunorubicin|daunorubicin|mesh-list
154451951|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154451952|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154451953|NCT04745949|Antibodies|antibodies|mesh-list
154451954|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
154451955|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154451956|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
154451957|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154451958|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
154451959|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451960|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154451961|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154451962|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
154451963|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451964|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451965|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154451966|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154451967|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154451968|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154451969|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154451970|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451971|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
154451972|NCT04745949|Hormones|hormones|mesh-ancestor
154451973|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451974|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154451975|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154451976|NCT04745949|Immunotoxins|immunotoxins|mesh-ancestor
154451977|NCT04721613|Melatonin|melatonin|mesh-list
154451978|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
154451979|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154451980|NCT04721613|Protective Agents|protective agents|mesh-ancestor
154451981|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451982|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154451983|NCT04643002|Dexamethasone|dexamethasone|mesh-list
154451984|NCT04643002|Pomalidomide|pomalidomide|mesh-list
154451985|NCT04643002|Belumosudil|belumosudil|mesh-list
154451986|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154451987|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
154451988|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
154026647|NCT06094140|Leucovorin|leucovorin|mesh-list
154451989|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154451990|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154451991|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154451992|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
154451993|NCT04643002|Hormones|hormones|mesh-ancestor
154451994|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154451995|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154451996|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154451997|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
154451998|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154451999|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154452000|NCT04643002|Growth Substances|growth substances|mesh-ancestor
154452001|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
154452002|NCT04643002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452003|NCT04643002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452004|NCT04643002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452005|NCT04642261|Empagliflozin|empagliflozin|mesh-list
154452006|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154452007|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452008|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154452009|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452010|NCT04551482|Oxytocin|oxytocin|mesh-list
154452011|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
154452012|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154452013|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452014|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154452015|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452016|NCT04417465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452017|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452018|NCT04359823|Lovastatin|lovastatin|mesh-list
154452019|NCT04359823|L 647318|l 647318|mesh-list
154452020|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
154452021|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154452022|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154452023|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
154452024|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452025|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154452026|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154452027|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452028|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
154452029|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154452030|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452031|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
154452032|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154452033|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154452034|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452035|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
154452036|NCT04304625|Coagulants|coagulants|mesh-ancestor
154452037|NCT04255602|Ticagrelor|ticagrelor|mesh-list
154452038|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154452039|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154452040|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154452041|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154452042|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
154452043|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452044|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452045|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452046|NCT04240756|Amphetamine|amphetamine|mesh-list
154452047|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154452048|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452049|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
154452050|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
154452051|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621132|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452052|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
154452053|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452054|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452055|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
154452056|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154452057|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154452058|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154452059|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154452060|NCT04228263|Aspirin|aspirin|mesh-list
154452061|NCT04228263|Folic Acid|folic acid|mesh-list
154452062|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
154452063|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154452064|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154452066|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
154452067|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452068|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452069|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452070|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452071|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154452072|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154452073|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452074|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154452075|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154452076|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452077|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
154452078|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
154452079|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154452080|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154452081|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452082|NCT04228263|Hematinics|hematinics|mesh-ancestor
154452083|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
154452084|NCT04228263|Vitamins|vitamins|mesh-ancestor
154452085|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
154452086|NCT04205812|Paclitaxel|paclitaxel|mesh-list
154452087|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154452088|NCT04205812|Carboplatin|carboplatin|mesh-list
154452089|NCT04205812|Pemetrexed|pemetrexed|mesh-list
154452090|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154452091|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452092|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154452093|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
154452094|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
154452095|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452096|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621188|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153621189|NCT01997112|Analgesics|analgesics|mesh-ancestor
154452097|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154452098|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154452099|NCT04175886|Tofacitinib|tofacitinib|mesh-list
154452100|NCT04175886|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154452101|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452102|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452103|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452104|NCT04151082|Prednisone|prednisone|mesh-list
154452105|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
154452106|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154452107|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154452108|NCT04151082|Prednisolone|prednisolone|mesh-list
154452109|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
154452110|NCT04151082|Cortisone|cortisone|mesh-list
154452111|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154452112|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
154452113|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452114|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
154452115|NCT04151082|Hormones|hormones|mesh-ancestor
154452116|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154452117|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452118|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154452119|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452120|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
154452121|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
154452122|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452123|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154452124|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154452125|NCT04151082|Protective Agents|protective agents|mesh-ancestor
154452126|NCT04134884|Talazoparib|talazoparib|mesh-list
154452127|NCT04134884|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154452128|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154452129|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452130|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452131|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452132|NCT04134884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452133|NCT04134884|Antimetabolites|antimetabolites|mesh-ancestor
154452134|NCT04132960|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154452135|NCT04132960|Immunoconjugates|immunoconjugates|mesh-ancestor
154026787|NCT05879107|Immunologic Factors|immunologic factors|mesh-ancestor
154452136|NCT04132960|Immunologic Factors|immunologic factors|mesh-ancestor
154452137|NCT04132960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080291|NCT06238167|Tislelizumab|tislelizumab|mesh-list
154452138|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154452140|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
154452141|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452142|NCT03970304|Vaccines|vaccines|mesh-list
154452143|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
154452144|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452145|NCT03921008|Paclitaxel|paclitaxel|mesh-list
154452146|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154452147|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452148|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
154452149|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
154452150|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
154452151|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452152|NCT03870919|Palbociclib|palbociclib|mesh-list
154452153|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452154|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452155|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452156|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452157|NCT03867357|Goserelin|goserelin|mesh-list
154452158|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154452159|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452160|NCT03850574|Venetoclax|venetoclax|mesh-list
154452161|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452162|NCT03800381|Rifampin|rifampin|mesh-list
154452163|NCT03800381|Isoniazid|isoniazid|mesh-list
154452164|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
154452165|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154452166|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
154452167|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154452168|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452169|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
154452170|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154452171|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452172|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452173|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154452174|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154452175|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154452176|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154452177|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153621237|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452178|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154452179|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154452180|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154452181|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
154452182|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154452183|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
154452184|NCT03785249|Cetuximab|cetuximab|mesh-list
154452185|NCT03785249|Afatinib|afatinib|mesh-list
154452186|NCT03785249|Adagrasib|adagrasib|mesh-list
154452187|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452188|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452189|NCT03785249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154452190|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452191|NCT03785249|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154452192|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452193|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452194|NCT03715946|Nivolumab|nivolumab|mesh-list
154452195|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452196|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452197|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154452198|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452199|NCT03701763|Apremilast|apremilast|mesh-list
154452200|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154452201|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154452202|NCT03701763|Analgesics|analgesics|mesh-ancestor
154452203|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
154452204|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452205|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452206|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452207|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452208|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154452209|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154452210|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452211|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452212|NCT03700541|Morphine|morphine|mesh-list
154452213|NCT03700541|Pirinitramide|pirinitramide|mesh-list
154452214|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154452215|NCT03700541|Narcotics|narcotics|mesh-ancestor
154452216|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452217|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452218|NCT03700541|Analgesics|analgesics|mesh-ancestor
154452219|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
154452220|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452221|NCT03700411|Morphine|morphine|mesh-list
154452222|NCT03700411|Pirinitramide|pirinitramide|mesh-list
154452223|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154452224|NCT03700411|Narcotics|narcotics|mesh-ancestor
154452225|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452226|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452227|NCT03700411|Analgesics|analgesics|mesh-ancestor
154452228|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
154452229|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452230|NCT03624101|Ivacaftor|ivacaftor|mesh-list
154452231|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154452232|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154452233|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452234|NCT03586661|Niraparib|niraparib|mesh-list
154452235|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154452236|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452237|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452238|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452239|NCT03493048|Leucovorin|leucovorin|mesh-list
154452240|NCT03493048|Fluorouracil|fluorouracil|mesh-list
154452241|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
154452242|NCT03493048|Irinotecan|irinotecan|mesh-list
154452243|NCT03493048|Cetuximab|cetuximab|mesh-list
154452244|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
154452245|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452246|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452247|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452248|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154452249|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
154452250|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452251|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154452252|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154452253|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452254|NCT03493048|Antidotes|antidotes|mesh-ancestor
154452255|NCT03493048|Protective Agents|protective agents|mesh-ancestor
154452256|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
154452257|NCT03493048|Vitamins|vitamins|mesh-ancestor
154452258|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
154452259|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452260|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154452261|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
154452262|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452263|NCT03433001|Dexamethasone|dexamethasone|mesh-list
154452264|NCT03433001|Lenalidomide|lenalidomide|mesh-list
154452265|NCT03433001|Ixazomib|ixazomib|mesh-list
154452266|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452267|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
154452268|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
154452269|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452270|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452271|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154452272|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
154452273|NCT03433001|Hormones|hormones|mesh-ancestor
154452274|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154452275|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154452276|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452277|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
154452278|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154452279|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154452280|NCT03433001|Growth Substances|growth substances|mesh-ancestor
154452281|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
154452282|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
154452283|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452284|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452285|NCT03314935|Leucovorin|leucovorin|mesh-list
154452286|NCT03314935|Paclitaxel|paclitaxel|mesh-list
154452287|NCT03314935|Gemcitabine|gemcitabine|mesh-list
154452288|NCT03314935|Fluorouracil|fluorouracil|mesh-list
154860526|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452289|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
154452290|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154452291|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452292|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
154452293|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
154452294|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
154452295|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452296|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452297|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
154452298|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154452299|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
154452300|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452301|NCT03314935|Antidotes|antidotes|mesh-ancestor
154452302|NCT03314935|Protective Agents|protective agents|mesh-ancestor
154452303|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
154452304|NCT03314935|Vitamins|vitamins|mesh-ancestor
154452305|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
154452306|NCT03181100|Paclitaxel|paclitaxel|mesh-list
154452307|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154452308|NCT03181100|Bevacizumab|bevacizumab|mesh-list
154452309|NCT03181100|Atezolizumab|atezolizumab|mesh-list
154452310|NCT03181100|Vemurafenib|vemurafenib|mesh-list
154452311|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154452312|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
154452313|NCT03181100|Antibodies|antibodies|mesh-list
154452314|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
154452315|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154452316|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
154452317|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154452318|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452319|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
154452320|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
154452321|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
154452322|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452323|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154452324|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154452325|NCT03181100|Growth Substances|growth substances|mesh-ancestor
154452326|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452327|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
154452328|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
154452329|NCT03181100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154452330|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452331|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452332|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
154452333|NCT03171818|Hematinics|hematinics|mesh-ancestor
154452334|NCT03169361|Ixazomib|ixazomib|mesh-list
154452335|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452336|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
154452337|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452338|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452339|NCT03101748|Paclitaxel|paclitaxel|mesh-list
154452340|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
154452341|NCT03101748|Doxorubicin|doxorubicin|mesh-list
154452342|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154452343|NCT03101748|Trastuzumab|trastuzumab|mesh-list
154452344|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154452345|NCT03101748|Daunorubicin|daunorubicin|mesh-list
154452346|NCT03101748|Pertuzumab|pertuzumab|mesh-list
154452347|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154452348|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154452349|NCT03101748|Antibodies|antibodies|mesh-list
154452350|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
154452351|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154452352|NCT03101748|Neratinib|neratinib|mesh-list
154452353|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154452354|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621441|NCT01998685|Narcotics|narcotics|mesh-ancestor
154452355|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
154452356|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
154452357|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
154452358|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452359|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154452360|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
154452361|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452362|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452363|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154452364|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
154452365|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154452366|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154452367|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154452368|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154452369|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452370|NCT03101748|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154452371|NCT03101748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452372|NCT02831764|Tenofovir|tenofovir|mesh-list
154452373|NCT02831764|Lamivudine|lamivudine|mesh-list
154452374|NCT02831764|Emtricitabine|emtricitabine|mesh-list
154452375|NCT02831764|Dolutegravir|dolutegravir|mesh-list
154452376|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
154452377|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452378|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154452379|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154452380|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452381|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452382|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154452383|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154452384|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154452385|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154452386|NCT02754011|Capecitabine|capecitabine|mesh-list
154452387|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452388|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
154452389|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452390|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452391|NCT02530034|Antibodies|antibodies|mesh-list
154452392|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154452393|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
154452394|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452395|NCT02528175|Capecitabine|capecitabine|mesh-list
154452396|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452397|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
154452398|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452399|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452400|NCT02339532|Carboplatin|carboplatin|mesh-list
154452401|NCT02339532|Docetaxel|docetaxel|mesh-list
154452402|NCT02339532|Trastuzumab|trastuzumab|mesh-list
154452403|NCT02339532|Pertuzumab|pertuzumab|mesh-list
154452404|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452405|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
154452406|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
154452407|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
154452408|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452409|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452410|NCT02101944|Dexamethasone|dexamethasone|mesh-list
154452411|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
154452412|NCT02101944|Ichthammol|ichthammol|mesh-list
154452413|NCT02101944|BB 1101|bb 1101|mesh-list
154452414|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621549|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
153621550|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
153621570|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154452415|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
154452416|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
154452417|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452418|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452419|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154452420|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
154452421|NCT02101944|Hormones|hormones|mesh-ancestor
154452422|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154452423|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154452424|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452425|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
154452426|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452427|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452428|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
154452429|NCT02034981|Crizotinib|crizotinib|mesh-list
154452430|NCT02034981|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154452431|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452432|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452433|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452434|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452435|NCT02003222|Cytarabine|cytarabine|mesh-list
154452436|NCT02003222|Dexamethasone|dexamethasone|mesh-list
154452437|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
154452438|NCT02003222|Prednisone|prednisone|mesh-list
154452439|NCT02003222|Cortisone|cortisone|mesh-list
154452440|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
154452441|NCT02003222|Rituximab|rituximab|mesh-list
154452442|NCT02003222|Methotrexate|methotrexate|mesh-list
154452443|NCT02003222|Etoposide|etoposide|mesh-list
154452444|NCT02003222|Vincristine|vincristine|mesh-list
154860527|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154452445|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
154452446|NCT02003222|Daunorubicin|daunorubicin|mesh-list
154452447|NCT02003222|Asparaginase|asparaginase|mesh-list
154452448|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
154452449|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
154452450|NCT02003222|Pegaspargase|pegaspargase|mesh-list
154452451|NCT02003222|Blinatumomab|blinatumomab|mesh-list
154452452|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154452453|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
154452455|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
154452456|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154452457|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154452458|NCT02003222|BB 1101|bb 1101|mesh-list
154452459|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154452460|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
154452461|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452462|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452463|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154452464|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
154452465|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452466|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452467|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154452468|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452469|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
154452470|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
154452471|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452472|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154452473|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
154452474|NCT02003222|Hormones|hormones|mesh-ancestor
154452475|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154452476|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154452477|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
154452478|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452479|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154452480|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
154452481|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154452482|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452483|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
154452484|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
154452485|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154452486|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154452487|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154452488|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154452489|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154452490|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
154452491|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452492|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
154452493|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
154452494|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
154452495|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154452496|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
154452497|NCT01661881|Cytarabine|cytarabine|mesh-list
154452498|NCT01661881|Rituximab|rituximab|mesh-list
154452499|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154452500|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452501|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452502|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
154452503|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452504|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452505|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452506|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
154452507|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452508|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
154452509|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452510|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154452511|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154452512|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
154452513|NCT01582269|Lomustine|lomustine|mesh-list
154452514|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154452515|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
154452516|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452517|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452518|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
154452519|NCT01550003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154860528|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
154452520|NCT01550003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452521|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154452522|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
154452523|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452524|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452525|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
154452526|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452527|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
154452528|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154452529|NCT01209871|Antibodies|antibodies|mesh-list
154452530|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
154452531|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452532|NCT03487172|Mannitol|mannitol|mesh-list
154452533|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154452534|NCT03487172|Diuretics|diuretics|mesh-ancestor
154452535|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
154452536|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452537|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
154452538|NCT04995016|Axitinib|axitinib|mesh-list
154452539|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452540|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452541|NCT04995016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153621664|NCT02000414|Daptomycin|daptomycin|mesh-list
153621709|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452542|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452543|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452544|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452545|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
154452546|NCT04994860|Zamicastat|zamicastat|mesh-list
154452547|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
154452548|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154452549|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154452550|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452551|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452552|NCT04994860|Urological Agents|urological agents|mesh-ancestor
154452553|NCT03481400|Calcitonin|calcitonin|mesh-list
154452554|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
154452555|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154452556|NCT03481400|Katacalcin|katacalcin|mesh-list
154452557|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154452558|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452559|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154452560|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
154452561|NCT02851407|Defibrotide|defibrotide|mesh-list
154452562|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154452563|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154452564|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452565|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154452566|NCT02167854|Trastuzumab|trastuzumab|mesh-list
154452567|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452568|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452569|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154452570|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154452571|NCT02161614|Estradiol|estradiol|mesh-list
154452572|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154452573|NCT02161614|Estrogens|estrogens|mesh-ancestor
154452574|NCT02161614|Hormones|hormones|mesh-ancestor
154452575|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154452576|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452577|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154452578|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
154452579|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154452580|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154452581|NCT04994626|Rituximab|rituximab|mesh-list
154452582|NCT04994626|Ibrutinib|ibrutinib|mesh-list
154452583|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452584|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452585|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
154452586|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452587|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452588|NCT04994626|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154452589|NCT04994626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452590|NCT04994626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452591|NCT04994626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452592|NCT02168010|Neurotropin|neurotropin|mesh-list
154452593|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154452594|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
154452595|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452596|NCT02168010|Analgesics|analgesics|mesh-ancestor
154452597|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
154452598|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452599|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
154452600|NCT04994314|Fluorides|fluorides|mesh-list
154452601|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452602|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
154452603|NCT04994314|Protective Agents|protective agents|mesh-ancestor
154452604|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
154452605|NCT02161692|Carboplatin|carboplatin|mesh-list
154452606|NCT02161692|Etoposide|etoposide|mesh-list
154452607|NCT02161692|Bleomycin|bleomycin|mesh-list
154452608|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154452609|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
154452610|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452611|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452612|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154452613|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
154452614|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452615|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452616|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154452617|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154452618|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154452619|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154452620|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452621|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154452622|NCT02746575|Metoprolol|metoprolol|mesh-list
154452623|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154452624|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154452625|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
154452626|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
154452627|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452628|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452629|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154452630|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154452631|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154452632|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
154452633|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452634|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452635|NCT02161770|Osimertinib|osimertinib|mesh-list
154452636|NCT02161770|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154452637|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452638|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452639|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452640|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452641|NCT03604575|Insulin|insulin|mesh-list
154452642|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154452643|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
154452644|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154452645|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452646|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
154452647|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154452648|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
154452649|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452650|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452651|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154452652|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
154452653|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154452654|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
154452655|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452656|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452657|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154452658|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
154452659|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
154452660|NCT04988932|Protective Agents|protective agents|mesh-ancestor
154452661|NCT03625466|Ivacaftor|ivacaftor|mesh-list
154452662|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154452663|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154452664|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452665|NCT03604419|Metformin|metformin|mesh-list
154452666|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154452667|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452668|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154860529|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154452670|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
154452671|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
154027307|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154452672|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452673|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452674|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
154452675|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452676|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154452677|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154452678|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154452679|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452680|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154452681|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
154452682|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154452683|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154452684|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
154452685|NCT02164812|Efavirenz|efavirenz|mesh-list
154452686|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154452687|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452688|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154452689|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154452690|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452691|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452692|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452693|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154452694|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154452695|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
154452696|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154452697|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154452698|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154452699|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154452700|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154452701|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154452702|NCT04988776|Bupivacaine|bupivacaine|mesh-list
154452703|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
154452704|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
154452705|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452706|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452707|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
154452708|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452709|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
154452710|NCT02853123|Olodaterol|olodaterol|mesh-list
154452711|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154452712|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
154452713|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452714|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452715|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154452716|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
154452717|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
154452718|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154452719|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
154452720|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452721|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452722|NCT02255370|Curcumin|curcumin|mesh-list
154452723|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154452724|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154452725|NCT02255370|Analgesics|analgesics|mesh-ancestor
154452726|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
154452727|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452728|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452729|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452730|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452731|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452732|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452733|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452734|NCT04984408|Vaccines|vaccines|mesh-list
154452735|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
154452736|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452737|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
154452738|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154452739|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154080847|NCT05421416|Loratadine|loratadine|mesh-list
154860530|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154452740|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452741|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
154452742|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452743|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452744|NCT04459676|Mitogens|mitogens|mesh-list
154452745|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
154452746|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452747|NCT02164890|Micafungin|micafungin|mesh-list
154452748|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
154452749|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452750|NCT02634346|Olanzapine|olanzapine|mesh-list
154452751|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
154452752|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
154452753|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452754|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452755|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154452756|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154452757|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154452758|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452759|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154452760|NCT02634346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154452761|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154452762|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154452763|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452764|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452765|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
154452766|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
154452767|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154452768|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154452769|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452770|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
154452771|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452772|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452773|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
154452774|NCT00812240|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154452775|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452776|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452777|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452778|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452779|NCT02165046|Budesonide|budesonide|mesh-list
154452780|NCT02165046|Procaterol|procaterol|mesh-list
154452781|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452782|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154452783|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
154452784|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452785|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452786|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154452787|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
154452788|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
154452789|NCT02165046|Hormones|hormones|mesh-ancestor
154452790|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154452791|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
154452792|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154452793|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154452794|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154452795|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
153622031|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154452796|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452797|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452798|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154452799|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
154452800|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154452801|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452802|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154452803|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452804|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154452805|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154452806|NCT03070678|Analgesics|analgesics|mesh-ancestor
154452807|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
154452808|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452809|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452811|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154452812|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452813|NCT00101166|Vaccines|vaccines|mesh-list
154452814|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
154452815|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452816|NCT04994236|Leucovorin|leucovorin|mesh-list
154452817|NCT04994236|Fluorouracil|fluorouracil|mesh-list
154452818|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
154452819|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
154452820|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452821|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452822|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452823|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154452824|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
154452825|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452826|NCT04994236|Antidotes|antidotes|mesh-ancestor
154452827|NCT04994236|Protective Agents|protective agents|mesh-ancestor
154452828|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
154452829|NCT04994236|Vitamins|vitamins|mesh-ancestor
154452830|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
154452831|NCT03601611|Prednisolone|prednisolone|mesh-list
154452832|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452833|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
154452834|NCT03601611|Hormones|hormones|mesh-ancestor
154452835|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154452836|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622058|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
154452837|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154452838|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452839|NCT03597945|Lidocaine|lidocaine|mesh-list
154452840|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
154452841|NCT03597945|Epinephrine|epinephrine|mesh-list
154452842|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
154452843|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
154452844|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452845|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452846|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
154452847|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452848|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154452849|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154452850|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154452851|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154452852|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452853|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154452854|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154452855|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154452856|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452857|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154452858|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154452859|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
154452860|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154452861|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
154452862|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
154452863|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
154452864|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154452865|NCT03597945|Analgesics|analgesics|mesh-ancestor
154452866|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
154452867|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154452868|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154452869|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
154452870|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154452871|NCT03601533|Phenol|phenol|mesh-list
154452872|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154452873|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452874|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
154452875|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154452876|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154452877|NCT03486626|Metformin|metformin|mesh-list
154452878|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154452879|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452880|NCT04983550|Doxorubicin|doxorubicin|mesh-list
154452881|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154452882|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154452883|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452884|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154452885|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154452886|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452887|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452889|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154452890|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154452891|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
154452892|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452893|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154452894|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154452895|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452896|NCT05153486|Ethanol|ethanol|mesh-list
154452897|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154452898|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452899|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452900|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452901|NCT03136263|Oxytocin|oxytocin|mesh-list
154452902|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
154452903|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154452904|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452905|NCT03486548|Dexamethasone|dexamethasone|mesh-list
154452906|NCT03486548|Lidocaine|lidocaine|mesh-list
154452907|NCT03486548|Bupivacaine|bupivacaine|mesh-list
154452908|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154452909|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
154452910|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
154452911|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452912|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452913|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154452914|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
154452915|NCT03486548|Hormones|hormones|mesh-ancestor
154452916|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154452917|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154452918|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452919|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
154452920|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
154452921|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452922|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
154452923|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154452924|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154452925|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154452926|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154452927|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452928|NCT04983160|Allopurinol|allopurinol|mesh-list
154452929|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
154452930|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452931|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452932|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
154452933|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154452934|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154452935|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
154452936|NCT04983160|Protective Agents|protective agents|mesh-ancestor
154452937|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452938|NCT02759016|BI 836826|bi 836826|mesh-list
154452939|NCT02759016|Ibrutinib|ibrutinib|mesh-list
154452940|NCT02759016|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154452941|NCT02759016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452942|NCT02759016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452943|NCT02759016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452944|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154452945|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154452946|NCT02852967|Belumosudil|belumosudil|mesh-list
154452947|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452948|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452949|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452950|NCT02169180|Ibrutinib|ibrutinib|mesh-list
154452951|NCT02169180|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154452952|NCT02169180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154452953|NCT02169180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154452954|NCT02169180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452955|NCT03593044|Atropine|atropine|mesh-list
154452956|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154452957|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154452958|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154452959|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
154081062|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
154452960|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452961|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452962|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154452963|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
154452964|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
154452965|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
154452966|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154176839|NCT00849329|Lapatinib|lapatinib|mesh-list
154452967|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154452968|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
154452969|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452970|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452971|NCT03597087|Anesthetics|anesthetics|mesh-list
154452972|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452973|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452974|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
154452975|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154452976|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
154452977|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154452978|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154452979|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452980|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154452981|NCT03596775|Analgesics|analgesics|mesh-ancestor
154452982|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
154452983|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154452984|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154452985|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154452986|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154452987|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
154452988|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154452989|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154452990|NCT03066466|Methotrexate|methotrexate|mesh-list
154452991|NCT03066466|Atorvastatin|atorvastatin|mesh-list
154452992|NCT03066466|Tacrolimus|tacrolimus|mesh-list
154452993|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154452994|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
154452995|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154452996|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154452997|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154452998|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
154452999|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453000|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453001|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
154453002|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453003|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154453004|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154453005|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
154453006|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154453007|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154453008|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154453009|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154453010|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154453011|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154453012|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154453013|NCT03603249|Trimetazidine|trimetazidine|mesh-list
154453014|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
154453015|NCT03068260|Acetaminophen|acetaminophen|mesh-list
154453016|NCT03068260|Ibuprofen|ibuprofen|mesh-list
154453017|NCT03068260|Morphine|morphine|mesh-list
154453018|NCT03068260|Ropivacaine|ropivacaine|mesh-list
154453019|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154453020|NCT03068260|Narcotics|narcotics|mesh-ancestor
154453021|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453022|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453023|NCT03068260|Analgesics|analgesics|mesh-ancestor
154453024|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
154453025|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453026|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
154453027|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
154453028|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154453029|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
154453030|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154453031|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154453032|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154453033|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154453034|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453035|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453036|NCT02237859|Vancomycin|vancomycin|mesh-list
154453037|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154453038|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453039|NCT03594825|Valsartan|valsartan|mesh-list
154453040|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154453041|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154453042|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154453043|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453044|NCT02162550|Exenatide|exenatide|mesh-list
154453045|NCT02162550|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154453046|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154453047|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453048|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154453049|NCT02162550|Incretins|incretins|mesh-ancestor
154453050|NCT02162550|Hormones|hormones|mesh-ancestor
154453051|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453052|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
154453053|NCT02852265|Etonogestrel|etonogestrel|mesh-list
154453054|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453055|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453056|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154453057|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154453058|NCT02162784|Budesonide|budesonide|mesh-list
154453059|NCT02162784|Albuterol|albuterol|mesh-list
154453060|NCT02162784|Procaterol|procaterol|mesh-list
154453061|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154453062|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154453063|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
154453064|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453065|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453066|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453067|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453068|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
154453069|NCT02162784|Hormones|hormones|mesh-ancestor
154453070|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453071|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
154453072|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453073|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154453074|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154453075|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154453076|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
154453077|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453078|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453079|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
154453080|NCT03539718|Taurolidine|taurolidine|mesh-list
154453081|NCT03539718|Heparin|heparin|mesh-list
154453082|NCT03539718|Calcium heparin|calcium heparin|mesh-list
154453083|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
154453084|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154453085|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154453086|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453087|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453088|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154453089|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453090|NCT02166450|Nystatin|nystatin|mesh-list
154453091|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154453092|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453093|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
154453094|NCT02166450|Ionophores|ionophores|mesh-ancestor
154453095|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154453096|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453097|NCT03600363|Metformin|metformin|mesh-list
154453098|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154453099|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453100|NCT03600129|Ropivacaine|ropivacaine|mesh-list
154453101|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
154453102|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
154453103|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453104|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453105|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
154453106|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453107|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
154453108|NCT02169570|Vitamin D|vitamin d|mesh-list
154453109|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
154453110|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
154453112|NCT02169570|Calcium|calcium|mesh-list
154453113|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
154453114|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453115|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154453116|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154453117|NCT02169648|Ranibizumab|ranibizumab|mesh-list
154453118|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154453119|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154453120|NCT02169648|Growth Substances|growth substances|mesh-ancestor
154453121|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453122|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
154453123|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453124|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154453125|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453126|NCT02170896|Pantoprazole|pantoprazole|mesh-list
154453127|NCT02170896|Dabigatran|dabigatran|mesh-list
154453128|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154453129|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154453130|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154453131|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453132|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453133|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
154453134|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453135|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453136|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
154453137|NCT03594513|Dipyrone|dipyrone|mesh-list
154453138|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
154453139|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154453140|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453141|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
154453142|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154453143|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154453144|NCT03594513|Analgesics|analgesics|mesh-ancestor
154453145|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
154453146|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453147|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453148|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154453149|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154453150|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
154453151|NCT02633800|Carboplatin|carboplatin|mesh-list
154453152|NCT02633800|Cetuximab|cetuximab|mesh-list
154453153|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453154|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453155|NCT02169804|Enclomiphene|enclomiphene|mesh-list
154453156|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154453157|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
154453158|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453159|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453160|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154453161|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
154453162|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453163|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154453164|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154453165|NCT02170974|Dabigatran|dabigatran|mesh-list
154453166|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
154453167|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453168|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453169|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622416|NCT02005575|Dexamethasone|dexamethasone|mesh-list
154453170|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453171|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
154453172|NCT02174718|Vitamin D|vitamin d|mesh-list
154453173|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
154453174|NCT02174718|Vitamins|vitamins|mesh-ancestor
154453175|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
154453176|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453177|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154453178|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154453179|NCT02238171|Ipratropium|ipratropium|mesh-list
154453180|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154453181|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
154453182|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453183|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453184|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453185|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453186|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154453187|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
154453188|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453189|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453190|NCT02169882|Rifampin|rifampin|mesh-list
154453191|NCT02169882|Dexamethasone|dexamethasone|mesh-list
154453192|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154453193|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
154453194|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
154453195|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453196|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453197|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154453198|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
154453199|NCT02169882|Hormones|hormones|mesh-ancestor
154453200|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453201|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154453202|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453203|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154453204|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
154453205|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154453206|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453207|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
154453208|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154453209|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453210|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453211|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154453212|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154453213|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154453214|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154453215|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154453216|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154453217|NCT03602547|Vorolanib|vorolanib|mesh-list
154453218|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154453219|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453220|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453221|NCT03602469|Bupivacaine|bupivacaine|mesh-list
154453222|NCT03602469|Propofol|propofol|mesh-list
154453223|NCT03602469|Sevoflurane|sevoflurane|mesh-list
154453224|NCT03602469|Rocuronium|rocuronium|mesh-list
154453225|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
154453226|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
154453227|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453228|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453229|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
154453230|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453231|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154453232|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154453233|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
154453234|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154453235|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154453236|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154453237|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154453238|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154453239|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154453240|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154453241|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154453242|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
154453243|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453244|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453245|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154453246|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154453247|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154453248|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154453249|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154453250|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154453251|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154453252|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154453253|NCT05001373|Vaccines|vaccines|mesh-list
154453254|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
154453255|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453256|NCT02171052|Digoxin|digoxin|mesh-list
154453257|NCT02171052|Dabigatran|dabigatran|mesh-list
154453258|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
154453259|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453260|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453261|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453262|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453263|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
154453264|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154453265|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154453266|NCT02171052|Protective Agents|protective agents|mesh-ancestor
154453267|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453269|NCT03591549|Goserelin|goserelin|mesh-list
154453270|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154453271|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453272|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154453273|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154453274|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
154453275|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453276|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453277|NCT02261220|Durvalumab|durvalumab|mesh-list
154453278|NCT02261220|Tremelimumab|tremelimumab|mesh-list
154453279|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453280|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453281|NCT02237937|Amitriptyline|amitriptyline|mesh-list
154453282|NCT02237937|Citalopram|citalopram|mesh-list
154453283|NCT02237937|Paroxetine|paroxetine|mesh-list
154453284|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154453285|NCT02237937|Sertraline|sertraline|mesh-list
154453286|NCT02237937|Nortriptyline|nortriptyline|mesh-list
154453287|NCT02237937|Trimipramine|trimipramine|mesh-list
154453288|NCT02237937|Escitalopram|escitalopram|mesh-list
154453289|NCT02237937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154453290|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154453291|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154453292|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453293|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453294|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
154453295|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453296|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453297|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154453298|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
154453299|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154453300|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154453301|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154453302|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453303|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154453304|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154453305|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154453306|NCT02237937|Analgesics|analgesics|mesh-ancestor
154453307|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
154453308|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154453309|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
154453310|NCT02170116|Dabigatran|dabigatran|mesh-list
154453311|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
154453312|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453313|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453314|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453315|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453316|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
154453317|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154453318|NCT03539562|Promethazine|promethazine|mesh-list
154453319|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
154453320|NCT03539562|Morphine|morphine|mesh-list
154453321|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154453322|NCT03539562|Narcotics|narcotics|mesh-ancestor
154453323|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453324|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453325|NCT03539562|Analgesics|analgesics|mesh-ancestor
154453326|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
154453327|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453328|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
154453329|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
154453330|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154453331|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
154453332|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
154453333|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453334|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453336|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154453337|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154453338|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
154453339|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
154453340|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
154453341|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
154453342|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154453344|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154453345|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453346|NCT00394069|Montelukast|montelukast|mesh-list
154453347|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453348|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453349|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154453350|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
154453351|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453352|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453353|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154453354|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154453355|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453356|NCT03598959|Tofacitinib|tofacitinib|mesh-list
154453357|NCT03598959|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154453358|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154453359|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453360|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453361|NCT02238717|Pregabalin|pregabalin|mesh-list
154453362|NCT02238717|PF-06372865|pf-06372865|mesh-list
154453363|NCT02238717|Analgesics|analgesics|mesh-ancestor
154453364|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
154453365|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453366|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453367|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
154453368|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154453369|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154453370|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453371|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154453372|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154453373|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154453374|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453375|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154453376|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
154453377|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
154453378|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453379|NCT03470311|Benralizumab|benralizumab|mesh-list
154453380|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453381|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453382|NCT03580005|Methylphenidate|methylphenidate|mesh-list
154453383|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154453384|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453385|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154453386|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154453387|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154453388|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453389|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
154453390|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453391|NCT03579927|Cytarabine|cytarabine|mesh-list
154453392|NCT03579927|Rituximab|rituximab|mesh-list
154453393|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154453394|NCT03579927|Etoposide|etoposide|mesh-list
154453395|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
154453396|NCT03579927|Melphalan|melphalan|mesh-list
154453397|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
154453398|NCT03579927|Carmustine|carmustine|mesh-list
154453399|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
154453400|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154453401|NCT03579927|Antibodies|antibodies|mesh-list
154453402|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
154453403|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154453404|NCT03579927|Lenograstim|lenograstim|mesh-list
154453405|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
154453406|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453407|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453408|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154453409|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154081508|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
154453410|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154453411|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154453412|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453413|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453414|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154453415|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
154453416|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
154453417|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453418|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154453419|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154453420|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154453421|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
154453422|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154453423|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
154453424|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
154453425|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
154453426|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
154453427|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
154453429|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154453430|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
154453431|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154453432|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154453433|NCT03587025|Analgesics|analgesics|mesh-ancestor
154453434|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
154453435|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453436|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453437|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154453438|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154453439|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154453440|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453441|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
154453442|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453443|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154453444|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
154453445|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154453446|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
154453447|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453448|NCT00140881|Montelukast|montelukast|mesh-list
154453449|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453450|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453451|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154453452|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
154453453|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453454|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453455|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154453456|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154453457|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453458|NCT02848833|Empagliflozin|empagliflozin|mesh-list
154453459|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154453460|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453461|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154453462|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453463|NCT03539328|Paclitaxel|paclitaxel|mesh-list
154453464|NCT03539328|Gemcitabine|gemcitabine|mesh-list
154453465|NCT03539328|Doxorubicin|doxorubicin|mesh-list
154453466|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154453467|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
154453468|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154453469|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453470|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
154453471|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
154453472|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
154453473|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453474|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154453475|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
154453476|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154453477|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154453478|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154453479|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453480|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453481|NCT03539328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154453482|NCT00111709|Rizatriptan|rizatriptan|mesh-list
154860531|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154860532|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154453484|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453485|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453486|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154453487|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
154453488|NCT02171442|Dabigatran|dabigatran|mesh-list
154453489|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
154453490|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453491|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453492|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453493|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453494|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
154453495|NCT02035527|Docetaxel|docetaxel|mesh-list
154453496|NCT02035527|Sorafenib|sorafenib|mesh-list
153622975|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153622976|NCT05694637|Varenicline|varenicline|mesh-list
154453497|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453498|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
154453499|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
154453500|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
154453501|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453502|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154453503|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453504|NCT00092131|Montelukast|montelukast|mesh-list
154453505|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453506|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453507|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154453508|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
154453509|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453510|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453511|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154453512|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154453513|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453514|NCT02170584|Dabigatran|dabigatran|mesh-list
154453515|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
154453516|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453517|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453518|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453519|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453520|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
154453521|NCT03577977|Interferons|interferons|mesh-list
154453522|NCT03577977|Interferon-beta|interferon-beta|mesh-list
154453523|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
154453524|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453525|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
154453526|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453527|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
154453528|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453529|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154453530|NCT02668783|Ibuprofen|ibuprofen|mesh-list
154453531|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154453532|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154453533|NCT02668783|Etonogestrel|etonogestrel|mesh-list
154453534|NCT02668783|Estradiol|estradiol|mesh-list
154453535|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154453536|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154453537|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154453538|NCT02668783|Analgesics|analgesics|mesh-ancestor
154453539|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
154453540|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453541|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453542|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154453543|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154453544|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154453545|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453546|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453547|NCT02668783|Estrogens|estrogens|mesh-ancestor
154453548|NCT02668783|Hormones|hormones|mesh-ancestor
154453549|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453550|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154453551|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
154453552|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453553|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154453554|NCT03577899|Aflibercept|aflibercept|mesh-list
154453555|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154453556|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154453557|NCT03577899|Growth Substances|growth substances|mesh-ancestor
154453558|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453559|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
154453560|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453562|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154453563|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
154177437|NCT00796068|Fludarabine|fludarabine|mesh-list
154453564|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453565|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453566|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453567|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453568|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
154453569|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154453570|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
154453571|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453572|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453573|NCT02171520|Dabigatran|dabigatran|mesh-list
154453574|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
154453575|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453576|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453577|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453578|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453579|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
154453580|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
154453581|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154453582|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453583|NCT00101010|Prednisone|prednisone|mesh-list
154453584|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
154453585|NCT00101010|Rituximab|rituximab|mesh-list
154453586|NCT00101010|Doxorubicin|doxorubicin|mesh-list
154453587|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154453588|NCT00101010|Vincristine|vincristine|mesh-list
154453589|NCT00101010|Lenograstim|lenograstim|mesh-list
154453590|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154453591|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
154453592|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453593|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154453594|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154453595|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
154453596|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453597|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453598|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154453599|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453600|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154453601|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153623180|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453602|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154453603|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453604|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154453605|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
154453606|NCT00101010|Hormones|hormones|mesh-ancestor
154453607|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453608|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154453609|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154453610|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154453611|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
154453612|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154453613|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154453614|NCT03539172|Apatinib|apatinib|mesh-list
154453615|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453616|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154453617|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453618|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453619|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
154453620|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
154453621|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453622|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154453623|NCT02170740|Pantoprazole|pantoprazole|mesh-list
154453624|NCT02170740|Dabigatran|dabigatran|mesh-list
154453625|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154453626|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154453627|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154453628|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453629|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860533|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860534|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
154860535|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860536|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860537|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154860538|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860539|NCT00986258|Tapentadol|tapentadol|mesh-list
154453630|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
154453631|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453632|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453633|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
154453634|NCT02848599|Morphine|morphine|mesh-list
154453635|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
154453636|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154453637|NCT02848599|Narcotics|narcotics|mesh-ancestor
154177513|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154453638|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453639|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453640|NCT02848599|Analgesics|analgesics|mesh-ancestor
154453641|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
154453642|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453643|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
154453644|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
154453645|NCT02171598|Dabigatran|dabigatran|mesh-list
154453646|NCT02171598|Clopidogrel|clopidogrel|mesh-list
154453647|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154453648|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154453649|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154453650|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154453651|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
154453652|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453653|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453654|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453655|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
154453656|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154453657|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453658|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453659|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
154453660|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154453661|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453662|NCT02171676|Docetaxel|docetaxel|mesh-list
154453663|NCT02171676|Afatinib|afatinib|mesh-list
154453664|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453665|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
154453666|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
154453667|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
154453668|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453669|NCT02171676|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154453670|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154453671|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453672|NCT03577743|Bevacizumab|bevacizumab|mesh-list
154453673|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453674|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453675|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154453676|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154453677|NCT03577743|Growth Substances|growth substances|mesh-ancestor
154453678|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453679|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
154453680|NCT04794790|Buprenorphine|buprenorphine|mesh-list
154453681|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154453682|NCT04794790|Naloxone|naloxone|mesh-list
154453683|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154453684|NCT04794790|Narcotics|narcotics|mesh-ancestor
154453685|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453686|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453687|NCT04794790|Analgesics|analgesics|mesh-ancestor
154453688|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
154453689|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453690|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154453691|NCT02171754|Ritonavir|ritonavir|mesh-list
154453692|NCT02171754|Afatinib|afatinib|mesh-list
154453693|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154453694|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154453695|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453696|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453697|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860540|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154453698|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154453699|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154453700|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
154453701|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453702|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154453703|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154453704|NCT02171754|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154453705|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154453706|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453707|NCT02171832|Olodaterol|olodaterol|mesh-list
154453708|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154453709|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
154453710|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453711|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453712|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453713|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453714|NCT02171910|Doxapram|doxapram|mesh-list
154453715|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154453716|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453717|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453718|NCT02178306|Telmisartan|telmisartan|mesh-list
154453719|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154453720|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154453721|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154453722|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453723|NCT05729386|Metformin|metformin|mesh-list
154453724|NCT05729386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154453725|NCT05729386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453726|NCT05729308|Anesthetics|anesthetics|mesh-list
154453727|NCT05729308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453728|NCT05729308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453729|NCT00778999|Desogestrel|desogestrel|mesh-list
154453730|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154453731|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154453732|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154453733|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
154453734|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453735|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453736|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154453737|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154453738|NCT00778999|Progestins|progestins|mesh-ancestor
154453739|NCT00778999|Hormones|hormones|mesh-ancestor
154453740|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453741|NCT02171988|Propranolol|propranolol|mesh-list
154453742|NCT02171988|Bisoprolol|bisoprolol|mesh-list
154453743|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154453744|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154453745|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154453746|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
154453747|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453748|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453749|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453750|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154453751|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154453752|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
154453753|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
154453754|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
154453755|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453756|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154453757|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154453758|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453759|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
154453760|NCT00725413|Etonogestrel|etonogestrel|mesh-list
154453761|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154453762|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
154453763|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453764|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453765|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154453766|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154453767|NCT00103038|Hematinics|hematinics|mesh-ancestor
154453768|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154453769|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154860541|NCT00986258|Narcotics|narcotics|mesh-ancestor
154453770|NCT00620035|Etonogestrel|etonogestrel|mesh-list
154453771|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154453772|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
154453773|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453774|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453775|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154453776|NCT02175888|Iron|iron|mesh-list
154453777|NCT02175888|Trace Elements|trace elements|mesh-ancestor
154453778|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
154453779|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453780|NCT05577637|Tacrolimus|tacrolimus|mesh-list
154453781|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154453782|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
154453783|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453784|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154453785|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453786|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453787|NCT02176044|Nitroprusside|nitroprusside|mesh-list
154453788|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154453789|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
153623414|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154453790|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154453791|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453792|NCT02176122|Meropenem|meropenem|mesh-list
154453793|NCT02176122|Tazobactam|tazobactam|mesh-list
154453794|NCT02176122|Piperacillin|piperacillin|mesh-list
154453795|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154453796|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154453797|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453798|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154453799|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453800|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453801|NCT04887064|Sotorasib|sotorasib|mesh-list
154453802|NCT04887064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154453803|NCT04887064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453804|NCT04887064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453805|NCT04887064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453806|NCT02967757|Liraglutide|liraglutide|mesh-list
154453807|NCT02967757|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154453808|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154453809|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453810|NCT02967757|Incretins|incretins|mesh-ancestor
154453811|NCT02967757|Hormones|hormones|mesh-ancestor
154453812|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453813|NCT02261298|Nivolumab|nivolumab|mesh-list
154453814|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453815|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453816|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154453817|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453818|NCT02176200|Fenoterol|fenoterol|mesh-list
154453819|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154453820|NCT02176200|Ipratropium|ipratropium|mesh-list
154453821|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154453822|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
154453823|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453824|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453825|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453826|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453827|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
154453828|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
154453829|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154453830|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154453831|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154453832|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154453833|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
154453834|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453835|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453836|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154453837|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
154453838|NCT03537612|Clonidine|clonidine|mesh-list
154453839|NCT03537612|Morphine|morphine|mesh-list
154453840|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154453841|NCT03537612|Narcotics|narcotics|mesh-ancestor
154453842|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154453843|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453844|NCT03537612|Analgesics|analgesics|mesh-ancestor
154453845|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
154453846|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453847|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154453848|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
154453849|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
154453850|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154453851|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154453852|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154453853|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154453854|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453855|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453856|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
154453857|NCT02172144|Olodaterol|olodaterol|mesh-list
154453858|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154453859|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453860|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154453861|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154177741|NCT00864305|Gabapentin|gabapentin|mesh-list
154453862|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453863|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453864|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623467|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453865|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453866|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154453868|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453869|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154453870|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
154453871|NCT05729074|Pimecrolimus|pimecrolimus|mesh-list
154453872|NCT05729074|Varespladib methyl|varespladib methyl|mesh-list
154453873|NCT05729074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154453874|NCT05729074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154453875|NCT05729074|Analgesics|analgesics|mesh-ancestor
154453876|NCT05729074|Sensory System Agents|sensory system agents|mesh-ancestor
154453877|NCT05729074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154453878|NCT05729074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453879|NCT05729074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154453880|NCT05729074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154453881|NCT05729074|Dermatologic Agents|dermatologic agents|mesh-ancestor
154453882|NCT05729074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154453883|NCT05729074|Immunologic Factors|immunologic factors|mesh-ancestor
154453884|NCT05729074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154453885|NCT05729074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453886|NCT05729074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453887|NCT05729074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154453888|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154453889|NCT02176512|Telmisartan|telmisartan|mesh-list
154453890|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154453891|NCT02176512|Diuretics|diuretics|mesh-ancestor
154453892|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
154453893|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453894|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154453895|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154453896|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453897|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154453898|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154453899|NCT03068650|Rindopepimut|rindopepimut|mesh-list
154453900|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453901|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453902|NCT02757768|Tamsulosin|tamsulosin|mesh-list
154453903|NCT02757768|Mirabegron|mirabegron|mesh-list
154453904|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154453905|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153623572|NCT04473664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453906|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154453907|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
154453908|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154453909|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453910|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453911|NCT02757768|Urological Agents|urological agents|mesh-ancestor
154453912|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154453913|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154453914|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154453915|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
154453916|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
154453917|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
154860542|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860543|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453918|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453919|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
154453920|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453921|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453922|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
154453923|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154453924|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453925|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154453926|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453927|NCT03067792|Leucovorin|leucovorin|mesh-list
154453928|NCT03067792|Docetaxel|docetaxel|mesh-list
154453929|NCT03067792|Fluorouracil|fluorouracil|mesh-list
154453930|NCT03067792|Irinotecan|irinotecan|mesh-list
154453931|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453932|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
154453933|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
154453934|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
154177816|NCT04137120|Aflibercept|aflibercept|mesh-list
154453935|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453936|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
154453937|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154453938|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154453939|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
154453940|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453941|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154453942|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154453943|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453944|NCT03067792|Antidotes|antidotes|mesh-ancestor
154453945|NCT03067792|Protective Agents|protective agents|mesh-ancestor
154453946|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
154453947|NCT03067792|Vitamins|vitamins|mesh-ancestor
154453948|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
154453949|NCT05224999|Nivolumab|nivolumab|mesh-list
154453950|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154453951|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453952|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154453953|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453954|NCT03066154|Ritonavir|ritonavir|mesh-list
154453955|NCT03066154|Docetaxel|docetaxel|mesh-list
154453956|NCT03066154|Androgens|androgens|mesh-list
154453957|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453958|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
154453959|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
154453960|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
154453961|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453962|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154453963|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154453964|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
154453965|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453966|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154453967|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154453968|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
154453969|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453970|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154453971|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154453972|NCT03066154|Hormones|hormones|mesh-ancestor
154453973|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453974|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453975|NCT05224687|Daptomycin|daptomycin|mesh-list
154453976|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154453977|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453978|NCT02753946|Tazobactam|tazobactam|mesh-list
154453979|NCT02753946|Piperacillin|piperacillin|mesh-list
154453980|NCT02753946|Fosfomycin|fosfomycin|mesh-list
154453981|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154453982|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154453983|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154453984|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154453985|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154453986|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154453987|NCT00431431|Tibolone|tibolone|mesh-list
154453988|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
154453989|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
154453990|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154453991|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154453992|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154453993|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154453994|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154453995|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153623675|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154453996|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
154453997|NCT00431431|Hormones|hormones|mesh-ancestor
154453998|NCT02172222|Linagliptin|linagliptin|mesh-list
154453999|NCT02172222|Empagliflozin|empagliflozin|mesh-list
154454000|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154454001|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454002|NCT02172222|Incretins|incretins|mesh-ancestor
154454003|NCT02172222|Hormones|hormones|mesh-ancestor
154454004|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454005|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154454006|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
154454007|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454008|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454009|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154454010|NCT03625219|Prednisone|prednisone|mesh-list
154454011|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454012|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
154454013|NCT03625219|Hormones|hormones|mesh-ancestor
154454014|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454015|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454016|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154454017|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454018|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
154454019|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154454020|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454021|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154454022|NCT02179008|Latanoprost|latanoprost|mesh-list
154454023|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154454024|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
154454025|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154454026|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
154454027|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454028|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454029|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154454030|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454031|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
154454032|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154454033|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
154454034|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454035|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454036|NCT05223907|Propofol|propofol|mesh-list
154454037|NCT05223907|Etomidate|etomidate|mesh-list
154454038|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154454039|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454040|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454041|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153623715|NCT04209296|Ketamine|ketamine|mesh-list
154454042|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
154454043|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
154454044|NCT03065998|Baclofen|baclofen|mesh-list
154454045|NCT03065998|Opipramol|opipramol|mesh-list
154454046|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154454047|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454048|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154454049|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454050|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154454051|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
154454052|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
154454053|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454054|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454055|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154454056|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
154454057|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154454058|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154454059|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154454060|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154454061|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
154454062|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
154454063|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154454064|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
154454065|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454066|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454067|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154454068|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454069|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
154454070|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154454071|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
154454072|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454073|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454074|NCT05728528|Factor VIII|factor viii|mesh-list
154454075|NCT05728528|Coagulants|coagulants|mesh-ancestor
154454076|NCT02256228|Ropivacaine|ropivacaine|mesh-list
154454077|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
154454078|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
154454079|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454080|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454081|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
154454082|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454083|NCT03067168|Bupivacaine|bupivacaine|mesh-list
154454084|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
154454085|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
153623790|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730638|NCT00134654|Hormones|hormones|mesh-ancestor
154454086|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623792|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154454087|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454088|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
154454089|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454090|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154454091|NCT04774237|Carbachol|carbachol|mesh-list
154454092|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154454093|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154454094|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154454095|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154454096|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
154454097|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454098|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454099|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454100|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154454101|NCT04774237|Miotics|miotics|mesh-ancestor
154454102|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
154454103|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454104|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154454105|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
154454106|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454107|NCT04774237|Analgesics|analgesics|mesh-ancestor
154454108|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
154454109|NCT04774237|Protective Agents|protective agents|mesh-ancestor
154454110|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
154454111|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154454112|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
154454113|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454114|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454115|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154454116|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454117|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
154454118|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154454119|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
154454120|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454121|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454122|NCT02172534|Bromides|bromides|mesh-list
154454123|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
154454124|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154454125|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
154454126|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454127|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454128|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154454129|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454130|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
154454131|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153623846|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154454132|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
154454133|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454134|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454135|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
154454136|NCT04713631|Artesunate|artesunate|mesh-list
154454137|NCT04713631|Curcumin|curcumin|mesh-list
154454138|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154454139|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454140|NCT04713631|Analgesics|analgesics|mesh-ancestor
154860544|NCT00986258|Analgesics|analgesics|mesh-ancestor
154454141|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
154454142|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454143|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454144|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454145|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454146|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454147|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454148|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454149|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
154454150|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154454151|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154454152|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454153|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
154454154|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
154454155|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154454156|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
154454157|NCT04459078|Apatinib|apatinib|mesh-list
154454158|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154454159|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454160|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154454161|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454162|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454163|NCT04459078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454164|NCT02756832|Alogliptin|alogliptin|mesh-list
154454165|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154454166|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454167|NCT02756832|Incretins|incretins|mesh-ancestor
154454168|NCT02756832|Hormones|hormones|mesh-ancestor
154454169|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454170|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154454171|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
154454172|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454173|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454174|NCT00108810|Ketoprofen|ketoprofen|mesh-list
154454175|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154454176|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454177|NCT00108810|Analgesics|analgesics|mesh-ancestor
154454178|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
154454179|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454180|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454181|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454182|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454183|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154454184|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454185|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454186|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
154454187|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154454188|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
154454189|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154454190|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
154454191|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454192|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454193|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
154454194|NCT02256150|Mizoribine|mizoribine|mesh-list
154454195|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
154454196|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154454197|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
154454198|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454199|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454200|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154454201|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
154454202|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454203|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454204|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154454205|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154454206|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454207|NCT02256150|Analgesics|analgesics|mesh-ancestor
153623931|NCT03859024|Acetaminophen|acetaminophen|mesh-list
154454208|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
154454209|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454210|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454211|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154454212|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454213|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154454214|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
154454215|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154454216|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154454217|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454219|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154454220|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
154454221|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454222|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454223|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154454224|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454225|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
154454226|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
154454227|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154454228|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154454229|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154454230|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154454231|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
154454232|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454233|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178108|NCT04040465|Analgesics|analgesics|mesh-ancestor
154454234|NCT03538704|Metformin|metformin|mesh-list
154454235|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154454236|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454238|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
154454239|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454240|NCT02172846|Paclitaxel|paclitaxel|mesh-list
154454241|NCT02172846|Carboplatin|carboplatin|mesh-list
154454242|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154454243|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454244|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
154454245|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
154454246|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
154454247|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454248|NCT00106626|Pemetrexed|pemetrexed|mesh-list
154454249|NCT00106626|Vorinostat|vorinostat|mesh-list
154454250|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454251|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454252|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454253|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154454254|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154454255|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154454256|NCT02177448|Enalapril|enalapril|mesh-list
154454257|NCT02177448|Enalaprilat|enalaprilat|mesh-list
154454258|NCT02177448|Telmisartan|telmisartan|mesh-list
154454259|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154454260|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
154454261|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454262|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624043|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
154454263|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154454264|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154454265|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154454266|NCT03537144|Acetaminophen|acetaminophen|mesh-list
154454267|NCT03537144|Indomethacin|indomethacin|mesh-list
154454268|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454269|NCT03537144|Analgesics|analgesics|mesh-ancestor
154454270|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
154454271|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454272|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454273|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
154454274|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154454275|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454276|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454277|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
154454278|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
154454279|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154454280|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154454281|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454282|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454283|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
154454284|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454285|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454286|NCT03065764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154454287|NCT03065764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454288|NCT02755818|Heparin|heparin|mesh-list
154454289|NCT02755818|Calcium heparin|calcium heparin|mesh-list
154454290|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
154454291|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154454292|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154454293|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454294|NCT02177760|Sirolimus|sirolimus|mesh-list
154454295|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154454296|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454297|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154454298|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454299|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
154454300|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154454301|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
154454302|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454303|NCT02173782|Fenoterol|fenoterol|mesh-list
154454304|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154454305|NCT02173782|Ipratropium|ipratropium|mesh-list
154454306|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154454307|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
154454308|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178180|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454309|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454310|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154454311|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454312|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
154454313|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
154454314|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154454315|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154454316|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154454317|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154454318|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
154454319|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454320|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454321|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154454322|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
154454323|NCT05717374|Dexamethasone|dexamethasone|mesh-list
154454324|NCT05717374|Dexamethasone acetate|dexamethasone acetate|mesh-list
154454325|NCT05717374|Methylprednisolone|methylprednisolone|mesh-list
154454326|NCT05717374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154454327|NCT05717374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154454328|NCT05717374|Prednisolone|prednisolone|mesh-list
154454329|NCT05717374|Prednisolone acetate|prednisolone acetate|mesh-list
154454330|NCT05717374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154454331|NCT05717374|Prednisolone phosphate|prednisolone phosphate|mesh-list
154454332|NCT05717374|BB 1101|bb 1101|mesh-list
154454333|NCT05717374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454334|NCT05717374|Antiemetics|antiemetics|mesh-ancestor
154454335|NCT05717374|Autonomic Agents|autonomic agents|mesh-ancestor
154454336|NCT05717374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454337|NCT05717374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454338|NCT05717374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454339|NCT05717374|Glucocorticoids|glucocorticoids|mesh-ancestor
154454340|NCT05717374|Hormones|hormones|mesh-ancestor
154454341|NCT05717374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454342|NCT05717374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154454343|NCT05717374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454344|NCT05717374|Protease Inhibitors|protease inhibitors|mesh-ancestor
154454345|NCT05717374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454346|NCT05717374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624122|NCT02960659|Hormones|hormones|mesh-ancestor
154454347|NCT05717374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154454348|NCT05717374|Protective Agents|protective agents|mesh-ancestor
154454349|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
154454350|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
154454351|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154454352|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
154454353|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154454354|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454355|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154454356|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154454357|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154454358|NCT02174094|Clobazam|clobazam|mesh-list
154454359|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
154454360|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154454361|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154454362|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454363|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454364|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154454365|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154454366|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
154454367|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
154454368|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454369|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454370|NCT02174172|Interferons|interferons|mesh-list
154454371|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
154454372|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
154454373|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154454374|NCT02174172|Bevacizumab|bevacizumab|mesh-list
154454375|NCT02174172|Ipilimumab|ipilimumab|mesh-list
154454376|NCT02174172|Atezolizumab|atezolizumab|mesh-list
154454377|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
154454378|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454379|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454380|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154454381|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154454382|NCT02174172|Growth Substances|growth substances|mesh-ancestor
154454383|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454384|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
154454385|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
154454386|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454387|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154454388|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454389|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
154454390|NCT02180334|Acetaminophen|acetaminophen|mesh-list
154454391|NCT02180334|Linagliptin|linagliptin|mesh-list
154454392|NCT02180334|Mosapride|mosapride|mesh-list
154454393|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454394|NCT02180334|Analgesics|analgesics|mesh-ancestor
154454395|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
154454396|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454397|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454398|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
154454399|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454400|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154454401|NCT02180334|Incretins|incretins|mesh-ancestor
154454402|NCT02180334|Hormones|hormones|mesh-ancestor
154454403|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454404|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154454405|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
154454406|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454407|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454408|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154454409|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
154454410|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454411|NCT02174250|Rifampin|rifampin|mesh-list
154454412|NCT02174250|Istradefylline|istradefylline|mesh-list
154454413|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154454414|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
154454415|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154454416|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454417|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
154454418|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154454419|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454420|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454421|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154454422|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154454423|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154454424|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154454425|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154454426|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154454427|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154454428|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154454429|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154454430|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
154454431|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454432|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454433|NCT02174328|Aspirin|aspirin|mesh-list
154454434|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154454435|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454436|NCT02174328|Analgesics|analgesics|mesh-ancestor
154454437|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
154454438|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454439|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454440|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454442|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154454443|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154454444|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454445|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154454446|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154454447|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454448|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
154454449|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
154454450|NCT02177994|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154454451|NCT02177994|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154454452|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154454453|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454454|NCT02755116|Olanzapine|olanzapine|mesh-list
154454455|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
154454456|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
154454457|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454458|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454459|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454460|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154454461|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154454462|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454463|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154454464|NCT02755116|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154454465|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154454466|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154454467|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454468|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454469|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
154454470|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
154454471|NCT02178150|Antacids|antacids|mesh-ancestor
154454472|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454473|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454474|NCT04411030|Itraconazole|itraconazole|mesh-list
154454475|NCT04411030|Midazolam|midazolam|mesh-list
154454476|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154454477|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154454478|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454479|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454480|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154454481|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154454482|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154454483|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154454484|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
154454485|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
154454486|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
154454487|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
154454488|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454489|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454490|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
154454491|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454492|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154454493|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154454494|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454495|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154454496|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
154454497|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454498|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154454499|NCT04437654|Apixaban|apixaban|mesh-list
154454500|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154454501|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
154454502|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154454503|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
154454504|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624270|NCT02460289|Minoxidil|minoxidil|mesh-list
153624338|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
154454505|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454506|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
154454507|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
154454508|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154454509|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
154454510|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
154454511|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
154454512|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454513|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454514|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
154454515|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454517|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454518|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154454519|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454520|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454521|NCT02182128|Nintedanib|nintedanib|mesh-list
154454522|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454523|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154454524|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454525|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454526|NCT02182206|Nintedanib|nintedanib|mesh-list
154454527|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454528|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154454529|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454530|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454531|NCT03963544|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154454532|NCT03963544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154454533|NCT03963544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454534|NCT03963544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454535|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
154454536|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454537|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
154454538|NCT02657889|Niraparib|niraparib|mesh-list
154454539|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454540|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454541|NCT02657889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154454542|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454543|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154454544|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454545|NCT03536208|Warfarin|warfarin|mesh-list
154454546|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
154454547|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154454548|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154454549|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
154454550|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454551|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454552|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154454553|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454554|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154454555|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154454556|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154454557|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
154454558|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454559|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454560|NCT02631538|Rituximab|rituximab|mesh-list
154454561|NCT02631538|Belimumab|belimumab|mesh-list
154454562|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454563|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454564|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
154454565|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454566|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454567|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154454568|NCT03578679|Ivermectin|ivermectin|mesh-list
154454569|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154454570|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454571|NCT02256462|Adalimumab|adalimumab|mesh-list
154454572|NCT02256462|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154454573|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454574|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454575|NCT02631148|Melatonin|melatonin|mesh-list
154454576|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
154454577|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454578|NCT02631148|Protective Agents|protective agents|mesh-ancestor
154454579|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454580|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454581|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
154454582|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154454583|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
154454584|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454585|NCT02239107|Expectorants|expectorants|mesh-ancestor
154454586|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454587|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154454588|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
154454589|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454590|NCT02239107|Protective Agents|protective agents|mesh-ancestor
154454591|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454593|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
154454594|NCT02182518|Ephedrine|ephedrine|mesh-list
154454595|NCT02182518|Epinastine|epinastine|mesh-list
154454596|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154454597|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
154454598|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454599|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454600|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154454601|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
154454602|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
154454603|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154454604|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154454605|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
154454606|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
154454607|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454608|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454609|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153624459|NCT02007603|Amoxicillin|amoxicillin|mesh-list
154454610|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
154454611|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
154454612|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154454613|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454614|NCT03574857|Metolazone|metolazone|mesh-list
154454615|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
154454616|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154454617|NCT03574857|Diuretics|diuretics|mesh-ancestor
154454618|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
154454619|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454620|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154454621|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154454622|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454623|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
154454624|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154454625|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154454626|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454627|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
154454628|NCT02238639|Coagulants|coagulants|mesh-ancestor
154454629|NCT02186028|Vitamin D|vitamin d|mesh-list
154454630|NCT02186028|Vitamins|vitamins|mesh-ancestor
154454631|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
154454632|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454633|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154454634|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
154454635|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454636|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454637|NCT02182596|Immunotoxins|immunotoxins|mesh-ancestor
154454638|NCT02182596|Immunoconjugates|immunoconjugates|mesh-ancestor
154454639|NCT02182596|Immunologic Factors|immunologic factors|mesh-ancestor
154454640|NCT02182596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454641|NCT03574701|Vitamin A|vitamin a|mesh-list
154454642|NCT03574701|Vitamins|vitamins|mesh-ancestor
154454643|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
154454644|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454645|NCT02180880|Pregabalin|pregabalin|mesh-list
154454646|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
154454647|NCT02180880|Analgesics|analgesics|mesh-ancestor
154454648|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
154454649|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454650|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454651|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
154454652|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154454653|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154454654|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454655|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154454656|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154454657|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154454658|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454659|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154454660|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154454661|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154454662|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154454663|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154454664|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
154454665|NCT02186106|Vitamin D|vitamin d|mesh-list
154454666|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154454667|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454668|NCT02186106|Vitamins|vitamins|mesh-ancestor
154454669|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
154454670|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154454671|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
154454672|NCT03943147|Deucravacitinib|deucravacitinib|mesh-list
154454673|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154454674|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454675|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154454676|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
154454677|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154454678|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454679|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454680|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454681|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
154454682|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154454683|NCT02182752|Tramadol|tramadol|mesh-list
154454684|NCT02182752|Ropivacaine|ropivacaine|mesh-list
154454685|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
154454686|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
154454687|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454688|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454689|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
154454690|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454691|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154454692|NCT02182752|Narcotics|narcotics|mesh-ancestor
154454693|NCT02182752|Analgesics|analgesics|mesh-ancestor
154454694|NCT03536598|Amlodipine|amlodipine|mesh-list
154454695|NCT03536598|Valsartan|valsartan|mesh-list
154454696|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154454697|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154454698|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154454699|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154454700|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454701|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154454702|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454703|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
154454704|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154454705|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154454706|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
154454707|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154454708|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154454709|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454710|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154454711|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154454712|NCT03576963|Nivolumab|nivolumab|mesh-list
154454713|NCT03576963|Guadecitabine|guadecitabine|mesh-list
154454714|NCT03576963|Azacitidine|azacitidine|mesh-list
154454715|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454716|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454717|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154454718|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454719|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154454720|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
154454721|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454722|NCT02186496|Amlodipine|amlodipine|mesh-list
154454723|NCT02186496|Candesartan|candesartan|mesh-list
154454724|NCT02186496|Candesartan cilexetil|candesartan cilexetil|mesh-list
154454725|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154454726|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154454727|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154454728|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454729|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154454730|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454731|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
154454732|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154454733|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154454734|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
154454735|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154454736|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454737|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454738|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454739|NCT05615194|Analgesics|analgesics|mesh-ancestor
154454740|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
154454741|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454742|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154454743|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154454744|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154454745|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
154454746|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454747|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454748|NCT02186574|Tenofovir|tenofovir|mesh-list
154454749|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
154454750|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454751|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154454752|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154454753|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454754|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454755|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154454756|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154454757|NCT03066700|Hemostatics|hemostatics|mesh-list
154178626|NCT05883345|Immunoglobulins|immunoglobulins|mesh-list
154454759|NCT03066544|Dexamethasone|dexamethasone|mesh-list
154454760|NCT03066544|Ketorolac|ketorolac|mesh-list
154454761|NCT03066544|Naratriptan|naratriptan|mesh-list
154454762|NCT03066544|Bupivacaine|bupivacaine|mesh-list
154454763|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454764|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
154454765|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
154454766|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454767|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454768|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454769|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
154454770|NCT03066544|Hormones|hormones|mesh-ancestor
153973771|NCT06247787|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153624723|NCT02009189|Taurolidine|taurolidine|mesh-list
154454771|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454772|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154454773|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454774|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
154454775|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
154454776|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454777|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
154454778|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154454779|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454780|NCT03066544|Analgesics|analgesics|mesh-ancestor
154454781|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454782|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154454783|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454784|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454785|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154454786|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154454787|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154454788|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
154454789|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454790|NCT03182179|Ondansetron|ondansetron|mesh-list
154454791|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
154454792|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
154454793|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454794|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454795|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454796|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
154454797|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
154454798|NCT03182179|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154454799|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154454800|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
154454801|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454802|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454803|NCT03576651|Bevacizumab|bevacizumab|mesh-list
154454804|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454805|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454806|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154454807|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154454808|NCT03576651|Growth Substances|growth substances|mesh-ancestor
154454809|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454810|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
154454811|NCT03064906|Pancrelipase|pancrelipase|mesh-list
154454812|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454813|NCT03034135|Copper|copper|mesh-list
154454814|NCT03034135|Temozolomide|temozolomide|mesh-list
154454816|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154454817|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
154454818|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454819|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454820|NCT03034135|Trace Elements|trace elements|mesh-ancestor
154454821|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
154454822|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454823|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154454824|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154454825|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454826|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154454827|NCT02239731|Doxycycline|doxycycline|mesh-list
153624728|NCT02009202|Cathartics|cathartics|mesh-ancestor
153624786|NCT05777369|Vincristine|vincristine|mesh-list
154454828|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454829|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
154454830|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154454831|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154454832|NCT03571815|Listerine|listerine|mesh-list
154454833|NCT03571815|Fluorides|fluorides|mesh-list
154454834|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
154454835|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
154454836|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
154454837|NCT03571815|Protective Agents|protective agents|mesh-ancestor
154454838|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454839|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154454840|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454841|NCT03573999|Mannitol|mannitol|mesh-list
154454842|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154454843|NCT03573999|Diuretics|diuretics|mesh-ancestor
154454844|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
154454845|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454846|NCT03063190|Vitamin D|vitamin d|mesh-list
154454847|NCT03063190|Vitamins|vitamins|mesh-ancestor
154454848|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
154454849|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454850|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154454851|NCT03573687|Caseins|caseins|mesh-list
154454852|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
154454853|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
154454854|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454855|NCT01671280|Azithromycin|azithromycin|mesh-list
154454856|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154454857|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454858|NCT03575637|Olanzapine|olanzapine|mesh-list
154454859|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
154454860|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
154454861|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454862|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454863|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454864|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154454865|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154454866|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454867|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154454868|NCT03575637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154454869|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154454870|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154454871|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454872|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454873|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
154454874|NCT03062800|Thalidomide|thalidomide|mesh-list
154454875|NCT03062800|Carboplatin|carboplatin|mesh-list
154454876|NCT03062800|Pemetrexed|pemetrexed|mesh-list
154454877|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454878|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454879|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454880|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154454881|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154454882|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154454883|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
154454884|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454885|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
154454886|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154454887|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454888|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154454889|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154454890|NCT03062800|Growth Substances|growth substances|mesh-ancestor
154454892|NCT05709015|Chlorhexidine|chlorhexidine|mesh-list
154454893|NCT05709015|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154454894|NCT05709015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154454895|NCT05709015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154454896|NCT05709015|Disinfectants|disinfectants|mesh-ancestor
154454897|NCT05709015|Dermatologic Agents|dermatologic agents|mesh-ancestor
154454898|NCT03573063|Androgens|androgens|mesh-list
154454899|NCT03573063|Hormones|hormones|mesh-ancestor
154454900|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454901|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454902|NCT03572829|Dexamethasone|dexamethasone|mesh-list
154454903|NCT03572829|Ondansetron|ondansetron|mesh-list
154454904|NCT03572829|Aprepitant|aprepitant|mesh-list
154454905|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454906|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
154454907|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
154454908|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454909|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454910|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454911|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
154454912|NCT03572829|Hormones|hormones|mesh-ancestor
154454913|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454914|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154454915|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454916|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454917|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
154454918|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
154454919|NCT03572829|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154454920|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154454921|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
154454922|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454923|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154454924|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
154454925|NCT03575247|Hormones|hormones|mesh-ancestor
154454926|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154454927|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454928|NCT03704623|Acetaminophen|acetaminophen|mesh-list
154454929|NCT03704623|Parecoxib|parecoxib|mesh-list
154454930|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454931|NCT03704623|Analgesics|analgesics|mesh-ancestor
154454932|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
154454933|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454934|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454935|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
154454936|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153624945|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454937|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154454938|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454939|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454940|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154454941|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454942|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154454943|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154454944|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154454945|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454946|NCT03572517|Morphine|morphine|mesh-list
154454947|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154454948|NCT03572517|Narcotics|narcotics|mesh-ancestor
154454949|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454950|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454951|NCT03572517|Analgesics|analgesics|mesh-ancestor
154454952|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
154454953|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454954|NCT03570645|Dexamethasone|dexamethasone|mesh-list
154454955|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
154454956|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154454957|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
154454958|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
154454959|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154454960|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454961|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154454962|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
154454963|NCT03570645|Hormones|hormones|mesh-ancestor
154454964|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083081|NCT00578565|Rituximab|rituximab|mesh-list
154454965|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154454966|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454967|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154454968|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154454969|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154454970|NCT03570645|Analgesics|analgesics|mesh-ancestor
154454971|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
154454972|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154454973|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154454974|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154454975|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
154454976|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154454977|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454978|NCT03567135|Temozolomide|temozolomide|mesh-list
154454979|NCT03567135|Apatinib|apatinib|mesh-list
154454980|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154454981|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
154454982|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454983|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454984|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154454985|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454986|NCT03698383|Trastuzumab|trastuzumab|mesh-list
154454987|NCT03698383|Gedatolisib|gedatolisib|mesh-list
154454988|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154454989|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154454990|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154454991|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454992|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154454993|NCT04760782|Abaloparatide|abaloparatide|mesh-list
154454994|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154454995|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154454996|NCT03064282|Papaverine|papaverine|mesh-list
154454997|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154454998|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154454999|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455000|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
154455001|NCT03064282|Urological Agents|urological agents|mesh-ancestor
154455002|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154455003|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455004|NCT03063112|Ethanol|ethanol|mesh-list
154455005|NCT03063112|Lidocaine|lidocaine|mesh-list
154455006|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
154455007|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
154455008|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455009|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455010|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
154455011|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455012|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154455013|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154455014|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154455015|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154455016|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455017|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154455018|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455019|NCT03701503|Hormones|hormones|mesh-list
154455020|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455021|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455022|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
154455023|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154455024|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154455025|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154455026|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154455027|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455028|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
154455029|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455030|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455031|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154455032|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455033|NCT03698227|Doxorubicin|doxorubicin|mesh-list
154455034|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
154455035|NCT03698227|Razoxane|razoxane|mesh-list
154455036|NCT03698227|Olaratumab|olaratumab|mesh-list
154860546|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455037|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154455038|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455039|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154455040|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154455041|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455042|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455043|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154455044|NCT03698227|Protective Agents|protective agents|mesh-ancestor
154455045|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455046|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154455047|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154455048|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154455049|NCT01342965|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154455050|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154455051|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455052|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455053|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455054|NCT02181348|Vitamin E|vitamin e|mesh-list
154455055|NCT02181348|Vitamins|vitamins|mesh-ancestor
154455056|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
154455057|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455058|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
154455059|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455060|NCT02181348|Protective Agents|protective agents|mesh-ancestor
154455061|NCT02186886|Golimumab|golimumab|mesh-list
154455062|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154455063|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455064|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154455065|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
154455066|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455067|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154455068|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
154455069|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455070|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
154455071|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
154455072|NCT03536910|Coagulants|coagulants|mesh-ancestor
154455073|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154455074|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154455075|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
153625134|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154455076|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455077|NCT02181660|Gilteritinib|gilteritinib|mesh-list
154455078|NCT02181660|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154455079|NCT02181660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154455080|NCT02181660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455081|NCT02181660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455082|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
154455083|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154455084|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154455085|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455086|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
154455087|NCT03697681|Coagulants|coagulants|mesh-ancestor
154455088|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154455089|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455090|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455091|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
154455092|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455093|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455094|NCT02183064|Meloxicam|meloxicam|mesh-list
154455095|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154455096|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455097|NCT02183064|Analgesics|analgesics|mesh-ancestor
154455098|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
154455099|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455100|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455101|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455102|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455103|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154455104|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154455105|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455106|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455107|NCT03704077|Paclitaxel|paclitaxel|mesh-list
154455108|NCT03704077|Nivolumab|nivolumab|mesh-list
154455109|NCT03704077|Ramucirumab|ramucirumab|mesh-list
154455110|NCT03704077|Relatlimab|relatlimab|mesh-list
154455111|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154455112|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455113|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
154455114|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
154455115|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
154455116|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455117|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154455118|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154455119|NCT03704077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154455120|NCT03704077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154455121|NCT03704077|Growth Substances|growth substances|mesh-ancestor
153973772|NCT06247787|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154455122|NCT03704077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455123|NCT03704077|Growth Inhibitors|growth inhibitors|mesh-ancestor
154455125|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154455126|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455127|NCT02183142|Analgesics|analgesics|mesh-ancestor
154455128|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
154455129|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455130|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455131|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455132|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455133|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154179012|NCT05764395|ON 01910|on 01910|mesh-list
154455134|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154455135|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455136|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455138|NCT02183220|Dipyrone|dipyrone|mesh-list
154455139|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154455140|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455141|NCT02183220|Analgesics|analgesics|mesh-ancestor
154455142|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
154455143|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455144|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455145|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455146|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455147|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154455148|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154455149|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455150|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154455151|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154455152|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455153|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
154455154|NCT02187588|Ibuprofen|ibuprofen|mesh-list
154455155|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154455156|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455157|NCT02187588|Analgesics|analgesics|mesh-ancestor
154455158|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
154455159|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455160|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455161|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455162|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455163|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154455164|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455165|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455166|NCT05364489|Bevacizumab|bevacizumab|mesh-list
154455167|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
154455168|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154455169|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455170|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154455171|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154455172|NCT05364489|Growth Substances|growth substances|mesh-ancestor
154455173|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455174|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
154455175|NCT02183298|Linagliptin|linagliptin|mesh-list
154455176|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154455177|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455178|NCT02183298|Incretins|incretins|mesh-ancestor
154455179|NCT02183298|Hormones|hormones|mesh-ancestor
153973773|NCT06247787|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154455180|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455181|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154455182|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455183|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860547|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154455184|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455185|NCT03697057|Anesthetics|anesthetics|mesh-list
154455186|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455187|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455188|NCT02183376|Linagliptin|linagliptin|mesh-list
154455189|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154455190|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455191|NCT02183376|Incretins|incretins|mesh-ancestor
154455193|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455194|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154455195|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455196|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455197|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455198|NCT02187822|Taxane|taxane|mesh-list
154455199|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455200|NCT03696901|Dalbavancin|dalbavancin|mesh-list
154455201|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154455202|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455203|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
154455204|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
154455205|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154455206|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179088|NCT05656521|Dexamethasone|dexamethasone|mesh-list
154455207|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154455208|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
154455209|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154455210|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455211|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455212|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455213|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154455214|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154455215|NCT02187900|Protective Agents|protective agents|mesh-ancestor
154455216|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455217|NCT03062644|Celecoxib|celecoxib|mesh-list
154455218|NCT03062644|Tramadol|tramadol|mesh-list
154455219|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154455220|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455221|NCT03062644|Analgesics|analgesics|mesh-ancestor
153625303|NCT01332097|Prednisone|prednisone|mesh-list
154455222|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
154455223|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455224|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455225|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455226|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455227|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154455228|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154455229|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455230|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455231|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154455232|NCT03062644|Narcotics|narcotics|mesh-ancestor
154455233|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455234|NCT02190318|Losartan|losartan|mesh-list
154455235|NCT02190318|Spironolactone|spironolactone|mesh-list
154455236|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154455237|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154455238|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154455239|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154455240|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455241|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154455242|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
154455243|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455244|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455245|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154455246|NCT02190318|Diuretics|diuretics|mesh-ancestor
154455247|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
154455248|NCT02183532|Linagliptin|linagliptin|mesh-list
154455249|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154455250|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455251|NCT02183532|Incretins|incretins|mesh-ancestor
154455252|NCT02183532|Hormones|hormones|mesh-ancestor
154455253|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455254|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154455255|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455256|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455257|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455258|NCT03569631|BPN14770|bpn14770|mesh-list
154455259|NCT03569631|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154455260|NCT03569631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154455261|NCT03569631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455262|NCT03569631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455263|NCT02629822|Tenofovir|tenofovir|mesh-list
154455264|NCT02629822|Lamivudine|lamivudine|mesh-list
154455265|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
154455266|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455267|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154455268|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455269|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455270|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455271|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455272|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154455273|NCT03700645|Allopurinol|allopurinol|mesh-list
154455274|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
154455275|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455276|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455277|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
154455278|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455279|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154455281|NCT03700645|Protective Agents|protective agents|mesh-ancestor
154455282|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455283|NCT04499053|Durvalumab|durvalumab|mesh-list
154455284|NCT04499053|Tremelimumab|tremelimumab|mesh-list
154455285|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154455286|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455287|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
154455288|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
154455289|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154455290|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154455291|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154455292|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455293|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154455294|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154455295|NCT03567447|Droxidopa|droxidopa|mesh-list
154455296|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154455297|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154455298|NCT03567369|Dexamethasone|dexamethasone|mesh-list
154455299|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
154455300|NCT03567369|BB 1101|bb 1101|mesh-list
154455301|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455302|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
154455303|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
154455304|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455305|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455306|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455307|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
154455308|NCT03567369|Hormones|hormones|mesh-ancestor
154455309|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455310|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154455311|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455312|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455313|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455314|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455315|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
154455316|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154455317|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455318|NCT03397654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153973774|NCT06247787|Methotrexate|methotrexate|mesh-list
153625526|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
154455319|NCT03397654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455320|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
154455321|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154455322|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154455323|NCT03266146|Prednisolone|prednisolone|mesh-list
154455324|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
154455325|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154455326|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
154455327|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455328|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
154455329|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
154455330|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455331|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455332|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455333|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
154455334|NCT03266146|Hormones|hormones|mesh-ancestor
154455335|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455336|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154455337|NCT03266146|Protective Agents|protective agents|mesh-ancestor
154455338|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154455339|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455340|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
154455341|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
154860548|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154455342|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154455343|NCT03700489|Protective Agents|protective agents|mesh-ancestor
154455344|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455345|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
154455346|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154455347|NCT02800941|Warfarin|warfarin|mesh-list
154455348|NCT02800941|Anticoagulants|anticoagulants|mesh-list
154455349|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
154455350|NCT02800941|Fluindione|fluindione|mesh-list
154455351|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
154455352|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154455353|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
154455354|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
154455355|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455356|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455357|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455358|NCT03695887|Analgesics|analgesics|mesh-ancestor
154455359|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
154455360|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455361|NCT04432714|Prednisone|prednisone|mesh-list
154455362|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
154455363|NCT04432714|Rituximab|rituximab|mesh-list
154455364|NCT04432714|Doxorubicin|doxorubicin|mesh-list
154455365|NCT04432714|Etoposide|etoposide|mesh-list
154455366|NCT04432714|Vincristine|vincristine|mesh-list
154455367|NCT04432714|Lenalidomide|lenalidomide|mesh-list
154455368|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154455369|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
154455370|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455371|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973775|NCT06247787|Fludarabine|fludarabine|mesh-list
154455372|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154455373|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
154455374|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455375|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455376|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154455377|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154455378|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154455379|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154455380|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154455381|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455382|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455383|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
154455384|NCT04432714|Hormones|hormones|mesh-ancestor
154455385|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455386|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154455387|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154455388|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
154455389|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
154455390|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
154455391|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154455392|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154455393|NCT04432714|Growth Substances|growth substances|mesh-ancestor
154455394|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
154455395|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
154455396|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154455397|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455398|NCT02752074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154455399|NCT02752074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455400|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
154455401|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154455402|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154455403|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455404|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154455405|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154455406|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
154455407|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154455408|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
154455409|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154455410|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455411|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455412|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455413|NCT03624595|Analgesics|analgesics|mesh-ancestor
154455414|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
154455415|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455416|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154455417|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154455418|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154455419|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
154455420|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455421|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455422|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
154455423|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154455424|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154455425|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455426|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
154455427|NCT03063892|Coagulants|coagulants|mesh-ancestor
154455428|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154179305|NCT06013293|Zinc Oxide|zinc oxide|mesh-list
154455429|NCT03063580|Rifampin|rifampin|mesh-list
154455430|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154455431|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
154455432|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154455433|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455434|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
154455435|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455436|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455437|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455438|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154455439|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154455440|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154455441|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154455442|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154455443|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154455444|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154455445|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154455446|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455447|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154455448|NCT05353101|Cyclosporine|cyclosporine|mesh-list
154455449|NCT05353101|Tobramycin|tobramycin|mesh-list
154455450|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154455451|NCT05353101|Cyclosporins|cyclosporins|mesh-list
154455452|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455453|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455454|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154455455|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
154455456|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455457|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
154455458|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455459|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
154455460|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455461|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154455462|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154455463|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154455464|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154455465|NCT03700333|Pemetrexed|pemetrexed|mesh-list
154455466|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455467|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455468|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455469|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154455470|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455471|NCT03700177|Dexamethasone|dexamethasone|mesh-list
154455472|NCT03700177|Ropivacaine|ropivacaine|mesh-list
154455473|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455474|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
154455475|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
154455476|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455477|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455478|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455479|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
154455481|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455482|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154455483|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455484|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
154455485|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
154455486|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455487|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
154455488|NCT02183610|Linagliptin|linagliptin|mesh-list
154455489|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154455490|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154455491|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455492|NCT02183610|Incretins|incretins|mesh-ancestor
154455493|NCT02183610|Hormones|hormones|mesh-ancestor
154455494|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455495|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154455496|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455497|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455498|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455499|NCT02183688|Acetaminophen|acetaminophen|mesh-list
154455500|NCT02183688|Caffeine|caffeine|mesh-list
154455501|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154179382|NCT05262855|FAPI-46|fapi-46|mesh-list
154455502|NCT02183688|Analgesics|analgesics|mesh-ancestor
154455503|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
154455504|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455505|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455506|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
154455507|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154455508|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154455509|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455510|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455511|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154455512|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154455513|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
154455514|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455516|NCT02190708|Omeprazole|omeprazole|mesh-list
154455517|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154455518|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154455519|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154455520|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455521|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455522|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154455523|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154455524|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154455525|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154455526|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
154455527|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
154455528|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
154455529|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
154455530|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455531|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455532|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154455533|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455534|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455535|NCT05338983|Anesthetics|anesthetics|mesh-list
154455536|NCT05338983|Mepivacaine|mepivacaine|mesh-list
154455537|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
154455538|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455539|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455540|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
154455541|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455542|NCT03063658|Acetaminophen|acetaminophen|mesh-list
154455543|NCT03063658|Ibuprofen|ibuprofen|mesh-list
154455544|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154455545|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455546|NCT03063658|Analgesics|analgesics|mesh-ancestor
154455547|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
154455548|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455549|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455550|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455551|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455552|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154860549|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154455553|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455554|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455555|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
154455556|NCT03695107|Nifedipine|nifedipine|mesh-list
154455557|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154455558|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154455559|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455560|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154455561|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455562|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
154455563|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
154455564|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154455565|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
154455566|NCT02835339|Analgesics|analgesics|mesh-ancestor
154455567|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
153625792|NCT02012387|Omalizumab|omalizumab|mesh-list
154455568|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455569|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455570|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
154455571|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455572|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154455573|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
154455574|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154455575|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154455576|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455577|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154455578|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
154455579|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154455580|NCT03695029|Tenofovir|tenofovir|mesh-list
154455581|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
154455582|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455583|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154455584|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455585|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455586|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455587|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455588|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154455589|NCT02259855|Interferons|interferons|mesh-list
154455590|NCT02259855|Ritonavir|ritonavir|mesh-list
154455591|NCT02259855|Ribavirin|ribavirin|mesh-list
154455592|NCT02259855|Tipranavir|tipranavir|mesh-list
154455593|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455594|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
154455595|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455596|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154455597|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154455598|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455599|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455600|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455601|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455602|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154455603|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154455604|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154455605|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
154455606|NCT03703063|Leucovorin|leucovorin|mesh-list
154455607|NCT03703063|Paclitaxel|paclitaxel|mesh-list
154455608|NCT03703063|Gemcitabine|gemcitabine|mesh-list
154455609|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154455610|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455611|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
154455612|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
154455613|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
154455614|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455615|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154455616|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
154455617|NCT03703063|Antidotes|antidotes|mesh-ancestor
154455618|NCT03703063|Protective Agents|protective agents|mesh-ancestor
154455619|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455620|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
154455621|NCT03703063|Vitamins|vitamins|mesh-ancestor
154455622|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
154455623|NCT03702985|Capecitabine|capecitabine|mesh-list
154455624|NCT03702985|Irinotecan|irinotecan|mesh-list
154455625|NCT03702985|Amifostine|amifostine|mesh-list
154455626|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154455627|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
154455628|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455629|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455630|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154455631|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154455632|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455633|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154455634|NCT03702985|Protective Agents|protective agents|mesh-ancestor
154455635|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455636|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154455637|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154455638|NCT02184078|Nevirapine|nevirapine|mesh-list
154455639|NCT02184078|Rifabutin|rifabutin|mesh-list
154455640|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154455641|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455642|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455643|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455644|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
154455645|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455646|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455647|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154455648|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154455649|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154455650|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626003|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154455651|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154179534|NCT04336098|Paclitaxel|paclitaxel|mesh-list
154455652|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
154455654|NCT03694873|Tramadol|tramadol|mesh-list
154455655|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154455656|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154455657|NCT03694873|Analgesics|analgesics|mesh-ancestor
154455658|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
154455659|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455660|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455661|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455662|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455663|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154455664|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154455665|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455666|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455667|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154455668|NCT03694873|Narcotics|narcotics|mesh-ancestor
154455669|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455670|NCT02191020|Acitretin|acitretin|mesh-list
154455671|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
154455672|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
154455673|NCT04476199|Venetoclax|venetoclax|mesh-list
154455674|NCT04476199|Decitabine|decitabine|mesh-list
154455675|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455676|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154455677|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
154455678|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455679|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455680|NCT02191176|Levomethorphan|levomethorphan|mesh-list
154455681|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
154455682|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
154455683|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
154455684|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154455685|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154455686|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455687|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455688|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455689|NCT02191176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154455690|NCT02191176|Narcotics|narcotics|mesh-ancestor
154455691|NCT02191176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455692|NCT02191176|Analgesics|analgesics|mesh-ancestor
154455693|NCT02191176|Sensory System Agents|sensory system agents|mesh-ancestor
154455694|NCT02191176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455695|NCT02184312|Nevirapine|nevirapine|mesh-list
154455696|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154455697|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455698|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455699|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455700|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
154455701|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455702|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455703|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154455704|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154455705|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154455707|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154455708|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455709|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455710|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455711|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
154455712|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455713|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455714|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154455715|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154455716|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154455717|NCT02256774|Ritonavir|ritonavir|mesh-list
154455718|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154455719|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154455720|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154455721|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455722|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455723|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455724|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455725|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154179606|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
154455726|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
154455727|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455728|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154455729|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154455730|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154455731|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455732|NCT02189304|Budesonide|budesonide|mesh-list
154455733|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
154455734|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
154455735|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154455736|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455737|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154455738|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
154455739|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455740|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455741|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154455742|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
154455743|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
154455744|NCT02189304|Hormones|hormones|mesh-ancestor
154455745|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455746|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154455747|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154455748|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153626104|NCT02014545|Lucanthone|lucanthone|mesh-list
154455749|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
154455750|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455751|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455752|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154455753|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154455754|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154455755|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
154455756|NCT02184858|Lisinopril|lisinopril|mesh-list
154455757|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154455758|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455759|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455760|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455761|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154455762|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154455763|NCT02184858|Protective Agents|protective agents|mesh-ancestor
154455764|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455765|NCT03535662|Itraconazole|itraconazole|mesh-list
154455766|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
154455767|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455768|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154455769|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154455770|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455771|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455772|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154455773|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
154083918|NCT00725829|Ezetimibe|ezetimibe|mesh-list
154455774|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455775|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455776|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154455777|NCT03702205|Betaine|betaine|mesh-list
154455778|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455779|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
154455780|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154455781|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
154455782|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455783|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154455784|NCT02189694|Hormones|hormones|mesh-list
154455785|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455786|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455787|NCT02189772|Metadoxine|metadoxine|mesh-list
154455788|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154455789|NCT02192424|Insulin|insulin|mesh-list
154455790|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154455791|NCT02192424|Metformin|metformin|mesh-list
154455792|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
154455793|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
154455794|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154455795|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455796|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
154455797|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154179678|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
154455798|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455800|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154455801|NCT02257008|Nelfinavir|nelfinavir|mesh-list
154455802|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154455803|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153626155|NCT02014714|Narcotics|narcotics|mesh-ancestor
154455804|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
154455805|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455806|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455807|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455808|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154455809|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
154455810|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455811|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154455812|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154455813|NCT03693391|Fluorides|fluorides|mesh-list
154455814|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
154455815|NCT03693391|Protective Agents|protective agents|mesh-ancestor
154455816|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455817|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
154455818|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455819|NCT02185326|Hormones|hormones|mesh-list
154455820|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455821|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455822|NCT04412707|Dexamethasone|dexamethasone|mesh-list
154455823|NCT04412707|Melphalan|melphalan|mesh-list
154455824|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455825|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
154455826|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
154455827|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455828|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455829|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455830|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
154455831|NCT04412707|Hormones|hormones|mesh-ancestor
154455832|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154455833|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154455834|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455835|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154455836|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
154455837|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455838|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154455839|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154455840|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
154455841|NCT03698695|Mefloquine|mefloquine|mesh-list
154455842|NCT03698695|Donepezil|donepezil|mesh-list
154455843|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154455844|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455845|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455846|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
154455847|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455848|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455849|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
154455850|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
154455851|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154455852|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154455853|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455854|NCT04729296|Golimumab|golimumab|mesh-list
154455855|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154455856|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154455857|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154455858|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
154455859|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455860|NCT03698617|Propofol|propofol|mesh-list
154455861|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154455862|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455863|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455864|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154455865|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
154455866|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
154455867|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
154455868|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154455869|NCT02194374|Rituximab|rituximab|mesh-list
154455870|NCT02194374|Fludarabine|fludarabine|mesh-list
154455871|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
154455872|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154455873|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
154455874|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455875|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154455876|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154455877|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
154455878|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455879|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455880|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154455881|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154455882|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154455883|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
154455885|NCT02194452|Edotreotide|edotreotide|mesh-list
154455886|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455887|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154455888|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455889|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154455890|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455891|NCT01358721|Nivolumab|nivolumab|mesh-list
154455892|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154455893|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154455894|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154455895|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455896|NCT02194686|Cilostazol|cilostazol|mesh-list
154455897|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154455898|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
154455899|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455900|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455901|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154455902|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
153626371|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
154455903|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154455904|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154455905|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455906|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154455907|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
154455908|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154455909|NCT02194686|Protective Agents|protective agents|mesh-ancestor
154455910|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154455911|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154455912|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455913|NCT04622995|Diazepam|diazepam|mesh-list
154455914|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154455915|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
154455916|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
154455917|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
154455918|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455919|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455920|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455921|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154455922|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455923|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154455924|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154455925|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154455926|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154455927|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154455928|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154455929|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
154455930|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
154455931|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
154455932|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
154455933|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455934|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455935|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154455936|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
154455937|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455938|NCT02194764|Naltrexone|naltrexone|mesh-list
154455939|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154455940|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154455941|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455942|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
154455943|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455944|NCT02967640|Ketamine|ketamine|mesh-list
154455945|NCT02967640|Analgesics|analgesics|mesh-ancestor
154455946|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
154455947|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154455948|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455949|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154455950|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154455951|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
154455952|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
154455953|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154455954|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154455955|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154455956|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154455957|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455958|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
154455959|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154455960|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455961|NCT02194218|Nevirapine|nevirapine|mesh-list
154455962|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154455963|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154455964|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154455965|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455966|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
154455967|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455968|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154455969|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154455970|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154455971|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154455972|NCT02194296|Ambroxol|ambroxol|mesh-list
154455973|NCT02194296|Expectorants|expectorants|mesh-ancestor
154455974|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
154455975|NCT02197026|Hylan|hylan|mesh-list
154455976|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
154455977|NCT02197026|Protective Agents|protective agents|mesh-ancestor
154455978|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455979|NCT02197104|Choline|choline|mesh-list
154455980|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
154455981|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154455982|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
153973776|NCT06247787|Calcium|calcium|mesh-list
154455983|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154455984|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154455985|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154455986|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
154455987|NCT02197182|Copper|copper|mesh-list
154455988|NCT02197182|Metronidazole|metronidazole|mesh-list
154455989|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154455990|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154455991|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154455992|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154455993|NCT02197182|Trace Elements|trace elements|mesh-ancestor
154455994|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
154455995|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154455996|NCT02197260|Amoxicillin|amoxicillin|mesh-list
154455997|NCT02197260|Metronidazole|metronidazole|mesh-list
154455998|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154455999|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456000|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154456001|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154456002|NCT03687931|Dexamethasone|dexamethasone|mesh-list
154456003|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456004|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
154456005|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
154456006|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456007|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456008|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154456009|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
154456010|NCT03687931|Hormones|hormones|mesh-ancestor
154456011|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154456012|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154456013|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456014|NCT03534024|Curcumin|curcumin|mesh-list
154456015|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154456016|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456017|NCT03534024|Analgesics|analgesics|mesh-ancestor
154456018|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
154456019|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456020|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179901|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154456021|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456022|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456023|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456024|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456025|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456026|NCT02753686|Tamoxifen|tamoxifen|mesh-list
154456027|NCT02753686|Everolimus|everolimus|mesh-list
154456028|NCT02753686|Letrozole|letrozole|mesh-list
154456029|NCT02753686|Fulvestrant|fulvestrant|mesh-list
154456030|NCT02753686|Anastrozole|anastrozole|mesh-list
154456031|NCT02753686|Exemestane|exemestane|mesh-list
154456032|NCT02753686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154456033|NCT02753686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154456034|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973777|NCT06247787|Imetelstat|imetelstat|mesh-list
154456035|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456036|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154456037|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
154456038|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456039|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456040|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154456041|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154456042|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154456043|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
154456044|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154456045|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154456046|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154456047|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154456048|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154456049|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154456050|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
154456051|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154456052|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
154456053|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456054|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456055|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154456056|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
154456057|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154456058|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
154456059|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456060|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456061|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154456062|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
154456063|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
154456064|NCT04216927|Protective Agents|protective agents|mesh-ancestor
154456065|NCT02329834|Furosemide|furosemide|mesh-list
154456066|NCT02329834|Diuretics|diuretics|mesh-ancestor
154456067|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
154456068|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456069|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154456070|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154456071|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456072|NCT02195466|Ritonavir|ritonavir|mesh-list
154456073|NCT02195466|Tipranavir|tipranavir|mesh-list
154456074|NCT02195466|Fluconazole|fluconazole|mesh-list
154456076|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154456077|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
154456078|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456079|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456080|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154456081|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154456082|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
154456083|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456084|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154456085|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154456086|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
154456087|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154456088|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154456089|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
154456090|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154456091|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456092|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154456093|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154456094|NCT02195544|Hylan|hylan|mesh-list
154456095|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
154456096|NCT02195544|Protective Agents|protective agents|mesh-ancestor
154456097|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456098|NCT02197494|Valsartan|valsartan|mesh-list
154456099|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154456100|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154456101|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154456102|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456103|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154456104|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
154456105|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456106|NCT03692299|Metronidazole|metronidazole|mesh-list
154456107|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456108|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154456109|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154456110|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154456111|NCT02197650|Asparaginase|asparaginase|mesh-list
154456112|NCT02197650|Eryaspase|eryaspase|mesh-list
154456113|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456114|NCT03682939|Vaccines|vaccines|mesh-list
154456115|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
154456116|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456117|NCT02201992|Crizotinib|crizotinib|mesh-list
154456118|NCT02201992|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154456119|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154456120|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456121|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456122|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456123|NCT03534492|Durvalumab|durvalumab|mesh-list
154456124|NCT03534492|Olaparib|olaparib|mesh-list
154456125|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154456126|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456127|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154456128|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456129|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456130|NCT03624283|Betahistine|betahistine|mesh-list
154456131|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
154456132|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
154456133|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
154456134|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456135|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456136|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456137|NCT03687463|Decitabine|decitabine|mesh-list
154456138|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154456139|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
154456140|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456141|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456142|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456143|NCT03692143|Alendronate|alendronate|mesh-list
154456144|NCT03692143|Teriparatide|teriparatide|mesh-list
154456145|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154456146|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084288|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
154456147|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154456148|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
154456149|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154456150|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456151|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154456152|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456153|NCT02197884|Clarithromycin|clarithromycin|mesh-list
154456154|NCT02197884|Itraconazole|itraconazole|mesh-list
154456155|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154456156|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456157|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154456158|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456159|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456160|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154456161|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154456162|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
154456163|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154456164|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154456165|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
154456166|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154456167|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456169|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154456170|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456171|NCT03687229|Insulin|insulin|mesh-list
154456172|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154456173|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456174|NCT05085054|Osimertinib|osimertinib|mesh-list
154456175|NCT05085054|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154456176|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154456177|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456178|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456179|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456180|NCT03969121|Palbociclib|palbociclib|mesh-list
154456181|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456182|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154456183|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456184|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456185|NCT02201238|Diclofenac|diclofenac|mesh-list
154456186|NCT02201238|Menthol|menthol|mesh-list
154456187|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154456188|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456189|NCT02201238|Analgesics|analgesics|mesh-ancestor
154456190|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
154456191|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456192|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456193|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456194|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456195|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154456196|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456197|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456198|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
154456199|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
154456200|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
154456201|NCT02257398|Gepotidacin|gepotidacin|mesh-list
154456202|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154456203|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154456204|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456205|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154456206|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154456207|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456208|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456209|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456210|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154456211|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
154456212|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154456213|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456214|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154456215|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154456216|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154456217|NCT02201316|Mosapride|mosapride|mesh-list
154456218|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456219|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154456220|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154456221|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
154456222|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456223|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456224|NCT02198820|Anesthetics|anesthetics|mesh-list
154456225|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456226|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456227|NCT02257476|Dexamethasone|dexamethasone|mesh-list
154456228|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456229|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
154456230|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
154456231|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456232|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456233|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154456234|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
154456235|NCT02257476|Hormones|hormones|mesh-ancestor
154456236|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154456237|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154456238|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456239|NCT03943927|Metoprolol|metoprolol|mesh-list
154456240|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154456241|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154456242|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
154456243|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
154456244|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456245|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456246|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154456247|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154456248|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154456249|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
154456250|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456251|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456252|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
154456253|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154456254|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456255|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
154456256|NCT03687073|Silybin|silybin|mesh-list
154456257|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
154456258|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154456259|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456260|NCT03687073|Protective Agents|protective agents|mesh-ancestor
154456261|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456262|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154456263|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
154456264|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154456265|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154456266|NCT02198352|Olcegepant|olcegepant|mesh-list
154456267|NCT02198352|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154456268|NCT02198352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456269|NCT02198352|Analgesics|analgesics|mesh-ancestor
154456270|NCT02198352|Sensory System Agents|sensory system agents|mesh-ancestor
154456271|NCT02198352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456272|NCT02198352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456273|NCT02202564|Ganciclovir|ganciclovir|mesh-list
154456274|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154456275|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
154456276|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456277|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154456278|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456279|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456280|NCT02198508|Deferasirox|deferasirox|mesh-list
154456281|NCT02198508|Deferiprone|deferiprone|mesh-list
154456282|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154456283|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
154456284|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
154456285|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456286|NCT02202720|Sevoflurane|sevoflurane|mesh-list
154456287|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154456288|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154456289|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
154456290|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
154456291|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456292|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456293|NCT02206308|Antibodies|antibodies|mesh-list
154456294|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154456295|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
154456296|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456297|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154456298|NCT03028129|Isoniazid|isoniazid|mesh-list
154456299|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456300|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
154456301|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154456302|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154456303|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
154456304|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456305|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154456306|NCT04059679|Aspirin|aspirin|mesh-list
154456307|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
154456308|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154456309|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456310|NCT04059679|Analgesics|analgesics|mesh-ancestor
154456311|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
154456312|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456313|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456314|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456315|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180198|NCT04319627|Calcium|calcium|mesh-list
154456316|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154456317|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154456318|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456319|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154456320|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154456321|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456322|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
154456323|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154456324|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
153736830|NCT06181682|Midazolam|midazolam|mesh-list
154456325|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154456326|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
154456327|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
154456329|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154456330|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456331|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154456332|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456333|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456334|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154456335|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154456336|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
154456337|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456338|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
154456339|NCT02206854|Tarenflurbil|tarenflurbil|mesh-list
154456340|NCT02206854|Analgesics|analgesics|mesh-ancestor
154456341|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
154456342|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456343|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456344|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154456345|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456346|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456347|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456348|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154456349|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456350|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456351|NCT02206854|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154456352|NCT03624205|Paclitaxel|paclitaxel|mesh-list
154456353|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154456354|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456355|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
154456356|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
154456357|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
154456358|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456359|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
154456360|NCT02206932|Simeprevir|simeprevir|mesh-list
154456361|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
154456362|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456363|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
154456364|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736947|NCT06180941|Clonidine|clonidine|mesh-list
154456365|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456366|NCT02207010|Adavosertib|adavosertib|mesh-list
154456367|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456368|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456369|NCT02203422|Cyclosporine|cyclosporine|mesh-list
154456370|NCT02203422|Cyclosporins|cyclosporins|mesh-list
154456371|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456372|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456373|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154456374|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
154456375|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456376|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
154456377|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456378|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
154456379|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456380|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154456381|NCT03532854|Valsartan|valsartan|mesh-list
154456382|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154456383|NCT03532854|Ezetimibe|ezetimibe|mesh-list
154456384|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154456385|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154456386|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
154456387|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456388|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154456389|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154456390|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456391|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154456392|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154456393|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154456395|NCT02203500|Lacidipine|lacidipine|mesh-list
154456396|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154456397|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154456398|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154456399|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456400|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154456401|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154456402|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154456403|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456404|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
154456405|NCT02203656|Testosterone|testosterone|mesh-list
154456406|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
154456407|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
154456408|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154456409|NCT02203656|Androgens|androgens|mesh-ancestor
154456410|NCT02203656|Hormones|hormones|mesh-ancestor
154456411|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154456412|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456413|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153736978|NCT06180863|Cc-486|cc-486|mesh-list
154456414|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456415|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
154456416|NCT02199444|Sevelamer|sevelamer|mesh-list
154456417|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
154456418|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
154456419|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456420|NCT02199522|Propofol|propofol|mesh-list
154456421|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154456422|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456423|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456424|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154456425|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
154456426|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
154456427|NCT03532698|Aspirin|aspirin|mesh-list
154456428|NCT03532698|Osimertinib|osimertinib|mesh-list
154456429|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154456430|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456431|NCT03532698|Analgesics|analgesics|mesh-ancestor
154456432|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
154456433|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456434|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456435|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456436|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456437|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154456438|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154456439|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456440|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154456441|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154456442|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456444|NCT03532698|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154456445|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154456446|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456447|NCT03690739|Paclitaxel|paclitaxel|mesh-list
154456448|NCT03690739|Bevacizumab|bevacizumab|mesh-list
154456449|NCT03690739|Carboplatin|carboplatin|mesh-list
154456450|NCT03690739|Gemcitabine|gemcitabine|mesh-list
154456451|NCT03690739|Trabectedin|trabectedin|mesh-list
154456452|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154456453|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456454|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
154456455|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
154456456|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
154456457|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456458|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154456459|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153973778|NCT06247787|Motesanib diphosphate|motesanib diphosphate|mesh-list
154456460|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154456461|NCT03690739|Growth Substances|growth substances|mesh-ancestor
154456462|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456463|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
154456464|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154456465|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
154456466|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154456467|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
154456468|NCT02199678|Ketamine|ketamine|mesh-list
154456469|NCT02199678|Analgesics|analgesics|mesh-ancestor
154456470|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
154456471|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456472|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456473|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154456474|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154456475|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
154456476|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
154456477|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456478|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154456479|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154456480|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456481|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456482|NCT03681613|Pyrantel|pyrantel|mesh-list
154456483|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
154456484|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
154456485|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
154456486|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154456487|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456488|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154456489|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154456490|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154456491|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456492|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456493|NCT03690583|Zinc|zinc|mesh-list
154456494|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
154456495|NCT03690583|Trace Elements|trace elements|mesh-ancestor
154456496|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
154456497|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456498|NCT03690583|Astringents|astringents|mesh-ancestor
154456499|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
154456500|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154456501|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
154456502|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154456503|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154456504|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456505|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
154456506|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
154456507|NCT02200146|Prednisone|prednisone|mesh-list
154456508|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456509|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
154456510|NCT02200146|Hormones|hormones|mesh-ancestor
154456511|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154456512|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456513|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154456514|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456515|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
154456516|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154456517|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154456518|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456519|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456520|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456521|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456522|NCT02208492|Levetiracetam|levetiracetam|mesh-list
154456523|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
154456524|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
154456525|NCT01933048|Vaccines|vaccines|mesh-list
154456526|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
154456527|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456528|NCT02208882|Midazolam|midazolam|mesh-list
154456529|NCT02208882|BMS-986120|bms-986120|mesh-list
154456530|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154456531|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154456532|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456533|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456534|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154456535|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154456536|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154456537|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154456538|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
154456539|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
154456540|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
154456541|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
154456542|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456543|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456544|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154456545|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154456546|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154456547|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456549|NCT02209350|Clopidogrel|clopidogrel|mesh-list
154456550|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154456551|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456552|NCT02209350|Analgesics|analgesics|mesh-ancestor
154456553|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
154456554|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456555|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456556|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456557|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456558|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154456559|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154456560|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456561|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154456562|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154456563|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456564|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
154456565|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154456566|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154456567|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154456568|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
154456569|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456570|NCT02209428|Temozolomide|temozolomide|mesh-list
154456571|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154456572|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
154456573|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456574|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456575|NCT02200848|Rituximab|rituximab|mesh-list
154456576|NCT02200848|Lenalidomide|lenalidomide|mesh-list
154456577|NCT02200848|Ibrutinib|ibrutinib|mesh-list
154456578|NCT02200848|Glutarimide|glutarimide|mesh-list
154456579|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154456580|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456581|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
154456582|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456583|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456584|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154456585|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154456586|NCT02200848|Growth Substances|growth substances|mesh-ancestor
154456587|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
154456588|NCT02200848|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154456589|NCT02200848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154860550|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456590|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456591|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456592|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154456594|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
154456595|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
154456596|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
154456597|NCT02751450|Protective Agents|protective agents|mesh-ancestor
154456598|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456599|NCT02209740|Tenofovir|tenofovir|mesh-list
154456600|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
154456601|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456602|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154456603|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154456604|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456605|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456606|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154456607|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154456608|NCT02257788|Leronlimab|leronlimab|mesh-list
154456609|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154456610|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154456611|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456612|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154456613|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154456614|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
154180495|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
154456615|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456617|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154456618|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
154456619|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456620|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456621|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154456622|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
154456623|NCT04973722|Denosumab|denosumab|mesh-list
154456624|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154456625|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456626|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154456627|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
154456628|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456629|NCT02209974|Fluticasone|fluticasone|mesh-list
154456630|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456631|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154456632|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
154456633|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456634|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456635|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154456636|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
154456637|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
154456638|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154456639|NCT02212392|Meropenem|meropenem|mesh-list
154456640|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154456641|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456642|NCT03679897|Ropivacaine|ropivacaine|mesh-list
154456643|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
154456644|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154456645|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
154456646|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
154456647|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456648|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456649|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
154456650|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456651|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
154456652|NCT03060070|Ketamine|ketamine|mesh-list
154456653|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154456654|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456655|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456656|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456657|NCT03060070|Analgesics|analgesics|mesh-ancestor
154456658|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
154456659|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456660|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154456661|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154456662|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154456663|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
154456664|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456665|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456666|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154456667|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154456668|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
154456669|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
154456670|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154456671|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154456672|NCT03683563|Citric Acid|citric acid|mesh-list
154456673|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
154456674|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
154456675|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154456676|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
154456677|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
154456678|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456679|NCT03563625|Bupivacaine|bupivacaine|mesh-list
154456680|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
154456681|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
154456682|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456683|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456684|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
154456685|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456686|NCT02832375|Fluorides|fluorides|mesh-list
154456687|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
154456688|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
154456689|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
154456690|NCT02832375|Protective Agents|protective agents|mesh-ancestor
154456691|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456692|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154456693|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456694|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
154456695|NCT02218476|Vitamins|vitamins|mesh-ancestor
154456696|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
154456697|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456698|NCT02205996|Insulin|insulin|mesh-list
154456699|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154456700|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154456701|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456702|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
154456703|NCT02220036|Antacids|antacids|mesh-ancestor
154456704|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456705|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154456706|NCT02220114|Vigabatrin|vigabatrin|mesh-list
154456707|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
154456708|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456709|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456710|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
154456711|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456712|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456713|NCT02221596|Vitamin D|vitamin d|mesh-list
154456714|NCT02221596|Vitamins|vitamins|mesh-ancestor
154456715|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
154456716|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456717|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154456718|NCT02221752|Folic Acid|folic acid|mesh-list
154456719|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
154456720|NCT02221752|Hematinics|hematinics|mesh-ancestor
154456721|NCT02221752|Vitamins|vitamins|mesh-ancestor
154456722|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
154456723|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456724|NCT04971382|Curcumin|curcumin|mesh-list
154456725|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154456726|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456727|NCT04971382|Analgesics|analgesics|mesh-ancestor
154456728|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
154456729|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456730|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456731|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456732|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456733|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456734|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456735|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456736|NCT02220348|Linaclotide|linaclotide|mesh-list
154456737|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154456738|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
154456739|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456740|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154456741|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
154456742|NCT04151680|Apixaban|apixaban|mesh-list
154860551|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
154456743|NCT04151680|Edoxaban|edoxaban|mesh-list
154456744|NCT04151680|Dabigatran|dabigatran|mesh-list
154456745|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154456746|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
154456747|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154456748|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
154456749|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456750|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456751|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
154456752|NCT02221830|Oxytocin|oxytocin|mesh-list
154456753|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
154456754|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154456755|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456756|NCT02224950|Emollients|emollients|mesh-list
154456757|NCT02224950|Chitosan|chitosan|mesh-list
154456758|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154456759|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154456760|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
154456761|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456762|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154456763|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
154456764|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
154456765|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
154456766|NCT02224950|Coagulants|coagulants|mesh-ancestor
154456767|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
154180654|NCT02333188|Vitamins|vitamins|mesh-ancestor
154456768|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154456769|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
154456770|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154456771|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
154456772|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456773|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456774|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154456775|NCT04970602|Methylene Blue|methylene blue|mesh-list
154456776|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456777|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456778|NCT02831673|Tenofovir|tenofovir|mesh-list
154456779|NCT02831673|Lamivudine|lamivudine|mesh-list
154456780|NCT02831673|Emtricitabine|emtricitabine|mesh-list
154456781|NCT02831673|Dolutegravir|dolutegravir|mesh-list
154456782|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
154456783|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456784|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154456785|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154456786|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456787|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456788|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154456789|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154456790|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154456791|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154456792|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
154456793|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154456794|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456795|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456796|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154456797|NCT04962958|Leucovorin|leucovorin|mesh-list
154456798|NCT04962958|Fluorouracil|fluorouracil|mesh-list
154456799|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
154456800|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
154456801|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456802|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154456803|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456804|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154456805|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
154456806|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456807|NCT04962958|Antidotes|antidotes|mesh-ancestor
154456808|NCT04962958|Protective Agents|protective agents|mesh-ancestor
154456809|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
154456810|NCT04962958|Vitamins|vitamins|mesh-ancestor
154456811|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
154456812|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
154456813|NCT02031510|Bupivacaine|bupivacaine|mesh-list
154456814|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
154456815|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
154456816|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456817|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860552|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456818|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
154456819|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456820|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154456821|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456822|NCT02031510|Analgesics|analgesics|mesh-ancestor
154456823|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154456824|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154456825|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154456826|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154456827|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456828|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456829|NCT04961788|Antibodies|antibodies|mesh-list
154456830|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
154456831|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456832|NCT02222142|Anesthetics|anesthetics|mesh-list
154456833|NCT02222142|Isoflurane|isoflurane|mesh-list
154456834|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456835|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456836|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154456837|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
154456838|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
154456839|NCT04425382|Ritonavir|ritonavir|mesh-list
154456840|NCT04425382|Lopinavir|lopinavir|mesh-list
154456841|NCT04425382|Darunavir|darunavir|mesh-list
154456842|NCT04425382|Cobicistat|cobicistat|mesh-list
154456843|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154456844|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154456845|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154456846|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
154456847|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456848|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456849|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153473509|NCT02987244|Hormones|hormones|mesh-ancestor
154456850|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154456851|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
154456852|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154456853|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154456854|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154456855|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
154456856|NCT03563937|Apixaban|apixaban|mesh-list
154456857|NCT03563937|Edoxaban|edoxaban|mesh-list
154456858|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
154456859|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154456860|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
154456861|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154456862|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
154456863|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456864|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456865|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
154456866|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154456867|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154456868|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
154456869|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456870|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456871|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154456872|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
154456873|NCT02225418|Ropivacaine|ropivacaine|mesh-list
154456874|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
154456875|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
154456876|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456877|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456878|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
154456879|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456880|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154456881|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154456882|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
154456883|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456884|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456885|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154456886|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
154456887|NCT05057130|Cisplatin|cisplatin|mesh-list
154456888|NCT05057130|Doxorubicin|doxorubicin|mesh-list
154456889|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154456890|NCT05057130|Methotrexate|methotrexate|mesh-list
154456891|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456892|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154456893|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154456894|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154860553|NCT00986180|Oxycodone|oxycodone|mesh-list
154860554|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154456895|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456896|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456897|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154456898|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
154456899|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154456900|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456901|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154456902|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
154456903|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
154456904|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154456905|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154456906|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
154456907|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456908|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154456909|NCT02222220|Metoclopramide|metoclopramide|mesh-list
154456910|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
154456911|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
154456912|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456913|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456914|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154456915|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154456916|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154456917|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
154456918|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456919|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456920|NCT03677323|Sufentanil|sufentanil|mesh-list
154456921|NCT03677323|Droperidol|droperidol|mesh-list
154456922|NCT03677323|Propofol|propofol|mesh-list
154456923|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154456924|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154456925|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456926|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154456927|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
154456928|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
154456929|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154456930|NCT03677323|Narcotics|narcotics|mesh-ancestor
154456931|NCT03677323|Analgesics|analgesics|mesh-ancestor
154456932|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
153973779|NCT06247787|Levoleucovorin|levoleucovorin|mesh-list
154456933|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456934|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154456935|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
154456936|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
154456937|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154456938|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154456939|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154456940|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154456941|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154456942|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154456943|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
154456944|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154456945|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456946|NCT02225574|Nilotinib|nilotinib|mesh-list
154456947|NCT02225574|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154456948|NCT02225574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154456949|NCT02225574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154456950|NCT02225574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456951|NCT02225652|Paclitaxel|paclitaxel|mesh-list
154456952|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
154456953|NCT02225652|Fluorouracil|fluorouracil|mesh-list
154456954|NCT02225652|Epirubicin|epirubicin|mesh-list
154456955|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154456956|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456957|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
154456958|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
154456959|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
154456960|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154456961|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154456962|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
154456963|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456964|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456965|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154456966|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
154456967|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154456968|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
154456969|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154860555|NCT00986180|Narcotics|narcotics|mesh-ancestor
154456970|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154456971|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154456972|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154456973|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737722|NCT04742023|Insulin|insulin|mesh-list
154456974|NCT02222376|Pirfenidone|pirfenidone|mesh-list
154456975|NCT02222376|Analgesics|analgesics|mesh-ancestor
154456976|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
154456977|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154456978|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456979|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154456980|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154456981|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154456982|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154456983|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154456984|NCT02231658|Liraglutide|liraglutide|mesh-list
154456985|NCT02231658|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154456986|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154456987|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154456988|NCT02231658|Incretins|incretins|mesh-ancestor
154456990|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154456991|NCT04542408|Heparin|heparin|mesh-list
154456992|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154456993|NCT04542408|Tinzaparin|tinzaparin|mesh-list
154456994|NCT04542408|Dalteparin|dalteparin|mesh-list
154456995|NCT04542408|Edoxaban|edoxaban|mesh-list
154456996|NCT04542408|Anticoagulants|anticoagulants|mesh-list
154456997|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154456998|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154456999|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457000|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154457001|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
154457002|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154457003|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
154457004|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457005|NCT03059134|Mirabegron|mirabegron|mesh-list
154457006|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154457007|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154457008|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154457009|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154457010|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457011|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457012|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457013|NCT03059134|Urological Agents|urological agents|mesh-ancestor
154457014|NCT02928991|Vidarabine|vidarabine|mesh-list
154457015|NCT02928991|Fludarabine|fludarabine|mesh-list
154457016|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
154457017|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457018|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154457019|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
154457020|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457021|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457022|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
154457023|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457024|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
154457025|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154457026|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153737768|NCT04535401|Leucovorin|leucovorin|mesh-list
154457027|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154457028|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457029|NCT04957420|Rotigotine|rotigotine|mesh-list
154457030|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
154457031|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
154457032|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457033|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457034|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457035|NCT03350035|Ganaxolone|ganaxolone|mesh-list
154457036|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
154457037|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457038|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457039|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457040|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
154457041|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
154457042|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
154457043|NCT02905188|Fludarabine|fludarabine|mesh-list
154457044|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457045|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
154457046|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457047|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457048|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154457049|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
154457050|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457051|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457052|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154457053|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
154457054|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
154457055|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457056|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
154457057|NCT03671941|Ticagrelor|ticagrelor|mesh-list
154457058|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154457059|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154457060|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154457061|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154457062|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
154457063|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457064|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457065|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457066|NCT03058900|Methotrexate|methotrexate|mesh-list
154457067|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154457068|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
154457069|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154457070|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457071|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154457072|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
154457073|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457074|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457075|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
154457076|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457077|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154457078|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457079|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
154457080|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457081|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154457082|NCT02226510|Metformin|metformin|mesh-list
154457083|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154457084|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457085|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
154457086|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
153737843|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
154457087|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457088|NCT02225886|Protective Agents|protective agents|mesh-ancestor
154457089|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457090|NCT02225886|Vitamins|vitamins|mesh-ancestor
154457091|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
154457092|NCT03671707|Nicotine|nicotine|mesh-list
154457093|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154457094|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
154457095|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457096|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457097|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154457098|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154457099|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
154457100|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457101|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457102|NCT02226588|Misoprostol|misoprostol|mesh-list
154457103|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154457104|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
154457105|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154457106|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457107|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154457108|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457109|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
154457110|NCT03676621|Misoprostol|misoprostol|mesh-list
154457111|NCT03676621|Oxytocin|oxytocin|mesh-list
154457112|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
154457113|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154457114|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457115|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154457116|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
154457117|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154457118|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457119|NCT03678649|Capecitabine|capecitabine|mesh-list
154457120|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154457121|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
154457122|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457123|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457124|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
154457125|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154457126|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457127|NCT02845297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154457128|NCT02845297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457129|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154457130|NCT02232360|Fenofibrate|fenofibrate|mesh-list
154457131|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154457132|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154457133|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
154457134|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457135|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153737938|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154457136|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154457137|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457138|NCT02226978|Ritonavir|ritonavir|mesh-list
154457139|NCT02226978|Tipranavir|tipranavir|mesh-list
154457140|NCT02226978|Valacyclovir|valacyclovir|mesh-list
154457141|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154457142|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154457143|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
154457144|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457145|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457146|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154457147|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154457148|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
154457149|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154457150|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154457151|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154457152|NCT02227056|Methylphenidate|methylphenidate|mesh-list
154457153|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154457154|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457155|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154457156|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154457157|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154457158|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457159|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
154457160|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457161|NCT05708157|Histamine Antagonists|histamine antagonists|mesh-list
154457162|NCT05708157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154457163|NCT05708157|Histamine Agents|histamine agents|mesh-ancestor
154457164|NCT05708157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457165|NCT05708157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457166|NCT05708157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457167|NCT03058744|Clobetasol|clobetasol|mesh-list
154457168|NCT03058744|Halobetasol|halobetasol|mesh-list
154457169|NCT03058744|Tazarotene|tazarotene|mesh-list
154457170|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
154457171|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
154457172|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154457173|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457174|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
154457175|NCT03058744|Hormones|hormones|mesh-ancestor
154457176|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457177|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457178|NCT02734537|Cisplatin|cisplatin|mesh-list
154457179|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457180|NCT03059056|Empagliflozin|empagliflozin|mesh-list
154457181|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154457182|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457183|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154457184|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457185|NCT03058666|Calfactant|calfactant|mesh-list
154457186|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154457187|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
154457188|NCT02227212|Insulin|insulin|mesh-list
154457189|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
154457190|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154457191|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457192|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
154457193|NCT00303849|Carboplatin|carboplatin|mesh-list
154457194|NCT00303849|Etoposide|etoposide|mesh-list
154457195|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
154457196|NCT00303849|Melphalan|melphalan|mesh-list
154457197|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
154457198|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
154457199|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154457200|NCT00303849|Mannitol|mannitol|mesh-list
154457201|NCT00303849|Antidotes|antidotes|mesh-list
154457202|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457203|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154457204|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154457205|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154457206|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457207|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457208|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154457209|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
154457210|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154457211|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457212|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
154457213|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457214|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154457215|NCT00303849|Diuretics|diuretics|mesh-ancestor
154457216|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
154457217|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
154457218|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154457219|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
154457220|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
154457221|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
154457222|NCT00303849|Protective Agents|protective agents|mesh-ancestor
154181102|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
154457223|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
154457224|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
154457225|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154457226|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154457227|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
154457228|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
154457229|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
154457230|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154457231|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
154457232|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457233|NCT01355523|Melatonin|melatonin|mesh-list
154457234|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
154457235|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457236|NCT01355523|Protective Agents|protective agents|mesh-ancestor
154457237|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457238|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457239|NCT02227914|Sorafenib|sorafenib|mesh-list
154457240|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457241|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457242|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457243|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457244|NCT04161456|Apremilast|apremilast|mesh-list
154457245|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154457246|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154457247|NCT04161456|Analgesics|analgesics|mesh-ancestor
154457248|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
154457249|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457250|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457251|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457252|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457253|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154457254|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154457255|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457256|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457257|NCT02224014|Brotizolam|brotizolam|mesh-list
154457258|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154457259|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457260|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457261|NCT03671161|Insulin|insulin|mesh-list
154457262|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154457263|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457264|NCT04950400|Apatinib|apatinib|mesh-list
154457265|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457266|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457267|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457268|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860556|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457269|NCT04949932|Turmeric extract|turmeric extract|mesh-list
154457270|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
154457271|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457272|NCT04949932|Protective Agents|protective agents|mesh-ancestor
154457273|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457274|NCT02826603|Ustekinumab|ustekinumab|mesh-list
154457275|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154457276|NCT02224170|Dexamethasone|dexamethasone|mesh-list
154457277|NCT02224170|Lidocaine|lidocaine|mesh-list
154457278|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457279|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
154457280|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
154457281|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457282|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457283|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457284|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
154457285|NCT02224170|Hormones|hormones|mesh-ancestor
154457286|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457287|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154457288|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457289|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
154457290|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
154457291|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457292|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
154457293|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154457294|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154457295|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154457296|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154457297|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181180|NCT00882323|Fludarabine|fludarabine|mesh-list
154457298|NCT05956639|Androgen Antagonists|androgen antagonists|mesh-list
154457299|NCT05956639|Hormone Antagonists|hormone antagonists|mesh-ancestor
154457300|NCT05956639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457301|NCT05956639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457302|NCT05956600|Amisulpride|amisulpride|mesh-list
154457303|NCT05956600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154457304|NCT05956600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154457305|NCT05956600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457306|NCT05956600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457307|NCT05956600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154457308|NCT05956600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154457309|NCT05956600|Dopamine Agents|dopamine agents|mesh-ancestor
154457310|NCT05956600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457311|NCT05956600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457312|NCT05956600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154457313|NCT05956600|Antidepressive Agents|antidepressive agents|mesh-ancestor
154457314|NCT05956561|Vitamin D|vitamin d|mesh-list
154457315|NCT05956561|Vitamins|vitamins|mesh-ancestor
154457316|NCT05956561|Micronutrients|micronutrients|mesh-ancestor
154457317|NCT05956561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457318|NCT05956561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154457319|NCT05956522|Empagliflozin|empagliflozin|mesh-list
154457320|NCT05956522|Linagliptin|linagliptin|mesh-list
154457321|NCT05956522|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154457322|NCT05956522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457323|NCT05956522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154457324|NCT05956522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457325|NCT05956522|Incretins|incretins|mesh-ancestor
154457326|NCT05956522|Hormones|hormones|mesh-ancestor
154457327|NCT05956522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457328|NCT05956522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154457329|NCT05956522|Protease Inhibitors|protease inhibitors|mesh-ancestor
154457330|NCT05956522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457331|NCT05956431|Simendan|simendan|mesh-list
154457332|NCT05956431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154457333|NCT05956431|Vasodilator Agents|vasodilator agents|mesh-ancestor
154457334|NCT05956431|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154457335|NCT05956431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154457336|NCT05956431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457337|NCT05956431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457338|NCT05956431|Protective Agents|protective agents|mesh-ancestor
154457339|NCT05956431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457340|NCT05956418|Citric Acid|citric acid|mesh-list
154457341|NCT05956418|Sodium Citrate|sodium citrate|mesh-list
154457342|NCT05956418|Anticoagulants|anticoagulants|mesh-ancestor
154457343|NCT05956418|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154457344|NCT05956418|Chelating Agents|chelating agents|mesh-ancestor
154457345|NCT05956418|Sequestering Agents|sequestering agents|mesh-ancestor
154457346|NCT05956418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457347|NCT05956275|Tramadol|tramadol|mesh-list
154457348|NCT05956275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154457349|NCT05956275|Narcotics|narcotics|mesh-ancestor
154457350|NCT05956275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457351|NCT05956275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457352|NCT05956275|Analgesics|analgesics|mesh-ancestor
154457353|NCT05956275|Sensory System Agents|sensory system agents|mesh-ancestor
154457354|NCT05956275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457355|NCT05956145|Colchicine|colchicine|mesh-list
154457356|NCT05956145|Gout Suppressants|gout suppressants|mesh-ancestor
154457357|NCT05956145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457358|NCT05956145|Tubulin Modulators|tubulin modulators|mesh-ancestor
154457359|NCT05956145|Antimitotic Agents|antimitotic agents|mesh-ancestor
154457360|NCT05956145|Mitosis Modulators|mitosis modulators|mesh-ancestor
154457361|NCT05956145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457362|NCT05956145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457363|NCT05955833|Trastuzumab|trastuzumab|mesh-list
154457364|NCT05955833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154457365|NCT05955833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457366|NCT05955677|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154457367|NCT05955677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154457368|NCT05955677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457369|NCT05955313|Naltrexone|naltrexone|mesh-list
154457370|NCT05955313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154457371|NCT05955313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154457372|NCT05955313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457373|NCT05955313|Sensory System Agents|sensory system agents|mesh-ancestor
154457374|NCT05955313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457375|NCT05955209|Disitamab vedotin|disitamab vedotin|mesh-list
154457376|NCT05955209|Immunoconjugates|immunoconjugates|mesh-ancestor
154457377|NCT05955209|Immunologic Factors|immunologic factors|mesh-ancestor
154457378|NCT05955209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457379|NCT05952349|Metformin|metformin|mesh-list
154457380|NCT05952349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154457381|NCT05952349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457382|NCT05952310|Immunomodulating Agents|immunomodulating agents|mesh-list
154457383|NCT05952310|Immunologic Factors|immunologic factors|mesh-ancestor
154457384|NCT05952310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457385|NCT05951504|Methylprednisolone|methylprednisolone|mesh-list
154457386|NCT05951504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154457387|NCT05951504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154457388|NCT05951504|Prednisolone|prednisolone|mesh-list
154457389|NCT05951504|Prednisolone acetate|prednisolone acetate|mesh-list
154457390|NCT05951504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154457391|NCT05951504|Prednisolone phosphate|prednisolone phosphate|mesh-list
154457392|NCT05951504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457393|NCT05951504|Antiemetics|antiemetics|mesh-ancestor
154457394|NCT05951504|Autonomic Agents|autonomic agents|mesh-ancestor
154457395|NCT05951504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457396|NCT05951504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457397|NCT05951504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457398|NCT05951504|Glucocorticoids|glucocorticoids|mesh-ancestor
154457399|NCT05951504|Hormones|hormones|mesh-ancestor
154457400|NCT05951504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457401|NCT05951504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154457402|NCT05951504|Protective Agents|protective agents|mesh-ancestor
154457403|NCT05951504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154457404|NCT05951504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457405|NCT05946200|Anesthetics|anesthetics|mesh-list
154457406|NCT05946200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457407|NCT05946200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457408|NCT05925166|Triamcinolone|triamcinolone|mesh-list
154457409|NCT05925166|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154457410|NCT05925166|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154457411|NCT05925166|Etanercept|etanercept|mesh-list
154457412|NCT05925166|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154457413|NCT05925166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457414|NCT05925166|Glucocorticoids|glucocorticoids|mesh-ancestor
154457415|NCT05925166|Hormones|hormones|mesh-ancestor
154457416|NCT05925166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457417|NCT05925166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457418|NCT05925166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457419|NCT05925166|Immunologic Factors|immunologic factors|mesh-ancestor
154457420|NCT05925166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457421|NCT05925166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457422|NCT05925166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154457423|NCT05925166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154457424|NCT05925166|Analgesics|analgesics|mesh-ancestor
154457425|NCT05925166|Sensory System Agents|sensory system agents|mesh-ancestor
154457426|NCT05925166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457427|NCT05925166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457428|NCT05925166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457429|NCT05914155|Rituximab|rituximab|mesh-list
154457430|NCT05914155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154457431|NCT05914155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457432|NCT05914155|Immunologic Factors|immunologic factors|mesh-ancestor
154457433|NCT05914155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457434|NCT05914155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457435|NCT05896293|Hormones|hormones|mesh-list
154457436|NCT05896293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457437|NCT05896293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457438|NCT05881928|Lamotrigine|lamotrigine|mesh-list
154457439|NCT05881928|Valproic Acid|valproic acid|mesh-list
154457440|NCT05881928|Anticonvulsants|anticonvulsants|mesh-ancestor
154457441|NCT05881928|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154457442|NCT05881928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154457443|NCT05881928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457444|NCT05881928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154457445|NCT05881928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457446|NCT05881928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154457447|NCT05881928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154457448|NCT05881928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457449|NCT05881928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154457450|NCT05881928|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154457451|NCT05881928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457452|NCT05881928|GABA Agents|gaba agents|mesh-ancestor
154457453|NCT05881928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457454|NCT05881928|Antimanic Agents|antimanic agents|mesh-ancestor
154457455|NCT05872893|Dexamethasone|dexamethasone|mesh-list
154457456|NCT05872893|Ondansetron|ondansetron|mesh-list
154457457|NCT05872893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457458|NCT05872893|Antiemetics|antiemetics|mesh-ancestor
154457459|NCT05872893|Autonomic Agents|autonomic agents|mesh-ancestor
154457460|NCT05872893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457461|NCT05872893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457462|NCT05872893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457463|NCT05872893|Glucocorticoids|glucocorticoids|mesh-ancestor
154457464|NCT05872893|Hormones|hormones|mesh-ancestor
153738352|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
154457465|NCT05872893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457466|NCT05872893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154457467|NCT05872893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457468|NCT05872893|Antipruritics|antipruritics|mesh-ancestor
154457469|NCT05872893|Dermatologic Agents|dermatologic agents|mesh-ancestor
154457470|NCT05872893|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154457471|NCT05872893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154457472|NCT05872893|Serotonin Agents|serotonin agents|mesh-ancestor
154457473|NCT05872893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457474|NCT05872893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457475|NCT05826275|Pembrolizumab|pembrolizumab|mesh-list
154457476|NCT05826275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154457477|NCT05826275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457478|NCT05826275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154457479|NCT05826275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457480|NCT05774249|Bupivacaine|bupivacaine|mesh-list
154457481|NCT05774249|Anesthetics, Local|anesthetics, local|mesh-ancestor
154457482|NCT05774249|Anesthetics|anesthetics|mesh-ancestor
154457483|NCT05774249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457484|NCT05774249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457485|NCT05774249|Sensory System Agents|sensory system agents|mesh-ancestor
154457486|NCT05774249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457487|NCT05767398|Zanubrutinib|zanubrutinib|mesh-list
154457488|NCT05767398|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154457489|NCT05767398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457490|NCT05767398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457491|NCT05767398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457493|NCT05634174|Mirabegron|mirabegron|mesh-list
154457494|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154457495|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154457496|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154457497|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
154457498|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457499|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457500|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457501|NCT05634174|Urological Agents|urological agents|mesh-ancestor
154457502|NCT05619705|Benzocaine|benzocaine|mesh-list
154457503|NCT05619705|Anesthetics, Local|anesthetics, local|mesh-ancestor
154457504|NCT05619705|Anesthetics|anesthetics|mesh-ancestor
154457505|NCT05619705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457506|NCT05619705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457507|NCT05619705|Sensory System Agents|sensory system agents|mesh-ancestor
154457508|NCT05619705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457509|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
154457510|NCT05604859|Heparin|heparin|mesh-list
154457511|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154457512|NCT05604859|Tinzaparin|tinzaparin|mesh-list
154457513|NCT05604859|Dalteparin|dalteparin|mesh-list
154457514|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
154457515|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154457516|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
154457517|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154457518|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457519|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
154457520|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
154457521|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457522|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457523|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457524|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
154457525|NCT05604859|Hormones|hormones|mesh-ancestor
154457526|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457527|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154457528|NCT05604859|Protective Agents|protective agents|mesh-ancestor
154457529|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
154457530|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154457531|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154457532|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457533|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
154457534|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
154457535|NCT05590234|Bupivacaine|bupivacaine|mesh-list
154457536|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
154457537|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
154457538|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457539|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457540|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
154457541|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457542|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154457543|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154457544|NCT05590234|Analgesics|analgesics|mesh-ancestor
154457545|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154457546|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154457547|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154457548|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
154457549|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457550|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457551|NCT05540223|Sirolimus|sirolimus|mesh-list
154457552|NCT05540223|Everolimus|everolimus|mesh-list
154457553|NCT05540223|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154457554|NCT05540223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457555|NCT05540223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457556|NCT05540223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457557|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457558|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
154457559|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457560|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457561|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154457562|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154457563|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154457564|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
154457565|NCT05476172|Dienogest|dienogest|mesh-list
154457566|NCT05476172|Norethindrone|norethindrone|mesh-list
154457567|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
153738510|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
154457568|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154457569|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154457570|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154457571|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
154457572|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154457573|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457574|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154457575|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154457576|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154457577|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
154457578|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457579|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154457580|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457581|NCT05432518|Everolimus|everolimus|mesh-list
154457582|NCT05432518|Dasatinib|dasatinib|mesh-list
154457583|NCT05432518|Olaparib|olaparib|mesh-list
154457584|NCT05432518|Palbociclib|palbociclib|mesh-list
154457585|NCT05432518|Afatinib|afatinib|mesh-list
154457586|NCT05432518|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154457587|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457588|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457589|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457590|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457591|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
154457592|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457593|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457594|NCT05432518|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154457595|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154457596|NCT05413096|Propolis|propolis|mesh-list
154457597|NCT05413096|Diclofenac|diclofenac|mesh-list
154457598|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154457599|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154457600|NCT05413096|Analgesics|analgesics|mesh-ancestor
154457601|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
154457602|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457603|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457604|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457605|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457606|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154457607|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457608|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457609|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154457610|NCT05391061|Abrocitinib|abrocitinib|mesh-list
154457611|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457612|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457613|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457614|NCT05375994|Adagrasib|adagrasib|mesh-list
154457615|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457616|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
154457617|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457618|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457619|NCT05214287|Nitrox|nitrox|mesh-list
154457620|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154457621|NCT05214287|Protective Agents|protective agents|mesh-ancestor
154457622|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457623|NCT05182931|Trametinib|trametinib|mesh-list
154457624|NCT05182931|Dabrafenib|dabrafenib|mesh-list
154457625|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457626|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457627|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457628|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457629|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
154457630|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
154457631|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457632|NCT05126836|Cilostazol|cilostazol|mesh-list
154457633|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154457634|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
154457635|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457636|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457637|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154457638|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
154457639|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154457640|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154254872|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860557|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457641|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457642|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154457643|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
154457644|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154457645|NCT05126836|Protective Agents|protective agents|mesh-ancestor
154457646|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154457647|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154457648|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457649|NCT05050357|Norethindrone|norethindrone|mesh-list
153738616|NCT00004198|Sargramostim|sargramostim|mesh-list
154457650|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
154457651|NCT05050357|Progestins|progestins|mesh-list
154457652|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154457653|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154457654|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154457655|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
154457656|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154457657|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457658|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154457659|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154457660|NCT05050357|Hormones|hormones|mesh-ancestor
154457661|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457662|NCT05008809|Leucovorin|leucovorin|mesh-list
154457663|NCT05008809|Fluorouracil|fluorouracil|mesh-list
154457664|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
154457665|NCT05008809|Irinotecan|irinotecan|mesh-list
154457666|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
154457667|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
154457668|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457669|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154457670|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457671|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457672|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
154457673|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457674|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154457675|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154457676|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457677|NCT05008809|Antidotes|antidotes|mesh-ancestor
154457678|NCT05008809|Protective Agents|protective agents|mesh-ancestor
154457679|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
154457680|NCT05008809|Vitamins|vitamins|mesh-ancestor
154457681|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
154457682|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
154457683|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154457684|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
154457685|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154457686|NCT04964843|Expectorants|expectorants|mesh-ancestor
154457687|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
154457688|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154457689|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
154457690|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457691|NCT04964843|Protective Agents|protective agents|mesh-ancestor
154457692|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457693|NCT04964843|Antidotes|antidotes|mesh-ancestor
154457694|NCT04946825|Nicotine|nicotine|mesh-list
154457695|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154457696|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
154457697|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457698|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457699|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154457700|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154457701|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
154457702|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457703|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457704|NCT04898387|Timolol|timolol|mesh-list
154457705|NCT04898387|Bimatoprost|bimatoprost|mesh-list
154457706|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154457707|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154457708|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
154457709|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457710|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457711|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457712|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154457713|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154457714|NCT04848753|Paclitaxel|paclitaxel|mesh-list
154457715|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154457716|NCT04848753|Cisplatin|cisplatin|mesh-list
154860558|NCT00986180|Analgesics|analgesics|mesh-ancestor
154457717|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154457718|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457720|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
154457721|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
154457722|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457723|NCT04823247|Interleukin-23|interleukin-23|mesh-list
154457724|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154457725|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154457726|NCT04823247|Growth Substances|growth substances|mesh-ancestor
154457727|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457728|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
154457729|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457730|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
154457731|NCT04772222|Morphine|morphine|mesh-list
154457732|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154457733|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154457734|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457735|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154457736|NCT04772222|Analgesics|analgesics|mesh-ancestor
154457737|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
154457738|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457739|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154457740|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154457741|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154457742|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
154457743|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457744|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457745|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154457746|NCT04772222|Narcotics|narcotics|mesh-ancestor
154457747|NCT04766021|Mirabegron|mirabegron|mesh-list
154457748|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154457749|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154457750|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154457751|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
154457752|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457753|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457754|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457755|NCT04766021|Urological Agents|urological agents|mesh-ancestor
154457757|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
154457758|NCT04648969|Hormones|hormones|mesh-list
154457759|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457760|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457761|NCT04545866|Budesonide|budesonide|mesh-list
154457762|NCT04545866|Poractant alfa|poractant alfa|mesh-list
154457763|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154457764|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457765|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154457766|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
154457767|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457768|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457769|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154457770|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
154457771|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
154457772|NCT04545866|Hormones|hormones|mesh-ancestor
154457773|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457774|NCT04407442|Dexamethasone|dexamethasone|mesh-list
154457775|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
154457776|NCT04407442|Azacitidine|azacitidine|mesh-list
154457777|NCT04407442|Daratumumab|daratumumab|mesh-list
154457778|NCT04407442|Ichthammol|ichthammol|mesh-list
154457779|NCT04407442|BB 1101|bb 1101|mesh-list
154457780|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457781|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
154457782|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
154457783|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457784|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457785|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457786|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
154457787|NCT04407442|Hormones|hormones|mesh-ancestor
154457788|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457789|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154457790|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457791|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
154457792|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457793|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457794|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154457795|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
154457796|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
154457797|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154457798|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
154457799|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457800|NCT04345796|Empagliflozin|empagliflozin|mesh-list
154457801|NCT04345796|Carvedilol|carvedilol|mesh-list
154457802|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154457803|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457804|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154457805|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457806|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154457807|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154457808|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
154457809|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457810|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154457811|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
154457812|NCT04345796|Protective Agents|protective agents|mesh-ancestor
154457813|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154457814|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154457815|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154457816|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
154457817|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154457818|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154457819|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154457820|NCT04265612|Laxatives|laxatives|mesh-ancestor
154457821|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457822|NCT04222088|Chloroquine|chloroquine|mesh-list
154457823|NCT04222088|Lumefantrine|lumefantrine|mesh-list
154457824|NCT04222088|Primaquine|primaquine|mesh-list
154457825|NCT04222088|Amebicides|amebicides|mesh-ancestor
154181706|NCT00518180|Lactitol|lactitol|mesh-list
154457826|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154457827|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154457828|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154457829|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
154457830|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457831|NCT03978520|Upadacitinib|upadacitinib|mesh-list
154457832|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154457833|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457834|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457835|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457836|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457837|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154457838|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154457839|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457840|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457841|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
154457842|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457843|NCT03896685|Linezolid|linezolid|mesh-list
154457844|NCT03896685|Bedaquiline|bedaquiline|mesh-list
154457845|NCT03896685|Clofazimine|clofazimine|mesh-list
154457846|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154457847|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154457848|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154457849|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457850|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457851|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
154457852|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457853|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
154457854|NCT03874715|Insulin|insulin|mesh-list
154457855|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154457856|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
154457857|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
154457858|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
154457859|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154457860|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154457861|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457862|NCT03801863|Ropivacaine|ropivacaine|mesh-list
154457863|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
154860559|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
154457864|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
154457865|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254873|NCT01252160|Capsaicin|capsaicin|mesh-list
154457866|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457867|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
154457868|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457869|NCT03664037|Dexamethasone|dexamethasone|mesh-list
154457870|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154457871|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457872|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
154457873|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
154457874|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457875|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457876|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154457877|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
154457878|NCT03664037|Hormones|hormones|mesh-ancestor
154457879|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154457880|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154457881|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457882|NCT03538457|Acetaminophen|acetaminophen|mesh-list
154457883|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154457884|NCT03538457|Analgesics|analgesics|mesh-ancestor
154457885|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
154457886|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457887|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457888|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
154457889|NCT03535376|Valsartan|valsartan|mesh-list
154457890|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154457891|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154457892|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154457893|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457894|NCT03336242|Cannabidiol|cannabidiol|mesh-list
154457895|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
154457896|NCT03333395|Heparin|heparin|mesh-list
154457897|NCT03333395|Albuterol|albuterol|mesh-list
154457898|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
154457899|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154457900|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154457901|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457902|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154457903|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
154457904|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457905|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457906|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154457907|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
154457908|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
154457909|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154457910|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154457911|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154457912|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154457913|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
154457914|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154457915|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
154457916|NCT03328104|Etoposide|etoposide|mesh-list
154457917|NCT03328104|Everolimus|everolimus|mesh-list
154457918|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154457919|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
154457920|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457921|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457922|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154457923|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
154457924|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457925|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457926|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154457927|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154457928|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154457929|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154457930|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457931|NCT03328104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154457932|NCT03328104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457933|NCT02919449|Atezolizumab|atezolizumab|mesh-list
154457934|NCT02919449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154457935|NCT02919449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457936|NCT02919449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154457937|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457938|NCT02904291|Amlodipine|amlodipine|mesh-list
154457939|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154860560|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457940|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154457941|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154457942|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457943|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154457944|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457945|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
154457946|NCT02796859|Siltuximab|siltuximab|mesh-list
154457947|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457948|NCT02769832|Paclitaxel|paclitaxel|mesh-list
154457949|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154457950|NCT02769832|Gemcitabine|gemcitabine|mesh-list
154457951|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154457952|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457953|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
154457954|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
154457955|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
154457956|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457957|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154457958|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
154457959|NCT02706704|Adalimumab|adalimumab|mesh-list
154457960|NCT02706704|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154457961|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457962|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154457963|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
154457964|NCT02326311|Dasatinib|dasatinib|mesh-list
154457965|NCT02326311|Nilotinib|nilotinib|mesh-list
154457966|NCT02326311|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154457967|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154457968|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457969|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457970|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457971|NCT02324543|Gemcitabine|gemcitabine|mesh-list
154457972|NCT02324543|Docetaxel|docetaxel|mesh-list
154457973|NCT02324543|Capecitabine|capecitabine|mesh-list
154457974|NCT02324543|Irinotecan|irinotecan|mesh-list
154457975|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457976|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154457977|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
154457978|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457979|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
154457980|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
154457981|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
154457982|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154457983|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153739282|NCT00509431|Sirolimus|sirolimus|mesh-list
154457984|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154457986|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154457987|NCT02055638|SRX246|srx246|mesh-list
154457988|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154457989|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154457990|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
154457991|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154457992|NCT01850524|Dexamethasone|dexamethasone|mesh-list
154457993|NCT01850524|Lenalidomide|lenalidomide|mesh-list
154457994|NCT01850524|Ixazomib|ixazomib|mesh-list
154457995|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154457996|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
154457997|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
154457998|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154457999|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458000|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154458001|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
154458002|NCT01850524|Hormones|hormones|mesh-ancestor
154458003|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458004|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154458005|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458006|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
154458007|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154458008|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154458009|NCT01850524|Growth Substances|growth substances|mesh-ancestor
154458010|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
154458011|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
154458012|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458013|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458014|NCT01664910|Rituximab|rituximab|mesh-list
154458015|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154458016|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154458017|NCT01664910|Methotrexate|methotrexate|mesh-list
154458018|NCT01664910|Fludarabine|fludarabine|mesh-list
154458019|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
154458020|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154458021|NCT01664910|Antibodies|antibodies|mesh-list
154458022|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
154458023|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154458024|NCT01664910|Tacrolimus|tacrolimus|mesh-list
154458025|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
154458026|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154458027|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
154458028|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458029|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458030|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458031|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154458032|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
154458033|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154458034|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154458035|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
154458036|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458037|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
154458038|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458039|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154458040|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458041|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154458042|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154458043|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458044|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
154458045|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154458046|NCT01664910|Immunotoxins|immunotoxins|mesh-ancestor
154458047|NCT01664910|Immunoconjugates|immunoconjugates|mesh-ancestor
154458048|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
154458049|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154458050|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
154458051|NCT00764595|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154458052|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154458053|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458054|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458055|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458056|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
154458057|NCT00576979|Etoposide|etoposide|mesh-list
154458058|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
154458059|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458060|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
154458061|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458062|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458063|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458064|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
154458065|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458066|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458067|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154458068|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154458069|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154458070|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154458071|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458072|NCT03563235|Calcitriol|calcitriol|mesh-list
153739507|NCT00338338|Amlodipine|amlodipine|mesh-list
154458073|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154458074|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458075|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154458076|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154458077|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458078|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154458079|NCT03563235|Vitamins|vitamins|mesh-ancestor
154458080|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
154458081|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154458082|NCT01329900|Etoposide|etoposide|mesh-list
154458083|NCT01329900|Ifosfamide|ifosfamide|mesh-list
154458084|NCT01329900|Ofatumumab|ofatumumab|mesh-list
154458085|NCT01329900|Lenograstim|lenograstim|mesh-list
154458086|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154458087|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458088|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154458089|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154458090|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458091|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860561|NCT01056601|Bortezomib|bortezomib|mesh-list
154458092|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458093|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
154458094|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154458095|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
154458096|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458097|NCT04948372|Terlipressin|terlipressin|mesh-list
154458098|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154458099|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154458100|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154458101|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458102|NCT04947826|Antibodies|antibodies|mesh-list
154458103|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
154458104|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
154458105|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458106|NCT02228616|Lactulose|lactulose|mesh-list
154458107|NCT02228616|Prucalopride|prucalopride|mesh-list
154458108|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154458109|NCT02228616|Laxatives|laxatives|mesh-ancestor
154458110|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154458111|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154458112|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
154458113|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458114|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458115|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458116|NCT02228772|Cytarabine|cytarabine|mesh-list
154458117|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
154458118|NCT02228772|Doxorubicin|doxorubicin|mesh-list
154458119|NCT02228772|Methotrexate|methotrexate|mesh-list
154458120|NCT02228772|Vincristine|vincristine|mesh-list
154458121|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
154182005|NCT06169280|Antidotes|antidotes|mesh-ancestor
154182006|NCT06164821|Luspatercept|luspatercept|mesh-list
154182007|NCT06164821|Hematinics|hematinics|mesh-ancestor
154182008|NCT06158841|Dexamethasone|dexamethasone|mesh-list
154182009|NCT06158841|Bortezomib|bortezomib|mesh-list
154182010|NCT06158841|Pomalidomide|pomalidomide|mesh-list
154182011|NCT06158841|Elotuzumab|elotuzumab|mesh-list
154182012|NCT06158841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182013|NCT06158841|Antiemetics|antiemetics|mesh-ancestor
154182014|NCT06158841|Autonomic Agents|autonomic agents|mesh-ancestor
154458123|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458124|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
154458125|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458126|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458127|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458128|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
154458129|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458130|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458131|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154458132|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154458133|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154458134|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154458135|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458136|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154458137|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
154458138|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154458139|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154458140|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
154458141|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
154458142|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154458143|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154458144|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
154458145|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458146|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154458147|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
154458148|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
154458149|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
154458150|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
154458151|NCT02228850|Alprostadil|alprostadil|mesh-list
154458152|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154458153|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
154458154|NCT02228850|Urological Agents|urological agents|mesh-ancestor
154458155|NCT03563001|Budesonide|budesonide|mesh-list
154458156|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
154458157|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860562|NCT01056601|Panobinostat|panobinostat|mesh-list
154458158|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154458159|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
154458160|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458162|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154458163|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
154458164|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
154458165|NCT03563001|Hormones|hormones|mesh-ancestor
154458166|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458167|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154458168|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154458169|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154458170|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
154458171|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458172|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458173|NCT02228928|Capsaicin|capsaicin|mesh-list
154458174|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
154458175|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
154458176|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
154458177|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458178|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458179|NCT03888378|Minocycline|minocycline|mesh-list
154458180|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154458181|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458182|NCT03603288|Idebenone|idebenone|mesh-list
154458183|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
154458184|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458185|NCT03603288|Protective Agents|protective agents|mesh-ancestor
154458186|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458187|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154458188|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154458189|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154458190|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154458191|NCT03844074|Bevacizumab|bevacizumab|mesh-list
154458192|NCT03844074|Ranibizumab|ranibizumab|mesh-list
154458193|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154458194|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458195|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154458196|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154458198|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458199|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
154458200|NCT02624986|Rituximab|rituximab|mesh-list
154458201|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
154458202|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154458203|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458204|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
154458205|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458206|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458207|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
154458208|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458209|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
154458210|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458211|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458212|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458213|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
154458214|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458215|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458216|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154458217|NCT04945096|Cytarabine|cytarabine|mesh-list
154458218|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
154458219|NCT04945096|Cyclosporine|cyclosporine|mesh-list
154458220|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
154458221|NCT04945096|Busulfan|busulfan|mesh-list
154458222|NCT04945096|Semustine|semustine|mesh-list
154458223|NCT04945096|Decitabine|decitabine|mesh-list
154458224|NCT04945096|Cyclosporins|cyclosporins|mesh-list
154458225|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
154458226|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154458227|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458228|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
154458229|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458230|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458231|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458232|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
154458233|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458234|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458235|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154458236|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154458237|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
154458238|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
154458239|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458240|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458241|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
154458242|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
154458243|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154458244|NCT04945096|Expectorants|expectorants|mesh-ancestor
154458245|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
154458246|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154458247|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
154458248|NCT04945096|Protective Agents|protective agents|mesh-ancestor
154458249|NCT04944082|Ivermectin|ivermectin|mesh-list
154458250|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154458251|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458252|NCT04943692|Metformin|metformin|mesh-list
154458253|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154458254|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458255|NCT02587598|Cytarabine|cytarabine|mesh-list
154458256|NCT02587598|Azacitidine|azacitidine|mesh-list
154458257|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154458258|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
154458259|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458260|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458261|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
154458262|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458263|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458264|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
154458265|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458266|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458267|NCT04943146|Aspirin|aspirin|mesh-list
154458268|NCT04943146|Prednisone|prednisone|mesh-list
154458269|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458270|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
154458271|NCT04943146|Hormones|hormones|mesh-ancestor
154458272|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458273|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458274|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154458275|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458276|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154458277|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154458279|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
154458280|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458281|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458282|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154458283|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154458284|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458285|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154458286|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154458287|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458288|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
154458289|NCT02485574|Calcium|calcium|mesh-list
154458290|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154458291|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458292|NCT04942834|Amiodarone|amiodarone|mesh-list
154458293|NCT04942834|Sotalol|sotalol|mesh-list
154458294|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154458295|NCT04942834|Dronedarone|dronedarone|mesh-list
154458296|NCT04942834|Propafenone|propafenone|mesh-list
154458297|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
154458298|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154458299|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154458300|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458301|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154458302|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154458303|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154458304|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458305|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154458306|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154458307|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154458308|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154458309|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154458310|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
154458311|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458312|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458313|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
154458315|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458316|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154458317|NCT04941976|Benzydamine|benzydamine|mesh-list
154458318|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458319|NCT01291004|Drospirenone|drospirenone|mesh-list
154458320|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154458321|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154458322|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
154458323|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154458324|NCT01291004|Desogestrel|desogestrel|mesh-list
154458325|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
154458326|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
154458327|NCT01291004|Estradiol|estradiol|mesh-list
154458328|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154458329|NCT01291004|Estrogens|estrogens|mesh-ancestor
154458330|NCT01291004|Hormones|hormones|mesh-ancestor
154458331|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458332|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458333|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154458334|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154458335|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154458336|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154458337|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154458338|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154458339|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
154458340|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154458341|NCT01291004|Diuretics|diuretics|mesh-ancestor
154458342|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
154458343|NCT01291004|Progestins|progestins|mesh-ancestor
154458344|NCT04941118|Anesthetics|anesthetics|mesh-list
154458345|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
154458346|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458347|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458348|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
154458349|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458350|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
154458351|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458352|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
154458353|NCT00374660|Irofulven|irofulven|mesh-list
154458354|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458355|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458356|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
154458357|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458358|NCT02624050|Propofol|propofol|mesh-list
154458359|NCT02624050|Methohexital|methohexital|mesh-list
154458360|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153740276|NCT00515788|Cytarabine|cytarabine|mesh-list
154458361|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458362|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458363|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154458364|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
154458365|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
154458366|NCT03131882|Triamcinolone|triamcinolone|mesh-list
154458367|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154458368|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154458369|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
154458370|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154458371|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458372|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
154458373|NCT03131882|Hormones|hormones|mesh-ancestor
154458374|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458375|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458376|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458377|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
154458378|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458379|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458380|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154458381|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
154458382|NCT03131882|Protective Agents|protective agents|mesh-ancestor
154458383|NCT03483350|Midazolam|midazolam|mesh-list
154458384|NCT03483350|Granisetron|granisetron|mesh-list
154458385|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154458386|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154458387|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458388|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254874|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
154458389|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154458390|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154458391|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154458392|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154458393|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
154458394|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
154458395|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
154458396|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
154458397|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458398|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458399|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
154458400|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
154458401|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458402|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154458403|NCT03483350|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154458404|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154458405|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
154458406|NCT03480308|Dexamethasone|dexamethasone|mesh-list
154458408|NCT03480308|Bupivacaine|bupivacaine|mesh-list
154458409|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458410|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
154458411|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
154458412|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458413|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458414|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154458415|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
154458416|NCT03480308|Hormones|hormones|mesh-ancestor
154458417|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458418|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154458419|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740352|NCT00516100|Pemetrexed|pemetrexed|mesh-list
154458420|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
154458421|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
154458422|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154182314|NCT05612490|Furosemide|furosemide|mesh-list
154458423|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
154458424|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154458425|NCT03480308|Narcotics|narcotics|mesh-ancestor
154458426|NCT03480308|Analgesics|analgesics|mesh-ancestor
154458427|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154458428|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154458429|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
154458430|NCT05151614|Colchicine|colchicine|mesh-list
154458431|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
154458432|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458433|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
154458434|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
154458435|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
154458436|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458437|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458438|NCT04937140|Antibodies|antibodies|mesh-list
153740372|NCT02950441|Niacinamide|niacinamide|mesh-list
154458439|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
154458440|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458441|NCT03482960|Xenon|xenon|mesh-list
154458442|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154458443|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
154458444|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
154458445|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458446|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458447|NCT03479996|Bupivacaine|bupivacaine|mesh-list
154458448|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
154458449|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
154458450|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458451|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458452|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
154458453|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458454|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
154458455|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
154458456|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154458457|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154458458|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458459|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458460|NCT02524184|Urological Agents|urological agents|mesh-ancestor
154458461|NCT03486236|Ivacaftor|ivacaftor|mesh-list
154458462|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154458463|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154458464|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860563|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458465|NCT03479918|Prednisone|prednisone|mesh-list
154458466|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
154458467|NCT03479918|Doxorubicin|doxorubicin|mesh-list
154458468|NCT03479918|Etoposide|etoposide|mesh-list
154458469|NCT03479918|Vincristine|vincristine|mesh-list
154458470|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458471|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
154458472|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458473|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458474|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458475|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
154458476|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458477|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458478|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154458479|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154458480|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154458481|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154458482|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458483|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154458484|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458485|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
154458486|NCT03479918|Hormones|hormones|mesh-ancestor
153740458|NCT05861297|Immunologic Factors|immunologic factors|mesh-ancestor
154458487|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458488|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154458489|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
154458490|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
154458491|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
154458492|NCT03486080|Lenograstim|lenograstim|mesh-list
154458493|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154458494|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
154458495|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458496|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154458497|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
154458498|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
154458499|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154182391|NCT05462613|Analgesics|analgesics|mesh-ancestor
154458500|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458501|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458502|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154458503|NCT03477344|Analgesics|analgesics|mesh-ancestor
154458504|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
154458505|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458506|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154458507|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154458508|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154458509|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
154458510|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458511|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458512|NCT04933864|Methylene Blue|methylene blue|mesh-list
154458513|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458514|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458515|NCT03477266|Mosapride|mosapride|mesh-list
154458516|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154458517|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154458518|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
154458519|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458520|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458521|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458522|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154458523|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154458524|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
154458525|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154458526|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
154458527|NCT03131336|Coagulants|coagulants|mesh-ancestor
154458528|NCT03482492|Acetaminophen|acetaminophen|mesh-list
154458529|NCT03482492|Tramadol|tramadol|mesh-list
154458530|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154458531|NCT03482492|Analgesics|analgesics|mesh-ancestor
154458532|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
154458533|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458534|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458535|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
154458536|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154458537|NCT03482492|Narcotics|narcotics|mesh-ancestor
154458538|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458539|NCT03874286|Liver Extracts|liver extracts|mesh-list
154458540|NCT03874286|Hematinics|hematinics|mesh-ancestor
154458541|NCT05259098|Sufentanil|sufentanil|mesh-list
154458542|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154458543|NCT05259098|Narcotics|narcotics|mesh-ancestor
154458544|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458545|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458546|NCT05259098|Analgesics|analgesics|mesh-ancestor
154458547|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
154458548|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458549|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154458550|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154458551|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
154458552|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
154458553|NCT03482180|Atorvastatin|atorvastatin|mesh-list
154458554|NCT03482180|Calcium|calcium|mesh-list
154458555|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154458556|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458557|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154458558|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154458559|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
154458560|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458561|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154458562|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154458563|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458564|NCT04294550|Naloxegol|naloxegol|mesh-list
154458565|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154458566|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458567|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
154458568|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458569|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
154458570|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154458571|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458572|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458573|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154458574|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154182466|NCT05141721|Leucovorin|leucovorin|mesh-list
154458575|NCT03476564|Protective Agents|protective agents|mesh-ancestor
154458576|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458577|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
153740624|NCT05829187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154458578|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154458580|NCT05258474|Niacinamide|niacinamide|mesh-list
154458581|NCT05258474|Niacin|niacin|mesh-list
154458582|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
154458583|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
154458584|NCT05258474|Vitamins|vitamins|mesh-ancestor
154458585|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
154458586|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458587|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154458588|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
154458589|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458590|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154458591|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
154458592|NCT03478436|Doxycycline|doxycycline|mesh-list
154458593|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154458594|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458595|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
154458596|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154458597|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154458598|NCT01338987|Alovudine|alovudine|mesh-list
154458599|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
154458600|NCT01338987|Busulfan|busulfan|mesh-list
154458601|NCT01338987|Methotrexate|methotrexate|mesh-list
154458602|NCT01338987|Fludarabine|fludarabine|mesh-list
154458603|NCT01338987|Leuprolide|leuprolide|mesh-list
154458604|NCT01338987|Tacrolimus|tacrolimus|mesh-list
154458605|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458606|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
154458607|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458608|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458609|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154458610|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
154458611|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458612|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458613|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154458614|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154458615|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
154458616|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154860564|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154458617|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154458618|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
154458619|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
154458620|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458621|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154458622|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154458623|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154458624|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154458625|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
154458626|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154458627|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
154458628|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458629|NCT03478280|Brodalumab|brodalumab|mesh-list
154458630|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
154458631|NCT04856007|Metformin|metformin|mesh-list
154458632|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
154458633|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154458634|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458635|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154458636|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458637|NCT04736979|Amoxicillin|amoxicillin|mesh-list
154458638|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
154458639|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
154458640|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154458641|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154458642|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458643|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154458644|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458645|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458646|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154458647|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154458648|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
154182540|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
154458649|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458650|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458652|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
154458653|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
154458654|NCT03562923|Hormones|hormones|mesh-ancestor
154458655|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458656|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
154458657|NCT03593252|Metronidazole|metronidazole|mesh-list
154458658|NCT03593252|Cefazolin|cefazolin|mesh-list
154458659|NCT03593252|Neomycin|neomycin|mesh-list
154458660|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
154458661|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
154458662|NCT03593252|Citric Acid|citric acid|mesh-list
154458663|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
154458664|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458665|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154458666|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154458667|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154458668|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
154458669|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154458670|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
154458671|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
154458672|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458673|NCT03593252|Cathartics|cathartics|mesh-ancestor
154458674|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154458675|NCT03593252|Antacids|antacids|mesh-ancestor
154458676|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154458677|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458678|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
154458679|NCT03476174|Interleukin-2|interleukin-2|mesh-list
154458680|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154458681|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458682|NCT03476174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154458683|NCT03476174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458684|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154458685|NCT03476174|Analgesics|analgesics|mesh-ancestor
154458686|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
154458687|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458688|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458689|NCT02523638|Interferons|interferons|mesh-list
154458690|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
154458691|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
154458692|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458693|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
154458694|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458695|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
154458696|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458698|NCT05257148|Zofenopril|zofenopril|mesh-list
154458699|NCT05257148|Captopril|captopril|mesh-list
154458700|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154458701|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
154458702|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154458703|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154458704|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154458705|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
154458706|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458707|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458708|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458709|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154458710|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
154458711|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458712|NCT03481790|Folic Acid|folic acid|mesh-list
154458713|NCT03481790|Lactoferrin|lactoferrin|mesh-list
154458714|NCT03481790|Vitamins|vitamins|mesh-ancestor
154458715|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
154458716|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458717|NCT03481790|Hematinics|hematinics|mesh-ancestor
154458718|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
154458719|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458720|NCT03475862|Oxycodone|oxycodone|mesh-list
154458721|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154458722|NCT03475862|Narcotics|narcotics|mesh-ancestor
154458723|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458724|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458725|NCT03475862|Analgesics|analgesics|mesh-ancestor
154458726|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
154458727|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458728|NCT03368066|Cosyntropin|cosyntropin|mesh-list
154458729|NCT03368066|Hormones|hormones|mesh-ancestor
154458730|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458731|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458732|NCT03475628|Daratumumab|daratumumab|mesh-list
154458733|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458735|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
154458736|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740789|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154458737|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154458738|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154458739|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458740|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458741|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154458742|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154458743|NCT03477422|Meropenem|meropenem|mesh-list
154458744|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
154458745|NCT03477422|Sulbactam|sulbactam|mesh-list
154458746|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154458747|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458748|NCT03477422|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154458749|NCT03477422|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154458750|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154458751|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458752|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458753|NCT01355289|Interferons|interferons|mesh-list
154458754|NCT01355289|Ribavirin|ribavirin|mesh-list
154458755|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458756|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
154458757|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458758|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
154458759|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458760|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154458761|NCT03473210|Erythromycin|erythromycin|mesh-list
154458762|NCT03473210|Ampicillin|ampicillin|mesh-list
154458763|NCT03473210|Dexamethasone|dexamethasone|mesh-list
154458764|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458765|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
154458766|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
154458767|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458768|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458769|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154458770|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
154458771|NCT03473210|Hormones|hormones|mesh-ancestor
154458772|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458773|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154458774|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458775|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458776|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458777|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458778|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154458779|NCT03473132|Thrombin|thrombin|mesh-list
154458780|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
154458781|NCT03473132|Coagulants|coagulants|mesh-ancestor
154458782|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
154458783|NCT03475160|Citric Acid|citric acid|mesh-list
154458784|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
154458785|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
154458786|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154458787|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
154458788|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
154458789|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458790|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
154458791|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154458792|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154458793|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458794|NCT03475160|Urological Agents|urological agents|mesh-ancestor
154458795|NCT00308516|Leucovorin|leucovorin|mesh-list
154458796|NCT00308516|Bevacizumab|bevacizumab|mesh-list
154458797|NCT00308516|Fluorouracil|fluorouracil|mesh-list
154458798|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
154458799|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154458800|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458801|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154458802|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154458803|NCT00308516|Growth Substances|growth substances|mesh-ancestor
154458804|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458805|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
154458806|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
154458807|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458808|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154458809|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458810|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
154458812|NCT00308516|Protective Agents|protective agents|mesh-ancestor
154458813|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
154458814|NCT00308516|Vitamins|vitamins|mesh-ancestor
154458815|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
154458816|NCT05155592|Adalimumab|adalimumab|mesh-list
154458817|NCT05155592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154458818|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458819|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458820|NCT03474614|Propranolol|propranolol|mesh-list
154458821|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154458822|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154458823|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
154458824|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458825|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458826|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458827|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154458828|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154458829|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
154458830|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
154458831|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154458832|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
154458833|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458834|NCT02737358|Expectorants|expectorants|mesh-ancestor
154458835|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
154458836|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154458837|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
154458838|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458839|NCT02737358|Protective Agents|protective agents|mesh-ancestor
154458840|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458841|NCT02737358|Antidotes|antidotes|mesh-ancestor
154458842|NCT05052710|Midazolam|midazolam|mesh-list
154458843|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154458844|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154458845|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458846|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458847|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154458848|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154458849|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154860565|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458850|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154458851|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
154458852|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
154458853|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
154458854|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
154458855|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458856|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458857|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
154458858|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154458859|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154458860|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458861|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
154458862|NCT02866838|Coagulants|coagulants|mesh-ancestor
154458863|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
154458864|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154458865|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154458866|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458867|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
154458868|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
154458869|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
154458870|NCT01090154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154458871|NCT01090154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458872|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458873|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
154458874|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458875|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458876|NCT01354431|Nivolumab|nivolumab|mesh-list
154458877|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154458878|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458879|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154458880|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458881|NCT02736578|Cetuximab|cetuximab|mesh-list
154458882|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154458883|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458884|NCT05157542|Paclitaxel|paclitaxel|mesh-list
154458885|NCT05157542|Durvalumab|durvalumab|mesh-list
154458886|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154458887|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154458888|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458889|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
153741002|NCT03914612|Paclitaxel|paclitaxel|mesh-list
154458890|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
154458891|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
154458892|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458893|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154458894|NCT03472976|Imiquimod|imiquimod|mesh-list
154458895|NCT03472976|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154458896|NCT03472976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458897|NCT03472976|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154458898|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
154458899|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458900|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154458901|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458902|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
154458903|NCT03473600|Triamcinolone|triamcinolone|mesh-list
154458904|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154458905|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154458906|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154458907|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458908|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
154458909|NCT03473600|Hormones|hormones|mesh-ancestor
154458910|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458911|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458912|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154458913|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
154458914|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458915|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458916|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154458917|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154458918|NCT02622724|Interferons|interferons|mesh-list
154458919|NCT02622724|Interferon-beta|interferon-beta|mesh-list
154458920|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
154458921|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458922|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
154458923|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154458924|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
154458925|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458926|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154458927|NCT01354353|Aripiprazole|aripiprazole|mesh-list
154458928|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
154458929|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154458930|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154458931|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154458932|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458933|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458934|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
154458935|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
154458936|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458937|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458938|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154458939|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154458940|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
154458941|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154458942|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154458943|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154458944|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154458945|NCT04931524|Mitogens|mitogens|mesh-list
154458946|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
154458947|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458948|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
154458949|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154458950|NCT03562611|Nalbuphine|nalbuphine|mesh-list
154458951|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154458952|NCT03562611|Narcotics|narcotics|mesh-ancestor
154458953|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154458954|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458955|NCT03562611|Analgesics|analgesics|mesh-ancestor
154458956|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
154458957|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154458958|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154458959|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154458960|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154458961|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458962|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154458963|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458964|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458965|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154458967|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154458968|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458969|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154458970|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154458971|NCT04929652|Irinotecan|irinotecan|mesh-list
154458972|NCT04929652|Molgramostim|molgramostim|mesh-list
154458973|NCT04929652|Sargramostim|sargramostim|mesh-list
154458974|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154458975|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154458976|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154458977|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458978|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458979|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
154458980|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458981|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154458982|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154458983|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154458984|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154458985|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154458986|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154458987|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458988|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
154458989|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154458990|NCT04927936|Vaccines|vaccines|mesh-list
154458991|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
154458992|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154458993|NCT03562533|Paclitaxel|paclitaxel|mesh-list
154458994|NCT03562533|Carboplatin|carboplatin|mesh-list
154458995|NCT03562533|Doxorubicin|doxorubicin|mesh-list
154458996|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154458997|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154458998|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154458999|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
154459000|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
154459001|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
154459002|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459003|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154459004|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154459005|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154459006|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459007|NCT04927858|Empagliflozin|empagliflozin|mesh-list
154459008|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154459009|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459010|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154459011|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459012|NCT04927000|Tofacitinib|tofacitinib|mesh-list
154459013|NCT04927000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154459014|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154459015|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741205|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154459016|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459017|NCT04926532|Sorafenib|sorafenib|mesh-list
154459018|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459019|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154459020|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459021|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459022|NCT03842709|Pramipexole|pramipexole|mesh-list
154459023|NCT03842709|Dexpramipexole|dexpramipexole|mesh-list
154459024|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
154459025|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459026|NCT03842709|Protective Agents|protective agents|mesh-ancestor
154459027|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459028|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154459029|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154459030|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
154459031|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
154459032|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459033|NCT05707533|Cefoxitin|cefoxitin|mesh-list
154459034|NCT05707533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154459035|NCT05707533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459036|NCT03056482|Haloperidol|haloperidol|mesh-list
154459037|NCT03056482|Ondansetron|ondansetron|mesh-list
154459038|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
154459039|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
154459040|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
154459041|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459042|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459043|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154459044|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
154459045|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
154459046|NCT03056482|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154459047|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154459048|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
154459049|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459050|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459051|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154459052|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154459053|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459054|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154459055|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154459056|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
154459057|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154459058|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
154459059|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
154459060|NCT02817555|Hematinics|hematinics|mesh-ancestor
154459061|NCT04924192|Irinotecan|irinotecan|mesh-list
154459062|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154459063|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154459064|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459065|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459066|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459067|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
154459068|NCT02036073|Hematinics|hematinics|mesh-ancestor
154459069|NCT02036229|Ivermectin|ivermectin|mesh-list
154459070|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154459071|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459072|NCT04922008|Capecitabine|capecitabine|mesh-list
154459073|NCT04922008|Trastuzumab|trastuzumab|mesh-list
154459074|NCT04922008|Vinorelbine|vinorelbine|mesh-list
154459075|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459076|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
154459077|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459078|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459079|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154459080|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154459081|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
154459082|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
154459083|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
154459084|NCT03056092|Ranibizumab|ranibizumab|mesh-list
154459085|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154459086|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154459087|NCT03056092|Growth Substances|growth substances|mesh-ancestor
154459088|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459089|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
154459090|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459091|NCT04921306|Clenbuterol|clenbuterol|mesh-list
154459092|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154459093|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154459094|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
154459095|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459096|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459097|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459098|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154459099|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
154459100|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459101|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154459102|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
154459103|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
154459104|NCT04920760|Vitamin A|vitamin a|mesh-list
154459105|NCT04920760|Vitamins|vitamins|mesh-ancestor
154459106|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
154459107|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459108|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
154459109|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
154459110|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154459111|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459112|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459113|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
154459114|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154459115|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459116|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459117|NCT04920604|Anesthetics|anesthetics|mesh-list
154459118|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459119|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459120|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
154459121|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154459122|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
154459123|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459124|NCT04920448|Expectorants|expectorants|mesh-ancestor
154459125|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
154459126|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154459127|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
154459128|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459129|NCT04920448|Protective Agents|protective agents|mesh-ancestor
154459130|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459131|NCT04920448|Antidotes|antidotes|mesh-ancestor
154459132|NCT04969354|Immunomodulating Agents|immunomodulating agents|mesh-list
154459133|NCT04969354|Immunologic Factors|immunologic factors|mesh-ancestor
154459134|NCT04969354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459135|NCT03061006|Warfarin|warfarin|mesh-list
154459136|NCT03061006|Dabigatran|dabigatran|mesh-list
154459137|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
154459138|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
154459139|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154459140|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
154459141|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459142|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459143|NCT03060850|Abivertinib|abivertinib|mesh-list
154459144|NCT03060850|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154459145|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154459146|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459147|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459148|NCT04432558|Acetaminophen|acetaminophen|mesh-list
154459149|NCT04432558|Diclofenac|diclofenac|mesh-list
154459150|NCT04432558|Tramadol|tramadol|mesh-list
154459151|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154459152|NCT04432558|Analgesics|analgesics|mesh-ancestor
154459153|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
154459154|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459155|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459156|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
154459157|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154459158|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459159|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459160|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154459161|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459162|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459163|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154459164|NCT04432558|Narcotics|narcotics|mesh-ancestor
154459165|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459166|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
154459167|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154459168|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154459169|NCT04979650|Prednisolone|prednisolone|mesh-list
154459170|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
154459171|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154459172|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
154459173|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459174|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
154459175|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
154459176|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459177|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459178|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154459179|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
154459180|NCT04979650|Hormones|hormones|mesh-ancestor
154459181|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154459182|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154459183|NCT04979650|Protective Agents|protective agents|mesh-ancestor
154459184|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154459185|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459186|NCT04650152|Fenofibrate|fenofibrate|mesh-list
154459187|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154459188|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
154459189|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459190|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154459191|NCT04967950|Methotrexate|methotrexate|mesh-list
154459192|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154459193|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154459194|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
154459195|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154459196|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459197|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459198|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
154459199|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459200|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459201|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
154459202|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459203|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154459204|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154459205|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
154459206|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459207|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154459208|NCT04967326|Carbamazepine|carbamazepine|mesh-list
154459209|NCT04967326|Phenytoin|phenytoin|mesh-list
154459210|NCT04967326|Valproic Acid|valproic acid|mesh-list
154459211|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
154459212|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459213|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459214|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
154459215|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459216|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459217|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
154459218|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154459219|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459220|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154459221|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154459222|NCT04967326|Analgesics|analgesics|mesh-ancestor
154459223|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
154459224|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459225|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154459226|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154459227|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154459228|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154459229|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154459230|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154459231|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154459232|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459233|NCT02620384|Metolazone|metolazone|mesh-list
154459234|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154459235|NCT02620384|Diuretics|diuretics|mesh-ancestor
154459236|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
154459237|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459238|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154459239|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154459240|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459241|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
154459242|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154459243|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154459244|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459245|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
154459246|NCT04918576|Coagulants|coagulants|mesh-ancestor
154459247|NCT03472508|Folic Acid|folic acid|mesh-list
154459248|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
154459249|NCT03472508|Enalapril|enalapril|mesh-list
154459250|NCT03472508|Enalaprilat|enalaprilat|mesh-list
154459251|NCT03472508|Hematinics|hematinics|mesh-ancestor
154459252|NCT03472508|Vitamins|vitamins|mesh-ancestor
154459253|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
154459254|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459255|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459256|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459257|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154183144|NCT01358877|Paclitaxel|paclitaxel|mesh-list
154459258|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
154459259|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154459260|NCT04966234|Posaconazole|posaconazole|mesh-list
154459261|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
154459262|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459263|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154459264|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154459265|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154459266|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154459267|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154459268|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459269|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459270|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154459271|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
154459272|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154459273|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459274|NCT03915860|Trifarotene|trifarotene|mesh-list
154459275|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
154459276|NCT04170998|Metformin|metformin|mesh-list
154459277|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
154459278|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154459279|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459280|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154459281|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459282|NCT04965532|Anesthetics|anesthetics|mesh-list
154459283|NCT04965532|Propofol|propofol|mesh-list
154459284|NCT04965532|Sevoflurane|sevoflurane|mesh-list
154459285|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459286|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459287|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154459288|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154459289|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
154459290|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154459291|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154459292|NCT03055546|Oxytocin|oxytocin|mesh-list
154459293|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
154459294|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154459295|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459296|NCT04918264|Capecitabine|capecitabine|mesh-list
154459297|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459298|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
154459299|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459300|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459301|NCT04917718|Tacrolimus|tacrolimus|mesh-list
154459302|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154459303|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
154459304|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459305|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154459306|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459307|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459308|NCT06016530|Dexamethasone|dexamethasone|mesh-list
154459309|NCT06016530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459310|NCT06016530|Antiemetics|antiemetics|mesh-ancestor
154459311|NCT06016530|Autonomic Agents|autonomic agents|mesh-ancestor
154459312|NCT06016530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459313|NCT06016530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459314|NCT06016530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153572035|NCT03769285|Niacin|niacin|mesh-list
154459315|NCT06016530|Glucocorticoids|glucocorticoids|mesh-ancestor
154459316|NCT06016530|Hormones|hormones|mesh-ancestor
154459317|NCT06016530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154459318|NCT06016530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154459319|NCT06016530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459320|NCT06016413|Paclitaxel|paclitaxel|mesh-list
154459321|NCT06016413|Carboplatin|carboplatin|mesh-list
154459322|NCT06016413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154459323|NCT06016413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459324|NCT06016413|Tubulin Modulators|tubulin modulators|mesh-ancestor
154459325|NCT06016413|Antimitotic Agents|antimitotic agents|mesh-ancestor
154459326|NCT06016413|Mitosis Modulators|mitosis modulators|mesh-ancestor
154459327|NCT06016413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459328|NCT06016400|Alfacalcidol|alfacalcidol|mesh-list
154459329|NCT06016400|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154459330|NCT06016400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154459331|NCT06016400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183218|NCT00002965|Interferons|interferons|mesh-list
154459332|NCT06016400|Vitamins|vitamins|mesh-ancestor
153741540|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
154459333|NCT06016400|Micronutrients|micronutrients|mesh-ancestor
154459334|NCT06015828|Lactoferrin|lactoferrin|mesh-list
154459335|NCT06015828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459336|NCT06015594|Metformin|metformin|mesh-list
154459337|NCT06015594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154459338|NCT06015594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459339|NCT06015373|Carvedilol|carvedilol|mesh-list
154459340|NCT06015373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154459341|NCT06015373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154459342|NCT06015373|Adrenergic Agents|adrenergic agents|mesh-ancestor
154459343|NCT06015373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459344|NCT06015373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459345|NCT06015373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459346|NCT06015373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154459347|NCT06015373|Antioxidants|antioxidants|mesh-ancestor
154459348|NCT06015373|Protective Agents|protective agents|mesh-ancestor
154459349|NCT06015373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154459350|NCT06015373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154459351|NCT06015373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154459352|NCT06015373|Vasodilator Agents|vasodilator agents|mesh-ancestor
154459353|NCT06015373|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153741557|NCT00519259|Lobeline|lobeline|mesh-list
154459354|NCT06015373|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154459355|NCT06015269|Vaccines|vaccines|mesh-list
154459356|NCT06015269|Immunologic Factors|immunologic factors|mesh-ancestor
154459357|NCT06015269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459358|NCT06015152|Tazarotene|tazarotene|mesh-list
154459359|NCT06015152|Dermatologic Agents|dermatologic agents|mesh-ancestor
154459360|NCT06015152|Keratolytic Agents|keratolytic agents|mesh-ancestor
154459361|NCT06015126|Vinorelbine|vinorelbine|mesh-list
154459362|NCT06015126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154459363|NCT06015126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459364|NCT06015126|Tubulin Modulators|tubulin modulators|mesh-ancestor
154459365|NCT06015126|Antimitotic Agents|antimitotic agents|mesh-ancestor
154459366|NCT06015126|Mitosis Modulators|mitosis modulators|mesh-ancestor
154459367|NCT06015126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459368|NCT06015113|Disitamab vedotin|disitamab vedotin|mesh-list
154459369|NCT06015113|Immunoconjugates|immunoconjugates|mesh-ancestor
154459370|NCT06015113|Immunologic Factors|immunologic factors|mesh-ancestor
154459371|NCT06015113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459372|NCT06015100|Capecitabine|capecitabine|mesh-list
154459373|NCT06015100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459374|NCT06015100|Antimetabolites|antimetabolites|mesh-ancestor
154860566|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459375|NCT06015100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459376|NCT06015100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459377|NCT06015074|Propofol|propofol|mesh-list
154459378|NCT06015074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154459379|NCT06015074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741586|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
154459380|NCT06015074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459381|NCT06015074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154459382|NCT06015074|Anesthetics, General|anesthetics, general|mesh-ancestor
154459383|NCT06015074|Anesthetics|anesthetics|mesh-ancestor
154459384|NCT05999773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154459385|NCT05999773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459386|NCT05999773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154459387|NCT05999773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459388|NCT05903820|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154459389|NCT05903820|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154459390|NCT05903820|Estradiol|estradiol|mesh-list
154459391|NCT05903820|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154459392|NCT05903820|Progesterone|progesterone|mesh-list
154459393|NCT05903820|Estrogens|estrogens|mesh-ancestor
154459394|NCT05903820|Hormones|hormones|mesh-ancestor
154459395|NCT05903820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154459396|NCT05903820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459397|NCT05903820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154459398|NCT05903820|Contraceptive Agents|contraceptive agents|mesh-ancestor
154459399|NCT05903820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154459400|NCT05903820|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154459401|NCT05903820|Progestins|progestins|mesh-ancestor
154459402|NCT05888402|Immunomodulating Agents|immunomodulating agents|mesh-list
154459403|NCT05888402|Immunologic Factors|immunologic factors|mesh-ancestor
153741605|NCT02948998|Diuretics|diuretics|mesh-ancestor
154459404|NCT05888402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459405|NCT05888207|Fluvoxamine|fluvoxamine|mesh-list
154459406|NCT05888207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154459407|NCT05888207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154459408|NCT05888207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459409|NCT05888207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459410|NCT05888207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154459411|NCT05888207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154459412|NCT05888207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154459413|NCT05888207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154459414|NCT05888207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459415|NCT05888207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459416|NCT05888207|Serotonin Agents|serotonin agents|mesh-ancestor
154459417|NCT05888207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154459418|NCT05888207|Antidepressive Agents|antidepressive agents|mesh-ancestor
154459419|NCT05888207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154459420|NCT05888207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154459421|NCT05888207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459422|NCT05888207|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154459423|NCT05887843|Mometasone Furoate|mometasone furoate|mesh-list
154459425|NCT05887843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459426|NCT05887843|Dermatologic Agents|dermatologic agents|mesh-ancestor
154459427|NCT05887843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154459428|NCT05887843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154459429|NCT05887843|Autonomic Agents|autonomic agents|mesh-ancestor
154459430|NCT05887843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741627|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
154459431|NCT05887843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459432|NCT05887843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154459433|NCT05887843|Respiratory System Agents|respiratory system agents|mesh-ancestor
154459434|NCT05887843|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154459435|NCT05887843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459436|NCT05887843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459437|NCT05887843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154459438|NCT05887843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154459439|NCT05887843|Histamine Antagonists|histamine antagonists|mesh-ancestor
154459440|NCT05887843|Histamine Agents|histamine agents|mesh-ancestor
154459441|NCT05887843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459442|NCT05866367|Insulin|insulin|mesh-list
154459443|NCT05866367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154459444|NCT05866367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154459445|NCT05866367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459446|NCT05836272|Norepinephrine|norepinephrine|mesh-list
154459447|NCT05836272|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154459448|NCT05836272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154459449|NCT05836272|Adrenergic Agents|adrenergic agents|mesh-ancestor
154459450|NCT05836272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459451|NCT05836272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459452|NCT05836272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459453|NCT05836272|Sympathomimetics|sympathomimetics|mesh-ancestor
154459454|NCT05836272|Autonomic Agents|autonomic agents|mesh-ancestor
154459455|NCT05836272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459456|NCT05836272|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154459457|NCT05795504|Vitamin D|vitamin d|mesh-list
154459458|NCT05795504|Calcium|calcium|mesh-list
154459459|NCT05795504|Vitamins|vitamins|mesh-ancestor
154459460|NCT05795504|Micronutrients|micronutrients|mesh-ancestor
154459461|NCT05795504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459462|NCT05795504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154459463|NCT05795504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154459464|NCT05738135|Aminophylline|aminophylline|mesh-list
154459465|NCT05738135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154459466|NCT05738135|Autonomic Agents|autonomic agents|mesh-ancestor
154459467|NCT05738135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459468|NCT05738135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459469|NCT05738135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154459470|NCT05738135|Respiratory System Agents|respiratory system agents|mesh-ancestor
154459471|NCT05738135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154459472|NCT05738135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154459473|NCT05738135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459474|NCT05738135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459475|NCT05738135|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154459476|NCT05738135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154459477|NCT05738135|Purinergic Agents|purinergic agents|mesh-ancestor
154459478|NCT05738135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459479|NCT05738135|Protective Agents|protective agents|mesh-ancestor
154459480|NCT05708625|Doxycycline|doxycycline|mesh-list
154459481|NCT05708625|Voriconazole|voriconazole|mesh-list
154459482|NCT05708625|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154459483|NCT05708625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154459484|NCT05708625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459485|NCT05708625|Antimalarials|antimalarials|mesh-ancestor
154459486|NCT05708625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154459487|NCT05708625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154459488|NCT05708625|Antifungal Agents|antifungal agents|mesh-ancestor
154459489|NCT05708625|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154459490|NCT05708625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154459491|NCT05708625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459492|NCT05708625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459493|NCT05708625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154459494|NCT05708625|Hormone Antagonists|hormone antagonists|mesh-ancestor
153741762|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459495|NCT05708625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154459496|NCT05708625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459497|NCT05708625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154459498|NCT05708625|Schistosomicides|schistosomicides|mesh-ancestor
154459499|NCT05708625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154459500|NCT05708625|Anthelmintics|anthelmintics|mesh-ancestor
154459501|NCT05697276|Lidocaine|lidocaine|mesh-list
154459502|NCT05697276|Bupivacaine|bupivacaine|mesh-list
154459503|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
154459504|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
154459505|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459506|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459507|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
154459508|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459509|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154459510|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154459511|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154459512|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154459513|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459514|NCT05672784|Acetaminophen|acetaminophen|mesh-list
154459515|NCT05672784|Meloxicam|meloxicam|mesh-list
154459516|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154459517|NCT05672784|Analgesics|analgesics|mesh-ancestor
154459518|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
154459519|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459520|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459521|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
154459522|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154459523|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459524|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459525|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154459526|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154459527|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459528|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459529|NCT05661253|Bupivacaine|bupivacaine|mesh-list
154459530|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
154459531|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
154459532|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459533|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741763|NCT00521092|Sunitinib|sunitinib|mesh-list
154459534|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
154459535|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459536|NCT05617885|Leuprolide|leuprolide|mesh-list
154459537|NCT05617885|Goserelin|goserelin|mesh-list
154459538|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154459539|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154459540|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
154459541|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154459542|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459543|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154459544|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459545|NCT05617885|Hormones|hormones|mesh-ancestor
154459546|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154459547|NCT05601271|Allopurinol|allopurinol|mesh-list
154459548|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
154459549|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459550|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459551|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
154459552|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459553|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154183442|NCT05580003|Moxifloxacin|moxifloxacin|mesh-list
154459554|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
154459555|NCT05601271|Protective Agents|protective agents|mesh-ancestor
154459556|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459557|NCT05565495|Hydromorphone|hydromorphone|mesh-list
154459558|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154459559|NCT05565495|Narcotics|narcotics|mesh-ancestor
154459560|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459561|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459562|NCT05565495|Analgesics|analgesics|mesh-ancestor
154459563|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
154459564|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459565|NCT05542394|Curcumin|curcumin|mesh-list
154459566|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154459567|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154459568|NCT05542394|Analgesics|analgesics|mesh-ancestor
154459569|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
154459570|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459571|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459572|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459573|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459574|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459575|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459576|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459577|NCT05519579|Methotrexate|methotrexate|mesh-list
154459578|NCT05519579|Blinatumomab|blinatumomab|mesh-list
154459579|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154459580|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
154459581|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154459582|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459583|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459584|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
154459585|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459586|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459587|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
154459588|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459589|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154459590|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154459591|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
154459592|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459593|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154459594|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
154459595|NCT05470517|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154459596|NCT05470517|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154459597|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154459598|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459599|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154459600|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
154459601|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459602|NCT05372588|Vaccines|vaccines|mesh-list
154459603|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
154459604|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459605|NCT05363267|Curcumin|curcumin|mesh-list
154459606|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154459607|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154459608|NCT05363267|Analgesics|analgesics|mesh-ancestor
154459609|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
154459610|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459611|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459612|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459613|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459614|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459615|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459616|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459617|NCT05276492|Prednisone|prednisone|mesh-list
154459618|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459619|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
154459620|NCT05276492|Hormones|hormones|mesh-ancestor
154459621|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154459622|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459623|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154459624|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459625|NCT05190315|Temozolomide|temozolomide|mesh-list
154459626|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
154459627|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154459628|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
154459629|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459630|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459631|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
154459632|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
154459633|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459634|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459635|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154459636|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154459637|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154459638|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459639|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154459640|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154459641|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
154459642|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459643|NCT05134974|Phentolamine|phentolamine|mesh-list
154459644|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154459645|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154459646|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154459647|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154459648|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
154459649|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459650|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459651|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459652|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154459653|NCT05134922|Gedatolisib|gedatolisib|mesh-list
154459654|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154459655|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459656|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459657|NCT05109442|Atezolizumab|atezolizumab|mesh-list
154459658|NCT05109442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154459659|NCT05109442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459660|NCT05109442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154459661|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459662|NCT05108870|Paclitaxel|paclitaxel|mesh-list
154459663|NCT05108870|Carboplatin|carboplatin|mesh-list
154459664|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154459665|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459666|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
154459667|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
153741899|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
154459668|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
154459669|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860568|NCT03014947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154459670|NCT05070650|Acetaminophen|acetaminophen|mesh-list
154459671|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
154459672|NCT05070650|Phenylephrine|phenylephrine|mesh-list
154459673|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
154459674|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154459675|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154459676|NCT05070650|Analgesics|analgesics|mesh-ancestor
154459677|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
154459678|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459679|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459680|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
154459681|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
154459682|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459683|NCT05070650|Expectorants|expectorants|mesh-ancestor
154459684|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
154459685|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154459686|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
154459687|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459688|NCT05070650|Protective Agents|protective agents|mesh-ancestor
154459689|NCT05070650|Antidotes|antidotes|mesh-ancestor
154459690|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154459691|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
154459692|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
154459693|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
154459694|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154459695|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
154459696|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154459697|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154459698|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154459699|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
154459700|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459701|NCT05047211|Dextrans|dextrans|mesh-list
154459702|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
154459703|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
154459704|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
154459705|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
154459707|NCT04956432|Allopurinol|allopurinol|mesh-list
154459708|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
153741938|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154459709|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459710|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459711|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
154459712|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459713|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154459714|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
154459715|NCT04956432|Protective Agents|protective agents|mesh-ancestor
154459716|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459717|NCT04912492|Ethanol|ethanol|mesh-list
154459718|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154459719|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459720|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459721|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459722|NCT04906278|Oxytocin|oxytocin|mesh-list
154459723|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
154459724|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154459725|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459726|NCT04895202|Siponimod|siponimod|mesh-list
154459727|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154459728|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459729|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154459730|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
154459731|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459732|NCT04845399|Factor VIII|factor viii|mesh-list
154459733|NCT04845399|Coagulants|coagulants|mesh-ancestor
154459734|NCT04766853|Dexamethasone|dexamethasone|mesh-list
154459735|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
154459736|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459737|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
154459738|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
154459739|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459740|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459741|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154459742|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
154459743|NCT04766853|Hormones|hormones|mesh-ancestor
153741976|NCT04726553|Antimalarials|antimalarials|mesh-list
154459744|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742028|NCT02951728|Prednisone|prednisone|mesh-list
153742029|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
153742030|NCT02951728|Rituximab|rituximab|mesh-list
153742031|NCT02951728|Doxorubicin|doxorubicin|mesh-list
154459745|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154459746|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459747|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154459748|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
154459750|NCT04766853|Protective Agents|protective agents|mesh-ancestor
154459751|NCT04755218|Misoprostol|misoprostol|mesh-list
154459752|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154459753|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
154459754|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154459755|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459756|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154459757|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154459758|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
154459759|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
154459760|NCT04732845|Fludarabine|fludarabine|mesh-list
154459761|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154459762|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
154459763|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459764|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459765|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154459766|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
154459767|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459768|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459769|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154459770|NCT04614610|Lidocaine|lidocaine|mesh-list
154459771|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
154459772|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
154459773|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459774|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459775|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
154459776|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459777|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154459778|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154459779|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154459780|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154459781|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459782|NCT04613453|Midazolam|midazolam|mesh-list
154459783|NCT04613453|Ketamine|ketamine|mesh-list
154459784|NCT04613453|Analgesics|analgesics|mesh-ancestor
154459785|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
153742032|NCT02951728|Vincristine|vincristine|mesh-list
153742033|NCT02951728|Decitabine|decitabine|mesh-list
154459786|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459787|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459788|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154459789|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154459790|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
154459791|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
154459792|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459793|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154459794|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154459795|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459796|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459797|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154459798|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154459799|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154459800|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154459801|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154459802|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
154459803|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
154459804|NCT04499924|Paclitaxel|paclitaxel|mesh-list
154459805|NCT04499924|Trastuzumab|trastuzumab|mesh-list
154459806|NCT04499924|Ramucirumab|ramucirumab|mesh-list
154459807|NCT04499924|Tucatinib|tucatinib|mesh-list
154459808|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154459809|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459810|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
154459811|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
154459812|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
154459813|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459814|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154459815|NCT04499924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154459816|NCT04499924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154459817|NCT04499924|Growth Substances|growth substances|mesh-ancestor
154459818|NCT04499924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459819|NCT04499924|Growth Inhibitors|growth inhibitors|mesh-ancestor
154459820|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154459821|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459822|NCT04481555|Azithromycin|azithromycin|mesh-list
154860569|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154459823|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154459824|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459825|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
154459826|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154459827|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459828|NCT04370587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154459829|NCT04370587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459830|NCT04318938|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154459831|NCT04318938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154459832|NCT04318938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459833|NCT04318938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459834|NCT04238754|Cannabidiol|cannabidiol|mesh-list
154459835|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
154459836|NCT04232358|Anesthetics|anesthetics|mesh-list
154459837|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459838|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459839|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
154459840|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154459841|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
154459842|NCT04208958|Vancomycin|vancomycin|mesh-list
154459843|NCT04208958|Nivolumab|nivolumab|mesh-list
154459844|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154459845|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459846|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154459847|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459848|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154459849|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459850|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
154459851|NCT04144153|Anesthetics|anesthetics|mesh-list
154459852|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459853|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459854|NCT04144153|Narcotics|narcotics|mesh-ancestor
154183746|NCT04278404|Azithromycin|azithromycin|mesh-list
154459855|NCT04144153|Analgesics|analgesics|mesh-ancestor
154459856|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
154459857|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459858|NCT03920293|Ravulizumab|ravulizumab|mesh-list
154459859|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154459860|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154459861|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
154459862|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459863|NCT03910387|Paclitaxel|paclitaxel|mesh-list
154459864|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154459865|NCT03910387|Gemcitabine|gemcitabine|mesh-list
154459866|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154459867|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459868|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154459869|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154459870|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154459871|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459872|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459873|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
154459874|NCT03844815|Venetoclax|venetoclax|mesh-list
154459875|NCT03844815|Decitabine|decitabine|mesh-list
154459876|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459877|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459878|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
154459879|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459880|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459881|NCT03530189|Insulin|insulin|mesh-list
154459882|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154459883|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459884|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
154459885|NCT03434769|Fludarabine|fludarabine|mesh-list
154459886|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154459887|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
154459888|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459889|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459890|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154459891|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
154459892|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459893|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459894|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154459895|NCT03331198|Venetoclax|venetoclax|mesh-list
154459896|NCT03331198|Ibrutinib|ibrutinib|mesh-list
154459897|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459898|NCT03331198|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154459899|NCT03331198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154459900|NCT03331198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459901|NCT03331198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459902|NCT03326310|Azacitidine|azacitidine|mesh-list
154459903|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459904|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
154459905|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459906|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459907|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459908|NCT03317496|Cisplatin|cisplatin|mesh-list
154459909|NCT03317496|Carboplatin|carboplatin|mesh-list
154459910|NCT03317496|Gemcitabine|gemcitabine|mesh-list
154459911|NCT03317496|Pemetrexed|pemetrexed|mesh-list
154459912|NCT03317496|Avelumab|avelumab|mesh-list
154459913|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154459914|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459915|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154459916|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
154459917|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459918|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459919|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154459920|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154459921|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154459922|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
154459923|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459924|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
154459925|NCT03228667|Nivolumab|nivolumab|mesh-list
154459926|NCT03228667|Atezolizumab|atezolizumab|mesh-list
154459927|NCT03228667|Durvalumab|durvalumab|mesh-list
154459928|NCT03228667|Avelumab|avelumab|mesh-list
154459929|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154459930|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154459931|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459932|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154459933|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459934|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
154459935|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459936|NCT03127215|Olaparib|olaparib|mesh-list
154459937|NCT03127215|Trabectedin|trabectedin|mesh-list
154459938|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154459939|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459940|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459941|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459942|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154459943|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
154459944|NCT03125811|Ethanol|ethanol|mesh-list
154459945|NCT03125811|Ondansetron|ondansetron|mesh-list
154459946|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154459947|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154459948|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459949|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459950|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
154459951|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
154459952|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459953|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154459954|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
154459955|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154459956|NCT03125811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154459957|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154459958|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
154459959|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459960|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459961|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
154459962|NCT02962401|Idelalisib|idelalisib|mesh-list
154459963|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154459964|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459965|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459966|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459967|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
154459968|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
154459969|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154459970|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
154459971|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459972|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
154860570|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154459973|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154459974|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154459975|NCT02669186|Fentanyl|fentanyl|mesh-list
154459976|NCT02669186|Bupivacaine|bupivacaine|mesh-list
154459977|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
154459978|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
154459979|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154459980|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459981|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
154459982|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154459983|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154459984|NCT02669186|Narcotics|narcotics|mesh-ancestor
154459985|NCT02669186|Analgesics|analgesics|mesh-ancestor
154459986|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154459987|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154459988|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
154459989|NCT02568566|Vaccines|vaccines|mesh-list
154459990|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
154459991|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154459992|NCT02536183|Doxorubicin|doxorubicin|mesh-list
154459993|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154459994|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154459995|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154459996|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154459997|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154459998|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154459999|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460000|NCT02317874|Paclitaxel|paclitaxel|mesh-list
154460001|NCT02317874|Carboplatin|carboplatin|mesh-list
154460002|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154460003|NCT02317874|Talazoparib|talazoparib|mesh-list
154460004|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154460005|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460006|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
154460007|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
154460009|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460010|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154460011|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460012|NCT02221999|Paclitaxel|paclitaxel|mesh-list
154460013|NCT02221999|Letrozole|letrozole|mesh-list
154460014|NCT02221999|Hormones|hormones|mesh-list
154460015|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154460016|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460017|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
154460018|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
154460019|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
154460020|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460021|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460022|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460023|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154460024|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154460025|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460026|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154460027|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
154460028|NCT01849562|Ribavirin|ribavirin|mesh-list
154460029|NCT01849562|Odalasvir|odalasvir|mesh-list
154460030|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
154460031|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460032|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
154460033|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460034|NCT01700179|Ribavirin|ribavirin|mesh-list
154460035|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
154460036|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460037|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
154460038|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460039|NCT01474200|Furosemide|furosemide|mesh-list
154460040|NCT01474200|Diuretics|diuretics|mesh-list
154460041|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154460042|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
154460043|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460044|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460045|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460046|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154460047|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
154460048|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154860571|NCT01057225|Thalidomide|thalidomide|mesh-list
154460049|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154460050|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
154460051|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460052|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460053|NCT03055234|Treprostinil|treprostinil|mesh-list
154460054|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154460055|NCT03055312|Bicalutamide|bicalutamide|mesh-list
153742333|NCT00525967|Acetaminophen|acetaminophen|mesh-list
154460056|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
154460057|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
154460058|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460059|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460060|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460062|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
154460063|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154460064|NCT04977544|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154460065|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154460066|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460067|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460068|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460069|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
154460070|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460071|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
154460072|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154460073|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742382|NCT00524875|Growth Substances|growth substances|mesh-ancestor
154460074|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460075|NCT02626000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154460076|NCT02626000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460077|NCT03769376|Salvin|salvin|mesh-list
154460078|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154460079|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460080|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
154460081|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460082|NCT03769376|Protective Agents|protective agents|mesh-ancestor
154460083|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460084|NCT05156450|Prednisone|prednisone|mesh-list
154460085|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
154460086|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460087|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
154460088|NCT05156450|Hormones|hormones|mesh-ancestor
154460089|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460090|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460091|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460092|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460093|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154460094|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460095|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460096|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
154460097|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154460098|NCT03060304|Tamoxifen|tamoxifen|mesh-list
154460099|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154460100|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154460101|NCT03060304|Estradiol|estradiol|mesh-list
154460102|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154460103|NCT03060304|Estrogens|estrogens|mesh-ancestor
154460104|NCT03060304|Hormones|hormones|mesh-ancestor
154460105|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460106|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460107|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154460108|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
154460109|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154460110|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154460111|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154460112|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
154460113|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460114|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460115|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154460116|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154460117|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153742403|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154460118|NCT04432402|Gemcitabine|gemcitabine|mesh-list
154460119|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
154860572|NCT01057225|Dexamethasone|dexamethasone|mesh-list
154460120|NCT04432402|Lenalidomide|lenalidomide|mesh-list
154460121|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460122|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
154460123|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460124|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460125|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
154460126|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460127|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154460128|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154460129|NCT04432402|Growth Substances|growth substances|mesh-ancestor
154460130|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
154460131|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
154460132|NCT04432324|Antibodies|antibodies|mesh-list
154460133|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
154460134|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154460135|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154460136|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
154460137|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460138|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
154460139|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154460140|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154460141|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154460142|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460143|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460144|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
154460145|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460146|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460147|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154460148|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460149|NCT04977388|Droxidopa|droxidopa|mesh-list
154460150|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154460151|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154460152|NCT03470480|Methamphetamine|methamphetamine|mesh-list
154460153|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154460154|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460155|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
154460156|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
154460157|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460158|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
154460159|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460160|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460161|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
154460162|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154460163|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154460164|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460165|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154460166|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154460167|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154460168|NCT04917250|Dexamethasone|dexamethasone|mesh-list
154460169|NCT04917250|Gemcitabine|gemcitabine|mesh-list
154460170|NCT04917250|Etoposide|etoposide|mesh-list
154460171|NCT04917250|Pegaspargase|pegaspargase|mesh-list
154460172|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460173|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
154460174|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
154460175|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460176|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460177|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154460178|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
154460179|NCT04917250|Hormones|hormones|mesh-ancestor
154460180|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460181|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460182|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460183|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460184|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
154460185|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460186|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154460187|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154460188|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154460189|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460190|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
154460191|NCT04859582|Capecitabine|capecitabine|mesh-list
154460192|NCT04859582|Fluorouracil|fluorouracil|mesh-list
154460193|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
154460194|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460195|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460196|NCT04859582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154460197|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460198|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460200|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154460201|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
154460202|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460203|NCT03469700|Anesthetics|anesthetics|mesh-list
154460204|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460205|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460206|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
154460207|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
154460208|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154460209|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154460210|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460211|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460212|NCT04912726|Urological Agents|urological agents|mesh-ancestor
154460213|NCT02603900|Bupivacaine|bupivacaine|mesh-list
154460214|NCT02603900|Ropivacaine|ropivacaine|mesh-list
154460215|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
154460216|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
154460217|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460218|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460219|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
154460220|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460221|NCT01669798|Nintedanib|nintedanib|mesh-list
154460222|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460223|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154460224|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460225|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460226|NCT02334722|Levetiracetam|levetiracetam|mesh-list
154460227|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
154460228|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
154184128|NCT06076551|Adenosine|adenosine|mesh-list
154460230|NCT03469544|Antibodies|antibodies|mesh-list
154460231|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460232|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460233|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
154460234|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154460235|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460236|NCT04912258|Irinotecan|irinotecan|mesh-list
154460237|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154460238|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154460239|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460240|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460241|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460242|NCT01952288|Simvastatin|simvastatin|mesh-list
154460243|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154460244|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154460245|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
154460246|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460247|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154460248|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154460249|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460250|NCT03054532|Durvalumab|durvalumab|mesh-list
154460251|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460252|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460253|NCT04975360|Caffeine|caffeine|mesh-list
154460254|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154460255|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460256|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154460257|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460258|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460259|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154460260|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153742613|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460261|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
154460262|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460263|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154460264|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
154460265|NCT00563576|Estradiol|estradiol|mesh-list
153742635|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153742636|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153742637|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742638|NCT00527059|Protective Agents|protective agents|mesh-ancestor
153742639|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
154460266|NCT00563576|Estrogens|estrogens|mesh-ancestor
154460267|NCT00563576|Hormones|hormones|mesh-ancestor
154088408|NCT02558361|Apremilast|apremilast|mesh-list
154460268|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460269|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460270|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154460271|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
154460272|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154460273|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154460274|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154460275|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154460276|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154460277|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154460278|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460279|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460280|NCT03782636|Aldesleukin|aldesleukin|mesh-list
154460281|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460282|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154460283|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154460284|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
154460285|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460286|NCT04911244|Dimercaprol|dimercaprol|mesh-list
154460287|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
154460288|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
154460289|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460290|NCT03761810|Tretinoin|tretinoin|mesh-list
154460291|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154460292|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
154460293|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460294|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
154460295|NCT04915456|Prednisolone|prednisolone|mesh-list
154460296|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460297|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
154460298|NCT04915456|Hormones|hormones|mesh-ancestor
154460299|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742640|NCT03156452|Prednisolone|prednisolone|mesh-list
154460300|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460301|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460302|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460304|NCT03469310|Tramadol|tramadol|mesh-list
154460305|NCT03469310|Codeine|codeine|mesh-list
154460306|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154460307|NCT03469310|Analgesics|analgesics|mesh-ancestor
154460308|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
154460309|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742678|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742679|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460310|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460311|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
154460312|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154460313|NCT03469310|Narcotics|narcotics|mesh-ancestor
154460314|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460315|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
154460316|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
153742680|NCT03109964|Hemostatics|hemostatics|mesh-list
153742682|NCT03109964|Coagulants|coagulants|mesh-ancestor
153742683|NCT00407433|Gemcitabine|gemcitabine|mesh-list
153742684|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
153742685|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153742686|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
153742687|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742688|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742689|NCT00516412|Everolimus|everolimus|mesh-list
153742690|NCT00516412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153742691|NCT00516412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154460317|NCT03527186|Risperidone|risperidone|mesh-list
154460318|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154460319|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
154460320|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460321|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460322|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460323|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154460324|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154460325|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460326|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154460327|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154460328|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
154460329|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
154460330|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154460331|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460332|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154460333|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460334|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154460335|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460336|NCT04455464|Midodrine|midodrine|mesh-list
154460337|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
154460338|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
154460339|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460340|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460341|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154460342|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154460343|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154460344|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154460345|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
154460346|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460347|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460348|NCT04914598|Cisplatin|cisplatin|mesh-list
154460349|NCT04914598|Endostar protein|endostar protein|mesh-list
154460350|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460351|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154460352|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154460353|NCT04914598|Growth Substances|growth substances|mesh-ancestor
154460354|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460355|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
154460356|NCT03054220|Tramadol|tramadol|mesh-list
154460357|NCT03054220|Levomethorphan|levomethorphan|mesh-list
154460358|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154460359|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
154460360|NCT03054220|Paroxetine|paroxetine|mesh-list
154460361|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154460362|NCT03054220|Narcotics|narcotics|mesh-ancestor
154460363|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460364|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460365|NCT03054220|Analgesics|analgesics|mesh-ancestor
154460366|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
154460367|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460368|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153742709|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
153742710|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153742711|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
153742712|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153742716|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460369|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154460370|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460371|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460372|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460373|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
154460374|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154460375|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
154460376|NCT03054220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154460377|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
154460378|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154460379|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154460380|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154460381|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460382|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
154460383|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
154460384|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154460385|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154460386|NCT05388188|Sufentanil|sufentanil|mesh-list
154460387|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154460388|NCT05388188|Narcotics|narcotics|mesh-ancestor
154460389|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460390|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460391|NCT05388188|Analgesics|analgesics|mesh-ancestor
154460392|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
154460393|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460394|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154460395|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154460396|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
153814658|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742742|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153742743|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154460397|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
154460398|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
154460399|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460400|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460401|NCT04118036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154460402|NCT04118036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460403|NCT04909918|Dexamethasone|dexamethasone|mesh-list
154460404|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
154460405|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154460406|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154460407|NCT04909918|Prednisolone|prednisolone|mesh-list
154460408|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
154460409|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154460410|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
154460411|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460412|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
154460413|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
154460414|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460415|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460416|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154460417|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
154460418|NCT04909918|Hormones|hormones|mesh-ancestor
154460419|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860573|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
154460420|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460421|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460422|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154460423|NCT04909918|Protective Agents|protective agents|mesh-ancestor
154460424|NCT04903678|Melphalan|melphalan|mesh-list
154460425|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154460426|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
154460427|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460428|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460429|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154460430|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742744|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154460431|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
154460432|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460433|NCT04903366|Timolol|timolol|mesh-list
154460434|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460435|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154460436|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154460437|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
154460438|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460439|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460440|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154460441|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154460442|NCT03054610|Betamethasone|betamethasone|mesh-list
154460443|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
154460444|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154460445|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
154460446|NCT03054610|Ropivacaine|ropivacaine|mesh-list
154460447|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
153742776|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742777|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153742778|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460448|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153742779|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
153742780|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153742781|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742782|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742783|NCT02945527|Diuretics|diuretics|mesh-ancestor
153742784|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
153742785|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153742786|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153742787|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153742788|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153742789|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153742790|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
153742791|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460449|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
154460450|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154460451|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154460452|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
154460453|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
154460454|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460455|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460456|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
154460457|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460458|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154460459|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460460|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460461|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
154460462|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460463|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460464|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
154460465|NCT03054610|Hormones|hormones|mesh-ancestor
154460466|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460467|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154460468|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
154460469|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154460470|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154460471|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
154460472|NCT03053830|Ketamine|ketamine|mesh-list
154460473|NCT03053830|Analgesics|analgesics|mesh-ancestor
154460474|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
154460475|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460476|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460477|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154460478|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154460479|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
154460480|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
154460481|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460482|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154460483|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154460484|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460485|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460486|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
154460487|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154460488|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460489|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742793|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742812|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153742813|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153742814|NCT00529594|Analgesics|analgesics|mesh-ancestor
154860574|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154460490|NCT04913896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460491|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154460492|NCT03053284|Pasireotide|pasireotide|mesh-list
154460493|NCT03053284|Hormones|hormones|mesh-ancestor
154460494|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460495|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460496|NCT04908982|Aspirin|aspirin|mesh-list
154460497|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154460498|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154460499|NCT04908982|Analgesics|analgesics|mesh-ancestor
154460500|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
154460501|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460502|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460503|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460504|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154460505|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154460506|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154460507|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460508|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154460509|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154460510|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460511|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
154460512|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
154460513|NCT04430998|Polaprezinc|polaprezinc|mesh-list
154460514|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154460515|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460516|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
154460517|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154460518|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154460519|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
154460520|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154460521|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154460522|NCT04900948|Prednisolone|prednisolone|mesh-list
154460523|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
154460524|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
154460525|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
154460526|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154460527|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
154460528|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460529|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
154460530|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
154460531|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460532|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460533|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154460534|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
154460535|NCT04900948|Hormones|hormones|mesh-ancestor
154460536|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460537|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154460538|NCT04900948|Protective Agents|protective agents|mesh-ancestor
154460539|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460540|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460541|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154460542|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154460543|NCT04900948|Analgesics|analgesics|mesh-ancestor
154460544|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
154460545|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154460546|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
154460547|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154460548|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
154460549|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154460550|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460551|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460552|NCT04901104|Thymalfasin|thymalfasin|mesh-list
154460553|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154460554|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
154460555|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460556|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
154460557|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154460558|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154460559|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460560|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
154860575|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
154460561|NCT04907812|Coagulants|coagulants|mesh-ancestor
154460562|NCT01889186|Venetoclax|venetoclax|mesh-list
153742833|NCT00529750|Irbesartan|irbesartan|mesh-list
154460563|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460564|NCT04892212|Sirolimus|sirolimus|mesh-list
154860576|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460565|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154460566|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460567|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154460568|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460569|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
154460570|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154460571|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
154460572|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460573|NCT01510184|Rituximab|rituximab|mesh-list
154460574|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154460575|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460576|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460577|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
154460578|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460579|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742897|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742898|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742899|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742900|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
153742901|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742902|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
153742903|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742904|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
153742905|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742906|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154460580|NCT04907344|Paclitaxel|paclitaxel|mesh-list
154460581|NCT04907344|Carboplatin|carboplatin|mesh-list
154460582|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154460583|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460584|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
154460585|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
154460586|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
154460587|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460588|NCT04906876|Gemcitabine|gemcitabine|mesh-list
154460589|NCT04906876|Docetaxel|docetaxel|mesh-list
154460590|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460591|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
154460592|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460593|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460594|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
154460595|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
154460596|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
154460597|NCT04891744|Thalidomide|thalidomide|mesh-list
154460598|NCT04891744|Dexamethasone|dexamethasone|mesh-list
153742907|NCT04692376|Hormones|hormones|mesh-ancestor
154460599|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460600|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
154460601|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
154460602|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460603|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460604|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154460605|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
154460606|NCT04891744|Hormones|hormones|mesh-ancestor
154460607|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460608|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460609|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460610|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154460611|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
154460612|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
154460613|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154460614|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460615|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153742937|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153742938|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
153742939|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
153742940|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153742941|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153742942|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742943|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153742944|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154460616|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154460617|NCT04891744|Growth Substances|growth substances|mesh-ancestor
154460618|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
154460619|NCT04891900|Capecitabine|capecitabine|mesh-list
154460620|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
154460621|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154460622|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460623|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
154460624|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460625|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460626|NCT04891900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460627|NCT04891588|Timolol|timolol|mesh-list
154460628|NCT04891588|Latanoprost|latanoprost|mesh-list
154460629|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154460630|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154460631|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460632|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154460633|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154460634|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
154460635|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460636|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460637|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154460638|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154460639|NCT03050866|Antiemetics|antiemetics|mesh-list
154860577|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154460640|NCT03050866|Histamine|histamine|mesh-list
154460641|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
154460642|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154460643|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
154460644|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
154460645|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460646|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742951|NCT02945293|Oxycodone|oxycodone|mesh-list
154460647|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742970|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154460648|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
154460649|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460650|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154460651|NCT03052660|Midazolam|midazolam|mesh-list
154460652|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154460653|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154460654|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460655|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460656|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154460657|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154460658|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154460659|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154460660|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
154460661|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
154460662|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
154460663|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
154460664|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460665|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460666|NCT05162456|Antibodies|antibodies|mesh-list
154460667|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
154460668|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
154460669|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
154460670|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460671|NCT05137886|Decitabine|decitabine|mesh-list
154460672|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154460673|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460674|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
154460675|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460676|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460677|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460678|NCT05137886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460679|NCT04890418|Ketamine|ketamine|mesh-list
154460680|NCT04890418|Analgesics|analgesics|mesh-ancestor
154460681|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
154460682|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460683|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460684|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154460685|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154460686|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
154460687|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
154460688|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460689|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154460690|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154460691|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460692|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460693|NCT04455932|Liver Extracts|liver extracts|mesh-list
154460694|NCT04455932|Hematinics|hematinics|mesh-ancestor
153743031|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153743032|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153743033|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743034|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743035|NCT00527995|Urological Agents|urological agents|mesh-ancestor
153743036|NCT00144833|Ritonavir|ritonavir|mesh-list
153743037|NCT00144833|Lopinavir|lopinavir|mesh-list
153743038|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
153743039|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153743040|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153743041|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
153743042|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743043|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743044|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153743045|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153743046|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
153743047|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460695|NCT03051022|Dexamethasone|dexamethasone|mesh-list
154460696|NCT03051022|Morphine|morphine|mesh-list
154460697|NCT03051022|Bupivacaine|bupivacaine|mesh-list
154460698|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460699|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
154460700|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
154460701|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460702|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460703|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154460704|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
154460705|NCT03051022|Hormones|hormones|mesh-ancestor
154460706|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460707|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460708|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460709|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
154460710|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
154460711|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460712|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
154460713|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154460714|NCT03051022|Narcotics|narcotics|mesh-ancestor
154460715|NCT03051022|Analgesics|analgesics|mesh-ancestor
154460716|NCT04648826|Azacitidine|azacitidine|mesh-list
154460717|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460718|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
154460719|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460720|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460721|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460722|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
154460723|NCT03052348|Betamethasone|betamethasone|mesh-list
154460724|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
154460725|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154460726|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
154460727|NCT03052348|Ether|ether|mesh-list
153743052|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743053|NCT00144872|Lamotrigine|lamotrigine|mesh-list
153743054|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
153743055|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153743056|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743057|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743058|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153743059|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743060|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153743061|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153743062|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460728|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154460729|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460730|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
154460731|NCT03052348|Hormones|hormones|mesh-ancestor
154460732|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460733|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460734|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154460735|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
154460736|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154460737|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
154460738|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
154460739|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460740|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154460741|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460742|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154460743|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460744|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460745|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154460746|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460747|NCT03963518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460748|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460749|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
154460750|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
154460751|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
154460752|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154460753|NCT04101890|Protective Agents|protective agents|mesh-ancestor
154460754|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460755|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
154460756|NCT04456712|Levofloxacin|levofloxacin|mesh-list
154460757|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154460758|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460759|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154460760|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154460761|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460762|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460763|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460764|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154460765|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154460766|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154460767|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154460768|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154460769|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154460770|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154460771|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
154460772|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154460773|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154460774|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
154460775|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154460776|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
154460777|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153743087|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460778|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
153743088|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743089|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743090|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743091|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743092|NCT00144911|Fluticasone|fluticasone|mesh-list
153743094|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153743095|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743096|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153743097|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
153743098|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743099|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743100|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154460779|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460780|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460781|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154460782|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
154460783|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154460784|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
154460785|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460786|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460787|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154460788|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
154460789|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
154460790|NCT04456088|Protective Agents|protective agents|mesh-ancestor
154460791|NCT04454840|Riluzole|riluzole|mesh-list
154460792|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
154460793|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154460794|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154460795|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460796|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460797|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460798|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154460799|NCT04454840|Protective Agents|protective agents|mesh-ancestor
154460800|NCT03050710|Lidocaine|lidocaine|mesh-list
154460801|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
154460802|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
154460803|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460804|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460805|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
154460806|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460807|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154460808|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153743108|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743109|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743110|NCT00168597|Vitamin A|vitamin a|mesh-list
153743111|NCT00168597|Vitamins|vitamins|mesh-ancestor
153743112|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
153743113|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743114|NCT00528385|Spironolactone|spironolactone|mesh-list
153743115|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153743116|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
153743117|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153743118|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460809|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154460810|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460811|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460812|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154460813|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154460814|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460815|NCT03993314|Bupivacaine|bupivacaine|mesh-list
154460816|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
154460817|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
154460818|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
154460819|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460820|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460821|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
154460822|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460823|NCT04883164|Antibodies|antibodies|mesh-list
154460824|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
154460825|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460826|NCT03161054|Prednisone|prednisone|mesh-list
154460827|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
154460828|NCT03161054|Rituximab|rituximab|mesh-list
154460829|NCT03161054|Etoposide|etoposide|mesh-list
154460830|NCT03161054|Vinorelbine|vinorelbine|mesh-list
154460831|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154460832|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
154460833|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460834|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154460835|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154460836|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
154460837|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460838|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460839|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153743120|NCT00528385|Diuretics|diuretics|mesh-ancestor
154460840|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460841|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460842|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
154460843|NCT03161054|Hormones|hormones|mesh-ancestor
154460844|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153743153|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
153743154|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460845|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460846|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154460847|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154460848|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154460849|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460850|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
154460851|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
153743155|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743156|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
153743157|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743158|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153730738|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730739|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743159|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153743160|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153743161|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743163|NCT00528619|Carboplatin|carboplatin|mesh-list
154460852|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
154460853|NCT03050554|Avelumab|avelumab|mesh-list
154460854|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460855|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460856|NCT03050164|Gefitinib|gefitinib|mesh-list
154460857|NCT03050164|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154460858|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154460859|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154460860|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460861|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460862|NCT03049930|Ketamine|ketamine|mesh-list
154460863|NCT03049930|Analgesics|analgesics|mesh-ancestor
154460864|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
154460865|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460866|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460868|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154460869|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
154460870|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
154460871|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460872|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154460873|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154460874|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460875|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460876|NCT02036463|Prednisone|prednisone|mesh-list
154460877|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460878|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
154460879|NCT02036463|Hormones|hormones|mesh-ancestor
154460880|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460881|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460882|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154460883|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460884|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154460885|NCT04887844|Lidocaine|lidocaine|mesh-list
154460886|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
154460887|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
154460888|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460889|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460890|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
154460891|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460892|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154460893|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154460894|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154460895|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460896|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460897|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460898|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
154460899|NCT04887844|Hormones|hormones|mesh-ancestor
154460900|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154460901|NCT02595320|Capecitabine|capecitabine|mesh-list
154460902|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460903|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
154460904|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460905|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460906|NCT02809053|Rituximab|rituximab|mesh-list
153743182|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743183|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
153743184|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743185|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153743186|NCT00528658|Acetaminophen|acetaminophen|mesh-list
154460907|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460908|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460909|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
154460910|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460911|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154460912|NCT04666688|Paclitaxel|paclitaxel|mesh-list
154460913|NCT04666688|Gemcitabine|gemcitabine|mesh-list
154460914|NCT04666688|Tislelizumab|tislelizumab|mesh-list
154460915|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154460916|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460917|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
154460918|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
154460919|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
154460920|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460921|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153743187|NCT00528658|Ibuprofen|ibuprofen|mesh-list
153743188|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154460922|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
154460923|NCT04666688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460924|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
154460925|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154460926|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154460927|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154460928|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154460929|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460930|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
154460931|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460932|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460933|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154460934|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460935|NCT02047539|Aspirin|aspirin|mesh-list
154460936|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154460937|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154460938|NCT02047539|Analgesics|analgesics|mesh-ancestor
154460939|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
154460940|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460941|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460942|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154460943|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154460944|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154460945|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154460946|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460947|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154460948|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154460949|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743220|NCT00531349|Sevoflurane|sevoflurane|mesh-list
153743221|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
153743222|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743223|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460950|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
154460951|NCT02522858|Atropine|atropine|mesh-list
154460952|NCT02522858|Ephedrine|ephedrine|mesh-list
154460953|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
154460954|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154460955|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460956|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460957|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154460958|NCT02522858|Analgesics|analgesics|mesh-ancestor
154460959|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
154460960|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460961|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154460962|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154460963|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154460964|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
154460965|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154460966|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154460967|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154460968|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154460969|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154460970|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
154460971|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154460972|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
154460973|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
154460974|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
153814659|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154460975|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154460976|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154460977|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
154460978|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154460979|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
154460980|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154460981|NCT02036697|Fentanyl|fentanyl|mesh-list
154460982|NCT02036697|Morphine|morphine|mesh-list
154460983|NCT02036697|Bupivacaine|bupivacaine|mesh-list
154460984|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
154460985|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
154460986|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154460987|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154460988|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
154460989|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154460990|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154460991|NCT02036697|Narcotics|narcotics|mesh-ancestor
154460992|NCT02036697|Analgesics|analgesics|mesh-ancestor
154460993|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154460994|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154460995|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
154460996|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
154460997|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154460998|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154460999|NCT03106688|Carfentanil|carfentanil|mesh-list
154461000|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154461001|NCT03106688|Narcotics|narcotics|mesh-ancestor
154461002|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461003|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461004|NCT03106688|Analgesics|analgesics|mesh-ancestor
154461005|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
154461006|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461007|NCT02037009|Anesthetics|anesthetics|mesh-list
154461008|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461009|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461010|NCT02260011|Bromides|bromides|mesh-list
154461011|NCT02260011|Norflurane|norflurane|mesh-list
154461012|NCT02260011|Ipratropium|ipratropium|mesh-list
154461013|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
154461014|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154461015|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
154461016|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461017|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461018|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154461019|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
154461020|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154461021|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
154461022|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461023|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461024|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
154461025|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461026|NCT02047773|Meropenem|meropenem|mesh-list
154461027|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461028|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461029|NCT04886752|Vitamins|vitamins|mesh-list
154461030|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
154461031|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
153743292|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153743293|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743294|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153743295|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153743296|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743297|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743298|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153743299|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
153743300|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743301|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
153743302|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153743303|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
154461032|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
154461033|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461034|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
154461035|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461036|NCT04886752|Protective Agents|protective agents|mesh-ancestor
154461037|NCT04895800|Caffeine|caffeine|mesh-list
154461038|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154461039|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461040|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154461041|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461042|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461043|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154461044|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154461045|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
154461046|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461047|NCT04886362|Ivermectin|ivermectin|mesh-list
154461048|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154461049|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461050|NCT02048007|Azithromycin|azithromycin|mesh-list
154461051|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461052|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461053|NCT02048085|Clopidogrel|clopidogrel|mesh-list
154461054|NCT02048085|Ticagrelor|ticagrelor|mesh-list
154461055|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154461056|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154461057|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154461058|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154461059|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
154461060|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461061|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461062|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461063|NCT02808975|Adalimumab|adalimumab|mesh-list
154461064|NCT02808975|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154461065|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461066|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154461067|NCT04885660|Lisinopril|lisinopril|mesh-list
154461068|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154461069|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
154461070|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461071|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814661|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743321|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153743322|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
153479253|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153743326|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
153743327|NCT02944201|Carvedilol|carvedilol|mesh-list
153743328|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153743329|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153743330|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
153743331|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461072|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154461073|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154461074|NCT04885660|Protective Agents|protective agents|mesh-ancestor
154461075|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461076|NCT02037633|Fentanyl|fentanyl|mesh-list
154461077|NCT02037633|Ropivacaine|ropivacaine|mesh-list
154461078|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461079|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
154461080|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461081|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461082|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
154461083|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461084|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154461085|NCT02037633|Narcotics|narcotics|mesh-ancestor
154461086|NCT02037633|Analgesics|analgesics|mesh-ancestor
154461087|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154461088|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154461089|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
154461090|NCT05684211|Cetuximab|cetuximab|mesh-list
154461091|NCT05684211|Antibodies|antibodies|mesh-list
154461092|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154461093|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
154461094|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461095|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154461096|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461097|NCT03130634|Silymarin|silymarin|mesh-list
154461098|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
154461099|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461100|NCT03130634|Protective Agents|protective agents|mesh-ancestor
154461101|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461102|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
154461103|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154461104|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154461105|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461106|NCT04880746|Cladribine|cladribine|mesh-list
154461107|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461108|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154461109|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
154461110|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461111|NCT03050086|Minocycline|minocycline|mesh-list
154461112|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461113|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461114|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
154461115|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154461116|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154461117|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154461118|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
154461119|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461120|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461121|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743355|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
153743356|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
153743357|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153743358|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153743359|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743360|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153743361|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743362|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461122|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
154461123|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154461124|NCT04885270|Cisplatin|cisplatin|mesh-list
154185027|NCT03990571|Axitinib|axitinib|mesh-list
154461125|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461126|NCT04885426|Metformin|metformin|mesh-list
154461127|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154461128|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461130|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154461131|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
154461132|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
154461133|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154461134|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
154461135|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154461136|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461137|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154461138|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153743363|NCT00530413|Phenobarbital|phenobarbital|mesh-list
153743364|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
153743365|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153743372|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
154461139|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154461140|NCT04872322|Ropivacaine|ropivacaine|mesh-list
154461141|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154461142|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461143|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
154461144|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461145|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461146|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
154461147|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461148|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
154461149|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
154461150|NCT04879030|Levofloxacin|levofloxacin|mesh-list
154461151|NCT04879030|Meropenem|meropenem|mesh-list
154461152|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
154461153|NCT04879030|Tazobactam|tazobactam|mesh-list
154461154|NCT04879030|Piperacillin|piperacillin|mesh-list
154461155|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
154461156|NCT04879030|Imipenem|imipenem|mesh-list
154461157|NCT04879030|Ceftazidime|ceftazidime|mesh-list
154461158|NCT04879030|Ertapenem|ertapenem|mesh-list
154461159|NCT04879030|Lactams|lactams|mesh-list
154461160|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154461161|NCT04879030|Cefotaxime|cefotaxime|mesh-list
154461162|NCT04879030|Cefixime|cefixime|mesh-list
154461163|NCT04879030|beta-Lactams|beta-lactams|mesh-list
154461164|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
154461165|NCT04879030|Ticarcillin|ticarcillin|mesh-list
154461166|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461167|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461168|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154461169|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154461170|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461171|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743383|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153743384|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154461172|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743385|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743386|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153743387|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153743388|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743391|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
154461173|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154461174|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154461175|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154461176|NCT04879030|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154461177|NCT04879030|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154461178|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154461179|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154461181|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461182|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461183|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154461184|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154461185|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154461186|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461187|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461188|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154461189|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154461190|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461191|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
154461192|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461193|NCT04870372|Selegiline|selegiline|mesh-list
154461194|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
154461195|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154461196|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154461197|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153743413|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461198|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154461199|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461200|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461201|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154461202|NCT04870372|Protective Agents|protective agents|mesh-ancestor
154461203|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461204|NCT02048319|Ethanol|ethanol|mesh-list
154461205|NCT02048319|Pasireotide|pasireotide|mesh-list
154461206|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154461207|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461208|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461209|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461210|NCT02048319|Hormones|hormones|mesh-ancestor
154461211|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461212|NCT01594762|Pexiganan|pexiganan|mesh-list
154461213|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461214|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461215|NCT02048475|Desflurane|desflurane|mesh-list
154461216|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154461217|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
154461218|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
154461219|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461220|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461221|NCT03562143|Iron|iron|mesh-list
154461222|NCT03562143|Trace Elements|trace elements|mesh-ancestor
154461223|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
154461224|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461225|NCT02048865|Apixaban|apixaban|mesh-list
154461226|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154461227|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
154461228|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154461229|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
154461230|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461231|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461232|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
154461233|NCT02048943|Paclitaxel|paclitaxel|mesh-list
154461234|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154461235|NCT02048943|Gemcitabine|gemcitabine|mesh-list
154461236|NCT02048943|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154461237|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154461238|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461239|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
154461240|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
154461241|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
154461242|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461243|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154461244|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
154461245|NCT02048943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154461246|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461247|NCT02050893|Midazolam|midazolam|mesh-list
154461248|NCT02050893|Propofol|propofol|mesh-list
154461249|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154461250|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461251|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461252|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154461253|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
154461254|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
154461255|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154461256|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154461257|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154461258|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154461259|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
154461260|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
154461261|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461262|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743454|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154461263|NCT02806947|Sirolimus|sirolimus|mesh-list
154461264|NCT02806947|Prednisone|prednisone|mesh-list
154461265|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743455|NCT05319340|Anticoagulants|anticoagulants|mesh-list
153743456|NCT05319301|Melatonin|melatonin|mesh-list
153743476|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743477|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743478|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
154461266|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
154461267|NCT02806947|Hormones|hormones|mesh-ancestor
154461268|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461269|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461270|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154461271|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461272|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461273|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461274|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154461275|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
154461276|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154461277|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
154461278|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
154461279|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743479|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153743480|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
154461280|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
154461281|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461282|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461283|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154461285|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461286|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
154461287|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
154461288|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461289|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461290|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154461291|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
154461292|NCT02037399|Hormones|hormones|mesh-ancestor
154461293|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461294|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154461295|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814662|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814663|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
153743497|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
153743498|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461296|NCT02260089|Telmisartan|telmisartan|mesh-list
154461297|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154461298|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154461299|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154461300|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461301|NCT02049255|Bupivacaine|bupivacaine|mesh-list
154461302|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
154461303|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461304|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
154461305|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461306|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461307|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
154461308|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461309|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
154461310|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461311|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
154461312|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461313|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461314|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
154461315|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461316|NCT03561675|Acetazolamide|acetazolamide|mesh-list
154860578|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154461317|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
154860579|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
154461318|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154461319|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461320|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461321|NCT03561675|Diuretics|diuretics|mesh-ancestor
154461322|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
154461323|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461324|NCT02049411|Ketamine|ketamine|mesh-list
154461325|NCT02049411|Analgesics|analgesics|mesh-ancestor
154461326|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
154461327|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461328|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461329|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154461330|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154461331|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
154461332|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
154461333|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461334|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154461335|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154461336|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461337|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461338|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
154461339|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461340|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
154461341|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
154461342|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
154461343|NCT02051751|Paclitaxel|paclitaxel|mesh-list
153743547|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743548|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153743549|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
153580581|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
153743550|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153743551|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
153743552|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
153743553|NCT02944825|Trimethoprim|trimethoprim|mesh-list
153743554|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
153743555|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153743556|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743557|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153743558|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153743559|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743560|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461344|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153743561|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743562|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154461345|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461346|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
154461347|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
154461348|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
154461349|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461350|NCT02049801|Cytarabine|cytarabine|mesh-list
154461351|NCT02049801|Idarubicin|idarubicin|mesh-list
154461352|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154461353|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
154461354|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461355|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461356|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
154461357|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461358|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154461359|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
154461360|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461361|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154461362|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154461363|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154461364|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461365|NCT02802345|Nintedanib|nintedanib|mesh-list
154461366|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
154461367|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
154461368|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154461369|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154461370|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461371|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461372|NCT02802345|Urological Agents|urological agents|mesh-ancestor
154461373|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461374|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154461375|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154461376|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
154461377|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154461378|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
153743565|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
153743566|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153743567|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153743568|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153743569|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153743570|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153743580|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743582|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
153743583|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
153743584|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743585|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153743586|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153743593|NCT02942563|Capecitabine|capecitabine|mesh-list
154461379|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154461380|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461381|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154461382|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154461383|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461384|NCT02056041|Liver Extracts|liver extracts|mesh-list
154461385|NCT02056041|Hematinics|hematinics|mesh-ancestor
154461386|NCT02053857|Amoxicillin|amoxicillin|mesh-list
154461387|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461388|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461389|NCT02053935|Dopamine|dopamine|mesh-list
154461390|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154461391|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
154461392|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
154461393|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461394|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461396|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461397|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461398|NCT02053935|Protective Agents|protective agents|mesh-ancestor
154461399|NCT02056353|Insulin|insulin|mesh-list
154461400|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154461401|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461402|NCT02056587|Everolimus|everolimus|mesh-list
154461403|NCT02056587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154461404|NCT02056587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154461405|NCT02056587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461406|NCT02056587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461407|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154461408|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
154461409|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814664|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814665|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153743602|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461410|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461411|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154461412|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154461413|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
154461414|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
154461415|NCT02038335|Etonogestrel|etonogestrel|mesh-list
154461416|NCT02038335|Norethindrone|norethindrone|mesh-list
154461417|NCT02038335|Estradiol|estradiol|mesh-list
154461418|NCT02038335|Estrogens|estrogens|mesh-ancestor
154461419|NCT02038335|Hormones|hormones|mesh-ancestor
154461420|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461421|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461422|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154461423|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
154461424|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154461425|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154461426|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154461427|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154461428|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154461429|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154461430|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154461431|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185327|NCT00262470|Midodrine|midodrine|mesh-list
154461432|NCT02056665|Minocycline|minocycline|mesh-list
154461433|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461434|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461435|NCT02056743|Fexofenadine|fexofenadine|mesh-list
154461436|NCT02056743|Losartan|losartan|mesh-list
154461437|NCT02056743|Midazolam|midazolam|mesh-list
154461438|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
154461439|NCT02056743|Caffeine|caffeine|mesh-list
154461440|NCT02056743|Omeprazole|omeprazole|mesh-list
154461441|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154461442|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154461443|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461444|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461445|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154461446|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154461447|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154461448|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154461449|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
154461450|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
154461451|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
154461452|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
154461453|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461454|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461455|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154461456|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154461457|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153743654|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153743655|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153743656|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743657|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153743658|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153743659|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743660|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153743661|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
154461458|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154461459|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154461460|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154461461|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461462|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154461463|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154461464|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
154461465|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154461466|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154254884|NCT03911570|Acetaminophen|acetaminophen|mesh-list
154461468|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
154461469|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
154461470|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154461471|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154461472|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154461473|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154461474|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154461475|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
154461476|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
154461477|NCT02052375|ASP2408|asp2408|mesh-list
154461478|NCT02052375|Immunoconjugates|immunoconjugates|mesh-ancestor
154461479|NCT02052375|Immunologic Factors|immunologic factors|mesh-ancestor
154461480|NCT02052375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461481|NCT02054637|Lanreotide|lanreotide|mesh-list
154461482|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461483|NCT02054793|Itraconazole|itraconazole|mesh-list
154461484|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
154461485|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461486|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154461487|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154461488|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461489|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743662|NCT00169299|Estrogens|estrogens|mesh-list
154461490|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154461491|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
154461492|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461493|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461494|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154461495|NCT02052687|Imiquimod|imiquimod|mesh-list
153814666|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154461496|NCT02052687|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154461497|NCT02052687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461498|NCT02052687|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154461499|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
154461500|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461501|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154461502|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461503|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
154461504|NCT02057289|Micafungin|micafungin|mesh-list
154185419|NCT00346216|Ibuprofen|ibuprofen|mesh-list
153814667|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
153814668|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743686|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743687|NCT02942329|Apatinib|apatinib|mesh-list
153743688|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743689|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153743690|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743691|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743692|NCT00174720|Ciclesonide|ciclesonide|mesh-list
153743693|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
154461505|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
154461506|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461507|NCT02057367|Bupivacaine|bupivacaine|mesh-list
154461508|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461509|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
154461510|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461511|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461512|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
154461513|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461514|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
154461515|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154461516|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
154461517|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461518|NCT02054949|Expectorants|expectorants|mesh-ancestor
154461519|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
154461520|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154461521|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
154461522|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461523|NCT02054949|Protective Agents|protective agents|mesh-ancestor
154461524|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461525|NCT02054949|Antidotes|antidotes|mesh-ancestor
154461526|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154461527|NCT02748057|Ezetimibe|ezetimibe|mesh-list
154461528|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154461529|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154461530|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
154461531|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461532|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154461533|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154461534|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461535|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
153743694|NCT00174720|Hormones|hormones|mesh-ancestor
154461536|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461537|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
154461538|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461539|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461541|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461542|NCT02057679|Amoxicillin|amoxicillin|mesh-list
154461543|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461544|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461545|NCT02038491|Anesthetics|anesthetics|mesh-list
154461546|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461547|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461548|NCT02748213|Docetaxel|docetaxel|mesh-list
154461549|NCT02748213|Capecitabine|capecitabine|mesh-list
154461550|NCT02748213|Trastuzumab|trastuzumab|mesh-list
154461551|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461552|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
154461553|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
154461554|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
154461555|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461556|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154461557|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
154461558|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154461559|NCT03804099|Aflibercept|aflibercept|mesh-list
154461560|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153743729|NCT02276989|Acetazolamide|acetazolamide|mesh-list
153743730|NCT02276989|Vitamins|vitamins|mesh-ancestor
154461561|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154461562|NCT03804099|Growth Substances|growth substances|mesh-ancestor
154461563|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461564|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
154461565|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461566|NCT02058303|Bupivacaine|bupivacaine|mesh-list
154461567|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461568|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
154461569|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461570|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461571|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
154461572|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461573|NCT04870060|Curcumin|curcumin|mesh-list
154461574|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154461575|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154461576|NCT04870060|Analgesics|analgesics|mesh-ancestor
154461577|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
154461578|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461579|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461580|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461581|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154461582|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461583|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461584|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461585|NCT02613910|Acetaminophen|acetaminophen|mesh-list
154461586|NCT02613910|Cetirizine|cetirizine|mesh-list
154461587|NCT02613910|Prednisone|prednisone|mesh-list
154461588|NCT02613910|Prednisolone|prednisolone|mesh-list
154461589|NCT02613910|Ofatumumab|ofatumumab|mesh-list
154461590|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
154461591|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154461592|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461593|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
154461594|NCT02613910|Hormones|hormones|mesh-ancestor
154461595|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461596|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461597|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154461598|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461599|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154461600|NCT02613910|Analgesics|analgesics|mesh-ancestor
154461601|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
154461602|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461603|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
154461604|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154461605|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154461606|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
154461607|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461608|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743754|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154461609|NCT02802735|Apremilast|apremilast|mesh-list
154461610|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154461611|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154461612|NCT02802735|Analgesics|analgesics|mesh-ancestor
154461613|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
154461614|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461615|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461616|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461617|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154461618|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154461619|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154461620|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461621|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461622|NCT03048214|Anesthetics|anesthetics|mesh-list
154461623|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461624|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461625|NCT02060955|Bevacizumab|bevacizumab|mesh-list
154461626|NCT02060955|Irinotecan|irinotecan|mesh-list
154461627|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154461628|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461629|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154461630|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154461631|NCT02060955|Growth Substances|growth substances|mesh-ancestor
154461632|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461633|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
154461634|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154461635|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154461636|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461637|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461638|NCT04877626|Artesunate|artesunate|mesh-list
154461639|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
153814669|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154461640|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154461641|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154461642|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461643|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461644|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
154461645|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
154461646|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154461647|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
154461648|NCT05255848|Heparin|heparin|mesh-list
154461649|NCT05255848|Calcium heparin|calcium heparin|mesh-list
154461650|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
153743801|NCT00169416|Valacyclovir|valacyclovir|mesh-list
153743802|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
153743803|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743804|NCT00174876|Aripiprazole|aripiprazole|mesh-list
153743805|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
153743821|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153743822|NCT00146471|Levetiracetam|levetiracetam|mesh-list
153743823|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
153743824|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
153743825|NCT00174993|Pioglitazone|pioglitazone|mesh-list
153743826|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743827|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461651|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154461652|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154461653|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461654|NCT04430062|Anesthetics|anesthetics|mesh-list
154461655|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461656|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461657|NCT02799381|Levodopa|levodopa|mesh-list
154461658|NCT02799381|Carbidopa|carbidopa|mesh-list
154461659|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154461660|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
154461661|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154461662|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
154461663|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461664|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461665|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461666|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154461667|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461668|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153743829|NCT02940379|Metoprolol|metoprolol|mesh-list
154461669|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
154461670|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
154461671|NCT04387942|Aldesleukin|aldesleukin|mesh-list
154461672|NCT04387942|Interleukin-2|interleukin-2|mesh-list
154461673|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461674|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154461675|NCT04387942|Analgesics|analgesics|mesh-ancestor
154461676|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
154461677|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461678|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461679|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154461680|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154461681|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
154461682|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461684|NCT01333059|Fentanyl|fentanyl|mesh-list
154461685|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154461686|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154461687|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461688|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461689|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154461690|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154461691|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154461692|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154461693|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
154461694|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
154461695|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
154461696|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
154461697|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461698|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461699|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153743847|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
153743848|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
153743849|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743850|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153743851|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153743852|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153743853|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
153743854|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153743855|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743856|NCT00146549|Paclitaxel|paclitaxel|mesh-list
153743857|NCT00146549|Vinorelbine|vinorelbine|mesh-list
153743858|NCT00146549|Docetaxel|docetaxel|mesh-list
153743859|NCT00146549|Trastuzumab|trastuzumab|mesh-list
154461700|NCT01333059|Narcotics|narcotics|mesh-ancestor
154461701|NCT01333059|Analgesics|analgesics|mesh-ancestor
154461702|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
154461703|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461704|NCT02060253|Paclitaxel|paclitaxel|mesh-list
154461705|NCT02060253|Trastuzumab|trastuzumab|mesh-list
154461706|NCT02060253|Pertuzumab|pertuzumab|mesh-list
154461707|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154461708|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461709|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
154461710|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
154461711|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
154461712|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461713|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153743860|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153743861|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461714|NCT03560973|Gemcitabine|gemcitabine|mesh-list
154461715|NCT03560973|Ramucirumab|ramucirumab|mesh-list
154461716|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154461717|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
154461718|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461719|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461720|NCT03560973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154461721|NCT03560973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154461722|NCT03560973|Growth Substances|growth substances|mesh-ancestor
154461723|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461724|NCT03560973|Growth Inhibitors|growth inhibitors|mesh-ancestor
154461725|NCT04383574|Vaccines|vaccines|mesh-list
154461726|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
154461727|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461728|NCT03046108|Triamcinolone|triamcinolone|mesh-list
154461729|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154461730|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154461731|NCT03046108|Mepivacaine|mepivacaine|mesh-list
154461732|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154461733|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461734|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
154461735|NCT03046108|Hormones|hormones|mesh-ancestor
153743886|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743887|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153743888|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
153743889|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743890|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743891|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153743892|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153743893|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
154461736|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461737|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461738|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154461739|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
154461740|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461741|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743894|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153743895|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154461742|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461743|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
154461744|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461745|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
154461746|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461747|NCT02061267|Niacin|niacin|mesh-list
154461748|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
154461749|NCT02061267|Vitamins|vitamins|mesh-ancestor
154461750|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
154461751|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461752|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
154461753|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154461754|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
154461755|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461756|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154461757|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
154461758|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154461759|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154461760|NCT01370655|Diuretics|diuretics|mesh-ancestor
154461761|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
154461762|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461763|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154461764|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154461765|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461766|NCT02612194|Crizotinib|crizotinib|mesh-list
154461767|NCT02612194|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154461769|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461770|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461771|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461772|NCT03044626|Nivolumab|nivolumab|mesh-list
154461773|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154461774|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461775|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154461776|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461777|NCT04865224|Chrysarobin|chrysarobin|mesh-list
154461778|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154461779|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154461780|NCT04865224|Analgesics|analgesics|mesh-ancestor
154461781|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
154461782|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461783|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461784|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461785|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154461786|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
154461787|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154461788|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154461789|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461790|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
154461791|NCT04865380|Coagulants|coagulants|mesh-ancestor
154461792|NCT04869046|Acetaminophen|acetaminophen|mesh-list
154461793|NCT04869046|Ibuprofen|ibuprofen|mesh-list
154461794|NCT04869046|Analgesics|analgesics|mesh-list
154461795|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
154461796|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154461797|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
154461798|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461799|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461800|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
154461801|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154461802|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461803|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154461804|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154461805|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743909|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461806|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461807|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
153743955|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743956|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743958|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
154461808|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
154461809|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461811|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154461812|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154461813|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461814|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
154461815|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
154461816|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154461817|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
154461818|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461819|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154461820|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154461821|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154461822|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154461823|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
154461824|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461825|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154461826|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154461827|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461828|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154461829|NCT05654415|Melatonin|melatonin|mesh-list
154461830|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
154461831|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461832|NCT05654415|Protective Agents|protective agents|mesh-ancestor
154461833|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461834|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461835|NCT03044938|Albuterol|albuterol|mesh-list
154461836|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154461837|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
154461838|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461839|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461840|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154461841|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
154461842|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
154461843|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154461844|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154461845|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154461846|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154461847|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
154461848|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461849|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461850|NCT03045484|Oxycodone|oxycodone|mesh-list
154461851|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154461852|NCT03045484|Narcotics|narcotics|mesh-ancestor
154461853|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461854|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461855|NCT03045484|Analgesics|analgesics|mesh-ancestor
154461856|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
154461857|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461859|NCT04874506|TEMPOL-H|tempol-h|mesh-list
154461860|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
154461861|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461862|NCT04874506|Protective Agents|protective agents|mesh-ancestor
154461863|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461864|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154461865|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
154461866|NCT04874428|Apixaban|apixaban|mesh-list
154461867|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154461868|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
154461869|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154461870|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
154461871|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461872|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461873|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
154461874|NCT04867720|Everolimus|everolimus|mesh-list
154461875|NCT04867720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154461876|NCT04867720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154461877|NCT04867720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461878|NCT04867720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461879|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154461880|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
154461881|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461882|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461883|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154461884|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154461885|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154461886|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
154461887|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154461888|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461889|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
154461890|NCT03045406|Dalteparin|dalteparin|mesh-list
154461891|NCT03045406|Tinzaparin|tinzaparin|mesh-list
154461892|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154461893|NCT03045406|Apixaban|apixaban|mesh-list
154461894|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154461895|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
154461896|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154461897|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
154461898|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461899|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461900|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
154461901|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154461902|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154461903|NCT02798835|Dexamethasone|dexamethasone|mesh-list
154461904|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
154461905|NCT02798835|Fentanyl|fentanyl|mesh-list
154461906|NCT02798835|Bupivacaine|bupivacaine|mesh-list
154461907|NCT02798835|Ropivacaine|ropivacaine|mesh-list
154461908|NCT02798835|BB 1101|bb 1101|mesh-list
154461909|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461910|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
154461911|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
154461912|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461913|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461914|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154461915|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
154461916|NCT02798835|Hormones|hormones|mesh-ancestor
154461917|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461918|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154461919|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744073|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744074|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
153744075|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744076|NCT02939482|Triamcinolone|triamcinolone|mesh-list
153744077|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153730744|NCT00135005|Nilotinib|nilotinib|mesh-list
153730745|NCT00135005|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154461920|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
154461921|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461922|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461923|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
154461924|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
154461925|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154461926|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
154461927|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154461928|NCT02798835|Narcotics|narcotics|mesh-ancestor
154461929|NCT02798835|Analgesics|analgesics|mesh-ancestor
154461930|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154461931|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154461932|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
154461933|NCT02061657|Misoprostol|misoprostol|mesh-list
154461934|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154461935|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
154461936|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154461937|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461938|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154461939|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154461940|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
154461941|NCT03048136|Nivolumab|nivolumab|mesh-list
154461942|NCT03048136|Ipilimumab|ipilimumab|mesh-list
154461943|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154461944|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461945|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154461946|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461947|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
154461948|NCT02062203|Glycine|glycine|mesh-list
154461949|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154461950|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154461951|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154461952|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154461953|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154461954|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744078|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153744079|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153744095|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154461955|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461956|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461957|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
154461958|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154461959|NCT04863742|Prednisolone|prednisolone|mesh-list
154461960|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154461961|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
154461962|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154461963|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
154461964|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154461965|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
153744096|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153744097|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744098|NCT02939248|Morphine|morphine|mesh-list
153744099|NCT02939248|Naloxone|naloxone|mesh-list
153744100|NCT02939248|Ticagrelor|ticagrelor|mesh-list
153744101|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153744102|NCT02939248|Narcotics|narcotics|mesh-ancestor
153744103|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744104|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461966|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154461967|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
154461968|NCT04863742|Hormones|hormones|mesh-ancestor
154461969|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154461970|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461971|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154461972|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154461973|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
154461974|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
154461975|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461976|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154461977|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154461978|NCT04863742|Protective Agents|protective agents|mesh-ancestor
154461979|NCT02611882|Edetic Acid|edetic acid|mesh-list
154461980|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
154461981|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154461982|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
154461983|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
154461984|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154461985|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
154461986|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154461987|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154461988|NCT02062281|Vaccines|vaccines|mesh-list
154461989|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154461990|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
154461991|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461992|NCT03560583|Metoclopramide|metoclopramide|mesh-list
154461993|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
154461994|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
154461995|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154461996|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154461997|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154461998|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154461999|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154462000|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
154462001|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744105|NCT02939248|Analgesics|analgesics|mesh-ancestor
153744170|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153744171|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
153744172|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744173|NCT00147524|Quinapril|quinapril|mesh-list
153744174|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153744175|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
153744176|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744177|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744178|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153744179|NCT00147563|Eplerenone|eplerenone|mesh-list
154462002|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462003|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154462004|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154462005|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154462006|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462007|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462008|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462009|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462010|NCT03560427|Analgesics|analgesics|mesh-ancestor
154462011|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
154462012|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462013|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
154462014|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154462015|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
154462016|NCT03797547|Aflibercept|aflibercept|mesh-list
154462017|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154462018|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154462019|NCT03797547|Growth Substances|growth substances|mesh-ancestor
154462020|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462021|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
154462022|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462023|NCT04867252|Inositol|inositol|mesh-list
154462024|NCT04867252|Metformin|metformin|mesh-list
154462025|NCT04867252|Pioglitazone|pioglitazone|mesh-list
154462026|NCT04867252|Resveratrol|resveratrol|mesh-list
154462027|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154462028|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462029|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
154462030|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462031|NCT04867252|Protective Agents|protective agents|mesh-ancestor
154462032|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462033|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154462034|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
154462035|NCT04867252|Vitamins|vitamins|mesh-ancestor
154462036|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
154462037|NCT04863274|Atorvastatin|atorvastatin|mesh-list
154462038|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154462039|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154462040|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
154462041|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462042|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154462043|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154462044|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462045|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
154462046|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154462047|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
154462048|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462049|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
154462050|NCT02063373|Protective Agents|protective agents|mesh-ancestor
154462051|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
154462052|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462053|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154462054|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
154462055|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154462056|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
154462057|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462058|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462059|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154462060|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
154462061|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154462062|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154462063|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154462064|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
154462065|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462066|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462067|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154462068|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154462069|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154462070|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154462071|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462072|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462073|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154462074|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462075|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462076|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
154462077|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462078|NCT04429282|Ibuprofen|ibuprofen|mesh-list
154462079|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154462080|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154462081|NCT04429282|Analgesics|analgesics|mesh-ancestor
153744242|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744243|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462082|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
154462083|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462084|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462085|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154462086|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154462087|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154462088|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462089|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462090|NCT02063529|Leucovorin|leucovorin|mesh-list
154462091|NCT02063529|Fluorouracil|fluorouracil|mesh-list
154462092|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
154462093|NCT02063529|Irinotecan|irinotecan|mesh-list
154462094|NCT02063529|Cetuximab|cetuximab|mesh-list
154462095|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
154462096|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
154462097|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462098|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154462099|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462100|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154462101|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
154462102|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462103|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154462104|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154462105|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462106|NCT02063529|Antidotes|antidotes|mesh-ancestor
154462107|NCT02063529|Protective Agents|protective agents|mesh-ancestor
154462108|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
154462109|NCT02063529|Vitamins|vitamins|mesh-ancestor
154462110|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
154462111|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462112|NCT02062983|Trastuzumab|trastuzumab|mesh-list
154462113|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462114|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744283|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153744284|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153744285|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
153744286|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744287|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153744288|NCT02931526|Tigecycline|tigecycline|mesh-list
153744289|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153744290|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462116|NCT02613208|Bevacizumab|bevacizumab|mesh-list
154462117|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154462118|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462119|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
154462120|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
154462121|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
154462122|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462123|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462124|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154462125|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154462126|NCT02613208|Growth Substances|growth substances|mesh-ancestor
154462127|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462128|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
154462129|NCT02063841|Bismuth|bismuth|mesh-list
154462130|NCT02063841|Antacids|antacids|mesh-ancestor
154462131|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462132|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462133|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
154462134|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154462135|NCT04872634|Cetuximab|cetuximab|mesh-list
154462136|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462137|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462138|NCT01668784|Nivolumab|nivolumab|mesh-list
154462139|NCT01668784|Everolimus|everolimus|mesh-list
154462140|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462141|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462142|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154462143|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462144|NCT01668784|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154462145|NCT01668784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154860580|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462146|NCT01668784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744306|NCT00147836|Insulin|insulin|mesh-list
154462147|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154462148|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
154462149|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462150|NCT02750514|Nivolumab|nivolumab|mesh-list
154462151|NCT02750514|Ipilimumab|ipilimumab|mesh-list
154462152|NCT02750514|Relatlimab|relatlimab|mesh-list
154462153|NCT02750514|Dasatinib|dasatinib|mesh-list
154462154|NCT02750514|Linrodostat|linrodostat|mesh-list
154462155|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462156|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462157|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154462158|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462159|NCT02750514|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154462160|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154462161|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462162|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
154462163|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154462164|NCT02229240|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154462165|NCT02229240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154462166|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462167|NCT02229240|Incretins|incretins|mesh-ancestor
154462168|NCT02229240|Hormones|hormones|mesh-ancestor
154462169|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154462170|NCT02820714|Laxatives|laxatives|mesh-list
154462171|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462172|NCT02259426|Primaquine|primaquine|mesh-list
154462173|NCT02259426|Piperaquine|piperaquine|mesh-list
154462174|NCT02259426|Artenimol|artenimol|mesh-list
154462175|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
154462176|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154462177|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154462178|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462179|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153744308|NCT00147836|Metformin|metformin|mesh-list
153744358|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153744360|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462180|NCT03412890|Norethindrone|norethindrone|mesh-list
154462181|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
154462182|NCT03412890|Estradiol|estradiol|mesh-list
154462183|NCT03412890|Relugolix|relugolix|mesh-list
154462184|NCT03412890|Estrogens|estrogens|mesh-ancestor
154462185|NCT03412890|Hormones|hormones|mesh-ancestor
154462186|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154462187|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462188|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154462189|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
154462190|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154462191|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154462192|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154462193|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154462194|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154462195|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
154462196|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
154462197|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
154462198|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154462199|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462201|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
154462202|NCT03340974|Trace Elements|trace elements|mesh-ancestor
154462203|NCT03340974|Micronutrients|micronutrients|mesh-ancestor
154462204|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462205|NCT03340974|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154462206|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
154462207|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462208|NCT03340974|Protective Agents|protective agents|mesh-ancestor
154462209|NCT02229786|Acetaminophen|acetaminophen|mesh-list
154462210|NCT02229786|Scopolamine|scopolamine|mesh-list
154462211|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154462212|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154462213|NCT02229786|Analgesics|analgesics|mesh-ancestor
154462214|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
154462215|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462216|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462217|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
154462218|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
154462219|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
154462220|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154462221|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154462222|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
154462223|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462224|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462225|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154462226|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
154462227|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462228|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
154462229|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154462230|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154462231|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
154462232|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462233|NCT02229942|Rituximab|rituximab|mesh-list
154462234|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462235|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462236|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
154462237|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462238|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154462239|NCT03047278|Cetirizine|cetirizine|mesh-list
154462240|NCT03047278|Gabapentin|gabapentin|mesh-list
154462241|NCT03047278|Analgesics|analgesics|mesh-ancestor
154462242|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
154462243|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462244|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462245|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
154462246|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154462247|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154462248|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462249|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154462250|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153744385|NCT00175617|Spironolactone|spironolactone|mesh-list
154462251|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154462252|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462253|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462254|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
154462255|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154462256|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154462257|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154462258|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
153744452|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154462259|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
154462260|NCT03045016|Prazosin|prazosin|mesh-list
154462261|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154462262|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154462263|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154462264|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154462265|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154462266|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462267|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462268|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462269|NCT04849858|Bupivacaine|bupivacaine|mesh-list
154462270|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
154462271|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
154462272|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462273|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462274|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
154462275|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462276|NCT03043612|Doxazosin|doxazosin|mesh-list
154462277|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154462278|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154462279|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154462280|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154462281|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154462282|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462283|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462284|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462285|NCT02230176|Sunitinib|sunitinib|mesh-list
154462286|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154462287|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462288|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154462289|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154462290|NCT02230176|Growth Substances|growth substances|mesh-ancestor
153744453|NCT00148148|Caspofungin|caspofungin|mesh-list
154462291|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462292|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
154462293|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154462294|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462295|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462296|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154462297|NCT02232516|Lenalidomide|lenalidomide|mesh-list
154462298|NCT02232516|Romidepsin|romidepsin|mesh-list
154462299|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
154462300|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462301|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154462302|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154462304|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
154462305|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462306|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154462307|NCT02232516|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154462308|NCT02232516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462309|NCT02232516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462310|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154462311|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154462312|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
154462313|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462314|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462315|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154462316|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
154462317|NCT04858516|Trastuzumab|trastuzumab|mesh-list
154462318|NCT04858516|Palbociclib|palbociclib|mesh-list
154462319|NCT04858516|Exemestane|exemestane|mesh-list
154462320|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462321|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462322|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154462323|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462324|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462325|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154462326|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154462327|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154462328|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
154462329|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154462330|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462331|NCT03148860|Methotrexate|methotrexate|mesh-list
154462332|NCT03148860|Ustekinumab|ustekinumab|mesh-list
154462333|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154462334|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
154462335|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154462336|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462337|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154462338|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
154462339|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462340|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462341|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
154462342|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462343|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154462344|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154462345|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
154462346|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154462347|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154462348|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154462349|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154462350|NCT02232672|Choline|choline|mesh-list
154462351|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
154462352|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154462353|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
154462354|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462355|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462356|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154462357|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
154462358|NCT05072262|Dexamethasone|dexamethasone|mesh-list
154462359|NCT05072262|Nepafenac|nepafenac|mesh-list
154462360|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154462361|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
154462362|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
154462363|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462364|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462365|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462366|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
154462367|NCT05072262|Hormones|hormones|mesh-ancestor
154462368|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154462369|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154462370|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462371|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154462372|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154462373|NCT05072262|Analgesics|analgesics|mesh-ancestor
154462374|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
154462375|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154462376|NCT04858048|Anesthetics|anesthetics|mesh-list
154462377|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462378|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462379|NCT02234466|Dexamethasone|dexamethasone|mesh-list
154462380|NCT02234466|Ondansetron|ondansetron|mesh-list
154462381|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154462382|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
154462383|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
154462384|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462385|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462386|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462387|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
154462388|NCT02234466|Hormones|hormones|mesh-ancestor
154462389|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154462390|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154462391|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462392|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
154462393|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
154462394|NCT02234466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154462395|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154462396|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
154462397|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462398|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462399|NCT02230800|Tocovid|tocovid|mesh-list
154462400|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
154462401|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154462402|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462403|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462404|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154462405|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154462406|NCT02230800|Protective Agents|protective agents|mesh-ancestor
154462407|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462408|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
154462409|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154462410|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
154462411|NCT02230800|Vitamins|vitamins|mesh-ancestor
154462412|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
154462413|NCT02234544|Vitamin D|vitamin d|mesh-list
154462414|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
154462415|NCT02234544|Ezetimibe|ezetimibe|mesh-list
154462416|NCT02234544|Vitamins|vitamins|mesh-ancestor
154462417|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
154462418|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744608|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
153744626|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744627|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153744628|NCT00175890|Levetiracetam|levetiracetam|mesh-list
153744629|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
153744630|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
153744631|NCT00148616|Memantine|memantine|mesh-list
153744632|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154462419|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154462420|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154462421|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154462422|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154462423|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
154462424|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462425|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154462426|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154462427|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154462428|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462429|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
154462430|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
154462431|NCT04860076|Nivolumab|nivolumab|mesh-list
154462432|NCT04860076|Ipilimumab|ipilimumab|mesh-list
154462433|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462434|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462435|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154462436|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462437|NCT04856878|Vancomycin|vancomycin|mesh-list
154462438|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154462439|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462440|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
154462441|NCT04856644|Rifapentine|rifapentine|mesh-list
154462442|NCT04856644|Rifampin|rifampin|mesh-list
154462443|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154462444|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462445|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154462446|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154462447|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462448|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462449|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462450|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154462451|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
154462452|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
153744633|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153744634|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
154462453|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154462454|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154462455|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154462456|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154462457|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154462458|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154462459|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154462460|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
154462461|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
154462462|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462463|NCT02233218|Amlodipine|amlodipine|mesh-list
154462464|NCT02233218|Telmisartan|telmisartan|mesh-list
154462465|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154462466|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154462467|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154462468|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462469|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462470|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154462471|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462472|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
154462473|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154462474|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154462475|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
154462476|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154462477|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154462478|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744678|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
154462479|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154462480|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154462481|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
154462482|NCT02262546|Pramipexole|pramipexole|mesh-list
154462483|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154462484|NCT02262546|Dexpramipexole|dexpramipexole|mesh-list
154462485|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154462486|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462487|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154462488|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154462489|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462490|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462491|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462492|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154462493|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
154462494|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154462495|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462496|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154462497|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154462498|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154462499|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
154462500|NCT02262546|Protective Agents|protective agents|mesh-ancestor
154462501|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154462502|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154462503|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
154462504|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
154462505|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462506|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
154462507|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154462508|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462509|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462510|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
154462511|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462512|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462513|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
154462514|NCT04856098|Bromides|bromides|mesh-list
154462515|NCT04856098|Maleic acid|maleic acid|mesh-list
154462516|NCT04856098|Charcoal|charcoal|mesh-list
154462517|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
153744703|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154462518|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462519|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462520|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154462521|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154462522|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154462523|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
154860581|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462524|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462525|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462526|NCT04856098|Antidotes|antidotes|mesh-ancestor
154462527|NCT04856098|Protective Agents|protective agents|mesh-ancestor
154462528|NCT04859452|Metformin|metformin|mesh-list
154462529|NCT04859452|Glyburide|glyburide|mesh-list
154462530|NCT04859452|Valsartan|valsartan|mesh-list
154462531|NCT04859452|Simvastatin|simvastatin|mesh-list
154462532|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154462533|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462534|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154462535|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154462536|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
154462537|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462538|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154462539|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154462540|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462541|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154462542|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154462543|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154462544|NCT02262624|Telmisartan|telmisartan|mesh-list
154462545|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154462546|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154462547|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154462548|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154462549|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462550|NCT02262624|Diuretics|diuretics|mesh-ancestor
154462551|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
154462552|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462553|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154462554|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462555|NCT02233452|Ketamine|ketamine|mesh-list
154462556|NCT02233452|Methadone|methadone|mesh-list
154462557|NCT02233452|Analgesics|analgesics|mesh-ancestor
154462558|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
154462559|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462560|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462561|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154462562|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153744811|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186464|NCT00896285|Narcotics|narcotics|mesh-ancestor
154462563|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
154462565|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462566|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154462567|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154462568|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462569|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462570|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154462571|NCT02233452|Narcotics|narcotics|mesh-ancestor
154462572|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
154462573|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
154462574|NCT02262702|Acetaminophen|acetaminophen|mesh-list
154462575|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154462576|NCT02262702|Analgesics|analgesics|mesh-ancestor
154462577|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
154462578|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462579|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462580|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
154462581|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154462582|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154462583|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462584|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
154462585|NCT04845880|Paraproteins|paraproteins|mesh-list
154462586|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
154462587|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462588|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154462589|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154462590|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462591|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154462592|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462593|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462594|NCT03041506|Lidocaine|lidocaine|mesh-list
154462595|NCT03041506|Midazolam|midazolam|mesh-list
154462596|NCT03041506|Ketamine|ketamine|mesh-list
154462597|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
154462598|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
154462599|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744815|NCT02925559|Gliclazide|gliclazide|mesh-list
153744865|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154462600|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462601|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
154462602|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462603|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154462604|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154462605|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154462606|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462607|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462608|NCT03041506|Analgesics|analgesics|mesh-ancestor
154462609|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154462610|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154462611|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
154462612|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154462613|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154462614|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462615|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154462616|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154462617|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154462618|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154462619|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154462620|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
154462621|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
154462622|NCT02580708|Trametinib|trametinib|mesh-list
154462623|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462624|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154462625|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462626|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462627|NCT04845646|Itraconazole|itraconazole|mesh-list
154462628|NCT04845646|Phenytoin|phenytoin|mesh-list
154462629|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
154462630|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462631|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154462632|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154462633|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744866|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154462634|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462635|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154462636|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
154462637|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154462638|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462639|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154462640|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
154462641|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154462642|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154462643|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462644|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154462645|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154462646|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
154462647|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
154462648|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
154462649|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462650|NCT03038776|Coagulants|coagulants|mesh-ancestor
154462651|NCT02570490|Linezolid|linezolid|mesh-list
154462652|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
154462653|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154462654|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462655|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154462656|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462657|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462658|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
154462659|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154462660|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154462661|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154462662|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462663|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462664|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
154462665|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462666|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462667|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154462668|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462669|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
154860582|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154462670|NCT02561442|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154462671|NCT02561442|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154462672|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154462673|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462675|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154462676|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154462677|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154462678|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154462679|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462680|NCT02262858|Diuretics|diuretics|mesh-ancestor
154462681|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
154462682|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462683|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154462684|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462685|NCT02235012|Ketamine|ketamine|mesh-list
154462686|NCT02235012|Analgesics|analgesics|mesh-ancestor
154462687|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
154462688|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462689|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462690|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154462691|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154462692|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
154462693|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
154462694|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462695|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154462696|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154462697|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462698|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462699|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154462700|NCT02262936|Fesoterodine|fesoterodine|mesh-list
154462701|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154462702|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154462703|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
154462704|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462705|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462706|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462707|NCT02262936|Urological Agents|urological agents|mesh-ancestor
154462708|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
154462709|NCT02262936|Coagulants|coagulants|mesh-ancestor
154462710|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154462711|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
154462712|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
154462713|NCT04838704|Methotrexate|methotrexate|mesh-list
154462714|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154462715|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
154462716|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154462717|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462718|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154462719|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
154462720|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462721|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462722|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
154462723|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462724|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154462725|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154462726|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
154462727|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154462728|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154462729|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154462730|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154462731|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
154462732|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154462733|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462734|NCT02259738|Kallikreins|kallikreins|mesh-list
154462735|NCT02259738|Coagulants|coagulants|mesh-ancestor
154462736|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154462737|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
154462738|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154462739|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462740|NCT04854460|Ivermectin|ivermectin|mesh-list
154462741|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154462742|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462743|NCT04854538|Budesonide|budesonide|mesh-list
154462744|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154462745|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154462746|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
154462747|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462748|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462749|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154462750|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
154462751|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
154462752|NCT04854538|Hormones|hormones|mesh-ancestor
153745017|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745049|NCT05786339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153745050|NCT05786339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154462753|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154462754|NCT05331690|Dexamethasone|dexamethasone|mesh-list
154462755|NCT05331690|Nepafenac|nepafenac|mesh-list
154462756|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154462757|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
154462758|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
154462759|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462760|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462761|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462762|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
154462763|NCT05331690|Hormones|hormones|mesh-ancestor
154462764|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154462765|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154462766|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462767|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154462768|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154462769|NCT05331690|Analgesics|analgesics|mesh-ancestor
154462770|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
154462771|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154462772|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154462773|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462774|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462775|NCT02263170|Phenobarbital|phenobarbital|mesh-list
154462776|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
154462777|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154462778|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462779|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462780|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154462781|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154462782|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462783|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462784|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
154462786|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154462787|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154462788|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154462789|NCT03038230|Antibodies|antibodies|mesh-list
154462790|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154462791|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
154462792|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462793|NCT02784288|Paclitaxel|paclitaxel|mesh-list
154462794|NCT02784288|Carboplatin|carboplatin|mesh-list
154462795|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154462796|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462797|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
154462798|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
154462799|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
154462800|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462801|NCT03040180|Bleomycin|bleomycin|mesh-list
154462802|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154462803|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462804|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
154462805|NCT02235246|Analgesics|analgesics|mesh-ancestor
154462806|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
154462807|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462808|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462809|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
154462810|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462811|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154462812|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
154462813|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154462814|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462815|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462816|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154462817|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
154462818|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154462820|NCT02235324|Fluorouracil|fluorouracil|mesh-list
154462821|NCT02235324|Aflibercept|aflibercept|mesh-list
154462822|NCT02235324|Calcium|calcium|mesh-list
154462823|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
154462824|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
154462825|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154462826|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462827|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
154462828|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462829|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154462830|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462831|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154462832|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
154462833|NCT02235324|Antidotes|antidotes|mesh-ancestor
154462834|NCT02235324|Protective Agents|protective agents|mesh-ancestor
154462835|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
154462836|NCT02235324|Vitamins|vitamins|mesh-ancestor
154462837|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
154462838|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154462839|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154462840|NCT02235324|Growth Substances|growth substances|mesh-ancestor
154462841|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
154462842|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
154462843|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154462844|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
154462845|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154462846|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462847|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154462848|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154462849|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154462850|NCT02263248|Buprenorphine|buprenorphine|mesh-list
154462851|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154462852|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154462853|NCT02263248|Narcotics|narcotics|mesh-ancestor
154462854|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462855|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462856|NCT02263248|Analgesics|analgesics|mesh-ancestor
154462857|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
154462858|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462859|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154186763|NCT05278637|Aspirin|aspirin|mesh-list
154462860|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154462861|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154462862|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154462863|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462864|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462865|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154462866|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
154462867|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154462868|NCT04838860|Siltuximab|siltuximab|mesh-list
154462869|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462870|NCT04853524|Tenofovir|tenofovir|mesh-list
154462871|NCT04853524|Emtricitabine|emtricitabine|mesh-list
154462872|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
154462873|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
154462874|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462875|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154462876|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154462877|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462878|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462879|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154462880|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154462881|NCT04852510|Metformin|metformin|mesh-list
154462882|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154462883|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745261|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
154462884|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
154462885|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154462886|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462887|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462888|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154462889|NCT05163704|Analgesics|analgesics|mesh-ancestor
154462890|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
154462891|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462892|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154462893|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154462895|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
154462896|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462897|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462898|NCT03130556|Rabeprazole|rabeprazole|mesh-list
154462899|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154462900|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462901|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154462902|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462903|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462904|NCT04838080|Vaccines|vaccines|mesh-list
154462905|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
154462906|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462907|NCT04842838|Paclitaxel|paclitaxel|mesh-list
154462908|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154462909|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462910|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
154462911|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
154462912|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
154462913|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462914|NCT03037606|Rabeprazole|rabeprazole|mesh-list
154462915|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154462916|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154462917|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154462918|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462919|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462920|NCT04842370|PHI-101|phi-101|mesh-list
154462921|NCT04842370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154462922|NCT04842370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462923|NCT04842370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462924|NCT04842370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462925|NCT03037372|Atorvastatin|atorvastatin|mesh-list
154462926|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154462927|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154462928|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154462929|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154462930|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
154462931|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186837|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
154462932|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154462933|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462934|NCT04842526|Irinotecan|irinotecan|mesh-list
154462935|NCT04842526|Temozolomide|temozolomide|mesh-list
154462936|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154462937|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154462938|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462939|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462940|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462941|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154462942|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
154462943|NCT04850950|Tenofovir|tenofovir|mesh-list
154462944|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
154462945|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154462946|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154462947|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154462948|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462949|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462950|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154462951|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154462952|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
154462953|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154462954|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462955|NCT04850560|Decitabine|decitabine|mesh-list
154462956|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154462957|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
154462958|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462959|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462960|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462961|NCT04850404|Ropivacaine|ropivacaine|mesh-list
154462962|NCT04850404|Rocuronium|rocuronium|mesh-list
154462963|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
154462964|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
154091099|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154462965|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154462966|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462967|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
154462968|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154462969|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154462970|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154462971|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154462972|NCT06059547|Nivolumab|nivolumab|mesh-list
154462973|NCT06059547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154462974|NCT06059547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462975|NCT06059547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154462976|NCT06059547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462977|NCT06059469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154462978|NCT06059469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154462979|NCT06059469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462980|NCT06059287|Metformin|metformin|mesh-list
154462981|NCT06059287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154462982|NCT06059287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462983|NCT06059261|Endostatins|endostatins|mesh-list
154462984|NCT06059261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154462985|NCT06059261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154462986|NCT06059261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154462987|NCT06059261|Growth Substances|growth substances|mesh-ancestor
153745406|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154462988|NCT06059261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462989|NCT06059261|Growth Inhibitors|growth inhibitors|mesh-ancestor
154462990|NCT06059144|Norepinephrine|norepinephrine|mesh-list
154462991|NCT06059144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154462992|NCT06059144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154462993|NCT06059144|Adrenergic Agents|adrenergic agents|mesh-ancestor
154462994|NCT06059144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154462995|NCT06059144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154462996|NCT06059144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154462997|NCT06059144|Sympathomimetics|sympathomimetics|mesh-ancestor
154462998|NCT06059144|Autonomic Agents|autonomic agents|mesh-ancestor
154462999|NCT06059144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463000|NCT06059144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154463001|NCT06059001|Paclitaxel|paclitaxel|mesh-list
154463002|NCT06059001|Gemcitabine|gemcitabine|mesh-list
154463003|NCT06059001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154463004|NCT06059001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463005|NCT06059001|Tubulin Modulators|tubulin modulators|mesh-ancestor
154186913|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
154463006|NCT06059001|Antimitotic Agents|antimitotic agents|mesh-ancestor
154463007|NCT06059001|Mitosis Modulators|mitosis modulators|mesh-ancestor
154463008|NCT06059001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463009|NCT06059001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154463010|NCT06059001|Antimetabolites|antimetabolites|mesh-ancestor
154463011|NCT06058988|Trastuzumab|trastuzumab|mesh-list
154463012|NCT06058988|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154463013|NCT06058988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463014|NCT06058988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463015|NCT06058988|Immunoconjugates|immunoconjugates|mesh-ancestor
154463016|NCT06058988|Immunologic Factors|immunologic factors|mesh-ancestor
154463017|NCT06058988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463018|NCT06058702|Dronabinol|dronabinol|mesh-list
154463019|NCT06058702|Hallucinogens|hallucinogens|mesh-ancestor
154463020|NCT06058702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463021|NCT06058702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154463022|NCT06058702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154463023|NCT06058702|Analgesics|analgesics|mesh-ancestor
154463024|NCT06058702|Sensory System Agents|sensory system agents|mesh-ancestor
154463025|NCT06058702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463026|NCT06058702|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154463027|NCT06058702|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154463028|NCT06058702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463029|NCT06058702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463030|NCT06058702|Hormones|hormones|mesh-ancestor
154463031|NCT06058702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463032|NCT06058689|Thalidomide|thalidomide|mesh-list
154463033|NCT06058689|Pomalidomide|pomalidomide|mesh-list
154463034|NCT06058689|Immunologic Factors|immunologic factors|mesh-ancestor
154463035|NCT06058689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463036|NCT06058689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154463037|NCT06058689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154463038|NCT06058689|Growth Substances|growth substances|mesh-ancestor
154463039|NCT06058689|Growth Inhibitors|growth inhibitors|mesh-ancestor
154463040|NCT06058689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463041|NCT06058689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463042|NCT06058689|Leprostatic Agents|leprostatic agents|mesh-ancestor
154463043|NCT06058689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154463044|NCT06058689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463045|NCT06058585|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154463046|NCT06058585|Mineralocorticoids|mineralocorticoids|mesh-list
154463047|NCT06058585|Hormone Antagonists|hormone antagonists|mesh-ancestor
154463048|NCT06058585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463049|NCT06058585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463050|NCT06058585|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154463051|NCT06058585|Diuretics|diuretics|mesh-ancestor
154463052|NCT06058585|Natriuretic Agents|natriuretic agents|mesh-ancestor
154463053|NCT06058585|Hormones|hormones|mesh-ancestor
154463054|NCT06058234|Antibodies|antibodies|mesh-list
154463055|NCT06058234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154463056|NCT06058234|Immunologic Factors|immunologic factors|mesh-ancestor
154463057|NCT06058234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463058|NCT06057935|Carboplatin|carboplatin|mesh-list
153745464|NCT04335669|Taxane|taxane|mesh-list
154463059|NCT06057935|Pemetrexed|pemetrexed|mesh-list
154463060|NCT06057935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463061|NCT06057935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463062|NCT06057935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463063|NCT06057935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154463064|NCT06057935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154463065|NCT06056349|Midazolam|midazolam|mesh-list
154463066|NCT06056349|Clonazepam|clonazepam|mesh-list
154463067|NCT06056349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154463068|NCT06056349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154463069|NCT06056349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463070|NCT06056349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463071|NCT06056349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154463072|NCT06056349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154463073|NCT06056349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154463074|NCT06056349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154463075|NCT06056349|Anesthetics, General|anesthetics, general|mesh-ancestor
154463076|NCT06056349|Anesthetics|anesthetics|mesh-ancestor
154463077|NCT06056349|GABA Modulators|gaba modulators|mesh-ancestor
154463078|NCT06056349|GABA Agents|gaba agents|mesh-ancestor
154463079|NCT06056349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463080|NCT06056349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463081|NCT06056349|Anticonvulsants|anticonvulsants|mesh-ancestor
154463082|NCT06047262|Dapansutrile|dapansutrile|mesh-list
154463083|NCT06047262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463084|NCT06021860|Spironolactone|spironolactone|mesh-list
154463085|NCT06021860|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154463086|NCT06021860|Hormone Antagonists|hormone antagonists|mesh-ancestor
154463087|NCT06021860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463088|NCT06021860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463089|NCT06021860|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154463090|NCT06021860|Diuretics|diuretics|mesh-ancestor
154463091|NCT06021860|Natriuretic Agents|natriuretic agents|mesh-ancestor
154463092|NCT05989165|Minoxidil|minoxidil|mesh-list
154463093|NCT05989165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154463094|NCT05989165|Vasodilator Agents|vasodilator agents|mesh-ancestor
154463095|NCT05913921|Amphotericin B|amphotericin b|mesh-list
154463096|NCT05913921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154463097|NCT05913921|Amebicides|amebicides|mesh-ancestor
154463098|NCT05913921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154463099|NCT05913921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154463100|NCT05913921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463101|NCT05913921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154463102|NCT05913921|Antifungal Agents|antifungal agents|mesh-ancestor
154463103|NCT05864742|Rituximab|rituximab|mesh-list
154463104|NCT05864742|Venetoclax|venetoclax|mesh-list
154463105|NCT05864742|Navitoclax|navitoclax|mesh-list
154463106|NCT05864742|Ibrutinib|ibrutinib|mesh-list
154463107|NCT05864742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463108|NCT05864742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463109|NCT05864742|Immunologic Factors|immunologic factors|mesh-ancestor
154463110|NCT05864742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463111|NCT05864742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463112|NCT05864742|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154463113|NCT05864742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154860583|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463114|NCT05864742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463115|NCT05864742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463116|NCT05845996|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154463117|NCT05845996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154463118|NCT05845996|Immunologic Factors|immunologic factors|mesh-ancestor
154463119|NCT05845996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463120|NCT05843253|Everolimus|everolimus|mesh-list
154463121|NCT05843253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154463122|NCT05843253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154463123|NCT05843253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463124|NCT05843253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463125|NCT05843253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463126|NCT05843253|Immunologic Factors|immunologic factors|mesh-ancestor
154463127|NCT05843253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463128|NCT05843253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463129|NCT05825235|Pramipexole|pramipexole|mesh-list
154463130|NCT05825235|Dexpramipexole|dexpramipexole|mesh-list
154463131|NCT05825235|Antioxidants|antioxidants|mesh-ancestor
154463132|NCT05825235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463133|NCT05825235|Protective Agents|protective agents|mesh-ancestor
154463134|NCT05825235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463135|NCT05825235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154463136|NCT05825235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154463137|NCT05825235|Dopamine Agonists|dopamine agonists|mesh-ancestor
154463138|NCT05825235|Dopamine Agents|dopamine agents|mesh-ancestor
154463139|NCT05825235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463140|NCT05785442|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154463141|NCT05785442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463142|NCT05753059|Bendroflumethiazide|bendroflumethiazide|mesh-list
154463143|NCT05753059|Amiloride|amiloride|mesh-list
154463144|NCT05753059|Diuretics|diuretics|mesh-ancestor
154463145|NCT05753059|Natriuretic Agents|natriuretic agents|mesh-ancestor
154463146|NCT05753059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463147|NCT05753059|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154463148|NCT05753059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154463149|NCT05753059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154463150|NCT05753059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463151|NCT05753059|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154463152|NCT05753059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154463153|NCT05753059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154463154|NCT05753059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154187068|NCT00908531|Letrozole|letrozole|mesh-list
154463155|NCT05752903|Dexmedetomidine|dexmedetomidine|mesh-list
154463156|NCT05752903|Ketamine|ketamine|mesh-list
154463157|NCT05752903|Propofol|propofol|mesh-list
154463158|NCT05752903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154463159|NCT05752903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463160|NCT05752903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463161|NCT05752903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154463162|NCT05752903|Analgesics|analgesics|mesh-ancestor
154463163|NCT05752903|Sensory System Agents|sensory system agents|mesh-ancestor
154463164|NCT05752903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463165|NCT05752903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154463166|NCT05752903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154463167|NCT05752903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154463168|NCT05752903|Adrenergic Agents|adrenergic agents|mesh-ancestor
154463169|NCT05752903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463170|NCT05752903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463171|NCT05752903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154463172|NCT05752903|Anesthetics, General|anesthetics, general|mesh-ancestor
154463173|NCT05752903|Anesthetics|anesthetics|mesh-ancestor
154463174|NCT05752903|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154463175|NCT05752903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154463176|NCT05752903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154463177|NCT05735353|Methamphetamine|methamphetamine|mesh-list
154463178|NCT05735353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154463179|NCT05735353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463180|NCT05735353|Sympathomimetics|sympathomimetics|mesh-ancestor
154463181|NCT05735353|Autonomic Agents|autonomic agents|mesh-ancestor
154463182|NCT05735353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463183|NCT05735353|Dopamine Agents|dopamine agents|mesh-ancestor
154463184|NCT05735353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463185|NCT05735353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463186|NCT05735353|Adrenergic Agents|adrenergic agents|mesh-ancestor
154463187|NCT05735353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154463188|NCT05735353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154463189|NCT05735353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154463190|NCT05735353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154463192|NCT05728619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154463193|NCT05728619|Alkylating Agents|alkylating agents|mesh-ancestor
154463194|NCT05728619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463195|NCT05728619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463196|NCT05726032|Empagliflozin|empagliflozin|mesh-list
154463197|NCT05726032|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154463198|NCT05726032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463199|NCT05726032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154463200|NCT05726032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463201|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
154463202|NCT05593341|Narcotics|narcotics|mesh-ancestor
154463203|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463204|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463205|NCT05593341|Analgesics|analgesics|mesh-ancestor
154463206|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
154463207|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463208|NCT05590312|Anesthetics|anesthetics|mesh-list
154463209|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463210|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463211|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
154463212|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
154463213|NCT05487755|Tadalafil|tadalafil|mesh-list
154463214|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
154463215|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
154463216|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154463217|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154463218|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463219|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463220|NCT05487755|Urological Agents|urological agents|mesh-ancestor
154463221|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154463222|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154463223|NCT05487755|Protective Agents|protective agents|mesh-ancestor
154463224|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463225|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154463226|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
154463227|NCT05476952|Rocuronium|rocuronium|mesh-list
154463228|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154463229|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154463230|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154463231|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463232|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463233|NCT05414838|Vitamin D|vitamin d|mesh-list
154463234|NCT05414838|Curcumin|curcumin|mesh-list
154463235|NCT05414838|Vitamins|vitamins|mesh-ancestor
154463236|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
154463237|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463238|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154463239|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154463240|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154463241|NCT05414838|Analgesics|analgesics|mesh-ancestor
154463242|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
154463243|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463244|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463245|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463246|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463247|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463248|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463249|NCT05368012|Dexamethasone|dexamethasone|mesh-list
154463250|NCT05368012|Bupivacaine|bupivacaine|mesh-list
154463251|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463252|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
154463253|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
154463254|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463255|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463256|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154463257|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
154463258|NCT05368012|Hormones|hormones|mesh-ancestor
154463259|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463260|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154091394|NCT00656019|Vitamin D|vitamin d|mesh-list
154463261|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463262|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
154463263|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
154463264|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463265|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
154463266|NCT05343702|Rocuronium|rocuronium|mesh-list
154463267|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154463268|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154463269|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154463270|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463271|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463272|NCT05238025|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154463273|NCT05238025|Antiviral Agents|antiviral agents|mesh-ancestor
154463274|NCT05238025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463275|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
154463276|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463277|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463278|NCT05182164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154463279|NCT05182164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463280|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154463281|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
154463282|NCT05169658|Antibodies|antibodies|mesh-list
154463283|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
154463284|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154463285|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154463286|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
154027597|NCT02650206|Liraglutide|liraglutide|mesh-list
154463287|NCT05169658|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154463288|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
154463289|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463290|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463291|NCT05093621|Torsemide|torsemide|mesh-list
154463292|NCT05093621|Furosemide|furosemide|mesh-list
154463293|NCT05093621|Diuretics|diuretics|mesh-ancestor
154463294|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
154463295|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463296|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154463297|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154463298|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463299|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154463300|NCT04960930|Minocycline|minocycline|mesh-list
154463301|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154463302|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463303|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
154463304|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154463305|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
154463306|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463307|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
154463308|NCT04883892|Protective Agents|protective agents|mesh-ancestor
154463310|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154463311|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463312|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154463313|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463314|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463315|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463316|NCT04807816|Gemcitabine|gemcitabine|mesh-list
154463317|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154463318|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
154463319|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463320|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463321|NCT04771962|Sevoflurane|sevoflurane|mesh-list
154463322|NCT04771962|Desflurane|desflurane|mesh-list
154463323|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154463324|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154463325|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
154463326|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
154463327|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463328|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463329|NCT04771026|Dexamethasone|dexamethasone|mesh-list
154463330|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463331|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
154463332|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
154463333|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463334|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463335|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154463336|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
154463337|NCT04771026|Hormones|hormones|mesh-ancestor
154463338|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463339|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154463340|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463341|NCT04768010|Misoprostol|misoprostol|mesh-list
154463342|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154463343|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
154463344|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154463345|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463346|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154463347|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154463348|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
154463349|NCT04749108|Folfirinox|folfirinox|mesh-list
154463350|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463351|NCT04730544|Nivolumab|nivolumab|mesh-list
154463352|NCT04730544|Ipilimumab|ipilimumab|mesh-list
154463353|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463354|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463355|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154463356|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463357|NCT04667234|Sotorasib|sotorasib|mesh-list
154463358|NCT04667234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154463359|NCT04667234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463360|NCT04667234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463361|NCT04667234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463362|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154463363|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154463364|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027712|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154463365|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
154463366|NCT04604353|Calcium|calcium|mesh-list
154463367|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154463368|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463369|NCT04540861|Siponimod|siponimod|mesh-list
154463370|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154463371|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463372|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463373|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
154463374|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463375|NCT04508244|Propranolol|propranolol|mesh-list
154463376|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154463377|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154463378|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
154463379|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463380|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463381|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463382|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154463383|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154463384|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
154463385|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
154463386|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463387|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463388|NCT04479241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154463389|NCT04479241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463391|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154463392|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
154463393|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463394|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463395|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154463396|NCT04325503|Levodopa|levodopa|mesh-list
154463397|NCT04325503|Carbidopa|carbidopa|mesh-list
154463398|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154463399|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154463400|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
154463401|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463402|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463403|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463404|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154463405|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463406|NCT04301843|Eflornithine|eflornithine|mesh-list
154463407|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463408|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154463409|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154860584|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
154463410|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154463411|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463412|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154463413|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463414|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463416|NCT04282031|Fulvestrant|fulvestrant|mesh-list
154463417|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463418|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154463419|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154463420|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463421|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027766|NCT04244591|Protective Agents|protective agents|mesh-ancestor
154027767|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154027768|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463422|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154463423|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
154463424|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463425|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463426|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154463427|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154463428|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
154463429|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154463430|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
154463431|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154463432|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
154463433|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463434|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463435|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
154463436|NCT04235816|Azithromycin|azithromycin|mesh-list
154463437|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154463438|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463439|NCT04226963|Ketamine|ketamine|mesh-list
154463440|NCT04226963|Analgesics|analgesics|mesh-ancestor
154463441|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
154463442|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463443|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463444|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154463445|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154463446|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
154463447|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
154463448|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463449|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154463450|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154463451|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187359|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027770|NCT04167696|Fludarabine|fludarabine|mesh-list
154463452|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463453|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154463454|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154463455|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154463456|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154463457|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463458|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463459|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463460|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154463461|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
154463462|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154463463|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
154463464|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
154463465|NCT04205240|Melphalan|melphalan|mesh-list
154463466|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
154463467|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154463468|NCT04205240|Fludarabine|fludarabine|mesh-list
154463469|NCT04205240|Daratumumab|daratumumab|mesh-list
154463470|NCT04205240|Tacrolimus|tacrolimus|mesh-list
154463471|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463472|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
154463473|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463474|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463475|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154463476|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
154463477|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463478|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463479|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154463480|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154463481|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463482|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154463483|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154027799|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463484|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
154463485|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154463486|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463488|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154463489|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154463490|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
154463491|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154463492|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154463493|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463494|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463495|NCT04153383|Protective Agents|protective agents|mesh-ancestor
154463496|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463497|NCT04109222|Vaccines|vaccines|mesh-list
154463498|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
154463499|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463500|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
154463501|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154463502|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
154463503|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463504|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
154463505|NCT04105920|Protective Agents|protective agents|mesh-ancestor
154463506|NCT04066348|Etanercept|etanercept|mesh-list
154463507|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154463508|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154463509|NCT04066348|Analgesics|analgesics|mesh-ancestor
154463510|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
154463511|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463512|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463513|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463514|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463515|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154463516|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463517|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
154463518|NCT03915678|Atezolizumab|atezolizumab|mesh-list
154463519|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154463520|NCT03915678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154463521|NCT03915678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463522|NCT03915678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463523|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463524|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
154187431|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154027835|NCT02654730|Primaquine|primaquine|mesh-list
154027878|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463525|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027882|NCT00651066|Ritonavir|ritonavir|mesh-list
154463526|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
154463527|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
154463528|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
154463529|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463530|NCT03854110|Gemcitabine|gemcitabine|mesh-list
154463531|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154463532|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
154463533|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463534|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463535|NCT03829462|Irinotecan|irinotecan|mesh-list
154463536|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154463537|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463538|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463539|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463540|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463541|NCT03825796|Cytarabine|cytarabine|mesh-list
154463542|NCT03825796|Daunorubicin|daunorubicin|mesh-list
154463543|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154463544|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
154463545|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463546|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463547|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
154463548|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463549|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463550|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
154463551|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463552|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154463553|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154463554|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463555|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463556|NCT03818061|Bevacizumab|bevacizumab|mesh-list
154463557|NCT03818061|Atezolizumab|atezolizumab|mesh-list
154463558|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463559|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463560|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154463561|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154463562|NCT03818061|Growth Substances|growth substances|mesh-ancestor
154463563|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463564|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
154463565|NCT03818061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154463566|NCT03818061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463567|NCT03783351|Clopidogrel|clopidogrel|mesh-list
154463569|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154463570|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154463571|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154463572|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154463573|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
154463574|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463575|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463576|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463577|NCT03729869|Progesterone|progesterone|mesh-list
154463578|NCT03729869|Progestins|progestins|mesh-ancestor
154463579|NCT03729869|Hormones|hormones|mesh-ancestor
154463580|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463581|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463582|NCT03713437|Insulin|insulin|mesh-list
154463583|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154463584|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463585|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154463586|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463587|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463588|NCT03581240|Eflornithine|eflornithine|mesh-list
154463589|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463590|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154463591|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154463592|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154463593|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463594|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154463595|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463596|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463597|NCT03573297|Cariprazine|cariprazine|mesh-list
154463598|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154463599|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154463600|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463601|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463602|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154463603|NCT03535116|Ketorolac|ketorolac|mesh-list
154463604|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154463605|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154463606|NCT03535116|Analgesics|analgesics|mesh-ancestor
154463607|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
154463608|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463609|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463610|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463611|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463612|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154463613|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463614|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463615|NCT03515213|Fenofibrate|fenofibrate|mesh-list
154463616|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154463617|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
154463618|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463619|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154463620|NCT03446040|Nivolumab|nivolumab|mesh-list
154463621|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463622|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463623|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154463624|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463625|NCT03406286|Tolvaptan|tolvaptan|mesh-list
154463626|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154091775|NCT00620854|Calcitonin|calcitonin|mesh-list
154463627|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463628|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
154463629|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463630|NCT03189641|Cilostazol|cilostazol|mesh-list
154463631|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154463632|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
154027948|NCT04167228|Avibactam|avibactam|mesh-list
154463633|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463634|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463635|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154463636|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
154463637|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154463638|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154463639|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463640|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154463641|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
154463642|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154463643|NCT03189641|Protective Agents|protective agents|mesh-ancestor
154463644|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154463645|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154463646|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463647|NCT03158389|Sirolimus|sirolimus|mesh-list
154463648|NCT03158389|Atezolizumab|atezolizumab|mesh-list
154463649|NCT03158389|Palbociclib|palbociclib|mesh-list
154463650|NCT03158389|Temsirolimus|temsirolimus|mesh-list
154463651|NCT03158389|MTOR Inhibitors|mtor inhibitors|mesh-list
154463652|NCT03158389|Alectinib|alectinib|mesh-list
154463653|NCT03158389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154463654|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463655|NCT03158389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463656|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463657|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154463658|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463659|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463660|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
154463661|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463662|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154463663|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463664|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154027986|NCT04243811|Anesthetics|anesthetics|mesh-list
154463665|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
154463666|NCT03158389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154463667|NCT03140670|Rucaparib|rucaparib|mesh-list
154463668|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154463669|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463670|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187581|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154463671|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463672|NCT02945280|Apixaban|apixaban|mesh-list
154463673|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154463674|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
154463675|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154463676|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
154463677|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463678|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463679|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
154463680|NCT02684474|HBOC 201|hboc 201|mesh-list
154463681|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
154463682|NCT02682927|Fenfluramine|fenfluramine|mesh-list
154463683|NCT02682927|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154463684|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154463685|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154463686|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463687|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463688|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
154463689|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463690|NCT02677493|Vaccines|vaccines|mesh-list
154463691|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
154463692|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463693|NCT02633059|Dexamethasone|dexamethasone|mesh-list
154463694|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
154463695|NCT02633059|Ixazomib|ixazomib|mesh-list
154463696|NCT02633059|Ichthammol|ichthammol|mesh-list
154463697|NCT02633059|BB 1101|bb 1101|mesh-list
154463698|NCT02633059|Glycine|glycine|mesh-list
154463699|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463700|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
154463701|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
154463702|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463703|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463704|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154463705|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
154463706|NCT02633059|Hormones|hormones|mesh-ancestor
154463707|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463708|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154463709|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463710|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463711|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
154463712|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463713|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
154463714|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
154463715|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463716|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
154463717|NCT02630043|Tolcapone|tolcapone|mesh-list
154463718|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463719|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154463720|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154463721|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154463722|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463723|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463724|NCT02614534|Mitomycins|mitomycins|mesh-list
154463725|NCT02614534|Mitomycin|mitomycin|mesh-list
154463726|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154463727|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463728|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
154463729|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463730|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154463731|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463732|NCT02460692|Dronabinol|dronabinol|mesh-list
154463733|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
154463734|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463735|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154463736|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154463737|NCT02460692|Analgesics|analgesics|mesh-ancestor
154463738|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
154463739|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463740|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154463741|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154463742|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463743|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463744|NCT02460692|Hormones|hormones|mesh-ancestor
154463745|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463746|NCT02408120|Insulin|insulin|mesh-list
154463747|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154463748|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
154463749|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
154463750|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
154463751|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154463752|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154463753|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463754|NCT02393183|Selenium|selenium|mesh-list
154463755|NCT02393183|Antioxidants|antioxidants|mesh-list
154463756|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463757|NCT02393183|Protective Agents|protective agents|mesh-ancestor
154463758|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463759|NCT02393183|Trace Elements|trace elements|mesh-ancestor
154463760|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
154463761|NCT02391545|Rituximab|rituximab|mesh-list
154463762|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
154463763|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463764|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463765|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
154463766|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463767|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463768|NCT02295475|Warfarin|warfarin|mesh-list
154463769|NCT02295475|Apixaban|apixaban|mesh-list
154463770|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
154463771|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154463772|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
154463773|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154463774|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
154463775|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463776|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463777|NCT02156739|Edetic Acid|edetic acid|mesh-list
154860585|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
154463778|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
154463779|NCT02156739|Antidotes|antidotes|mesh-ancestor
154463780|NCT02156739|Protective Agents|protective agents|mesh-ancestor
154463781|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463782|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
154463783|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
154463784|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463785|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154463786|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
154463787|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154463788|NCT01920932|Prednisone|prednisone|mesh-list
154463789|NCT01920932|Prednisolone|prednisolone|mesh-list
154463790|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
154463791|NCT01920932|Dacarbazine|dacarbazine|mesh-list
154463792|NCT01920932|Doxorubicin|doxorubicin|mesh-list
154463793|NCT01920932|Etoposide|etoposide|mesh-list
154463794|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154463795|NCT01920932|Imidazole|imidazole|mesh-list
154463796|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463797|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
154463798|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463799|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463800|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154463801|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
154463802|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463803|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463804|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154463805|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154463806|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154463807|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463808|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463809|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463810|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
154463811|NCT01920932|Hormones|hormones|mesh-ancestor
154463812|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154463813|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154463814|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154463815|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463816|NCT01920932|Immunotoxins|immunotoxins|mesh-ancestor
154463817|NCT01920932|Immunoconjugates|immunoconjugates|mesh-ancestor
154463818|NCT01505608|Irinotecan|irinotecan|mesh-list
154187731|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
154463819|NCT01505608|Temozolomide|temozolomide|mesh-list
154463820|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154463821|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463822|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463823|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463824|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463825|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154463827|NCT01491893|Vaccines|vaccines|mesh-list
154463828|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
154463829|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463830|NCT01143766|Gabapentin|gabapentin|mesh-list
154463831|NCT01143766|Analgesics|analgesics|mesh-ancestor
154463832|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
154463833|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463834|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463835|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
154463836|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154463837|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154463838|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463839|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154463840|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154463841|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154463842|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463843|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463844|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
154463845|NCT01106898|Paclitaxel|paclitaxel|mesh-list
154463846|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
154463847|NCT01106898|Trastuzumab|trastuzumab|mesh-list
154028132|NCT00887159|Cisplatin|cisplatin|mesh-list
154463848|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154463849|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463850|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
154463851|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
154463852|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
154091996|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
154463853|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463854|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463855|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
154463856|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463857|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463858|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154463859|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
154463860|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154463861|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463862|NCT01059071|Eflornithine|eflornithine|mesh-list
154463863|NCT01059071|Etoposide|etoposide|mesh-list
154463864|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154463865|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463866|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154463867|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463868|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463869|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463870|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154463871|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154463872|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154463873|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463874|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154463875|NCT01001637|Curcumin|curcumin|mesh-list
154463876|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154463877|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154463878|NCT01001637|Analgesics|analgesics|mesh-ancestor
154463879|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
154463880|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463881|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463882|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463883|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463884|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463885|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463886|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463887|NCT00601003|Nifurtimox|nifurtimox|mesh-list
154463888|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
154463889|NCT00601003|Topotecan|topotecan|mesh-list
154463890|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463891|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
154463892|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463893|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463894|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154463895|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
154463896|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463897|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463898|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154463899|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154463900|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463901|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463902|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154463903|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154463904|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154463905|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463906|NCT00575718|Nicotine|nicotine|mesh-list
154463907|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154463908|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
154463909|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463910|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463911|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154463912|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154463913|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
154463914|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463915|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463916|NCT00571493|Cytarabine|cytarabine|mesh-list
154463917|NCT00571493|Etoposide|etoposide|mesh-list
154463918|NCT00571493|Etoposide phosphate|etoposide phosphate|mesh-list
154463919|NCT00571493|Bortezomib|bortezomib|mesh-list
154463920|NCT00571493|Melphalan|melphalan|mesh-list
154463921|NCT00571493|Carmustine|carmustine|mesh-list
154463922|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154463923|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463924|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154463925|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463926|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463927|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463928|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154463929|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
154463930|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
154463931|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154463932|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463933|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
154463934|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463935|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154463936|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
154463937|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154463938|NCT00552461|Rituximab|rituximab|mesh-list
154463939|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154463940|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463941|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
154463942|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463943|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154463944|NCT00479128|Gemcitabine|gemcitabine|mesh-list
154463945|NCT00479128|Doxorubicin|doxorubicin|mesh-list
154463946|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154463947|NCT00479128|Bortezomib|bortezomib|mesh-list
154463948|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154463949|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
154463950|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463951|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463952|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154463953|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154463954|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154463955|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154463956|NCT04428814|Ustekinumab|ustekinumab|mesh-list
154463957|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
154463958|NCT03036514|Sufentanil|sufentanil|mesh-list
154028296|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154463959|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154463960|NCT03036514|Narcotics|narcotics|mesh-ancestor
154463961|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463962|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463963|NCT03036514|Analgesics|analgesics|mesh-ancestor
154463964|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
154463965|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463966|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154463967|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154463968|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
154463969|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
154463970|NCT04835896|Paclitaxel|paclitaxel|mesh-list
154463971|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154463972|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154463973|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
154463974|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
154187880|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
154463976|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463977|NCT01668004|Golimumab|golimumab|mesh-list
154463978|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154463979|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154463980|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154463981|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
154463982|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463983|NCT04835350|Pancrelipase|pancrelipase|mesh-list
154463984|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154463985|NCT01667926|Ketamine|ketamine|mesh-list
154463986|NCT01667926|Analgesics|analgesics|mesh-ancestor
154463987|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
154463988|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154463989|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154463990|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154463991|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154463992|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
154463993|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
154463994|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154463995|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154463996|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154463997|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154463998|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154463999|NCT03039478|Erythritol|erythritol|mesh-list
154464000|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
154464001|NCT04832776|Bevacizumab|bevacizumab|mesh-list
154464002|NCT04832776|Cetuximab|cetuximab|mesh-list
154464003|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464004|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860586|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464005|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154464006|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154464007|NCT04832776|Growth Substances|growth substances|mesh-ancestor
154464008|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464009|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
154464010|NCT04835116|Acetaminophen|acetaminophen|mesh-list
154464011|NCT04835116|Tramadol|tramadol|mesh-list
154464012|NCT04835116|Analgesics|analgesics|mesh-list
154464013|NCT04835116|Orphenadrine|orphenadrine|mesh-list
154464014|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
154464015|NCT04835116|Bupivacaine|bupivacaine|mesh-list
154464016|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
154464017|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
154464018|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464019|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464020|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
154464021|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464022|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154464023|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
154464024|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154464025|NCT04835116|Narcotics|narcotics|mesh-ancestor
154464026|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154464027|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154464028|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154464029|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154464030|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
154464031|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
154464032|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154464033|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154464034|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
154464035|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464036|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464037|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154464038|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154464039|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464040|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
154464041|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154464042|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154464043|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
154464044|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
154028378|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464045|NCT03036826|Meropenem|meropenem|mesh-list
154464046|NCT03036826|Tazobactam|tazobactam|mesh-list
154464047|NCT03036826|Piperacillin|piperacillin|mesh-list
154464048|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154464049|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154187953|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
154464050|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464051|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154464052|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464053|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464054|NCT03036046|Fluconazole|fluconazole|mesh-list
154464055|NCT03036046|Posaconazole|posaconazole|mesh-list
154464056|NCT03036046|Olorofim|olorofim|mesh-list
154464057|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
154464058|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464059|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154464060|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154464061|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464062|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464063|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154464064|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
154464065|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464066|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464067|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154464068|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154464069|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154464070|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154464071|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154464072|NCT04831528|Bevacizumab|bevacizumab|mesh-list
154464073|NCT04831528|Trastuzumab|trastuzumab|mesh-list
154464074|NCT04831528|Cetuximab|cetuximab|mesh-list
154464075|NCT04831528|Pertuzumab|pertuzumab|mesh-list
154464076|NCT04831528|Lapatinib|lapatinib|mesh-list
154464077|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464078|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464079|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154464080|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154464081|NCT04831528|Growth Substances|growth substances|mesh-ancestor
154028415|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
154028416|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464082|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028417|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
154464083|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
154464084|NCT04831528|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154464085|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154464086|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464087|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464088|NCT04824586|Insulin|insulin|mesh-list
154464089|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154464090|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154464091|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464092|NCT04824898|Simvastatin|simvastatin|mesh-list
154464093|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154464094|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154464095|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
154464096|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464097|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154464098|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154464099|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464100|NCT04824352|Apatinib|apatinib|mesh-list
154464101|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464102|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154464103|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464104|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464105|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
154464106|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154464107|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154464108|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464109|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
154464110|NCT04319614|Coagulants|coagulants|mesh-ancestor
154464111|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
154464112|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154464113|NCT04823260|Niacinamide|niacinamide|mesh-list
154464114|NCT04823260|Niacin|niacin|mesh-list
154464115|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
154464116|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
154464117|NCT04823260|Vitamins|vitamins|mesh-ancestor
154464118|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
154464119|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464120|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154464121|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
154464122|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253699|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464123|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154464124|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
154464125|NCT04816240|Midodrine|midodrine|mesh-list
154464126|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
154464127|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
154464128|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464129|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464130|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154464131|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154464132|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154464133|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154464134|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
154464135|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464136|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464137|NCT04822012|Antibodies|antibodies|mesh-list
154464138|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
154464139|NCT04822012|Progesterone|progesterone|mesh-list
154464140|NCT04822012|Estrogens|estrogens|mesh-list
154464141|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
154464142|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464143|NCT04822012|Progestins|progestins|mesh-ancestor
154464144|NCT04822012|Hormones|hormones|mesh-ancestor
154464145|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464146|NCT05399732|Cyclosporine|cyclosporine|mesh-list
154464147|NCT05399732|Luspatercept|luspatercept|mesh-list
154464148|NCT05399732|Cyclosporins|cyclosporins|mesh-list
154464149|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464150|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464151|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154464152|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
154464153|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464154|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
154464155|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464156|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
154464157|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464158|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154464159|NCT05399732|Hematinics|hematinics|mesh-ancestor
154464160|NCT05399576|Nicorandil|nicorandil|mesh-list
154464161|NCT05399576|Verapamil|verapamil|mesh-list
154464162|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154464163|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154464164|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154464165|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464166|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154464167|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464168|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
154464169|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154464170|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
154464171|NCT05399576|Vitamins|vitamins|mesh-ancestor
154464172|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
154464173|NCT05398718|Sotrovimab|sotrovimab|mesh-list
154464174|NCT05398718|Antiviral Agents|antiviral agents|mesh-ancestor
154464175|NCT05398718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464176|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154464177|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154464178|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464179|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
154464180|NCT05397938|Alendronate|alendronate|mesh-list
154464181|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154464182|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464183|NCT05133674|Tamoxifen|tamoxifen|mesh-list
154028521|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154464184|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154464185|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
154464186|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464187|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464188|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464189|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464190|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154464191|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154464192|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154464193|NCT02522936|Muramidase|muramidase|mesh-list
154464194|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464195|NCT04525898|Methadone|methadone|mesh-list
154464196|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154464197|NCT04525898|Narcotics|narcotics|mesh-ancestor
154464198|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464199|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464200|NCT04525898|Analgesics|analgesics|mesh-ancestor
154464201|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
154464202|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464203|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
154464204|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
154464205|NCT04282070|Paclitaxel|paclitaxel|mesh-list
154464206|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154464207|NCT04282070|Cisplatin|cisplatin|mesh-list
154464208|NCT04282070|Gemcitabine|gemcitabine|mesh-list
154464209|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154464210|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464211|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
154464212|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
154464213|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
154464214|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464215|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154464216|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
154464217|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
154464218|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154464219|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154464220|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464221|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
154464222|NCT04347122|Coagulants|coagulants|mesh-ancestor
154464223|NCT03467438|Polaprezinc|polaprezinc|mesh-list
154464224|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154464225|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154464226|NCT05397236|Dexamethasone|dexamethasone|mesh-list
154464227|NCT05397236|Bupivacaine|bupivacaine|mesh-list
154464228|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464229|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
154464230|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
154464231|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860587|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154860588|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
154464232|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464233|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154464234|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
154464235|NCT05397236|Hormones|hormones|mesh-ancestor
154464236|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464237|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464238|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464239|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
154464240|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
154464241|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464242|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
154464243|NCT05439278|Temozolomide|temozolomide|mesh-list
154464244|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154464245|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
154464246|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464247|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464248|NCT03130010|Nefopam|nefopam|mesh-list
154028557|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028585|NCT02642718|Ketorolac|ketorolac|mesh-list
154464249|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154464250|NCT03130010|Analgesics|analgesics|mesh-ancestor
154464251|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
154464252|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464253|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464254|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
154464255|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154464256|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
154464257|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
154464258|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464259|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464260|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154464261|NCT05396144|Analgesics|analgesics|mesh-ancestor
154464262|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
154464263|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464264|NCT06150898|Ketorolac|ketorolac|mesh-list
154464265|NCT06150898|Pregabalin|pregabalin|mesh-list
154464266|NCT06150898|Analgesics|analgesics|mesh-ancestor
154464267|NCT06150898|Sensory System Agents|sensory system agents|mesh-ancestor
154464268|NCT06150898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464269|NCT06150898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464270|NCT06150898|Anticonvulsants|anticonvulsants|mesh-ancestor
154464271|NCT06150898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154464272|NCT06150898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154464273|NCT06150898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464274|NCT06150898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154464275|NCT06150898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154464276|NCT06150898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154464277|NCT06150898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464278|NCT06150898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154464279|NCT06150898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154464280|NCT06150898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154464281|NCT06150898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464282|NCT06150898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464283|NCT06150898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154464284|NCT06150898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464285|NCT06150833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154464286|NCT06150833|Immunologic Factors|immunologic factors|mesh-ancestor
154464287|NCT06150833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464288|NCT06150781|Erenumab|erenumab|mesh-list
154464289|NCT06150781|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154464290|NCT06150781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464291|NCT06150781|Analgesics|analgesics|mesh-ancestor
154464292|NCT06150781|Sensory System Agents|sensory system agents|mesh-ancestor
154464293|NCT06150781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464294|NCT06150781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464295|NCT06150703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154464296|NCT06150703|Nafarelin|nafarelin|mesh-list
154464297|NCT06150703|Progesterone|progesterone|mesh-list
154464298|NCT06150703|Progestins|progestins|mesh-ancestor
154464299|NCT06150703|Hormones|hormones|mesh-ancestor
154464300|NCT06150703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464301|NCT06150703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028615|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
154464302|NCT06150703|Luteolytic Agents|luteolytic agents|mesh-ancestor
154464303|NCT06150703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154464304|NCT06150703|Contraceptive Agents|contraceptive agents|mesh-ancestor
154464305|NCT06150703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154464306|NCT06150703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154464307|NCT06150703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464308|NCT06150703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464309|NCT06150703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154464310|NCT06150703|Fertility Agents|fertility agents|mesh-ancestor
154464311|NCT06150547|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154464312|NCT06150547|Dopamine Agents|dopamine agents|mesh-ancestor
154464313|NCT06150547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464314|NCT06150547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464315|NCT06150547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464316|NCT06150417|Ascorbic Acid|ascorbic acid|mesh-list
154464317|NCT06150417|Methyltestosterone|methyltestosterone|mesh-list
154464318|NCT06150417|Androgens|androgens|mesh-list
154464319|NCT06150417|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154464320|NCT06150417|Hormones|hormones|mesh-ancestor
154464321|NCT06150417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464322|NCT06150417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464323|NCT06150417|Antioxidants|antioxidants|mesh-ancestor
154464324|NCT06150417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464325|NCT06150417|Protective Agents|protective agents|mesh-ancestor
154464326|NCT06150417|Vitamins|vitamins|mesh-ancestor
154464327|NCT06150417|Micronutrients|micronutrients|mesh-ancestor
154464328|NCT06150417|Estrogens|estrogens|mesh-ancestor
154464329|NCT06150417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464330|NCT06150417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464331|NCT06150417|Anabolic Agents|anabolic agents|mesh-ancestor
154464332|NCT06150001|Lidocaine|lidocaine|mesh-list
154464333|NCT06150001|Rocuronium|rocuronium|mesh-list
154464334|NCT06150001|Anesthetics, Local|anesthetics, local|mesh-ancestor
154464335|NCT06150001|Anesthetics|anesthetics|mesh-ancestor
154464336|NCT06150001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464337|NCT06150001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464338|NCT06150001|Sensory System Agents|sensory system agents|mesh-ancestor
154464339|NCT06150001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464340|NCT06150001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154464341|NCT06150001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154464342|NCT06150001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154464343|NCT06150001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154464344|NCT06150001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464345|NCT06150001|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154464346|NCT06150001|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154464347|NCT06150001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154464348|NCT06149988|Dronabinol|dronabinol|mesh-list
154464349|NCT06149988|Hallucinogens|hallucinogens|mesh-ancestor
154464350|NCT06149988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253700|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
154464351|NCT06149988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154464352|NCT06149988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154464353|NCT06149988|Analgesics|analgesics|mesh-ancestor
154464354|NCT06149988|Sensory System Agents|sensory system agents|mesh-ancestor
154464355|NCT06149988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464356|NCT06149988|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154464357|NCT06149988|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154464358|NCT06149988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028675|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
154028676|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464359|NCT06149988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464360|NCT06149988|Hormones|hormones|mesh-ancestor
154464361|NCT06149988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464362|NCT06149806|Valsartan|valsartan|mesh-list
154464363|NCT06149806|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154464364|NCT06149806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154464365|NCT06149806|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154464366|NCT06149806|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154464367|NCT06149806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464368|NCT06149767|Paclitaxel|paclitaxel|mesh-list
154464369|NCT06149767|Cisplatin|cisplatin|mesh-list
154464370|NCT06149767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154464371|NCT06149767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464372|NCT06149767|Tubulin Modulators|tubulin modulators|mesh-ancestor
154464373|NCT06149767|Antimitotic Agents|antimitotic agents|mesh-ancestor
154464374|NCT06149767|Mitosis Modulators|mitosis modulators|mesh-ancestor
154464375|NCT06149767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464376|NCT06149676|Ciprofloxacin|ciprofloxacin|mesh-list
154464377|NCT06149676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154464378|NCT06149676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464379|NCT06149676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154464380|NCT06149676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154464381|NCT06149676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464382|NCT06149676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464383|NCT06149676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464384|NCT06149676|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154464385|NCT06149676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154464386|NCT06149533|Edoxaban|edoxaban|mesh-list
154464387|NCT06149533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154464388|NCT06149533|Antithrombins|antithrombins|mesh-ancestor
154464389|NCT06149533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154464390|NCT06149533|Protease Inhibitors|protease inhibitors|mesh-ancestor
154464391|NCT06149533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464392|NCT06149533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464393|NCT06149533|Anticoagulants|anticoagulants|mesh-ancestor
154464394|NCT06149455|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154464395|NCT06149455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464396|NCT06146777|Pembrolizumab|pembrolizumab|mesh-list
154464397|NCT06146777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464398|NCT06146777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464399|NCT06146777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154464400|NCT06146777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464401|NCT06144567|Upadacitinib|upadacitinib|mesh-list
154464402|NCT06144567|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154464403|NCT06144567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154464404|NCT06144567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464405|NCT06144567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464406|NCT06144567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464407|NCT06143410|Lidocaine|lidocaine|mesh-list
154464408|NCT06143410|Propofol|propofol|mesh-list
154464409|NCT06143410|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154464410|NCT06143410|Anesthetics, Local|anesthetics, local|mesh-ancestor
154464411|NCT06143410|Anesthetics|anesthetics|mesh-ancestor
154464412|NCT06143410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464413|NCT06143410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464414|NCT06143410|Sensory System Agents|sensory system agents|mesh-ancestor
154464415|NCT06143410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464416|NCT06143410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154464417|NCT06143410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154464418|NCT06143410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154464419|NCT06143410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154464420|NCT06143410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464421|NCT06143410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154188326|NCT03972137|Nicotine|nicotine|mesh-list
154464422|NCT06143410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154464423|NCT06143410|Anesthetics, General|anesthetics, general|mesh-ancestor
154464424|NCT06142656|Metformin|metformin|mesh-list
154464425|NCT06142656|Vildagliptin|vildagliptin|mesh-list
154464426|NCT06142656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154464427|NCT06142656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464428|NCT06142656|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154464429|NCT06142656|Protease Inhibitors|protease inhibitors|mesh-ancestor
154464430|NCT06142656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464431|NCT06142656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464432|NCT06141876|Psilocybin|psilocybin|mesh-list
154464433|NCT06141876|Hallucinogens|hallucinogens|mesh-ancestor
154464434|NCT06141876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464435|NCT06141876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154464436|NCT06139133|Vitamin D|vitamin d|mesh-list
154464437|NCT06139133|Vitamins|vitamins|mesh-ancestor
154464438|NCT06139133|Micronutrients|micronutrients|mesh-ancestor
154464439|NCT06139133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464440|NCT06139133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154464441|NCT06136403|Deucravacitinib|deucravacitinib|mesh-list
154464442|NCT06136403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154464443|NCT06136403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154464444|NCT06136403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464445|NCT06136403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464446|NCT06136351|Rituximab|rituximab|mesh-list
154464447|NCT06136351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154464448|NCT06136351|Zanubrutinib|zanubrutinib|mesh-list
154464450|NCT06136351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464451|NCT06136351|Immunologic Factors|immunologic factors|mesh-ancestor
154464452|NCT06136351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464453|NCT06136351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464454|NCT06136351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154464455|NCT06136351|Alkylating Agents|alkylating agents|mesh-ancestor
154464456|NCT06136351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464457|NCT06136351|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154464458|NCT06136351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154464459|NCT06136351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464460|NCT06113302|Luspatercept|luspatercept|mesh-list
154464461|NCT06113302|Hematinics|hematinics|mesh-ancestor
154464462|NCT06082856|Sufentanil|sufentanil|mesh-list
154464463|NCT06082856|Dexmedetomidine|dexmedetomidine|mesh-list
154464464|NCT06082856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154464465|NCT06082856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464466|NCT06082856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464467|NCT06082856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154464468|NCT06082856|Analgesics|analgesics|mesh-ancestor
154464469|NCT06082856|Sensory System Agents|sensory system agents|mesh-ancestor
154464470|NCT06082856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464471|NCT06082856|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154464472|NCT06082856|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154464473|NCT06082856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154464474|NCT06082856|Adrenergic Agents|adrenergic agents|mesh-ancestor
154464475|NCT06082856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464476|NCT06082856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464477|NCT06082856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154464478|NCT06082856|Narcotics|narcotics|mesh-ancestor
154464479|NCT06082856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154464480|NCT06082856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154464481|NCT06082856|Anesthetics, General|anesthetics, general|mesh-ancestor
154464482|NCT06082856|Anesthetics|anesthetics|mesh-ancestor
154464483|NCT06081283|Lacosamide|lacosamide|mesh-list
154464484|NCT06081283|Levetiracetam|levetiracetam|mesh-list
154464485|NCT06081283|Valproic Acid|valproic acid|mesh-list
154464486|NCT06081283|Phenobarbital|phenobarbital|mesh-list
154464487|NCT06081283|Anticonvulsants|anticonvulsants|mesh-ancestor
154464488|NCT06081283|Nootropic Agents|nootropic agents|mesh-ancestor
154464489|NCT06081283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464490|NCT06081283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464491|NCT06081283|GABA Agents|gaba agents|mesh-ancestor
154464492|NCT06081283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464493|NCT06081283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464494|NCT06081283|Antimanic Agents|antimanic agents|mesh-ancestor
154464495|NCT06081283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154464496|NCT06081283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464497|NCT06081283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154464498|NCT06081283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154464499|NCT06081283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154464500|NCT06081283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154464501|NCT06081283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154464502|NCT06081283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154464503|NCT06081283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154464504|NCT06081283|GABA Modulators|gaba modulators|mesh-ancestor
154464505|NCT06081283|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154464506|NCT06081283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154464507|NCT06081283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154464508|NCT06065462|Dostarlimab|dostarlimab|mesh-list
154464509|NCT06065462|LB100|lb100|mesh-list
154464510|NCT06065462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464511|NCT06065462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464512|NCT06065462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464513|NCT06061848|Vitamin D|vitamin d|mesh-list
154464514|NCT06061848|Vitamins|vitamins|mesh-ancestor
154464515|NCT06061848|Micronutrients|micronutrients|mesh-ancestor
154464516|NCT06061848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464517|NCT06061848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154464518|NCT06034366|Atropine|atropine|mesh-list
154464519|NCT06034366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154028828|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
154464520|NCT06034366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154464521|NCT06034366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154464522|NCT06034366|Autonomic Agents|autonomic agents|mesh-ancestor
154464523|NCT06034366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464524|NCT06034366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464525|NCT06034366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154464526|NCT06034366|Respiratory System Agents|respiratory system agents|mesh-ancestor
154464527|NCT06034366|Mydriatics|mydriatics|mesh-ancestor
154464528|NCT06034366|Parasympatholytics|parasympatholytics|mesh-ancestor
154464529|NCT06034366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154464530|NCT06034366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154464531|NCT06034366|Cholinergic Agents|cholinergic agents|mesh-ancestor
154464532|NCT06034366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464533|NCT06034366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464534|NCT06027801|Vaccines|vaccines|mesh-list
154464535|NCT06027801|Immunologic Factors|immunologic factors|mesh-ancestor
154464536|NCT06027801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464537|NCT06021977|Zanubrutinib|zanubrutinib|mesh-list
154464538|NCT06021977|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154464539|NCT06021977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154464540|NCT06021977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464541|NCT06021977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464542|NCT06021977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464543|NCT06005532|Adalimumab|adalimumab|mesh-list
154464544|NCT06005532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154464545|NCT06005532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464546|NCT06005532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464547|NCT05980481|Capecitabine|capecitabine|mesh-list
154464548|NCT05980481|Oxaliplatin|oxaliplatin|mesh-list
154464549|NCT05980481|Trastuzumab|trastuzumab|mesh-list
154464550|NCT05980481|Disitamab vedotin|disitamab vedotin|mesh-list
154464551|NCT05980481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154464552|NCT05980481|Antimetabolites|antimetabolites|mesh-ancestor
154464553|NCT05980481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464554|NCT05980481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028870|NCT02821559|Growth Substances|growth substances|mesh-ancestor
154464555|NCT05980481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464556|NCT05980481|Immunoconjugates|immunoconjugates|mesh-ancestor
154464557|NCT05980481|Immunologic Factors|immunologic factors|mesh-ancestor
154464558|NCT05980481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464559|NCT05977699|Albuterol|albuterol|mesh-list
154464560|NCT05977699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154464561|NCT05977699|Autonomic Agents|autonomic agents|mesh-ancestor
154464562|NCT05977699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464563|NCT05977699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464564|NCT05977699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154464565|NCT05977699|Respiratory System Agents|respiratory system agents|mesh-ancestor
154464566|NCT05977699|Tocolytic Agents|tocolytic agents|mesh-ancestor
154464567|NCT05977699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154464568|NCT05977699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154464569|NCT05977699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154464570|NCT05977699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154464571|NCT05977699|Adrenergic Agents|adrenergic agents|mesh-ancestor
154464572|NCT05977699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464573|NCT05977699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464574|NCT05976451|Melatonin|melatonin|mesh-list
154464575|NCT05976451|Antioxidants|antioxidants|mesh-ancestor
154464576|NCT05976451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464577|NCT05976451|Protective Agents|protective agents|mesh-ancestor
154464578|NCT05976451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464579|NCT05976451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464580|NCT05974462|Methylprednisolone|methylprednisolone|mesh-list
154464581|NCT05974462|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154464582|NCT05974462|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154464583|NCT05974462|Prednisolone|prednisolone|mesh-list
154464584|NCT05974462|Prednisolone acetate|prednisolone acetate|mesh-list
154464585|NCT05974462|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154464586|NCT05974462|Prednisolone phosphate|prednisolone phosphate|mesh-list
154464587|NCT05974462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464588|NCT05974462|Antiemetics|antiemetics|mesh-ancestor
154464589|NCT05974462|Autonomic Agents|autonomic agents|mesh-ancestor
154464590|NCT05974462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464591|NCT05974462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464592|NCT05974462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154464593|NCT05974462|Glucocorticoids|glucocorticoids|mesh-ancestor
154464594|NCT05974462|Hormones|hormones|mesh-ancestor
154464595|NCT05974462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464596|NCT05974462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154464597|NCT05974462|Protective Agents|protective agents|mesh-ancestor
154464598|NCT05974462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464600|NCT05965479|Trastuzumab|trastuzumab|mesh-list
154464601|NCT05965479|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154464602|NCT05965479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464603|NCT05965479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464604|NCT05965479|Immunoconjugates|immunoconjugates|mesh-ancestor
154464605|NCT05965479|Immunologic Factors|immunologic factors|mesh-ancestor
154464606|NCT05965479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464607|NCT05965440|Dapagliflozin|dapagliflozin|mesh-list
154464608|NCT05965440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154464609|NCT05965440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464610|NCT05965440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154464611|NCT05965440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464612|NCT05964686|Edetic Acid|edetic acid|mesh-list
154464613|NCT05964686|Pentetic Acid|pentetic acid|mesh-list
154464614|NCT05964686|Anticoagulants|anticoagulants|mesh-ancestor
154464615|NCT05964686|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154464616|NCT05964686|Chelating Agents|chelating agents|mesh-ancestor
154464617|NCT05964686|Sequestering Agents|sequestering agents|mesh-ancestor
154464618|NCT05964686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464619|NCT05964686|Antidotes|antidotes|mesh-ancestor
154464620|NCT05964686|Protective Agents|protective agents|mesh-ancestor
154464621|NCT05964686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464622|NCT05964686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154464623|NCT05959252|Heparin|heparin|mesh-list
154464624|NCT05959252|Calcium heparin|calcium heparin|mesh-list
154464625|NCT05959252|Bivalirudin|bivalirudin|mesh-list
154464626|NCT05959252|Anticoagulants|anticoagulants|mesh-ancestor
154464627|NCT05959252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154464628|NCT05959252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154464629|NCT05959252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464630|NCT05959252|Antithrombins|antithrombins|mesh-ancestor
154464631|NCT05959252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154464632|NCT05959252|Protease Inhibitors|protease inhibitors|mesh-ancestor
154464633|NCT05959252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464634|NCT05949424|Sunitinib|sunitinib|mesh-list
154464635|NCT05949424|Lenvatinib|lenvatinib|mesh-list
154464636|NCT05949424|Olaparib|olaparib|mesh-list
154464637|NCT05949424|Palbociclib|palbociclib|mesh-list
154464638|NCT05949424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464639|NCT05949424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154464640|NCT05949424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154464641|NCT05949424|Growth Substances|growth substances|mesh-ancestor
154028950|NCT02638428|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154464642|NCT05949424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028990|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
154464643|NCT05949424|Growth Inhibitors|growth inhibitors|mesh-ancestor
154464644|NCT05949424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154464645|NCT05949424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464646|NCT05949424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464647|NCT05949424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154464648|NCT05926258|Chloroprocaine|chloroprocaine|mesh-list
154464649|NCT05926258|Benoxinate|benoxinate|mesh-list
154464650|NCT05926258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154464651|NCT05926258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154464652|NCT05926258|Anesthetics, Local|anesthetics, local|mesh-ancestor
154464653|NCT05926258|Anesthetics|anesthetics|mesh-ancestor
154464654|NCT05926258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464655|NCT05926258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464656|NCT05926258|Sensory System Agents|sensory system agents|mesh-ancestor
154464657|NCT05926258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464658|NCT05920122|Chlorhexidine|chlorhexidine|mesh-list
154464659|NCT05920122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154464660|NCT05920122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154464661|NCT05920122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464662|NCT05920122|Disinfectants|disinfectants|mesh-ancestor
154464663|NCT05920122|Dermatologic Agents|dermatologic agents|mesh-ancestor
154464664|NCT05915884|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154464665|NCT05915884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464666|NCT05915884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154464667|NCT05915884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464668|NCT05893771|Methylprednisolone|methylprednisolone|mesh-list
154464669|NCT05893771|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154464670|NCT05893771|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154464671|NCT05893771|Prednisolone|prednisolone|mesh-list
154464672|NCT05893771|Prednisolone acetate|prednisolone acetate|mesh-list
154464673|NCT05893771|Bupivacaine|bupivacaine|mesh-list
154464674|NCT05893771|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154464675|NCT05893771|Prednisolone phosphate|prednisolone phosphate|mesh-list
154464676|NCT05893771|Anesthetics, Local|anesthetics, local|mesh-ancestor
154464677|NCT05893771|Anesthetics|anesthetics|mesh-ancestor
154464678|NCT05893771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464679|NCT05893771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464680|NCT05893771|Sensory System Agents|sensory system agents|mesh-ancestor
154464681|NCT05893771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464682|NCT05893771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028991|NCT02638584|Rabeprazole|rabeprazole|mesh-list
154464683|NCT05893771|Antiemetics|antiemetics|mesh-ancestor
154464684|NCT05893771|Autonomic Agents|autonomic agents|mesh-ancestor
154464685|NCT05893771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154464686|NCT05893771|Glucocorticoids|glucocorticoids|mesh-ancestor
154464688|NCT05893771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464689|NCT05893771|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154464690|NCT05893771|Protective Agents|protective agents|mesh-ancestor
154464691|NCT05893771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464692|NCT05893771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464693|NCT05874154|Botulinum Toxins|botulinum toxins|mesh-list
154464694|NCT05874154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154464695|NCT05874154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154464696|NCT05874154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464697|NCT05874154|Cholinergic Agents|cholinergic agents|mesh-ancestor
154464698|NCT05874154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464699|NCT05874154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464700|NCT05859269|Methylprednisolone|methylprednisolone|mesh-list
154464701|NCT05859269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154464702|NCT05859269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154464703|NCT05859269|Prednisolone|prednisolone|mesh-list
154464704|NCT05859269|Prednisolone acetate|prednisolone acetate|mesh-list
154464705|NCT05859269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154464706|NCT05859269|Prednisolone phosphate|prednisolone phosphate|mesh-list
154464707|NCT05859269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464708|NCT05859269|Antiemetics|antiemetics|mesh-ancestor
154464709|NCT05859269|Autonomic Agents|autonomic agents|mesh-ancestor
154464710|NCT05859269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464711|NCT05859269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464712|NCT05859269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154464713|NCT05859269|Glucocorticoids|glucocorticoids|mesh-ancestor
154464714|NCT05859269|Hormones|hormones|mesh-ancestor
153973780|NCT06247787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154464715|NCT05859269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464716|NCT05859269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154464717|NCT05859269|Protective Agents|protective agents|mesh-ancestor
154464718|NCT05859269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464719|NCT05859269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464720|NCT05851781|Propranolol|propranolol|mesh-list
154464721|NCT05851781|Lacosamide|lacosamide|mesh-list
154464722|NCT05851781|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154464723|NCT05851781|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154464724|NCT05851781|Adrenergic Agents|adrenergic agents|mesh-ancestor
154464725|NCT05851781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464726|NCT05851781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464727|NCT05851781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464728|NCT05851781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154464729|NCT05851781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154464730|NCT05851781|Vasodilator Agents|vasodilator agents|mesh-ancestor
154464731|NCT05851781|Anticonvulsants|anticonvulsants|mesh-ancestor
154464732|NCT05851781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154464733|NCT05851781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154464734|NCT05851781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154464735|NCT05849610|Lenalidomide|lenalidomide|mesh-list
154464736|NCT05849610|Bortezomib|bortezomib|mesh-list
154464737|NCT05849610|Daratumumab|daratumumab|mesh-list
154464738|NCT05849610|Immunologic Factors|immunologic factors|mesh-ancestor
154464739|NCT05849610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464740|NCT05849610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154464741|NCT05849610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154464742|NCT05849610|Growth Substances|growth substances|mesh-ancestor
154464743|NCT05849610|Growth Inhibitors|growth inhibitors|mesh-ancestor
154464744|NCT05849610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464745|NCT05848765|Prednisone|prednisone|mesh-list
154464746|NCT05848765|Cyclophosphamide|cyclophosphamide|mesh-list
154464747|NCT05848765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154464748|NCT05848765|Rituximab|rituximab|mesh-list
154464749|NCT05848765|Doxorubicin|doxorubicin|mesh-list
153814752|NCT00446979|UC-781|uc-781|mesh-list
154029098|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154464750|NCT05848765|Vincristine|vincristine|mesh-list
154464752|NCT05848765|Obinutuzumab|obinutuzumab|mesh-list
154464753|NCT05848765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154464754|NCT05848765|Immunologic Factors|immunologic factors|mesh-ancestor
154464755|NCT05848765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464756|NCT05848765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464757|NCT05848765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154464758|NCT05848765|Alkylating Agents|alkylating agents|mesh-ancestor
154464759|NCT05848765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464760|NCT05848765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464761|NCT05848765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154464762|NCT05848765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464763|NCT05848765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154464764|NCT05848765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154464765|NCT05848765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154464766|NCT05848765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464767|NCT05848765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464768|NCT05848765|Glucocorticoids|glucocorticoids|mesh-ancestor
154464769|NCT05848765|Hormones|hormones|mesh-ancestor
154464770|NCT05848765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464771|NCT05848765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464772|NCT05848765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154464773|NCT05848765|Tubulin Modulators|tubulin modulators|mesh-ancestor
154464774|NCT05848765|Antimitotic Agents|antimitotic agents|mesh-ancestor
154464775|NCT05848765|Mitosis Modulators|mitosis modulators|mesh-ancestor
154464776|NCT05848765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154464777|NCT05848765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154464778|NCT05848765|Growth Substances|growth substances|mesh-ancestor
154464779|NCT05848765|Growth Inhibitors|growth inhibitors|mesh-ancestor
154464780|NCT05816733|Dapagliflozin|dapagliflozin|mesh-list
154464781|NCT05816733|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154464782|NCT05816733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464783|NCT05816733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154464784|NCT05816733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464785|NCT05794425|Cyclosporine|cyclosporine|mesh-list
154464786|NCT05794425|Cyclosporins|cyclosporins|mesh-list
154464787|NCT05794425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464788|NCT05794425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464789|NCT05794425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154464790|NCT05794425|Immunologic Factors|immunologic factors|mesh-ancestor
154464791|NCT05794425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464792|NCT05794425|Antifungal Agents|antifungal agents|mesh-ancestor
154464793|NCT05794425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464794|NCT05794425|Dermatologic Agents|dermatologic agents|mesh-ancestor
154464795|NCT05794425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464796|NCT05794425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154464797|NCT05791565|Norflurane|norflurane|mesh-list
154464798|NCT05791565|Albuterol|albuterol|mesh-list
154464799|NCT05791565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154464800|NCT05791565|Autonomic Agents|autonomic agents|mesh-ancestor
154464801|NCT05791565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464802|NCT05791565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464803|NCT05791565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154464804|NCT05791565|Respiratory System Agents|respiratory system agents|mesh-ancestor
154464805|NCT05791565|Tocolytic Agents|tocolytic agents|mesh-ancestor
154464806|NCT05791565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154464807|NCT05791565|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154464808|NCT05791565|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154464809|NCT05791565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154464810|NCT05791565|Adrenergic Agents|adrenergic agents|mesh-ancestor
154464811|NCT05791565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464812|NCT05791565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464813|NCT05791565|Anesthetics|anesthetics|mesh-ancestor
154464814|NCT05791565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464815|NCT05785897|Sirolimus|sirolimus|mesh-list
154464816|NCT05785897|Ticagrelor|ticagrelor|mesh-list
154464817|NCT05785897|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154464818|NCT05785897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464819|NCT05785897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029138|NCT04238975|Vaccines|vaccines|mesh-list
154464820|NCT05785897|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154029166|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464821|NCT05785897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154464822|NCT05785897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154464823|NCT05785897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154464824|NCT05785897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464825|NCT05785897|Antifungal Agents|antifungal agents|mesh-ancestor
154464826|NCT05785897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154464827|NCT05785897|Immunologic Factors|immunologic factors|mesh-ancestor
154464828|NCT05785897|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154464829|NCT05785897|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154464830|NCT05785897|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154464831|NCT05785897|Purinergic Agents|purinergic agents|mesh-ancestor
154464832|NCT05785897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464834|NCT05776459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464835|NCT05776459|Glucocorticoids|glucocorticoids|mesh-ancestor
154464836|NCT05776459|Hormones|hormones|mesh-ancestor
154464837|NCT05776459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154464838|NCT05776459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464839|NCT05776459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154464840|NCT05776459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464841|NCT05738057|Cisplatin|cisplatin|mesh-list
154464842|NCT05738057|Gemcitabine|gemcitabine|mesh-list
154464843|NCT05738057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464844|NCT05738057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154464845|NCT05738057|Antimetabolites|antimetabolites|mesh-ancestor
154464846|NCT05738057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464847|NCT05732948|Cyclophosphamide|cyclophosphamide|mesh-list
154464848|NCT05732948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154464849|NCT05732948|Immunologic Factors|immunologic factors|mesh-ancestor
154464850|NCT05732948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464851|NCT05732948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464852|NCT05732948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154464853|NCT05732948|Alkylating Agents|alkylating agents|mesh-ancestor
153973781|NCT06247787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464854|NCT05732948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464855|NCT05732948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029210|NCT02815787|Glyburide|glyburide|mesh-list
154464856|NCT05732948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154464857|NCT05715073|Caffeine|caffeine|mesh-list
154464858|NCT05715073|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154464859|NCT05715073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464860|NCT05715073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154464861|NCT05715073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464862|NCT05715073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464863|NCT05715073|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154464864|NCT05715073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154464865|NCT05715073|Purinergic Agents|purinergic agents|mesh-ancestor
154464866|NCT05715073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464867|NCT05710666|Trastuzumab|trastuzumab|mesh-list
154464868|NCT05710666|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154464869|NCT05710666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464870|NCT05710666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464871|NCT05710666|Immunoconjugates|immunoconjugates|mesh-ancestor
154464872|NCT05710666|Immunologic Factors|immunologic factors|mesh-ancestor
154464873|NCT05710666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464874|NCT05710185|Deucravacitinib|deucravacitinib|mesh-list
154464875|NCT05710185|Dermatologic Agents|dermatologic agents|mesh-ancestor
154464876|NCT05710185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154464877|NCT05710185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464878|NCT05710185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464880|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
154464881|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
154464882|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464883|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464884|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
154464885|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464886|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154464887|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154464888|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154464889|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154464890|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464891|NCT05680857|Ubiquinone|ubiquinone|mesh-list
154464892|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
154464893|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
154464894|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464895|NCT05680857|Vitamins|vitamins|mesh-ancestor
154464896|NCT05680545|Sevoflurane|sevoflurane|mesh-list
154464897|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154464899|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
154464900|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
154464901|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154464902|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464903|NCT05668026|Venetoclax|venetoclax|mesh-list
154464904|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464905|NCT05663268|Infliximab|infliximab|mesh-list
154464906|NCT05663268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154464907|NCT05663268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464908|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
154464909|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154464910|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464911|NCT05654454|Paclitaxel|paclitaxel|mesh-list
154464912|NCT05654454|Bevacizumab|bevacizumab|mesh-list
154464913|NCT05654454|Carboplatin|carboplatin|mesh-list
154464914|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154464915|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464916|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
154464917|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
154464918|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
154464919|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464920|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464921|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154464922|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154464923|NCT05654454|Growth Substances|growth substances|mesh-ancestor
154464924|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464925|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
154464926|NCT05653713|Lenograstim|lenograstim|mesh-list
154464927|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154464928|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
154464929|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464930|NCT05653024|Albuterol|albuterol|mesh-list
154464931|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154464932|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
154464933|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029239|NCT02815319|Hormones|hormones|mesh-ancestor
154464934|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464935|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154464936|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
154464937|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
154464938|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154464939|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154464940|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154464941|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154464942|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
154464943|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154464944|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464945|NCT05648006|Bevacizumab|bevacizumab|mesh-list
154464946|NCT05648006|Capecitabine|capecitabine|mesh-list
154464947|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464948|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464949|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154464950|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154464951|NCT05648006|Growth Substances|growth substances|mesh-ancestor
154464952|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464953|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
154464954|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154464955|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
154464956|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464957|NCT05644626|Tislelizumab|tislelizumab|mesh-list
154464958|NCT05644626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464959|NCT05644626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464960|NCT05627115|Tislelizumab|tislelizumab|mesh-list
154029292|NCT02684786|Lidocaine|lidocaine|mesh-list
154464961|NCT05627115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464962|NCT05627115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464963|NCT05597306|Venetoclax|venetoclax|mesh-list
154464964|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464965|NCT05559879|Dostarlimab|dostarlimab|mesh-list
154464966|NCT05559879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464967|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154464968|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
154464969|NCT05545527|Hematinics|hematinics|mesh-ancestor
154464970|NCT05538091|Atezolizumab|atezolizumab|mesh-list
154464971|NCT05538091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154464972|NCT05538091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464973|NCT05538091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154464974|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154464975|NCT05512013|Ibuprofen|ibuprofen|mesh-list
154464976|NCT05512013|Celecoxib|celecoxib|mesh-list
154464977|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
154464978|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154464979|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154464980|NCT05512013|Analgesics|analgesics|mesh-ancestor
154464981|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
154464982|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464983|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464984|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154464985|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154464986|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154464987|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154464988|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154464989|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154464990|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154464991|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
154464992|NCT05504863|Hematinics|hematinics|mesh-ancestor
154464993|NCT05464264|Ketamine|ketamine|mesh-list
154464994|NCT05464264|Analgesics|analgesics|mesh-ancestor
154464995|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
154464996|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154464997|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154464998|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154464999|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154465000|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
154465001|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
154465002|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465003|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154465004|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154465005|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465006|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465007|NCT05443009|Lidocaine|lidocaine|mesh-list
154465008|NCT05443009|Carticaine|carticaine|mesh-list
154465009|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
154465010|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
154465011|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465012|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465013|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
154465014|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465015|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154465016|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154465017|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154465018|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029336|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
154465019|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465020|NCT05441410|Artesunate|artesunate|mesh-list
154465021|NCT05441410|Pyronaridine|pyronaridine|mesh-list
154465022|NCT05441410|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154465023|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
154465024|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154465025|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154465026|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465027|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465028|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
154465029|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
154465030|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154465031|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
154465032|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154465033|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465034|NCT05440916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465035|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465036|NCT05418777|Trimethoprim|trimethoprim|mesh-list
154465037|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154465038|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
154465039|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154465040|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465041|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
154465042|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154465043|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154465044|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154465045|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465046|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029396|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
154029397|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154860590|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154465047|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154465048|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154465049|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154465050|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154465051|NCT05414292|Sirolimus|sirolimus|mesh-list
154465052|NCT05414292|Temsirolimus|temsirolimus|mesh-list
154465053|NCT05414292|MTOR Inhibitors|mtor inhibitors|mesh-list
154465054|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154465055|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465056|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154465057|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465058|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
154465059|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465060|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
154465061|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465062|NCT05414292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154465063|NCT05414292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465064|NCT05414292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465065|NCT05404048|Atezolizumab|atezolizumab|mesh-list
154465066|NCT05404048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154465067|NCT05404048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465068|NCT05404048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465069|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465070|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154465071|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
154465072|NCT05358509|Hematinics|hematinics|mesh-ancestor
154465073|NCT05354986|Povidone|povidone|mesh-list
154465074|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
154465075|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
154465076|NCT05331521|Vincristine|vincristine|mesh-list
154465077|NCT05331521|Temozolomide|temozolomide|mesh-list
154465078|NCT05331521|Lomustine|lomustine|mesh-list
154465079|NCT05331521|Procarbazine|procarbazine|mesh-list
154465080|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154465081|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465082|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
154465083|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
154465084|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
154465085|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465086|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154465087|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
154465088|NCT05327426|Vaccines|vaccines|mesh-list
154465089|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
154465090|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465091|NCT05326776|Oxytocin|oxytocin|mesh-list
154465092|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
154465093|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154465094|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465095|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
154465096|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465097|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465098|NCT05323656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154465099|NCT05323656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465101|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154465102|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465103|NCT05321043|Riboflavin|riboflavin|mesh-list
154465104|NCT05321043|Vitamins|vitamins|mesh-ancestor
154465105|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
154465106|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465107|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
154465108|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154465109|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
154465110|NCT05289869|Oxytocin|oxytocin|mesh-list
154465111|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
154465112|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154465113|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465114|NCT05289804|Lidocaine|lidocaine|mesh-list
154465115|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
154465116|NCT05289804|Prilocaine|prilocaine|mesh-list
154465117|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154465118|NCT05289804|Anesthetics|anesthetics|mesh-list
154029438|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
154465119|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465120|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465121|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
154465122|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465123|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154465124|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154465125|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154465126|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154465127|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465128|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154465129|NCT05271162|Empagliflozin|empagliflozin|mesh-list
154465130|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154465131|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465132|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154465133|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465134|NCT05259943|Psilocybin|psilocybin|mesh-list
154465135|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
154465136|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465137|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465138|NCT05236842|Sulthiame|sulthiame|mesh-list
154465139|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
154465140|NCT05217498|Istradefylline|istradefylline|mesh-list
154465141|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154465142|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154465143|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154465144|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
154465145|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465146|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465147|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465148|NCT05215327|Vaccines|vaccines|mesh-list
154465149|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
154465150|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465151|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154465152|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
154029474|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
154465153|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465154|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465155|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154465156|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
154465157|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465158|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465159|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154465160|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
154465161|NCT05162417|Methylene Blue|methylene blue|mesh-list
153814757|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
154029508|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029509|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
154029510|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029511|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029512|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154029514|NCT02809781|Etanercept|etanercept|mesh-list
154465162|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465163|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465164|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
154465165|NCT05162417|Coagulants|coagulants|mesh-ancestor
154465166|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
154465167|NCT05156749|Calpastatin|calpastatin|mesh-list
154465168|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154465169|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
154465170|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465171|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465172|NCT05149092|Caseins|caseins|mesh-list
154465173|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
154465174|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
154465175|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465176|NCT05122546|Nivolumab|nivolumab|mesh-list
154465177|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465178|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465179|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154465180|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465181|NCT05071937|Talazoparib|talazoparib|mesh-list
154465182|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154465183|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465184|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465185|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465186|NCT05069051|Belimumab|belimumab|mesh-list
154465187|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465188|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
154465189|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465190|NCT05067387|Dronabinol|dronabinol|mesh-list
154465191|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
154465192|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465193|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465194|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154465195|NCT05067387|Analgesics|analgesics|mesh-ancestor
154465196|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
154860591|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154465197|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465198|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154465199|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154029545|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154465200|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465201|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465202|NCT05067387|Hormones|hormones|mesh-ancestor
154465203|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154465204|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
154465205|NCT05064280|Lenvatinib|lenvatinib|mesh-list
154465206|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465207|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465208|NCT05064280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154465209|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465210|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154465211|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465212|NCT05030298|Temozolomide|temozolomide|mesh-list
154465213|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154465214|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
154465215|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465216|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465217|NCT04984733|Nivolumab|nivolumab|mesh-list
154465218|NCT04984733|Temozolomide|temozolomide|mesh-list
154465219|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465220|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465221|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154465222|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465223|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154465224|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
154465225|NCT04975958|Atezolizumab|atezolizumab|mesh-list
154465226|NCT04975958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154465227|NCT04975958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465228|NCT04975958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465229|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465230|NCT04944173|Durvalumab|durvalumab|mesh-list
154465231|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465232|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465233|NCT04927052|Lidocaine|lidocaine|mesh-list
154465234|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
154465235|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
154465236|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465237|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465238|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
154465239|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465240|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154465241|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154465242|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154465243|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154465244|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465245|NCT04899583|Sirolimus|sirolimus|mesh-list
154465246|NCT04899583|Paclitaxel|paclitaxel|mesh-list
154465247|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154465248|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465249|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
154465250|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
154029582|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
154029583|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
154029584|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
154029585|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465251|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
154465252|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465253|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154465254|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465255|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154465256|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
154465257|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465258|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
154465259|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465260|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
154465261|NCT04877834|Lansoprazole|lansoprazole|mesh-list
154465262|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154465263|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154465264|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154465265|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465266|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465267|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154465268|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154465269|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154465270|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154465271|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465272|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465273|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465274|NCT04870957|Analgesics|analgesics|mesh-ancestor
154465275|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
154029614|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154465276|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465277|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
154465278|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465279|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
154465280|NCT04853251|Ranibizumab|ranibizumab|mesh-list
154465281|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154465282|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154465283|NCT04853251|Growth Substances|growth substances|mesh-ancestor
154465284|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465285|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
154465286|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465287|NCT04844333|Anesthetics|anesthetics|mesh-list
154465288|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465289|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465290|NCT04819503|Anesthetics|anesthetics|mesh-list
154465291|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465292|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465293|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154465294|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154465295|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465296|NCT04752696|Leucovorin|leucovorin|mesh-list
154465297|NCT04752696|Fluorouracil|fluorouracil|mesh-list
154465298|NCT04752696|Irinotecan|irinotecan|mesh-list
154465299|NCT04752696|Onvansertib|onvansertib|mesh-list
154465300|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
154465301|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465302|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465303|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465304|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465305|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
154465306|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465307|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154465308|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154465309|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465310|NCT04752696|Antidotes|antidotes|mesh-ancestor
154465311|NCT04752696|Protective Agents|protective agents|mesh-ancestor
154465312|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
154465313|NCT04752696|Vitamins|vitamins|mesh-ancestor
154465314|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
154465315|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154465316|NCT04739371|Insulin|insulin|mesh-list
154465317|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154465318|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154465319|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465320|NCT04732507|Lidocaine|lidocaine|mesh-list
154465321|NCT04732507|Bupivacaine|bupivacaine|mesh-list
154465322|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
154465323|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
154465324|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465325|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465326|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
154465327|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465328|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154465329|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154465330|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154465331|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154465332|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465333|NCT04725812|Eculizumab|eculizumab|mesh-list
154465334|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154465335|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465336|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
154465337|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465338|NCT04717765|Vitamin E|vitamin e|mesh-list
154465339|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
154465340|NCT04717765|Tocopherols|tocopherols|mesh-list
154465341|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
154465342|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465343|NCT04717765|Protective Agents|protective agents|mesh-ancestor
154465344|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465345|NCT04717765|Vitamins|vitamins|mesh-ancestor
154465346|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
154465347|NCT04713969|Pantoprazole|pantoprazole|mesh-list
154465348|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154465349|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154465350|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154465351|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465352|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465353|NCT04706429|Trientine|trientine|mesh-list
154465354|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
154465355|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
154465356|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465357|NCT04659174|Xanomeline|xanomeline|mesh-list
154465358|NCT04659174|Trospium chloride|trospium chloride|mesh-list
154465359|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
154465360|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
154465361|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465362|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465363|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154465364|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154465365|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
154465366|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465367|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465368|NCT04659174|Urological Agents|urological agents|mesh-ancestor
154465369|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154465370|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465371|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154465372|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154465373|NCT04628338|Interferons|interferons|mesh-list
154465374|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
154465375|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465376|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
154465377|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465378|NCT04622020|Anesthetics|anesthetics|mesh-list
154465379|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465380|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465381|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
154465382|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154465383|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465384|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465385|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465386|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154465387|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154465388|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465389|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465390|NCT04516993|Aspirin|aspirin|mesh-list
154465391|NCT04516993|Plasminogen|plasminogen|mesh-list
154465392|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154465393|NCT04516993|Tenecteplase|tenecteplase|mesh-list
154465394|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154465395|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154465396|NCT04516993|Analgesics|analgesics|mesh-ancestor
154465397|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
154465398|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465399|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465400|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154465401|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465402|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154465403|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154465404|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465405|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154465406|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154465407|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465408|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
154465409|NCT04513015|Antioxidants|antioxidants|mesh-list
154465410|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465411|NCT04513015|Protective Agents|protective agents|mesh-ancestor
154465412|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465413|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154465414|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154465415|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465416|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
154465417|NCT04478942|Misoprostol|misoprostol|mesh-list
154465418|NCT04478942|Oxytocin|oxytocin|mesh-list
154465419|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
154465420|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154465421|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465422|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154465423|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
154465424|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154465425|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154465426|NCT04472416|Analgesics|analgesics|mesh-list
154465427|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
154465428|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465429|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465430|NCT04447716|Rituximab|rituximab|mesh-list
154465431|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154465432|NCT04447716|Lenalidomide|lenalidomide|mesh-list
154465433|NCT04447716|Venetoclax|venetoclax|mesh-list
154465434|NCT04447716|Piperidine|piperidine|mesh-list
154465435|NCT04447716|Antibodies|antibodies|mesh-list
154465436|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
154465437|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154465438|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
154465439|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465440|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465441|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465442|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154465443|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154465444|NCT04447716|Growth Substances|growth substances|mesh-ancestor
154029764|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029765|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029766|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029767|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154029768|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154465445|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
154465446|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465447|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154465448|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154465449|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154465450|NCT04427826|Morphine|morphine|mesh-list
154465451|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154465452|NCT04427826|Narcotics|narcotics|mesh-ancestor
154465453|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465454|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465455|NCT04427826|Analgesics|analgesics|mesh-ancestor
154465456|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
154465457|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465458|NCT04424511|Azithromycin|azithromycin|mesh-list
154465459|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154465460|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465461|NCT04315948|Interferons|interferons|mesh-list
154465462|NCT04315948|Ritonavir|ritonavir|mesh-list
154465463|NCT04315948|Lopinavir|lopinavir|mesh-list
154465464|NCT04315948|Interferon-beta|interferon-beta|mesh-list
154465465|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
154465466|NCT04315948|Remdesivir|remdesivir|mesh-list
154465467|NCT04315948|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154465468|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
154465469|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465470|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
154465471|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465472|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154465473|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154465474|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
154465475|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465476|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465477|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154465478|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154029770|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154465479|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154465480|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154465481|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
154465482|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154465483|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154465484|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465485|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
154465486|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465487|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154465488|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
154465489|NCT04310059|Folic Acid|folic acid|mesh-list
154465490|NCT04310059|Hematinics|hematinics|mesh-ancestor
154465491|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
154465492|NCT04310059|Vitamins|vitamins|mesh-ancestor
154029797|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029798|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029799|NCT04183556|Naproxen|naproxen|mesh-list
154029800|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154029801|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154029802|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029803|NCT04183556|Analgesics|analgesics|mesh-ancestor
154029804|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
154029805|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029806|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029807|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029808|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
154465493|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
154465494|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465495|NCT04302870|Amantadine|amantadine|mesh-list
154465496|NCT04302870|Memantine|memantine|mesh-list
154465497|NCT04302870|Trazodone|trazodone|mesh-list
154465498|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154465499|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154465500|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154465501|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
154465502|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465503|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465504|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465505|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154465506|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154465507|NCT04302870|Antiviral Agents|antiviral agents|mesh-ancestor
154465508|NCT04302870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465509|NCT04302870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154465510|NCT04302870|Analgesics|analgesics|mesh-ancestor
154465511|NCT04302870|Sensory System Agents|sensory system agents|mesh-ancestor
154465512|NCT04302870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465513|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154465514|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154465515|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465516|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465517|NCT04302870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154465518|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154465519|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154465520|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
154465521|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154465522|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
154465523|NCT04290429|Teduglutide|teduglutide|mesh-list
154029809|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154465524|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154029828|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
154465525|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154465526|NCT04290429|Protective Agents|protective agents|mesh-ancestor
154465527|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465528|NCT04280692|Lumefantrine|lumefantrine|mesh-list
154465529|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
154465530|NCT04280692|Artemether|artemether|mesh-list
154465531|NCT04280692|Primaquine|primaquine|mesh-list
154465532|NCT04280692|Piperaquine|piperaquine|mesh-list
154465533|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
154465534|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154465535|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154465536|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
154465537|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154465538|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154465539|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465540|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154465541|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465542|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465543|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154465544|NCT04276857|Leucovorin|leucovorin|mesh-list
154465545|NCT04276857|Paclitaxel|paclitaxel|mesh-list
154465546|NCT04276857|Gemcitabine|gemcitabine|mesh-list
154465547|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
154465548|NCT04276857|Irinotecan|irinotecan|mesh-list
154189464|NCT00510146|Olanzapine|olanzapine|mesh-list
154465549|NCT04276857|Folfirinox|folfirinox|mesh-list
154465550|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154465551|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465552|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
154465553|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
154465554|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
154465555|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465556|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465557|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
154465558|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154465559|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154465560|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465561|NCT04276857|Antidotes|antidotes|mesh-ancestor
154465562|NCT04276857|Protective Agents|protective agents|mesh-ancestor
154465563|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465564|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
154465565|NCT04276857|Vitamins|vitamins|mesh-ancestor
154465566|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
154465567|NCT04268277|Rituximab|rituximab|mesh-list
154465568|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
154465569|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465570|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465571|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
154465572|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465573|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465574|NCT04268277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154465575|NCT04268277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465576|NCT04246684|Leucovorin|leucovorin|mesh-list
154465577|NCT04246684|Folic Acid|folic acid|mesh-list
154465578|NCT04246684|Capecitabine|capecitabine|mesh-list
154465579|NCT04246684|Fluorouracil|fluorouracil|mesh-list
154465580|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
154465581|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
153814762|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
154029874|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
154029875|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
154029876|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
154029877|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029878|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029879|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
154465582|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465583|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
154465584|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465585|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465586|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465587|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
154465588|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465589|NCT04246684|Antidotes|antidotes|mesh-ancestor
154465590|NCT04246684|Protective Agents|protective agents|mesh-ancestor
154465591|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
154465592|NCT04246684|Vitamins|vitamins|mesh-ancestor
154465593|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
154465594|NCT04246684|Hematinics|hematinics|mesh-ancestor
154465595|NCT04234997|Suvorexant|suvorexant|mesh-list
154465596|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154465597|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154465598|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465599|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465600|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154465601|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465602|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465603|NCT04187404|Nivolumab|nivolumab|mesh-list
154465604|NCT04187404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465605|NCT04187404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465606|NCT04187404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154465607|NCT04187404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465608|NCT04151472|Ubiquinone|ubiquinone|mesh-list
154465609|NCT04151472|Idebenone|idebenone|mesh-list
154465610|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
154465611|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465612|NCT04151472|Protective Agents|protective agents|mesh-ancestor
154465613|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465614|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
154465615|NCT04130438|Nebivolol|nebivolol|mesh-list
154465616|NCT04130438|Diltiazem|diltiazem|mesh-list
154465617|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154465618|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
154465619|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154465620|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154465621|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154465622|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
154465623|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465624|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465625|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465626|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154465627|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154189533|NCT06314126|Inositol|inositol|mesh-list
154465628|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154465629|NCT04128722|Sirolimus|sirolimus|mesh-list
154465630|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154465631|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465632|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154465633|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465634|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
154465635|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465636|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
154465637|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465638|NCT04120805|Hemostatics|hemostatics|mesh-list
154465639|NCT04120805|Coagulants|coagulants|mesh-ancestor
154465640|NCT04119180|Midazolam|midazolam|mesh-list
154465641|NCT04119180|Ketamine|ketamine|mesh-list
154465642|NCT04119180|Analgesics|analgesics|mesh-ancestor
154465643|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
154465644|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465645|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465646|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154465647|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154465648|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
154860592|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
154465650|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465651|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154465652|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154465653|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465654|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465655|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154465656|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154465657|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154465658|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154465659|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465660|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
154465661|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
154465662|NCT04083118|Listerine|listerine|mesh-list
154465663|NCT04083118|Fluorides|fluorides|mesh-list
154465664|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
154465665|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
154465666|NCT04083118|Protective Agents|protective agents|mesh-ancestor
154465667|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465668|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154465669|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465670|NCT04070378|Daratumumab|daratumumab|mesh-list
154465671|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465672|NCT04037527|Gemcitabine|gemcitabine|mesh-list
154465673|NCT04037527|Docetaxel|docetaxel|mesh-list
154465674|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465675|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
154465676|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029962|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154029963|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154029964|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154029965|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029966|NCT04236323|Remifentanil|remifentanil|mesh-list
154029967|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154465677|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465678|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
154465679|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
154465680|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
154465681|NCT04007367|Zuranolone|zuranolone|mesh-list
154465682|NCT04007367|Antidepressive Agents|antidepressive agents|mesh-ancestor
154465683|NCT04007367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465684|NCT03979885|Nicotine|nicotine|mesh-list
154465685|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154465686|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
154465687|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465688|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465689|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154465690|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154465691|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
154465692|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465693|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465694|NCT03966014|Amoxicillin|amoxicillin|mesh-list
154465695|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154465696|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465697|NCT03941886|Aspirin|aspirin|mesh-list
154465698|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154465699|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154465700|NCT03941886|Analgesics|analgesics|mesh-ancestor
154465701|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
154465702|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465703|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465704|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154465705|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465706|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154465707|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154465708|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465709|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154465710|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154465711|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465712|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
154465713|NCT03934710|Serotonin|serotonin|mesh-list
154465714|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
154465715|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
154465716|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465717|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465718|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465719|NCT03867370|Lenvatinib|lenvatinib|mesh-list
154465720|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465721|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154465722|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465723|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465724|NCT03866525|Irinotecan|irinotecan|mesh-list
154465725|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154465726|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154465727|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465728|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465729|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465730|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
154465731|NCT03859921|Progestins|progestins|mesh-ancestor
154029997|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029998|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154029999|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030000|NCT04010929|Pemetrexed|pemetrexed|mesh-list
154030001|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030002|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030003|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030004|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154030005|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154030006|NCT00956215|Aprepitant|aprepitant|mesh-list
154030007|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
154465732|NCT03859921|Hormones|hormones|mesh-ancestor
154465733|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154465734|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465735|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154465736|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465737|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465738|NCT03844412|Lidocaine|lidocaine|mesh-list
154465739|NCT03844412|Nortriptyline|nortriptyline|mesh-list
154465740|NCT03844412|Estradiol|estradiol|mesh-list
154465741|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
154465742|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
154465743|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465744|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465745|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
154465746|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465747|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154465748|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154465749|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154465750|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154465751|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465752|NCT03844412|Estrogens|estrogens|mesh-ancestor
154465753|NCT03844412|Hormones|hormones|mesh-ancestor
154465754|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814763|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465755|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154465756|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
154465757|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465758|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154465759|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154465760|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
154465761|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465762|NCT03826875|Fluoxetine|fluoxetine|mesh-list
154465763|NCT03826875|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154465764|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154465765|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154465766|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465767|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465768|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
154465769|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465770|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154465771|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
154465772|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465773|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154465774|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154465775|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465776|NCT03802591|Capecitabine|capecitabine|mesh-list
154465777|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
154465778|NCT03802591|Antibodies|antibodies|mesh-list
154465779|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154465780|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
154465781|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465782|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465783|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
154465784|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465785|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465786|NCT03793114|Cosyntropin|cosyntropin|mesh-list
154465788|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154465789|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465790|NCT03771664|Zuranolone|zuranolone|mesh-list
154465791|NCT03771664|Antidepressive Agents|antidepressive agents|mesh-ancestor
154465792|NCT03771664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465793|NCT03753074|Tenofovir|tenofovir|mesh-list
153814764|NCT00343070|Escitalopram|escitalopram|mesh-list
154465794|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
154465795|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465796|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154465797|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154465798|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465799|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465800|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154465801|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154465802|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
154465803|NCT03739853|Adalimumab|adalimumab|mesh-list
154465804|NCT03739853|Methotrexate|methotrexate|mesh-list
154465805|NCT03739853|Leflunomide|leflunomide|mesh-list
154465806|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154465807|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
154465808|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154465809|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030058|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030059|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154030060|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154030061|NCT04115189|Growth Substances|growth substances|mesh-ancestor
154030062|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030063|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
154030064|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154030065|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030066|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030067|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
154030068|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154030069|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030070|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
154030071|NCT02678234|Acetaminophen|acetaminophen|mesh-list
154465810|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465811|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
154465812|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465813|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465814|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
154465815|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465816|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154465817|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465818|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
154465819|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465820|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154465821|NCT03739853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154465822|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154465823|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465824|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154465825|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154465826|NCT03739853|Analgesics|analgesics|mesh-ancestor
154465827|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
154465828|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465829|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154465830|NCT03672175|Zuranolone|zuranolone|mesh-list
154465831|NCT03672175|Antidepressive Agents|antidepressive agents|mesh-ancestor
154465832|NCT03672175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154465833|NCT03653832|Clonidine|clonidine|mesh-list
154465834|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
154465835|NCT03653832|Propofol|propofol|mesh-list
154465836|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154465837|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154465838|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465839|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154465840|NCT03653832|Analgesics|analgesics|mesh-ancestor
154465841|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
154465842|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030089|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154030090|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154030091|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154030092|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
154465843|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154465844|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154465845|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154465846|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
154465847|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154465848|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465849|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154465850|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
154465851|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
154465852|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154465853|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
154465854|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
154465855|NCT03643276|Cytarabine|cytarabine|mesh-list
154465856|NCT03643276|Dexamethasone|dexamethasone|mesh-list
154465857|NCT03643276|Prednisone|prednisone|mesh-list
154465858|NCT03643276|Prednisolone|prednisolone|mesh-list
154465859|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
154465860|NCT03643276|Ifosfamide|ifosfamide|mesh-list
154465861|NCT03643276|Doxorubicin|doxorubicin|mesh-list
154465862|NCT03643276|Methotrexate|methotrexate|mesh-list
154465863|NCT03643276|Fludarabine|fludarabine|mesh-list
154465864|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
154465865|NCT03643276|Etoposide|etoposide|mesh-list
154465866|NCT03643276|Vincristine|vincristine|mesh-list
154465867|NCT03643276|Bortezomib|bortezomib|mesh-list
154465868|NCT03643276|Daunorubicin|daunorubicin|mesh-list
154465869|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
154465870|NCT03643276|Pegaspargase|pegaspargase|mesh-list
154465871|NCT03643276|Blinatumomab|blinatumomab|mesh-list
154465872|NCT03643276|Vindesine|vindesine|mesh-list
154465873|NCT03643276|Asparaginase|asparaginase|mesh-list
154465874|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465875|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
154465876|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465877|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465878|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154465879|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
154465880|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465881|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814765|NCT00343070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154465882|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154465883|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154465885|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
154465886|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465887|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154465888|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
154465889|NCT03643276|Hormones|hormones|mesh-ancestor
154465890|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154465891|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154465892|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154465893|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154465894|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154465895|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465896|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154465897|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
154465898|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154465899|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465900|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
154465901|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
154465902|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154465903|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154465904|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154465905|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
154465906|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465907|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
154465908|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
154465909|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
154465910|NCT03617471|Acetaminophen|acetaminophen|mesh-list
154465911|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154465912|NCT03617471|Analgesics|analgesics|mesh-ancestor
154465913|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
154465914|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465915|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465916|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
154465917|NCT03611595|Tretinoin|tretinoin|mesh-list
154465918|NCT03611595|Isotretinoin|isotretinoin|mesh-list
154465919|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465920|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
154465921|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
154465922|NCT03586284|Valganciclovir|valganciclovir|mesh-list
154465923|NCT03586284|Ganciclovir|ganciclovir|mesh-list
154465924|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154465925|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
154465926|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465927|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154465928|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465929|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465930|NCT03571321|Cytarabine|cytarabine|mesh-list
154465931|NCT03571321|Dexamethasone|dexamethasone|mesh-list
154465932|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
154465933|NCT03571321|Rituximab|rituximab|mesh-list
154465934|NCT03571321|Doxorubicin|doxorubicin|mesh-list
154465936|NCT03571321|Vincristine|vincristine|mesh-list
154465937|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
154465938|NCT03571321|Pegaspargase|pegaspargase|mesh-list
154465939|NCT03571321|Thioguanine|thioguanine|mesh-list
154465940|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465941|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
154465942|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465943|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465944|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154465945|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
154465946|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465947|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465948|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154465949|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465950|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154465951|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
154465952|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
154465953|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154465954|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154465955|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
154465956|NCT03571321|Hormones|hormones|mesh-ancestor
154860593|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154465957|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154465958|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154465959|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154465960|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154465961|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154465962|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465963|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154465964|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
154465965|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154465966|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465967|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
154465968|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
154030169|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
154465969|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154465970|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154465971|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
154465972|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154465973|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154465974|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
154465975|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
154465976|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
154465977|NCT03531073|Methotrexate|methotrexate|mesh-list
154465978|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154465979|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
154465980|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154465981|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154465982|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154465983|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
154465984|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154465985|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465986|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
154465987|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154465988|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154465989|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154465990|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
154465991|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154465992|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154465993|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
154465994|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
154465995|NCT03516617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154465996|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154465997|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154465998|NCT03516617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154465999|NCT03516617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466000|NCT03516617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466001|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154466002|NCT03462329|Doxycycline|doxycycline|mesh-list
154466003|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466004|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
154466005|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154466006|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154466007|NCT03451370|Bevacizumab|bevacizumab|mesh-list
154466008|NCT03451370|Capecitabine|capecitabine|mesh-list
154466009|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
154466010|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466011|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466012|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154466013|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153814767|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154030248|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
154030249|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
154030250|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
154030251|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030252|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030269|NCT00641264|Omeprazole|omeprazole|mesh-list
154466014|NCT03451370|Growth Substances|growth substances|mesh-ancestor
154466015|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466016|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
154466017|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154466018|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
154466019|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466020|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154466021|NCT03678350|Trioxsalen|trioxsalen|mesh-list
154466022|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466023|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
154466024|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154466025|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
154466026|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154466027|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466028|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860594|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466029|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154466030|NCT03437421|Vitamin D|vitamin d|mesh-list
154466031|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
154466032|NCT03437421|Vitamins|vitamins|mesh-ancestor
154466033|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
154466034|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466035|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154466036|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154466037|NCT03401294|Leucovorin|leucovorin|mesh-list
154466038|NCT03401294|Bevacizumab|bevacizumab|mesh-list
154466039|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
154466040|NCT03401294|Irinotecan|irinotecan|mesh-list
154466041|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466042|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466043|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154466044|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154466045|NCT03401294|Growth Substances|growth substances|mesh-ancestor
154466046|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466047|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
154466048|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154466049|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154466050|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466051|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466052|NCT03401294|Antidotes|antidotes|mesh-ancestor
154466053|NCT03401294|Protective Agents|protective agents|mesh-ancestor
154466054|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
154466055|NCT03401294|Vitamins|vitamins|mesh-ancestor
154466056|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
154466057|NCT03337932|Doxycycline|doxycycline|mesh-list
154466058|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154466059|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466060|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
154466061|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154466062|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154030282|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
154030283|NCT05484167|Hormones|hormones|mesh-ancestor
154030284|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030285|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030286|NCT05484167|Androgens|androgens|mesh-ancestor
154030287|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154030288|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
154030289|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030290|NCT04180982|Febuxostat|febuxostat|mesh-list
154030291|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
154030292|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030293|NCT02802605|Bemiparin|bemiparin|mesh-list
154030294|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
154030295|NCT02800265|Sulforaphane|sulforaphane|mesh-list
154466063|NCT03284931|Zuranolone|zuranolone|mesh-list
154466064|NCT03284931|Antidepressive Agents|antidepressive agents|mesh-ancestor
154466065|NCT03284931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154466066|NCT03279471|Sertraline|sertraline|mesh-list
154466067|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
154466068|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154466069|NCT03279471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154466070|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154466071|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466072|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466073|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466074|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
154466075|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466076|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
154466077|NCT03193281|Dasatinib|dasatinib|mesh-list
154466078|NCT03193281|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466079|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466080|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466081|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466082|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466083|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154466084|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154466085|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466086|NCT03150173|Buprenorphine|buprenorphine|mesh-list
154466087|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154466088|NCT03150173|Narcotics|narcotics|mesh-ancestor
154466089|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466090|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466091|NCT03150173|Analgesics|analgesics|mesh-ancestor
154466092|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
154466093|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466094|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154466095|NCT03000569|Levodopa|levodopa|mesh-list
154466096|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
154466097|NCT03000569|Zuranolone|zuranolone|mesh-list
154466098|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154466099|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
154466100|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466101|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466102|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466103|NCT03000569|Antidepressive Agents|antidepressive agents|mesh-ancestor
154466104|NCT03000569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154466105|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154466106|NCT02997761|Blinatumomab|blinatumomab|mesh-list
154466107|NCT02997761|Antibodies|antibodies|mesh-list
154466108|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
154466109|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154466110|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
154466111|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154466112|NCT02997761|Ibrutinib|ibrutinib|mesh-list
154466113|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
154466114|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466115|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466116|NCT02997761|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466117|NCT02997761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466118|NCT02997761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466119|NCT02997761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466120|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154466121|NCT02949921|Lidocaine|lidocaine|mesh-list
154466122|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
154466123|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
154466124|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466125|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466126|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
154466127|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466128|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154466129|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154466130|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154030319|NCT02799797|Dsuvia|dsuvia|mesh-list
154466131|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466132|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466133|NCT02935205|Indomethacin|indomethacin|mesh-list
154466134|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154466135|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154466136|NCT02935205|Analgesics|analgesics|mesh-ancestor
154466137|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
154466138|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466139|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466140|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154466141|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154466142|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
154466143|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
154466144|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154466145|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154466146|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466147|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466148|NCT02860091|Ropivacaine|ropivacaine|mesh-list
154466149|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
154466150|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
154466151|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466152|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466153|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
154466154|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466155|NCT02835222|Cytarabine|cytarabine|mesh-list
154466156|NCT02835222|Daunorubicin|daunorubicin|mesh-list
154466157|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154466158|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
154466159|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466160|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466161|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
154466162|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466163|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154466164|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
154466165|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466166|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154466167|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154030351|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466168|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154466169|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466171|NCT02807805|Prednisone|prednisone|mesh-list
154466172|NCT02807805|Cortisone|cortisone|mesh-list
154466173|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
154466174|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154466175|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
154466176|NCT02807805|Hormones|hormones|mesh-ancestor
154030389|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
154030390|NCT02817191|Hormones|hormones|mesh-ancestor
154030391|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030392|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154030393|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030394|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
154030395|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466177|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154466178|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466179|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154466180|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466181|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154860595|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154466182|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466183|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466184|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
154466185|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154466186|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
154466187|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154466188|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
154466189|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154466190|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466191|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
154466192|NCT02783092|Cannabidiol|cannabidiol|mesh-list
154466193|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
154466194|NCT02780128|Ceritinib|ceritinib|mesh-list
154466195|NCT02780128|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466196|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466197|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466198|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466199|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466200|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
154466201|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466202|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466203|NCT02775851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154466204|NCT02775851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466205|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
154466206|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466207|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466208|NCT02733159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154466209|NCT02733159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030422|NCT02801357|Narcotics|narcotics|mesh-ancestor
154030423|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466210|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154466211|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154466212|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154466213|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466214|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466215|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154466216|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154466217|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154466218|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154466219|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154466220|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466221|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466222|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154466223|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154466224|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
154466225|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154466226|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154466227|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
154466228|NCT02594072|Goserelin|goserelin|mesh-list
154466229|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154466230|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466231|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154466232|NCT02541955|Hormones|hormones|mesh-ancestor
154466233|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154466234|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466236|NCT02486133|Darunavir|darunavir|mesh-list
154466237|NCT02486133|Tenofovir|tenofovir|mesh-list
154466238|NCT02486133|Lamivudine|lamivudine|mesh-list
154466239|NCT02486133|Emtricitabine|emtricitabine|mesh-list
154466240|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154466241|NCT02486133|Dolutegravir|dolutegravir|mesh-list
154466242|NCT02486133|Abacavir|abacavir|mesh-list
154466243|NCT02486133|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154466244|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154030425|NCT02801357|Analgesics|analgesics|mesh-ancestor
154466245|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154030457|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154466246|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
154466247|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466248|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466249|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154466250|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154466251|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
154466252|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466253|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154466254|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154466255|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154466256|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154466257|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154466258|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154466259|NCT02457442|Remifentanil|remifentanil|mesh-list
154466260|NCT02457442|Propofol|propofol|mesh-list
154466261|NCT02457442|Sevoflurane|sevoflurane|mesh-list
154466262|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154466263|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466264|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466265|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154466266|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
154466267|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
154466268|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154466269|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154466270|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154466271|NCT02457442|Narcotics|narcotics|mesh-ancestor
154466272|NCT02457442|Analgesics|analgesics|mesh-ancestor
154466273|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
154466274|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466275|NCT02347111|Flecainide|flecainide|mesh-list
154466276|NCT02347111|Sotalol|sotalol|mesh-list
154466277|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154466278|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154466279|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154466280|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154030458|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154466281|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466282|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154030493|NCT02817113|Fluorouracil|fluorouracil|mesh-list
154030494|NCT02817113|Cetuximab|cetuximab|mesh-list
154466283|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154466284|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
154466285|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466286|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466287|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
154466288|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
154466289|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466290|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
154466291|NCT02315768|Ibrutinib|ibrutinib|mesh-list
154466292|NCT02315768|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466293|NCT02315768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466294|NCT02315768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466295|NCT02315768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466296|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466297|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466298|NCT02183883|Afatinib|afatinib|mesh-list
154466299|NCT02183883|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466300|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466301|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466302|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466303|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466304|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
154466305|NCT02088645|Gastrins|gastrins|mesh-list
154466306|NCT02088645|Hormones|hormones|mesh-ancestor
154466307|NCT02088645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154466308|NCT02088645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466309|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154466310|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154466311|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
154466312|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154466313|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154466314|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466316|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
154466317|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
154466318|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466319|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466320|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
154466321|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466322|NCT01979536|Cytarabine|cytarabine|mesh-list
154466323|NCT01979536|Dexamethasone|dexamethasone|mesh-list
154466324|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
154030495|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
154466325|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
154466326|NCT01979536|Ifosfamide|ifosfamide|mesh-list
154466327|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
154466328|NCT01979536|Doxorubicin|doxorubicin|mesh-list
154466329|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154466330|NCT01979536|Methotrexate|methotrexate|mesh-list
154466331|NCT01979536|Etoposide|etoposide|mesh-list
154466332|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
154466333|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154466335|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
154466336|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154466337|NCT01979536|Antibodies|antibodies|mesh-list
154466338|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
154466339|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154466340|NCT01979536|BB 1101|bb 1101|mesh-list
154466341|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
154466342|NCT01979536|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154466343|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154466344|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
154466345|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466346|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154466347|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154466348|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
154466349|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466350|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466351|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154466352|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154466353|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
154466354|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
154466355|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466356|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154466357|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
154466358|NCT01979536|Hormones|hormones|mesh-ancestor
154466359|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154466360|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154466361|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
154466362|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466363|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154466364|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154466365|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154466366|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154466367|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
154030536|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030576|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466368|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154466369|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154466370|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
154466371|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
154466372|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154466373|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154466374|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154466375|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
154466376|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466377|NCT01979536|Immunotoxins|immunotoxins|mesh-ancestor
154466378|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466379|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
154466380|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
154466381|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
154466382|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
154466383|NCT01880723|Albuterol|albuterol|mesh-list
154466384|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154466385|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
154466386|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466387|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466388|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154466389|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
154466390|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
154466391|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154466392|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154466393|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154466394|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154466395|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
154466396|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466397|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466398|NCT01824836|Anastrozole|anastrozole|mesh-list
154466399|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154466400|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466401|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154466402|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154466403|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466404|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466405|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154466406|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
154466407|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030577|NCT00962767|Immunotoxins|immunotoxins|mesh-ancestor
154466408|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466409|NCT01798992|Metoprolol|metoprolol|mesh-list
154466410|NCT01798992|Carvedilol|carvedilol|mesh-list
154466411|NCT01798992|Doxazosin|doxazosin|mesh-list
154466412|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154466413|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154466414|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
154466415|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
154466416|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814769|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814770|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
154030618|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030619|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030620|NCT00883116|Paclitaxel|paclitaxel|mesh-list
154030621|NCT00883116|Doxorubicin|doxorubicin|mesh-list
154030622|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154466417|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466418|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154466419|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154466420|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154466421|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
154466422|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466423|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466424|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
154466425|NCT01798992|Protective Agents|protective agents|mesh-ancestor
154466426|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154466427|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466428|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154466429|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
154466430|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154466431|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154466432|NCT01746836|Ponatinib|ponatinib|mesh-list
154466433|NCT01746836|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466434|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466435|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466436|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466437|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466438|NCT01570868|Ponatinib|ponatinib|mesh-list
154466439|NCT01570868|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466440|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466441|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466442|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466443|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466444|NCT01415752|Rituximab|rituximab|mesh-list
154466445|NCT01415752|Lenalidomide|lenalidomide|mesh-list
154466446|NCT01415752|Bortezomib|bortezomib|mesh-list
154466447|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154466448|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466449|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030633|NCT00643292|Amoxicillin|amoxicillin|mesh-list
154466450|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
154466451|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466452|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190336|NCT06274333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190337|NCT06274333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154190338|NCT06274333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154190339|NCT06274333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154190340|NCT06274333|Adrenergic Agents|adrenergic agents|mesh-ancestor
154190343|NCT06274333|Antipyretics|antipyretics|mesh-ancestor
154466453|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154466454|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154466455|NCT01415752|Growth Substances|growth substances|mesh-ancestor
154466456|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
154466457|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154466458|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
154466459|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466460|NCT01391962|Sunitinib|sunitinib|mesh-list
154466461|NCT01391962|Cediranib|cediranib|mesh-list
154466462|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466463|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154466464|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154466465|NCT01391962|Growth Substances|growth substances|mesh-ancestor
154466466|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466467|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
154466468|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466469|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466470|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466471|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
154466472|NCT01187485|Testosterone|testosterone|mesh-list
154466473|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
154466474|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
154466476|NCT01187485|Androgens|androgens|mesh-ancestor
154466477|NCT01187485|Hormones|hormones|mesh-ancestor
154466478|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154466479|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466480|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154466481|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466482|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
154466483|NCT01185158|Gefitinib|gefitinib|mesh-list
154466484|NCT01185158|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466485|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466486|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466487|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466488|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466489|NCT01172470|Carboplatin|carboplatin|mesh-list
154466490|NCT01172470|Gemcitabine|gemcitabine|mesh-list
154466491|NCT01172470|Pemetrexed|pemetrexed|mesh-list
154466492|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466493|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154466494|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
154466495|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466496|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466497|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154466498|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154466499|NCT01085617|Cytarabine|cytarabine|mesh-list
154466500|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
154466501|NCT01085617|Melphalan|melphalan|mesh-list
154466502|NCT01085617|Rituximab|rituximab|mesh-list
154466503|NCT01085617|Methotrexate|methotrexate|mesh-list
154466504|NCT01085617|Fludarabine|fludarabine|mesh-list
154466505|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
154466506|NCT01085617|Etoposide|etoposide|mesh-list
154466507|NCT01085617|Vincristine|vincristine|mesh-list
154466508|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
154466509|NCT01085617|Daunorubicin|daunorubicin|mesh-list
154466510|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
154466511|NCT01085617|Pegaspargase|pegaspargase|mesh-list
154466512|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154466513|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
154466514|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466515|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154466516|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154466517|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
153973782|NCT06247787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154466518|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466519|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466520|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154466521|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466522|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154466523|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
154466524|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154466525|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154466526|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
154466527|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
154466528|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466529|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154466530|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154466531|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154466532|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154466533|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154466534|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
154466535|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466536|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
154466537|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
154466538|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
154466539|NCT01085617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154466540|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466541|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154466542|NCT00606866|Sorafenib|sorafenib|mesh-list
154466543|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466544|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154466545|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466546|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466547|NCT00594542|Lidocaine|lidocaine|mesh-list
154466548|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154466549|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
154466550|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860596|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154466551|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466552|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
154030764|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154030765|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
154466553|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466554|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154466555|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154466556|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154466557|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466558|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466559|NCT00542451|Paclitaxel|paclitaxel|mesh-list
154466560|NCT00542451|Trastuzumab|trastuzumab|mesh-list
154466561|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154466562|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466563|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
154466564|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
154466565|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
154466566|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466567|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466568|NCT00336232|Vitamin K|vitamin k|mesh-list
154466569|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
154466570|NCT00336232|Vitamins|vitamins|mesh-ancestor
154466571|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
154466572|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466573|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154466574|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154466575|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466576|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
154466577|NCT00336232|Coagulants|coagulants|mesh-ancestor
154466578|NCT00153075|Fenoterol|fenoterol|mesh-list
154466579|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154466580|NCT00153075|Ipratropium|ipratropium|mesh-list
154466581|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154466582|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
154466583|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466584|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466585|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154466586|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
154466587|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
154466588|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
154466589|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154030766|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466590|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154466591|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154466592|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154466593|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
154466594|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466595|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466596|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154466597|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
154466598|NCT00131235|Azithromycin|azithromycin|mesh-list
154466599|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
154466600|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
154466601|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154466602|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154466603|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190485|NCT06218797|Analgesics|analgesics|mesh-ancestor
154466605|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154466606|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154466607|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154466608|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466609|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466610|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154466611|NCT00157248|Dabigatran|dabigatran|mesh-list
154466612|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
154466613|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154466614|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
154466615|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466616|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466617|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
154466618|NCT02504580|Bupivacaine|bupivacaine|mesh-list
154466619|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
154466620|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
154466621|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466622|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466623|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
154254894|NCT01250366|Ribavirin|ribavirin|mesh-list
154466624|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466625|NCT02235402|Lacidipine|lacidipine|mesh-list
154466626|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
154466627|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154466628|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154466629|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466630|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466631|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154466632|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466633|NCT02235402|Diuretics|diuretics|mesh-ancestor
154466634|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
154466635|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154466636|NCT02235480|Tazarotene|tazarotene|mesh-list
154466637|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
154466638|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
154466639|NCT02235558|Verapamil|verapamil|mesh-list
154466640|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154466641|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154466642|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466643|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466644|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154466645|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466646|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
154466647|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
154466648|NCT04214418|Atezolizumab|atezolizumab|mesh-list
154466649|NCT04214418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154466650|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466651|NCT04214418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466652|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466653|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
154466654|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154466655|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154466656|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466657|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466658|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154466659|NCT02233920|Oxitropium|oxitropium|mesh-list
154466660|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
154466661|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
154466662|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466663|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466664|NCT02235948|Folic Acid|folic acid|mesh-list
154466665|NCT02235948|Hematinics|hematinics|mesh-ancestor
154466666|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
154466667|NCT02235948|Vitamins|vitamins|mesh-ancestor
154466668|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
154466669|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466670|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
154466671|NCT02236026|ST 1435|st 1435|mesh-list
154466672|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154466673|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466674|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154466675|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154466676|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466677|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466678|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466679|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154466680|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
154466681|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154466682|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466683|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154466684|NCT02236182|Bromides|bromides|mesh-list
154466685|NCT02236182|Ipratropium|ipratropium|mesh-list
154466686|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
154466687|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154466688|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
154466689|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466690|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466691|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154466692|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
154466693|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154466694|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
154466695|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466696|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860597|NCT01057225|Growth Substances|growth substances|mesh-ancestor
154466697|NCT04453280|Antibodies|antibodies|mesh-list
154466698|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
154860598|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
154466699|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466700|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154466701|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154466702|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466703|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154466704|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154466705|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466706|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466707|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
154466708|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466709|NCT05392634|Amoxicillin|amoxicillin|mesh-list
154466710|NCT05392634|Meropenem|meropenem|mesh-list
154466711|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
154466712|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
154466713|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154466714|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154466715|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466716|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030895|NCT02816567|Sufentanil|sufentanil|mesh-list
154466717|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030933|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154466718|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154466719|NCT01593228|Paclitaxel|paclitaxel|mesh-list
154466720|NCT01593228|Carboplatin|carboplatin|mesh-list
154466721|NCT01593228|Gemcitabine|gemcitabine|mesh-list
154466722|NCT01593228|Doxorubicin|doxorubicin|mesh-list
154466723|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154466724|NCT01593228|Irinotecan|irinotecan|mesh-list
154466725|NCT01593228|Topotecan|topotecan|mesh-list
154466726|NCT01593228|Iniparib|iniparib|mesh-list
154466727|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154466728|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466729|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
154466730|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
154466731|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
154466732|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466733|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154466734|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
154466735|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154466736|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154466737|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154466738|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466739|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154466740|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154466741|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154466742|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154466743|NCT02236260|Lidocaine|lidocaine|mesh-list
154466744|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
154466745|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
154466746|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466747|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466748|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
154466749|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466750|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154466751|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154466752|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154190636|NCT06159777|Laxatives|laxatives|mesh-ancestor
154466753|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466754|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466755|NCT01555554|Propranolol|propranolol|mesh-list
154030955|NCT00655512|Clobetasol|clobetasol|mesh-list
154466756|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154466757|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154466758|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
154466759|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466760|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466761|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466762|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154466763|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154466764|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
154466765|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
154466766|NCT01435044|Ribavirin|ribavirin|mesh-list
154466767|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
154466768|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466769|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
154466770|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466771|NCT01434498|Ribavirin|ribavirin|mesh-list
154466773|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
154466774|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466775|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
154466776|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466777|NCT03735966|Carboplatin|carboplatin|mesh-list
154466778|NCT03735966|Docetaxel|docetaxel|mesh-list
154466779|NCT03735966|Trastuzumab|trastuzumab|mesh-list
154466780|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466781|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
154466782|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
154466783|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
154466784|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466785|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154466786|NCT01554696|Methotrexate|methotrexate|mesh-list
154466787|NCT01554696|Peficitinib|peficitinib|mesh-list
154466788|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154466789|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
154466790|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154466791|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466792|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154466793|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
154466794|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466795|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466796|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
154466797|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466798|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154466799|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154466800|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
154466801|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031017|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154466802|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154466803|NCT02265276|Pioglitazone|pioglitazone|mesh-list
154466804|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154466805|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466806|NCT02263872|Minocycline|minocycline|mesh-list
154466807|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154466808|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466809|NCT02261376|DS-1971a|ds-1971a|mesh-list
154466810|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154466811|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154466812|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466813|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466814|NCT01535508|Vitamin D|vitamin d|mesh-list
154466815|NCT01535508|Vitamins|vitamins|mesh-ancestor
154466816|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
154466817|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466818|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154466819|NCT01416402|Colchicine|colchicine|mesh-list
154466820|NCT01416402|Febuxostat|febuxostat|mesh-list
154466821|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
154466822|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154466823|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
154466824|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
154466825|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
154466826|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466827|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466828|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154466829|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154466830|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466831|NCT01414920|Incretins|incretins|mesh-ancestor
154466832|NCT01414920|Hormones|hormones|mesh-ancestor
154466833|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154466834|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154466835|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
154466836|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466837|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466838|NCT02263950|Artemether|artemether|mesh-list
154466839|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
154466840|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154466841|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154466842|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466843|NCT02261844|Resveratrol|resveratrol|mesh-list
154466844|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
154466845|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466846|NCT02261844|Protective Agents|protective agents|mesh-ancestor
154031055|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154031056|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154031057|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154031058|NCT04016246|Propofol|propofol|mesh-list
154031063|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
154094999|NCT00618748|Olanzapine|olanzapine|mesh-list
154466847|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466848|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466849|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154466850|NCT02261922|Ticagrelor|ticagrelor|mesh-list
154466851|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154466852|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154466853|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154466854|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154466855|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154466856|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
154466857|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466858|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466859|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466860|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154466861|NCT02264106|Pantoprazole|pantoprazole|mesh-list
154466862|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154466863|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154466864|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154466865|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466866|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466867|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
154466868|NCT02262156|Serotonin|serotonin|mesh-list
154466869|NCT02262156|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154466870|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154466871|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154466872|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
154466873|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466874|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466875|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466876|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154466877|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466878|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
154466879|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154466880|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466881|NCT01516476|Liraglutide|liraglutide|mesh-list
154466882|NCT01516476|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154466883|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154466884|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814773|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153387548|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154031089|NCT00959101|Metformin|metformin|mesh-list
154031090|NCT00959101|Repaglinide|repaglinide|mesh-list
154466885|NCT01516476|Incretins|incretins|mesh-ancestor
154466886|NCT01516476|Hormones|hormones|mesh-ancestor
154466887|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154466888|NCT01516086|Fluticasone|fluticasone|mesh-list
154466889|NCT01516086|Xhance|xhance|mesh-list
154466890|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154466891|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154466892|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
154466893|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466894|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466895|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154466896|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
154466897|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
154466898|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154466899|NCT01497834|Asunaprevir|asunaprevir|mesh-list
154466900|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
154466901|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466902|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466903|NCT02265822|Midazolam|midazolam|mesh-list
154466904|NCT02265822|Melatonin|melatonin|mesh-list
154466905|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154466906|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154466907|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466908|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466909|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154466910|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154466911|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154466912|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154466913|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
154466914|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
154466915|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
154466916|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
154466917|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466918|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466919|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
154466920|NCT02265822|Protective Agents|protective agents|mesh-ancestor
154860599|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
154860600|NCT01057381|Morphine|morphine|mesh-list
154466921|NCT02607930|Lamivudine|lamivudine|mesh-list
154466922|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154466923|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154466924|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466925|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466926|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
154466927|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154466928|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154466929|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154466930|NCT02264184|Paroxetine|paroxetine|mesh-list
154466931|NCT02264184|Tamsulosin|tamsulosin|mesh-list
154466932|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154466933|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154466934|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154466935|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
154466936|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154466937|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466938|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466939|NCT02264184|Urological Agents|urological agents|mesh-ancestor
154466940|NCT02264184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154466941|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154466942|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466943|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
154466944|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154466945|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
154466946|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154466947|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154466948|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154466949|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154466950|NCT02266056|Rocuronium|rocuronium|mesh-list
154466951|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154466952|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154466953|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154466954|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466955|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466956|NCT01482390|Ribavirin|ribavirin|mesh-list
154466957|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154466958|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
154466959|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466960|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
154466961|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814774|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154466962|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
154466963|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154466964|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
154466965|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466966|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466967|NCT01366014|Oxycodone|oxycodone|mesh-list
154031169|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031170|NCT06322212|Thiamine|thiamine|mesh-list
154031171|NCT06322212|Vitamin B Complex|vitamin b complex|mesh-ancestor
154031172|NCT06322212|Vitamins|vitamins|mesh-ancestor
154031173|NCT06322212|Micronutrients|micronutrients|mesh-ancestor
154466968|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154466969|NCT01366014|Narcotics|narcotics|mesh-ancestor
154466970|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154466971|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466972|NCT01366014|Analgesics|analgesics|mesh-ancestor
154466973|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
154466974|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154466975|NCT01361802|Ambroxol|ambroxol|mesh-list
154466976|NCT01361802|Expectorants|expectorants|mesh-ancestor
154190866|NCT06094816|Furosemide|furosemide|mesh-list
154466977|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
154466978|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
154466979|NCT01235754|Testosterone|testosterone|mesh-list
154466980|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
154466981|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
154466982|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154466983|NCT01235754|Androgens|androgens|mesh-ancestor
154466984|NCT01235754|Hormones|hormones|mesh-ancestor
154466985|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154466986|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154466987|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154466988|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466989|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
154466990|NCT01234038|Paclitaxel|paclitaxel|mesh-list
154466991|NCT01234038|Carboplatin|carboplatin|mesh-list
154466992|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154466993|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154466995|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
154466996|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
154466997|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154466998|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
154466999|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154467000|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
154467001|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467002|NCT01229982|Latanoprost|latanoprost|mesh-list
154467003|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154467004|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154467005|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154467006|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
154467007|NCT01225380|Ribavirin|ribavirin|mesh-list
154467008|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
154467009|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467010|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
154467011|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467012|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
154467013|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467014|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
154467015|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154467016|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
154467017|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467018|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467019|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154467020|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
154467021|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154467022|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154467023|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154467024|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
154467025|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467026|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467027|NCT02266524|Tamsulosin|tamsulosin|mesh-list
154467028|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154467029|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154467030|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154467031|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
154467032|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467033|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467034|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467035|NCT02266524|Urological Agents|urological agents|mesh-ancestor
154467036|NCT01336686|Colchicine|colchicine|mesh-list
154467037|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
154467038|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031211|NCT06321887|Iron|iron|mesh-list
154467039|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
154467040|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031242|NCT06321354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467041|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
154467042|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467043|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467044|NCT01455090|Ribavirin|ribavirin|mesh-list
154467045|NCT01455090|Asunaprevir|asunaprevir|mesh-list
154467046|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
154031243|NCT06321354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031244|NCT06321354|Sensory System Agents|sensory system agents|mesh-ancestor
154031245|NCT06321354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031246|NCT06321354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154031247|NCT06321354|Glucocorticoids|glucocorticoids|mesh-ancestor
154031248|NCT06321354|Hormones|hormones|mesh-ancestor
154031249|NCT06321354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154467047|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467048|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
154467049|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190940|NCT06077760|Pembrolizumab|pembrolizumab|mesh-list
154467050|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
154467051|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467053|NCT02056782|Anticoagulants|anticoagulants|mesh-ancestor
154467054|NCT02056782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154467055|NCT02056782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154467056|NCT02056782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467057|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
154467058|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467059|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467060|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154467061|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154467062|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467063|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467064|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467065|NCT01194960|Docetaxel|docetaxel|mesh-list
154467066|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467067|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
154467068|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
154467070|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467071|NCT01331850|Ritonavir|ritonavir|mesh-list
154467072|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154467073|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
154467074|NCT01331850|Ribavirin|ribavirin|mesh-list
154467075|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154467076|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154467077|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
154467078|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467079|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467080|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154467081|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154467082|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
154467083|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467084|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154467085|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154467086|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
154467087|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467088|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
154467089|NCT01328808|Acetaminophen|acetaminophen|mesh-list
154467090|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154467091|NCT01328808|Analgesics|analgesics|mesh-ancestor
154467092|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
154467093|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467094|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467095|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
154467096|NCT01968590|Vitamin D|vitamin d|mesh-list
154467097|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
154467098|NCT01968590|Vitamins|vitamins|mesh-ancestor
154467099|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
154467100|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467101|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154467102|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154467103|NCT01314222|Pregabalin|pregabalin|mesh-list
154467104|NCT01314222|Analgesics|analgesics|mesh-ancestor
154467105|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
154467106|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467107|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467108|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
154467109|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154467110|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467111|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467112|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154467113|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154467114|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154467115|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467116|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154467117|NCT01309932|Interferons|interferons|mesh-list
154467118|NCT01309932|Ribavirin|ribavirin|mesh-list
154467119|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
154467120|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
154467121|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154467122|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154031313|NCT06320405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154191014|NCT06046859|Fluoxetine|fluoxetine|mesh-list
154467123|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
154467124|NCT01309932|Asunaprevir|asunaprevir|mesh-list
154467125|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467126|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
154467127|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467129|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467130|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
154467131|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467132|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467133|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154467134|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154467135|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154467136|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154467137|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154467138|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467139|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154467140|NCT01101594|Doxorubicin|doxorubicin|mesh-list
154467141|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154467142|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467143|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154467144|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154467145|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467146|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467147|NCT02269176|Losartan|losartan|mesh-list
154467148|NCT02269176|Telmisartan|telmisartan|mesh-list
154467149|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154467150|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154467151|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154467152|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154467153|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467154|NCT01094262|Oxycodone|oxycodone|mesh-list
154467155|NCT01094262|Analgesics|analgesics|mesh-list
154467156|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154467157|NCT01094262|Narcotics|narcotics|mesh-ancestor
154467158|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467159|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467160|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
154031352|NCT06320067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154467161|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467162|NCT04476186|Acyclovir|acyclovir|mesh-list
154467163|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
154467164|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467165|NCT03440216|Meropenem|meropenem|mesh-list
154467166|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
154467167|NCT03440216|Temocillin|temocillin|mesh-list
154467168|NCT03440216|Penicillins|penicillins|mesh-list
154467169|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467170|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467171|NCT03440216|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154467172|NCT03440216|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154467173|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
154467174|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154467175|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
154467176|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154467177|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467178|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154467179|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154467180|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154467181|NCT05370716|Pregabalin|pregabalin|mesh-list
154467182|NCT05370716|Analgesics|analgesics|mesh-ancestor
154467183|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
154467184|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467185|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467186|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
154467187|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154467188|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467189|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467190|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154467191|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154467192|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154467193|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467194|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154467195|NCT01038804|Docetaxel|docetaxel|mesh-list
154467196|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467197|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
154467198|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
154467199|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
154467200|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467201|NCT05118776|Bevacizumab|bevacizumab|mesh-list
154467202|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031392|NCT06319859|Morphine|morphine|mesh-list
154467203|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467204|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154467205|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154467207|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467208|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
154467209|NCT02269644|Azithromycin|azithromycin|mesh-list
154467210|NCT02269644|Linezolid|linezolid|mesh-list
154467211|NCT02269644|Dalbavancin|dalbavancin|mesh-list
154467212|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467213|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467214|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154467215|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467216|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467217|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
154467218|NCT03367988|Anesthetics|anesthetics|mesh-list
154467219|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467220|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467221|NCT03367988|Narcotics|narcotics|mesh-ancestor
154860601|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154467222|NCT03367988|Analgesics|analgesics|mesh-ancestor
154467223|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
154467224|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467225|NCT03465488|Albendazole|albendazole|mesh-list
154467226|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
154467227|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154467228|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467229|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
154467230|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154467231|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154467232|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
154467233|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
154467234|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
154467235|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467236|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467237|NCT02267304|Morphine|morphine|mesh-list
154467238|NCT02267304|Naloxone|naloxone|mesh-list
154467239|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154467240|NCT02267304|Narcotics|narcotics|mesh-ancestor
154467241|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467242|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467243|NCT02267304|Analgesics|analgesics|mesh-ancestor
154031432|NCT06319638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031433|NCT06319625|Lidocaine|lidocaine|mesh-list
154031434|NCT06319625|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031435|NCT06319625|Anesthetics|anesthetics|mesh-ancestor
154031436|NCT06319625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467244|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
154467245|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467246|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154467247|NCT03465410|Tacrolimus|tacrolimus|mesh-list
154467248|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154467249|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
154467250|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467251|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154467252|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467253|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467254|NCT02522234|Lenograstim|lenograstim|mesh-list
154467255|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154467256|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
154467257|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467258|NCT00154284|Cyclosporine|cyclosporine|mesh-list
154467259|NCT00154284|Prednisone|prednisone|mesh-list
154467260|NCT00154284|Everolimus|everolimus|mesh-list
154467261|NCT00154284|Cyclosporins|cyclosporins|mesh-list
154467262|NCT00154284|Basiliximab|basiliximab|mesh-list
154467263|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154467264|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
154467265|NCT00154284|Hormones|hormones|mesh-ancestor
154467266|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154467267|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467268|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154467269|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467270|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467271|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467272|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154467273|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
154467274|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
154467275|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467276|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
154467277|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154467278|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154467279|NCT00154284|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154467280|NCT00154284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154467281|NCT04973306|Tislelizumab|tislelizumab|mesh-list
154467282|NCT04973306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154467283|NCT04973306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467284|NCT01037166|Entecavir|entecavir|mesh-list
154467285|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
154467286|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467287|NCT04491032|Anesthetics|anesthetics|mesh-list
154467288|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467289|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467290|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154467291|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154467292|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467293|NCT04487756|Carboplatin|carboplatin|mesh-list
154467294|NCT04487756|Atezolizumab|atezolizumab|mesh-list
154467295|NCT04487756|Vaccines|vaccines|mesh-list
154467296|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
154467297|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467298|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467299|NCT04487756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154467300|NCT04487756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467301|NCT04487756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154467302|NCT01281462|Ceftaroline|ceftaroline|mesh-list
154467303|NCT01281462|Cephalosporins|cephalosporins|mesh-list
154467304|NCT01281462|Avibactam|avibactam|mesh-list
154467305|NCT01281462|Doripenem|doripenem|mesh-list
154467306|NCT01281462|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154467307|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467308|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467309|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154467310|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467311|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467312|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154467313|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467314|NCT01024062|Paclitaxel|paclitaxel|mesh-list
154467315|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154467316|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467317|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
154467318|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154467319|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
154467320|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467321|NCT04453436|Tenofovir|tenofovir|mesh-list
154467322|NCT04453436|Lamivudine|lamivudine|mesh-list
154467323|NCT04453436|Dolutegravir|dolutegravir|mesh-list
154467324|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
154467325|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467326|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154467327|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154467328|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467329|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467330|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154467331|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154467332|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154467333|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154467334|NCT02267616|Etonogestrel|etonogestrel|mesh-list
154467335|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154467336|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
154467337|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154467338|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467339|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154467340|NCT05232734|Caffeine|caffeine|mesh-list
154467341|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
154467342|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467343|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154467344|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467345|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154467346|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467347|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154467348|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154467349|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
154467350|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467351|NCT01023204|Paclitaxel|paclitaxel|mesh-list
154467352|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154467353|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467354|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
154467355|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
154467356|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
154467357|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467358|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
154467359|NCT04460456|Cemiplimab|cemiplimab|mesh-list
154467360|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154467361|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467362|NCT04460456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154467363|NCT04460456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467364|NCT02268006|Capecitabine|capecitabine|mesh-list
154467365|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154467366|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
154467367|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467368|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467369|NCT03462212|Paclitaxel|paclitaxel|mesh-list
154467370|NCT03462212|Bevacizumab|bevacizumab|mesh-list
154467371|NCT03462212|Carboplatin|carboplatin|mesh-list
154467372|NCT03462212|Rucaparib|rucaparib|mesh-list
154467373|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154467374|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467375|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
154467376|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
154467377|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
154467378|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467379|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154467380|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154467381|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154467382|NCT03462212|Growth Substances|growth substances|mesh-ancestor
154467383|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467384|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
154467385|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154467386|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467387|NCT01016808|Morphine|morphine|mesh-list
154467388|NCT01016808|Oxycodone|oxycodone|mesh-list
154467389|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154467390|NCT01016808|Narcotics|narcotics|mesh-ancestor
154467391|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467392|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467393|NCT01016808|Analgesics|analgesics|mesh-ancestor
154467394|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
154467395|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467396|NCT01014078|Azithromycin|azithromycin|mesh-list
154467397|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154467398|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154467399|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467400|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467401|NCT02522078|Misoprostol|misoprostol|mesh-list
154467402|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154467403|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
154467404|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154467405|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467406|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154467407|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154467408|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
154467409|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
154467410|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154467411|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467412|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154467413|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
154467414|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467415|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467416|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467417|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467418|NCT03468296|Aflibercept|aflibercept|mesh-list
154467419|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154467420|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154467421|NCT03468296|Growth Substances|growth substances|mesh-ancestor
154467422|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467423|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
154467424|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467425|NCT01130142|Gemcitabine|gemcitabine|mesh-list
154467426|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154467427|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
154467428|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467429|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467430|NCT03464864|Treprostinil|treprostinil|mesh-list
154467431|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154467432|NCT03468140|Eculizumab|eculizumab|mesh-list
154467433|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154467434|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154467435|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
154467436|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467437|NCT01009242|Methotrexate|methotrexate|mesh-list
154467438|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154467439|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
154467440|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154467441|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467442|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154467443|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
154467444|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467445|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467446|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
154467447|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467448|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154860602|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467450|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
154467451|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154467452|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154467453|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
154467454|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154467455|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467456|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467457|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154467458|NCT03468062|Analgesics|analgesics|mesh-ancestor
154467459|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
154467460|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467461|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154467462|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154467463|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154467464|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154467465|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467466|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467467|NCT03464552|Celecoxib|celecoxib|mesh-list
154467468|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154467469|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154467470|NCT03464552|Analgesics|analgesics|mesh-ancestor
154467471|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
154467472|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467473|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467474|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154467475|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154467476|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154467477|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154467478|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467479|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467480|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154467481|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
154467482|NCT05628558|Coagulants|coagulants|mesh-ancestor
154467483|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154467484|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
154467485|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467486|NCT01007292|Rituximab|rituximab|mesh-list
154467487|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154467488|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467489|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
154467490|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467491|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154467492|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154467493|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
154467494|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467495|NCT01005108|Gabapentin|gabapentin|mesh-list
154467496|NCT01005108|Analgesics|analgesics|mesh-ancestor
154467497|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
154467498|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031617|NCT06315972|Clemastine|clemastine|mesh-list
154467499|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467500|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
154467501|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154467502|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154467503|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467504|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154467505|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154467506|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154467507|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467508|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467509|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
154467510|NCT00905346|Topiramate|topiramate|mesh-list
154467511|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
154467512|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154467513|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467514|NCT00902928|Enoxaparin|enoxaparin|mesh-list
154467515|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
154467516|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154467517|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154467518|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467519|NCT01129674|Olanzapine|olanzapine|mesh-list
154467520|NCT01129674|Risperidone|risperidone|mesh-list
154467521|NCT01129674|Aripiprazole|aripiprazole|mesh-list
154467522|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154467523|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154467524|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
154467525|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467526|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467527|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467528|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154467529|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154467530|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467531|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154467532|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154467533|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
154467535|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
154467536|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467537|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154467538|NCT01129674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154467539|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154467540|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467541|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
154467542|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
154031682|NCT06281756|Antidepressive Agents|antidepressive agents|mesh-ancestor
154467543|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154467544|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154467545|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154467546|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154467547|NCT05045378|Midazolam|midazolam|mesh-list
154467548|NCT05045378|Ketamine|ketamine|mesh-list
154467549|NCT05045378|Analgesics|analgesics|mesh-ancestor
154467550|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
154467551|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467552|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467553|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154467554|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154467555|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
154467556|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
154467557|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467558|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154467559|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154467560|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467561|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467562|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154467563|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154467564|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154467565|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154467566|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154467567|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
154467568|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
154467569|NCT03460964|Pilocarpine|pilocarpine|mesh-list
154467570|NCT03460964|Miotics|miotics|mesh-ancestor
154467571|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
154467572|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467573|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467574|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154467575|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154467576|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
154467577|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467578|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467579|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
154467580|NCT03460808|Atorvastatin|atorvastatin|mesh-list
154467581|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154467582|NCT03460808|Danazol|danazol|mesh-list
154467583|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154467584|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154467585|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
154467586|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467587|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154467588|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154467589|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467590|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
154467591|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467592|NCT03460808|Expectorants|expectorants|mesh-ancestor
154467593|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
154467594|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154467595|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
154254897|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
154860603|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467596|NCT03460808|Protective Agents|protective agents|mesh-ancestor
154467597|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467599|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154467600|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
154467601|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154467602|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154467603|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154467604|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
154467605|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467606|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467607|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154467608|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
154467609|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
154467610|NCT04946630|Hormones|hormones|mesh-ancestor
154467611|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154467612|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
154467613|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154467614|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154467615|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
154467616|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467617|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154467618|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
154467619|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467620|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154467621|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154467622|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467623|NCT01120470|Prednisone|prednisone|mesh-list
154467624|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154467625|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
154467626|NCT01120470|Hormones|hormones|mesh-ancestor
154467627|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154467628|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467629|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154467630|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467631|NCT01117584|Metformin|metformin|mesh-list
154467632|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
154467633|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154467634|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467635|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154467636|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467637|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
154467638|NCT03135054|Quizartinib|quizartinib|mesh-list
154467639|NCT03135054|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154467640|NCT03135054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154467641|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467642|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467643|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154467644|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467645|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154191533|NCT05742607|Carboplatin|carboplatin|mesh-list
154191534|NCT05742607|Pemetrexed|pemetrexed|mesh-list
154191535|NCT05742607|Durvalumab|durvalumab|mesh-list
154031787|NCT06217757|Etoposide|etoposide|mesh-list
154191536|NCT05742607|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154191537|NCT05742607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154191538|NCT05742607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191539|NCT05742607|Tubulin Modulators|tubulin modulators|mesh-ancestor
154191540|NCT05742607|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191557|NCT05712278|Cytarabine|cytarabine|mesh-list
154467646|NCT00991068|Lidocaine|lidocaine|mesh-list
154467647|NCT00991068|Tetracaine|tetracaine|mesh-list
154467648|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
154467649|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
154467650|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467651|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467652|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
154467653|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467654|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154467655|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154467656|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154467657|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467658|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860604|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154467659|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154467660|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154467661|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154467662|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467663|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467664|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467665|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467666|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154467667|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
154467668|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154467669|NCT01114308|Buprenorphine|buprenorphine|mesh-list
154467670|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154467671|NCT01114308|Narcotics|narcotics|mesh-ancestor
154467672|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467673|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467674|NCT01114308|Analgesics|analgesics|mesh-ancestor
154467675|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
154467676|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467677|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154467678|NCT05469126|Clarithromycin|clarithromycin|mesh-list
154467679|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467680|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031875|NCT06175000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031876|NCT06154252|Cyclophosphamide|cyclophosphamide|mesh-list
154031877|NCT06154252|Fludarabine|fludarabine|mesh-list
154031879|NCT06154252|Immunologic Factors|immunologic factors|mesh-ancestor
154467681|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154467682|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467683|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467684|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154467685|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154467686|NCT00887250|Losartan|losartan|mesh-list
154467687|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154467688|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154467689|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154467690|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154467691|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467692|NCT00990912|Carboplatin|carboplatin|mesh-list
154467693|NCT00990912|Irinotecan|irinotecan|mesh-list
154467694|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467695|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154467696|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154467697|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467698|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467699|NCT00973284|Mannitol|mannitol|mesh-list
154467700|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154467701|NCT00973284|Diuretics|diuretics|mesh-ancestor
154467702|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
154467703|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467704|NCT02599402|Nivolumab|nivolumab|mesh-list
154467705|NCT02599402|Ipilimumab|ipilimumab|mesh-list
154467706|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154467707|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467708|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154467709|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467710|NCT00879762|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154467711|NCT00879762|Antiviral Agents|antiviral agents|mesh-ancestor
154467712|NCT00879762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467713|NCT04768166|Miglustat|miglustat|mesh-list
154467714|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467715|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467716|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154191610|NCT05691010|Paclitaxel|paclitaxel|mesh-list
154467717|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154467718|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
154467719|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467720|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154467721|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154467722|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467723|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
154467724|NCT04822090|Antibodies|antibodies|mesh-list
154467725|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
154467726|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154467727|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154467728|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
154467729|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860605|NCT01057381|Analgesics|analgesics|mesh-ancestor
154467730|NCT03463382|Bupivacaine|bupivacaine|mesh-list
154467731|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
154467732|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
154467733|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467734|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467735|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
154467736|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467737|NCT00872430|Laxatives|laxatives|mesh-list
154467738|NCT00872430|Cathartics|cathartics|mesh-list
154467739|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154467740|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
154467741|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154467742|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
154467743|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467744|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467745|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154467746|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
154467747|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
154467748|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154467749|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
154467750|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467751|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467752|NCT04814056|Afatinib|afatinib|mesh-list
154467753|NCT04814056|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154467754|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154467755|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467756|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467757|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814776|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154467758|NCT05627154|Citalopram|citalopram|mesh-list
154467759|NCT05627154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154467760|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154467761|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467762|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467763|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467764|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
154467765|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467766|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154467767|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
154467768|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154467769|NCT00957918|Nicotine|nicotine|mesh-list
154467770|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154467771|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
154467772|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467773|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467774|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154467775|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154467776|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
154467777|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467778|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467779|NCT02734862|Fluconazole|fluconazole|mesh-list
154467780|NCT02734862|Caspofungin|caspofungin|mesh-list
154467781|NCT02734862|Rezafungin|rezafungin|mesh-list
154467782|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
154467783|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467784|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154467785|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154467786|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467787|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467788|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154467789|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
154467790|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154467791|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467792|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154467793|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154467794|NCT00818844|Nepafenac|nepafenac|mesh-list
154467795|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154467796|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154467797|NCT00818844|Analgesics|analgesics|mesh-ancestor
154467798|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
154031993|NCT06030089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031994|NCT06030089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031995|NCT06021145|Empagliflozin|empagliflozin|mesh-list
154467799|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467800|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467801|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154467802|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154467803|NCT00862524|Gemcitabine|gemcitabine|mesh-list
154467804|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154467805|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
154467806|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467807|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467808|NCT00858702|Olmesartan|olmesartan|mesh-list
154467809|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154467810|NCT00858702|Diuretics|diuretics|mesh-list
154467811|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154467812|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154467813|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154467814|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467815|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
154467816|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467817|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
154467818|NCT00817986|Baclofen|baclofen|mesh-list
154467819|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154467820|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467821|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154467822|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467823|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154467824|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
154467825|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
154467826|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467827|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467828|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
154467829|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154467830|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467831|NCT00817362|Trastuzumab|trastuzumab|mesh-list
154467832|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031998|NCT06021145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154467833|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467834|NCT04176848|Durvalumab|durvalumab|mesh-list
154467835|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154467836|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467837|NCT04163978|Budesonide|budesonide|mesh-list
154467838|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
153814777|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032029|NCT06005610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154032030|NCT06005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032031|NCT06002477|Mecamylamine|mecamylamine|mesh-list
154032033|NCT06002477|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154467839|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154467840|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154467841|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
154467842|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467843|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467844|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154467845|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
154467846|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
154467847|NCT04163978|Hormones|hormones|mesh-ancestor
154467848|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154467849|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154467850|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
154467851|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467852|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467853|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154467854|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
154467855|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
154467856|NCT04163978|Protective Agents|protective agents|mesh-ancestor
154467857|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
154467858|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
154467859|NCT02598622|Vitamins|vitamins|mesh-ancestor
154467860|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
154467861|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467862|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
154467863|NCT03463070|Misoprostol|misoprostol|mesh-list
154467864|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154467865|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
154467866|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154467867|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467868|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154467869|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154467870|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
154467871|NCT00807612|Paclitaxel|paclitaxel|mesh-list
154467872|NCT00807612|Carboplatin|carboplatin|mesh-list
154467873|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154467874|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154467875|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467876|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
154860606|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
154467877|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
154467878|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
154467879|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467880|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
154467881|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467883|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154467884|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154467885|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467886|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154467887|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154467888|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
154467889|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467890|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467891|NCT03462836|Lidocaine|lidocaine|mesh-list
154467892|NCT03462836|Ketamine|ketamine|mesh-list
154467893|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
154467894|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
154467895|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154467896|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467897|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
154467898|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467899|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154467900|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154467901|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154467902|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467903|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467904|NCT03462836|Analgesics|analgesics|mesh-ancestor
154467905|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154467906|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154467907|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
154467908|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154032071|NCT05892341|Laxatives|laxatives|mesh-ancestor
154467909|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154467910|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467911|NCT00849576|Insulin|insulin|mesh-list
154467912|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154032100|NCT05884528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154032101|NCT05884528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032102|NCT05844501|Ondansetron|ondansetron|mesh-list
154467913|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
154467914|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154467915|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467916|NCT00841698|Paroxetine|paroxetine|mesh-list
154467917|NCT00841698|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154467918|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154467919|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467920|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467921|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467922|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
154467923|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467924|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154467925|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
154467926|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154467927|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154467928|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154467929|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467930|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
154467931|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154467932|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
154467933|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467934|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467935|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154467936|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
154467937|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154467938|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
154191830|NCT05468320|Hormones|hormones|mesh-ancestor
154467939|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467940|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467941|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154467942|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
154467943|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
154467944|NCT04383002|Protective Agents|protective agents|mesh-ancestor
154467945|NCT00841542|Amlodipine|amlodipine|mesh-list
154467946|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154467947|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154467948|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467949|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467950|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154032135|NCT05813912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032136|NCT05813912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032137|NCT05813912|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154467951|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467952|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
154467953|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
154467954|NCT03623750|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154467955|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154467956|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
154467957|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467958|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154467959|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154467960|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
154467961|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467962|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154467963|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154467964|NCT03623750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154467965|NCT03623750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467966|NCT00840840|Amoxicillin|amoxicillin|mesh-list
154467967|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
154467968|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
154467969|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154467970|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467971|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154467972|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154467973|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154467974|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467975|NCT03595982|Nifedipine|nifedipine|mesh-list
154467976|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154467977|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154467978|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154467979|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154467980|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467981|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
154467982|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
154467983|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154467984|NCT00944970|Adenosine|adenosine|mesh-list
154467985|NCT00944970|Binodenoson|binodenoson|mesh-list
154467986|NCT00944970|Analgesics|analgesics|mesh-ancestor
154467987|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
154467988|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154467989|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154467990|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154467991|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
154467992|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154467993|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
154467994|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
154467995|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154467996|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032170|NCT05722886|Trastuzumab|trastuzumab|mesh-list
154467997|NCT00840216|Clarithromycin|clarithromycin|mesh-list
154032171|NCT05722886|Atezolizumab|atezolizumab|mesh-list
154032172|NCT05722886|Pertuzumab|pertuzumab|mesh-list
154032173|NCT05722886|Vemurafenib|vemurafenib|mesh-list
154032174|NCT05722886|Alectinib|alectinib|mesh-list
154032175|NCT05722886|Entrectinib|entrectinib|mesh-list
154032176|NCT05722886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032177|NCT05722886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032178|NCT05722886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032179|NCT05722886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032180|NCT05722886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154032181|NCT05722886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032182|NCT05722886|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154032183|NCT05722418|Cyclophosphamide|cyclophosphamide|mesh-list
154032184|NCT05722418|Fludarabine|fludarabine|mesh-list
154032185|NCT05722418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154467998|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154467999|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468000|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154468001|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468002|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468003|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154468004|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154468005|NCT03462446|Vitamin K|vitamin k|mesh-list
154468006|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
154468007|NCT03462446|Vitamins|vitamins|mesh-ancestor
154468008|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
154468009|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468010|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154468011|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
154468012|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154468013|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
153458171|NCT03023358|Hormones|hormones|mesh-ancestor
154468014|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468015|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468016|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
154468017|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154468018|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154468019|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
154468020|NCT03462446|Coagulants|coagulants|mesh-ancestor
154468021|NCT00944892|Fasinumab|fasinumab|mesh-list
153814778|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153814779|NCT00343187|Dapsone|dapsone|mesh-list
154468022|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468023|NCT00944892|Analgesics|analgesics|mesh-ancestor
154468024|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
154468025|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468026|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468027|NCT00939276|Nepafenac|nepafenac|mesh-list
153814780|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032186|NCT05722418|Immunologic Factors|immunologic factors|mesh-ancestor
154032187|NCT05722418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032188|NCT05722418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032189|NCT05722418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154032190|NCT05722418|Alkylating Agents|alkylating agents|mesh-ancestor
154032191|NCT05722418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032192|NCT05722418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468028|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154468029|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468030|NCT00939276|Analgesics|analgesics|mesh-ancestor
154468031|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
154468032|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468033|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468034|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468035|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468036|NCT03455426|Letrozole|letrozole|mesh-list
154468037|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468038|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154468039|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154468040|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468041|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468042|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154468043|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
154468044|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468045|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468046|NCT00791154|Carboplatin|carboplatin|mesh-list
154468047|NCT00791154|Etoposide|etoposide|mesh-list
154468048|NCT00791154|Rilotumumab|rilotumumab|mesh-list
154468049|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468050|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154468051|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154468052|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154468053|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468054|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468055|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154468056|NCT00938652|Carboplatin|carboplatin|mesh-list
154468057|NCT00938652|Gemcitabine|gemcitabine|mesh-list
154468058|NCT00938652|Iniparib|iniparib|mesh-list
154468059|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468060|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154468061|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
154468062|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032220|NCT05711628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032221|NCT05711628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154032222|NCT05711628|Antimetabolites|antimetabolites|mesh-ancestor
154032223|NCT05711628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468063|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154468064|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468065|NCT00928590|Timolol|timolol|mesh-list
154468066|NCT00928590|Travoprost|travoprost|mesh-list
154468067|NCT00928590|Cloprostenol|cloprostenol|mesh-list
154468068|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468069|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154468070|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154468071|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468072|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468073|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468074|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154468075|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154468076|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
154468077|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154468078|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
154468079|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154468080|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154468081|NCT03512756|Sirolimus|sirolimus|mesh-list
154468082|NCT03512756|Gemcitabine|gemcitabine|mesh-list
154468083|NCT03512756|Capecitabine|capecitabine|mesh-list
154468084|NCT03512756|Phenytoin|phenytoin|mesh-list
154468085|NCT03512756|Methoxsalen|methoxsalen|mesh-list
154468086|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191979|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
154468087|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
154468088|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468089|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468090|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468091|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468092|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154468093|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
154468094|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154468095|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
154468096|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468098|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154468099|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154468100|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814781|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
154468101|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154468102|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154468103|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154468104|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
154468105|NCT00836706|Clarithromycin|clarithromycin|mesh-list
154468106|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468107|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468108|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154468109|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468110|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468111|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154468112|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154468113|NCT00836472|Metformin|metformin|mesh-list
154468114|NCT00836472|Glyburide|glyburide|mesh-list
154468115|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154468116|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468117|NCT04473846|Anesthetics|anesthetics|mesh-list
154468118|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468119|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468120|NCT03129698|Apatinib|apatinib|mesh-list
154468121|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468122|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154468123|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468124|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468125|NCT03355118|Anesthetics|anesthetics|mesh-list
154468126|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468127|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468128|NCT03263078|Propofol|propofol|mesh-list
154468129|NCT03263078|Sevoflurane|sevoflurane|mesh-list
154468130|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154468131|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468132|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468133|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154468134|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
154468135|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
154468136|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154468137|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154032259|NCT05672342|Analgesics|analgesics|mesh-ancestor
154468138|NCT05349006|Azathioprine|azathioprine|mesh-list
154468139|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
154468140|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468141|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154468142|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468143|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154468144|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
154468145|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468146|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468147|NCT00785226|Sorafenib|sorafenib|mesh-list
154468148|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468149|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154468150|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468151|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468152|NCT02598388|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154468153|NCT02598388|Antiviral Agents|antiviral agents|mesh-ancestor
154468154|NCT02598388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468155|NCT03448640|Tropicamide|tropicamide|mesh-list
154468156|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
154468157|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
154468158|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468159|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468160|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154468161|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154468162|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
154468163|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468164|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468165|NCT00836004|Clindamycin|clindamycin|mesh-list
154468166|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
154468167|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
154468168|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468169|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468170|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154468171|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468172|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468173|NCT00917826|Valganciclovir|valganciclovir|mesh-list
154468174|NCT00917826|Ganciclovir|ganciclovir|mesh-list
154468175|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154468176|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
154468177|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
154468178|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468179|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154032298|NCT05644496|Analgesics|analgesics|mesh-ancestor
154468180|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468181|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468182|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468183|NCT03102320|Gemcitabine|gemcitabine|mesh-list
154468184|NCT03102320|Maytansine|maytansine|mesh-list
154468185|NCT03102320|Anetumab ravtansine|anetumab ravtansine|mesh-list
154468186|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468187|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154468188|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
153814783|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154468189|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468190|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032333|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
154032334|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032335|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032336|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
154032337|NCT05553366|Acetaminophen|acetaminophen|mesh-list
154032338|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154032339|NCT05553366|Analgesics|analgesics|mesh-ancestor
154032340|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
154468191|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
154468192|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
154468193|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
154468194|NCT03102320|Immunoconjugates|immunoconjugates|mesh-ancestor
154468195|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
154468196|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468197|NCT00835692|Clarithromycin|clarithromycin|mesh-list
154468198|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468199|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468200|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154468201|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468202|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468203|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154468204|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154468205|NCT00835614|Cefprozil|cefprozil|mesh-list
154468206|NCT00835614|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154468207|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468208|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468209|NCT00835536|Ribavirin|ribavirin|mesh-list
154468210|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
154468211|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468212|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
154468213|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468214|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154468215|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
154468216|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154468217|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
154468218|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154468219|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468220|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154468221|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154468222|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468223|NCT04037072|Mitomycins|mitomycins|mesh-list
154468224|NCT04037072|Mitomycin|mitomycin|mesh-list
154468225|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154468226|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468227|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
154468228|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468229|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154192131|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192132|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192133|NCT05255991|Treprostinil|treprostinil|mesh-list
154192134|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154468230|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468231|NCT04819438|Riluzole|riluzole|mesh-list
154468232|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
154468233|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154468234|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154468235|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468236|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468237|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468238|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154860607|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468240|NCT04819828|Diclofenac|diclofenac|mesh-list
154468241|NCT04819828|Tamsulosin|tamsulosin|mesh-list
154468242|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154468243|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468244|NCT04819828|Analgesics|analgesics|mesh-ancestor
154468245|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
154468246|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468247|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468248|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468249|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468250|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154468251|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468252|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468253|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154468254|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154468255|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154468256|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468257|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468258|NCT04819828|Urological Agents|urological agents|mesh-ancestor
154468259|NCT02602288|Nicotine|nicotine|mesh-list
154468260|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154468261|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
154468262|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468263|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468264|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154468265|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154468266|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
154468267|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468268|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468269|NCT03745352|Azacitidine|azacitidine|mesh-list
154468270|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154468271|NCT03745352|Pevonedistat|pevonedistat|mesh-list
154468272|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154468273|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
154468274|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468275|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468276|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154468277|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154468278|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468279|NCT05617690|Propofol|propofol|mesh-list
154468280|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154468281|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468282|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468283|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154468284|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
154468285|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
154468286|NCT03448094|Resveratrol|resveratrol|mesh-list
154468287|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
154468288|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468289|NCT03448094|Protective Agents|protective agents|mesh-ancestor
154468290|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468291|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468292|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154468293|NCT04819204|Cetrorelix|cetrorelix|mesh-list
154468294|NCT04819204|Testosterone|testosterone|mesh-list
154468295|NCT04819204|Androgens|androgens|mesh-ancestor
154468296|NCT04819204|Hormones|hormones|mesh-ancestor
154468297|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468298|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468299|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154468300|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
154468301|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154468302|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
154468303|NCT02807454|Dexamethasone|dexamethasone|mesh-list
154468304|NCT02807454|Durvalumab|durvalumab|mesh-list
154468305|NCT02807454|Daratumumab|daratumumab|mesh-list
154468307|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468308|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
154468309|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
154468310|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468311|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468312|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154468313|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
154468314|NCT02807454|Hormones|hormones|mesh-ancestor
154096465|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468315|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468316|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154468317|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468318|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154468320|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154468321|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154468322|NCT02807454|Growth Substances|growth substances|mesh-ancestor
154468323|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
154468324|NCT03718286|Alirocumab|alirocumab|mesh-list
154468325|NCT03718286|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154468326|NCT03718286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154468327|NCT03718286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154468328|NCT03718286|Antimetabolites|antimetabolites|mesh-ancestor
154468329|NCT03718286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468330|NCT03718286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154468331|NCT03718286|Protease Inhibitors|protease inhibitors|mesh-ancestor
154468332|NCT03718286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468333|NCT03718286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154468334|NCT05320874|Antibodies|antibodies|mesh-list
154468335|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154468336|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
154468337|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468338|NCT05320640|Decitabine|decitabine|mesh-list
154468339|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154468340|NCT05320640|Antibodies|antibodies|mesh-list
154468341|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
154468342|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468343|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153814785|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468344|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
154468345|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468346|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468347|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468348|NCT05320640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154468349|NCT00835146|Ribavirin|ribavirin|mesh-list
154468350|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
154468351|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468352|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
154468353|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032492|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154032493|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032494|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154032495|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154032496|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154032497|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032498|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032499|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
154032500|NCT05201248|Hormones|hormones|mesh-ancestor
154032504|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
154468354|NCT04818736|Vaccines|vaccines|mesh-list
154468355|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
154468356|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468357|NCT04811326|Latanoprost|latanoprost|mesh-list
154468358|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154468359|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154468360|NCT00834990|Valproic Acid|valproic acid|mesh-list
154468361|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
154468362|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468363|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468364|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
154468365|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468366|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468367|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
154468368|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154468369|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468370|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154468371|NCT04479072|Aspirin|aspirin|mesh-list
154468372|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154468373|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468374|NCT04479072|Analgesics|analgesics|mesh-ancestor
154468375|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
154468376|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468377|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468378|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468379|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468380|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154468381|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154468382|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468383|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154468384|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154468386|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
154468387|NCT03036202|Epinephrine|epinephrine|mesh-list
154468388|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154468389|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154468390|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468391|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468392|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468393|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468394|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154468395|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154468396|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
154468397|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468398|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154468399|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
154468400|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
154468401|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
154468402|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154468403|NCT03245918|Aprepitant|aprepitant|mesh-list
154468404|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
154468405|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
154468406|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
154468407|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468408|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468409|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154468410|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154468411|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468412|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468413|NCT00834756|Azithromycin|azithromycin|mesh-list
154468414|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468415|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468416|NCT00828854|Entinostat|entinostat|mesh-list
154468417|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154468418|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154468419|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468420|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468421|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154468422|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
154468423|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468424|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468425|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468426|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154468427|NCT00834522|Granisetron|granisetron|mesh-list
154468428|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
154468429|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
154468430|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468431|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468432|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154468433|NCT00834522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154468434|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154468435|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
154468436|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468437|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468438|NCT00834444|Famciclovir|famciclovir|mesh-list
154468439|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
154468440|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468441|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154468442|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468443|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468444|NCT05174858|Hemostatics|hemostatics|mesh-list
154468445|NCT05174858|Coagulants|coagulants|mesh-ancestor
154468446|NCT00834132|Azithromycin|azithromycin|mesh-list
154468447|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468448|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468449|NCT00833586|Terbinafine|terbinafine|mesh-list
154468450|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
154468451|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468452|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468453|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468454|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154468455|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
154468456|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468457|NCT03447470|Nivolumab|nivolumab|mesh-list
154468458|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154468459|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468460|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154468461|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468462|NCT00765804|Dexamethasone|dexamethasone|mesh-list
154468463|NCT00765804|Citric Acid|citric acid|mesh-list
154468464|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
154468465|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154468466|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154468467|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154468468|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468469|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
154468470|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
154468471|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468472|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468473|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154468474|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
154468475|NCT00765804|Hormones|hormones|mesh-ancestor
154468476|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468477|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154468478|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468479|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468480|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
154468481|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154468482|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
154468483|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
154468484|NCT00764634|Vaccines|vaccines|mesh-list
154468485|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
154468486|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468487|NCT03443726|Epinephrine|epinephrine|mesh-list
154468488|NCT03443726|Carticaine|carticaine|mesh-list
154468489|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154468490|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154468491|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468492|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468493|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730815|NCT00135434|Ritonavir|ritonavir|mesh-list
154468494|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468495|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154468496|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154468497|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
154468498|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468499|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154468500|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
154468501|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
154468502|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
154468503|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154468504|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
154468505|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
154468506|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468507|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
154468508|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154468509|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154468510|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468511|NCT00760344|Incretins|incretins|mesh-ancestor
154468512|NCT00760344|Hormones|hormones|mesh-ancestor
154468513|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468514|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154468515|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
154468516|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468517|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468518|NCT03443570|Rituximab|rituximab|mesh-list
154468519|NCT03443570|Bortezomib|bortezomib|mesh-list
154468520|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154468521|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468522|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
154468523|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468524|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468525|NCT02718404|Analgesics|analgesics|mesh-list
154468526|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
154468527|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468528|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468529|NCT03443492|Leucovorin|leucovorin|mesh-list
154468530|NCT03443492|Gemcitabine|gemcitabine|mesh-list
154468531|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
154468532|NCT03443492|Irinotecan|irinotecan|mesh-list
154468534|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154468535|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
154468536|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468537|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468538|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154468539|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154468540|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468541|NCT03443492|Antidotes|antidotes|mesh-ancestor
154468542|NCT03443492|Protective Agents|protective agents|mesh-ancestor
154468543|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468544|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
154468545|NCT03443492|Vitamins|vitamins|mesh-ancestor
154468546|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
154468547|NCT00724698|Desloratadine|desloratadine|mesh-list
154468548|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154468549|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
154468550|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468551|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468552|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468553|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154468554|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154468555|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
154468556|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
154468557|NCT00722592|Doxorubicin|doxorubicin|mesh-list
154468558|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154468559|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154468560|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468561|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154468562|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154468563|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468564|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468565|NCT00829998|Zaleplon|zaleplon|mesh-list
154468566|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
154468567|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154468568|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468569|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468570|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
154468571|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
154468572|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468573|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468574|NCT00722358|Asunaprevir|asunaprevir|mesh-list
154468575|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
154468576|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468577|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468578|NCT00719550|Capecitabine|capecitabine|mesh-list
154032745|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468579|NCT00719550|Epirubicin|epirubicin|mesh-list
154468580|NCT00719550|Rilotumumab|rilotumumab|mesh-list
154468581|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468582|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154468583|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
154468584|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032746|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154032747|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032748|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
154468585|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154468586|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154468587|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154468588|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468589|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154468590|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
154468591|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154468592|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
154468593|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468594|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468595|NCT05016518|Propofol|propofol|mesh-list
154468596|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154468597|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468598|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468599|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154468600|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
154468601|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
154468602|NCT03446534|Amoxicillin|amoxicillin|mesh-list
154468603|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468604|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468605|NCT00829764|Doxycycline|doxycycline|mesh-list
154468606|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468607|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468609|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154468610|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154468611|NCT00718224|Enoxaparin|enoxaparin|mesh-list
154468612|NCT00718224|Semuloparin|semuloparin|mesh-list
154468613|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
154468614|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154468615|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154468616|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468617|NCT03129542|Midodrine|midodrine|mesh-list
154468618|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
154860608|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154860609|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154468619|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
154468620|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468621|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468622|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154468623|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154468624|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154468625|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154468626|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468627|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468628|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468629|NCT03129074|Capecitabine|capecitabine|mesh-list
154032780|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154032781|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154032782|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
154032783|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032785|NCT04809974|Vitamins|vitamins|mesh-ancestor
154032786|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
154032787|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032788|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
154032789|NCT04785820|Nivolumab|nivolumab|mesh-list
154032791|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468630|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154468631|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
154468632|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468633|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468634|NCT03449654|Liraglutide|liraglutide|mesh-list
154468635|NCT03449654|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154468636|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154468637|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468638|NCT03449654|Incretins|incretins|mesh-ancestor
154468639|NCT03449654|Hormones|hormones|mesh-ancestor
154468640|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468641|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
154468642|NCT03388008|Prednisone|prednisone|mesh-list
154468643|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
154468644|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154468645|NCT03388008|Abatacept|abatacept|mesh-list
154468646|NCT03388008|Tacrolimus|tacrolimus|mesh-list
154468647|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
154468648|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468649|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
154468650|NCT03388008|Hormones|hormones|mesh-ancestor
154468651|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468652|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468653|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154468654|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468655|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154468656|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
154468657|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154468658|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468659|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468660|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153814788|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468661|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154468662|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
154468663|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468664|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468665|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
154468666|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
154468667|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468668|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154468669|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154468670|NCT03388008|Protective Agents|protective agents|mesh-ancestor
154468671|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154468672|NCT03388008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154468673|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468674|NCT00710580|Etanercept|etanercept|mesh-list
154468675|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154468676|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468677|NCT00710580|Analgesics|analgesics|mesh-ancestor
154468678|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
154468679|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468680|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468681|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468682|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468683|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154468684|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154468685|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
154468686|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154468687|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154468688|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468689|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154468690|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
154860610|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154468691|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154468692|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154468694|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154468695|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
154468696|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468697|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468698|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154468699|NCT01377194|Milnacipran|milnacipran|mesh-list
154468700|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
154468701|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154468702|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154468703|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154468704|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468705|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468706|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468707|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
154468708|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154468709|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468710|NCT01377194|Analgesics|analgesics|mesh-ancestor
154468711|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
154468712|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468713|NCT00829452|Ramipril|ramipril|mesh-list
154468714|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154468715|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
154468716|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468717|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468718|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153814789|NCT00343226|Basiliximab|basiliximab|mesh-list
154032870|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154468719|NCT00747318|Fluticasone|fluticasone|mesh-list
154468720|NCT00747318|Xhance|xhance|mesh-list
154468721|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
154468722|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468723|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154468724|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
154468725|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468726|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468727|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154468728|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
154468729|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
154468730|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154468731|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154468732|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154468733|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154468734|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468735|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468736|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468737|NCT00744276|Danazol|danazol|mesh-list
154468738|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154468739|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
154468740|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468741|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468742|NCT03438344|Vaccines|vaccines|mesh-list
154468743|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
154468744|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468745|NCT04640402|Vaccines|vaccines|mesh-list
154468746|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
154468747|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468748|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154468749|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154468750|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468751|NCT00646542|Vildagliptin|vildagliptin|mesh-list
154468752|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154468753|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468754|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154468755|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
154192656|NCT04793100|Aflibercept|aflibercept|mesh-list
154468756|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468757|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468759|NCT02063139|Beclomethasone|beclomethasone|mesh-list
154468760|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468761|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154468762|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
154468763|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096934|NCT00653523|Ezetimibe|ezetimibe|mesh-list
154468764|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468765|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154468766|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
154032911|NCT04243785|Antimetabolites|antimetabolites|mesh-ancestor
154032912|NCT04243785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032913|NCT04243785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032914|NCT04243785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032915|NCT04227431|Insulin|insulin|mesh-list
154032916|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032917|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032918|NCT04195945|Cytarabine|cytarabine|mesh-list
154468767|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
154468768|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154468769|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
154468770|NCT02063139|Hormones|hormones|mesh-ancestor
154468771|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468772|NCT00690456|Metformin|metformin|mesh-list
154468773|NCT00690456|Rimonabant|rimonabant|mesh-list
154468774|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154468775|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468776|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154468777|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154468778|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154468779|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468780|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468781|NCT00690456|Hormones|hormones|mesh-ancestor
154468782|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468783|NCT01370499|Serotonin|serotonin|mesh-list
154468784|NCT01370499|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154468785|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154468786|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
154468787|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468788|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468789|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468790|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154468791|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154468792|NCT03445286|Fluorides|fluorides|mesh-list
154468793|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
154468794|NCT03445286|Protective Agents|protective agents|mesh-ancestor
154468795|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468796|NCT00626106|Fulvestrant|fulvestrant|mesh-list
154468797|NCT00626106|Exemestane|exemestane|mesh-list
154468798|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154468799|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154468800|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468801|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154468802|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153814790|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814791|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
154468803|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
154468804|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154468805|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468806|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154468807|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154468808|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468809|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468810|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
154468811|NCT02064465|Lamotrigine|lamotrigine|mesh-list
154468812|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
154468813|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154468814|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154468815|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468816|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154468817|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468818|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154468819|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154468820|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468821|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154468822|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154468823|NCT04530656|Vaccines|vaccines|mesh-list
154468824|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
154468825|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468826|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
154468827|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468828|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
154468829|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468830|NCT01370265|Adenosine|adenosine|mesh-list
154468831|NCT01370265|Regadenoson|regadenoson|mesh-list
154468832|NCT01370265|Analgesics|analgesics|mesh-ancestor
154468833|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
154468834|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468835|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468836|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154468837|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
154468838|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154468839|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
154468840|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
154468841|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468842|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468843|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154468844|NCT00734292|Fluticasone|fluticasone|mesh-list
154468845|NCT00734292|Xhance|xhance|mesh-list
154468846|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
154468847|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468848|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154468849|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
154468850|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468851|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468852|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154468853|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
154468854|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
154468855|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154468856|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154468857|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154468858|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154468859|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468860|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468861|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468862|NCT00687882|Anticoagulants|anticoagulants|mesh-list
154468863|NCT02064621|Amlodipine|amlodipine|mesh-list
154468864|NCT02064621|Candesartan|candesartan|mesh-list
154468865|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
154468866|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154468867|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154468868|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154468869|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468870|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154468871|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468872|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
154468873|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154468874|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154468875|NCT00684918|Obatoclax|obatoclax|mesh-list
154468876|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468877|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468878|NCT00726336|Tenofovir|tenofovir|mesh-list
154468879|NCT00726336|Dolutegravir|dolutegravir|mesh-list
154468880|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
154468881|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468882|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154468883|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154468884|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468885|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814792|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468886|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154468887|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154468888|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154468889|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154468890|NCT02280720|Tryptophan|tryptophan|mesh-list
154468891|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154468892|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
154468893|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154468894|NCT02068131|Capecitabine|capecitabine|mesh-list
154468895|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154468896|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
154468897|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468898|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154468899|NCT02068209|Tramadol|tramadol|mesh-list
154468900|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154468901|NCT02068209|Narcotics|narcotics|mesh-ancestor
154468902|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468903|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468904|NCT02068209|Analgesics|analgesics|mesh-ancestor
154468905|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
154468906|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468907|NCT00680784|Ketoprofen|ketoprofen|mesh-list
154468908|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154468909|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468910|NCT00680784|Analgesics|analgesics|mesh-ancestor
154468911|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
154860611|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468912|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468913|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468914|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468916|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154468917|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468918|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468919|NCT02068287|Esmolol|esmolol|mesh-list
154468920|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154468921|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154468922|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154468923|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
154468924|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468925|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468926|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468927|NCT02280876|Andrographolide|andrographolide|mesh-list
154468928|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468929|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154468930|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468931|NCT02280876|Analgesics|analgesics|mesh-ancestor
154468932|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
154468933|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468934|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468935|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468936|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154468937|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154468938|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154468939|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
154468940|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154468941|NCT00680472|Ketoprofen|ketoprofen|mesh-list
154468942|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154468943|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468944|NCT00680472|Analgesics|analgesics|mesh-ancestor
154468945|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
154468946|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468947|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468948|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468949|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468950|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154468951|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154468952|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468953|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154468954|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
154468955|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154468956|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154468957|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154468958|NCT03444506|Analgesics|analgesics|mesh-ancestor
154468959|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
154468960|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468961|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468962|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154468963|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154468964|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154468965|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154468966|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154468967|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
154468968|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
154468969|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154468970|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468971|NCT02065947|Lidocaine|lidocaine|mesh-list
154468972|NCT02065947|Epinephrine|epinephrine|mesh-list
154468973|NCT02065947|Racepinephrine|racepinephrine|mesh-list
153814794|NCT00343265|Progestins|progestins|mesh-ancestor
154468974|NCT02065947|Midazolam|midazolam|mesh-list
154468975|NCT02065947|Fentanyl|fentanyl|mesh-list
154468976|NCT02065947|Ketamine|ketamine|mesh-list
154468977|NCT02065947|Bupivacaine|bupivacaine|mesh-list
154468978|NCT02065947|Propofol|propofol|mesh-list
154468979|NCT02065947|Sevoflurane|sevoflurane|mesh-list
154468980|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
154468981|NCT02065947|Atracurium|atracurium|mesh-list
154468982|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
154468983|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
154468984|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154468985|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154468986|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
154468987|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154468988|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154468989|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154468990|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154468991|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154468992|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154468993|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154468994|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154468995|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
154468996|NCT02065947|Analgesics|analgesics|mesh-ancestor
154468997|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154468998|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154468999|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154469000|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469001|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154469002|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154469003|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154469004|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154469005|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
154469006|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
154469007|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154469008|NCT02065947|Narcotics|narcotics|mesh-ancestor
154469009|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154469010|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154469011|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154469012|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154469013|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
154469014|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154469015|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154469016|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
154469017|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154469018|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
154469019|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
154469020|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
154469021|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154469022|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154469023|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154469024|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154469025|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154469026|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154469027|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
154469028|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
154469029|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154469030|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469031|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469032|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154469033|NCT03436472|Analgesics|analgesics|mesh-ancestor
154469034|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
154469035|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469036|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154469037|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154469038|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154469039|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
154469040|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469041|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469042|NCT02066103|Paclitaxel|paclitaxel|mesh-list
154469043|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154469044|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469045|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
154469046|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
154469047|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
154469048|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469049|NCT04809532|Tramadol|tramadol|mesh-list
154469050|NCT04809532|Bupivacaine|bupivacaine|mesh-list
154469051|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
154469052|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
154469053|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469054|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469055|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
154469056|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469057|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154469058|NCT04809532|Narcotics|narcotics|mesh-ancestor
154469059|NCT04809532|Analgesics|analgesics|mesh-ancestor
154469060|NCT04809142|Gemcitabine|gemcitabine|mesh-list
154469061|NCT04809142|Capecitabine|capecitabine|mesh-list
154469062|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
154469063|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154469064|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
154469065|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469066|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469067|NCT02064777|Tacrolimus|tacrolimus|mesh-list
154469068|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154469069|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
154469070|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469071|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154469072|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469073|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469074|NCT02069145|Sorafenib|sorafenib|mesh-list
154469075|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154469076|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469077|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154469078|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469079|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469080|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
154469081|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469082|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154469083|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
154469084|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469085|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
154469086|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
154469087|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469088|NCT03347331|Befiradol|befiradol|mesh-list
154469089|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154469090|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154469091|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
154469092|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469093|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469094|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469095|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
154469096|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154469097|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154469098|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469099|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
154469100|NCT03109652|Coagulants|coagulants|mesh-ancestor
154469101|NCT02069301|Fluoxetine|fluoxetine|mesh-list
154469102|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
154469103|NCT02069301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154469104|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154469105|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973783|NCT06247787|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154469106|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033257|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
154469107|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469108|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
154469109|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469110|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154469111|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154469112|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154469113|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154469114|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193031|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
154469115|NCT03035656|Ropivacaine|ropivacaine|mesh-list
154469116|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
154469117|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
154469118|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469119|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469120|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
154469121|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469122|NCT03443960|Amitriptyline|amitriptyline|mesh-list
154469123|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
154469124|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154469125|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
154469126|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154469127|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154469128|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469129|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154469130|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469131|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154469132|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469133|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154469134|NCT03443960|Analgesics|analgesics|mesh-ancestor
154469135|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
154469136|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154469137|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154469138|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154469139|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469140|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
154033258|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
154469141|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469142|NCT05616754|Vaccines|vaccines|mesh-list
154469143|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
154469144|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469145|NCT03440996|Listerine|listerine|mesh-list
154469146|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
154469147|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
154469148|NCT03440996|Protective Agents|protective agents|mesh-ancestor
154469149|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469150|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154469151|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469152|NCT04451174|Prednisone|prednisone|mesh-list
154469153|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154469154|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
154469155|NCT04451174|Hormones|hormones|mesh-ancestor
154469156|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469157|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469158|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154469159|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469160|NCT04828642|Vitamins|vitamins|mesh-list
154469161|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
154469162|NCT04828642|Vitamin E|vitamin e|mesh-list
154469163|NCT04828642|Tocopherols|tocopherols|mesh-list
154469164|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
154469165|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469166|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
154469167|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469168|NCT04828642|Protective Agents|protective agents|mesh-ancestor
154469169|NCT03433352|Methimazole|methimazole|mesh-list
154469170|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
154469171|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
154469172|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
154469173|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469174|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469175|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
154469176|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469177|NCT04828564|Ribavirin|ribavirin|mesh-list
154469178|NCT04828564|Favipiravir|favipiravir|mesh-list
154469179|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
154469180|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469181|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
154469182|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469183|NCT03435302|Temozolomide|temozolomide|mesh-list
154469184|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469185|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154469186|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
153973784|NCT06247787|Abortifacient Agents|abortifacient agents|mesh-ancestor
154469187|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469188|NCT04973150|Anesthetics|anesthetics|mesh-list
154193108|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
154469189|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033338|NCT02576574|Gemcitabine|gemcitabine|mesh-list
154033339|NCT02576574|Pemetrexed|pemetrexed|mesh-list
154469190|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469191|NCT03433196|Atorvastatin|atorvastatin|mesh-list
154469192|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154469193|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154469194|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
154469195|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469196|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154469197|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154469198|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469199|NCT02792829|Lenvatinib|lenvatinib|mesh-list
154469200|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469201|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154469202|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469203|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469204|NCT02066571|Droxidopa|droxidopa|mesh-list
154469205|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154469206|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154469207|NCT02066649|Carvedilol|carvedilol|mesh-list
154469208|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154469209|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154469210|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
154469211|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469212|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469213|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469214|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154469215|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
154469216|NCT02066649|Protective Agents|protective agents|mesh-ancestor
154469217|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154469218|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154469219|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154469220|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
154469221|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154469222|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154469223|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
154469224|NCT02070003|Narcotics|narcotics|mesh-ancestor
154033340|NCT02576574|Avelumab|avelumab|mesh-list
154033341|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154469225|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469226|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469227|NCT02070003|Analgesics|analgesics|mesh-ancestor
154469228|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
154469229|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469230|NCT02070159|Clopidogrel|clopidogrel|mesh-list
154469231|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154469232|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154469233|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154469234|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154469235|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154469236|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
154469237|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469238|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469239|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469240|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
154469241|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
154469242|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154469243|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469244|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154469245|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154469246|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469247|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469248|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469249|NCT03432884|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154469250|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154469251|NCT04827784|Anesthetics|anesthetics|mesh-list
154469252|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
154469253|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469254|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469255|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
154469256|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469257|NCT03986996|Amoxicillin|amoxicillin|mesh-list
154469258|NCT03986996|Metronidazole|metronidazole|mesh-list
154469259|NCT03986996|Doxycycline|doxycycline|mesh-list
154469260|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154469261|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469262|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154469263|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154469264|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
154469265|NCT04827472|Fexuprazan|fexuprazan|mesh-list
154469266|NCT04827472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154469267|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
154469268|NCT04796428|Empagliflozin|empagliflozin|mesh-list
154469269|NCT04796428|Canagliflozin|canagliflozin|mesh-list
154469270|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154469271|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469272|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154469273|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469274|NCT03432728|Anesthetics|anesthetics|mesh-list
154469275|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469276|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469277|NCT04450160|Temozolomide|temozolomide|mesh-list
154469278|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154469279|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
154469280|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469281|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469282|NCT03432572|Riboflavin|riboflavin|mesh-list
154469283|NCT03432572|Thiamine|thiamine|mesh-list
154469284|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
154469285|NCT03432572|Vitamins|vitamins|mesh-ancestor
154469286|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
154469287|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469288|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154469289|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
154469290|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
154469291|NCT02805504|Bupivacaine|bupivacaine|mesh-list
154469292|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
154469293|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
154469294|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469295|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469296|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
154469297|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469298|NCT02783508|Meperidine|meperidine|mesh-list
154469299|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
154469300|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154469301|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
154469302|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
154469303|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469304|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469305|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154469306|NCT02783508|Analgesics|analgesics|mesh-ancestor
154469307|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
154469308|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469309|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154469310|NCT02783508|Narcotics|narcotics|mesh-ancestor
154469311|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154469312|NCT02071407|Midazolam|midazolam|mesh-list
154469313|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154469314|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154469315|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469316|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469317|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154469318|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154469319|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154469320|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154469321|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
154469322|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
154469323|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
154469324|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
154469325|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469326|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469327|NCT02281266|Entecavir|entecavir|mesh-list
154469328|NCT02281266|Thymalfasin|thymalfasin|mesh-list
154469329|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
154469330|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469331|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154469332|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
154469333|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469334|NCT00625326|Calcipotriene|calcipotriene|mesh-list
154469335|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
154469336|NCT03434054|Losartan|losartan|mesh-list
154193286|NCT03972488|Octreotide|octreotide|mesh-list
154469337|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154469338|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154469339|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154469340|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154469341|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469342|NCT03433976|Anesthetics|anesthetics|mesh-list
154469343|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469344|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469345|NCT04473144|Urinastatin|urinastatin|mesh-list
154469346|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154469347|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154469348|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
154469349|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033457|NCT02052778|Futibatinib|futibatinib|mesh-list
154469350|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469351|NCT02605642|Infliximab|infliximab|mesh-list
154469352|NCT02605642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154469353|NCT02605642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154469354|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
154469355|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154469356|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154469357|NCT00624858|Naltrexone|naltrexone|mesh-list
154469358|NCT00624858|Bupropion|bupropion|mesh-list
154469359|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154469360|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154469361|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469362|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
154469363|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469364|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154469365|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
154469366|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154469367|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154469368|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154469369|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154469370|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469371|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
154469372|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469373|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154469374|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154469375|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469376|NCT03128528|Empagliflozin|empagliflozin|mesh-list
154469377|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154469378|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469379|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154469380|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469381|NCT02071641|Sunitinib|sunitinib|mesh-list
154469382|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469383|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154469384|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154469385|NCT02071641|Growth Substances|growth substances|mesh-ancestor
154469386|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469387|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
154469388|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154469389|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033540|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154033541|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
154033542|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154469390|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469391|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
154469392|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154469393|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154469394|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469395|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
154469396|NCT02253810|Coagulants|coagulants|mesh-ancestor
154469397|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
154469398|NCT00673062|Ephedrine|ephedrine|mesh-list
154469399|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154469400|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
154469401|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469402|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469403|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154469404|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
154469405|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
154469406|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154469407|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154469408|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
154469409|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154469410|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469411|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193336|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
154469412|NCT03559803|Cisplatin|cisplatin|mesh-list
154469413|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469414|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
154469415|NCT03439358|Analgesics|analgesics|mesh-ancestor
154469416|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
154469417|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469418|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469419|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
154469420|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469421|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154469422|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
154469423|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154033543|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154469424|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154469425|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469426|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154033575|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154033576|NCT01294020|Tacrolimus|tacrolimus|mesh-list
154033577|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154469427|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
154469428|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154469429|NCT02072031|Sunitinib|sunitinib|mesh-list
154469430|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469431|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154469432|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154469433|NCT02072031|Growth Substances|growth substances|mesh-ancestor
154469434|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469435|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
154469436|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154469437|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469438|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469440|NCT05616442|Ketotifen|ketotifen|mesh-list
154469441|NCT05616442|Vitamins|vitamins|mesh-ancestor
154469442|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
154469443|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469444|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
154469445|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469446|NCT05616442|Protective Agents|protective agents|mesh-ancestor
154469447|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
154469448|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
154469449|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154469450|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
154469451|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
154469452|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469453|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154469454|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154469455|NCT02065401|Antacids|antacids|mesh-ancestor
154469456|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469457|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154469458|NCT00620256|Timolol|timolol|mesh-list
154469459|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154469460|NCT00620256|Latanoprost|latanoprost|mesh-list
154469461|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154469462|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154469463|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154469464|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154469465|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469466|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469467|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469468|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154469469|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154469470|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
154469471|NCT04805710|Clopidogrel|clopidogrel|mesh-list
154469472|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154469473|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154469474|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154469475|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154469476|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
154469477|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469478|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469479|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033584|NCT01246869|Imidazole|imidazole|mesh-list
154469480|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154469481|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
154469482|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154469483|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
154469484|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469485|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
154469486|NCT02076477|Docetaxel|docetaxel|mesh-list
154469487|NCT02076477|Pemetrexed|pemetrexed|mesh-list
154469489|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
154469490|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
154469491|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
154469492|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469493|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469494|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154469495|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154469496|NCT04472832|Mitapivat|mitapivat|mesh-list
154469497|NCT04472832|Enzyme Activators|enzyme activators|mesh-ancestor
154469498|NCT04472832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469499|NCT04879550|Antithrombins|antithrombins|mesh-list
154469500|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
154469501|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154469502|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
154469503|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469504|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469505|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
154469506|NCT00613002|Testosterone|testosterone|mesh-list
154469507|NCT00613002|Androgens|androgens|mesh-ancestor
154469508|NCT00613002|Hormones|hormones|mesh-ancestor
154469509|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469510|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469512|NCT02076945|Bupivacaine|bupivacaine|mesh-list
154469513|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
154469514|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
154469515|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469516|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469517|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
154469518|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469519|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154469520|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154469521|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154469522|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154469523|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469524|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
154469525|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154469526|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469527|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
154469528|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154469529|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154469530|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
154469531|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814798|NCT00453609|Naltrexone|naltrexone|mesh-list
154469532|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154469533|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154469534|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154469535|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
154469536|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469537|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154469538|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154469539|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469540|NCT02732912|Zopiclone|zopiclone|mesh-list
154469541|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154469542|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469543|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469544|NCT02792517|Erenumab|erenumab|mesh-list
154033668|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154033669|NCT00959569|Esmolol|esmolol|mesh-list
154033670|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154033671|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
154033672|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154033673|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033674|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033675|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154033676|NCT00881868|Clobetasol|clobetasol|mesh-list
154033677|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033678|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
154033679|NCT00881868|Hormones|hormones|mesh-ancestor
154033680|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469545|NCT02792517|Norgestimate|norgestimate|mesh-list
154469546|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
154469547|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
154469548|NCT02792517|Estradiol|estradiol|mesh-list
154469549|NCT02792517|Estrogens|estrogens|mesh-ancestor
154469550|NCT02792517|Hormones|hormones|mesh-ancestor
154469551|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469552|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469553|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154469554|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154469555|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154469556|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154469557|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469558|NCT02792517|Analgesics|analgesics|mesh-ancestor
154469559|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
154469560|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469561|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154469562|NCT03431714|Artesunate|artesunate|mesh-list
154469563|NCT03431714|Piperaquine|piperaquine|mesh-list
154469564|NCT03431714|Amodiaquine|amodiaquine|mesh-list
154469565|NCT03431714|Artenimol|artenimol|mesh-list
154469566|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
154469567|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154469568|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154469569|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469570|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469571|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
154469572|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
154469573|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154469574|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
154469575|NCT03433586|Aspirin|aspirin|mesh-list
154469576|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154469577|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154469578|NCT03433586|Analgesics|analgesics|mesh-ancestor
154469579|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
154469580|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814821|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
154469581|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469582|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154469583|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154469584|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154469585|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154469586|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469587|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154469588|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154469589|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469591|NCT03431558|Lactoferrin|lactoferrin|mesh-list
154469592|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469593|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154469594|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469595|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
154469596|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469597|NCT02273622|Protective Agents|protective agents|mesh-ancestor
154469598|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469599|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154469600|NCT02077803|Metformin|metformin|mesh-list
154469601|NCT02077803|Canagliflozin|canagliflozin|mesh-list
154469602|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154469603|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469604|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154469605|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469606|NCT02072811|Cytarabine|cytarabine|mesh-list
154469607|NCT02072811|Daunorubicin|daunorubicin|mesh-list
154469608|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
154469609|NCT02072811|Cladribine|cladribine|mesh-list
154469610|NCT02072811|Lenograstim|lenograstim|mesh-list
154469611|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154469612|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
154469613|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469614|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469615|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
154469616|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469617|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154469618|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
154469619|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469620|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154469621|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154469622|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154469623|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469624|NCT02072811|Analgesics|analgesics|mesh-ancestor
154469625|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
154469626|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469627|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154469628|NCT02080377|Glyburide|glyburide|mesh-list
154469629|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154469630|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469631|NCT02072967|Rituximab|rituximab|mesh-list
154469632|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154469633|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154469634|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469635|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
154469636|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469637|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154469638|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154469639|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
154469640|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469642|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469643|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469644|NCT02073669|Interferons|interferons|mesh-list
154469645|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
154469646|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469647|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
154469648|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469649|NCT03428282|Anesthetics|anesthetics|mesh-list
154469650|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469651|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469652|NCT00463242|Agomelatine|agomelatine|mesh-list
154469653|NCT00463242|Paroxetine|paroxetine|mesh-list
154469654|NCT00463242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154469655|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154469656|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154469657|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469659|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
154469660|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469661|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154469662|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
154469663|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154469664|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154469665|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154469666|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469667|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154469668|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469669|NCT02074137|Prednisone|prednisone|mesh-list
154469670|NCT02074137|Prednisolone|prednisolone|mesh-list
154469671|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154469672|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
154469673|NCT02074137|Hormones|hormones|mesh-ancestor
154469674|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469675|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469676|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154469677|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469678|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154469679|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154469680|NCT00594984|Irinotecan|irinotecan|mesh-list
154469681|NCT00594984|Cetuximab|cetuximab|mesh-list
154469682|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154469683|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154469684|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469685|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469686|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469687|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154469688|NCT01369485|Caffeine|caffeine|mesh-list
154469689|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154469690|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469691|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154469692|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469693|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469694|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154469695|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154469696|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
154469697|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469698|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
154469699|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154469700|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469701|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469702|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154469703|NCT03422978|Analgesics|analgesics|mesh-ancestor
154469704|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
154469705|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469706|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154469707|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154469708|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154193628|NCT03441061|Immunotoxins|immunotoxins|mesh-ancestor
154469709|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
154469710|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469711|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469712|NCT02278692|Vitamin K|vitamin k|mesh-list
154469713|NCT02278692|Vitamins|vitamins|mesh-ancestor
154469714|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
154469715|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469716|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154469717|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154469718|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469719|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
154469720|NCT02278692|Coagulants|coagulants|mesh-ancestor
154469721|NCT02281968|Naproxen|naproxen|mesh-list
154469722|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154469723|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154469724|NCT02281968|Analgesics|analgesics|mesh-ancestor
154469725|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
154469726|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469727|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469728|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154469729|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860613|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469730|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
154033839|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154033840|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033841|NCT00960349|Cisplatin|cisplatin|mesh-list
154033842|NCT00960349|Capecitabine|capecitabine|mesh-list
154033843|NCT00960349|Cediranib|cediranib|mesh-list
154033844|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033845|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154469731|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154469732|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469733|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469734|NCT02080845|Theobromine|theobromine|mesh-list
154469735|NCT02080845|Caffeine|caffeine|mesh-list
154469736|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154469737|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469738|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154469739|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469740|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469741|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154469742|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154469743|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
154469744|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469745|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154469746|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
154469747|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469748|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154469749|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
154469750|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
154469751|NCT02284230|Liraglutide|liraglutide|mesh-list
154469752|NCT02284230|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154469753|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154469754|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469755|NCT02284230|Incretins|incretins|mesh-ancestor
154469756|NCT02284230|Hormones|hormones|mesh-ancestor
154469757|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469758|NCT02792088|Tenofovir|tenofovir|mesh-list
154469759|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
154469760|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469761|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154469762|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154033846|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
154033848|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154469763|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469764|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469765|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154469766|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154469767|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154469768|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154469769|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154469770|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469771|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469772|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154469773|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154469774|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469775|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
154469776|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469777|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
154469778|NCT00451152|Anecortave|anecortave|mesh-list
154469779|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154469780|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154469781|NCT00451152|Growth Substances|growth substances|mesh-ancestor
154469782|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469783|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
154469784|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469785|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154469786|NCT02078583|Fentanyl|fentanyl|mesh-list
154469787|NCT02078583|Remifentanil|remifentanil|mesh-list
154469788|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154469789|NCT02078583|Narcotics|narcotics|mesh-ancestor
154469790|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469791|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469792|NCT02078583|Analgesics|analgesics|mesh-ancestor
154469793|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
154469794|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469795|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154469796|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154469797|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
154469798|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
154469799|NCT02948660|Zolpidem|zolpidem|mesh-list
154469800|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154469801|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154254903|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469802|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469803|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469804|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154469805|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
154469806|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
154469807|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814825|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154469808|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469809|NCT02074605|Interferons|interferons|mesh-list
154469810|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
154469811|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469812|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
154469813|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469814|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
154469815|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469816|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
154469817|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154469818|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469819|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154469820|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154469821|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469822|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469823|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469824|NCT00583830|Paclitaxel|paclitaxel|mesh-list
154469825|NCT00583830|Carboplatin|carboplatin|mesh-list
154469826|NCT00583830|Mapatumumab|mapatumumab|mesh-list
154469827|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154469828|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154469829|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469830|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
154469831|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
154469832|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
154469833|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469834|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
154469835|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469836|NCT03430544|Cariprazine|cariprazine|mesh-list
154469837|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154469838|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154469839|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469840|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469841|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154469842|NCT00583674|Cisplatin|cisplatin|mesh-list
154469843|NCT00583674|Capecitabine|capecitabine|mesh-list
154469844|NCT00583674|Trebananib|trebananib|mesh-list
154469845|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469846|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154469847|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
154469848|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469849|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154469850|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154469851|NCT00583674|Growth Substances|growth substances|mesh-ancestor
154469852|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469853|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
154469854|NCT03422510|CXA-10|cxa-10|mesh-list
154469855|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154469856|NCT03430466|Fulvestrant|fulvestrant|mesh-list
154193776|NCT03012529|Riboflavin|riboflavin|mesh-list
154469857|NCT03430466|Tremelimumab|tremelimumab|mesh-list
154469858|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154469859|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469860|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154469861|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154469862|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
154469863|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469864|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469865|NCT02280174|Linagliptin|linagliptin|mesh-list
154469866|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154469867|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469868|NCT02280174|Incretins|incretins|mesh-ancestor
154469869|NCT02280174|Hormones|hormones|mesh-ancestor
154469870|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154469871|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154469872|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
154469873|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469874|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860614|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154469875|NCT00447564|Buprenorphine|buprenorphine|mesh-list
154860615|NCT01057381|Narcotics|narcotics|mesh-ancestor
154860616|NCT00986102|Doripenem|doripenem|mesh-list
154469876|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154469877|NCT00447564|Narcotics|narcotics|mesh-ancestor
154469878|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469879|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469880|NCT00447564|Analgesics|analgesics|mesh-ancestor
154469881|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
154469882|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469883|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154469884|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
154469885|NCT00576810|Cathartics|cathartics|mesh-ancestor
154469886|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154469887|NCT00576342|Timolol|timolol|mesh-list
154469888|NCT00576342|Dorzolamide|dorzolamide|mesh-list
154469889|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154469890|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154469891|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154469892|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154469893|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
154469894|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469895|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469896|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469897|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154469898|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154469899|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154469900|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469901|NCT02282280|Prilocaine|prilocaine|mesh-list
154469902|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154469903|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
154469904|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469905|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469906|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
154469907|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469908|NCT03429998|Evolocumab|evolocumab|mesh-list
154469909|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154469910|NCT03429998|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154469911|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154469912|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154469913|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
154469914|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469915|NCT03429998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154469916|NCT03429998|Protease Inhibitors|protease inhibitors|mesh-ancestor
154469917|NCT03429998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469918|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154469919|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
154469920|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469921|NCT00658008|Paroxetine|paroxetine|mesh-list
154469922|NCT00658008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154469923|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154469924|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154469925|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469926|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469927|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
154469928|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469929|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154469930|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
154469931|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154469932|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154193858|NCT02842749|Everolimus|everolimus|mesh-list
154469933|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154469934|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469935|NCT03427502|Epinephrine|epinephrine|mesh-list
154469936|NCT03427502|Bupivacaine|bupivacaine|mesh-list
154469937|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
154469938|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
154469939|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154469940|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469941|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
154469942|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469943|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154469944|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154469945|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
154469946|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154469947|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469949|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154469950|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
154469951|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154469952|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
154469953|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
154469954|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
154469955|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154469956|NCT00440388|Rituximab|rituximab|mesh-list
154469957|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154469958|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469959|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
154034026|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469960|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469961|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154034073|NCT05003245|Antibodies|antibodies|mesh-list
154034075|NCT05003245|Mitogens|mitogens|mesh-list
154469962|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154469963|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154469964|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154469965|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
154469966|NCT04449224|Etanercept|etanercept|mesh-list
154469967|NCT04449224|Abatacept|abatacept|mesh-list
154469968|NCT04449224|Tofacitinib|tofacitinib|mesh-list
154469969|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154469970|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154469971|NCT04449224|Analgesics|analgesics|mesh-ancestor
154469972|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
154469973|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154469974|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469975|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154469976|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154469977|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154469978|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154469979|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
154469980|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154469981|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154469982|NCT04449224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154469983|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154469984|NCT04449224|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154469985|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154469986|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154469987|NCT00437112|Insulin|insulin|mesh-list
154469988|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154469989|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
154469990|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154469991|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154469992|NCT00434850|Gusperimus|gusperimus|mesh-list
154469993|NCT00434850|Sirolimus|sirolimus|mesh-list
154469994|NCT00434850|Etanercept|etanercept|mesh-list
154469995|NCT00434850|Tacrolimus|tacrolimus|mesh-list
154469996|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154469997|NCT00434850|Basiliximab|basiliximab|mesh-list
154469998|NCT00434850|Daclizumab|daclizumab|mesh-list
154469999|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154470000|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
154470001|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470002|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154470003|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470004|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470005|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154470006|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470007|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154470008|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470009|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
154470010|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154470011|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470012|NCT00434850|Analgesics|analgesics|mesh-ancestor
154470013|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
154470014|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470015|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470016|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470017|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470018|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154470019|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154470020|NCT00434850|Protective Agents|protective agents|mesh-ancestor
154470021|NCT04449380|Interferons|interferons|mesh-list
154470022|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470023|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
154470024|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860617|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154470026|NCT03128216|Ropivacaine|ropivacaine|mesh-list
154470027|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
154470028|NCT03128216|Anesthetics|anesthetics|mesh-list
154470029|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470030|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470031|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
154470032|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470033|NCT00566202|Escitalopram|escitalopram|mesh-list
154470034|NCT00566202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154470035|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154470036|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470037|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470038|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470039|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
154470040|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470041|NCT02280486|Glimepiride|glimepiride|mesh-list
154470042|NCT02280486|Saxagliptin|saxagliptin|mesh-list
154470043|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154470044|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154470045|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470046|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154470047|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
154034120|NCT00961207|Aliskiren|aliskiren|mesh-list
154034158|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470048|NCT02280486|Incretins|incretins|mesh-ancestor
154470049|NCT02280486|Hormones|hormones|mesh-ancestor
154470050|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154470051|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154470052|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
154470053|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470054|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470055|NCT00434226|Paclitaxel|paclitaxel|mesh-list
154470056|NCT00434226|Bevacizumab|bevacizumab|mesh-list
154470057|NCT00434226|Carboplatin|carboplatin|mesh-list
154470058|NCT00434226|Sunitinib|sunitinib|mesh-list
154470059|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154470060|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470061|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
154470062|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
154470063|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
154470064|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470065|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154470066|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154470067|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154470068|NCT00434226|Growth Substances|growth substances|mesh-ancestor
154470069|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470070|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
154470071|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154470072|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470073|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154470074|NCT00430950|Olmesartan|olmesartan|mesh-list
154470075|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154470076|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154470077|NCT00430950|Diuretics|diuretics|mesh-ancestor
154470078|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
154470079|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470080|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154470081|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470082|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470083|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154194004|NCT01976286|Analgesics|analgesics|mesh-ancestor
154470084|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154470085|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
154470086|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154470087|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154470088|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034160|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
154470089|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034200|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154470090|NCT02081391|Tapentadol|tapentadol|mesh-list
154470091|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154470092|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154470093|NCT02081391|Narcotics|narcotics|mesh-ancestor
154470094|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154860618|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470095|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470096|NCT02081391|Analgesics|analgesics|mesh-ancestor
154470097|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
154470098|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470099|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154470100|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154470101|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470102|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470103|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
154470104|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470105|NCT00549510|Lisinopril|lisinopril|mesh-list
154470106|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154470107|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
154470108|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470109|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470110|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154470111|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154470112|NCT00549510|Protective Agents|protective agents|mesh-ancestor
154470113|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470114|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
154470115|NCT00430092|Difluprednate|difluprednate|mesh-list
154470116|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
154470117|NCT00430092|Hormones|hormones|mesh-ancestor
154470118|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154470119|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470120|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470121|NCT00427440|Rilotumumab|rilotumumab|mesh-list
154470122|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154470123|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154470124|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470125|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
154470126|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470127|NCT00650832|Darunavir|darunavir|mesh-list
154470128|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154470129|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154034212|NCT00961753|Ibuprofen|ibuprofen|mesh-list
154470130|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
154470131|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470132|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470133|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154470134|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154470135|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
154470136|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470137|NCT00425100|Fesoterodine|fesoterodine|mesh-list
154470138|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154470139|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154470140|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
154470141|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470142|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470143|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470144|NCT00425100|Urological Agents|urological agents|mesh-ancestor
154470145|NCT00546780|Bortezomib|bortezomib|mesh-list
154470146|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470147|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154470148|NCT00420888|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
154470149|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
154470150|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
154470151|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470152|NCT00543582|Azacitidine|azacitidine|mesh-list
154470153|NCT00543582|Mocetinostat|mocetinostat|mesh-list
154470154|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154470155|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
154470156|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470157|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254907|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
154860619|NCT01058239|Rituximab|rituximab|mesh-list
154860620|NCT01058239|Bortezomib|bortezomib|mesh-list
154860621|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154860622|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860623|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
154860624|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860625|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860626|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
154860627|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
154860628|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470159|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154470160|NCT00542724|Insulin|insulin|mesh-list
154470161|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154470162|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154470163|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034285|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154470164|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154470165|NCT00412932|Olmesartan|olmesartan|mesh-list
154470166|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154470167|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154470168|NCT00412932|Diuretics|diuretics|mesh-ancestor
154470169|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
154470170|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470171|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154470172|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470173|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470174|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154470175|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154470176|NCT00411528|Prednisone|prednisone|mesh-list
154470177|NCT00411528|Docetaxel|docetaxel|mesh-list
154470178|NCT00411528|Epothilone B|epothilone b|mesh-list
154470179|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470180|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
154470181|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
154470182|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
154470183|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470184|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470185|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
154470186|NCT00411528|Hormones|hormones|mesh-ancestor
154470187|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154470188|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470189|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154470190|NCT00384150|Galiximab|galiximab|mesh-list
154470191|NCT00384150|Rituximab|rituximab|mesh-list
154470192|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154470193|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470194|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
154470195|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470196|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470197|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470198|NCT00532038|Ketoprofen|ketoprofen|mesh-list
154470199|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154470200|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470201|NCT00532038|Analgesics|analgesics|mesh-ancestor
154470202|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
154470203|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470204|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470205|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470206|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470207|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154470208|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470209|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470210|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
154470211|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154470212|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470213|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154470214|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
154470215|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154470216|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470217|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470218|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470219|NCT00401388|Allopurinol|allopurinol|mesh-list
154470220|NCT00401388|Antiemetics|antiemetics|mesh-list
154470221|NCT00401388|Loperamide|loperamide|mesh-list
154470222|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
154470223|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
154470224|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470225|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470226|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
154470227|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470228|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154470229|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
154470230|NCT00401388|Protective Agents|protective agents|mesh-ancestor
154470231|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098413|NCT04189783|Bupivacaine|bupivacaine|mesh-list
154860630|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470232|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470234|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470235|NCT02282826|Acyclovir|acyclovir|mesh-list
154470236|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
154470237|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470238|NCT00374166|Paroxetine|paroxetine|mesh-list
154470239|NCT00374166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154470240|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154470241|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470242|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470243|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470244|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
154470245|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470246|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154470247|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
154470248|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154470249|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154470250|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154470251|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470252|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
154470253|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154470254|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154470255|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154470256|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470257|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470258|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
154470259|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470260|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470261|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154470262|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470263|NCT02078973|Tolvaptan|tolvaptan|mesh-list
154470264|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154470265|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470266|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
154470267|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470268|NCT00397254|Rizatriptan|rizatriptan|mesh-list
154470269|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154470270|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
154470271|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470272|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470273|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470274|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
154470275|NCT01369641|Cisplatin|cisplatin|mesh-list
154470276|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034380|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154034381|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
154034382|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034383|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034384|NCT02668172|Pasireotide|pasireotide|mesh-list
154034385|NCT02668172|Hormones|hormones|mesh-ancestor
154034386|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034387|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470277|NCT01369641|Antidotes|antidotes|mesh-ancestor
154470278|NCT01369641|Protective Agents|protective agents|mesh-ancestor
154470279|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470280|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
154470281|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470282|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
154470283|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154470284|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470285|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
154470286|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
154470287|NCT02283060|Tenofovir|tenofovir|mesh-list
154470288|NCT02283060|Emtricitabine|emtricitabine|mesh-list
154470289|NCT02283060|Efavirenz|efavirenz|mesh-list
154470290|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154470291|NCT02283060|Cobicistat|cobicistat|mesh-list
154470292|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154034388|NCT00660270|Interferons|interferons|mesh-list
154034389|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
154034390|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154034391|NCT00660270|Gemcitabine|gemcitabine|mesh-list
154034392|NCT00660270|Fluorouracil|fluorouracil|mesh-list
154034395|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
154470293|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154470294|NCT02283060|Elvitegravir|elvitegravir|mesh-list
154470295|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
154470296|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470297|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154470298|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154470299|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470300|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470301|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154470302|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154860631|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
154470303|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154470304|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154470305|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154470307|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154470308|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154470309|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154470310|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154470311|NCT03559725|Menthol|menthol|mesh-list
154470312|NCT03559725|Nicotine|nicotine|mesh-list
154470313|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154470314|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
154470315|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470316|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470317|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154470318|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154470319|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
154470320|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470321|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470322|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
154470323|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
154470324|NCT00529152|Deferiprone|deferiprone|mesh-list
154470325|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154470326|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
154470327|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
154470328|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470329|NCT00525330|Metformin|metformin|mesh-list
154470330|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154470331|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470332|NCT02287272|Cimetidine|cimetidine|mesh-list
154470333|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154470334|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470335|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154470336|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
154470337|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
154470338|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470339|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470340|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470341|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154034419|NCT00967057|Idarubicin|idarubicin|mesh-list
154470342|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154470343|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470344|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
154470345|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154470346|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470347|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154470348|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154470349|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470350|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470351|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470352|NCT04470414|Antibodies|antibodies|mesh-list
154470353|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
154470354|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
154470355|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470356|NCT00363636|Galiximab|galiximab|mesh-list
154470357|NCT00363636|Rituximab|rituximab|mesh-list
154470358|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154470359|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470360|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
154470361|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034452|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154034453|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154034454|NCT02633514|Etoposide|etoposide|mesh-list
154034455|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034456|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154034457|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154034458|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154470362|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470363|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470364|NCT02605174|Lasmiditan|lasmiditan|mesh-list
154470365|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154470366|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
154470367|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470368|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470369|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470370|NCT00522834|Paclitaxel|paclitaxel|mesh-list
154470371|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154470372|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470373|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
154470374|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
154470375|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
154194301|NCT00414609|Renin Inhibitors|renin inhibitors|mesh-ancestor
154470376|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860632|NCT01058941|Vitamins|vitamins|mesh-ancestor
154860633|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
154860634|NCT00985946|Panobinostat|panobinostat|mesh-list
154860635|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860636|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154860637|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470378|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154470379|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154470380|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154470381|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470382|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470383|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154470384|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470385|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
154470386|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154470387|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154470388|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
154470389|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154470390|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154470391|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470392|NCT00358878|Satavaptan|satavaptan|mesh-list
154470393|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154470394|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470395|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
154470396|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470397|NCT02283372|Paclitaxel|paclitaxel|mesh-list
154470398|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154470399|NCT02283372|Gemcitabine|gemcitabine|mesh-list
154470400|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154470401|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470402|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
154470403|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
154470404|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
154470405|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470406|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154470407|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
154470408|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154470409|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154470410|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154470411|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470412|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470413|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470414|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470415|NCT00507936|Analgesics|analgesics|mesh-ancestor
154470416|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
154034513|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
154470417|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470418|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
154470419|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154470420|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
154470421|NCT04427020|Caseins|caseins|mesh-list
154470422|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
154470423|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
154470424|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470425|NCT02083575|Vitamins|vitamins|mesh-list
154470426|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
154470427|NCT02083575|Deferiprone|deferiprone|mesh-list
154470428|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
154470429|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470430|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
154470431|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470432|NCT02083575|Protective Agents|protective agents|mesh-ancestor
154470433|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154470434|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
154470435|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
154470436|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
154470437|NCT02286258|Edetic Acid|edetic acid|mesh-list
154470438|NCT02286258|Calcium|calcium|mesh-list
154470439|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154470440|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470441|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154470442|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
154470443|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
154098630|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470445|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
154470446|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154470447|NCT02088411|Diclofenac|diclofenac|mesh-list
154470448|NCT02088411|Wobenzym|wobenzym|mesh-list
154470449|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154470450|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470451|NCT02088411|Analgesics|analgesics|mesh-ancestor
154470452|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
154470453|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470454|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470455|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577193|NCT01716442|Rituximab|rituximab|mesh-list
154470456|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470457|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154470458|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470459|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470460|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154470461|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
154470462|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
154470463|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
154470464|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470465|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470466|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470467|NCT02604550|Naproxen|naproxen|mesh-list
154470468|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154470469|NCT02604550|Ropivacaine|ropivacaine|mesh-list
154470470|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
154470471|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
154470472|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470473|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470474|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
154470475|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470476|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154470477|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470478|NCT02604550|Analgesics|analgesics|mesh-ancestor
154470479|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470480|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470481|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
154470482|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154470483|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470484|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470485|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154470486|NCT02604550|Narcotics|narcotics|mesh-ancestor
154470487|NCT02084043|Amikacin|amikacin|mesh-list
154470488|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154470489|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470490|NCT03530670|Midazolam|midazolam|mesh-list
154470491|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154470492|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154470493|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470494|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034557|NCT00645398|Pregabalin|pregabalin|mesh-list
154470495|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154034602|NCT00660582|Vitamins|vitamins|mesh-ancestor
154470496|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154470497|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154470498|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154470499|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
154470500|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
154470501|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
154470502|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
154470503|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470504|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470505|NCT00120042|Misoprostol|misoprostol|mesh-list
154470506|NCT00120042|Oxytocin|oxytocin|mesh-list
154470507|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
154470508|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154470509|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470510|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154470511|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
154470512|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154470513|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470514|NCT02084355|Fentanyl|fentanyl|mesh-list
154470515|NCT02084355|Oxycodone|oxycodone|mesh-list
154470516|NCT02084355|Hydromorphone|hydromorphone|mesh-list
154470517|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154470518|NCT02084355|Narcotics|narcotics|mesh-ancestor
154254920|NCT01237808|Cytarabine|cytarabine|mesh-list
154470519|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470520|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470522|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
154194453|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
154470523|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470524|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154470525|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154470526|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
154470527|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
154470528|NCT00353574|Darusentan|darusentan|mesh-list
154470529|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154470530|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470531|NCT02082405|Dexamethasone|dexamethasone|mesh-list
154470532|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
154470533|NCT02082405|Bortezomib|bortezomib|mesh-list
154470534|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154470535|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
154470536|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470537|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470538|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154470539|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
154470540|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470541|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470542|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154470543|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470544|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
154470545|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
154470546|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470547|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470548|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
154470549|NCT02082405|Hormones|hormones|mesh-ancestor
154470550|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154470551|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154470552|NCT04428268|Chloroquine|chloroquine|mesh-list
154470553|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154470554|NCT04428268|Losartan|losartan|mesh-list
154470555|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154470556|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154470557|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154470558|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154470559|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470560|NCT04428268|Amebicides|amebicides|mesh-ancestor
154470561|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154470562|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154470563|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470564|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
154470565|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154470566|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154470567|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470568|NCT04428268|Analgesics|analgesics|mesh-ancestor
154470569|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
154470570|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470571|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470572|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470573|NCT04428268|Filaricides|filaricides|mesh-ancestor
154470574|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
154470575|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
154470576|NCT02084433|Anesthetics|anesthetics|mesh-list
154470577|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470578|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470579|NCT04427098|Enoxaparin|enoxaparin|mesh-list
154470580|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
154470581|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
154470582|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154470583|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154470584|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470585|NCT00352560|Irbesartan|irbesartan|mesh-list
154470586|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154470587|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154470588|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154470589|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470590|NCT00115050|Darunavir|darunavir|mesh-list
154470591|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154254922|NCT01237808|Tretinoin|tretinoin|mesh-list
154470592|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154470594|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470595|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470596|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154470597|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154470598|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
154470599|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470600|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
154470601|NCT05616364|Tramadol|tramadol|mesh-list
154470602|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154470603|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470604|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470605|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470607|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
154470608|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470609|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154470610|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154470611|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154470612|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
154470613|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470614|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470615|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154470616|NCT05616364|Narcotics|narcotics|mesh-ancestor
154470617|NCT00345618|Biotin|biotin|mesh-list
154470618|NCT00345618|Enoxaparin|enoxaparin|mesh-list
154470619|NCT00345618|Warfarin|warfarin|mesh-list
154470620|NCT00345618|Idraparinux|idraparinux|mesh-list
154470621|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
154470622|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
154470623|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154470624|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154470625|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470626|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154470627|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
154470628|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154470629|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
154470630|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470631|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
154470632|NCT00345618|Vitamins|vitamins|mesh-ancestor
154470633|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
154470634|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470635|NCT00116298|Lamivudine|lamivudine|mesh-list
154470636|NCT00116298|Efavirenz|efavirenz|mesh-list
154470637|NCT00116298|Stavudine|stavudine|mesh-list
154470638|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154470639|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154470640|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470641|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470642|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
154470643|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470644|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154470645|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154470646|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154470647|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154470648|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154470649|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154470650|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154470651|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154470652|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
154470653|NCT01866111|Cenobamate|cenobamate|mesh-list
154470654|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
154470655|NCT02084589|Fentanyl|fentanyl|mesh-list
154470656|NCT02084589|Ropivacaine|ropivacaine|mesh-list
154470657|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
154470658|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
154470659|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470660|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470661|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
154470662|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470663|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154470664|NCT02084589|Narcotics|narcotics|mesh-ancestor
154470665|NCT02084589|Analgesics|analgesics|mesh-ancestor
154470666|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154470667|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154470668|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
154470669|NCT03557853|Golimumab|golimumab|mesh-list
154470670|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154470671|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470672|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154470673|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
154470674|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470675|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
154470676|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154470677|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470678|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470680|NCT04346290|Analgesics|analgesics|mesh-ancestor
154470681|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
154470682|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470683|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154470684|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154470685|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154470686|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
154470687|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470688|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470689|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
154034758|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154034759|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034760|NCT02785757|Thrombin|thrombin|mesh-list
154034761|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
154034762|NCT02785757|Coagulants|coagulants|mesh-ancestor
154034763|NCT00645554|Galantamine|galantamine|mesh-list
154034764|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154470690|NCT04426552|Sevoflurane|sevoflurane|mesh-list
154470691|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154470692|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470693|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470694|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470695|NCT04426552|Analgesics|analgesics|mesh-ancestor
154470696|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
154470697|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470698|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154470699|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154470700|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154470701|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
154470702|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470703|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470704|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154470705|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154470706|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
154470707|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
154470708|NCT04803370|Antibodies|antibodies|mesh-list
154470709|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
154470710|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470711|NCT01369329|Ustekinumab|ustekinumab|mesh-list
154470712|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
154470713|NCT04802980|Paclitaxel|paclitaxel|mesh-list
154470714|NCT04802980|Carboplatin|carboplatin|mesh-list
154470715|NCT04802980|Gemcitabine|gemcitabine|mesh-list
154470716|NCT04802980|Capecitabine|capecitabine|mesh-list
154034781|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154034782|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154034783|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470717|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
154470718|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154470719|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470720|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
154470721|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
154470722|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
154470723|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470724|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154470725|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
154470726|NCT05616052|Semaglutide|semaglutide|mesh-list
154470727|NCT05616052|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154470728|NCT05616052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154470729|NCT05616052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470730|NCT03558477|Esomeprazole|esomeprazole|mesh-list
154470731|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154470732|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470733|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154470734|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470735|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470736|NCT04792840|Letrozole|letrozole|mesh-list
154470737|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470738|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154470739|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154470740|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470741|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470742|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154470743|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
154098930|NCT02903680|Dexamethasone|dexamethasone|mesh-list
154860638|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470744|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154470745|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470746|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
154470747|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
154470748|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
154470749|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
154470750|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
154194683|NCT00496470|Budesonide|budesonide|mesh-list
154470751|NCT02085291|Norepinephrine|norepinephrine|mesh-list
154470752|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154470753|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154470754|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
154470755|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470756|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470757|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470758|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
154470759|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
154470760|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470761|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154470762|NCT04792138|Phenobarbital|phenobarbital|mesh-list
154470763|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
154470764|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154470765|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470766|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470767|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154470768|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154470769|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470770|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470771|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
154470772|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
154470773|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154470774|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154470775|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154470776|NCT04802122|Propofol|propofol|mesh-list
154470777|NCT04802122|Sevoflurane|sevoflurane|mesh-list
154470778|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154470779|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470780|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470781|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154470782|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
154470783|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
154470784|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154470785|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154470786|NCT04784728|Lidocaine|lidocaine|mesh-list
154470787|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
154470788|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
154470789|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470790|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470791|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
154470792|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470793|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154470794|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154470795|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154470796|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470797|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470798|NCT02085603|Saracatinib|saracatinib|mesh-list
154470799|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470800|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034855|NCT05276960|Vitamins|vitamins|mesh-ancestor
154034856|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
154034857|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154034858|NCT02787317|Heparin|heparin|mesh-list
154034859|NCT02787317|Bivalirudin|bivalirudin|mesh-list
154034860|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
154034861|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154034862|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154034863|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034864|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
154034865|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154034866|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
154470801|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470802|NCT02090829|Oxytocin|oxytocin|mesh-list
154470803|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
154470804|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154470805|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470806|NCT04801888|Vaccines|vaccines|mesh-list
154470807|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
154470808|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470809|NCT02089503|Ranibizumab|ranibizumab|mesh-list
154470810|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154470811|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154470812|NCT02089503|Growth Substances|growth substances|mesh-ancestor
154470813|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470814|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
154470815|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470816|NCT02091063|Ricolinostat|ricolinostat|mesh-list
154470817|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470818|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154470819|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470820|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470821|NCT02091219|Vitamin D|vitamin d|mesh-list
154470822|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
154470823|NCT02091219|Calcifediol|calcifediol|mesh-list
154470824|NCT02091219|Vitamins|vitamins|mesh-ancestor
154470825|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
154470826|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470827|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154470828|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154470830|NCT02091297|Morphine|morphine|mesh-list
154470831|NCT02091297|Ropivacaine|ropivacaine|mesh-list
154034867|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470832|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154470833|NCT02091297|Narcotics|narcotics|mesh-ancestor
154470834|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814831|NCT00447369|Pregabalin|pregabalin|mesh-list
154470835|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470836|NCT02091297|Analgesics|analgesics|mesh-ancestor
154470837|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
154470838|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470839|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
154470840|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
154470841|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470842|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
154470843|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
154470844|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154470845|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154470846|NCT04791202|Prednisolone|prednisolone|mesh-list
154470847|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
154470848|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154470849|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
154470850|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154470851|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
154470852|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
154470853|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470854|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470855|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470856|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
154470857|NCT04791202|Hormones|hormones|mesh-ancestor
154470858|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154470859|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154470860|NCT04791202|Protective Agents|protective agents|mesh-ancestor
154470861|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154470862|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470863|NCT04801342|Memantine|memantine|mesh-list
154470864|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154470865|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154470866|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
154470867|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470868|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470869|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470870|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154470871|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154470872|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154470873|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
154470874|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154470875|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470876|NCT02590588|Idelalisib|idelalisib|mesh-list
154470877|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470878|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470879|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470880|NCT02086227|Glucagon|glucagon|mesh-list
154470881|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153814832|NCT00447369|Valproic Acid|valproic acid|mesh-list
154470882|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470883|NCT02086227|Hormones|hormones|mesh-ancestor
154470884|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154470885|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470886|NCT02086227|Incretins|incretins|mesh-ancestor
154470887|NCT02086929|Trazodone|trazodone|mesh-list
154470888|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154470889|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154860639|NCT02170519|Iloprost|iloprost|mesh-list
154470890|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154470891|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470892|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470893|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154470894|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470895|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154470896|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
154470897|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154470898|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154470899|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154470900|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470901|NCT02086929|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154470902|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
154470903|NCT02249013|Paclitaxel|paclitaxel|mesh-list
154470904|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154470905|NCT02249013|Carboplatin|carboplatin|mesh-list
154470906|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154470907|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470908|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
154470909|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
154470910|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
154470911|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470912|NCT02249871|Semaglutide|semaglutide|mesh-list
154470913|NCT02249871|Omeprazole|omeprazole|mesh-list
154470914|NCT02249871|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154470915|NCT02249871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154470916|NCT02249871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470917|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154470918|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154470919|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154470920|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814833|NCT00447369|Analgesics|analgesics|mesh-ancestor
154470921|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470922|NCT02087007|Cilostazol|cilostazol|mesh-list
154470923|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154470924|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
154470925|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470926|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470927|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154470928|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
154470929|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154470930|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154470931|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470932|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154470933|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
154470934|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154470935|NCT02087007|Protective Agents|protective agents|mesh-ancestor
154470936|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154470937|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154470938|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470939|NCT01434602|Everolimus|everolimus|mesh-list
154470940|NCT01434602|Sorafenib|sorafenib|mesh-list
154470941|NCT01434602|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154470942|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154470943|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470944|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470945|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154470946|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
154470947|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470948|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470949|NCT02087475|Fluorouracil|fluorouracil|mesh-list
154470950|NCT02087475|Irinotecan|irinotecan|mesh-list
154470951|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
154470952|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470953|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154470954|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154470955|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154470956|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
154470957|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470958|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154470959|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154470960|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154470961|NCT05486949|Itraconazole|itraconazole|mesh-list
154470962|NCT05486949|Carbamazepine|carbamazepine|mesh-list
154470963|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
154470964|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154470965|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154470966|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154470967|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814834|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
154470968|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470969|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154470970|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
154470971|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154470972|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470973|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154470974|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
154470975|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
154470976|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154470977|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154470978|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154470979|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154470980|NCT05486949|Analgesics|analgesics|mesh-ancestor
154470981|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
154470982|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154470983|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154470984|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154470985|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154470986|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154470987|NCT03558243|Hemostatics|hemostatics|mesh-list
154470988|NCT03558243|Coagulants|coagulants|mesh-ancestor
154470989|NCT03426956|Canagliflozin|canagliflozin|mesh-list
154470990|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154470991|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154470992|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154470993|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154470994|NCT03557229|Vitamins|vitamins|mesh-list
154470995|NCT03557229|Vitamin E|vitamin e|mesh-list
154470996|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
154470997|NCT03557229|Melatonin|melatonin|mesh-list
154470998|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154470999|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
154471000|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471001|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
154471002|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471003|NCT03557229|Protective Agents|protective agents|mesh-ancestor
154471004|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471005|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
154471006|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471007|NCT03557229|Expectorants|expectorants|mesh-ancestor
154471008|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471009|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154471010|NCT03557229|Antidotes|antidotes|mesh-ancestor
154035063|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035077|NCT00647660|Nadolol|nadolol|mesh-list
154471011|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154471012|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
154471013|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471014|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154471015|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154471016|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471017|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471018|NCT00940940|Vaccines|vaccines|mesh-list
154471019|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
154471020|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471021|NCT03557840|Temocillin|temocillin|mesh-list
154471022|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154471023|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471024|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
154471025|NCT02092701|Vitamin D|vitamin d|mesh-list
154471026|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154471027|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471028|NCT02092701|Vitamins|vitamins|mesh-ancestor
154471029|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
154471030|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154471031|NCT01767129|Quinidine|quinidine|mesh-list
154471032|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
154471033|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
154471034|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471035|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154471036|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154471037|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471038|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471039|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860640|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154471040|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154471041|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154471042|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
154471043|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154471044|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
154471045|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154471046|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154471047|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471048|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471049|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154471050|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154471051|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
154471052|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154471054|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471055|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154471056|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154471058|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154471059|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
154471060|NCT03420638|Epinephrine|epinephrine|mesh-list
154471061|NCT03420638|Bupivacaine|bupivacaine|mesh-list
154471062|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
154471063|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
154471064|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471065|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471066|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
154471067|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471068|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154471069|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154471070|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
154471071|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471072|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471073|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154471074|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154471075|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
154471076|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154471077|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471078|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
154471079|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
154471080|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154471081|NCT00715988|Methadone|methadone|mesh-list
154471082|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471083|NCT00715988|Narcotics|narcotics|mesh-ancestor
154471084|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471085|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471086|NCT00715988|Analgesics|analgesics|mesh-ancestor
154471087|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
154471088|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471089|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
154471090|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471091|NCT02093091|Vitremer|vitremer|mesh-list
154471092|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
154471093|NCT02093091|Protective Agents|protective agents|mesh-ancestor
154471094|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471095|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154471096|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
154471097|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471098|NCT03556917|Caffeine|caffeine|mesh-list
154471099|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154471100|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471101|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154471102|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471103|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471104|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154471105|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154471106|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
154471107|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471108|NCT02090439|Silodosin|silodosin|mesh-list
154471109|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154471110|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154471111|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154471112|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
154471113|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471114|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099312|NCT00525759|Epirubicin|epirubicin|mesh-list
154471115|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471116|NCT02090439|Urological Agents|urological agents|mesh-ancestor
154471117|NCT02696564|Losartan|losartan|mesh-list
154471118|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154471119|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154471120|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154471121|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154471122|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471123|NCT02093403|Decitabine|decitabine|mesh-list
154195053|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
154471124|NCT02093403|Azacitidine|azacitidine|mesh-list
154471125|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154471126|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
154471127|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471128|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471129|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471130|NCT03426176|Oxytocin|oxytocin|mesh-list
154471131|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
154471132|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154471133|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471134|NCT02095899|Rufinamide|rufinamide|mesh-list
154471135|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
154471136|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154471137|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154471138|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471139|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471140|NCT03426020|Midazolam|midazolam|mesh-list
154471141|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154471142|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154471143|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471144|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471145|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154471146|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154471147|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471148|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154471149|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
154471150|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
154471151|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
154471152|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
154471153|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471154|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471155|NCT03428906|Oxytocin|oxytocin|mesh-list
154471156|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
154471157|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154471158|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471159|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154471160|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
154471161|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154471162|NCT02521298|Prednisolone|prednisolone|mesh-list
154471163|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
154471164|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154471165|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
154471166|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154471167|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
154471168|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
154471169|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471170|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471171|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154471172|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
154471173|NCT02521298|Hormones|hormones|mesh-ancestor
154471174|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471175|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154471176|NCT02521298|Protective Agents|protective agents|mesh-ancestor
154471177|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154471178|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471179|NCT00389870|Cyclosporine|cyclosporine|mesh-list
154471180|NCT00389870|Irinotecan|irinotecan|mesh-list
154471181|NCT00389870|Panitumumab|panitumumab|mesh-list
154471182|NCT00389870|Cyclosporins|cyclosporins|mesh-list
154471183|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154471184|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154471185|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471186|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471187|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471188|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154471189|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
154860641|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
154471190|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471191|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
154471192|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471193|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
154471194|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154471195|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154471196|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471198|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154471199|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471200|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
154471201|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471202|NCT03417206|Remifentanil|remifentanil|mesh-list
154471203|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471204|NCT03417206|Narcotics|narcotics|mesh-ancestor
154471205|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471206|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471207|NCT03417206|Analgesics|analgesics|mesh-ancestor
154471208|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
154471209|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471210|NCT00003716|Rituximab|rituximab|mesh-list
154471211|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471212|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471213|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
154471214|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471215|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154471216|NCT02593786|Nivolumab|nivolumab|mesh-list
154471217|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471218|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471219|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154471220|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471221|NCT03425708|Febuxostat|febuxostat|mesh-list
154471222|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
154471223|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154471224|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154471225|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154471226|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154471227|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471228|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471229|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471230|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154471231|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154471232|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
154471233|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471234|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471235|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154471236|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154471237|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
154471238|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
154471239|NCT03425474|Propofol|propofol|mesh-list
154471240|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154471241|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471242|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471243|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154471244|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
154471245|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
154471246|NCT03419624|Metformin|metformin|mesh-list
154471247|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
154471248|NCT03419624|Exenatide|exenatide|mesh-list
154471249|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154471250|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471251|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154471252|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471253|NCT03419624|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154035292|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
154035293|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154035294|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035295|NCT02624505|Albuterol|albuterol|mesh-list
154035296|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154035297|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
154035298|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035299|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035300|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154035301|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
154035302|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
154035303|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154035304|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154035305|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154035306|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154471254|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154471255|NCT03419624|Incretins|incretins|mesh-ancestor
154471256|NCT03419624|Hormones|hormones|mesh-ancestor
154471257|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471258|NCT03425162|Morphine|morphine|mesh-list
154471259|NCT03425162|Bupivacaine|bupivacaine|mesh-list
154471260|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
154471261|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
154471262|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471263|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860642|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
154860643|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154471264|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
154471265|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471266|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471267|NCT03425162|Narcotics|narcotics|mesh-ancestor
154471268|NCT03425162|Analgesics|analgesics|mesh-ancestor
154471269|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
154471270|NCT02096133|Vitamin D|vitamin d|mesh-list
154471271|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154471272|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471273|NCT02096133|Vitamins|vitamins|mesh-ancestor
154471274|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
154195202|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154471275|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154471277|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154471278|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154471279|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471280|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471281|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471282|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154035322|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154035323|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471283|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
154471284|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471285|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471286|NCT02090673|Exenatide|exenatide|mesh-list
154471287|NCT02090673|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154471288|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154471289|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471290|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154471291|NCT02090673|Incretins|incretins|mesh-ancestor
154471292|NCT02090673|Hormones|hormones|mesh-ancestor
154471293|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471294|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
154471295|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154471296|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
154471297|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471298|NCT03556371|Expectorants|expectorants|mesh-ancestor
154471299|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471300|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154471301|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
154471302|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471303|NCT03556371|Protective Agents|protective agents|mesh-ancestor
154471304|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471305|NCT03556371|Antidotes|antidotes|mesh-ancestor
154471306|NCT02827526|Ketamine|ketamine|mesh-list
154471307|NCT02827526|Analgesics|analgesics|mesh-ancestor
154471308|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
154471309|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471310|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471311|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154471312|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154471313|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
154471314|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
154471315|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471316|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154471317|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154471318|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471319|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471320|NCT04799314|Tislelizumab|tislelizumab|mesh-list
154471321|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154471322|NCT04799314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471323|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471324|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471325|NCT03425084|Morphine|morphine|mesh-list
154471326|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471327|NCT03425084|Narcotics|narcotics|mesh-ancestor
154471328|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471329|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471330|NCT03425084|Analgesics|analgesics|mesh-ancestor
154471331|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
154471332|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471333|NCT03424928|Thalidomide|thalidomide|mesh-list
154471334|NCT03424928|Pomalidomide|pomalidomide|mesh-list
154471335|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
154471336|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471337|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154471339|NCT03424928|Growth Substances|growth substances|mesh-ancestor
154471340|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
154471341|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471342|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154471343|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
154471344|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154471345|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471346|NCT04799002|Melphalan|melphalan|mesh-list
154471347|NCT04799002|Topotecan|topotecan|mesh-list
154471348|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154195277|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154471349|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
154471350|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471351|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471352|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154471353|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154471354|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
154471355|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471356|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154471357|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154471358|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471359|NCT02098785|Caffeine|caffeine|mesh-list
154471360|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
154471361|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471362|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154471363|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471364|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154471365|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471366|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154471367|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154471368|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
154471369|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471370|NCT02521064|Prednisone|prednisone|mesh-list
154471371|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154471372|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
154471373|NCT02521064|Hormones|hormones|mesh-ancestor
154471374|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471375|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471376|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154471377|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471378|NCT02096913|Ibuprofen|ibuprofen|mesh-list
154471379|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154471380|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154471381|NCT02096913|Analgesics|analgesics|mesh-ancestor
154471382|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
154471383|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471384|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471385|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154471386|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154471387|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154471388|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471389|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471390|NCT03418610|Azelaic acid|azelaic acid|mesh-list
154471391|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471392|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
154471393|NCT04604366|Alprostadil|alprostadil|mesh-list
154471394|NCT04604366|Misoprostol|misoprostol|mesh-list
154471395|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154471396|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
154471397|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154471398|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471399|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154471400|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154471401|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
154471402|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154471403|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
154471404|NCT04604366|Urological Agents|urological agents|mesh-ancestor
154471405|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
154471406|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154471407|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471408|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471409|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154471410|NCT02099253|Analgesics|analgesics|mesh-ancestor
154860644|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471411|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
154035454|NCT02783183|Pregabalin|pregabalin|mesh-list
154471412|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471413|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154471414|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154471415|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154471416|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
154471417|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471418|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471419|NCT05818111|Lidocaine|lidocaine|mesh-list
154471420|NCT05818111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154471421|NCT05818111|Anesthetics|anesthetics|mesh-ancestor
154471422|NCT05818111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471423|NCT05818111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471424|NCT05818111|Sensory System Agents|sensory system agents|mesh-ancestor
154471425|NCT05818111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471426|NCT05818111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154471427|NCT05818111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154471428|NCT05818111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154471429|NCT05818111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471430|NCT05818111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471431|NCT05818007|Hyaluronic Acid|hyaluronic acid|mesh-list
154471432|NCT05818007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154471433|NCT05818007|Immunologic Factors|immunologic factors|mesh-ancestor
154471434|NCT05818007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471435|NCT05818007|Viscosupplements|viscosupplements|mesh-ancestor
154471436|NCT05818007|Protective Agents|protective agents|mesh-ancestor
154471437|NCT05817955|Azacitidine|azacitidine|mesh-list
154471438|NCT05817955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154471439|NCT05817955|Antimetabolites|antimetabolites|mesh-ancestor
154471440|NCT05817955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471441|NCT05817955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471442|NCT05817955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471443|NCT05817409|Baclofen|baclofen|mesh-list
154471444|NCT05817409|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154471445|NCT05817409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471446|NCT05817409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154471447|NCT05817409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471448|NCT05817409|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154471449|NCT05817409|GABA Agonists|gaba agonists|mesh-ancestor
154471450|NCT05817409|GABA Agents|gaba agents|mesh-ancestor
154471451|NCT05817409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471452|NCT05817409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471453|NCT05817253|Coal Tar|coal tar|mesh-list
154471454|NCT05817253|Keratolytic Agents|keratolytic agents|mesh-ancestor
154471455|NCT05817253|Dermatologic Agents|dermatologic agents|mesh-ancestor
154471456|NCT05817201|Tegafur|tegafur|mesh-list
154471457|NCT05817201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154471458|NCT05817201|Antimetabolites|antimetabolites|mesh-ancestor
154471459|NCT05817201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471460|NCT05817201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471461|NCT05817019|Neostigmine|neostigmine|mesh-list
154471462|NCT05817019|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154471463|NCT05817019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471464|NCT05817019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471465|NCT05817019|Cholinergic Agents|cholinergic agents|mesh-ancestor
154471466|NCT05817019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471467|NCT05817019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471468|NCT05817019|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154471469|NCT05817019|Autonomic Agents|autonomic agents|mesh-ancestor
154471470|NCT05817019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471471|NCT05816772|Calcium|calcium|mesh-list
154471472|NCT05816772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154471473|NCT05816772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471474|NCT05816720|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154471475|NCT05816720|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154471476|NCT05816720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471477|NCT05816694|Paclitaxel|paclitaxel|mesh-list
154471478|NCT05816694|Cyclophosphamide|cyclophosphamide|mesh-list
154471479|NCT05816694|Cisplatin|cisplatin|mesh-list
154471480|NCT05816694|Epirubicin|epirubicin|mesh-list
154471481|NCT05816694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154471482|NCT05816694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471483|NCT05816694|Tubulin Modulators|tubulin modulators|mesh-ancestor
154471485|NCT05816694|Mitosis Modulators|mitosis modulators|mesh-ancestor
154471486|NCT05816694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471487|NCT05816694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154471488|NCT05816694|Immunologic Factors|immunologic factors|mesh-ancestor
154471489|NCT05816694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471490|NCT05816694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154471491|NCT05816694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154471492|NCT05816694|Alkylating Agents|alkylating agents|mesh-ancestor
154471493|NCT05816694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154471494|NCT05816694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154471495|NCT05816694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154471496|NCT05816694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154471497|NCT05816694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471499|NCT05816668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154471500|NCT05816668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154471501|NCT05816668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471502|NCT05816668|Hemostatics|hemostatics|mesh-ancestor
154471503|NCT05816668|Coagulants|coagulants|mesh-ancestor
154471504|NCT05816642|Sunitinib|sunitinib|mesh-list
154471505|NCT05816642|Axitinib|axitinib|mesh-list
154471506|NCT05816642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154035549|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471507|NCT05816642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471508|NCT05816642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154471509|NCT05816642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154471510|NCT05816642|Growth Substances|growth substances|mesh-ancestor
154471511|NCT05816642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471512|NCT05816642|Growth Inhibitors|growth inhibitors|mesh-ancestor
154471513|NCT05816642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154471514|NCT05816642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471515|NCT05816642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471516|NCT05816642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471517|NCT05816538|Anesthetics|anesthetics|mesh-list
154471518|NCT05816538|Levobupivacaine|levobupivacaine|mesh-list
154471519|NCT05816538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471520|NCT05816538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471521|NCT05816538|Anesthetics, Local|anesthetics, local|mesh-ancestor
154471522|NCT05816538|Sensory System Agents|sensory system agents|mesh-ancestor
154471523|NCT05816538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471524|NCT05809583|Ozanimod|ozanimod|mesh-list
154471525|NCT05809583|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154471526|NCT05809583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471527|NCT05809583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154471528|NCT05809583|Immunologic Factors|immunologic factors|mesh-ancestor
154471529|NCT05809583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471530|NCT05803629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154471531|NCT05803629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154471532|NCT05803629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471533|NCT05803434|Cannabidiol|cannabidiol|mesh-list
154471534|NCT05803434|Anticonvulsants|anticonvulsants|mesh-ancestor
154471535|NCT05777226|Epalrestat|epalrestat|mesh-list
154471536|NCT05777226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471537|NCT05777226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471538|NCT05769920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154471539|NCT05769920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154471540|NCT05716607|Hydrocortisone|hydrocortisone|mesh-list
154035563|NCT00975325|Yohimbine|yohimbine|mesh-list
154471541|NCT05716607|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154471542|NCT05716607|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154471543|NCT05716607|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154471544|NCT05716607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154471545|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154471546|NCT05688579|Mineralocorticoids|mineralocorticoids|mesh-list
154471547|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
154471548|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471549|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471550|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154471551|NCT05688579|Diuretics|diuretics|mesh-ancestor
154471552|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
154471553|NCT05688579|Hormones|hormones|mesh-ancestor
154471554|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154471555|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
154471556|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
154471557|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154471558|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471560|NCT05659823|Morphine|morphine|mesh-list
154471561|NCT05659823|Bupivacaine|bupivacaine|mesh-list
154471562|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
154471563|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
154471564|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471565|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471566|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
154471567|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471568|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471569|NCT05659823|Narcotics|narcotics|mesh-ancestor
154471570|NCT05659823|Analgesics|analgesics|mesh-ancestor
154471571|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154471572|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154471573|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
154471575|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
154471576|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154471577|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471578|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471579|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154471580|NCT05640453|Analgesics|analgesics|mesh-ancestor
154471581|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
154471582|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471583|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154471584|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154471585|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154471586|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
154471587|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471588|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471589|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
154471590|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154471591|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471592|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154471593|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154471594|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154471595|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471596|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
154471597|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
154471598|NCT05581901|Methadone|methadone|mesh-list
154471599|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471600|NCT05581901|Narcotics|narcotics|mesh-ancestor
154471601|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471602|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471603|NCT05581901|Analgesics|analgesics|mesh-ancestor
154471604|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
154471605|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471606|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
154471607|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471608|NCT05508061|Insulin|insulin|mesh-list
154471609|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154471610|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
154471611|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154471612|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471613|NCT05504642|Nivolumab|nivolumab|mesh-list
154471614|NCT05504642|Ipilimumab|ipilimumab|mesh-list
154471615|NCT05504642|Immunomodulating Agents|immunomodulating agents|mesh-list
154471616|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
154471617|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471618|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471619|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154471620|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471621|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471622|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
154471623|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154471624|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471625|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471626|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154471627|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154471628|NCT05490953|Protective Agents|protective agents|mesh-ancestor
154471629|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471630|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
154471631|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154471632|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
154471633|NCT05474729|Minocycline|minocycline|mesh-list
154471634|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154471635|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471637|NCT05474001|Bupivacaine|bupivacaine|mesh-list
154471638|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
154471639|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
153814841|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154471640|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471641|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471642|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
154471643|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471644|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471645|NCT05474001|Narcotics|narcotics|mesh-ancestor
154471646|NCT05474001|Analgesics|analgesics|mesh-ancestor
154471647|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154471648|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154471649|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
154471651|NCT05445232|Caffeine|caffeine|mesh-list
154471652|NCT05445232|Warfarin|warfarin|mesh-list
154471653|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154471654|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154471655|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471656|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471657|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154471658|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154471659|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471660|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154471661|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
154471662|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
154471663|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
154471664|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
154471665|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471666|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471667|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
154471668|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154471669|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154471670|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471671|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154471672|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154471673|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
154471674|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
154471675|NCT05420805|Butyric Acid|butyric acid|mesh-list
154471676|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
154471677|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
154471678|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154471679|NCT05420805|Protective Agents|protective agents|mesh-ancestor
154471680|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471681|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
154471682|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
154471683|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471684|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035715|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
154035716|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
154035717|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154471685|NCT05395533|Antibodies|antibodies|mesh-list
154471686|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154471687|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
154471688|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471689|NCT05355974|Norepinephrine|norepinephrine|mesh-list
154471690|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
154471691|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154471692|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154471693|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
154471694|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471695|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471696|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471697|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
154471698|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
154471699|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471700|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154471701|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154471702|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154471703|NCT05340413|Olaparib|olaparib|mesh-list
154471704|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154471705|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471706|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471707|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471708|NCT05112211|Doxycycline|doxycycline|mesh-list
154471709|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154471710|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471711|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
154099909|NCT00711516|Modafinil|modafinil|mesh-list
154860645|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154471712|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154471713|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154471714|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154471715|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
154471716|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471717|NCT05107427|Avelumab|avelumab|mesh-list
154471718|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471719|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471720|NCT05035745|Talazoparib|talazoparib|mesh-list
154471721|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154471722|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195647|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
154471723|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471724|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471726|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
154471727|NCT05005897|Vitamins|vitamins|mesh-ancestor
154471728|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
154471729|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471730|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
154471731|NCT05005897|Hematinics|hematinics|mesh-ancestor
154471732|NCT04994977|Carboplatin|carboplatin|mesh-list
154471733|NCT04994977|Melphalan|melphalan|mesh-list
154471734|NCT04994977|Topotecan|topotecan|mesh-list
154471735|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471736|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154471737|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
154471738|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471739|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154471740|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154471741|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
154471742|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471743|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154471744|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154471745|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471746|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
154471747|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154471748|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
154471749|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471750|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
154471751|NCT04866706|Protective Agents|protective agents|mesh-ancestor
154471752|NCT04846478|Talazoparib|talazoparib|mesh-list
154471753|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154471754|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471755|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471756|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471757|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
154471758|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471759|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471760|NCT04834973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154471761|NCT04834973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471762|NCT04764825|Morphine|morphine|mesh-list
154471763|NCT04764825|Methadone|methadone|mesh-list
154471764|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471765|NCT04764825|Narcotics|narcotics|mesh-ancestor
154471766|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035763|NCT05263583|Bromides|bromides|mesh-list
154471767|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471768|NCT04764825|Analgesics|analgesics|mesh-ancestor
154471769|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
154471770|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471771|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
154471772|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471773|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
154471774|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154471775|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
154471776|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471777|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154471778|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
154471779|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154471780|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
154471781|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471782|NCT04706910|Furosemide|furosemide|mesh-list
154471783|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154471784|NCT04706910|Diuretics|diuretics|mesh-ancestor
154471785|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
154471786|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471787|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154471788|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471789|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471790|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
154471791|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471793|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
154471794|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471795|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471796|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154471797|NCT04704271|Analgesics|analgesics|mesh-ancestor
154471798|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
154471799|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471800|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154471801|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154471802|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471803|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471804|NCT04704271|Hormones|hormones|mesh-ancestor
154471805|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471806|NCT04680286|Methadone|methadone|mesh-list
154471807|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471808|NCT04680286|Narcotics|narcotics|mesh-ancestor
154471809|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471810|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471811|NCT04680286|Analgesics|analgesics|mesh-ancestor
154471812|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
154471813|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471814|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
154471815|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471816|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154035798|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154471817|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154471818|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471819|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154471820|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
154471821|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471822|NCT04672018|Omeprazole|omeprazole|mesh-list
154471823|NCT04672018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154471824|NCT04672018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154471825|NCT04672018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154471826|NCT04672018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471827|NCT04672018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471828|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
154471829|NCT04638881|Analgesics|analgesics|mesh-ancestor
154471830|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
154471831|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471832|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471833|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
154471834|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471835|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154471836|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
154471837|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154471838|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471839|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471840|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154471841|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
154471842|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154471843|NCT04627753|Rituximab|rituximab|mesh-list
154471844|NCT04627753|Lenalidomide|lenalidomide|mesh-list
154471845|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471846|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471847|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
154471848|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471849|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154471850|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154471851|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154471852|NCT04627753|Growth Substances|growth substances|mesh-ancestor
154471853|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
154471854|NCT04564612|Itraconazole|itraconazole|mesh-list
154471855|NCT04564612|Rabeprazole|rabeprazole|mesh-list
154471856|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
154471857|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471858|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154100070|NCT00879892|Xenon|xenon|mesh-list
154471859|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154471860|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471861|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471862|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154471863|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
154471864|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471865|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471866|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154471867|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154471868|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154471869|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154471870|NCT04518319|Olanzapine|olanzapine|mesh-list
154471871|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
154471872|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
154471873|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471874|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471875|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154471877|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154471878|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471879|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471880|NCT04518319|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154471881|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154471882|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471883|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471884|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471885|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
154471886|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
154471887|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154471888|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154471889|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154471890|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
154471891|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
154471892|NCT04495868|Lidocaine|lidocaine|mesh-list
154471893|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
154471894|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
154471895|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471896|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471897|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
154471898|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471899|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154471900|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154471901|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154471902|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471903|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471904|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
154471905|NCT04483544|Olaparib|olaparib|mesh-list
154471906|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471907|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471908|NCT04483544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154471909|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973785|NCT06247787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154471910|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154471911|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471912|NCT04475029|Morphine|morphine|mesh-list
154471913|NCT04475029|Methadone|methadone|mesh-list
154471914|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154471915|NCT04475029|Narcotics|narcotics|mesh-ancestor
154471916|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471917|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471918|NCT04475029|Analgesics|analgesics|mesh-ancestor
154471919|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
154471920|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471921|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
154471922|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
154471923|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
154471924|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
154471925|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154471926|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471927|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471928|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
154471929|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154471930|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154471931|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471932|NCT04253561|Trastuzumab|trastuzumab|mesh-list
154471933|NCT04253561|Pertuzumab|pertuzumab|mesh-list
154471934|NCT04253561|Ipatasertib|ipatasertib|mesh-list
154471935|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154471936|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471937|NCT04253561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154471938|NCT04253561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471939|NCT04253561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471940|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
154471941|NCT04240171|Glimepiride|glimepiride|mesh-list
154471942|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154471943|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471944|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154195876|NCT00385593|Budesonide|budesonide|mesh-list
154471945|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471946|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154471947|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154471948|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
154471949|NCT04170738|Amphetamine|amphetamine|mesh-list
154471950|NCT04170738|Adderall|adderall|mesh-list
154471951|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
154471952|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154471953|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471954|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
154471955|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
154471956|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154471957|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
154035944|NCT00981487|Ondansetron|ondansetron|mesh-list
154471958|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154471959|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471960|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
154471961|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154471962|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154471963|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154471964|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154471965|NCT04094142|Lenalidomide|lenalidomide|mesh-list
154471966|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
154471967|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471968|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
154471969|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471970|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154471971|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154471972|NCT04094142|Growth Substances|growth substances|mesh-ancestor
154471973|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
154471974|NCT04094142|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154471975|NCT04094142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154471976|NCT04094142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154471977|NCT04094142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154471978|NCT04089514|Adalimumab|adalimumab|mesh-list
154471979|NCT04089514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154471980|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154471981|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154471982|NCT04088409|Adalimumab|adalimumab|mesh-list
154471983|NCT04088409|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154471984|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154471985|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154471986|NCT04004988|Tirzepatide|tirzepatide|mesh-list
154471987|NCT04004988|Incretins|incretins|mesh-ancestor
154471988|NCT04004988|Hormones|hormones|mesh-ancestor
154471989|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471990|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471991|NCT03934840|Prednisone|prednisone|mesh-list
154471992|NCT03934840|Carboplatin|carboplatin|mesh-list
154471993|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154471994|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154471995|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
154471996|NCT03934840|Hormones|hormones|mesh-ancestor
154035990|NCT00977353|Citalopram|citalopram|mesh-list
154471997|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154471998|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154471999|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154472000|NCT03781765|Methylphenidate|methylphenidate|mesh-list
154472001|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154472002|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154472003|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472004|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154860646|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
154860647|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472005|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154472006|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472007|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472008|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
154472009|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472010|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154472011|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472012|NCT03781752|Methylphenidate|methylphenidate|mesh-list
154472013|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154472014|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472015|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154472016|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154472017|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195956|NCT00395967|Plerixafor|plerixafor|mesh-list
154472018|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472019|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
154472020|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472021|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
154472022|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154472023|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
154472024|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154472025|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
154472026|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472027|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472028|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
154472030|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472031|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154472032|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472033|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036029|NCT00981721|Cediranib|cediranib|mesh-list
154472034|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
154472035|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154472036|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472037|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472038|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472039|NCT03708315|Analgesics|analgesics|mesh-ancestor
154472040|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
154472041|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472042|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154472043|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154472044|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154472045|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472046|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472047|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472048|NCT03579966|Amifampridine|amifampridine|mesh-list
154472049|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154472050|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472051|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472052|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154472053|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472054|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472055|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154472056|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154472057|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154472058|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154472059|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154472060|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154472061|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154472062|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472063|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472064|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472065|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472066|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154472067|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472068|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
154472069|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154472070|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472071|NCT03507699|Nivolumab|nivolumab|mesh-list
154472072|NCT03507699|Ipilimumab|ipilimumab|mesh-list
154472073|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472074|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472075|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154860648|NCT01924910|Vitamin D|vitamin d|mesh-list
154472076|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472077|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
154472078|NCT03497923|Analgesics|analgesics|mesh-ancestor
154472079|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
154472080|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472081|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472082|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
154472083|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472084|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154472085|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
154472086|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154472087|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472088|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196017|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
154472089|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154472090|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
154472091|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154472092|NCT03377387|Capecitabine|capecitabine|mesh-list
154472093|NCT03377387|Neratinib|neratinib|mesh-list
154472094|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154472095|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
154472096|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472097|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472098|NCT03377387|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154472099|NCT03377387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154472100|NCT03377387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472101|NCT03372837|Rituximab|rituximab|mesh-list
154472102|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472103|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472104|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
154472105|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472106|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154472107|NCT03261284|Heparin|heparin|mesh-list
154472108|NCT03261284|Calcium heparin|calcium heparin|mesh-list
154472109|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
154472110|NCT03261284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154472111|NCT03261284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154472112|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472113|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
154472114|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
154472115|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
154472116|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472117|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154472118|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154472119|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154472120|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
154472121|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472122|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472123|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154472124|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472125|NCT03219450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154472126|NCT03127267|Riluzole|riluzole|mesh-list
154472127|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
154472128|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154472129|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154472130|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472131|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472132|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472133|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154472134|NCT03127267|Protective Agents|protective agents|mesh-ancestor
154472135|NCT03092466|Ropivacaine|ropivacaine|mesh-list
154472136|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
154472137|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
154472138|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472139|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472140|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
154472141|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472142|NCT03017872|Ritonavir|ritonavir|mesh-list
154472143|NCT03017872|Darunavir|darunavir|mesh-list
154472144|NCT03017872|Dolutegravir|dolutegravir|mesh-list
154472145|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154472146|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154472147|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
154472148|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860649|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
154472149|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472150|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154472151|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154472152|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
154472153|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472154|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154472155|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154472156|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154472157|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154472158|NCT03000205|Lidocaine|lidocaine|mesh-list
154472159|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
154472160|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
154472161|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472162|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472163|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
154472164|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472165|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154472166|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154472167|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154472168|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472169|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472170|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154472171|NCT02942095|Ixazomib|ixazomib|mesh-list
154472172|NCT02942095|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154472173|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154472174|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472175|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472176|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472177|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
154472178|NCT02872467|Oxytocin|oxytocin|mesh-list
154472179|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
154472180|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154472181|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472182|NCT02781519|Dronabinol|dronabinol|mesh-list
154472183|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
154472184|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472185|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154472186|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472187|NCT02781519|Analgesics|analgesics|mesh-ancestor
154472188|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
154472189|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472190|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154472191|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154472192|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472193|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472194|NCT02781519|Hormones|hormones|mesh-ancestor
154472195|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472196|NCT02536664|Rituximab|rituximab|mesh-list
154472197|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472198|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472199|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
154472200|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472201|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154472202|NCT02426892|Nivolumab|nivolumab|mesh-list
154472203|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472204|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472205|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154472206|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472207|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
154472208|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154472209|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
154472210|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472211|NCT02094625|Expectorants|expectorants|mesh-ancestor
154472212|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
154472213|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154472214|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
154472215|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472216|NCT02094625|Protective Agents|protective agents|mesh-ancestor
154472217|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472218|NCT02094625|Antidotes|antidotes|mesh-ancestor
154472219|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
154472220|NCT02054520|Nivolumab|nivolumab|mesh-list
154472221|NCT02054520|Ipilimumab|ipilimumab|mesh-list
154472222|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472223|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472224|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154472225|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472226|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
154472227|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154472228|NCT01922921|Trastuzumab|trastuzumab|mesh-list
154472229|NCT01922921|Pertuzumab|pertuzumab|mesh-list
154472230|NCT01922921|Antibodies|antibodies|mesh-list
154472231|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
154472232|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154472233|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
154472234|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472235|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472236|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154472237|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154196165|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154472238|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
154472239|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472240|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
154472241|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154472242|NCT01922921|Protective Agents|protective agents|mesh-ancestor
154472243|NCT01546987|Leuprolide|leuprolide|mesh-list
154472244|NCT01546987|Goserelin|goserelin|mesh-list
154472245|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154472246|NCT01546987|Flutamide|flutamide|mesh-list
154472247|NCT01546987|Bicalutamide|bicalutamide|mesh-list
154472248|NCT01546987|Buserelin|buserelin|mesh-list
154472249|NCT01546987|Androgens|androgens|mesh-list
154472250|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-list
154472251|NCT01546987|Hormones|hormones|mesh-ancestor
154472252|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472253|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472254|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154472255|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
154472256|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154472257|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154472258|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472259|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
154472260|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
154472261|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154472262|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
154472263|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154472264|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
154472265|NCT00268476|Metformin|metformin|mesh-list
154472266|NCT00268476|Prednisone|prednisone|mesh-list
154472267|NCT00268476|Prednisolone|prednisolone|mesh-list
154472268|NCT00268476|Celecoxib|celecoxib|mesh-list
154472269|NCT00268476|Docetaxel|docetaxel|mesh-list
154472270|NCT00268476|Estradiol|estradiol|mesh-list
154472271|NCT00268476|Androgens|androgens|mesh-list
154472272|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154472273|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472274|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472275|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
154472276|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
154472277|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
154472278|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472279|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154472280|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
154472281|NCT00268476|Hormones|hormones|mesh-ancestor
154472282|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472283|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154472284|NCT00268476|Estrogens|estrogens|mesh-ancestor
154472285|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472286|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154472287|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472288|NCT00268476|Analgesics|analgesics|mesh-ancestor
154472289|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
154472290|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154472291|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154472292|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154472293|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472294|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154472295|NCT00261443|Valproic Acid|valproic acid|mesh-list
154036339|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154472296|NCT00261443|Aripiprazole|aripiprazole|mesh-list
154472297|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
154472298|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
154472299|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154472300|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154472301|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154472302|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472303|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472304|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
154472306|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472307|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472308|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154472309|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154472310|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
154472311|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154472312|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154472313|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154472314|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154472315|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472316|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
154472317|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
154472318|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
154472319|NCT00093379|Capecitabine|capecitabine|mesh-list
154472320|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
154472321|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154472322|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
154472323|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472324|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472325|NCT00000524|Cyclosporine|cyclosporine|mesh-list
154472326|NCT00000524|Prednisone|prednisone|mesh-list
154472327|NCT00000524|Cyclosporins|cyclosporins|mesh-list
154472328|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154472329|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
154472330|NCT00000524|Hormones|hormones|mesh-ancestor
154472331|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472332|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472333|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154472334|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472335|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472336|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472337|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154472338|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
154472339|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
154472340|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472341|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
154472342|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154472343|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154472344|NCT02099331|Melatonin|melatonin|mesh-list
154472345|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
154472346|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472347|NCT02099331|Protective Agents|protective agents|mesh-ancestor
154472348|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472349|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472350|NCT05328388|Lycopene|lycopene|mesh-list
154472351|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154472352|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
154472353|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472354|NCT05328388|Protective Agents|protective agents|mesh-ancestor
154472355|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472356|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154472357|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154472358|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472359|NCT02097069|Folic Acid|folic acid|mesh-list
154472360|NCT02097069|Inositol|inositol|mesh-list
154472361|NCT02097069|Hematinics|hematinics|mesh-ancestor
154472362|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
154472363|NCT02097069|Vitamins|vitamins|mesh-ancestor
154472364|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
154472365|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472366|NCT03424226|Acetazolamide|acetazolamide|mesh-list
154472367|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
154472368|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154472369|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472370|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472371|NCT03424226|Diuretics|diuretics|mesh-ancestor
154472372|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
154472373|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472374|NCT02250729|Pholcodine|pholcodine|mesh-list
154472375|NCT02250729|Analgesics|analgesics|mesh-ancestor
154472376|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
154472377|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472378|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472379|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
154472380|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
154472381|NCT02097147|Paroxetine|paroxetine|mesh-list
154472382|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154472383|NCT02097147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154472384|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154472385|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472386|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472387|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472388|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
154472389|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472390|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154472391|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
154472392|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154472393|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154472394|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154472395|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472396|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154472397|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154472398|NCT03415802|Paclitaxel|paclitaxel|mesh-list
154472399|NCT03415802|Tegafur|tegafur|mesh-list
154472400|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154472401|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472402|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
154472403|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
154472404|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
154472405|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472406|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154472407|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
154472408|NCT02099877|Fentanyl|fentanyl|mesh-list
154472409|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154472410|NCT02099877|Narcotics|narcotics|mesh-ancestor
154472411|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472412|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472413|NCT02099877|Analgesics|analgesics|mesh-ancestor
154472414|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
154472415|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472416|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154472417|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154472418|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
154472419|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
154472420|NCT02097381|Ritonavir|ritonavir|mesh-list
154472421|NCT02097381|Lopinavir|lopinavir|mesh-list
154472422|NCT02097381|Darunavir|darunavir|mesh-list
154472423|NCT02097381|Tenofovir|tenofovir|mesh-list
154472424|NCT02097381|Emtricitabine|emtricitabine|mesh-list
154472425|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154472426|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154472427|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
154472428|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472429|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036432|NCT02660840|Flupenthixol|flupenthixol|mesh-list
154472430|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154472431|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154472432|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
154472433|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472434|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154472435|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154472436|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154472437|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154472438|NCT02099955|Vitamin D|vitamin d|mesh-list
154472439|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
154472440|NCT02099955|Vitamins|vitamins|mesh-ancestor
154472441|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
154472442|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472443|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154472444|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154472445|NCT02097459|Tamoxifen|tamoxifen|mesh-list
154472446|NCT02097459|Toremifene|toremifene|mesh-list
154472447|NCT02097459|Anastrozole|anastrozole|mesh-list
154472448|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154472449|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
154472450|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472451|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472452|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154472453|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472454|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154472455|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154472456|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154472457|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154472458|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154472459|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472460|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472462|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154472463|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154472464|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472465|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
154472466|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
154472467|NCT02590432|Linaclotide|linaclotide|mesh-list
154472468|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154472469|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
154472470|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472471|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154472472|NCT02094339|Analgesics|analgesics|mesh-list
154472473|NCT02094339|Ropivacaine|ropivacaine|mesh-list
154472474|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
154472475|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
154472476|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472477|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472478|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
154472479|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472480|NCT03415646|Morphine|morphine|mesh-list
154472481|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154472482|NCT03415646|Narcotics|narcotics|mesh-ancestor
154036473|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154472483|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472484|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036523|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036524|NCT04226885|Midazolam|midazolam|mesh-list
154472485|NCT03415646|Analgesics|analgesics|mesh-ancestor
154472486|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
154472487|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472488|NCT03417518|Propofol|propofol|mesh-list
154472489|NCT03417518|Desflurane|desflurane|mesh-list
154472490|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154472491|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472492|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472493|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154472494|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
154472495|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
154472496|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154472497|NCT02094651|Valproic Acid|valproic acid|mesh-list
154472498|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
154472499|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472500|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472501|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
154472502|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472503|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472504|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
154472505|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154472506|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472507|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154472508|NCT02094807|Acetaminophen|acetaminophen|mesh-list
154472509|NCT02094807|Diclofenac|diclofenac|mesh-list
154472510|NCT02094807|Oxycodone|oxycodone|mesh-list
154472511|NCT02094807|Tramadol|tramadol|mesh-list
154472512|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472513|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472514|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472515|NCT02094807|Analgesics|analgesics|mesh-ancestor
154472516|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
154472517|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472518|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
154472519|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154472520|NCT02094807|Narcotics|narcotics|mesh-ancestor
154472521|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154472522|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154472523|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814847|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
154472524|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154472525|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472526|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472527|NCT05139472|Empagliflozin|empagliflozin|mesh-list
154472528|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154472529|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472530|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154472531|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472532|NCT04757090|Trastuzumab|trastuzumab|mesh-list
154472533|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472534|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472535|NCT03397862|Donepezil|donepezil|mesh-list
154472536|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154472537|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472538|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472539|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
154472540|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472541|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472542|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
154196461|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154472543|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
154472544|NCT02100267|Miotics|miotics|mesh-ancestor
154472545|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
154472546|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472547|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472548|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154472549|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154472550|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
154472551|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154472552|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154472553|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
154472554|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472555|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472556|NCT02094963|Clopidogrel|clopidogrel|mesh-list
154472557|NCT02094963|Ticagrelor|ticagrelor|mesh-list
154472558|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154472559|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154472560|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154472561|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154472562|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
154036560|NCT02777489|Perindopril|perindopril|mesh-list
154472563|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472564|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472565|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472566|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154472567|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154472568|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472569|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
154472570|NCT02098317|Vitamin D|vitamin d|mesh-list
154472571|NCT02098317|Vitamins|vitamins|mesh-ancestor
154472572|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
154472573|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472574|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154472575|NCT02100423|Vitamin D|vitamin d|mesh-list
154472576|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
154472577|NCT02100423|Curcumin|curcumin|mesh-list
154472578|NCT02100423|Vitamins|vitamins|mesh-ancestor
154472579|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
154472580|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472581|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154472582|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154472583|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154472584|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472585|NCT02100423|Analgesics|analgesics|mesh-ancestor
154472586|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
154472587|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472588|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154472589|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154472590|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472591|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472592|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472593|NCT02520752|Midazolam|midazolam|mesh-list
154472594|NCT02520752|Caffeine|caffeine|mesh-list
154472595|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154472596|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154472597|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472598|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472599|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154472600|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154472601|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154472602|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154472603|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
154472604|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
154472605|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
154472606|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
154472607|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472608|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472609|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154472610|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154472611|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472612|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154472613|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154472614|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
154472615|NCT02095119|Gemcitabine|gemcitabine|mesh-list
154472616|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
154472617|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472618|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154472619|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
154472620|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472621|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472622|NCT02098629|Milrinone|milrinone|mesh-list
154472623|NCT02098629|Esmolol|esmolol|mesh-list
154472624|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154472625|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154472626|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154472627|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472628|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472629|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472630|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472631|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154472632|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154472633|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
154472634|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154472635|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154472636|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472637|NCT02098629|Protective Agents|protective agents|mesh-ancestor
154472638|NCT02095509|Enoxaparin|enoxaparin|mesh-list
154472639|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
154472640|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154472641|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154472642|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472643|NCT03397082|Lidocaine|lidocaine|mesh-list
154472644|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
154472645|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
154472646|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472647|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472648|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
154472649|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472650|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154472651|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154472652|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154472653|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472654|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472655|NCT02101047|Phenylephrine|phenylephrine|mesh-list
154472656|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
154472657|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154472658|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
154472659|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
154472660|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472661|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814850|NCT00343655|Atorvastatin|atorvastatin|mesh-list
154472662|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
154472663|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154472664|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
154472665|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154472666|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154472667|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154472668|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154472669|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472670|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472671|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472672|NCT02101047|Protective Agents|protective agents|mesh-ancestor
154472673|NCT02095665|Acetaminophen|acetaminophen|mesh-list
154472674|NCT02095665|Tamsulosin|tamsulosin|mesh-list
154472675|NCT02095665|Mirabegron|mirabegron|mesh-list
154860650|NCT01924910|Vitamins|vitamins|mesh-ancestor
154472676|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154472677|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154472678|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154472679|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472680|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472681|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472682|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472683|NCT02095665|Urological Agents|urological agents|mesh-ancestor
154472684|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472685|NCT02095665|Analgesics|analgesics|mesh-ancestor
154472686|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
154472687|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472688|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
154472689|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154472690|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154472691|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154472692|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154472693|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154472694|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154472695|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
154472696|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472697|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154472698|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154472699|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472700|NCT02101203|Buspirone|buspirone|mesh-list
154472701|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154472702|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154472703|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472704|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472705|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154472706|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154472707|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
154472708|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472709|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472710|NCT04523246|Vaccines|vaccines|mesh-list
154472711|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
154472712|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472713|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
154472714|NCT03396380|Vitamin D|vitamin d|mesh-list
154472715|NCT03396380|Citric Acid|citric acid|mesh-list
154472716|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
154472717|NCT03396380|Clomiphene|clomiphene|mesh-list
154472718|NCT03396380|Enclomiphene|enclomiphene|mesh-list
154472719|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
154472720|NCT03396380|Calcium|calcium|mesh-list
154472721|NCT03396380|Vitamins|vitamins|mesh-ancestor
154472722|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
154472723|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472724|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154472725|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154472726|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
154472727|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154472728|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
154472729|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
154472730|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472731|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154472732|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
154472733|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472734|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154472735|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
154472736|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154472737|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154472738|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154472739|NCT03414164|Procyanidin|procyanidin|mesh-list
154472740|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
154472741|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472742|NCT03414164|Protective Agents|protective agents|mesh-ancestor
154472743|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472744|NCT05613478|Apatinib|apatinib|mesh-list
154472745|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
154472746|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472747|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154472748|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814853|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
154472749|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860651|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
154472750|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154472751|NCT05613478|Estrogens|estrogens|mesh-ancestor
154472752|NCT05613478|Hormones|hormones|mesh-ancestor
154472753|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472754|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472755|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154472756|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154472757|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154472758|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154472759|NCT03406988|Nifedipine|nifedipine|mesh-list
154472760|NCT03406988|Iloprost|iloprost|mesh-list
154472761|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154472762|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472763|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472764|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154472765|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472766|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
154472767|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
154472768|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154472769|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154472771|NCT03406832|Tirofiban|tirofiban|mesh-list
154472772|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154472773|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
154472774|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154472775|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472776|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154472777|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154472778|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154472779|NCT03405974|Aspirin|aspirin|mesh-list
154472780|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154472781|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472782|NCT03405974|Analgesics|analgesics|mesh-ancestor
154472783|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
154472784|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472785|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472786|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154472787|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154472788|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154472789|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154472790|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472791|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154472792|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154472793|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472794|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
154472795|NCT04337060|Lidocaine|lidocaine|mesh-list
154472796|NCT04337060|Morphine|morphine|mesh-list
154472797|NCT04337060|Bupivacaine|bupivacaine|mesh-list
154472798|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
154472799|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
154472800|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472801|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472802|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
154036783|NCT00983125|Clonidine|clonidine|mesh-list
154472803|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472804|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154472805|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154472806|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154472807|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472808|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472809|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154472810|NCT04337060|Narcotics|narcotics|mesh-ancestor
154472811|NCT04337060|Analgesics|analgesics|mesh-ancestor
154472812|NCT04447274|Apatinib|apatinib|mesh-list
154472813|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472814|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154472815|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472816|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472817|NCT02977156|Ipilimumab|ipilimumab|mesh-list
154472818|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154472819|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472820|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154472821|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472822|NCT02413138|Hormones|hormones|mesh-list
154472823|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472824|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472825|NCT01014598|Cisplatin|cisplatin|mesh-list
154472826|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472827|NCT03404804|Amoxicillin|amoxicillin|mesh-list
154472828|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154472829|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472830|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
154472831|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
154472832|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
154472833|NCT05611372|Rasagiline|rasagiline|mesh-list
154472834|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154472835|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472836|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472837|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154472838|NCT05611372|Protective Agents|protective agents|mesh-ancestor
154472839|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472840|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154472841|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
154472842|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154472843|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154036836|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472844|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154472845|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
154472846|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154472847|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472848|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154472849|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154472850|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154472851|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154472852|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472853|NCT05613166|Everolimus|everolimus|mesh-list
154472854|NCT05613166|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154472855|NCT05613166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154472856|NCT05613166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472857|NCT05613166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472858|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154472859|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
154472860|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472861|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472862|NCT05166668|Letrozole|letrozole|mesh-list
154472863|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472864|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154472865|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154472866|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472867|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472868|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154472869|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
154472870|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472871|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472872|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
154472873|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472874|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
154472875|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154472876|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154472877|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472878|NCT05558176|Urological Agents|urological agents|mesh-ancestor
154472879|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
154472880|NCT04748224|Bupivacaine|bupivacaine|mesh-list
154472881|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
154472882|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
154472883|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472884|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472885|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
154472886|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472887|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154472888|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472889|NCT04748224|Analgesics|analgesics|mesh-ancestor
154472890|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154472891|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154472892|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154472893|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472894|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973786|NCT06247787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154472895|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472896|NCT03413150|Amiodarone|amiodarone|mesh-list
154472897|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154472898|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
154472899|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154472900|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154472901|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472902|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154472903|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154472904|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154472905|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472906|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154472907|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154472908|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154472909|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154472910|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154472911|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154472912|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154472913|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154472914|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154472915|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154472916|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472917|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472918|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472919|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472921|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154472922|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154472923|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472924|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472925|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154472926|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154472927|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154472928|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154472929|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
154472930|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
154472931|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
154472932|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
154472933|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472934|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472935|NCT03412994|Apatinib|apatinib|mesh-list
154472936|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472937|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154472938|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472939|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472940|NCT02588248|Peppermint oil|peppermint oil|mesh-list
154472941|NCT02588248|Menthol|menthol|mesh-list
154472942|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
154472943|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
154472944|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
154472945|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
154472946|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472947|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472948|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154472949|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
154472950|NCT03412682|Budesonide|budesonide|mesh-list
154472951|NCT03412682|Mesalamine|mesalamine|mesh-list
154472952|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154472953|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154472954|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
154472955|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472956|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472957|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154472958|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
154472959|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
154472960|NCT03412682|Hormones|hormones|mesh-ancestor
154472961|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472962|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154472963|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472964|NCT03412682|Analgesics|analgesics|mesh-ancestor
154472965|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
154472966|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154472967|NCT03412526|Fludarabine|fludarabine|mesh-list
154472968|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154472969|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
154472970|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154472971|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154472972|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472973|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154472975|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
154472976|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154472977|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154472978|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154472979|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154472980|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
154472981|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154472982|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472983|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
154472984|NCT03395132|Betamethasone|betamethasone|mesh-list
154472985|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154472986|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
154472987|NCT03395132|Hormones|hormones|mesh-ancestor
154472988|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154472989|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154472991|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
154472992|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154472993|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154472994|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154472995|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154472996|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154472997|NCT03127124|Leucovorin|leucovorin|mesh-list
154472998|NCT03127124|Fluorouracil|fluorouracil|mesh-list
154472999|NCT03127124|Bevacizumab|bevacizumab|mesh-list
154473000|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
154473001|NCT03127124|Calcium|calcium|mesh-list
154473002|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
154473003|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154473004|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473005|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
154473006|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473007|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154473008|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473009|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473010|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
154473011|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154473012|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154473013|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154473014|NCT03127124|Growth Substances|growth substances|mesh-ancestor
154473015|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
154473016|NCT03127124|Antidotes|antidotes|mesh-ancestor
154473017|NCT03127124|Protective Agents|protective agents|mesh-ancestor
154473018|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
154473019|NCT03127124|Vitamins|vitamins|mesh-ancestor
154473020|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
154473021|NCT03127046|Aceclofenac|aceclofenac|mesh-list
154473022|NCT03127046|Diclofenac|diclofenac|mesh-list
154473023|NCT03127046|Esomeprazole|esomeprazole|mesh-list
154473024|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154473025|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473026|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154473027|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473028|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473029|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154473030|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154473031|NCT03127046|Analgesics|analgesics|mesh-ancestor
154473032|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
154473033|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037033|NCT04072198|Antidotes|antidotes|mesh-ancestor
154473034|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473035|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473036|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473037|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154473038|NCT05105672|Cisplatin|cisplatin|mesh-list
154473039|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473040|NCT03394820|Dexamethasone|dexamethasone|mesh-list
154473041|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473042|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
154473043|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
154473044|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473045|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473046|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473047|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
154473048|NCT03394820|Hormones|hormones|mesh-ancestor
154473049|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473050|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154473051|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037072|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037073|NCT04666961|Tamoxifen|tamoxifen|mesh-list
154037074|NCT04666961|Anastrozole|anastrozole|mesh-list
154037075|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154037076|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
154037077|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037078|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037079|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154037092|NCT00601172|Dexamethasone|dexamethasone|mesh-list
154473052|NCT01328054|Lapatinib|lapatinib|mesh-list
154473053|NCT01328054|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154473054|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154473055|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473056|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473057|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473058|NCT05067920|Antibodies|antibodies|mesh-list
154473059|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
154473060|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473061|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154473062|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154473063|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154473064|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154473065|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
154473066|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473067|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154473068|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154473069|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473070|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154473071|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154473073|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154473074|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
154473075|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473076|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473077|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154473078|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154473079|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
153973787|NCT06247787|Antimetabolites|antimetabolites|mesh-ancestor
154473080|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473081|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473082|NCT03394586|Golimumab|golimumab|mesh-list
154473083|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154473084|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473085|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473086|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
154473087|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473088|NCT03394430|Midazolam|midazolam|mesh-list
154473089|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
154473090|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154473091|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473092|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473093|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154473094|NCT03394430|Analgesics|analgesics|mesh-ancestor
154473095|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
154473096|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037100|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154037101|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
154037102|NCT00601172|Hormones|hormones|mesh-ancestor
154037103|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037104|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154037105|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037106|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
154037107|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154037108|NCT00601172|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154037109|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154037110|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
154037111|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473097|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154473098|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154473099|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154473100|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
154473101|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473102|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473103|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154473104|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154473105|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154473106|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154473107|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154473108|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
154473109|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
154473110|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
154473111|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
154473112|NCT03394196|Ritonavir|ritonavir|mesh-list
154473113|NCT03394196|Lopinavir|lopinavir|mesh-list
154473114|NCT03394196|Darunavir|darunavir|mesh-list
154473115|NCT03394196|Tenofovir|tenofovir|mesh-list
154473116|NCT03394196|Lamivudine|lamivudine|mesh-list
154473117|NCT03394196|Emtricitabine|emtricitabine|mesh-list
154473118|NCT03394196|Zidovudine|zidovudine|mesh-list
154473119|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
154473120|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154473121|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154473122|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
154473123|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254932|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860652|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473124|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473125|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154473126|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154473127|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
154473128|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473129|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154473130|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154473131|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154473132|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154037128|NCT00988897|Fluorouracil|fluorouracil|mesh-list
154037129|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
154037130|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037131|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037132|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154037133|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154037134|NCT00988897|Growth Substances|growth substances|mesh-ancestor
154037135|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473133|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
154473134|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154473135|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154473136|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154197066|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
154473137|NCT03398018|Hormones|hormones|mesh-ancestor
154473138|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473139|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473140|NCT03411434|Methylphenidate|methylphenidate|mesh-list
154473141|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154473142|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473143|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154473144|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154473145|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154473146|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473147|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
154473148|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473149|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
154473150|NCT03126656|Testosterone|testosterone|mesh-list
154473151|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
154473152|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
154473153|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154473154|NCT03126656|Androgens|androgens|mesh-ancestor
154473155|NCT03126656|Hormones|hormones|mesh-ancestor
154473156|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473157|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473158|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154473159|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473160|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
154473161|NCT03385382|Dexamethasone|dexamethasone|mesh-list
154473162|NCT03385382|Ranibizumab|ranibizumab|mesh-list
154037136|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
154037137|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
154473163|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473164|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
154473165|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
154473166|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473167|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473168|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473169|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
154473170|NCT03385382|Hormones|hormones|mesh-ancestor
154473171|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037160|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473172|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154473173|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473174|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154473175|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154473176|NCT03385382|Growth Substances|growth substances|mesh-ancestor
154473177|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
154473178|NCT03394118|Osimertinib|osimertinib|mesh-list
154473179|NCT03394118|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154473180|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154473181|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473182|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473183|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473184|NCT03389672|Anesthetics|anesthetics|mesh-list
154037161|NCT00989053|Escitalopram|escitalopram|mesh-list
154037162|NCT00989053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154037163|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154037164|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154037165|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473185|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473186|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473187|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
154473188|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154473189|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473190|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154473191|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154473192|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473193|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473194|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473195|NCT01907360|Methylphenidate|methylphenidate|mesh-list
154473196|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154473198|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154473199|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154473200|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154473201|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473202|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
154473203|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473204|NCT03126188|Sertraline|sertraline|mesh-list
154473205|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154473206|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
154473207|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154473208|NCT03126188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154473209|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154473210|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154473211|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473212|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473213|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
154473214|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473215|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154473216|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154473217|NCT04446338|Antibodies|antibodies|mesh-list
154473218|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
154473219|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473220|NCT03393728|Propranolol|propranolol|mesh-list
154473221|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154473222|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154473223|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
154473224|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473225|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473226|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473227|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154473228|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154473229|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
154473230|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
154473231|NCT03393572|Nalbuphine|nalbuphine|mesh-list
154473232|NCT03393572|Bupivacaine|bupivacaine|mesh-list
154473233|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
154473234|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
154473235|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473236|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473237|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
154473238|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473239|NCT03393572|Analgesics|analgesics|mesh-ancestor
154473240|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154473241|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
154473242|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154473243|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154473244|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473245|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154473246|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
154473247|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154473248|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154473249|NCT03393572|Narcotics|narcotics|mesh-ancestor
154473250|NCT03393416|Antibodies|antibodies|mesh-list
154473251|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
154473252|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473253|NCT04445948|Amoxicillin|amoxicillin|mesh-list
154473254|NCT04445948|Metronidazole|metronidazole|mesh-list
154473255|NCT04445948|Clarithromycin|clarithromycin|mesh-list
154473256|NCT04445948|Lactoferrin|lactoferrin|mesh-list
154473257|NCT04445948|Esomeprazole|esomeprazole|mesh-list
154473258|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154473259|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473260|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154473261|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154473262|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154473263|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473264|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154473265|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473266|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814856|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154037237|NCT00649922|Adalimumab|adalimumab|mesh-list
154473267|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154473268|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154473269|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154473271|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154473272|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
154473273|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473274|NCT02467868|Lenograstim|lenograstim|mesh-list
154473275|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154473276|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
154473277|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473278|NCT02103465|Rotigotine|rotigotine|mesh-list
154473279|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
154473280|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
154473281|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473282|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473283|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473284|NCT02102139|Propofol|propofol|mesh-list
154473285|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154473286|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154197220|NCT03996252|Vitamins|vitamins|mesh-ancestor
154473287|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473288|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154473289|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
154473290|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
154473291|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
154473292|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
154473293|NCT02102295|Fluorides|fluorides|mesh-list
154473294|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
154473295|NCT02102295|Protective Agents|protective agents|mesh-ancestor
154473296|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473297|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
154473298|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473299|NCT02102295|Vitamins|vitamins|mesh-ancestor
154473300|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
154037249|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037250|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154473301|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473302|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154473303|NCT02102373|Laxatives|laxatives|mesh-ancestor
154473304|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473305|NCT02103777|Caffeine|caffeine|mesh-list
154473306|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
154473307|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473308|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154473309|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473310|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154473311|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473312|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154473313|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154473314|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
154473315|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473316|NCT02104011|Propranolol|propranolol|mesh-list
154473317|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154473318|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154473319|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
154473320|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473321|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473322|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473323|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154473324|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154473325|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
154473326|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
154473327|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154473328|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473329|NCT02251041|Tocopherols|tocopherols|mesh-list
154473330|NCT02251041|Vitamin E|vitamin e|mesh-list
154473331|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
154473332|NCT02251041|Infliximab|infliximab|mesh-list
154473333|NCT02251041|Epoprostenol|epoprostenol|mesh-list
154473334|NCT02251041|Tezosentan|tezosentan|mesh-list
154473335|NCT02251041|Melatonin|melatonin|mesh-list
154473336|NCT02251041|Antithrombins|antithrombins|mesh-list
154473337|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
154473338|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
154473339|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154473340|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
154473341|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473342|NCT02251041|Protective Agents|protective agents|mesh-ancestor
154473343|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473344|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473345|NCT02251041|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154473346|NCT02251041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473347|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
154473348|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473349|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473350|NCT02251041|Hematinics|hematinics|mesh-ancestor
154473351|NCT02251041|Vitamins|vitamins|mesh-ancestor
154473352|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
154473353|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154473354|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
154473355|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473356|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
154473357|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154473358|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154473359|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
154473360|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154473361|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473362|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
154473363|NCT02104323|Endostatins|endostatins|mesh-list
154473364|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473365|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154473366|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154473367|NCT02104323|Growth Substances|growth substances|mesh-ancestor
154473368|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473369|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
154473370|NCT02107365|Interferons|interferons|mesh-list
154473371|NCT02107365|Ribavirin|ribavirin|mesh-list
154473372|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
154473373|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
154473374|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154473375|NCT02107365|Asunaprevir|asunaprevir|mesh-list
154473376|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473377|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
154473378|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473379|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
153814857|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473380|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473381|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
154473382|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473383|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
154473384|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473385|NCT02110719|Acetaminophen|acetaminophen|mesh-list
154037321|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
154037322|NCT00650468|Prednisone|prednisone|mesh-list
154037323|NCT00650468|Tacrolimus|tacrolimus|mesh-list
154037324|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037325|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
154037326|NCT00650468|Hormones|hormones|mesh-ancestor
154473386|NCT02110719|Dexamethasone|dexamethasone|mesh-list
154473387|NCT02110719|Ibuprofen|ibuprofen|mesh-list
154473388|NCT02110719|Celecoxib|celecoxib|mesh-list
154473389|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154473390|NCT02110719|Oxycodone|oxycodone|mesh-list
154473391|NCT02110719|Gabapentin|gabapentin|mesh-list
154473392|NCT02110719|Hydromorphone|hydromorphone|mesh-list
154473393|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473394|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
154473395|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
154473396|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473397|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473398|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473399|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
154473400|NCT02110719|Hormones|hormones|mesh-ancestor
154473401|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473402|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154473403|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473404|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154473405|NCT02110719|Analgesics|analgesics|mesh-ancestor
154473406|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
154473407|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
154473408|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154473409|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473410|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154473411|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473412|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473413|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154473414|NCT02110719|Narcotics|narcotics|mesh-ancestor
154473415|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473416|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
154473417|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154473418|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154473419|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154037327|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473420|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154037355|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
154473421|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154473422|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473423|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
154473424|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154473425|NCT02105103|Insulin|insulin|mesh-list
154473426|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154473427|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473428|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154473429|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154473430|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154473431|NCT02107755|Ipilimumab|ipilimumab|mesh-list
154473432|NCT02107755|Antibodies|antibodies|mesh-list
154473433|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
154473434|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154473435|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
154473436|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473437|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197365|NCT00450216|Ibuprofen|ibuprofen|mesh-list
154473438|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154473439|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473440|NCT02110953|Irinotecan|irinotecan|mesh-list
154473441|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154473443|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473444|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473445|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473446|NCT03554109|Leucovorin|leucovorin|mesh-list
154473447|NCT03554109|Paclitaxel|paclitaxel|mesh-list
154473448|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154473449|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
154473450|NCT03554109|Doxorubicin|doxorubicin|mesh-list
154473451|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154473452|NCT03554109|Fluorouracil|fluorouracil|mesh-list
154473453|NCT03554109|Avelumab|avelumab|mesh-list
154473454|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154473455|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473456|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
154473457|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
154473458|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
154473459|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473460|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473461|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
154473462|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473463|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473464|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154037356|NCT02651792|Analgesics|analgesics|mesh-ancestor
154473465|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
154473466|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154473467|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154473468|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154473469|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154473470|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473471|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
154473472|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154473473|NCT03554109|Antidotes|antidotes|mesh-ancestor
154473474|NCT03554109|Protective Agents|protective agents|mesh-ancestor
154473475|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
154473476|NCT03554109|Vitamins|vitamins|mesh-ancestor
154473477|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
154473478|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154473479|NCT03554031|Hormones|hormones|mesh-list
154473480|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473481|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473482|NCT02111265|Sufentanil|sufentanil|mesh-list
154473483|NCT02111265|Remifentanil|remifentanil|mesh-list
154473484|NCT02111265|Cisatracurium|cisatracurium|mesh-list
154473485|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154473486|NCT02111265|Narcotics|narcotics|mesh-ancestor
154473487|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473488|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473489|NCT02111265|Analgesics|analgesics|mesh-ancestor
154473490|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
154473491|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473492|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154473493|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154473494|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
154473495|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
154473496|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154473497|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154473498|NCT02251119|Ritonavir|ritonavir|mesh-list
154473499|NCT02251119|Tipranavir|tipranavir|mesh-list
154473500|NCT02251119|Loperamide|loperamide|mesh-list
154473501|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
154473502|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154473503|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154473504|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
154473505|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814860|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
154473506|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473507|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154473508|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154473509|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
154473510|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473511|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154473512|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154473513|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473514|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
154473515|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
154473516|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
154473517|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154473518|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473519|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473520|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154473521|NCT02111421|Analgesics|analgesics|mesh-ancestor
154473522|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
154473523|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473524|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154473525|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154473526|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154473527|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
154473528|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473529|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473530|NCT02108301|Cyclosporine|cyclosporine|mesh-list
154473531|NCT02108301|Tacrolimus|tacrolimus|mesh-list
154473532|NCT02108301|Cyclosporins|cyclosporins|mesh-list
154473533|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473534|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
154473535|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473536|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154473537|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473538|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473539|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
154473540|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473541|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
154473542|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473543|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
154473544|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154473545|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154473546|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473547|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154473548|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154473549|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
154473550|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154473551|NCT02114073|Cyclosporine|cyclosporine|mesh-list
154473552|NCT02114073|Betamethasone|betamethasone|mesh-list
154473553|NCT02114073|Cyclosporins|cyclosporins|mesh-list
154473554|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473555|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473556|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473557|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
154473558|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473559|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
154473560|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473561|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
154473562|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473563|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154473564|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473565|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
154473566|NCT02114073|Hormones|hormones|mesh-ancestor
154473567|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473568|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154473569|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
154473570|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
154473571|NCT02114463|Analgesics|analgesics|mesh-list
154473572|NCT02114463|Ropivacaine|ropivacaine|mesh-list
154473573|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
154473574|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
154473575|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473576|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473577|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
154473578|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473579|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154473580|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154473581|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473582|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473583|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154473584|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473585|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473586|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154473587|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154473588|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154473589|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
154037470|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473590|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473591|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154037517|NCT02655380|Remifentanil|remifentanil|mesh-list
154473592|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154473593|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473594|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
154473595|NCT02114775|Hormones|hormones|mesh-list
154473596|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473597|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473598|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
154473599|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154473600|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154473601|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473602|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473603|NCT02114775|Urological Agents|urological agents|mesh-ancestor
154473604|NCT02108847|Ropivacaine|ropivacaine|mesh-list
154473605|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
154473606|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
154473607|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473608|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473609|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
154473610|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473611|NCT03553329|Trametinib|trametinib|mesh-list
154473612|NCT03553329|Dabrafenib|dabrafenib|mesh-list
154473613|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473614|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154473615|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473616|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473617|NCT02115087|Morphine|morphine|mesh-list
154473618|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154473619|NCT02115087|Narcotics|narcotics|mesh-ancestor
154473620|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473621|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473622|NCT02115087|Analgesics|analgesics|mesh-ancestor
154473623|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
154473624|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473625|NCT02115243|Ipilimumab|ipilimumab|mesh-list
154473626|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154473627|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473628|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154473629|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473630|NCT02109315|Liraglutide|liraglutide|mesh-list
154473631|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473632|NCT02109315|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154473633|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154473634|NCT02109315|Incretins|incretins|mesh-ancestor
154473635|NCT02109315|Hormones|hormones|mesh-ancestor
154473636|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473637|NCT02112903|Vortioxetine|vortioxetine|mesh-list
154473638|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
154473639|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154473640|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154473641|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154473642|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473643|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473644|NCT02112903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154473645|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154473646|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154473647|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473648|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473649|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
154473650|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154473651|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154473652|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154473653|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154473655|NCT02112981|Everolimus|everolimus|mesh-list
154473656|NCT02112981|MTOR Inhibitors|mtor inhibitors|mesh-list
154473657|NCT02112981|Temsirolimus|temsirolimus|mesh-list
154473658|NCT02112981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154473659|NCT02112981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473660|NCT02112981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473661|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473662|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
154473663|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473664|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473665|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154473666|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473667|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154037596|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473668|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
154473669|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
154473670|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
154473671|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
154473672|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473673|NCT02116257|Propacetamol|propacetamol|mesh-list
154473674|NCT02116257|Analgesics|analgesics|mesh-ancestor
154473675|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
154473676|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473677|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473678|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154473679|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154473680|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473681|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473682|NCT02109627|Cytarabine|cytarabine|mesh-list
154473683|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154473684|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
154473685|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473686|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473687|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
154473688|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473689|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473690|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
154473691|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473692|NCT02116569|Daratumumab|daratumumab|mesh-list
154473693|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473694|NCT02109783|Caffeine|caffeine|mesh-list
154473695|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154473696|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473697|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154473698|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473699|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473700|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154473701|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154473702|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
154473703|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473704|NCT02109861|Dexamethasone|dexamethasone|mesh-list
154473705|NCT02109861|Bortezomib|bortezomib|mesh-list
154473706|NCT02109861|Melphalan|melphalan|mesh-list
154473707|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154473708|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
154473709|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
154473710|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473711|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473712|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154473713|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
154473714|NCT02109861|Hormones|hormones|mesh-ancestor
154037597|NCT02651168|Aflibercept|aflibercept|mesh-list
154473715|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473716|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154037650|NCT04686929|Abatacept|abatacept|mesh-list
154473717|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473718|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154473719|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
154473720|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473721|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154473722|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473723|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
154473724|NCT02118753|Eplerenone|eplerenone|mesh-list
154473725|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154473726|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
154473727|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473728|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473729|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154473730|NCT02118753|Diuretics|diuretics|mesh-ancestor
154473731|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
154473732|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154473733|NCT02118909|Itraconazole|itraconazole|mesh-list
154473734|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
154473735|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
154473736|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473737|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154473738|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154473739|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197662|NCT00384189|Ciclesonide|ciclesonide|mesh-list
154473740|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473741|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154473742|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
154473743|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473744|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473745|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154473746|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154473747|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154473748|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154473749|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473750|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154473751|NCT02118987|Omalizumab|omalizumab|mesh-list
154473752|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154473753|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154473754|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
154473755|NCT02119143|Vitamins|vitamins|mesh-list
154473756|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
154473757|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473758|NCT02116959|Carboplatin|carboplatin|mesh-list
154473759|NCT02116959|Etoposide|etoposide|mesh-list
154473760|NCT02116959|Vincristine|vincristine|mesh-list
154473761|NCT02116959|Melphalan|melphalan|mesh-list
154473762|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473763|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154473764|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154473765|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154473766|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473767|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473768|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
154473769|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
154473770|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
154473771|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154473772|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
154473773|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154473774|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473775|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
154473776|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473777|NCT03553173|Bupropion|bupropion|mesh-list
154473778|NCT03553173|Varenicline|varenicline|mesh-list
154473779|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154473780|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
154473781|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154473782|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154473783|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154473784|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154473785|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473786|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
154037715|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154473787|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473788|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473789|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154473790|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154473791|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473792|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154473793|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154473794|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
154473795|NCT01330017|Loratadine|loratadine|mesh-list
154473796|NCT01330017|Phenylephrine|phenylephrine|mesh-list
154860653|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154473797|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
154473798|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154473799|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
154473800|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
154473801|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473802|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473803|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
154473804|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154473805|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
154473806|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
154473807|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154473808|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154473809|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154473810|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
154473811|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473812|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473813|NCT01330017|Protective Agents|protective agents|mesh-ancestor
154473814|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
154473815|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
154473816|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154473817|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154473818|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154473819|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
154473820|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
154473822|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154473823|NCT02117583|Narcotics|narcotics|mesh-ancestor
154473824|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473825|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473826|NCT02117583|Analgesics|analgesics|mesh-ancestor
154473827|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
154473828|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473829|NCT02117739|Dapsone|dapsone|mesh-list
154473830|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473831|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
154473832|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154473833|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154473834|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154473835|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154473836|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473837|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
154473838|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154473839|NCT02251509|Metoprolol|metoprolol|mesh-list
154473840|NCT02251509|Carvedilol|carvedilol|mesh-list
154473841|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154473842|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154473843|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
154473844|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
154473845|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473846|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473847|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154473848|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154473849|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154473850|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
154473851|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473852|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473853|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
154473854|NCT02251509|Protective Agents|protective agents|mesh-ancestor
154473855|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154473856|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154473857|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154473858|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
154473859|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154473860|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154473861|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154473862|NCT02118051|Progesterone|progesterone|mesh-list
154473863|NCT02118051|Ganirelix|ganirelix|mesh-list
154473864|NCT02118051|Progestins|progestins|mesh-ancestor
154473865|NCT02118051|Hormones|hormones|mesh-ancestor
154473866|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473867|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473868|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
154473869|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154473870|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
154473871|NCT02123355|Remifentanil|remifentanil|mesh-list
154473872|NCT02123355|Sevoflurane|sevoflurane|mesh-list
154473873|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
154473875|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473876|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473877|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154473878|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154473879|NCT02123355|Analgesics|analgesics|mesh-ancestor
154473880|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
154473881|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473882|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154473883|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154473884|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154473885|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
154473886|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814863|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154473887|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197817|NCT00959621|Aspirin|aspirin|mesh-list
154473888|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154473889|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154473890|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
154473891|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154473892|NCT02123355|Narcotics|narcotics|mesh-ancestor
154473893|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154473894|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154473895|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154473896|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154473897|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154473898|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
154473899|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154473900|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
154473901|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473903|NCT02123589|Fentanyl|fentanyl|mesh-list
154473904|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154473905|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154473906|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473907|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473908|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154473909|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154473910|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154473911|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154473912|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
154473913|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
154473914|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
154473915|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
154473916|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473917|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473918|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154473919|NCT02123589|Narcotics|narcotics|mesh-ancestor
154473920|NCT02123589|Analgesics|analgesics|mesh-ancestor
154473921|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
154473922|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473923|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
154473924|NCT02120547|Liver Extracts|liver extracts|mesh-list
154473925|NCT02120547|Hematinics|hematinics|mesh-ancestor
154473926|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154473927|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473928|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154473929|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154473930|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
154473931|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473932|NCT02120703|Pregabalin|pregabalin|mesh-list
154473933|NCT02120703|Gabapentin|gabapentin|mesh-list
154473934|NCT02120703|Analgesics|analgesics|mesh-ancestor
154037856|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
154473935|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
154473936|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473937|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473938|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
154473939|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154473940|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154473941|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473942|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154473943|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154473944|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154473945|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154473946|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154473947|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154473948|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154473949|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473950|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
154473951|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
154473952|NCT02118285|Fludarabine|fludarabine|mesh-list
154473953|NCT02118285|Interleukin-2|interleukin-2|mesh-list
154473954|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154473955|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
154473956|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473957|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154473958|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154473959|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
154473960|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473961|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473962|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154473963|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154473964|NCT02118285|Analgesics|analgesics|mesh-ancestor
154473965|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
154473966|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154473967|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
154473968|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473969|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154473970|NCT02118675|Protective Agents|protective agents|mesh-ancestor
154473971|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473973|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
154473974|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
154473975|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154473976|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473977|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473978|NCT03552315|Chromium|chromium|mesh-list
154473979|NCT03552315|Trace Elements|trace elements|mesh-ancestor
154473980|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
154473981|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154473982|NCT02120859|Paclitaxel|paclitaxel|mesh-list
154473983|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154473984|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473985|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
154473986|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
154473987|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
154473988|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154473989|NCT06284395|Bortezomib|bortezomib|mesh-list
154473990|NCT06284395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154473991|NCT06284343|Anticoagulants|anticoagulants|mesh-list
154473992|NCT06284174|Chlorhexidine|chlorhexidine|mesh-list
154473993|NCT06284174|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154473994|NCT06284174|Povidone-Iodine|povidone-iodine|mesh-list
154473995|NCT06284174|Povidone|povidone|mesh-list
154473996|NCT06284174|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154473997|NCT06284174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154473998|NCT06284174|Disinfectants|disinfectants|mesh-ancestor
154473999|NCT06284174|Dermatologic Agents|dermatologic agents|mesh-ancestor
154474000|NCT06284174|Plasma Substitutes|plasma substitutes|mesh-ancestor
154474001|NCT06284174|Blood Substitutes|blood substitutes|mesh-ancestor
154474002|NCT06283927|Temozolomide|temozolomide|mesh-list
154474003|NCT06283927|Lomustine|lomustine|mesh-list
154474004|NCT06283927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154474005|NCT06283927|Alkylating Agents|alkylating agents|mesh-ancestor
154474006|NCT06283927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474007|NCT06283927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474008|NCT06283836|Dexmedetomidine|dexmedetomidine|mesh-list
154474009|NCT06283836|Remifentanil|remifentanil|mesh-list
154474010|NCT06283836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154474011|NCT06283836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474012|NCT06283836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474013|NCT06283836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154474014|NCT06283836|Analgesics|analgesics|mesh-ancestor
154474015|NCT06283836|Sensory System Agents|sensory system agents|mesh-ancestor
154474016|NCT06283836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474017|NCT06283836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154474018|NCT06283836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154474019|NCT06283836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154474020|NCT06283836|Adrenergic Agents|adrenergic agents|mesh-ancestor
154474021|NCT06283836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474022|NCT06283836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474023|NCT06283836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154474024|NCT06283836|Narcotics|narcotics|mesh-ancestor
154474025|NCT06283667|Semaglutide|semaglutide|mesh-list
154474026|NCT06283667|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154474028|NCT06283667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474029|NCT06283641|Liraglutide|liraglutide|mesh-list
154474030|NCT06283641|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154474031|NCT06283641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154474032|NCT06283641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474033|NCT06283641|Incretins|incretins|mesh-ancestor
154474034|NCT06283641|Hormones|hormones|mesh-ancestor
154474035|NCT06283641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474036|NCT06283381|Esomeprazole|esomeprazole|mesh-list
154474037|NCT06283381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154474038|NCT06283381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154474039|NCT06283381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154474040|NCT06283381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474041|NCT06283381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474042|NCT06283238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154474043|NCT06283238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474044|NCT06283238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474045|NCT06283238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474046|NCT06282965|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154474047|NCT06282965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154474048|NCT06282965|Vasodilator Agents|vasodilator agents|mesh-ancestor
154474049|NCT06282939|Tryptophan|tryptophan|mesh-list
154474050|NCT06282939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154474051|NCT06282939|Antidepressive Agents|antidepressive agents|mesh-ancestor
154474052|NCT06282939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154474053|NCT06282861|Formoterol Fumarate|formoterol fumarate|mesh-list
154474054|NCT06282861|Tiotropium Bromide|tiotropium bromide|mesh-list
154474055|NCT06282861|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154474056|NCT06282861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154474057|NCT06282861|Autonomic Agents|autonomic agents|mesh-ancestor
154474058|NCT06282861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474059|NCT06282861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474060|NCT06282861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154474061|NCT06282861|Respiratory System Agents|respiratory system agents|mesh-ancestor
154474062|NCT06282861|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154474063|NCT06282861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154474064|NCT06282861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154474065|NCT06282861|Adrenergic Agents|adrenergic agents|mesh-ancestor
154474066|NCT06282861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474067|NCT06282861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474068|NCT06282861|Parasympatholytics|parasympatholytics|mesh-ancestor
154474069|NCT06282861|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154474070|NCT06282861|Cholinergic Agents|cholinergic agents|mesh-ancestor
154474071|NCT06282783|Topiramate|topiramate|mesh-list
154474072|NCT06282783|Anticonvulsants|anticonvulsants|mesh-ancestor
154474073|NCT06282783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154474074|NCT06282783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474075|NCT06282731|Doxazosin|doxazosin|mesh-list
154474076|NCT06282731|Tamsulosin|tamsulosin|mesh-list
154474077|NCT06282731|Finasteride|finasteride|mesh-list
154474078|NCT06282731|Silodosin|silodosin|mesh-list
154474079|NCT06282731|Dutasteride|dutasteride|mesh-list
154474080|NCT06282731|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154474081|NCT06282731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154474082|NCT06282731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154474083|NCT06282731|Adrenergic Agents|adrenergic agents|mesh-ancestor
154474084|NCT06282731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474085|NCT06282731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474086|NCT06282731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474087|NCT06282731|Urological Agents|urological agents|mesh-ancestor
154474088|NCT06282731|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154474089|NCT06282731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154474090|NCT06282731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474091|NCT06282731|Hormone Antagonists|hormone antagonists|mesh-ancestor
154474092|NCT06282731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474093|NCT06282731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154474094|NCT06282679|Botulinum Toxins|botulinum toxins|mesh-list
154474095|NCT06282679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154474096|NCT06282679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154474097|NCT06282679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154474098|NCT06282679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154474099|NCT06282679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474100|NCT06282679|Cholinergic Agents|cholinergic agents|mesh-ancestor
154474101|NCT06282679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474102|NCT06282679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474103|NCT06282679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154474104|NCT06282679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474106|NCT06282666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474107|NCT06282666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474108|NCT06282640|Vitamin D|vitamin d|mesh-list
154474109|NCT06282640|Vitamins|vitamins|mesh-ancestor
154474110|NCT06282640|Micronutrients|micronutrients|mesh-ancestor
154474111|NCT06282640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474112|NCT06282640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154474113|NCT06282588|Docetaxel|docetaxel|mesh-list
154474114|NCT06282588|Goserelin|goserelin|mesh-list
154474115|NCT06282588|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154474116|NCT06282588|Leuprolide|leuprolide|mesh-list
154474117|NCT06282588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474118|NCT06282588|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038009|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
154474119|NCT06282588|Antimitotic Agents|antimitotic agents|mesh-ancestor
154474120|NCT06282588|Mitosis Modulators|mitosis modulators|mesh-ancestor
154474121|NCT06282588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474122|NCT06282588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154474123|NCT06282588|Luteolytic Agents|luteolytic agents|mesh-ancestor
154474124|NCT06282588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154474125|NCT06282588|Contraceptive Agents|contraceptive agents|mesh-ancestor
154474126|NCT06282588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154474127|NCT06282588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474128|NCT06282588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154474129|NCT06282588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154474130|NCT06282588|Fertility Agents|fertility agents|mesh-ancestor
154474131|NCT06282575|Gemcitabine|gemcitabine|mesh-list
154474132|NCT06282575|Pembrolizumab|pembrolizumab|mesh-list
154474133|NCT06282575|Durvalumab|durvalumab|mesh-list
154474134|NCT06282575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474135|NCT06282575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474136|NCT06282575|Antimetabolites|antimetabolites|mesh-ancestor
154474137|NCT06282575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474138|NCT06282575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474139|NCT06282575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154474140|NCT06282549|Amlodipine|amlodipine|mesh-list
154474141|NCT06282549|Telmisartan|telmisartan|mesh-list
154474142|NCT06282549|Chlorthalidone|chlorthalidone|mesh-list
154474143|NCT06282549|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154474144|NCT06282549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154474145|NCT06282549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154474146|NCT06282549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154474147|NCT06282549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474148|NCT06282549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154474149|NCT06282549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474150|NCT06282549|Vasodilator Agents|vasodilator agents|mesh-ancestor
154474151|NCT06282549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154474152|NCT06282549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154474153|NCT06282549|Diuretics|diuretics|mesh-ancestor
154474154|NCT06282549|Natriuretic Agents|natriuretic agents|mesh-ancestor
154474155|NCT06282549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154474156|NCT06282510|Povidone-Iodine|povidone-iodine|mesh-list
154474157|NCT06282510|Povidone|povidone|mesh-list
154474158|NCT06282510|Plasma Substitutes|plasma substitutes|mesh-ancestor
154474159|NCT06282510|Blood Substitutes|blood substitutes|mesh-ancestor
154474160|NCT06282510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154474161|NCT06282510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474162|NCT06282445|Bevacizumab|bevacizumab|mesh-list
154474163|NCT06282445|Capecitabine|capecitabine|mesh-list
154474164|NCT06282445|Oxaliplatin|oxaliplatin|mesh-list
154474165|NCT06282445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474166|NCT06282445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474167|NCT06282445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154474168|NCT06282445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154474169|NCT06282445|Growth Substances|growth substances|mesh-ancestor
154474170|NCT06282445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474171|NCT06282445|Growth Inhibitors|growth inhibitors|mesh-ancestor
154474172|NCT06282445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474173|NCT06282445|Antimetabolites|antimetabolites|mesh-ancestor
154474174|NCT06282445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474175|NCT06282211|Ondansetron|ondansetron|mesh-list
154474176|NCT06282211|Antiemetics|antiemetics|mesh-ancestor
154474177|NCT06282211|Autonomic Agents|autonomic agents|mesh-ancestor
154474178|NCT06282211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474179|NCT06282211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474180|NCT06282211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154474181|NCT06282211|Antipruritics|antipruritics|mesh-ancestor
154474182|NCT06282211|Dermatologic Agents|dermatologic agents|mesh-ancestor
154474183|NCT06282211|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154474184|NCT06282211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154474185|NCT06282211|Serotonin Agents|serotonin agents|mesh-ancestor
154474186|NCT06282211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474187|NCT06282211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474188|NCT06282120|Leucovorin|leucovorin|mesh-list
154198106|NCT00968435|Cetuximab|cetuximab|mesh-list
154474189|NCT06282120|Fluorouracil|fluorouracil|mesh-list
154474190|NCT06282120|Irinotecan|irinotecan|mesh-list
154474191|NCT06282120|Antimetabolites|antimetabolites|mesh-ancestor
154474192|NCT06282120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474193|NCT06282120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474194|NCT06282120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474195|NCT06282120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154474196|NCT06282120|Immunologic Factors|immunologic factors|mesh-ancestor
154474197|NCT06282120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474198|NCT06282120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154474199|NCT06282120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154474200|NCT06282120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474201|NCT06282120|Antidotes|antidotes|mesh-ancestor
154474202|NCT06282120|Protective Agents|protective agents|mesh-ancestor
154474203|NCT06282120|Vitamin B Complex|vitamin b complex|mesh-ancestor
154474204|NCT06282120|Vitamins|vitamins|mesh-ancestor
154474205|NCT06282120|Micronutrients|micronutrients|mesh-ancestor
154474206|NCT06282107|Antihypertensive Agents|antihypertensive agents|mesh-list
154474207|NCT06281977|Dexmedetomidine|dexmedetomidine|mesh-list
154474208|NCT06281977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154474209|NCT06281977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474210|NCT06281977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474211|NCT06281977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154474212|NCT06281977|Analgesics|analgesics|mesh-ancestor
154474213|NCT06281977|Sensory System Agents|sensory system agents|mesh-ancestor
154474214|NCT06281977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474215|NCT06281977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154474216|NCT06281977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154474217|NCT06281977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154474218|NCT06281977|Adrenergic Agents|adrenergic agents|mesh-ancestor
154474219|NCT06281977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474220|NCT06281977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474221|NCT06281964|Carboplatin|carboplatin|mesh-list
154474222|NCT06281964|Pemetrexed|pemetrexed|mesh-list
154474223|NCT06281964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474224|NCT06281964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474225|NCT06281964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474226|NCT06281964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154474227|NCT06281964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154474228|NCT06281899|Dapagliflozin|dapagliflozin|mesh-list
154474229|NCT06281899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154474230|NCT06281899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474231|NCT06281899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154474232|NCT06281899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474233|NCT06281886|Paclitaxel|paclitaxel|mesh-list
154474234|NCT06281886|Capecitabine|capecitabine|mesh-list
154474235|NCT06281886|Apatinib|apatinib|mesh-list
154474236|NCT06281886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154474237|NCT06281886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474238|NCT06281886|Tubulin Modulators|tubulin modulators|mesh-ancestor
154474239|NCT06281886|Antimitotic Agents|antimitotic agents|mesh-ancestor
154474240|NCT06281886|Mitosis Modulators|mitosis modulators|mesh-ancestor
154474241|NCT06281886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474242|NCT06281886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474243|NCT06281886|Antimetabolites|antimetabolites|mesh-ancestor
154474244|NCT06281886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154474245|NCT06281886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474246|NCT06281834|Dolutegravir|dolutegravir|mesh-list
154474247|NCT06281834|Rifapentine|rifapentine|mesh-list
154474248|NCT06281834|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154474249|NCT06281834|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154474250|NCT06281834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474251|NCT06281834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474252|NCT06281834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154474253|NCT06281834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154474254|NCT06281834|Antiviral Agents|antiviral agents|mesh-ancestor
154474255|NCT06281834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474256|NCT06281834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154474257|NCT06281834|Antitubercular Agents|antitubercular agents|mesh-ancestor
154474258|NCT06281834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154474259|NCT06281834|Leprostatic Agents|leprostatic agents|mesh-ancestor
154474260|NCT06281665|Aspirin|aspirin|mesh-list
154474261|NCT06281665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154474262|NCT06281665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154474263|NCT06281665|Analgesics|analgesics|mesh-ancestor
154474264|NCT06281665|Sensory System Agents|sensory system agents|mesh-ancestor
154474265|NCT06281665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474266|NCT06281665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474267|NCT06281665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154474268|NCT06281665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154474269|NCT06281665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154474270|NCT06281665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154474271|NCT06281665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474272|NCT06281665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154474273|NCT06281665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154474274|NCT06281665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474275|NCT06281665|Antipyretics|antipyretics|mesh-ancestor
154474276|NCT06281405|Capecitabine|capecitabine|mesh-list
154474277|NCT06281405|Antibodies|antibodies|mesh-list
154474278|NCT06281405|Immunologic Factors|immunologic factors|mesh-ancestor
154474279|NCT06281405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474280|NCT06281405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474281|NCT06281405|Antimetabolites|antimetabolites|mesh-ancestor
154474282|NCT06281405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474283|NCT06281405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474284|NCT06281353|Curcumin|curcumin|mesh-list
154474285|NCT06281353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154474286|NCT06281353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154474287|NCT06281353|Analgesics|analgesics|mesh-ancestor
154474288|NCT06281353|Sensory System Agents|sensory system agents|mesh-ancestor
154474289|NCT06281353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474290|NCT06281353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474291|NCT06281353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154474292|NCT06281353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154474293|NCT06281353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474294|NCT06281353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474295|NCT06281353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474296|NCT06281236|Prednisolone|prednisolone|mesh-list
154474297|NCT06281236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154474298|NCT06281236|Glucocorticoids|glucocorticoids|mesh-ancestor
154474299|NCT06281236|Hormones|hormones|mesh-ancestor
154474300|NCT06281236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474301|NCT06281236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038172|NCT00668616|Paclitaxel|paclitaxel|mesh-list
154474302|NCT06281236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154474303|NCT06281236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474304|NCT06281184|Methotrexate|methotrexate|mesh-list
154474305|NCT06281184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154474306|NCT06281184|Abortifacient Agents|abortifacient agents|mesh-ancestor
154474307|NCT06281184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154474308|NCT06281184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474309|NCT06281184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474310|NCT06281184|Antimetabolites|antimetabolites|mesh-ancestor
154474311|NCT06281184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474312|NCT06281184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038224|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038225|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154038226|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
154038227|NCT04155918|Protective Agents|protective agents|mesh-ancestor
154038228|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038229|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154038230|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154038231|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
154038232|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038233|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154038234|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154474313|NCT06281184|Dermatologic Agents|dermatologic agents|mesh-ancestor
154474314|NCT06281184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474315|NCT06281184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154474316|NCT06281184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154474317|NCT06281184|Immunologic Factors|immunologic factors|mesh-ancestor
154474318|NCT06281184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154474319|NCT06281184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154474320|NCT06281106|Deucravacitinib|deucravacitinib|mesh-list
154474321|NCT06281106|Dermatologic Agents|dermatologic agents|mesh-ancestor
154474322|NCT06281106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154474324|NCT06281106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474325|NCT06281041|Clopidogrel|clopidogrel|mesh-list
154474326|NCT06281041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154474327|NCT06281041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474328|NCT06281041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474329|NCT06281041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154474330|NCT06281041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154474331|NCT06281041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154474332|NCT06281041|Purinergic Agents|purinergic agents|mesh-ancestor
154474333|NCT06281041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474334|NCT06280950|Everolimus|everolimus|mesh-list
154474335|NCT06280950|Tacrolimus|tacrolimus|mesh-list
154474336|NCT06280950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154474337|NCT06280950|Immunologic Factors|immunologic factors|mesh-ancestor
154474338|NCT06280950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474339|NCT06280950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154474340|NCT06280950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474341|NCT06280950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474342|NCT06280950|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154474343|NCT06280950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154038235|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
154474344|NCT06280950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474345|NCT06280508|Gemcitabine|gemcitabine|mesh-list
154474346|NCT06280508|Apatinib|apatinib|mesh-list
154474347|NCT06280508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814866|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154038256|NCT02575768|Adenosine|adenosine|mesh-list
154474348|NCT06280508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474349|NCT06280508|Antimetabolites|antimetabolites|mesh-ancestor
154474350|NCT06280508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474351|NCT06280508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154474352|NCT06280508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474353|NCT06280482|Niacinamide|niacinamide|mesh-list
154474354|NCT06280482|Niacin|niacin|mesh-list
154474355|NCT06280482|Nicotinic Acids|nicotinic acids|mesh-list
154474356|NCT06280482|Vitamin B Complex|vitamin b complex|mesh-ancestor
154474357|NCT06280482|Vitamins|vitamins|mesh-ancestor
154474358|NCT06280482|Micronutrients|micronutrients|mesh-ancestor
154474359|NCT06280482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474360|NCT06280482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154474361|NCT06280482|Antimetabolites|antimetabolites|mesh-ancestor
154474362|NCT06280482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474363|NCT06280482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154474364|NCT06280482|Vasodilator Agents|vasodilator agents|mesh-ancestor
154474365|NCT06280456|Tranexamic Acid|tranexamic acid|mesh-list
154474366|NCT06280456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154474367|NCT06280456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154474368|NCT06280456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474369|NCT06280456|Hemostatics|hemostatics|mesh-ancestor
154474370|NCT06280456|Coagulants|coagulants|mesh-ancestor
154474371|NCT06279910|Calcifediol|calcifediol|mesh-list
154474372|NCT06279910|Vitamins|vitamins|mesh-ancestor
154474373|NCT06279910|Micronutrients|micronutrients|mesh-ancestor
154474374|NCT06279910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474375|NCT06279910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154474376|NCT06279871|Vaccines|vaccines|mesh-list
154474377|NCT06279871|Immunologic Factors|immunologic factors|mesh-ancestor
154474378|NCT06279871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474379|NCT06279767|Mercaptopurine|mercaptopurine|mesh-list
154474380|NCT06279767|Antimetabolites|antimetabolites|mesh-ancestor
154474381|NCT06279767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474382|NCT06279767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474383|NCT06279767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474384|NCT06279767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154474385|NCT06279767|Immunologic Factors|immunologic factors|mesh-ancestor
154474386|NCT06279767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474387|NCT06279767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154474388|NCT06279767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474389|NCT06279754|Endostatins|endostatins|mesh-list
154474390|NCT06279754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474391|NCT06279754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154474392|NCT06279754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154474393|NCT06279754|Growth Substances|growth substances|mesh-ancestor
154474394|NCT06279754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474395|NCT06279754|Growth Inhibitors|growth inhibitors|mesh-ancestor
154474396|NCT06279507|Triamcinolone|triamcinolone|mesh-list
154474397|NCT06279507|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154474398|NCT06279507|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154474399|NCT06279507|Hyaluronic Acid|hyaluronic acid|mesh-list
154474400|NCT06279507|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154474401|NCT06279507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154474402|NCT06279507|Glucocorticoids|glucocorticoids|mesh-ancestor
154474403|NCT06279507|Hormones|hormones|mesh-ancestor
154474404|NCT06279507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474405|NCT06279507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474406|NCT06279507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154474407|NCT06279507|Immunologic Factors|immunologic factors|mesh-ancestor
154474408|NCT06279507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474409|NCT06279507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474410|NCT06279507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154474411|NCT06279507|Viscosupplements|viscosupplements|mesh-ancestor
154198329|NCT00972101|Thiotepa|thiotepa|mesh-list
154474412|NCT06279507|Protective Agents|protective agents|mesh-ancestor
154474413|NCT06279403|Axitinib|axitinib|mesh-list
154474414|NCT06279403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474415|NCT06279403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154474416|NCT06279403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474417|NCT06279403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474418|NCT06279364|Paclitaxel|paclitaxel|mesh-list
154474419|NCT06279364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154474420|NCT06279364|Carboplatin|carboplatin|mesh-list
154474421|NCT06279364|Capecitabine|capecitabine|mesh-list
154474422|NCT06279364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154474423|NCT06279364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474424|NCT06279364|Tubulin Modulators|tubulin modulators|mesh-ancestor
154474425|NCT06279364|Antimitotic Agents|antimitotic agents|mesh-ancestor
154474426|NCT06279364|Mitosis Modulators|mitosis modulators|mesh-ancestor
154474427|NCT06279364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474428|NCT06279364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474429|NCT06279364|Antimetabolites|antimetabolites|mesh-ancestor
154474430|NCT06279351|Thalidomide|thalidomide|mesh-list
154474431|NCT06279351|Cetuximab|cetuximab|mesh-list
154474432|NCT06279351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474433|NCT06279351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474434|NCT06279351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154474435|NCT06279351|Immunologic Factors|immunologic factors|mesh-ancestor
154474436|NCT06279351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474437|NCT06279351|Leprostatic Agents|leprostatic agents|mesh-ancestor
154474438|NCT06279351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154474439|NCT06279351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474440|NCT06279351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154474441|NCT06279351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154474442|NCT06279351|Growth Substances|growth substances|mesh-ancestor
154474443|NCT06279351|Growth Inhibitors|growth inhibitors|mesh-ancestor
154474444|NCT06279338|Azacitidine|azacitidine|mesh-list
154474445|NCT06279338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474446|NCT06279338|Antimetabolites|antimetabolites|mesh-ancestor
154474447|NCT06279338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474448|NCT06279338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474449|NCT06279338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474450|NCT06279195|Norethindrone|norethindrone|mesh-list
154474451|NCT06279195|Norethindrone Acetate|norethindrone acetate|mesh-list
154474452|NCT06279195|Estradiol|estradiol|mesh-list
154474453|NCT06279195|Relugolix|relugolix|mesh-list
154474454|NCT06279195|Estrogens|estrogens|mesh-ancestor
154474455|NCT06279195|Hormones|hormones|mesh-ancestor
154474456|NCT06279195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474457|NCT06279195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474458|NCT06279195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154474459|NCT06279195|Contraceptive Agents|contraceptive agents|mesh-ancestor
154474460|NCT06279195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154474461|NCT06279195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154474462|NCT06279195|Androgen Antagonists|androgen antagonists|mesh-ancestor
154474463|NCT06279195|Hormone Antagonists|hormone antagonists|mesh-ancestor
154474464|NCT06279195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154474465|NCT06279195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154474466|NCT06279195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154474467|NCT06279000|Colchicine|colchicine|mesh-list
154474468|NCT06279000|Gout Suppressants|gout suppressants|mesh-ancestor
154474469|NCT06279000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154474470|NCT06279000|Tubulin Modulators|tubulin modulators|mesh-ancestor
154474471|NCT06279000|Antimitotic Agents|antimitotic agents|mesh-ancestor
154860654|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154474472|NCT06279000|Mitosis Modulators|mitosis modulators|mesh-ancestor
154474473|NCT06279000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474474|NCT06279000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474475|NCT06278220|Frovatriptan|frovatriptan|mesh-list
154474476|NCT06278220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154474477|NCT06278220|Serotonin Agents|serotonin agents|mesh-ancestor
154474478|NCT06278220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474479|NCT06278220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474480|NCT06278220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474481|NCT06278116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154474482|NCT06278116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474483|NCT06278090|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154474484|NCT06278090|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154474485|NCT06278090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154474486|NCT06277466|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154474487|NCT06277466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474488|NCT06276569|Sivelestat|sivelestat|mesh-list
154474489|NCT06276569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154474490|NCT06276569|Protease Inhibitors|protease inhibitors|mesh-ancestor
154474491|NCT06276569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474492|NCT06276569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474493|NCT06276179|Oxycodone|oxycodone|mesh-list
154474494|NCT06276179|Bupivacaine|bupivacaine|mesh-list
154474495|NCT06276179|Anesthetics, Local|anesthetics, local|mesh-ancestor
154474496|NCT06276179|Anesthetics|anesthetics|mesh-ancestor
154474497|NCT06276179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474498|NCT06276179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474499|NCT06276179|Sensory System Agents|sensory system agents|mesh-ancestor
154474500|NCT06276179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474501|NCT06276179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154474502|NCT06276179|Narcotics|narcotics|mesh-ancestor
154474503|NCT06276179|Analgesics|analgesics|mesh-ancestor
154474504|NCT06269328|Remifentanil|remifentanil|mesh-list
154474505|NCT06269328|Anesthetics|anesthetics|mesh-list
154474506|NCT06269328|Propofol|propofol|mesh-list
154474507|NCT06269328|Sevoflurane|sevoflurane|mesh-list
154474508|NCT06269328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474509|NCT06269328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474510|NCT06269328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154474511|NCT06269328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154474512|NCT06269328|Anesthetics, General|anesthetics, general|mesh-ancestor
154474513|NCT06269328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154474514|NCT06269328|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154474515|NCT06269328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154474516|NCT06269328|Narcotics|narcotics|mesh-ancestor
154474517|NCT06269328|Analgesics|analgesics|mesh-ancestor
154474518|NCT06269328|Sensory System Agents|sensory system agents|mesh-ancestor
154474519|NCT06269328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474520|NCT06267859|Vitamins|vitamins|mesh-list
154474521|NCT06267859|Micronutrients|micronutrients|mesh-ancestor
154474522|NCT06267859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474523|NCT06267092|Semaglutide|semaglutide|mesh-list
154474524|NCT06267092|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154474525|NCT06267092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154474526|NCT06267092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474527|NCT06247839|Psilocybin|psilocybin|mesh-list
154474528|NCT06247839|Hallucinogens|hallucinogens|mesh-ancestor
154474529|NCT06247839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474530|NCT06247839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154474531|NCT06246396|Minocycline|minocycline|mesh-list
154474532|NCT06246396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154474533|NCT06246396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474534|NCT06241326|Immunomodulating Agents|immunomodulating agents|mesh-list
154474535|NCT06241326|Immunologic Factors|immunologic factors|mesh-ancestor
154474536|NCT06241326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474537|NCT06233877|Mitomycins|mitomycins|mesh-list
154474538|NCT06233877|Mitomycin|mitomycin|mesh-list
154474539|NCT06233877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154474540|NCT06233877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474541|NCT06233877|Alkylating Agents|alkylating agents|mesh-ancestor
154474542|NCT06233877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474543|NCT06233877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154474544|NCT06233877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860655|NCT04395638|Vitamin D|vitamin d|mesh-list
154474545|NCT06230471|Gemcitabine|gemcitabine|mesh-list
154474546|NCT06230471|Pembrolizumab|pembrolizumab|mesh-list
154474547|NCT06230471|Oxaliplatin|oxaliplatin|mesh-list
154474548|NCT06230471|Lenvatinib|lenvatinib|mesh-list
154474549|NCT06230471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474550|NCT06230471|Antimetabolites|antimetabolites|mesh-ancestor
154474551|NCT06230471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474552|NCT06230471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474553|NCT06230471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474554|NCT06230471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154474555|NCT06230471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154474556|NCT06230471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474557|NCT06230003|Ropivacaine|ropivacaine|mesh-list
154474558|NCT06230003|Anesthetics, Local|anesthetics, local|mesh-ancestor
154474559|NCT06230003|Anesthetics|anesthetics|mesh-ancestor
154474560|NCT06230003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474561|NCT06230003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474562|NCT06230003|Sensory System Agents|sensory system agents|mesh-ancestor
154474563|NCT06230003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474564|NCT06222749|Oxytocin|oxytocin|mesh-list
154474565|NCT06222749|Oxytocics|oxytocics|mesh-ancestor
154474566|NCT06222749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154474567|NCT06222749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474568|NCT06221969|Semaglutide|semaglutide|mesh-list
154474570|NCT06221969|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154474571|NCT06221969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154474572|NCT06221969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474573|NCT06221969|Incretins|incretins|mesh-ancestor
154474574|NCT06221969|Hormones|hormones|mesh-ancestor
154474575|NCT06221969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474576|NCT06220422|Anticoagulants|anticoagulants|mesh-list
154474577|NCT06220422|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
154474578|NCT06220422|Antithrombins|antithrombins|mesh-ancestor
154474579|NCT06220422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154474580|NCT06220422|Protease Inhibitors|protease inhibitors|mesh-ancestor
154474581|NCT06220422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038488|NCT02758067|Risperidone|risperidone|mesh-list
154474582|NCT06220422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474583|NCT06217185|Capecitabine|capecitabine|mesh-list
154474584|NCT06217185|Trastuzumab|trastuzumab|mesh-list
154474585|NCT06217185|Taxane|taxane|mesh-list
154474586|NCT06217185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474587|NCT06217185|Antimetabolites|antimetabolites|mesh-ancestor
154474588|NCT06217185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474589|NCT06217185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474590|NCT06217185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474591|NCT06198556|Rifampin|rifampin|mesh-list
154474592|NCT06198556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154474593|NCT06198556|Antitubercular Agents|antitubercular agents|mesh-ancestor
154474594|NCT06198556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154474595|NCT06198556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474596|NCT06198556|Leprostatic Agents|leprostatic agents|mesh-ancestor
154474597|NCT06198556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154474598|NCT06198556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474599|NCT06198556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474600|NCT06198556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154474601|NCT06198556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154474602|NCT06198556|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154474603|NCT06198556|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154474604|NCT06198556|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154474605|NCT06198556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154474606|NCT06188715|Albendazole|albendazole|mesh-list
154474607|NCT06188715|Moxidectin|moxidectin|mesh-list
154474608|NCT06188715|Anthelmintics|anthelmintics|mesh-ancestor
154474609|NCT06188715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154474610|NCT06188715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474611|NCT06188715|Anticestodal Agents|anticestodal agents|mesh-ancestor
154474612|NCT06188715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154474613|NCT06188715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154474614|NCT06188715|Tubulin Modulators|tubulin modulators|mesh-ancestor
154474615|NCT06188715|Antimitotic Agents|antimitotic agents|mesh-ancestor
154474616|NCT06188715|Mitosis Modulators|mitosis modulators|mesh-ancestor
154474617|NCT06188715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474618|NCT06188715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474619|NCT06188715|Antinematodal Agents|antinematodal agents|mesh-ancestor
154474620|NCT06184399|Ivermectin|ivermectin|mesh-list
154474621|NCT06184399|Albendazole|albendazole|mesh-list
154474622|NCT06184399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154474623|NCT06184399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474624|NCT06184399|Anthelmintics|anthelmintics|mesh-ancestor
154474625|NCT06184399|Anticestodal Agents|anticestodal agents|mesh-ancestor
154474626|NCT06184399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154474627|NCT06184399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154474628|NCT06184399|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038532|NCT02760953|Epirubicin|epirubicin|mesh-list
154474629|NCT06184399|Antimitotic Agents|antimitotic agents|mesh-ancestor
154474630|NCT06184399|Mitosis Modulators|mitosis modulators|mesh-ancestor
154474631|NCT06184399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474632|NCT06184399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474634|NCT06181734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474635|NCT06181734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474636|NCT06181734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474637|NCT06181032|Cisplatin|cisplatin|mesh-list
154474638|NCT06181032|Gemcitabine|gemcitabine|mesh-list
154474639|NCT06181032|Apatinib|apatinib|mesh-list
154474640|NCT06181032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474641|NCT06181032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474642|NCT06181032|Antimetabolites|antimetabolites|mesh-ancestor
154474643|NCT06181032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474644|NCT06181032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154474645|NCT06181032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474646|NCT06177041|Capecitabine|capecitabine|mesh-list
154474647|NCT06177041|Oxaliplatin|oxaliplatin|mesh-list
154474648|NCT06177041|Antibodies|antibodies|mesh-list
154474649|NCT06177041|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154474650|NCT06177041|Immunologic Factors|immunologic factors|mesh-ancestor
154474651|NCT06177041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474652|NCT06177041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474653|NCT06177041|Antimetabolites|antimetabolites|mesh-ancestor
154474654|NCT06177041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474655|NCT06177041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474656|NCT06175338|Rituximab|rituximab|mesh-list
154474657|NCT06175338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474658|NCT06175338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474659|NCT06175338|Immunologic Factors|immunologic factors|mesh-ancestor
154474660|NCT06175338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474661|NCT06175338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154474662|NCT06174987|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154474663|NCT06174987|Immunoconjugates|immunoconjugates|mesh-ancestor
154474664|NCT06174987|Immunologic Factors|immunologic factors|mesh-ancestor
154474665|NCT06174987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474666|NCT06167681|Dopamine|dopamine|mesh-list
154474667|NCT06167681|Dopamine Agonists|dopamine agonists|mesh-list
154474668|NCT06167681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154474669|NCT06167681|Sympathomimetics|sympathomimetics|mesh-ancestor
154474670|NCT06167681|Autonomic Agents|autonomic agents|mesh-ancestor
154474671|NCT06167681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474672|NCT06167681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474673|NCT06167681|Dopamine Agents|dopamine agents|mesh-ancestor
154474674|NCT06167681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474675|NCT06167681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474676|NCT06167681|Protective Agents|protective agents|mesh-ancestor
154474677|NCT06156514|Gemcitabine|gemcitabine|mesh-list
154474678|NCT06156514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474679|NCT06156514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474680|NCT06156514|Antimetabolites|antimetabolites|mesh-ancestor
154474681|NCT06156514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474682|NCT06155396|Disitamab vedotin|disitamab vedotin|mesh-list
154474683|NCT06155396|Immunoconjugates|immunoconjugates|mesh-ancestor
154474684|NCT06155396|Immunologic Factors|immunologic factors|mesh-ancestor
154474685|NCT06155396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474686|NCT06153043|Epinephrine|epinephrine|mesh-list
154474687|NCT06153043|Racepinephrine|racepinephrine|mesh-list
154474688|NCT06153043|Epinephryl borate|epinephryl borate|mesh-list
154474689|NCT06153043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154474690|NCT06153043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154474691|NCT06153043|Adrenergic Agents|adrenergic agents|mesh-ancestor
154474692|NCT06153043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474693|NCT06153043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474694|NCT06153043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474695|NCT06153043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154474696|NCT06153043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154474697|NCT06153043|Autonomic Agents|autonomic agents|mesh-ancestor
154860656|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
154474698|NCT06153043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474699|NCT06153043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154474700|NCT06153043|Respiratory System Agents|respiratory system agents|mesh-ancestor
154474701|NCT06153043|Mydriatics|mydriatics|mesh-ancestor
154474702|NCT06153043|Sympathomimetics|sympathomimetics|mesh-ancestor
154474703|NCT06153043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154474704|NCT06152809|Aldesleukin|aldesleukin|mesh-list
154474705|NCT06152809|Venetoclax|venetoclax|mesh-list
154474706|NCT06152809|Interleukin-2|interleukin-2|mesh-list
154474707|NCT06152809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474708|NCT06152809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154474709|NCT06152809|Analgesics|analgesics|mesh-ancestor
154474710|NCT06152809|Sensory System Agents|sensory system agents|mesh-ancestor
154474711|NCT06152809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474712|NCT06152809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474713|NCT06152809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154474714|NCT06152809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154474715|NCT06152809|Antiviral Agents|antiviral agents|mesh-ancestor
154474716|NCT06152809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198626|NCT00372567|Sunitinib|sunitinib|mesh-list
154474717|NCT06151847|Cyclophosphamide|cyclophosphamide|mesh-list
154474718|NCT06151847|Fludarabine|fludarabine|mesh-list
153814872|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038616|NCT02757209|Fluticasone|fluticasone|mesh-list
154474719|NCT06151847|Interleukin-2|interleukin-2|mesh-list
154474720|NCT06151847|Mitogens|mitogens|mesh-list
154474721|NCT06151847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154474722|NCT06151847|Immunologic Factors|immunologic factors|mesh-ancestor
154474723|NCT06151847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474724|NCT06151847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154474725|NCT06151847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154474726|NCT06151847|Alkylating Agents|alkylating agents|mesh-ancestor
154474727|NCT06151847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474728|NCT06151847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474729|NCT06151847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154474730|NCT06151847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154474731|NCT06151847|Analgesics|analgesics|mesh-ancestor
154474732|NCT06151847|Sensory System Agents|sensory system agents|mesh-ancestor
154474733|NCT06151847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474734|NCT06151847|Mitosis Modulators|mitosis modulators|mesh-ancestor
154474735|NCT06145321|Lenograstim|lenograstim|mesh-list
154474736|NCT06145321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154474737|NCT06145321|Immunologic Factors|immunologic factors|mesh-ancestor
154474738|NCT06145321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474739|NCT06142552|Factor VIII|factor viii|mesh-list
154474740|NCT06142552|Coagulants|coagulants|mesh-ancestor
154474741|NCT06138587|Aldesleukin|aldesleukin|mesh-list
154474742|NCT06138587|Interleukin-2|interleukin-2|mesh-list
154474743|NCT06138587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474744|NCT06138587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154474745|NCT06138587|Analgesics|analgesics|mesh-ancestor
154474746|NCT06138587|Sensory System Agents|sensory system agents|mesh-ancestor
154474747|NCT06138587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474748|NCT06138587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474749|NCT06138587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154474750|NCT06138587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154474751|NCT06138587|Antiviral Agents|antiviral agents|mesh-ancestor
154474752|NCT06138587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474753|NCT06137300|Kallikreins|kallikreins|mesh-list
154474754|NCT06137300|Coagulants|coagulants|mesh-ancestor
154474755|NCT06137300|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154474756|NCT06137300|Fertility Agents|fertility agents|mesh-ancestor
154474757|NCT06137300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154474758|NCT06137300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474759|NCT06133881|Bupivacaine|bupivacaine|mesh-list
154474760|NCT06133881|Prilocaine|prilocaine|mesh-list
154474761|NCT06133881|Anesthetics, Local|anesthetics, local|mesh-ancestor
154474762|NCT06133881|Anesthetics|anesthetics|mesh-ancestor
154038618|NCT02757209|Budesonide|budesonide|mesh-list
154474763|NCT06133881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474764|NCT06133881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474765|NCT06133881|Sensory System Agents|sensory system agents|mesh-ancestor
154474766|NCT06133881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474767|NCT06128954|Trientine|trientine|mesh-list
154474768|NCT06128954|Chelating Agents|chelating agents|mesh-ancestor
154474769|NCT06128954|Sequestering Agents|sequestering agents|mesh-ancestor
154474770|NCT06128954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474771|NCT06124209|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154474772|NCT06124209|Hemostatics|hemostatics|mesh-ancestor
154474773|NCT06124209|Coagulants|coagulants|mesh-ancestor
154474774|NCT06122883|Anesthetics|anesthetics|mesh-list
154474775|NCT06122883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474776|NCT06122883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474777|NCT06119581|Carboplatin|carboplatin|mesh-list
154474778|NCT06119581|Pembrolizumab|pembrolizumab|mesh-list
154474780|NCT06119581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474781|NCT06119581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474782|NCT06119581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154474783|NCT06119581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474784|NCT06119581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474785|NCT06119581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154474786|NCT06119581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154474787|NCT06118684|Digoxin|digoxin|mesh-list
154474788|NCT06118684|Verapamil|verapamil|mesh-list
154474789|NCT06118684|Midazolam|midazolam|mesh-list
154474790|NCT06118684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154474791|NCT06118684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154474792|NCT06118684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474793|NCT06118684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474794|NCT06118684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154474795|NCT06118684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154474796|NCT06118684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154474797|NCT06118684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154474798|NCT06118684|Anesthetics, General|anesthetics, general|mesh-ancestor
154474799|NCT06118684|Anesthetics|anesthetics|mesh-ancestor
154474800|NCT06118684|GABA Modulators|gaba modulators|mesh-ancestor
154474801|NCT06118684|GABA Agents|gaba agents|mesh-ancestor
154474802|NCT06118684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474803|NCT06118684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474804|NCT06118684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154474805|NCT06118684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154474806|NCT06118684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474807|NCT06118684|Protective Agents|protective agents|mesh-ancestor
154474808|NCT06118684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154474809|NCT06118684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154038659|NCT02757287|Progestins|progestins|mesh-ancestor
154474810|NCT06118684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154474811|NCT06118684|Vasodilator Agents|vasodilator agents|mesh-ancestor
154474812|NCT06113640|Levodopa|levodopa|mesh-list
154474813|NCT06113640|Carbidopa|carbidopa|mesh-list
154474814|NCT06113640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154474815|NCT06113640|Montelukast|montelukast|mesh-list
154474816|NCT06113640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154474817|NCT06113640|Respiratory System Agents|respiratory system agents|mesh-ancestor
154474818|NCT06113640|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154474819|NCT06113640|Hormone Antagonists|hormone antagonists|mesh-ancestor
154474820|NCT06113640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474821|NCT06113640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474822|NCT06113640|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154474823|NCT06113640|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154474824|NCT06113640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474825|NCT06113640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154474826|NCT06113640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154474827|NCT06113640|Dopamine Agents|dopamine agents|mesh-ancestor
154474828|NCT06113640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474829|NCT06113640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154474830|NCT06113640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474831|NCT06113640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154474832|NCT06113640|Immunologic Factors|immunologic factors|mesh-ancestor
154474833|NCT06113640|Dopamine Agonists|dopamine agonists|mesh-ancestor
154474834|NCT06097026|Nitric Oxide|nitric oxide|mesh-list
154474835|NCT06097026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154474836|NCT06097026|Autonomic Agents|autonomic agents|mesh-ancestor
154474837|NCT06097026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474838|NCT06097026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474839|NCT06097026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154474840|NCT06097026|Respiratory System Agents|respiratory system agents|mesh-ancestor
154474841|NCT06097026|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154474842|NCT06097026|Antioxidants|antioxidants|mesh-ancestor
154474843|NCT06097026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474844|NCT06097026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474845|NCT06097026|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154474846|NCT06097026|Vasodilator Agents|vasodilator agents|mesh-ancestor
154474847|NCT06097026|Gasotransmitters|gasotransmitters|mesh-ancestor
154474848|NCT06097026|Protective Agents|protective agents|mesh-ancestor
154474849|NCT06087588|Ethanol|ethanol|mesh-list
154474850|NCT06087588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154474851|NCT06087588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474852|NCT06087588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474853|NCT06087588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474854|NCT06087549|Ropivacaine|ropivacaine|mesh-list
154474855|NCT06087549|Anesthetics, Local|anesthetics, local|mesh-ancestor
154474856|NCT06087549|Anesthetics|anesthetics|mesh-ancestor
154474857|NCT06087549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814873|NCT00343733|Analgesics|analgesics|mesh-ancestor
154474858|NCT06087549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474859|NCT06087549|Sensory System Agents|sensory system agents|mesh-ancestor
153729902|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729903|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
154474860|NCT06087549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474861|NCT06081101|Methylprednisolone|methylprednisolone|mesh-list
154474862|NCT06081101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154474863|NCT06081101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154474864|NCT06081101|Prednisolone|prednisolone|mesh-list
154474865|NCT06081101|Prednisolone acetate|prednisolone acetate|mesh-list
154474866|NCT06081101|Ketorolac|ketorolac|mesh-list
154474867|NCT06081101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154474868|NCT06081101|Prednisolone phosphate|prednisolone phosphate|mesh-list
154474869|NCT06081101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154474870|NCT06081101|Antiemetics|antiemetics|mesh-ancestor
154474871|NCT06081101|Autonomic Agents|autonomic agents|mesh-ancestor
154474872|NCT06081101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198779|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
154474873|NCT06081101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474874|NCT06081101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154474875|NCT06081101|Glucocorticoids|glucocorticoids|mesh-ancestor
154474877|NCT06081101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474878|NCT06081101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154474879|NCT06081101|Protective Agents|protective agents|mesh-ancestor
154474880|NCT06081101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154474881|NCT06081101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474882|NCT06081101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154474883|NCT06081101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154474884|NCT06081101|Analgesics|analgesics|mesh-ancestor
154474885|NCT06081101|Sensory System Agents|sensory system agents|mesh-ancestor
154474886|NCT06081101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154474887|NCT06081101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154474888|NCT06081101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474889|NCT06081101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474890|NCT06078709|Calcium, Dietary|calcium, dietary|mesh-list
154474891|NCT06078709|Leucovorin|leucovorin|mesh-list
154474892|NCT06078709|Folic Acid|folic acid|mesh-list
154474893|NCT06078709|Fluorouracil|fluorouracil|mesh-list
154474894|NCT06078709|Oxaliplatin|oxaliplatin|mesh-list
154474895|NCT06078709|Calcium|calcium|mesh-list
154474896|NCT06078709|Levoleucovorin|levoleucovorin|mesh-list
154474897|NCT06078709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154474898|NCT06078709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474899|NCT06078709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154474900|NCT06078709|Antimetabolites|antimetabolites|mesh-ancestor
154474901|NCT06078709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474902|NCT06078709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154474903|NCT06078709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474904|NCT06078709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154474905|NCT06078709|Immunologic Factors|immunologic factors|mesh-ancestor
154474906|NCT06078709|Antidotes|antidotes|mesh-ancestor
154474907|NCT06078709|Protective Agents|protective agents|mesh-ancestor
154474908|NCT06078709|Vitamin B Complex|vitamin b complex|mesh-ancestor
154474909|NCT06078709|Vitamins|vitamins|mesh-ancestor
154474910|NCT06078709|Micronutrients|micronutrients|mesh-ancestor
154474911|NCT06078709|Hematinics|hematinics|mesh-ancestor
154474912|NCT06077240|Menthol|menthol|mesh-list
154474913|NCT06077240|Nicotine|nicotine|mesh-list
154474914|NCT06077240|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154474915|NCT06077240|Autonomic Agents|autonomic agents|mesh-ancestor
154474916|NCT06077240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474917|NCT06077240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474918|NCT06077240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154474919|NCT06077240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154474920|NCT06077240|Cholinergic Agents|cholinergic agents|mesh-ancestor
154474921|NCT06077240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474922|NCT06077240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474923|NCT06077240|Antipruritics|antipruritics|mesh-ancestor
154474924|NCT06077240|Dermatologic Agents|dermatologic agents|mesh-ancestor
154474925|NCT06068179|Mycophenolic Acid|mycophenolic acid|mesh-list
154474926|NCT06068179|Methimazole|methimazole|mesh-list
154474927|NCT06068179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154474928|NCT06068179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474929|NCT06068179|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154860657|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
154474930|NCT06068179|Antitubercular Agents|antitubercular agents|mesh-ancestor
154474931|NCT06068179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154474932|NCT06068179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154474933|NCT06068179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154474934|NCT06068179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474935|NCT06068179|Antithyroid Agents|antithyroid agents|mesh-ancestor
154474936|NCT06068179|Hormone Antagonists|hormone antagonists|mesh-ancestor
154474937|NCT06068179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154474938|NCT06068179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474940|NCT06048484|Quemliclustat|quemliclustat|mesh-list
154474941|NCT06048484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474942|NCT06048484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154474943|NCT06048484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474944|NCT06048484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154474945|NCT06045156|Tirofiban|tirofiban|mesh-list
154474946|NCT06045156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154198858|NCT00271024|Naltrexone|naltrexone|mesh-list
154474947|NCT06045156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154474948|NCT06045156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814875|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474949|NCT06045156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154474951|NCT06043362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154474952|NCT06043362|Autonomic Agents|autonomic agents|mesh-ancestor
154474953|NCT06043362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474954|NCT06043362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474955|NCT06043362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154474956|NCT06043362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154474957|NCT06043362|Cholinergic Agents|cholinergic agents|mesh-ancestor
154474958|NCT06043362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154474959|NCT06043362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474960|NCT06041425|Sufentanil|sufentanil|mesh-list
154474961|NCT06041425|Oxycodone|oxycodone|mesh-list
154474962|NCT06041425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154474963|NCT06041425|Narcotics|narcotics|mesh-ancestor
154474964|NCT06041425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474965|NCT06041425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474966|NCT06041425|Analgesics|analgesics|mesh-ancestor
154474967|NCT06041425|Sensory System Agents|sensory system agents|mesh-ancestor
154474968|NCT06041425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474969|NCT06041425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154474970|NCT06041425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154474971|NCT06041425|Anesthetics, General|anesthetics, general|mesh-ancestor
154474972|NCT06041425|Anesthetics|anesthetics|mesh-ancestor
154474973|NCT06038695|Mitogens|mitogens|mesh-list
154474974|NCT06038695|Mitosis Modulators|mitosis modulators|mesh-ancestor
154474975|NCT06038695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474976|NCT06037460|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154474977|NCT06037460|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154474978|NCT06037460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154474979|NCT06035692|Ropivacaine|ropivacaine|mesh-list
154474980|NCT06035692|Anesthetics, Local|anesthetics, local|mesh-ancestor
154474981|NCT06035692|Anesthetics|anesthetics|mesh-ancestor
154474982|NCT06035692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154474983|NCT06035692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474984|NCT06035692|Sensory System Agents|sensory system agents|mesh-ancestor
154474985|NCT06035692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474986|NCT06035679|Trastuzumab|trastuzumab|mesh-list
154474987|NCT06035679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154038817|NCT02577094|Fludarabine|fludarabine|mesh-list
154474988|NCT06035679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154474989|NCT06018727|Hydrocortisone|hydrocortisone|mesh-list
154474990|NCT06018727|Yohimbine|yohimbine|mesh-list
154474991|NCT06018727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154474992|NCT06018727|Mydriatics|mydriatics|mesh-ancestor
154474993|NCT06018727|Autonomic Agents|autonomic agents|mesh-ancestor
154474994|NCT06018727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154474995|NCT06018727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154474996|NCT06018727|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154474997|NCT06018727|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154474998|NCT06018727|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154474999|NCT06018727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154475000|NCT06018727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475001|NCT06018727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475002|NCT06018727|Urological Agents|urological agents|mesh-ancestor
154475003|NCT06012279|Dapagliflozin|dapagliflozin|mesh-list
154475004|NCT06012279|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154475005|NCT06012279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475006|NCT06012279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154475007|NCT06012279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475008|NCT06001788|Cytarabine|cytarabine|mesh-list
154475009|NCT06001788|Fludarabine|fludarabine|mesh-list
154475010|NCT06001788|Idarubicin|idarubicin|mesh-list
154475011|NCT06001788|Lenograstim|lenograstim|mesh-list
154475012|NCT06001788|Gilteritinib|gilteritinib|mesh-list
154475013|NCT06001788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475014|NCT06001788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154475015|NCT06001788|Antimetabolites|antimetabolites|mesh-ancestor
154475016|NCT06001788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475017|NCT06001788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154475018|NCT06001788|Immunologic Factors|immunologic factors|mesh-ancestor
154475019|NCT06001788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475020|NCT06001788|Antiviral Agents|antiviral agents|mesh-ancestor
154475021|NCT06001788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198926|NCT01049763|Oseltamivir|oseltamivir|mesh-list
154475022|NCT06001788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154475023|NCT06001788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154475024|NCT06001788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154475025|NCT06001788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154475026|NCT06001788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475027|NCT06001788|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154475028|NCT06001788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475029|NCT05995405|Nimodipine|nimodipine|mesh-list
154038850|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
154475030|NCT05995405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154475031|NCT05995405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814877|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154475032|NCT05995405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154475033|NCT05995405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475034|NCT05995405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154475035|NCT05995405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475036|NCT05995405|Vasodilator Agents|vasodilator agents|mesh-ancestor
154475037|NCT05990686|Fentanyl|fentanyl|mesh-list
154475038|NCT05990686|Tramadol|tramadol|mesh-list
154475039|NCT05990686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154475040|NCT05990686|Narcotics|narcotics|mesh-ancestor
154475041|NCT05990686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475042|NCT05990686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475043|NCT05990686|Analgesics|analgesics|mesh-ancestor
154475044|NCT05990686|Sensory System Agents|sensory system agents|mesh-ancestor
154475045|NCT05990686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475046|NCT05990686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154475047|NCT05990686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154475048|NCT05990686|Anesthetics, General|anesthetics, general|mesh-ancestor
154475049|NCT05990686|Anesthetics|anesthetics|mesh-ancestor
154475050|NCT05986240|Venetoclax|venetoclax|mesh-list
154475051|NCT05986240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475052|NCT05983198|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154475053|NCT05983198|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154475054|NCT05983198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475055|NCT05976347|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154475056|NCT05976347|Fluoxetine|fluoxetine|mesh-list
154475057|NCT05976347|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154475058|NCT05976347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154475059|NCT05976347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154475060|NCT05976347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475061|NCT05976347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475062|NCT05976347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475063|NCT05976347|Analgesics|analgesics|mesh-ancestor
154475064|NCT05976347|Sensory System Agents|sensory system agents|mesh-ancestor
154475065|NCT05976347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475066|NCT05976347|Antidepressive Agents|antidepressive agents|mesh-ancestor
154475067|NCT05976347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154475068|NCT05976347|Dopamine Agents|dopamine agents|mesh-ancestor
154475069|NCT05976347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154475070|NCT05976347|Serotonin Agents|serotonin agents|mesh-ancestor
154475071|NCT05976347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154475072|NCT05976347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154475073|NCT05976347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154475074|NCT05976347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475075|NCT05970666|Bevacizumab|bevacizumab|mesh-list
154475076|NCT05970666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475077|NCT05970666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475078|NCT05970666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154475079|NCT05970666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154475080|NCT05970666|Growth Substances|growth substances|mesh-ancestor
154475081|NCT05970666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475082|NCT05970666|Growth Inhibitors|growth inhibitors|mesh-ancestor
154475083|NCT05964361|Vaccines|vaccines|mesh-list
154475084|NCT05964361|Immunologic Factors|immunologic factors|mesh-ancestor
154475085|NCT05964361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475086|NCT05957978|Paromomycin|paromomycin|mesh-list
154475087|NCT05957978|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154475088|NCT05957978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154475089|NCT05957978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154475090|NCT05957978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154475091|NCT05957978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154475092|NCT05957978|Schistosomicides|schistosomicides|mesh-ancestor
154475093|NCT05957978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154475094|NCT05957978|Anthelmintics|anthelmintics|mesh-ancestor
154475095|NCT05941767|Lidocaine|lidocaine|mesh-list
154475096|NCT05941767|Dexmedetomidine|dexmedetomidine|mesh-list
154475097|NCT05941767|Anesthetics, Local|anesthetics, local|mesh-ancestor
154475098|NCT05941767|Anesthetics|anesthetics|mesh-ancestor
154475099|NCT05941767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475100|NCT05941767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475101|NCT05941767|Sensory System Agents|sensory system agents|mesh-ancestor
154475102|NCT05941767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475103|NCT05941767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154475104|NCT05941767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154475105|NCT05941767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154475106|NCT05941767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154475107|NCT05941767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475108|NCT05941767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154475109|NCT05941767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154475110|NCT05941767|Analgesics|analgesics|mesh-ancestor
154475111|NCT05941767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154475112|NCT05941767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154475113|NCT05941767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154475114|NCT05941767|Adrenergic Agents|adrenergic agents|mesh-ancestor
154475115|NCT05941767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475116|NCT05938946|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154475117|NCT05929898|Dopamine|dopamine|mesh-list
154475118|NCT05929898|Dopamine Agonists|dopamine agonists|mesh-list
154475119|NCT05929898|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154475120|NCT05929898|Sympathomimetics|sympathomimetics|mesh-ancestor
154475121|NCT05929898|Autonomic Agents|autonomic agents|mesh-ancestor
154475122|NCT05929898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038937|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154475123|NCT05929898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475124|NCT05929898|Dopamine Agents|dopamine agents|mesh-ancestor
154475125|NCT05929898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475126|NCT05929898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475127|NCT05929898|Protective Agents|protective agents|mesh-ancestor
154475128|NCT05928728|Colchicine|colchicine|mesh-list
154475129|NCT05928728|Gout Suppressants|gout suppressants|mesh-ancestor
154475130|NCT05928728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475131|NCT05928728|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475132|NCT05928728|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475133|NCT05928728|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475134|NCT05928728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475135|NCT05928728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475136|NCT05926505|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154475137|NCT05926505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475138|NCT05922761|Fluticasone|fluticasone|mesh-list
154475139|NCT05922761|Xhance|xhance|mesh-list
154475140|NCT05922761|Azithromycin|azithromycin|mesh-list
154475141|NCT05922761|Prednisone|prednisone|mesh-list
154475142|NCT05922761|Montelukast|montelukast|mesh-list
154475143|NCT05922761|Belumosudil|belumosudil|mesh-list
154475144|NCT05922761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475145|NCT05922761|Glucocorticoids|glucocorticoids|mesh-ancestor
154475146|NCT05922761|Hormones|hormones|mesh-ancestor
154475147|NCT05922761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154475148|NCT05922761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475149|NCT05922761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154475150|NCT05922761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475151|NCT05922761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154475152|NCT05922761|Autonomic Agents|autonomic agents|mesh-ancestor
154860658|NCT04395638|Vitamins|vitamins|mesh-list
154475153|NCT05922761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475154|NCT05922761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154475155|NCT05922761|Respiratory System Agents|respiratory system agents|mesh-ancestor
154475156|NCT05922761|Dermatologic Agents|dermatologic agents|mesh-ancestor
154475157|NCT05922761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154475158|NCT05922761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154475159|NCT05922761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154475160|NCT05922761|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154475161|NCT05922761|Hormone Antagonists|hormone antagonists|mesh-ancestor
154475162|NCT05922761|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154475163|NCT05922761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154475164|NCT05922761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475165|NCT05922761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475166|NCT05922761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038989|NCT00877890|Exenatide|exenatide|mesh-list
154475167|NCT05915702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154475168|NCT05915702|Chelating Agents|chelating agents|mesh-ancestor
154475169|NCT05915702|Sequestering Agents|sequestering agents|mesh-ancestor
154475170|NCT05915702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475171|NCT05911308|Paclitaxel|paclitaxel|mesh-list
154475172|NCT05911308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154475173|NCT05911308|Carboplatin|carboplatin|mesh-list
154475174|NCT05911308|Pemetrexed|pemetrexed|mesh-list
154475175|NCT05911308|Durvalumab|durvalumab|mesh-list
154475176|NCT05911308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475177|NCT05911308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475178|NCT05911308|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475179|NCT05911308|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475180|NCT05911308|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475181|NCT05911308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475182|NCT05911308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475183|NCT05911308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154475184|NCT05911308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154475185|NCT05911308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475186|NCT05909137|Immunomodulating Agents|immunomodulating agents|mesh-list
154475187|NCT05909137|Immunologic Factors|immunologic factors|mesh-ancestor
154475188|NCT05909137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475189|NCT05905887|Paclitaxel|paclitaxel|mesh-list
154475190|NCT05905887|Apatinib|apatinib|mesh-list
154475191|NCT05905887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475192|NCT05905887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475193|NCT05905887|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475194|NCT05905887|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475195|NCT05905887|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475196|NCT05905887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475197|NCT05905887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475198|NCT05905887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475199|NCT05898854|FAPI-46|fapi-46|mesh-list
154475200|NCT05898854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154475201|NCT05898854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475202|NCT05897658|Levetiracetam|levetiracetam|mesh-list
154475203|NCT05897658|Anticonvulsants|anticonvulsants|mesh-ancestor
154475204|NCT05897658|Nootropic Agents|nootropic agents|mesh-ancestor
154475205|NCT05896943|Ustekinumab|ustekinumab|mesh-list
154475206|NCT05896943|Dermatologic Agents|dermatologic agents|mesh-ancestor
154475207|NCT05891249|Luspatercept|luspatercept|mesh-list
154475208|NCT05891249|Hematinics|hematinics|mesh-ancestor
154475209|NCT05887765|Dexamethasone|dexamethasone|mesh-list
154475210|NCT05887765|Dexamethasone acetate|dexamethasone acetate|mesh-list
154475211|NCT05887765|BB 1101|bb 1101|mesh-list
154475212|NCT05887765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475213|NCT05887765|Antiemetics|antiemetics|mesh-ancestor
154475214|NCT05887765|Autonomic Agents|autonomic agents|mesh-ancestor
154475215|NCT05887765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475216|NCT05887765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475217|NCT05887765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154475218|NCT05887765|Glucocorticoids|glucocorticoids|mesh-ancestor
154475219|NCT05887765|Hormones|hormones|mesh-ancestor
154475220|NCT05887765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154475221|NCT05887765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154475222|NCT05887765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475223|NCT05887765|Protease Inhibitors|protease inhibitors|mesh-ancestor
154475224|NCT05887765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475225|NCT05887765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475226|NCT05882812|Diclofenac|diclofenac|mesh-list
154475227|NCT05882812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154475228|NCT05882812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154475229|NCT05882812|Analgesics|analgesics|mesh-ancestor
154475230|NCT05882812|Sensory System Agents|sensory system agents|mesh-ancestor
154475231|NCT05882812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475232|NCT05882812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475233|NCT05882812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475234|NCT05882812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475235|NCT05882812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154475236|NCT05882812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475237|NCT05882812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475238|NCT05881915|Phenylephrine|phenylephrine|mesh-list
154475239|NCT05881915|Epinephrine|epinephrine|mesh-list
154475240|NCT05881915|Oxymetazoline|oxymetazoline|mesh-list
154475241|NCT05881915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154475242|NCT05881915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154475243|NCT05881915|Adrenergic Agents|adrenergic agents|mesh-ancestor
154475244|NCT05881915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475245|NCT05881915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475246|NCT05881915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475247|NCT05881915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154475248|NCT05881915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154475250|NCT05881915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475251|NCT05881915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154475252|NCT05881915|Respiratory System Agents|respiratory system agents|mesh-ancestor
154475253|NCT05881915|Mydriatics|mydriatics|mesh-ancestor
154475254|NCT05881915|Sympathomimetics|sympathomimetics|mesh-ancestor
154475255|NCT05881915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154475256|NCT05881915|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154039117|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
154475257|NCT05881915|Nasal Decongestants|nasal decongestants|mesh-ancestor
154475258|NCT05881915|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154475259|NCT05881915|Protective Agents|protective agents|mesh-ancestor
154475260|NCT05873192|Talazoparib|talazoparib|mesh-list
154475261|NCT05873192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154475262|NCT05873192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475263|NCT05873192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475264|NCT05873192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475265|NCT05870553|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154475266|NCT05870553|Laxatives|laxatives|mesh-ancestor
154475267|NCT05870553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154475268|NCT05853458|Hydroxyurea|hydroxyurea|mesh-list
154475269|NCT05853458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475270|NCT05853458|Antisickling Agents|antisickling agents|mesh-ancestor
154475271|NCT05853458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475272|NCT05853458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475273|NCT05853458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154475274|NCT05851898|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154475275|NCT05851898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154475276|NCT05851898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154475277|NCT05851898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154475278|NCT05851898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475279|NCT05851898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475280|NCT05851898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475281|NCT05851898|Analgesics|analgesics|mesh-ancestor
154475282|NCT05851898|Sensory System Agents|sensory system agents|mesh-ancestor
154475283|NCT05851898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475284|NCT05851898|Antidepressive Agents|antidepressive agents|mesh-ancestor
154475285|NCT05851898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154475286|NCT05851898|Dopamine Agents|dopamine agents|mesh-ancestor
154475287|NCT05847686|Psilocybin|psilocybin|mesh-list
154475288|NCT05847686|Hallucinogens|hallucinogens|mesh-ancestor
154475289|NCT05847686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475290|NCT05847686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154475291|NCT05840211|Paclitaxel|paclitaxel|mesh-list
154475292|NCT05840211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154475293|NCT05840211|Capecitabine|capecitabine|mesh-list
154475294|NCT05840211|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154475295|NCT05840211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475296|NCT05840211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475297|NCT05840211|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475298|NCT05840211|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475299|NCT05840211|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475300|NCT05840211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475301|NCT05840211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154475302|NCT05840211|Antimetabolites|antimetabolites|mesh-ancestor
154475303|NCT05840211|Immunoconjugates|immunoconjugates|mesh-ancestor
154475304|NCT05840211|Immunologic Factors|immunologic factors|mesh-ancestor
154475305|NCT05840211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475306|NCT05831176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154475307|NCT05831176|Immunologic Factors|immunologic factors|mesh-ancestor
154475308|NCT05831176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475309|NCT05827614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154475310|NCT05827614|Futibatinib|futibatinib|mesh-list
154475311|NCT05827614|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154475312|NCT05827614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475313|NCT05827614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475314|NCT05827614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475315|NCT05827614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475316|NCT05827016|Lenalidomide|lenalidomide|mesh-list
154475317|NCT05827016|Immunologic Factors|immunologic factors|mesh-ancestor
154475318|NCT05827016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475319|NCT05827016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154199241|NCT00985361|Vitamin D|vitamin d|mesh-list
154475320|NCT05827016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154475321|NCT05827016|Growth Substances|growth substances|mesh-ancestor
154475322|NCT05827016|Growth Inhibitors|growth inhibitors|mesh-ancestor
154475323|NCT05827016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475324|NCT05825781|Pertuzumab|pertuzumab|mesh-list
154475325|NCT05825781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475326|NCT05825781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475327|NCT05807399|Moxifloxacin|moxifloxacin|mesh-list
154475328|NCT05807399|Rifampin|rifampin|mesh-list
154475329|NCT05807399|Isoniazid|isoniazid|mesh-list
154475330|NCT05807399|Pyrazinamide|pyrazinamide|mesh-list
154475331|NCT05807399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154475332|NCT05807399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154475333|NCT05807399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154475334|NCT05807399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154475335|NCT05807399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475336|NCT05807399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475337|NCT05807399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475338|NCT05807399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154475339|NCT05807399|Antitubercular Agents|antitubercular agents|mesh-ancestor
154475340|NCT05807399|Leprostatic Agents|leprostatic agents|mesh-ancestor
154475341|NCT05807399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154475342|NCT05807399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154475343|NCT05807399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154475344|NCT05807399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154475345|NCT05807399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154475346|NCT05807399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154475347|NCT05807399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154475348|NCT05807399|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154475349|NCT05807399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154475350|NCT05807399|Antimetabolites|antimetabolites|mesh-ancestor
154475351|NCT05807399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154475352|NCT05797662|Propranolol|propranolol|mesh-list
154475353|NCT05797662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154475354|NCT05797662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154475355|NCT05797662|Adrenergic Agents|adrenergic agents|mesh-ancestor
154475356|NCT05797662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475357|NCT05797662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475358|NCT05797662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475359|NCT05797662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154475360|NCT05797662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154039169|NCT00676416|Propofol|propofol|mesh-list
154475361|NCT05797662|Vasodilator Agents|vasodilator agents|mesh-ancestor
154475362|NCT05797506|Sulforaphane|sulforaphane|mesh-list
154475363|NCT05797506|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154475364|NCT05797506|Protective Agents|protective agents|mesh-ancestor
154475365|NCT05797506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475366|NCT05797506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475367|NCT05792774|Bupivacaine|bupivacaine|mesh-list
154475368|NCT05792774|Anesthetics, Local|anesthetics, local|mesh-ancestor
154475369|NCT05792774|Anesthetics|anesthetics|mesh-ancestor
154475370|NCT05792774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475371|NCT05792774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475372|NCT05792774|Sensory System Agents|sensory system agents|mesh-ancestor
154475373|NCT05792774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475374|NCT05792319|Copper|copper|mesh-list
154475375|NCT05792319|Trace Elements|trace elements|mesh-ancestor
154475376|NCT05792319|Micronutrients|micronutrients|mesh-ancestor
154860659|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
154475377|NCT05792319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475379|NCT05776953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154475380|NCT05776953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154475381|NCT05776953|Analgesics|analgesics|mesh-ancestor
154475382|NCT05776953|Sensory System Agents|sensory system agents|mesh-ancestor
154475383|NCT05776953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475384|NCT05776953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475385|NCT05776953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475386|NCT05776953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475387|NCT05776953|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154475388|NCT05776953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475389|NCT05776953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475390|NCT05774717|Tranexamic Acid|tranexamic acid|mesh-list
154475391|NCT05774717|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154475392|NCT05774717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154475393|NCT05774717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475394|NCT05774717|Hemostatics|hemostatics|mesh-ancestor
154475395|NCT05774717|Coagulants|coagulants|mesh-ancestor
154475396|NCT05766345|BCG Vaccine|bcg vaccine|mesh-list
154475397|NCT05766345|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154475398|NCT05766345|Immunologic Factors|immunologic factors|mesh-ancestor
154475399|NCT05766345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475400|NCT05764733|Diphosphonates|diphosphonates|mesh-list
154475401|NCT05764733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154475402|NCT05764733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475403|NCT05761574|Acetaminophen|acetaminophen|mesh-list
154475404|NCT05761574|Naproxen|naproxen|mesh-list
154475405|NCT05761574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154475406|NCT05761574|Analgesics|analgesics|mesh-ancestor
154475407|NCT05761574|Sensory System Agents|sensory system agents|mesh-ancestor
154475408|NCT05761574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475409|NCT05761574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475410|NCT05761574|Antipyretics|antipyretics|mesh-ancestor
153814883|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154475411|NCT05761574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154475412|NCT05761574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475413|NCT05761574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039268|NCT06261580|Chelating Agents|chelating agents|mesh-ancestor
154475414|NCT05761574|Gout Suppressants|gout suppressants|mesh-ancestor
154475415|NCT05761574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154475416|NCT05761574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475417|NCT05761574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475418|NCT05761444|Atorvastatin|atorvastatin|mesh-list
154475419|NCT05761444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154475420|NCT05761444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154475421|NCT05761444|Antimetabolites|antimetabolites|mesh-ancestor
154475422|NCT05761444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475423|NCT05761444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154475424|NCT05761444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154475425|NCT05761444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475426|NCT05757791|Empagliflozin|empagliflozin|mesh-list
154475427|NCT05757791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154475428|NCT05757791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475429|NCT05757791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154475430|NCT05757791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475431|NCT05753592|Remibrutinib|remibrutinib|mesh-list
154475432|NCT05753592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475433|NCT05753592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475434|NCT05753592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475435|NCT05736406|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154475436|NCT05736406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154475437|NCT05736406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154475438|NCT05736406|Dermatologic Agents|dermatologic agents|mesh-ancestor
154475439|NCT05731492|Macitentan|macitentan|mesh-list
154475440|NCT05731492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154475441|NCT05731492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154475442|NCT05731492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475443|NCT05731492|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154475444|NCT05729932|Analgesics, Opioid|analgesics, opioid|mesh-list
154475445|NCT05729932|Narcotics|narcotics|mesh-ancestor
154475446|NCT05729932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039269|NCT06261580|Sequestering Agents|sequestering agents|mesh-ancestor
154475447|NCT05729932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475448|NCT05729932|Analgesics|analgesics|mesh-ancestor
154475449|NCT05729932|Sensory System Agents|sensory system agents|mesh-ancestor
154475450|NCT05729932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475451|NCT05726097|Ascorbic Acid|ascorbic acid|mesh-list
154475452|NCT05726097|Prucalopride|prucalopride|mesh-list
154475453|NCT05726097|Picosulfate sodium|picosulfate sodium|mesh-list
154475454|NCT05726097|Antioxidants|antioxidants|mesh-ancestor
154475455|NCT05726097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475456|NCT05726097|Protective Agents|protective agents|mesh-ancestor
154475457|NCT05726097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475458|NCT05726097|Vitamins|vitamins|mesh-ancestor
154475459|NCT05726097|Micronutrients|micronutrients|mesh-ancestor
154475460|NCT05726097|Laxatives|laxatives|mesh-ancestor
154475461|NCT05726097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154475462|NCT05726097|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154475463|NCT05726097|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154475464|NCT05726097|Serotonin Agents|serotonin agents|mesh-ancestor
154475465|NCT05726097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475466|NCT05726097|Cathartics|cathartics|mesh-ancestor
154475467|NCT05722015|Paclitaxel|paclitaxel|mesh-list
154475468|NCT05722015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154475469|NCT05722015|Carboplatin|carboplatin|mesh-list
154475470|NCT05722015|Pembrolizumab|pembrolizumab|mesh-list
154475471|NCT05722015|Pemetrexed|pemetrexed|mesh-list
154475472|NCT05722015|Lenograstim|lenograstim|mesh-list
154475473|NCT05722015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475474|NCT05722015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475475|NCT05722015|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475476|NCT05722015|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475477|NCT05722015|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475478|NCT05722015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475479|NCT05722015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475480|NCT05722015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154475481|NCT05722015|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154475482|NCT05722015|Immunologic Factors|immunologic factors|mesh-ancestor
154475483|NCT05722015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475484|NCT05722015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475485|NCT05722015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154475486|NCT05722015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154475487|NCT05703555|Maytansine|maytansine|mesh-list
154475488|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475489|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475490|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475491|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475492|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475493|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475494|NCT05701995|Deucravacitinib|deucravacitinib|mesh-list
154475495|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
154475496|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475497|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475498|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475499|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154475500|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
154475501|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475502|NCT05683574|Etoricoxib|etoricoxib|mesh-list
154475503|NCT05683574|Amitriptyline|amitriptyline|mesh-list
154475504|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
154475505|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154475506|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154475507|NCT05683574|Analgesics|analgesics|mesh-ancestor
154475508|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
154475509|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475510|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475511|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475512|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475513|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154475514|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154475515|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475516|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475517|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154475518|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
154475519|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154475520|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154475521|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154475522|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154475523|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475524|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154475525|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154475527|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
154475528|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475529|NCT05673811|Paclitaxel|paclitaxel|mesh-list
154475530|NCT05673811|Gemcitabine|gemcitabine|mesh-list
154475531|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475532|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475533|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475534|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475535|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475536|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475537|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154475538|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
154475539|NCT05664737|Luspatercept|luspatercept|mesh-list
154475540|NCT05664737|Hematinics|hematinics|mesh-ancestor
154475541|NCT05656911|Zabedosertib|zabedosertib|mesh-list
154475542|NCT05656911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475543|NCT05656911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475544|NCT05656911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475545|NCT05654467|Vaccines|vaccines|mesh-list
154475546|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
154475547|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475548|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
154475549|NCT05653271|Fludarabine|fludarabine|mesh-list
154039360|NCT06260904|Hormones|hormones|mesh-ancestor
154475550|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
154475551|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154475552|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
154475553|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475554|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475555|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154475556|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
154475557|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475558|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475559|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154475560|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475561|NCT05650697|Cannabidiol|cannabidiol|mesh-list
154475562|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
154475563|NCT05643573|Apixaban|apixaban|mesh-list
154475564|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154475565|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
154475566|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154475567|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
154475568|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475569|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475570|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
154475571|NCT05635708|Paclitaxel|paclitaxel|mesh-list
154475572|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154475573|NCT05635708|Carboplatin|carboplatin|mesh-list
154475574|NCT05635708|Pemetrexed|pemetrexed|mesh-list
154475575|NCT05635708|Tislelizumab|tislelizumab|mesh-list
154475576|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475577|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475578|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475579|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475580|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475581|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475582|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475583|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154475584|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154475585|NCT05635708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475586|NCT05627752|Docetaxel|docetaxel|mesh-list
154475587|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475588|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475589|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475590|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
154039414|NCT06260033|Estradiol|estradiol|mesh-list
154475591|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475592|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154475593|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154475594|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
154475595|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475596|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154475597|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
154475598|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475599|NCT05621616|Mirabegron|mirabegron|mesh-list
154103787|NCT01042951|Vaccines|vaccines|mesh-list
154475600|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154475602|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154475603|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
154475604|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475605|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475606|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475607|NCT05621616|Urological Agents|urological agents|mesh-ancestor
154475608|NCT05620407|Deucravacitinib|deucravacitinib|mesh-list
154475609|NCT05620407|Dermatologic Agents|dermatologic agents|mesh-ancestor
154475610|NCT05620407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475611|NCT05620407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475612|NCT05620407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475613|NCT05597839|Nivolumab|nivolumab|mesh-list
154475614|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475615|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475616|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154475617|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475618|NCT05587361|Propranolol|propranolol|mesh-list
154475619|NCT05587361|Nicotine|nicotine|mesh-list
154475620|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154475621|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
154475622|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475623|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475624|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154475625|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154475626|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
154475627|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475628|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475629|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154475630|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154475631|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
154475632|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154475633|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154475634|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
154475635|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154475636|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
154475637|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475638|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
154475639|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475640|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475641|NCT05572684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154475642|NCT05572684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475643|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
154475644|NCT05565664|Ketamine|ketamine|mesh-list
154475645|NCT05565664|Analgesics|analgesics|mesh-ancestor
154475646|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
154475647|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475648|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475649|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154475650|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154475651|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
154475652|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
154475653|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475654|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154475655|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154475656|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475657|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475658|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154475659|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
154475660|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154475661|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154475662|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154475663|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
154475664|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154475665|NCT05559112|Vitamin D|vitamin d|mesh-list
154475666|NCT05559112|Vitamins|vitamins|mesh-ancestor
154475667|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
154475668|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475669|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154475670|NCT05549661|Onvansertib|onvansertib|mesh-list
154475671|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475672|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475673|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475675|NCT05548582|Ibuprofen|ibuprofen|mesh-list
154475676|NCT05548582|Oxycodone|oxycodone|mesh-list
154475677|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154475678|NCT05548582|Analgesics|analgesics|mesh-ancestor
154475679|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
154475680|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475681|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475682|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
154475683|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154475684|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475685|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475686|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154475687|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475688|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475689|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154475690|NCT05548582|Narcotics|narcotics|mesh-ancestor
154475691|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475692|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
154475693|NCT05541172|Testosterone|testosterone|mesh-list
154199603|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
153814885|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154039551|NCT06177964|Alkylating Agents|alkylating agents|mesh-ancestor
154475694|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
154475695|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
154475696|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154475697|NCT05541172|Androgens|androgens|mesh-ancestor
154475699|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154475700|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475701|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154475702|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475703|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
154475704|NCT05538910|Nicotine|nicotine|mesh-list
154475705|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154475706|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
154475707|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475708|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475709|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154475710|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154475711|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
154475712|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475713|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475714|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
154475715|NCT05535166|Carboplatin|carboplatin|mesh-list
154475716|NCT05535166|Methotrexate|methotrexate|mesh-list
154475717|NCT05535166|Etoposide|etoposide|mesh-list
154475718|NCT05535166|Vincristine|vincristine|mesh-list
154475719|NCT05535166|Topotecan|topotecan|mesh-list
154475720|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154475721|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
154475722|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475723|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475724|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154475725|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
154475726|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475727|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475728|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154475729|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154475730|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
154475731|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154475732|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154475733|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
154475734|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
154475735|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475736|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154475737|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154475738|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475739|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154475740|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154475741|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
154475742|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
154475743|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
154475744|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154475745|NCT05530655|Lisinopril|lisinopril|mesh-list
154475746|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154475747|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
154475748|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475749|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475750|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154475751|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154475752|NCT05530655|Protective Agents|protective agents|mesh-ancestor
154475753|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475754|NCT05514132|Durvalumab|durvalumab|mesh-list
154475755|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154475756|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475757|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475758|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
154475759|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475760|NCT05497765|Silybin|silybin|mesh-list
154475761|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154475762|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475763|NCT05497765|Protective Agents|protective agents|mesh-ancestor
154475764|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475765|NCT05495750|Bupivacaine|bupivacaine|mesh-list
154475766|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
154475767|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
154475768|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199674|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154475769|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475770|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
154475771|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475773|NCT05489211|Prednisone|prednisone|mesh-list
154475774|NCT05489211|Prednisolone|prednisolone|mesh-list
154475775|NCT05489211|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154475776|NCT05489211|Methylprednisolone|methylprednisolone|mesh-list
154475777|NCT05489211|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154475778|NCT05489211|Prednisolone acetate|prednisolone acetate|mesh-list
154475779|NCT05489211|Bevacizumab|bevacizumab|mesh-list
154475780|NCT05489211|Durvalumab|durvalumab|mesh-list
154475781|NCT05489211|Carboplatin|carboplatin|mesh-list
154475782|NCT05489211|Capecitabine|capecitabine|mesh-list
154475783|NCT05489211|Fluorouracil|fluorouracil|mesh-list
154475784|NCT05489211|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154475785|NCT05489211|Prednisolone phosphate|prednisolone phosphate|mesh-list
154475786|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475787|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475788|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154475789|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154475790|NCT05489211|Growth Substances|growth substances|mesh-ancestor
154475791|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475792|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
154475793|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154475794|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
154475795|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475796|NCT05489211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475797|NCT05489211|Glucocorticoids|glucocorticoids|mesh-ancestor
154475798|NCT05489211|Hormones|hormones|mesh-ancestor
154475799|NCT05489211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154475800|NCT05489211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154475801|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154475802|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
154475803|NCT05489211|Antidotes|antidotes|mesh-ancestor
154475804|NCT05489211|Protective Agents|protective agents|mesh-ancestor
154475805|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
154475806|NCT05489211|Vitamins|vitamins|mesh-ancestor
154475807|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
154475808|NCT05489211|Antiemetics|antiemetics|mesh-ancestor
154475809|NCT05489211|Autonomic Agents|autonomic agents|mesh-ancestor
154475810|NCT05489211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475811|NCT05489211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154475812|NCT05489211|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154475813|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154860660|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860661|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154860662|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154860663|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
154860664|NCT04347980|Dexamethasone|dexamethasone|mesh-list
154860665|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860666|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
154860667|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
154860668|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475814|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475815|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860669|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475816|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154475817|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475818|NCT05486650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475819|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475821|NCT05463419|Immunologic Factors|immunologic factors|mesh-ancestor
154475822|NCT05463419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475823|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
154475824|NCT05462236|Irinotecan|irinotecan|mesh-list
154475825|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475826|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475827|NCT05462236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154475828|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475829|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154475830|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154475831|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475832|NCT05458609|Naltrexone|naltrexone|mesh-list
154475833|NCT05458609|Lemborexant|lemborexant|mesh-list
154475834|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154475835|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154475836|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475837|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
153582389|NCT03642028|Suvorexant|suvorexant|mesh-list
154475838|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475839|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154475840|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475841|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475842|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154475843|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154199760|NCT00293020|Fentanyl|fentanyl|mesh-list
154475844|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475845|NCT05452577|Estazolam|estazolam|mesh-list
154475846|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
154475847|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154475848|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154475849|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475850|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475851|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154475852|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
154475853|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
154475854|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475855|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475856|NCT05441527|Muramidase|muramidase|mesh-list
154475857|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154475858|NCT05440786|Irinotecan|irinotecan|mesh-list
154475859|NCT05440786|Temozolomide|temozolomide|mesh-list
154475860|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154475861|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154475862|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475863|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475864|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475865|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154475866|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
154475867|NCT05440708|Bevacizumab|bevacizumab|mesh-list
154475868|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
154475869|NCT05440708|Atezolizumab|atezolizumab|mesh-list
154475870|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475871|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475872|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154475873|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154475874|NCT05440708|Growth Substances|growth substances|mesh-ancestor
154475875|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475876|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
154475877|NCT05440708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154475878|NCT05440708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475879|NCT05439616|Cariprazine|cariprazine|mesh-list
154475880|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154475881|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154475882|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475883|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475884|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154475885|NCT05416476|Anisodine|anisodine|mesh-list
154475886|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154475887|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154475888|NCT05416476|Analgesics|analgesics|mesh-ancestor
154475889|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
154475890|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475891|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475892|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475893|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475894|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
154475895|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
154475896|NCT05413304|Temozolomide|temozolomide|mesh-list
154475897|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
154475898|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154475899|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
154475900|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475901|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475902|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154475903|NCT05391750|Venetoclax|venetoclax|mesh-list
154475904|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
154475905|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
154475906|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
154475907|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475908|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475909|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
154475910|NCT05390307|Liraglutide|liraglutide|mesh-list
154475911|NCT05390307|Semaglutide|semaglutide|mesh-list
154475912|NCT05390307|Glucagon|glucagon|mesh-list
154475913|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154475914|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154475915|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475916|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154475917|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475918|NCT05390307|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154475919|NCT05390307|Incretins|incretins|mesh-ancestor
154039739|NCT05663710|Nivolumab|nivolumab|mesh-list
154475921|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154475922|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154475923|NCT05383495|Midazolam|midazolam|mesh-list
154475924|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
154475925|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
154475926|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154475927|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154475928|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475929|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154475930|NCT05383495|Analgesics|analgesics|mesh-ancestor
154475931|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
154475932|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475933|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154475934|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154475935|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154475936|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
154475937|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154475938|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475939|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154475940|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154475941|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154475942|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154475943|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154475944|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
154475945|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
154475946|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
154475947|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
154475948|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154475949|NCT05373615|Cefiderocol|cefiderocol|mesh-list
154475950|NCT05373615|Siderophores|siderophores|mesh-ancestor
154475951|NCT05373615|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154475952|NCT05373615|Chelating Agents|chelating agents|mesh-ancestor
154475953|NCT05373615|Sequestering Agents|sequestering agents|mesh-ancestor
154475954|NCT05373615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475955|NCT05373615|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154475956|NCT05373615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154475957|NCT05373615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154475958|NCT05372354|Dexamethasone|dexamethasone|mesh-list
154475959|NCT05372354|Trametinib|trametinib|mesh-list
154475960|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475961|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
154475962|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
154475963|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154475964|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475965|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153814887|NCT00453804|Naltrexone|naltrexone|mesh-list
154475966|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
154475967|NCT05372354|Hormones|hormones|mesh-ancestor
154475968|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154475969|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154475970|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475971|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154475972|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475973|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475974|NCT05371093|Prednisone|prednisone|mesh-list
154475975|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
154475976|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154475977|NCT05371093|Rituximab|rituximab|mesh-list
154475978|NCT05371093|Doxorubicin|doxorubicin|mesh-list
154475979|NCT05371093|Fludarabine|fludarabine|mesh-list
154475980|NCT05371093|Vincristine|vincristine|mesh-list
154475981|NCT05371093|Lenalidomide|lenalidomide|mesh-list
154475982|NCT05371093|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154475983|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154475984|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
154475985|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154475986|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154475987|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154475988|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
154475989|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154475990|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154475991|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154475992|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154475993|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154475994|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154475995|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154475996|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154475997|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154475998|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
154475999|NCT05371093|Hormones|hormones|mesh-ancestor
154476000|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154476001|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154476002|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154476003|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
154476004|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
154476005|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
154476006|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154476007|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154476008|NCT05371093|Growth Substances|growth substances|mesh-ancestor
154476009|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
154476010|NCT05364944|Octreotide|octreotide|mesh-list
154476011|NCT05364944|Lanreotide|lanreotide|mesh-list
154476012|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476013|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154476014|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476015|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
154476016|NCT05358522|Narcotics|narcotics|mesh-ancestor
154476017|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476018|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476019|NCT05358522|Analgesics|analgesics|mesh-ancestor
154476020|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
154476021|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476022|NCT05357612|Pimavanserin|pimavanserin|mesh-list
154476023|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154476024|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154476025|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154476026|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154476027|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476028|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476029|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476030|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154476031|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154476032|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
154476033|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476034|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476035|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154476036|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154476037|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154476038|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
154476039|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476040|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154476041|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154476042|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476043|NCT05331053|Atorvastatin|atorvastatin|mesh-list
154476044|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154476045|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154476046|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
154476047|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476048|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154476049|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154476050|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476051|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
154476052|NCT05325580|Analgesics|analgesics|mesh-ancestor
154476053|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
154476054|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476055|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476056|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
154476057|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476058|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154476059|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
154476060|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154476061|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154476062|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476063|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154476064|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
154476065|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154476066|NCT05305508|Mannitol|mannitol|mesh-list
154476067|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
154476068|NCT05305508|Calcium|calcium|mesh-list
154476069|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154476070|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476071|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154476072|NCT05305508|Diuretics|diuretics|mesh-ancestor
154476073|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
154476074|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
154476075|NCT05305508|Coagulants|coagulants|mesh-ancestor
154476076|NCT05258773|Azasetron|azasetron|mesh-list
154476077|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
154476078|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
154476079|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476080|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476081|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476082|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154476083|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
154476084|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476085|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476086|NCT05255601|Nivolumab|nivolumab|mesh-list
154476087|NCT05255601|Relatlimab|relatlimab|mesh-list
154476088|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476089|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476090|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154476091|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476092|NCT05252390|Olaparib|olaparib|mesh-list
154476093|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154476094|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476095|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476096|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476097|NCT05246644|Acetaminophen|acetaminophen|mesh-list
154476098|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154476099|NCT05246644|Analgesics|analgesics|mesh-ancestor
154476100|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
154476101|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814889|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154476102|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476103|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
154476104|NCT05232630|Fenfluramine|fenfluramine|mesh-list
154476105|NCT05232630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154476106|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154476107|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154476108|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476109|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476110|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
154476111|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476112|NCT05214911|Loratadine|loratadine|mesh-list
154476113|NCT05214911|Prednisolone|prednisolone|mesh-list
154476114|NCT05214911|Desloratadine|desloratadine|mesh-list
154476115|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154476117|NCT05214911|Hormones|hormones|mesh-ancestor
154476118|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154476119|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476120|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154476121|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476122|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154476123|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
154476124|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476125|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476126|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154476127|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154476128|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
154476129|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
154476130|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
154476131|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
154476132|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154476133|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
154476134|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154476135|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
154476136|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476137|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
154476138|NCT05188898|Protective Agents|protective agents|mesh-ancestor
154476139|NCT05184803|Docetaxel|docetaxel|mesh-list
154476140|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
154476141|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476142|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
154476143|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
154476144|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
154200052|NCT00483002|Varenicline|varenicline|mesh-list
154476145|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476146|NCT05176379|Fluconazole|fluconazole|mesh-list
154476147|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
154476148|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476149|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154476150|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154476151|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476152|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476153|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154476154|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
154476155|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154476156|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476157|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154476158|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154476159|NCT05161195|Tamoxifen|tamoxifen|mesh-list
154476160|NCT05161195|Letrozole|letrozole|mesh-list
154476161|NCT05161195|Fulvestrant|fulvestrant|mesh-list
154476162|NCT05161195|Anastrozole|anastrozole|mesh-list
154476163|NCT05161195|Goserelin|goserelin|mesh-list
154476164|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476165|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154476166|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154476167|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476168|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476169|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154476170|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
154476171|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154476172|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476173|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154476174|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154476175|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154476176|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154476177|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154476178|NCT05149378|Azacitidine|azacitidine|mesh-list
154476179|NCT05149378|Venetoclax|venetoclax|mesh-list
154476180|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154476181|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
154476182|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476183|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476184|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476185|NCT05136287|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154476186|NCT05136287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104368|NCT00907972|Vitamins|vitamins|mesh-list
154860670|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476187|NCT05136287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476189|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476190|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040059|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
154476191|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
154476192|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
154476193|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476194|NCT05116917|Nivolumab|nivolumab|mesh-list
154476195|NCT05116917|Ipilimumab|ipilimumab|mesh-list
154476196|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476197|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476198|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154476199|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476200|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
154476201|NCT05106127|Lenvatinib|lenvatinib|mesh-list
154476202|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476203|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476204|NCT05106127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154476205|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476206|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154476207|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476208|NCT05104554|Folic Acid|folic acid|mesh-list
154476209|NCT05104554|Micronutrients|micronutrients|mesh-list
154476210|NCT05104554|Trace Elements|trace elements|mesh-list
154476211|NCT05104554|Hematinics|hematinics|mesh-ancestor
154476212|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
154476213|NCT05104554|Vitamins|vitamins|mesh-ancestor
154476214|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476215|NCT05075993|Paclitaxel|paclitaxel|mesh-list
154476216|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154476217|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
154200126|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
154476218|NCT05075993|Bevacizumab|bevacizumab|mesh-list
154476219|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154476220|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476221|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154476222|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154476223|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
154476224|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476225|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154476226|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
154476227|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476228|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154476229|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154476230|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
154476231|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154476232|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476233|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154476234|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154476235|NCT05075993|Growth Substances|growth substances|mesh-ancestor
154476236|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
154476237|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
154476238|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154476239|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
154476240|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476241|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
154476242|NCT05073575|Protective Agents|protective agents|mesh-ancestor
154476243|NCT06294639|Esketamine|esketamine|mesh-list
154476244|NCT06294639|Antidepressive Agents|antidepressive agents|mesh-ancestor
154476245|NCT06294639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476246|NCT06294483|Antibodies|antibodies|mesh-list
154476247|NCT06294483|Complement System Proteins|complement system proteins|mesh-list
154476248|NCT06294483|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
154476249|NCT06294483|Complement C4|complement c4|mesh-list
154476250|NCT06294483|Immunologic Factors|immunologic factors|mesh-ancestor
154476251|NCT06294483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476252|NCT06293989|Diazepam|diazepam|mesh-list
154476253|NCT06293989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154476254|NCT06293989|Anticonvulsants|anticonvulsants|mesh-ancestor
154476255|NCT06293989|Antiemetics|antiemetics|mesh-ancestor
154476256|NCT06293989|Autonomic Agents|autonomic agents|mesh-ancestor
154476257|NCT06293989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476258|NCT06293989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476259|NCT06293989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476260|NCT06293989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154476261|NCT06293989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476262|NCT06293989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154860671|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
154476263|NCT06293989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154476264|NCT06293989|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154476265|NCT06293989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154476266|NCT06293989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476267|NCT06293989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154476268|NCT06293989|Anesthetics, General|anesthetics, general|mesh-ancestor
154476269|NCT06293989|Anesthetics|anesthetics|mesh-ancestor
154476270|NCT06293989|GABA Modulators|gaba modulators|mesh-ancestor
154476271|NCT06293989|GABA Agents|gaba agents|mesh-ancestor
154476272|NCT06293989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476273|NCT06293989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476274|NCT06293742|Digoxin|digoxin|mesh-list
154476275|NCT06293742|Midazolam|midazolam|mesh-list
154476276|NCT06293742|Atorvastatin|atorvastatin|mesh-list
154476277|NCT06293742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154476278|NCT06293742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154476279|NCT06293742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154476280|NCT06293742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476281|NCT06293742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476282|NCT06293742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154476283|NCT06293742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154476284|NCT06293742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476285|NCT06293742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154476286|NCT06293742|Anesthetics, General|anesthetics, general|mesh-ancestor
154476287|NCT06293742|Anesthetics|anesthetics|mesh-ancestor
154476288|NCT06293742|GABA Modulators|gaba modulators|mesh-ancestor
154476289|NCT06293742|GABA Agents|gaba agents|mesh-ancestor
154476290|NCT06293742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476291|NCT06293742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476292|NCT06293742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154476293|NCT06293742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154476294|NCT06293742|Antimetabolites|antimetabolites|mesh-ancestor
154476295|NCT06293742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154476296|NCT06293742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154476297|NCT06293742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476298|NCT06293742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154476299|NCT06293742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154476300|NCT06293742|Protective Agents|protective agents|mesh-ancestor
154476301|NCT06293677|Meropenem|meropenem|mesh-list
154476302|NCT06293677|Tazobactam|tazobactam|mesh-list
154476303|NCT06293677|Piperacillin|piperacillin|mesh-list
154476304|NCT06293677|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154476305|NCT06293677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154476306|NCT06293677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476307|NCT06293677|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154476308|NCT06293677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476309|NCT06293677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476310|NCT06293651|Pembrolizumab|pembrolizumab|mesh-list
154476311|NCT06293651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476312|NCT06293651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476313|NCT06293651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154476314|NCT06293651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476315|NCT06293638|Alprazolam|alprazolam|mesh-list
154476316|NCT06293638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154476317|NCT06293638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476318|NCT06293638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476319|NCT06293638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154476320|NCT06293638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154476321|NCT06293638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476322|NCT06293638|GABA Modulators|gaba modulators|mesh-ancestor
154476323|NCT06293638|GABA Agents|gaba agents|mesh-ancestor
154476324|NCT06293638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476325|NCT06293638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476326|NCT06293586|Acetaminophen|acetaminophen|mesh-list
154476327|NCT06293586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154476328|NCT06293586|Analgesics|analgesics|mesh-ancestor
154476329|NCT06293586|Sensory System Agents|sensory system agents|mesh-ancestor
154476330|NCT06293586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476331|NCT06293586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476332|NCT06293586|Antipyretics|antipyretics|mesh-ancestor
154476333|NCT06293547|Fluorides|fluorides|mesh-list
154476334|NCT06293547|Cariostatic Agents|cariostatic agents|mesh-ancestor
154476335|NCT06293547|Protective Agents|protective agents|mesh-ancestor
154476336|NCT06293547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476337|NCT06293404|Bupivacaine|bupivacaine|mesh-list
154476338|NCT06293404|Anesthetics, Local|anesthetics, local|mesh-ancestor
154476339|NCT06293404|Anesthetics|anesthetics|mesh-ancestor
154476340|NCT06293404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476341|NCT06293404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476342|NCT06293404|Sensory System Agents|sensory system agents|mesh-ancestor
154476343|NCT06293404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476344|NCT06293378|Sulfasalazine|sulfasalazine|mesh-list
154476345|NCT06293378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476346|NCT06293378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154476347|NCT06293378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154476348|NCT06293378|Analgesics|analgesics|mesh-ancestor
154476349|NCT06293378|Sensory System Agents|sensory system agents|mesh-ancestor
154476350|NCT06293378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476351|NCT06293378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476352|NCT06293378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154476353|NCT06293378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154476354|NCT06293378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476355|NCT06293300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154476356|NCT06293300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154476357|NCT06293300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476358|NCT06293300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476359|NCT06293300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154476360|NCT06293300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154476361|NCT06293300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476362|NCT06293300|Cholinergic Agents|cholinergic agents|mesh-ancestor
154476363|NCT06293300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476364|NCT06293157|Carbon Fiber|carbon fiber|mesh-list
154476365|NCT06293157|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154476366|NCT06293157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476367|NCT06293144|Ropivacaine|ropivacaine|mesh-list
154476368|NCT06293144|Anesthetics, Local|anesthetics, local|mesh-ancestor
154476369|NCT06293144|Anesthetics|anesthetics|mesh-ancestor
154476370|NCT06293144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476371|NCT06293144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476372|NCT06293144|Sensory System Agents|sensory system agents|mesh-ancestor
154476373|NCT06293144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476374|NCT06293131|Ropivacaine|ropivacaine|mesh-list
154476375|NCT06293131|Anesthetics, Local|anesthetics, local|mesh-ancestor
154476376|NCT06293131|Anesthetics|anesthetics|mesh-ancestor
154476377|NCT06293131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476378|NCT06293131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476379|NCT06293131|Sensory System Agents|sensory system agents|mesh-ancestor
154476380|NCT06293131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476381|NCT06293040|Ethanol|ethanol|mesh-list
154476382|NCT06293040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154476383|NCT06293040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476384|NCT06293040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476385|NCT06293040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476386|NCT06293014|Trifluridine|trifluridine|mesh-list
154476387|NCT06293014|Bevacizumab|bevacizumab|mesh-list
154476388|NCT06293014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476389|NCT06293014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476390|NCT06293014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154476391|NCT06293014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154476392|NCT06293014|Growth Substances|growth substances|mesh-ancestor
154476393|NCT06293014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476394|NCT06293014|Growth Inhibitors|growth inhibitors|mesh-ancestor
154476395|NCT06293014|Antimetabolites|antimetabolites|mesh-ancestor
154476396|NCT06293014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476397|NCT06293014|Antiviral Agents|antiviral agents|mesh-ancestor
154476398|NCT06293014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476399|NCT06292286|Paclitaxel|paclitaxel|mesh-list
154476400|NCT06292286|Bevacizumab|bevacizumab|mesh-list
154476401|NCT06292286|Carboplatin|carboplatin|mesh-list
154476402|NCT06292286|Gemcitabine|gemcitabine|mesh-list
154476403|NCT06292286|Doxorubicin|doxorubicin|mesh-list
154476404|NCT06292286|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154476405|NCT06292286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154476406|NCT06292286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476407|NCT06292286|Tubulin Modulators|tubulin modulators|mesh-ancestor
154476408|NCT06292286|Antimitotic Agents|antimitotic agents|mesh-ancestor
154476409|NCT06292286|Mitosis Modulators|mitosis modulators|mesh-ancestor
154476410|NCT06292286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476411|NCT06292286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476412|NCT06292286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154476413|NCT06292286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154476414|NCT06292286|Growth Substances|growth substances|mesh-ancestor
154476415|NCT06292286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476416|NCT06292286|Growth Inhibitors|growth inhibitors|mesh-ancestor
154476417|NCT06292286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154476418|NCT06292286|Antimetabolites|antimetabolites|mesh-ancestor
154476419|NCT06292286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154476420|NCT06292286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154476421|NCT06292286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154476422|NCT06292286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476423|NCT06292273|Dexamethasone|dexamethasone|mesh-list
154476424|NCT06292273|Bupivacaine|bupivacaine|mesh-list
154476425|NCT06292273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154476426|NCT06292273|Antiemetics|antiemetics|mesh-ancestor
154476427|NCT06292273|Autonomic Agents|autonomic agents|mesh-ancestor
154476428|NCT06292273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476429|NCT06292273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476430|NCT06292273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476431|NCT06292273|Glucocorticoids|glucocorticoids|mesh-ancestor
154476432|NCT06292273|Hormones|hormones|mesh-ancestor
154476433|NCT06292273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154476434|NCT06292273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154476435|NCT06292273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476436|NCT06292273|Anesthetics, Local|anesthetics, local|mesh-ancestor
154476437|NCT06292273|Anesthetics|anesthetics|mesh-ancestor
154476438|NCT06292273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476439|NCT06292273|Sensory System Agents|sensory system agents|mesh-ancestor
154476440|NCT06290583|Bupivacaine|bupivacaine|mesh-list
154476441|NCT06290583|Prilocaine|prilocaine|mesh-list
154476442|NCT06290583|Anesthetics, Local|anesthetics, local|mesh-ancestor
154476443|NCT06290583|Anesthetics|anesthetics|mesh-ancestor
154476444|NCT06290583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476445|NCT06290583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476446|NCT06290583|Sensory System Agents|sensory system agents|mesh-ancestor
154476447|NCT06290583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476448|NCT06288919|Erythritol|erythritol|mesh-list
154476449|NCT06288919|Vasodilator Agents|vasodilator agents|mesh-ancestor
154476450|NCT06284668|Esketamine|esketamine|mesh-list
154476451|NCT06284668|Antidepressive Agents|antidepressive agents|mesh-ancestor
154476452|NCT06284668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476453|NCT06278389|Tenofovir|tenofovir|mesh-list
154476454|NCT06278389|Emtricitabine|emtricitabine|mesh-list
154476455|NCT06278389|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154476456|NCT06278389|Antiviral Agents|antiviral agents|mesh-ancestor
154476457|NCT06278389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476458|NCT06278389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154476459|NCT06278389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154476460|NCT06278389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476461|NCT06278389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476462|NCT06278389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154476463|NCT06278389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154476464|NCT06276127|Bisoprolol|bisoprolol|mesh-list
154476465|NCT06276127|Diltiazem|diltiazem|mesh-list
154476466|NCT06276127|Calcium Channel Blockers|calcium channel blockers|mesh-list
154476467|NCT06276127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154476468|NCT06276127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476469|NCT06276127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154476470|NCT06276127|Sympatholytics|sympatholytics|mesh-ancestor
154476471|NCT06276127|Autonomic Agents|autonomic agents|mesh-ancestor
154476472|NCT06276127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476473|NCT06276127|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154476474|NCT06276127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154476475|NCT06276127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154476476|NCT06276127|Adrenergic Agents|adrenergic agents|mesh-ancestor
154476477|NCT06276127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476478|NCT06276127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476479|NCT06276127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154476480|NCT06276127|Vasodilator Agents|vasodilator agents|mesh-ancestor
154476481|NCT06275204|Levofloxacin|levofloxacin|mesh-list
154476482|NCT06275204|Ofloxacin|ofloxacin|mesh-list
154476483|NCT06275204|Bismuth|bismuth|mesh-list
154476484|NCT06275204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154040287|NCT04068597|Dexamethasone|dexamethasone|mesh-list
154476485|NCT06275204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476486|NCT06275204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154476487|NCT06275204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154476488|NCT06275204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154476489|NCT06275204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476490|NCT06275204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476491|NCT06275204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476492|NCT06275204|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154476493|NCT06275204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154476495|NCT06275204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476496|NCT06270108|Riluzole|riluzole|mesh-list
154476497|NCT06270108|Anticonvulsants|anticonvulsants|mesh-ancestor
154476498|NCT06270108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154476499|NCT06270108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154476500|NCT06270108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476501|NCT06270108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476502|NCT06270108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476503|NCT06270108|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154476504|NCT06270108|Protective Agents|protective agents|mesh-ancestor
154476505|NCT06257979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154476506|NCT06257979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476507|NCT06253663|Cyclophosphamide|cyclophosphamide|mesh-list
154476508|NCT06253663|Fludarabine|fludarabine|mesh-list
154476509|NCT06253663|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154476510|NCT06253663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154476511|NCT06253663|Immunologic Factors|immunologic factors|mesh-ancestor
154476512|NCT06253663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476513|NCT06253663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154476514|NCT06253663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154476515|NCT06253663|Alkylating Agents|alkylating agents|mesh-ancestor
154476516|NCT06253663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476517|NCT06253663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476518|NCT06253663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154476519|NCT06253663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476520|NCT06253234|Vaccines|vaccines|mesh-list
154200437|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
154476521|NCT06253234|Immunologic Factors|immunologic factors|mesh-ancestor
154476522|NCT06253234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476523|NCT06225869|Levodopa|levodopa|mesh-list
154476524|NCT06225869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154476525|NCT06225869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154476526|NCT06225869|Dopamine Agents|dopamine agents|mesh-ancestor
154476527|NCT06225869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476528|NCT06225869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476529|NCT06225869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476530|NCT06225076|Lidocaine|lidocaine|mesh-list
154476531|NCT06225076|Anesthetics, Local|anesthetics, local|mesh-ancestor
154476532|NCT06225076|Anesthetics|anesthetics|mesh-ancestor
154476533|NCT06225076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154040341|NCT03840148|Meropenem|meropenem|mesh-list
154476534|NCT06225076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476535|NCT06225076|Sensory System Agents|sensory system agents|mesh-ancestor
154476536|NCT06225076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476537|NCT06225076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154476538|NCT06225076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154476539|NCT06225076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154476540|NCT06225076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154476541|NCT06225076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476542|NCT06224452|Ibrutinib|ibrutinib|mesh-list
154476543|NCT06224452|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154476544|NCT06224452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154476545|NCT06224452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476546|NCT06224452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476547|NCT06220461|Folic Acid|folic acid|mesh-list
154476548|NCT06220461|Hematinics|hematinics|mesh-ancestor
154476549|NCT06220461|Vitamin B Complex|vitamin b complex|mesh-ancestor
154476550|NCT06220461|Vitamins|vitamins|mesh-ancestor
154476551|NCT06220461|Micronutrients|micronutrients|mesh-ancestor
154476552|NCT06220461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476553|NCT06215859|Tramadol|tramadol|mesh-list
154476554|NCT06215859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154476555|NCT06215859|Narcotics|narcotics|mesh-ancestor
154476556|NCT06215859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476557|NCT06215859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476558|NCT06215859|Analgesics|analgesics|mesh-ancestor
154476559|NCT06215859|Sensory System Agents|sensory system agents|mesh-ancestor
154476560|NCT06215859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476562|NCT06215820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154476563|NCT06215820|Narcotics|narcotics|mesh-ancestor
154476564|NCT06215820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476565|NCT06215820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476566|NCT06215820|Analgesics|analgesics|mesh-ancestor
154476567|NCT06215820|Sensory System Agents|sensory system agents|mesh-ancestor
154476568|NCT06215820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476569|NCT06199778|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154476570|NCT06199778|Levofloxacin|levofloxacin|mesh-list
154476571|NCT06199778|Reserpine|reserpine|mesh-list
154476572|NCT06199778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476573|NCT06199778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154476574|NCT06199778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154476575|NCT06199778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154476576|NCT06199778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476577|NCT06199778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476578|NCT06199778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040393|NCT03600961|Sirolimus|sirolimus|mesh-list
154476579|NCT06199778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154476580|NCT06199778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154476581|NCT06199778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154476582|NCT06199778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154476583|NCT06199778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154476584|NCT06199778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476585|NCT06199778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476586|NCT06199778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476587|NCT06199778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154476588|NCT06199778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154476589|NCT06199778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154476590|NCT06199778|Adrenergic Agents|adrenergic agents|mesh-ancestor
154476591|NCT06199778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476592|NCT06189209|Tenalisib|tenalisib|mesh-list
154476593|NCT06189209|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154476594|NCT06189209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200510|NCT00473876|Metformin|metformin|mesh-list
154476595|NCT06189209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476597|NCT06173531|Oxytocics|oxytocics|mesh-ancestor
154476598|NCT06173531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154476599|NCT06173531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476600|NCT06172829|Imidacloprid|imidacloprid|mesh-list
154476601|NCT06172829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154476602|NCT06172829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476603|NCT06172829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476604|NCT06172829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476605|NCT06155955|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154476606|NCT06155955|Immunologic Factors|immunologic factors|mesh-ancestor
154476607|NCT06155955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476608|NCT06149260|Semaglutide|semaglutide|mesh-list
154476609|NCT06149260|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154476610|NCT06149260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154476611|NCT06149260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476612|NCT06124924|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154476613|NCT06124924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476614|NCT06124924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154476615|NCT06124924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476616|NCT06124157|Leucovorin|leucovorin|mesh-list
154476617|NCT06124157|Cytarabine|cytarabine|mesh-list
154476618|NCT06124157|Prednisone|prednisone|mesh-list
154476619|NCT06124157|Prednisolone|prednisolone|mesh-list
154476620|NCT06124157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154476621|NCT06124157|Methylprednisolone|methylprednisolone|mesh-list
154476622|NCT06124157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154476623|NCT06124157|Prednisolone acetate|prednisolone acetate|mesh-list
154476624|NCT06124157|Hydrocortisone|hydrocortisone|mesh-list
154476625|NCT06124157|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154476626|NCT06124157|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154476627|NCT06124157|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154476628|NCT06124157|Cortisone|cortisone|mesh-list
154476629|NCT06124157|Cyclophosphamide|cyclophosphamide|mesh-list
154476630|NCT06124157|Doxorubicin|doxorubicin|mesh-list
154476631|NCT06124157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154476632|NCT06124157|Methotrexate|methotrexate|mesh-list
154476633|NCT06124157|Vincristine|vincristine|mesh-list
154476634|NCT06124157|Daunorubicin|daunorubicin|mesh-list
154476635|NCT06124157|Asparaginase|asparaginase|mesh-list
154476637|NCT06124157|Mercaptopurine|mercaptopurine|mesh-list
154476638|NCT06124157|Pegaspargase|pegaspargase|mesh-list
154476639|NCT06124157|Thioguanine|thioguanine|mesh-list
154476640|NCT06124157|Blinatumomab|blinatumomab|mesh-list
154476641|NCT06124157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154476642|NCT06124157|Muromonab-CD3|muromonab-cd3|mesh-list
154476643|NCT06124157|Antibodies|antibodies|mesh-list
154476644|NCT06124157|Immunoglobulins|immunoglobulins|mesh-list
154476645|NCT06124157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154476646|NCT06124157|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154476647|NCT06124157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154476648|NCT06124157|Prednisolone phosphate|prednisolone phosphate|mesh-list
154476649|NCT06124157|2-Aminopurine|2-aminopurine|mesh-list
154476650|NCT06124157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154476651|NCT06124157|Immunologic Factors|immunologic factors|mesh-ancestor
154476652|NCT06124157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476653|NCT06124157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154476654|NCT06124157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154476655|NCT06124157|Alkylating Agents|alkylating agents|mesh-ancestor
154476656|NCT06124157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476657|NCT06124157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476658|NCT06124157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154476659|NCT06124157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154476660|NCT06124157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154476661|NCT06124157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154476662|NCT06124157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476663|NCT06124157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154476664|NCT06124157|Glucocorticoids|glucocorticoids|mesh-ancestor
154476665|NCT06124157|Hormones|hormones|mesh-ancestor
154476666|NCT06124157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154476667|NCT06124157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154476668|NCT06124157|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154476669|NCT06124157|Abortifacient Agents|abortifacient agents|mesh-ancestor
154476670|NCT06124157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200588|NCT00264550|Golimumab|golimumab|mesh-list
154476671|NCT06124157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154476673|NCT06124157|Dermatologic Agents|dermatologic agents|mesh-ancestor
154476674|NCT06124157|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154476675|NCT06124157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154476676|NCT06124157|Antiviral Agents|antiviral agents|mesh-ancestor
154476677|NCT06124157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476678|NCT06124157|Antidotes|antidotes|mesh-ancestor
154476679|NCT06124157|Protective Agents|protective agents|mesh-ancestor
154476680|NCT06124157|Vitamin B Complex|vitamin b complex|mesh-ancestor
154476681|NCT06124157|Vitamins|vitamins|mesh-ancestor
154476682|NCT06124157|Micronutrients|micronutrients|mesh-ancestor
154476683|NCT06124157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154476684|NCT06124157|Tubulin Modulators|tubulin modulators|mesh-ancestor
154476685|NCT06124157|Antimitotic Agents|antimitotic agents|mesh-ancestor
154476686|NCT06124157|Mitosis Modulators|mitosis modulators|mesh-ancestor
154476687|NCT06124157|Antiemetics|antiemetics|mesh-ancestor
154476688|NCT06124157|Autonomic Agents|autonomic agents|mesh-ancestor
154476689|NCT06124157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476690|NCT06124157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476691|NCT06124157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154476692|NCT06124157|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154476693|NCT06124157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154476694|NCT06121011|Miglustat|miglustat|mesh-list
154476695|NCT06121011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476696|NCT06121011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476697|NCT06121011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154476698|NCT06121011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154476699|NCT06121011|Antiviral Agents|antiviral agents|mesh-ancestor
154476700|NCT06121011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476701|NCT06121011|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154476702|NCT06121011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154476703|NCT06121011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040501|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154476704|NCT06120504|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154476705|NCT06120504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476706|NCT06120504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476707|NCT06120504|Immunotoxins|immunotoxins|mesh-ancestor
154476708|NCT06120504|Immunoconjugates|immunoconjugates|mesh-ancestor
154476709|NCT06120504|Immunologic Factors|immunologic factors|mesh-ancestor
154476710|NCT06120504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476711|NCT06100822|Metformin|metformin|mesh-list
154476712|NCT06100822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154476713|NCT06100822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476715|NCT06099639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476716|NCT06099639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476717|NCT06096779|Bevacizumab|bevacizumab|mesh-list
154476718|NCT06096779|Atezolizumab|atezolizumab|mesh-list
154476719|NCT06096779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476720|NCT06096779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476721|NCT06096779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154476722|NCT06096779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154476723|NCT06096779|Growth Substances|growth substances|mesh-ancestor
154476724|NCT06096779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476725|NCT06096779|Growth Inhibitors|growth inhibitors|mesh-ancestor
154476726|NCT06096779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154476727|NCT06096779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476728|NCT06088797|Metronidazole|metronidazole|mesh-list
154476729|NCT06088797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476730|NCT06088797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154476731|NCT06088797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154476732|NCT06088797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154476733|NCT06087601|Ethanol|ethanol|mesh-list
154476734|NCT06087601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154476735|NCT06087601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476736|NCT06087601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476737|NCT06087601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476738|NCT06083428|Ropivacaine|ropivacaine|mesh-list
154476739|NCT06083428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154476740|NCT06083428|Anesthetics, Local|anesthetics, local|mesh-ancestor
154476741|NCT06083428|Anesthetics|anesthetics|mesh-ancestor
154200721|NCT04573673|Emodin|emodin|mesh-list
154476742|NCT06083428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476743|NCT06083428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476744|NCT06083428|Sensory System Agents|sensory system agents|mesh-ancestor
154476745|NCT06083428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476746|NCT06076135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154476747|NCT06076135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476748|NCT06076135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476749|NCT06076135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476750|NCT06057038|Carboplatin|carboplatin|mesh-list
154476751|NCT06057038|Pembrolizumab|pembrolizumab|mesh-list
154476752|NCT06057038|Fluorouracil|fluorouracil|mesh-list
154476753|NCT06057038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476754|NCT06057038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476755|NCT06057038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154476756|NCT06057038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476757|NCT06057038|Antimetabolites|antimetabolites|mesh-ancestor
154476758|NCT06057038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154476759|NCT06057038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154476760|NCT06057038|Immunologic Factors|immunologic factors|mesh-ancestor
154476761|NCT06057038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476762|NCT06050941|Cytarabine|cytarabine|mesh-list
154476763|NCT06050941|Idarubicin|idarubicin|mesh-list
154476764|NCT06050941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154476765|NCT06050941|Antimetabolites|antimetabolites|mesh-ancestor
154476766|NCT06050941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476767|NCT06050941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476768|NCT06050941|Antiviral Agents|antiviral agents|mesh-ancestor
154476769|NCT06050941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476770|NCT06050941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154476771|NCT06050941|Immunologic Factors|immunologic factors|mesh-ancestor
154476772|NCT06050941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476773|NCT06050941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154476774|NCT06050941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154476775|NCT06050941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154476776|NCT06050941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476777|NCT06047366|Lidocaine|lidocaine|mesh-list
154476778|NCT06047366|Epinephrine|epinephrine|mesh-list
154476779|NCT06047366|Racepinephrine|racepinephrine|mesh-list
154476780|NCT06047366|Mepivacaine|mepivacaine|mesh-list
154476781|NCT06047366|Carticaine|carticaine|mesh-list
154476782|NCT06047366|Epinephryl borate|epinephryl borate|mesh-list
154476783|NCT06047366|Anesthetics, Local|anesthetics, local|mesh-ancestor
154476784|NCT06047366|Anesthetics|anesthetics|mesh-ancestor
154476785|NCT06047366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476786|NCT06047366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476788|NCT06047366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476789|NCT06047366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154476790|NCT06047366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154476791|NCT06047366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154476792|NCT06047366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154476793|NCT06047366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476794|NCT06047366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154476795|NCT06047366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154476796|NCT06047366|Adrenergic Agents|adrenergic agents|mesh-ancestor
154476797|NCT06047366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476798|NCT06047366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154476799|NCT06047366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154476800|NCT06047366|Autonomic Agents|autonomic agents|mesh-ancestor
154476801|NCT06047366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154476802|NCT06047366|Respiratory System Agents|respiratory system agents|mesh-ancestor
154476803|NCT06047366|Mydriatics|mydriatics|mesh-ancestor
154476804|NCT06047366|Sympathomimetics|sympathomimetics|mesh-ancestor
154476805|NCT06047366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154476806|NCT06046313|Decitabine|decitabine|mesh-list
154476807|NCT06046313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154476808|NCT06046313|Antimetabolites|antimetabolites|mesh-ancestor
154476809|NCT06046313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476810|NCT06046313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476811|NCT06046313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476812|NCT06036836|Pembrolizumab|pembrolizumab|mesh-list
154476813|NCT06036836|Lenvatinib|lenvatinib|mesh-list
154476814|NCT06036836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476815|NCT06036836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476816|NCT06036836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154476817|NCT06036836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476818|NCT06036836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154476819|NCT06036836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476820|NCT06024421|Favipiravir|favipiravir|mesh-list
154476821|NCT06024421|Antiviral Agents|antiviral agents|mesh-ancestor
154476822|NCT06024421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476823|NCT06020963|Tamsulosin|tamsulosin|mesh-list
154476824|NCT06020963|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154476825|NCT06020963|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154476826|NCT06020963|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154476827|NCT06020963|Adrenergic Agents|adrenergic agents|mesh-ancestor
154476828|NCT06020963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476829|NCT06020963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476830|NCT06020963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476831|NCT06020963|Urological Agents|urological agents|mesh-ancestor
154476832|NCT06005571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154476833|NCT06000657|Entecavir|entecavir|mesh-list
154476834|NCT06000657|Antiviral Agents|antiviral agents|mesh-ancestor
154476835|NCT06000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476836|NCT05999994|Cyclophosphamide|cyclophosphamide|mesh-list
154476837|NCT05999994|Temozolomide|temozolomide|mesh-list
154476838|NCT05999994|Gemcitabine|gemcitabine|mesh-list
154476839|NCT05999994|Docetaxel|docetaxel|mesh-list
154476840|NCT05999994|Irinotecan|irinotecan|mesh-list
154476841|NCT05999994|Vinorelbine|vinorelbine|mesh-list
154476842|NCT05999994|Ramucirumab|ramucirumab|mesh-list
154476843|NCT05999994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154476844|NCT05999994|Immunologic Factors|immunologic factors|mesh-ancestor
154476845|NCT05999994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476846|NCT05999994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154476847|NCT05999994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154476848|NCT05999994|Alkylating Agents|alkylating agents|mesh-ancestor
154476849|NCT05999994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476850|NCT05999994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476851|NCT05999994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154476852|NCT05999994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154476853|NCT05999994|Antimetabolites|antimetabolites|mesh-ancestor
154476854|NCT05999994|Tubulin Modulators|tubulin modulators|mesh-ancestor
154476855|NCT05999994|Antimitotic Agents|antimitotic agents|mesh-ancestor
154476856|NCT05999994|Mitosis Modulators|mitosis modulators|mesh-ancestor
154476857|NCT05999994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154476858|NCT05999994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154476859|NCT05999994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476860|NCT05999994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154476861|NCT05999994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154476862|NCT05999994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154476863|NCT05999994|Growth Substances|growth substances|mesh-ancestor
154476864|NCT05999994|Growth Inhibitors|growth inhibitors|mesh-ancestor
154476865|NCT05999955|Neomycin|neomycin|mesh-list
154476866|NCT05999955|Xylometazoline|xylometazoline|mesh-list
154476867|NCT05999955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154476868|NCT05999955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476869|NCT05999955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154476870|NCT05999955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476871|NCT05999955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476872|NCT05999955|Nasal Decongestants|nasal decongestants|mesh-ancestor
154476873|NCT05999955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154476874|NCT05999955|Respiratory System Agents|respiratory system agents|mesh-ancestor
154476875|NCT05991232|Ketamine|ketamine|mesh-list
154476876|NCT05991232|Analgesics|analgesics|mesh-ancestor
154476877|NCT05991232|Sensory System Agents|sensory system agents|mesh-ancestor
154476878|NCT05991232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476879|NCT05991232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476880|NCT05991232|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154476881|NCT05991232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154476882|NCT05991232|Anesthetics, General|anesthetics, general|mesh-ancestor
154476883|NCT05991232|Anesthetics|anesthetics|mesh-ancestor
154476884|NCT05991232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476885|NCT05991232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154476886|NCT05991232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154476887|NCT05991232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476888|NCT05991232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476889|NCT05990738|Topotecan|topotecan|mesh-list
154476890|NCT05990738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154476891|NCT05990738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154476892|NCT05990738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476893|NCT05990738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476894|NCT05990738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476895|NCT05990088|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154200805|NCT01048515|Caffeine|caffeine|mesh-list
154476896|NCT05990088|Vasodilator Agents|vasodilator agents|mesh-ancestor
154476897|NCT05990088|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154476898|NCT05990088|Protective Agents|protective agents|mesh-ancestor
154476899|NCT05990088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476900|NCT05968599|Abiraterone Acetate|abiraterone acetate|mesh-list
154476901|NCT05968599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476902|NCT05968599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154476903|NCT05968599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476904|NCT05968599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476905|NCT05968599|Hormone Antagonists|hormone antagonists|mesh-ancestor
154476906|NCT05968599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154476907|NCT05968599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476908|NCT05968599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154476910|NCT05934669|Dexmedetomidine|dexmedetomidine|mesh-list
154476911|NCT05934669|Ketamine|ketamine|mesh-list
154476912|NCT05934669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154476913|NCT05934669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476914|NCT05934669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476915|NCT05934669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154476916|NCT05934669|Analgesics|analgesics|mesh-ancestor
154476917|NCT05934669|Sensory System Agents|sensory system agents|mesh-ancestor
154476918|NCT05934669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476919|NCT05934669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154476920|NCT05934669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154476921|NCT05934669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154476922|NCT05934669|Adrenergic Agents|adrenergic agents|mesh-ancestor
154476923|NCT05934669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154476924|NCT05934669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476925|NCT05934669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154040738|NCT01997840|BB 1101|bb 1101|mesh-list
154476926|NCT05934669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154476927|NCT05934669|Anesthetics, General|anesthetics, general|mesh-ancestor
154476928|NCT05934669|Anesthetics|anesthetics|mesh-ancestor
154476929|NCT05934669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154476930|NCT05934669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154476931|NCT05934669|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154476932|NCT05934669|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154476933|NCT05934669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154476934|NCT05934669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476936|NCT05934669|GABA Agents|gaba agents|mesh-ancestor
154476937|NCT05934214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154476938|NCT05934214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476939|NCT05934214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476940|NCT05934214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476941|NCT05925530|Durvalumab|durvalumab|mesh-list
154476942|NCT05925530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154476943|NCT05925530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476944|NCT05915286|Chlorthalidone|chlorthalidone|mesh-list
154476945|NCT05915286|Furosemide|furosemide|mesh-list
154476946|NCT05915286|Diuretics|diuretics|mesh-ancestor
154476947|NCT05915286|Natriuretic Agents|natriuretic agents|mesh-ancestor
154476948|NCT05915286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476949|NCT05915286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154476950|NCT05915286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154476951|NCT05915286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476952|NCT05915286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154476953|NCT05915286|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154476954|NCT05895747|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
154476955|NCT05895747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154476956|NCT05895747|Antidepressive Agents|antidepressive agents|mesh-ancestor
154476957|NCT05895747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154476958|NCT05889793|Emetine|emetine|mesh-list
154476959|NCT05889793|Amebicides|amebicides|mesh-ancestor
154476960|NCT05889793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154476961|NCT05889793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154476962|NCT05889793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154476963|NCT05889793|Antinematodal Agents|antinematodal agents|mesh-ancestor
154476964|NCT05889793|Anthelmintics|anthelmintics|mesh-ancestor
154476965|NCT05889793|Cathartics|cathartics|mesh-ancestor
154476966|NCT05889793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154476967|NCT05889793|Emetics|emetics|mesh-ancestor
154476968|NCT05889793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476969|NCT05889793|Autonomic Agents|autonomic agents|mesh-ancestor
154476970|NCT05889793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154476971|NCT05889793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154476972|NCT05889793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476973|NCT05889793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476974|NCT05879926|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154476975|NCT05879926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154476976|NCT05879926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476977|NCT05879926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476978|NCT05879926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154476979|NCT05879926|Hormone Antagonists|hormone antagonists|mesh-ancestor
154476980|NCT05879926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154476981|NCT05879926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476982|NCT05876754|Ivosidenib|ivosidenib|mesh-list
154476983|NCT05876754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154476984|NCT05876754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154476985|NCT05876754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476986|NCT05875701|Vaccines|vaccines|mesh-list
154476987|NCT05875701|Immunologic Factors|immunologic factors|mesh-ancestor
154476988|NCT05875701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476989|NCT05857046|Melatonin|melatonin|mesh-list
154476990|NCT05857046|Antioxidants|antioxidants|mesh-ancestor
154476991|NCT05857046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154476992|NCT05857046|Protective Agents|protective agents|mesh-ancestor
154476993|NCT05857046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154476994|NCT05857046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154476995|NCT05845008|Acetaminophen|acetaminophen|mesh-list
154476996|NCT05845008|Naproxen|naproxen|mesh-list
154476997|NCT05845008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154476998|NCT05845008|Analgesics|analgesics|mesh-ancestor
154476999|NCT05845008|Sensory System Agents|sensory system agents|mesh-ancestor
154477000|NCT05845008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477001|NCT05845008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477002|NCT05845008|Antipyretics|antipyretics|mesh-ancestor
154477003|NCT05845008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154477004|NCT05845008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477005|NCT05845008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477006|NCT05845008|Gout Suppressants|gout suppressants|mesh-ancestor
154477007|NCT05845008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154477008|NCT05845008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477009|NCT05845008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477011|NCT05834478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154477012|NCT05834478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154477013|NCT05834478|Dopamine Agents|dopamine agents|mesh-ancestor
154477014|NCT05834478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477015|NCT05834478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477016|NCT05834478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477017|NCT05789537|Protein C|protein c|mesh-list
154477018|NCT05789537|Anticoagulants|anticoagulants|mesh-ancestor
154477019|NCT05789537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154477020|NCT05789537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154477021|NCT05789537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477022|NCT05785754|Pembrolizumab|pembrolizumab|mesh-list
154477023|NCT05785754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477024|NCT05785754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477025|NCT05785754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477026|NCT05785754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477027|NCT05767515|Inositol|inositol|mesh-list
154477028|NCT05767515|Acetylcarnitine|acetylcarnitine|mesh-list
154477029|NCT05767515|Metformin|metformin|mesh-list
154477030|NCT05767515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154477031|NCT05767515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477032|NCT05767515|Vitamin B Complex|vitamin b complex|mesh-ancestor
154477033|NCT05767515|Vitamins|vitamins|mesh-ancestor
154477034|NCT05767515|Micronutrients|micronutrients|mesh-ancestor
154477035|NCT05767515|Nootropic Agents|nootropic agents|mesh-ancestor
154477036|NCT05741164|Pembrolizumab|pembrolizumab|mesh-list
154477037|NCT05741164|Propranolol|propranolol|mesh-list
154477038|NCT05741164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477039|NCT05741164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477040|NCT05741164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477041|NCT05741164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477042|NCT05741164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154477043|NCT05741164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154477044|NCT05741164|Adrenergic Agents|adrenergic agents|mesh-ancestor
154477045|NCT05741164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477046|NCT05741164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477047|NCT05741164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154477048|NCT05741164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154477049|NCT05741164|Vasodilator Agents|vasodilator agents|mesh-ancestor
154477050|NCT05729282|Diazoxide|diazoxide|mesh-list
154477051|NCT05729282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154477052|NCT05729282|Vasodilator Agents|vasodilator agents|mesh-ancestor
154477053|NCT05713851|Dapagliflozin|dapagliflozin|mesh-list
154477054|NCT05713851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154477055|NCT05713851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477056|NCT05713851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154477057|NCT05713851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477058|NCT05711667|Acetic Acid|acetic acid|mesh-list
154477059|NCT05711667|Letermovir|letermovir|mesh-list
154477060|NCT05711667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154477061|NCT05711667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477062|NCT05711667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477063|NCT05711667|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154477064|NCT05711667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040872|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
154477065|NCT05711667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477066|NCT05711667|Antiviral Agents|antiviral agents|mesh-ancestor
154477067|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
154477068|NCT05703854|Fludarabine|fludarabine|mesh-list
154477069|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
154477070|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477071|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
154477072|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477073|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477074|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477075|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
154477076|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477077|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477078|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154477079|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477080|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
154477081|NCT05669482|Paclitaxel|paclitaxel|mesh-list
154477082|NCT05669482|Gemcitabine|gemcitabine|mesh-list
154477083|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477084|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477085|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477086|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477087|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477088|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477089|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477090|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
154477091|NCT05668091|Ritonavir|ritonavir|mesh-list
154477092|NCT05668091|Nirmatrelvir|nirmatrelvir|mesh-list
154477093|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154477094|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154477095|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
154477096|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477097|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477098|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154477099|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154477100|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
154477101|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477102|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154477103|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154477104|NCT05660967|Lenalidomide|lenalidomide|mesh-list
154477105|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
154477106|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477107|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154477108|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154477109|NCT05660967|Growth Substances|growth substances|mesh-ancestor
154477110|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
154477111|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477112|NCT05660746|Infliximab|infliximab|mesh-list
154477113|NCT05660746|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154477114|NCT05660746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477115|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
154477116|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154477117|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477118|NCT05651126|Psilocybin|psilocybin|mesh-list
154477119|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
154477120|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477121|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154477122|NCT05648110|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154477123|NCT05648110|Antiviral Agents|antiviral agents|mesh-ancestor
154477124|NCT05648110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477125|NCT05629234|Osimertinib|osimertinib|mesh-list
154477126|NCT05629234|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154477127|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154477128|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477129|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477130|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477131|NCT05613088|Paclitaxel|paclitaxel|mesh-list
154477132|NCT05613088|Doxorubicin|doxorubicin|mesh-list
154477133|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154477134|NCT05613088|Topotecan|topotecan|mesh-list
154477135|NCT05613088|Farletuzumab|farletuzumab|mesh-list
154477136|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477137|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477138|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477139|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477140|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477141|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477142|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154477143|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154477144|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154477145|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477146|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154477147|NCT05599295|Oritavancin|oritavancin|mesh-list
154477148|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154477149|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477150|NCT05586516|Paclitaxel|paclitaxel|mesh-list
154477151|NCT05586516|Gemcitabine|gemcitabine|mesh-list
154477152|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477153|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477154|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477155|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477156|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477157|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477158|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477159|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
154477161|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477162|NCT05578092|Adagrasib|adagrasib|mesh-list
154477163|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477164|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
154477165|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154477166|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
154477167|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477168|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
154477169|NCT05571527|Protective Agents|protective agents|mesh-ancestor
154477170|NCT05564416|Atezolizumab|atezolizumab|mesh-list
154477171|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154477172|NCT05564416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477173|NCT05564416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477174|NCT05564416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477175|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477176|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
154477177|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477178|NCT05561738|Niacinamide|niacinamide|mesh-list
154477179|NCT05561738|Niacin|niacin|mesh-list
154477180|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
154477181|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
154477182|NCT05561738|Vitamins|vitamins|mesh-ancestor
154477183|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
154477184|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477185|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154477186|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
154477187|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477188|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154477189|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
154477190|NCT05556616|Lenalidomide|lenalidomide|mesh-list
154477191|NCT05556616|Pomalidomide|pomalidomide|mesh-list
154477192|NCT05556616|Bortezomib|bortezomib|mesh-list
154477193|NCT05556616|Daratumumab|daratumumab|mesh-list
154201121|NCT00444678|Capecitabine|capecitabine|mesh-list
154477194|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
154477195|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477196|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154477197|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154477198|NCT05556616|Growth Substances|growth substances|mesh-ancestor
154477199|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
154477200|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477202|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
154477203|NCT05533775|Carboplatin|carboplatin|mesh-list
154477204|NCT05533775|Etoposide|etoposide|mesh-list
154477205|NCT05533775|Ifosfamide|ifosfamide|mesh-list
154477206|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477207|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477208|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
154477209|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477210|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477211|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477212|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154477213|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154477214|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477215|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477216|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477217|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
154477218|NCT05522673|Rolipram|rolipram|mesh-list
154477219|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
154477220|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154477221|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154477222|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154477223|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477224|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477225|NCT05511038|Aflibercept|aflibercept|mesh-list
154477226|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154477227|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154477228|NCT05511038|Growth Substances|growth substances|mesh-ancestor
154477229|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477230|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
154477231|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477232|NCT05507658|Capecitabine|capecitabine|mesh-list
154477233|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
154477234|NCT05507658|Tislelizumab|tislelizumab|mesh-list
154477235|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154105413|NCT00741780|Plerixafor|plerixafor|mesh-list
154477236|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
154477237|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477238|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477239|NCT05507658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477241|NCT05498220|Rituximab|rituximab|mesh-list
154477242|NCT05498220|Gemcitabine|gemcitabine|mesh-list
154477243|NCT05498220|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154477244|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477245|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477246|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
154477247|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477248|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477249|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477250|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
154477251|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
154477252|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477253|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154477254|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
154477255|NCT05498220|Hormones|hormones|mesh-ancestor
154477256|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477257|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154477258|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477259|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
154477260|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477261|NCT05498220|Immunoconjugates|immunoconjugates|mesh-ancestor
154477262|NCT05477823|Androgens|androgens|mesh-list
154477263|NCT05477823|Hormones|hormones|mesh-ancestor
154477264|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477265|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477266|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
154477267|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
154477268|NCT05468099|Povidone|povidone|mesh-list
154477269|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154201200|NCT01340417|Melatonin|melatonin|mesh-list
154477270|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477271|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
154477273|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
154477274|NCT05425056|Sirolimus|sirolimus|mesh-list
154477275|NCT05425056|Temsirolimus|temsirolimus|mesh-list
154477276|NCT05425056|MTOR Inhibitors|mtor inhibitors|mesh-list
154477277|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154477278|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477279|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154477280|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477281|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
154477282|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477283|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
154477284|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477285|NCT05425056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154477286|NCT05425056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477287|NCT05425056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477288|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154477289|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154477290|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477291|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477292|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
154477293|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477294|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
154477295|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
154477296|NCT05370326|Narcotics|narcotics|mesh-ancestor
154477297|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154477298|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477299|NCT05370326|Analgesics|analgesics|mesh-ancestor
154477300|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
154477301|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477302|NCT05333003|Semaglutide|semaglutide|mesh-list
154477303|NCT05333003|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154477304|NCT05333003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154477305|NCT05333003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477306|NCT05316129|Hormones|hormones|mesh-list
154477307|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154477308|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477309|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477310|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
154477311|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154477312|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154477313|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477314|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
154477315|NCT05302986|Coagulants|coagulants|mesh-ancestor
154477316|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
154477317|NCT05286437|Letrozole|letrozole|mesh-list
154477318|NCT05286437|Lenvatinib|lenvatinib|mesh-list
154477319|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477320|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477321|NCT05286437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477322|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477323|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154477324|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154477325|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477326|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154477327|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
154477328|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477329|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477330|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154477331|NCT05269849|Sirolimus|sirolimus|mesh-list
154477332|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154477333|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477334|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154477335|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477336|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
154477337|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477338|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
154477339|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477340|NCT05267886|Dobutamine|dobutamine|mesh-list
154477341|NCT05267886|Milrinone|milrinone|mesh-list
154477342|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154477343|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
154477344|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
154477345|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477346|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477347|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154477348|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154477349|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154477350|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
154477351|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477352|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477353|NCT05267886|Protective Agents|protective agents|mesh-ancestor
154477354|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154477355|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
154477356|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154477357|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154477358|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477359|NCT05242315|Tacrolimus|tacrolimus|mesh-list
154477360|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477361|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
154477362|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477363|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154477364|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477365|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477366|NCT05241249|Paclitaxel|paclitaxel|mesh-list
154477367|NCT05241249|Gemcitabine|gemcitabine|mesh-list
154477368|NCT05241249|Bethanechol|bethanechol|mesh-list
154477369|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477370|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477371|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477372|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477373|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477374|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477375|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477376|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
154477377|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154477378|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
154477379|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477380|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477381|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154477382|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154477383|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
154041178|NCT04070794|Metformin|metformin|mesh-list
154477384|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477385|NCT05237947|Vaccines|vaccines|mesh-list
154477386|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
154477387|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477388|NCT05223673|Trifluridine|trifluridine|mesh-list
154477389|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
154477390|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477391|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
154477392|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477393|NCT05219487|Risdiplam|risdiplam|mesh-list
154477394|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154477395|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477396|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477397|NCT05209295|Azacitidine|azacitidine|mesh-list
154477398|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477399|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
154477400|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477401|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477402|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477403|NCT05208762|Pembrolizumab|pembrolizumab|mesh-list
154477404|NCT05208762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477405|NCT05208762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477406|NCT05208762|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477407|NCT05208762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477408|NCT05180474|Antibodies|antibodies|mesh-list
154477409|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154477410|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
154477411|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477412|NCT05153317|Ivacaftor|ivacaftor|mesh-list
154477413|NCT05153317|Elexacaftor|elexacaftor|mesh-list
154477414|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154477415|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154477416|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477417|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
154477418|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477419|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201333|NCT01053039|Morphine|morphine|mesh-list
154477420|NCT05128487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477421|NCT05128487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477422|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
154041251|NCT03083041|Apatinib|apatinib|mesh-list
154477423|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154477424|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154477425|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477426|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
154477427|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477428|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477429|NCT05115110|Risdiplam|risdiplam|mesh-list
154477430|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154477431|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477432|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477433|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154477434|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154477435|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
154477436|NCT05095311|Cetirizine|cetirizine|mesh-list
154477437|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154477438|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154477439|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154477440|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
154477441|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
154477442|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477443|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477444|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477445|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
154477446|NCT05077527|Fludarabine|fludarabine|mesh-list
154477447|NCT05077527|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154477448|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477449|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
154477450|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477451|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477452|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477453|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
154477454|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477455|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477456|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154477457|NCT05077527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477458|NCT05041426|Valganciclovir|valganciclovir|mesh-list
154477459|NCT05041426|Letermovir|letermovir|mesh-list
154477460|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
154477461|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477462|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154477463|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477464|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477465|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477466|NCT05005728|Carboplatin|carboplatin|mesh-list
154477467|NCT05005728|Docetaxel|docetaxel|mesh-list
154477468|NCT05005728|Olaparib|olaparib|mesh-list
154477469|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477470|NCT05005728|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477471|NCT05005728|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477472|NCT05005728|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477473|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477474|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154477475|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477476|NCT04988074|Cemiplimab|cemiplimab|mesh-list
154477477|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477478|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477479|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
154477480|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154477481|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154477482|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154477483|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154477484|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477485|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
154477486|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477487|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477488|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154477489|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477490|NCT04984811|Atezolizumab|atezolizumab|mesh-list
154477491|NCT04984811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477492|NCT04984811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477493|NCT04984811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477494|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477495|NCT04974528|Insulin|insulin|mesh-list
154477496|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154477497|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
154477498|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
154477499|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
154477500|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
154477501|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
154477502|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
154477503|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154477504|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477505|NCT04920032|Irinotecan|irinotecan|mesh-list
154477506|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154477507|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154477508|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477509|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477510|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477511|NCT04919226|Leucovorin|leucovorin|mesh-list
154477512|NCT04919226|Folic Acid|folic acid|mesh-list
154477513|NCT04919226|Capecitabine|capecitabine|mesh-list
154477514|NCT04919226|Fluorouracil|fluorouracil|mesh-list
154477515|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
154477516|NCT04919226|Everolimus|everolimus|mesh-list
154477517|NCT04919226|Temozolomide|temozolomide|mesh-list
154477518|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154477519|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
154477520|NCT04919226|Edotreotide|edotreotide|mesh-list
154477521|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
154477522|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477523|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
154477524|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477525|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477526|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477527|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
154477528|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477529|NCT04919226|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154477530|NCT04919226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154477531|NCT04919226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477532|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477533|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
154477534|NCT04919226|Antidotes|antidotes|mesh-ancestor
154477535|NCT04919226|Protective Agents|protective agents|mesh-ancestor
154477536|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
154477537|NCT04919226|Vitamins|vitamins|mesh-ancestor
154477538|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
154477539|NCT04919226|Hematinics|hematinics|mesh-ancestor
154477540|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154477541|NCT04880707|Anesthetics|anesthetics|mesh-list
154477542|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
154477543|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154477544|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477545|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
154477546|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477547|NCT04878627|Cannabidiol|cannabidiol|mesh-list
154477548|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
154477549|NCT04852887|Tamoxifen|tamoxifen|mesh-list
154477550|NCT04852887|Letrozole|letrozole|mesh-list
154477551|NCT04852887|Exemestane|exemestane|mesh-list
154477552|NCT04852887|Anastrozole|anastrozole|mesh-list
154477553|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477554|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154477555|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154477556|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477557|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477558|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154477559|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
154477560|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477561|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477562|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154477563|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154477564|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154477565|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154477566|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154477567|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
154477568|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
154477569|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477570|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
154477571|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477572|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154477573|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477574|NCT04824794|Daratumumab|daratumumab|mesh-list
154477575|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477576|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154477577|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477578|NCT04799236|Amphotericin B|amphotericin b|mesh-list
154477579|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154477580|NCT04799236|Miltefosine|miltefosine|mesh-list
154477581|NCT04799236|Amebicides|amebicides|mesh-ancestor
154477582|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154477583|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154477584|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477585|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154477586|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
154477587|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477588|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
154477589|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477590|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477591|NCT04799054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477592|NCT04799054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477593|NCT04790032|Cangrelor|cangrelor|mesh-list
154477594|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154477595|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154477596|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154477597|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154477598|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
154477599|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477600|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730977|NCT00135902|Progestins|progestins|mesh-ancestor
154477601|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477602|NCT04776252|Islatravir|islatravir|mesh-list
154477603|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
154477604|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477605|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477606|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477607|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154477608|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154477609|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154860673|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477610|NCT04774393|Venetoclax|venetoclax|mesh-list
154477611|NCT04774393|Decitabine|decitabine|mesh-list
154477612|NCT04774393|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154477613|NCT04774393|Ivosidenib|ivosidenib|mesh-list
154477614|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477615|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477616|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
154477617|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477618|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477619|NCT04771754|Dolutegravir|dolutegravir|mesh-list
154477620|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154477621|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154477622|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477623|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477624|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154477625|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154477626|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
154477627|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477628|NCT04727242|Gemcitabine|gemcitabine|mesh-list
154477629|NCT04727242|Dacarbazine|dacarbazine|mesh-list
154477630|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477631|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
154477632|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477633|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477634|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477635|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
154477636|NCT04716946|Durvalumab|durvalumab|mesh-list
154477637|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477638|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477639|NCT04708782|Treprostinil|treprostinil|mesh-list
154477640|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154477641|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
154477642|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477643|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477644|NCT04699123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477645|NCT04699123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477646|NCT04690608|Triamcinolone|triamcinolone|mesh-list
154477647|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154477648|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154477649|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154477650|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477652|NCT04690608|Hormones|hormones|mesh-ancestor
154477653|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477654|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477655|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477656|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
154477657|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477658|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477659|NCT04650581|Fulvestrant|fulvestrant|mesh-list
154477660|NCT04650581|Ipatasertib|ipatasertib|mesh-list
154477661|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154477662|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477663|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154477664|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154477665|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
154477666|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477667|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477668|NCT04650581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154477669|NCT04650581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477670|NCT04650581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477671|NCT04649229|Aprepitant|aprepitant|mesh-list
154477672|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154477673|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
154477674|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
154477675|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477676|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477677|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154477678|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154477679|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477680|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477681|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154860674|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154477682|NCT04633239|Olaparib|olaparib|mesh-list
154477683|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154477684|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477685|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477686|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477687|NCT04624230|Tofacitinib|tofacitinib|mesh-list
154477688|NCT04624230|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154477689|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154477690|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477691|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477692|NCT04623541|Prednisone|prednisone|mesh-list
154477693|NCT04623541|Cyclophosphamide|cyclophosphamide|mesh-list
154477694|NCT04623541|Rituximab|rituximab|mesh-list
154477695|NCT04623541|Doxorubicin|doxorubicin|mesh-list
154477696|NCT04623541|Vincristine|vincristine|mesh-list
154041557|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
154477697|NCT04623541|Lenalidomide|lenalidomide|mesh-list
154477698|NCT04623541|Venetoclax|venetoclax|mesh-list
154477699|NCT04623541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477700|NCT04623541|Immunologic Factors|immunologic factors|mesh-ancestor
154477701|NCT04623541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477702|NCT04623541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477703|NCT04623541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477704|NCT04623541|Alkylating Agents|alkylating agents|mesh-ancestor
154477705|NCT04623541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477706|NCT04623541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477707|NCT04623541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154477708|NCT04623541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477709|NCT04623541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154477710|NCT04623541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154477711|NCT04623541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154477712|NCT04623541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477713|NCT04623541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477714|NCT04623541|Glucocorticoids|glucocorticoids|mesh-ancestor
154477715|NCT04623541|Hormones|hormones|mesh-ancestor
154477716|NCT04623541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477717|NCT04623541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154477718|NCT04623541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477719|NCT04623541|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477720|NCT04623541|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477721|NCT04623541|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477722|NCT04623541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154477723|NCT04623541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154477724|NCT04623541|Growth Substances|growth substances|mesh-ancestor
154477725|NCT04623541|Growth Inhibitors|growth inhibitors|mesh-ancestor
154477726|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
154477727|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154477728|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477729|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477730|NCT04609566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477731|NCT04609566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477732|NCT04609566|Immunotoxins|immunotoxins|mesh-ancestor
154477733|NCT04609566|Immunoconjugates|immunoconjugates|mesh-ancestor
154477734|NCT04609566|Immunologic Factors|immunologic factors|mesh-ancestor
154477735|NCT04609566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477736|NCT04585789|Tenofovir|tenofovir|mesh-list
154477737|NCT04585789|Entecavir|entecavir|mesh-list
154477738|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
154477739|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154477740|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
154477741|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154477742|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154477743|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154477744|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477745|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477746|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154477747|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154477748|NCT04555577|Temozolomide|temozolomide|mesh-list
154477749|NCT04555577|Peposertib|peposertib|mesh-list
154477750|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477751|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
154477752|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477753|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477754|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154477755|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477756|NCT04552327|Diclofenac|diclofenac|mesh-list
154477757|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154477758|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154477759|NCT04552327|Analgesics|analgesics|mesh-ancestor
154477760|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
154477761|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477762|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477763|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477764|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477765|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154477766|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477767|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477768|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154477769|NCT04549116|Progesterone|progesterone|mesh-list
154477770|NCT04549116|Progestins|progestins|mesh-ancestor
154477771|NCT04549116|Hormones|hormones|mesh-ancestor
154477772|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477773|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477774|NCT04542824|Prednisone|prednisone|mesh-list
154477775|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
154477776|NCT04542824|Rituximab|rituximab|mesh-list
154477777|NCT04542824|Gemcitabine|gemcitabine|mesh-list
154477778|NCT04542824|Doxorubicin|doxorubicin|mesh-list
154477779|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
154477780|NCT04542824|Vincristine|vincristine|mesh-list
154477781|NCT04542824|Lenalidomide|lenalidomide|mesh-list
154477782|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477783|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
154477784|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477785|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477786|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477787|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
154477788|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477789|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477790|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154477791|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477792|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477793|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
154477794|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154477795|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154477796|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154477797|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477798|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477800|NCT04542824|Hormones|hormones|mesh-ancestor
154477801|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477802|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154477803|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477804|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477805|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477806|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477807|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154477808|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154477809|NCT04542824|Growth Substances|growth substances|mesh-ancestor
154477810|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
154477811|NCT04526730|Nivolumab|nivolumab|mesh-list
154477812|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477813|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477814|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477815|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477816|NCT04502693|Vaccines|vaccines|mesh-list
154477817|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
154477818|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477819|NCT04485949|Temozolomide|temozolomide|mesh-list
154477820|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154477821|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
154477822|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477823|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477824|NCT04472767|Nivolumab|nivolumab|mesh-list
154477825|NCT04472767|Ipilimumab|ipilimumab|mesh-list
154477826|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477827|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477828|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477829|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477830|NCT04461639|Factor VIII|factor viii|mesh-list
154477831|NCT04461639|Coagulants|coagulants|mesh-ancestor
154477832|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
154477833|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
154477834|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
154477835|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154477836|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477837|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
154477838|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477839|NCT04417088|Carboplatin|carboplatin|mesh-list
154477840|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477841|NCT04343872|Metformin|metformin|mesh-list
154477842|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154477843|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477844|NCT04340947|Nicotine|nicotine|mesh-list
154477845|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154477846|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
154477847|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477848|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477849|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154477850|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154477851|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
154477852|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477853|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477854|NCT04291521|Ketamine|ketamine|mesh-list
154477855|NCT04291521|Propofol|propofol|mesh-list
154477856|NCT04291521|Etomidate|etomidate|mesh-list
154477857|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154477858|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154477859|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477860|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154477861|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
154477862|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
154477863|NCT04291521|Analgesics|analgesics|mesh-ancestor
154477864|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
154477865|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477866|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154477867|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154477868|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154477869|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477870|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477871|NCT04277442|Nivolumab|nivolumab|mesh-list
154477872|NCT04277442|Venetoclax|venetoclax|mesh-list
154477873|NCT04277442|Decitabine|decitabine|mesh-list
154477874|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477875|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477876|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477877|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477878|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477879|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
154477880|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477881|NCT04269200|Paclitaxel|paclitaxel|mesh-list
154477882|NCT04269200|Carboplatin|carboplatin|mesh-list
154477883|NCT04269200|Durvalumab|durvalumab|mesh-list
154477884|NCT04269200|Olaparib|olaparib|mesh-list
154477885|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154477886|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477887|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477888|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477889|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477890|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477891|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477892|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477893|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
154477894|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477895|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154477896|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477897|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154477898|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477899|NCT04199728|Liraglutide|liraglutide|mesh-list
154477900|NCT04199728|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154477901|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154477902|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477903|NCT04199728|Incretins|incretins|mesh-ancestor
154477904|NCT04199728|Hormones|hormones|mesh-ancestor
154477905|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477906|NCT04179864|Prednisone|prednisone|mesh-list
154477907|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477908|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
154477910|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477911|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477912|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154477913|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477914|NCT04168203|Apixaban|apixaban|mesh-list
154477915|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154477916|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
154477917|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154477918|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
154477919|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477920|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477921|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
154477922|NCT04128683|Bromocriptine|bromocriptine|mesh-list
154477923|NCT04128683|Amisulpride|amisulpride|mesh-list
154477924|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154477925|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154477926|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154477927|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477928|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154477929|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154477930|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
154477931|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154477932|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477933|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154041722|NCT02652728|Enalapril|enalapril|mesh-list
154477934|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
154477935|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154477936|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154477937|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
154477938|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154477939|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
154477940|NCT04113109|Icatibant|icatibant|mesh-list
154477941|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154477942|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154477943|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477944|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154477945|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154477946|NCT04113109|Analgesics|analgesics|mesh-ancestor
154477947|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
154477948|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154477949|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477950|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154477951|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154477952|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154477953|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154477954|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154477955|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477956|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
154477957|NCT04083599|Paclitaxel|paclitaxel|mesh-list
154477958|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154477959|NCT04083599|Carboplatin|carboplatin|mesh-list
154477960|NCT04083599|Gemcitabine|gemcitabine|mesh-list
154477961|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
154477962|NCT04083599|Pemetrexed|pemetrexed|mesh-list
154477963|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154477964|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477965|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
154477966|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
154477967|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
154477968|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154477969|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477970|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
154477971|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154477972|NCT04083599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154477973|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154477974|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154477975|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154477976|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
154477977|NCT04068103|Leucovorin|leucovorin|mesh-list
154477978|NCT04068103|Folic Acid|folic acid|mesh-list
154477979|NCT04068103|Capecitabine|capecitabine|mesh-list
154477980|NCT04068103|Fluorouracil|fluorouracil|mesh-list
154477982|NCT04068103|Calcium|calcium|mesh-list
154477983|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
154477984|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154477985|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154477986|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154477987|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154477988|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
154477989|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814918|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154477990|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154477991|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154477992|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
154477993|NCT04068103|Antidotes|antidotes|mesh-ancestor
154477994|NCT04068103|Protective Agents|protective agents|mesh-ancestor
154477995|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
154477996|NCT04068103|Vitamins|vitamins|mesh-ancestor
154477997|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
154477998|NCT04068103|Hematinics|hematinics|mesh-ancestor
154477999|NCT04057937|Apremilast|apremilast|mesh-list
154478000|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154478001|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154478002|NCT04057937|Analgesics|analgesics|mesh-ancestor
154478003|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
154478004|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478005|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478006|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478007|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478008|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154478009|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154478010|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478011|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478012|NCT04041791|Amoxicillin|amoxicillin|mesh-list
154478013|NCT04041791|Gentamicins|gentamicins|mesh-list
154478014|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
154478015|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
154478016|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
154478017|NCT04041791|Penicillins|penicillins|mesh-list
154478018|NCT04041791|Ampicillin|ampicillin|mesh-list
154478019|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154478020|NCT04041791|Penicillin G|penicillin g|mesh-list
154478021|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154478022|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
154478023|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154478024|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478025|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154478026|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478027|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478028|NCT04041791|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154478029|NCT04041791|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154478030|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154478031|NCT04041310|Pembrolizumab|pembrolizumab|mesh-list
154478032|NCT04041310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478033|NCT04041310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478034|NCT04041310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478035|NCT04041310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478036|NCT04015180|Aflibercept|aflibercept|mesh-list
154478037|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154478038|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154478039|NCT04015180|Growth Substances|growth substances|mesh-ancestor
153814919|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478040|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478041|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
154478042|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478043|NCT04003636|Cisplatin|cisplatin|mesh-list
154478044|NCT04003636|Gemcitabine|gemcitabine|mesh-list
154478045|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
154478046|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478047|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478048|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
154478049|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478050|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478051|NCT04003636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478052|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
154478053|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154478054|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154478055|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154106224|NCT05602064|Ibuprofen|ibuprofen|mesh-list
154478056|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154478057|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154478058|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478059|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
154478060|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154478061|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478062|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154478063|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478065|NCT03929666|Bevacizumab|bevacizumab|mesh-list
154478066|NCT03929666|Gemcitabine|gemcitabine|mesh-list
154478067|NCT03929666|Capecitabine|capecitabine|mesh-list
154478068|NCT03929666|Fluorouracil|fluorouracil|mesh-list
154478069|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
154478070|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478071|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478072|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154478073|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154478074|NCT03929666|Growth Substances|growth substances|mesh-ancestor
154478075|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478076|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
154478077|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478078|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
154478079|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478080|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154478081|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
154478082|NCT03929666|Antidotes|antidotes|mesh-ancestor
154478083|NCT03929666|Protective Agents|protective agents|mesh-ancestor
154478084|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
154478085|NCT03929666|Vitamins|vitamins|mesh-ancestor
154478086|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
154478087|NCT03871348|Cemiplimab|cemiplimab|mesh-list
154478088|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478089|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478090|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
154478091|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478092|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478093|NCT03861793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478094|NCT03861793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478095|NCT03786796|Olaparib|olaparib|mesh-list
154478096|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154478097|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478098|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478099|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478100|NCT03777436|Apremilast|apremilast|mesh-list
154478101|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154478102|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154478103|NCT03777436|Analgesics|analgesics|mesh-ancestor
154478104|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
154478105|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478106|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478107|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478108|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478109|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154478110|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154478111|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478112|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478113|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154478114|NCT03738878|Valsartan|valsartan|mesh-list
154478115|NCT03738878|Bradykinin|bradykinin|mesh-list
154478116|NCT03738878|Kininogens|kininogens|mesh-list
154478117|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154478118|NCT03738878|Substance P|substance p|mesh-list
154478119|NCT03738878|Neurokinin A|neurokinin a|mesh-list
154478120|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154478121|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478122|NCT03738878|Incretins|incretins|mesh-ancestor
154478123|NCT03738878|Hormones|hormones|mesh-ancestor
154478124|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478125|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154478126|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
154478127|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478128|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478129|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154478130|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154478131|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154478132|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
154478133|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154478134|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154478135|NCT03735433|Aspirin|aspirin|mesh-list
154478136|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154478137|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154478138|NCT03735433|Analgesics|analgesics|mesh-ancestor
154478139|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
154478140|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478141|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478142|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478143|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478144|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154478145|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154478146|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478147|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154478148|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154478149|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478150|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
154478151|NCT03721172|Apremilast|apremilast|mesh-list
154478152|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154478153|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154478154|NCT03721172|Analgesics|analgesics|mesh-ancestor
154478155|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
154478156|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478157|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478158|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478159|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478160|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154478161|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154478162|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478163|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478164|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
154478165|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
154478166|NCT03712878|Tacrolimus|tacrolimus|mesh-list
154478167|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154478168|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
154478169|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478170|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478171|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154478172|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
154478173|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478174|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478175|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154478176|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154478177|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478178|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154478179|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154478180|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
154478181|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154478182|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478183|NCT03709082|Trastuzumab|trastuzumab|mesh-list
154478184|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154478185|NCT03709082|Letrozole|letrozole|mesh-list
154478186|NCT03709082|Palbociclib|palbociclib|mesh-list
154478187|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478188|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478189|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154478190|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154478191|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478192|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478193|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154478194|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
154478195|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478196|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478197|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478198|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
154478199|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
154478200|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
154478201|NCT03709082|Immunotoxins|immunotoxins|mesh-ancestor
154478202|NCT03709082|Immunoconjugates|immunoconjugates|mesh-ancestor
154860675|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860676|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
154478203|NCT03709082|Immunologic Factors|immunologic factors|mesh-ancestor
154478204|NCT03646461|Nivolumab|nivolumab|mesh-list
154478205|NCT03646461|Cetuximab|cetuximab|mesh-list
154478206|NCT03646461|Ibrutinib|ibrutinib|mesh-list
154478207|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153814922|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154478208|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478209|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478210|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478211|NCT03646461|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154478212|NCT03646461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478213|NCT03646461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478214|NCT03625986|Nicotine|nicotine|mesh-list
154478215|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154478216|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
154478217|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478218|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478219|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154478220|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154478221|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
154478222|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154478223|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478224|NCT03616587|Everolimus|everolimus|mesh-list
154478225|NCT03616587|Palbociclib|palbociclib|mesh-list
154478226|NCT03616587|Anastrozole|anastrozole|mesh-list
154478227|NCT03616587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154478228|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478229|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478230|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478231|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154478232|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
154478233|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478234|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478235|NCT03616587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154478236|NCT03616587|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154478237|NCT03616587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154478238|NCT03616587|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154478239|NCT03616587|Hormone Antagonists|hormone antagonists|mesh-ancestor
154478240|NCT03616587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478241|NCT03607422|Upadacitinib|upadacitinib|mesh-list
154478242|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154478244|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478245|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478246|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478247|NCT03603808|Vaccines|vaccines|mesh-list
154478248|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
154478249|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478250|NCT03569293|Upadacitinib|upadacitinib|mesh-list
154478251|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154478252|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478253|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814923|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
154478254|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478255|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478256|NCT03556839|Paclitaxel|paclitaxel|mesh-list
154478257|NCT03556839|Bevacizumab|bevacizumab|mesh-list
154478258|NCT03556839|Carboplatin|carboplatin|mesh-list
154478259|NCT03556839|Atezolizumab|atezolizumab|mesh-list
154478260|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154478261|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478262|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
154478263|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
154478264|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154478265|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478266|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478267|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154478268|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154478269|NCT03556839|Growth Substances|growth substances|mesh-ancestor
154478270|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478271|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
154478272|NCT03556839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478273|NCT03526874|Lidocaine|lidocaine|mesh-list
154478274|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
154478275|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
154478276|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154478277|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860677|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154478278|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
154478279|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478280|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154478281|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154478282|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154478283|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154478284|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478286|NCT03526835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478287|NCT03526835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478288|NCT03526835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478289|NCT03526835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478290|NCT03496610|Bupivacaine|bupivacaine|mesh-list
154478291|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
154478292|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
154042100|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
154478293|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154478294|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478295|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
154478296|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478297|NCT03484819|Nivolumab|nivolumab|mesh-list
154478298|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478299|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478300|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478301|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478302|NCT03410654|Tacrolimus|tacrolimus|mesh-list
154478303|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154478304|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
154478305|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478306|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154478307|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478308|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478309|NCT03399318|Acetaminophen|acetaminophen|mesh-list
154478310|NCT03399318|Ibuprofen|ibuprofen|mesh-list
154478311|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154478312|NCT03399318|Analgesics|analgesics|mesh-ancestor
154478313|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
154478314|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202229|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154478315|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478316|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
154478317|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154478318|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478319|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478320|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154478321|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478322|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478323|NCT03397706|Valganciclovir|valganciclovir|mesh-list
154478324|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
154478325|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478326|NCT03397004|Doxycycline|doxycycline|mesh-list
154478327|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154478328|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478329|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
154478330|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154478331|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154478332|NCT03375307|Olaparib|olaparib|mesh-list
154478333|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154478334|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478335|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478336|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478337|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
154478338|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154478339|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154478340|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478341|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
154478342|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154478343|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478344|NCT03338790|Prednisone|prednisone|mesh-list
154478345|NCT03338790|Docetaxel|docetaxel|mesh-list
154478346|NCT03338790|Nivolumab|nivolumab|mesh-list
154478347|NCT03338790|Rucaparib|rucaparib|mesh-list
154478348|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478349|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
154478350|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
154478351|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
154478352|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478353|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478354|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
154478355|NCT03338790|Hormones|hormones|mesh-ancestor
154478356|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478357|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478358|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154478359|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478360|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478361|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154478362|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478363|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
154478364|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154478365|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
154478366|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478367|NCT03306979|Expectorants|expectorants|mesh-ancestor
154478368|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
154478369|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154478370|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
154478371|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478372|NCT03306979|Protective Agents|protective agents|mesh-ancestor
154478373|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478374|NCT03306979|Antidotes|antidotes|mesh-ancestor
154478375|NCT03278509|Metoprolol|metoprolol|mesh-list
154478376|NCT03278509|Bisoprolol|bisoprolol|mesh-list
154478377|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154478378|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154478379|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
154478380|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
154478381|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478382|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478383|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154478384|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154478385|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154478386|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
154478387|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154478388|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478389|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154478390|NCT03270059|Hematinics|hematinics|mesh-ancestor
154478391|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154478392|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154478393|NCT03259503|Rituximab|rituximab|mesh-list
154478394|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154478395|NCT03259503|Gemcitabine|gemcitabine|mesh-list
154478396|NCT03259503|Melphalan|melphalan|mesh-list
154478397|NCT03259503|Busulfan|busulfan|mesh-list
154478398|NCT03259503|Olaparib|olaparib|mesh-list
154478399|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
154478400|NCT03259503|Vorinostat|vorinostat|mesh-list
154478401|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154478402|NCT03259503|Antibodies|antibodies|mesh-list
154478403|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
154478404|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154478405|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
154478406|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478407|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478408|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478409|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478410|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
154478411|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478412|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154478413|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
154478414|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154478415|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154478416|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154478417|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478418|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154478419|NCT03228537|Cisplatin|cisplatin|mesh-list
154478420|NCT03228537|Pemetrexed|pemetrexed|mesh-list
154478421|NCT03228537|Atezolizumab|atezolizumab|mesh-list
154478422|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154478423|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478424|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478425|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478426|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154860678|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154478427|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154478428|NCT03228537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478429|NCT03228537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478430|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
154478431|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478432|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
154478433|NCT03198026|Ibrutinib|ibrutinib|mesh-list
154478434|NCT03198026|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154478435|NCT03198026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478436|NCT03198026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478437|NCT03198026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478438|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478439|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478440|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154478441|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154478442|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154478443|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478444|NCT03173248|Azacitidine|azacitidine|mesh-list
154478445|NCT03173248|Ivosidenib|ivosidenib|mesh-list
154478446|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478447|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
154478448|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478449|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478450|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478451|NCT03164616|Cisplatin|cisplatin|mesh-list
154478452|NCT03164616|Carboplatin|carboplatin|mesh-list
154478453|NCT03164616|Gemcitabine|gemcitabine|mesh-list
154478454|NCT03164616|Pemetrexed|pemetrexed|mesh-list
154478455|NCT03164616|Durvalumab|durvalumab|mesh-list
154478456|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154478457|NCT03164616|Tremelimumab|tremelimumab|mesh-list
154478458|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478459|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478460|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
154478461|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478462|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202380|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
154478463|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154478464|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154478465|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478466|NCT03158688|Dexamethasone|dexamethasone|mesh-list
154478467|NCT03158688|Daratumumab|daratumumab|mesh-list
154478468|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478469|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
154478470|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
154478471|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478472|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478473|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154478474|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
154478475|NCT03158688|Hormones|hormones|mesh-ancestor
154478476|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478477|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154478478|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478479|NCT03151707|Niacinamide|niacinamide|mesh-list
154478480|NCT03151707|Niacin|niacin|mesh-list
154478481|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
154478482|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
154478483|NCT03151707|Vitamins|vitamins|mesh-ancestor
154478484|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
154478485|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478486|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154478487|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
154478488|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478489|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154478490|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
154478491|NCT03117751|Cytarabine|cytarabine|mesh-list
154478492|NCT03117751|Dexamethasone|dexamethasone|mesh-list
154478493|NCT03117751|Prednisone|prednisone|mesh-list
154478494|NCT03117751|Prednisolone|prednisolone|mesh-list
154478495|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
154478496|NCT03117751|Doxorubicin|doxorubicin|mesh-list
154478497|NCT03117751|Methotrexate|methotrexate|mesh-list
154478498|NCT03117751|Etoposide|etoposide|mesh-list
154478499|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
154478500|NCT03117751|Vincristine|vincristine|mesh-list
154478501|NCT03117751|Bortezomib|bortezomib|mesh-list
154478502|NCT03117751|Daunorubicin|daunorubicin|mesh-list
154478503|NCT03117751|Asparaginase|asparaginase|mesh-list
154478504|NCT03117751|Dasatinib|dasatinib|mesh-list
154478505|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
154478506|NCT03117751|Vorinostat|vorinostat|mesh-list
154478507|NCT03117751|Idarubicin|idarubicin|mesh-list
154478508|NCT03117751|Clofarabine|clofarabine|mesh-list
154478509|NCT03117751|Pegaspargase|pegaspargase|mesh-list
154478510|NCT03117751|Thioguanine|thioguanine|mesh-list
154478511|NCT03117751|Blinatumomab|blinatumomab|mesh-list
154478512|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
154478513|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154478514|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
154478515|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478516|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478517|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154478518|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
153814927|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154478519|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478520|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478521|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154478522|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478523|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
154478524|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
154478525|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478526|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154478527|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
154478528|NCT03117751|Hormones|hormones|mesh-ancestor
154478529|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478530|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154478531|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154478532|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154478533|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154478534|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478535|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154478536|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
154478537|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154478538|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478539|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
154478540|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
154478541|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154478542|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154478543|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154478544|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
154478545|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478546|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
154478547|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
154478548|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
154478549|NCT03117751|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154478550|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478551|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154478552|NCT03099174|Letrozole|letrozole|mesh-list
154478553|NCT03099174|Fulvestrant|fulvestrant|mesh-list
154478554|NCT03099174|Anastrozole|anastrozole|mesh-list
154478555|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478556|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154478557|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154478558|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478559|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478560|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154478561|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
154478562|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478563|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478564|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154478565|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154478566|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
154478567|NCT03088852|Cathartics|cathartics|mesh-ancestor
154478568|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154478569|NCT03069131|Rifaximin|rifaximin|mesh-list
154478570|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154478571|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478572|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154478573|NCT02974621|Bevacizumab|bevacizumab|mesh-list
154478574|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154478575|NCT02974621|Olaparib|olaparib|mesh-list
154478576|NCT02974621|Cediranib|cediranib|mesh-list
154478577|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
154478578|NCT02974621|Antibodies|antibodies|mesh-list
154478579|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
154478580|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154478582|NCT02974621|Maleic acid|maleic acid|mesh-list
154478583|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478584|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154478585|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154478586|NCT02974621|Growth Substances|growth substances|mesh-ancestor
154478587|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478588|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
154478589|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
154478590|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478591|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154478592|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478593|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478594|NCT02797548|Aspirin|aspirin|mesh-list
154478595|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154478596|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154478597|NCT02797548|Analgesics|analgesics|mesh-ancestor
154478598|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
154478599|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478600|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478601|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478602|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478603|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154478604|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154478605|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478606|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154478607|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154478608|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478609|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
154478610|NCT02795858|Octreotide|octreotide|mesh-list
154478611|NCT02795858|Ramucirumab|ramucirumab|mesh-list
154478612|NCT02795858|Lanreotide|lanreotide|mesh-list
154478613|NCT02795858|Somatostatin|somatostatin|mesh-list
154478614|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154478615|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154478616|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478617|NCT02795858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154478618|NCT02795858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154478619|NCT02795858|Growth Substances|growth substances|mesh-ancestor
154478620|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478621|NCT02795858|Growth Inhibitors|growth inhibitors|mesh-ancestor
154478622|NCT02795858|Hormones|hormones|mesh-ancestor
154478623|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478624|NCT02759419|Riociguat|riociguat|mesh-list
154478625|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
154478626|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478627|NCT02723006|Nivolumab|nivolumab|mesh-list
154478628|NCT02723006|Ipilimumab|ipilimumab|mesh-list
154478629|NCT02723006|Vedolizumab|vedolizumab|mesh-list
154478630|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478631|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478632|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478633|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478634|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154478635|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
154478636|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478637|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478638|NCT02632344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478639|NCT02632344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478640|NCT02592356|Lenvatinib|lenvatinib|mesh-list
154478641|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478642|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478643|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478644|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478645|NCT02562235|Riociguat|riociguat|mesh-list
154478646|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
154478647|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478648|NCT02517684|Prednisolone|prednisolone|mesh-list
154478649|NCT02517684|Infliximab|infliximab|mesh-list
154478650|NCT02517684|Azathioprine|azathioprine|mesh-list
154478651|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478652|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
154478653|NCT02517684|Hormones|hormones|mesh-ancestor
154478654|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478655|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478656|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154478657|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478658|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154478659|NCT02517684|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154478660|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
154478661|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478663|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478664|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478665|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154478666|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
154478667|NCT02498600|Nivolumab|nivolumab|mesh-list
154478668|NCT02498600|Ipilimumab|ipilimumab|mesh-list
154478669|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478670|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478671|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478672|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042519|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
154478673|NCT02487095|Topotecan|topotecan|mesh-list
154478674|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154478675|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154478676|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478677|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478678|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478679|NCT02446600|Paclitaxel|paclitaxel|mesh-list
154478680|NCT02446600|Carboplatin|carboplatin|mesh-list
154478681|NCT02446600|Gemcitabine|gemcitabine|mesh-list
154478682|NCT02446600|Doxorubicin|doxorubicin|mesh-list
154478683|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154478684|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154478685|NCT02446600|Olaparib|olaparib|mesh-list
154478686|NCT02446600|Cediranib|cediranib|mesh-list
154478687|NCT02446600|Maleic acid|maleic acid|mesh-list
154478688|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154478689|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478690|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
154478691|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
154478692|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
154478693|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478694|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478695|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
154478696|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154202605|NCT00436644|Topotecan|topotecan|mesh-list
154478697|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154478698|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154478699|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478700|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154478701|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478702|NCT02428192|Nivolumab|nivolumab|mesh-list
154478703|NCT02428192|Ipilimumab|ipilimumab|mesh-list
154478704|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478705|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478706|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478707|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478708|NCT02345265|Olaparib|olaparib|mesh-list
154478709|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154478710|NCT02345265|Cediranib|cediranib|mesh-list
154478711|NCT02345265|Maleic acid|maleic acid|mesh-list
154478712|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478713|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478714|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478715|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478716|NCT02320435|Trastuzumab|trastuzumab|mesh-list
154478717|NCT02320435|Pertuzumab|pertuzumab|mesh-list
154478718|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154042522|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154478719|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478720|NCT02281955|Cisplatin|cisplatin|mesh-list
154042565|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
154478721|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478722|NCT02275533|Nivolumab|nivolumab|mesh-list
154478723|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478724|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478725|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478726|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478727|NCT02264678|Carboplatin|carboplatin|mesh-list
154478728|NCT02264678|Durvalumab|durvalumab|mesh-list
154478729|NCT02264678|Olaparib|olaparib|mesh-list
154478730|NCT02264678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154478731|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478732|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478733|NCT02264678|Immunologic Factors|immunologic factors|mesh-ancestor
154478734|NCT02264678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478735|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154478736|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478737|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478738|NCT02261883|Treprostinil|treprostinil|mesh-list
154478739|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154478740|NCT02257528|Nivolumab|nivolumab|mesh-list
154478741|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478742|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478743|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478744|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478745|NCT02247349|Nivolumab|nivolumab|mesh-list
154478746|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478747|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478748|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478749|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478750|NCT02182687|Doxorubicin|doxorubicin|mesh-list
154478751|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154478752|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154478753|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478754|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154478755|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154478756|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478757|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478758|NCT02159066|Infigratinib|infigratinib|mesh-list
154478759|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478760|NCT02152995|Iodine|iodine|mesh-list
154478761|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
154478762|NCT02152995|Trametinib|trametinib|mesh-list
154478763|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154478764|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478765|NCT02152995|Trace Elements|trace elements|mesh-ancestor
154478766|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
154478767|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478768|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478769|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478770|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478771|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478772|NCT02135133|Ofatumumab|ofatumumab|mesh-list
154478773|NCT02135133|Idelalisib|idelalisib|mesh-list
154478774|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478775|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478776|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478777|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
154478778|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478779|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154478780|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478781|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478782|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
154478783|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478784|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478785|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154478786|NCT02000427|Blinatumomab|blinatumomab|mesh-list
154478787|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478788|NCT01909453|Vemurafenib|vemurafenib|mesh-list
154478789|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478790|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478791|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478792|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478793|NCT01012817|Topotecan|topotecan|mesh-list
154478794|NCT01012817|Veliparib|veliparib|mesh-list
154478795|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154478796|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154478797|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478798|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478799|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478800|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154478801|NCT00278915|Fulvestrant|fulvestrant|mesh-list
154478802|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154478803|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478804|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154478805|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154478806|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
154478807|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478808|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478809|NCT05052957|Temozolomide|temozolomide|mesh-list
154478810|NCT05052957|Carmustine|carmustine|mesh-list
154478811|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
154478812|NCT05052957|Lenograstim|lenograstim|mesh-list
154478813|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154478814|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
154478815|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478816|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154478817|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
154478818|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478819|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478820|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478821|NCT05031078|Lidocaine|lidocaine|mesh-list
154478822|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478823|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
154478824|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
154478825|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154478826|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
154478827|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478828|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154478829|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154478830|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154478831|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154478832|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478833|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154478834|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154478835|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154478836|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154478837|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478838|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154478839|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478840|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154478841|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
154478842|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154478843|NCT05017012|Paclitaxel|paclitaxel|mesh-list
154478844|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154478845|NCT05017012|Carboplatin|carboplatin|mesh-list
154478846|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
154478847|NCT05017012|Pemetrexed|pemetrexed|mesh-list
154478848|NCT05017012|Axitinib|axitinib|mesh-list
154478849|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154478850|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478851|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
154478852|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
154478853|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
154478854|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478855|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478856|NCT05017012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478857|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478858|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154478859|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154478860|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478861|NCT05013060|Butyric Acid|butyric acid|mesh-list
154478862|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
154478863|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
154478864|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154478865|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478866|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478867|NCT05005273|Nivolumab|nivolumab|mesh-list
154478868|NCT05005273|Ipilimumab|ipilimumab|mesh-list
154478869|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478870|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478871|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478872|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478873|NCT04999969|Paclitaxel|paclitaxel|mesh-list
154478874|NCT04999969|Gemcitabine|gemcitabine|mesh-list
154478875|NCT04999969|Durvalumab|durvalumab|mesh-list
154478876|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154478878|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
154478879|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
154478880|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
153814932|NCT00344123|Ritonavir|ritonavir|mesh-list
154478881|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478882|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154478883|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
154478884|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478885|NCT04999228|Infliximab|infliximab|mesh-list
154478886|NCT04999228|Mesalamine|mesalamine|mesh-list
154478887|NCT04999228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154478888|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478889|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
154478890|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154478891|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478892|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154478893|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154478894|NCT04999228|Analgesics|analgesics|mesh-ancestor
154478895|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
154478896|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478897|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478898|NCT04996823|Ipilimumab|ipilimumab|mesh-list
154478899|NCT04996823|Axitinib|axitinib|mesh-list
154478900|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478901|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478902|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154478903|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478904|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154478905|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478906|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154478907|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154478908|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154478909|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154478910|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478911|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478912|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
154478913|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154478914|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154478915|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154478916|NCT04990791|Aspirin|aspirin|mesh-list
154478917|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
154478918|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154478919|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154478920|NCT04990791|Analgesics|analgesics|mesh-ancestor
154478921|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
154478922|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478923|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478924|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478925|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478926|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154478927|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154478928|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478929|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154478930|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154478931|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478932|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
154478933|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154478934|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
154478935|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154478936|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
154478937|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
154478938|NCT04990713|Ropivacaine|ropivacaine|mesh-list
154478939|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
154478940|NCT04990713|Anesthetics|anesthetics|mesh-list
154478941|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154478942|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478943|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
154478944|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478945|NCT04989348|Hormones|hormones|mesh-list
154478946|NCT04989348|Progestins|progestins|mesh-list
154478947|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
154478948|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478949|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478950|NCT04980222|Prednisone|prednisone|mesh-list
154478951|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
154478952|NCT04980222|Rituximab|rituximab|mesh-list
154478953|NCT04980222|Doxorubicin|doxorubicin|mesh-list
154478954|NCT04980222|Vincristine|vincristine|mesh-list
154478955|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154478956|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
154478957|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478958|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154478959|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154478960|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
154478961|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478962|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154478963|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154478964|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154478965|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154478966|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154478967|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154478968|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478969|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154478970|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
154478971|NCT04980222|Hormones|hormones|mesh-ancestor
154478972|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154478973|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154042767|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154478974|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154478975|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
154478976|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
154478977|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
154478978|NCT04971785|Semaglutide|semaglutide|mesh-list
154478979|NCT04971785|Firsocostat|firsocostat|mesh-list
154478980|NCT04971785|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154478981|NCT04971785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154478982|NCT04971785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478983|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154478984|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154478985|NCT04944225|Analgesics, Opioid|analgesics, opioid|mesh-list
154478986|NCT04944225|Narcotics|narcotics|mesh-ancestor
154478987|NCT04944225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154478988|NCT04944225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478989|NCT04944225|Analgesics|analgesics|mesh-ancestor
154478990|NCT04944225|Sensory System Agents|sensory system agents|mesh-ancestor
154478991|NCT04944225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154478992|NCT04940689|Lidocaine|lidocaine|mesh-list
154478994|NCT04940689|Remifentanil|remifentanil|mesh-list
154478995|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
154478996|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
154478997|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154478998|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154478999|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
154479000|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479001|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154479002|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154479003|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154479004|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154479005|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479006|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154479007|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154479008|NCT04940689|Analgesics|analgesics|mesh-ancestor
154479009|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154479010|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154479011|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154479012|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
154479013|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479014|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154479015|NCT04940689|Narcotics|narcotics|mesh-ancestor
154479016|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
154479017|NCT04936971|Everolimus|everolimus|mesh-list
154479018|NCT04936971|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154479019|NCT04936971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479020|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479021|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479022|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154479023|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
154479024|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860679|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154479025|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479026|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154479027|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154042820|NCT01564303|Antidotes|antidotes|mesh-ancestor
154479028|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
154479029|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154479030|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814936|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154042877|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154479031|NCT04935359|Paclitaxel|paclitaxel|mesh-list
154479032|NCT04935359|Gemcitabine|gemcitabine|mesh-list
154479033|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479034|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479035|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479036|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479037|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479038|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479039|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154479040|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
154479041|NCT04921358|Docetaxel|docetaxel|mesh-list
154479042|NCT04921358|Tislelizumab|tislelizumab|mesh-list
154479043|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479044|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479045|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479046|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479047|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479048|NCT04921358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479049|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154479050|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154479051|NCT04908202|Deucravacitinib|deucravacitinib|mesh-list
154479052|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
154479053|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479054|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479055|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479056|NCT04907227|Dexamethasone|dexamethasone|mesh-list
154479057|NCT04907227|Prednisone|prednisone|mesh-list
154479058|NCT04907227|Docetaxel|docetaxel|mesh-list
154479059|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
154479060|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479061|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
154479062|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
154479063|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479064|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479065|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154479066|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
154479067|NCT04907227|Hormones|hormones|mesh-ancestor
154203016|NCT03882047|Xhance|xhance|mesh-list
154479068|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479069|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479071|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479072|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479073|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479074|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479075|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479076|NCT04907227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479077|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
154479078|NCT04906902|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154479079|NCT04906902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479080|NCT04906902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479081|NCT04906902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479082|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479083|NCT04906213|Empagliflozin|empagliflozin|mesh-list
154479084|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154042885|NCT00720616|Insulin|insulin|mesh-list
154479085|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479086|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154479087|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479088|NCT04898946|Vaccines|vaccines|mesh-list
154479089|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
154479090|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479091|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
154479092|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154479093|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154479094|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479095|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154479096|NCT04878510|Analgesics|analgesics|mesh-ancestor
154479097|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
154479098|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479099|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154479100|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154479101|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154479102|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154479103|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479104|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479106|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
154479107|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479108|NCT04878198|Protective Agents|protective agents|mesh-ancestor
154479109|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479110|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154479111|NCT04877093|Clonidine|clonidine|mesh-list
154479112|NCT04877093|Analgesics|analgesics|mesh-ancestor
154479113|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
154479114|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479115|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479116|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154479117|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
154479118|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
154479119|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154479120|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154479121|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154479122|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
154479123|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479124|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479125|NCT04873362|Trastuzumab|trastuzumab|mesh-list
154479126|NCT04873362|Atezolizumab|atezolizumab|mesh-list
154479127|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154479128|NCT04873362|Maytansine|maytansine|mesh-list
154479129|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479130|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479131|NCT04873362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479132|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479133|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479134|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479135|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479136|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479137|NCT04873362|Immunotoxins|immunotoxins|mesh-ancestor
154479138|NCT04873362|Immunoconjugates|immunoconjugates|mesh-ancestor
154479139|NCT04873362|Immunologic Factors|immunologic factors|mesh-ancestor
154479140|NCT04873362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479142|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154479143|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154479144|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479145|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
154479146|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479147|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479148|NCT04815187|Montelukast|montelukast|mesh-list
154479149|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154479150|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
154479151|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154479152|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
154479153|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479154|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479155|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154479156|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154479157|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479158|NCT04812366|Prednisone|prednisone|mesh-list
154479159|NCT04812366|Docetaxel|docetaxel|mesh-list
154479160|NCT04812366|Atezolizumab|atezolizumab|mesh-list
154479161|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
154479162|NCT04812366|Niraparib|niraparib|mesh-list
154479163|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479164|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479165|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479166|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479167|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479168|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479169|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
154479170|NCT04812366|Hormones|hormones|mesh-ancestor
154479171|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860680|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479172|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479173|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479174|NCT04812366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479175|NCT04812366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479176|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154479177|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479178|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
154479179|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154479180|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154479181|NCT04799015|Dexamethasone|dexamethasone|mesh-list
154479182|NCT04799015|Metoclopramide|metoclopramide|mesh-list
154479183|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479184|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
154479185|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
154479186|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479187|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479188|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154479189|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
154479190|NCT04799015|Hormones|hormones|mesh-ancestor
154479191|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479192|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479193|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479194|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154479195|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154479196|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
154479197|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479198|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479199|NCT04790903|Prednisone|prednisone|mesh-list
154479200|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
154479201|NCT04790903|Rituximab|rituximab|mesh-list
154479202|NCT04790903|Doxorubicin|doxorubicin|mesh-list
154479203|NCT04790903|Venetoclax|venetoclax|mesh-list
154479204|NCT04790903|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154479205|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154479206|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
154479207|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479208|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479209|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154479210|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
154479211|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479212|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479213|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154479214|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479215|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154479216|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154479217|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154479218|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479219|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479220|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
154479221|NCT04790903|Hormones|hormones|mesh-ancestor
154479222|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479223|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479224|NCT04790903|Immunoconjugates|immunoconjugates|mesh-ancestor
154479225|NCT04764214|Osimertinib|osimertinib|mesh-list
154479226|NCT04764214|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154479227|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479228|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479229|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479230|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479231|NCT04751929|Atezolizumab|atezolizumab|mesh-list
154479232|NCT04751929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479233|NCT04751929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479234|NCT04751929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479235|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479236|NCT04745299|Riluzole|riluzole|mesh-list
154479237|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
154479238|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154479239|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154479240|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479241|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479242|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479243|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154479244|NCT04745299|Protective Agents|protective agents|mesh-ancestor
154479245|NCT04733040|Felzartamab|felzartamab|mesh-list
154479246|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479247|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
154479248|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479249|NCT04729387|Paclitaxel|paclitaxel|mesh-list
154479250|NCT04729387|Doxorubicin|doxorubicin|mesh-list
154479251|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154479252|NCT04729387|Olaparib|olaparib|mesh-list
154479253|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479254|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479255|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479256|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479257|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479258|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479259|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154479260|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154479261|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154479262|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479263|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154479264|NCT04698031|Aspirin|aspirin|mesh-list
154479265|NCT04698031|Clopidogrel|clopidogrel|mesh-list
154479266|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154479267|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154479268|NCT04698031|Analgesics|analgesics|mesh-ancestor
154479269|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
154479270|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479271|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479272|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479273|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479274|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154479275|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154479276|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479277|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154479278|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154479279|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479280|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
154479281|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154479282|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154479283|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154479284|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
154479285|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203200|NCT04000295|Paclitaxel|paclitaxel|mesh-list
154479286|NCT04661007|Lenalidomide|lenalidomide|mesh-list
154479287|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
154479288|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479289|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154479290|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154479291|NCT04661007|Growth Substances|growth substances|mesh-ancestor
154479292|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
154479293|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479294|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154479295|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
154479296|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154479297|NCT04656184|Antibodies|antibodies|mesh-list
154479298|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
154479299|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154479300|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
154479301|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479302|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479303|NCT04641871|Irinotecan|irinotecan|mesh-list
154479304|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154479305|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154479306|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479307|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479308|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479309|NCT04629248|Acetaminophen|acetaminophen|mesh-list
154479310|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
154479311|NCT04629248|Promethazine|promethazine|mesh-list
154479312|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
154479313|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
154479314|NCT04629248|Tacrolimus|tacrolimus|mesh-list
154479315|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154479316|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
154479317|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479318|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154479319|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479320|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479321|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154479322|NCT04629248|Analgesics|analgesics|mesh-ancestor
154479323|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
154479324|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479325|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
154479326|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479327|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
154479328|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
154479329|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154479330|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
154479331|NCT04629248|Hormones|hormones|mesh-ancestor
154479332|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479333|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154479334|NCT04629248|Protective Agents|protective agents|mesh-ancestor
154479335|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479336|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479337|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154479338|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154479339|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154479340|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
154479341|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
154479342|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154479343|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
154479344|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
154043160|NCT02732249|Bismuth|bismuth|mesh-list
154479345|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479346|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154479347|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
154479348|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
154479349|NCT04623086|Insulin|insulin|mesh-list
154479350|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154479351|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
154479352|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154479353|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479354|NCT04619797|Carboplatin|carboplatin|mesh-list
154479355|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
154479356|NCT04619797|Pemetrexed|pemetrexed|mesh-list
154479357|NCT04619797|Atezolizumab|atezolizumab|mesh-list
154479358|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479359|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479360|NCT04619797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479361|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479362|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479363|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154479364|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154479365|NCT04592237|Carboplatin|carboplatin|mesh-list
154479366|NCT04592237|Niraparib|niraparib|mesh-list
154479367|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479368|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154479369|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479370|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479371|NCT04576455|Fulvestrant|fulvestrant|mesh-list
154479372|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154479373|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479374|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479375|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154479376|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154479377|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
154479378|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479379|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479380|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154479381|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479382|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479383|NCT04566991|Deferoxamine|deferoxamine|mesh-list
154479384|NCT04566991|Siderophores|siderophores|mesh-ancestor
154479385|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154479386|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
154479387|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
154479388|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479389|NCT04562246|Antibodies|antibodies|mesh-list
154479390|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
154479391|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479392|NCT04543617|Atezolizumab|atezolizumab|mesh-list
154479393|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154479394|NCT04543617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479395|NCT04543617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479396|NCT04543617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479398|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
154479399|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479400|NCT04543071|Paclitaxel|paclitaxel|mesh-list
154479401|NCT04543071|Gemcitabine|gemcitabine|mesh-list
154479402|NCT04543071|Cemiplimab|cemiplimab|mesh-list
154479403|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479404|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479405|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479406|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479407|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479408|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479409|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154479410|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
154479411|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479412|NCT04541147|Dexamethasone|dexamethasone|mesh-list
154479413|NCT04541147|Analgesics|analgesics|mesh-list
154479414|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479415|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
154479416|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
154479417|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479418|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479419|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154479420|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
154479421|NCT04541147|Hormones|hormones|mesh-ancestor
154479422|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479423|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479424|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479425|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
154479426|NCT04540705|Nivolumab|nivolumab|mesh-list
154479427|NCT04540705|Axitinib|axitinib|mesh-list
154479428|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479429|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479430|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479431|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479432|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479433|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479434|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
154479435|NCT04527393|Morphine|morphine|mesh-list
154479436|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154203340|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154479437|NCT04527393|Narcotics|narcotics|mesh-ancestor
154479438|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154479439|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479440|NCT04527393|Analgesics|analgesics|mesh-ancestor
154479441|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
154479442|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479443|NCT04520776|Meloxicam|meloxicam|mesh-list
154479444|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154479445|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154479446|NCT04520776|Analgesics|analgesics|mesh-ancestor
154479447|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
154479448|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479449|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479450|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479451|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479452|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154479453|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154479454|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479455|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479456|NCT04513925|Atezolizumab|atezolizumab|mesh-list
154479457|NCT04513925|Durvalumab|durvalumab|mesh-list
154479458|NCT04513925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479459|NCT04513925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479460|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479461|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479462|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
154479463|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154479464|NCT04509791|Antibodies|antibodies|mesh-list
154479465|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
154479466|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
154479467|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479469|NCT04503668|Dexamethasone|dexamethasone|mesh-list
154479470|NCT04503668|Ondansetron|ondansetron|mesh-list
154479471|NCT04503668|Olanzapine|olanzapine|mesh-list
154479472|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
154479473|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
154479474|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
154479475|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479476|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
154479477|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
154479478|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479479|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479480|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154479481|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
154479482|NCT04503668|Hormones|hormones|mesh-ancestor
154479483|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479484|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479485|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479486|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
154479487|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
154479488|NCT04503668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154479489|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154479490|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
154479491|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479492|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479493|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154479494|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154479495|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154479496|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154479497|NCT04503668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154479498|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154479499|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154479500|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154479501|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
154479502|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
154479503|NCT04503616|Abatacept|abatacept|mesh-list
154479504|NCT04503616|Tacrolimus|tacrolimus|mesh-list
154479505|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154479506|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
154479507|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479508|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479509|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154479510|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
154479511|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203417|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
154479512|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479513|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154479514|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154479515|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479516|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479517|NCT04503616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479518|NCT04496141|Antibodies|antibodies|mesh-list
154479519|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
154479520|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479521|NCT04491084|Antibodies|antibodies|mesh-list
154479522|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
154479523|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
154479524|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479525|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154479526|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154479527|NCT04491084|Protective Agents|protective agents|mesh-ancestor
154479528|NCT04470791|Antivenins|antivenins|mesh-list
154479529|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
154479530|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479531|NCT04462471|Vemurafenib|vemurafenib|mesh-list
154479532|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479533|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479534|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479535|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479536|NCT04431206|Oxytocin|oxytocin|mesh-list
154479537|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
154479538|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154479539|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479540|NCT04414540|Metformin|metformin|mesh-list
154479541|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
154479542|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154479543|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479544|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479545|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479546|NCT04414540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479547|NCT04414540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479548|NCT04401800|Lenvatinib|lenvatinib|mesh-list
154479549|NCT04401800|Tislelizumab|tislelizumab|mesh-list
154479550|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479551|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479552|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479553|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479554|NCT04401800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479555|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
154479556|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
154479557|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154479558|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154479559|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154479560|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479561|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479562|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479563|NCT04375033|Buprenorphine|buprenorphine|mesh-list
154479564|NCT04375033|Naloxone|naloxone|mesh-list
154479565|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154479566|NCT04375033|Narcotics|narcotics|mesh-ancestor
154479567|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154479568|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479569|NCT04375033|Analgesics|analgesics|mesh-ancestor
154479570|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
154479571|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479572|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154479573|NCT04372628|Ritonavir|ritonavir|mesh-list
154479574|NCT04372628|Lopinavir|lopinavir|mesh-list
154479575|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154479576|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154479577|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
154479578|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479579|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479580|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154479581|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154479582|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
154479583|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154479584|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154043395|NCT02729285|Ketorolac|ketorolac|mesh-list
154479585|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154203491|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154479586|NCT04367311|Docetaxel|docetaxel|mesh-list
154479587|NCT04367311|Pemetrexed|pemetrexed|mesh-list
154479589|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479590|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479591|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479592|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479593|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479594|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479595|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154479596|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154479597|NCT04367311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479598|NCT04367311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479599|NCT04336982|Azacitidine|azacitidine|mesh-list
154479600|NCT04336982|Venetoclax|venetoclax|mesh-list
154479601|NCT04336982|Gilteritinib|gilteritinib|mesh-list
154479602|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154479603|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
154479604|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479605|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479606|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479607|NCT04336982|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154479608|NCT04336982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479609|NCT04330820|Venetoclax|venetoclax|mesh-list
154479610|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479611|NCT04313504|Niraparib|niraparib|mesh-list
154479612|NCT04313504|Dostarlimab|dostarlimab|mesh-list
154479613|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154479614|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479615|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479616|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479617|NCT04305327|Ustekinumab|ustekinumab|mesh-list
154479618|NCT04305327|Brodalumab|brodalumab|mesh-list
154479619|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
154479620|NCT04302454|Leuprolide|leuprolide|mesh-list
154479621|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154479622|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
154479623|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154479624|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479625|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479626|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479627|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154479628|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154479629|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154479630|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154479631|NCT04285671|Trastuzumab|trastuzumab|mesh-list
154479632|NCT04285671|Necitumumab|necitumumab|mesh-list
154479633|NCT04285671|Osimertinib|osimertinib|mesh-list
154479634|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154479635|NCT04285671|Antibodies|antibodies|mesh-list
154479636|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
154479637|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154479638|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
154479639|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479640|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479641|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479642|NCT04285671|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154479643|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479644|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479645|NCT04251533|Paclitaxel|paclitaxel|mesh-list
154479646|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479647|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043432|NCT00636545|Oblimersen|oblimersen|mesh-list
154479648|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479649|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479650|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479651|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479652|NCT04249232|Abaloparatide|abaloparatide|mesh-list
154479653|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154479654|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479655|NCT04238819|Irinotecan|irinotecan|mesh-list
154479656|NCT04238819|Temozolomide|temozolomide|mesh-list
154479657|NCT04238819|Dinutuximab|dinutuximab|mesh-list
154479658|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154479659|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154479660|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479661|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479662|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203567|NCT00461630|Niacin|niacin|mesh-list
154479663|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154479664|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
154479665|NCT04238169|Bevacizumab|bevacizumab|mesh-list
154479666|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479667|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479668|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154479669|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154479670|NCT04238169|Growth Substances|growth substances|mesh-ancestor
154479671|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479672|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
154479673|NCT04214834|Morphine|morphine|mesh-list
154479674|NCT04214834|Methadone|methadone|mesh-list
154479675|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154479676|NCT04214834|Narcotics|narcotics|mesh-ancestor
154479677|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154479678|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479679|NCT04214834|Analgesics|analgesics|mesh-ancestor
154479680|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
154479681|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479682|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
154479683|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
154479684|NCT04208178|Trastuzumab|trastuzumab|mesh-list
154479685|NCT04208178|Pertuzumab|pertuzumab|mesh-list
154479686|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479687|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479688|NCT04207944|Sulindac|sulindac|mesh-list
154479689|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154479690|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154479691|NCT04207944|Analgesics|analgesics|mesh-ancestor
154479692|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
154479693|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479694|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479695|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479696|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479697|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479698|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154479699|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479700|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479701|NCT04193215|Vaccines|vaccines|mesh-list
154479702|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
154479703|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479704|NCT04124588|Hemostatics|hemostatics|mesh-list
154479705|NCT04124588|Coagulants|coagulants|mesh-ancestor
154479706|NCT04122443|Acetaminophen|acetaminophen|mesh-list
154479707|NCT04122443|Oxycodone|oxycodone|mesh-list
154479708|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154479709|NCT04122443|Analgesics|analgesics|mesh-ancestor
154479710|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
154479711|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479712|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479713|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
154479714|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154479715|NCT04122443|Narcotics|narcotics|mesh-ancestor
154479716|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154479717|NCT04103398|Sorafenib|sorafenib|mesh-list
154479718|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
154479719|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479720|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479721|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479722|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479723|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154479724|NCT04103398|Estrogens|estrogens|mesh-ancestor
154479725|NCT04103398|Hormones|hormones|mesh-ancestor
154479726|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479727|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479728|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479729|NCT04083963|Paclitaxel|paclitaxel|mesh-list
154479730|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
154479731|NCT04083963|Carboplatin|carboplatin|mesh-list
154479732|NCT04083963|Doxorubicin|doxorubicin|mesh-list
154479733|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479734|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479735|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479736|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479737|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479738|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479739|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154479740|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
154479741|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479742|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479743|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154479744|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
154479745|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154479746|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154479747|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154479748|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154479749|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479750|NCT04078269|Immunomodulating Agents|immunomodulating agents|mesh-list
154479751|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
154479752|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479753|NCT04075396|Lazertinib|lazertinib|mesh-list
154479754|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479755|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479756|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479757|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
154479758|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479759|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479760|NCT04074759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479761|NCT04074759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479762|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
154479763|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479764|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
154479765|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154479766|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154479767|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479768|NCT04058132|Urological Agents|urological agents|mesh-ancestor
154479769|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
154479770|NCT04042155|Apixaban|apixaban|mesh-list
154479771|NCT04042155|Edoxaban|edoxaban|mesh-list
154479772|NCT04042155|Dabigatran|dabigatran|mesh-list
154479773|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154479774|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
154479775|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154479776|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
154479777|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479778|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479779|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
154479780|NCT04001829|Paclitaxel|paclitaxel|mesh-list
154479781|NCT04001829|Docetaxel|docetaxel|mesh-list
154479782|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154479783|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479784|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479785|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479786|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479787|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479788|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479789|NCT03993535|Serotonin|serotonin|mesh-list
154479790|NCT03993535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154479791|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154479792|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
154479793|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479794|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479795|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479796|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154479797|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154479798|NCT03982693|Edetic Acid|edetic acid|mesh-list
154479799|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
154479800|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
154479801|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154479802|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
154479803|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
154479804|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479805|NCT03982693|Antidotes|antidotes|mesh-ancestor
154479806|NCT03982693|Protective Agents|protective agents|mesh-ancestor
154479807|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479808|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154479809|NCT03976362|Paclitaxel|paclitaxel|mesh-list
154479810|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154479811|NCT03976362|Carboplatin|carboplatin|mesh-list
154479812|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
154479813|NCT03976362|Olaparib|olaparib|mesh-list
154479814|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479815|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479816|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479817|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479818|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479819|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479820|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479821|NCT03976362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154479822|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154479823|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479824|NCT03975829|Trametinib|trametinib|mesh-list
154479825|NCT03975829|Dabrafenib|dabrafenib|mesh-list
154479826|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479827|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479828|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479829|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479830|NCT03968653|Carboplatin|carboplatin|mesh-list
154479831|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479832|NCT03965468|Paclitaxel|paclitaxel|mesh-list
154479833|NCT03965468|Carboplatin|carboplatin|mesh-list
154479834|NCT03965468|Durvalumab|durvalumab|mesh-list
154479835|NCT03965468|Tremelimumab|tremelimumab|mesh-list
154479836|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154479837|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479838|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479839|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479840|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
154860681|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479841|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479842|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479843|NCT03961568|Cenobamate|cenobamate|mesh-list
154479844|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
154479845|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
154860682|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479846|NCT03959085|Leucovorin|leucovorin|mesh-list
154479847|NCT03959085|Folic Acid|folic acid|mesh-list
154479848|NCT03959085|Cytarabine|cytarabine|mesh-list
154479849|NCT03959085|Dexamethasone|dexamethasone|mesh-list
154479850|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
154479851|NCT03959085|Prednisolone|prednisolone|mesh-list
154479852|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154479853|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
154479854|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154479855|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
154479856|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
154479857|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154479858|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154479859|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154479860|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
154479861|NCT03959085|Doxorubicin|doxorubicin|mesh-list
154479862|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154479863|NCT03959085|Methotrexate|methotrexate|mesh-list
154479864|NCT03959085|Vincristine|vincristine|mesh-list
154479865|NCT03959085|Daunorubicin|daunorubicin|mesh-list
154479866|NCT03959085|Asparaginase|asparaginase|mesh-list
154479867|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
154479868|NCT03959085|Pegaspargase|pegaspargase|mesh-list
154479869|NCT03959085|Thioguanine|thioguanine|mesh-list
154479870|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154479871|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154479872|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
154479873|NCT03959085|BB 1101|bb 1101|mesh-list
154479874|NCT03959085|Calcium|calcium|mesh-list
154479875|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
154479876|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
154479877|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154479878|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
154479879|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479880|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154479881|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154479882|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
154479883|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479884|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479885|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154479886|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154479887|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
154479888|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
154479889|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203792|NCT00320385|Trastuzumab|trastuzumab|mesh-list
154479890|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154479891|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
154479892|NCT03959085|Hormones|hormones|mesh-ancestor
154479893|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154479894|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154479895|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
154479896|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479897|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154479898|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154479899|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154479900|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154479901|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154479902|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154479903|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
154479904|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154479905|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154479906|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
154479907|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
154479908|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154479909|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154479910|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
154479911|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154479912|NCT03959085|Antidotes|antidotes|mesh-ancestor
154479913|NCT03959085|Protective Agents|protective agents|mesh-ancestor
154479914|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
154479916|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
154479917|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154860683|NCT01925300|Bisoprolol|bisoprolol|mesh-list
154479918|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
154479919|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
154479920|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
154479921|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154479922|NCT03959085|Hematinics|hematinics|mesh-ancestor
154479923|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479924|NCT03959085|Immunotoxins|immunotoxins|mesh-ancestor
154479925|NCT03959085|Immunoconjugates|immunoconjugates|mesh-ancestor
154479926|NCT03950271|Capecitabine|capecitabine|mesh-list
154479927|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
154479928|NCT03950271|Trastuzumab|trastuzumab|mesh-list
154479929|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154479930|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
154479931|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479932|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479933|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479934|NCT03946111|Naltrexone|naltrexone|mesh-list
154479935|NCT03946111|Bupropion|bupropion|mesh-list
154479936|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154479937|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154479938|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479939|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
154479940|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479941|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154479942|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
154479943|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154479944|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154479945|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154479946|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154479947|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479948|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
154479949|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479950|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154479951|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154479952|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479953|NCT03945305|Antihypertensive Agents|antihypertensive agents|mesh-list
154479954|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
154479955|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154479956|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479957|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479958|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479959|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154479960|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154479961|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154479962|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479963|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154479964|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154479965|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154479966|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479967|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
154479968|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479969|NCT03899428|Sorafenib|sorafenib|mesh-list
154479970|NCT03899428|Durvalumab|durvalumab|mesh-list
154479971|NCT03899428|Lenvatinib|lenvatinib|mesh-list
154479972|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154479973|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154479974|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154479975|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479976|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154479977|NCT03877991|Cannabidiol|cannabidiol|mesh-list
154479978|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
154479979|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154479980|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154479981|NCT03825536|Methamphetamine|methamphetamine|mesh-list
154479982|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154479983|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154479984|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
154479985|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
154479986|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154479987|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
154479988|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154479989|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154479990|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
154043791|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154479991|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154479992|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154479993|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154479994|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154860684|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154860685|NCT01925300|Calcium|calcium|mesh-list
154479995|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
154479996|NCT03825289|Trametinib|trametinib|mesh-list
154479997|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
154479998|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154479999|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154480000|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480001|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480002|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480003|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480004|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480005|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480006|NCT03822897|Cisplatin|cisplatin|mesh-list
154480007|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480008|NCT03815448|Methotrexate|methotrexate|mesh-list
154480009|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154480010|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
154480011|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154480012|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480013|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480014|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
154480015|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480016|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480017|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
154480018|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480019|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154480020|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480021|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
154480022|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480023|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480024|NCT03807817|Ethanol|ethanol|mesh-list
154480025|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154480026|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480027|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154480028|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480029|NCT03794349|Eflornithine|eflornithine|mesh-list
154480030|NCT03794349|Irinotecan|irinotecan|mesh-list
154480031|NCT03794349|Camptothecin|camptothecin|mesh-list
154480032|NCT03794349|Temozolomide|temozolomide|mesh-list
154480033|NCT03794349|Dinutuximab|dinutuximab|mesh-list
154480034|NCT03794349|Sargramostim|sargramostim|mesh-list
154480035|NCT03794349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154480036|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154480037|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154480038|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480039|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480040|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480041|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154480042|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
154480043|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
154480044|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480045|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154480046|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154480047|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154480048|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154480049|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480050|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154480051|NCT03785106|Vitamins|vitamins|mesh-list
154480052|NCT03785106|Pyridoxine|pyridoxine|mesh-list
154480053|NCT03785106|Pyridoxal|pyridoxal|mesh-list
154480054|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
154480055|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
154480056|NCT03785106|Isoniazid|isoniazid|mesh-list
154480057|NCT03785106|Rifapentine|rifapentine|mesh-list
154480058|NCT03785106|Rifampin|rifampin|mesh-list
154480059|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
154480060|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480061|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
154480062|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154480063|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480064|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154480065|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154480066|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
154480067|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480068|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154480069|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154480070|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
154480071|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480072|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480073|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154480074|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154480075|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154480076|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154480077|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154480078|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154480079|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
154480080|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480081|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480082|NCT03783078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480083|NCT03783078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480084|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
154480085|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480086|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480087|NCT03757689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480088|NCT03757689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480089|NCT03732820|Olaparib|olaparib|mesh-list
154480090|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
154480091|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154480092|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480093|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480094|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480095|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154480096|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
154480097|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480098|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480099|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154480100|NCT03725878|Folic Acid|folic acid|mesh-list
154480101|NCT03725878|Hematinics|hematinics|mesh-ancestor
154480102|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
154480103|NCT03725878|Vitamins|vitamins|mesh-ancestor
154480104|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
154480105|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480106|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
154480107|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154480108|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
154480109|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480110|NCT03707951|Expectorants|expectorants|mesh-ancestor
154480111|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
154480112|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154480113|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
154480114|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480115|NCT03707951|Protective Agents|protective agents|mesh-ancestor
154480116|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480117|NCT03707951|Antidotes|antidotes|mesh-ancestor
154480118|NCT03706690|Durvalumab|durvalumab|mesh-list
154480119|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480120|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480121|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
154480122|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480123|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480124|NCT03671330|Letrozole|letrozole|mesh-list
154480125|NCT03671330|Goserelin|goserelin|mesh-list
154480126|NCT03671330|Anastrozole|anastrozole|mesh-list
154480127|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480128|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154480129|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154480130|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480131|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480132|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154480133|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
154480134|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480135|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480136|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154480137|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154480138|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
154480139|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480140|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
154480141|NCT03589339|Nivolumab|nivolumab|mesh-list
154480142|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480144|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480145|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480146|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
154480147|NCT03582280|Calcium|calcium|mesh-list
154480148|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154480149|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480150|NCT03582280|Antacids|antacids|mesh-ancestor
154480151|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480152|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480153|NCT03554018|Acetaminophen|acetaminophen|mesh-list
154480154|NCT03554018|Ibuprofen|ibuprofen|mesh-list
154480155|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154480156|NCT03554018|Analgesics|analgesics|mesh-ancestor
154480157|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
154480158|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480159|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480160|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
154480161|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154480162|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154480163|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480164|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154480165|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480166|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480167|NCT03523221|Dexamethasone|dexamethasone|mesh-list
154480168|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154480169|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
154480170|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
154480171|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480172|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480173|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480174|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
154480175|NCT03523221|Hormones|hormones|mesh-ancestor
154043969|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154480176|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480177|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154480178|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480179|NCT03501368|Trametinib|trametinib|mesh-list
154480180|NCT03501368|Ceritinib|ceritinib|mesh-list
154480181|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480182|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480183|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480184|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480185|NCT03501368|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154480186|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
154480187|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154480188|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
154480189|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204092|NCT00443534|Sunitinib|sunitinib|mesh-list
154480190|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
154480191|NCT03491761|Protective Agents|protective agents|mesh-ancestor
154480192|NCT03477175|Sorafenib|sorafenib|mesh-list
154480193|NCT03477175|Lenvatinib|lenvatinib|mesh-list
154480194|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480195|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480196|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480197|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480198|NCT03475004|Bevacizumab|bevacizumab|mesh-list
154480199|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
154480200|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480201|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480202|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154480203|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154480204|NCT03475004|Growth Substances|growth substances|mesh-ancestor
154480205|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480206|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
154480207|NCT03475004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480208|NCT03475004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480209|NCT03467958|Ozanimod|ozanimod|mesh-list
154480210|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154480211|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480212|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480213|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
154480214|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480215|NCT03440372|Ozanimod|ozanimod|mesh-list
154480216|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154480217|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480218|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480219|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
154480220|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480221|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
154480222|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480223|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480224|NCT03414229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480225|NCT03414229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480226|NCT03355560|Nivolumab|nivolumab|mesh-list
154480227|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480228|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480229|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480230|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480231|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
154480232|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480233|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480234|NCT03340506|Trametinib|trametinib|mesh-list
154480235|NCT03340506|Dabrafenib|dabrafenib|mesh-list
154480236|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480237|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480238|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480239|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480240|NCT03242915|Carboplatin|carboplatin|mesh-list
154480241|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
154480242|NCT03242915|Pemetrexed|pemetrexed|mesh-list
154480243|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480244|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480245|NCT03242915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480246|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480247|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480248|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154480249|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480250|NCT03241706|Glucagon|glucagon|mesh-list
154480251|NCT03241706|Somatostatin|somatostatin|mesh-list
154480252|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480253|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480254|NCT03241706|Hormones|hormones|mesh-ancestor
154480255|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480256|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
154480257|NCT03233854|Fludarabine|fludarabine|mesh-list
154480258|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
154480259|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480260|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
154480261|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480262|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480263|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154480264|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
154480265|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480266|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480267|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154480268|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480269|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
154480270|NCT03190239|Pemetrexed|pemetrexed|mesh-list
154480271|NCT03190239|Apatinib|apatinib|mesh-list
154480272|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480273|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480274|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480275|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154480276|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480277|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480278|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154480279|NCT03179163|Enalapril|enalapril|mesh-list
154480280|NCT03179163|Captopril|captopril|mesh-list
154480281|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154480282|NCT03179163|Diuretics|diuretics|mesh-ancestor
154480283|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
154480284|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480285|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154480286|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154480287|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480288|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154480289|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
154480290|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480291|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
154480292|NCT03057314|Calcium|calcium|mesh-list
154480293|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154480294|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480295|NCT03057314|Antacids|antacids|mesh-ancestor
154480296|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480297|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480298|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
154480299|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154480300|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
154480301|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480302|NCT03055377|Expectorants|expectorants|mesh-ancestor
154480303|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
154480304|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154480305|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
154480306|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480307|NCT03055377|Protective Agents|protective agents|mesh-ancestor
154480308|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480309|NCT03055377|Antidotes|antidotes|mesh-ancestor
154480310|NCT03051516|Vaccines|vaccines|mesh-list
154480311|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
154480312|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480313|NCT03041688|Venetoclax|venetoclax|mesh-list
154480314|NCT03041688|Decitabine|decitabine|mesh-list
154480315|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480316|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480317|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
154480318|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480319|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480320|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
154480321|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480322|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480323|NCT03012620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480324|NCT03012620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480325|NCT03012581|Nivolumab|nivolumab|mesh-list
154480326|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480327|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480328|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480329|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480330|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
154480331|NCT02981628|Leucovorin|leucovorin|mesh-list
154480332|NCT02981628|Folic Acid|folic acid|mesh-list
154480333|NCT02981628|Cytarabine|cytarabine|mesh-list
154480334|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
154480335|NCT02981628|Methotrexate|methotrexate|mesh-list
154480336|NCT02981628|Vincristine|vincristine|mesh-list
154480337|NCT02981628|Asparaginase|asparaginase|mesh-list
154204230|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480338|NCT02981628|Pegaspargase|pegaspargase|mesh-list
154480339|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154480340|NCT02981628|Calcium|calcium|mesh-list
154480341|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
154480342|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480343|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
154480344|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480345|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480346|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154480347|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
154480348|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480349|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480350|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154480351|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154480352|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154480353|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154480354|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
154480355|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154480356|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480357|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
154480358|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
154480359|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480360|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154480361|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480362|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
154480363|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480364|NCT02981628|Antidotes|antidotes|mesh-ancestor
154480365|NCT02981628|Protective Agents|protective agents|mesh-ancestor
154480366|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
154480368|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
154480369|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154480370|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
154480371|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
154480372|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
154480373|NCT02981628|Hematinics|hematinics|mesh-ancestor
154480374|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480375|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154480376|NCT02981628|Immunotoxins|immunotoxins|mesh-ancestor
154480377|NCT02981628|Immunoconjugates|immunoconjugates|mesh-ancestor
154480378|NCT02914366|Ambroxol|ambroxol|mesh-list
154480379|NCT02914366|Expectorants|expectorants|mesh-ancestor
154480380|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
154480381|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
154480382|NCT02864784|Calcium|calcium|mesh-list
154480383|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154480384|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480385|NCT02864784|Antacids|antacids|mesh-ancestor
154480386|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480387|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480388|NCT02794571|Paclitaxel|paclitaxel|mesh-list
154480389|NCT02794571|Etoposide|etoposide|mesh-list
154480390|NCT02794571|Bevacizumab|bevacizumab|mesh-list
154480391|NCT02794571|Carboplatin|carboplatin|mesh-list
154480392|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
154480393|NCT02794571|Capecitabine|capecitabine|mesh-list
154480394|NCT02794571|Pemetrexed|pemetrexed|mesh-list
154480395|NCT02794571|Atezolizumab|atezolizumab|mesh-list
154480396|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154480397|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480398|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
154480399|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
154480400|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
154480401|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480402|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480403|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154480404|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154480405|NCT02794571|Growth Substances|growth substances|mesh-ancestor
154480406|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480407|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
154480408|NCT02794571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480409|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480410|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
154480411|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154480412|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154480413|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480414|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154480415|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480416|NCT02790515|Sirolimus|sirolimus|mesh-list
154204304|NCT00441974|Adefovir|adefovir|mesh-list
154480417|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
154480418|NCT02790515|Melphalan|melphalan|mesh-list
154480419|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
154480420|NCT02790515|Thiotepa|thiotepa|mesh-list
154480421|NCT02790515|Rituximab|rituximab|mesh-list
154480422|NCT02790515|Fludarabine|fludarabine|mesh-list
154480423|NCT02790515|Blinatumomab|blinatumomab|mesh-list
154480424|NCT02790515|Tacrolimus|tacrolimus|mesh-list
154480425|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
154480426|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154480427|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480428|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
154480429|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480430|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480431|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154480432|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
154480433|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480434|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480435|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154480436|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480437|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154480438|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480439|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154480440|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480441|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154480442|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
154480443|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154480445|NCT02773030|Dexamethasone|dexamethasone|mesh-list
154480446|NCT02773030|Bortezomib|bortezomib|mesh-list
154480447|NCT02773030|Daratumumab|daratumumab|mesh-list
154480448|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044277|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154044278|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
154044279|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044280|NCT02732405|Grazoprevir|grazoprevir|mesh-list
154480449|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
154480450|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
154480451|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480452|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480453|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480454|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
154480455|NCT02773030|Hormones|hormones|mesh-ancestor
154480456|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480457|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154480458|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480459|NCT02766322|Ethanol|ethanol|mesh-list
154480460|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154480461|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480462|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154480463|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480464|NCT02735707|Aspirin|aspirin|mesh-list
154480465|NCT02735707|Vitamins|vitamins|mesh-list
154480466|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
154480467|NCT02735707|Interferons|interferons|mesh-list
154480468|NCT02735707|Ritonavir|ritonavir|mesh-list
154480469|NCT02735707|Lopinavir|lopinavir|mesh-list
154480470|NCT02735707|Interferon-beta|interferon-beta|mesh-list
154480471|NCT02735707|Oseltamivir|oseltamivir|mesh-list
154480472|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
154480473|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
154480474|NCT02735707|Remdesivir|remdesivir|mesh-list
154480475|NCT02735707|Nirmatrelvir|nirmatrelvir|mesh-list
154480476|NCT02735707|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154480477|NCT02735707|Baloxavir|baloxavir|mesh-list
154480478|NCT02735707|Amoxicillin|amoxicillin|mesh-list
154480479|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
154480480|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
154480481|NCT02735707|Levofloxacin|levofloxacin|mesh-list
154480482|NCT02735707|Ivermectin|ivermectin|mesh-list
154480483|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
154480484|NCT02735707|Tazobactam|tazobactam|mesh-list
154480485|NCT02735707|Piperacillin|piperacillin|mesh-list
154480486|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
154480487|NCT02735707|Ceftaroline|ceftaroline|mesh-list
154480488|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154480489|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154480490|NCT02735707|Dexamethasone|dexamethasone|mesh-list
154480491|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
154480492|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154480493|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154480494|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154480495|NCT02735707|Apremilast|apremilast|mesh-list
154480496|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154480497|NCT02735707|Losartan|losartan|mesh-list
154480498|NCT02735707|Valsartan|valsartan|mesh-list
154480499|NCT02735707|Telmisartan|telmisartan|mesh-list
154480500|NCT02735707|Candesartan|candesartan|mesh-list
154480501|NCT02735707|Ramipril|ramipril|mesh-list
154480502|NCT02735707|Olmesartan|olmesartan|mesh-list
154480503|NCT02735707|Enalapril|enalapril|mesh-list
154480504|NCT02735707|Lisinopril|lisinopril|mesh-list
154480505|NCT02735707|Irbesartan|irbesartan|mesh-list
154480506|NCT02735707|Perindopril|perindopril|mesh-list
154480507|NCT02735707|Captopril|captopril|mesh-list
154480508|NCT02735707|Trandolapril|trandolapril|mesh-list
154480509|NCT02735707|Clopidogrel|clopidogrel|mesh-list
154480510|NCT02735707|Ticagrelor|ticagrelor|mesh-list
154480511|NCT02735707|Simvastatin|simvastatin|mesh-list
154480512|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154480513|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
154480514|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154044281|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
154480515|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154480516|NCT02735707|Cysteamine|cysteamine|mesh-list
154480517|NCT02735707|Immunomodulating Agents|immunomodulating agents|mesh-list
154480518|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
154480519|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480520|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154480521|NCT02735707|Antiemetics|antiemetics|mesh-ancestor
154480522|NCT02735707|Autonomic Agents|autonomic agents|mesh-ancestor
154480523|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480524|NCT02735707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480525|NCT02735707|Glucocorticoids|glucocorticoids|mesh-ancestor
154480526|NCT02735707|Hormones|hormones|mesh-ancestor
154480527|NCT02735707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480528|NCT02735707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154480529|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480530|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480531|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154480532|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154480534|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
154480535|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480536|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154480537|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154480538|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480539|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154480540|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154480541|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
154480542|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154480543|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154480544|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
154480545|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154480546|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154480547|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154480548|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154480549|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154480550|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154480551|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154480552|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
154480553|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154480554|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154480555|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154480556|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154480557|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
154480558|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154480559|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154480560|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154480561|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154480562|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
154480563|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154480564|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154480565|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
154480566|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154480567|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154480568|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
154480569|NCT02735707|Protective Agents|protective agents|mesh-ancestor
154480570|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154480571|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154480572|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154480573|NCT02735707|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154480574|NCT02735707|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154480575|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154480576|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154480577|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154480578|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154480579|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154480580|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154480581|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
154480582|NCT02724579|Lomustine|lomustine|mesh-list
154480583|NCT02724579|Cisplatin|cisplatin|mesh-list
154480584|NCT02724579|Vincristine|vincristine|mesh-list
154480585|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480586|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
154480587|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480588|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480589|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154480590|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
154480591|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480592|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480593|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154480594|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154480595|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
154480596|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
154480597|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
154480598|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154480599|NCT02616965|Romidepsin|romidepsin|mesh-list
154480600|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480601|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480603|NCT02616965|Immunoconjugates|immunoconjugates|mesh-ancestor
154480604|NCT02616965|Immunologic Factors|immunologic factors|mesh-ancestor
154480605|NCT02616965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480606|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154480607|NCT02616965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154480608|NCT02616965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480609|NCT02616965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480610|NCT02584933|Ceritinib|ceritinib|mesh-list
154480611|NCT02584933|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154480612|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480613|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480614|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480615|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480616|NCT02484404|Durvalumab|durvalumab|mesh-list
154480617|NCT02484404|Olaparib|olaparib|mesh-list
154480618|NCT02484404|Cediranib|cediranib|mesh-list
154480619|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480620|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480621|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154480622|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480623|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480624|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480625|NCT02471430|Interferons|interferons|mesh-list
154480626|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
154480627|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
154480628|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154480629|NCT02471430|Panobinostat|panobinostat|mesh-list
154480630|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480631|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
154480632|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480633|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
154480634|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480635|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154480636|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480637|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480638|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
154480639|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154480640|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154480641|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480642|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
154480643|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
154480644|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480645|NCT02390427|Paclitaxel|paclitaxel|mesh-list
154480646|NCT02390427|Maytansine|maytansine|mesh-list
154480647|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154480648|NCT02390427|Trastuzumab|trastuzumab|mesh-list
154480649|NCT02390427|Pertuzumab|pertuzumab|mesh-list
154480650|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154480651|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204538|NCT00418938|Antidotes|antidotes|mesh-ancestor
154480652|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
154480653|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
154480654|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
154480655|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480656|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480657|NCT02390427|Immunotoxins|immunotoxins|mesh-ancestor
154480658|NCT02390427|Immunoconjugates|immunoconjugates|mesh-ancestor
154480659|NCT02390427|Immunologic Factors|immunologic factors|mesh-ancestor
154480660|NCT02390427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480661|NCT02389309|Sirolimus|sirolimus|mesh-list
154480662|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
154480663|NCT02389309|Temsirolimus|temsirolimus|mesh-list
154480664|NCT02389309|Dasatinib|dasatinib|mesh-list
154480665|NCT02389309|MTOR Inhibitors|mtor inhibitors|mesh-list
154480666|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480667|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
154480668|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480669|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480670|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154480671|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
154480672|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480673|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480674|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154480676|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480677|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154480678|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
154480679|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480680|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480681|NCT02389309|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154480682|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
154480683|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154480684|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154480685|NCT02378298|Prednisolone|prednisolone|mesh-list
154480686|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
154480687|NCT02378298|Rituximab|rituximab|mesh-list
154480688|NCT02378298|Methotrexate|methotrexate|mesh-list
154480689|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154480690|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
154480691|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480692|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480693|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
154480694|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480695|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480696|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154480697|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
154480698|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154480699|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480700|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
154480701|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480702|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
154480703|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480704|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154480705|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480706|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480707|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154480708|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
154480709|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
154480710|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480711|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480712|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
154480713|NCT02378298|Hormones|hormones|mesh-ancestor
154480714|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480715|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154480716|NCT02378298|Protective Agents|protective agents|mesh-ancestor
154480717|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154480718|NCT02359968|Paclitaxel|paclitaxel|mesh-list
154480719|NCT02359968|Fluorouracil|fluorouracil|mesh-list
154480720|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
154480721|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154480722|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480723|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
154480724|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
154480725|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
154480726|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480727|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
154480728|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480729|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480730|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
154480731|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480732|NCT02326974|Pertuzumab|pertuzumab|mesh-list
154480733|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480734|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480735|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
154480736|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480737|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480738|NCT02318771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154480739|NCT02318771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480740|NCT02283281|Dronabinol|dronabinol|mesh-list
154480741|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
154480742|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480743|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154480744|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154480745|NCT02283281|Analgesics|analgesics|mesh-ancestor
154480746|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
154480747|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480748|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154480750|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154480751|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480752|NCT02283281|Hormones|hormones|mesh-ancestor
154480753|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480754|NCT02281084|Azacitidine|azacitidine|mesh-list
154480755|NCT02281084|Durvalumab|durvalumab|mesh-list
154480756|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480757|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
154480758|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480759|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480760|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480761|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154480762|NCT02159989|Aflibercept|aflibercept|mesh-list
154480763|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
154480764|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154480765|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154480766|NCT02159989|Growth Substances|growth substances|mesh-ancestor
154480767|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480768|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
154480769|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480770|NCT02126579|Resiquimod|resiquimod|mesh-list
154480771|NCT02126579|Poly ICLC|poly iclc|mesh-list
154480772|NCT02126579|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154480773|NCT02126579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480774|NCT02126579|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154480775|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
154480776|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480777|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
154480778|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
154480779|NCT01953900|Fludarabine|fludarabine|mesh-list
154480780|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480781|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
154480782|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480783|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480784|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154480785|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
154480786|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480787|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480788|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154480789|NCT01935778|Docetaxel|docetaxel|mesh-list
154480790|NCT01935778|Capecitabine|capecitabine|mesh-list
154480791|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
154480792|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480793|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
154480794|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154480795|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154480796|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480797|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480798|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
154480799|NCT01935713|Nicotine|nicotine|mesh-list
154480800|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154480801|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
154480802|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480803|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480804|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154480805|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154480806|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
154480807|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154480808|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480809|NCT01892371|Cytarabine|cytarabine|mesh-list
154480810|NCT01892371|Azacitidine|azacitidine|mesh-list
154480811|NCT01892371|Quizartinib|quizartinib|mesh-list
154480812|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154480813|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
154480814|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480815|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480816|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
154480817|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480818|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480819|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
154480820|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480821|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480822|NCT01892371|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154480823|NCT01892371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480825|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154480826|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154480827|NCT01886872|Antibodies|antibodies|mesh-list
154480828|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
154480829|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154480830|NCT01886872|Ibrutinib|ibrutinib|mesh-list
154480831|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
154480832|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480833|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480834|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480835|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154480836|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
154480837|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480838|NCT01886872|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154480839|NCT01886872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480840|NCT01886872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480841|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154480842|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154480843|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154480844|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
154480845|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480846|NCT01793519|Adalimumab|adalimumab|mesh-list
154480847|NCT01793519|Infliximab|infliximab|mesh-list
154480848|NCT01793519|Etanercept|etanercept|mesh-list
154480849|NCT01793519|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154480850|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154480851|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480852|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
154480853|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480854|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154480855|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154480856|NCT01793519|Analgesics|analgesics|mesh-ancestor
154480857|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
154480858|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480859|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480860|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154480861|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
154480862|NCT01764633|Evolocumab|evolocumab|mesh-list
154480863|NCT01764633|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154480864|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154480865|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154480866|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
154480867|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480868|NCT01764633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154480869|NCT01764633|Protease Inhibitors|protease inhibitors|mesh-ancestor
154480870|NCT01764633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480871|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154480872|NCT01724190|Vitamin D|vitamin d|mesh-list
154480873|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
154480874|NCT01724190|Vitamins|vitamins|mesh-ancestor
154480875|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
154480876|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480877|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154204756|NCT00405756|Aspirin|aspirin|mesh-list
154480878|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154480880|NCT01719016|Analgesics|analgesics|mesh-ancestor
154480881|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
154480882|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480883|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480884|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154480885|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
154480886|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154480887|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
154480888|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
154480889|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154480890|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480891|NCT01334957|Ibuprofen|ibuprofen|mesh-list
154480892|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154480893|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154480894|NCT01334957|Analgesics|analgesics|mesh-ancestor
154480895|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
154480896|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154480897|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480898|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154480899|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154480900|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154480901|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480902|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480904|NCT01167712|Bevacizumab|bevacizumab|mesh-list
154480905|NCT01167712|Carboplatin|carboplatin|mesh-list
154480906|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154480907|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154480908|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
154480909|NCT01167712|Antibodies|antibodies|mesh-list
154480910|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
154480911|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154480912|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
154480913|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154480914|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480915|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
154480916|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
154480917|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
154480918|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480919|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154480920|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154480921|NCT01167712|Growth Substances|growth substances|mesh-ancestor
154480922|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480923|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
154480924|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
154480925|NCT01116648|Olaparib|olaparib|mesh-list
154480926|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154480927|NCT01116648|Cediranib|cediranib|mesh-list
154480928|NCT01116648|Maleic acid|maleic acid|mesh-list
154480929|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480930|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480931|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480932|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154480933|NCT01001910|Carboplatin|carboplatin|mesh-list
154480934|NCT01001910|Pemetrexed|pemetrexed|mesh-list
154480935|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480936|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480937|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480938|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154480939|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480940|NCT00618657|Paclitaxel|paclitaxel|mesh-list
154480941|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154480942|NCT00618657|Bevacizumab|bevacizumab|mesh-list
154480943|NCT00618657|Carboplatin|carboplatin|mesh-list
154480944|NCT00618657|Trastuzumab|trastuzumab|mesh-list
154480945|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154480946|NCT00618657|Antibodies|antibodies|mesh-list
154480947|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
154480948|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154480949|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154480950|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154480951|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
154480952|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204846|NCT00410514|Mirabegron|mirabegron|mesh-list
154480954|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480955|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154480956|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154480957|NCT00618657|Growth Substances|growth substances|mesh-ancestor
154480958|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480959|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
154480960|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
154480961|NCT00609154|Glucagon|glucagon|mesh-list
154480962|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154480963|NCT00609154|Incretins|incretins|mesh-list
154480964|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154480965|NCT00609154|Hormones|hormones|mesh-ancestor
154480966|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154480967|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154480968|NCT00476606|Ritonavir|ritonavir|mesh-list
154480969|NCT00476606|Nelfinavir|nelfinavir|mesh-list
154480970|NCT00476606|Indinavir|indinavir|mesh-list
154480971|NCT00476606|Saquinavir|saquinavir|mesh-list
154480972|NCT00476606|Lamivudine|lamivudine|mesh-list
154480973|NCT00476606|Zidovudine|zidovudine|mesh-list
154480974|NCT00476606|Nevirapine|nevirapine|mesh-list
154480975|NCT00476606|Didanosine|didanosine|mesh-list
154480976|NCT00476606|Stavudine|stavudine|mesh-list
154480977|NCT00476606|Efavirenz|efavirenz|mesh-list
154480978|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154480979|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154480980|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
154480981|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154480982|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154480983|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154480984|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154480985|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
154480986|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154480987|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154480988|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154480989|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154480990|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154480991|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
154480992|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154044755|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
154480993|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154480994|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154480995|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154480996|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154480997|NCT00304070|Cisplatin|cisplatin|mesh-list
154480998|NCT00304070|Doxorubicin|doxorubicin|mesh-list
154480999|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154481000|NCT00304070|Etoposide|etoposide|mesh-list
154481001|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
154481002|NCT00304070|Podophyllotoxin|podophyllotoxin|mesh-list
154481003|NCT00304070|Mitotane|mitotane|mesh-list
154481004|NCT00304070|Lenograstim|lenograstim|mesh-list
154481005|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481006|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154481007|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154481008|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154481009|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481010|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481011|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154481012|NCT00304070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154481013|NCT00304070|Immunologic Factors|immunologic factors|mesh-ancestor
154481014|NCT00304070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481015|NCT00304070|Keratolytic Agents|keratolytic agents|mesh-ancestor
154481016|NCT00304070|Dermatologic Agents|dermatologic agents|mesh-ancestor
154481017|NCT00304070|Tubulin Modulators|tubulin modulators|mesh-ancestor
154481018|NCT00304070|Antimitotic Agents|antimitotic agents|mesh-ancestor
154481019|NCT00304070|Mitosis Modulators|mitosis modulators|mesh-ancestor
154481020|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154481021|NCT02126943|Macitentan|macitentan|mesh-list
154481022|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154481023|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154481024|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481025|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154481026|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154481027|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154481028|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481029|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
154481030|NCT00150462|Dexamethasone|dexamethasone|mesh-list
154481031|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481032|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
154481033|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
154481034|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481035|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481036|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154481037|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
154481038|NCT00150462|Hormones|hormones|mesh-ancestor
154481039|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154481040|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154481041|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481042|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154481043|NCT00095550|Irbesartan|irbesartan|mesh-list
154481044|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154481045|NCT00095550|Diuretics|diuretics|mesh-ancestor
154481046|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
154481047|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481048|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154481049|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154481050|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481052|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154481053|NCT00095394|Irbesartan|irbesartan|mesh-list
154481054|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154481055|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154481056|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154481057|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481058|NCT00093132|Satraplatin|satraplatin|mesh-list
154481059|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481060|NCT00080106|Vaccines|vaccines|mesh-list
154481061|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
154481062|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481063|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
154481064|NCT00333216|Anecortave|anecortave|mesh-list
154481065|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154481066|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154481067|NCT00333216|Growth Substances|growth substances|mesh-ancestor
154481068|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481069|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
154481070|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481071|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481072|NCT00332748|Taxane|taxane|mesh-list
154481073|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481074|NCT03530436|Curcumin|curcumin|mesh-list
154481075|NCT03530436|Turmeric extract|turmeric extract|mesh-list
154481076|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154481077|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154481078|NCT03530436|Analgesics|analgesics|mesh-ancestor
154481079|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
154481080|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481081|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481082|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481083|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481084|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481085|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481086|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481087|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
154481088|NCT03530436|Protective Agents|protective agents|mesh-ancestor
154481089|NCT03530280|Pregabalin|pregabalin|mesh-list
154481090|NCT03530280|Bupivacaine|bupivacaine|mesh-list
154044867|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
154481091|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154481092|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
154481093|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481094|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481095|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
154481096|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481097|NCT03530280|Analgesics|analgesics|mesh-ancestor
154481098|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
154481099|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154481100|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154481101|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481102|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154481103|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154481104|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154481105|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154481106|NCT00079482|Cytarabine|cytarabine|mesh-list
154481107|NCT00079482|Etoposide|etoposide|mesh-list
154481108|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
154481109|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154481110|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481111|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154481112|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154481113|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481114|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481115|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481116|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
154481117|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
154481118|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481119|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481120|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
154481121|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481122|NCT00079482|Analgesics|analgesics|mesh-ancestor
154481123|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
154481124|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481125|NCT00073866|Celecoxib|celecoxib|mesh-list
154481126|NCT00073866|Docetaxel|docetaxel|mesh-list
154481127|NCT00073866|Irinotecan|irinotecan|mesh-list
154481128|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481129|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
154481130|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
154481131|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
154481132|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481133|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154481134|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154481135|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481136|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154481137|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154481138|NCT00073866|Analgesics|analgesics|mesh-ancestor
154481139|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
154481140|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481141|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481142|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481143|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481144|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154481145|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154481146|NCT00325650|Rimonabant|rimonabant|mesh-list
154481147|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154481148|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154481149|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154481150|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481151|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481152|NCT00325650|Hormones|hormones|mesh-ancestor
154481153|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154481154|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481155|NCT00070590|Bosentan|bosentan|mesh-list
154481156|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154481157|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154481158|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481159|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154481160|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154481161|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154481162|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
154481163|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481164|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481165|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154481166|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154481167|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
154481168|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481169|NCT00058266|Genistein|genistein|mesh-list
154481170|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154481171|NCT00058266|Protective Agents|protective agents|mesh-ancestor
154481172|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481173|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481174|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154481175|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481176|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481177|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
154481178|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154481180|NCT00058266|Hormones|hormones|mesh-ancestor
154481181|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154481182|NCT00313794|Tremelimumab|tremelimumab|mesh-list
154481183|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481184|NCT00313248|Sagopilone|sagopilone|mesh-list
154481185|NCT00313248|Epothilones|epothilones|mesh-list
154481186|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481187|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
154481188|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
154481189|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
154481190|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481191|NCT00310830|Bosentan|bosentan|mesh-list
154481192|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154481193|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154044949|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154045005|NCT02723669|Antidotes|antidotes|mesh-ancestor
154481194|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481195|NCT00035568|Metformin|metformin|mesh-list
154481196|NCT00035568|Glyburide|glyburide|mesh-list
154481197|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154481198|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481199|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
154481200|NCT00307398|Anecortave|anecortave|mesh-list
154109360|NCT00612807|Bupropion|bupropion|mesh-list
154860686|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154481201|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154481202|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154481203|NCT00307398|Growth Substances|growth substances|mesh-ancestor
154481204|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481205|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
154481206|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481207|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481208|NCT01368081|Metformin|metformin|mesh-list
154481209|NCT01368081|Empagliflozin|empagliflozin|mesh-list
154481210|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154481211|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481212|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154481213|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481214|NCT02127489|Bupivacaine|bupivacaine|mesh-list
154481215|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
154481216|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
154481217|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481218|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481219|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
154481220|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481221|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
154481222|NCT00004914|Hematinics|hematinics|mesh-ancestor
154481223|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
154481224|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154481225|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481226|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154481227|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
154481228|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154481229|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481230|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154481231|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154045007|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
154481232|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154481233|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
154481234|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481235|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
154481236|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481237|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481238|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154481239|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
154481240|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481241|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481242|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154481243|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
154481244|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481245|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
154481246|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481247|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
154481248|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154481249|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481250|NCT03551067|Midazolam|midazolam|mesh-list
154481251|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
154481252|NCT03551067|Ketamine|ketamine|mesh-list
154481253|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154205137|NCT00410124|Everolimus|everolimus|mesh-list
154481254|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481255|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481256|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154481257|NCT03551067|Analgesics|analgesics|mesh-ancestor
154481258|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
154481259|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481260|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154481261|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154481262|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154481263|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
154481264|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481265|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481266|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154481267|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154481268|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
154481269|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
154481270|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154481271|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154481272|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154481273|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154481274|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154481275|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154481276|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
154481277|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
154481278|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154481279|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
154481280|NCT03529266|Coagulants|coagulants|mesh-ancestor
154481281|NCT02128191|Ibuprofen|ibuprofen|mesh-list
154481282|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154481283|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154481284|NCT02128191|Analgesics|analgesics|mesh-ancestor
154481285|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
154481286|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481287|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481288|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481289|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481290|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154481291|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481292|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481293|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
154481294|NCT00004896|Busulfan|busulfan|mesh-list
154481295|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481296|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
154481297|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481298|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481299|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154481300|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
154481301|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481302|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481303|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154481304|NCT02121951|Lidocaine|lidocaine|mesh-list
154481305|NCT02121951|Midazolam|midazolam|mesh-list
154481306|NCT02121951|Fentanyl|fentanyl|mesh-list
154481307|NCT02121951|Anesthetics|anesthetics|mesh-list
154481308|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
154481309|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
154481310|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154481311|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154481312|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481313|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481314|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154481315|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154481316|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154481317|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154481318|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
154481319|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
154481320|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
154481321|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481322|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481323|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154481324|NCT02121951|Narcotics|narcotics|mesh-ancestor
154481325|NCT02121951|Analgesics|analgesics|mesh-ancestor
154481326|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
154481327|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481328|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154481329|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154481330|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154481331|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154481332|NCT05473858|Phentolamine|phentolamine|mesh-list
154481333|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154481334|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154481335|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
154481336|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481337|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481338|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481339|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154481340|NCT00004584|Ritonavir|ritonavir|mesh-list
154481341|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154481342|NCT00004584|Saquinavir|saquinavir|mesh-list
154481343|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154481344|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154481345|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
154481346|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481347|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860687|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481348|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154481349|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154481350|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
154481351|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481352|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154481353|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154481354|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
154481355|NCT00004230|Captopril|captopril|mesh-list
154481356|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481357|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
154481358|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481359|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481360|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154481361|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
154481362|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481363|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481364|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154481365|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154481366|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
154481367|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481368|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154481369|NCT02252367|Tadalafil|tadalafil|mesh-list
154481370|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
154481371|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154481372|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154481373|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481374|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481375|NCT02252367|Urological Agents|urological agents|mesh-ancestor
154481376|NCT00004182|Irinotecan|irinotecan|mesh-list
154481377|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154481378|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154481379|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481380|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481381|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481382|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
154481383|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154481384|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
154481385|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481386|NCT02124525|Expectorants|expectorants|mesh-ancestor
154481387|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
154481388|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154481389|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
154045148|NCT00693576|Simvastatin|simvastatin|mesh-list
154481390|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481391|NCT02124525|Protective Agents|protective agents|mesh-ancestor
154481392|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481393|NCT02124525|Antidotes|antidotes|mesh-ancestor
154481394|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
154481395|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
154481396|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154481397|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154481398|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481399|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481400|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481401|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481402|NCT02128425|Leucovorin|leucovorin|mesh-list
154481403|NCT02128425|Fluorouracil|fluorouracil|mesh-list
154481404|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
154481405|NCT02128425|Irinotecan|irinotecan|mesh-list
154481406|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
154481407|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
154481408|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481409|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481410|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481411|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481412|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
154481413|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481414|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154481415|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154481416|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481417|NCT02128425|Antidotes|antidotes|mesh-ancestor
154481418|NCT02128425|Protective Agents|protective agents|mesh-ancestor
154481419|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
154481420|NCT02128425|Vitamins|vitamins|mesh-ancestor
154481421|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
154481422|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
154481423|NCT03532620|Atorvastatin|atorvastatin|mesh-list
154481424|NCT03532620|Pitavastatin|pitavastatin|mesh-list
154860688|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154481426|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154481427|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481428|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154481429|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154481430|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154481431|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
154481432|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481433|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154481434|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154481435|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481436|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
154481437|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154481438|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
154481439|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154481440|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481441|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154481442|NCT03529032|Methadone|methadone|mesh-list
154481443|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154481444|NCT03529032|Narcotics|narcotics|mesh-ancestor
154481445|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481446|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481447|NCT03529032|Analgesics|analgesics|mesh-ancestor
154481448|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
154481449|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481450|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
154481451|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
154481452|NCT02122731|Amiloride|amiloride|mesh-list
154481453|NCT02122731|Diuretics|diuretics|mesh-ancestor
154481454|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
154481455|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481456|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154481457|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154481458|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154481459|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481460|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154481461|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154481462|NCT05458726|Paclitaxel|paclitaxel|mesh-list
154481463|NCT05458726|Carboplatin|carboplatin|mesh-list
154481464|NCT05458726|Pemetrexed|pemetrexed|mesh-list
154481465|NCT05458726|Osimertinib|osimertinib|mesh-list
154481466|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154481467|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481468|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
154481469|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
154481470|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
154481471|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481472|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481473|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154481474|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154481475|NCT05458726|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154481476|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154481477|NCT02122809|Chiauranib|chiauranib|mesh-list
154481478|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481479|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154205360|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
154481480|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481481|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481482|NCT00150618|Guanfacine|guanfacine|mesh-list
154481483|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154481484|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154481485|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154481486|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154481487|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
154481488|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481489|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481490|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481491|NCT03532464|Azithromycin|azithromycin|mesh-list
154481492|NCT03532464|Doxycycline|doxycycline|mesh-list
154481493|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154481494|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481495|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
154481496|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154860689|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154481497|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154481498|NCT02128893|Isavuconazole|isavuconazole|mesh-list
154481499|NCT02128893|Esomeprazole|esomeprazole|mesh-list
154481500|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154481501|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154481502|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154481503|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481504|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481505|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
154481506|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481507|NCT02124369|Paclitaxel|paclitaxel|mesh-list
154481508|NCT02124369|Gemcitabine|gemcitabine|mesh-list
154481509|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154481510|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154481511|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481512|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
154481513|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
154481514|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
154481515|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481516|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481517|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
154481518|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
154481519|NCT02128971|Trace Elements|trace elements|mesh-ancestor
154481520|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
154481521|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481522|NCT02288208|Tenofovir|tenofovir|mesh-list
154481523|NCT02288208|Entecavir|entecavir|mesh-list
154481524|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
154481525|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481526|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154481527|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154481528|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481529|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481530|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154481531|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154481532|NCT02288286|Vaccines|vaccines|mesh-list
154481533|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
154481534|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481535|NCT02251977|Leucovorin|leucovorin|mesh-list
154481536|NCT02251977|Capecitabine|capecitabine|mesh-list
154481537|NCT02251977|Fluorouracil|fluorouracil|mesh-list
154481538|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481539|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481540|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
154481541|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481542|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481543|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481544|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
154481545|NCT02251977|Antidotes|antidotes|mesh-ancestor
154481546|NCT02251977|Protective Agents|protective agents|mesh-ancestor
154481547|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
154481548|NCT02251977|Vitamins|vitamins|mesh-ancestor
154481549|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
154481550|NCT03528954|Propofol|propofol|mesh-list
154481551|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154481552|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481553|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481554|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154481555|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
154481556|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
154481557|NCT02125227|Metformin|metformin|mesh-list
154481558|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154481559|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154481560|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481561|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154481562|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154481563|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
154481564|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481565|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154481566|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154481567|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481568|NCT02129127|Paclitaxel|paclitaxel|mesh-list
154481569|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154481570|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481571|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
154481572|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
154481573|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
154860690|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
154481574|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481576|NCT05554822|Clopidogrel|clopidogrel|mesh-list
154481577|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154481578|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154481579|NCT05554822|Analgesics|analgesics|mesh-ancestor
154481580|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
154481581|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481582|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481583|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481584|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481585|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154481586|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154481587|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481588|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154481589|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154481590|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481591|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
154481592|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154481593|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154481594|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154481595|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
154481596|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481597|NCT02125305|Metformin|metformin|mesh-list
154481598|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154481599|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481600|NCT00254904|Cisplatin|cisplatin|mesh-list
154481601|NCT00254904|Gemcitabine|gemcitabine|mesh-list
154481602|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481603|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481604|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
154481605|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481606|NCT05725122|Tamsulosin|tamsulosin|mesh-list
154481607|NCT05725122|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154481608|NCT05725122|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154481609|NCT05725122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154481610|NCT05725122|Adrenergic Agents|adrenergic agents|mesh-ancestor
154481611|NCT05725122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481612|NCT05725122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481613|NCT05725122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481614|NCT05725122|Urological Agents|urological agents|mesh-ancestor
154481615|NCT03880396|Cisplatin|cisplatin|mesh-list
154481616|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481617|NCT00253968|SR 46349B|sr 46349b|mesh-list
154481618|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154481619|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154481620|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481621|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154481622|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154481623|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
154481624|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481625|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481626|NCT03544606|Pyridoxine|pyridoxine|mesh-list
154481627|NCT03544606|Isosorbide|isosorbide|mesh-list
154481628|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154481629|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154481630|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
154481631|NCT03544606|Vitamins|vitamins|mesh-ancestor
154481632|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
154481633|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481634|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154481635|NCT03544606|Diuretics|diuretics|mesh-ancestor
154481636|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
154481637|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
154481638|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154481639|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481640|NCT02741310|Sumatriptan|sumatriptan|mesh-list
154481641|NCT02741310|Erenumab|erenumab|mesh-list
154481642|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154481643|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154481644|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154481645|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
154481646|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481647|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109803|NCT05954078|Irinotecan|irinotecan|mesh-list
154481649|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154481650|NCT02741310|Analgesics|analgesics|mesh-ancestor
154481651|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
154481652|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481653|NCT00243906|Plasminogen|plasminogen|mesh-list
154481654|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154481655|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154481656|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154481657|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481658|NCT03532360|Immunomodulating Agents|immunomodulating agents|mesh-list
154481659|NCT03532360|Immunologic Factors|immunologic factors|mesh-ancestor
154481660|NCT03532360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481661|NCT01367457|Sirolimus|sirolimus|mesh-list
154481662|NCT01367457|Temsirolimus|temsirolimus|mesh-list
154481663|NCT01367457|MTOR Inhibitors|mtor inhibitors|mesh-list
154481664|NCT01367457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154481665|NCT01367457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481666|NCT01367457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481667|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481668|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
154481669|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481670|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481671|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154481672|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481673|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154481674|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
154481675|NCT05553496|Cyclosporine|cyclosporine|mesh-list
154481676|NCT05553496|Dexamethasone|dexamethasone|mesh-list
154481677|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
154481678|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
154481679|NCT05553496|Rituximab|rituximab|mesh-list
154481680|NCT05553496|Tacrolimus|tacrolimus|mesh-list
154481681|NCT05553496|Cyclosporins|cyclosporins|mesh-list
154481682|NCT05553496|BB 1101|bb 1101|mesh-list
154481683|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481684|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
154481685|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481686|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481687|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154481688|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
154481689|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481690|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481691|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154481692|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154481693|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481694|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
154481695|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
154481696|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481697|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154481698|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
154481699|NCT05553496|Hormones|hormones|mesh-ancestor
154481700|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154481701|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154481702|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
154481703|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481704|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154481705|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
154481706|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205583|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
154481707|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
154481708|NCT00239694|Vaccines|vaccines|mesh-list
154481709|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154481710|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
154481711|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481712|NCT05549284|Rituximab|rituximab|mesh-list
154481713|NCT05549284|Methotrexate|methotrexate|mesh-list
154481714|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154481715|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481716|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
154481717|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481718|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154481719|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154481720|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
154481721|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154481722|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481723|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
154481724|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481725|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
154481726|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481727|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154481728|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481729|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154481730|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154481731|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154481732|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481733|NCT00232752|Sirolimus|sirolimus|mesh-list
154481734|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154481735|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481736|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154481737|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481738|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
154481739|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154481740|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
154481741|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481742|NCT02125617|Prednisolone|prednisolone|mesh-list
154481743|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481744|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
154481745|NCT02125617|Hormones|hormones|mesh-ancestor
154481746|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154481747|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481748|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154481749|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481750|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154481751|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
154481752|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154481753|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154481754|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154481755|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481756|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481757|NCT00229008|Linezolid|linezolid|mesh-list
154481758|NCT00229008|Ceftazidime|ceftazidime|mesh-list
154481759|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
154481760|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154481761|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154481762|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481763|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154481764|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481765|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481766|NCT00229008|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154481767|NCT00229008|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154481768|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
154481769|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154481770|NCT03528564|Hematinics|hematinics|mesh-ancestor
154481771|NCT03531372|Antacids|antacids|mesh-list
154481772|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481773|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154481774|NCT02129595|Resveratrol|resveratrol|mesh-list
154481775|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
154481776|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481777|NCT02129595|Protective Agents|protective agents|mesh-ancestor
154481778|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481779|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481780|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154481781|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154481782|NCT02129673|Latanoprost|latanoprost|mesh-list
154205654|NCT00393042|Amphetamine|amphetamine|mesh-list
154481783|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154481784|NCT02260557|Selexipag|selexipag|mesh-list
154481785|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154481786|NCT02129829|Tenofovir|tenofovir|mesh-list
154481787|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
154481788|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481789|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154481790|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154481791|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481792|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481793|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154045575|NCT00731224|Rivastigmine|rivastigmine|mesh-list
154481794|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154481795|NCT02129985|Metformin|metformin|mesh-list
154481796|NCT02129985|Exenatide|exenatide|mesh-list
154481797|NCT02129985|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154481798|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154481799|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481800|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154481802|NCT02129985|Hormones|hormones|mesh-ancestor
154481803|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154481804|NCT01730638|Histamine|histamine|mesh-list
154481805|NCT01730638|Glycine|glycine|mesh-list
154481806|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
154481807|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
154481808|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481809|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481810|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481811|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
154481812|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
154481813|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154481814|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481815|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481816|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154481817|NCT02252523|Analgesics|analgesics|mesh-ancestor
154481818|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
154481819|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481820|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154481821|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154481822|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154481823|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
154481824|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481825|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481826|NCT02132091|Vitamins|vitamins|mesh-list
154481827|NCT02132091|Vitamin E|vitamin e|mesh-list
154481828|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
154481829|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481830|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
154481831|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481832|NCT02132091|Protective Agents|protective agents|mesh-ancestor
154481833|NCT05548348|Aflutinib|aflutinib|mesh-list
154481834|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154481835|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481836|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481837|NCT04469010|Iron|iron|mesh-list
154481838|NCT04469010|Chelating Agents|chelating agents|mesh-list
154481839|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
154481840|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481841|NCT04469010|Trace Elements|trace elements|mesh-ancestor
154481842|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481843|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
154481844|NCT01121224|Clopidogrel|clopidogrel|mesh-list
154481845|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154481846|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154481847|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154481848|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154481849|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
154481850|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045623|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154481851|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481852|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481853|NCT00138762|Atorvastatin|atorvastatin|mesh-list
154481854|NCT00138762|Torcetrapib|torcetrapib|mesh-list
154481855|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154481856|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154205728|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
154481857|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
154481858|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481859|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154481860|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154481861|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481862|NCT03531294|Aflibercept|aflibercept|mesh-list
154481863|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154481864|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154481865|NCT03531294|Growth Substances|growth substances|mesh-ancestor
154481866|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481867|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
154481868|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110030|NCT05512481|Temozolomide|temozolomide|mesh-list
154481870|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154481871|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154481872|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154481873|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154481874|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481875|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
154481876|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481877|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481878|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154481879|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481880|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
154481881|NCT05551624|Atorvastatin|atorvastatin|mesh-list
154481882|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154481883|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154481884|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154481885|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
154481886|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045679|NCT04131231|Analgesics|analgesics|mesh-ancestor
154481887|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154481888|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154481889|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481890|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
154481891|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481892|NCT05551624|Expectorants|expectorants|mesh-ancestor
154481893|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
154481894|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154481895|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
154481896|NCT05551624|Protective Agents|protective agents|mesh-ancestor
154481897|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481898|NCT05551624|Antidotes|antidotes|mesh-ancestor
154481899|NCT00134238|Atorvastatin|atorvastatin|mesh-list
154481900|NCT00134238|Torcetrapib|torcetrapib|mesh-list
154481901|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154481902|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154481903|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
154481904|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481905|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154481906|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154481907|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481908|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154481909|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154481910|NCT03550677|Anesthetics|anesthetics|mesh-list
154481911|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154481912|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481913|NCT02132403|Milk fat globule|milk fat globule|mesh-list
154481914|NCT02132403|Gemcitabine|gemcitabine|mesh-list
154481915|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481916|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
154481917|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481918|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481919|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481920|NCT04264806|Azacitidine|azacitidine|mesh-list
154481921|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481922|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
154481923|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481924|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481925|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481926|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154481927|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154481928|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
154481929|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481930|NCT00126984|Vaccines|vaccines|mesh-list
154481931|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
154205803|NCT03973138|Ranibizumab|ranibizumab|mesh-list
154481932|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481933|NCT05699746|Capecitabine|capecitabine|mesh-list
154481934|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
154481935|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154481936|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
154481937|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481938|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481939|NCT03549897|Albuterol|albuterol|mesh-list
154481940|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154481941|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
154481942|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860691|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481943|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481944|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154481945|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
154481946|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
154481947|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154481948|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154481949|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154481950|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154481951|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
154481952|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481953|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481954|NCT02133105|Simendan|simendan|mesh-list
154481955|NCT02133105|Dobutamine|dobutamine|mesh-list
154481956|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154481957|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
154481958|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154481959|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154481960|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154481961|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154481962|NCT02133105|Protective Agents|protective agents|mesh-ancestor
154481963|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481964|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
154481965|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
154481966|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154481967|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154481968|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154481969|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154481970|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
154481971|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154481972|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
154481973|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154481974|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
154481975|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
154481976|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
154481977|NCT02136693|Psyllium|psyllium|mesh-list
154481978|NCT02136693|Cathartics|cathartics|mesh-ancestor
154481979|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154481980|NCT02136771|Vitamin D|vitamin d|mesh-list
154481981|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
154481982|NCT02136771|Vitamins|vitamins|mesh-ancestor
154481983|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
154481984|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481985|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154481986|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154481987|NCT00125970|Vaccines|vaccines|mesh-list
154481988|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
154481989|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481990|NCT03549663|Prednisone|prednisone|mesh-list
154481991|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
154481992|NCT03549663|Tacrolimus|tacrolimus|mesh-list
154481993|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154481994|NCT03549663|Hormones|hormones|mesh-ancestor
154481995|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154481996|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154481997|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154481998|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154481999|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154482000|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
154482001|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154482002|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482003|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205875|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482004|NCT02137083|Docetaxel|docetaxel|mesh-list
154482005|NCT02137083|Fulvestrant|fulvestrant|mesh-list
154482006|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482007|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
154482008|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
154482009|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154482010|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482011|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154482012|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154482013|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154482014|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
154482015|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482016|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482018|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154482019|NCT02137161|Dexamethasone|dexamethasone|mesh-list
154482020|NCT02137161|Bromfenac|bromfenac|mesh-list
154482021|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154482022|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482023|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
154482024|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
154482025|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482026|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482027|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154482028|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
154482029|NCT02137161|Hormones|hormones|mesh-ancestor
154482030|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482031|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154482032|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482033|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154482034|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154482035|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482036|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154482037|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482038|NCT02137161|Analgesics|analgesics|mesh-ancestor
154482039|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
154482040|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154482041|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154482042|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482043|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
154482044|NCT03527628|Dacarbazine|dacarbazine|mesh-list
154482045|NCT03527628|Doxorubicin|doxorubicin|mesh-list
154482046|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154482047|NCT03527628|Bleomycin|bleomycin|mesh-list
154482048|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154482049|NCT03527628|Vinblastine|vinblastine|mesh-list
154482050|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154482051|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
154482052|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482053|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154482054|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154482055|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
154482056|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482057|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482058|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154482059|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154482060|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154482061|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154482062|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482063|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154482064|NCT03527628|Immunotoxins|immunotoxins|mesh-ancestor
154482065|NCT03527628|Immunoconjugates|immunoconjugates|mesh-ancestor
154482066|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154482067|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
154482068|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
154482069|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
154482070|NCT04466670|Aspirin|aspirin|mesh-list
154482071|NCT04466670|Heparin|heparin|mesh-list
154482072|NCT04466670|Calcium heparin|calcium heparin|mesh-list
154482073|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154482074|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482075|NCT04466670|Analgesics|analgesics|mesh-ancestor
154482076|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
154482077|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482078|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482079|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482080|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205949|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482081|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154482082|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154482083|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482084|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154482085|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154482087|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
154482088|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
154482089|NCT04468542|Triamcinolone|triamcinolone|mesh-list
154482090|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154482091|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154482092|NCT04468542|Bupivacaine|bupivacaine|mesh-list
154482093|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154482094|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154482095|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
154482096|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482097|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482098|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
154482099|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482100|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482101|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
154482102|NCT04468542|Hormones|hormones|mesh-ancestor
154482103|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482104|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154482105|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
154482106|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482107|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482108|NCT03525522|Betamethasone|betamethasone|mesh-list
154482109|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154482110|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482111|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
154482112|NCT03525522|Hormones|hormones|mesh-ancestor
154482113|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482114|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482115|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154482116|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
154482117|NCT04466436|Tryptophan|tryptophan|mesh-list
154482118|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154482119|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
154482120|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482121|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154482122|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
154482123|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154482124|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154482125|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154482126|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154482127|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482128|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
154482129|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482130|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482131|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154482132|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482133|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482134|NCT03008382|Metoprolol|metoprolol|mesh-list
154482135|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154482136|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154482137|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
154482138|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
154482139|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045930|NCT00999973|Mitomycins|mitomycins|mesh-list
154482140|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482141|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154482142|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154482143|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154482144|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
154482145|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482146|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482147|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
154482148|NCT02137239|Prednisone|prednisone|mesh-list
154482149|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
154482150|NCT02137239|Everolimus|everolimus|mesh-list
154482151|NCT02137239|Abatacept|abatacept|mesh-list
154482152|NCT02137239|Tacrolimus|tacrolimus|mesh-list
154482153|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
154482154|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482155|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
154482156|NCT02137239|Hormones|hormones|mesh-ancestor
154206022|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482157|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482158|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482159|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154482161|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154482162|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
154482163|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154482164|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482165|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482166|NCT02137239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154482168|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154482169|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154482170|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
154482171|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154482172|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482173|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
154482174|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
154482175|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482176|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154482177|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154482178|NCT02137239|Protective Agents|protective agents|mesh-ancestor
154482179|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154482180|NCT02137239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154482181|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154482182|NCT02137395|Dexamethasone|dexamethasone|mesh-list
154482183|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482184|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
154482185|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
154045970|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154482186|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482187|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482188|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154482189|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
154482190|NCT02137395|Hormones|hormones|mesh-ancestor
154482191|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482192|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154482193|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482194|NCT02137629|Azacitidine|azacitidine|mesh-list
154482195|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154482196|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
154482197|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482198|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482199|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482200|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154482201|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154482202|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482203|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154482204|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
154482205|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482206|NCT02261025|Aspirin|aspirin|mesh-list
154482207|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154482208|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482209|NCT02261025|Analgesics|analgesics|mesh-ancestor
154482210|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
154482211|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482212|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482213|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482214|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154482215|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154482216|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154482217|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482218|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154482219|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154482220|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482221|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
154482222|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
154482223|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154482224|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482225|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482226|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482227|NCT02137863|Analgesics|analgesics|mesh-ancestor
154482228|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
154482229|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482230|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154482231|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154482232|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154482233|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
154482234|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482235|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482236|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154482238|NCT02138019|Coagulants|coagulants|mesh-ancestor
154482239|NCT02138409|Fentanyl|fentanyl|mesh-list
154482240|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154860692|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154482241|NCT02138409|Narcotics|narcotics|mesh-ancestor
154482242|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482243|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482244|NCT02138409|Analgesics|analgesics|mesh-ancestor
154482245|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
154482246|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482247|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154482248|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154482249|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
154482250|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
154482251|NCT02138799|Rifampin|rifampin|mesh-list
154482252|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154482253|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
154482254|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154482255|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482256|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
154482257|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154482258|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482259|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482260|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154482261|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154482262|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154482263|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154482264|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154482265|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154482266|NCT02975271|Serlopitant|serlopitant|mesh-list
154482267|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154482268|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482269|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482270|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482271|NCT02741076|Oxymorphone|oxymorphone|mesh-list
154482272|NCT02741076|Morphine|morphine|mesh-list
154482273|NCT02741076|Oxycodone|oxycodone|mesh-list
154482274|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
154482275|NCT02741076|Narcotics|narcotics|mesh-ancestor
154482276|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482277|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482278|NCT02741076|Analgesics|analgesics|mesh-ancestor
154482279|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
154482280|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482281|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154482282|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154482283|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
154482284|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
154482285|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482286|NCT01666444|Doxorubicin|doxorubicin|mesh-list
154482287|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154482288|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154046066|NCT02751593|Dexamethasone|dexamethasone|mesh-list
154482289|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482290|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154482291|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154482292|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482293|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482294|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154482295|NCT05120934|Amitriptyline|amitriptyline|mesh-list
154482296|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154482297|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154482298|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154482299|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206173|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
154482300|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482301|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482302|NCT05120934|Analgesics|analgesics|mesh-ancestor
154482303|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
154482304|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482305|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
154482306|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482307|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
154482308|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154482309|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482310|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154482312|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
154482313|NCT03548493|Fentanyl|fentanyl|mesh-list
154482314|NCT03548493|Propofol|propofol|mesh-list
154482315|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154482316|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482317|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482318|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154482319|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
154482320|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
154482321|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154482322|NCT03548493|Narcotics|narcotics|mesh-ancestor
154482323|NCT03548493|Analgesics|analgesics|mesh-ancestor
154482324|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
154482325|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482326|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154482327|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154482328|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
154482329|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154482330|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154482331|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482332|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154482333|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
154482334|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154482335|NCT02139267|Vaccines|vaccines|mesh-list
154482336|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
154482337|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482338|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154482339|NCT03549819|Cannabidiol|cannabidiol|mesh-list
154482340|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
154482341|NCT03549741|Cabergoline|cabergoline|mesh-list
154482342|NCT03549741|Clomiphene|clomiphene|mesh-list
154482343|NCT03549741|Enclomiphene|enclomiphene|mesh-list
154482344|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
154482345|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482346|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154482347|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
154482348|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482349|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482350|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154482351|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
154482352|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154482353|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154482354|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154482355|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154482356|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154482357|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
154482358|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
154482359|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482360|NCT03522402|Sevoflurane|sevoflurane|mesh-list
154482361|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154482362|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154482363|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
154482364|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
154482365|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482366|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482367|NCT02134899|Everolimus|everolimus|mesh-list
154482368|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154482369|NCT02134899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154482370|NCT02134899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154482371|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482372|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482373|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154482374|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
154482375|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482376|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482377|NCT02135055|Midazolam|midazolam|mesh-list
154482378|NCT02135055|Morphine|morphine|mesh-list
154482379|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154482380|NCT02135055|Narcotics|narcotics|mesh-ancestor
154482381|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482382|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482383|NCT02135055|Analgesics|analgesics|mesh-ancestor
154482384|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
154482385|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482386|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154482387|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154482388|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154482389|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154482390|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482391|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154482392|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
154482394|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
154482395|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
154482396|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482397|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482398|NCT02139579|Bevacizumab|bevacizumab|mesh-list
154482399|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154482400|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482401|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154482402|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154482403|NCT02139579|Growth Substances|growth substances|mesh-ancestor
154482404|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482405|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
154046183|NCT01004419|Fulvestrant|fulvestrant|mesh-list
154482406|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
154482407|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
154482408|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482409|NCT04076826|Midazolam|midazolam|mesh-list
154482410|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
154482411|NCT04076826|Propofol|propofol|mesh-list
154482412|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154482413|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482414|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482415|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482416|NCT04076826|Analgesics|analgesics|mesh-ancestor
154482417|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
154482418|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482419|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154482420|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154482421|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154482422|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
154482423|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482424|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482425|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154482426|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
154482427|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
154482428|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154482429|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154482430|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154482431|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482432|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
154482433|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
154482434|NCT05577585|Midazolam|midazolam|mesh-list
154482435|NCT05577585|Ketamine|ketamine|mesh-list
154482436|NCT05577585|Analgesics|analgesics|mesh-ancestor
154482437|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
154482438|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482439|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482440|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154482441|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154482442|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
154482443|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
154482444|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482445|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154482446|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154482447|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482448|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206320|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154482449|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154482450|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154482451|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154482453|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482454|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
154482455|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
154482456|NCT04465968|Durvalumab|durvalumab|mesh-list
154482457|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154482458|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482459|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154482460|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
154482461|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482462|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
154110678|NCT02507284|SRX246|srx246|mesh-list
154482463|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154482464|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482465|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
154482466|NCT01565655|Peficitinib|peficitinib|mesh-list
154482467|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482468|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482469|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154482470|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
154482471|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482472|NCT05535322|Insulin|insulin|mesh-list
154482473|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154482474|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482475|NCT05577273|Trimethoprim|trimethoprim|mesh-list
154482476|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
154482477|NCT05577273|Penicillins|penicillins|mesh-list
154482478|NCT05577273|Cefuroxime|cefuroxime|mesh-list
154482479|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
154482480|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154482481|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482482|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
154482483|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154482484|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154482485|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154482486|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482487|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482488|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154482489|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154482490|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154482491|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154482492|NCT02252913|Docetaxel|docetaxel|mesh-list
154482493|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482494|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
154482495|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
154482496|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
154482497|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482498|NCT02253459|Capecitabine|capecitabine|mesh-list
154482499|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154482500|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
154482501|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482502|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482503|NCT02140047|Vaccines|vaccines|mesh-list
154482504|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
154482505|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482506|NCT02135913|Vitamin D|vitamin d|mesh-list
154482507|NCT02135913|Vitamins|vitamins|mesh-ancestor
154482508|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
154482509|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482510|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154482511|NCT02140125|ASP2408|asp2408|mesh-list
154482512|NCT02140125|Immunoconjugates|immunoconjugates|mesh-ancestor
154482513|NCT02140125|Immunologic Factors|immunologic factors|mesh-ancestor
154482514|NCT02140125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482515|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
154482516|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
154482517|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154482518|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482519|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154482520|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154482521|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482522|NCT02140281|Cefadroxil|cefadroxil|mesh-list
154482523|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154482524|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482525|NCT05541328|Tisagenlecleucel|tisagenlecleucel|mesh-list
154482526|NCT05541328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154482527|NCT05541328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482528|NCT05545462|Doxycycline|doxycycline|mesh-list
154482529|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154482530|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482531|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
154482532|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154482533|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154482535|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154482536|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482537|NCT05699356|Hormones|hormones|mesh-ancestor
154482538|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482539|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154482540|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482541|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482542|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154482543|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
154482544|NCT03989232|Semaglutide|semaglutide|mesh-list
154482545|NCT03989232|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154482546|NCT03989232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154482547|NCT03989232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482548|NCT02140437|Fulvestrant|fulvestrant|mesh-list
154482549|NCT02140437|Anastrozole|anastrozole|mesh-list
154482550|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154482551|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482552|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154482553|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154482554|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
154482555|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482556|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482557|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154482558|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154482559|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482560|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482561|NCT05591560|Itraconazole|itraconazole|mesh-list
154482562|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
154482563|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482564|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154482565|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154482566|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482567|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482568|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154482569|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
154482570|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482571|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482572|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154482573|NCT05540470|Chloroquine|chloroquine|mesh-list
154482574|NCT05540470|Primaquine|primaquine|mesh-list
154482575|NCT05540470|Tafenoquine|tafenoquine|mesh-list
154482576|NCT05540470|Amebicides|amebicides|mesh-ancestor
154482577|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154482578|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154482579|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482580|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
154482581|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154482582|NCT02140515|Hormones|hormones|mesh-list
154482583|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154482584|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482585|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482586|NCT02260947|Ibuprofen|ibuprofen|mesh-list
154482587|NCT02260947|Pregabalin|pregabalin|mesh-list
154482588|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154482589|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482590|NCT02260947|Analgesics|analgesics|mesh-ancestor
154482591|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
154482592|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482593|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482594|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482595|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154482596|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154482597|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482598|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482599|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
154482600|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154482601|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154482602|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154482603|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154482604|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154482605|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482606|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482607|NCT03547791|Betamethasone|betamethasone|mesh-list
154482608|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
154482609|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154482610|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
154482611|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154482612|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
154860693|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154860694|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482613|NCT03547791|Hormones|hormones|mesh-ancestor
154482614|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482615|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482616|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482617|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154482618|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
154482619|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154482620|NCT04425460|Favipiravir|favipiravir|mesh-list
154482621|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
154482622|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482623|NCT05576272|Gemcitabine|gemcitabine|mesh-list
154482624|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482625|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154482626|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
154482627|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482628|NCT05576116|Pancrelipase|pancrelipase|mesh-list
154482629|NCT05576116|Pancreatin|pancreatin|mesh-list
154482630|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154482631|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
154482632|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
154482633|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
154482634|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482635|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482636|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
154482637|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482638|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
154482639|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
154482640|NCT04703673|Ephedrine|ephedrine|mesh-list
154482641|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
154482642|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154046437|NCT01004497|Analgesics|analgesics|mesh-ancestor
154482643|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
154482644|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154482645|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482646|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
154482647|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482648|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
154482649|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482650|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482651|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154482652|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154482653|NCT05543746|Brexanolone|brexanolone|mesh-list
154482654|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
154482655|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482656|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482657|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482658|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
154482659|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
154482660|NCT03526536|Insulin|insulin|mesh-list
154482661|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154482662|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154482663|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482664|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
154482665|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154482666|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
154482667|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482668|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
154482669|NCT05543434|Protective Agents|protective agents|mesh-ancestor
154482670|NCT05538988|Cemiplimab|cemiplimab|mesh-list
154482671|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154482672|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482673|NCT04667637|Edaravone|edaravone|mesh-list
154482674|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154482675|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
154482676|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482677|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154482678|NCT04667637|Protective Agents|protective agents|mesh-ancestor
154482679|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482680|NCT02253927|Ritonavir|ritonavir|mesh-list
154482681|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154482682|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154482683|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
154482684|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482685|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482686|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154482687|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154482688|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
154482689|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482690|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154482691|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154482692|NCT05697016|Sivelestat|sivelestat|mesh-list
154482693|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154482694|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
154482695|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482696|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482697|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
154482698|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154482699|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
154482700|NCT01567995|Hormones|hormones|mesh-ancestor
153589209|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
154482701|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482702|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482703|NCT05567523|Midazolam|midazolam|mesh-list
154482704|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
154482705|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154482706|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482707|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482708|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482709|NCT05567523|Analgesics|analgesics|mesh-ancestor
154482710|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
154482711|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482712|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154482713|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154482714|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154482715|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
154482716|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482717|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482718|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154482719|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154482720|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154482721|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482722|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154482723|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
154482724|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
154482725|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
154482726|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
154482727|NCT02584504|Atorvastatin|atorvastatin|mesh-list
154482728|NCT02584504|Alirocumab|alirocumab|mesh-list
154482729|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154482730|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154482731|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
154482732|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482733|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154482734|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154482735|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482736|NCT02584504|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154482737|NCT02584504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154482738|NCT02584504|Protease Inhibitors|protease inhibitors|mesh-ancestor
154482739|NCT04599777|Sorafenib|sorafenib|mesh-list
154482740|NCT04599777|Tislelizumab|tislelizumab|mesh-list
154482741|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482742|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154482743|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482744|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482745|NCT04599777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154482746|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
154482747|NCT05007262|Calcium|calcium|mesh-list
154482748|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154482749|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482750|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
154482751|NCT05007262|Coagulants|coagulants|mesh-ancestor
154206624|NCT00400764|Rituximab|rituximab|mesh-list
154482752|NCT03546075|Resveratrol|resveratrol|mesh-list
154482753|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
154482754|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482755|NCT03546075|Protective Agents|protective agents|mesh-ancestor
154046548|NCT04191863|Valproic Acid|valproic acid|mesh-list
154482756|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482757|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482758|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154482759|NCT05537584|Bupropion|bupropion|mesh-list
154482760|NCT05537584|Sertraline|sertraline|mesh-list
154482761|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154860695|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154482762|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
154482763|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482764|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154482765|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154482766|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154482767|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482768|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
154482769|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482770|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482771|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154482772|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154482773|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482774|NCT05537584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154482775|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
154482776|NCT04459377|Ketamine|ketamine|mesh-list
154482777|NCT04459377|Esketamine|esketamine|mesh-list
154482778|NCT04459377|Analgesics|analgesics|mesh-ancestor
154482779|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
154482780|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482781|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482782|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154482783|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154482784|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
154482785|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
154482786|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482787|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154482788|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154482789|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482790|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482791|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
154482792|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482793|NCT00748618|Vitamin D|vitamin d|mesh-list
154482794|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
154482795|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
154482796|NCT00748618|Vitamins|vitamins|mesh-list
154482797|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
154482798|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482799|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154482800|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154482801|NCT03546855|Apatinib|apatinib|mesh-list
154482802|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482803|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154482804|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482805|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482806|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154482807|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482808|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
154482809|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482810|NCT05679310|Protective Agents|protective agents|mesh-ancestor
154482811|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482812|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154482813|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
154482814|NCT05537272|Tadalafil|tadalafil|mesh-list
154482815|NCT05537272|Tamsulosin|tamsulosin|mesh-list
154482816|NCT05537272|Vitamins|vitamins|mesh-ancestor
154482817|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
154482818|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482819|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
154482820|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482821|NCT05537272|Protective Agents|protective agents|mesh-ancestor
154482822|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
154482823|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154482824|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154482825|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206692|NCT00388674|Entecavir|entecavir|mesh-list
154482826|NCT05537272|Urological Agents|urological agents|mesh-ancestor
154482827|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154482828|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154482829|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154482830|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
154482831|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482832|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
154482833|NCT05537194|Calcium|calcium|mesh-list
154482834|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154860696|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
154482835|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482836|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154482837|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154482838|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482839|NCT03931161|Evolocumab|evolocumab|mesh-list
154482840|NCT03931161|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154482841|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154482842|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154482843|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
154482844|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482845|NCT03931161|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154482846|NCT03931161|Protease Inhibitors|protease inhibitors|mesh-ancestor
154482847|NCT03931161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482848|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154482849|NCT05037123|Ketamine|ketamine|mesh-list
154482850|NCT05037123|Analgesics|analgesics|mesh-ancestor
154482851|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
154482852|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482853|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482854|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154482855|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154482856|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
154482857|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
154482858|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482859|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154482860|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154482861|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482862|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482863|NCT04354155|Enoxaparin|enoxaparin|mesh-list
154482864|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
154482865|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154482866|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154482867|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482868|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154482869|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
154482870|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482871|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154482872|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154482873|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482874|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482875|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154482876|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154482877|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482878|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
154482879|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154482880|NCT03877965|Digoxin|digoxin|mesh-list
154482881|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154482882|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154482883|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482884|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482885|NCT03877965|Protective Agents|protective agents|mesh-ancestor
154482886|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482887|NCT02253849|Ritonavir|ritonavir|mesh-list
154482888|NCT02253849|Tipranavir|tipranavir|mesh-list
154482889|NCT02253849|Carbamazepine|carbamazepine|mesh-list
154482890|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154482891|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154482892|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
154482893|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482894|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482895|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154482896|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154482897|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
154482898|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206785|NCT01234532|Entinostat|entinostat|mesh-list
154482899|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154482900|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154482901|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
154482902|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
154482903|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154482904|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154482905|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482906|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154482907|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154482908|NCT02253849|Analgesics|analgesics|mesh-ancestor
154482909|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
154482910|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482911|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154482912|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154482913|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154482914|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154482915|NCT03545997|Montelukast|montelukast|mesh-list
154482916|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154482917|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
154482918|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154482919|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
154482920|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154482921|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482922|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154482923|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154482924|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482925|NCT03810495|Naltrexone|naltrexone|mesh-list
154482926|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154482927|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154482928|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482929|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
154482930|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482931|NCT04980885|Azacitidine|azacitidine|mesh-list
154482932|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154482933|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
154482934|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482935|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482936|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482937|NCT04184505|Azacitidine|azacitidine|mesh-list
154482938|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154482939|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
154482940|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482941|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154482942|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482943|NCT03760458|Lamivudine|lamivudine|mesh-list
154482944|NCT03760458|Abacavir|abacavir|mesh-list
154482945|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
154482946|NCT03760458|Dolutegravir|dolutegravir|mesh-list
154482947|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154482948|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154482949|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482950|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482951|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
154482952|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482953|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154482954|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154482955|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154482956|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154482957|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
154482958|NCT02066415|Erenumab|erenumab|mesh-list
154482959|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154482960|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482961|NCT02066415|Analgesics|analgesics|mesh-ancestor
154482962|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
154482963|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154482964|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482965|NCT04467918|Cannabidiol|cannabidiol|mesh-list
154482966|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
154482967|NCT04720612|Omalizumab|omalizumab|mesh-list
154482968|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154482969|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154482970|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
154482971|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
154482972|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154206836|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
154482973|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
154482974|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154482975|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
154482976|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482977|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482978|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
154482979|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154482980|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
154860697|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
154482981|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482982|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154482983|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154482984|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154482985|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154482986|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154482987|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154482989|NCT04466904|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154482990|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154482991|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482992|NCT03524274|Antibodies|antibodies|mesh-list
154482993|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154482994|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
154482995|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154482996|NCT02143479|Tacrolimus|tacrolimus|mesh-list
154482997|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154482998|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
154482999|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483000|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154483001|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483002|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483003|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154483004|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154483005|NCT02254239|Everolimus|everolimus|mesh-list
154483006|NCT02254239|Antibodies|antibodies|mesh-list
154483007|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
154483008|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154483009|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
154483010|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
154483011|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483012|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483013|NCT02254239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154483014|NCT02254239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154483015|NCT02254239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483016|NCT02254239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483017|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154483018|NCT02254239|Immunotoxins|immunotoxins|mesh-ancestor
154483019|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
154483020|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154483021|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154483022|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
154483023|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483024|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483025|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154483026|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483027|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154483028|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
154483029|NCT05088369|Protective Agents|protective agents|mesh-ancestor
154483030|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154483031|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154483032|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154483033|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
154483034|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483035|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154483036|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154483037|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483038|NCT02144025|Cyclosporine|cyclosporine|mesh-list
154483039|NCT02144025|Cyclosporins|cyclosporins|mesh-list
154483040|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483041|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483042|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154483043|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
154483044|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206921|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
154483045|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
154483046|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483047|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
154483048|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483049|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154483050|NCT03523650|Propranolol|propranolol|mesh-list
154483051|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154483052|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154483053|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111233|NCT00766818|Lopinavir|lopinavir|mesh-list
154483054|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483055|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483056|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483057|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154483058|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154483059|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
154483060|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
154483061|NCT01025505|Nilotinib|nilotinib|mesh-list
154483062|NCT01025505|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154483063|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154483064|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483065|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483066|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483067|NCT02582632|Ritonavir|ritonavir|mesh-list
154483068|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154483069|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154483070|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
154483071|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483072|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483073|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154483074|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154483075|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
154483076|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483077|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154483078|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154483079|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
154483080|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154483081|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483082|NCT02178722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154483083|NCT02178722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483084|NCT03523572|Nivolumab|nivolumab|mesh-list
154483085|NCT03523572|Trastuzumab|trastuzumab|mesh-list
154483086|NCT03523572|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154483087|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154483088|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483089|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154046879|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
154483090|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483091|NCT03523572|Immunoconjugates|immunoconjugates|mesh-ancestor
154483092|NCT03523572|Immunologic Factors|immunologic factors|mesh-ancestor
154483093|NCT03523572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483094|NCT00972309|Vaccines|vaccines|mesh-list
154483095|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
154483096|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483097|NCT03526224|Teriflunomide|teriflunomide|mesh-list
154483098|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154483099|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
154483100|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154483101|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
154483102|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483103|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154483104|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154483105|NCT03526224|Analgesics|analgesics|mesh-ancestor
154483106|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
154483107|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483108|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483109|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483110|NCT03639246|Paclitaxel|paclitaxel|mesh-list
154483111|NCT03639246|Doxorubicin|doxorubicin|mesh-list
154483112|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154483113|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154483114|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483115|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
154483116|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
154483117|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
154483118|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483119|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154483120|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154483121|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154483122|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483123|NCT00545324|Fluticasone|fluticasone|mesh-list
154483124|NCT00545324|Montelukast|montelukast|mesh-list
154483125|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483126|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154483127|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
154483128|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483129|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483130|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154483131|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483132|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
154483133|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154483134|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483135|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154483136|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
154483137|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483138|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154483139|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154483140|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
154483141|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
154483142|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154483143|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154483144|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483145|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
154483146|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154483147|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
154483148|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483149|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
154483150|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483151|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
154483152|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483153|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483154|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154483156|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154483157|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483158|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
154483159|NCT04446104|Ivermectin|ivermectin|mesh-list
154483160|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
154483161|NCT04446104|Povidone|povidone|mesh-list
154483162|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
154483163|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154483164|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154483165|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483166|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483167|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483168|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483169|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
154483170|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
154483171|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154483172|NCT03388970|Vitamin K|vitamin k|mesh-list
154483173|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
154483174|NCT03388970|Vitamins|vitamins|mesh-ancestor
154483175|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
154483176|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483177|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154483178|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154483179|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483180|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
154483181|NCT03388970|Coagulants|coagulants|mesh-ancestor
154483182|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154483183|NCT00616941|Poly ICLC|poly iclc|mesh-list
154483184|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154483185|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
154483186|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483187|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
154483188|NCT03388892|Paclitaxel|paclitaxel|mesh-list
154483189|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154483190|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483191|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
154483192|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
154483193|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
154483194|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483195|NCT02577718|Ethanol|ethanol|mesh-list
154483196|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
154483197|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154483198|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483199|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483200|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483201|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
154483202|NCT00520533|Sunitinib|sunitinib|mesh-list
154483203|NCT00520533|Antibodies|antibodies|mesh-list
154483204|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154483205|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
154483206|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483207|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483208|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154483209|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154483210|NCT00520533|Growth Substances|growth substances|mesh-ancestor
154483211|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
154483212|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154483213|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483214|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483215|NCT03388814|Bupivacaine|bupivacaine|mesh-list
154483216|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
154483217|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
154483218|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483219|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483220|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
154483221|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483222|NCT04680988|Paclitaxel|paclitaxel|mesh-list
154483223|NCT04680988|Gemcitabine|gemcitabine|mesh-list
154483224|NCT04680988|Pemetrexed|pemetrexed|mesh-list
154483225|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154483226|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154483227|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483228|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
154483229|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
154483230|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
154483231|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483232|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154483233|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
154483234|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483235|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154483236|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154483237|NCT02289144|Ceritinib|ceritinib|mesh-list
154483238|NCT02289144|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154483239|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154483240|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483241|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483242|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483243|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154483244|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154483245|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154483246|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483247|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483248|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154483249|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154483250|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154483251|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154483252|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
154047046|NCT00731926|Vitamins|vitamins|mesh-list
154483253|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483254|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483255|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154483256|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154483257|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
154483258|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154483259|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154483260|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
154483261|NCT02144415|Amphetamine|amphetamine|mesh-list
154483262|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154483263|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
154483264|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154483265|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483266|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
154483267|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
154483268|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483269|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
154483270|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483271|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483272|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
154483273|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154483274|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154483275|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154483276|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154483277|NCT02739984|Evolocumab|evolocumab|mesh-list
154483278|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154483279|NCT02739984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154483280|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154483281|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154483282|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
154483283|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483284|NCT02739984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154483285|NCT02739984|Protease Inhibitors|protease inhibitors|mesh-ancestor
154483286|NCT02739984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483287|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154483288|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
154483289|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483290|NCT00496730|Atorvastatin|atorvastatin|mesh-list
154483291|NCT00496730|Simvastatin|simvastatin|mesh-list
154483292|NCT00496730|Ezetimibe|ezetimibe|mesh-list
154483293|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154483294|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154483295|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
154483296|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483297|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154483298|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154483299|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483300|NCT00446186|Montelukast|montelukast|mesh-list
154483301|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483302|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483303|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483304|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154483305|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154483306|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
154483307|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483308|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154483309|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154483310|NCT02140983|Liraglutide|liraglutide|mesh-list
154483311|NCT02140983|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154483312|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154483313|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483314|NCT02140983|Incretins|incretins|mesh-ancestor
154483315|NCT02140983|Hormones|hormones|mesh-ancestor
154483316|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483317|NCT00394160|Montelukast|montelukast|mesh-list
154483318|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154483319|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483320|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154483321|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
154483322|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483323|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483324|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154483325|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154483326|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483327|NCT03392792|Plasminogen|plasminogen|mesh-list
154483328|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154483329|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154483330|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154483331|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483332|NCT02739828|Adalimumab|adalimumab|mesh-list
154483333|NCT02739828|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154483334|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483335|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483336|NCT02141139|Ibuprofen|ibuprofen|mesh-list
154483337|NCT02141139|Ketorolac|ketorolac|mesh-list
154483338|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154047194|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
154483339|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154483340|NCT02141139|Analgesics|analgesics|mesh-ancestor
154483341|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
154483342|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483343|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483344|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483345|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483346|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154483347|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483348|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483349|NCT05297032|Quercetin|quercetin|mesh-list
154483350|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
154111530|NCT00967096|Rifaximin|rifaximin|mesh-list
154860698|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860699|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154483351|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483352|NCT05297032|Protective Agents|protective agents|mesh-ancestor
154483353|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483354|NCT03388580|Dimercaprol|dimercaprol|mesh-list
154483355|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
154483356|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
154483357|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483358|NCT03525912|Ketamine|ketamine|mesh-list
154483359|NCT03525912|Analgesics|analgesics|mesh-list
154483360|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
154483361|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483362|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483363|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154483364|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154483365|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
154483366|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
154483367|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483368|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154483369|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154483370|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483371|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483372|NCT02289378|Docetaxel|docetaxel|mesh-list
154483373|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
154483374|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483375|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
154483376|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
154483377|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
154483378|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483379|NCT04565600|Etoricoxib|etoricoxib|mesh-list
154483380|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154483381|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154483382|NCT04565600|Analgesics|analgesics|mesh-ancestor
154483383|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
154047195|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483384|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483385|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483386|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483387|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483388|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154483389|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154483390|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483391|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483392|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
154483393|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
154483394|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154483395|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154483396|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483397|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483398|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483399|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483400|NCT05631730|Metoprolol|metoprolol|mesh-list
154483401|NCT05631730|Flecainide|flecainide|mesh-list
154483402|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154483403|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154483404|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
154483405|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
154483406|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483407|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483408|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154483409|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154483410|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154483411|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
154483412|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483413|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483414|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154483415|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154483416|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154483417|NCT00092144|Montelukast|montelukast|mesh-list
154207280|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
154483418|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483419|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483420|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483421|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154483423|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
154483424|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483425|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154483426|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154483427|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
154483428|NCT02289768|Salicylates|salicylates|mesh-list
154483429|NCT02289768|Fluorouracil|fluorouracil|mesh-list
154483430|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
154483431|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483432|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154483433|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483434|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154483435|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
154483436|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483437|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483438|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
154483439|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
154483440|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
154483441|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154483442|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154483443|NCT02289768|Analgesics|analgesics|mesh-ancestor
154047249|NCT00727870|Glycerol|glycerol|mesh-list
154483444|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
154483445|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483446|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483447|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483448|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154483449|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483450|NCT04330430|Nivolumab|nivolumab|mesh-list
154483451|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154483452|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483453|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154483454|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483455|NCT03387956|Dexamethasone|dexamethasone|mesh-list
154483456|NCT03387956|Atropine|atropine|mesh-list
154483457|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483458|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
154483459|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
154483460|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483461|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483462|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154483463|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
154483464|NCT03387956|Hormones|hormones|mesh-ancestor
154483465|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483466|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154483467|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483468|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154483469|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154483470|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154483471|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154483472|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483473|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
154483474|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
154483475|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154483476|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154483477|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
154483478|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483479|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483480|NCT03384524|Metoprolol|metoprolol|mesh-list
154483481|NCT03384524|Bromocriptine|bromocriptine|mesh-list
154483482|NCT03384524|Tamsulosin|tamsulosin|mesh-list
154483483|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154483484|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154483485|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
154047345|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483486|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
154483487|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483488|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483489|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154483490|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154483491|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154483492|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
154483493|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483494|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111674|NCT00545740|Mesalamine|mesalamine|mesh-list
154483495|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154483496|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154483497|NCT03384524|Urological Agents|urological agents|mesh-ancestor
154483498|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154483499|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154483500|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
154483501|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483502|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
154483503|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
154483504|NCT03387644|Pregabalin|pregabalin|mesh-list
154483505|NCT03387644|Analgesics|analgesics|mesh-ancestor
154483506|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
154483507|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483508|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483509|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
154483510|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154483511|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154483512|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483513|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154483514|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154483515|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154483516|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483517|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154483518|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
154483519|NCT02290002|Calcium|calcium|mesh-list
154483520|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154483521|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483522|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
154483523|NCT02290002|Coagulants|coagulants|mesh-ancestor
154483524|NCT02294292|Carvedilol|carvedilol|mesh-list
154483525|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154483526|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154483527|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
154483528|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483529|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483530|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483531|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154483532|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
154483533|NCT02294292|Protective Agents|protective agents|mesh-ancestor
154483534|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154483535|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154483536|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154483537|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
154483538|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154483539|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154483540|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
154483541|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
154483542|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
154483543|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483544|NCT03387566|Growth Substances|growth substances|mesh-ancestor
154483545|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
154483546|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154483547|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
154483548|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483549|NCT03391856|Expectorants|expectorants|mesh-ancestor
154483550|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483551|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154483552|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
154483553|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483554|NCT03391856|Protective Agents|protective agents|mesh-ancestor
154483555|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483556|NCT03391856|Antidotes|antidotes|mesh-ancestor
154483557|NCT01664494|Capecitabine|capecitabine|mesh-list
154483558|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154483559|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
154483560|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483561|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483562|NCT02290470|Dexamethasone|dexamethasone|mesh-list
154483563|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
154483564|NCT02290470|Paclitaxel|paclitaxel|mesh-list
154483565|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154207434|NCT01070511|Tadalafil|tadalafil|mesh-list
154483566|NCT02290470|Carboplatin|carboplatin|mesh-list
154483567|NCT02290470|Olanzapine|olanzapine|mesh-list
154483568|NCT02290470|Palonosetron|palonosetron|mesh-list
154483569|NCT02290470|BB 1101|bb 1101|mesh-list
154483570|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154483571|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483572|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154483573|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154483574|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154483575|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483576|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483577|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
154483578|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
154483579|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483580|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483581|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154483582|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
154483583|NCT02290470|Hormones|hormones|mesh-ancestor
154483584|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483585|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154483586|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
154483587|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483588|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154483589|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154483590|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483591|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154483592|NCT02290470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154483593|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154483594|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154483595|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483596|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
154483597|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154483598|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154483599|NCT05172518|Capecitabine|capecitabine|mesh-list
154483600|NCT05172518|Taxane|taxane|mesh-list
154483601|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154483602|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
154483603|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483604|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483605|NCT03724084|Cytarabine|cytarabine|mesh-list
154483606|NCT03724084|Daunorubicin|daunorubicin|mesh-list
154483607|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154483608|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
154483609|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483610|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483611|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
154483612|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483613|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154483614|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
154483615|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483616|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154483617|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154483618|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154483619|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483620|NCT05172440|Tislelizumab|tislelizumab|mesh-list
154483621|NCT05172440|Axitinib|axitinib|mesh-list
154483622|NCT05172440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154483623|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483624|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154483625|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483626|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483627|NCT02298582|Fentanyl|fentanyl|mesh-list
154483628|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154483629|NCT02298582|Narcotics|narcotics|mesh-ancestor
154483630|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483631|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483632|NCT02298582|Analgesics|analgesics|mesh-ancestor
154483633|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
154483634|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483635|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154483636|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154483637|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
154483638|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
154483639|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
154483640|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154207506|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483641|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154483642|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154483643|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860700|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154483644|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483645|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
154483646|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483647|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483648|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154483649|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483650|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154483651|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154483652|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483653|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483654|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154483655|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154483656|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483657|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
154483658|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483659|NCT02291094|Lidocaine|lidocaine|mesh-list
154483660|NCT02291094|Remifentanil|remifentanil|mesh-list
154483661|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
154483662|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
154483663|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483664|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483665|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
154483666|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483667|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154483668|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154483669|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154483670|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047489|NCT03860597|Memantine|memantine|mesh-list
154483671|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483672|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154483673|NCT02291094|Narcotics|narcotics|mesh-ancestor
154483674|NCT02291094|Analgesics|analgesics|mesh-ancestor
154483675|NCT03387098|Leucovorin|leucovorin|mesh-list
154483676|NCT03387098|Paclitaxel|paclitaxel|mesh-list
154483677|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
154483678|NCT03387098|Bevacizumab|bevacizumab|mesh-list
154483679|NCT03387098|Capecitabine|capecitabine|mesh-list
154483680|NCT03387098|Fluorouracil|fluorouracil|mesh-list
154483681|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
154483682|NCT03387098|Avelumab|avelumab|mesh-list
154483683|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154483684|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483685|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
154483686|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
154483687|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
154483688|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483689|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154483690|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
154483691|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483692|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483693|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154483694|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
154483695|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154483696|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154483697|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154483698|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154483699|NCT03387098|Growth Substances|growth substances|mesh-ancestor
154483700|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
154483701|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154483702|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
154483703|NCT03387098|Antidotes|antidotes|mesh-ancestor
154483704|NCT03387098|Protective Agents|protective agents|mesh-ancestor
154483705|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
154483706|NCT03387098|Vitamins|vitamins|mesh-ancestor
154483707|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
154483708|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154483709|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
154483710|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154483711|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483712|NCT02577016|Incretins|incretins|mesh-ancestor
154483713|NCT02577016|Hormones|hormones|mesh-ancestor
154483714|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207582|NCT01040702|Methylphenidate|methylphenidate|mesh-list
154483715|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154483716|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
154483717|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483718|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483719|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154483720|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
154483721|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154483722|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483723|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
154483724|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483725|NCT04465110|Protective Agents|protective agents|mesh-ancestor
154483726|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483727|NCT03391700|Rocuronium|rocuronium|mesh-list
154483728|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154483729|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154483730|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154483731|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483732|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483733|NCT02294838|Citric Acid|citric acid|mesh-list
154483734|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
154483735|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
154483736|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154483737|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
154483738|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
154483739|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483740|NCT03383822|Insulin|insulin|mesh-list
154483741|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154483742|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154483743|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483744|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154483745|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483746|NCT03383744|Vitamin A|vitamin a|mesh-list
154483747|NCT03383744|Vitamins|vitamins|mesh-ancestor
154483748|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
154483749|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483750|NCT05662358|Denosumab|denosumab|mesh-list
154483751|NCT05662358|Alendronate|alendronate|mesh-list
154483752|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154483753|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483754|NCT02294994|Tirofiban|tirofiban|mesh-list
154483755|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154483756|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154483757|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483758|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154483759|NCT03386630|Sufentanil|sufentanil|mesh-list
154483760|NCT03386630|Morphine|morphine|mesh-list
154483762|NCT03386630|Bupivacaine|bupivacaine|mesh-list
154483763|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
154483764|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
154483765|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483766|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483767|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
154483768|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483769|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154483770|NCT03386630|Narcotics|narcotics|mesh-ancestor
154483771|NCT03386630|Analgesics|analgesics|mesh-ancestor
154483772|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154483773|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154483774|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
154483775|NCT03132714|Amoxicillin|amoxicillin|mesh-list
154483776|NCT03132714|Metronidazole|metronidazole|mesh-list
154483777|NCT03132714|Clarithromycin|clarithromycin|mesh-list
154483778|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154483779|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483780|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154483781|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154483782|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154483783|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483784|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483785|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154483786|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154483787|NCT03386318|Oxycodone|oxycodone|mesh-list
154483788|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154207656|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
154483789|NCT03386318|Narcotics|narcotics|mesh-ancestor
154483790|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483791|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860701|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154483792|NCT03386318|Analgesics|analgesics|mesh-ancestor
154047650|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154483793|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
154483794|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483795|NCT03339284|Dexamethasone|dexamethasone|mesh-list
154483796|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
154483797|NCT03339284|Ropivacaine|ropivacaine|mesh-list
154483798|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154483799|NCT03339284|BB 1101|bb 1101|mesh-list
154483800|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483801|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
154483802|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
154483803|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483804|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483805|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154483806|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
154483807|NCT03339284|Hormones|hormones|mesh-ancestor
154483808|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483809|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154483810|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483811|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
154483812|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
154483813|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483814|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
154483815|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
154483816|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483817|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483818|NCT02291562|Dronabinol|dronabinol|mesh-list
154483819|NCT02291562|Cannabidiol|cannabidiol|mesh-list
154483820|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
154483821|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
154483822|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483823|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154483824|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154483825|NCT02291562|Analgesics|analgesics|mesh-ancestor
154483826|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
154483827|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047655|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
154483828|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154483829|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154483830|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483831|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483832|NCT02291562|Hormones|hormones|mesh-ancestor
154483833|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483834|NCT03316586|Nivolumab|nivolumab|mesh-list
154483835|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154483836|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483837|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154483838|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483839|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154483840|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483841|NCT02295150|Nadroparin|nadroparin|mesh-list
154483842|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
154483843|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154483844|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154483845|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483846|NCT03390608|Trastuzumab|trastuzumab|mesh-list
154483847|NCT03390608|Estrogens|estrogens|mesh-list
154483848|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154483849|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483850|NCT03390608|Hormones|hormones|mesh-ancestor
154483851|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154483852|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483853|NCT03513822|Midazolam|midazolam|mesh-list
154483854|NCT03513822|Ketamine|ketamine|mesh-list
154483855|NCT03513822|Analgesics|analgesics|mesh-ancestor
154483856|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
154483857|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483858|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483859|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154483860|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154483861|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
154483862|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
154483863|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483864|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154483865|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154207728|NCT01041170|Hormones|hormones|mesh-ancestor
154483867|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860702|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
154483868|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154483869|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154483870|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154483871|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154483872|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154483873|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
154483874|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
154483875|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154483876|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483877|NCT03513432|Ethanol|ethanol|mesh-list
154483878|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154483879|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047743|NCT00612989|Temozolomide|temozolomide|mesh-list
154483880|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483881|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483882|NCT02299440|Ketamine|ketamine|mesh-list
154483883|NCT02299440|Analgesics|analgesics|mesh-ancestor
154483884|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
154483885|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483886|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483887|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154483888|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154483889|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
154483890|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
154483891|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483892|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154483893|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154483894|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483895|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483896|NCT02145195|Vitamin D|vitamin d|mesh-list
154483897|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
154483898|NCT02145195|Vitamins|vitamins|mesh-ancestor
154483899|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
154483900|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483901|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154483902|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154483903|NCT03517020|Nebivolol|nebivolol|mesh-list
154483904|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154483905|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
154483906|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154483907|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154483908|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154483909|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
154483910|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483911|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483912|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483913|NCT02254629|Laxatives|laxatives|mesh-list
154483914|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154483915|NCT02145585|Anesthetics|anesthetics|mesh-list
154483916|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483917|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483918|NCT02291796|Bezafibrate|bezafibrate|mesh-list
154483919|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154483920|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
154483921|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483922|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154483923|NCT03544827|Atropine|atropine|mesh-list
154483924|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154483925|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154483926|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154483927|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
154483928|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483929|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483930|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154483931|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483932|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
154483933|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
154483934|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154483935|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154483936|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
154483937|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483938|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483939|NCT00107991|Etanercept|etanercept|mesh-list
154207870|NCT00381888|PENTA|penta|mesh-list
154483940|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154483941|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154483942|NCT00107991|Analgesics|analgesics|mesh-ancestor
154860703|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483943|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
154483944|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483945|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483946|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154483947|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154483948|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154483949|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154483950|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
154483951|NCT03513276|Epinephrine|epinephrine|mesh-list
154483952|NCT03513276|Racepinephrine|racepinephrine|mesh-list
154483953|NCT03513276|Ropivacaine|ropivacaine|mesh-list
154483954|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
154483955|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
154483956|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
154483957|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483958|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483959|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
154483960|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154483961|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154483962|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154483963|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
154483964|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483965|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483966|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154483967|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154483968|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
154483969|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154483970|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
154483971|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
154483972|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
154483973|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154483974|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
154483975|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154483976|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483977|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154483978|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483979|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
154483980|NCT03516630|Trazodone|trazodone|mesh-list
154483981|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154483982|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154483983|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154483984|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154483985|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154483986|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154483987|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154483988|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154483989|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154483990|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154483991|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154483992|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154483993|NCT03516630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154483994|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154483995|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154483996|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154483997|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
154483998|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154483999|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
154484000|NCT02142075|Daptomycin|daptomycin|mesh-list
154484001|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154484002|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484003|NCT02145975|Fentanyl|fentanyl|mesh-list
154484004|NCT02145975|Morphine|morphine|mesh-list
154484005|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
154484006|NCT02145975|Narcotics|narcotics|mesh-ancestor
154484007|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484008|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484009|NCT02145975|Analgesics|analgesics|mesh-ancestor
154484010|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
154484011|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484012|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154484013|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154860704|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154484014|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
154484015|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
154484016|NCT02295852|Calcium|calcium|mesh-list
154484017|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154484018|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484020|NCT02295930|Cetuximab|cetuximab|mesh-list
154484021|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154484022|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484023|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154484024|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154484025|NCT02295930|Growth Substances|growth substances|mesh-ancestor
154484026|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484027|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
154484028|NCT02142309|Pioglitazone|pioglitazone|mesh-list
154484029|NCT02142309|Glimepiride|glimepiride|mesh-list
154484030|NCT02142309|Vildagliptin|vildagliptin|mesh-list
154484031|NCT02142309|Canagliflozin|canagliflozin|mesh-list
154484032|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154047842|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
154484033|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484034|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154484035|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484036|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
154484037|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154484038|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
154484039|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484040|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484041|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154484042|NCT02146209|Metronidazole|metronidazole|mesh-list
154484043|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484044|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154484045|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154484046|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154484047|NCT02299908|Bupivacaine|bupivacaine|mesh-list
154484048|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
154484049|NCT02299908|Anesthetics|anesthetics|mesh-list
154484050|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154484051|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484052|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484053|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
154484054|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484055|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
154484056|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
154484057|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
154484058|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154484059|NCT02142543|Protective Agents|protective agents|mesh-ancestor
154484060|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484061|NCT03390374|Nystatin|nystatin|mesh-list
154484062|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154484063|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484064|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
154484065|NCT03390374|Ionophores|ionophores|mesh-ancestor
154484066|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484067|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484068|NCT03545373|Amoxicillin|amoxicillin|mesh-list
154484069|NCT03545373|Azithromycin|azithromycin|mesh-list
154484070|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154484071|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484072|NCT00492856|Methotrexate|methotrexate|mesh-list
154484073|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
154484074|NCT00492856|Tretinoin|tretinoin|mesh-list
154484075|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154484076|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
154484077|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154484078|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484079|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154484080|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
154484081|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484082|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484083|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
154484084|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484085|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154484086|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484087|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
154484088|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154484089|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154207949|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
154484090|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
154484092|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
154484094|NCT02142777|Estrogens|estrogens|mesh-ancestor
154484095|NCT02142777|Hormones|hormones|mesh-ancestor
154484096|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484097|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484098|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
154484099|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154484100|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484101|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484102|NCT03544671|Vitamin D|vitamin d|mesh-list
154484103|NCT03544671|Vitamins|vitamins|mesh-ancestor
154484104|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
154484105|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484106|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154484107|NCT03390062|Apatinib|apatinib|mesh-list
154484108|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484109|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154484110|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484111|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484112|NCT03382886|Bevacizumab|bevacizumab|mesh-list
154484113|NCT03382886|Nivolumab|nivolumab|mesh-list
154484114|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154484115|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484116|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154484117|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154484118|NCT03382886|Growth Substances|growth substances|mesh-ancestor
154484119|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484120|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
154484121|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154484122|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484123|NCT03125486|Belimumab|belimumab|mesh-list
154484124|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484125|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
154484126|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484127|NCT02147925|Metformin|metformin|mesh-list
154484128|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
154484129|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154484130|NCT02147925|Liraglutide|liraglutide|mesh-list
154484131|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154484132|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484133|NCT02147925|Incretins|incretins|mesh-ancestor
154484134|NCT02147925|Hormones|hormones|mesh-ancestor
154484135|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484136|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154484137|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
154484138|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484139|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484140|NCT02147925|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154484141|NCT03544047|Paclitaxel|paclitaxel|mesh-list
154484142|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154484143|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484144|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
154484145|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
154484146|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
154484147|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484148|NCT03544125|Durvalumab|durvalumab|mesh-list
154484149|NCT03544125|Olaparib|olaparib|mesh-list
154484150|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154484151|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
154484152|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154484153|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
154484154|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154484155|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484156|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
154484157|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484158|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484159|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484160|NCT02146911|Bupropion|bupropion|mesh-list
154484161|NCT02146911|Varenicline|varenicline|mesh-list
154484162|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154484163|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
154484164|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208031|NCT02457702|Glycerol|glycerol|mesh-list
154484165|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154484166|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154484167|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484168|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484170|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484171|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484172|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154484173|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154484174|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484175|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154484176|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154484177|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
154484178|NCT02776683|Bevacizumab|bevacizumab|mesh-list
154484179|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154484180|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484181|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154484182|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154484183|NCT02776683|Growth Substances|growth substances|mesh-ancestor
154484184|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484185|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
154484186|NCT02963714|Vaccines|vaccines|mesh-list
154484187|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
154484188|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484189|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154484190|NCT02148393|Estradiol|estradiol|mesh-list
154484191|NCT02148393|Progesterone|progesterone|mesh-list
154484192|NCT02148393|Estrogens|estrogens|mesh-ancestor
154484193|NCT02148393|Hormones|hormones|mesh-ancestor
154484194|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484195|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484196|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154484197|NCT02148393|Progestins|progestins|mesh-ancestor
154484198|NCT00104871|Bortezomib|bortezomib|mesh-list
154484199|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484200|NCT03385538|Clopidogrel|clopidogrel|mesh-list
154484201|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154484202|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154484203|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154484204|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154484205|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
154484206|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484207|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484208|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484209|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154484210|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154484211|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154484212|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484213|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484214|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154484215|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154484216|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154484217|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154484218|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
154484219|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484220|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484221|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154484222|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154484223|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
154484224|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154484225|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154484226|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
154484227|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
154484228|NCT02148549|Irinotecan|irinotecan|mesh-list
154484229|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484230|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154484231|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154484232|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484233|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484234|NCT03375398|PAZ320|paz320|mesh-list
154484235|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154484236|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484237|NCT02147535|Methylphenidate|methylphenidate|mesh-list
154484238|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154484239|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484241|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154484242|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484243|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484244|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
154484245|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484246|NCT02148783|Methylphenidate|methylphenidate|mesh-list
154484247|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154484248|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484249|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154484250|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154484251|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484252|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484253|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
154484254|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484255|NCT02155803|Hormones|hormones|mesh-list
154484256|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154484257|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154484258|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
154484259|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484260|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484261|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484262|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484263|NCT02148861|Insulin|insulin|mesh-list
154484264|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154484265|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154484266|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484267|NCT02152059|Nintedanib|nintedanib|mesh-list
154484268|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484269|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154484270|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048088|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
154484271|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484272|NCT02149095|Treprostinil|treprostinil|mesh-list
154484273|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154484274|NCT02149329|Meropenem|meropenem|mesh-list
154484275|NCT02149329|Imipenem|imipenem|mesh-list
154484276|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
154484277|NCT02149329|Cilastatin|cilastatin|mesh-list
154484278|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154484279|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484280|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
154484281|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484282|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484283|NCT03255512|Isosorbide|isosorbide|mesh-list
154484284|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154484285|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154484286|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154484287|NCT03255512|Diuretics|diuretics|mesh-ancestor
154484288|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
154484289|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484290|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
154484291|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154484292|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484293|NCT02149407|Glycerol|glycerol|mesh-list
154484294|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154484295|NCT02149407|Protective Agents|protective agents|mesh-ancestor
154484296|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484297|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
154484298|NCT03543657|Hematinics|hematinics|mesh-ancestor
154484299|NCT03542955|Etoricoxib|etoricoxib|mesh-list
154484300|NCT03542955|Analgesics|analgesics|mesh-list
154484301|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
154484302|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484303|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484304|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154484305|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154484306|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154484307|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154484308|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154484309|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154484310|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484311|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208168|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
154484312|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
154484313|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484314|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
154484315|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484316|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
154484317|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154484318|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154484319|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484320|NCT00104637|Urological Agents|urological agents|mesh-ancestor
154484321|NCT04810208|Docetaxel|docetaxel|mesh-list
154484322|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484323|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
154484324|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
154484325|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
154484326|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484327|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
154484328|NCT04445636|Morphine|morphine|mesh-list
154484329|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154484330|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484331|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484332|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154484333|NCT04445636|Analgesics|analgesics|mesh-ancestor
154484334|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
154484335|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484336|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154484337|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154484338|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154484339|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
154484340|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484341|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484342|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154484343|NCT04445636|Narcotics|narcotics|mesh-ancestor
154484344|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
154484345|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154484346|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154484347|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484348|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
154484349|NCT02152917|Coagulants|coagulants|mesh-ancestor
154484350|NCT03111212|Iloprost|iloprost|mesh-list
154484351|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154484352|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
154484353|NCT02149953|Glycine|glycine|mesh-list
154484354|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
154484355|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484356|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484357|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484358|NCT03380936|Tacrolimus|tacrolimus|mesh-list
154484359|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
154484360|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154484361|NCT03380936|Antibodies|antibodies|mesh-list
154484362|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
154484363|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154484364|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484365|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
154484366|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484367|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154484368|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484369|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484370|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
154484371|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154484372|NCT02150031|Lidocaine|lidocaine|mesh-list
154484373|NCT02150031|Epinephrine|epinephrine|mesh-list
154484374|NCT02150031|Racepinephrine|racepinephrine|mesh-list
154484375|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
154484376|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
154484377|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
154484378|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484379|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484380|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
154484381|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484382|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154484383|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154484384|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154484385|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484386|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484387|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154484388|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484389|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
154484390|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
154484391|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154484392|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154484393|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
154484394|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484395|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154484396|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154484397|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
154484398|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154484399|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
154484400|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
154484401|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
154484402|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154484403|NCT04655170|Albuterol|albuterol|mesh-list
154484404|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
154484405|NCT04655170|Ipratropium|ipratropium|mesh-list
154484406|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154484407|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154484408|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
154484409|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484410|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484411|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154484412|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
154484413|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154484414|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154484415|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154484416|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
154484417|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484418|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484419|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
154484420|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154484421|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
154484422|NCT02156661|Oxytocin|oxytocin|mesh-list
154484423|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
154484424|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154484425|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484426|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154484427|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154484428|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484429|NCT03374540|Vitamin K|vitamin k|mesh-list
154484430|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
154484431|NCT03374540|Vitamins|vitamins|mesh-ancestor
154484432|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
154484433|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484434|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154484435|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
154484436|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154484437|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
154484438|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484439|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484440|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
154484441|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154484442|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154484443|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
154484444|NCT03374540|Coagulants|coagulants|mesh-ancestor
154484445|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154484446|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154484447|NCT03378674|Remifentanil|remifentanil|mesh-list
154484448|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154484449|NCT03378674|Narcotics|narcotics|mesh-ancestor
154484450|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484451|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484452|NCT03378674|Analgesics|analgesics|mesh-ancestor
154484453|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
154484454|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484455|NCT02157207|Vitamins|vitamins|mesh-list
154484456|NCT02157207|Vitamin E|vitamin e|mesh-list
154484457|NCT02157207|Antioxidants|antioxidants|mesh-list
154484458|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
154484459|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484460|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484461|NCT02157207|Protective Agents|protective agents|mesh-ancestor
154484462|NCT02261103|Pramipexole|pramipexole|mesh-list
154484463|NCT02261103|Dexpramipexole|dexpramipexole|mesh-list
154484464|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
154484465|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484466|NCT02261103|Protective Agents|protective agents|mesh-ancestor
154484467|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484468|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154484469|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154484470|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
154484471|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
154484472|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484474|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154484475|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484476|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484477|NCT03374306|Atropine|atropine|mesh-list
154484478|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
154484479|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154484480|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154484481|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154484482|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
154484483|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484484|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484485|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154484486|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
154484487|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
154484488|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
154484489|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154484490|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154484491|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
154484492|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484493|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484494|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154484495|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154484496|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
154484497|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154484498|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154484499|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484500|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484501|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154484502|NCT05534230|Analgesics|analgesics|mesh-ancestor
154484503|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
154484504|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484505|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154484506|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154484507|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154048317|NCT04116411|Temozolomide|temozolomide|mesh-list
154484508|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
154484509|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484510|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484511|NCT03369782|Rocuronium|rocuronium|mesh-list
154484512|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154484513|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154484514|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154484515|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484516|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484517|NCT00157014|Cyclosporine|cyclosporine|mesh-list
154484518|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
154484519|NCT00157014|Prednisone|prednisone|mesh-list
154484520|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
154484521|NCT00157014|Tacrolimus|tacrolimus|mesh-list
154484522|NCT00157014|Cyclosporins|cyclosporins|mesh-list
154484523|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154484524|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
154484525|NCT00157014|Hormones|hormones|mesh-ancestor
154484526|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484527|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484528|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154484529|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484530|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484531|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
154484532|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154484533|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484534|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484535|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
154484536|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484537|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
154860705|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154484538|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154484539|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154484540|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154484541|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
154484542|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154484544|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
154484545|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484546|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154484547|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154484548|NCT00157014|Protective Agents|protective agents|mesh-ancestor
154484549|NCT03374228|Linrodostat|linrodostat|mesh-list
154484550|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484551|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048371|NCT01840007|Metformin|metformin|mesh-list
154484552|NCT02778867|Fluticasone|fluticasone|mesh-list
154484553|NCT02778867|Xhance|xhance|mesh-list
154484554|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154484555|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154484556|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
154484557|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484558|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484559|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154484560|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
154484561|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
154484562|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154484563|NCT04232072|Ibuprofen|ibuprofen|mesh-list
154484564|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154484565|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154484566|NCT04232072|Analgesics|analgesics|mesh-ancestor
154484567|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
154484568|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484569|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484570|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154484571|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154484572|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154484573|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484574|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484575|NCT02300064|Antioxidants|antioxidants|mesh-list
154484576|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484577|NCT02300064|Protective Agents|protective agents|mesh-ancestor
154484578|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484579|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154484580|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154484581|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484582|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
154484583|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
154484584|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154484585|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154484586|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154484587|NCT02519582|Niclosamide|niclosamide|mesh-list
154484588|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
154484589|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154484590|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
154484591|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154484592|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484593|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
154484594|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
154484595|NCT05467462|Oxytocin|oxytocin|mesh-list
154484596|NCT05467462|Carbetocin|carbetocin|mesh-list
154484597|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
154484598|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154484599|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484600|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154484601|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154484602|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484603|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
154484604|NCT05467462|Coagulants|coagulants|mesh-ancestor
154484605|NCT03369002|Seladelpar|seladelpar|mesh-list
154484606|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154484607|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
154484608|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484609|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154484610|NCT02300376|Edetic Acid|edetic acid|mesh-list
154860706|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154484611|NCT02300376|Calcium|calcium|mesh-list
154484612|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
154860707|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
154484613|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154484615|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
154484616|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154484617|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
154484618|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
154484619|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484620|NCT02300376|Antidotes|antidotes|mesh-ancestor
154484621|NCT02300376|Protective Agents|protective agents|mesh-ancestor
154484622|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154484623|NCT02296398|Romidepsin|romidepsin|mesh-list
154484624|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154484625|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484626|NCT02296398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154484627|NCT02296398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484628|NCT02296398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484629|NCT03520062|Liraglutide|liraglutide|mesh-list
154484630|NCT03520062|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154484631|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154484632|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484633|NCT03520062|Incretins|incretins|mesh-ancestor
154484634|NCT03520062|Hormones|hormones|mesh-ancestor
154484635|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484636|NCT03512574|Pregabalin|pregabalin|mesh-list
154484637|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
154484638|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154484639|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484640|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484641|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154484642|NCT03512574|Analgesics|analgesics|mesh-ancestor
154484643|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
154484644|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484645|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154484646|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154484647|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154484648|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
154484649|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484650|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484651|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
154484652|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154484653|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484654|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154484655|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154484656|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154484657|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154484658|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154484659|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154484660|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484661|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
154484662|NCT03377348|Triamcinolone|triamcinolone|mesh-list
154484663|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154484664|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154484665|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154484666|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154484667|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
154484668|NCT03377348|Hormones|hormones|mesh-ancestor
154484669|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484670|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484671|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484672|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
154484673|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484674|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484675|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154484676|NCT02255253|Telmisartan|telmisartan|mesh-list
154484677|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154484678|NCT02255253|Diuretics|diuretics|mesh-ancestor
154484679|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
154484680|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484681|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154484682|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484683|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048497|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154484684|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154484685|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154484687|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484688|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484689|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154484690|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484691|NCT02151279|Chitosan|chitosan|mesh-list
154484692|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154484693|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154484694|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
154484695|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484696|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154484697|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
154484698|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
154484699|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
154484700|NCT02151279|Coagulants|coagulants|mesh-ancestor
154484701|NCT02159313|Riociguat|riociguat|mesh-list
154484702|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
154484703|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484704|NCT03515772|Darunavir|darunavir|mesh-list
154484705|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154484706|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154484707|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
154484708|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484709|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484710|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154484711|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154484712|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
154484713|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484714|NCT03519750|Melatonin|melatonin|mesh-list
154484715|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
154484716|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484717|NCT03519750|Protective Agents|protective agents|mesh-ancestor
154484718|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484719|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484720|NCT02158143|Vitamin D|vitamin d|mesh-list
154484721|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
154484722|NCT02158143|Vitamins|vitamins|mesh-ancestor
154484723|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
154484724|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484725|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154484726|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154484727|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154484728|NCT02158221|Growth Substances|growth substances|mesh-ancestor
154484729|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484730|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048562|NCT03435107|Durvalumab|durvalumab|mesh-list
154484731|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484732|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484733|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
154484734|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154484735|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154484736|NCT02301000|Metronidazole|metronidazole|mesh-list
154484737|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484738|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154484739|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154484740|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154484741|NCT02292732|Trametinib|trametinib|mesh-list
154484742|NCT02292732|Norinyl|norinyl|mesh-list
154484743|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484744|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154484745|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484746|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484747|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154484748|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154484749|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154484750|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
154484751|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154484752|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484753|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154484754|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154484755|NCT03376958|Apatinib|apatinib|mesh-list
154484756|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484757|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154484758|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112942|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
154484759|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484761|NCT03367676|Trastuzumab|trastuzumab|mesh-list
154484762|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484763|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
154484764|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
154484765|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
154484766|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484767|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154048598|NCT00707421|Ketorolac|ketorolac|mesh-list
154484769|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484771|NCT02158689|Menotropins|menotropins|mesh-list
154484772|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484773|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154484774|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154484775|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484776|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484777|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154484778|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
154484779|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484780|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484781|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154484782|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
154484783|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154484784|NCT03372200|Febuxostat|febuxostat|mesh-list
154484785|NCT03372200|Dotinurad|dotinurad|mesh-list
154484786|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
154484787|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154484788|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
154484789|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
154484790|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154484791|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154484792|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484793|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
154484794|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
154484795|NCT02158845|Leuprolide|leuprolide|mesh-list
154484796|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
154484797|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154484798|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
154484799|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154484800|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484801|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154484802|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484803|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154484804|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
154484805|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154484806|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154484807|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154484808|NCT02292966|Asunaprevir|asunaprevir|mesh-list
154484809|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
154484810|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484811|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484812|NCT02519660|Lidocaine|lidocaine|mesh-list
154484813|NCT02519660|Tetracaine|tetracaine|mesh-list
154484814|NCT02519660|Prilocaine|prilocaine|mesh-list
154048628|NCT00826449|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154484815|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154484816|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
154484817|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
154484818|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484819|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484820|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
154484821|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484822|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154484823|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154484824|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154484825|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484826|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484827|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154484828|NCT02297490|Immunomodulating Agents|immunomodulating agents|mesh-list
154484829|NCT02297490|Immunologic Factors|immunologic factors|mesh-ancestor
154484830|NCT02297490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484831|NCT02297568|Vitamin D|vitamin d|mesh-list
154484832|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
154484833|NCT02297568|Vitamins|vitamins|mesh-ancestor
154484834|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
154484835|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484836|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154484837|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154484838|NCT03515382|Itraconazole|itraconazole|mesh-list
154484839|NCT03515382|Voriconazole|voriconazole|mesh-list
154484840|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
154484841|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208695|NCT03972358|Misoprostol|misoprostol|mesh-list
154484842|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154484843|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154484844|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484845|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484846|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154484847|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
154484848|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154484849|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484850|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154484851|NCT03511560|Tacrolimus|tacrolimus|mesh-list
154484852|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484853|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
154484854|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484855|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154484856|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484857|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484858|NCT03688802|Varenicline|varenicline|mesh-list
154484859|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154484860|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154484861|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
154484862|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484863|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484864|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484865|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
154484866|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154484867|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484868|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
154484869|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154484870|NCT03376178|Lidocaine|lidocaine|mesh-list
154484871|NCT03376178|Ropivacaine|ropivacaine|mesh-list
154484872|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
154484873|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
154484874|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484875|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484876|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
154484877|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484878|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154484879|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154484880|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154484881|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484882|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484883|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
154484884|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484885|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
154484886|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484887|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154484888|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154484889|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
154484890|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484891|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484892|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154484893|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154484894|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154484895|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484896|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484897|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154484898|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484899|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484900|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
154484901|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484902|NCT02302326|Folic Acid|folic acid|mesh-list
154484903|NCT02302326|Inositol|inositol|mesh-list
154484904|NCT02302326|Metformin|metformin|mesh-list
154484905|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154484906|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484907|NCT02302326|Hematinics|hematinics|mesh-ancestor
154484908|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
154484909|NCT02302326|Vitamins|vitamins|mesh-ancestor
154484910|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
154484911|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
154484912|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
154484913|NCT02293590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154484914|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154484915|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484916|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
154484917|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484918|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154484919|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154484920|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154484921|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154484922|NCT02293590|Analgesics|analgesics|mesh-ancestor
154484923|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
154048727|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
154484924|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484925|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154484926|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154484927|NCT03124082|Lidocaine|lidocaine|mesh-list
154484928|NCT03124082|Clonidine|clonidine|mesh-list
154484929|NCT03124082|Ketamine|ketamine|mesh-list
154484930|NCT03124082|Remifentanil|remifentanil|mesh-list
154484931|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
154484932|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
154484933|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154484934|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484935|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
154484936|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484937|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154484938|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154484939|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154484940|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154484941|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484942|NCT03124082|Analgesics|analgesics|mesh-ancestor
154484943|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154484944|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154484945|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
154484946|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154484947|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154484948|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154484949|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154484950|NCT03124082|Narcotics|narcotics|mesh-ancestor
154484951|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154484952|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
154484953|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
154484954|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154484955|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154484956|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154484957|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
154484958|NCT03518502|Sorafenib|sorafenib|mesh-list
154484959|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484960|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154484961|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860708|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860709|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154048821|NCT00660062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154860710|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154860711|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860712|NCT01925378|Nelfinavir|nelfinavir|mesh-list
154484962|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484963|NCT02301780|Aspirin|aspirin|mesh-list
154484964|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154484965|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154484966|NCT02301780|Analgesics|analgesics|mesh-ancestor
154484967|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
154484968|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154484969|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484970|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154484971|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154484972|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154484973|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154484974|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484975|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154484976|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154484977|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484978|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
154484979|NCT04527068|Bevacizumab|bevacizumab|mesh-list
154484980|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154484981|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484982|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154484983|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154484984|NCT04527068|Growth Substances|growth substances|mesh-ancestor
154484985|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484986|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
154484987|NCT02739360|Idelalisib|idelalisib|mesh-list
154484988|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154484989|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154484990|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154484992|NCT03123770|Docetaxel|docetaxel|mesh-list
154484993|NCT03123770|Doxorubicin|doxorubicin|mesh-list
154484994|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154484995|NCT03123770|Epirubicin|epirubicin|mesh-list
154484996|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154484997|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
154484998|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154484999|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485000|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154485001|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
154485002|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485003|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485004|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154485005|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
154485006|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
154485007|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
154485008|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154485009|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154485010|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154485011|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485012|NCT04464642|Methotrexate|methotrexate|mesh-list
154485013|NCT04464642|Tofacitinib|tofacitinib|mesh-list
154485014|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154485015|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
154485016|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154485017|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485018|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154485019|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
154485020|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485021|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485022|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
154485023|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485024|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154485025|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154485026|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
154485027|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485028|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154485029|NCT04464642|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154485030|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154485031|NCT02293668|Letrozole|letrozole|mesh-list
154485032|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485033|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154485034|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154485035|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485036|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485037|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154485038|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
154485039|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485040|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485041|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
154485042|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
154485043|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
154485044|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485045|NCT03375632|Dotinurad|dotinurad|mesh-list
154485046|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
154485047|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
154485048|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485049|NCT02302170|Vaccines|vaccines|mesh-list
154860713|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154485050|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
154485051|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485052|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
154485053|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154485054|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485055|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
154485056|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154485057|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154048873|NCT02633930|Bismuth|bismuth|mesh-list
154485058|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
154485059|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485060|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154485061|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154485062|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208917|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
154485063|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485064|NCT02293824|Caffeine|caffeine|mesh-list
154485065|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
154485066|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485067|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154485068|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485069|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154485070|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485071|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154485072|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154485073|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
154485074|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485075|NCT03366584|Vitamin D|vitamin d|mesh-list
154485076|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
154485077|NCT03366584|Beta Carotene|beta carotene|mesh-list
154485079|NCT03366584|Dexamethasone|dexamethasone|mesh-list
154485080|NCT03366584|Carotenoids|carotenoids|mesh-list
154485081|NCT03366584|Picolinic acid|picolinic acid|mesh-list
154485082|NCT03366584|Vitamins|vitamins|mesh-ancestor
154485083|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
154485084|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485085|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485086|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
154485087|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
154485088|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485089|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154485090|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
154485091|NCT03366584|Hormones|hormones|mesh-ancestor
154485092|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485093|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154485094|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485095|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154485096|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154485097|NCT03366584|Trace Elements|trace elements|mesh-ancestor
154485098|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
154485099|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485100|NCT03366584|Protective Agents|protective agents|mesh-ancestor
154485101|NCT03366584|Provitamins|provitamins|mesh-ancestor
154485102|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154485103|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
154485104|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
154485105|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
154485106|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154485107|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485108|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485109|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154485110|NCT03370562|Analgesics|analgesics|mesh-ancestor
154485111|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
154485112|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485113|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154485114|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154485115|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154485116|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
154485117|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485118|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485119|NCT03370328|Peppermint oil|peppermint oil|mesh-list
154485120|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
154485121|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
154485122|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485123|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485124|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154485125|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
154485127|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
154485128|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154485129|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154485130|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485131|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154485132|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485133|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154485134|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154485135|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485136|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154485137|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154485139|NCT04525664|Clarithromycin|clarithromycin|mesh-list
154485140|NCT04525664|Omeprazole|omeprazole|mesh-list
154485141|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485142|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485143|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154485144|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154485145|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154485146|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485147|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485148|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154485149|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154485150|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154485151|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154485152|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154485153|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048954|NCT00865020|Renin Inhibitors|renin inhibitors|mesh-ancestor
154049014|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
154485154|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049028|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
154485155|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
154485156|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485157|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485158|NCT03505008|Adalimumab|adalimumab|mesh-list
154485159|NCT03505008|Methotrexate|methotrexate|mesh-list
154485160|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154485161|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
154485162|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154485163|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485164|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154485165|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
154485166|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485167|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485168|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
154485169|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485170|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154485171|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154485172|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
154485173|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485174|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154485175|NCT03505008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154485176|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485177|NCT03507426|Ketamine|ketamine|mesh-list
154485178|NCT03507426|Analgesics|analgesics|mesh-ancestor
154485179|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
154485180|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485181|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485182|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154485183|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154485184|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
154049044|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485185|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
154485186|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485187|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154485188|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154485189|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485190|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485191|NCT02311530|Felodipine|felodipine|mesh-list
154485192|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154485193|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154485194|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154485195|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154485196|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485197|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154113381|NCT01053169|Thrombin|thrombin|mesh-list
154485198|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485200|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
154485201|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
154485202|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154485203|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154485204|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485205|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485206|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485207|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485208|NCT02306772|Mesalamine|mesalamine|mesh-list
154485209|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154209069|NCT01048398|Analgesics|analgesics|mesh-ancestor
154485210|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154485211|NCT02306772|Analgesics|analgesics|mesh-ancestor
154485212|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
154485213|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485214|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485215|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485216|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485217|NCT03507348|Rituximab|rituximab|mesh-list
154485218|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485219|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485220|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
154485221|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485222|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485223|NCT02518802|Pemetrexed|pemetrexed|mesh-list
154485224|NCT02518802|Gefitinib|gefitinib|mesh-list
154485225|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485226|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485227|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485228|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154485229|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154485230|NCT02518802|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154485231|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154485232|NCT04524026|Letrozole|letrozole|mesh-list
154485233|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154485234|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485235|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154485236|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485237|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485238|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154485239|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
154485240|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485241|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485242|NCT02311608|Octreotide|octreotide|mesh-list
154485243|NCT02311608|Terlipressin|terlipressin|mesh-list
154485244|NCT02311608|Somatostatin|somatostatin|mesh-list
154485245|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154049081|NCT00525031|Temozolomide|temozolomide|mesh-list
154485246|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154485247|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485248|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154485249|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154485250|NCT02311608|Hormones|hormones|mesh-ancestor
154485251|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485252|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485253|NCT02307006|Vancomycin|vancomycin|mesh-list
154485254|NCT02307006|Cefazolin|cefazolin|mesh-list
154485255|NCT02307006|Ceftaroline|ceftaroline|mesh-list
154485256|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485257|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485258|NCT02307006|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154485259|NCT03362684|Cetuximab|cetuximab|mesh-list
154485260|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485261|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485262|NCT02311686|Ethanol|ethanol|mesh-list
154485263|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154485264|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485265|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485266|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485267|NCT02311764|Carboplatin|carboplatin|mesh-list
154485268|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485269|NCT03365726|Dobutamine|dobutamine|mesh-list
154485270|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154485271|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
154485272|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
154485273|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485274|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485275|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154485276|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154485277|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154485278|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
154485279|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485280|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485281|NCT03365726|Protective Agents|protective agents|mesh-ancestor
154860714|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154485283|NCT02303418|Carbetocin|carbetocin|mesh-list
154485284|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
154485285|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154485286|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485287|NCT03510000|Empagliflozin|empagliflozin|mesh-list
154485288|NCT03510000|Pancrelipase|pancrelipase|mesh-list
154485290|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049108|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485291|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485292|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154485293|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485294|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154485295|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154485296|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
154485297|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154485298|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154485299|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154485300|NCT03358082|Tacrolimus|tacrolimus|mesh-list
154485301|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154485302|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
154485303|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485304|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154485305|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485306|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485307|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485308|NCT03358004|Capecitabine|capecitabine|mesh-list
154485309|NCT03358004|Vinorelbine|vinorelbine|mesh-list
154485310|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154485311|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
154485312|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485313|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485314|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154485315|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
154485316|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
154485317|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154485318|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
154485319|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154485320|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154485321|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485322|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154485323|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154485324|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
154485325|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485326|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485327|NCT03365336|Oseltamivir|oseltamivir|mesh-list
154485328|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
154485329|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485330|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485331|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485332|NCT03362216|Diclofenac|diclofenac|mesh-list
154485333|NCT03362216|Salicylates|salicylates|mesh-list
154485334|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
154485335|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154485336|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154485337|NCT03362216|Analgesics|analgesics|mesh-ancestor
154485338|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
154485339|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485340|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485341|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485342|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485343|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154485344|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485345|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485346|NCT02307396|Haloperidol|haloperidol|mesh-list
154485348|NCT02307396|Olanzapine|olanzapine|mesh-list
154485349|NCT02307396|Risperidone|risperidone|mesh-list
154485350|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154485351|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154485352|NCT02307396|Ziprasidone|ziprasidone|mesh-list
154485353|NCT02307396|Amisulpride|amisulpride|mesh-list
154485354|NCT02307396|Perphenazine|perphenazine|mesh-list
154485355|NCT02307396|Sertindole|sertindole|mesh-list
154485356|NCT02307396|Fluphenazine|fluphenazine|mesh-list
154485357|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
154485358|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
154485359|NCT02307396|Sulpiride|sulpiride|mesh-list
154485360|NCT02307396|Thioridazine|thioridazine|mesh-list
154485361|NCT02307396|Clopenthixol|clopenthixol|mesh-list
154209229|NCT00187096|Analgesics|analgesics|mesh-ancestor
154485362|NCT02307396|Fluspirilene|fluspirilene|mesh-list
154485363|NCT02307396|Benperidol|benperidol|mesh-list
154485364|NCT02307396|Bromperidol|bromperidol|mesh-list
154485365|NCT02307396|Perazine|perazine|mesh-list
154485366|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154485367|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
154485368|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485369|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485370|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485371|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154485372|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154485373|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485374|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154485375|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154485376|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
154485377|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
154485378|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
154485379|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485380|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154485381|NCT02307396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154485382|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154485383|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154485384|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
154485385|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154485386|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154485387|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154049213|NCT02313389|Rituximab|rituximab|mesh-list
154485388|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154485389|NCT03509688|Entecavir|entecavir|mesh-list
154485390|NCT03509688|Resveratrol|resveratrol|mesh-list
154485391|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
154485392|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485393|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
154485394|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485395|NCT03509688|Protective Agents|protective agents|mesh-ancestor
154485396|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485397|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485398|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154485399|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
154485400|NCT02303730|Exenatide|exenatide|mesh-list
154485401|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154485402|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485403|NCT02303730|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154485404|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154485405|NCT02303730|Incretins|incretins|mesh-ancestor
154485406|NCT02303730|Hormones|hormones|mesh-ancestor
154485407|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485408|NCT04524728|Letrozole|letrozole|mesh-list
154485409|NCT04524728|Fulvestrant|fulvestrant|mesh-list
154485410|NCT04524728|Palbociclib|palbociclib|mesh-list
154485411|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485412|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154485413|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154485414|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485415|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485416|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154485417|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
154485418|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485419|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485420|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154860715|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
154485421|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154485422|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154485424|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154485425|NCT04523792|Narcotics|narcotics|mesh-ancestor
154485426|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485427|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485428|NCT04523792|Analgesics|analgesics|mesh-ancestor
154485429|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
154485430|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485431|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154485432|NCT02312232|Levodopa|levodopa|mesh-list
154485433|NCT02312232|Carbidopa|carbidopa|mesh-list
154485434|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154485435|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154485436|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
154485437|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485438|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485439|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485440|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154485441|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485442|NCT02303886|Methylene Blue|methylene blue|mesh-list
154485443|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485444|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485445|NCT02518958|Nivolumab|nivolumab|mesh-list
154485446|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485447|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485448|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154485449|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485450|NCT03506802|Aldesleukin|aldesleukin|mesh-list
154485451|NCT03506802|Plerixafor|plerixafor|mesh-list
154485452|NCT03506802|Lenalidomide|lenalidomide|mesh-list
154485453|NCT03506802|Melphalan|melphalan|mesh-list
154485454|NCT03506802|Interleukin-2|interleukin-2|mesh-list
154485455|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
154485456|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154485457|NCT03506802|Lenograstim|lenograstim|mesh-list
154485458|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154485459|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
154485460|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485461|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154485462|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154485463|NCT03506802|Growth Substances|growth substances|mesh-ancestor
154485464|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
154485465|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485466|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154485467|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
154485468|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485469|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154485470|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154485471|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154485472|NCT03506802|Analgesics|analgesics|mesh-ancestor
154485473|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
154485474|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485475|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154485476|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154485477|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
154485478|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485479|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
154485480|NCT02307864|Tramadol|tramadol|mesh-list
154485481|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154485482|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485483|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485484|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154485485|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154485486|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485487|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485488|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485489|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154485490|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
154485491|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154485492|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485493|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154485494|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154485495|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154113685|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
154485496|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154485497|NCT02307864|Narcotics|narcotics|mesh-ancestor
154485498|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485499|NCT02307864|Analgesics|analgesics|mesh-ancestor
154485500|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
154485501|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485502|NCT02304042|Oxytocin|oxytocin|mesh-list
154485503|NCT02304042|Carbetocin|carbetocin|mesh-list
154485504|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
154485505|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154485506|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485507|NCT02308098|Budesonide|budesonide|mesh-list
154485508|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
154485509|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154485510|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485511|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154485512|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
154485513|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485514|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485515|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154485516|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
154485517|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
154485518|NCT02308098|Hormones|hormones|mesh-ancestor
154485519|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485520|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154485521|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154485522|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154485523|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
154485524|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485525|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485526|NCT03504072|Etanercept|etanercept|mesh-list
154485527|NCT03504072|Tofacitinib|tofacitinib|mesh-list
154485528|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154049345|NCT01455389|Hormones|hormones|mesh-ancestor
154485529|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154485530|NCT03504072|Analgesics|analgesics|mesh-ancestor
154485531|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
154485532|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485533|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485534|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485535|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485536|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154485537|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154485538|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
154485539|NCT03504072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154485540|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154485541|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485542|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485543|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154485544|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154485545|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
154485546|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485547|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485548|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485549|NCT03361124|Oxytocin|oxytocin|mesh-list
154485550|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
154485551|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154485552|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485553|NCT03364088|Oxycodone|oxycodone|mesh-list
154485554|NCT03364088|Anesthetics|anesthetics|mesh-list
154485555|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485556|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485557|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154485558|NCT03364088|Narcotics|narcotics|mesh-ancestor
154485559|NCT03364088|Analgesics|analgesics|mesh-ancestor
154485560|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
154485561|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485562|NCT02304198|Udenafil|udenafil|mesh-list
154485563|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154485564|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154485565|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485566|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485567|NCT02304276|Calcium|calcium|mesh-list
154485568|NCT02304276|Fluorides|fluorides|mesh-list
154485569|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154485570|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860716|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485571|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
154485572|NCT02304276|Protective Agents|protective agents|mesh-ancestor
154485573|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154485575|NCT02308332|Emtricitabine|emtricitabine|mesh-list
154485576|NCT02308332|Rilpivirine|rilpivirine|mesh-list
154485577|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
154485578|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485579|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154485580|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154485581|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485582|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485583|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154485584|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154485585|NCT03509298|Antibodies|antibodies|mesh-list
154485586|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154485587|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
154485588|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485589|NCT03503994|Beclomethasone|beclomethasone|mesh-list
154485590|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485591|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
154485592|NCT03503994|Hormones|hormones|mesh-ancestor
154485593|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485594|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485595|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154485596|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
154485597|NCT01796002|Romidepsin|romidepsin|mesh-list
154485598|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154485599|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485600|NCT01796002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154485601|NCT01796002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485602|NCT01796002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485603|NCT03509142|Sirolimus|sirolimus|mesh-list
154485604|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485605|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049460|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154485606|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154485607|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485608|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
154485609|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154485610|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
154485611|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485612|NCT03356912|Prednisone|prednisone|mesh-list
154485613|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485614|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
154485615|NCT03356912|Hormones|hormones|mesh-ancestor
154485616|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485617|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485618|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154485619|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485620|NCT00102687|Azacitidine|azacitidine|mesh-list
154485621|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154485622|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
154485623|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485624|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485625|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485626|NCT04509440|Triamcinolone|triamcinolone|mesh-list
154485627|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154485628|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154485629|NCT04509440|Anesthetics|anesthetics|mesh-list
154485630|NCT04509440|Mepivacaine|mepivacaine|mesh-list
154485631|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
154485632|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154485633|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485634|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485635|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485636|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
154485637|NCT04509440|Hormones|hormones|mesh-ancestor
154485638|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485639|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154485640|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
154485641|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485642|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485643|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
154485644|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485646|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154485647|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154485648|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
154485649|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485650|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485651|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485652|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154485653|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154485654|NCT03360734|Cetuximab|cetuximab|mesh-list
154485655|NCT03360734|Panitumumab|panitumumab|mesh-list
154485656|NCT03360734|Necitumumab|necitumumab|mesh-list
154485657|NCT03360734|Antibodies|antibodies|mesh-list
154485658|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
154485659|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485660|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485661|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485662|NCT02308644|Bevacizumab|bevacizumab|mesh-list
154485663|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485664|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485665|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154485666|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154485667|NCT02308644|Growth Substances|growth substances|mesh-ancestor
154485668|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485669|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
154485670|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
154485671|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154485672|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485673|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485674|NCT04510636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154485675|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485676|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154485677|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
154485678|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154485679|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485680|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485681|NCT03540849|Immunotoxins|immunotoxins|mesh-ancestor
154049537|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049538|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
154049539|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049540|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049541|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154485682|NCT03540849|Immunoconjugates|immunoconjugates|mesh-ancestor
154485683|NCT03540849|Immunologic Factors|immunologic factors|mesh-ancestor
154485684|NCT03540849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485686|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485687|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485688|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
154485689|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485690|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485691|NCT03356600|Apatinib|apatinib|mesh-list
154485692|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485693|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154485694|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485695|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485696|NCT00102531|Cisplatin|cisplatin|mesh-list
154485697|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485698|NCT03360266|Listerine|listerine|mesh-list
154485699|NCT03360266|Fluorides|fluorides|mesh-list
154485700|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
154485701|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
154485702|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
154485703|NCT03360266|Protective Agents|protective agents|mesh-ancestor
154485704|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485705|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154485706|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485707|NCT02154789|Polidocanol|polidocanol|mesh-list
154485708|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154485709|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154485710|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154485711|NCT03506256|Norfloxacin|norfloxacin|mesh-list
154485712|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485713|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485714|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154485715|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154485716|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485717|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485718|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485719|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154113922|NCT00908817|Hormones|hormones|mesh-ancestor
154485721|NCT03356444|Docetaxel|docetaxel|mesh-list
154485722|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
154485723|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485724|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
154485725|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
154485726|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
154485727|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485728|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154485729|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485730|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
154485731|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485732|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485733|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154485734|NCT03503604|Leucovorin|leucovorin|mesh-list
154485735|NCT03503604|Paclitaxel|paclitaxel|mesh-list
154209597|NCT00360282|Rizatriptan|rizatriptan|mesh-list
154485736|NCT03503604|Carboplatin|carboplatin|mesh-list
154485737|NCT03503604|Gemcitabine|gemcitabine|mesh-list
154485738|NCT03503604|Fluorouracil|fluorouracil|mesh-list
154049574|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049575|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
154049576|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154049577|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154049578|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154049580|NCT02705573|Mannitol|mannitol|mesh-list
154485739|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
154485740|NCT03503604|Irinotecan|irinotecan|mesh-list
154485741|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154485742|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485743|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
154485744|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
154485745|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
154485746|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485747|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154485748|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
154485749|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154485750|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
154485751|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485752|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154485753|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154485754|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485755|NCT03503604|Antidotes|antidotes|mesh-ancestor
154485756|NCT03503604|Protective Agents|protective agents|mesh-ancestor
154485757|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
154485758|NCT03503604|Vitamins|vitamins|mesh-ancestor
154485759|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
154485760|NCT04508816|Cetuximab|cetuximab|mesh-list
154485761|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
154485762|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485763|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485764|NCT03359876|Warfarin|warfarin|mesh-list
154485765|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
154485766|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
154485767|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154485768|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
154485769|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154485770|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
154485771|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485772|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485773|NCT05226832|Triamcinolone|triamcinolone|mesh-list
154485774|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485775|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
154485776|NCT05226832|Hormones|hormones|mesh-ancestor
154485777|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485778|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485779|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
154485780|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154485781|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
154485782|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485783|NCT03354572|Expectorants|expectorants|mesh-ancestor
154485784|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
154485785|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154485786|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
154485787|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049621|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
154049622|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154049623|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154049624|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154485788|NCT03354572|Protective Agents|protective agents|mesh-ancestor
154485789|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485790|NCT03354572|Antidotes|antidotes|mesh-ancestor
154485791|NCT03359798|Narcotics|narcotics|mesh-list
154485792|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485793|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485794|NCT03359798|Analgesics|analgesics|mesh-ancestor
154485795|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
154485796|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485797|NCT02309346|Clindamycin|clindamycin|mesh-list
154485798|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
154485799|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
154485800|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485801|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485802|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154485803|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485804|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485805|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154485806|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154485807|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485808|NCT03356054|Immunotoxins|immunotoxins|mesh-ancestor
154485809|NCT03356054|Immunoconjugates|immunoconjugates|mesh-ancestor
154485810|NCT03356054|Immunologic Factors|immunologic factors|mesh-ancestor
154485811|NCT03356054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485812|NCT03354494|Desogestrel|desogestrel|mesh-list
154485813|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154485814|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154485815|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154485816|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
154485817|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154485818|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485819|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154485820|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154485821|NCT03354494|Progestins|progestins|mesh-ancestor
154485823|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485824|NCT03354338|Amoxicillin|amoxicillin|mesh-list
154485825|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485826|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485827|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
154485828|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485829|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485830|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154485831|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154485832|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485833|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485834|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485835|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154485836|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154485837|NCT02309424|Acetic Acid|acetic acid|mesh-list
154485838|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154485839|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154485840|NCT03506178|Phenylephrine|phenylephrine|mesh-list
154485841|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
154485842|NCT03506178|Menthol|menthol|mesh-list
154485843|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
154485844|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
154485845|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154485846|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154485847|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
154485848|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485849|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485850|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485851|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
154485852|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
154485853|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485854|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
154485855|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154485856|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
154485857|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154485858|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
154485859|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154485860|NCT03506178|Protective Agents|protective agents|mesh-ancestor
154485861|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
154485862|NCT02578186|Promethazine|promethazine|mesh-list
154485863|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154485864|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154485865|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154485866|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485867|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
154485868|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
154485869|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
154485870|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485872|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
154485873|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154485874|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154485875|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
154485876|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
154485877|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485878|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485879|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154485880|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
154485881|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
154485882|NCT04128436|Progesterone|progesterone|mesh-list
154485883|NCT04128436|Progestins|progestins|mesh-ancestor
154485884|NCT04128436|Hormones|hormones|mesh-ancestor
154485885|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485886|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485887|NCT02309658|Cisplatin|cisplatin|mesh-list
154485888|NCT02309658|Gemcitabine|gemcitabine|mesh-list
154485889|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485890|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154485891|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
154485892|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485894|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154485895|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154485896|NCT05532280|Analgesics|analgesics|mesh-ancestor
154485897|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
154485898|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485899|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485900|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485901|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485902|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154485903|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154485904|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485905|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485906|NCT04517162|Povidone|povidone|mesh-list
154485907|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
154485908|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
154485909|NCT02155023|Insulin|insulin|mesh-list
154485910|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154485911|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154485912|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485913|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
154485914|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154485915|NCT02163213|Antibodies|antibodies|mesh-list
154485916|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
154485917|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485918|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
154485919|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154485920|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154485921|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485922|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
154485923|NCT04443920|Coagulants|coagulants|mesh-ancestor
154485924|NCT03359018|Apatinib|apatinib|mesh-list
154485925|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485926|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154485927|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485928|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485929|NCT05530252|Minocycline|minocycline|mesh-list
154485930|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154485931|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
154485932|NCT02163291|Paclitaxel|paclitaxel|mesh-list
154485933|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154485934|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485935|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
154485936|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
154485937|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
154485938|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485939|NCT03505788|Acetazolamide|acetazolamide|mesh-list
154485940|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
154049712|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
154485941|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154485942|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485943|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485944|NCT03505788|Diuretics|diuretics|mesh-ancestor
154485945|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
154485946|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485947|NCT02309970|Aspirin|aspirin|mesh-list
154485949|NCT02309970|Warfarin|warfarin|mesh-list
154485950|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
154485951|NCT02309970|Dabigatran|dabigatran|mesh-list
154485952|NCT02309970|Apixaban|apixaban|mesh-list
154485953|NCT02309970|Clopidogrel|clopidogrel|mesh-list
154485954|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154485955|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154485956|NCT02309970|Analgesics|analgesics|mesh-ancestor
154485957|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
154485958|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154485959|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485960|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485961|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154485962|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154485963|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154485964|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485965|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154485966|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154485967|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485968|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
154485969|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154485970|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154485971|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154485972|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
154485973|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154485974|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
154485975|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154485976|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
154485977|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154485978|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
154485980|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154485981|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154485982|NCT02161653|Pyridoxine|pyridoxine|mesh-list
154485983|NCT02161653|Prednisone|prednisone|mesh-list
154485984|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
154485985|NCT02161653|Metadoxine|metadoxine|mesh-list
154485986|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154485987|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
154485988|NCT02161653|Hormones|hormones|mesh-ancestor
154485989|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154485990|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049769|NCT00707746|Mipomersen|mipomersen|mesh-list
154049814|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
154049816|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154485991|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154485992|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154485993|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154485994|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154485995|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154485996|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154485997|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154485998|NCT02161653|Protective Agents|protective agents|mesh-ancestor
154485999|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
154486000|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154486001|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
154486002|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154486003|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
154486004|NCT02161653|Vitamins|vitamins|mesh-ancestor
154486005|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
154486006|NCT02576938|Triamcinolone|triamcinolone|mesh-list
154486007|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154486008|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
154486009|NCT02576938|Hormones|hormones|mesh-ancestor
154486010|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486011|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486012|NCT02305836|Donepezil|donepezil|mesh-list
154486013|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154486014|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486015|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486016|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
154486017|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486018|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486019|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
154486020|NCT03503136|Cisplatin|cisplatin|mesh-list
154486021|NCT03503136|Docetaxel|docetaxel|mesh-list
154486022|NCT03503136|Capecitabine|capecitabine|mesh-list
154486023|NCT03503136|Fluorouracil|fluorouracil|mesh-list
154486024|NCT03503136|Nedaplatin|nedaplatin|mesh-list
154486025|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486026|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
154486027|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
154486028|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
154486029|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486030|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154486032|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154486033|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
154486034|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486035|NCT02305992|Bupivacaine|bupivacaine|mesh-list
154486036|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
154486037|NCT02305992|Anesthetics|anesthetics|mesh-list
154486038|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486039|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486040|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
154486041|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486042|NCT03355352|Sufentanil|sufentanil|mesh-list
154209893|NCT00174382|Donepezil|donepezil|mesh-list
154486043|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154486044|NCT03355352|Narcotics|narcotics|mesh-ancestor
154486045|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486046|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486047|NCT03355352|Analgesics|analgesics|mesh-ancestor
154486048|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
154486049|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486050|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154486051|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154486052|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
154486053|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
154486054|NCT05529940|Folfirinox|folfirinox|mesh-list
154486055|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486056|NCT04463784|Efavirenz|efavirenz|mesh-list
154486057|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154486058|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154486059|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486060|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486061|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
154486062|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486063|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154486064|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154486065|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154486066|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154486067|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154486068|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154486069|NCT02310360|Fallypride|fallypride|mesh-list
154486070|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154486071|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154486072|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
154486073|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486074|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486075|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486076|NCT03353480|Azithromycin|azithromycin|mesh-list
154486077|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154486078|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486079|NCT02306070|Metformin|metformin|mesh-list
154486080|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154486081|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486082|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
154486083|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154486084|NCT03353324|Bevacizumab|bevacizumab|mesh-list
154486085|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486086|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486087|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154486088|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154486089|NCT03353324|Growth Substances|growth substances|mesh-ancestor
154486090|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486091|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
154486092|NCT03354962|Nivolumab|nivolumab|mesh-list
154486093|NCT03354962|Ipilimumab|ipilimumab|mesh-list
154486094|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486095|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486096|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154486097|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486098|NCT04511468|Copper|copper|mesh-list
154486099|NCT04511468|Chromium|chromium|mesh-list
154860717|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486100|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
154486101|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486102|NCT04511468|Trace Elements|trace elements|mesh-ancestor
154486103|NCT05531422|Fentanyl|fentanyl|mesh-list
154486104|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154486105|NCT05531422|Narcotics|narcotics|mesh-ancestor
154486106|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486107|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486108|NCT05531422|Analgesics|analgesics|mesh-ancestor
154486109|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
154486110|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486111|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154486112|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154486113|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
154486114|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
154486115|NCT03354806|Analgesics|analgesics|mesh-list
154209971|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
154486116|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
154486117|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486118|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486120|NCT05529082|Narcotics|narcotics|mesh-ancestor
154486121|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486122|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486123|NCT05529082|Analgesics|analgesics|mesh-ancestor
154486124|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
154486125|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486126|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154486127|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154486128|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486129|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154486130|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
154486131|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486132|NCT02314182|Bevacizumab|bevacizumab|mesh-list
154486133|NCT02314182|Capecitabine|capecitabine|mesh-list
154486134|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
154486135|NCT02314182|Irinotecan|irinotecan|mesh-list
154486136|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486137|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486138|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154486139|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154486140|NCT02314182|Growth Substances|growth substances|mesh-ancestor
154049961|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154486141|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486142|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
154486143|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154486144|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
154486145|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486146|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154486147|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154486148|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486149|NCT05531344|Tamsulosin|tamsulosin|mesh-list
154486150|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154486151|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154486152|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154486153|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
154486154|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486155|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486156|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486157|NCT05531344|Urological Agents|urological agents|mesh-ancestor
154486158|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
154486159|NCT05531266|Hormones|hormones|mesh-ancestor
154486160|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486161|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486162|NCT03349658|Anesthetics|anesthetics|mesh-list
154486163|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486164|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486165|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
154486166|NCT03353012|Etonogestrel|etonogestrel|mesh-list
154486167|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154486168|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
154486169|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154486170|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486171|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154114362|NCT00541450|Incretins|incretins|mesh-ancestor
154486172|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154486174|NCT04462614|Heparin|heparin|mesh-list
154486175|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
154486176|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154486177|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154486178|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486179|NCT03349424|Somatostatin|somatostatin|mesh-list
154486180|NCT03349424|Hormones|hormones|mesh-ancestor
154486181|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486182|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486183|NCT03349346|Rituximab|rituximab|mesh-list
154486184|NCT03349346|Carboplatin|carboplatin|mesh-list
154486185|NCT03349346|Etoposide|etoposide|mesh-list
154486186|NCT03349346|Ifosfamide|ifosfamide|mesh-list
154486187|NCT03349346|Idelalisib|idelalisib|mesh-list
154486188|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486189|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486190|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
154486191|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486192|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154486193|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154486194|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154486195|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154486196|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486197|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486198|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154486199|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
154486200|NCT03502434|Petrolatum|petrolatum|mesh-list
154486201|NCT03502434|Emollients|emollients|mesh-ancestor
154486202|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
154486203|NCT03352700|Dyclonine|dyclonine|mesh-list
154486204|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
154486205|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
154486206|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486207|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486208|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
154486209|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486210|NCT05522998|Propofol|propofol|mesh-list
154486211|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154486212|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486213|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486214|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154486215|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
154486216|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
154486217|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
154486218|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154486219|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
154486220|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154486221|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486222|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154486223|NCT03498534|Isoniazid|isoniazid|mesh-list
154486224|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
154486225|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154486226|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486227|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154486228|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154486229|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
154486230|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486231|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154486232|NCT03502356|Azithromycin|azithromycin|mesh-list
154486233|NCT03502356|Cefazolin|cefazolin|mesh-list
154486234|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154486235|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486236|NCT03498456|Amoxicillin|amoxicillin|mesh-list
154486237|NCT03498456|Clarithromycin|clarithromycin|mesh-list
154486238|NCT03498456|Lansoprazole|lansoprazole|mesh-list
154486239|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
154486240|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154486241|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486242|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154486243|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486244|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486245|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154860718|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154050067|NCT00663182|Entecavir|entecavir|mesh-list
154486246|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154486247|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154486248|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154486249|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154486250|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
154486251|NCT02317146|Analgesics|analgesics|mesh-ancestor
154486252|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
154486253|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486254|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486255|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
154486256|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486257|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154486258|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
154486259|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154486260|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154486261|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486262|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154486263|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
154486264|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154486265|NCT05528146|Psyllium|psyllium|mesh-list
154486266|NCT05528146|Cathartics|cathartics|mesh-ancestor
154486267|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154486268|NCT03349112|Lidocaine|lidocaine|mesh-list
154486270|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
154486271|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486272|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486273|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
154486274|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486275|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154486276|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154486277|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154486278|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154050068|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
154050070|NCT00616031|Paclitaxel|paclitaxel|mesh-list
154486279|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486280|NCT03498222|Carboplatin|carboplatin|mesh-list
154486281|NCT03498222|Pemetrexed|pemetrexed|mesh-list
154486282|NCT03498222|Atezolizumab|atezolizumab|mesh-list
154486283|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486284|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486285|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486286|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154486287|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154486288|NCT03498222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154486289|NCT03498222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486290|NCT02518022|Insulin|insulin|mesh-list
154486291|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
154486292|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
154486293|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154486294|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486295|NCT03497988|Oxytocin|oxytocin|mesh-list
154486296|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
154486297|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154486298|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486299|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
154486300|NCT04610476|Prednisolone|prednisolone|mesh-list
154486301|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154486302|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
154486303|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154486304|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
154486305|NCT04610476|Adalimumab|adalimumab|mesh-list
154486306|NCT04610476|Infliximab|infliximab|mesh-list
154486307|NCT04610476|Etanercept|etanercept|mesh-list
154486308|NCT04610476|Apremilast|apremilast|mesh-list
154486309|NCT04610476|Golimumab|golimumab|mesh-list
154486310|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
154486311|NCT04610476|Methotrexate|methotrexate|mesh-list
154486312|NCT04610476|Abatacept|abatacept|mesh-list
154486313|NCT04610476|Ustekinumab|ustekinumab|mesh-list
154486314|NCT04610476|Ixekizumab|ixekizumab|mesh-list
154486315|NCT04610476|Tofacitinib|tofacitinib|mesh-list
154050136|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050137|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154486316|NCT04610476|Leflunomide|leflunomide|mesh-list
154486317|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154486318|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
154486319|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154860719|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154486320|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
154486321|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154486322|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486323|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154486324|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
154860720|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
154486325|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486327|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
154486328|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486329|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154486330|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154486331|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
154486332|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154486333|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154486334|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154486335|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
154486336|NCT04610476|Hormones|hormones|mesh-ancestor
154486337|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486338|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154486339|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
154486340|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
154486341|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486342|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154486343|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154486344|NCT04610476|Protective Agents|protective agents|mesh-ancestor
154486345|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154486346|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154486347|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154486348|NCT04610476|Analgesics|analgesics|mesh-ancestor
154486349|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
154486350|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154486351|NCT04610476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486352|NCT04610476|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154486353|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154486354|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154486355|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154486356|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486357|NCT03348800|Anesthetics|anesthetics|mesh-list
153592812|NCT01830153|Everolimus|everolimus|mesh-list
154486358|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486359|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486360|NCT02314806|Clindamycin|clindamycin|mesh-list
154486361|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
154486362|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
154050179|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486363|NCT02314806|Gentamicins|gentamicins|mesh-list
154050180|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050181|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154050182|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
154486364|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154486365|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154486366|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486367|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154486368|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486369|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486370|NCT00709202|Betahistine|betahistine|mesh-list
154486371|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
154486372|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
154486373|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
154486374|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486375|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486376|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486377|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
154486378|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154486379|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154486380|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154486381|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154486382|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486383|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
154486384|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486385|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486386|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154486387|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486388|NCT02321280|Denosumab|denosumab|mesh-list
154486389|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154486390|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486391|NCT02315118|Rituximab|rituximab|mesh-list
154486392|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486393|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486394|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
154486395|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486396|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154486397|NCT03122756|Dexamethasone|dexamethasone|mesh-list
154486398|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154486399|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
154486400|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
154486401|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486402|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486403|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154486404|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
154486405|NCT03122756|Hormones|hormones|mesh-ancestor
154486406|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050224|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486407|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154486408|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486409|NCT03122678|Thiamine|thiamine|mesh-list
154486410|NCT03122678|Vitamins|vitamins|mesh-ancestor
154486411|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
154486412|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486413|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
154486414|NCT02317770|Lidocaine|lidocaine|mesh-list
154486415|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
154486416|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
154486417|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486418|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486419|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
154210271|NCT01046864|Antidotes|antidotes|mesh-ancestor
154486420|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486421|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154486422|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154486423|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154486424|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154486425|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486426|NCT04506242|Apatinib|apatinib|mesh-list
154486427|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486428|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154486429|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486430|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486431|NCT05526898|Triamcinolone|triamcinolone|mesh-list
154050252|NCT00672776|Paroxetine|paroxetine|mesh-list
154486432|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154486433|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
154486434|NCT05526898|Hormones|hormones|mesh-ancestor
154486435|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486436|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486437|NCT05526820|Vaccines|vaccines|mesh-list
154486438|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
154486439|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486440|NCT03352076|Danazol|danazol|mesh-list
154486441|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154486442|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
154486443|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486444|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486445|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154486446|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154486447|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154486448|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154486449|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154486450|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
154486451|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486452|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486453|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486454|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154486455|NCT02738580|Hormones|hormones|mesh-ancestor
154486456|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486457|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486458|NCT03497364|Bupivacaine|bupivacaine|mesh-list
154486459|NCT03497364|Ropivacaine|ropivacaine|mesh-list
154486460|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
154486461|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
154486462|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486463|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486464|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
154486465|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486466|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154050258|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
154486467|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154486468|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486469|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
154486470|NCT05516446|Chromium|chromium|mesh-list
154860721|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486472|NCT05516446|Everolimus|everolimus|mesh-list
154486473|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154486474|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486475|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
154486476|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
154486477|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
154486478|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486479|NCT05516446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154486480|NCT05516446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154486481|NCT05516446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486482|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154486483|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
154486484|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486485|NCT05516446|Trace Elements|trace elements|mesh-ancestor
154486486|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
154486487|NCT02318082|Aldesleukin|aldesleukin|mesh-list
154486488|NCT02318082|Interleukin-2|interleukin-2|mesh-list
154486489|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486490|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154486491|NCT02318082|Analgesics|analgesics|mesh-ancestor
154050311|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154486492|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
154486493|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486494|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486495|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154486496|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154486497|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
154486498|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486499|NCT03348098|Paclitaxel|paclitaxel|mesh-list
154486500|NCT03348098|Apatinib|apatinib|mesh-list
154486501|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154486502|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486503|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
154486504|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
154486505|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
154486506|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486507|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154486508|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486509|NCT03351842|Cisplatin|cisplatin|mesh-list
154486510|NCT03351842|Carboplatin|carboplatin|mesh-list
154486511|NCT03351842|Pemetrexed|pemetrexed|mesh-list
154486512|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486513|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486514|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486515|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154486516|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154486517|NCT02447406|Docetaxel|docetaxel|mesh-list
154486518|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486519|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
154486520|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
154486521|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
154486522|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486523|NCT04505228|Atropine|atropine|mesh-list
154486524|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154486525|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154486526|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154486527|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
154486528|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486529|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486530|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154486531|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
154486532|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
154486533|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
154486534|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154486535|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154486536|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
154486537|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486538|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486539|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154486540|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
154486541|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486542|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154486543|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
154486544|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486545|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486546|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154486547|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154486548|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154486549|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
154486550|NCT02322372|Bupivacaine|bupivacaine|mesh-list
154486551|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
154486552|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486553|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486554|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
154486555|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
154486556|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486557|NCT01376804|Valganciclovir|valganciclovir|mesh-list
154486558|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
154486559|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486560|NCT05526118|Tenofovir|tenofovir|mesh-list
154486561|NCT05526118|Emtricitabine|emtricitabine|mesh-list
154486562|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154486563|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
154486564|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486565|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154486566|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154486567|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486568|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486569|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154486570|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154486571|NCT03122132|Ritonavir|ritonavir|mesh-list
154486572|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154486573|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154486574|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
154486575|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486576|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486577|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154486578|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154486579|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
154486580|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486581|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154486582|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154486583|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
154486584|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154486585|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154486586|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486587|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
154486588|NCT03351686|Coagulants|coagulants|mesh-ancestor
154486589|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
154486590|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154486591|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486592|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
154486593|NCT02319018|Leucovorin|leucovorin|mesh-list
154486594|NCT02319018|Folic Acid|folic acid|mesh-list
154486595|NCT02319018|Fluorouracil|fluorouracil|mesh-list
154486596|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
154486597|NCT02319018|Calcium|calcium|mesh-list
154486598|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
154486599|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154486600|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486601|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154486602|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
154486603|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486604|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154486605|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486606|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154486607|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
154486608|NCT02319018|Antidotes|antidotes|mesh-ancestor
154486609|NCT02319018|Protective Agents|protective agents|mesh-ancestor
154486610|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
154050425|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154486611|NCT02319018|Vitamins|vitamins|mesh-ancestor
154486612|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
154486613|NCT02319018|Hematinics|hematinics|mesh-ancestor
154486614|NCT02574520|Bupivacaine|bupivacaine|mesh-list
154486615|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154486616|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
154486617|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
154486618|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486619|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860722|NCT01925456|Fesoterodine|fesoterodine|mesh-list
154486620|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
154486621|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486623|NCT04425226|Lenvatinib|lenvatinib|mesh-list
154486624|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486625|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486626|NCT04425226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154486627|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486628|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154486629|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486630|NCT05520658|Fluorouracil|fluorouracil|mesh-list
154486631|NCT05520658|Digoxin|digoxin|mesh-list
154486632|NCT05520658|Furosemide|furosemide|mesh-list
154486633|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
154486634|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486635|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154486636|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486637|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154486638|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
154486639|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486640|NCT05520658|Diuretics|diuretics|mesh-ancestor
154486641|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
154486642|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154486643|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154050433|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
154050457|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
154486644|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154210493|NCT01044446|Icodextrin|icodextrin|mesh-list
154486646|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486647|NCT05520658|Protective Agents|protective agents|mesh-ancestor
154486648|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154486649|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154486650|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486651|NCT03351062|Tamoxifen|tamoxifen|mesh-list
154486652|NCT03351062|Toremifene|toremifene|mesh-list
154486653|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154486654|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
154486655|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486656|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486657|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154486658|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486659|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154486660|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154486661|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154486662|NCT03496740|Bupivacaine|bupivacaine|mesh-list
154486663|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
154486664|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
154486665|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486666|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486667|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
154486668|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486669|NCT05515822|Oxycodone|oxycodone|mesh-list
154486670|NCT05515822|Dezocine|dezocine|mesh-list
154486671|NCT05515822|Esketamine|esketamine|mesh-list
154486672|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154486673|NCT05515822|Narcotics|narcotics|mesh-ancestor
154486674|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486675|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486676|NCT05515822|Analgesics|analgesics|mesh-ancestor
154486677|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
154486678|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486679|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
154486680|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154486681|NCT04294654|Vortioxetine|vortioxetine|mesh-list
154486682|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
154486683|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154486684|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154486685|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154486686|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486687|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486688|NCT04294654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154486689|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154486690|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154486691|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486692|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486693|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
154486694|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154114890|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
154486695|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154486696|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154486697|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154486698|NCT03496506|Selexipag|selexipag|mesh-list
154486699|NCT03496506|Clopidogrel|clopidogrel|mesh-list
154486700|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154486701|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154486702|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154486703|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154486704|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
154486705|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486706|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486707|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486708|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154486709|NCT02325024|Nabiximols|nabiximols|mesh-list
154486710|NCT02325024|Analgesics|analgesics|mesh-ancestor
154486711|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
154486712|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486713|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486714|NCT02319564|Beclomethasone|beclomethasone|mesh-list
154486715|NCT02319564|Albuterol|albuterol|mesh-list
154486716|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154486717|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
154210614|NCT01071525|Niacin|niacin|mesh-list
154486718|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486719|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486720|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154486721|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
154486722|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
154486723|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154486724|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154486725|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154486726|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154486727|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
154486728|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486729|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486730|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154486731|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
154486732|NCT02319564|Hormones|hormones|mesh-ancestor
154486733|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486734|NCT02325180|Lumefantrine|lumefantrine|mesh-list
154486735|NCT02325180|Artemether|artemether|mesh-list
154486736|NCT02325180|Piperaquine|piperaquine|mesh-list
154486737|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154486738|NCT02325180|Artenimol|artenimol|mesh-list
154486739|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
154486740|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154486741|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154486742|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486743|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
154486744|NCT00709592|Tacrolimus|tacrolimus|mesh-list
154486745|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
154486746|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154486747|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154486748|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
154486749|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486750|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154486751|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486752|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486753|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154486754|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486755|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154486756|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
154486757|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154486758|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486759|NCT05515354|Nicotine|nicotine|mesh-list
154486760|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154486761|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
154486762|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486763|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486764|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154486765|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154486766|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
154486767|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486768|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486769|NCT02437370|Gemcitabine|gemcitabine|mesh-list
154486771|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
154486772|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154486773|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
154486774|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486775|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486776|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
154486777|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
154486778|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
154486779|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486780|NCT02437370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154486781|NCT05515120|Aspirin|aspirin|mesh-list
154486782|NCT05515120|Vitamin K|vitamin k|mesh-list
154486783|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
154486784|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
154486785|NCT05515120|Vitamins|vitamins|mesh-ancestor
154486786|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
154486787|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486788|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154486789|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154486790|NCT05515120|Analgesics|analgesics|mesh-ancestor
154486791|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
154486792|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486793|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154486794|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154486796|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154486797|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486798|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154486799|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154486800|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486801|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
154050557|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
154050609|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
154050610|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050611|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
154050612|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050613|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
154486802|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154486803|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
154486804|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154486805|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
154486806|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
154486807|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154486808|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
154486809|NCT05515120|Coagulants|coagulants|mesh-ancestor
154486810|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
154486811|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050614|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050615|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154050616|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154050617|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
154050618|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154050619|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154486812|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
154486813|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486814|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154486815|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154486816|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
154486817|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486818|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486819|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154486820|NCT03495804|Mannitol|mannitol|mesh-list
154486821|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154486822|NCT03495804|Diuretics|diuretics|mesh-ancestor
154486823|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
154486824|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486825|NCT05519410|Lenvatinib|lenvatinib|mesh-list
154486826|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486827|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154486828|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486829|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486830|NCT05578586|Meropenem|meropenem|mesh-list
154486831|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154486832|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486833|NCT02570074|Fosfomycin|fosfomycin|mesh-list
154486834|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154486835|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486836|NCT02569996|Rituximab|rituximab|mesh-list
154486837|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154486838|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486839|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
154486840|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486841|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154486842|NCT02325882|Fentanyl|fentanyl|mesh-list
154486843|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
154486844|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154486845|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486846|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486847|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154486848|NCT02325882|Analgesics|analgesics|mesh-ancestor
154486849|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
154486850|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486851|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154050645|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050646|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
154050647|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154050648|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
154486852|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154486853|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154486854|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
154486855|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486856|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486857|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154486858|NCT02325882|Narcotics|narcotics|mesh-ancestor
154486859|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154486860|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154486861|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
154486862|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
154486863|NCT00708500|Interferons|interferons|mesh-list
154486865|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
154486866|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
154486867|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154486868|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486869|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
154486870|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486871|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
154486872|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486873|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
154486874|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486875|NCT05144100|Cisplatin|cisplatin|mesh-list
154486876|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486877|NCT02320032|Aripiprazole|aripiprazole|mesh-list
154486878|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
154486879|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
154486880|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154486881|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154486882|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154486883|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486884|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486885|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
154486886|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
154486887|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486888|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486889|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154486890|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154486891|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
154486892|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154486893|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154486894|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154486895|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154486896|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
154486897|NCT05514652|Anesthetics|anesthetics|mesh-list
154486898|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486899|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486900|NCT05514652|Narcotics|narcotics|mesh-ancestor
154486901|NCT05514652|Analgesics|analgesics|mesh-ancestor
154486902|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
154486903|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486904|NCT00673244|Furosemide|furosemide|mesh-list
154486905|NCT00673244|Diuretics|diuretics|mesh-ancestor
154486906|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
154486907|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486908|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154486909|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154486910|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486911|NCT02517788|Interferons|interferons|mesh-list
154486912|NCT02517788|Interferon-beta|interferon-beta|mesh-list
154050649|NCT02629718|Paclitaxel|paclitaxel|mesh-list
154486913|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
154486914|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486915|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
154486916|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154486917|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
154486918|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486919|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154486920|NCT04599790|Lenvatinib|lenvatinib|mesh-list
154486921|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486922|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154486923|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486924|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486925|NCT03132168|Anesthetics|anesthetics|mesh-list
154486926|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486927|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486928|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154486929|NCT04937062|Glycerol|glycerol|mesh-list
154486930|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154486931|NCT04937062|Protective Agents|protective agents|mesh-ancestor
154486932|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486933|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486934|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154486935|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154486936|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486937|NCT02324010|Incretins|incretins|mesh-ancestor
154486938|NCT02324010|Hormones|hormones|mesh-ancestor
154486939|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154486940|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154486941|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
154486942|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486943|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486944|NCT02320734|Rocuronium|rocuronium|mesh-list
154486945|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154486946|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154486947|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154486948|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486949|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486950|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
154486951|NCT03346226|Propofol|propofol|mesh-list
154486952|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154486953|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154486954|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486955|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154486956|NCT03346226|Analgesics|analgesics|mesh-ancestor
154486957|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
154486958|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486959|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154486960|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154486961|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154486962|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
154486963|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486964|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486965|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154486966|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
154486967|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
154486968|NCT03347240|Baclofen|baclofen|mesh-list
154486969|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154486970|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486971|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154486972|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154486973|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154486974|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
154486975|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
154486976|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154486977|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486978|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
154486979|NCT02324088|Docetaxel|docetaxel|mesh-list
154486980|NCT02324088|Epirubicin|epirubicin|mesh-list
154486981|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154486982|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
154486983|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154486984|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154486985|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154486986|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
154486987|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154486988|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154486989|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154486990|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
154486991|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
154486992|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
154486993|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154486994|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154486995|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154486996|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154486997|NCT02324166|Cefazolin|cefazolin|mesh-list
154486998|NCT02324166|Lidocaine|lidocaine|mesh-list
154486999|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
154487000|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
154487001|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487002|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487003|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
154487004|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487005|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154487006|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154050797|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154050798|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050799|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154050800|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487007|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154487008|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154487009|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487010|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487011|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487012|NCT03346538|Edaravone|edaravone|mesh-list
154487013|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154487014|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
154487015|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487016|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154487017|NCT03346538|Protective Agents|protective agents|mesh-ancestor
154487018|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487019|NCT02513342|Docetaxel|docetaxel|mesh-list
154487020|NCT02513342|Endostar protein|endostar protein|mesh-list
154487021|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487022|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
154487023|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
154487024|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
154487025|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487026|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154487027|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154487028|NCT02513342|Growth Substances|growth substances|mesh-ancestor
154487029|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487030|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
154487031|NCT03495024|Varenicline|varenicline|mesh-list
154487032|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154487033|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154487034|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
154487035|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487036|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487037|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487038|NCT04188314|Desflurane|desflurane|mesh-list
154487039|NCT04188314|Isoflurane|isoflurane|mesh-list
154487040|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154487041|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
154487042|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
154487043|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487044|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487045|NCT05512780|Letrozole|letrozole|mesh-list
154487046|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487047|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154487048|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154487049|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487050|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487051|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154487052|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
154487053|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487054|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487055|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154487056|NCT02517164|Calcifediol|calcifediol|mesh-list
154487057|NCT02517164|Vitamins|vitamins|mesh-ancestor
154487058|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
154487059|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487060|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154487061|NCT04834362|Insulin|insulin|mesh-list
154487062|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154487063|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
154050851|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154487064|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
154487065|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154487066|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487067|NCT05512702|Heparin|heparin|mesh-list
154487068|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154487069|NCT05512702|Plasminogen|plasminogen|mesh-list
154487070|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154487071|NCT05512702|Tinzaparin|tinzaparin|mesh-list
154487072|NCT05512702|Dalteparin|dalteparin|mesh-list
154487073|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
154487074|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154487075|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154487076|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487077|NCT05512546|Aspirin|aspirin|mesh-list
154487078|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154487079|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487080|NCT05512546|Analgesics|analgesics|mesh-ancestor
154487081|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
154487082|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487083|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487084|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154487085|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154487086|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154487087|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154487088|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487089|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154487090|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154487091|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487092|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
154487093|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
154210945|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487094|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154487095|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487096|NCT03345134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154487097|NCT03345134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487098|NCT02512562|Simeprevir|simeprevir|mesh-list
154487099|NCT02512562|Odalasvir|odalasvir|mesh-list
154487100|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
154487101|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487102|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
154487103|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487104|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487105|NCT02516774|Adalimumab|adalimumab|mesh-list
154487106|NCT02516774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154487107|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154487108|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154487109|NCT05510986|Fentanyl|fentanyl|mesh-list
154487110|NCT05510986|Oxycodone|oxycodone|mesh-list
154487111|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154487112|NCT05510986|Narcotics|narcotics|mesh-ancestor
154487113|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487114|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487115|NCT05510986|Analgesics|analgesics|mesh-ancestor
154487116|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
154487117|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487118|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154487119|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154487120|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
154487121|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
154487122|NCT00101907|Gemcitabine|gemcitabine|mesh-list
154487123|NCT00101907|Panitumumab|panitumumab|mesh-list
154487124|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
154487125|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487126|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154487127|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
154487128|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487129|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154487130|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154487131|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487132|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
154487133|NCT03491748|Cefpodoxime Proxetil|cefpodoxime proxetil|mesh-list
154487134|NCT03491748|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154487135|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487136|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487137|NCT04769206|Galantamine|galantamine|mesh-list
154487138|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154487139|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487140|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487141|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
154487142|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487143|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487144|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154487145|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
153593553|NCT01843452|Capecitabine|capecitabine|mesh-list
154050931|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154050932|NCT00677144|Capecitabine|capecitabine|mesh-list
154487146|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487147|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
154487148|NCT03492996|Delpazolid|delpazolid|mesh-list
154487149|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487150|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487151|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154487152|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487153|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487155|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
154487156|NCT02161965|Fluindione|fluindione|mesh-list
154487157|NCT02161965|Phenindione|phenindione|mesh-list
154487158|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
154487159|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154487160|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
154487161|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154487162|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
154487163|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487164|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487165|NCT02050308|Nicotine|nicotine|mesh-list
154487166|NCT02050308|Varenicline|varenicline|mesh-list
154487167|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154487168|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
154487169|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211020|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487170|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487171|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154487172|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154487173|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
154487174|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487175|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487176|NCT02516618|Fasinumab|fasinumab|mesh-list
154487177|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487178|NCT02516618|Analgesics|analgesics|mesh-ancestor
154487179|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
154487180|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487181|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487182|NCT05507554|Analgesics|analgesics|mesh-list
154487183|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
154487184|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487185|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
154487186|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487187|NCT02516462|Hormones|hormones|mesh-list
154487188|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154487189|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487190|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487191|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
154487192|NCT04501250|Insulin|insulin|mesh-list
154487193|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154487194|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154487195|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487196|NCT02761629|Interferons|interferons|mesh-list
154487197|NCT02761629|Ribavirin|ribavirin|mesh-list
154487198|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
154487199|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
154487200|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154487201|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487202|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
154487203|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487204|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
154487205|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487206|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
154487207|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487208|NCT03345992|Clarithromycin|clarithromycin|mesh-list
154487209|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487210|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487211|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154487212|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487213|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487214|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154487215|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154487216|NCT02162121|Ketorolac|ketorolac|mesh-list
154487217|NCT02162121|Buprenorphine|buprenorphine|mesh-list
154487218|NCT02162121|Anesthetics|anesthetics|mesh-list
154487219|NCT02162121|Ropivacaine|ropivacaine|mesh-list
154050999|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154051000|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487220|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
154487221|NCT02162121|Mepivacaine|mepivacaine|mesh-list
154487222|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
154487223|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487224|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487225|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
154487226|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487227|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154487228|NCT02162121|Narcotics|narcotics|mesh-ancestor
154487229|NCT02162121|Analgesics|analgesics|mesh-ancestor
154487230|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154487231|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154487232|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487233|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154487234|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154487235|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154487236|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487237|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487238|NCT02511704|Nicotine|nicotine|mesh-list
154487239|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154487240|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
154487241|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487242|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487243|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154487244|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154487245|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
154487246|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487247|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211095|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
154487248|NCT04500704|Carboplatin|carboplatin|mesh-list
154487249|NCT04500704|Pemetrexed|pemetrexed|mesh-list
154487250|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487251|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487252|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487253|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154487254|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154487255|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
154487256|NCT02164773|Analgesics|analgesics|mesh-ancestor
154487257|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
154487258|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487259|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487260|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
154487261|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487262|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154487263|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
154487264|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154487265|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154487266|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487267|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154487268|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
154487269|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154487270|NCT00101439|Ezetimibe|ezetimibe|mesh-list
154487271|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154487272|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154487273|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
154487274|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487275|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154051046|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154487276|NCT03344822|Choline|choline|mesh-list
154487277|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154487278|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154487279|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487280|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
154487281|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154487282|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
154487283|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487284|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154487285|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
154487286|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154487287|NCT02506790|Toremifene|toremifene|mesh-list
154487288|NCT02506790|Metformin|metformin|mesh-list
154487289|NCT02506790|Melatonin|melatonin|mesh-list
154487290|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154487291|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487292|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
154487293|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487294|NCT02506790|Protective Agents|protective agents|mesh-ancestor
154487295|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487296|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154487297|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487298|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154860723|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154487299|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154487300|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
154487301|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487302|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154487303|NCT04500002|Isoniazid|isoniazid|mesh-list
154487304|NCT04500002|Misoprostol|misoprostol|mesh-list
154487305|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154487306|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
154487307|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154051047|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051077|NCT02566096|Bupivacaine|bupivacaine|mesh-list
154051078|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
154051079|NCT02566096|Anesthetics|anesthetics|mesh-list
154051080|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051081|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051082|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
154051083|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051084|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154051085|NCT02566096|Narcotics|narcotics|mesh-ancestor
154051086|NCT02566096|Analgesics|analgesics|mesh-ancestor
154487308|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487309|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154487310|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487311|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
154487312|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
154487313|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487314|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487315|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154487316|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154487317|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
154487318|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487319|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154487320|NCT02515682|Equol|equol|mesh-list
154487321|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
154487322|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154487323|NCT02515682|Estrogens|estrogens|mesh-ancestor
154051087|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154051088|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154487324|NCT02515682|Hormones|hormones|mesh-ancestor
154487325|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487326|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487327|NCT02515604|Misoprostol|misoprostol|mesh-list
154487328|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154487329|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
154487330|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154487331|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487332|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154487333|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487334|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
154487335|NCT02510534|Menotropins|menotropins|mesh-list
154487336|NCT02510534|Progesterone|progesterone|mesh-list
154487337|NCT02510534|Progestins|progestins|mesh-ancestor
154487338|NCT02510534|Hormones|hormones|mesh-ancestor
154487339|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487340|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487341|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154487342|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
154487343|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154487344|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
154487345|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154487346|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487347|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487348|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487349|NCT02510612|Analgesics|analgesics|mesh-ancestor
154487350|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
154487351|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487352|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154487353|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154487354|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154487355|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154487356|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487357|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051108|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154051109|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051110|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154487358|NCT03749616|Acetaminophen|acetaminophen|mesh-list
154487359|NCT03749616|Ibuprofen|ibuprofen|mesh-list
154487360|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487361|NCT03749616|Analgesics|analgesics|mesh-ancestor
154487362|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
154487363|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487364|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487365|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
154487366|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154487367|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154487368|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154487369|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154487370|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487371|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487372|NCT04532502|Anesthetics|anesthetics|mesh-list
154487373|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
154487374|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487375|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487376|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
154487377|NCT02515526|Tolbutamide|tolbutamide|mesh-list
154487378|NCT02515526|Ethanol|ethanol|mesh-list
154487379|NCT02515526|Digoxin|digoxin|mesh-list
154487380|NCT02515526|Midazolam|midazolam|mesh-list
154487381|NCT02515526|Levomethorphan|levomethorphan|mesh-list
154487382|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
154487383|NCT02515526|Caffeine|caffeine|mesh-list
154487384|NCT02515526|Omeprazole|omeprazole|mesh-list
154487385|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154487386|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154487387|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487388|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487389|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154487390|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154487391|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154487392|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154487393|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
154487394|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
154487395|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
154487396|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
154211243|NCT00126490|Interleukin-2|interleukin-2|mesh-list
154487397|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487398|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487399|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154487400|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154487401|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487402|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154487403|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154487404|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
154487405|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154487406|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487407|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154487408|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154487409|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487410|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154487411|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154487412|NCT02515526|Protective Agents|protective agents|mesh-ancestor
154487413|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
154487414|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487415|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154487416|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154487417|NCT02515526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154487418|NCT02515526|Narcotics|narcotics|mesh-ancestor
154487419|NCT02515526|Analgesics|analgesics|mesh-ancestor
154487420|NCT02515526|Sensory System Agents|sensory system agents|mesh-ancestor
154487421|NCT02515526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487422|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154487423|NCT02515448|Gentamicins|gentamicins|mesh-list
154487424|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487425|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487426|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154487427|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487428|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487429|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
154487430|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154487431|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
154487432|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487433|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
154487434|NCT02170857|Protective Agents|protective agents|mesh-ancestor
154487435|NCT04460820|Doxorubicin|doxorubicin|mesh-list
154487436|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154487437|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154487438|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487439|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154487440|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154487441|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487442|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487443|NCT02170935|Dabigatran|dabigatran|mesh-list
154487444|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
154487445|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154487446|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
154487447|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487448|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487449|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
154487450|NCT03488316|Calcium|calcium|mesh-list
154487451|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154487452|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487453|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
154487454|NCT02510222|Analgesics|analgesics|mesh-ancestor
154487455|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
154487456|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487457|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487458|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
154487459|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487460|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154487461|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
154487462|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154487463|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154487464|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487465|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154487466|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
154487467|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154487468|NCT02505776|Bimatoprost|bimatoprost|mesh-list
154487469|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154487470|NCT02171013|Dabigatran|dabigatran|mesh-list
154487471|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
154487472|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154487473|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
154487474|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487475|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487476|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
154487477|NCT02167425|Methadone|methadone|mesh-list
154487478|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154487479|NCT02167425|Narcotics|narcotics|mesh-ancestor
154487480|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487481|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487482|NCT02167425|Analgesics|analgesics|mesh-ancestor
154487483|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
154487484|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487485|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
154487486|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487487|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
154487488|NCT03111732|Capecitabine|capecitabine|mesh-list
154487489|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
154051200|NCT06156592|Anesthetics|anesthetics|mesh-list
154487490|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154487491|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487492|NCT03111732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154487493|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487494|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154487495|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
154487496|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
154487497|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487498|NCT02505386|Ertapenem|ertapenem|mesh-list
154487499|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487500|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487501|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
154487502|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154487503|NCT02514980|Ketamine|ketamine|mesh-list
154487504|NCT02514980|Bupivacaine|bupivacaine|mesh-list
154487505|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
154487506|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
154487507|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487508|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487509|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
154487510|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487511|NCT02514980|Analgesics|analgesics|mesh-ancestor
154487512|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154487513|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154487514|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
154487515|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154487516|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154487517|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487518|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487519|NCT02165475|Loperamide|loperamide|mesh-list
154487520|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
154487521|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487522|NCT04862338|Niacinamide|niacinamide|mesh-list
154487523|NCT04862338|Niacin|niacin|mesh-list
154487524|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
154487525|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
154487526|NCT04862338|Vitamins|vitamins|mesh-ancestor
154487527|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
154487528|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487529|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154487530|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
154487531|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487532|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154487533|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
154487534|NCT02171325|Irinotecan|irinotecan|mesh-list
154487535|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154487536|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154487537|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487538|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487539|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487540|NCT02509286|Leucovorin|leucovorin|mesh-list
154487541|NCT02509286|Paclitaxel|paclitaxel|mesh-list
154487542|NCT02509286|Docetaxel|docetaxel|mesh-list
154860724|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154487543|NCT02509286|Carboplatin|carboplatin|mesh-list
154487544|NCT02509286|Fluorouracil|fluorouracil|mesh-list
154487545|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
154487546|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154487547|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487548|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
154487549|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
154487550|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
154487551|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487553|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154487554|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154487555|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
154487556|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487557|NCT02509286|Antidotes|antidotes|mesh-ancestor
154487558|NCT02509286|Protective Agents|protective agents|mesh-ancestor
154487559|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
154487560|NCT02509286|Vitamins|vitamins|mesh-ancestor
154487561|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
154487562|NCT03065244|Infliximab|infliximab|mesh-list
154487563|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
154487564|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154487565|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
154487566|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154487567|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
154487568|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487569|NCT03065244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154487570|NCT03065244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154487571|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
154487572|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487573|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154487574|NCT02171481|Dabigatran|dabigatran|mesh-list
154487575|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
154487576|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154487577|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
154487578|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487579|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487580|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
154487581|NCT02171559|Enoxaparin|enoxaparin|mesh-list
154487582|NCT02171559|Dabigatran|dabigatran|mesh-list
154487583|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
154487584|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154487585|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154487586|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487587|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
154487588|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154487589|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
154487590|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487591|NCT04901754|Apatinib|apatinib|mesh-list
154487592|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487593|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154487594|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487595|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487596|NCT02509208|Hemostatics|hemostatics|mesh-list
154487597|NCT02509208|Coagulants|coagulants|mesh-ancestor
154487598|NCT02504996|Acetaminophen|acetaminophen|mesh-list
154487599|NCT02504996|Morphine|morphine|mesh-list
154487600|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154487601|NCT02504996|Narcotics|narcotics|mesh-ancestor
154487602|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487603|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487604|NCT02504996|Analgesics|analgesics|mesh-ancestor
154487605|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
154487606|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487607|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487608|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
154487609|NCT00100815|Bevacizumab|bevacizumab|mesh-list
154487610|NCT00100815|Gemcitabine|gemcitabine|mesh-list
154487611|NCT00100815|Capecitabine|capecitabine|mesh-list
154487612|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154487613|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487614|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154487615|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154487616|NCT00100815|Growth Substances|growth substances|mesh-ancestor
154487617|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487618|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
154487619|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154487620|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
154487621|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487622|NCT00708422|Travoprost|travoprost|mesh-list
154487623|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154487624|NCT00708422|Latanoprost|latanoprost|mesh-list
154487625|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154487626|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154487627|NCT02514200|Riboflavin|riboflavin|mesh-list
154487628|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
154487629|NCT02514200|Vitamins|vitamins|mesh-ancestor
154487630|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
154487631|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487632|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154487633|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
154487634|NCT02504450|Haloperidol|haloperidol|mesh-list
154487635|NCT02504450|Ziprasidone|ziprasidone|mesh-list
154487636|NCT02504450|Loxapine|loxapine|mesh-list
154487637|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
154487638|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
154487639|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487640|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487641|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487642|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154487643|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154487644|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487645|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154487646|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154487647|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
154487648|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487649|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487650|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154487651|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154487652|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
154487653|NCT02171637|Afatinib|afatinib|mesh-list
154487654|NCT02171637|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154487655|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154487656|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487657|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487658|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487659|NCT02171715|Afatinib|afatinib|mesh-list
154487660|NCT02171715|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154487661|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154487662|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487663|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487664|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487665|NCT02760069|Ondansetron|ondansetron|mesh-list
154487666|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
154487667|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
154487668|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487669|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487670|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487671|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
154487672|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154487673|NCT02760069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154487674|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154487675|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
154487676|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487677|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487678|NCT02504138|Anesthetics|anesthetics|mesh-list
154487679|NCT02504138|Propofol|propofol|mesh-list
154487680|NCT02504138|Desflurane|desflurane|mesh-list
154487681|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487682|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487683|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154487684|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154487685|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
154487686|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154487687|NCT02508584|Antibodies|antibodies|mesh-list
154487688|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
154487689|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487690|NCT02171793|Olodaterol|olodaterol|mesh-list
154487691|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154487692|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
154487693|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487694|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487695|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154487696|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487697|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
154487698|NCT02508350|Daptomycin|daptomycin|mesh-list
154487699|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487700|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487701|NCT02503826|Midazolam|midazolam|mesh-list
154487702|NCT02503826|Sufentanil|sufentanil|mesh-list
154487703|NCT02503826|Dsuvia|dsuvia|mesh-list
154487704|NCT02503826|Propofol|propofol|mesh-list
154487705|NCT02503826|Cisatracurium|cisatracurium|mesh-list
154487706|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154487707|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487708|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487709|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154487710|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
154487711|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
154487712|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154487713|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154487714|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154487715|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154487716|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
154487717|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
154487718|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487719|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487720|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154487721|NCT02503826|Narcotics|narcotics|mesh-ancestor
154487722|NCT02503826|Analgesics|analgesics|mesh-ancestor
154487723|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
154487724|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487725|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154487726|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154487727|NCT03121664|Itraconazole|itraconazole|mesh-list
154487728|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
154487729|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487730|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154487731|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154487732|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487733|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487734|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154487735|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
154487736|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487737|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487738|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154487739|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154487740|NCT02503904|Metronidazole|metronidazole|mesh-list
154487742|NCT02503904|Epinephrine|epinephrine|mesh-list
154487743|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
154487744|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
154487745|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487746|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487747|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
154487748|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487749|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154487750|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154487751|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154487752|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154487753|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487754|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487755|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154487756|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154487757|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
154051459|NCT05794230|Vaccines|vaccines|mesh-list
154860725|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
154487758|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487759|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154487760|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154487762|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154487763|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487764|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
154487765|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
154487766|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154487767|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154487768|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154487769|NCT02172105|Olodaterol|olodaterol|mesh-list
154487770|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154487771|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
154487772|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487773|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487774|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154487775|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487776|NCT02513654|Lamotrigine|lamotrigine|mesh-list
154487777|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
154487778|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154487779|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154487780|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487781|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154487782|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487783|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154487784|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154487785|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487786|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154487787|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154487788|NCT02513888|Vitamin D|vitamin d|mesh-list
154487789|NCT02513888|Vitamins|vitamins|mesh-ancestor
154487790|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
154487791|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487792|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154487793|NCT00101595|Dasatinib|dasatinib|mesh-list
154487794|NCT00101595|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154487795|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154487796|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487797|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487798|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487799|NCT02174757|Doxycycline|doxycycline|mesh-list
154487800|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154487801|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487802|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
154487803|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154487804|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154487805|NCT02168127|Methylphenidate|methylphenidate|mesh-list
154487806|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154487807|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487808|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154487809|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154487810|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154487811|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487812|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
154487813|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487814|NCT02255955|Acetaminophen|acetaminophen|mesh-list
154487815|NCT02255955|Naproxen|naproxen|mesh-list
154487816|NCT02255955|Codeine|codeine|mesh-list
154487817|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487818|NCT02255955|Analgesics|analgesics|mesh-ancestor
154487819|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
154487820|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487821|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487822|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
154487823|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154487824|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154487825|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154487826|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
154487827|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154487828|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487829|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487830|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154487831|NCT02255955|Narcotics|narcotics|mesh-ancestor
154487832|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487833|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
154487834|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487835|NCT02172261|Glimepiride|glimepiride|mesh-list
154487836|NCT02172261|Empagliflozin|empagliflozin|mesh-list
154487837|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154487838|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154487839|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487840|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154487841|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
154487842|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154487843|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487844|NCT02501564|Naproxen|naproxen|mesh-list
154487845|NCT02501564|Codeine|codeine|mesh-list
154487846|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154487847|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154487848|NCT02501564|Analgesics|analgesics|mesh-ancestor
154487849|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
154487850|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487851|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487852|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154487853|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154487854|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
154487855|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154487856|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487857|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487858|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154487859|NCT02501564|Narcotics|narcotics|mesh-ancestor
154487860|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487861|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
154487862|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487863|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
154487864|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154487865|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
154487866|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487867|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487868|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154487869|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487870|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
154487871|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154487872|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
154487873|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487874|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487875|NCT02172417|Ranitidine|ranitidine|mesh-list
154487876|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154487877|NCT02172417|Cimetidine|cimetidine|mesh-list
154487878|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
154487879|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154487880|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
154487881|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487882|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487883|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154487884|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487885|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
154487886|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154487887|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
154487888|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487889|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487890|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154487891|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154487892|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154487893|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
154487894|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
154487895|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154487896|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154487897|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487898|NCT02168205|Pomalidomide|pomalidomide|mesh-list
154487899|NCT02168205|Caffeine|caffeine|mesh-list
154487900|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154487901|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487902|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154487903|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487904|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487905|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154487906|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154487907|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
154487908|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487909|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
154487910|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154487911|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154487912|NCT02168205|Growth Substances|growth substances|mesh-ancestor
154487913|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
154487914|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487915|NCT03343652|Nivolumab|nivolumab|mesh-list
154487916|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154487917|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154487918|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487919|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154487920|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487921|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154487922|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
154487923|NCT02175069|Ropivacaine|ropivacaine|mesh-list
154487924|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
154487925|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
154487926|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487927|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487928|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
154487929|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487930|NCT04498520|Fulvestrant|fulvestrant|mesh-list
154487931|NCT04498520|Palbociclib|palbociclib|mesh-list
154487932|NCT04498520|Abexinostat|abexinostat|mesh-list
154487933|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154487934|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487935|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154487936|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154487937|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
154487938|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487939|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487940|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154487941|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487942|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487943|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154487945|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
154487946|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154487947|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
154487948|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487949|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487950|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154487951|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
154487952|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
154487953|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154487954|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
154487955|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487956|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487957|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
154487958|NCT02172573|Pramipexole|pramipexole|mesh-list
154487959|NCT02172573|Bromocriptine|bromocriptine|mesh-list
154487960|NCT02172573|Dexpramipexole|dexpramipexole|mesh-list
154487961|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
154487962|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487963|NCT02172573|Protective Agents|protective agents|mesh-ancestor
154487964|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051687|NCT05181527|Serotonin|serotonin|mesh-list
154487965|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154487966|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154487967|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
154487968|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
154487969|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154487970|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
154487971|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487972|NCT02175381|Carboplatin|carboplatin|mesh-list
154487973|NCT02175381|Gemcitabine|gemcitabine|mesh-list
154487974|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154487975|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154487976|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
154487977|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487978|NCT03540225|Progesterone|progesterone|mesh-list
154487979|NCT03540225|Progestins|progestins|mesh-ancestor
154487980|NCT03540225|Hormones|hormones|mesh-ancestor
154487981|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154487982|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487984|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
154487985|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154487986|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154487987|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154487988|NCT02172729|Lidocaine|lidocaine|mesh-list
154487989|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
154487990|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
154487991|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154487992|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154487993|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
154487994|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154487995|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154487996|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154487997|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154487998|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154487999|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488000|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
154488001|NCT02172807|Oxitropium|oxitropium|mesh-list
154488002|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154488003|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
154488004|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051713|NCT05093790|Aspirin|aspirin|mesh-list
154488005|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488006|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154488007|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
154488008|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
154488009|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154488010|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
154488011|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488012|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488013|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154488014|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
154488015|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488017|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154488018|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
154488019|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488020|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488021|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
154488022|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488023|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154488024|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
154488025|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488026|NCT02168751|Propofol|propofol|mesh-list
154488027|NCT02168751|Sevoflurane|sevoflurane|mesh-list
154488028|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154488029|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488030|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488031|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154488032|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
154488033|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
154488034|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154488035|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154488036|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154488037|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488038|NCT03344042|Fentanyl|fentanyl|mesh-list
154488039|NCT03344042|Sufentanil|sufentanil|mesh-list
154488040|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154488041|NCT03344042|Narcotics|narcotics|mesh-ancestor
154488042|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488043|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488044|NCT03344042|Analgesics|analgesics|mesh-ancestor
154488045|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
154488046|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488047|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154488048|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154488049|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
154488050|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
154488051|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154488052|NCT02175927|Amoxicillin|amoxicillin|mesh-list
154488053|NCT02175927|Metronidazole|metronidazole|mesh-list
154488054|NCT02175927|Tetracycline|tetracycline|mesh-list
154488055|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154488056|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
154488057|NCT02175927|Lansoprazole|lansoprazole|mesh-list
154488058|NCT02175927|Bismuth|bismuth|mesh-list
154488059|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154488060|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488061|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
154488062|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488063|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154488064|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154488065|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154488066|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154488067|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488068|NCT02175927|Antacids|antacids|mesh-ancestor
154488069|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154488070|NCT02175927|Diuretics|diuretics|mesh-ancestor
154488071|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
154488072|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488073|NCT02175927|Expectorants|expectorants|mesh-ancestor
154488074|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
154488075|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154488076|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
154488077|NCT00707486|Coagulants|coagulants|mesh-ancestor
154488078|NCT02496182|Pirfenidone|pirfenidone|mesh-list
154488079|NCT02496182|Analgesics|analgesics|mesh-ancestor
154211927|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154488080|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
154488081|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488082|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488083|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154488084|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488085|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488086|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488087|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488088|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
154488089|NCT02168907|Rituximab|rituximab|mesh-list
154488090|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154488091|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154488092|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488093|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
154488094|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488095|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488096|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154488097|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
154488098|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488099|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
154488100|NCT02168907|Protective Agents|protective agents|mesh-ancestor
154488101|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
154488102|NCT02168907|Vitamins|vitamins|mesh-ancestor
154488103|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
154488104|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
154488105|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154488106|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
154488107|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488108|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488109|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154488110|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
154488111|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154488112|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154488113|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154488114|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
154488115|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488116|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488117|NCT02500940|Leucovorin|leucovorin|mesh-list
154488118|NCT02500940|Fluorouracil|fluorouracil|mesh-list
154488119|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488120|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488121|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
154488122|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488123|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154488124|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154488125|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
154488126|NCT02500940|Antidotes|antidotes|mesh-ancestor
154488127|NCT02500940|Protective Agents|protective agents|mesh-ancestor
154488128|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
154488129|NCT02500940|Vitamins|vitamins|mesh-ancestor
154488130|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
154488131|NCT02495636|Atezolizumab|atezolizumab|mesh-list
154488132|NCT02495636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154051840|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051876|NCT04620759|Psilocybin|psilocybin|mesh-list
154488133|NCT02495636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488134|NCT02495636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154488136|NCT02169063|Listerine|listerine|mesh-list
154488137|NCT02169063|Fluorides|fluorides|mesh-list
154488138|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
154488139|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
154488140|NCT02169063|Protective Agents|protective agents|mesh-ancestor
154488141|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488142|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154488143|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488144|NCT04496882|Tenofovir|tenofovir|mesh-list
154488145|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
154488146|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488147|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154488148|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154488149|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488150|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488151|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154488152|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154488153|NCT02502500|Celecoxib|celecoxib|mesh-list
154212007|NCT01059396|Propranolol|propranolol|mesh-list
154488154|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154488155|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488156|NCT02502500|Analgesics|analgesics|mesh-ancestor
154488157|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
154488158|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488159|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488161|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488162|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154488163|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154488164|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051877|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154488165|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488166|NCT02173665|Linagliptin|linagliptin|mesh-list
154488167|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154488168|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488169|NCT02173665|Incretins|incretins|mesh-ancestor
154488170|NCT02173665|Hormones|hormones|mesh-ancestor
154488171|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154488172|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154488173|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
154488174|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488175|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488176|NCT02495324|Valsartan|valsartan|mesh-list
154488177|NCT02495324|Olmesartan|olmesartan|mesh-list
154488178|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154488179|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154488180|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154488181|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154488182|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488183|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
154488184|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
154488185|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488186|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
154488187|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488188|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488189|NCT02256033|Istradefylline|istradefylline|mesh-list
154488190|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154488191|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154488192|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154488193|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
154488194|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488195|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488196|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488197|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154488198|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154488199|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154488200|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
154488201|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488202|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154488203|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154488204|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488205|NCT02502344|Metformin|metformin|mesh-list
154488206|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154051908|NCT04524000|Fulvestrant|fulvestrant|mesh-list
154488207|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488209|NCT02174211|Aflibercept|aflibercept|mesh-list
154488210|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154488211|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154488212|NCT02174211|Growth Substances|growth substances|mesh-ancestor
154488213|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488214|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
154488215|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488216|NCT04496492|Tocotrienols|tocotrienols|mesh-list
154488217|NCT04496492|Vitamin E|vitamin e|mesh-list
154488218|NCT04496492|Tocopherols|tocopherols|mesh-list
154488219|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
154488220|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488221|NCT04496492|Protective Agents|protective agents|mesh-ancestor
154488222|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488223|NCT04496492|Vitamins|vitamins|mesh-ancestor
154488224|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
154488225|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154488226|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154488227|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488228|NCT02502032|Cisatracurium|cisatracurium|mesh-list
154488229|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154488230|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154488231|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488232|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488233|NCT02494856|Naproxen|naproxen|mesh-list
154488234|NCT02494856|Esomeprazole|esomeprazole|mesh-list
154488235|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154488236|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154488237|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154488238|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488239|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488240|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154488241|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488242|NCT02494856|Analgesics|analgesics|mesh-ancestor
154488243|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
154488244|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488245|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488246|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488247|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488248|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
154488249|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154488250|NCT04495010|Nivolumab|nivolumab|mesh-list
154488251|NCT04495010|Ipilimumab|ipilimumab|mesh-list
154488252|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154488253|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488254|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154488255|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488256|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154488257|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
154488258|NCT03343418|Coagulants|coagulants|mesh-ancestor
154488259|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154488260|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
154488261|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488262|NCT02501798|Methylphenidate|methylphenidate|mesh-list
154488263|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154488264|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488265|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154488266|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154488267|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154488268|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488269|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
154488270|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488271|NCT02169609|Interleukin-2|interleukin-2|mesh-list
154488272|NCT02169609|Dinutuximab|dinutuximab|mesh-list
154488273|NCT02169609|Isotretinoin|isotretinoin|mesh-list
154488274|NCT02169609|Sargramostim|sargramostim|mesh-list
154488275|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
154488276|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488277|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488278|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488279|NCT02169609|Analgesics|analgesics|mesh-ancestor
154488280|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
154488281|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488282|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
154488283|NCT02499614|Crizotinib|crizotinib|mesh-list
154488284|NCT02499614|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154488285|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154488286|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488287|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488288|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488289|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
154488290|NCT02169843|Sevoflurane|sevoflurane|mesh-list
154488291|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154488292|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488293|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488294|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488295|NCT02169843|Analgesics|analgesics|mesh-ancestor
154488296|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
154488297|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488298|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154051996|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
154488299|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154488300|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154488301|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
154488302|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488303|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488304|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154488305|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154488306|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
154488308|NCT03341390|Aspirin|aspirin|mesh-list
154488309|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154488310|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488311|NCT03341390|Analgesics|analgesics|mesh-ancestor
154488312|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
154488313|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488314|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488315|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488316|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488317|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154488318|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154488319|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488320|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154488321|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154488322|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488323|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
154488324|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
154488325|NCT02174445|Nilotinib|nilotinib|mesh-list
154488326|NCT02174445|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154488327|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154488328|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488329|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488330|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488331|NCT00707174|Imiquimod|imiquimod|mesh-list
154488332|NCT00707174|Tazarotene|tazarotene|mesh-list
154488333|NCT00707174|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154052042|NCT04225598|Narcotics|narcotics|mesh-ancestor
154488334|NCT00707174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488335|NCT00707174|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154488336|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
154488337|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488338|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154488339|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488340|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
154488341|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
154488342|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
154488343|NCT03341234|Bupivacaine|bupivacaine|mesh-list
154488344|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
154488345|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
154488346|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488347|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488348|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
154488349|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488350|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
154488351|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488352|NCT03120494|Tenofovir|tenofovir|mesh-list
154488353|NCT03120494|Emtricitabine|emtricitabine|mesh-list
154488354|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
154488355|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488356|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154488357|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154488358|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488359|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488361|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154488362|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
154488363|NCT03537573|Narcotics|narcotics|mesh-ancestor
154488364|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488365|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488366|NCT03537573|Analgesics|analgesics|mesh-ancestor
154488367|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
154488368|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488369|NCT03120962|Famciclovir|famciclovir|mesh-list
154488370|NCT03120962|Oxycodone|oxycodone|mesh-list
154488371|NCT03120962|Gabapentin|gabapentin|mesh-list
154488372|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154052105|NCT04196868|Metformin|metformin|mesh-list
154052123|NCT04179162|Gemcitabine|gemcitabine|mesh-list
154488373|NCT03120962|Narcotics|narcotics|mesh-ancestor
154488374|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488375|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488376|NCT03120962|Analgesics|analgesics|mesh-ancestor
154488377|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
154488378|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488379|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
154488380|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154488382|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154488383|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154488384|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154488385|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488386|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488387|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
154488388|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
154488389|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488390|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154488391|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488392|NCT02178813|Minocycline|minocycline|mesh-list
154488393|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154488394|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488395|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
154488396|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
154488397|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488398|NCT02177253|Bromides|bromides|mesh-list
154488399|NCT02177253|Albuterol|albuterol|mesh-list
154488400|NCT02177253|Ipratropium|ipratropium|mesh-list
154488401|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
154488402|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154488403|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
154488404|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488405|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488406|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154488407|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
154488408|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
154488409|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154488410|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154488411|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154488412|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154488413|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
154488414|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488415|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488416|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154488417|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
154488418|NCT02177331|Lacidipine|lacidipine|mesh-list
154488419|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154488420|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154488421|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154488422|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488423|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154488424|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488425|NCT02177409|Amlodipine|amlodipine|mesh-list
154488426|NCT02177409|Telmisartan|telmisartan|mesh-list
154488427|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154488428|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154488429|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154488430|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488431|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154488432|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860726|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488433|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
154488434|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154488435|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154488436|NCT02170623|Pantoprazole|pantoprazole|mesh-list
154488437|NCT02170623|Dabigatran|dabigatran|mesh-list
154488438|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154488439|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154488440|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154488441|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052146|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488442|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488443|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
154488444|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154488445|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
154488446|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
154488447|NCT02170701|Dabigatran|dabigatran|mesh-list
154488448|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
154488449|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154488450|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
154488451|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488452|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488453|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
154488454|NCT02498756|Ipilimumab|ipilimumab|mesh-list
154488455|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154488456|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488457|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154488458|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488459|NCT03336632|Cyclosporine|cyclosporine|mesh-list
154488460|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
154488461|NCT03336632|Cyclosporins|cyclosporins|mesh-list
154488462|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154488463|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
154488464|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488465|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488466|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154488467|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
154488468|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488469|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488470|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154488471|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488472|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
154488473|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488474|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154488475|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154488476|NCT02498288|Isotretinoin|isotretinoin|mesh-list
154488477|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154488478|NCT02756403|Azithromycin|azithromycin|mesh-list
154488479|NCT02756403|Metronidazole|metronidazole|mesh-list
154488480|NCT02756403|Doxycycline|doxycycline|mesh-list
154488481|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154488482|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488483|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154488484|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154488485|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
154488486|NCT02494466|Montelukast|montelukast|mesh-list
154488487|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154052193|NCT03820193|Celecoxib|celecoxib|mesh-list
154488488|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
154488489|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154488490|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
154488491|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154488492|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488493|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154488494|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154488495|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488496|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154488497|NCT02177487|Telmisartan|telmisartan|mesh-list
154488498|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154488499|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154488500|NCT02177487|Diuretics|diuretics|mesh-ancestor
154488501|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
154488502|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488503|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154488504|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860727|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488505|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488506|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154488507|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154488508|NCT02177643|Diacerein|diacerein|mesh-list
154488509|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488510|NCT03340376|Doxorubicin|doxorubicin|mesh-list
154488511|NCT03340376|Atezolizumab|atezolizumab|mesh-list
154488512|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154488513|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488514|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154488515|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154488516|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488517|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488518|NCT03340376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154488519|NCT03340376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154488520|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
154488521|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154488522|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
154488523|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488524|NCT02182167|Expectorants|expectorants|mesh-ancestor
154488525|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
154488526|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154488527|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
154488528|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488529|NCT02182167|Protective Agents|protective agents|mesh-ancestor
154488530|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488531|NCT02182167|Antidotes|antidotes|mesh-ancestor
154488532|NCT02182245|Paclitaxel|paclitaxel|mesh-list
154488533|NCT02182245|Carboplatin|carboplatin|mesh-list
154488534|NCT02182245|Nintedanib|nintedanib|mesh-list
154488535|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154488536|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488537|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
154488538|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
154488539|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
154488540|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488541|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154488542|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488543|NCT05233124|Aspirin|aspirin|mesh-list
154488544|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
154488545|NCT05233124|Clopidogrel|clopidogrel|mesh-list
154488546|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154488547|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488548|NCT05233124|Analgesics|analgesics|mesh-ancestor
154488549|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
154052265|NCT03735979|Argatroban|argatroban|mesh-list
154052304|NCT03638141|Durvalumab|durvalumab|mesh-list
154488550|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488551|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488552|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488553|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488554|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154488555|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154488556|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488557|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154488558|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154488559|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488560|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
154488561|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154488562|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154488563|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154488564|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
154488565|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488566|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154488567|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
154488568|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154488569|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
154488570|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
154488571|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
154488572|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154488573|NCT03339362|Bupivacaine|bupivacaine|mesh-list
154488574|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
154488575|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
154488576|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488577|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488578|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
154488579|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488580|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860728|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488581|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
154488582|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
154488583|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154488584|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
154488585|NCT03339362|Hormones|hormones|mesh-ancestor
154488586|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154488587|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154488588|NCT03339362|Protective Agents|protective agents|mesh-ancestor
154488589|NCT02497820|Aspirin|aspirin|mesh-list
154488590|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154488591|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488592|NCT02497820|Analgesics|analgesics|mesh-ancestor
154488593|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
154488594|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488595|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488596|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488597|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488598|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154488599|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154488600|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488601|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154488602|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154488603|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488604|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
154488605|NCT02497508|Nivolumab|nivolumab|mesh-list
154488606|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154488607|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488608|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154488609|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488610|NCT03338426|Atorvastatin|atorvastatin|mesh-list
154488611|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154488612|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154488613|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
154488614|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488615|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154488616|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154488617|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488618|NCT03338348|Azacitidine|azacitidine|mesh-list
154488619|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154488620|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
154488621|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488622|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488623|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488624|NCT03334838|Nifurtimox|nifurtimox|mesh-list
154488625|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154488626|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154488627|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154488628|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488629|NCT02497118|Vinorelbine|vinorelbine|mesh-list
154488630|NCT02497118|Endostatins|endostatins|mesh-list
154488631|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488632|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154488633|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154488634|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154488635|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154488636|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488637|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154488638|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154488639|NCT02497118|Growth Substances|growth substances|mesh-ancestor
154488640|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488641|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154488642|NCT02496962|Atorvastatin|atorvastatin|mesh-list
154488643|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154488644|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154488645|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
154488646|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488647|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154052380|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488648|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154488649|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488650|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154488651|NCT03334136|Calcifediol|calcifediol|mesh-list
154488652|NCT03334136|Vitamins|vitamins|mesh-ancestor
154488653|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
154488654|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860729|NCT01925456|Urological Agents|urological agents|mesh-ancestor
154488655|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154488656|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154488657|NCT03120728|Etonogestrel|etonogestrel|mesh-list
154488658|NCT03120728|NuvaRing|nuvaring|mesh-list
154488659|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
154488660|NCT03120728|Estradiol|estradiol|mesh-list
154488661|NCT03120728|Estrogens|estrogens|mesh-ancestor
154488662|NCT03120728|Hormones|hormones|mesh-ancestor
154488663|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154488664|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488665|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154488666|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154488667|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154488668|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154488669|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154488670|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
154488671|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154488672|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488673|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488674|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488675|NCT02496650|Analgesics|analgesics|mesh-ancestor
154488676|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
154488677|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488678|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154212541|NCT06084663|Apremilast|apremilast|mesh-list
154488679|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154488680|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154488681|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
154488682|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488683|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052406|NCT03334617|Immunoconjugates|immunoconjugates|mesh-ancestor
154488684|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154488685|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
154488686|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488687|NCT03342170|Thrombin|thrombin|mesh-list
154488688|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
154488689|NCT03342170|Coagulants|coagulants|mesh-ancestor
154488690|NCT03333824|Midazolam|midazolam|mesh-list
154488691|NCT03333824|Granisetron|granisetron|mesh-list
154488692|NCT03333824|Caffeine|caffeine|mesh-list
154488693|NCT03333824|Omeprazole|omeprazole|mesh-list
154488694|NCT03333824|Adavosertib|adavosertib|mesh-list
154488695|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154488696|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154488697|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488698|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488699|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154488700|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154488701|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154488702|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154488703|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
154488704|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
154488705|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
154488706|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
154488707|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488708|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488709|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154488710|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154488711|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488712|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154488713|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154488714|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
154488715|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154488716|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154488717|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154488718|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
154488719|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
154488720|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488721|NCT03333824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154488722|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154488723|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
154488724|NCT02496494|Tacrolimus|tacrolimus|mesh-list
154488725|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154488726|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
154488727|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488728|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154488729|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860730|NCT02226159|Dexamethasone|dexamethasone|mesh-list
154488730|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488732|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
154488733|NCT03333278|Thiamine|thiamine|mesh-list
154488734|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
154488735|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154488736|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
154488737|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488738|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488739|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
154488740|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488741|NCT03333278|Protective Agents|protective agents|mesh-ancestor
154488742|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
154488743|NCT04847596|Ofatumumab|ofatumumab|mesh-list
154488744|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488745|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154488746|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154488747|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154488748|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
154488749|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488750|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154488751|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154212599|NCT05984381|Immunologic Factors|immunologic factors|mesh-ancestor
154488752|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488753|NCT00706628|Nintedanib|nintedanib|mesh-list
154488754|NCT00706628|Afatinib|afatinib|mesh-list
154488755|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488756|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154488757|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488758|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488759|NCT00706628|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154488760|NCT05463614|Propranolol|propranolol|mesh-list
154488761|NCT05463614|Propafenone|propafenone|mesh-list
154488762|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154488763|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154488764|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
154488765|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488766|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488767|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488768|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154488769|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154488770|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
154488771|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154488772|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154488773|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154488774|NCT03332888|Rituximab|rituximab|mesh-list
154488775|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154488776|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488777|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
154488778|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488779|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488780|NCT03332732|Metronidazole|metronidazole|mesh-list
154488781|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488782|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154488783|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154488784|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154488785|NCT02492360|Cisplatin|cisplatin|mesh-list
154488786|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488787|NCT02492282|Remifentanil|remifentanil|mesh-list
154488788|NCT02492282|Propofol|propofol|mesh-list
154488789|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154488790|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488791|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488792|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154488793|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
154488794|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
154488795|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154488796|NCT02492282|Narcotics|narcotics|mesh-ancestor
154488797|NCT02492282|Analgesics|analgesics|mesh-ancestor
154488798|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
154488799|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488800|NCT02492126|Citric Acid|citric acid|mesh-list
154488801|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
154488802|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
154488803|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154488804|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
154488805|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
154488806|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488807|NCT05464862|Lidocaine|lidocaine|mesh-list
154488808|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
154488809|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
154488810|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488811|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488812|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
154488813|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488814|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154488815|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154488816|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154488817|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154488818|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052577|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488819|NCT03324776|Insulin|insulin|mesh-list
154488820|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154488821|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154488822|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488823|NCT02561806|Ustekinumab|ustekinumab|mesh-list
154488824|NCT02561806|Ixekizumab|ixekizumab|mesh-list
154488825|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
154488826|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
154488827|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154488828|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
154488829|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488830|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488831|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154488832|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
154488833|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488834|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488835|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154488836|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154488837|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154488838|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
154488839|NCT03330860|Hormones|hormones|mesh-ancestor
154488840|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154488841|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488842|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488843|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488844|NCT03324542|Ranibizumab|ranibizumab|mesh-list
154488845|NCT03324542|Aflibercept|aflibercept|mesh-list
154488846|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488847|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154488848|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154488849|NCT03324542|Growth Substances|growth substances|mesh-ancestor
154488850|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488851|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
154488852|NCT03330782|Remifentanil|remifentanil|mesh-list
154488853|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154488854|NCT03330782|Narcotics|narcotics|mesh-ancestor
154488855|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488856|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488857|NCT03330782|Analgesics|analgesics|mesh-ancestor
154488858|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
154488859|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488860|NCT05506462|Ketamine|ketamine|mesh-list
154488861|NCT05506462|Analgesics|analgesics|mesh-ancestor
154488862|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
154052589|NCT02394834|Vitamins|vitamins|mesh-ancestor
154488863|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488864|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488865|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154488866|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154488867|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
154488868|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
154488869|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488870|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154488871|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154488872|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488873|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488874|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
154488875|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154488876|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488877|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154860731|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
154488878|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488879|NCT02491268|Cilostazol|cilostazol|mesh-list
154488880|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154488881|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
154488882|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488883|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488884|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154488885|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
154488886|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154488887|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154488888|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488889|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154488890|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
154488891|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154488892|NCT02491268|Protective Agents|protective agents|mesh-ancestor
154488893|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154488894|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154488895|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488896|NCT03323684|Acetaminophen|acetaminophen|mesh-list
154488897|NCT03323684|Ketorolac|ketorolac|mesh-list
154488898|NCT03323684|Fentanyl|fentanyl|mesh-list
154488899|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154488900|NCT03323684|Narcotics|narcotics|mesh-ancestor
153595291|NCT01855568|Methotrexate|methotrexate|mesh-list
154488901|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488902|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488903|NCT03323684|Analgesics|analgesics|mesh-ancestor
154488904|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
154488905|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488906|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154488907|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154488908|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
154488909|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
154488910|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154488911|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
154488912|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154488913|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154488914|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154488915|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154488916|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488917|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488918|NCT02182401|Tolbutamide|tolbutamide|mesh-list
154488919|NCT02182401|Midazolam|midazolam|mesh-list
154488920|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154488921|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154488922|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488923|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488924|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154488925|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154488926|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154488927|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154488928|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
154488929|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
154488930|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
154488931|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
154488932|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488933|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488934|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154488935|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154488936|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
154488937|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154488938|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
154488939|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488940|NCT02177955|Midazolam|midazolam|mesh-list
154488941|NCT02177955|Diazepam|diazepam|mesh-list
154488942|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154488943|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154488944|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488945|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488946|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154488947|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154488948|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154052665|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154488949|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154488950|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
154488951|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
154488952|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
154488953|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
154488954|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488955|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488956|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
154488957|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
154488958|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
154488959|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488960|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154488961|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154488962|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154488963|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154488964|NCT03323528|Benzocaine|benzocaine|mesh-list
154488965|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
154488966|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
154488967|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154488968|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488969|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
154488970|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488971|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154488972|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154488973|NCT05501158|Tamoxifen|tamoxifen|mesh-list
154488974|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154488975|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
154488976|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154488977|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488978|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154488979|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154488980|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154488981|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154488982|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154488984|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
154488985|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154488986|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154488987|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154488988|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154488989|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488990|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154488991|NCT03537807|Protective Agents|protective agents|mesh-ancestor
154488992|NCT02182479|Fenoterol|fenoterol|mesh-list
154488993|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154488994|NCT02182479|Ipratropium|ipratropium|mesh-list
154488995|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154488996|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
154488997|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154488998|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154488999|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154489000|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
154489001|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
154489002|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
154489003|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154489004|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154489005|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154489006|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154489007|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489008|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489009|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489010|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154489011|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
154489012|NCT02560558|Abatacept|abatacept|mesh-list
154489013|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154489014|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489015|NCT02560558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489016|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489017|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489018|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
154489019|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489020|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489021|NCT03329456|Ropivacaine|ropivacaine|mesh-list
154489022|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
154489023|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
154489024|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489025|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489026|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
154489027|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489028|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154489029|NCT02491736|Ketoprofen|ketoprofen|mesh-list
154489030|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154489031|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154489032|NCT02491736|Analgesics|analgesics|mesh-ancestor
154489033|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
154489034|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489035|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489036|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489037|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489038|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154489039|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489040|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489041|NCT05501080|Spironolactone|spironolactone|mesh-list
154489042|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154489043|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
154489044|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489045|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489046|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154489047|NCT05501080|Diuretics|diuretics|mesh-ancestor
154489048|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
154489049|NCT02491970|Fluticasone|fluticasone|mesh-list
154489050|NCT02491970|Xhance|xhance|mesh-list
154489051|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
154489052|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154489053|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154489054|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489055|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154489056|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
154489057|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489058|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489059|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154489060|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
154489061|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
154489062|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154489063|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154489064|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154489065|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154489066|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489067|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489068|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489069|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
154489071|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489072|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
154489073|NCT02182557|Ketotifen|ketotifen|mesh-list
154489074|NCT02182557|Epinastine|epinastine|mesh-list
154489075|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
154489076|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
154489077|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154489078|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
154489079|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
154489080|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489081|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489082|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489083|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154489084|NCT02182635|Oxitropium|oxitropium|mesh-list
154489085|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
154489086|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
154489087|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489088|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489089|NCT02182713|Bromides|bromides|mesh-list
154489090|NCT02182713|Albuterol|albuterol|mesh-list
154489091|NCT02182713|Ipratropium|ipratropium|mesh-list
154489092|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
154489093|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154489094|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
154489095|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489096|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489097|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154489098|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
154489099|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
154489100|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154489101|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154489102|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154860732|NCT02226159|Lidocaine|lidocaine|mesh-list
154489103|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154860733|NCT02226159|BB 1101|bb 1101|mesh-list
154489104|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489105|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489106|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489107|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154489108|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
154489110|NCT03323372|Fluorides|fluorides|mesh-list
154489111|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
154489112|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
154489113|NCT03323372|Protective Agents|protective agents|mesh-ancestor
154489114|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489115|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154489116|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489117|NCT02180529|Methylphenidate|methylphenidate|mesh-list
154489118|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154489119|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489120|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154489121|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154489122|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489123|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489124|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
154489125|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489126|NCT02182791|Nevirapine|nevirapine|mesh-list
154489127|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154489128|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154489129|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489130|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489131|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
154489132|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489133|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154489134|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154489135|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154489136|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154489137|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154489138|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
154489139|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489140|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154489141|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154489142|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489143|NCT02488538|Fluoxetine|fluoxetine|mesh-list
154489144|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
154489145|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
154489146|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154489147|NCT02488538|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154489148|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154489149|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489150|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489151|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489152|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
154489153|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489154|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154489155|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
154489156|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154489157|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154489158|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154489159|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489160|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154489161|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154489162|NCT02568046|Leucovorin|leucovorin|mesh-list
154489163|NCT02568046|Fluorouracil|fluorouracil|mesh-list
154489164|NCT02568046|Irinotecan|irinotecan|mesh-list
154489165|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
154489166|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489167|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154489168|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489169|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489170|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
154489171|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489172|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154489173|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154489174|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489175|NCT02568046|Antidotes|antidotes|mesh-ancestor
154489176|NCT02568046|Protective Agents|protective agents|mesh-ancestor
154489178|NCT02568046|Vitamins|vitamins|mesh-ancestor
154489179|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
154489180|NCT03536481|Ensartinib|ensartinib|mesh-list
154489181|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489182|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154489183|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489184|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489185|NCT02488616|Insulin|insulin|mesh-list
154489186|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154489187|NCT02488616|Hormones|hormones|mesh-list
154489188|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154489189|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052913|NCT00878072|Famciclovir|famciclovir|mesh-list
154489190|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489191|NCT02256423|Ibuprofen|ibuprofen|mesh-list
154489192|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154489193|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154489194|NCT02256423|Analgesics|analgesics|mesh-ancestor
154489195|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
154489196|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489197|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489198|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489199|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489200|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154489201|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489202|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489203|NCT03320486|Ketoconazole|ketoconazole|mesh-list
154489204|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
154489205|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489206|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154489207|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154489208|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489209|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489210|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154489211|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
154489212|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489213|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489214|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154489215|NCT02567656|Tenalisib|tenalisib|mesh-list
154489216|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154489217|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489218|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489219|NCT02185833|Dirithromycin|dirithromycin|mesh-list
154489220|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154052955|NCT00921388|Varenicline|varenicline|mesh-list
154489221|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489222|NCT02180997|Tamsulosin|tamsulosin|mesh-list
154489223|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
154489224|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154489225|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154489226|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154489227|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489228|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489229|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489230|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489231|NCT02180997|Urological Agents|urological agents|mesh-ancestor
154489232|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154489233|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154489234|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
154489235|NCT02560012|Sirolimus|sirolimus|mesh-list
154489236|NCT02560012|Everolimus|everolimus|mesh-list
154489237|NCT02560012|Temsirolimus|temsirolimus|mesh-list
154489238|NCT02560012|MTOR Inhibitors|mtor inhibitors|mesh-list
154489239|NCT02560012|Sorafenib|sorafenib|mesh-list
154489240|NCT02560012|Sunitinib|sunitinib|mesh-list
154489241|NCT02560012|Axitinib|axitinib|mesh-list
154489242|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154489243|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489244|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489245|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489246|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
154489247|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489248|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489249|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154254980|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489250|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154489251|NCT02560012|Growth Substances|growth substances|mesh-ancestor
154489252|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
154489253|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154489254|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489255|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154489256|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
154489257|NCT03320174|Tafenoquine|tafenoquine|mesh-list
154489258|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
154489259|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154489260|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154489261|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489262|NCT03328364|Docetaxel|docetaxel|mesh-list
154489263|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052987|NCT02627222|Vitamin A|vitamin a|mesh-list
154489264|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
154489265|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
154489266|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
154489267|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489268|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
154489269|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154489270|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
154489271|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154489272|NCT04514302|Antibodies|antibodies|mesh-list
154489273|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
154489274|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489275|NCT03319784|Triamcinolone|triamcinolone|mesh-list
154489276|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154489277|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154489278|NCT03319784|Ketorolac|ketorolac|mesh-list
154489279|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154489280|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489282|NCT03319784|Hormones|hormones|mesh-ancestor
154489283|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489284|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489285|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489286|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
154489287|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489288|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489289|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154489290|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154489291|NCT03319784|Analgesics|analgesics|mesh-ancestor
154489292|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
154489293|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489294|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489295|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154489296|NCT03319706|Olmesartan|olmesartan|mesh-list
154489297|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154489298|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154489299|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154489300|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154489301|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489302|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
154489303|NCT05045170|Propofol|propofol|mesh-list
154489304|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
154489305|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489306|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489307|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154489308|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154489309|NCT05045170|Analgesics|analgesics|mesh-ancestor
154489310|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
154489311|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489312|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154489313|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154489314|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154053037|NCT00619541|Sorafenib|sorafenib|mesh-list
154053082|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489315|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489316|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489317|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489318|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154489319|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
154489320|NCT03322124|Octenidine|octenidine|mesh-list
154489321|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489322|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154489323|NCT04442984|Leucovorin|leucovorin|mesh-list
154489324|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
154489325|NCT04442984|Irinotecan|irinotecan|mesh-list
154860734|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489326|NCT04442984|Fluorouracil|fluorouracil|mesh-list
154489327|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489328|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154489329|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154489330|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489331|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489332|NCT04442984|Antidotes|antidotes|mesh-ancestor
154489333|NCT04442984|Protective Agents|protective agents|mesh-ancestor
154489334|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489335|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
154489336|NCT04442984|Vitamins|vitamins|mesh-ancestor
154489337|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
154489338|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
154489339|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154489340|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489341|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
154489342|NCT03327506|Alprazolam|alprazolam|mesh-list
154489343|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154489344|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489345|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489346|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154489347|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154489348|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154489349|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
154489350|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
154489351|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489352|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489353|NCT02487914|Lidocaine|lidocaine|mesh-list
154213194|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489354|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
154489355|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
154489356|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489357|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489358|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
154489359|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489360|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154489361|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154489362|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154489363|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489364|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489365|NCT02487680|Chromium|chromium|mesh-list
154489366|NCT02487680|Picolinic acid|picolinic acid|mesh-list
154489367|NCT02487680|Trace Elements|trace elements|mesh-ancestor
154489368|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
154489369|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489370|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154489371|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
154489372|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
154489373|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489374|NCT03319550|Caseins|caseins|mesh-list
154489375|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
154489376|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
154489377|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489378|NCT04442906|Fentanyl|fentanyl|mesh-list
154489379|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
154489380|NCT04442906|Bupivacaine|bupivacaine|mesh-list
154489381|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
154489382|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
154489383|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489384|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489385|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
154489386|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489387|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154489388|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154489389|NCT04442906|Analgesics|analgesics|mesh-ancestor
154489390|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154489391|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154489392|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154489393|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489394|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489395|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489396|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154489397|NCT04442906|Narcotics|narcotics|mesh-ancestor
154489398|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154489399|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154489400|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
154489401|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
154489402|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
154489403|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489404|NCT03327350|Anticoagulants|anticoagulants|mesh-list
154489405|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
154489406|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154489407|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154489408|NCT03327272|Prednisolone|prednisolone|mesh-list
154489409|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
154489410|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154489411|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
154489412|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489413|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
154489414|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
154489415|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489416|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489417|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154489418|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
154489419|NCT03327272|Hormones|hormones|mesh-ancestor
154489420|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489421|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154489422|NCT03327272|Protective Agents|protective agents|mesh-ancestor
154489423|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154489424|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489425|NCT05508178|Vaccines|vaccines|mesh-list
154489426|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
154489427|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489428|NCT03327116|Methotrexate|methotrexate|mesh-list
154489429|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154489430|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
154489431|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154489432|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489433|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154489434|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
154489435|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489436|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489437|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
154489438|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489439|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154489440|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489441|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
154489442|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489443|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154489444|NCT06036095|Anesthetics|anesthetics|mesh-list
154489445|NCT06036095|Propofol|propofol|mesh-list
154489446|NCT06036095|Sevoflurane|sevoflurane|mesh-list
154489447|NCT06036095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489448|NCT06036095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489449|NCT06036095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154489450|NCT06036095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154489451|NCT06036095|Anesthetics, General|anesthetics, general|mesh-ancestor
154489452|NCT06036095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154489453|NCT06036095|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154489454|NCT06036043|Botulinum Toxins|botulinum toxins|mesh-list
154489455|NCT06036043|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154489456|NCT06036043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154489457|NCT06036043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154489458|NCT06036043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489459|NCT06036043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053277|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
154489460|NCT06036043|Cholinergic Agents|cholinergic agents|mesh-ancestor
154489461|NCT06036043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489462|NCT06036043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489463|NCT06036043|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154489464|NCT06036043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489465|NCT06036030|Primaquine|primaquine|mesh-list
154489466|NCT06036030|Piperaquine|piperaquine|mesh-list
154489467|NCT06036030|Artenimol|artenimol|mesh-list
154489468|NCT06036030|Antimalarials|antimalarials|mesh-ancestor
154489469|NCT06036030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154489470|NCT06036030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154489471|NCT06036030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489472|NCT06035978|Metoprolol|metoprolol|mesh-list
154489473|NCT06035978|Valsartan|valsartan|mesh-list
154489474|NCT06035978|Carvedilol|carvedilol|mesh-list
154489475|NCT06035978|Nebivolol|nebivolol|mesh-list
154489476|NCT06035978|Bisoprolol|bisoprolol|mesh-list
154489477|NCT06035978|Spironolactone|spironolactone|mesh-list
154860735|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
154489478|NCT06035978|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154489479|NCT06035978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154489480|NCT06035978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154489481|NCT06035978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154489482|NCT06035978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489483|NCT06035978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154489484|NCT06035978|Sympatholytics|sympatholytics|mesh-ancestor
154489485|NCT06035978|Autonomic Agents|autonomic agents|mesh-ancestor
154053300|NCT00577096|Thalidomide|thalidomide|mesh-list
154489486|NCT06035978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489487|NCT06035978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489488|NCT06035978|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154489489|NCT06035978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154489490|NCT06035978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154489491|NCT06035978|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489492|NCT06035978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489493|NCT06035978|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154489494|NCT06035978|Hormone Antagonists|hormone antagonists|mesh-ancestor
154489495|NCT06035978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489496|NCT06035978|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154489497|NCT06035978|Diuretics|diuretics|mesh-ancestor
154489498|NCT06035978|Natriuretic Agents|natriuretic agents|mesh-ancestor
154489499|NCT06035978|Antioxidants|antioxidants|mesh-ancestor
154489500|NCT06035978|Protective Agents|protective agents|mesh-ancestor
154489501|NCT06035978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154489502|NCT06035978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489503|NCT06035978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154489504|NCT06035978|Vasodilator Agents|vasodilator agents|mesh-ancestor
154489505|NCT06035978|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154489506|NCT06035978|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154489507|NCT06035978|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154489508|NCT06035978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154489509|NCT06035978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154489510|NCT06035900|Psilocin|psilocin|mesh-list
154489511|NCT06035900|Hallucinogens|hallucinogens|mesh-ancestor
154489512|NCT06035900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489513|NCT06035900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154489514|NCT06035757|Neostigmine|neostigmine|mesh-list
154489515|NCT06035757|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154489516|NCT06035757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489517|NCT06035757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489518|NCT06035757|Cholinergic Agents|cholinergic agents|mesh-ancestor
154489519|NCT06035757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489520|NCT06035757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489521|NCT06035757|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154489522|NCT06035757|Autonomic Agents|autonomic agents|mesh-ancestor
154489523|NCT06035757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489524|NCT06035614|Tacrolimus|tacrolimus|mesh-list
154489525|NCT06035614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489526|NCT06035614|Immunologic Factors|immunologic factors|mesh-ancestor
154489527|NCT06035614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489528|NCT06035614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154489529|NCT06035614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489530|NCT06035614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489531|NCT06035315|Micronutrients|micronutrients|mesh-list
154489532|NCT06035315|Trace Elements|trace elements|mesh-list
154489533|NCT06035315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489534|NCT06035224|Lenvatinib|lenvatinib|mesh-list
154489535|NCT06035224|Antibodies|antibodies|mesh-list
154489536|NCT06035224|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154489537|NCT06035224|Immunologic Factors|immunologic factors|mesh-ancestor
154489538|NCT06035224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053328|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
154053329|NCT00577096|Hormones|hormones|mesh-ancestor
154053332|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489539|NCT06035224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489540|NCT06035224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154489541|NCT06035224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489542|NCT06035224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489543|NCT06035133|Bevacizumab|bevacizumab|mesh-list
154489544|NCT06035133|Cetuximab|cetuximab|mesh-list
154489545|NCT06035133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489546|NCT06035133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489547|NCT06035133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154489548|NCT06035133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154489549|NCT06035133|Growth Substances|growth substances|mesh-ancestor
154489550|NCT06035133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489551|NCT06035133|Growth Inhibitors|growth inhibitors|mesh-ancestor
154489552|NCT06035055|Tazobactam|tazobactam|mesh-list
154489553|NCT06035055|Ceftolozane|ceftolozane|mesh-list
154489554|NCT06035055|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154489555|NCT06035055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154489556|NCT06035055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489557|NCT06035055|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154489558|NCT06035055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489559|NCT06035055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489560|NCT06035055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154489561|NCT06035016|Capecitabine|capecitabine|mesh-list
154489562|NCT06035016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154489563|NCT06035016|Antimetabolites|antimetabolites|mesh-ancestor
154489564|NCT06035016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489565|NCT06035016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489566|NCT06034964|Tislelizumab|tislelizumab|mesh-list
154489567|NCT06034964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489568|NCT06034964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489569|NCT06034938|Tenofovir|tenofovir|mesh-list
154489570|NCT06034938|Lamivudine|lamivudine|mesh-list
154489571|NCT06034938|Antiviral Agents|antiviral agents|mesh-ancestor
154489572|NCT06034938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489573|NCT06034938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154489574|NCT06034938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154489575|NCT06034938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489576|NCT06034938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489577|NCT06034938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154489578|NCT06034938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154213423|NCT03122197|Letrozole|letrozole|mesh-list
154489579|NCT06034691|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154489580|NCT06034691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154489581|NCT06034691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154489582|NCT06034691|Antimetabolites|antimetabolites|mesh-ancestor
154489583|NCT06034691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489584|NCT06034691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154489585|NCT06034691|Protease Inhibitors|protease inhibitors|mesh-ancestor
154489586|NCT06034691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489587|NCT06034691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154489588|NCT06034626|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154489589|NCT06034626|Hyaluronic Acid|hyaluronic acid|mesh-list
154489590|NCT06034626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154489591|NCT06034626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154489592|NCT06034626|Immunologic Factors|immunologic factors|mesh-ancestor
154489593|NCT06034626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489594|NCT06034626|Viscosupplements|viscosupplements|mesh-ancestor
154489595|NCT06034626|Protective Agents|protective agents|mesh-ancestor
154489596|NCT06030713|Cefazolin|cefazolin|mesh-list
154489597|NCT06030713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154489598|NCT06030713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489599|NCT06021379|Trastuzumab|trastuzumab|mesh-list
154489600|NCT06021379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489601|NCT06021379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489602|NCT06003933|Lidocaine|lidocaine|mesh-list
154489603|NCT06003933|Bupivacaine|bupivacaine|mesh-list
154489604|NCT06003933|Anesthetics, Local|anesthetics, local|mesh-ancestor
154489605|NCT06003933|Anesthetics|anesthetics|mesh-ancestor
154053396|NCT00695110|Testosterone|testosterone|mesh-list
154053427|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489606|NCT06003933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489607|NCT06003933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489608|NCT06003933|Sensory System Agents|sensory system agents|mesh-ancestor
154489609|NCT06003933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489610|NCT06003933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154489611|NCT06003933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154489612|NCT06003933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154489613|NCT06003933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489614|NCT06003933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489615|NCT05994807|Itraconazole|itraconazole|mesh-list
154489616|NCT05994807|Carbamazepine|carbamazepine|mesh-list
154489617|NCT05994807|Antifungal Agents|antifungal agents|mesh-ancestor
154489618|NCT05994807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489619|NCT05994807|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154489620|NCT05994807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154489621|NCT05994807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860736|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
154489622|NCT05994807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489623|NCT05994807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154489624|NCT05994807|Hormone Antagonists|hormone antagonists|mesh-ancestor
154489625|NCT05994807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489626|NCT05994807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489627|NCT05994807|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154489628|NCT05994807|Anticonvulsants|anticonvulsants|mesh-ancestor
154489629|NCT05994807|Antimanic Agents|antimanic agents|mesh-ancestor
154489630|NCT05994807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154489631|NCT05994807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489632|NCT05994807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154053456|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
154489633|NCT05994807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154489634|NCT05994807|Analgesics|analgesics|mesh-ancestor
154489635|NCT05994807|Sensory System Agents|sensory system agents|mesh-ancestor
154489636|NCT05994807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489637|NCT05994807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154489638|NCT05994807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489639|NCT05994807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154489640|NCT05994807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154489641|NCT05957926|Hyaluronic Acid|hyaluronic acid|mesh-list
154489642|NCT05957926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154489643|NCT05957926|Immunologic Factors|immunologic factors|mesh-ancestor
154489644|NCT05957926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489645|NCT05957926|Viscosupplements|viscosupplements|mesh-ancestor
154489646|NCT05957926|Protective Agents|protective agents|mesh-ancestor
154489647|NCT05946902|Mirabegron|mirabegron|mesh-list
154489648|NCT05946902|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154489649|NCT05946902|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154489650|NCT05946902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154489651|NCT05946902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154489652|NCT05946902|Adrenergic Agents|adrenergic agents|mesh-ancestor
154213507|NCT02561273|Prednisone|prednisone|mesh-list
154489653|NCT05946902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489654|NCT05946902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489655|NCT05946902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489656|NCT05946902|Urological Agents|urological agents|mesh-ancestor
154489657|NCT05946902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154053483|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489658|NCT05946902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154489659|NCT05946902|Cholinergic Agents|cholinergic agents|mesh-ancestor
154489660|NCT05919277|Antibodies|antibodies|mesh-list
154489661|NCT05919277|Immunoglobulins|immunoglobulins|mesh-list
154489662|NCT05919277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154489663|NCT05919277|Immunoglobulin G|immunoglobulin g|mesh-list
154489664|NCT05919277|Immunologic Factors|immunologic factors|mesh-ancestor
154489665|NCT05919277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489666|NCT05898763|Pembrolizumab|pembrolizumab|mesh-list
154489667|NCT05898763|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154489668|NCT05898763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489669|NCT05898763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489670|NCT05898763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154489671|NCT05898763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489672|NCT05898763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154489673|NCT05898763|Immunologic Factors|immunologic factors|mesh-ancestor
154489674|NCT05898763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489675|NCT05884242|Adalimumab|adalimumab|mesh-list
154489676|NCT05884242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154489677|NCT05884242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489678|NCT05884242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489679|NCT05868837|Rituximab|rituximab|mesh-list
154489680|NCT05868837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489681|NCT05868837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489682|NCT05868837|Immunologic Factors|immunologic factors|mesh-ancestor
154489683|NCT05868837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489684|NCT05868837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489685|NCT05866627|Famotidine|famotidine|mesh-list
154489686|NCT05866627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154489687|NCT05866627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154489688|NCT05866627|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154489689|NCT05866627|Histamine Antagonists|histamine antagonists|mesh-ancestor
154489690|NCT05866627|Histamine Agents|histamine agents|mesh-ancestor
154489691|NCT05866627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489692|NCT05866627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489693|NCT05866627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489694|NCT05786066|Ketamine|ketamine|mesh-list
154489695|NCT05786066|Analgesics|analgesics|mesh-ancestor
154489696|NCT05786066|Sensory System Agents|sensory system agents|mesh-ancestor
154489697|NCT05786066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860737|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489698|NCT05786066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489699|NCT05786066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154489700|NCT05786066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154489701|NCT05786066|Anesthetics, General|anesthetics, general|mesh-ancestor
154489702|NCT05786066|Anesthetics|anesthetics|mesh-ancestor
154489703|NCT05786066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489704|NCT05786066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154489705|NCT05786066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154489706|NCT05786066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489707|NCT05786066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489708|NCT05776888|Ofatumumab|ofatumumab|mesh-list
154489709|NCT05776888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489710|NCT05744648|Titanium dioxide|titanium dioxide|mesh-list
154489711|NCT05744648|Sunscreening Agents|sunscreening agents|mesh-ancestor
154489712|NCT05744648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154053511|NCT00690872|Carboplatin|carboplatin|mesh-list
154489713|NCT05744648|Protective Agents|protective agents|mesh-ancestor
154489714|NCT05744648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489715|NCT05744648|Dermatologic Agents|dermatologic agents|mesh-ancestor
154489716|NCT05744648|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154489717|NCT05708053|Metformin|metformin|mesh-list
154489718|NCT05708053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154489719|NCT05708053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489720|NCT05661188|Atezolizumab|atezolizumab|mesh-list
154489721|NCT05661188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154489722|NCT05661188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489723|NCT05661188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489724|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489725|NCT05640674|Acetaminophen|acetaminophen|mesh-list
154489726|NCT05640674|Ibuprofen|ibuprofen|mesh-list
154489727|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154489728|NCT05640674|Hydrocodone|hydrocodone|mesh-list
154489729|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053543|NCT02622126|Atropine|atropine|mesh-list
154053556|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154489730|NCT05640674|Analgesics|analgesics|mesh-ancestor
154489731|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
154489732|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489733|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489734|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
154489735|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154489736|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489737|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489738|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154489739|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489740|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489741|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154489742|NCT05640674|Narcotics|narcotics|mesh-ancestor
154489743|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489744|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
154489745|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
154489747|NCT05620784|Diuretics|diuretics|mesh-list
154489748|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154489749|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
154489750|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489751|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154489752|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489753|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
154489754|NCT05586477|Promethazine|promethazine|mesh-list
154489755|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154489756|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154489757|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489758|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489759|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
154489760|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
154489761|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
154489762|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489763|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
154489764|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
154489765|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154489766|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154489767|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
154489768|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
154489769|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489770|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489771|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154489773|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
154489774|NCT05535023|Cemiplimab|cemiplimab|mesh-list
154489775|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489776|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489777|NCT05449366|Paclitaxel|paclitaxel|mesh-list
154489778|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154489779|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154489780|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489781|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
154489782|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
154489783|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
154489784|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489785|NCT05415462|Vaccines|vaccines|mesh-list
154489786|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
154489787|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489788|NCT05395494|Cycloserine|cycloserine|mesh-list
154489789|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154489790|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489791|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154489792|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
154489793|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154489794|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
154489795|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489796|NCT05334433|Anesthetics|anesthetics|mesh-list
154489797|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489798|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489799|NCT05327309|Bleomycin|bleomycin|mesh-list
154489800|NCT05327309|Propranolol|propranolol|mesh-list
154489801|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154213648|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
154489802|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154489803|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489804|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489805|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489806|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489807|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154489808|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154489809|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
154489810|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154489811|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489813|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489814|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154489815|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154489816|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154489817|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489818|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489819|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
154489820|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154489821|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489822|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
154489823|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
154489824|NCT05256901|Neostigmine|neostigmine|mesh-list
154489825|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154489826|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489827|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489828|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
154489829|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489830|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489831|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154489832|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
154489833|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489834|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154489835|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154489836|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154489837|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
154489838|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489839|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
154489840|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489841|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489842|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154489843|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
154489844|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489845|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489846|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154489847|NCT05226455|Azacitidine|azacitidine|mesh-list
154489848|NCT05226455|Venetoclax|venetoclax|mesh-list
154489849|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154489850|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
154489851|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489852|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489853|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489854|NCT05215418|Topiramate|topiramate|mesh-list
154489855|NCT05215418|Phentermine|phentermine|mesh-list
154489856|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
154489857|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154489858|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489859|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154489860|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
154489861|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154489862|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
154489863|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
154489864|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489865|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154489866|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489867|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489868|NCT05209425|Vitamin D|vitamin d|mesh-list
154489869|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
154489870|NCT05209425|Vitamins|vitamins|mesh-ancestor
154489871|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
154489872|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489873|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154489874|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154489875|NCT05177601|Cycloserine|cycloserine|mesh-list
154213721|NCT00393471|Analgesics|analgesics|mesh-ancestor
154489876|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154489877|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489878|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154489879|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
154489880|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154489881|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
154489882|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489883|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
154489885|NCT05067621|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154489886|NCT05067621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154489887|NCT05067621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489888|NCT05031494|Paclitaxel|paclitaxel|mesh-list
154489889|NCT05031494|Gemcitabine|gemcitabine|mesh-list
154489890|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154489891|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489892|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
154489893|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
154489894|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
154489895|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489896|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154489897|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
154489898|NCT05019703|Atezolizumab|atezolizumab|mesh-list
154489899|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154489900|NCT05019703|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154489901|NCT05019703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489902|NCT05019703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489903|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489904|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
154489905|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489906|NCT05010681|Lenvatinib|lenvatinib|mesh-list
154489907|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489908|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154489909|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489910|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489911|NCT05010668|Lenvatinib|lenvatinib|mesh-list
154489912|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489913|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154489914|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489915|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489916|NCT04979377|Insulin|insulin|mesh-list
154489917|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154489918|NCT04979377|Hormones|hormones|mesh-list
154489919|NCT04979377|Testosterone|testosterone|mesh-list
154489920|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154489921|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154489922|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489923|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489925|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154489926|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
154489927|NCT04965181|Nicotine|nicotine|mesh-list
154489928|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154489929|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
154489930|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053753|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
154489931|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489932|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154489933|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154489934|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
154489935|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154489936|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489937|NCT04964128|Insulin|insulin|mesh-list
154489938|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154489939|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489940|NCT04943341|Triamcinolone|triamcinolone|mesh-list
154489941|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154489942|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154489943|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154489944|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489945|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
154489946|NCT04943341|Hormones|hormones|mesh-ancestor
154489947|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154489948|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489949|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154489950|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
154489951|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489952|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489953|NCT04857645|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154489954|NCT04857645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154489955|NCT04857645|Antimetabolites|antimetabolites|mesh-ancestor
154489956|NCT04857645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489957|NCT04857645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489958|NCT04844099|Piperaquine|piperaquine|mesh-list
154489959|NCT04844099|Artenimol|artenimol|mesh-list
154489960|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
154489961|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154489962|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154489963|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154489964|NCT04837014|Acetaminophen|acetaminophen|mesh-list
154489965|NCT04837014|Naproxen|naproxen|mesh-list
154489966|NCT04837014|Hydromorphone|hydromorphone|mesh-list
154489967|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154489968|NCT04837014|Analgesics|analgesics|mesh-ancestor
154489969|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
154489970|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154489971|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489972|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
154489973|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154489974|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154489975|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154489976|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
154489977|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154489978|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154489979|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489980|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154489981|NCT04837014|Narcotics|narcotics|mesh-ancestor
154489982|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489983|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
154489984|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154489985|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489986|NCT04834349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154489987|NCT04834349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489988|NCT04762069|Lomustine|lomustine|mesh-list
154489989|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154489990|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
154489991|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154489992|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154489993|NCT04749797|Bupivacaine|bupivacaine|mesh-list
154489994|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
154053819|NCT04118322|Peppermint oil|peppermint oil|mesh-list
154489995|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
154489996|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154489997|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154489998|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
154489999|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490000|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154490001|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154490002|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490003|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
154490004|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
154490005|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154490006|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154490007|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154490008|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154490009|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490010|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
154490011|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154490012|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490013|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154490014|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490015|NCT04685577|Nefopam|nefopam|mesh-list
154490016|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154490017|NCT04685577|Analgesics|analgesics|mesh-ancestor
154490018|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
154490019|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490020|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490021|NCT04671810|Eculizumab|eculizumab|mesh-list
154490022|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154490023|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154490024|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
154490025|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490026|NCT04667039|Ranibizumab|ranibizumab|mesh-list
154490027|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154053820|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
154053853|NCT04660097|Etoposide|etoposide|mesh-list
154490028|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154490029|NCT04667039|Growth Substances|growth substances|mesh-ancestor
154490030|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490031|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154490032|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490033|NCT04628988|Prednisone|prednisone|mesh-list
154490034|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
154490035|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490036|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
154490037|NCT04628988|Hormones|hormones|mesh-ancestor
154490038|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490039|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490040|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154490041|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490042|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490043|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490044|NCT04621435|Copper|copper|mesh-list
154490045|NCT04621435|Trace Elements|trace elements|mesh-ancestor
154490046|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
154490047|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490048|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
154490049|NCT04598009|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154490050|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154490051|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490052|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490053|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490054|NCT04523493|Lenvatinib|lenvatinib|mesh-list
154490055|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490056|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154490057|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490058|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053855|NCT04660097|Durvalumab|durvalumab|mesh-list
154053884|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154490059|NCT04503551|Ranibizumab|ranibizumab|mesh-list
154490060|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154490061|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154490062|NCT04503551|Growth Substances|growth substances|mesh-ancestor
154490063|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490064|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
154490065|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490066|NCT04485195|Procainamide|procainamide|mesh-list
154490067|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154490068|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154860738|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490069|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154490070|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154490071|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490073|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154490074|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154490075|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490076|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490077|NCT04469491|Interferons|interferons|mesh-list
154490078|NCT04469491|Interferon Type I|interferon type i|mesh-list
154490079|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490080|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
154490081|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490082|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
154490083|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490084|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490085|NCT04458948|Azithromycin|azithromycin|mesh-list
154490086|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
154490087|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154490088|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490089|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
154053885|NCT00709215|Cordycepin|cordycepin|mesh-list
154490090|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154490091|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154490092|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490093|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490094|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490095|NCT04386746|Gemcitabine|gemcitabine|mesh-list
154490096|NCT04386746|Docetaxel|docetaxel|mesh-list
154490097|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154490098|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
154490099|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490100|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490101|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
154490102|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
154490103|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
154490104|NCT04383119|Gemcitabine|gemcitabine|mesh-list
154490105|NCT04383119|Trabectedin|trabectedin|mesh-list
154490106|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154490107|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
154490108|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490109|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490110|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490111|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
154490112|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154490113|NCT04350502|Amoxicillin|amoxicillin|mesh-list
154490114|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
154490115|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
154490116|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154490117|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490118|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490119|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490120|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154490121|NCT04339101|Sirolimus|sirolimus|mesh-list
154490122|NCT04339101|Fludarabine|fludarabine|mesh-list
154490123|NCT04339101|Melphalan|melphalan|mesh-list
154490124|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
154490125|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154490126|NCT04339101|Tacrolimus|tacrolimus|mesh-list
154490127|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490128|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490129|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154490130|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
154490131|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490132|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154490133|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490134|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154490135|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490136|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154490137|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
154490138|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490139|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
154490140|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154490141|NCT04305548|Trabectedin|trabectedin|mesh-list
154490142|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490143|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
154490144|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490146|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
154490147|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154490148|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
154490149|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154490150|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053949|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154490151|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490152|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
154490153|NCT04246177|Lenvatinib|lenvatinib|mesh-list
154490154|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490155|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490156|NCT04246177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490157|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490158|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154490159|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490160|NCT04222010|Anesthetics|anesthetics|mesh-list
154490161|NCT04222010|Ropivacaine|ropivacaine|mesh-list
154490162|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154490163|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490164|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
154490165|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
154490166|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490167|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
154490168|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
154490169|NCT04179500|Bedaquiline|bedaquiline|mesh-list
154490170|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154490171|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490172|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154214025|NCT00362414|Mitogens|mitogens|mesh-list
154490173|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154490174|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490175|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490176|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490177|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
154490178|NCT04145700|Gemcitabine|gemcitabine|mesh-list
154490179|NCT04145700|Docetaxel|docetaxel|mesh-list
154490180|NCT04145700|Ramucirumab|ramucirumab|mesh-list
154490181|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154490182|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
154490183|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490184|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490185|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
154490186|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
154490187|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
154490188|NCT04145700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154490189|NCT04145700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154490190|NCT04145700|Growth Substances|growth substances|mesh-ancestor
154490191|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490192|NCT04145700|Growth Inhibitors|growth inhibitors|mesh-ancestor
154490193|NCT04108156|Ranibizumab|ranibizumab|mesh-list
154490194|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154490195|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154490196|NCT04108156|Growth Substances|growth substances|mesh-ancestor
154490197|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490198|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
154490199|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490200|NCT04079738|Ixazomib|ixazomib|mesh-list
154490201|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490202|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
154490203|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490204|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490205|NCT04054635|Fluorides|fluorides|mesh-list
154490206|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
154490207|NCT04054635|Protective Agents|protective agents|mesh-ancestor
154490208|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490209|NCT04017247|Oxytocin|oxytocin|mesh-list
154490210|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
154490211|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154490212|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490213|NCT03953235|Nivolumab|nivolumab|mesh-list
154490214|NCT03953235|Ipilimumab|ipilimumab|mesh-list
154490215|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490216|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490217|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490218|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490219|NCT03897998|Naloxone|naloxone|mesh-list
154490220|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154490221|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490222|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
154490223|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490224|NCT03891706|Interleukin-2|interleukin-2|mesh-list
154490225|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490226|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154490227|NCT03891706|Analgesics|analgesics|mesh-ancestor
154490228|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
154490229|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490230|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490231|NCT03852992|Minoxidil|minoxidil|mesh-list
154490232|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154490233|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
154490234|NCT03820726|Nintedanib|nintedanib|mesh-list
154490235|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490236|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154490237|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490238|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054065|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154490239|NCT03774446|Roscovitine|roscovitine|mesh-list
154490240|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490241|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
154490242|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490243|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154490244|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490245|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490246|NCT03754634|Diacerein|diacerein|mesh-list
154490247|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490248|NCT03745404|Lidocaine|lidocaine|mesh-list
154490249|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
154490250|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
154490251|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154490252|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490253|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
154490254|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490255|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154490256|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154490257|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154490258|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154490259|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490260|NCT03737123|Carboplatin|carboplatin|mesh-list
154490261|NCT03737123|Gemcitabine|gemcitabine|mesh-list
154490262|NCT03737123|Docetaxel|docetaxel|mesh-list
154490263|NCT03737123|Atezolizumab|atezolizumab|mesh-list
154490264|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490265|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154490266|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
154490267|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490268|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
154490269|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
154490270|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
154490271|NCT03737123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154054066|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154490272|NCT03737123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490273|NCT03639714|Nivolumab|nivolumab|mesh-list
154490274|NCT03639714|Ipilimumab|ipilimumab|mesh-list
154490275|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490276|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490277|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490278|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490279|NCT03567876|Venetoclax|venetoclax|mesh-list
154490280|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490281|NCT03518801|Cannabidiol|cannabidiol|mesh-list
154490282|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
154490283|NCT03480334|Nivolumab|nivolumab|mesh-list
154490284|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490285|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490286|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490287|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490288|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
154490289|NCT03432741|Rituximab|rituximab|mesh-list
154490290|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154490291|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
154490292|NCT03432741|Nivolumab|nivolumab|mesh-list
154490293|NCT03432741|Trastuzumab|trastuzumab|mesh-list
154490295|NCT03432741|Gemcitabine|gemcitabine|mesh-list
154490296|NCT03432741|Daratumumab|daratumumab|mesh-list
154490297|NCT03432741|Romidepsin|romidepsin|mesh-list
154490298|NCT03432741|Belinostat|belinostat|mesh-list
154490299|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154490300|NCT03432741|Antibodies|antibodies|mesh-list
154490301|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
154490302|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154490303|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154490304|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
154490305|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490306|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490307|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490308|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154490309|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
154490310|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490311|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490312|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490313|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154490314|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154490315|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154490316|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490317|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
154490318|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
154490319|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490320|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490321|NCT03425006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490322|NCT03425006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214177|NCT00104572|Vitamin D|vitamin d|mesh-list
154490323|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
154490324|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154490325|NCT03401073|Antibodies|antibodies|mesh-list
154490326|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
154490327|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154490328|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
154490329|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490330|NCT03227419|Abatacept|abatacept|mesh-list
154490331|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490332|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490333|NCT03227419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490334|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490335|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154490336|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
154490337|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490338|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490339|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
154490340|NCT03127774|Antidotes|antidotes|mesh-ancestor
154490341|NCT03127774|Protective Agents|protective agents|mesh-ancestor
154490342|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490343|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
154490344|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490345|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
154490346|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154490347|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490348|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
154490349|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
154490350|NCT03116529|Immunomodulating Agents|immunomodulating agents|mesh-list
154490351|NCT03116529|Immunologic Factors|immunologic factors|mesh-ancestor
154490352|NCT03116529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490353|NCT03004833|Nivolumab|nivolumab|mesh-list
154490354|NCT03004833|Doxorubicin|doxorubicin|mesh-list
154490355|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154490356|NCT03004833|Dacarbazine|dacarbazine|mesh-list
154490357|NCT03004833|Vinblastine|vinblastine|mesh-list
154490358|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490359|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490360|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490361|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054143|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
154490362|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154490363|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154490364|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154490365|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490366|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490367|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
154490368|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154490370|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
154490371|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
154490372|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
154490373|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
154490374|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490375|NCT02825160|Iloprost|iloprost|mesh-list
154490376|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154490377|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
154490378|NCT02631447|Nivolumab|nivolumab|mesh-list
154490379|NCT02631447|Ipilimumab|ipilimumab|mesh-list
154490380|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490381|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490382|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490383|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490384|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
154490385|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490386|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154490387|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154490388|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490389|NCT02390869|Rituximab|rituximab|mesh-list
154490390|NCT02390869|Lenalidomide|lenalidomide|mesh-list
154490391|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490392|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490393|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
154490394|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490395|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490396|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154490397|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154490398|NCT02390869|Growth Substances|growth substances|mesh-ancestor
154490399|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
154490400|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
154214244|NCT03235505|Nicotine|nicotine|mesh-list
154490401|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490402|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490403|NCT02343952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490404|NCT02343952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490405|NCT02250937|Fludarabine|fludarabine|mesh-list
154490406|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
154490407|NCT02250937|Busulfan|busulfan|mesh-list
154490408|NCT02250937|Venetoclax|venetoclax|mesh-list
154490409|NCT02250937|Cladribine|cladribine|mesh-list
154490410|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154490411|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490412|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154490413|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
154490414|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490415|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154490416|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
154490417|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490418|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
154490419|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490420|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154490421|NCT02223208|Prednisone|prednisone|mesh-list
154490422|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
154490423|NCT02223208|Doxorubicin|doxorubicin|mesh-list
154490424|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154490425|NCT02223208|Etoposide|etoposide|mesh-list
154490426|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
154490427|NCT02223208|Romidepsin|romidepsin|mesh-list
154490428|NCT02223208|Vincristine|vincristine|mesh-list
154490429|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154490430|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
154490431|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490432|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490433|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490434|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
154490435|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490436|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490437|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154490438|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154490439|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154490440|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154490441|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490442|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490443|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
154490444|NCT02223208|Hormones|hormones|mesh-ancestor
154490445|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490446|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154490447|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154490448|NCT02223208|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154490449|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
154490450|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
154490451|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
154490452|NCT01710176|Gemcitabine|gemcitabine|mesh-list
154490453|NCT01710176|Docetaxel|docetaxel|mesh-list
154490454|NCT01710176|Etoposide|etoposide|mesh-list
154490455|NCT01710176|Epirubicin|epirubicin|mesh-list
154490456|NCT01710176|Ifosfamide|ifosfamide|mesh-list
154490457|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
154490458|NCT01710176|Dacarbazine|dacarbazine|mesh-list
154490459|NCT01710176|Trabectedin|trabectedin|mesh-list
154490460|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154490461|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
154490462|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490463|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490464|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
154490465|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
154490466|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054236|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154490467|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154490468|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154490469|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154490470|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490471|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154490472|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490473|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
154490474|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
154214318|NCT00099268|Levodopa|levodopa|mesh-list
154490475|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490476|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490477|NCT01592370|Dexamethasone|dexamethasone|mesh-list
154490479|NCT01592370|Ipilimumab|ipilimumab|mesh-list
154490480|NCT01592370|Daratumumab|daratumumab|mesh-list
154490481|NCT01592370|Pomalidomide|pomalidomide|mesh-list
154490482|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490483|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
154490484|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
154490485|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490486|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490487|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154490488|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
154490489|NCT01592370|Hormones|hormones|mesh-ancestor
154490490|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490491|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154490492|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490493|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490494|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490495|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490496|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
154490497|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154490498|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154490499|NCT01592370|Growth Substances|growth substances|mesh-ancestor
154490500|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
154490501|NCT01495637|Sargramostim|sargramostim|mesh-list
154490502|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
154490503|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490504|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154490505|NCT01437709|Ofatumumab|ofatumumab|mesh-list
154490506|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154490507|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490508|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
154490509|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490510|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490511|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
154490512|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490513|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
154490514|NCT01093183|Lenalidomide|lenalidomide|mesh-list
154490515|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154490516|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
154490517|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490518|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490519|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490520|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
154490521|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490522|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490523|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154490524|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154490525|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154490526|NCT01093183|Growth Substances|growth substances|mesh-ancestor
154490527|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
154490528|NCT00777036|Dasatinib|dasatinib|mesh-list
154490529|NCT00777036|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154490530|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154490531|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490532|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490533|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490534|NCT00176644|Estradiol|estradiol|mesh-list
154490535|NCT00176644|Estrogens|estrogens|mesh-ancestor
154490536|NCT00176644|Hormones|hormones|mesh-ancestor
154490537|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490538|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490539|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154490540|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
154490541|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490542|NCT00045201|Irinotecan|irinotecan|mesh-list
154490543|NCT00045201|Camptothecin|camptothecin|mesh-list
154490544|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154490545|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154490546|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154490547|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490548|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490549|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490550|NCT00045201|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154214388|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490551|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154490552|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154490553|NCT03326960|Propofol|propofol|mesh-list
154490554|NCT03326960|Sevoflurane|sevoflurane|mesh-list
154490555|NCT03326960|Desflurane|desflurane|mesh-list
154490556|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154490557|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154490558|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490559|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154490560|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
154490561|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
154490562|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154490563|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154490564|NCT03319238|Ketamine|ketamine|mesh-list
154490565|NCT03319238|Analgesics|analgesics|mesh-ancestor
154490566|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
154490567|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490568|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490569|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154490570|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154490571|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
154490572|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
154490573|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154490574|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154490575|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154490576|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154490577|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490578|NCT03321890|Prednisone|prednisone|mesh-list
154490579|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
154490580|NCT03321890|Methotrexate|methotrexate|mesh-list
154490581|NCT03321890|Etoposide|etoposide|mesh-list
154490582|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154490583|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
154490584|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490585|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490586|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490587|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
154490588|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490589|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490590|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154490591|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490592|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
154490593|NCT03321890|Hormones|hormones|mesh-ancestor
154490594|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054381|NCT02167763|Copper|copper|mesh-list
154490595|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154490596|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154490597|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
154490598|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154490599|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154490600|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
154490601|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
154490602|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490603|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154490604|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154490605|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154490606|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154490607|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154490608|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
154490609|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154490610|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154490611|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490612|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
154490613|NCT05464394|Coagulants|coagulants|mesh-ancestor
154490614|NCT05499598|Vitamin A|vitamin a|mesh-list
154490615|NCT05499598|Vitamins|vitamins|mesh-ancestor
154490616|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
154490617|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490618|NCT04442750|Bupivacaine|bupivacaine|mesh-list
154490619|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
154490620|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
154490621|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154490622|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490623|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
154490624|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490625|NCT03326258|Nivolumab|nivolumab|mesh-list
154490626|NCT03326258|Ipilimumab|ipilimumab|mesh-list
154490628|NCT03326258|Antibodies|antibodies|mesh-list
154490629|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
154490630|NCT03326258|Immunotoxins|immunotoxins|mesh-list
154490631|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154490632|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
154490633|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
154490634|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490635|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154490636|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490637|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154490638|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490639|NCT02487212|Clobetasol|clobetasol|mesh-list
154490640|NCT02487212|Petrolatum|petrolatum|mesh-list
154490641|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490642|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
154490643|NCT02487212|Hormones|hormones|mesh-ancestor
154490644|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490645|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490646|NCT02487212|Emollients|emollients|mesh-ancestor
154490647|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
154490648|NCT03318536|Granisetron|granisetron|mesh-list
154490649|NCT03318536|Serotonin|serotonin|mesh-list
154490650|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
154490651|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
154490652|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490653|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490654|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154490655|NCT03318536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154490656|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154490657|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
154490658|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154490659|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490660|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154490661|NCT03537027|Vitamin D|vitamin d|mesh-list
154490662|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
154490663|NCT03537027|Vitamins|vitamins|mesh-ancestor
154490664|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
154490665|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490666|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154490667|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154490668|NCT02183025|Meloxicam|meloxicam|mesh-list
154490669|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
154490670|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154490671|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154490672|NCT02183025|Analgesics|analgesics|mesh-ancestor
154490673|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
154490674|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490675|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490676|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490678|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154490679|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154490680|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490681|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490682|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
154490683|NCT04282174|Melphalan|melphalan|mesh-list
154490684|NCT04282174|Busulfan|busulfan|mesh-list
154490685|NCT04282174|Thiotepa|thiotepa|mesh-list
154490686|NCT04282174|Fludarabine|fludarabine|mesh-list
154490687|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154490688|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
154490689|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490690|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490691|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154490692|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
154490693|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490694|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490695|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154490696|NCT02181309|Meloxicam|meloxicam|mesh-list
154490697|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154490698|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154490699|NCT02181309|Analgesics|analgesics|mesh-ancestor
154490700|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
154490701|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490702|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490703|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490705|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154490706|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154490707|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490708|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490709|NCT02186145|Metronidazole|metronidazole|mesh-list
154490710|NCT02186145|Nystatin|nystatin|mesh-list
154490711|NCT02186145|Dexamethasone|dexamethasone|mesh-list
154490712|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490713|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
154490714|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
154490715|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490716|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490717|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154490718|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
154490719|NCT02186145|Hormones|hormones|mesh-ancestor
154490720|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490721|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154490722|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490723|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490724|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154490725|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154490726|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154490727|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
154490728|NCT02186145|Ionophores|ionophores|mesh-ancestor
154490729|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154490730|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490731|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
154490732|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154490733|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
154490734|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154490735|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490736|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154490737|NCT02183103|Meloxicam|meloxicam|mesh-list
154490738|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154490739|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154490740|NCT02183103|Analgesics|analgesics|mesh-ancestor
154490741|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
154490742|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490743|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490744|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490745|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490746|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154490747|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154490748|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490749|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490751|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154490752|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154490753|NCT03325790|Analgesics|analgesics|mesh-ancestor
154490754|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
154490755|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490756|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490757|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490758|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490759|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154490760|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154490761|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
154490762|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490763|NCT03325790|Protective Agents|protective agents|mesh-ancestor
154490764|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154490765|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490766|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154490767|NCT02181543|Clonidine|clonidine|mesh-list
154490768|NCT02181543|Analgesics|analgesics|mesh-ancestor
154490769|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
154490770|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490771|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490772|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154490773|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
154214614|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154490774|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
154490775|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154490776|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154490777|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154490778|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
154490779|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154490780|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490782|NCT02490176|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154490783|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154490784|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490785|NCT02490176|Incretins|incretins|mesh-ancestor
154490786|NCT02490176|Hormones|hormones|mesh-ancestor
154054563|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154490787|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490788|NCT02183181|Meloxicam|meloxicam|mesh-list
154490789|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154490790|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154490791|NCT02183181|Analgesics|analgesics|mesh-ancestor
154490792|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
154490793|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490794|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490795|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154490796|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154490797|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154490798|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154490799|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490800|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490801|NCT02490098|Insulin|insulin|mesh-list
154490802|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154490803|NCT02490098|Glucagon|glucagon|mesh-list
154490804|NCT02490098|Hormones|hormones|mesh-list
154490805|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154490806|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490807|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490808|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154490809|NCT02486822|Oxytocin|oxytocin|mesh-list
154490810|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
154490811|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154490812|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490813|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154490814|NCT02186457|Polymyxins|polymyxins|mesh-list
154490815|NCT02186457|Polymyxin B|polymyxin b|mesh-list
154490816|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490817|NCT02186535|Vitamin D|vitamin d|mesh-list
154490818|NCT02186535|Calcium|calcium|mesh-list
154490819|NCT02186535|Vitamins|vitamins|mesh-ancestor
154490820|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
154490821|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490822|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154490824|NCT03325400|Fluorides|fluorides|mesh-list
154490825|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
154490826|NCT03325400|Protective Agents|protective agents|mesh-ancestor
154490827|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490828|NCT02181933|Lamivudine|lamivudine|mesh-list
154490829|NCT02181933|Zidovudine|zidovudine|mesh-list
154490830|NCT02181933|Nevirapine|nevirapine|mesh-list
154490831|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154490832|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154490833|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490834|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490835|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
154490836|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490837|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154490838|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154490839|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
154490840|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154490841|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154490842|NCT02183337|Pioglitazone|pioglitazone|mesh-list
154490843|NCT02183337|Linagliptin|linagliptin|mesh-list
154490844|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154490845|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490846|NCT02183337|Incretins|incretins|mesh-ancestor
154490847|NCT02183337|Hormones|hormones|mesh-ancestor
154490848|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490849|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154490850|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
154490851|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490852|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490853|NCT02489786|Digoxin|digoxin|mesh-list
154490854|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154490855|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154490856|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490857|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490858|NCT02489786|Protective Agents|protective agents|mesh-ancestor
154490859|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490860|NCT02489864|Terlipressin|terlipressin|mesh-list
154490861|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154490862|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154490863|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154490864|NCT02182011|Tenecteplase|tenecteplase|mesh-list
154490865|NCT02182011|Streptokinase|streptokinase|mesh-list
154490866|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154490867|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154490868|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490869|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154490870|NCT02486744|Hormones|hormones|mesh-ancestor
154490871|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490872|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054688|NCT00810069|Escitalopram|escitalopram|mesh-list
154490873|NCT02186769|Risperidone|risperidone|mesh-list
154490874|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154490875|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
154490876|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154490877|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490878|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490879|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154490880|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154490881|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154490882|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154490883|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154490884|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
154490885|NCT02486432|Levodopa|levodopa|mesh-list
154490886|NCT02486432|Carbidopa|carbidopa|mesh-list
154490887|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154490888|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154490889|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154490890|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
154490891|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154490892|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490893|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054707|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490894|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154490895|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490896|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154490897|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
154490898|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
154490899|NCT02489240|Vitamin D|vitamin d|mesh-list
154490900|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
154490901|NCT02489240|Vitamins|vitamins|mesh-ancestor
154490902|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
154490903|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490904|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154490905|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154490906|NCT02183415|Linagliptin|linagliptin|mesh-list
154490907|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154490908|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490909|NCT02183415|Incretins|incretins|mesh-ancestor
154490910|NCT02183415|Hormones|hormones|mesh-ancestor
154490911|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490912|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154490913|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
154490914|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490915|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490916|NCT02486510|Maraviroc|maraviroc|mesh-list
154490917|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154490918|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154490919|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490920|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154490921|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154490922|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
154490923|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490924|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154214760|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
154490925|NCT04493528|Lidocaine|lidocaine|mesh-list
154490926|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
154490927|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
154490928|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154490929|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490930|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
154490931|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490932|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154490933|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154490934|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154490935|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154490936|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490937|NCT02183493|Linagliptin|linagliptin|mesh-list
154490938|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154490939|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490940|NCT02183493|Incretins|incretins|mesh-ancestor
154490941|NCT02183493|Hormones|hormones|mesh-ancestor
154490942|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154490943|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154490944|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
154490945|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490946|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490947|NCT02187081|Sorafenib|sorafenib|mesh-list
154490948|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490949|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154490950|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490951|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490952|NCT02485106|Rifaximin|rifaximin|mesh-list
154490953|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
154490954|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154490955|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490956|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154490957|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154490958|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490959|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490960|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154490961|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154490962|NCT02485106|Protective Agents|protective agents|mesh-ancestor
154490963|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490964|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
154490965|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154490966|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
154860739|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154490967|NCT02485028|Mirodenafil|mirodenafil|mesh-list
154490968|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154490969|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154490970|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054787|NCT01016821|Oxycodone|oxycodone|mesh-list
154490971|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490972|NCT02183571|Metformin|metformin|mesh-list
154490973|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154490974|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490975|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154490976|NCT03318146|Latanoprost|latanoprost|mesh-list
154490977|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154490978|NCT02183649|Carbetapentane|carbetapentane|mesh-list
154490979|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
154490980|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
154490981|NCT02187315|Cisplatin|cisplatin|mesh-list
154490982|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490983|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
154490984|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
154490985|NCT02256735|Ritobegron|ritobegron|mesh-list
154490986|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154490987|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154490988|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154490989|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154490990|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154490991|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154490992|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154490993|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154490994|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
154490995|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
154490996|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154490997|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
154054788|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154490998|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154490999|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154491000|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154491001|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
154491002|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491003|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
154491004|NCT02183805|Carboplatin|carboplatin|mesh-list
154491005|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154491006|NCT02183805|Paclitaxel|paclitaxel|mesh-list
154491007|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491008|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
154491009|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491010|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154491011|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154491012|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
154491013|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491014|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491015|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154491016|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154491017|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
154491018|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
154491019|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
154491020|NCT03316352|Bupivacaine|bupivacaine|mesh-list
154491021|NCT03316352|Anesthetics|anesthetics|mesh-list
154491022|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
154491023|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491024|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491025|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
154491026|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491027|NCT02187705|Telmisartan|telmisartan|mesh-list
154491028|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154491029|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154491030|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154491031|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491032|NCT03317912|Lidocaine|lidocaine|mesh-list
154491033|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
154491034|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
154491035|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491036|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491037|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
154491038|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491039|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154491040|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154491041|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154491042|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154054814|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491043|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491044|NCT03321110|Ubiquinone|ubiquinone|mesh-list
154491045|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
154491046|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
154491047|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491048|NCT03321110|Vitamins|vitamins|mesh-ancestor
154491049|NCT03317600|Lidocaine|lidocaine|mesh-list
154491050|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
154491051|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
154491052|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491053|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491054|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
154491055|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491056|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154491057|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154491058|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154491059|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154491060|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491061|NCT02184117|Adenosine|adenosine|mesh-list
154491062|NCT02184117|Analgesics|analgesics|mesh-ancestor
154491063|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
154491064|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491065|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491066|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154491067|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
154491068|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154491069|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
154491070|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
154491071|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491072|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491073|NCT02184273|Dipyrone|dipyrone|mesh-list
154491074|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154491075|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154491077|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
154491078|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491079|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491080|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491081|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154491082|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
154491083|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
154491084|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491085|NCT02188173|Dexamethasone|dexamethasone|mesh-list
154491086|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491087|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
154491088|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
154491089|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491090|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491091|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154491092|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
154491093|NCT02188173|Hormones|hormones|mesh-ancestor
154491094|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491095|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154491096|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491097|NCT02184351|Clotrimazole|clotrimazole|mesh-list
154491098|NCT02184351|Miconazole|miconazole|mesh-list
154491099|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154491100|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491101|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
154491102|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154491103|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154491104|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491105|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491106|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154491107|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
154491108|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491109|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491110|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154491111|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154491112|NCT02184429|PF-06669571|pf-06669571|mesh-list
154491113|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
154491114|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
154491115|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491116|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491117|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491118|NCT02484170|Mannitol|mannitol|mesh-list
154491119|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154491120|NCT02484170|Diuretics|diuretics|mesh-ancestor
154491121|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
154491122|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491123|NCT02188407|Propofol|propofol|mesh-list
154491124|NCT02188407|Sevoflurane|sevoflurane|mesh-list
154491125|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154491126|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491127|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491128|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154491129|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
154491130|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
154491131|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154491132|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154491133|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
154491134|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154491135|NCT03317210|Hematinics|hematinics|mesh-ancestor
154491136|NCT02488694|Pemetrexed|pemetrexed|mesh-list
154491137|NCT02488694|Afatinib|afatinib|mesh-list
154491138|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491139|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491140|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491141|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154491142|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154491143|NCT02488694|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154491144|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154491145|NCT03316898|Memantine|memantine|mesh-list
154491146|NCT03316898|Donepezil|donepezil|mesh-list
154491147|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154491148|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491149|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491150|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
154491151|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491152|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491153|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
154491154|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154491155|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154491156|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
154491157|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154491158|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154491159|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
154491160|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
154491161|NCT02188953|Calcium|calcium|mesh-list
154491162|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154491163|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491164|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154491165|NCT02188953|Antacids|antacids|mesh-ancestor
154491166|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491167|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154491168|NCT02184819|Riboflavin|riboflavin|mesh-list
154491169|NCT02184819|Simendan|simendan|mesh-list
154491170|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
154491171|NCT02184819|Vitamins|vitamins|mesh-ancestor
154491172|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
154491173|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491174|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154491175|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
154491176|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154054993|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491177|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
154491178|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154491179|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154491180|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491181|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491182|NCT02184819|Protective Agents|protective agents|mesh-ancestor
154491183|NCT02256813|Vitamin K|vitamin k|mesh-list
154491184|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
154491185|NCT02256813|Midazolam|midazolam|mesh-list
154491186|NCT02256813|Levomethorphan|levomethorphan|mesh-list
154491187|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
154491188|NCT02256813|Caffeine|caffeine|mesh-list
154491189|NCT02256813|Omeprazole|omeprazole|mesh-list
154491190|NCT02256813|Warfarin|warfarin|mesh-list
154491191|NCT02256813|Vitamins|vitamins|mesh-ancestor
154491192|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
154491193|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491194|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154491195|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154491196|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491197|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154491198|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154491199|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154491200|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154491201|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
154491202|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
154491203|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
154491204|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
154491205|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491206|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491207|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
154491208|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154491209|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154491210|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054994|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
154055025|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491211|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154491212|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154491213|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
154491214|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154491215|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154491216|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154491217|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154491218|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154491219|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
154491220|NCT02256813|Coagulants|coagulants|mesh-ancestor
154491221|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
154491222|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
154215070|NCT00380588|Gemcitabine|gemcitabine|mesh-list
154491223|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154491224|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154491225|NCT02256813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154491226|NCT02256813|Narcotics|narcotics|mesh-ancestor
154491227|NCT02256813|Analgesics|analgesics|mesh-ancestor
154491228|NCT02256813|Sensory System Agents|sensory system agents|mesh-ancestor
154491229|NCT02256813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491230|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
154491231|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
154491232|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154491233|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154491234|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
154491235|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
154491236|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154491237|NCT02483624|Protective Agents|protective agents|mesh-ancestor
154491238|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491239|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491240|NCT02184897|Lenograstim|lenograstim|mesh-list
154491241|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154491242|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
154491243|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491244|NCT02184975|Hemostatics|hemostatics|mesh-list
154491245|NCT02184975|Coagulants|coagulants|mesh-ancestor
154491246|NCT02189343|Thalidomide|thalidomide|mesh-list
154491247|NCT02189343|Dexamethasone|dexamethasone|mesh-list
154491248|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
154491249|NCT02189343|Pomalidomide|pomalidomide|mesh-list
154491250|NCT02189343|Ricolinostat|ricolinostat|mesh-list
154491251|NCT02189343|BB 1101|bb 1101|mesh-list
154491252|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491253|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
154491254|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
154491255|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491256|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491257|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154491258|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
154491259|NCT02189343|Hormones|hormones|mesh-ancestor
154491260|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491261|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154491262|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491263|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
154491264|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491265|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491266|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
154491267|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154491268|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154491269|NCT02189343|Growth Substances|growth substances|mesh-ancestor
154491270|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
154491271|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491272|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
154491273|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154491274|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491275|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154491276|NCT03535701|Paclitaxel|paclitaxel|mesh-list
154491277|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154491278|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154491279|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491280|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
154491281|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
154491282|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
154491283|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491284|NCT02486276|Cilostazol|cilostazol|mesh-list
154491285|NCT02486276|Sumatriptan|sumatriptan|mesh-list
154491286|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154491287|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
154491288|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491289|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491290|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154491291|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
154491292|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154491293|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154491294|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491295|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154491296|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
154491297|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154491298|NCT02486276|Protective Agents|protective agents|mesh-ancestor
154215143|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
154491299|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154491300|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154491301|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491303|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154491304|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154055078|NCT00689624|Antidotes|antidotes|mesh-ancestor
154055120|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
154491305|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
154491306|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491307|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
154491308|NCT02189577|Bromides|bromides|mesh-list
154491309|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
154491310|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154491311|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154491312|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154491313|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
154491314|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491315|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491316|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491317|NCT02189655|Bupivacaine|bupivacaine|mesh-list
154491318|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
154491319|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
154491320|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491321|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491322|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
154491323|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491324|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
154491325|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154491326|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154491327|NCT02193633|Paclitaxel|paclitaxel|mesh-list
154491328|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154491329|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154491330|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055131|NCT00499369|Vitamins|vitamins|mesh-ancestor
154491331|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
154491332|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
154491333|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
154491334|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491335|NCT03315338|Prednisone|prednisone|mesh-list
154491336|NCT03315338|Cortisone|cortisone|mesh-list
154491337|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491338|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
154491339|NCT03315338|Hormones|hormones|mesh-ancestor
154491340|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491341|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491342|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154491343|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491344|NCT02483156|Ribavirin|ribavirin|mesh-list
154491345|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
154491346|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
154491347|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491348|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
154491349|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491350|NCT00706004|Lubiprostone|lubiprostone|mesh-list
154491351|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154491352|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154491353|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491354|NCT02485340|Isosorbide|isosorbide|mesh-list
154491355|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154491356|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154491357|NCT02485340|Sumatriptan|sumatriptan|mesh-list
154491358|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154491359|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154055157|NCT00696566|Rifampin|rifampin|mesh-list
153597842|NCT01871675|Rituximab|rituximab|mesh-list
154491360|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154491361|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
154491362|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491363|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491364|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491365|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154491366|NCT02485340|Diuretics|diuretics|mesh-ancestor
154491367|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
154491368|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
154491369|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154491370|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
154491371|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154491372|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
154491373|NCT02485262|Simeprevir|simeprevir|mesh-list
154491374|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
154491375|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491376|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
154491377|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491378|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491379|NCT02479490|Prednisone|prednisone|mesh-list
154491380|NCT02479490|Everolimus|everolimus|mesh-list
154491381|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491382|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
154491383|NCT02479490|Hormones|hormones|mesh-ancestor
154491384|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491385|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491386|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154491387|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491388|NCT02479490|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154491389|NCT02479490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154491390|NCT02479490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491391|NCT02479490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491392|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491393|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
154491394|NCT02479256|Tamoxifen|tamoxifen|mesh-list
154491395|NCT02479256|Citric Acid|citric acid|mesh-list
154491396|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
154491397|NCT02479256|Clomiphene|clomiphene|mesh-list
154491398|NCT02479256|Enclomiphene|enclomiphene|mesh-list
154491399|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
154491400|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
154491401|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154491402|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
154491403|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
154491404|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491405|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154491406|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
154491407|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491408|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491409|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154491410|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491411|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154491412|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154491413|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154491414|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154491415|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
154491416|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154491417|NCT02482766|Poractant alfa|poractant alfa|mesh-list
154491418|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154491419|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
154491420|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
154491421|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
154491422|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491423|NCT02479178|Docetaxel|docetaxel|mesh-list
154491424|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860740|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
154491425|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
154491426|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
154491427|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
154491428|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491429|NCT03314792|Oxycodone|oxycodone|mesh-list
154491430|NCT03314792|Tapentadol|tapentadol|mesh-list
154491431|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154491432|NCT03314792|Narcotics|narcotics|mesh-ancestor
154491433|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491434|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491435|NCT03314792|Analgesics|analgesics|mesh-ancestor
154491436|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
154491437|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491438|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154491439|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154491440|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154491441|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491442|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
154491443|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491444|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
154491445|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154491446|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
154491447|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491448|NCT02476526|Expectorants|expectorants|mesh-ancestor
154491449|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
154491450|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154215295|NCT00507455|Tamsulosin|tamsulosin|mesh-list
154491451|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
154491452|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491454|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491455|NCT02476526|Antidotes|antidotes|mesh-ancestor
154491456|NCT02479022|Insulin|insulin|mesh-list
154491457|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154491458|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
154491459|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154491460|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491461|NCT02476760|Insulin|insulin|mesh-list
154491462|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154491463|NCT02476760|Metformin|metformin|mesh-list
154491464|NCT02476760|Pioglitazone|pioglitazone|mesh-list
154491465|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154491466|NCT02476760|Liraglutide|liraglutide|mesh-list
154491467|NCT02476760|Exenatide|exenatide|mesh-list
154491468|NCT02476760|Glimepiride|glimepiride|mesh-list
154491469|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
154491470|NCT02476760|Vildagliptin|vildagliptin|mesh-list
154491471|NCT02476760|Saxagliptin|saxagliptin|mesh-list
154491472|NCT02476760|Acarbose|acarbose|mesh-list
154491473|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154491474|NCT02476760|Repaglinide|repaglinide|mesh-list
154491475|NCT02476760|Gliclazide|gliclazide|mesh-list
154491476|NCT02476760|Glipizide|glipizide|mesh-list
154491477|NCT02476760|Biguanides|biguanides|mesh-list
154491478|NCT02476760|Tolbutamide|tolbutamide|mesh-list
154491479|NCT02476760|Voglibose|voglibose|mesh-list
154491480|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154491481|NCT02476760|Nateglinide|nateglinide|mesh-list
154491482|NCT02476760|Miglitol|miglitol|mesh-list
154491483|NCT02476760|Troglitazone|troglitazone|mesh-list
154491484|NCT02476760|Meglitinide|meglitinide|mesh-list
154491485|NCT02476760|Acetohexamide|acetohexamide|mesh-list
154491486|NCT02476760|Buformin|buformin|mesh-list
154491487|NCT02476760|Phenformin|phenformin|mesh-list
154491488|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
154491489|NCT02476760|Glibornuride|glibornuride|mesh-list
154491490|NCT02476760|Tolazamide|tolazamide|mesh-list
154491491|NCT02476760|Carbutamide|carbutamide|mesh-list
154491492|NCT02476760|Gliquidone|gliquidone|mesh-list
154491493|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154491494|NCT02476760|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154491495|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
154491496|NCT02476760|Incretins|incretins|mesh-list
154491497|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491498|NCT02476760|Hormones|hormones|mesh-ancestor
154491499|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491500|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
154491501|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055269|NCT02563288|Analgesics|analgesics|mesh-ancestor
154491502|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491503|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154491504|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154491505|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491506|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
154491507|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
154491508|NCT05460338|Vitamin D|vitamin d|mesh-list
154491509|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154491510|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491512|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
154491513|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154491514|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154491515|NCT02476136|Fluoxetine|fluoxetine|mesh-list
154491516|NCT02476136|Paroxetine|paroxetine|mesh-list
154491517|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154491518|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154491519|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154491520|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154491521|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491522|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491523|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491524|NCT02476136|Analgesics|analgesics|mesh-ancestor
154491525|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
154491526|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491527|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
154491528|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154491529|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
154491530|NCT02476136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154491531|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
154491532|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154491533|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154491534|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154491535|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491536|NCT05437094|Itraconazole|itraconazole|mesh-list
154491537|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
154491538|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491539|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154491540|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154491541|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491542|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491543|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154491544|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
154491545|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491546|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491547|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154491548|NCT05413772|Temocillin|temocillin|mesh-list
154491549|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154491550|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491551|NCT05713292|Pirfenidone|pirfenidone|mesh-list
154491552|NCT05713292|Analgesics|analgesics|mesh-ancestor
154491553|NCT05713292|Sensory System Agents|sensory system agents|mesh-ancestor
154491554|NCT05713292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491555|NCT05713292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491556|NCT05713292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154491557|NCT05713292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154491558|NCT05713292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491559|NCT05713292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154491560|NCT05713292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491561|NCT02475824|Midazolam|midazolam|mesh-list
154491562|NCT02475824|Meperidine|meperidine|mesh-list
154491563|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
154491564|NCT02475824|Propofol|propofol|mesh-list
154491565|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154491566|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491567|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491568|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154491569|NCT02475824|Analgesics|analgesics|mesh-ancestor
154491570|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
154491571|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491572|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154491573|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154491574|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154491575|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
154491576|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491577|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491578|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154491579|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
154491580|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
154491581|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154491582|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154491583|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154491584|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154491586|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
154491587|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154491588|NCT02475824|Narcotics|narcotics|mesh-ancestor
154491589|NCT02478242|Nafamostat|nafamostat|mesh-list
154491590|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154491591|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154491592|NCT02478242|Analgesics|analgesics|mesh-ancestor
154491593|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
154491594|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491595|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491596|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491597|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154491598|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
154491599|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
154055405|NCT02686619|Sirolimus|sirolimus|mesh-list
154491600|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491601|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491602|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154491603|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154491604|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154491605|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491606|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
154215435|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154491607|NCT02475746|Itraconazole|itraconazole|mesh-list
154491608|NCT02475746|PF-06372865|pf-06372865|mesh-list
154491609|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
154491610|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491611|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154491612|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154491613|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491614|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491615|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154491616|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
154491617|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491618|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491619|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154491620|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
154491621|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
154491622|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491623|NCT05715164|Nicotine|nicotine|mesh-list
154491624|NCT05715164|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154491625|NCT05715164|Autonomic Agents|autonomic agents|mesh-ancestor
154491626|NCT05715164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491627|NCT05715164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491628|NCT05715164|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154491629|NCT05715164|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154491630|NCT05715164|Cholinergic Agents|cholinergic agents|mesh-ancestor
154491631|NCT05715164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055406|NCT02686619|Prednisolone|prednisolone|mesh-list
154491632|NCT05715164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491633|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
154491634|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154491635|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
154491636|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154491637|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491638|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154491639|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154491640|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154491641|NCT02480894|Maraviroc|maraviroc|mesh-list
154491642|NCT02480894|Fostemsavir|fostemsavir|mesh-list
154491643|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154491644|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154491645|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491646|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154491647|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154491648|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
154491649|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491650|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154491651|NCT02474654|Ketorolac|ketorolac|mesh-list
154491652|NCT02474654|Epinephrine|epinephrine|mesh-list
154491653|NCT02474654|Racepinephrine|racepinephrine|mesh-list
154491654|NCT02474654|Fentanyl|fentanyl|mesh-list
154491655|NCT02474654|Bupivacaine|bupivacaine|mesh-list
154491656|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
154860741|NCT02226159|Hormones|hormones|mesh-ancestor
154491658|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
154491659|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055445|NCT01017679|Gefitinib|gefitinib|mesh-list
154491660|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491661|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
154491662|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491663|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154491664|NCT02474654|Narcotics|narcotics|mesh-ancestor
154491665|NCT02474654|Analgesics|analgesics|mesh-ancestor
154491666|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154491667|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154491668|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
154491669|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154491670|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154491671|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
154491672|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491673|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491674|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154491675|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154491676|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
154491677|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154491678|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
154491679|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
154491680|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
154491681|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154491682|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154491683|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154491684|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491685|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154491686|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154491687|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491689|NCT02477852|Isoniazid|isoniazid|mesh-list
154491690|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
154491691|NCT02477852|Ethambutol|ethambutol|mesh-list
154491692|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154491693|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
154491694|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154491695|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491696|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
154491697|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154491698|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491699|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491700|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154491701|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154491702|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154491703|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154491704|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154491705|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154491706|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154491707|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154491708|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
154491709|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154491710|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154491711|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154491712|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154491713|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491714|NCT02725268|Paclitaxel|paclitaxel|mesh-list
154491715|NCT02725268|Serabelisib|serabelisib|mesh-list
154491716|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154491717|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491718|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154055530|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491719|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154491720|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154491721|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491722|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491723|NCT00705536|Insulin|insulin|mesh-list
154491724|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154491725|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
154491726|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154491727|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491728|NCT02474420|Amlodipine|amlodipine|mesh-list
154491729|NCT02474420|Deferasirox|deferasirox|mesh-list
154491730|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154491731|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154255897|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
154491733|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491734|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154491735|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491736|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
154491737|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154491738|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
154491739|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
154491740|NCT02474186|Paclitaxel|paclitaxel|mesh-list
154491741|NCT02474186|Docetaxel|docetaxel|mesh-list
154491742|NCT02474186|Capecitabine|capecitabine|mesh-list
154491743|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154491744|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491745|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154491746|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154491747|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154491748|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491749|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154491750|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
154491751|NCT02477306|Rabeprazole|rabeprazole|mesh-list
154491752|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154491753|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154491754|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154491755|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491756|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491757|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
154491758|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154491760|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154491761|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
154491762|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154491763|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491764|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491765|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491766|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
154491767|NCT02472626|Cytarabine|cytarabine|mesh-list
154491768|NCT02472626|Daunorubicin|daunorubicin|mesh-list
154491769|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154491770|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
154491771|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491772|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491773|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
154491774|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491775|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491776|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
154491777|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491778|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154491779|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154491780|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154491781|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491782|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
154491783|NCT02472626|Protective Agents|protective agents|mesh-ancestor
154491784|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
154491785|NCT02472626|Vitamins|vitamins|mesh-ancestor
154491786|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
154491787|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
154491788|NCT02472392|Melphalan|melphalan|mesh-list
154491789|NCT02472392|Busulfan|busulfan|mesh-list
154491790|NCT02472392|Fludarabine|fludarabine|mesh-list
154491791|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
154491792|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154491793|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491794|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
154491795|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491796|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154491797|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154491798|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
154491799|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491800|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491801|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154491802|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
154491803|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154491804|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491805|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
154491806|NCT02472080|Gemcitabine|gemcitabine|mesh-list
154491807|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
154491808|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154491810|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491811|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491812|NCT02473562|Varenicline|varenicline|mesh-list
154491813|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154491814|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154491815|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
154491816|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491817|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491818|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491819|NCT02724020|Everolimus|everolimus|mesh-list
154491820|NCT02724020|Serabelisib|serabelisib|mesh-list
154491821|NCT02724020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154491822|NCT02724020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154491823|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491824|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491825|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491826|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
154491827|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491828|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491829|NCT02660034|Tislelizumab|tislelizumab|mesh-list
154491830|NCT02660034|Pamiparib|pamiparib|mesh-list
154491831|NCT02660034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154491832|NCT02660034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491833|NCT02660034|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154491834|NCT02660034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491835|NCT02660034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491836|NCT02816736|Valsartan|valsartan|mesh-list
154491837|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154491838|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154491839|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154491840|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154491841|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491842|NCT02477072|Heparin|heparin|mesh-list
154491843|NCT02477072|Calcium heparin|calcium heparin|mesh-list
154491844|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
154491845|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154491846|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154491847|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491848|NCT05103410|Aripiprazole|aripiprazole|mesh-list
154491849|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
154491850|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154491851|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154491852|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154491853|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491854|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491855|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
154491856|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
154055621|NCT00699114|Analgesics|analgesics|mesh-ancestor
154491857|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491858|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491859|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154491860|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154491861|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
154491862|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154491863|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154491864|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154491865|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154491866|NCT02472236|Digoxin|digoxin|mesh-list
154491867|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154491868|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154491869|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491870|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491871|NCT02472236|Protective Agents|protective agents|mesh-ancestor
154491872|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491873|NCT03108872|Anticoagulants|anticoagulants|mesh-list
154491874|NCT02194491|AS2471907|as2471907|mesh-list
154491875|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154491876|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491877|NCT03487770|Aripiprazole|aripiprazole|mesh-list
154491878|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154491879|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
154491880|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154491881|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154491882|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154491883|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154491884|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491885|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
154491886|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
154491887|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491888|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491889|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154491890|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154491891|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
154491892|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154491893|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154491894|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154491895|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154491897|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154491898|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154491899|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154491900|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
154491901|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491902|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491903|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154491904|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154491905|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
154491906|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215733|NCT01061658|Vaccines|vaccines|mesh-list
154491907|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154491908|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154491909|NCT02473406|Thymalfasin|thymalfasin|mesh-list
154491910|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154491911|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
154491912|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491913|NCT02473094|Metformin|metformin|mesh-list
154491914|NCT02473094|Capecitabine|capecitabine|mesh-list
154491915|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154491916|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491917|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154491918|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
154491919|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491920|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491921|NCT03492138|Dexamethasone|dexamethasone|mesh-list
154491922|NCT03492138|Ixazomib|ixazomib|mesh-list
154491923|NCT03492138|TIC10 compound|tic10 compound|mesh-list
154491924|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154491925|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
154491926|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
154491927|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491928|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491929|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154491930|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
154491931|NCT03492138|Hormones|hormones|mesh-ancestor
154491932|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154491933|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154491934|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491935|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
154491936|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491937|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491938|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154491939|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
154491940|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491941|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
154491942|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491943|NCT03131700|Bevacizumab|bevacizumab|mesh-list
154491944|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154491945|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491946|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154491947|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154491948|NCT03131700|Growth Substances|growth substances|mesh-ancestor
154491949|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491950|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
154491951|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
154491952|NCT04706936|Fludarabine|fludarabine|mesh-list
154491953|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154491954|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
154255898|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
154491955|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491956|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154491957|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154491958|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
154491959|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491960|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154491961|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154491962|NCT02194881|Ivacaftor|ivacaftor|mesh-list
154491963|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154491964|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154491965|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491966|NCT02194179|Nevirapine|nevirapine|mesh-list
154491967|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154491968|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154491969|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154491970|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491971|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
154491972|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154491973|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154491974|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154491975|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154491976|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154491977|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154491978|NCT02194257|Ambroxol|ambroxol|mesh-list
154491979|NCT02194257|Expectorants|expectorants|mesh-ancestor
154491980|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
154491981|NCT02195115|Amitriptyline|amitriptyline|mesh-list
154491982|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154491983|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
154491984|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154491985|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154491986|NCT02195115|Analgesics|analgesics|mesh-ancestor
154491987|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
154491988|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154491989|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154491990|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154491991|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154491992|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154491993|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491994|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
154491995|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154491996|NCT02194335|Olcegepant|olcegepant|mesh-list
154491997|NCT02194335|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154491998|NCT02194335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154491999|NCT02194335|Analgesics|analgesics|mesh-ancestor
154492000|NCT02194335|Sensory System Agents|sensory system agents|mesh-ancestor
154492001|NCT02194335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492002|NCT02194335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492003|NCT02195973|Paclitaxel|paclitaxel|mesh-list
154492004|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154492005|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492006|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
154492007|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
154492008|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
154492009|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492010|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154492011|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
154492012|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492013|NCT02195271|Melatonin|melatonin|mesh-list
154492014|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
154492015|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492016|NCT02195271|Protective Agents|protective agents|mesh-ancestor
154492017|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492018|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492019|NCT02196285|Vaccines|vaccines|mesh-list
154492020|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
154492021|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492022|NCT02196441|Bupivacaine|bupivacaine|mesh-list
154492023|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
154492024|NCT02196441|Tetracaine|tetracaine|mesh-list
154492025|NCT02196441|Anesthetics|anesthetics|mesh-list
154492026|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492027|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492028|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
154492029|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492031|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
154492032|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
154492033|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492034|NCT02195661|Protective Agents|protective agents|mesh-ancestor
154492035|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492036|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492037|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154492038|NCT03534297|Dapansutrile|dapansutrile|mesh-list
154492039|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492040|NCT02195817|Nalmefene|nalmefene|mesh-list
154492041|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154492042|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492043|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
154492044|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492045|NCT03534063|Analgesics, Opioid|analgesics, opioid|mesh-list
154492046|NCT03534063|Narcotics|narcotics|mesh-ancestor
154492047|NCT03534063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492048|NCT03534063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492049|NCT03534063|Analgesics|analgesics|mesh-ancestor
154492050|NCT03534063|Sensory System Agents|sensory system agents|mesh-ancestor
154492051|NCT03534063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492052|NCT02197143|Esomeprazole|esomeprazole|mesh-list
154492053|NCT02197143|Ranitidine|ranitidine|mesh-list
154215883|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
154492054|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154492055|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154492056|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492057|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154492058|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492059|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492060|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154492061|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
154492062|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
154492063|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492064|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492065|NCT02096874|Bevacizumab|bevacizumab|mesh-list
154492066|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154492067|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492068|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154492069|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154492070|NCT02096874|Growth Substances|growth substances|mesh-ancestor
154492071|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492072|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
154492073|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
154492074|NCT02198547|Ropivacaine|ropivacaine|mesh-list
154492075|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
154492076|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
154492077|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492078|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492079|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
154492080|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492081|NCT02198547|Analgesics|analgesics|mesh-ancestor
154492082|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154492083|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
154492084|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154492085|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154492086|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492087|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154492088|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
154492089|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154492090|NCT01024608|Beclomethasone|beclomethasone|mesh-list
154492091|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492092|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
154492093|NCT01024608|Hormones|hormones|mesh-ancestor
154492094|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492095|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492096|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154492097|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
154492098|NCT03489798|Alprostadil|alprostadil|mesh-list
154492099|NCT03489798|Misoprostol|misoprostol|mesh-list
154055874|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492100|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154492101|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
154492102|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154492103|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492104|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154492105|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492106|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
154492107|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154492108|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
154492109|NCT03489798|Urological Agents|urological agents|mesh-ancestor
154492110|NCT02031081|Prucalopride|prucalopride|mesh-list
154492111|NCT02031081|Laxatives|laxatives|mesh-ancestor
154492112|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492113|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154492114|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154492115|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
154492116|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492117|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492118|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492119|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
154492120|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
154492121|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154492122|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492123|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492124|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
154492125|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154492126|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492127|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492128|NCT02199171|Carboplatin|carboplatin|mesh-list
154492129|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492130|NCT00910650|Aldesleukin|aldesleukin|mesh-list
154492131|NCT00910650|Interleukin-2|interleukin-2|mesh-list
154492132|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492133|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154492134|NCT00910650|Analgesics|analgesics|mesh-ancestor
154492135|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
154492136|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492137|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492138|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154492139|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154492140|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
154492141|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492142|NCT02199327|Interferons|interferons|mesh-list
154492143|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
154492144|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
154492145|NCT02199327|Mitomycins|mitomycins|mesh-list
154492146|NCT02199327|Mitomycin|mitomycin|mesh-list
154492147|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492148|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
154492149|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492150|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
154492151|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492152|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154492153|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
154492154|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492155|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154492156|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492157|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
154492158|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154492159|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154492160|NCT02198001|Amoxicillin|amoxicillin|mesh-list
154492161|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
154055951|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055952|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
154055955|NCT00743470|Ritonavir|ritonavir|mesh-list
154055972|NCT00688324|Acamprosate|acamprosate|mesh-list
154492162|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
154492163|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154492164|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492165|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154492166|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492167|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492168|NCT05116800|Gemcitabine|gemcitabine|mesh-list
154492169|NCT05116800|Docetaxel|docetaxel|mesh-list
154492170|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154492171|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
154492172|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492173|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492174|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
154492175|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
154492176|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
154492177|NCT04078737|Aspirin|aspirin|mesh-list
154492178|NCT04078737|Clopidogrel|clopidogrel|mesh-list
154492179|NCT04078737|Ticagrelor|ticagrelor|mesh-list
154492180|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154492181|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154492182|NCT04078737|Analgesics|analgesics|mesh-ancestor
154492183|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
154492184|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492185|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492186|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492187|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154492188|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154492189|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154492190|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492191|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154492192|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154492193|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492194|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
154492195|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154492196|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154492197|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154492198|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
154492199|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492200|NCT03491904|Fasinumab|fasinumab|mesh-list
154492201|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154492202|NCT03491904|Analgesics|analgesics|mesh-ancestor
154216032|NCT01055522|Interleukin-2|interleukin-2|mesh-list
154492203|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
154492204|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492205|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492207|NCT02199951|Artenimol|artenimol|mesh-list
154492208|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
154492209|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154492210|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154492211|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492212|NCT03533361|Lenvatinib|lenvatinib|mesh-list
154492213|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492214|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154492215|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492216|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492217|NCT01433328|Lidocaine|lidocaine|mesh-list
154492218|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
154492219|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
154492220|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492221|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492222|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
154492223|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492224|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154492225|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154492226|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154492227|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154492228|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492229|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154492230|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154492231|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
154492232|NCT02200185|Morphine|morphine|mesh-list
154492233|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154492234|NCT02200185|Narcotics|narcotics|mesh-ancestor
154492235|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492236|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492237|NCT02200185|Analgesics|analgesics|mesh-ancestor
154492238|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
154492239|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492240|NCT02201043|Thalidomide|thalidomide|mesh-list
154492241|NCT02201043|Tolnaftate|tolnaftate|mesh-list
154492242|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154492243|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
154492244|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492245|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
154492246|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154492247|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492248|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154492249|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154492250|NCT02201043|Growth Substances|growth substances|mesh-ancestor
154492251|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
154492252|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860742|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492253|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
154492254|NCT02201121|Phenylephrine|phenylephrine|mesh-list
154492255|NCT02201121|Dopamine|dopamine|mesh-list
154492256|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
154492257|NCT02201121|Ephedrine|ephedrine|mesh-list
154492258|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154492259|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
154492260|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
154492261|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492262|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492263|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
154492264|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154492265|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
154492266|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
154492267|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154492268|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154492269|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154492270|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154492271|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492272|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492273|NCT02201121|Protective Agents|protective agents|mesh-ancestor
154492274|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154492275|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
154492276|NCT02200575|Telmisartan|telmisartan|mesh-list
154056087|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
154492277|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154492278|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154492279|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154492280|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492281|NCT02201199|Insulin|insulin|mesh-list
154492282|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154492283|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
154492284|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154492285|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492286|NCT02200653|Losartan|losartan|mesh-list
154492287|NCT02200653|Telmisartan|telmisartan|mesh-list
154492288|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154492289|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154492290|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154492291|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154492292|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492293|NCT05261997|Metformin|metformin|mesh-list
154492294|NCT05261997|Acarbose|acarbose|mesh-list
154492295|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154492296|NCT05261997|Pancreatin|pancreatin|mesh-list
154492297|NCT05261997|Pancrelipase|pancrelipase|mesh-list
154492298|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492299|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154492300|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492301|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492302|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492303|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
154492304|NCT02206425|Dexamethasone|dexamethasone|mesh-list
154492305|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
154492306|NCT02206425|Prednisone|prednisone|mesh-list
154492307|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
154492308|NCT02206425|Melphalan|melphalan|mesh-list
154492309|NCT02206425|Doxorubicin|doxorubicin|mesh-list
154492310|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154492311|NCT02206425|Lenalidomide|lenalidomide|mesh-list
154492312|NCT02206425|Pomalidomide|pomalidomide|mesh-list
154492313|NCT02206425|BB 1101|bb 1101|mesh-list
154492314|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154492315|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
154492316|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492317|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154492318|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154492319|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
154492320|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492321|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492322|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154056128|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154492323|NCT02206425|Vitamins|vitamins|mesh-ancestor
154492324|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
154492325|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492326|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
154492327|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
154492328|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492329|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492330|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
154492331|NCT02206425|Hormones|hormones|mesh-ancestor
154860743|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154492332|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492333|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154492334|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
154492335|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492336|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154492337|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154492338|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154492339|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154492340|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154492341|NCT02206425|Growth Substances|growth substances|mesh-ancestor
154492342|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
154492343|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
154492344|NCT02206425|Protective Agents|protective agents|mesh-ancestor
154492345|NCT02201667|Aspirin|aspirin|mesh-list
154492346|NCT02201667|Clopidogrel|clopidogrel|mesh-list
154492347|NCT02201667|Ticagrelor|ticagrelor|mesh-list
154056132|NCT00849186|Sunitinib|sunitinib|mesh-list
154056154|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056155|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154492348|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154492349|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154492350|NCT02201667|Analgesics|analgesics|mesh-ancestor
154492351|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
154492352|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492353|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492354|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492355|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154492356|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154492357|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154492358|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492359|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154492360|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154492362|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
154492363|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154492364|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154492365|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154492366|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
154492367|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492368|NCT02206503|Dexamethasone|dexamethasone|mesh-list
154492369|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
154492370|NCT02206503|Lenalidomide|lenalidomide|mesh-list
154492371|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154492372|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
154492373|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492374|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154492375|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154492376|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
154492377|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492378|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492379|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154492380|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492381|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
154492382|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
154492383|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492384|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492385|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
154492386|NCT02206503|Hormones|hormones|mesh-ancestor
154492387|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492388|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154492389|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154492390|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154492391|NCT02206503|Growth Substances|growth substances|mesh-ancestor
154492392|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
154492393|NCT02206659|Telmisartan|telmisartan|mesh-list
154492394|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154492395|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154492396|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154492397|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492398|NCT02206737|Nicotine|nicotine|mesh-list
154492399|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154492400|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
154492401|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492402|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492403|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154492404|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154492405|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
154492406|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492407|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492408|NCT03533127|Bevacizumab|bevacizumab|mesh-list
154492409|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154492410|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492411|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154492412|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154492413|NCT03533127|Growth Substances|growth substances|mesh-ancestor
154492414|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492415|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
154492416|NCT02207361|Paclitaxel|paclitaxel|mesh-list
154492417|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154492418|NCT02207361|Carboplatin|carboplatin|mesh-list
154492419|NCT02207361|Epirubicin|epirubicin|mesh-list
154492420|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154492421|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492422|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
154492423|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
154492424|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
154492425|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492426|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154492427|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154492428|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154492429|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492430|NCT02202525|Telmisartan|telmisartan|mesh-list
154492431|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154492432|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154216256|NCT01058876|Nicotine|nicotine|mesh-list
154492433|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154492434|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492435|NCT02202603|Teriparatide|teriparatide|mesh-list
154492436|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154492437|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492438|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154492439|NCT02202993|Mibefradil|mibefradil|mesh-list
154492440|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154492441|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154492442|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154492443|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492444|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154492445|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492446|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
154492447|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154492448|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154492449|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492450|NCT02190357|Rifaximin|rifaximin|mesh-list
154492451|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154492452|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492453|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492454|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
154492455|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
154492456|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154492457|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
154492458|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154492459|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492460|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154492461|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154492462|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154492463|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154492464|NCT02257671|Estrogens|estrogens|mesh-ancestor
154492465|NCT02257671|Hormones|hormones|mesh-ancestor
154492466|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492467|NCT01460160|Dasatinib|dasatinib|mesh-list
154492468|NCT01460160|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154492469|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154492470|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492471|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492472|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492473|NCT02203227|Turmeric extract|turmeric extract|mesh-list
154492474|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
154492475|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492476|NCT02203227|Protective Agents|protective agents|mesh-ancestor
154492477|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492478|NCT01170702|Ropivacaine|ropivacaine|mesh-list
154492479|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
154492480|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
154056252|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492481|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492482|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492483|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
154492484|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492485|NCT02203461|Ritonavir|ritonavir|mesh-list
154492486|NCT02203461|Lopinavir|lopinavir|mesh-list
154492487|NCT02203461|Darunavir|darunavir|mesh-list
154492488|NCT02203461|Tenofovir|tenofovir|mesh-list
154492489|NCT02203461|Emtricitabine|emtricitabine|mesh-list
154492490|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154492491|NCT02203461|Cobicistat|cobicistat|mesh-list
154492492|NCT02203461|Elvitegravir|elvitegravir|mesh-list
154492493|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154492494|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154492495|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
154492496|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492497|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492498|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154492499|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154492500|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
154492501|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492502|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154492503|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154492504|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154492505|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154492506|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154492507|NCT02191059|Docetaxel|docetaxel|mesh-list
154492508|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492509|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
154492510|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
154492511|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
154492512|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492513|NCT02191215|Nevirapine|nevirapine|mesh-list
154492514|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154492515|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154492516|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492517|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492518|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
154492519|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492520|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154492521|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154492522|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154492523|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154492524|NCT02209155|Verapamil|verapamil|mesh-list
154492525|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154492526|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154492527|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154492528|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492529|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154492530|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492531|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
154492532|NCT03485118|Rituximab|rituximab|mesh-list
154492533|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154492534|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492535|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
154056291|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154492536|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492537|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154492538|NCT02191293|Nevirapine|nevirapine|mesh-list
154492539|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154492540|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154492541|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492542|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492543|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
154492544|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492545|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154492546|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154492547|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154492548|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154492549|NCT02880540|Fentanyl|fentanyl|mesh-list
154492550|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
154492551|NCT02880540|Morphine|morphine|mesh-list
154492552|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154860744|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492553|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492554|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492555|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154492556|NCT02880540|Analgesics|analgesics|mesh-ancestor
154492557|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
154492558|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492559|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154492560|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154492561|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154056348|NCT00869960|Ritonavir|ritonavir|mesh-list
154492562|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
154492563|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492564|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492565|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154492566|NCT02880540|Narcotics|narcotics|mesh-ancestor
154492567|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154492568|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154492569|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
154492570|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
154492571|NCT02191371|Propofol|propofol|mesh-list
154492572|NCT02191371|Desflurane|desflurane|mesh-list
154492573|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154492574|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492575|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492576|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154492577|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
154492578|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
154492579|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154216419|NCT00335738|Carboplatin|carboplatin|mesh-list
154492580|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
154492581|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154492582|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492583|NCT03532737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154492584|NCT03532737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492585|NCT02741388|Cytarabine|cytarabine|mesh-list
154492586|NCT02741388|Dexamethasone|dexamethasone|mesh-list
154492587|NCT02741388|Rituximab|rituximab|mesh-list
154492588|NCT02741388|Gemcitabine|gemcitabine|mesh-list
154492589|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
154492590|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154492591|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492592|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
154492593|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492594|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154492595|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492596|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
154492597|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
154492598|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492599|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492600|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
154492601|NCT02741388|Hormones|hormones|mesh-ancestor
154492602|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492603|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154492604|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154492605|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
154492606|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492607|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
154492608|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492609|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154492610|NCT02191527|Chrysarobin|chrysarobin|mesh-list
154492611|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154492612|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154492613|NCT02191527|Analgesics|analgesics|mesh-ancestor
154492614|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
154492615|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492616|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492617|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492618|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154492619|NCT03484962|Antibodies|antibodies|mesh-list
154492620|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154492621|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
154492622|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492623|NCT01331616|Bevacizumab|bevacizumab|mesh-list
154492624|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154492625|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492626|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154492627|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154492628|NCT01331616|Growth Substances|growth substances|mesh-ancestor
154492629|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492630|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
154492631|NCT02209701|Porfiromycin|porfiromycin|mesh-list
154492632|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154492633|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492634|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154492635|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
154492636|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154492637|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154492638|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
154492639|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492640|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492641|NCT02204397|Ustekinumab|ustekinumab|mesh-list
154492642|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
154492644|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
154492645|NCT02192229|Vitamins|vitamins|mesh-ancestor
154492646|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
154492647|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492648|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154492649|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154056463|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056464|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154492650|NCT02192463|Nevirapine|nevirapine|mesh-list
154492651|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154492652|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154492653|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492654|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492655|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
154492656|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492657|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154492658|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154492659|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154492660|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154492661|NCT02204475|Interferons|interferons|mesh-list
154492662|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154492663|NCT02204475|Grazoprevir|grazoprevir|mesh-list
154492664|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154492665|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492666|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
154492667|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492668|NCT02210169|Vancomycin|vancomycin|mesh-list
154492669|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154492670|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492671|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
154492672|NCT02210949|Hematinics|hematinics|mesh-ancestor
154492673|NCT02204553|Panobinostat|panobinostat|mesh-list
154492674|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492675|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154492676|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492677|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492678|NCT01109004|Dexamethasone|dexamethasone|mesh-list
154492679|NCT01109004|Lenalidomide|lenalidomide|mesh-list
154492680|NCT01109004|Bortezomib|bortezomib|mesh-list
154492681|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492682|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
154492683|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
154492684|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492685|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492686|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492687|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
154492688|NCT01109004|Hormones|hormones|mesh-ancestor
154492689|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492690|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154492691|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492692|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
154492693|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154492694|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154492695|NCT01109004|Growth Substances|growth substances|mesh-ancestor
154492696|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
154492697|NCT02211729|Azithromycin|azithromycin|mesh-list
154492698|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
154492699|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
154492700|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154492701|NCT02211729|Amodiaquine|amodiaquine|mesh-list
154492702|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154492703|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492704|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
154492705|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154492706|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154492707|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154492708|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492709|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492710|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154492711|NCT05151510|Lidocaine|lidocaine|mesh-list
154492712|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
154056490|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056522|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
154492713|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
154056523|NCT00494221|Vitamins|vitamins|mesh-ancestor
154492714|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492715|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492716|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
154492717|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492718|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154492719|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154492720|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154492721|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154492722|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492723|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
154492724|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154492725|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154492726|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492727|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
154492728|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492729|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492730|NCT03484650|Lidocaine|lidocaine|mesh-list
154492731|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
154492732|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
154492733|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492734|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492735|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
154492736|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492737|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154492738|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154492739|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154492740|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154492741|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492742|NCT02192697|Naquotinib|naquotinib|mesh-list
154492743|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492744|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154492745|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492746|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492747|NCT05153928|Norethindrone|norethindrone|mesh-list
154492748|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
154492749|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154492750|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154492751|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154492752|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
154492753|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154492754|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492755|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154492756|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154492757|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
154492758|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154492759|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492760|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154492761|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154492762|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492763|NCT02192853|Incretins|incretins|mesh-ancestor
154492764|NCT02192853|Hormones|hormones|mesh-ancestor
154492765|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492766|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154492767|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
154492768|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492769|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492770|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
154492771|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492772|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
154492773|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
154492774|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
154492775|NCT04574154|Anesthetics|anesthetics|mesh-list
154056554|NCT00857792|Regadenoson|regadenoson|mesh-list
154860745|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
154492776|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492777|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492778|NCT03484416|Vitamin D|vitamin d|mesh-list
154492779|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
154492780|NCT03484416|Calcium|calcium|mesh-list
154492781|NCT03484416|Vitamins|vitamins|mesh-ancestor
154492782|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
154492783|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492784|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154492785|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154492786|NCT03484416|Antacids|antacids|mesh-ancestor
154492787|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492788|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492789|NCT02205255|Azithromycin|azithromycin|mesh-list
154492790|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154492791|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492792|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
154492793|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154492794|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
154492795|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492796|NCT03476772|Nalbuphine|nalbuphine|mesh-list
154492797|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154492798|NCT03476772|Narcotics|narcotics|mesh-ancestor
154492799|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492800|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492801|NCT03476772|Analgesics|analgesics|mesh-ancestor
154492802|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
154492803|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492804|NCT03535233|Triamcinolone|triamcinolone|mesh-list
154492805|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154492806|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154492807|NCT03535233|Clobetasol|clobetasol|mesh-list
154492808|NCT03535233|Minoxidil|minoxidil|mesh-list
154492809|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154492810|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492811|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
154492812|NCT03535233|Hormones|hormones|mesh-ancestor
154492813|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492814|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492815|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154492816|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
154492817|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492818|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492819|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154492820|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
154492821|NCT02205489|Cetirizine|cetirizine|mesh-list
154492822|NCT02205489|Acyclovir|acyclovir|mesh-list
154492823|NCT02205489|Ibuprofen|ibuprofen|mesh-list
154492824|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
154492825|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154492826|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154492827|NCT02205489|Prednisolone|prednisolone|mesh-list
154492828|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
154492829|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
154492830|NCT02205489|Esomeprazole|esomeprazole|mesh-list
154492831|NCT02205489|Ranitidine|ranitidine|mesh-list
154492832|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154492833|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
154492834|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154492835|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154492836|NCT02205489|Analgesics|analgesics|mesh-ancestor
154492837|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
154492838|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492839|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492840|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154492841|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154492842|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154492843|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492844|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492845|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
154492846|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
154492847|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492848|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
154492849|NCT02205489|Hormones|hormones|mesh-ancestor
154860746|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492850|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492851|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154492852|NCT02205489|Protective Agents|protective agents|mesh-ancestor
154492853|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154492854|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492855|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154492856|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154492857|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154492858|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
154492859|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492860|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154492861|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154492862|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154492863|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
154492864|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
154492865|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492866|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154492868|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154492869|NCT02523846|Narcotics|narcotics|mesh-ancestor
154492870|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492871|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492872|NCT02523846|Analgesics|analgesics|mesh-ancestor
154492873|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
154492874|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492875|NCT03484260|Testosterone|testosterone|mesh-list
154492876|NCT03484260|Androgens|androgens|mesh-ancestor
154492877|NCT03484260|Hormones|hormones|mesh-ancestor
154492878|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492879|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492880|NCT03480906|Latanoprost|latanoprost|mesh-list
154492881|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154492882|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154492883|NCT05262465|Azacitidine|azacitidine|mesh-list
154492884|NCT05262465|Venetoclax|venetoclax|mesh-list
154492885|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154492886|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
154492887|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056695|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492888|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492889|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492890|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
154492891|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154492892|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
154492893|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492894|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
154492895|NCT02220621|Protective Agents|protective agents|mesh-ancestor
154492896|NCT04370418|Fluorouracil|fluorouracil|mesh-list
154492897|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
154492898|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492899|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154492900|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492901|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154492902|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
154492903|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492904|NCT02220777|Omeprazole|omeprazole|mesh-list
154492905|NCT02220777|ASP8477|asp8477|mesh-list
154492906|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154492907|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492908|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154492909|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492910|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492911|NCT03476616|Valsartan|valsartan|mesh-list
154492912|NCT03476616|Eplerenone|eplerenone|mesh-list
154492913|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154492914|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154492915|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154492916|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492917|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154492918|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
154492919|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492920|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492921|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154492922|NCT03476616|Diuretics|diuretics|mesh-ancestor
154492923|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
154492924|NCT02205879|Pregabalin|pregabalin|mesh-list
154492925|NCT02205879|Analgesics|analgesics|mesh-ancestor
154492926|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
154492927|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492928|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492929|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
154492930|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154492931|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154492932|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492933|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154492934|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154492935|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154492936|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492937|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154492939|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154492940|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
154492941|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492942|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154492943|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154492944|NCT03483870|Morphine|morphine|mesh-list
154492945|NCT03483870|Granisetron|granisetron|mesh-list
154860747|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492946|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154492947|NCT03483870|Narcotics|narcotics|mesh-ancestor
154492948|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492949|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492950|NCT03483870|Analgesics|analgesics|mesh-ancestor
154492951|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
154492952|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154492953|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
154492954|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
154492955|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154492956|NCT03483870|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154492957|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154216780|NCT06251635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154492958|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
154492959|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492960|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492961|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
154492962|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154492963|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492964|NCT03480516|Fluorides|fluorides|mesh-list
154492965|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
154492966|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
154492967|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
154492968|NCT03480516|Protective Agents|protective agents|mesh-ancestor
154492969|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492970|NCT02221401|Metformin|metformin|mesh-list
154492971|NCT02221401|Linagliptin|linagliptin|mesh-list
154492972|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154492973|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492974|NCT02221401|Incretins|incretins|mesh-ancestor
154492975|NCT02221401|Hormones|hormones|mesh-ancestor
154492976|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154492977|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154492978|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
154492979|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056741|NCT04182191|Analgesics|analgesics|mesh-ancestor
154492980|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492981|NCT03483636|Lemborexant|lemborexant|mesh-list
154492982|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154492983|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492984|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492985|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154492986|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154492987|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154492988|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154492989|NCT02221479|Plerixafor|plerixafor|mesh-list
154492990|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154492991|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154492992|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
154492993|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154492994|NCT02221635|Risperidone|risperidone|mesh-list
154492995|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154492996|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
154492997|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154492998|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154492999|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493000|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154493001|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154493002|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493003|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154493004|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154493005|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
154493006|NCT02723864|Veliparib|veliparib|mesh-list
154493007|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493008|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154493009|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493010|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493011|NCT02225067|Calcium|calcium|mesh-list
154493012|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154493013|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493014|NCT03475758|Goserelin|goserelin|mesh-list
154493015|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154493016|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493017|NCT02231385|Acetic Acid|acetic acid|mesh-list
154493018|NCT02231385|Retinol acetate|retinol acetate|mesh-list
154493019|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154493020|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493021|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154493022|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
154493023|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493024|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154493025|NCT02231385|Protective Agents|protective agents|mesh-ancestor
154493026|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493027|NCT02523768|Basiliximab|basiliximab|mesh-list
154493028|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154493029|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
154493030|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493031|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154493032|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
154493033|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154493034|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493035|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
154493036|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154493037|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493038|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493039|NCT03203642|XL647|xl647|mesh-list
154493040|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493041|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154493042|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493043|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493044|NCT03475680|Gentamicins|gentamicins|mesh-list
154493045|NCT03475680|Ornidazole|ornidazole|mesh-list
154493046|NCT03475680|Sennosides|sennosides|mesh-list
154493047|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154493048|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493049|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154493050|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493051|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493052|NCT03475680|Laxatives|laxatives|mesh-ancestor
154493053|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493054|NCT03475680|Amebicides|amebicides|mesh-ancestor
154493055|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154493056|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154493057|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154493058|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154493059|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154493060|NCT03475524|Metformin|metformin|mesh-list
154493061|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154493062|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493063|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
154493064|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154493065|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154493066|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154493067|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154493068|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493069|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
154493070|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493071|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493072|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154493073|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493074|NCT02471846|Atezolizumab|atezolizumab|mesh-list
154493075|NCT02471846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154493076|NCT02471846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493077|NCT02471846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493078|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493079|NCT02472782|Teriparatide|teriparatide|mesh-list
154493080|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154493081|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493082|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154493083|NCT02258607|Trametinib|trametinib|mesh-list
154493084|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154493085|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493086|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154493087|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493088|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493089|NCT03792750|Nivolumab|nivolumab|mesh-list
154493090|NCT03792750|Linrodostat|linrodostat|mesh-list
154493091|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493092|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493093|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154493094|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493095|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493096|NCT02258763|Amoxicillin|amoxicillin|mesh-list
154493097|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
154493098|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
154493099|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154493100|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154493101|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493102|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154493103|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493104|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493105|NCT02469974|Busulfan|busulfan|mesh-list
154493106|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
154493107|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493109|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493110|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154493111|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154493112|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493113|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154493114|NCT03131622|Coal Tar|coal tar|mesh-list
154493115|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
154493116|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
154493117|NCT03482544|Pregabalin|pregabalin|mesh-list
154493118|NCT03482544|Analgesics|analgesics|mesh-ancestor
154493119|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
154493120|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493121|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493122|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
154493123|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154493124|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154493125|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493126|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154493127|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154056898|NCT01018849|Vitamin D|vitamin d|mesh-list
154493128|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154493129|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493130|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154493131|NCT02750709|Nitisinone|nitisinone|mesh-list
154493132|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493133|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493134|NCT02222649|Vitamin D|vitamin d|mesh-list
154493135|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
154493136|NCT02222649|Vitamins|vitamins|mesh-ancestor
154493137|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
154493138|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493139|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154493140|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154493141|NCT02222727|Donepezil|donepezil|mesh-list
154493142|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154493143|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493144|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493145|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
154493146|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493147|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493148|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
154860748|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
154493149|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
154493150|NCT02723786|Azathioprine|azathioprine|mesh-list
154493151|NCT02723786|Tacrolimus|tacrolimus|mesh-list
154493152|NCT02723786|Basiliximab|basiliximab|mesh-list
154493153|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154493154|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
154493155|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493156|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154493157|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493158|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493159|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154493160|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493161|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154493162|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
154493163|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154493164|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493165|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
154493166|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154493167|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493168|NCT03310736|Hepcidins|hepcidins|mesh-list
154493169|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493170|NCT02226783|Omeprazole|omeprazole|mesh-list
154493171|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154493172|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493173|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154493174|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493175|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493176|NCT03482232|Acetaminophen|acetaminophen|mesh-list
154493177|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154493178|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154493179|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
154493180|NCT03482232|Ibuprofen|ibuprofen|mesh-list
154493181|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154493186|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154493187|NCT03482232|Analgesics|analgesics|mesh-ancestor
154493188|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
154493189|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493190|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493191|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493192|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154493193|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493194|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493195|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
154493196|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
154493197|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154493198|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
154493199|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154493200|NCT04542200|Antibodies|antibodies|mesh-list
154493201|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
154493202|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493203|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
154493204|NCT02227173|Digoxin|digoxin|mesh-list
154493205|NCT02227173|Montelukast|montelukast|mesh-list
154493206|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154493207|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
154493208|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154493209|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
154493210|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493211|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493212|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154493213|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154493214|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493215|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154493216|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154493217|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493218|NCT02227173|Protective Agents|protective agents|mesh-ancestor
154493219|NCT02227173|Analgesics|analgesics|mesh-ancestor
154493220|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
154493221|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493222|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154493223|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056988|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
154057037|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493224|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154493225|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493226|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154493227|NCT02469740|Clopidogrel|clopidogrel|mesh-list
154493228|NCT02469740|Ticagrelor|ticagrelor|mesh-list
154493229|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154493230|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154493231|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154493232|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154493233|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
154493234|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493235|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493236|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493237|NCT04432220|Apixaban|apixaban|mesh-list
154493238|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154493239|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
154493240|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154493241|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
154493242|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493243|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493244|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
154493245|NCT04405622|Gemcitabine|gemcitabine|mesh-list
154493246|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154493247|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
154493248|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493249|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493250|NCT02723084|Ribavirin|ribavirin|mesh-list
154493251|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
154493252|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
154493253|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493255|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493256|NCT02750943|Fluorides|fluorides|mesh-list
154493257|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
154493258|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
154493259|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
154493260|NCT02750943|Protective Agents|protective agents|mesh-ancestor
154493261|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493262|NCT03481920|Avelumab|avelumab|mesh-list
154493263|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493264|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493265|NCT02227797|Voriconazole|voriconazole|mesh-list
154493266|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
154860749|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
154493267|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493268|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154493269|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154493270|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493271|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493272|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154493273|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
154493274|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493275|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493276|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154493277|NCT05783778|Testosterone|testosterone|mesh-list
154493278|NCT05783778|Androgens|androgens|mesh-ancestor
154493279|NCT05783778|Hormones|hormones|mesh-ancestor
154493280|NCT05783778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493281|NCT05783778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493282|NCT05783557|Clevidipine|clevidipine|mesh-list
154493283|NCT05783557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154493284|NCT05783557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154493285|NCT05783557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493286|NCT05783557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154057102|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493287|NCT05783557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493288|NCT05783518|Propofol|propofol|mesh-list
154493289|NCT05783518|Desflurane|desflurane|mesh-list
154493290|NCT05783518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154493291|NCT05783518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493292|NCT05783518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493293|NCT05783518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154493294|NCT05783518|Anesthetics, General|anesthetics, general|mesh-ancestor
154493295|NCT05783518|Anesthetics|anesthetics|mesh-ancestor
154493296|NCT05783518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154493297|NCT05783492|Ketamine|ketamine|mesh-list
154493298|NCT05783492|Analgesics|analgesics|mesh-ancestor
154493299|NCT05783492|Sensory System Agents|sensory system agents|mesh-ancestor
154493300|NCT05783492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493301|NCT05783492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493302|NCT05783492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154493303|NCT05783492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154493304|NCT05783492|Anesthetics, General|anesthetics, general|mesh-ancestor
154493305|NCT05783492|Anesthetics|anesthetics|mesh-ancestor
154493306|NCT05783492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493307|NCT05783492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154493308|NCT05783492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154493309|NCT05783492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493310|NCT05783492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493311|NCT05783479|Estradiol|estradiol|mesh-list
154493312|NCT05783479|Hyaluronic Acid|hyaluronic acid|mesh-list
154493313|NCT05783479|Estrogens|estrogens|mesh-ancestor
154493314|NCT05783479|Hormones|hormones|mesh-ancestor
154493315|NCT05783479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493316|NCT05783479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493317|NCT05783479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154493318|NCT05783479|Immunologic Factors|immunologic factors|mesh-ancestor
154493319|NCT05783479|Viscosupplements|viscosupplements|mesh-ancestor
154493320|NCT05783479|Protective Agents|protective agents|mesh-ancestor
154493321|NCT05783453|Emollients|emollients|mesh-list
154493322|NCT05783453|Dermatologic Agents|dermatologic agents|mesh-ancestor
154493323|NCT05782933|Rituximab|rituximab|mesh-list
154493324|NCT05782933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493325|NCT05782933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493326|NCT05782933|Immunologic Factors|immunologic factors|mesh-ancestor
154493327|NCT05782933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493328|NCT05782933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493329|NCT05782920|Hyaluronic Acid|hyaluronic acid|mesh-list
154493330|NCT05782920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154493331|NCT05782920|Immunologic Factors|immunologic factors|mesh-ancestor
154493332|NCT05782920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493333|NCT05782920|Viscosupplements|viscosupplements|mesh-ancestor
154493334|NCT05782920|Protective Agents|protective agents|mesh-ancestor
154493335|NCT05782764|Endostar protein|endostar protein|mesh-list
154493336|NCT05782764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154493337|NCT05782764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154493338|NCT05782764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154493339|NCT05782764|Growth Substances|growth substances|mesh-ancestor
154493340|NCT05782764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493341|NCT05782764|Growth Inhibitors|growth inhibitors|mesh-ancestor
154493342|NCT05782764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493343|NCT05782764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493344|NCT05782764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493346|NCT05782751|Mitosis Modulators|mitosis modulators|mesh-ancestor
154493347|NCT05782751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493348|NCT05781074|Lenvatinib|lenvatinib|mesh-list
154493349|NCT05781074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493350|NCT05781074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154493351|NCT05781074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493352|NCT05781074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493353|NCT05779657|Midazolam|midazolam|mesh-list
154493354|NCT05779657|Ketamine|ketamine|mesh-list
154493355|NCT05779657|Analgesics|analgesics|mesh-ancestor
154493356|NCT05779657|Sensory System Agents|sensory system agents|mesh-ancestor
154493357|NCT05779657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493358|NCT05779657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493359|NCT05779657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154493360|NCT05779657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154493361|NCT05779657|Anesthetics, General|anesthetics, general|mesh-ancestor
154493362|NCT05779657|Anesthetics|anesthetics|mesh-ancestor
154493363|NCT05779657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493364|NCT05779657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154493365|NCT05779657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154493366|NCT05779657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493367|NCT05779657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493368|NCT05779657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154493369|NCT05779657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154493370|NCT05779657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154493371|NCT05779657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154493372|NCT05779657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154493373|NCT05779657|GABA Modulators|gaba modulators|mesh-ancestor
154493374|NCT05779657|GABA Agents|gaba agents|mesh-ancestor
154493375|NCT05774054|Norepinephrine|norepinephrine|mesh-list
154493376|NCT05774054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154493377|NCT05774054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154493378|NCT05774054|Adrenergic Agents|adrenergic agents|mesh-ancestor
154493379|NCT05774054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493380|NCT05774054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493381|NCT05774054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493382|NCT05774054|Sympathomimetics|sympathomimetics|mesh-ancestor
154493383|NCT05774054|Autonomic Agents|autonomic agents|mesh-ancestor
154493384|NCT05774054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493385|NCT05774054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154493386|NCT05751148|Bupivacaine|bupivacaine|mesh-list
154493387|NCT05751148|Prilocaine|prilocaine|mesh-list
154493388|NCT05751148|Anesthetics, Local|anesthetics, local|mesh-ancestor
154493389|NCT05751148|Anesthetics|anesthetics|mesh-ancestor
154493390|NCT05751148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493391|NCT05751148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493392|NCT05751148|Sensory System Agents|sensory system agents|mesh-ancestor
154493393|NCT05751148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493394|NCT05711199|Nitroglycerin|nitroglycerin|mesh-list
154493395|NCT05711199|Vasodilator Agents|vasodilator agents|mesh-ancestor
154493396|NCT05703074|Niacinamide|niacinamide|mesh-list
154493397|NCT05703074|Niacin|niacin|mesh-list
154493398|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
154493399|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
154493400|NCT05703074|Vitamins|vitamins|mesh-ancestor
154493401|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
154493402|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493403|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154493404|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
154493405|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493406|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154493407|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
154493408|NCT05701865|Ethanol|ethanol|mesh-list
154493409|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154493410|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493411|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493412|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493413|NCT05674721|Ibuprofen|ibuprofen|mesh-list
154493414|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154493415|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154493416|NCT05674721|Analgesics|analgesics|mesh-ancestor
154493417|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
154493418|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057227|NCT02677259|Estrogens|estrogens|mesh-ancestor
154493419|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493420|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154493421|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493422|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154493423|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493424|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493425|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
154493426|NCT05664464|Temozolomide|temozolomide|mesh-list
154493427|NCT05664464|Gabapentin|gabapentin|mesh-list
154493428|NCT05664464|Memantine|memantine|mesh-list
154493429|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154493430|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
154493431|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493432|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493433|NCT05664464|Analgesics|analgesics|mesh-ancestor
154493434|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
154493435|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493436|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493437|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
154493438|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154493439|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154493440|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493441|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154493442|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154493443|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154493444|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493445|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
154493446|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154493447|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154493448|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
154493449|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493450|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154493451|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154493452|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860750|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493453|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493454|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493455|NCT05657457|Tenecteplase|tenecteplase|mesh-list
154493456|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154493457|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154493458|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493459|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
154493460|NCT05630989|Mitogens|mitogens|mesh-list
154493461|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
154493462|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154493463|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154493464|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493465|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493466|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493467|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493468|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
154493469|NCT05601674|Anesthetics|anesthetics|mesh-list
154493470|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493471|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493472|NCT05527314|Fentanyl|fentanyl|mesh-list
154493473|NCT05527314|Remifentanil|remifentanil|mesh-list
154493474|NCT05527314|Sevoflurane|sevoflurane|mesh-list
154493475|NCT05527314|Cisatracurium|cisatracurium|mesh-list
154493476|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154493477|NCT05527314|Narcotics|narcotics|mesh-ancestor
154493478|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493479|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493480|NCT05527314|Analgesics|analgesics|mesh-ancestor
154493481|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
154493482|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493483|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154493484|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154493485|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
154493486|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
154493487|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154493488|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154493489|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154493490|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154493491|NCT05484505|Nicotine|nicotine|mesh-list
154493492|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154493493|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
154493494|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493495|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493496|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154493497|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154493498|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
154493499|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493500|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493501|NCT05478161|Fexofenadine|fexofenadine|mesh-list
154493502|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154493503|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154493504|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154493505|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
154493506|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
154493507|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493508|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493509|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493510|NCT05476822|Antibodies|antibodies|mesh-list
154493511|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
154493512|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493513|NCT05473364|Acetazolamide|acetazolamide|mesh-list
154493514|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
154493515|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154493516|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493517|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493518|NCT05473364|Diuretics|diuretics|mesh-ancestor
154493519|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
154493520|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493521|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
154493522|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154493523|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
154493524|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154493525|NCT05351346|Prednisone|prednisone|mesh-list
154493526|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
154493527|NCT05351346|Rituximab|rituximab|mesh-list
154493528|NCT05351346|Doxorubicin|doxorubicin|mesh-list
154493529|NCT05351346|Vincristine|vincristine|mesh-list
154493530|NCT05351346|Lenalidomide|lenalidomide|mesh-list
154493532|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154493533|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
154493534|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493535|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493536|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154493537|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
154493538|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493539|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493540|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154493541|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493542|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154493543|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154493544|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154493545|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493546|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154493547|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
154493548|NCT05351346|Hormones|hormones|mesh-ancestor
154493549|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493550|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154493551|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154493552|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
154493553|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
154493554|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
154493555|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154493556|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154493557|NCT05351346|Growth Substances|growth substances|mesh-ancestor
154493558|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
154493559|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154493560|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
154493562|NCT05323019|Esketamine|esketamine|mesh-list
154493563|NCT05323019|Analgesics|analgesics|mesh-ancestor
154493564|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
154493565|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493566|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493567|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154493568|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154493569|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
154493570|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
154493571|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493572|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154493573|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154493574|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493575|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493576|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
154493577|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154493578|NCT05276258|Bupivacaine|bupivacaine|mesh-list
154493579|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
154493580|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
154493581|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493582|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493583|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
154493584|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493585|NCT06145126|Prednisolone|prednisolone|mesh-list
154493586|NCT06145126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154493587|NCT06145126|Glucocorticoids|glucocorticoids|mesh-ancestor
154493588|NCT06145126|Hormones|hormones|mesh-ancestor
154493589|NCT06145126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493590|NCT06145126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493591|NCT06145126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154493592|NCT06145126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493593|NCT06144983|Chlorhexidine|chlorhexidine|mesh-list
154493594|NCT06144983|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154493595|NCT06144983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154493596|NCT06144983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493597|NCT06144983|Disinfectants|disinfectants|mesh-ancestor
154493598|NCT06144983|Dermatologic Agents|dermatologic agents|mesh-ancestor
154493599|NCT06144814|Hyaluronic Acid|hyaluronic acid|mesh-list
154493600|NCT06144814|Estrogens|estrogens|mesh-list
154493601|NCT06144814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154493602|NCT06144814|Immunologic Factors|immunologic factors|mesh-ancestor
154493603|NCT06144814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493604|NCT06144814|Viscosupplements|viscosupplements|mesh-ancestor
154493605|NCT06144814|Protective Agents|protective agents|mesh-ancestor
154493607|NCT06144814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493608|NCT06144788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154493609|NCT06144788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493610|NCT06144788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154493611|NCT06144788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493612|NCT06144736|Etoposide|etoposide|mesh-list
154493613|NCT06144736|Bleomycin|bleomycin|mesh-list
154493614|NCT06144736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493615|NCT06144736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154493616|NCT06144736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154493617|NCT06144736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154493618|NCT06144736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493619|NCT06144736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493620|NCT06144736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154493621|NCT06144697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154493622|NCT06144697|Famotidine|famotidine|mesh-list
154493623|NCT06144697|Antiviral Agents|antiviral agents|mesh-ancestor
154493624|NCT06144697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493625|NCT06144697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154493626|NCT06144697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493627|NCT06144697|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154493628|NCT06144697|Histamine Antagonists|histamine antagonists|mesh-ancestor
154493629|NCT06144697|Histamine Agents|histamine agents|mesh-ancestor
154493631|NCT06144697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493632|NCT06144697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493633|NCT06144125|Thrombin|thrombin|mesh-list
154493634|NCT06144125|Hemostatics|hemostatics|mesh-ancestor
154493635|NCT06144125|Coagulants|coagulants|mesh-ancestor
154493636|NCT06144112|Thrombin|thrombin|mesh-list
154493637|NCT06144112|Hemostatics|hemostatics|mesh-ancestor
154493638|NCT06144112|Coagulants|coagulants|mesh-ancestor
154493639|NCT06144060|Imipenem|imipenem|mesh-list
154493640|NCT06144060|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
154493641|NCT06144060|Cilastatin|cilastatin|mesh-list
154493642|NCT06144060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154493643|NCT06144060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493644|NCT06144060|Protease Inhibitors|protease inhibitors|mesh-ancestor
154493645|NCT06144060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493646|NCT06144060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493647|NCT06144034|Erythritol|erythritol|mesh-list
154493648|NCT06144034|Vasodilator Agents|vasodilator agents|mesh-ancestor
154493649|NCT06143904|Eliglustat|eliglustat|mesh-list
154493650|NCT06143904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493651|NCT06143904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493652|NCT06143787|Tranexamic Acid|tranexamic acid|mesh-list
154493653|NCT06143787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154493654|NCT06143787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154493655|NCT06143787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493656|NCT06143787|Hemostatics|hemostatics|mesh-ancestor
154493657|NCT06143787|Coagulants|coagulants|mesh-ancestor
154493658|NCT06143761|Paclitaxel|paclitaxel|mesh-list
154493659|NCT06143761|Carboplatin|carboplatin|mesh-list
154493660|NCT06143761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154493661|NCT06143761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154493662|NCT06143761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154493663|NCT06143761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493664|NCT06143761|Tubulin Modulators|tubulin modulators|mesh-ancestor
154493665|NCT06143761|Antimitotic Agents|antimitotic agents|mesh-ancestor
154493666|NCT06143761|Mitosis Modulators|mitosis modulators|mesh-ancestor
154493667|NCT06143761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493668|NCT06143761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493669|NCT06143631|Letrozole|letrozole|mesh-list
154493670|NCT06143631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493671|NCT06143631|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154493672|NCT06143631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154493673|NCT06143631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493674|NCT06143631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493675|NCT06143631|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154493676|NCT06143631|Hormone Antagonists|hormone antagonists|mesh-ancestor
154493677|NCT06143631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493678|NCT06143631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860751|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
154493679|NCT06143579|Lenvatinib|lenvatinib|mesh-list
154493680|NCT06143579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493681|NCT06143579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154493683|NCT06143579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493684|NCT06143553|Paclitaxel|paclitaxel|mesh-list
154493685|NCT06143553|Vinorelbine|vinorelbine|mesh-list
154493686|NCT06143553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154493687|NCT06143553|Gemcitabine|gemcitabine|mesh-list
154493688|NCT06143553|Capecitabine|capecitabine|mesh-list
154493689|NCT06143553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154493690|NCT06143553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493691|NCT06143553|Tubulin Modulators|tubulin modulators|mesh-ancestor
154057446|NCT02674139|Copper|copper|mesh-list
154493692|NCT06143553|Antimitotic Agents|antimitotic agents|mesh-ancestor
154493693|NCT06143553|Mitosis Modulators|mitosis modulators|mesh-ancestor
154493694|NCT06143553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493695|NCT06143553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154493696|NCT06143553|Antimetabolites|antimetabolites|mesh-ancestor
154493697|NCT06143124|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154493698|NCT06143124|Bismuth|bismuth|mesh-list
154493699|NCT06143124|Antacids|antacids|mesh-ancestor
154493700|NCT06143124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493701|NCT06143124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493702|NCT06143124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493703|NCT06143124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154493704|NCT06140485|Metformin|metformin|mesh-list
154493705|NCT06140485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154493706|NCT06140485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493707|NCT06136546|Infliximab|infliximab|mesh-list
154493708|NCT06136546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154493709|NCT06136546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154493710|NCT06136546|Dermatologic Agents|dermatologic agents|mesh-ancestor
154493711|NCT06136546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493712|NCT06136546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493713|NCT06124937|Empagliflozin|empagliflozin|mesh-list
154493714|NCT06124937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154493715|NCT06124937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493716|NCT06124937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154493717|NCT06124937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493718|NCT06107114|Docetaxel|docetaxel|mesh-list
154493719|NCT06107114|Cetuximab|cetuximab|mesh-list
154493720|NCT06107114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493721|NCT06107114|Tubulin Modulators|tubulin modulators|mesh-ancestor
154493722|NCT06107114|Antimitotic Agents|antimitotic agents|mesh-ancestor
154493723|NCT06107114|Mitosis Modulators|mitosis modulators|mesh-ancestor
154493724|NCT06107114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493725|NCT06107114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493726|NCT06095596|Upadacitinib|upadacitinib|mesh-list
154493727|NCT06095596|Vedolizumab|vedolizumab|mesh-list
154493728|NCT06095596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493729|NCT06095596|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154493730|NCT06095596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154493731|NCT06095596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493732|NCT06095596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493733|NCT06095596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493734|NCT06080555|Ferric Compounds|ferric compounds|mesh-list
154057546|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154493735|NCT06080555|Hematinics|hematinics|mesh-ancestor
154057561|NCT02670317|Hormones|hormones|mesh-ancestor
154493736|NCT06076681|Amoxicillin|amoxicillin|mesh-list
154493737|NCT06076681|Rabeprazole|rabeprazole|mesh-list
154493738|NCT06076681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154493739|NCT06076681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493740|NCT06076681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154493741|NCT06076681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493742|NCT06076681|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154493743|NCT06076681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493744|NCT06076681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493745|NCT06063109|Dapagliflozin|dapagliflozin|mesh-list
154493746|NCT06063109|Telmisartan|telmisartan|mesh-list
154493747|NCT06063109|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154493748|NCT06063109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493749|NCT06063109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154493750|NCT06063109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493751|NCT06063109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154493752|NCT06063109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154493753|NCT06063109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154493754|NCT06025344|Probenecid|probenecid|mesh-list
154493755|NCT06025344|Uricosuric Agents|uricosuric agents|mesh-ancestor
154493756|NCT06025344|Gout Suppressants|gout suppressants|mesh-ancestor
154493757|NCT06025344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493758|NCT06016556|Ritonavir|ritonavir|mesh-list
154493759|NCT06016556|Nirmatrelvir|nirmatrelvir|mesh-list
154493760|NCT06016556|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154493761|NCT06016556|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154493762|NCT06016556|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154493763|NCT06016556|Protease Inhibitors|protease inhibitors|mesh-ancestor
154493764|NCT06016556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493765|NCT06016556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493766|NCT06016556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154493767|NCT06016556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154493768|NCT06016556|Antiviral Agents|antiviral agents|mesh-ancestor
154493769|NCT06016556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493770|NCT06016556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154493771|NCT06016556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154493772|NCT05998941|Paclitaxel|paclitaxel|mesh-list
154493773|NCT05998941|Bevacizumab|bevacizumab|mesh-list
154493774|NCT05998941|Carboplatin|carboplatin|mesh-list
154493775|NCT05998941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154493776|NCT05998941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493777|NCT05998941|Tubulin Modulators|tubulin modulators|mesh-ancestor
154493778|NCT05998941|Antimitotic Agents|antimitotic agents|mesh-ancestor
154493779|NCT05998941|Mitosis Modulators|mitosis modulators|mesh-ancestor
154493780|NCT05998941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493781|NCT05998941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493782|NCT05998941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154493783|NCT05998941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154493784|NCT05998941|Growth Substances|growth substances|mesh-ancestor
154493785|NCT05998941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493786|NCT05998941|Growth Inhibitors|growth inhibitors|mesh-ancestor
154493787|NCT05988463|Artesunate|artesunate|mesh-list
154493788|NCT05988463|Antimalarials|antimalarials|mesh-ancestor
154493789|NCT05988463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154493790|NCT05988463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154493791|NCT05988463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493792|NCT05988463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493793|NCT05988463|Antiviral Agents|antiviral agents|mesh-ancestor
154493794|NCT05988463|Schistosomicides|schistosomicides|mesh-ancestor
154493795|NCT05988463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154493796|NCT05988463|Anthelmintics|anthelmintics|mesh-ancestor
154493797|NCT05973903|Pembrolizumab|pembrolizumab|mesh-list
154493798|NCT05973903|Lenvatinib|lenvatinib|mesh-list
154493799|NCT05973903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493800|NCT05973903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493801|NCT05973903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154493802|NCT05973903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493803|NCT05973903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154493804|NCT05973903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493805|NCT05961124|Niraparib|niraparib|mesh-list
154493806|NCT05961124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154493807|NCT05961124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493808|NCT05961124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493809|NCT05961124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493810|NCT05960864|Celecoxib|celecoxib|mesh-list
154493811|NCT05960864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154493812|NCT05960864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154493813|NCT05960864|Analgesics|analgesics|mesh-ancestor
154493814|NCT05960864|Sensory System Agents|sensory system agents|mesh-ancestor
154493815|NCT05960864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493816|NCT05960864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493817|NCT05960864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154493818|NCT05960864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154493819|NCT05960864|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154493820|NCT05960864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154493821|NCT05960864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493822|NCT05960864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493823|NCT05946642|Ivermectin|ivermectin|mesh-list
154493824|NCT05946642|Pyrimethamine|pyrimethamine|mesh-list
154493825|NCT05946642|Piperaquine|piperaquine|mesh-list
154493826|NCT05946642|Sulfadoxine|sulfadoxine|mesh-list
154493827|NCT05946642|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154493828|NCT05946642|Amodiaquine|amodiaquine|mesh-list
154493829|NCT05946642|Artenimol|artenimol|mesh-list
154493830|NCT05946642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154493831|NCT05946642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493832|NCT05946642|Antimalarials|antimalarials|mesh-ancestor
154493833|NCT05946642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154493834|NCT05946642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154493835|NCT05946642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493836|NCT05946642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493837|NCT05946642|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154057647|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493838|NCT05936710|Dialysis Solutions|dialysis solutions|mesh-list
154493839|NCT05936710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154493841|NCT05921604|Baclofen|baclofen|mesh-list
154493842|NCT05921604|Analgesics|analgesics|mesh-ancestor
154493843|NCT05921604|Sensory System Agents|sensory system agents|mesh-ancestor
154493844|NCT05921604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493845|NCT05921604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493846|NCT05921604|Anticonvulsants|anticonvulsants|mesh-ancestor
154493847|NCT05921604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154493848|NCT05921604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154493849|NCT05921604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493850|NCT05921604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154493851|NCT05921604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154493852|NCT05921604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154493853|NCT05921604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493854|NCT05921604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217683|NCT04262492|Edoxaban|edoxaban|mesh-list
154493855|NCT05921604|Antimanic Agents|antimanic agents|mesh-ancestor
154493856|NCT05921604|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154493857|NCT05921604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154493858|NCT05921604|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154493859|NCT05921604|GABA Agonists|gaba agonists|mesh-ancestor
154493860|NCT05921604|GABA Agents|gaba agents|mesh-ancestor
154493861|NCT05893069|Oxandrolone|oxandrolone|mesh-list
154493862|NCT05893069|Androgens|androgens|mesh-ancestor
154493863|NCT05893069|Hormones|hormones|mesh-ancestor
154493864|NCT05893069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154493865|NCT05893069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493866|NCT05893069|Anabolic Agents|anabolic agents|mesh-ancestor
154493867|NCT05887479|Botulinum Toxins|botulinum toxins|mesh-list
154493868|NCT05887479|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154493869|NCT05887479|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154493870|NCT05887479|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154493871|NCT05887479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154493872|NCT05887479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493873|NCT05887479|Cholinergic Agents|cholinergic agents|mesh-ancestor
154493874|NCT05887479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493875|NCT05887479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493876|NCT05887479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154493877|NCT05887479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493879|NCT05882643|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154493880|NCT05882643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493881|NCT05882643|Trace Elements|trace elements|mesh-ancestor
154493882|NCT05882643|Micronutrients|micronutrients|mesh-ancestor
154493883|NCT05882643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493884|NCT05879120|Pembrolizumab|pembrolizumab|mesh-list
154493885|NCT05879120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154493886|NCT05879120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493887|NCT05879120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154493888|NCT05879120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057679|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057683|NCT00644735|Esomeprazole|esomeprazole|mesh-list
154493889|NCT05857631|Cisplatin|cisplatin|mesh-list
154493890|NCT05857631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493891|NCT05839366|Remifentanil|remifentanil|mesh-list
154493892|NCT05839366|Propofol|propofol|mesh-list
154493893|NCT05839366|Esketamine|esketamine|mesh-list
154493894|NCT05839366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154493895|NCT05839366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493896|NCT05839366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493897|NCT05839366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154493898|NCT05839366|Anesthetics, General|anesthetics, general|mesh-ancestor
154493899|NCT05839366|Anesthetics|anesthetics|mesh-ancestor
154493900|NCT05839366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154493901|NCT05839366|Narcotics|narcotics|mesh-ancestor
154493902|NCT05839366|Analgesics|analgesics|mesh-ancestor
154493903|NCT05839366|Sensory System Agents|sensory system agents|mesh-ancestor
154493904|NCT05839366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493905|NCT05839366|Antidepressive Agents|antidepressive agents|mesh-ancestor
154860752|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154493906|NCT05839366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154493908|NCT05838716|Ergocalciferols|ergocalciferols|mesh-list
154493909|NCT05838716|Cholecalciferol|cholecalciferol|mesh-list
154493910|NCT05838716|Vitamins|vitamins|mesh-list
154493911|NCT05838716|Micronutrients|micronutrients|mesh-ancestor
154493912|NCT05838716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493913|NCT05838716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154493914|NCT05838716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154493915|NCT05810792|Interleukin-2|interleukin-2|mesh-list
154493916|NCT05810792|Histamine|histamine|mesh-list
154493917|NCT05810792|Histamine phosphate|histamine phosphate|mesh-list
154493918|NCT05810792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493919|NCT05810792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154493920|NCT05810792|Analgesics|analgesics|mesh-ancestor
154493921|NCT05810792|Sensory System Agents|sensory system agents|mesh-ancestor
154493922|NCT05810792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493923|NCT05810792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493924|NCT05810792|Histamine Agonists|histamine agonists|mesh-ancestor
154493925|NCT05810792|Histamine Agents|histamine agents|mesh-ancestor
154493926|NCT05810792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493927|NCT05810792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493928|NCT05774067|Terlipressin|terlipressin|mesh-list
154493929|NCT05774067|Vasopressins|vasopressins|mesh-list
154493930|NCT05774067|Norepinephrine|norepinephrine|mesh-list
154057737|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
154217771|NCT03914742|Pamiparib|pamiparib|mesh-list
154493931|NCT05774067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154493932|NCT05774067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154493934|NCT05774067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493935|NCT05774067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493936|NCT05774067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493937|NCT05774067|Sympathomimetics|sympathomimetics|mesh-ancestor
154493938|NCT05774067|Autonomic Agents|autonomic agents|mesh-ancestor
154493939|NCT05774067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493940|NCT05774067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154493941|NCT05774067|Hemostatics|hemostatics|mesh-ancestor
154493942|NCT05774067|Coagulants|coagulants|mesh-ancestor
154493943|NCT05774067|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154493944|NCT05774067|Natriuretic Agents|natriuretic agents|mesh-ancestor
154493945|NCT05774067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154493946|NCT05774015|Magnesium Oxide|magnesium oxide|mesh-list
154493947|NCT05774015|Antacids|antacids|mesh-ancestor
154493948|NCT05774015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493949|NCT05774015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154493950|NCT05709171|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154493951|NCT05709171|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154493952|NCT05709171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493953|NCT05681572|Midazolam|midazolam|mesh-list
154493954|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
154493955|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154493956|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154493957|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154493958|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154493959|NCT05681572|Analgesics|analgesics|mesh-ancestor
154493960|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
154493961|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154493962|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154493963|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154493964|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154493965|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
154493966|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154493967|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493968|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154493969|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154493970|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154493971|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154057777|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493972|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154493973|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
154493974|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
154493975|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
154493976|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
154493977|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154493978|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154493979|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154493980|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154493981|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493982|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154493983|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154493984|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493986|NCT05639218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154493987|NCT05639218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154493988|NCT05639218|Antimetabolites|antimetabolites|mesh-ancestor
154493989|NCT05639218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154493990|NCT05639218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154493991|NCT05639218|Protease Inhibitors|protease inhibitors|mesh-ancestor
154493992|NCT05639218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154493993|NCT05639218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154493994|NCT05630976|Isavuconazole|isavuconazole|mesh-list
154493995|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
154493996|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154493997|NCT05625087|Fulvestrant|fulvestrant|mesh-list
154493998|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154493999|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494000|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154494001|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154494002|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
154057778|NCT02666417|Iron|iron|mesh-list
154494003|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494004|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494005|NCT05624359|Ropivacaine|ropivacaine|mesh-list
154494006|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
154494007|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
154494008|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494009|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494010|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
154494011|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494012|NCT05620641|Gabapentin|gabapentin|mesh-list
154494013|NCT05620641|Ondansetron|ondansetron|mesh-list
154494014|NCT05620641|Analgesics|analgesics|mesh-ancestor
154494015|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
154494016|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494017|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494018|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
154494019|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154494020|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154494021|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494022|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154494023|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154494024|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154494025|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494026|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494027|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
154494028|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
154494029|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
154494030|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494031|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
154494032|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
154494033|NCT05620641|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154494034|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154494035|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
154494036|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154494037|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
154494038|NCT05605080|Coagulants|coagulants|mesh-ancestor
154494039|NCT05599347|Azithromycin|azithromycin|mesh-list
154494040|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057845|NCT00647621|Phenytoin|phenytoin|mesh-list
154494041|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154494042|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
154494043|NCT05588609|Afatinib|afatinib|mesh-list
154494044|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494045|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154494046|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494047|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494048|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
154494049|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494050|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494051|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154494052|NCT05588609|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154494053|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494054|NCT05580445|Gemcitabine|gemcitabine|mesh-list
154494055|NCT05580445|Conteltinib|conteltinib|mesh-list
154494056|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154494057|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
154494058|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494059|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494060|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494061|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494062|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154494063|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
154494064|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494066|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154494067|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494068|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
154494069|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
154494070|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
154494071|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494072|NCT05516953|Baclofen|baclofen|mesh-list
154494073|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154494074|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494075|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154494076|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494077|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154494078|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
154494079|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
154494080|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494081|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494083|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
154494084|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494085|NCT05502900|Protective Agents|protective agents|mesh-ancestor
154494086|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494087|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494088|NCT05436652|Prednisolone|prednisolone|mesh-list
154494089|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154494090|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
154494091|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154494092|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
154494093|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154494094|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
154494095|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154494096|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
154494097|NCT05436652|Hormones|hormones|mesh-ancestor
154494098|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494099|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494100|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154494101|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494102|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
154494103|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
154494104|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494105|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494106|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154494107|NCT05436652|Protective Agents|protective agents|mesh-ancestor
154494108|NCT05423951|Sufentanil|sufentanil|mesh-list
154494109|NCT05423951|Propofol|propofol|mesh-list
154494110|NCT05423951|Rocuronium|rocuronium|mesh-list
154494111|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154494112|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494113|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494114|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154494115|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
154494116|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
154494117|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154494118|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154494119|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154494120|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494121|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154494122|NCT05423951|Narcotics|narcotics|mesh-ancestor
154494123|NCT05423951|Analgesics|analgesics|mesh-ancestor
154494124|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
154494125|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154494126|NCT05397886|Propofol|propofol|mesh-list
154494127|NCT05397886|Flumazenil|flumazenil|mesh-list
154494128|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154494129|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494130|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494131|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154494132|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
154494133|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
154860753|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154494134|NCT05397886|Antidotes|antidotes|mesh-ancestor
154494135|NCT05397886|Protective Agents|protective agents|mesh-ancestor
154494136|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
154494137|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
154494138|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494139|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494140|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154494141|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154494142|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494143|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154494144|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154494145|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
154057949|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494146|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
154494147|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494148|NCT05369793|Protective Agents|protective agents|mesh-ancestor
154494149|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494150|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
154494151|NCT05369793|Vitamins|vitamins|mesh-ancestor
154494152|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
154494153|NCT05357859|Vitamin D|vitamin d|mesh-list
154494154|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
154494155|NCT05357859|Vitamins|vitamins|mesh-ancestor
154494156|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
154494157|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494158|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154494159|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154494160|NCT05348356|Nirogacestat|nirogacestat|mesh-list
154494161|NCT05348356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154494162|NCT05348356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494163|NCT05348356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494164|NCT05338866|Capecitabine|capecitabine|mesh-list
154494165|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154494166|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
154494167|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494168|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494169|NCT05303064|Olanzapine|olanzapine|mesh-list
154494170|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
154494171|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
154494172|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494173|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494174|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494175|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154494176|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154494177|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494178|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154494179|NCT05303064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154494180|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154494181|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154494182|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494183|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494184|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
154494185|NCT05253118|Pemetrexed|pemetrexed|mesh-list
154494186|NCT05253118|Tislelizumab|tislelizumab|mesh-list
154494187|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494188|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494189|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494190|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154494191|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154494192|NCT05253118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494193|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154494194|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154494195|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
154494196|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494197|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494198|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494199|NCT05251714|Fulvestrant|fulvestrant|mesh-list
154494200|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154494201|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494202|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154494203|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154494204|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
154494205|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494206|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494207|NCT05251493|Iron|iron|mesh-list
154494208|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154494209|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154494210|NCT05251493|Trace Elements|trace elements|mesh-ancestor
154494211|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
154494212|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494213|NCT05251493|Hematinics|hematinics|mesh-ancestor
154494214|NCT05227456|Etonogestrel|etonogestrel|mesh-list
154494215|NCT05227456|Desogestrel|desogestrel|mesh-list
154494216|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154494217|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
154494218|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154494219|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494220|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154058042|NCT02656121|Vitamin D|vitamin d|mesh-list
154494221|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154494222|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154494223|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154494224|NCT05227456|Progestins|progestins|mesh-ancestor
154494225|NCT05227456|Hormones|hormones|mesh-ancestor
154494226|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494227|NCT05209074|Ivosidenib|ivosidenib|mesh-list
154494228|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494229|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494230|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494231|NCT05208619|Anesthetics|anesthetics|mesh-list
154494232|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494233|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494234|NCT05195060|Sotrovimab|sotrovimab|mesh-list
154494235|NCT05195060|Molnupiravir|molnupiravir|mesh-list
154494236|NCT05195060|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154494237|NCT05195060|Antiviral Agents|antiviral agents|mesh-ancestor
154494238|NCT05195060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154494239|NCT05178849|Anesthetics|anesthetics|mesh-list
154494240|NCT05178849|Anesthetics, Local|anesthetics, local|mesh-list
154494241|NCT05178849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494242|NCT05178849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494243|NCT05178849|Sensory System Agents|sensory system agents|mesh-ancestor
154494244|NCT05178849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494245|NCT05164367|Atropine|atropine|mesh-list
154494246|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154494247|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154494248|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154494249|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
154494250|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494251|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494252|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154494253|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
154494254|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
154494255|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
154494256|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154494257|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154494258|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
154494259|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494260|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494261|NCT05125055|Paclitaxel|paclitaxel|mesh-list
154494262|NCT05125055|Docetaxel|docetaxel|mesh-list
154494263|NCT05125055|Fluorouracil|fluorouracil|mesh-list
154494264|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154494265|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494266|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
154494267|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
154494268|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
154494269|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494270|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
154494271|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154494272|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154494273|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
154058079|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058080|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058081|NCT02655965|Clonidine|clonidine|mesh-list
154058082|NCT02655965|Ropivacaine|ropivacaine|mesh-list
154058083|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
154058084|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
154058085|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058086|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058087|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
154058088|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494274|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860754|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154494275|NCT05107921|Bromfenac|bromfenac|mesh-list
154494276|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154494277|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154494278|NCT05107921|Analgesics|analgesics|mesh-ancestor
154494279|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
154494280|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494281|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494282|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154494283|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154494284|NCT05098041|Rifampin|rifampin|mesh-list
154494285|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154494286|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
154494287|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154494288|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154494289|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
154494290|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154494291|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494292|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494293|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154494294|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154494295|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154494296|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154494297|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154494298|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154494299|NCT05076838|Diazepam|diazepam|mesh-list
154494300|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154494301|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
154494302|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
154494303|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
154494304|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494305|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494306|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494307|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154058089|NCT02655965|Analgesics|analgesics|mesh-ancestor
154494308|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494309|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154494310|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154494311|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154494312|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154494313|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154494314|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154494315|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
154494316|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
154494317|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
154494318|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
154494319|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494320|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494321|NCT05069857|Apatinib|apatinib|mesh-list
154494322|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154494323|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494324|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494325|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494326|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494327|NCT05069857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494328|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
154494329|NCT05049863|Irinotecan|irinotecan|mesh-list
154494330|NCT05049863|Allopurinol|allopurinol|mesh-list
154494331|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154494332|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154494333|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494334|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494335|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494336|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154494337|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154494338|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
154494339|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154494340|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154494341|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
154494342|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
154494343|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154494344|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154494345|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
154058141|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
154058142|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154058143|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154494346|NCT05049863|Protective Agents|protective agents|mesh-ancestor
154494347|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494348|NCT04981067|Ropivacaine|ropivacaine|mesh-list
154494349|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
154494350|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
154494351|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494352|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494353|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
154494354|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494355|NCT04965597|Methotrexate|methotrexate|mesh-list
154494356|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
154494357|NCT04965597|Fludarabine|fludarabine|mesh-list
154494358|NCT04965597|Treosulfan|treosulfan|mesh-list
154494359|NCT04965597|Busulfan|busulfan|mesh-list
154494360|NCT04965597|Tacrolimus|tacrolimus|mesh-list
154494361|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
154494362|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154494363|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
154494364|NCT04965597|Antibodies|antibodies|mesh-list
154494365|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
154494366|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154494367|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154494368|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154494369|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
154494370|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154494371|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494372|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154494373|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
154494374|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494375|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494376|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
154058144|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154494377|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494378|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154494379|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154494380|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
154494381|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154494382|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154494383|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154494384|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154494385|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
154494386|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154494388|NCT04905810|Decitabine|decitabine|mesh-list
154494389|NCT04905810|Venetoclax|venetoclax|mesh-list
154494390|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154494391|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
154494392|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494393|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494394|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494395|NCT04891809|Dexamethasone|dexamethasone|mesh-list
154494396|NCT04891809|Lenalidomide|lenalidomide|mesh-list
154494397|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154494398|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
154494399|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
154494400|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494401|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494402|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494403|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
154494404|NCT04891809|Hormones|hormones|mesh-ancestor
154494405|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494406|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154494407|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494408|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
154494409|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154494410|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154494411|NCT04891809|Growth Substances|growth substances|mesh-ancestor
154494412|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
154494413|NCT04883242|Thalidomide|thalidomide|mesh-list
154494414|NCT04883242|Dexamethasone|dexamethasone|mesh-list
154494415|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
154494416|NCT04883242|Pomalidomide|pomalidomide|mesh-list
154494417|NCT04883242|Ichthammol|ichthammol|mesh-list
154494418|NCT04883242|BB 1101|bb 1101|mesh-list
154494419|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154494420|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154494421|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
154494422|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
154494423|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494424|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494425|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494426|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
154494427|NCT04883242|Hormones|hormones|mesh-ancestor
154494428|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494429|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154494430|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494431|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
154494432|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494433|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494434|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
154494435|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154494436|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154494437|NCT04883242|Growth Substances|growth substances|mesh-ancestor
154494438|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
154494439|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
154494440|NCT04883242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154494441|NCT04883242|Leprostatic Agents|leprostatic agents|mesh-ancestor
154494442|NCT04883242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154494443|NCT04883242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154494445|NCT04864067|Capecitabine|capecitabine|mesh-list
154494446|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
154058232|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154494447|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154494448|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
154494449|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494450|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494451|NCT04864067|Antidotes|antidotes|mesh-ancestor
154494452|NCT04864067|Protective Agents|protective agents|mesh-ancestor
154494453|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494454|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
154494455|NCT04864067|Vitamins|vitamins|mesh-ancestor
154494456|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
154494457|NCT04856176|Paclitaxel|paclitaxel|mesh-list
154494458|NCT04856176|Carboplatin|carboplatin|mesh-list
154494459|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
154494460|NCT04856176|Pemetrexed|pemetrexed|mesh-list
154494461|NCT04856176|Molgramostim|molgramostim|mesh-list
154494462|NCT04856176|Sargramostim|sargramostim|mesh-list
154494463|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154494464|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494465|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
154494466|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
154494467|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
154494468|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494469|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494470|NCT04856176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154494471|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494472|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154494473|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154494474|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
154494475|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494476|NCT04814355|Celecoxib|celecoxib|mesh-list
154494477|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154494478|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154494479|NCT04814355|Analgesics|analgesics|mesh-ancestor
154494480|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
154494481|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494482|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494483|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154494484|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154494485|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154494486|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154494487|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494488|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494489|NCT04759274|Diuretics|diuretics|mesh-list
154494490|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
154494491|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494492|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
154494493|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154494494|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
154494495|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154494496|NCT04732000|Expectorants|expectorants|mesh-ancestor
154494497|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
154494498|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154494499|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
154494500|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494501|NCT04732000|Protective Agents|protective agents|mesh-ancestor
154494502|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494503|NCT04732000|Antidotes|antidotes|mesh-ancestor
154494504|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154494505|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154494506|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494507|NCT04682158|Paclitaxel|paclitaxel|mesh-list
154494508|NCT04682158|Carboplatin|carboplatin|mesh-list
154494509|NCT04682158|Propranolol|propranolol|mesh-list
154494510|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154494511|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494513|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
154494514|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
154494515|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494516|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154494517|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154494518|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
154494519|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494520|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494521|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154494522|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154494523|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
154494524|NCT04658160|Imidacloprid|imidacloprid|mesh-list
154494525|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
154494526|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494527|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494528|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494529|NCT04648241|Vaccines|vaccines|mesh-list
154494530|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
154494531|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494532|NCT04614584|Mirtazapine|mirtazapine|mesh-list
154494533|NCT04614584|Methamphetamine|methamphetamine|mesh-list
154494534|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
154494535|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154494536|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154494537|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
154494538|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
154494539|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494540|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494541|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494542|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154494543|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154494544|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494545|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154494546|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154494547|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154494548|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
154494549|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154494550|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154494551|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
154494552|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154494553|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154494554|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
154494555|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
154494556|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494557|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
154494558|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154494559|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154494560|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154494561|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154494562|NCT04606264|Dexamethasone|dexamethasone|mesh-list
154494563|NCT04606264|Morphine|morphine|mesh-list
154494564|NCT04606264|Hydromorphone|hydromorphone|mesh-list
154494565|NCT04606264|Ondansetron|ondansetron|mesh-list
154494566|NCT04606264|Aprepitant|aprepitant|mesh-list
154494567|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
154494568|NCT04606264|Perphenazine|perphenazine|mesh-list
154494569|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154494570|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
154494571|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
154494572|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494573|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494574|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154058332|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154058350|NCT00600821|Paclitaxel|paclitaxel|mesh-list
154058369|NCT00699764|Vaccines|vaccines|mesh-list
154494575|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
154494576|NCT04606264|Hormones|hormones|mesh-ancestor
154494577|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494578|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154494579|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494580|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154494581|NCT04606264|Narcotics|narcotics|mesh-ancestor
154494582|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494583|NCT04606264|Analgesics|analgesics|mesh-ancestor
154494584|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
154494585|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
154494586|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
154494587|NCT04606264|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154494588|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154494589|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
154494590|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494591|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494592|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154494593|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154494594|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154494595|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154494596|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154494597|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
154494598|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154494599|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
154494600|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
154494601|NCT04604782|Regadenoson|regadenoson|mesh-list
154494602|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154494603|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154494604|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
154494605|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
154494606|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494607|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494608|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494609|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
154494610|NCT04602598|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154218443|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
154494611|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494613|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494614|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494615|NCT04589832|Entrectinib|entrectinib|mesh-list
154494616|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494617|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494618|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494619|NCT04573192|Lomustine|lomustine|mesh-list
154494620|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154494621|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
154494622|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494623|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494624|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
154494625|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
154494626|NCT04518124|Propranolol|propranolol|mesh-list
154494627|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154494628|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154494629|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
154494630|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494631|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494632|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494633|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154494634|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154494635|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
154494636|NCT04487834|Simethicone|simethicone|mesh-list
154494637|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
154494638|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494639|NCT04487834|Emollients|emollients|mesh-ancestor
154494640|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
154494641|NCT04473716|Paclitaxel|paclitaxel|mesh-list
154494642|NCT04473716|Cisplatin|cisplatin|mesh-list
154494643|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154494644|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494645|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
154494646|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
154494647|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
154058395|NCT02662283|Protective Agents|protective agents|mesh-ancestor
154058427|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
154494648|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494649|NCT04469855|Semaglutide|semaglutide|mesh-list
154494650|NCT04469855|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154494651|NCT04469855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154494652|NCT04469855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494653|NCT04458259|Axitinib|axitinib|mesh-list
154494654|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494655|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494656|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494657|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494658|NCT04432623|Benserazide|benserazide|mesh-list
154494659|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154494660|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154494661|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494662|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494663|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
154494664|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494665|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494667|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
154494668|NCT04426591|Vitamins|vitamins|mesh-ancestor
154494669|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
154494670|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494671|NCT04396587|Sufentanil|sufentanil|mesh-list
154494672|NCT04396587|Oxycodone|oxycodone|mesh-list
154494673|NCT04396587|Hydromorphone|hydromorphone|mesh-list
154494674|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154494675|NCT04396587|Narcotics|narcotics|mesh-ancestor
154494676|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494677|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494678|NCT04396587|Analgesics|analgesics|mesh-ancestor
154494679|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
154494680|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494681|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154494682|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154494683|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
154494684|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
154494685|NCT04393506|Apatinib|apatinib|mesh-list
154218528|NCT00224133|Silodosin|silodosin|mesh-list
154494686|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154494687|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494688|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494689|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494690|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494691|NCT04393506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494692|NCT04366726|Abaloparatide|abaloparatide|mesh-list
154494693|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154860755|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154494694|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494695|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
154494696|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494697|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494698|NCT04318717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154494699|NCT04318717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494700|NCT04291885|Avelumab|avelumab|mesh-list
154494701|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494702|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494703|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154494704|NCT04270682|Cathartics|cathartics|mesh-ancestor
154494705|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494706|NCT04261855|Avelumab|avelumab|mesh-list
154494707|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154494708|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494709|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494710|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154494711|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494712|NCT04259398|Propofol|propofol|mesh-list
154494713|NCT04259398|Sevoflurane|sevoflurane|mesh-list
154494714|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154494715|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494716|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494717|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154494718|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
154494719|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
154494720|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154494721|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154494722|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
154494723|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494724|NCT04250064|Bevacizumab|bevacizumab|mesh-list
154494725|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494726|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494727|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154494728|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154494729|NCT04250064|Growth Substances|growth substances|mesh-ancestor
154494730|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494731|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
154494732|NCT04245514|Durvalumab|durvalumab|mesh-list
154494733|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494734|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494735|NCT04184999|Dexamethasone|dexamethasone|mesh-list
154494736|NCT04184999|Prednisolone|prednisolone|mesh-list
154494737|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154494738|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
154494739|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154494740|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
154494741|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154494742|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
154494743|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154494744|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
154494745|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
154494746|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494747|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494748|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494749|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
154494750|NCT04184999|Hormones|hormones|mesh-ancestor
154494751|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494752|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154494753|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494754|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154494755|NCT04184999|Protective Agents|protective agents|mesh-ancestor
154494756|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
154494757|NCT04173416|Narcotics|narcotics|mesh-ancestor
154494758|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494759|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494760|NCT04173416|Analgesics|analgesics|mesh-ancestor
154494761|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
154494762|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494764|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154494765|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494766|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
154494767|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
154494768|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154494769|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154494770|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154494771|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494772|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494773|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154494774|NCT04131829|Fluoxetine|fluoxetine|mesh-list
154494775|NCT04131829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154494776|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154494777|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154494778|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494779|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494780|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
154494781|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494782|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154494783|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
154494784|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154494785|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154494786|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154494787|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494788|NCT04058990|Paclitaxel|paclitaxel|mesh-list
154494789|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154494790|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154494791|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494792|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
154494793|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
154494794|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
154494795|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494796|NCT04028466|Omeprazole|omeprazole|mesh-list
154494797|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154494798|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154494799|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154494800|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494801|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494802|NCT04007393|Topiramate|topiramate|mesh-list
154494803|NCT04007393|Phentermine|phentermine|mesh-list
154494804|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
154494805|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154494806|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494807|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154494808|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
154494809|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154494810|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
154860756|NCT03241030|Acetaminophen|acetaminophen|mesh-list
154494811|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
154494812|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058552|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
154058593|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
154494813|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
154494814|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494815|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494816|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
154494817|NCT03999203|Citric Acid|citric acid|mesh-list
154494818|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
154494819|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154494820|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
154494821|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494822|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494823|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154494824|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
154494825|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154494826|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
154494827|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494828|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494829|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154494830|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
154494831|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
154494832|NCT03999203|Protective Agents|protective agents|mesh-ancestor
154494833|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
154058611|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154494834|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154494835|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
154494836|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
154494838|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154494839|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
154494840|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154494841|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154494842|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154494843|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154494844|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494845|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
154494846|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494847|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494848|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154494849|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154494850|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494851|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154494852|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
154494853|NCT03989466|Antibodies|antibodies|mesh-list
154494854|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
154494855|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154494856|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
154494857|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494858|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494859|NCT03984214|Dronabinol|dronabinol|mesh-list
154494860|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
154494861|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494862|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154494863|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154494864|NCT03984214|Analgesics|analgesics|mesh-ancestor
154494865|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
154494866|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494867|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153601283|NCT01888861|Vitamins|vitamins|mesh-ancestor
154058647|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494868|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154494869|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494870|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494871|NCT03984214|Hormones|hormones|mesh-ancestor
154494872|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494873|NCT03982381|Metformin|metformin|mesh-list
154494874|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
154494875|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154494876|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494877|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154494878|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494879|NCT03979365|Tacrolimus|tacrolimus|mesh-list
154494880|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154494881|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
154494882|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494883|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154494884|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494885|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494886|NCT03969823|Osimertinib|osimertinib|mesh-list
154494887|NCT03969823|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154494888|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154494889|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494890|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494891|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494892|NCT03917940|Glimepiride|glimepiride|mesh-list
154494893|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154494894|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154494895|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494896|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154494897|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
154494898|NCT03906669|Tamoxifen|tamoxifen|mesh-list
154494899|NCT03906669|Letrozole|letrozole|mesh-list
154494900|NCT03906669|Progesterone|progesterone|mesh-list
154494901|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494902|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154494903|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154058683|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058684|NCT02651519|Ropivacaine|ropivacaine|mesh-list
154058685|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
154058686|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
154058687|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058688|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494904|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494905|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494906|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154494907|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
154494908|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154494909|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494910|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154494911|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154494912|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154494913|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154494914|NCT03906669|Progestins|progestins|mesh-ancestor
154494915|NCT03906669|Hormones|hormones|mesh-ancestor
154494916|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
154494917|NCT03882060|Hematinics|hematinics|mesh-ancestor
154494918|NCT03831295|Antibodies|antibodies|mesh-list
154494919|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
154494920|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494921|NCT03818191|Acamprosate|acamprosate|mesh-list
154494922|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154494923|NCT03792763|Denosumab|denosumab|mesh-list
154494924|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154494925|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154494926|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494927|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
154494928|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494929|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494930|NCT03792347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154494931|NCT03792347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494932|NCT03771651|Aspirin|aspirin|mesh-list
154494933|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154494934|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154494935|NCT03771651|Analgesics|analgesics|mesh-ancestor
154494936|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
154494937|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494938|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494939|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154494940|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154494941|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154494942|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154494943|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494944|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154494945|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154494946|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494947|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
154494948|NCT03738696|Bupivacaine|bupivacaine|mesh-list
154494949|NCT03738696|Ropivacaine|ropivacaine|mesh-list
154494950|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
154494951|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
154494952|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154494953|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494954|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
154494955|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494956|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
154494957|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
154494958|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154860757|NCT03241030|Ibuprofen|ibuprofen|mesh-list
154494959|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154494960|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154494961|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494962|NCT03686306|Urological Agents|urological agents|mesh-ancestor
154494963|NCT03681652|Azathioprine|azathioprine|mesh-list
154494964|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154494965|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
154494966|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494967|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154494968|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494969|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154494970|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
154494971|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494972|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154494973|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154494974|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154494975|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154494976|NCT03677596|Immunotoxins|immunotoxins|mesh-ancestor
154494977|NCT03677596|Immunoconjugates|immunoconjugates|mesh-ancestor
154494978|NCT03677596|Immunologic Factors|immunologic factors|mesh-ancestor
154494979|NCT03677596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494980|NCT03614741|Tinzaparin|tinzaparin|mesh-list
154494981|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154494982|NCT03614741|Dalteparin|dalteparin|mesh-list
154058714|NCT02651207|Lidocaine|lidocaine|mesh-list
154494983|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
154218814|NCT00295932|Bortezomib|bortezomib|mesh-list
154494984|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154494985|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154494986|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494987|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154494988|NCT03548454|Desipramine|desipramine|mesh-list
154494989|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154494990|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154494991|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154494992|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154494993|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154494994|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154494995|NCT03548454|Analgesics|analgesics|mesh-ancestor
154494996|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
154494997|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154494998|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
154494999|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154495000|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
154058752|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154495001|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154495002|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495003|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154495004|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
154495005|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
154495006|NCT03513211|Itraconazole|itraconazole|mesh-list
154495007|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
154495008|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154495009|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154495010|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495011|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495012|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495013|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495014|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
154495015|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154495016|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154495017|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154495018|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
154495019|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495020|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495021|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154495022|NCT03458429|Lenograstim|lenograstim|mesh-list
154495023|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154495024|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
154495025|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495026|NCT03448718|Olaparib|olaparib|mesh-list
154495027|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154495028|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495029|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495030|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495032|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
154495033|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495034|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154495035|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154495036|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154495037|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154495038|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154495039|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495040|NCT03361735|Leuprolide|leuprolide|mesh-list
154495041|NCT03361735|Goserelin|goserelin|mesh-list
154495042|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154495043|NCT03361735|Hormones|hormones|mesh-list
154495044|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495045|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495046|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154495047|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
154495048|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154495049|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154058823|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154495050|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495051|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
154495052|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495053|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495054|NCT03217071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495055|NCT03217071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495056|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
154495057|NCT03199053|Saxagliptin|saxagliptin|mesh-list
154495058|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154495059|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495060|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154495061|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495062|NCT03199053|Incretins|incretins|mesh-ancestor
154495064|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495065|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154495066|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
154495067|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495068|NCT03168880|Paclitaxel|paclitaxel|mesh-list
154495069|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154495070|NCT03168880|Carboplatin|carboplatin|mesh-list
154495071|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495072|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495073|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495074|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495075|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495076|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495077|NCT03149575|Carboplatin|carboplatin|mesh-list
154495078|NCT03149575|Temozolomide|temozolomide|mesh-list
154495079|NCT03149575|Lomustine|lomustine|mesh-list
154495080|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
154495081|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495082|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154058824|NCT00853970|Bromfenac|bromfenac|mesh-list
154058855|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495083|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
154495084|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495085|NCT03063749|Sirolimus|sirolimus|mesh-list
154495086|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154495087|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495088|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154495089|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495090|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
154495091|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495092|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
154495093|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495094|NCT03042936|Insulin|insulin|mesh-list
154495095|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154495096|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495097|NCT03027388|LB100|lb100|mesh-list
154495098|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495099|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495100|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495101|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
154495102|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154495103|NCT03007589|Protective Agents|protective agents|mesh-ancestor
154495104|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495105|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
154495106|NCT02993029|Celecoxib|celecoxib|mesh-list
154860758|NCT03241030|Sucralfate|sucralfate|mesh-list
154495107|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154495108|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154495109|NCT02993029|Analgesics|analgesics|mesh-ancestor
154495110|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
154495111|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495112|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495113|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154495114|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495115|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154495116|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154495117|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495118|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495119|NCT02992964|Nivolumab|nivolumab|mesh-list
154495120|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495121|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495122|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495123|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495124|NCT02934282|HBOC 201|hboc 201|mesh-list
154058857|NCT02644811|Anesthetics|anesthetics|mesh-list
154495125|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
154495126|NCT02900976|Rituximab|rituximab|mesh-list
154495127|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154495128|NCT02900976|Antibodies|antibodies|mesh-list
154495129|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
154495130|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154495131|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
154495132|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495133|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495134|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495135|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
154495136|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
154495137|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154495138|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495139|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495140|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
154495141|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154495142|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154495143|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495144|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
154495145|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154495146|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
154495147|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495148|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495149|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
154495150|NCT02693535|Nivolumab|nivolumab|mesh-list
154495151|NCT02693535|Trastuzumab|trastuzumab|mesh-list
154495152|NCT02693535|Ipilimumab|ipilimumab|mesh-list
154495153|NCT02693535|Atezolizumab|atezolizumab|mesh-list
154495154|NCT02693535|Pertuzumab|pertuzumab|mesh-list
154495155|NCT02693535|Sunitinib|sunitinib|mesh-list
154495156|NCT02693535|Olaparib|olaparib|mesh-list
154495157|NCT02693535|Palbociclib|palbociclib|mesh-list
154495158|NCT02693535|Temsirolimus|temsirolimus|mesh-list
154495159|NCT02693535|Vemurafenib|vemurafenib|mesh-list
154495160|NCT02693535|Talazoparib|talazoparib|mesh-list
154495161|NCT02693535|Tucatinib|tucatinib|mesh-list
154495162|NCT02693535|Futibatinib|futibatinib|mesh-list
154495163|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154495164|NCT02693535|Entrectinib|entrectinib|mesh-list
154495165|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495166|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495167|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495168|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495169|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
154058897|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154495170|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495171|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154495172|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154495173|NCT02693535|Growth Substances|growth substances|mesh-ancestor
154495174|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
154495175|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154495176|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495177|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154495178|NCT02693535|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154495179|NCT02693535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154860759|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154495180|NCT02672917|Paclitaxel|paclitaxel|mesh-list
154495181|NCT02672917|Gemcitabine|gemcitabine|mesh-list
154495182|NCT02672917|Folfirinox|folfirinox|mesh-list
154495183|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495184|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495185|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495186|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495187|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495188|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495189|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495190|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
154495191|NCT02672475|Paclitaxel|paclitaxel|mesh-list
154495192|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154495193|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495194|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495195|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495196|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495197|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495198|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495199|NCT02572843|Durvalumab|durvalumab|mesh-list
154495200|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495201|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495202|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
154495203|NCT02546583|Furosemide|furosemide|mesh-list
154495204|NCT02546583|Bumetanide|bumetanide|mesh-list
154495205|NCT02546583|Diuretics|diuretics|mesh-list
154495206|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154495207|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
154495208|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495209|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154495210|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495211|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154495212|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154495214|NCT02542696|Emetics|emetics|mesh-ancestor
154495215|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495216|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
154495217|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495218|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495219|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
154495220|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
154495221|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154495222|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495223|NCT02503722|Osimertinib|osimertinib|mesh-list
154495224|NCT02503722|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154495225|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154495226|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495227|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495228|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495229|NCT02346253|Leuprolide|leuprolide|mesh-list
154495230|NCT02346253|Goserelin|goserelin|mesh-list
154495231|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154495232|NCT02346253|Bicalutamide|bicalutamide|mesh-list
154495233|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154495234|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
154495235|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154495236|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495237|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154495238|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495239|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
154495240|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
154495241|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495242|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
154495243|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154495244|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
154495245|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154495246|NCT02339740|Vitamins|vitamins|mesh-list
154495247|NCT02339740|Vitamin A|vitamin a|mesh-list
154495248|NCT02339740|Cytarabine|cytarabine|mesh-list
154495249|NCT02339740|Dexamethasone|dexamethasone|mesh-list
154059020|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495250|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
154495251|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
154495252|NCT02339740|Idarubicin|idarubicin|mesh-list
154495253|NCT02339740|Tretinoin|tretinoin|mesh-list
154495254|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
154495255|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
154495256|NCT02339740|BB 1101|bb 1101|mesh-list
154495257|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
154495258|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495259|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154495260|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
154495261|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
154495262|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495263|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495264|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
154495266|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495267|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154495268|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495269|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
154495270|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495271|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495272|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495273|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
154495274|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
154495275|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495276|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495277|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
154495278|NCT02339740|Analgesics|analgesics|mesh-ancestor
154495279|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
154495280|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154495281|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154495282|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154495283|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
154495284|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
154495285|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
154495286|NCT02339740|Protective Agents|protective agents|mesh-ancestor
154495287|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154495288|NCT02311179|Cimetidine|cimetidine|mesh-list
154495289|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154495290|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495291|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154495292|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
154495293|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
154495294|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154495295|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495296|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495297|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154495298|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154495299|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495300|NCT01916317|Lidocaine|lidocaine|mesh-list
154495301|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
154495302|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
154495303|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154495304|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495305|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
154495306|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495307|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154495308|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154495309|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154495310|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154495311|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495312|NCT01785420|Trastuzumab|trastuzumab|mesh-list
154495313|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495314|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495315|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
154495316|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154495317|NCT01682941|Estrogens|estrogens|mesh-ancestor
154495318|NCT01682941|Hormones|hormones|mesh-ancestor
154495319|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495320|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495321|NCT01631292|Vitamin D|vitamin d|mesh-list
154495322|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
154495323|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
154495324|NCT01631292|Vitamins|vitamins|mesh-list
154495325|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
154495326|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495327|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154495328|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154495329|NCT01397552|Dexamethasone|dexamethasone|mesh-list
154059099|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
154495330|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
154495331|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154495332|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154495333|NCT01397552|Prednisolone|prednisolone|mesh-list
154495334|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
154123500|NCT00825864|Diclofenac|diclofenac|mesh-list
154495335|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154495336|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
154495337|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154495338|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
154495339|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
154495340|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495341|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495342|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495343|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
154495344|NCT01397552|Hormones|hormones|mesh-ancestor
154495345|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495346|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154495347|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495348|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154495349|NCT01397552|Protective Agents|protective agents|mesh-ancestor
154495350|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
154495351|NCT01096368|Cisplatin|cisplatin|mesh-list
154495352|NCT01096368|Carboplatin|carboplatin|mesh-list
154495353|NCT01096368|Etoposide|etoposide|mesh-list
154495354|NCT01096368|Vincristine|vincristine|mesh-list
154495355|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
154495356|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
154495357|NCT01096368|Lenograstim|lenograstim|mesh-list
154495358|NCT01096368|Mesna|mesna|mesh-list
154059126|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495359|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495360|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
154495361|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495362|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495363|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154495364|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
154495365|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495366|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495367|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154495368|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495369|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154495370|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154495371|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495372|NCT01096368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154495373|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495374|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495375|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495376|NCT01096368|Protective Agents|protective agents|mesh-ancestor
154495377|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
154495378|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
154495379|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154495380|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495382|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
154495383|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
154495384|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495385|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495386|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495387|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154495388|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154495389|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495390|NCT00938587|Prednisone|prednisone|mesh-list
154495391|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154495392|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
154495393|NCT00938587|Hormones|hormones|mesh-ancestor
154495394|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495395|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495396|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154495397|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495398|NCT00810693|Riociguat|riociguat|mesh-list
154495399|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
154495400|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495401|NCT00679120|Cimetidine|cimetidine|mesh-list
154495402|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154495403|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495404|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154495405|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
154495406|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
154495407|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154495408|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495409|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495410|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154860760|NCT03241030|Analgesics|analgesics|mesh-ancestor
154495411|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154495412|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495413|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
154059159|NCT02641301|Morphine|morphine|mesh-list
154059185|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495414|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154059186|NCT00653315|Analgesics|analgesics|mesh-ancestor
154495415|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495417|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495418|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154495419|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154495420|NCT00381641|Growth Substances|growth substances|mesh-ancestor
154495421|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495422|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
154495423|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154495424|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495425|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495426|NCT05233982|Olaparib|olaparib|mesh-list
154495427|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154495428|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495429|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495430|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495431|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
154495432|NCT05199493|Giapreza|giapreza|mesh-list
154495433|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
154495434|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154495435|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154495436|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
154495437|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495438|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495439|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
154495440|NCT05109455|Procyanidin|procyanidin|mesh-list
154495441|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
154495442|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495443|NCT05109455|Protective Agents|protective agents|mesh-ancestor
154495444|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495445|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154495446|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154495447|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495448|NCT05079360|Everolimus|everolimus|mesh-list
154495449|NCT05079360|Exemestane|exemestane|mesh-list
154495450|NCT05079360|Estrogens|estrogens|mesh-list
154495451|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
154495452|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
154495453|NCT05079360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154495454|NCT05079360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154495455|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495456|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495457|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495458|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
154495459|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495460|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495461|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154495462|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154495463|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154495464|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
154495465|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495466|NCT05079360|Hormones|hormones|mesh-ancestor
154495467|NCT05078060|Vaccines|vaccines|mesh-list
154495468|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
154495469|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495470|NCT05063786|Capecitabine|capecitabine|mesh-list
154495471|NCT05063786|Trastuzumab|trastuzumab|mesh-list
154495472|NCT05063786|Vinorelbine|vinorelbine|mesh-list
154495473|NCT05063786|Fulvestrant|fulvestrant|mesh-list
154495474|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495475|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
154495476|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495477|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495478|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495479|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495480|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495481|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495482|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495483|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154495484|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154495485|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154860761|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
154495486|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
154495487|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495488|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495489|NCT05012787|Vaccines|vaccines|mesh-list
154495490|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
154495491|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
154495492|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495493|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154495494|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
154495495|NCT04918927|Favipiravir|favipiravir|mesh-list
154495496|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154495497|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495498|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
154495499|NCT04857983|Memantine|memantine|mesh-list
154495500|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154495501|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154495502|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
154495503|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154495504|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495505|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495506|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154495507|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154495508|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
154495509|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154219341|NCT00294684|Protective Agents|protective agents|mesh-ancestor
154495510|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495511|NCT04777708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495512|NCT04777708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495514|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
154495515|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
154495516|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495517|NCT04730349|Nivolumab|nivolumab|mesh-list
154495518|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495519|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495520|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495521|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495522|NCT04517396|Fenofibrate|fenofibrate|mesh-list
154495523|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
154495524|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154495525|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
154495526|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495527|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154495528|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154059281|NCT02639741|Melatonin|melatonin|mesh-list
154059304|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495529|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154495530|NCT04382352|Trastuzumab|trastuzumab|mesh-list
154495531|NCT04382352|Antibodies|antibodies|mesh-list
154495532|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
154495533|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154495534|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
154495535|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495536|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495537|NCT04311424|Tirzepatide|tirzepatide|mesh-list
154495538|NCT04311424|Incretins|incretins|mesh-ancestor
154495539|NCT04311424|Hormones|hormones|mesh-ancestor
154495540|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495541|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495542|NCT04291456|Minocycline|minocycline|mesh-list
154495543|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154495544|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495545|NCT04266977|Dexamethasone|dexamethasone|mesh-list
154495546|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154495547|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
154495548|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
154495549|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495550|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495551|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495552|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
154495553|NCT04266977|Hormones|hormones|mesh-ancestor
154495554|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495555|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154495556|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495557|NCT04263480|Ibrutinib|ibrutinib|mesh-list
154495558|NCT04263480|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154495559|NCT04263480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154495561|NCT04263480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495562|NCT04172922|Sirolimus|sirolimus|mesh-list
154495563|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154495564|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495565|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154495566|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495567|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
154495568|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495569|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
154495570|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495571|NCT04139772|Docetaxel|docetaxel|mesh-list
154495572|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
154495573|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495574|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495575|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495576|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495577|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495578|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154495579|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495580|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
154495581|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495582|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495583|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154495584|NCT04091204|Olaparib|olaparib|mesh-list
154495585|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154495586|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495587|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495588|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495589|NCT04028245|Spartalizumab|spartalizumab|mesh-list
154495590|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495591|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495592|NCT04028245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495593|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495594|NCT03975114|Durvalumab|durvalumab|mesh-list
154059335|NCT02562664|Metformin|metformin|mesh-list
154059368|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495595|NCT03975114|Tremelimumab|tremelimumab|mesh-list
154495596|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495597|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495598|NCT03955783|Venetoclax|venetoclax|mesh-list
154495599|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495600|NCT03942120|Ustekinumab|ustekinumab|mesh-list
154495601|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
154495602|NCT03940742|Tirzepatide|tirzepatide|mesh-list
154495603|NCT03940742|Incretins|incretins|mesh-ancestor
154495604|NCT03940742|Hormones|hormones|mesh-ancestor
154495605|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154495606|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495607|NCT03893240|Antibodies|antibodies|mesh-list
154495608|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
154495609|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
154495610|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495611|NCT03875274|Morphine|morphine|mesh-list
154495612|NCT03875274|Ropivacaine|ropivacaine|mesh-list
154495613|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154495614|NCT03875274|Narcotics|narcotics|mesh-ancestor
154495615|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154495616|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495617|NCT03875274|Analgesics|analgesics|mesh-ancestor
154495618|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
154495619|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495620|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
154495621|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
154495622|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
154495623|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495624|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495625|NCT03775850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495626|NCT03775850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495627|NCT03762109|Dantrolene|dantrolene|mesh-list
154495628|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154495629|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495630|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154495631|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495632|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
154495633|NCT03732664|Nivolumab|nivolumab|mesh-list
154495634|NCT03732664|Durvalumab|durvalumab|mesh-list
154495636|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495637|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495638|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495639|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495640|NCT03410784|Paclitaxel|paclitaxel|mesh-list
154495641|NCT03410784|Carboplatin|carboplatin|mesh-list
154495642|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
154495643|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495644|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495645|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495646|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495647|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495648|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495649|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495650|NCT03410784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495651|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
154495652|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
154495653|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495654|NCT03310619|Nivolumab|nivolumab|mesh-list
154495655|NCT03310619|Durvalumab|durvalumab|mesh-list
154495656|NCT03310619|Relatlimab|relatlimab|mesh-list
154495657|NCT03310619|Ibrutinib|ibrutinib|mesh-list
154495658|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495659|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219487|NCT01325610|Vitamin D|vitamin d|mesh-list
154495660|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495661|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495662|NCT03310619|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154495663|NCT03310619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154495664|NCT03310619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495665|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
154495666|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
154495667|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495669|NCT03060577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154495670|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154495671|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154495672|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
154495673|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495674|NCT03060577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154495675|NCT03060577|Protease Inhibitors|protease inhibitors|mesh-ancestor
154495676|NCT03060577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495677|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154495678|NCT02797275|Albuterol|albuterol|mesh-list
154495679|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154495680|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
154495681|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495682|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495683|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154495684|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
154059434|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
154059435|NCT00883337|Teriflunomide|teriflunomide|mesh-list
154495685|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
154495686|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154495687|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154495688|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154495689|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154495690|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
154495691|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154495692|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495693|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
154495694|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495695|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495696|NCT02787005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495697|NCT02787005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495698|NCT02633189|Bevacizumab|bevacizumab|mesh-list
154495699|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154495700|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495701|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495702|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154495703|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154495704|NCT02633189|Growth Substances|growth substances|mesh-ancestor
154495705|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495706|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
154495707|NCT02633189|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154495708|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154495709|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495710|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495711|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154495712|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154495713|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154495714|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495715|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495716|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
154495717|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495718|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154495719|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154495720|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
154495721|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154495722|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495723|NCT02514083|Fludarabine|fludarabine|mesh-list
154495724|NCT02514083|Ibrutinib|ibrutinib|mesh-list
154495725|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495726|NCT02514083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495727|NCT02514083|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154495728|NCT02514083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154495729|NCT02514083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495730|NCT02500576|Aldesleukin|aldesleukin|mesh-list
154495731|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
154495732|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
154495733|NCT02500576|Fludarabine|fludarabine|mesh-list
154495734|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
154219573|NCT01067118|Insulin|insulin|mesh-list
154495736|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495737|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
154495738|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495739|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495740|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154495741|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
154495742|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495743|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495744|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154495745|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495746|NCT02500576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495747|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495748|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
154495749|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154495750|NCT02500576|Analgesics|analgesics|mesh-ancestor
154495751|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
154495752|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059524|NCT00885755|Taxane|taxane|mesh-list
154059525|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495753|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154495754|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154495755|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
154495756|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495757|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
154495758|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154495759|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495760|NCT02214381|Paclitaxel|paclitaxel|mesh-list
154495761|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
154495762|NCT02214381|Doxorubicin|doxorubicin|mesh-list
154495763|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495764|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495765|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495766|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495767|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495768|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495769|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495770|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
154495771|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495772|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495773|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154495774|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
154495775|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154495776|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154495777|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154495778|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154495779|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495780|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
154495781|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154495782|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
154123921|NCT04095455|Ketamine|ketamine|mesh-list
154495783|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495784|NCT02061761|Nivolumab|nivolumab|mesh-list
154495785|NCT02061761|Relatlimab|relatlimab|mesh-list
154495786|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495787|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495788|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154495789|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495790|NCT01927068|Paclitaxel|paclitaxel|mesh-list
154495791|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154059545|NCT04058236|Polygeline|polygeline|mesh-list
154059562|NCT00845676|Interferons|interferons|mesh-list
154495792|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495793|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495794|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495795|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495796|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495797|NCT01898104|Capecitabine|capecitabine|mesh-list
154495798|NCT01898104|Valproic Acid|valproic acid|mesh-list
154495799|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495800|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
154495801|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495802|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495803|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
154495804|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495805|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
154495806|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154495807|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495808|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
154495809|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154495810|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154495811|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154495812|NCT01817452|Paclitaxel|paclitaxel|mesh-list
154495813|NCT01817452|Trastuzumab|trastuzumab|mesh-list
154495814|NCT01817452|Pertuzumab|pertuzumab|mesh-list
154495815|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495816|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495817|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495818|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495819|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495820|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495821|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495822|NCT01815242|Paclitaxel|paclitaxel|mesh-list
154495823|NCT01815242|Carboplatin|carboplatin|mesh-list
154495824|NCT01815242|Gemcitabine|gemcitabine|mesh-list
154495825|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154059593|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154495826|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495827|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495828|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495829|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495830|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495831|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495832|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
154495833|NCT01802749|Paclitaxel|paclitaxel|mesh-list
154495834|NCT01802749|Bevacizumab|bevacizumab|mesh-list
154495835|NCT01802749|Carboplatin|carboplatin|mesh-list
154495836|NCT01802749|Gemcitabine|gemcitabine|mesh-list
154495837|NCT01802749|Doxorubicin|doxorubicin|mesh-list
154495838|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154495839|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495840|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495841|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495842|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495843|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495844|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495845|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495846|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154495847|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154495848|NCT01802749|Growth Substances|growth substances|mesh-ancestor
154495849|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495850|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
154495851|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495852|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
154495853|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154495854|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154495855|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154495856|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860762|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495857|NCT01801904|Panitumumab|panitumumab|mesh-list
154495858|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495859|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495860|NCT01779206|Paclitaxel|paclitaxel|mesh-list
154495861|NCT01779206|Docetaxel|docetaxel|mesh-list
154059629|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154059630|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154059631|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154059632|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
154059633|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154059634|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
154059635|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059636|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
154059637|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059638|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154059639|NCT00885365|Tobramycin|tobramycin|mesh-list
154059640|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154495862|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
154495863|NCT01779206|Epirubicin|epirubicin|mesh-list
154495864|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495865|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495866|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495867|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495868|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495869|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495870|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495871|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
154495872|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495873|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495874|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154495875|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
154495876|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154495877|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154495878|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154495879|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154495880|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495881|NCT01745965|Trastuzumab|trastuzumab|mesh-list
154495882|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495883|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495884|NCT01706120|Paclitaxel|paclitaxel|mesh-list
154219710|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
154495885|NCT01706120|Bevacizumab|bevacizumab|mesh-list
154495886|NCT01706120|Carboplatin|carboplatin|mesh-list
154495887|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495888|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495889|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495890|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495891|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495892|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495893|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495894|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154495895|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154495896|NCT01706120|Growth Substances|growth substances|mesh-ancestor
154495897|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059641|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495898|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
154495899|NCT01656551|Gemcitabine|gemcitabine|mesh-list
154495900|NCT01656551|Pemetrexed|pemetrexed|mesh-list
154495901|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495902|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495903|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
154495904|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495905|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495906|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154495907|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154495908|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
154495909|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
154495910|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154495911|NCT01649674|Cathartics|cathartics|mesh-ancestor
154495912|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154495913|NCT01628211|Leucovorin|leucovorin|mesh-list
154495914|NCT01628211|Folic Acid|folic acid|mesh-list
154495915|NCT01628211|Fluorouracil|fluorouracil|mesh-list
154495916|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
154495917|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
154495918|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
154495919|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495920|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495921|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495922|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495923|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
154495924|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495925|NCT01628211|Antidotes|antidotes|mesh-ancestor
154495926|NCT01628211|Protective Agents|protective agents|mesh-ancestor
154495927|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
154495928|NCT01628211|Vitamins|vitamins|mesh-ancestor
154495929|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
154495930|NCT01628211|Hematinics|hematinics|mesh-ancestor
154495931|NCT01593488|Cytarabine|cytarabine|mesh-list
154495932|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495933|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
154860763|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495934|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495935|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495936|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
154495937|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154495938|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154495939|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
154495940|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495941|NCT01405586|Gemcitabine|gemcitabine|mesh-list
154495942|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495943|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154495944|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
154495945|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495946|NCT01309230|Immunomodulating Agents|immunomodulating agents|mesh-list
154495947|NCT01309230|Immunologic Factors|immunologic factors|mesh-ancestor
154495948|NCT01309230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860764|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
154495949|NCT01238692|Rituximab|rituximab|mesh-list
154495950|NCT01238692|Panobinostat|panobinostat|mesh-list
154495951|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154495952|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495953|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
154495954|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495955|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154495956|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154495957|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495958|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495959|NCT00996983|Ziconotide|ziconotide|mesh-list
154219786|NCT00286494|Incretins|incretins|mesh-ancestor
154495960|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154495961|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154495962|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495963|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154495964|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059690|NCT02638415|Carvedilol|carvedilol|mesh-list
154059719|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495965|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154495966|NCT00996983|Protective Agents|protective agents|mesh-ancestor
154495967|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154495968|NCT00996983|Analgesics|analgesics|mesh-ancestor
154495969|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
154495970|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154495971|NCT00660842|Paclitaxel|paclitaxel|mesh-list
154495972|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154495973|NCT00660842|Carboplatin|carboplatin|mesh-list
154495974|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154495975|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495976|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
154495977|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
154495978|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
154495979|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495980|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
154495981|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154495982|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154495983|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154495984|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495985|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
154495986|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154495987|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154495988|NCT00526396|Cisplatin|cisplatin|mesh-list
154495989|NCT00526396|Etoposide|etoposide|mesh-list
154495990|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
154495991|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154495992|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154059746|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154495993|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154495994|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154495995|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154495996|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154495997|NCT00431704|Carboplatin|carboplatin|mesh-list
154495998|NCT00431704|Trastuzumab|trastuzumab|mesh-list
154495999|NCT00431704|Vinorelbine|vinorelbine|mesh-list
154496000|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496001|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154496002|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154496003|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
154496004|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
154496005|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
154496006|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496008|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
154496009|NCT00412022|Letrozole|letrozole|mesh-list
154496010|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154496011|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496012|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154496013|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154059747|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154059765|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154496014|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496015|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496016|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154496017|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
154496018|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496019|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496020|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154496021|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154496022|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154496023|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154496024|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
154496025|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154496026|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
154496027|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154496028|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154496029|NCT03474510|Bupivacaine|bupivacaine|mesh-list
154496030|NCT03474510|Ropivacaine|ropivacaine|mesh-list
154496031|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
154496032|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
154496033|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496034|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496035|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
154496036|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496038|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
154496039|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496040|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154496041|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154496042|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496043|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496044|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154496045|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
154496046|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496047|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496048|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154496049|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
154496050|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154496051|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
154496052|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496053|NCT05258682|Expectorants|expectorants|mesh-ancestor
154496054|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
154496055|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154496056|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
154496057|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496058|NCT05258682|Protective Agents|protective agents|mesh-ancestor
154496059|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496060|NCT05258682|Antidotes|antidotes|mesh-ancestor
154496061|NCT02228031|Oxytocin|oxytocin|mesh-list
154496062|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
154496063|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154496064|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496065|NCT00704522|Ribavirin|ribavirin|mesh-list
154496066|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154496067|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
154496068|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496069|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
154496070|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496071|NCT04458558|Mifepristone|mifepristone|mesh-list
154496072|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154059825|NCT00686374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154496073|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
154496074|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154496075|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496076|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154496077|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154496078|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154496079|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
154496080|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154496081|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154496082|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
154496083|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496084|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
154496085|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154496086|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154496088|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
154496089|NCT03930498|Antibodies|antibodies|mesh-list
154496090|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
154496091|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
154496092|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496093|NCT03817554|Dopamine|dopamine|mesh-list
154496094|NCT03817554|Pramipexole|pramipexole|mesh-list
154496095|NCT03817554|Dexpramipexole|dexpramipexole|mesh-list
154496096|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
154496097|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
154496098|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496099|NCT03817554|Protective Agents|protective agents|mesh-ancestor
154496100|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496101|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154059854|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154496102|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154059856|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154496103|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
154496104|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496105|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154496106|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
154496107|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
154496108|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496109|NCT02723630|Lenvatinib|lenvatinib|mesh-list
154496110|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496111|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154496112|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496113|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496114|NCT02866227|TOL-463|tol-463|mesh-list
154496115|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496116|NCT05258136|Antibodies|antibodies|mesh-list
154496117|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154496118|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
154496119|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496120|NCT02224131|Aspirin|aspirin|mesh-list
154496121|NCT02224131|Clopidogrel|clopidogrel|mesh-list
154496122|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154496123|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154496124|NCT02224131|Analgesics|analgesics|mesh-ancestor
154496125|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
154496126|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496127|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496128|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496129|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154496130|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154496131|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154496132|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496133|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154496134|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154496135|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496136|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
154496137|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154496138|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154496139|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154496140|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
154496141|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496142|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154496143|NCT03473964|Hormones|hormones|mesh-ancestor
154059893|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
154496144|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496145|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496147|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154496148|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496149|NCT03309644|Trace Elements|trace elements|mesh-ancestor
154496150|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
154496151|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496152|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
154496153|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
154496154|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154496155|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154496157|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154496158|NCT02008292|Physostigmine|physostigmine|mesh-list
154496159|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154496160|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496161|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496162|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
154496163|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496164|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496165|NCT02008292|Miotics|miotics|mesh-ancestor
154496166|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
154496167|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496168|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154496169|NCT03477864|Ipilimumab|ipilimumab|mesh-list
154496170|NCT03477864|Cemiplimab|cemiplimab|mesh-list
154496171|NCT03477864|Antibodies|antibodies|mesh-list
154496172|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
154496173|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154496174|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
154496175|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496176|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496177|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154496178|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496179|NCT02229045|Paclitaxel|paclitaxel|mesh-list
154496180|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154496181|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154496182|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496183|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220013|NCT00282984|Varenicline|varenicline|mesh-list
154496184|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
154496185|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
154496186|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496187|NCT02229201|Propofol|propofol|mesh-list
154496188|NCT02229201|Sevoflurane|sevoflurane|mesh-list
154496189|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154496190|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496191|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496192|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154496193|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
154496194|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
154496195|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154496196|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154496197|NCT02224443|Midazolam|midazolam|mesh-list
154496198|NCT02224443|Fentanyl|fentanyl|mesh-list
154496199|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
154496200|NCT02224443|Remifentanil|remifentanil|mesh-list
154496201|NCT02224443|Propofol|propofol|mesh-list
154496202|NCT02224443|Etomidate|etomidate|mesh-list
154496203|NCT02224443|Sevoflurane|sevoflurane|mesh-list
154496204|NCT02224443|Atracurium|atracurium|mesh-list
154496205|NCT02224443|Cisatracurium|cisatracurium|mesh-list
154496206|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154496207|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496208|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496209|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154496210|NCT02224443|Analgesics|analgesics|mesh-ancestor
154496211|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
154496212|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496213|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154496214|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154496215|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154496216|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
154496217|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496218|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496219|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154496220|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
154496221|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
154496222|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154496223|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154496224|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154496225|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154496226|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
154496227|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
154496228|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154496229|NCT02224443|Narcotics|narcotics|mesh-ancestor
154496230|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154496231|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154496232|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154496233|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154496234|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154496235|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154496236|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154496237|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
154496238|NCT01944800|Ticagrelor|ticagrelor|mesh-list
154496239|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154496240|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154496241|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154496242|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154496243|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154496244|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
154496245|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496246|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496247|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496248|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154496249|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154496250|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154496251|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496252|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496253|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154496254|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154496255|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496256|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
154496257|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496258|NCT02470676|Progesterone|progesterone|mesh-list
154496259|NCT02470676|Progestins|progestins|mesh-ancestor
154496260|NCT02470676|Hormones|hormones|mesh-ancestor
154496261|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496262|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496264|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
154496265|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496266|NCT01933724|Hormones|hormones|mesh-ancestor
154496267|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496268|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496269|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154059978|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
154496270|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496271|NCT02229747|Diclofenac|diclofenac|mesh-list
154496272|NCT02229747|Meloxicam|meloxicam|mesh-list
154496273|NCT02229747|Nimesulide|nimesulide|mesh-list
154496274|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154496275|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154496276|NCT02229747|Analgesics|analgesics|mesh-ancestor
154496277|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
154496278|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496279|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496280|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496281|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154496282|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154496283|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496284|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496285|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154496286|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154496287|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
154496288|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496289|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154496290|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
154496291|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496292|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496293|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154496294|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154496295|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154496296|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154496297|NCT03030222|Empagliflozin|empagliflozin|mesh-list
154496298|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154496299|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496300|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154496301|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496302|NCT02232945|Oseltamivir|oseltamivir|mesh-list
154496303|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
154496304|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496306|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458509|NCT05586204|Vaccines|vaccines|mesh-list
154496307|NCT02546622|Factor VIII|factor viii|mesh-list
154496308|NCT02546622|Coagulants|coagulants|mesh-ancestor
154496309|NCT03309566|Tenofovir|tenofovir|mesh-list
154496310|NCT03309566|Emtricitabine|emtricitabine|mesh-list
154496311|NCT03309566|Efavirenz|efavirenz|mesh-list
154496312|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
154496313|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496314|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154496315|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154496316|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496317|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496318|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154496319|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154496320|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154496321|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154496322|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154496323|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154496324|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154496325|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154496326|NCT00735657|Iodine|iodine|mesh-list
154496327|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154496328|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496329|NCT00735657|Trace Elements|trace elements|mesh-ancestor
154496330|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
154496331|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496332|NCT02470442|Sevoflurane|sevoflurane|mesh-list
154496333|NCT02470442|Desflurane|desflurane|mesh-list
154496334|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154496335|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154496336|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
154496337|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
154496338|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496339|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496340|NCT01329939|Montelukast|montelukast|mesh-list
154496341|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154496342|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
154496343|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154496344|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
154496345|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496346|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496347|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154496348|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154496349|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496350|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
154496351|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
154496352|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154496353|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
154496354|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496355|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154496356|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154496357|NCT02230371|Granisetron|granisetron|mesh-list
154496358|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
154496359|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
154496360|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496361|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496362|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496363|NCT02230371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154496364|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154496365|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
154496366|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496367|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060098|NCT00834912|Tramadol|tramadol|mesh-list
154496368|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
154496369|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154496370|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
154496371|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496372|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
154496373|NCT03313934|Protective Agents|protective agents|mesh-ancestor
154496374|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
154496375|NCT03313856|Antacids|antacids|mesh-ancestor
154496376|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496377|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496378|NCT05137626|Digoxin|digoxin|mesh-list
154496379|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154496380|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154496381|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496382|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496383|NCT05137626|Protective Agents|protective agents|mesh-ancestor
154496384|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496385|NCT02233023|Dopamine|dopamine|mesh-list
154496386|NCT02233023|Pramipexole|pramipexole|mesh-list
154496387|NCT02233023|Bromocriptine|bromocriptine|mesh-list
154496388|NCT02233023|Dexpramipexole|dexpramipexole|mesh-list
154496389|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
154496390|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
154496391|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496392|NCT02233023|Protective Agents|protective agents|mesh-ancestor
154496393|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496394|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154060116|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
154060141|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154496395|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154496396|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
154496397|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496398|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154496399|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
154496400|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
154496401|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496402|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
154496403|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496404|NCT03710642|Prazosin|prazosin|mesh-list
154496405|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154496406|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154496407|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154496408|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154496409|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
154496410|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496411|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496412|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496414|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154496415|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
154496416|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154496417|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496418|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154496419|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496420|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
154496421|NCT04459026|Ropivacaine|ropivacaine|mesh-list
154496422|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
154496423|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
154496424|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496425|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496426|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
154496427|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496428|NCT03473418|Ketoconazole|ketoconazole|mesh-list
154060173|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154496429|NCT03473418|Terconazole|terconazole|mesh-list
154496430|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
154496431|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496432|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154496433|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154496434|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496435|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496436|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154496437|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
154496438|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496439|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496440|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154496441|NCT04282278|Apatinib|apatinib|mesh-list
154496442|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496443|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154496444|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496445|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496446|NCT00705224|Interferons|interferons|mesh-list
154496447|NCT00705224|Ribavirin|ribavirin|mesh-list
154496448|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496449|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
154496450|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496451|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
154496452|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496453|NCT02457156|Octreotide|octreotide|mesh-list
154860765|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154496454|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060174|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
154496455|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154496456|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496457|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
154496458|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
154496459|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496460|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
154496461|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
154496462|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496463|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496464|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496465|NCT02523300|Hormones|hormones|mesh-ancestor
154496466|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496467|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154496468|NCT02523300|Protective Agents|protective agents|mesh-ancestor
154496469|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
154496470|NCT02325960|Exenatide|exenatide|mesh-list
154496471|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154496472|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496473|NCT02325960|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154496474|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154496475|NCT02325960|Incretins|incretins|mesh-ancestor
154496476|NCT02325960|Hormones|hormones|mesh-ancestor
154496477|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496478|NCT05265650|Nivolumab|nivolumab|mesh-list
154496479|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154496480|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496481|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154220314|NCT00295022|Montelukast|montelukast|mesh-list
154496482|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496483|NCT02234349|Pancrelipase|pancrelipase|mesh-list
154496484|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496485|NCT04458636|Prednisolone|prednisolone|mesh-list
154496486|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496487|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
154496488|NCT04458636|Hormones|hormones|mesh-ancestor
154496489|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496490|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496491|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154496492|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496493|NCT03304652|Zaleplon|zaleplon|mesh-list
154496494|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
154496495|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154496496|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496497|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496498|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
154496499|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
154496500|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496501|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496502|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154496503|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154496504|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
154496505|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
154496506|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154496507|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496508|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496509|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154496510|NCT02523144|Analgesics|analgesics|mesh-ancestor
154496511|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
154496512|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496513|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154496514|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154496515|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154060269|NCT05862402|Amikacin|amikacin|mesh-list
154496516|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
154496517|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496518|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496519|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154496520|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154496521|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496522|NCT00704132|Incretins|incretins|mesh-ancestor
154496523|NCT00704132|Hormones|hormones|mesh-ancestor
154496524|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496525|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154496526|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
154496527|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496528|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496529|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
154496530|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154496531|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
154496532|NCT03527238|Tacrolimus|tacrolimus|mesh-list
154496533|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154496534|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
154496535|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496536|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154496537|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496538|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496539|NCT03832179|Dexamethasone|dexamethasone|mesh-list
154496540|NCT03832179|Bevacizumab|bevacizumab|mesh-list
154496541|NCT03832179|Ranibizumab|ranibizumab|mesh-list
154496542|NCT03832179|Aflibercept|aflibercept|mesh-list
154496543|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154496544|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496545|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154496546|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154496547|NCT03832179|Growth Substances|growth substances|mesh-ancestor
154496548|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496549|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
154496550|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496551|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
154496552|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
154496553|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496554|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496555|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
154496556|NCT03832179|Hormones|hormones|mesh-ancestor
154496557|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496558|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154496560|NCT05154396|Neratinib|neratinib|mesh-list
154496561|NCT05154396|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154496562|NCT05154396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154496563|NCT05154396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496564|NCT05154396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496565|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
154496566|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496567|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154496568|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
154496569|NCT04740645|Coagulants|coagulants|mesh-ancestor
154496570|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154496571|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
154496572|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496573|NCT02802813|Primaquine|primaquine|mesh-list
154496574|NCT02802813|Piperaquine|piperaquine|mesh-list
154496575|NCT02802813|Artenimol|artenimol|mesh-list
154496576|NCT02802813|Artemisinins|artemisinins|mesh-list
154496577|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
154496578|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154496579|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154496580|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496581|NCT05134584|Lactulose|lactulose|mesh-list
154496582|NCT05134584|Linaclotide|linaclotide|mesh-list
154496583|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496584|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154496585|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
154496586|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496587|NCT05633277|Polidocanol|polidocanol|mesh-list
154496588|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154496589|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154496590|NCT03312140|Choline|choline|mesh-list
154496591|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
154496592|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154496593|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
154496594|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496595|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496596|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154496597|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
154496598|NCT02233179|Calpastatin|calpastatin|mesh-list
154496599|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154496600|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
154496601|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496602|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496603|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154496604|NCT03311984|Dalteparin|dalteparin|mesh-list
154496606|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154496607|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154496608|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496609|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
154496610|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154496611|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
154496612|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496613|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
154496614|NCT03311906|Protective Agents|protective agents|mesh-ancestor
154496615|NCT03311750|Panitumumab|panitumumab|mesh-list
154060324|NCT05861687|Esomeprazole|esomeprazole|mesh-list
154496616|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154496617|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496618|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
154496619|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154496620|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496621|NCT03311672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154496622|NCT03311672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496623|NCT03311516|Insulin|insulin|mesh-list
154496624|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154496625|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154496626|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496627|NCT02811939|Dronabinol|dronabinol|mesh-list
154496628|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
154496629|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496630|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154496631|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154496632|NCT02811939|Analgesics|analgesics|mesh-ancestor
154496633|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
154496634|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496635|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154496636|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154496637|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496638|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496639|NCT02811939|Hormones|hormones|mesh-ancestor
154496640|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496641|NCT01329549|Carboplatin|carboplatin|mesh-list
154496642|NCT01329549|Nintedanib|nintedanib|mesh-list
154496643|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496644|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154496645|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496646|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496647|NCT02234739|Voriconazole|voriconazole|mesh-list
154496648|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
154060403|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
154496649|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496650|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154496651|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154496652|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496653|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496654|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154496655|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
154496656|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496657|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496658|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154496659|NCT02736474|Naltrexone|naltrexone|mesh-list
154496660|NCT02736474|Bupropion|bupropion|mesh-list
154496661|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154496662|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154496663|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496664|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
154496665|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496666|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154496667|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
154496668|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154496669|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154496670|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154496671|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154496672|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496673|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
154496674|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496675|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154124827|NCT00957177|Pregabalin|pregabalin|mesh-list
154860766|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496676|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154496677|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496678|NCT03302390|Lidocaine|lidocaine|mesh-list
154496679|NCT03302390|Epinephrine|epinephrine|mesh-list
154496680|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
154496681|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
154496682|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496683|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496684|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
154496685|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496686|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154496687|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154496688|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154496689|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154496690|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496691|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154496692|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154496693|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
154496694|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496695|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154496696|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154496697|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
154496698|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154496699|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
154496700|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
154496701|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
154496702|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154496703|NCT03712371|Chitosan|chitosan|mesh-list
154496704|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154496705|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154496706|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
154496707|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496708|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154496709|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
154496710|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
154496711|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
154496712|NCT03712371|Coagulants|coagulants|mesh-ancestor
154496713|NCT03472950|Ranolazine|ranolazine|mesh-list
154496714|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154496715|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154496716|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496717|NCT03706521|Lorecivivint|lorecivivint|mesh-list
154496718|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496719|NCT02259543|Tetracycline|tetracycline|mesh-list
154496720|NCT02259543|Citric Acid|citric acid|mesh-list
154496721|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
154496722|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154496723|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154496724|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154496725|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496726|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496727|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
154496728|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154496729|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
154496730|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
154496731|NCT03301454|Paclitaxel|paclitaxel|mesh-list
154496732|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154496733|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496734|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
154496735|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
154496736|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
154496737|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496738|NCT05727410|Docetaxel|docetaxel|mesh-list
154496739|NCT05727410|Nivolumab|nivolumab|mesh-list
154496740|NCT05727410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496741|NCT05727410|Tubulin Modulators|tubulin modulators|mesh-ancestor
154496742|NCT05727410|Antimitotic Agents|antimitotic agents|mesh-ancestor
154496743|NCT05727410|Mitosis Modulators|mitosis modulators|mesh-ancestor
154496744|NCT05727410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496745|NCT05727410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154496746|NCT05727410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154496747|NCT02467010|Dexamethasone|dexamethasone|mesh-list
154496748|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
154860767|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154496749|NCT02467010|Bortezomib|bortezomib|mesh-list
154496750|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154496752|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496753|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154496754|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154496755|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
154496756|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496757|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496758|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154496759|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496760|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
154496761|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
154060521|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496762|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496763|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496764|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
154496765|NCT02467010|Hormones|hormones|mesh-ancestor
154496766|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496767|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154496768|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154496769|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154496770|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154496771|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154496772|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496773|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496774|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496775|NCT02232555|Analgesics|analgesics|mesh-ancestor
154496776|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
154496777|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496778|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
154496779|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154496780|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
154496781|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154496782|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154496783|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154496784|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496785|NCT00702650|Testosterone|testosterone|mesh-list
154496786|NCT00702650|Androgens|androgens|mesh-ancestor
154496787|NCT00702650|Hormones|hormones|mesh-ancestor
154496788|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496789|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496790|NCT01337115|Ropivacaine|ropivacaine|mesh-list
154496791|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
154496792|NCT01337115|Anesthetics|anesthetics|mesh-list
154496793|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496794|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496795|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
154496796|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496797|NCT03761784|Tretinoin|tretinoin|mesh-list
154496798|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154496799|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
154496800|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496801|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
154496802|NCT03300440|Vitamins|vitamins|mesh-list
154496803|NCT03300440|Biotin|biotin|mesh-list
154496804|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
154496805|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
154496806|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496807|NCT02236065|Lenograstim|lenograstim|mesh-list
154496808|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154496809|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
154496810|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496811|NCT02467556|Morphine|morphine|mesh-list
154496812|NCT02467556|Memantine|memantine|mesh-list
154496813|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154496814|NCT02467556|Narcotics|narcotics|mesh-ancestor
154496815|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496816|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496817|NCT02467556|Analgesics|analgesics|mesh-ancestor
154496818|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
154496819|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496820|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154496821|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154496822|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
154496823|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496824|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496825|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154496827|NCT02262585|Telmisartan|telmisartan|mesh-list
154496828|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154496829|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154496830|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154496831|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496832|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154496833|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
154496834|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154496835|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154496836|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154496837|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
154496838|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154496839|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496840|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154496841|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154496842|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154496843|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154496844|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496845|NCT02602353|Loxoprofen|loxoprofen|mesh-list
154496846|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154496847|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154496848|NCT02602353|Analgesics|analgesics|mesh-ancestor
154496849|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
154060558|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154496850|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060611|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
154496851|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496852|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496853|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154496854|NCT04983498|Ondansetron|ondansetron|mesh-list
154496855|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
154496856|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
154496857|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496858|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496859|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154496860|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
154496861|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
154496862|NCT04983498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154496863|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154496864|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
154496865|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496866|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496867|NCT03300362|Vaccines|vaccines|mesh-list
154496868|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
154496869|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496870|NCT02467400|Propranolol|propranolol|mesh-list
154496871|NCT02467400|Atenolol|atenolol|mesh-list
154496872|NCT02467400|Nebivolol|nebivolol|mesh-list
154496873|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154496874|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154496875|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
154496876|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496877|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496878|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496879|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154496880|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154496881|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
154496882|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
154496883|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
154496884|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496885|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154496886|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154496887|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154496888|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154496889|NCT03308708|Norepinephrine|norepinephrine|mesh-list
154496890|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154496891|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154496892|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
154496893|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060613|NCT04556526|Antiviral Agents|antiviral agents|mesh-ancestor
154496894|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496895|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496896|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
154496897|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
154496898|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496899|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154496900|NCT02262741|Durvalumab|durvalumab|mesh-list
154496901|NCT02262741|Tremelimumab|tremelimumab|mesh-list
154496902|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154496903|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496904|NCT00250341|Beclomethasone|beclomethasone|mesh-list
154496905|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154496906|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496907|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
154496908|NCT00250341|Hormones|hormones|mesh-ancestor
154496909|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154496910|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496911|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154496912|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
154496913|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154496914|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
154496915|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496916|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
154496917|NCT05156970|Carboplatin|carboplatin|mesh-list
154060653|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154496918|NCT05156970|Docetaxel|docetaxel|mesh-list
154496919|NCT05156970|Apatinib|apatinib|mesh-list
154496920|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496921|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
154496922|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
154496923|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
154496924|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496925|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154496926|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496927|NCT02233881|Ipratropium|ipratropium|mesh-list
154496928|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154496929|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
154496930|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220760|NCT00293384|Dexamethasone|dexamethasone|mesh-list
154496931|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496932|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154496933|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
154496934|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154496935|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
154496936|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154496937|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496938|NCT02234037|Decitabine|decitabine|mesh-list
154496939|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154496940|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
154496941|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496942|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496943|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496944|NCT02234193|Lidocaine|lidocaine|mesh-list
154496945|NCT02234193|Epinephrine|epinephrine|mesh-list
154496946|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
154496947|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
154496948|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154496949|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154496950|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
154496951|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154496952|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154496953|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154496954|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154496955|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154496956|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496957|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154496958|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154496959|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
154496960|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060681|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
154496961|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154496962|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154496963|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
154496964|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154496965|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
154496966|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
154496967|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
154496968|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154496969|NCT04476459|Apatinib|apatinib|mesh-list
154496970|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496971|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154496972|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154496973|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860768|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154496975|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154496976|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154496977|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496978|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
154496979|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
154496980|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
154496981|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496982|NCT03308552|Paclitaxel|paclitaxel|mesh-list
154496983|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154496984|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154496985|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154496986|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
154496987|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
154496988|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
154496989|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154496990|NCT03308084|Dexamethasone|dexamethasone|mesh-list
154496991|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
154496992|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154496993|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154496994|NCT03308084|Prednisolone|prednisolone|mesh-list
154496995|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
154496996|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154496997|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
154496998|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154496999|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
154497000|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
154060770|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
154497001|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497002|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497003|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154497004|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
154497005|NCT03308084|Hormones|hormones|mesh-ancestor
154497006|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497007|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154497008|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497009|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154497010|NCT03308084|Protective Agents|protective agents|mesh-ancestor
154497011|NCT00702962|Carboplatin|carboplatin|mesh-list
154497012|NCT00702962|Etoposide|etoposide|mesh-list
154497013|NCT00702962|Vorinostat|vorinostat|mesh-list
154497014|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497015|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497016|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154497017|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154497018|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497019|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497020|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154497021|NCT01379508|Tenofovir|tenofovir|mesh-list
154497022|NCT01379508|Telbivudine|telbivudine|mesh-list
154497023|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
154497024|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497025|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154497026|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154497027|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497028|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497029|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154060809|NCT02578680|Folic Acid|folic acid|mesh-list
154497030|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154497031|NCT05162430|Propofol|propofol|mesh-list
154497032|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154497033|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497034|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497035|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154497036|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
154497037|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
154497038|NCT02264769|Carbetocin|carbetocin|mesh-list
154497039|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
154497040|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154497041|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497042|NCT02264847|Clomiphene|clomiphene|mesh-list
154497043|NCT02264847|Enclomiphene|enclomiphene|mesh-list
154497044|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
154497045|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154497046|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154497047|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
154497048|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497049|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497050|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154497051|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
154497052|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154497053|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154497054|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154497056|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
154497057|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154497058|NCT03469128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154497059|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154497060|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154497061|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497062|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497063|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
154497064|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497065|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
154497066|NCT05161572|Tegafur|tegafur|mesh-list
154497067|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497068|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154497069|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
154497070|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497071|NCT03472170|Lactoferrin|lactoferrin|mesh-list
154497072|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497073|NCT04156698|Docetaxel|docetaxel|mesh-list
154497074|NCT04156698|Capecitabine|capecitabine|mesh-list
154497075|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497076|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497077|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497078|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497079|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497080|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154497081|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
154497082|NCT03108326|Infliximab|infliximab|mesh-list
154497083|NCT03108326|Ustekinumab|ustekinumab|mesh-list
154497084|NCT03108326|Vedolizumab|vedolizumab|mesh-list
154497085|NCT03108326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154497086|NCT03108326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154497087|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154497088|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
154497089|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154497090|NCT04964024|Antibodies|antibodies|mesh-list
154497091|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
154497092|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497093|NCT02466542|Esmolol|esmolol|mesh-list
154497094|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154497095|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154497096|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154497097|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
154497098|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497099|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497100|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497101|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
154497102|NCT05067270|Treprostinil|treprostinil|mesh-list
154497103|NCT05067270|Citric Acid|citric acid|mesh-list
154497104|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
154497105|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
154497106|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154497107|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
154497108|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
154497109|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497110|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154497111|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497112|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154497113|NCT01437735|Montelukast|montelukast|mesh-list
154060879|NCT04158167|Oxytocin|oxytocin|mesh-list
154497114|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154497115|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
154497116|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154497117|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
154497118|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497119|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497120|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154497121|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154497122|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497123|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
154497124|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154497125|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497126|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497127|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154497128|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154497129|NCT03470610|Estradiol|estradiol|mesh-list
154497130|NCT03470610|Progesterone|progesterone|mesh-list
154497131|NCT03470610|Estrogens|estrogens|mesh-ancestor
154497132|NCT03470610|Hormones|hormones|mesh-ancestor
154497133|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497134|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497135|NCT03470610|Progestins|progestins|mesh-ancestor
154497136|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
154497137|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154497138|NCT03307148|Paclitaxel|paclitaxel|mesh-list
154497139|NCT03307148|Gemcitabine|gemcitabine|mesh-list
154497140|NCT03307148|Tretinoin|tretinoin|mesh-list
154497141|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497142|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497143|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497144|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497145|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497146|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497147|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154497148|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
154497149|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
154497150|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
154497151|NCT03984591|Eplerenone|eplerenone|mesh-list
154497152|NCT03984591|Spironolactone|spironolactone|mesh-list
154497153|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154497154|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
154497155|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220985|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
154497156|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497157|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154497158|NCT03984591|Diuretics|diuretics|mesh-ancestor
154497159|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
154497160|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154497161|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154497162|NCT03470532|Epinephrine|epinephrine|mesh-list
154497163|NCT03470532|Racepinephrine|racepinephrine|mesh-list
154497164|NCT03470532|Mepivacaine|mepivacaine|mesh-list
154497165|NCT03470532|Carticaine|carticaine|mesh-list
154497166|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
154497167|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154497168|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154497169|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
154497170|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497171|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497172|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497173|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154497174|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154497175|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
154497176|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497177|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154497178|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
154497179|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
154497180|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
154497181|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154497182|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
154497183|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
154497184|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497185|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
154497186|NCT02502669|Finasteride|finasteride|mesh-list
154497187|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154497188|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154497189|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497190|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497191|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
154497192|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497193|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497194|NCT02502669|Urological Agents|urological agents|mesh-ancestor
154497195|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154860769|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497197|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
154497198|NCT03306836|Heparin|heparin|mesh-list
154497199|NCT03306836|Calcium heparin|calcium heparin|mesh-list
154497200|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
154497201|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154497202|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154497203|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497204|NCT04487145|Piperaquine|piperaquine|mesh-list
154497205|NCT04487145|Artenimol|artenimol|mesh-list
154497206|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
154497207|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154497208|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154497209|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497210|NCT00709956|Iloprost|iloprost|mesh-list
154497211|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154497212|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
154497213|NCT02268201|Tacrolimus|tacrolimus|mesh-list
154497214|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154497215|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
154497216|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497217|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154497218|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497219|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497220|NCT03306602|Z 350|z 350|mesh-list
154497221|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154497222|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154497223|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497224|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497225|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
154497226|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497227|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497228|NCT02268279|Solithromycin|solithromycin|mesh-list
154497229|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154497230|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497231|NCT02268357|Propranolol|propranolol|mesh-list
154497232|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154497233|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154497234|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
154497235|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497236|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497237|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497238|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154497239|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154497240|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
154497241|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
154497242|NCT02268435|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154497243|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154497244|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497245|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497246|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497247|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
154497248|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
154497249|NCT02466464|Coagulants|coagulants|mesh-ancestor
154497250|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
154497251|NCT01423149|Combretastatin|combretastatin|mesh-list
154497252|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497253|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497254|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497255|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497256|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497257|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497258|NCT03470454|Linagliptin|linagliptin|mesh-list
154497259|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154497260|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497261|NCT03470454|Incretins|incretins|mesh-ancestor
154497262|NCT03470454|Hormones|hormones|mesh-ancestor
154497263|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497264|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154497265|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
154497266|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497267|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497268|NCT03130842|Midazolam|midazolam|mesh-list
154497269|NCT03130842|Alprazolam|alprazolam|mesh-list
154497270|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154497272|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497273|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497274|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154497275|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154497276|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154497277|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154497278|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
154497279|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
154497280|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
154497281|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
154497282|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497283|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497284|NCT03130764|Durvalumab|durvalumab|mesh-list
154497285|NCT03130764|Tremelimumab|tremelimumab|mesh-list
154497286|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154497287|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497288|NCT01234779|Olanzapine|olanzapine|mesh-list
154497289|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
154497290|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
154497291|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497292|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497293|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154497294|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154497295|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154497296|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497297|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154497298|NCT01234779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154497299|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154497300|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154497301|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497302|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497303|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
154497304|NCT03223350|Capsaicin|capsaicin|mesh-list
154497305|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
154497306|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
154497307|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
154497308|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497309|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497310|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
154497311|NCT03306368|Narcotics|narcotics|mesh-ancestor
154497312|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497313|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497314|NCT03306368|Analgesics|analgesics|mesh-ancestor
154497315|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
154497316|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497318|NCT02840136|Tazobactam|tazobactam|mesh-list
154497319|NCT02840136|Piperacillin|piperacillin|mesh-list
154497320|NCT02840136|Ceftazidime|ceftazidime|mesh-list
154497321|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154497322|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154497323|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497324|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154497325|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497326|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497327|NCT02840136|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154497328|NCT02840136|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154497329|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154497330|NCT03306290|Cefoxitin|cefoxitin|mesh-list
154497331|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497332|NCT01616199|Vemurafenib|vemurafenib|mesh-list
154497333|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497334|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154497335|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497336|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497337|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
154497338|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154497339|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154497340|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154497341|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154497342|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497343|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
154497344|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497345|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497346|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154497347|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497348|NCT04506138|Paclitaxel|paclitaxel|mesh-list
154497349|NCT04506138|Carboplatin|carboplatin|mesh-list
154497350|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497351|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497352|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497353|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497354|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497355|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497356|NCT01407003|Licogliflozin|licogliflozin|mesh-list
154497357|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154497358|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497359|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154497360|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497361|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154497362|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
154497363|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497364|NCT01232595|Vancomycin|vancomycin|mesh-list
154497365|NCT01232595|LFF571|lff571|mesh-list
154497366|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154497367|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497368|NCT01231347|Gemcitabine|gemcitabine|mesh-list
154497369|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154497370|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154497371|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
154497372|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497373|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497374|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
154497375|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497376|NCT01230957|Vaccines|vaccines|mesh-list
154497377|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
154497378|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497379|NCT01228383|Vaccines|vaccines|mesh-list
154497380|NCT01228383|Antibodies|antibodies|mesh-list
154221213|NCT00115804|Fluoxetine|fluoxetine|mesh-list
154497381|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154497382|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
154497383|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
154497384|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154497385|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154497386|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
154497387|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497388|NCT03305978|Ivermectin|ivermectin|mesh-list
154497389|NCT03305978|Selamectin|selamectin|mesh-list
154497390|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154497391|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497392|NCT01594983|Fenofibrate|fenofibrate|mesh-list
154497393|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154497394|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
154497395|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497396|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154497397|NCT03305510|Vitamin D|vitamin d|mesh-list
154497398|NCT03305510|Vitamins|vitamins|mesh-ancestor
154497399|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
154497400|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497401|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154497402|NCT01224795|Peramivir|peramivir|mesh-list
154497403|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
154497404|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497405|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497406|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497407|NCT01402401|Trastuzumab|trastuzumab|mesh-list
154497408|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154497409|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497410|NCT02720510|Dexamethasone|dexamethasone|mesh-list
154497411|NCT02720510|Lenalidomide|lenalidomide|mesh-list
154497412|NCT02720510|Bortezomib|bortezomib|mesh-list
154497413|NCT02720510|Panobinostat|panobinostat|mesh-list
154497414|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154497415|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
154497416|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
154497417|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497418|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497419|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154497420|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
154497421|NCT02720510|Hormones|hormones|mesh-ancestor
154497422|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497423|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154497425|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
154497426|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154497427|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154497428|NCT02720510|Growth Substances|growth substances|mesh-ancestor
154497429|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
154497430|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154497431|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497432|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497433|NCT01220271|Temozolomide|temozolomide|mesh-list
154497434|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154497435|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
154497436|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497437|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497438|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
154497439|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154497440|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
154497441|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154497442|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
154497443|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497444|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497445|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
154497446|NCT01204749|Paclitaxel|paclitaxel|mesh-list
154497447|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154497448|NCT01204749|Trebananib|trebananib|mesh-list
154497449|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154497450|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497451|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497452|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497453|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497454|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497455|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497456|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154497457|NCT01204749|Growth Substances|growth substances|mesh-ancestor
154497458|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497459|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
154497460|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154497461|NCT02466698|Metronidazole|metronidazole|mesh-list
154497462|NCT02466698|Vancomycin|vancomycin|mesh-list
154497463|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154497464|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154497465|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497466|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
154497467|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154497468|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154497469|NCT02466698|Laxatives|laxatives|mesh-ancestor
154497470|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154497471|NCT02720198|Milnacipran|milnacipran|mesh-list
154497472|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154497473|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
154497474|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
154497475|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154497476|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154497477|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154497478|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497479|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497480|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154497481|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154497482|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154497483|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497484|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497485|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154497486|NCT02720198|Analgesics|analgesics|mesh-ancestor
154497487|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
154497488|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497489|NCT01193361|Interferons|interferons|mesh-list
154497490|NCT01193361|Ribavirin|ribavirin|mesh-list
154497491|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
154497492|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
154497493|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154497494|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497495|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
154497496|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497497|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
154497498|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061250|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497500|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497501|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154497502|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154497503|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497504|NCT02263677|Incretins|incretins|mesh-ancestor
154497505|NCT02263677|Hormones|hormones|mesh-ancestor
154497506|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497507|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154497508|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
154497509|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497510|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497511|NCT01390545|Veltuzumab|veltuzumab|mesh-list
154497512|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497513|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154497514|NCT01591473|Poly I-C|poly i-c|mesh-list
154497515|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
154497516|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497517|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
154497518|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
154497519|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497520|NCT01192035|Ritonavir|ritonavir|mesh-list
154497521|NCT01192035|Lopinavir|lopinavir|mesh-list
154497522|NCT01192035|Nevirapine|nevirapine|mesh-list
154497523|NCT01192035|Efavirenz|efavirenz|mesh-list
154497524|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154497525|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154497526|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
154497527|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497528|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497529|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154497530|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154497531|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
154497532|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497533|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154497534|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154497535|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154497536|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154497537|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154497538|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154497539|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154497540|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154497541|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154497542|NCT02268747|Dacomitinib|dacomitinib|mesh-list
154497543|NCT02268747|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154497544|NCT02268747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154497545|NCT02268747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497546|NCT02268747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497547|NCT01384383|Ledipasvir|ledipasvir|mesh-list
154497548|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
154497549|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497550|NCT01557777|Navitoclax|navitoclax|mesh-list
154497551|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497552|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
154497553|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154497554|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497555|NCT02268825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154497556|NCT02268825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497557|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154497558|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154497559|NCT02268903|Furosemide|furosemide|mesh-list
154497560|NCT02268903|Diuretics|diuretics|mesh-list
154497561|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
154497562|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497563|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154497564|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154497565|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497566|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154497567|NCT01369095|Escitalopram|escitalopram|mesh-list
154497568|NCT01369095|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154497569|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154125726|NCT00574080|Cytarabine|cytarabine|mesh-list
154497570|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154497571|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497572|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497573|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
154497574|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497575|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497576|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
154497577|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154497578|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154497579|NCT01369095|Analgesics|analgesics|mesh-ancestor
154497580|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
154497581|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
154497582|NCT02266173|Pertuzumab|pertuzumab|mesh-list
154497583|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154497584|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497585|NCT01168713|Levofloxacin|levofloxacin|mesh-list
154497586|NCT01168713|Solithromycin|solithromycin|mesh-list
154061291|NCT00668759|Amiodarone|amiodarone|mesh-list
154497587|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154497588|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497589|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154497590|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154497591|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154497592|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497593|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497594|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497595|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154497596|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154497597|NCT02269293|Paclitaxel|paclitaxel|mesh-list
154497598|NCT02269293|Carboplatin|carboplatin|mesh-list
154497599|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497600|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497601|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497602|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497603|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497604|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497605|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154497606|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
154497607|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497609|NCT01366131|Bevacizumab|bevacizumab|mesh-list
154497610|NCT01366131|Carboplatin|carboplatin|mesh-list
154497611|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497612|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497613|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497614|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497615|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497616|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497617|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154497618|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154497619|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154497620|NCT01366131|Growth Substances|growth substances|mesh-ancestor
154497621|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497622|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
154497623|NCT01365195|Ketamine|ketamine|mesh-list
154497624|NCT01365195|Analgesics|analgesics|mesh-ancestor
154497625|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
154497626|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497627|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497628|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154497629|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154497630|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
154497631|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
154497632|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497633|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154497634|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154497635|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497636|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497637|NCT02269449|Hemostatics|hemostatics|mesh-list
154497638|NCT02269449|Coagulants|coagulants|mesh-ancestor
154497639|NCT01160601|Paclitaxel|paclitaxel|mesh-list
154497640|NCT01160601|Carboplatin|carboplatin|mesh-list
154497641|NCT01160601|Bavituximab|bavituximab|mesh-list
154497642|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497643|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497644|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497645|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497646|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497647|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497648|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154497649|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
154497650|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154497651|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
154497652|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497653|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497654|NCT01356849|Atrasentan|atrasentan|mesh-list
154497655|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497656|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154497657|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154497658|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497659|NCT02266485|Pravastatin|pravastatin|mesh-list
154497660|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154497661|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154497662|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
154497663|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497664|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154497665|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154497666|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497667|NCT02263989|Telmisartan|telmisartan|mesh-list
154497668|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154497669|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154497670|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154497671|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497672|NCT01516203|Rifampin|rifampin|mesh-list
154497673|NCT01516203|Isoniazid|isoniazid|mesh-list
154497674|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
154497675|NCT01516203|Ethambutol|ethambutol|mesh-list
154497676|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154497677|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
154497678|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154061391|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
154061430|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497679|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497680|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
154497681|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154497682|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497683|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497684|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154497685|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154497686|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154497687|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154497688|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154497689|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154497690|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154497691|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154497692|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
154497693|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154497694|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
154497695|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
154497696|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497697|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497698|NCT00703118|Ribavirin|ribavirin|mesh-list
154497699|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
154497700|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154497701|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
154497702|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497703|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
154497704|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497705|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497706|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
154497707|NCT01510119|Everolimus|everolimus|mesh-list
154497708|NCT01510119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154497709|NCT01510119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154497710|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497711|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497712|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154497713|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
154497714|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497715|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497716|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
154497717|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154497719|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497720|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154497721|NCT01150695|Vaccines|vaccines|mesh-list
154497722|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
154497723|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497724|NCT01302249|Timolol|timolol|mesh-list
154497725|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154497726|NCT01302249|Latanoprost|latanoprost|mesh-list
154497727|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154497728|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497729|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154497730|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154497731|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
154497732|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497733|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497734|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154497735|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154497736|NCT02261636|Mesalamine|mesalamine|mesh-list
154497737|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154497738|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154497739|NCT02261636|Analgesics|analgesics|mesh-ancestor
154497740|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
154497741|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497742|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497743|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154497744|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154497745|NCT01493505|Paclitaxel|paclitaxel|mesh-list
154497746|NCT01493505|Carboplatin|carboplatin|mesh-list
154497747|NCT01493505|Trebananib|trebananib|mesh-list
154497748|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154497749|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497750|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
154497751|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
154497752|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
154497753|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497754|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154497755|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154497756|NCT01493505|Growth Substances|growth substances|mesh-ancestor
154497757|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497758|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
154497759|NCT01301157|Calcipotriene|calcipotriene|mesh-list
154497760|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
154497761|NCT02264145|Norflurane|norflurane|mesh-list
154497762|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154497763|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
154497764|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497765|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497766|NCT02264301|Puerarin|puerarin|mesh-list
154497767|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
154497768|NCT02267109|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154497769|NCT02267109|Antiviral Agents|antiviral agents|mesh-ancestor
154497770|NCT02267109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497771|NCT04476069|Ibuprofen|ibuprofen|mesh-list
154497772|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154061482|NCT00708318|Fentanyl|fentanyl|mesh-list
154497773|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154497774|NCT04476069|Analgesics|analgesics|mesh-ancestor
154497775|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
154497776|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497777|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497778|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154497779|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154497780|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154497781|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497782|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497783|NCT01480479|Temozolomide|temozolomide|mesh-list
154497784|NCT01480479|Molgramostim|molgramostim|mesh-list
154497785|NCT01480479|Rindopepimut|rindopepimut|mesh-list
154497786|NCT01480479|Sargramostim|sargramostim|mesh-list
154497787|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154497788|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
154497789|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497790|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497791|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
154497792|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497793|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154497795|NCT01116141|Methotrexate|methotrexate|mesh-list
154497796|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154497797|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
154497798|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154497799|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497800|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154497801|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
154497802|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497803|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497804|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
154497805|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497806|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154497807|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154497808|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
154497809|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154497810|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154497811|NCT01116141|Hematinics|hematinics|mesh-ancestor
154497812|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
154497813|NCT01116141|Vitamins|vitamins|mesh-ancestor
154497814|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
154497815|NCT01280565|Dacarbazine|dacarbazine|mesh-list
154497816|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154497817|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
154497818|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497819|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497820|NCT01113957|Doxorubicin|doxorubicin|mesh-list
154497821|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154497822|NCT01113957|Temozolomide|temozolomide|mesh-list
154497823|NCT01113957|Veliparib|veliparib|mesh-list
154497824|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154497825|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497826|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154061522|NCT00670553|Panobinostat|panobinostat|mesh-list
154497827|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154497828|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497829|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497830|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154497831|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
154497832|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154497834|NCT01111773|Tetracaine|tetracaine|mesh-list
154497835|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
154497836|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
154497837|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497838|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497839|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
154497840|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061577|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061587|NCT04154813|Topiramate|topiramate|mesh-list
154497841|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154497842|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154497843|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154497844|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154497845|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497846|NCT01280331|Morphine|morphine|mesh-list
154497847|NCT01280331|Oxycodone|oxycodone|mesh-list
154497848|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154497849|NCT01280331|Narcotics|narcotics|mesh-ancestor
154497850|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154497851|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497852|NCT01280331|Analgesics|analgesics|mesh-ancestor
154497853|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
154497854|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497855|NCT01266525|Donepezil|donepezil|mesh-list
154497856|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154497857|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497858|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497859|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
154497860|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497861|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497862|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
154497863|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
154497864|NCT01265901|Sunitinib|sunitinib|mesh-list
154497865|NCT01265901|Molgramostim|molgramostim|mesh-list
154497866|NCT01265901|Sargramostim|sargramostim|mesh-list
154497867|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
154497868|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497870|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154497871|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154497872|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
154497873|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497874|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497875|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154497876|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154497877|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154497878|NCT01265901|Growth Substances|growth substances|mesh-ancestor
154497879|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
154497880|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154497881|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497882|NCT05231382|Leucovorin|leucovorin|mesh-list
154497883|NCT05231382|Fluorouracil|fluorouracil|mesh-list
154497884|NCT05231382|Raltitrexed|raltitrexed|mesh-list
154497885|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
154497886|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
154497887|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497888|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154497889|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061605|NCT00664703|Lobeline|lobeline|mesh-list
154497890|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154497891|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
154497892|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497893|NCT05231382|Antidotes|antidotes|mesh-ancestor
154497894|NCT05231382|Protective Agents|protective agents|mesh-ancestor
154497895|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
154497896|NCT05231382|Vitamins|vitamins|mesh-ancestor
154497897|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
154497898|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154497899|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497900|NCT01262235|TKM-080301|tkm-080301|mesh-list
154497901|NCT01262235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154497902|NCT01262235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154497903|NCT01262235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497904|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154497905|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
154497906|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497907|NCT01460511|Epinephrine|epinephrine|mesh-list
154497908|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154497909|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154497910|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
154497911|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497912|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497913|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497914|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154497915|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154497916|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
154497917|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497918|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154497919|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
154497920|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
154497921|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
154497922|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154497923|NCT03135171|Trastuzumab|trastuzumab|mesh-list
154497924|NCT03135171|Pertuzumab|pertuzumab|mesh-list
154497925|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154497926|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497927|NCT01449591|Metronidazole|metronidazole|mesh-list
154497928|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497929|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154497930|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154497931|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154497932|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154497933|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154497934|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154497935|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154497936|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154497937|NCT01444365|Analgesics|analgesics|mesh-ancestor
154497938|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
154497939|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497940|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497941|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154497942|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154497943|NCT01098435|ALKS-33|alks-33|mesh-list
154497944|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154497946|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
154497947|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497948|NCT00909597|Pioglitazone|pioglitazone|mesh-list
154497949|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154497950|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154497951|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497952|NCT00909597|Incretins|incretins|mesh-ancestor
154497953|NCT00909597|Hormones|hormones|mesh-ancestor
154497954|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154497955|NCT01077297|Tezosentan|tezosentan|mesh-list
154497956|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
154497957|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
154497958|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497959|NCT05379855|Atropine|atropine|mesh-list
154497960|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154497961|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154497962|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154497963|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154497964|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154497965|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
154497966|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154497967|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497968|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154497969|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
154497970|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
154497971|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
154497972|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154497973|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154497974|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
154497975|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154497976|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497977|NCT02718326|Aflibercept|aflibercept|mesh-list
154497978|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154497979|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154497980|NCT02718326|Growth Substances|growth substances|mesh-ancestor
154497981|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497982|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
154497983|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497984|NCT03691584|Dimercaprol|dimercaprol|mesh-list
154497985|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
154497986|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
154497987|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154497988|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154497989|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
154497990|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154497991|NCT03600714|Interferons|interferons|mesh-list
154497992|NCT03600714|Ritonavir|ritonavir|mesh-list
154497993|NCT03600714|Lonafarnib|lonafarnib|mesh-list
154497994|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154497995|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
154497996|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154497997|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154497998|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154497999|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
154498000|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498001|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498002|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154498003|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154498004|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154498005|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154498006|NCT05163366|Ketamine|ketamine|mesh-list
154498007|NCT05163366|Morphine|morphine|mesh-list
154498008|NCT05163366|Analgesics|analgesics|mesh-ancestor
154498009|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
154498010|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498011|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498012|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154498013|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154498014|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
154498015|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
154498016|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498017|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154498018|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154498019|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498020|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498022|NCT05163366|Narcotics|narcotics|mesh-ancestor
154498023|NCT00900783|Valacyclovir|valacyclovir|mesh-list
154498024|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
154498025|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498026|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154498027|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154498028|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498029|NCT01035879|Incretins|incretins|mesh-ancestor
154498030|NCT01035879|Hormones|hormones|mesh-ancestor
154498031|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154498032|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154498033|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
154498034|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498035|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498036|NCT01029873|Cisplatin|cisplatin|mesh-list
154498037|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498038|NCT01024101|Paclitaxel|paclitaxel|mesh-list
154498039|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154498040|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498041|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
154498042|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
154498043|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
154498044|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498045|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
154498046|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498047|NCT00818571|Vildagliptin|vildagliptin|mesh-list
154498048|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154498049|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498050|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154498051|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
154498052|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498053|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498054|NCT00818493|Acetaminophen|acetaminophen|mesh-list
154498055|NCT00818493|Morphine|morphine|mesh-list
154498056|NCT00818493|Oxycodone|oxycodone|mesh-list
154498057|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154498058|NCT00818493|Narcotics|narcotics|mesh-ancestor
154498059|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498060|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498061|NCT00818493|Analgesics|analgesics|mesh-ancestor
154498062|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
154498063|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498064|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154498065|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
154498066|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154498067|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154498068|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154498069|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154498070|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154498071|NCT01378962|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154498072|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154498073|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498074|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498075|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498076|NCT00892203|Sumatriptan|sumatriptan|mesh-list
154498077|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154498078|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154498079|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154498080|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
154498081|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498082|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498083|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498084|NCT00810147|BMS 708163|bms 708163|mesh-list
154498085|NCT00810147|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154498086|NCT00810147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498087|NCT00810147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498088|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
154498089|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154498090|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498091|NCT04375956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154498092|NCT04375956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498094|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154498095|NCT04495478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154498096|NCT04495478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154498097|NCT04495478|Growth Substances|growth substances|mesh-ancestor
154498098|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498099|NCT04495478|Growth Inhibitors|growth inhibitors|mesh-ancestor
154498100|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498101|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
154498102|NCT04487444|Thymalfasin|thymalfasin|mesh-list
154498103|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154498104|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
154498105|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498107|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154498108|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154498109|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498110|NCT03603080|Metformin|metformin|mesh-list
154498111|NCT03603080|Topiramate|topiramate|mesh-list
154498112|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
154498113|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154498114|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498115|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
154498116|NCT01019187|Modafinil|modafinil|mesh-list
154498117|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154498118|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498119|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154498120|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154498121|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154498122|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498123|NCT01018875|Donepezil|donepezil|mesh-list
154498124|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154498125|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498126|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498127|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
154498128|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498129|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498130|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
154498131|NCT00806403|Reteplase|reteplase|mesh-list
154498133|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154498134|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498135|NCT01007721|Fluticasone|fluticasone|mesh-list
154498136|NCT01007721|Xhance|xhance|mesh-list
154498137|NCT01007721|Montelukast|montelukast|mesh-list
154498138|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498139|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154498140|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
154498141|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498142|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498143|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154061858|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498144|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
154498145|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
154498146|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154498147|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154498148|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
154498149|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154498150|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154498151|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154498152|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498153|NCT00701558|Gemcitabine|gemcitabine|mesh-list
154498154|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154498155|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498156|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
154498157|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498158|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498159|NCT00701558|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154498160|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154498161|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498162|NCT03233828|Aldesleukin|aldesleukin|mesh-list
154498163|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498164|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154498165|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154498166|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
154498167|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498169|NCT03882177|Pyridoxal|pyridoxal|mesh-list
154498170|NCT03882177|Pyridoxine|pyridoxine|mesh-list
154498171|NCT03882177|Pravastatin|pravastatin|mesh-list
154498172|NCT03882177|Vitamins|vitamins|mesh-ancestor
154498173|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
154498174|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498175|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
154498176|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154498177|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154498178|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
154498179|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498180|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154498181|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154498182|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498183|NCT01007097|Glimepiride|glimepiride|mesh-list
154498184|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154498185|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154498186|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498187|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154498188|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
154498189|NCT01663402|Alirocumab|alirocumab|mesh-list
154498190|NCT01663402|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154498191|NCT01663402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154498192|NCT01663402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154498193|NCT01663402|Antimetabolites|antimetabolites|mesh-ancestor
154498194|NCT01663402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498195|NCT01663402|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154498196|NCT01663402|Protease Inhibitors|protease inhibitors|mesh-ancestor
154498197|NCT01663402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498198|NCT01663402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154498199|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
154498200|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154498201|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154498202|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154498203|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061878|NCT00672659|Dexetimide|dexetimide|mesh-list
154498204|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498205|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
154498206|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498207|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498209|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498210|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154498211|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
154498212|NCT00869661|Ribavirin|ribavirin|mesh-list
154498213|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
154498214|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498215|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
154498216|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498217|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
154498218|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498219|NCT03192566|Acetaminophen|acetaminophen|mesh-list
154498220|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154498221|NCT03192566|Analgesics|analgesics|mesh-ancestor
154498222|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
154498223|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498224|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498225|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
154498226|NCT03296930|Ritonavir|ritonavir|mesh-list
154498227|NCT03296930|Ribavirin|ribavirin|mesh-list
154498228|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
154498229|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154498230|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154498231|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
154498232|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498233|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498234|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154498235|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154498236|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
154498237|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498238|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154498239|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154498240|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
154498241|NCT04607772|Rituximab|rituximab|mesh-list
154498242|NCT04607772|Gemcitabine|gemcitabine|mesh-list
154498243|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
154498244|NCT04607772|Lenalidomide|lenalidomide|mesh-list
154498245|NCT04607772|Venetoclax|venetoclax|mesh-list
154126389|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
154498247|NCT04607772|Ibrutinib|ibrutinib|mesh-list
154498248|NCT04607772|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154498249|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154498250|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498251|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
154498252|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498253|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154498254|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498255|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
154498256|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498257|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154498258|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154498259|NCT04607772|Growth Substances|growth substances|mesh-ancestor
154498260|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
154498261|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154498262|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
154498263|NCT04607772|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154498264|NCT04607772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154498265|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498266|NCT04607772|Immunoconjugates|immunoconjugates|mesh-ancestor
154498267|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
154498268|NCT02464124|Lactulose|lactulose|mesh-list
154498269|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154498270|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154498271|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498272|NCT00859521|Levetiracetam|levetiracetam|mesh-list
154498273|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
154498274|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
154498275|NCT05398770|Vitamin D|vitamin d|mesh-list
154498276|NCT05398770|Vitamins|vitamins|mesh-ancestor
154498277|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
154498278|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498279|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154498280|NCT00843687|Risperidone|risperidone|mesh-list
154498281|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154498282|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
154498283|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498284|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498285|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498287|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154498288|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498289|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154498290|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154498291|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
154498292|NCT04642131|Caffeine|caffeine|mesh-list
154498293|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154498294|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498295|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154498296|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498297|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498298|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154498299|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154498300|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
154498301|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498302|NCT01001715|Fasinumab|fasinumab|mesh-list
154498303|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154498304|NCT01001715|Analgesics|analgesics|mesh-ancestor
154498305|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
154498306|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498307|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498308|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154498309|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154498310|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154498311|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154498312|NCT00789633|Gemcitabine|gemcitabine|mesh-list
154498313|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498314|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
154498315|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498316|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498317|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
154498318|NCT00788541|Anecortave|anecortave|mesh-list
154498319|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154498320|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154498321|NCT00788541|Growth Substances|growth substances|mesh-ancestor
154498322|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498323|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
154498324|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498325|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498326|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154498327|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154498328|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154498329|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154498330|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154498331|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
154498332|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498333|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154498334|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
154498335|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498336|NCT00841815|Amlodipine|amlodipine|mesh-list
154498337|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154498338|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154498339|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154498340|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498341|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154498342|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498343|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
154498344|NCT03296306|Cisplatin|cisplatin|mesh-list
154498345|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498346|NCT00841659|Paroxetine|paroxetine|mesh-list
154498347|NCT00841659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154498348|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154498349|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154498350|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498351|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498352|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
154498353|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498354|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154498355|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
154498356|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154498357|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154498358|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154498359|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498360|NCT04061252|Brodalumab|brodalumab|mesh-list
154498361|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
154498362|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
154498363|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154498364|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498365|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154498366|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498367|NCT01001091|Dexamethasone|dexamethasone|mesh-list
154498368|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154498369|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154498370|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498371|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
154498372|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
154498373|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498374|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498375|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154498376|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
154498377|NCT01001091|Hormones|hormones|mesh-ancestor
154498378|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154498379|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154498380|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498381|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
154498382|NCT05076682|Efavirenz|efavirenz|mesh-list
154498383|NCT05076682|Choline|choline|mesh-list
154498384|NCT05076682|Antibodies|antibodies|mesh-list
154498385|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
154498386|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498387|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154498388|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154498389|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498390|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498391|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
154498392|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498393|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154498394|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154498395|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154498396|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154498397|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154498398|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154498399|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
154498400|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154498401|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
154498402|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154498403|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154498404|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
154498405|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154498406|NCT05076682|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154498407|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498408|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154498409|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
154498410|NCT00840879|Meloxicam|meloxicam|mesh-list
154498411|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154498412|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154498413|NCT00840879|Analgesics|analgesics|mesh-ancestor
154498414|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
154498415|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498416|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498417|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498418|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154498419|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154498420|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154498421|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498422|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498423|NCT02163434|Gabapentin|gabapentin|mesh-list
154498424|NCT02163434|Metoclopramide|metoclopramide|mesh-list
154498425|NCT02163434|Analgesics|analgesics|mesh-ancestor
154498426|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
154498427|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498428|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498429|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
154498430|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154498431|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154498432|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498433|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154498434|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154498435|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154498436|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498437|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498438|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
154498439|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
154498440|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
154498441|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154498442|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154498443|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154860770|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860771|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154860772|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154498444|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
154498445|NCT00840411|Clarithromycin|clarithromycin|mesh-list
154498446|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154498447|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498448|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154498449|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498450|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498451|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154498452|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154498453|NCT00840099|Amoxicillin|amoxicillin|mesh-list
154498454|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
154498455|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
154498456|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154498457|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154498458|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498459|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154498460|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498461|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498462|NCT03108248|Doxorubicin|doxorubicin|mesh-list
154498463|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
154498464|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154254995|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
154498465|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154498466|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498467|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154498468|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154498469|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498470|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498471|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
154498472|NCT03108248|Coagulants|coagulants|mesh-ancestor
154498473|NCT00836901|Amoxicillin|amoxicillin|mesh-list
154498474|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154498475|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
154498476|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
154498477|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154498478|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498479|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154498480|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498481|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498482|NCT04460560|Terlipressin|terlipressin|mesh-list
154498483|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154498484|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154498485|NCT04537689|Cyclosporine|cyclosporine|mesh-list
154498486|NCT04537689|Methotrexate|methotrexate|mesh-list
154498487|NCT04537689|Ixekizumab|ixekizumab|mesh-list
154498488|NCT04537689|Acitretin|acitretin|mesh-list
154498489|NCT04537689|Cyclosporins|cyclosporins|mesh-list
154498490|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154498491|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
154498492|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154498493|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498494|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498495|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
154498496|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498497|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498498|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
154498499|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498500|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154498501|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154498502|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
154498503|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154222340|NCT00459875|Growth Substances|growth substances|mesh-ancestor
154498504|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154498505|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
154498506|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498507|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154498508|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
154498509|NCT03295760|Ubiquinone|ubiquinone|mesh-list
154498510|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
154498511|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
154498512|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498513|NCT03295760|Vitamins|vitamins|mesh-ancestor
154498514|NCT05563012|Capecitabine|capecitabine|mesh-list
154498515|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
154498516|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498517|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
154498518|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498519|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498520|NCT04501653|Methylphenidate|methylphenidate|mesh-list
154498521|NCT04501653|Psilocybin|psilocybin|mesh-list
154498522|NCT04501653|Psilocin|psilocin|mesh-list
154498523|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154498524|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498525|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154498526|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154498527|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154498528|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498529|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
154498530|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498531|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
154498532|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154498533|NCT04730206|Molnupiravir|molnupiravir|mesh-list
154498534|NCT04730206|Camostat|camostat|mesh-list
154498535|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
154498536|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860773|NCT03241810|Fulvestrant|fulvestrant|mesh-list
154498537|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498538|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154498539|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154498541|NCT04730206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498542|NCT00990327|Adenosine|adenosine|mesh-list
154498543|NCT00990327|Analgesics|analgesics|mesh-ancestor
154498544|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
154498545|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498546|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498547|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154498548|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
154498549|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154498550|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
154498551|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
154498552|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498553|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498554|NCT03050814|Leucovorin|leucovorin|mesh-list
154498555|NCT03050814|Bevacizumab|bevacizumab|mesh-list
154498556|NCT03050814|Avelumab|avelumab|mesh-list
154498557|NCT03050814|Capecitabine|capecitabine|mesh-list
154498558|NCT03050814|Fluorouracil|fluorouracil|mesh-list
154498559|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
154498560|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154498561|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498562|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154498563|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154498564|NCT03050814|Growth Substances|growth substances|mesh-ancestor
154498565|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498566|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
154498567|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498568|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
154498569|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498570|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154498571|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
154498572|NCT03050814|Antidotes|antidotes|mesh-ancestor
154498573|NCT03050814|Protective Agents|protective agents|mesh-ancestor
154498574|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
154498575|NCT03050814|Vitamins|vitamins|mesh-ancestor
154498576|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
154498577|NCT02462174|Ketamine|ketamine|mesh-list
154498578|NCT02462174|Bupivacaine|bupivacaine|mesh-list
154498579|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
154498580|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
154498581|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498582|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498583|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
154498584|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498585|NCT02462174|Analgesics|analgesics|mesh-ancestor
154498586|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154498587|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154498588|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
154498589|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154498590|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154498591|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498592|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498593|NCT02564146|Paclitaxel|paclitaxel|mesh-list
154498594|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154498595|NCT02564146|Gemcitabine|gemcitabine|mesh-list
154498596|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154498597|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498598|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
154498599|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
154498600|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
154498601|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498602|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498603|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
154498604|NCT00981357|Naproxen|naproxen|mesh-list
154498605|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154498606|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154498607|NCT00981357|Analgesics|analgesics|mesh-ancestor
154498608|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
154498609|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498610|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498611|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498612|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154498613|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
154498614|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154498615|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498616|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498618|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
154498619|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154498620|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154498621|NCT02462252|Cyclosporins|cyclosporins|mesh-list
154498622|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154498623|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498624|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498625|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154498626|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
154498627|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498628|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
154498629|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498630|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
154498631|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154498632|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154498633|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498634|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
154498635|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
154498636|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498637|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154498638|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
154498639|NCT02462252|Hormones|hormones|mesh-ancestor
154498640|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154498641|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154498642|NCT02462252|Protective Agents|protective agents|mesh-ancestor
154498643|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154498644|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498645|NCT03130452|Amoxicillin|amoxicillin|mesh-list
154498646|NCT03130452|Metronidazole|metronidazole|mesh-list
154498647|NCT03130452|Clarithromycin|clarithromycin|mesh-list
154498648|NCT03130452|Lansoprazole|lansoprazole|mesh-list
154498649|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
154498650|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154498651|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498652|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154498653|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154498654|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154498655|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498656|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498657|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154498658|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154498659|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154498660|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154498661|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154498662|NCT00979251|Oseltamivir|oseltamivir|mesh-list
154498663|NCT00979251|Amantadine|amantadine|mesh-list
154498664|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
154498665|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498666|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498667|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498668|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154498669|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154498670|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
154498671|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498672|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498673|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154498674|NCT00979251|Analgesics|analgesics|mesh-ancestor
154498675|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
154498676|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498677|NCT04551352|Adalimumab|adalimumab|mesh-list
154498678|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
154498679|NCT04551352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154498680|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498681|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154498682|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154498683|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498684|NCT05398224|Rituximab|rituximab|mesh-list
154498685|NCT05398224|Methotrexate|methotrexate|mesh-list
154498686|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
154498687|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154498688|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498689|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
154498690|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498691|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154498692|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154498693|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
154498694|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154062424|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154062425|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
154062426|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062427|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154062428|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154062429|NCT02561494|Nefopam|nefopam|mesh-list
154498695|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498696|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
154498697|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498698|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
154498699|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498700|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154498701|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154498702|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154498703|NCT05398224|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154498704|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154498705|NCT04542304|Metolazone|metolazone|mesh-list
154498706|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154498707|NCT04542304|Diuretics|diuretics|mesh-ancestor
154498708|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
154498709|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498710|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154498711|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154498712|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498713|NCT02463110|Sertraline|sertraline|mesh-list
154498714|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
154498715|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154498716|NCT02463110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154498717|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154498718|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154498719|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498720|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498721|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
154498722|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498723|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
154498724|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154498725|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498726|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498727|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154498728|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154498729|NCT05502952|Protective Agents|protective agents|mesh-ancestor
154498730|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498731|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
154222564|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
154498733|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
154498734|NCT00835575|Mirtazapine|mirtazapine|mesh-list
154498735|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
154498736|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154498737|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154062462|NCT05958173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498738|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
154498739|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
154498740|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498741|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498742|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498743|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154498744|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154498745|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498746|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154498747|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154498748|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154498749|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
154498750|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154498751|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154498752|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
154498753|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154498754|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154498755|NCT00777309|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154498756|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154498757|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498758|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498759|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498760|NCT03295214|Acetaminophen|acetaminophen|mesh-list
154498761|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154498762|NCT03295214|Analgesics|analgesics|mesh-ancestor
154860774|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154498763|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
154498764|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498765|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498767|NCT04604704|Niacinamide|niacinamide|mesh-list
154498768|NCT04604704|Naltrexone|naltrexone|mesh-list
154498769|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154498770|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154498771|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498772|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
154498773|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498774|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
154498775|NCT04604704|Vitamins|vitamins|mesh-ancestor
154498776|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
154498777|NCT00776373|Cytarabine|cytarabine|mesh-list
154498778|NCT00776373|Sirolimus|sirolimus|mesh-list
154498779|NCT00776373|Etoposide|etoposide|mesh-list
154498780|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154498781|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498782|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154498783|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154498784|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498785|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498786|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498787|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
154498788|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
154498789|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498790|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154498791|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
154498792|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498793|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154498794|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154498795|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
154498796|NCT00772785|Buprenorphine|buprenorphine|mesh-list
154498797|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154498798|NCT00772785|Narcotics|narcotics|mesh-ancestor
154498799|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498800|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498801|NCT00772785|Analgesics|analgesics|mesh-ancestor
154498802|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
154498803|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498804|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154498805|NCT02461706|Cannabidiol|cannabidiol|mesh-list
154498806|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
154498807|NCT05497570|Tenoxicam|tenoxicam|mesh-list
154498808|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154498809|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154498810|NCT05497570|Analgesics|analgesics|mesh-ancestor
154498811|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
154498812|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498813|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498814|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498815|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154498816|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154498817|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498818|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498819|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154498820|NCT00963885|Lactams|lactams|mesh-list
154498821|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
154498822|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498823|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154498824|NCT00835497|Metformin|metformin|mesh-list
154498825|NCT00835497|Glipizide|glipizide|mesh-list
154498826|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154498827|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498828|NCT00763503|Calcitriol|calcitriol|mesh-list
154498829|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154498830|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498831|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154498832|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154498833|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498834|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154498835|NCT00763503|Vitamins|vitamins|mesh-ancestor
154498836|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
154498837|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154062525|NCT05957328|Vitamins|vitamins|mesh-ancestor
154498838|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154498839|NCT00761709|Latanoprost|latanoprost|mesh-list
154498840|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154498841|NCT00760539|Timolol|timolol|mesh-list
154498842|NCT00760539|Travoprost|travoprost|mesh-list
154498843|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154498844|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154498845|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154498846|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154498847|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
154498848|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498849|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498850|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498851|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154498852|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154498853|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154498854|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154498855|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
154498856|NCT00759135|Finasteride|finasteride|mesh-list
154498857|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154498858|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154498859|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498860|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498861|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
154498862|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154498863|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498864|NCT00759135|Urological Agents|urological agents|mesh-ancestor
154498865|NCT00835263|Lamotrigine|lamotrigine|mesh-list
154498866|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
154498867|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154498868|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154498869|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498870|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154498871|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498872|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154498873|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154498874|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498875|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154498876|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154498877|NCT02639910|Venetoclax|venetoclax|mesh-list
154498878|NCT02639910|Idelalisib|idelalisib|mesh-list
154498879|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498880|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498881|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498882|NCT04454580|Azacitidine|azacitidine|mesh-list
154498883|NCT04454580|Decitabine|decitabine|mesh-list
154498884|NCT04454580|Venetoclax|venetoclax|mesh-list
154498885|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154498886|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
154498887|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498888|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498889|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498890|NCT00948909|Donepezil|donepezil|mesh-list
154498891|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154498892|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498893|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498894|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
154498895|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062561|NCT05951712|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154498896|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498897|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
154498898|NCT02522910|Docetaxel|docetaxel|mesh-list
154498899|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154498900|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
154498901|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
154498902|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
154498903|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498904|NCT00948753|Maraviroc|maraviroc|mesh-list
154498905|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498906|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154498907|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154498908|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498909|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154498910|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154498911|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
154498912|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154498913|NCT05397834|Fluticasone|fluticasone|mesh-list
154498914|NCT05397834|Xhance|xhance|mesh-list
154498915|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154498916|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154498917|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
154498918|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498919|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498920|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154498921|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
154498922|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
154498923|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154498924|NCT03134547|Sevoflurane|sevoflurane|mesh-list
154498925|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154498926|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154498927|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
154498928|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
154498929|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498930|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498931|NCT01963208|Ganaxolone|ganaxolone|mesh-list
154498932|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
154498933|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498934|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498935|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498936|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
154498937|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
154498938|NCT00834873|Carvedilol|carvedilol|mesh-list
154498939|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154498940|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154498941|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
154498942|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498943|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498944|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498945|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154498946|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
154062632|NCT05809895|Antimetabolites|antimetabolites|mesh-ancestor
154498947|NCT00834873|Protective Agents|protective agents|mesh-ancestor
154498948|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154498949|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154498950|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154498951|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
154498952|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154498953|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154498954|NCT01377480|Posaconazole|posaconazole|mesh-list
154498955|NCT01377480|Benzonidazole|benzonidazole|mesh-list
154498956|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
154498957|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154498959|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154498960|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154498961|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154498962|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154498963|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154498964|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498965|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154498966|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
154498967|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154498968|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498969|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154498970|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
154498971|NCT04263909|Sufentanil|sufentanil|mesh-list
154498972|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154498973|NCT04263909|Narcotics|narcotics|mesh-ancestor
154498974|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498975|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498976|NCT04263909|Analgesics|analgesics|mesh-ancestor
154498977|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
154498978|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498979|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154498980|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154498981|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
154498982|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
154498983|NCT01421264|Gabapentin|gabapentin|mesh-list
154498984|NCT01421264|Analgesics|analgesics|mesh-ancestor
154498985|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
154498986|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154498987|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154498988|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
154498989|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154498990|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154498991|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154498992|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154498993|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154498994|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154498995|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154498996|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154498997|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
154498998|NCT04415840|Acetic Acid|acetic acid|mesh-list
154498999|NCT04415840|Retinol acetate|retinol acetate|mesh-list
154499000|NCT04415840|Lugol's solution|lugol's solution|mesh-list
154499001|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154499002|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499003|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154499004|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
154499005|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499006|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154499007|NCT04415840|Protective Agents|protective agents|mesh-ancestor
154499008|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499009|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
154499010|NCT04415840|Coagulants|coagulants|mesh-ancestor
154499011|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
154499012|NCT04488614|Estrogens|estrogens|mesh-list
154499013|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154499014|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499015|NCT04488614|Hormones|hormones|mesh-ancestor
154499016|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499017|NCT00834795|Carvedilol|carvedilol|mesh-list
154499018|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154499019|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154499020|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
154499021|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499022|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499023|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499024|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154499025|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
154499026|NCT00834795|Protective Agents|protective agents|mesh-ancestor
154499027|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154499028|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499029|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154499030|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
154499031|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154499032|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154499033|NCT00834717|Granisetron|granisetron|mesh-list
154499034|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
154499035|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
154499036|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499037|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499038|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499039|NCT00834717|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154499040|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154499041|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
154499042|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499043|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499044|NCT00834639|Valproic Acid|valproic acid|mesh-list
154499045|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
154499046|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499047|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499048|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
154499049|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499050|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499051|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
154499052|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154499053|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499054|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154499055|NCT00834561|Lamotrigine|lamotrigine|mesh-list
154499056|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
154499057|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154499058|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499059|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499060|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154499061|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499062|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154499063|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154499064|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499066|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154499067|NCT00754221|Reboxetine|reboxetine|mesh-list
154499068|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
154499069|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154499070|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154499071|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154499072|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499073|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499074|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
154062746|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
154499075|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499076|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499077|NCT00834405|Leflunomide|leflunomide|mesh-list
154499078|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499079|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499080|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154499081|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
154499082|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499083|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154499084|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154499085|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154499086|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499087|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499088|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499089|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499090|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154499091|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
154499092|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154499093|NCT00751803|Eletriptan|eletriptan|mesh-list
154499094|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154499095|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
154499096|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499097|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499098|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499099|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154499100|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
154499101|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499102|NCT05402397|Losartan|losartan|mesh-list
154499103|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154499104|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154499105|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154499106|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154499107|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499108|NCT00833937|Zolpidem|zolpidem|mesh-list
154499109|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154499110|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154499111|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499112|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499113|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154499114|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
154499115|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
154499116|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499117|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499118|NCT00831051|Morphine|morphine|mesh-list
154499119|NCT00831051|Oxycodone|oxycodone|mesh-list
154499120|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154499121|NCT00831051|Narcotics|narcotics|mesh-ancestor
154499122|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499123|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499124|NCT00831051|Analgesics|analgesics|mesh-ancestor
154499125|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
154499126|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499127|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
154499128|NCT00750633|Dexamethasone|dexamethasone|mesh-list
154499129|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154499130|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154499131|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499132|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
154499133|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
154499134|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499135|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499136|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499138|NCT00750633|Hormones|hormones|mesh-ancestor
154499139|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499140|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499141|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499142|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154499143|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499144|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154499145|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154499146|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499147|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499148|NCT00750243|Naproxen|naproxen|mesh-list
154499149|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154499150|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154499151|NCT00750243|Analgesics|analgesics|mesh-ancestor
154499152|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
154499153|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499154|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499155|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499156|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154499157|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
154499158|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154499159|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499160|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499161|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
154499162|NCT00924170|Fludarabine|fludarabine|mesh-list
154499163|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154499164|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
154499165|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499166|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154499167|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154062903|NCT04521140|Dexamethasone|dexamethasone|mesh-list
154062904|NCT04521140|Prednisolone|prednisolone|mesh-list
154062905|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154062906|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
154062907|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154062908|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
154062909|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154499168|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
154499169|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499170|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499171|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154499172|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
154499173|NCT00920985|Gestodene|gestodene|mesh-list
154499174|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
154499175|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154499176|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499177|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154499178|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154499179|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154499180|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154499181|NCT00920985|Progestins|progestins|mesh-ancestor
154499182|NCT00920985|Hormones|hormones|mesh-ancestor
154499183|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499184|NCT05388747|Cefuroxime|cefuroxime|mesh-list
154499185|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
154499186|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154499187|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499188|NCT00828321|Ramipril|ramipril|mesh-list
154499189|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154499190|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
154499191|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499192|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499193|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154499194|NCT01352715|Ritonavir|ritonavir|mesh-list
154499195|NCT01352715|Lopinavir|lopinavir|mesh-list
154499196|NCT01352715|Tenofovir|tenofovir|mesh-list
154499197|NCT01352715|Lamivudine|lamivudine|mesh-list
154499198|NCT01352715|Emtricitabine|emtricitabine|mesh-list
154499199|NCT01352715|Zidovudine|zidovudine|mesh-list
154499200|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
154499201|NCT01352715|Abacavir|abacavir|mesh-list
154499202|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154499203|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
154499204|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154499205|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154499206|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
154499207|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499208|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499209|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154499210|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154499211|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
154499213|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154499214|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154499215|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154499216|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154499217|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
154499218|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154499219|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154499220|NCT00743925|Atorvastatin|atorvastatin|mesh-list
154499221|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
154499222|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154499223|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154499224|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
154499225|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499226|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154499227|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154499228|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499229|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154499230|NCT00738387|Docetaxel|docetaxel|mesh-list
154062959|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
154499231|NCT00738387|Vadimezan|vadimezan|mesh-list
154499232|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499233|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154499234|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154499235|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154499236|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499237|NCT00645177|Paclitaxel|paclitaxel|mesh-list
154499238|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154499239|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499240|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154499241|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154499242|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154499243|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499244|NCT00643383|Acetaminophen|acetaminophen|mesh-list
154499245|NCT00643383|Tramadol|tramadol|mesh-list
154499246|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154499247|NCT00643383|Analgesics|analgesics|mesh-ancestor
154499248|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
154499249|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499250|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499251|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
154499252|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154499253|NCT00643383|Narcotics|narcotics|mesh-ancestor
154499254|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499255|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154499256|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
154499257|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499258|NCT04285450|Vitamin K|vitamin k|mesh-list
154499259|NCT04285450|Vitamins|vitamins|mesh-ancestor
154499260|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
154499261|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499262|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154499263|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154499264|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499265|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
154499266|NCT04285450|Coagulants|coagulants|mesh-ancestor
154499267|NCT05497102|Lenalidomide|lenalidomide|mesh-list
154499268|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
154499269|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499270|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154499271|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154499272|NCT05497102|Growth Substances|growth substances|mesh-ancestor
154499273|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
154499274|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499275|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
154499276|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154499277|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154499278|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499279|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
154499280|NCT05490160|Coagulants|coagulants|mesh-ancestor
154499281|NCT05495620|Dexamethasone|dexamethasone|mesh-list
154499282|NCT05495620|Lenalidomide|lenalidomide|mesh-list
154499283|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499284|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
154499285|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
154499286|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499287|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499288|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499290|NCT05495620|Hormones|hormones|mesh-ancestor
154499291|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499292|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499293|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499294|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
154499295|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154499296|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154499297|NCT05495620|Growth Substances|growth substances|mesh-ancestor
154499298|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
154499299|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
154499300|NCT05490082|Mirabegron|mirabegron|mesh-list
154499301|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154499302|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154499303|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
154499304|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499305|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499306|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499307|NCT05490082|Urological Agents|urological agents|mesh-ancestor
154499308|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154499309|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154499310|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154499311|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
154499312|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
154499313|NCT02559310|Linezolid|linezolid|mesh-list
154499314|NCT02559310|Lefamulin|lefamulin|mesh-list
154499315|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154499316|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499317|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154499318|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154499319|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499320|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499321|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499322|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154499323|NCT05489848|Paclitaxel|paclitaxel|mesh-list
154499324|NCT05489848|Carboplatin|carboplatin|mesh-list
154499325|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154499326|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499327|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
154499328|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
154499329|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
154499330|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499331|NCT05489692|Leucovorin|leucovorin|mesh-list
154499333|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
154499334|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154499335|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
154499336|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499337|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154499338|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499339|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154499340|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
154499341|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499342|NCT05489692|Antidotes|antidotes|mesh-ancestor
154499343|NCT05489692|Protective Agents|protective agents|mesh-ancestor
154499344|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
154499345|NCT05489692|Vitamins|vitamins|mesh-ancestor
154499346|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
154499347|NCT05489692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063021|NCT03580369|Omalizumab|omalizumab|mesh-list
154499348|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154499349|NCT00721695|Mydriatics|mydriatics|mesh-list
154499350|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
154499351|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499352|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499353|NCT00625833|Reboxetine|reboxetine|mesh-list
154499354|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
154499355|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154499356|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154499357|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154499358|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499359|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499360|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
154499361|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499362|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499363|NCT03299036|Doxorubicin|doxorubicin|mesh-list
154499364|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154499365|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499366|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154499367|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154499368|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499369|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499370|NCT03290846|Secretin|secretin|mesh-list
154499371|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499372|NCT03290846|Hormones|hormones|mesh-ancestor
154499373|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499374|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499375|NCT03298958|Sirolimus|sirolimus|mesh-list
154499376|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154499377|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499378|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154499379|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499380|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
154499381|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154499382|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
154499383|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499384|NCT03290456|Prednisone|prednisone|mesh-list
154499385|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499386|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
154499387|NCT03290456|Hormones|hormones|mesh-ancestor
154499388|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499389|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499390|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499391|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499392|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
154499393|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154499394|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
154499395|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154499396|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
154499397|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499398|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499399|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
154499400|NCT03298646|Diclofenac|diclofenac|mesh-list
154499401|NCT03298646|Lidocaine|lidocaine|mesh-list
154499402|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
154499403|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
154499404|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499405|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499406|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
154499407|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499408|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154499409|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154499410|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154499411|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499412|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499413|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154499414|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154499415|NCT03298646|Analgesics|analgesics|mesh-ancestor
154499416|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499417|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154499418|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154499419|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499420|NCT05488990|Calcitriol|calcitriol|mesh-list
154499421|NCT05488990|Calcipotriene|calcipotriene|mesh-list
154499422|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
154499423|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154499424|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499425|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154499426|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499427|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499428|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154499429|NCT05488990|Vitamins|vitamins|mesh-ancestor
154499430|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
154499431|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154499432|NCT03289520|Clopidogrel|clopidogrel|mesh-list
154499433|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154499434|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154499435|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154499436|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154499437|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
154499438|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499439|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499440|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499441|NCT03293108|Vitamin D|vitamin d|mesh-list
154499442|NCT03293108|Denosumab|denosumab|mesh-list
154499443|NCT03293108|Calcium|calcium|mesh-list
154499444|NCT03293108|Vitamins|vitamins|mesh-ancestor
154499445|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
154499446|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499447|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154499448|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154499449|NCT03292796|Bimatoprost|bimatoprost|mesh-list
154499450|NCT03292796|Latanoprost|latanoprost|mesh-list
154499451|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154499452|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154499453|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154499454|NCT03288896|Ethanol|ethanol|mesh-list
154499455|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154499456|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499457|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499458|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499459|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
154499460|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
154499461|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499462|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154499463|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499464|NCT03288740|Semaglutide|semaglutide|mesh-list
154499465|NCT03288740|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154499466|NCT03288740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154499467|NCT03288740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499468|NCT03292172|Atezolizumab|atezolizumab|mesh-list
154499469|NCT03292172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154499470|NCT03292172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499471|NCT03292172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154499472|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499473|NCT02461004|Ezetimibe|ezetimibe|mesh-list
154499474|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154499475|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154499476|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
154499477|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499478|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154499479|NCT03288428|Morphine|morphine|mesh-list
154499480|NCT03288428|Nalbuphine|nalbuphine|mesh-list
154499482|NCT03288428|Narcotics|narcotics|mesh-ancestor
154499483|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499484|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499485|NCT03288428|Analgesics|analgesics|mesh-ancestor
154499486|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
154499487|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499488|NCT03288350|Avelumab|avelumab|mesh-list
154499489|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154499490|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499491|NCT00003224|Vaccines|vaccines|mesh-list
154499492|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
154499493|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
154499494|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499495|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154499496|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154499497|NCT03288038|Ezetimibe|ezetimibe|mesh-list
154499498|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154499499|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154499500|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
154499501|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499502|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154499503|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154499504|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499505|NCT03287882|Micronutrients|micronutrients|mesh-list
154499506|NCT03287882|Trace Elements|trace elements|mesh-list
154499507|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499508|NCT03291314|Avelumab|avelumab|mesh-list
154499509|NCT03291314|Axitinib|axitinib|mesh-list
154499510|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154499511|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499512|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154499513|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499514|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860775|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499515|NCT03283202|Prednisone|prednisone|mesh-list
154499516|NCT03283202|Prednisolone|prednisolone|mesh-list
154499517|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
154499518|NCT03283202|Rituximab|rituximab|mesh-list
154499519|NCT03283202|Vincristine|vincristine|mesh-list
154499520|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154499521|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
154499522|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499523|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154499524|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154499525|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
154499526|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499527|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499528|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154499529|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154499530|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499531|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
154499532|NCT03283202|Hormones|hormones|mesh-ancestor
154499533|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499534|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499535|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154499536|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
154499537|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
154499538|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
154499539|NCT03283046|Dexamethasone|dexamethasone|mesh-list
154499540|NCT03283046|Nivolumab|nivolumab|mesh-list
154499541|NCT03283046|Lenalidomide|lenalidomide|mesh-list
154499542|NCT03283046|Ipilimumab|ipilimumab|mesh-list
154499543|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499544|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
154499545|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
154499546|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499547|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499548|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499549|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
154499550|NCT03283046|Hormones|hormones|mesh-ancestor
154499551|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499552|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499553|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499554|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154499555|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154223401|NCT04624217|Paclitaxel|paclitaxel|mesh-list
154499556|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499558|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154499559|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154499560|NCT03283046|Growth Substances|growth substances|mesh-ancestor
154499561|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
154499562|NCT03287180|Buprenorphine|buprenorphine|mesh-list
154499563|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154499564|NCT03287180|Naloxone|naloxone|mesh-list
154499565|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154499566|NCT03287180|Narcotics|narcotics|mesh-ancestor
154499567|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499568|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499569|NCT03287180|Analgesics|analgesics|mesh-ancestor
154499570|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
154499571|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499572|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154499574|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499575|NCT03282188|Sargramostim|sargramostim|mesh-list
154499576|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
154499577|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499578|NCT03384212|Cytarabine|cytarabine|mesh-list
154499579|NCT03384212|Fludarabine|fludarabine|mesh-list
154499580|NCT03384212|Busulfan|busulfan|mesh-list
154499581|NCT03384212|Cladribine|cladribine|mesh-list
154499582|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499583|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154499584|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
154499585|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499586|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154499587|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
154499588|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499589|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
154499590|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499591|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
154499592|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154499593|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154499595|NCT02460068|Ipilimumab|ipilimumab|mesh-list
154499596|NCT02460068|Fotemustine|fotemustine|mesh-list
154499597|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154499598|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499599|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154499600|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499601|NCT03286244|Paclitaxel|paclitaxel|mesh-list
154499602|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154499603|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499604|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
154499605|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
154499606|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
154499607|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499608|NCT03282110|Citalopram|citalopram|mesh-list
154499609|NCT03282110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154499610|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154499611|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499612|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063332|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
154499613|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499614|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
154499615|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499616|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154499617|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
154499618|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154499619|NCT03269786|Bilirubin|bilirubin|mesh-list
154499620|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
154499621|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499622|NCT03269786|Protective Agents|protective agents|mesh-ancestor
154499623|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499624|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
154499625|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
154499626|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
154499627|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499628|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499629|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
154499630|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154499631|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154499632|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
154499633|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499634|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499635|NCT03269318|Theophylline|theophylline|mesh-list
154499636|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154499637|NCT03269318|Montelukast|montelukast|mesh-list
154499638|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154499639|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
154499640|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499641|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499642|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154499643|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
154499644|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154499645|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154499646|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154499647|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
154499648|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063333|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154499649|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499650|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154499651|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
154499652|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499653|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154499654|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154499655|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154499656|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499657|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
154499658|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154499659|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154499660|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
154499661|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
154499662|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154499663|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
154499664|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154499665|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
154499666|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499667|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499669|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154499670|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154499671|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154499672|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499673|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499674|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154499675|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499676|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499677|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
154499678|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499679|NCT03107858|Dopamine|dopamine|mesh-list
154499680|NCT03107858|Norepinephrine|norepinephrine|mesh-list
154499681|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154499682|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154499683|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
154499684|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499685|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499686|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499687|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
154499688|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
154499689|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499690|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154499691|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154499692|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
154499693|NCT03107858|Protective Agents|protective agents|mesh-ancestor
154499694|NCT03269162|Docetaxel|docetaxel|mesh-list
154499695|NCT03269162|Pemetrexed|pemetrexed|mesh-list
154499696|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499697|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
154499698|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
154499699|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
154499700|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499701|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499702|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154499703|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154499704|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
154499706|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154499707|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499708|NCT03284294|Vitamins|vitamins|mesh-ancestor
154499709|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
154499710|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154499711|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
154499712|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154499713|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499714|NCT03268226|Beclomethasone|beclomethasone|mesh-list
154499715|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
154499716|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
154499717|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154499718|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
154499719|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499720|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499721|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154499722|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
154499723|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154499724|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154499725|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154499726|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
154499727|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499728|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499729|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154499730|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154499731|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154499732|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
154499733|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499734|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
154499735|NCT03268226|Hormones|hormones|mesh-ancestor
154499736|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499737|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
154499738|NCT02737475|Nivolumab|nivolumab|mesh-list
154499739|NCT02737475|Ipilimumab|ipilimumab|mesh-list
154499741|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
154499742|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499743|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154499744|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154499745|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154499746|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
154499747|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499748|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499749|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154499750|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154499751|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154499752|NCT02457806|Phenylephrine|phenylephrine|mesh-list
154499753|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
154499754|NCT02457806|Tetracaine|tetracaine|mesh-list
154499755|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
154499756|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
154499757|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499758|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499759|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
154499760|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499761|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154499762|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154499763|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
154499764|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499765|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499766|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
154499767|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
154499768|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
154499769|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154499770|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
154499771|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154499772|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
154499773|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154499774|NCT02457806|Protective Agents|protective agents|mesh-ancestor
154499775|NCT02459756|Citric Acid|citric acid|mesh-list
154499776|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
154223627|NCT03456843|Androgens|androgens|mesh-list
154499777|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499778|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
154499779|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154499781|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
154499782|NCT02557672|Thrombin|thrombin|mesh-list
154499783|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
154499784|NCT02557672|Coagulants|coagulants|mesh-ancestor
154499785|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
154499786|NCT02458196|Prednisone|prednisone|mesh-list
154499787|NCT02458196|Prednisolone|prednisolone|mesh-list
154499788|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499789|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
154499790|NCT02458196|Hormones|hormones|mesh-ancestor
154499791|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499792|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499793|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499794|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499795|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154499796|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154499797|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
154499798|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154499799|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499800|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499801|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499802|NCT05207735|Capecitabine|capecitabine|mesh-list
154499803|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154499804|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
154499805|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499806|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499807|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
154499808|NCT03264638|Cyproterone|cyproterone|mesh-list
154499809|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
154499810|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
154499811|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
154499812|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499813|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127969|NCT00976755|Everolimus|everolimus|mesh-list
154860776|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154499814|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499815|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154499816|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
154499817|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154499818|NCT03264794|Gefitinib|gefitinib|mesh-list
154499819|NCT03264794|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154499820|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154499821|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499822|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499823|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499824|NCT02925923|Clopidogrel|clopidogrel|mesh-list
154499825|NCT02925923|Ticagrelor|ticagrelor|mesh-list
154499826|NCT02925923|Eptifibatide|eptifibatide|mesh-list
154499827|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154499828|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154499829|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154499830|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154499831|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
154499832|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499833|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499834|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499835|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154499836|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
154499837|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154499838|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154499839|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154499840|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499841|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499842|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
154499843|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499844|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499845|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154499846|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499847|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154499848|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154499849|NCT03280316|Urological Agents|urological agents|mesh-ancestor
154499850|NCT02410343|Hormones|hormones|mesh-list
154499851|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223701|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154499852|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499853|NCT05234840|Triamcinolone|triamcinolone|mesh-list
154499854|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499855|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
154499856|NCT05234840|Hormones|hormones|mesh-ancestor
154499857|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499858|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499859|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
154499860|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154499861|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154499862|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154499863|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154499864|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154499865|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499866|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499867|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499868|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154499869|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
154499870|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154499871|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499872|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154499873|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154499874|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154499875|NCT02459288|Clopidogrel|clopidogrel|mesh-list
154499876|NCT02459288|Ticagrelor|ticagrelor|mesh-list
154499877|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154499878|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154499879|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154499880|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154499881|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
154499882|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499883|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499884|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499885|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
154499886|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
154499887|NCT00734253|Vitamins|vitamins|mesh-ancestor
154499888|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
154499889|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499890|NCT00730665|Esomeprazole|esomeprazole|mesh-list
154499891|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154499892|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499893|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154499894|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499895|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499896|NCT00714597|Enoxaparin|enoxaparin|mesh-list
154499897|NCT00714597|Semuloparin|semuloparin|mesh-list
154499898|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
154499899|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
154499900|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154499901|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154063566|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
154499902|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499903|NCT03265886|Bupivacaine|bupivacaine|mesh-list
154499904|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
154499905|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
154499906|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499907|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499908|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
154499909|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499910|NCT00728091|Satavaptan|satavaptan|mesh-list
154499911|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154499912|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499913|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
154499914|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499915|NCT03275090|SMOFlipid|smoflipid|mesh-list
154499916|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154499917|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154499918|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154499919|NCT03382821|Dexamethasone|dexamethasone|mesh-list
154499920|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
154499921|NCT03382821|Triamcinolone|triamcinolone|mesh-list
154499922|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154499923|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154499924|NCT03382821|Lidocaine|lidocaine|mesh-list
154499925|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154499926|NCT03382821|BB 1101|bb 1101|mesh-list
154499927|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154499928|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499930|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
154499931|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499932|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499933|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499934|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
154499935|NCT03382821|Hormones|hormones|mesh-ancestor
154499936|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499937|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499938|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499939|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
154499940|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154499941|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499942|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
154499943|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
154499944|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154499945|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
154499946|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154499947|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154499948|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154499949|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154499950|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154499951|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
154499952|NCT03263624|Tazarotene|tazarotene|mesh-list
154499953|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
154499954|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
154499955|NCT00711555|Dexamethasone|dexamethasone|mesh-list
154499956|NCT00711555|Ondansetron|ondansetron|mesh-list
154499957|NCT00711555|Aprepitant|aprepitant|mesh-list
154499958|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499959|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
154499960|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
154499961|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499962|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499963|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499964|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
154499965|NCT00711555|Hormones|hormones|mesh-ancestor
154499966|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499967|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499968|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063608|NCT00822120|Vinblastine|vinblastine|mesh-list
154499969|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
154499970|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
154499971|NCT00711555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154499972|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154499973|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
154499974|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154499975|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154499976|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154499977|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
154499978|NCT02280993|Dexamethasone|dexamethasone|mesh-list
154499979|NCT02280993|Cisplatin|cisplatin|mesh-list
154499980|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154499981|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154499982|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154499983|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
154499984|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
154499985|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154499986|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154499987|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154499988|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
154499989|NCT02280993|Hormones|hormones|mesh-ancestor
154499990|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154499991|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154499992|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154499993|NCT02280993|Immunotoxins|immunotoxins|mesh-ancestor
154499994|NCT02280993|Immunoconjugates|immunoconjugates|mesh-ancestor
154499995|NCT02280993|Immunologic Factors|immunologic factors|mesh-ancestor
154499996|NCT05492968|Phenylephrine|phenylephrine|mesh-list
154499997|NCT05492968|Epinephrine|epinephrine|mesh-list
154499998|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
154499999|NCT05492968|Norepinephrine|norepinephrine|mesh-list
154500000|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154500001|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154500002|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
154500003|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500004|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500005|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500006|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154500007|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154500008|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
154500009|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500010|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154500011|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
154500012|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
154500013|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
154500014|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154500015|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154500016|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
154500017|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154500018|NCT05492968|Protective Agents|protective agents|mesh-ancestor
154500019|NCT02457026|Triamcinolone|triamcinolone|mesh-list
154500020|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154500021|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154500022|NCT02457026|Aflibercept|aflibercept|mesh-list
154500023|NCT02457026|Verteporfin|verteporfin|mesh-list
154500024|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154500025|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154500026|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
154500027|NCT02457026|Hormones|hormones|mesh-ancestor
154500028|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500029|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500030|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500031|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
154500032|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500033|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500034|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154500035|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154500036|NCT02457026|Growth Substances|growth substances|mesh-ancestor
154500037|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
154500038|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500039|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154500040|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
154500042|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
154500043|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
154500044|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
154500045|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500046|NCT05492812|Protective Agents|protective agents|mesh-ancestor
154500047|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500048|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500049|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
154500050|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
154500051|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154500052|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
154500053|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
154500054|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500055|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154500056|NCT02458118|Secretin|secretin|mesh-list
154500057|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154500058|NCT02458118|Hormones|hormones|mesh-ancestor
154500059|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500060|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500061|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
154500062|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154500063|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500064|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500065|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154500066|NCT05487742|Analgesics|analgesics|mesh-ancestor
154500067|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
154500068|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500069|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154500070|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154500071|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154500072|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
154500073|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500074|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500075|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
154500076|NCT02457650|Fludarabine|fludarabine|mesh-list
154500077|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500079|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500080|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500081|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154500082|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
154500083|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500084|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500085|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154500086|NCT02456948|Minocycline|minocycline|mesh-list
154500087|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154500088|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500089|NCT05487508|Dexamethasone|dexamethasone|mesh-list
154500090|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154500091|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
154500092|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
154500093|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500094|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500095|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154500096|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
154500097|NCT05487508|Hormones|hormones|mesh-ancestor
154500098|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500099|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154500100|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500101|NCT02713490|Bupivacaine|bupivacaine|mesh-list
154500102|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500103|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
154500104|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500105|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500106|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
154500107|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500108|NCT05387954|Anticoagulants|anticoagulants|mesh-list
154500109|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
154500110|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
154500111|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154500112|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
154500113|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500114|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500115|NCT03262688|Bupivacaine|bupivacaine|mesh-list
154500116|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500117|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
154500118|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500119|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500120|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
154500121|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500122|NCT05486884|Benzocaine|benzocaine|mesh-list
154500123|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500124|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
154500125|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500126|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500127|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
154500128|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500129|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154500130|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154500131|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500132|NCT05485402|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154500133|NCT05485402|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
154500134|NCT05485402|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
154500135|NCT05485402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500136|NCT05485402|Antioxidants|antioxidants|mesh-ancestor
154500137|NCT05485402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500138|NCT05485402|Protective Agents|protective agents|mesh-ancestor
154500139|NCT05485402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500140|NCT05485402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154500141|NCT05485402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154500142|NCT05485402|Disinfectants|disinfectants|mesh-ancestor
154500143|NCT05485402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154500144|NCT03797924|Ropivacaine|ropivacaine|mesh-list
154500145|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500146|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
154500147|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063809|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154500148|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500149|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
154500150|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500151|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
154500152|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154500153|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500154|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154500155|NCT02458742|Morphine|morphine|mesh-list
154500156|NCT02458742|Bupivacaine|bupivacaine|mesh-list
154500157|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500158|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
154500159|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500160|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500161|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
154500162|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500163|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154500164|NCT02458742|Narcotics|narcotics|mesh-ancestor
154500165|NCT02458742|Analgesics|analgesics|mesh-ancestor
154500166|NCT02403310|Cytarabine|cytarabine|mesh-list
154500167|NCT02403310|Daunorubicin|daunorubicin|mesh-list
154500168|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154500169|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
154500170|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500171|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500172|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
154500173|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500174|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500175|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
154500176|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500177|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154500178|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154500179|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154500180|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500181|NCT01665274|Capecitabine|capecitabine|mesh-list
154500182|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
154500183|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154500184|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
154500185|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500186|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500187|NCT05387876|Vitamin D|vitamin d|mesh-list
154500188|NCT05387876|Vitamins|vitamins|mesh-ancestor
154500189|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
154500190|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063847|NCT02813824|Analgesics|analgesics|mesh-ancestor
154500191|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154500192|NCT03262376|Vitamins|vitamins|mesh-list
154500193|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
154500194|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500195|NCT02456714|Folfirinox|folfirinox|mesh-list
154500196|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500197|NCT03258866|Rituximab|rituximab|mesh-list
154500198|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154500199|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500200|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
154500201|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500202|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500203|NCT03258476|Guanfacine|guanfacine|mesh-list
154500204|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154500205|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154500206|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154500207|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154500208|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
154500209|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500210|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500211|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500212|NCT03258398|Avelumab|avelumab|mesh-list
154500213|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154500214|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500215|NCT03261596|Mebendazole|mebendazole|mesh-list
154500216|NCT03261596|Piperazine|piperazine|mesh-list
154500217|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
154500218|NCT03261596|DMP 777|dmp 777|mesh-list
154500219|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
154500220|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
154500221|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154500222|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500223|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
154500224|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
154500225|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
154500226|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500227|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500228|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500229|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154500230|NCT03825874|Amikacin|amikacin|mesh-list
154500231|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500232|NCT03772574|Nicotine|nicotine|mesh-list
154500233|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154500234|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
154500235|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500236|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500237|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154500238|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154500239|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
154500240|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500241|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500242|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154500243|NCT02456558|Deferiprone|deferiprone|mesh-list
154500244|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154500245|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
154500246|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
154500247|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500248|NCT03798080|Insulin|insulin|mesh-list
154500249|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154500250|NCT03798080|Metformin|metformin|mesh-list
154500251|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
154500252|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154500253|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500254|NCT03257930|Ethanol|ethanol|mesh-list
154500255|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154500256|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500257|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500258|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500259|NCT03257852|Methotrexate|methotrexate|mesh-list
154500260|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154500261|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
154500262|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154500263|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500264|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154500265|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
154860777|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154860778|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
154500266|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500267|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500268|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154500269|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500270|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154500271|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500272|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
154500273|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500274|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154500275|NCT05498896|Paclitaxel|paclitaxel|mesh-list
154500276|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
154500277|NCT05498896|Doxorubicin|doxorubicin|mesh-list
154500278|NCT05498896|Atezolizumab|atezolizumab|mesh-list
154500279|NCT05498896|Ipatasertib|ipatasertib|mesh-list
154500280|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154500281|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500282|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
154500283|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
154500284|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
154500285|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500286|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500287|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
154500288|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500289|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500290|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154500291|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
154500292|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154500293|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154500294|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154500295|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154500296|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500297|NCT05498896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154500298|NCT05498896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154500299|NCT05498896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154500300|NCT02743221|Trifluridine|trifluridine|mesh-list
154500301|NCT02743221|Bevacizumab|bevacizumab|mesh-list
154500302|NCT02743221|Capecitabine|capecitabine|mesh-list
154500303|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154500304|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500305|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154500306|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154500308|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500309|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
154500310|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154500311|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
154500312|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500313|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
154500314|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500315|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
154500316|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500317|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
154500318|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500319|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500320|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
154500321|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500322|NCT03370263|Belimumab|belimumab|mesh-list
154500323|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500324|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
154500325|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500326|NCT00692445|Mecamylamine|mecamylamine|mesh-list
154500327|NCT00692445|Dexetimide|dexetimide|mesh-list
154500328|NCT00692445|Citalopram|citalopram|mesh-list
154500329|NCT00692445|Escitalopram|escitalopram|mesh-list
154500330|NCT00692445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154500331|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154500332|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500333|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500334|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500335|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
154500336|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500337|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154500338|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
154500339|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154500340|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154500341|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154500342|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
154500343|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
154500344|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500345|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154500346|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154500347|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
154500348|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154500349|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154500350|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154500351|NCT03256292|Testosterone|testosterone|mesh-list
154500352|NCT03256292|Androgens|androgens|mesh-ancestor
154500353|NCT03256292|Hormones|hormones|mesh-ancestor
154500354|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500355|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500356|NCT04473261|Iodine|iodine|mesh-list
154500357|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
154500358|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154500359|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500360|NCT04473261|Trace Elements|trace elements|mesh-ancestor
154500361|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
154500362|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500363|NCT01358968|Gemcitabine|gemcitabine|mesh-list
154500364|NCT01358968|Pemetrexed|pemetrexed|mesh-list
154500365|NCT01358968|Desipramine|desipramine|mesh-list
154500366|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154500367|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
154500368|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500369|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500370|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500371|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154500372|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154500373|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154500374|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
154500375|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154500376|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154500377|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154500378|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500379|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
154224217|NCT00281840|Bevacizumab|bevacizumab|mesh-list
154500380|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500381|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500383|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
154500384|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500385|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
154500386|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
154500387|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
154500388|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500389|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500390|NCT00624351|Epratuzumab|epratuzumab|mesh-list
154500391|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154500392|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500393|NCT03251690|Tenofovir|tenofovir|mesh-list
154500394|NCT03251690|Emtricitabine|emtricitabine|mesh-list
154500395|NCT03251690|Efavirenz|efavirenz|mesh-list
154500396|NCT03251690|Rilpivirine|rilpivirine|mesh-list
154500397|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
154500398|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500399|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154500400|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154500401|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500402|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500403|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154500404|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154500405|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154500406|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154500407|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154500408|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154064060|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
154500409|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154500410|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154500411|NCT03251768|Lenograstim|lenograstim|mesh-list
154500412|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154500413|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
154500414|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500415|NCT00687687|Paclitaxel|paclitaxel|mesh-list
154500416|NCT00687687|Carboplatin|carboplatin|mesh-list
154500417|NCT00687687|Iniparib|iniparib|mesh-list
154500418|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154500419|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500420|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
154500421|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
154500422|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
154500423|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500424|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154500425|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500426|NCT00701090|Metformin|metformin|mesh-list
154500427|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154500428|NCT00701090|Glimepiride|glimepiride|mesh-list
154500429|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154500430|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500431|NCT00701090|Incretins|incretins|mesh-ancestor
154500432|NCT00701090|Hormones|hormones|mesh-ancestor
154500433|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500434|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154500435|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
154500436|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500437|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500438|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154500439|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500440|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
154500441|NCT00614601|Vaccines|vaccines|mesh-list
154500442|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
154500443|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500444|NCT02283489|Paclitaxel|paclitaxel|mesh-list
154500445|NCT02283489|Endostatins|endostatins|mesh-list
154500446|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154500447|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500448|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154500449|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154500450|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154500451|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500452|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154500453|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154500454|NCT02283489|Growth Substances|growth substances|mesh-ancestor
154500455|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500456|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
154500457|NCT02455232|Lidocaine|lidocaine|mesh-list
154500458|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500459|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
154500460|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500461|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500462|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
154500463|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500464|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154500465|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154500466|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154500467|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500468|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500469|NCT03259958|Donepezil|donepezil|mesh-list
154500470|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154500471|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500472|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500473|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
154500474|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500475|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500476|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
154500477|NCT00679731|Methotrexate|methotrexate|mesh-list
154500478|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154500479|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
154500480|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154500481|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500482|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154500483|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
154500484|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500485|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500486|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
154500487|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500488|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154500489|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500490|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
154500491|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500492|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154500493|NCT02455856|Itraconazole|itraconazole|mesh-list
154500494|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
154500495|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500496|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154500497|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154500498|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500499|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500500|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154500501|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
154500502|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500503|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500504|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154500505|NCT02283645|Minoxidil|minoxidil|mesh-list
154500506|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154500507|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
154500508|NCT00602745|Fluorouracil|fluorouracil|mesh-list
154500509|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
154500510|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500511|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154500512|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500513|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500514|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
154500515|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500516|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
154500517|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154500518|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500519|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500520|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154500521|NCT03251222|Analgesics|analgesics|mesh-ancestor
154500522|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
154500523|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500524|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154500525|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154500526|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154500527|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
154500528|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500529|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500531|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
154500532|NCT03250910|Velpatasvir|velpatasvir|mesh-list
154500533|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154500534|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
154500535|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500536|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
154500537|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500538|NCT02283801|Lamotrigine|lamotrigine|mesh-list
154500539|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154500540|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
154500541|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154500542|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500543|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500544|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154500545|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500546|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154500547|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154500548|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500549|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154500550|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154500551|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154500552|NCT02455154|Letrozole|letrozole|mesh-list
154500553|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500554|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154500555|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154500556|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500557|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500558|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154500559|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
154500560|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500561|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500562|NCT03254810|Adalimumab|adalimumab|mesh-list
154500563|NCT03254810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154500565|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500566|NCT03255044|Atorvastatin|atorvastatin|mesh-list
154500567|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154500568|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154500569|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154500570|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
154500571|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500572|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154500573|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154500574|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500575|NCT00677079|Iniparib|iniparib|mesh-list
154500576|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154500577|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500578|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500579|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500580|NCT03245996|Atenolol|atenolol|mesh-list
154500581|NCT03245996|Nebivolol|nebivolol|mesh-list
154500582|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154500583|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154500584|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
154500585|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
154500586|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500587|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500588|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154500589|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154500590|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154500591|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154500592|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500593|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500594|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
154500595|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154500596|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154500597|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154500598|NCT02281929|Amoxicillin|amoxicillin|mesh-list
154500599|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
154500600|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
154500601|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154500602|NCT02281929|Prednisolone|prednisolone|mesh-list
154500603|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154500604|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500605|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154500606|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
154500607|NCT02281929|Hormones|hormones|mesh-ancestor
154064282|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154064303|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500608|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500609|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500610|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154500611|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500612|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500613|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500614|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154500615|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154500616|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500617|NCT05478772|Fluconazole|fluconazole|mesh-list
154500618|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
154500619|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500620|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154500621|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154500622|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500623|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500624|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154500625|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
154500626|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500627|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500628|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154500629|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154500630|NCT02945852|Apatinib|apatinib|mesh-list
154500631|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500632|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154500633|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500634|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500635|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
154500636|NCT03245528|Giapreza|giapreza|mesh-list
154500637|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154500638|NCT00495885|Volinanserin|volinanserin|mesh-list
154500639|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154500640|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
154500641|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500642|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500643|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500644|NCT03254186|Propranolol|propranolol|mesh-list
154500645|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154500646|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154500647|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
154500648|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500649|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500650|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500651|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154500652|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154500653|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
154500654|NCT03250598|Mitapivat|mitapivat|mesh-list
154500655|NCT03250598|Enzyme Activators|enzyme activators|mesh-ancestor
154500656|NCT03250598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500657|NCT02282085|Olanzapine|olanzapine|mesh-list
154500658|NCT02282085|Risperidone|risperidone|mesh-list
154500659|NCT02282085|Aripiprazole|aripiprazole|mesh-list
154500660|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154500661|NCT02282085|Ziprasidone|ziprasidone|mesh-list
154500662|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
154500663|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154500664|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154500665|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
154500666|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500667|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500668|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500669|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154500670|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500671|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154500672|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154500673|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
154500674|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
154500675|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
154500676|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500677|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154500678|NCT02282085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154500679|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154500680|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500681|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
154500682|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
154064317|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154500683|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154500684|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154500685|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154500686|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154500687|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154500688|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154500689|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154500690|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
154500691|NCT03244592|Minocycline|minocycline|mesh-list
154500692|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154500693|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500694|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
154500695|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154500696|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
154500697|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500698|NCT03253328|Expectorants|expectorants|mesh-ancestor
154500699|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
154500700|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154500701|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
154500702|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500703|NCT03253328|Protective Agents|protective agents|mesh-ancestor
154500704|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500705|NCT03253328|Antidotes|antidotes|mesh-ancestor
154500707|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154500708|NCT03253250|Entecavir|entecavir|mesh-list
154500709|NCT03253250|Adefovir|adefovir|mesh-list
154500710|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
154500711|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500713|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154500714|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500715|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500716|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154500717|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154500718|NCT03253562|Metformin|metformin|mesh-list
154500719|NCT03253562|Vildagliptin|vildagliptin|mesh-list
154500720|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154500721|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500722|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154500723|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
154500724|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500725|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500726|NCT03250052|Linagliptin|linagliptin|mesh-list
154500727|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154500728|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500729|NCT03250052|Incretins|incretins|mesh-ancestor
154500730|NCT03250052|Hormones|hormones|mesh-ancestor
154500731|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500732|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154500733|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
154500734|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500735|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500736|NCT05478382|Pregabalin|pregabalin|mesh-list
154500737|NCT05478382|Analgesics|analgesics|mesh-ancestor
154500738|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
154500739|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500740|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500741|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
154500742|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154500743|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500744|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500745|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154500746|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154500747|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154500748|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500749|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154500750|NCT03244358|Epalrestat|epalrestat|mesh-list
154500751|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500752|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500753|NCT03249740|Sunitinib|sunitinib|mesh-list
154500754|NCT03249740|Aflibercept|aflibercept|mesh-list
154500755|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500756|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154500757|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154500758|NCT03249740|Growth Substances|growth substances|mesh-ancestor
154500759|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500760|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
154500761|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154500762|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500763|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500764|NCT03057977|Empagliflozin|empagliflozin|mesh-list
154500765|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154500766|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500767|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154500768|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500769|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
154500770|NCT03249506|Empagliflozin|empagliflozin|mesh-list
154500771|NCT03249506|Canagliflozin|canagliflozin|mesh-list
154500772|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154500773|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154500774|NCT03249506|Glucagon|glucagon|mesh-list
154500775|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154500776|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154500777|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500778|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154500779|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500780|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154500781|NCT03249506|Hormones|hormones|mesh-ancestor
154500782|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500783|NCT03249506|Incretins|incretins|mesh-ancestor
154500784|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
154500785|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500786|NCT03249662|Bupivacaine|bupivacaine|mesh-list
154500787|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500788|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
154500789|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500790|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500791|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
154500792|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500793|NCT03249428|Nicotine|nicotine|mesh-list
154500794|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154500795|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
154500796|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500797|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500798|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154500799|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154500800|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
154500801|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500802|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500803|NCT03243500|Lidocaine|lidocaine|mesh-list
154500804|NCT03243500|Bupivacaine|bupivacaine|mesh-list
154500805|NCT03243500|Atracurium|atracurium|mesh-list
154500806|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
154500807|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
154500808|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500809|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500810|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
154500811|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500812|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154500813|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154500814|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154500815|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500816|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500817|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154500818|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154500819|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154224662|NCT06185127|Midazolam|midazolam|mesh-list
154500820|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154500821|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154500822|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
154500823|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500824|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
154500825|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154500826|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154500827|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154500828|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500829|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500830|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
154500831|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500832|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500833|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154500834|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500835|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154500836|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154500837|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
154500838|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500839|NCT04486508|Heparin|heparin|mesh-list
154500840|NCT04486508|Calcium heparin|calcium heparin|mesh-list
154500841|NCT04486508|Enoxaparin|enoxaparin|mesh-list
154500842|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
154500843|NCT04486508|Atorvastatin|atorvastatin|mesh-list
154500844|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154500845|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154500846|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154500847|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
154500848|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500849|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154500850|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500851|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
154500852|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154500853|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154500854|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
154500855|NCT02552212|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154500856|NCT02552212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154500857|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154500859|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500860|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500861|NCT02454764|Interferons|interferons|mesh-list
154500862|NCT02454764|Tenofovir|tenofovir|mesh-list
154500863|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
154500864|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
154500865|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500866|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
154500867|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500868|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154500869|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154500870|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500871|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500872|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154500873|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154500874|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
154500875|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500876|NCT00685919|Carbidopa|carbidopa|mesh-list
154500877|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154500878|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154500879|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
154500880|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500881|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500882|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500883|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154500884|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500885|NCT03243344|Surgiflo|surgiflo|mesh-list
154224738|NCT06162819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224739|NCT06162819|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154224740|NCT06162819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154224741|NCT06162819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154224742|NCT06162819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224743|NCT06162819|Adrenergic Agents|adrenergic agents|mesh-ancestor
154224744|NCT06162819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224745|NCT06162819|Anticonvulsants|anticonvulsants|mesh-ancestor
154500886|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
154500887|NCT03243344|Coagulants|coagulants|mesh-ancestor
154500888|NCT03243032|Ibuprofen|ibuprofen|mesh-list
154500889|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154500890|NCT03243032|Anesthetics|anesthetics|mesh-list
154500891|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
154500892|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500893|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500894|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154500895|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154500896|NCT03243032|Analgesics|analgesics|mesh-ancestor
154500897|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
154500898|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500899|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500900|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154500901|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500902|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500903|NCT03249038|Chrysarobin|chrysarobin|mesh-list
154500904|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154500905|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154500906|NCT03249038|Analgesics|analgesics|mesh-ancestor
154500907|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
154500908|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500909|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500910|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154500911|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500912|NCT03061331|Ivacaftor|ivacaftor|mesh-list
154500913|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154500914|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154500915|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500916|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154500917|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154500918|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500919|NCT05213585|Ivermectin|ivermectin|mesh-list
154500920|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154500921|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154500922|NCT05482282|Vaccines|vaccines|mesh-list
154500923|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
154500924|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500925|NCT05209529|Durvalumab|durvalumab|mesh-list
154500926|NCT05209529|Olaparib|olaparib|mesh-list
154500927|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154500928|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500929|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154500930|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500931|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500932|NCT04424134|Spironolactone|spironolactone|mesh-list
154500933|NCT04424134|Bromhexine|bromhexine|mesh-list
154500934|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154500935|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
154500936|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154500937|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500938|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154500939|NCT04424134|Diuretics|diuretics|mesh-ancestor
154500940|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
154500941|NCT04424134|Expectorants|expectorants|mesh-ancestor
154500942|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
154500943|NCT04486430|Salicylates|salicylates|mesh-list
154500944|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154500945|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154500946|NCT04486430|Analgesics|analgesics|mesh-ancestor
154500947|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
154500948|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500949|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500950|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154500951|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154500952|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154500953|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500954|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500955|NCT03248726|Bisacodyl|bisacodyl|mesh-list
154500956|NCT03248726|Cathartics|cathartics|mesh-ancestor
154500957|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154500958|NCT03248726|Laxatives|laxatives|mesh-ancestor
154500959|NCT05208827|Vitamin D|vitamin d|mesh-list
154500960|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
154500961|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
154500962|NCT05208827|Vitamins|vitamins|mesh-list
154500963|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
154500964|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500965|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154500966|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154500967|NCT04947059|Gemcitabine|gemcitabine|mesh-list
154500968|NCT04947059|Epirubicin|epirubicin|mesh-list
154500969|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154500970|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
154500971|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500972|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500973|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154500974|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154500975|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154500976|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500977|NCT03248648|Ketamine|ketamine|mesh-list
154500978|NCT03248648|Neostigmine|neostigmine|mesh-list
154500979|NCT03248648|Analgesics|analgesics|mesh-ancestor
154500980|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
154500981|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154500982|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154500983|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154500984|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154500985|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
154500986|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
154500987|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154500988|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154500989|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154500990|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154500991|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154500992|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154500993|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154500994|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
154500995|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154500996|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
154500997|NCT03241784|Interleukin-2|interleukin-2|mesh-list
154500998|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154500999|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154501001|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
154501002|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154501003|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501004|NCT03242096|Sirolimus|sirolimus|mesh-list
154501005|NCT03242096|Paclitaxel|paclitaxel|mesh-list
154501006|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154501007|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501008|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
154501009|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
154501010|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
154501011|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501012|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501013|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501014|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154501015|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
154501016|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154501017|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
154501018|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501019|NCT03241472|Letrozole|letrozole|mesh-list
154501020|NCT03241472|Clomiphene|clomiphene|mesh-list
154501021|NCT03241472|Enclomiphene|enclomiphene|mesh-list
154501022|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
154501023|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501024|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154501025|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154501026|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154501027|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501028|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154501029|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
154501030|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154501031|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501032|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154501033|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
154501034|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154501035|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154501036|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154501037|NCT04313075|Leronlimab|leronlimab|mesh-list
154501038|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154501039|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154501040|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501041|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154501042|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154501043|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
154501044|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501045|NCT03237416|Midazolam|midazolam|mesh-list
154501046|NCT03237416|Dabigatran|dabigatran|mesh-list
154501047|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154501048|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154501049|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501050|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501051|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154501052|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154501053|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154501054|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154501055|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
154501056|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
154501057|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
154501058|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
154501059|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501060|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501061|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
154501062|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154501063|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
154501064|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501065|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
154501066|NCT05211011|Fosfomycin|fosfomycin|mesh-list
154501067|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501068|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501069|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
154501070|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154501071|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154501072|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501073|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
154501074|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501080|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
154501081|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501082|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154501083|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154501084|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501085|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154501086|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154501087|NCT04094519|Protective Agents|protective agents|mesh-ancestor
154501088|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501090|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
154501091|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154501092|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501093|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501094|NCT03107702|Melatonin|melatonin|mesh-list
154501095|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
154501096|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154501097|NCT03107702|Protective Agents|protective agents|mesh-ancestor
154501098|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154501099|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154501100|NCT02554318|Rifampin|rifampin|mesh-list
154501101|NCT02554318|Isoniazid|isoniazid|mesh-list
154501102|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
154501103|NCT02554318|Ethambutol|ethambutol|mesh-list
154501104|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154501105|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
154501106|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154501107|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154501108|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
154501109|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154501110|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154501111|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224960|NCT05125185|Insulin|insulin|mesh-list
154255530|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154255532|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153571458|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571459|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571460|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153571461|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153571462|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
153571463|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571464|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153571465|NCT04133922|Insulin|insulin|mesh-list
154255533|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255534|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579876|NCT01742676|Tacrolimus|tacrolimus|mesh-list
153580339|NCT01745081|Mannitol|mannitol|mesh-list
154255535|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580985|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
153581149|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
153581334|NCT06176157|Vitamins|vitamins|mesh-list
154255536|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582173|NCT04181749|Analgesics|analgesics|mesh-ancestor
153582256|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
153582574|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
154255537|NCT00314249|Analgesics|analgesics|mesh-ancestor
154860779|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860780|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582847|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582935|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154860781|NCT02129751|Bupropion|bupropion|mesh-list
154860782|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154860783|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
154860784|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154860785|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153585144|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
153585329|NCT01766089|Analgesics|analgesics|mesh-ancestor
153462742|NCT04129788|Bisacodyl|bisacodyl|mesh-list
153586164|NCT01770301|Paclitaxel|paclitaxel|mesh-list
153463851|NCT05585736|Mydriatics|mydriatics|mesh-list
153587184|NCT01779362|Liraglutide|liraglutide|mesh-list
153587639|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
154255544|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153589121|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255545|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153589560|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153589675|NCT01807910|Choline|choline|mesh-list
153589879|NCT01809743|Adenosine|adenosine|mesh-list
154255546|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590165|NCT01811810|Androgens|androgens|mesh-list
153360121|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154255547|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255548|NCT03905018|Urological Agents|urological agents|mesh-ancestor
154255549|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
154255550|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154255551|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255553|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
153599128|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154255554|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154255555|NCT03894800|Narcotics|narcotics|mesh-ancestor
154255556|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255557|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255558|NCT03894800|Analgesics|analgesics|mesh-ancestor
154255559|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
154255560|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255561|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154255562|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154255563|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
153599552|NCT01876290|Dexamethasone|dexamethasone|mesh-list
154255564|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
153469504|NCT04924075|Belzutifan|belzutifan|mesh-list
154255565|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154255567|NCT03900026|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154255568|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153600017|NCT01880125|Narcotics|narcotics|mesh-ancestor
154255569|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153600282|NCT01882530|Ketoprofen|ketoprofen|mesh-list
153600618|NCT01885338|Expectorants|expectorants|mesh-ancestor
153600794|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
154255570|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
153731560|NCT00138554|Vildagliptin|vildagliptin|mesh-list
153731561|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153601936|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602041|NCT01902160|Immunotoxins|immunotoxins|mesh-ancestor
153602231|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
153602628|NCT01906216|Sorafenib|sorafenib|mesh-list
153602709|NCT01906879|Bismuth|bismuth|mesh-list
153602920|NCT01907997|Lidocaine|lidocaine|mesh-list
153603790|NCT01913964|Vitamins|vitamins|mesh-ancestor
153603908|NCT01914627|Analgesics|analgesics|mesh-ancestor
153604172|NCT01916382|Nitisinone|nitisinone|mesh-list
153474353|NCT00666978|Bupropion|bupropion|mesh-list
153605166|NCT01930877|Lidocaine|lidocaine|mesh-list
153605252|NCT01931332|Analgesics|analgesics|mesh-ancestor
153475765|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
153605714|NCT01934634|Gemcitabine|gemcitabine|mesh-list
153605795|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153476293|NCT00916032|Factor VIII|factor viii|mesh-list
153605889|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
153605989|NCT01935869|Petrolatum|petrolatum|mesh-list
153606164|NCT06070766|Anesthetics|anesthetics|mesh-ancestor
153606397|NCT05741502|Olanzapine|olanzapine|mesh-list
154255577|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154255578|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255579|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255580|NCT01149746|Tamsulosin|tamsulosin|mesh-list
154255581|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154255582|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154255583|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154255584|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
154255585|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255586|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255587|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255588|NCT01149746|Urological Agents|urological agents|mesh-ancestor
154255589|NCT01149824|Salvinorin A|salvinorin a|mesh-list
154255590|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
154255591|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606848|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
153606971|NCT04386317|Terazosin|terazosin|mesh-list
154255592|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153607843|NCT01937338|AZD7624|azd7624|mesh-list
153608005|NCT01938235|Exenatide|exenatide|mesh-list
153478601|NCT01146600|Clarithromycin|clarithromycin|mesh-list
153608356|NCT01940224|Pregabalin|pregabalin|mesh-list
154255595|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154255596|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
153479349|NCT01291056|Clomiphene|clomiphene|mesh-list
154255597|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609093|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
154255598|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153609318|NCT04487990|Heparin|heparin|mesh-list
154255599|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154255600|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
154255601|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610819|NCT01949571|Mirtazapine|mirtazapine|mesh-list
154255602|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255603|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154255604|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
153611861|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
154255605|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612413|NCT01954043|Dabrafenib|dabrafenib|mesh-list
154255606|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612870|NCT01957007|Docetaxel|docetaxel|mesh-list
153612962|NCT01957631|Hormones|hormones|mesh-ancestor
153613054|NCT01958866|Acetaminophen|acetaminophen|mesh-list
153483964|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
154255607|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
154255609|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
153613985|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
153615138|NCT01973114|Latanoprost|latanoprost|mesh-list
154255610|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154255611|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
154255612|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
154255613|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731567|NCT00138593|Vildagliptin|vildagliptin|mesh-list
153486370|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
153486717|NCT01844388|Laxatives|laxatives|mesh-ancestor
153616035|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153616036|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616037|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153616038|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153616039|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153616073|NCT06329258|Glucocorticoids|glucocorticoids|mesh-ancestor
153616364|NCT06327399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153616365|NCT06327386|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153616366|NCT06327386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153616367|NCT06327386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616368|NCT06327321|Deucravacitinib|deucravacitinib|mesh-list
153617415|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
153617416|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617460|NCT05334472|Ofatumumab|ofatumumab|mesh-list
153617461|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617486|NCT05197192|Venetoclax|venetoclax|mesh-list
153617487|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
153617488|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
153617489|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617490|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617491|NCT05197192|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153617492|NCT05197192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617493|NCT05197192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617494|NCT05197192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617530|NCT05172258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154064917|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617531|NCT05172258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617532|NCT05172258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617533|NCT05172258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617534|NCT05171387|Androgens|androgens|mesh-list
154255614|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617822|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153617920|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617921|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617923|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
153617924|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255615|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618237|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618238|NCT03735121|Atezolizumab|atezolizumab|mesh-list
153618239|NCT03735121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618240|NCT03735121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618241|NCT03735121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618242|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255617|NCT01149980|Citalopram|citalopram|mesh-list
153488460|NCT02239770|Nicotine|nicotine|mesh-list
154255619|NCT01149980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154255620|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154255621|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255622|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255623|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255625|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255626|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154255628|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154255629|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154255630|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154255631|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
154255632|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
154255633|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255634|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154255635|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154255636|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
154255637|NCT01258322|Pioglitazone|pioglitazone|mesh-list
154255638|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154255639|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255640|NCT01255358|Dexamethasone|dexamethasone|mesh-list
154255641|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
154860786|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154255642|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154255644|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860787|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860788|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860789|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
154860790|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860791|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860792|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154255653|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154255655|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
154255656|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255657|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255658|NCT03899246|Capsaicin|capsaicin|mesh-list
154255659|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
154064978|NCT00657059|Prednisone|prednisone|mesh-list
154255660|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
154255661|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
154255662|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255663|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255664|NCT03893864|Ubiquinone|ubiquinone|mesh-list
154255665|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
154255666|NCT03893864|Antioxidants|antioxidants|mesh-list
153731587|NCT00160875|Irinotecan|irinotecan|mesh-list
154255667|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255668|NCT03893864|Protective Agents|protective agents|mesh-ancestor
154255669|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255670|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
154255672|NCT03899324|Bumetanide|bumetanide|mesh-list
154255673|NCT03899324|Diuretics|diuretics|mesh-ancestor
154255674|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
154255675|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255676|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154255677|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255678|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255679|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154255680|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154255681|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
154255682|NCT01258634|Leucovorin|leucovorin|mesh-list
154255683|NCT01258634|Doxorubicin|doxorubicin|mesh-list
154255684|NCT01258634|Etoposide|etoposide|mesh-list
154255685|NCT01258634|Ifosfamide|ifosfamide|mesh-list
154255686|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
154255687|NCT01258634|Razoxane|razoxane|mesh-list
154255688|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255689|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154255690|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154255691|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154255692|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065044|NCT00681785|Dalteparin|dalteparin|mesh-list
154255693|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255694|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154255695|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255696|NCT01258634|Antidotes|antidotes|mesh-ancestor
154255697|NCT01258634|Protective Agents|protective agents|mesh-ancestor
154255698|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
154255699|NCT01258634|Vitamins|vitamins|mesh-ancestor
154255700|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
154255701|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154255702|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
154255703|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154255704|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
154255705|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
154255706|NCT01258712|Methotrexate|methotrexate|mesh-list
154255707|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154255708|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
154255709|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154255710|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255711|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154255712|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
154255720|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255721|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154255722|NCT01258868|Celecoxib|celecoxib|mesh-list
154255723|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154255724|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154255725|NCT01258868|Analgesics|analgesics|mesh-ancestor
153731637|NCT00138944|Eplerenone|eplerenone|mesh-list
154255726|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
154255727|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255728|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255729|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154255730|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255732|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154255733|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255734|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255736|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
154255737|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255738|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154255740|NCT01254578|Growth Substances|growth substances|mesh-ancestor
154255741|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
153489165|NCT04143204|Insulin|insulin|mesh-list
153489391|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
153489561|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
153490523|NCT05730738|4-Aminopyridine|4-aminopyridine|mesh-list
154255742|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255744|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153490817|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
154255745|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255747|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255750|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154255751|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153492004|NCT05032183|Antidotes|antidotes|mesh-ancestor
153492088|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
153492089|NCT04677049|Vitamins|vitamins|mesh-ancestor
153492090|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
153492091|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492092|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
153492093|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153492094|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
154255752|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255753|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
154065069|NCT00777166|Oxytocin|oxytocin|mesh-list
154255754|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255755|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255756|NCT01149122|Gemcitabine|gemcitabine|mesh-list
154255757|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
154255758|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154255764|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492251|NCT03776487|Nivolumab|nivolumab|mesh-list
153493427|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
153493513|NCT01463670|Lenalidomide|lenalidomide|mesh-list
153493662|NCT03315780|Dulaglutide|dulaglutide|mesh-list
153493736|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493738|NCT03395886|Analgesics|analgesics|mesh-ancestor
153494043|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
153494119|NCT03933618|Clomiphene|clomiphene|mesh-list
154255865|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154255866|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494897|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
154255867|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154255868|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
154255869|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153495538|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
154255870|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154255871|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154255872|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153496116|NCT00002040|Fluconazole|fluconazole|mesh-list
154255873|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153496190|NCT00002094|Atevirdine|atevirdine|mesh-list
154255874|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
154255875|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153496484|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
154255876|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496568|NCT00002340|Atovaquone|atovaquone|mesh-list
154255766|NCT01152398|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154255767|NCT01152398|Antiviral Agents|antiviral agents|mesh-ancestor
154255768|NCT01152398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255769|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154255770|NCT03892148|Furosemide|furosemide|mesh-list
153731643|NCT00138944|Diuretics|diuretics|mesh-ancestor
154255771|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153731645|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154255773|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
154255774|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255775|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154255776|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255777|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255778|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154255779|NCT01152476|Remifentanil|remifentanil|mesh-list
154255780|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154255781|NCT01152476|Narcotics|narcotics|mesh-ancestor
154255782|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255783|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497513|NCT00002772|Tamoxifen|tamoxifen|mesh-list
154255785|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
153731657|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154255786|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255788|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154255789|NCT03892070|Diuretics|diuretics|mesh-ancestor
154255790|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
154255791|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255792|NCT01155440|Lidocaine|lidocaine|mesh-list
153731662|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
154255794|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
153731663|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153731664|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
154255795|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731665|NCT00138983|Vitamin D|vitamin d|mesh-list
154255796|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255797|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
154255798|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255803|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255806|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255807|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154255808|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154255809|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255810|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255811|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154255812|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
153504822|NCT03786783|Thiotepa|thiotepa|mesh-list
154255813|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505389|NCT01385826|Antibodies|antibodies|mesh-list
154255815|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154255816|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
153507078|NCT01395433|Dexetimide|dexetimide|mesh-list
153507969|NCT04115384|Insulin|insulin|mesh-list
153731681|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154255818|NCT03314662|Vaccines|vaccines|mesh-list
154255819|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154255820|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
154255821|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509707|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154255822|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154255823|NCT01152710|Capecitabine|capecitabine|mesh-list
153510144|NCT01399151|Vitamin D|vitamin d|mesh-list
154255824|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153731686|NCT01243177|Analgesics|analgesics|mesh-ancestor
154255826|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255827|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255828|NCT03271528|Lacosamide|lacosamide|mesh-list
154255829|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
154255830|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154065220|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154255831|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153512284|NCT01412515|Everolimus|everolimus|mesh-list
154255832|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153731691|NCT00154440|Amoxicillin|amoxicillin|mesh-list
154255833|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255834|NCT04480372|Gemcitabine|gemcitabine|mesh-list
154255835|NCT04480372|Atezolizumab|atezolizumab|mesh-list
153731696|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255836|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154255837|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
153513085|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
153514341|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154255879|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154253867|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154253868|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
153516516|NCT01435902|Xhance|xhance|mesh-list
154255838|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255880|NCT01153802|Dopamine|dopamine|mesh-list
154255840|NCT04480372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154253869|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154253870|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
154253871|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253872|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253873|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154253874|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154065226|NCT02556658|Anesthetics|anesthetics|mesh-list
154253875|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253876|NCT01231490|Naproxen|naproxen|mesh-list
154253877|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154253878|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154253880|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
154253881|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253882|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518975|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
154255881|NCT01153802|Norepinephrine|norepinephrine|mesh-list
154255882|NCT01153802|Serotonin|serotonin|mesh-list
153519341|NCT01453062|Ofatumumab|ofatumumab|mesh-list
154253883|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253884|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154253885|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
154253886|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154253887|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255841|NCT04480372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154253888|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253889|NCT01141244|Sirolimus|sirolimus|mesh-list
154253890|NCT01141244|Irinotecan|irinotecan|mesh-list
154253891|NCT01141244|Temozolomide|temozolomide|mesh-list
154253892|NCT01141244|Temsirolimus|temsirolimus|mesh-list
154253893|NCT01141244|MTOR Inhibitors|mtor inhibitors|mesh-list
154253894|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154253895|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154253896|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253897|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253898|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253899|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154253900|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
153520364|NCT06162949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154253901|NCT01141244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253902|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154253903|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
154253904|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253905|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153731727|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154253906|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253907|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154253908|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
154065248|NCT00682955|Zinc|zinc|mesh-list
154253909|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154253910|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154253911|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253913|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
154255843|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253914|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253915|NCT01141556|Protective Agents|protective agents|mesh-ancestor
154253916|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253917|NCT01141556|Trace Elements|trace elements|mesh-ancestor
154253918|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
154253919|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154253920|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
154253921|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154253922|NCT03638440|Naloxegol|naloxegol|mesh-list
154000849|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253923|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154253925|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
154253926|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253927|NCT01719640|Insulin|insulin|mesh-list
154253929|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253931|NCT02439658|Dofetilide|dofetilide|mesh-list
154253932|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153814551|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
154065307|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253933|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154253934|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525172|NCT06076759|Dexmedetomidine|dexmedetomidine|mesh-list
154253935|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525399|NCT06017583|Capecitabine|capecitabine|mesh-list
154255844|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253936|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526792|NCT02315326|Rituximab|rituximab|mesh-list
153526967|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
154253937|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253938|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154253940|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
153528771|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
154253941|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860793|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154255845|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153530007|NCT01488526|Tenofovir|tenofovir|mesh-list
154253943|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154253944|NCT05191394|Antibodies|antibodies|mesh-list
154253945|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
153530413|NCT01490268|Sufentanil|sufentanil|mesh-list
154253946|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530775|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
154253947|NCT04895098|Ezetimibe|ezetimibe|mesh-list
153531048|NCT01494363|Vitamins|vitamins|mesh-ancestor
154253948|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153567517|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154065309|NCT04141787|Cefazolin|cefazolin|mesh-list
154065336|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154253949|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153533258|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
153476779|NCT00997620|Xhance|xhance|mesh-list
153533602|NCT01507077|CKD732|ckd732|mesh-list
153533974|NCT01508806|Hormones|hormones|mesh-ancestor
154253950|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153534649|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
154253951|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
153534829|NCT01513083|Immunotoxins|immunotoxins|mesh-ancestor
153535012|NCT01514227|Aspirin|aspirin|mesh-list
153730487|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536242|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730488|NCT00141414|Pregabalin|pregabalin|mesh-list
154253952|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537119|NCT05891262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153537120|NCT05891262|Contraceptive Agents|contraceptive agents|mesh-ancestor
153537121|NCT05891262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153537122|NCT05891262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153537124|NCT05891262|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154253953|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154253954|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253955|NCT00318461|Metformin|metformin|mesh-list
154253956|NCT00318461|Liraglutide|liraglutide|mesh-list
154253957|NCT00318461|Glimepiride|glimepiride|mesh-list
154253958|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253959|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253960|NCT00318461|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154253961|NCT00318461|Incretins|incretins|mesh-ancestor
154253962|NCT00318461|Hormones|hormones|mesh-ancestor
154255846|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154255847|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255848|NCT01153568|Vitamin D|vitamin d|mesh-list
154255849|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
154255850|NCT01153568|Vitamins|vitamins|mesh-ancestor
154255851|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
154253963|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253964|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153538512|NCT01528644|Iron|iron|mesh-list
154253965|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154253966|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
154253968|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154253969|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538745|NCT01529528|Anagliptin|anagliptin|mesh-list
154253970|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253971|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539036|NCT01531140|Bisacodyl|bisacodyl|mesh-list
154253972|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154253973|NCT01142258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153730507|NCT00141492|Androgens|androgens|mesh-ancestor
154253974|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154253975|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154860794|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253976|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253977|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253978|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
154253979|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154253980|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
154253981|NCT01139840|Vitamin D|vitamin d|mesh-list
154253982|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
154253983|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
154253984|NCT01139840|Vitamins|vitamins|mesh-list
153539993|NCT01536665|Liraglutide|liraglutide|mesh-list
154860795|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
154860796|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154860797|NCT03242590|Testosterone|testosterone|mesh-list
154253987|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154253988|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154253989|NCT02945410|Vitamin D|vitamin d|mesh-list
154253990|NCT02945410|Calcium|calcium|mesh-list
154253991|NCT02945410|Vitamins|vitamins|mesh-ancestor
154253992|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
154255852|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541026|NCT01542242|Incretins|incretins|mesh-ancestor
154253994|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154253995|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153541456|NCT01544907|Paclitaxel|paclitaxel|mesh-list
154065408|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253996|NCT05032508|Lidocaine|lidocaine|mesh-list
154253997|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
154253998|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
154253999|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541729|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254000|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254001|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
154254002|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254003|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154254004|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154254005|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154254006|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255853|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154255883|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154254007|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254008|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
154254009|NCT01140074|Astringents|astringents|mesh-ancestor
154254010|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254011|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
154254012|NCT01142414|Fluorouracil|fluorouracil|mesh-list
153542704|NCT01553903|Tamoxifen|tamoxifen|mesh-list
154254013|NCT01142414|Panitumumab|panitumumab|mesh-list
154254014|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254015|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
154254016|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730542|NCT00134147|Insulin|insulin|mesh-list
154254017|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254018|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254020|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730546|NCT00403988|Vinorelbine|vinorelbine|mesh-list
154254021|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154254024|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
154254025|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153543695|NCT04087421|Glycerol|glycerol|mesh-list
154065442|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254026|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254027|NCT01142492|Interferons|interferons|mesh-list
154254028|NCT01142492|Interferon-beta|interferon-beta|mesh-list
154254029|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
153544010|NCT02968108|Ustekinumab|ustekinumab|mesh-list
154254030|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254031|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
153544369|NCT01557647|Treprostinil|treprostinil|mesh-list
154254032|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254033|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
154254034|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254035|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154254036|NCT01234142|Varenicline|varenicline|mesh-list
154254037|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153730559|NCT00141648|Doxorubicin|doxorubicin|mesh-list
154254038|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154254039|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
154254040|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254041|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254042|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254043|NCT01140308|Ubiquinone|ubiquinone|mesh-list
154254044|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
154860798|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
154254045|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
154254046|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254048|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
154254049|NCT01142648|Neostigmine|neostigmine|mesh-list
154860799|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
154860800|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153545478|NCT06307652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545479|NCT06305546|Chlorhexidine|chlorhexidine|mesh-list
153545480|NCT06305546|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153545481|NCT06305546|Metronidazole|metronidazole|mesh-list
153545482|NCT06305546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153545483|NCT06305546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545484|NCT06305546|Disinfectants|disinfectants|mesh-ancestor
153545485|NCT06305546|Dermatologic Agents|dermatologic agents|mesh-ancestor
153545486|NCT06305546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153545487|NCT06305546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153545488|NCT06305546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154255884|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154255886|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
153619372|NCT01984099|Vitamins|vitamins|mesh-ancestor
153619373|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
154254052|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254053|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
153730576|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
153619845|NCT01986998|Prednisolone|prednisolone|mesh-list
154254054|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620108|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254055|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254057|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
154254058|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254059|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153730580|NCT00141648|Hormones|hormones|mesh-ancestor
154065462|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254060|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154254061|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154254062|NCT02143726|Everolimus|everolimus|mesh-list
154254063|NCT02143726|Sorafenib|sorafenib|mesh-list
154254064|NCT02143726|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154254065|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154254066|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254067|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254068|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254069|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
154254070|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254071|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254073|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254074|NCT02088112|Durvalumab|durvalumab|mesh-list
154254075|NCT02088112|Gefitinib|gefitinib|mesh-list
154254076|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154254077|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254078|NCT02088112|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154254079|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154254080|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254081|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254082|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
154254084|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
154254085|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730602|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153621238|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
153621240|NCT01997593|Ropivacaine|ropivacaine|mesh-list
154254086|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254087|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154254088|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154254089|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
154254090|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154254091|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154254092|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
153621592|NCT02000102|Aflibercept|aflibercept|mesh-list
154254093|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730609|NCT00134498|Torcetrapib|torcetrapib|mesh-list
154254094|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254096|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154254097|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254098|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153622030|NCT02002377|Aflibercept|aflibercept|mesh-list
153622210|NCT02003768|Propofol|propofol|mesh-list
154130144|NCT00800150|Melphalan|melphalan|mesh-list
154254101|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254102|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
154254103|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254104|NCT05308342|Hormones|hormones|mesh-list
154254105|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154254106|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254107|NCT03332212|Empagliflozin|empagliflozin|mesh-list
153730617|NCT00141843|Factor VIII|factor viii|mesh-list
154254108|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153730623|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254109|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622725|NCT05968885|Mirabegron|mirabegron|mesh-list
154254110|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254111|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254112|NCT01144988|Bevacizumab|bevacizumab|mesh-list
154254113|NCT01144988|Irinotecan|irinotecan|mesh-list
153622911|NCT05835258|Antioxidants|antioxidants|mesh-ancestor
153622913|NCT05835258|Protective Agents|protective agents|mesh-ancestor
154254114|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154254115|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254116|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154254117|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154254118|NCT01144988|Growth Substances|growth substances|mesh-ancestor
153730628|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154254119|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254120|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
154254121|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154254122|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154254123|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730636|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154254124|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254126|NCT03331666|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154254127|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154254128|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153624087|NCT03149770|Naloxone|naloxone|mesh-list
153624177|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154254130|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624369|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
154254131|NCT03331666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154254132|NCT03331666|Protease Inhibitors|protease inhibitors|mesh-ancestor
154254133|NCT03331666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254134|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154254136|NCT04828538|Vitamins|vitamins|mesh-list
154254137|NCT04828538|Folic Acid|folic acid|mesh-list
154254138|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
154254139|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
154254140|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254141|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154254142|NCT04828538|Hematinics|hematinics|mesh-ancestor
154254143|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154254144|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154254145|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
154254146|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254147|NCT03638206|Immunomodulating Agents|immunomodulating agents|mesh-list
154254148|NCT03638206|Immunologic Factors|immunologic factors|mesh-ancestor
154254149|NCT03638206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254150|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
154254151|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154254152|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254153|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154254154|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153625737|NCT02012140|Ticagrelor|ticagrelor|mesh-list
154254155|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
154254156|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254157|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254159|NCT01234454|Risperidone|risperidone|mesh-list
153626297|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
153626326|NCT02015923|Panitumumab|panitumumab|mesh-list
154254160|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154254161|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
153736559|NCT01602666|Ifosfamide|ifosfamide|mesh-list
154254163|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730664|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
154254165|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154254166|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154254167|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254168|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154254169|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154254170|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
154254171|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
154065579|NCT00853580|Lovastatin|lovastatin|mesh-list
154254172|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
154254173|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254174|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153737501|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
154254175|NCT01234454|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154254176|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154254177|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154254178|NCT01145456|Gemcitabine|gemcitabine|mesh-list
153737946|NCT04338191|Antidotes|antidotes|mesh-ancestor
154255854|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154255855|NCT03889808|Antitoxins|antitoxins|mesh-list
153738138|NCT03787628|Cannabidiol|cannabidiol|mesh-list
154255856|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
154255857|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255858|NCT03890042|Dienogest|dienogest|mesh-list
154255859|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154255860|NCT03890042|Gestodene|gestodene|mesh-list
154255861|NCT03890042|Femovan|femovan|mesh-list
154255862|NCT03890042|Estradiol|estradiol|mesh-list
154255863|NCT03890042|Estrogens|estrogens|mesh-ancestor
154254179|NCT01145456|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154254180|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254181|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
154255864|NCT03890042|Hormones|hormones|mesh-ancestor
153739526|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739593|NCT00150384|Amlodipine|amlodipine|mesh-list
153731753|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153740000|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740175|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
154254182|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254184|NCT01145456|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154254185|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254187|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
154254188|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
154254189|NCT04939636|Vitamins|vitamins|mesh-list
154254190|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
154254191|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254192|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154254193|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154254194|NCT01238276|Cefazolin|cefazolin|mesh-list
154254195|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154254196|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254197|NCT01145534|Glyburide|glyburide|mesh-list
154254198|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254199|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741621|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
154254200|NCT01145612|Losartan|losartan|mesh-list
154254201|NCT01145612|Atenolol|atenolol|mesh-list
154254202|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154254203|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153741828|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
154254204|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154254205|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154254206|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254208|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
154254209|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254210|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254211|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154254212|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154254213|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154254214|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
153730701|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
153730711|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254215|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254216|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
154254220|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154254221|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
153742410|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
154254223|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254224|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254225|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
154254226|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254227|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254228|NCT01143584|Protective Agents|protective agents|mesh-ancestor
154254229|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154254230|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154254232|NCT01145846|Daunorubicin|daunorubicin|mesh-list
154254234|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254235|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
154254236|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254237|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254238|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
154254239|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254240|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730731|NCT00134966|Levodopa|levodopa|mesh-list
154254241|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
154254242|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254243|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153743335|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
153743530|NCT00145847|Naltrexone|naltrexone|mesh-list
154254244|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154254246|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254247|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
153743987|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254248|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154254249|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730743|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
154254250|NCT03134456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153730746|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153744681|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
153731759|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154254251|NCT03134456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254252|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154254253|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
154254254|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745368|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
153745369|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
153745370|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745371|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153745372|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153745373|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
153745374|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153745375|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745377|NCT04610658|Ipilimumab|ipilimumab|mesh-list
153745378|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153745379|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745380|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153745382|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
154254256|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154254257|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027528|NCT04168944|Lenvatinib|lenvatinib|mesh-list
154254258|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254259|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154254260|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
154254261|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
154254262|NCT01146548|Fluoxetine|fluoxetine|mesh-list
154065703|NCT00688961|Aspirin|aspirin|mesh-list
154065739|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254263|NCT01146548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154254264|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154254265|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154254266|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254267|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254268|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
154254269|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254270|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154254271|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
154254272|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154254273|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154254274|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154254275|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254276|NCT03478930|Omalizumab|omalizumab|mesh-list
154254277|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154254278|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154254279|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154254280|NCT01312714|Vitamin D|vitamin d|mesh-list
154254281|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
154254282|NCT01312714|Vitamins|vitamins|mesh-ancestor
154254283|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
154027797|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154254284|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254285|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154028016|NCT04187456|Midazolam|midazolam|mesh-list
154028090|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
154028241|NCT00886379|Vitamin D|vitamin d|mesh-list
154028312|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028385|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254286|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154254287|NCT04188028|Levomethorphan|levomethorphan|mesh-list
154254288|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
154254290|NCT04188028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154028755|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154254291|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154028982|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254292|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029051|NCT00681603|Bevacizumab|bevacizumab|mesh-list
154029348|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154029423|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154029499|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
154029570|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154029642|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029724|NCT00602030|Entinostat|entinostat|mesh-list
154254293|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254294|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001224|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154254295|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
154254296|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254297|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154030168|NCT02802995|Thrombin|thrombin|mesh-list
154254298|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
154254299|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154030236|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
154254300|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154030383|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154254301|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154254302|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254303|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
154254304|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
154254305|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154030753|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030827|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
154254306|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154030997|NCT02634528|Insulin|insulin|mesh-list
154254307|NCT04188028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154031128|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
154254308|NCT04188028|Narcotics|narcotics|mesh-ancestor
154254309|NCT04188028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254310|NCT04188028|Analgesics|analgesics|mesh-ancestor
154254311|NCT04188028|Sensory System Agents|sensory system agents|mesh-ancestor
154254312|NCT04188028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254313|NCT01312792|Ampicillin|ampicillin|mesh-list
154254314|NCT01312792|Cephradine|cephradine|mesh-list
154254315|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154254316|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254317|NCT03523000|Fentanyl|fentanyl|mesh-list
154254318|NCT03523000|Bupivacaine|bupivacaine|mesh-list
154254319|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
154254320|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
154254321|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254322|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254323|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
154254324|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032165|NCT05742841|Antimetabolites|antimetabolites|mesh-ancestor
154254325|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154032394|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
154254328|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154254329|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154254330|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
154254331|NCT04705480|Pregabalin|pregabalin|mesh-list
154254332|NCT04705480|Gabapentin|gabapentin|mesh-list
154254333|NCT04705480|Analgesics|analgesics|mesh-ancestor
154254334|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
154254335|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254336|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254337|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
154254338|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154254339|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154254340|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254341|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154254342|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154254343|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154254344|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254345|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154254346|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154254347|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154254348|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254349|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
154254350|NCT01238978|Vildagliptin|vildagliptin|mesh-list
154254351|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254352|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254353|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154254354|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
154254355|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254356|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254357|NCT00318149|Vaccines|vaccines|mesh-list
154254358|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
154254359|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254360|NCT01236716|Paclitaxel|paclitaxel|mesh-list
154254361|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154254362|NCT01236716|Carboplatin|carboplatin|mesh-list
154254363|NCT01236716|Gemcitabine|gemcitabine|mesh-list
154254364|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032598|NCT05034536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032599|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
154032600|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154032601|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032602|NCT05013892|Memantine|memantine|mesh-list
154032603|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154032604|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154032605|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
154032606|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032607|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032608|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032609|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154032610|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154254365|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254366|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
154254367|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
154254368|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
154254369|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254370|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254372|NCT04154800|Itraconazole|itraconazole|mesh-list
154254373|NCT04154800|Diltiazem|diltiazem|mesh-list
154254374|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
154254375|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254376|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154254377|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154254378|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254379|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254380|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154254381|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
154254382|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154254383|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032660|NCT04876781|Tofacitinib|tofacitinib|mesh-list
154254384|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154254385|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154130508|NCT00886002|Fentanyl|fentanyl|mesh-list
154254386|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154254387|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154032857|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
154254388|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154254389|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
154254390|NCT01048229|Pramipexole|pramipexole|mesh-list
154254392|NCT01048229|Dexpramipexole|dexpramipexole|mesh-list
154254393|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
154254394|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254395|NCT01048229|Protective Agents|protective agents|mesh-ancestor
154254396|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033094|NCT03823768|Tacrolimus|tacrolimus|mesh-list
154254397|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154254399|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
154254400|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
154254401|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254402|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154254403|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254404|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154254405|NCT01048307|Polihexanide|polihexanide|mesh-list
154254406|NCT01048307|Betaine|betaine|mesh-list
154254407|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154254408|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154033831|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
154254409|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
154254410|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154254411|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
154034052|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254412|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254413|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154254414|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
154254415|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254416|NCT02049905|Gemcitabine|gemcitabine|mesh-list
154254417|NCT02049905|Docetaxel|docetaxel|mesh-list
154254418|NCT02049905|Doxorubicin|doxorubicin|mesh-list
154254419|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154254420|NCT02049905|Ifosfamide|ifosfamide|mesh-list
154254421|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
154034415|NCT00967057|Methotrexate|methotrexate|mesh-list
154065911|NCT02555644|Cetuximab|cetuximab|mesh-list
154065934|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154254422|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034508|NCT00967135|Pregabalin|pregabalin|mesh-list
154254423|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
154254424|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254425|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254426|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
154034939|NCT00969085|Curcumin|curcumin|mesh-list
154254427|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
154254428|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
154254429|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154254430|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154035234|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
154035310|NCT00969631|Metformin|metformin|mesh-list
154254431|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154254432|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254433|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154254434|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
154035530|NCT00648440|Midodrine|midodrine|mesh-list
154254435|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154035613|NCT00970411|Tivozanib|tivozanib|mesh-list
154035681|NCT02781467|Analgesics|analgesics|mesh-ancestor
154254437|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154254438|NCT01058759|Enoxaparin|enoxaparin|mesh-list
154254439|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
154254440|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
154254441|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154254442|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154036037|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036188|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036337|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036411|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154036482|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254443|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001372|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
154254444|NCT01239368|Sirolimus|sirolimus|mesh-list
154254445|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
154254446|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037000|NCT00600938|Deferoxamine|deferoxamine|mesh-list
154254447|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154037088|NCT04006639|Analgesics|analgesics|mesh-list
154254448|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254449|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154254450|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254451|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
154254452|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254454|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154254455|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154254456|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154254457|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154254458|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
154254459|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037731|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254460|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037952|NCT00649688|Diuretics|diuretics|mesh-ancestor
154038025|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
154254461|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254463|NCT01146626|Ribavirin|ribavirin|mesh-list
154254464|NCT01146626|Vitamins|vitamins|mesh-ancestor
154254465|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
154254466|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254467|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154038545|NCT00129922|Paclitaxel|paclitaxel|mesh-list
154038617|NCT02757209|Xhance|xhance|mesh-list
154254469|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254470|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
154038812|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
154254471|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254472|NCT02924324|Propofol|propofol|mesh-list
154066003|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154039113|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
154254474|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154039478|NCT06236165|Antiviral Agents|antiviral agents|mesh-ancestor
154254475|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254476|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254477|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154254478|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
154254479|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
154254480|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
154254481|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
154039924|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254482|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254485|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154040214|NCT04223752|Tazobactam|tazobactam|mesh-list
154254486|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154040288|NCT04068597|Azacitidine|azacitidine|mesh-list
154254487|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254488|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154254489|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
154254491|NCT05137574|Analgesics|analgesics|mesh-ancestor
154040362|NCT03715933|Pemetrexed|pemetrexed|mesh-list
154254492|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
154254493|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254494|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154254495|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154040499|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254496|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154254497|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254498|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254499|NCT01236950|Listerine|listerine|mesh-list
154254500|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154254501|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254504|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254505|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154254507|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254508|NCT04971746|Analgesics|analgesics|mesh-ancestor
154254509|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
154254510|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254511|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254512|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154041394|NCT00652886|Hormones|hormones|mesh-ancestor
154254513|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254514|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154254515|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154001450|NCT05550636|Midazolam|midazolam|mesh-list
154254516|NCT00369161|Everolimus|everolimus|mesh-list
154254518|NCT00369161|Basiliximab|basiliximab|mesh-list
154254519|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254520|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
154254521|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254522|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154254523|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254524|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254525|NCT00369161|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154254526|NCT00369161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154254527|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254529|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254530|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254531|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254532|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154254533|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154254534|NCT00337571|Aripiprazole|aripiprazole|mesh-list
154041470|NCT00715858|Rifampin|rifampin|mesh-list
154254536|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154254537|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154254538|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154254539|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254540|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254541|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
154254542|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
154254543|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254544|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254545|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154254546|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154254548|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154254549|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154254550|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154254551|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154254552|NCT01247870|Metformin|metformin|mesh-list
154254553|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254554|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254555|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
154254556|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254557|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254558|NCT03985319|Esomeprazole|esomeprazole|mesh-list
154254559|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154254560|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154254561|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154254562|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254563|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254564|NCT01237028|Calcitriol|calcitriol|mesh-list
154254565|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154254566|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254567|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154254568|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154254569|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254570|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154254571|NCT01237028|Vitamins|vitamins|mesh-ancestor
154254572|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
154041941|NCT04391855|Tramadol|tramadol|mesh-list
154254573|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154254574|NCT01240850|Prednisone|prednisone|mesh-list
154254575|NCT01240850|Methotrexate|methotrexate|mesh-list
154254576|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154254577|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
154254578|NCT01240850|Hormones|hormones|mesh-ancestor
154042071|NCT02748005|Fenugreek seed meal|fenugreek seed meal|mesh-list
154254579|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154254580|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254581|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154254582|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254583|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154254584|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
154254585|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154254586|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254587|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
154254588|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254589|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
154254590|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254591|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154254592|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254593|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
154254594|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154042147|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
154254595|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154254596|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
154254597|NCT04813016|Tramadol|tramadol|mesh-list
154254598|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154042205|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154254599|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254600|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254601|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254602|NCT04813016|Analgesics|analgesics|mesh-ancestor
154254603|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
154254604|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254605|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154254606|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154254607|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154254608|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154254609|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254610|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254611|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154254612|NCT04813016|Narcotics|narcotics|mesh-ancestor
154254613|NCT00368927|Sulindac|sulindac|mesh-list
154254614|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154254615|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254616|NCT00368927|Analgesics|analgesics|mesh-ancestor
154254617|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
154254618|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254619|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254620|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154254621|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154254623|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154254624|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254625|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254626|NCT01242410|Silicon|silicon|mesh-list
154254627|NCT01242410|Trace Elements|trace elements|mesh-ancestor
154254628|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
154254629|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254632|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
154254633|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254634|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254635|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154254636|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154254638|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
154254639|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254640|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154254641|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154254642|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254643|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254644|NCT01237262|Adalimumab|adalimumab|mesh-list
154254645|NCT01237262|Infliximab|infliximab|mesh-list
154254646|NCT01237262|Etanercept|etanercept|mesh-list
154044194|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254647|NCT01237262|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154254648|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154254649|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154254650|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044486|NCT00585247|Imiquimod|imiquimod|mesh-list
154044556|NCT02721173|Clindamycin|clindamycin|mesh-list
154254651|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154254652|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154254653|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254654|NCT01237262|Analgesics|analgesics|mesh-ancestor
154254655|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
154066190|NCT00873119|Carboplatin|carboplatin|mesh-list
154254656|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254657|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254658|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254659|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
154254660|NCT01329770|Vitamins|vitamins|mesh-list
154254661|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
154254662|NCT01329770|Vitamin E|vitamin e|mesh-list
154254663|NCT01329770|Tocopherols|tocopherols|mesh-list
154254664|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
154254665|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
154254666|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254667|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
154254668|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254669|NCT01329770|Protective Agents|protective agents|mesh-ancestor
154860801|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254670|NCT00316589|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154254671|NCT00316589|Antiviral Agents|antiviral agents|mesh-ancestor
154254672|NCT00316589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254673|NCT01048385|Ubiquinone|ubiquinone|mesh-list
154254674|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
154254675|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
154044769|NCT04139070|Bleomycin|bleomycin|mesh-list
154254676|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254677|NCT01048385|Vitamins|vitamins|mesh-ancestor
154045055|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
154254678|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
154066191|NCT00873119|Belinostat|belinostat|mesh-list
154254679|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254680|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254681|NCT03916250|Petrolatum|petrolatum|mesh-list
154254682|NCT03916250|PF-06700841|pf-06700841|mesh-list
154254683|NCT03916250|Emollients|emollients|mesh-ancestor
154254684|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
154254685|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154254686|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045824|NCT04000633|Lidocaine|lidocaine|mesh-list
154254687|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254688|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
154254689|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154254690|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254692|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154254693|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154254694|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254695|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046333|NCT04234217|Niacin|niacin|mesh-list
154254696|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154254697|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154046778|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
154046850|NCT00598832|Adapalene|adapalene|mesh-list
154254698|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154254699|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154254700|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
154254701|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
154254702|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
154254703|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
154048057|NCT00729118|Lenalidomide|lenalidomide|mesh-list
154048130|NCT00636935|Clindamycin|clindamycin|mesh-list
154048203|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154254704|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048791|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154049021|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
154254705|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254706|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
154049984|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
154254707|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154050660|NCT01009879|Analgesics|analgesics|mesh-ancestor
154254708|NCT00316277|Narcotics|narcotics|mesh-ancestor
154050736|NCT00673556|Alefacept|alefacept|mesh-list
154050960|NCT00677300|Ritonavir|ritonavir|mesh-list
154051111|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154051184|NCT06156761|Capecitabine|capecitabine|mesh-list
154254709|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051642|NCT05239533|Nivolumab|nivolumab|mesh-list
154254710|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254711|NCT00316277|Analgesics|analgesics|mesh-ancestor
154254712|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
154051941|NCT04509115|Analgesics|analgesics|mesh-ancestor
154254713|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254714|NCT01249352|Fluorouracil|fluorouracil|mesh-list
154254715|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
154254716|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254717|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
154254718|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254719|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254720|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254721|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
154254722|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254723|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052377|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
154052449|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052450|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
154052451|NCT02873962|Bevacizumab|bevacizumab|mesh-list
154052452|NCT02873962|Nivolumab|nivolumab|mesh-list
154052453|NCT02873962|Rucaparib|rucaparib|mesh-list
154053129|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154053130|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154053131|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
154053132|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053133|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053134|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154053135|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
154053136|NCT02566252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154053137|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053138|NCT00823719|Ofatumumab|ofatumumab|mesh-list
154053139|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154053140|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053141|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
154053142|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053143|NCT03953170|Teduglutide|teduglutide|mesh-list
154053144|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154053145|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154053146|NCT03953170|Protective Agents|protective agents|mesh-ancestor
154053147|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053148|NCT00708591|Sirolimus|sirolimus|mesh-list
154053149|NCT00708591|Ketoconazole|ketoconazole|mesh-list
154053150|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154053151|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053153|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254725|NCT03912974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154254726|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154053506|NCT00742846|Hormones|hormones|mesh-ancestor
154254727|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154053584|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053654|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154053804|NCT00686192|Antacids|antacids|mesh-ancestor
154054255|NCT02624726|Antidotes|antidotes|mesh-ancestor
154054334|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
154254728|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254729|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254730|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
154254731|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254732|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154254733|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154254734|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154254735|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154254736|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254737|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
154254738|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054768|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
154254739|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054913|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
154254741|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154055218|NCT00696956|Paclitaxel|paclitaxel|mesh-list
154055285|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154055363|NCT04539223|Evolocumab|evolocumab|mesh-list
154055435|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
154055589|NCT02685059|Durvalumab|durvalumab|mesh-list
154254742|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154055812|NCT00701532|Modafinil|modafinil|mesh-list
154254744|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254745|NCT00316199|Paclitaxel|paclitaxel|mesh-list
154055956|NCT00743470|Lopinavir|lopinavir|mesh-list
154056032|NCT04122716|Incretins|incretins|mesh-ancestor
154254746|NCT00316199|Gemcitabine|gemcitabine|mesh-list
154254747|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154056410|NCT02963831|Durvalumab|durvalumab|mesh-list
154056629|NCT02683031|Ionophores|ionophores|mesh-list
154056781|NCT02687867|Dabigatran|dabigatran|mesh-list
154057084|NCT04181489|Prednisolone|prednisolone|mesh-list
154057535|NCT02670785|Estradiol|estradiol|mesh-list
154057611|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154057912|NCT00646529|Budesonide|budesonide|mesh-list
154254748|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058056|NCT00648713|Terbinafine|terbinafine|mesh-list
154058574|NCT00649805|Verapamil|verapamil|mesh-list
154058793|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
154058869|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
154254750|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
154059843|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
153602748|NCT01907165|Copper|copper|mesh-list
154060066|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154060222|NCT05863195|Antidotes|antidotes|mesh-ancestor
154060290|NCT05861791|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154060379|NCT05686564|Choline|choline|mesh-list
154060444|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060517|NCT04812548|Azacitidine|azacitidine|mesh-list
154060666|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
154130961|NCT00808184|Midazolam|midazolam|mesh-list
154860802|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
154060667|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060668|NCT04138394|Protective Agents|protective agents|mesh-ancestor
154060669|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
154254752|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254753|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254754|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
154254755|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
154061113|NCT00913224|Diclofenac|diclofenac|mesh-list
154061185|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154061633|NCT00664781|Rucaparib|rucaparib|mesh-list
154254758|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154062000|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
154062302|NCT00705120|Busulfan|busulfan|mesh-list
154254759|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066370|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154062446|NCT05958589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062520|NCT05957328|Ascorbic Acid|ascorbic acid|mesh-list
154062597|NCT05929157|Schistosomicides|schistosomicides|mesh-ancestor
154254760|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254761|NCT01147718|Protective Agents|protective agents|mesh-ancestor
154254762|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254763|NCT01147718|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154254764|NCT01147718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254765|NCT03913052|Viscosupplements|viscosupplements|mesh-list
154254766|NCT03913052|Protective Agents|protective agents|mesh-ancestor
154254767|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254768|NCT03915938|Ketamine|ketamine|mesh-list
154254769|NCT03915938|Analgesics|analgesics|mesh-ancestor
154254770|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
154254771|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063264|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063416|NCT00755014|Ethanol|ethanol|mesh-list
154063541|NCT00680992|Denosumab|denosumab|mesh-list
154063622|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254772|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063843|NCT02813824|Aspirin|aspirin|mesh-list
154064361|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254773|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154254774|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154254775|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
154254776|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
154254777|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254778|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154254779|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154254780|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254781|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254782|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154254783|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
154254784|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254785|NCT01251458|Temsirolimus|temsirolimus|mesh-list
154254786|NCT01251458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154254788|NCT01251458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254789|NCT01251458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254790|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254792|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254793|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254794|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
154254795|NCT03912740|Remifentanil|remifentanil|mesh-list
154065316|NCT02557594|Tenofovir|tenofovir|mesh-list
154065390|NCT04047394|Rasburicase|rasburicase|mesh-list
154065545|NCT00778180|Furosemide|furosemide|mesh-list
154254796|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154065691|NCT00769522|Rituximab|rituximab|mesh-list
154065762|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
154065834|NCT00783016|Morphine|morphine|mesh-list
154065940|NCT02624531|Taxane|taxane|mesh-list
154065990|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
154254797|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254798|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254799|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254800|NCT03912740|Analgesics|analgesics|mesh-ancestor
154254801|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
154254802|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254803|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154254804|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154254805|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154254806|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
154254807|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066518|NCT00790816|Lapatinib|lapatinib|mesh-list
154254808|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254809|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154254810|NCT03912740|Narcotics|narcotics|mesh-ancestor
154254811|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154254812|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154066660|NCT00913614|SR 46349B|sr 46349b|mesh-list
154254813|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154066441|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
154067315|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154254815|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254816|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154067616|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
154254817|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154254818|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068277|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
154254820|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154068646|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
154068798|NCT00839306|Rabeprazole|rabeprazole|mesh-list
154254821|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254822|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
154254823|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254824|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069100|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
154069207|NCT03770455|Avelumab|avelumab|mesh-list
154069316|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254826|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154069624|NCT00789321|Amlodipine|amlodipine|mesh-list
154069767|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
154254827|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
154070145|NCT04111848|Ketamine|ketamine|mesh-list
154254828|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
154070286|NCT00855335|Rilpivirine|rilpivirine|mesh-list
154070360|NCT00593489|Insulin|insulin|mesh-list
154070506|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
154070657|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070806|NCT04110210|Analgesics|analgesics|mesh-ancestor
154254829|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254830|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254831|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071698|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
154254833|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
154072156|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
154066442|NCT00795262|Vitamins|vitamins|mesh-ancestor
154254834|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154072303|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
154072369|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154254835|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154254836|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
154072816|NCT00784875|Zolpidem|zolpidem|mesh-list
154860804|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860805|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860806|NCT03242590|Androgens|androgens|mesh-ancestor
154860807|NCT03247738|Cangrelor|cangrelor|mesh-list
154860808|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154860809|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154860810|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154860811|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154860812|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
154860813|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154860814|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073109|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154073183|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154073254|NCT00762411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254838|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254839|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154073452|NCT00703235|Bevacizumab|bevacizumab|mesh-list
154254840|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154254841|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
154074123|NCT00761280|Carmustine|carmustine|mesh-list
153730208|NCT00132938|Telithromycin|telithromycin|mesh-list
153730244|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
154074414|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
154074465|NCT05693090|Osimertinib|osimertinib|mesh-list
154254842|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074822|NCT00917358|Interferons|interferons|mesh-list
154254843|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154074896|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
154255010|NCT03910088|Diclofenac|diclofenac|mesh-list
154254844|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154254845|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154075116|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154254847|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154254848|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254849|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154075866|NCT00915200|Silybin|silybin|mesh-list
154076014|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254850|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154076762|NCT05728151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154076837|NCT00589667|Gemcitabine|gemcitabine|mesh-list
154254852|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254853|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
154254854|NCT03911648|Lidocaine|lidocaine|mesh-list
154254855|NCT03911648|Bupivacaine|bupivacaine|mesh-list
154077217|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
154254856|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
154077962|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
154078041|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154254858|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154254859|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078334|NCT00760214|Ramipril|ramipril|mesh-list
154254860|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
154078706|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
154254861|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079104|NCT00727506|Afatinib|afatinib|mesh-list
154079465|NCT02517099|Hormones|hormones|mesh-ancestor
154079541|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
154079759|NCT04072263|Interferons|interferons|mesh-list
154079836|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154080213|NCT06239714|Atorvastatin|atorvastatin|mesh-list
154080357|NCT06231745|Antimetabolites|antimetabolites|mesh-ancestor
154080497|NCT06001125|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080633|NCT05883124|Cholinergic Agents|cholinergic agents|mesh-ancestor
154254862|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154080786|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080909|NCT05286554|Progesterone|progesterone|mesh-list
154081297|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
154081437|NCT04271475|Macitentan|macitentan|mesh-list
154081583|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
154254863|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154081741|NCT03422328|Macitentan|macitentan|mesh-list
154081797|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081798|NCT03298893|Nivolumab|nivolumab|mesh-list
154081799|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081800|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081801|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081802|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081803|NCT03264079|Itraconazole|itraconazole|mesh-list
154066524|NCT00873041|Deferasirox|deferasirox|mesh-list
154254864|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154081872|NCT03047005|Naltrexone|naltrexone|mesh-list
154082094|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082246|NCT02578719|Bupivacaine|bupivacaine|mesh-list
154254865|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154083227|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254866|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083534|NCT00713271|AZD-3199|azd-3199|mesh-list
154254867|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154254868|NCT01237730|Cefuroxime|cefuroxime|mesh-list
154083981|NCT04080726|Esomeprazole|esomeprazole|mesh-list
154084372|NCT00729339|Mosapride|mosapride|mesh-list
154254869|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
154084511|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154254870|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084746|NCT02567955|Vaccines|vaccines|mesh-list
154084895|NCT00785213|Analgesics|analgesics|mesh-ancestor
154084964|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
154254871|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154085114|NCT04076436|Fosfomycin|fosfomycin|mesh-list
154085415|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
154085718|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
154085872|NCT00720902|Hormones|hormones|mesh-list
154086013|NCT00746031|Goserelin|goserelin|mesh-list
154086092|NCT01090089|BB 1101|bb 1101|mesh-list
154086325|NCT00745173|Hormones|hormones|mesh-ancestor
154860815|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086405|NCT00751959|Poractant alfa|poractant alfa|mesh-list
154086621|NCT02562417|Hormones|hormones|mesh-ancestor
154254875|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
154254876|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
153410163|NCT00002805|Cobalt|cobalt|mesh-list
154087066|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
154254877|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254878|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254879|NCT00337103|Capecitabine|capecitabine|mesh-list
154087876|NCT00673179|Antidotes|antidotes|mesh-ancestor
154088033|NCT00764907|Vitamins|vitamins|mesh-ancestor
154088182|NCT00766545|Cilostazol|cilostazol|mesh-list
154254880|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154088260|NCT00671931|Propofol|propofol|mesh-list
154254881|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
154088654|NCT05338502|Omeprazole|omeprazole|mesh-list
154088703|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154088774|NCT00779649|Laxatives|laxatives|mesh-ancestor
154088847|NCT00667251|Trastuzumab|trastuzumab|mesh-list
154089074|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
154089378|NCT00774735|Dolutegravir|dolutegravir|mesh-list
154254882|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254883|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089676|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
154089749|NCT00427999|Hormones|hormones|mesh-ancestor
154089981|NCT00426361|Vaccines|vaccines|mesh-list
154254885|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154090510|NCT00712400|Latanoprost|latanoprost|mesh-list
154090724|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090800|NCT00793923|Dexamethasone|dexamethasone|mesh-list
154091024|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154091261|NCT02573558|Propofol|propofol|mesh-list
154091547|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
154254886|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154254887|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254888|NCT03911570|Analgesics|analgesics|mesh-ancestor
154092519|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254889|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
154092820|NCT04508634|Metformin|metformin|mesh-list
154092970|NCT03941873|Tislelizumab|tislelizumab|mesh-list
154093118|NCT06062953|Antioxidants|antioxidants|mesh-ancestor
154093266|NCT05825092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093415|NCT04650893|Dexamethasone|dexamethasone|mesh-list
154093797|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
154254890|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094188|NCT02575092|Folic Acid|folic acid|mesh-list
154254891|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254892|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
154066587|NCT04030572|Clonidine|clonidine|mesh-list
154254893|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154094849|NCT00852670|Ponesimod|ponesimod|mesh-list
154254895|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
154095050|NCT00717678|Tacrolimus|tacrolimus|mesh-list
154095120|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095191|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
154095265|NCT02571816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154095420|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
154254896|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095795|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095869|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
154254898|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096023|NCT00798915|Incretins|incretins|mesh-ancestor
154096247|NCT00726258|Ketamine|ketamine|mesh-list
154254899|NCT00075504|Gemcitabine|gemcitabine|mesh-list
154254900|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254901|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
154096838|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
154254902|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097663|NCT05632809|Durvalumab|durvalumab|mesh-list
154097742|NCT05438875|Tretinoin|tretinoin|mesh-list
154097823|NCT05265065|Vaccines|vaccines|mesh-list
154097888|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
154254904|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
154098038|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
154254905|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154098112|NCT04786275|Narcotics|narcotics|mesh-ancestor
154098184|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
154254906|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154098266|NCT04472910|Folfirinox|folfirinox|mesh-list
154254908|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254909|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066634|NCT00692159|Pemetrexed|pemetrexed|mesh-list
154254910|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254911|NCT01092624|Urological Agents|urological agents|mesh-ancestor
154254912|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
154254913|NCT00321464|Denosumab|denosumab|mesh-list
154254914|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154254915|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254916|NCT02889796|Adalimumab|adalimumab|mesh-list
154098333|NCT04307511|Aspirin|aspirin|mesh-list
154254917|NCT02889796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154254918|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154254919|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098631|NCT03529201|Fentanyl|fentanyl|mesh-list
154098632|NCT03529201|Oxycodone|oxycodone|mesh-list
154098633|NCT03529201|Sevoflurane|sevoflurane|mesh-list
154098634|NCT03529201|Rocuronium|rocuronium|mesh-list
154098635|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154098636|NCT03529201|Narcotics|narcotics|mesh-ancestor
154254921|NCT01237808|Etoposide|etoposide|mesh-list
154254923|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154099084|NCT02339922|Ixazomib|ixazomib|mesh-list
154254924|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254925|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154254926|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154099540|NCT00863668|Tenofovir|tenofovir|mesh-list
154254927|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099686|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154099759|NCT02568488|Metformin|metformin|mesh-list
154254928|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254929|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100281|NCT00713258|Alendronate|alendronate|mesh-list
154254930|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
154254931|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
154101259|NCT00611806|Folic Acid|folic acid|mesh-list
154101998|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
154102592|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154102668|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254933|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254934|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
154103196|NCT02540824|Apatinib|apatinib|mesh-list
154103342|NCT00820911|Cyclosporine|cyclosporine|mesh-list
154103862|NCT00924430|Simvastatin|simvastatin|mesh-list
154254935|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254936|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
154254937|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
154254938|NCT03910634|Carboplatin|carboplatin|mesh-list
154254939|NCT03910634|Fluorouracil|fluorouracil|mesh-list
154254940|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254941|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
154254942|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066699|NCT02620163|Diuretics|diuretics|mesh-ancestor
154254943|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154254944|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154104074|NCT02710890|Lacosamide|lacosamide|mesh-list
154254945|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
154104450|NCT00395629|Deferasirox|deferasirox|mesh-list
154104514|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
154254946|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254947|NCT03910712|Trastuzumab|trastuzumab|mesh-list
154254948|NCT03910712|Letrozole|letrozole|mesh-list
154254949|NCT03910712|Anastrozole|anastrozole|mesh-list
154254950|NCT03910712|Exemestane|exemestane|mesh-list
154254951|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154254952|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154105477|NCT00690612|Candesartan|candesartan|mesh-list
154254953|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254954|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154105848|NCT00845559|Exenatide|exenatide|mesh-list
154254955|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066713|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154105922|NCT02546349|Fluticasone|fluticasone|mesh-list
154106073|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106149|NCT04012606|Carboplatin|carboplatin|mesh-list
154106294|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
154106371|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
154106442|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106675|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
154106832|NCT00943462|Temozolomide|temozolomide|mesh-list
154107123|NCT04054128|Heparin|heparin|mesh-list
154107270|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154107347|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107645|NCT04049916|Artesunate|artesunate|mesh-list
154107720|NCT00617409|Paclitaxel|paclitaxel|mesh-list
154107876|NCT00955162|Naloxone|naloxone|mesh-list
154108022|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108094|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154108161|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
154108234|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154108311|NCT00677352|Sertraline|sertraline|mesh-list
154108685|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
154108907|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108981|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154109133|NCT00880815|Rituximab|rituximab|mesh-list
154109284|NCT00613509|Interferons|interferons|mesh-list
154109428|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109509|NCT00761670|Risperidone|risperidone|mesh-list
154109580|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
154109654|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154109880|NCT05917509|Rilpivirine|rilpivirine|mesh-list
154110179|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110252|NCT04694976|Vitamin D|vitamin d|mesh-list
154110405|NCT03948074|Dronabinol|dronabinol|mesh-list
154254956|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254957|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154254958|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
154110852|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066717|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154110926|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111167|NCT00965926|Mirabegron|mirabegron|mesh-list
154111598|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
154111895|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
154111971|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154112055|NCT00979966|Sirolimus|sirolimus|mesh-list
154112193|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112346|NCT00869271|Vitamins|vitamins|mesh-ancestor
154112494|NCT00894231|Levocetirizine|levocetirizine|mesh-list
154112718|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
154255887|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112870|NCT00895167|Analgesics|analgesics|mesh-ancestor
154255888|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254959|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154254960|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254961|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154254962|NCT03910556|Propofol|propofol|mesh-list
154254963|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154255889|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
154254964|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255890|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
154113830|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
154113985|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154254965|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114288|NCT01054027|Protective Agents|protective agents|mesh-ancestor
154254966|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154066784|NCT00871169|Irinotecan|irinotecan|mesh-list
154254967|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
154001894|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
154254968|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
154254969|NCT03659578|Thymalfasin|thymalfasin|mesh-list
154254970|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154114742|NCT00924963|Lidocaine|lidocaine|mesh-list
154114824|NCT00773058|Hormones|hormones|mesh-ancestor
154115039|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
154254971|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
154115643|NCT00688688|Mirabegron|mirabegron|mesh-list
154254972|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254974|NCT02889562|Apixaban|apixaban|mesh-list
154116387|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
154254975|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
154116620|NCT00687440|Docetaxel|docetaxel|mesh-list
154254976|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154116689|NCT00792246|Voriconazole|voriconazole|mesh-list
154116761|NCT00990886|Oxybutynin|oxybutynin|mesh-list
154254977|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
154254978|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154254979|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
154117364|NCT00801450|Hormones|hormones|mesh-ancestor
154255891|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255892|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154117953|NCT03743259|Antidotes|antidotes|mesh-ancestor
154118033|NCT00936195|Ritonavir|ritonavir|mesh-list
154118180|NCT00350779|Hormones|hormones|mesh-ancestor
154118252|NCT00575042|Fenofibrate|fenofibrate|mesh-list
154118329|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
154118408|NCT00921830|Ibuprofen|ibuprofen|mesh-list
154255893|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154255894|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
154255895|NCT01153802|Protective Agents|protective agents|mesh-ancestor
154119603|NCT00654732|Rituximab|rituximab|mesh-list
154255896|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154119971|NCT00952029|Antidotes|antidotes|mesh-ancestor
154255899|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154120565|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154120792|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
154121021|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154254981|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254982|NCT03323164|Timolol|timolol|mesh-list
154121389|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254983|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154121625|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
154121772|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154255900|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255901|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
154255902|NCT01153256|Analgesics|analgesics|mesh-ancestor
154122071|NCT00317473|Vaccines|vaccines|mesh-list
154122140|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
154255903|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
154122367|NCT05732051|Niacinamide|niacinamide|mesh-list
154255904|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154254984|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123031|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
154123113|NCT00635154|BB 1101|bb 1101|mesh-list
154123254|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
154254985|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154123343|NCT01067989|Celecoxib|celecoxib|mesh-list
154123555|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
154254986|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154254987|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
154123848|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
154254988|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124145|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154124293|NCT02599337|Sorafenib|sorafenib|mesh-list
154124370|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
154254989|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124664|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
154254990|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154124920|NCT02548806|Clonidine|clonidine|mesh-list
154254991|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154125347|NCT00956163|Listerine|listerine|mesh-list
154125413|NCT00843570|Hormones|hormones|mesh-ancestor
154125486|NCT00962637|Citric Acid|citric acid|mesh-list
154125946|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
154126027|NCT00250705|Aripiprazole|aripiprazole|mesh-list
154126093|NCT00842556|Incretins|incretins|mesh-ancestor
154126179|NCT00853320|Oxycodone|oxycodone|mesh-list
154126241|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
154126316|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126467|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
154254992|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154254993|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154254994|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154254996|NCT03914690|Hematinics|hematinics|mesh-ancestor
154254997|NCT03914534|Valproic Acid|valproic acid|mesh-list
154254998|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
154127004|NCT00663962|Pregabalin|pregabalin|mesh-list
154127287|NCT00786812|Nilotinib|nilotinib|mesh-list
154127453|NCT05147493|Hormones|hormones|mesh-ancestor
154254999|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127881|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154128031|NCT00864552|Factor VIII|factor viii|mesh-list
154128414|NCT02598011|Flucytosine|flucytosine|mesh-list
154128480|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128782|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154128931|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
154255905|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129233|NCT00659438|Bicalutamide|bicalutamide|mesh-list
154255906|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
154129337|NCT00881088|PENTA|penta|mesh-list
154129452|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
154129538|NCT00881400|Cefprozil|cefprozil|mesh-list
154129677|NCT00613626|Etoposide|etoposide|mesh-list
154129900|NCT00613080|Antidotes|antidotes|mesh-ancestor
154129978|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154255907|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255908|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154255000|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255001|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
154255002|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255003|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255004|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
154255005|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154255006|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154255007|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154255008|NCT03910088|Acetaminophen|acetaminophen|mesh-list
154255009|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
154255011|NCT03910088|Pregabalin|pregabalin|mesh-list
154255012|NCT03910088|Caffeine|caffeine|mesh-list
154255013|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154255014|NCT03910088|Analgesics|analgesics|mesh-ancestor
154255909|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
154255015|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
153376741|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153376742|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
153376743|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376745|NCT05681299|Hormones|hormones|mesh-list
153376746|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376747|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376748|NCT05681299|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153376749|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153836657|NCT02951234|Analgesics|analgesics|mesh-ancestor
153836658|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
153836661|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376779|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
153376780|NCT05610085|Levetiracetam|levetiracetam|mesh-list
153376781|NCT05610085|Phenobarbital|phenobarbital|mesh-list
153376782|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
153376783|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
153836696|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836697|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836698|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153836699|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153376996|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377696|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838260|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066870|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
154066871|NCT00786370|Propofol|propofol|mesh-list
153378347|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378348|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
153378349|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153378350|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378351|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378352|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153378353|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153378354|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
153378355|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153378356|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378357|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
153378358|NCT01606878|Doxorubicin|doxorubicin|mesh-list
153838261|NCT02946437|Midazolam|midazolam|mesh-list
153378639|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153378640|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153378641|NCT01524302|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153378642|NCT02802111|Albuterol|albuterol|mesh-list
153378643|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153378644|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
153378645|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378646|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378647|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153378648|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
153378795|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
153378796|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378797|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378798|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153378799|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
153378800|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
153378801|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153378802|NCT01580618|Tenecteplase|tenecteplase|mesh-list
153378803|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153378804|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153378805|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378806|NCT01581710|Montelukast|montelukast|mesh-list
153838707|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153838708|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153378808|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
153378809|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153838868|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838869|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838870|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153838871|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
153838872|NCT02925975|Protective Agents|protective agents|mesh-ancestor
153838873|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153838874|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153850708|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850709|NCT00557843|Bupivacaine|bupivacaine|mesh-list
153732585|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
153732586|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153732587|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
153732588|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
153732589|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732590|NCT04516681|Vitamins|vitamins|mesh-ancestor
153732591|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
154066951|NCT00593957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255016|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732592|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
153396396|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
153850921|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153850922|NCT00544128|Tenofovir|tenofovir|mesh-list
153850923|NCT00544128|Lamivudine|lamivudine|mesh-list
153850924|NCT00544128|Emtricitabine|emtricitabine|mesh-list
153850925|NCT00544128|Abacavir|abacavir|mesh-list
153392452|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852232|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
153852233|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852234|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852235|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153852236|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
153392490|NCT00000723|Zidovudine|zidovudine|mesh-list
153392491|NCT00000723|Dexamethasone|dexamethasone|mesh-list
153392492|NCT00000723|Methotrexate|methotrexate|mesh-list
153392493|NCT00000723|Calcium|calcium|mesh-list
153392494|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
153392495|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392496|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
153392497|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
153392498|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392499|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392500|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153392501|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
153392502|NCT00000723|Hormones|hormones|mesh-ancestor
153392503|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392504|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153392546|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392626|NCT02975219|Growth Substances|growth substances|mesh-ancestor
153392673|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392674|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153852470|NCT06235931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153392780|NCT05738564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392781|NCT05738564|Sensory System Agents|sensory system agents|mesh-ancestor
153852549|NCT06224569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153852550|NCT06224569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852551|NCT06224569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153852552|NCT06224569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852553|NCT06224569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852554|NCT06224569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153852555|NCT06224569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153852559|NCT06222489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153852560|NCT06222489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852561|NCT06207305|Diphenhydramine|diphenhydramine|mesh-list
153852562|NCT06207305|Promethazine|promethazine|mesh-list
153852563|NCT06207305|Dexamethasone|dexamethasone|mesh-list
153852564|NCT06207305|Paclitaxel|paclitaxel|mesh-list
153852565|NCT06207305|Famotidine|famotidine|mesh-list
153852566|NCT06207305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153392782|NCT05738564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392783|NCT05738564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153392784|NCT05738564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153392785|NCT05738564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153852572|NCT06207305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852573|NCT06207305|Antiemetics|antiemetics|mesh-ancestor
153852574|NCT06207305|Autonomic Agents|autonomic agents|mesh-ancestor
153852575|NCT06207305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852576|NCT06207305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852577|NCT06207305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153852578|NCT06207305|Glucocorticoids|glucocorticoids|mesh-ancestor
153852579|NCT06207305|Hormones|hormones|mesh-ancestor
153392795|NCT05738564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153392808|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392809|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153392810|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153732927|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732929|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153732930|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153732931|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
153732932|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153732933|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
153732934|NCT00142727|Methadone|methadone|mesh-list
154860816|NCT03345160|Immunomodulating Agents|immunomodulating agents|mesh-list
154255017|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732936|NCT00142727|Narcotics|narcotics|mesh-ancestor
153732937|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732938|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732939|NCT00142727|Analgesics|analgesics|mesh-ancestor
153732940|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
153732941|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732942|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
153732943|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
153732944|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
153392901|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
153392902|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
153392903|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392904|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153852809|NCT05963984|Fulvestrant|fulvestrant|mesh-list
153852810|NCT05963984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153852839|NCT05872425|Hormones|hormones|mesh-ancestor
153852840|NCT05854537|Lidocaine|lidocaine|mesh-list
153852841|NCT05854537|Bupivacaine|bupivacaine|mesh-list
153852842|NCT05854537|Anesthetics, Local|anesthetics, local|mesh-ancestor
153852843|NCT05854537|Anesthetics|anesthetics|mesh-ancestor
153852844|NCT05854537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852845|NCT05854537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393070|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153393123|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393124|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393125|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153393126|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153393127|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
153393129|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153393130|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153733060|NCT00143195|Amlodipine|amlodipine|mesh-list
153733061|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153733062|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153733063|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153733064|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733065|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153733066|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733067|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
153733068|NCT00163449|Ciclesonide|ciclesonide|mesh-list
153733069|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
153733070|NCT00163449|Hormones|hormones|mesh-ancestor
153733071|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733072|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733073|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153733074|NCT00143234|Amlodipine|amlodipine|mesh-list
153733075|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153733076|NCT00143234|Atorvastatin|atorvastatin|mesh-list
153733077|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153733078|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153393309|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
153393311|NCT02730962|Neomycin|neomycin|mesh-list
153393343|NCT02501330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853118|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853119|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853120|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853121|NCT05291156|Cetuximab|cetuximab|mesh-list
153853122|NCT05291156|Avelumab|avelumab|mesh-list
153393471|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393472|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393474|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153393479|NCT05316649|Chrysarobin|chrysarobin|mesh-list
153393480|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154067045|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
153394110|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394287|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394288|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153394289|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394290|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153394291|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153394292|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153854066|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860817|NCT03345160|Immunologic Factors|immunologic factors|mesh-ancestor
154255019|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
153854067|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153394297|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153394298|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394300|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
153394301|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153394302|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153394303|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
153394304|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394839|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153394842|NCT02531321|Estrogens|estrogens|mesh-ancestor
153397607|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153397608|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153397609|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
153397610|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
153397611|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397612|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154260155|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260156|NCT00054132|Bevacizumab|bevacizumab|mesh-list
153857891|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153398150|NCT05738317|Paclitaxel|paclitaxel|mesh-list
153398151|NCT05738317|Bevacizumab|bevacizumab|mesh-list
153398152|NCT05738317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153398153|NCT05738317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398154|NCT05738317|Tubulin Modulators|tubulin modulators|mesh-ancestor
153398155|NCT05738317|Antimitotic Agents|antimitotic agents|mesh-ancestor
153398156|NCT05738317|Mitosis Modulators|mitosis modulators|mesh-ancestor
153398157|NCT05738317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858263|NCT02910206|Analgesics|analgesics|mesh-ancestor
153858264|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
153858265|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858266|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153858267|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153398525|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
153398526|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
153398527|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153398528|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153398529|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153398530|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
153398531|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398532|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398549|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398550|NCT02990845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153398552|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153398974|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398976|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
153398977|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398978|NCT01754779|Expectorants|expectorants|mesh-ancestor
153398979|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
153398980|NCT02149277|Lenograstim|lenograstim|mesh-list
153398981|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153398982|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
153398983|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858730|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
153858731|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153858732|NCT01780428|Narcotics|narcotics|mesh-ancestor
153858734|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
153858857|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
153399133|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399135|NCT02912195|Morphine|morphine|mesh-list
153399136|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
153399137|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
153399138|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399139|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399140|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
153399141|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399142|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153399143|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153399144|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153399145|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399154|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
153399155|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860818|NCT03345160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399156|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859080|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153859081|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
153859082|NCT04658355|Povidone|povidone|mesh-list
153859225|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859226|NCT01215253|Ranolazine|ranolazine|mesh-list
153859227|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154261177|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
154261208|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067152|NCT00703430|Memantine|memantine|mesh-list
154261209|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
154261210|NCT01199432|Fluorouracil|fluorouracil|mesh-list
154261212|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154261213|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
154261214|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261215|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154261216|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154261217|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
154261218|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733804|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
154261250|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154261251|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154261252|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154261253|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154261254|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154261255|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154261256|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154261257|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
154261258|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261259|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154261286|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
154261287|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261288|NCT00308087|Rituximab|rituximab|mesh-list
154261289|NCT00308087|Molgramostim|molgramostim|mesh-list
154261290|NCT00308087|Sargramostim|sargramostim|mesh-list
154261291|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261292|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261293|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
154261294|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261295|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154261296|NCT04942184|Complement Factor H|complement factor h|mesh-list
154261297|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154261298|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154261299|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
154261300|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261301|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
154261302|NCT00307931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154261303|NCT00307931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154261304|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154261305|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
153733899|NCT00157326|Tadalafil|tadalafil|mesh-list
154261335|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
154261336|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
154261337|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154008266|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261338|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154261339|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154261340|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154261341|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
154261342|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261343|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261344|NCT04133792|Simvastatin|simvastatin|mesh-list
154261345|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154261346|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154261347|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
154261348|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261383|NCT01204112|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154261384|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154261385|NCT01204190|Gestodene|gestodene|mesh-list
154261411|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154261412|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
154261413|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
154261414|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154261415|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261416|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261417|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131923|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
154261419|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
154261421|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261422|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261423|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
154261424|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261425|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154261426|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
154261427|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261428|NCT00307151|Ritonavir|ritonavir|mesh-list
154261429|NCT00307151|Lopinavir|lopinavir|mesh-list
154261430|NCT00307151|Lamivudine|lamivudine|mesh-list
154261431|NCT00307151|Zidovudine|zidovudine|mesh-list
154261432|NCT00307151|Nevirapine|nevirapine|mesh-list
154261433|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154261434|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154261435|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
154261468|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261470|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261471|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
154261472|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261473|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261474|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
154261475|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154261476|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154261477|NCT02654132|Growth Substances|growth substances|mesh-ancestor
153734076|NCT03271450|Dabigatran|dabigatran|mesh-list
154261514|NCT03978845|Lidocaine|lidocaine|mesh-list
154261548|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261549|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261550|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154261551|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
154261552|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261618|NCT01066247|Narcotics|narcotics|mesh-ancestor
154261619|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261620|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261621|NCT01066247|Analgesics|analgesics|mesh-ancestor
154067266|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154067288|NCT00787462|Pregabalin|pregabalin|mesh-list
154261655|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261656|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154261657|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154261658|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
154261659|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
154261660|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
154261661|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154261662|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154261663|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153734272|NCT06246695|Rifampin|rifampin|mesh-list
154261694|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261695|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261696|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154261697|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
154261698|NCT03980249|Protective Agents|protective agents|mesh-ancestor
154261699|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154261700|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261701|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154261702|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
154261703|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154261704|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154261736|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261737|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154261739|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
154067289|NCT00787462|Analgesics|analgesics|mesh-ancestor
154261740|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261741|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261742|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154261743|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154261744|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261745|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261746|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154261747|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154261795|NCT01205516|Narcotics|narcotics|mesh-ancestor
154261796|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261797|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860819|NCT01567605|Lidocaine|lidocaine|mesh-list
154261798|NCT01205516|Analgesics|analgesics|mesh-ancestor
154261799|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
154261800|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261801|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
154261802|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
154261835|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261836|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
154261837|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154261838|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154261839|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261840|NCT03012386|Urological Agents|urological agents|mesh-ancestor
154261841|NCT01202552|Vaccines|vaccines|mesh-list
154261842|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
154261843|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261844|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154261845|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
153734450|NCT06241781|Antimetabolites|antimetabolites|mesh-ancestor
154261900|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261901|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154261902|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154261903|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154261904|NCT04472494|Abatacept|abatacept|mesh-list
154261905|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154261906|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261907|NCT04472494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261908|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261909|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154261910|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
154261911|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261912|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154261913|NCT04568200|Paclitaxel|paclitaxel|mesh-list
154261914|NCT04568200|Carboplatin|carboplatin|mesh-list
154261915|NCT04568200|Durvalumab|durvalumab|mesh-list
154261916|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154261917|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261918|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
154261919|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
154261920|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153734524|NCT06191094|Faricimab|faricimab|mesh-list
154262006|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262007|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262008|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154262009|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154262033|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154262034|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262036|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262037|NCT00331799|Analgesics|analgesics|mesh-ancestor
154262038|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
154262039|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262040|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
154262041|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154262042|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
154262043|NCT03826940|Lovastatin|lovastatin|mesh-list
154262044|NCT03826940|L 647318|l 647318|mesh-list
154262045|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
154262046|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154262047|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154262048|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
154262049|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262050|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154262051|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154262052|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262053|NCT01201694|Curcumin|curcumin|mesh-list
154262054|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154262055|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154262056|NCT01201694|Analgesics|analgesics|mesh-ancestor
154262057|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
154262083|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262084|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
154262085|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262086|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154262087|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154067345|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
154067402|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
154262088|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154262089|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154262090|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
154262091|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154262092|NCT01207310|Nicotine|nicotine|mesh-list
154262093|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154262094|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
154262095|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262096|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262097|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154262098|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154262099|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
154262100|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262101|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262102|NCT00331409|Everolimus|everolimus|mesh-list
154262103|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
154262104|NCT00331409|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154262105|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154262106|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734715|NCT05915169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154262181|NCT01314274|Growth Substances|growth substances|mesh-ancestor
154262182|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262183|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
154262184|NCT02935894|Ibuprofen|ibuprofen|mesh-list
154262185|NCT02935894|Pilocarpine|pilocarpine|mesh-list
154262186|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154262187|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154262188|NCT02935894|Analgesics|analgesics|mesh-ancestor
154262189|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
154262190|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262191|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262192|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262193|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262194|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154262195|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262196|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262197|NCT02935894|Miotics|miotics|mesh-ancestor
154262198|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
154262199|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154262200|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154262201|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
154262202|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262203|NCT03224182|Apaziquone|apaziquone|mesh-list
154262204|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262205|NCT03821480|Fluconazole|fluconazole|mesh-list
154262206|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
154262207|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262208|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154262209|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154262210|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262211|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262212|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154262213|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
154262214|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262215|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262216|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154262217|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154262253|NCT03221842|Complement C1s|complement c1s|mesh-list
154262288|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154262289|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
154262290|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262291|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262372|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
154262373|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262374|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262375|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
154262376|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262377|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
154262378|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262379|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262380|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
154262381|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154262382|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262383|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154262384|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154262385|NCT03814226|Growth Substances|growth substances|mesh-ancestor
154262386|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132146|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154262387|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
154262388|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262389|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735010|NCT05458024|Vitamin D|vitamin d|mesh-list
154262455|NCT01097382|Zolpidem|zolpidem|mesh-list
154262456|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154262457|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154067450|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262458|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262459|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262460|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154262461|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
154262462|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
154262463|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735091|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154262525|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154262526|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154262527|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
154262528|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154262529|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
154262530|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
154262532|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
154262533|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154009466|NCT04238702|Empagliflozin|empagliflozin|mesh-list
154262535|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
154262536|NCT00048048|Hematinics|hematinics|mesh-ancestor
154262537|NCT03953118|Azithromycin|azithromycin|mesh-list
154262538|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154262539|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262540|NCT01101204|Metformin|metformin|mesh-list
154262541|NCT01101204|Simvastatin|simvastatin|mesh-list
154262542|NCT01101204|Fenofibrate|fenofibrate|mesh-list
154262543|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154262544|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262545|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154262546|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154262547|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
154262548|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262549|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154262550|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153735182|NCT05213832|Isoflurane|isoflurane|mesh-list
154262572|NCT01098084|Decitabine|decitabine|mesh-list
154262573|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154262574|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
154262575|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262576|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262577|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262578|NCT03952572|Prednisone|prednisone|mesh-list
154262579|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
154262580|NCT03952572|Doxorubicin|doxorubicin|mesh-list
154262581|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154262582|NCT03952572|Vincristine|vincristine|mesh-list
154262583|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262584|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
154262585|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262586|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262587|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154262588|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
154262589|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262590|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262591|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154262592|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154262593|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154262594|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154262595|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262596|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262597|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
154262598|NCT03952572|Hormones|hormones|mesh-ancestor
154262599|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262600|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154262601|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154262602|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
154262686|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154860820|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
154262687|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262688|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262689|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154262724|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154262725|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
154262726|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067527|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458742|NCT03589326|Hormones|hormones|mesh-ancestor
154067559|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262727|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067561|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262729|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154262730|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
154392036|NCT04482621|Decitabine|decitabine|mesh-list
154392037|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392038|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
154392069|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392070|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392071|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392072|NCT04449874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392073|NCT04449874|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154392074|NCT04444921|Paclitaxel|paclitaxel|mesh-list
154392075|NCT04444921|Carboplatin|carboplatin|mesh-list
154392076|NCT04444921|Nivolumab|nivolumab|mesh-list
154392077|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154392078|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154392079|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392080|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
154392081|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
154392082|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
154392083|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392235|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
154392272|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154392274|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392275|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392276|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154392277|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154392278|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
154392279|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154392375|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154392392|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154392393|NCT03856632|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154392394|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154392395|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392396|NCT03856632|Incretins|incretins|mesh-ancestor
154392397|NCT03856632|Hormones|hormones|mesh-ancestor
154392398|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392399|NCT03851159|Mannitol|mannitol|mesh-list
154392400|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154392401|NCT03851159|Diuretics|diuretics|mesh-ancestor
154392402|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
154392403|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392404|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
154392405|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392406|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392407|NCT03832569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392408|NCT03832569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392409|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154392410|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
154392411|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392412|NCT03811561|Semaglutide|semaglutide|mesh-list
154392413|NCT03811561|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154392414|NCT03811561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154392415|NCT03811561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392416|NCT03811015|Deoxyglucose|deoxyglucose|mesh-list
154392417|NCT03811015|Cisplatin|cisplatin|mesh-list
154392418|NCT03811015|Nivolumab|nivolumab|mesh-list
154392419|NCT03811015|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154392420|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392421|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392422|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392423|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392424|NCT03811015|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154392425|NCT03811015|Antimetabolites|antimetabolites|mesh-ancestor
154392426|NCT03811015|Antiviral Agents|antiviral agents|mesh-ancestor
154392427|NCT03811015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392428|NCT03807765|Nivolumab|nivolumab|mesh-list
154392429|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392430|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392431|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153754156|NCT00407459|Growth Substances|growth substances|mesh-ancestor
154392457|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154392458|NCT03743025|Dulaglutide|dulaglutide|mesh-list
154392459|NCT03743025|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154392460|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154067636|NCT05757336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392461|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067650|NCT00871871|Isosorbide|isosorbide|mesh-list
154392462|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
154392463|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392464|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392465|NCT03674567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392466|NCT03674567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392467|NCT03604978|Nivolumab|nivolumab|mesh-list
154392468|NCT03604978|Ipilimumab|ipilimumab|mesh-list
154392469|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392470|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392471|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392472|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392473|NCT03600701|Atezolizumab|atezolizumab|mesh-list
154392474|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154392475|NCT03600701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392476|NCT03600701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392477|NCT03600701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392478|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392479|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
154392480|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392481|NCT03568994|Cytarabine|cytarabine|mesh-list
154392482|NCT03568994|Atovaquone|atovaquone|mesh-list
154392483|NCT03568994|Etoposide|etoposide|mesh-list
154392484|NCT03568994|Daunorubicin|daunorubicin|mesh-list
154392485|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
154392510|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
154392511|NCT03552705|Coagulants|coagulants|mesh-ancestor
154392512|NCT03507413|Metformin|metformin|mesh-list
154392513|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154392514|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392515|NCT03499119|Erenumab|erenumab|mesh-list
154392516|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154392517|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392518|NCT03499119|Analgesics|analgesics|mesh-ancestor
154392519|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
154392520|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392521|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392522|NCT03492177|Selexipag|selexipag|mesh-list
154392523|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154392524|NCT03473743|Carboplatin|carboplatin|mesh-list
154392525|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392526|NCT03466450|Temozolomide|temozolomide|mesh-list
154392527|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154392528|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
154392529|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392530|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392531|NCT03462719|Venetoclax|venetoclax|mesh-list
154392532|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
154392533|NCT03462719|Chlorambucil|chlorambucil|mesh-list
154392534|NCT03462719|Ibrutinib|ibrutinib|mesh-list
154392551|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392553|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154392554|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392555|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392556|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
154392557|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154392558|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154392559|NCT03406247|Nivolumab|nivolumab|mesh-list
154392560|NCT03406247|Ipilimumab|ipilimumab|mesh-list
154392561|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392562|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392564|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392565|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
154392566|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
154392567|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154392568|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154392569|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392570|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392571|NCT03382106|Urological Agents|urological agents|mesh-ancestor
154392572|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
154392573|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132373|NCT01075555|Pravastatin|pravastatin|mesh-list
154392574|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392575|NCT03329950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392576|NCT03329950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392577|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
154392578|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392579|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392580|NCT03319940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392581|NCT03319940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392583|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154392584|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392585|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154392586|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392587|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154392588|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
154392589|NCT03255174|Coagulants|coagulants|mesh-ancestor
154392590|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
154392622|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392624|NCT03006172|Trastuzumab|trastuzumab|mesh-list
154392625|NCT03006172|Pertuzumab|pertuzumab|mesh-list
154392626|NCT03006172|Letrozole|letrozole|mesh-list
154392627|NCT03006172|Fulvestrant|fulvestrant|mesh-list
154392628|NCT03006172|Palbociclib|palbociclib|mesh-list
154392629|NCT03006172|Inavolisib|inavolisib|mesh-list
154392630|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154392631|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392632|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392633|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392634|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153754377|NCT05755048|Trastuzumab|trastuzumab|mesh-list
154392667|NCT02997228|Antidotes|antidotes|mesh-ancestor
154392668|NCT02997228|Protective Agents|protective agents|mesh-ancestor
154392669|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
154392670|NCT02997228|Vitamins|vitamins|mesh-ancestor
154392671|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
154392672|NCT02997228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392673|NCT02951767|Atezolizumab|atezolizumab|mesh-list
154392674|NCT02951767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392709|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392710|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392711|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
154067745|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392712|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154392713|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154392714|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392736|NCT02682147|Urological Agents|urological agents|mesh-ancestor
154392737|NCT02568267|Entrectinib|entrectinib|mesh-list
154392738|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392739|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392740|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392741|NCT02498613|Misonidazole|misonidazole|mesh-list
154392742|NCT02498613|Olaparib|olaparib|mesh-list
154392743|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154392744|NCT02498613|Cediranib|cediranib|mesh-list
154392745|NCT02498613|Maleic acid|maleic acid|mesh-list
154392746|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392747|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392748|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392749|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392750|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154392751|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154392752|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392753|NCT02489318|Androgens|androgens|mesh-list
154392754|NCT02489318|Hormones|hormones|mesh-ancestor
154067746|NCT00837434|Adalimumab|adalimumab|mesh-list
154067764|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392755|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392756|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392757|NCT02277444|Golimumab|golimumab|mesh-list
154392758|NCT02277444|Methotrexate|methotrexate|mesh-list
154392759|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154392760|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
154392761|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154392762|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392763|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154860821|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
154392764|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
154392765|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392766|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392767|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
154392768|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754556|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
154392833|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392834|NCT02108652|Atezolizumab|atezolizumab|mesh-list
154392835|NCT02108652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392836|NCT02108652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392837|NCT02108652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392838|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392839|NCT02076009|Dexamethasone|dexamethasone|mesh-list
154392840|NCT02076009|Lenalidomide|lenalidomide|mesh-list
154067779|NCT00702260|Ramipril|ramipril|mesh-list
154392841|NCT02076009|Daratumumab|daratumumab|mesh-list
154392842|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392843|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
154392844|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
154392845|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392846|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392847|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154392848|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
154392849|NCT02076009|Hormones|hormones|mesh-ancestor
154392850|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392851|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392852|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392853|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
154392854|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154392855|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392889|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154392890|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392892|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
154392893|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392894|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392923|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154392924|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392926|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
154392927|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392928|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154392929|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
154392930|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154392931|NCT00980538|Etravirine|etravirine|mesh-list
154392932|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154392933|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154392934|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392935|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392936|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
154142544|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
154142630|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
154142992|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
154143571|NCT02272049|Xenon|xenon|mesh-list
154143981|NCT00129389|Paclitaxel|paclitaxel|mesh-list
154144059|NCT02578277|BMS-955176|bms-955176|mesh-list
154144275|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
154144356|NCT00950898|Caffeine|caffeine|mesh-list
154144570|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145022|NCT00712049|Niacinamide|niacinamide|mesh-list
154027433|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154145319|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
154145395|NCT01026610|Entecavir|entecavir|mesh-list
154172174|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172175|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172176|NCT00640835|Analgesics|analgesics|mesh-ancestor
154172177|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
154172178|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172179|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154172214|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
154172215|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172216|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154172217|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154172218|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154172219|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172220|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172221|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154172256|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172258|NCT00452361|Sirolimus|sirolimus|mesh-list
154172259|NCT00452361|Tacrolimus|tacrolimus|mesh-list
154172260|NCT00452361|Cyclosporins|cyclosporins|mesh-list
154172261|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154172262|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172263|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
154172264|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172265|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172329|NCT00459537|Amorolfine|amorolfine|mesh-list
154172330|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
154172331|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172332|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172333|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172334|NCT03866421|Liver Extracts|liver extracts|mesh-list
154172335|NCT03866421|Hematinics|hematinics|mesh-ancestor
154172336|NCT00819377|Milrinone|milrinone|mesh-list
154172337|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154172338|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154172339|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
154172340|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154172341|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154172342|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172372|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172373|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172374|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172375|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
154172376|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172377|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154172378|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172379|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
154172380|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
154172381|NCT00469209|Protective Agents|protective agents|mesh-ancestor
154172382|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154172383|NCT00635219|Vortioxetine|vortioxetine|mesh-list
154172384|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154172385|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154172386|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172387|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172388|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172417|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172418|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154172419|NCT01026129|Narcotics|narcotics|mesh-ancestor
154172420|NCT01026129|Analgesics|analgesics|mesh-ancestor
154172421|NCT01026285|Risperidone|risperidone|mesh-list
154172422|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
154172423|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154172424|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
154172425|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172426|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172427|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172428|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154172429|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172430|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154172431|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154172432|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
154172433|NCT01026363|Vitamin D|vitamin d|mesh-list
154172460|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154172461|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172462|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172464|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172465|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172466|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154172467|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172468|NCT00451035|Panobinostat|panobinostat|mesh-list
154172469|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172470|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154172471|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172472|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067890|NCT00663052|Analgesics|analgesics|mesh-ancestor
153576255|NCT01711463|Xhance|xhance|mesh-list
154172474|NCT00468585|Capecitabine|capecitabine|mesh-list
154172475|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154172476|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172477|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172478|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172479|NCT00468585|Growth Substances|growth substances|mesh-ancestor
154172480|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172481|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
154132591|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172482|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154172483|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
154172514|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154172515|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154172516|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154172517|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154172518|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154172520|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154172521|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
154172522|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154172523|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154172524|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
154172525|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
154172526|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154172527|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154172528|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154067920|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
154172529|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
154172530|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172596|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172597|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172598|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172599|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154172600|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
154172601|NCT00819845|Protective Agents|protective agents|mesh-ancestor
154172602|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154172603|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172604|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154172605|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
154172606|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154172607|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153755260|NCT00553618|Aldesleukin|aldesleukin|mesh-list
154172641|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
154172642|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172643|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172644|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172645|NCT00812435|Eptifibatide|eptifibatide|mesh-list
154172646|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154172647|NCT00812513|Becaplermin|becaplermin|mesh-list
154172648|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
154172649|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154172679|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154172680|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172681|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
154172682|NCT00815867|Hematinics|hematinics|mesh-ancestor
154172683|NCT00815945|Carboplatin|carboplatin|mesh-list
154172684|NCT00815945|Doxorubicin|doxorubicin|mesh-list
154172685|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172686|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154172687|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154172688|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154172689|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172690|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172691|NCT00812825|Prednisolone|prednisolone|mesh-list
154172692|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154172693|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
154172694|NCT00812825|Hormones|hormones|mesh-ancestor
154172695|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154172724|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172725|NCT00813059|Growth Substances|growth substances|mesh-ancestor
154172726|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172727|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172728|NCT00467649|Insulin|insulin|mesh-list
154172729|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154172730|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
154172731|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
154172732|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
154172733|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
154172734|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
154172735|NCT00467649|Pramlintide|pramlintide|mesh-list
154172736|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
154172737|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154172738|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172739|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
154860822|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172740|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154172741|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172742|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154172743|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172837|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172838|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154172839|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154172840|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
154172841|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068012|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154172842|NCT01022151|Protective Agents|protective agents|mesh-ancestor
154172843|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154172845|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
154172846|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
154172847|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172848|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
154172850|NCT00449787|Sumatriptan|sumatriptan|mesh-list
154172851|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153755498|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
154172917|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172918|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172919|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
154172920|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172921|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154172922|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154172923|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154172924|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154172925|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154172926|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154172927|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154172928|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154172959|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172960|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
154172961|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172962|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154172963|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154172964|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154172965|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172966|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172967|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154172968|NCT01024413|Gefitinib|gefitinib|mesh-list
154172969|NCT01024413|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154172970|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154172971|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173061|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173062|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154173063|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154173064|NCT00456495|Ranibizumab|ranibizumab|mesh-list
154173065|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154173066|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154173067|NCT00456495|Growth Substances|growth substances|mesh-ancestor
154173068|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173069|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
154173070|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173072|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173073|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
154173074|NCT00445341|Growth Substances|growth substances|mesh-ancestor
154173132|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173133|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
154173134|NCT00443781|Anesthetics|anesthetics|mesh-list
154068013|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
154068063|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173135|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154173136|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173137|NCT00443703|Ritonavir|ritonavir|mesh-list
154173138|NCT00443703|Lopinavir|lopinavir|mesh-list
154173139|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
154173140|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154173141|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154173199|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173201|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154173202|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154173203|NCT00370552|Growth Substances|growth substances|mesh-ancestor
154173204|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173205|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
154132744|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
154173206|NCT00537030|Asparaginase|asparaginase|mesh-list
154173207|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173208|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
154173209|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154173210|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173211|NCT04928820|Edetic Acid|edetic acid|mesh-list
154173212|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154173213|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
154173214|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
154173215|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173216|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
154173217|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154168834|NCT06222437|Semaglutide|semaglutide|mesh-list
154173218|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154173219|NCT04429152|Tenofovir|tenofovir|mesh-list
154173220|NCT04429152|Lamivudine|lamivudine|mesh-list
154173221|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
154173222|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173223|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154173224|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154173225|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173226|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173227|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154173228|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154173229|NCT04001400|Rabeprazole|rabeprazole|mesh-list
154173256|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
154173257|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173258|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173259|NCT00991848|Lidocaine|lidocaine|mesh-list
154173260|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
154173261|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
154173262|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154173263|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173264|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
154173265|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173266|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154173267|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154173268|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154173269|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154173270|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173271|NCT05281068|Danazol|danazol|mesh-list
154173272|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154173273|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
154173274|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173275|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173276|NCT00380068|Ambrisentan|ambrisentan|mesh-list
153755905|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
154173339|NCT00455013|Tacrolimus|tacrolimus|mesh-list
154173340|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
154173341|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173342|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
154173343|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173344|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154173345|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173346|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173347|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154173348|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173349|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154173350|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
154173351|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154173352|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173353|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
154173354|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154173355|NCT00455013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173356|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173357|NCT00363298|Caffeine|caffeine|mesh-list
154173358|NCT00363298|Amphetamine|amphetamine|mesh-list
154173359|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
154173360|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154173361|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755981|NCT00171626|Diclofenac|diclofenac|mesh-list
154173410|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154173411|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
154173412|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860823|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173413|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173415|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154173416|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
154173417|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173418|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154173419|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154173420|NCT05246982|Capecitabine|capecitabine|mesh-list
154173421|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
154173422|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173423|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
154173424|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173425|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173426|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
154173427|NCT04002024|Salicylates|salicylates|mesh-list
154173428|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173429|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
154173430|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
154173431|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
154173432|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154173433|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154173434|NCT04002024|Analgesics|analgesics|mesh-ancestor
154173435|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
154173436|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173437|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173438|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173439|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173440|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154173441|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173442|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173443|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
154173444|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154173445|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154173446|NCT01028313|Prednisolone|prednisolone|mesh-list
154173447|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
154068147|NCT00707642|Vaccines|vaccines|mesh-list
154068185|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173448|NCT01028313|Panobinostat|panobinostat|mesh-list
154173449|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154173480|NCT00992160|Vestipitant|vestipitant|mesh-list
154173481|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154173482|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173483|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173484|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173485|NCT00379912|Azacitidine|azacitidine|mesh-list
154173486|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
154173487|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173488|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
154173489|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173490|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756114|NCT02240407|Promethazine|promethazine|mesh-list
154173526|NCT05354700|Carboplatin|carboplatin|mesh-list
154173527|NCT05354700|Etoposide|etoposide|mesh-list
154173528|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173529|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154173530|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154173531|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154173589|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154173590|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154173591|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154173592|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173593|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173594|NCT03469713|Nivolumab|nivolumab|mesh-list
154173595|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169206|NCT05908331|Sirolimus|sirolimus|mesh-list
154068192|NCT00801580|Doxorubicin|doxorubicin|mesh-list
154173596|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173597|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154173598|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173600|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154173601|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154173602|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154173603|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173604|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173605|NCT00993642|Panobinostat|panobinostat|mesh-list
154173606|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173607|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154173608|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182194|NCT05868525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154173644|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173645|NCT00993720|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154173646|NCT00993720|Incretins|incretins|mesh-ancestor
154173647|NCT00993720|Hormones|hormones|mesh-ancestor
154182195|NCT05868525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173708|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154173709|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
154173710|NCT01646814|Aspirin|aspirin|mesh-list
154173711|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154173712|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154173713|NCT01646814|Analgesics|analgesics|mesh-ancestor
154173714|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
154173715|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173716|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173717|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173718|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173719|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154173720|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154173721|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173722|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154173723|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154173724|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173754|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
154173755|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068251|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154173756|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173757|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154173758|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173760|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154173761|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173762|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154173763|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173764|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
154173765|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173766|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
154173767|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173768|NCT00994734|Mifepristone|mifepristone|mesh-list
154173769|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154173770|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
154173835|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154173836|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
154173838|NCT00995046|Coagulants|coagulants|mesh-ancestor
154173839|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154173840|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154173841|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173842|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
154173843|NCT04000932|Hormones|hormones|mesh-ancestor
154173844|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173845|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173846|NCT05170230|Terlipressin|terlipressin|mesh-list
154173847|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154173848|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154068252|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154068279|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173849|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154173850|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
154173876|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154173877|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173878|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173879|NCT05249712|Androgens|androgens|mesh-list
154173880|NCT05249712|Hormones|hormones|mesh-ancestor
154173881|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173882|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173883|NCT01000896|Paclitaxel|paclitaxel|mesh-list
154173884|NCT01000896|Carboplatin|carboplatin|mesh-list
154173885|NCT01000896|Saracatinib|saracatinib|mesh-list
154173886|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154173887|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173888|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
154173889|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
154173890|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
154173891|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173892|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173893|NCT00997542|Allopurinol|allopurinol|mesh-list
154173894|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
154068282|NCT04045678|Rotigotine|rotigotine|mesh-list
154173895|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173896|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173897|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
154173898|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173931|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173933|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
154173934|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
154173935|NCT01001364|Hormones|hormones|mesh-ancestor
154173936|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173937|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154173938|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154173939|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154173940|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
154173941|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173974|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154173975|NCT04000386|Protective Agents|protective agents|mesh-ancestor
154173976|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173977|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
154173978|NCT00998088|Hematinics|hematinics|mesh-ancestor
154173979|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
154173980|NCT00377962|Everolimus|everolimus|mesh-list
154173981|NCT00377962|Azathioprine|azathioprine|mesh-list
154173982|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154173983|NCT00377962|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154173984|NCT00377962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154173985|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174047|NCT00377260|Amoxicillin|amoxicillin|mesh-list
154174048|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
154174049|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
154174050|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154174051|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154174052|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174053|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154174054|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174055|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174056|NCT00441441|Fluticasone|fluticasone|mesh-list
154174057|NCT00441441|Xhance|xhance|mesh-list
154174058|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154174059|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174060|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154174061|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
154174062|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174063|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174064|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154174065|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
154174066|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
154174127|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154174128|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174129|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
154174130|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
154174131|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
154174132|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174133|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154174134|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154174135|NCT00368992|Growth Substances|growth substances|mesh-ancestor
154174136|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174137|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
154174138|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
154174139|NCT00376246|Ezetimibe|ezetimibe|mesh-list
154174140|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154174141|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154174142|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
154068333|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154068361|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
154174143|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174144|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154174145|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154174146|NCT00375934|Diclofenac|diclofenac|mesh-list
154174147|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154174148|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153756803|NCT01859962|Ribavirin|ribavirin|mesh-list
154174186|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154174219|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
154174220|NCT01001754|Ribavirin|ribavirin|mesh-list
154174221|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154174222|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
154860824|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
154133043|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154174223|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174224|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
154174225|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174226|NCT00825851|Nicotine|nicotine|mesh-list
154174227|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154174261|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174262|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154174263|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
154174264|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
154174265|NCT00826163|Hormones|hormones|mesh-ancestor
154174266|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174267|NCT00998166|Bevacizumab|bevacizumab|mesh-list
154174299|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174301|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174302|NCT00822263|Antidotes|antidotes|mesh-ancestor
154174303|NCT03992170|Daratumumab|daratumumab|mesh-list
154174304|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174305|NCT00817037|Nifedipine|nifedipine|mesh-list
154174306|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
154174307|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154174308|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068362|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174309|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174381|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174382|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174419|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
154174446|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154174447|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174448|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
154174449|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
154174450|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
154174451|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174452|NCT03883386|Loratadine|loratadine|mesh-list
154174453|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
154174454|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
154174455|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154174456|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154174457|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154174458|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
154174459|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
154174460|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174461|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174462|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174463|NCT00530946|Amlodipine|amlodipine|mesh-list
154174464|NCT00530946|Atorvastatin|atorvastatin|mesh-list
154068396|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154068420|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174465|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154174466|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154174467|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
153757096|NCT00203775|Risperidone|risperidone|mesh-list
154174519|NCT00530088|Trioxsalen|trioxsalen|mesh-list
154174520|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174521|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
154174522|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154174523|NCT01006668|Propofol|propofol|mesh-list
154174524|NCT01006668|Sevoflurane|sevoflurane|mesh-list
154174525|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154174526|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174527|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174528|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154174529|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
154174530|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
154174531|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154174532|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154174533|NCT00360568|Levodopa|levodopa|mesh-list
154174534|NCT00360568|Carbidopa|carbidopa|mesh-list
154174535|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154174536|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154174537|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154174538|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
154068423|NCT00803530|Vitamins|vitamins|mesh-ancestor
154174539|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174540|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182196|NCT05868525|Antipyretics|antipyretics|mesh-ancestor
154174566|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154174567|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154174568|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
154860825|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174569|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174570|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174571|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
154174572|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
154174573|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174574|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174576|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154174577|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174578|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154174579|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174580|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174581|NCT00826553|Midazolam|midazolam|mesh-list
154174582|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
154174583|NCT00826553|Lorazepam|lorazepam|mesh-list
154174584|NCT00826553|Propofol|propofol|mesh-list
154174585|NCT00826553|GABA Agonists|gaba agonists|mesh-list
154174586|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154174587|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174588|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182197|NCT05856695|Paclitaxel|paclitaxel|mesh-list
154174622|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174623|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154174624|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154174625|NCT00626561|Growth Substances|growth substances|mesh-ancestor
154174626|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174627|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
154174628|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
154174629|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154174630|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154174631|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154174647|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174648|NCT00822809|Prednisolone|prednisolone|mesh-list
154174649|NCT00822809|Catumaxomab|catumaxomab|mesh-list
154174650|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174651|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
154174652|NCT00822809|Hormones|hormones|mesh-ancestor
154174653|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174654|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174655|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154174656|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174657|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154174658|NCT02549651|Durvalumab|durvalumab|mesh-list
154174659|NCT02549651|Tremelimumab|tremelimumab|mesh-list
154174660|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174661|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174662|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
154174663|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154174664|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
154174665|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174666|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
154174667|NCT03999372|Protective Agents|protective agents|mesh-ancestor
154174668|NCT05733468|Calcium, Dietary|calcium, dietary|mesh-list
154174669|NCT05733468|Calcium|calcium|mesh-list
154174670|NCT05733468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154174671|NCT05733468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174672|NCT05733468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154174673|NCT00830843|Propofol|propofol|mesh-list
154174674|NCT00830843|Isoflurane|isoflurane|mesh-list
154174675|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154174676|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174677|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174678|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154174679|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
154174680|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
154174681|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154174682|NCT00826787|Levetiracetam|levetiracetam|mesh-list
154174683|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
154174684|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
154174685|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154174686|NCT00823121|Buserelin|buserelin|mesh-list
154174687|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154174688|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174689|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154174690|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
154174691|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153757312|NCT01640080|Esketamine|esketamine|mesh-list
154174726|NCT05889871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133192|NCT03947099|Ketamine|ketamine|mesh-list
154174727|NCT05889871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154174728|NCT05889871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068500|NCT00708344|Diuretics|diuretics|mesh-ancestor
154174729|NCT05889871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174730|NCT05889455|Sildenafil Citrate|sildenafil citrate|mesh-list
154174731|NCT05889455|Vasodilator Agents|vasodilator agents|mesh-ancestor
154174732|NCT05889455|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154174733|NCT05889455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154174734|NCT05889455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174761|NCT05889390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154174762|NCT05889390|Alkylating Agents|alkylating agents|mesh-ancestor
154174763|NCT05889390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154174764|NCT05889390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154174765|NCT05889390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154174766|NCT05889390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154174767|NCT05889390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174768|NCT05889338|Adalimumab|adalimumab|mesh-list
154174769|NCT05889338|Methotrexate|methotrexate|mesh-list
154174770|NCT05889338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154174771|NCT05889338|Abortifacient Agents|abortifacient agents|mesh-ancestor
154174772|NCT05889338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154174773|NCT05889338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174774|NCT05889338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154174775|NCT05889338|Antimetabolites|antimetabolites|mesh-ancestor
154174776|NCT05889338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174777|NCT05889338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174778|NCT05889338|Dermatologic Agents|dermatologic agents|mesh-ancestor
154174779|NCT05889338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174780|NCT05889338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154174781|NCT05889338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154174782|NCT05889338|Immunologic Factors|immunologic factors|mesh-ancestor
154174783|NCT05889338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174810|NCT05887947|Cholinergic Agents|cholinergic agents|mesh-ancestor
154174811|NCT05887947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174812|NCT05887947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174814|NCT05887908|Cefepime|cefepime|mesh-list
154174815|NCT05887908|Aztreonam|aztreonam|mesh-list
154174816|NCT05887908|Cilastatin|cilastatin|mesh-list
154174817|NCT05887908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154174818|NCT05887908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174819|NCT05887908|Protease Inhibitors|protease inhibitors|mesh-ancestor
154174820|NCT05887908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174821|NCT05887908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174822|NCT05887778|Dexamethasone|dexamethasone|mesh-list
154174823|NCT05887778|Dexamethasone acetate|dexamethasone acetate|mesh-list
154174824|NCT05887778|BB 1101|bb 1101|mesh-list
154174825|NCT05887778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174826|NCT05887778|Antiemetics|antiemetics|mesh-ancestor
154174827|NCT05887778|Autonomic Agents|autonomic agents|mesh-ancestor
154174828|NCT05887778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174829|NCT05887778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174830|NCT05887778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154174856|NCT05743946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154174857|NCT05743946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174859|NCT05742789|Sevoflurane|sevoflurane|mesh-list
154174860|NCT05742789|Isoflurane|isoflurane|mesh-list
154174861|NCT05742789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154174862|NCT05742789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174863|NCT05742789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174864|NCT05742789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154174865|NCT05742789|Anesthetics, General|anesthetics, general|mesh-ancestor
154174866|NCT05742789|Anesthetics|anesthetics|mesh-ancestor
154174867|NCT05742789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154174868|NCT05742789|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154174869|NCT05721846|Nivolumab|nivolumab|mesh-list
154068586|NCT00708578|Glimepiride|glimepiride|mesh-list
154174870|NCT05721846|Ipilimumab|ipilimumab|mesh-list
154174871|NCT05721846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174872|NCT05721846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174873|NCT05721846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154174874|NCT05721846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174875|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154174876|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153757505|NCT04675177|Polidocanol|polidocanol|mesh-list
154174908|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154860826|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154255020|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154174909|NCT05389514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154174910|NCT05327777|Oxycodone|oxycodone|mesh-list
154174911|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154174912|NCT05327777|Narcotics|narcotics|mesh-ancestor
154174913|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174914|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174915|NCT05327777|Analgesics|analgesics|mesh-ancestor
154174916|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
154174917|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174918|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
154174919|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174920|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174921|NCT05304546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154174950|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174951|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174952|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
154174953|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174954|NCT04680975|Belumosudil|belumosudil|mesh-list
154174955|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154174956|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174957|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174958|NCT04673786|Ustekinumab|ustekinumab|mesh-list
154174959|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
154174960|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154174961|NCT04602533|Durvalumab|durvalumab|mesh-list
154174962|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174963|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174964|NCT04597671|Durvalumab|durvalumab|mesh-list
154174965|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174966|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174967|NCT04583969|Remdesivir|remdesivir|mesh-list
154174968|NCT04583969|Lenzilumab|lenzilumab|mesh-list
154174996|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174997|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154174998|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
154174999|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
154175000|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175001|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175002|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154175003|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154175004|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154175005|NCT04468776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154175006|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154175007|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175008|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
154175009|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154175010|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
154175011|NCT04416269|Insulin|insulin|mesh-list
154175012|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154175013|NCT04416269|Metformin|metformin|mesh-list
154175014|NCT04416269|Pioglitazone|pioglitazone|mesh-list
154182198|NCT05856695|Carboplatin|carboplatin|mesh-list
154175046|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
154175047|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175048|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154175049|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
154175050|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175051|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154175053|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154175054|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175055|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175056|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068659|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175057|NCT04219280|Methylphenidate|methylphenidate|mesh-list
154175058|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154175059|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175082|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154175083|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154175084|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154175085|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
154175086|NCT04177693|Protective Agents|protective agents|mesh-ancestor
154175087|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154175088|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154860827|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154175089|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154175090|NCT04118387|Acetazolamide|acetazolamide|mesh-list
154175091|NCT04118387|Zolpidem|zolpidem|mesh-list
154175092|NCT04118387|Buspirone|buspirone|mesh-list
154175093|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
154175094|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154175095|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175096|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175098|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
154175099|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175100|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154175101|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154175102|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175103|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154175104|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
154175105|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
154175106|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175107|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154175108|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154175109|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154175110|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154175111|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
154175112|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
154175143|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175144|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
154175145|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154175146|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
154175147|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175148|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154175149|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
154175150|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
154175151|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154175152|NCT03859869|Pancrelipase|pancrelipase|mesh-list
154175153|NCT03859869|Pancreatin|pancreatin|mesh-list
154175154|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154175155|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154175185|NCT03735563|Narcotics|narcotics|mesh-ancestor
154175186|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154175187|NCT03715153|Bumetanide|bumetanide|mesh-list
154175188|NCT03715153|Diuretics|diuretics|mesh-ancestor
154175189|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
154175190|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175191|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154175192|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175193|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175194|NCT03685773|Niacin|niacin|mesh-list
154175195|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
154175196|NCT03685773|Niacinamide|niacinamide|mesh-list
154175197|NCT03685773|Diazoxide|diazoxide|mesh-list
154175198|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154175199|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
154175200|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175201|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154175274|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175405|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175406|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175407|NCT01082679|Analgesics|analgesics|mesh-ancestor
154175408|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
154175409|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175410|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153758043|NCT00554476|Triamcinolone|triamcinolone|mesh-list
154175444|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
154175445|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154175446|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175447|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154175448|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
154175449|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175450|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175484|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154175486|NCT00357994|Carbidopa|carbidopa|mesh-list
154175487|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154175488|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154175489|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154175490|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
154175491|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175511|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
154175512|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175513|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175514|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154175515|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154175516|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
154175517|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175518|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175519|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
154175520|NCT00827021|Hematinics|hematinics|mesh-list
154175521|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
154175522|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
154175523|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175524|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
154175525|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175526|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175527|NCT02550119|Dexamethasone|dexamethasone|mesh-list
154175528|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
154175529|NCT02550119|Aprepitant|aprepitant|mesh-list
154175530|NCT02550119|Dolasetron|dolasetron|mesh-list
154175531|NCT02550119|Ichthammol|ichthammol|mesh-list
154175532|NCT02550119|BB 1101|bb 1101|mesh-list
154175533|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175534|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
154175535|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
154175536|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175537|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175538|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154175539|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
154175540|NCT02550119|Hormones|hormones|mesh-ancestor
154175541|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175542|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154175543|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175544|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
154175545|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175546|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175547|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154175548|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175549|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
154175550|NCT02550119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154175577|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154175578|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154175579|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175580|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175581|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154175582|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
154175583|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175584|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175585|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154175586|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154175587|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154175588|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154175589|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154175590|NCT02549261|Etoposide|etoposide|mesh-list
154175591|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
154175592|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175593|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154175594|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154175595|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154175596|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175597|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175598|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175650|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154175651|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154175652|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
154175654|NCT01053208|Promethazine|promethazine|mesh-list
154175655|NCT01053208|Ibuprofen|ibuprofen|mesh-list
154175656|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175657|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154175658|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154175659|NCT01053208|Analgesics|analgesics|mesh-ancestor
154175660|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
154175661|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175662|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175663|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175664|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175665|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154175666|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175667|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154175668|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154175669|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175670|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
154175671|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
154175672|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
154175673|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
154175674|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154175675|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154175676|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
154175677|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
154175678|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175679|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154175680|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
154175681|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
154175682|NCT00423189|Ranibizumab|ranibizumab|mesh-list
154175683|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154175739|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154175741|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175742|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
154175743|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154175744|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154175745|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154175746|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
154175747|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175748|NCT00435045|Atorvastatin|atorvastatin|mesh-list
154175749|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154175750|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154175751|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
154175772|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175774|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154175775|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175776|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175777|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154175778|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
154175779|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
154175780|NCT00832481|Metformin|metformin|mesh-list
154175781|NCT00832481|Repaglinide|repaglinide|mesh-list
154175782|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175783|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175784|NCT04044287|Misoprostol|misoprostol|mesh-list
154175785|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154175786|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
154175787|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154175788|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175789|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154175790|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154175791|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
154175792|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
154175793|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154068875|NCT00803712|Vitamins|vitamins|mesh-list
154175794|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175795|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175796|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175797|NCT00825071|Dexamethasone|dexamethasone|mesh-list
154175798|NCT00825071|Ondansetron|ondansetron|mesh-list
154175799|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175800|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
154175801|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
154175802|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175803|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175804|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154175880|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175881|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154175882|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154175883|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154175884|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175885|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175886|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154175887|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
154175888|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154175889|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
154175890|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175891|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175892|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154175893|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
154175894|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
154175895|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154175896|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
154175897|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175898|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175899|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
154068876|NCT00803712|Cinacalcet|cinacalcet|mesh-list
154175900|NCT02549963|Anticoagulants|anticoagulants|mesh-list
154175901|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154175902|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
154175903|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154176027|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
154176028|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
154176029|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176030|NCT00833963|Immunotoxins|immunotoxins|mesh-ancestor
154176031|NCT00833963|Immunoconjugates|immunoconjugates|mesh-ancestor
154176032|NCT00833963|Immunologic Factors|immunologic factors|mesh-ancestor
154176033|NCT00833963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176035|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154176036|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176037|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
154176038|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154176039|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154176040|NCT04043897|Rifaximin|rifaximin|mesh-list
153758657|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
154176094|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176096|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176097|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176098|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
154176099|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154176100|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176101|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154176102|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154176103|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154176104|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176105|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
154176106|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176107|NCT00356278|Cycloserine|cycloserine|mesh-list
154176108|NCT00356278|Alprazolam|alprazolam|mesh-list
154176109|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154176145|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154176146|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154176166|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
154176167|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
154176168|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176169|NCT00356200|Fluphenazine|fluphenazine|mesh-list
154176170|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
154176171|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
154176172|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154176173|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154176174|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176175|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176176|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154176177|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154176178|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
154176179|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176180|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176181|NCT00356122|Bevacizumab|bevacizumab|mesh-list
154176182|NCT00356122|Docetaxel|docetaxel|mesh-list
154176183|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
154176184|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154176185|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176186|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154176187|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154176188|NCT00356122|Growth Substances|growth substances|mesh-ancestor
154176189|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176190|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
154176191|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
154176192|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
154176193|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
154176194|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176195|NCT00828815|Etravirine|etravirine|mesh-list
154176196|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154176197|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154176198|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176199|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176200|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
154176201|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176202|NCT01053520|Navitoclax|navitoclax|mesh-list
154176203|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176204|NCT00347932|Besifloxacin|besifloxacin|mesh-list
154176211|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176212|NCT00828971|Amoxicillin|amoxicillin|mesh-list
154176213|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
154176214|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154068988|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
154176215|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176216|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176217|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154176218|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154171834|NCT02203526|Cytarabine|cytarabine|mesh-list
154176219|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176220|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176221|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176222|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154176223|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
154176224|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154176225|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176226|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154176227|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154176228|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154176229|NCT00528996|Bromides|bromides|mesh-list
154176230|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
154176231|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154176232|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
154176233|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176234|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176235|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154176236|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
154176237|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
154176238|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154176239|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
154176240|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068989|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154069016|NCT00590538|Protective Agents|protective agents|mesh-ancestor
154176241|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176242|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
154176243|NCT00359788|Albuterol|albuterol|mesh-list
154176244|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
154176245|NCT00359788|Ipratropium|ipratropium|mesh-list
154176246|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154176247|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
154176248|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176249|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176250|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154176251|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
154176252|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
154176253|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154176254|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
154176255|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176256|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176257|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
154176258|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154176259|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154176260|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154176261|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154176262|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
154176263|NCT00623597|Ritonavir|ritonavir|mesh-list
154176264|NCT00623597|Saquinavir|saquinavir|mesh-list
154176265|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154176266|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154176267|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
154176268|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069024|NCT00590538|Hormones|hormones|mesh-ancestor
154176269|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176270|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154176271|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154176282|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176283|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
154176284|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176285|NCT00838955|Sirolimus|sirolimus|mesh-list
154176286|NCT00838955|Temsirolimus|temsirolimus|mesh-list
154176287|NCT00838955|MTOR Inhibitors|mtor inhibitors|mesh-list
154176288|NCT00838955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154176289|NCT00838955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176290|NCT00838955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176291|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176292|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
154176293|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176294|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176295|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176296|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176297|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154176298|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
154176299|NCT00347776|Azithromycin|azithromycin|mesh-list
154176300|NCT00347776|Tetracycline|tetracycline|mesh-list
154176301|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176302|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176303|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154176304|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176305|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176306|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154176307|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154176308|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176309|NCT00829205|Rituximab|rituximab|mesh-list
154176310|NCT00829205|Carboplatin|carboplatin|mesh-list
154176311|NCT00829205|Etoposide|etoposide|mesh-list
154176312|NCT00829205|Ifosfamide|ifosfamide|mesh-list
154176313|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
154176314|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154176315|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176316|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
154176317|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176318|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176319|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154176320|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154176321|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154176322|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176323|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176324|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154176325|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
154176326|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154176327|NCT00829205|Protective Agents|protective agents|mesh-ancestor
154176328|NCT00839111|Irinotecan|irinotecan|mesh-list
154176329|NCT00839111|Sorafenib|sorafenib|mesh-list
154176330|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154176331|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154176332|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176333|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069049|NCT04110873|Ubiquinone|ubiquinone|mesh-list
154176334|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176335|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154176336|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154176361|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176362|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154176363|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154176365|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176366|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176367|NCT00836849|Sertraline|sertraline|mesh-list
154176368|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
154176370|NCT00836849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154176371|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154176372|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154176373|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176374|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176375|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
154176376|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176377|NCT00839345|Clopidogrel|clopidogrel|mesh-list
154176378|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154176379|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154176380|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154176381|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154176382|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
154176383|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176384|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176385|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176416|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
154176417|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
154176418|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154176419|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176420|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
154176421|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154176422|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176423|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154176424|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176425|NCT00840125|Docetaxel|docetaxel|mesh-list
154176426|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154176427|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176428|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069116|NCT02607072|Aspirin|aspirin|mesh-list
154176429|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154176442|NCT05014542|Analgesics|analgesics|mesh-list
154176443|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
154176444|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176445|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176446|NCT00621257|Vitamin D|vitamin d|mesh-list
154176447|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
154176448|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
154176449|NCT00621257|Vitamins|vitamins|mesh-list
154176450|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
154176451|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176452|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154176453|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154176454|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
154176455|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154176456|NCT00840671|Protective Agents|protective agents|mesh-ancestor
154176457|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176458|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
154176459|NCT02546531|Gemcitabine|gemcitabine|mesh-list
154176460|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
154176461|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154176462|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
154176463|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176464|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176465|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154176466|NCT02546531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154176467|NCT05205720|Ropivacaine|ropivacaine|mesh-list
154176468|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
154176469|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
154027476|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027477|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154027478|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027479|NCT02832089|Carvedilol|carvedilol|mesh-list
154027480|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154027481|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154027482|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
154027483|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027484|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027485|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027486|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154027487|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
154027488|NCT02832089|Protective Agents|protective agents|mesh-ancestor
154027489|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154027490|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154027491|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154027492|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
154027493|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154027494|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154027495|NCT04247633|Palbociclib|palbociclib|mesh-list
154027496|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027513|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027514|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027515|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027516|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
154027517|NCT02829281|Hormones|hormones|mesh-ancestor
154027518|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027519|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154027520|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
153972027|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153972028|NCT02960763|Aripiprazole|aripiprazole|mesh-list
153972029|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
153972030|NCT02960763|Bupropion|bupropion|mesh-list
153972031|NCT02960763|Nortriptyline|nortriptyline|mesh-list
153972032|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153972033|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
153972034|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153972035|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153972036|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153972037|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972038|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972039|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
153972040|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069209|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972041|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972042|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153972043|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153972044|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972045|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153972046|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153972047|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972048|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
153972049|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153972050|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153972051|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
153972052|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153972053|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153972054|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153972055|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153972056|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
153972057|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153972058|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153972059|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
153972069|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
153972070|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972071|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153972072|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153972073|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153972074|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154069210|NCT01026337|Sunitinib|sunitinib|mesh-list
154069211|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972075|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972076|NCT02586961|Betamethasone|betamethasone|mesh-list
153972077|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
153972078|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153972079|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
153972080|NCT02586961|Epinephrine|epinephrine|mesh-list
153972081|NCT02586961|Racepinephrine|racepinephrine|mesh-list
153972082|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153972083|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
153972084|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972085|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
153972086|NCT02586961|Hormones|hormones|mesh-ancestor
153972087|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153972088|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972089|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153972090|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
153972091|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153972092|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153972093|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
153972094|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972095|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972096|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153972097|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153972098|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
153972099|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069261|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153729664|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
153972101|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
153972102|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153972103|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153972104|NCT02700711|Methylphenidate|methylphenidate|mesh-list
153972105|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153972106|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972107|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153972108|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153972109|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972110|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972111|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
153972112|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972113|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153972115|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
153972116|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972117|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
153972118|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153972119|NCT04215159|Gemcitabine|gemcitabine|mesh-list
153972120|NCT04215159|Trastuzumab|trastuzumab|mesh-list
153972121|NCT04215159|Irinotecan|irinotecan|mesh-list
153972122|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153972123|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
153972124|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972125|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972145|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972147|NCT02700087|Ranitidine|ranitidine|mesh-list
153972148|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153972149|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153972150|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972151|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153972152|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
153972153|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
153972154|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972155|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972156|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972157|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
153972158|NCT02586181|Vitamin D|vitamin d|mesh-list
153972159|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
153972160|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
153972161|NCT02586181|Vitamins|vitamins|mesh-list
153972162|NCT02586181|Folic Acid|folic acid|mesh-list
153972163|NCT02586181|Calcium|calcium|mesh-list
153972164|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
153972165|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972166|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153972167|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153972168|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
153972169|NCT02586181|Hematinics|hematinics|mesh-ancestor
153972170|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153972171|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153972172|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972173|NCT00775138|Amikacin|amikacin|mesh-list
153729749|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
153972174|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153972175|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972176|NCT03236805|Ketamine|ketamine|mesh-list
153972177|NCT03236805|Morphine|morphine|mesh-list
153972178|NCT03236805|Analgesics|analgesics|mesh-ancestor
153972179|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
153972180|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972181|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972182|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153972195|NCT02698995|Lidocaine|lidocaine|mesh-list
154069324|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972196|NCT02698995|Morphine|morphine|mesh-list
154069325|NCT00802074|Ritonavir|ritonavir|mesh-list
153972197|NCT02698995|Ropivacaine|ropivacaine|mesh-list
153972198|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972199|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
153972200|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
153972201|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972202|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972203|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972204|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
153972205|NCT02698995|Hormones|hormones|mesh-ancestor
153972206|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153972207|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153972208|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972209|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
153972210|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
153972211|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972212|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
153972213|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153972214|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154134004|NCT01563939|Remifentanil|remifentanil|mesh-list
153972215|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153972216|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972217|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972218|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153972219|NCT02698995|Narcotics|narcotics|mesh-ancestor
153972220|NCT02698995|Analgesics|analgesics|mesh-ancestor
153972221|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153972222|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
153972223|NCT00920101|Atorvastatin|atorvastatin|mesh-list
153972224|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153972225|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153972226|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
153972227|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972228|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154069326|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
154069347|NCT00450385|Prednisone|prednisone|mesh-list
153972229|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153972230|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972231|NCT00616785|Irinotecan|irinotecan|mesh-list
153972232|NCT00616785|Etoposide|etoposide|mesh-list
153972233|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972234|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153972235|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153972236|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972237|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972238|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153972239|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153972240|NCT00616005|Irinotecan|irinotecan|mesh-list
153972241|NCT00616005|Temozolomide|temozolomide|mesh-list
153972242|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153972243|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153972244|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972245|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972262|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153972263|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153972264|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
153972265|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972266|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153972267|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153972268|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972269|NCT02586649|Bromides|bromides|mesh-list
153972270|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
153972271|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153972272|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153972273|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
153972274|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972275|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972276|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153972277|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
153972278|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
153972279|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
153972280|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972281|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972282|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
153972283|NCT04213833|Lidocaine|lidocaine|mesh-list
153972284|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
153972285|NCT04213833|Propofol|propofol|mesh-list
153972286|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
153972287|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
153972288|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972289|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972290|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
153972291|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972292|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153972293|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153972294|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153972295|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972296|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972297|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153972298|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153972299|NCT04213833|Analgesics|analgesics|mesh-ancestor
153972300|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153972301|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153972302|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154860828|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153972303|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
153972335|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972336|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153972337|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153972338|NCT00617253|Growth Substances|growth substances|mesh-ancestor
153972339|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972340|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
153972341|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972342|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972343|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972344|NCT02585947|Tenofovir|tenofovir|mesh-list
153972345|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
153972346|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972347|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153972363|NCT04079725|Mitomycins|mitomycins|mesh-list
153972364|NCT04079725|Mitomycin|mitomycin|mesh-list
153972365|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153972366|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972367|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
153972368|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972369|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153972370|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972371|NCT00783718|Vedolizumab|vedolizumab|mesh-list
153972372|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972373|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153972374|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972375|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153972376|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153972377|NCT04213287|Analgesics|analgesics|mesh-ancestor
153972378|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
153972379|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972380|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972381|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153972382|NCT02585791|Glycerol|glycerol|mesh-list
153972383|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153972384|NCT02585791|Protective Agents|protective agents|mesh-ancestor
153972385|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972386|NCT04913389|Acetazolamide|acetazolamide|mesh-list
153972387|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
153972388|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153972389|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972390|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972391|NCT04913389|Diuretics|diuretics|mesh-ancestor
154069408|NCT00449761|Panobinostat|panobinostat|mesh-list
153972392|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
153972393|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972394|NCT04904965|Propofol|propofol|mesh-list
153972395|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153972396|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972397|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972398|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153972399|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
153972400|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
153972401|NCT00617565|Insulin|insulin|mesh-list
153972402|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153972403|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
153972404|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
153972405|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153972406|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972407|NCT04079413|Insulin|insulin|mesh-list
153972430|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153972431|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153972432|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153972433|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153972434|NCT02584075|Metformin|metformin|mesh-list
153972435|NCT02584075|Exenatide|exenatide|mesh-list
153972436|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153972437|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972438|NCT02584075|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153972439|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153972440|NCT02584075|Incretins|incretins|mesh-ancestor
153972441|NCT02584075|Hormones|hormones|mesh-ancestor
153972442|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153972443|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
153972444|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
153972445|NCT02585479|Pirarubicin|pirarubicin|mesh-list
153972446|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
153972447|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972448|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
153972449|NCT02585479|Coagulants|coagulants|mesh-ancestor
153972450|NCT00583453|Celecoxib|celecoxib|mesh-list
153972451|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153972452|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153972453|NCT00583453|Analgesics|analgesics|mesh-ancestor
153972454|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
153972455|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972456|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972457|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972458|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153972459|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154069469|NCT01566253|Ketoprofen|ketoprofen|mesh-list
153972460|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153972461|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972470|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153972471|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972472|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972473|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
153972474|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972475|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972476|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153972477|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
153972478|NCT02584153|Coagulants|coagulants|mesh-ancestor
153972479|NCT02585401|Aflibercept|aflibercept|mesh-list
153972480|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153972481|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153972482|NCT02585401|Growth Substances|growth substances|mesh-ancestor
153972483|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972484|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
153972485|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972486|NCT04080349|Misoprostol|misoprostol|mesh-list
153972487|NCT04080349|Dinoprostone|dinoprostone|mesh-list
153972488|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153972489|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
153972490|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153972491|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972492|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153972493|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972494|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
153972495|NCT02585011|Epinephrine|epinephrine|mesh-list
153972496|NCT02585011|Ropivacaine|ropivacaine|mesh-list
153972497|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
153972498|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
153972499|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972500|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972501|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
153972502|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972503|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153972504|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153972505|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
153972506|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972507|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972508|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153972509|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153972510|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
153972511|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153972512|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
153972513|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
153972514|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
153972515|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153972516|NCT00920725|Insulin|insulin|mesh-list
153972517|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153972518|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
153972519|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154069507|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153972520|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972521|NCT02583451|Lemborexant|lemborexant|mesh-list
153972522|NCT02583451|Zopiclone|zopiclone|mesh-list
153972523|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153972524|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972525|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972526|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153972527|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153972528|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972529|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972551|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
154134230|NCT00832442|Metoprolol|metoprolol|mesh-list
153972552|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972553|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
153972554|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972555|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
153972556|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972557|NCT04606771|Osimertinib|osimertinib|mesh-list
153972558|NCT04606771|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153972559|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972560|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972561|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972562|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972563|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153972564|NCT04504123|Doxycycline|doxycycline|mesh-list
153972565|NCT04504123|Tetracycline|tetracycline|mesh-list
153972566|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972567|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
153972568|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153972569|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153972570|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153972571|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972572|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972573|NCT02584543|Vaccines|vaccines|mesh-list
153972574|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
153972575|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972576|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153972577|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153972578|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153972579|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
153972580|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153972581|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972582|NCT04077853|Progestins|progestins|mesh-ancestor
153972583|NCT04077853|Hormones|hormones|mesh-ancestor
153972609|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153972610|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153972611|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
153972612|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972613|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972614|NCT01072175|Trametinib|trametinib|mesh-list
153972615|NCT01072175|Dabrafenib|dabrafenib|mesh-list
153972616|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972617|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972618|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972619|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972620|NCT04078711|Losartan|losartan|mesh-list
153972621|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153972622|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153972623|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153972624|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153972625|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730194|NCT00140868|Phenobarbital|phenobarbital|mesh-list
153972626|NCT04304573|Calcium|calcium|mesh-list
153972627|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153972628|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972629|NCT04426669|Aldesleukin|aldesleukin|mesh-list
153759744|NCT01054248|Artesunate|artesunate|mesh-list
153972634|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
153972635|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972636|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153972637|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153972638|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
153972639|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972640|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972641|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153972642|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153972643|NCT04426669|Analgesics|analgesics|mesh-ancestor
153972644|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
153972645|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972646|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153972647|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153972648|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
153972649|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972650|NCT02874989|Dasatinib|dasatinib|mesh-list
153972651|NCT02874989|Quercetin|quercetin|mesh-list
154860829|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972652|NCT02874989|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153972653|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972654|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972655|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972656|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972657|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
153972658|NCT02874989|Protective Agents|protective agents|mesh-ancestor
153972659|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972660|NCT01071317|Naproxen|naproxen|mesh-list
153972661|NCT01071317|Sumatriptan|sumatriptan|mesh-list
153972662|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153972663|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153972664|NCT01071317|Analgesics|analgesics|mesh-ancestor
153972665|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
153972666|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972667|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972668|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972669|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153972670|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
153972671|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153972672|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972673|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972674|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153972675|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153972676|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153972677|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
153972678|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972679|NCT00783094|Tadalafil|tadalafil|mesh-list
153972680|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
153972681|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153972682|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153972683|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972684|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972685|NCT00783094|Urological Agents|urological agents|mesh-ancestor
153972686|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
153972687|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
153972688|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153972689|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069654|NCT00448669|Tenofovir|tenofovir|mesh-list
153972690|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972691|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
153972692|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153972693|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972694|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972695|NCT02583217|Ketamine|ketamine|mesh-list
153972696|NCT02583217|Remifentanil|remifentanil|mesh-list
153972697|NCT02583217|Propofol|propofol|mesh-list
153972698|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154027521|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972699|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972700|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972727|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153972728|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
153972729|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972730|NCT00774046|Analgesics|analgesics|mesh-ancestor
153972731|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
153972732|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972733|NCT01046903|Dalteparin|dalteparin|mesh-list
153972734|NCT01046903|Tinzaparin|tinzaparin|mesh-list
153972735|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153972736|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
153972737|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153972738|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153972739|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972740|NCT02581423|Capecitabine|capecitabine|mesh-list
153972741|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153972742|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
153972743|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972744|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972745|NCT04102072|Dobutamine|dobutamine|mesh-list
153972746|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153972747|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
153972748|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
153972749|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255022|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730341|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153972776|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153972778|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
153972779|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972780|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972781|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972782|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153972783|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153972784|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972785|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972786|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153972787|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153972788|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
153972789|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972790|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153972791|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153972792|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
153972793|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153972794|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
153972795|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
153972796|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
153972797|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153972798|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153972799|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
153972815|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153972816|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
153972817|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972818|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972819|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972820|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153972821|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153972822|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972823|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153972824|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153972825|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
153972827|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
153972828|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972829|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972830|NCT04076371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153972831|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153972832|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972833|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
153972834|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153972835|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153972836|NCT01071083|Interferons|interferons|mesh-list
153972837|NCT01071083|Interferon-beta|interferon-beta|mesh-list
153972838|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
153972839|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
153972840|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
153972841|NCT01071083|Natalizumab|natalizumab|mesh-list
153972842|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
153972843|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972844|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
153972845|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069734|NCT00848393|Analgesics|analgesics|mesh-ancestor
153972846|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972847|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
153972848|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
153972849|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176471|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972850|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972851|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972852|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
153972853|NCT01071083|Hormones|hormones|mesh-ancestor
153972854|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153972855|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153972856|NCT01071083|Protective Agents|protective agents|mesh-ancestor
153972857|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
153972858|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153972859|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153972860|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153972888|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972889|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154860830|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860831|NCT02604537|Ketorolac|ketorolac|mesh-list
153972890|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153972891|NCT01010126|Growth Substances|growth substances|mesh-ancestor
153972892|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972893|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
153972894|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
153972895|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153972896|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972897|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153972898|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
153972899|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153972900|NCT01010126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972901|NCT01010126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972902|NCT01010126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972903|NCT04076137|Decitabine|decitabine|mesh-list
153972904|NCT04076137|Antibodies|antibodies|mesh-list
153972905|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153972906|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
153972907|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972908|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153972909|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
153972910|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972954|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
153972955|NCT02582437|Narcotics|narcotics|mesh-ancestor
153972956|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972957|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972958|NCT02582437|Analgesics|analgesics|mesh-ancestor
153972959|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
153972960|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972961|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
153972962|NCT05674201|Remifentanil|remifentanil|mesh-list
153972963|NCT05674201|Propofol|propofol|mesh-list
153972964|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153972965|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972966|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972967|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153972968|NCT05674201|Analgesics|analgesics|mesh-ancestor
153972969|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
153972970|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972971|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153972972|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153972973|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153972974|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
153972975|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972976|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972977|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153972978|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
153972979|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
153972980|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153972981|NCT05674201|Narcotics|narcotics|mesh-ancestor
153972982|NCT01070303|Adalimumab|adalimumab|mesh-list
153972983|NCT01070303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153972984|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972985|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153972986|NCT00618111|Granisetron|granisetron|mesh-list
153972987|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
153972988|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
154069811|NCT00448591|Taxane|taxane|mesh-list
153972989|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972990|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972991|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972992|NCT00618111|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153972993|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153972994|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
153972995|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972996|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972997|NCT01009814|Ritonavir|ritonavir|mesh-list
153972998|NCT01009814|Fostemsavir|fostemsavir|mesh-list
153973041|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
153973042|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153973043|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973044|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153973045|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153973046|NCT00773734|Growth Substances|growth substances|mesh-ancestor
153973047|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
153973048|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973049|NCT04297202|Apatinib|apatinib|mesh-list
153973050|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973051|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153973052|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973053|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973054|NCT02691897|Melatonin|melatonin|mesh-list
153973055|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
153973056|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973057|NCT02691897|Protective Agents|protective agents|mesh-ancestor
153973058|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973059|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973060|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
153973061|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973062|NCT01009580|Insulin|insulin|mesh-list
153973063|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153973064|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
153973065|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
153973066|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153973067|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
153973068|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153973069|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973070|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973071|NCT01009346|Cisplatin|cisplatin|mesh-list
153973072|NCT01009346|Carboplatin|carboplatin|mesh-list
153973073|NCT01009346|Cetuximab|cetuximab|mesh-list
153973074|NCT01009346|Everolimus|everolimus|mesh-list
153626684|NCT02018289|Triclosan|triclosan|mesh-list
153973075|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973076|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153973077|NCT01009346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153973078|NCT01009346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153973079|NCT01009346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973080|NCT01009346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973081|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973083|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973085|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
153973116|NCT00618345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973118|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
153973119|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973120|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973121|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
153973122|NCT02601898|Progesterone|progesterone|mesh-list
153973123|NCT02601898|Progestins|progestins|mesh-ancestor
153973124|NCT02601898|Hormones|hormones|mesh-ancestor
153973125|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153973126|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973127|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
154182199|NCT05856695|Durvalumab|durvalumab|mesh-list
153973142|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973143|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153973144|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153973145|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973146|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973147|NCT04101760|Lenograstim|lenograstim|mesh-list
153973148|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153626758|NCT02018874|Gemcitabine|gemcitabine|mesh-list
153973149|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
153973150|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973151|NCT00616551|Octreotide|octreotide|mesh-list
153973152|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153973153|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153973154|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973155|NCT04214145|Phenylephrine|phenylephrine|mesh-list
153973156|NCT04214145|Vasopressins|vasopressins|mesh-list
153973157|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
153973158|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
153973159|NCT04214145|Norepinephrine|norepinephrine|mesh-list
153973160|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153973161|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
153973162|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
153973163|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973164|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973165|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
153973166|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153973167|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
153973168|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
153973169|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154255023|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153973170|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153973171|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153973172|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
153973173|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973174|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973175|NCT04214145|Protective Agents|protective agents|mesh-ancestor
153973176|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
153973177|NCT04214145|Coagulants|coagulants|mesh-ancestor
153973178|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153973179|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
153973180|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
153973181|NCT04212429|Levofloxacin|levofloxacin|mesh-list
153973182|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153973183|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153973184|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153973185|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973186|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153973187|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153973188|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760273|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
153973200|NCT00618501|Cytarabine|cytarabine|mesh-list
153973201|NCT00618501|Prednisolone|prednisolone|mesh-list
153973202|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
153973203|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153973204|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153973205|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153973206|NCT00618501|Methotrexate|methotrexate|mesh-list
153973207|NCT00618501|Etoposide|etoposide|mesh-list
153973208|NCT00618501|Vincristine|vincristine|mesh-list
153973209|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
153973210|NCT00618501|Daunorubicin|daunorubicin|mesh-list
153973211|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
153973212|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973213|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153973214|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
153973215|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153973216|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153973217|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
153973218|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973219|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973220|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
153973221|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973222|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153973223|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176472|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
153973224|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
153973225|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973226|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153973227|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153973228|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153973229|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153973230|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
153973231|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973232|NCT00618501|Antidotes|antidotes|mesh-ancestor
153973233|NCT00618501|Protective Agents|protective agents|mesh-ancestor
153973234|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
153973236|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
153973237|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
153973238|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
153973239|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
153973240|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973241|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
153973242|NCT00618501|Hormones|hormones|mesh-ancestor
153973243|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153973244|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153973245|NCT00618501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153973246|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153973247|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153973248|NCT00772954|Vaccines|vaccines|mesh-list
153973249|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
153973250|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973251|NCT05322681|Pregabalin|pregabalin|mesh-list
153973252|NCT05322681|Analgesics|analgesics|mesh-ancestor
153973253|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
153973264|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153973265|NCT05322603|Diclofenac|diclofenac|mesh-list
154860832|NCT02604537|Betamethasone|betamethasone|mesh-list
154134684|NCT00840398|Buspirone|buspirone|mesh-list
153973266|NCT05322603|Morphine|morphine|mesh-list
153973267|NCT05322603|Analgesics|analgesics|mesh-list
153973268|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
153973269|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153973270|NCT05322603|Narcotics|narcotics|mesh-ancestor
153973271|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973272|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973273|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
153973274|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973275|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973276|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973277|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973278|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153973279|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973280|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973281|NCT00618579|Warfarin|warfarin|mesh-list
153973282|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
153973283|NCT00781768|Ondansetron|ondansetron|mesh-list
153973284|NCT00781768|Aprepitant|aprepitant|mesh-list
153973285|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
153973286|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
153973287|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973288|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973289|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153973290|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
153973291|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
153973292|NCT00781768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153973293|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153973294|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
153973295|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973296|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973297|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153973298|NCT01005680|Gemcitabine|gemcitabine|mesh-list
153973299|NCT01005680|Pemetrexed|pemetrexed|mesh-list
153973300|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626904|NCT02019524|Folic Acid|folic acid|mesh-list
153973301|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153973302|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
153973303|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973304|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973305|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153973306|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153973307|NCT04101370|Bosentan|bosentan|mesh-list
153973308|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153973309|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153973310|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973312|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153973313|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973314|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973315|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
153973316|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973339|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153973340|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153973341|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
153973342|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
153973343|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973344|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153973345|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154070043|NCT00447421|Pemetrexed|pemetrexed|mesh-list
153973346|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973347|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973348|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153973349|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153973350|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153973351|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153973352|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153973353|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
153973354|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
153973355|NCT04101136|Atorvastatin|atorvastatin|mesh-list
153973356|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153973357|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153973358|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
153973359|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973360|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154860833|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973361|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153973362|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973363|NCT00618969|Busulfan|busulfan|mesh-list
153973364|NCT00618969|Melphalan|melphalan|mesh-list
153973365|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
153973366|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973367|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973368|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
153973369|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760463|NCT00216684|Fentanyl|fentanyl|mesh-list
153973383|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973384|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153973385|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153973386|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973388|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973389|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
153973390|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
153973391|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
153973392|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
153973393|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153973394|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973395|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153973396|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153973397|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153973398|NCT00582907|Rilonacept|rilonacept|mesh-list
153973399|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973400|NCT01062113|Celecoxib|celecoxib|mesh-list
153973401|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973402|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973403|NCT01062113|Analgesics|analgesics|mesh-ancestor
153973404|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
153973405|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973406|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973407|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973408|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973409|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153973410|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153973411|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973412|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973413|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153973414|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153973415|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
153973416|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973417|NCT04075201|Vaccines|vaccines|mesh-list
153973418|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
153973419|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973420|NCT01038869|Azelaic acid|azelaic acid|mesh-list
153973421|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973422|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
153973423|NCT00768040|Aliskiren|aliskiren|mesh-list
153973424|NCT00768040|Renin Inhibitors|renin inhibitors|mesh-ancestor
153973425|NCT00768040|Protease Inhibitors|protease inhibitors|mesh-ancestor
153973426|NCT00768040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973427|NCT00768040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973428|NCT02580331|Metformin|metformin|mesh-list
153973429|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973430|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973467|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973468|NCT06184698|Leucovorin|leucovorin|mesh-list
153973469|NCT06184698|Bevacizumab|bevacizumab|mesh-list
153973470|NCT06184698|Fluorouracil|fluorouracil|mesh-list
153973471|NCT06184698|Irinotecan|irinotecan|mesh-list
153973472|NCT06184698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153973473|NCT06184698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973474|NCT06184698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153973475|NCT06184698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153973476|NCT06184698|Growth Substances|growth substances|mesh-ancestor
153973477|NCT06184698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973478|NCT06184698|Growth Inhibitors|growth inhibitors|mesh-ancestor
153973479|NCT06184698|Antimetabolites|antimetabolites|mesh-ancestor
153973531|NCT06184139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973532|NCT06184139|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153973533|NCT06184139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153973536|NCT06250062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153973537|NCT06250062|Immunologic Factors|immunologic factors|mesh-ancestor
154255025|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153973538|NCT06250062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973539|NCT06249984|Lobeline|lobeline|mesh-list
153973540|NCT06249984|Carbon Monoxide|carbon monoxide|mesh-list
153973541|NCT06249984|Antimetabolites|antimetabolites|mesh-ancestor
153973542|NCT06249984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973543|NCT06249984|Gasotransmitters|gasotransmitters|mesh-ancestor
153973544|NCT06249984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973545|NCT06249984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973546|NCT06249984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153973547|NCT06249984|Autonomic Agents|autonomic agents|mesh-ancestor
153973548|NCT06249984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973549|NCT06249984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153973550|NCT06249984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153973551|NCT06249984|Cholinergic Agents|cholinergic agents|mesh-ancestor
153973552|NCT06249984|Respiratory System Agents|respiratory system agents|mesh-ancestor
153973553|NCT06249945|Empagliflozin|empagliflozin|mesh-list
153973554|NCT06249945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153973555|NCT06249945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973556|NCT06249945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973557|NCT06249945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973558|NCT06249932|Empagliflozin|empagliflozin|mesh-list
153973559|NCT06249932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153973560|NCT06249932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973561|NCT06249932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973562|NCT06249932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973563|NCT06249867|Darifenacin|darifenacin|mesh-list
153973564|NCT06249867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153973565|NCT06249867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153973589|NCT06249659|Anesthetics|anesthetics|mesh-list
153973590|NCT06249659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973591|NCT06249659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973592|NCT06249633|Nitric Oxide|nitric oxide|mesh-list
153973593|NCT06249633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153973594|NCT06249633|Autonomic Agents|autonomic agents|mesh-ancestor
153973595|NCT06249633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973596|NCT06249633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973597|NCT06249633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153973598|NCT06249633|Respiratory System Agents|respiratory system agents|mesh-ancestor
153973599|NCT06249633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153973600|NCT06249633|Antioxidants|antioxidants|mesh-ancestor
153973601|NCT06249633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973602|NCT06249633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973603|NCT06249633|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153973604|NCT06249633|Vasodilator Agents|vasodilator agents|mesh-ancestor
153973605|NCT06249633|Gasotransmitters|gasotransmitters|mesh-ancestor
153731167|NCT00136565|Bortezomib|bortezomib|mesh-list
153973606|NCT06249633|Protective Agents|protective agents|mesh-ancestor
153973607|NCT06249620|Immunoferon|immunoferon|mesh-list
153973608|NCT06249620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153973609|NCT06249620|Immunologic Factors|immunologic factors|mesh-ancestor
153973610|NCT06249620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973611|NCT06249555|Ustekinumab|ustekinumab|mesh-list
153973612|NCT06249555|Vedolizumab|vedolizumab|mesh-list
153973613|NCT06249555|Dermatologic Agents|dermatologic agents|mesh-ancestor
153973630|NCT06249191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153973631|NCT06249191|Alkylating Agents|alkylating agents|mesh-ancestor
153973632|NCT06249191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973633|NCT06249191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973634|NCT06249191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153973635|NCT06249191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153973636|NCT06249191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153973637|NCT06249191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153973638|NCT06249191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973639|NCT06249191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973640|NCT06249191|Glucocorticoids|glucocorticoids|mesh-ancestor
153973642|NCT06249191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153973643|NCT06249191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153973644|NCT06249191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153973645|NCT06249191|Tubulin Modulators|tubulin modulators|mesh-ancestor
153973646|NCT06249191|Antimitotic Agents|antimitotic agents|mesh-ancestor
153973647|NCT06249191|Mitosis Modulators|mitosis modulators|mesh-ancestor
153973648|NCT06249191|Keratolytic Agents|keratolytic agents|mesh-ancestor
154860834|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973649|NCT06249191|Dermatologic Agents|dermatologic agents|mesh-ancestor
153973650|NCT06248931|Topiramate|topiramate|mesh-list
153973651|NCT06248931|Valproic Acid|valproic acid|mesh-list
153973652|NCT06248931|Anticonvulsants|anticonvulsants|mesh-ancestor
153973653|NCT06248931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973654|NCT06248931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973655|NCT06248931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973656|NCT06248931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973657|NCT06248931|GABA Agents|gaba agents|mesh-ancestor
153973658|NCT06248931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973659|NCT06248931|Antimanic Agents|antimanic agents|mesh-ancestor
153973660|NCT06248931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153973661|NCT06248931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973662|NCT06248931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153973663|NCT06248801|Metformin|metformin|mesh-list
153973664|NCT06248801|Vildagliptin|vildagliptin|mesh-list
153973665|NCT06248801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973666|NCT06248801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973667|NCT06248801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153973668|NCT06248801|Protease Inhibitors|protease inhibitors|mesh-ancestor
153973669|NCT06248801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973670|NCT06248801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070264|NCT00811408|Carboplatin|carboplatin|mesh-list
153973671|NCT06248749|Iron|iron|mesh-list
153973672|NCT06248749|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153973673|NCT06248749|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153973674|NCT06248749|Ferric gluconate|ferric gluconate|mesh-list
153973675|NCT06248749|Trace Elements|trace elements|mesh-ancestor
153973676|NCT06248749|Micronutrients|micronutrients|mesh-ancestor
153973694|NCT06248554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973696|NCT06248554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973697|NCT06248346|Dexmedetomidine|dexmedetomidine|mesh-list
153973698|NCT06248346|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153973699|NCT06248346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973700|NCT06248346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973701|NCT06248346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973702|NCT06248346|Analgesics|analgesics|mesh-ancestor
153973703|NCT06248346|Sensory System Agents|sensory system agents|mesh-ancestor
153973704|NCT06248346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973705|NCT06248346|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153973706|NCT06248346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153973707|NCT06248346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153973708|NCT06248346|Adrenergic Agents|adrenergic agents|mesh-ancestor
153973709|NCT06248346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973710|NCT06248346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973711|NCT06248242|Edaravone|edaravone|mesh-list
153973712|NCT06248242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153973713|NCT06248242|Antioxidants|antioxidants|mesh-ancestor
153973714|NCT06248242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973715|NCT06248242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153973716|NCT06248242|Protective Agents|protective agents|mesh-ancestor
153973717|NCT06248242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973718|NCT06248229|Amphetamine|amphetamine|mesh-list
154582995|NCT05394350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154582996|NCT05346224|Pertuzumab|pertuzumab|mesh-list
154582997|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154582998|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154582999|NCT05302804|Menthol|menthol|mesh-list
154583000|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
154583001|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
154583002|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154583003|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154583004|NCT05208307|Dexamethasone|dexamethasone|mesh-list
154583005|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
154583006|NCT05208307|Pomalidomide|pomalidomide|mesh-list
154583007|NCT05208307|Ichthammol|ichthammol|mesh-list
154583008|NCT05208307|BB 1101|bb 1101|mesh-list
154583009|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583010|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
154583011|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
154583012|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583013|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583014|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154583015|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
154583016|NCT05208307|Hormones|hormones|mesh-ancestor
154583017|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583018|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154583019|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583020|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
154583021|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583022|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583023|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
154583024|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154583025|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154583026|NCT05208307|Growth Substances|growth substances|mesh-ancestor
154583027|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
154583028|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
154583029|NCT05156658|Etonogestrel|etonogestrel|mesh-list
154583030|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154583031|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
154583032|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154070332|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583033|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583034|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154583035|NCT05095961|Prednisone|prednisone|mesh-list
154583036|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583037|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
154583038|NCT05095961|Hormones|hormones|mesh-ancestor
154583039|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583040|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583041|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154306859|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
154583042|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583043|NCT04998617|Curcumin|curcumin|mesh-list
154583044|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154583045|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154583046|NCT04998617|Analgesics|analgesics|mesh-ancestor
154583047|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
154583048|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583049|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583050|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583051|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583052|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583053|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583054|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583055|NCT04914247|Selexipag|selexipag|mesh-list
154583056|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154070333|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154583057|NCT04908449|Bupivacaine|bupivacaine|mesh-list
154583058|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
154583059|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
154583060|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583061|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583062|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
154583063|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583064|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154583065|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154583066|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154583067|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
154583068|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583069|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154255616|NCT01149980|Dexetimide|dexetimide|mesh-list
154862265|NCT03023189|Coagulants|coagulants|mesh-ancestor
154583070|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154583071|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583072|NCT04640636|Midazolam|midazolam|mesh-list
154583073|NCT04640636|Ketamine|ketamine|mesh-list
154583074|NCT04640636|Analgesics|analgesics|mesh-ancestor
154583075|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
154583076|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583077|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583078|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154583079|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154583080|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
154583081|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
154583082|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583083|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154583084|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154583085|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583086|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583087|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154583088|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154070393|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154070394|NCT00792636|Analgesics|analgesics|mesh-ancestor
154583089|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154583090|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154583091|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154583092|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
154583093|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
154070395|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
154070396|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070397|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583094|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
154583095|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583096|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
154583097|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583098|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583099|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154583100|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
154583101|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583102|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583103|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154583104|NCT04573946|Vitamin D|vitamin d|mesh-list
154583105|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
154583106|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
154583107|NCT04573946|Vitamins|vitamins|mesh-list
154583108|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
154583109|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583110|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154583111|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154583112|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
154583113|NCT04558359|Giapreza|giapreza|mesh-list
154583114|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
154583115|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154583116|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154583117|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
154583118|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583119|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583120|NCT04538053|Cefazolin|cefazolin|mesh-list
154583121|NCT04538053|Cephalexin|cephalexin|mesh-list
154583122|NCT04538053|Floxacillin|floxacillin|mesh-list
154583123|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583124|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583125|NCT04495179|Durvalumab|durvalumab|mesh-list
154583126|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583127|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583128|NCT04385290|Cytarabine|cytarabine|mesh-list
154583129|NCT04385290|Daunorubicin|daunorubicin|mesh-list
154583130|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
154583131|NCT04385290|Midostaurin|midostaurin|mesh-list
154583132|NCT04385290|Staurosporine|staurosporine|mesh-list
154583133|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154583134|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
154583135|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583136|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583137|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
154583138|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583139|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583140|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
154583141|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583142|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154583143|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154583144|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154583145|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583146|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583147|NCT04385290|Immunotoxins|immunotoxins|mesh-ancestor
154583148|NCT04385290|Immunoconjugates|immunoconjugates|mesh-ancestor
154583149|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154583150|NCT04336241|Nivolumab|nivolumab|mesh-list
154583151|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583152|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583153|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154583154|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583155|NCT04313712|Ibogaine|ibogaine|mesh-list
154583156|NCT04313712|Hallucinogens|hallucinogens|mesh-ancestor
154583157|NCT04313712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583158|NCT04313712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154583159|NCT04313712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154583160|NCT04313712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154583161|NCT04313712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583162|NCT04313712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583163|NCT04272242|Pyridoxine|pyridoxine|mesh-list
154583164|NCT04272242|Pyridoxal|pyridoxal|mesh-list
154583165|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
154583166|NCT04272242|Isoniazid|isoniazid|mesh-list
154583167|NCT04272242|Rifapentine|rifapentine|mesh-list
154583168|NCT04272242|Dolutegravir|dolutegravir|mesh-list
154583169|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154583170|NCT04272242|Vitamins|vitamins|mesh-ancestor
154583171|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
154583172|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583173|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
154583174|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
154583175|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583176|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583177|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154583178|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154583179|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
154583180|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583181|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154583182|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154583183|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154583184|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583185|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154583186|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
154583187|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154583188|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
154583189|NCT04241549|Azacitidine|azacitidine|mesh-list
154583190|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154583191|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
154583192|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583193|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583194|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583195|NCT04240626|Acetaminophen|acetaminophen|mesh-list
154583196|NCT04240626|Scopolamine|scopolamine|mesh-list
154583197|NCT04240626|Oxycodone|oxycodone|mesh-list
154583198|NCT04240626|Gabapentin|gabapentin|mesh-list
154583199|NCT04240626|Hydromorphone|hydromorphone|mesh-list
154070451|NCT00814216|Xhance|xhance|mesh-list
154583200|NCT04240626|Hydrocodone|hydrocodone|mesh-list
154583201|NCT04240626|Bupivacaine|bupivacaine|mesh-list
154583202|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
154583203|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154583204|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154583205|NCT04240626|Analgesics|analgesics|mesh-ancestor
154583206|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
154583207|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583208|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583209|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
154583210|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154583211|NCT04240626|Narcotics|narcotics|mesh-ancestor
154583212|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583213|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
154583214|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154583215|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154583216|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154583217|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154583218|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154583219|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583220|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583221|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
154583222|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
154583223|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
154583224|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
154583225|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
154583226|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154583227|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
154583228|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
154583229|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154583230|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
154583231|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154583232|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
154583233|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154583234|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
154583235|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154583236|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
154583237|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154583238|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154583239|NCT04231318|Triamcinolone|triamcinolone|mesh-list
154583240|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154583241|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154583242|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154583243|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583244|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
154583245|NCT04231318|Hormones|hormones|mesh-ancestor
154583246|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583247|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583248|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583249|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
154583250|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583251|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583252|NCT04201262|Ravulizumab|ravulizumab|mesh-list
154583253|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154583254|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583255|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
154583256|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583257|NCT04150887|Azacitidine|azacitidine|mesh-list
154583258|NCT04150887|Venetoclax|venetoclax|mesh-list
154583259|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154583260|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
154583261|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583262|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583263|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583264|NCT04072445|Trifluridine|trifluridine|mesh-list
154583265|NCT04072445|Irinotecan|irinotecan|mesh-list
154583266|NCT04072445|Camptothecin|camptothecin|mesh-list
154583267|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154583268|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154583269|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583270|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583271|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583272|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
154583273|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
154583274|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583275|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154583276|NCT04050540|Doxycycline|doxycycline|mesh-list
154070529|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583277|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583278|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583279|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
154583280|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154583281|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154583282|NCT04032197|Semaglutide|semaglutide|mesh-list
154583283|NCT04032197|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154583284|NCT04032197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154583285|NCT04032197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583286|NCT04023526|Azacitidine|azacitidine|mesh-list
154583287|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154583288|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
154583289|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583290|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583291|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583292|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
154583293|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583294|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583295|NCT03957551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154583296|NCT03957551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583297|NCT03862495|Azithromycin|azithromycin|mesh-list
154583298|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583299|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583300|NCT03691662|Timolol|timolol|mesh-list
154862266|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
154583301|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154583302|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154583303|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583304|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154583305|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154583306|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
154583307|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583308|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583309|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154583310|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154583311|NCT03689244|Selexipag|selexipag|mesh-list
154583312|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154583313|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154583314|NCT03594175|Reteplase|reteplase|mesh-list
154583315|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154583316|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154583317|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583318|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
154583319|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583320|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583321|NCT03338959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154583322|NCT03338959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583323|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154583324|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
154583325|NCT03278782|Romidepsin|romidepsin|mesh-list
154583326|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583327|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583328|NCT03278782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154583329|NCT03278782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583330|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583331|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154583332|NCT03278782|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154583333|NCT03278782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583334|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154583335|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583336|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583337|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154583338|NCT03104491|Immunotoxins|immunotoxins|mesh-ancestor
154583339|NCT03104491|Immunoconjugates|immunoconjugates|mesh-ancestor
154583340|NCT03104491|Immunologic Factors|immunologic factors|mesh-ancestor
154583341|NCT03104491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583342|NCT02977780|Temozolomide|temozolomide|mesh-list
154583343|NCT02977780|Neratinib|neratinib|mesh-list
154583344|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154583345|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
154583346|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583347|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583348|NCT02977780|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154583349|NCT02977780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154583350|NCT02977780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583352|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154583353|NCT02804022|Narcotics|narcotics|mesh-ancestor
154583354|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583355|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583356|NCT02804022|Analgesics|analgesics|mesh-ancestor
154583357|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
154583358|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583359|NCT02792413|Denosumab|denosumab|mesh-list
154583360|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154583361|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583362|NCT02714439|Proflavine|proflavine|mesh-list
154583363|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154583364|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583365|NCT02133573|Progesterone|progesterone|mesh-list
154583366|NCT02133573|Progestins|progestins|mesh-ancestor
154583367|NCT02133573|Hormones|hormones|mesh-ancestor
154583368|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583369|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583370|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
154583371|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154583372|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
154583373|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583374|NCT01878669|Expectorants|expectorants|mesh-ancestor
154583375|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
154583376|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154583377|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
154583378|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583379|NCT01878669|Protective Agents|protective agents|mesh-ancestor
154583380|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583381|NCT01878669|Antidotes|antidotes|mesh-ancestor
154583382|NCT01704859|Vitamin D|vitamin d|mesh-list
154583383|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
154583384|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
154583385|NCT01704859|Vitamins|vitamins|mesh-list
154583386|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
154583387|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583388|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154583389|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154583390|NCT00869232|Thalidomide|thalidomide|mesh-list
154583391|NCT00869232|Dexamethasone|dexamethasone|mesh-list
154583392|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
154583393|NCT00869232|Melphalan|melphalan|mesh-list
154583394|NCT00869232|Doxorubicin|doxorubicin|mesh-list
154583395|NCT00869232|Etoposide|etoposide|mesh-list
154583396|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154583397|NCT00869232|Bortezomib|bortezomib|mesh-list
154583398|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583399|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
154583400|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583401|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583402|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154583403|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
154583404|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583405|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583406|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154583407|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583408|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
154583409|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
154583410|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583411|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154583412|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
154583413|NCT00869232|Hormones|hormones|mesh-ancestor
154583414|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583415|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154583416|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154583417|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154583418|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154583419|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583420|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154583421|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
154583422|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583423|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583424|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154583425|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154583426|NCT00869232|Growth Substances|growth substances|mesh-ancestor
154583427|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
154583428|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
154583429|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
154583430|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154583431|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154583432|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070718|NCT00701285|Pravastatin|pravastatin|mesh-list
154583433|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583434|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583435|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583436|NCT00734877|Thalidomide|thalidomide|mesh-list
154583437|NCT00734877|Dexamethasone|dexamethasone|mesh-list
154583438|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
154583439|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
154583440|NCT00734877|Melphalan|melphalan|mesh-list
154583441|NCT00734877|Cisplatin|cisplatin|mesh-list
154583442|NCT00734877|Etoposide|etoposide|mesh-list
154583443|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
154583444|NCT00734877|Doxorubicin|doxorubicin|mesh-list
154583445|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154583446|NCT00734877|Bortezomib|bortezomib|mesh-list
154583447|NCT00734877|BB 1101|bb 1101|mesh-list
154583448|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583449|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
154583450|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583451|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583452|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154583453|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
154583454|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862267|NCT02561832|Carboplatin|carboplatin|mesh-list
154583455|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583456|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154583457|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583458|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
154583459|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
154583460|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583461|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154583462|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
154583463|NCT00734877|Hormones|hormones|mesh-ancestor
153973719|NCT06248229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154583464|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583465|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154583466|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
154583467|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583468|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154583469|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154583470|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154583471|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154583472|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
154583473|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583474|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583475|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154583476|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154583477|NCT00734877|Growth Substances|growth substances|mesh-ancestor
154583478|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
154583479|NCT00686595|Infliximab|infliximab|mesh-list
154583480|NCT00686595|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154583481|NCT00686595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583482|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
154583483|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154583484|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583485|NCT00640159|Selegiline|selegiline|mesh-list
154583486|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
154583487|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154583488|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154583489|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154583490|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154583491|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583492|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583493|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154583494|NCT00640159|Protective Agents|protective agents|mesh-ancestor
154583495|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583496|NCT03483415|Morphine|morphine|mesh-list
154583497|NCT03483415|Bupivacaine|bupivacaine|mesh-list
154583498|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
154583499|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
154583500|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583501|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583502|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
154583503|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583504|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154583505|NCT03483415|Narcotics|narcotics|mesh-ancestor
154583506|NCT03483415|Analgesics|analgesics|mesh-ancestor
154583507|NCT03487003|Bromides|bromides|mesh-list
154583508|NCT03487003|Rocuronium|rocuronium|mesh-list
154583509|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
154583510|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154583511|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154583512|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154583513|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583514|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583515|NCT03486925|Oxytocin|oxytocin|mesh-list
154583516|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
154583517|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154583518|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583519|NCT02262754|Naproxen|naproxen|mesh-list
154583520|NCT02262754|PF-06372865|pf-06372865|mesh-list
154583521|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154583522|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154583523|NCT02262754|Analgesics|analgesics|mesh-ancestor
154583524|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
154583525|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583526|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583527|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583528|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154862268|NCT02561832|Olaparib|olaparib|mesh-list
154583529|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
154583530|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154583531|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583532|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583533|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
154583534|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
154583535|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583537|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
154583538|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154583539|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
154583540|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154583541|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
154583542|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583543|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583544|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
154583545|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154583546|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154583547|NCT02356588|Sufentanil|sufentanil|mesh-list
154583548|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154583549|NCT02356588|Narcotics|narcotics|mesh-ancestor
154583550|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583551|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583552|NCT02356588|Analgesics|analgesics|mesh-ancestor
154583553|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
154583554|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583555|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154583556|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154583557|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
154583558|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
154583559|NCT04445389|Vaccines|vaccines|mesh-list
154583560|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
154583561|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583562|NCT02355028|Ranibizumab|ranibizumab|mesh-list
154583563|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154583564|NCT02355028|Acrizanib|acrizanib|mesh-list
154583565|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154583566|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154583567|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154583568|NCT02355028|Growth Substances|growth substances|mesh-ancestor
154583569|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583570|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
154583571|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583572|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154583573|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583574|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583575|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
154583576|NCT05647330|Chloroquine|chloroquine|mesh-list
154583577|NCT05647330|Gemcitabine|gemcitabine|mesh-list
154583578|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154583579|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
154583580|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583581|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583582|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
154583583|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154583584|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154583585|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583586|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583587|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583588|NCT05647330|Amebicides|amebicides|mesh-ancestor
154583589|NCT01643668|Busulfan|busulfan|mesh-list
154583590|NCT01643668|Clofarabine|clofarabine|mesh-list
154583591|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
154583592|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583593|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583594|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
154583595|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583596|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154583597|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583598|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154583599|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154583600|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
154583601|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154583602|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
154583603|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862269|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583604|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
154583605|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
154255618|NCT01149980|Escitalopram|escitalopram|mesh-list
154583607|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583608|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154583609|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
154583610|NCT02260804|Rituximab|rituximab|mesh-list
154583611|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583612|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583613|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
154583614|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583615|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583616|NCT02260648|Atorvastatin|atorvastatin|mesh-list
154583617|NCT02260648|Ezetimibe|ezetimibe|mesh-list
154583618|NCT02260648|Evacetrapib|evacetrapib|mesh-list
154583619|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154583620|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154583621|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
154583622|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583623|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154583624|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154583625|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583626|NCT02260492|Fluticasone|fluticasone|mesh-list
154583628|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154583629|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154583630|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583631|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154583632|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
154583633|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583634|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583635|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154583636|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
154583637|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
154583638|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154583639|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154583640|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154583641|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154583642|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
154583643|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583644|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583645|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
154583646|NCT02260492|Hormones|hormones|mesh-ancestor
154583647|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583648|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
154583649|NCT03966625|Autoantibodies|autoantibodies|mesh-list
154583650|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
154583651|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583652|NCT02260258|Rocuronium|rocuronium|mesh-list
154583653|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154583654|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154583655|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154583656|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583657|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583658|NCT05151679|Iron|iron|mesh-list
154583659|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154583660|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
154583661|NCT05151679|Trace Elements|trace elements|mesh-ancestor
154583662|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
154583663|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583664|NCT05151679|Hematinics|hematinics|mesh-ancestor
154583665|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
154583666|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
154583667|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583668|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
154583669|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583670|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583671|NCT02353468|Dexamethasone|dexamethasone|mesh-list
154583672|NCT02353468|Lenalidomide|lenalidomide|mesh-list
154583673|NCT02353468|Bortezomib|bortezomib|mesh-list
154583674|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154583675|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
154583676|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
154583677|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583678|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583679|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154583680|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
154583681|NCT02353468|Hormones|hormones|mesh-ancestor
154583682|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583683|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154583684|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583685|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
154583686|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154583687|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154583688|NCT02353468|Growth Substances|growth substances|mesh-ancestor
154583689|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
154583690|NCT04459663|Axitinib|axitinib|mesh-list
154583691|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583692|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154583693|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583694|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583695|NCT05150899|Fexofenadine|fexofenadine|mesh-list
154583696|NCT05150899|Tamsulosin|tamsulosin|mesh-list
154583697|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154583698|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154583699|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154583700|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
154583701|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583702|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583703|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583704|NCT05150899|Urological Agents|urological agents|mesh-ancestor
154583705|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154583706|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154583707|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154583708|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
154583709|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
154583710|NCT01530997|Cisplatin|cisplatin|mesh-list
154070976|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
154583711|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583712|NCT00593905|Bosentan|bosentan|mesh-list
154583713|NCT00593905|Ambrisentan|ambrisentan|mesh-list
154583714|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
154583715|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154583716|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154583717|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583718|NCT02259088|Ranibizumab|ranibizumab|mesh-list
154583719|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154583720|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154583721|NCT02259088|Growth Substances|growth substances|mesh-ancestor
154583722|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583723|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
154583724|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583725|NCT02259010|Itraconazole|itraconazole|mesh-list
154583726|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
154583727|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583728|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154583729|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154583730|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583731|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583732|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154583733|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
154583734|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583735|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583736|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154583737|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154583738|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
154583739|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583740|NCT05153785|Lidocaine|lidocaine|mesh-list
154583741|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
154583742|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
154583743|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583744|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583745|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
154583746|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583747|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154583748|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154583749|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154583750|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154583751|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583752|NCT00151775|Olmesartan|olmesartan|mesh-list
154583753|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154862270|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
154583754|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154583755|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154583756|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154583757|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583758|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154583759|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583760|NCT03476941|Clindamycin|clindamycin|mesh-list
154583761|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
154583762|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
154583763|NCT03476941|Gentamicins|gentamicins|mesh-list
154583764|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583765|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583766|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154583767|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583768|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583769|NCT00609323|Lidocaine|lidocaine|mesh-list
154583770|NCT00609323|Tetracaine|tetracaine|mesh-list
154583771|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
154583772|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
154583773|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583774|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583775|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
154583776|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583777|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154583778|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154583779|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154583780|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154583781|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583782|NCT02682901|Bromocriptine|bromocriptine|mesh-list
154583783|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154583784|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154583785|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
154583786|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583787|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583788|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
154583789|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
154583790|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583791|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583792|NCT02258074|Niacinamide|niacinamide|mesh-list
154583794|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
154583795|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
154583796|NCT02258074|Vitamins|vitamins|mesh-ancestor
154583797|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
154583798|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583799|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154583800|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
154583801|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583802|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154583803|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
154583804|NCT02281643|Doxycycline|doxycycline|mesh-list
154583805|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583806|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583807|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
154583808|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154583809|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154583810|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
154583811|NCT02281721|Antacids|antacids|mesh-ancestor
154583812|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583813|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154583814|NCT01642732|Everolimus|everolimus|mesh-list
154583815|NCT01642732|Leuprolide|leuprolide|mesh-list
154583816|NCT01642732|Bicalutamide|bicalutamide|mesh-list
154583817|NCT01642732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154583818|NCT01642732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154583819|NCT01642732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583820|NCT01642732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583821|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583822|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
154583823|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583824|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583825|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154583826|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
154583827|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154583828|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154583829|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
154583830|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
154583831|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583832|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
154583833|NCT02281799|Azathioprine|azathioprine|mesh-list
154583834|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
154583835|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583836|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154583837|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583838|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154583839|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
154583840|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583841|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154583842|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583843|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583844|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154583845|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154583846|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154583847|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
154583848|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583849|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154583850|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154583851|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583852|NCT00589823|Fentanyl|fentanyl|mesh-list
154583853|NCT00589823|Morphine|morphine|mesh-list
154583854|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154583855|NCT00589823|Narcotics|narcotics|mesh-ancestor
154583856|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583857|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583858|NCT00589823|Analgesics|analgesics|mesh-ancestor
154583859|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
154583860|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583861|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154583862|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154583863|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
154583864|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
154583865|NCT02190721|Lenograstim|lenograstim|mesh-list
154583866|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154583867|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
154583868|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583869|NCT00581477|Droxidopa|droxidopa|mesh-list
154583870|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154583871|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154583872|NCT03134339|Nicotine|nicotine|mesh-list
154583873|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154583874|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
154583875|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583876|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583877|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154583878|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154583879|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
154583880|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583881|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583882|NCT02282267|Gefitinib|gefitinib|mesh-list
154583883|NCT02282267|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154583884|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154583885|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583886|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583887|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583888|NCT02283905|Voriconazole|voriconazole|mesh-list
154583889|NCT02283905|Amphotericin B|amphotericin b|mesh-list
154583890|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154583891|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
154583892|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154583893|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154583894|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154583895|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583896|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583897|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154583898|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
154583899|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154583900|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583901|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154583902|NCT02283905|Amebicides|amebicides|mesh-ancestor
154862271|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583903|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154583904|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154583905|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583907|NCT03480997|Albuterol|albuterol|mesh-list
154583908|NCT03480997|Ipratropium|ipratropium|mesh-list
154583909|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
154583910|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154583911|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
154583912|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583913|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583914|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154583915|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
154583916|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
154583917|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154583918|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154583919|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154583920|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154583921|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
154583922|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583923|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583924|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154583925|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
154583926|NCT04660747|Anticoagulants|anticoagulants|mesh-list
154583927|NCT02348008|Bevacizumab|bevacizumab|mesh-list
154583928|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
154583929|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154583930|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583931|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154583932|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154583933|NCT02348008|Growth Substances|growth substances|mesh-ancestor
154583934|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583935|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
154583936|NCT02348008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154583937|NCT02348008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583938|NCT00569387|Vaccines|vaccines|mesh-list
154071225|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154583939|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
154583940|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583941|NCT05944783|Dasatinib|dasatinib|mesh-list
154583942|NCT05944783|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154583943|NCT05944783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154583944|NCT05944783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154583945|NCT05944783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154583946|NCT05944783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154583947|NCT05944393|Ropivacaine|ropivacaine|mesh-list
154583948|NCT05944393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154583949|NCT05944393|Anesthetics, Local|anesthetics, local|mesh-ancestor
154583950|NCT05944393|Anesthetics|anesthetics|mesh-ancestor
154583951|NCT05944393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583952|NCT05944393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583953|NCT05944393|Sensory System Agents|sensory system agents|mesh-ancestor
154583954|NCT05944393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583955|NCT05944380|Ropivacaine|ropivacaine|mesh-list
154583956|NCT05944380|Anesthetics, Local|anesthetics, local|mesh-ancestor
154583957|NCT05944380|Anesthetics|anesthetics|mesh-ancestor
154583958|NCT05944380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583959|NCT05944380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583960|NCT05944380|Sensory System Agents|sensory system agents|mesh-ancestor
154583961|NCT05944380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583963|NCT05944341|Epinephrine|epinephrine|mesh-list
154583964|NCT05944341|Racepinephrine|racepinephrine|mesh-list
154583965|NCT05944341|Carticaine|carticaine|mesh-list
154583966|NCT05944341|Epinephryl borate|epinephryl borate|mesh-list
154583967|NCT05944341|Anesthetics, Local|anesthetics, local|mesh-ancestor
154583968|NCT05944341|Anesthetics|anesthetics|mesh-ancestor
154583969|NCT05944341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154583970|NCT05944341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583971|NCT05944341|Sensory System Agents|sensory system agents|mesh-ancestor
154583972|NCT05944341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583973|NCT05944341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154583974|NCT05944341|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154583975|NCT05944341|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154583976|NCT05944341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154583977|NCT05944341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862272|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154583978|NCT05944341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154583980|NCT05944341|Adrenergic Agents|adrenergic agents|mesh-ancestor
154583981|NCT05944341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154583982|NCT05944341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154583983|NCT05944341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154583984|NCT05944341|Autonomic Agents|autonomic agents|mesh-ancestor
154583985|NCT05944341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154583986|NCT05944341|Respiratory System Agents|respiratory system agents|mesh-ancestor
154583987|NCT05944341|Mydriatics|mydriatics|mesh-ancestor
154583988|NCT05944341|Sympathomimetics|sympathomimetics|mesh-ancestor
154583989|NCT05944341|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154583990|NCT05944146|Dobutamine|dobutamine|mesh-list
154583991|NCT05944146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154583992|NCT05944146|Sympathomimetics|sympathomimetics|mesh-ancestor
154583993|NCT05944146|Autonomic Agents|autonomic agents|mesh-ancestor
154583994|NCT05944146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154583995|NCT05944146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154583996|NCT05944146|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154583997|NCT05944146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154583998|NCT05944146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154583999|NCT05944146|Adrenergic Agents|adrenergic agents|mesh-ancestor
154584000|NCT05944146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584001|NCT05944146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584002|NCT05944146|Protective Agents|protective agents|mesh-ancestor
154584003|NCT05943613|Clonidine|clonidine|mesh-list
154584004|NCT05943613|Analgesics|analgesics|mesh-ancestor
154584005|NCT05943613|Sensory System Agents|sensory system agents|mesh-ancestor
154584006|NCT05943613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584007|NCT05943613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584008|NCT05943613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154584009|NCT05943613|Sympatholytics|sympatholytics|mesh-ancestor
154584010|NCT05943613|Autonomic Agents|autonomic agents|mesh-ancestor
154584011|NCT05943613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154584012|NCT05943613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154584013|NCT05943613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154584014|NCT05943613|Adrenergic Agents|adrenergic agents|mesh-ancestor
154584015|NCT05943613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584016|NCT05943613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584017|NCT05943470|Icodextrin|icodextrin|mesh-list
154584018|NCT05943470|Dialysis Solutions|dialysis solutions|mesh-list
154584019|NCT05943470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154584020|NCT05943457|Vitamin K|vitamin k|mesh-list
154584021|NCT05943457|Vitamin K 2|vitamin k 2|mesh-list
154584022|NCT05943457|Menaquinone 7|menaquinone 7|mesh-list
154584023|NCT05943457|Vitamins|vitamins|mesh-ancestor
154584024|NCT05943457|Micronutrients|micronutrients|mesh-ancestor
154584025|NCT05943457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584026|NCT05943457|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154584027|NCT05943457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154584028|NCT05943457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584029|NCT05943457|Hemostatics|hemostatics|mesh-ancestor
154584030|NCT05943457|Coagulants|coagulants|mesh-ancestor
154584031|NCT05943379|Gemcitabine|gemcitabine|mesh-list
154307869|NCT01199757|Xhance|xhance|mesh-list
154584032|NCT05943379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584034|NCT05943379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584035|NCT05943379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584036|NCT05943353|Pentoxifylline|pentoxifylline|mesh-list
154584037|NCT05943353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154584038|NCT05943353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584039|NCT05943353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584040|NCT05943353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154584041|NCT05943353|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154584042|NCT05943353|Protective Agents|protective agents|mesh-ancestor
154584043|NCT05943353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584044|NCT05943353|Vasodilator Agents|vasodilator agents|mesh-ancestor
154584045|NCT05943353|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154584046|NCT05943353|Antioxidants|antioxidants|mesh-ancestor
154584047|NCT05943223|Metronidazole|metronidazole|mesh-list
154584048|NCT05943223|Ceftriaxone|ceftriaxone|mesh-list
154584049|NCT05943223|Tazobactam|tazobactam|mesh-list
154584050|NCT05943223|Piperacillin|piperacillin|mesh-list
154584051|NCT05943223|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154584052|NCT05943223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584053|NCT05943223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154584054|NCT05943223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154584056|NCT05943223|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154584057|NCT05943223|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154584058|NCT05943223|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154584059|NCT05943223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584060|NCT05943223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584061|NCT05943158|Folic Acid|folic acid|mesh-list
154584062|NCT05943158|Vitamin B Complex|vitamin b complex|mesh-list
154584063|NCT05943158|Inositol|inositol|mesh-list
154584064|NCT05943158|Hematinics|hematinics|mesh-ancestor
154584065|NCT05943158|Vitamins|vitamins|mesh-ancestor
154584066|NCT05943158|Micronutrients|micronutrients|mesh-ancestor
154584067|NCT05943158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584068|NCT05941949|Vitamins|vitamins|mesh-list
154584069|NCT05941949|Vitamin E|vitamin e|mesh-list
154584070|NCT05941949|Tocopherols|tocopherols|mesh-list
154584071|NCT05941949|Tocotrienols|tocotrienols|mesh-list
154584072|NCT05941949|alpha-Tocopherol|alpha-tocopherol|mesh-list
154584073|NCT05941949|Micronutrients|micronutrients|mesh-ancestor
154584074|NCT05941949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584075|NCT05941949|Antioxidants|antioxidants|mesh-ancestor
154584076|NCT05941949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584077|NCT05941949|Protective Agents|protective agents|mesh-ancestor
154584078|NCT05939622|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
154584079|NCT05939622|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154584080|NCT05939622|Immunologic Factors|immunologic factors|mesh-ancestor
154584081|NCT05939622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584082|NCT05939544|Milk fat globule|milk fat globule|mesh-list
154584083|NCT05939544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584084|NCT05920213|Lactulose|lactulose|mesh-list
154584085|NCT05920213|N-Methylaspartate|n-methylaspartate|mesh-list
154584086|NCT05920213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154584087|NCT05920213|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154584088|NCT05920213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154584089|NCT05920213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584090|NCT05920213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584091|NCT05920213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584092|NCT05901714|Phenytoin|phenytoin|mesh-list
154584093|NCT05901714|Midazolam|midazolam|mesh-list
154584094|NCT05901714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154584095|NCT05901714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154584096|NCT05901714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584097|NCT05901714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584098|NCT05901714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154584099|NCT05901714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154584100|NCT05901714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154584101|NCT05901714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154584102|NCT05901714|Anesthetics, General|anesthetics, general|mesh-ancestor
154584103|NCT05901714|Anesthetics|anesthetics|mesh-ancestor
154584104|NCT05901714|GABA Modulators|gaba modulators|mesh-ancestor
154584105|NCT05901714|GABA Agents|gaba agents|mesh-ancestor
154584106|NCT05901714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154307909|NCT01199835|Calcium|calcium|mesh-list
154584107|NCT05901714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584108|NCT05901714|Anticonvulsants|anticonvulsants|mesh-ancestor
154584109|NCT05901714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154584110|NCT05901714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154584111|NCT05901714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154584112|NCT05901714|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154584113|NCT05901714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154584114|NCT05838391|Capecitabine|capecitabine|mesh-list
154584115|NCT05838391|Fluorouracil|fluorouracil|mesh-list
154584116|NCT05838391|Mitomycins|mitomycins|mesh-list
154584117|NCT05838391|Mitomycin|mitomycin|mesh-list
154584118|NCT05838391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584119|NCT05838391|Antimetabolites|antimetabolites|mesh-ancestor
154584120|NCT05838391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584121|NCT05838391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584122|NCT05838391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154584123|NCT05838391|Immunologic Factors|immunologic factors|mesh-ancestor
154584124|NCT05838391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584125|NCT05838391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154584126|NCT05838391|Alkylating Agents|alkylating agents|mesh-ancestor
154584127|NCT05838391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154584128|NCT05838391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584129|NCT05768360|Metformin|metformin|mesh-list
154584130|NCT05768360|Digoxin|digoxin|mesh-list
154584132|NCT05768360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154584133|NCT05768360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154584134|NCT05768360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584135|NCT05768360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154584136|NCT05768360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154584137|NCT05768360|Antimetabolites|antimetabolites|mesh-ancestor
154584138|NCT05768360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584139|NCT05768360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154584140|NCT05768360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154584141|NCT05768360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584142|NCT05768360|Diuretics|diuretics|mesh-ancestor
154584143|NCT05768360|Natriuretic Agents|natriuretic agents|mesh-ancestor
154584144|NCT05768360|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154584145|NCT05768360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154584146|NCT05768360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154584147|NCT05768360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154584148|NCT05768360|Protective Agents|protective agents|mesh-ancestor
154584149|NCT05756972|Carboplatin|carboplatin|mesh-list
154584150|NCT05756972|Pemetrexed|pemetrexed|mesh-list
154584151|NCT05756972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584152|NCT05756972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584153|NCT05756972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584154|NCT05756972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154584155|NCT05756972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154584156|NCT05708950|Pembrolizumab|pembrolizumab|mesh-list
154584157|NCT05708950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584158|NCT05708950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584159|NCT05708950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154584160|NCT05708950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071411|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071438|NCT00444535|Bevacizumab|bevacizumab|mesh-list
154584161|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
154584162|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154584163|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
154584164|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584165|NCT05624528|Tolcapone|tolcapone|mesh-list
154584166|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154584167|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154584168|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154584169|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584170|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584171|NCT05602818|Alprazolam|alprazolam|mesh-list
154584172|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154584173|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584174|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584175|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154584176|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154584177|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154584178|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
154584179|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
154584180|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584181|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307988|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
154584182|NCT05568407|Avelumab|avelumab|mesh-list
154584183|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584184|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584185|NCT05430399|Docetaxel|docetaxel|mesh-list
154584186|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584187|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
154584188|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
154584189|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
154584190|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584191|NCT05399329|Palbociclib|palbociclib|mesh-list
154584192|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584193|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154584194|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584195|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584196|NCT05386888|Paclitaxel|paclitaxel|mesh-list
154584197|NCT05386888|Carboplatin|carboplatin|mesh-list
154584198|NCT05386888|Pemetrexed|pemetrexed|mesh-list
154584199|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154584200|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584201|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
154584202|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
154584203|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
154584204|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584205|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584206|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154584207|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154584208|NCT05354674|Bevacizumab|bevacizumab|mesh-list
154584209|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584210|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584211|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154584212|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154584213|NCT05354674|Growth Substances|growth substances|mesh-ancestor
154584214|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071493|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154584215|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
154584216|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
154584217|NCT05334329|Fludarabine|fludarabine|mesh-list
154584218|NCT05334329|Atezolizumab|atezolizumab|mesh-list
154584219|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
154584220|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154584221|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154584222|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
154584223|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584224|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584225|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154584226|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
154584227|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584228|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154584229|NCT05334329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154584230|NCT05334329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584231|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
154584232|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
154584233|NCT05293041|Coagulants|coagulants|mesh-ancestor
154584234|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154584235|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154584236|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
154584237|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584238|NCT05255653|Cisplatin|cisplatin|mesh-list
154584239|NCT05255653|Carboplatin|carboplatin|mesh-list
154584240|NCT05255653|Durvalumab|durvalumab|mesh-list
154584241|NCT05255653|Olaparib|olaparib|mesh-list
154584242|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154584243|NCT05255653|Megestrol|megestrol|mesh-list
154584244|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
154584245|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
154584246|NCT05255653|Progestins|progestins|mesh-list
154584247|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584248|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584249|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584250|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154584251|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584252|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154584253|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154584254|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154584255|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
154584256|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154584257|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584258|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154584259|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154584260|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154584261|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154584262|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
154584263|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154584264|NCT05255653|Hormones|hormones|mesh-ancestor
154584265|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584266|NCT05236894|Nicotine|nicotine|mesh-list
154584267|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154584268|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
154584269|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584270|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584271|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154584272|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154584273|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
154584274|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584275|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584276|NCT05109052|Bevacizumab|bevacizumab|mesh-list
154584277|NCT05109052|Atezolizumab|atezolizumab|mesh-list
154584278|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584279|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584280|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154584281|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154071532|NCT00794040|Citalopram|citalopram|mesh-list
154071539|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
154584282|NCT05109052|Growth Substances|growth substances|mesh-ancestor
154584283|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584284|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
154584285|NCT05109052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154584286|NCT05109052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584287|NCT04962022|Ritonavir|ritonavir|mesh-list
154584288|NCT04962022|Itraconazole|itraconazole|mesh-list
154584289|NCT04962022|Nirmatrelvir|nirmatrelvir|mesh-list
154584290|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154584291|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154584292|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
154584293|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584294|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584295|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154584296|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154584297|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
154584298|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584299|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154584300|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154584301|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
154584302|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154584303|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154584304|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
154584305|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584306|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584307|NCT04929808|Emollients|emollients|mesh-list
154584308|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
154584309|NCT04910386|Cisplatin|cisplatin|mesh-list
154584310|NCT04910386|Gemcitabine|gemcitabine|mesh-list
154584311|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584312|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584313|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
154584314|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584315|NCT04895137|Bevacizumab|bevacizumab|mesh-list
154584316|NCT04895137|Antibodies|antibodies|mesh-list
154584317|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154584318|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584319|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584320|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154584321|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154584322|NCT04895137|Growth Substances|growth substances|mesh-ancestor
154584323|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584324|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
154584325|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
154584326|NCT04744545|Curcumin|curcumin|mesh-list
154584327|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154584328|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154584329|NCT04744545|Analgesics|analgesics|mesh-ancestor
154584330|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
154308134|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154071558|NCT00813488|Fentanyl|fentanyl|mesh-list
154584331|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584332|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584333|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584334|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584335|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584336|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584337|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584338|NCT04742751|Metformin|metformin|mesh-list
154584339|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154584340|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584341|NCT04740905|Aflibercept|aflibercept|mesh-list
154584342|NCT04740905|Faricimab|faricimab|mesh-list
154584343|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154584344|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154584345|NCT04740905|Growth Substances|growth substances|mesh-ancestor
154584346|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584347|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
154584348|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584349|NCT04667117|Ofatumumab|ofatumumab|mesh-list
154584350|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584351|NCT04594551|Vaccines|vaccines|mesh-list
154584352|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
154584353|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154584354|NCT04594551|Antibodies|antibodies|mesh-list
154584355|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
154584356|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584357|NCT04510194|Metformin|metformin|mesh-list
154584358|NCT04510194|Ivermectin|ivermectin|mesh-list
154584359|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
154584360|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154584361|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584362|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154584363|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584364|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154584365|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154584366|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584367|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154584368|NCT04510194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154584369|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154584370|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154584371|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584372|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584373|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
154584374|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154584375|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
154584376|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154584377|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154584378|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584379|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154584380|NCT04502966|Immunomodulating Agents|immunomodulating agents|mesh-list
154584381|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
154584382|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154584383|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584384|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154584385|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154584386|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
154584387|NCT04482803|Hormones|hormones|mesh-ancestor
154584388|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584389|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584390|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584391|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584392|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154584393|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584394|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154584395|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584396|NCT04335461|Anesthetics|anesthetics|mesh-list
154584397|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
154584398|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584399|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584400|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
154584401|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584402|NCT04300192|Vaccines|vaccines|mesh-list
154584403|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
154584404|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584405|NCT04188665|Lectins|lectins|mesh-list
154584406|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
154584407|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
154584408|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584409|NCT04188665|Coagulants|coagulants|mesh-ancestor
154584410|NCT04064294|Levodopa|levodopa|mesh-list
154584411|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154584412|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154584413|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
154584414|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584415|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584416|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584417|NCT04009044|Tamoxifen|tamoxifen|mesh-list
154584418|NCT04009044|Afimoxifene|afimoxifene|mesh-list
154584419|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154584420|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
154584421|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584422|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584423|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154584424|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584425|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154584426|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154584427|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154584428|NCT03699319|Leucovorin|leucovorin|mesh-list
154584429|NCT03699319|Folic Acid|folic acid|mesh-list
154584430|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
154584431|NCT03699319|Irinotecan|irinotecan|mesh-list
154584432|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
154584433|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584434|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584435|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154584436|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154584437|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584438|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584439|NCT03699319|Antidotes|antidotes|mesh-ancestor
154584440|NCT03699319|Protective Agents|protective agents|mesh-ancestor
154584441|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
154584442|NCT03699319|Vitamins|vitamins|mesh-ancestor
154584443|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
154584444|NCT03699319|Hematinics|hematinics|mesh-ancestor
154584445|NCT03594435|Ibudilast|ibudilast|mesh-list
154584446|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154584447|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
154584448|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584449|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584450|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154584451|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
154584452|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154584453|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584454|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584455|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154584456|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
154584457|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
154584458|NCT03563729|Nivolumab|nivolumab|mesh-list
154584459|NCT03563729|Ipilimumab|ipilimumab|mesh-list
154584460|NCT03563729|Trametinib|trametinib|mesh-list
154584461|NCT03563729|Dabrafenib|dabrafenib|mesh-list
154584462|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584463|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584464|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154071723|NCT02549326|Vitamin D|vitamin d|mesh-list
154584465|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584466|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154584467|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584468|NCT03539822|Durvalumab|durvalumab|mesh-list
154584469|NCT03539822|Tremelimumab|tremelimumab|mesh-list
154584470|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154584471|NCT03539822|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154584472|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584473|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584474|NCT03539822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154584475|NCT03539822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584476|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584477|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
154584478|NCT03257163|Capecitabine|capecitabine|mesh-list
154584479|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584480|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584481|NCT03257163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154584482|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584483|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584484|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
154584485|NCT02861300|Capecitabine|capecitabine|mesh-list
154584486|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584487|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
154584488|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584489|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584490|NCT02611960|Gemcitabine|gemcitabine|mesh-list
154584491|NCT02611960|Capecitabine|capecitabine|mesh-list
154584492|NCT02611960|Docetaxel|docetaxel|mesh-list
154584493|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
154584494|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584495|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
154584496|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584497|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584498|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
154584499|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
154584500|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
154584501|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584502|NCT02611960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154584503|NCT02358850|Acetaminophen|acetaminophen|mesh-list
154584504|NCT02358850|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154584505|NCT02358850|Oxycodone|oxycodone|mesh-list
154584506|NCT02358850|Hydromorphone|hydromorphone|mesh-list
154584507|NCT02358850|Hydrocodone|hydrocodone|mesh-list
154584508|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154584509|NCT02358850|Analgesics|analgesics|mesh-ancestor
154584510|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
154071745|NCT00827320|Levetiracetam|levetiracetam|mesh-list
154584511|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584512|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584513|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
154584514|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154584515|NCT02358850|Narcotics|narcotics|mesh-ancestor
154584516|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584517|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
154584518|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
154584519|NCT02358850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154584520|NCT02358850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584521|NCT02358850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584522|NCT01784159|Aspirin|aspirin|mesh-list
154584523|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154584524|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154584525|NCT01784159|Analgesics|analgesics|mesh-ancestor
154584526|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
154584527|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584528|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584529|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584530|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584531|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154584532|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154584533|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584534|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154584535|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154584536|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584537|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
154584538|NCT01749969|Dexamethasone|dexamethasone|mesh-list
154584539|NCT01749969|Lenalidomide|lenalidomide|mesh-list
154584540|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584541|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
154584542|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
154584543|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584544|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584545|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154584546|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
154584547|NCT01749969|Hormones|hormones|mesh-ancestor
154584548|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584549|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154584550|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584551|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
154584552|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154584553|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154584554|NCT01749969|Growth Substances|growth substances|mesh-ancestor
154584555|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
154584556|NCT01203020|Fludarabine|fludarabine|mesh-list
154584557|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
154584558|NCT01203020|Busulfan|busulfan|mesh-list
154071794|NCT00846521|Acarbose|acarbose|mesh-list
154584559|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584560|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584561|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
154584562|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584563|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154584564|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
154584565|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584566|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
154584567|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154584568|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154584569|NCT00006256|Paclitaxel|paclitaxel|mesh-list
154584570|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154584571|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584572|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
154584573|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
154584574|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
154584575|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584576|NCT00495131|Interferons|interferons|mesh-list
154584577|NCT00495131|Ribavirin|ribavirin|mesh-list
154862273|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154584578|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
154584580|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154584581|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584582|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
154584583|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584584|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
154584585|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584586|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
154584587|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584588|NCT02257372|Albuterol|albuterol|mesh-list
154584589|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154584590|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
154584591|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584592|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584593|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154584594|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
154584595|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
154584596|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154584597|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154584598|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154584599|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154584600|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
154584601|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584602|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584603|NCT02256982|Cisplatin|cisplatin|mesh-list
154584604|NCT02256982|Gemcitabine|gemcitabine|mesh-list
154584605|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584606|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584607|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
154584608|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584609|NCT03480607|Dexamethasone|dexamethasone|mesh-list
154584610|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
154584611|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584612|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
154584613|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
154584614|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584615|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584616|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154584617|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
154584618|NCT03480607|Hormones|hormones|mesh-ancestor
154584619|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584620|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154584621|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584622|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154584623|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584624|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154584625|NCT03480607|Analgesics|analgesics|mesh-ancestor
154584626|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
154584627|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154584628|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154584629|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154584630|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
154584631|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584632|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584633|NCT00489203|Beclomethasone|beclomethasone|mesh-list
154584634|NCT00489203|Methotrexate|methotrexate|mesh-list
154584635|NCT00489203|Tacrolimus|tacrolimus|mesh-list
154584636|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154584637|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
154071907|NCT00823186|Paclitaxel|paclitaxel|mesh-list
154584638|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154584639|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584640|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584641|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
154584642|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584643|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584644|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
154584645|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584646|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154584647|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154584648|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
154584649|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584650|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154584651|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154584652|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584653|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
154584654|NCT00489203|Hormones|hormones|mesh-ancestor
154584655|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584656|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154584657|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
154584658|NCT05646394|Aspirin|aspirin|mesh-list
154584659|NCT05646394|Vitamins|vitamins|mesh-list
154584660|NCT05646394|Vitamin K|vitamin k|mesh-list
154584661|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154584662|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
154584663|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584664|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154584665|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154584666|NCT05646394|Analgesics|analgesics|mesh-ancestor
154584667|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
154584668|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584669|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584670|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584671|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154584672|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154584673|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584674|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154584675|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584676|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
154584677|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154584678|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
154584679|NCT05646394|Coagulants|coagulants|mesh-ancestor
154584680|NCT00563459|Topiramate|topiramate|mesh-list
154584681|NCT00563459|Levetiracetam|levetiracetam|mesh-list
154584682|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
154584683|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154584684|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584685|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
154584686|NCT00561743|Dexamethasone|dexamethasone|mesh-list
154584687|NCT00561743|Doxorubicin|doxorubicin|mesh-list
154584688|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154584689|NCT00561743|Bortezomib|bortezomib|mesh-list
154584690|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584691|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
154584692|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
154584693|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584694|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584695|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154584696|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
154584697|NCT00561743|Hormones|hormones|mesh-ancestor
154584698|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584699|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154584700|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584701|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154584702|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154584703|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154584704|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584705|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584706|NCT00488267|Ketoprofen|ketoprofen|mesh-list
154584707|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154308508|NCT01203111|Insulin|insulin|mesh-list
154584708|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154584710|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
154584711|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584712|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584713|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584714|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584715|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154584716|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584717|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584718|NCT00560183|Morphine|morphine|mesh-list
154584719|NCT00560183|Oxycodone|oxycodone|mesh-list
154584720|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154584721|NCT00560183|Narcotics|narcotics|mesh-ancestor
154584722|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584723|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584724|NCT00560183|Analgesics|analgesics|mesh-ancestor
154584725|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
154584726|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584727|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154584728|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
154584729|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584730|NCT00542633|Insulin|insulin|mesh-list
154584731|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154584732|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154584733|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584734|NCT02523547|Entecavir|entecavir|mesh-list
154584735|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
154584736|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584737|NCT00483977|Oxycodone|oxycodone|mesh-list
154584738|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154584739|NCT00483977|Narcotics|narcotics|mesh-ancestor
154584740|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584741|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584742|NCT00483977|Analgesics|analgesics|mesh-ancestor
154584743|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
154584744|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584745|NCT00481325|Escitalopram|escitalopram|mesh-list
154584746|NCT00481325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154584747|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154584748|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154584749|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584750|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584751|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
154584752|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584753|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
154584754|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154584755|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154584756|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584757|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584758|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584759|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
154584760|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154584761|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
154584762|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584763|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
154584764|NCT03480295|Protective Agents|protective agents|mesh-ancestor
154584765|NCT03472963|Darunavir|darunavir|mesh-list
154584766|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154584767|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154584768|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154584769|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
154584770|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584771|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584772|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154584773|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154584774|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
154584775|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584776|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154584777|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154584778|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584779|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584780|NCT00465959|Trospium chloride|trospium chloride|mesh-list
154584781|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
154584782|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
154072048|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
154072067|NCT04105023|Hormones|hormones|mesh-ancestor
154584783|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584784|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584785|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154584786|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154584787|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
154584788|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584789|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584790|NCT00465959|Urological Agents|urological agents|mesh-ancestor
154584791|NCT00465803|Timolol|timolol|mesh-list
154584792|NCT00465803|Travoprost|travoprost|mesh-list
154584793|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154584794|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154584795|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584796|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154584797|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154584798|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
154584799|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584800|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584801|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154584803|NCT02282891|Ketamine|ketamine|mesh-list
154584804|NCT02282891|Propofol|propofol|mesh-list
154584805|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154584806|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584807|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584808|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154584809|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
154584810|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
154584811|NCT02282891|Analgesics|analgesics|mesh-ancestor
154584812|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
154584813|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584814|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154584815|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154584816|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154072093|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584817|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584818|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584819|NCT00464633|Alvocidib|alvocidib|mesh-list
154584820|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584821|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
154584822|NCT00464633|Growth Substances|growth substances|mesh-ancestor
154584823|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584824|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154584825|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584826|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584827|NCT00464555|Sirolimus|sirolimus|mesh-list
154584828|NCT00464555|Lisofylline|lisofylline|mesh-list
154584829|NCT00464555|Tacrolimus|tacrolimus|mesh-list
154584830|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154584831|NCT00464555|Basiliximab|basiliximab|mesh-list
154584832|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154584833|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
154584834|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584835|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154584836|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584837|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584838|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154584839|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584840|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154584841|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584842|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
154584843|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154584844|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154584845|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154584846|NCT00464555|Analgesics|analgesics|mesh-ancestor
154584847|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
154584848|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584849|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154584850|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584851|NCT00464243|Volinanserin|volinanserin|mesh-list
154584852|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154584853|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
154584854|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584855|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584856|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308655|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
154584858|NCT03336541|Analgesics|analgesics|mesh-ancestor
154584859|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
154584860|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584861|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584862|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154584863|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154584864|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
154584865|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
154584866|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584867|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154584868|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154584869|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584870|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584871|NCT00525941|Indiplon|indiplon|mesh-list
154584872|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154584873|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584874|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584875|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
154584877|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584878|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584879|NCT03476083|Tenofovir|tenofovir|mesh-list
154584880|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
154584881|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584882|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154584883|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154584884|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584885|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584886|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154584887|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154584888|NCT02738203|Lidocaine|lidocaine|mesh-list
154584889|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
154584890|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
154584891|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584892|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584893|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
154584894|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584895|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154584896|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154584897|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154584898|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154584899|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584900|NCT00457457|Tamsulosin|tamsulosin|mesh-list
154584901|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154584902|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154584903|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154584904|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
154584905|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584906|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584907|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584908|NCT00457457|Urological Agents|urological agents|mesh-ancestor
154584909|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154584910|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
154584911|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
154584912|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584913|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
154584914|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584915|NCT03472651|Flupenthixol|flupenthixol|mesh-list
154584916|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154584917|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154584918|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154584919|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154584920|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584921|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154584922|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154584923|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
154584924|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154584925|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584926|NCT00517049|Rituximab|rituximab|mesh-list
154584927|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584928|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584929|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
154584930|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584931|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154584932|NCT02283203|Acetaminophen|acetaminophen|mesh-list
154584933|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154584934|NCT02283203|Analgesics|analgesics|mesh-ancestor
154584935|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
154584936|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154584937|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584938|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
154584939|NCT02523313|Nivolumab|nivolumab|mesh-list
154584940|NCT02523313|Ipilimumab|ipilimumab|mesh-list
154584941|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154072170|NCT00915564|Simeprevir|simeprevir|mesh-list
154584942|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584943|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154584944|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584945|NCT02452034|Posaconazole|posaconazole|mesh-list
154584946|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
154584947|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154584948|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154584949|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154584950|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154584951|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154584952|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154584953|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584954|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584955|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154584956|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
154584957|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154584958|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584959|NCT02283359|Irinotecan|irinotecan|mesh-list
154584960|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154584961|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154584962|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584963|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584964|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584965|NCT00511043|Vatalanib|vatalanib|mesh-list
154584966|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154584967|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154584968|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584969|NCT00508625|Paclitaxel|paclitaxel|mesh-list
154584970|NCT00508625|Bevacizumab|bevacizumab|mesh-list
154584971|NCT00508625|Carboplatin|carboplatin|mesh-list
154584972|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154584973|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584974|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
154584975|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
154584976|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
154584977|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584978|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154584979|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154072221|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154584980|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154584981|NCT00508625|Growth Substances|growth substances|mesh-ancestor
154584982|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584983|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
154584984|NCT02284529|Leucovorin|leucovorin|mesh-list
154584985|NCT02284529|Fluorouracil|fluorouracil|mesh-list
154584986|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
154584987|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154584988|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154584989|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154584990|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154584991|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
154584992|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154584993|NCT02284529|Antidotes|antidotes|mesh-ancestor
154584994|NCT02284529|Protective Agents|protective agents|mesh-ancestor
154584995|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
154584996|NCT02284529|Vitamins|vitamins|mesh-ancestor
154584997|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
154584998|NCT02482298|Ticagrelor|ticagrelor|mesh-list
154584999|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154585000|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154585001|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154585002|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154585003|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
154308805|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
154585004|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585005|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585006|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585007|NCT04470479|Pilocarpine|pilocarpine|mesh-list
154585009|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
154585010|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585011|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585012|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154585013|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154585014|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
154585015|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585016|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585017|NCT00383513|Epratuzumab|epratuzumab|mesh-list
154585018|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154585019|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585020|NCT00382811|Carboplatin|carboplatin|mesh-list
154585021|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585022|NCT02286635|Clarithromycin|clarithromycin|mesh-list
154585023|NCT02286635|Rifampin|rifampin|mesh-list
154585024|NCT02286635|Deflazacort|deflazacort|mesh-list
154585025|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585026|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585027|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154585028|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585029|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585030|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154585031|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154585032|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154585033|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
154585034|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
154585035|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154585036|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154585037|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154585038|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154585039|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154585040|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154585041|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154585042|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585043|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154585044|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
154585045|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585046|NCT00440531|Vaccines|vaccines|mesh-list
154585047|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
154585048|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585049|NCT00437021|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154585050|NCT00437021|Antiviral Agents|antiviral agents|mesh-ancestor
154585051|NCT00437021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585052|NCT00375791|Dexamethasone|dexamethasone|mesh-list
154585053|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585054|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
154585055|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
154585056|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585057|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585058|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154585059|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
154585060|NCT00375791|Hormones|hormones|mesh-ancestor
154585061|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154585062|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154585063|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585064|NCT00431873|Mocetinostat|mocetinostat|mesh-list
154585065|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154585066|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585067|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585068|NCT02287181|Remifentanil|remifentanil|mesh-list
154585069|NCT02287181|Propofol|propofol|mesh-list
154585070|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154585071|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585072|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585073|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154585074|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
154585075|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
154585076|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154585077|NCT02287181|Narcotics|narcotics|mesh-ancestor
154585078|NCT02287181|Analgesics|analgesics|mesh-ancestor
154585079|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
154585080|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585082|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
154585083|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
154585084|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585085|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585086|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154585087|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154585088|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154585089|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585090|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154585091|NCT02287259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154585092|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154585093|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585094|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585095|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154862275|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585097|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
154585098|NCT00429923|Difluprednate|difluprednate|mesh-list
154585099|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
154585100|NCT00429923|Hormones|hormones|mesh-ancestor
154585101|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154585102|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585103|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585104|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
154585105|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154585106|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154072389|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585107|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585108|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
154585109|NCT04470557|Coagulants|coagulants|mesh-ancestor
154585110|NCT00372437|Gemcitabine|gemcitabine|mesh-list
154585111|NCT00372437|Mocetinostat|mocetinostat|mesh-list
154585112|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154585113|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
154585114|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585115|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585116|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154585117|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585118|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154585119|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
154585120|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585121|NCT00364247|Tapentadol|tapentadol|mesh-list
154585122|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154585123|NCT00364247|Narcotics|narcotics|mesh-ancestor
154585124|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585125|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585126|NCT00364247|Analgesics|analgesics|mesh-ancestor
154585127|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
154585128|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585129|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154585130|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154585131|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585132|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585133|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585134|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585135|NCT00424697|Lorazepam|lorazepam|mesh-list
154585136|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
154585137|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
154585138|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
154585139|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585140|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585141|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154585142|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154585143|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585144|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154585145|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154585146|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154585147|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
154585148|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
154585149|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585150|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585151|NCT00360035|Obatoclax|obatoclax|mesh-list
154585152|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585153|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585154|NCT00356681|Niacinamide|niacinamide|mesh-list
154585155|NCT00356681|Paclitaxel|paclitaxel|mesh-list
154585156|NCT00356681|Bevacizumab|bevacizumab|mesh-list
154585157|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
154585158|NCT00356681|Imetelstat|imetelstat|mesh-list
154585159|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154585160|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585161|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
154585162|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
154585163|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
154585164|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585165|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154585166|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154585167|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154585168|NCT00356681|Growth Substances|growth substances|mesh-ancestor
154585169|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585170|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
154585171|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154585172|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585173|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
154585174|NCT00356681|Vitamins|vitamins|mesh-ancestor
154585175|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
154585176|NCT00417209|Capecitabine|capecitabine|mesh-list
154585177|NCT00417209|Fluorouracil|fluorouracil|mesh-list
154585178|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154585179|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
154585180|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585181|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585182|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154585183|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
154585184|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585185|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154585186|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154585187|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154585188|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585189|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585190|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
154585191|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585192|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585193|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154585194|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585195|NCT00355355|Talaporfin|talaporfin|mesh-list
154585196|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585197|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154585198|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
154585199|NCT00407303|Bortezomib|bortezomib|mesh-list
154585200|NCT00407303|Obatoclax|obatoclax|mesh-list
154585201|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585202|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585203|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585204|NCT00344045|Acetaminophen|acetaminophen|mesh-list
154585205|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154585206|NCT00344045|Analgesics|analgesics|mesh-ancestor
154585207|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
154585208|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585209|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585210|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
154585211|NCT02256436|Paclitaxel|paclitaxel|mesh-list
154585212|NCT02256436|Docetaxel|docetaxel|mesh-list
154585213|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
154585214|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154585215|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585216|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154585217|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154585218|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154585219|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072472|NCT02602938|Aspirin|aspirin|mesh-list
154585220|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154585221|NCT02256436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154585222|NCT00343109|Sargramostim|sargramostim|mesh-list
154585223|NCT00343109|Vaccines|vaccines|mesh-list
154585224|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
154585225|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585226|NCT00405743|Cytarabine|cytarabine|mesh-list
154585227|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154585228|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
154585229|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585230|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585231|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
154585232|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585233|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154585234|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
154585235|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585236|NCT00403169|Lenalidomide|lenalidomide|mesh-list
154585237|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
154585238|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585239|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154585240|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154585241|NCT00403169|Growth Substances|growth substances|mesh-ancestor
154585242|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
154585243|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862276|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585244|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
154585245|NCT00332657|Anecortave|anecortave|mesh-list
154255624|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
154585246|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154585247|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154585248|NCT00332657|Growth Substances|growth substances|mesh-ancestor
154585249|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585250|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
154585251|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585252|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585253|NCT00330473|Insulin|insulin|mesh-list
154585254|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154585255|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154585256|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585257|NCT00327743|Capecitabine|capecitabine|mesh-list
154585258|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154585259|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
154585260|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585261|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585262|NCT02285075|Temocillin|temocillin|mesh-list
154585263|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585264|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585265|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154585266|NCT00321815|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154585267|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154585268|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585269|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585270|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585271|NCT00398879|Capecitabine|capecitabine|mesh-list
154585272|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154585273|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
154585274|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585275|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585276|NCT00309179|Cetuximab|cetuximab|mesh-list
154585277|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154585278|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585279|NCT00394199|Fluticasone|fluticasone|mesh-list
154585280|NCT00394199|Xhance|xhance|mesh-list
154585281|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
154585282|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585283|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154585284|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
154585285|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585286|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585287|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154585288|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
154585289|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
154585290|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154585291|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154585292|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154585293|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154585294|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585295|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585296|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585297|NCT00394121|Fluticasone|fluticasone|mesh-list
154585298|NCT00394121|Xhance|xhance|mesh-list
154585299|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
154585300|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585301|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154585302|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
154585303|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585304|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585305|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154585306|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
154585307|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
154585308|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154585309|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154585310|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154585311|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154585312|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585313|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585314|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585315|NCT02480114|Acetaminophen|acetaminophen|mesh-list
154585316|NCT02480114|Ibuprofen|ibuprofen|mesh-list
153973720|NCT06248229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585317|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154585318|NCT02480114|Fentanyl|fentanyl|mesh-list
154585319|NCT02480114|Oxycodone|oxycodone|mesh-list
154585321|NCT02480114|Gabapentin|gabapentin|mesh-list
154585322|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154585323|NCT02480114|Narcotics|narcotics|mesh-ancestor
154585324|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585325|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585326|NCT02480114|Analgesics|analgesics|mesh-ancestor
154585327|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
154585328|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585329|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154585330|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154585331|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
154585332|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
154585333|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154585334|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
154585335|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154585336|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585337|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154585338|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154585339|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585340|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585341|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
154585342|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154585343|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154585344|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154585345|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154585346|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154585347|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585348|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
154585349|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
154585350|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
154585351|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
154585352|NCT00299507|Anecortave|anecortave|mesh-list
154585353|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154585354|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154585355|NCT00299507|Growth Substances|growth substances|mesh-ancestor
154585356|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585357|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
154585358|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585359|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585360|NCT02285309|Enoximone|enoximone|mesh-list
154585361|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154585362|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
154585363|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154585364|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154585365|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585366|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585367|NCT02285309|Protective Agents|protective agents|mesh-ancestor
154585368|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585369|NCT02479880|Tenofovir|tenofovir|mesh-list
154585370|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
154585371|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585372|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154585373|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154585374|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585375|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585376|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154585377|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154585378|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
154585379|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585380|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585381|NCT00297089|Pemetrexed|pemetrexed|mesh-list
154585382|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585383|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585384|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585385|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154585386|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154585387|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
154585388|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154585389|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585390|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154585391|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
154585392|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154585393|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585394|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154585395|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154585396|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154585397|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
154585398|NCT02285699|Citalopram|citalopram|mesh-list
154585399|NCT02285699|Fluoxetine|fluoxetine|mesh-list
154585400|NCT02285699|Paroxetine|paroxetine|mesh-list
154585401|NCT02285699|Sertraline|sertraline|mesh-list
154585402|NCT02285699|Escitalopram|escitalopram|mesh-list
154585403|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154585404|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154585405|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585406|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585407|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585408|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
154585409|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585410|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154585411|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
154585412|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154585413|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154585414|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154585415|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585416|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154585417|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154585418|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585419|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154585420|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154585421|NCT02288429|Colistin|colistin|mesh-list
154585422|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585423|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585424|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
154585425|NCT03133637|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154585426|NCT03133637|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154585427|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585428|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585429|NCT00265655|Satraplatin|satraplatin|mesh-list
154585430|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585431|NCT00254891|Paclitaxel|paclitaxel|mesh-list
154585432|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154585433|NCT00254891|Carboplatin|carboplatin|mesh-list
154585434|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154585435|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585436|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
154585437|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
154585438|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
154585439|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585440|NCT02479412|Albuterol|albuterol|mesh-list
154585441|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154585442|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
154072726|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154585443|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585444|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585445|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154585446|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
154585447|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
154585448|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154585449|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154585450|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154585451|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154585452|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585453|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154309260|NCT02037802|Fentanyl|fentanyl|mesh-list
154585454|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585455|NCT00254579|Tremelimumab|tremelimumab|mesh-list
154585456|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585457|NCT00252005|Apixaban|apixaban|mesh-list
154585458|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154585459|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
154585460|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154585461|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
154585462|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585463|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585464|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
154072727|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154585465|NCT02288507|Sorafenib|sorafenib|mesh-list
154585466|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585467|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154585468|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585469|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585471|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585472|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585473|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154585474|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585475|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
154585476|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154585477|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
154585478|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585479|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
154585480|NCT00224003|Hematinics|hematinics|mesh-ancestor
154585481|NCT00216593|Galantamine|galantamine|mesh-list
154585482|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154585483|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585484|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585485|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
154585486|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585487|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585488|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154585489|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
154585490|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585491|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
154585492|NCT00389675|Guanfacine|guanfacine|mesh-list
154585493|NCT00389675|Darusentan|darusentan|mesh-list
154585494|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154585495|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154585496|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154585497|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154585498|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585499|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585500|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585501|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585502|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154585503|NCT02288741|Dexamethasone|dexamethasone|mesh-list
154585504|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
154585505|NCT02288741|Melphalan|melphalan|mesh-list
154585506|NCT02288741|BB 1101|bb 1101|mesh-list
154585507|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585508|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
154585509|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
154585510|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585511|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585512|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154585513|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
154585514|NCT02288741|Hormones|hormones|mesh-ancestor
154585515|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154585516|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154585517|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585518|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
154585519|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585520|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585521|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154585522|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
154585523|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154585524|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154585525|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
154585526|NCT02450552|Ezogabine|ezogabine|mesh-list
154585527|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
154309342|NCT03811509|Denosumab|denosumab|mesh-list
154585528|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585529|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585531|NCT02508428|Diuretics|diuretics|mesh-ancestor
154585532|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
154585533|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585534|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154585535|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585536|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585537|NCT02448446|Ranibizumab|ranibizumab|mesh-list
154585538|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154585539|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154585540|NCT02448446|Growth Substances|growth substances|mesh-ancestor
154585541|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585542|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
154585543|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585544|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
154585545|NCT02478398|Loratadine|loratadine|mesh-list
154585546|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154585547|NCT02478398|Epinephrine|epinephrine|mesh-list
154585548|NCT02478398|Albuterol|albuterol|mesh-list
154585549|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154585550|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154585551|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585552|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585553|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585554|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585555|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154585556|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154585557|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
154585558|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585559|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154585560|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
154585561|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
154585562|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
154585563|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154585564|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
154585565|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154585566|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154585567|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585568|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
154585569|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154585570|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
154585571|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154585572|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154585573|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
154585574|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
154585575|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154585576|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154585577|NCT02478398|Analgesics|analgesics|mesh-ancestor
154585578|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
154585579|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154585580|NCT02478164|Ponatinib|ponatinib|mesh-list
154585581|NCT02478164|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154585582|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154585583|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585584|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072842|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585585|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585586|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154585587|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154585588|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154585589|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154585590|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
154585591|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154585592|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585593|NCT05259007|Amoxicillin|amoxicillin|mesh-list
154585594|NCT05259007|Clarithromycin|clarithromycin|mesh-list
154585595|NCT05259007|Propolis|propolis|mesh-list
154585596|NCT05259007|Lansoprazole|lansoprazole|mesh-list
154585597|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
154585598|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585599|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585600|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154585601|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585602|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309450|NCT02052388|Daptomycin|daptomycin|mesh-list
154585603|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154585604|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154585605|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154585606|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154585607|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154585608|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
154585609|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154585610|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585611|NCT00380653|Sapacitabine|sapacitabine|mesh-list
154585612|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585614|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154585615|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154585616|NCT03472339|Analgesics|analgesics|mesh-ancestor
154585617|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
154585618|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585619|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585620|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585621|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154585622|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154585623|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973721|NCT06248229|Sympathomimetics|sympathomimetics|mesh-ancestor
154585624|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585625|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
154585626|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154585627|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154585628|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154585629|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585630|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585631|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
154585632|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585633|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585634|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154585635|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585637|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
154585638|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585639|NCT03951025|Protective Agents|protective agents|mesh-ancestor
154585640|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585641|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585642|NCT02255500|Bupivacaine|bupivacaine|mesh-list
154585643|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
154585644|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
154585645|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585646|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585647|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
154585648|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585649|NCT03475693|Acetaminophen|acetaminophen|mesh-list
154585650|NCT03475693|Ondansetron|ondansetron|mesh-list
154585651|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
154585652|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154585653|NCT03475693|Analgesics|analgesics|mesh-ancestor
154585654|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
154585655|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585656|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585657|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
154585658|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
154585659|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
154585660|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154585661|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
154585662|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
154585663|NCT03475693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154585664|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154585665|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
154585666|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585667|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585668|NCT03475693|Antacids|antacids|mesh-ancestor
154585669|NCT03475615|Paclitaxel|paclitaxel|mesh-list
154585670|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
154585671|NCT03475615|Tegafur|tegafur|mesh-list
154585672|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154585673|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585674|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
154585675|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
154585676|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
154585677|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585678|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154585679|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
154585680|NCT03478423|Oxycodone|oxycodone|mesh-list
154585681|NCT03478423|Hydromorphone|hydromorphone|mesh-list
154585682|NCT03478423|Codeine|codeine|mesh-list
154585683|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154585684|NCT03478423|Narcotics|narcotics|mesh-ancestor
154585685|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585686|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585687|NCT03478423|Analgesics|analgesics|mesh-ancestor
154585688|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
154585689|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585690|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
154585691|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
154585692|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
154585693|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585694|NCT03130933|Amoxicillin|amoxicillin|mesh-list
154585695|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585696|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585697|NCT05155969|Ketamine|ketamine|mesh-list
154585698|NCT05155969|Esketamine|esketamine|mesh-list
154585699|NCT05155969|Analgesics|analgesics|mesh-ancestor
154585700|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
154585701|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585702|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072936|NCT00913055|Octreotide|octreotide|mesh-list
154072977|NCT00767325|Abatacept|abatacept|mesh-list
154585703|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154585704|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154585705|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
154585706|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
154585707|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585708|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154585709|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154585710|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585711|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585712|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
154585713|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154585714|NCT05112913|Vaccines|vaccines|mesh-list
154585715|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
154585716|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585717|NCT03475459|Melatonin|melatonin|mesh-list
154585718|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
154585719|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585720|NCT03475459|Protective Agents|protective agents|mesh-ancestor
154585721|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585722|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585723|NCT03478111|Infliximab|infliximab|mesh-list
154585724|NCT03478111|Methotrexate|methotrexate|mesh-list
154585725|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154585726|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
154585727|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154585728|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585729|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154585730|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
154585731|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585732|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585733|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
154585734|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585735|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154585736|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154585737|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
154585738|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154585739|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154585740|NCT03478111|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154585741|NCT03478111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585742|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154585743|NCT03478033|Rifampin|rifampin|mesh-list
154585744|NCT03478033|Rifabutin|rifabutin|mesh-list
154585745|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154585746|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
154585747|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585748|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585749|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
154585750|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154585751|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585752|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585753|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154585754|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154585755|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154585756|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154585757|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154585758|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154585759|NCT03477955|Silicon|silicon|mesh-list
154585760|NCT03477955|Trace Elements|trace elements|mesh-ancestor
154585761|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
154585762|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585763|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
154585764|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585765|NCT05189197|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154585766|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154585767|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585768|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585770|NCT02505542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154585771|NCT02505542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585772|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154585773|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
154585774|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585775|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154585776|NCT00701623|Heparin|heparin|mesh-list
154585777|NCT00701623|Calcium heparin|calcium heparin|mesh-list
154585778|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
154585779|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154585780|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154585781|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585782|NCT04456153|Atovaquone|atovaquone|mesh-list
154585783|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585784|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
154585785|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154585786|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154585787|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585788|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585789|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
154585790|NCT04403971|Listerine|listerine|mesh-list
154585791|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154585792|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585793|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
154585794|NCT02447432|Vaccines|vaccines|mesh-list
154585795|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154585796|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
154585797|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585798|NCT02446886|Hormones|hormones|mesh-list
154585799|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154585800|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154585801|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
154585802|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154585803|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585804|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585805|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585806|NCT04351243|Gimsilumab|gimsilumab|mesh-list
154585807|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585808|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
154585809|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585810|NCT05008003|Vitamin D|vitamin d|mesh-list
154585811|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
154585812|NCT05008003|Vitamins|vitamins|mesh-ancestor
154585813|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
154073085|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585814|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585815|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154585816|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154585817|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
154585818|NCT03475225|Vitamin D|vitamin d|mesh-list
154585819|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154585820|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585821|NCT03475225|Vitamins|vitamins|mesh-ancestor
154585822|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
154585823|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154585824|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154585825|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
154585826|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
154309642|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
154585827|NCT02504294|Hematinics|hematinics|mesh-ancestor
154585828|NCT02446418|Fluticasone|fluticasone|mesh-list
154585830|NCT02446418|Budesonide|budesonide|mesh-list
154585831|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
154585832|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154585833|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585834|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154585835|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
154585836|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585837|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585838|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154585839|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
154585840|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
154585841|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154585842|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
154585843|NCT02446418|Hormones|hormones|mesh-ancestor
154585844|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154585845|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154585846|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154585847|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154585848|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585849|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585850|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585852|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
154585853|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
154585854|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585855|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585856|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
154585857|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585858|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154585859|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154585860|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154585861|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585862|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585863|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
154585864|NCT01641640|Ribavirin|ribavirin|mesh-list
154585865|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
154585866|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585867|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
154585868|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585869|NCT05650216|Paclitaxel|paclitaxel|mesh-list
154585870|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154585871|NCT05650216|Carboplatin|carboplatin|mesh-list
154585872|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154585873|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585874|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
154585875|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
154585876|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
154585877|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585878|NCT05369650|Lidocaine|lidocaine|mesh-list
154585879|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
154585880|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
154585881|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154585882|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585883|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
154585884|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585885|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154585886|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154585887|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154585888|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585889|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585890|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154585891|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154585892|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154585893|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585894|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585895|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585896|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585897|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585898|NCT01601626|Pyridoxine|pyridoxine|mesh-list
154585899|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
154585900|NCT01601626|Ritonavir|ritonavir|mesh-list
154585901|NCT01601626|Lopinavir|lopinavir|mesh-list
154309714|NCT03793725|Apatinib|apatinib|mesh-list
154585902|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
154585904|NCT01601626|Isoniazid|isoniazid|mesh-list
154585905|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
154585906|NCT01601626|Ethambutol|ethambutol|mesh-list
154585907|NCT01601626|Rifabutin|rifabutin|mesh-list
154585908|NCT01601626|Vitamins|vitamins|mesh-ancestor
154585909|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
154585910|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585911|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154585912|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154585913|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
154585914|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585915|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585916|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154585917|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154585918|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
154585919|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154585920|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154585922|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
154585923|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154585924|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154585925|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154585926|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
154585927|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154585928|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
154585929|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154585930|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154585931|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154585932|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154585933|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153615911|NCT01979510|Acetaminophen|acetaminophen|mesh-list
154585934|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154585935|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154585936|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154585937|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154585938|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
154585939|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154585940|NCT05428150|Pirfenidone|pirfenidone|mesh-list
154585941|NCT05428150|Analgesics|analgesics|mesh-ancestor
154585942|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
154585943|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585944|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585945|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154585946|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154585947|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154585948|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154585949|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585950|NCT02737501|Crizotinib|crizotinib|mesh-list
154585951|NCT02737501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154585952|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154585953|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585954|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585955|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154585956|NCT03471559|Cannabidiol|cannabidiol|mesh-list
154585957|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
154585958|NCT05641480|Donepezil|donepezil|mesh-list
154585959|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154585960|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585961|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585962|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
154585963|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585964|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585965|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
154585966|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154585967|NCT03377803|Cantharidin|cantharidin|mesh-list
154585968|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154585969|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585970|NCT03471325|Methamphetamine|methamphetamine|mesh-list
154585971|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154585972|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585973|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
154585974|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
154585975|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154585976|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
154585977|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154585978|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154585979|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
154585980|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154585981|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154585982|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154585983|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154585984|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
154585985|NCT04844164|Vitamin D|vitamin d|mesh-list
154585986|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154585987|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585988|NCT04844164|Vitamins|vitamins|mesh-ancestor
154585989|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
154585990|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154585991|NCT05392972|Anesthetics|anesthetics|mesh-list
154585992|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154862278|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154585993|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585994|NCT03474601|Hormones|hormones|mesh-list
154585995|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154585996|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154585997|NCT04984798|Vitamin E|vitamin e|mesh-list
154585998|NCT04984798|Tocopherols|tocopherols|mesh-list
154585999|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
154586000|NCT04984798|Vitamins|vitamins|mesh-ancestor
154586001|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
154586002|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586003|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
154586004|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073249|NCT00842153|Hormones|hormones|mesh-ancestor
154586005|NCT04984798|Protective Agents|protective agents|mesh-ancestor
154586006|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
154586007|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154586008|NCT02230163|Antibodies|antibodies|mesh-list
154586009|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
154586010|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586011|NCT02230319|Paclitaxel|paclitaxel|mesh-list
154586012|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154586013|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586014|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
154586015|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
154586016|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
154586017|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586018|NCT00135395|Ritonavir|ritonavir|mesh-list
154586019|NCT00135395|Lopinavir|lopinavir|mesh-list
154586020|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154586021|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154586022|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154586023|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586024|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586025|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586026|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154586027|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154586028|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
154586029|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586030|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154586031|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154586032|NCT02230553|Lapatinib|lapatinib|mesh-list
154586033|NCT02230553|Trametinib|trametinib|mesh-list
154586034|NCT02230553|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154586035|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154586036|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729942|NCT00131846|Diuretics|diuretics|mesh-list
154586037|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586038|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586039|NCT04261049|Triamcinolone|triamcinolone|mesh-list
154586040|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154586041|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154586042|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154586043|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154586044|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
154586045|NCT04261049|Hormones|hormones|mesh-ancestor
154586046|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586047|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586048|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154586049|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
154586050|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586051|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586052|NCT00057473|Carboplatin|carboplatin|mesh-list
154586053|NCT00057473|Irinotecan|irinotecan|mesh-list
154586054|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586055|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154586056|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586057|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586058|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586059|NCT00035789|Entecavir|entecavir|mesh-list
154586060|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
154586061|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586062|NCT00035633|Entecavir|entecavir|mesh-list
154586063|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
154586064|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586065|NCT00028301|Ritonavir|ritonavir|mesh-list
154586066|NCT00028301|Lopinavir|lopinavir|mesh-list
154586067|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154586068|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154586069|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154586070|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586071|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586072|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586073|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154586074|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154586075|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
154586076|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586077|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154586078|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154586079|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154586080|NCT00028067|Nelfinavir|nelfinavir|mesh-list
154586081|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154586082|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154586083|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586084|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586085|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586086|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154586087|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154586088|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
154586089|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586090|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
154586091|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586092|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
154586093|NCT00004907|Busulfan|busulfan|mesh-list
154586094|NCT00004907|Etoposide|etoposide|mesh-list
154586095|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154586096|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
154586097|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586098|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586099|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154586100|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
154586101|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586102|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586103|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154586104|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154586105|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154586106|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586107|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586108|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
154586109|NCT04469777|Hematinics|hematinics|mesh-ancestor
154586110|NCT00004895|Octreotide|octreotide|mesh-list
154586111|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154586112|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154586113|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586114|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
154586115|NCT00004181|Busulfan|busulfan|mesh-list
154586116|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154586117|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
154586118|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586119|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586120|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154586121|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
154586122|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586123|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586124|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154586125|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
154586126|NCT00004175|Docetaxel|docetaxel|mesh-list
154586127|NCT00004175|Doxorubicin|doxorubicin|mesh-list
154586128|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154586129|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154586130|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
154586131|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586132|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586133|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154586134|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
154586135|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586136|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586137|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154586138|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
154586139|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
154586140|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
154586141|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154586142|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154862279|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586143|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586144|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586145|NCT05708573|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154586146|NCT05708573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154586147|NCT05708573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154586148|NCT05708573|Antimetabolites|antimetabolites|mesh-ancestor
154586149|NCT05708573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586150|NCT05708573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154586151|NCT05708573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154586152|NCT05708573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586153|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
154586154|NCT00004169|Carboplatin|carboplatin|mesh-list
154586155|NCT00004169|Etoposide|etoposide|mesh-list
154586156|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154586157|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
154586158|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586159|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586160|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154586161|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
154586162|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586163|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586164|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154586165|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154586166|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154586167|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586168|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586169|NCT00002429|Lamivudine|lamivudine|mesh-list
154586170|NCT00002429|Zidovudine|zidovudine|mesh-list
154586171|NCT00002429|Didanosine|didanosine|mesh-list
154586172|NCT00002429|Stavudine|stavudine|mesh-list
154586173|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154586174|NCT00002429|Nelfinavir|nelfinavir|mesh-list
154586175|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154586176|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154586177|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586178|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586179|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
154586180|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586181|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154586182|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154586183|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
154586184|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154586185|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154586186|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586187|NCT00002411|Lamivudine|lamivudine|mesh-list
154586188|NCT00002411|Zidovudine|zidovudine|mesh-list
154586189|NCT00002411|Didanosine|didanosine|mesh-list
154586190|NCT00002411|Stavudine|stavudine|mesh-list
154586191|NCT00002411|Nelfinavir|nelfinavir|mesh-list
154586192|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154586193|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154586194|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586195|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586196|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
154586197|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586198|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154586199|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154586200|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
154586201|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154586202|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154586203|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586204|NCT03530033|Lidocaine|lidocaine|mesh-list
154586205|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
154586206|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
154586207|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586209|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
154586210|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586211|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154586212|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154586213|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154586214|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154586215|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586216|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
154586217|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154586218|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586219|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586220|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154586221|NCT03529643|Analgesics|analgesics|mesh-ancestor
154586222|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
154586223|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586224|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154586225|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154586226|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154586227|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
154586228|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586229|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586230|NCT03529331|Acetaminophen|acetaminophen|mesh-list
154586231|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154586232|NCT03529331|Morphine|morphine|mesh-list
154586233|NCT03529331|Oxycodone|oxycodone|mesh-list
154586234|NCT03529331|Hydrocodone|hydrocodone|mesh-list
154586235|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154586236|NCT03529331|Narcotics|narcotics|mesh-ancestor
154586237|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586238|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586239|NCT03529331|Analgesics|analgesics|mesh-ancestor
154586240|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
154586241|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586242|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154586243|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
154586244|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
154586245|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
154586246|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154586247|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073492|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
154586248|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586249|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154586250|NCT03529253|Alirocumab|alirocumab|mesh-list
154586251|NCT03529253|Calcium|calcium|mesh-list
154586252|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154586253|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586254|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154586255|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154586256|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
154586257|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586258|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154586259|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154586260|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586261|NCT03529253|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154586262|NCT03529253|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154586263|NCT03529253|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586264|NCT03529175|Paclitaxel|paclitaxel|mesh-list
154586265|NCT03529175|Gemcitabine|gemcitabine|mesh-list
154586266|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154586267|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154586268|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586269|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
154586270|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
154586271|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
154586272|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586273|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154586274|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
154586275|NCT00002207|Didanosine|didanosine|mesh-list
154586276|NCT00002207|Stavudine|stavudine|mesh-list
154586277|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
154586278|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586279|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154586280|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154586281|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586282|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
154586283|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586284|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154586285|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154586286|NCT03529097|Dipyrone|dipyrone|mesh-list
154586287|NCT03529097|Diclofenac|diclofenac|mesh-list
154586288|NCT03529097|Morphine|morphine|mesh-list
154586289|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154586290|NCT03529097|Narcotics|narcotics|mesh-ancestor
154586291|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586292|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862280|NCT02982161|Celecoxib|celecoxib|mesh-list
154586293|NCT03529097|Analgesics|analgesics|mesh-ancestor
154586294|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
154586295|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862281|NCT02982161|Tramadol|tramadol|mesh-list
154586296|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154586297|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154586298|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154586299|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586300|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154586301|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586302|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586303|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
154586304|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
154586305|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
154586306|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586307|NCT03531749|Protective Agents|protective agents|mesh-ancestor
154586308|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586309|NCT03531749|Vitamins|vitamins|mesh-ancestor
154586310|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
154586311|NCT03528785|Leucovorin|leucovorin|mesh-list
154586312|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
154586313|NCT03528785|Irinotecan|irinotecan|mesh-list
154586314|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
154586315|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586316|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154586317|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586318|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586319|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586320|NCT03528785|Antidotes|antidotes|mesh-ancestor
154586321|NCT03528785|Protective Agents|protective agents|mesh-ancestor
154586322|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586323|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
154586324|NCT03528785|Vitamins|vitamins|mesh-ancestor
154586325|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
154586326|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154586327|NCT03531437|Gestodene|gestodene|mesh-list
154586328|NCT03531437|Estradiol|estradiol|mesh-list
154586329|NCT03531437|Estrogens|estrogens|mesh-ancestor
154586330|NCT03531437|Hormones|hormones|mesh-ancestor
154586331|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586332|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586333|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154586334|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
154586335|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154586336|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154586337|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154586338|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154586339|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154586340|NCT03531437|Progestins|progestins|mesh-ancestor
154586341|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
154586342|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154586343|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
154586344|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586345|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586346|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154586347|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
154586348|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154586349|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
154586350|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586351|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586352|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154586353|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
154586354|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
154586355|NCT03527381|Protective Agents|protective agents|mesh-ancestor
154586356|NCT04441385|Maraviroc|maraviroc|mesh-list
154586357|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154586358|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154586359|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586360|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154586361|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154586362|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
154586363|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586364|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154586366|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154586367|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154586368|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586369|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586370|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154862282|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154586371|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154586373|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154586374|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
154586375|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
154586376|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
154586377|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
154586378|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586379|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586380|NCT03531281|Sirolimus|sirolimus|mesh-list
154586381|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
154586382|NCT03531281|Etoposide|etoposide|mesh-list
154586383|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
154586384|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
154586385|NCT03531281|Tacrolimus|tacrolimus|mesh-list
154586386|NCT03531281|Mitogens|mitogens|mesh-list
154586387|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154586388|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
154586389|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586390|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586391|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154586392|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
154586393|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586394|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586395|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154586396|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154586397|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154586398|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586399|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586400|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154586401|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154586402|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586403|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154586404|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
154586405|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
154586406|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
154586407|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
154586408|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
154586409|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
154586410|NCT04468685|Ondansetron|ondansetron|mesh-list
154586411|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
154586412|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
154586413|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586414|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586415|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154586416|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
154586417|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
154586418|NCT04468685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154586419|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154586420|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
154586421|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586422|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586423|NCT03531047|Riboflavin|riboflavin|mesh-list
154586424|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
154586425|NCT03531047|Vitamins|vitamins|mesh-ancestor
154586426|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
154586427|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586428|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154586429|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
154586430|NCT04440917|Apatinib|apatinib|mesh-list
154586431|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154586432|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586433|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073602|NCT02600988|Vitamin D|vitamin d|mesh-list
154586434|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586435|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586436|NCT04440917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154586437|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
154586438|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586439|NCT04468139|Quercetin|quercetin|mesh-list
154586440|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586441|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
154586442|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586443|NCT04468139|Protective Agents|protective agents|mesh-ancestor
154586444|NCT03526445|Glucagon|glucagon|mesh-list
154586445|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154586446|NCT03526445|Hormones|hormones|mesh-ancestor
154586447|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586448|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586449|NCT04939649|Midazolam|midazolam|mesh-list
154586450|NCT04939649|Ketamine|ketamine|mesh-list
154586451|NCT04939649|Analgesics|analgesics|mesh-ancestor
154586452|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
154586453|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586454|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586455|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154586456|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154586457|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
154586458|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
154586459|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586460|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154586461|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154586462|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586463|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586464|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154586465|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154586466|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154586467|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154586468|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154586469|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
154586470|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
154586471|NCT04927949|Cangrelor|cangrelor|mesh-list
154586472|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154586473|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154586474|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154586475|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154586476|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
154586477|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586478|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586479|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586480|NCT04589819|Teriparatide|teriparatide|mesh-list
154586481|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154586482|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586483|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154586484|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154586485|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154586486|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154586487|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
154586488|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586489|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154586490|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154586491|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586492|NCT04467983|Denosumab|denosumab|mesh-list
154586493|NCT04467983|Abaloparatide|abaloparatide|mesh-list
154586494|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154586495|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586496|NCT04839731|Fluorouracil|fluorouracil|mesh-list
154586497|NCT04839731|Calcipotriene|calcipotriene|mesh-list
154586498|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
154586499|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586500|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154586501|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586502|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154586503|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
154586504|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586505|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
154586506|NCT03525509|Morphine|morphine|mesh-list
154586507|NCT03525509|Methadone|methadone|mesh-list
154310314|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
154586508|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154586509|NCT03525509|Narcotics|narcotics|mesh-ancestor
154586510|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586511|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586512|NCT03525509|Analgesics|analgesics|mesh-ancestor
154586513|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
154586514|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586515|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
154586516|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
154586517|NCT04699721|Paclitaxel|paclitaxel|mesh-list
154586518|NCT04699721|Carboplatin|carboplatin|mesh-list
154586519|NCT04699721|Nivolumab|nivolumab|mesh-list
154586520|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154073681|NCT04100226|Vitamins|vitamins|mesh-ancestor
154586521|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586523|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
154586524|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
154586525|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586526|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154586527|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154586528|NCT03525821|Ketamine|ketamine|mesh-list
154586529|NCT03525821|Analgesics|analgesics|mesh-ancestor
154586530|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
154586531|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586532|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586533|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154586534|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154586535|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
154586536|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
154586537|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586538|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154586539|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154586540|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586541|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586542|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
154586543|NCT04221035|Temozolomide|temozolomide|mesh-list
154586544|NCT04221035|Melphalan|melphalan|mesh-list
154586545|NCT04221035|Busulfan|busulfan|mesh-list
154586546|NCT04221035|Ifosfamide|ifosfamide|mesh-list
154586547|NCT04221035|Thiotepa|thiotepa|mesh-list
154586548|NCT04221035|Dacarbazine|dacarbazine|mesh-list
154586549|NCT04221035|Carboplatin|carboplatin|mesh-list
154586550|NCT04221035|Doxorubicin|doxorubicin|mesh-list
154586551|NCT04221035|Irinotecan|irinotecan|mesh-list
154586552|NCT04221035|Etoposide|etoposide|mesh-list
154586553|NCT04221035|Vincristine|vincristine|mesh-list
154586554|NCT04221035|Vindesine|vindesine|mesh-list
154586555|NCT04221035|Dinutuximab|dinutuximab|mesh-list
154586556|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154586557|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
154586558|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586559|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586560|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154586561|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
154586562|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586563|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586564|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154586565|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154586566|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154586567|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586568|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586569|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154586570|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154586571|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
154586572|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
154586573|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
154586574|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
154586575|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154586576|NCT04842682|Diazepam|diazepam|mesh-list
154586577|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154586578|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
154586579|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
154586580|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
154586581|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586582|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310393|NCT01309425|Tapentadol|tapentadol|mesh-list
154586583|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154586584|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154586585|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586586|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154586587|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154586588|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154586589|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154586590|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154586591|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154586592|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
154586593|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
154586594|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
154586595|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
154586596|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255627|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
154586597|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586599|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154586600|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154586601|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154586602|NCT05198362|Metoprolol|metoprolol|mesh-list
154586603|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154586604|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154586605|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
154586606|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
154586607|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586608|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586609|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154586610|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154586611|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154586612|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
154586613|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586614|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586615|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
154586616|NCT04810156|Prednisone|prednisone|mesh-list
154586617|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
154586618|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154586619|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154586620|NCT04810156|Prednisolone|prednisolone|mesh-list
154586621|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
154586622|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154586623|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154586624|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
154586625|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154586626|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
154586627|NCT04810156|Hormones|hormones|mesh-ancestor
154586628|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586629|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586630|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154586631|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586632|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154586633|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154586634|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
154586635|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154586636|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586637|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586638|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586639|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
154586640|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
154586641|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586642|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154586643|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154586644|NCT04810156|Protective Agents|protective agents|mesh-ancestor
154586645|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154586646|NCT04837924|Acetaminophen|acetaminophen|mesh-list
154586647|NCT04837924|Tramadol|tramadol|mesh-list
154586648|NCT04837924|Analgesics|analgesics|mesh-list
154586649|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
154586650|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154586651|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
154586652|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586653|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586654|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
154586655|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154586656|NCT04837924|Narcotics|narcotics|mesh-ancestor
154586657|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586658|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
154586659|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
154586660|NCT05406466|Lenvatinib|lenvatinib|mesh-list
154586661|NCT05406466|Tislelizumab|tislelizumab|mesh-list
154586662|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586663|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154586664|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586665|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586666|NCT05406466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154586667|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
154586669|NCT05152420|Edoxaban|edoxaban|mesh-list
154586670|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153730049|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154586671|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
154586672|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154586673|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586674|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586675|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586676|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
154586677|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
154586678|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154586679|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
154586680|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154586681|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154586682|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586683|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586684|NCT01601470|Urological Agents|urological agents|mesh-ancestor
154586685|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154586686|NCT04418908|Cetrorelix|cetrorelix|mesh-list
154586687|NCT04418908|Estradiol|estradiol|mesh-list
154586688|NCT04418908|Estrogens|estrogens|mesh-ancestor
154586689|NCT04418908|Hormones|hormones|mesh-ancestor
154586690|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586691|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586692|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154586693|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154586694|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
154586695|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
154586696|NCT04831450|Cemiplimab|cemiplimab|mesh-list
154586697|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154586698|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586699|NCT04830982|Diazoxide|diazoxide|mesh-list
154586700|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154586701|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
154586702|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
154586703|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586704|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
154586705|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154586706|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586707|NCT04508140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154586708|NCT04508140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586709|NCT04820452|Aflibercept|aflibercept|mesh-list
154586710|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154586711|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154586712|NCT04820452|Growth Substances|growth substances|mesh-ancestor
154586713|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586714|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
154586715|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586716|NCT01637272|Pasireotide|pasireotide|mesh-list
154586717|NCT01637272|Hormones|hormones|mesh-ancestor
154586718|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586719|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586720|NCT03178864|Heparin|heparin|mesh-list
154586721|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
154586722|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
154586723|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154586724|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154586725|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586726|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154586727|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
154586728|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154586729|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586730|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586731|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154586732|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
154586733|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586734|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
154586735|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586736|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
154310542|NCT03308786|Analgesics|analgesics|mesh-ancestor
154586737|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154586738|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586739|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154586740|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586741|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586742|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586743|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586744|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
154586745|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154862283|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154586746|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
154586747|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154586748|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586749|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586750|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586751|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
154586752|NCT05277922|Nitroprusside|nitroprusside|mesh-list
154586753|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154586754|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
154586755|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154586756|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586757|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
154586758|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
154586759|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154586760|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154586761|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586762|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586763|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586764|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154586765|NCT04194424|Metformin|metformin|mesh-list
154586766|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154586767|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586768|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
154586769|NCT02473640|Esomeprazole|esomeprazole|mesh-list
154586770|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154586771|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154586772|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154586773|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586774|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586775|NCT02473640|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154586776|NCT02473640|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154586777|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154586778|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586779|NCT01637584|Prazosin|prazosin|mesh-list
154586780|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154586781|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154586782|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154586783|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154586784|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
154586785|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586786|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586787|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586788|NCT02502734|Fluticasone|fluticasone|mesh-list
154586789|NCT02502734|Xhance|xhance|mesh-list
154586790|NCT02502734|Albuterol|albuterol|mesh-list
154586791|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154586792|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154586793|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
154586794|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586795|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586796|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154586797|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154586798|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
154586799|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154586800|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
154586801|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154586802|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154586803|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154586804|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153730092|NCT00140751|Lopinavir|lopinavir|mesh-list
154586805|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
154586806|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586807|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586808|NCT04193878|Budesonide|budesonide|mesh-list
154586809|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
154586810|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154586811|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154586812|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
154586813|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586814|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586815|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154586816|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
154586818|NCT04193878|Hormones|hormones|mesh-ancestor
154586819|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586820|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154586821|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154586822|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154586823|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
154586824|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586825|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586827|NCT02473250|Citalopram|citalopram|mesh-list
154586828|NCT02473250|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154586829|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154586830|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154586831|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586832|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586833|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
154586834|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586835|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154586836|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
154586837|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154586838|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154586839|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154586840|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586841|NCT04821778|Paclitaxel|paclitaxel|mesh-list
154586842|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
154586843|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154586844|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586845|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
154586846|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154586847|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154586848|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586849|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154586850|NCT02611024|Irinotecan|irinotecan|mesh-list
154586851|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154586852|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586853|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586854|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586855|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586856|NCT02500706|Insulin|insulin|mesh-list
154586857|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154586858|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
154586859|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
154586860|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154586861|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154586862|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586863|NCT04201496|Empagliflozin|empagliflozin|mesh-list
154586864|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154586865|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586866|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154586867|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586868|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
154586869|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
154586870|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154586871|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154586872|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586873|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586874|NCT04797286|Urological Agents|urological agents|mesh-ancestor
154586875|NCT03682276|Nivolumab|nivolumab|mesh-list
154586876|NCT03682276|Ipilimumab|ipilimumab|mesh-list
154586877|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154586878|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586879|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154586880|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586881|NCT02499770|Carboplatin|carboplatin|mesh-list
154586882|NCT02499770|Etoposide|etoposide|mesh-list
154586883|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310696|NCT01321125|Povidone|povidone|mesh-list
154586884|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154586885|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154586886|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154586887|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586888|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586889|NCT04418674|Fentanyl|fentanyl|mesh-list
154586890|NCT04418674|Ketamine|ketamine|mesh-list
154586891|NCT04418674|Analgesics|analgesics|mesh-ancestor
154586892|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
154586893|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862284|NCT02982161|Analgesics|analgesics|mesh-ancestor
154862285|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
154586894|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586895|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154586896|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154586897|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
154586898|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
154586899|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586900|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154586901|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154586902|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154586903|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586904|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154586905|NCT04418674|Narcotics|narcotics|mesh-ancestor
154586906|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154586907|NCT02442284|Ritonavir|ritonavir|mesh-list
154586908|NCT02442284|Ribavirin|ribavirin|mesh-list
154586909|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154586910|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154586911|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
154586912|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586913|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586914|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154586915|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154586916|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
154586917|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586918|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154586919|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154586920|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
154586921|NCT03781960|Nivolumab|nivolumab|mesh-list
154586922|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154586923|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586924|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154586925|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586926|NCT02499146|Letrozole|letrozole|mesh-list
154586927|NCT02499146|Palbociclib|palbociclib|mesh-list
154586928|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586929|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154586930|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154586931|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154586932|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586933|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154586934|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
154586935|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586936|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586937|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154586938|NCT01634854|Misoprostol|misoprostol|mesh-list
154586939|NCT01634854|Oxytocin|oxytocin|mesh-list
154586940|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
154586941|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154586942|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586943|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154586944|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
154586945|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154586946|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154586947|NCT05651464|Vancomycin|vancomycin|mesh-list
154586948|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154586949|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154586950|NCT02441114|Fluticasone|fluticasone|mesh-list
154586951|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
154586952|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154586953|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154586954|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154586955|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154586956|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
154586957|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310777|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
154586958|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586959|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154586960|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
154586961|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
154586962|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154586963|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
154586964|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154586965|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
154586966|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154862286|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586967|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154586968|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154586969|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154586970|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154586971|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
154586972|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
154586974|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586975|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
154586976|NCT02498444|Treprostinil|treprostinil|mesh-list
154586977|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154586978|NCT05235256|Dexamethasone|dexamethasone|mesh-list
154586979|NCT05235256|Lidocaine|lidocaine|mesh-list
154586980|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154586981|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
154586982|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
154586983|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154586984|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154586985|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154586986|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
154586987|NCT05235256|Hormones|hormones|mesh-ancestor
154586988|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154586989|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154586990|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154586991|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
154586992|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
154586993|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154586994|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
154586995|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154586996|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154586997|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154586998|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154586999|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587000|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
154587001|NCT02497976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154587002|NCT02497976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587003|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154587004|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
154587005|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587006|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587007|NCT04596826|Dronabinol|dronabinol|mesh-list
154587008|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
154587009|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587010|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154587011|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154587012|NCT04596826|Analgesics|analgesics|mesh-ancestor
154587013|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
154587014|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587015|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154587016|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154587017|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587018|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587019|NCT04596826|Hormones|hormones|mesh-ancestor
154587020|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587021|NCT02440568|Cytarabine|cytarabine|mesh-list
154587022|NCT02440568|Idarubicin|idarubicin|mesh-list
154587023|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
154587024|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154587025|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
154587026|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587027|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587028|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
154587029|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587030|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154587031|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
154587032|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587033|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154587034|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154587035|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154587036|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587037|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154587038|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154587040|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
154587041|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587042|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
154587044|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
154587045|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587046|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587047|NCT04782778|Bupivacaine|bupivacaine|mesh-list
154587048|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
154587049|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
154587050|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973722|NCT06248229|Autonomic Agents|autonomic agents|mesh-ancestor
154587051|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587052|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
154587053|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587054|NCT00434434|Omalizumab|omalizumab|mesh-list
154587055|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154587056|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154587057|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154587058|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
154587059|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
154587060|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587061|NCT03046511|Cefazolin|cefazolin|mesh-list
154587062|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154587063|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587064|NCT02439320|Lasmiditan|lasmiditan|mesh-list
154587065|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154587066|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
154587067|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587068|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587069|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587070|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
154587071|NCT02468648|Velpatasvir|velpatasvir|mesh-list
154587072|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
154587073|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587074|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154587075|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154587076|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587077|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154587078|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154587079|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154587080|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587081|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
154587082|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587083|NCT01633060|Fulvestrant|fulvestrant|mesh-list
154587084|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154587085|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587086|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154587087|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154587088|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
154587089|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587090|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587091|NCT03906695|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154587092|NCT03906695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154587093|NCT03906695|Antimetabolites|antimetabolites|mesh-ancestor
154587094|NCT03906695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587095|NCT03906695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587096|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
154587097|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587098|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
154587099|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587100|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587101|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154587102|NCT04467125|Lidocaine|lidocaine|mesh-list
154587103|NCT04467125|Prilocaine|prilocaine|mesh-list
154587104|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154587105|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
154587106|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
154587107|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587108|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587109|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
154587110|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587111|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154587112|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154587113|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154587114|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154587115|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587116|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154587118|NCT02465528|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154587119|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587120|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587121|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587122|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587123|NCT03524261|Antibodies|antibodies|mesh-list
154587124|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154587125|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
154587126|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587127|NCT03386721|Gemcitabine|gemcitabine|mesh-list
154587128|NCT03386721|Atezolizumab|atezolizumab|mesh-list
154587129|NCT03386721|Vinorelbine|vinorelbine|mesh-list
154587130|NCT03386721|Antibodies|antibodies|mesh-list
154587131|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
154587132|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587133|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154587134|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
154587135|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587136|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587137|NCT03386721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154587138|NCT03386721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154587139|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154587140|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
154587141|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
154587142|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
154587143|NCT02462720|Polidocanol|polidocanol|mesh-list
154074175|NCT00760266|Aliskiren|aliskiren|mesh-list
154587144|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154587145|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154587146|NCT02246218|Glycerol|glycerol|mesh-list
154587147|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154587148|NCT02246218|Protective Agents|protective agents|mesh-ancestor
154587149|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587150|NCT05073939|Oxytocin|oxytocin|mesh-list
154587151|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
154587152|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154587153|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587154|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
154587155|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154587156|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
154587157|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587158|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
154587159|NCT04192630|Protective Agents|protective agents|mesh-ancestor
154587160|NCT00159783|Olanzapine|olanzapine|mesh-list
154587161|NCT00159783|Asenapine|asenapine|mesh-list
154587162|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
154587163|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
154587164|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587165|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587166|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154587167|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154587168|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154587169|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587170|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154587171|NCT00159783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154587172|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154587173|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973723|NCT06248229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587174|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587175|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587176|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
154587177|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
154310990|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154587178|NCT01023737|Vorinostat|vorinostat|mesh-list
154587179|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
154587180|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154587181|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154587182|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587183|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587184|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587185|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587186|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587187|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154587188|NCT00646204|Memantine|memantine|mesh-list
154587189|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154587190|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154587191|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
154587192|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587193|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587194|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587195|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154587196|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154587197|NCT02243176|Saxagliptin|saxagliptin|mesh-list
154587198|NCT02243176|Acarbose|acarbose|mesh-list
154587199|NCT02243176|Incretins|incretins|mesh-ancestor
154587200|NCT02243176|Hormones|hormones|mesh-ancestor
154587201|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587202|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587203|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154587204|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
154587205|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587206|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587207|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154587208|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154587209|NCT04551261|Ritonavir|ritonavir|mesh-list
154587210|NCT04551261|Tenofovir|tenofovir|mesh-list
154587211|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153973724|NCT06248229|Dopamine Agents|dopamine agents|mesh-ancestor
154587212|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154587213|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
154587214|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587215|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587216|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154587217|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154587218|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
154587219|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587220|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154587221|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154587222|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154587223|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154587224|NCT04534257|Sirolimus|sirolimus|mesh-list
154587225|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154587226|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587227|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154587228|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587229|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
154587230|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154587231|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
154587232|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587233|NCT03522935|Elafin|elafin|mesh-list
154587234|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
154587235|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587236|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587237|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
154587238|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154587239|NCT03138681|Protective Agents|protective agents|mesh-ancestor
154587240|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587241|NCT05392257|Rituximab|rituximab|mesh-list
154587242|NCT05392257|Lenalidomide|lenalidomide|mesh-list
154587243|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
154587244|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154587245|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587246|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
154587247|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587248|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587249|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154587250|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154587251|NCT05392257|Growth Substances|growth substances|mesh-ancestor
154587252|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
154587253|NCT05392257|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154311065|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587254|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587255|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587256|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587257|NCT02240680|Linagliptin|linagliptin|mesh-list
154587258|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154587259|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587260|NCT02240680|Incretins|incretins|mesh-ancestor
154587261|NCT02240680|Hormones|hormones|mesh-ancestor
154862287|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862288|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587262|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587263|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154587264|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
154587265|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587266|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587267|NCT05391867|Sorafenib|sorafenib|mesh-list
154587268|NCT05391867|Lenvatinib|lenvatinib|mesh-list
154587269|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587270|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587271|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587272|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587273|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
154587274|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154587275|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
154587276|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587277|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
154587278|NCT03110679|Protective Agents|protective agents|mesh-ancestor
154587279|NCT05391789|Urinastatin|urinastatin|mesh-list
154587280|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154587281|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154587282|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
154587283|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587284|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587285|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
154587286|NCT04699071|Lenvatinib|lenvatinib|mesh-list
154587287|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154587288|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587289|NCT04699071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154587290|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587291|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587292|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587293|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
154587294|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
154587295|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154587296|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
154587297|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587298|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587299|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154587300|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
154587301|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587302|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587303|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154587304|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154587305|NCT03139851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154587306|NCT03962062|Moxidectin|moxidectin|mesh-list
154587307|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
154587308|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154587309|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587310|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
154587311|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154587312|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587313|NCT02239510|Linaclotide|linaclotide|mesh-list
154587314|NCT02239510|Sennosides|sennosides|mesh-list
154587315|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154587316|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
154587317|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587318|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154587319|NCT02239510|Laxatives|laxatives|mesh-ancestor
154587320|NCT04507581|Anesthetics|anesthetics|mesh-list
154587321|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587322|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587323|NCT02291471|T0001|t0001|mesh-list
154587324|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154587325|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587326|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
154587327|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587328|NCT03899961|Oxytocin|oxytocin|mesh-list
154587329|NCT03899961|Carbetocin|carbetocin|mesh-list
154587330|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
154587331|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154587332|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587333|NCT02462486|Ranibizumab|ranibizumab|mesh-list
154587334|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154587335|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154587336|NCT02462486|Growth Substances|growth substances|mesh-ancestor
154862289|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587337|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587338|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
154587339|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587341|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074251|NCT00823979|Etravirine|etravirine|mesh-list
154587342|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587343|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587344|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587345|NCT05318157|Emedastine|emedastine|mesh-list
154587346|NCT05318157|Budesonide|budesonide|mesh-list
154587347|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154587348|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154587349|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587350|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154587351|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
154587352|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587353|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587354|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154587355|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
154587356|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
154587357|NCT05318157|Hormones|hormones|mesh-ancestor
154587358|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587359|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154587360|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
154587361|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
154587362|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587363|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587364|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154587365|NCT02294279|Beclomethasone|beclomethasone|mesh-list
154587366|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587367|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
154587368|NCT02294279|Hormones|hormones|mesh-ancestor
154587369|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587370|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587371|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154587372|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
154587373|NCT03880539|Vancomycin|vancomycin|mesh-list
154587374|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154587375|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587376|NCT03518021|Naloxone|naloxone|mesh-list
154587377|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154587378|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587379|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
154587380|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587381|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154587382|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154587383|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154587384|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587385|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
154587386|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154587387|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
154587388|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587389|NCT02294591|Expectorants|expectorants|mesh-ancestor
154587390|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
154587391|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154587392|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
154587393|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587394|NCT02294591|Protective Agents|protective agents|mesh-ancestor
154074288|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745626|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154587395|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587396|NCT02294591|Antidotes|antidotes|mesh-ancestor
154587397|NCT03521063|Budesonide|budesonide|mesh-list
154587398|NCT03521063|Poractant alfa|poractant alfa|mesh-list
154587399|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587400|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154587401|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
154587402|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587403|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587404|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154587405|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
154587407|NCT03521063|Hormones|hormones|mesh-ancestor
154587408|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587409|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154587410|NCT03520985|Dexamethasone|dexamethasone|mesh-list
154587411|NCT03520985|Pomalidomide|pomalidomide|mesh-list
154862290|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154587412|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587413|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
154587414|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
154587415|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587416|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587417|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154587418|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
154587420|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587421|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154587422|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587423|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
154587424|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154587425|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154587426|NCT03520985|Growth Substances|growth substances|mesh-ancestor
154587427|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
154587428|NCT03517943|Loratadine|loratadine|mesh-list
154587429|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
154587430|NCT03517943|Ephedrine|ephedrine|mesh-list
154587431|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
154587432|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
154587433|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154587434|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154587435|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154587436|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
154587437|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
154587438|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587439|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587440|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587441|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154587442|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
154587443|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587444|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154587445|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
154587446|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
154587447|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154587448|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154587449|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
154587450|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
154587451|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
154587452|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154587453|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154587454|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154587455|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154587456|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154587457|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587458|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
154587459|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587460|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587461|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154587462|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587463|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
154587464|NCT04465175|Analgesics|analgesics|mesh-ancestor
154587465|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
154587466|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862291|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154587467|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587468|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
154587469|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587470|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154587471|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
154587472|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154587473|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154587474|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587475|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154587476|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
154587477|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154587478|NCT03158883|Avelumab|avelumab|mesh-list
154862292|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862293|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862294|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154862295|NCT02982161|Narcotics|narcotics|mesh-ancestor
154862296|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154862297|NCT05506488|Dasatinib|dasatinib|mesh-list
154862298|NCT05506488|Quercetin|quercetin|mesh-list
154862299|NCT05506488|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154587479|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154587482|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154587483|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587484|NCT03109977|Pertuzumab|pertuzumab|mesh-list
154587485|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154587486|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587487|NCT03520595|Diclofenac|diclofenac|mesh-list
154587488|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154587489|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154587490|NCT03520595|Analgesics|analgesics|mesh-ancestor
154587491|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
154587492|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587493|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587494|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587495|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587496|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154587497|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587498|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587499|NCT03520439|Mifepristone|mifepristone|mesh-list
154587500|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154587501|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
154587502|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154587503|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587504|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154587505|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154587506|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154587507|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
154587508|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154587509|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154587510|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
154587511|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587512|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
154587513|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154587514|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154587515|NCT04542993|Zinc|zinc|mesh-list
154587516|NCT04542993|Resveratrol|resveratrol|mesh-list
154587517|NCT04542993|Picolinic acid|picolinic acid|mesh-list
154587518|NCT04542993|Trace Elements|trace elements|mesh-ancestor
154587519|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
154587520|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587521|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
154587522|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587523|NCT04542993|Protective Agents|protective agents|mesh-ancestor
154587524|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587525|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154587526|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154587527|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
154587528|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
154587529|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154587530|NCT02292173|Sorafenib|sorafenib|mesh-list
154587531|NCT02292173|Trametinib|trametinib|mesh-list
154587532|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587533|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587534|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587535|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587536|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
154587537|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154587538|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154587539|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154587540|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154587541|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587542|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
154587543|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587544|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587545|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154587546|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587547|NCT03520049|Oseltamivir|oseltamivir|mesh-list
154587548|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
154587549|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587550|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587551|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587552|NCT03517631|Busulfan|busulfan|mesh-list
154587553|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
154587555|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154587556|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
154587557|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587558|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154587559|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587560|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154587561|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
154587562|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154587563|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587565|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154587566|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154587567|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587568|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587569|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154587570|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154587571|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154587572|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154587573|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
154587574|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
154587575|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
154587576|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
154587577|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587578|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587579|NCT02296073|Midazolam|midazolam|mesh-list
154587580|NCT02296073|Fentanyl|fentanyl|mesh-list
154587581|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
154587582|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154587583|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587584|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587585|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154587586|NCT02296073|Analgesics|analgesics|mesh-ancestor
154587587|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
154074480|NCT04093518|Estradiol|estradiol|mesh-list
153730309|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587588|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587589|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154587590|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154587591|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154587592|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
154587593|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587594|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587595|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154587596|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154587597|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154587598|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154587599|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154587600|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
154587601|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
154587602|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
154587603|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
154587604|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154587605|NCT02296073|Narcotics|narcotics|mesh-ancestor
154587606|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154587607|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154587608|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154587609|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154587610|NCT02293187|Vitamin D|vitamin d|mesh-list
154587611|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
154587612|NCT02293187|Vitamins|vitamins|mesh-ancestor
154587613|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
154587614|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587615|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154587616|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154587617|NCT02296463|Vaccines|vaccines|mesh-list
154587618|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
154587619|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587620|NCT02495168|Budesonide|budesonide|mesh-list
154587621|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
154587622|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154587623|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587624|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154587625|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
154587626|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587627|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862300|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587628|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154587629|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
154587630|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
154587631|NCT02495168|Hormones|hormones|mesh-ancestor
154587632|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587633|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154587634|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154587635|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154587636|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
154587637|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587638|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587639|NCT04934072|Denosumab|denosumab|mesh-list
154587640|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154587641|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587642|NCT03518489|Lappaconitine|lappaconitine|mesh-list
154587643|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154587644|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154587645|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154587646|NCT03518489|Analgesics|analgesics|mesh-ancestor
154587647|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
154587648|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587649|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587650|NCT04933526|Dasatinib|dasatinib|mesh-list
154587651|NCT04933526|Flumatinib|flumatinib|mesh-list
154587652|NCT04933526|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154587653|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587654|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587655|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587656|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587657|NCT02293889|Vitamin D|vitamin d|mesh-list
154587658|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
154587659|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
154587660|NCT02293889|Vitamins|vitamins|mesh-list
154587661|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
154587662|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587663|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154587664|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154587665|NCT02298335|Prednisone|prednisone|mesh-list
154587666|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587667|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
154587668|NCT02298335|Hormones|hormones|mesh-ancestor
154587669|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587670|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587671|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154587672|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587673|NCT03514667|Curcumin|curcumin|mesh-list
154587674|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154587675|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154587676|NCT03514667|Analgesics|analgesics|mesh-ancestor
154587677|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
154587678|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587679|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587680|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587681|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587682|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587683|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587684|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587685|NCT02493764|Tazobactam|tazobactam|mesh-list
154587686|NCT02493764|Linezolid|linezolid|mesh-list
154074575|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154587687|NCT02493764|Piperacillin|piperacillin|mesh-list
154587688|NCT02493764|Imipenem|imipenem|mesh-list
154587689|NCT02493764|Relebactam|relebactam|mesh-list
154587690|NCT02493764|Cilastatin|cilastatin|mesh-list
154587691|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154587692|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587693|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154587694|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587695|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587696|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154587697|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
154587698|NCT02297477|Artesunate|artesunate|mesh-list
154587699|NCT02297477|Atovaquone|atovaquone|mesh-list
154587700|NCT02297477|Proguanil|proguanil|mesh-list
154587701|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154587702|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
154587703|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154587704|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154311513|NCT06262945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154587705|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587706|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587707|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
154587708|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
154587709|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154587710|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
154587711|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587712|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587713|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
154587714|NCT02460380|Vitamin D|vitamin d|mesh-list
154587715|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
154587716|NCT02460380|Vitamins|vitamins|mesh-ancestor
154587717|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
154587718|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587719|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154587720|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154587721|NCT02299115|Prednisolone|prednisolone|mesh-list
154587722|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154587723|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
154587724|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154587725|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
154587726|NCT02299115|Vigabatrin|vigabatrin|mesh-list
154587727|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154587728|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
154587729|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587730|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
154587731|NCT02299115|Hormones|hormones|mesh-ancestor
154587732|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074585|NCT00751101|Nicotine|nicotine|mesh-list
154074617|NCT03977142|Chrysarobin|chrysarobin|mesh-list
154587733|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587734|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154587735|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587736|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
154587737|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
154587738|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587739|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154587740|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154587741|NCT02299115|Protective Agents|protective agents|mesh-ancestor
154587742|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
154587743|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587744|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587745|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
154587746|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587747|NCT02297945|Metyrapone|metyrapone|mesh-list
154587748|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
154587749|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587750|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587751|NCT02492984|Factor VIII|factor viii|mesh-list
154587752|NCT02492984|Coagulants|coagulants|mesh-ancestor
154587753|NCT03132623|Andrographolide|andrographolide|mesh-list
154587754|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587755|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154587756|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154587757|NCT03132623|Analgesics|analgesics|mesh-ancestor
154587758|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
154587759|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587760|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587761|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587762|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154587763|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154074645|NCT02599311|Urological Agents|urological agents|mesh-ancestor
154587764|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587765|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
154587766|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154587767|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154587768|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
154587769|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587770|NCT02298101|Edetic Acid|edetic acid|mesh-list
154587771|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
154587772|NCT02298101|Antidotes|antidotes|mesh-ancestor
154587773|NCT02298101|Protective Agents|protective agents|mesh-ancestor
154587774|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587775|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
154862301|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587776|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
154587777|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587778|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154587779|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
154587780|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154587781|NCT02491892|Pertuzumab|pertuzumab|mesh-list
154587782|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154587783|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587785|NCT03476811|Bupivacaine|bupivacaine|mesh-list
154587786|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
154587787|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
154587788|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587789|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587790|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
154587791|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587792|NCT02299271|Ropivacaine|ropivacaine|mesh-list
154587793|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
154587794|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
154587795|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587796|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587797|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
154587798|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587799|NCT02302469|Lenalidomide|lenalidomide|mesh-list
154587800|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
154587801|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587802|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154587803|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154587804|NCT02302469|Growth Substances|growth substances|mesh-ancestor
154587805|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
154587806|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587807|NCT02302547|Ritonavir|ritonavir|mesh-list
154587808|NCT02302547|Lopinavir|lopinavir|mesh-list
154587809|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154587810|NCT02302547|Darunavir|darunavir|mesh-list
154587811|NCT02302547|Indinavir|indinavir|mesh-list
154587812|NCT02302547|Saquinavir|saquinavir|mesh-list
154587813|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
154587814|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154587815|NCT02302547|Tenofovir|tenofovir|mesh-list
154587816|NCT02302547|Emtricitabine|emtricitabine|mesh-list
154587817|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
154587818|NCT02302547|Nevirapine|nevirapine|mesh-list
154587819|NCT02302547|Dolutegravir|dolutegravir|mesh-list
154587820|NCT02302547|Maraviroc|maraviroc|mesh-list
154587821|NCT02302547|Cobicistat|cobicistat|mesh-list
154587822|NCT02302547|Rilpivirine|rilpivirine|mesh-list
154587823|NCT02302547|Tipranavir|tipranavir|mesh-list
154587824|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
154587825|NCT02302547|Elvitegravir|elvitegravir|mesh-list
154587826|NCT02302547|Efavirenz|efavirenz|mesh-list
154587827|NCT02302547|Etravirine|etravirine|mesh-list
154587828|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154587829|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
154587830|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
154587831|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154587832|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587833|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587834|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154587835|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154587836|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
154587837|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587838|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154587839|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154587840|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154587841|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154074667|NCT04091763|Polidocanol|polidocanol|mesh-list
154587842|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154587843|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154587844|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154587845|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154587846|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154587847|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154587848|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154587849|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154587850|NCT03515369|Liver Extracts|liver extracts|mesh-list
154587851|NCT03515369|Hematinics|hematinics|mesh-ancestor
154587852|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154587853|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154587854|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587855|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
154587856|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
154862302|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587857|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154255643|NCT01255358|BB 1101|bb 1101|mesh-list
154587858|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587860|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154587861|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587862|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154587863|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154587864|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
154587865|NCT03510611|Ensartinib|ensartinib|mesh-list
154587866|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587867|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587868|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587869|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587870|NCT02299817|Denosumab|denosumab|mesh-list
154587871|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154587872|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587873|NCT01679613|Ketoconazole|ketoconazole|mesh-list
154587874|NCT01679613|Nintedanib|nintedanib|mesh-list
154587875|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
154587876|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587877|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154587878|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154587879|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587880|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587881|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154587882|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
154587883|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587884|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587885|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154587886|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154587887|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154587888|NCT02489630|Ketamine|ketamine|mesh-list
154587889|NCT02489630|Analgesics|analgesics|mesh-list
154587890|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
154587891|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587892|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587893|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154587894|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154587895|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
154587896|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
154074723|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
154074729|NCT00749463|Nicotine|nicotine|mesh-list
154074747|NCT00821327|Growth Substances|growth substances|mesh-ancestor
154587897|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587898|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154587899|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154587900|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587901|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587902|NCT05089539|Valsartan|valsartan|mesh-list
154587903|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154587904|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154587905|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154587906|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154587907|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587908|NCT05089383|Progesterone|progesterone|mesh-list
154587909|NCT05089383|Progestins|progestins|mesh-ancestor
154587910|NCT05089383|Hormones|hormones|mesh-ancestor
154587911|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587912|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587913|NCT03510533|Autoantibodies|autoantibodies|mesh-list
154587914|NCT03510533|alpha-MSH|alpha-msh|mesh-list
154587915|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
154587916|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587917|NCT03510533|Hormones|hormones|mesh-ancestor
154587918|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154587919|NCT03512873|Tranilast|tranilast|mesh-list
154587920|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154587921|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154587922|NCT03512873|Analgesics|analgesics|mesh-ancestor
154587923|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
154587924|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730359|NCT00133406|Glycine|glycine|mesh-list
153730377|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587925|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587926|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154587927|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154587928|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154587929|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154587930|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587931|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154587932|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154587933|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
154587935|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587936|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154587937|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154587938|NCT01678911|Gabapentin|gabapentin|mesh-list
154587939|NCT01678911|Analgesics|analgesics|mesh-ancestor
154587940|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
154587941|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587942|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587943|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
154587944|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154587945|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154587946|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587947|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154587948|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154587949|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154587950|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587951|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587952|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
154587953|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
154587954|NCT03132701|Analgesics|analgesics|mesh-ancestor
154587955|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
154587956|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154587957|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587958|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
154587959|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154587960|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154587961|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
154587962|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154587963|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154587964|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587965|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154587966|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
154587967|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154587968|NCT02322099|Alendronate|alendronate|mesh-list
154587969|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
154587970|NCT02322099|Vitamin D|vitamin d|mesh-list
154587971|NCT02322099|Tenofovir|tenofovir|mesh-list
154587972|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
154587973|NCT02322099|Calcium|calcium|mesh-list
154587974|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154587975|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587976|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
154587977|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154587978|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154587979|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154587980|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154587981|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587982|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154587983|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154587984|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154587985|NCT02322099|Antacids|antacids|mesh-ancestor
154587986|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154587987|NCT02322099|Vitamins|vitamins|mesh-ancestor
154587988|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
154587989|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
154587990|NCT02487446|Bromides|bromides|mesh-list
154587991|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
154587992|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154587993|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154587994|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154587995|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154587996|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
154587997|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154587998|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154587999|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
154588000|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588001|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
154588002|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588003|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588004|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154588005|NCT02303327|Androgens|androgens|mesh-list
154588006|NCT02303327|Hormones|hormones|mesh-ancestor
154588007|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588008|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588009|NCT03510221|Antioxidants|antioxidants|mesh-list
154588010|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588011|NCT03510221|Protective Agents|protective agents|mesh-ancestor
154588012|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588013|NCT03509831|Irsogladine|irsogladine|mesh-list
154588014|NCT03509831|Nizatidine|nizatidine|mesh-list
154588015|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588016|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154588017|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588018|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154588019|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
154588020|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
154588021|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588022|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588023|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588024|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154588025|NCT03509831|Protective Agents|protective agents|mesh-ancestor
154588026|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154588027|NCT02303483|Niacinamide|niacinamide|mesh-list
154588028|NCT02303483|Niacin|niacin|mesh-list
154588029|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
154588030|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
154588031|NCT02303483|Vitamins|vitamins|mesh-ancestor
154588032|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
154588033|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588034|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154588035|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
154588036|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588037|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154588038|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
154588039|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154588040|NCT05378061|Growth Substances|growth substances|mesh-ancestor
154588041|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588042|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
154588043|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074877|NCT02597322|Axitinib|axitinib|mesh-list
154588044|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588045|NCT02303639|Amiodarone|amiodarone|mesh-list
154588046|NCT02303639|Sotalol|sotalol|mesh-list
154588047|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154588048|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
154588049|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154588050|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588051|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588052|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154588053|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154588054|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154588055|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588056|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154588057|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154588058|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154588059|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154588060|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154588061|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
154588062|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588063|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588064|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
154588065|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
154588066|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588067|NCT02303873|Alendronate|alendronate|mesh-list
154588068|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154588069|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588070|NCT04757493|Prucalopride|prucalopride|mesh-list
154588071|NCT04757493|Laxatives|laxatives|mesh-ancestor
154588072|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588073|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154588074|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154588075|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
154588076|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588077|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588078|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588079|NCT02303951|Atezolizumab|atezolizumab|mesh-list
154588081|NCT02303951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154074878|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588082|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588083|NCT02303951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154588084|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588085|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154588086|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588087|NCT04406415|Nafamostat|nafamostat|mesh-list
154588088|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154588089|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154588090|NCT04406415|Analgesics|analgesics|mesh-ancestor
154588091|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
154588092|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588093|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588094|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588095|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154588096|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
154588097|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
154588098|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588099|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588100|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154588101|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154588102|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154588103|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154588104|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
154588105|NCT02304107|Letrozole|letrozole|mesh-list
154588106|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588107|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154588108|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154588109|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588110|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588111|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154588112|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
154588113|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588114|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588115|NCT03509285|Cenobamate|cenobamate|mesh-list
154588116|NCT03509285|Alprazolam|alprazolam|mesh-list
154588117|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154588118|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588119|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588120|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154588121|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154588122|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154588123|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
154588124|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
154588125|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588126|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588127|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
154074915|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
154074961|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588128|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154588129|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154588130|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154588131|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154588132|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
154588133|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588134|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154588135|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154588136|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588137|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154588138|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154588139|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588140|NCT03135795|Parecoxib|parecoxib|mesh-list
154588141|NCT03135795|Sufentanil|sufentanil|mesh-list
154588142|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
154588143|NCT03135795|Remifentanil|remifentanil|mesh-list
154588144|NCT03135795|Dsuvia|dsuvia|mesh-list
154588145|NCT03135795|Bromides|bromides|mesh-list
154588146|NCT03135795|Propofol|propofol|mesh-list
154588147|NCT03135795|Sevoflurane|sevoflurane|mesh-list
154588148|NCT03135795|Citric Acid|citric acid|mesh-list
154588149|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
154588150|NCT03135795|Rocuronium|rocuronium|mesh-list
154588151|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154588152|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588153|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074985|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154588154|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154588156|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
154588157|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588158|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154588159|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154588160|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154588161|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
154588162|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588163|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588164|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154588165|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
154588166|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
154588167|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
154588168|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154588169|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
154588170|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
154588171|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154588172|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154588173|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154588174|NCT03135795|Narcotics|narcotics|mesh-ancestor
154588175|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
154588176|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154588177|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154588178|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154588179|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154588180|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154588181|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154588182|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588183|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154588184|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588185|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154588187|NCT04958967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154588188|NCT04958967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588189|NCT04958967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588190|NCT03469531|Cisplatin|cisplatin|mesh-list
154588191|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
154588192|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588193|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154588194|NCT03508817|Atropine|atropine|mesh-list
154588195|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154588196|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154588197|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154588198|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154588199|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154588200|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
154588201|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588202|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588203|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154588204|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154588205|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
154588206|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
154588207|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154588208|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154588209|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
154588210|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588211|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588212|NCT01678209|Methylphenidate|methylphenidate|mesh-list
154588213|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154588214|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154588215|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588216|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154588217|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154588218|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588219|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588220|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
154588221|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588222|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154588223|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
154588224|NCT02239120|Dabigatran|dabigatran|mesh-list
154075052|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588225|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
154588226|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154588227|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
154588228|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588229|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588230|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
154588231|NCT04464863|Metronidazole|metronidazole|mesh-list
154588232|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588233|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154588234|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154588235|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154588236|NCT05158699|Dexamethasone|dexamethasone|mesh-list
154588237|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
154588238|NCT05158699|Triamcinolone|triamcinolone|mesh-list
154588239|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154588240|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154588241|NCT05158699|Ketorolac|ketorolac|mesh-list
154588242|NCT05158699|Bromfenac|bromfenac|mesh-list
154588243|NCT05158699|Phenylephrine|phenylephrine|mesh-list
154588244|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154588245|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154588246|NCT05158699|BB 1101|bb 1101|mesh-list
154588247|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154588248|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588249|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
154588250|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
154588251|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588252|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588253|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588254|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
154588255|NCT05158699|Hormones|hormones|mesh-ancestor
154588256|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588257|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154588258|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588259|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
154588260|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588261|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075054|NCT00819767|Valsartan|valsartan|mesh-list
154588262|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154588263|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
154588264|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154588265|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154588266|NCT05158699|Analgesics|analgesics|mesh-ancestor
154588267|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
154588268|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154588269|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154588270|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154588271|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
154588272|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
154588273|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154588274|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
154588275|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
154588276|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154588277|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154588278|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154588279|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
154588280|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588281|NCT05158699|Protective Agents|protective agents|mesh-ancestor
154588282|NCT02304887|Denosumab|denosumab|mesh-list
154588283|NCT02304887|Teriparatide|teriparatide|mesh-list
154588284|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154588285|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588286|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154588287|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154588288|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154588289|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588290|NCT03474133|Immunotoxins|immunotoxins|mesh-ancestor
154588291|NCT03474133|Immunoconjugates|immunoconjugates|mesh-ancestor
154588292|NCT03474133|Immunologic Factors|immunologic factors|mesh-ancestor
154588293|NCT03474133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588294|NCT03512171|Amphetamine|amphetamine|mesh-list
154075121|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588295|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
154588296|NCT03512171|Fallypride|fallypride|mesh-list
154588297|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154588298|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588299|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
154588300|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
154588301|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588302|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
154588303|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588304|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588305|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
154588306|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154588307|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154588308|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588309|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154588310|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154588311|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154588312|NCT03739099|Pancrelipase|pancrelipase|mesh-list
154588313|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588314|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154588315|NCT03469375|Folfirinox|folfirinox|mesh-list
154588316|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588317|NCT01603407|Prednisone|prednisone|mesh-list
154588318|NCT01603407|Deflazacort|deflazacort|mesh-list
154588319|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588320|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
154588321|NCT01603407|Hormones|hormones|mesh-ancestor
154588322|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588323|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588324|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154588325|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588326|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154588327|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
154588328|NCT02305355|Atorvastatin|atorvastatin|mesh-list
154588329|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154588330|NCT02305355|Simvastatin|simvastatin|mesh-list
154588331|NCT02305355|Pravastatin|pravastatin|mesh-list
154588332|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154588333|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154588334|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
154588335|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588336|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154588337|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154588338|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588339|NCT03511703|Apatinib|apatinib|mesh-list
154588340|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588341|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154588342|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588343|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588344|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154588345|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154588346|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154588347|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588348|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588349|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154588350|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588351|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588352|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
154588353|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588354|NCT02301221|Vancomycin|vancomycin|mesh-list
154588355|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154588356|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588357|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
154588358|NCT03122431|Thalidomide|thalidomide|mesh-list
154588359|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
154588360|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154588361|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154588362|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588363|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973725|NCT06248229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588364|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588365|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154588366|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154588367|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
154588368|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588369|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
154588370|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154588371|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154588372|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154588373|NCT03122431|Growth Substances|growth substances|mesh-ancestor
154588374|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
154588375|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588376|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154588377|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154588378|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588379|NCT02305823|Aripiprazole|aripiprazole|mesh-list
154588380|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154588381|NCT02305823|Ziprasidone|ziprasidone|mesh-list
154588382|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
154588383|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154588384|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154588385|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154588386|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588387|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588388|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
154588389|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
154588390|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588391|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588392|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154588393|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154588394|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
154588395|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154588396|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154588397|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154588398|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154588399|NCT05376189|Vitamin D|vitamin d|mesh-list
154588400|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
154588401|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
154588402|NCT05376189|Vitamins|vitamins|mesh-list
154588403|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
154588404|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588405|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154588406|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154588407|NCT02235298|Metformin|metformin|mesh-list
154588408|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
154588409|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154588410|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588411|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154588412|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588413|NCT02305901|Repaglinide|repaglinide|mesh-list
154588414|NCT02305901|Bupropion|bupropion|mesh-list
154588415|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154588416|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
154588417|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154588418|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154588419|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154588420|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588421|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588422|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
154588423|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588424|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588425|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154588426|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154588427|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588428|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154588429|NCT02234596|Nintedanib|nintedanib|mesh-list
154588430|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588431|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154588432|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588433|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588434|NCT02305979|Loratadine|loratadine|mesh-list
154588435|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
154588436|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
154588437|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154588438|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154588439|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154588440|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
154588441|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
154588442|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588443|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588444|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588445|NCT04539951|Memantine|memantine|mesh-list
154588446|NCT04539951|Aripiprazole|aripiprazole|mesh-list
154588447|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
154588448|NCT04539951|Sertraline|sertraline|mesh-list
154588449|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154588450|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
154588451|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154588452|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154588453|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154588454|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588455|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588457|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
154312263|NCT04211675|Irinotecan|irinotecan|mesh-list
154588458|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588459|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588460|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154588461|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154588462|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
154588463|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154588464|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154588465|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154588466|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154588467|NCT04539951|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154588468|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154588469|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588470|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154588471|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154588472|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154588473|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154588474|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154588475|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154588476|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154588477|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154588478|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154588479|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588480|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154588481|NCT04539327|Rucaparib|rucaparib|mesh-list
154588482|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154588483|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588484|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588485|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588486|NCT02234362|Vortioxetine|vortioxetine|mesh-list
154588487|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
154588488|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154588489|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154588490|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154588491|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588492|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588493|NCT02234362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154588494|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154588495|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588496|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588497|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588498|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
154588499|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154588500|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154588501|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154588502|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154588503|NCT05091177|Acetylcholine|acetylcholine|mesh-list
154588504|NCT05091177|Antibodies|antibodies|mesh-list
154588505|NCT05091177|Neostigmine|neostigmine|mesh-list
154588506|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
154588507|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588508|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154588509|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588510|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588511|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
154588512|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588513|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154588514|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
154588515|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588516|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
154588517|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154588518|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
154588519|NCT05091099|Alendronate|alendronate|mesh-list
154588520|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154588521|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588522|NCT03505151|BI 409306|bi 409306|mesh-list
154588523|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154588524|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862303|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588525|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588526|NCT02232880|Abatacept|abatacept|mesh-list
154588527|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154588528|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588529|NCT02232880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154588530|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075293|NCT00726609|Posaconazole|posaconazole|mesh-list
154588531|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154588532|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
154588533|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588534|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154588535|NCT02896855|Docetaxel|docetaxel|mesh-list
154588536|NCT02896855|Trastuzumab|trastuzumab|mesh-list
154588537|NCT02896855|Pertuzumab|pertuzumab|mesh-list
154588538|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588539|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
154588540|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
154588541|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
154588542|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588543|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154588544|NCT02311439|Folfirinox|folfirinox|mesh-list
154588545|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588546|NCT02311517|Ropivacaine|ropivacaine|mesh-list
154588547|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
154588548|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
154588549|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588550|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588551|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
154588552|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588553|NCT02232802|Enoxaparin|enoxaparin|mesh-list
154588554|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
154588555|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
154588556|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154588557|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154588558|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588559|NCT04463459|Vitamins|vitamins|mesh-list
154588560|NCT04463459|Vitamin E|vitamin e|mesh-list
154588561|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
154588562|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588563|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
154588564|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588565|NCT04463459|Protective Agents|protective agents|mesh-ancestor
154588566|NCT02434328|Aflibercept|aflibercept|mesh-list
154588567|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154588568|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154588569|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154588570|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154588571|NCT02434328|Growth Substances|growth substances|mesh-ancestor
154588572|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588573|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
154588574|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588575|NCT04785274|Chrysarobin|chrysarobin|mesh-list
154588576|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154588577|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154588578|NCT04785274|Analgesics|analgesics|mesh-ancestor
154588579|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
154588580|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588581|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588582|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588583|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154588584|NCT04778176|Levodopa|levodopa|mesh-list
154588585|NCT04778176|Carbidopa|carbidopa|mesh-list
154588586|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154588587|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154588588|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
154588589|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588590|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588591|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588592|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154588593|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588594|NCT05076253|Ivermectin|ivermectin|mesh-list
154588595|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154588596|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588597|NCT05077839|Trifluridine|trifluridine|mesh-list
154862304|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
154588598|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
154588599|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588600|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
154588601|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588602|NCT03132233|Calcium|calcium|mesh-list
154588603|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154588604|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588605|NCT02307227|Paclitaxel|paclitaxel|mesh-list
154588607|NCT02307227|Trastuzumab|trastuzumab|mesh-list
154588608|NCT02307227|Epirubicin|epirubicin|mesh-list
154588609|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154588610|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588611|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
154588612|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154588613|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154588614|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588615|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154588616|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154588617|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154588618|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154588619|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588620|NCT02307305|Acetaminophen|acetaminophen|mesh-list
154588621|NCT02307305|Celecoxib|celecoxib|mesh-list
154588622|NCT02307305|Naproxen|naproxen|mesh-list
154588623|NCT02307305|Oxycodone|oxycodone|mesh-list
154588624|NCT02307305|Tramadol|tramadol|mesh-list
154588625|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154588626|NCT02307305|Naloxone|naloxone|mesh-list
154588627|NCT02307305|Esomeprazole|esomeprazole|mesh-list
154588628|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154588629|NCT02307305|Analgesics|analgesics|mesh-ancestor
154588630|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
154588631|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588632|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588633|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
154588634|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154588635|NCT02307305|Narcotics|narcotics|mesh-ancestor
154588636|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588637|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154588638|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588639|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154588640|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154588641|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154588642|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588643|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588644|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154588645|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588646|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154588647|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154588648|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154588649|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588650|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588651|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
154588652|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154588653|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
154588654|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
154588655|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154588656|NCT02660229|Morphine|morphine|mesh-list
154588657|NCT02660229|Oxycodone|oxycodone|mesh-list
154588658|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154588659|NCT02660229|Narcotics|narcotics|mesh-ancestor
154588660|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588661|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588662|NCT02660229|Analgesics|analgesics|mesh-ancestor
154588663|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
154588664|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588665|NCT02307383|Lactitol|lactitol|mesh-list
154588666|NCT02307383|Cathartics|cathartics|mesh-ancestor
154588667|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588668|NCT02232178|Bupivacaine|bupivacaine|mesh-list
154588669|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
154588670|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
154588671|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588672|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588673|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
154862305|NCT05506488|Protective Agents|protective agents|mesh-ancestor
154075432|NCT04115462|Morphine|morphine|mesh-list
154588674|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588675|NCT04457323|Metoprolol|metoprolol|mesh-list
154588676|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154588677|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154588678|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
154588679|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
154588680|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588681|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588682|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154588683|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154588684|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154588685|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
154588686|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588687|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588688|NCT04448431|Vortioxetine|vortioxetine|mesh-list
154588689|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154588690|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
154588691|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154588692|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154588693|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154588694|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588695|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588696|NCT04448431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154588697|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154588698|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588699|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588700|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588701|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
154588702|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154588703|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154588704|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154588705|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154588706|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154588707|NCT05713149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154588708|NCT05713149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588709|NCT02307695|Saxagliptin|saxagliptin|mesh-list
154588710|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154588711|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154588712|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588713|NCT02307695|Incretins|incretins|mesh-ancestor
154588714|NCT02307695|Hormones|hormones|mesh-ancestor
154588715|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588716|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
154588717|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588718|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588719|NCT05161975|Vitamin K|vitamin k|mesh-list
154588720|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
154588721|NCT05161975|Vitamins|vitamins|mesh-ancestor
154588722|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
154588723|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588724|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154588725|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154588726|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588727|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
154588728|NCT05161975|Coagulants|coagulants|mesh-ancestor
154588729|NCT03504527|Budesonide|budesonide|mesh-list
154588730|NCT03504527|Bromides|bromides|mesh-list
154588731|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
154588732|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588733|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154588734|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
154588735|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588736|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588737|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154588738|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
154588739|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
154588740|NCT03504527|Hormones|hormones|mesh-ancestor
154588741|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588742|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
154588743|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154588744|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
154588745|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588746|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588747|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
154588748|NCT01678131|Ribavirin|ribavirin|mesh-list
154588749|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154588750|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
154588751|NCT01678131|Liver Extracts|liver extracts|mesh-list
154588753|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588754|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
154312559|NCT02901184|Diuretics|diuretics|mesh-ancestor
154588755|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588756|NCT01678131|Hematinics|hematinics|mesh-ancestor
154588757|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588758|NCT04579783|Triamcinolone|triamcinolone|mesh-list
154588759|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154588760|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154588761|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154588762|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588763|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
154588764|NCT04579783|Hormones|hormones|mesh-ancestor
154588765|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588766|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588767|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154588768|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
154588769|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588770|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588771|NCT02231164|Docetaxel|docetaxel|mesh-list
154588772|NCT02231164|Nintedanib|nintedanib|mesh-list
154588773|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588774|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
154588775|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
154588776|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
154588777|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588778|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154588779|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588780|NCT03506789|Dexamethasone|dexamethasone|mesh-list
154588781|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588782|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
154588783|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
154588784|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588785|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588786|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588787|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
154588788|NCT03506789|Hormones|hormones|mesh-ancestor
154588789|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588790|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154588791|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588792|NCT02312297|Minocycline|minocycline|mesh-list
154588793|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154588794|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588795|NCT03473431|Ketamine|ketamine|mesh-list
154588796|NCT03473431|Analgesics|analgesics|mesh-ancestor
154588797|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
154588798|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588799|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588800|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154588801|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154588802|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
154588803|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
154588804|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154588805|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154588806|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154588807|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588808|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588809|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154588810|NCT02378805|Ramipril|ramipril|mesh-list
154588811|NCT02378805|Spironolactone|spironolactone|mesh-list
154588812|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154588813|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154588814|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
154075578|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588815|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588816|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588817|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154588818|NCT02378805|Diuretics|diuretics|mesh-ancestor
154588819|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
154588820|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
154588821|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588822|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588823|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154588824|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154862306|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588825|NCT05094375|Misoprostol|misoprostol|mesh-list
154588826|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154588827|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
154588828|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154588829|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312629|NCT02744612|Immunotoxins|immunotoxins|mesh-ancestor
154588830|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154588831|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588832|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
154588833|NCT04345861|Azithromycin|azithromycin|mesh-list
154588834|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
154588835|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154588836|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588837|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
154588838|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154588839|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154588840|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588841|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588842|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154588843|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
154588844|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588845|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
154588846|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
154588847|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
154588848|NCT02230306|Vemurafenib|vemurafenib|mesh-list
154588849|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588850|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154588851|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588852|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588853|NCT04266379|Insulin|insulin|mesh-list
154588854|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154588855|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154588856|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588857|NCT02308319|Tenofovir|tenofovir|mesh-list
154588858|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
154588859|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588860|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154588861|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154588862|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588863|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588864|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154588865|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154588866|NCT02312375|Amlodipine|amlodipine|mesh-list
154588867|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154588868|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154588869|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588870|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588871|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154588872|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588873|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
154588874|NCT05062174|Mifepristone|mifepristone|mesh-list
154588875|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154588876|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
154588877|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154588878|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588879|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154588880|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154588881|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154588882|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
154588883|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154588884|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154588885|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
154588886|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588887|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
154588888|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154588889|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154588890|NCT05095467|Paclitaxel|paclitaxel|mesh-list
154588891|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154588892|NCT05095467|Tegafur|tegafur|mesh-list
154588893|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154588894|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588895|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
154862307|NCT00942149|Daptomycin|daptomycin|mesh-list
154588896|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
154588897|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
154588898|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588899|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154588900|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
154588901|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
154588902|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154588903|NCT02312531|Antibodies|antibodies|mesh-list
154312707|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
154588904|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
154588905|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588906|NCT04234477|Metoprolol|metoprolol|mesh-list
154588907|NCT04234477|Verapamil|verapamil|mesh-list
154588908|NCT04234477|Diltiazem|diltiazem|mesh-list
154588909|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
154588910|NCT04234477|Calcium|calcium|mesh-list
154588911|NCT04234477|Esmolol|esmolol|mesh-list
154588912|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154588913|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154588914|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588915|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154588916|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154588917|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
154588918|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
154588919|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588920|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154588921|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154588922|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
154588923|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588924|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588925|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154588926|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
154588927|NCT02449031|Tobramycin|tobramycin|mesh-list
154588928|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154588929|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588930|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
154588931|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
154588932|NCT01680861|Everolimus|everolimus|mesh-list
154588933|NCT01680861|Tacrolimus|tacrolimus|mesh-list
154588934|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154588935|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
154588936|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588937|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154588938|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154588939|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588940|NCT01680861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154588941|NCT01680861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154588942|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588943|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154588944|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154588945|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
154588946|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154588947|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154588948|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154588949|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
154588950|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
154588951|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588952|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154588953|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
154588954|NCT01680861|Hormones|hormones|mesh-ancestor
154075719|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154588955|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154588956|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154588957|NCT01680861|Protective Agents|protective agents|mesh-ancestor
154588958|NCT02229214|Topiramate|topiramate|mesh-list
154588959|NCT02229214|Phentermine|phentermine|mesh-list
154588960|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
154588961|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154588962|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588963|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154588964|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
154588965|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154588966|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
154588967|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
154588968|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154588969|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
154588970|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154588971|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588972|NCT02308553|Paclitaxel|paclitaxel|mesh-list
154588973|NCT02308553|Nintedanib|nintedanib|mesh-list
154588974|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154588975|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588976|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
154588977|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
154588978|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
154588979|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588980|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154588982|NCT05093907|Capecitabine|capecitabine|mesh-list
154588983|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154588984|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
154588985|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154588986|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154588987|NCT02228980|Vaccines|vaccines|mesh-list
154588988|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
154588989|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588990|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
154588991|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
154588992|NCT03783091|Hematinics|hematinics|mesh-ancestor
154588993|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
154588994|NCT03783091|Vitamins|vitamins|mesh-ancestor
154588995|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
154588996|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154588997|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
154588998|NCT05057481|Rituximab|rituximab|mesh-list
154588999|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589000|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589001|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
154589002|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589003|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154589004|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154589005|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154589006|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
154589007|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154589008|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589009|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589010|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589011|NCT02312609|Minocycline|minocycline|mesh-list
154589012|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154589013|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589014|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
154589015|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154589016|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
154589017|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
154589018|NCT03506399|Estradiol|estradiol|mesh-list
154589019|NCT03506399|Estrogens|estrogens|mesh-ancestor
154589020|NCT03506399|Hormones|hormones|mesh-ancestor
154589021|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589022|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589023|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154589024|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154589025|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154589026|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154589027|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154589028|NCT02228590|Apomorphine|apomorphine|mesh-list
154589029|NCT02228590|Emetics|emetics|mesh-ancestor
154589030|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589031|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
154589032|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589033|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154589034|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
154589035|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
154589036|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589037|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589038|NCT03503201|Chromium|chromium|mesh-list
154589039|NCT03503201|Trace Elements|trace elements|mesh-ancestor
154589040|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
154589041|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589042|NCT05095077|Tadalafil|tadalafil|mesh-list
154589043|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
154589044|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154589045|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154589046|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255647|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862308|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154862309|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589047|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589048|NCT05095077|Urological Agents|urological agents|mesh-ancestor
154589049|NCT02309177|Paclitaxel|paclitaxel|mesh-list
154589050|NCT02309177|Carboplatin|carboplatin|mesh-list
154589051|NCT02309177|Gemcitabine|gemcitabine|mesh-list
154589052|NCT02309177|Nivolumab|nivolumab|mesh-list
154589053|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154589054|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589055|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154589056|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154589057|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154589058|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589059|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154589060|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
154589061|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589062|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154589063|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
154589064|NCT02227108|Immunotoxins|immunotoxins|mesh-ancestor
154589065|NCT02227108|Immunoconjugates|immunoconjugates|mesh-ancestor
154589066|NCT02227108|Immunologic Factors|immunologic factors|mesh-ancestor
154589067|NCT02227108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589068|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589069|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154589070|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154589071|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
154589072|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154589073|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154589074|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
154589075|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154589076|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154589077|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
154589078|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589079|NCT02313077|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154589080|NCT02313077|Antiviral Agents|antiviral agents|mesh-ancestor
154589081|NCT02313077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589082|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
154589083|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154589084|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154589085|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589086|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154589087|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589088|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154589089|NCT03423355|Diuretics|diuretics|mesh-ancestor
154589090|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
154589091|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154589092|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589093|NCT02226562|Listerine|listerine|mesh-list
154589094|NCT02226562|Fluorides|fluorides|mesh-list
154589095|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
154589096|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
154589097|NCT02226562|Protective Agents|protective agents|mesh-ancestor
154589098|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589099|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154589100|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589101|NCT04430985|Leucovorin|leucovorin|mesh-list
154589102|NCT04430985|Nivolumab|nivolumab|mesh-list
154589103|NCT04430985|Ipilimumab|ipilimumab|mesh-list
154589104|NCT04430985|Fluorouracil|fluorouracil|mesh-list
154589105|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
154589106|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589107|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589108|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154589109|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589110|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
154589111|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154589112|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154589113|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
154589114|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589115|NCT04430985|Antidotes|antidotes|mesh-ancestor
154589116|NCT04430985|Protective Agents|protective agents|mesh-ancestor
154589117|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
154589118|NCT04430985|Vitamins|vitamins|mesh-ancestor
154589119|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
154589120|NCT03365635|Ribavirin|ribavirin|mesh-list
154589121|NCT03365635|Grazoprevir|grazoprevir|mesh-list
154862310|NCT03023111|Miltefosine|miltefosine|mesh-list
154589122|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154589124|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589125|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
154589126|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589127|NCT04658277|Clarithromycin|clarithromycin|mesh-list
154589128|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154589129|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589130|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154589131|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589132|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589133|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154589134|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154589136|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
154589137|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154589138|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154589139|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154589140|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589141|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589142|NCT04456777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154589143|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154589144|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589145|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589146|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589147|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
154589148|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154589149|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154589150|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154589151|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154589153|NCT02874430|Doxycycline|doxycycline|mesh-list
154589154|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154589155|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589156|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154589157|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589158|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
154589159|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154589160|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154589161|NCT05160727|Irinotecan|irinotecan|mesh-list
154589162|NCT05160727|Tislelizumab|tislelizumab|mesh-list
154589163|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154589164|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154589165|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589166|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589167|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589168|NCT05160727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589169|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154589170|NCT03506009|Argatroban|argatroban|mesh-list
154589171|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154589172|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154589173|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589174|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
154589175|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154589176|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
154589177|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589178|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
154589179|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154589180|NCT03130855|Carticaine|carticaine|mesh-list
154589181|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
154589182|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
154589183|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589184|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589185|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
154589186|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589187|NCT02309801|Daidzin|daidzin|mesh-list
154589188|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154589189|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589190|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589191|NCT02309879|Lidocaine|lidocaine|mesh-list
154589192|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
154589193|NCT02309879|Remifentanil|remifentanil|mesh-list
154589194|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
154589195|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
154589196|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589197|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589198|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
154589199|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589200|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154589201|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154589202|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154589203|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589204|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589205|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154589206|NCT02309879|Narcotics|narcotics|mesh-ancestor
154589207|NCT02309879|Analgesics|analgesics|mesh-ancestor
154589208|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
154589209|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154589210|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154589211|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
154589212|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154589213|NCT02820961|Exemestane|exemestane|mesh-list
154589214|NCT02820961|Entinostat|entinostat|mesh-list
154589215|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589216|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154589217|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154589218|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589219|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589220|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154589221|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
154589222|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589223|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589224|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154589225|NCT04658173|Alfentanil|alfentanil|mesh-list
154589226|NCT04658173|Propofol|propofol|mesh-list
154589227|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154589228|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589229|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589230|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154589231|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
154589232|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
154589233|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154589234|NCT04658173|Narcotics|narcotics|mesh-ancestor
154589235|NCT04658173|Analgesics|analgesics|mesh-ancestor
154589236|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
154589237|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589238|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
154589239|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154589240|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154589241|NCT03636165|Prednisolone|prednisolone|mesh-list
154589242|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
154589243|NCT03636165|Ropivacaine|ropivacaine|mesh-list
154589244|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154589245|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
154589246|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
154589247|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
154589248|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589249|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589250|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
154589251|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589252|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154589253|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
154589254|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
154589255|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154589256|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
154589257|NCT03636165|Hormones|hormones|mesh-ancestor
154589258|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589259|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154589260|NCT03636165|Protective Agents|protective agents|mesh-ancestor
154589261|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154589262|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589263|NCT02310347|Dronabinol|dronabinol|mesh-list
154589264|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
154589265|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589266|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154589267|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154589268|NCT02310347|Analgesics|analgesics|mesh-ancestor
154589269|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
154589270|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862311|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154589271|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154862312|NCT03023111|Molgramostim|molgramostim|mesh-list
154589272|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154589273|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589274|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589275|NCT02310347|Hormones|hormones|mesh-ancestor
154589276|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589277|NCT04429425|Anesthetics|anesthetics|mesh-list
154589278|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589279|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589280|NCT03502889|Ropivacaine|ropivacaine|mesh-list
154589281|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
154589282|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
154589283|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589284|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589285|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
154589286|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589287|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154589288|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
154589289|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154589290|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154589291|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154589292|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589293|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589294|NCT02738879|Metformin|metformin|mesh-list
154589295|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
154589296|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154589297|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154589298|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589299|NCT02738879|Incretins|incretins|mesh-ancestor
154589300|NCT02738879|Hormones|hormones|mesh-ancestor
154589301|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589302|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154589303|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
154589304|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589305|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589306|NCT03253913|Sirolimus|sirolimus|mesh-list
154589307|NCT03253913|Resveratrol|resveratrol|mesh-list
154589308|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154589309|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589310|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154589311|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589312|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
154589313|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154589314|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
154589315|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589316|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589317|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589318|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
154589319|NCT03253913|Protective Agents|protective agents|mesh-ancestor
154589320|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154589321|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
154589322|NCT03237819|Analgesics|analgesics|mesh-ancestor
154589323|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
154589324|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589325|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589326|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
154589327|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589328|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154589329|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
154589330|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154589331|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589332|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589333|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154589334|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
154589335|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154589336|NCT03468907|Tenofovir|tenofovir|mesh-list
154589337|NCT03468907|Telbivudine|telbivudine|mesh-list
154589338|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
154589339|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589340|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154589341|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154589342|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589343|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589344|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154589345|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154589346|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
154589347|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
154589348|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154589349|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154589350|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154589351|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589352|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589353|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
154589354|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589355|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589356|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154589357|NCT05089851|Protective Agents|protective agents|mesh-ancestor
154589358|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
154589359|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154589360|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589361|NCT04657809|Insulin|insulin|mesh-list
154589362|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154589363|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589364|NCT05350917|Tislelizumab|tislelizumab|mesh-list
154589365|NCT05350917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589366|NCT05350917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589367|NCT02311205|Sorafenib|sorafenib|mesh-list
154589368|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589369|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154589370|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589371|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589372|NCT05390749|Rituximab|rituximab|mesh-list
154589373|NCT05390749|Methotrexate|methotrexate|mesh-list
154589374|NCT05390749|Pomalidomide|pomalidomide|mesh-list
154589375|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589376|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589377|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
154589378|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589379|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154589380|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154589381|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
154589382|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154589383|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154589384|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
154589385|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589386|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154589387|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589388|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154589389|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154589390|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154589391|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154589392|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154589393|NCT05390749|Growth Substances|growth substances|mesh-ancestor
154589394|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
154589395|NCT03468829|Gontivimab|gontivimab|mesh-list
154589396|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
154589397|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589398|NCT04912791|Anesthetics|anesthetics|mesh-list
154589399|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589400|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589401|NCT02316197|Peposertib|peposertib|mesh-list
154589402|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154589403|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589404|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589405|NCT02314013|Metronidazole|metronidazole|mesh-list
154589406|NCT02314013|Cephalosporins|cephalosporins|mesh-list
154589407|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589408|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154589409|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154589410|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154589411|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
154589412|NCT01677195|Antacids|antacids|mesh-ancestor
154589413|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589414|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154862313|NCT03023111|Sargramostim|sargramostim|mesh-list
154862314|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
154862315|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862316|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862317|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
154862318|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589416|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
154589417|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
154589418|NCT05331807|Vitamins|vitamins|mesh-list
154589419|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
154589420|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589421|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154589422|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154589423|NCT02314325|Factor VIII|factor viii|mesh-list
154589424|NCT02314325|Coagulants|coagulants|mesh-ancestor
154589425|NCT03502421|Ketamine|ketamine|mesh-list
154589426|NCT03502421|Analgesics|analgesics|mesh-ancestor
154589427|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
154589428|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589429|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589430|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154589431|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154589432|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
154589433|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
154589434|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589435|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154589436|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154589437|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589438|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589440|NCT03502343|Gemcitabine|gemcitabine|mesh-list
154589441|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154589442|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589443|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
154589444|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
154589445|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
154589446|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589447|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154589448|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
154589449|NCT04345887|Spironolactone|spironolactone|mesh-list
154589450|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154589451|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
154589452|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589453|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589454|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154589455|NCT04345887|Diuretics|diuretics|mesh-ancestor
154589456|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
154589457|NCT02316899|Linaclotide|linaclotide|mesh-list
154589458|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154589459|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
154589460|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589461|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154589462|NCT02314871|Morphine|morphine|mesh-list
154589463|NCT02314871|Pirinitramide|pirinitramide|mesh-list
154589464|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154589465|NCT02314871|Narcotics|narcotics|mesh-ancestor
154589466|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589467|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589468|NCT02314871|Analgesics|analgesics|mesh-ancestor
154589469|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
154589470|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589471|NCT02224846|Tadalafil|tadalafil|mesh-list
154589472|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
154589473|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154589474|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154589475|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589476|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589477|NCT02224846|Urological Agents|urological agents|mesh-ancestor
154589478|NCT03470077|Nalbuphine|nalbuphine|mesh-list
154589479|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589480|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589481|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154589482|NCT03470077|Narcotics|narcotics|mesh-ancestor
154589483|NCT03470077|Analgesics|analgesics|mesh-ancestor
154589484|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
154589485|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589486|NCT02224690|Cannabidiol|cannabidiol|mesh-list
154589487|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
154589488|NCT03501251|Albendazole|albendazole|mesh-list
154589489|NCT03501251|Moxidectin|moxidectin|mesh-list
154862319|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154589490|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
154589491|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154589492|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589493|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
154589494|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154589495|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154589496|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154589497|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154589498|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154589499|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589500|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589501|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
154589502|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154589503|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
154589504|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589505|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154589506|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154589507|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
154589508|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589509|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589510|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154589511|NCT05390203|Testosterone|testosterone|mesh-list
154589512|NCT05390203|Androgens|androgens|mesh-ancestor
154589513|NCT05390203|Hormones|hormones|mesh-ancestor
154589514|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589515|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589516|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
154589517|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154589518|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
154589519|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589520|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589521|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154589522|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
154589523|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
154589524|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154589525|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
154589526|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589527|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589528|NCT02315495|Saxagliptin|saxagliptin|mesh-list
154589529|NCT02315495|Acarbose|acarbose|mesh-list
154589530|NCT02315495|Incretins|incretins|mesh-ancestor
154589531|NCT02315495|Hormones|hormones|mesh-ancestor
154589532|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589533|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589534|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154589535|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
154589536|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589537|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589538|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154589539|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154589540|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
154589541|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154589542|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154589543|NCT02317601|Prednisolone|prednisolone|mesh-list
154589544|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
154589545|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154589546|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
154589547|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154589548|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
154589549|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
154589550|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589551|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589552|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154589553|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
154589554|NCT02317601|Hormones|hormones|mesh-ancestor
154589555|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589556|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154589557|NCT02317601|Protective Agents|protective agents|mesh-ancestor
154589558|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154589559|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589560|NCT05101785|Lidocaine|lidocaine|mesh-list
154589561|NCT05101785|Epinephrine|epinephrine|mesh-list
154589562|NCT05101785|Racepinephrine|racepinephrine|mesh-list
154589563|NCT05101785|Carticaine|carticaine|mesh-list
154589564|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
154862320|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154589565|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
154589566|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
154589567|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589568|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589569|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
154589570|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589571|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154589572|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154589573|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154589574|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589575|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589576|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154589577|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154589578|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
154589579|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589580|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154589581|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154589582|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
154589583|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154589584|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
154589585|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
154589586|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
154589587|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154589588|NCT02315573|Lidocaine|lidocaine|mesh-list
154589589|NCT02315573|Epinephrine|epinephrine|mesh-list
154589590|NCT02315573|Racepinephrine|racepinephrine|mesh-list
154589591|NCT02315573|Bupivacaine|bupivacaine|mesh-list
154589592|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
154589593|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
154589594|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
154589595|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589596|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589597|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
154589598|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076380|NCT00807599|Hormones|hormones|mesh-ancestor
154589599|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154589600|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154589601|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154589602|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589603|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589604|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154589605|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154589606|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
154589607|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589608|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154589609|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154589610|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
154589611|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154589612|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
154589613|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
154589614|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
154589615|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154589616|NCT02724241|Nicotine|nicotine|mesh-list
154589617|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154589618|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
154589619|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589620|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589621|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154589622|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154589623|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
154589624|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589625|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589626|NCT02315651|Ubiquinone|ubiquinone|mesh-list
154589627|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
154589628|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
154589629|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589630|NCT02315651|Vitamins|vitamins|mesh-ancestor
154589631|NCT06229990|Furosemide|furosemide|mesh-list
154589632|NCT06229990|Diuretics|diuretics|mesh-ancestor
154589633|NCT06229990|Natriuretic Agents|natriuretic agents|mesh-ancestor
154589634|NCT06229990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589635|NCT06229990|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154589636|NCT06229990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589637|NCT06229990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589638|NCT06229977|Palmidrol|palmidrol|mesh-list
154589639|NCT06229977|Analgesics|analgesics|mesh-ancestor
154589640|NCT06229977|Sensory System Agents|sensory system agents|mesh-ancestor
154862321|NCT03022253|Acetaminophen|acetaminophen|mesh-list
154589641|NCT06229977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589642|NCT06229977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589643|NCT06229977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154589644|NCT06229977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154589645|NCT06229977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154589646|NCT06229977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154589647|NCT06229977|Antiviral Agents|antiviral agents|mesh-ancestor
154589648|NCT06229977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589649|NCT06229977|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154589650|NCT06229977|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154589651|NCT06229977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589652|NCT06229977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589654|NCT06229977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589655|NCT06229795|Metformin|metformin|mesh-list
154589656|NCT06229795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154313471|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
154589657|NCT06229795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589658|NCT06229496|Paclitaxel|paclitaxel|mesh-list
154589659|NCT06229496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154589660|NCT06229496|Gemcitabine|gemcitabine|mesh-list
154589661|NCT06229496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154589662|NCT06229496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589663|NCT06229496|Tubulin Modulators|tubulin modulators|mesh-ancestor
154589664|NCT06229496|Antimitotic Agents|antimitotic agents|mesh-ancestor
154589665|NCT06229496|Mitosis Modulators|mitosis modulators|mesh-ancestor
154589666|NCT06229496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589667|NCT06229496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154589668|NCT06229496|Antimetabolites|antimetabolites|mesh-ancestor
154589669|NCT06229340|Hydroxychloroquine|hydroxychloroquine|mesh-list
154589670|NCT06229340|Bevacizumab|bevacizumab|mesh-list
154589671|NCT06229340|Leflunomide|leflunomide|mesh-list
154589672|NCT06229340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589673|NCT06229340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589674|NCT06229340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154589675|NCT06229340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154589676|NCT06229340|Growth Substances|growth substances|mesh-ancestor
154589677|NCT06229340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589678|NCT06229340|Growth Inhibitors|growth inhibitors|mesh-ancestor
154589679|NCT06229340|Antimalarials|antimalarials|mesh-ancestor
154589680|NCT06229340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154589681|NCT06229340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154589682|NCT06229340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589683|NCT06229340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589684|NCT06229340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589685|NCT06229340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154589686|NCT06229340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154589687|NCT06229340|Immunologic Factors|immunologic factors|mesh-ancestor
154589688|NCT06229288|Amoxicillin|amoxicillin|mesh-list
154589689|NCT06229288|Clavulanic Acid|clavulanic acid|mesh-list
154589690|NCT06229288|Clavulanic Acids|clavulanic acids|mesh-list
154589691|NCT06229288|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154589692|NCT06229288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154589693|NCT06229288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589694|NCT06229288|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154589695|NCT06229288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589696|NCT06229288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589697|NCT06229067|Cyclophosphamide|cyclophosphamide|mesh-list
154589698|NCT06229067|Capecitabine|capecitabine|mesh-list
154589699|NCT06229067|Vinorelbine|vinorelbine|mesh-list
154589700|NCT06229067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154589701|NCT06229067|Immunologic Factors|immunologic factors|mesh-ancestor
154589702|NCT06229067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589703|NCT06229067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154589704|NCT06229067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154589705|NCT06229067|Alkylating Agents|alkylating agents|mesh-ancestor
154589706|NCT06229067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589707|NCT06229067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589708|NCT06229067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154589709|NCT06229067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154589710|NCT06229067|Antimetabolites|antimetabolites|mesh-ancestor
154589711|NCT06229067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154589712|NCT06229067|Tubulin Modulators|tubulin modulators|mesh-ancestor
154862322|NCT03022253|Ibuprofen|ibuprofen|mesh-list
154862323|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154589713|NCT06229067|Antimitotic Agents|antimitotic agents|mesh-ancestor
154589714|NCT06229067|Mitosis Modulators|mitosis modulators|mesh-ancestor
154589715|NCT06229041|Immunomodulating Agents|immunomodulating agents|mesh-list
154589716|NCT06229041|Immunologic Factors|immunologic factors|mesh-ancestor
154589717|NCT06229041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589719|NCT06228820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154589720|NCT06228820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154589721|NCT06228820|Analgesics|analgesics|mesh-ancestor
154589722|NCT06228820|Sensory System Agents|sensory system agents|mesh-ancestor
154589723|NCT06228820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589724|NCT06228820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589725|NCT06228820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154589726|NCT06228820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154589727|NCT06228820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154589728|NCT06228820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154589729|NCT06228820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589730|NCT06228820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154589731|NCT06228820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154589732|NCT06228820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589733|NCT06228820|Antipyretics|antipyretics|mesh-ancestor
154589734|NCT06228677|Epinephrine|epinephrine|mesh-list
154589736|NCT06228677|Epinephryl borate|epinephryl borate|mesh-list
154589737|NCT06228677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154589738|NCT06228677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154589739|NCT06228677|Adrenergic Agents|adrenergic agents|mesh-ancestor
154589740|NCT06228677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589741|NCT06228677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589742|NCT06228677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589743|NCT06228677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154589744|NCT06228677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154589745|NCT06228677|Autonomic Agents|autonomic agents|mesh-ancestor
154589746|NCT06228677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589747|NCT06228677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154589748|NCT06228677|Respiratory System Agents|respiratory system agents|mesh-ancestor
154589749|NCT06228677|Mydriatics|mydriatics|mesh-ancestor
154589750|NCT06228677|Sympathomimetics|sympathomimetics|mesh-ancestor
154589751|NCT06228677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154589752|NCT06228443|Leflunomide|leflunomide|mesh-list
154589753|NCT06228443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589754|NCT06228443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589755|NCT06228443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154589756|NCT06228443|Immunologic Factors|immunologic factors|mesh-ancestor
154589757|NCT06228443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589758|NCT06228430|Acyclovir|acyclovir|mesh-list
154589759|NCT06228430|Antiviral Agents|antiviral agents|mesh-ancestor
154589760|NCT06228430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589761|NCT06228391|Midazolam|midazolam|mesh-list
154589762|NCT06228391|Ketamine|ketamine|mesh-list
154589763|NCT06228391|Analgesics|analgesics|mesh-ancestor
154589764|NCT06228391|Sensory System Agents|sensory system agents|mesh-ancestor
154589765|NCT06228391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589766|NCT06228391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589767|NCT06228391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154589768|NCT06228391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154589769|NCT06228391|Anesthetics, General|anesthetics, general|mesh-ancestor
154589770|NCT06228391|Anesthetics|anesthetics|mesh-ancestor
154589771|NCT06228391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589772|NCT06228391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154589773|NCT06228391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154589774|NCT06228391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589775|NCT06228391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589776|NCT06228391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154589777|NCT06228391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154589778|NCT06228391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154589779|NCT06228391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154589780|NCT06228391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154589781|NCT06228391|GABA Modulators|gaba modulators|mesh-ancestor
154589782|NCT06228391|GABA Agents|gaba agents|mesh-ancestor
154589783|NCT06228339|Alfuzosin|alfuzosin|mesh-list
154589784|NCT06228339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154589785|NCT06228339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154589786|NCT06228339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154589787|NCT06228339|Adrenergic Agents|adrenergic agents|mesh-ancestor
154589788|NCT06228339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589789|NCT06228339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589790|NCT06228339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589792|NCT06228092|Glycopyrrolate|glycopyrrolate|mesh-list
154589793|NCT06228092|Neostigmine|neostigmine|mesh-list
154589794|NCT06228092|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154589795|NCT06228092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589796|NCT06228092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589797|NCT06228092|Cholinergic Agents|cholinergic agents|mesh-ancestor
154589798|NCT06228092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589799|NCT06228092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589800|NCT06228092|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154589801|NCT06228092|Autonomic Agents|autonomic agents|mesh-ancestor
154589802|NCT06228092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589803|NCT06228092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154589804|NCT06228092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154589805|NCT06228092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154589806|NCT06228079|Gemcitabine|gemcitabine|mesh-list
154589807|NCT06228079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154589808|NCT06228079|Antimetabolites|antimetabolites|mesh-ancestor
154313612|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
154589809|NCT06228079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589810|NCT06228079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589811|NCT06227988|Liver Extracts|liver extracts|mesh-list
154589812|NCT06227988|Hematinics|hematinics|mesh-ancestor
154589813|NCT06227689|Vaccines|vaccines|mesh-list
154589814|NCT06227689|Immunologic Factors|immunologic factors|mesh-ancestor
154589815|NCT06227689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076596|NCT00733902|Tanezumab|tanezumab|mesh-list
154589816|NCT06227624|Zinc Sulfate|zinc sulfate|mesh-list
154589817|NCT06227624|Astringents|astringents|mesh-ancestor
154589818|NCT06227624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589819|NCT06227624|Dermatologic Agents|dermatologic agents|mesh-ancestor
154589820|NCT06227533|Mitogens|mitogens|mesh-list
154589821|NCT06227533|Mitosis Modulators|mitosis modulators|mesh-ancestor
154589822|NCT06227533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589823|NCT06226857|Cetuximab|cetuximab|mesh-list
154589824|NCT06226857|Panitumumab|panitumumab|mesh-list
154589825|NCT06226857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589826|NCT06226857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589827|NCT06225947|Lemborexant|lemborexant|mesh-list
154589828|NCT06225947|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154589829|NCT06225947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589830|NCT06225947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589831|NCT06225947|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154589832|NCT06225947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154589833|NCT06225947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589834|NCT06225947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589835|NCT06225492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154589836|NCT06225492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154589837|NCT06225492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154589838|NCT06225492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589839|NCT06225492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589840|NCT06225492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154589841|NCT06225492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589842|NCT06225492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589843|NCT06225492|Cholinergic Agents|cholinergic agents|mesh-ancestor
154589844|NCT06225492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589845|NCT06224140|Heparin|heparin|mesh-list
154589846|NCT06224140|Anticoagulants|anticoagulants|mesh-ancestor
154589847|NCT06224140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154589848|NCT06224140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154589849|NCT06224140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589850|NCT06192186|Oxaliplatin|oxaliplatin|mesh-list
154589851|NCT06192186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589852|NCT06187298|Curcumin|curcumin|mesh-list
154589853|NCT06187298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154589854|NCT06187298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154589855|NCT06187298|Analgesics|analgesics|mesh-ancestor
154589856|NCT06187298|Sensory System Agents|sensory system agents|mesh-ancestor
154589857|NCT06187298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589858|NCT06187298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589859|NCT06187298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154589860|NCT06187298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154589861|NCT06187298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589862|NCT06187298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589863|NCT06187298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589864|NCT06142383|Valsartan|valsartan|mesh-list
154589865|NCT06142383|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154589866|NCT06142383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154589867|NCT06142383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154589868|NCT06142383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154589869|NCT06142383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589870|NCT06121349|Ofatumumab|ofatumumab|mesh-list
154589871|NCT06121349|Ocrelizumab|ocrelizumab|mesh-list
154589872|NCT06121349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589873|NCT06121349|Immunologic Factors|immunologic factors|mesh-ancestor
154589874|NCT06121349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589875|NCT06115031|Propofol|propofol|mesh-list
154589876|NCT06115031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154589877|NCT06115031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154589878|NCT06115031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589879|NCT06115031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154589880|NCT06115031|Anesthetics, General|anesthetics, general|mesh-ancestor
154589881|NCT06115031|Anesthetics|anesthetics|mesh-ancestor
154313694|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
154589882|NCT06081946|Histamine|histamine|mesh-list
154589883|NCT06081946|Histamine Agonists|histamine agonists|mesh-ancestor
154589884|NCT06081946|Histamine Agents|histamine agents|mesh-ancestor
154589885|NCT06081946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589886|NCT06081946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589887|NCT06081946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589888|NCT06046287|Daratumumab|daratumumab|mesh-list
154589889|NCT06046287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589890|NCT06030193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154589891|NCT06030193|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154589892|NCT06021678|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154589893|NCT06021678|Immunologic Factors|immunologic factors|mesh-ancestor
154589894|NCT06021678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589895|NCT05997901|Varenicline|varenicline|mesh-list
154589896|NCT05997901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154589897|NCT05997901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154589898|NCT05997901|Cholinergic Agents|cholinergic agents|mesh-ancestor
154589899|NCT05997901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589900|NCT05997901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589901|NCT05997901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589902|NCT05991284|Valsartan|valsartan|mesh-list
154589903|NCT05991284|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154589904|NCT05991284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154589905|NCT05991284|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154589906|NCT05991284|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154589907|NCT05991284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589908|NCT05954624|Itraconazole|itraconazole|mesh-list
154589909|NCT05954624|Probenecid|probenecid|mesh-list
154589910|NCT05954624|Digoxin|digoxin|mesh-list
154589911|NCT05954624|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154589912|NCT05954624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154589913|NCT05954624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154589914|NCT05954624|Antimetabolites|antimetabolites|mesh-ancestor
154589915|NCT05954624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589916|NCT05954624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154589917|NCT05954624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154589918|NCT05954624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589919|NCT05954624|Antifungal Agents|antifungal agents|mesh-ancestor
154589920|NCT05954624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154589921|NCT05954624|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154589922|NCT05954624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154862324|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154862325|NCT03022253|Analgesics|analgesics|mesh-ancestor
154862326|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
154862327|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862328|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862329|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862330|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154862331|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154862332|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862333|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589924|NCT05954624|Hormone Antagonists|hormone antagonists|mesh-ancestor
154589925|NCT05954624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589926|NCT05954624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589927|NCT05954624|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154589928|NCT05954624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154589929|NCT05954624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154589930|NCT05954624|Protective Agents|protective agents|mesh-ancestor
154589931|NCT05954624|Uricosuric Agents|uricosuric agents|mesh-ancestor
154589932|NCT05954624|Gout Suppressants|gout suppressants|mesh-ancestor
154589933|NCT05954624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154589934|NCT05948579|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154589935|NCT05948579|Antidepressive Agents|antidepressive agents|mesh-ancestor
154589936|NCT05948579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154589937|NCT05948579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154589938|NCT05948579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154589939|NCT05948579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589940|NCT05948579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589941|NCT05948579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589942|NCT05948579|Serotonin Agents|serotonin agents|mesh-ancestor
154589943|NCT05948579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589944|NCT05948579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154589945|NCT05948579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154589946|NCT05948553|Fluoxetine|fluoxetine|mesh-list
154589947|NCT05948553|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154589948|NCT05948553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154589949|NCT05948553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589950|NCT05948553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589951|NCT05948553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589952|NCT05948553|Serotonin Agents|serotonin agents|mesh-ancestor
154313765|NCT02088502|Expectorants|expectorants|mesh-ancestor
154589953|NCT05948553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589954|NCT05948553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154589955|NCT05948553|Antidepressive Agents|antidepressive agents|mesh-ancestor
154589956|NCT05948553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154589957|NCT05948553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154589958|NCT05948553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154589959|NCT05948553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154589960|NCT05924672|Diphosphonates|diphosphonates|mesh-list
154589961|NCT05924672|Methylene diphosphonate|methylene diphosphonate|mesh-list
154589962|NCT05924672|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154589963|NCT05924672|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
154589964|NCT05924672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589965|NCT05924672|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154589966|NCT05924672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589967|NCT05924672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154589968|NCT05924672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589969|NCT05899608|Pembrolizumab|pembrolizumab|mesh-list
154589970|NCT05899608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154589971|NCT05899608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154589972|NCT05899608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154589973|NCT05899608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589974|NCT05872932|Botulinum Toxins|botulinum toxins|mesh-list
154589975|NCT05872932|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154589976|NCT05872932|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154589977|NCT05872932|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154589978|NCT05872932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154589979|NCT05872932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154589980|NCT05872932|Cholinergic Agents|cholinergic agents|mesh-ancestor
154589981|NCT05872932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154589982|NCT05872932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589983|NCT05872932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154589984|NCT05872932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154589985|NCT05840718|Thiamine|thiamine|mesh-list
154589986|NCT05840718|Vitamin B Complex|vitamin b complex|mesh-ancestor
154589987|NCT05840718|Vitamins|vitamins|mesh-ancestor
154589988|NCT05840718|Micronutrients|micronutrients|mesh-ancestor
154589989|NCT05840718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589990|NCT05837624|Drospirenone|drospirenone|mesh-list
154862334|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
154862335|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
154589991|NCT05837624|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154589992|NCT05837624|Hormone Antagonists|hormone antagonists|mesh-ancestor
154589993|NCT05837624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154589994|NCT05837624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154589995|NCT05837624|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154589996|NCT05837624|Diuretics|diuretics|mesh-ancestor
154589997|NCT05837624|Natriuretic Agents|natriuretic agents|mesh-ancestor
154589998|NCT05766371|Pembrolizumab|pembrolizumab|mesh-list
154589999|NCT05766371|Pluvicto|pluvicto|mesh-list
154590000|NCT05766371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590001|NCT05766371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590002|NCT05766371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590003|NCT05766371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590004|NCT05766371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154590005|NCT05757843|Durvalumab|durvalumab|mesh-list
154590006|NCT05757843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590007|NCT05757843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590008|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
154590009|NCT05618925|Rituximab|rituximab|mesh-list
154590010|NCT05618925|Fludarabine|fludarabine|mesh-list
154590011|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590012|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
154590013|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590014|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590015|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590016|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
154590017|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590018|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590019|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590020|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590021|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154590022|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154590023|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590024|NCT05607004|Exemestane|exemestane|mesh-list
154590025|NCT05607004|Goserelin|goserelin|mesh-list
154590026|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590027|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154590028|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154590029|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590030|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590031|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154590032|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
154590033|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154590034|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590035|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590036|NCT05605964|Leuprolide|leuprolide|mesh-list
154590037|NCT05605964|Relugolix|relugolix|mesh-list
154590038|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154590039|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
154590040|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154590041|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590042|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590043|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590044|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
154590045|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
154590046|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154590047|NCT05556746|Rifampin|rifampin|mesh-list
154590048|NCT05556746|Clofazimine|clofazimine|mesh-list
154590049|NCT05556746|Isoniazid|isoniazid|mesh-list
154590050|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
154590051|NCT05556746|Ethambutol|ethambutol|mesh-list
154590052|NCT05556746|Bedaquiline|bedaquiline|mesh-list
154590053|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154590054|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
154590055|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154590056|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590057|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
154590058|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154590059|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590060|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590061|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154590062|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154590063|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154590064|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154590066|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154590067|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154590068|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154590069|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
154590070|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154590071|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154590072|NCT05539872|Insulin|insulin|mesh-list
154590073|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154590074|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
154590075|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
154590076|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154590077|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154590078|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590079|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
154590080|NCT05463848|Temozolomide|temozolomide|mesh-list
154590081|NCT05463848|Olaparib|olaparib|mesh-list
154590082|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590083|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590084|NCT05463848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590085|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590086|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590087|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
154590088|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154590089|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590090|NCT05456490|Bupivacaine|bupivacaine|mesh-list
154590091|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154590092|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
154590093|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590094|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590095|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
154590096|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590097|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
154590098|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154590099|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590100|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590102|NCT05431322|Analgesics|analgesics|mesh-ancestor
154590103|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
154590104|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590105|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154590106|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154590107|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154590108|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
154590109|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590110|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590111|NCT05422612|Fluoxetine|fluoxetine|mesh-list
154590112|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154590113|NCT05422612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154590114|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154590115|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154590116|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590117|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590118|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
154590119|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590120|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154590121|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
154590122|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154590123|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154590124|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154590125|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590126|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154590127|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154590128|NCT05406622|Sirolimus|sirolimus|mesh-list
154590129|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154590130|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590131|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154590132|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590133|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
154590134|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590135|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
154590136|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590137|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
154590138|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590139|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590140|NCT05378425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590141|NCT05378425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590142|NCT05281510|Vesatolimod|vesatolimod|mesh-list
154590143|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
154590144|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590145|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
154590146|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590147|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590148|NCT05271318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590149|NCT05271318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590150|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154590151|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154590152|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590153|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
154590155|NCT05256745|Docetaxel|docetaxel|mesh-list
154590156|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
154590157|NCT05256745|Carboplatin|carboplatin|mesh-list
154590158|NCT05256745|Doxorubicin|doxorubicin|mesh-list
154590159|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154590160|NCT05256745|Trastuzumab|trastuzumab|mesh-list
154590161|NCT05256745|Pertuzumab|pertuzumab|mesh-list
154590162|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154590163|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077053|NCT04107194|Antacids|antacids|mesh-ancestor
154590164|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
154590165|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
154590166|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
154590167|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590168|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590169|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
154590170|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590171|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313988|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590172|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590173|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
154590174|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590175|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154590176|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154590177|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154590178|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590179|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590181|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590182|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590183|NCT05185999|Icodextrin|icodextrin|mesh-list
154590184|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
154590185|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154590186|NCT05179005|Imidacloprid|imidacloprid|mesh-list
154590187|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
154590188|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590189|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590190|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590191|NCT05176925|Tislelizumab|tislelizumab|mesh-list
154590192|NCT05176925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590193|NCT05176925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590194|NCT05147272|Gemcitabine|gemcitabine|mesh-list
154590195|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154590196|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
154590197|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590198|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590199|NCT05120895|Pravastatin|pravastatin|mesh-list
154590200|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154590201|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154590202|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
154590203|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590204|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154590205|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154590206|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590207|NCT05091203|Vitamin D|vitamin d|mesh-list
154590208|NCT05091203|Vitamins|vitamins|mesh-ancestor
154590209|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
154590210|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590211|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154590212|NCT05028634|Vaccines|vaccines|mesh-list
154590213|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154590215|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590216|NCT04950764|Seladelpar|seladelpar|mesh-list
154590217|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154590218|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
154590219|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590220|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154590221|NCT04950608|Psilocybin|psilocybin|mesh-list
154590222|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
154590223|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590224|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154590225|NCT04940065|Ofatumumab|ofatumumab|mesh-list
154590226|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590227|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154590228|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154590229|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
154590230|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590231|NCT04915768|Antacids|antacids|mesh-ancestor
154590232|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590233|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154590234|NCT04827030|Ropivacaine|ropivacaine|mesh-list
154590235|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
154590236|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
154590237|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590238|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590239|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
154590240|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590241|NCT04804553|Apremilast|apremilast|mesh-list
154590242|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154590243|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154590244|NCT04804553|Analgesics|analgesics|mesh-ancestor
154590245|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
154590246|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590247|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590248|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154590249|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590250|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154590251|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154590252|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590253|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590254|NCT04801641|Nabilone|nabilone|mesh-list
154590255|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
154590256|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
154590257|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590258|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590259|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154590260|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154590261|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154590262|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590263|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154590264|NCT04796012|Irinotecan|irinotecan|mesh-list
154590265|NCT04796012|Vincristine|vincristine|mesh-list
154590266|NCT04796012|Temozolomide|temozolomide|mesh-list
154590267|NCT04796012|Atezolizumab|atezolizumab|mesh-list
154590268|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154590269|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154590270|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590271|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590272|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590273|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154590274|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
154590275|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
154590276|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
154590277|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590278|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
154590279|NCT04796012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590280|NCT04796012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590281|NCT04781972|Methylphenidate|methylphenidate|mesh-list
154590282|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154590283|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590284|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154590285|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154590286|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154590288|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
154590289|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590290|NCT04679389|Acetazolamide|acetazolamide|mesh-list
154590291|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
154590292|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154590293|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590294|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590295|NCT04679389|Diuretics|diuretics|mesh-ancestor
154590296|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
154590297|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590298|NCT04649489|Bevacizumab|bevacizumab|mesh-list
154590299|NCT04649489|Atezolizumab|atezolizumab|mesh-list
154590300|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154590301|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590302|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590303|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154590304|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154590305|NCT04649489|Growth Substances|growth substances|mesh-ancestor
154590306|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590307|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
154590308|NCT04649489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590309|NCT04649489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590310|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
154590311|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
154590312|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154590313|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154590314|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154590315|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
154590316|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590317|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590318|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590319|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
154590320|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590321|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590322|NCT04570332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590323|NCT04570332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590324|NCT04547777|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
154590325|NCT04547777|Immunoconjugates|immunoconjugates|mesh-ancestor
154590326|NCT04547777|Immunologic Factors|immunologic factors|mesh-ancestor
154590327|NCT04547777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590329|NCT04518228|Lopinavir|lopinavir|mesh-list
154590330|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154590331|NCT04518228|Darunavir|darunavir|mesh-list
154590332|NCT04518228|Tenofovir|tenofovir|mesh-list
154590333|NCT04518228|Dolutegravir|dolutegravir|mesh-list
154590334|NCT04518228|Cobicistat|cobicistat|mesh-list
154590335|NCT04518228|Cabotegravir|cabotegravir|mesh-list
154590336|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154590337|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154590338|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
154590339|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590340|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590341|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154590342|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154590343|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
154590344|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590345|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154590346|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154590347|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154590348|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154590349|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154590350|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154590351|NCT04506086|Blinatumomab|blinatumomab|mesh-list
154590352|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590353|NCT04491682|Megestrol|megestrol|mesh-list
154590354|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
154590355|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154590356|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154590357|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154590358|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
154590359|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590360|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154590361|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154590362|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590363|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154590364|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154590365|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154590366|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
154590367|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154590368|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590369|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154590370|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154590371|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590372|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590373|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
154590374|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154590375|NCT04491643|Megestrol|megestrol|mesh-list
154590376|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
154590377|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154590378|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154590379|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154590380|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
154590381|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590382|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154590383|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154590384|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590385|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154590386|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154590387|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154590388|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
154590389|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154590390|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590391|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154590392|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154590393|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590394|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590395|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
154590396|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154590397|NCT04454203|Anesthetics|anesthetics|mesh-list
154590398|NCT04454203|Mepivacaine|mepivacaine|mesh-list
154590399|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
154590400|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590401|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590402|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
154590403|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590404|NCT04327063|Ropivacaine|ropivacaine|mesh-list
154590405|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
154590406|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
154590407|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590408|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590409|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
154590410|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590411|NCT04293809|Bupivacaine|bupivacaine|mesh-list
154590412|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
154590413|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
154590414|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590415|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590416|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
154590417|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590418|NCT04226950|Interferons|interferons|mesh-list
154590419|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
154590420|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
154590421|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154590422|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590423|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
154590424|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590425|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
154590426|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590427|NCT04209504|Bupivacaine|bupivacaine|mesh-list
154590428|NCT04209504|Ropivacaine|ropivacaine|mesh-list
154590429|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
154590430|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
154590431|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590432|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590433|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
154590434|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590437|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
154590438|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590439|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154590440|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154590441|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590442|NCT04160494|Atezolizumab|atezolizumab|mesh-list
154590443|NCT04160494|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
154590444|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
154590445|NCT04160494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590446|NCT04160494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590447|NCT04160494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590448|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590449|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
154590450|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590452|NCT04143711|Nivolumab|nivolumab|mesh-list
154590453|NCT04143711|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154590454|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154590455|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590456|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
154590457|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
154590458|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
154590459|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590460|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590461|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590462|NCT04143711|Immunoconjugates|immunoconjugates|mesh-ancestor
154590463|NCT04143711|Immunologic Factors|immunologic factors|mesh-ancestor
154590464|NCT04143711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590465|NCT04140721|Moxonidine|moxonidine|mesh-list
154590466|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154590467|NCT04124757|Rocuronium|rocuronium|mesh-list
154590468|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154590469|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154590470|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154590471|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590472|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590473|NCT04050410|Moxonidine|moxonidine|mesh-list
154590474|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154590475|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
154590476|NCT04047628|Ofatumumab|ofatumumab|mesh-list
154590477|NCT04047628|Cladribine|cladribine|mesh-list
154590478|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
154590479|NCT04047628|Natalizumab|natalizumab|mesh-list
154590480|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590481|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590482|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
154590483|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590484|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590485|NCT03995147|Prednisone|prednisone|mesh-list
154590486|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
154590487|NCT03995147|Doxorubicin|doxorubicin|mesh-list
154590488|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
154590489|NCT03995147|Vincristine|vincristine|mesh-list
154590490|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590491|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
154590492|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590493|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590494|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590495|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
154590496|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590497|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590498|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590499|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590500|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154590501|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154590502|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154590503|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590504|NCT03995147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590505|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154590506|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
154590507|NCT03995147|Hormones|hormones|mesh-ancestor
154590508|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154590509|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590510|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154590511|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
154590512|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
154590513|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
154590514|NCT03936933|Goserelin|goserelin|mesh-list
154590515|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590516|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590517|NCT03879629|Carvedilol|carvedilol|mesh-list
154590518|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154590519|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154590520|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
154590521|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590522|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590523|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590524|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154590525|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
154590526|NCT03879629|Protective Agents|protective agents|mesh-ancestor
154590527|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154590528|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154590529|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154590530|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
154590531|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154590532|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154590533|NCT03872947|Leucovorin|leucovorin|mesh-list
154590534|NCT03872947|Bevacizumab|bevacizumab|mesh-list
154590535|NCT03872947|Carboplatin|carboplatin|mesh-list
154590536|NCT03872947|Gemcitabine|gemcitabine|mesh-list
154590537|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
154590538|NCT03872947|Nivolumab|nivolumab|mesh-list
154590539|NCT03872947|Irinotecan|irinotecan|mesh-list
154590540|NCT03872947|Imiquimod|imiquimod|mesh-list
154590541|NCT03872947|Ramucirumab|ramucirumab|mesh-list
154590542|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590543|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590544|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590545|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154314370|NCT02098330|Hormones|hormones|mesh-ancestor
154590546|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154590547|NCT03872947|Growth Substances|growth substances|mesh-ancestor
154590548|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590549|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
154590550|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154590551|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
154590552|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590553|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154590554|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154590555|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590556|NCT03872947|Antidotes|antidotes|mesh-ancestor
154590557|NCT03872947|Protective Agents|protective agents|mesh-ancestor
154590558|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
154590559|NCT03872947|Vitamins|vitamins|mesh-ancestor
154590560|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
154590561|NCT03872947|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154590562|NCT03872947|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154590563|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
154590564|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154590565|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
154590566|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
154590567|NCT03805594|Pluvicto|pluvicto|mesh-list
154590568|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590569|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590570|NCT03805594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590571|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590572|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154590573|NCT03718884|Mirikizumab|mirikizumab|mesh-list
154590574|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154590575|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154590576|NCT03718884|Analgesics|analgesics|mesh-ancestor
154590577|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
154590578|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590579|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590580|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154590581|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154862336|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154590582|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154590583|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154590584|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
154590585|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590586|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590587|NCT03595683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590588|NCT03595683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590589|NCT03436485|Midazolam|midazolam|mesh-list
154590590|NCT03436485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154590591|NCT03436485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154590592|NCT03436485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590593|NCT03436485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590594|NCT03436485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154590595|NCT03436485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154590596|NCT03436485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154590597|NCT03436485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154590598|NCT03436485|Anesthetics, General|anesthetics, general|mesh-ancestor
154590599|NCT03436485|Anesthetics|anesthetics|mesh-ancestor
154590600|NCT03436485|GABA Modulators|gaba modulators|mesh-ancestor
154590601|NCT03436485|GABA Agents|gaba agents|mesh-ancestor
154590602|NCT03436485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590603|NCT03436485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590604|NCT03423264|Gabapentin|gabapentin|mesh-list
154590605|NCT03423264|Analgesics|analgesics|mesh-ancestor
154590606|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
154590607|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590608|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590609|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
154590610|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154590611|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154590612|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590613|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154590614|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154590615|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154590616|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590617|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590618|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
154590619|NCT03406156|Venetoclax|venetoclax|mesh-list
154590620|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154590621|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
154590622|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590623|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590625|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590626|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590627|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
154590628|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590629|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590630|NCT03283137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590631|NCT03283137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590632|NCT03223155|Nivolumab|nivolumab|mesh-list
154590633|NCT03223155|Ipilimumab|ipilimumab|mesh-list
154590634|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590635|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590636|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590637|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590638|NCT03194815|Rituximab|rituximab|mesh-list
154590639|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
154590640|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154590641|NCT03194815|Antibodies|antibodies|mesh-list
154590642|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
154590643|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154590644|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590645|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590646|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
154590647|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590648|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590649|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
154590650|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
154590651|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590652|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
154590653|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590654|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590655|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590656|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
154590657|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590658|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590659|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590661|NCT03153410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590662|NCT03025256|Nivolumab|nivolumab|mesh-list
154590663|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590664|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590665|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590666|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590667|NCT03000387|Nicotine|nicotine|mesh-list
154590668|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154590669|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
154590670|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590671|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590672|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154590673|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154590674|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
154590675|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590676|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590677|NCT02994927|Prednisone|prednisone|mesh-list
154590678|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
154590679|NCT02994927|Rituximab|rituximab|mesh-list
154590680|NCT02994927|Azathioprine|azathioprine|mesh-list
154590681|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590682|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
154590683|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590684|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590685|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590686|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
154590687|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590688|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590689|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590690|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590691|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154590692|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
154590693|NCT02994927|Hormones|hormones|mesh-ancestor
154590694|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314514|NCT03554590|Insulin|insulin|mesh-list
154590695|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590696|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
154590697|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154590698|NCT02721459|Vemurafenib|vemurafenib|mesh-list
154590699|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590700|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154590701|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590702|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590703|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
154590704|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590705|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
154590706|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590707|NCT02629120|Sirolimus|sirolimus|mesh-list
154590708|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
154590709|NCT02629120|Busulfan|busulfan|mesh-list
154590710|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
154590711|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590712|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
154590713|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590714|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590715|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590716|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
154590717|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590718|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590719|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590720|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154590721|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590722|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154590723|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
154590724|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590725|NCT02513186|Dexamethasone|dexamethasone|mesh-list
154590726|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
154590727|NCT02513186|Lenalidomide|lenalidomide|mesh-list
154590728|NCT02513186|Bortezomib|bortezomib|mesh-list
154590729|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590730|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
154590731|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590732|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590733|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590734|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
154590735|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590736|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590737|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590738|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154590739|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
154590740|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
154590741|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590742|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154590743|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
154590744|NCT02513186|Hormones|hormones|mesh-ancestor
154590745|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154590746|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590747|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154590748|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154590749|NCT02513186|Growth Substances|growth substances|mesh-ancestor
154590750|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
154590751|NCT02428985|Riociguat|riociguat|mesh-list
154590752|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
154590753|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590754|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
154590755|NCT02333162|Fludarabine|fludarabine|mesh-list
154590756|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
154590757|NCT02333162|Melphalan|melphalan|mesh-list
154590758|NCT02333162|Tacrolimus|tacrolimus|mesh-list
154590759|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590760|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154590761|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
154590762|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590763|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590764|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
154590765|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590766|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154590767|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590768|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154590769|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154590770|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
154590771|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154590772|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590773|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590774|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
154590775|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590776|NCT02310867|Abatacept|abatacept|mesh-list
154590777|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154590778|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590779|NCT02310867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590780|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590781|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590782|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
154590783|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590784|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590785|NCT02296918|Rituximab|rituximab|mesh-list
154590786|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
154590787|NCT02296918|Venetoclax|venetoclax|mesh-list
154590788|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
154590789|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154590790|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590791|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
154590792|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590793|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590794|NCT02296918|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154590795|NCT02296918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154590796|NCT02296918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590797|NCT02296918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590798|NCT02117791|Riociguat|riociguat|mesh-list
154590799|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
154590800|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590801|NCT02032823|Olaparib|olaparib|mesh-list
154590802|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154590803|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590804|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590805|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862337|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154590806|NCT01847326|Paclitaxel|paclitaxel|mesh-list
154590807|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154590808|NCT01847326|Carboplatin|carboplatin|mesh-list
154590809|NCT01847326|Fluorouracil|fluorouracil|mesh-list
154590810|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
154590811|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154590812|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590813|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
154590814|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
154590815|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
154590816|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590817|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
154590818|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154590819|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590820|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
154590821|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590822|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
154590823|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590824|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154590825|NCT01693718|Fluorouracil|fluorouracil|mesh-list
154590826|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
154590827|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590828|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
154590829|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590830|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154590831|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590832|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
154590833|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590834|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
154590835|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590836|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154590837|NCT01526096|Plerixafor|plerixafor|mesh-list
154590838|NCT01526096|Melphalan|melphalan|mesh-list
154590839|NCT01526096|Basiliximab|basiliximab|mesh-list
154590840|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590841|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
154590842|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590843|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590844|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154314667|NCT05568836|Vitamin D|vitamin d|mesh-list
154590845|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590846|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
154590847|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590848|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154590849|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154590850|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
154590851|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590852|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
154590853|NCT00961792|Promethazine|promethazine|mesh-list
154590854|NCT00961792|Ethanol|ethanol|mesh-list
154590855|NCT00961792|Caffeine|caffeine|mesh-list
154590856|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154590857|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590858|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154590859|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590860|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590861|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154590862|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154590863|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
154590864|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590865|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154590866|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590867|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590868|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154590869|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154590870|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
154590871|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
154590872|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
154590873|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590874|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
154590875|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
154590876|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154590877|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154590878|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
154590879|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
154590880|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154590881|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
154590882|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
154590884|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
154590885|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154590886|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154590887|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154077694|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
154590888|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590889|NCT00630565|Dexamethasone|dexamethasone|mesh-list
154590890|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
154590891|NCT00630565|Busulfan|busulfan|mesh-list
154590892|NCT00630565|Etoposide|etoposide|mesh-list
154590893|NCT00630565|Sargramostim|sargramostim|mesh-list
154590894|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590895|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
154590896|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590897|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590898|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590899|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
154590900|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590901|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590902|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590903|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154590904|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
154590905|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
154590906|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590907|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154590908|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
154590909|NCT00630565|Hormones|hormones|mesh-ancestor
154590910|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154590911|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154590912|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154590913|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154590914|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154590915|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590916|NCT00598481|Busulfan|busulfan|mesh-list
154590917|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
154590918|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590919|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154590920|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
154590921|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590922|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154590923|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154590924|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154590925|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
154590926|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
154590927|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154590928|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154590929|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590930|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590931|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590932|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590933|NCT02317679|Bosentan|bosentan|mesh-list
154590934|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154590935|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154590936|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590937|NCT03475381|Ivacaftor|ivacaftor|mesh-list
154590938|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154590939|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154590940|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590941|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154590942|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154590943|NCT04535505|Erythromycin|erythromycin|mesh-list
154590944|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
154590945|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154590946|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
154590947|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154590948|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590949|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154590950|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154590951|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154590952|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590953|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
154590954|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154862338|NCT01037881|Analgesics|analgesics|mesh-ancestor
154590955|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
154590956|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590957|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077767|NCT04099238|Phenindione|phenindione|mesh-list
154590958|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154590959|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
154590960|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154590961|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
154590962|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154590963|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154590964|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154590965|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
154590966|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
154590967|NCT03500783|Protective Agents|protective agents|mesh-ancestor
154590968|NCT03353233|Ropivacaine|ropivacaine|mesh-list
154590969|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
154590970|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
154590971|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590972|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590973|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
154590974|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590975|NCT02320877|Methaqualone|methaqualone|mesh-list
154590976|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154590977|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154590978|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590979|NCT01322971|Metronidazole|metronidazole|mesh-list
154590980|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154590981|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154590982|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154590983|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154590984|NCT04454281|Naloxone|naloxone|mesh-list
154590985|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154590986|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590987|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
154590988|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154590989|NCT02318225|Misoprostol|misoprostol|mesh-list
154590990|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154590991|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
154590992|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154590993|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154590994|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154590995|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154590996|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
154590997|NCT01378429|Ciclesonide|ciclesonide|mesh-list
154590998|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
154590999|NCT01378429|Hormones|hormones|mesh-ancestor
154591000|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591001|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591002|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154591003|NCT01599754|Axitinib|axitinib|mesh-list
154591004|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591005|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154591006|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591007|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591008|NCT02321267|Ranibizumab|ranibizumab|mesh-list
154591009|NCT02321267|Aflibercept|aflibercept|mesh-list
154591010|NCT02321267|Verteporfin|verteporfin|mesh-list
154591011|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154591012|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154591013|NCT02321267|Growth Substances|growth substances|mesh-ancestor
154591014|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591015|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
154591016|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591017|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154591018|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591019|NCT02318537|Cannabidiol|cannabidiol|mesh-list
154591020|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154591021|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
154591022|NCT04936399|Nivolumab|nivolumab|mesh-list
154591023|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255671|NCT03893864|Vitamins|vitamins|mesh-ancestor
154862339|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
154862340|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862341|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862342|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862343|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154862344|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
154077842|NCT04112147|Ubiquinone|ubiquinone|mesh-list
154591024|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591025|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154591026|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591027|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
154591028|NCT02319161|Calcium|calcium|mesh-list
154591029|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154591030|NCT02319161|Esmolol|esmolol|mesh-list
154591031|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154591032|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591033|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154591034|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
154591035|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591036|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591037|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591038|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154591039|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
154591040|NCT02321579|Pyridoxal|pyridoxal|mesh-list
154591041|NCT02321579|Pyridoxine|pyridoxine|mesh-list
154591042|NCT02321579|Vitamins|vitamins|mesh-ancestor
154591043|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
154591044|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591045|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
154591046|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
154591047|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154591048|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154591049|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
154591050|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
154591051|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591052|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591053|NCT03109691|Dexamethasone|dexamethasone|mesh-list
154591054|NCT03109691|Bupivacaine|bupivacaine|mesh-list
154591055|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591056|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
154591057|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
154591058|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591059|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591060|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154591061|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
154591062|NCT03109691|Hormones|hormones|mesh-ancestor
154591063|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591064|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154591065|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591066|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
154591067|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
154591068|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591069|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
154591070|NCT03497351|Nicardipine|nicardipine|mesh-list
154591071|NCT03497351|Urapidil|urapidil|mesh-list
154591072|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154591073|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154591074|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591075|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591076|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154591077|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591078|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
154591079|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154591080|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
154591081|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591082|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154591083|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154591084|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154591085|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
154591086|NCT02223364|Bupivacaine|bupivacaine|mesh-list
154591087|NCT02223364|Ropivacaine|ropivacaine|mesh-list
154591088|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
154591089|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
154591090|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591091|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591092|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
154591093|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591094|NCT01378975|Vemurafenib|vemurafenib|mesh-list
154591095|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591096|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154591097|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591098|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591099|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
154591100|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154591101|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154591102|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591103|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
154591104|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591105|NCT03499457|Amoxicillin|amoxicillin|mesh-list
154591106|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154591107|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591108|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
154591109|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154591110|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
154591111|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154591112|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591113|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154591114|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154591115|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154591117|NCT02322203|Niacinamide|niacinamide|mesh-list
154591118|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
154591119|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154591120|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
154591121|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591122|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154591123|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
154591124|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
154591125|NCT02322203|Vitamins|vitamins|mesh-ancestor
154591126|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
154591127|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591128|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154591129|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154591130|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154591131|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
154591132|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154591133|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154591134|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591135|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
154591136|NCT04691362|Coagulants|coagulants|mesh-ancestor
154591137|NCT03499223|Ranibizumab|ranibizumab|mesh-list
154591138|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154591139|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154591140|NCT03499223|Growth Substances|growth substances|mesh-ancestor
154591141|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591142|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
154591143|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591144|NCT02319707|Oxytocin|oxytocin|mesh-list
154591145|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
154591146|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154314961|NCT02118844|Rocuronium|rocuronium|mesh-list
154591147|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591148|NCT05398861|Bevacizumab|bevacizumab|mesh-list
154591149|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154591150|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591151|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154591152|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154591153|NCT05398861|Growth Substances|growth substances|mesh-ancestor
154591154|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591155|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
154591157|NCT02448329|Adavosertib|adavosertib|mesh-list
154591158|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154591159|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591160|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
154591161|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
154591162|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
154591163|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591164|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591165|NCT05398393|Tenofovir|tenofovir|mesh-list
154591166|NCT05398393|Amlodipine|amlodipine|mesh-list
154591167|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
154591168|NCT05398393|Atorvastatin|atorvastatin|mesh-list
154591169|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154591170|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154591171|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
154591172|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591173|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154591174|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154862345|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154862346|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
154591175|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591176|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
154591177|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591178|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154591179|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154591180|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154591181|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154591182|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154591183|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154591184|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591185|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154591186|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591187|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
154591188|NCT02319941|Clopidogrel|clopidogrel|mesh-list
154591189|NCT02319941|Ticagrelor|ticagrelor|mesh-list
154591190|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154591191|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154591192|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154591193|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154591194|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
154591195|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591196|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591197|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591198|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
154591199|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
154591200|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154591201|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591202|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591203|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154591204|NCT05164627|Analgesics|analgesics|mesh-ancestor
154591205|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
154591206|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591207|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154591208|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154591209|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154591210|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154591211|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591212|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591213|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
154591214|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154591215|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
154591216|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154591217|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591218|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154315037|NCT03743883|Aspirin|aspirin|mesh-list
154591220|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154591221|NCT02322671|Montelukast|montelukast|mesh-list
154591222|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154591223|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
154591224|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154591225|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
154591226|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591227|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591228|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154591229|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154591230|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591231|NCT05096143|Valsartan|valsartan|mesh-list
154591232|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154591233|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154591234|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154591235|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154591236|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591237|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
154591238|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
154591239|NCT03494387|Antioxidants|antioxidants|mesh-list
154591240|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
154591241|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591242|NCT03494387|Expectorants|expectorants|mesh-ancestor
154591243|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
154591244|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154591245|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591246|NCT03494387|Protective Agents|protective agents|mesh-ancestor
154591247|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591249|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
154591250|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154591251|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154591252|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591253|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591254|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
154591255|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591256|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591257|NCT02324621|TIC10 compound|tic10 compound|mesh-list
154591258|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591259|NCT03821545|Lidocaine|lidocaine|mesh-list
154591260|NCT03821545|Ketamine|ketamine|mesh-list
154591261|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
154591262|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
154591263|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591264|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591265|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
154591266|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591267|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154591268|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154591269|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154591270|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591271|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591272|NCT03821545|Analgesics|analgesics|mesh-ancestor
154591273|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154591274|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154591275|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
154591276|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154591277|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154591278|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591279|NCT02324933|Fentanyl|fentanyl|mesh-list
154591280|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154591281|NCT02324933|Narcotics|narcotics|mesh-ancestor
154591282|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591283|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591284|NCT02324933|Analgesics|analgesics|mesh-ancestor
154591285|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
154591286|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591287|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154591288|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154591289|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
154591290|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
154591291|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
154591292|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154591293|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
154591294|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154591295|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591296|NCT01378117|Incretins|incretins|mesh-ancestor
154591297|NCT01378117|Hormones|hormones|mesh-ancestor
154591298|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591299|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154591300|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
154591301|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591302|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591303|NCT02323139|Azacitidine|azacitidine|mesh-list
154591304|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154591305|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
154591306|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591307|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591308|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591309|NCT02325245|Metformin|metformin|mesh-list
154591310|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154591311|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591312|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
154591313|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154591314|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154591315|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591316|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
154591317|NCT02323373|Coagulants|coagulants|mesh-ancestor
154591318|NCT02325479|Enoxaparin|enoxaparin|mesh-list
154591319|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
154591320|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154591321|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154591322|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591323|NCT05236231|Tadalafil|tadalafil|mesh-list
154591324|NCT05236231|Macitentan|macitentan|mesh-list
154591325|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
154591326|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154591327|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154591328|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591329|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591330|NCT05236231|Urological Agents|urological agents|mesh-ancestor
154591331|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154591332|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154591333|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154591334|NCT03495323|Prexasertib|prexasertib|mesh-list
154591335|NCT03495323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154591336|NCT03495323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591337|NCT03495323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591338|NCT02323451|Chitosan|chitosan|mesh-list
154591339|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
154591340|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154591341|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
154591342|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591343|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
154591344|NCT02323451|Protective Agents|protective agents|mesh-ancestor
154591345|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154591346|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154591347|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
154591348|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591349|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154591350|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
154591351|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
154591352|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
154591353|NCT02323451|Coagulants|coagulants|mesh-ancestor
154591354|NCT02323529|Nitisinone|nitisinone|mesh-list
154591355|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591356|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591357|NCT02323607|Cytarabine|cytarabine|mesh-list
154591358|NCT02323607|Decitabine|decitabine|mesh-list
154591359|NCT02323607|Daunorubicin|daunorubicin|mesh-list
154591360|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154591361|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
154591362|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591363|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591364|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
154315191|NCT00180479|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154591365|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591366|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154591368|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591369|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154591370|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154591371|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154591372|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591373|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
154591374|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
154591375|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591376|NCT03493841|Protective Agents|protective agents|mesh-ancestor
154591377|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591378|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
154591379|NCT03493841|Vitamins|vitamins|mesh-ancestor
154591380|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
154591381|NCT05118737|Colchicine|colchicine|mesh-list
154591382|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
154591383|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154591384|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
154591385|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
154591386|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
154591387|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591388|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591389|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
154591390|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154591391|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154591392|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591393|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
154862347|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154591394|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591395|NCT03491579|Cytarabine|cytarabine|mesh-list
154591396|NCT03491579|Cladribine|cladribine|mesh-list
154591397|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154591398|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
154591399|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591400|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591401|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
154591402|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591403|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154591404|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
154591405|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591407|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
154591408|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591409|NCT03492593|Beta Carotene|beta carotene|mesh-list
154591410|NCT03492593|Lycopene|lycopene|mesh-list
154591411|NCT03492593|Carotenoids|carotenoids|mesh-list
154591412|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591413|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
154591414|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591415|NCT03492593|Protective Agents|protective agents|mesh-ancestor
154591416|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591417|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154591418|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154591419|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591420|NCT03492593|Provitamins|provitamins|mesh-ancestor
154591421|NCT03492593|Vitamins|vitamins|mesh-ancestor
154591422|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
154591423|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
154591424|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
154591425|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154591426|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154591427|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591428|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591429|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591430|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154591431|NCT03914885|Fludarabine|fludarabine|mesh-list
154591432|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154591433|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591434|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591435|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154591436|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
154591437|NCT03779243|Melatonin|melatonin|mesh-list
154591438|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
154591439|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591440|NCT03779243|Protective Agents|protective agents|mesh-ancestor
154591441|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591442|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591443|NCT03757013|Apremilast|apremilast|mesh-list
154591444|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154591445|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154591446|NCT03757013|Analgesics|analgesics|mesh-ancestor
154591447|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
154591448|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591449|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591450|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591451|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154591452|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154591453|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154591454|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591455|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591456|NCT02736409|Budesonide|budesonide|mesh-list
154591457|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591458|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154591459|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
154591460|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591461|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591462|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154591463|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
154591464|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
154591465|NCT02736409|Hormones|hormones|mesh-ancestor
154591466|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591467|NCT05396677|Acetaminophen|acetaminophen|mesh-list
154591468|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154591469|NCT05396677|Analgesics|analgesics|mesh-ancestor
154591470|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
154591471|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591472|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591473|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
154591474|NCT05131867|Nimodipine|nimodipine|mesh-list
154591475|NCT05131867|Milrinone|milrinone|mesh-list
154591476|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154591477|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154591478|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
154591479|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154591480|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154591481|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591482|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591483|NCT05131867|Protective Agents|protective agents|mesh-ancestor
154591484|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591485|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154591486|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154591487|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591488|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154591489|NCT02837783|Linaclotide|linaclotide|mesh-list
154591490|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154591491|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
154591492|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591493|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154591494|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154591495|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154591496|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154591497|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591498|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591499|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
154591500|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591501|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591502|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154591503|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591504|NCT05007145|Paclitaxel|paclitaxel|mesh-list
154591505|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154591506|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154591507|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154591508|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591509|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
154591510|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
154591511|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
154591512|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591513|NCT05007145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154591514|NCT04952857|Vitamin D|vitamin d|mesh-list
154591515|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
154591516|NCT04952857|Vitamins|vitamins|mesh-ancestor
154591517|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
154591518|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591519|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154591520|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154591521|NCT02220712|Aripiprazole|aripiprazole|mesh-list
154591522|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
154591523|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154591524|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154591525|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154078344|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
154591526|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591527|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591528|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
154591529|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
154591530|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591531|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591532|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154591533|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154591534|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
154591535|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154591536|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154591537|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154591538|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154591539|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
154591540|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154591541|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591542|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154591543|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591544|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
154591545|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
154591546|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
154591547|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591548|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591549|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154591550|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154591551|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
154591552|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
154591553|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591554|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591555|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
154591556|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154591557|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591558|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591559|NCT00846430|Interferons|interferons|mesh-list
154591560|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
154591561|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
154591562|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154591563|NCT00846430|Celecoxib|celecoxib|mesh-list
154591564|NCT00846430|Vincristine|vincristine|mesh-list
154591565|NCT00846430|Temozolomide|temozolomide|mesh-list
154591566|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591567|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
154591568|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591569|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154591570|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
154591571|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
154591572|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
154591573|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591574|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154591575|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
154591576|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
154591577|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591578|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154591579|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154591580|NCT00846430|Analgesics|analgesics|mesh-ancestor
154591581|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
154591582|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591583|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591584|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154591585|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154591586|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154591587|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591588|NCT05439577|Heparinoids|heparinoids|mesh-list
154591589|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
154591590|NCT05439577|Hormones|hormones|mesh-ancestor
154591591|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591592|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591593|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591595|NCT05385523|Dexamethasone|dexamethasone|mesh-list
154591596|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591597|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
154591598|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
154591599|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591600|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591601|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154591602|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
154591603|NCT05385523|Hormones|hormones|mesh-ancestor
154591604|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591605|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154591606|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591607|NCT03910621|Miglustat|miglustat|mesh-list
154591608|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591609|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591610|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154591611|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154591612|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
154591613|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591614|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154591615|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154591616|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591617|NCT02218372|Vancomycin|vancomycin|mesh-list
154591618|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
154591619|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154591620|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591621|NCT02217982|Simethicone|simethicone|mesh-list
154591622|NCT02217982|Loperamide|loperamide|mesh-list
154591623|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
154591624|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154591625|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
154591626|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591627|NCT02217982|Emollients|emollients|mesh-ancestor
154591628|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591629|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
154591630|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154591631|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
154591632|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591633|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
154591634|NCT02207608|Protective Agents|protective agents|mesh-ancestor
154591635|NCT03530995|Itraconazole|itraconazole|mesh-list
154591636|NCT03530995|Rifampin|rifampin|mesh-list
154591637|NCT03530995|Omeprazole|omeprazole|mesh-list
154591638|NCT03530995|Rabeprazole|rabeprazole|mesh-list
154591639|NCT03530995|Belumosudil|belumosudil|mesh-list
154591640|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154591641|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154591642|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154591643|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591644|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591645|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
154591646|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591647|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154591648|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154591649|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154591650|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
154591651|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591652|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591653|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154591654|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154591655|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
154591656|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154591657|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
154591658|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154591659|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154591660|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154591661|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154591662|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154591663|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154591664|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154591665|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154591666|NCT02207530|Durvalumab|durvalumab|mesh-list
154591667|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154591668|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591669|NCT05359315|Interferons|interferons|mesh-list
154591670|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
154591671|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591672|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
154591673|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591674|NCT02616055|XL647|xl647|mesh-list
154591675|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591676|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154591677|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591678|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591679|NCT02207374|Semaglutide|semaglutide|mesh-list
154591680|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154591681|NCT02207374|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154591682|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154591683|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591684|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
154862348|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154862349|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862350|NCT03017807|Antibodies|antibodies|mesh-list
154862351|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
154862352|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862353|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
154862354|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154862355|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154862356|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154862357|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154862358|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862359|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
154591685|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591686|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591687|NCT02786537|Ritonavir|ritonavir|mesh-list
154591688|NCT02786537|Ribavirin|ribavirin|mesh-list
154591689|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
154591690|NCT02786537|Grazoprevir|grazoprevir|mesh-list
154591691|NCT02786537|Ledipasvir|ledipasvir|mesh-list
154591692|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154591693|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154591694|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154591695|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
154591696|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591697|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591698|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154591699|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154591700|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
154591701|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591702|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154591703|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154591704|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
154591705|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
154591706|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154591707|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591708|NCT03307759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154591709|NCT03307759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591710|NCT03466645|Vancomycin|vancomycin|mesh-list
154591711|NCT03466645|Cefazolin|cefazolin|mesh-list
154591712|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154591713|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591714|NCT04461665|Vitamin D|vitamin d|mesh-list
154591715|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
154591716|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
154591717|NCT04461665|Vitamins|vitamins|mesh-list
154591718|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
154591719|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591720|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154591721|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154591722|NCT02252536|Gabapentin|gabapentin|mesh-list
154591723|NCT02252536|Analgesics|analgesics|mesh-ancestor
154591724|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
154591725|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591726|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591727|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
154591728|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154591729|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154591730|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591731|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154591732|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154591733|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154591734|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591735|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591736|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
154591737|NCT03490487|Prednisolone|prednisolone|mesh-list
154591738|NCT03490487|Carbamazepine|carbamazepine|mesh-list
154591739|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
154591740|NCT03490487|Levetiracetam|levetiracetam|mesh-list
154591741|NCT03490487|Valproic Acid|valproic acid|mesh-list
154591742|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
154591743|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591745|NCT03490487|Hormones|hormones|mesh-ancestor
154591746|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591747|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591748|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154591749|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591750|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591751|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
154591752|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591753|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591754|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
154591755|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591756|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
154591757|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154591758|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591759|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154591760|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154591761|NCT03490487|Analgesics|analgesics|mesh-ancestor
154591762|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
154591763|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154591764|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591765|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154591766|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154591767|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154591768|NCT05271331|Anesthetics|anesthetics|mesh-list
154591769|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
154591770|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591771|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591772|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
154591773|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591774|NCT03466567|Semaglutide|semaglutide|mesh-list
154591775|NCT03466567|Cyclosporine|cyclosporine|mesh-list
154591776|NCT03466567|Probenecid|probenecid|mesh-list
154591777|NCT03466567|Cyclosporins|cyclosporins|mesh-list
154591778|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591779|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591780|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154591781|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
154591782|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591783|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
154591784|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591785|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591786|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154591787|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154591788|NCT03466567|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154591789|NCT03466567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154591790|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
154591791|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
154591792|NCT03130153|Aspirin|aspirin|mesh-list
154591793|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
154591794|NCT03130153|Salicylates|salicylates|mesh-list
154591795|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154591796|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154591797|NCT03130153|Analgesics|analgesics|mesh-ancestor
154591798|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
154591799|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591800|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591801|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591802|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154591803|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154591804|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154591805|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591806|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154591807|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154591808|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591809|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
154591810|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591811|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
154591812|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
154591813|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591814|NCT03466333|Enalapril|enalapril|mesh-list
154591815|NCT03466333|Enalaprilat|enalaprilat|mesh-list
154315657|NCT02124850|Nivolumab|nivolumab|mesh-list
154591816|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591817|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591818|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154591819|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
154591820|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154591821|NCT05382715|Ozanimod|ozanimod|mesh-list
154591822|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154591823|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591824|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154591825|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
154591826|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591827|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
154591828|NCT03492047|Paclitaxel|paclitaxel|mesh-list
154591829|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154591830|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154591831|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591832|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
154591833|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
154591834|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
154862360|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591835|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591836|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
154591837|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591838|NCT03492047|Expectorants|expectorants|mesh-ancestor
154591839|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154591840|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154591841|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
154591842|NCT03492047|Protective Agents|protective agents|mesh-ancestor
154591843|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591844|NCT03492047|Antidotes|antidotes|mesh-ancestor
154591845|NCT02251990|Grazoprevir|grazoprevir|mesh-list
154591846|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154591847|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
154591848|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591849|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
154591850|NCT03490097|Simvastatin|simvastatin|mesh-list
154591851|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154591852|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154591853|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
154591854|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591855|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154591856|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154591857|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591858|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
154591859|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591860|NCT04453735|Atorvastatin|atorvastatin|mesh-list
154591861|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154591862|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154591863|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
154591864|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591865|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154591866|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154591867|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591868|NCT03490019|Metformin|metformin|mesh-list
154591869|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154591870|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591871|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
154591872|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
154591873|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591874|NCT03491969|Protective Agents|protective agents|mesh-ancestor
154078705|NCT00802529|Prednisolone|prednisolone|mesh-list
154591875|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591876|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
154591877|NCT03491969|Vitamins|vitamins|mesh-ancestor
154591878|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
154591879|NCT05349409|Fluzoparib|fluzoparib|mesh-list
154591880|NCT05349409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154591881|NCT05349409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591882|NCT05349409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591883|NCT05349409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591884|NCT02251912|Oxytocin|oxytocin|mesh-list
154591885|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
154591886|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154591887|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591888|NCT01976273|Glycolic acid|glycolic acid|mesh-list
154591889|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
154591890|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591891|NCT02206048|Proflavine|proflavine|mesh-list
154591892|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154591893|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591895|NCT03466021|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154591896|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154591897|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591898|NCT03466021|Incretins|incretins|mesh-ancestor
154591899|NCT03466021|Hormones|hormones|mesh-ancestor
154591900|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154591901|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154591902|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591903|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
154862361|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862362|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154862363|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862364|NCT03017495|Midazolam|midazolam|mesh-list
154862365|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154862366|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154862367|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591904|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154591905|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154591906|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591907|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154591908|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154591909|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
154591910|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591911|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154591912|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
154591913|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591914|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154591915|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154591916|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591917|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
154591918|NCT03489005|Zamicastat|zamicastat|mesh-list
154591919|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154591920|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591921|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154591922|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154591923|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591924|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591925|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591926|NCT02215252|Pregabalin|pregabalin|mesh-list
154591927|NCT02215252|Analgesics|analgesics|mesh-ancestor
154591928|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
154591929|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591930|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591931|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
154591932|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154591933|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591934|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591935|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154591936|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154591937|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154591938|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591939|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154591940|NCT04894721|Ivermectin|ivermectin|mesh-list
154591941|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154591942|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591943|NCT02204410|Methylphenidate|methylphenidate|mesh-list
154591944|NCT02204410|Amphetamine|amphetamine|mesh-list
154591945|NCT02204410|Adderall|adderall|mesh-list
154591946|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
154591947|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154591948|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591949|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154591950|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154591951|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154591952|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591953|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
154591954|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154591955|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
154591956|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
154591957|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591958|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
154591959|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154591960|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154591961|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
154591962|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591963|NCT03461575|Cyclosporine|cyclosporine|mesh-list
154591964|NCT03461575|Cyclosporins|cyclosporins|mesh-list
154591965|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591966|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591967|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154591968|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
154591969|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862368|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862369|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154862370|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154862371|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154862372|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154862373|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
154862374|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
154862375|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
154591970|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
154591971|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591972|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
154591973|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154591974|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154591976|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154591977|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154591978|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591979|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591980|NCT02213380|Anesthetics|anesthetics|mesh-list
154591981|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154591982|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591983|NCT03488147|Esomeprazole|esomeprazole|mesh-list
154591984|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154591985|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154591986|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154591987|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154591988|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154591989|NCT03797261|Venetoclax|venetoclax|mesh-list
154591990|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154591991|NCT02202850|Etanercept|etanercept|mesh-list
154591992|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154591993|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154591994|NCT02202850|Analgesics|analgesics|mesh-ancestor
154591995|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
154591996|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154591997|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154591998|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154591999|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154592000|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154592001|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154592002|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
154592003|NCT03489395|Edoxaban|edoxaban|mesh-list
154592004|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154592005|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
154592006|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154592007|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154592008|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592009|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592010|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
154592011|NCT03489317|Metformin|metformin|mesh-list
154592012|NCT03489317|Amlodipine|amlodipine|mesh-list
154592013|NCT03489317|Simvastatin|simvastatin|mesh-list
154592014|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154592015|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592016|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154592017|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154592018|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154592019|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592020|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154592021|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
154592022|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154592023|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154592024|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
154592025|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154592026|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154592027|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592028|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
154592029|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154592030|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
154592031|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592032|NCT02212678|Expectorants|expectorants|mesh-ancestor
154592033|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
154592034|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154592035|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
154592036|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592037|NCT02212678|Protective Agents|protective agents|mesh-ancestor
154592038|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592039|NCT02212678|Antidotes|antidotes|mesh-ancestor
154315868|NCT06148025|Vancomycin|vancomycin|mesh-list
154592040|NCT03489239|Tenofovir|tenofovir|mesh-list
154592041|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
154592042|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592043|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154592044|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154592045|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592046|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592047|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154592048|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154592049|NCT03489161|Buprenorphine|buprenorphine|mesh-list
154592050|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154592051|NCT03489161|Narcotics|narcotics|mesh-ancestor
154592052|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592053|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592054|NCT03489161|Analgesics|analgesics|mesh-ancestor
154592055|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
154592056|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592057|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154592058|NCT04804709|Panobinostat|panobinostat|mesh-list
154592059|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592060|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154592061|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078932|NCT00756938|Losartan|losartan|mesh-list
154592062|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592063|NCT04690673|Acetaminophen|acetaminophen|mesh-list
154592064|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154592065|NCT04690673|Analgesics|analgesics|mesh-ancestor
154592066|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
154592067|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592068|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592069|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
154592071|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154592072|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
154592073|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592074|NCT04388501|Atorvastatin|atorvastatin|mesh-list
154592075|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154592076|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154592077|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
154592078|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592079|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154592080|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154592081|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592082|NCT02249182|Ribavirin|ribavirin|mesh-list
154592083|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
154592084|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154592085|NCT02249182|Ledipasvir|ledipasvir|mesh-list
154592086|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
154592087|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592088|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
154592089|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592090|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154592091|NCT03487211|Escitalopram|escitalopram|mesh-list
154592092|NCT03487211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154592093|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154592094|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154592095|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592096|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592097|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
154592098|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592099|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592100|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
154592101|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154592102|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154592103|NCT03487211|Analgesics|analgesics|mesh-ancestor
154592104|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
154592105|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
154592106|NCT03487133|Dexamethasone|dexamethasone|mesh-list
154862376|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
154862377|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154862378|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862379|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154862380|NCT01039207|Rilotumumab|rilotumumab|mesh-list
154862381|NCT01039207|Antibodies|antibodies|mesh-list
154862382|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
154862383|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154862384|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
154862385|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862386|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862387|NCT01125163|Iron|iron|mesh-list
154862388|NCT01125163|Trace Elements|trace elements|mesh-ancestor
154592107|NCT03487133|Bortezomib|bortezomib|mesh-list
154592108|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592109|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
154592110|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
154592111|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592112|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592113|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154592114|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
154592115|NCT03487133|Hormones|hormones|mesh-ancestor
154592116|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592117|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154592118|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592119|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154592120|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154592121|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154592122|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154592123|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592124|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592125|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592126|NCT02248480|Analgesics|analgesics|mesh-ancestor
154592127|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
154592128|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592129|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
154592130|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154592131|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
154592132|NCT01653158|Docetaxel|docetaxel|mesh-list
154592133|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592134|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
154592135|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
154592136|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
154592137|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592138|NCT00701207|Nicotine|nicotine|mesh-list
154592139|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154592140|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
154592141|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592142|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592143|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154592144|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154592145|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
154592146|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592147|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592148|NCT02247466|Rocuronium|rocuronium|mesh-list
154592149|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154592150|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154592151|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154592152|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592153|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592154|NCT03417479|Gabapentin|gabapentin|mesh-list
154592155|NCT03417479|Analgesics|analgesics|mesh-ancestor
154592156|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
154592157|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592158|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592159|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
154592160|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154592161|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154592162|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592163|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154592164|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154592165|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154592166|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592167|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592168|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
154592169|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
154592170|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
154592171|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154592172|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154592173|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592174|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
154592175|NCT03317795|Coagulants|coagulants|mesh-ancestor
154592176|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154592177|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
154592178|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154592179|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592180|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154592181|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154592182|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154592184|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592185|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154592186|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154316009|NCT06065176|Vaccines|vaccines|mesh-list
154592187|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154592188|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
154592189|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592190|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592191|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154592192|NCT03876119|Plasminogen|plasminogen|mesh-list
154592193|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154592194|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154592195|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592196|NCT02455076|Exenatide|exenatide|mesh-list
154592197|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
154592198|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154592199|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592200|NCT02455076|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154592201|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154592202|NCT02455076|Incretins|incretins|mesh-ancestor
154592203|NCT02455076|Hormones|hormones|mesh-ancestor
154592204|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592205|NCT02432846|Sunitinib|sunitinib|mesh-list
154592206|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592207|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154592208|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154592209|NCT02432846|Growth Substances|growth substances|mesh-ancestor
154592210|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592211|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
154592212|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592213|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592214|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592215|NCT03486509|Afatinib|afatinib|mesh-list
154592216|NCT03486509|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154592217|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592218|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592219|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592220|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592221|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154592222|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
154592223|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592224|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154592225|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154592226|NCT04928222|Doxorubicin|doxorubicin|mesh-list
154592227|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154592228|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592229|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154592230|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154592231|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592232|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592233|NCT00805961|Bevacizumab|bevacizumab|mesh-list
154592234|NCT00805961|Everolimus|everolimus|mesh-list
154592235|NCT00805961|Temozolomide|temozolomide|mesh-list
154592236|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154592237|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592238|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154592239|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154592240|NCT00805961|Growth Substances|growth substances|mesh-ancestor
154592241|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592242|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
154592243|NCT00805961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154592244|NCT00805961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592245|NCT00805961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592246|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592247|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154592248|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
154592249|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154592250|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
154592251|NCT02454608|Verapamil|verapamil|mesh-list
154592252|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154592253|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154592254|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154592255|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592256|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154592257|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592258|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
154592259|NCT05152355|Budesonide|budesonide|mesh-list
154592260|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592261|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154592262|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
154592263|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592264|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592265|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154592266|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
154592267|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
154592268|NCT05152355|Hormones|hormones|mesh-ancestor
154592269|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592270|NCT02246764|Timolol|timolol|mesh-list
154592271|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154592272|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154592273|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592274|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154592275|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154592276|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
154592277|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592278|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592279|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154592280|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154592281|NCT03484091|Hylan|hylan|mesh-list
154592282|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
154592283|NCT03484091|Protective Agents|protective agents|mesh-ancestor
154592284|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592285|NCT03486353|Azacitidine|azacitidine|mesh-list
154592286|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154592287|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
154592288|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592289|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592290|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592291|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154592292|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154592293|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154592294|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154592295|NCT02431676|Metformin|metformin|mesh-list
154592296|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154592297|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592298|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154592299|NCT03483545|Hormones|hormones|mesh-ancestor
154592300|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592301|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592302|NCT03483389|Ethanol|ethanol|mesh-list
154592303|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154592304|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592305|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592306|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592307|NCT03486119|Nivolumab|nivolumab|mesh-list
154592308|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154592309|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592310|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154592311|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592312|NCT02523833|Albuterol|albuterol|mesh-list
154592313|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154592314|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
154592315|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592316|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592317|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154592318|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
154592319|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
154592320|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154592321|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154592322|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154592323|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154592324|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
154592325|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592326|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592327|NCT04234529|Caffeine|caffeine|mesh-list
154592328|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154592329|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592330|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154592331|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592332|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592333|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154592334|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154592335|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
154592336|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592338|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154592339|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592340|NCT03481517|Bupivacaine|bupivacaine|mesh-list
154592341|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
154592342|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
154592343|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592344|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592345|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
154592346|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592347|NCT02429258|Metformin|metformin|mesh-list
154592348|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
154592349|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154592350|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592351|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154592352|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592353|NCT02201524|Abrocitinib|abrocitinib|mesh-list
154592354|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592355|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592356|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592357|NCT05153603|Olaparib|olaparib|mesh-list
154592358|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154592359|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592360|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592361|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592362|NCT02137252|Naltrexone|naltrexone|mesh-list
154592363|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154592364|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154592365|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592366|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
154592367|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592368|NCT05152667|Dienogest|dienogest|mesh-list
154592369|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
154592370|NCT05152667|Progestins|progestins|mesh-list
154592371|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154592372|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
154592373|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154592374|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592375|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154592376|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154592377|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154592378|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154592379|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154592380|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
154592381|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592382|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154592383|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592384|NCT05152667|Hormones|hormones|mesh-ancestor
154592385|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
154592386|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154592387|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592388|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592389|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154592390|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154592391|NCT05152511|Protective Agents|protective agents|mesh-ancestor
154592392|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592393|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
154592394|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154592395|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
154592396|NCT02568449|Nintedanib|nintedanib|mesh-list
154592397|NCT02568449|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154592398|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592399|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592400|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592401|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592402|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
154592403|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
154592404|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592405|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
154592406|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154592407|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
154592408|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
154592409|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592410|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592411|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154592412|NCT04884893|Analgesics|analgesics|mesh-ancestor
154592413|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
154592414|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592415|NCT03479879|Misoprostol|misoprostol|mesh-list
154592416|NCT03479879|Estradiol|estradiol|mesh-list
154592417|NCT03479879|Estrogens|estrogens|mesh-ancestor
154592418|NCT03479879|Hormones|hormones|mesh-ancestor
154592419|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592420|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592421|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154592422|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154592423|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
154592424|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154592425|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154592426|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
154592427|NCT03479411|Itraconazole|itraconazole|mesh-list
154592428|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154592429|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
154592430|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592431|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154592432|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154592433|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592434|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592435|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154592436|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
154592437|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592438|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592439|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154592440|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
154592441|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154592442|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592443|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592444|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154592445|NCT03131375|Analgesics|analgesics|mesh-ancestor
154592446|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
154592447|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592448|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154592449|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154592450|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154592451|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
154592452|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592453|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592454|NCT03475589|Apatinib|apatinib|mesh-list
154592455|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592456|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592457|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592458|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592459|NCT03478709|Norepinephrine|norepinephrine|mesh-list
154592460|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154592461|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154592462|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
154592463|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592464|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592465|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592466|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
154592467|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
154592468|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592469|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154592470|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
154592471|NCT03478475|Vitamin D|vitamin d|mesh-list
154079345|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154592472|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154862389|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
154592473|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592474|NCT03478475|Vitamins|vitamins|mesh-ancestor
154592475|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
154592476|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154592477|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154592478|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592479|NCT02523755|Ropivacaine|ropivacaine|mesh-list
154592480|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
154592481|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
154592482|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592483|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592484|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
154592485|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592486|NCT02168842|Isradipine|isradipine|mesh-list
154592487|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154592488|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154592489|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154592490|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592491|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154592492|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592493|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
154592494|NCT03347123|Nivolumab|nivolumab|mesh-list
154592495|NCT03347123|Ipilimumab|ipilimumab|mesh-list
154592496|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154592497|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592498|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154592499|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592500|NCT03131141|Lefamulin|lefamulin|mesh-list
154592501|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154592502|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592503|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154592504|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154592505|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592506|NCT03477929|Cetrorelix|cetrorelix|mesh-list
154592507|NCT03477929|Ganirelix|ganirelix|mesh-list
154592508|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
154592509|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592510|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592511|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154592512|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
154592513|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154592514|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154592515|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154592516|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592517|NCT03474263|Antibodies|antibodies|mesh-list
154592518|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154592519|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
154592520|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592521|NCT03477461|Terlipressin|terlipressin|mesh-list
154592522|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154592523|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154592524|NCT03473093|Pregabalin|pregabalin|mesh-list
154592525|NCT03473093|Morphine|morphine|mesh-list
154592526|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154592527|NCT03473093|Narcotics|narcotics|mesh-ancestor
154592528|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592529|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592530|NCT03473093|Analgesics|analgesics|mesh-ancestor
154592531|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
154592532|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592533|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
154592534|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154592535|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154592536|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592537|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154592538|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154592539|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154592540|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154592541|NCT02523131|Insulin|insulin|mesh-list
154592542|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154592543|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592544|NCT04339049|Lidocaine|lidocaine|mesh-list
154592545|NCT04339049|Misoprostol|misoprostol|mesh-list
154592546|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
154592547|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
154862390|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592548|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592549|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592550|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
154592551|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592552|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154592553|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154592554|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154316402|NCT05060731|Iron|iron|mesh-list
154592555|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154592556|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592557|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154592558|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
154592559|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154592560|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154592561|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154592562|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
154592563|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
154592564|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
154592565|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592566|NCT02133664|Protective Agents|protective agents|mesh-ancestor
154592567|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592568|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
154592569|NCT02133664|Vitamins|vitamins|mesh-ancestor
154592570|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
154592571|NCT02133352|Ranolazine|ranolazine|mesh-list
154592572|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154592573|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154592574|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592575|NCT04418128|Nafamostat|nafamostat|mesh-list
154592576|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154592577|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154592578|NCT04418128|Analgesics|analgesics|mesh-ancestor
154592579|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
154592580|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592581|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592582|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592583|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154592584|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
154592585|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
154592586|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592587|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592588|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154592589|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154592590|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154592591|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154592592|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
154592593|NCT02555657|Gemcitabine|gemcitabine|mesh-list
154592594|NCT02555657|Capecitabine|capecitabine|mesh-list
154592595|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
154592596|NCT02555657|Vinorelbine|vinorelbine|mesh-list
154592597|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154592598|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
154592599|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592600|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592601|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154592602|NCT02555657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154592603|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154592604|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
154592605|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
154592606|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
154592607|NCT02195518|Tenofovir|tenofovir|mesh-list
154592608|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
154592609|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592610|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154592611|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154592612|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592613|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592614|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154592615|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154592616|NCT03990077|Docetaxel|docetaxel|mesh-list
154592617|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592618|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
154862391|NCT03019991|Ritonavir|ritonavir|mesh-list
154592619|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
154592620|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
154592621|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592623|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
154592624|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
154592625|NCT03380507|Thiamine|thiamine|mesh-list
154592626|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
154592627|NCT03380507|Vitamins|vitamins|mesh-ancestor
154592628|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
154592629|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592630|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592631|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
154592632|NCT03471455|Itraconazole|itraconazole|mesh-list
154592633|NCT03471455|Terbinafine|terbinafine|mesh-list
154592634|NCT03471455|Isotretinoin|isotretinoin|mesh-list
154592635|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
154592636|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592637|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154592638|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154592639|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592640|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592641|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154592642|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
154592643|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592644|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592645|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154592646|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
154592647|NCT02824679|Scopolamine|scopolamine|mesh-list
154592648|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154592649|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154592650|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
154592651|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
154592652|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592653|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592654|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154592655|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
154592656|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154592657|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
154592658|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592659|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592660|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154592661|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
154592662|NCT03202667|Empagliflozin|empagliflozin|mesh-list
154592663|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154592664|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592665|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154592666|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592667|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
154592668|NCT02133742|Axitinib|axitinib|mesh-list
154592669|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154592670|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592671|NCT02133742|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154592672|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592673|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592674|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592675|NCT05157893|Analgesics|analgesics|mesh-list
154592676|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
154592677|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592678|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592679|NCT02523053|Fluorouracil|fluorouracil|mesh-list
154592680|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
154592681|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592682|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154592683|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592684|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154592685|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
154592686|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592687|NCT04457609|Azithromycin|azithromycin|mesh-list
154592688|NCT04457609|Oseltamivir|oseltamivir|mesh-list
154592689|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154592690|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592691|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
154592692|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592693|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862392|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154862393|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154592694|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
154592695|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154592696|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592697|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
154592698|NCT04457765|Povidone|povidone|mesh-list
154592699|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
154592700|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
154592701|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154592702|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592703|NCT03795233|Vancomycin|vancomycin|mesh-list
154592704|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154316539|NCT04685616|Mitogens|mitogens|mesh-list
154592705|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592706|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154592707|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
154592708|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154592709|NCT04503707|Hormones|hormones|mesh-ancestor
154592710|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592711|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592712|NCT03470597|Iodine|iodine|mesh-list
154592713|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154592714|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592715|NCT03470597|Trace Elements|trace elements|mesh-ancestor
154592716|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
154592717|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592718|NCT02522897|Ranibizumab|ranibizumab|mesh-list
154592719|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154592720|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154592721|NCT02522897|Growth Substances|growth substances|mesh-ancestor
154592722|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592723|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
154592724|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592725|NCT04351061|Acetazolamide|acetazolamide|mesh-list
154592726|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
154592727|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154592728|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592729|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592730|NCT04351061|Diuretics|diuretics|mesh-ancestor
154592731|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
154592732|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592733|NCT03130829|Fucoidan|fucoidan|mesh-list
154592734|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154592735|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154592736|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
154592737|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592738|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154592739|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
154592740|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
154592741|NCT04206761|Bromides|bromides|mesh-list
154592742|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
154592743|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592744|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
154592745|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154592746|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154592747|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154592748|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154592749|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
154592750|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592751|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592752|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592753|NCT03181529|Psilocybin|psilocybin|mesh-list
154592754|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
154592755|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592756|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154592757|NCT03668639|Dexamethasone|dexamethasone|mesh-list
154592758|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592759|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
154592760|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
154592761|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592762|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592763|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154592764|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
154862394|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154592765|NCT03668639|Hormones|hormones|mesh-ancestor
154592766|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592767|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154592768|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592769|NCT03470363|Sufentanil|sufentanil|mesh-list
154592770|NCT03470363|Bupivacaine|bupivacaine|mesh-list
154592771|NCT03470363|Sevoflurane|sevoflurane|mesh-list
154592772|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
154592773|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
154592774|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592775|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592776|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
154592777|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592778|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154592779|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154592780|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
154316616|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
154592781|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154592782|NCT03470363|Narcotics|narcotics|mesh-ancestor
154592783|NCT03470363|Analgesics|analgesics|mesh-ancestor
154592784|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154592785|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154592786|NCT03469895|Idelalisib|idelalisib|mesh-list
154592787|NCT03469895|Ibrutinib|ibrutinib|mesh-list
154592788|NCT03469895|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154592789|NCT03469895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592790|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592791|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592792|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592793|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
154592794|NCT05160623|Povidone|povidone|mesh-list
154592795|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
154592796|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
154592797|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154592798|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592799|NCT04713137|Erythritol|erythritol|mesh-list
154592800|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
154592801|NCT04456985|Folic Acid|folic acid|mesh-list
154592802|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
154592803|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
154592804|NCT04456985|Vitamins|vitamins|mesh-ancestor
154592805|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
154592806|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592807|NCT04456985|Hematinics|hematinics|mesh-ancestor
154592808|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
154592809|NCT03469583|Entecavir|entecavir|mesh-list
154592810|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
154592811|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592812|NCT05096039|Valsartan|valsartan|mesh-list
154592813|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154592814|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154592815|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154592816|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154592817|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592818|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
154592819|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154592820|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592821|NCT03361865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154592822|NCT03361865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592823|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154592824|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154592825|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
154592826|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592827|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592828|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154592829|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154592830|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154592831|NCT02421341|Fentanyl|fentanyl|mesh-list
154592832|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
154592833|NCT02421341|Analgesics|analgesics|mesh-list
154592834|NCT02421341|Narcotics|narcotics|mesh-ancestor
154592835|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154592836|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592837|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
154592838|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154592839|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154592840|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154592841|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
154592842|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
154592843|NCT02149121|Rituximab|rituximab|mesh-list
154592844|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154592845|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592846|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
154592847|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592848|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154592849|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
154592850|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154592851|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
154592852|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592853|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
154592854|NCT05161403|Protective Agents|protective agents|mesh-ancestor
154592855|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
154592856|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154592857|NCT03166085|Paclitaxel|paclitaxel|mesh-list
154592858|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
154592859|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154592860|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592861|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
154592862|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
154592863|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
154592864|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592865|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
154592866|NCT05390255|Omalizumab|omalizumab|mesh-list
154592867|NCT05390255|Hormones|hormones|mesh-list
154592868|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592869|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592870|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592871|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
154592872|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154592873|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154592874|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
154592875|NCT04456829|Resveratrol|resveratrol|mesh-list
154592876|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
154592877|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592878|NCT04456829|Protective Agents|protective agents|mesh-ancestor
154592879|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592880|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592881|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154592882|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
154592883|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154592884|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154592885|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
154592886|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592887|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592888|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592889|NCT02522221|Warfarin|warfarin|mesh-list
154592890|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
154592891|NCT05389943|Vitamin D|vitamin d|mesh-list
154592892|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
154592893|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
154592894|NCT05389943|Vitamins|vitamins|mesh-list
154592895|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
154592896|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592897|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154592898|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154592899|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
154592900|NCT02522975|Hematinics|hematinics|mesh-ancestor
154592901|NCT04508803|Trastuzumab|trastuzumab|mesh-list
154592902|NCT04508803|Niraparib|niraparib|mesh-list
154592903|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154592904|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592905|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154592906|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592907|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592908|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154592909|NCT03461185|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154592910|NCT03461185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154592911|NCT03461185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592912|NCT03461185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592913|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154592914|NCT03461185|Growth Substances|growth substances|mesh-ancestor
154592915|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592916|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
154592917|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592918|NCT04453423|Carboplatin|carboplatin|mesh-list
154862395|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592919|NCT04453423|Pemetrexed|pemetrexed|mesh-list
154592920|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592921|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592922|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592923|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154592924|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154592925|NCT04453189|Lansoprazole|lansoprazole|mesh-list
154592926|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
154592927|NCT04453189|Famotidine|famotidine|mesh-list
154592928|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154592929|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154592930|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154316766|NCT03805932|Hormones|hormones|mesh-ancestor
154592931|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592932|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592933|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154592934|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
154592935|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
154592936|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154592937|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592938|NCT03465085|Heparin|heparin|mesh-list
154592939|NCT03465085|Calcium heparin|calcium heparin|mesh-list
154592940|NCT03465085|Streptokinase|streptokinase|mesh-list
154592941|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
154592942|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154592943|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154592944|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592945|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
154592946|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592947|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
154592948|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154592949|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
154592950|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592951|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
154592952|NCT04453111|Protective Agents|protective agents|mesh-ancestor
154592953|NCT03468595|Listerine|listerine|mesh-list
154592954|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154592955|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592956|NCT04453345|Thalidomide|thalidomide|mesh-list
154592957|NCT04453345|Prednisone|prednisone|mesh-list
154592958|NCT04453345|Methotrexate|methotrexate|mesh-list
154592959|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154592960|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
154592961|NCT04453345|Hormones|hormones|mesh-ancestor
154592962|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154592963|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154592964|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154592965|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592966|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154592967|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
154592968|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154592969|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154592970|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
154592971|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592972|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
154592973|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154592974|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154592975|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154592976|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
154592977|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154592978|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154592979|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
154592980|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154592981|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154592982|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154592983|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154592984|NCT04453345|Growth Substances|growth substances|mesh-ancestor
154592985|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
154592986|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
154592987|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154592988|NCT03464539|Chitosan|chitosan|mesh-list
154592989|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154592990|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154592991|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
154592992|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154592993|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154592994|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
154592995|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
154592996|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
154592997|NCT03464539|Coagulants|coagulants|mesh-ancestor
154592998|NCT03460405|Vaccines|vaccines|mesh-list
154592999|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
154593000|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593001|NCT05166005|Vitamin D|vitamin d|mesh-list
154593002|NCT05166005|Vitamins|vitamins|mesh-ancestor
154593003|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
154593004|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593005|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154593006|NCT05165615|Insulin|insulin|mesh-list
154593007|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154316841|NCT03537742|Alirocumab|alirocumab|mesh-list
154593008|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593009|NCT03468439|Phenol|phenol|mesh-list
154593010|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154593011|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593012|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
154593013|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154593014|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154593015|NCT05165303|Lidocaine|lidocaine|mesh-list
154593016|NCT05165303|Propofol|propofol|mesh-list
154593017|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
154593018|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
154593019|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593020|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593021|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
154593022|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593023|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154593024|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154593025|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154593026|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154593027|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593028|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154593029|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154593030|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
154593031|NCT03376763|Aripiprazole|aripiprazole|mesh-list
154593032|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
154593033|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154593034|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154593035|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154593036|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593037|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593038|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
154593039|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
154593040|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593041|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593042|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154593043|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154593044|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
154593045|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154593046|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154593047|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154593048|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154593049|NCT05153135|Palbociclib|palbociclib|mesh-list
154593050|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593051|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593052|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593053|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593054|NCT04857307|Alprazolam|alprazolam|mesh-list
154593055|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154593056|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593057|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593058|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154593059|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154593060|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154593061|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
154593062|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
154593063|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593064|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593065|NCT03467893|Antacids|antacids|mesh-list
154593066|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862396|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862397|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154593067|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154593068|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
154593070|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593071|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593072|NCT03454945|Doxycycline|doxycycline|mesh-list
154593073|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154593074|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593075|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
154593076|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154593077|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154593078|NCT03453541|Ketorolac|ketorolac|mesh-list
154593079|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154593080|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154316919|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
154593081|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154593082|NCT03453541|Analgesics|analgesics|mesh-ancestor
154593083|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
154593084|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593085|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593086|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593087|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154593088|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154593089|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593090|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593091|NCT00893789|Modafinil|modafinil|mesh-list
154593092|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154593093|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593094|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154593095|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154593096|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154593097|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593098|NCT05322499|Paclitaxel|paclitaxel|mesh-list
154593099|NCT05322499|Docetaxel|docetaxel|mesh-list
154593100|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154593101|NCT05322499|Irinotecan|irinotecan|mesh-list
154593102|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154593103|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593104|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
154593105|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
154593106|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
154593107|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593108|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154593109|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154593110|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593111|NCT03449173|Sunitinib|sunitinib|mesh-list
154593112|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593113|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154593114|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154593115|NCT03449173|Growth Substances|growth substances|mesh-ancestor
154593116|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593117|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
154593118|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593119|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593120|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593121|NCT04760041|Midazolam|midazolam|mesh-list
154593122|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154593123|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154593124|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593125|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593126|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154593127|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154593128|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154593129|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154593130|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
154593131|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
154593132|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
154593133|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
154593134|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593135|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593136|NCT05322265|Epinephrine|epinephrine|mesh-list
154593137|NCT05322265|Racepinephrine|racepinephrine|mesh-list
154593138|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
154593139|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154593140|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154593142|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593143|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593144|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593145|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154593146|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154593147|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
154593148|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593149|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154593150|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
154593151|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
154593152|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
154593153|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154593154|NCT02164864|Aspirin|aspirin|mesh-list
154593155|NCT02164864|Warfarin|warfarin|mesh-list
154593156|NCT02164864|Dabigatran|dabigatran|mesh-list
154316993|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
154593157|NCT02164864|Clopidogrel|clopidogrel|mesh-list
154593158|NCT02164864|Ticagrelor|ticagrelor|mesh-list
154593159|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154593160|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154593161|NCT02164864|Analgesics|analgesics|mesh-ancestor
154593162|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
154593163|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593164|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593165|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593166|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154593167|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154593168|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154593169|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593170|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154593171|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154593172|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593173|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
154593174|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154593175|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154593176|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154593177|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
154593178|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593179|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
154593180|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
154593181|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154593182|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
154593183|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154593184|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154593185|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154593186|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593187|NCT05386589|Molnupiravir|molnupiravir|mesh-list
154593188|NCT05386589|Antiviral Agents|antiviral agents|mesh-ancestor
154593189|NCT05386589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593190|NCT01998529|Cisplatin|cisplatin|mesh-list
154593191|NCT01998529|Amifostine|amifostine|mesh-list
154593192|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593193|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154593194|NCT01998529|Protective Agents|protective agents|mesh-ancestor
154593195|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593196|NCT03448705|Vaccines|vaccines|mesh-list
154593197|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
154593198|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593199|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
154593200|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154593201|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
154593202|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593203|NCT03448549|Capecitabine|capecitabine|mesh-list
154593204|NCT03448549|Tegafur|tegafur|mesh-list
154593205|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
154593206|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154593207|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
154593208|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593209|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593210|NCT03679091|Clopidogrel|clopidogrel|mesh-list
154593211|NCT03679091|Ticagrelor|ticagrelor|mesh-list
154593212|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154593213|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154593214|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154593215|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154593216|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
154593217|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593218|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593219|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593220|NCT01628926|Ropinirole|ropinirole|mesh-list
154593221|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154593222|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154593223|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
154593224|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
154593225|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593226|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593227|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593228|NCT05313659|Ketamine|ketamine|mesh-list
154593229|NCT05313659|Analgesics|analgesics|mesh-ancestor
154593230|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
154317067|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
154593231|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593232|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593233|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154593234|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154593235|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
154593236|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
154593237|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593238|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154593239|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154593240|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080157|NCT02579187|Anesthetics|anesthetics|mesh-list
154593241|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593242|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
154593243|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154593244|NCT05322187|Lenvatinib|lenvatinib|mesh-list
154593245|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154593246|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593247|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593248|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593249|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593250|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
154593251|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
153546657|NCT06001385|Melphalan|melphalan|mesh-list
154080197|NCT06240039|Hormones|hormones|mesh-ancestor
154593252|NCT03436199|Amantadine|amantadine|mesh-list
154593253|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154593254|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154593255|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
154593256|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593257|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
154593258|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593259|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593260|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593261|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154593262|NCT03436199|Analgesics|analgesics|mesh-ancestor
154593263|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
154080208|NCT06239727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459021|NCT04765098|Tamoxifen|tamoxifen|mesh-list
154593264|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593265|NCT02131324|Clobetasol|clobetasol|mesh-list
154593266|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593267|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
154593268|NCT02131324|Hormones|hormones|mesh-ancestor
154593269|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154593270|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593271|NCT04749394|Apatinib|apatinib|mesh-list
154593272|NCT04749394|Antibodies|antibodies|mesh-list
154593273|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
154593274|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154593275|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
154593276|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593277|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593278|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593279|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593280|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593281|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
154593282|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154593283|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
154080240|NCT06239311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154593284|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593285|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154593286|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154593287|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
154593288|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593289|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593290|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154593291|NCT05159219|Colchicine|colchicine|mesh-list
154593292|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
154593293|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154593294|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
154593295|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
154593296|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
154593297|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593298|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593299|NCT05321329|Capecitabine|capecitabine|mesh-list
154593300|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154593301|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
154593302|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593303|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317143|NCT02196961|Nivolumab|nivolumab|mesh-list
154593304|NCT02521831|Bupivacaine|bupivacaine|mesh-list
154593305|NCT02521831|Anesthetics|anesthetics|mesh-list
154593306|NCT02521831|Isoflurane|isoflurane|mesh-list
154593307|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
154593308|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593309|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593310|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
154593311|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593312|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154593313|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
154593314|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
154593315|NCT03447925|Salicylates|salicylates|mesh-list
154593316|NCT03447925|Petrolatum|petrolatum|mesh-list
154593317|NCT03447925|Emollients|emollients|mesh-ancestor
154593318|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080259|NCT06238934|Viscosupplements|viscosupplements|mesh-ancestor
154080260|NCT06238934|Protective Agents|protective agents|mesh-ancestor
154593319|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154593320|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154593321|NCT03447925|Analgesics|analgesics|mesh-ancestor
154593322|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
154593323|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593324|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593325|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593326|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154593327|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154593328|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593329|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593330|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593331|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
154593332|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
154593333|NCT04928183|Nitroprusside|nitroprusside|mesh-list
154593334|NCT04928183|Phenylephrine|phenylephrine|mesh-list
154593335|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
154593336|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
154593337|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154593338|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
154593339|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
153563798|NCT01666067|Simvastatin|simvastatin|mesh-list
154593340|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593341|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593342|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
154593343|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154593344|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
154593345|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
154593346|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154593347|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154593348|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154593349|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
154593350|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593351|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593352|NCT04928183|Protective Agents|protective agents|mesh-ancestor
154593353|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
154593354|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
154593355|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154593356|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
154593357|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154593358|NCT03447691|Remifentanil|remifentanil|mesh-list
154593359|NCT03447691|Anesthetics|anesthetics|mesh-list
154593360|NCT03447691|Propofol|propofol|mesh-list
154593361|NCT03447691|Desflurane|desflurane|mesh-list
154593362|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593363|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593364|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154593365|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154593367|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154593368|NCT03447691|Narcotics|narcotics|mesh-ancestor
154593369|NCT03447691|Analgesics|analgesics|mesh-ancestor
154593370|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
154593371|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080319|NCT06236724|Asciminib|asciminib|mesh-list
154593372|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154593373|NCT04923659|Nimodipine|nimodipine|mesh-list
154593374|NCT04923659|Carbamazepine|carbamazepine|mesh-list
154593375|NCT04923659|Levomethorphan|levomethorphan|mesh-list
154593376|NCT04923659|Lorazepam|lorazepam|mesh-list
154593377|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
154593378|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
154593379|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
154593380|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154080324|NCT06235801|Gilteritinib|gilteritinib|mesh-list
154593381|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154593382|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593383|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593384|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593385|NCT04923659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154593386|NCT04923659|Narcotics|narcotics|mesh-ancestor
154593387|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593388|NCT04923659|Analgesics|analgesics|mesh-ancestor
154593389|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
154593390|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080330|NCT06234072|Gemcitabine|gemcitabine|mesh-list
154593391|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
153546805|NCT05922930|Alkylating Agents|alkylating agents|mesh-ancestor
154593392|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
154593393|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
154593394|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154593395|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154593396|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154593397|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154593398|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154593399|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
154593400|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
154593401|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
154593402|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154593403|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154593404|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546812|NCT05910554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593405|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154593406|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154593407|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154593408|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154593409|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154593410|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
154593411|NCT05398679|Amoxicillin|amoxicillin|mesh-list
154593412|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
154593413|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
154593414|NCT05398679|Levofloxacin|levofloxacin|mesh-list
154593415|NCT05398679|Ofloxacin|ofloxacin|mesh-list
154593416|NCT05398679|Rifampin|rifampin|mesh-list
154593417|NCT05398679|Clindamycin|clindamycin|mesh-list
154593418|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
154593419|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
154593420|NCT05398679|Linezolid|linezolid|mesh-list
154593421|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154593422|NCT05398679|Tedizolid|tedizolid|mesh-list
154593423|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
154593424|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
154593425|NCT05398679|Cefaclor|cefaclor|mesh-list
154593426|NCT05398679|Trimethoprim|trimethoprim|mesh-list
154593427|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
154593428|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
154593429|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154593430|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154593431|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593432|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154593433|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154593434|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593435|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593436|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593437|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154593438|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
154593439|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154593440|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593441|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154593442|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154593443|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154593444|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154593445|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154593446|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154593447|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154593448|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
154593449|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
154593450|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154593451|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154593452|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154593453|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154593454|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154593455|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154593456|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154593457|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154593458|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
154593459|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154593460|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154593461|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154593462|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154593463|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153546870|NCT05889624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154593464|NCT04817501|Edetic Acid|edetic acid|mesh-list
154593465|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
154593466|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154593467|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
154593468|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
154593469|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593470|NCT05398055|Azithromycin|azithromycin|mesh-list
154593471|NCT05398055|Doxycycline|doxycycline|mesh-list
154080409|NCT06190288|Imidacloprid|imidacloprid|mesh-list
154593472|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154593473|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593474|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
154593475|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154593476|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154593477|NCT01378325|Phenylephrine|phenylephrine|mesh-list
154593478|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
154593479|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154593480|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
154593481|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
154593482|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593483|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593484|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
154593485|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154593486|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
154593487|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
154593488|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154593489|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154593490|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153648137|NCT00020761|Paclitaxel|paclitaxel|mesh-list
154593491|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
154593492|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593493|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593494|NCT01378325|Protective Agents|protective agents|mesh-ancestor
154593495|NCT01093573|Azacitidine|azacitidine|mesh-list
154593496|NCT01093573|Midostaurin|midostaurin|mesh-list
154593497|NCT01093573|Staurosporine|staurosporine|mesh-list
154593498|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154593499|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
154593500|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593501|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593502|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593503|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593504|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
154593505|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
154593506|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593507|NCT05174845|Protective Agents|protective agents|mesh-ancestor
154593508|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593510|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
154593511|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
154593512|NCT04155203|Mupirocin|mupirocin|mesh-list
154593513|NCT04155203|Calcium|calcium|mesh-list
154080427|NCT06170372|Gasotransmitters|gasotransmitters|mesh-ancestor
154593514|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154593515|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593516|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154593517|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154593518|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593519|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154593520|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593521|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593522|NCT04238143|Complement Factor H|complement factor h|mesh-list
154593523|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154593524|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154593525|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
154593526|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593527|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
154593528|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154593529|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593530|NCT03057613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154080452|NCT06049654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154080462|NCT06022614|Dexmedetomidine|dexmedetomidine|mesh-list
154593531|NCT03057613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593532|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
154593533|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154593534|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317368|NCT01074905|Analgesics|analgesics|mesh-ancestor
154593535|NCT03446911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154593536|NCT03446911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593537|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
154080468|NCT06022614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593538|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
154593539|NCT03446599|Methylene Blue|methylene blue|mesh-list
154593540|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593541|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593542|NCT03446599|Hematinics|hematinics|mesh-ancestor
154593543|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
154593544|NCT03446599|Vitamins|vitamins|mesh-ancestor
154593545|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
154593546|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593547|NCT02856451|Nivolumab|nivolumab|mesh-list
154593548|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154593549|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593550|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154593551|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593552|NCT03446443|Metronidazole|metronidazole|mesh-list
154593553|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593554|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154593555|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154593556|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154593557|NCT05102071|Metformin|metformin|mesh-list
154593558|NCT05102071|Empagliflozin|empagliflozin|mesh-list
154593559|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154593560|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593561|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154593562|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593563|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
154593564|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154593565|NCT03130517|Antibodies|antibodies|mesh-list
154593566|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
154593567|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154593568|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
154593569|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593570|NCT03445897|Miltefosine|miltefosine|mesh-list
154593571|NCT03445897|Pentamidine|pentamidine|mesh-list
154593572|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
154593573|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593574|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593575|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154593576|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153730383|NCT00133523|Vaccines|vaccines|mesh-list
154593577|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154593578|NCT04676243|Quizartinib|quizartinib|mesh-list
154593579|NCT04676243|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154593580|NCT04676243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593581|NCT04676243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593582|NCT04676243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593583|NCT03234491|Insulin|insulin|mesh-list
154593584|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153730385|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593585|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154593586|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593587|NCT02951377|Dexamethasone|dexamethasone|mesh-list
154593588|NCT02951377|Lidocaine|lidocaine|mesh-list
154593589|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593590|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
154593591|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
154593592|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154862398|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154593593|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593594|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154593595|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
154593596|NCT02951377|Hormones|hormones|mesh-ancestor
154593597|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154593598|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154593599|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593600|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
154593601|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
154593602|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593603|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
154593604|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154593605|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154593606|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154593607|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154593608|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593609|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
154593610|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593611|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593612|NCT03442621|Cortisone|cortisone|mesh-list
154080517|NCT05981365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154593613|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593614|NCT03444649|Cytarabine|cytarabine|mesh-list
154593615|NCT03444649|Daunorubicin|daunorubicin|mesh-list
154593616|NCT03444649|Idarubicin|idarubicin|mesh-list
154593617|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154593618|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
154593619|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593620|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593621|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
154593622|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080528|NCT05981365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154593623|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154593624|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
154593625|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593626|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154593627|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154593628|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154593629|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593630|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154593631|NCT01328951|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154593632|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593633|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080537|NCT05981365|Antidepressive Agents|antidepressive agents|mesh-ancestor
154593634|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593635|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593636|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
154593637|NCT03466775|Giapreza|giapreza|mesh-list
154593638|NCT03466775|Antibodies|antibodies|mesh-list
154593639|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
154593640|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
154593641|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593642|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154593643|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154593644|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
154593645|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593646|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593647|NCT02611817|Vedolizumab|vedolizumab|mesh-list
154593648|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154593649|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
154593650|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154593651|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154593652|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154593653|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154080558|NCT05952947|Immunologic Factors|immunologic factors|mesh-ancestor
154593654|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593655|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
154593656|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593657|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593658|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154593659|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593660|NCT02557139|Belumosudil|belumosudil|mesh-list
154593661|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593662|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593663|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593664|NCT01677741|Dabrafenib|dabrafenib|mesh-list
154593665|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593666|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593667|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593668|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593669|NCT02457221|Prednisone|prednisone|mesh-list
154593670|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
154593671|NCT02457221|Tacrolimus|tacrolimus|mesh-list
154593672|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154593673|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
154593674|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593675|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154593676|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154593677|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
154593678|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593679|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593680|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154593681|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593682|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
154593683|NCT02457221|Hormones|hormones|mesh-ancestor
154317519|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154593684|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154593685|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154593686|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154593687|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593688|NCT05263895|Ritonavir|ritonavir|mesh-list
154593689|NCT05263895|Nirmatrelvir|nirmatrelvir|mesh-list
154593690|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154593691|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154593692|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
154862399|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
154593693|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593694|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593695|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154593696|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154080602|NCT05920967|Hormones|hormones|mesh-ancestor
154593697|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
154593698|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593699|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154593700|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154593701|NCT01709981|Colchicine|colchicine|mesh-list
154593702|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
154593703|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154593704|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
154593705|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
154593706|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
154593707|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593708|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593709|NCT03268083|Vaccines|vaccines|mesh-list
154593710|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
154593711|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593712|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
154593713|NCT03465059|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154593714|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154593715|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593716|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593717|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593718|NCT03170817|Regadenoson|regadenoson|mesh-list
154593719|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154593720|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154593721|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
154593722|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
154593723|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593724|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593725|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593726|NCT05101005|Sirolimus|sirolimus|mesh-list
154593727|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154080632|NCT05883124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593728|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593729|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154593730|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593731|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
154593732|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154593733|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
154593734|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862400|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154862401|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154862402|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154862403|NCT05307835|Molgramostim|molgramostim|mesh-list
154862404|NCT05307835|Sargramostim|sargramostim|mesh-list
154593735|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154593736|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154593737|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593738|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
154593739|NCT05015387|Procyanidin|procyanidin|mesh-list
154593740|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
154593741|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593742|NCT05015387|Protective Agents|protective agents|mesh-ancestor
154593743|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593744|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154080648|NCT05840159|Doxycycline|doxycycline|mesh-list
154593745|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154593746|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593748|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154593749|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154593750|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080663|NCT05822609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154593751|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593752|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154593753|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593754|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154593755|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154593756|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154593757|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154593758|NCT03464435|Tobramycin|tobramycin|mesh-list
154593759|NCT03464435|Tacrolimus|tacrolimus|mesh-list
154593760|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154593761|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
154593762|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593763|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154593764|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593765|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593766|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154593767|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593768|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154080676|NCT05743504|Atezolizumab|atezolizumab|mesh-list
154593769|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154593770|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593772|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593773|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
154593774|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593775|NCT03463967|Protective Agents|protective agents|mesh-ancestor
154593776|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593777|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154593778|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154593779|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593780|NCT03463733|Temozolomide|temozolomide|mesh-list
154080687|NCT05724329|Quercetin|quercetin|mesh-list
154593781|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
154593782|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154593783|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
154593784|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593785|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593786|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
154593787|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593788|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154593789|NCT04222595|Vaccines|vaccines|mesh-list
154593790|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
154593791|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593792|NCT03468023|Calpastatin|calpastatin|mesh-list
154593793|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154593794|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
154593795|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080704|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593796|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593797|NCT05100303|Cytarabine|cytarabine|mesh-list
154593798|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
154593799|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154593800|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
154593801|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593802|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593803|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
154593804|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593805|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154593806|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
154593807|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593808|NCT05100303|Analgesics|analgesics|mesh-ancestor
154593809|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
154080714|NCT05670795|Hormones|hormones|mesh-list
154593810|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593811|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154593812|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154593813|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593814|NCT03462173|Yimitasvir|yimitasvir|mesh-list
154593815|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
154593816|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593817|NCT05096715|Bevacizumab|bevacizumab|mesh-list
154593818|NCT05096715|Atezolizumab|atezolizumab|mesh-list
154080728|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
154593819|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154593820|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593821|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154593822|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154593823|NCT05096715|Growth Substances|growth substances|mesh-ancestor
154593824|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593825|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
154593826|NCT05096715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154593827|NCT05096715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593828|NCT05099601|Silymarin|silymarin|mesh-list
154593829|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
154593830|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593831|NCT05099601|Protective Agents|protective agents|mesh-ancestor
154593832|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593833|NCT03461783|Charcoal|charcoal|mesh-list
154593834|NCT03461783|Antidotes|antidotes|mesh-ancestor
154593835|NCT03461783|Protective Agents|protective agents|mesh-ancestor
154593836|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593837|NCT01677507|Timolol|timolol|mesh-list
154593838|NCT01677507|Latanoprost|latanoprost|mesh-list
154593839|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154593840|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154593841|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
154080753|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
154593842|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593843|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593844|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593845|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154593846|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154593847|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154593848|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154593849|NCT04796363|Anesthetics|anesthetics|mesh-list
154593850|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154593851|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593852|NCT03593109|Immunomodulating Agents|immunomodulating agents|mesh-list
154593853|NCT03593109|Immunologic Factors|immunologic factors|mesh-ancestor
154593854|NCT03593109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593855|NCT05103813|Beraprost|beraprost|mesh-list
154593856|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154593857|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
154593858|NCT03461627|Fluticasone|fluticasone|mesh-list
154593859|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154593860|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154593861|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154593862|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154593863|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
154593864|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593865|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593866|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154593867|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
154593868|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
154593869|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154593870|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154593871|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154593872|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154593873|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154593874|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593875|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080777|NCT05525858|Pertuzumab|pertuzumab|mesh-list
154593876|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
154593877|NCT03461627|Hormones|hormones|mesh-ancestor
154593878|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154593879|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
154593880|NCT04452929|Calcitonin|calcitonin|mesh-list
154593881|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
154593882|NCT04452929|Cilostazol|cilostazol|mesh-list
154593883|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154593884|NCT04452929|Erenumab|erenumab|mesh-list
154593885|NCT04452929|Katacalcin|katacalcin|mesh-list
154593886|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154593887|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
154593888|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154593889|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593890|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154080801|NCT05525858|Immunotoxins|immunotoxins|mesh-ancestor
154593891|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
154593892|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154593893|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154593894|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593895|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154593896|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
154593897|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154593898|NCT04452929|Protective Agents|protective agents|mesh-ancestor
154593899|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153547281|NCT05634057|Analgesics|analgesics|mesh-ancestor
154593900|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154593901|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593902|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154593903|NCT04452929|Analgesics|analgesics|mesh-ancestor
154593904|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
154593905|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154593906|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154593907|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
154593908|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154593909|NCT05103501|Fluorouracil|fluorouracil|mesh-list
154593911|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154593912|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593913|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593914|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
154593915|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154593916|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154593917|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
154593918|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593919|NCT02522117|Atorvastatin|atorvastatin|mesh-list
154593920|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154593921|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154593922|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
154593923|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593924|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154593925|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154593926|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593927|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
154593928|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154593929|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153730410|NCT00144807|Rituximab|rituximab|mesh-list
154593930|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593931|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
154593932|NCT05087199|Coagulants|coagulants|mesh-ancestor
154593933|NCT03461081|Amlodipine|amlodipine|mesh-list
154593934|NCT03461081|Telmisartan|telmisartan|mesh-list
154593935|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154593936|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
154593937|NCT03461081|Atorvastatin|atorvastatin|mesh-list
154593938|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154593939|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154593940|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
154593941|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593942|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154593943|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154593944|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593945|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154593946|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154593947|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154593948|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154593949|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593950|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
154593951|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154593952|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154593953|NCT02522039|Timolol|timolol|mesh-list
154593954|NCT02522039|Dorzolamide|dorzolamide|mesh-list
154593955|NCT02522039|Latanoprost|latanoprost|mesh-list
154593956|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154593957|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154593958|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
154862405|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
154593959|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154593960|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593961|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080848|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
154593962|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154593963|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154593964|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154593965|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154593966|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154593967|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593968|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154593969|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154593970|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154593971|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
154593972|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593973|NCT04358003|Coal Tar|coal tar|mesh-list
154593974|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
154593975|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
154593976|NCT04519905|Paclitaxel|paclitaxel|mesh-list
154593977|NCT04519905|Carboplatin|carboplatin|mesh-list
154593978|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154593979|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154593980|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
154593981|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
154593982|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
154317821|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
154593983|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593984|NCT04423341|Cannabidiol|cannabidiol|mesh-list
154593985|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
154593986|NCT03378479|Posaconazole|posaconazole|mesh-list
154593987|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
154593988|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154593989|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154593990|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154080878|NCT05375825|LMB-100|lmb-100|mesh-list
154593991|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154593992|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154593993|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154080888|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154593994|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154593995|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154593996|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154593997|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
154593998|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154593999|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594000|NCT03460145|Propofol|propofol|mesh-list
154594001|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154594002|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594003|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594004|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154594005|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
154594006|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
154594007|NCT04125771|Diclofenac|diclofenac|mesh-list
154594008|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154594009|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594010|NCT04125771|Analgesics|analgesics|mesh-ancestor
154594011|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
154594012|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594013|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594014|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594015|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594016|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154594017|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594018|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594019|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154594020|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154594021|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154594022|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154594023|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594024|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594025|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594026|NCT05115123|Analgesics|analgesics|mesh-ancestor
154594027|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
154594028|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594029|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
154594030|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154594031|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
154594032|NCT04636671|Dexamethasone|dexamethasone|mesh-list
154594033|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
154594034|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154594035|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154594036|NCT04636671|Prednisolone|prednisolone|mesh-list
154594037|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
154594038|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154594039|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
154594040|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594041|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
154594042|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
154594043|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594044|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594045|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154594046|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
154594047|NCT04636671|Hormones|hormones|mesh-ancestor
154594048|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594049|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154594050|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594051|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154594052|NCT04636671|Protective Agents|protective agents|mesh-ancestor
154594053|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154594054|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154594055|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594056|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154594057|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594058|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594059|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
154594060|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154080946|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154594061|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594062|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594063|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594064|NCT03645603|Analgesics|analgesics|mesh-ancestor
154594065|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
154594066|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594067|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154594068|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154594069|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594070|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
154862406|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594071|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594072|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594073|NCT04771689|Buprenorphine|buprenorphine|mesh-list
154594074|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154594075|NCT04771689|Naloxone|naloxone|mesh-list
154594076|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154594077|NCT04771689|Narcotics|narcotics|mesh-ancestor
154594078|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594079|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594080|NCT04771689|Analgesics|analgesics|mesh-ancestor
154594081|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
154594082|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594083|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154594084|NCT04674345|Sorafenib|sorafenib|mesh-list
154594085|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594086|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154594087|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594088|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594089|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
154594090|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
154594091|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594092|NCT04165239|Protective Agents|protective agents|mesh-ancestor
154594093|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594094|NCT04576767|Anesthetics|anesthetics|mesh-list
154594095|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594096|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594097|NCT03248531|Adalimumab|adalimumab|mesh-list
154594098|NCT03248531|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154594099|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594100|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594101|NCT03129347|Nalmefene|nalmefene|mesh-list
154594102|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154594103|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594104|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
154594105|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594106|NCT02262923|Metoclopramide|metoclopramide|mesh-list
154594107|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
154594108|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
154594109|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594110|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594111|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154594112|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154594113|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154594114|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
154594115|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594116|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594117|NCT02194595|Insulin|insulin|mesh-list
154594118|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154594119|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
154594120|NCT02194595|Exenatide|exenatide|mesh-list
154594121|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
154594122|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154594123|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594124|NCT02194595|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154594125|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154594126|NCT02194595|Incretins|incretins|mesh-ancestor
154594127|NCT02194595|Hormones|hormones|mesh-ancestor
154081010|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594128|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594129|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154594130|NCT02656329|Lugol's solution|lugol's solution|mesh-list
154594131|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594132|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594133|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594134|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154594135|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
154594136|NCT02656329|Coagulants|coagulants|mesh-ancestor
154594137|NCT02712905|Nivolumab|nivolumab|mesh-list
154594138|NCT02712905|Azacitidine|azacitidine|mesh-list
154594139|NCT02712905|Tretinoin|tretinoin|mesh-list
154594140|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594141|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594142|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154594143|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594144|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154594145|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
154594146|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594147|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
154594148|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
154594149|NCT01166633|Atorvastatin|atorvastatin|mesh-list
154594150|NCT01166633|Pitavastatin|pitavastatin|mesh-list
154594151|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154594152|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154594153|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
154594154|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594155|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154594156|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154594157|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594158|NCT04315311|Pancrelipase|pancrelipase|mesh-list
154594159|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154594160|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
154594161|NCT03449693|Antacids|antacids|mesh-ancestor
154594162|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594163|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154594164|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
154594165|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594166|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594167|NCT03371979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154594168|NCT03371979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594169|NCT05104437|Vaccines|vaccines|mesh-list
154594170|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
154594171|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594172|NCT03179943|Atezolizumab|atezolizumab|mesh-list
154594173|NCT03179943|Guadecitabine|guadecitabine|mesh-list
154594174|NCT03179943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154594175|NCT03179943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594176|NCT03179943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594177|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594178|NCT05114499|Donepezil|donepezil|mesh-list
154862407|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594179|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154594180|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594181|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594182|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
154594183|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594184|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594185|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
154594186|NCT04520997|Hyaluronic Acid|hyaluronic acid|mesh-list
154594187|NCT04520997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154594188|NCT04520997|Immunologic Factors|immunologic factors|mesh-ancestor
154594189|NCT04520997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594190|NCT04520997|Viscosupplements|viscosupplements|mesh-ancestor
154594191|NCT04520997|Protective Agents|protective agents|mesh-ancestor
154594192|NCT05109585|Antibodies|antibodies|mesh-list
154594193|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
154594194|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
154594195|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
154594196|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594197|NCT05283161|Dronabinol|dronabinol|mesh-list
154594198|NCT05283161|Cannabidiol|cannabidiol|mesh-list
154594199|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
154594200|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
154594201|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594202|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154594203|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594204|NCT05283161|Analgesics|analgesics|mesh-ancestor
154594205|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
154594206|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594207|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154594208|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154594209|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594210|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594211|NCT05283161|Hormones|hormones|mesh-ancestor
154594212|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594213|NCT03691311|Denosumab|denosumab|mesh-list
154594214|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154594215|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594216|NCT03448835|Docetaxel|docetaxel|mesh-list
154594217|NCT03448835|Capecitabine|capecitabine|mesh-list
154594218|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
154594219|NCT03448835|Atezolizumab|atezolizumab|mesh-list
154594220|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594221|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
154594222|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
154594223|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
154594224|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594225|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154594226|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
154594227|NCT03448835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154594228|NCT03448835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594229|NCT03690453|Ivermectin|ivermectin|mesh-list
154594230|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154594231|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594232|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154594233|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154594234|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594235|NCT01709123|Chromium|chromium|mesh-list
154594236|NCT01709123|Trace Elements|trace elements|mesh-ancestor
154594237|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
154594238|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594239|NCT01301807|Panobinostat|panobinostat|mesh-list
154594240|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594241|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154594242|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594243|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594244|NCT04962893|Vaccines|vaccines|mesh-list
154594245|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
154594246|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594247|NCT03443141|Vitamin E|vitamin e|mesh-list
154594248|NCT03443141|Vitamins|vitamins|mesh-ancestor
154594249|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
154594250|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594251|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
154862408|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154594252|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594253|NCT03443141|Protective Agents|protective agents|mesh-ancestor
154594254|NCT04937543|Beclomethasone|beclomethasone|mesh-list
154594255|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
154594256|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
154594257|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154594258|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
154594259|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594260|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594261|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154594262|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
154594263|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154594264|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154594265|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594266|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594267|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594268|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594269|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594270|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
154594271|NCT04937543|Hormones|hormones|mesh-ancestor
154594272|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594273|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154594274|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154594275|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154594276|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
154594277|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154594278|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
154594279|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154594280|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594281|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594282|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594283|NCT04923737|Analgesics|analgesics|mesh-ancestor
154594284|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
154594285|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594286|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154594287|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154594288|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594289|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594290|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594291|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594292|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
154594293|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594294|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594295|NCT02452424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154594296|NCT02452424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594297|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154594298|NCT02419508|Bimatoprost|bimatoprost|mesh-list
154594299|NCT02419508|Travoprost|travoprost|mesh-list
154594300|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154594301|NCT02419508|Latanoprost|latanoprost|mesh-list
154594302|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154594303|NCT02419508|Brinzolamide|brinzolamide|mesh-list
154594304|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154594305|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154594306|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154594307|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594308|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594309|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594310|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594311|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594312|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154594313|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594314|NCT03442283|Vitamins|vitamins|mesh-list
154594315|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
154594316|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594317|NCT03441815|Histamine|histamine|mesh-list
154594318|NCT03441815|Glutarimide|glutarimide|mesh-list
154594319|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
154594320|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
154594321|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594322|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594323|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594324|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154594325|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594326|NCT02426918|Vancomycin|vancomycin|mesh-list
154594327|NCT02426918|Linezolid|linezolid|mesh-list
154594328|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154862409|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594329|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594330|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154594331|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594332|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594333|NCT02387762|Methotrexate|methotrexate|mesh-list
154594334|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
154594335|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154594336|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
154594337|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154594338|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594339|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154594340|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
154594341|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594342|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594343|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
154594344|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594345|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154594346|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154594347|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
154594348|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594349|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154594350|NCT02387762|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154594351|NCT02387762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154594352|NCT02418182|Acetaminophen|acetaminophen|mesh-list
154594353|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594354|NCT02418182|Analgesics|analgesics|mesh-ancestor
154594355|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
154594356|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594357|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594358|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
154594359|NCT02387372|Tazobactam|tazobactam|mesh-list
154594360|NCT02387372|Ceftolozane|ceftolozane|mesh-list
154594361|NCT02387372|Cephalosporins|cephalosporins|mesh-list
154594362|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154594363|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
154594364|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154594365|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594366|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154594367|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594368|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594369|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154594370|NCT03446495|Trabectedin|trabectedin|mesh-list
154594371|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154594372|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
154594373|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594374|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594375|NCT03441035|Anesthetics|anesthetics|mesh-list
154594376|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594377|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594378|NCT04807673|Paclitaxel|paclitaxel|mesh-list
154594379|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
154594380|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154594381|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594382|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154594383|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154594384|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154594385|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594386|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594387|NCT04807673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154594388|NCT02656173|Tamsulosin|tamsulosin|mesh-list
154594389|NCT02656173|Mirabegron|mirabegron|mesh-list
154594390|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154594391|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154594392|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154594393|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594394|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594395|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594396|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594397|NCT02656173|Urological Agents|urological agents|mesh-ancestor
154594398|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154594399|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154594400|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594401|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154594402|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
154594403|NCT04418895|Leucovorin|leucovorin|mesh-list
154594404|NCT04418895|Capecitabine|capecitabine|mesh-list
154594405|NCT04418895|Fluorouracil|fluorouracil|mesh-list
154594406|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
154594407|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
154594408|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594409|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154594410|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
154594411|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594412|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594413|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154594414|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
154594415|NCT04418895|Antidotes|antidotes|mesh-ancestor
154594416|NCT04418895|Protective Agents|protective agents|mesh-ancestor
154594417|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
154594418|NCT04418895|Vitamins|vitamins|mesh-ancestor
154594419|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
154594420|NCT04715633|Apatinib|apatinib|mesh-list
154594421|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154594422|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594423|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154594424|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594425|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594426|NCT04715633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594427|NCT04152915|Semaglutide|semaglutide|mesh-list
154594428|NCT04152915|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154594429|NCT04152915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154594430|NCT04152915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594431|NCT03439787|Epinephrine|epinephrine|mesh-list
154594432|NCT03439787|Bupivacaine|bupivacaine|mesh-list
154594433|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
154594434|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
154594435|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594436|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594437|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
154594438|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594439|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154594440|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594441|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594442|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594443|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594444|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154594445|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154594446|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
154594447|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154594448|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
154594449|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
154594450|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
154594451|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154594452|NCT05082155|Bupivacaine|bupivacaine|mesh-list
154594453|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
154594454|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
154594455|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594456|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594457|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
154594458|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594459|NCT02656017|Metformin|metformin|mesh-list
154594460|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154594461|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594462|NCT03439709|Lanreotide|lanreotide|mesh-list
154594463|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594464|NCT04451447|SMOFlipid|smoflipid|mesh-list
154594465|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154594466|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154594467|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154594468|NCT04516941|Colchicine|colchicine|mesh-list
154594469|NCT04516941|Edoxaban|edoxaban|mesh-list
154594470|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
154594471|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594472|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
154594473|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
154594474|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
154594475|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594476|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862410|NCT03019835|Neostigmine|neostigmine|mesh-list
154594477|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154594478|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
154862411|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154594479|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154594480|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
154594481|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594482|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
154594483|NCT03444467|Glucagon|glucagon|mesh-list
154594484|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154594485|NCT03444467|Hormones|hormones|mesh-ancestor
154594486|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594487|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594488|NCT02657343|Trastuzumab|trastuzumab|mesh-list
154594489|NCT02657343|Fulvestrant|fulvestrant|mesh-list
154594490|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594491|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594492|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154594493|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154594494|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154594495|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
154594496|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594497|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594498|NCT03445169|Belzutifan|belzutifan|mesh-list
154594499|NCT03445169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594500|NCT02655237|Leuprolide|leuprolide|mesh-list
154594501|NCT02655237|Relugolix|relugolix|mesh-list
154594502|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154594503|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
154594504|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154594505|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594506|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154594507|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594508|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
154594509|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
154594510|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594511|NCT03890133|Pregabalin|pregabalin|mesh-list
154594512|NCT03890133|Analgesics|analgesics|mesh-ancestor
154594513|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
154594514|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594515|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594516|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
154594517|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154594518|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154594519|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594520|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154594521|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154594522|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154594523|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594524|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154594525|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154594526|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154594527|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594528|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081343|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
154594529|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594530|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594531|NCT03443921|Paclitaxel|paclitaxel|mesh-list
154594532|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154594533|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594534|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
154594535|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
154594536|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
154594537|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594538|NCT03443843|Fluticasone|fluticasone|mesh-list
154594539|NCT03443843|Xhance|xhance|mesh-list
154594540|NCT03443843|Loratadine|loratadine|mesh-list
154594541|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
154594542|NCT03443843|Ephedrine|ephedrine|mesh-list
154594543|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594544|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154594545|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
154594546|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594547|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594548|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154594549|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
154594550|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
154594551|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154594552|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
154594553|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154594554|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154594555|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
154594556|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
154594557|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594558|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594559|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
154594560|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154594561|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154594562|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
154594563|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594564|NCT03438227|Dextrans|dextrans|mesh-list
154594565|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
154594566|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
154594567|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
154594568|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
154594569|NCT03438227|Hematinics|hematinics|mesh-ancestor
154594570|NCT03433235|Edoxaban|edoxaban|mesh-list
154594571|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154594572|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
154594573|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154594574|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
154594575|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594576|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594577|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
154594578|NCT03342417|Nivolumab|nivolumab|mesh-list
154594579|NCT03342417|Ipilimumab|ipilimumab|mesh-list
154594580|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594581|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594582|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154594583|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318421|NCT00126191|Ifosfamide|ifosfamide|mesh-list
154594584|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154594585|NCT03234309|Hematinics|hematinics|mesh-ancestor
154594586|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154594587|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154594588|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
154594589|NCT02657031|Promethazine|promethazine|mesh-list
154594590|NCT02657031|Ketamine|ketamine|mesh-list
154594591|NCT02657031|Ondansetron|ondansetron|mesh-list
154594592|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
154594593|NCT02657031|Analgesics|analgesics|mesh-ancestor
154594594|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
154594595|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594596|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594597|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154594598|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154594599|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
154594600|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
154594601|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594602|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154594603|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154594604|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594605|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594606|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
154594607|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
154594608|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154594609|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
154594610|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
154594611|NCT02657031|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154594612|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154594613|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
154594614|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154594615|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154594616|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
154594617|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154594618|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
154594619|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
154594620|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154594621|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154594622|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154594623|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154594624|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154594625|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
154594626|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
154594627|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154594628|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154594629|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154594630|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154862412|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594631|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594632|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
154594633|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594634|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594635|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154594636|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594637|NCT03797469|Niacinamide|niacinamide|mesh-list
154594638|NCT03797469|Niacin|niacin|mesh-list
154594639|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
154594640|NCT03797469|Vitamins|vitamins|mesh-ancestor
154594641|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
154594642|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594643|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
154594644|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154594645|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
154594646|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594647|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154594648|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
154594649|NCT03432923|Benzocaine|benzocaine|mesh-list
154594650|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
154594651|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
154594652|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594653|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594654|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
154594655|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594656|NCT02384577|Budesonide|budesonide|mesh-list
154594657|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
154594658|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594659|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154594660|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
154594661|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594662|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594663|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154594664|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
154594665|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
154594666|NCT02384577|Hormones|hormones|mesh-ancestor
154594667|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594668|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154594669|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154594670|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594671|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594672|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594673|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594674|NCT03437213|Anesthetics|anesthetics|mesh-list
154594675|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594676|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594677|NCT02030457|Beclomethasone|beclomethasone|mesh-list
154594678|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594679|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
154594680|NCT02030457|Hormones|hormones|mesh-ancestor
154594681|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594682|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594683|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154594684|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
154594685|NCT03432767|Chrysarobin|chrysarobin|mesh-list
154594686|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154594687|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594688|NCT03432767|Analgesics|analgesics|mesh-ancestor
154594689|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
154594690|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594691|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594692|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594693|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594694|NCT03437057|Aspirin|aspirin|mesh-list
154594695|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154594696|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594697|NCT03437057|Analgesics|analgesics|mesh-ancestor
154594698|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
154594699|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594700|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594701|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594702|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594703|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154594704|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154594705|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594706|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154594707|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154594708|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594709|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
154594710|NCT03579693|Niacinamide|niacinamide|mesh-list
154594711|NCT03579693|Niacin|niacin|mesh-list
154594712|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
154594713|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
154594714|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
154594715|NCT03579693|Vitamins|vitamins|mesh-ancestor
154594716|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
154594717|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594718|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154594719|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
154594720|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594721|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154594722|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
154594723|NCT03432689|Cycloserine|cycloserine|mesh-list
154594724|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154594725|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594726|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154594727|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
154594728|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154594729|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
154594730|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594731|NCT02991807|Everolimus|everolimus|mesh-list
154594732|NCT02991807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154594733|NCT02991807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154318575|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
154594734|NCT02991807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594735|NCT02991807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594736|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154594737|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
154594738|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594739|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594740|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154594741|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154594742|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154594743|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154594744|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594745|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594746|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594747|NCT05018013|Analgesics|analgesics|mesh-ancestor
154594748|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
154594749|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594750|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
154594751|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154594752|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
154594753|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154594754|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154594755|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154594756|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154594757|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594758|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594759|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594760|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
154594761|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154594762|NCT04375397|Ibrutinib|ibrutinib|mesh-list
154594763|NCT04375397|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154594764|NCT04375397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154594765|NCT04375397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594766|NCT04375397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594767|NCT05112471|Erythritol|erythritol|mesh-list
154594768|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
154594769|NCT02387216|Docetaxel|docetaxel|mesh-list
154594770|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594771|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
154594772|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
154594773|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
154594774|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594775|NCT03431909|Aspirin|aspirin|mesh-list
154594776|NCT03431909|Kallikreins|kallikreins|mesh-list
154862413|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594777|NCT03431909|Clopidogrel|clopidogrel|mesh-list
154594778|NCT03431909|Atorvastatin|atorvastatin|mesh-list
154081608|NCT03726268|Fentanyl|fentanyl|mesh-list
154594779|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154594780|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594781|NCT03431909|Analgesics|analgesics|mesh-ancestor
154594782|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
154594783|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594784|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594785|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594786|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594787|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154594788|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154594789|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594790|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154594791|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154594792|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594793|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
154594794|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154594795|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154594796|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
154594797|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154594798|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154594799|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154594800|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154594801|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154594802|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
154594803|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594804|NCT03431909|Coagulants|coagulants|mesh-ancestor
154594805|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154594806|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
154594807|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154594809|NCT03436121|Ketamine|ketamine|mesh-list
154594811|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
154594812|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594813|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594814|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154594815|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154594816|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
154594817|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
154594818|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594819|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154594820|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154594821|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594822|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594823|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154594824|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154594825|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154594826|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154594827|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154594828|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
154594829|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
154594830|NCT02417246|Metoprolol|metoprolol|mesh-list
154594831|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154594832|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154594833|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
154594834|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
154594835|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594836|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594837|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154594838|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154594839|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154594840|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594841|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594842|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594843|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
154594844|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154594845|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594846|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154594847|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154594848|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594849|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594850|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154862414|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
154594851|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154594852|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154594853|NCT02424734|Ampicillin|ampicillin|mesh-list
154594854|NCT02424734|Ceftaroline|ceftaroline|mesh-list
154594855|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154594856|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594857|NCT02424734|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154594858|NCT03431597|Micronutrients|micronutrients|mesh-list
154594859|NCT03431597|Trace Elements|trace elements|mesh-list
154594860|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594861|NCT02424578|Diclofenac|diclofenac|mesh-list
154594862|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154594863|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594864|NCT02424578|Analgesics|analgesics|mesh-ancestor
154594865|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
154594866|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594867|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594868|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594869|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594870|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154594871|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594872|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594873|NCT03431285|Ketamine|ketamine|mesh-list
154594874|NCT03431285|Morphine|morphine|mesh-list
154594875|NCT03431285|Analgesics|analgesics|mesh-ancestor
154594876|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
154594877|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594878|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594879|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154594880|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154594881|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
154594882|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
154594883|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594884|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154594885|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154594886|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594887|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594888|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154594890|NCT02416934|Dexamethasone|dexamethasone|mesh-list
154594891|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594892|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
154594893|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
154594894|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594895|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594896|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154594897|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
154594898|NCT02416934|Hormones|hormones|mesh-ancestor
154594899|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594900|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154594901|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594902|NCT02819635|Upadacitinib|upadacitinib|mesh-list
154594903|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154594904|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154594905|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594906|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594907|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594908|NCT03874325|Durvalumab|durvalumab|mesh-list
154594909|NCT03874325|Letrozole|letrozole|mesh-list
154594910|NCT03874325|Anastrozole|anastrozole|mesh-list
154594911|NCT03874325|Exemestane|exemestane|mesh-list
154594912|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154594913|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154594914|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154594915|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154594916|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594917|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594918|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154594919|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
154594920|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154594921|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594922|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154594923|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
154594924|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154594925|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
154594926|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594927|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594928|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154594929|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
154594930|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154594931|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154594932|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594933|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594934|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594935|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594936|NCT03861611|Ibuprofen|ibuprofen|mesh-list
154594937|NCT03861611|Diclofenac|diclofenac|mesh-list
154594938|NCT03861611|Ketorolac|ketorolac|mesh-list
154594939|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154594940|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594941|NCT03861611|Analgesics|analgesics|mesh-ancestor
154594942|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
154594943|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594944|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594945|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154594946|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154594947|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154594948|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154594949|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594950|NCT03430817|Amantadine|amantadine|mesh-list
154594951|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154594952|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154594953|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154594954|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
154594955|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154594956|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
154594957|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594958|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594959|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594960|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154594961|NCT03430817|Analgesics|analgesics|mesh-ancestor
154594962|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
154594963|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594964|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
154594965|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154594966|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154594967|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594968|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154594969|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594970|NCT03430505|Albuterol|albuterol|mesh-list
154594971|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154594972|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
154594973|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594974|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594975|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154594976|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
154594977|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
154594978|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154594979|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154594980|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154594981|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154594982|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
154594983|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154594984|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154594985|NCT03434951|Morphine|morphine|mesh-list
154594986|NCT03434951|Bupivacaine|bupivacaine|mesh-list
154594987|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
154594988|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
154594989|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154594990|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154594991|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
154594992|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154594993|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154594994|NCT03434951|Narcotics|narcotics|mesh-ancestor
154594995|NCT03434951|Analgesics|analgesics|mesh-ancestor
154594996|NCT02234323|Factor VIII|factor viii|mesh-list
154594997|NCT02234323|Coagulants|coagulants|mesh-ancestor
154594998|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
154594999|NCT02413346|Sarecycline|sarecycline|mesh-list
154595000|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595001|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595002|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
154595003|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154595004|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154595005|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154595006|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595007|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595008|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154595009|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595010|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595011|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
154595012|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595013|NCT03429179|Butorphanol|butorphanol|mesh-list
154595014|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154595015|NCT03429179|Narcotics|narcotics|mesh-ancestor
154595016|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595017|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595018|NCT03429179|Analgesics|analgesics|mesh-ancestor
154595019|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
154595020|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595021|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
154595022|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
154595023|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154595024|NCT03429101|Trastuzumab|trastuzumab|mesh-list
154595025|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154595026|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154595027|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595028|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
154595029|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
154595030|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
154595031|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595032|NCT03429101|Immunotoxins|immunotoxins|mesh-ancestor
154595033|NCT03429101|Immunoconjugates|immunoconjugates|mesh-ancestor
154595034|NCT03429101|Immunologic Factors|immunologic factors|mesh-ancestor
154595035|NCT03429101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595036|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154595037|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
154595038|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595039|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154595040|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154595041|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154595042|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154595043|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
154595044|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154595045|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595046|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154595047|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154595048|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154595049|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154595050|NCT02732639|Interferons|interferons|mesh-list
154595051|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595052|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
154595053|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595054|NCT02412878|Dexamethasone|dexamethasone|mesh-list
154595055|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595056|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
154595057|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
154595058|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595059|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595060|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154595061|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
154595063|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595064|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154595065|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595066|NCT03423329|Ibuprofen|ibuprofen|mesh-list
154595067|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154595068|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595069|NCT03423329|Analgesics|analgesics|mesh-ancestor
154595070|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
154595071|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595072|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595073|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595075|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154595076|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595077|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595078|NCT02380742|Lidocaine|lidocaine|mesh-list
154595079|NCT02380742|Prilocaine|prilocaine|mesh-list
154595080|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154595081|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
154595082|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
154595083|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595084|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595085|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
154595086|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595087|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154595088|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154595089|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154595090|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595091|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595092|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154595093|NCT02944019|Edoxaban|edoxaban|mesh-list
154595094|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154595095|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
154595096|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154595097|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
154595098|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595099|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595100|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
154595101|NCT02022059|Lidocaine|lidocaine|mesh-list
154595102|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
154595103|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
154595104|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595105|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595106|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
154595107|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595108|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154595109|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154595110|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154595111|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595112|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595113|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
154595114|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154595115|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
154595116|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154595117|NCT03422315|Propofol|propofol|mesh-list
154595118|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154595119|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595120|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595121|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154595122|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
154595123|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
154595124|NCT03427385|Ropivacaine|ropivacaine|mesh-list
154595125|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
154595126|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
154595127|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595128|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595129|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
154595130|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595131|NCT03427229|Vancomycin|vancomycin|mesh-list
154595132|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595133|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595134|NCT04449185|Amoxicillin|amoxicillin|mesh-list
154595135|NCT04449185|Clarithromycin|clarithromycin|mesh-list
154595136|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595137|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595138|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154595139|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595140|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595141|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154595142|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154595143|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
154595144|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
154595145|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
154595146|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595147|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595148|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154595149|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595150|NCT03426527|Analgesics|analgesics|mesh-ancestor
154595151|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
154595152|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595153|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154595154|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154595155|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154595156|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
154595157|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595158|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595159|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
154595160|NCT02805257|Mitomycins|mitomycins|mesh-list
154595161|NCT02805257|Mitomycin|mitomycin|mesh-list
154595162|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154595163|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595164|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
154082001|NCT02259231|Nivolumab|nivolumab|mesh-list
154595165|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595166|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154595167|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595168|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154595169|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
154595170|NCT02636387|Coagulants|coagulants|mesh-ancestor
154595171|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154595172|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
154595173|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595174|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
154595175|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
154595176|NCT03425747|Calcium|calcium|mesh-list
154595177|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154595178|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595179|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154595180|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595181|NCT03425747|Antacids|antacids|mesh-ancestor
154595182|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154595183|NCT03424889|Xylometazoline|xylometazoline|mesh-list
154595184|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
154595185|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154595186|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
154595187|NCT03424733|Acetaminophen|acetaminophen|mesh-list
154595188|NCT03424733|Interferons|interferons|mesh-list
154595189|NCT03424733|Interferon-beta|interferon-beta|mesh-list
154595190|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
154595191|NCT03424733|Prednisone|prednisone|mesh-list
154595192|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595193|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
154595194|NCT03424733|Hormones|hormones|mesh-ancestor
154595195|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595196|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595197|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154595198|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595199|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
154595200|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595201|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595202|NCT03424733|Analgesics|analgesics|mesh-ancestor
154595203|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
154595204|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595205|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
154595206|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
154595207|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154595208|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154595209|NCT03441841|Lidocaine|lidocaine|mesh-list
154595210|NCT03441841|Prilocaine|prilocaine|mesh-list
154595211|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154595212|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
154595213|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
154595214|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595215|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595216|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
154595217|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595218|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154595219|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154595220|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154595221|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154862415|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595222|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595223|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154595224|NCT02692339|Dexamethasone|dexamethasone|mesh-list
154595225|NCT02692339|Lenalidomide|lenalidomide|mesh-list
154595226|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595227|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
154595228|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
154595229|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595230|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595231|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154595232|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
154595233|NCT02692339|Hormones|hormones|mesh-ancestor
154595234|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595235|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154595236|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595237|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
154595238|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154595239|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154595240|NCT02692339|Growth Substances|growth substances|mesh-ancestor
154595241|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
154595242|NCT03444025|Goserelin|goserelin|mesh-list
154595243|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154595244|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595245|NCT03438253|Anesthetics|anesthetics|mesh-list
154595246|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319093|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595247|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595248|NCT02535325|Cisplatin|cisplatin|mesh-list
154595249|NCT02535325|Pemetrexed|pemetrexed|mesh-list
154595250|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595251|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595252|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595253|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154595254|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154595256|NCT03441529|Piperacillin|piperacillin|mesh-list
154595257|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154595258|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595259|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595260|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154595261|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595262|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595263|NCT03441373|Histamine|histamine|mesh-list
154595264|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
154595265|NCT03441373|Glutarimide|glutarimide|mesh-list
154595266|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
154595267|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
154595268|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595269|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595270|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595271|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154595272|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595273|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
154595274|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154595275|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154595276|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154595277|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595278|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
154595279|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595280|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154595281|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595282|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595283|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
154595284|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595285|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595286|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154595287|NCT03437785|Ethanol|ethanol|mesh-list
154595288|NCT03437785|Rebamipide|rebamipide|mesh-list
154595289|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154595290|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595291|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595292|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595293|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154595294|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154595295|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
154595296|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595298|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595299|NCT03437707|Acetaminophen|acetaminophen|mesh-list
154595300|NCT03437707|Ibuprofen|ibuprofen|mesh-list
154595301|NCT03437707|Morphine|morphine|mesh-list
154595302|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154595303|NCT03437707|Narcotics|narcotics|mesh-ancestor
154595304|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595305|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595306|NCT03437707|Analgesics|analgesics|mesh-ancestor
154595307|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
154595308|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595309|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154595310|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595311|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595312|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595313|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154595314|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595315|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595316|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
154595317|NCT03437629|Calcium|calcium|mesh-list
154595318|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154595319|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595320|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154595321|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
154595322|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595323|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595324|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319165|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595325|NCT03441217|Scopolamine|scopolamine|mesh-list
154595326|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154595327|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154595328|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
154595329|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
154595330|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595331|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595332|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154595333|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
154595334|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154595335|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
154595336|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595337|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595338|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154595339|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
154595340|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
154595341|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595342|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
154595343|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595344|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595345|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154595346|NCT02521441|Lenograstim|lenograstim|mesh-list
154595347|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154595348|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
154595349|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595350|NCT04451239|Cyclosporine|cyclosporine|mesh-list
154595351|NCT04451239|Cyclosporins|cyclosporins|mesh-list
154595352|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595353|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595354|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154595355|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
154595356|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595357|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
154595358|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595359|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
154595360|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595361|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154595362|NCT03440515|Prednisone|prednisone|mesh-list
154595363|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595364|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
154595365|NCT03440515|Hormones|hormones|mesh-ancestor
154595366|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595367|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595368|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154595370|NCT03432793|Itraconazole|itraconazole|mesh-list
154595371|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
154595372|NCT03432793|Caffeine|caffeine|mesh-list
154595373|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154595374|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595375|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154595376|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595377|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595378|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154595379|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154595380|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
154595381|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595382|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
154595383|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595384|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154595385|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154595386|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154595387|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
154595388|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595389|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154595390|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154595391|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154595392|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595393|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154595394|NCT03432793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154595395|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154595396|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595397|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
154319240|NCT02954601|Insulin|insulin|mesh-list
154595398|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154595399|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
154595400|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154595401|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154595402|NCT03436693|Canagliflozin|canagliflozin|mesh-list
154595403|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154595404|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595405|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154595406|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595407|NCT03432637|Anesthetics|anesthetics|mesh-list
154595408|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595409|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595410|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
154595411|NCT03436303|Progestins|progestins|mesh-ancestor
154595412|NCT03436303|Hormones|hormones|mesh-ancestor
154595413|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595414|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595415|NCT03436225|Dexamethasone|dexamethasone|mesh-list
154595416|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
154595417|NCT03436225|Budesonide|budesonide|mesh-list
154595418|NCT03436225|Albuterol|albuterol|mesh-list
154595419|NCT03436225|BB 1101|bb 1101|mesh-list
154595420|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595421|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
154595422|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
154595423|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082266|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
154595424|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595425|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154595426|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
154595427|NCT03436225|Hormones|hormones|mesh-ancestor
154595428|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595429|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154595430|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595431|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
154595432|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595433|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595434|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154595435|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154595436|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
154595437|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
154595438|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154255731|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154595439|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154595440|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154595441|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154595442|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
154595443|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595445|NCT03440359|Progesterone|progesterone|mesh-list
154595446|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595447|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154595448|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154595449|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595450|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595451|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154595452|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
154595453|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595454|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595455|NCT03440359|Progestins|progestins|mesh-ancestor
154595456|NCT03440359|Hormones|hormones|mesh-ancestor
154595457|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154595458|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
154595459|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595460|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154595461|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
154595462|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
154595463|NCT03431623|Hematinics|hematinics|mesh-ancestor
154595464|NCT04451395|Micronutrients|micronutrients|mesh-list
154595465|NCT04451395|Trace Elements|trace elements|mesh-list
154595466|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595467|NCT04451083|Camostat|camostat|mesh-list
154595468|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
154595469|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595470|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595471|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154595472|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154595473|NCT03435289|Paclitaxel|paclitaxel|mesh-list
154595474|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154595476|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154595477|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595478|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
154595479|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
154595480|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
154595481|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595482|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154595483|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
154595484|NCT03435133|Ticagrelor|ticagrelor|mesh-list
154595485|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154595486|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154595487|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154595488|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154595489|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154595490|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
154595491|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595492|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595493|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595494|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
154595495|NCT03431077|Giapreza|giapreza|mesh-list
154595496|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
154595497|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154595498|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154595499|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
154595500|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595501|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595502|NCT03439501|Avelumab|avelumab|mesh-list
154595503|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154595504|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595505|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154595506|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154595507|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595508|NCT04255381|Pancrelipase|pancrelipase|mesh-list
154595509|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154595510|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
154595511|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154595512|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595513|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595514|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595515|NCT03757897|Analgesics|analgesics|mesh-ancestor
154595516|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
154595517|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595518|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154595519|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154595520|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154595521|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
154595522|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595523|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595524|NCT03434197|Diclofenac|diclofenac|mesh-list
154595525|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154595526|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595527|NCT03434197|Analgesics|analgesics|mesh-ancestor
154595528|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
154595529|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595530|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595531|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595532|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595533|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154595534|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595535|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595536|NCT03430609|Hormones|hormones|mesh-list
154595537|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595538|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595539|NCT03438955|Telmisartan|telmisartan|mesh-list
154595540|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154595541|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154595542|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154595543|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595544|NCT04219735|Minocycline|minocycline|mesh-list
154595545|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595546|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595547|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154595548|NCT03621553|Vitamin D|vitamin d|mesh-list
154595549|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
154595550|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
154595551|NCT03621553|Vitamins|vitamins|mesh-list
154595552|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
154595553|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595554|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154595555|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154595556|NCT01559363|XL647|xl647|mesh-list
154595557|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595558|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154595559|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595560|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595561|NCT01504919|Nicotine|nicotine|mesh-list
154595562|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154595563|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
154595564|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595565|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595566|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154595567|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154595568|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
154595569|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595570|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595571|NCT02732327|Vancomycin|vancomycin|mesh-list
154595572|NCT02732327|Meropenem|meropenem|mesh-list
154595573|NCT02732327|Tazobactam|tazobactam|mesh-list
154595574|NCT02732327|Linezolid|linezolid|mesh-list
154595575|NCT02732327|Piperacillin|piperacillin|mesh-list
154595576|NCT02732327|Cefepime|cefepime|mesh-list
154595577|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154595578|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595579|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595580|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154595581|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595582|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595583|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154595584|NCT03428503|Acetaminophen|acetaminophen|mesh-list
154595585|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154595586|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595587|NCT03428503|Analgesics|analgesics|mesh-ancestor
154595588|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
154595589|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595590|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595591|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
154595592|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154595593|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595594|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595595|NCT03428425|Paclitaxel|paclitaxel|mesh-list
154595596|NCT03428425|Apatinib|apatinib|mesh-list
154595597|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154595598|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595599|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
154595600|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
154595601|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
154595602|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595603|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154595604|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595605|NCT03416777|Tocopherols|tocopherols|mesh-list
154595606|NCT03416777|Vitamin E|vitamin e|mesh-list
154595607|NCT03416777|Tocotrienols|tocotrienols|mesh-list
154595608|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
154595609|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
154595610|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595611|NCT03416777|Protective Agents|protective agents|mesh-ancestor
154595612|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595613|NCT03416777|Vitamins|vitamins|mesh-ancestor
154595614|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
154595615|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
154595616|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595617|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
154595618|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154595619|NCT03422887|Nalbuphine|nalbuphine|mesh-list
154595620|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154595621|NCT03422887|Narcotics|narcotics|mesh-ancestor
154595622|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595623|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595624|NCT03422887|Analgesics|analgesics|mesh-ancestor
154595625|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
154595626|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595627|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154595628|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595629|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595630|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595631|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154595632|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595633|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595634|NCT02521207|Ibuprofen|ibuprofen|mesh-list
154595635|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154595636|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595637|NCT02521207|Analgesics|analgesics|mesh-ancestor
154595638|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
154595639|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595640|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595641|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595642|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595643|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154595644|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595645|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595646|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
154595647|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
154595648|NCT03173053|Clarithromycin|clarithromycin|mesh-list
154595649|NCT03173053|Doxycycline|doxycycline|mesh-list
154595650|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
154595651|NCT03173053|Rifampin|rifampin|mesh-list
154595652|NCT03173053|Clindamycin|clindamycin|mesh-list
154595653|NCT03173053|Trimethoprim|trimethoprim|mesh-list
154595654|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
154595655|NCT03173053|Mupirocin|mupirocin|mesh-list
154595656|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
154595657|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154595658|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154595659|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595660|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
154595661|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595662|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154595663|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595664|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595665|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154595666|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154595667|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
154595668|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154595669|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154595670|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154595671|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154595672|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595673|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154595674|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154595675|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
154595676|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
154595677|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154595678|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154595679|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154595680|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154595681|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154595682|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154595683|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154595684|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154595685|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154595686|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154595687|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154595688|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
154595689|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154595690|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154595691|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
154595693|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154595694|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595695|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595696|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595697|NCT03428191|Analgesics|analgesics|mesh-ancestor
154595698|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
154595699|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595700|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154595701|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154595702|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154595703|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
154595704|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595705|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595706|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154595707|NCT03428191|Narcotics|narcotics|mesh-ancestor
154595708|NCT03422575|Etoricoxib|etoricoxib|mesh-list
154595709|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154595710|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595711|NCT03422575|Analgesics|analgesics|mesh-ancestor
154595712|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
154595713|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595714|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595715|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595716|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595717|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154595718|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154595719|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595720|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595721|NCT02412722|Paclitaxel|paclitaxel|mesh-list
154595722|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154595723|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595724|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
154595725|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
154595726|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
154595727|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595728|NCT03422419|Heparin|heparin|mesh-list
154595729|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
154595730|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154595731|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154595732|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595733|NCT04449289|Lidocaine|lidocaine|mesh-list
154595734|NCT04449289|Ropivacaine|ropivacaine|mesh-list
154595735|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
154595736|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
154595737|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595738|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154862416|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595740|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595741|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154595742|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154595743|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154595744|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595745|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595746|NCT03128203|Oxytocin|oxytocin|mesh-list
154595747|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
154595748|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154595749|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595750|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
154595751|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154595752|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154595753|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154595754|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595755|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595756|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
154595757|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595758|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595759|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154595760|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595761|NCT02935309|Capecitabine|capecitabine|mesh-list
154595762|NCT02935309|Lenvatinib|lenvatinib|mesh-list
154595763|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154595764|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
154595765|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595766|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595767|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154595768|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595769|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
154595770|NCT03463993|Oxytocin|oxytocin|mesh-list
154595771|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
154595772|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154595773|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595774|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154595775|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154595776|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595778|NCT03463993|Coagulants|coagulants|mesh-ancestor
154595779|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154595780|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154595781|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595782|NCT03417037|Nivolumab|nivolumab|mesh-list
154595783|NCT03417037|Linrodostat|linrodostat|mesh-list
154595784|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154595785|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595786|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154595787|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595788|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595789|NCT02378480|Linezolid|linezolid|mesh-list
154595790|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595791|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595792|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154595793|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595794|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595795|NCT03421717|Chitosan|chitosan|mesh-list
154595796|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154595797|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154595798|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
154595799|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595800|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154595801|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
154595802|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
154595803|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
154595804|NCT03421717|Coagulants|coagulants|mesh-ancestor
154595805|NCT03427801|Hematinics|hematinics|mesh-list
154595806|NCT03416569|Prazosin|prazosin|mesh-list
154595807|NCT03416569|Nicotine|nicotine|mesh-list
154595808|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154595809|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
154595810|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595811|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595812|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154595813|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154082661|NCT00468169|Cetuximab|cetuximab|mesh-list
154595814|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
154595815|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595816|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595817|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154595818|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154595819|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154595820|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154595821|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
154595822|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154595823|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154595824|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154595825|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
154595826|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595827|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595828|NCT01004029|Progestins|progestins|mesh-ancestor
154595829|NCT01004029|Hormones|hormones|mesh-ancestor
154595830|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
154595831|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
154595832|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595833|NCT03420937|Atropine|atropine|mesh-list
154595834|NCT03420937|Neostigmine|neostigmine|mesh-list
154595835|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154595836|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154595837|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154595838|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
154595839|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595840|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595841|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154595842|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
154595843|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
154595844|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
154595845|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154595846|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154595847|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
154319687|NCT03599193|Tazarotene|tazarotene|mesh-list
154595848|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595849|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595850|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154595851|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595852|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154595853|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
154595854|NCT02900443|Azathioprine|azathioprine|mesh-list
154595855|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154595856|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595857|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154595858|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
154595859|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154595860|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595861|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595862|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595863|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
154595864|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154595865|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154595866|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
154595867|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595868|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595869|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
154595870|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154595871|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154595872|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154595873|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154595874|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595875|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595876|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
154595877|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595878|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595879|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154595880|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595881|NCT03420703|Morphine|morphine|mesh-list
154595882|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154595883|NCT03420703|Narcotics|narcotics|mesh-ancestor
154595884|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595885|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595886|NCT03420703|Analgesics|analgesics|mesh-ancestor
154595887|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
154595888|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595890|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154595891|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
154595892|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154595893|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154595894|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154595895|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595896|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595897|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
154595898|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595899|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595900|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154595901|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154595902|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595903|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
154595904|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595905|NCT03415711|Mesalamine|mesalamine|mesh-list
154595906|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154595907|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154595908|NCT03415711|Analgesics|analgesics|mesh-ancestor
154595909|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
154595910|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595911|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595912|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154595913|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154595914|NCT03420313|Buprenorphine|buprenorphine|mesh-list
154595915|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154595916|NCT03420313|Naloxone|naloxone|mesh-list
154595917|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154595918|NCT03420313|Narcotics|narcotics|mesh-ancestor
154595919|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154319764|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154595920|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595921|NCT03420313|Analgesics|analgesics|mesh-ancestor
154595922|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
154595923|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595924|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154595925|NCT03415477|Denosumab|denosumab|mesh-list
154595926|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154595927|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595928|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
154595929|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
154595930|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154595931|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154595932|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154595933|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595934|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595935|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154595936|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154595937|NCT03419923|Citric Acid|citric acid|mesh-list
154595938|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
154595939|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
154595940|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154595941|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
154595942|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
154595943|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595944|NCT03426553|Riboflavin|riboflavin|mesh-list
154595945|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
154595946|NCT03426553|Vitamins|vitamins|mesh-ancestor
154595947|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
154595948|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595949|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154595950|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
154595951|NCT03415087|Fentanyl|fentanyl|mesh-list
154595952|NCT03415087|Bupivacaine|bupivacaine|mesh-list
154595953|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
154595954|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
154595955|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595956|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595957|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
154595958|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154595959|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154595960|NCT03415087|Narcotics|narcotics|mesh-ancestor
154595961|NCT03415087|Analgesics|analgesics|mesh-ancestor
154595962|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154595963|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154595964|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
154595965|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
154595966|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154595967|NCT03419767|Melatonin|melatonin|mesh-list
154595968|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
154595969|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595970|NCT03419767|Protective Agents|protective agents|mesh-ancestor
154595971|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595972|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154595973|NCT03414931|Sertraline|sertraline|mesh-list
154595974|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
154595975|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154595976|NCT03414931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154595977|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154595978|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154595979|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595980|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154595981|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
154595982|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595983|NCT04448821|Metformin|metformin|mesh-list
154595984|NCT04448821|Nilotinib|nilotinib|mesh-list
154595985|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154595986|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595987|NCT04448821|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154595988|NCT04448821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154595989|NCT04448821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154595990|NCT04448821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154595991|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154595992|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154595993|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154595994|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
154595995|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154595996|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154595997|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154595998|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154595999|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154596000|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154596001|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154596002|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596003|NCT04448587|Incretins|incretins|mesh-ancestor
154596004|NCT04448587|Hormones|hormones|mesh-ancestor
154082845|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
154596005|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596006|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154596007|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
154596008|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596009|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596010|NCT03426085|Liraglutide|liraglutide|mesh-list
154596011|NCT03426085|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154596012|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154596013|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596014|NCT03426085|Incretins|incretins|mesh-ancestor
154596015|NCT03426085|Hormones|hormones|mesh-ancestor
154596016|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596017|NCT03418597|Anesthetics|anesthetics|mesh-list
154596018|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596019|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596020|NCT03425929|Oxytocin|oxytocin|mesh-list
154596021|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
154596022|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154596023|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596024|NCT03127189|Rilpivirine|rilpivirine|mesh-list
154596025|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154596026|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154596027|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596028|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596029|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
154596030|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596031|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154596032|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154596033|NCT02521051|Bevacizumab|bevacizumab|mesh-list
154596034|NCT02521051|Alectinib|alectinib|mesh-list
154596035|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154596036|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596037|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154596038|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154596039|NCT02521051|Growth Substances|growth substances|mesh-ancestor
154596040|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596041|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
154596042|NCT02521051|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154596043|NCT02521051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596044|NCT02521051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596045|NCT02521051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596046|NCT01239797|Dexamethasone|dexamethasone|mesh-list
154596047|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
154596048|NCT01239797|Lenalidomide|lenalidomide|mesh-list
154596050|NCT01239797|BB 1101|bb 1101|mesh-list
154596051|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596052|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
154596053|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
154596054|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596055|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596056|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154596057|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
154596058|NCT01239797|Hormones|hormones|mesh-ancestor
154596059|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596060|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154596061|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596062|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
154596063|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596064|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596065|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
154596066|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154596067|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154596068|NCT01239797|Growth Substances|growth substances|mesh-ancestor
154596069|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
154596070|NCT01092143|Fluticasone|fluticasone|mesh-list
154596071|NCT01092143|Xhance|xhance|mesh-list
154596072|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596073|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154596074|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
154596075|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596076|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596077|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154596078|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
154596079|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
154596080|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154596081|NCT00950989|Folic Acid|folic acid|mesh-list
154596082|NCT00950989|Methotrexate|methotrexate|mesh-list
154596083|NCT00950989|Brodalumab|brodalumab|mesh-list
154596084|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154596085|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
154596086|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154596087|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596088|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154596089|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
154596090|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596091|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596092|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
154596093|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596094|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154596095|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154596096|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
154596097|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154596098|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154596099|NCT00950989|Hematinics|hematinics|mesh-ancestor
154596100|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
154596101|NCT00950989|Vitamins|vitamins|mesh-ancestor
154596102|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
154596103|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154596104|NCT03420911|Midazolam|midazolam|mesh-list
154596105|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154596106|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154596107|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596108|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596109|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154596110|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154596111|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154596112|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154596113|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
154596114|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
154596115|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
154596116|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
154596117|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596118|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596119|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154596120|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154596121|NCT03420911|Analgesics|analgesics|mesh-ancestor
154596122|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
154596123|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596124|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596125|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154596126|NCT03416231|Docetaxel|docetaxel|mesh-list
154596127|NCT03416231|Apatinib|apatinib|mesh-list
154596128|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596129|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596130|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596131|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596132|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596133|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596134|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596135|NCT03415763|Leucovorin|leucovorin|mesh-list
154596136|NCT03415763|Capecitabine|capecitabine|mesh-list
154596137|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
154596138|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154596139|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
154596140|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596141|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596142|NCT03415763|Antidotes|antidotes|mesh-ancestor
154596143|NCT03415763|Protective Agents|protective agents|mesh-ancestor
154596144|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596145|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
154596146|NCT03415763|Vitamins|vitamins|mesh-ancestor
154596147|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
154596148|NCT00593567|Levofloxacin|levofloxacin|mesh-list
154596149|NCT00593567|Gentamicins|gentamicins|mesh-list
154596150|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154596151|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596152|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154596153|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154596154|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154596155|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596156|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596157|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596158|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154596159|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154596160|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154596161|NCT03419975|Latanoprost|latanoprost|mesh-list
154596162|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154596163|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154596164|NCT00006455|Leucovorin|leucovorin|mesh-list
154596165|NCT00006455|Cytarabine|cytarabine|mesh-list
154596166|NCT00006455|Dexamethasone|dexamethasone|mesh-list
154596167|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
154596168|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154596169|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154596170|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154596171|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
154596172|NCT00006455|Ifosfamide|ifosfamide|mesh-list
154596173|NCT00006455|Doxorubicin|doxorubicin|mesh-list
154596174|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154596175|NCT00006455|Methotrexate|methotrexate|mesh-list
154596176|NCT00006455|Etoposide|etoposide|mesh-list
154596177|NCT00006455|Vinblastine|vinblastine|mesh-list
154596178|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
154596179|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154596180|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
154596181|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596182|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154596183|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154596184|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
154596185|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154862417|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154596186|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596187|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154596188|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596189|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
154596190|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
154596191|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596192|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154596193|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
154596194|NCT00006455|Hormones|hormones|mesh-ancestor
154596195|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596196|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154596197|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154596198|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154596199|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154596200|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596201|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154596202|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
154596203|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154596204|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154596205|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
154596206|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
154596207|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154596208|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154596209|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154596210|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
154596211|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596212|NCT00006455|Antidotes|antidotes|mesh-ancestor
154596213|NCT00006455|Protective Agents|protective agents|mesh-ancestor
154596214|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
154596215|NCT00006455|Vitamins|vitamins|mesh-ancestor
154596216|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
154596217|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596218|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596219|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596220|NCT01602315|Cetuximab|cetuximab|mesh-list
154596221|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154596222|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320062|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
154596223|NCT02537197|Naltrexone|naltrexone|mesh-list
154596224|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154596225|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154596226|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596227|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
154596228|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596229|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154596230|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154596231|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154596232|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154596233|NCT03413371|Acetaminophen|acetaminophen|mesh-list
154596234|NCT03413371|Lidocaine|lidocaine|mesh-list
154596235|NCT03413371|Bupivacaine|bupivacaine|mesh-list
154596236|NCT03413371|Ropivacaine|ropivacaine|mesh-list
154596237|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
154596238|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
154596239|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596240|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596241|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
154596242|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596243|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154596244|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154596245|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154596246|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154596247|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596248|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154596249|NCT03413371|Analgesics|analgesics|mesh-ancestor
154596250|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
154596251|NCT02344004|Amikacin|amikacin|mesh-list
154596252|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154596253|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596254|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
154596255|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154596256|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596257|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596258|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154596259|NCT03677115|Analgesics|analgesics|mesh-ancestor
154596260|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
154596261|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596262|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154596263|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154596264|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154596265|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
154596266|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596267|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596269|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154596270|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
154596271|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
154596272|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154596273|NCT05116371|Estradiol|estradiol|mesh-list
154596274|NCT05116371|Estrogens|estrogens|mesh-ancestor
154596275|NCT05116371|Hormones|hormones|mesh-ancestor
154596276|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596277|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596278|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154596279|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154596280|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154596281|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154596282|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154596283|NCT01328093|Aripiprazole|aripiprazole|mesh-list
154596284|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
154596285|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154596286|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154596287|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154596288|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596289|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596290|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
154596291|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
154596292|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596293|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596294|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154596295|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154596296|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
154862418|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
154596297|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154320138|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596298|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154596299|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154596300|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154596301|NCT03417427|Cytarabine|cytarabine|mesh-list
154596302|NCT03417427|Decitabine|decitabine|mesh-list
154596303|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154596304|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
154596305|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596306|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596307|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596308|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
154596309|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596310|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154596311|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
154596312|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596313|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
154596314|NCT03425617|Olodaterol|olodaterol|mesh-list
154596315|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154596316|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
154596317|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596318|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596319|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154596320|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
154596321|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
154596322|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154596323|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
154596324|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596325|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596326|NCT03419429|Simvastatin|simvastatin|mesh-list
154596327|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154596328|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154596329|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
154596330|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596331|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154596332|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154596333|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596334|NCT02654145|Omalizumab|omalizumab|mesh-list
154596335|NCT02654145|Albuterol|albuterol|mesh-list
154596336|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154596337|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
154596338|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596339|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596340|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154596341|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
154596342|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
154596343|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154596344|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154596345|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154596346|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154596347|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
154596348|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596349|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596350|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154596351|NCT05122455|Edoxaban|edoxaban|mesh-list
154596352|NCT05122455|Clopidogrel|clopidogrel|mesh-list
154596353|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154596354|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154596355|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154596356|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154596357|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
154596358|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596359|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596360|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596361|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154596362|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
154596363|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154596364|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
154596365|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596366|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
154596367|NCT03413059|Triamcinolone|triamcinolone|mesh-list
154596368|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154596369|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154596370|NCT03413059|Morphine|morphine|mesh-list
154596371|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154596372|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154596373|NCT03413059|Narcotics|narcotics|mesh-ancestor
154596374|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596375|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596376|NCT03413059|Analgesics|analgesics|mesh-ancestor
154596377|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
154596378|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596379|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596380|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
154596381|NCT03413059|Hormones|hormones|mesh-ancestor
154596382|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596383|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154596384|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
154596385|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596386|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596387|NCT05122377|Goserelin|goserelin|mesh-list
154596388|NCT05122377|Leuprolide|leuprolide|mesh-list
154596389|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154596390|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596391|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154596392|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
154596393|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154596394|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596395|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154596396|NCT03425461|Nivolumab|nivolumab|mesh-list
154596397|NCT03425461|Ipilimumab|ipilimumab|mesh-list
154596398|NCT03425461|Antibodies|antibodies|mesh-list
154596399|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
154596400|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154596401|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
154596402|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596403|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596404|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154596405|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596406|NCT03411109|Hydromorphone|hydromorphone|mesh-list
154596407|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154596408|NCT03411109|Narcotics|narcotics|mesh-ancestor
154596409|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596410|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596412|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
154596413|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596414|NCT01111565|Aripiprazole|aripiprazole|mesh-list
154596415|NCT01111565|Escitalopram|escitalopram|mesh-list
154596416|NCT01111565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154596417|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154596418|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154596419|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596420|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596421|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
154596422|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596423|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
154596424|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154596425|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154596426|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154596427|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596428|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
154596429|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
154596430|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154596431|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154596432|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154596433|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154596434|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154596435|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154596436|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154596437|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154596438|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
154596439|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596440|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596441|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596442|NCT03412513|Mirabegron|mirabegron|mesh-list
154596443|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154596444|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154596445|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154596446|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
154320293|NCT00111761|Vitamins|vitamins|mesh-ancestor
154596447|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596448|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596449|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596450|NCT03412513|Urological Agents|urological agents|mesh-ancestor
154596451|NCT04370379|Aflibercept|aflibercept|mesh-list
154596452|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154596453|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154596454|NCT04370379|Growth Substances|growth substances|mesh-ancestor
154596455|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596456|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
154596457|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596458|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
154596459|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154596460|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154596461|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596462|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
154596463|NCT03413891|Coagulants|coagulants|mesh-ancestor
154596464|NCT03317613|Capsaicin|capsaicin|mesh-list
154596465|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
154596466|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
154596467|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
154596468|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596469|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596470|NCT03126877|Mitomycins|mitomycins|mesh-list
154596471|NCT03126877|Mitomycin|mitomycin|mesh-list
154596472|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154596473|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596474|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
154596475|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596476|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154596477|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596478|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
154596479|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
154596480|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154596481|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
154596482|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154255735|NCT01254578|Lenalidomide|lenalidomide|mesh-list
154596483|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596485|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
154596486|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154596487|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154596488|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154596489|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
154596490|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596491|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596492|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154596493|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154596494|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154596495|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
154596496|NCT03424759|Osimertinib|osimertinib|mesh-list
154596497|NCT03424759|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154596498|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596499|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596500|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596501|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596502|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
154596503|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154596504|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596505|NCT04814745|Morphine|morphine|mesh-list
154596506|NCT04814745|Tramadol|tramadol|mesh-list
154596507|NCT04814745|Ropivacaine|ropivacaine|mesh-list
154596508|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154596509|NCT04814745|Narcotics|narcotics|mesh-ancestor
154596510|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596511|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596512|NCT04814745|Analgesics|analgesics|mesh-ancestor
154596513|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
154596514|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596515|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
154596516|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
154596517|NCT04640571|Metformin|metformin|mesh-list
154596518|NCT04640571|Valacyclovir|valacyclovir|mesh-list
154596519|NCT04640571|Enalaprilat|enalaprilat|mesh-list
154596520|NCT04640571|Enalapril|enalapril|mesh-list
154596521|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154596522|NCT04640571|Pravastatin|pravastatin|mesh-list
154596523|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154596524|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596525|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154596526|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154596527|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
154596528|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596529|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154596530|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154596531|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596532|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
154596533|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596535|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154596536|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154596537|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
154596538|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154596539|NCT04431141|Empagliflozin|empagliflozin|mesh-list
154596540|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154596541|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083402|NCT04070391|Pyridoxal|pyridoxal|mesh-list
154596542|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154596543|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596544|NCT05229627|Methylphenidate|methylphenidate|mesh-list
154596545|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154596546|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154596547|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596548|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154596549|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154596550|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154596551|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596552|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
154596553|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596554|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154596555|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154596556|NCT01976169|Palbociclib|palbociclib|mesh-list
154596557|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154596558|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596559|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596560|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596561|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596562|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154596563|NCT01976169|Immunotoxins|immunotoxins|mesh-ancestor
154596564|NCT01976169|Immunoconjugates|immunoconjugates|mesh-ancestor
154596565|NCT01976169|Immunologic Factors|immunologic factors|mesh-ancestor
154596566|NCT01976169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596567|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596568|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596569|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596570|NCT00148629|Mebendazole|mebendazole|mesh-list
154596571|NCT00148629|Piperazine|piperazine|mesh-list
154596572|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
154596573|NCT00148629|DMP 777|dmp 777|mesh-list
154596574|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
154596575|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
154596576|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154596577|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596578|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596579|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596580|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596581|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596582|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596583|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596584|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
154596585|NCT04448015|Narcotics|narcotics|mesh-ancestor
154596586|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596587|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596588|NCT04448015|Analgesics|analgesics|mesh-ancestor
154596589|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
154596590|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596591|NCT01328041|Dolutegravir|dolutegravir|mesh-list
154596592|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154596593|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154596594|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596595|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596596|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154596597|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154596598|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
154596599|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596600|NCT03412721|Analgesics|analgesics|mesh-list
154596601|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
154596602|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596603|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596604|NCT03418337|Lansoprazole|lansoprazole|mesh-list
154596605|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
154596606|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154596607|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154596608|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154596609|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596610|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596611|NCT03411967|Docetaxel|docetaxel|mesh-list
154596612|NCT03411967|Apatinib|apatinib|mesh-list
154596613|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596614|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596615|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596616|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596617|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596618|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596619|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596620|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
154596621|NCT02410772|Rifapentine|rifapentine|mesh-list
154596622|NCT02410772|Rifampin|rifampin|mesh-list
154596623|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154596624|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596625|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154596626|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154596627|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596628|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596629|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596630|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154596631|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
154596632|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
154596633|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154596634|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154596635|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154596636|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154596637|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154596638|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154596639|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154596640|NCT03814317|Treprostinil|treprostinil|mesh-list
154596641|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154596642|NCT03127319|Docetaxel|docetaxel|mesh-list
154596643|NCT03127319|Apatinib|apatinib|mesh-list
154596644|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596645|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596646|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596647|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596648|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596649|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596650|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596651|NCT03417947|Vitamin D|vitamin d|mesh-list
154596652|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
154596653|NCT03417947|Vitamins|vitamins|mesh-ancestor
154596654|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
154596655|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596656|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154596657|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154596658|NCT03905811|Terazosin|terazosin|mesh-list
154596659|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154596660|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154596661|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154596662|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
154596663|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596664|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596665|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596666|NCT03905811|Urological Agents|urological agents|mesh-ancestor
154596667|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154596668|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154596669|NCT05171309|Apatinib|apatinib|mesh-list
154596670|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596671|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596672|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320514|NCT02165566|Insulin|insulin|mesh-list
154596673|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083593|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596674|NCT03409237|Mannitol|mannitol|mesh-list
154596675|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154596676|NCT03409237|Diuretics|diuretics|mesh-ancestor
154596677|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
154596678|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596679|NCT03408847|Beclomethasone|beclomethasone|mesh-list
154596680|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596681|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
154596682|NCT03408847|Hormones|hormones|mesh-ancestor
154596683|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596684|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596685|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154596686|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
154596687|NCT03424291|Apatinib|apatinib|mesh-list
154596688|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596689|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596690|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596691|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596692|NCT04447859|Semaglutide|semaglutide|mesh-list
154596693|NCT04447859|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154596694|NCT04447859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154596695|NCT04447859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596696|NCT04412889|Immunomodulating Agents|immunomodulating agents|mesh-list
154596697|NCT04412889|Immunologic Factors|immunologic factors|mesh-ancestor
154596698|NCT04412889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596699|NCT03407521|Isosorbide|isosorbide|mesh-list
154596700|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154596701|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154596702|NCT03407521|Misoprostol|misoprostol|mesh-list
154596703|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154596704|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
154596705|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154596706|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596707|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154596708|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154596709|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
154596710|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154596711|NCT03407521|Diuretics|diuretics|mesh-ancestor
154596712|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
154596713|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
154596714|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154596715|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596716|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
154596717|NCT03424135|Promethazine|promethazine|mesh-list
154596718|NCT03424135|Naproxen|naproxen|mesh-list
154596719|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154596720|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154596721|NCT03424135|Analgesics|analgesics|mesh-ancestor
154596722|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
154596723|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596724|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596725|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596726|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154596727|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
154596728|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154596729|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596730|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596731|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154596732|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154596733|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596734|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
154596735|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
154596736|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
154596737|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
154596738|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154596739|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154596740|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
154596741|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
154596742|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596743|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154596744|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
154596745|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
154596746|NCT03411941|Aflibercept|aflibercept|mesh-list
154596747|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154596748|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154596749|NCT03411941|Growth Substances|growth substances|mesh-ancestor
154596750|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596751|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
154596752|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596753|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154596754|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
154596755|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154596756|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596758|NCT03406819|Tirofiban|tirofiban|mesh-list
154596759|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154596760|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
154596761|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154596762|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596763|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154596764|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154596765|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154596766|NCT05170217|Cannabidiol|cannabidiol|mesh-list
154596767|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
154596768|NCT03411551|Anesthetics|anesthetics|mesh-list
154596769|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596770|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596771|NCT05170061|Valsartan|valsartan|mesh-list
154596772|NCT05170061|Nebivolol|nebivolol|mesh-list
154596773|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154596774|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154596775|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154596776|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596777|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
154596778|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154596779|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154596780|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154596781|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
154596782|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596783|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596784|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
154862419|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596785|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154862420|NCT00955877|Morphine|morphine|mesh-list
154596786|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154596787|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
154596788|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596789|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154596790|NCT02520635|Temozolomide|temozolomide|mesh-list
154596791|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154596792|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
154596793|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596794|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596795|NCT03404947|Ethanol|ethanol|mesh-list
154596796|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154596797|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596798|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596799|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596800|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
154596801|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154596802|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596803|NCT03411473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154596804|NCT03411473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596805|NCT03423823|Ranibizumab|ranibizumab|mesh-list
154596806|NCT03423823|Aflibercept|aflibercept|mesh-list
154596807|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596808|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154596809|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154596810|NCT03423823|Growth Substances|growth substances|mesh-ancestor
154596811|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596812|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
154596813|NCT03411161|Paclitaxel|paclitaxel|mesh-list
154596814|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154596815|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154596816|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596817|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596818|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596819|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596820|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596821|NCT05168137|Colchicine|colchicine|mesh-list
154596822|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
154596823|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154596824|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596825|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596826|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596827|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596828|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596829|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154596830|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596832|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154596833|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154596834|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596835|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154596836|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596837|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
154596838|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154596839|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
154596840|NCT02375295|Trimethoprim|trimethoprim|mesh-list
154596841|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154596842|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596843|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154596844|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154596845|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596846|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596847|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596848|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154596849|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154596850|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154596851|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
154596852|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154596853|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154596854|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154596855|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154596856|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154862421|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154596857|NCT03394105|Docetaxel|docetaxel|mesh-list
154596858|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596859|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
154596860|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
154596861|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
154596862|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596863|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
154596864|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154596865|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154596866|NCT03393949|Prednisolone|prednisolone|mesh-list
154596867|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
154596868|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154596869|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
154596870|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596871|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
154596872|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
154596873|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596874|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596875|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154596876|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
154596877|NCT03393949|Hormones|hormones|mesh-ancestor
154596878|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596879|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154596880|NCT03393949|Protective Agents|protective agents|mesh-ancestor
154596881|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154596882|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596883|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
154596884|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154596885|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
154596886|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154596887|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596888|NCT04435743|Lenalidomide|lenalidomide|mesh-list
154596889|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
154596890|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596891|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154596892|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154596893|NCT04435743|Growth Substances|growth substances|mesh-ancestor
154596894|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
154596895|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596896|NCT03393715|Perindopril|perindopril|mesh-list
154596897|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154596898|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
154596899|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596900|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596901|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154596903|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596904|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154596905|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154596906|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596907|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596908|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154596909|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
154596910|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154596911|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596912|NCT03612921|Amantadine|amantadine|mesh-list
154596913|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154596914|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154596915|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
154596916|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596917|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
154596918|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596919|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596920|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596921|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154596922|NCT03612921|Analgesics|analgesics|mesh-ancestor
154596923|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
154596924|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596925|NCT03393481|Enoxaparin|enoxaparin|mesh-list
154596926|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
154596927|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154596928|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154596929|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596930|NCT01936857|Buprenorphine|buprenorphine|mesh-list
154596931|NCT01936857|Methadone|methadone|mesh-list
154596932|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154596934|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154596935|NCT01936857|Narcotics|narcotics|mesh-ancestor
154596936|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596937|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596938|NCT01936857|Analgesics|analgesics|mesh-ancestor
154596939|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
154596940|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596941|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154596942|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
154596943|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
154596944|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
154596945|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154596946|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154596947|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154596948|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154596949|NCT03393403|Analgesics|analgesics|mesh-ancestor
154596950|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
154596951|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154596952|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154596953|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154596954|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154596955|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
154596956|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154596957|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596958|NCT03399955|Amphotericin B|amphotericin b|mesh-list
154596959|NCT03399955|Paromomycin|paromomycin|mesh-list
154596960|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154596961|NCT03399955|Miltefosine|miltefosine|mesh-list
154596962|NCT03399955|Amebicides|amebicides|mesh-ancestor
154596963|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154596964|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154596965|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154596966|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154596967|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
154596968|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596969|NCT03397199|Apatinib|apatinib|mesh-list
154596970|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596971|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154596973|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596974|NCT03393325|Tadalafil|tadalafil|mesh-list
154596975|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
154596976|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154596977|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154596978|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154596979|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596980|NCT03393325|Urological Agents|urological agents|mesh-ancestor
154596981|NCT03399643|Atezolizumab|atezolizumab|mesh-list
154596982|NCT03399643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154596983|NCT03399643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596984|NCT03399643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154596985|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596986|NCT03393247|Infliximab|infliximab|mesh-list
154596987|NCT03393247|Azathioprine|azathioprine|mesh-list
154596988|NCT03393247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154596989|NCT03393247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154596990|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
154596991|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154596992|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154596993|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
154596994|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154596995|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154596996|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154596997|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154596998|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
154596999|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597000|NCT03407027|Triamcinolone|triamcinolone|mesh-list
154597001|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154597002|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154597003|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154597004|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154597005|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
154597006|NCT03407027|Hormones|hormones|mesh-ancestor
154862422|NCT00955877|Narcotics|narcotics|mesh-ancestor
154597007|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597008|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597009|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154597010|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
154597011|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597012|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597014|NCT01602224|Bortezomib|bortezomib|mesh-list
154597015|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154597016|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
154597017|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
154597018|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597019|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597020|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597021|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
154597022|NCT01602224|Hormones|hormones|mesh-ancestor
154597023|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597024|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154597025|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597026|NCT03399487|Ceritinib|ceritinib|mesh-list
154597027|NCT03399487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154597028|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154597029|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597030|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597031|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597032|NCT05161429|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154597033|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154597034|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597035|NCT03984045|Lidocaine|lidocaine|mesh-list
154597036|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
154597037|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
154597038|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
154597039|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597040|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597041|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
154597042|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597043|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154320885|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154597044|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154597045|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154597046|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154597047|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597048|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
154597049|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
154597050|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597051|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154597052|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154597053|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597054|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154597055|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
154597056|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597057|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154597058|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154597059|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154597060|NCT05060991|Antimetabolites|antimetabolites|mesh-list
154597061|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597062|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154597063|NCT03397069|Midazolam|midazolam|mesh-list
154597064|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154597065|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597066|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597067|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597068|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154597069|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154597070|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597071|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597072|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
154597073|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
154597074|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
154597075|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
154597076|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597077|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597078|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
154597079|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597080|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597082|NCT03396497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597083|NCT03399019|Midazolam|midazolam|mesh-list
154597084|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
154597085|NCT03399019|Propofol|propofol|mesh-list
154597086|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597087|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597088|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597089|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154597090|NCT03399019|Analgesics|analgesics|mesh-ancestor
154597091|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
154597092|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597093|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154597094|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154597095|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154597096|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
154597097|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597098|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083968|NCT04250883|Iodine|iodine|mesh-list
154597099|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597100|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
154597101|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
154597102|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154597103|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154597104|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154597105|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597106|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
154597107|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
154597108|NCT04452383|Ketamine|ketamine|mesh-list
154597109|NCT04452383|Propofol|propofol|mesh-list
154597110|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597111|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597112|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597113|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597114|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
154597115|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
154597116|NCT04452383|Analgesics|analgesics|mesh-ancestor
154597117|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
154597118|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597119|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154597120|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154597121|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154597122|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597123|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597124|NCT02520479|Pegaspargase|pegaspargase|mesh-list
154597125|NCT02520479|Asparaginase|asparaginase|mesh-list
154597126|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597127|NCT02520947|Desflurane|desflurane|mesh-list
154597128|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154597129|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
154597130|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
154597131|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597132|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597133|NCT03398941|Octreotide|octreotide|mesh-list
154597134|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597135|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154597136|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597137|NCT03392623|Niacinamide|niacinamide|mesh-list
154597138|NCT03392623|Niacin|niacin|mesh-list
154597139|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
154597140|NCT03392623|Tretinoin|tretinoin|mesh-list
154597141|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
154597142|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597143|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
154597144|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
154597145|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154597146|NCT03392623|Protective Agents|protective agents|mesh-ancestor
154597147|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597148|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
154597149|NCT03392623|Vitamins|vitamins|mesh-ancestor
154597150|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
154597151|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154597152|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
154597153|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597154|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154597155|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
154597156|NCT03396107|Dexamethasone|dexamethasone|mesh-list
154597157|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154862423|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597159|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
154597160|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597161|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597162|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597163|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
154597164|NCT03396107|Hormones|hormones|mesh-ancestor
154597165|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597166|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154597167|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597168|NCT03398785|Epinephrine|epinephrine|mesh-list
154597169|NCT03398785|Racepinephrine|racepinephrine|mesh-list
154597170|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
154597171|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154597172|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154597173|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
154597174|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597175|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597176|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597177|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154597178|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154597179|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
154597180|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597181|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154597182|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
154597183|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
154597184|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
154597185|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154597186|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154597187|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
154597188|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597189|NCT03126695|Ticagrelor|ticagrelor|mesh-list
154597190|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154597191|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154597192|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154321036|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
154597193|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154597194|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
154597195|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597196|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597198|NCT04647643|Paclitaxel|paclitaxel|mesh-list
154597199|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154597200|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597201|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
154597202|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
154597203|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
154597204|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597205|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154597206|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
154597207|NCT04167761|Glipizide|glipizide|mesh-list
154597208|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597209|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154597210|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597211|NCT03401177|Naproxen|naproxen|mesh-list
154597212|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154597213|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154597214|NCT03401177|Analgesics|analgesics|mesh-ancestor
154597215|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
154597216|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597217|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597218|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154597219|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154597220|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
154597221|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154597222|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597223|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597224|NCT04446715|Sufentanil|sufentanil|mesh-list
154597225|NCT04446715|Meperidine|meperidine|mesh-list
154597226|NCT04446715|Bupivacaine|bupivacaine|mesh-list
154597227|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
154597228|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
154597229|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597230|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597231|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
154597232|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597233|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154597234|NCT04446715|Narcotics|narcotics|mesh-ancestor
154597235|NCT04446715|Analgesics|analgesics|mesh-ancestor
154597236|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154597237|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597238|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
154597239|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
154597240|NCT03398473|Hematinics|hematinics|mesh-ancestor
154597241|NCT03395951|Diuretics|diuretics|mesh-list
154597242|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
154597243|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597244|NCT04535791|Vitamin D|vitamin d|mesh-list
154597245|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
154597246|NCT04535791|Vitamins|vitamins|mesh-ancestor
154597247|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
154597248|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597249|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154597250|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154597251|NCT03395873|Decitabine|decitabine|mesh-list
154597252|NCT03395873|Avelumab|avelumab|mesh-list
154597253|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154597254|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
154597255|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597256|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597257|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597258|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597259|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154597260|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154597261|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154597262|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
154597263|NCT03396523|Losartan|losartan|mesh-list
154597264|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154597265|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154597266|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154597267|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154597268|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597269|NCT03126097|Drospirenone|drospirenone|mesh-list
154597270|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154597271|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154597272|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154597273|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
154597274|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597275|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597276|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154597277|NCT03126097|Diuretics|diuretics|mesh-ancestor
154597278|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
154597279|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154597280|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154597281|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154597282|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
154597283|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154597284|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154597285|NCT03126097|Estrogens|estrogens|mesh-ancestor
154597286|NCT03126097|Hormones|hormones|mesh-ancestor
154597287|NCT03398083|Alprazolam|alprazolam|mesh-list
154597288|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597289|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597290|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597291|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154597292|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154597293|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597294|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
154597295|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
154597296|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597297|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597298|NCT03126721|Midazolam|midazolam|mesh-list
154597299|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154597300|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597301|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597302|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597303|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154597304|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154597305|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597306|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597307|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
154597308|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
154597309|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
154597310|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
154597311|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597312|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597313|NCT04928521|Bupivacaine|bupivacaine|mesh-list
154597314|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
154597315|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
154597316|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597317|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597318|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
154597319|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597320|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
154597321|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
154597322|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597323|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
154597324|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597325|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597326|NCT03391843|Cetuximab|cetuximab|mesh-list
154597327|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
154597328|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597329|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597330|NCT03389659|Vitamin D|vitamin d|mesh-list
154597331|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
154597332|NCT03389659|Vitamins|vitamins|mesh-ancestor
154597333|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
154597334|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597335|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154597336|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154597337|NCT04446637|Albuterol|albuterol|mesh-list
154597338|NCT04446637|Ipratropium|ipratropium|mesh-list
154597339|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154597340|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
154597341|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597342|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597343|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154597344|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
154597345|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
154597346|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154597347|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154597348|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154597349|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154597350|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
154597351|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597352|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597353|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154597354|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
154597355|NCT03395171|Vitamin D|vitamin d|mesh-list
154597356|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
154597357|NCT03395171|Vitamins|vitamins|mesh-ancestor
154597358|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
154597359|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597360|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154597361|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154597362|NCT03395977|Febuxostat|febuxostat|mesh-list
154597363|NCT03395977|Rasburicase|rasburicase|mesh-list
154597364|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
154597365|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154597366|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
154597367|NCT02678143|Sirolimus|sirolimus|mesh-list
154597368|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
154597369|NCT02678143|Fludarabine|fludarabine|mesh-list
154597370|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
154597371|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154597372|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
154597373|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597374|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154597375|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154597376|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
154597377|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597378|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597379|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154597380|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154597381|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154597382|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
154597383|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154597384|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154597385|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597386|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
154597387|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597388|NCT03395093|Midazolam|midazolam|mesh-list
154597389|NCT03395093|Fentanyl|fentanyl|mesh-list
154597390|NCT03395093|Propofol|propofol|mesh-list
154597391|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597392|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597393|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597394|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597395|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
154597396|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
154597397|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154597398|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154597399|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154597400|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597401|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
154597402|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
154597403|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597404|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597405|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154597406|NCT03395093|Narcotics|narcotics|mesh-ancestor
154597407|NCT03395093|Analgesics|analgesics|mesh-ancestor
154597408|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
154597409|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597410|NCT03389191|Acyclovir|acyclovir|mesh-list
154597411|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
154597412|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154597413|NCT04330183|Ketamine|ketamine|mesh-list
154597414|NCT04330183|Analgesics|analgesics|mesh-ancestor
154597415|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
154597416|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597417|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597418|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154597419|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154321259|NCT02184286|Nevirapine|nevirapine|mesh-list
154597420|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
154597421|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
154597422|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597423|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154597424|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154597425|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084273|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154597426|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597428|NCT03398993|Enclomiphene|enclomiphene|mesh-list
154597429|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
154597430|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154597431|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154597432|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
154597433|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597434|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597435|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154597436|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
154597437|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154597438|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154597439|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154597440|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
154597441|NCT04249297|Progestins|progestins|mesh-ancestor
154597442|NCT04249297|Hormones|hormones|mesh-ancestor
154597443|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597444|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597445|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
154597446|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597447|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597448|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597449|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154597450|NCT03391609|Analgesics|analgesics|mesh-ancestor
154597451|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
154597452|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597453|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154597454|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154597455|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154597456|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154597457|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255739|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154862424|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597458|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597459|NCT03398837|Dronabinol|dronabinol|mesh-list
154597460|NCT03398837|Lenabasum|lenabasum|mesh-list
154597461|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154597462|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154597463|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597464|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597465|NCT03398837|Hormones|hormones|mesh-ancestor
154597466|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597467|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597468|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
154597469|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597470|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154597471|NCT03398837|Analgesics|analgesics|mesh-ancestor
154597472|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
154597473|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597474|NCT03398759|Butorphanol|butorphanol|mesh-list
154597475|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154597476|NCT03398759|Narcotics|narcotics|mesh-ancestor
154597477|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597478|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597479|NCT03398759|Analgesics|analgesics|mesh-ancestor
154597480|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
154597481|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597482|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
154597483|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
154597484|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154597485|NCT03391219|Bevacizumab|bevacizumab|mesh-list
154597486|NCT03391219|Fasudil|fasudil|mesh-list
154597487|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597488|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597489|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154597490|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154597491|NCT03391219|Growth Substances|growth substances|mesh-ancestor
154597492|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597493|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
154597494|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154597495|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154597496|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597497|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154597498|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
154597499|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154597500|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597501|NCT04446923|Propranolol|propranolol|mesh-list
154597502|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154597503|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154597504|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154597505|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597506|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597507|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597508|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154597509|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154597510|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
154597511|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
154597512|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154597513|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084375|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
154084421|NCT00737373|Antidotes|antidotes|mesh-ancestor
154597514|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597515|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
154597516|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154597517|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154597518|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154597519|NCT04447105|Anesthetics|anesthetics|mesh-list
154597520|NCT04447105|Propofol|propofol|mesh-list
154597521|NCT04447105|Desflurane|desflurane|mesh-list
154597522|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597523|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597524|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597525|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597526|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
154597527|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154597528|NCT03126461|Nivolumab|nivolumab|mesh-list
154597529|NCT03126461|Ipilimumab|ipilimumab|mesh-list
154597530|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597531|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597532|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154597533|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597534|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154597535|NCT03394001|Ketorolac|ketorolac|mesh-list
154597536|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154597537|NCT03394001|Lidocaine|lidocaine|mesh-list
154597538|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
154597539|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
154597540|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597541|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597542|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
154597543|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597544|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154597545|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154597546|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154597547|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154597548|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597549|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154597550|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154597551|NCT03394001|Analgesics|analgesics|mesh-ancestor
154597552|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154597553|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154597554|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154597555|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597556|NCT03393767|Ranibizumab|ranibizumab|mesh-list
154597557|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154597558|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154597559|NCT03393767|Growth Substances|growth substances|mesh-ancestor
154597560|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597561|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
154597562|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597563|NCT03389321|Macitentan|macitentan|mesh-list
154597564|NCT03389321|Riociguat|riociguat|mesh-list
154597565|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154597566|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154597567|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597568|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154597569|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
154597570|NCT03393377|Valsartan|valsartan|mesh-list
154321424|NCT01083875|Amlexanox|amlexanox|mesh-list
154597571|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154597572|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154597573|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154597574|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597576|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
154597577|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597578|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597579|NCT01889303|Docetaxel|docetaxel|mesh-list
154597580|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597581|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
154597582|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
154597583|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
154597584|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597585|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154597586|NCT00783263|Ezetimibe|ezetimibe|mesh-list
154597587|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154597588|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154597589|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
154597590|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597591|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154597592|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154597593|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597594|NCT00664937|Montelukast|montelukast|mesh-list
154597595|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154597596|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
154597597|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154597598|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
154597599|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597600|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597601|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154597602|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154597603|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597604|NCT00540839|Fluticasone|fluticasone|mesh-list
154862425|NCT00955877|Analgesics|analgesics|mesh-ancestor
154597607|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154597608|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154597609|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
154597610|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597611|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597612|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154597613|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
154597614|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
154597615|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154597616|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154597617|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
154597618|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597619|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154597620|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154597621|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597622|NCT03389087|Etoposide|etoposide|mesh-list
154597623|NCT03389087|Apatinib|apatinib|mesh-list
154597624|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154597625|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597626|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154597627|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154597628|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597629|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597630|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154597631|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
154597632|NCT03388853|Doxofylline|doxofylline|mesh-list
154597633|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154597634|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
154597635|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154597636|NCT03388853|Expectorants|expectorants|mesh-ancestor
154597637|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
154597638|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154597639|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
154597640|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597641|NCT03388853|Protective Agents|protective agents|mesh-ancestor
154597642|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597643|NCT03388853|Antidotes|antidotes|mesh-ancestor
154597644|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
154597645|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154597646|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
154597647|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597648|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154597649|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154597650|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597651|NCT00380705|Montelukast|montelukast|mesh-list
154597652|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154597653|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
154597654|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154597655|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
154597656|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597657|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597658|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154597659|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154597660|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597661|NCT03388697|Insulin|insulin|mesh-list
154597662|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154597663|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597664|NCT03987919|Semaglutide|semaglutide|mesh-list
154597665|NCT03987919|Tirzepatide|tirzepatide|mesh-list
154597666|NCT03987919|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154597667|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154597668|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597669|NCT03987919|Incretins|incretins|mesh-ancestor
154597670|NCT03987919|Hormones|hormones|mesh-ancestor
154597671|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597672|NCT03388957|Propranolol|propranolol|mesh-list
154597673|NCT03388957|Midazolam|midazolam|mesh-list
154597674|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154597675|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597676|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154862426|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
154597677|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597678|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154597679|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154597680|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597681|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597682|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
154597683|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
154597684|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
154597685|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
154597686|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597687|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597688|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154597689|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154597690|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
154597691|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154597692|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154597693|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
154597695|NCT03395665|Progesterone|progesterone|mesh-list
154597696|NCT03395665|Estrogens|estrogens|mesh-ancestor
154597697|NCT03395665|Hormones|hormones|mesh-ancestor
154597698|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597699|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597700|NCT03395665|Progestins|progestins|mesh-ancestor
154597701|NCT00535405|Atorvastatin|atorvastatin|mesh-list
154597702|NCT00535405|Simvastatin|simvastatin|mesh-list
154597703|NCT00535405|Ezetimibe|ezetimibe|mesh-list
154597704|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154597705|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154597706|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
154597707|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597708|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154597709|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154597710|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597711|NCT00271817|Niacin|niacin|mesh-list
154597712|NCT00271817|Niacinamide|niacinamide|mesh-list
154597713|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
154597714|NCT00271817|Simvastatin|simvastatin|mesh-list
154597715|NCT00271817|Ezetimibe|ezetimibe|mesh-list
154597716|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154597717|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154084585|NCT00733239|Cycloserine|cycloserine|mesh-list
154321556|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
154597718|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154597719|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
154597720|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597721|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154597722|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154597723|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597724|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
154597725|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
154597727|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
154597728|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597729|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
154597730|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597731|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597732|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597733|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154597734|NCT03388541|Analgesics|analgesics|mesh-ancestor
154597735|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
154597736|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597737|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154597738|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154597739|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154597740|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
154597741|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597742|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597743|NCT00092989|Montelukast|montelukast|mesh-list
154597744|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154597745|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
154597746|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154597747|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
154597748|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597749|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597750|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154597751|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154597752|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597753|NCT03388463|Omeprazole|omeprazole|mesh-list
154597754|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154597755|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597756|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154597757|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597758|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597759|NCT03388151|Midazolam|midazolam|mesh-list
154597760|NCT03388151|Propofol|propofol|mesh-list
154597761|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597762|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597763|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597764|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154597765|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
154597766|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
154597767|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154597768|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154597769|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154597770|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154597771|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
154597772|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
154597773|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084629|NCT00577629|Doxorubicin|doxorubicin|mesh-list
154597774|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597775|NCT03392909|Gentamicins|gentamicins|mesh-list
154597776|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154597777|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154597778|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154597779|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597780|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597781|NCT04501211|Granisetron|granisetron|mesh-list
154597782|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
154597783|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
154597784|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597785|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597786|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597787|NCT04501211|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154597788|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154597789|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
154597790|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597791|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597792|NCT03126071|Bevacizumab|bevacizumab|mesh-list
154597793|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
154597794|NCT03126071|Irinotecan|irinotecan|mesh-list
154597795|NCT03126071|Raltitrexed|raltitrexed|mesh-list
154597796|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597797|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597798|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154597799|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154597800|NCT03126071|Growth Substances|growth substances|mesh-ancestor
154597801|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597802|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
154597803|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154597804|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154597805|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597806|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597807|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154597808|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
154597809|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154597810|NCT03392051|Clopidogrel|clopidogrel|mesh-list
154597811|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154597812|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154597813|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154597814|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154597815|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
154597816|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597817|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597818|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597819|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
154597820|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154597821|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154597822|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
154597823|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154597824|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154862427|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597825|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
154597826|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
154597827|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154597828|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
154597829|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597831|NCT04446533|Protective Agents|protective agents|mesh-ancestor
154597832|NCT03386591|Naloxone|naloxone|mesh-list
154597833|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154597834|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597835|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
154597836|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597837|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
154597838|NCT03386279|Abrocitinib|abrocitinib|mesh-list
154597839|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154597840|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154597841|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154597842|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154597843|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597844|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597845|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597846|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154597847|NCT03386201|Methylene Blue|methylene blue|mesh-list
154597848|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597849|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597850|NCT03268811|Teduglutide|teduglutide|mesh-list
154597851|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597852|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154597853|NCT03268811|Protective Agents|protective agents|mesh-ancestor
154597854|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597855|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
154597856|NCT03385967|Ropivacaine|ropivacaine|mesh-list
154597857|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154597858|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154597859|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597860|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154597861|NCT03385967|Analgesics|analgesics|mesh-ancestor
154084736|NCT00700011|Clofarabine|clofarabine|mesh-list
154597862|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
154597863|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597864|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154597865|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154597866|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154597867|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
154597868|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597869|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597870|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
154597871|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
154597872|NCT02732015|Dexamethasone|dexamethasone|mesh-list
154597873|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
154597874|NCT02732015|Doxorubicin|doxorubicin|mesh-list
154597875|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154597876|NCT02732015|Vincristine|vincristine|mesh-list
154597877|NCT02732015|Daunorubicin|daunorubicin|mesh-list
154597879|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
154597880|NCT02732015|Ondansetron|ondansetron|mesh-list
154597881|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
154597882|NCT02732015|Aprepitant|aprepitant|mesh-list
154597883|NCT02732015|BB 1101|bb 1101|mesh-list
154597884|NCT02732015|Rolapitant|rolapitant|mesh-list
154597885|NCT02732015|Mesna|mesna|mesh-list
154597886|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154597887|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
154597888|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
154597889|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597890|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597891|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597892|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
154597893|NCT02732015|Hormones|hormones|mesh-ancestor
154597894|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597895|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154597896|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597897|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
154597898|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597899|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597900|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154597901|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154597902|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154597903|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154597904|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
154597905|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
154597906|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
154597907|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
154597908|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
154597909|NCT02732015|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154597910|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154597911|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
154597912|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597913|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154597914|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
154597915|NCT02732015|Protective Agents|protective agents|mesh-ancestor
154597916|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154597917|NCT02520245|Cemiplimab|cemiplimab|mesh-list
154597918|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597919|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597920|NCT03537833|Pemetrexed|pemetrexed|mesh-list
154597921|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597922|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597923|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597924|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154597925|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154597926|NCT03439085|Durvalumab|durvalumab|mesh-list
154597927|NCT03439085|Interleukin-12|interleukin-12|mesh-list
154597928|NCT03439085|Vaccines|vaccines|mesh-list
154597929|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
154597930|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154597931|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
154597932|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
154597933|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597934|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154597935|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597936|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154597937|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154597938|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154597939|NCT03439085|Growth Substances|growth substances|mesh-ancestor
154597940|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
154597941|NCT01964807|Nicotine|nicotine|mesh-list
154597942|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154597943|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
154321782|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154597944|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154597945|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597946|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154597947|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154597948|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
154597949|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154597950|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597951|NCT00999401|Roscovitine|roscovitine|mesh-list
154597952|NCT00999401|Sapacitabine|sapacitabine|mesh-list
154597953|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597954|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
154597955|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154597956|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154597957|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597958|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597959|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154597960|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
154597961|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597962|NCT04446065|Protective Agents|protective agents|mesh-ancestor
154597963|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084825|NCT02568111|Interferons|interferons|mesh-list
154597964|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154597965|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154597966|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597967|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154597968|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
154597969|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154597970|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
154597971|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597972|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
154597973|NCT00225095|Protective Agents|protective agents|mesh-ancestor
154597974|NCT02732119|Everolimus|everolimus|mesh-list
154597975|NCT02732119|Exemestane|exemestane|mesh-list
154597976|NCT02732119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154597977|NCT02732119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154597978|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154597979|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154597980|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154597981|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
154597982|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597983|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154597984|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154597985|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154597986|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154597987|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
154597988|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154597990|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
154597991|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154597992|NCT05174195|Desogestrel|desogestrel|mesh-list
154597993|NCT05174195|Etonogestrel|etonogestrel|mesh-list
154597994|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154597995|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154597996|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154597997|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
154597998|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154597999|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598000|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154598001|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154598002|NCT05174195|Progestins|progestins|mesh-ancestor
154598003|NCT05174195|Hormones|hormones|mesh-ancestor
154598004|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598005|NCT05238727|Mepivacaine|mepivacaine|mesh-list
154598006|NCT05238727|Carticaine|carticaine|mesh-list
154598007|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
154598008|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
154598009|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598010|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598011|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
154598012|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598013|NCT03754153|Atropine|atropine|mesh-list
154084926|NCT00740415|Dexamethasone|dexamethasone|mesh-list
154598014|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154598015|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154598016|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154598017|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
154598018|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321856|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598019|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598020|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154598021|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
154598022|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
154598023|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
154598024|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154598025|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154598026|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
154598027|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598028|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598029|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
154598030|NCT03380039|Fludarabine|fludarabine|mesh-list
154598031|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154598032|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
154598033|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598034|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154598035|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154598036|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
154598037|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598038|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598039|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154598040|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154598041|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
154598042|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598043|NCT02520817|Vitamins|vitamins|mesh-list
154598044|NCT02520817|Vitamin E|vitamin e|mesh-list
154598045|NCT02520817|Vitamin A|vitamin a|mesh-list
154598046|NCT02520817|Lactulose|lactulose|mesh-list
154598047|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
154598048|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598049|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
154598050|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598051|NCT02520817|Protective Agents|protective agents|mesh-ancestor
154598053|NCT03387943|Cisplatin|cisplatin|mesh-list
154598054|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598055|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
154598056|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154598057|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
154598058|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598059|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
154598060|NCT03384095|Protective Agents|protective agents|mesh-ancestor
154598061|NCT03379181|Propranolol|propranolol|mesh-list
154598062|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154598063|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154598064|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
154598065|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598066|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598067|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598068|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154598069|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154598070|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
154598071|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154598072|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154598073|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154598074|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
154598075|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598076|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598077|NCT03379103|Propofol|propofol|mesh-list
154598078|NCT03379103|Sevoflurane|sevoflurane|mesh-list
154598079|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154598080|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598081|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598082|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154598083|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
154598084|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
154598085|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154598086|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154598087|NCT03387631|Lumefantrine|lumefantrine|mesh-list
154598088|NCT03387631|Artemether|artemether|mesh-list
154598089|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154598090|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
154598091|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154598092|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154598093|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598094|NCT03383393|Adenosine|adenosine|mesh-list
154598095|NCT03383393|Eptifibatide|eptifibatide|mesh-list
154598096|NCT03383393|Analgesics|analgesics|mesh-ancestor
154598097|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
154598098|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598099|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598100|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154598101|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
154598102|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154598103|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
154598104|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
154598105|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598106|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598107|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154598108|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
154598109|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
154598110|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
154598111|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598112|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598113|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
154598114|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598115|NCT03383315|Tramadol|tramadol|mesh-list
154598116|NCT03383315|Metoclopramide|metoclopramide|mesh-list
154598117|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154598118|NCT03383315|Narcotics|narcotics|mesh-ancestor
154598119|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598120|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598121|NCT03383315|Analgesics|analgesics|mesh-ancestor
154598122|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
154598123|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598124|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
154598125|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
154598126|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154598127|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154598128|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154598129|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
154598130|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598131|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598132|NCT03394729|Propolis|propolis|mesh-list
154598133|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598134|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
154598135|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154598136|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
154598137|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598138|NCT03252925|Expectorants|expectorants|mesh-ancestor
154598139|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
154598140|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154598141|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
154598142|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598143|NCT03252925|Protective Agents|protective agents|mesh-ancestor
154598144|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598145|NCT03252925|Antidotes|antidotes|mesh-ancestor
154598146|NCT03383237|Apatinib|apatinib|mesh-list
154598147|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598148|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154598149|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598150|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598151|NCT03387241|Fluticasone|fluticasone|mesh-list
154598152|NCT03387241|Xhance|xhance|mesh-list
154598153|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
154598154|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154598155|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154598156|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154598157|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154598158|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
154598159|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598160|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598161|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154598162|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
154598163|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
154598164|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154598165|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154598166|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154598167|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154598168|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
154598169|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598170|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598171|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
154598172|NCT03387241|Hormones|hormones|mesh-ancestor
154598173|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598174|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
154598175|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
154598176|NCT03378791|Trace Elements|trace elements|mesh-ancestor
154598177|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
154598178|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598179|NCT03383003|Amoxicillin|amoxicillin|mesh-list
154598180|NCT03383003|Metronidazole|metronidazole|mesh-list
154598181|NCT03383003|Clarithromycin|clarithromycin|mesh-list
154598182|NCT03383003|Esomeprazole|esomeprazole|mesh-list
154598183|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154598184|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598185|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154598186|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154598187|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154598188|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154598189|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154598190|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598191|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598192|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154598193|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154598194|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154598195|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
154598196|NCT03378713|Testosterone|testosterone|mesh-list
154598197|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
154598198|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
154598199|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154598200|NCT03378713|Androgens|androgens|mesh-ancestor
154598201|NCT03378713|Hormones|hormones|mesh-ancestor
154598202|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598203|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598204|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154598205|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598206|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
154598207|NCT03378323|Anesthetics|anesthetics|mesh-list
154598208|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
154598209|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598210|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598211|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
154598212|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598214|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598215|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154598216|NCT01327885|Dacarbazine|dacarbazine|mesh-list
154598217|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154598218|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
154598219|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598220|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598221|NCT03381833|Hepcidins|hepcidins|mesh-list
154598222|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598223|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154598224|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
154598225|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
154598226|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598227|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598228|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598229|NCT03381755|Ticagrelor|ticagrelor|mesh-list
154598230|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154598231|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154598232|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154598233|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154598234|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
154598235|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598236|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598237|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598238|NCT03387163|Valsartan|valsartan|mesh-list
154598239|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154598240|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154598241|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154598242|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154598243|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598244|NCT04446403|Anesthetics|anesthetics|mesh-list
154598245|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598246|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598247|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
154598248|NCT05237791|Analgesics|analgesics|mesh-ancestor
154598249|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
154598250|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598251|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598252|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
154598253|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598254|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154598255|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
154598256|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154598257|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154598258|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598259|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154598260|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
154598261|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154598262|NCT03381599|Lenograstim|lenograstim|mesh-list
154598263|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154085177|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154598264|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
154598265|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598266|NCT03394573|Aflibercept|aflibercept|mesh-list
154598267|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154598268|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154598269|NCT03394573|Growth Substances|growth substances|mesh-ancestor
154598270|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598271|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
154598272|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598273|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
154598274|NCT03381053|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154598275|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154598276|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598277|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598278|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598279|NCT03380975|Montelukast|montelukast|mesh-list
154598280|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154598281|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
154598282|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154598283|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
154598284|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598285|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598286|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154598287|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154598288|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598289|NCT03460015|Propofol|propofol|mesh-list
154598290|NCT03460015|Sevoflurane|sevoflurane|mesh-list
154598291|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154598292|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598293|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598294|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154598295|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
154598296|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
154598297|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154598298|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154598299|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
154598300|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154598301|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598302|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154598303|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154598304|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
154598305|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598306|NCT03375515|Hydromorphone|hydromorphone|mesh-list
154598307|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154598308|NCT03375515|Narcotics|narcotics|mesh-ancestor
154598309|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598310|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598311|NCT03375515|Analgesics|analgesics|mesh-ancestor
154598312|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
154598313|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598314|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
154598315|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154598316|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598317|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154322159|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154598319|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154598320|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598321|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
154598322|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598323|NCT03374345|Mitogens|mitogens|mesh-ancestor
154598324|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
154598325|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598326|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
154598327|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154598328|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598329|NCT03373955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154598330|NCT03373955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598331|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
154598332|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
154598333|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598334|NCT02814695|Protective Agents|protective agents|mesh-ancestor
154598335|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598336|NCT02814695|Vitamins|vitamins|mesh-ancestor
154598337|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
154598338|NCT03386305|Tacrolimus|tacrolimus|mesh-list
154598339|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154598340|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
154598341|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598342|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154598343|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598344|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598345|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154598346|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598347|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
154598348|NCT05237323|Azathioprine|azathioprine|mesh-list
154598349|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154598350|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598351|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154598352|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
154598353|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154598354|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598355|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598356|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598357|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
154598358|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154598359|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154598360|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
154598361|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598362|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154598363|NCT02520505|Citric Acid|citric acid|mesh-list
154598364|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
154598365|NCT02520505|Clomiphene|clomiphene|mesh-list
154598366|NCT02520505|Enclomiphene|enclomiphene|mesh-list
154598367|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
154598368|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
154598369|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154598370|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
154598371|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
154598372|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598373|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154598374|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
154598375|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598376|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598377|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154598378|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
154598379|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154598380|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154598381|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154598382|NCT03380689|Bevacizumab|bevacizumab|mesh-list
154598383|NCT03380689|Irinotecan|irinotecan|mesh-list
154598384|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154598385|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598386|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154598387|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154598388|NCT03380689|Growth Substances|growth substances|mesh-ancestor
154598389|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322249|NCT02200354|Pemetrexed|pemetrexed|mesh-list
154598390|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
154598391|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154598392|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154598394|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598395|NCT03380533|Buprenorphine|buprenorphine|mesh-list
154598396|NCT03380533|Tramadol|tramadol|mesh-list
154598397|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154598398|NCT03380533|Narcotics|narcotics|mesh-ancestor
154598399|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598400|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598401|NCT03380533|Analgesics|analgesics|mesh-ancestor
154598402|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
154598403|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598404|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154598405|NCT03386149|Loxoprofen|loxoprofen|mesh-list
154598406|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154598407|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154598408|NCT03386149|Analgesics|analgesics|mesh-ancestor
154598409|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
154085288|NCT00698841|Cetuximab|cetuximab|mesh-list
154598410|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598411|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598412|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154598413|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154598414|NCT03386071|Trametinib|trametinib|mesh-list
154598415|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598416|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154598417|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598418|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598419|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
154598420|NCT03231085|Trace Elements|trace elements|mesh-ancestor
154598421|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
154598422|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598423|NCT03385135|Allopurinol|allopurinol|mesh-list
154598424|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
154598425|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598426|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598427|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
154598428|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154598429|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154598430|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
154598431|NCT03385135|Protective Agents|protective agents|mesh-ancestor
154598432|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598433|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
154598434|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154598435|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598436|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154598437|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598438|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598439|NCT04436965|Cisplatin|cisplatin|mesh-list
154598440|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598441|NCT04420741|Iloprost|iloprost|mesh-list
154598442|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154598443|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
154598444|NCT04409041|Naltrexone|naltrexone|mesh-list
154598445|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154598446|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154598447|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598448|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
154598449|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598450|NCT03090997|Vitamins|vitamins|mesh-list
154598451|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
154598452|NCT03090997|Resveratrol|resveratrol|mesh-list
154598453|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
154598454|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598455|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
154598456|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598457|NCT03090997|Protective Agents|protective agents|mesh-ancestor
154598458|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598459|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154598460|NCT04446091|Irinotecan|irinotecan|mesh-list
154598461|NCT04446091|Apatinib|apatinib|mesh-list
154598462|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154598463|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154598464|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154598465|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598466|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598467|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598468|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154598469|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154598470|NCT04446091|Growth Substances|growth substances|mesh-ancestor
154598471|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598472|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
154598473|NCT04445935|Bivalirudin|bivalirudin|mesh-list
154598474|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
154598475|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154598476|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
154598477|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598478|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598479|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
154598480|NCT03385057|Acetaminophen|acetaminophen|mesh-list
154598481|NCT03385057|Ibuprofen|ibuprofen|mesh-list
154598482|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154598483|NCT03385057|Analgesics|analgesics|mesh-ancestor
154598484|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
154598485|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598486|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598487|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
154598488|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154598489|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154598490|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154598491|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154598492|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598493|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598494|NCT02051309|Guanfacine|guanfacine|mesh-list
154598495|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154598496|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154598497|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154598498|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154598499|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
154598500|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598501|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598502|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598503|NCT00372073|Roscovitine|roscovitine|mesh-list
154598504|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598505|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
154598506|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598507|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154598508|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598509|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598510|NCT03373409|Albuterol|albuterol|mesh-list
154598511|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154598512|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
154598513|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598514|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598515|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154598516|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
154598517|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
154598518|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154598519|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154598520|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154598521|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154598522|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
154598523|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598524|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598525|NCT03379987|Morphine|morphine|mesh-list
154598526|NCT03379987|Bupivacaine|bupivacaine|mesh-list
154598527|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
154598528|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
154598529|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598530|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598531|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
154598532|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598533|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154598534|NCT03379987|Narcotics|narcotics|mesh-ancestor
154598535|NCT03379987|Analgesics|analgesics|mesh-ancestor
154598536|NCT02730793|Aztreonam|aztreonam|mesh-list
154598537|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154598538|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598539|NCT02678533|Plerixafor|plerixafor|mesh-list
154598540|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154598541|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154322384|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598542|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
154598543|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598544|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
154598545|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154598546|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598547|NCT03379441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154598548|NCT03379441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598549|NCT03384511|Apatinib|apatinib|mesh-list
154598550|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598551|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154598552|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598553|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598554|NCT03385525|Valproic Acid|valproic acid|mesh-list
154598555|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
154598556|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598557|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598558|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
154598559|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598560|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598561|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
154598562|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154085426|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598563|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598564|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154598565|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
154598566|NCT05172739|Anesthetics|anesthetics|mesh-list
154598567|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598568|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598569|NCT05172739|Narcotics|narcotics|mesh-ancestor
154598570|NCT05172739|Analgesics|analgesics|mesh-ancestor
154598571|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
154598572|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598573|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154598574|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154598575|NCT04445311|Ivermectin|ivermectin|mesh-list
154598576|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154598577|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598578|NCT03384121|Rifampin|rifampin|mesh-list
154598579|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154598580|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
154598581|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154598582|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598583|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
154598584|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154598585|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598586|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598587|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154598588|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154598589|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154598590|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154598591|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154598592|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154598593|NCT03378661|Benzonidazole|benzonidazole|mesh-list
154598594|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154598595|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
154598596|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598597|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154598598|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154598599|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154598600|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598601|NCT03378427|Doxycycline|doxycycline|mesh-list
154598602|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
154598603|NCT03378427|Levofloxacin|levofloxacin|mesh-list
154598604|NCT03378427|Ofloxacin|ofloxacin|mesh-list
154598605|NCT03378427|Minocycline|minocycline|mesh-list
154598606|NCT03378427|Rifampin|rifampin|mesh-list
154598607|NCT03378427|Clindamycin|clindamycin|mesh-list
154598608|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154598609|NCT03378427|Tedizolid|tedizolid|mesh-list
154598610|NCT03378427|Teicoplanin|teicoplanin|mesh-list
154598611|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
154598612|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
154598613|NCT03378427|Trimethoprim|trimethoprim|mesh-list
154598614|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
154598615|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154598616|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598617|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
154322452|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154598618|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154598619|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154598621|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154598622|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598623|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598624|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598625|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154598626|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154598627|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154598628|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154598629|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
154598630|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
154598631|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154598632|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154598633|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154598634|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154598635|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154598636|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154598637|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154598638|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154598639|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154598640|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154598641|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154598642|NCT05172115|Heparin|heparin|mesh-list
154598643|NCT05172115|Enoxaparin|enoxaparin|mesh-list
154598644|NCT05172115|Plasminogen|plasminogen|mesh-list
154598645|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154598646|NCT05172115|Tinzaparin|tinzaparin|mesh-list
154598647|NCT05172115|Dalteparin|dalteparin|mesh-list
154598648|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154598649|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
154598650|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154598651|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154598652|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598653|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154598654|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
154598655|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
154598656|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
154598657|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154598658|NCT03383185|Progestins|progestins|mesh-list
154598659|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154598660|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598661|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154598662|NCT03383185|Hormones|hormones|mesh-ancestor
154598663|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598664|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154598665|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154598666|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154598667|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154598668|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154598669|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598670|NCT03374293|Antibodies|antibodies|mesh-list
154598671|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
154598672|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598673|NCT02730871|Timolol|timolol|mesh-list
154598674|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154598675|NCT02730871|Travoprost|travoprost|mesh-list
154598676|NCT02730871|Brinzolamide|brinzolamide|mesh-list
154598677|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154598678|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154598679|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
154598680|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598681|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598682|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598683|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154598684|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154598685|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154598686|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154598687|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154598688|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154598689|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598690|NCT03377335|Metformin|metformin|mesh-list
154598691|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
154598692|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154598693|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598694|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154598695|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598697|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
154598698|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154598699|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154598700|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
154598701|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598702|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598703|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598704|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598705|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154598706|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598707|NCT03373903|Everolimus|everolimus|mesh-list
154598708|NCT03373903|Dactolisib|dactolisib|mesh-list
154598709|NCT03373903|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154598710|NCT03373903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154598711|NCT03373903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598712|NCT03373903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598713|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154598714|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
154598715|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598716|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598717|NCT04445857|Calcitonin|calcitonin|mesh-list
154598718|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
154598719|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154598720|NCT04445857|Katacalcin|katacalcin|mesh-list
153489803|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
154598721|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154598722|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598723|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154598724|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
154598726|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154598727|NCT03373825|Narcotics|narcotics|mesh-ancestor
154598728|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598729|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598730|NCT03373825|Analgesics|analgesics|mesh-ancestor
154598731|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
154598732|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598733|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154598734|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154598735|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
154598736|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
154598737|NCT04445779|Ubiquinone|ubiquinone|mesh-list
154598738|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
154598739|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
154598740|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598741|NCT04445779|Vitamins|vitamins|mesh-ancestor
154598742|NCT03377101|Fulvestrant|fulvestrant|mesh-list
154598743|NCT03377101|Palbociclib|palbociclib|mesh-list
154598744|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154598745|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598746|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154598747|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154598748|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
154598749|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598750|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598751|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154598752|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598753|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598754|NCT04445467|Favipiravir|favipiravir|mesh-list
154598755|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
154598756|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598757|NCT03373669|Vaccines|vaccines|mesh-list
154598758|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
154598759|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598760|NCT03125473|Vaccines|vaccines|mesh-list
154598761|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
154598762|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598763|NCT03376789|MYL-1501D|myl-1501d|mesh-list
154598764|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154598765|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598766|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
154598767|NCT03376555|Acetylcholine|acetylcholine|mesh-list
154598768|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
154598769|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154598770|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
154598771|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598772|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598773|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598774|NCT03376243|Emollients|emollients|mesh-list
154598775|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
154598776|NCT03381859|Grazoprevir|grazoprevir|mesh-list
154598777|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154598778|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
154598779|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598780|NCT03381781|Cytarabine|cytarabine|mesh-list
154598781|NCT03381781|Decitabine|decitabine|mesh-list
154598782|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
154598783|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154598784|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
154598785|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598786|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598787|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
154598788|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598789|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154598790|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
154598791|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598792|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598793|NCT03381703|YH12852|yh12852|mesh-list
154598794|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154598795|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154598796|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
154598797|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598798|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598799|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598800|NCT03372265|Ropivacaine|ropivacaine|mesh-list
154598801|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
154598802|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
154598803|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598804|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598805|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
154598806|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598807|NCT03372109|Calcium|calcium|mesh-list
154598808|NCT03372109|Turmeric extract|turmeric extract|mesh-list
154598809|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154598810|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598811|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
154598812|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598813|NCT03372109|Protective Agents|protective agents|mesh-ancestor
154598814|NCT03371953|Atracurium|atracurium|mesh-list
154598815|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
154598816|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154598817|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154598818|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154598819|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598820|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598821|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154598822|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154598823|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
154598824|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598825|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598826|NCT03371797|Amlodipine|amlodipine|mesh-list
154598827|NCT03371797|Valsartan|valsartan|mesh-list
154598828|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154598829|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154598830|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154598831|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598832|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154598833|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598834|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
154598835|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154598836|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154598837|NCT02520115|Dexamethasone|dexamethasone|mesh-list
154598838|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
154598839|NCT02520115|Valproic Acid|valproic acid|mesh-list
154598840|NCT02520115|Ichthammol|ichthammol|mesh-list
154598841|NCT02520115|BB 1101|bb 1101|mesh-list
154598842|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154598843|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
154598844|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
154598845|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598846|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598847|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154598848|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
154598849|NCT02520115|Hormones|hormones|mesh-ancestor
154598850|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598851|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154598852|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598853|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
154598854|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598855|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598856|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
154598857|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
154598858|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598859|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
154598860|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154598861|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598862|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154598863|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
154598864|NCT03375775|Immunomodulating Agents|immunomodulating agents|mesh-list
154598865|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
154598866|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598867|NCT04527133|Aprotinin|aprotinin|mesh-list
154598868|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
154598869|NCT04527133|Coagulants|coagulants|mesh-ancestor
154598870|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154598871|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154598872|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
154598873|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598874|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598875|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154598876|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598877|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154598878|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
154598879|NCT03369847|Budesonide|budesonide|mesh-list
154598880|NCT03369847|Beclomethasone|beclomethasone|mesh-list
154598881|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154598882|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154598883|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
154598884|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598885|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598886|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154598887|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
154598888|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
154598889|NCT03369847|Hormones|hormones|mesh-ancestor
154598890|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154598891|NCT04526353|Oxybutynin|oxybutynin|mesh-list
154598892|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
154598893|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
154598894|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598895|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598896|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154598897|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154598898|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
154598899|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598900|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598901|NCT04526353|Urological Agents|urological agents|mesh-ancestor
154598902|NCT03371173|Ferric maltol|ferric maltol|mesh-list
154598903|NCT03371173|Hematinics|hematinics|mesh-ancestor
154598904|NCT03371095|Infliximab|infliximab|mesh-list
154598905|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
154598906|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154598907|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
154598908|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598909|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154598910|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154598911|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
154598912|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598913|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598914|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154598915|NCT03371095|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154598916|NCT03371095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154598917|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
154598918|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154598919|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154598920|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598921|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
154598922|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154598923|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154598924|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154598925|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154598926|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598927|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598928|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598929|NCT03370861|Immunomodulating Agents|immunomodulating agents|mesh-list
154598930|NCT03370861|Immunologic Factors|immunologic factors|mesh-ancestor
154598931|NCT03370861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598932|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154598933|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
154598935|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154598936|NCT03370705|Atorvastatin|atorvastatin|mesh-list
154598937|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154598938|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154598939|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154598940|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
154598941|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598942|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154598943|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154598944|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154598945|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
154598946|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154598947|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
154598948|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154598949|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154598950|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154598951|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598952|NCT03370705|Analgesics|analgesics|mesh-ancestor
154598953|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
154598954|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598955|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154598956|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154598957|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154598958|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154598959|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154598960|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
154598961|NCT03369379|Vitamins|vitamins|mesh-ancestor
154598962|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
154598963|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598964|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154598965|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154598966|NCT03362905|Lidocaine|lidocaine|mesh-list
154598967|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
154598968|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
154598969|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154598970|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598971|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
154598972|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154598973|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154598974|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154598975|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154598976|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154598977|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598978|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
154598979|NCT03370159|Docetaxel|docetaxel|mesh-list
154598980|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154598981|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
154598982|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
154598983|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
154598984|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154598985|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
154598986|NCT03370159|Protective Agents|protective agents|mesh-ancestor
154598987|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154598988|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
154598989|NCT03370159|Vitamins|vitamins|mesh-ancestor
154598990|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
154598991|NCT04522297|Octreotide|octreotide|mesh-list
154598992|NCT04522297|Epinephrine|epinephrine|mesh-list
154598993|NCT04522297|Midodrine|midodrine|mesh-list
154598994|NCT04522297|Norepinephrine|norepinephrine|mesh-list
154598995|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154598996|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154598997|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
154598998|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154598999|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599000|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599001|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154599002|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154599003|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
154599004|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599005|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154599006|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
154599007|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
154599008|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
154599009|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154599010|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599011|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154599012|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599013|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154599014|NCT03369067|Insulin|insulin|mesh-list
154599015|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154599016|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599017|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599018|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154599019|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599020|NCT04525729|Rituximab|rituximab|mesh-list
154599021|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154599022|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599023|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
154599024|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599025|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599026|NCT04525495|Dopamine|dopamine|mesh-list
154599027|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154599028|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
154599029|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
154599030|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599031|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599032|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
154599033|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599034|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599035|NCT04525495|Protective Agents|protective agents|mesh-ancestor
154599036|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154599037|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599038|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154599039|NCT03362281|Amoxicillin|amoxicillin|mesh-list
154599040|NCT03362281|Clarithromycin|clarithromycin|mesh-list
154599041|NCT03362281|Omeprazole|omeprazole|mesh-list
154599042|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154599043|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599044|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154599045|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599046|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154599047|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599048|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599049|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154599050|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154599051|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154599052|NCT02518789|Midazolam|midazolam|mesh-list
154599053|NCT02518789|Fentanyl|fentanyl|mesh-list
154599054|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
154599055|NCT02518789|Remifentanil|remifentanil|mesh-list
154599056|NCT02518789|Propofol|propofol|mesh-list
154599057|NCT02518789|Etomidate|etomidate|mesh-list
154599058|NCT02518789|Atracurium|atracurium|mesh-list
154599059|NCT02518789|Rocuronium|rocuronium|mesh-list
154599060|NCT02518789|Cisatracurium|cisatracurium|mesh-list
154599061|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154599062|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599063|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599064|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154599065|NCT02518789|Analgesics|analgesics|mesh-ancestor
154599066|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
154599067|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599068|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154599069|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154599070|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154599071|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154599072|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599073|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599074|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154599075|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
154599076|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
154599077|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154599078|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154599079|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154599080|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154599081|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
154599082|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
154599083|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154599084|NCT02518789|Narcotics|narcotics|mesh-ancestor
154599085|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154599086|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154599087|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154599088|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154599089|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154599090|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
154599091|NCT02929485|Bromocriptine|bromocriptine|mesh-list
154599092|NCT02929485|Tolcapone|tolcapone|mesh-list
154599093|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154599094|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154599095|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
154599096|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154599097|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599098|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
154599099|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
154599100|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599101|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599102|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154599103|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599104|NCT04523623|Ibuprofen|ibuprofen|mesh-list
154599105|NCT04523623|Oxycodone|oxycodone|mesh-list
154599106|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154599107|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154599108|NCT04523623|Analgesics|analgesics|mesh-ancestor
154599109|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
154599110|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599111|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599112|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154599113|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599114|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154599115|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599116|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599117|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154599118|NCT04523623|Narcotics|narcotics|mesh-ancestor
154599119|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599120|NCT03357289|Immunomodulating Agents|immunomodulating agents|mesh-list
154599121|NCT03357289|Immunologic Factors|immunologic factors|mesh-ancestor
154599122|NCT03357289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599123|NCT03368131|Capecitabine|capecitabine|mesh-list
154599124|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
154599125|NCT03368131|Trastuzumab|trastuzumab|mesh-list
154599126|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154599127|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
154599128|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599129|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599130|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154599131|NCT04521751|Acarbose|acarbose|mesh-list
154599132|NCT04521751|Orlistat|orlistat|mesh-list
154599133|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154599134|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599135|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599136|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599137|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599138|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154599139|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154599140|NCT04521517|Imidacloprid|imidacloprid|mesh-list
154599141|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
154599142|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599143|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599144|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599145|NCT01675167|Buprenorphine|buprenorphine|mesh-list
154599146|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154599147|NCT01675167|Narcotics|narcotics|mesh-ancestor
154599148|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599149|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599150|NCT01675167|Analgesics|analgesics|mesh-ancestor
154599151|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
154599152|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599153|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154599154|NCT03370627|Antibodies|antibodies|mesh-list
154599155|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
154599156|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599157|NCT03367663|Prednisone|prednisone|mesh-list
154599158|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154599159|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
154599160|NCT03367663|Hormones|hormones|mesh-ancestor
154599161|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154599162|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599163|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154599164|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599165|NCT03123289|Gallium citrate|gallium citrate|mesh-list
154599166|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599167|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154599168|NCT04521049|Saxagliptin|saxagliptin|mesh-list
154599169|NCT04521049|Incretins|incretins|mesh-ancestor
154599170|NCT04521049|Hormones|hormones|mesh-ancestor
154599171|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154599172|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599173|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154599174|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
154599175|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599176|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599177|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599178|NCT02267343|Nivolumab|nivolumab|mesh-list
154599179|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154599180|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599181|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154599182|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599183|NCT03123445|Gemcitabine|gemcitabine|mesh-list
154599184|NCT03123445|Endostar protein|endostar protein|mesh-list
154599185|NCT03123445|Endostatins|endostatins|mesh-list
154599186|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599187|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154599188|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
154599189|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599190|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154599191|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154599192|NCT03123445|Growth Substances|growth substances|mesh-ancestor
154599193|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599194|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
154599195|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154599196|NCT03357133|Tirofiban|tirofiban|mesh-list
154599197|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154599198|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154599199|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599200|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154599201|NCT03357055|Ketamine|ketamine|mesh-list
154599202|NCT03357055|Analgesics|analgesics|mesh-ancestor
154599203|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
154599204|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599205|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599206|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154599207|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154599208|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
154599209|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
154599210|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599211|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154599212|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154599213|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599214|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599215|NCT03367585|Vitamin D|vitamin d|mesh-list
154599216|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
154599217|NCT03367585|Vitamins|vitamins|mesh-ancestor
154599218|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
154599219|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599220|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154599221|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154599222|NCT03360955|Anesthetics|anesthetics|mesh-list
154599223|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599224|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599225|NCT00584025|Levetiracetam|levetiracetam|mesh-list
154599226|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
154599227|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
154599228|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
154599229|NCT01735461|Calcium|calcium|mesh-list
154599230|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154599231|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599232|NCT01735461|Antacids|antacids|mesh-ancestor
154599233|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599234|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599235|NCT01595841|Sirolimus|sirolimus|mesh-list
154599236|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154599237|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599238|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154599239|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599240|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
154599241|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154599242|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
154599243|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599244|NCT05405049|Lidocaine|lidocaine|mesh-list
154599245|NCT05405049|Fentanyl|fentanyl|mesh-list
154599246|NCT05405049|Morphine|morphine|mesh-list
154599247|NCT05405049|Bupivacaine|bupivacaine|mesh-list
154599248|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
154599249|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
154599250|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599251|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599252|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
154599253|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599254|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154599255|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154599256|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154599257|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154599258|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599259|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154599260|NCT05405049|Narcotics|narcotics|mesh-ancestor
154599261|NCT05405049|Analgesics|analgesics|mesh-ancestor
154599262|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154599263|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154599264|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
154599265|NCT02871843|Temozolomide|temozolomide|mesh-list
154599266|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154599267|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
154599268|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599269|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599270|NCT03356899|Bupivacaine|bupivacaine|mesh-list
154599271|NCT03356899|Anesthetics|anesthetics|mesh-list
154599272|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
154599273|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599274|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599275|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
154599276|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086131|NCT00744549|Vitamin D|vitamin d|mesh-list
154599277|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154599278|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
154599279|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154599280|NCT04523467|Growth Substances|growth substances|mesh-ancestor
154599281|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599282|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
154599283|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599284|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154599285|NCT02801097|Irinotecan|irinotecan|mesh-list
154599286|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154599287|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154599288|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599289|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599290|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599291|NCT03367195|Omeprazole|omeprazole|mesh-list
154599292|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154599293|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599294|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154599295|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323133|NCT01082627|Hormones|hormones|mesh-ancestor
154599296|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599297|NCT05123781|Metformin|metformin|mesh-list
154599298|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599299|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599300|NCT04523233|Vitamins|vitamins|mesh-list
154599301|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
154599302|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599303|NCT05127369|Fluoxetine|fluoxetine|mesh-list
154599304|NCT05127369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154599305|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154599306|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154599307|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599308|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599309|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
154599310|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599311|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154599312|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
154599313|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154599314|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154599315|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154599316|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599317|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
154599318|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599319|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
154599320|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154599321|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154599322|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599324|NCT04520035|Paclitaxel|paclitaxel|mesh-list
154599325|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154599326|NCT04520035|Cisplatin|cisplatin|mesh-list
154599327|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154599328|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599329|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
154599330|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
154599331|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
154599332|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599333|NCT04208997|Amiodarone|amiodarone|mesh-list
154599334|NCT04208997|Sotalol|sotalol|mesh-list
154599335|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154599336|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
154599337|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154599338|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086191|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
154599339|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599340|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154599341|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154599342|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154599343|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599344|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154599345|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154599346|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154599347|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154599348|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154599349|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
154599350|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599351|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599352|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
154599353|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
154599354|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599355|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
154599356|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154599357|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154599358|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154599359|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154599360|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599361|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
154599362|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599363|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599364|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154599365|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599366|NCT04518475|Rituximab|rituximab|mesh-list
154599367|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154599368|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599369|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
154599370|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599371|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599372|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154599373|NCT04278651|Hematinics|hematinics|mesh-ancestor
154599374|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154599375|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154599376|NCT05125575|Metformin|metformin|mesh-list
154599377|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599378|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599379|NCT03366883|Paclitaxel|paclitaxel|mesh-list
154599380|NCT03366883|Cisplatin|cisplatin|mesh-list
154599381|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154599382|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599383|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
154599384|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
154599385|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
154599386|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599387|NCT03366571|Entecavir|entecavir|mesh-list
154599388|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
154599389|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599390|NCT05124951|Carboplatin|carboplatin|mesh-list
154599391|NCT05124951|Etoposide|etoposide|mesh-list
154599392|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
154599393|NCT05124951|Ifosfamide|ifosfamide|mesh-list
154599394|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599395|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154599396|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154599397|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154599398|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599399|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599400|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154599401|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
154599402|NCT04523077|Antibodies|antibodies|mesh-list
154599403|NCT04523077|Hormones|hormones|mesh-list
154599404|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
154599405|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599406|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154599407|NCT05124717|Metformin|metformin|mesh-list
154599408|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599409|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599410|NCT04139655|Colchicine|colchicine|mesh-list
154599411|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
154599412|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599413|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
154599414|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
154599415|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
154599416|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599417|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599418|NCT04109547|Semaglutide|semaglutide|mesh-list
154599419|NCT04109547|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154599420|NCT04109547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599421|NCT04109547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599422|NCT03366259|Misoprostol|misoprostol|mesh-list
154599423|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154599424|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
154599425|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154599426|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599427|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154599428|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599429|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
154599430|NCT03366025|Progesterone|progesterone|mesh-list
154599431|NCT03366025|Progestins|progestins|mesh-ancestor
154599432|NCT03366025|Hormones|hormones|mesh-ancestor
154599433|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086298|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154599434|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599435|NCT05115591|Anesthetics|anesthetics|mesh-list
154599436|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599437|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599438|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
154599439|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154599440|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
154599441|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599442|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
154599443|NCT05403099|Protective Agents|protective agents|mesh-ancestor
154599444|NCT03365869|Sirolimus|sirolimus|mesh-list
154599445|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154599446|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599447|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154599448|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599449|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
154599450|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154599451|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
154599452|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599453|NCT04932213|Tropicamide|tropicamide|mesh-list
154599454|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
154599455|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
154599456|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599457|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599458|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154599459|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154599460|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
154599461|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599462|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599463|NCT03365479|Iloprost|iloprost|mesh-list
154599464|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154599465|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
154599466|NCT03355027|Atorvastatin|atorvastatin|mesh-list
154599467|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154599468|NCT03355027|Simvastatin|simvastatin|mesh-list
154599469|NCT03355027|Ezetimibe|ezetimibe|mesh-list
154599470|NCT03355027|Alirocumab|alirocumab|mesh-list
154599471|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154599472|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154599473|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
154599474|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599475|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154599476|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154599477|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599479|NCT03355027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154599480|NCT03355027|Protease Inhibitors|protease inhibitors|mesh-ancestor
154599481|NCT03828045|Apremilast|apremilast|mesh-list
154599482|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154599483|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154599484|NCT03828045|Analgesics|analgesics|mesh-ancestor
154599485|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
154599486|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599487|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599488|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154599489|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599490|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154599491|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154599492|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599493|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599494|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
154599495|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154599496|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599497|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154599498|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
154599499|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154599500|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
154599501|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599502|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
154599503|NCT02519335|Razoxane|razoxane|mesh-list
154599504|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599505|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154599506|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154599507|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154599508|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599509|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599510|NCT02519335|Protective Agents|protective agents|mesh-ancestor
154599511|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599512|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
154599513|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
154599514|NCT04509583|Vitamin E|vitamin e|mesh-list
154599515|NCT04509583|Vitamins|vitamins|mesh-ancestor
154599516|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
154599517|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599518|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
154599519|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599520|NCT04509583|Protective Agents|protective agents|mesh-ancestor
154599521|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
154599522|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
154599523|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599524|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599525|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154599526|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
154599527|NCT03350737|Heparin|heparin|mesh-list
154599528|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
154599529|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154599530|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154599531|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599532|NCT03350659|Midodrine|midodrine|mesh-list
154599533|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154599534|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154599535|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154599536|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154599537|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599538|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
154599539|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599540|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599541|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
154599542|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
154599543|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599544|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154599545|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154255743|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
154599546|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154086413|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
154599547|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154599548|NCT04443517|Propofol|propofol|mesh-list
154599549|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
154599550|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599551|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599552|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154599553|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154599554|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
154599555|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
154599556|NCT03350347|Hematinics|hematinics|mesh-ancestor
154599557|NCT03350191|Exenatide|exenatide|mesh-list
154599558|NCT03350191|Glucagon|glucagon|mesh-list
154599559|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599560|NCT03350191|Hormones|hormones|mesh-ancestor
154599561|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154599562|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599563|NCT03350191|Incretins|incretins|mesh-ancestor
154599564|NCT03350191|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154599565|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599566|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154599567|NCT02649231|Ketamine|ketamine|mesh-list
154599568|NCT02649231|Analgesics|analgesics|mesh-ancestor
154599569|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
154599570|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599571|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599572|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154599573|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154599574|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
154599575|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
154599576|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599577|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154599578|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154599579|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599580|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599581|NCT03364075|Propranolol|propranolol|mesh-list
154599582|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154599583|NCT03364075|Serotonin|serotonin|mesh-list
154599584|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154599585|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154599586|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154599587|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599588|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599589|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599590|NCT03364075|Analgesics|analgesics|mesh-ancestor
154599591|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
154599592|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599593|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
154323432|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599594|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154599595|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
154599596|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154599597|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154599598|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
154599599|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154599600|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154599601|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
154599602|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154599603|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
154599604|NCT03349957|Idarubicin|idarubicin|mesh-list
154599605|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154599606|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599607|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154599608|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154599609|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599610|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599611|NCT04524169|Thymalfasin|thymalfasin|mesh-list
154599612|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154599613|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
154599614|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599615|NCT03568929|Idelalisib|idelalisib|mesh-list
154599616|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599617|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599618|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599620|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154599621|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599622|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154599623|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599624|NCT04841499|Niacinamide|niacinamide|mesh-list
154599625|NCT04841499|Niacin|niacin|mesh-list
154599626|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
154599627|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
154599628|NCT04841499|Vitamins|vitamins|mesh-ancestor
154599629|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
154599630|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599631|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154599632|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
154599633|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599634|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154599635|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
154599636|NCT04773405|Lidocaine|lidocaine|mesh-list
154599637|NCT04773405|Epinephrine|epinephrine|mesh-list
154599638|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
154599639|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
154599640|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
154599641|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599642|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599643|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
154599644|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599645|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154599646|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154599647|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154599648|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154599649|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599650|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154599651|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154599652|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
154599653|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599654|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154599655|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154599656|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
154599657|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154599658|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
154599659|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
154599660|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
154599661|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154599662|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
154599663|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154599664|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599665|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599666|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599667|NCT01376245|Fluticasone|fluticasone|mesh-list
154599668|NCT01376245|Xhance|xhance|mesh-list
154599669|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154599670|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154599671|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
154599672|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599673|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599674|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154599675|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
154599676|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
154599677|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154599678|NCT03349489|Insulin|insulin|mesh-list
154599679|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154599680|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599681|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599682|NCT04584567|Doxycycline|doxycycline|mesh-list
154599683|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154599684|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599685|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
154599686|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154599687|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154599688|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
154599689|NCT03349177|Docetaxel|docetaxel|mesh-list
154599690|NCT03349177|Fluorouracil|fluorouracil|mesh-list
154599691|NCT03349177|Epirubicin|epirubicin|mesh-list
154599692|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154599693|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
154599694|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599695|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599696|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154599697|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
154599698|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599699|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599700|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154599701|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154599702|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154599703|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154599704|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
154599705|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154599706|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154599707|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154599708|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154599709|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599710|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
154599711|NCT04691505|Methotrexate|methotrexate|mesh-list
154599712|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154599713|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
154599714|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154599715|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599716|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154599717|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
154599718|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599719|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599720|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
154599721|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599722|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154599723|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154599724|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
154599725|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599726|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154599727|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
154599728|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154599729|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154599730|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599732|NCT05364619|Antacids|antacids|mesh-ancestor
154599733|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599734|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599735|NCT03353857|Rifampin|rifampin|mesh-list
154599736|NCT03353857|Dienogest|dienogest|mesh-list
154599737|NCT03353857|Drospirenone|drospirenone|mesh-list
154599738|NCT03353857|Midazolam|midazolam|mesh-list
154599739|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
154599740|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154599741|NCT03353857|Norethindrone|norethindrone|mesh-list
154599742|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
154599743|NCT03353857|Desogestrel|desogestrel|mesh-list
154599744|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154599745|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154599746|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599747|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599748|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154599749|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154599750|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154599751|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154599752|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
154599753|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
154599754|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
154599755|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
154599756|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599757|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599758|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154599759|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
154599760|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154599761|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154599762|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154599763|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154599764|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154599765|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
154599766|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154599767|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599768|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
154599769|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154599770|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599771|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154599772|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154599773|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154599774|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154599775|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154599776|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154599777|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154599778|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154599779|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154599780|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154599781|NCT03353857|Diuretics|diuretics|mesh-ancestor
154599782|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
154599783|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154599784|NCT03353857|Estrogens|estrogens|mesh-ancestor
154599785|NCT03353857|Hormones|hormones|mesh-ancestor
154599786|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154599787|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154599788|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599789|NCT03353857|Progestins|progestins|mesh-ancestor
154599790|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154599791|NCT04499859|Ezetimibe|ezetimibe|mesh-list
154599792|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154599793|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154599794|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
154086658|NCT00749853|Hormones|hormones|mesh-list
154599795|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599796|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154599797|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154599798|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599799|NCT05306899|Ketamine|ketamine|mesh-list
154599800|NCT05306899|Analgesics|analgesics|mesh-ancestor
154599801|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
154599802|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599803|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599804|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154599805|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154599806|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
154599807|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
154599808|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154599809|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154599810|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154599811|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599812|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599813|NCT00807651|Insulin|insulin|mesh-list
154599814|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154599815|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154599816|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599817|NCT00700791|Vitamins|vitamins|mesh-list
154599818|NCT00700791|Vitamin E|vitamin e|mesh-list
154599819|NCT00700791|Tocopherols|tocopherols|mesh-list
154599820|NCT00700791|Tocotrienols|tocotrienols|mesh-list
154599821|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
154599822|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
154599823|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599824|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
154599825|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599826|NCT00700791|Protective Agents|protective agents|mesh-ancestor
154599827|NCT04373733|Favipiravir|favipiravir|mesh-list
154599828|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
154599829|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599830|NCT05403489|Dimercaprol|dimercaprol|mesh-list
154599831|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
154599832|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
154599833|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599834|NCT04969731|Gemcitabine|gemcitabine|mesh-list
154599835|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154599836|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
154599837|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599838|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599839|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
154599840|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
154599841|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
154599842|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599843|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599844|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599845|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154599846|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
154599847|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
154599848|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154599849|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599850|NCT01674621|Abaloparatide|abaloparatide|mesh-list
154599851|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
154599852|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154599853|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599854|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154599855|NCT04644705|Niclosamide|niclosamide|mesh-list
154599856|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
154599857|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154599858|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
154599859|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154599860|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599861|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
154599862|NCT04038489|Aspirin|aspirin|mesh-list
154599863|NCT04038489|Tamoxifen|tamoxifen|mesh-list
154599864|NCT04038489|Paclitaxel|paclitaxel|mesh-list
154599865|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
154599866|NCT04038489|Doxorubicin|doxorubicin|mesh-list
154599867|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154599868|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599869|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154599870|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154599871|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154599872|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599873|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154599874|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
154599875|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599876|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599877|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154599878|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
154599879|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154599880|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154599881|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154599882|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154599883|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599884|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154599885|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154599886|NCT04038489|Analgesics|analgesics|mesh-ancestor
154599887|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
154599888|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599889|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154599890|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154599891|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154599892|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154599893|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154599894|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
154599895|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154599896|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
154323727|NCT01091753|Amlodipine|amlodipine|mesh-list
154599897|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154599899|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154599900|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154599901|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154599902|NCT04468425|Tofacitinib|tofacitinib|mesh-list
154599903|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599904|NCT04468425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154599905|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154599906|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599907|NCT04287855|Dexamethasone|dexamethasone|mesh-list
154599908|NCT04287855|Pomalidomide|pomalidomide|mesh-list
154599909|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154599910|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
154599911|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
154599912|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154599913|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599914|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154599915|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
154599916|NCT04287855|Hormones|hormones|mesh-ancestor
154599917|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154255746|NCT03341806|Avelumab|avelumab|mesh-list
154599918|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154599919|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599920|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
154599921|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154599922|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154599923|NCT04287855|Growth Substances|growth substances|mesh-ancestor
154599924|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
154599926|NCT04435587|Darunavir|darunavir|mesh-list
154599927|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
154599928|NCT04435587|Ivermectin|ivermectin|mesh-list
154599929|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154599930|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154599931|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
154599932|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599933|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599934|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154599935|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154599936|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
154599937|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154599938|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154599939|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154599940|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
154599941|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154599942|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154599943|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599944|NCT05131893|Tamoxifen|tamoxifen|mesh-list
154599945|NCT05131893|Docetaxel|docetaxel|mesh-list
154599946|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
154599947|NCT05131893|Capecitabine|capecitabine|mesh-list
154599948|NCT05131893|Trastuzumab|trastuzumab|mesh-list
154599949|NCT05131893|Letrozole|letrozole|mesh-list
154599950|NCT05131893|Epirubicin|epirubicin|mesh-list
154599951|NCT05131893|Pertuzumab|pertuzumab|mesh-list
154599952|NCT05131893|Goserelin|goserelin|mesh-list
154599953|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599954|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
154599955|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
154599956|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
154599957|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154599958|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154599959|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
154599960|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599961|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154599962|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154599963|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
154599964|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154599965|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154599966|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
154599967|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154599968|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154599969|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154599970|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154599971|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154599972|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
154599973|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154599974|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154599975|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154599976|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154599977|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154599978|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154599979|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154599980|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154599981|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
154599983|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
154599984|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
154599985|NCT02889237|Vitamins|vitamins|mesh-list
154599986|NCT02889237|Calcium|calcium|mesh-list
154599987|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
154599988|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599989|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154599990|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154599991|NCT02689167|Sunitinib|sunitinib|mesh-list
154599992|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154599993|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154599994|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154599995|NCT02689167|Growth Substances|growth substances|mesh-ancestor
154599996|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154599997|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
154599998|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154599999|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600000|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600001|NCT02582697|Cisplatin|cisplatin|mesh-list
154600002|NCT02582697|Etoposide|etoposide|mesh-list
154600003|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
154600004|NCT02582697|Bleomycin|bleomycin|mesh-list
154600005|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600006|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154600007|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154600008|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154600009|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600010|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600011|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154600012|NCT01503489|Norepinephrine|norepinephrine|mesh-list
154600013|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
154600014|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
154600015|NCT01503489|Serotonin|serotonin|mesh-list
154600016|NCT01503489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154600017|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600018|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154600019|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
154600020|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600021|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600022|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600023|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
154600024|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
154600025|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600026|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154600027|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154600028|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154600029|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
154600030|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154600031|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154600032|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154600033|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154600034|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600035|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600036|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154600037|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154600038|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600039|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
154600040|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600041|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
154600042|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154600043|NCT05185167|Propofol|propofol|mesh-list
154600044|NCT05185167|Anesthetics|anesthetics|mesh-list
154600045|NCT05185167|Desflurane|desflurane|mesh-list
154600046|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
154600047|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154600048|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600049|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600050|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154600051|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154600052|NCT05133453|Pirfenidone|pirfenidone|mesh-list
154600053|NCT05133453|Analgesics|analgesics|mesh-ancestor
154600054|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
154600055|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600056|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600057|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154600058|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154600059|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600060|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154600061|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600062|NCT04244877|Rifaximin|rifaximin|mesh-list
154600063|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154600064|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600065|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154600066|NCT05118945|Insulin|insulin|mesh-list
154600067|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154600068|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154600069|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600070|NCT05305131|Bevacizumab|bevacizumab|mesh-list
154600071|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
154600072|NCT05305131|Cisplatin|cisplatin|mesh-list
154600073|NCT05305131|Gemcitabine|gemcitabine|mesh-list
154600074|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154600075|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600076|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154600077|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154600078|NCT05305131|Growth Substances|growth substances|mesh-ancestor
154600079|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600080|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
154600081|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154600082|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
154600083|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600084|NCT05305131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154600085|NCT03122665|Nefopam|nefopam|mesh-list
154600086|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154600087|NCT03122665|Analgesics|analgesics|mesh-ancestor
154600088|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
154600089|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600090|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600091|NCT05099913|Flupenthixol|flupenthixol|mesh-list
154600092|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154600093|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154600094|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600095|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600096|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154600097|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154600098|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
154600099|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600100|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600101|NCT03346993|Bupivacaine|bupivacaine|mesh-list
154600102|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
154600103|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
154600104|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600105|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600106|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
154600107|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600108|NCT03346837|Itraconazole|itraconazole|mesh-list
154600109|NCT03346837|Rifampin|rifampin|mesh-list
154600110|NCT03346837|Linrodostat|linrodostat|mesh-list
154600111|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
154600112|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600113|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154600114|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154600115|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600116|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600117|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154600118|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
154600119|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600120|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600121|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154600122|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154600123|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
154600124|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154600125|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
154600126|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154600127|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154600128|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154600129|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154600130|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154600131|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154600132|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154600133|NCT05303961|Rebamipide|rebamipide|mesh-list
154600134|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154600135|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154600136|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
154600137|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600138|NCT05303961|Protective Agents|protective agents|mesh-ancestor
154600139|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600140|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600141|NCT03122353|Calcitriol|calcitriol|mesh-list
154600142|NCT03122353|Betamethasone|betamethasone|mesh-list
154600144|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154600145|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
154600146|NCT03122353|Calcipotriene|calcipotriene|mesh-list
154600147|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154600148|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600149|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
154600150|NCT03122353|Hormones|hormones|mesh-ancestor
154600151|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600152|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600153|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154600154|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600155|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
154600156|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154600157|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154600158|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154600159|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600160|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154600161|NCT03122353|Vitamins|vitamins|mesh-ancestor
154600162|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
154600163|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154600164|NCT05303259|Bevacizumab|bevacizumab|mesh-list
154600165|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154600166|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600167|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154600168|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154600169|NCT05303259|Growth Substances|growth substances|mesh-ancestor
154600170|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600171|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
154600172|NCT03121963|Acetaminophen|acetaminophen|mesh-list
154600173|NCT03121963|Celecoxib|celecoxib|mesh-list
154600174|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154600175|NCT03121963|Oxycodone|oxycodone|mesh-list
154600176|NCT03121963|Gabapentin|gabapentin|mesh-list
154600177|NCT03121963|Hydrocodone|hydrocodone|mesh-list
154600178|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154600179|NCT03121963|Analgesics|analgesics|mesh-ancestor
154600180|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
154600181|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600182|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600183|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
154600184|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154600185|NCT03121963|Narcotics|narcotics|mesh-ancestor
154600186|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600187|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154087048|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
154600188|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600189|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154600190|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154600191|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154600192|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600193|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600194|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
154600195|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154324028|NCT00043979|Cyclosporins|cyclosporins|mesh-list
154600197|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154600198|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154600199|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154600200|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600201|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
154600202|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
154600203|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600204|NCT04502251|Naltrexone|naltrexone|mesh-list
154600205|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154600206|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154600207|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600208|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
154600209|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600210|NCT02648217|Insulin|insulin|mesh-list
154600211|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154600212|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
154600213|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
154600214|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154600215|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
154600216|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154600217|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600218|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154600219|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154600220|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600221|NCT03122041|Incretins|incretins|mesh-ancestor
154600222|NCT03122041|Hormones|hormones|mesh-ancestor
154600223|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600224|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154600225|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
154600226|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600227|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600228|NCT04943679|Interferons|interferons|mesh-list
154600229|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
154600230|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600231|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
154600232|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600233|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
154600234|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600235|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
154600236|NCT04507165|Anesthetics|anesthetics|mesh-list
154600237|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600238|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600239|NCT04507165|Narcotics|narcotics|mesh-ancestor
154600240|NCT04507165|Analgesics|analgesics|mesh-ancestor
154600241|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
154600242|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600243|NCT04475991|Maraviroc|maraviroc|mesh-list
154600244|NCT04475991|Favipiravir|favipiravir|mesh-list
154600245|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154600246|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154600247|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600248|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154600249|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154600250|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
154600251|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600252|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154600253|NCT03387475|Deferasirox|deferasirox|mesh-list
154600254|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154600255|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
154600256|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
154600257|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600258|NCT04502017|Clopidogrel|clopidogrel|mesh-list
154600259|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154600260|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154600261|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154600262|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154600263|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
154600264|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600265|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324104|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
154600266|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600267|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
154600268|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
154600269|NCT05302713|Calcium|calcium|mesh-list
154600270|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154600271|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600272|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154600273|NCT05302713|Antacids|antacids|mesh-ancestor
154600274|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600275|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154600276|NCT04921033|Prednisolone|prednisolone|mesh-list
154600277|NCT04921033|Budesonide|budesonide|mesh-list
154600278|NCT04921033|Azathioprine|azathioprine|mesh-list
154600279|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600280|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
154600281|NCT04921033|Hormones|hormones|mesh-ancestor
154600282|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600283|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600284|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154600285|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600286|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
154600287|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600288|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154600289|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154600290|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600291|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
154600292|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600293|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154600294|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154600295|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
154600296|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154600297|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
154600298|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154600299|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
154600300|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600301|NCT03346681|Expectorants|expectorants|mesh-ancestor
154600302|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600303|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154600304|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
154600305|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600306|NCT03346681|Protective Agents|protective agents|mesh-ancestor
154600307|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600308|NCT03346681|Antidotes|antidotes|mesh-ancestor
154600309|NCT00709735|Propranolol|propranolol|mesh-list
154600310|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154600311|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154600312|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
154600313|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600314|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600315|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600316|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154600317|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154600318|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
154600319|NCT04505995|Azacitidine|azacitidine|mesh-list
154600320|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
154600321|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154600322|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
154600323|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600324|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600325|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600326|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154600327|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154600329|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600330|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154600331|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154600332|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600333|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600334|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154600335|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
154600336|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600337|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600338|NCT05135013|Drospirenone|drospirenone|mesh-list
154600339|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154600340|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154600341|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154600342|NCT05135013|Norethindrone|norethindrone|mesh-list
154324173|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154600343|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
154600344|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154600345|NCT05135013|Estradiol|estradiol|mesh-list
154600346|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154600347|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
154600348|NCT05135013|Estrogens|estrogens|mesh-ancestor
154600349|NCT05135013|Hormones|hormones|mesh-ancestor
154600350|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600351|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600352|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154600353|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
154600354|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154600355|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154600356|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154600357|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154600358|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154600359|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
154600360|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154600361|NCT05135013|Diuretics|diuretics|mesh-ancestor
154600362|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
154600363|NCT05135013|Progestins|progestins|mesh-ancestor
154600364|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154600366|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600367|NCT04505917|Misoprostol|misoprostol|mesh-list
154600368|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154600369|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
154600370|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154600371|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600372|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154600373|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154600374|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
154600375|NCT04505683|Ertapenem|ertapenem|mesh-list
154600376|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154600377|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600378|NCT05576155|Compound 21|compound 21|mesh-list
154600379|NCT05576155|Losartan|losartan|mesh-list
154600380|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154600381|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154600382|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154600383|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154600384|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600385|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600386|NCT04501783|Favipiravir|favipiravir|mesh-list
154600387|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
154600388|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600389|NCT03351751|PF-06372865|pf-06372865|mesh-list
154600390|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
154600391|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
154600392|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600393|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600394|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600395|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
154600396|NCT03347461|Dexamethasone|dexamethasone|mesh-list
154600397|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600398|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
154600399|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
154600400|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600401|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600402|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154600403|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
154600404|NCT03347461|Hormones|hormones|mesh-ancestor
154600405|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087266|NCT05266040|Valacyclovir|valacyclovir|mesh-list
154600406|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154600407|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600408|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600409|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600410|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154600411|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600412|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154600413|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154600414|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154600415|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154600416|NCT03351517|Tapentadol|tapentadol|mesh-list
154600417|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154600418|NCT03351517|Narcotics|narcotics|mesh-ancestor
154600419|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600420|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600421|NCT03351517|Analgesics|analgesics|mesh-ancestor
154600422|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
154600423|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600424|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154600425|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154600426|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154600427|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600428|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
154600429|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600430|NCT03346525|Penicillins|penicillins|mesh-list
154600431|NCT03346525|Penicillin G|penicillin g|mesh-list
154600432|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154600433|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
154600434|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154600435|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600437|NCT05060523|Midodrine|midodrine|mesh-list
154600438|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154255748|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600439|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600440|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
154600441|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600442|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
154600443|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
154600444|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600445|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154600446|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154600447|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600448|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154600449|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
154087328|NCT00758199|Hormones|hormones|mesh-ancestor
154600450|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600452|NCT04502641|Fluorouracil|fluorouracil|mesh-list
154600453|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600454|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
154600455|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
154600456|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
154600457|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600458|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
154600459|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154600460|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154600461|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
154600462|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600463|NCT05555797|Betamethasone|betamethasone|mesh-list
154600464|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
154600465|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154600466|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
154600467|NCT05555797|Tazarotene|tazarotene|mesh-list
154600468|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154600469|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600470|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
154600471|NCT05555797|Hormones|hormones|mesh-ancestor
154600472|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600473|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600474|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154600475|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600476|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
154600477|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
154600478|NCT03955575|Liraglutide|liraglutide|mesh-list
154600479|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154600480|NCT03955575|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154600481|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154600482|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600483|NCT03955575|Incretins|incretins|mesh-ancestor
154600484|NCT03955575|Hormones|hormones|mesh-ancestor
154600485|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600486|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154600487|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154600488|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
154600489|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600490|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154324323|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600492|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154600493|NCT03351205|Estradiol|estradiol|mesh-list
154600494|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154600495|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
154600496|NCT03351205|Estrogens|estrogens|mesh-ancestor
154600497|NCT03351205|Hormones|hormones|mesh-ancestor
154600498|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600499|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600500|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154600501|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
154600502|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154600503|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154600504|NCT03351205|Progestins|progestins|mesh-ancestor
154600505|NCT04698057|Amoxicillin|amoxicillin|mesh-list
154600506|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
154600507|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
154600508|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
154600509|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154600510|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154600511|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600512|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153491771|NCT06077032|Chlorhexidine|chlorhexidine|mesh-list
154600513|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154600514|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600515|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600516|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600517|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154600518|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154600519|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154600520|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154600521|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
154600522|NCT02449005|Coagulants|coagulants|mesh-ancestor
154600523|NCT04132791|Aspirin|aspirin|mesh-list
154600524|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154600525|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154600526|NCT04132791|Analgesics|analgesics|mesh-ancestor
154600527|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
154600528|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600529|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600530|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600531|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154600532|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154600533|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154600534|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600535|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154600536|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154600537|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600538|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
154600539|NCT04250493|Insulin|insulin|mesh-list
154600540|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154600541|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600542|NCT04147221|Imipenem|imipenem|mesh-list
154600543|NCT04147221|Relebactam|relebactam|mesh-list
154600544|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154600545|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600546|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154600547|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600548|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600549|NCT02517619|Dexamethasone|dexamethasone|mesh-list
154600550|NCT02517619|Prednisolone|prednisolone|mesh-list
154600551|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154600552|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
154600553|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154600554|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
154600555|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154600556|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154600557|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
154600558|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154600559|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154600560|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
154600561|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
154600562|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600563|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600564|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154600565|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
154600566|NCT02517619|Hormones|hormones|mesh-ancestor
154600567|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600568|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154600569|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600570|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154600571|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154600572|NCT02517619|Protective Agents|protective agents|mesh-ancestor
154600573|NCT03892395|Vitamin D|vitamin d|mesh-list
154600574|NCT03892395|Vitamins|vitamins|mesh-list
154600575|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
154600576|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
154600577|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600578|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154600579|NCT04086147|Tenecteplase|tenecteplase|mesh-list
154600580|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154600581|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154600582|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600583|NCT03161223|Azacitidine|azacitidine|mesh-list
154600584|NCT03161223|Durvalumab|durvalumab|mesh-list
154600585|NCT03161223|Romidepsin|romidepsin|mesh-list
154600586|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154600587|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
154600588|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600589|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600590|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600591|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154600592|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154600593|NCT03161223|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154600594|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154600595|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
154600596|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154600597|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
154600598|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154600599|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600600|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154600601|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154600602|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600603|NCT06152458|Thiamine|thiamine|mesh-list
154600604|NCT06152458|Vitamins|vitamins|mesh-ancestor
154600605|NCT06152458|Micronutrients|micronutrients|mesh-ancestor
154600606|NCT06152458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600607|NCT06152458|Vitamin B Complex|vitamin b complex|mesh-ancestor
154600608|NCT06152393|Antibodies|antibodies|mesh-list
154600609|NCT06152393|Immunologic Factors|immunologic factors|mesh-ancestor
154600610|NCT06152393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600611|NCT06152367|Aldesleukin|aldesleukin|mesh-list
154600612|NCT06152367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600613|NCT06152367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154600614|NCT06152367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154600615|NCT06152367|Antiviral Agents|antiviral agents|mesh-ancestor
154600616|NCT06152367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600617|NCT06151743|Cetuximab|cetuximab|mesh-list
154600618|NCT06151743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154600619|NCT06151743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600620|NCT06151639|Anesthetics|anesthetics|mesh-list
154600621|NCT06151639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600622|NCT06151639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600623|NCT06151522|Norepinephrine|norepinephrine|mesh-list
154600624|NCT06151522|Adrenergic Agents|adrenergic agents|mesh-list
154600625|NCT06151522|Adrenergic Agonists|adrenergic agonists|mesh-list
154600626|NCT06151522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600627|NCT06151522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600628|NCT06151522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600629|NCT06151522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600630|NCT06151522|Sympathomimetics|sympathomimetics|mesh-ancestor
154600631|NCT06151522|Autonomic Agents|autonomic agents|mesh-ancestor
154600632|NCT06151522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600633|NCT06151522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154600634|NCT06151509|Norepinephrine|norepinephrine|mesh-list
154600635|NCT06151509|Adrenergic Agents|adrenergic agents|mesh-list
154600636|NCT06151509|Adrenergic Agonists|adrenergic agonists|mesh-list
154600637|NCT06151509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600638|NCT06151509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600639|NCT06151509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600640|NCT06151509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600641|NCT06151509|Sympathomimetics|sympathomimetics|mesh-ancestor
154600642|NCT06151509|Autonomic Agents|autonomic agents|mesh-ancestor
154600643|NCT06151509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600644|NCT06151509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154600645|NCT06151496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154600646|NCT06151496|Adrenergic Agents|adrenergic agents|mesh-list
154600647|NCT06151496|Adrenergic Agonists|adrenergic agonists|mesh-list
154600648|NCT06151496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600649|NCT06151496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600650|NCT06151496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600651|NCT06151470|Phenylephrine|phenylephrine|mesh-list
154600652|NCT06151470|Oxymetazoline|oxymetazoline|mesh-list
154600653|NCT06151470|Adrenergic Agents|adrenergic agents|mesh-list
154600654|NCT06151470|Adrenergic Agonists|adrenergic agonists|mesh-list
154600655|NCT06151470|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154600656|NCT06151470|Mydriatics|mydriatics|mesh-ancestor
154600657|NCT06151470|Autonomic Agents|autonomic agents|mesh-ancestor
154600658|NCT06151470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600659|NCT06151470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600660|NCT06151470|Sympathomimetics|sympathomimetics|mesh-ancestor
154255749|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
154600662|NCT06151470|Nasal Decongestants|nasal decongestants|mesh-ancestor
154600663|NCT06151470|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600664|NCT06151470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154600665|NCT06151470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600666|NCT06151470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600667|NCT06151470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600668|NCT06151470|Protective Agents|protective agents|mesh-ancestor
154600669|NCT06151457|Norepinephrine|norepinephrine|mesh-list
154600670|NCT06151457|Adrenergic Agents|adrenergic agents|mesh-list
154600671|NCT06151457|Adrenergic Agonists|adrenergic agonists|mesh-list
154600672|NCT06151457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600673|NCT06151457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600674|NCT06151457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600675|NCT06151457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600676|NCT06151457|Sympathomimetics|sympathomimetics|mesh-ancestor
154600677|NCT06151457|Autonomic Agents|autonomic agents|mesh-ancestor
154600678|NCT06151457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600679|NCT06151457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154600680|NCT06151444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154600681|NCT06151444|Adrenergic Agents|adrenergic agents|mesh-list
154600682|NCT06151444|Adrenergic Agonists|adrenergic agonists|mesh-list
154600683|NCT06151444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600684|NCT06151444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600685|NCT06151444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600686|NCT06151392|Zinc|zinc|mesh-list
154600687|NCT06151392|Zinc Sulfate|zinc sulfate|mesh-list
154600688|NCT06151392|Trace Elements|trace elements|mesh-ancestor
154600689|NCT06151392|Micronutrients|micronutrients|mesh-ancestor
154600690|NCT06151392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600691|NCT06151392|Astringents|astringents|mesh-ancestor
154600692|NCT06151392|Dermatologic Agents|dermatologic agents|mesh-ancestor
154600693|NCT06147622|Cyproheptadine|cyproheptadine|mesh-list
154600694|NCT06147622|Prazosin|prazosin|mesh-list
154600695|NCT06147622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154600696|NCT06147622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154600697|NCT06147622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154600698|NCT06147622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154600699|NCT06147622|Adrenergic Agents|adrenergic agents|mesh-ancestor
154600700|NCT06147622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600701|NCT06147622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600702|NCT06147622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600703|NCT06147622|Antipruritics|antipruritics|mesh-ancestor
154600704|NCT06147622|Dermatologic Agents|dermatologic agents|mesh-ancestor
154600705|NCT06147622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154600706|NCT06147622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154600707|NCT06147622|Histamine Antagonists|histamine antagonists|mesh-ancestor
154600708|NCT06147622|Histamine Agents|histamine agents|mesh-ancestor
154600709|NCT06147622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154600710|NCT06147622|Serotonin Agents|serotonin agents|mesh-ancestor
154600711|NCT06147622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154600712|NCT06138600|Tenofovir|tenofovir|mesh-list
154600713|NCT06138600|Lamivudine|lamivudine|mesh-list
154600714|NCT06138600|Emtricitabine|emtricitabine|mesh-list
154600715|NCT06138600|Cabotegravir|cabotegravir|mesh-list
154600716|NCT06138600|Antiviral Agents|antiviral agents|mesh-ancestor
154600717|NCT06138600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600718|NCT06138600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154600719|NCT06138600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154600720|NCT06138600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600721|NCT06138600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600723|NCT06138600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154600724|NCT06138600|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154600725|NCT06138600|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154600726|NCT06108596|Interleukin-2|interleukin-2|mesh-list
154600727|NCT06108596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600728|NCT06108596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154600729|NCT06108596|Analgesics|analgesics|mesh-ancestor
154600730|NCT06108596|Sensory System Agents|sensory system agents|mesh-ancestor
154600731|NCT06108596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600732|NCT06108596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600733|NCT06085144|Erenumab|erenumab|mesh-list
154600734|NCT06085144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154600735|NCT06085144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600736|NCT06085144|Analgesics|analgesics|mesh-ancestor
154600737|NCT06085144|Sensory System Agents|sensory system agents|mesh-ancestor
154600738|NCT06085144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600739|NCT06085144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600740|NCT06061354|Teriparatide|teriparatide|mesh-list
154600741|NCT06061354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154600742|NCT06061354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600743|NCT06061354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154600744|NCT06037564|Lamivudine|lamivudine|mesh-list
154600745|NCT06037564|Dolutegravir|dolutegravir|mesh-list
154600746|NCT06037564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154600747|NCT06037564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154600748|NCT06037564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600749|NCT06037564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600750|NCT06037564|Antiviral Agents|antiviral agents|mesh-ancestor
154600751|NCT06037564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600752|NCT06037564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154600753|NCT06037564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154600754|NCT06037564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154600755|NCT06037564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154600756|NCT06033352|Ivermectin|ivermectin|mesh-list
154600757|NCT06033352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154600758|NCT06033352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600759|NCT06008275|Neratinib|neratinib|mesh-list
154600760|NCT06008275|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154600761|NCT06008275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154600762|NCT06008275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600763|NCT06008275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600764|NCT06000423|Tranexamic Acid|tranexamic acid|mesh-list
154600765|NCT06000423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154600766|NCT06000423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154600767|NCT06000423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600768|NCT06000423|Hemostatics|hemostatics|mesh-ancestor
154600769|NCT06000423|Coagulants|coagulants|mesh-ancestor
154600770|NCT05994768|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154600771|NCT05994768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154600772|NCT05994768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600773|NCT05978648|Paclitaxel|paclitaxel|mesh-list
154600774|NCT05978648|Docetaxel|docetaxel|mesh-list
154600775|NCT05978648|Cyclophosphamide|cyclophosphamide|mesh-list
154600776|NCT05978648|Carboplatin|carboplatin|mesh-list
154600777|NCT05978648|Trastuzumab|trastuzumab|mesh-list
154600778|NCT05978648|Epirubicin|epirubicin|mesh-list
154600779|NCT05978648|Pertuzumab|pertuzumab|mesh-list
154600780|NCT05978648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154600781|NCT05978648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600782|NCT05978648|Tubulin Modulators|tubulin modulators|mesh-ancestor
154600783|NCT05978648|Antimitotic Agents|antimitotic agents|mesh-ancestor
154600784|NCT05978648|Mitosis Modulators|mitosis modulators|mesh-ancestor
154600785|NCT05978648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600786|NCT05978648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154600787|NCT05978648|Immunologic Factors|immunologic factors|mesh-ancestor
154600788|NCT05978648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600789|NCT05978648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154600790|NCT05978648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154600791|NCT05978648|Alkylating Agents|alkylating agents|mesh-ancestor
154600792|NCT05978648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154600793|NCT05978648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154324628|NCT01198834|Analgesics|analgesics|mesh-ancestor
154600794|NCT05978648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154600795|NCT05978648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154600796|NCT05978648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154600797|NCT05978648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600798|NCT05898633|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154600799|NCT05898633|Pulmonary Surfactant-Associated Protein D|pulmonary surfactant-associated protein d|mesh-list
154600800|NCT05898633|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600801|NCT05877846|Vitamin D|vitamin d|mesh-list
154600802|NCT05877846|Ergocalciferols|ergocalciferols|mesh-list
154600803|NCT05877846|Cholecalciferol|cholecalciferol|mesh-list
154600804|NCT05877846|Vitamins|vitamins|mesh-list
154600805|NCT05877846|Micronutrients|micronutrients|mesh-ancestor
154600806|NCT05877846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600807|NCT05877846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154600808|NCT05877846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154600809|NCT05876806|Trametinib|trametinib|mesh-list
154600810|NCT05876806|Dabrafenib|dabrafenib|mesh-list
154600811|NCT05876806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600812|NCT05876806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154600813|NCT05876806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600814|NCT05876806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600815|NCT05868109|Nitric Oxide|nitric oxide|mesh-list
154600816|NCT05868109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154600817|NCT05868109|Autonomic Agents|autonomic agents|mesh-ancestor
154600818|NCT05868109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600819|NCT05868109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600820|NCT05868109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154600821|NCT05868109|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600822|NCT05868109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154600823|NCT05868109|Antioxidants|antioxidants|mesh-ancestor
154600824|NCT05868109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600825|NCT05868109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600826|NCT05868109|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154087682|NCT03205137|Diuretics|diuretics|mesh-ancestor
154600827|NCT05868109|Vasodilator Agents|vasodilator agents|mesh-ancestor
154600828|NCT05868109|Gasotransmitters|gasotransmitters|mesh-ancestor
154600829|NCT05868109|Protective Agents|protective agents|mesh-ancestor
154600830|NCT05859464|Pembrolizumab|pembrolizumab|mesh-list
154600831|NCT05859464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154600832|NCT05859464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600833|NCT05859464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154600834|NCT05859464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600835|NCT05821686|Aldesleukin|aldesleukin|mesh-list
154600836|NCT05821686|Interleukin-2|interleukin-2|mesh-list
154600837|NCT05821686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600838|NCT05821686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154600839|NCT05821686|Analgesics|analgesics|mesh-ancestor
154600840|NCT05821686|Sensory System Agents|sensory system agents|mesh-ancestor
154600841|NCT05821686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600842|NCT05821686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600843|NCT05821686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154600844|NCT05821686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154600845|NCT05821686|Antiviral Agents|antiviral agents|mesh-ancestor
154600846|NCT05821686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600847|NCT05807620|Sunscreening Agents|sunscreening agents|mesh-list
154600848|NCT05807620|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154600849|NCT05807620|Protective Agents|protective agents|mesh-ancestor
154600850|NCT05807620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600851|NCT05807620|Dermatologic Agents|dermatologic agents|mesh-ancestor
154600852|NCT05763823|Letermovir|letermovir|mesh-list
154600853|NCT05763823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154600854|NCT05763823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600855|NCT05763823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600856|NCT05763823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600857|NCT05763823|Antiviral Agents|antiviral agents|mesh-ancestor
154600858|NCT05763823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600859|NCT05741658|Dapagliflozin|dapagliflozin|mesh-list
154600860|NCT05741658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154600861|NCT05741658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600862|NCT05741658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154600863|NCT05741658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600864|NCT05738148|Vasopressins|vasopressins|mesh-list
154600865|NCT05738148|Arginine Vasopressin|arginine vasopressin|mesh-list
154600866|NCT05738148|Epinephrine|epinephrine|mesh-list
154600867|NCT05738148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600868|NCT05738148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154600869|NCT05738148|Adrenergic Agents|adrenergic agents|mesh-ancestor
154600870|NCT05738148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600871|NCT05738148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600872|NCT05738148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600873|NCT05738148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154600874|NCT05738148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154600875|NCT05738148|Autonomic Agents|autonomic agents|mesh-ancestor
154600876|NCT05738148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600877|NCT05738148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154600878|NCT05738148|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600879|NCT05738148|Mydriatics|mydriatics|mesh-ancestor
154600880|NCT05738148|Sympathomimetics|sympathomimetics|mesh-ancestor
154600881|NCT05738148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154600882|NCT05738148|Hemostatics|hemostatics|mesh-ancestor
154600883|NCT05738148|Coagulants|coagulants|mesh-ancestor
154600884|NCT05738148|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154600885|NCT05738148|Natriuretic Agents|natriuretic agents|mesh-ancestor
154600886|NCT05715216|Nivolumab|nivolumab|mesh-list
154600887|NCT05715216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154600888|NCT05715216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600889|NCT05715216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154600890|NCT05715216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600891|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154600892|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
154600893|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600894|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154600895|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154600896|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
154600897|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600898|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600899|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154600900|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
154600901|NCT05686356|Bedaquiline|bedaquiline|mesh-list
154600902|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154600903|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
154600904|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154600905|NCT05686356|Expectorants|expectorants|mesh-ancestor
154600906|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
154600907|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154600908|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
154600909|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600910|NCT05686356|Protective Agents|protective agents|mesh-ancestor
154600911|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600912|NCT05686356|Antidotes|antidotes|mesh-ancestor
154600913|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
154600914|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154600915|NCT05670379|Exenatide|exenatide|mesh-list
154600916|NCT05670379|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154600917|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154600918|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600919|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154600920|NCT05670379|Incretins|incretins|mesh-ancestor
154600921|NCT05670379|Hormones|hormones|mesh-ancestor
154600922|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154600923|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
154600924|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154600925|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600926|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600927|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154600928|NCT05658510|Analgesics|analgesics|mesh-ancestor
154600929|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
154600930|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600931|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154600932|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154600933|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154600934|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154600935|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154600936|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600937|NCT05633979|Trastuzumab|trastuzumab|mesh-list
154600938|NCT05633979|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154255765|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600939|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154600941|NCT05633979|Immunoconjugates|immunoconjugates|mesh-ancestor
154600942|NCT05633979|Immunologic Factors|immunologic factors|mesh-ancestor
154600943|NCT05633979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600944|NCT05626920|Disulfiram|disulfiram|mesh-list
154600945|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154600946|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154600947|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154600948|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600949|NCT05622812|Lidocaine|lidocaine|mesh-list
154600950|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
154600951|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
154600952|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154087853|NCT00673179|Methotrexate|methotrexate|mesh-list
154600953|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600954|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
154600955|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600956|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154600957|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154600958|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154600959|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154600960|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600961|NCT05620108|Rocuronium|rocuronium|mesh-list
154600962|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154600963|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154600964|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154600965|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600966|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600967|NCT05615779|Levan|levan|mesh-list
154600968|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154600969|NCT05603741|Lidocaine|lidocaine|mesh-list
154600970|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
154600971|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
154600972|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600973|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600974|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
154600975|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600976|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154600977|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154600978|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154600979|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154600980|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600981|NCT05537883|Bupivacaine|bupivacaine|mesh-list
154600982|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
154600983|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
154600984|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154600985|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600986|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
154600987|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154600988|NCT05505552|Vitamin K|vitamin k|mesh-list
154600989|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
154600990|NCT05505552|Vitamins|vitamins|mesh-ancestor
154600991|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
154600992|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154600993|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154600994|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154600995|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154600996|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
154600997|NCT05505552|Coagulants|coagulants|mesh-ancestor
154600998|NCT05471076|Complement C4b|complement c4b|mesh-list
154600999|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
154601000|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601001|NCT05441215|Ritonavir|ritonavir|mesh-list
154601002|NCT05441215|Nirmatrelvir|nirmatrelvir|mesh-list
154601003|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154601004|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154601005|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
154601006|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601007|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601008|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154601009|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154601010|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
154601011|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492322|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601012|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154601013|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154601015|NCT05413122|Varenicline|varenicline|mesh-list
154601016|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154601017|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
154601018|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601019|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601020|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154601021|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154601022|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
154601023|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601024|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601025|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154601026|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601027|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601028|NCT05357794|Immunotoxins|immunotoxins|mesh-ancestor
154601029|NCT05357794|Immunoconjugates|immunoconjugates|mesh-ancestor
154601030|NCT05357794|Immunologic Factors|immunologic factors|mesh-ancestor
154601031|NCT05357794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601032|NCT05345002|Tretinoin|tretinoin|mesh-list
154601033|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601034|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
154601035|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
154601036|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
154601037|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
154601038|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601039|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601040|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601041|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
154601042|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
154601043|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
154601044|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
154601045|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601046|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601047|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601048|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
154601049|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
154601050|NCT05294679|Propofol|propofol|mesh-list
154601051|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154601052|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601053|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253754|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253755|NCT00369629|Gemcitabine|gemcitabine|mesh-list
154253756|NCT00369629|Pemetrexed|pemetrexed|mesh-list
154253757|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154253758|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
154253759|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253760|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253761|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253762|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154253763|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154253764|NCT01133600|Vancomycin|vancomycin|mesh-list
154253765|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154253766|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253767|NCT01133912|Paclitaxel|paclitaxel|mesh-list
154253768|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154253769|NCT01133912|Gemcitabine|gemcitabine|mesh-list
154253770|NCT01133912|Lapatinib|lapatinib|mesh-list
154253771|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154253772|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253773|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
154253774|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
154253775|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
154253776|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253777|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154253778|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
154253779|NCT01133912|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154253780|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253781|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253782|NCT05320094|Sorbitol|sorbitol|mesh-list
154253783|NCT05320094|Charcoal|charcoal|mesh-list
154253784|NCT05320094|Antidotes|antidotes|mesh-ancestor
154253785|NCT05320094|Protective Agents|protective agents|mesh-ancestor
153492411|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
154253786|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253787|NCT05320094|Cathartics|cathartics|mesh-ancestor
154253788|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253789|NCT01233752|Morphine|morphine|mesh-list
154253790|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154253791|NCT01233752|Narcotics|narcotics|mesh-ancestor
154253792|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253793|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253794|NCT01233752|Analgesics|analgesics|mesh-ancestor
154324928|NCT00033371|Eflornithine|eflornithine|mesh-list
154601054|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154601055|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
154601056|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
154601057|NCT05269615|Valsartan|valsartan|mesh-list
154601058|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154601059|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154601060|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154601061|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601062|NCT05180968|Dronabinol|dronabinol|mesh-list
154601063|NCT05180968|Nabilone|nabilone|mesh-list
154601064|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
154601065|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
154601066|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601067|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601068|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601069|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154601070|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154601071|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601072|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154601073|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
154601074|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154601075|NCT05180968|Analgesics|analgesics|mesh-ancestor
154601076|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
154601077|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154601078|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154087978|NCT02583854|Hemostatics|hemostatics|mesh-list
154601079|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601080|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601081|NCT05180968|Hormones|hormones|mesh-ancestor
154601082|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601083|NCT05130619|Ethanol|ethanol|mesh-list
154601084|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154601085|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601086|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601087|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601088|NCT05130268|Dronedarone|dronedarone|mesh-list
154601089|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154601090|NCT05082285|Vaccines|vaccines|mesh-list
154601091|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
154601092|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601093|NCT05055323|Pyrvinium|pyrvinium|mesh-list
154601094|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
154601095|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154601096|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601097|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
154601098|NCT05036681|Futibatinib|futibatinib|mesh-list
154601099|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601100|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601101|NCT05036681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154601102|NCT05036681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601103|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
154601104|NCT05004519|Remifentanil|remifentanil|mesh-list
154601105|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154601106|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601107|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601108|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154601109|NCT05004519|Analgesics|analgesics|mesh-ancestor
154601110|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
154601111|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601112|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154601113|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154601114|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154601115|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
154601116|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601117|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601118|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154601119|NCT05004519|Narcotics|narcotics|mesh-ancestor
154601121|NCT04991103|Lenalidomide|lenalidomide|mesh-list
154601123|NCT04991103|Daratumumab|daratumumab|mesh-list
154601124|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601125|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
154601126|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
154601127|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601128|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601129|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601130|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
154601131|NCT04991103|Hormones|hormones|mesh-ancestor
154601132|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601133|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154601134|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601135|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
154601136|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154601137|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154601138|NCT04991103|Growth Substances|growth substances|mesh-ancestor
154601139|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
154601140|NCT04988256|Cyclosporine|cyclosporine|mesh-list
154601141|NCT04988256|Prednisone|prednisone|mesh-list
154601142|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
154601143|NCT04988256|Cyclosporins|cyclosporins|mesh-list
154601144|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601145|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
154601146|NCT04988256|Hormones|hormones|mesh-ancestor
154601147|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601148|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601149|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154601150|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601151|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601152|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601153|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601154|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
154601155|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
154601156|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601157|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
154601158|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601159|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154601160|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
154601161|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
154601162|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601163|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601164|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154601165|NCT04988256|Protective Agents|protective agents|mesh-ancestor
154601166|NCT04948203|Sirolimus|sirolimus|mesh-list
154601167|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154601168|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601169|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154601170|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601171|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
154601172|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601173|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
154601174|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601175|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
154601176|NCT04939623|Probenecid|probenecid|mesh-list
154601177|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
154601178|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
154601179|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601180|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
154601181|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601182|NCT04897516|Benzonidazole|benzonidazole|mesh-list
154601183|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601184|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
154601185|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601186|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154601187|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154601188|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154601189|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601190|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154601191|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601192|NCT04828226|Clonidine|clonidine|mesh-list
154601193|NCT04828226|Analgesics|analgesics|mesh-ancestor
154601194|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
154601195|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601196|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601197|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154601199|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
154601200|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154601201|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154601202|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154601203|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
154601204|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601205|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601206|NCT04781855|Nivolumab|nivolumab|mesh-list
154601207|NCT04781855|Ipilimumab|ipilimumab|mesh-list
154601208|NCT04781855|Ibrutinib|ibrutinib|mesh-list
154601209|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601210|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601211|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154601212|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601213|NCT04781855|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154601214|NCT04781855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601215|NCT04781855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601216|NCT04754399|Cannabidiol|cannabidiol|mesh-list
154601217|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
154601218|NCT04734990|Azacitidine|azacitidine|mesh-list
154601219|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154601220|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
154601221|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601222|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601223|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601224|NCT04661280|Donepezil|donepezil|mesh-list
154601225|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154601226|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601227|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601228|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
154601229|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601230|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601231|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
154601232|NCT04646187|Adalimumab|adalimumab|mesh-list
154601233|NCT04646187|Infliximab|infliximab|mesh-list
154601234|NCT04646187|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154601235|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601236|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601237|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
154601238|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601239|NCT04617522|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154601240|NCT04617522|Immunoconjugates|immunoconjugates|mesh-ancestor
154601241|NCT04617522|Immunologic Factors|immunologic factors|mesh-ancestor
154601242|NCT04617522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601243|NCT04606914|Maytansine|maytansine|mesh-list
154601244|NCT04606914|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154601245|NCT04606914|Immunoconjugates|immunoconjugates|mesh-ancestor
154601246|NCT04606914|Immunologic Factors|immunologic factors|mesh-ancestor
154601247|NCT04606914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601248|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154601249|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601250|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
154601251|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
154601252|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
154601253|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601254|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
154601255|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601256|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
154601257|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601258|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601259|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601260|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
154601261|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601262|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601263|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601264|NCT04552223|Nivolumab|nivolumab|mesh-list
154601265|NCT04552223|Relatlimab|relatlimab|mesh-list
154601266|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601267|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088170|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
154601268|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154601269|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601270|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
154601271|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154601272|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154601273|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
154601274|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601275|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154601276|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154601277|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601278|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601279|NCT04504825|Dexamethasone|dexamethasone|mesh-list
154601280|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
154601281|NCT04504825|Bortezomib|bortezomib|mesh-list
154325110|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601282|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601283|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
154601284|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601285|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601286|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601287|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
154601288|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601289|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601290|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601291|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601292|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
154601293|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
154601294|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601295|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601296|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
154601297|NCT04504825|Hormones|hormones|mesh-ancestor
154601298|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601299|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154601300|NCT04442503|Zuranolone|zuranolone|mesh-list
154601301|NCT04442503|Antidepressive Agents|antidepressive agents|mesh-ancestor
154601302|NCT04442503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154601303|NCT04427072|Docetaxel|docetaxel|mesh-list
154601304|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601305|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
154601306|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
154601307|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
154601308|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601309|NCT04401774|Nivolumab|nivolumab|mesh-list
154601310|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601311|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601312|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154601313|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601314|NCT04374773|Dronabinol|dronabinol|mesh-list
154601315|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
154601316|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601317|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154601318|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154601319|NCT04374773|Analgesics|analgesics|mesh-ancestor
154601320|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
154601321|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601322|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154601323|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154601324|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601325|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601326|NCT04374773|Hormones|hormones|mesh-ancestor
154601327|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601328|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
154601329|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154601330|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
154601331|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601332|NCT04331704|Tenofovir|tenofovir|mesh-list
154601333|NCT04331704|Emtricitabine|emtricitabine|mesh-list
154601334|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
154601335|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601336|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154601337|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154601338|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601339|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601340|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154601341|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154601342|NCT04304144|Dexamethasone|dexamethasone|mesh-list
154601343|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
154601344|NCT04304144|Bortezomib|bortezomib|mesh-list
154601345|NCT04304144|Daratumumab|daratumumab|mesh-list
154601346|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601348|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601349|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601350|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601351|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
154601352|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601353|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601354|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601355|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601356|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
154601358|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601359|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601360|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
154601361|NCT04304144|Hormones|hormones|mesh-ancestor
154601362|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601363|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154601364|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
154601365|NCT04300751|Narcotics|narcotics|mesh-ancestor
154601366|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088313|NCT00759993|Chromium|chromium|mesh-list
154601367|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601368|NCT04300751|Analgesics|analgesics|mesh-ancestor
154601369|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
154601370|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601371|NCT04285086|Anagrelide|anagrelide|mesh-list
154601372|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154601373|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154601374|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601375|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154601376|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
154601377|NCT04265872|Bortezomib|bortezomib|mesh-list
154601378|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601379|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601380|NCT04265872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154601381|NCT04265872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601382|NCT04249037|Tenofovir|tenofovir|mesh-list
154601383|NCT04249037|Emtricitabine|emtricitabine|mesh-list
154601384|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154601385|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154601386|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
154601387|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601388|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154601389|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154601390|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601391|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601392|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154601393|NCT04245865|Leucovorin|leucovorin|mesh-list
154601394|NCT04245865|Tocotrienols|tocotrienols|mesh-list
154601395|NCT04245865|Vitamin E|vitamin e|mesh-list
154601396|NCT04245865|Tocopherols|tocopherols|mesh-list
154601397|NCT04245865|Bevacizumab|bevacizumab|mesh-list
154601398|NCT04245865|Capecitabine|capecitabine|mesh-list
154601399|NCT04245865|Fluorouracil|fluorouracil|mesh-list
154601400|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
154601401|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
154601402|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601403|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601404|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154601405|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154601406|NCT04245865|Growth Substances|growth substances|mesh-ancestor
154601407|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601408|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
154601409|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154601410|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
154601411|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601412|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601413|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
154601414|NCT04245865|Antidotes|antidotes|mesh-ancestor
154601415|NCT04245865|Protective Agents|protective agents|mesh-ancestor
154601416|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
154601417|NCT04245865|Vitamins|vitamins|mesh-ancestor
154601418|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
154601419|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
154601420|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
154601421|NCT04245839|Fludarabine|fludarabine|mesh-list
154601422|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601423|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
154601425|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601426|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601427|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
154601428|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601429|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601430|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601431|NCT04239716|Anesthetics|anesthetics|mesh-list
154601432|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601433|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601434|NCT04140396|Lidocaine|lidocaine|mesh-list
154601435|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
154601436|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
154601437|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601438|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601439|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
154601440|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601441|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154601442|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154601443|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154601444|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154601445|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601446|NCT04135456|Mannitol|mannitol|mesh-list
154601447|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154601448|NCT04135456|Diuretics|diuretics|mesh-ancestor
154601449|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
154601450|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601451|NCT04128748|Cytarabine|cytarabine|mesh-list
154601452|NCT04128748|Daunorubicin|daunorubicin|mesh-list
154601453|NCT04128748|Quizartinib|quizartinib|mesh-list
154601454|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154601455|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
154601456|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601457|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601458|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
154601459|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601460|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601461|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
154601462|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601463|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154601464|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154601465|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154088354|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154601466|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601467|NCT04128748|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154601468|NCT04128748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601469|NCT04068519|Tislelizumab|tislelizumab|mesh-list
154601470|NCT04068519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601471|NCT04068519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601472|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
154601473|NCT04059458|Calcium|calcium|mesh-list
154601474|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154601475|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601476|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154601477|NCT04059172|Ibuprofen|ibuprofen|mesh-list
154601478|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154601479|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154601480|NCT04059172|Analgesics|analgesics|mesh-ancestor
154601481|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
154601482|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601483|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601484|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601485|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601486|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154601487|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601488|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601489|NCT04047641|Cytarabine|cytarabine|mesh-list
154601490|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154601491|NCT04047641|Idarubicin|idarubicin|mesh-list
154601492|NCT04047641|Cladribine|cladribine|mesh-list
154601493|NCT04047641|Quizartinib|quizartinib|mesh-list
154601494|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154601495|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
154601496|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601497|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601498|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
154601499|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601500|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601501|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
154601502|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601503|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154601504|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154325336|NCT03135106|Itraconazole|itraconazole|mesh-list
154601505|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154601506|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601507|NCT04047641|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154601508|NCT04047641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601509|NCT04038008|Fluconazole|fluconazole|mesh-list
154601510|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
154601511|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601512|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154601513|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154601514|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601515|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601516|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154601517|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
154601518|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601519|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601520|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154601521|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154601522|NCT04019821|Insulin|insulin|mesh-list
154601523|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154601524|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
154601525|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
154601526|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
154601527|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154601528|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601529|NCT04009343|Lumefantrine|lumefantrine|mesh-list
154601530|NCT04009343|Artemether|artemether|mesh-list
154601531|NCT04009343|Piperaquine|piperaquine|mesh-list
154601532|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154601533|NCT04009343|Artenimol|artenimol|mesh-list
154601534|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
154601535|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154601536|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154601537|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601538|NCT03940703|Osimertinib|osimertinib|mesh-list
154601539|NCT03940703|Tepotinib|tepotinib|mesh-list
154601540|NCT03940703|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154601541|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601542|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601543|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601544|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601545|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
154601546|NCT03918798|Procaine|procaine|mesh-list
154601547|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154601548|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
154601549|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
154601550|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601551|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601552|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
154601553|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601554|NCT03909737|Azithromycin|azithromycin|mesh-list
154601555|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154601556|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601557|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
154601558|NCT03861403|Avelumab|avelumab|mesh-list
154601559|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601560|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
154601561|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601562|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601563|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601564|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
154601565|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601566|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601567|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601568|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601569|NCT03853395|Antibodies|antibodies|mesh-list
154601570|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
154601571|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601574|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601575|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088518|NCT00770835|Metformin|metformin|mesh-list
154601576|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154601577|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154601578|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601579|NCT03818672|Rifaximin|rifaximin|mesh-list
154601580|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154601581|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325404|NCT00945646|Hormones|hormones|mesh-ancestor
154601582|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601583|NCT03792490|Fasudil|fasudil|mesh-list
154601584|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154601585|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154601586|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601587|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154601588|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601589|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
154601590|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601591|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601592|NCT03771612|Naproxen|naproxen|mesh-list
154601593|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154601594|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154601595|NCT03771612|Analgesics|analgesics|mesh-ancestor
154601596|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
154601597|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601598|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601599|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601600|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601601|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
154601602|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154601603|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601604|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601605|NCT03752216|Niraparib|niraparib|mesh-list
154601606|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154601607|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601608|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601609|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601610|NCT03729687|Capecitabine|capecitabine|mesh-list
154601611|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
154601612|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154601613|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
154601614|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601615|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601616|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
154601617|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
154601618|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154601619|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601620|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601621|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601622|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154601623|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
154601624|NCT03710421|Fludarabine|fludarabine|mesh-list
154601625|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601626|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
154601627|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601628|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601629|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601630|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
154601631|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601632|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601633|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601634|NCT03618537|Dexamethasone|dexamethasone|mesh-list
154601635|NCT03618537|Ixazomib|ixazomib|mesh-list
154601636|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601637|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
154601638|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
154601639|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601640|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601641|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601642|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
154601643|NCT03618537|Hormones|hormones|mesh-ancestor
154601644|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601645|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154601646|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601647|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
154601648|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601649|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601650|NCT03612960|Nicotine|nicotine|mesh-list
154601651|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154601652|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
154601653|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601654|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601655|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154601656|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154601657|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
154601658|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601659|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601660|NCT03605758|Ivermectin|ivermectin|mesh-list
154601661|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154601662|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601663|NCT03586414|Ubiquinone|ubiquinone|mesh-list
154601664|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
154601665|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601666|NCT03546894|Ceritinib|ceritinib|mesh-list
154601667|NCT03546894|Alectinib|alectinib|mesh-list
154601668|NCT03546894|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154601669|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601670|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601671|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601672|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601673|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
154601674|NCT03531736|Fludarabine|fludarabine|mesh-list
154601675|NCT03531736|Rituximab|rituximab|mesh-list
154601676|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154601677|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
154601678|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601679|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
154601680|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601681|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601682|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601683|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
154601684|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601685|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601686|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601687|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601688|NCT03504501|Lamotrigine|lamotrigine|mesh-list
154601689|NCT03504501|Lovastatin|lovastatin|mesh-list
154601690|NCT03504501|L 647318|l 647318|mesh-list
154601691|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
154601692|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
154601693|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154601694|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154601695|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601696|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154601697|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601698|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154601699|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154601700|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601701|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154601702|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154601703|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154601704|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154601705|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
154601706|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154601707|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154601708|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601709|NCT03371017|Carboplatin|carboplatin|mesh-list
154601710|NCT03371017|Gemcitabine|gemcitabine|mesh-list
154601711|NCT03371017|Capecitabine|capecitabine|mesh-list
154601712|NCT03371017|Atezolizumab|atezolizumab|mesh-list
154601713|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601714|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154601715|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
154601716|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601717|NCT03371017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154601718|NCT03371017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601719|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
154601720|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601721|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601722|NCT03341143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154601723|NCT03341143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601724|NCT03076021|Levomethorphan|levomethorphan|mesh-list
154601725|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
154601726|NCT03076021|Isotretinoin|isotretinoin|mesh-list
154601727|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
154601728|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
154601729|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154601730|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154601731|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601732|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601733|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601734|NCT03076021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154601735|NCT03076021|Narcotics|narcotics|mesh-ancestor
154601736|NCT03076021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601737|NCT03076021|Analgesics|analgesics|mesh-ancestor
154601738|NCT03076021|Sensory System Agents|sensory system agents|mesh-ancestor
154601739|NCT03076021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601740|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
154601741|NCT03049189|Everolimus|everolimus|mesh-list
154601742|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154601743|NCT03049189|Edotreotide|edotreotide|mesh-list
154601744|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
154601745|NCT03049189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154601746|NCT03049189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601747|NCT03049189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601748|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601749|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601750|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
154601751|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601752|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601753|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154601754|NCT03005782|Cemiplimab|cemiplimab|mesh-list
154601755|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154601756|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601757|NCT02911792|Metformin|metformin|mesh-list
154601758|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
154601759|NCT02911792|Glipizide|glipizide|mesh-list
154601760|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154601761|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601762|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154601763|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601764|NCT02804815|Aspirin|aspirin|mesh-list
154601765|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154601766|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154601767|NCT02804815|Analgesics|analgesics|mesh-ancestor
154601768|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
154601769|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601770|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601771|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601772|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601773|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154601774|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154601775|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601776|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154601777|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154601778|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601779|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
154601780|NCT02622854|Insulin|insulin|mesh-list
154601781|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154601782|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601783|NCT02460887|Cisplatin|cisplatin|mesh-list
154601784|NCT02460887|Gemcitabine|gemcitabine|mesh-list
154601785|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601786|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154601787|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
154601788|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601789|NCT02203643|Dexamethasone|dexamethasone|mesh-list
154601790|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
154601791|NCT02203643|Lenalidomide|lenalidomide|mesh-list
154601792|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601793|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
154601794|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601795|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154601796|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601797|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
154601798|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601799|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601800|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601801|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601802|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
154601803|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
154601804|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601805|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601806|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
154601807|NCT02203643|Hormones|hormones|mesh-ancestor
154601808|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601809|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154601810|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154601811|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154601812|NCT02203643|Growth Substances|growth substances|mesh-ancestor
154601813|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
154601814|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
154601815|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154601816|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
154601817|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601818|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601819|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
154601820|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154601821|NCT01867606|Antibodies|antibodies|mesh-list
154601822|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
154601823|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601824|NCT01828112|Docetaxel|docetaxel|mesh-list
154601825|NCT01828112|Pemetrexed|pemetrexed|mesh-list
154601826|NCT01828112|Ceritinib|ceritinib|mesh-list
154601827|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601828|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
154601829|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
154601830|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
154601831|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601832|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601833|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154601834|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154601835|NCT01828112|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154601836|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601837|NCT01740427|Letrozole|letrozole|mesh-list
154601838|NCT01740427|Palbociclib|palbociclib|mesh-list
154601839|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601840|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154601841|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154601842|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601843|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601844|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154601845|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
154601846|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601847|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601848|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154601849|NCT01657682|Crenolanib|crenolanib|mesh-list
154601850|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601851|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
154601852|NCT01135199|Pomalidomide|pomalidomide|mesh-list
154601853|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
154601854|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601855|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154601856|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154601857|NCT01135199|Growth Substances|growth substances|mesh-ancestor
154601858|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
154601859|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601860|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154601861|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154601862|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
154601863|NCT00882193|Ribavirin|ribavirin|mesh-list
154601864|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154601865|NCT00882193|Betaine|betaine|mesh-list
154601866|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
154601867|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601868|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
154601869|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601870|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154601871|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
154601872|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154601873|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154601874|NCT00755898|Amantadine|amantadine|mesh-list
154601875|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154601876|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154601877|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
154601878|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601879|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
154601880|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601881|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601882|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601883|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154601884|NCT00755898|Analgesics|analgesics|mesh-ancestor
154601885|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
154601886|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601887|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
154601888|NCT00567606|Etidronic Acid|etidronic acid|mesh-list
154601889|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154601890|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154601891|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601892|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154601893|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601894|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154601895|NCT00540995|Etoposide|etoposide|mesh-list
154601896|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
154601897|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
154601898|NCT00540995|Busulfan|busulfan|mesh-list
154601899|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154601900|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601901|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154601902|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154601903|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154601904|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601905|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
154601906|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601907|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
154601908|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601909|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601910|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601911|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
154601912|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
154601913|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
154601914|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
154601915|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
154601916|NCT01285557|Cisplatin|cisplatin|mesh-list
154601917|NCT01285557|Fluorouracil|fluorouracil|mesh-list
154601918|NCT01285557|Tegafur|tegafur|mesh-list
154601919|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601920|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
154601921|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601922|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154601923|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601924|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
154601925|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601926|NCT03083067|Budesonide|budesonide|mesh-list
154601927|NCT03083067|Bromides|bromides|mesh-list
154601928|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
154601929|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
154601930|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154601931|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154601932|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
154601933|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601934|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601935|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154601936|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
154601937|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
154601938|NCT03083067|Hormones|hormones|mesh-ancestor
154601939|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601940|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154601941|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154601942|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154601943|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
154601944|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601945|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601946|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
154601947|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154601948|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
154601949|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
154601950|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
154601951|NCT05638399|Denosumab|denosumab|mesh-list
154601952|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154601953|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601954|NCT02512471|Ropivacaine|ropivacaine|mesh-list
154601955|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
154601956|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
154601957|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154601958|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601959|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
154601960|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154601961|NCT02507479|Thiotepa|thiotepa|mesh-list
154601962|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154601963|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
154601964|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601965|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601966|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154601967|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154601968|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
154601969|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601970|NCT02512315|Cisplatin|cisplatin|mesh-list
154601971|NCT02512315|Docetaxel|docetaxel|mesh-list
154601972|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601973|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
154601974|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
154601975|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
154601976|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601977|NCT02507323|Ticagrelor|ticagrelor|mesh-list
154601978|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154601979|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154601980|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154601981|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154601982|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154601983|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
154601984|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154601985|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154601986|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601987|NCT02507245|Hormones|hormones|mesh-list
154601988|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154601989|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154601990|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154601991|NCT05431257|Venetoclax|venetoclax|mesh-list
154601992|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154601993|NCT05431023|Lactoferrin|lactoferrin|mesh-list
154601994|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154601995|NCT02507167|Rifampin|rifampin|mesh-list
154601996|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154601997|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
154601998|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154601999|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602000|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
154088881|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602001|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154602002|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602003|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602004|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154602005|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154602006|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154602007|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154602008|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154602009|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154602010|NCT01376167|Chloroquine|chloroquine|mesh-list
154602011|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154602012|NCT01376167|Primaquine|primaquine|mesh-list
154602013|NCT01376167|Tafenoquine|tafenoquine|mesh-list
154602014|NCT01376167|Amebicides|amebicides|mesh-ancestor
154602015|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154602017|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602018|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
154602019|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154602020|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154602021|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154602022|NCT01376167|Analgesics|analgesics|mesh-ancestor
154602023|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
154602024|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602025|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602026|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602027|NCT01376167|Filaricides|filaricides|mesh-ancestor
154602028|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
154602029|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
154602030|NCT02511613|Squalamine|squalamine|mesh-list
154602031|NCT02511613|Ranibizumab|ranibizumab|mesh-list
154602032|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154602033|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154602034|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154602035|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154602036|NCT02511613|Growth Substances|growth substances|mesh-ancestor
154602037|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602038|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
154602039|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602040|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154602041|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602042|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154602043|NCT02511613|Protective Agents|protective agents|mesh-ancestor
154602045|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
154602046|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602047|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602048|NCT02506777|Metformin|metformin|mesh-list
154602049|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
154602050|NCT02506777|Doxorubicin|doxorubicin|mesh-list
154602051|NCT02506777|Fluorouracil|fluorouracil|mesh-list
154602052|NCT02506777|Melatonin|melatonin|mesh-list
154602053|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154602054|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
154602055|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602056|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154602057|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154602058|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
154602059|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602060|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602061|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154602062|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154602063|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154602064|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154602065|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154602066|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602067|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
154602068|NCT02506777|Protective Agents|protective agents|mesh-ancestor
154602069|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602070|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
154602071|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154602072|NCT02516527|Ipilimumab|ipilimumab|mesh-list
154602073|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154602074|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602075|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154602076|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602077|NCT02511847|Afatinib|afatinib|mesh-list
154602078|NCT02511847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154602079|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602080|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602081|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602082|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602083|NCT02506855|Ropivacaine|ropivacaine|mesh-list
154602084|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
154602085|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
154602086|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602087|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602088|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
154602089|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602090|NCT02511223|Olaparib|olaparib|mesh-list
154602091|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154602092|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602093|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602094|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602095|NCT02516059|Oxycodone|oxycodone|mesh-list
154602096|NCT02516059|Naloxone|naloxone|mesh-list
154602097|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154602098|NCT02516059|Narcotics|narcotics|mesh-ancestor
154602099|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602100|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602101|NCT02516059|Analgesics|analgesics|mesh-ancestor
154602102|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
154602103|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602104|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154602105|NCT02506231|Leucovorin|leucovorin|mesh-list
154602106|NCT02506231|Folic Acid|folic acid|mesh-list
154602107|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
154602108|NCT02506231|Antidotes|antidotes|mesh-ancestor
154602109|NCT02506231|Protective Agents|protective agents|mesh-ancestor
154602110|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602111|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
154602112|NCT02506231|Vitamins|vitamins|mesh-ancestor
154602113|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
154602114|NCT02506231|Hematinics|hematinics|mesh-ancestor
154602115|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154089010|NCT00570687|Insulin|insulin|mesh-list
154602116|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154602117|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154602118|NCT02505997|Delafloxacin|delafloxacin|mesh-list
154602119|NCT02505997|Midazolam|midazolam|mesh-list
154602120|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154602121|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154602122|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602123|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602124|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154602125|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154602126|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154602127|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154602128|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
154602129|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
154602130|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
154602131|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
154602132|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602133|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602134|NCT02505997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602135|NCT02505841|Ropivacaine|ropivacaine|mesh-list
154602136|NCT02505841|Succinylcholine|succinylcholine|mesh-list
154602137|NCT02505841|Curare|curare|mesh-list
154602138|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
154602139|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
154602140|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602141|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602142|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
154602143|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602144|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154602145|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154602146|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154602147|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154602148|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154602149|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154602150|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
154602151|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602152|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602153|NCT03345667|Ranibizumab|ranibizumab|mesh-list
154602154|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154602155|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154602156|NCT03345667|Growth Substances|growth substances|mesh-ancestor
154602157|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602158|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
154602159|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602160|NCT04499989|Isoniazid|isoniazid|mesh-list
154602161|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
154602162|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154602163|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602164|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154602165|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154602166|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
154602167|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602168|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154602169|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
154602170|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
154602171|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602172|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
154602173|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
154602174|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602175|NCT02505451|Dobutamine|dobutamine|mesh-list
154602176|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154602177|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
154602178|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
154602179|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602180|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602181|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154602182|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154602183|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154325995|NCT00770848|Rilotumumab|rilotumumab|mesh-list
154602184|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602185|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602186|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602187|NCT02505451|Protective Agents|protective agents|mesh-ancestor
154602188|NCT02505295|Selenium|selenium|mesh-list
154602189|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
154602190|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602191|NCT02505295|Protective Agents|protective agents|mesh-ancestor
154602192|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602193|NCT02505295|Trace Elements|trace elements|mesh-ancestor
154602194|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
154602195|NCT02510911|Caffeine|caffeine|mesh-list
154602196|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154602197|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602198|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154602199|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602200|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602201|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154602202|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154602203|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
154602204|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602205|NCT03121807|Leucovorin|leucovorin|mesh-list
154602206|NCT03121807|Fluorouracil|fluorouracil|mesh-list
154602207|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
154602208|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
154602209|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602210|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154602211|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602212|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154602213|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
154602214|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602215|NCT03121807|Antidotes|antidotes|mesh-ancestor
154602216|NCT03121807|Protective Agents|protective agents|mesh-ancestor
154602217|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
154602218|NCT03121807|Vitamins|vitamins|mesh-ancestor
154602219|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
154602220|NCT03343873|Midazolam|midazolam|mesh-list
154602221|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
154602222|NCT03343873|Propofol|propofol|mesh-list
154602223|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154602224|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602225|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602226|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154602227|NCT03343873|Analgesics|analgesics|mesh-ancestor
154602228|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
154602229|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602230|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154602231|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154602232|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154602233|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602234|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602235|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602236|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154602237|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
154602238|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
154602239|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154602240|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154602241|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154602242|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154602243|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
154602244|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
154602245|NCT03343795|Progesterone|progesterone|mesh-list
154602246|NCT03343795|Progestins|progestins|mesh-ancestor
154602247|NCT03343795|Hormones|hormones|mesh-ancestor
154602248|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154602249|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602250|NCT02510287|Lidocaine|lidocaine|mesh-list
154602251|NCT02510287|Fentanyl|fentanyl|mesh-list
154602252|NCT02510287|Bupivacaine|bupivacaine|mesh-list
154602253|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
154602254|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
154602255|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602256|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602257|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
154602258|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602259|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154602260|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154602261|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154602262|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326071|NCT00042289|Ritonavir|ritonavir|mesh-list
154602263|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602264|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154602265|NCT02510287|Narcotics|narcotics|mesh-ancestor
154602266|NCT02510287|Analgesics|analgesics|mesh-ancestor
154602267|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154602268|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154602269|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
154602270|NCT02515435|Apatinib|apatinib|mesh-list
154602271|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602272|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602273|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602274|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602275|NCT02515201|Taurolidine|taurolidine|mesh-list
154602276|NCT02515201|Heparin|heparin|mesh-list
154602277|NCT02515201|Calcium heparin|calcium heparin|mesh-list
154602278|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
154602279|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154602280|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154602281|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602282|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602283|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154602284|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602285|NCT02504983|Sorafenib|sorafenib|mesh-list
154602286|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602287|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602288|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602289|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602290|NCT02510053|Caspofungin|caspofungin|mesh-list
154602291|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
154602292|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602293|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602294|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602295|NCT02504359|Cytarabine|cytarabine|mesh-list
154602296|NCT02504359|Methotrexate|methotrexate|mesh-list
154602297|NCT02504359|Etoposide|etoposide|mesh-list
154602298|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
154602299|NCT02504359|Melphalan|melphalan|mesh-list
154602300|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
154602301|NCT02504359|Carmustine|carmustine|mesh-list
154602302|NCT02504359|Ixazomib|ixazomib|mesh-list
154602303|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
154602304|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154602305|NCT02504359|Tacrolimus|tacrolimus|mesh-list
154602306|NCT02504359|Glycine|glycine|mesh-list
154602307|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154602308|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
154602309|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154602310|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602311|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154602312|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
154602313|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602314|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602315|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
154602316|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602317|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154602318|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154602319|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
154602320|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154602321|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154602322|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154602323|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154602324|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154602325|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
154602326|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602327|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154602328|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154602329|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
154602330|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154602331|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
154602332|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
154602333|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154602334|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154602335|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154602336|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
154602337|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602338|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
154602339|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154602340|NCT02729545|Cyproterone|cyproterone|mesh-list
154602341|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154602342|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154602343|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154602344|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
154602345|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154602346|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602347|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154602348|NCT02729545|Estrogens|estrogens|mesh-ancestor
154602349|NCT02729545|Hormones|hormones|mesh-ancestor
154602350|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154602351|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
154602352|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
154602353|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602354|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154602355|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
154602356|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154602357|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154602358|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602359|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
154602360|NCT02504125|Coagulants|coagulants|mesh-ancestor
154602361|NCT02509429|Insulin|insulin|mesh-list
154602362|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154602363|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
154602364|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
154602365|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154602366|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
154602367|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154602368|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602369|NCT02509273|Clonidine|clonidine|mesh-list
154602370|NCT02509273|Midazolam|midazolam|mesh-list
154602371|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154602372|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154602373|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602374|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602375|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154602376|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154602377|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154602378|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154602379|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
154602380|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
154602381|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
154602382|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
154602383|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602384|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602385|NCT02509273|Analgesics|analgesics|mesh-ancestor
154602386|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
154602387|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602388|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154602389|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
154602390|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
154602391|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154602392|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154602393|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154602394|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602395|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
154602396|NCT02514343|Bupivacaine|bupivacaine|mesh-list
154602397|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
154602398|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
154602399|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602400|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602401|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
154602402|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602403|NCT02514343|Analgesics|analgesics|mesh-ancestor
154602404|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154602405|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
154602406|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154602407|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154602408|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602409|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154602410|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
154602411|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154602412|NCT02514421|Paclitaxel|paclitaxel|mesh-list
154602413|NCT02514421|Gemcitabine|gemcitabine|mesh-list
154602414|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154602415|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602416|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
154602417|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
154602418|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
154602419|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602420|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154602421|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
154602422|NCT04499209|Naproxen|naproxen|mesh-list
154602423|NCT04499209|Pregabalin|pregabalin|mesh-list
154602424|NCT04499209|Analgesics|analgesics|mesh-ancestor
154602425|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
154602426|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602427|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602428|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
154602429|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154602430|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154602431|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602432|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154602433|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154602434|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154089327|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602435|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602436|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154602437|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154602438|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154602439|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602440|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154602441|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
154602442|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154602443|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602444|NCT02509351|Misoprostol|misoprostol|mesh-list
154602445|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154602446|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
154602447|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154602448|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602449|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154602450|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154602451|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
154602452|NCT02509195|Lamivudine|lamivudine|mesh-list
154602453|NCT02509195|Abacavir|abacavir|mesh-list
154602454|NCT02509195|Dolutegravir|dolutegravir|mesh-list
154602455|NCT02509195|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
154602456|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154602457|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154602458|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602459|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602460|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
154602461|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602462|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154602463|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154602464|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154602465|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154602466|NCT02508805|Diclofenac|diclofenac|mesh-list
154602467|NCT02508805|Tizanidine|tizanidine|mesh-list
153493891|NCT03572478|Nivolumab|nivolumab|mesh-list
154602468|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154602469|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154602470|NCT02508805|Analgesics|analgesics|mesh-ancestor
154602471|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
154602472|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602473|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602474|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602475|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154602476|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154602477|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602478|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602479|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
154602480|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154602481|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154602482|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
154602483|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
154602484|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154602485|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154602486|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154602487|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602488|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602489|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154602490|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154602491|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154602492|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154602493|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602494|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602495|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602496|NCT03121573|Analgesics|analgesics|mesh-ancestor
154602497|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
154602498|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602499|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
154602500|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154602501|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
154602503|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154602504|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602505|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154602506|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602507|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154602508|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154602509|NCT02502643|Picibanil|picibanil|mesh-list
154602510|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602511|NCT02502565|Uric Acid|uric acid|mesh-list
154602512|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
154602513|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602514|NCT02502565|Protective Agents|protective agents|mesh-ancestor
154602515|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602516|NCT04498897|Acamprosate|acamprosate|mesh-list
154602517|NCT04498897|Vortioxetine|vortioxetine|mesh-list
154602518|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
154602519|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154602520|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154602521|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154602522|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602523|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602524|NCT04498897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154602525|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154602526|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154602527|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602528|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602529|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
154602530|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154602531|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154602532|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154602533|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154602534|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154602535|NCT02502877|Midazolam|midazolam|mesh-list
154602536|NCT02502877|Propofol|propofol|mesh-list
154602537|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154602538|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089429|NCT00785109|Vitamin K|vitamin k|mesh-list
154602539|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602540|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154602541|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
154602542|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
154602543|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154602544|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154602545|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154602546|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154602547|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
154602548|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
154602549|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602550|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602551|NCT03121339|Vaccines|vaccines|mesh-list
154602552|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
154602553|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602554|NCT03343327|Hydrocortisone|hydrocortisone|mesh-list
154602555|NCT03343327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602556|NCT02502175|Methadone|methadone|mesh-list
154602557|NCT02502175|Opium|opium|mesh-list
154602558|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154602559|NCT02502175|Narcotics|narcotics|mesh-ancestor
154602560|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602561|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602562|NCT02502175|Analgesics|analgesics|mesh-ancestor
154602563|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
154602564|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326392|NCT01101685|Escitalopram|escitalopram|mesh-list
154602565|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
154602566|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
154602567|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
154602568|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154602569|NCT02500927|Naquotinib|naquotinib|mesh-list
154602570|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602571|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602572|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602573|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602574|NCT02501863|Fentanyl|fentanyl|mesh-list
154602575|NCT02501863|Ropivacaine|ropivacaine|mesh-list
154602576|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
154602577|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
154602578|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602579|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602580|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
154602581|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602582|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154602583|NCT02501863|Narcotics|narcotics|mesh-ancestor
154602584|NCT02501863|Analgesics|analgesics|mesh-ancestor
154602585|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154602586|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154602587|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
154602588|NCT02500459|Topotecan|topotecan|mesh-list
154602589|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154602590|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154602591|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602592|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602593|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602594|NCT02500225|Sevoflurane|sevoflurane|mesh-list
154602595|NCT02500225|Etomidate|etomidate|mesh-list
154602596|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154602597|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154602598|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
154602599|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
154602600|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602601|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602602|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154602603|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154602604|NCT02507635|Levocetirizine|levocetirizine|mesh-list
154602605|NCT02507635|Desloratadine|desloratadine|mesh-list
154602606|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154602607|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154602608|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
154602609|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
154602610|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602611|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602612|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602613|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154602614|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
154602615|NCT04495933|Vaccines|vaccines|mesh-list
154602616|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154602617|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
154602618|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602619|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154602620|NCT02500069|Caseins|caseins|mesh-list
154602621|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
154602622|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
154602623|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602624|NCT03344029|Vaccines|vaccines|mesh-list
154602625|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
154602626|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602627|NCT03120637|Methylene Blue|methylene blue|mesh-list
154602628|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602629|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602630|NCT02499757|Nicotine|nicotine|mesh-list
154602631|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154602632|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
154602633|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602634|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602635|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154602636|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154602637|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
154602638|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602639|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602640|NCT00706849|Mipomersen|mipomersen|mesh-list
154602641|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154602642|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154602643|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
154602644|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602645|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154602646|NCT02499445|Sufentanil|sufentanil|mesh-list
154602647|NCT02499445|Remifentanil|remifentanil|mesh-list
154602648|NCT02499445|Propofol|propofol|mesh-list
154602649|NCT02499445|Sevoflurane|sevoflurane|mesh-list
154602650|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154602651|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602652|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602653|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154602654|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
154602655|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
154602656|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154602657|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154602658|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154602659|NCT02499445|Narcotics|narcotics|mesh-ancestor
154602660|NCT02499445|Analgesics|analgesics|mesh-ancestor
154602661|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
154602662|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602663|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154602664|NCT04443049|Mebendazole|mebendazole|mesh-list
154602665|NCT04443049|Piperazine|piperazine|mesh-list
154602666|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
154602667|NCT04443049|Lenvatinib|lenvatinib|mesh-list
154602668|NCT04443049|DMP 777|dmp 777|mesh-list
154602669|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602670|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602671|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602672|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602673|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
154602674|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
154602675|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154602676|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602677|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
154602678|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
154602679|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
154602680|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154602681|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
154602682|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602683|NCT03341845|Avelumab|avelumab|mesh-list
154602684|NCT03341845|Axitinib|axitinib|mesh-list
154602685|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154602686|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602687|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602688|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602689|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602690|NCT02494687|Domperidone|domperidone|mesh-list
154602691|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
154602692|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
154602693|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602694|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602695|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154602696|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154602697|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
154602698|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602699|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602700|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154602701|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
154602702|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
154602703|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154602704|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602705|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154602706|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154602707|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602708|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154602709|NCT03341767|Clofazimine|clofazimine|mesh-list
154602710|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602711|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
154602712|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154602713|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602714|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
154602715|NCT02498509|Levocabastine|levocabastine|mesh-list
154602716|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602717|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
154602718|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154602719|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154602720|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154602721|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
154602722|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
154602723|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602724|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602725|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602726|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
154602727|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154602728|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
154602729|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154602730|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602731|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154602732|NCT02493283|Dapsone|dapsone|mesh-list
154602733|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602734|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
154602735|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154602736|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154602737|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154602738|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602739|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602740|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
154602741|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154602742|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
154602743|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154602744|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602745|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602746|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154602747|NCT03335527|Analgesics|analgesics|mesh-ancestor
154602748|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
154602749|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602750|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154602751|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154602752|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154602753|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602754|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602755|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602756|NCT02493049|Domperidone|domperidone|mesh-list
154602757|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602758|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
154602759|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
154602760|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602761|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602762|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154602763|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154602765|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602766|NCT03120715|Heparin|heparin|mesh-list
154602767|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154602768|NCT03120715|Tinzaparin|tinzaparin|mesh-list
154602769|NCT03120715|Dalteparin|dalteparin|mesh-list
154602770|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154602771|NCT03120715|Progesterone|progesterone|mesh-list
154602772|NCT03120715|Estrogens|estrogens|mesh-list
154602773|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
154602774|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154602775|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154602776|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602777|NCT03120715|Progestins|progestins|mesh-ancestor
154602778|NCT03120715|Hormones|hormones|mesh-ancestor
154602779|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154602780|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602781|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154602782|NCT03120403|Morphine|morphine|mesh-list
154602783|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154602784|NCT03120403|Narcotics|narcotics|mesh-ancestor
154602785|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602786|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602787|NCT03120403|Analgesics|analgesics|mesh-ancestor
154602788|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
154602789|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602790|NCT03335293|Epinephrine|epinephrine|mesh-list
154602791|NCT03335293|Racepinephrine|racepinephrine|mesh-list
154602792|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
154602793|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154602794|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154602795|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602796|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602797|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602798|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602799|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154602800|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154602801|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
154602802|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602803|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154602804|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
154602805|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
154602806|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
154602807|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154602808|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154602809|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154602810|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602811|NCT03340597|Olorofim|olorofim|mesh-list
154602812|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
154602813|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602814|NCT00707161|Cisplatin|cisplatin|mesh-list
154602815|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602816|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
154602817|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154602818|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602819|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602820|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154602821|NCT03120247|Analgesics|analgesics|mesh-ancestor
154602822|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
154602823|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602824|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154602825|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154602826|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154602827|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602828|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602829|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602830|NCT03335059|Mitomycins|mitomycins|mesh-list
154602831|NCT03335059|Mitomycin|mitomycin|mesh-list
154602832|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154602833|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602834|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
154602835|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602836|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154602837|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602838|NCT03334981|Buprenorphine|buprenorphine|mesh-list
154602839|NCT03334981|Methadone|methadone|mesh-list
154602840|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154602841|NCT03334981|Narcotics|narcotics|mesh-ancestor
154602842|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602843|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602844|NCT03334981|Analgesics|analgesics|mesh-ancestor
154602845|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
154602846|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602847|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154602848|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
154602849|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
154602850|NCT02492503|Paclitaxel|paclitaxel|mesh-list
154602851|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154602852|NCT02492503|Carboplatin|carboplatin|mesh-list
154602853|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154602854|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602855|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
154602856|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
154602857|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
154602858|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602859|NCT03334591|Apatinib|apatinib|mesh-list
154602860|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602861|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602862|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602863|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602864|NCT03334513|Bevacizumab|bevacizumab|mesh-list
154602865|NCT03334513|Ranibizumab|ranibizumab|mesh-list
154602866|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154602867|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602868|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154326688|NCT01334684|Metformin|metformin|mesh-list
154602869|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154602870|NCT03334513|Growth Substances|growth substances|mesh-ancestor
154602871|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602872|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
154602873|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
154602874|NCT02130466|Trametinib|trametinib|mesh-list
154602875|NCT02130466|Dabrafenib|dabrafenib|mesh-list
154602876|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154602877|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602878|NCT02130466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154602879|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602880|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602881|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602882|NCT03339427|Vitamin D|vitamin d|mesh-list
154602883|NCT03339427|Vitamins|vitamins|mesh-ancestor
154602884|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
154602885|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602886|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154602887|NCT02496715|Fluticasone|fluticasone|mesh-list
154602888|NCT02496715|Xhance|xhance|mesh-list
154602889|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154602890|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602891|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154602892|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
154602893|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602894|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602895|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154602896|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
154602897|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
154602898|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154602899|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154602900|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154602901|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154602902|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602903|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602904|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602905|NCT02492581|Nalmefene|nalmefene|mesh-list
154602906|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154602907|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602908|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
154602909|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602910|NCT02129062|Ibrutinib|ibrutinib|mesh-list
154602911|NCT02129062|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154602912|NCT02129062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154602913|NCT02129062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602914|NCT02129062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602915|NCT04494763|Propranolol|propranolol|mesh-list
154602916|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154602917|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154602918|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
154602919|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602920|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602921|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602922|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154602923|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154602924|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
154602925|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
154602926|NCT02162758|Lansoprazole|lansoprazole|mesh-list
154602927|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154602928|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154602929|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154602930|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602931|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602932|NCT03333499|Trimetazidine|trimetazidine|mesh-list
154602933|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
154602935|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154602936|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154602937|NCT02491879|Analgesics|analgesics|mesh-ancestor
154602938|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
154602939|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602940|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602941|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602942|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154602943|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154326750|NCT01776424|Aspirin|aspirin|mesh-list
154602944|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602945|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602946|NCT03332953|Nicotine|nicotine|mesh-list
154602947|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154602948|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
154602949|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602950|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602951|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154602952|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154602953|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
154602954|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154602955|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602956|NCT02491723|Azithromycin|azithromycin|mesh-list
154602957|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154602958|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602959|NCT03332719|Etanercept|etanercept|mesh-list
154602960|NCT03332719|Methotrexate|methotrexate|mesh-list
154602961|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154602962|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
154602963|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154602964|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602965|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154602966|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
154602967|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154602968|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602969|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154602970|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154602971|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154602972|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154602973|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
154602974|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089865|NCT02576366|Rifampin|rifampin|mesh-list
154602975|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154602976|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154602977|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154602978|NCT03332719|Analgesics|analgesics|mesh-ancestor
154602979|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
154602980|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154602981|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154602982|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154602983|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
154602984|NCT03330613|Anesthetics|anesthetics|mesh-list
154602985|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154602986|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602987|NCT03332329|Entecavir|entecavir|mesh-list
154602988|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154602989|NCT03332329|Molgramostim|molgramostim|mesh-list
154602990|NCT03332329|Vaccines|vaccines|mesh-list
154602991|NCT03332329|Sargramostim|sargramostim|mesh-list
154602992|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
154602993|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154602994|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
154602995|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154602996|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154602997|NCT03330223|Clopidogrel|clopidogrel|mesh-list
154602998|NCT03330223|Ticagrelor|ticagrelor|mesh-list
154602999|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154603000|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154603001|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154603002|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154603003|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
154603004|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603005|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603006|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603007|NCT03331861|Metformin|metformin|mesh-list
154603008|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154603009|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603010|NCT03329443|Spironolactone|spironolactone|mesh-list
154603011|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154603012|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
154603013|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603014|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603015|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154603016|NCT03329443|Diuretics|diuretics|mesh-ancestor
154603017|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
154326828|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
154603018|NCT03328975|Dexamethasone|dexamethasone|mesh-list
154603019|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154603020|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
154603021|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
154603022|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603023|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603024|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154603025|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
154603026|NCT03328975|Hormones|hormones|mesh-ancestor
154603027|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603028|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154603029|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603030|NCT05430711|Dinoprostone|dinoprostone|mesh-list
154603031|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
154603032|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603033|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603034|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
154603035|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154603036|NCT03324685|Estradiol|estradiol|mesh-list
154603037|NCT03324685|Estrogens|estrogens|mesh-ancestor
154603038|NCT03324685|Hormones|hormones|mesh-ancestor
154603039|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603040|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603041|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154603042|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
154603043|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603044|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154603045|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154603046|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154603047|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154603048|NCT03324139|Heparin|heparin|mesh-list
154603049|NCT03324139|Calcium heparin|calcium heparin|mesh-list
154603050|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154603051|NCT03324139|Tinzaparin|tinzaparin|mesh-list
154603052|NCT03324139|Dalteparin|dalteparin|mesh-list
154603053|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
154603054|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154603055|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154603056|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603057|NCT03324061|Fulvestrant|fulvestrant|mesh-list
154603058|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154603059|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603060|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154603061|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154603062|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
154603063|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603064|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603066|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154603067|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
154603068|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603069|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603070|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154603071|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603072|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154603073|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154603074|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154603075|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
154603076|NCT03328117|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154603077|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154603078|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603079|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603080|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603081|NCT05430087|Vitamin D|vitamin d|mesh-list
154603082|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
154603083|NCT05430087|Curcumin|curcumin|mesh-list
154603084|NCT05430087|Piperine|piperine|mesh-list
154603085|NCT05430087|Vitamins|vitamins|mesh-ancestor
154603086|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
154603087|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603088|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154603089|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154603090|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154603091|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603092|NCT05430087|Analgesics|analgesics|mesh-ancestor
154603093|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
154603094|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603095|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154603096|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154603097|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603098|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603099|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603100|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154603101|NCT03327727|Voriconazole|voriconazole|mesh-list
154603102|NCT03327727|Amphotericin B|amphotericin b|mesh-list
154603103|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154603104|NCT03327727|Isavuconazole|isavuconazole|mesh-list
154603105|NCT03327727|VL-2397|vl-2397|mesh-list
154603106|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
154603107|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603108|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154603109|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154603110|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603111|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603112|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154603113|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
154603114|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603115|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603116|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154603117|NCT03327727|Amebicides|amebicides|mesh-ancestor
154603118|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154603119|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154603120|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154603121|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
154603122|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154603123|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603124|NCT03323671|Analgesics|analgesics|mesh-ancestor
154603125|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
154603126|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603127|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603128|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154603129|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154603130|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154603131|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603132|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603133|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
154603134|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154603135|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090034|NCT00786669|Temozolomide|temozolomide|mesh-list
154603136|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603137|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603138|NCT03323593|Analgesics|analgesics|mesh-ancestor
154603139|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
154603140|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603141|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154603142|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154603143|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154603144|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
154603145|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603146|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603147|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
154603148|NCT02499003|Pixantrone|pixantrone|mesh-list
154603149|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154603150|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603151|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154603152|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154603153|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603154|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603155|NCT04492813|Remifentanil|remifentanil|mesh-list
154603156|NCT04492813|Propofol|propofol|mesh-list
154603157|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154603158|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603159|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603160|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154603161|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
154603162|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
154603163|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154603164|NCT04492813|Narcotics|narcotics|mesh-ancestor
154603165|NCT04492813|Analgesics|analgesics|mesh-ancestor
154326974|NCT01105351|Folic Acid|folic acid|mesh-list
154603166|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
154603167|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603168|NCT03102801|Insulin|insulin|mesh-list
154603169|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154603170|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154603171|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603172|NCT02488057|Liraglutide|liraglutide|mesh-list
154603173|NCT02488057|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154603174|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154603175|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603176|NCT02488057|Incretins|incretins|mesh-ancestor
154603177|NCT02488057|Hormones|hormones|mesh-ancestor
154603178|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603179|NCT04039347|Cyclosporine|cyclosporine|mesh-list
154603180|NCT04039347|Cyclosporins|cyclosporins|mesh-list
154603181|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603182|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603183|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603184|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
154603185|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603186|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
154603187|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603188|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
154603189|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154603190|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154603191|NCT02488291|Sufentanil|sufentanil|mesh-list
154603192|NCT02488291|Dsuvia|dsuvia|mesh-list
154603193|NCT02488291|Ropivacaine|ropivacaine|mesh-list
154603194|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
154603195|NCT02488291|Anesthetics|anesthetics|mesh-list
154603196|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603197|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603198|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
154603199|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603200|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154603201|NCT02488291|Narcotics|narcotics|mesh-ancestor
154603202|NCT02488291|Analgesics|analgesics|mesh-ancestor
154603203|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154603204|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154603205|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
154603206|NCT03323047|Acetaminophen|acetaminophen|mesh-list
154603207|NCT03323047|Dexamethasone|dexamethasone|mesh-list
154603208|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
154603209|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154603210|NCT03323047|BB 1101|bb 1101|mesh-list
154603211|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154603213|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
154603214|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603215|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603216|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154603217|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
154603218|NCT03323047|Hormones|hormones|mesh-ancestor
154603219|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603220|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154603221|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603222|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154603223|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603224|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603225|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603226|NCT03323047|Analgesics|analgesics|mesh-ancestor
154603227|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
154603228|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
154603229|NCT03322969|Paclitaxel|paclitaxel|mesh-list
154603230|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154603231|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603232|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
154603233|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
154603234|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
154603235|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603236|NCT05464303|Antibodies|antibodies|mesh-list
154603237|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154603238|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
154603239|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154603240|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
154603241|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603242|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
154603243|NCT03322735|Fludarabine|fludarabine|mesh-list
154603244|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603245|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
154603246|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603247|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154603248|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154603249|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
154603250|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603251|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603252|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154603254|NCT02487823|Buserelin|buserelin|mesh-list
154603255|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
154603256|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
154603257|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603258|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603259|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603260|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154603261|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
154603262|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603263|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154603264|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154603265|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603266|NCT02487433|Tofacitinib|tofacitinib|mesh-list
154603267|NCT02487433|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154603268|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154603269|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603270|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603271|NCT04493125|Mosapride|mosapride|mesh-list
154603272|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603273|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154603274|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154603275|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
154603276|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603277|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603278|NCT03318835|Thalidomide|thalidomide|mesh-list
154603279|NCT03318835|Prednisone|prednisone|mesh-list
154603280|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
154603281|NCT03318835|Vincristine|vincristine|mesh-list
154603282|NCT03318835|Rituximab|rituximab|mesh-list
154603283|NCT03318835|Doxorubicin|doxorubicin|mesh-list
154603284|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603285|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
154603286|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603287|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
154603288|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154603289|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603290|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154603291|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154603292|NCT03318835|Growth Substances|growth substances|mesh-ancestor
154603293|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
154603294|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603295|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154603296|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154603297|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
154603298|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603299|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154603300|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154603301|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
154603302|NCT03318835|Hormones|hormones|mesh-ancestor
154603303|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603304|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154603305|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154603306|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
154603307|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
154603308|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
154603309|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154603310|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154603311|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154603312|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154603313|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603314|NCT03318757|Bupivacaine|bupivacaine|mesh-list
154603315|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
154603316|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
154603317|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603318|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603319|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
154603320|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603321|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
154603322|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
154603323|NCT02487355|Bupivacaine|bupivacaine|mesh-list
154603324|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
154603325|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
154603326|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603327|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603328|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
154603329|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603330|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154603331|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603332|NCT02487355|Analgesics|analgesics|mesh-ancestor
154603333|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154603334|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154603335|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154603336|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
154603337|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603338|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603339|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154603340|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
154603341|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154603342|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154603343|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154603344|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
154603345|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603346|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
154603347|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154603348|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603349|NCT03325465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154603350|NCT03325465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603351|NCT01876953|Cytarabine|cytarabine|mesh-list
154603352|NCT01876953|Dasatinib|dasatinib|mesh-list
154603353|NCT01876953|Idarubicin|idarubicin|mesh-list
154603354|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154603355|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
154603356|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603357|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603358|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
154603359|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603360|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603361|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
154603362|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603363|NCT01876953|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154603364|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154603365|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603366|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154603367|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154603368|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154603369|NCT03321955|Ziconotide|ziconotide|mesh-list
154603370|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154603371|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154603372|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603373|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154603374|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603375|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154603376|NCT03321955|Protective Agents|protective agents|mesh-ancestor
154603377|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603378|NCT03321955|Analgesics|analgesics|mesh-ancestor
154603379|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
154603380|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603381|NCT04493281|Edaravone|edaravone|mesh-list
154603382|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154603383|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
154603384|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603385|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154603386|NCT04493281|Protective Agents|protective agents|mesh-ancestor
154603387|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603388|NCT01764711|Cosyntropin|cosyntropin|mesh-list
154603389|NCT01764711|Hormones|hormones|mesh-ancestor
154603390|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327196|NCT02880956|Tilavonemab|tilavonemab|mesh-list
154603391|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603393|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
154603394|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603395|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603396|NCT03318445|Irinotecan|irinotecan|mesh-list
154603397|NCT03318445|Rucaparib|rucaparib|mesh-list
154603398|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154603399|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154603400|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603401|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603402|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603403|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154603404|NCT02485015|Apatinib|apatinib|mesh-list
154603405|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603406|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154603407|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603408|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603409|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
154603410|NCT03316339|Remifentanil|remifentanil|mesh-list
154603411|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154603412|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603413|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603414|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603415|NCT03316339|Analgesics|analgesics|mesh-ancestor
154603416|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
154603417|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603418|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154603419|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154603420|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154603421|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
154603422|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603423|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603424|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154603425|NCT03316339|Narcotics|narcotics|mesh-ancestor
154603426|NCT02490865|RNS60|rns60|mesh-list
154603427|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154603428|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603429|NCT02490865|Analgesics|analgesics|mesh-ancestor
154603430|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
154603431|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603432|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603433|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154603434|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154603435|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154603436|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
154603437|NCT03318211|Analgesics|analgesics|mesh-ancestor
154603438|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
154603439|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603440|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603441|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
154603442|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603443|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154603444|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
154603445|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154603446|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154603447|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603448|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154603449|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
154603450|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603451|NCT02483767|Goserelin|goserelin|mesh-list
154603452|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154603453|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603454|NCT02483845|Natalizumab|natalizumab|mesh-list
154603455|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
154603456|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603457|NCT02486341|Insulin|insulin|mesh-list
154603458|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154603459|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603460|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154603461|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
154603462|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154603463|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154603464|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154603465|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603466|NCT02483923|Ropivacaine|ropivacaine|mesh-list
154603467|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
154603468|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
154603469|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603470|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603471|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
154603472|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603473|NCT02483689|Bupivacaine|bupivacaine|mesh-list
154603474|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
154603475|NCT02483689|Anesthetics|anesthetics|mesh-list
154603476|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603477|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603478|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
154603479|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603481|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154603482|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154603483|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603484|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
154603485|NCT03102021|Hematinics|hematinics|mesh-ancestor
154603486|NCT04916691|Ropivacaine|ropivacaine|mesh-list
154603487|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
154603488|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
154603489|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603490|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603491|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
154603492|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603493|NCT05105139|Triclosan|triclosan|mesh-list
154603494|NCT05105139|Coal Tar|coal tar|mesh-list
154603495|NCT05105139|Allantoin|allantoin|mesh-list
154603496|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154603497|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603498|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154603499|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154603500|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
154603501|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603502|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154603503|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
154603504|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
154603505|NCT03317275|Fluorides|fluorides|mesh-list
154603506|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
154603507|NCT03317275|Protective Agents|protective agents|mesh-ancestor
154603508|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603509|NCT03317197|Vasopressins|vasopressins|mesh-list
154603510|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
154603511|NCT03317197|Epinephrine|epinephrine|mesh-list
154603512|NCT03317197|Racepinephrine|racepinephrine|mesh-list
154603513|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
154603514|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154603515|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154603516|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
154603517|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603518|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603519|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603520|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154603521|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154603522|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
154603523|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603524|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154090421|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
154603525|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
154603526|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
154603527|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
154603528|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154603529|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
154603530|NCT03317197|Coagulants|coagulants|mesh-ancestor
154603531|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154603532|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
154603533|NCT02483299|Metformin|metformin|mesh-list
154603534|NCT02483299|Liraglutide|liraglutide|mesh-list
154603535|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154603536|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603537|NCT02483299|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154603538|NCT02483299|Incretins|incretins|mesh-ancestor
154603539|NCT02483299|Hormones|hormones|mesh-ancestor
154603540|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327398|NCT00580216|Biotin|biotin|mesh-list
154603541|NCT01597479|Anesthetics|anesthetics|mesh-list
154603542|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
154603543|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
154603544|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603545|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603546|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
154603547|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603548|NCT03316963|Neostigmine|neostigmine|mesh-list
154603549|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154603550|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603551|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603552|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
154603553|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603554|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603555|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154603556|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
154603557|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603558|NCT02489929|Azacitidine|azacitidine|mesh-list
154603559|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154603560|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
154603561|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603562|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603563|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603564|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154603565|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
154603566|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
154603567|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
154603568|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603569|NCT02483143|Expectorants|expectorants|mesh-ancestor
154603570|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
154603571|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154603572|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
154603573|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603574|NCT02483143|Protective Agents|protective agents|mesh-ancestor
154603575|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603576|NCT02483221|Morphine|morphine|mesh-list
154603577|NCT02483221|Hydromorphone|hydromorphone|mesh-list
154603578|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154603579|NCT02483221|Narcotics|narcotics|mesh-ancestor
154603580|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603581|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603582|NCT02483221|Analgesics|analgesics|mesh-ancestor
154603583|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
154603584|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603585|NCT02489461|Efavirenz|efavirenz|mesh-list
154603586|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
154603587|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154603588|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154603589|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154603590|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603591|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603592|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
154603593|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603594|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154603595|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154603596|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154603597|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154603598|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154603599|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154603600|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154603602|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
154603603|NCT02485873|Vitamins|vitamins|mesh-ancestor
154603604|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
154603605|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603606|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154603607|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
154603608|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154603609|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
154603610|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603611|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603612|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
154603613|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154603614|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154603615|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
154603616|NCT02485873|Coagulants|coagulants|mesh-ancestor
154603617|NCT04412421|Vitamins|vitamins|mesh-list
154603619|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603620|NCT03315091|Adavosertib|adavosertib|mesh-list
154603621|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603622|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603623|NCT02488993|Rifaximin|rifaximin|mesh-list
154603624|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154603625|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603626|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154603627|NCT02485327|Insulin|insulin|mesh-list
154603628|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154090513|NCT03015792|Dexamethasone|dexamethasone|mesh-list
154603629|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154603630|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603631|NCT02485249|Dexamethasone|dexamethasone|mesh-list
154603632|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
154603633|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154603634|NCT02485249|BB 1101|bb 1101|mesh-list
154603635|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154603636|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
154603637|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
154603638|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603639|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603640|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154603641|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
154603642|NCT02485249|Hormones|hormones|mesh-ancestor
154603643|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603644|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154603645|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603646|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
154603647|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603648|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603649|NCT03320707|Daratumumab|daratumumab|mesh-list
154603650|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603651|NCT03320629|Apatinib|apatinib|mesh-list
154603652|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603653|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154603654|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603655|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603656|NCT03316417|Immunomodulating Agents|immunomodulating agents|mesh-list
154603657|NCT03316417|Immunologic Factors|immunologic factors|mesh-ancestor
154603658|NCT03316417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603659|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154603660|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154603661|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154603662|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
154603663|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603664|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154603665|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154603666|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603668|NCT02476981|Midazolam|midazolam|mesh-list
154603669|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
154603670|NCT02476981|Remifentanil|remifentanil|mesh-list
154603671|NCT02476981|Propofol|propofol|mesh-list
154603672|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154603673|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603674|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603675|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154603676|NCT02476981|Analgesics|analgesics|mesh-ancestor
154603677|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
154603678|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603679|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154603680|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154603681|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154603682|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
154603683|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603684|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603685|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154603686|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
154603687|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
154603688|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154603689|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154603690|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154603691|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154603692|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
154603693|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
154603694|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154603695|NCT02476981|Narcotics|narcotics|mesh-ancestor
154603696|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154603697|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
154603698|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
154603699|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154603700|NCT04248465|Ravulizumab|ravulizumab|mesh-list
154603701|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154603702|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603703|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
154603704|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603705|NCT02480335|Bosentan|bosentan|mesh-list
154603706|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154603707|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154603708|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603709|NCT05245227|Misoprostol|misoprostol|mesh-list
154603710|NCT05245227|Oxytocin|oxytocin|mesh-list
154603711|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
154603712|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603713|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603714|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154603715|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
154603716|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154603717|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154603718|NCT02479867|Cefadroxil|cefadroxil|mesh-list
154603719|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154603720|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603721|NCT05244837|Paclitaxel|paclitaxel|mesh-list
154603722|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154603723|NCT05244837|Carboplatin|carboplatin|mesh-list
154603724|NCT05244837|Pemetrexed|pemetrexed|mesh-list
154603725|NCT05244837|Tislelizumab|tislelizumab|mesh-list
154603726|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154603727|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603728|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
154603729|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
154603730|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
154603731|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603732|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603733|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154603734|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154603735|NCT05244837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154603736|NCT03103893|Sirolimus|sirolimus|mesh-list
154603737|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154603738|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603739|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154603740|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603741|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
154603742|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603743|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
154603744|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603745|NCT02479789|Lidocaine|lidocaine|mesh-list
154603746|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
154603747|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
154603748|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603749|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603750|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
154603751|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603752|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154603753|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154603754|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154603755|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154603756|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603757|NCT02726113|Vitamin D|vitamin d|mesh-list
154603758|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
154603759|NCT02726113|Vitamins|vitamins|mesh-ancestor
154603760|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
154603761|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603762|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154603763|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154603764|NCT05243355|Endostatins|endostatins|mesh-list
154603765|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603766|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154603767|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154603768|NCT05243355|Growth Substances|growth substances|mesh-ancestor
154603769|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603770|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
154603771|NCT02479711|Methamphetamine|methamphetamine|mesh-list
154603772|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154603773|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603774|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
154603775|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
154603776|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603777|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
154603778|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154603779|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603780|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
154603781|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154603782|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154603783|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154603784|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154603785|NCT05196945|Amoxicillin|amoxicillin|mesh-list
154603786|NCT05196945|Clarithromycin|clarithromycin|mesh-list
154603787|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
154603788|NCT05196945|Esomeprazole|esomeprazole|mesh-list
154603789|NCT05196945|Bismuth|bismuth|mesh-list
154090665|NCT00581360|Doxorubicin|doxorubicin|mesh-list
154603790|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603791|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154603792|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603793|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154603794|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154603795|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154603796|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603797|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154603798|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154603799|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154603800|NCT05196945|Antacids|antacids|mesh-ancestor
154603801|NCT05196945|Diuretics|diuretics|mesh-ancestor
154603802|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
154603803|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603804|NCT05196945|Expectorants|expectorants|mesh-ancestor
154603805|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
154603806|NCT03800979|Tofacitinib|tofacitinib|mesh-list
154603807|NCT03800979|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154603808|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154603809|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603810|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603811|NCT02476123|Nivolumab|nivolumab|mesh-list
154603812|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
154603813|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154603814|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603815|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154603816|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603817|NCT02481193|Cisatracurium|cisatracurium|mesh-list
154603818|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154603819|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154603820|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603821|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603822|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
154603823|NCT03101709|Fludarabine|fludarabine|mesh-list
154603824|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603825|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
154603826|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603827|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154603828|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154603829|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
154603830|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603831|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603832|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154603833|NCT02479555|Dexamethasone|dexamethasone|mesh-list
154603834|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
154603835|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154603837|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154603838|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
154603839|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
154603840|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603841|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603842|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154327648|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603843|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
154603844|NCT02479555|Hormones|hormones|mesh-ancestor
154603845|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603846|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154603848|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
154603849|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603850|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603851|NCT02476045|Leucovorin|leucovorin|mesh-list
154603852|NCT02476045|Fluorouracil|fluorouracil|mesh-list
154603853|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
154603854|NCT02476045|Panitumumab|panitumumab|mesh-list
154603855|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
154603856|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
154603857|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603858|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154603859|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154603860|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603861|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
154603862|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603863|NCT02476045|Antidotes|antidotes|mesh-ancestor
154603864|NCT02476045|Protective Agents|protective agents|mesh-ancestor
154603865|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
154603866|NCT02476045|Vitamins|vitamins|mesh-ancestor
154603867|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
154603868|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154603869|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
154603870|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154603871|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603872|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154603873|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603874|NCT03885921|Atorvastatin|atorvastatin|mesh-list
154603875|NCT03885921|Simvastatin|simvastatin|mesh-list
154603876|NCT03885921|Ezetimibe|ezetimibe|mesh-list
154603877|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154603878|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154603879|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
154603880|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603881|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154603882|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154603883|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603884|NCT02480881|Fostemsavir|fostemsavir|mesh-list
154603885|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
154603886|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154603888|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603889|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603890|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154603891|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154603892|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154603893|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154603894|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154603895|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154603896|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154603897|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154603898|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
154603899|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154603900|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154603901|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154603902|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603903|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
154603904|NCT02480647|Etonogestrel|etonogestrel|mesh-list
154603905|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154603906|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
154603907|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154603908|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603909|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154603910|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154603911|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154603912|NCT03100071|Apixaban|apixaban|mesh-list
154603913|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154603914|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
154603915|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154603916|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
154603917|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603918|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603919|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
154603921|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154603922|NCT02479165|Narcotics|narcotics|mesh-ancestor
154603923|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603924|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603925|NCT02479165|Analgesics|analgesics|mesh-ancestor
154603926|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
154603927|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603928|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
154603929|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154603930|NCT05072691|Antibodies|antibodies|mesh-list
154603931|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
154603932|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603933|NCT02475499|Metformin|metformin|mesh-list
154603934|NCT02475499|Pioglitazone|pioglitazone|mesh-list
154603935|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154603936|NCT02475499|Liraglutide|liraglutide|mesh-list
154603937|NCT02475499|Exenatide|exenatide|mesh-list
154603938|NCT02475499|Glimepiride|glimepiride|mesh-list
154603939|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
154603940|NCT02475499|Vildagliptin|vildagliptin|mesh-list
154603941|NCT02475499|Saxagliptin|saxagliptin|mesh-list
154603942|NCT02475499|Acarbose|acarbose|mesh-list
154603943|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154603944|NCT02475499|Repaglinide|repaglinide|mesh-list
154603945|NCT02475499|Gliclazide|gliclazide|mesh-list
154603946|NCT02475499|Glipizide|glipizide|mesh-list
154603947|NCT02475499|Biguanides|biguanides|mesh-list
154603948|NCT02475499|Tolbutamide|tolbutamide|mesh-list
154603949|NCT02475499|Voglibose|voglibose|mesh-list
154603950|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154603951|NCT02475499|Nateglinide|nateglinide|mesh-list
154603952|NCT02475499|Miglitol|miglitol|mesh-list
154603953|NCT02475499|Troglitazone|troglitazone|mesh-list
154603954|NCT02475499|Meglitinide|meglitinide|mesh-list
154603955|NCT02475499|Acetohexamide|acetohexamide|mesh-list
154603956|NCT02475499|Buformin|buformin|mesh-list
154603957|NCT02475499|Phenformin|phenformin|mesh-list
154603958|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
154603959|NCT02475499|Glibornuride|glibornuride|mesh-list
154603960|NCT02475499|Tolazamide|tolazamide|mesh-list
154603961|NCT02475499|Carbutamide|carbutamide|mesh-list
154603962|NCT02475499|Gliquidone|gliquidone|mesh-list
154603963|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154603964|NCT02475499|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154603965|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
154603966|NCT02475499|Incretins|incretins|mesh-list
154603967|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603968|NCT02475499|Hormones|hormones|mesh-ancestor
154603969|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603971|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154603972|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154603973|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154603974|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154603975|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154603976|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
154603977|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
154603978|NCT03375645|Narcotics|narcotics|mesh-ancestor
154603979|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154603980|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603981|NCT03375645|Analgesics|analgesics|mesh-ancestor
154603982|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
154603983|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154603984|NCT03136809|Copper|copper|mesh-list
154603985|NCT03136809|Trace Elements|trace elements|mesh-ancestor
154603986|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
154603987|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603988|NCT02475421|Glucagon|glucagon|mesh-list
154603989|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154603990|NCT02475421|Hormones|hormones|mesh-ancestor
154327804|NCT00364546|Tapentadol|tapentadol|mesh-list
154603991|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154603992|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603993|NCT02475343|Riboflavin|riboflavin|mesh-list
154603994|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
154603995|NCT02475343|Vitamins|vitamins|mesh-ancestor
154603996|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
154603997|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154603998|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154603999|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
154604000|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154604001|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154604002|NCT04492501|Remdesivir|remdesivir|mesh-list
154604003|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
154604004|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604005|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
154604006|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604007|NCT03101085|Equol|equol|mesh-list
154604008|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
154604009|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154604010|NCT03101085|Estrogens|estrogens|mesh-ancestor
154604011|NCT03101085|Hormones|hormones|mesh-ancestor
154604012|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604013|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604014|NCT05070195|Midazolam|midazolam|mesh-list
154604015|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154604016|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154604017|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604018|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604019|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154604020|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154604021|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154090901|NCT00660309|Irbesartan|irbesartan|mesh-list
154604022|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154604023|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
154604024|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
154604025|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
154604026|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
154604027|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604028|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604029|NCT02474953|Curcumin|curcumin|mesh-list
154604030|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154604031|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154604032|NCT02474953|Analgesics|analgesics|mesh-ancestor
154604033|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
154604034|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604035|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604036|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604037|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154604038|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604039|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604040|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604041|NCT05714371|Pembrolizumab|pembrolizumab|mesh-list
154604042|NCT05714371|Nivolumab|nivolumab|mesh-list
154604043|NCT05714371|Ipilimumab|ipilimumab|mesh-list
154604044|NCT05714371|Trametinib|trametinib|mesh-list
154604046|NCT05714371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154604047|NCT05714371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604048|NCT05714371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154604049|NCT05714371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604050|NCT05714371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154604051|NCT05714371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604052|NCT02472613|Fluoxetine|fluoxetine|mesh-list
154604053|NCT02472613|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154604054|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154604055|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604056|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604057|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604058|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
154604059|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604060|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154604061|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
154090983|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
154604062|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604063|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154604064|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154604065|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604066|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
154604067|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604068|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
154604069|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154604070|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
154604071|NCT02478229|Ledipasvir|ledipasvir|mesh-list
154604072|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
154604073|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604074|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154327871|NCT02284282|Narcotics|narcotics|mesh-ancestor
154604075|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154604076|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154604077|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604078|NCT05713045|Vitamin K 1|vitamin k 1|mesh-list
154604079|NCT05713045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154604080|NCT05713045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154604081|NCT05713045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604082|NCT05713045|Hemostatics|hemostatics|mesh-ancestor
154604083|NCT05713045|Coagulants|coagulants|mesh-ancestor
154604084|NCT05713045|Vitamins|vitamins|mesh-ancestor
154604085|NCT05713045|Micronutrients|micronutrients|mesh-ancestor
154604086|NCT05713045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604087|NCT00653835|Simvastatin|simvastatin|mesh-list
154604088|NCT00653835|Ezetimibe|ezetimibe|mesh-list
154604089|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154604090|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154604091|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
154604092|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604093|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154604094|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154604095|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604096|NCT03099759|Vitamin D|vitamin d|mesh-list
154604097|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
154604098|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
154604099|NCT03099759|Vitamins|vitamins|mesh-ancestor
154604100|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
154604101|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604102|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154604103|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154604104|NCT05244577|Olanzapine|olanzapine|mesh-list
154604105|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
154604106|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
154604107|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604108|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604109|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604110|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154604111|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154090986|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604112|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604113|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604114|NCT05244577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154604115|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154604116|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604117|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604119|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
154604120|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154604121|NCT05067699|Calcifediol|calcifediol|mesh-list
154604122|NCT05067699|Vitamins|vitamins|mesh-ancestor
154604123|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
154604124|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604125|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154604126|NCT05067153|Heparin|heparin|mesh-list
154604127|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154604128|NCT05067153|Tinzaparin|tinzaparin|mesh-list
154604129|NCT05067153|Dalteparin|dalteparin|mesh-list
154604130|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
154604131|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154604132|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154604133|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604134|NCT05067309|Letrozole|letrozole|mesh-list
154604135|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604136|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154604137|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154604138|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604139|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604140|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154604141|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
154604142|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604143|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604144|NCT02474563|Prednisone|prednisone|mesh-list
154604145|NCT02474563|Bortezomib|bortezomib|mesh-list
154604146|NCT02474563|Melphalan|melphalan|mesh-list
154604147|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604148|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
154604149|NCT02474563|Hormones|hormones|mesh-ancestor
154604150|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604151|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604152|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154604153|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604154|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154604155|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
154604156|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604157|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154604158|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154604159|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
154604160|NCT02477995|Vaccines|vaccines|mesh-list
154604161|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
154604162|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604163|NCT03098823|Prednisone|prednisone|mesh-list
154604164|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604165|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
154604166|NCT03098823|Hormones|hormones|mesh-ancestor
154604167|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604168|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604169|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154604170|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604171|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
154604172|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154604173|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604174|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604175|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154604176|NCT03108937|Analgesics|analgesics|mesh-ancestor
154604177|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
154604178|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604179|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154604180|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154604181|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154604182|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
154604183|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604184|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604185|NCT00705523|Varenicline|varenicline|mesh-list
154604186|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154604187|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154604188|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
154604189|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604190|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604191|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604193|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154604194|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
154604195|NCT02725411|Celecoxib|celecoxib|mesh-list
154604196|NCT02725411|Tanezumab|tanezumab|mesh-list
154604197|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154604198|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154604199|NCT02725411|Analgesics|analgesics|mesh-ancestor
154604200|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
154604201|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604202|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604203|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604204|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154604205|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154604206|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154604207|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604208|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604209|NCT05058105|Meropenem|meropenem|mesh-list
154604210|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154604211|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604212|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
154604213|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154604214|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604215|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
154604216|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154604217|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604218|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604219|NCT03099213|Ramipril|ramipril|mesh-list
154604220|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154091087|NCT00794859|Sorafenib|sorafenib|mesh-list
154604221|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
154604222|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604223|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604225|NCT05061147|Azacitidine|azacitidine|mesh-list
154604226|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154604227|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
154604228|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604229|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604230|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604231|NCT02127970|Dalbavancin|dalbavancin|mesh-list
154604232|NCT02127970|Teicoplanin|teicoplanin|mesh-list
154604233|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154604234|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604235|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
154604236|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604237|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154604238|NCT02471677|Hormones|hormones|mesh-ancestor
154604239|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604240|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604241|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
154604242|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154604243|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
154604244|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604245|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
154604246|NCT04755634|Protective Agents|protective agents|mesh-ancestor
154604247|NCT04470843|Acetazolamide|acetazolamide|mesh-list
154604248|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
154604249|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154604250|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604251|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604252|NCT04470843|Diuretics|diuretics|mesh-ancestor
154604253|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
154604254|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604255|NCT05161741|Insulin|insulin|mesh-list
154604256|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154604257|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604258|NCT02473627|Pioglitazone|pioglitazone|mesh-list
154604259|NCT02473627|Tolbutamide|tolbutamide|mesh-list
154604260|NCT02473627|DS-1971a|ds-1971a|mesh-list
154604261|NCT02473627|Midazolam|midazolam|mesh-list
154604262|NCT02473627|Omeprazole|omeprazole|mesh-list
154604263|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154604264|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154604265|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604266|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604267|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153495811|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154604268|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154604269|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604270|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154604271|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
154604272|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
154604273|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
154604274|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
154604275|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604276|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604277|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154604278|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154604279|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604280|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154604281|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604282|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154604283|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154604284|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604285|NCT03095703|Sirolimus|sirolimus|mesh-list
154091149|NCT00795015|Insulin|insulin|mesh-list
154604286|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154604287|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604288|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154604289|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604290|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
154604291|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154604292|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
154604293|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604294|NCT05035953|Edaravone|edaravone|mesh-list
154604295|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154604296|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
154604297|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604298|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154604299|NCT05035953|Protective Agents|protective agents|mesh-ancestor
154328115|NCT05981001|Paclitaxel|paclitaxel|mesh-list
154604300|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604301|NCT02471209|Sevoflurane|sevoflurane|mesh-list
154604302|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154604303|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154604304|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
154604305|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
154604306|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604307|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604308|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
154604309|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154604310|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
154604311|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604312|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
154604313|NCT02476903|Protective Agents|protective agents|mesh-ancestor
154604314|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
154604315|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154604316|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
154604317|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604318|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604319|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154604320|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
154604321|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
154604322|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154604323|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
154604324|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604325|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604326|NCT04220125|Midazolam|midazolam|mesh-list
154604327|NCT04220125|Ketamine|ketamine|mesh-list
154604328|NCT04220125|Analgesics|analgesics|mesh-ancestor
154604329|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
154604330|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604331|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604332|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154604333|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154604334|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
154604335|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
154604336|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604337|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154604338|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154604339|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604340|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604341|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154604342|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154604343|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154604344|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154604345|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604346|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
154604347|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
154604348|NCT02472691|Lenalidomide|lenalidomide|mesh-list
154604349|NCT02472691|Azacitidine|azacitidine|mesh-list
154604350|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
154604351|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604352|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154604353|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154604354|NCT02472691|Growth Substances|growth substances|mesh-ancestor
154604355|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
154604356|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604357|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154604358|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
154604359|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604360|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604361|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
154604362|NCT02470663|Calcium|calcium|mesh-list
154604363|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154604364|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604365|NCT02470663|Antacids|antacids|mesh-ancestor
154604366|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604367|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604368|NCT00705367|Abatacept|abatacept|mesh-list
154604369|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154604370|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604371|NCT00705367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154604372|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604373|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328192|NCT05975489|Caffeine|caffeine|mesh-list
154604374|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
154604375|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604376|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154604377|NCT03043729|Leucovorin|leucovorin|mesh-list
154604378|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
154604379|NCT03043729|Aflibercept|aflibercept|mesh-list
154604380|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604381|NCT03043729|Antidotes|antidotes|mesh-ancestor
154604382|NCT03043729|Protective Agents|protective agents|mesh-ancestor
154604383|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604384|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
154604385|NCT03043729|Vitamins|vitamins|mesh-ancestor
154604386|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
154604387|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154604388|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154604389|NCT03043729|Growth Substances|growth substances|mesh-ancestor
154604390|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
154604391|NCT05306431|Biguanides|biguanides|mesh-list
154604392|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154604393|NCT05306431|Polihexanide|polihexanide|mesh-list
154604394|NCT05306431|Eusol|eusol|mesh-list
154604395|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
154604396|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604397|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154604398|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604399|NCT03108313|Fluorides|fluorides|mesh-list
154604400|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
154604401|NCT03108313|Protective Agents|protective agents|mesh-ancestor
154604402|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604403|NCT03108625|Vortioxetine|vortioxetine|mesh-list
154604404|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
154604405|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604406|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154604407|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154604408|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604409|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604410|NCT03108625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154604411|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154604412|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604413|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604414|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604415|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
154604416|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154604417|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154604418|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154604419|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154604420|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
154604421|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154604422|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604423|NCT03310567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154604424|NCT03310567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604425|NCT02468791|Rituximab|rituximab|mesh-list
154604426|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154604427|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604428|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
154604429|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604430|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154604431|NCT02693821|Gabapentin|gabapentin|mesh-list
154604432|NCT02693821|Analgesics|analgesics|mesh-ancestor
154604433|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
154604434|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604435|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604436|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
154604437|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154604438|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154604439|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604440|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604441|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154604442|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154604443|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091315|NCT00836212|Efavirenz|efavirenz|mesh-list
154604444|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604445|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
154604446|NCT02470117|Antacids|antacids|mesh-list
154604447|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604448|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604449|NCT03310333|Dinoprostone|dinoprostone|mesh-list
154604451|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154604452|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604453|NCT00705289|Infliximab|infliximab|mesh-list
154604454|NCT00705289|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154604455|NCT00705289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604456|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
154604457|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604458|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154604459|NCT03309865|Vedolizumab|vedolizumab|mesh-list
154604460|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604461|NCT03309709|Progesterone|progesterone|mesh-list
154604462|NCT03309709|Progestins|progestins|mesh-ancestor
154604463|NCT03309709|Hormones|hormones|mesh-ancestor
154604464|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604465|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604466|NCT01720147|Quercetin|quercetin|mesh-list
154604467|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
154604468|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604469|NCT01720147|Protective Agents|protective agents|mesh-ancestor
154604470|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604471|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
154604472|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154604473|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604474|NCT03309163|Tramadol|tramadol|mesh-list
154604475|NCT03309163|Hydromorphone|hydromorphone|mesh-list
154604476|NCT03309163|Ropivacaine|ropivacaine|mesh-list
154604477|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
154604478|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
154604479|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604480|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604481|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
154604482|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604483|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154604484|NCT03309163|Narcotics|narcotics|mesh-ancestor
154604485|NCT03309163|Analgesics|analgesics|mesh-ancestor
154604486|NCT03174847|Eplerenone|eplerenone|mesh-list
154604487|NCT03174847|Amiloride|amiloride|mesh-list
154604488|NCT03174847|Spironolactone|spironolactone|mesh-list
154604489|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154604490|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
154604491|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
154604492|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604493|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604494|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154604496|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
154604497|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154604498|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154604499|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154604500|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604501|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604502|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154604503|NCT03174847|Hormones|hormones|mesh-ancestor
154604504|NCT03313531|Thrombin|thrombin|mesh-list
154604505|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
154604506|NCT03313531|Coagulants|coagulants|mesh-ancestor
154604507|NCT02468167|Polidocanol|polidocanol|mesh-list
154604508|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154604509|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154604510|NCT03308149|Triamcinolone|triamcinolone|mesh-list
154604511|NCT03308149|Bupivacaine|bupivacaine|mesh-list
154604512|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
154604513|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
154604514|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604515|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604516|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
154604517|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604518|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604519|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
154604520|NCT03308149|Hormones|hormones|mesh-ancestor
154604521|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604522|NCT03303235|Methylergonovine|methylergonovine|mesh-list
154328325|NCT06098625|Incretins|incretins|mesh-ancestor
154604523|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
154604524|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154604525|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604526|NCT03307993|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154604527|NCT03307993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154604528|NCT03307993|Serotonin Agents|serotonin agents|mesh-ancestor
154604529|NCT03307993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604530|NCT03307993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604531|NCT03307993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604532|NCT03302845|Omeprazole|omeprazole|mesh-list
154604533|NCT03302845|Famotidine|famotidine|mesh-list
154604534|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154604535|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604536|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154604537|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091419|NCT00836368|Vitamins|vitamins|mesh-ancestor
154604538|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604539|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154604540|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
154604541|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
154604542|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604543|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604544|NCT03302689|Ropivacaine|ropivacaine|mesh-list
154604545|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
154604546|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154604547|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
154604548|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
154604549|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604550|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604551|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
154604552|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604553|NCT03307603|Nivolumab|nivolumab|mesh-list
154604554|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154604555|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604556|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154604557|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604558|NCT02468323|Ondansetron|ondansetron|mesh-list
154604559|NCT02468323|Palonosetron|palonosetron|mesh-list
154604560|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
154604561|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
154604562|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604563|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604564|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604565|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
154604566|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
154604567|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154604569|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
154604570|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604571|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604572|NCT02469259|Oxytocin|oxytocin|mesh-list
154604573|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
154604574|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154604575|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604576|NCT03307213|Sirolimus|sirolimus|mesh-list
154604577|NCT03307213|Umirolimus|umirolimus|mesh-list
154604578|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604579|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154604580|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
154604581|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604582|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154604583|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604584|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154604585|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604586|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
154604587|NCT03302221|Ropivacaine|ropivacaine|mesh-list
154604588|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
154604589|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604590|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604591|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
154604592|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
154604593|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604594|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
154604595|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154604596|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
154604597|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604598|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604599|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154604600|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
154604601|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
154604602|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154604603|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
154604604|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604605|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604607|NCT03306745|Hematinics|hematinics|mesh-ancestor
154604608|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
154604609|NCT03306745|Vitamins|vitamins|mesh-ancestor
154604610|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
154604611|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604612|NCT03306667|Dotinurad|dotinurad|mesh-list
154604613|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
154604614|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
154604615|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154604616|NCT03312283|Ranibizumab|ranibizumab|mesh-list
154604617|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154604618|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154091498|NCT00719108|Insulin|insulin|mesh-list
154604619|NCT03312283|Growth Substances|growth substances|mesh-ancestor
154604620|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604621|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
154604622|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604623|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
154604624|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154604625|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604626|NCT03301207|Midazolam|midazolam|mesh-list
154604627|NCT03301207|Bupropion|bupropion|mesh-list
154604628|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
154604629|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154604630|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154604631|NCT03301207|Ibrutinib|ibrutinib|mesh-list
154604632|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154604633|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154604634|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604635|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604636|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154604637|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154604638|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604639|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154604640|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
154604641|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
154604642|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
154604643|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
154604644|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604645|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604646|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154604648|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154604649|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154604650|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604651|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
154604652|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154604653|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154604654|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604655|NCT03301207|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154604656|NCT03301207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154604657|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154604658|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
154604659|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154604660|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154604661|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154604662|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154604663|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154604664|NCT03301207|Estrogens|estrogens|mesh-ancestor
154604665|NCT03301207|Hormones|hormones|mesh-ancestor
154604666|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604667|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154604668|NCT03311971|Methamphetamine|methamphetamine|mesh-list
154604669|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154604670|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604671|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
154604672|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
154604673|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604674|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
154604675|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604676|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604677|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
154604678|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154604679|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154604680|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604681|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154604682|NCT03311737|Anesthetics|anesthetics|mesh-list
154604683|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604684|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604685|NCT02467543|Ethanol|ethanol|mesh-list
154604686|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154604687|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604688|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604689|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604690|NCT03311581|Propofol|propofol|mesh-list
154604691|NCT03311581|Sevoflurane|sevoflurane|mesh-list
154604692|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154604693|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604694|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604695|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154604696|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
154604697|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
154604698|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154604699|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154604700|NCT03311425|Dexamethasone|dexamethasone|mesh-list
154604701|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
154604702|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154604703|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154604704|NCT03311425|Prednisolone|prednisolone|mesh-list
154604705|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
154604706|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154604707|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
154604708|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604709|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
154604710|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
154604711|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604712|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604713|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604714|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
154604715|NCT03311425|Hormones|hormones|mesh-ancestor
154604716|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604717|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154604718|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604719|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154604721|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
154604722|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
154604723|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154604724|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154604725|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604726|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604727|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604728|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154604729|NCT03300115|Abivertinib|abivertinib|mesh-list
154604730|NCT03300115|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154604731|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154604732|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604733|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604734|NCT00702949|Pregabalin|pregabalin|mesh-list
154604735|NCT00702949|Analgesics|analgesics|mesh-ancestor
154604736|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
154604737|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604738|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604739|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
154604740|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154604741|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604742|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604743|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154604744|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154604745|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154604746|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604747|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604748|NCT04791475|Dexamethasone|dexamethasone|mesh-list
154604749|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
154604750|NCT04791475|Bupivacaine|bupivacaine|mesh-list
154604751|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604752|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
154604753|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
154604754|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604755|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604756|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604757|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
154604758|NCT04791475|Hormones|hormones|mesh-ancestor
154604759|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604760|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154604761|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604762|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
154604763|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
154604764|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604765|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
154604766|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154604767|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154604768|NCT04791475|Analgesics|analgesics|mesh-ancestor
154604769|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154604770|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154604771|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154604772|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
154604773|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604774|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604775|NCT03299725|Bismuth|bismuth|mesh-list
154604776|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604777|NCT03299725|Antacids|antacids|mesh-ancestor
154604778|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604779|NCT02466997|Tacrolimus|tacrolimus|mesh-list
154604780|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154604781|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
154604782|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604783|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154604784|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604785|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604786|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
154604787|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154604788|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154604789|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154604790|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604791|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604792|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
154604793|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604794|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604795|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154604796|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604797|NCT03299257|Donepezil|donepezil|mesh-list
154604798|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154604799|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604800|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604801|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
154604802|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604803|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604804|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
154604805|NCT02466373|Clonidine|clonidine|mesh-list
154604806|NCT02466373|Analgesics|analgesics|mesh-ancestor
154604807|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
154604808|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604809|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604810|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154604811|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
154604812|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
154604813|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154604814|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154604815|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154604816|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
154604817|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604818|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604819|NCT02466919|Amoxicillin|amoxicillin|mesh-list
154604820|NCT02466919|Metronidazole|metronidazole|mesh-list
154604821|NCT02466919|Clarithromycin|clarithromycin|mesh-list
154604822|NCT02466919|Levofloxacin|levofloxacin|mesh-list
154604823|NCT02466919|Pantoprazole|pantoprazole|mesh-list
154604824|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154604825|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604827|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154604828|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154604829|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604830|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604831|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154604832|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154604833|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154604834|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154604835|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154604836|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604837|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154604838|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154604839|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604840|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154604841|NCT05259709|Cemiplimab|cemiplimab|mesh-list
154604842|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154604843|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604844|NCT05302531|Amoxicillin|amoxicillin|mesh-list
154604845|NCT05302531|Levofloxacin|levofloxacin|mesh-list
154604846|NCT05302531|Ofloxacin|ofloxacin|mesh-list
154604847|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154604848|NCT05302531|Trimethoprim|trimethoprim|mesh-list
154604849|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
154604850|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154604851|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604852|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154604853|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154604854|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154604855|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604856|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604857|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604858|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154604859|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154604860|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
154604861|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154604862|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154604863|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154604864|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154604865|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154604866|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
154604867|NCT00702403|Nilotinib|nilotinib|mesh-list
154604868|NCT00702403|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154604869|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154604870|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604871|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604872|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604873|NCT00702325|Budesonide|budesonide|mesh-list
154604874|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
154604875|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154604876|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154604877|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154604878|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
154604879|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604880|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604881|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154604882|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
154604883|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
154604884|NCT00702325|Hormones|hormones|mesh-ancestor
154604885|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604886|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154604887|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154604888|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154604889|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
154604890|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604891|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604892|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154604893|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
154604894|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604895|NCT02464813|Pregabalin|pregabalin|mesh-list
154604896|NCT02464813|Oxycodone|oxycodone|mesh-list
154604897|NCT02464813|Analgesics|analgesics|mesh-ancestor
154604898|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
154604899|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604900|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604902|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154604903|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154604904|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604905|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154604906|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154604907|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154604908|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604909|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154604910|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154604911|NCT02464813|Narcotics|narcotics|mesh-ancestor
154604912|NCT05726929|Capsaicin|capsaicin|mesh-list
154604913|NCT05726929|Antipruritics|antipruritics|mesh-ancestor
154604914|NCT05726929|Dermatologic Agents|dermatologic agents|mesh-ancestor
154604915|NCT05726929|Sensory System Agents|sensory system agents|mesh-ancestor
154604916|NCT05726929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604917|NCT05726929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604918|NCT05122351|Acetaminophen|acetaminophen|mesh-list
154604919|NCT05122351|Bupivacaine|bupivacaine|mesh-list
154604920|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
154604921|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
154604922|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604923|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604924|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
154604925|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604926|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154604927|NCT05122351|Analgesics|analgesics|mesh-ancestor
154604928|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
154604929|NCT02464501|Paclitaxel|paclitaxel|mesh-list
154604930|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154604931|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604932|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
154604933|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
154604934|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
154604935|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604936|NCT02465827|Ropivacaine|ropivacaine|mesh-list
154604937|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
154604938|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
154604939|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154604940|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604941|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
154604942|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154604944|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154604945|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
154604946|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154604947|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604948|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
154604949|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
154604950|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154604951|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
154604952|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604953|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154604954|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154604955|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
154604956|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604957|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154604958|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154604959|NCT02465749|Vitamins|vitamins|mesh-list
154604960|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
154604961|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604962|NCT00701779|Tamsulosin|tamsulosin|mesh-list
154604963|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154604964|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154604965|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154604966|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154604967|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154604968|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604969|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604970|NCT00701779|Urological Agents|urological agents|mesh-ancestor
154604971|NCT02463643|Rabeprazole|rabeprazole|mesh-list
154604972|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154604973|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154604974|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154604975|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604976|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604977|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154604978|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154604979|NCT04150861|Hormones|hormones|mesh-ancestor
154604980|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154604981|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604982|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
154604983|NCT02465359|Antibodies|antibodies|mesh-list
154604984|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
154604985|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154091852|NCT00429793|Sirolimus|sirolimus|mesh-list
154604986|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154604987|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
154604988|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154604989|NCT02463019|Tenofovir|tenofovir|mesh-list
154604990|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
154604991|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154604992|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154604993|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154604994|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154604995|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154604996|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154604997|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154604998|NCT02462941|Adenosine|adenosine|mesh-list
154604999|NCT02462941|Analgesics|analgesics|mesh-ancestor
154605000|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
154605001|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605002|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605003|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154605004|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
154605005|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154605006|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
154605007|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
154605008|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605009|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605010|NCT02462707|Nirogacestat|nirogacestat|mesh-list
154605011|NCT02462707|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154605012|NCT02462707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605013|NCT02462707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605014|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
154605015|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154605016|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154605017|NCT03297073|Acetaminophen|acetaminophen|mesh-list
154605018|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154605019|NCT03297073|Analgesics|analgesics|mesh-ancestor
154605020|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
154605021|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605022|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605023|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
154605024|NCT02462317|Baclofen|baclofen|mesh-list
154605025|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154605026|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154605027|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154605028|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605029|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154605030|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605031|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154605032|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
154605033|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
154605034|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605035|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091898|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605036|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154605037|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154605038|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
154605039|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154605040|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154605041|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154605042|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
154605043|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605044|NCT03332095|Tenofovir|tenofovir|mesh-list
154605045|NCT03332095|Lamivudine|lamivudine|mesh-list
154605046|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154605047|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
154605048|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328846|NCT06216132|Naltrexone|naltrexone|mesh-list
154605049|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154605050|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154605051|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605052|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605053|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154605054|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
154605055|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154605056|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605057|NCT04489849|Apixaban|apixaban|mesh-list
154605058|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154605059|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
154605060|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154605061|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
154605062|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605063|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605064|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
154605065|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
154605066|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154605067|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154605068|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605069|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
154605070|NCT04488367|Coagulants|coagulants|mesh-ancestor
154605071|NCT04489459|Meropenem|meropenem|mesh-list
154605072|NCT04489459|Colistin|colistin|mesh-list
154605073|NCT04489459|Tigecycline|tigecycline|mesh-list
154605074|NCT04489459|Polymyxins|polymyxins|mesh-list
154605075|NCT04489459|Polymyxin B|polymyxin b|mesh-list
154605076|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154605077|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605078|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154605079|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605080|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605081|NCT03296137|Aldesleukin|aldesleukin|mesh-list
154605082|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
154605083|NCT03296137|Nivolumab|nivolumab|mesh-list
154605084|NCT03296137|Ipilimumab|ipilimumab|mesh-list
154605085|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
154605086|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154605087|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
154605088|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605089|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154605090|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154605091|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
154605092|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091966|NCT00424489|Hormones|hormones|mesh-ancestor
154605093|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605094|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154605095|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154605096|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154605097|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154605098|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
154605099|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154605100|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154605101|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
154605102|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605103|NCT03295903|Cannabidiol|cannabidiol|mesh-list
154605104|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
154605105|NCT02460913|Morphine|morphine|mesh-list
154605106|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154605107|NCT02460913|Narcotics|narcotics|mesh-ancestor
154605108|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605109|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605110|NCT02460913|Analgesics|analgesics|mesh-ancestor
154605111|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
154605112|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605113|NCT03295825|Heparin|heparin|mesh-list
154605114|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
154605115|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154605116|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154605117|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605118|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
154605119|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154605120|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
154605121|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605122|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
154605123|NCT03290365|Protective Agents|protective agents|mesh-ancestor
154605124|NCT02764489|Thrombin|thrombin|mesh-list
154605125|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
154605126|NCT02764489|Coagulants|coagulants|mesh-list
154605127|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
154605128|NCT02462161|Insulin|insulin|mesh-list
154605129|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154605130|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
154605131|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
154605132|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154605133|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154605134|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605135|NCT03289819|Paclitaxel|paclitaxel|mesh-list
154605136|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154605137|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
154605138|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
154605139|NCT03289819|Epirubicin|epirubicin|mesh-list
154605140|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154605141|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605142|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
154605143|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
154605144|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
154605145|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605146|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154605147|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
154092018|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
154605148|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605149|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154605150|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154605151|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
154605152|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154605153|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154605154|NCT03289819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154605155|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154605156|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154605157|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154605158|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605159|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
154605160|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154605161|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605162|NCT02713867|Nivolumab|nivolumab|mesh-list
154605163|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154605164|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605165|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154605166|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605167|NCT03372785|Aspirin|aspirin|mesh-list
154605168|NCT03372785|Metoprolol|metoprolol|mesh-list
154605169|NCT03372785|Clopidogrel|clopidogrel|mesh-list
154605170|NCT03372785|Ticagrelor|ticagrelor|mesh-list
154605171|NCT03372785|Atorvastatin|atorvastatin|mesh-list
154605172|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154605173|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154605174|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154605175|NCT03372785|Analgesics|analgesics|mesh-ancestor
154605176|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
154605177|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605178|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605179|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154605180|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154605181|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154605182|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154605183|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605184|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154605185|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154605186|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605187|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
154605188|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154605189|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154605190|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
154605191|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154605192|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154605193|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154605194|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154605195|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154605196|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
154605197|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092061|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
154605198|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154605199|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154605200|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
154605201|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
154328999|NCT06203912|Dermatologic Agents|dermatologic agents|mesh-ancestor
154605202|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154605203|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154605204|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154605205|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
154605206|NCT03372473|Loratadine|loratadine|mesh-list
154605207|NCT03372473|Montelukast|montelukast|mesh-list
154605208|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154605209|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
154605210|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154605211|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
154605212|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154605213|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605214|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154605215|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154605216|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605217|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
154605218|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
154605219|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154605220|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154605221|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154605222|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
154605223|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
154605224|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605225|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
154605226|NCT03289429|Atorvastatin|atorvastatin|mesh-list
154605227|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154605228|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154605229|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
154605230|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605231|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154605232|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154605233|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605234|NCT03289429|Analgesics|analgesics|mesh-ancestor
154605235|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
154605236|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605237|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605238|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
154605239|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605240|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154605241|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
154605242|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154605243|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154605244|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154605245|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
154605246|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154605247|NCT03372239|Tryptophan|tryptophan|mesh-list
154605248|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154605249|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
154605250|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154605251|NCT03294967|Vitamin E|vitamin e|mesh-list
154605252|NCT03294967|Caffeine|caffeine|mesh-list
154605253|NCT03294967|Vitamins|vitamins|mesh-ancestor
154605254|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
154092112|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
154605255|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605256|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154605257|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154605258|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605259|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605260|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154605261|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154605262|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
154605263|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605264|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
154605265|NCT03294967|Protective Agents|protective agents|mesh-ancestor
154605266|NCT03371849|Montelukast|montelukast|mesh-list
154605267|NCT03371849|Levocetirizine|levocetirizine|mesh-list
154605268|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154605269|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
154605270|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154605271|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
154605272|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154605273|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605274|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154329077|NCT05625724|Analgesics|analgesics|mesh-ancestor
154605275|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154605276|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605277|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154605278|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154605279|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
154605280|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
154605281|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605282|NCT04307329|Trastuzumab|trastuzumab|mesh-list
154605283|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154605284|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605285|NCT03371069|Methylphenidate|methylphenidate|mesh-list
154605286|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154605287|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605288|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154605289|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154605290|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154605291|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605292|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
154605293|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605294|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
154605295|NCT03294577|Docetaxel|docetaxel|mesh-list
154605296|NCT03294577|Doxorubicin|doxorubicin|mesh-list
154605297|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154605298|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
154605299|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605300|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154605301|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154605302|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
154605303|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605304|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605305|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154605306|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
154605307|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
154092168|NCT01033279|Warfarin|warfarin|mesh-list
154605308|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
154605309|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154605310|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154605311|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154605312|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605314|NCT03370835|Carvedilol|carvedilol|mesh-list
154605315|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154605316|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154605317|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
154605318|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
154605319|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605320|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605321|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154605322|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154605323|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154605324|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
154605325|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605326|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605327|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
154605328|NCT03370835|Protective Agents|protective agents|mesh-ancestor
154605329|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154605330|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154605331|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154605332|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
154605333|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154605334|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154605335|NCT02460367|Docetaxel|docetaxel|mesh-list
154605336|NCT02460367|Tryptophan|tryptophan|mesh-list
154605337|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605338|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
154605339|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
154605340|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
154605341|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605342|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154605343|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
154605344|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154605345|NCT03370601|Infliximab|infliximab|mesh-list
154605346|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
154605347|NCT03370601|Azathioprine|azathioprine|mesh-list
154605348|NCT03370601|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154605349|NCT03370601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154605350|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
154605351|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605352|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154605353|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
154605354|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605355|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154605356|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605357|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154605358|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
154605359|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605360|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154605361|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605362|NCT03376529|Tazobactam|tazobactam|mesh-list
154605363|NCT03376529|Piperacillin|piperacillin|mesh-list
154605364|NCT03376529|Ceftazidime|ceftazidime|mesh-list
154605365|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154605366|NCT03376529|Aztreonam|aztreonam|mesh-list
154605367|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154605368|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605369|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154605370|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605371|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605372|NCT03376529|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154605373|NCT03376529|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154605374|NCT04132661|Bisacodyl|bisacodyl|mesh-list
154605375|NCT04132661|Cathartics|cathartics|mesh-ancestor
154605376|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605377|NCT04132661|Laxatives|laxatives|mesh-ancestor
154605378|NCT02460211|Vitamin D|vitamin d|mesh-list
154605379|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
154605380|NCT02460211|Vitamins|vitamins|mesh-ancestor
154605381|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
154605382|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605383|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154605384|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154605385|NCT03288259|Anesthetics|anesthetics|mesh-list
154605386|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
154605387|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605388|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605389|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
154605390|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605391|NCT02730455|Natalizumab|natalizumab|mesh-list
154605392|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
154605393|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605394|NCT03376139|Zonisamide|zonisamide|mesh-list
154605395|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
154605396|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154605397|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154605398|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605399|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154605400|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605401|NCT03369119|Montelukast|montelukast|mesh-list
154605402|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154605403|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
154605404|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154605405|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
154092281|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605406|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154605407|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605408|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154605409|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154605410|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605411|NCT03287011|Listerine|listerine|mesh-list
154605412|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
154605413|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
154605414|NCT03287011|Protective Agents|protective agents|mesh-ancestor
154605415|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605416|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154605417|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605418|NCT03293641|Folic Acid|folic acid|mesh-list
154605419|NCT03293641|Penicillins|penicillins|mesh-list
154605420|NCT03293641|Penicillin V|penicillin v|mesh-list
154605421|NCT03293641|Proguanil|proguanil|mesh-list
154605422|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
154605423|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
154605424|NCT03293641|Hematinics|hematinics|mesh-ancestor
154605425|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
154605426|NCT03293641|Vitamins|vitamins|mesh-ancestor
154605427|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
154605428|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605429|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605430|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
154605431|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605432|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605433|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154605434|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154605435|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605436|NCT03293641|Astringents|astringents|mesh-ancestor
154605437|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
154605438|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
154605439|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154605440|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154255772|NCT03892148|Diuretics|diuretics|mesh-ancestor
154605441|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
154605442|NCT02519543|Metformin|metformin|mesh-list
154605443|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154605444|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605445|NCT03293407|Iloprost|iloprost|mesh-list
154605446|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154605447|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
154605448|NCT02519699|Norepinephrine|norepinephrine|mesh-list
154605449|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154605450|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154605451|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
154605452|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605453|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605454|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605455|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
154605456|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
154605457|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605458|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154605459|NCT00701311|Apremilast|apremilast|mesh-list
154605460|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154605461|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154605462|NCT00701311|Analgesics|analgesics|mesh-ancestor
154605463|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
154605464|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605465|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605466|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154605467|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154605468|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154605469|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154605470|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605471|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605472|NCT03375671|Midazolam|midazolam|mesh-list
154605473|NCT03375671|Ketamine|ketamine|mesh-list
154605474|NCT03375671|Haloperidol|haloperidol|mesh-list
154605475|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
154605476|NCT03375671|Analgesics|analgesics|mesh-ancestor
154605477|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
154605478|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605479|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605480|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154605481|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154605482|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
154605483|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
154605484|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605485|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154605486|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154605487|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605488|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605489|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154605490|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154605491|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154605492|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154605493|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154605494|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
154605495|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
154605496|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
154605497|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
154605498|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605499|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154329300|NCT04914390|Paclitaxel|paclitaxel|mesh-list
154605500|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154605501|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
154605502|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154605503|NCT03375593|Acetaminophen|acetaminophen|mesh-list
154605504|NCT03375593|Ibuprofen|ibuprofen|mesh-list
154605505|NCT03375593|Oxycodone|oxycodone|mesh-list
154605506|NCT03375593|Hydrocodone|hydrocodone|mesh-list
154605507|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154605508|NCT03375593|Analgesics|analgesics|mesh-ancestor
154605509|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
154605510|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605511|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605512|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
154605513|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154605514|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154605515|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154605516|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154605517|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605518|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605519|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154605520|NCT03375593|Narcotics|narcotics|mesh-ancestor
154605521|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605522|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
154605523|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
154605524|NCT04525235|Tolbutamide|tolbutamide|mesh-list
154605525|NCT04525235|Rifampin|rifampin|mesh-list
154605526|NCT04525235|Digoxin|digoxin|mesh-list
154605527|NCT04525235|Midazolam|midazolam|mesh-list
154605528|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
154605529|NCT04525235|Caffeine|caffeine|mesh-list
154605530|NCT04525235|Omeprazole|omeprazole|mesh-list
154605531|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154605532|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154605533|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605534|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605535|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154605536|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154605537|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154605538|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154605539|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
154605540|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
154605541|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
154605542|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
154605543|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605544|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605545|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154605546|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154605547|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605548|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154605549|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154605550|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
154605551|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154605552|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605553|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154605554|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154605555|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
154605556|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154605557|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605558|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
154605559|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154605560|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154605561|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154605562|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154605563|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154605564|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154605565|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154605566|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154605567|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154605568|NCT04525235|Protective Agents|protective agents|mesh-ancestor
154605569|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
154605570|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
154605571|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154605572|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154605573|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154605574|NCT03363815|Vitamin K|vitamin k|mesh-list
154605575|NCT03363815|Metformin|metformin|mesh-list
154605576|NCT03363815|Nintedanib|nintedanib|mesh-list
154329375|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154605577|NCT03363815|Digoxin|digoxin|mesh-list
154605578|NCT03363815|Midazolam|midazolam|mesh-list
154605579|NCT03363815|Omeprazole|omeprazole|mesh-list
154605580|NCT03363815|Warfarin|warfarin|mesh-list
154605581|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154605582|NCT03363815|Vitamins|vitamins|mesh-ancestor
154605583|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
154605584|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605585|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154605586|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154605587|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154605588|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605589|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154605590|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154605591|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154605592|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154605593|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
154605594|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
154605595|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
154605596|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
154605597|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605598|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605599|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154605600|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154605601|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
154605602|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154605603|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154605604|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605605|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
154605606|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154605607|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605608|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154605609|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154605610|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154605611|NCT03363815|Protective Agents|protective agents|mesh-ancestor
154605612|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154605613|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154605614|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
154605615|NCT03363815|Coagulants|coagulants|mesh-ancestor
154605616|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605617|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154605618|NCT03363425|Lidocaine|lidocaine|mesh-list
154605619|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
154605620|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
154605621|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
154605622|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605623|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605624|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
154605625|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605626|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154605627|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154605628|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154605629|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154605630|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605631|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154605632|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154605633|NCT03363425|Analgesics|analgesics|mesh-ancestor
154605634|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154605635|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154605636|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154605637|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
154605638|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605639|NCT03292783|Asciminib|asciminib|mesh-list
154605640|NCT03292783|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154605641|NCT03292783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154605642|NCT03292783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605643|NCT03292783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605644|NCT02459977|Basiliximab|basiliximab|mesh-list
154605645|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154605646|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
154605647|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605648|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
154605649|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
154605650|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154605651|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154605652|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605653|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605654|NCT02519153|Urological Agents|urological agents|mesh-ancestor
154605655|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
154605656|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154605657|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605658|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154605659|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154605660|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605661|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605662|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605663|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154605664|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154605665|NCT03363191|Fluticasone|fluticasone|mesh-list
154605667|NCT03363191|Albuterol|albuterol|mesh-list
154605668|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154605669|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154605670|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
154605671|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605672|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605673|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154605674|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
154605675|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
154605676|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154605677|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
154605678|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154605679|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154605680|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154605681|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154605682|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
154605683|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605684|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605685|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
154605686|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154605687|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154605688|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605689|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
154605690|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605691|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605692|NCT03285607|Paclitaxel|paclitaxel|mesh-list
154605693|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
154605694|NCT03285607|Doxorubicin|doxorubicin|mesh-list
154605695|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154605696|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605697|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
154605698|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
154605699|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
154605700|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605701|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154605702|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
154605703|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605704|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154605705|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154605706|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
154605707|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154605708|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154605709|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154605710|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154605711|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605712|NCT03298321|Azacitidine|azacitidine|mesh-list
154605713|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154605714|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
154605715|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605716|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605717|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605718|NCT04527055|Metronidazole|metronidazole|mesh-list
154605719|NCT04527055|Tetracycline|tetracycline|mesh-list
154605720|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154605721|NCT04527055|Esomeprazole|esomeprazole|mesh-list
154605722|NCT04527055|Bismuth|bismuth|mesh-list
154605723|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605724|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154605725|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154605726|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154605727|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154605728|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605729|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154605730|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605731|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605732|NCT04527055|Antacids|antacids|mesh-ancestor
154605733|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154605734|NCT02518763|Vitamin D|vitamin d|mesh-list
154605735|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
154605736|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
154605737|NCT02518763|Vitamins|vitamins|mesh-list
154605738|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
154605739|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605740|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154605741|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154605742|NCT03362411|Linrodostat|linrodostat|mesh-list
154605743|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605744|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605745|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
154605746|NCT03291457|Hormones|hormones|mesh-ancestor
154605747|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154605748|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605749|NCT03361709|Dexamethasone|dexamethasone|mesh-list
154605750|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154605751|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
154605752|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
154605753|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605754|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605755|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605756|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
154605757|NCT03361709|Hormones|hormones|mesh-ancestor
154605758|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154605759|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154605760|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605761|NCT03284749|Copper|copper|mesh-list
154605762|NCT03284749|Trace Elements|trace elements|mesh-ancestor
154605763|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
154605764|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605765|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
154605766|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154605767|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
154605768|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605769|NCT04523675|Expectorants|expectorants|mesh-ancestor
154605770|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
154605771|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154605772|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
154605773|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605774|NCT04523675|Protective Agents|protective agents|mesh-ancestor
154605775|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605776|NCT04523675|Antidotes|antidotes|mesh-ancestor
154605777|NCT03298009|Canagliflozin|canagliflozin|mesh-list
154605778|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154605779|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605780|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154605781|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605782|NCT03291145|Spironolactone|spironolactone|mesh-list
154605783|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154605784|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154605785|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
154605786|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154605787|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605788|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154605789|NCT03291145|Diuretics|diuretics|mesh-ancestor
154605790|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
154605791|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154605792|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
154605793|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605794|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605795|NCT03297931|Iproplatin|iproplatin|mesh-list
154605796|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605797|NCT03284593|Azacitidine|azacitidine|mesh-list
154605798|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154605799|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
154605800|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605801|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605802|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605803|NCT03361397|Lidocaine|lidocaine|mesh-list
154605804|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
154605805|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
154605806|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605807|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605808|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
154605809|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605810|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154605811|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154605812|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154605813|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154605814|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605815|NCT03109379|Trospium chloride|trospium chloride|mesh-list
154605817|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
154605818|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605819|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605820|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154605821|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154605822|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
154605823|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605824|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605825|NCT03109379|Urological Agents|urological agents|mesh-ancestor
154605826|NCT03361319|Paclitaxel|paclitaxel|mesh-list
154605827|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154605828|NCT03361319|Nintedanib|nintedanib|mesh-list
154605829|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154605830|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605831|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
154605832|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
154605833|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
154605834|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605835|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154605836|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605837|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
154605838|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
154605839|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154605840|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154605841|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605842|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
154605843|NCT03365999|Coagulants|coagulants|mesh-ancestor
154605844|NCT02460055|Dexamethasone|dexamethasone|mesh-list
154605845|NCT02460055|Fentanyl|fentanyl|mesh-list
154605846|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
154605847|NCT02460055|Ondansetron|ondansetron|mesh-list
154605848|NCT02460055|Propofol|propofol|mesh-list
154605849|NCT02460055|Sevoflurane|sevoflurane|mesh-list
154605850|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154605851|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
154605852|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
154605853|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605854|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605855|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605856|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
154605857|NCT02460055|Hormones|hormones|mesh-ancestor
154605858|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154605859|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154605860|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605861|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154605862|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605863|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154605864|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
154605865|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
154605866|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154605867|NCT02460055|Narcotics|narcotics|mesh-ancestor
154605868|NCT02460055|Analgesics|analgesics|mesh-ancestor
154605869|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
154605870|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154605871|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154605872|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154605873|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
154605874|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
154605875|NCT02460055|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154605876|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154605877|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
154605878|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605879|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605880|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154605881|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
154605882|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154605883|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154605884|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
154605885|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605886|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605887|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605888|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154605889|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154605890|NCT03365765|Fluorouracil|fluorouracil|mesh-list
154605891|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
154605893|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
154605894|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605895|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154605896|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605897|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154605898|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
154605899|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605900|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154605901|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605902|NCT03297463|Ipilimumab|ipilimumab|mesh-list
154605903|NCT03297463|Interleukin-2|interleukin-2|mesh-list
154605904|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154605905|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154605906|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154605907|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605908|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154605909|NCT03297463|Analgesics|analgesics|mesh-ancestor
154605910|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
154605911|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605912|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605913|NCT03282643|Heparin|heparin|mesh-list
154605914|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154605915|NCT03282643|Tinzaparin|tinzaparin|mesh-list
154605916|NCT03282643|Dalteparin|dalteparin|mesh-list
154605917|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
154605918|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
154605919|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154605920|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154605921|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605922|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154605923|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
154605924|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154605925|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
154605926|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605927|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
154605928|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154605929|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
154605930|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
154605931|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
154605932|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154605933|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154605934|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605935|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
154605936|NCT02458729|Coagulants|coagulants|mesh-ancestor
154605937|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154605938|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
154605939|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154605940|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
154605941|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154605942|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
154605943|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
154605944|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154605945|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154605946|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154605947|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154605948|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605949|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605950|NCT03920527|Itraconazole|itraconazole|mesh-list
154605951|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
154605952|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605953|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154605954|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154605955|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329738|NCT05877807|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154605956|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605957|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154605958|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
154092817|NCT04536532|Entecavir|entecavir|mesh-list
154605959|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154605960|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605961|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154605963|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
154605964|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154605965|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497583|NCT00002790|Cyclosporine|cyclosporine|mesh-list
154605966|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605968|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
154605969|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605970|NCT03529825|Rifaximin|rifaximin|mesh-list
154605971|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154605972|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154605973|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154605974|NCT03281941|Capsaicin|capsaicin|mesh-list
154605975|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
154605976|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
154605977|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
154605978|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605979|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605980|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
154605981|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154605982|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154605983|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154605984|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154605985|NCT02459509|Analgesics|analgesics|mesh-ancestor
154605986|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
154605987|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154605988|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154605989|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154605990|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154605991|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
154605992|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154605993|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154605994|NCT03264781|CycloProvera|cycloprovera|mesh-list
154605995|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154605996|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154605997|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154605998|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
154605999|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154606000|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606001|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154606002|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154606003|NCT03281863|Antibodies|antibodies|mesh-list
154606004|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
154606005|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
154606006|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606007|NCT03264625|Vitamin D|vitamin d|mesh-list
154606008|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
154606009|NCT03264625|Vitamins|vitamins|mesh-ancestor
154606010|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
154606011|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606012|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154606013|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154606014|NCT03269929|Midazolam|midazolam|mesh-list
154606015|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154606016|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154606017|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606018|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606019|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154606020|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154606021|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154606022|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154606023|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
154606024|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
154606025|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
154606026|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
154606027|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606028|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606029|NCT02730377|Liraglutide|liraglutide|mesh-list
154606030|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154606031|NCT02730377|Meglitinide|meglitinide|mesh-list
154606032|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154606033|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154606034|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
154606035|NCT02730377|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154606036|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154606037|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606038|NCT02730377|Incretins|incretins|mesh-ancestor
154606039|NCT02730377|Hormones|hormones|mesh-ancestor
154255784|NCT01152476|Analgesics|analgesics|mesh-ancestor
154606040|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606041|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606043|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606044|NCT03264547|Paclitaxel|paclitaxel|mesh-list
154606045|NCT03264547|Docetaxel|docetaxel|mesh-list
154606046|NCT03264547|Trastuzumab|trastuzumab|mesh-list
154606047|NCT03264547|Pertuzumab|pertuzumab|mesh-list
154606048|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154606049|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606050|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
154606051|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
154606052|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
154606053|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606054|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154606055|NCT03365141|Triamcinolone|triamcinolone|mesh-list
154606056|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154606057|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154606058|NCT03365141|Tacrolimus|tacrolimus|mesh-list
154606059|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154606060|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154606061|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
154606062|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606063|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154606064|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606065|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606066|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606067|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
154606068|NCT03365141|Hormones|hormones|mesh-ancestor
154606069|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606070|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
154606071|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154606072|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606073|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154606074|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606075|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
154606076|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154606077|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154606078|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154606079|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154606080|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606081|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606082|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606083|NCT03359837|Insulin|insulin|mesh-list
154606084|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154606085|NCT03359837|Metformin|metformin|mesh-list
154606086|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
154606087|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
154606088|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
154606089|NCT03359837|Acarbose|acarbose|mesh-list
154606090|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154606091|NCT03359837|Repaglinide|repaglinide|mesh-list
154606092|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
154606093|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154606094|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606095|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154606096|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606097|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606098|NCT03359681|Metformin|metformin|mesh-list
154606099|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154606100|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606101|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
154606102|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154606103|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154329886|NCT05631262|Docetaxel|docetaxel|mesh-list
154606104|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606105|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
154606106|NCT03359525|Coagulants|coagulants|mesh-ancestor
154606107|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
154606108|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154606109|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154606110|NCT03359291|Macitentan|macitentan|mesh-list
154606111|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154606112|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154606113|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
154606114|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606115|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154606116|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154606117|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606118|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154606119|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154606120|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154606121|NCT03358277|Methylphenidate|methylphenidate|mesh-list
154606122|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606123|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
154606124|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606125|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606126|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154606127|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154606128|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154606129|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154606130|NCT03359057|Folic Acid|folic acid|mesh-list
154606131|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
154606132|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
154606133|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154606134|NCT03359057|Estradiol|estradiol|mesh-list
154606135|NCT03359057|Estrogens|estrogens|mesh-ancestor
154606136|NCT03359057|Hormones|hormones|mesh-ancestor
154606137|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606138|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606139|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154606140|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
154606141|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154606142|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154606143|NCT03359057|Hematinics|hematinics|mesh-ancestor
154606144|NCT03359057|Vitamins|vitamins|mesh-ancestor
154606145|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
154606146|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154606147|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154606148|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154606149|NCT02714569|Atorvastatin|atorvastatin|mesh-list
154606150|NCT02714569|Simvastatin|simvastatin|mesh-list
154606151|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154606152|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154606153|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
154606154|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606155|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154606156|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154606157|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606158|NCT04522037|Morphine|morphine|mesh-list
154606159|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154606160|NCT04522037|Narcotics|narcotics|mesh-ancestor
154606161|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606162|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606163|NCT04522037|Analgesics|analgesics|mesh-ancestor
154606164|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
154606165|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606166|NCT03357653|Losartan|losartan|mesh-list
154606167|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154606168|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154606169|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154606170|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154093038|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
154606171|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606172|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
154606173|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154329965|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
154606174|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
154606175|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606176|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
154606177|NCT03357575|Protective Agents|protective agents|mesh-ancestor
154606178|NCT03280927|Efinaconazole|efinaconazole|mesh-list
154606179|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
154606180|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606181|NCT03269383|Bupivacaine|bupivacaine|mesh-list
154606182|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606183|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
153497794|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
154606184|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606185|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606186|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
154606187|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606188|NCT03280849|Chitosan|chitosan|mesh-list
154606189|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154606190|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154606191|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
154606192|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606193|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154606194|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
154606195|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
154606196|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
154606197|NCT03280849|Coagulants|coagulants|mesh-ancestor
154606198|NCT04521491|Leucovorin|leucovorin|mesh-list
154606199|NCT04521491|Fluorouracil|fluorouracil|mesh-list
154606200|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
154606201|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
154606202|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606203|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154606204|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606205|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154606206|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
154606207|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606208|NCT04521491|Antidotes|antidotes|mesh-ancestor
154606209|NCT04521491|Protective Agents|protective agents|mesh-ancestor
154606210|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
154606211|NCT04521491|Vitamins|vitamins|mesh-ancestor
154606212|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
154606213|NCT04509635|Cetuximab|cetuximab|mesh-list
154606214|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154606215|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606216|NCT04444817|Tacrolimus|tacrolimus|mesh-list
154606217|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154606218|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
154606219|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606220|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154606221|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606222|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606223|NCT04509323|Huperzine A|huperzine a|mesh-list
154606224|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154606225|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606226|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606227|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
154606228|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606229|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606230|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154606231|NCT04509323|Protective Agents|protective agents|mesh-ancestor
154606232|NCT04443647|Oxytocin|oxytocin|mesh-list
154606233|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
154606234|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154606235|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606236|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154606237|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606238|NCT02458339|Methotrexate|methotrexate|mesh-list
154606239|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154606240|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
154606241|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154606242|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606243|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154606244|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
154606245|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606246|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606247|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
154606248|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606249|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154606250|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154606251|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
154606252|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606253|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154606254|NCT03268525|Bupivacaine|bupivacaine|mesh-list
154606255|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606256|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
154606257|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606258|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606259|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
154606260|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606261|NCT02456935|Esomeprazole|esomeprazole|mesh-list
154606262|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154606263|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606264|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154606265|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606266|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606267|NCT03263689|Morphine|morphine|mesh-list
154606268|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154606269|NCT03263689|Narcotics|narcotics|mesh-ancestor
154606270|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606271|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606272|NCT03263689|Analgesics|analgesics|mesh-ancestor
154606273|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
154606274|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606275|NCT03279679|Ropivacaine|ropivacaine|mesh-list
154606276|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606277|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
154606278|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606279|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606280|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
154606281|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606282|NCT02518451|Valsartan|valsartan|mesh-list
154606283|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154606284|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154606285|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154606286|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606287|NCT03263299|Aspirin|aspirin|mesh-list
154606288|NCT03263299|Cabergoline|cabergoline|mesh-list
154606289|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154606290|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606291|NCT03263299|Analgesics|analgesics|mesh-ancestor
154606292|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
154606293|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606294|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606295|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606296|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606297|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154606298|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154606299|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606300|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154606301|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154606302|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606303|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
154606304|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154606305|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154606306|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
154606307|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
154606308|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606309|NCT04444349|Ubiquinone|ubiquinone|mesh-list
154606310|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
154606311|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
154606312|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606313|NCT04444349|Vitamins|vitamins|mesh-ancestor
154606314|NCT03263533|Vorinostat|vorinostat|mesh-list
154606315|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606316|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154606317|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606318|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606319|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
154606320|NCT03123107|Vitamins|vitamins|mesh-ancestor
154606321|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
154606322|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606323|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
154606324|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606325|NCT03123107|Protective Agents|protective agents|mesh-ancestor
154606326|NCT04516655|Rituximab|rituximab|mesh-list
154606327|NCT04516655|Methotrexate|methotrexate|mesh-list
154606328|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154606329|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606330|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
154606331|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606333|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154606334|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
154606335|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154606336|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154606337|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
154606338|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606339|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
154606340|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606341|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154606342|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154606343|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154606344|NCT02458183|Vaccines|vaccines|mesh-list
154606345|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
154606346|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606347|NCT04444193|Durvalumab|durvalumab|mesh-list
154606348|NCT04444193|Lenvatinib|lenvatinib|mesh-list
154606349|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154606350|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154606351|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606352|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
154606353|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606354|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154606355|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606356|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606357|NCT03984955|Mannitol|mannitol|mesh-list
154606358|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
154606359|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154606360|NCT03984955|Diuretics|diuretics|mesh-ancestor
154606361|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
154606362|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606363|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154606364|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
154606365|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
154606366|NCT03984955|Protective Agents|protective agents|mesh-ancestor
154606367|NCT03946969|Paclitaxel|paclitaxel|mesh-list
154606368|NCT03946969|Cisplatin|cisplatin|mesh-list
154606369|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154606370|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606371|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
154606372|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
154606373|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
154606374|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606375|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154606376|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154606377|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606378|NCT03277573|Analgesics|analgesics|mesh-ancestor
154606379|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
154606380|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606381|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606382|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606383|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606384|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
154606385|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154606386|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
154606387|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606388|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
154606389|NCT03353909|Protective Agents|protective agents|mesh-ancestor
154606390|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
154606391|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154606392|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606393|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154606394|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606395|NCT04508231|Hormones|hormones|mesh-list
154606396|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606397|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606398|NCT03263065|Psyllium|psyllium|mesh-list
154606399|NCT03263065|Cathartics|cathartics|mesh-ancestor
154606400|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606401|NCT02518373|Omeprazole|omeprazole|mesh-list
154606402|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154606403|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606404|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154606405|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606406|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606407|NCT03266965|Carbidopa|carbidopa|mesh-list
154606408|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154606409|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154606410|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
154606411|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606412|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606413|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606414|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154606415|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606416|NCT03266731|Aspirin|aspirin|mesh-list
154606417|NCT03266731|Clopidogrel|clopidogrel|mesh-list
154606418|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154606419|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606420|NCT03266731|Analgesics|analgesics|mesh-ancestor
154606421|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
154606422|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606423|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606424|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606425|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606426|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154606427|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154606428|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606429|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154606430|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154606431|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606432|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
154606433|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154606434|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154606435|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154606436|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
154606437|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606438|NCT02458963|Menotropins|menotropins|mesh-list
154606439|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154606440|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
154606441|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154606442|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606443|NCT04507607|Tenofovir|tenofovir|mesh-list
154606444|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
154606445|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606446|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154606447|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154606448|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606449|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606450|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154606451|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154606452|NCT03353441|Glycine|glycine|mesh-list
154606453|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
154606454|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606455|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606456|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606457|NCT03353363|Bupivacaine|bupivacaine|mesh-list
154606458|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606459|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
154606460|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606461|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606462|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
154606463|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606464|NCT04511195|Diclofenac|diclofenac|mesh-list
154606465|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154606466|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606467|NCT04511195|Analgesics|analgesics|mesh-ancestor
154606468|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
154606469|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606470|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606471|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606472|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606473|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154606474|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606475|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606476|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
154606477|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
154606478|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
154330257|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606479|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154606480|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154606481|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606482|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606483|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606484|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606485|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
154606486|NCT03262363|Curcumin|curcumin|mesh-list
154606487|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154606488|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606489|NCT03262363|Analgesics|analgesics|mesh-ancestor
154606490|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
154606491|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606492|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606493|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606494|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606495|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606496|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606497|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606498|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
154606499|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154606500|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
154606501|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606502|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
154606503|NCT04506827|Protective Agents|protective agents|mesh-ancestor
154606504|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
154606505|NCT03352895|Resveratrol|resveratrol|mesh-list
154606506|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
154606507|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606508|NCT03352895|Protective Agents|protective agents|mesh-ancestor
154606509|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606510|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606511|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154606512|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154606513|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606514|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154606515|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606516|NCT03350633|Azathioprine|azathioprine|mesh-list
154606517|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
154606518|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606519|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154606520|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093376|NCT05064332|Hormones|hormones|mesh-ancestor
154606521|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154606522|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
154606523|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606524|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606526|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154606527|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
154606528|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
154606529|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606530|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606531|NCT03350399|Mitogens|mitogens|mesh-list
154606532|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
154606533|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606534|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
154606535|NCT03350321|Hematinics|hematinics|mesh-ancestor
154606536|NCT03352349|Terlipressin|terlipressin|mesh-list
154606537|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154606538|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154606539|NCT03265171|Plasminogen|plasminogen|mesh-list
154606540|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154606541|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154606542|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606543|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
154606544|NCT04933669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154606545|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154606546|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606547|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606548|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606549|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154606550|NCT04669561|Lifitegrast|lifitegrast|mesh-list
154606551|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154606552|NCT02729909|Lubiprostone|lubiprostone|mesh-list
154606553|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154330340|NCT04724343|Cetrorelix|cetrorelix|mesh-list
154606554|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255787|NCT03892070|Mannitol|mannitol|mesh-list
154606555|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606556|NCT03352115|Prednisolone|prednisolone|mesh-list
154606557|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606558|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
154606559|NCT03352115|Hormones|hormones|mesh-ancestor
154606560|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606561|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606562|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154606563|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606564|NCT03252457|Dexamethasone|dexamethasone|mesh-list
154606565|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
154606566|NCT03252457|Decitabine|decitabine|mesh-list
154606567|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606568|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
154606569|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
154606570|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606571|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606572|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606573|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
154606574|NCT03252457|Hormones|hormones|mesh-ancestor
154606575|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606576|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154606577|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606578|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154606579|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
154606580|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606581|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606582|NCT03258931|Cytarabine|cytarabine|mesh-list
154606583|NCT03258931|Midostaurin|midostaurin|mesh-list
154606584|NCT03258931|Crenolanib|crenolanib|mesh-list
154606585|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154606586|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
154606587|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606588|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606589|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
154606590|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606591|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154606592|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
154606593|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606594|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154606595|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606596|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
154606597|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154606598|NCT03261349|Ledipasvir|ledipasvir|mesh-list
154606599|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
154606600|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606601|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
154606602|NCT02455609|Ketamine|ketamine|mesh-list
154606603|NCT02455609|Bupivacaine|bupivacaine|mesh-list
154606604|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606605|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
154606606|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606607|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606608|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
154606609|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606610|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154606611|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606612|NCT02455609|Analgesics|analgesics|mesh-ancestor
154606613|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154606614|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154606615|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154606616|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154606617|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606618|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606619|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154606620|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154606621|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
154606622|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154606623|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154606624|NCT05723627|Propofol|propofol|mesh-list
154606625|NCT05723627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154606626|NCT05723627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606627|NCT05723627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606628|NCT05723627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154606629|NCT05723627|Anesthetics, General|anesthetics, general|mesh-ancestor
154606630|NCT05723627|Anesthetics|anesthetics|mesh-ancestor
154606631|NCT03349619|Resveratrol|resveratrol|mesh-list
154606632|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
154606633|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606634|NCT03349619|Protective Agents|protective agents|mesh-ancestor
154606635|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606636|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606637|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154606638|NCT04505657|Celecoxib|celecoxib|mesh-list
154606639|NCT04505657|Lidocaine|lidocaine|mesh-list
154606640|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606641|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
154606642|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606643|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606644|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
154606645|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606646|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154093503|NCT04203901|Ipilimumab|ipilimumab|mesh-list
154606647|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154606648|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154606649|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154606650|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606651|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154606652|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606653|NCT04505657|Analgesics|analgesics|mesh-ancestor
154606654|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154606655|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154606656|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154606657|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154606658|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606659|NCT03259243|Bupivacaine|bupivacaine|mesh-list
154606660|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606661|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
154606662|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606663|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606664|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
154606665|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606666|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
154606667|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606668|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
154606669|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606670|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606671|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
154606672|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606673|NCT02456701|Vemurafenib|vemurafenib|mesh-list
154606674|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606675|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154606676|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606677|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606678|NCT03252067|Azithromycin|azithromycin|mesh-list
154606679|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154606680|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154606681|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606682|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154606683|NCT03252223|Hormones|hormones|mesh-list
154606684|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154606685|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093566|NCT03909165|Atropine|atropine|mesh-list
154606686|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606687|NCT05513807|Niacinamide|niacinamide|mesh-list
154606688|NCT05513807|Niacin|niacin|mesh-list
154606689|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
154606690|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
154606691|NCT05513807|Vitamins|vitamins|mesh-ancestor
154606692|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
154606693|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606694|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154606695|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
154606696|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606697|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154606698|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
154606699|NCT04504877|Cannabidiol|cannabidiol|mesh-list
154606700|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
154606701|NCT02518295|Sulfalene|sulfalene|mesh-list
154606702|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606703|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154606704|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
154606705|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154606706|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154606708|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154606709|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154606710|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606711|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
154606712|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154606713|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154606714|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606715|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
154606716|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606717|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606718|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
154606719|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154606720|NCT03351569|Antibodies|antibodies|mesh-list
154606721|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
154606722|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154606723|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
154606724|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606725|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
154606726|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
154606727|NCT03348917|Povidone|povidone|mesh-list
154606728|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154606729|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606730|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
154606731|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
154606732|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
154606733|NCT03251365|Gemcitabine|gemcitabine|mesh-list
154606734|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154606735|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
154606736|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606737|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606738|NCT03251443|Apatinib|apatinib|mesh-list
154606739|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606740|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154606741|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606742|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606743|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154606744|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154606745|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606746|NCT05350943|Gemcitabine|gemcitabine|mesh-list
154606747|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
154606748|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154606749|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
154606750|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606751|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606752|NCT03261427|Pregabalin|pregabalin|mesh-list
154606753|NCT03261427|Analgesics|analgesics|mesh-ancestor
154606754|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
154606755|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606756|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606757|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
154606758|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154606759|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154606760|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606761|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154606762|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154606763|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154606764|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606765|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154606766|NCT03261115|Anesthetics|anesthetics|mesh-list
154606767|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606768|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606769|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
154606770|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
154606771|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
154606772|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606773|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606774|NCT05320133|Bismuth|bismuth|mesh-list
154606775|NCT05320133|Antacids|antacids|mesh-ancestor
154606776|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606777|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606778|NCT03122561|Acetaminophen|acetaminophen|mesh-list
154606779|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606780|NCT03122561|Analgesics|analgesics|mesh-ancestor
154606781|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
154606782|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606783|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606784|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
154606785|NCT04503629|Rabeprazole|rabeprazole|mesh-list
154606786|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154606787|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606788|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154606789|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606790|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606791|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
154606792|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154606793|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
154606794|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
154606795|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606796|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606797|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
154606798|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154606799|NCT03348371|Ethanol|ethanol|mesh-list
154606800|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154606801|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606802|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606803|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606804|NCT05231603|Ivermectin|ivermectin|mesh-list
154606805|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154606806|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606807|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154606808|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154606809|NCT03434041|Sertraline|sertraline|mesh-list
154606810|NCT03434041|Esketamine|esketamine|mesh-list
154606811|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
154606812|NCT03434041|Escitalopram|escitalopram|mesh-list
154606813|NCT03434041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154606814|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154606815|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154606816|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606817|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606818|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
154606819|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606820|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606821|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154606822|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154606823|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154606824|NCT03434041|Analgesics|analgesics|mesh-ancestor
154606825|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
154606826|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
154606827|NCT03250741|Rotigotine|rotigotine|mesh-list
154606828|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
154606829|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
154606830|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606831|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606832|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606833|NCT03255811|Apatinib|apatinib|mesh-list
154606834|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606835|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154606836|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606837|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606838|NCT01842035|Regadenoson|regadenoson|mesh-list
154606839|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154606840|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154606841|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
154606842|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
154606843|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606844|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606845|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606846|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
154606847|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606848|NCT05585177|Hormones|hormones|mesh-list
154606849|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606850|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606851|NCT03250039|Abrocitinib|abrocitinib|mesh-list
154606852|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154606854|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606856|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154606857|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606858|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
154606859|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
154606860|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
154606861|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606862|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154606863|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154093785|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606864|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154606865|NCT03246451|Metformin|metformin|mesh-list
154606866|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154606867|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606868|NCT05013437|Acetaminophen|acetaminophen|mesh-list
154606869|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
154606870|NCT05013437|Promethazine|promethazine|mesh-list
154606871|NCT05013437|Melphalan|melphalan|mesh-list
154606872|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
154606873|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154606874|NCT05013437|Analgesics|analgesics|mesh-ancestor
154606875|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
154606876|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606877|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606878|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
154606879|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154606880|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
154606881|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606882|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606883|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154606884|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154606885|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
154606886|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154606887|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154606888|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606889|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
154606890|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
154606891|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
154606892|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
154606893|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606894|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154606895|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
154606896|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
154606897|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606898|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154606899|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
154606900|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
154606901|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154606902|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154606903|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154606904|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154606905|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
154606906|NCT03246295|Insulin|insulin|mesh-list
154606907|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154606908|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606909|NCT03346733|Psyllium|psyllium|mesh-list
154606910|NCT03346733|Cathartics|cathartics|mesh-ancestor
154606911|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606912|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154606913|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154606914|NCT03346187|Atorvastatin|atorvastatin|mesh-list
154606915|NCT03346187|Fenofibrate|fenofibrate|mesh-list
154606916|NCT03346187|Calcium|calcium|mesh-list
154606917|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154606918|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606919|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154606920|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154606921|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
154606922|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606923|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154606924|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154606925|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606926|NCT04487743|Liraglutide|liraglutide|mesh-list
154330710|NCT03680508|Antibodies|antibodies|mesh-list
154606927|NCT04487743|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154606928|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154606929|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606930|NCT04487743|Incretins|incretins|mesh-ancestor
154606931|NCT04487743|Hormones|hormones|mesh-ancestor
154606932|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154606933|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
154606934|NCT05584631|Antibodies|antibodies|mesh-list
154606935|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
154606936|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154606937|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154606938|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
154606939|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
154606940|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606941|NCT03249259|Choline|choline|mesh-list
154606942|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
154606943|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154606944|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
154606945|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606946|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154606947|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154606948|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
154606949|NCT04487587|Olaparib|olaparib|mesh-list
154606950|NCT04487587|Cediranib|cediranib|mesh-list
154606951|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154606952|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606953|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606954|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154606955|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154606956|NCT04833413|Insulin|insulin|mesh-list
154606957|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154606958|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154606959|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606960|NCT02454751|Fentanyl|fentanyl|mesh-list
154606961|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154606962|NCT02454751|Narcotics|narcotics|mesh-ancestor
154606963|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154606964|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606965|NCT02454751|Analgesics|analgesics|mesh-ancestor
154606966|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
154606967|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093855|NCT00138216|Irinotecan|irinotecan|mesh-list
154606968|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154606969|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154606970|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
154606971|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
154606972|NCT02455921|Atropine|atropine|mesh-list
154606973|NCT02455921|Neostigmine|neostigmine|mesh-list
154606974|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154606975|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154606976|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154606977|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
154606978|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154606979|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606980|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154606981|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
154606982|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
154606983|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
154606984|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154606985|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154606986|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
154606987|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154606988|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154606989|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154606990|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154606991|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154606992|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
154606993|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154606994|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
154606995|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154606996|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
154606997|NCT04786613|Protective Agents|protective agents|mesh-ancestor
154606998|NCT00700999|Paroxetine|paroxetine|mesh-list
154606999|NCT00700999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154607000|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154607001|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607002|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607003|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607004|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
154330794|NCT03034356|Levetiracetam|levetiracetam|mesh-list
154607005|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607006|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154607007|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
154607008|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154607009|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154607010|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154607011|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607012|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
154607013|NCT04502771|Clotrimazole|clotrimazole|mesh-list
154607014|NCT04502771|Miconazole|miconazole|mesh-list
154607015|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607016|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154607017|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154607018|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154607019|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607020|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607021|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154607022|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
154607023|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607024|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607025|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154607026|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154607027|NCT04761887|Ropivacaine|ropivacaine|mesh-list
154607028|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
154607029|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
154607030|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607031|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607032|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
154607033|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607034|NCT03249025|Lidocaine|lidocaine|mesh-list
154607035|NCT03249025|Ketamine|ketamine|mesh-list
154607036|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
154607037|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
154607038|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607039|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607040|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
154607041|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607042|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607043|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154607044|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154607045|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607046|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607047|NCT03249025|Analgesics|analgesics|mesh-ancestor
154607048|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154607049|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154607050|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
154607051|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154607052|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154607053|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607054|NCT03248713|Mifepristone|mifepristone|mesh-list
154607055|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154607056|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
154607057|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154607058|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607059|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154607060|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154607061|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154607062|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
154607063|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154607064|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154607065|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
154607066|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607067|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
154607068|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154607069|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154607070|NCT03245671|Dexamethasone|dexamethasone|mesh-list
154607071|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
154607072|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154607073|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154607074|NCT03245671|BB 1101|bb 1101|mesh-list
154607075|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154330860|NCT02640313|Choline|choline|mesh-list
154607076|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
154607077|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
154607078|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607079|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607080|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154607081|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
154607082|NCT03245671|Hormones|hormones|mesh-ancestor
154607083|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607084|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154607085|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607086|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
154607087|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607088|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607089|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154607090|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
154607091|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154607092|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154607093|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607094|NCT03245515|Branebrutinib|branebrutinib|mesh-list
154607095|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154607096|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607097|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607098|NCT03363503|Fluticasone|fluticasone|mesh-list
154607100|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154607101|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154607102|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154607103|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
154607104|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607105|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607106|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154607107|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
154607108|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
154607109|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154607110|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154607111|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154607112|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154607113|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607114|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607115|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607116|NCT03248791|Phenylephrine|phenylephrine|mesh-list
154607117|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
154607118|NCT03248791|Norepinephrine|norepinephrine|mesh-list
154607119|NCT03248791|Bupivacaine|bupivacaine|mesh-list
154607120|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
154607121|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
154607122|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607123|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607124|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
154607125|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607126|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154607127|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
154607128|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
154607129|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
154607130|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154607131|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
154607132|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
154607133|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154607134|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154607135|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154094007|NCT02078869|Progesterone|progesterone|mesh-list
154607136|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607137|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607138|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607139|NCT03248791|Protective Agents|protective agents|mesh-ancestor
154607140|NCT03254173|Mirtazapine|mirtazapine|mesh-list
154607141|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
154607142|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154607143|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154607144|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
154607145|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
154607146|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607147|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607148|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607149|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154607150|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154607151|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607152|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154607153|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154607154|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154607156|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154607157|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154607158|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
154607159|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154607160|NCT03248401|Aspirin|aspirin|mesh-list
154607161|NCT03248401|Cilostazol|cilostazol|mesh-list
154607162|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154607163|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154607164|NCT03248401|Analgesics|analgesics|mesh-ancestor
154607165|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
154607166|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607167|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607168|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154607169|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154607170|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154607171|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154607172|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607173|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154607174|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154607175|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607176|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
154607177|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154607178|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
154607179|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154607180|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
154607181|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
154607182|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154607183|NCT03248401|Protective Agents|protective agents|mesh-ancestor
154607184|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154607185|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154607186|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
154607187|NCT02516423|Dexamethasone|dexamethasone|mesh-list
154607188|NCT02516423|Lenalidomide|lenalidomide|mesh-list
154607189|NCT02516423|Ixazomib|ixazomib|mesh-list
154607190|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154607191|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
154607192|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
154607193|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607194|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607195|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154607196|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
154607197|NCT02516423|Hormones|hormones|mesh-ancestor
154607198|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607199|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154607200|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607201|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
154607202|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154607203|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154607204|NCT02516423|Growth Substances|growth substances|mesh-ancestor
154607205|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
154607206|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154607207|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
154607208|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607209|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607210|NCT03245281|Diuretics|diuretics|mesh-list
154607211|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
154607212|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607213|NCT02515955|Minocycline|minocycline|mesh-list
154607214|NCT02515955|Amphetamine|amphetamine|mesh-list
154607215|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
154607216|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607217|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607218|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154607219|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607220|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
154607221|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
154607222|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607223|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
154607224|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607225|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607226|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607227|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154607228|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154607229|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607230|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154607231|NCT04500743|Leuprolide|leuprolide|mesh-list
154607232|NCT04500743|Dienogest|dienogest|mesh-list
154607233|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154607234|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
154607235|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154607236|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607237|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154607238|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607239|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154607240|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
154607241|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154607242|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154607243|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154607244|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154607245|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
154094129|NCT00233675|Tiagabine|tiagabine|mesh-list
154607246|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607247|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154607248|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607249|NCT03239353|Entecavir|entecavir|mesh-list
154607250|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
154607251|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607252|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
154607253|NCT03347591|Hemostatics|hemostatics|mesh-list
154607254|NCT03347591|Coagulants|coagulants|mesh-ancestor
154607255|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154607256|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
154607257|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607258|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154607259|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607260|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
154607261|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607262|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
154607263|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154607264|NCT03347591|Protective Agents|protective agents|mesh-ancestor
154607265|NCT04486651|Irinotecan|irinotecan|mesh-list
154607266|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154607267|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154607268|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607269|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607270|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607271|NCT03347513|Glycine|glycine|mesh-list
154607272|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
154607273|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607274|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607275|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607276|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
154607277|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
154607278|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607279|NCT04088591|Protective Agents|protective agents|mesh-ancestor
154607280|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607281|NCT04088591|Vitamins|vitamins|mesh-ancestor
154607282|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
154607283|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
154607284|NCT04501289|Analgesics|analgesics|mesh-ancestor
154607285|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
154607286|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607287|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607288|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
154607289|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607290|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607291|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
154607292|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154607293|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607294|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607295|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154607296|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
154607297|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154607298|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
154607299|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154607300|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154255793|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
154607301|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607302|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
154607303|NCT03244423|Coagulants|coagulants|mesh-ancestor
154607304|NCT03347357|Tacrolimus|tacrolimus|mesh-list
154607305|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154607306|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
154607307|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607308|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154607309|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607310|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607311|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154607312|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607313|NCT02515877|Carboplatin|carboplatin|mesh-list
154607314|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607315|NCT03246919|Oxytocin|oxytocin|mesh-list
154607316|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
154607317|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154607318|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607319|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
154607320|NCT04502537|Hematinics|hematinics|mesh-ancestor
154607321|NCT02453659|Nicotine|nicotine|mesh-list
154607322|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154607323|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
154607324|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607325|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607326|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154607327|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154607328|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
154607329|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607330|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607331|NCT02513147|Lopinavir|lopinavir|mesh-list
154607332|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154607333|NCT02513147|Darunavir|darunavir|mesh-list
154607334|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
154607335|NCT02513147|Dolutegravir|dolutegravir|mesh-list
154607336|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154607337|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154607338|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
154607339|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607340|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607341|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154607342|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154607343|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
154607344|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607345|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154607346|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154607347|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154607348|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154607349|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
154607350|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154607351|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607352|NCT03246685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154607353|NCT03246685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607354|NCT02453893|Risperidone|risperidone|mesh-list
154607355|NCT02453893|Iloperidone|iloperidone|mesh-list
154607356|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154607357|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
154607358|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607359|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607360|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607361|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154607362|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154607363|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607364|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154607365|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154607366|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
154607367|NCT02513069|Nicotine|nicotine|mesh-list
154607368|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
154607369|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154607370|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
154607371|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607372|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607373|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154607374|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154607375|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
154331179|NCT01205061|Lidocaine|lidocaine|mesh-list
154607377|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607378|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
154607379|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
154607380|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
154607381|NCT02454205|Levofloxacin|levofloxacin|mesh-list
154607382|NCT02454205|Isoniazid|isoniazid|mesh-list
154607383|NCT02454205|Linezolid|linezolid|mesh-list
154607384|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
154607385|NCT02454205|Bedaquiline|bedaquiline|mesh-list
154607386|NCT02454205|Ethionamide|ethionamide|mesh-list
154607387|NCT02454205|Kanamycin|kanamycin|mesh-list
154607388|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607389|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607390|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154607391|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154607392|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607393|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607394|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607395|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154607396|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154607397|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154607398|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
154607399|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154607400|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154607401|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
154607402|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154607403|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154607404|NCT03235141|Azithromycin|azithromycin|mesh-list
154607405|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154094292|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
154607406|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607407|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607408|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154607409|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154607410|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
154607411|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607412|NCT03234673|Calcipotriene|calcipotriene|mesh-list
154607413|NCT03234673|Tacrolimus|tacrolimus|mesh-list
154607414|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154607415|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
154607416|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607417|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154607418|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607419|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607420|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
154607421|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
154607422|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
154607423|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607424|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
154607425|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607426|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607427|NCT03243643|Apatinib|apatinib|mesh-list
154607428|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607429|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154607430|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607431|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607432|NCT03234517|Clindamycin|clindamycin|mesh-list
154607433|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
154607434|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
154607435|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607436|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607437|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154607438|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607439|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607440|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
154607441|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154607442|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
154607443|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607444|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
154607445|NCT03238183|Protective Agents|protective agents|mesh-ancestor
154607446|NCT02729051|Albuterol|albuterol|mesh-list
154607447|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154607448|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
154607449|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607450|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331252|NCT00572936|Timolol|timolol|mesh-list
154607451|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154607452|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
154607453|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
154607454|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154607455|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154607456|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154607457|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154607458|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607459|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607460|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607461|NCT03237637|Propranolol|propranolol|mesh-list
154607462|NCT03237637|Atenolol|atenolol|mesh-list
154607463|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154607464|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154607465|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607466|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607467|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607468|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607469|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607470|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154607471|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
154607472|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
154607473|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
154607474|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607475|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154607476|NCT03243331|Gedatolisib|gedatolisib|mesh-list
154607477|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154607478|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607479|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607480|NCT03237715|Bilirubin|bilirubin|mesh-list
154607481|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
154607482|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607483|NCT03237715|Protective Agents|protective agents|mesh-ancestor
154607484|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607485|NCT02515565|Erythromycin|erythromycin|mesh-list
154607486|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
154607487|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154607488|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
154607489|NCT02515565|Cephalosporins|cephalosporins|mesh-list
154607490|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607491|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607492|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154607493|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154607494|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607495|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607496|NCT05600075|Insulin|insulin|mesh-list
154607497|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154607498|NCT05600075|Glycolic acid|glycolic acid|mesh-list
154607499|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154607500|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607501|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
154607502|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
154607503|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154607504|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
154607505|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154607506|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
154607507|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607508|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154607509|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154607510|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154607511|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154607512|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607513|NCT03233815|Propofol|propofol|mesh-list
154607514|NCT03233815|Sevoflurane|sevoflurane|mesh-list
154607515|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154607516|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607517|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607518|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154607519|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
154607520|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
154607521|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154607522|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154607523|NCT02507609|Rocuronium|rocuronium|mesh-list
154331335|NCT05534672|Sirolimus|sirolimus|mesh-list
154607524|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094404|NCT00618982|Sorafenib|sorafenib|mesh-list
154607525|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154607526|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154607528|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607529|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154607530|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154607531|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607532|NCT02512523|Incretins|incretins|mesh-ancestor
154607533|NCT02512523|Hormones|hormones|mesh-ancestor
154607534|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607535|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154607536|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
154607537|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607538|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607539|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
154607540|NCT03233893|Calcium|calcium|mesh-list
154607541|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154607542|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607543|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154607544|NCT05597813|Timolol|timolol|mesh-list
154607545|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154607546|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154607547|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607548|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607549|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607550|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607551|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607552|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154607553|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
154607554|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154607555|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
154607556|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607557|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
154607558|NCT03242707|Protective Agents|protective agents|mesh-ancestor
154607559|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
154607560|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154607561|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607562|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607563|NCT02512055|Atropine|atropine|mesh-list
154607564|NCT02512055|Ketamine|ketamine|mesh-list
154607565|NCT02512055|Analgesics|analgesics|mesh-ancestor
154607566|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
154607567|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607568|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607569|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154607570|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154607571|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
154607572|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
154607573|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607574|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154607575|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154607576|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607577|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607578|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154607579|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607580|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154607581|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
154607582|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154607583|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
154607584|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
154607585|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
154607586|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154607587|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154607588|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
154607589|NCT02514941|Acetaminophen|acetaminophen|mesh-list
154607590|NCT02514941|Amoxicillin|amoxicillin|mesh-list
154607591|NCT02514941|Talinolol|talinolol|mesh-list
154607592|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607593|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607594|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154607595|NCT02514941|Analgesics|analgesics|mesh-ancestor
154607596|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
154607597|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607598|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607599|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
154607600|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154607601|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154607602|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607603|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607604|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607605|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607606|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154607607|NCT02511665|Metformin|metformin|mesh-list
154607608|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154607609|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607610|NCT02514629|Metformin|metformin|mesh-list
154607611|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
154607612|NCT02514629|Testosterone|testosterone|mesh-list
154607613|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
154607614|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
154607615|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154607616|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154607617|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607618|NCT02514629|Androgens|androgens|mesh-ancestor
154607619|NCT02514629|Hormones|hormones|mesh-ancestor
154607620|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607621|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154607622|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607623|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
154607624|NCT02511353|Ivermectin|ivermectin|mesh-list
154607625|NCT02511353|Piperaquine|piperaquine|mesh-list
154607626|NCT02511353|Artenimol|artenimol|mesh-list
154607627|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154607628|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607629|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
154607630|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154607631|NCT03242317|Mitomycins|mitomycins|mesh-list
154607632|NCT03242317|Mitomycin|mitomycin|mesh-list
154607633|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154607634|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607635|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
154607636|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607637|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154607638|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607639|NCT02453503|Triamcinolone|triamcinolone|mesh-list
154607640|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154607641|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154607642|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154607643|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154607644|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
154607645|NCT02453503|Hormones|hormones|mesh-ancestor
154607646|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607647|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607648|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154607649|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
154607650|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607651|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607652|NCT04499885|Mineral Oil|mineral oil|mesh-list
154607653|NCT04499885|Emollients|emollients|mesh-ancestor
154607654|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
154607655|NCT02453425|Norepinephrine|norepinephrine|mesh-list
154607656|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154607657|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154607658|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607659|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607660|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607661|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607662|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
154607663|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
154607664|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607665|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154607666|NCT03233035|Ketamine|ketamine|mesh-list
154607667|NCT03233035|Analgesics|analgesics|mesh-ancestor
154607668|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
154607669|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607670|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607671|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154607672|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154607673|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
154607674|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
154607675|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607676|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154607677|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154607678|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607679|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607680|NCT03242239|Trastuzumab|trastuzumab|mesh-list
154607681|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154607682|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607683|NCT03232957|Morphine|morphine|mesh-list
154607684|NCT03232957|Bupivacaine|bupivacaine|mesh-list
154607685|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
154607686|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
154607687|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607688|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607689|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
154607690|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607691|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154607692|NCT03232957|Narcotics|narcotics|mesh-ancestor
154607693|NCT03232957|Analgesics|analgesics|mesh-ancestor
154607694|NCT02513849|Tamoxifen|tamoxifen|mesh-list
154607695|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154607696|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
154607697|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607698|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607699|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154607700|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607701|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154607702|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154607703|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154607704|NCT02513927|Metoprolol|metoprolol|mesh-list
154607705|NCT02513927|Nifedipine|nifedipine|mesh-list
154607706|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607707|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154607708|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
154607709|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
154607710|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607711|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607712|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154607713|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154607714|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154607715|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607716|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607717|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607718|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154607719|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607720|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154607721|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
154607722|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
154607723|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154607724|NCT03236623|Menthol|menthol|mesh-list
154607725|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
154607726|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
154607727|NCT03121313|Tegafur|tegafur|mesh-list
154607728|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154607729|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
154607730|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607731|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607732|NCT03236233|PC-786|pc-786|mesh-list
154607733|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
154607734|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607735|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607736|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607737|NCT02513693|Rocuronium|rocuronium|mesh-list
154607738|NCT02513693|Neostigmine|neostigmine|mesh-list
154607739|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154607740|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154607741|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154607742|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607743|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607744|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154607745|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607746|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607747|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
154607748|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607749|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154607750|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
154607751|NCT03121547|Tramadol|tramadol|mesh-list
154331537|NCT04520178|Carbidopa|carbidopa|mesh-list
154607752|NCT03121547|Tapentadol|tapentadol|mesh-list
154607753|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607754|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154607755|NCT03121547|Narcotics|narcotics|mesh-ancestor
154607756|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607757|NCT03121547|Analgesics|analgesics|mesh-ancestor
154607758|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
154607759|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607760|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154607761|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154607762|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607763|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607764|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607765|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607766|NCT03241381|Vitamin D|vitamin d|mesh-list
154607767|NCT03241381|Vitamins|vitamins|mesh-ancestor
154607768|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
154607769|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607770|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154607771|NCT03241303|Acarbose|acarbose|mesh-list
154607772|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154607773|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607774|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607775|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154607776|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607777|NCT02510963|Tenofovir|tenofovir|mesh-list
154607778|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
154607779|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607780|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154607781|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154607782|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607783|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607784|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154607785|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154607786|NCT02513381|Vitamin D|vitamin d|mesh-list
154607787|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
154607788|NCT02513381|Vitamins|vitamins|mesh-ancestor
154607789|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
154607790|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607791|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154607792|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154607793|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
154607794|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
154607795|NCT03232021|Pregabalin|pregabalin|mesh-list
154607796|NCT03232021|Analgesics|analgesics|mesh-ancestor
154607797|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
154607798|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607799|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607800|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
154607801|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154607802|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607803|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607804|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154607805|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154607806|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154607807|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607808|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154607809|NCT03235609|Fentanyl|fentanyl|mesh-list
154607810|NCT03235609|Ketamine|ketamine|mesh-list
154607811|NCT03235609|Analgesics|analgesics|mesh-ancestor
154607812|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
154607813|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607814|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607815|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154607816|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154607817|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
154607818|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
154607819|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607820|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154607821|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154607822|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607823|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607824|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154607826|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154607828|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154607829|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607830|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607831|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154607832|NCT02509949|Analgesics|analgesics|mesh-ancestor
154607833|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
154607834|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607835|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154607836|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154607837|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154607838|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
154607839|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607840|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607841|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
154607842|NCT03344705|Fludarabine|fludarabine|mesh-list
154607843|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154607844|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
154607845|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607846|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154607847|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154607848|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
154607849|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607850|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607851|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154607852|NCT02501603|Paclitaxel|paclitaxel|mesh-list
154607853|NCT02501603|Afatinib|afatinib|mesh-list
154607854|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154607855|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607856|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
154607857|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
154607858|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
154607859|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607860|NCT02501603|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154607861|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154607862|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607863|NCT03344627|Meropenem|meropenem|mesh-list
154607864|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607865|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607866|NCT02501213|Furosemide|furosemide|mesh-list
154607867|NCT02501213|Spironolactone|spironolactone|mesh-list
154607868|NCT02501213|Diuretics|diuretics|mesh-ancestor
154607869|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
154607870|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607871|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154607872|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607873|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607874|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154607875|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
154607876|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607877|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154607878|NCT02501291|Thalidomide|thalidomide|mesh-list
154607879|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154607880|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
154607881|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607882|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
154607883|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607884|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607885|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154607886|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154607887|NCT02501291|Growth Substances|growth substances|mesh-ancestor
154607888|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
154607889|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607890|NCT02509559|Propranolol|propranolol|mesh-list
154607891|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154607892|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153499686|NCT00004440|Ibuprofen|ibuprofen|mesh-list
154607894|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607895|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607896|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607897|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607898|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154331687|NCT03654274|Estradiol|estradiol|mesh-list
154607899|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
154607901|NCT00707993|Glipizide|glipizide|mesh-list
154607902|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154607903|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607904|NCT00707993|Incretins|incretins|mesh-ancestor
154607905|NCT00707993|Hormones|hormones|mesh-ancestor
154607906|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154607907|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154607908|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
154607909|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607910|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607911|NCT02509091|Amikacin|amikacin|mesh-list
154607912|NCT02509091|Dimercaprol|dimercaprol|mesh-list
154607913|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607914|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607915|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
154607916|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
154607917|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607918|NCT02508857|Ketorolac|ketorolac|mesh-list
154607919|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
154607920|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154607921|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154607922|NCT02508857|Analgesics|analgesics|mesh-ancestor
154607923|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
154607924|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607925|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607926|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154607927|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154607928|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154607929|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607930|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607931|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
154607932|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154607933|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154607934|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
154607935|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154607936|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154607937|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154607938|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
154607939|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154607940|NCT02508623|Rifaximin|rifaximin|mesh-list
154607941|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607942|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607943|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154607944|NCT02500667|Rifampin|rifampin|mesh-list
154607945|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154607946|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
154607947|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154607948|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154607949|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
154607950|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154607951|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607952|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607953|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154607954|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154607955|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154607956|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154607957|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154607958|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154607959|NCT02500511|Vaccines|vaccines|mesh-list
154607960|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
154607961|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607962|NCT03344393|Ketamine|ketamine|mesh-list
154607963|NCT03344393|Analgesics|analgesics|mesh-ancestor
154607964|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
154607965|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154607967|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154607968|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154607969|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
154607970|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
154607971|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253795|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
154607972|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154607973|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154607974|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154607975|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607976|NCT04498793|Paclitaxel|paclitaxel|mesh-list
154607977|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
154607978|NCT04498793|Doxorubicin|doxorubicin|mesh-list
154607979|NCT04498793|Epirubicin|epirubicin|mesh-list
154607980|NCT04498793|Tislelizumab|tislelizumab|mesh-list
154607981|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154607982|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154607983|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
154607984|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
154607985|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
154607986|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154607987|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154607988|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
154607989|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154607990|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154607991|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154607992|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
154607993|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154607994|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154607995|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154607996|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154607997|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154607998|NCT04498793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154607999|NCT04498325|Antibodies|antibodies|mesh-list
154608000|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
154608001|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608002|NCT02507843|Vitamin D|vitamin d|mesh-list
154608003|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
154608004|NCT02507843|Vitamins|vitamins|mesh-ancestor
154608005|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
154608006|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608007|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154608008|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154608009|NCT02425891|Paclitaxel|paclitaxel|mesh-list
154608010|NCT02425891|Atezolizumab|atezolizumab|mesh-list
154608011|NCT02425891|Antibodies|antibodies|mesh-list
154608012|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154608013|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154608014|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608015|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
154608016|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
154608017|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
154608018|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608019|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
154608020|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608021|NCT02425891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154608022|NCT02425891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608023|NCT02499965|Anesthetics|anesthetics|mesh-list
154608024|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
154608025|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608026|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608027|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
154608028|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
154608029|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608030|NCT05504057|Amantadine|amantadine|mesh-list
154608031|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
154608032|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154608033|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154608034|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154608035|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
154608036|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608037|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
154608038|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608039|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608040|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608042|NCT05504057|Analgesics|analgesics|mesh-ancestor
154608043|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
154608044|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608045|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
154608046|NCT03344003|Factor VIII|factor viii|mesh-list
154608047|NCT03344003|Coagulants|coagulants|mesh-ancestor
154608048|NCT03235531|Valproic Acid|valproic acid|mesh-list
154608049|NCT03235531|Lorazepam|lorazepam|mesh-list
154608050|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
154608051|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608052|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608053|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
154608054|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608055|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608056|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
154608057|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154608058|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608059|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154608060|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
154608061|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
154094905|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608062|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608063|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154608064|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154608065|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154608066|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
154608067|NCT02506829|Nicotine|nicotine|mesh-list
154608068|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154608069|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
154608070|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608071|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608072|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154608073|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154608074|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
154608075|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608076|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608077|NCT02506439|Vitamin D|vitamin d|mesh-list
154608078|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
154608079|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
154608080|NCT02506439|Vitamins|vitamins|mesh-list
154608081|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
154608082|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608083|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154608084|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154608085|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
154608086|NCT02495519|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154608087|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154608088|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608089|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608090|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608091|NCT02499341|Ketamine|ketamine|mesh-list
154608092|NCT02499341|Tramadol|tramadol|mesh-list
154608093|NCT02499341|Analgesics|analgesics|mesh-ancestor
154608094|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
154608095|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608096|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608097|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154608098|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154608099|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
154608100|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
154608101|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608102|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154608103|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154608104|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608105|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608106|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154608107|NCT02499341|Narcotics|narcotics|mesh-ancestor
154608108|NCT02495285|Polygeline|polygeline|mesh-list
154608109|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
154608110|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
154608111|NCT02495363|Bupivacaine|bupivacaine|mesh-list
154608112|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
154608113|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
154608114|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608115|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608116|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
154094958|NCT05373134|Protective Agents|protective agents|mesh-ancestor
154608117|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608119|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
154608120|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608121|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
154608122|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608123|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
154608124|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608125|NCT02494895|Aspirin|aspirin|mesh-list
154608126|NCT02494895|Ticagrelor|ticagrelor|mesh-list
154608127|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154608128|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608129|NCT02494895|Analgesics|analgesics|mesh-ancestor
154608130|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
154608131|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608132|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608133|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608134|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608135|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154608136|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154608137|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608138|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154608139|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154608140|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608141|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
154608142|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154608143|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154608144|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154608145|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
154608146|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608147|NCT03341741|Tobramycin|tobramycin|mesh-list
154608148|NCT03341741|Colistin|colistin|mesh-list
154608149|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608150|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608151|NCT01597245|Etanercept|etanercept|mesh-list
154608152|NCT01597245|Ixekizumab|ixekizumab|mesh-list
154608153|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154608154|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608155|NCT01597245|Analgesics|analgesics|mesh-ancestor
154608156|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
154608157|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608158|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608159|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608160|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608161|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154608162|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154608163|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
154608164|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
154608165|NCT03341429|Liraglutide|liraglutide|mesh-list
154608166|NCT03341429|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154608167|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154608168|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608169|NCT03341429|Incretins|incretins|mesh-ancestor
154608170|NCT03341429|Hormones|hormones|mesh-ancestor
154608171|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608172|NCT04494659|Rifampin|rifampin|mesh-list
154095014|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
154608173|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154608174|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
154608175|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608176|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608177|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
154608178|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154608179|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608180|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608181|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154608182|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154608183|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154608184|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154608185|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153731669|NCT00138983|Vitamins|vitamins|mesh-ancestor
154608186|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154608187|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
154608188|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
154608189|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608190|NCT03342599|Protective Agents|protective agents|mesh-ancestor
154608191|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608192|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
154608193|NCT03342599|Vitamins|vitamins|mesh-ancestor
154608194|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
154608195|NCT03341117|Aspirin|aspirin|mesh-list
154608196|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
154608197|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154608198|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608199|NCT03341117|Analgesics|analgesics|mesh-ancestor
154608200|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
154608201|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608202|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608203|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608204|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608205|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154608206|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154608207|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608208|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154608209|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154608210|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608211|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
154608212|NCT03341117|Antacids|antacids|mesh-ancestor
154608213|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154608214|NCT02498171|Fentanyl|fentanyl|mesh-list
154608215|NCT02498171|Morphine|morphine|mesh-list
154608216|NCT02498171|Bupivacaine|bupivacaine|mesh-list
154608217|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
154608218|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
154608219|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608220|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608221|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
154095067|NCT02571842|Enalapril|enalapril|mesh-list
154608222|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608223|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154608224|NCT02498171|Narcotics|narcotics|mesh-ancestor
154608225|NCT02498171|Analgesics|analgesics|mesh-ancestor
154608226|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154608227|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154608228|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
154608229|NCT03120533|Treprostinil|treprostinil|mesh-list
154608230|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154608231|NCT03342443|Memantine|memantine|mesh-list
154608232|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154608233|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154608234|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
154608235|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608236|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608237|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608238|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154608239|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154608240|NCT02498015|Ribavirin|ribavirin|mesh-list
154608241|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
154608242|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608243|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
154608244|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608245|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
154608246|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154608247|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608248|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154608249|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
154608250|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608251|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608252|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608253|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608254|NCT03340493|Tenecteplase|tenecteplase|mesh-list
154608255|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154608256|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154608257|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608258|NCT03098199|Menotropins|menotropins|mesh-list
154608259|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608260|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154608261|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
154608262|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154608263|NCT00707057|Ibuprofen|ibuprofen|mesh-list
154608264|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154608265|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608266|NCT00707057|Analgesics|analgesics|mesh-ancestor
154608267|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
154608268|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608269|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608270|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608271|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608272|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154608273|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608274|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608275|NCT02494349|Tamsulosin|tamsulosin|mesh-list
154608276|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
154608277|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154608278|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154608279|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154608280|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
154608281|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608282|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608283|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608284|NCT02494349|Urological Agents|urological agents|mesh-ancestor
154608285|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154608286|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154608287|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
154608289|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154608290|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608291|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608292|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608293|NCT03095469|Analgesics|analgesics|mesh-ancestor
154608294|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
154608295|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608296|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154608297|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154608298|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154608299|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
154608300|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608301|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608302|NCT02497547|Oxytocin|oxytocin|mesh-list
154608303|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
154608304|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154608305|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608306|NCT05043129|Vaccines|vaccines|mesh-list
154608307|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
154608308|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608309|NCT02497313|Metformin|metformin|mesh-list
154608310|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
154608311|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154608312|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608313|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154608314|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154608315|NCT02497157|Leucovorin|leucovorin|mesh-list
154608316|NCT02497157|Bevacizumab|bevacizumab|mesh-list
154608317|NCT02497157|Fluorouracil|fluorouracil|mesh-list
154608318|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
154608319|NCT02497157|Irinotecan|irinotecan|mesh-list
154608320|NCT02497157|Calcium|calcium|mesh-list
154608321|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
154608322|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608323|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608324|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154608325|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154608326|NCT02497157|Growth Substances|growth substances|mesh-ancestor
154095180|NCT04066790|Paclitaxel|paclitaxel|mesh-list
154608327|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608328|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
154608329|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154608330|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
154608331|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608332|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154608333|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154608334|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
154608335|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154608336|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154608337|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608338|NCT02497157|Antidotes|antidotes|mesh-ancestor
154608339|NCT02497157|Protective Agents|protective agents|mesh-ancestor
154608340|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
154608341|NCT02497157|Vitamins|vitamins|mesh-ancestor
154608342|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
154608343|NCT03095079|Endostatins|endostatins|mesh-list
154608344|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154608345|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154608346|NCT03095079|Growth Substances|growth substances|mesh-ancestor
154608347|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608348|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
154608349|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608350|NCT03120923|Triamcinolone|triamcinolone|mesh-list
154608351|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154608352|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154608354|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154608355|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
154608356|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
154608357|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608358|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608359|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
154608360|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608361|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154608362|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154608363|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154608364|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154608365|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608366|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608367|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
154608368|NCT03120923|Hormones|hormones|mesh-ancestor
154608369|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608370|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154608371|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
154608372|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608373|NCT02497079|Formaldehyde|formaldehyde|mesh-list
154608374|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
154608375|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608376|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
154608377|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154608378|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
154608379|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154608380|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
154608381|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608382|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608383|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
154608384|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
154608385|NCT02639247|Velpatasvir|velpatasvir|mesh-list
154608386|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
154608387|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608388|NCT05033535|Olmesartan|olmesartan|mesh-list
154608389|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154608390|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154608391|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154608392|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154608393|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608394|NCT05053893|Valsartan|valsartan|mesh-list
154608395|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154608396|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154608397|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154608398|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154608399|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608400|NCT03096327|Montelukast|montelukast|mesh-list
154608401|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154608402|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
154608403|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154608404|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
154608405|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608406|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608407|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154608408|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154608409|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608410|NCT03098121|Grazoprevir|grazoprevir|mesh-list
154608411|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
154608412|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608413|NCT03095001|Paclitaxel|paclitaxel|mesh-list
154608414|NCT03095001|Bevacizumab|bevacizumab|mesh-list
154608415|NCT03095001|Carboplatin|carboplatin|mesh-list
154608416|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154608417|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608418|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
154608419|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
154608420|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
154608421|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608422|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608423|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154332209|NCT01112449|Selenium|selenium|mesh-list
154608424|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154095268|NCT02571140|Teriparatide|teriparatide|mesh-list
154608426|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608427|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
154608428|NCT05042271|Meropenem|meropenem|mesh-list
154608429|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608430|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608431|NCT02138955|Curcumin|curcumin|mesh-list
154608432|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154608433|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608434|NCT02138955|Analgesics|analgesics|mesh-ancestor
154608435|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
154608436|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608437|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608438|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608439|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608440|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608441|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608442|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608443|NCT03096405|Methicillin|methicillin|mesh-list
154608444|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608445|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608446|NCT05032287|Tamsulosin|tamsulosin|mesh-list
154608447|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154608448|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154608449|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154608450|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
154608451|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608452|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608453|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608454|NCT05032287|Urological Agents|urological agents|mesh-ancestor
154608455|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154608456|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154608457|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608458|NCT02493959|Incretins|incretins|mesh-ancestor
154608459|NCT02493959|Hormones|hormones|mesh-ancestor
154608460|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608461|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154608462|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
154608463|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095330|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
154608464|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608465|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
154608466|NCT02496377|Glycine|glycine|mesh-list
154608467|NCT02496377|Hematinics|hematinics|mesh-ancestor
154608468|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
154608469|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608470|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608471|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608472|NCT02496455|Tramadol|tramadol|mesh-list
154608473|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154608474|NCT02496455|Narcotics|narcotics|mesh-ancestor
154608475|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608476|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608477|NCT02496455|Analgesics|analgesics|mesh-ancestor
154608478|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
154608479|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608480|NCT02496299|Dexamethasone|dexamethasone|mesh-list
154608481|NCT02496299|Bupivacaine|bupivacaine|mesh-list
154608482|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608483|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
154608484|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
154608485|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608486|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608487|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154608488|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
154608489|NCT02496299|Hormones|hormones|mesh-ancestor
154608490|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608491|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154608492|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608493|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
154608494|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
154608495|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608496|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
154332277|NCT00064714|Incretins|incretins|mesh-ancestor
154608497|NCT02493725|Eculizumab|eculizumab|mesh-list
154608498|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154608499|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154608500|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
154608501|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608502|NCT02121405|Capecitabine|capecitabine|mesh-list
154608503|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
154608504|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154608505|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
154608506|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608507|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608508|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
154608509|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608510|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608511|NCT03337841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154608512|NCT03337841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608513|NCT02493335|Budesonide|budesonide|mesh-list
154608514|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608515|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154608516|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
154608517|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608518|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608519|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154608520|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
154608521|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
154608522|NCT02493335|Hormones|hormones|mesh-ancestor
154608523|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608524|NCT03336593|Vaccines|vaccines|mesh-list
154608525|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
154608526|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608527|NCT03337607|Celecoxib|celecoxib|mesh-list
154608528|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154608529|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154608530|NCT03337607|Eperisone|eperisone|mesh-list
154608531|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
154608532|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608533|NCT03337607|Analgesics|analgesics|mesh-ancestor
154608534|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
154608535|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608536|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608537|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608538|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154608539|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154608540|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608541|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608542|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
154608543|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154608544|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154608545|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154608546|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154608547|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154608548|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
154608549|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
154608550|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
154608551|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154608552|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608553|NCT02493179|Analgesics|analgesics|mesh-ancestor
154608554|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
154608555|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608556|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608557|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608558|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608559|NCT03336437|Estradiol|estradiol|mesh-list
154608560|NCT03336437|Estrogens|estrogens|mesh-ancestor
154608561|NCT03336437|Hormones|hormones|mesh-ancestor
154608562|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608563|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608564|NCT03337373|Cisatracurium|cisatracurium|mesh-list
154608565|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154608566|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154608567|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608568|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608569|NCT03336281|Ustekinumab|ustekinumab|mesh-list
154608570|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
154608571|NCT03336125|Vitamin D|vitamin d|mesh-list
154332349|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608573|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
154608574|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608575|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154608576|NCT05051163|Gentamicins|gentamicins|mesh-list
154608577|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
154608578|NCT05051163|Ampicillin|ampicillin|mesh-list
154608579|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608580|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608581|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154608582|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608583|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608584|NCT05051163|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154608585|NCT05051163|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154608586|NCT06067412|Phenytoin|phenytoin|mesh-list
154608587|NCT06067412|Levetiracetam|levetiracetam|mesh-list
154608588|NCT06067412|Anticonvulsants|anticonvulsants|mesh-ancestor
154608589|NCT06067412|Nootropic Agents|nootropic agents|mesh-ancestor
154608590|NCT06067412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154608591|NCT06067412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154608592|NCT06067412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154608593|NCT06067412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608594|NCT06067412|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154608595|NCT06067412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154608596|NCT06067386|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154608597|NCT06067386|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154608598|NCT06067386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608599|NCT06067386|Antitubercular Agents|antitubercular agents|mesh-ancestor
154608600|NCT06067256|Contraceptive Agents|contraceptive agents|mesh-list
154608601|NCT06067256|Contraceptive Agents, Female|contraceptive agents, female|mesh-list
154608602|NCT06067256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154608603|NCT06067256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608604|NCT06067061|Atezolizumab|atezolizumab|mesh-list
154608605|NCT06067061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154608606|NCT06067061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608607|NCT06067061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608608|NCT06067061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608609|NCT06067048|Zanubrutinib|zanubrutinib|mesh-list
154608610|NCT06067048|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154608611|NCT06067048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154608612|NCT06067048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608613|NCT06067048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608614|NCT06067048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608615|NCT06066879|Ketamine|ketamine|mesh-list
154608616|NCT06066879|Analgesics|analgesics|mesh-ancestor
154608617|NCT06066879|Sensory System Agents|sensory system agents|mesh-ancestor
154608618|NCT06066879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608619|NCT06066879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608620|NCT06066879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154608621|NCT06066879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154608622|NCT06066879|Anesthetics, General|anesthetics, general|mesh-ancestor
154608623|NCT06066879|Anesthetics|anesthetics|mesh-ancestor
154608624|NCT06066879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608625|NCT06066879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154608626|NCT06066879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154608627|NCT06066879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608628|NCT06066879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608629|NCT06066840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154608630|NCT06066840|Vedolizumab|vedolizumab|mesh-list
154608632|NCT06066840|Immunoglobulins|immunoglobulins|mesh-list
154608633|NCT06066840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154608634|NCT06066840|Basiliximab|basiliximab|mesh-list
154608635|NCT06066840|Immunologic Factors|immunologic factors|mesh-ancestor
154608636|NCT06066840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608637|NCT06066840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608638|NCT06066840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154608639|NCT06066840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154608640|NCT06066645|Travoprost|travoprost|mesh-list
154608641|NCT06066645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154608642|NCT06066606|Fluticasone|fluticasone|mesh-list
154608643|NCT06066606|Xhance|xhance|mesh-list
154608644|NCT06066606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608645|NCT06066606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154332425|NCT00267592|Temozolomide|temozolomide|mesh-list
154608646|NCT06066606|Autonomic Agents|autonomic agents|mesh-ancestor
154608647|NCT06066606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608648|NCT06066606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608649|NCT06066606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154608650|NCT06066606|Respiratory System Agents|respiratory system agents|mesh-ancestor
154608651|NCT06066606|Dermatologic Agents|dermatologic agents|mesh-ancestor
154608652|NCT06066606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154608653|NCT06066333|Pembrolizumab|pembrolizumab|mesh-list
154608654|NCT06066333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608655|NCT06066333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608656|NCT06066333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154608657|NCT06066333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608658|NCT06066112|Amisulpride|amisulpride|mesh-list
154608659|NCT06066112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154608660|NCT06066112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154608661|NCT06066112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608662|NCT06066112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608663|NCT06066112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154608664|NCT06066112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154608665|NCT06066112|Dopamine Agents|dopamine agents|mesh-ancestor
154608666|NCT06066112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608667|NCT06066112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608668|NCT06066112|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154608669|NCT06066112|Antidepressive Agents|antidepressive agents|mesh-ancestor
154608670|NCT06066060|Metformin|metformin|mesh-list
154608671|NCT06066060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154608672|NCT06066060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608673|NCT06065956|Morphine|morphine|mesh-list
154608674|NCT06065956|Esmolol|esmolol|mesh-list
154608675|NCT06065956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154608676|NCT06065956|Narcotics|narcotics|mesh-ancestor
154608677|NCT06065956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608678|NCT06065956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608679|NCT06065956|Analgesics|analgesics|mesh-ancestor
154608680|NCT06065956|Sensory System Agents|sensory system agents|mesh-ancestor
154608681|NCT06065956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608682|NCT06065956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154608683|NCT06065956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154608684|NCT06065956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154608685|NCT06065956|Adrenergic Agents|adrenergic agents|mesh-ancestor
154608686|NCT06065956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608687|NCT06065956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608688|NCT06065722|Olanzapine|olanzapine|mesh-list
154608689|NCT06065722|Antiemetics|antiemetics|mesh-ancestor
154608690|NCT06065722|Autonomic Agents|autonomic agents|mesh-ancestor
154608691|NCT06065722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608692|NCT06065722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608693|NCT06065722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154608694|NCT06065722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154608695|NCT06065722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154608696|NCT06065722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608697|NCT06065722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154608698|NCT06065722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154608699|NCT06065722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154608700|NCT06065722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154608701|NCT06065722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608702|NCT06065722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608703|NCT06065722|Serotonin Agents|serotonin agents|mesh-ancestor
154608704|NCT06062550|Esketamine|esketamine|mesh-list
154608705|NCT06062550|Antidepressive Agents|antidepressive agents|mesh-ancestor
154608706|NCT06062550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154608707|NCT06055712|Cefazolin|cefazolin|mesh-list
154608708|NCT06055712|Cephalexin|cephalexin|mesh-list
154608709|NCT06055712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608710|NCT06055712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608711|NCT06014957|Anesthetics|anesthetics|mesh-list
154608712|NCT06014957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608713|NCT06014957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608714|NCT06013163|Orlistat|orlistat|mesh-list
154608715|NCT06013163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608716|NCT06013163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608717|NCT06013163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154608718|NCT06013163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154608719|NCT05999084|Antibodies|antibodies|mesh-list
154608720|NCT05999084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154608721|NCT05999084|Immunologic Factors|immunologic factors|mesh-ancestor
154608722|NCT05999084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608723|NCT05916963|Furosemide|furosemide|mesh-list
154608724|NCT05916963|Diuretics|diuretics|mesh-ancestor
154608725|NCT05916963|Natriuretic Agents|natriuretic agents|mesh-ancestor
154608726|NCT05916963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608727|NCT05916963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154608728|NCT05916963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154608729|NCT05916963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608730|NCT05879250|Tyrphostins|tyrphostins|mesh-list
154608731|NCT05879250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608732|NCT05879250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608733|NCT05879250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608734|NCT05850611|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154608735|NCT05850611|Methylene Blue|methylene blue|mesh-list
154608736|NCT05850611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608737|NCT05850611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608738|NCT05850611|Hemostatics|hemostatics|mesh-ancestor
154608739|NCT05850611|Coagulants|coagulants|mesh-ancestor
154608740|NCT05831098|Antibodies|antibodies|mesh-list
154608741|NCT05831098|Immunologic Factors|immunologic factors|mesh-ancestor
154608742|NCT05831098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608743|NCT05824832|Dexamethasone|dexamethasone|mesh-list
154608744|NCT05824832|Dexamethasone acetate|dexamethasone acetate|mesh-list
154608745|NCT05824832|Clonidine|clonidine|mesh-list
154608746|NCT05824832|Buprenorphine|buprenorphine|mesh-list
154608747|NCT05824832|BB 1101|bb 1101|mesh-list
154608748|NCT05824832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608749|NCT05824832|Antiemetics|antiemetics|mesh-ancestor
154608750|NCT05824832|Autonomic Agents|autonomic agents|mesh-ancestor
154608751|NCT05824832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608752|NCT05824832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608753|NCT05824832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154608754|NCT05824832|Glucocorticoids|glucocorticoids|mesh-ancestor
154608755|NCT05824832|Hormones|hormones|mesh-ancestor
154608756|NCT05824832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608757|NCT05824832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154608758|NCT05824832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608759|NCT05824832|Protease Inhibitors|protease inhibitors|mesh-ancestor
154608760|NCT05824832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608761|NCT05824832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608762|NCT05824832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154608763|NCT05824832|Narcotics|narcotics|mesh-ancestor
154608764|NCT05824832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608765|NCT05824832|Analgesics|analgesics|mesh-ancestor
154608766|NCT05824832|Sensory System Agents|sensory system agents|mesh-ancestor
154608767|NCT05824832|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154608768|NCT05824832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154608769|NCT05824832|Sympatholytics|sympatholytics|mesh-ancestor
154608770|NCT05824832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154608771|NCT05824832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154608772|NCT05824832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154608773|NCT05824832|Adrenergic Agents|adrenergic agents|mesh-ancestor
154608774|NCT05824832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154608775|NCT05809609|Ketamine|ketamine|mesh-list
154608776|NCT05809609|Analgesics|analgesics|mesh-ancestor
154608777|NCT05809609|Sensory System Agents|sensory system agents|mesh-ancestor
154608778|NCT05809609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608779|NCT05809609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608780|NCT05809609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154608781|NCT05809609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154608782|NCT05809609|Anesthetics, General|anesthetics, general|mesh-ancestor
154608783|NCT05809609|Anesthetics|anesthetics|mesh-ancestor
154608784|NCT05809609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608785|NCT05809609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154608786|NCT05809609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154608787|NCT05809609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095652|NCT00854776|Lansoprazole|lansoprazole|mesh-list
154608788|NCT05809609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608789|NCT05787600|Chlorhexidine|chlorhexidine|mesh-list
154608790|NCT05787600|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154608791|NCT05787600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154608792|NCT05787600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608793|NCT05787600|Disinfectants|disinfectants|mesh-ancestor
154608794|NCT05787600|Dermatologic Agents|dermatologic agents|mesh-ancestor
154608795|NCT05742269|Atezolizumab|atezolizumab|mesh-list
154608796|NCT05742269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154608797|NCT05742269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608798|NCT05742269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608799|NCT05742269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608800|NCT05708742|Bupivacaine|bupivacaine|mesh-list
154608801|NCT05708742|Anesthetics, Local|anesthetics, local|mesh-list
154608802|NCT05708742|Anesthetics|anesthetics|mesh-list
154608803|NCT05708742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608804|NCT05708742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608805|NCT05708742|Sensory System Agents|sensory system agents|mesh-ancestor
154608806|NCT05708742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608807|NCT05705427|Tenofovir|tenofovir|mesh-list
154608808|NCT05705427|Vaccines|vaccines|mesh-list
154608809|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
154608810|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608811|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
154608812|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608813|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154608814|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154608815|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608816|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608817|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154608818|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154608819|NCT05688202|Acetaminophen|acetaminophen|mesh-list
154608820|NCT05688202|Lidocaine|lidocaine|mesh-list
154608821|NCT05688202|Prilocaine|prilocaine|mesh-list
154608822|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154608823|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
154608824|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
154608825|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608826|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608827|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
154608828|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608829|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154095691|NCT00725036|Insulin|insulin|mesh-list
154608830|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154608831|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154608832|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154608833|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608834|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608835|NCT05688202|Analgesics|analgesics|mesh-ancestor
154608836|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
154608837|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154608838|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
154608839|NCT05621759|Abatacept|abatacept|mesh-list
154608840|NCT05621759|Tacrolimus|tacrolimus|mesh-list
154608841|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154608842|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
154608843|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608844|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608845|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154608846|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
154608847|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608848|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608849|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154608850|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154608851|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608852|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154608853|NCT05621759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608854|NCT05519241|Paclitaxel|paclitaxel|mesh-list
154608855|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154608856|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608857|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
154608858|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
154608859|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
154608860|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608861|NCT05404919|Tenofovir|tenofovir|mesh-list
154608862|NCT05404919|Entecavir|entecavir|mesh-list
154608863|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
154608864|NCT05404919|Antibodies|antibodies|mesh-list
154608865|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
154608866|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154608867|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154608868|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
154608869|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608870|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154332657|NCT03527836|Lidocaine|lidocaine|mesh-list
154608871|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154608872|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608873|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608874|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154608875|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154608876|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
154608877|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608878|NCT05401110|Osimertinib|osimertinib|mesh-list
154608879|NCT05401110|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154608880|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154608881|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608882|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608883|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608884|NCT05388656|Estradiol|estradiol|mesh-list
154608885|NCT05388656|Progesterone|progesterone|mesh-list
154608886|NCT05388656|Estrogens|estrogens|mesh-ancestor
154608887|NCT05388656|Hormones|hormones|mesh-ancestor
154608888|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154608889|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608890|NCT05388656|Progestins|progestins|mesh-ancestor
154608891|NCT05381623|Hemostatics|hemostatics|mesh-list
154608892|NCT05381623|Coagulants|coagulants|mesh-ancestor
154608893|NCT05378971|Pomalidomide|pomalidomide|mesh-list
154608894|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
154608895|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608896|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154608897|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154608898|NCT05378971|Growth Substances|growth substances|mesh-ancestor
154608899|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
154608900|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608901|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154608902|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608903|NCT05347069|Aspirin|aspirin|mesh-list
154608904|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154608905|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154608906|NCT05347069|Analgesics|analgesics|mesh-ancestor
154608907|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
154608908|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608909|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608910|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154608911|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154608912|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154608913|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154608914|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608915|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154608916|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154608917|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608918|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
154608919|NCT05338086|Vitamin D|vitamin d|mesh-list
154608920|NCT05338086|Denosumab|denosumab|mesh-list
154608921|NCT05338086|Calcium|calcium|mesh-list
154608922|NCT05338086|Vitamins|vitamins|mesh-ancestor
154608923|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
154608924|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608925|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154608926|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154608927|NCT05268120|Doxycycline|doxycycline|mesh-list
154608928|NCT05268120|Rifampin|rifampin|mesh-list
154608929|NCT05268120|Trimethoprim|trimethoprim|mesh-list
154608930|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608931|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608932|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
154095786|NCT04067856|Dexamethasone|dexamethasone|mesh-list
154608933|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154608934|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154608935|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154608936|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
154608937|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
154608938|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154608939|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608940|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608941|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154608942|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154608943|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154608944|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154608945|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154608946|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154608947|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154608948|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154608949|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154608950|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154608951|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154608952|NCT05258279|Carboplatin|carboplatin|mesh-list
154608953|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
154608954|NCT05258279|Pemetrexed|pemetrexed|mesh-list
154608955|NCT05258279|Lenvatinib|lenvatinib|mesh-list
154608956|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608957|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154608958|NCT05258279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154608959|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608960|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608961|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154608962|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154608963|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154608964|NCT05142267|Oxycodone|oxycodone|mesh-list
154608965|NCT05142267|Naloxone|naloxone|mesh-list
154608966|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154608967|NCT05142267|Narcotics|narcotics|mesh-ancestor
154608968|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154608969|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608970|NCT05142267|Analgesics|analgesics|mesh-ancestor
154608971|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
154608972|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154608973|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154608974|NCT05121246|Palivizumab|palivizumab|mesh-list
154608975|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
154608976|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608977|NCT05083026|Antibodies|antibodies|mesh-list
154608978|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
154608979|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
154608980|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608981|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
154608982|NCT05077254|Vaccines|vaccines|mesh-list
154608983|NCT05077254|Tacrolimus|tacrolimus|mesh-list
154608984|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
154608985|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154608986|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154608987|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154608988|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154608989|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154608990|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154608991|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154608992|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154608993|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
154608994|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154608995|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154608996|NCT05032950|Ritonavir|ritonavir|mesh-list
154608997|NCT05032950|Nirmatrelvir|nirmatrelvir|mesh-list
154608998|NCT05032950|Midazolam|midazolam|mesh-list
154608999|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154609000|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154609001|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609002|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609003|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154609004|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154609005|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154609006|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154609007|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
154609008|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
154609009|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
154609010|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
154609011|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609012|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609013|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154609014|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154609015|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
154609016|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609017|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154609018|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154609019|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
154609020|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609021|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154332801|NCT05064488|Metformin|metformin|mesh-list
154609022|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154609023|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
154609024|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154609025|NCT04877990|Deucravacitinib|deucravacitinib|mesh-list
154609026|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
154609027|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154609028|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609029|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609030|NCT04856488|Lugol's solution|lugol's solution|mesh-list
154609031|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154609032|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
154609033|NCT04856488|Coagulants|coagulants|mesh-ancestor
154609034|NCT04808973|Lamivudine|lamivudine|mesh-list
154609035|NCT04808973|Dolutegravir|dolutegravir|mesh-list
154609036|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154609037|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154609038|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609039|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609040|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
154609041|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609042|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154609043|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154609044|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154609045|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154609046|NCT04758975|Rituximab|rituximab|mesh-list
154609047|NCT04758975|Venetoclax|venetoclax|mesh-list
154609048|NCT04758975|Ibrutinib|ibrutinib|mesh-list
154609049|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609050|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609051|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
154609052|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609053|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609054|NCT04758975|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154609055|NCT04758975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154609056|NCT04758975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609057|NCT04758975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609058|NCT04631029|Carboplatin|carboplatin|mesh-list
154609059|NCT04631029|Etoposide|etoposide|mesh-list
154609060|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
154609061|NCT04631029|Atezolizumab|atezolizumab|mesh-list
154609062|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
154609063|NCT04631029|Entinostat|entinostat|mesh-list
154609064|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154609065|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154609066|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609067|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154609068|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154609069|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154609070|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609071|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609072|NCT04631029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154609073|NCT04631029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609074|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
154609075|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609076|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
154609077|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
154609078|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
154609079|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
154609080|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
154609081|NCT04542148|Insulin|insulin|mesh-list
154609082|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154609083|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
154609084|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
154609085|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154609086|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609087|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
154609088|NCT04521946|Fludarabine|fludarabine|mesh-list
154609089|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
154609090|NCT04521946|Etoposide|etoposide|mesh-list
154609091|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
154609092|NCT04521946|Melphalan|melphalan|mesh-list
154609093|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
154609094|NCT04521946|Thiotepa|thiotepa|mesh-list
154609095|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
154609096|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154609097|NCT04521946|Tacrolimus|tacrolimus|mesh-list
154609098|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
154609099|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154609100|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
154609101|NCT04521946|Antibodies|antibodies|mesh-list
154609102|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
154609103|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154609104|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154609105|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609106|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154609107|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
154609108|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609109|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609110|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
154609111|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609112|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154609113|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154609114|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154609115|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609116|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154609117|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154609118|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154609119|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
154609120|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154609121|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609122|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609123|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
154609124|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154609125|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
154609126|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
154609127|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
154609128|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
154609129|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
154609130|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
154609131|NCT04505774|Empagliflozin|empagliflozin|mesh-list
154609132|NCT04505774|Canagliflozin|canagliflozin|mesh-list
154609133|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154609134|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
154609135|NCT04505774|Heparin|heparin|mesh-list
154609136|NCT04505774|Calcium heparin|calcium heparin|mesh-list
154609137|NCT04505774|Enoxaparin|enoxaparin|mesh-list
154609138|NCT04505774|Dalteparin|dalteparin|mesh-list
154609139|NCT04505774|Tinzaparin|tinzaparin|mesh-list
154609140|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154609141|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
154609142|NCT04505774|Clopidogrel|clopidogrel|mesh-list
154609143|NCT04505774|Ticagrelor|ticagrelor|mesh-list
154609144|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154609145|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154609146|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154609147|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154609148|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
154609149|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609150|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609151|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609152|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
154609153|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154609154|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154609155|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154609156|NCT04472299|Ropivacaine|ropivacaine|mesh-list
154609157|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
154609158|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
154609159|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609160|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609161|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
154609162|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609163|NCT04464798|Rituximab|rituximab|mesh-list
154609164|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
154609165|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609166|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609167|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
154609168|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609169|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609170|NCT04360785|Methotrexate|methotrexate|mesh-list
154609171|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154609172|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
154609173|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154609174|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609175|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154609176|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
154609177|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609178|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609179|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154609180|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609181|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154609182|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609183|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
154609184|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609185|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154609187|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154609188|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154609189|NCT04338022|Analgesics|analgesics|mesh-ancestor
154609190|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
154609191|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609192|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609193|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154609194|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609195|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609196|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
154609197|NCT04226495|Sufentanil|sufentanil|mesh-list
154609199|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154609200|NCT04226495|Narcotics|narcotics|mesh-ancestor
154609201|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609202|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609203|NCT04226495|Analgesics|analgesics|mesh-ancestor
154609204|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
154609205|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609206|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154609207|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154609208|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
154609209|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
154609210|NCT04203641|Doxorubicin|doxorubicin|mesh-list
154609211|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154609212|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609213|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154609214|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154609215|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609216|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609217|NCT06338683|Olanzapine|olanzapine|mesh-list
154609218|NCT06338683|Antiemetics|antiemetics|mesh-ancestor
154609219|NCT06338683|Autonomic Agents|autonomic agents|mesh-ancestor
154609220|NCT06338683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609221|NCT06338683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609222|NCT06338683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154609223|NCT06338683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154609224|NCT06338683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154609225|NCT06338683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609226|NCT06338683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154609227|NCT06338683|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154609228|NCT06338683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154609229|NCT06338683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154609230|NCT06338683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609231|NCT06338683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609232|NCT06338683|Serotonin Agents|serotonin agents|mesh-ancestor
154609233|NCT06338657|Paclitaxel|paclitaxel|mesh-list
154609234|NCT06338657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154609235|NCT06338657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154609236|NCT06338657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609237|NCT06338657|Tubulin Modulators|tubulin modulators|mesh-ancestor
154609238|NCT06338657|Antimitotic Agents|antimitotic agents|mesh-ancestor
154609239|NCT06338657|Mitosis Modulators|mitosis modulators|mesh-ancestor
154609240|NCT06338657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609241|NCT06338644|Palbociclib|palbociclib|mesh-list
154609242|NCT06338644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609243|NCT06338644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154609244|NCT06338644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609245|NCT06338644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609246|NCT06338553|Semaglutide|semaglutide|mesh-list
154609247|NCT06338553|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154609248|NCT06338553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154609249|NCT06338553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609250|NCT06338345|Lactams|lactams|mesh-list
154609251|NCT06338345|beta-Lactams|beta-lactams|mesh-list
154609252|NCT06338345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154609253|NCT06338345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609254|NCT06338306|Tacrolimus|tacrolimus|mesh-list
154609255|NCT06338306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609256|NCT06338306|Immunologic Factors|immunologic factors|mesh-ancestor
154609257|NCT06338306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609258|NCT06338306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154609259|NCT06338306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609260|NCT06338306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609261|NCT06338293|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154609262|NCT06338293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154609263|NCT06338293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154609265|NCT06338293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609266|NCT06338293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154609267|NCT06338293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154609268|NCT06338293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609269|NCT06338241|Simvastatin|simvastatin|mesh-list
154609270|NCT06338241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154609271|NCT06338241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154609272|NCT06338241|Antimetabolites|antimetabolites|mesh-ancestor
154609273|NCT06338241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609274|NCT06338241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154609275|NCT06338241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154609276|NCT06338241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609277|NCT06338163|Polihexanide|polihexanide|mesh-list
154609278|NCT06338163|Disinfectants|disinfectants|mesh-ancestor
154609279|NCT06338163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609280|NCT06338059|Vitamin D|vitamin d|mesh-list
154609281|NCT06338059|Vitamins|vitamins|mesh-list
154609282|NCT06338059|Vitamin B 12|vitamin b 12|mesh-list
154609283|NCT06338059|Hydroxocobalamin|hydroxocobalamin|mesh-list
154609284|NCT06338059|Micronutrients|micronutrients|mesh-ancestor
154609285|NCT06338059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609286|NCT06338059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154609287|NCT06338059|Vitamin B Complex|vitamin b complex|mesh-ancestor
154609288|NCT06338059|Hematinics|hematinics|mesh-ancestor
154609289|NCT06337994|Memantine|memantine|mesh-list
154609290|NCT06337994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154609291|NCT06337994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154609292|NCT06337994|Dopamine Agents|dopamine agents|mesh-ancestor
154609293|NCT06337994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609294|NCT06337994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609295|NCT06337994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609296|NCT06337994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154609297|NCT06337994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154609298|NCT06337838|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154609299|NCT06337838|Tranexamic Acid|tranexamic acid|mesh-list
154609300|NCT06337838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154609301|NCT06337838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154609302|NCT06337838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609303|NCT06337838|Hemostatics|hemostatics|mesh-ancestor
154609304|NCT06337838|Coagulants|coagulants|mesh-ancestor
154609305|NCT06337838|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154609306|NCT06337838|Natriuretic Agents|natriuretic agents|mesh-ancestor
154609307|NCT06337838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609308|NCT06337695|Vedolizumab|vedolizumab|mesh-list
154609309|NCT06337695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154609310|NCT06337604|Rifamycins|rifamycins|mesh-list
154609311|NCT06337604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154609312|NCT06337604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609313|NCT06337539|Fluvoxamine|fluvoxamine|mesh-list
154609314|NCT06337539|Citalopram|citalopram|mesh-list
154609315|NCT06337539|Fluoxetine|fluoxetine|mesh-list
154609316|NCT06337539|Paroxetine|paroxetine|mesh-list
154609317|NCT06337539|Sertraline|sertraline|mesh-list
154609318|NCT06337539|Escitalopram|escitalopram|mesh-list
154609319|NCT06337539|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154609320|NCT06337539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154609321|NCT06337539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154609322|NCT06337539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609323|NCT06337539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609324|NCT06337539|Serotonin Agents|serotonin agents|mesh-ancestor
154609325|NCT06337539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609326|NCT06337539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154609327|NCT06337539|Antidepressive Agents|antidepressive agents|mesh-ancestor
154609328|NCT06337539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154609329|NCT06337539|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154609330|NCT06337539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154609332|NCT06337539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154609333|NCT06337539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154609334|NCT06337539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609335|NCT06337539|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154609336|NCT06337539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154609337|NCT06337422|Celecoxib|celecoxib|mesh-list
154609338|NCT06337422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154609339|NCT06337422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154609340|NCT06337422|Analgesics|analgesics|mesh-ancestor
154609341|NCT06337422|Sensory System Agents|sensory system agents|mesh-ancestor
154609342|NCT06337422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609343|NCT06337422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609344|NCT06337422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154609345|NCT06337422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609346|NCT06337422|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154609347|NCT06337422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154609348|NCT06337422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609349|NCT06337422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609350|NCT06337409|Empagliflozin|empagliflozin|mesh-list
154609351|NCT06337409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154609352|NCT06337409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609353|NCT06337409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154609354|NCT06337409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609355|NCT06337331|Fludarabine|fludarabine|mesh-list
154609356|NCT06337331|Busulfan|busulfan|mesh-list
154609357|NCT06337331|Venetoclax|venetoclax|mesh-list
154609358|NCT06337331|Decitabine|decitabine|mesh-list
154609359|NCT06337331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609360|NCT06337331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154609361|NCT06337331|Antimetabolites|antimetabolites|mesh-ancestor
154609362|NCT06337331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609363|NCT06337331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609364|NCT06337331|Immunologic Factors|immunologic factors|mesh-ancestor
154609365|NCT06337331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609366|NCT06337331|Alkylating Agents|alkylating agents|mesh-ancestor
154609367|NCT06337331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609368|NCT06337331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154609369|NCT06337331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609370|NCT06337318|Rituximab|rituximab|mesh-list
154609371|NCT06337318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154609372|NCT06337318|Antibodies|antibodies|mesh-list
154609373|NCT06337318|Immunoglobulins|immunoglobulins|mesh-list
154609374|NCT06337318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154609375|NCT06337318|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154609376|NCT06337318|Immunologic Factors|immunologic factors|mesh-ancestor
154609377|NCT06337318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609378|NCT06337318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609379|NCT06337318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609380|NCT06337253|Pyrimethamine|pyrimethamine|mesh-list
154609381|NCT06337253|Sulfadoxine|sulfadoxine|mesh-list
154609382|NCT06337253|Amodiaquine|amodiaquine|mesh-list
154609383|NCT06337253|Antimalarials|antimalarials|mesh-ancestor
154609384|NCT06337253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154609385|NCT06337253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154609386|NCT06337253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609387|NCT06337253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154609388|NCT06337253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609389|NCT06337253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609390|NCT06337253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154609391|NCT06337175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154609392|NCT06337175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154609393|NCT06337175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154609394|NCT06337175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609395|NCT06337071|Vaccines|vaccines|mesh-list
154609396|NCT06337071|Immunologic Factors|immunologic factors|mesh-ancestor
154609397|NCT06337071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609398|NCT06337032|Ritonavir|ritonavir|mesh-list
154609399|NCT06337032|Lopinavir|lopinavir|mesh-list
154609400|NCT06337032|Cobicistat|cobicistat|mesh-list
154609401|NCT06337032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154609402|NCT06337032|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154609403|NCT06337032|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154609404|NCT06337032|Protease Inhibitors|protease inhibitors|mesh-ancestor
154609405|NCT06337032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609406|NCT06337032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609407|NCT06337032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154609408|NCT06337032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154609409|NCT06337032|Antiviral Agents|antiviral agents|mesh-ancestor
154609410|NCT06337032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609411|NCT06337032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154609412|NCT06337032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154609413|NCT06337032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154609414|NCT06336993|Celecoxib|celecoxib|mesh-list
154609415|NCT06336993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154609416|NCT06336993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154609417|NCT06336993|Analgesics|analgesics|mesh-ancestor
154609418|NCT06336993|Sensory System Agents|sensory system agents|mesh-ancestor
154609419|NCT06336993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609420|NCT06336993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609421|NCT06336993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154609422|NCT06336993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609423|NCT06336993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154609424|NCT06336993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154609425|NCT06336993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609426|NCT06336993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609427|NCT06336824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154609428|NCT06336824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154609429|NCT06336824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609430|NCT06336824|Antitubercular Agents|antitubercular agents|mesh-ancestor
154609431|NCT06336798|Pioglitazone|pioglitazone|mesh-list
154609432|NCT06336798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154609433|NCT06336798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609434|NCT06336785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154609435|NCT06336785|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154609436|NCT06336785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154609437|NCT06336785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154609438|NCT06336785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609439|NCT06336785|Cholinergic Agents|cholinergic agents|mesh-ancestor
154609440|NCT06336785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609441|NCT06336759|Hyaluronic Acid|hyaluronic acid|mesh-list
154609442|NCT06336759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154609443|NCT06336759|Immunologic Factors|immunologic factors|mesh-ancestor
154609444|NCT06336759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609445|NCT06336759|Viscosupplements|viscosupplements|mesh-ancestor
154609446|NCT06336759|Protective Agents|protective agents|mesh-ancestor
154609447|NCT06336733|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154609448|NCT06336733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609449|NCT06336707|Bevacizumab|bevacizumab|mesh-list
154609450|NCT06336707|Carboplatin|carboplatin|mesh-list
154609451|NCT06336707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609452|NCT06336707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609453|NCT06336707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154609454|NCT06336707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153419572|NCT03004261|Foscarnet|foscarnet|mesh-list
154609455|NCT06336707|Growth Substances|growth substances|mesh-ancestor
154609456|NCT06336707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609457|NCT06336707|Growth Inhibitors|growth inhibitors|mesh-ancestor
154609458|NCT06336603|Adapalene|adapalene|mesh-list
154609459|NCT06336603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154609460|NCT06336603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154609461|NCT06336603|Analgesics|analgesics|mesh-ancestor
154609462|NCT06336603|Sensory System Agents|sensory system agents|mesh-ancestor
154609463|NCT06336603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609464|NCT06336603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609465|NCT06336603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154609466|NCT06336603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609467|NCT06336603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154609468|NCT06336486|Pregabalin|pregabalin|mesh-list
154609469|NCT06336486|Analgesics|analgesics|mesh-ancestor
154609470|NCT06336486|Sensory System Agents|sensory system agents|mesh-ancestor
154609471|NCT06336486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609472|NCT06336486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609473|NCT06336486|Anticonvulsants|anticonvulsants|mesh-ancestor
154609474|NCT06336486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154609475|NCT06336486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154609476|NCT06336486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609477|NCT06336486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154609478|NCT06336486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154609480|NCT06336486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609481|NCT06336486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154609482|NCT06333314|Dostarlimab|dostarlimab|mesh-list
154609483|NCT06333314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609484|NCT06333223|Phenol|phenol|mesh-list
154609485|NCT06333223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154609486|NCT06333223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609487|NCT06333223|Disinfectants|disinfectants|mesh-ancestor
154609488|NCT06333223|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154609489|NCT06333223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154609490|NCT06331533|Botulinum Toxins|botulinum toxins|mesh-list
154609491|NCT06331533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154609492|NCT06331533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154609493|NCT06331533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154609494|NCT06331533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154096345|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154096383|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
154609495|NCT06331533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609496|NCT06331533|Cholinergic Agents|cholinergic agents|mesh-ancestor
154609497|NCT06331533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609498|NCT06331533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609499|NCT06331533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154609500|NCT06331533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609501|NCT06331143|Morphine|morphine|mesh-list
154609502|NCT06331143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154609503|NCT06331143|Narcotics|narcotics|mesh-ancestor
154609504|NCT06331143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609505|NCT06331143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609506|NCT06331143|Analgesics|analgesics|mesh-ancestor
154609507|NCT06331143|Sensory System Agents|sensory system agents|mesh-ancestor
154609508|NCT06331143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609509|NCT06325709|Plerixafor|plerixafor|mesh-list
154609510|NCT06325709|Busulfan|busulfan|mesh-list
154609511|NCT06325709|Immunologic Factors|immunologic factors|mesh-ancestor
154609512|NCT06325709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609513|NCT06325709|Alkylating Agents|alkylating agents|mesh-ancestor
154609514|NCT06325709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609515|NCT06325709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609516|NCT06325709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609517|NCT06325709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609518|NCT06325709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154609519|NCT06325709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154609520|NCT06325709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154609521|NCT06325709|Antiviral Agents|antiviral agents|mesh-ancestor
154609522|NCT06325709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609523|NCT06323161|Semaglutide|semaglutide|mesh-list
154609524|NCT06323161|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154609525|NCT06323161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154609526|NCT06323161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609527|NCT06313398|Biotin|biotin|mesh-list
154609528|NCT06313398|Vitamin B Complex|vitamin b complex|mesh-ancestor
154609529|NCT06313398|Vitamins|vitamins|mesh-ancestor
154609530|NCT06313398|Micronutrients|micronutrients|mesh-ancestor
154609531|NCT06313398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609532|NCT06310876|Moxifloxacin|moxifloxacin|mesh-list
154609533|NCT06310876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154609534|NCT06310876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609535|NCT06310876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154609536|NCT06310876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154609537|NCT06310876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609538|NCT06310876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609539|NCT06310876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609540|NCT06302465|Cisplatin|cisplatin|mesh-list
154609541|NCT06302465|Doxorubicin|doxorubicin|mesh-list
154609542|NCT06302465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154609543|NCT06302465|Methotrexate|methotrexate|mesh-list
154609544|NCT06302465|Ifosfamide|ifosfamide|mesh-list
154609545|NCT06302465|Isophosphamide mustard|isophosphamide mustard|mesh-list
154609546|NCT06302465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609547|NCT06302465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154609548|NCT06302465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154609549|NCT06302465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154609550|NCT06302465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609551|NCT06302465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609552|NCT06302465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154609553|NCT06302465|Abortifacient Agents|abortifacient agents|mesh-ancestor
154609554|NCT06302465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154609555|NCT06302465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609556|NCT06302465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154609557|NCT06302465|Antimetabolites|antimetabolites|mesh-ancestor
154609558|NCT06302465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154609559|NCT06302465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154609560|NCT06302465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609561|NCT06302465|Immunologic Factors|immunologic factors|mesh-ancestor
154609562|NCT06302465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609563|NCT06302465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154609564|NCT06302465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609565|NCT06302465|Alkylating Agents|alkylating agents|mesh-ancestor
154609566|NCT06302140|Valganciclovir|valganciclovir|mesh-list
154609567|NCT06302140|Antiviral Agents|antiviral agents|mesh-ancestor
154609568|NCT06302140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609569|NCT06298084|Olaparib|olaparib|mesh-list
154609570|NCT06298084|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154609571|NCT06298084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154609572|NCT06298084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609573|NCT06298084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609574|NCT06298084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096420|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096459|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609575|NCT06298084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609576|NCT06294600|Clarithromycin|clarithromycin|mesh-list
154609577|NCT06294600|Lactams|lactams|mesh-list
154609578|NCT06294600|Cephalosporins|cephalosporins|mesh-list
154609579|NCT06294600|Fluoroquinolones|fluoroquinolones|mesh-list
154609580|NCT06294600|beta-Lactams|beta-lactams|mesh-list
154609581|NCT06294600|Third Generation Cephalosporins|third generation cephalosporins|mesh-list
154609582|NCT06294600|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
154609583|NCT06294600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154609584|NCT06294600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609585|NCT06294600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154609586|NCT06294600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609587|NCT06294600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609588|NCT06294600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154609589|NCT06294600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154609590|NCT06294600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154609591|NCT06294600|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154609592|NCT06294236|Cyclophosphamide|cyclophosphamide|mesh-list
154609593|NCT06294236|Fludarabine|fludarabine|mesh-list
154609594|NCT06294236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609595|NCT06294236|Immunologic Factors|immunologic factors|mesh-ancestor
154609596|NCT06294236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609597|NCT06294236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609598|NCT06294236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609599|NCT06294236|Alkylating Agents|alkylating agents|mesh-ancestor
154609600|NCT06294236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609601|NCT06294236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609602|NCT06294236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154609603|NCT06290141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154609604|NCT06290141|gamma-Globulins|gamma-globulins|mesh-list
154609605|NCT06290141|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154609606|NCT06290141|Immunologic Factors|immunologic factors|mesh-ancestor
154609607|NCT06290141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609608|NCT06288412|Insulin|insulin|mesh-list
154609609|NCT06288412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154609610|NCT06288412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154609611|NCT06288412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609612|NCT06281561|Dexmedetomidine|dexmedetomidine|mesh-list
154609613|NCT06281561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154609614|NCT06281561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609615|NCT06281561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609616|NCT06281561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154609617|NCT06281561|Analgesics|analgesics|mesh-ancestor
154609618|NCT06281561|Sensory System Agents|sensory system agents|mesh-ancestor
154609619|NCT06281561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609620|NCT06281561|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154609621|NCT06281561|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154609622|NCT06281561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154609623|NCT06281561|Adrenergic Agents|adrenergic agents|mesh-ancestor
154609624|NCT06281561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609625|NCT06281561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609626|NCT06274528|Lemborexant|lemborexant|mesh-list
154609627|NCT06274528|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154609628|NCT06274528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609629|NCT06274528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609630|NCT06274528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154609631|NCT06274528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154609632|NCT06274528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609633|NCT06274528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609634|NCT06269627|Acamprosate|acamprosate|mesh-list
154609635|NCT06269627|Calcium|calcium|mesh-list
154609636|NCT06269627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154609637|NCT06269627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609638|NCT06269627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154609639|NCT06268704|Dexamethasone|dexamethasone|mesh-list
154609640|NCT06268704|Methylprednisolone|methylprednisolone|mesh-list
154609641|NCT06268704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154609642|NCT06268704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154609643|NCT06268704|Prednisolone|prednisolone|mesh-list
154609644|NCT06268704|Prednisolone acetate|prednisolone acetate|mesh-list
154609645|NCT06268704|Lidocaine|lidocaine|mesh-list
154609646|NCT06268704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154609647|NCT06268704|Prednisolone phosphate|prednisolone phosphate|mesh-list
154609648|NCT06268704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154609649|NCT06268704|Antiemetics|antiemetics|mesh-ancestor
154609650|NCT06268704|Autonomic Agents|autonomic agents|mesh-ancestor
154609651|NCT06268704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609652|NCT06268704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609653|NCT06268704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154609654|NCT06268704|Glucocorticoids|glucocorticoids|mesh-ancestor
154609655|NCT06268704|Hormones|hormones|mesh-ancestor
154609656|NCT06268704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154609657|NCT06268704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154609658|NCT06268704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609659|NCT06268704|Anesthetics, Local|anesthetics, local|mesh-ancestor
154609660|NCT06268704|Anesthetics|anesthetics|mesh-ancestor
154609661|NCT06268704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609662|NCT06268704|Sensory System Agents|sensory system agents|mesh-ancestor
154609663|NCT06268704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154609664|NCT06268704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154609665|NCT06268704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154609666|NCT06268704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154609667|NCT06268704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609668|NCT06268704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154609669|NCT06268704|Protective Agents|protective agents|mesh-ancestor
154609670|NCT06267274|Bimatoprost|bimatoprost|mesh-list
154609671|NCT06267274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154609672|NCT06267274|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154609673|NCT06267274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154609674|NCT06256445|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
154609675|NCT06256445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154609676|NCT06256445|Antimetabolites|antimetabolites|mesh-ancestor
154609677|NCT06256445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609678|NCT06256445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154609679|NCT06253520|Aldesleukin|aldesleukin|mesh-list
154609680|NCT06253520|Cyclophosphamide|cyclophosphamide|mesh-list
154609681|NCT06253520|Fludarabine|fludarabine|mesh-list
154609682|NCT06253520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609683|NCT06253520|Immunologic Factors|immunologic factors|mesh-ancestor
154609684|NCT06253520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609685|NCT06253520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609686|NCT06253520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609687|NCT06253520|Alkylating Agents|alkylating agents|mesh-ancestor
154609688|NCT06253520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609689|NCT06253520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609690|NCT06253520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154609691|NCT06253520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154609692|NCT06253520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154609693|NCT06253520|Antiviral Agents|antiviral agents|mesh-ancestor
154609694|NCT06253520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609695|NCT06253494|Pembrolizumab|pembrolizumab|mesh-list
154609696|NCT06253494|Lenvatinib|lenvatinib|mesh-list
154096541|NCT04065230|Tenofovir|tenofovir|mesh-list
154096582|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609697|NCT06253494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609698|NCT06253494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609699|NCT06253494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154609700|NCT06253494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333476|NCT05301634|Bupivacaine|bupivacaine|mesh-list
154609701|NCT06253494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154609702|NCT06253494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609703|NCT06250634|Amoxicillin|amoxicillin|mesh-list
154609704|NCT06250634|Clarithromycin|clarithromycin|mesh-list
154609705|NCT06250634|Esomeprazole|esomeprazole|mesh-list
154609706|NCT06250634|Bismuth|bismuth|mesh-list
154609707|NCT06250634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154609708|NCT06250634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609709|NCT06250634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154609710|NCT06250634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154609711|NCT06250634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154609712|NCT06250634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609713|NCT06250634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609714|NCT06250634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154609715|NCT06250634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154609716|NCT06250634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154609717|NCT06250634|Antacids|antacids|mesh-ancestor
154609718|NCT06243692|Topiramate|topiramate|mesh-list
154609719|NCT06243692|Lacosamide|lacosamide|mesh-list
154609720|NCT06243692|Anticonvulsants|anticonvulsants|mesh-ancestor
154609721|NCT06243692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154609722|NCT06243692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609723|NCT06243692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154609724|NCT06243692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154609725|NCT06243692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154609726|NCT06243692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609727|NCT06232577|Oxycodone|oxycodone|mesh-list
154609728|NCT06232577|Tramadol|tramadol|mesh-list
154609729|NCT06232577|Hydrocodone|hydrocodone|mesh-list
154609730|NCT06232577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154609731|NCT06232577|Narcotics|narcotics|mesh-ancestor
154609732|NCT06232577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609733|NCT06232577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609734|NCT06232577|Analgesics|analgesics|mesh-ancestor
154609735|NCT06232577|Sensory System Agents|sensory system agents|mesh-ancestor
154609736|NCT06232577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609737|NCT06232577|Antitussive Agents|antitussive agents|mesh-ancestor
154609738|NCT06232577|Respiratory System Agents|respiratory system agents|mesh-ancestor
154609739|NCT06231680|Thalidomide|thalidomide|mesh-list
154609740|NCT06231680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609741|NCT06231680|Immunologic Factors|immunologic factors|mesh-ancestor
154609742|NCT06231680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609743|NCT06231680|Leprostatic Agents|leprostatic agents|mesh-ancestor
154609744|NCT06231680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154609745|NCT06231680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609746|NCT06231680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154609747|NCT06231680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154609748|NCT06231680|Growth Substances|growth substances|mesh-ancestor
154609749|NCT06231680|Growth Inhibitors|growth inhibitors|mesh-ancestor
154609750|NCT06231680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609751|NCT06229353|Vaccines|vaccines|mesh-list
154609752|NCT06229353|Immunologic Factors|immunologic factors|mesh-ancestor
154609753|NCT06229353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609754|NCT06228456|Clopidogrel|clopidogrel|mesh-list
154609755|NCT06228456|Ticagrelor|ticagrelor|mesh-list
154609756|NCT06228456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154609757|NCT06228456|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154609758|NCT06228456|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154609759|NCT06228456|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154609760|NCT06228456|Purinergic Agents|purinergic agents|mesh-ancestor
154609761|NCT06228456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609762|NCT06228456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609763|NCT06228456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609764|NCT06228066|Avelumab|avelumab|mesh-list
154609765|NCT06228066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609766|NCT06228066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609767|NCT06223568|Docetaxel|docetaxel|mesh-list
154609768|NCT06223568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609769|NCT06223568|Tubulin Modulators|tubulin modulators|mesh-ancestor
154609770|NCT06223568|Antimitotic Agents|antimitotic agents|mesh-ancestor
154609771|NCT06223568|Mitosis Modulators|mitosis modulators|mesh-ancestor
154609772|NCT06223568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609773|NCT06213454|Bupivacaine|bupivacaine|mesh-list
154609774|NCT06213454|Anesthetics, Local|anesthetics, local|mesh-list
154096660|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154609775|NCT06213454|Anesthetics|anesthetics|mesh-list
154609776|NCT06213454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609777|NCT06213454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333543|NCT03522532|Zinc|zinc|mesh-list
154609778|NCT06213454|Sensory System Agents|sensory system agents|mesh-ancestor
154609779|NCT06213454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609780|NCT06212661|Erenumab|erenumab|mesh-list
154609781|NCT06212661|Botulinum Toxins|botulinum toxins|mesh-list
154609782|NCT06212661|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154609783|NCT06212661|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154609784|NCT06212661|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154609785|NCT06212661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154609786|NCT06212661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609787|NCT06212661|Cholinergic Agents|cholinergic agents|mesh-ancestor
154609788|NCT06212661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609789|NCT06212661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609790|NCT06212661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154609791|NCT06212661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609792|NCT06212661|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154609793|NCT06212661|Analgesics|analgesics|mesh-ancestor
154609794|NCT06212661|Sensory System Agents|sensory system agents|mesh-ancestor
154609795|NCT06193889|Cyclophosphamide|cyclophosphamide|mesh-list
154609796|NCT06193889|Fludarabine|fludarabine|mesh-list
154609797|NCT06193889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609798|NCT06193889|Immunologic Factors|immunologic factors|mesh-ancestor
154609799|NCT06193889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609800|NCT06193889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609801|NCT06193889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609802|NCT06193889|Alkylating Agents|alkylating agents|mesh-ancestor
154609803|NCT06193889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609804|NCT06193889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609805|NCT06193889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154609806|NCT06190093|Bevacizumab|bevacizumab|mesh-list
154609807|NCT06190093|Ranibizumab|ranibizumab|mesh-list
154609808|NCT06190093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609809|NCT06190093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609810|NCT06190093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154609811|NCT06190093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154609812|NCT06190093|Growth Substances|growth substances|mesh-ancestor
154609813|NCT06190093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609814|NCT06190093|Growth Inhibitors|growth inhibitors|mesh-ancestor
154609815|NCT06177067|Cytarabine|cytarabine|mesh-list
154609816|NCT06177067|Hydrocortisone|hydrocortisone|mesh-list
154609817|NCT06177067|Methotrexate|methotrexate|mesh-list
154609818|NCT06177067|Azacitidine|azacitidine|mesh-list
154609819|NCT06177067|Venetoclax|venetoclax|mesh-list
154609820|NCT06177067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154609821|NCT06177067|Abortifacient Agents|abortifacient agents|mesh-ancestor
154609822|NCT06177067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154609823|NCT06177067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609824|NCT06177067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154609825|NCT06177067|Antimetabolites|antimetabolites|mesh-ancestor
154609826|NCT06177067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609827|NCT06177067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609828|NCT06177067|Dermatologic Agents|dermatologic agents|mesh-ancestor
154609829|NCT06177067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609830|NCT06177067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154609831|NCT06177067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609832|NCT06177067|Immunologic Factors|immunologic factors|mesh-ancestor
154609833|NCT06177067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609834|NCT06177067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154609835|NCT06177067|Antiviral Agents|antiviral agents|mesh-ancestor
154609836|NCT06177067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609837|NCT06177067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154609838|NCT06169124|Leuprolide|leuprolide|mesh-list
154609839|NCT06169124|Exemestane|exemestane|mesh-list
154609840|NCT06169124|Androgen Antagonists|androgen antagonists|mesh-list
154609841|NCT06169124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154609842|NCT06169124|Fertility Agents|fertility agents|mesh-ancestor
154609843|NCT06169124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154609844|NCT06169124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609845|NCT06169124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154609846|NCT06169124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609847|NCT06169124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154609848|NCT06169124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154609849|NCT06169124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609850|NCT06169124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609851|NCT06169124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154609852|NCT06169124|Hormone Antagonists|hormone antagonists|mesh-ancestor
154609853|NCT06169124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154609854|NCT06161558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154609855|NCT06161558|Lenvatinib|lenvatinib|mesh-list
154609856|NCT06161558|Axitinib|axitinib|mesh-list
154609857|NCT06161558|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154609858|NCT06161558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154609859|NCT06161558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609860|NCT06161558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609861|NCT06161558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609862|NCT06161545|Pembrolizumab|pembrolizumab|mesh-list
154609863|NCT06161545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609864|NCT06161545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609865|NCT06161545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154609866|NCT06161545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609867|NCT06161532|Atezolizumab|atezolizumab|mesh-list
154609868|NCT06161532|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154609869|NCT06161532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154609870|NCT06161532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609871|NCT06161532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609872|NCT06161532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609873|NCT06161532|Immunoconjugates|immunoconjugates|mesh-ancestor
154609874|NCT06161532|Immunologic Factors|immunologic factors|mesh-ancestor
154609875|NCT06161532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609876|NCT06161415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154609877|NCT06161415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154609878|NCT06150560|Losartan|losartan|mesh-list
154609879|NCT06150560|Amlodipine|amlodipine|mesh-list
154609880|NCT06150560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154609881|NCT06150560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154609882|NCT06150560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154609883|NCT06150560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609884|NCT06150560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154609885|NCT06150560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609886|NCT06150560|Vasodilator Agents|vasodilator agents|mesh-ancestor
154609887|NCT06150560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154096739|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154609888|NCT06150560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154609889|NCT06150560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154609890|NCT06145282|Abatacept|abatacept|mesh-list
154609891|NCT06145282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154609892|NCT06145282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609893|NCT06145282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609894|NCT06145282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609895|NCT06145282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609896|NCT06145282|Immunologic Factors|immunologic factors|mesh-ancestor
154609897|NCT06145282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609898|NCT06145282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609899|NCT06121362|Protocatechuic acid|protocatechuic acid|mesh-list
154609900|NCT06121362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154609901|NCT06121362|Protective Agents|protective agents|mesh-ancestor
154609902|NCT06121362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609903|NCT06121362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609905|NCT06118905|Denosumab|denosumab|mesh-list
154609906|NCT06118905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154609907|NCT06118905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609908|NCT06101329|Tenofovir|tenofovir|mesh-list
154609909|NCT06101329|Emtricitabine|emtricitabine|mesh-list
154609910|NCT06101329|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154609911|NCT06101329|Antiviral Agents|antiviral agents|mesh-ancestor
154609912|NCT06101329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609913|NCT06101329|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154609914|NCT06101329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154609915|NCT06101329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609916|NCT06101329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609917|NCT06101329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154609918|NCT06101329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154609919|NCT06096844|Paclitaxel|paclitaxel|mesh-list
154609920|NCT06096844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154609921|NCT06096844|Carboplatin|carboplatin|mesh-list
154609922|NCT06096844|Pembrolizumab|pembrolizumab|mesh-list
154609923|NCT06096844|Pemetrexed|pemetrexed|mesh-list
154609924|NCT06096844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154609925|NCT06096844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609926|NCT06096844|Tubulin Modulators|tubulin modulators|mesh-ancestor
154609927|NCT06096844|Antimitotic Agents|antimitotic agents|mesh-ancestor
154609929|NCT06096844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096777|NCT00868426|Hormones|hormones|mesh-ancestor
154609930|NCT06096844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154609931|NCT06096844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154609932|NCT06096844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609933|NCT06096844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154609934|NCT06096844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154609935|NCT06092333|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154609936|NCT06092333|Antiviral Agents|antiviral agents|mesh-ancestor
154609937|NCT06092333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609938|NCT06086704|Anastrozole|anastrozole|mesh-list
154609939|NCT06086704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154609940|NCT06086704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609941|NCT06086704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154609942|NCT06086704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154609943|NCT06086704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609944|NCT06086704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609945|NCT06086704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154609946|NCT06086704|Hormone Antagonists|hormone antagonists|mesh-ancestor
154609947|NCT06086704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154609948|NCT06086704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609949|NCT06083883|Cyclophosphamide|cyclophosphamide|mesh-list
154609950|NCT06083883|Fludarabine|fludarabine|mesh-list
154609951|NCT06083883|Fludarabine phosphate|fludarabine phosphate|mesh-list
154609952|NCT06083883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609953|NCT06083883|Immunologic Factors|immunologic factors|mesh-ancestor
154609954|NCT06083883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609955|NCT06083883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609956|NCT06083883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609957|NCT06083883|Alkylating Agents|alkylating agents|mesh-ancestor
154609958|NCT06083883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609959|NCT06083883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609960|NCT06083883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154609961|NCT06083883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154609962|NCT06083883|Antimetabolites|antimetabolites|mesh-ancestor
154609963|NCT06082037|Azithromycin|azithromycin|mesh-list
154609964|NCT06082037|Belumosudil|belumosudil|mesh-list
154609965|NCT06082037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154609966|NCT06082037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154609967|NCT06082037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154609968|NCT06082037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154609969|NCT06082037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609970|NCT06079164|Cyclophosphamide|cyclophosphamide|mesh-list
154609971|NCT06079164|Fludarabine|fludarabine|mesh-list
154609972|NCT06079164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154609973|NCT06079164|Immunologic Factors|immunologic factors|mesh-ancestor
154609974|NCT06079164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609975|NCT06079164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154609976|NCT06079164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154609977|NCT06079164|Alkylating Agents|alkylating agents|mesh-ancestor
154609978|NCT06079164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609979|NCT06079164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154609980|NCT06079164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154609982|NCT06077487|Analgesics|analgesics|mesh-ancestor
154609983|NCT06077487|Sensory System Agents|sensory system agents|mesh-ancestor
154609984|NCT06077487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154609985|NCT06077487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154609986|NCT06077487|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154609987|NCT06077487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154609988|NCT06077487|Anesthetics, General|anesthetics, general|mesh-ancestor
154609989|NCT06077487|Anesthetics|anesthetics|mesh-ancestor
154609990|NCT06077487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154609991|NCT06077487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154609992|NCT06077487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154609993|NCT06077487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154609994|NCT06077487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154609995|NCT06072781|Paclitaxel|paclitaxel|mesh-list
154609996|NCT06072781|Doxorubicin|doxorubicin|mesh-list
154609997|NCT06072781|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154609998|NCT06072781|Letrozole|letrozole|mesh-list
154609999|NCT06072781|Topotecan|topotecan|mesh-list
154610000|NCT06072781|Anastrozole|anastrozole|mesh-list
154333818|NCT01124383|Dsuvia|dsuvia|mesh-list
154610001|NCT06072781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154610002|NCT06072781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610003|NCT06072781|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610004|NCT06072781|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610005|NCT06072781|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610006|NCT06072781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610007|NCT06072781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610008|NCT06072781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154610009|NCT06072781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154610010|NCT06072781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610011|NCT06072781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154610012|NCT06072781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154610013|NCT06072781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154610014|NCT06072781|Hormone Antagonists|hormone antagonists|mesh-ancestor
154610015|NCT06072781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610016|NCT06072781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610017|NCT06072781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154610018|NCT06072781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610019|NCT06070649|Diphenhydramine|diphenhydramine|mesh-list
154610020|NCT06070649|Promethazine|promethazine|mesh-list
154610021|NCT06070649|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154610022|NCT06070649|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154610023|NCT06070649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154610024|NCT06070649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154610025|NCT06070649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610026|NCT06070649|Anesthetics, Local|anesthetics, local|mesh-ancestor
154610027|NCT06070649|Anesthetics|anesthetics|mesh-ancestor
154610028|NCT06070649|Sensory System Agents|sensory system agents|mesh-ancestor
154610029|NCT06070649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610030|NCT06070649|Antiemetics|antiemetics|mesh-ancestor
154610031|NCT06070649|Autonomic Agents|autonomic agents|mesh-ancestor
154610032|NCT06070649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154610033|NCT06070649|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154610034|NCT06070649|Histamine Antagonists|histamine antagonists|mesh-ancestor
154610035|NCT06070649|Histamine Agents|histamine agents|mesh-ancestor
154610036|NCT06070649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154610037|NCT06070649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610038|NCT06070649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154610039|NCT06070649|Antipruritics|antipruritics|mesh-ancestor
154610040|NCT06070649|Dermatologic Agents|dermatologic agents|mesh-ancestor
154610041|NCT06070649|Hallucinogens|hallucinogens|mesh-ancestor
154610042|NCT06070649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154610043|NCT06070649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154610044|NCT06070649|Serotonin Agents|serotonin agents|mesh-ancestor
154610045|NCT06070649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154610046|NCT06069375|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154610047|NCT06069375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610048|NCT06066359|Cyclophosphamide|cyclophosphamide|mesh-list
154610049|NCT06066359|Fludarabine|fludarabine|mesh-list
154610050|NCT06066359|Fludarabine phosphate|fludarabine phosphate|mesh-list
154610051|NCT06066359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610052|NCT06066359|Immunologic Factors|immunologic factors|mesh-ancestor
154610053|NCT06066359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610054|NCT06066359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096904|NCT03743376|UB-421|ub-421|mesh-list
154610055|NCT06066359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154610056|NCT06066359|Alkylating Agents|alkylating agents|mesh-ancestor
154610057|NCT06066359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610058|NCT06066359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610059|NCT06066359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154610060|NCT06066359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154610061|NCT06066359|Antimetabolites|antimetabolites|mesh-ancestor
154610062|NCT06066138|Atezolizumab|atezolizumab|mesh-list
154610063|NCT06066138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610064|NCT06066138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610065|NCT06066138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610066|NCT06066138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610067|NCT06065748|Fulvestrant|fulvestrant|mesh-list
154610068|NCT06065748|Palbociclib|palbociclib|mesh-list
154610069|NCT06065748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610070|NCT06065748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610071|NCT06065748|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154610072|NCT06065748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154610073|NCT06065748|Hormone Antagonists|hormone antagonists|mesh-ancestor
154610074|NCT06065748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610075|NCT06065748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610076|NCT06065748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610077|NCT06065748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610078|NCT06065748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610079|NCT06065540|Semaglutide|semaglutide|mesh-list
154610080|NCT06065540|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154610081|NCT06065540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610082|NCT06065540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610083|NCT06058377|Paclitaxel|paclitaxel|mesh-list
154610084|NCT06058377|Cyclophosphamide|cyclophosphamide|mesh-list
154610085|NCT06058377|Doxorubicin|doxorubicin|mesh-list
154610086|NCT06058377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154610087|NCT06058377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154610088|NCT06058377|Durvalumab|durvalumab|mesh-list
154610089|NCT06058377|Daunorubicin|daunorubicin|mesh-list
154610090|NCT06058377|Immunoglobulins|immunoglobulins|mesh-list
154610091|NCT06058377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154610092|NCT06058377|Immunoglobulin G|immunoglobulin g|mesh-list
154610093|NCT06058377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154610094|NCT06058377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610095|NCT06058377|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610096|NCT06058377|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610097|NCT06058377|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610098|NCT06058377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610099|NCT06058377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610100|NCT06058377|Immunologic Factors|immunologic factors|mesh-ancestor
154610101|NCT06058377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610102|NCT06058377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610103|NCT06058377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154610104|NCT06058377|Alkylating Agents|alkylating agents|mesh-ancestor
154610105|NCT06058377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154610106|NCT06058377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610107|NCT06058377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154610108|NCT06058377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154610109|NCT06058377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610110|NCT06058377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610111|NCT06051890|Buprenorphine|buprenorphine|mesh-list
154610112|NCT06051890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154610113|NCT06051890|Narcotics|narcotics|mesh-ancestor
154610114|NCT06051890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154610115|NCT06051890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610116|NCT06051890|Analgesics|analgesics|mesh-ancestor
154610117|NCT06051890|Sensory System Agents|sensory system agents|mesh-ancestor
154610118|NCT06051890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610119|NCT06051890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154610120|NCT06049693|Ferrous gluconate|ferrous gluconate|mesh-list
154610121|NCT06049693|Hematinics|hematinics|mesh-ancestor
154610122|NCT06041503|Pembrolizumab|pembrolizumab|mesh-list
154610123|NCT06041503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610124|NCT06041503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610125|NCT06041503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610126|NCT06041503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610127|NCT06033521|Hormones|hormones|mesh-list
154610128|NCT06033521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610129|NCT06033521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610130|NCT06033131|Metformin|metformin|mesh-list
154610131|NCT06033131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610132|NCT06033131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610133|NCT06016738|Letrozole|letrozole|mesh-list
154096984|NCT00729170|Calcium|calcium|mesh-list
154610134|NCT06016738|Fulvestrant|fulvestrant|mesh-list
154610135|NCT06016738|Anastrozole|anastrozole|mesh-list
154610136|NCT06016738|Exemestane|exemestane|mesh-list
154610137|NCT06016738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610138|NCT06016738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154610139|NCT06016738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154610140|NCT06016738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610141|NCT06016738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610142|NCT06016738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154610143|NCT06016738|Hormone Antagonists|hormone antagonists|mesh-ancestor
154610144|NCT06016738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610145|NCT06016738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610146|NCT06016738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610147|NCT06016738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154610148|NCT06015893|Semaglutide|semaglutide|mesh-list
154610149|NCT06015893|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154610150|NCT06015893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610151|NCT06015893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610152|NCT06015308|Vaccines|vaccines|mesh-list
154610153|NCT06015308|Immunologic Factors|immunologic factors|mesh-ancestor
154610154|NCT06015308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610155|NCT05987241|Nivolumab|nivolumab|mesh-list
154610156|NCT05987241|Relatlimab|relatlimab|mesh-list
154610157|NCT05987241|Immunoglobulins|immunoglobulins|mesh-list
154610158|NCT05987241|Immunoglobulin G|immunoglobulin g|mesh-list
154610159|NCT05987241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610160|NCT05987241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610161|NCT05987241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610162|NCT05987241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610163|NCT05987241|Immunologic Factors|immunologic factors|mesh-ancestor
154610164|NCT05987241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610165|NCT05986071|Fulvestrant|fulvestrant|mesh-list
154610166|NCT05986071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610167|NCT05986071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610168|NCT05986071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154610169|NCT05986071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154610170|NCT05986071|Hormone Antagonists|hormone antagonists|mesh-ancestor
154610171|NCT05986071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610172|NCT05986071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610173|NCT05982678|Trastuzumab|trastuzumab|mesh-list
154610174|NCT05982678|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154610175|NCT05982678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610176|NCT05982678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610177|NCT05982678|Immunoconjugates|immunoconjugates|mesh-ancestor
154610178|NCT05982678|Immunologic Factors|immunologic factors|mesh-ancestor
154610179|NCT05982678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610180|NCT05972993|Vaccines|vaccines|mesh-list
154610181|NCT05972993|Immunologic Factors|immunologic factors|mesh-ancestor
154610182|NCT05972993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610183|NCT05949658|Sirolimus|sirolimus|mesh-list
154610184|NCT05949658|Everolimus|everolimus|mesh-list
154610185|NCT05949658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154610186|NCT05949658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610187|NCT05949658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610188|NCT05949658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610189|NCT05949658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610190|NCT05949658|Immunologic Factors|immunologic factors|mesh-ancestor
154610191|NCT05949658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610192|NCT05949658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610193|NCT05949658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154610194|NCT05949658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255814|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610195|NCT05949658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610196|NCT05949658|Antifungal Agents|antifungal agents|mesh-ancestor
154610197|NCT05910827|Docetaxel|docetaxel|mesh-list
154610198|NCT05910827|Cetuximab|cetuximab|mesh-list
154610199|NCT05910827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610200|NCT05910827|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610201|NCT05910827|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610202|NCT05910827|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610203|NCT05910827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610204|NCT05910827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610205|NCT05907759|Daratumumab|daratumumab|mesh-list
154610206|NCT05907759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610207|NCT05898828|Nivolumab|nivolumab|mesh-list
154610208|NCT05898828|Entinostat|entinostat|mesh-list
154610209|NCT05898828|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154610210|NCT05898828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610211|NCT05898828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610212|NCT05898828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610213|NCT05898828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610214|NCT05898828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154610215|NCT05898828|Immunologic Factors|immunologic factors|mesh-ancestor
154610216|NCT05898828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610217|NCT05898828|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154610218|NCT05898828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610219|NCT05896839|Sirolimus|sirolimus|mesh-list
154610220|NCT05896839|Prednisone|prednisone|mesh-list
154610221|NCT05896839|Cortisone|cortisone|mesh-list
154610222|NCT05896839|Nivolumab|nivolumab|mesh-list
154610223|NCT05896839|Ipilimumab|ipilimumab|mesh-list
154333985|NCT01125787|Ofatumumab|ofatumumab|mesh-list
154610224|NCT05896839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610225|NCT05896839|Glucocorticoids|glucocorticoids|mesh-ancestor
154610226|NCT05896839|Hormones|hormones|mesh-ancestor
154610227|NCT05896839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610228|NCT05896839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610229|NCT05896839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610230|NCT05896839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610231|NCT05896839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610232|NCT05896839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610233|NCT05896839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610234|NCT05896839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154610235|NCT05896839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610236|NCT05896839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610237|NCT05896839|Antifungal Agents|antifungal agents|mesh-ancestor
154610238|NCT05896839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610239|NCT05896839|Immunologic Factors|immunologic factors|mesh-ancestor
154610240|NCT05883644|Durvalumab|durvalumab|mesh-list
154610241|NCT05883644|Tremelimumab|tremelimumab|mesh-list
154610242|NCT05883644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610243|NCT05883644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610244|NCT05879484|Pembrolizumab|pembrolizumab|mesh-list
154610245|NCT05879484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610246|NCT05879484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610247|NCT05879484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610248|NCT05879484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610249|NCT05866471|Psilocybin|psilocybin|mesh-list
154610250|NCT05866471|Hallucinogens|hallucinogens|mesh-ancestor
154610251|NCT05866471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610252|NCT05866471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154610253|NCT05854992|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
154610254|NCT05854992|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154610255|NCT05854992|Serotonin Agents|serotonin agents|mesh-ancestor
154610256|NCT05854992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154610257|NCT05854992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610258|NCT05854992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610259|NCT05849480|Capecitabine|capecitabine|mesh-list
154610260|NCT05849480|Oxaliplatin|oxaliplatin|mesh-list
154610261|NCT05849480|Pembrolizumab|pembrolizumab|mesh-list
154610262|NCT05849480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154610263|NCT05849480|Antimetabolites|antimetabolites|mesh-ancestor
154610264|NCT05849480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610265|NCT05849480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610266|NCT05849480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610267|NCT05849480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610268|NCT05843643|Upadacitinib|upadacitinib|mesh-list
154610269|NCT05843643|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154610270|NCT05843643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610272|NCT05843643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610273|NCT05843643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610274|NCT05837104|Vitamin B 6|vitamin b 6|mesh-list
154610275|NCT05837104|Pyridoxal|pyridoxal|mesh-list
154610276|NCT05837104|Pyridoxine|pyridoxine|mesh-list
154610277|NCT05837104|Vitamins|vitamins|mesh-ancestor
154610278|NCT05837104|Micronutrients|micronutrients|mesh-ancestor
154610279|NCT05837104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610280|NCT05837104|Vitamin B Complex|vitamin b complex|mesh-ancestor
154610281|NCT05836857|Cannabidiol|cannabidiol|mesh-list
154610282|NCT05836857|Anticonvulsants|anticonvulsants|mesh-ancestor
154610283|NCT05835479|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154610284|NCT05835479|Rezafungin|rezafungin|mesh-list
154610285|NCT05835479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154610286|NCT05835479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610287|NCT05835479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154610288|NCT05835479|Antimalarials|antimalarials|mesh-ancestor
154610289|NCT05835479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154610290|NCT05835479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154610291|NCT05835479|Antifungal Agents|antifungal agents|mesh-ancestor
154610292|NCT05815186|Sotorasib|sotorasib|mesh-list
154610293|NCT05815186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610294|NCT05815186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610295|NCT05815186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610296|NCT05815186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610297|NCT05814627|Adalimumab|adalimumab|mesh-list
154610298|NCT05814627|Upadacitinib|upadacitinib|mesh-list
154334073|NCT06128863|Pembrolizumab|pembrolizumab|mesh-list
154610299|NCT05814627|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154610300|NCT05814627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610301|NCT05814627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610302|NCT05814627|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154610303|NCT05814627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610304|NCT05814627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610305|NCT05814627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610306|NCT05777603|Vancomycin|vancomycin|mesh-list
154610307|NCT05777603|Aztreonam|aztreonam|mesh-list
154610308|NCT05777603|Pembrolizumab|pembrolizumab|mesh-list
154610309|NCT05777603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610310|NCT05777603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610311|NCT05777603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610312|NCT05777603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610313|NCT05777603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154610314|NCT05777603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610315|NCT05767346|Metoprolol|metoprolol|mesh-list
154610316|NCT05767346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154610317|NCT05767346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154610318|NCT05767346|Sympatholytics|sympatholytics|mesh-ancestor
154610319|NCT05767346|Autonomic Agents|autonomic agents|mesh-ancestor
154610320|NCT05767346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610321|NCT05767346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610322|NCT05767346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154610323|NCT05767346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154610324|NCT05767346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154610325|NCT05767346|Adrenergic Agents|adrenergic agents|mesh-ancestor
154610326|NCT05767346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154610327|NCT05767346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610328|NCT05749289|Octreotide|octreotide|mesh-list
154610329|NCT05749289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154610330|NCT05749289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610331|NCT05749289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610332|NCT05735184|Cytarabine|cytarabine|mesh-list
154610333|NCT05735184|Azacitidine|azacitidine|mesh-list
154610334|NCT05735184|Daunorubicin|daunorubicin|mesh-list
154610335|NCT05735184|Venetoclax|venetoclax|mesh-list
154610336|NCT05735184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154610337|NCT05735184|Antimetabolites|antimetabolites|mesh-ancestor
154610338|NCT05735184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610339|NCT05735184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610340|NCT05735184|Antiviral Agents|antiviral agents|mesh-ancestor
154610341|NCT05735184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610342|NCT05735184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610343|NCT05735184|Immunologic Factors|immunologic factors|mesh-ancestor
154610344|NCT05735184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610346|NCT05735184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610347|NCT05735184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154610348|NCT05735184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154610349|NCT05727904|Pembrolizumab|pembrolizumab|mesh-list
154610350|NCT05727904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610351|NCT05727904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610352|NCT05727904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610353|NCT05727904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610354|NCT05713799|Thioctic Acid|thioctic acid|mesh-list
154610355|NCT05713799|Mirabegron|mirabegron|mesh-list
154610356|NCT05713799|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154610357|NCT05713799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154610358|NCT05713799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154610359|NCT05713799|Adrenergic Agents|adrenergic agents|mesh-ancestor
154610360|NCT05713799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154610361|NCT05713799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610362|NCT05713799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610363|NCT05713799|Urological Agents|urological agents|mesh-ancestor
154610364|NCT05713799|Antioxidants|antioxidants|mesh-ancestor
154610365|NCT05713799|Protective Agents|protective agents|mesh-ancestor
154610366|NCT05713799|Vitamin B Complex|vitamin b complex|mesh-ancestor
154610367|NCT05713799|Vitamins|vitamins|mesh-ancestor
154610368|NCT05713799|Micronutrients|micronutrients|mesh-ancestor
154610369|NCT05711615|Doxorubicin|doxorubicin|mesh-list
154610370|NCT05711615|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154610371|NCT05711615|Peposertib|peposertib|mesh-list
154610372|NCT05711615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610373|NCT05711615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334129|NCT06128213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154610374|NCT05711615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154610375|NCT05711615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154610376|NCT05711615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610377|NCT05711615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610378|NCT05711615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610379|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154610380|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154610381|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610382|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154610383|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
154610384|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154610385|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154610386|NCT05690815|Tenofovir|tenofovir|mesh-list
154610387|NCT05690815|Emtricitabine|emtricitabine|mesh-list
154610388|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154610389|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
154610390|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610391|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154610392|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154610393|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610394|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610395|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154610396|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154610397|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
154610398|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610399|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
154610400|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610401|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
154610402|NCT05675410|Prednisone|prednisone|mesh-list
154610403|NCT05675410|Prednisolone|prednisolone|mesh-list
154610404|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154610405|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
154610406|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154610407|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
154610408|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
154610409|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154610410|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154610411|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154610412|NCT05675410|Cortisone|cortisone|mesh-list
154610413|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
154610414|NCT05675410|Dacarbazine|dacarbazine|mesh-list
154610415|NCT05675410|Doxorubicin|doxorubicin|mesh-list
154610416|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154610417|NCT05675410|Nivolumab|nivolumab|mesh-list
154610418|NCT05675410|Etoposide|etoposide|mesh-list
154610419|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
154610420|NCT05675410|Vincristine|vincristine|mesh-list
154610421|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154610423|NCT05675410|Vinblastine|vinblastine|mesh-list
154610424|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
154610425|NCT05675410|Procarbazine|procarbazine|mesh-list
154610426|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154610427|NCT05675410|Antibodies|antibodies|mesh-list
154610428|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
154610429|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154610430|NCT05675410|Imidazole|imidazole|mesh-list
154610431|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154610432|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
154610433|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154610434|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
154610435|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610436|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
154610437|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610438|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610439|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154610440|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
154610441|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610442|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610443|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154610444|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610445|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154610446|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154610447|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610448|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610449|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
154610450|NCT05675410|Hormones|hormones|mesh-ancestor
154610451|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610452|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610453|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610454|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154610455|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610456|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610457|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610458|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
154610459|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
154610460|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610461|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154610462|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154610463|NCT05675410|Protective Agents|protective agents|mesh-ancestor
154610464|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154610465|NCT05675410|Immunotoxins|immunotoxins|mesh-ancestor
154610466|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
154610467|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
154610468|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
154610469|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
154610470|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610471|NCT05669755|Semaglutide|semaglutide|mesh-list
154610472|NCT05669755|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154610473|NCT05669755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610474|NCT05669755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610475|NCT05669664|Leuprolide|leuprolide|mesh-list
154610476|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
154610477|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154610478|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
154610479|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154610480|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610481|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610482|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610483|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
154610484|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610485|NCT05665530|Zanubrutinib|zanubrutinib|mesh-list
154610486|NCT05665530|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154610487|NCT05665530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610488|NCT05665530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610489|NCT05665530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610490|NCT05665530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610491|NCT05652478|Tenofovir|tenofovir|mesh-list
154610492|NCT05652478|Dolutegravir|dolutegravir|mesh-list
154610493|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
154610494|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610495|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154610496|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154610497|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610498|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610499|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154610500|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154610501|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154610502|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154610503|NCT05647122|Leucovorin|leucovorin|mesh-list
154610504|NCT05647122|Bevacizumab|bevacizumab|mesh-list
154610505|NCT05647122|Fluorouracil|fluorouracil|mesh-list
154610506|NCT05647122|Osimertinib|osimertinib|mesh-list
154610507|NCT05647122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610508|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610509|NCT05647122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154610510|NCT05647122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154610511|NCT05647122|Growth Substances|growth substances|mesh-ancestor
154610512|NCT05647122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610513|NCT05647122|Growth Inhibitors|growth inhibitors|mesh-ancestor
154610514|NCT05647122|Antimetabolites|antimetabolites|mesh-ancestor
154610515|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610516|NCT05647122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154610517|NCT05647122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610518|NCT05647122|Immunologic Factors|immunologic factors|mesh-ancestor
154610519|NCT05647122|Antidotes|antidotes|mesh-ancestor
154610520|NCT05647122|Protective Agents|protective agents|mesh-ancestor
154610521|NCT05647122|Vitamin B Complex|vitamin b complex|mesh-ancestor
154610522|NCT05647122|Vitamins|vitamins|mesh-ancestor
154610523|NCT05647122|Micronutrients|micronutrients|mesh-ancestor
154610524|NCT05647122|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154610525|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610526|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610527|NCT05645406|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154610528|NCT05645406|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154610529|NCT05645406|Estradiol|estradiol|mesh-list
154610530|NCT05645406|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154610532|NCT05645406|Hormones|hormones|mesh-ancestor
154610533|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610534|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610535|NCT05645406|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154610536|NCT05645406|Contraceptive Agents|contraceptive agents|mesh-ancestor
154610537|NCT05645406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154610538|NCT05645406|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154610539|NCT05645393|Estrogens|estrogens|mesh-list
154610540|NCT05645393|Hormones|hormones|mesh-ancestor
154610541|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610542|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610543|NCT05645146|Nicotine|nicotine|mesh-list
154610544|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154610545|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
154610546|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610547|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610548|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154610549|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154610550|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
154610551|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154610552|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610553|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154610554|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154610555|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
154610556|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610557|NCT05625412|Docetaxel|docetaxel|mesh-list
154610558|NCT05625412|Capecitabine|capecitabine|mesh-list
154610559|NCT05625412|Nivolumab|nivolumab|mesh-list
154610560|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610561|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610562|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610563|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610564|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610565|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154610566|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
154610567|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610568|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610569|NCT05601492|Thalidomide|thalidomide|mesh-list
154610570|NCT05601492|Apremilast|apremilast|mesh-list
154610571|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154610572|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154610573|NCT05601492|Analgesics|analgesics|mesh-ancestor
154610574|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
154610575|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610576|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610577|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610578|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610579|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154610580|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154610581|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610582|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610583|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610584|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
154610585|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
154610586|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154610587|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610588|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154097427|NCT06017284|Growth Substances|growth substances|mesh-ancestor
154610589|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154610590|NCT05601492|Growth Substances|growth substances|mesh-ancestor
154610591|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
154610592|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610593|NCT05590728|Apramycin|apramycin|mesh-list
154610594|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154610595|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610596|NCT05582434|Clindamycin|clindamycin|mesh-list
154610597|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
154610598|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
154610599|NCT05582434|Adapalene|adapalene|mesh-list
154610600|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154610601|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154610602|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610603|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154610604|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334354|NCT05156905|Docetaxel|docetaxel|mesh-list
154610605|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610606|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
154610607|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154610608|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154610610|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
154610611|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610612|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610613|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610614|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610615|NCT05578976|Prednisone|prednisone|mesh-list
154610616|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
154610617|NCT05578976|Rituximab|rituximab|mesh-list
154610618|NCT05578976|Doxorubicin|doxorubicin|mesh-list
154610619|NCT05578976|Vincristine|vincristine|mesh-list
154610620|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610621|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
154610622|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610623|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610624|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154610625|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
154610626|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610627|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610628|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154610629|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610630|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610631|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154610632|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154610633|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610634|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610635|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
154610636|NCT05578976|Hormones|hormones|mesh-ancestor
154610637|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610638|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610639|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154610640|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610641|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610642|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610643|NCT05556265|Deucravacitinib|deucravacitinib|mesh-list
154610644|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
154610645|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610646|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610647|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610648|NCT05552196|Carbamazepine|carbamazepine|mesh-list
154610649|NCT05552196|Ponesimod|ponesimod|mesh-list
154610650|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
154610651|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
154610652|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154610653|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154610654|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610655|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154610656|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154610657|NCT05552196|Analgesics|analgesics|mesh-ancestor
154610658|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
154610659|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610660|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154610661|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154610662|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610663|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154610664|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154610665|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154610666|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610667|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
154610668|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
154610669|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154610670|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610671|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610672|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610673|NCT05465174|Nivolumab|nivolumab|mesh-list
154610674|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610675|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097566|NCT05732883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154610676|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154334441|NCT04776148|Lenvatinib|lenvatinib|mesh-list
154610677|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610679|NCT05445778|Maytansine|maytansine|mesh-list
154610680|NCT05445778|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154610681|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610682|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610683|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154610684|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154610685|NCT05445778|Growth Substances|growth substances|mesh-ancestor
154610686|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610687|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
154610688|NCT05445778|Immunoconjugates|immunoconjugates|mesh-ancestor
154610689|NCT05445778|Immunologic Factors|immunologic factors|mesh-ancestor
154610690|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154610691|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610692|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610693|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610694|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610695|NCT05416333|Azelaic acid|azelaic acid|mesh-list
154610696|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610697|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
154610698|NCT05409066|Rituximab|rituximab|mesh-list
154610699|NCT05409066|Lenalidomide|lenalidomide|mesh-list
154610700|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610701|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610702|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
154610703|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610704|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610705|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154610706|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154610707|NCT05409066|Growth Substances|growth substances|mesh-ancestor
154610708|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
154610709|NCT05407961|Dulaglutide|dulaglutide|mesh-list
154610710|NCT05407961|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154610711|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610712|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610713|NCT05406700|Niraparib|niraparib|mesh-list
154610714|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154610715|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610716|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610717|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610718|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
154610719|NCT05400109|Fludarabine|fludarabine|mesh-list
154610720|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
154610721|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610722|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
154610723|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610724|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610725|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154610726|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
154610727|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610728|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610729|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154610730|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154610731|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
154610732|NCT05388877|Dabrafenib|dabrafenib|mesh-list
154610733|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610734|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610735|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610736|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610737|NCT05371496|Semaglutide|semaglutide|mesh-list
154610738|NCT05371496|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154610739|NCT05371496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610740|NCT05371496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610741|NCT05289492|Dexamethasone|dexamethasone|mesh-list
154610742|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610743|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
154610744|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
154610745|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610746|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610747|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154610748|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
154610749|NCT05289492|Hormones|hormones|mesh-ancestor
154334499|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154610750|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610751|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610752|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610753|NCT05269355|Dacarbazine|dacarbazine|mesh-list
154610754|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154610755|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
154610756|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610757|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610758|NCT05268614|Cisplatin|cisplatin|mesh-list
154610759|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610760|NCT05264974|Vaccines|vaccines|mesh-list
154610761|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
154610762|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610763|NCT05218499|Doxorubicin|doxorubicin|mesh-list
154610764|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610765|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610766|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154610767|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154610768|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610769|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610770|NCT05185024|Iron|iron|mesh-list
154610771|NCT05185024|Trace Elements|trace elements|mesh-ancestor
154610772|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
154610773|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610774|NCT05144542|Nicotine|nicotine|mesh-list
154610775|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154610776|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
154610777|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610778|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610779|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154610780|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154610781|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
154610782|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154610783|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610784|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
154610785|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154610786|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154610787|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610788|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
154610789|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154610790|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610791|NCT05109234|Brivaracetam|brivaracetam|mesh-list
154610792|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
154610793|NCT05093296|Naltrexone|naltrexone|mesh-list
154610794|NCT05093296|Oxytocin|oxytocin|mesh-list
154610795|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
154610796|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154610797|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610798|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154610799|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154610800|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
154610801|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610802|NCT05086692|Pembrolizumab|pembrolizumab|mesh-list
154610803|NCT05086692|Interleukin-2|interleukin-2|mesh-list
154610804|NCT05086692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610805|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610806|NCT05086692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610807|NCT05086692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610808|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154610809|NCT05086692|Analgesics|analgesics|mesh-ancestor
154610810|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
154610811|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610812|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610814|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154610815|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154610816|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610817|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154610818|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154610819|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154610820|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
154610821|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
154610822|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097666|NCT05588219|Cisplatin|cisplatin|mesh-list
154610823|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334576|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154610824|NCT05076175|Ozanimod|ozanimod|mesh-list
154610825|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154610826|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610827|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610828|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
154610829|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610830|NCT05075980|Cisplatin|cisplatin|mesh-list
154610831|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610832|NCT05074290|Taxane|taxane|mesh-list
154610833|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610834|NCT05069545|Insulin|insulin|mesh-list
154610835|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154610836|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
154610837|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610838|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610839|NCT05065866|Azacitidine|azacitidine|mesh-list
154610840|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154610841|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
154610842|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610843|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610844|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610845|NCT05064800|Ritonavir|ritonavir|mesh-list
154610846|NCT05064800|Nirmatrelvir|nirmatrelvir|mesh-list
154610847|NCT05064800|Dabigatran|dabigatran|mesh-list
154610848|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154610849|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154610850|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
154610851|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610852|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610853|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154610854|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154610855|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
154610856|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610857|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154610858|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154610859|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
154610860|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154610861|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
154610862|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
154610863|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610864|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
154610865|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610866|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
154610867|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154610868|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153506938|NCT01394770|Aliskiren|aliskiren|mesh-list
154610869|NCT05058287|Prednisolone|prednisolone|mesh-list
154610870|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
154610871|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154610872|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
154610873|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610874|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
154610875|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
154610876|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610877|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610878|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154610879|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
154610880|NCT05058287|Hormones|hormones|mesh-ancestor
154610881|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610882|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154610883|NCT05058287|Protective Agents|protective agents|mesh-ancestor
154610884|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610885|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610886|NCT05035082|Semaglutide|semaglutide|mesh-list
154610887|NCT05035082|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154610888|NCT05035082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154610889|NCT05035082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610890|NCT04971720|Valsartan|valsartan|mesh-list
154610891|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154610892|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154610893|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154610894|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154610895|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610896|NCT04964934|Letrozole|letrozole|mesh-list
154610897|NCT04964934|Palbociclib|palbociclib|mesh-list
154610898|NCT04964934|Anastrozole|anastrozole|mesh-list
154610899|NCT04964934|Hormones|hormones|mesh-list
154610900|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154610901|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610902|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610903|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610904|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154610905|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154610906|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610907|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610908|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154610909|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
154610910|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154610911|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610913|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610914|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610915|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610916|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610917|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610918|NCT04915183|Atorvastatin|atorvastatin|mesh-list
154610919|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154610920|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154610921|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
154610922|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610923|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154610924|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154610925|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610926|NCT04910503|Dexamethasone|dexamethasone|mesh-list
154610927|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154610928|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610929|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
154610930|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
154610931|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610932|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610933|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154610934|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
154610935|NCT04910503|Hormones|hormones|mesh-ancestor
154610936|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610937|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610938|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610939|NCT04892264|Dexamethasone|dexamethasone|mesh-list
154610940|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
154610941|NCT04892264|Lenalidomide|lenalidomide|mesh-list
154610942|NCT04892264|Daratumumab|daratumumab|mesh-list
154610943|NCT04892264|Ichthammol|ichthammol|mesh-list
154610944|NCT04892264|BB 1101|bb 1101|mesh-list
154610945|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154610946|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
154610947|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
154610948|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154610949|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610950|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154610951|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
154610952|NCT04892264|Hormones|hormones|mesh-ancestor
154610953|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154610954|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154610955|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610956|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
154610957|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610958|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610959|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
154610960|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154610961|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154610962|NCT04892264|Growth Substances|growth substances|mesh-ancestor
154610963|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
154610964|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
154610965|NCT04890093|Vincristine|vincristine|mesh-list
154610966|NCT04890093|Temozolomide|temozolomide|mesh-list
154610967|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154610968|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610969|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
154610970|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
154610971|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
154610972|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610973|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154610974|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
154610975|NCT04877288|Cyclosporine|cyclosporine|mesh-list
154610976|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
154610977|NCT04877288|Abatacept|abatacept|mesh-list
154610978|NCT04877288|Tacrolimus|tacrolimus|mesh-list
154610979|NCT04877288|Cyclosporins|cyclosporins|mesh-list
154610980|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610981|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
154610982|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154610983|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154610984|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154610985|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154610986|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
154610987|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154610988|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154610989|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154610990|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154610991|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154610992|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154610993|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
154610994|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154610995|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154610996|NCT04877288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154610997|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
154610998|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154610999|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
154611000|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611001|NCT04857034|Deucravacitinib|deucravacitinib|mesh-list
154611002|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
154611003|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611004|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611005|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611006|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
154611007|NCT04828486|Futibatinib|futibatinib|mesh-list
154611008|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611009|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611010|NCT04828486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611011|NCT04828486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611012|NCT04759586|Prednisone|prednisone|mesh-list
154611013|NCT04759586|Prednisolone|prednisolone|mesh-list
154611014|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154611015|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
154611016|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154611017|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
154611018|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
154611019|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154611021|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154611022|NCT04759586|Cortisone|cortisone|mesh-list
154611023|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
154611024|NCT04759586|Rituximab|rituximab|mesh-list
154611025|NCT04759586|Doxorubicin|doxorubicin|mesh-list
154611026|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154611027|NCT04759586|Nivolumab|nivolumab|mesh-list
154611028|NCT04759586|Etoposide|etoposide|mesh-list
154611029|NCT04759586|Vincristine|vincristine|mesh-list
154611030|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
154611031|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154611032|NCT04759586|Antibodies|antibodies|mesh-list
154611033|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
154611034|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154611035|NCT04759586|Lenograstim|lenograstim|mesh-list
154611036|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154611037|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
154611038|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611039|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
154611040|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611041|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611042|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611043|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
154611044|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611045|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611046|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154611047|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154611048|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154611049|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154334800|NCT03931135|Dexamethasone|dexamethasone|mesh-list
154611050|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611051|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611052|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
154611053|NCT04759586|Hormones|hormones|mesh-ancestor
154611054|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611055|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611056|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611057|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611058|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154611059|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611060|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611061|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611062|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
154611063|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
154611064|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611065|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154611066|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154611067|NCT04759586|Protective Agents|protective agents|mesh-ancestor
154611068|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154611069|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154611070|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154611071|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611072|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
154611073|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611074|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611075|NCT04743661|Antipyretics|antipyretics|mesh-list
154611076|NCT04743661|Dexamethasone|dexamethasone|mesh-list
154611077|NCT04743661|Bevacizumab|bevacizumab|mesh-list
154611078|NCT04743661|Irinotecan|irinotecan|mesh-list
154611079|NCT04743661|Temozolomide|temozolomide|mesh-list
154611080|NCT04743661|Antiemetics|antiemetics|mesh-list
154611081|NCT04743661|Emetics|emetics|mesh-list
154611082|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
154611083|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154611084|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611085|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611086|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154611087|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154611088|NCT04743661|Growth Substances|growth substances|mesh-ancestor
154611089|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611090|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
154611091|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611092|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
154611093|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507475|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
154611094|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154611095|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
154611096|NCT04743661|Hormones|hormones|mesh-ancestor
154611097|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611098|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611099|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154611100|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154611101|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611102|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611103|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611104|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
154611105|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
154611106|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611107|NCT04717414|Luspatercept|luspatercept|mesh-list
154611108|NCT04717414|Hematinics|hematinics|mesh-ancestor
154611109|NCT04707534|Dexamethasone|dexamethasone|mesh-list
154611110|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611111|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
154611112|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
154611113|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611114|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611115|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154611116|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
154611117|NCT04707534|Hormones|hormones|mesh-ancestor
154611118|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611119|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611120|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611121|NCT04703075|Rifapentine|rifapentine|mesh-list
154611122|NCT04703075|Rifampin|rifampin|mesh-list
154253796|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611123|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154611124|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
154611125|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154611126|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611128|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154611129|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611130|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611131|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154611132|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154611133|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154611134|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154611135|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154611136|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154611137|NCT04666610|Brivaracetam|brivaracetam|mesh-list
154611138|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
154611139|NCT04644094|Dexamethasone|dexamethasone|mesh-list
154611140|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611141|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
154611142|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
154611143|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611144|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611145|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098007|NCT04973163|Midazolam|midazolam|mesh-list
154611146|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
154611147|NCT04644094|Hormones|hormones|mesh-ancestor
154611148|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611149|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611150|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611151|NCT04643405|Paclitaxel|paclitaxel|mesh-list
154611152|NCT04643405|Gemcitabine|gemcitabine|mesh-list
154611153|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611154|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611155|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611156|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611157|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611158|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611159|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611160|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
154611161|NCT04616014|Insulin|insulin|mesh-list
154611162|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154611163|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611164|NCT04602767|Phenylephrine|phenylephrine|mesh-list
154611165|NCT04602767|Vasopressins|vasopressins|mesh-list
154611166|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
154611167|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
154611168|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154611170|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
154611171|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611172|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611173|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
154611174|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154611175|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
154611176|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
154611177|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154611178|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154611179|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154611180|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
154611181|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611182|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611183|NCT04602767|Protective Agents|protective agents|mesh-ancestor
154611184|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
154611185|NCT04602767|Coagulants|coagulants|mesh-ancestor
154611186|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154611187|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
154611188|NCT04586023|Teriflunomide|teriflunomide|mesh-list
154611189|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154611190|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154611191|NCT04586023|Analgesics|analgesics|mesh-ancestor
154611192|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
154611193|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611194|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611195|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611196|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611197|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611198|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
154611199|NCT04576117|Vinblastine|vinblastine|mesh-list
154611200|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611201|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611203|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611204|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611205|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611206|NCT04563507|Letrozole|letrozole|mesh-list
154611207|NCT04563507|Palbociclib|palbociclib|mesh-list
154611208|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611209|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154611210|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154611211|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611212|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611213|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154611214|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
154611215|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611216|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611217|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611218|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154611219|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154611220|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154611221|NCT04501406|Pioglitazone|pioglitazone|mesh-list
154611222|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154611223|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611224|NCT04500158|Lidocaine|lidocaine|mesh-list
154611225|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
154611226|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
154611227|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154611228|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611229|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
154611230|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611231|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154611232|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154611233|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154611234|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154611235|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611236|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
154611237|NCT04484272|Narcotics|narcotics|mesh-ancestor
154611238|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154611239|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611240|NCT04484272|Analgesics|analgesics|mesh-ancestor
154611241|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
154611242|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611244|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154611245|NCT04402788|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611246|NCT04402788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611247|NCT04402788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611248|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611249|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
154611250|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611251|NCT04388163|Gentian Violet|gentian violet|mesh-list
154611252|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154611253|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611254|NCT04381143|Aspirin|aspirin|mesh-list
154611255|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154611256|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154611257|NCT04381143|Analgesics|analgesics|mesh-ancestor
154611258|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
154611259|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611260|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611261|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611262|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611263|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154611264|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154611265|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611266|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154611267|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154611268|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611269|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
154611270|NCT04370795|Sirolimus|sirolimus|mesh-list
154611271|NCT04370795|Busulfan|busulfan|mesh-list
154611272|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154611273|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611274|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154611275|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611276|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
154611277|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611278|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
154611279|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611280|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611281|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
154611282|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611283|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154611284|NCT04356352|Lidocaine|lidocaine|mesh-list
154611285|NCT04356352|Esmolol|esmolol|mesh-list
154611286|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
154611287|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
154611288|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098142|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611289|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611290|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
154611291|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611292|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154611293|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154611294|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154611295|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154611296|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611297|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154611298|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154611299|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154611300|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
154611301|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611302|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
154611303|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611304|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611305|NCT04340258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611306|NCT04340258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611307|NCT04339751|Vorinostat|vorinostat|mesh-list
154611308|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611309|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154611310|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611311|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611312|NCT04338269|Atezolizumab|atezolizumab|mesh-list
154611313|NCT04338269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611314|NCT04338269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611316|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611317|NCT04318548|Vaccines|vaccines|mesh-list
154611318|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
154611319|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611320|NCT04310540|Edetic Acid|edetic acid|mesh-list
154611321|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154611322|NCT04310540|Chelating Agents|chelating agents|mesh-ancestor
154611323|NCT04310540|Sequestering Agents|sequestering agents|mesh-ancestor
154611324|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611325|NCT04310540|Anticoagulants|anticoagulants|mesh-ancestor
154611326|NCT04310540|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154611327|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154611328|NCT04288427|Finasteride|finasteride|mesh-list
154611329|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154611330|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154611331|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098180|NCT04667663|Growth Substances|growth substances|mesh-ancestor
154611332|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611333|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
154611334|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611335|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611336|NCT04288427|Urological Agents|urological agents|mesh-ancestor
154611337|NCT04230252|Acetaminophen|acetaminophen|mesh-list
154611338|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154611339|NCT04230252|Analgesics|analgesics|mesh-ancestor
154611340|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
154611341|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611342|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611343|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
154611344|NCT04222972|Paclitaxel|paclitaxel|mesh-list
154611345|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154611346|NCT04222972|Carboplatin|carboplatin|mesh-list
154611347|NCT04222972|Gemcitabine|gemcitabine|mesh-list
154611348|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
154611349|NCT04222972|Pemetrexed|pemetrexed|mesh-list
154611350|NCT04222972|Pralsetinib|pralsetinib|mesh-list
154611351|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611352|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611353|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611354|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611355|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611356|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611357|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611358|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
154611359|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611360|NCT04222972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611361|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611362|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154611363|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154611364|NCT04216316|Carboplatin|carboplatin|mesh-list
154611365|NCT04216316|Gemcitabine|gemcitabine|mesh-list
154611366|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
154611367|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611368|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611369|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
154611370|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611371|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611372|NCT04216316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611373|NCT04209868|Bupivacaine|bupivacaine|mesh-list
154611374|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
154611375|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
154611376|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
154611377|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154611378|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611379|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
154611380|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611381|NCT04206319|Listerine|listerine|mesh-list
154611382|NCT04206319|Fluorides|fluorides|mesh-list
154611383|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
154611384|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
154611385|NCT04206319|Protective Agents|protective agents|mesh-ancestor
154611386|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611387|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154611388|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611389|NCT04166409|Carboplatin|carboplatin|mesh-list
154611390|NCT04166409|Vincristine|vincristine|mesh-list
154611392|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611393|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611394|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611395|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611396|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611397|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
154611398|NCT04123795|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154611399|NCT04123795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611400|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611401|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
154611402|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611403|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611404|NCT04090398|Paclitaxel|paclitaxel|mesh-list
154611405|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154611406|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154611407|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611408|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611409|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611410|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611411|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611412|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611413|NCT04083235|Leucovorin|leucovorin|mesh-list
154611414|NCT04083235|Paclitaxel|paclitaxel|mesh-list
154611415|NCT04083235|Gemcitabine|gemcitabine|mesh-list
154611416|NCT04083235|Fluorouracil|fluorouracil|mesh-list
154611417|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
154611418|NCT04083235|Irinotecan|irinotecan|mesh-list
154611419|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611420|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611421|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611422|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
154335181|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
154611423|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611424|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611425|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611426|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
154611427|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611428|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
154611429|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611430|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154611431|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154611432|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611433|NCT04083235|Antidotes|antidotes|mesh-ancestor
154611434|NCT04083235|Protective Agents|protective agents|mesh-ancestor
154611435|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
154611436|NCT04083235|Vitamins|vitamins|mesh-ancestor
154611437|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
154611438|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154611439|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611440|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154611441|NCT04029688|Cytarabine|cytarabine|mesh-list
154611442|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
154611443|NCT04029688|Fludarabine|fludarabine|mesh-list
154611444|NCT04029688|Venetoclax|venetoclax|mesh-list
154611445|NCT04029688|Topotecan|topotecan|mesh-list
154611446|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611447|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
154611448|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611449|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611450|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611451|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
154611452|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611453|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611454|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154611455|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611456|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
154611457|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
154611458|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611459|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154611460|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154611461|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611462|NCT04026113|Linaclotide|linaclotide|mesh-list
154611463|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154611464|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
154611465|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611467|NCT03994601|Nivolumab|nivolumab|mesh-list
154611468|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611469|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611470|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611471|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611472|NCT03940196|Paclitaxel|paclitaxel|mesh-list
154611473|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154611474|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611475|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611476|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611477|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611478|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611479|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611480|NCT03922555|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154611481|NCT03922555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611482|NCT03922555|Antimetabolites|antimetabolites|mesh-ancestor
154611483|NCT03922555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611484|NCT03922555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611485|NCT03919071|Trametinib|trametinib|mesh-list
154611486|NCT03919071|Dabrafenib|dabrafenib|mesh-list
154611487|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154611488|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611489|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611490|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611491|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098319|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
154611492|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154611493|NCT03919071|Protective Agents|protective agents|mesh-ancestor
154611494|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611495|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154611496|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
154611497|NCT03914092|Triamcinolone|triamcinolone|mesh-list
154611498|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154611499|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154611500|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154611501|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611502|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
154611503|NCT03914092|Hormones|hormones|mesh-ancestor
154611504|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611505|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611506|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611507|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
154611508|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611509|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611510|NCT03871257|Carboplatin|carboplatin|mesh-list
154611511|NCT03871257|Vincristine|vincristine|mesh-list
154611512|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611513|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611514|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611515|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611516|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611517|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611518|NCT03856515|Nicotine|nicotine|mesh-list
154611519|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154611520|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
154611521|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611522|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611523|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154611524|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154611525|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
154611526|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611527|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611528|NCT03816345|Nivolumab|nivolumab|mesh-list
154611529|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611530|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611531|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611532|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611533|NCT03815890|Nivolumab|nivolumab|mesh-list
154611534|NCT03815890|Ipilimumab|ipilimumab|mesh-list
154611535|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611536|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611537|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508452|NCT05274139|Cytarabine|cytarabine|mesh-list
154611538|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611539|NCT03793166|Nivolumab|nivolumab|mesh-list
154611540|NCT03793166|Ipilimumab|ipilimumab|mesh-list
154611541|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611542|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611543|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611544|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611545|NCT03778931|Fulvestrant|fulvestrant|mesh-list
154611546|NCT03778931|Anastrozole|anastrozole|mesh-list
154611547|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611548|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611549|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154611550|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154611551|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
154611552|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611553|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611554|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154611555|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154611556|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611557|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611558|NCT03733132|Metformin|metformin|mesh-list
154611559|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154611560|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611561|NCT03727061|Nivolumab|nivolumab|mesh-list
154611562|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154611563|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
154611564|NCT03727061|Trioxsalen|trioxsalen|mesh-list
154611565|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611566|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611567|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611568|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611569|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
154611570|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154611571|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
154335324|NCT04443309|Lenvatinib|lenvatinib|mesh-list
154611572|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154611573|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611574|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154611575|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611576|NCT03718767|Nivolumab|nivolumab|mesh-list
154611577|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611578|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611579|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611580|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611581|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
154611582|NCT03630991|Edetic Acid|edetic acid|mesh-list
154611583|NCT03630991|Calcium|calcium|mesh-list
154611584|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
154611585|NCT03630991|Succimer|succimer|mesh-list
154611586|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611587|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154611588|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154611589|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
154611590|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154611591|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
154611592|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
154611593|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611594|NCT03630991|Antidotes|antidotes|mesh-ancestor
154611595|NCT03630991|Protective Agents|protective agents|mesh-ancestor
154611596|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154611597|NCT03595124|Nivolumab|nivolumab|mesh-list
154611598|NCT03595124|Axitinib|axitinib|mesh-list
154611599|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611600|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611601|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611602|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611603|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611604|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611605|NCT03575325|Cytarabine|cytarabine|mesh-list
154611606|NCT03575325|Daunorubicin|daunorubicin|mesh-list
154611607|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611608|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
154255817|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611609|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611610|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611611|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
154098495|NCT04017650|Nivolumab|nivolumab|mesh-list
154611612|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611613|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611614|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
154611615|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611616|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154611617|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154611618|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154611619|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611620|NCT03506061|Ivacaftor|ivacaftor|mesh-list
154611621|NCT03506061|Elexacaftor|elexacaftor|mesh-list
154611622|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154611623|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154611624|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611625|NCT03465774|Doxycycline|doxycycline|mesh-list
154611626|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154611627|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611628|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
154611629|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154611630|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154611631|NCT03450057|Dexamethasone|dexamethasone|mesh-list
154611632|NCT03450057|Daratumumab|daratumumab|mesh-list
154611633|NCT03450057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611634|NCT03450057|Antiemetics|antiemetics|mesh-ancestor
154611635|NCT03450057|Autonomic Agents|autonomic agents|mesh-ancestor
154611636|NCT03450057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611637|NCT03450057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611638|NCT03450057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154611639|NCT03450057|Glucocorticoids|glucocorticoids|mesh-ancestor
154611640|NCT03450057|Hormones|hormones|mesh-ancestor
154611641|NCT03450057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611642|NCT03450057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611643|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611644|NCT03440567|Rituximab|rituximab|mesh-list
154611645|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154611646|NCT03440567|Avelumab|avelumab|mesh-list
154335400|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
154611648|NCT03440567|Etoposide|etoposide|mesh-list
154611649|NCT03440567|Ifosfamide|ifosfamide|mesh-list
154611650|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
154611651|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
154611652|NCT03440567|Antibodies|antibodies|mesh-list
154611653|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
154611654|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154611655|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
154611656|NCT03440567|Ibrutinib|ibrutinib|mesh-list
154611657|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
154611658|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611659|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611660|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611661|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611662|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154611663|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154611664|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611665|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611666|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611667|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
154611668|NCT03440567|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154611669|NCT03440567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611670|NCT03297606|Nivolumab|nivolumab|mesh-list
154611671|NCT03297606|Trastuzumab|trastuzumab|mesh-list
154611672|NCT03297606|Ipilimumab|ipilimumab|mesh-list
154611673|NCT03297606|Pertuzumab|pertuzumab|mesh-list
154611674|NCT03297606|Sunitinib|sunitinib|mesh-list
154611675|NCT03297606|Dasatinib|dasatinib|mesh-list
154611676|NCT03297606|Olaparib|olaparib|mesh-list
154611677|NCT03297606|Palbociclib|palbociclib|mesh-list
154611678|NCT03297606|Temsirolimus|temsirolimus|mesh-list
154611679|NCT03297606|Axitinib|axitinib|mesh-list
154611680|NCT03297606|Vemurafenib|vemurafenib|mesh-list
154611681|NCT03297606|Crizotinib|crizotinib|mesh-list
154611682|NCT03297606|Tucatinib|tucatinib|mesh-list
154611683|NCT03297606|Bosutinib|bosutinib|mesh-list
154611684|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611685|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611686|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611687|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611688|NCT03297606|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154611689|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611690|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611691|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154611692|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154611693|NCT03297606|Growth Substances|growth substances|mesh-ancestor
154611694|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611695|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
154611696|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154611698|NCT03297606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611699|NCT03297606|Immunologic Factors|immunologic factors|mesh-ancestor
154611700|NCT03223610|Prednisone|prednisone|mesh-list
154611701|NCT03223610|Lenalidomide|lenalidomide|mesh-list
154611702|NCT03223610|Venetoclax|venetoclax|mesh-list
154611703|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
154611704|NCT03223610|Ibrutinib|ibrutinib|mesh-list
154611705|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611706|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
154611707|NCT03223610|Hormones|hormones|mesh-ancestor
154611708|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611709|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611710|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611711|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611712|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
154611713|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154611714|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154611715|NCT03223610|Growth Substances|growth substances|mesh-ancestor
154611716|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
154611717|NCT03223610|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154611718|NCT03223610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611719|NCT03223610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611720|NCT03223610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611721|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611722|NCT03220022|Prednisone|prednisone|mesh-list
154611723|NCT03220022|Cortisone|cortisone|mesh-list
154611724|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
154611725|NCT03220022|Rituximab|rituximab|mesh-list
154611726|NCT03220022|Doxorubicin|doxorubicin|mesh-list
154611727|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154611728|NCT03220022|Etoposide|etoposide|mesh-list
154611729|NCT03220022|Vincristine|vincristine|mesh-list
154611730|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
154611731|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
154611732|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154611733|NCT03220022|Antibodies|antibodies|mesh-list
154611734|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
154611735|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154611736|NCT03220022|Lenograstim|lenograstim|mesh-list
154611737|NCT03220022|Ibrutinib|ibrutinib|mesh-list
154611738|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611739|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
154611740|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611741|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611742|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611743|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
154098620|NCT03679650|Decitabine|decitabine|mesh-list
154611744|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611745|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611746|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154611747|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154611748|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154611749|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154611750|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611751|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611752|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
154611753|NCT03220022|Hormones|hormones|mesh-ancestor
154611754|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611755|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611756|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611757|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154611758|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611759|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611760|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611761|NCT03220022|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154611762|NCT03220022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611763|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
154611764|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
154611765|NCT03213652|Ensartinib|ensartinib|mesh-list
154611767|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611768|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611769|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611770|NCT03136146|Dexamethasone|dexamethasone|mesh-list
154611771|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
154611772|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
154611773|NCT03136146|Rituximab|rituximab|mesh-list
154611774|NCT03136146|Etoposide|etoposide|mesh-list
154611775|NCT03136146|Vincristine|vincristine|mesh-list
154611776|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
154611777|NCT03136146|Bortezomib|bortezomib|mesh-list
154611778|NCT03136146|Clofarabine|clofarabine|mesh-list
154611779|NCT03136146|Ofatumumab|ofatumumab|mesh-list
154611780|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
154611781|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154611782|NCT03136146|Antibodies|antibodies|mesh-list
154611783|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
154611784|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154611785|NCT03136146|Lenograstim|lenograstim|mesh-list
154098702|NCT03404908|Dipyrone|dipyrone|mesh-list
154611786|NCT03136146|BB 1101|bb 1101|mesh-list
154611787|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611788|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
154611789|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611790|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611791|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611792|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
154611793|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611794|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611795|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154611796|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611797|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
154611798|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
154611799|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611800|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154611801|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
154611802|NCT03136146|Hormones|hormones|mesh-ancestor
154611803|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611804|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611805|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
154611806|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611807|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611808|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154611809|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154611810|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154611811|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
154611812|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
154611813|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
154611814|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611815|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
154611816|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
154611817|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
154611818|NCT03109288|Pioglitazone|pioglitazone|mesh-list
154611819|NCT03109288|Clemastine|clemastine|mesh-list
154611820|NCT03109288|Pirfenidone|pirfenidone|mesh-list
154611821|NCT03109288|Dantrolene|dantrolene|mesh-list
154611822|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154611823|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611824|NCT03109288|Analgesics|analgesics|mesh-ancestor
154611825|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
154611826|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611827|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154611828|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154611829|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611830|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611831|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611832|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
154611833|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154611834|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154611835|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
154611836|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
154611837|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611838|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611839|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154611840|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154611841|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154611842|NCT03070184|Metoprolol|metoprolol|mesh-list
154611843|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154611844|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154611845|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
154611846|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
154611847|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611848|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611849|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154611850|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154611851|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154611852|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
154611853|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611854|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611855|NCT03017820|Iodine|iodine|mesh-list
154611856|NCT03017820|Interferons|interferons|mesh-list
154611857|NCT03017820|Interferon-beta|interferon-beta|mesh-list
154611858|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
154611859|NCT03017820|Nivolumab|nivolumab|mesh-list
154611860|NCT03017820|Ipilimumab|ipilimumab|mesh-list
154611861|NCT03017820|Cemiplimab|cemiplimab|mesh-list
154611862|NCT03017820|Immunoglobulins|immunoglobulins|mesh-list
154611863|NCT03017820|Immunoglobulin G|immunoglobulin g|mesh-list
154611864|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611865|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
154098738|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
154611866|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611867|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611868|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611869|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
154611870|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611871|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611872|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154611873|NCT03017820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611874|NCT03017820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611875|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
154611876|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611877|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154611878|NCT03017820|Trace Elements|trace elements|mesh-ancestor
154611879|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
154611880|NCT02979873|Sirolimus|sirolimus|mesh-list
154611881|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154611882|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611883|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154611884|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611885|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
154611886|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611887|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
154611888|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611890|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154611891|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
154611892|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611893|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611894|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154611895|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154611896|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
154611897|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611898|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611899|NCT02905318|Palbociclib|palbociclib|mesh-list
154611900|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611901|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611902|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611903|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611904|NCT02891811|Thalidomide|thalidomide|mesh-list
154611905|NCT02891811|Dexamethasone|dexamethasone|mesh-list
154611906|NCT02891811|Lenalidomide|lenalidomide|mesh-list
154611907|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154611908|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
154611909|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
154611910|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154611911|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611912|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154611913|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
154611914|NCT02891811|Hormones|hormones|mesh-ancestor
154611915|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611916|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154611917|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611918|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
154611919|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154611920|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154611921|NCT02891811|Growth Substances|growth substances|mesh-ancestor
154611922|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
154611923|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611924|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
154611925|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154611926|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611927|NCT02830724|Aldesleukin|aldesleukin|mesh-list
154611928|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
154611929|NCT02830724|Fludarabine|fludarabine|mesh-list
154611930|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154611931|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
154611932|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611933|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154611934|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154611935|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
154611936|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611937|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611938|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154611939|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154611940|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154611941|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
154611942|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154611943|NCT02812420|Durvalumab|durvalumab|mesh-list
154611944|NCT02812420|Ipilimumab|ipilimumab|mesh-list
154611945|NCT02812420|Tremelimumab|tremelimumab|mesh-list
154611946|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
154611947|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154611948|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
154611949|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611950|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611951|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
154611952|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611953|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154611954|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611955|NCT02810743|Olaparib|olaparib|mesh-list
154611956|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154335700|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
154611957|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611958|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611959|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611960|NCT02799212|Somatostatin|somatostatin|mesh-list
154611961|NCT02799212|Hormones|hormones|mesh-ancestor
154611962|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154611963|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611964|NCT02650401|Entrectinib|entrectinib|mesh-list
154611965|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154611966|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154611967|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611968|NCT02632448|Gemcitabine|gemcitabine|mesh-list
154611969|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611970|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
154611971|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611972|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611973|NCT02519452|Daratumumab|daratumumab|mesh-list
154611974|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611975|NCT02516241|Carboplatin|carboplatin|mesh-list
154611976|NCT02516241|Gemcitabine|gemcitabine|mesh-list
154611977|NCT02516241|Durvalumab|durvalumab|mesh-list
154611978|NCT02516241|Tremelimumab|tremelimumab|mesh-list
154611979|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611980|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154611981|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
154611982|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611983|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154611984|NCT02456532|Zolpidem|zolpidem|mesh-list
154611985|NCT02456532|Eszopiclone|eszopiclone|mesh-list
154611986|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154611987|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154611988|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154611989|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154611990|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154611991|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
154611992|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
154611993|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154611994|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154611996|NCT02379416|Nilotinib|nilotinib|mesh-list
154611997|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154611998|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154611999|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612000|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612001|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612002|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612003|NCT02379416|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154612004|NCT02379416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154612005|NCT02379416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612006|NCT02356159|Rituximab|rituximab|mesh-list
154612007|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612008|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612009|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
154612010|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612011|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612012|NCT02211755|Bortezomib|bortezomib|mesh-list
154612013|NCT02211755|Clofarabine|clofarabine|mesh-list
154612014|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612015|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154612016|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
154612017|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612018|NCT02176148|Fluocinonide|fluocinonide|mesh-list
154612019|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154612020|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
154612021|NCT02176148|Hormones|hormones|mesh-ancestor
154612022|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612023|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612024|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154612025|NCT02133196|Aldesleukin|aldesleukin|mesh-list
154612026|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
154612027|NCT02133196|Fludarabine|fludarabine|mesh-list
154612028|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612029|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
154098896|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154612030|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612031|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612032|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154612033|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
154612034|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612035|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612036|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154612037|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154612038|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154612039|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
154612040|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612041|NCT02015117|Trametinib|trametinib|mesh-list
154612042|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612043|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154612044|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612045|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612046|NCT02003209|Carboplatin|carboplatin|mesh-list
154612047|NCT02003209|Docetaxel|docetaxel|mesh-list
154612048|NCT02003209|Trastuzumab|trastuzumab|mesh-list
154612049|NCT02003209|Pertuzumab|pertuzumab|mesh-list
154612050|NCT02003209|Goserelin|goserelin|mesh-list
154612051|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154612052|NCT02003209|Antibodies|antibodies|mesh-list
154612053|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
154612054|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612055|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154612056|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
154612057|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612058|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612059|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612060|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612061|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612062|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612063|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612064|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154612065|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154612066|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612067|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154612068|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
154612069|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612070|NCT01996267|Paclitaxel|paclitaxel|mesh-list
154612071|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
154612072|NCT01996267|Carboplatin|carboplatin|mesh-list
154612073|NCT01996267|Fluorouracil|fluorouracil|mesh-list
154612074|NCT01996267|Trastuzumab|trastuzumab|mesh-list
154612075|NCT01996267|Pertuzumab|pertuzumab|mesh-list
154098940|NCT02903680|Hormones|hormones|mesh-ancestor
154612076|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154612077|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612078|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612079|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612080|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612081|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612082|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612083|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
154612084|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612085|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612086|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154612087|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
154612088|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154612089|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
154612090|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154612091|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612092|NCT01968109|Nivolumab|nivolumab|mesh-list
154612093|NCT01968109|Relatlimab|relatlimab|mesh-list
154612094|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612095|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612096|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612097|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612098|NCT01898117|Paclitaxel|paclitaxel|mesh-list
154612099|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154612100|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
154612101|NCT01898117|Carboplatin|carboplatin|mesh-list
154612102|NCT01898117|Atezolizumab|atezolizumab|mesh-list
154612103|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612104|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154612105|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612106|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612107|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612108|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612109|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612110|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612111|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
154612112|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612113|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154612114|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154612115|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
154612116|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154612117|NCT01898117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612118|NCT01898117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154612119|NCT01810913|Cisplatin|cisplatin|mesh-list
154612120|NCT01810913|Docetaxel|docetaxel|mesh-list
154612121|NCT01810913|Cetuximab|cetuximab|mesh-list
154612122|NCT01810913|Atezolizumab|atezolizumab|mesh-list
154612123|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154612124|NCT01810913|Antibodies|antibodies|mesh-list
154612125|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
154612126|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154612127|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
154612128|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612129|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612130|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612131|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612132|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612133|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612134|NCT01810913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154612135|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154612136|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154612137|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612138|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612139|NCT01553214|Dexamethasone|dexamethasone|mesh-list
154612140|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154612141|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
154612142|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
154612143|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154612144|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612145|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154612146|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
154612147|NCT01553214|Hormones|hormones|mesh-ancestor
154612148|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612149|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154612150|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612151|NCT00862433|Vitamins|vitamins|mesh-list
154612152|NCT00862433|Vitamin E|vitamin e|mesh-list
154612153|NCT00862433|Tocopherols|tocopherols|mesh-list
154612154|NCT00862433|Tocotrienols|tocotrienols|mesh-list
154612155|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
154612156|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
154612157|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612158|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
154612159|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612160|NCT00862433|Protective Agents|protective agents|mesh-ancestor
154612161|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
154612162|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154612163|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
154612164|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154612165|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612166|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154612167|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154612168|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154612169|NCT00707473|Cisplatin|cisplatin|mesh-list
154612170|NCT00707473|Carboplatin|carboplatin|mesh-list
154612171|NCT00707473|Docetaxel|docetaxel|mesh-list
154612172|NCT00707473|Fluorouracil|fluorouracil|mesh-list
154612173|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612174|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
154612175|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
154612176|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
154612177|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612178|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
154612179|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154612180|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154612181|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
154612182|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612183|NCT00359684|Cysteamine|cysteamine|mesh-list
154335922|NCT03706898|Dolutegravir|dolutegravir|mesh-list
154612184|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154612185|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612186|NCT00353158|Doxycycline|doxycycline|mesh-list
154612187|NCT00353158|Voriconazole|voriconazole|mesh-list
154612188|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154612189|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612190|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
154612191|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154612192|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154612193|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
154612194|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154612195|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154612196|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612197|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612198|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154612199|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
154612200|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612201|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612202|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154612203|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154612204|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154612205|NCT00080756|Estradiol|estradiol|mesh-list
154612206|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154612207|NCT00080756|Testosterone|testosterone|mesh-list
154612208|NCT00080756|Deslorelin|deslorelin|mesh-list
154612209|NCT00080756|Estrogens|estrogens|mesh-ancestor
154612210|NCT00080756|Hormones|hormones|mesh-ancestor
154612211|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612212|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612213|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154612214|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
154612215|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154612216|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154612217|NCT00080756|Androgens|androgens|mesh-ancestor
154612218|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612219|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612220|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
154612221|NCT00044304|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154612222|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154612223|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612224|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612225|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612226|NCT00018044|Clofazimine|clofazimine|mesh-list
154612227|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154612228|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
154612229|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154612230|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154612231|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154612232|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154612233|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612234|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
154612235|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
154612236|NCT00001521|Letrozole|letrozole|mesh-list
154612237|NCT00001521|Flutamide|flutamide|mesh-list
154612238|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154612239|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154099114|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154612240|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154612241|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154612242|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154612243|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154612244|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
154612245|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154612246|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154612247|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154612248|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
154612249|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154336231|NCT02298166|Analgesics|analgesics|mesh-ancestor
154337502|NCT01473628|Rituximab|rituximab|mesh-list
154253799|NCT01140620|Analgesics|analgesics|mesh-ancestor
154338245|NCT01349738|Ofloxacin|ofloxacin|mesh-list
154338319|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
154339178|NCT01233895|Bortezomib|bortezomib|mesh-list
154339452|NCT02310490|Mannitol|mannitol|mesh-list
154340044|NCT03452072|Emollients|emollients|mesh-ancestor
154340348|NCT01238965|Antidotes|antidotes|mesh-ancestor
154340801|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
154340952|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
154341472|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
154341622|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154341847|NCT01375556|Ethanol|ethanol|mesh-list
154342217|NCT03480568|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154342447|NCT01253473|Hormones|hormones|mesh-ancestor
154342588|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
154342807|NCT03905317|Bevacizumab|bevacizumab|mesh-list
154253800|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
154344307|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
154344532|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
154344909|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
154344984|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253801|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345361|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
154345967|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
154346203|NCT01105871|Naloxone|naloxone|mesh-list
154346419|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
154346943|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347420|NCT03707652|Niacin|niacin|mesh-list
154347853|NCT03084718|Beclomethasone|beclomethasone|mesh-list
154347998|NCT03431337|Amoxicillin|amoxicillin|mesh-list
154348065|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
154349556|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349784|NCT02330757|Clomiphene|clomiphene|mesh-list
154349934|NCT01196065|Memantine|memantine|mesh-list
154350530|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350684|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
154351276|NCT01220375|Plerixafor|plerixafor|mesh-list
154351530|NCT03468790|Xhance|xhance|mesh-list
154351574|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154351729|NCT03824119|Ibuprofen|ibuprofen|mesh-list
154352776|NCT05387200|Alendronate|alendronate|mesh-list
154353608|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353686|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
154354292|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
154354971|NCT03631862|Apatinib|apatinib|mesh-list
154355118|NCT01313611|Rituximab|rituximab|mesh-list
154355434|NCT01136759|Tenofovir|tenofovir|mesh-list
154355722|NCT03440788|Immunotoxins|immunotoxins|mesh-ancestor
154355871|NCT03433222|Coal Tar|coal tar|mesh-list
154253802|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356473|NCT01239485|Irinotecan|irinotecan|mesh-list
154356618|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356841|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
154357150|NCT03415750|Everolimus|everolimus|mesh-list
154357297|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
154357595|NCT03413722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357785|NCT04447612|Durvalumab|durvalumab|mesh-list
154357819|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358045|NCT01974609|Ibuprofen|ibuprofen|mesh-list
154358565|NCT01328002|Milnacipran|milnacipran|mesh-list
154358634|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154358710|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
154358786|NCT03389776|Anesthetics|anesthetics|mesh-list
154359087|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
154359309|NCT01382498|Calcium|calcium|mesh-list
154359467|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
154359839|NCT03069482|Nicotine|nicotine|mesh-list
154359987|NCT04892420|Hormones|hormones|mesh-ancestor
154360062|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
154360880|NCT01152047|Oxytocin|oxytocin|mesh-list
154361106|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
154361400|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
154361475|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
154361850|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154361927|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154362111|NCT03380728|Ibogaine|ibogaine|mesh-list
154253803|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154362678|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154362827|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
154363736|NCT03744091|Hormones|hormones|mesh-ancestor
154364636|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
154364712|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154364861|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
154365159|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154365385|NCT03178851|Atezolizumab|atezolizumab|mesh-list
154365530|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
154365687|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154365786|NCT05666089|Calcium|calcium|mesh-list
154366211|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366288|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366598|NCT01295099|Hormones|hormones|mesh-ancestor
154366807|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154366892|NCT03121846|Apatinib|apatinib|mesh-list
154366955|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
154367030|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
154367098|NCT04501900|Clopidogrel|clopidogrel|mesh-list
154367698|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
154368000|NCT05217836|Hepcidins|hepcidins|mesh-list
154368142|NCT02504164|Midazolam|midazolam|mesh-list
154368673|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
154368818|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154369044|NCT02499874|Tenofovir|tenofovir|mesh-list
154369195|NCT05863858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154369283|NCT05860998|Antibodies|antibodies|mesh-list
154369424|NCT04967495|Estrogens|estrogens|mesh-ancestor
154369569|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369738|NCT01808599|Rituximab|rituximab|mesh-list
154370106|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154370178|NCT03796403|Analgesics|analgesics|mesh-ancestor
154370251|NCT01303055|Hormones|hormones|mesh-ancestor
154370698|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154370930|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
154371009|NCT03799913|Fludarabine|fludarabine|mesh-list
154371231|NCT01305707|Analgesics|analgesics|mesh-ancestor
154371676|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
154371931|NCT02486458|Listerine|listerine|mesh-list
154372276|NCT01313429|Analgesics|analgesics|mesh-ancestor
154372575|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373102|NCT01309685|Varenicline|varenicline|mesh-list
154373694|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
154373995|NCT06209229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374076|NCT06208683|Vaccines|vaccines|mesh-list
154374221|NCT06207123|Autonomic Agents|autonomic agents|mesh-ancestor
154374297|NCT06205823|Immunologic Factors|immunologic factors|mesh-ancestor
154374447|NCT06175832|Desogestrel|desogestrel|mesh-list
154374596|NCT06080178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154253804|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154253805|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
154253806|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
154376250|NCT04100018|Hormones|hormones|mesh-ancestor
154376624|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376700|NCT03083691|Nivolumab|nivolumab|mesh-list
154376773|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154376922|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
154377076|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154377321|NCT03078192|Xenon|xenon|mesh-list
154377390|NCT06065137|Midazolam|midazolam|mesh-list
154377532|NCT06041932|Carvedilol|carvedilol|mesh-list
154377830|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
154378287|NCT03426761|Nafcillin|nafcillin|mesh-list
154378367|NCT02647827|Metformin|metformin|mesh-list
154378819|NCT04296942|Immunologic Factors|immunologic factors|mesh-ancestor
154379800|NCT04897503|Riboflavin|riboflavin|mesh-list
154379877|NCT01845441|Analgesics|analgesics|mesh-ancestor
154379952|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
154380177|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
154380255|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154380473|NCT05959720|Cytarabine|cytarabine|mesh-list
154380931|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
154381004|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
154381081|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
154253807|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381604|NCT01335321|Protective Agents|protective agents|mesh-ancestor
154381678|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382127|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
154382275|NCT01367418|Narcotics|narcotics|mesh-ancestor
154382728|NCT01364376|Protective Agents|protective agents|mesh-ancestor
154383180|NCT02454712|Naltrexone|naltrexone|mesh-list
154383775|NCT03236584|Lamivudine|lamivudine|mesh-list
154383850|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154384028|NCT02452450|Ibuprofen|ibuprofen|mesh-list
154384682|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
154385279|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
154385359|NCT05480150|Dexetimide|dexetimide|mesh-list
154385810|NCT02442466|BQ 788|bq 788|mesh-list
154386030|NCT03186040|Lacosamide|lacosamide|mesh-list
154386177|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
154386716|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
154386932|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387538|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
154387996|NCT05189067|Paclitaxel|paclitaxel|mesh-list
154388142|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
154253808|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154388365|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
154388507|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154388654|NCT03672812|Liraglutide|liraglutide|mesh-list
154388806|NCT04039919|Padsevonil|padsevonil|mesh-list
154388972|NCT03116542|Alovudine|alovudine|mesh-list
154389333|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154389409|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154389934|NCT06336395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154390011|NCT06336161|Fentanyl|fentanyl|mesh-list
154390237|NCT06334198|Analgesics|analgesics|mesh-ancestor
154253809|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154390837|NCT05882877|KHK4083|khk4083|mesh-list
154391077|NCT05638295|Sotorasib|sotorasib|mesh-list
154391288|NCT05456685|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154391371|NCT05382286|Paclitaxel|paclitaxel|mesh-list
154253810|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391522|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
154391592|NCT05206773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391666|NCT05063565|Durvalumab|durvalumab|mesh-list
154391891|NCT04767022|Paclitaxel|paclitaxel|mesh-list
154391964|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392192|NCT04240002|Cytarabine|cytarabine|mesh-list
154392563|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392790|NCT02252172|Dexamethasone|dexamethasone|mesh-list
154253811|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253812|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154253813|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
154253814|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154253815|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154253816|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154253817|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154253818|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
154253819|NCT01140932|Prednisolone|prednisolone|mesh-list
154253820|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154253821|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
154253822|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154253823|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
154253824|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154253825|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
154253826|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253827|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
154253828|NCT01140932|Hormones|hormones|mesh-ancestor
154253829|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253830|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253831|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154253832|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253833|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
154253834|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
154253835|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253836|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253837|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154253838|NCT01140932|Protective Agents|protective agents|mesh-ancestor
154253839|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
154253840|NCT01138904|Irinotecan|irinotecan|mesh-list
154253841|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253842|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154253843|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154253844|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253845|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253846|NCT04582448|Insulin|insulin|mesh-list
154253847|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253848|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253849|NCT01139138|Irinotecan|irinotecan|mesh-list
154253850|NCT01139138|Everolimus|everolimus|mesh-list
154253851|NCT01139138|Panitumumab|panitumumab|mesh-list
154253852|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154253853|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154253854|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253855|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253856|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253857|NCT01139138|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154253858|NCT01139138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253859|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154253860|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
154253861|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253862|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154253863|NCT01134224|Insulin|insulin|mesh-list
154253864|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154253865|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
154099332|NCT00482807|Docetaxel|docetaxel|mesh-list
154225036|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225037|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154225038|NCT04738318|Protective Agents|protective agents|mesh-ancestor
154225039|NCT04721353|Prazosin|prazosin|mesh-list
154225040|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154225041|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154225042|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154225043|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154225044|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
154225045|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225046|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225047|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225048|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
154225049|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225050|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
154225051|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225052|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225053|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154225054|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
154225055|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225056|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225057|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154225058|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
154225059|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225060|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
154225061|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225062|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225063|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154225064|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
154225065|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225066|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225067|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154225068|NCT04684420|Metformin|metformin|mesh-list
154225069|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154225070|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225071|NCT04557449|Letrozole|letrozole|mesh-list
154225072|NCT04557449|Fulvestrant|fulvestrant|mesh-list
154225073|NCT04557449|Midazolam|midazolam|mesh-list
154225074|NCT04557449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154225075|NCT04557449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154225076|NCT04557449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225077|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225078|NCT04557449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154225079|NCT04557449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225081|NCT04557449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154225082|NCT04557449|Anesthetics, General|anesthetics, general|mesh-ancestor
154225083|NCT04557449|Anesthetics|anesthetics|mesh-ancestor
154225084|NCT04557449|GABA Modulators|gaba modulators|mesh-ancestor
154225085|NCT04557449|GABA Agents|gaba agents|mesh-ancestor
154225086|NCT04557449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225087|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225088|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225089|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154225090|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154225091|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225092|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154225093|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
154225094|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225095|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154225096|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154225097|NCT04538352|Insulin|insulin|mesh-list
154225098|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154225099|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
154225100|NCT04538352|Semaglutide|semaglutide|mesh-list
154225101|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154225102|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225103|NCT04538352|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154225104|NCT04352101|Bupropion|bupropion|mesh-list
154225105|NCT04352101|Escitalopram|escitalopram|mesh-list
154225106|NCT04352101|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154225107|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154225108|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154225109|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225110|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225111|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
154225112|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225113|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154225114|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
154225115|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225116|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154225117|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
154225118|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154225119|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154225120|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225121|NCT04317872|Dexamethasone|dexamethasone|mesh-list
154225122|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
154225123|NCT04317872|BB 1101|bb 1101|mesh-list
154225124|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225125|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
154225126|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
154225127|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225128|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225129|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225130|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
154225131|NCT04317872|Hormones|hormones|mesh-ancestor
154225132|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225133|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154225134|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225135|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
154225136|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225137|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225138|NCT04244552|Doxorubicin|doxorubicin|mesh-list
154225139|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154225140|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
154225141|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154225142|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225143|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154225144|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154225145|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225146|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225147|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225148|NCT04244552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154225149|NCT04221555|Docetaxel|docetaxel|mesh-list
154225150|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
154225151|NCT04221555|Durvalumab|durvalumab|mesh-list
154225152|NCT04221555|Tremelimumab|tremelimumab|mesh-list
154225153|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154225154|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225155|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
154225156|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
154225157|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
154225158|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225159|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225160|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
154225161|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225162|NCT04170556|Nivolumab|nivolumab|mesh-list
154225163|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225164|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225165|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154225166|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225167|NCT04135898|Bevacizumab|bevacizumab|mesh-list
154225168|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225169|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225170|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154225171|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154225172|NCT04135898|Growth Substances|growth substances|mesh-ancestor
154225173|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225174|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
154225175|NCT03879694|Octreotide|octreotide|mesh-list
154225176|NCT03879694|Sargramostim|sargramostim|mesh-list
154225177|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154225178|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
154225179|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
154225180|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225181|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225182|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225183|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153972100|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
154225184|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154225185|NCT03833479|Dostarlimab|dostarlimab|mesh-list
154225186|NCT03833479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225187|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
154225188|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154225189|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225190|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154225191|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225192|NCT03749460|Nivolumab|nivolumab|mesh-list
154225193|NCT03749460|Ipilimumab|ipilimumab|mesh-list
154225194|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225195|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225196|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154225197|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225198|NCT03430843|Paclitaxel|paclitaxel|mesh-list
154225199|NCT03430843|Docetaxel|docetaxel|mesh-list
154225200|NCT03430843|Irinotecan|irinotecan|mesh-list
154225201|NCT03430843|Tislelizumab|tislelizumab|mesh-list
154225202|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154225203|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225204|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
154225205|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
154225206|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
154225207|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225208|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154225209|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154225210|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225211|NCT03430843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225212|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
154225213|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
154225214|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225215|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225216|NCT03382600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154225217|NCT03382600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225218|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
154225219|NCT03211416|Sorafenib|sorafenib|mesh-list
154225220|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225221|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225222|NCT03211416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154225223|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225224|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154255825|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
154225225|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225226|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
154225228|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154225229|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
154225230|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225231|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225232|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225233|NCT02787369|Idelalisib|idelalisib|mesh-list
154225234|NCT02787369|Ricolinostat|ricolinostat|mesh-list
154225235|NCT02787369|Ibrutinib|ibrutinib|mesh-list
154225236|NCT02787369|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154225237|NCT02787369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154225238|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225239|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225240|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225241|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154225242|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
154225243|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154225244|NCT02759861|Ledipasvir|ledipasvir|mesh-list
154225245|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
154225246|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225247|NCT02550028|Levetiracetam|levetiracetam|mesh-list
154225248|NCT02550028|Phenobarbital|phenobarbital|mesh-list
154225249|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
154225250|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
154225251|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154225252|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225253|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225254|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154225255|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154225256|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225257|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225258|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
154225259|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
154225260|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154225261|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154225262|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154225263|NCT02520063|Everolimus|everolimus|mesh-list
154225264|NCT02520063|Letrozole|letrozole|mesh-list
154225265|NCT02520063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154225266|NCT02520063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154225267|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225268|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225269|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225270|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
154225271|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225272|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225273|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154225274|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154225275|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154225276|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
154225277|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225278|NCT02472314|Bupivacaine|bupivacaine|mesh-list
154225279|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
154225280|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
154225281|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225282|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225283|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
154225284|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225285|NCT02158507|Lapatinib|lapatinib|mesh-list
154225286|NCT02158507|Veliparib|veliparib|mesh-list
154225287|NCT02158507|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154225288|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154225289|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225290|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225291|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225292|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154225293|NCT01561391|Factor VIII|factor viii|mesh-list
154225294|NCT01561391|Coagulants|coagulants|mesh-ancestor
154225295|NCT01524705|Insulin|insulin|mesh-list
154225296|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154225297|NCT01524705|Metformin|metformin|mesh-list
154225298|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
154225299|NCT01524705|Exenatide|exenatide|mesh-list
154225300|NCT01524705|Glucagon|glucagon|mesh-list
154225301|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154225302|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225303|NCT01524705|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154225304|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154225305|NCT01524705|Incretins|incretins|mesh-ancestor
154225306|NCT01524705|Hormones|hormones|mesh-ancestor
154225307|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225308|NCT01524705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225309|NCT01072539|Tigecycline|tigecycline|mesh-list
154225310|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154225311|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225312|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154225313|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225314|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225315|NCT00715611|Carboplatin|carboplatin|mesh-list
154225316|NCT00715611|Pemetrexed|pemetrexed|mesh-list
154225317|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225318|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225319|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225320|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154225321|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154225322|NCT00667043|Midazolam|midazolam|mesh-list
154225323|NCT00667043|Fentanyl|fentanyl|mesh-list
154225324|NCT00667043|Remifentanil|remifentanil|mesh-list
154225325|NCT00667043|Propofol|propofol|mesh-list
154225326|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154225327|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225328|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225329|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154225330|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
154225331|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
154225332|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154225333|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154225334|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225335|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225336|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
154225338|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225339|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225340|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154225341|NCT00667043|Narcotics|narcotics|mesh-ancestor
154225342|NCT00667043|Analgesics|analgesics|mesh-ancestor
154225343|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
154225344|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225345|NCT03953716|Desogestrel|desogestrel|mesh-list
154225346|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154225347|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154225348|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154225349|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
154225350|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154225351|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225352|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154225353|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154225354|NCT03953716|Progestins|progestins|mesh-ancestor
154225356|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225357|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
154225358|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154225359|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
154225360|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154225361|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225362|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154225363|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154225364|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154225365|NCT00147537|Paclitaxel|paclitaxel|mesh-list
154225366|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154225367|NCT00147537|Carboplatin|carboplatin|mesh-list
154225368|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154225369|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154225370|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154225371|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225372|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
154225373|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
154225374|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
154225375|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225376|NCT00147537|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154225377|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154225378|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225379|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
154225380|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225381|NCT00222729|Bevacizumab|bevacizumab|mesh-list
154225382|NCT00222729|Pemetrexed|pemetrexed|mesh-list
154225383|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225384|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225385|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154225386|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154225387|NCT00222729|Growth Substances|growth substances|mesh-ancestor
154225388|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225389|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
154225390|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225391|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225392|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154225393|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154225394|NCT00147225|Carboplatin|carboplatin|mesh-list
154225395|NCT00147225|Doxorubicin|doxorubicin|mesh-list
154225396|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154225397|NCT00147225|Ifosfamide|ifosfamide|mesh-list
154225398|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225399|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154225400|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154225401|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154225402|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225403|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225404|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154225405|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
154225406|NCT00222105|Thalidomide|thalidomide|mesh-list
154225407|NCT00222105|Dexamethasone|dexamethasone|mesh-list
154225408|NCT00222105|Doxorubicin|doxorubicin|mesh-list
154225409|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154225410|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225411|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
154225412|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
154225413|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225414|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225415|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225416|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
154225417|NCT00222105|Hormones|hormones|mesh-ancestor
154225418|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225419|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154225420|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225421|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154225422|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154225423|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154225424|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225425|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225426|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225427|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
154225428|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
154225429|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154225430|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225431|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154225432|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154225433|NCT00222105|Growth Substances|growth substances|mesh-ancestor
154225434|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
154225435|NCT00247676|Sunitinib|sunitinib|mesh-list
154225436|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225437|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154225438|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154225439|NCT00247676|Growth Substances|growth substances|mesh-ancestor
154225440|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225441|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
154225442|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154225443|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225444|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225445|NCT00267020|Gemcitabine|gemcitabine|mesh-list
154225446|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154225447|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
154225448|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225449|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225450|NCT03975062|Dabigatran|dabigatran|mesh-list
154225451|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
154225452|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154225453|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
154225454|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225455|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225456|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
154225458|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225459|NCT03970772|Hormones|hormones|mesh-ancestor
154225460|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225461|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225462|NCT00242216|Ritonavir|ritonavir|mesh-list
154225463|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154225464|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
154225465|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154225466|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154225467|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
154225468|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225469|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225470|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154225471|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154225472|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
154225473|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225474|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154225475|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154225476|NCT00240110|Valproic Acid|valproic acid|mesh-list
154225477|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
154225478|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
154225479|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225480|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225481|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225482|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
154225483|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225484|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225485|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225486|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
154225487|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
154225488|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225489|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
154225490|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
154225491|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225492|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225493|NCT02532140|Cefepime|cefepime|mesh-list
154225494|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154225495|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099841|NCT00711594|Afatinib|afatinib|mesh-list
154225496|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
154225497|NCT00266864|Testosterone|testosterone|mesh-list
154225498|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
154225499|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
154225500|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154225501|NCT00266864|Androgens|androgens|mesh-ancestor
154225502|NCT00266864|Hormones|hormones|mesh-ancestor
154225503|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225504|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225505|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154225506|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225507|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
154225508|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
154225509|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
154225510|NCT00266708|Diphosphonates|diphosphonates|mesh-list
154225511|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154225512|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154225513|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225514|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154225515|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225516|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154225517|NCT00266630|Carbamazepine|carbamazepine|mesh-list
154225518|NCT00266630|Valproic Acid|valproic acid|mesh-list
154225519|NCT00266630|Olanzapine|olanzapine|mesh-list
154225520|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
154225521|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
154225522|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225523|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225524|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225525|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154225526|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225527|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225529|NCT00266630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154225530|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154225531|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154225532|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225533|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225534|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
154225535|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225536|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
154225537|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
154225538|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
154225539|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154225540|NCT00266630|Analgesics|analgesics|mesh-ancestor
154225541|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
154225542|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154225543|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154225544|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154225545|NCT02531672|Choline|choline|mesh-list
154225546|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
154225547|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154225548|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
154225549|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099893|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154225550|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225551|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154225552|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
154225553|NCT00129129|Vaccines|vaccines|mesh-list
154225554|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
154225555|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225556|NCT00221403|Valproic Acid|valproic acid|mesh-list
154225557|NCT00221403|Risperidone|risperidone|mesh-list
154225558|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154225559|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154225560|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
154225561|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225562|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225563|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225564|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154225565|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225566|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225567|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225568|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154225569|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
154225570|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
154225571|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225572|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
154225573|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
154225574|NCT00145977|Vitamin D|vitamin d|mesh-list
154225575|NCT00145977|Alendronate|alendronate|mesh-list
154225576|NCT00145977|Calcium|calcium|mesh-list
154225577|NCT00145977|Vitamins|vitamins|mesh-ancestor
154225578|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
154225579|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225580|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154225581|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154225582|NCT00238238|Rituximab|rituximab|mesh-list
154225583|NCT00238238|Lenalidomide|lenalidomide|mesh-list
154225584|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225585|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225586|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
154225587|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225588|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225589|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154225590|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154225591|NCT00238238|Growth Substances|growth substances|mesh-ancestor
154225592|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
154225593|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
154225594|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
154225595|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154225596|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154225597|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225598|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225599|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225600|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225601|NCT01071122|Valsartan|valsartan|mesh-list
154225602|NCT01071122|Nifedipine|nifedipine|mesh-list
154225603|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154225604|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154225605|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154225606|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225607|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154225608|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154225609|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154225610|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225611|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
154225612|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
154225613|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154225615|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154225616|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154225617|NCT01072604|Analgesics|analgesics|mesh-ancestor
154225618|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
154225619|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225620|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225621|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225622|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225623|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154225624|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154225625|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225626|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154225627|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154225628|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225629|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
154225630|NCT00128661|Vaccines|vaccines|mesh-list
154225631|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
154225632|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225633|NCT00145509|Asenapine|asenapine|mesh-list
154225634|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154225635|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225636|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225637|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225638|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225639|NCT03965871|Esketamine|esketamine|mesh-list
154225640|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
154225641|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225643|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225644|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225645|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
154225646|NCT00220779|Antibodies|antibodies|mesh-list
154225647|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
154225648|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154225649|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154225650|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
154225651|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
154225652|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225653|NCT00207740|Golimumab|golimumab|mesh-list
154225654|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154225655|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225656|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225657|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
154225658|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225659|NCT00265382|Ziprasidone|ziprasidone|mesh-list
154225660|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154225661|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
154225662|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225663|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225664|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225665|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154225666|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225667|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225668|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225669|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154225670|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
154225671|NCT03974984|Anesthetics|anesthetics|mesh-list
154225672|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225673|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225674|NCT00206726|Fludarabine|fludarabine|mesh-list
154225675|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
154225676|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225677|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225679|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
154225680|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154225681|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154225682|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154225683|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225684|NCT01581788|Valproic Acid|valproic acid|mesh-list
154225685|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
154225686|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225687|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225688|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
154225689|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225690|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225691|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
154225692|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225693|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225694|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225695|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
154225696|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154225697|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225698|NCT00043186|Denosumab|denosumab|mesh-list
154225699|NCT00043186|Alendronate|alendronate|mesh-list
154225700|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154225701|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225702|NCT00041470|Paclitaxel|paclitaxel|mesh-list
154225703|NCT00041470|Vinorelbine|vinorelbine|mesh-list
154225704|NCT00041470|Trastuzumab|trastuzumab|mesh-list
154225705|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154225706|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225707|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154225708|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154225709|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154225710|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225711|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225712|NCT03953950|Losartan|losartan|mesh-list
154225713|NCT03953950|Spironolactone|spironolactone|mesh-list
154225714|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154225715|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154225716|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154225717|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154225718|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225719|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154225720|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
154225721|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225722|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225723|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154225724|NCT03953950|Diuretics|diuretics|mesh-ancestor
154225725|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
154225726|NCT00206102|Risperidone|risperidone|mesh-list
154225727|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154225728|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154225729|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
154225730|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225731|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225732|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225733|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154225734|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154225735|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225736|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154225737|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154225738|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
154225739|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
154225740|NCT03954262|Propofol|propofol|mesh-list
154225741|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154225742|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225743|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225744|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154225745|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
154225746|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
154225747|NCT00041080|Tamoxifen|tamoxifen|mesh-list
154225748|NCT00041080|Thalidomide|thalidomide|mesh-list
154225749|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154225750|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
154225751|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225752|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225753|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154225754|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225755|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154225756|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154225757|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154225758|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225759|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
154225760|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
154225761|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154225762|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225763|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154225764|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154225765|NCT00041080|Growth Substances|growth substances|mesh-ancestor
154225766|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
154225768|NCT00205712|Ketamine|ketamine|mesh-list
154225769|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154225770|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225771|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225772|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154225773|NCT00205712|Analgesics|analgesics|mesh-ancestor
154225774|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
154225775|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225776|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154225777|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154225778|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154225779|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
154225780|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225781|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225782|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154225783|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154225784|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
154225785|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
154225786|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154225787|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154225788|NCT03969758|Metronidazole|metronidazole|mesh-list
154225789|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
154225790|NCT03969758|Cefixime|cefixime|mesh-list
154225792|NCT03969758|Hematinics|hematinics|mesh-ancestor
154225793|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225794|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154225795|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154225796|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154225797|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154225798|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154225799|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225800|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225801|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225802|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154225803|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154225804|NCT03969758|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154225805|NCT03969758|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154225806|NCT00203294|Triamcinolone|triamcinolone|mesh-list
154225807|NCT00203294|Lidocaine|lidocaine|mesh-list
154225808|NCT00203294|Bupivacaine|bupivacaine|mesh-list
154225809|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
154225810|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
154225811|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154225812|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225813|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
154225814|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225815|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154225816|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154225817|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154225818|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154225819|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225820|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225821|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
154225822|NCT00203294|Hormones|hormones|mesh-ancestor
154225823|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225824|NCT01074086|Everolimus|everolimus|mesh-list
154225825|NCT01074086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154100111|NCT04039126|Iodine|iodine|mesh-list
154225826|NCT01074086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154225827|NCT01074086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225828|NCT01074086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225829|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225830|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
154225831|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225832|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225833|NCT00264290|Valganciclovir|valganciclovir|mesh-list
154225834|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
154225835|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225836|NCT00234494|Bevacizumab|bevacizumab|mesh-list
154225837|NCT00234494|Gemcitabine|gemcitabine|mesh-list
154225838|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225839|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225840|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154225841|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154225842|NCT00234494|Growth Substances|growth substances|mesh-ancestor
154225843|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225844|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
154225845|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154225846|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
154225847|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225848|NCT00234104|Tolvaptan|tolvaptan|mesh-list
154225849|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154225850|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225851|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
154225852|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225853|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
154225854|NCT01582568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154225855|NCT01582568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225856|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225857|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
154225858|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225859|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225860|NCT00195338|Etanercept|etanercept|mesh-list
154225861|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153972777|NCT04060381|Analgesics|analgesics|mesh-ancestor
154225862|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154225863|NCT00195338|Analgesics|analgesics|mesh-ancestor
154225864|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
154225865|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225866|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225867|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225868|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225869|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225870|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225871|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
154225872|NCT01096654|Epinephrine|epinephrine|mesh-list
154225873|NCT01096654|Racepinephrine|racepinephrine|mesh-list
154225874|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
154225875|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154225876|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154225877|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
154225878|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225879|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225880|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225881|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154225882|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154225883|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
154225884|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225885|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154225886|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
154225887|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
154225888|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
154225889|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154225890|NCT00035932|Ritonavir|ritonavir|mesh-list
154225891|NCT00035932|Lopinavir|lopinavir|mesh-list
154225892|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154225893|NCT00035932|Saquinavir|saquinavir|mesh-list
154225894|NCT00035932|Tenofovir|tenofovir|mesh-list
154225895|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154225896|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154225897|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
154225898|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225899|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225900|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154225901|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154225902|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
154225903|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154225904|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154225905|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154225906|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154225907|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154225908|NCT03953326|Nitroprusside|nitroprusside|mesh-list
154225909|NCT03953326|Acetylcholine|acetylcholine|mesh-list
154225910|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154225911|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
154225912|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154225913|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225914|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154225915|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
154225916|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154225917|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225918|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
154225919|NCT01097278|Vitamin D|vitamin d|mesh-list
154225920|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154225921|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225922|NCT01097278|Vitamins|vitamins|mesh-ancestor
154225923|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
154225924|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154225925|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
154225926|NCT00022516|Methotrexate|methotrexate|mesh-list
154225927|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225928|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
154225929|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225930|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225931|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154225932|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
154225933|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225934|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225935|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154225936|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154225937|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
154225938|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154225939|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154225940|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
154225941|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
154100242|NCT05529056|Atropine|atropine|mesh-list
153347113|NCT00167102|Alefacept|alefacept|mesh-list
154225942|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225943|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154225944|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154225945|NCT01097512|Gemcitabine|gemcitabine|mesh-list
154225946|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154225947|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
154225948|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225949|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225950|NCT00033514|Trastuzumab|trastuzumab|mesh-list
154225951|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154225952|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154225953|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225954|NCT00033514|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154225955|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154225956|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225957|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225958|NCT00006916|Bleomycin|bleomycin|mesh-list
154225959|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154225960|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225961|NCT02529982|Curcumin|curcumin|mesh-list
154225962|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154225963|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154225964|NCT02529982|Analgesics|analgesics|mesh-ancestor
154225965|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
154225966|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225967|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225968|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225969|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154225970|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225971|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225972|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225973|NCT00454649|Paclitaxel|paclitaxel|mesh-list
154225974|NCT00454649|Docetaxel|docetaxel|mesh-list
154225975|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154225976|NCT00454649|Cisplatin|cisplatin|mesh-list
154225977|NCT00454649|Carboplatin|carboplatin|mesh-list
154225978|NCT00454649|Gemcitabine|gemcitabine|mesh-list
154225979|NCT00454649|Capecitabine|capecitabine|mesh-list
154225980|NCT00454649|Pemetrexed|pemetrexed|mesh-list
154225981|NCT00454649|Axitinib|axitinib|mesh-list
154225982|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154225983|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154225984|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
154225985|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
154225986|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
154225987|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225988|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154225989|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
154225990|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225991|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154225992|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154225993|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154225994|NCT00454571|Leuprolide|leuprolide|mesh-list
154225995|NCT00454571|Goserelin|goserelin|mesh-list
154225996|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154225997|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
154225998|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154225999|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226000|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154226001|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226002|NCT01323257|Ritonavir|ritonavir|mesh-list
154226003|NCT01323257|Darunavir|darunavir|mesh-list
154226004|NCT01323257|Erythromycin|erythromycin|mesh-list
154226005|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
154226006|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154226007|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
154226008|NCT01323257|Simeprevir|simeprevir|mesh-list
154226009|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154226010|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154226011|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
154226012|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226013|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226014|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226015|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226016|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
154226017|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226018|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154226019|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154226020|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154226021|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154226022|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154226023|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154226025|NCT01323335|Uric Acid|uric acid|mesh-list
154226026|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
154226027|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226028|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
154226029|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226030|NCT01323335|Protective Agents|protective agents|mesh-ancestor
154226031|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226032|NCT03836729|Tenofovir|tenofovir|mesh-list
154226033|NCT03836729|Emtricitabine|emtricitabine|mesh-list
154226034|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
154226035|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226036|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154226037|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154226038|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226039|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226040|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226041|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226042|NCT01027481|Ranibizumab|ranibizumab|mesh-list
154226043|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154226044|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154226045|NCT01027481|Growth Substances|growth substances|mesh-ancestor
154226046|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226047|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
154226048|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226049|NCT00443729|Ritonavir|ritonavir|mesh-list
154226050|NCT00443729|Lopinavir|lopinavir|mesh-list
154226051|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
154226052|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154226053|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154226054|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
154226055|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226056|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226057|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226058|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226059|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
154226060|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226061|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154226062|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154226063|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154226064|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154226065|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154226066|NCT00443651|Rituximab|rituximab|mesh-list
154226067|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154226068|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226069|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
154226070|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226071|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226072|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
154226073|NCT00443261|Azacitidine|azacitidine|mesh-list
154226074|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226075|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226076|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
154226077|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226078|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226079|NCT00439517|Cetuximab|cetuximab|mesh-list
154226080|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154100413|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154226081|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226083|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154226084|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154226085|NCT01028261|Growth Substances|growth substances|mesh-ancestor
154226086|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226087|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
154226088|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226089|NCT01028339|Mannitol|mannitol|mesh-list
153973006|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
154226091|NCT01028339|Diuretics|diuretics|mesh-ancestor
154226092|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
154226093|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226094|NCT01031459|Interferons|interferons|mesh-list
154226095|NCT01031459|Interferon-beta|interferon-beta|mesh-list
154226096|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
154226097|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226098|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
154226099|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226100|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
154226101|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226102|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154226103|NCT00438815|Complement C1s|complement c1s|mesh-list
154226104|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154226105|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154226106|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
154226107|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226108|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154226109|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154226110|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
154226111|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226112|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
154226113|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154226114|NCT01028495|Gemcitabine|gemcitabine|mesh-list
154226115|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226116|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
154226117|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226118|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226119|NCT00437645|Amlodipine|amlodipine|mesh-list
154226120|NCT00437645|Valsartan|valsartan|mesh-list
154226121|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154226122|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154226123|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154226124|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226125|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154226126|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226127|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
154226128|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154226129|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154226130|NCT00437489|Insulin|insulin|mesh-list
154226131|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154226132|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154226133|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226134|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154226135|NCT01028573|Laxatives|laxatives|mesh-ancestor
154226136|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154226137|NCT04683575|Selenium|selenium|mesh-list
154226138|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
154226139|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226140|NCT04683575|Protective Agents|protective agents|mesh-ancestor
154226141|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226142|NCT04683575|Trace Elements|trace elements|mesh-ancestor
154226143|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
154226144|NCT00442559|Montelukast|montelukast|mesh-list
154226145|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154226146|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
154226147|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154226148|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
154226149|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154226150|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226151|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154226152|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154226153|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226154|NCT01323491|Nicotine|nicotine|mesh-list
154226155|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154226156|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
154226157|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226158|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226159|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154226160|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154226161|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
154226162|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973082|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
154226175|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226176|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154226177|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
154226178|NCT01028729|Gemcitabine|gemcitabine|mesh-list
154226179|NCT01028729|Endostar protein|endostar protein|mesh-list
154226180|NCT01028729|Endostatins|endostatins|mesh-list
154226181|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226182|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226183|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
154226184|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226185|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154226186|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154226187|NCT01028729|Growth Substances|growth substances|mesh-ancestor
154226188|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226189|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
154226190|NCT03357419|Clindamycin|clindamycin|mesh-list
154226191|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
154226192|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
154226193|NCT03357419|Cephalexin|cephalexin|mesh-list
154226194|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154226195|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226196|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154226197|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226198|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226199|NCT01031927|Glycine|glycine|mesh-list
154226200|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
154226201|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226202|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226203|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226215|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154226216|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
154226217|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226219|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154226220|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154226221|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
154226222|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226223|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226224|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226225|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226226|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
154226227|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226228|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154226229|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154226230|NCT01097902|Ibuprofen|ibuprofen|mesh-list
154226231|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154226232|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154226233|NCT01097902|Analgesics|analgesics|mesh-ancestor
154226234|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
154226235|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226236|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226237|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226238|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226239|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154226240|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226241|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226242|NCT00436007|Vaccines|vaccines|mesh-list
154226243|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
154226244|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226245|NCT00435461|Fluticasone|fluticasone|mesh-list
154226246|NCT00435461|Xhance|xhance|mesh-list
154226247|NCT00435461|Fexofenadine|fexofenadine|mesh-list
154226248|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226249|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154226250|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
154226251|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226252|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226253|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154226254|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
154226255|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
154226256|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154226257|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154226258|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154226259|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
154226260|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
154226261|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226262|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226263|NCT01097980|Trazodone|trazodone|mesh-list
154226264|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154226265|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154226266|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154226267|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226268|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154226269|NCT01097980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154226270|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154226271|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154226272|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226273|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226274|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
154226275|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154226276|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
154226277|NCT01029275|Octreotide|octreotide|mesh-list
154226278|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154226279|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154226280|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226281|NCT04829903|Liraglutide|liraglutide|mesh-list
154226282|NCT04829903|Dulaglutide|dulaglutide|mesh-list
154226283|NCT04829903|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154226284|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154226285|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226286|NCT04829903|Incretins|incretins|mesh-ancestor
154226287|NCT04829903|Hormones|hormones|mesh-ancestor
154226288|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154226289|NCT00440999|Artesunate|artesunate|mesh-list
154226290|NCT00440999|Chloroquine|chloroquine|mesh-list
154226291|NCT00440999|Pyronaridine|pyronaridine|mesh-list
154226292|NCT00440999|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154226293|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
154226294|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154226295|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154226296|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226297|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226298|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
154226299|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
154226300|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154226301|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
154226302|NCT00440999|Amebicides|amebicides|mesh-ancestor
154226303|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226304|NCT00434213|Methylphenidate|methylphenidate|mesh-list
154226305|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154226306|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226307|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154226308|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154226309|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154226310|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226311|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
154226312|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226313|NCT01029743|Aspirin|aspirin|mesh-list
154226314|NCT01029743|PENTA|penta|mesh-list
154226315|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
154226316|NCT01029743|Fondaparinux|fondaparinux|mesh-list
154226317|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154226318|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154226319|NCT01029743|Analgesics|analgesics|mesh-ancestor
154226320|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
154226321|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226322|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226323|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226324|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226325|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154226326|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154226327|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226328|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154226329|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154226330|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226331|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
154226332|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154226333|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
154226334|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154226335|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
154226336|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
154226337|NCT01029821|Heparin|heparin|mesh-list
154226338|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154226340|NCT01029821|Dalteparin|dalteparin|mesh-list
154226341|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
154226342|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154226343|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154226344|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226345|NCT00006184|Cyclosporine|cyclosporine|mesh-list
154226346|NCT00006184|Prednisone|prednisone|mesh-list
154226347|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
154226348|NCT00006184|Doxorubicin|doxorubicin|mesh-list
154226349|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154226350|NCT00006184|Methotrexate|methotrexate|mesh-list
154226351|NCT00006184|Fludarabine|fludarabine|mesh-list
154226352|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
154226353|NCT00006184|Etoposide|etoposide|mesh-list
154226354|NCT00006184|Vincristine|vincristine|mesh-list
154226355|NCT00006184|Bortezomib|bortezomib|mesh-list
154226356|NCT00006184|Molgramostim|molgramostim|mesh-list
154226357|NCT00006184|Cyclosporins|cyclosporins|mesh-list
154226358|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
154226359|NCT00006184|Lenograstim|lenograstim|mesh-list
154226360|NCT00006184|Sargramostim|sargramostim|mesh-list
154226361|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
154226362|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154226363|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
154226364|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226365|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226366|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154226367|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
154226368|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226369|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226370|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154226372|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154226373|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154226374|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226375|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226376|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
154226377|NCT00006184|Hormones|hormones|mesh-ancestor
154226378|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154226379|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154226380|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154226381|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
154226382|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154226383|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226384|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
153973311|NCT04188249|Golimumab|golimumab|mesh-list
154226385|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
154226386|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154226387|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154226388|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154226389|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
154226390|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
154226391|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
154226392|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
154226393|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226394|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154226395|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154226396|NCT00433199|Testosterone|testosterone|mesh-list
154226397|NCT00433199|Androgens|androgens|mesh-ancestor
154226398|NCT00433199|Hormones|hormones|mesh-ancestor
154226399|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154226400|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226401|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154226402|NCT01098448|Amoxicillin|amoxicillin|mesh-list
154226403|NCT01098448|Metronidazole|metronidazole|mesh-list
154226404|NCT01098448|Tetracycline|tetracycline|mesh-list
154226405|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226406|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154226407|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154226408|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154226409|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226410|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226411|NCT01098526|Efavirenz|efavirenz|mesh-list
154226412|NCT01098526|Dolutegravir|dolutegravir|mesh-list
154226413|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154226414|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154226415|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226416|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226417|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
154226418|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226419|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154226420|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154226421|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154226422|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154226423|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154226424|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154226425|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154226426|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154226427|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226428|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226429|NCT00005908|Tamoxifen|tamoxifen|mesh-list
154226430|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
154226431|NCT00005908|Docetaxel|docetaxel|mesh-list
154226432|NCT00005908|Doxorubicin|doxorubicin|mesh-list
154226433|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154226434|NCT00005908|Capecitabine|capecitabine|mesh-list
154226435|NCT00005908|Anastrozole|anastrozole|mesh-list
154226436|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154226437|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
154226438|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226439|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226440|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154226441|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
154226442|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226443|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226444|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154226445|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
154226446|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
154226447|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
154226448|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154226449|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154226450|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154226451|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226452|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226453|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
154226454|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154226455|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
154226456|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154226457|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154226458|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154226459|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154226460|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154226461|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154226462|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154226463|NCT00431951|Tecovirimat|tecovirimat|mesh-list
154226464|NCT00431951|Antiviral Agents|antiviral agents|mesh-ancestor
154226465|NCT00431951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226466|NCT00004978|Aldesleukin|aldesleukin|mesh-list
154226467|NCT00004978|Interleukin-2|interleukin-2|mesh-list
154226468|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226469|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154226470|NCT00004978|Analgesics|analgesics|mesh-ancestor
154226471|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
154226472|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226473|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226474|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226475|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226476|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
154226477|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226478|NCT01030601|Dexamethasone|dexamethasone|mesh-list
154226479|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
154226480|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154226481|NCT01030601|BB 1101|bb 1101|mesh-list
154226482|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226483|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
154226484|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
154226485|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226486|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226487|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154226488|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
154226489|NCT01030601|Hormones|hormones|mesh-ancestor
154226490|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154226491|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154226492|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226493|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
154226494|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226495|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226496|NCT00430937|Vancomycin|vancomycin|mesh-list
154226497|NCT00430937|Daptomycin|daptomycin|mesh-list
154226498|NCT00430937|Teicoplanin|teicoplanin|mesh-list
154226499|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154226500|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226501|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
154226502|NCT01101412|Ethanol|ethanol|mesh-list
154226503|NCT01101412|Trimethoprim|trimethoprim|mesh-list
154226504|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
154226505|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154226506|NCT01101412|Edetic Acid|edetic acid|mesh-list
154226507|NCT01101412|Calcium|calcium|mesh-list
154226508|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
154226509|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154226510|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226511|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154226512|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154226513|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226514|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154226515|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154226516|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
154226517|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154226518|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154226519|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154226520|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226521|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226522|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154226523|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154226524|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154226525|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154226526|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
154226527|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154226528|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
154226529|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
154226530|NCT01101412|Antidotes|antidotes|mesh-ancestor
154226531|NCT01101412|Protective Agents|protective agents|mesh-ancestor
154226532|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154226533|NCT00004888|Docetaxel|docetaxel|mesh-list
154226534|NCT00004888|Doxorubicin|doxorubicin|mesh-list
154226535|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154226536|NCT00004888|Trastuzumab|trastuzumab|mesh-list
154226537|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226538|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
154226539|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
154226540|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
154226541|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226542|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154226543|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154226544|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154226545|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226546|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154226547|NCT01098760|Sorafenib|sorafenib|mesh-list
154226548|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226549|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154226550|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226551|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226552|NCT00430781|Lapatinib|lapatinib|mesh-list
154226553|NCT00430781|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154226554|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154226555|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226556|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226557|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226558|NCT01033097|Betamethasone|betamethasone|mesh-list
154226559|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226560|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
154226561|NCT01033097|Hormones|hormones|mesh-ancestor
154226562|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154226563|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226564|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154226565|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
154226566|NCT00429299|Paclitaxel|paclitaxel|mesh-list
154100845|NCT04038034|Vitamins|vitamins|mesh-ancestor
154226567|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
154226568|NCT00429299|Fluorouracil|fluorouracil|mesh-list
154226569|NCT00429299|Trastuzumab|trastuzumab|mesh-list
154226570|NCT00429299|Lapatinib|lapatinib|mesh-list
154226571|NCT00429299|Epirubicin|epirubicin|mesh-list
154226572|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154226573|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226574|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
154226575|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
154226576|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
154226577|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226578|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154226579|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
154226580|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226581|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226582|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154226583|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
154226584|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154226585|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
154226586|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226587|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154226588|NCT00429299|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154226589|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154226590|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226591|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154226592|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154226593|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154226594|NCT01033877|Vaccines|vaccines|mesh-list
154226595|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
154226596|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226598|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226599|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154226600|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154226601|NCT00428597|Growth Substances|growth substances|mesh-ancestor
154226602|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226603|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
154226604|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154226605|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226606|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226607|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154226608|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154226609|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154226610|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
154226611|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226612|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154226613|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153973534|NCT06184139|Oxytocics|oxytocics|mesh-ancestor
154226614|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226615|NCT00428441|Warfarin|warfarin|mesh-list
154226616|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
154226617|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
154226618|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154226619|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
154226620|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226621|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226622|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154226623|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
154226624|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
154226625|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154226626|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
154226627|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226628|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226629|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
154226630|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154226631|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
154226632|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226633|NCT03967665|Expectorants|expectorants|mesh-ancestor
154226634|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
154226635|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154226636|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
154226637|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226638|NCT03967665|Protective Agents|protective agents|mesh-ancestor
154226639|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226641|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
154226642|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154226643|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154226644|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226645|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154226646|NCT00127803|Vaccines|vaccines|mesh-list
154226647|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
154226648|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226649|NCT01077999|Paclitaxel|paclitaxel|mesh-list
154226650|NCT01077999|Carboplatin|carboplatin|mesh-list
154226651|NCT01077999|Panitumumab|panitumumab|mesh-list
154226652|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154226653|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226654|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
154226655|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
154226656|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
154226657|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226658|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154226659|NCT01033409|Vaccines|vaccines|mesh-list
154226660|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
154226661|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226662|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
154226663|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154226664|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
154226665|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226666|NCT01037465|Expectorants|expectorants|mesh-ancestor
154226667|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
154226668|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154226669|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
154226670|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226671|NCT01037465|Protective Agents|protective agents|mesh-ancestor
154226672|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226673|NCT01037465|Antidotes|antidotes|mesh-ancestor
154226674|NCT01582425|Isavuconazole|isavuconazole|mesh-list
154226675|NCT01582425|Methadone|methadone|mesh-list
154226676|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154226677|NCT01582425|Narcotics|narcotics|mesh-ancestor
154226678|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154226679|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226680|NCT01582425|Analgesics|analgesics|mesh-ancestor
154226681|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
154226682|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226683|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
154226684|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
154226685|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
154226686|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226687|NCT00143403|Leucovorin|leucovorin|mesh-list
154226688|NCT00143403|Folic Acid|folic acid|mesh-list
154226689|NCT00143403|Irinotecan|irinotecan|mesh-list
154226690|NCT00143403|Fluorouracil|fluorouracil|mesh-list
154226691|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
154226692|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154226693|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154226694|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226695|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226696|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226697|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
154226698|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226699|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154226700|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
154100951|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
154226701|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226702|NCT00143403|Antidotes|antidotes|mesh-ancestor
154226703|NCT00143403|Protective Agents|protective agents|mesh-ancestor
154226704|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
154226705|NCT00143403|Vitamins|vitamins|mesh-ancestor
154226706|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
154226707|NCT00143403|Hematinics|hematinics|mesh-ancestor
154226708|NCT00220701|Dexetimide|dexetimide|mesh-list
154226709|NCT00220701|Citalopram|citalopram|mesh-list
154226710|NCT00220701|Escitalopram|escitalopram|mesh-list
154226711|NCT00220701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154226712|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154226713|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154226714|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226715|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226716|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
154226717|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226718|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154226719|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154226720|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
154226721|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
154226722|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226723|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154226724|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154226725|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
154226726|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154226727|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
154226728|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154226729|NCT00127101|Vorinostat|vorinostat|mesh-list
154226730|NCT00127101|Bexarotene|bexarotene|mesh-list
154226731|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226732|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154226733|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226734|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226735|NCT00126555|Gefitinib|gefitinib|mesh-list
154226736|NCT00126555|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154226737|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154226738|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226739|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226740|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226741|NCT00004228|Leucovorin|leucovorin|mesh-list
154226742|NCT00004228|Cytarabine|cytarabine|mesh-list
154226743|NCT00004228|Dexamethasone|dexamethasone|mesh-list
154226744|NCT00004228|Prednisone|prednisone|mesh-list
154226745|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
154226746|NCT00004228|Doxorubicin|doxorubicin|mesh-list
154226747|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154226748|NCT00004228|Methotrexate|methotrexate|mesh-list
154226750|NCT00004228|Daunorubicin|daunorubicin|mesh-list
154226751|NCT00004228|Asparaginase|asparaginase|mesh-list
154226752|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
154226753|NCT00004228|Thioguanine|thioguanine|mesh-list
154226754|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
154226755|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154226756|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
154226757|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226758|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226759|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154226760|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
154226761|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226762|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226763|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154226764|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226765|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
154226766|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
154226767|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226768|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154226769|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
154226770|NCT00004228|Hormones|hormones|mesh-ancestor
154226771|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154226772|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154226773|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154226774|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154226775|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154226776|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226777|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154226778|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
154226779|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154226780|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226781|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
154226782|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
154226783|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154226784|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154226785|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
154226786|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226787|NCT00004228|Antidotes|antidotes|mesh-ancestor
154226788|NCT00004228|Protective Agents|protective agents|mesh-ancestor
154226789|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
154226790|NCT00004228|Vitamins|vitamins|mesh-ancestor
154226791|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
154226792|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154226793|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
154226794|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
154226795|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
154226796|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154226797|NCT01101568|Simvastatin|simvastatin|mesh-list
154226798|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154226799|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154226800|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
154226801|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226802|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154226803|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154226804|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226805|NCT01087840|Tenofovir|tenofovir|mesh-list
154226806|NCT01087840|Emtricitabine|emtricitabine|mesh-list
154226807|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
154226808|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
154226809|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226810|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154226811|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154226812|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226813|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226814|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226815|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226816|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154226817|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154226818|NCT01098994|Vitamin E|vitamin e|mesh-list
154226819|NCT01098994|Tocopherols|tocopherols|mesh-list
154226820|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
154226821|NCT01098994|Vitamins|vitamins|mesh-ancestor
154226822|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
154226823|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226824|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
154226825|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101090|NCT00422383|Rituximab|rituximab|mesh-list
154226826|NCT01098994|Protective Agents|protective agents|mesh-ancestor
154226827|NCT01099072|Methylphenidate|methylphenidate|mesh-list
154226828|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154226829|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226830|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154226831|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154226832|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154226833|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226834|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
154226835|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226837|NCT00195260|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154226838|NCT00195260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154226839|NCT00195260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226840|NCT00195260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226841|NCT00031486|Valacyclovir|valacyclovir|mesh-list
154226842|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
154226843|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226844|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
154226845|NCT01099150|Procyanidin|procyanidin|mesh-list
154226846|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
153973757|NCT06247956|Oxaliplatin|oxaliplatin|mesh-list
154226847|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226849|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226850|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154226851|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154226852|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226853|NCT02530060|Tenofovir|tenofovir|mesh-list
154226854|NCT02530060|Emtricitabine|emtricitabine|mesh-list
154226855|NCT02530060|Rilpivirine|rilpivirine|mesh-list
154226856|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
154226857|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226858|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154226859|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154226860|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226861|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226862|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226863|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226864|NCT01101646|Rabeprazole|rabeprazole|mesh-list
154226865|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154226866|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154226867|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154226868|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226869|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226870|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
154226871|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154226872|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226873|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154226874|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
154226875|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154226876|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226877|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226878|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226879|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154226880|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226881|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226882|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226883|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154226884|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
154226885|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154226886|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154226887|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226888|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
154226889|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226890|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226891|NCT01099462|Ibuprofen|ibuprofen|mesh-list
154226892|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154226893|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154226894|NCT01099462|Analgesics|analgesics|mesh-ancestor
154226895|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
154226896|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226897|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226898|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154226899|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154226900|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154226901|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226902|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226903|NCT00003298|Leucovorin|leucovorin|mesh-list
154226904|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
154226905|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
154226906|NCT00003298|Paclitaxel|paclitaxel|mesh-list
154226907|NCT00003298|Cisplatin|cisplatin|mesh-list
154226908|NCT00003298|Fluorouracil|fluorouracil|mesh-list
154226909|NCT00003298|Calcium|calcium|mesh-list
154226910|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
154226911|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154226912|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226913|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
154226914|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
154226915|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
154226916|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226917|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154226918|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226919|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
153973835|NCT06247488|Analgesics|analgesics|mesh-ancestor
154226921|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154226922|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
154226923|NCT00003298|Antidotes|antidotes|mesh-ancestor
154226924|NCT00003298|Protective Agents|protective agents|mesh-ancestor
154226925|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
154226926|NCT00003298|Vitamins|vitamins|mesh-ancestor
154226927|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
154226928|NCT03960970|Azithromycin|azithromycin|mesh-list
154226929|NCT03960970|Cefoxitin|cefoxitin|mesh-list
154226930|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154226931|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226932|NCT00002842|Leucovorin|leucovorin|mesh-list
154226933|NCT00002842|Fluorouracil|fluorouracil|mesh-list
154226934|NCT00002842|Floxuridine|floxuridine|mesh-list
154226935|NCT00002842|Calcium|calcium|mesh-list
154226936|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
154226937|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154226938|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226939|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
154226940|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226941|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154226942|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154226943|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154226944|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
154226945|NCT00002842|Antidotes|antidotes|mesh-ancestor
154226946|NCT00002842|Protective Agents|protective agents|mesh-ancestor
154226947|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
154226948|NCT00002842|Vitamins|vitamins|mesh-ancestor
154226949|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
154226950|NCT00143247|Insulin|insulin|mesh-list
154226951|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154226952|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226953|NCT00125853|Atenolol|atenolol|mesh-list
154226954|NCT00125853|Nebivolol|nebivolol|mesh-list
154226955|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154226956|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
154226957|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154226958|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154226959|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154226960|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
154226961|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154226962|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226963|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154226964|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154226965|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
154226966|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
154226967|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154226968|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154226969|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154226970|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154226971|NCT00219141|Losartan|losartan|mesh-list
154226972|NCT00219141|Aliskiren|aliskiren|mesh-list
154226973|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154226974|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154226975|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154226976|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154226977|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226978|NCT00219141|Renin Inhibitors|renin inhibitors|mesh-ancestor
154226979|NCT00219141|Protease Inhibitors|protease inhibitors|mesh-ancestor
154226980|NCT00219141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226981|NCT00233948|Nelfinavir|nelfinavir|mesh-list
154226982|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154226983|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154226984|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
154226985|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226986|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226987|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154226988|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154226989|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
154226990|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154226991|NCT00233480|Atorvastatin|atorvastatin|mesh-list
154226992|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154226993|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154226994|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
154226995|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154226996|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154226997|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154226998|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154226999|NCT03801928|Infliximab|infliximab|mesh-list
154227000|NCT03801928|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154227001|NCT03801928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227002|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
154227003|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154227004|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227005|NCT02530918|Ranibizumab|ranibizumab|mesh-list
154227006|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154227007|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154227008|NCT02530918|Growth Substances|growth substances|mesh-ancestor
154227009|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227010|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
154227011|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227012|NCT03950518|Levamisole|levamisole|mesh-list
154227013|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154227014|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
154227015|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227016|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
154227017|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
154227018|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154227019|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227020|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227021|NCT01100164|Eszopiclone|eszopiclone|mesh-list
154227022|NCT01100164|Zopiclone|zopiclone|mesh-list
154227023|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154227024|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227025|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227027|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
154227028|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227029|NCT01327222|Bevacizumab|bevacizumab|mesh-list
154227030|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227031|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227032|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154227033|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154227034|NCT01327222|Growth Substances|growth substances|mesh-ancestor
154227035|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227036|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
154227037|NCT03950362|Avelumab|avelumab|mesh-list
154227038|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227039|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227040|NCT00263588|Lapatinib|lapatinib|mesh-list
154227041|NCT00263588|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154227042|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227043|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227044|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227045|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227046|NCT00213135|Cladribine|cladribine|mesh-list
154227047|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227048|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227049|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
154227050|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227051|NCT00077974|Sunitinib|sunitinib|mesh-list
154227052|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227053|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154227054|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154227055|NCT00077974|Growth Substances|growth substances|mesh-ancestor
154227056|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227057|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
154227058|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227059|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227060|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227061|NCT00141921|Etanercept|etanercept|mesh-list
154227062|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154227063|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154227064|NCT00141921|Analgesics|analgesics|mesh-ancestor
154227065|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
154227066|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227067|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227068|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227069|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227070|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154227071|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227072|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
154227073|NCT01088620|Pemetrexed|pemetrexed|mesh-list
154227074|NCT01088620|Panitumumab|panitumumab|mesh-list
154227075|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227076|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227077|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227078|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154227079|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154227080|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227081|NCT00026494|Temozolomide|temozolomide|mesh-list
154227082|NCT00026494|Vinorelbine|vinorelbine|mesh-list
154227083|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154227084|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
154227085|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227086|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227087|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154227088|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227089|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227090|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227091|NCT03950050|Ambroxol|ambroxol|mesh-list
154227092|NCT03950050|Expectorants|expectorants|mesh-ancestor
154227093|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
154227094|NCT00023764|Bortezomib|bortezomib|mesh-list
154227095|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227096|NCT03961126|Clobetasol|clobetasol|mesh-list
154227097|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227098|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
154227099|NCT03961126|Hormones|hormones|mesh-ancestor
154141199|NCT04940299|Nivolumab|nivolumab|mesh-list
154227100|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154227101|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227102|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
154227103|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
154227104|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227105|NCT00189488|Methotrexate|methotrexate|mesh-list
154227106|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154227107|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
154227108|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154227109|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227110|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154227111|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
154227112|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227113|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227114|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
154227115|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227116|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154227117|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227118|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
154227119|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227120|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154227121|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154227122|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
154227123|NCT00023452|Isoniazid|isoniazid|mesh-list
154227124|NCT00023452|Rifapentine|rifapentine|mesh-list
154227125|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
154227126|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154227127|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227128|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154227129|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154227130|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
154227131|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227132|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154227133|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154227134|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
154227135|NCT01088932|SRX246|srx246|mesh-list
154227136|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154227137|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227138|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
154227139|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227140|NCT03961048|Ropivacaine|ropivacaine|mesh-list
154227141|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154227142|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
154227143|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
154227144|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227145|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227146|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
153974069|NCT05941897|Durvalumab|durvalumab|mesh-list
154227147|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227149|NCT00022672|Anastrozole|anastrozole|mesh-list
154227150|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227151|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227152|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154227153|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154227154|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154227155|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227156|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227157|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154227158|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
154227159|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154227160|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227161|NCT00141453|Olmesartan|olmesartan|mesh-list
154227162|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154227163|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154227164|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154227165|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154227166|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227167|NCT00076570|Sirolimus|sirolimus|mesh-list
154227168|NCT00076570|Tacrolimus|tacrolimus|mesh-list
154227169|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227170|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
154227171|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227172|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154227173|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227174|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227175|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154227176|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227177|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154227178|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227179|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
154227181|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154227182|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227183|NCT00124449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227184|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227185|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227186|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
154227187|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227188|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227189|NCT00076336|Lamivudine|lamivudine|mesh-list
154227190|NCT00076336|Telbivudine|telbivudine|mesh-list
154227191|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154227192|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154227193|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227194|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227195|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
154227196|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227197|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154227198|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154227199|NCT00185588|Gemcitabine|gemcitabine|mesh-list
154227201|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154227202|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
154227203|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227204|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227205|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227206|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227207|NCT00231842|Ifosfamide|ifosfamide|mesh-list
154227208|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227209|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154227210|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
154227211|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227212|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
154227213|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154227214|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227215|NCT00076102|Pirfenidone|pirfenidone|mesh-list
154227216|NCT00076102|Analgesics|analgesics|mesh-ancestor
154227217|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
154227218|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227219|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227220|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154101463|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154227221|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154227222|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227223|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227224|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227225|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
154227226|NCT03968588|Tacrolimus|tacrolimus|mesh-list
154227227|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227228|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
154227229|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227230|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154227231|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227232|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227233|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154227234|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227235|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154227236|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
154227237|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154227238|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227239|NCT01582646|Terbutaline|terbutaline|mesh-list
154227240|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154227241|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
154227242|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227243|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227244|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154227245|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
154227246|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
154227247|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
154227248|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154227249|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154227250|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154227251|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154227252|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
154227253|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227254|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227256|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154227257|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227258|NCT03974360|Analgesics|analgesics|mesh-ancestor
154227259|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
154227260|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227261|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227262|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
154227263|NCT00184028|Docetaxel|docetaxel|mesh-list
154227264|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227265|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227266|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227267|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227268|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227269|NCT00183872|Docetaxel|docetaxel|mesh-list
154227270|NCT00183872|Irinotecan|irinotecan|mesh-list
154227271|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227272|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227273|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227274|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227275|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227276|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154227277|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154227278|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227279|NCT03815175|Aspirin|aspirin|mesh-list
154227280|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154227281|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154227282|NCT03815175|Analgesics|analgesics|mesh-ancestor
154227283|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
154227284|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227285|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227286|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227287|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227288|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154227289|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154227290|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227291|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154227292|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154227293|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227295|NCT01080027|Interferons|interferons|mesh-list
154227296|NCT01080027|Interferon-beta|interferon-beta|mesh-list
154227297|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
154227298|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227299|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
154227300|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227301|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
154227302|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227303|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154227304|NCT00262028|Vaccines|vaccines|mesh-list
154227305|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
154227306|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227307|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
154227308|NCT00183248|Sirolimus|sirolimus|mesh-list
154227309|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
154227310|NCT00183248|Tacrolimus|tacrolimus|mesh-list
154227311|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227312|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
154227313|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227314|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154227315|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227316|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227317|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154227318|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227319|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154227320|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
154227321|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154227322|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227323|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
154227324|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227325|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
154227326|NCT00230282|Fludarabine|fludarabine|mesh-list
154227327|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
154227328|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227329|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
154227330|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227331|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227332|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154227333|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
154227334|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227335|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227336|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154227337|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227338|NCT00261950|Cinacalcet|cinacalcet|mesh-list
154227339|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154227340|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227341|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154227342|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
154227343|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154227344|NCT00229658|Pramlintide|pramlintide|mesh-list
154227345|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154227346|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227347|NCT00182078|Sertraline|sertraline|mesh-list
154227348|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
154227349|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154227350|NCT00182078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154227351|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154227352|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227353|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227354|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227355|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
154227356|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227357|NCT00181844|Lamotrigine|lamotrigine|mesh-list
154227358|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
154227359|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154227360|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227361|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227362|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154227363|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227364|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154227365|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154227366|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227367|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154101606|NCT01038505|Sirolimus|sirolimus|mesh-list
154227368|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154227369|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154227370|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154227371|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154227372|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227373|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227374|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
154227375|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227376|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227378|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
154227379|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154227380|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154227381|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154227382|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227383|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227384|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154227385|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154227386|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154227387|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154227388|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
154227389|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227390|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227391|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154227392|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154227393|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
154227394|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154227395|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154227396|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
154227397|NCT00076024|Docetaxel|docetaxel|mesh-list
154227398|NCT00076024|Axitinib|axitinib|mesh-list
154227399|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227400|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227401|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227402|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227403|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227404|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227405|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227406|NCT01103050|Cetirizine|cetirizine|mesh-list
154227407|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154227408|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154227409|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154227410|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
154227411|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
154227412|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227413|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227414|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227415|NCT00075478|Cyclosporine|cyclosporine|mesh-list
154227416|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
154227417|NCT00075478|Fludarabine|fludarabine|mesh-list
154227418|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
154101705|NCT00402103|Amlodipine|amlodipine|mesh-list
154227419|NCT00075478|Cyclosporins|cyclosporins|mesh-list
154227420|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227421|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154227422|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
154227423|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227424|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227425|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
154227426|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227427|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227428|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
154227429|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227430|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
154227431|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227432|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154227433|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154227434|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154227435|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
154227436|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154227437|NCT00175916|Brivaracetam|brivaracetam|mesh-list
154227438|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
154227439|NCT01089088|Gemcitabine|gemcitabine|mesh-list
154227440|NCT01089088|Sunitinib|sunitinib|mesh-list
154227441|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227442|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154227443|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
154227444|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227445|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154227446|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154227447|NCT01089088|Growth Substances|growth substances|mesh-ancestor
154227448|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227449|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
154227450|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227451|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227452|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
154227453|NCT00075400|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154227454|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227455|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227456|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227457|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227459|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154227460|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227461|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154227462|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
154227463|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154227464|NCT00228566|Modafinil|modafinil|mesh-list
154227465|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154227466|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227467|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154227468|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154227469|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154227470|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227472|NCT00261846|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154227473|NCT00261846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227474|NCT00261846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227475|NCT00261846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227476|NCT01089166|Metformin|metformin|mesh-list
154227477|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154227478|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227479|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
154227480|NCT00203502|Bevacizumab|bevacizumab|mesh-list
154227481|NCT00203502|Docetaxel|docetaxel|mesh-list
154227482|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227483|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
154227484|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227485|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227486|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154227487|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
154227488|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227489|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227490|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154227491|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227492|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154227493|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154227494|NCT00203502|Growth Substances|growth substances|mesh-ancestor
154227495|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
154227496|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227497|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227498|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227499|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
154227500|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154227501|NCT01103518|Estradiol|estradiol|mesh-list
154227502|NCT01103518|Cyproterone|cyproterone|mesh-list
154227503|NCT01103518|Estrogens|estrogens|mesh-ancestor
154227504|NCT01103518|Hormones|hormones|mesh-ancestor
154227505|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154227506|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227507|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154227508|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
154227509|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154227510|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154227511|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154227512|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154227513|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
154227514|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
154227515|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227516|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154227517|NCT01327534|Clopidogrel|clopidogrel|mesh-list
154227518|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154227519|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154227520|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154227521|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154227522|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154227523|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
154227524|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227525|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227526|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227527|NCT00232596|Ezogabine|ezogabine|mesh-list
154227528|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
154227529|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227530|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227531|NCT00073918|Iodine|iodine|mesh-list
154227532|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
154227533|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
154227534|NCT00073918|Etoposide|etoposide|mesh-list
154227535|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
154227536|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
154227537|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154227538|NCT00073918|Antibodies|antibodies|mesh-list
154227539|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
154227540|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154227541|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227542|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
154227543|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227544|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227545|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154227546|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
154227547|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227548|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227549|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154227550|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154227551|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154227552|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154227553|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227554|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154227555|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227556|NCT00073918|Trace Elements|trace elements|mesh-ancestor
154227557|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
154227558|NCT00231894|Pioglitazone|pioglitazone|mesh-list
154227559|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154227560|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227561|NCT00203424|Bevacizumab|bevacizumab|mesh-list
154227562|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154227563|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227564|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227565|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154227566|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154227567|NCT00203424|Growth Substances|growth substances|mesh-ancestor
154227568|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227569|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
154227570|NCT00203424|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154227571|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227572|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227573|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227574|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
154227575|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154227576|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
154227577|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
154227578|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227579|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227580|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227581|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154227582|NCT00203268|Analgesics|analgesics|mesh-ancestor
154227583|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
154227584|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227586|NCT00168818|Dabigatran|dabigatran|mesh-list
154227587|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
154227588|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154227589|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154227590|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227591|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
154227592|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154227593|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
154227594|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227596|NCT00260832|Decitabine|decitabine|mesh-list
154227597|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154227598|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
154227599|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227600|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227601|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
154227602|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227603|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227604|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
154227605|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227606|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227607|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
154227608|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154227609|NCT00168038|Antibodies|antibodies|mesh-list
154227610|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
154227611|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227612|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
154227613|NCT00166712|Sirolimus|sirolimus|mesh-list
154227614|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
154227615|NCT00166712|Tacrolimus|tacrolimus|mesh-list
154227616|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227617|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
154227618|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227619|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154227620|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227621|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227622|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154227623|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227624|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154227625|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
154227626|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154227627|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227628|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
154227629|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227631|NCT00073528|Lapatinib|lapatinib|mesh-list
154227632|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227633|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154227634|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154227635|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227636|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227637|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154227638|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
154227639|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154227640|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227641|NCT00073528|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154227642|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227643|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
154227644|NCT03801148|Lansoprazole|lansoprazole|mesh-list
154227645|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154227646|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154227647|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154227648|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227649|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227650|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
154227651|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154227652|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227653|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
154227654|NCT01103830|Lumefantrine|lumefantrine|mesh-list
154227655|NCT01103830|Artemether|artemether|mesh-list
154227656|NCT01103830|Piperaquine|piperaquine|mesh-list
154227657|NCT01103830|Artenimol|artenimol|mesh-list
154227658|NCT01103830|Artemisinins|artemisinins|mesh-list
154227659|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154227660|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154227661|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154227662|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227663|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154227664|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154227665|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974573|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227666|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227667|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227668|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154227669|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
154227670|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154227671|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227672|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154227673|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154227674|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154227675|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
154227676|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154227677|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154227678|NCT00072280|Dactinomycin|dactinomycin|mesh-list
154227679|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
154227680|NCT00072280|Ifosfamide|ifosfamide|mesh-list
154227681|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
154227682|NCT00072280|Etoposide|etoposide|mesh-list
154227683|NCT00072280|Vincristine|vincristine|mesh-list
154227684|NCT00072280|Lenograstim|lenograstim|mesh-list
154227685|NCT00072280|Mesna|mesna|mesh-list
154227686|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227687|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
154227688|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227689|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227690|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154227691|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
154227692|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227693|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227694|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154227695|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154227696|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154227697|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154227698|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227699|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154101944|NCT00890500|Sirolimus|sirolimus|mesh-list
154227700|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227701|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227702|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227703|NCT00072280|Protective Agents|protective agents|mesh-ancestor
154227704|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154227705|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227706|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154227707|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154227708|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154227709|NCT01106716|Lidocaine|lidocaine|mesh-list
154227710|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
154227711|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
154227712|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227713|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227714|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
154227715|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227716|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154227717|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154227718|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154255839|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227719|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227720|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227721|NCT00071812|Belimumab|belimumab|mesh-list
154227722|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227723|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
154227724|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227725|NCT01104298|Doxorubicin|doxorubicin|mesh-list
154227726|NCT01104298|Trabectedin|trabectedin|mesh-list
154227727|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154227728|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227729|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154227730|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154227731|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227732|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227733|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154227734|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
154227735|NCT01106872|Bevacizumab|bevacizumab|mesh-list
154227736|NCT01106872|Gemcitabine|gemcitabine|mesh-list
154227737|NCT01106872|Docetaxel|docetaxel|mesh-list
154227738|NCT01106872|Valproic Acid|valproic acid|mesh-list
154227739|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227740|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974650|NCT04810559|Antibodies|antibodies|mesh-list
154227741|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154227742|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154227743|NCT01106872|Growth Substances|growth substances|mesh-ancestor
154227744|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227745|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
154227746|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154227747|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
154227748|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227749|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227750|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227751|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227752|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
154227753|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227754|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
154227755|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227756|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
154227757|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154227758|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227759|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154227760|NCT03960268|Brodalumab|brodalumab|mesh-list
154227761|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
154227762|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
154227763|NCT05485480|Narcotics|narcotics|mesh-ancestor
154227764|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227765|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227766|NCT05485480|Analgesics|analgesics|mesh-ancestor
154227767|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
154227768|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227769|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
154227770|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227771|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
154227772|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227773|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227774|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154227775|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
154227776|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154227777|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
154227778|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154227779|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227780|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154227781|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
154227782|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
154227783|NCT00259610|Etanercept|etanercept|mesh-list
154227784|NCT00259610|Methotrexate|methotrexate|mesh-list
154227785|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154227786|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
154227787|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154227788|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227789|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154227790|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
154227791|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102037|NCT00821535|Maraviroc|maraviroc|mesh-list
154227792|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227793|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
154227794|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227795|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154227796|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227797|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
154227798|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227799|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154227800|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
154227801|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154227802|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154227803|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154227804|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154227805|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154227806|NCT00259610|Analgesics|analgesics|mesh-ancestor
154227807|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
154227808|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227809|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227810|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154227811|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154227812|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
154227813|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154227814|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154227815|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154227816|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227817|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227818|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
154227819|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227820|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227821|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154227822|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227823|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154227824|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
154227825|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154227826|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154227827|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227828|NCT00165698|Vitamins|vitamins|mesh-ancestor
154227829|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
154227830|NCT01075022|Vitamin D|vitamin d|mesh-list
154227831|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
154227832|NCT01075022|Vitamins|vitamins|mesh-ancestor
154227833|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
154227834|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227835|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154227836|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154227837|NCT00225758|Lapatinib|lapatinib|mesh-list
154227838|NCT00225758|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154227839|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154227840|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227841|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227842|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227843|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154227844|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
154227845|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154227846|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227848|NCT01104532|Hormones|hormones|mesh-ancestor
154227849|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154227850|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154227851|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
154227852|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227853|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227854|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154227855|NCT01107574|Gabapentin|gabapentin|mesh-list
154227856|NCT01107574|Analgesics|analgesics|mesh-ancestor
154227857|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
154227858|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227859|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227860|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
154227861|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154227862|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154227863|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227864|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154227865|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154227866|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154227867|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227868|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227869|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
154227870|NCT00259298|Teriparatide|teriparatide|mesh-list
154227871|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154227872|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227873|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154227874|NCT01108744|Mannitol|mannitol|mesh-list
154227875|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154227876|NCT01108744|Diuretics|diuretics|mesh-ancestor
154227877|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
154227878|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227879|NCT01581866|Ziprasidone|ziprasidone|mesh-list
154227880|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154227881|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
154227882|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227883|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227884|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227885|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154227886|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154227887|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154227888|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154227889|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153974796|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154227890|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
154227891|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
154227893|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
154227894|NCT01107808|Metformin|metformin|mesh-list
154227895|NCT01107808|Calcium|calcium|mesh-list
154227896|NCT01107808|Vitamins|vitamins|mesh-ancestor
154227897|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
154227898|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227899|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154227900|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154227901|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154227902|NCT01104844|Acetaminophen|acetaminophen|mesh-list
154227903|NCT01104844|Ibuprofen|ibuprofen|mesh-list
154227904|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154227905|NCT01104844|Analgesics|analgesics|mesh-ancestor
154227906|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
154227907|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154227908|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227909|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
154227910|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154227911|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227912|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154227913|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154227914|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227915|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227916|NCT03750136|Furosemide|furosemide|mesh-list
154227917|NCT03750136|Diuretics|diuretics|mesh-ancestor
154227918|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
154227919|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227920|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154227921|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227922|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227923|NCT01108042|Docetaxel|docetaxel|mesh-list
154227924|NCT01108042|Fluorouracil|fluorouracil|mesh-list
154227925|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227926|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227927|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227928|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227929|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227930|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
154227931|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154227932|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154227933|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
154227934|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227935|NCT01105234|Vitamin D|vitamin d|mesh-list
154227936|NCT01105234|Calcipotriene|calcipotriene|mesh-list
154227937|NCT01105234|Vitamins|vitamins|mesh-ancestor
154227938|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
154227939|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227940|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154227941|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
154227942|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
154227943|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154227944|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
154227946|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
154227947|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
154227948|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154227949|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154227950|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227951|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227952|NCT01108900|Urological Agents|urological agents|mesh-ancestor
154227953|NCT01105390|Pemetrexed|pemetrexed|mesh-list
154227954|NCT01105390|Rilotumumab|rilotumumab|mesh-list
154227955|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154227956|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227957|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154227958|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227959|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154227960|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154227961|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227962|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
154227963|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227964|NCT03947242|Trastuzumab|trastuzumab|mesh-list
153732567|NCT04517188|Iodine|iodine|mesh-list
154227965|NCT03947242|Vinorelbine|vinorelbine|mesh-list
154227966|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154227967|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227968|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154227969|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227970|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227971|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227972|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227973|NCT03944980|Docetaxel|docetaxel|mesh-list
154227974|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154227975|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
154227976|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
154227977|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
154227978|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227979|NCT03576664|Carvedilol|carvedilol|mesh-list
154227980|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154227981|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154227982|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
154227983|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154227984|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227985|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154227986|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154227987|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
154227988|NCT03576664|Protective Agents|protective agents|mesh-ancestor
154227989|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154227990|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154227991|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154227992|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
154253866|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
154227993|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154227994|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154227995|NCT01109134|Tirofiban|tirofiban|mesh-list
154227996|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154227997|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154227998|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154227999|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154228000|NCT01108588|Aspirin|aspirin|mesh-list
154228001|NCT01108588|Clopidogrel|clopidogrel|mesh-list
154228002|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154228003|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154228004|NCT01108588|Analgesics|analgesics|mesh-ancestor
154228005|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
154228006|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228007|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228008|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228009|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228010|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154228011|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154228012|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228013|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154228014|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154228015|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228016|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
154228017|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154228018|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154228019|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154228020|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
154228021|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228022|NCT01208740|Metformin|metformin|mesh-list
154228023|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154228024|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228025|NCT01208818|Dexamethasone|dexamethasone|mesh-list
154228026|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
154228027|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
154228028|NCT01208818|Bortezomib|bortezomib|mesh-list
154228029|NCT01208818|BB 1101|bb 1101|mesh-list
154228030|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154228031|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
154228032|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228033|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228034|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154228035|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
154228036|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228037|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228038|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154228039|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228040|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
154228041|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
154228042|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228043|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228044|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
154228045|NCT01208818|Hormones|hormones|mesh-ancestor
154228046|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228047|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154228048|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
154228049|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228050|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
154228051|NCT01111630|Hematinics|hematinics|mesh-ancestor
154228052|NCT03942796|Pregabalin|pregabalin|mesh-list
154228053|NCT03942796|Analgesics|analgesics|mesh-ancestor
154228054|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
154228055|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228056|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228057|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
154228058|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154228059|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228060|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228061|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154228062|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154228063|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154228064|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228065|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154228066|NCT01114282|Bortezomib|bortezomib|mesh-list
154228067|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228068|NCT01109212|Bindarit|bindarit|mesh-list
154228069|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228070|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154228071|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228072|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228073|NCT01111864|Micronutrients|micronutrients|mesh-list
154228074|NCT01111864|Trace Elements|trace elements|mesh-list
154228075|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228076|NCT01111942|Cisplatin|cisplatin|mesh-list
154228077|NCT01111942|Carboplatin|carboplatin|mesh-list
154228078|NCT01111942|Docetaxel|docetaxel|mesh-list
154228079|NCT01111942|Fluorouracil|fluorouracil|mesh-list
154228080|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228081|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
154228082|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
154228083|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
154228084|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228085|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
154228086|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154228087|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154228088|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
154228089|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228090|NCT01211860|Diazoxide|diazoxide|mesh-list
154228091|NCT01211860|Choline|choline|mesh-list
154228092|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
154228093|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154228095|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228096|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228097|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154228098|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
154228099|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154228100|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
154228101|NCT01211938|Cetuximab|cetuximab|mesh-list
154228102|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154228103|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228104|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
154228105|NCT02947438|Hematinics|hematinics|mesh-ancestor
154228106|NCT01209130|Rituximab|rituximab|mesh-list
154228107|NCT01209130|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
154228108|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154228109|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228110|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
154228111|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228112|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228113|NCT01209130|Immunoconjugates|immunoconjugates|mesh-ancestor
154228114|NCT01209208|Budesonide|budesonide|mesh-list
154228115|NCT01209208|Mesalamine|mesalamine|mesh-list
154228116|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228117|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154228118|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
154228119|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228120|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228121|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154228122|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
154228124|NCT01209208|Hormones|hormones|mesh-ancestor
154228125|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228126|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154228127|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154228128|NCT01209208|Analgesics|analgesics|mesh-ancestor
154228129|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
154228130|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228131|NCT01114750|Dextrans|dextrans|mesh-list
154228132|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
154228133|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
154228134|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
154228135|NCT01328470|Cilostazol|cilostazol|mesh-list
154228136|NCT01328470|Clopidogrel|clopidogrel|mesh-list
154228137|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154228138|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154228139|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154228140|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154228141|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
154228142|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228143|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228144|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228145|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154228146|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
154228147|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228148|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154102386|NCT01039363|Vorinostat|vorinostat|mesh-list
154228149|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
154228150|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154228151|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154228152|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
154228153|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154228154|NCT01328470|Protective Agents|protective agents|mesh-ancestor
154228155|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154228156|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154228157|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228158|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154228159|NCT03940378|Levamisole|levamisole|mesh-list
154228160|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154228161|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
154228162|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228163|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
154228164|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
154228165|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154228166|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228167|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228168|NCT01115062|Lidocaine|lidocaine|mesh-list
153517841|NCT01442311|Ribavirin|ribavirin|mesh-list
154228169|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
154228170|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
154228171|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228172|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228173|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
154228174|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228175|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154228176|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154228177|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154228178|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228179|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228180|NCT01115140|Folic Acid|folic acid|mesh-list
154228181|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
154228182|NCT01115140|Metformin|metformin|mesh-list
154228183|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154228184|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228185|NCT01115140|Hematinics|hematinics|mesh-ancestor
154228186|NCT01115140|Vitamins|vitamins|mesh-ancestor
154228187|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
154228188|NCT01112644|Oxycodone|oxycodone|mesh-list
154228189|NCT01112644|Naloxone|naloxone|mesh-list
154228190|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154228191|NCT01112644|Narcotics|narcotics|mesh-ancestor
154228192|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228193|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228194|NCT01112644|Analgesics|analgesics|mesh-ancestor
154228195|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
154228196|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228197|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154228198|NCT01112722|Histamine|histamine|mesh-list
154228199|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
154228200|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
154228201|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228202|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228203|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228204|NCT01015222|Paclitaxel|paclitaxel|mesh-list
154228205|NCT01015222|Bevacizumab|bevacizumab|mesh-list
154228206|NCT01015222|Dasatinib|dasatinib|mesh-list
154228207|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154228208|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228209|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
154228210|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
154228211|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
154228212|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228213|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154228214|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154228215|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154228216|NCT01015222|Growth Substances|growth substances|mesh-ancestor
154228217|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228218|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
154228219|NCT01015222|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154228220|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154228221|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228222|NCT01212250|Carvedilol|carvedilol|mesh-list
154228223|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154228224|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154228225|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
154228226|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228227|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228228|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228229|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154228230|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
154228231|NCT01212250|Protective Agents|protective agents|mesh-ancestor
154228232|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154228233|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228234|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154228235|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
154228236|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154228237|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154228238|NCT01209988|Tamsulosin|tamsulosin|mesh-list
154228239|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154102475|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
154228240|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154228241|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154228242|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
154228243|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228244|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228245|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228246|NCT01209988|Urological Agents|urological agents|mesh-ancestor
154228247|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
154228248|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154228249|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
154228250|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228251|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
154228252|NCT03943186|Protective Agents|protective agents|mesh-ancestor
154228253|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154228254|NCT01210066|Fentanyl|fentanyl|mesh-list
154228255|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
154228256|NCT01210066|Narcotics|narcotics|mesh-ancestor
154228257|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228258|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228259|NCT01210066|Analgesics|analgesics|mesh-ancestor
154228260|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
154228261|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228262|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154228263|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154228264|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
154228265|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
154228266|NCT01112878|Clonidine|clonidine|mesh-list
154228267|NCT01112878|Gabapentin|gabapentin|mesh-list
154228268|NCT01112878|Analgesics|analgesics|mesh-ancestor
154228269|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
153975169|NCT03107416|Bumetanide|bumetanide|mesh-list
154228270|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228271|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228272|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
154228273|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154228274|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154228275|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228276|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154228277|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154228278|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154228279|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228280|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228281|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
154228282|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154228283|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
154228284|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
154228285|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154228286|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154228287|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154228288|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
154228289|NCT01212406|Vitamin D|vitamin d|mesh-list
154228290|NCT01212406|Vitamins|vitamins|mesh-ancestor
154228291|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
154228292|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228293|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154228294|NCT01109758|Fenofibrate|fenofibrate|mesh-list
154228295|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154228296|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
154228297|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228298|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154228300|NCT01328236|Doxorubicin|doxorubicin|mesh-list
154228301|NCT01328236|Bortezomib|bortezomib|mesh-list
154228302|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228303|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
154228304|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
154228305|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228306|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228307|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228308|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
154228309|NCT01328236|Hormones|hormones|mesh-ancestor
154228310|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228311|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154228312|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228313|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154228314|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154228315|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154228316|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228317|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228318|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
154228319|NCT01328392|Lansoprazole|lansoprazole|mesh-list
154228320|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154228321|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228322|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154228323|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228324|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228325|NCT01115842|Vitamin D|vitamin d|mesh-list
154228326|NCT01115842|Vitamins|vitamins|mesh-ancestor
154228327|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
154228328|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228329|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154228330|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
154228331|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
154228332|NCT01116154|Lenalidomide|lenalidomide|mesh-list
154228333|NCT01116154|Vorinostat|vorinostat|mesh-list
154228334|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
154228335|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228336|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154228337|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154228338|NCT01116154|Growth Substances|growth substances|mesh-ancestor
154228339|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
154228340|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228341|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154228342|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228343|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228344|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
154228345|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154228346|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
154228347|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228348|NCT01210456|Expectorants|expectorants|mesh-ancestor
154228349|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
154228350|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154228351|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
154228352|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228353|NCT01210456|Protective Agents|protective agents|mesh-ancestor
154228354|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228355|NCT01210456|Antidotes|antidotes|mesh-ancestor
154228356|NCT01116310|Glycine|glycine|mesh-list
154228357|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
154228358|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228359|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228360|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228361|NCT01210846|Tivozanib|tivozanib|mesh-list
154228362|NCT01210846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154228363|NCT01210846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228364|NCT01210846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228365|NCT01116388|Caseins|caseins|mesh-list
154228366|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
154228367|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
154228368|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228369|NCT03941626|Immunomodulating Agents|immunomodulating agents|mesh-list
154228370|NCT03941626|Immunologic Factors|immunologic factors|mesh-ancestor
154228371|NCT03941626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228372|NCT01211002|Endostatins|endostatins|mesh-list
154228373|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392961|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
154228374|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154228375|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154228376|NCT01211002|Growth Substances|growth substances|mesh-ancestor
154228377|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228378|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
154228379|NCT01211080|Propranolol|propranolol|mesh-list
154228380|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154228381|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154228382|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
154228383|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228384|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228385|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228386|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154228387|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154228388|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
154228389|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
154228390|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154228391|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228392|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228394|NCT01116700|Analgesics|analgesics|mesh-ancestor
154228395|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
154228396|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228397|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154228398|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154228399|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154228400|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
154228401|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228402|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228403|NCT01113424|Nicotine|nicotine|mesh-list
154228404|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154228405|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
154228406|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228407|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228408|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154228409|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154228410|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
154228411|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228412|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228413|NCT01211158|Ketamine|ketamine|mesh-list
154228414|NCT01211158|Propofol|propofol|mesh-list
154228415|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154228416|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228417|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228418|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154228419|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
154228420|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
154228421|NCT01211158|Analgesics|analgesics|mesh-ancestor
154228422|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
154228423|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228424|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154228425|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154228426|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154228427|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228428|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228429|NCT01110226|Cisplatin|cisplatin|mesh-list
154228430|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
154228431|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228432|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228433|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228434|NCT03789292|Adalimumab|adalimumab|mesh-list
154228435|NCT03789292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154228436|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228437|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228438|NCT01211314|Enalapril|enalapril|mesh-list
154228439|NCT01211314|Lercanidipine|lercanidipine|mesh-list
154228440|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154228441|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
154228442|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228443|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228444|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154228445|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154228446|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228447|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154228448|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228450|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
154228451|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228452|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228453|NCT02529514|Baclofen|baclofen|mesh-list
154228454|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154228455|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228456|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154228457|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228458|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154228459|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
154228460|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
154228461|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228462|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228463|NCT01211470|Daptomycin|daptomycin|mesh-list
154228464|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154228465|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228466|NCT01114048|Thalidomide|thalidomide|mesh-list
154228467|NCT01114048|Dexamethasone|dexamethasone|mesh-list
154228468|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
154228469|NCT01114048|Bortezomib|bortezomib|mesh-list
154228470|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154228471|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
154228472|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228473|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228474|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154228475|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
154228476|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228477|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228478|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154228479|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228480|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
154228481|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
154228482|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228483|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228484|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
154228485|NCT01114048|Hormones|hormones|mesh-ancestor
154228486|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228487|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154228488|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
154228489|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154228490|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228491|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154228492|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154228493|NCT01114048|Growth Substances|growth substances|mesh-ancestor
154228494|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
154228495|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
154228496|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228497|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154228498|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154228499|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154228500|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228501|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228502|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154228503|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154228504|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154228505|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
154228506|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228507|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228508|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154228509|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154228510|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
154228511|NCT02529670|Lidocaine|lidocaine|mesh-list
154228512|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
154228513|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
154228514|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228515|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228516|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
154228517|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228518|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154228519|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154228520|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154228521|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228522|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228523|NCT01117636|Aspirin|aspirin|mesh-list
154228524|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154228525|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154228526|NCT01117636|Analgesics|analgesics|mesh-ancestor
154228527|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
154228528|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228529|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228530|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228531|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228532|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154228533|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154228534|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228535|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154228536|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154228537|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228538|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
154228539|NCT03938740|Insulin|insulin|mesh-list
154228540|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154228541|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
154228542|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
154228543|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154228544|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228545|NCT01110616|Lorazepam|lorazepam|mesh-list
154228546|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
154228547|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
154228548|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
154228549|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228550|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228551|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228552|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154228553|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228554|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154228555|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154228556|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154228557|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
154228558|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
154228559|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228560|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228561|NCT03938662|Choline|choline|mesh-list
154228562|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
154228563|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154228564|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
154228565|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228566|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228567|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154228568|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
154228569|NCT01213498|Atorvastatin|atorvastatin|mesh-list
154228570|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154228571|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154228572|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
154228573|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228574|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154228575|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154228576|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228577|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154228578|NCT01111084|Hormones|hormones|mesh-ancestor
154228579|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228580|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228581|NCT01118260|Anesthetics|anesthetics|mesh-list
154228582|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228583|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228584|NCT01121770|PENTA|penta|mesh-list
154228585|NCT01121770|Fondaparinux|fondaparinux|mesh-list
154228586|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154228587|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
154228588|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154228589|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
154228590|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228591|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228592|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
154228593|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154228594|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154228595|NCT01121848|Leucovorin|leucovorin|mesh-list
154228596|NCT01121848|Fluorouracil|fluorouracil|mesh-list
154228597|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
154228598|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
154228599|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228600|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154228601|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228602|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154228603|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
154228604|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228605|NCT01121848|Antidotes|antidotes|mesh-ancestor
154228606|NCT01121848|Protective Agents|protective agents|mesh-ancestor
154228607|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
154228608|NCT01121848|Vitamins|vitamins|mesh-ancestor
154228609|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
154228610|NCT01122004|Pregabalin|pregabalin|mesh-list
154228611|NCT01122004|Analgesics|analgesics|mesh-ancestor
154228612|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
154228613|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228614|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228615|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
154228616|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154228617|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228618|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228619|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154228620|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154228621|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154228622|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228623|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154228624|NCT03933982|Vinorelbine|vinorelbine|mesh-list
154228625|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154228626|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228627|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
154228628|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
154228629|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
154228630|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228631|NCT01118572|Celecoxib|celecoxib|mesh-list
154228632|NCT01118572|Etodolac|etodolac|mesh-list
154228633|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154228634|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154228635|NCT01118572|Analgesics|analgesics|mesh-ancestor
154228636|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
154228637|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228638|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228639|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228640|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228641|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154228642|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154228643|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228644|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228645|NCT03937648|Lasmiditan|lasmiditan|mesh-list
154228646|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154228647|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
154228648|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228649|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228650|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228651|NCT01219036|Budesonide|budesonide|mesh-list
154228652|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228653|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154228654|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
154228655|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228656|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228657|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154228658|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
154228659|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
154228660|NCT01219036|Hormones|hormones|mesh-ancestor
154228661|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228662|NCT01124500|Methylphenidate|methylphenidate|mesh-list
154228663|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154228664|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228665|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154228666|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154228667|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228668|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228669|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
154392962|NCT02693002|Estradiol|estradiol|mesh-list
154102945|NCT00631371|MTOR Inhibitors|mtor inhibitors|mesh-list
154228670|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228671|NCT01118884|Promethazine|promethazine|mesh-list
154228672|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
154228673|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
154228674|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
154228675|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154228676|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
154228677|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
154228678|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228679|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228680|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228681|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154228682|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154228683|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154228684|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228685|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
154228687|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
154228688|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228689|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
154228690|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
154228691|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228692|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
154228693|NCT01119196|Icodextrin|icodextrin|mesh-list
154228694|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154228695|NCT01213888|Trientine|trientine|mesh-list
154228696|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
154228697|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
154228698|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228699|NCT01119430|Fluoxetine|fluoxetine|mesh-list
154228700|NCT01119430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154228701|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154228702|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228703|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228704|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228705|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
154228706|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228707|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154228708|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
154228709|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154228710|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154228711|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154228712|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228713|NCT02529124|Caseins|caseins|mesh-list
154228714|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
154228715|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
154228716|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228717|NCT03780244|Mannitol|mannitol|mesh-list
154228718|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154228719|NCT03780244|Diuretics|diuretics|mesh-ancestor
154228720|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
154228721|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228722|NCT01119742|Butenafine|butenafine|mesh-list
154228723|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
154228724|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228725|NCT01216696|Ipilimumab|ipilimumab|mesh-list
154228726|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154228727|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228728|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154228729|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228730|NCT03937258|Probenecid|probenecid|mesh-list
154228731|NCT03937258|Abrocitinib|abrocitinib|mesh-list
154228732|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
154228733|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
154228734|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228735|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154228736|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228737|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228738|NCT01124656|Pioglitazone|pioglitazone|mesh-list
154228739|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154228740|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154228741|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228742|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154228743|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154228744|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228745|NCT01122472|Lenalidomide|lenalidomide|mesh-list
154228746|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
154228747|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228748|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154228749|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154228750|NCT01122472|Growth Substances|growth substances|mesh-ancestor
154228751|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
154228752|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228753|NCT01214122|Warfarin|warfarin|mesh-list
154228754|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
154228755|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
154228756|NCT03935152|Progestins|progestins|mesh-ancestor
154102984|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228758|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228759|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228760|NCT01216852|Losartan|losartan|mesh-list
154228761|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154228762|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154228763|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154228764|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154228765|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228766|NCT03933748|Teicoplanin|teicoplanin|mesh-list
154228767|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154228768|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228769|NCT01120366|Methotrexate|methotrexate|mesh-list
154228770|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154228771|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
154228772|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154228773|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228774|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154228775|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
154228776|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228777|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228778|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
154228779|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228780|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154228781|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154228782|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
154228783|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228784|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154228785|NCT01217086|Infliximab|infliximab|mesh-list
154228786|NCT01217086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154228787|NCT01217086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228788|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
154228789|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228790|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228791|NCT01120444|Insulin|insulin|mesh-list
154228792|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154228793|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228794|NCT01217398|Bevacizumab|bevacizumab|mesh-list
154228796|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154228797|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228798|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154228799|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154228800|NCT01217398|Growth Substances|growth substances|mesh-ancestor
154228801|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228802|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
154228803|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154228804|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
154228805|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228806|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
154228807|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154228808|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228809|NCT01214746|Atorvastatin|atorvastatin|mesh-list
154228810|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154228811|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154228812|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
154228813|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228814|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154228815|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154228816|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228817|NCT03935074|Melphalan|melphalan|mesh-list
154228818|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154228819|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
154392963|NCT02693002|Estrogens|estrogens|mesh-ancestor
154228820|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228821|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228822|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154228823|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154228824|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
154228825|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228826|NCT01217632|Entecavir|entecavir|mesh-list
154228827|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
154228828|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228829|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
154228830|NCT03933280|Nalbuphine|nalbuphine|mesh-list
154228831|NCT03933280|Propofol|propofol|mesh-list
154228832|NCT03933280|Benoxinate|benoxinate|mesh-list
154228833|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154228834|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154228835|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228836|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228837|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154228838|NCT03933280|Analgesics|analgesics|mesh-ancestor
154228839|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
154228840|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228841|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154228842|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154228843|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154228844|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
154228845|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228846|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228847|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154228848|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
154228849|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
154228850|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154228851|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154228852|NCT03933280|Narcotics|narcotics|mesh-ancestor
154228853|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154228854|NCT01120912|Insulin|insulin|mesh-list
154228855|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154228856|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228857|NCT01219582|Metformin|metformin|mesh-list
154228858|NCT01219582|Acarbose|acarbose|mesh-list
154228859|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154228860|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228861|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154228862|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228863|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228864|NCT03933358|Hormones|hormones|mesh-list
154228865|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154228866|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228867|NCT01122940|Phenytoin|phenytoin|mesh-list
153975767|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154228868|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
154228869|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154228870|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154228871|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228872|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228873|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154228874|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154228875|NCT01219816|Epratuzumab|epratuzumab|mesh-list
154228876|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154228877|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228878|NCT01218022|Losartan|losartan|mesh-list
154228879|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154228880|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154228881|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154228882|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154228883|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228884|NCT01121458|Clevidipine|clevidipine|mesh-list
154228885|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154228886|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228887|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228888|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154228889|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228890|NCT01215214|Midazolam|midazolam|mesh-list
154228891|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154228892|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154228893|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228894|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228895|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154228896|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154228897|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154228898|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154228899|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
154228900|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
154228901|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
154228902|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
154228903|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228904|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228905|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154228906|NCT01125670|Darexaban|darexaban|mesh-list
154228907|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154228908|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
154228909|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154228910|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
154228911|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228912|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228913|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
154228914|NCT03934450|Primaquine|primaquine|mesh-list
154228915|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
154228916|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154228917|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154228918|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154228919|NCT01215682|Vitamin D|vitamin d|mesh-list
154228920|NCT01215682|Vitamins|vitamins|mesh-ancestor
154228921|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
154228922|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228923|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154228924|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154228925|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154228926|NCT01123408|Haloperidol|haloperidol|mesh-list
154228927|NCT01123408|Olanzapine|olanzapine|mesh-list
154228928|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
154228929|NCT01123408|Clozapine|clozapine|mesh-list
154228930|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
154228931|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
154228932|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228933|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228934|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154228935|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154228936|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154228937|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228938|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154228939|NCT01123408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154228940|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154228941|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228942|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228943|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154228944|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
154228945|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154228946|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
154228947|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154228948|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154228949|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
154228950|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
154228951|NCT00141297|Palbociclib|palbociclib|mesh-list
154228952|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228953|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154228954|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154228955|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228956|NCT01123486|Hydromorphone|hydromorphone|mesh-list
154228957|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154228958|NCT01123486|Narcotics|narcotics|mesh-ancestor
154228959|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154228960|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228961|NCT01123486|Analgesics|analgesics|mesh-ancestor
154228962|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
154228963|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228964|NCT01123564|Ranibizumab|ranibizumab|mesh-list
154228965|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154228966|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154228967|NCT01123564|Growth Substances|growth substances|mesh-ancestor
154228968|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228969|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
154228970|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228972|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
154228973|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228974|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
154228975|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
154228976|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
154228977|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228978|NCT03932266|Docetaxel|docetaxel|mesh-list
154228979|NCT03932266|Endostar protein|endostar protein|mesh-list
154228980|NCT03932266|Endostatins|endostatins|mesh-list
154228981|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154228982|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
154228983|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
154228984|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
154103218|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154228985|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154228986|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154228987|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154228988|NCT03932266|Growth Substances|growth substances|mesh-ancestor
154228989|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228990|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
154228991|NCT00141219|Pregabalin|pregabalin|mesh-list
154228992|NCT00141219|Analgesics|analgesics|mesh-ancestor
154228993|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
154228994|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154228995|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154228996|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
154228997|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154228998|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154228999|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229000|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154229001|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154229002|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154229003|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229004|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154229005|NCT01222468|Nabilone|nabilone|mesh-list
154229006|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
154229007|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
154229008|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229009|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229010|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229011|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154229012|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154229013|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229014|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154229015|NCT01220284|Vinorelbine|vinorelbine|mesh-list
154229016|NCT01220284|Satraplatin|satraplatin|mesh-list
154229017|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154229018|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229019|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
154229020|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
154229021|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
154229022|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229023|NCT01127464|Poly ICLC|poly iclc|mesh-list
154229024|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
154229025|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
154229026|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229027|NCT01222780|Vincristine|vincristine|mesh-list
154229028|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154229029|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229030|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
154229031|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
154229032|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
154229033|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229034|NCT01222936|Panobinostat|panobinostat|mesh-list
154229035|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229036|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154229037|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229038|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229039|NCT01125904|Crizotinib|crizotinib|mesh-list
154229040|NCT01125904|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154229041|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154229042|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229043|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229044|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229045|NCT01125982|Propofol|propofol|mesh-list
154229046|NCT01125982|Desflurane|desflurane|mesh-list
154229047|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154229048|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229049|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229050|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154229051|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
154229052|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
154229053|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154229054|NCT01220362|Fentanyl|fentanyl|mesh-list
154229055|NCT01220362|Bupivacaine|bupivacaine|mesh-list
154229056|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
154229057|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
154229058|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229059|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229060|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
154229061|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229062|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154229063|NCT01220362|Narcotics|narcotics|mesh-ancestor
154229064|NCT01220362|Analgesics|analgesics|mesh-ancestor
154229065|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154229066|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154229067|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
154229068|NCT01220440|Methylphenidate|methylphenidate|mesh-list
154229069|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
154229070|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154229071|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229072|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154229073|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154229074|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154229075|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229076|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
154229077|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229078|NCT01123876|Veliparib|veliparib|mesh-list
154229079|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154229080|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229081|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229082|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229083|NCT01124032|Methylphenidate|methylphenidate|mesh-list
154229084|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154229085|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229086|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154229087|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154229088|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154229089|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229090|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
154229091|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229092|NCT03934294|Metoclopramide|metoclopramide|mesh-list
154229093|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
154229094|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
154229095|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229096|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229097|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229098|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154229099|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154229100|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
154229101|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229102|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229103|NCT01218568|Rifaximin|rifaximin|mesh-list
154229104|NCT01218568|Lactulose|lactulose|mesh-list
154229105|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229106|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229107|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229108|NCT01127542|Lenalidomide|lenalidomide|mesh-list
154229109|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
154229110|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229111|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154229112|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154229113|NCT01127542|Growth Substances|growth substances|mesh-ancestor
154229114|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
154229115|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229116|NCT01127620|Cetirizine|cetirizine|mesh-list
154229117|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154229118|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154229119|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154229120|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
154229121|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
154229122|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103350|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
154229123|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229124|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229125|NCT01220518|Infliximab|infliximab|mesh-list
154229126|NCT01220518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154229127|NCT01220518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229128|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
154229129|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229130|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229131|NCT01220596|Interferons|interferons|mesh-list
154229132|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154229133|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
154229134|NCT01220596|Entecavir|entecavir|mesh-list
154229135|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229136|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
154229137|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229138|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
154229139|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229140|NCT01218724|Losartan|losartan|mesh-list
154229141|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154229142|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154229143|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154229144|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154229145|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154229146|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229147|NCT01218724|Diuretics|diuretics|mesh-ancestor
154229148|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
154229149|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229150|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154229151|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154229152|NCT01126216|Paclitaxel|paclitaxel|mesh-list
154229153|NCT01126216|Cisplatin|cisplatin|mesh-list
154229154|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154229155|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229156|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
154229157|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
154229158|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
154229159|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229160|NCT01329016|Metformin|metformin|mesh-list
154229161|NCT01329016|Glyburide|glyburide|mesh-list
154229162|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154229163|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229164|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
154229165|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154229166|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
154229167|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229168|NCT01223326|Expectorants|expectorants|mesh-ancestor
154229169|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
154229170|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154229171|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
154229172|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229173|NCT01223326|Protective Agents|protective agents|mesh-ancestor
154229174|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229175|NCT01223326|Antidotes|antidotes|mesh-ancestor
154229176|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
154229177|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154229178|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229179|NCT01126294|Melatonin|melatonin|mesh-list
154229180|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
154229181|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229182|NCT01126294|Protective Agents|protective agents|mesh-ancestor
154229183|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229184|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229185|NCT00162266|Abatacept|abatacept|mesh-list
154229186|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154229187|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229188|NCT00162266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154229189|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229190|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229191|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
154229192|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229193|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229194|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154229195|NCT01126450|Cetuximab|cetuximab|mesh-list
154229196|NCT01126450|Lenalidomide|lenalidomide|mesh-list
154229197|NCT01126450|Antibodies|antibodies|mesh-list
154229198|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
154229199|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154229200|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
154229201|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229202|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229203|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154229204|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154229206|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
154229207|NCT01073384|Beclomethasone|beclomethasone|mesh-list
154229208|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229209|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
154229210|NCT01073384|Hormones|hormones|mesh-ancestor
154229211|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229212|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229213|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154229214|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
154229215|NCT01126528|Vitamin D|vitamin d|mesh-list
154229216|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
154229217|NCT01126528|Vitamins|vitamins|mesh-ancestor
154229218|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
154229219|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229220|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154229221|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154229222|NCT00225212|Rituximab|rituximab|mesh-list
154229223|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154229224|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229225|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
154229226|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229227|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229228|NCT03853330|Bupivacaine|bupivacaine|mesh-list
154229229|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
154103502|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229230|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
154229231|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229232|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229233|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
154229234|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229235|NCT01581944|Goserelin|goserelin|mesh-list
154229236|NCT01581944|Hormones|hormones|mesh-list
154229237|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229238|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229239|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154229240|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229241|NCT01226056|Everolimus|everolimus|mesh-list
154229242|NCT01226056|Sorafenib|sorafenib|mesh-list
154229243|NCT01226056|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154229244|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154229245|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229246|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229247|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229248|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
154229249|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229250|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229251|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154229252|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154229253|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229254|NCT01126606|Glycerol|glycerol|mesh-list
154229255|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154229256|NCT01126606|Protective Agents|protective agents|mesh-ancestor
154229257|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229258|NCT01329406|Milnacipran|milnacipran|mesh-list
154229259|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
154229260|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154229261|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154229262|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154229263|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229264|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229265|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229266|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154229267|NCT01329406|Analgesics|analgesics|mesh-ancestor
154229268|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
154143378|NCT00004197|Prednisone|prednisone|mesh-list
154229269|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229270|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
154229271|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154229272|NCT01126684|Atorvastatin|atorvastatin|mesh-list
154229273|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154229274|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154229275|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
154229276|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229277|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154229278|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154229279|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229280|NCT01224028|Tacrolimus|tacrolimus|mesh-list
154229281|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229282|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
154229283|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229284|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154229285|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229286|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229287|NCT01226212|Sulfalene|sulfalene|mesh-list
154229288|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229289|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154229290|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
154229291|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154229292|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154229293|NCT01075490|Clonidine|clonidine|mesh-list
154229294|NCT01075490|Analgesics|analgesics|mesh-ancestor
154229295|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
154229296|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229297|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229298|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154229299|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
154229300|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
154229301|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154229302|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154229303|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154229304|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229305|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229306|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229307|NCT01126138|Docetaxel|docetaxel|mesh-list
154229308|NCT01126138|Capecitabine|capecitabine|mesh-list
154229309|NCT01126138|Vinorelbine|vinorelbine|mesh-list
154229310|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229311|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
154229312|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
154229313|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
154229314|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229315|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154229316|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
154229317|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154229318|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154229319|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154229320|NCT03930706|Estradiol|estradiol|mesh-list
153976220|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
154229321|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154229322|NCT03930706|Estrogens|estrogens|mesh-ancestor
154229323|NCT03930706|Hormones|hormones|mesh-ancestor
154229324|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229325|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229326|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154229327|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
154229328|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154229329|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154229330|NCT03932578|Atropine|atropine|mesh-list
154229331|NCT03932578|Metoclopramide|metoclopramide|mesh-list
154229332|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154229333|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154229334|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154229335|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
154229336|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229337|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229338|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154229339|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
154229340|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
154229341|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
154229342|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154229343|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154229344|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
154229345|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229346|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229347|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
154229348|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229349|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154229350|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154229352|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
154229353|NCT00258440|Hematinics|hematinics|mesh-ancestor
154229354|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
154229355|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103590|NCT02549469|Analgesics|analgesics|mesh-ancestor
154229356|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229357|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154229358|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154229359|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229360|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229361|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229362|NCT00224120|Silodosin|silodosin|mesh-list
154229363|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154229364|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154229365|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154229366|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229367|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229368|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229369|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229370|NCT00224120|Urological Agents|urological agents|mesh-ancestor
154229371|NCT01226446|Vitamin D|vitamin d|mesh-list
154229372|NCT01226446|Vitamins|vitamins|mesh-ancestor
154229373|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
154229374|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229375|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154229376|NCT01224418|Tacrolimus|tacrolimus|mesh-list
154229377|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229378|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
154229379|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229380|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154229381|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229382|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229383|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
154229384|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154229385|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154229386|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154229387|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154229388|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229389|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
154229390|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229391|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229392|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154229393|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229394|NCT01129180|Azacitidine|azacitidine|mesh-list
154229395|NCT01129180|Bortezomib|bortezomib|mesh-list
154229396|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154229397|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
154229398|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229399|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229400|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229401|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
154229402|NCT00224042|Hematinics|hematinics|mesh-ancestor
154229403|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
154229404|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229405|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229406|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
154229407|NCT01221376|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154229408|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154229409|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229410|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229411|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229412|NCT01224652|Paclitaxel|paclitaxel|mesh-list
154229413|NCT01224652|Irinotecan|irinotecan|mesh-list
154229414|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154229415|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229416|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
154229417|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
154229418|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
154229419|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229420|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154229421|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154229422|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229423|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
154229424|NCT00160706|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154229425|NCT00160706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229426|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229427|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
154229428|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229429|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229431|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154229432|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154229433|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154229434|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154229435|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
154229436|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229437|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229438|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229439|NCT01226680|Tofacitinib|tofacitinib|mesh-list
154229440|NCT01226680|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154229441|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154229442|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229443|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229444|NCT00257192|Ziprasidone|ziprasidone|mesh-list
154229445|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154229446|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
154229447|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229448|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229449|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229450|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154229451|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154229452|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229453|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154229454|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154229455|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
154229456|NCT01224964|Montelukast|montelukast|mesh-list
154229457|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154229458|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
154229459|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154229460|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
154229461|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229462|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229463|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154229464|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154229465|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229466|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
154229467|NCT03967964|Testosterone|testosterone|mesh-list
154229468|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
154229470|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154229471|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154229472|NCT03967964|Androgens|androgens|mesh-ancestor
154229473|NCT03967964|Hormones|hormones|mesh-ancestor
154229474|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229475|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229476|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154229477|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229478|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
154229479|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154229480|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
154229481|NCT01129414|Omeprazole|omeprazole|mesh-list
154229482|NCT01129414|Clopidogrel|clopidogrel|mesh-list
154229483|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154229484|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154229485|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154229486|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154229487|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
154229488|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229489|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229490|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229491|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154229492|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229494|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229495|NCT03967886|Esomeprazole|esomeprazole|mesh-list
154229496|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154229497|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229498|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154229499|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229500|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229501|NCT03968042|Thiamine|thiamine|mesh-list
154229502|NCT03968042|Edaravone|edaravone|mesh-list
154229503|NCT03968042|Mitogens|mitogens|mesh-list
154229504|NCT03968042|Vitamins|vitamins|mesh-ancestor
154229505|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
154229506|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229507|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
154229508|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229509|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
154229510|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154229511|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
154229512|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154229513|NCT03968042|Protective Agents|protective agents|mesh-ancestor
154229514|NCT01128322|Niacin|niacin|mesh-list
154229515|NCT01128322|Amlodipine|amlodipine|mesh-list
154229516|NCT01128322|Telmisartan|telmisartan|mesh-list
154229517|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154229518|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154229519|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154229520|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229521|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154229522|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229523|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
154229524|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154229525|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154229526|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154229527|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
154229528|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154229529|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
154229530|NCT01128322|Vitamins|vitamins|mesh-ancestor
154229531|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
154229532|NCT01129570|Silybin|silybin|mesh-list
154229533|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154229534|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229535|NCT01129570|Protective Agents|protective agents|mesh-ancestor
154229536|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229537|NCT01073540|Cephalexin|cephalexin|mesh-list
154229538|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229539|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229540|NCT03740386|Phentolamine|phentolamine|mesh-list
154229541|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154229542|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154229543|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229544|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229545|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229546|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229547|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154229549|NCT03927352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154229550|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229551|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229552|NCT01225198|Vitamins|vitamins|mesh-list
154229553|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
154229554|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229555|NCT01226992|Vancomycin|vancomycin|mesh-list
154229556|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229557|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229558|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
154229559|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154229560|NCT03740464|Lenograstim|lenograstim|mesh-list
154229561|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154229562|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
154229563|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229564|NCT03927118|Dexamethasone|dexamethasone|mesh-list
154229565|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
154229566|NCT03927118|BB 1101|bb 1101|mesh-list
154229567|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229568|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
154229569|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
154229570|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229571|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229572|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229573|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
154229575|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229576|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154229577|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229578|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
154229579|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229580|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229581|NCT01227148|Insulin|insulin|mesh-list
154229582|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154229583|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229584|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
154229585|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154229586|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154229587|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
154229588|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154229589|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229590|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154229591|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229592|NCT01128712|Pregabalin|pregabalin|mesh-list
154229593|NCT01128712|Analgesics|analgesics|mesh-ancestor
154229594|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
154229595|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229596|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229597|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
154229598|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154229599|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154229600|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229601|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154229602|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154229603|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154229604|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229605|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154229606|NCT01127386|Lenalidomide|lenalidomide|mesh-list
154229607|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
154229608|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229609|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154229610|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154229611|NCT01127386|Growth Substances|growth substances|mesh-ancestor
154229612|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
154229613|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229614|NCT01130194|Procarbazine|procarbazine|mesh-list
154229615|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229616|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
154229617|NCT01225744|Irinotecan|irinotecan|mesh-list
154229618|NCT01225744|Cetuximab|cetuximab|mesh-list
154229619|NCT01225744|Tegafur|tegafur|mesh-list
154103842|NCT00903292|Pemetrexed|pemetrexed|mesh-list
154229620|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229621|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154229622|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154229623|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229624|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229625|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154229626|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154229627|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
154229628|NCT03926806|Vitamins|vitamins|mesh-list
154229629|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
154229630|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
154229631|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229632|NCT03926962|Nafithromycin|nafithromycin|mesh-list
154229633|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229634|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229635|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154229636|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229637|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229638|NCT03919786|Anesthetics|anesthetics|mesh-list
154229639|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229640|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229641|NCT03924544|Mitomycins|mitomycins|mesh-list
154229642|NCT03924544|Mitomycin|mitomycin|mesh-list
154229643|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154229644|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255842|NCT03890510|Anesthetics|anesthetics|mesh-list
154229645|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
154229646|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229647|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154229648|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229649|NCT01131364|Doxorubicin|doxorubicin|mesh-list
154229650|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154229651|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229652|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154229653|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154229654|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229655|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229656|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
154229657|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154229658|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154229659|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229660|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154229661|NCT02529202|Analgesics|analgesics|mesh-ancestor
154229662|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
154229663|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229664|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154229665|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154229666|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154229667|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229668|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229669|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229670|NCT00154310|Cyclosporine|cyclosporine|mesh-list
154229671|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
154229672|NCT00154310|Everolimus|everolimus|mesh-list
154229673|NCT00154310|Cyclosporins|cyclosporins|mesh-list
154229674|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229675|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229676|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229677|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
154229678|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229679|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
154229680|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229681|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
154229682|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229683|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154229684|NCT00154310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154229685|NCT00154310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154229686|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229687|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154229688|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154229689|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
154229690|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229691|NCT03770728|Metformin|metformin|mesh-list
154229692|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
154229693|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153976595|NCT01059539|Cariprazine|cariprazine|mesh-list
154229695|NCT01132222|Ibuprofen|ibuprofen|mesh-list
154229696|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
154229697|NCT01132222|Ephedrine|ephedrine|mesh-list
154229698|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154229699|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154229700|NCT01132222|Analgesics|analgesics|mesh-ancestor
154229701|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
154229702|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229703|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229704|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229705|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229706|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154229707|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229708|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229709|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154229710|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
154229711|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154229712|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
154229713|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
154229714|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154229715|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154229716|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
154229717|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229718|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229721|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229722|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229723|NCT01130506|Cytarabine|cytarabine|mesh-list
154229724|NCT01130506|Decitabine|decitabine|mesh-list
154229725|NCT01130506|Vorinostat|vorinostat|mesh-list
154229726|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154229727|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
154229728|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229729|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229730|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
154229731|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229732|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229733|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
154229734|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229735|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229736|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154229737|NCT01130662|Decitabine|decitabine|mesh-list
154229738|NCT01130662|Midostaurin|midostaurin|mesh-list
154229739|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154229740|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
154229741|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229742|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229743|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229744|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154229745|NCT03925714|Metformin|metformin|mesh-list
154229746|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154229747|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229748|NCT01228552|Ketoprofen|ketoprofen|mesh-list
154229749|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154229750|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154229751|NCT01228552|Analgesics|analgesics|mesh-ancestor
154229752|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
154229753|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229754|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229755|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229756|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229757|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154229758|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229759|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229760|NCT03919084|Nicotine|nicotine|mesh-list
154229761|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154229762|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
154229763|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229764|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229765|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154229766|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154229767|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
154229768|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229769|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229770|NCT03923842|Denosumab|denosumab|mesh-list
154229771|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154229772|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229773|NCT01132768|Atenolol|atenolol|mesh-list
154229774|NCT01132768|Olmesartan|olmesartan|mesh-list
154229775|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154229776|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154229777|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154229778|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154229779|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229780|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154229781|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
154229782|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
154229783|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229784|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229786|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154229787|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154229788|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229789|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229790|NCT01230034|Ramipril|ramipril|mesh-list
154229791|NCT01230034|Imidapril|imidapril|mesh-list
154229792|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154143900|NCT00519285|Docetaxel|docetaxel|mesh-list
154229793|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
154229794|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229795|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229796|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154229797|NCT03918616|Dopamine|dopamine|mesh-list
154229798|NCT03918616|Memantine|memantine|mesh-list
154229799|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
154229800|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154229801|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154104063|NCT00921570|Amlodipine|amlodipine|mesh-list
154229802|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
154229803|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229804|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229805|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229806|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154229807|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154229808|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154229809|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
154229810|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
154229811|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229812|NCT03918616|Protective Agents|protective agents|mesh-ancestor
154229813|NCT01228630|Loratadine|loratadine|mesh-list
154229814|NCT01228630|Fexofenadine|fexofenadine|mesh-list
154229815|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
154229816|NCT01228630|Ephedrine|ephedrine|mesh-list
154229817|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
154229818|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
154229819|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154229820|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154229821|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154229822|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
154229823|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
154229824|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229825|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229826|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229827|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154229828|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
154229829|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229830|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154229831|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
154229832|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
154229833|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154229834|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154229835|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
154229836|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229837|NCT01134406|Hylan|hylan|mesh-list
154229838|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
154229839|NCT01134406|Protective Agents|protective agents|mesh-ancestor
154229840|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104064|NCT00921570|Valsartan|valsartan|mesh-list
154229841|NCT01231828|Lactulose|lactulose|mesh-list
154229842|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229843|NCT03923218|Vitamin D|vitamin d|mesh-list
154229844|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
154229845|NCT03923218|Vitamins|vitamins|mesh-ancestor
154229846|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
154229847|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229848|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154229849|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154229850|NCT03923140|Tranilast|tranilast|mesh-list
154229851|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154229852|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154229853|NCT03923140|Analgesics|analgesics|mesh-ancestor
154229854|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
154229855|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229856|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229857|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229858|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154229859|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154229860|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154229861|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229862|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154229863|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154229864|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
154229865|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
154229866|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229867|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154229868|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154229870|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229871|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229872|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154229873|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154229874|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
154229875|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
154229876|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229877|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229878|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229879|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154229880|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154229882|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154229883|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154229884|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229885|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229886|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
154229887|NCT01134484|Thalidomide|thalidomide|mesh-list
154229888|NCT01134484|Dexamethasone|dexamethasone|mesh-list
154229889|NCT01134484|Bortezomib|bortezomib|mesh-list
154229890|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229891|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
154229892|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
154229893|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229894|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229895|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229896|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
154229897|NCT01134484|Hormones|hormones|mesh-ancestor
154229898|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229899|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154229900|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229901|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154229902|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
154229903|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
154229904|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229905|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229906|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154229907|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154229908|NCT01134484|Growth Substances|growth substances|mesh-ancestor
154229909|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
154229910|NCT01133470|Fexofenadine|fexofenadine|mesh-list
154229911|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
154229912|NCT01133470|Ephedrine|ephedrine|mesh-list
154229913|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154229914|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154229915|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154229916|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
154229917|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
154229918|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229919|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229920|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229921|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154229922|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
154229923|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229924|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154229925|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
154229926|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
154229927|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154104147|NCT02564094|Hematinics|hematinics|mesh-ancestor
154229928|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154229929|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
154229930|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229931|NCT01134718|Simeprevir|simeprevir|mesh-list
154229932|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
154229933|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229934|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
154229935|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154229936|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229937|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
154229938|NCT03917758|Empagliflozin|empagliflozin|mesh-list
154229939|NCT03917758|Canagliflozin|canagliflozin|mesh-list
154229940|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154229941|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229942|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154229943|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229944|NCT01230736|Timolol|timolol|mesh-list
154229945|NCT01230736|Travoprost|travoprost|mesh-list
154229946|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154229947|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154229948|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154229949|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154229950|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
154229951|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154229952|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154229953|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229954|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154229955|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154229956|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
154229957|NCT01133548|Testosterone|testosterone|mesh-list
154229958|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
154229959|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
154229960|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154229961|NCT01133548|Androgens|androgens|mesh-ancestor
154229962|NCT01133548|Hormones|hormones|mesh-ancestor
154229963|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229964|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229965|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154229966|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154229967|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
154229968|NCT03917134|Metronidazole|metronidazole|mesh-list
154229969|NCT03917134|Cephalosporins|cephalosporins|mesh-list
154229970|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229971|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154229972|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154229973|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154229974|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154229975|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154229976|NCT01231126|Misoprostol|misoprostol|mesh-list
154229977|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154229978|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
154229979|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154229980|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229981|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154229982|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154229983|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
154229984|NCT03769090|Budesonide|budesonide|mesh-list
154229985|NCT03769090|Albuterol|albuterol|mesh-list
154229986|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154229987|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154229988|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
154229989|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154229990|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154229991|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154229992|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
153976899|NCT00622011|Risperidone|risperidone|mesh-list
154229993|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
154229994|NCT03769090|Hormones|hormones|mesh-ancestor
154229995|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154229996|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
154229997|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154229998|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154229999|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154230000|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154230001|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
154230002|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230003|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230004|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154230005|NCT03921736|Perindopril|perindopril|mesh-list
154230006|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154230007|NCT03921736|Diuretics|diuretics|mesh-ancestor
154230008|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
154230009|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230010|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154230011|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154230012|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230013|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154230014|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
154230015|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230016|NCT05401006|Acitretin|acitretin|mesh-list
154230017|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
154230018|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
154230019|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
154230020|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230021|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230022|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
154230023|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154230024|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230025|NCT01131754|Heparin|heparin|mesh-list
154230026|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
154230027|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154230028|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154230029|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230030|NCT01231594|Trametinib|trametinib|mesh-list
154230031|NCT01231594|Dabrafenib|dabrafenib|mesh-list
154230032|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
154104234|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
154230033|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230034|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230035|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230036|NCT01136278|Clonidine|clonidine|mesh-list
154230037|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154230038|NCT01136278|Analgesics|analgesics|mesh-ancestor
154230039|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
154230040|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230041|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230042|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154230043|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
154230044|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
154230045|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154230046|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154230047|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154230048|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
154230049|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230050|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230051|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
154230052|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154230053|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
154230054|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154230055|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154230056|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154230057|NCT05402722|Antibodies|antibodies|mesh-list
154230058|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
154230059|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230060|NCT05480488|Midazolam|midazolam|mesh-list
154230061|NCT05480488|Warfarin|warfarin|mesh-list
154230062|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154230063|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154230064|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230065|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230066|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154230067|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154230068|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154230069|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153976972|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154230070|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
154230071|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
154230072|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
154230073|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
154230074|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230075|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230076|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
154230077|NCT01229332|Carbidopa|carbidopa|mesh-list
154230078|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154230079|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154230080|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
154230081|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230082|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230083|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230084|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154230085|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230086|NCT03921034|Ropivacaine|ropivacaine|mesh-list
154230087|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
154230088|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
154230089|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230090|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230091|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
154230092|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230093|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
154230094|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154230095|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154230096|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230098|NCT01136590|Coagulants|coagulants|mesh-ancestor
154230099|NCT03920878|Aflibercept|aflibercept|mesh-list
154230100|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154230101|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154230102|NCT03920878|Growth Substances|growth substances|mesh-ancestor
154230103|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230104|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
154230105|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230106|NCT03920644|Scopolamine|scopolamine|mesh-list
154230107|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154230108|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154230109|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
154230110|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
154230111|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230112|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230113|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154230114|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
154230115|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154230116|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
154230117|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230118|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230119|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154104375|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230120|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
154230121|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
154230122|NCT01137916|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154230123|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230124|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230125|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230126|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230128|NCT01137994|Vinorelbine|vinorelbine|mesh-list
154230129|NCT01137994|Docetaxel|docetaxel|mesh-list
154230130|NCT01137994|Trastuzumab|trastuzumab|mesh-list
154230131|NCT01137994|Lapatinib|lapatinib|mesh-list
154230132|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154230133|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230134|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
154230135|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
154230136|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
154230137|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230138|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230139|NCT01137994|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154230140|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230141|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230142|NCT01138072|Atorvastatin|atorvastatin|mesh-list
154230143|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154230144|NCT01138072|Simvastatin|simvastatin|mesh-list
154230145|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153977052|NCT02347917|Pemetrexed|pemetrexed|mesh-list
154230146|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154230147|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
154230148|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230149|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154230150|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154230151|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230152|NCT01131910|Vaccines|vaccines|mesh-list
154230153|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
154230154|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230156|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
154230157|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154230158|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154230159|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
154230160|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230161|NCT01233622|Vildagliptin|vildagliptin|mesh-list
154230162|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154230163|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230164|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154230165|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
154230166|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230167|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230168|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
154230170|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230171|NCT01138774|Protective Agents|protective agents|mesh-ancestor
154230172|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230173|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
154230174|NCT01138774|Vitamins|vitamins|mesh-ancestor
154230175|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
154230176|NCT01131988|Tacrolimus|tacrolimus|mesh-list
154230177|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230178|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
154230179|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230180|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154230181|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230182|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230183|NCT01138852|Ampicillin|ampicillin|mesh-list
154230184|NCT01138852|Cefuroxime|cefuroxime|mesh-list
154230185|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
154230186|NCT01138852|Sulbactam|sulbactam|mesh-list
154230187|NCT01138852|Sultamicillin|sultamicillin|mesh-list
154230188|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154230189|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230190|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154230191|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230192|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230193|NCT01585870|Sorafenib|sorafenib|mesh-list
154230194|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230195|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230196|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230197|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230198|NCT05210140|Escitalopram|escitalopram|mesh-list
154230199|NCT05210140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154104409|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
154104452|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
154230200|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154230201|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154230202|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230203|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230204|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
154230205|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230206|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
154230207|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154230208|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154230209|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
154230210|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
154230211|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230212|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230213|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230214|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
154230215|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154230216|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154230217|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154230218|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154230219|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230220|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154230221|NCT05195944|Semaglutide|semaglutide|mesh-list
154230222|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154230223|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230224|NCT05195944|Incretins|incretins|mesh-ancestor
154230225|NCT05195944|Hormones|hormones|mesh-ancestor
154230226|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230227|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154230228|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
154230229|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230230|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230231|NCT05195944|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154230232|NCT01236586|Dexamethasone|dexamethasone|mesh-list
154230233|NCT01236586|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154230234|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154230235|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
154230236|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
154230237|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230238|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230239|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154230240|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
154230241|NCT01236586|Hormones|hormones|mesh-ancestor
154104453|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
154230242|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230243|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154230244|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230245|NCT01236586|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154230246|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230247|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230249|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154230250|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
154230251|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230252|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230253|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154230254|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154230255|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
154230256|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230257|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230258|NCT03467932|Insulin|insulin|mesh-list
154230259|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154230260|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154230261|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230262|NCT01140100|Thiopental|thiopental|mesh-list
154230263|NCT01140100|Propofol|propofol|mesh-list
154230264|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154230265|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230266|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230267|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154230268|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
154230269|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
154230270|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
154230271|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
154230272|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
154230273|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230274|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230275|NCT01141036|Midazolam|midazolam|mesh-list
154230276|NCT01141036|Propofol|propofol|mesh-list
154230277|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154230278|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230279|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230280|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154230281|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
154230282|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
154230283|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154230284|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154230285|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154230286|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154230287|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
154230288|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
154230289|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230290|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230291|NCT04906720|Colchicine|colchicine|mesh-list
154230292|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
154230293|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230294|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
154230295|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
154230296|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
154230297|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230298|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230300|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
154230301|NCT01141192|Vitamins|vitamins|mesh-ancestor
154230302|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
154230303|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230304|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154230305|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154230306|NCT01144000|Daptomycin|daptomycin|mesh-list
154230307|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154230308|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230309|NCT01140412|Ritonavir|ritonavir|mesh-list
154230310|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
154230311|NCT01140412|Maraviroc|maraviroc|mesh-list
154230312|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154230313|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154230314|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
154230315|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230316|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230317|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154230318|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154230319|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
154230320|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230321|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154230322|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154230323|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154230324|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154230325|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154230326|NCT01234324|Cisplatin|cisplatin|mesh-list
154230327|NCT01234324|Capecitabine|capecitabine|mesh-list
154230328|NCT01234324|Epirubicin|epirubicin|mesh-list
154230329|NCT01234324|Panitumumab|panitumumab|mesh-list
154230330|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230331|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154230332|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
154230333|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230334|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154230335|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154230336|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154230337|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230338|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230339|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
154230340|NCT02334124|Floxacillin|floxacillin|mesh-list
154230341|NCT02334124|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154230342|NCT02334124|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154230343|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154230344|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230345|NCT01144156|Adalimumab|adalimumab|mesh-list
154230346|NCT01144156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154230347|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154230348|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230349|NCT01235260|Becaplermin|becaplermin|mesh-list
154230350|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
154230351|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154230352|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154230353|NCT01235260|Growth Substances|growth substances|mesh-ancestor
154230354|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230355|NCT01144312|Fentanyl|fentanyl|mesh-list
154230356|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154230357|NCT01144312|Narcotics|narcotics|mesh-ancestor
154230358|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230359|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230360|NCT01144312|Analgesics|analgesics|mesh-ancestor
154230361|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
154230362|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230363|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154230364|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154230365|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
154230366|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
154230367|NCT01144390|Methadone|methadone|mesh-list
154230368|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154230369|NCT01144390|Narcotics|narcotics|mesh-ancestor
154230370|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230371|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230372|NCT01144390|Analgesics|analgesics|mesh-ancestor
154230373|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
154230374|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230375|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
154230376|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
154230377|NCT01329640|Paclitaxel|paclitaxel|mesh-list
154230380|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154230381|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230382|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
154230383|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
154230384|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
154230385|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230386|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230387|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
154230388|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230389|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230390|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154230391|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
154230392|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154230393|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230394|NCT05335018|Lenalidomide|lenalidomide|mesh-list
154230395|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
154230396|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230397|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154230398|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154230399|NCT05335018|Growth Substances|growth substances|mesh-ancestor
154230400|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
154230401|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230403|NCT00114777|Abatacept|abatacept|mesh-list
154230404|NCT00114777|Cyclosporins|cyclosporins|mesh-list
154230405|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230406|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230407|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230408|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
154230409|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230410|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
154230411|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230412|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
154230413|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230414|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154230415|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154230416|NCT00114777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230417|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230418|NCT00139737|Ziprasidone|ziprasidone|mesh-list
154230419|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154230420|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
154230421|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104623|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154230422|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230423|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230424|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154230425|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154230426|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230427|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154230428|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154230429|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
154230430|NCT00139659|Insulin|insulin|mesh-list
154230431|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154230432|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154230433|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230434|NCT01076439|Fluticasone|fluticasone|mesh-list
154230435|NCT01076439|Xhance|xhance|mesh-list
154230436|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154230437|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154230438|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154230439|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
154230440|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230441|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230442|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154230443|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
154230444|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
153977347|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
154230445|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154230446|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154230447|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154230449|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
154230450|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230451|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154230452|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154230453|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
154230454|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
154230455|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230456|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230457|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
154230458|NCT03965637|Vitamins|vitamins|mesh-ancestor
154230459|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
154230460|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230461|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
154230462|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230463|NCT03965637|Protective Agents|protective agents|mesh-ancestor
154230464|NCT01078779|Chloroquine|chloroquine|mesh-list
154230465|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154230466|NCT01078779|Amebicides|amebicides|mesh-ancestor
154230467|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154230468|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154230469|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230470|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
154230471|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230472|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154230473|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154230474|NCT01078779|Analgesics|analgesics|mesh-ancestor
154230475|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
154230476|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230477|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230478|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154230479|NCT01078779|Filaricides|filaricides|mesh-ancestor
154230480|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
154230481|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
154230482|NCT00114231|Capecitabine|capecitabine|mesh-list
154230483|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
154230484|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154230485|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
154230486|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230487|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230489|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
154230490|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230491|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230492|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
154230493|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230494|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154230495|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230496|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154230497|NCT00113841|Curcumin|curcumin|mesh-list
154230498|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154230499|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154230500|NCT00113841|Analgesics|analgesics|mesh-ancestor
154104748|NCT00839397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154230501|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
154230502|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230503|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230504|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154230505|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230506|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230507|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230508|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230509|NCT00113607|Dexamethasone|dexamethasone|mesh-list
154230510|NCT00113607|Trabectedin|trabectedin|mesh-list
154230511|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154230512|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
154230513|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
154230514|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230515|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230516|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154230517|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
154230518|NCT00113607|Hormones|hormones|mesh-ancestor
154230519|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230520|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154230521|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230522|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154230523|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
154230524|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230525|NCT00113529|Sunitinib|sunitinib|mesh-list
154230527|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230528|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154230529|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154230530|NCT00113529|Growth Substances|growth substances|mesh-ancestor
154230531|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230532|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
154230533|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230534|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230535|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230536|NCT00113529|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154230537|NCT01079013|Treosulfan|treosulfan|mesh-list
154230538|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154230539|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
154230540|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230541|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230542|NCT00134901|Memantine|memantine|mesh-list
154230543|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154230544|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154230545|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
154230546|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230547|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230548|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230549|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154230550|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154230551|NCT01076595|Interferons|interferons|mesh-list
154230552|NCT01076595|Interferon-beta|interferon-beta|mesh-list
154230553|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
154230554|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230555|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
154230556|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230557|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
154230558|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230559|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154230560|NCT00113373|Lapatinib|lapatinib|mesh-list
154230561|NCT00113373|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154230562|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230563|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230564|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230565|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230566|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154230567|NCT00113295|Paroxetine|paroxetine|mesh-list
154230568|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
154230569|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154230570|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154230571|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154230572|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230573|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230574|NCT00113295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154230575|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154230576|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154230577|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230578|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230579|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
154230580|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154230581|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154230582|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154230583|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230584|NCT00112905|Sorafenib|sorafenib|mesh-list
154104789|NCT00621309|Protective Agents|protective agents|mesh-ancestor
154230585|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230586|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230587|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230588|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230589|NCT00427895|Vaccines|vaccines|mesh-list
154230590|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154230591|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
154230592|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230593|NCT01034189|Paclitaxel|paclitaxel|mesh-list
154230594|NCT01034189|Cetuximab|cetuximab|mesh-list
154230595|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154253912|NCT01141556|Selenium|selenium|mesh-list
154230596|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230597|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
154230598|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
154230599|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
154230600|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230601|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230602|NCT00425945|Pycnogenols|pycnogenols|mesh-list
154230603|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154230604|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
154230605|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230606|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
154230607|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230608|NCT00425945|Protective Agents|protective agents|mesh-ancestor
154230609|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154230610|NCT00121641|Metformin|metformin|mesh-list
154230611|NCT00121641|Saxagliptin|saxagliptin|mesh-list
154230612|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154230613|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230614|NCT00121641|Incretins|incretins|mesh-ancestor
154230615|NCT00121641|Hormones|hormones|mesh-ancestor
154230616|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230617|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154230618|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
154230619|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230620|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230621|NCT00425555|Panobinostat|panobinostat|mesh-list
154230622|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230623|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154230624|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230625|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230626|NCT00424775|Vorinostat|vorinostat|mesh-list
154230627|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230628|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154230629|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230630|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230631|NCT01034345|Sirolimus|sirolimus|mesh-list
154230632|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154230633|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154230634|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230635|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154230636|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230637|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
154230638|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230639|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
154230640|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230641|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230642|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230643|NCT01763866|Atorvastatin|atorvastatin|mesh-list
154230644|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154230645|NCT01763866|Simvastatin|simvastatin|mesh-list
154230646|NCT01763866|Ezetimibe|ezetimibe|mesh-list
154230647|NCT01763866|Evolocumab|evolocumab|mesh-list
154230648|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154230649|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154230650|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154230651|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
154230652|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230653|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154230654|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154230655|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230656|NCT01763866|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154230657|NCT01763866|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154230658|NCT01763866|Protease Inhibitors|protease inhibitors|mesh-ancestor
154230659|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
154230660|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230661|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
154230662|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154104873|NCT00623727|Coagulants|coagulants|mesh-ancestor
154230663|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154230664|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
154230665|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
154230666|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731737|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
154230667|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230668|NCT01588925|Dexamethasone|dexamethasone|mesh-list
154230669|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
154230671|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
154230672|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154230673|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
154230674|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
154230675|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230676|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230677|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154230678|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
154230679|NCT01588925|Hormones|hormones|mesh-ancestor
154230680|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230681|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154230682|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230683|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
154230684|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230685|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230686|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154230687|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
154230688|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
154230689|NCT01588925|Protective Agents|protective agents|mesh-ancestor
154230690|NCT01238146|Rituximab|rituximab|mesh-list
154230691|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154230692|NCT01238146|Obatoclax|obatoclax|mesh-list
154230693|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230694|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230695|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
154230696|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230697|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230698|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154230699|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
154230700|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230701|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230702|NCT01141894|Phenylephrine|phenylephrine|mesh-list
154230703|NCT01141894|Dobutamine|dobutamine|mesh-list
154230704|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
154230705|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154230706|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154230707|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
154230708|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
154230709|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230710|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230711|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
154230712|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154230713|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
154230714|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
154230715|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154230716|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154230717|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154230718|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
154230719|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154230720|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230721|NCT01141894|Protective Agents|protective agents|mesh-ancestor
154230722|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154230723|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154230724|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
154230725|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
154230726|NCT01238224|Tadalafil|tadalafil|mesh-list
154230727|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
154230728|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154230729|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154230730|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230731|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230732|NCT01238224|Urological Agents|urological agents|mesh-ancestor
154230733|NCT01237444|Ritonavir|ritonavir|mesh-list
154230734|NCT01237444|Lopinavir|lopinavir|mesh-list
154230735|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154230736|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154230737|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
154230738|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230739|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230740|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154230741|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154230742|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
154230743|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230744|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154230745|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154230746|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
154230747|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230748|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230749|NCT01141972|Vitamin D|vitamin d|mesh-list
154230750|NCT01141972|Vitamins|vitamins|mesh-ancestor
154230751|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
154230752|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230753|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154230754|NCT04316806|Rifaximin|rifaximin|mesh-list
154230755|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154230756|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230757|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154230758|NCT01145326|Lidocaine|lidocaine|mesh-list
154230759|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
154230760|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
154230761|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230762|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230763|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
154230764|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230765|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154230766|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154230767|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154230768|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154230769|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230770|NCT01144702|Artesunate|artesunate|mesh-list
154230771|NCT01144702|Mefloquine|mefloquine|mesh-list
154230772|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
154230773|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154230774|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154230775|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230776|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230777|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
154230778|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
154230779|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154230780|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
154230781|NCT01145404|Capecitabine|capecitabine|mesh-list
154230782|NCT01145404|Lapatinib|lapatinib|mesh-list
154230783|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154230784|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
154230785|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230786|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230787|NCT01145404|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154230788|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230789|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230790|NCT01237522|Metformin|metformin|mesh-list
154104998|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
154230791|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154230792|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230793|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
154230794|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230795|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230796|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230797|NCT04246996|Gentamicins|gentamicins|mesh-list
154230798|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154230799|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230800|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154230801|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230802|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230803|NCT00424463|Edaravone|edaravone|mesh-list
154230804|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154230805|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
154230806|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230807|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154230808|NCT00424463|Protective Agents|protective agents|mesh-ancestor
154230809|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230810|NCT01324115|Nitroarginine|nitroarginine|mesh-list
154230811|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230812|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230813|NCT01037621|Valacyclovir|valacyclovir|mesh-list
154230814|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
154230815|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230816|NCT00424385|Sorafenib|sorafenib|mesh-list
154230817|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
154230818|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230819|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230820|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977719|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
154230821|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230822|NCT00424385|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154230824|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154230825|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230826|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230827|NCT00423917|Bevacizumab|bevacizumab|mesh-list
154230828|NCT00423917|Fulvestrant|fulvestrant|mesh-list
154230829|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230830|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230831|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154230832|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154230833|NCT00423917|Growth Substances|growth substances|mesh-ancestor
154230834|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230835|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
154230836|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154230837|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154230838|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154230839|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
154230840|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230841|NCT00845026|Olanzapine|olanzapine|mesh-list
154230842|NCT00845026|Risperidone|risperidone|mesh-list
154230843|NCT00845026|Aripiprazole|aripiprazole|mesh-list
154230844|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154230845|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
154105045|NCT00935194|Oseltamivir|oseltamivir|mesh-list
154230847|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230848|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230849|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154230850|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154230851|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154230852|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154230853|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154230854|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
154230855|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
154230856|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
154230857|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230858|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154230859|NCT00845026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154230860|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154230861|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154230862|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
154230863|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
154230864|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154230865|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154230866|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154230867|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154230868|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154230869|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
154230870|NCT02445131|Idelalisib|idelalisib|mesh-list
154230871|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154230872|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
154230873|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230874|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230875|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154230876|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230877|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
154230878|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230879|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
154230880|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230881|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230882|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154230883|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
154230884|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105094|NCT00935506|Aspirin|aspirin|mesh-list
154230885|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230886|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154230887|NCT01145950|Etanercept|etanercept|mesh-list
154230888|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154230889|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154230890|NCT01145950|Analgesics|analgesics|mesh-ancestor
154230891|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
154230892|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154230893|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230894|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154230895|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154230896|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154230897|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230898|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
154230899|NCT01238926|Vitamins|vitamins|mesh-list
154230900|NCT01238926|Folic Acid|folic acid|mesh-list
154230901|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
154230902|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
154230903|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
154230904|NCT01238926|Pyridoxal|pyridoxal|mesh-list
154230905|NCT01238926|Pyridoxine|pyridoxine|mesh-list
154230906|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
154230907|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
154230908|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230909|NCT01238926|Hematinics|hematinics|mesh-ancestor
154230910|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154230911|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154230912|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154230913|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
154230914|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230915|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154230916|NCT01142518|Interferons|interferons|mesh-list
154230917|NCT01142518|Interferon-beta|interferon-beta|mesh-list
154230918|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
154230919|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230920|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
154230921|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230922|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
154230923|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230924|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154230925|NCT00423449|Gemcitabine|gemcitabine|mesh-list
154230926|NCT00423449|Vorinostat|vorinostat|mesh-list
154230927|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154230928|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
154230929|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230930|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230931|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154230932|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230933|NCT00423293|Fluorouracil|fluorouracil|mesh-list
154230934|NCT00423293|Mitomycins|mitomycins|mesh-list
154230935|NCT00423293|Mitomycin|mitomycin|mesh-list
154230936|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
154230937|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230938|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154230939|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230940|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230941|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
154230942|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230943|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154230944|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
154230945|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154230946|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230947|NCT00422903|Letrozole|letrozole|mesh-list
154230948|NCT00422903|Lapatinib|lapatinib|mesh-list
154230949|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230950|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154230951|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154230952|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230953|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230954|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154230955|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
154230956|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154230957|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230958|NCT00422903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154230959|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154230960|NCT00422591|Cytarabine|cytarabine|mesh-list
154230961|NCT00422591|Idarubicin|idarubicin|mesh-list
154230962|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154230963|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
154105169|NCT00840489|Ribavirin|ribavirin|mesh-list
154230964|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230965|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230966|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
154230967|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230968|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154230969|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
154230970|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154230971|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154230972|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154230973|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154230974|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230975|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
154230976|NCT00422513|Hematinics|hematinics|mesh-ancestor
154230977|NCT00202878|Simvastatin|simvastatin|mesh-list
154230978|NCT00202878|Ezetimibe|ezetimibe|mesh-list
154230979|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154230980|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154230981|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154230982|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
154230983|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230984|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154230985|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154230986|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230987|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
154230988|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
154230989|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154230990|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154230991|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154230992|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154230993|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154230994|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154230995|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154230996|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154230997|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154230998|NCT00260208|Cyclosporine|cyclosporine|mesh-list
154230999|NCT00260208|Tacrolimus|tacrolimus|mesh-list
154231000|NCT00260208|Cyclosporins|cyclosporins|mesh-list
154231001|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154231002|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
154231003|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231004|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154231005|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231006|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231007|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
154231008|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231009|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
154231010|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154231011|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
154231012|NCT00202644|Anagrelide|anagrelide|mesh-list
154231013|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231014|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
154231015|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231016|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231017|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154231018|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154231019|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154231020|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154231021|NCT00259740|Denosumab|denosumab|mesh-list
154231022|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154231023|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231024|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154231025|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154231026|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231027|NCT01236040|Vaccines|vaccines|mesh-list
154231028|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
154231029|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231030|NCT01146028|Tizanidine|tizanidine|mesh-list
154231031|NCT01146028|Analgesics|analgesics|mesh-ancestor
154231032|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
154231033|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231034|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231035|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
154231036|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154231037|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154231038|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
154231039|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
154231040|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154231041|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154231042|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154231043|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
154231044|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231045|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231046|NCT03530800|Dronabinol|dronabinol|mesh-list
154231048|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231049|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154231050|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154231051|NCT03530800|Analgesics|analgesics|mesh-ancestor
154231052|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
154231053|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231054|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154231055|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154231056|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231057|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231058|NCT03530800|Hormones|hormones|mesh-ancestor
154231059|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231060|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
154231061|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154231062|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
154231063|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231064|NCT04982146|Expectorants|expectorants|mesh-ancestor
154231065|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
154231066|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154231067|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
154231068|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231069|NCT04982146|Protective Agents|protective agents|mesh-ancestor
154231070|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392965|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231071|NCT04982146|Antidotes|antidotes|mesh-ancestor
154231072|NCT04958746|Propofol|propofol|mesh-list
154231073|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154231074|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231075|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231076|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154231077|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
154231078|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
154231079|NCT01146106|Pravastatin|pravastatin|mesh-list
154231080|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154231081|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154231082|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
154231083|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231084|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154231085|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154231086|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231087|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
154231088|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154231089|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
154231090|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231091|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
154231092|NCT03431584|Protective Agents|protective agents|mesh-ancestor
154231093|NCT00259272|Olanzapine|olanzapine|mesh-list
154231094|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
154231095|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
154231096|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231097|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231098|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231099|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154231100|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154105304|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
154231101|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231102|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154231103|NCT00259272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154231104|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154231105|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154253928|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154231106|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231107|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231109|NCT03106324|Lenalidomide|lenalidomide|mesh-list
154231110|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
154231111|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231112|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154231113|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154231114|NCT03106324|Growth Substances|growth substances|mesh-ancestor
154231115|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
154231116|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231117|NCT01147276|Vildagliptin|vildagliptin|mesh-list
154231118|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154231119|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231120|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154231122|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231123|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231124|NCT01239940|Paclitaxel|paclitaxel|mesh-list
154231125|NCT01239940|Everolimus|everolimus|mesh-list
154231126|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154231127|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231128|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
154231129|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
154231130|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
154231131|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231132|NCT01239940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154231133|NCT01239940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154231134|NCT01239940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231135|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154231136|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
154231137|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231138|NCT02526004|Tobramycin|tobramycin|mesh-list
154231139|NCT02526004|Ceftazidime|ceftazidime|mesh-list
154231140|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154231141|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231142|NCT02526004|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154231143|NCT02526004|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154231144|NCT00421889|Paclitaxel|paclitaxel|mesh-list
154231145|NCT00421889|Carboplatin|carboplatin|mesh-list
154231146|NCT00421889|Belinostat|belinostat|mesh-list
154231147|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154231148|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231149|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
154231150|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
154231151|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
154231152|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231153|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154231154|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231155|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
154231156|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
154231157|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231158|NCT03913468|Protective Agents|protective agents|mesh-ancestor
154231159|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231160|NCT03913468|Vitamins|vitamins|mesh-ancestor
154231161|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
154231162|NCT01147354|Selenium|selenium|mesh-list
154231163|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
154231164|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231165|NCT01147354|Protective Agents|protective agents|mesh-ancestor
154231166|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231167|NCT01147354|Trace Elements|trace elements|mesh-ancestor
154231168|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
154231169|NCT04744480|Anesthetics|anesthetics|mesh-list
154231170|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231171|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231172|NCT01147432|Capsaicin|capsaicin|mesh-list
154231173|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
154231174|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
154231175|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
154231176|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231177|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231178|NCT01147510|Montelukast|montelukast|mesh-list
154105422|NCT00936442|Anastrozole|anastrozole|mesh-list
154231179|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154231180|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
154231181|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154231182|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
154231183|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231184|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231185|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154231186|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154231187|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231188|NCT03916432|Sirolimus|sirolimus|mesh-list
154231189|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154231190|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231191|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154231192|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231193|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
154231194|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154231195|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
154231196|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231197|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
154231198|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154231199|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231200|NCT00421733|Vitamins|vitamins|mesh-ancestor
154231201|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
154231202|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154231203|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
154231204|NCT00421343|Vitamin D|vitamin d|mesh-list
154231205|NCT00421343|Alendronate|alendronate|mesh-list
154231206|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
154231207|NCT00421343|Calcium|calcium|mesh-list
154231208|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154231209|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231210|NCT00421343|Vitamins|vitamins|mesh-ancestor
154231211|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
154231212|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154231213|NCT00421343|Antacids|antacids|mesh-ancestor
154231214|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231215|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231216|NCT01147588|Esomeprazole|esomeprazole|mesh-list
154231217|NCT01147588|Omeprazole|omeprazole|mesh-list
154231218|NCT01147588|Lansoprazole|lansoprazole|mesh-list
154231219|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
154231220|NCT01147588|Clopidogrel|clopidogrel|mesh-list
154231221|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154231222|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154392966|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231223|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154231225|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
154231226|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231227|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231228|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231229|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154231230|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231231|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154231232|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231233|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
154231234|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231235|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231236|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231237|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154231238|NCT00230178|Allopurinol|allopurinol|mesh-list
154231239|NCT00230178|Rasburicase|rasburicase|mesh-list
154231240|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
154231241|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231242|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231243|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
154231244|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154231245|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154231246|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
154231247|NCT00230178|Protective Agents|protective agents|mesh-ancestor
154231248|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231249|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
154231250|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154231251|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154231252|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154231253|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231254|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231255|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
154231256|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231257|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231258|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154231259|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231261|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
154231262|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154231263|NCT01251172|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154231264|NCT01251172|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154231265|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154231266|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
154231267|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231268|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231269|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154231270|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154231271|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
154231272|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231273|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231274|NCT00413777|Tolvaptan|tolvaptan|mesh-list
154231275|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154231276|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231277|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
154231278|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231279|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154231280|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154231281|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154231282|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154231283|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154231284|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
154231285|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231286|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231287|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231288|NCT01074060|Plerixafor|plerixafor|mesh-list
154231289|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
154231290|NCT01074060|Lenograstim|lenograstim|mesh-list
154231291|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154231292|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
154231293|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231294|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154231295|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154231296|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
154231297|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231298|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231299|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154231300|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154231301|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154231302|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154231303|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
154231304|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231305|NCT03915340|Propafenone|propafenone|mesh-list
154231306|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154231307|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154231308|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154231309|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231310|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231311|NCT01581918|Carbamazepine|carbamazepine|mesh-list
154231312|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
154231313|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
154231314|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154231315|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231316|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231317|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154231318|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154231319|NCT01581918|Analgesics|analgesics|mesh-ancestor
154231320|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
154231321|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231322|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154231323|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231324|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231325|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154231326|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153523688|NCT02715609|Copper|copper|mesh-list
154231327|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154231328|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
154231329|NCT01582542|Coagulants|coagulants|mesh-ancestor
154231330|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154231331|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
154231332|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231333|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
154231334|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
154231335|NCT03912766|Coagulants|coagulants|mesh-ancestor
154231336|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154231337|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154231338|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
154231339|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231340|NCT01251328|Anesthetics|anesthetics|mesh-list
154231341|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231342|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231344|NCT00420641|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154231345|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154231346|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231347|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231348|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231349|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
154231350|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231351|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154231352|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
154231353|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154231354|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154231355|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154231356|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231357|NCT00257556|Menotropins|menotropins|mesh-list
154231358|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154231359|NCT00257556|Hormones|hormones|mesh-ancestor
154231360|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231361|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231362|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154231363|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
154231364|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154231365|NCT03906916|Micafungin|micafungin|mesh-list
154231366|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
154231367|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231369|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154231370|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
154231371|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231372|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154231373|NCT01250548|Apremilast|apremilast|mesh-list
154105617|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
154231374|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154231375|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154231376|NCT01250548|Analgesics|analgesics|mesh-ancestor
154231377|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
154231378|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231379|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231380|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154231381|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154231382|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154231383|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154231384|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231385|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231386|NCT03906838|Ropivacaine|ropivacaine|mesh-list
154231387|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
154231388|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
154231389|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231390|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231391|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
154231392|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231393|NCT01251484|Nintedanib|nintedanib|mesh-list
154231394|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231395|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154231396|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231397|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231398|NCT03914638|Albuterol|albuterol|mesh-list
154231399|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154231400|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
154231401|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231402|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231403|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154231404|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
154231405|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
154231406|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154231407|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154231408|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154231409|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154231410|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
154231411|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231412|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231413|NCT01148446|Prednisone|prednisone|mesh-list
154231414|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
154231415|NCT01148446|Rituximab|rituximab|mesh-list
154231416|NCT01148446|Doxorubicin|doxorubicin|mesh-list
153978321|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231418|NCT01148446|Epirubicin|epirubicin|mesh-list
154231419|NCT01148446|Vinblastine|vinblastine|mesh-list
154231420|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154231421|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
154231422|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231423|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154231424|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154231425|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
154231426|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231427|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231428|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154231429|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154231430|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154231431|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154231432|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154231433|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231434|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154231435|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
154231436|NCT01148446|Hormones|hormones|mesh-ancestor
154231437|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231438|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154231439|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154231440|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
154231455|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231456|NCT00257166|Ziprasidone|ziprasidone|mesh-list
154231457|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154231458|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
154231459|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231460|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231461|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231462|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154231463|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154231464|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231465|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154231466|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154231467|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
154231481|NCT03913858|Anesthetics|anesthetics|mesh-list
154231482|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231483|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231484|NCT00227370|Valganciclovir|valganciclovir|mesh-list
154231485|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
154231486|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231487|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154231488|NCT01251796|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154231489|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154231490|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231491|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231492|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231494|NCT01251874|Carboplatin|carboplatin|mesh-list
154231495|NCT01251874|Veliparib|veliparib|mesh-list
154231496|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231497|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154231498|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231499|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231500|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
154231501|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231502|NCT03911440|Azithromycin|azithromycin|mesh-list
154231503|NCT03911440|Doxycycline|doxycycline|mesh-list
154253930|NCT02439658|Sotalol|sotalol|mesh-list
154231504|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154231505|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231506|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
154231507|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154231508|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154231509|NCT00191100|Gemcitabine|gemcitabine|mesh-list
154231510|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231511|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154231512|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
154231513|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231514|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
154231515|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154231516|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231518|NCT01252342|Oxytocin|oxytocin|mesh-list
154231519|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
154231520|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154231521|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231522|NCT01254994|Entecavir|entecavir|mesh-list
154231523|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
154231524|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231525|NCT03904732|Aspirin|aspirin|mesh-list
154231526|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154231527|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154231528|NCT03904732|Analgesics|analgesics|mesh-ancestor
154231529|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
154231530|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231531|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231532|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154231533|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154231534|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154231535|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154231536|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231537|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154231538|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154231539|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231540|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
154231541|NCT01252420|Enoxaparin|enoxaparin|mesh-list
154231542|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
154231543|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154231544|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154231545|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231546|NCT01149304|Enoxaparin|enoxaparin|mesh-list
154231547|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
154231548|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154105702|NCT00842595|Prednisone|prednisone|mesh-list
154231549|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
154231550|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154231551|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154231552|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231553|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154231554|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231555|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154231556|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154231557|NCT01149304|Protective Agents|protective agents|mesh-ancestor
154231558|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231559|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
154231560|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154231561|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
154231562|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154231563|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231564|NCT01254526|Paclitaxel|paclitaxel|mesh-list
154231565|NCT01254526|Bevacizumab|bevacizumab|mesh-list
154231566|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154231568|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
154231569|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
154231570|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
154231571|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231572|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154231573|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154231574|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154231575|NCT01254526|Growth Substances|growth substances|mesh-ancestor
154231576|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231577|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
154231578|NCT01148992|Lofexidine|lofexidine|mesh-list
154231579|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154231580|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154231581|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231583|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231584|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154231585|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154231586|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154231587|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
154231588|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231589|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231590|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
154231591|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
154231592|NCT03903952|Vitamins|vitamins|mesh-ancestor
154231593|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
154231594|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231595|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
154231596|NCT03903952|Hematinics|hematinics|mesh-ancestor
154231597|NCT00257010|Almotriptan|almotriptan|mesh-list
154231598|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154231599|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
154231600|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231601|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231602|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231603|NCT03901768|Dexamethasone|dexamethasone|mesh-list
154231604|NCT03901768|Triamcinolone|triamcinolone|mesh-list
154231605|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154231606|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
154231607|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
154231608|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231609|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231610|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231611|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
154231612|NCT03901768|Hormones|hormones|mesh-ancestor
154231613|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231614|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154231615|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231616|NCT03903718|Oseltamivir|oseltamivir|mesh-list
154231617|NCT03903718|MEDI8852|medi8852|mesh-list
154231618|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
154231619|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231620|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231621|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231622|NCT03910504|Rocuronium|rocuronium|mesh-list
154231623|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154231624|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154231625|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154231626|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231627|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231628|NCT03901690|Imiquimod|imiquimod|mesh-list
154231629|NCT03901690|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154231630|NCT03901690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231631|NCT03901690|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154231632|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
154231633|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231634|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154231635|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231636|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
154231637|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
154231638|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154231639|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231640|NCT03901378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154231641|NCT03901378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231642|NCT00256854|Ropinirole|ropinirole|mesh-list
154231643|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154231644|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154231645|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
154231646|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
154231647|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231648|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231649|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231650|NCT00189462|Montelukast|montelukast|mesh-list
154231651|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154231652|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
154231653|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154231654|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
154231655|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231656|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231657|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154231658|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154231659|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231661|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154231662|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231663|NCT01150318|Trace Elements|trace elements|mesh-ancestor
154231664|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
154231665|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231666|NCT05667298|Immunomodulating Agents|immunomodulating agents|mesh-list
154231667|NCT05667298|Immunologic Factors|immunologic factors|mesh-ancestor
154231668|NCT05667298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231669|NCT01256632|Ranibizumab|ranibizumab|mesh-list
154231670|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154231671|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154231672|NCT01256632|Growth Substances|growth substances|mesh-ancestor
154231673|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231674|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
154231675|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231676|NCT00256698|Fulvestrant|fulvestrant|mesh-list
154231677|NCT00256698|Anastrozole|anastrozole|mesh-list
154231678|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154231679|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231680|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154231681|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154231682|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
154231683|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231684|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231685|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154231686|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154231687|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231688|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231689|NCT01150630|Gemcitabine|gemcitabine|mesh-list
154231690|NCT01150630|Capecitabine|capecitabine|mesh-list
154231692|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231693|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154231694|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
154231695|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231696|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154231697|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154231698|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154231699|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231700|NCT00189306|Imiquimod|imiquimod|mesh-list
154231701|NCT00189306|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154231702|NCT00189306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231703|NCT00189306|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154231704|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
154231705|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231706|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154231707|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231708|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
154231709|NCT03898336|Micronutrients|micronutrients|mesh-list
154231710|NCT03898336|Trace Elements|trace elements|mesh-list
154231711|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231712|NCT03972462|Sirolimus|sirolimus|mesh-list
154231713|NCT03972462|Temsirolimus|temsirolimus|mesh-list
153978621|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
154231715|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154231716|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154231717|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154231718|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231719|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
154231720|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154231721|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
154231722|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231723|NCT03972462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154231724|NCT03972462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231725|NCT03972462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231726|NCT01150786|Selenium|selenium|mesh-list
154231727|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
154231728|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105898|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154231730|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231731|NCT01150786|Trace Elements|trace elements|mesh-ancestor
154231732|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
154231733|NCT03909724|Sunitinib|sunitinib|mesh-list
154231734|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231735|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154231736|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154231737|NCT03909724|Growth Substances|growth substances|mesh-ancestor
154231738|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231739|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
154231740|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154231741|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231742|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231743|NCT03909646|Fluorouracil|fluorouracil|mesh-list
154231744|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154231745|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154231746|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
154231747|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231748|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154231749|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231750|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154231751|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
154231752|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231753|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154231754|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
154231755|NCT01256866|Midazolam|midazolam|mesh-list
154231756|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
154231757|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154231758|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231759|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231760|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154231761|NCT01256866|Analgesics|analgesics|mesh-ancestor
154231762|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
154231763|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231764|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154231765|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154231766|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154231767|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
154231768|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231769|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231770|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154231771|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154231772|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154231773|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154231774|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154231775|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
154231776|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
154231777|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
154231778|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
154231779|NCT03908944|Methadone|methadone|mesh-list
154231780|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154231781|NCT03908944|Narcotics|narcotics|mesh-ancestor
154231782|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231783|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231784|NCT03908944|Analgesics|analgesics|mesh-ancestor
154231785|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
154231786|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231787|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
153978697|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154231788|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
154231789|NCT03899506|Midazolam|midazolam|mesh-list
154231790|NCT03899506|Olanzapine|olanzapine|mesh-list
154231791|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154231792|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154231793|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231794|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231795|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154231796|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154231797|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154231798|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154231799|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
154231800|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
154231801|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
154231802|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
154231803|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231804|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231805|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
154231806|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
154231807|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231808|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231809|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154231810|NCT03899506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154231811|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154231812|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231813|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
154231814|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
154231815|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154231816|NCT03896932|Antibodies|antibodies|mesh-list
154231817|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
154231818|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154231819|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
154231820|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231821|NCT01257334|Empagliflozin|empagliflozin|mesh-list
154231822|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154231823|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231824|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154231825|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231826|NCT01151176|Insulin|insulin|mesh-list
154231827|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154231828|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154231829|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231830|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
154231831|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154231832|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231833|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154231834|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231835|NCT01257490|Bupropion|bupropion|mesh-list
154231836|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154231837|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
154231838|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154231839|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154231840|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154231841|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231842|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231843|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
154231844|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231845|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231846|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154231847|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154231848|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231849|NCT03894280|Fluticasone|fluticasone|mesh-list
154231850|NCT03894280|Xhance|xhance|mesh-list
154231851|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154231852|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154231853|NCT03894280|Charcoal|charcoal|mesh-list
154231854|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154231855|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154231856|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
154231857|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231858|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231859|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154231860|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
154231861|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
153978772|NCT04291118|Hormones|hormones|mesh-ancestor
154231862|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154231863|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154231864|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154231865|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154231866|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
154231867|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231868|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231869|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
154231870|NCT03894280|Hormones|hormones|mesh-ancestor
154231871|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106093|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154231872|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
154231873|NCT03894280|Antidotes|antidotes|mesh-ancestor
154231874|NCT03894280|Protective Agents|protective agents|mesh-ancestor
154231875|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
154231876|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154231878|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231879|NCT01150162|Omeprazole|omeprazole|mesh-list
154231880|NCT01150162|Rebamipide|rebamipide|mesh-list
154231881|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154231882|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231883|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154231884|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231885|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231886|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
154231887|NCT01150162|Protective Agents|protective agents|mesh-ancestor
154231888|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231889|NCT03893734|Methadone|methadone|mesh-list
154231890|NCT03893734|Hydromorphone|hydromorphone|mesh-list
154231891|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154231892|NCT03893734|Narcotics|narcotics|mesh-ancestor
154231893|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231894|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231895|NCT03893734|Analgesics|analgesics|mesh-ancestor
154231896|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
154231897|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231898|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
154231899|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154231900|NCT03899194|Escitalopram|escitalopram|mesh-list
154231901|NCT03899194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154231902|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154231903|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231904|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231905|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231906|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
154231907|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231908|NCT01151800|Benzocaine|benzocaine|mesh-list
154231909|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
154231910|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
154231911|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231912|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231913|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
154231914|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231915|NCT03896074|Bevacizumab|bevacizumab|mesh-list
154231916|NCT03896074|Atezolizumab|atezolizumab|mesh-list
154231917|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154231918|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231919|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154231920|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154231921|NCT03896074|Growth Substances|growth substances|mesh-ancestor
154106094|NCT00742404|Bortezomib|bortezomib|mesh-list
154231922|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231923|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
154231924|NCT03896074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154231925|NCT03896074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231926|NCT03899038|Anesthetics|anesthetics|mesh-list
154231927|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231928|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231929|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154231930|NCT01151878|Cathartics|cathartics|mesh-ancestor
154231931|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231932|NCT03898882|Oxytocin|oxytocin|mesh-list
154231933|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
154231934|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154231935|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231936|NCT01151254|Propofol|propofol|mesh-list
154231938|NCT01151254|Isoflurane|isoflurane|mesh-list
154231939|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154231940|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154231941|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231942|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154231943|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
154231944|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
154231945|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154231946|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154231947|NCT01255774|Ranibizumab|ranibizumab|mesh-list
154231948|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154231949|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154231950|NCT01255774|Growth Substances|growth substances|mesh-ancestor
154231951|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231953|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154231954|NCT01255852|Atorvastatin|atorvastatin|mesh-list
154231955|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154231956|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154231957|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
154231958|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231959|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154231960|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154231961|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231962|NCT03895528|Lonafarnib|lonafarnib|mesh-list
154231963|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154231964|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231965|NCT01257958|Vitamin D|vitamin d|mesh-list
154231967|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
154231968|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231969|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154231970|NCT03893032|Modafinil|modafinil|mesh-list
154231971|NCT03893032|Amphetamine|amphetamine|mesh-list
154231972|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154231973|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231974|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154231975|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154231976|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154231977|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154231978|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
154231979|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
154231980|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231981|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
154231982|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231983|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
154231984|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154231985|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154231986|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154231987|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154231988|NCT01258036|Hormones|hormones|mesh-list
154231989|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154231990|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231991|NCT03889366|Aprepitant|aprepitant|mesh-list
154231992|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
154231993|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
154231994|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154231995|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154231996|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154231997|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154231998|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154231999|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232000|NCT03894826|Vorinostat|vorinostat|mesh-list
154232001|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232002|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154232003|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232004|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232005|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
154232006|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154232007|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154232008|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154232009|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154232010|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232011|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
154232012|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232013|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232014|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154232015|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232016|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
154232017|NCT01153750|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154232018|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154232019|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232020|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232021|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232022|NCT03888664|Interferons|interferons|mesh-list
154232023|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
154232024|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232025|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
154232026|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232027|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
154232028|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232030|NCT01153828|Retapamulin|retapamulin|mesh-list
154232031|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
154232032|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154232033|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232034|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154232035|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232036|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232037|NCT01151722|Bevacizumab|bevacizumab|mesh-list
154232038|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154232039|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232040|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154232041|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154232042|NCT01151722|Growth Substances|growth substances|mesh-ancestor
154232043|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232044|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
154232045|NCT01258192|Paclitaxel|paclitaxel|mesh-list
154232046|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154232047|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154232048|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232049|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
154232050|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
154232051|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
154232052|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232053|NCT01326078|Propofol|propofol|mesh-list
154232054|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154232055|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232056|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232057|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154232058|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
154232059|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
154232060|NCT01260376|Acipimox|acipimox|mesh-list
154232061|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154232062|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
154232063|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232064|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154232065|NCT01259050|Copper|copper|mesh-list
154232066|NCT01259050|Trace Elements|trace elements|mesh-ancestor
154232067|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
154232068|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232069|NCT00255840|Ritonavir|ritonavir|mesh-list
154232070|NCT00255840|Lopinavir|lopinavir|mesh-list
154232071|NCT00255840|Lamivudine|lamivudine|mesh-list
154232072|NCT00255840|Nevirapine|nevirapine|mesh-list
154232073|NCT00255840|Stavudine|stavudine|mesh-list
154232074|NCT00255840|Efavirenz|efavirenz|mesh-list
154232075|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154232076|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154232077|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
154232078|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232079|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232080|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154232081|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154232082|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
154232083|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232084|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153978997|NCT02600650|Testosterone|testosterone|mesh-list
154232085|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154232086|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154232087|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154232088|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154232089|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154232090|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154232091|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154232092|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154232093|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
154232094|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
154232095|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
154232096|NCT00224874|Etanercept|etanercept|mesh-list
154232097|NCT00224874|Pentostatin|pentostatin|mesh-list
154232098|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
154232099|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154232100|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232101|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154232102|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
154232103|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154232104|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232105|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232106|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232107|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154232108|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154232109|NCT00224874|Analgesics|analgesics|mesh-ancestor
154232110|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
154232111|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232112|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232113|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392967|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154232114|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232115|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232116|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232117|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
154232118|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154232119|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
154232120|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
154232121|NCT03892330|Doxorubicin|doxorubicin|mesh-list
154232122|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154232123|NCT03892330|Vincristine|vincristine|mesh-list
154232124|NCT03892330|Pirarubicin|pirarubicin|mesh-list
154232125|NCT03892330|Epirubicin|epirubicin|mesh-list
154232126|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232127|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
154232128|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232129|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232130|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154232131|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
154232132|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232133|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232134|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154232135|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154232136|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154232137|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154232138|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232139|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154232140|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
154232141|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
154232142|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
154232143|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154232144|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232145|NCT00186186|Valproic Acid|valproic acid|mesh-list
154232146|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
154232147|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232148|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232149|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
154232150|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232151|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232152|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
154232153|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154232154|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232155|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154232156|NCT00185640|Cyclosporine|cyclosporine|mesh-list
154232157|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
154232158|NCT00185640|Lenograstim|lenograstim|mesh-list
154232159|NCT00185640|Cyclosporins|cyclosporins|mesh-list
154232160|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
154232161|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154232162|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154232163|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
154232164|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232165|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232166|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232167|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232168|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
154232169|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232170|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
154232171|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232172|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154232173|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154232174|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232175|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154232176|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
154232177|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154232178|NCT03885388|Dactinomycin|dactinomycin|mesh-list
154232179|NCT03885388|Methotrexate|methotrexate|mesh-list
154232180|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154232181|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
154232182|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154232183|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232184|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154232185|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
154232186|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232187|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232188|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
154232189|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392968|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
154232190|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154232191|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232192|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
154232193|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232194|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154232195|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154232196|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232197|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154232198|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154232199|NCT01152346|Azacitidine|azacitidine|mesh-list
154232200|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154232201|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
154232202|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232203|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232204|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232206|NCT01260610|Telbivudine|telbivudine|mesh-list
154232207|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
154232208|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232209|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154232210|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154232211|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232212|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232213|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154232214|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154232215|NCT01155700|Omalizumab|omalizumab|mesh-list
154232216|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154232217|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154232218|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
154232219|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154232220|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154232221|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
154232222|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232223|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154232224|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154232225|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
154232226|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
154232227|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232228|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232229|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
154232230|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154232231|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232232|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
154232233|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
154232234|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154232235|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232236|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154232237|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232238|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154232239|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
154232240|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232241|NCT03891472|Fluorouracil|fluorouracil|mesh-list
154232242|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
154232244|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
154232245|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232246|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154232247|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232248|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232249|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
154232250|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232251|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154232253|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232254|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
154232255|NCT01262482|Sorafenib|sorafenib|mesh-list
154232256|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232257|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154232258|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232259|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232260|NCT01261078|Epinephrine|epinephrine|mesh-list
154232261|NCT01261078|Racepinephrine|racepinephrine|mesh-list
154232262|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
154232263|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154232264|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154146376|NCT00728195|Olanzapine|olanzapine|mesh-list
154232265|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
154232266|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232267|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232268|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232269|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154232270|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154232271|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
154232272|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232273|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154232274|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
154232276|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
154232277|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154232278|NCT01155934|Risperidone|risperidone|mesh-list
154232279|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154232280|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
154232281|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232282|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232283|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232284|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154232285|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154232286|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232287|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154232288|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154232289|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
154232290|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154232291|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
154232292|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232293|NCT01261156|Diltiazem|diltiazem|mesh-list
154232294|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154232295|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154232296|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154232297|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232298|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154232299|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232300|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
154232301|NCT03884530|Aspirin|aspirin|mesh-list
154232302|NCT03884530|Ticagrelor|ticagrelor|mesh-list
154232303|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154232304|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154232305|NCT03884530|Analgesics|analgesics|mesh-ancestor
154232306|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
154232307|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232308|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232309|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232310|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232311|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154232312|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154232313|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232314|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154232315|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154232316|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232317|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
154232318|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154232319|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154232320|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154232321|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
154232322|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232323|NCT03891316|Sevoflurane|sevoflurane|mesh-list
154232324|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154232325|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154232326|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
154232327|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
154232328|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232329|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232331|NCT03887260|Morphine|morphine|mesh-list
154232332|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154232333|NCT03887260|Narcotics|narcotics|mesh-ancestor
154232334|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232335|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232336|NCT03887260|Analgesics|analgesics|mesh-ancestor
154232337|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
154232338|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232339|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154232340|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154232341|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
154232342|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
154232343|NCT03883984|Cysteamine|cysteamine|mesh-list
154232344|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154232345|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232346|NCT01586494|Tramadol|tramadol|mesh-list
154232347|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154232348|NCT01586494|Narcotics|narcotics|mesh-ancestor
154232349|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232350|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232351|NCT01586494|Analgesics|analgesics|mesh-ancestor
154232352|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
154232353|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232354|NCT01259362|Cocaine|cocaine|mesh-list
154232355|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
154232356|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
154232357|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232358|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232359|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
154232360|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232361|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154232362|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154232363|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154232364|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154232365|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232366|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
154232367|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232368|NCT01261234|Cilostazol|cilostazol|mesh-list
154232369|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154232370|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
154232371|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232372|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232373|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154232374|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
154232375|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154232376|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154232377|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232378|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154232379|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
154232380|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154232381|NCT01261234|Protective Agents|protective agents|mesh-ancestor
154232382|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154232383|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154232384|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232385|NCT01152736|Nicotine|nicotine|mesh-list
154232386|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154232387|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
154232388|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232389|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232390|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154232391|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154232392|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
154232393|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232394|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232395|NCT01261546|Dexamethasone|dexamethasone|mesh-list
154232396|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232397|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
154232398|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
154232399|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232400|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232401|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232402|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
154232403|NCT01261546|Hormones|hormones|mesh-ancestor
154232404|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154232405|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154232406|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232407|NCT03883360|Cannabidiol|cannabidiol|mesh-list
154232408|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
154232409|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
154232410|NCT01261702|Analgesics|analgesics|mesh-ancestor
154232411|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
154232412|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232413|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232415|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232416|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154232417|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
154232418|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154232419|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154232420|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232421|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154232422|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
154232423|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154232424|NCT01156246|Metformin|metformin|mesh-list
154232425|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
154232426|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154232427|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232428|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154232429|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232430|NCT03890770|Deucravacitinib|deucravacitinib|mesh-list
154232431|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
154106601|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232432|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154232433|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232434|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232435|NCT03883204|Risperidone|risperidone|mesh-list
154232436|NCT03883204|Aripiprazole|aripiprazole|mesh-list
154232437|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154232438|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
154232439|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232440|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232441|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232442|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154232443|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154232444|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232445|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154232446|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154232447|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
154232448|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
154232449|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
154232450|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154232451|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154232452|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154232453|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154232454|NCT01263418|Ofatumumab|ofatumumab|mesh-list
154232455|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232456|NCT03882814|Meperidine|meperidine|mesh-list
154232457|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154232458|NCT03882814|Narcotics|narcotics|mesh-ancestor
154232459|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979378|NCT02866370|Topotecan|topotecan|mesh-list
154232460|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232462|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
154232463|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232464|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154232465|NCT03647566|Listerine|listerine|mesh-list
154232466|NCT03647566|Fluorides|fluorides|mesh-list
154232467|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
154232468|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
154232469|NCT03647566|Protective Agents|protective agents|mesh-ancestor
154232470|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232471|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154232472|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232473|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
154232474|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
154232475|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154232476|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154232477|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232478|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232479|NCT01156636|Urological Agents|urological agents|mesh-ancestor
154232480|NCT03889288|Analgesics|analgesics|mesh-list
154232481|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
154232482|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232483|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232484|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
154232485|NCT01153204|Citric Acid|citric acid|mesh-list
154232486|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
154232487|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
154232488|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154232489|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
154232490|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
154232491|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232492|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
154232493|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154232494|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154232495|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232496|NCT01153204|Urological Agents|urological agents|mesh-ancestor
154232497|NCT03760666|Ribavirin|ribavirin|mesh-list
154232498|NCT03760666|Brequinar|brequinar|mesh-list
154232499|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
154232500|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232501|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
154232502|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232503|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232504|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232505|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232506|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
154232507|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232508|NCT01263574|Ethanol|ethanol|mesh-list
154232509|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154232510|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232511|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232512|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232513|NCT03464734|Paclitaxel|paclitaxel|mesh-list
154232514|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
154232515|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154232516|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154232517|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232518|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
154232519|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
154232520|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154232521|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232522|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154232523|NCT03464734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154232524|NCT01156948|Misoprostol|misoprostol|mesh-list
154232525|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154232526|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
154232527|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154232528|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232529|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154232530|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232531|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
154232532|NCT01157026|Tamoxifen|tamoxifen|mesh-list
154232533|NCT01157026|Tocotrienols|tocotrienols|mesh-list
154232534|NCT01157026|Vitamin E|vitamin e|mesh-list
154232535|NCT01157026|Tocopherols|tocopherols|mesh-list
154232536|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154232537|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
154106701|NCT00619983|Donepezil|donepezil|mesh-list
154106761|NCT00854139|Cyclosporins|cyclosporins|mesh-list
154232538|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154232539|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232540|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154232541|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232542|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154232543|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154232544|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154232545|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
154232546|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232547|NCT01157026|Protective Agents|protective agents|mesh-ancestor
154232548|NCT01157026|Vitamins|vitamins|mesh-ancestor
154232549|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
154232550|NCT01263652|Dipyrone|dipyrone|mesh-list
154232551|NCT01263652|Diclofenac|diclofenac|mesh-list
154232552|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154232553|NCT01263652|Tramadol|tramadol|mesh-list
154232554|NCT01263652|Orphenadrine|orphenadrine|mesh-list
154232555|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154232556|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154232557|NCT01263652|Analgesics|analgesics|mesh-ancestor
154232558|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
154232559|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232560|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232561|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232562|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232563|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154232564|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232565|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232566|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154232567|NCT01263652|Narcotics|narcotics|mesh-ancestor
154232568|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232569|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
154232570|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154232571|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154232572|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154232573|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154232574|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
154232575|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
154232576|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154232577|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154232578|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
154232579|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232580|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154232581|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154232582|NCT03881644|Sumatriptan|sumatriptan|mesh-list
154232583|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154232584|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154232585|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154232586|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154232587|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
154232588|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232589|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232590|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232591|NCT03881644|Growth Substances|growth substances|mesh-ancestor
154232592|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
154232593|NCT01259830|Etoricoxib|etoricoxib|mesh-list
154232594|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154232595|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154232596|NCT01259830|Analgesics|analgesics|mesh-ancestor
154232597|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
154232598|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232599|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232600|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232601|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232602|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154232603|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154232604|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232605|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232606|NCT00224484|Vaccines|vaccines|mesh-list
154232607|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
154232608|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979526|NCT04093648|Fludarabine|fludarabine|mesh-list
154232609|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
154232610|NCT01265680|Hematinics|hematinics|mesh-ancestor
154232611|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
154232612|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154232613|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232614|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154232615|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154232616|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232617|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232618|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232619|NCT01157572|Metoprolol|metoprolol|mesh-list
154232620|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154232621|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154232622|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
154232623|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
154232624|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232625|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106805|NCT00755976|Sulindac|sulindac|mesh-list
154232626|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154232627|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154232628|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154232629|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
154232630|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232631|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232632|NCT01074372|Alirocumab|alirocumab|mesh-list
154232633|NCT01074372|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154232634|NCT01074372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154232635|NCT01074372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154232636|NCT01074372|Antimetabolites|antimetabolites|mesh-ancestor
154146743|NCT00732407|Losartan|losartan|mesh-list
154392969|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154232637|NCT01074372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232639|NCT01074372|Protease Inhibitors|protease inhibitors|mesh-ancestor
154232640|NCT01074372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232641|NCT01074372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154232642|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154232643|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154232644|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232645|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154232646|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232647|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232648|NCT00254982|Infliximab|infliximab|mesh-list
154232649|NCT00254982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154232650|NCT00254982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232651|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
154232652|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232653|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232654|NCT01586572|Vaccines|vaccines|mesh-list
154232655|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
154232656|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232657|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
154232658|NCT00224016|Oxybutynin|oxybutynin|mesh-list
154232659|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
154232660|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
154232661|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232662|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232663|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154232664|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154232665|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
154232666|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232667|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232668|NCT00224016|Urological Agents|urological agents|mesh-ancestor
154232669|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154232670|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106895|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
154232671|NCT02527174|Cytarabine|cytarabine|mesh-list
154232672|NCT02527174|Idarubicin|idarubicin|mesh-list
154232673|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154232674|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
154232675|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232676|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232677|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
154232678|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232679|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232680|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
154232681|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232682|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154232683|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154232684|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154232685|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232686|NCT01161940|Nizatidine|nizatidine|mesh-list
154232687|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154232688|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232689|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154232690|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
154232691|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
154232692|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232693|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232694|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232695|NCT01160068|Metformin|metformin|mesh-list
154232696|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154232697|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232698|NCT01266694|Colchicine|colchicine|mesh-list
154232699|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
154232700|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232701|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
154232702|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
154232703|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
154232704|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232705|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232706|NCT03876886|Paclitaxel|paclitaxel|mesh-list
154232707|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154232708|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
154232709|NCT03876886|Carboplatin|carboplatin|mesh-list
154232710|NCT03876886|Epirubicin|epirubicin|mesh-list
154232711|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154232712|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232713|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
154232714|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
154232715|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
154232716|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106896|NCT00861627|Paclitaxel|paclitaxel|mesh-list
154232717|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232718|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
154232719|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232720|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232721|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154232722|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
154232723|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154232724|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154232725|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154232726|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154232727|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232728|NCT01266772|Budesonide|budesonide|mesh-list
154232729|NCT01266772|Montelukast|montelukast|mesh-list
154232730|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232731|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154232732|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
154232733|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232734|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232735|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154232736|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
154232737|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
154232738|NCT01266772|Hormones|hormones|mesh-ancestor
154232739|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154232740|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154232741|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
154232742|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154232743|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154232744|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232745|NCT01264354|Adefovir|adefovir|mesh-list
154232746|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154232747|NCT01264354|Clevudine|clevudine|mesh-list
154232748|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
154232749|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232750|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154232751|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154232752|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232753|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232754|NCT01264432|Veliparib|veliparib|mesh-list
154232755|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154232756|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232757|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232758|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232759|NCT02527096|Lamivudine|lamivudine|mesh-list
154232760|NCT02527096|Dolutegravir|dolutegravir|mesh-list
154232761|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154232762|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154106986|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154232764|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232765|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
154232766|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232767|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154232768|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154232769|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154232770|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154232771|NCT01160302|Curcumin|curcumin|mesh-list
154232772|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154232773|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154232774|NCT01160302|Analgesics|analgesics|mesh-ancestor
154232775|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
154232776|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232777|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232778|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232779|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232780|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232781|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232782|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232783|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
154232784|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154232785|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154232786|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
154232787|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232788|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232789|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232790|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
154232791|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
154232792|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232793|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
154232794|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154232795|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
154232797|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
154232798|NCT01268176|Vitamins|vitamins|mesh-ancestor
154232799|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
154232800|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232801|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154232802|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154232803|NCT01264588|Calcium|calcium|mesh-list
154232804|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154232805|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232806|NCT01158274|Capecitabine|capecitabine|mesh-list
154232807|NCT01158274|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154232808|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154232809|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
154232810|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232811|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232812|NCT01158274|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154232813|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232814|NCT01267084|Ketoconazole|ketoconazole|mesh-list
154232815|NCT01267084|Dexamethasone|dexamethasone|mesh-list
154232816|NCT01267084|Trabectedin|trabectedin|mesh-list
154232817|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232818|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
154232819|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
154232820|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232821|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232822|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232823|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
154232824|NCT01267084|Hormones|hormones|mesh-ancestor
154232825|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154232826|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154232827|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232828|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
154232829|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232830|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154232831|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154232832|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232833|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232834|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154232835|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
154232836|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154232837|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154232838|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
154232839|NCT01264822|Rabeprazole|rabeprazole|mesh-list
154232840|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154232841|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232842|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154107028|NCT00861939|Bupropion|bupropion|mesh-list
154107068|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154232843|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232844|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232846|NCT03876574|Gemcitabine|gemcitabine|mesh-list
154232847|NCT03876574|Floxuridine|floxuridine|mesh-list
154232848|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232849|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
154232850|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
154232851|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232852|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232853|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232854|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
154232856|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154232857|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154232858|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232859|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154232861|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232862|NCT01161082|Alirocumab|alirocumab|mesh-list
154232863|NCT01161082|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154232864|NCT01161082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154232865|NCT01161082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154232866|NCT01161082|Antimetabolites|antimetabolites|mesh-ancestor
154232867|NCT01161082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232868|NCT01161082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154232869|NCT01161082|Protease Inhibitors|protease inhibitors|mesh-ancestor
154232870|NCT01161082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232871|NCT01161082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154232872|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
154232873|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
154232874|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
154232875|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232876|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232877|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
154232878|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232879|NCT01267396|Sertraline|sertraline|mesh-list
154232880|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
154232881|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154232882|NCT01267396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154232883|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154232884|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154232885|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232886|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232887|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
154232888|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232889|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
154232890|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154232891|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154232892|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
154232893|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232894|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154232895|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154232896|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232897|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232898|NCT01161316|Cetuximab|cetuximab|mesh-list
154232899|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154232900|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232901|NCT01161550|Cytarabine|cytarabine|mesh-list
154232902|NCT01161550|Tretinoin|tretinoin|mesh-list
154232903|NCT01161550|Cladribine|cladribine|mesh-list
154232904|NCT01161550|Midostaurin|midostaurin|mesh-list
154232905|NCT01161550|Lenograstim|lenograstim|mesh-list
154232906|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154232907|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
154232908|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232909|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232911|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232912|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232913|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
154232914|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232915|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154232916|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
154232917|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
154232918|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154232919|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232920|NCT01159210|Thrombin|thrombin|mesh-list
154232921|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
154232923|NCT03879460|Naltrexone|naltrexone|mesh-list
154232924|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154232925|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154232926|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232927|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
154232928|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232929|NCT03877120|Diazepam|diazepam|mesh-list
154232930|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
154232931|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154232932|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154232933|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232934|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154232935|NCT03877120|Analgesics|analgesics|mesh-ancestor
154232936|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
154232937|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232938|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154232939|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154232940|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154232941|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
154232942|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232943|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232944|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154232945|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
154232946|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
154232947|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
154232948|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154232949|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154107111|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
154232950|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154232951|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154232952|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154232953|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154232954|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154232955|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
154232956|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
154232957|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
154232958|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
154232959|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
154232960|NCT03879382|Fludarabine|fludarabine|mesh-list
154232961|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154232962|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
154232963|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232964|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154232965|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154232966|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
154232967|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232968|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154232969|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154232970|NCT01166932|Amoxicillin|amoxicillin|mesh-list
154232971|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
154232972|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
154232973|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
154232974|NCT01166932|Oxacillin|oxacillin|mesh-list
154232975|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154232976|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154232977|NCT01166932|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154232978|NCT01166932|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154232979|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154232980|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154232981|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154232982|NCT01167010|Budesonide|budesonide|mesh-list
154232983|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
154232984|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154232985|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154232986|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
154232987|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154232988|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154232989|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154232990|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
154232991|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
154232993|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154232994|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154232995|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154232996|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154232997|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
154232998|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154232999|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233000|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154233001|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
154233002|NCT01280188|Coagulants|coagulants|mesh-ancestor
154233003|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154233004|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
154233005|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233006|NCT03871972|Sirolimus|sirolimus|mesh-list
154233007|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154233008|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233009|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154233010|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233011|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
154233012|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233013|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
154233014|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233015|NCT01165060|Bezafibrate|bezafibrate|mesh-list
154233016|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154233017|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
154233018|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233019|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154233020|NCT01165294|Ketamine|ketamine|mesh-list
154233021|NCT01165294|Analgesics|analgesics|mesh-ancestor
154233022|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
154233023|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233024|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233025|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154233026|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154233027|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
154233028|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
154233029|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233030|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154233031|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154233032|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233033|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233034|NCT01165372|Artesunate|artesunate|mesh-list
154233035|NCT01165372|Piperaquine|piperaquine|mesh-list
154233036|NCT01165372|Artenimol|artenimol|mesh-list
154233037|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
154233038|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154233039|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154233040|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233041|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233042|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
154233043|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
154233044|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154233045|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
154233046|NCT01280734|Melatonin|melatonin|mesh-list
154233047|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
154233048|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233049|NCT01280734|Protective Agents|protective agents|mesh-ancestor
154233050|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233051|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233052|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154233053|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154233054|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233055|NCT01587430|Cytarabine|cytarabine|mesh-list
154233056|NCT01587430|Daunorubicin|daunorubicin|mesh-list
154233057|NCT01587430|Idarubicin|idarubicin|mesh-list
154233058|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
154233059|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154233060|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233061|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154233062|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154233063|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233064|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233065|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154233066|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
154233067|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
154233068|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233069|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233070|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
154233071|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233072|NCT01587430|Analgesics|analgesics|mesh-ancestor
154233073|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
154233074|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233075|NCT03874000|Metformin|metformin|mesh-list
154233076|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154233077|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233079|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154233080|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233081|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154233082|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154233083|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154233084|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233085|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233086|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107292|NCT00696410|Zinc|zinc|mesh-list
154233087|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154233088|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154233089|NCT03874156|Atorvastatin|atorvastatin|mesh-list
154233090|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154233091|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154233092|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
154233093|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233094|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154233095|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154233096|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233097|NCT01167478|Caffeine|caffeine|mesh-list
154233098|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154233099|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233100|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154233101|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233102|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233103|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154233104|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154233105|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
154233106|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233107|NCT01587196|Naltrexone|naltrexone|mesh-list
154233108|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154233109|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154233110|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233111|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
154233112|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233113|NCT01281514|Carboplatin|carboplatin|mesh-list
154233114|NCT01281514|Doxorubicin|doxorubicin|mesh-list
154233115|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154233116|NCT01281514|Everolimus|everolimus|mesh-list
154233117|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233118|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154233119|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154233120|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154233121|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233122|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233123|NCT01281514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154233124|NCT01281514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154233125|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233126|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
154233127|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233128|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154233129|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
154233130|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233131|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154233132|NCT00223080|Antacids|antacids|mesh-ancestor
154233133|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233134|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233135|NCT03971604|Vitamins|vitamins|mesh-list
154233136|NCT03971604|Vitamin E|vitamin e|mesh-list
154233137|NCT03971604|Vitamin A|vitamin a|mesh-list
154233138|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
154233139|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233140|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
154233141|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233142|NCT03971604|Protective Agents|protective agents|mesh-ancestor
154233143|NCT02531490|Labetalol|labetalol|mesh-list
154233144|NCT02531490|Methyldopa|methyldopa|mesh-list
154233145|NCT02531490|Nifedipine|nifedipine|mesh-list
154233146|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154233147|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154233148|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233149|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154233150|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233151|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
154233152|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
154233153|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154233154|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154233155|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154233156|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
154233157|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233158|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154233159|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
154233160|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
154233161|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233162|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154233163|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154233164|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
154233165|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154233167|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154233168|NCT03871114|Triamcinolone|triamcinolone|mesh-list
154233169|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154233170|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154233171|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154233172|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233173|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
154233174|NCT03871114|Hormones|hormones|mesh-ancestor
154233175|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233176|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233177|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233178|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
154233179|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233180|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233181|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
154233182|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154233183|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154233184|NCT01281748|Prednisolone|prednisolone|mesh-list
154233185|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
154233186|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154233187|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
154233188|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233189|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
154233190|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
154233191|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233192|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233193|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233194|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
154233195|NCT01281748|Hormones|hormones|mesh-ancestor
154233196|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233197|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154233198|NCT01281748|Protective Agents|protective agents|mesh-ancestor
154233199|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154233200|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233201|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
154233202|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154233203|NCT00220740|Antibodies|antibodies|mesh-list
154233204|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
154233205|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154233206|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
154233207|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
154233208|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233209|NCT01273402|Antibodies|antibodies|mesh-list
154233210|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
153980126|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154233211|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154233212|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
154233213|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233214|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
154233215|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154233216|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
154233217|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233218|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107433|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154233219|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154233220|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
154233221|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154233222|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
154233223|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233224|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233225|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154233226|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
154233227|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
154233228|NCT03873298|Protective Agents|protective agents|mesh-ancestor
154233229|NCT00184002|Prednisone|prednisone|mesh-list
154233230|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
154233231|NCT00184002|Doxorubicin|doxorubicin|mesh-list
154233232|NCT00184002|Vincristine|vincristine|mesh-list
154233233|NCT00184002|Rituximab|rituximab|mesh-list
154233234|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233235|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
154233236|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233237|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233238|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154233239|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
154233240|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233241|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233242|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154233243|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154233244|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154233245|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154233246|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233247|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233248|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
154233249|NCT00184002|Hormones|hormones|mesh-ancestor
154233250|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233251|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154233252|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154233253|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
154233254|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
154233255|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
154233256|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154233257|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
154233258|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154233259|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154233260|NCT01167946|Prednisolone|prednisolone|mesh-list
154233261|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
154233262|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154233263|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
154233264|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233265|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
154233266|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
154233267|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233268|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233269|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233270|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
154233271|NCT01167946|Hormones|hormones|mesh-ancestor
154233272|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233273|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154233274|NCT01167946|Protective Agents|protective agents|mesh-ancestor
154233275|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154233276|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233277|NCT01275508|Adalimumab|adalimumab|mesh-list
154233278|NCT01275508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154233279|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233280|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233281|NCT01073670|Acetaminophen|acetaminophen|mesh-list
154233282|NCT01073670|Indomethacin|indomethacin|mesh-list
154233283|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154233284|NCT01073670|Analgesics|analgesics|mesh-ancestor
154233285|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
154233286|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233287|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233288|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
154233289|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154233290|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233291|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233292|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
154233293|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
154233294|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154233295|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154233296|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233297|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233298|NCT03971370|Vaccines|vaccines|mesh-list
154233299|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
154233300|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233301|NCT01168336|Betahistine|betahistine|mesh-list
154233302|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
154233303|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
154233304|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
154233305|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233306|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233307|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233308|NCT00165672|Rabeprazole|rabeprazole|mesh-list
154233309|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154233310|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233311|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154233312|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233313|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233314|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
154233316|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
154107477|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
154233317|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233318|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
154233319|NCT03870646|Protective Agents|protective agents|mesh-ancestor
154233320|NCT01168492|Ketamine|ketamine|mesh-list
154233321|NCT01168492|Analgesics|analgesics|mesh-ancestor
154233322|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
154233323|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233324|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233325|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154233326|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154233327|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
154233328|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
154233329|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233330|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154233331|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154233332|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233333|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233334|NCT03870490|Cefepime|cefepime|mesh-list
154233335|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154233336|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233337|NCT01278082|Budesonide|budesonide|mesh-list
154233338|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233339|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154233340|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
154233341|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233342|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233343|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154233344|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
154233345|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
154233346|NCT01278082|Hormones|hormones|mesh-ancestor
154233347|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233348|NCT03870256|Misoprostol|misoprostol|mesh-list
154233349|NCT03870256|Carbetocin|carbetocin|mesh-list
154233350|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154233351|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
154233352|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154233353|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233354|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154233355|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233356|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
154233357|NCT01166542|Paclitaxel|paclitaxel|mesh-list
154233358|NCT01166542|Carboplatin|carboplatin|mesh-list
154233359|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154233360|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980295|NCT00642291|Emtricitabine|emtricitabine|mesh-list
154233361|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
154233362|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
154233363|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
154233364|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233365|NCT00169104|Trastuzumab|trastuzumab|mesh-list
154233366|NCT00169104|Vinorelbine|vinorelbine|mesh-list
154233367|NCT00169104|Lenograstim|lenograstim|mesh-list
154233368|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154233369|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233370|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154233371|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
154233372|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233373|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154233374|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
154233375|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
154233376|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
154233377|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233378|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
154233379|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154233380|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154233381|NCT03872830|Analgesics|analgesics|mesh-ancestor
154233382|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
154233383|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233384|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233385|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233386|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233387|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154233388|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
154233389|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154233390|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
154233391|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233392|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154233393|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
154233394|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154233395|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154233396|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154233397|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233398|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233399|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154233400|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154233401|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154233402|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
154233403|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233404|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233405|NCT00163020|Progestins|progestins|mesh-ancestor
154233407|NCT01168804|Dexamethasone|dexamethasone|mesh-list
154233408|NCT01168804|Bortezomib|bortezomib|mesh-list
154233409|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154233410|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233411|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
154233412|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
154233413|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233414|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233415|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233416|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
154233417|NCT01168804|Hormones|hormones|mesh-ancestor
154233418|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233419|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154233420|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233421|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154233422|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
154233423|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233424|NCT03873532|Capecitabine|capecitabine|mesh-list
154233425|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154233426|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
154233427|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233428|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233429|NCT01282528|Infliximab|infliximab|mesh-list
154233430|NCT01282528|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154233431|NCT01282528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233432|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
154233433|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233434|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980374|NCT00910065|Aspirin|aspirin|mesh-list
154233435|NCT01169506|Silicon|silicon|mesh-list
154233437|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
154233438|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233439|NCT01169740|Bilirubin|bilirubin|mesh-list
154233440|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
154233441|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233442|NCT01169740|Protective Agents|protective agents|mesh-ancestor
154233443|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233444|NCT01169584|Molgramostim|molgramostim|mesh-list
154233445|NCT01169584|Sargramostim|sargramostim|mesh-list
154233446|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
154233447|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233448|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233449|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
154233450|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154233451|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233452|NCT01282762|Vaccines|vaccines|mesh-list
154233453|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
154233454|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233455|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154233456|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154233457|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154233458|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
154233459|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233460|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233461|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233462|NCT01282840|Urological Agents|urological agents|mesh-ancestor
154233463|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
154233464|NCT01172548|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154233465|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154233467|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233468|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233469|NCT01172626|Valproic Acid|valproic acid|mesh-list
154233470|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
154233471|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233472|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233473|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
154233474|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233475|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233476|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
154233477|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154233478|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233479|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154233480|NCT01172782|Hydromorphone|hydromorphone|mesh-list
154233481|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154233482|NCT01172782|Narcotics|narcotics|mesh-ancestor
154233483|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233484|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233485|NCT01172782|Analgesics|analgesics|mesh-ancestor
154233486|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
154233487|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233488|NCT03866746|Aflibercept|aflibercept|mesh-list
154233489|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154233490|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154233491|NCT03866746|Growth Substances|growth substances|mesh-ancestor
154233492|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233493|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
154233494|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233495|NCT03869398|Calcitriol|calcitriol|mesh-list
154233496|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154233497|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233498|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154233499|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154233500|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233501|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154233502|NCT03869398|Vitamins|vitamins|mesh-ancestor
154233503|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
154233504|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154233505|NCT01170052|Sirolimus|sirolimus|mesh-list
154233506|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154233507|NCT01170052|Temsirolimus|temsirolimus|mesh-list
154233508|NCT01170052|MTOR Inhibitors|mtor inhibitors|mesh-list
154233509|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154233510|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
154233511|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233512|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233513|NCT01170052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154233514|NCT01170052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233515|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233516|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
154233517|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233518|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154233519|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233520|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154233521|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
154233522|NCT01284478|Dexamethasone|dexamethasone|mesh-list
154233523|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233524|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
154233526|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233527|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233528|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233529|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
154233530|NCT01284478|Hormones|hormones|mesh-ancestor
154233531|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233532|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154233533|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233534|NCT00252720|Candesartan|candesartan|mesh-list
154233535|NCT00252720|Candesartan cilexetil|candesartan cilexetil|mesh-list
154233536|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154233537|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154233538|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154233539|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233540|NCT01284556|Phenobarbital|phenobarbital|mesh-list
154233541|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
154233542|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154233543|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233544|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233545|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154233546|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154233547|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233548|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233549|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
154233550|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
154233551|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154233552|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154233553|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154233554|NCT01170130|Lidocaine|lidocaine|mesh-list
154233555|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
154233556|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
154233557|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233558|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233559|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
154233560|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233561|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154233562|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154233563|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154233564|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154233565|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233566|NCT03868852|Apatinib|apatinib|mesh-list
154233567|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233568|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154233569|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233570|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233571|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
154233572|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233573|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
154233574|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233575|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233576|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154233577|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
154233578|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233579|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233580|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154233581|NCT01163500|Ubiquinone|ubiquinone|mesh-list
154233582|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
154107796|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153980501|NCT00970268|Bromides|bromides|mesh-list
154233583|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
154233584|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233585|NCT01163500|Vitamins|vitamins|mesh-ancestor
154233586|NCT01163734|Ranolazine|ranolazine|mesh-list
154233587|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154233588|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154233589|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233590|NCT01284868|Propranolol|propranolol|mesh-list
154233591|NCT01284868|Bisoprolol|bisoprolol|mesh-list
154233592|NCT01284868|Mirabegron|mirabegron|mesh-list
154233593|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154233594|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154233595|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
154233596|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233597|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233598|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233600|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154233601|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
154233602|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154233603|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154233604|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154233605|NCT01284868|Urological Agents|urological agents|mesh-ancestor
154233606|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
154233607|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
154233608|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233609|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154233610|NCT01170442|Vitamin D|vitamin d|mesh-list
154233611|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
154392970|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154233612|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
154233613|NCT01170442|Vitamins|vitamins|mesh-list
154233614|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
154233615|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233616|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154233617|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154233618|NCT00252564|Leucovorin|leucovorin|mesh-list
154233619|NCT00252564|Bevacizumab|bevacizumab|mesh-list
154233620|NCT00252564|Cetuximab|cetuximab|mesh-list
154233621|NCT00252564|Fluorouracil|fluorouracil|mesh-list
154233622|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
154233623|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154233624|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233625|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154233626|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154233627|NCT00252564|Growth Substances|growth substances|mesh-ancestor
154233628|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233629|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
154233630|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
154233631|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233632|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154233633|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233634|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
154233635|NCT00252564|Antidotes|antidotes|mesh-ancestor
154233636|NCT00252564|Protective Agents|protective agents|mesh-ancestor
154233637|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
154233638|NCT00252564|Vitamins|vitamins|mesh-ancestor
154233639|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
154233640|NCT01284946|Deferasirox|deferasirox|mesh-list
154233641|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154233642|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
154233643|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
154233644|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233645|NCT01173562|Mebendazole|mebendazole|mesh-list
154233646|NCT01173562|Piperazine|piperazine|mesh-list
154233647|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
154233648|NCT01173562|DMP 777|dmp 777|mesh-list
154233649|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
154233650|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
154233651|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154233652|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233653|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
154233654|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154233655|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
154233656|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233657|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233658|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233659|NCT00166296|Escitalopram|escitalopram|mesh-list
154233660|NCT00166296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154233661|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154107844|NCT00862875|Insulin|insulin|mesh-list
154233662|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107874|NCT00955162|Buprenorphine|buprenorphine|mesh-list
154233663|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233664|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233665|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
154233666|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233667|NCT01173640|Midazolam|midazolam|mesh-list
154233668|NCT01173640|Resveratrol|resveratrol|mesh-list
154233669|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154233670|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154233671|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233672|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233673|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154233674|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154233675|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154233676|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154233677|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
154233678|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
154233679|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
154233680|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
154233681|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233682|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233683|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
154233684|NCT01173640|Protective Agents|protective agents|mesh-ancestor
154233685|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233686|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154233687|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154233688|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
154233689|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233690|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154233691|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
154233692|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233693|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233694|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154233695|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154233696|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154233697|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
154233698|NCT03868306|Chrysarobin|chrysarobin|mesh-list
154233699|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154233700|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154233701|NCT03868306|Analgesics|analgesics|mesh-ancestor
154233702|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
154233703|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233704|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233705|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233706|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233707|NCT01164046|Vitamin K|vitamin k|mesh-list
154233708|NCT01164046|Heparin|heparin|mesh-list
154233709|NCT01164046|Enoxaparin|enoxaparin|mesh-list
154233710|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154233711|NCT01164046|Tinzaparin|tinzaparin|mesh-list
154233712|NCT01164046|Dalteparin|dalteparin|mesh-list
154233713|NCT01164046|Nadroparin|nadroparin|mesh-list
154233714|NCT01164046|Reviparin|reviparin|mesh-list
154233715|NCT01164046|Warfarin|warfarin|mesh-list
154233716|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
154233717|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
154233718|NCT01164046|Bemiparin|bemiparin|mesh-list
154233719|NCT01164046|Certoparin|certoparin|mesh-list
154233720|NCT01164046|Vitamins|vitamins|mesh-ancestor
154233721|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
154233722|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233723|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
154233724|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154233725|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154233726|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233727|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154233728|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
154233729|NCT01164046|Coagulants|coagulants|mesh-ancestor
154233730|NCT01075464|Paclitaxel|paclitaxel|mesh-list
154233731|NCT01075464|Bevacizumab|bevacizumab|mesh-list
154233732|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153980654|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154233733|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233734|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
154233735|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
154233736|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
154233737|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233738|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154233739|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154233740|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154233741|NCT01075464|Growth Substances|growth substances|mesh-ancestor
154233742|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233743|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
154233744|NCT01074996|Leucovorin|leucovorin|mesh-list
154107951|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154233745|NCT01074996|Antidotes|antidotes|mesh-ancestor
154233746|NCT01074996|Protective Agents|protective agents|mesh-ancestor
154233747|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233748|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
154233749|NCT01074996|Vitamins|vitamins|mesh-ancestor
154233750|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
154233751|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
154233752|NCT00160524|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154233753|NCT00160524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233754|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233755|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
154233756|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233757|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233758|NCT01077570|Repaglinide|repaglinide|mesh-list
154233759|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154233760|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233761|NCT01075698|Telmisartan|telmisartan|mesh-list
154233762|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154233763|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154233764|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154392971|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154233765|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233766|NCT00159822|Voriconazole|voriconazole|mesh-list
154233767|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
154233768|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233769|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154233770|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154233771|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233772|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233773|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154233774|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
154233775|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233776|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233777|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154233778|NCT00158262|Propranolol|propranolol|mesh-list
154233779|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154233780|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154233781|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
154233782|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233783|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233784|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233785|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154233786|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154233787|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
154233788|NCT03868072|Tofacitinib|tofacitinib|mesh-list
154233789|NCT03868072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154233790|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154233791|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233792|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233794|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
154233795|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233796|NCT01283932|Pantoprazole|pantoprazole|mesh-list
154233797|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154233798|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233799|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154233800|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233801|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233802|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154233803|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154233804|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233805|NCT01171378|Ofatumumab|ofatumumab|mesh-list
154233806|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233807|NCT01171456|Metformin|metformin|mesh-list
154233808|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154233809|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233810|NCT03865888|Cyclosporine|cyclosporine|mesh-list
154233811|NCT03865888|Tacrolimus|tacrolimus|mesh-list
154233812|NCT03865888|Cyclosporins|cyclosporins|mesh-list
154233813|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233814|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
154233815|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233816|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154233817|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233818|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233819|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
154233820|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233821|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
154233822|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233824|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154233825|NCT01284166|Dorzolamide|dorzolamide|mesh-list
154233826|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154233827|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154233828|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154233829|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154233830|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
154233831|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233832|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233833|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233834|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154233835|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154233836|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154233837|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154233838|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154392972|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154233839|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154233840|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233841|NCT01285414|Temozolomide|temozolomide|mesh-list
154233842|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154233843|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
154233844|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233845|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233846|NCT01172002|Azathioprine|azathioprine|mesh-list
154233847|NCT01172002|Leflunomide|leflunomide|mesh-list
154233848|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
154233849|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233850|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154233851|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233852|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154233853|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
154233854|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233855|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233856|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233857|NCT03867994|Carvedilol|carvedilol|mesh-list
154233858|NCT03867994|Atorvastatin|atorvastatin|mesh-list
154233859|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154233860|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154233861|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
154233862|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233863|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154233864|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154233865|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233866|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154233867|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154233868|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
154233869|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233870|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233871|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154233872|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
154233873|NCT03867994|Protective Agents|protective agents|mesh-ancestor
154233874|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154233875|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154233876|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154233877|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
154233878|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154233879|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154233880|NCT01172236|Lactoferrin|lactoferrin|mesh-list
154233881|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233882|NCT02525848|Dexamethasone|dexamethasone|mesh-list
154233883|NCT02525848|Gabapentin|gabapentin|mesh-list
154233884|NCT02525848|Aprepitant|aprepitant|mesh-list
154233885|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233886|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
154233887|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
154233888|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233889|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233890|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233891|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
154233892|NCT02525848|Hormones|hormones|mesh-ancestor
154233893|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154233894|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154233895|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233896|NCT02525848|Analgesics|analgesics|mesh-ancestor
154233897|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
154233898|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
154233899|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154233900|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154233901|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233902|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154233903|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154233904|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154233905|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233906|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233907|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
154233908|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154233909|NCT01269112|Citric Acid|citric acid|mesh-list
154233910|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
154233911|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
154233912|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154233913|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
154233914|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
154233915|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233917|NCT01174420|Mitomycin|mitomycin|mesh-list
154233918|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154233919|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233920|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
154233921|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233922|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154233923|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233924|NCT01164826|Nabumetone|nabumetone|mesh-list
154233925|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154233926|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154233927|NCT01164826|Analgesics|analgesics|mesh-ancestor
154233928|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
154233929|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233930|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233931|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154233932|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154233933|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154233934|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154233935|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154233936|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233937|NCT01172392|Interferons|interferons|mesh-list
154233938|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
154233939|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
154233940|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154233941|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154233942|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
154233943|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233944|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
154233945|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233946|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
154233947|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154233948|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154233949|NCT03864016|Sufentanil|sufentanil|mesh-list
154233950|NCT03864016|Dsuvia|dsuvia|mesh-list
154233951|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
154233952|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233953|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233954|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154233955|NCT03864016|Narcotics|narcotics|mesh-ancestor
154233956|NCT03864016|Analgesics|analgesics|mesh-ancestor
154233957|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
154233958|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233959|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154233960|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154233961|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
154233962|NCT03860662|Baclofen|baclofen|mesh-list
154233963|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154233964|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233966|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233967|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154233968|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
154233969|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
154233970|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108165|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154233971|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233972|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
154233973|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
154233975|NCT01177852|Brompheniramine|brompheniramine|mesh-list
154233976|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
154233977|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
154233978|NCT01177852|Ephedrine|ephedrine|mesh-list
154233979|NCT01177852|Dipropizine|dipropizine|mesh-list
154233980|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154233981|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154233982|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154233983|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154233984|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154233985|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
154233986|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
154233987|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
154233988|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154233989|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
154233990|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
154233991|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154233992|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154233993|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
154233994|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
154233995|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154233996|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154233997|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
154233998|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154233999|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154234000|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154234001|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
154234002|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
154234003|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154234004|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154234005|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
154234006|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
154234007|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
154234008|NCT03863392|Misoprostol|misoprostol|mesh-list
154234009|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154234010|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
154234011|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154234012|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234013|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154234014|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234015|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
154234016|NCT01175200|Lansoprazole|lansoprazole|mesh-list
154234017|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
154234018|NCT01175200|Clopidogrel|clopidogrel|mesh-list
154234019|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154234020|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154234021|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154234022|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154234023|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154234024|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
154234025|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234026|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234027|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234028|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154234029|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234030|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154234031|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234032|NCT03863626|Furosemide|furosemide|mesh-list
154234033|NCT03863626|Diuretics|diuretics|mesh-ancestor
154234034|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
154234035|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234036|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154234037|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234038|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234039|NCT01178320|Niacin|niacin|mesh-list
154234040|NCT01178320|Niacinamide|niacinamide|mesh-list
154234041|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
154234042|NCT01178320|Simvastatin|simvastatin|mesh-list
154234043|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154234044|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154234045|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
154234046|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234047|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154234048|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154234050|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
154234051|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
154234052|NCT01178320|Vitamins|vitamins|mesh-ancestor
154234053|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
154234054|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234055|NCT01175512|Naltrexone|naltrexone|mesh-list
154234056|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154234057|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154234058|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234059|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
154234060|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234061|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
154234062|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154234063|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234064|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392973|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154234065|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154234066|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154234067|NCT03859570|Protective Agents|protective agents|mesh-ancestor
154234068|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234069|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
154234070|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154234071|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
154234072|NCT03745222|Tislelizumab|tislelizumab|mesh-list
154234073|NCT03745222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154234074|NCT03745222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234075|NCT01286584|Varenicline|varenicline|mesh-list
154234076|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154234077|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154234078|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
154234079|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234080|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234081|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234082|NCT03743038|Minocycline|minocycline|mesh-list
154234083|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154234084|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234085|NCT03864250|Prednisone|prednisone|mesh-list
154234086|NCT03864250|Tacrolimus|tacrolimus|mesh-list
154234087|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234088|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
154234089|NCT03864250|Hormones|hormones|mesh-ancestor
154234090|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234091|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234092|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154234093|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234094|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154234095|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
154234096|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154234097|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234098|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234099|NCT01175746|Nicardipine|nicardipine|mesh-list
154234100|NCT01175746|Remifentanil|remifentanil|mesh-list
154234101|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154234102|NCT01175746|Narcotics|narcotics|mesh-ancestor
154234103|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234104|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234105|NCT01175746|Analgesics|analgesics|mesh-ancestor
154234106|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
154234107|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234108|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154234109|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154234110|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234111|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234112|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154234114|NCT01174810|Exenatide|exenatide|mesh-list
154234115|NCT01174810|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154234116|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154234117|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234118|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154234119|NCT01174810|Incretins|incretins|mesh-ancestor
154234120|NCT01174810|Hormones|hormones|mesh-ancestor
154234121|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234122|NCT01178710|Simvastatin|simvastatin|mesh-list
154234123|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154234124|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154234125|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
154234126|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234127|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154234128|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154234129|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234131|NCT01174888|Etoposide|etoposide|mesh-list
154234132|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
154234133|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
154234134|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
154234135|NCT01174888|Bortezomib|bortezomib|mesh-list
154234136|NCT01174888|Midostaurin|midostaurin|mesh-list
154234137|NCT01174888|Staurosporine|staurosporine|mesh-list
154234138|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154234139|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234140|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154234141|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154234142|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234143|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234144|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154234145|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
154234146|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
154108301|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
154234147|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234148|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154234149|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
154234150|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234151|NCT01174888|Analgesics|analgesics|mesh-ancestor
154234152|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
154234153|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234154|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
154234155|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
154234156|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
154234157|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
154234158|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
154234159|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154234160|NCT01178788|Progesterone|progesterone|mesh-list
154234161|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154234162|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154234163|NCT01178788|Progestins|progestins|mesh-ancestor
154234164|NCT01178788|Hormones|hormones|mesh-ancestor
154234165|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234166|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234167|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154234168|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
154234169|NCT00153816|Vitamin D|vitamin d|mesh-list
154234170|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
154234171|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
154234172|NCT00153816|Calcium|calcium|mesh-list
154234173|NCT00153816|Vitamins|vitamins|mesh-ancestor
154234174|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
154234175|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234176|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154234177|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154234178|NCT00153816|Antacids|antacids|mesh-ancestor
154234179|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234180|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234181|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154234182|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
154234183|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234184|NCT01077648|Trastuzumab|trastuzumab|mesh-list
154234185|NCT01077648|Lapatinib|lapatinib|mesh-list
154234186|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153981099|NCT00648765|Anagrelide|anagrelide|mesh-list
154234187|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234188|NCT01077648|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154234189|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154234190|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234191|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234192|NCT00151476|Celecoxib|celecoxib|mesh-list
154234193|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154234194|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154234195|NCT00151476|Analgesics|analgesics|mesh-ancestor
154234196|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
154234197|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527788|NCT01473914|Vitamins|vitamins|mesh-list
154234199|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234200|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234201|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154234202|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154234203|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234204|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234205|NCT01077726|Capecitabine|capecitabine|mesh-list
154234206|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154234207|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
154234208|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234209|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234210|NCT01179100|Lidocaine|lidocaine|mesh-list
154234211|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
154234212|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
154234213|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234214|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234215|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
154392974|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
154234216|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234217|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154234218|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154234219|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154234220|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234221|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234222|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
154234223|NCT03864172|Calcium|calcium|mesh-list
154234224|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154234225|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234226|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154234227|NCT02525302|Halofuginone|halofuginone|mesh-list
154234228|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234229|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
154234230|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154234231|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154234232|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234233|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154234234|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234235|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234236|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154234237|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154234238|NCT02525302|Growth Substances|growth substances|mesh-ancestor
154234239|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234240|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
154234241|NCT01286194|Rabeprazole|rabeprazole|mesh-list
154234242|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154234243|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234244|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154234245|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234246|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234247|NCT01179256|Curcumin|curcumin|mesh-list
154234248|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154234249|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154234250|NCT01179256|Analgesics|analgesics|mesh-ancestor
154234251|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
154234252|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234253|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234254|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234255|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234256|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234257|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234258|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234260|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
154234261|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
154234262|NCT01179412|Povidone|povidone|mesh-list
154108419|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234263|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154234264|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234265|NCT01179412|Trace Elements|trace elements|mesh-ancestor
154234266|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
154234267|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234268|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
154234269|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
154253939|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
154234270|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154234271|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154234272|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234274|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
154234275|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234276|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154234277|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154234278|NCT03862768|Growth Substances|growth substances|mesh-ancestor
154234279|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234280|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
154234281|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154234282|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234283|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234284|NCT03862768|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154234285|NCT03862456|Azithromycin|azithromycin|mesh-list
154234286|NCT03862456|Metronidazole|metronidazole|mesh-list
154234287|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154234288|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234289|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154392975|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154234290|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154234291|NCT03859102|Acetaminophen|acetaminophen|mesh-list
154234292|NCT03859102|Dexamethasone|dexamethasone|mesh-list
154234294|NCT03859102|Ondansetron|ondansetron|mesh-list
154234295|NCT03859102|Anesthetics|anesthetics|mesh-list
154234296|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
154234297|NCT03859102|Lansoprazole|lansoprazole|mesh-list
154234298|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
154234299|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234300|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
154234301|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
154234302|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234303|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108457|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
154234304|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234305|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
154234306|NCT03859102|Hormones|hormones|mesh-ancestor
154234307|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234308|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154234309|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234310|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234311|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154234312|NCT03859102|Analgesics|analgesics|mesh-ancestor
154234313|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
154234314|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
154234315|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
154234316|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154234317|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154234318|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154234319|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154234320|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154234321|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234322|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234323|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
154234324|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
154234325|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
154234326|NCT03859102|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154234327|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154234328|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
154234329|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154234330|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154234331|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234332|NCT00149994|Cyclosporine|cyclosporine|mesh-list
154234333|NCT00149994|Prednisone|prednisone|mesh-list
154234334|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
154234335|NCT00149994|Tacrolimus|tacrolimus|mesh-list
154234336|NCT00149994|Cyclosporins|cyclosporins|mesh-list
154234337|NCT00149994|Basiliximab|basiliximab|mesh-list
154234338|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234339|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
154234340|NCT00149994|Hormones|hormones|mesh-ancestor
154234341|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234342|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234343|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154234344|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234345|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154234346|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
154234347|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154234349|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234350|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
154234351|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234352|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
154234353|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234354|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
154234355|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
154234356|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234357|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234358|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154234359|NCT00149994|Protective Agents|protective agents|mesh-ancestor
154234360|NCT01179646|Pantoprazole|pantoprazole|mesh-list
154234361|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154234362|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234363|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154234364|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234365|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234366|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
154234367|NCT01075776|Acetylcholine|acetylcholine|mesh-list
154234368|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
154234369|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154234370|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
154234371|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234372|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234373|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234374|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
154234375|NCT01079910|Fluorides|fluorides|mesh-list
154234376|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
154234377|NCT01079910|Protective Agents|protective agents|mesh-ancestor
154234378|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234379|NCT01286896|Sunitinib|sunitinib|mesh-list
154234380|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234381|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154234382|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154234383|NCT01286896|Growth Substances|growth substances|mesh-ancestor
154234384|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234385|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
154234386|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154234387|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234388|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234389|NCT03857854|Pirfenidone|pirfenidone|mesh-list
154234390|NCT03857854|Analgesics|analgesics|mesh-ancestor
154234391|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
154234392|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234393|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234394|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154234395|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154234396|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234397|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234398|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234399|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
154234400|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154234401|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
154234402|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
154234403|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234404|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234405|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154234406|NCT01287052|Analgesics|analgesics|mesh-ancestor
154234407|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
154234408|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234409|NCT01288924|Parecoxib|parecoxib|mesh-list
154234410|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154234411|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154234412|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234413|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234414|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154234415|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154234417|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
154234418|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234419|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234420|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234421|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234422|NCT01179724|Pantoprazole|pantoprazole|mesh-list
154234423|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154234424|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154234425|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234426|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234427|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234428|NCT03862612|Anesthetics|anesthetics|mesh-list
154234429|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234430|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234431|NCT01287130|Cetuximab|cetuximab|mesh-list
154234432|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154234433|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234434|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
154234435|NCT00149214|Docetaxel|docetaxel|mesh-list
154234436|NCT00149214|Doxorubicin|doxorubicin|mesh-list
154234437|NCT00149214|Pemetrexed|pemetrexed|mesh-list
154234438|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154234439|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
154234440|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234441|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234442|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154234443|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
154234444|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234445|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234446|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154234447|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
154234448|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
154234449|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
154234450|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154234451|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154234452|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154234453|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234454|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154234455|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154234456|NCT03034018|Suvorexant|suvorexant|mesh-list
154234457|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154234458|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154234459|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234460|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234461|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154108611|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
154234462|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234463|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234464|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154234465|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
154234466|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154234467|NCT02525458|Protective Agents|protective agents|mesh-ancestor
154234468|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234469|NCT02555254|Methamphetamine|methamphetamine|mesh-list
154234470|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154234471|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234472|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
154234473|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
154234474|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234475|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
154234476|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234477|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234478|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
154234479|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154234480|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154234481|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234482|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154234483|NCT00114972|Paclitaxel|paclitaxel|mesh-list
154234484|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154234485|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154234486|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234487|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
153981409|NCT02568709|Oxytocin|oxytocin|mesh-list
154234488|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
154234489|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
154234490|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234491|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
154234492|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
154234493|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
154234494|NCT02444728|Azathioprine|azathioprine|mesh-list
154234495|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154234496|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
154234497|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108657|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
154234498|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234499|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154234500|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
154234501|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234502|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234503|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154234504|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234505|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
154234506|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
154234507|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234508|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234509|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
154234510|NCT02444728|Hormones|hormones|mesh-ancestor
154234511|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234512|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154234513|NCT02444728|Protective Agents|protective agents|mesh-ancestor
154234514|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
154234515|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154234516|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154234517|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234518|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234519|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
154234520|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154234521|NCT00129402|Simvastatin|simvastatin|mesh-list
154234522|NCT00129402|Ezetimibe|ezetimibe|mesh-list
154234523|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154234524|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154234525|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
154234526|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234527|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154234528|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154234529|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234530|NCT03739528|Levofloxacin|levofloxacin|mesh-list
154234531|NCT03739528|Ofloxacin|ofloxacin|mesh-list
154234532|NCT03739528|Tobramycin|tobramycin|mesh-list
154234533|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154234534|NCT03739528|Dexamethasone|dexamethasone|mesh-list
154234535|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
154234536|NCT03739528|BB 1101|bb 1101|mesh-list
154234537|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234538|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
154234539|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
154234540|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234541|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234542|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234543|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
154234544|NCT03739528|Hormones|hormones|mesh-ancestor
154234545|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234546|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154234547|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234548|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
154234549|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234550|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234551|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154234552|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234553|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154234554|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154234555|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154234556|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154234557|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153981477|NCT02652507|Ketamine|ketamine|mesh-list
154234558|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154234559|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154234560|NCT03857386|Anesthetics|anesthetics|mesh-list
154234561|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234562|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234564|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
154234565|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234566|NCT01289236|Milnacipran|milnacipran|mesh-list
154234567|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
154234568|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154234569|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154234570|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234571|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234572|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234573|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234574|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154234575|NCT01289236|Analgesics|analgesics|mesh-ancestor
154234576|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
154234577|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234578|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
154234579|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154234580|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
154234581|NCT01289938|Promethazine|promethazine|mesh-list
154234582|NCT01289938|Metoclopramide|metoclopramide|mesh-list
154234583|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154234584|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154234585|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234586|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234587|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
154234588|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
154234589|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
154234590|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234591|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
154392976|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154234592|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
154234593|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234594|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154234595|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
154234596|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
154234597|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234598|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234599|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154234600|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
154234601|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
154234602|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154234603|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154234604|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
154234605|NCT00114738|Rituximab|rituximab|mesh-list
154234606|NCT00114738|Bortezomib|bortezomib|mesh-list
154234607|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154234608|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234609|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
154234610|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234611|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234612|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
154234613|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154234614|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154234615|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154234616|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234617|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234618|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
154234619|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234620|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234621|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154234622|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234623|NCT01180426|Tosedostat|tosedostat|mesh-list
154234624|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234625|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234626|NCT00148122|Docetaxel|docetaxel|mesh-list
154234627|NCT00148122|Capecitabine|capecitabine|mesh-list
154234628|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234629|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
154108786|NCT00878631|Dextrans|dextrans|mesh-list
154234630|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
154234631|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
154234632|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234633|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154234634|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
154234635|NCT01182142|Capecitabine|capecitabine|mesh-list
154234636|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154234637|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
154234638|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234639|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234640|NCT01180816|Temozolomide|temozolomide|mesh-list
154234641|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154234642|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
154234643|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234644|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234645|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
154234646|NCT01287598|Midazolam|midazolam|mesh-list
154234647|NCT01287598|Omeprazole|omeprazole|mesh-list
154234648|NCT01287598|Warfarin|warfarin|mesh-list
154234649|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154234650|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154234651|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234652|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234653|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154234654|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154234655|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154234656|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154234657|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
154234658|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
154234659|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
154234660|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
154234661|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234662|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234663|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
154234664|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154234665|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234666|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154234667|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234668|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154234669|NCT03862144|Palonosetron|palonosetron|mesh-list
154234670|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
154234671|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
154234672|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234673|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234674|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234675|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154108826|NCT00369967|NuvaRing|nuvaring|mesh-list
154234676|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154234677|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
154234678|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234679|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234680|NCT01290172|Somatostatin|somatostatin|mesh-list
154234681|NCT01290172|Hormones|hormones|mesh-ancestor
154234682|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234683|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234684|NCT03861598|Carvedilol|carvedilol|mesh-list
154234685|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154234686|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154234687|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
154234688|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234689|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234690|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234691|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154234692|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
154234693|NCT03861598|Protective Agents|protective agents|mesh-ancestor
154234694|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154234695|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234696|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154234697|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
154234698|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154234699|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154234700|NCT01184482|Cetuximab|cetuximab|mesh-list
154234701|NCT01184482|Lapatinib|lapatinib|mesh-list
154234702|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154234703|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234704|NCT01184482|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154234705|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154234706|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234707|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234708|NCT01184560|Orlistat|orlistat|mesh-list
154234709|NCT01184560|Sibutramine|sibutramine|mesh-list
154234710|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234711|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234712|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154234713|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154234714|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
154234715|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154234716|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
154234717|NCT01184638|Propofol|propofol|mesh-list
154234718|NCT01184638|Sevoflurane|sevoflurane|mesh-list
154234719|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154108871|NCT02534467|Montelukast|montelukast|mesh-list
154234720|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234722|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154234723|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
154234724|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
154234725|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154234726|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154234727|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
154234728|NCT01290328|Hematinics|hematinics|mesh-ancestor
154234729|NCT01184716|Vitamin D|vitamin d|mesh-list
154234730|NCT01184716|Vitamins|vitamins|mesh-ancestor
154234731|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
154234732|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234733|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154234734|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
154234735|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
154234736|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
154234737|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234738|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234739|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
154234740|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234741|NCT01587508|Meloxicam|meloxicam|mesh-list
154234742|NCT01587508|Amitriptyline|amitriptyline|mesh-list
154234744|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154234745|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154234746|NCT01587508|Analgesics|analgesics|mesh-ancestor
154234747|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
154234748|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234749|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234750|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234751|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234752|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154234753|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154234754|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234755|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234756|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154234757|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
154234758|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154234759|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154108917|NCT00879099|Timolol|timolol|mesh-list
154234760|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154234761|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154234762|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234763|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154234764|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154234765|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234766|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
154234767|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234768|NCT00147498|Tofacitinib|tofacitinib|mesh-list
154234769|NCT00147498|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154234770|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154234771|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234772|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234773|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154234774|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
154234775|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234776|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234777|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154234778|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234779|NCT01080066|Cetuximab|cetuximab|mesh-list
154234780|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154234781|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234782|NCT01185184|Tofacitinib|tofacitinib|mesh-list
154234783|NCT01185184|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154234784|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154234785|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234786|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981693|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154234787|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
154234788|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154234789|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154234790|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234791|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
154234792|NCT00113568|Coagulants|coagulants|mesh-ancestor
154234793|NCT01185262|Rituximab|rituximab|mesh-list
154234794|NCT01185262|Lenalidomide|lenalidomide|mesh-list
154234795|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108953|NCT00676338|Metformin|metformin|mesh-list
154234796|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234797|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
154234798|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234799|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154234800|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154234801|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154234802|NCT01185262|Growth Substances|growth substances|mesh-ancestor
154234803|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
154234805|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
154234806|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154234807|NCT00146640|Prednisone|prednisone|mesh-list
154234808|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234809|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
154234810|NCT00146640|Hormones|hormones|mesh-ancestor
154234811|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154234812|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234813|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154234814|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234815|NCT01185418|Haloperidol|haloperidol|mesh-list
154234816|NCT01185418|Risperidone|risperidone|mesh-list
154234817|NCT01185418|Aripiprazole|aripiprazole|mesh-list
154234818|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
154234819|NCT01185418|Amisulpride|amisulpride|mesh-list
154234820|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154234821|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
154234822|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234823|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234824|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234825|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154234826|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154234827|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234828|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154234829|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154234830|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
154234831|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
154234832|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
154234833|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154234834|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154234835|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154234836|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154234837|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
154234838|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
154234839|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234840|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154234841|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154234842|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154234843|NCT01185574|Vitamin D|vitamin d|mesh-list
154234844|NCT01185574|Vitamins|vitamins|mesh-ancestor
154234845|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
154234846|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234847|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154234848|NCT03861364|Propofol|propofol|mesh-list
154234849|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154234850|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234851|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234852|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154234853|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
154234854|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
154234855|NCT01185808|Vitamin D|vitamin d|mesh-list
154234856|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
154234857|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
154234858|NCT01185808|Vitamins|vitamins|mesh-list
154234859|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
154234860|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234861|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153981770|NCT02646189|Interferons|interferons|mesh-list
154234862|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154234863|NCT01183624|Analgesics|analgesics|mesh-list
154234864|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
154234865|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234866|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234867|NCT01291186|Epinephrine|epinephrine|mesh-list
154234868|NCT01291186|Racepinephrine|racepinephrine|mesh-list
154234869|NCT01291186|Bupivacaine|bupivacaine|mesh-list
154234870|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
154234871|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
154234872|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
154234873|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234874|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234875|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
154234876|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234877|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154234878|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154234879|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
154234880|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234881|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234882|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154234883|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154234884|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
154234885|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154234886|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
154234887|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
154234888|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
154234889|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154234890|NCT04979338|Bupivacaine|bupivacaine|mesh-list
154234891|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
154234892|NCT04979338|Anesthetics|anesthetics|mesh-list
154234893|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109040|NCT00874419|Gemcitabine|gemcitabine|mesh-list
154234894|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234895|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
154234896|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234897|NCT01177306|Guanfacine|guanfacine|mesh-list
154234898|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154234899|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154234900|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154234901|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154234902|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
154234903|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234904|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234905|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234906|NCT01290406|Dactolisib|dactolisib|mesh-list
154234907|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234908|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
154234909|NCT03854812|Fentanyl|fentanyl|mesh-list
154234910|NCT03854812|Propofol|propofol|mesh-list
154234911|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154234912|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154234913|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234914|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154234915|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
154234916|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
154234917|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154234918|NCT03854812|Narcotics|narcotics|mesh-ancestor
154234919|NCT03854812|Analgesics|analgesics|mesh-ancestor
154234920|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
154234921|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154234922|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154234923|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154234924|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
154234925|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154234926|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234927|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234928|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154234929|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
154234930|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154234931|NCT01186120|Umirolimus|umirolimus|mesh-list
154234932|NCT01186120|Everolimus|everolimus|mesh-list
154234933|NCT01186120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154234934|NCT01186120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154234935|NCT01186120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234936|NCT01186120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234937|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154234938|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
154234939|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234940|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234941|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154234942|NCT03855826|Amiodarone|amiodarone|mesh-list
154234943|NCT03855826|Nifekalant|nifekalant|mesh-list
154234944|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154234945|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
154234946|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154234947|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154234948|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234949|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154234950|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154234951|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154234952|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234953|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154234954|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154234955|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154234956|NCT01184404|Bosentan|bosentan|mesh-list
154234957|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154234958|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154234959|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234960|NCT01186588|Canagliflozin|canagliflozin|mesh-list
154234961|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154234962|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234963|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154234964|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234965|NCT03854266|Heparin|heparin|mesh-list
154234967|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154234968|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
154234969|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154234970|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154234971|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234972|NCT01187992|Atorvastatin|atorvastatin|mesh-list
154234973|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154234974|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154234975|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
154234976|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234977|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154234978|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154234979|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154234980|NCT01191034|Imiquimod|imiquimod|mesh-list
154234981|NCT01191034|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154234982|NCT01191034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234983|NCT01191034|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154234984|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
154234985|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234986|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154234987|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154234988|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
154234989|NCT01188148|Memantine|memantine|mesh-list
154234990|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154234991|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154234992|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
154234993|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154234994|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154234995|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154234996|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154234997|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154234998|NCT01187212|Cisplatin|cisplatin|mesh-list
154234999|NCT01187212|Capecitabine|capecitabine|mesh-list
154235000|NCT01187212|Sorafenib|sorafenib|mesh-list
154235001|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235002|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154235003|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
154235004|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235005|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154235006|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235007|NCT03849508|Phenylephrine|phenylephrine|mesh-list
154235008|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
154235009|NCT03849508|Norepinephrine|norepinephrine|mesh-list
154235010|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154235011|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
154235012|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
154235013|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235014|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235015|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
154235016|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154235017|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
154235018|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235019|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154235020|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154235021|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154235022|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
154235023|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235024|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235025|NCT03849508|Protective Agents|protective agents|mesh-ancestor
154235026|NCT03849664|Niacinamide|niacinamide|mesh-list
154235027|NCT03849664|Niacin|niacin|mesh-list
154235028|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
154235029|NCT03849664|Riboflavin|riboflavin|mesh-list
154235030|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
154235031|NCT03849664|Povidone|povidone|mesh-list
154235032|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154235033|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235034|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
154235035|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
154235036|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
154235037|NCT03849664|Vitamins|vitamins|mesh-ancestor
154235038|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
154235039|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154235040|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
154235041|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235042|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154235043|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
154235044|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154235045|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
154235046|NCT01293838|Escitalopram|escitalopram|mesh-list
154235047|NCT01293838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154235048|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154235049|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235050|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235051|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235052|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
154235053|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235054|NCT01188304|Aspirin|aspirin|mesh-list
154235055|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154235056|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154235057|NCT01188304|Analgesics|analgesics|mesh-ancestor
154235058|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
154235059|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235060|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235061|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235062|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154235063|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154235064|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154235065|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235066|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154235067|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154235068|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235069|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
154235070|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
154235071|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
154235072|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154235073|NCT02524444|Mefloquine|mefloquine|mesh-list
154235074|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
154235075|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154235076|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154235077|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235078|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154235079|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235080|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235081|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154235082|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
154235083|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154235084|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
154235085|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235086|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235087|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154235088|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235089|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154235091|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235092|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235093|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154235094|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
154235095|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
154235096|NCT03853642|Protective Agents|protective agents|mesh-ancestor
154235097|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
154235098|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154235099|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
154235100|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235101|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235102|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154235103|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235104|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154235105|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154235106|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154235107|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
154235108|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235109|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235110|NCT01291654|Acetaminophen|acetaminophen|mesh-list
154235111|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154235112|NCT01291654|Analgesics|analgesics|mesh-ancestor
154235113|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
154235114|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235115|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235116|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
154235117|NCT03853096|Cefazolin|cefazolin|mesh-list
154235118|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154235119|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235120|NCT05671276|Aspirin|aspirin|mesh-list
154235121|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
154235122|NCT05671276|Clopidogrel|clopidogrel|mesh-list
154235123|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154235124|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154235125|NCT05671276|Analgesics|analgesics|mesh-ancestor
154235126|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
154235127|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235128|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235129|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235130|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154235131|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154235132|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154235133|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235134|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154235135|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154235136|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235137|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
154235138|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154235139|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154235140|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154235141|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
154235142|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235143|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154235144|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
154235145|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154235146|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
154235147|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
154235148|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154235149|NCT03852160|Mirtazapine|mirtazapine|mesh-list
154235150|NCT03852160|Trazodone|trazodone|mesh-list
154235151|NCT03852160|Agomelatine|agomelatine|mesh-list
154235152|NCT03852160|Bupropion|bupropion|mesh-list
154235153|NCT03852160|Sertraline|sertraline|mesh-list
154235154|NCT03852160|Esketamine|esketamine|mesh-list
154235155|NCT03852160|Escitalopram|escitalopram|mesh-list
154235156|NCT03852160|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154235157|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154235158|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235159|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235160|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235161|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
154235162|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235163|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235164|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154235165|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
154235166|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154235167|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154235168|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
154235169|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154235170|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154235172|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154235173|NCT03852160|Analgesics|analgesics|mesh-ancestor
154235174|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
154235175|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154235176|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
154235177|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
154235178|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154235179|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154235180|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235181|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154235182|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154235183|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154235184|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
154235185|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154235186|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154235187|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154235188|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154235189|NCT02524210|Omeprazole|omeprazole|mesh-list
154235190|NCT02524210|Rabeprazole|rabeprazole|mesh-list
154235191|NCT02524210|Dabigatran|dabigatran|mesh-list
154235192|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154235193|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154235194|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154235195|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235196|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235197|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
154235198|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154235199|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
154235200|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
154235201|NCT03847792|Dexamethasone|dexamethasone|mesh-list
154235202|NCT03847792|Fentanyl|fentanyl|mesh-list
154235203|NCT03847792|Bupivacaine|bupivacaine|mesh-list
154235204|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235205|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
154235206|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
154235207|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235208|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235209|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154235210|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
154235211|NCT03847792|Hormones|hormones|mesh-ancestor
154235212|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235213|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154235214|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235215|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
154235216|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
154235217|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235218|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
154235219|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154235220|NCT03847792|Narcotics|narcotics|mesh-ancestor
154235221|NCT03847792|Analgesics|analgesics|mesh-ancestor
154235222|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154109362|NCT00612807|Sertraline|sertraline|mesh-list
154235223|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154235224|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
154235225|NCT01294618|Interferons|interferons|mesh-list
154235226|NCT01294618|Nilotinib|nilotinib|mesh-list
154235227|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235228|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
154235229|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235230|NCT01294618|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154235231|NCT01294618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154235232|NCT01294618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235233|NCT01294618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235234|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
154235235|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
154235236|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154235237|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154235238|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235239|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235240|NCT01194232|Urological Agents|urological agents|mesh-ancestor
154235241|NCT01296334|Morphine|morphine|mesh-list
154235242|NCT01296334|Buprenorphine|buprenorphine|mesh-list
154235243|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154235244|NCT01296334|Narcotics|narcotics|mesh-ancestor
154235245|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235246|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235247|NCT01296334|Analgesics|analgesics|mesh-ancestor
154235248|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
154235249|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235250|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154235252|NCT03847558|Testosterone|testosterone|mesh-list
154235253|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154235254|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235255|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235256|NCT03847558|Androgens|androgens|mesh-ancestor
154235257|NCT01189006|Levomethorphan|levomethorphan|mesh-list
154235258|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
154235259|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
154235260|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235261|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154235262|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154235263|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235264|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235265|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235266|NCT01189006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154235267|NCT01189006|Narcotics|narcotics|mesh-ancestor
154235268|NCT01189006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235269|NCT01189006|Analgesics|analgesics|mesh-ancestor
154235270|NCT01189006|Sensory System Agents|sensory system agents|mesh-ancestor
154235271|NCT01189006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235272|NCT01292356|Cetuximab|cetuximab|mesh-list
154235273|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154235274|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235275|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154235276|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235277|NCT03847246|Entecavir|entecavir|mesh-list
154235278|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
154235279|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235280|NCT03849196|Bisacodyl|bisacodyl|mesh-list
154235281|NCT03849196|Cathartics|cathartics|mesh-ancestor
154235282|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154235283|NCT03849196|Laxatives|laxatives|mesh-ancestor
154235284|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154235285|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154235286|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154235287|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
154235288|NCT01296802|Fenfluramine|fenfluramine|mesh-list
154235289|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
154235290|NCT01296802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154235291|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154235292|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235293|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235294|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235295|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
154235296|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235297|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154235298|NCT01296958|Niclosamide|niclosamide|mesh-list
154235299|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
154235300|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154235301|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
154235302|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154235303|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235304|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
154235305|NCT01295086|Docetaxel|docetaxel|mesh-list
154235306|NCT01295086|Capecitabine|capecitabine|mesh-list
154235307|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
154235308|NCT01295086|Trastuzumab|trastuzumab|mesh-list
154235309|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235310|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
154235311|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
154235312|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
154235313|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235314|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153982220|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
154235315|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
154235316|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154235317|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154235318|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154235319|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
154235320|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235321|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235322|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154235323|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235324|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
154235325|NCT01194700|Hormones|hormones|mesh-ancestor
154235326|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235327|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
154235328|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154235329|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
154235330|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154235331|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154235332|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154235333|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235334|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235335|NCT01194778|Vitamins|vitamins|mesh-list
154235336|NCT01194778|Vitamin K|vitamin k|mesh-list
154235337|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
154235338|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
154235339|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
154235340|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235341|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154235342|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154235343|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235344|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
154235345|NCT01194778|Coagulants|coagulants|mesh-ancestor
154235346|NCT01194934|Lenograstim|lenograstim|mesh-list
154235347|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154235348|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
154235349|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235350|NCT01297036|Donepezil|donepezil|mesh-list
154235351|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154235352|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235353|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235354|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
154235355|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235356|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235357|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
154235358|NCT03848806|Calcitriol|calcitriol|mesh-list
154235359|NCT03848806|Calcipotriene|calcipotriene|mesh-list
154235360|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
154235361|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154235362|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235363|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154235364|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235365|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235366|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154235367|NCT03848806|Vitamins|vitamins|mesh-ancestor
154235368|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
154235369|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154235370|NCT01189864|Diclofenac|diclofenac|mesh-list
154235371|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
154235372|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154235373|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
154235374|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154235375|NCT01189864|Prednisolone|prednisolone|mesh-list
154235376|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154235377|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
154235378|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154235379|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154235380|NCT01189864|Analgesics|analgesics|mesh-ancestor
154235381|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
154235382|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235383|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235384|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235385|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154235386|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154235387|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235388|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235389|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
154235390|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
154235391|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154235392|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
154235393|NCT01189864|Hormones|hormones|mesh-ancestor
154235394|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235395|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154235396|NCT01189864|Protective Agents|protective agents|mesh-ancestor
154235397|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154235398|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235399|NCT01195246|Vaccines|vaccines|mesh-list
154235400|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
154235401|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235402|NCT01191892|Carboplatin|carboplatin|mesh-list
154235403|NCT01191892|Gemcitabine|gemcitabine|mesh-list
154235404|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235405|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154235406|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
154235407|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235408|NCT01293058|Naloxone|naloxone|mesh-list
154235409|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154235410|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235411|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
154235412|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235413|NCT01195324|Canagliflozin|canagliflozin|mesh-list
154235414|NCT01195324|Warfarin|warfarin|mesh-list
154235415|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
154235416|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154235417|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235418|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154235419|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235420|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
154235421|NCT01293136|Narcotics|narcotics|mesh-ancestor
154235422|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235423|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235424|NCT01293136|Analgesics|analgesics|mesh-ancestor
154235425|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
154235426|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235427|NCT01293292|Teriparatide|teriparatide|mesh-list
154235428|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154235429|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235430|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154235431|NCT01195714|Ofatumumab|ofatumumab|mesh-list
154235432|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235433|NCT01190722|Diclofenac|diclofenac|mesh-list
154235434|NCT01190722|Etoricoxib|etoricoxib|mesh-list
154235435|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154235436|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154235437|NCT01190722|Analgesics|analgesics|mesh-ancestor
154235438|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
154235439|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235440|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235441|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235442|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154235443|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154235444|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235445|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235446|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154235447|NCT01196260|Capecitabine|capecitabine|mesh-list
154235448|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
154235449|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154235450|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
154235451|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235452|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235453|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
154235454|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235455|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154235456|NCT01193296|Vildagliptin|vildagliptin|mesh-list
154235457|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154235458|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235459|NCT01193296|Incretins|incretins|mesh-ancestor
154235460|NCT01193296|Hormones|hormones|mesh-ancestor
154235461|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235462|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154235463|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
154235464|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235465|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235466|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
154235467|NCT01197040|Prednisone|prednisone|mesh-list
154235468|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235469|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
154235471|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235472|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235473|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154235474|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235475|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154235476|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154235477|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
154235478|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154235479|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235480|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235481|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235482|NCT01193452|Leucovorin|leucovorin|mesh-list
154235483|NCT01193452|Fluorouracil|fluorouracil|mesh-list
154235484|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
154235485|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
154235486|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235487|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154235488|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235489|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154235490|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
154235491|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235492|NCT01193452|Antidotes|antidotes|mesh-ancestor
154235493|NCT01193452|Protective Agents|protective agents|mesh-ancestor
154235494|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
154235495|NCT01193452|Vitamins|vitamins|mesh-ancestor
154235496|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
154235497|NCT05670886|Carbetocin|carbetocin|mesh-list
154235498|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
154235499|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154235500|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235501|NCT01295632|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
154235502|NCT01295632|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154235503|NCT01295632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235504|NCT01295632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235505|NCT03844594|Eptifibatide|eptifibatide|mesh-list
154235506|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154235507|NCT03848182|Gemcitabine|gemcitabine|mesh-list
154235508|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154235509|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
154235510|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235511|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235513|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154235514|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154235515|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
154235516|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235517|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
154235518|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
154235519|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154235520|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
154235521|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235522|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235523|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154235524|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235525|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154235526|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
154235527|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235528|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235529|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154235530|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
154235531|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
154235532|NCT01295866|Protective Agents|protective agents|mesh-ancestor
154235533|NCT03848104|Cefoxitin|cefoxitin|mesh-list
154235534|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154235535|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235536|NCT05670808|Epinephrine|epinephrine|mesh-list
154235537|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154235538|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154235539|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
154235540|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235541|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235542|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235543|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154235544|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154235546|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235547|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154235548|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235549|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
154235550|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
154235551|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154235552|NCT01197664|Fluorouracil|fluorouracil|mesh-list
154235553|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
154235554|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235555|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154235556|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235557|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154235558|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
154235559|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235560|NCT01199458|Alfentanil|alfentanil|mesh-list
154235561|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154235562|NCT01199458|Narcotics|narcotics|mesh-ancestor
154235563|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235564|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235565|NCT01199458|Analgesics|analgesics|mesh-ancestor
154235566|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
154235567|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235568|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154235569|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
154235570|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
154235571|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
154392977|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235572|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235573|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154235574|NCT01588522|Calcitriol|calcitriol|mesh-list
154235575|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154235576|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235577|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154235578|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235579|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235580|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154235581|NCT01588522|Vitamins|vitamins|mesh-ancestor
154235582|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
154235583|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154235584|NCT01296178|Idarubicin|idarubicin|mesh-list
154235585|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154235586|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235587|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154235588|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154235589|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235590|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235591|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154235592|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154235593|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
154235594|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235595|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235596|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154235597|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
154235598|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235599|NCT03730012|Atezolizumab|atezolizumab|mesh-list
154235600|NCT03730012|Gilteritinib|gilteritinib|mesh-list
154235601|NCT03730012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154235602|NCT03730012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235603|NCT03730012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154235604|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235605|NCT03730012|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154235606|NCT03730012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154235607|NCT03730012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235608|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
154235609|NCT03844360|Bortezomib|bortezomib|mesh-list
154235610|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
154235611|NCT03844360|Dasatinib|dasatinib|mesh-list
154235612|NCT03844360|Pegaspargase|pegaspargase|mesh-list
154235613|NCT03844360|Lenograstim|lenograstim|mesh-list
154235614|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235615|NCT03844360|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154235616|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154235617|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109771|NCT00964288|Lidocaine|lidocaine|mesh-list
154235618|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235619|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154235620|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
154235621|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235622|NCT01198054|Lenalidomide|lenalidomide|mesh-list
154235623|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
154235624|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235625|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154235626|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154235627|NCT01198054|Growth Substances|growth substances|mesh-ancestor
154235628|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
154235629|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235630|NCT01202032|Bevacizumab|bevacizumab|mesh-list
154235631|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154235632|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235633|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154235634|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154235635|NCT01202032|Growth Substances|growth substances|mesh-ancestor
154235636|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235637|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
154235639|NCT03844984|Midazolam|midazolam|mesh-list
154235640|NCT03844984|Ketamine|ketamine|mesh-list
154235641|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
154235642|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
154235643|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235644|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235645|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
154235646|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235647|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154235648|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154235649|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154235650|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235651|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235652|NCT03844984|Analgesics|analgesics|mesh-ancestor
154235653|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154235654|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154235655|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
154235656|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154235657|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154235658|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235659|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154235660|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154235661|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154235662|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154235663|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154235664|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
154235665|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
154235666|NCT03842020|Amiodarone|amiodarone|mesh-list
154235667|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154235668|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
154235669|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154235670|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235671|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235672|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154235673|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154235674|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154235675|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235676|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154235677|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154235678|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154235679|NCT01200004|Lenalidomide|lenalidomide|mesh-list
154235680|NCT01200004|Azacitidine|azacitidine|mesh-list
154235681|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
154235682|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235683|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154235684|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154235685|NCT01200004|Growth Substances|growth substances|mesh-ancestor
154235686|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
154235687|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235688|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154235689|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
154235690|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235691|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529811|NCT01487226|Paclitaxel|paclitaxel|mesh-list
154235693|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
154235694|NCT01198210|Ketamine|ketamine|mesh-list
154235695|NCT01198210|BB 1101|bb 1101|mesh-list
154235696|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235697|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
154235698|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
154235699|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235700|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235701|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154235702|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
154235703|NCT01198210|Hormones|hormones|mesh-ancestor
154235704|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235705|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154235706|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235707|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
154235708|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235709|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235710|NCT01198210|Analgesics|analgesics|mesh-ancestor
154235711|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
154235712|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154235713|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154235714|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
154235715|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
154235716|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235717|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154235718|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154235719|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235720|NCT03843736|Drospirenone|drospirenone|mesh-list
154235721|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
154235722|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154235723|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
154235724|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154235725|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154235726|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235727|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154235728|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154235729|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
154235730|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235731|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154235732|NCT03843736|Diuretics|diuretics|mesh-ancestor
154235733|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
154235734|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154235735|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154235736|NCT03843736|Estrogens|estrogens|mesh-ancestor
154235738|NCT01200472|Apremilast|apremilast|mesh-list
154235739|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154235740|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154235741|NCT01200472|Analgesics|analgesics|mesh-ancestor
154235742|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
154235743|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235744|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235745|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235746|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154235747|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154235748|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154235749|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235750|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235751|NCT04638790|Dexamethasone|dexamethasone|mesh-list
154235752|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
154235753|NCT04638790|Dacarbazine|dacarbazine|mesh-list
154235754|NCT04638790|Doxorubicin|doxorubicin|mesh-list
154235755|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154235756|NCT04638790|Etoposide|etoposide|mesh-list
154235757|NCT04638790|Vincristine|vincristine|mesh-list
154235758|NCT04638790|Bleomycin|bleomycin|mesh-list
154235759|NCT04638790|Vinblastine|vinblastine|mesh-list
154235760|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154235761|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
154235762|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235763|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154235764|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154235765|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
154235766|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235767|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235768|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154235769|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235770|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
154235771|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
154235772|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235773|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154235774|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
154235776|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235777|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154235778|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154235779|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154235780|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154235781|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235782|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154235783|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
154235784|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
154235785|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
154235786|NCT01200706|Amoxicillin|amoxicillin|mesh-list
154235787|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154235788|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235789|NCT01200784|Niacinamide|niacinamide|mesh-list
154235790|NCT01200784|Niacin|niacin|mesh-list
154235791|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
154235792|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
154235793|NCT01200784|Vitamins|vitamins|mesh-ancestor
154235794|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
154235795|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235796|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154235797|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
154235798|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235799|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154235800|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
154235801|NCT03841474|Sertraline|sertraline|mesh-list
154235802|NCT03841474|Escitalopram|escitalopram|mesh-list
154235803|NCT03841474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154235804|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154235805|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235806|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235807|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235808|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
154235809|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235810|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
154235811|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154235812|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154235813|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154235814|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235815|NCT05670184|Ethanol|ethanol|mesh-list
154235816|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154235817|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154235818|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235819|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235820|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235821|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
154235822|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154235823|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154235824|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
154235825|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235826|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235827|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154235828|NCT03842800|Ketamine|ketamine|mesh-list
154235829|NCT03842800|Analgesics|analgesics|mesh-ancestor
154235830|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
154235831|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235832|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235833|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154235834|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154235835|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
154235836|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
154235837|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235838|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154235839|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154235840|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235841|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235842|NCT01202422|Pregabalin|pregabalin|mesh-list
154235843|NCT01202422|Analgesics|analgesics|mesh-ancestor
154235844|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
154235845|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235846|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235847|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
154235848|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154235849|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235850|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235851|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154235852|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154235853|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154235854|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154235855|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154235856|NCT03892018|Paclitaxel|paclitaxel|mesh-list
154235857|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154235858|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235859|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154235860|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
154235861|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154235862|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235863|NCT01198912|Doxycycline|doxycycline|mesh-list
154235864|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154235865|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235866|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
154235867|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154235868|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154235869|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
154235870|NCT03842488|Darunavir|darunavir|mesh-list
154235871|NCT03842488|Cobicistat|cobicistat|mesh-list
154235872|NCT03842488|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154235873|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154235874|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154235875|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
154235876|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235877|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154235878|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154235879|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235880|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235881|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154235882|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154235883|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
154235884|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154235885|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154235886|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
154235887|NCT03842254|Hematinics|hematinics|mesh-ancestor
154235888|NCT01201642|Prednisolone|prednisolone|mesh-list
154235889|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235890|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
154235891|NCT01201642|Hormones|hormones|mesh-ancestor
154235892|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154235893|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235894|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154235895|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235896|NCT05004064|Rituximab|rituximab|mesh-list
154235897|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
154235898|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154235899|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235900|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
154235901|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235902|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154235903|NCT05004064|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154235904|NCT05004064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154235905|NCT05004064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235906|NCT05004064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235907|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154235908|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154235909|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
154235910|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235911|NCT01202734|Methylphenidate|methylphenidate|mesh-list
153982823|NCT03662074|Gemcitabine|gemcitabine|mesh-list
154235912|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154235913|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235914|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154235915|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154235916|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154235917|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235918|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
154235919|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154235920|NCT02966314|Omalizumab|omalizumab|mesh-list
154235921|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154235922|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154235923|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
154235924|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154235925|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154235926|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154235927|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
154235928|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235929|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154235930|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154235931|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235932|NCT01202890|Bevacizumab|bevacizumab|mesh-list
154235933|NCT01202890|Lenalidomide|lenalidomide|mesh-list
154235934|NCT01202890|Doxorubicin|doxorubicin|mesh-list
154235935|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154235936|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154235937|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235938|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154235939|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154235940|NCT01202890|Growth Substances|growth substances|mesh-ancestor
154235941|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235942|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392978|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
154235943|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154235944|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154235945|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154235946|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235947|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235948|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
154235949|NCT01199224|Veliparib|veliparib|mesh-list
154235950|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154235951|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235952|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235953|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235954|NCT01204138|Apremilast|apremilast|mesh-list
154235955|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154235956|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154235957|NCT01204138|Analgesics|analgesics|mesh-ancestor
154235958|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
154235959|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154235960|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235961|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154235962|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154235963|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154235964|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154235965|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235966|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235967|NCT01206088|Nilotinib|nilotinib|mesh-list
154235968|NCT01206088|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154235969|NCT01206088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154235970|NCT01206088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235971|NCT01206088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235972|NCT01204372|Gemcitabine|gemcitabine|mesh-list
154235973|NCT01204372|Trastuzumab|trastuzumab|mesh-list
154235974|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154235975|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154235976|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
154235977|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235978|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235979|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154235980|NCT01204372|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154235981|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154235982|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235983|NCT01204450|Sirolimus|sirolimus|mesh-list
154235984|NCT01204450|Temsirolimus|temsirolimus|mesh-list
154235985|NCT01204450|MTOR Inhibitors|mtor inhibitors|mesh-list
154235986|NCT01204450|Valproic Acid|valproic acid|mesh-list
153982901|NCT02914405|Nivolumab|nivolumab|mesh-list
154235987|NCT01204450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154235988|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154235989|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154235990|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154235991|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
154235992|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154235993|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154235994|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154235995|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154235996|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154235997|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
154235998|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
154235999|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
154236000|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236001|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
154236002|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154236003|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236004|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236005|NCT03834454|Bupivacaine|bupivacaine|mesh-list
154236006|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
154236007|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
154236008|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236009|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236010|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
154236011|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236013|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236014|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236015|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392979|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
154392980|NCT03707509|Gemcitabine|gemcitabine|mesh-list
154236016|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236018|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236019|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154236020|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236021|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236022|NCT01203202|Clomipramine|clomipramine|mesh-list
154236023|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154236024|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
154236025|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236026|NCT01203202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154236027|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154236028|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154236029|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236030|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236031|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
154236032|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236033|NCT01298284|Propranolol|propranolol|mesh-list
154236034|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154236035|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154236036|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
154236037|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110191|NCT04907214|Empagliflozin|empagliflozin|mesh-list
154236038|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236039|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236040|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154236041|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154236042|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
154236043|NCT01204840|Hormones|hormones|mesh-list
154236044|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236045|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236046|NCT01203358|Beractant|beractant|mesh-list
154236047|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154236048|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
154236049|NCT03832426|Ritonavir|ritonavir|mesh-list
154236050|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154236051|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154236052|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
154236053|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236054|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236055|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154236056|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154236057|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
154236058|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236059|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154236060|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154236061|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
154236062|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154236063|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
154236064|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236065|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
154236066|NCT03840070|Protective Agents|protective agents|mesh-ancestor
154236068|NCT01203514|Hematinics|hematinics|mesh-ancestor
154236069|NCT01204996|Paclitaxel|paclitaxel|mesh-list
154236070|NCT01204996|Docetaxel|docetaxel|mesh-list
154236071|NCT01204996|Carboplatin|carboplatin|mesh-list
154236072|NCT01204996|Gemcitabine|gemcitabine|mesh-list
154236073|NCT01204996|Doxorubicin|doxorubicin|mesh-list
154236074|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154236075|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154236076|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236077|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
154236078|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
154236079|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
154236080|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236081|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154236082|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
154236083|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154236084|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154236085|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154236086|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236087|NCT01297192|Mirabegron|mirabegron|mesh-list
154236088|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
154236089|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154236090|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154236091|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154236092|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
154236093|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236094|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236095|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236096|NCT01297192|Urological Agents|urological agents|mesh-ancestor
154236097|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154236098|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154236099|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
154236100|NCT01205074|Ethanol|ethanol|mesh-list
154236101|NCT01205074|Propranolol|propranolol|mesh-list
154236102|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154236103|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154236104|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
154236105|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236106|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236107|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236108|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154236109|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154236110|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
154236111|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154236112|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236113|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236114|NCT03722524|Amlodipine|amlodipine|mesh-list
154236115|NCT03722524|Perindopril|perindopril|mesh-list
154236116|NCT03722524|Indapamide|indapamide|mesh-list
154236117|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
154236118|NCT03722524|Diuretics|diuretics|mesh-list
154236119|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154236120|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154236121|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154236122|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154236123|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236124|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154236125|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236126|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
154236127|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
154236128|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
154236129|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236130|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154236131|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154236132|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154236133|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236135|NCT05667220|Hormones|hormones|mesh-ancestor
154236136|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236137|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154236138|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
154236139|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236140|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236141|NCT01203592|Albuterol|albuterol|mesh-list
154236142|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154236143|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
154236144|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236145|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236146|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154236147|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
154236148|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
154236149|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154236150|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154236151|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154236152|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154236153|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
154236154|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236155|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236156|NCT03829150|Amoxicillin|amoxicillin|mesh-list
154236157|NCT03829150|Metronidazole|metronidazole|mesh-list
154236158|NCT03829150|Clarithromycin|clarithromycin|mesh-list
154236159|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
154236160|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154236161|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236162|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154236163|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154236164|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154236165|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236166|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236167|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154236168|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154236169|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154236170|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236171|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154236172|NCT01205464|Doxycycline|doxycycline|mesh-list
154236173|NCT01205464|Tetracycline|tetracycline|mesh-list
154236174|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154236175|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236176|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
154236177|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154236178|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154236179|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154236180|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236181|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236182|NCT03819010|Letrozole|letrozole|mesh-list
154236183|NCT03819010|Palbociclib|palbociclib|mesh-list
154236184|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236185|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154236186|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154236187|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236188|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236189|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154236190|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
154236191|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236192|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236193|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236194|NCT03818932|Acetaminophen|acetaminophen|mesh-list
154236195|NCT03818932|Celecoxib|celecoxib|mesh-list
154236196|NCT03818932|Ketorolac|ketorolac|mesh-list
154236197|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154236198|NCT03818932|Diazepam|diazepam|mesh-list
154236199|NCT03818932|Gabapentin|gabapentin|mesh-list
154236200|NCT03818932|Hydrocodone|hydrocodone|mesh-list
154236201|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154236202|NCT03818932|Analgesics|analgesics|mesh-ancestor
154236203|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
154236204|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236205|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236206|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
154236207|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154236208|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154236209|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236210|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154236211|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154236212|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236213|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236214|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
154236215|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154236216|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154236217|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236218|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236219|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154236220|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154236221|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236222|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
154236223|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154236224|NCT03818932|Narcotics|narcotics|mesh-ancestor
154236225|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
154236226|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
154236227|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154236228|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
154236229|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
154236230|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236231|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154236232|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154236233|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154236234|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154236235|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
154236236|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
154236237|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
154236238|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
154236239|NCT01205932|Enoxaparin|enoxaparin|mesh-list
154236240|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
154236241|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154236242|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
154236243|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154236244|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
154236245|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236246|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236247|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
154236248|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154236249|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154236250|NCT01300780|Etoricoxib|etoricoxib|mesh-list
154236251|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154236252|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154236253|NCT01300780|Analgesics|analgesics|mesh-ancestor
154236254|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
154236255|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236256|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236257|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154236258|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236259|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154236260|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154236261|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236262|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236263|NCT01297816|Minocycline|minocycline|mesh-list
154236264|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154236265|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236266|NCT01297894|Colistin|colistin|mesh-list
154236267|NCT01297894|Fosfomycin|fosfomycin|mesh-list
154236268|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154236269|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236270|NCT01206010|Varenicline|varenicline|mesh-list
154236271|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154236272|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154236273|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
154236274|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236275|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236276|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236277|NCT05665114|Cytarabine|cytarabine|mesh-list
154236278|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
154236279|NCT05665114|Fludarabine|fludarabine|mesh-list
154236280|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236281|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
154236282|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236283|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236284|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154236285|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
154236286|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236287|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236288|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154236289|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154236291|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
154236292|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236293|NCT00146172|Neratinib|neratinib|mesh-list
154236294|NCT00146172|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154236295|NCT00146172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236296|NCT00146172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236297|NCT00146172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236298|NCT03814642|Esomeprazole|esomeprazole|mesh-list
154236299|NCT03814642|Clopidogrel|clopidogrel|mesh-list
154236300|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154236301|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154236302|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154236303|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154236304|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
154236305|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236306|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236307|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236308|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154236309|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236310|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154236311|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236312|NCT01299220|Acitretin|acitretin|mesh-list
154236313|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
154236314|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
154236315|NCT03813784|Capecitabine|capecitabine|mesh-list
154236316|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
154236317|NCT03813784|Apatinib|apatinib|mesh-list
154236318|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154236319|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
154236320|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236321|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236322|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236323|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236324|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
154236325|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154236326|NCT03818308|Velpatasvir|velpatasvir|mesh-list
154236327|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
154236328|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236329|NCT03827044|Avelumab|avelumab|mesh-list
154236330|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154236331|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236332|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
154236333|NCT00145626|Melphalan|melphalan|mesh-list
154236334|NCT00145626|Thiotepa|thiotepa|mesh-list
154236335|NCT00145626|Fludarabine|fludarabine|mesh-list
154236336|NCT00145626|Antibodies|antibodies|mesh-list
154236337|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236338|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
154236339|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236340|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236341|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154236342|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
154236343|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236344|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236345|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154236346|NCT01206946|Betamethasone|betamethasone|mesh-list
154236347|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154236348|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
154236349|NCT01206946|Hormones|hormones|mesh-ancestor
154236350|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236351|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236352|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154236353|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
154236354|NCT03813940|Vaccines|vaccines|mesh-list
154236355|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
154236356|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236357|NCT03967938|Olaparib|olaparib|mesh-list
154236358|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154236359|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236360|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236361|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236362|NCT01299298|Mipomersen|mipomersen|mesh-list
154236363|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154236364|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154236365|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
154236366|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236367|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154236368|NCT00153062|Telmisartan|telmisartan|mesh-list
154236369|NCT00153062|Clopidogrel|clopidogrel|mesh-list
154236370|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
154236371|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154236372|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154236373|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154236374|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154236375|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
154236376|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236377|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236378|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236379|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154236380|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154236381|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154236382|NCT00145470|Asenapine|asenapine|mesh-list
154236383|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154236384|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154236385|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236386|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236387|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236388|NCT03813394|Bevacizumab|bevacizumab|mesh-list
154236389|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
154236390|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154236391|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236392|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154236393|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154236394|NCT03813394|Growth Substances|growth substances|mesh-ancestor
154236395|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236396|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
154236397|NCT03813394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154236398|NCT03813394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236399|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154236400|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
154236401|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154236402|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154236403|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154236404|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236405|NCT03813316|Incretins|incretins|mesh-ancestor
154236406|NCT03813316|Hormones|hormones|mesh-ancestor
154236407|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236408|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
154236409|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236410|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236411|NCT01301248|Cisplatin|cisplatin|mesh-list
154236412|NCT01301248|Cetuximab|cetuximab|mesh-list
154236413|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236414|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154236415|NCT03817684|BPN14770|bpn14770|mesh-list
154236416|NCT03817684|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154236417|NCT03817684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154236418|NCT03817684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236419|NCT03817684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236420|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
154236421|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154236422|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236423|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154110581|NCT03006848|Avelumab|avelumab|mesh-list
154236424|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236425|NCT01302106|Clofarabine|clofarabine|mesh-list
154236426|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154236427|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
154236428|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236429|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236430|NCT00152516|Levetiracetam|levetiracetam|mesh-list
154236431|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
154236432|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
154236433|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154236434|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153983343|NCT02599090|Temozolomide|temozolomide|mesh-list
154236435|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
154236436|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236437|NCT05624008|Methamphetamine|methamphetamine|mesh-list
154236438|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154236439|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236440|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
154236441|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
154236442|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236443|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
154236444|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236445|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236446|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
154236447|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154236448|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154236449|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154236450|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154236451|NCT05623852|Fucoidan|fucoidan|mesh-list
154236452|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154236453|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236454|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
154236455|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236456|NCT01302340|Dronabinol|dronabinol|mesh-list
154236457|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
154236458|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236459|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236460|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154236461|NCT01302340|Analgesics|analgesics|mesh-ancestor
154236462|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
154236463|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236464|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154236465|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154236466|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236467|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236468|NCT01302340|Hormones|hormones|mesh-ancestor
154236469|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236470|NCT00150800|Brivaracetam|brivaracetam|mesh-list
154236471|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
154236472|NCT03812770|Leucovorin|leucovorin|mesh-list
154236473|NCT03812770|Fluorouracil|fluorouracil|mesh-list
154236474|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
154236475|NCT03812770|Sorafenib|sorafenib|mesh-list
154236476|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
154236477|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236478|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154236479|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236480|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236481|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
154236482|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236483|NCT03812770|Antidotes|antidotes|mesh-ancestor
154236484|NCT03812770|Protective Agents|protective agents|mesh-ancestor
154236485|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
154236486|NCT03812770|Vitamins|vitamins|mesh-ancestor
154236487|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
154236488|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236489|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236490|NCT00144300|Pramipexole|pramipexole|mesh-list
154236491|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
154236492|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236493|NCT00144300|Protective Agents|protective agents|mesh-ancestor
154236494|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236495|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154236496|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154236497|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
154236498|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
154236499|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236500|NCT00149630|Disulfiram|disulfiram|mesh-list
154236501|NCT00149630|Methadone|methadone|mesh-list
154236502|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154236503|NCT00149630|Narcotics|narcotics|mesh-ancestor
154236504|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236505|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236506|NCT00149630|Analgesics|analgesics|mesh-ancestor
154236507|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
154236508|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236509|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
154236510|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
154236511|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154236512|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154236513|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236514|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236515|NCT01302496|Ipilimumab|ipilimumab|mesh-list
154236516|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154236517|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236518|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154236519|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236520|NCT00127842|Etanercept|etanercept|mesh-list
154236521|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154236522|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154236523|NCT00127842|Analgesics|analgesics|mesh-ancestor
154236524|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
154236525|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236526|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236527|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154236528|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236529|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236530|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236531|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
154236532|NCT01075802|Tamoxifen|tamoxifen|mesh-list
154236533|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154236534|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
154236535|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236536|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236537|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154236538|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236539|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154236540|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154236541|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154236542|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
154236543|NCT03816592|Anesthetics|anesthetics|mesh-list
154236544|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236545|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236546|NCT03816592|Narcotics|narcotics|mesh-ancestor
154236547|NCT03816592|Analgesics|analgesics|mesh-ancestor
154236548|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
154236549|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236550|NCT01078038|Sirolimus|sirolimus|mesh-list
154236551|NCT01078038|Everolimus|everolimus|mesh-list
154236552|NCT01078038|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154236553|NCT01078038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236554|NCT01078038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236555|NCT01078038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236556|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236557|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
154236558|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236559|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236560|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154236561|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236562|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154236563|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
154236564|NCT00223496|Aripiprazole|aripiprazole|mesh-list
154236565|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
154236566|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236567|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154236568|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154236569|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236570|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236571|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
154236572|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
154236573|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236574|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236575|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154236576|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154236577|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
154236578|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154236579|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154236580|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154236581|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154236582|NCT02531412|Spironolactone|spironolactone|mesh-list
154236583|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154236584|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
154236585|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236586|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236587|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154236588|NCT02531412|Diuretics|diuretics|mesh-ancestor
154236589|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
154236590|NCT00126672|Sirolimus|sirolimus|mesh-list
154236591|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154236592|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236593|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154236594|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236595|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
154236596|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236597|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
154236598|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236599|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154236600|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154236601|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154236602|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
154236603|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236604|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154236605|NCT00145496|Olanzapine|olanzapine|mesh-list
154236606|NCT00145496|Asenapine|asenapine|mesh-list
154236607|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
154236608|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
154236609|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236610|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236611|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236612|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154236613|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154236614|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236615|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236616|NCT00145496|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154236617|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154236618|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154236619|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236620|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236621|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
154236622|NCT01299922|Cyclosporine|cyclosporine|mesh-list
154236623|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
154236624|NCT01299922|Cyclosporins|cyclosporins|mesh-list
154236625|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236626|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236627|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236628|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
154236629|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236630|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
154236631|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236632|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
154236633|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236634|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154236635|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154236636|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236637|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154236638|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
154236639|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154236640|NCT05030818|Aspirin|aspirin|mesh-list
154236641|NCT05030818|Ramipril|ramipril|mesh-list
154236642|NCT05030818|Atorvastatin|atorvastatin|mesh-list
153491234|NCT04522206|Oxycodone|oxycodone|mesh-list
154236643|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154236644|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154236645|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
154236646|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236647|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154236648|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154236649|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236650|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154236651|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154236652|NCT05030818|Analgesics|analgesics|mesh-ancestor
154236653|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
154236654|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236655|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236656|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154236657|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236658|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154236659|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154236660|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154236661|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154236663|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154236664|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
154236665|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154236666|NCT01582022|Bupivacaine|bupivacaine|mesh-list
154236667|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
154236668|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
154236669|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236670|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236671|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
154236672|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236673|NCT01582412|Isavuconazole|isavuconazole|mesh-list
154236674|NCT01582412|Digoxin|digoxin|mesh-list
154236675|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154236676|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154236677|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236678|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236679|NCT01582412|Protective Agents|protective agents|mesh-ancestor
154236680|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236681|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
154236682|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236683|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
154236684|NCT00255164|Lansoprazole|lansoprazole|mesh-list
154236685|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154236686|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236687|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154236688|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236689|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236690|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
154236691|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236692|NCT00126594|Interferons|interferons|mesh-list
154236693|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
154236694|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
154236695|NCT00126594|Sorafenib|sorafenib|mesh-list
154236696|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236697|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
154236698|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236699|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236700|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236701|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236702|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
154236703|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236704|NCT01080456|Tacrolimus|tacrolimus|mesh-list
154236705|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236706|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
154236707|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236708|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154236709|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236710|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236711|NCT03811054|Apatinib|apatinib|mesh-list
154236712|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236713|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236714|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236715|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236716|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154236717|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236718|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236719|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236720|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154236721|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154236722|NCT01075854|Hormones|hormones|mesh-ancestor
154236723|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236724|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236725|NCT03967392|Lidocaine|lidocaine|mesh-list
154236726|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
154236727|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
154236728|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236729|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236730|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
154236731|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236732|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154236733|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154236734|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154236735|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154236736|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236739|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154236740|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154236741|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
154236742|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
154236743|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236744|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236745|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154236746|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154236747|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154236748|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
154236749|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236750|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236751|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
154236752|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154236753|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154236754|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154236755|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
154236756|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154236757|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154236758|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154236759|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154236760|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236761|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
154236762|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236763|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236764|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154236765|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236766|NCT01080534|Tacrolimus|tacrolimus|mesh-list
154236767|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236768|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
154236769|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236770|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154236771|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236772|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236773|NCT00125190|Mecasermin|mecasermin|mesh-list
154236774|NCT00125190|Growth Substances|growth substances|mesh-ancestor
154236775|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236776|NCT00141726|Etanercept|etanercept|mesh-list
154236777|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154236778|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154236779|NCT00141726|Analgesics|analgesics|mesh-ancestor
154236780|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
154236781|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236782|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236783|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154236784|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236785|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236786|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154236787|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
154236788|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154236789|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154236790|NCT01301716|Paclitaxel|paclitaxel|mesh-list
154236791|NCT01301716|Bevacizumab|bevacizumab|mesh-list
154236792|NCT01301716|Carboplatin|carboplatin|mesh-list
154236793|NCT01301716|Pemetrexed|pemetrexed|mesh-list
154236794|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154236795|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236796|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
154236797|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
154236798|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
154236799|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236800|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154236801|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154236802|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154236803|NCT01301716|Growth Substances|growth substances|mesh-ancestor
154236804|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236805|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
154236806|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236807|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153983720|NCT00630110|Docetaxel|docetaxel|mesh-list
154236808|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154236810|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
154236811|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154236812|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236813|NCT01300312|Diclofenac|diclofenac|mesh-list
154236814|NCT01300312|Eperisone|eperisone|mesh-list
154110974|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
154236815|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154236816|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154236817|NCT01300312|Analgesics|analgesics|mesh-ancestor
154236818|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
154236819|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236820|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236821|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154236822|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154236823|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154236824|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236825|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236826|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
154236827|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154236828|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154236829|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154236830|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154236831|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154236832|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
154236833|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
154236834|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
154236835|NCT01567384|Pemetrexed|pemetrexed|mesh-list
154236836|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236837|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236838|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236840|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154236841|NCT01080612|Pregabalin|pregabalin|mesh-list
154236842|NCT01080612|Analgesics|analgesics|mesh-ancestor
154236843|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
154236844|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236845|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236846|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
154236847|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154236848|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154236849|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236850|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154236851|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154236852|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154236853|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236854|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236855|NCT03819790|Insulin|insulin|mesh-list
154236856|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154236857|NCT03819790|Metformin|metformin|mesh-list
154236858|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
154236859|NCT03819790|Gliclazide|gliclazide|mesh-list
154236860|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154236861|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236862|NCT01560442|Buprenorphine|buprenorphine|mesh-list
154236863|NCT01560442|Methadone|methadone|mesh-list
154236864|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154236865|NCT01560442|Narcotics|narcotics|mesh-ancestor
154236866|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236867|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236868|NCT01560442|Analgesics|analgesics|mesh-ancestor
154236869|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
154236870|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236871|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154236872|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
154236873|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
154236874|NCT00110994|Sorafenib|sorafenib|mesh-list
154236875|NCT00110994|Dacarbazine|dacarbazine|mesh-list
154236876|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236877|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154236878|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236879|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236880|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154236881|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
153983790|NCT02595190|Gabapentin|gabapentin|mesh-list
154236882|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
154236883|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154236884|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154236885|NCT01560052|Prednisolone|prednisolone|mesh-list
154236886|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
154236887|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154236888|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
154236889|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154236890|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
154236891|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
154236892|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154236893|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236894|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154236895|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
154236897|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236898|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154236899|NCT01560052|Protective Agents|protective agents|mesh-ancestor
154236900|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154236901|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236902|NCT05622994|Rimonabant|rimonabant|mesh-list
154236903|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154236904|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154236905|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154236906|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236907|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236908|NCT05622994|Hormones|hormones|mesh-ancestor
154236909|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154236910|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236911|NCT05622916|Ethanol|ethanol|mesh-list
154236912|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154236913|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236914|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236915|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236917|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
154236918|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
154236919|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236920|NCT03804034|Molybdenum|molybdenum|mesh-list
154236921|NCT03804034|Trace Elements|trace elements|mesh-ancestor
154236922|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
154236923|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236924|NCT04246762|Vitamin K|vitamin k|mesh-list
154236925|NCT04246762|Midazolam|midazolam|mesh-list
154236926|NCT04246762|Caffeine|caffeine|mesh-list
154236927|NCT04246762|Omeprazole|omeprazole|mesh-list
154236928|NCT04246762|Warfarin|warfarin|mesh-list
154236929|NCT04246762|Vitamins|vitamins|mesh-ancestor
154236930|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
154236931|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236932|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154236933|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154236934|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154236935|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154236936|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154236937|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154236938|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154236939|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
154236940|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
154236941|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
154236942|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
154236943|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236944|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236945|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
154236946|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154236947|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154236948|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236949|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154236950|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154236951|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
154236952|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154236953|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153983873|NCT00960986|Analgesics|analgesics|mesh-ancestor
154236954|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154236955|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154236956|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154236957|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
154236958|NCT04246762|Coagulants|coagulants|mesh-ancestor
154236959|NCT03799120|Tamsulosin|tamsulosin|mesh-list
154236960|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154236961|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154236962|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154236963|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
154236964|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236965|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236966|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236967|NCT03799120|Urological Agents|urological agents|mesh-ancestor
154236968|NCT03792724|Nivolumab|nivolumab|mesh-list
154236969|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154236970|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154236971|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154236972|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236973|NCT00144170|Ritonavir|ritonavir|mesh-list
154236974|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154236975|NCT00144170|Tipranavir|tipranavir|mesh-list
154236976|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
154236977|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154236978|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111140|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154236979|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236980|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154236981|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154236982|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
154236983|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154236984|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154236985|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154236986|NCT00255086|Memantine|memantine|mesh-list
154236987|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154236988|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154236989|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
154236990|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154236991|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154236992|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154236993|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154236994|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154236995|NCT00110214|Prednisone|prednisone|mesh-list
154236996|NCT00110214|Bevacizumab|bevacizumab|mesh-list
154236997|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154236998|NCT00110214|Docetaxel|docetaxel|mesh-list
154236999|NCT00110214|Antibodies|antibodies|mesh-list
154237000|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
154237001|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154237002|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237003|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154237004|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154237005|NCT00110214|Growth Substances|growth substances|mesh-ancestor
154237006|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237007|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
154237008|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
154237009|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
154237010|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
154237011|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
154237012|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237013|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237014|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
154237015|NCT00110214|Hormones|hormones|mesh-ancestor
154237016|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154237017|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154237018|NCT04176172|Nicotine|nicotine|mesh-list
154237019|NCT04176172|Varenicline|varenicline|mesh-list
154237020|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154237021|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
154111179|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154237022|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237023|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237024|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154237025|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154237026|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
154237027|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237028|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237029|NCT03795844|Liver Extracts|liver extracts|mesh-list
154237030|NCT03795844|Hematinics|hematinics|mesh-ancestor
154237031|NCT05669170|Methylphenidate|methylphenidate|mesh-list
154237032|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154237033|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237034|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154237035|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154237036|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154237037|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237039|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237041|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
154237042|NCT03799822|Vitamins|vitamins|mesh-ancestor
154237043|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
154237044|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237045|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154237046|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
154237047|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154237048|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
154237049|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237050|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237051|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
154237052|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154237053|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154237054|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
154237055|NCT03799822|Coagulants|coagulants|mesh-ancestor
154237056|NCT03799900|Ketamine|ketamine|mesh-list
154237057|NCT03799900|Analgesics|analgesics|mesh-ancestor
154237058|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
154237059|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237060|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237061|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154237062|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154237063|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
154237064|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
154237065|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237066|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154237067|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154237068|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111245|NCT00966316|Aspirin|aspirin|mesh-list
154237069|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237070|NCT01304602|Irinotecan|irinotecan|mesh-list
154237071|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154237072|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154237073|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237074|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237075|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237076|NCT01304134|Morphine|morphine|mesh-list
154237077|NCT01304134|Oxycodone|oxycodone|mesh-list
154237078|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154237079|NCT01304134|Narcotics|narcotics|mesh-ancestor
154237080|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237081|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237082|NCT01304134|Analgesics|analgesics|mesh-ancestor
154237083|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
154237084|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237085|NCT00124020|Vancomycin|vancomycin|mesh-list
154237086|NCT00124020|Telavancin|telavancin|mesh-list
154237087|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154237088|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237089|NCT01080846|Misoprostol|misoprostol|mesh-list
154237090|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154237091|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
154237092|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154237093|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237094|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154237095|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237096|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
154237097|NCT01076322|Albuterol|albuterol|mesh-list
154237098|NCT01076322|Procaterol|procaterol|mesh-list
154237099|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154237100|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
154237101|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237102|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237103|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154237104|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
154237105|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
154237106|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154237107|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154237108|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154237109|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154237110|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
154237111|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237112|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237113|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
154237114|NCT03966066|Erythromycin|erythromycin|mesh-list
154237115|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
154237116|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154237117|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
154237118|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154237119|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237120|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237121|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154237122|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237123|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237124|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154237125|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
154237126|NCT01304212|Ketorolac|ketorolac|mesh-list
154237127|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154237128|NCT01304212|Epinephrine|epinephrine|mesh-list
154237129|NCT01304212|Racepinephrine|racepinephrine|mesh-list
154237130|NCT01304212|Morphine|morphine|mesh-list
154237131|NCT01304212|Ropivacaine|ropivacaine|mesh-list
154237132|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
154237133|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154237134|NCT01304212|Narcotics|narcotics|mesh-ancestor
154237135|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237136|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237137|NCT01304212|Analgesics|analgesics|mesh-ancestor
154237138|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
154237139|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237140|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
154237141|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
154237142|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154237143|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154237144|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
154237145|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237146|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237147|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154237148|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154237149|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
154237150|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154237151|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
154237152|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
154237153|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
154237154|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154237155|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237156|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237157|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237158|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237159|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154237160|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237161|NCT00143390|Anastrozole|anastrozole|mesh-list
154237163|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154237164|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237165|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154237166|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154237167|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237168|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237169|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154237170|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
154237171|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154237172|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237173|NCT03238534|Omeprazole|omeprazole|mesh-list
154237174|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154237175|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237176|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154237177|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237178|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237179|NCT00141102|Celecoxib|celecoxib|mesh-list
154237180|NCT00141102|Diclofenac|diclofenac|mesh-list
154237181|NCT00141102|Omeprazole|omeprazole|mesh-list
154237182|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237183|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237185|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
154237186|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237187|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237188|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237189|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237190|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154237191|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154237192|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237193|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237194|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154237195|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237196|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154237197|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154237198|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154237199|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237200|NCT01078428|Petrolatum|petrolatum|mesh-list
154237201|NCT01078428|Emollients|emollients|mesh-ancestor
154237202|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
154237203|NCT01081002|Lidocaine|lidocaine|mesh-list
154237204|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
154237205|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
154237206|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237207|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237208|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
154237209|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237210|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154237211|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154237212|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154237213|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154237214|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237215|NCT03789058|Ibuprofen|ibuprofen|mesh-list
154237216|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237217|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237218|NCT03789058|Analgesics|analgesics|mesh-ancestor
154237219|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
154237220|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237221|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237222|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237223|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237224|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154237225|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237226|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237227|NCT03788902|Methylphenidate|methylphenidate|mesh-list
154237228|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154237229|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237230|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154237231|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154237232|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154237233|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237234|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
154237235|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237236|NCT05669092|Capecitabine|capecitabine|mesh-list
154237237|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
154237238|NCT05669092|Irinotecan|irinotecan|mesh-list
154237239|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154237240|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154237241|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
154237242|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237243|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237244|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154237245|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154237246|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237247|NCT05669092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154237248|NCT00255008|Ribavirin|ribavirin|mesh-list
154237249|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154237250|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
154237251|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
154237252|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111398|NCT00674154|Vitamin D|vitamin d|mesh-list
154237253|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
154237254|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237255|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
154237256|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237257|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154237258|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
154237260|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154237261|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237262|NCT03714022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154237263|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237264|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237265|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
154237266|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237267|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237268|NCT00143312|Voriconazole|voriconazole|mesh-list
154237269|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
154237270|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237271|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154237272|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154237273|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237274|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237275|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154237276|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
154237277|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154237278|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237279|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154237280|NCT04833946|Andrographolide|andrographolide|mesh-list
154237281|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237282|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237283|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237284|NCT04833946|Analgesics|analgesics|mesh-ancestor
154237285|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
154237286|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237287|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237288|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237289|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154237290|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154237291|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237292|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
154237293|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154237294|NCT01077206|Simvastatin|simvastatin|mesh-list
154237295|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154237296|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154237297|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
154111449|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154237298|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237299|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154237300|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154237301|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237302|NCT05623540|Diphosphonates|diphosphonates|mesh-list
154237303|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154237304|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237305|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154237306|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
154237307|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154237308|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154237309|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
154237310|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237311|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237313|NCT01306318|Eperisone|eperisone|mesh-list
154237314|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237315|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237316|NCT01306318|Analgesics|analgesics|mesh-ancestor
154237317|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
154237318|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237319|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237320|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237321|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237322|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154237323|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237324|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237325|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
154237326|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154237327|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531990|NCT01500070|Everolimus|everolimus|mesh-list
154237328|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154237329|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154237330|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154237331|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
154237332|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
154237333|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
154237334|NCT00254540|Sunitinib|sunitinib|mesh-list
154237335|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237336|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154237337|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154237338|NCT00254540|Growth Substances|growth substances|mesh-ancestor
154237339|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237340|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
154237341|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237342|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237343|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237344|NCT01326494|Prednisone|prednisone|mesh-list
154237345|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237346|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
154237347|NCT01326494|Hormones|hormones|mesh-ancestor
154111493|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
154237348|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154237349|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237350|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154237351|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237352|NCT01305850|Losartan|losartan|mesh-list
154237353|NCT01305850|Enalapril|enalapril|mesh-list
154237354|NCT01305850|Enalaprilat|enalaprilat|mesh-list
154237355|NCT01305850|Aliskiren|aliskiren|mesh-list
154237356|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154237357|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154237358|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154237359|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154237360|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237361|NCT01305850|Renin Inhibitors|renin inhibitors|mesh-ancestor
154237362|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
154237363|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237364|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154237365|NCT01306630|Capecitabine|capecitabine|mesh-list
154237366|NCT01306630|Tivozanib|tivozanib|mesh-list
154237367|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154237368|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
154237369|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237370|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237371|NCT01306630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237372|NCT01306630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237373|NCT01306708|Amitriptyline|amitriptyline|mesh-list
154237374|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154237375|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
154237376|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154237377|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237378|NCT01306708|Analgesics|analgesics|mesh-ancestor
154237379|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
154237380|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237381|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237382|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154237383|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154237384|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154237385|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237386|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
154237387|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237388|NCT03794518|Pioglitazone|pioglitazone|mesh-list
154237389|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154237390|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237391|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
154237392|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154237393|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237394|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154237395|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154237396|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237397|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237398|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237399|NCT03790540|Benzocaine|benzocaine|mesh-list
154237400|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
154237401|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
154237402|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237403|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237404|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
154237405|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237407|NCT03794596|Avelumab|avelumab|mesh-list
154237408|NCT03794596|Lansoprazole|lansoprazole|mesh-list
154237409|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
154237410|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154237411|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237412|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237413|NCT03794596|Analgesics|analgesics|mesh-ancestor
154237414|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
154237415|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237416|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237417|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237418|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237419|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154237420|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154237421|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237422|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154237423|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154237424|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237425|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
154237426|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154237427|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237428|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154237429|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237430|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
154237431|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
154237432|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237433|NCT05571748|Protective Agents|protective agents|mesh-ancestor
154237434|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237435|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
154237436|NCT05571748|Vitamins|vitamins|mesh-ancestor
154237437|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
154237438|NCT03790618|Methamphetamine|methamphetamine|mesh-list
154237439|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154237440|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
154237441|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237442|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154237443|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
154237444|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237445|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237446|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154237447|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154237448|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154237449|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
154237450|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154237451|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
154237452|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
154237453|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237454|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
154237455|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154237456|NCT03790228|Carboplatin|carboplatin|mesh-list
154237457|NCT03790228|Pemetrexed|pemetrexed|mesh-list
154237458|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237459|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237460|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237461|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154237462|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154237463|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
154237464|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
154237465|NCT01304836|Prednisolone|prednisolone|mesh-list
154237466|NCT01304836|Tacrolimus|tacrolimus|mesh-list
154237467|NCT01304836|Basiliximab|basiliximab|mesh-list
154237468|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237469|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
154237470|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237471|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154237472|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111628|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
154237473|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237474|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154237475|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237476|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153730485|NCT00133874|Retapamulin|retapamulin|mesh-list
154237477|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
154237478|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154237479|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237480|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237482|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
154237483|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237484|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237485|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
154237486|NCT01304836|Hormones|hormones|mesh-ancestor
154237487|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154237488|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154237489|NCT01304836|Protective Agents|protective agents|mesh-ancestor
154237490|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154237491|NCT01306864|Hemostatics|hemostatics|mesh-list
154237492|NCT01306864|Coagulants|coagulants|mesh-ancestor
154237493|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
154237494|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154237495|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237496|NCT03790384|Mitomycins|mitomycins|mesh-list
154237497|NCT03790384|Mitomycin|mitomycin|mesh-list
154237498|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
154237499|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154237500|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237501|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
154237502|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237503|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154237504|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237505|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154237506|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
154237507|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237508|NCT01307488|Ritonavir|ritonavir|mesh-list
154237509|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154237510|NCT01307488|Lamivudine|lamivudine|mesh-list
154237511|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154237512|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154237513|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
154237514|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237515|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237516|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154237517|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154237518|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
154237519|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237520|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154237521|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154111671|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154237522|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154237523|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154237524|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
154237525|NCT03790072|Fludarabine|fludarabine|mesh-list
154237526|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237527|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
154237528|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237529|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237530|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154237531|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
154237532|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237533|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237534|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154237535|NCT01306006|Vaccines|vaccines|mesh-list
154237536|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
154237537|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237538|NCT03794440|Sorafenib|sorafenib|mesh-list
154237539|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237540|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237541|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237542|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237543|NCT00139776|Celecoxib|celecoxib|mesh-list
154237544|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237545|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237546|NCT00139776|Analgesics|analgesics|mesh-ancestor
154237547|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
154237548|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237549|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237550|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237551|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237553|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154237554|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237555|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237556|NCT00413699|Tofacitinib|tofacitinib|mesh-list
154237557|NCT00413699|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154237558|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237559|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237560|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237561|NCT03713320|Vorinostat|vorinostat|mesh-list
154237562|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237563|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154237564|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237565|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237566|NCT03712930|Pamiparib|pamiparib|mesh-list
154237567|NCT03712930|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154237568|NCT03712930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237569|NCT03712930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237570|NCT03712930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237571|NCT00420407|Vasopressins|vasopressins|mesh-list
154237572|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
154237573|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
154237574|NCT00420407|Coagulants|coagulants|mesh-ancestor
154237575|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154237576|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154237577|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
154237578|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237579|NCT03789370|Propofol|propofol|mesh-list
154237580|NCT03789370|Sevoflurane|sevoflurane|mesh-list
154237581|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154237582|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237583|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237584|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154237585|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
154237586|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
154237587|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154237588|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154237589|NCT00420095|Insulin|insulin|mesh-list
154237590|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154237591|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
154237592|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154237593|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237594|NCT01038089|Resveratrol|resveratrol|mesh-list
154237595|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
154237596|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237597|NCT01038089|Protective Agents|protective agents|mesh-ancestor
154237598|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237599|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237600|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154237601|NCT00419393|Levetiracetam|levetiracetam|mesh-list
154237602|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
154237603|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
154237604|NCT01038167|Cyclosporine|cyclosporine|mesh-list
154237605|NCT01038167|Tacrolimus|tacrolimus|mesh-list
154237606|NCT01038167|Cyclosporins|cyclosporins|mesh-list
154237607|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237608|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
154237609|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237610|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154237611|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237612|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237613|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
154237614|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237615|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154237616|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237617|NCT03787030|Vitamin E|vitamin e|mesh-list
154237618|NCT03787030|Tocopherols|tocopherols|mesh-list
154237619|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
154237620|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
154237621|NCT03787030|Vitamins|vitamins|mesh-ancestor
154237622|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
154237623|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237624|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
154237625|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237626|NCT03787030|Protective Agents|protective agents|mesh-ancestor
154237627|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
154237628|NCT03786562|Morphine|morphine|mesh-list
153984535|NCT03646825|Antioxidants|antioxidants|mesh-list
154237630|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154237631|NCT03786562|Narcotics|narcotics|mesh-ancestor
154237632|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237633|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237634|NCT03786562|Analgesics|analgesics|mesh-ancestor
154237635|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
154237636|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237637|NCT01305148|Warfarin|warfarin|mesh-list
154237638|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
154237639|NCT01305226|Streptokinase|streptokinase|mesh-list
154237640|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154237641|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154237642|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237643|NCT01308268|Ivermectin|ivermectin|mesh-list
154237644|NCT01308268|Albendazole|albendazole|mesh-list
154237645|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154237646|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237647|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
154237648|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
154237649|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154237650|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154237651|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154237652|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154237653|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154237654|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237655|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237656|NCT01308346|Everolimus|everolimus|mesh-list
154237657|NCT01308346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154237658|NCT01308346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237659|NCT01308346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237660|NCT01308346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237661|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237662|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
154237663|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237664|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237665|NCT05694130|Prednisolone|prednisolone|mesh-list
154237666|NCT05694130|Tacrolimus|tacrolimus|mesh-list
154237667|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237668|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
154237669|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237670|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154237671|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237672|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237673|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237674|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
154237675|NCT05694130|Hormones|hormones|mesh-ancestor
154237676|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154237677|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154237678|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237679|NCT00419159|Everolimus|everolimus|mesh-list
154237680|NCT00419159|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154237681|NCT00419159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237682|NCT00419159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237683|NCT00419159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237684|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237685|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
154237686|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237687|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237688|NCT03717064|Pitavastatin|pitavastatin|mesh-list
154237689|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154237690|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154237691|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154237692|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
154237693|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237694|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237695|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154237696|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
154237697|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
154237698|NCT02113163|Metformin|metformin|mesh-list
154237699|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154237700|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154237701|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237702|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153532428|NCT01501747|Cephalexin|cephalexin|mesh-list
154237703|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154237705|NCT00413153|Lopinavir|lopinavir|mesh-list
154237706|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154237707|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154237708|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154237709|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
154237710|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237711|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237713|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154237714|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
154237715|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237716|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154237717|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154237718|NCT02107937|Paclitaxel|paclitaxel|mesh-list
154237719|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154237720|NCT02107937|Carboplatin|carboplatin|mesh-list
154237721|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154237722|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237723|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
154237724|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
154237725|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
154237726|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237727|NCT01312402|Brinzolamide|brinzolamide|mesh-list
154237728|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154237729|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237730|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237731|NCT05693428|Propofol|propofol|mesh-list
154237732|NCT05693428|Sevoflurane|sevoflurane|mesh-list
154237733|NCT05693428|Isoflurane|isoflurane|mesh-list
154237734|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154237735|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237736|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237737|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154237738|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
154237739|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
154237740|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154237741|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154237742|NCT01035281|Nabilone|nabilone|mesh-list
154237743|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
154237744|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
154237745|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237746|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237747|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237748|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154237749|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154237750|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237751|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154237752|NCT01561066|Octreotide|octreotide|mesh-list
154237753|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154237754|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237755|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154237756|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237757|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
154237758|NCT01561066|Coagulants|coagulants|mesh-ancestor
154237759|NCT00419003|Lamotrigine|lamotrigine|mesh-list
154237760|NCT00419003|Ketamine|ketamine|mesh-list
154237761|NCT00419003|Riluzole|riluzole|mesh-list
154237762|NCT00419003|Analgesics|analgesics|mesh-ancestor
154237763|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
154237764|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237765|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237766|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154237767|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154237768|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
154237769|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
154237770|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237771|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154237772|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154237773|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237774|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237775|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
154237776|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154237777|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154237778|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154237779|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154237780|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154237781|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154237782|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154237783|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154237784|NCT00419003|Protective Agents|protective agents|mesh-ancestor
154237785|NCT00418691|Methylphenidate|methylphenidate|mesh-list
154237786|NCT00418691|Modafinil|modafinil|mesh-list
154237787|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154237788|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237789|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154237790|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154237791|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154237792|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237793|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
154237794|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237795|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154237796|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154237797|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154237798|NCT03781258|Warfarin|warfarin|mesh-list
154237799|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
154237800|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154237801|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154237802|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154237803|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154237804|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237805|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154237806|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154237807|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154237808|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
154237809|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237810|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237811|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154237812|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154237813|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
154237814|NCT01308658|Ritonavir|ritonavir|mesh-list
154237815|NCT01308658|Darunavir|darunavir|mesh-list
154237816|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154237817|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154237818|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
154237819|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237820|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237821|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154237822|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154237823|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
154237824|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237825|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154237826|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154237827|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154237828|NCT03777514|Hematinics|hematinics|mesh-ancestor
154237829|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154237830|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154237831|NCT03777124|Carboplatin|carboplatin|mesh-list
154237832|NCT03777124|Pemetrexed|pemetrexed|mesh-list
154237833|NCT03777124|Apatinib|apatinib|mesh-list
154237834|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237835|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237836|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237837|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154237838|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154237839|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237840|NCT00418379|Immunomodulating Agents|immunomodulating agents|mesh-list
154237841|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
154237842|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237843|NCT03780556|Lornoxicam|lornoxicam|mesh-list
154237844|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154237845|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154237846|NCT03780556|Analgesics|analgesics|mesh-ancestor
154237847|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
154237848|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237849|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237850|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237851|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237852|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
154237853|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154237854|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154237855|NCT00418145|Prednisolone|prednisolone|mesh-list
154237856|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
154237857|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154237858|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
154237859|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237860|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
154237861|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
154237862|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154237863|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237864|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154237865|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
154237866|NCT00418145|Hormones|hormones|mesh-ancestor
154237867|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154237868|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154237869|NCT00418145|Protective Agents|protective agents|mesh-ancestor
154237870|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154237871|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237872|NCT03780634|Sorafenib|sorafenib|mesh-list
154237873|NCT03780634|Antibodies|antibodies|mesh-list
154237874|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
154237875|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
154237876|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237877|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237878|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237879|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237880|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237881|NCT03777280|Cobalt|cobalt|mesh-list
154237882|NCT03777280|Chromium|chromium|mesh-list
154237883|NCT03777280|Trace Elements|trace elements|mesh-ancestor
154237884|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
154237885|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237886|NCT02043587|Leucovorin|leucovorin|mesh-list
154237887|NCT02043587|Cytarabine|cytarabine|mesh-list
154237888|NCT02043587|Prednisone|prednisone|mesh-list
154237889|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
154112056|NCT00979966|Sunitinib|sunitinib|mesh-list
154237890|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154237891|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154237892|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154237893|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
154237894|NCT02043587|Rituximab|rituximab|mesh-list
154237895|NCT02043587|Methotrexate|methotrexate|mesh-list
154237896|NCT02043587|Etoposide|etoposide|mesh-list
154237897|NCT02043587|Vincristine|vincristine|mesh-list
154237898|NCT02043587|Daunorubicin|daunorubicin|mesh-list
154237899|NCT02043587|Asparaginase|asparaginase|mesh-list
154237900|NCT02043587|Dasatinib|dasatinib|mesh-list
154237901|NCT02043587|Pegaspargase|pegaspargase|mesh-list
154237902|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237903|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
154237904|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237905|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237906|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154237907|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
154237908|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237909|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237910|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154237911|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154237912|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154237913|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
154237915|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154237916|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154237917|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154237918|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
154237919|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154237920|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154237921|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
154237922|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154237923|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237924|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154237925|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154237926|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154237927|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154237928|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154237929|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
154237930|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154237931|NCT02043587|Antidotes|antidotes|mesh-ancestor
154237932|NCT02043587|Protective Agents|protective agents|mesh-ancestor
154237933|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
154237934|NCT02043587|Vitamins|vitamins|mesh-ancestor
154237935|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
154237936|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
154112081|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
154237937|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
154237938|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
154237939|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154237940|NCT02043587|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154237941|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237942|NCT01561222|Calcitriol|calcitriol|mesh-list
154237943|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154237944|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237945|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154237946|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154237947|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237948|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154237949|NCT01561222|Vitamins|vitamins|mesh-ancestor
154237950|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
154237951|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154237952|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
154237953|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154237954|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154237955|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154237956|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
154237957|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154237958|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237959|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237960|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
154237961|NCT01039025|Melphalan|melphalan|mesh-list
154237962|NCT01039025|Topotecan|topotecan|mesh-list
154237963|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237964|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
154237965|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237966|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154237967|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154237968|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
154237969|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237970|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237971|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154237972|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154112126|NCT00969982|Misoprostol|misoprostol|mesh-list
154237973|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154237975|NCT03779776|Vitamins|vitamins|mesh-list
154237976|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
154237977|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237978|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154237979|NCT00412217|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154237980|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154237981|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154237982|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237983|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237984|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154237985|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154237986|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154237987|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
154237988|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237989|NCT01317784|Antibodies|antibodies|mesh-list
154237990|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
154237991|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
154237992|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
154237993|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154237994|NCT03779464|Gemcitabine|gemcitabine|mesh-list
154237995|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154237996|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
154237997|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154237998|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154237999|NCT01309126|Cetuximab|cetuximab|mesh-list
154238000|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154238001|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238002|NCT03784378|Agerafenib|agerafenib|mesh-list
154238003|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238004|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238005|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238006|NCT01314898|Spironolactone|spironolactone|mesh-list
154238007|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154238009|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238010|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984912|NCT04088110|Trastuzumab|trastuzumab|mesh-list
154238011|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154238013|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
154238014|NCT01315912|Letrozole|letrozole|mesh-list
154238015|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238016|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154238017|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154238018|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238019|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238020|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154238021|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
154238022|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238023|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238024|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
154238025|NCT03778450|Analgesics|analgesics|mesh-list
154238026|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
154238027|NCT03778450|Narcotics|narcotics|mesh-ancestor
154238028|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238029|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238030|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
154238031|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238032|NCT03776500|Macozinone|macozinone|mesh-list
154238033|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
154238034|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238035|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238036|NCT03778138|Pemetrexed|pemetrexed|mesh-list
154238037|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238038|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238039|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238040|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154238041|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154238042|NCT03783754|Amlodipine|amlodipine|mesh-list
154238043|NCT03783754|Telmisartan|telmisartan|mesh-list
154238044|NCT03783754|Indapamide|indapamide|mesh-list
154238045|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154152148|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
154238046|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154238047|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154238048|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238049|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154238050|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238051|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
154238052|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154238053|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154238054|NCT03783754|Diuretics|diuretics|mesh-ancestor
154238055|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
154238056|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154238057|NCT01309438|Erythromycin|erythromycin|mesh-list
154238058|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
154238059|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154238060|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
154238061|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
154238062|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154238063|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
154238064|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154238065|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
154238066|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238067|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238068|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
154238069|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238070|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238071|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154238072|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154238073|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
154238074|NCT03776032|Hematinics|hematinics|mesh-ancestor
154238075|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
154238076|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238077|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
154238079|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154238080|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238081|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238082|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154238083|NCT03775876|Analgesics|analgesics|mesh-ancestor
154238084|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
154238085|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238086|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154238087|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154238088|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154238089|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
154238090|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238091|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238092|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154238093|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
154238094|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
154238095|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154238096|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
154238097|NCT01320514|Coagulants|coagulants|mesh-ancestor
154238098|NCT03773536|Artesunate|artesunate|mesh-list
154238099|NCT03773536|Primaquine|primaquine|mesh-list
154238100|NCT03773536|Amodiaquine|amodiaquine|mesh-list
154238101|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
154238102|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154238103|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154238104|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238105|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238106|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
154238107|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
154238108|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154238109|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
154238110|NCT01320592|Paclitaxel|paclitaxel|mesh-list
154238111|NCT01320592|Palbociclib|palbociclib|mesh-list
154238112|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154238113|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238114|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
154238115|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
154238116|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
154238117|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238118|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238119|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238120|NCT03783676|Remifentanil|remifentanil|mesh-list
154238121|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154238122|NCT03783676|Narcotics|narcotics|mesh-ancestor
154238123|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238124|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238125|NCT03783676|Analgesics|analgesics|mesh-ancestor
154238126|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
154238127|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238128|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154238129|NCT03783520|Eusol|eusol|mesh-list
154238130|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
154238131|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238132|NCT01320982|Aspirin|aspirin|mesh-list
154238133|NCT01320982|Minocycline|minocycline|mesh-list
154238134|NCT01320982|Pramipexole|pramipexole|mesh-list
154238135|NCT01320982|Dexpramipexole|dexpramipexole|mesh-list
154238136|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154238137|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154238138|NCT01320982|Analgesics|analgesics|mesh-ancestor
154238139|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
154238140|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238141|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238142|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238143|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154238144|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154238145|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154238146|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238147|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154238148|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154238149|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238150|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
154238151|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238152|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238153|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
154238154|NCT01320982|Protective Agents|protective agents|mesh-ancestor
154238155|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154238156|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154238157|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
154238158|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
154238159|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238160|NCT01321138|Morphine|morphine|mesh-list
154238161|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154238162|NCT01321138|Narcotics|narcotics|mesh-ancestor
154238163|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238164|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392981|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392982|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392983|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
154392984|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392985|NCT03710395|Nifedipine|nifedipine|mesh-list
154392986|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154392987|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154392988|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392989|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154392990|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392991|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
154392992|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
154392993|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154392994|NCT03093870|Capecitabine|capecitabine|mesh-list
154392995|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392996|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
154392997|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392998|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392999|NCT05744908|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
154393000|NCT05744908|Anticoagulants|anticoagulants|mesh-ancestor
154393001|NCT02394106|Ofatumumab|ofatumumab|mesh-list
154393002|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393003|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
154393004|NCT02393482|Vitamin D|vitamin d|mesh-list
154393005|NCT02393482|Leuprolide|leuprolide|mesh-list
154393006|NCT02393482|Tibolone|tibolone|mesh-list
154393007|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
154393008|NCT02393482|Hormones|hormones|mesh-list
154393009|NCT02393482|Estradiol|estradiol|mesh-list
154393010|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154393011|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393012|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393013|NCT02393482|Estrogens|estrogens|mesh-ancestor
154393014|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154393015|NCT02393482|Antacids|antacids|mesh-ancestor
154238166|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
154238167|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238168|NCT04628572|Ceftazidime|ceftazidime|mesh-list
154238169|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154238170|NCT04628572|Avibactam|avibactam|mesh-list
154112357|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
154238171|NCT04628572|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154238172|NCT04628572|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154238173|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238174|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238175|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154238176|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238177|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238178|NCT03772990|Calcium|calcium|mesh-list
154238179|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154238180|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238181|NCT03782662|Itraconazole|itraconazole|mesh-list
154238182|NCT03782662|Rifampin|rifampin|mesh-list
154238183|NCT03782662|Verapamil|verapamil|mesh-list
154238184|NCT03782662|Midazolam|midazolam|mesh-list
154238185|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154238186|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154238187|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238188|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238189|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154238190|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154238191|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154238192|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154238193|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
154238194|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
154238195|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
154238196|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
154238197|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238198|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238199|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
154238200|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238201|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154238202|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154238203|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238204|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154238205|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
154238206|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238207|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154238208|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154238209|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
154238210|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238211|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
154112394|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238212|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154238213|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154238214|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154238215|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154238216|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154238217|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154238218|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154238219|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154238220|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154238221|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154238222|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154238223|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
154238225|NCT01309984|Fospropofol|fospropofol|mesh-list
154238226|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154238227|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238228|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238229|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154238230|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
154238231|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
154238232|NCT03772054|Propofol|propofol|mesh-list
154238233|NCT03772054|Sevoflurane|sevoflurane|mesh-list
154238234|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154238235|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238236|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238237|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154238238|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
154238239|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
154238240|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154238241|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154238242|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
154238243|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154238244|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238245|NCT03771820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154238246|NCT03771820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238247|NCT05531890|Betamethasone|betamethasone|mesh-list
154238248|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
154238249|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154238250|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
154238251|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154238252|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154238253|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238254|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
154238255|NCT05531890|Hormones|hormones|mesh-ancestor
154238256|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238257|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238258|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154238259|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
154238260|NCT00123474|Dasatinib|dasatinib|mesh-list
154238261|NCT00123474|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154238262|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238263|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238264|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238265|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238266|NCT00142298|Telbivudine|telbivudine|mesh-list
154238267|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
154238268|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238269|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154238270|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238271|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238272|NCT03774706|Misoprostol|misoprostol|mesh-list
154238273|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
154238274|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154238275|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154238276|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238277|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
154238278|NCT03774706|Coagulants|coagulants|mesh-ancestor
154238279|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154238280|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
154238281|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154238282|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238283|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154238284|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154238285|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
154238286|NCT03967496|Metformin|metformin|mesh-list
154238287|NCT03967496|Amlodipine|amlodipine|mesh-list
154238288|NCT03967496|Lisinopril|lisinopril|mesh-list
154238289|NCT03967496|Bisoprolol|bisoprolol|mesh-list
154238290|NCT03967496|Hydralazine|hydralazine|mesh-list
154238291|NCT03967496|Anesthetics|anesthetics|mesh-list
154238292|NCT03967496|Atorvastatin|atorvastatin|mesh-list
154238293|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154238294|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238295|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238296|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154238297|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154238298|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
154238299|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238300|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154238301|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154238302|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238303|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154238304|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154238305|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154238306|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154238307|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
154238308|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154238309|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
154238310|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154238311|NCT03967496|Protective Agents|protective agents|mesh-ancestor
154238312|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
154238314|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238315|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154238316|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154238317|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154238319|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238320|NCT00412061|Everolimus|everolimus|mesh-list
154238321|NCT00412061|Octreotide|octreotide|mesh-list
154238322|NCT00412061|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154238323|NCT00412061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154112506|NCT03472365|Apatinib|apatinib|mesh-list
154238324|NCT00412061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238325|NCT00412061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238326|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154238327|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
154238328|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238329|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238330|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154238331|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154238332|NCT03964350|Ethanol|ethanol|mesh-list
154238333|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154238334|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238335|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238336|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238337|NCT01310452|Insulin|insulin|mesh-list
154238338|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154238339|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
154238340|NCT01310452|Protamines|protamines|mesh-list
154238341|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154238342|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238343|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
154238344|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238345|NCT01310452|Coagulants|coagulants|mesh-ancestor
154238346|NCT01035671|Vitamin E|vitamin e|mesh-list
154238347|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
154238348|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
154238349|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154238350|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
154238351|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238352|NCT01035671|Protective Agents|protective agents|mesh-ancestor
154238353|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238354|NCT01035671|Vitamins|vitamins|mesh-ancestor
154238355|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
154238356|NCT04560868|Nicotine|nicotine|mesh-list
154238357|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154238358|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
154238359|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238360|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238361|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154238362|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154238363|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
154238364|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238365|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238366|NCT03769402|Citric Acid|citric acid|mesh-list
154238367|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
154238368|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
154238369|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154238370|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
154238371|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
154238372|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238373|NCT00411671|Sorafenib|sorafenib|mesh-list
154238374|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238375|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238376|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238377|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238378|NCT03770806|Acetaminophen|acetaminophen|mesh-list
154238379|NCT03770806|Celecoxib|celecoxib|mesh-list
154238380|NCT03770806|Oxycodone|oxycodone|mesh-list
154238381|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154238382|NCT03770806|Analgesics|analgesics|mesh-ancestor
154238383|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
154238384|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238385|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238386|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
154238387|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154238388|NCT03770806|Narcotics|narcotics|mesh-ancestor
154238389|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985293|NCT00721630|Lapatinib|lapatinib|mesh-list
154238390|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154238391|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238392|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154238393|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154238394|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154238395|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238396|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238397|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
154238398|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154238399|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154238400|NCT01039103|Prednisolone|prednisolone|mesh-list
154238401|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
154238402|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154238403|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
154238404|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238405|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
154238406|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
154238407|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238408|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238409|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154238410|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
154238411|NCT01039103|Hormones|hormones|mesh-ancestor
154238412|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238413|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154238414|NCT01039103|Protective Agents|protective agents|mesh-ancestor
154238415|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154238416|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238417|NCT01039181|Vitamin D|vitamin d|mesh-list
154238418|NCT01039181|Calcitriol|calcitriol|mesh-list
154238419|NCT01039181|Vitamins|vitamins|mesh-ancestor
154238420|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
154238421|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238422|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154238423|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154238424|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154238425|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154238426|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238427|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154238429|NCT03770026|Enclomiphene|enclomiphene|mesh-list
154238430|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
154238431|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154238432|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
154238433|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238434|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238435|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154238436|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
154238437|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154238438|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154238439|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154238440|NCT03769870|Atorvastatin|atorvastatin|mesh-list
154238441|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154238442|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154238443|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
154238444|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238445|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154238446|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154238447|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238448|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154238449|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154238450|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238451|NCT01567540|Incretins|incretins|mesh-ancestor
154238452|NCT01567540|Hormones|hormones|mesh-ancestor
154238453|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238454|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154238455|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
154238456|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238457|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238458|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154238459|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
154238460|NCT01036841|Coagulants|coagulants|mesh-ancestor
154238461|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154238462|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
153985361|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
154238463|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238464|NCT03709576|Azacitidine|azacitidine|mesh-list
154238465|NCT03709576|Pevonedistat|pevonedistat|mesh-list
154238466|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154238467|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
154238468|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238469|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238470|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238471|NCT00122460|Cisplatin|cisplatin|mesh-list
154238472|NCT00122460|Carboplatin|carboplatin|mesh-list
154238473|NCT00122460|Fluorouracil|fluorouracil|mesh-list
154238474|NCT00122460|Cetuximab|cetuximab|mesh-list
154238475|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238476|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
154238477|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238478|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154238479|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154238480|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
154238481|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238482|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154238483|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154238484|NCT01320436|Curcumin|curcumin|mesh-list
154238485|NCT01320436|Mesalamine|mesalamine|mesh-list
154238486|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154238487|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154238488|NCT01320436|Analgesics|analgesics|mesh-ancestor
154238489|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
154238490|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238491|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238492|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238493|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154238494|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238495|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238496|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238497|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
154238498|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238499|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238500|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
154238501|NCT04794088|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154238502|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238503|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238504|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238505|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238506|NCT03763084|Acetaminophen|acetaminophen|mesh-list
154238507|NCT03763084|Sufentanil|sufentanil|mesh-list
154238508|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154238509|NCT03763084|Analgesics|analgesics|mesh-ancestor
154238510|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
154238511|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238512|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238513|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
154238514|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154238515|NCT03763084|Narcotics|narcotics|mesh-ancestor
154238516|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238517|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154238518|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154238519|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
154238520|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
154238521|NCT01567618|Docetaxel|docetaxel|mesh-list
154238522|NCT01567618|Fluorouracil|fluorouracil|mesh-list
154238523|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238524|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
154238525|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
154238526|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
154238527|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238528|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
154238529|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154238530|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154238531|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
154238532|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238533|NCT04771078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154238534|NCT04771078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154238535|NCT04771078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238536|NCT03762928|Efavirenz|efavirenz|mesh-list
154238537|NCT03762928|Midazolam|midazolam|mesh-list
154238538|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154238539|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154238540|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238541|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238542|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154238543|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154238544|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154238545|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154238546|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
154238548|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
154238549|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
154238550|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238551|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238552|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154238553|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154238554|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238555|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
154238556|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238557|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154238558|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154238559|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154238560|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154238561|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154238562|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154238563|NCT01561456|Docetaxel|docetaxel|mesh-list
154238564|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238565|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
154238566|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
154238567|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
154238568|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238569|NCT00137436|Prednisone|prednisone|mesh-list
154238570|NCT00137436|Docetaxel|docetaxel|mesh-list
154238571|NCT00137436|Sunitinib|sunitinib|mesh-list
154238572|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238573|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154238574|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154238575|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154238576|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238577|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238578|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
154238579|NCT00137436|Hormones|hormones|mesh-ancestor
154238580|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238581|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238582|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154238583|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154238584|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154238585|NCT00137436|Growth Substances|growth substances|mesh-ancestor
154238586|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
154238587|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238588|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238589|NCT03762538|Propofol|propofol|mesh-list
154238590|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154238591|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238592|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238593|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154238594|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
154238595|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
154238596|NCT03762382|Tenofovir|tenofovir|mesh-list
154238597|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
154238598|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
154238599|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238600|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154238601|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154238602|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238603|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238604|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154238605|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154238606|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154238607|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
154238608|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154238609|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238610|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154238611|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154238612|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154238613|NCT03767920|Dexamethasone|dexamethasone|mesh-list
154238614|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
154238616|NCT03767920|BB 1101|bb 1101|mesh-list
154238617|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238618|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
154238619|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
154238620|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238621|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238622|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154238623|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
154238624|NCT03767920|Hormones|hormones|mesh-ancestor
154238625|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238626|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154238627|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238628|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
154238629|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238630|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238631|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
154238632|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
154238633|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238634|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
154238635|NCT03834623|Nivolumab|nivolumab|mesh-list
154238636|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154238637|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238638|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154238639|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238640|NCT03762148|Vitamins|vitamins|mesh-list
154238641|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
154238642|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
154238644|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
154238645|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238646|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
154238647|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238648|NCT03762148|Protective Agents|protective agents|mesh-ancestor
154238649|NCT03762148|Trace Elements|trace elements|mesh-ancestor
154238650|NCT01589159|Capecitabine|capecitabine|mesh-list
154238651|NCT01589159|Etoposide|etoposide|mesh-list
154238652|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154238653|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
154238654|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238655|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238656|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154238657|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154238658|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154238659|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238660|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154238661|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238662|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
154238663|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154238664|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238665|NCT03937895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154238666|NCT03937895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238667|NCT03767296|Phenylephrine|phenylephrine|mesh-list
154238668|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
154238669|NCT03767296|Ephedrine|ephedrine|mesh-list
154238670|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
154238671|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154238672|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
154238673|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
154238674|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238675|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238676|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
154238677|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154238678|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
154112853|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
154238679|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
154238680|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154238681|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154238682|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154238683|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
154238684|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238685|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238686|NCT03767296|Protective Agents|protective agents|mesh-ancestor
154238687|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154238688|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154238689|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154238690|NCT00410813|Dasatinib|dasatinib|mesh-list
154238691|NCT00410813|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154238692|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238693|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238694|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238695|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238696|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
154238697|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154238698|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238699|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238700|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154238701|NCT03760978|Analgesics|analgesics|mesh-ancestor
154238702|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
154238703|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238704|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154238705|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154238706|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154238707|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
154238708|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238709|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238710|NCT03766984|Diclofenac|diclofenac|mesh-list
154238711|NCT03766984|Tramadol|tramadol|mesh-list
154238712|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154238713|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154238714|NCT03766984|Analgesics|analgesics|mesh-ancestor
154238715|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
154238716|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238717|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238718|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238719|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154238720|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154238721|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238722|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112899|NCT00350545|Cyclosporine|cyclosporine|mesh-list
154238723|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154238724|NCT03766984|Narcotics|narcotics|mesh-ancestor
154238725|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238727|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
154238728|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238729|NCT03928600|Misoprostol|misoprostol|mesh-list
154238730|NCT03928600|Dinoprostone|dinoprostone|mesh-list
154238731|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154238732|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
154238733|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154238734|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238735|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154238736|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154238737|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
154238738|NCT01322152|Capecitabine|capecitabine|mesh-list
154238739|NCT01322152|Irinotecan|irinotecan|mesh-list
154238740|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154238741|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
154238742|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238743|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238744|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154238745|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154238746|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238747|NCT01446016|Paclitaxel|paclitaxel|mesh-list
154238748|NCT01446016|Docetaxel|docetaxel|mesh-list
154238749|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154238750|NCT01446016|Taxane|taxane|mesh-list
154238751|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154238752|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238753|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
154238754|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
154238755|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
154238756|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238757|NCT00137046|Insulin|insulin|mesh-list
154238758|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154238759|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154238760|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238761|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
154238762|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154238763|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154238764|NCT03760354|Prednisolone|prednisolone|mesh-list
154238765|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
154238766|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154238767|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
154238768|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154238769|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
154238770|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
154238771|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238772|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238773|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154238774|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
154238775|NCT03760354|Hormones|hormones|mesh-ancestor
154238776|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238777|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154238778|NCT03760354|Protective Agents|protective agents|mesh-ancestor
154238779|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154238780|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238781|NCT03760276|Voriconazole|voriconazole|mesh-list
154238782|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
154238783|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238784|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154238785|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154238786|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238787|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238788|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154238789|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
154238790|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238791|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238792|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154238793|NCT03766594|Folic Acid|folic acid|mesh-list
154238794|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
154238795|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238796|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
154238797|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154238798|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154238799|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238800|NCT03766594|Urological Agents|urological agents|mesh-ancestor
154238801|NCT03766594|Hematinics|hematinics|mesh-ancestor
154238802|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
154238803|NCT03766594|Vitamins|vitamins|mesh-ancestor
154238804|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
154238805|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238806|NCT00122382|Methotrexate|methotrexate|mesh-list
154238807|NCT00122382|Abatacept|abatacept|mesh-list
154238808|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154238809|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
154238810|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154238811|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238812|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154238813|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
154238814|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238815|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238816|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
154238817|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238818|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154238819|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154238820|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
154238821|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154238822|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154238823|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154238824|NCT00122382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154238825|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
154238826|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
154238827|NCT01028716|Fludarabine|fludarabine|mesh-list
154238828|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
154238829|NCT01028716|Tacrolimus|tacrolimus|mesh-list
154238830|NCT01028716|Lenograstim|lenograstim|mesh-list
154238831|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154238832|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
154238833|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238834|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154238835|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154238836|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
154238837|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238838|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238839|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153985750|NCT01001429|Propofol|propofol|mesh-list
154238840|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154238841|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
154238842|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154238843|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154238844|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238845|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154238846|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154238847|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
154238848|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238849|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238850|NCT02531724|Simendan|simendan|mesh-list
154238851|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154238852|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
154238853|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154238854|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154238855|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238856|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238857|NCT02531724|Protective Agents|protective agents|mesh-ancestor
154238858|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238859|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154238860|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154238861|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238862|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238863|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154238864|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154238865|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238866|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
154238867|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238868|NCT00106704|Pioglitazone|pioglitazone|mesh-list
154238869|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154238870|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154238871|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238872|NCT00106704|Incretins|incretins|mesh-ancestor
154238873|NCT00106704|Hormones|hormones|mesh-ancestor
154238874|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238875|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154238876|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
154238877|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238878|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238879|NCT03759886|Metronidazole|metronidazole|mesh-list
154238880|NCT03759886|Paromomycin|paromomycin|mesh-list
154238881|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238882|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154238883|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154238884|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154238885|NCT01081158|Ritonavir|ritonavir|mesh-list
154238886|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154238887|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
154238888|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154238889|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154238890|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
154238891|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238892|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238893|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154238894|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154238895|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
154238896|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154238897|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154238898|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154238899|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
154238900|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238901|NCT00105066|Metformin|metformin|mesh-list
154238902|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154238903|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238904|NCT01322308|Pioglitazone|pioglitazone|mesh-list
154238905|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154238906|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238907|NCT05208268|Rabeprazole|rabeprazole|mesh-list
154238908|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154238909|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154238910|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154238911|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238912|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238913|NCT03759262|Vitamin D|vitamin d|mesh-list
154238914|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
154238915|NCT03759262|Vitamins|vitamins|mesh-ancestor
154238916|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
154238917|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238918|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154238919|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154238920|NCT00135330|Exenatide|exenatide|mesh-list
154238921|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
154238922|NCT00135330|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154238923|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154238924|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238925|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154238926|NCT00135330|Incretins|incretins|mesh-ancestor
154238927|NCT00135330|Hormones|hormones|mesh-ancestor
154238928|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154238929|NCT01076478|Cilostazol|cilostazol|mesh-list
154238930|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154238931|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
154238932|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238933|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238934|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154238935|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
154238936|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154238937|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154238938|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238939|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154238940|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
154238941|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154238942|NCT01076478|Protective Agents|protective agents|mesh-ancestor
154238943|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154238944|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154238945|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238946|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
154238947|NCT01076556|Rituximab|rituximab|mesh-list
154238948|NCT01076556|Alvocidib|alvocidib|mesh-list
154238949|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154238950|NCT01076556|Antibodies|antibodies|mesh-list
154238951|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
154238952|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154238953|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154238954|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
154238955|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238956|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154238957|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154238958|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
154238959|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238960|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238961|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154238962|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
154238963|NCT01076556|Growth Substances|growth substances|mesh-ancestor
154238964|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154238965|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154238966|NCT03965442|Esmolol|esmolol|mesh-list
154238967|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154238968|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154238969|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154238970|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
154238971|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154238972|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238973|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238974|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
154238975|NCT00134082|Rituximab|rituximab|mesh-list
154238976|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154238977|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
154238978|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238979|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154238980|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154238981|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
154238982|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154238983|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154238984|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154238985|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154238986|NCT03765346|Oxycodone|oxycodone|mesh-list
154238987|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153985889|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
154238988|NCT03765346|Narcotics|narcotics|mesh-ancestor
154238989|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154238990|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238991|NCT03765346|Analgesics|analgesics|mesh-ancestor
154238992|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
154238993|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154238994|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
154238995|NCT01078818|Trace Elements|trace elements|mesh-ancestor
154238996|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
154238997|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154238998|NCT03964038|Gilteritinib|gilteritinib|mesh-list
154238999|NCT03964038|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154239000|NCT03964038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154239001|NCT03964038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239002|NCT03964038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239003|NCT01079052|Famotidine|famotidine|mesh-list
154239004|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154239005|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154239006|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154239007|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
154239008|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
154239009|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239010|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239011|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239012|NCT01326468|Sirolimus|sirolimus|mesh-list
154239013|NCT01326468|Cisplatin|cisplatin|mesh-list
154239014|NCT01326468|Cetuximab|cetuximab|mesh-list
154239015|NCT01326468|Temsirolimus|temsirolimus|mesh-list
154239016|NCT01326468|MTOR Inhibitors|mtor inhibitors|mesh-list
154239017|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239018|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154239019|NCT01326468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154239020|NCT01326468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239021|NCT01326468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239022|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239023|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
154239024|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239025|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154239026|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239027|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154239028|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
154239030|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154239031|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
154239032|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239033|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239034|NCT00132678|Risperidone|risperidone|mesh-list
154239035|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154239036|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
154239037|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239038|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239039|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239040|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154239041|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154239042|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239043|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239044|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154239045|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
154239046|NCT01081548|Atorvastatin|atorvastatin|mesh-list
154239047|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154239048|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154239049|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
154239050|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239051|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154239052|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154239053|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239054|NCT00101400|Sorafenib|sorafenib|mesh-list
154239055|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239056|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154239057|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239058|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239059|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
154239060|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154239061|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239062|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239063|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154239064|NCT01076790|Analgesics|analgesics|mesh-ancestor
154239065|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
154239066|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239067|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154239068|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154239069|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154239070|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
154239071|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239072|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239073|NCT01582932|Calcipotriene|calcipotriene|mesh-list
154239074|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
154239075|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
154239076|NCT03965286|Ledipasvir|ledipasvir|mesh-list
154239077|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154239078|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
154239079|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239080|NCT01079286|Sirolimus|sirolimus|mesh-list
154239081|NCT01079286|Nelfinavir|nelfinavir|mesh-list
154239082|NCT01079286|Temsirolimus|temsirolimus|mesh-list
154239083|NCT01079286|MTOR Inhibitors|mtor inhibitors|mesh-list
154239084|NCT01079286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154239085|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239086|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239087|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239088|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
154239089|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239090|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239091|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154239092|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239093|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154239094|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
154239095|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154239096|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154239097|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
154239098|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154239099|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154239100|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
154239101|NCT01081704|Ustekinumab|ustekinumab|mesh-list
154239102|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
154239103|NCT00141518|Levodopa|levodopa|mesh-list
154239104|NCT00141518|Carbidopa|carbidopa|mesh-list
154239105|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154239106|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154239107|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154239108|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
154239109|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239110|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239111|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239112|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154239113|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239114|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154239115|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
154239116|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
154239117|NCT01075880|Interferons|interferons|mesh-list
154239118|NCT01075880|Interferon-beta|interferon-beta|mesh-list
154239119|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
154239120|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239121|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
154239122|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239123|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
154239124|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239125|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154239126|NCT00098748|Maraviroc|maraviroc|mesh-list
154239127|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154239128|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154239129|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239130|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154239131|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154239132|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
154239133|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239134|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154239135|NCT00130520|Bevacizumab|bevacizumab|mesh-list
154239136|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154239137|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154239138|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239139|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154239140|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154239141|NCT00130520|Growth Substances|growth substances|mesh-ancestor
154239142|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239143|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
154239144|NCT00130520|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154239145|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154239146|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239147|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239149|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154239150|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
154239151|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239152|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239153|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154239154|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
154239155|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154239156|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
154239157|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239158|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154239159|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154239160|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154113326|NCT00336583|Etoposide|etoposide|mesh-list
154239161|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239162|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239163|NCT00253370|Cisplatin|cisplatin|mesh-list
154239164|NCT00253370|Docetaxel|docetaxel|mesh-list
154239165|NCT00253370|Sorafenib|sorafenib|mesh-list
154239166|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239167|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
154239168|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
154239169|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
154239170|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239171|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154239172|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239173|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154239174|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
154239176|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154239177|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
154239178|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239179|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239180|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239181|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154239182|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154239183|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239184|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239185|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154239186|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
154239187|NCT03966560|Timolol|timolol|mesh-list
154239188|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154239189|NCT03966560|Bimatoprost|bimatoprost|mesh-list
154239190|NCT03966560|Travoprost|travoprost|mesh-list
154239191|NCT03966560|Dorzolamide|dorzolamide|mesh-list
154239192|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154239193|NCT03966560|Latanoprost|latanoprost|mesh-list
154239194|NCT03966560|Brinzolamide|brinzolamide|mesh-list
154239195|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154239196|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239197|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239198|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154239199|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154239200|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
154239201|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239202|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239203|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154239204|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154239205|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154239206|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154239207|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154239208|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154239209|NCT01072058|Adalimumab|adalimumab|mesh-list
154239210|NCT01072058|Infliximab|infliximab|mesh-list
154239211|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154239212|NCT01072058|Etanercept|etanercept|mesh-list
154239213|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154239214|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154239215|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
154239216|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154239217|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154239218|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154239219|NCT01072058|Analgesics|analgesics|mesh-ancestor
154239220|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
154239221|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239222|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239223|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239224|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
154239225|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
154239226|NCT00121134|Bevacizumab|bevacizumab|mesh-list
154239227|NCT00121134|Capecitabine|capecitabine|mesh-list
154239228|NCT00121134|Methotrexate|methotrexate|mesh-list
154239229|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239230|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
154239231|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239232|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154239233|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154239234|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
154239235|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239236|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239237|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154239238|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154239239|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154239240|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154239241|NCT00121134|Growth Substances|growth substances|mesh-ancestor
154239242|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
154239243|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154239244|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
154239245|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154239246|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
154239247|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154239248|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
154239249|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239250|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154239251|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154239252|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
154239253|NCT03966378|Calcium|calcium|mesh-list
154239254|NCT03966378|Caseins|caseins|mesh-list
154239255|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154239256|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239257|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
154239258|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
154239259|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239260|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154239261|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239262|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
154239263|NCT03966378|Protective Agents|protective agents|mesh-ancestor
154239264|NCT00119262|Tamoxifen|tamoxifen|mesh-list
154239265|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
154239266|NCT00119262|Bevacizumab|bevacizumab|mesh-list
154239267|NCT00119262|Doxorubicin|doxorubicin|mesh-list
154239268|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154239269|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154239270|NCT00119262|Antibodies|antibodies|mesh-list
154239271|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
154239272|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154239273|NCT00119262|Lenograstim|lenograstim|mesh-list
154239274|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154239275|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239276|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239277|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239278|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
154239279|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239280|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154239281|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154239282|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
154239283|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154239284|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154239285|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154239286|NCT00119262|Growth Substances|growth substances|mesh-ancestor
154239287|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
154239288|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154239289|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154239290|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154239291|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239292|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154239293|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154239294|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
154239295|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239296|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154239297|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154239298|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154239299|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154239300|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154239301|NCT00131664|Metformin|metformin|mesh-list
154239302|NCT00131664|Glimepiride|glimepiride|mesh-list
154239303|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
154239304|NCT00131664|Maleic acid|maleic acid|mesh-list
154239305|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239306|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239307|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239308|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239309|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154239310|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239311|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
154239312|NCT05050318|Vaccines|vaccines|mesh-list
154239313|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
154239314|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239315|NCT03778996|Sirolimus|sirolimus|mesh-list
154239316|NCT03778996|Phenytoin|phenytoin|mesh-list
154239317|NCT03778996|Methoxsalen|methoxsalen|mesh-list
154239318|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
154239319|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154239320|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239321|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154239322|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239323|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
154239324|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239325|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
154239326|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239327|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239328|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239329|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
154239330|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154239331|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154239332|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154239333|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154239334|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154239335|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154239336|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
154239337|NCT03764722|Simendan|simendan|mesh-list
154239338|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154239339|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
154239340|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154239341|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154239342|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239343|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239344|NCT03764722|Protective Agents|protective agents|mesh-ancestor
154239345|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239346|NCT05024734|Gemcitabine|gemcitabine|mesh-list
154239347|NCT05024734|Docetaxel|docetaxel|mesh-list
154239348|NCT05024734|Epirubicin|epirubicin|mesh-list
154239349|NCT05024734|Mitomycins|mitomycins|mesh-list
154239350|NCT05024734|Mitomycin|mitomycin|mesh-list
154239351|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154239352|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
154239353|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239354|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239355|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
154239356|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
154239357|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154239358|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154239359|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154239360|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154239361|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239362|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
154239363|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154239364|NCT03699124|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154239365|NCT03699124|Antiviral Agents|antiviral agents|mesh-ancestor
154239366|NCT03699124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986261|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
154239367|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
154239369|NCT03756220|Vitamins|vitamins|mesh-ancestor
154239370|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
154239371|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239372|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
154239373|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239374|NCT03756220|Protective Agents|protective agents|mesh-ancestor
154239375|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
154239376|NCT04980040|Alogliptin|alogliptin|mesh-list
154239377|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239378|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239379|NCT04980040|Incretins|incretins|mesh-ancestor
154239380|NCT04980040|Hormones|hormones|mesh-ancestor
154239381|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239382|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154239383|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
154239384|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239385|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239386|NCT00131352|Hylan|hylan|mesh-list
154239387|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
154239388|NCT00131352|Protective Agents|protective agents|mesh-ancestor
154239389|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239390|NCT00136916|Insulin|insulin|mesh-list
154239391|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154239392|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239393|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239394|NCT04633564|Bevacizumab|bevacizumab|mesh-list
154239395|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154239396|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239397|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154239398|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154239399|NCT04633564|Growth Substances|growth substances|mesh-ancestor
154239400|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239401|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
154239402|NCT03756064|Carboplatin|carboplatin|mesh-list
154239404|NCT03756064|Trastuzumab|trastuzumab|mesh-list
154239405|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239406|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
154239407|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
154239408|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
154239409|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239410|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154239411|NCT03764020|Melatonin|melatonin|mesh-list
154239412|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
154239413|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239414|NCT03764020|Protective Agents|protective agents|mesh-ancestor
154239415|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239416|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239417|NCT00135512|Bupropion|bupropion|mesh-list
154239418|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154239419|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
154239420|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239421|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154239422|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154239423|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154239424|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239425|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
154239426|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239427|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239428|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154239429|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154239430|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239431|NCT00130728|Bevacizumab|bevacizumab|mesh-list
154239432|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154239433|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154239434|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239435|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154239436|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154239437|NCT00130728|Growth Substances|growth substances|mesh-ancestor
154239438|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239439|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
154239440|NCT00130728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154239441|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154239442|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239443|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239444|NCT00129974|Gemcitabine|gemcitabine|mesh-list
154239445|NCT00129974|Pemetrexed|pemetrexed|mesh-list
154239446|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154239447|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
154239448|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239449|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239450|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239451|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154239452|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154239453|NCT03966326|Fentanyl|fentanyl|mesh-list
154239454|NCT03966326|Anesthetics|anesthetics|mesh-list
154239455|NCT03966326|Sevoflurane|sevoflurane|mesh-list
154239456|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239457|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239458|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154239459|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154239460|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
154239461|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154239462|NCT03966326|Narcotics|narcotics|mesh-ancestor
154239463|NCT03966326|Analgesics|analgesics|mesh-ancestor
154239464|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
154239465|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239466|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154239467|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154239468|NCT00119106|Tenofovir|tenofovir|mesh-list
154239469|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
154239470|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239471|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154239472|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154239473|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239474|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239475|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154239476|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154239477|NCT03758014|Lomustine|lomustine|mesh-list
154239478|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154239479|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
154239480|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239481|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239482|NCT00135356|Ritonavir|ritonavir|mesh-list
154239483|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154239484|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154239485|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154239486|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
154239487|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154239488|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239489|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239490|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154239491|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154239492|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
154239493|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239494|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154239495|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154239496|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154239497|NCT00118716|Fluticasone|fluticasone|mesh-list
154239498|NCT00118716|Xhance|xhance|mesh-list
154239499|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154239500|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154239501|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154239502|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
154239503|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239504|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239505|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154239506|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
154239507|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
154239508|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154239509|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154239510|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154239511|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154239512|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
154239513|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239514|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239515|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
154239516|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154239518|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
154239519|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239520|NCT03966950|Protective Agents|protective agents|mesh-ancestor
154239521|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239522|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239523|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
154239524|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154239525|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154239526|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239527|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154239528|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154239529|NCT01076582|Desogestrel|desogestrel|mesh-list
154239530|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154239531|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154239532|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154239533|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
154239534|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154239535|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239536|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154239537|NCT01076582|Estrogens|estrogens|mesh-ancestor
154239538|NCT01076582|Hormones|hormones|mesh-ancestor
154239539|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239540|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154239541|NCT01076582|Progestins|progestins|mesh-ancestor
154239542|NCT01081938|Insulin|insulin|mesh-list
154239543|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154239544|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
154239545|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
154239546|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239547|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239548|NCT01082796|Glipizide|glipizide|mesh-list
154239549|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239550|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239551|NCT03763786|Cetrorelix|cetrorelix|mesh-list
154239552|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154239553|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
154239554|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154239555|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239556|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
154239557|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239558|NCT01079364|Insulin|insulin|mesh-list
154239559|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154239560|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
154239561|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
154239562|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
154239563|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154239564|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239565|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239566|NCT01077752|Acetaminophen|acetaminophen|mesh-list
154239567|NCT01077752|Lidocaine|lidocaine|mesh-list
154239568|NCT01077752|Morphine|morphine|mesh-list
154239569|NCT01077752|Ropivacaine|ropivacaine|mesh-list
154239570|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
154239571|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
154239572|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239573|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239574|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
154239575|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239576|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154239577|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154239578|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154239579|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154239580|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239581|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154239582|NCT01077752|Narcotics|narcotics|mesh-ancestor
154239583|NCT01077752|Analgesics|analgesics|mesh-ancestor
154239584|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154239585|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
154239586|NCT00129272|Bupropion|bupropion|mesh-list
154239587|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154239588|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
154239589|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239590|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154239591|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153986487|NCT00919282|Vitamins|vitamins|mesh-ancestor
154239592|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154239593|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239595|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239596|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239597|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154239598|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154239599|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239600|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
154239601|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154239602|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239603|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
154239604|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154239605|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
154239606|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239607|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239608|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154239609|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
154239610|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154239611|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
154239612|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239613|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239614|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154239615|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
154239616|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
154239617|NCT03963648|Protective Agents|protective agents|mesh-ancestor
154239618|NCT04899232|Antithrombins|antithrombins|mesh-list
154239619|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
154239620|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154239621|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
154239623|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239624|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
154239625|NCT01079676|Lenograstim|lenograstim|mesh-list
154239626|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154239627|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
154239628|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239629|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154239630|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154239631|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154239632|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239633|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239634|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239635|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154239636|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154239637|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154239638|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
154239639|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239640|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239641|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154239642|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154239643|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
154239644|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154239645|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154239646|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
154239647|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
154239648|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239649|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239650|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
154239651|NCT04555096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154239652|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
154239653|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239654|NCT04555096|Protective Agents|protective agents|mesh-ancestor
154239655|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239656|NCT00097500|Metformin|metformin|mesh-list
154239657|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
154239658|NCT00097500|Exenatide|exenatide|mesh-list
154239659|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154239660|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239661|NCT00097500|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154239662|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154239663|NCT00097500|Incretins|incretins|mesh-ancestor
154239664|NCT00097500|Hormones|hormones|mesh-ancestor
153986565|NCT01031069|Vaccines|vaccines|mesh-list
154239665|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239666|NCT01082484|Treprostinil|treprostinil|mesh-list
154239667|NCT01082484|Iloprost|iloprost|mesh-list
154239668|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154239669|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154239670|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
154239671|NCT05459974|Colchicine|colchicine|mesh-list
154113844|NCT00983398|Mannitol|mannitol|mesh-list
154239672|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
154239673|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154239674|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
154239675|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
154239676|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
154239677|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239678|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239679|NCT03754816|Anesthetics|anesthetics|mesh-list
154239680|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
154239681|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239682|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239683|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
154239684|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
154239685|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239686|NCT04542694|Favipiravir|favipiravir|mesh-list
154239687|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
154239688|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239689|NCT03965208|Heparin|heparin|mesh-list
154239690|NCT03965208|Calcium heparin|calcium heparin|mesh-list
154239691|NCT03965208|Bivalirudin|bivalirudin|mesh-list
154239692|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
154239693|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154239694|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154239695|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239696|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
154239697|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154239698|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
154239699|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239701|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154239702|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154239703|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154239704|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
154239705|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154239706|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239707|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154239708|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154239709|NCT01083264|Progestins|progestins|mesh-ancestor
154239710|NCT01083264|Hormones|hormones|mesh-ancestor
154239711|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239712|NCT00129116|Vaccines|vaccines|mesh-list
154239713|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
154239714|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239715|NCT00117156|Rituximab|rituximab|mesh-list
154239716|NCT00117156|Fludarabine|fludarabine|mesh-list
154239717|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154239718|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239719|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
154239720|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239721|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154239722|NCT01083420|Minocycline|minocycline|mesh-list
154239723|NCT01083420|Dexamethasone|dexamethasone|mesh-list
154239724|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154239725|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
154239726|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
154239727|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239728|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239729|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154239730|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
154239731|NCT01083420|Hormones|hormones|mesh-ancestor
154239732|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239733|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154239734|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239735|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154239736|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239737|NCT00096954|Omalizumab|omalizumab|mesh-list
154239738|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154239739|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153986640|NCT00713830|Metformin|metformin|mesh-list
154239740|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
154239742|NCT00096486|Gefitinib|gefitinib|mesh-list
154239743|NCT00096486|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154239744|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154239746|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239747|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239748|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
154239749|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239750|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239751|NCT00096486|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154239752|NCT00116844|Valacyclovir|valacyclovir|mesh-list
154239753|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
154239754|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239755|NCT03963336|Acetazolamide|acetazolamide|mesh-list
154239756|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
154239757|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154239758|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239759|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239760|NCT03963336|Diuretics|diuretics|mesh-ancestor
154239761|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
154239762|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239763|NCT00132314|Risperidone|risperidone|mesh-list
154239764|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
154239765|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154239766|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
154239767|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239768|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239769|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239770|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154239771|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239772|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239773|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154239774|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
154239775|NCT04539262|Remdesivir|remdesivir|mesh-list
154239776|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
154239777|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239778|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
154239779|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239780|NCT04537234|Vaccines|vaccines|mesh-list
154239781|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
154239782|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239783|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154239784|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
154239785|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
154239786|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154239787|NCT04537078|Cetrorelix|cetrorelix|mesh-list
154239788|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154239789|NCT04537078|Progesterone|progesterone|mesh-list
154239790|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
154239791|NCT04537078|Estradiol|estradiol|mesh-list
154239792|NCT04537078|Progestins|progestins|mesh-ancestor
154239793|NCT04537078|Hormones|hormones|mesh-ancestor
154239794|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239795|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239796|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154239797|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154239798|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
154239799|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154239800|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154239801|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239802|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154239803|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
154239804|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
154239805|NCT04537078|Estrogens|estrogens|mesh-ancestor
154239806|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
154239807|NCT04532164|Clotrimazole|clotrimazole|mesh-list
154239808|NCT04532164|Miconazole|miconazole|mesh-list
154239809|NCT04532164|Butenafine|butenafine|mesh-list
154239810|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239811|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154239812|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154239813|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154239814|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239815|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239816|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154239817|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
154239818|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154239819|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239820|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154239821|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154239823|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
154239824|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239825|NCT04799782|Mirtazapine|mirtazapine|mesh-list
154239826|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
154239827|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239828|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154239829|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
154239830|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
154239831|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239832|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239833|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239834|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154239835|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154239836|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239837|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154239838|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154239839|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154239840|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
154239841|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154239842|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154239843|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
154239844|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154239845|NCT03697252|Xanomeline|xanomeline|mesh-list
154239846|NCT03697252|Trospium chloride|trospium chloride|mesh-list
154239847|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
154239848|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
154239849|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239850|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239851|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154239852|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154239853|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
154239854|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239855|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239856|NCT03697252|Urological Agents|urological agents|mesh-ancestor
154239857|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154239858|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239859|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154239860|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154239861|NCT03701074|Acetaminophen|acetaminophen|mesh-list
154239862|NCT03701074|Ibuprofen|ibuprofen|mesh-list
154239863|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154239864|NCT03701074|Analgesics|analgesics|mesh-ancestor
154239865|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
154239866|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239867|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239868|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
154239869|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154239870|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154239871|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154239872|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154239873|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239874|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239875|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154239876|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154239877|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154239878|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154239879|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
154239880|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239881|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154239882|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154239883|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239884|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154239885|NCT03757156|Aspirin|aspirin|mesh-list
154239886|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154239887|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154239888|NCT03757156|Analgesics|analgesics|mesh-ancestor
154239889|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
154239890|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239891|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239892|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154239893|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154239894|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154239895|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154239896|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239897|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154239898|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154239899|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239902|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239903|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
154239904|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
154239905|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
154239906|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239907|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154239908|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154239909|NCT03750760|Atorvastatin|atorvastatin|mesh-list
154239910|NCT03750760|Ezetimibe|ezetimibe|mesh-list
154239911|NCT03750760|Alirocumab|alirocumab|mesh-list
154239912|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154239913|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154239914|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
154239915|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239916|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154239917|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154239918|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239919|NCT03750760|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154239920|NCT03750760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154239921|NCT03750760|Protease Inhibitors|protease inhibitors|mesh-ancestor
154239922|NCT01076894|Anesthetics|anesthetics|mesh-list
154239923|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239924|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239925|NCT00130832|Vaccines|vaccines|mesh-list
154239926|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
154239927|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239928|NCT00096018|Thalidomide|thalidomide|mesh-list
154239929|NCT00096018|Fludarabine|fludarabine|mesh-list
154239930|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
154239931|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239932|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154239933|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
154239934|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239935|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239936|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
154239937|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239938|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
154239939|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154239940|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239941|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154239942|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154239943|NCT00096018|Growth Substances|growth substances|mesh-ancestor
154239944|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
154239946|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
154239947|NCT01079754|Narcotics|narcotics|mesh-ancestor
154239948|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154239949|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239950|NCT01079754|Analgesics|analgesics|mesh-ancestor
154239951|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
154239952|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239953|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
154239954|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
154239955|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239956|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
154239957|NCT01322776|Fludarabine|fludarabine|mesh-list
154239958|NCT01322776|Bortezomib|bortezomib|mesh-list
154239959|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154239960|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
154239961|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239962|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154239963|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154239964|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
154239965|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239966|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239967|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154239969|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154239970|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154114143|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
154239971|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154098|NCT00965172|Calcium|calcium|mesh-list
154239972|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239974|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
154239975|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154239976|NCT04668274|Resveratrol|resveratrol|mesh-list
154239977|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
154239978|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154239979|NCT04668274|Protective Agents|protective agents|mesh-ancestor
154239980|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239981|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154239982|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154239983|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
154239984|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239985|NCT04406194|Favipiravir|favipiravir|mesh-list
154239986|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
154239987|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154239988|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
154239989|NCT03822884|Hematinics|hematinics|mesh-ancestor
154239990|NCT03822416|Nicotine|nicotine|mesh-list
154239991|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154239992|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
154239993|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154239994|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154239995|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154239996|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154239997|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
154239998|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154239999|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240000|NCT04405570|Molnupiravir|molnupiravir|mesh-list
154240001|NCT04405570|Antiviral Agents|antiviral agents|mesh-ancestor
154240002|NCT04405570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240003|NCT00127712|Amiodarone|amiodarone|mesh-list
154240004|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154240005|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
154240006|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154240007|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154240008|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240009|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154240010|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154240011|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154240012|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240013|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154240014|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154240015|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154240016|NCT01082744|Sufentanil|sufentanil|mesh-list
154240017|NCT01082744|Ropivacaine|ropivacaine|mesh-list
154240018|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
154240019|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
154240020|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240021|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240022|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
154240023|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240024|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154240025|NCT01082744|Narcotics|narcotics|mesh-ancestor
154240026|NCT01082744|Analgesics|analgesics|mesh-ancestor
154240027|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154240028|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154240029|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
154240030|NCT00096356|Vitamins|vitamins|mesh-list
154240031|NCT00096356|Vitamin E|vitamin e|mesh-list
154240032|NCT00096356|Tocopherols|tocopherols|mesh-list
154240033|NCT00096356|Tocotrienols|tocotrienols|mesh-list
154240034|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
154240035|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
154240036|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240037|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
154240038|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240039|NCT00096356|Protective Agents|protective agents|mesh-ancestor
154240040|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
154240041|NCT03749590|Analgesics|analgesics|mesh-ancestor
154240042|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
154240043|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240044|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240046|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240047|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154240048|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
154240049|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154240050|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154240051|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240052|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154240053|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
154240054|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154240055|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
154240056|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154240057|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240058|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240059|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240060|NCT01076816|Analgesics|analgesics|mesh-ancestor
154240061|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
154240062|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240063|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154240064|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154240065|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154240066|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
154240067|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240068|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240069|NCT03749356|Tacrolimus|tacrolimus|mesh-list
154240070|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240071|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
154240072|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240073|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154240074|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240075|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240076|NCT04358068|Azithromycin|azithromycin|mesh-list
154240077|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
154240078|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154240079|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240080|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
154240081|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154240082|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154240083|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240084|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240085|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240086|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
154240087|NCT00096278|Leucovorin|leucovorin|mesh-list
154240088|NCT00096278|Folic Acid|folic acid|mesh-list
154240089|NCT00096278|Bevacizumab|bevacizumab|mesh-list
154240090|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154240091|NCT00096278|Fluorouracil|fluorouracil|mesh-list
154240092|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
154240093|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
154240094|NCT00096278|Antibodies|antibodies|mesh-list
154240095|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
154240096|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154240097|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
154240098|NCT00096278|Calcium|calcium|mesh-list
154240099|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
154240100|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240101|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154240102|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154240103|NCT00096278|Growth Substances|growth substances|mesh-ancestor
154240104|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240105|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
154240106|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
154240107|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154240108|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154240109|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
154240110|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240111|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154240112|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240113|NCT00096278|Antidotes|antidotes|mesh-ancestor
154240114|NCT00096278|Protective Agents|protective agents|mesh-ancestor
154240115|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
154240116|NCT00096278|Vitamins|vitamins|mesh-ancestor
154240117|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
154240118|NCT00096278|Hematinics|hematinics|mesh-ancestor
154240119|NCT00095940|Lapatinib|lapatinib|mesh-list
154240120|NCT00095940|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154240121|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240122|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240123|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240124|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240126|NCT00114218|Docetaxel|docetaxel|mesh-list
154240127|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154240128|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
154240129|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240130|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240131|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
154240132|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
154240133|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
154240134|NCT01077986|Capecitabine|capecitabine|mesh-list
154240135|NCT01077986|Cetuximab|cetuximab|mesh-list
154240136|NCT01077986|Everolimus|everolimus|mesh-list
154240137|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154240138|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
154240139|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240140|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240141|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154240142|NCT01077986|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154240143|NCT01077986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240144|NCT01077986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240145|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240146|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
154240147|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240148|NCT03963024|Treosulfan|treosulfan|mesh-list
154240149|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154240150|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
154240151|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114319|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
154240152|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240153|NCT01082718|Artesunate|artesunate|mesh-list
154240154|NCT01082718|Mefloquine|mefloquine|mesh-list
154240155|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
154240156|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154240157|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154240158|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240159|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240160|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
154240161|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
154240162|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154240163|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
154240164|NCT04380142|Levodopa|levodopa|mesh-list
154240165|NCT04380142|Carbidopa|carbidopa|mesh-list
154240166|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154240167|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154240168|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
154240169|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240170|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240171|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240172|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154240173|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240174|NCT04336228|Dexetimide|dexetimide|mesh-list
154240175|NCT04336228|Citalopram|citalopram|mesh-list
154240176|NCT04336228|Escitalopram|escitalopram|mesh-list
154240177|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240178|NCT04336228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154240179|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154240180|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154240181|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240182|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240183|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
154240184|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154240185|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154240186|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
154240187|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
154240188|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240189|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154240190|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154240191|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
154240192|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154240193|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
154240194|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154240195|NCT03917446|Propofol|propofol|mesh-list
154240196|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154240197|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240198|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240199|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154154287|NCT00972660|Cyclosporine|cyclosporine|mesh-list
154240200|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
154240201|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
154240202|NCT03748108|Lidocaine|lidocaine|mesh-list
154240203|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
154240204|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
154240205|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240206|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240207|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
154240208|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240209|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154240210|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154240211|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154240212|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154240213|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240214|NCT04171414|Adalimumab|adalimumab|mesh-list
154240215|NCT04171414|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154240216|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240217|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240218|NCT04167670|Amoxicillin|amoxicillin|mesh-list
154240219|NCT04167670|Clarithromycin|clarithromycin|mesh-list
154240220|NCT04167670|Lansoprazole|lansoprazole|mesh-list
154240221|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
154240222|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154240223|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240224|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154240225|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240226|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240227|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154240228|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154240229|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154240230|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240232|NCT00113516|Paclitaxel|paclitaxel|mesh-list
154240233|NCT00113516|Carboplatin|carboplatin|mesh-list
154240234|NCT00113516|Sunitinib|sunitinib|mesh-list
154240235|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154240236|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240237|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
154240238|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
154240239|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
154240240|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240241|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154240242|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154240243|NCT00113516|Growth Substances|growth substances|mesh-ancestor
154240244|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240245|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
154240246|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240247|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240248|NCT03251326|Propranolol|propranolol|mesh-list
154240249|NCT03251326|Nabilone|nabilone|mesh-list
154240250|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154240251|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154240252|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
154240253|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240254|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240255|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240256|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154240257|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154240258|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
154240259|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
154240260|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
154240261|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240262|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240263|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154240264|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154240265|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240266|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154240267|NCT04140292|Vitamin D|vitamin d|mesh-list
154240268|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
154240269|NCT04140292|Vitamins|vitamins|mesh-ancestor
154240270|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
154240271|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240272|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154240273|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154240274|NCT00127166|Fluticasone|fluticasone|mesh-list
154240276|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154240277|NCT00127166|Montelukast|montelukast|mesh-list
154240278|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240279|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154240280|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
154240281|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240282|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240283|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154240284|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
154240285|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
154240286|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154240287|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154240288|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154240289|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154240290|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
154240291|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240292|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240293|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154240294|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
154240295|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154240296|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154240297|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154240298|NCT00125138|Metylperon|metylperon|mesh-list
154240299|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154240300|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154240301|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240302|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240303|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154240304|NCT04132336|Naproxen|naproxen|mesh-list
154240305|NCT04132336|Caffeine|caffeine|mesh-list
154240306|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154240307|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240308|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154240309|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240310|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240311|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154240312|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154240313|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
154240314|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240315|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240316|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240317|NCT04132336|Analgesics|analgesics|mesh-ancestor
154240318|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
154240319|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240320|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240321|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240322|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
154240323|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154240324|NCT04131556|Maribavir|maribavir|mesh-list
154240325|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
154240326|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240327|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154240328|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
154240329|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
154240330|NCT03691948|Narcotics|narcotics|mesh-ancestor
154240331|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240332|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240333|NCT03691948|Analgesics|analgesics|mesh-ancestor
154240334|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
154240335|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240336|NCT04124926|Lansoprazole|lansoprazole|mesh-list
154240337|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
154240338|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154240339|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240340|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154240341|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240342|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240343|NCT03746158|Curcumin|curcumin|mesh-list
154240344|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240345|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240346|NCT03746158|Analgesics|analgesics|mesh-ancestor
154240347|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
154240348|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240349|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240350|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240351|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240352|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240353|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240354|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240356|NCT03747094|Ketamine|ketamine|mesh-list
154240357|NCT03747094|Analgesics|analgesics|mesh-ancestor
154240358|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
154240359|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240360|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240361|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154240362|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154240363|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
154240364|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
154240365|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240366|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154240367|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154240368|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240369|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240370|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154240371|NCT03747094|Narcotics|narcotics|mesh-ancestor
154240372|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154240373|NCT04105972|Ivacaftor|ivacaftor|mesh-list
154240374|NCT04105972|Elexacaftor|elexacaftor|mesh-list
154240375|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154240376|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154240377|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240378|NCT00124982|Abatacept|abatacept|mesh-list
154240379|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
154240380|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154240381|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240382|NCT00124982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154240383|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240384|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240385|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
154240386|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240387|NCT04249336|Listerine|listerine|mesh-list
154240388|NCT04249336|Calcium|calcium|mesh-list
154240389|NCT04249336|Fluorides|fluorides|mesh-list
154240390|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
154240391|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154240392|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240393|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
154240394|NCT04249336|Protective Agents|protective agents|mesh-ancestor
154240395|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154240396|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240397|NCT03752476|Lactams|lactams|mesh-list
154240398|NCT03752476|beta-Lactams|beta-lactams|mesh-list
154240399|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154240400|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240401|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154240402|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154240403|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
154240404|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
154240405|NCT04380688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154240406|NCT04380688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240407|NCT04380688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240408|NCT04380688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240409|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240410|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
154240411|NCT00124748|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154240412|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240413|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240414|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240415|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240416|NCT01078142|Sirolimus|sirolimus|mesh-list
154240417|NCT01078142|Rituximab|rituximab|mesh-list
154240418|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154240419|NCT01078142|Temsirolimus|temsirolimus|mesh-list
154240420|NCT01078142|MTOR Inhibitors|mtor inhibitors|mesh-list
153987310|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
154240421|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154240422|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240423|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
154240424|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240426|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154240427|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
154240428|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240429|NCT01078142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240430|NCT01078142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240431|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240432|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154240433|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240434|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154240435|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
154240436|NCT04060654|Buprenorphine|buprenorphine|mesh-list
154240437|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154240438|NCT04060654|Narcotics|narcotics|mesh-ancestor
154240439|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240440|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240441|NCT04060654|Analgesics|analgesics|mesh-ancestor
154240442|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
154240443|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240444|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154240445|NCT00096200|Paclitaxel|paclitaxel|mesh-list
154240446|NCT00096200|Carboplatin|carboplatin|mesh-list
154240447|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154240448|NCT00096200|Sorafenib|sorafenib|mesh-list
154240449|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154240450|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240451|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
154240452|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
154240453|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
154240454|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240455|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240456|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240457|NCT00096044|Rituximab|rituximab|mesh-list
154240459|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154240460|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240461|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
154240462|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240463|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240464|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154240465|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154240466|NCT00096044|Growth Substances|growth substances|mesh-ancestor
154240467|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
154240468|NCT03963128|Vitamin D|vitamin d|mesh-list
154240469|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
154240470|NCT03963128|Vitamins|vitamins|mesh-ancestor
154240471|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
154240472|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240473|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154240474|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154240475|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
154240476|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154240477|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
154240478|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240479|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154240480|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154240481|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154240482|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240483|NCT01083290|Spironolactone|spironolactone|mesh-list
154240484|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154240485|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
154240486|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154240487|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240488|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154240489|NCT01083290|Diuretics|diuretics|mesh-ancestor
154240490|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
154240491|NCT01326650|Vitamin D|vitamin d|mesh-list
154240492|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
154240493|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
154240494|NCT01326650|Vitamins|vitamins|mesh-list
154240495|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154240496|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
154240497|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240498|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154240499|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154240501|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154240502|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
154240503|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
154240504|NCT03689374|Semaglutide|semaglutide|mesh-list
154240505|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154240506|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240507|NCT03689374|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154240508|NCT03745300|Atorvastatin|atorvastatin|mesh-list
154240509|NCT03745300|Simvastatin|simvastatin|mesh-list
154240510|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154240511|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154240512|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
154240513|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240514|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154240515|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154240516|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240517|NCT00112736|Sirolimus|sirolimus|mesh-list
154240518|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154240519|NCT00112736|Temsirolimus|temsirolimus|mesh-list
154240520|NCT00112736|MTOR Inhibitors|mtor inhibitors|mesh-list
154240521|NCT00112736|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154240522|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240523|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240524|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240525|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240526|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240527|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
154240528|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240529|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154240530|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240531|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154240532|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
154240533|NCT04052620|Diclofenac|diclofenac|mesh-list
154240534|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240535|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240537|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
154240538|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240539|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240540|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240541|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240542|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154240543|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240544|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240545|NCT00112580|Ipilimumab|ipilimumab|mesh-list
154240546|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154240547|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240548|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154240549|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240550|NCT04238650|Bevacizumab|bevacizumab|mesh-list
154240551|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154240552|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240553|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154114719|NCT01056757|Ribavirin|ribavirin|mesh-list
154240554|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154240555|NCT04238650|Growth Substances|growth substances|mesh-ancestor
154240556|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240557|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
154240558|NCT04049578|Balovaptan|balovaptan|mesh-list
154240559|NCT04049578|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154240560|NCT04049578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240561|NCT04049578|Natriuretic Agents|natriuretic agents|mesh-ancestor
154240562|NCT04049578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240563|NCT00095498|Denosumab|denosumab|mesh-list
154240564|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154240565|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240566|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
154240567|NCT04237792|Propofol|propofol|mesh-list
154240568|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154240569|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240570|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240571|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240572|NCT04237792|Analgesics|analgesics|mesh-ancestor
154240573|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
154240574|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240575|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154240576|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154240577|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154240578|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
154240579|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240580|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240581|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154240582|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
154240583|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
154240584|NCT03744988|Androgens|androgens|mesh-list
154240585|NCT03744988|Hormones|hormones|mesh-ancestor
154240586|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154240587|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240588|NCT03746782|Thrombin|thrombin|mesh-list
154240589|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
154240590|NCT03746782|Coagulants|coagulants|mesh-ancestor
154240591|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
154240592|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154240593|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154240594|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240595|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
154240596|NCT04024228|Vaccines|vaccines|mesh-list
154240597|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
154240598|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240599|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
154240600|NCT04024228|Coagulants|coagulants|mesh-ancestor
154240601|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
154240602|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154240603|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240604|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
154240605|NCT04018612|Acetaminophen|acetaminophen|mesh-list
154240606|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240608|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
154240609|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240610|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240611|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
154240612|NCT04207840|Epinephrine|epinephrine|mesh-list
154240613|NCT04207840|Racepinephrine|racepinephrine|mesh-list
154240614|NCT04207840|Albuterol|albuterol|mesh-list
154240615|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
154240616|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154240617|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154240618|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
154240619|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240620|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240621|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240622|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154240623|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154240624|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
154240625|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240626|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154240627|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
154240628|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
154240629|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
154240630|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154240631|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
154240632|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154240633|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154240634|NCT03744364|Misoprostol|misoprostol|mesh-list
154240635|NCT03744364|Dinoprostone|dinoprostone|mesh-list
154240636|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154240637|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
154240638|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154240639|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987535|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153987536|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154240640|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154240641|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240642|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
154240643|NCT03744208|Antibodies|antibodies|mesh-list
154240644|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154240645|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
154393016|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240646|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240647|NCT05069896|Mirikizumab|mirikizumab|mesh-list
154240648|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240649|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240651|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
154240652|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240653|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240654|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240655|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240656|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154240657|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240658|NCT01562626|Flucytosine|flucytosine|mesh-list
154240659|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
154240660|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240661|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
154240662|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240663|NCT04470622|Aprepitant|aprepitant|mesh-list
154240664|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
154240665|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
154240666|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114828|NCT00776334|Fosinopril|fosinopril|mesh-list
154240667|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240668|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240669|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154240670|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240671|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240672|NCT04465396|Teduglutide|teduglutide|mesh-list
154240673|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240674|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154240675|NCT04465396|Protective Agents|protective agents|mesh-ancestor
154240676|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240677|NCT03996694|Oxycodone|oxycodone|mesh-list
154240678|NCT03996694|Buprenorphine|buprenorphine|mesh-list
154240679|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154240680|NCT03996694|Narcotics|narcotics|mesh-ancestor
154240681|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240682|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240683|NCT03996694|Analgesics|analgesics|mesh-ancestor
154240684|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
154240685|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240686|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154240687|NCT03743896|Capsaicin|capsaicin|mesh-list
154240688|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
154240689|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
154240690|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
154240691|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240692|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240693|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154240694|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240695|NCT03751228|Deucravacitinib|deucravacitinib|mesh-list
154240696|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
154240697|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240698|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240699|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240700|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154240701|NCT03656692|Hormones|hormones|mesh-ancestor
154240702|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154240703|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240704|NCT01329796|Lidocaine|lidocaine|mesh-list
154240705|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
154240706|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
154240707|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240708|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240709|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
154240710|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240711|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154240712|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154240713|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154240714|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154240715|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240716|NCT04428502|Etanercept|etanercept|mesh-list
154240717|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240718|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153987657|NCT04806906|Cc-486|cc-486|mesh-list
154240720|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
154027474|NCT02650596|Incretins|incretins|mesh-ancestor
154240721|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240722|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240723|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240724|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240725|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240726|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240727|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
154240728|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
154240729|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154240730|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240731|NCT03736330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154240732|NCT03736330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240733|NCT04428424|Etanercept|etanercept|mesh-list
154240734|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240735|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240736|NCT04428424|Analgesics|analgesics|mesh-ancestor
154240737|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
154240738|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240739|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240740|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240741|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240742|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240743|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240744|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
154240745|NCT00095238|Irbesartan|irbesartan|mesh-list
154240746|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154240747|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154240748|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154240749|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240750|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
154240751|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154240752|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240753|NCT01084044|Urinastatin|urinastatin|mesh-list
154240754|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154240755|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154240756|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
154240757|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240758|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240759|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
154240760|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240761|NCT01090596|Naproxen|naproxen|mesh-list
154240762|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240763|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240764|NCT01090596|Analgesics|analgesics|mesh-ancestor
154240765|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
154240766|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240767|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240768|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240769|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240770|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
154240771|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154240772|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240773|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240774|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154240775|NCT01084122|Hematinics|hematinics|mesh-ancestor
154240776|NCT01084200|Propofol|propofol|mesh-list
154240777|NCT01084200|Sevoflurane|sevoflurane|mesh-list
154240778|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154240779|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240780|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240781|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154240782|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
154240783|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
154240784|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154240785|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154240786|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154240787|NCT00094770|Glipizide|glipizide|mesh-list
154240788|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154240789|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240790|NCT00094770|Incretins|incretins|mesh-ancestor
154240791|NCT00094770|Hormones|hormones|mesh-ancestor
154240792|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154240793|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154240794|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
154240795|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240796|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240797|NCT01087398|Cyclosporine|cyclosporine|mesh-list
154240798|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
154240799|NCT01087398|Busulfan|busulfan|mesh-list
154240800|NCT01087398|Methotrexate|methotrexate|mesh-list
154240801|NCT01087398|Fludarabine|fludarabine|mesh-list
154240802|NCT01087398|Cyclosporins|cyclosporins|mesh-list
154240803|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
154240804|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240805|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
154240806|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240807|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240808|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154240809|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
154240810|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240811|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240812|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154240813|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154240814|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
154240815|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154240816|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154240817|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
154240818|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
154240819|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240820|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154240821|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154240822|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
154240823|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240824|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154240825|NCT01087476|Doxycycline|doxycycline|mesh-list
154240826|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154240827|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240829|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154240830|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154240831|NCT00069108|Leucovorin|leucovorin|mesh-list
154240832|NCT00069108|Capecitabine|capecitabine|mesh-list
154240833|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
154240834|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154240835|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
154240836|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240837|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240838|NCT00069108|Antidotes|antidotes|mesh-ancestor
154240839|NCT00069108|Protective Agents|protective agents|mesh-ancestor
154240840|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240841|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
154240842|NCT00069108|Vitamins|vitamins|mesh-ancestor
154240843|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
154240844|NCT00405587|Vemurafenib|vemurafenib|mesh-list
154240845|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240846|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240847|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240848|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240849|NCT01040429|Clonidine|clonidine|mesh-list
154240850|NCT01040429|Analgesics|analgesics|mesh-ancestor
154240851|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
154240852|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240853|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240854|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154240855|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
154240856|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
154240857|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154240858|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154240859|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154240860|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
154240861|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154240862|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240863|NCT01039883|Albaconazole|albaconazole|mesh-list
154240864|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
154240865|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240866|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
154240867|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
154240868|NCT00405275|Etanercept|etanercept|mesh-list
154240869|NCT00405275|Methotrexate|methotrexate|mesh-list
154240870|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154240871|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
154240872|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154240873|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240874|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154240875|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
154240876|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240877|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240878|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
154240879|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240880|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154240881|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240882|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
154240883|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240884|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154240885|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
154240886|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154240887|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154240888|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240889|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240890|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240891|NCT00405275|Analgesics|analgesics|mesh-ancestor
154240892|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
154240893|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240894|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240895|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240896|NCT00404651|Vaccines|vaccines|mesh-list
154240897|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
154240898|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240899|NCT00404495|Irinotecan|irinotecan|mesh-list
154240900|NCT00404495|Temozolomide|temozolomide|mesh-list
154240901|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154240902|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154240903|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240904|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240905|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240906|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154240907|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
154240908|NCT00409409|Immunomodulating Agents|immunomodulating agents|mesh-list
154240909|NCT00409409|Immunologic Factors|immunologic factors|mesh-ancestor
154240910|NCT00409409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240911|NCT00409331|Amifostine|amifostine|mesh-list
154240912|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154240913|NCT00409331|Protective Agents|protective agents|mesh-ancestor
154240914|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240915|NCT00362219|Morphine|morphine|mesh-list
154240916|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154240917|NCT00362219|Narcotics|narcotics|mesh-ancestor
154240918|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240919|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240920|NCT00362219|Analgesics|analgesics|mesh-ancestor
154240921|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
154240922|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240923|NCT01040585|Linezolid|linezolid|mesh-list
154240924|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154240925|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240926|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154240927|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240928|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240929|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
154240930|NCT01040195|Methotrexate|methotrexate|mesh-list
154240931|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154240932|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
154240933|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154240934|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240935|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154240936|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
154240937|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240938|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380204|NCT02071394|Xenon|xenon|mesh-list
154240939|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
154240940|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240941|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154240942|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240943|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
154240944|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153987833|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
154240945|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154240946|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
154240947|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154240948|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154240949|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240950|NCT01040273|Bupivacaine|bupivacaine|mesh-list
154240951|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
154240952|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
154240953|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154240954|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240955|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
154240956|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240957|NCT00408629|Adalimumab|adalimumab|mesh-list
154240958|NCT00408629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154240959|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240960|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154240961|NCT00408317|Pancrelipase|pancrelipase|mesh-list
154240962|NCT00408317|Pancreatin|pancreatin|mesh-list
154240963|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154240964|NCT00112502|Thalidomide|thalidomide|mesh-list
154240965|NCT00112502|Celecoxib|celecoxib|mesh-list
154240966|NCT00112502|Temozolomide|temozolomide|mesh-list
154240967|NCT00112502|Isotretinoin|isotretinoin|mesh-list
154240968|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154240969|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
154240970|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240971|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240972|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154240973|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154240974|NCT00112502|Analgesics|analgesics|mesh-ancestor
154240975|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
154240976|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154240977|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154240978|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154240980|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154240981|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154240982|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240983|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154240984|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
154240985|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
154240986|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154240987|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154240988|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154240989|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154240990|NCT00112502|Growth Substances|growth substances|mesh-ancestor
154240991|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
154240992|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
154240993|NCT03965546|Sorafenib|sorafenib|mesh-list
154240994|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154240995|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154240996|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154240997|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154240998|NCT01083992|Vitamin D|vitamin d|mesh-list
154240999|NCT01083992|Vildagliptin|vildagliptin|mesh-list
154241000|NCT01083992|Vitamins|vitamins|mesh-ancestor
154241001|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
154241002|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241003|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154241004|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154241005|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154241006|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
154241007|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241008|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241009|NCT03822182|Dexamethasone|dexamethasone|mesh-list
154241010|NCT03822182|Bupivacaine|bupivacaine|mesh-list
154241011|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241012|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
154241013|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
154241014|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241015|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241016|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987919|NCT02630641|Hormones|hormones|mesh-list
154241017|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
154241018|NCT03822182|Hormones|hormones|mesh-ancestor
154241019|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241020|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154241021|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241022|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
154241024|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154241026|NCT01078610|Adalimumab|adalimumab|mesh-list
154241027|NCT01078610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154241028|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241029|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241030|NCT01080482|Tacrolimus|tacrolimus|mesh-list
154241031|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241032|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
154241033|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241034|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154241035|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241036|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241037|NCT03965624|Ixazomib|ixazomib|mesh-list
154241038|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241039|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
154241040|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241041|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241042|NCT01080560|Cyclosporine|cyclosporine|mesh-list
154241043|NCT01080560|Cyclosporins|cyclosporins|mesh-list
154241044|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241045|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241046|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241047|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
154241048|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241049|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
154241050|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241051|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
154241052|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241053|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154241054|NCT00094328|Anastrozole|anastrozole|mesh-list
154241055|NCT00094328|Bicalutamide|bicalutamide|mesh-list
154241056|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154241057|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241058|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154241059|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154241060|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241061|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241062|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154241063|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
154241064|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241065|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241066|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
154241067|NCT00094172|Atorvastatin|atorvastatin|mesh-list
154241068|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154241069|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154241070|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
154241071|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241072|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154241073|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154241074|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241075|NCT00094094|Axitinib|axitinib|mesh-list
154241076|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241077|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241078|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241079|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241080|NCT03962816|Vaccines|vaccines|mesh-list
154241081|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
154241082|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241083|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
154241084|NCT01080638|Abciximab|abciximab|mesh-list
154241085|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
154241086|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154241087|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154241088|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
154241089|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241090|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154241091|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241092|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
154241093|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241094|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
153987987|NCT00572169|Thalidomide|thalidomide|mesh-list
154241096|NCT01080638|Protective Agents|protective agents|mesh-ancestor
154241097|NCT00110396|Interferons|interferons|mesh-list
154241098|NCT00110396|Interferon-beta|interferon-beta|mesh-list
154241099|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
154241100|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241101|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
154241102|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241103|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
154241104|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241105|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154241107|NCT00407537|Atorvastatin|atorvastatin|mesh-list
154241108|NCT00407537|Calcium|calcium|mesh-list
154241109|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154241110|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241111|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154241112|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154241113|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
154241114|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241115|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154241116|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154241117|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241118|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154241119|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154241120|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154241121|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
154241122|NCT00094458|Infliximab|infliximab|mesh-list
154241123|NCT00094458|Azathioprine|azathioprine|mesh-list
154241124|NCT00094458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154241125|NCT00094458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241126|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
154241127|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154241128|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241129|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
154115283|NCT00929877|Analgesics|analgesics|mesh-ancestor
154241130|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241131|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241132|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241133|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241134|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
154241135|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241136|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154241137|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154241138|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241139|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241140|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154241141|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154241142|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241143|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
154241144|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241145|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
154241146|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
154241147|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241148|NCT03961464|Cycloserine|cycloserine|mesh-list
154241149|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154241150|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241151|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154241152|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
154241153|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154241154|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
154241155|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241156|NCT01087632|Folic Acid|folic acid|mesh-list
154241157|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
154241158|NCT01087632|Policosanol|policosanol|mesh-list
154241159|NCT01087632|Red yeast rice|red yeast rice|mesh-list
154241160|NCT01087632|Hematinics|hematinics|mesh-ancestor
154241161|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
154241162|NCT01087632|Vitamins|vitamins|mesh-ancestor
154241163|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
154241164|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241165|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154241166|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154241167|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153988065|NCT04080310|Ezetimibe|ezetimibe|mesh-list
154241168|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
154241169|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241170|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241171|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154155259|NCT01033318|Losartan|losartan|mesh-list
154241172|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154241173|NCT00394589|Infliximab|infliximab|mesh-list
154241174|NCT00394589|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154241175|NCT00394589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115339|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
154241176|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
154241177|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154241178|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241179|NCT00068406|Cisplatin|cisplatin|mesh-list
154241180|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241181|NCT00403559|Ketoconazole|ketoconazole|mesh-list
154241182|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
154241183|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
154241184|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241185|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154241186|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154241187|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241188|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241189|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154241190|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
154241191|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241192|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241193|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154241194|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154241195|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154241196|NCT00403559|Analgesics|analgesics|mesh-ancestor
154241197|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
154241199|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241200|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241201|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
154241202|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241203|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
154241204|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154241205|NCT01087710|Vitamins|vitamins|mesh-list
154241206|NCT01087710|Antioxidants|antioxidants|mesh-list
154241207|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
154241208|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241209|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241210|NCT01087710|Protective Agents|protective agents|mesh-ancestor
154241211|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154241212|NCT00403481|Olmesartan|olmesartan|mesh-list
154241213|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154241214|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154241215|NCT00403481|Diuretics|diuretics|mesh-ancestor
154241216|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
154241217|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241218|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154241219|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154241220|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241221|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154241222|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154241223|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154241224|NCT00402779|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154241225|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241226|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241227|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241228|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241229|NCT00394433|Bevacizumab|bevacizumab|mesh-list
154241230|NCT00394433|Cisplatin|cisplatin|mesh-list
154241231|NCT00394433|Docetaxel|docetaxel|mesh-list
154241232|NCT00394433|Irinotecan|irinotecan|mesh-list
154115389|NCT00777972|Diuretics|diuretics|mesh-ancestor
154241233|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241234|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241235|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154241236|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154241237|NCT00394433|Growth Substances|growth substances|mesh-ancestor
154241238|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241239|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
154241240|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241241|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
154241242|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
154241243|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241244|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154241245|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154241248|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
154241249|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241250|NCT00068250|Rituximab|rituximab|mesh-list
154241251|NCT00068250|Methotrexate|methotrexate|mesh-list
154241252|NCT00068250|Temozolomide|temozolomide|mesh-list
154241253|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241254|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241255|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
154241256|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241257|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241258|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154241259|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
154241260|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154241261|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241262|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
154241263|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241264|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
154241265|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241266|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154241267|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241268|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154241269|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154241270|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
154241271|NCT03957720|Penicillamine|penicillamine|mesh-list
154241272|NCT03957720|Succimer|succimer|mesh-list
154241273|NCT03957720|Antidotes|antidotes|mesh-ancestor
154241274|NCT03957720|Protective Agents|protective agents|mesh-ancestor
154241275|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241276|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
154241277|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
154115445|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
154241278|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241279|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241280|NCT00393029|Aldesleukin|aldesleukin|mesh-list
154241281|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
154241282|NCT00393029|Fludarabine|fludarabine|mesh-list
154241283|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
154241284|NCT00393029|Interleukin-2|interleukin-2|mesh-list
154241285|NCT00393029|Lenograstim|lenograstim|mesh-list
154241286|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241287|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
154241288|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241289|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241290|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154241291|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
154241292|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241293|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241294|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154241295|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241296|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
154241297|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154241298|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154241299|NCT00393029|Analgesics|analgesics|mesh-ancestor
154241300|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
154241301|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241302|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154241303|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154241304|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
154241305|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241306|NCT00402233|Pramipexole|pramipexole|mesh-list
154241307|NCT00402233|Dexpramipexole|dexpramipexole|mesh-list
154241308|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
154241309|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241310|NCT00402233|Protective Agents|protective agents|mesh-ancestor
154241311|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241312|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154241313|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154241314|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
154241315|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
154241316|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241317|NCT03993431|Methamphetamine|methamphetamine|mesh-list
154241318|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154241319|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241320|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
154241321|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
154241322|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241324|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241325|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241326|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
154241327|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154241328|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154241329|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154241330|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154241331|NCT00401843|Dexamethasone|dexamethasone|mesh-list
154241332|NCT00401843|Bortezomib|bortezomib|mesh-list
154241333|NCT00401843|Siltuximab|siltuximab|mesh-list
154241334|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241335|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
154241336|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
154241337|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241338|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241339|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154241340|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
154241341|NCT00401843|Hormones|hormones|mesh-ancestor
154241342|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241343|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154241344|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241345|NCT00401531|Vaccines|vaccines|mesh-list
154241346|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154241347|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
154241348|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241349|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
154241350|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154241351|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241352|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
154241353|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241354|NCT00400517|Thalidomide|thalidomide|mesh-list
154241355|NCT00400517|Sargramostim|sargramostim|mesh-list
154241356|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241357|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
154241358|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241359|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
154241360|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154241361|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241362|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154241363|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154241364|NCT00400517|Growth Substances|growth substances|mesh-ancestor
154241365|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
154241366|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241367|NCT01044095|Vaccines|vaccines|mesh-list
154241368|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
154241369|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241370|NCT00392171|Temozolomide|temozolomide|mesh-list
154241371|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154241372|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
154241373|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241374|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241375|NCT00091832|Denosumab|denosumab|mesh-list
154241376|NCT00091832|Diphosphonates|diphosphonates|mesh-list
154241377|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154241378|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241379|NCT00391391|Vaccines|vaccines|mesh-list
154241380|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
154241381|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241382|NCT01044251|Frovatriptan|frovatriptan|mesh-list
154241383|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154241384|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
154241385|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241386|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241387|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241388|NCT01044329|Triamcinolone|triamcinolone|mesh-list
154241389|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154241390|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154241391|NCT01044329|Bevacizumab|bevacizumab|mesh-list
154241392|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153988279|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241393|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241395|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154241396|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154241397|NCT01044329|Growth Substances|growth substances|mesh-ancestor
154241398|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241399|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
154241400|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241401|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
154241403|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241404|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241405|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
154241406|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241407|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241408|NCT00091442|Docetaxel|docetaxel|mesh-list
154241409|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154241410|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241411|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241412|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
154241413|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
154241414|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241415|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154241416|NCT00390689|Pramipexole|pramipexole|mesh-list
154241417|NCT00390689|Dexpramipexole|dexpramipexole|mesh-list
154241418|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
154241419|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241420|NCT00390689|Protective Agents|protective agents|mesh-ancestor
154241421|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241422|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154241423|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154241424|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
154241425|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
154241426|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241427|NCT01079078|Acetaminophen|acetaminophen|mesh-list
154241428|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154241429|NCT01079078|Analgesics|analgesics|mesh-ancestor
154241430|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
154241431|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241432|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241433|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
154241434|NCT00390455|Fulvestrant|fulvestrant|mesh-list
154241435|NCT00390455|Lapatinib|lapatinib|mesh-list
154241436|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154241437|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241438|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154241439|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154241440|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
154241441|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241442|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241443|NCT00390455|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154241444|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241445|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241446|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241447|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154241448|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154241449|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241450|NCT01583114|Perindopril|perindopril|mesh-list
154241451|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154241452|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
154241453|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241454|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241455|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154241456|NCT01079312|Fentanyl|fentanyl|mesh-list
154241457|NCT01079312|Remifentanil|remifentanil|mesh-list
154241458|NCT01079312|Propofol|propofol|mesh-list
154241459|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154241460|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154241461|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241462|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154241463|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
154241464|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
154241465|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154241466|NCT01079312|Narcotics|narcotics|mesh-ancestor
154241467|NCT01079312|Analgesics|analgesics|mesh-ancestor
154241468|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
154241469|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241470|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154241471|NCT01044485|Docetaxel|docetaxel|mesh-list
154241472|NCT01044485|Lapatinib|lapatinib|mesh-list
154027475|NCT02650596|Hormones|hormones|mesh-ancestor
154241473|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241474|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241475|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
154241476|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
154241477|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241478|NCT01044485|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154241479|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241480|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241482|NCT00119678|Abatacept|abatacept|mesh-list
154241483|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241484|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
154241485|NCT00119678|Hormones|hormones|mesh-ancestor
154241486|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241487|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241488|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154241489|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241490|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154241491|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241492|NCT00119678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241493|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241494|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
154241495|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241496|NCT00110084|Paclitaxel|paclitaxel|mesh-list
154241497|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154241498|NCT00110084|Gemcitabine|gemcitabine|mesh-list
154241499|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154241500|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241501|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241502|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
154241503|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
154241504|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241505|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241506|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
154241507|NCT00390221|Daclizumab|daclizumab|mesh-list
154241508|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241509|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
154241510|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241511|NCT00389831|Rotigotine|rotigotine|mesh-list
154241512|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
154241513|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
154241514|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241515|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241516|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241517|NCT00389519|Ramipril|ramipril|mesh-list
154241518|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154241519|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
154241520|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241521|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241522|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154241523|NCT00389441|Axitinib|axitinib|mesh-list
154241524|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241525|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241526|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241527|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241528|NCT00118898|Ritonavir|ritonavir|mesh-list
154241529|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154241530|NCT00118898|Tenofovir|tenofovir|mesh-list
154241531|NCT00118898|Lamivudine|lamivudine|mesh-list
154241532|NCT00118898|Emtricitabine|emtricitabine|mesh-list
154241533|NCT00118898|Abacavir|abacavir|mesh-list
154241534|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154241535|NCT00118898|Efavirenz|efavirenz|mesh-list
154241536|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
154241537|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154241538|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154241539|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
154241540|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241541|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241542|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154241543|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154241544|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
154241545|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241546|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154393017|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154241547|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154241548|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154241549|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154241550|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154241551|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154241552|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154241553|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154241554|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154241555|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
154241556|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
154241557|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154241558|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
154241559|NCT01085552|Hematinics|hematinics|mesh-ancestor
154241560|NCT01085708|Rabeprazole|rabeprazole|mesh-list
154241561|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154241562|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154241563|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154241564|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115731|NCT00665652|Lenalidomide|lenalidomide|mesh-list
154241565|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241566|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154241567|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154241568|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154241569|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
154241570|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241571|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241572|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241573|NCT00090584|Urological Agents|urological agents|mesh-ancestor
154241574|NCT01079624|Glucagon|glucagon|mesh-list
154241575|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154241576|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154241577|NCT01079624|Hormones|hormones|mesh-ancestor
154241578|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241579|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241580|NCT01079624|Incretins|incretins|mesh-ancestor
154241581|NCT01086020|Atorvastatin|atorvastatin|mesh-list
154241582|NCT01086020|Ezetimibe|ezetimibe|mesh-list
154241583|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154241584|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154241585|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
154241586|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241587|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154241588|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154241589|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241590|NCT03670810|Lasmiditan|lasmiditan|mesh-list
154241591|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154241592|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
154241593|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241594|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241595|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241596|NCT01086254|Gemcitabine|gemcitabine|mesh-list
154241597|NCT01086254|Iniparib|iniparib|mesh-list
154241598|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241599|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241600|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
154241601|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241602|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154241603|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241604|NCT01086332|Nelfinavir|nelfinavir|mesh-list
154241605|NCT01086332|Gemcitabine|gemcitabine|mesh-list
154241606|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241607|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
154241608|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241609|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241610|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154241611|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154241612|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
154241613|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241614|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154241615|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154241616|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
154241617|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988506|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241619|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
154241620|NCT01811368|Rituximab|rituximab|mesh-list
154241621|NCT01811368|Cyclosporins|cyclosporins|mesh-list
154241623|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154241624|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
154241625|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241626|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241627|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
154241628|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241629|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241630|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241631|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241632|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241633|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
154241634|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241635|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
154241636|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154241637|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154241638|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154241639|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
154241640|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154241641|NCT00089648|Sunitinib|sunitinib|mesh-list
154241642|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241643|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154241644|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154241645|NCT00089648|Growth Substances|growth substances|mesh-ancestor
154241646|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241647|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
154241648|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241649|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241650|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241651|NCT01079702|Capecitabine|capecitabine|mesh-list
154241652|NCT01079702|Everolimus|everolimus|mesh-list
154241653|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241654|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
154241655|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241656|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241657|NCT01079702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154241658|NCT01079702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241659|NCT01079702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241660|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241661|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
154241662|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241663|NCT00118040|Genistein|genistein|mesh-list
154241664|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154241665|NCT00118040|Protective Agents|protective agents|mesh-ancestor
154241666|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241667|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241668|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241669|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241670|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241671|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
154241672|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154241673|NCT00118040|Estrogens|estrogens|mesh-ancestor
154241674|NCT00118040|Hormones|hormones|mesh-ancestor
154241675|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241676|NCT03961958|Propofol|propofol|mesh-list
154241677|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154241678|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154241679|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241680|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154241681|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
154241682|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
154241683|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154241684|NCT00389207|Nevirapine|nevirapine|mesh-list
154241685|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154241686|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154241687|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
154241688|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241689|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241690|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153988584|NCT02582476|Bumetanide|bumetanide|mesh-list
154241691|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154241692|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
154241693|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241694|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154155781|NCT05132829|Azithromycin|azithromycin|mesh-list
154241695|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154241697|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154241698|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154241699|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
154241700|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154241701|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154241702|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154241703|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154241704|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241705|NCT00388583|Vaccines|vaccines|mesh-list
154241706|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
154241707|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241708|NCT00117572|Docetaxel|docetaxel|mesh-list
154241709|NCT00117572|Fluorouracil|fluorouracil|mesh-list
154241710|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
154241711|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241712|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241713|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
154241714|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
154241715|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241716|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
154241717|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241718|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241719|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
154241720|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241721|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
154241722|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241723|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154241724|NCT00388505|Tobramycin|tobramycin|mesh-list
154241725|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154241726|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241727|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
154241728|NCT00388349|Carmustine|carmustine|mesh-list
154241729|NCT00388349|Gemcitabine|gemcitabine|mesh-list
154241730|NCT00388349|Etoposide|etoposide|mesh-list
154241731|NCT00388349|Vinorelbine|vinorelbine|mesh-list
154241732|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241733|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
154241734|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241735|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241736|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154241737|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
154241738|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241739|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241740|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154115923|NCT00783900|Metoprolol|metoprolol|mesh-list
154241741|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241742|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
154241743|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154241744|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154241745|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154241746|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241747|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241748|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
154241749|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
154241750|NCT00117338|Montelukast|montelukast|mesh-list
154241751|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154241752|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
154241753|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154241754|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
154241755|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241756|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241757|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154241758|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154241759|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241760|NCT00388037|Sunitinib|sunitinib|mesh-list
154241761|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241762|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154241763|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154241764|NCT00388037|Growth Substances|growth substances|mesh-ancestor
154241765|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988656|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241766|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
154241767|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154241768|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241769|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241770|NCT00387881|Naproxen|naproxen|mesh-list
154241771|NCT00387881|Sumatriptan|sumatriptan|mesh-list
154241772|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154241773|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154241774|NCT00387881|Analgesics|analgesics|mesh-ancestor
154241775|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
154241776|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241777|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241778|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241779|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241780|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
154241781|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154241782|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241783|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241784|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154241785|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154241786|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154241787|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
154241788|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241789|NCT00084656|Ipilimumab|ipilimumab|mesh-list
154241790|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241791|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241792|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154241793|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241794|NCT00387647|Azacitidine|azacitidine|mesh-list
154241795|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241796|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
154241797|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241798|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241799|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241800|NCT00386009|Tadalafil|tadalafil|mesh-list
154241801|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
154241802|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154241803|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154241804|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241805|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241806|NCT00386009|Urological Agents|urological agents|mesh-ancestor
154241807|NCT01045889|Prednisone|prednisone|mesh-list
154241808|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
154241809|NCT01045889|Melphalan|melphalan|mesh-list
154241810|NCT01045889|Rituximab|rituximab|mesh-list
154241811|NCT01045889|Etoposide|etoposide|mesh-list
154241812|NCT01045889|Vincristine|vincristine|mesh-list
154241813|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241814|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
154241815|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241816|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241817|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154241818|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
154241819|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241820|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241821|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154241822|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241823|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241824|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
154241825|NCT01045889|Hormones|hormones|mesh-ancestor
154241826|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241827|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154241828|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154241829|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154241830|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154241831|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241832|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241833|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
154241834|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
154241835|NCT00373685|Celecoxib|celecoxib|mesh-list
154241836|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154241837|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154241838|NCT00373685|Analgesics|analgesics|mesh-ancestor
154241839|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
154241840|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241841|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241842|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241843|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241844|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154241845|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154241846|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241847|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241848|NCT00373529|Clofarabine|clofarabine|mesh-list
154241849|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241850|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
154241851|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241852|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241853|NCT00373295|Baclofen|baclofen|mesh-list
154241854|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154241855|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241856|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154241857|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241858|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154241859|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
154241860|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
154241861|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241862|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241863|NCT00385541|Morphine|morphine|mesh-list
154241864|NCT00385541|Hydromorphone|hydromorphone|mesh-list
154241865|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154241866|NCT00385541|Narcotics|narcotics|mesh-ancestor
154241867|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154241868|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241869|NCT00385541|Analgesics|analgesics|mesh-ancestor
154241870|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
154241871|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241872|NCT01046045|Everolimus|everolimus|mesh-list
154241873|NCT01046045|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154241874|NCT01046045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154116054|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
154241875|NCT01046045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241876|NCT01046045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241877|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241878|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
154241879|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241880|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241881|NCT01044719|Meropenem|meropenem|mesh-list
154241882|NCT01044719|Tobramycin|tobramycin|mesh-list
154241883|NCT01044719|Ceftazidime|ceftazidime|mesh-list
154241884|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154241885|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154241886|NCT01044719|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154241887|NCT01044719|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154241888|NCT01045109|Vitamin D|vitamin d|mesh-list
154241889|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
154241890|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
154241891|NCT01045109|Vitamins|vitamins|mesh-list
154241892|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
154241893|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241894|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154241895|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154241896|NCT00094302|Spironolactone|spironolactone|mesh-list
154241897|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154241898|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
154241899|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241900|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241901|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154241902|NCT00094302|Diuretics|diuretics|mesh-ancestor
154241903|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
154241904|NCT00372905|Rituximab|rituximab|mesh-list
154241905|NCT00372905|Bortezomib|bortezomib|mesh-list
154241906|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154241907|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241908|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241909|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
154241910|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241911|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241912|NCT00384839|Azacitidine|azacitidine|mesh-list
154241913|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154241914|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
154241915|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241916|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393018|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154393019|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
154241917|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241918|NCT01046279|Bevacizumab|bevacizumab|mesh-list
154241919|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241920|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241921|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154241922|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154241923|NCT01046279|Growth Substances|growth substances|mesh-ancestor
154241924|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241925|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
154241927|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154241928|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
154241929|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241930|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154241931|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
154241932|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
154241933|NCT00384293|Vitamins|vitamins|mesh-ancestor
154241934|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
154241935|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241936|NCT01087866|Metformin|metformin|mesh-list
154241937|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154241938|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241939|NCT01090830|Paclitaxel|paclitaxel|mesh-list
154241940|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154241941|NCT01090830|Bevacizumab|bevacizumab|mesh-list
154241942|NCT01090830|Carboplatin|carboplatin|mesh-list
154241943|NCT01090830|Belinostat|belinostat|mesh-list
154241944|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154241945|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241946|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
154241947|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
154241948|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
154241949|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241950|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154241951|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154241952|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154241953|NCT01090830|Growth Substances|growth substances|mesh-ancestor
154241954|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241955|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
154241956|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154241957|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241958|NCT01084824|Cantharidin|cantharidin|mesh-list
154241959|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241960|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241961|NCT01088022|Dexamethasone|dexamethasone|mesh-list
154241962|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
154241963|NCT01088022|Aprepitant|aprepitant|mesh-list
154241964|NCT01088022|Palonosetron|palonosetron|mesh-list
154241965|NCT01088022|BB 1101|bb 1101|mesh-list
154241966|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154241967|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
154241968|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
154241969|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154241970|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241971|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154241972|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
154241973|NCT01088022|Hormones|hormones|mesh-ancestor
154241974|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154241975|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154241976|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241977|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
154241978|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154241979|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241980|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154241981|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154241982|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154241983|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154241984|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
154241985|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
154241986|NCT00067002|Melphalan|melphalan|mesh-list
154241987|NCT00067002|Thiotepa|thiotepa|mesh-list
154241988|NCT00067002|Rituximab|rituximab|mesh-list
154241989|NCT00067002|Fludarabine|fludarabine|mesh-list
154241990|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
154241991|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154241992|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
153988883|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241993|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154241994|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154241995|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154241996|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
154241997|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154241998|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154241999|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154242000|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154242001|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242002|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
154242003|NCT01084902|Latanoprost|latanoprost|mesh-list
154242004|NCT01084902|Brinzolamide|brinzolamide|mesh-list
154242005|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154242006|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154242007|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154242008|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242009|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242010|NCT01084980|Tacrolimus|tacrolimus|mesh-list
154242011|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242012|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
154242013|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242014|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154242015|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242016|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242017|NCT01085058|Lenograstim|lenograstim|mesh-list
154242018|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154242019|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
154242020|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242021|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
154242022|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154242023|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
154242024|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154242025|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242026|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154242027|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154242028|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154242029|NCT01088256|Etoricoxib|etoricoxib|mesh-list
154242030|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154242031|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154242032|NCT01088256|Analgesics|analgesics|mesh-ancestor
154242033|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
154242034|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242035|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242036|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242037|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242038|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154242039|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154242040|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242041|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242042|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154242043|NCT01326858|Ketotifen|ketotifen|mesh-list
154242044|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154242045|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154242046|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154242047|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154242048|NCT01326858|Analgesics|analgesics|mesh-ancestor
154242049|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
154242050|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242051|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242052|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242053|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242054|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154242055|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154242056|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154242057|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
154242058|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
154242059|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242060|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242061|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
154242062|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
154242063|NCT00091572|Temozolomide|temozolomide|mesh-list
154242064|NCT00091572|Dacarbazine|dacarbazine|mesh-list
154242065|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154242066|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
154242067|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242068|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116229|NCT00540514|Paclitaxel|paclitaxel|mesh-list
154242069|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
154242070|NCT01091220|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154242071|NCT01091220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242072|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242073|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
154242074|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242075|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242076|NCT00084266|Vancomycin|vancomycin|mesh-list
154242077|NCT00084266|Linezolid|linezolid|mesh-list
154242078|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242079|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242080|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154242081|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242082|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242083|NCT01086878|Trimethoprim|trimethoprim|mesh-list
154242084|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154242085|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
154242086|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154242087|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242088|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
154242089|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154242090|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154242091|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154242092|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242093|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242094|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154242095|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154242096|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154242097|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242098|NCT01086956|Sufentanil|sufentanil|mesh-list
154242099|NCT01086956|Ropivacaine|ropivacaine|mesh-list
154242100|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
154242101|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
154242102|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154242103|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242104|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
154242105|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242106|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154242107|NCT01086956|Narcotics|narcotics|mesh-ancestor
154242108|NCT01086956|Analgesics|analgesics|mesh-ancestor
154242109|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154242110|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154242111|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
154242112|NCT00091026|Bevacizumab|bevacizumab|mesh-list
154242113|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154242114|NCT00091026|Cetuximab|cetuximab|mesh-list
154242115|NCT00091026|Gemcitabine|gemcitabine|mesh-list
154242116|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154242117|NCT00091026|Antibodies|antibodies|mesh-list
154242118|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
154242119|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154242120|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242121|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154242122|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154242123|NCT00091026|Growth Substances|growth substances|mesh-ancestor
154242124|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242125|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
154242126|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
154242127|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242128|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
154242129|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242130|NCT00091026|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154242131|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154242132|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242133|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154242134|NCT01091376|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154242135|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154242136|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242137|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242138|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242139|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
154242140|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154242141|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
154242142|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154242143|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
154242144|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242145|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
154242146|NCT00100178|Daclizumab|daclizumab|mesh-list
154242147|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154242148|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242149|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154242150|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
154242151|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242152|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242153|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242154|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242155|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242156|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
154242157|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242158|NCT00099632|Ritonavir|ritonavir|mesh-list
154242159|NCT00099632|Lopinavir|lopinavir|mesh-list
154242160|NCT00099632|Tenofovir|tenofovir|mesh-list
154242161|NCT00099632|Lamivudine|lamivudine|mesh-list
154242162|NCT00099632|Emtricitabine|emtricitabine|mesh-list
154242163|NCT00099632|Zidovudine|zidovudine|mesh-list
154242164|NCT00099632|Nevirapine|nevirapine|mesh-list
154242165|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154242166|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154242167|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154242168|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154242169|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
154242170|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242171|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242172|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154242173|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154242174|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
154242175|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242176|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154242177|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154242178|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154242179|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242180|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
154242181|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154242182|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154242183|NCT01087190|Isoniazid|isoniazid|mesh-list
154242184|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
154242185|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242186|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242187|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154242188|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154242189|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
154242190|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242191|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154242192|NCT01090466|Sirolimus|sirolimus|mesh-list
154242193|NCT01090466|Gemcitabine|gemcitabine|mesh-list
154242194|NCT01090466|Temsirolimus|temsirolimus|mesh-list
154242195|NCT01090466|MTOR Inhibitors|mtor inhibitors|mesh-list
154242196|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242197|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242198|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
154242199|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242200|NCT01090466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154242201|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242202|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242203|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
154242204|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242205|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242206|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242207|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154242208|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
154242209|NCT04116398|Dexamethasone|dexamethasone|mesh-list
154242210|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242211|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
154242212|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
154242213|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242214|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242215|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154242216|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
154242218|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242219|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154242220|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242221|NCT00098774|Leucovorin|leucovorin|mesh-list
154242222|NCT00098774|Cytarabine|cytarabine|mesh-list
154242223|NCT00098774|Rituximab|rituximab|mesh-list
154242224|NCT00098774|Methotrexate|methotrexate|mesh-list
154242225|NCT00098774|Etoposide|etoposide|mesh-list
154242226|NCT00098774|Temozolomide|temozolomide|mesh-list
154242227|NCT00098774|Calcium|calcium|mesh-list
154242228|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
154242229|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154242230|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242231|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
154242232|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242233|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242234|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154242235|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154242236|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
154242237|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154242238|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242239|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
154242240|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242241|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
154242242|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242243|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154242244|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242245|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242246|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154242247|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154242248|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154242249|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
154242250|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242251|NCT00098774|Antidotes|antidotes|mesh-ancestor
154242252|NCT00098774|Protective Agents|protective agents|mesh-ancestor
154242253|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
154242254|NCT00098774|Vitamins|vitamins|mesh-ancestor
154242255|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
154242256|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154242257|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
154242258|NCT01081652|Progesterone|progesterone|mesh-list
154242259|NCT01081652|Progestins|progestins|mesh-ancestor
154242260|NCT01081652|Hormones|hormones|mesh-ancestor
154242261|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242262|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242263|NCT01087580|Prednisone|prednisone|mesh-list
154242264|NCT01087580|Docetaxel|docetaxel|mesh-list
154242265|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242266|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
154242267|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
154242268|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
154242269|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242270|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242271|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
154242272|NCT01087580|Hormones|hormones|mesh-ancestor
154242273|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242274|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242275|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154242276|NCT01087658|Calcium|calcium|mesh-list
154242277|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154242278|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242279|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154242280|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154242281|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242282|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
154242283|NCT01081730|Ustekinumab|ustekinumab|mesh-list
154242284|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
154242285|NCT01090700|Simeprevir|simeprevir|mesh-list
154242286|NCT01090700|Dexetimide|dexetimide|mesh-list
154242287|NCT01090700|Citalopram|citalopram|mesh-list
154242288|NCT01090700|Escitalopram|escitalopram|mesh-list
154242289|NCT01090700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154242290|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154242291|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154156375|NCT06269705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242292|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989200|NCT02579590|Hormones|hormones|mesh-ancestor
154242293|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242294|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
154242295|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242296|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154242297|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154242298|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
154242299|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
154242300|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242301|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154242302|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154242303|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
154242304|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154242305|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
154242306|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154242307|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
154242308|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242309|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
154242310|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242311|NCT03957902|Aspirin|aspirin|mesh-list
154242312|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154242313|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154242314|NCT03957902|Analgesics|analgesics|mesh-ancestor
154242315|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
154242316|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242317|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116490|NCT00747110|Budesonide|budesonide|mesh-list
154242318|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242319|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242320|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154242321|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154242322|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242323|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154242324|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154242325|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242326|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
154242327|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154242328|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
154242329|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242330|NCT01046435|Amoxicillin|amoxicillin|mesh-list
154242331|NCT01046435|Metronidazole|metronidazole|mesh-list
154242332|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242333|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242334|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154242335|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154242336|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
154242337|NCT00858364|Hematinics|hematinics|mesh-ancestor
154242338|NCT00382733|Topotecan|topotecan|mesh-list
154242339|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154242340|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154242341|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242342|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242343|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242344|NCT03992885|Pemetrexed|pemetrexed|mesh-list
154242345|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242346|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242347|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242348|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154242349|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242350|NCT03739294|Fluticasone|fluticasone|mesh-list
154242351|NCT03739294|Xhance|xhance|mesh-list
154242352|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242353|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154242354|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
154242355|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242356|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242357|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154242358|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
154242359|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
154242360|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154242361|NCT03732508|Fluorouracil|fluorouracil|mesh-list
154242362|NCT03732508|Irinotecan|irinotecan|mesh-list
154242363|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
154242364|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242365|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242366|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242367|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242368|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
154242369|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242370|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154242371|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154242372|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242373|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154242374|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
154242375|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242376|NCT00112437|Vitamin D|vitamin d|mesh-list
154242377|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
154242378|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
154242379|NCT00112437|Calcium|calcium|mesh-list
154242380|NCT00112437|Vitamins|vitamins|mesh-ancestor
154242381|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
154242382|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242383|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153730499|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154242384|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154242385|NCT00112437|Antacids|antacids|mesh-ancestor
154242386|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242387|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154242388|NCT03653416|Bupivacaine|bupivacaine|mesh-list
154242389|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
154242390|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
154242391|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154242392|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242393|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
154242394|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242395|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
154242396|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154242397|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
154242398|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242399|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
154242400|NCT01076673|Protective Agents|protective agents|mesh-ancestor
154242401|NCT00119379|Tenofovir|tenofovir|mesh-list
154242402|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
154242403|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242404|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154242405|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242406|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242407|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242408|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154242409|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154242410|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
154242411|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154242412|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242413|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154242414|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
154242415|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242416|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242417|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242418|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242419|NCT01079481|Everolimus|everolimus|mesh-list
154242420|NCT01079481|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154242421|NCT01079481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154242422|NCT01079481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242423|NCT01079481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242424|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242425|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
154242426|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242427|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242428|NCT03964779|Antibodies|antibodies|mesh-list
154242429|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
154242430|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
154242431|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242432|NCT00131937|Sorafenib|sorafenib|mesh-list
154242433|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242434|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154242435|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242436|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242437|NCT01079559|Tobramycin|tobramycin|mesh-list
154242438|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242439|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242440|NCT00131469|Teriparatide|teriparatide|mesh-list
154242441|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154242442|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242443|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153989378|NCT00934700|Xenon|xenon|mesh-list
154242444|NCT00372593|Cytarabine|cytarabine|mesh-list
154242445|NCT00372593|Etoposide|etoposide|mesh-list
154242446|NCT00372593|Daunorubicin|daunorubicin|mesh-list
154242447|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
154242448|NCT00372593|Asparaginase|asparaginase|mesh-list
154242449|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
154242450|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154242451|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242452|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154242453|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154242454|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242455|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253967|NCT01142258|Trazodone|trazodone|mesh-list
154242456|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242457|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
154242458|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
154242459|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242460|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242461|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
154242462|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242463|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154242464|NCT00372593|Analgesics|analgesics|mesh-ancestor
154242465|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
154242466|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242467|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154242468|NCT00372593|Immunotoxins|immunotoxins|mesh-ancestor
154242469|NCT00372593|Immunoconjugates|immunoconjugates|mesh-ancestor
154242470|NCT01324583|Prednisolone|prednisolone|mesh-list
154242471|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242472|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
154242474|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242475|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242476|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154242477|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242478|NCT00382109|Sirolimus|sirolimus|mesh-list
154242479|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
154242480|NCT00382109|Thiotepa|thiotepa|mesh-list
154242481|NCT00382109|Methotrexate|methotrexate|mesh-list
154242482|NCT00382109|Tacrolimus|tacrolimus|mesh-list
154242483|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242484|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
154242485|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242486|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242487|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154242488|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
154242489|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242490|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242491|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154242492|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154242493|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
154242494|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154242495|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242496|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
154242497|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
154242498|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242499|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154242500|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242501|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154242502|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242503|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242504|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154242505|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
154242506|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
154242507|NCT00381797|Bevacizumab|bevacizumab|mesh-list
154242508|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154242509|NCT00381797|Irinotecan|irinotecan|mesh-list
154242510|NCT00381797|Camptothecin|camptothecin|mesh-list
154242511|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
154242512|NCT00381797|Antibodies|antibodies|mesh-list
154242513|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
154242514|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154242515|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
154242516|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154242517|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242518|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154242519|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154242520|NCT00381797|Growth Substances|growth substances|mesh-ancestor
154242521|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242522|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
154242523|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
154242524|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154242525|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154242526|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242527|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242528|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154242529|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154242530|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
154242531|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
154242532|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242534|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
154242535|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242536|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242537|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242538|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
154242539|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
154242540|NCT03664024|Carboplatin|carboplatin|mesh-list
154242541|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
154242543|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242544|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154242545|NCT03664024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154242546|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242547|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242548|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154242549|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242550|NCT03735082|Paclitaxel|paclitaxel|mesh-list
154242551|NCT03735082|Carboplatin|carboplatin|mesh-list
154242552|NCT03735082|Apatinib|apatinib|mesh-list
154242553|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154242554|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242555|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
154242556|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
154242557|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
154242558|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242559|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154242560|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242561|NCT00381095|Pregabalin|pregabalin|mesh-list
154242562|NCT00381095|Analgesics|analgesics|mesh-ancestor
154242563|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
154242564|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242565|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242566|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
154242567|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154242568|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154242569|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242570|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154242571|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154242572|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154242573|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154242574|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154242575|NCT03737656|Progesterone|progesterone|mesh-list
154242576|NCT03737656|Progestins|progestins|mesh-ancestor
154242577|NCT03737656|Hormones|hormones|mesh-ancestor
154242578|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242579|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242580|NCT00112047|Tenofovir|tenofovir|mesh-list
154242581|NCT00112047|Lamivudine|lamivudine|mesh-list
154242582|NCT00112047|Emtricitabine|emtricitabine|mesh-list
154242583|NCT00112047|Zidovudine|zidovudine|mesh-list
154242584|NCT00112047|Efavirenz|efavirenz|mesh-list
154242585|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154242586|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
154242587|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116742|NCT00797160|Propofol|propofol|mesh-list
154242588|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154242589|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242590|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242591|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242592|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154242593|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154242594|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
154242595|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154242596|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154242597|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154242598|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154242599|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154242600|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154242601|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154242602|NCT03658876|Hematinics|hematinics|mesh-ancestor
154242603|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
154242604|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153538851|NCT01530217|Ibuprofen|ibuprofen|mesh-list
154242605|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242606|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
154242607|NCT03639922|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154242608|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154242609|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242610|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242611|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242612|NCT03734614|Aspirin|aspirin|mesh-list
154242613|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154242614|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154242615|NCT03734614|Analgesics|analgesics|mesh-ancestor
154242616|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
154242617|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242618|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242619|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242620|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242621|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154242622|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154242623|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242624|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154242625|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154242626|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242627|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
154242628|NCT00380393|Vaccines|vaccines|mesh-list
154242629|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
154242630|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242631|NCT00380081|Zolpidem|zolpidem|mesh-list
154242632|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154242633|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154242634|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154242635|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242636|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154242637|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
154242638|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
154242639|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242640|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242641|NCT03579940|Lasmiditan|lasmiditan|mesh-list
154242642|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154242643|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
154242644|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242645|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242646|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242647|NCT03732040|Fluorides|fluorides|mesh-list
154242648|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
154242649|NCT03732040|Protective Agents|protective agents|mesh-ancestor
154242650|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242651|NCT00098306|Maraviroc|maraviroc|mesh-list
154242652|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154242653|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154242654|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242655|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154242656|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154242657|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
154242658|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242659|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154242660|NCT03615040|Astegolimab|astegolimab|mesh-list
154242661|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154242662|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242663|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
154242664|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242665|NCT01090778|Hormones|hormones|mesh-list
154242666|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242667|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242668|NCT00068588|Capecitabine|capecitabine|mesh-list
154242669|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242670|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
154242671|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242672|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242673|NCT01088282|Dipivefrin|dipivefrin|mesh-list
154242674|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154242675|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
154242676|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242677|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242678|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242679|NCT01310296|Lofexidine|lofexidine|mesh-list
154242680|NCT01310296|Clonidine|clonidine|mesh-list
154242681|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154242682|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154242683|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242684|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
154242685|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242686|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154242687|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154242688|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154242689|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
154242690|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242691|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242692|NCT01310296|Analgesics|analgesics|mesh-ancestor
154242693|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
154242694|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
154242695|NCT03734068|Doxorubicin|doxorubicin|mesh-list
154242696|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154242697|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242698|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154242699|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154242700|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242701|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242702|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
154242703|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242704|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154242705|NCT03575806|Estrogens|estrogens|mesh-ancestor
154242706|NCT03575806|Hormones|hormones|mesh-ancestor
154242707|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242708|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154242709|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242710|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
154242711|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
154242712|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242713|NCT03729310|Triamcinolone|triamcinolone|mesh-list
154242714|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242715|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
154242716|NCT03729310|Hormones|hormones|mesh-ancestor
154242717|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242718|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242719|NCT03731494|Nickel|nickel|mesh-list
154242720|NCT03731494|Trace Elements|trace elements|mesh-ancestor
154242721|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
154242722|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242723|NCT00111813|Bortezomib|bortezomib|mesh-list
154242724|NCT00111813|Vorinostat|vorinostat|mesh-list
154242725|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242726|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154242727|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242728|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242729|NCT00118287|Etanercept|etanercept|mesh-list
154242730|NCT00118287|Azacitidine|azacitidine|mesh-list
154242731|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242732|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
154242733|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242734|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242735|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242736|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154242737|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154242738|NCT00118287|Analgesics|analgesics|mesh-ancestor
154242739|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
154242740|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242741|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242742|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242743|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242744|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154242745|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242746|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
154242747|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
154242748|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
154242749|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154242750|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242751|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242752|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
154242753|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154242754|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154242755|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242756|NCT01079715|Propranolol|propranolol|mesh-list
154242757|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154242758|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154242759|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
154242760|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242761|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242762|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242763|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154242764|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154242765|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
154242766|NCT00130689|Cetuximab|cetuximab|mesh-list
154242767|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154242768|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242769|NCT01326585|Dexamethasone|dexamethasone|mesh-list
154242770|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
154242771|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154242772|NCT01326585|BB 1101|bb 1101|mesh-list
154242773|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242774|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
154242775|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
154242776|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242777|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242778|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154242779|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
154242780|NCT01326585|Hormones|hormones|mesh-ancestor
154242781|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242782|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154242783|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242784|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
154242785|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242786|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242787|NCT03964935|Minocycline|minocycline|mesh-list
154242788|NCT03964935|Lycopene|lycopene|mesh-list
154242789|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242790|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242791|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242792|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
154242793|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242794|NCT03964935|Protective Agents|protective agents|mesh-ancestor
154242795|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242796|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154242797|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154242798|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242799|NCT03605212|Febuxostat|febuxostat|mesh-list
154242800|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
154242801|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242802|NCT00117507|Deferasirox|deferasirox|mesh-list
154242803|NCT00117507|Chelating Agents|chelating agents|mesh-list
154242804|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154242805|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
154242806|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242807|NCT03621046|Zolpidem|zolpidem|mesh-list
154242808|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154242809|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154242810|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154242811|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242812|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154242813|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
154242814|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
154242815|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242816|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242817|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
154242818|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154242819|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242820|NCT03603496|Nicotine|nicotine|mesh-list
154242821|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154242822|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
154242823|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242824|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242825|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154242826|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154242827|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
154242828|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242829|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242830|NCT00096135|Leucovorin|leucovorin|mesh-list
154242831|NCT00096135|Cytarabine|cytarabine|mesh-list
154242832|NCT00096135|Dexamethasone|dexamethasone|mesh-list
154242833|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
154242834|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154242835|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154242836|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154242837|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
154242838|NCT00096135|Methotrexate|methotrexate|mesh-list
154242839|NCT00096135|Etoposide|etoposide|mesh-list
154242840|NCT00096135|Vincristine|vincristine|mesh-list
154242841|NCT00096135|Daunorubicin|daunorubicin|mesh-list
154242842|NCT00096135|Asparaginase|asparaginase|mesh-list
154242843|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
154242844|NCT00096135|Pegaspargase|pegaspargase|mesh-list
154242845|NCT00096135|Lenograstim|lenograstim|mesh-list
154242846|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
154242847|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154242848|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
154242849|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242850|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154242851|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154242852|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
154242853|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242854|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242855|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154242856|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154242857|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
154242858|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
154242859|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242860|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154242861|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
154242862|NCT00096135|Hormones|hormones|mesh-ancestor
154242863|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242864|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154242865|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154242866|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
154242867|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154242868|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154242869|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
154242870|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
154242871|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242872|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154242873|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242874|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154242875|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154242876|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154242877|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
154242878|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242879|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154242880|NCT00096135|Antidotes|antidotes|mesh-ancestor
154242881|NCT00096135|Protective Agents|protective agents|mesh-ancestor
154242882|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
154242883|NCT00096135|Vitamins|vitamins|mesh-ancestor
154242884|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
154242885|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
154242886|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
154242887|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
154242888|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154242889|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154242890|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154242891|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154242892|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154242893|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242894|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242895|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
154242896|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242898|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154242899|NCT00116649|Imiquimod|imiquimod|mesh-list
154242900|NCT00116649|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154242901|NCT00116649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242902|NCT00116649|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154242903|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
154242904|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242905|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154242906|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242907|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
154242908|NCT01080651|Voriconazole|voriconazole|mesh-list
154242909|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
154242910|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242911|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154242912|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154242913|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242914|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242915|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154242916|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
154242917|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242918|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242919|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154242920|NCT01080729|Hormones|hormones|mesh-list
154242921|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154242922|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242923|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242924|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
154242925|NCT03962907|Mupirocin|mupirocin|mesh-list
154242926|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154242927|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242928|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
154242929|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154242930|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154242931|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242932|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242933|NCT00083889|Interferons|interferons|mesh-list
154242934|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
154242935|NCT00083889|Sunitinib|sunitinib|mesh-list
154242936|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242937|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
154242938|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154242939|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
154242940|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242941|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154242942|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154242943|NCT00083889|Growth Substances|growth substances|mesh-ancestor
154242944|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154242945|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154242946|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242947|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242948|NCT03639532|Tacrine|tacrine|mesh-list
154242949|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154242950|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242951|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242952|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
154242953|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154242954|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242955|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154242956|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
154242957|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242958|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
154242959|NCT03571516|Teduglutide|teduglutide|mesh-list
154242960|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154242961|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154242962|NCT03571516|Protective Agents|protective agents|mesh-ancestor
154242963|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242964|NCT03600376|Dantrolene|dantrolene|mesh-list
154242965|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154242966|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242967|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154242968|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154242970|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
154242971|NCT03961659|Acarbose|acarbose|mesh-list
154242972|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154242973|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242974|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154242975|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242976|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154242977|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154242978|NCT03599362|Nivolumab|nivolumab|mesh-list
154242979|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154242980|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154242981|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154242982|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154242983|NCT03741309|Calcium|calcium|mesh-list
154242984|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154242985|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242986|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
154242987|NCT00082407|Exenatide|exenatide|mesh-list
154242988|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
154242989|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154242990|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154242991|NCT00082407|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154242992|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154242993|NCT00082407|Incretins|incretins|mesh-ancestor
154242994|NCT00082407|Hormones|hormones|mesh-ancestor
154242995|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154242996|NCT01080963|Daptomycin|daptomycin|mesh-list
154242997|NCT01080963|Cefuroxime|cefuroxime|mesh-list
154242998|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
154242999|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154243000|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243001|NCT01083381|Risperidone|risperidone|mesh-list
154243002|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154243003|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
154243004|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243005|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243006|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243007|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154243008|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154243009|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243010|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154243011|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154243012|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
154243013|NCT01087359|Melatonin|melatonin|mesh-list
154243014|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
154243015|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243016|NCT01087359|Protective Agents|protective agents|mesh-ancestor
154243017|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243018|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243019|NCT01087437|Calcium|calcium|mesh-list
154243020|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154243021|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243022|NCT01083537|Paclitaxel|paclitaxel|mesh-list
154243023|NCT01083537|Cisplatin|cisplatin|mesh-list
154243024|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154243025|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243026|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
154243027|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
154243028|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
154243029|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243030|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
154243031|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
154243032|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
154243033|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
154243034|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243035|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
154243036|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154243037|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154243038|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243039|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154243040|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
154243041|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243043|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
154243044|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
153989932|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154243045|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
154243046|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154243047|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154243048|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154243049|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154243050|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243051|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
154243052|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243053|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243054|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154243055|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243056|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
154243057|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
154243058|NCT03569098|Coagulants|coagulants|mesh-ancestor
154243059|NCT03727282|Dobutamine|dobutamine|mesh-list
154243060|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154243061|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
154243062|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
154243063|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243064|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243065|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154243066|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154243067|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154243068|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
154243069|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243070|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243071|NCT03727282|Protective Agents|protective agents|mesh-ancestor
154243072|NCT03568942|Gepotidacin|gepotidacin|mesh-list
154243073|NCT03568942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243074|NCT03568942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243075|NCT03568942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243076|NCT03568942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243077|NCT00110019|Paclitaxel|paclitaxel|mesh-list
154243078|NCT00110019|Carboplatin|carboplatin|mesh-list
154243079|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154243080|NCT00110019|Sorafenib|sorafenib|mesh-list
154243081|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154243082|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243083|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
154243084|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
154243085|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
154243086|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243087|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154243088|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243089|NCT03642262|Guaifenesin|guaifenesin|mesh-list
154243090|NCT03642262|Expectorants|expectorants|mesh-ancestor
154243091|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
154243092|NCT03727048|Ketorolac|ketorolac|mesh-list
154243093|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154243094|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154243095|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154243096|NCT03727048|Analgesics|analgesics|mesh-ancestor
154243097|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
154243098|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243099|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243100|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154243101|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154243102|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154243103|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243104|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243105|NCT00109707|Nilotinib|nilotinib|mesh-list
154243106|NCT00109707|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154243107|NCT00109707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154243108|NCT00109707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243109|NCT00109707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243110|NCT00095979|Epothilones|epothilones|mesh-list
154243111|NCT00095979|Epothilone B|epothilone b|mesh-list
154243112|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
154243113|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
154243114|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
154243115|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243116|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990024|NCT00664677|Masoprocol|masoprocol|mesh-list
154243117|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154243118|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154243119|NCT01087593|Estradiol|estradiol|mesh-list
154243120|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154243121|NCT01087593|Estrogens|estrogens|mesh-ancestor
154243122|NCT01087593|Hormones|hormones|mesh-ancestor
154243123|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154243124|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243125|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154243126|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
154243127|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154243128|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154243129|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
154243130|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154243131|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243132|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154243133|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243134|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243135|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243136|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243137|NCT01087749|Losartan|losartan|mesh-list
154243138|NCT01087749|Propranolol|propranolol|mesh-list
154243139|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154243140|NCT01087749|Eprosartan|eprosartan|mesh-list
154243141|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154243142|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154243143|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154243144|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154243145|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243146|NCT01087749|Diuretics|diuretics|mesh-ancestor
154243147|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
154243148|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243149|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154243150|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154243151|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154243152|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154243153|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
154243154|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243155|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
154243156|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
154243157|NCT00108069|Tamoxifen|tamoxifen|mesh-list
154243158|NCT00108069|Bortezomib|bortezomib|mesh-list
154243159|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243160|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154243161|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
154243162|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154243163|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243164|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154243165|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154243166|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154243167|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154243168|NCT00079274|Leucovorin|leucovorin|mesh-list
154243169|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154243170|NCT00079274|Cetuximab|cetuximab|mesh-list
154243171|NCT00079274|Fluorouracil|fluorouracil|mesh-list
154243172|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
154243173|NCT00079274|Irinotecan|irinotecan|mesh-list
154243174|NCT00079274|Antibodies|antibodies|mesh-list
154243175|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
154243176|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154243177|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
154243178|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
154243179|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243180|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243181|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
154243182|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243183|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154243184|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154243185|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154243186|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243187|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243188|NCT00079274|Antidotes|antidotes|mesh-ancestor
154243189|NCT00079274|Protective Agents|protective agents|mesh-ancestor
154243190|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
154243192|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
154243193|NCT01081964|Levofloxacin|levofloxacin|mesh-list
154243194|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
154243195|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154243196|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243197|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154243198|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154243199|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243200|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243201|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243202|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243203|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154243204|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154243205|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154243206|NCT00079040|Bevacizumab|bevacizumab|mesh-list
154243207|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154243209|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
154243210|NCT00079040|Antibodies|antibodies|mesh-list
154243211|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
154243212|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154243213|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243214|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243215|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243216|NCT00079040|Growth Substances|growth substances|mesh-ancestor
154243217|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243218|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243219|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
154243220|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154243221|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154243222|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243223|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243224|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243225|NCT01088516|Ritonavir|ritonavir|mesh-list
154243226|NCT01088516|Lopinavir|lopinavir|mesh-list
154243227|NCT01088516|Zidovudine|zidovudine|mesh-list
154243228|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154243229|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154243230|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
154243231|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243232|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243233|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154243234|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154243235|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
154243236|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243237|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154243238|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154243239|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
154243240|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154243241|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154243242|NCT00078806|Etanercept|etanercept|mesh-list
154243243|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154243244|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154243245|NCT00078806|Analgesics|analgesics|mesh-ancestor
154243246|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
154117409|NCT04003402|Analgesics|analgesics|mesh-ancestor
154243247|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243248|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243249|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154243250|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154243251|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154243252|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154243253|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
154243254|NCT00078338|Interferons|interferons|mesh-list
154243255|NCT00078338|Interferon-beta|interferon-beta|mesh-list
154243256|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
154243257|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
154243258|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
154243259|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243260|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
154243261|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243262|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
154243263|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243264|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154243265|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154243266|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154243267|NCT01088594|Pioglitazone|pioglitazone|mesh-list
154243268|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
154157359|NCT05852262|Cephalexin|cephalexin|mesh-list
153990150|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154243269|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154243270|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243271|NCT01082120|Pioglitazone|pioglitazone|mesh-list
154243272|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154243273|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243274|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154243275|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154243276|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
154243277|NCT03808298|Balovaptan|balovaptan|mesh-list
154243278|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154243279|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154243280|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243281|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154243282|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243283|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243284|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243285|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243286|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154243287|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
154243288|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154243289|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243290|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154243291|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154243292|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154243293|NCT03808298|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154243294|NCT03808298|Natriuretic Agents|natriuretic agents|mesh-ancestor
154243295|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154243296|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
154243297|NCT00077636|Ribavirin|ribavirin|mesh-list
154243298|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
154243299|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243300|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
154243301|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243302|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
154243303|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243304|NCT01082198|Vaccines|vaccines|mesh-list
154243305|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154243306|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
154243307|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243308|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154243309|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
154243310|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
154243311|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154243312|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154243313|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243314|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243315|NCT01091012|Urological Agents|urological agents|mesh-ancestor
154243316|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154243317|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154243318|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154243319|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243320|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243321|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154243322|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154243323|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154243324|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154243325|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
154243326|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243327|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243328|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154243329|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154243330|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
154243331|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154243332|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154243333|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
154243335|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243336|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243337|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243338|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154243339|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154243340|NCT00095199|Docetaxel|docetaxel|mesh-list
154243341|NCT00095199|Pemetrexed|pemetrexed|mesh-list
154243343|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243344|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
153990227|NCT00781417|Vitamin D|vitamin d|mesh-list
154243346|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
154243347|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243348|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243349|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154243350|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154243351|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154243352|NCT00075764|Fulvestrant|fulvestrant|mesh-list
154243353|NCT00075764|Anastrozole|anastrozole|mesh-list
154243354|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154243355|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243356|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154243357|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154243358|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
154243359|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154243360|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243361|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154243362|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154243363|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243364|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243365|NCT03567616|Dexamethasone|dexamethasone|mesh-list
154243366|NCT03567616|Venetoclax|venetoclax|mesh-list
154243367|NCT03567616|Pomalidomide|pomalidomide|mesh-list
154243368|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154243369|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
154243370|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
154243371|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243372|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243373|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154243374|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
154243375|NCT03567616|Hormones|hormones|mesh-ancestor
154243376|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154243377|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154243378|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243379|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
154243380|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243381|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243382|NCT03567616|Growth Substances|growth substances|mesh-ancestor
154243383|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243384|NCT03567382|Tenofovir|tenofovir|mesh-list
154243385|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
154243386|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243387|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154243388|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154243389|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243390|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243391|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154243392|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154243393|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154243394|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154243395|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154243396|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154243397|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154243398|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154243399|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243400|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243401|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243402|NCT03730714|Epinephrine|epinephrine|mesh-list
154243403|NCT03730714|Racepinephrine|racepinephrine|mesh-list
154243404|NCT03730714|Morphine|morphine|mesh-list
154243405|NCT03730714|Anesthetics|anesthetics|mesh-list
154243406|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
154243407|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
154243408|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154243409|NCT03730714|Narcotics|narcotics|mesh-ancestor
154243410|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243411|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243412|NCT03730714|Analgesics|analgesics|mesh-ancestor
154243413|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
154243414|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243415|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154243416|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154243418|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243419|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243420|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154243421|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154243423|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154243424|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
154243425|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
154243426|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
154243427|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154243428|NCT00106353|Temsirolimus|temsirolimus|mesh-list
154243429|NCT00106353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154243430|NCT00106353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154243431|NCT00106353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243432|NCT00106353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243433|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154243434|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
154243435|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243436|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243437|NCT01087983|Metformin|metformin|mesh-list
154243438|NCT01087983|Sirolimus|sirolimus|mesh-list
154243439|NCT01087983|Lapatinib|lapatinib|mesh-list
154243440|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154243441|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243442|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154243443|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243444|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154243445|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243446|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
154243447|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154243448|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
154243449|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154243450|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243451|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243452|NCT01087983|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154243453|NCT00080301|Capecitabine|capecitabine|mesh-list
154243454|NCT00080301|Epothilones|epothilones|mesh-list
154243455|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154243456|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
154243457|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243458|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243459|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
154243460|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
154243461|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
154243462|NCT03961503|Vancomycin|vancomycin|mesh-list
154243463|NCT03961503|Daptomycin|daptomycin|mesh-list
154243464|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154243465|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243466|NCT00079677|Modafinil|modafinil|mesh-list
154243467|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154243468|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243469|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154243470|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154243471|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154243472|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243473|NCT01081353|Aspirin|aspirin|mesh-list
154243474|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154243475|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154243476|NCT01081353|Analgesics|analgesics|mesh-ancestor
154243477|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
154243478|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243479|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243480|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154243481|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154243482|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154243483|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154243484|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243485|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154243486|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154243487|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243488|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
154243489|NCT00095121|Lamivudine|lamivudine|mesh-list
154243490|NCT00095121|Adefovir|adefovir|mesh-list
154243491|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154243492|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154243493|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154243494|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243495|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243496|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
154243497|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243498|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154243499|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154243500|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
154243501|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154243502|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
154243503|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243504|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243505|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243506|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
154243507|NCT01084473|Morphine|morphine|mesh-list
154243508|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154243509|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243510|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243511|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154243512|NCT01084473|Analgesics|analgesics|mesh-ancestor
154243513|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
154243514|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243515|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154243516|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154243517|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154243518|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
154243519|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243520|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243521|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154243522|NCT01084473|Narcotics|narcotics|mesh-ancestor
154243523|NCT01088373|Lenalidomide|lenalidomide|mesh-list
154243524|NCT01088373|Azacitidine|azacitidine|mesh-list
154243525|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
154243526|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243527|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243528|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243529|NCT01088373|Growth Substances|growth substances|mesh-ancestor
154243530|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243531|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243532|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154243533|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
154243534|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243535|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243536|NCT01088451|Insulin|insulin|mesh-list
154243537|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154243538|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243539|NCT00075218|Sunitinib|sunitinib|mesh-list
154243540|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243541|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243542|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243543|NCT00075218|Growth Substances|growth substances|mesh-ancestor
154243544|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243545|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243546|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154243547|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243548|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243549|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
154243550|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154243551|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154243552|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243553|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
154243554|NCT01089140|Coagulants|coagulants|mesh-ancestor
154243555|NCT00094653|Ipilimumab|ipilimumab|mesh-list
154243556|NCT00094653|Vaccines|vaccines|mesh-list
154243557|NCT00094653|Antibodies|antibodies|mesh-list
154243558|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154243559|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
154243560|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243561|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154243562|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243563|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154243564|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243565|NCT00104247|Verapamil|verapamil|mesh-list
154243566|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154243567|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153990451|NCT00787657|Interferons|interferons|mesh-list
154243568|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154243569|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243570|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154243571|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243572|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
154243573|NCT05665348|Bevacizumab|bevacizumab|mesh-list
154243575|NCT05665348|Atezolizumab|atezolizumab|mesh-list
154243576|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154243577|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154243578|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243579|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243580|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243581|NCT05665348|Growth Substances|growth substances|mesh-ancestor
154243582|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243583|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243584|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154243585|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243586|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
154243587|NCT03726736|Docetaxel|docetaxel|mesh-list
154243588|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243589|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
154243590|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
154243591|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
154243592|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243593|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154243594|NCT03591406|Hematinics|hematinics|mesh-ancestor
154243595|NCT03726580|Propofol|propofol|mesh-list
154243596|NCT03726580|Sevoflurane|sevoflurane|mesh-list
154243597|NCT03726580|Isoflurane|isoflurane|mesh-list
154243598|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154243599|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243600|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243601|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154243602|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
154243603|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
154243604|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154243605|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154243606|NCT03730558|Aflibercept|aflibercept|mesh-list
154243607|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243608|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243609|NCT03730558|Growth Substances|growth substances|mesh-ancestor
154243610|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243611|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243612|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243613|NCT03588910|Acetaminophen|acetaminophen|mesh-list
154243614|NCT03588910|Ibuprofen|ibuprofen|mesh-list
154243615|NCT03588910|Oxycodone|oxycodone|mesh-list
154243616|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154243617|NCT03588910|Analgesics|analgesics|mesh-ancestor
154243618|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
154243619|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243620|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243621|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
154243622|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154243623|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154243624|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154243625|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154243626|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243627|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243628|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154243629|NCT03588910|Narcotics|narcotics|mesh-ancestor
154243630|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243631|NCT03730402|Bupivacaine|bupivacaine|mesh-list
154243632|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
154243633|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
154243634|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243635|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243636|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
154243637|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243639|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154243640|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154243641|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990522|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
154243642|NCT00103857|Incretins|incretins|mesh-ancestor
154243643|NCT00103857|Hormones|hormones|mesh-ancestor
154243644|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154243645|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154243646|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
154243647|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243648|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243649|NCT03587584|Bupivacaine|bupivacaine|mesh-list
154243650|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
154243651|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
154243652|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243653|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243654|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
154243655|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243656|NCT03586726|Rifampin|rifampin|mesh-list
154243657|NCT03586726|Balovaptan|balovaptan|mesh-list
154243658|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154243659|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
154243660|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154243661|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243662|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
154243663|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154243664|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243665|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243666|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154243667|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154243668|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154243669|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154243670|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154243671|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154243672|NCT03586726|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154243673|NCT03586726|Natriuretic Agents|natriuretic agents|mesh-ancestor
154243674|NCT03586726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243675|NCT03721900|Ketamine|ketamine|mesh-list
154243676|NCT03721900|Analgesics|analgesics|mesh-ancestor
154243677|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
154243678|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117825|NCT01057849|Olanzapine|olanzapine|mesh-list
154243679|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243680|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154243681|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154243682|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
154243683|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
154243684|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243685|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154243686|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154243687|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243688|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243689|NCT03585712|Norgestrel|norgestrel|mesh-list
154243690|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154243691|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154243692|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154243693|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
154243694|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154243695|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243696|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154243697|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154243698|NCT01082510|Tegafur|tegafur|mesh-list
154243699|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154243700|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
154243701|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243702|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243703|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154243704|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154243705|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154243706|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
154243707|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243708|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243709|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243710|NCT03583372|Urological Agents|urological agents|mesh-ancestor
154243711|NCT01091324|Levomethorphan|levomethorphan|mesh-list
154243712|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
154243713|NCT01091324|Silymarin|silymarin|mesh-list
154243714|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
153990596|NCT02535273|Analgesics|analgesics|mesh-ancestor
154243715|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
154243716|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154243717|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154243718|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243719|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243720|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243721|NCT01091324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154243722|NCT01091324|Narcotics|narcotics|mesh-ancestor
154243723|NCT01091324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243724|NCT01091324|Analgesics|analgesics|mesh-ancestor
154243725|NCT01091324|Sensory System Agents|sensory system agents|mesh-ancestor
154243726|NCT01091324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243727|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
154243728|NCT01091324|Protective Agents|protective agents|mesh-ancestor
154243729|NCT05782426|Paclitaxel|paclitaxel|mesh-list
154243730|NCT05782426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154243731|NCT05782426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243732|NCT05782426|Tubulin Modulators|tubulin modulators|mesh-ancestor
154243733|NCT05782426|Antimitotic Agents|antimitotic agents|mesh-ancestor
154243734|NCT05782426|Mitosis Modulators|mitosis modulators|mesh-ancestor
154243735|NCT05782426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243736|NCT05782374|Ibrutinib|ibrutinib|mesh-list
154243737|NCT05782374|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154243738|NCT05782374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154243739|NCT05782374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243740|NCT05782374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243741|NCT05782348|Listerine|listerine|mesh-list
154243742|NCT05782348|Sodium Fluoride|sodium fluoride|mesh-list
154243743|NCT05782348|Cariostatic Agents|cariostatic agents|mesh-ancestor
154243744|NCT05782348|Protective Agents|protective agents|mesh-ancestor
154243745|NCT05782348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243746|NCT05782348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154243747|NCT05782348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243748|NCT05782192|Alogliptin|alogliptin|mesh-list
154243749|NCT05782192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154243750|NCT05782192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243751|NCT05782192|Incretins|incretins|mesh-ancestor
154243752|NCT05782192|Hormones|hormones|mesh-ancestor
154243753|NCT05782192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154243754|NCT05782192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154243755|NCT05782192|Protease Inhibitors|protease inhibitors|mesh-ancestor
154243756|NCT05782192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243757|NCT05782192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243758|NCT05781997|Mydriatics|mydriatics|mesh-list
154243759|NCT05781997|Autonomic Agents|autonomic agents|mesh-ancestor
154243760|NCT05781997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243761|NCT05781997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243762|NCT05781854|Dexmedetomidine|dexmedetomidine|mesh-list
154243763|NCT05781854|Bupivacaine|bupivacaine|mesh-list
154243764|NCT05781854|Anesthetics, Local|anesthetics, local|mesh-ancestor
154243765|NCT05781854|Anesthetics|anesthetics|mesh-ancestor
154243766|NCT05781854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243767|NCT05781854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243768|NCT05781854|Sensory System Agents|sensory system agents|mesh-ancestor
154243769|NCT05781854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243770|NCT05781854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154243771|NCT05781854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154243772|NCT05781854|Analgesics|analgesics|mesh-ancestor
154243773|NCT05781854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154243774|NCT05781854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154243775|NCT05781854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154243776|NCT05781854|Adrenergic Agents|adrenergic agents|mesh-ancestor
154243777|NCT05781854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243778|NCT05781854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243779|NCT05781685|Testosterone|testosterone|mesh-list
154243780|NCT05781685|Androgens|androgens|mesh-ancestor
154243781|NCT05781685|Hormones|hormones|mesh-ancestor
154243782|NCT05781685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154243783|NCT05781685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243784|NCT05781633|Bevacizumab|bevacizumab|mesh-list
154243785|NCT05781633|Etoposide|etoposide|mesh-list
154243786|NCT05781633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154243787|NCT05781633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243788|NCT05781633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243789|NCT05781633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243790|NCT05781633|Growth Substances|growth substances|mesh-ancestor
154243791|NCT05781633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243792|NCT05781633|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243793|NCT05781633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154243794|NCT05781633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154243795|NCT05781633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243796|NCT05781633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243797|NCT05781633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243798|NCT05781529|Hyaluronic Acid|hyaluronic acid|mesh-list
154243799|NCT05781529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154243800|NCT05781529|Immunologic Factors|immunologic factors|mesh-ancestor
154243801|NCT05781529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243802|NCT05781529|Viscosupplements|viscosupplements|mesh-ancestor
154243803|NCT05781529|Protective Agents|protective agents|mesh-ancestor
154243804|NCT05780905|Semaglutide|semaglutide|mesh-list
154243805|NCT05780905|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154243806|NCT05780905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154243807|NCT05780905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243808|NCT05780554|Cyclophosphamide|cyclophosphamide|mesh-list
154243809|NCT05780554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154243810|NCT05780554|Immunologic Factors|immunologic factors|mesh-ancestor
154243811|NCT05780554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243812|NCT05780554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154243813|NCT05780554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154243814|NCT05780554|Alkylating Agents|alkylating agents|mesh-ancestor
154243815|NCT05780554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243816|NCT05780554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243817|NCT05780554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154243818|NCT05869578|Anesthetics|anesthetics|mesh-list
154243819|NCT05869578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243820|NCT05869578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243821|NCT05869227|Capecitabine|capecitabine|mesh-list
154243822|NCT05869227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154243823|NCT05869227|Antimetabolites|antimetabolites|mesh-ancestor
154243824|NCT05869227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243825|NCT05869227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243827|NCT05869201|Immunologic Factors|immunologic factors|mesh-ancestor
154243828|NCT05869201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243829|NCT05869097|Trifluridine|trifluridine|mesh-list
154243830|NCT05869097|Bevacizumab|bevacizumab|mesh-list
154243831|NCT05869097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154243832|NCT05869097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243833|NCT05869097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243834|NCT05869097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243835|NCT05869097|Growth Substances|growth substances|mesh-ancestor
154243836|NCT05869097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243837|NCT05869097|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243838|NCT05869097|Antimetabolites|antimetabolites|mesh-ancestor
154243839|NCT05869097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243840|NCT05869097|Antiviral Agents|antiviral agents|mesh-ancestor
154243841|NCT05869097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243842|NCT05868993|Ropivacaine|ropivacaine|mesh-list
154243843|NCT05868993|Anesthetics, Local|anesthetics, local|mesh-ancestor
154243844|NCT05868993|Anesthetics|anesthetics|mesh-ancestor
154243845|NCT05868993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243846|NCT05868993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243847|NCT05868993|Sensory System Agents|sensory system agents|mesh-ancestor
154243848|NCT05868993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243849|NCT05868967|Fexuprazan|fexuprazan|mesh-list
154243850|NCT05868967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154243851|NCT05868720|Risperidone|risperidone|mesh-list
154243852|NCT05868720|Aripiprazole|aripiprazole|mesh-list
154243853|NCT05868720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154243854|NCT05868720|Serotonin Agents|serotonin agents|mesh-ancestor
154118007|NCT00935961|Docetaxel|docetaxel|mesh-list
154243855|NCT05868720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243856|NCT05868720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243857|NCT05868720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243858|NCT05868720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154243859|NCT05868720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154243860|NCT05868720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243861|NCT05868720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153990746|NCT00996281|Diuretics|diuretics|mesh-ancestor
154393020|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154243862|NCT05868720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154243863|NCT05868720|Dopamine Agents|dopamine agents|mesh-ancestor
154243864|NCT05868720|Antidepressive Agents|antidepressive agents|mesh-ancestor
154243865|NCT05868720|Dopamine Agonists|dopamine agonists|mesh-ancestor
154243866|NCT05868720|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154243867|NCT05868720|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154243868|NCT05868720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154243869|NCT05868720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154243870|NCT05868395|Rituximab|rituximab|mesh-list
154243871|NCT05868395|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154243872|NCT05868395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154243873|NCT05868395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243874|NCT05868395|Immunologic Factors|immunologic factors|mesh-ancestor
154243875|NCT05868395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243876|NCT05868395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154243877|NCT05868395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154243878|NCT05868395|Alkylating Agents|alkylating agents|mesh-ancestor
154243879|NCT05868395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243880|NCT05868317|Fluorouracil|fluorouracil|mesh-list
154243881|NCT05868317|Irinotecan|irinotecan|mesh-list
154243882|NCT05868317|Folfirinox|folfirinox|mesh-list
154243883|NCT05868317|Oxaliplatin|oxaliplatin|mesh-list
154243884|NCT05868317|Antimetabolites|antimetabolites|mesh-ancestor
154243885|NCT05868317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243886|NCT05868317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154243887|NCT05868317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243888|NCT05868317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154243889|NCT05868317|Immunologic Factors|immunologic factors|mesh-ancestor
154243890|NCT05868317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243891|NCT05868317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154243892|NCT05868317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243893|NCT05868317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243894|NCT05868200|Listerine|listerine|mesh-list
154243895|NCT05868200|Sodium Fluoride|sodium fluoride|mesh-list
154243896|NCT05868200|Cariostatic Agents|cariostatic agents|mesh-ancestor
154243897|NCT05868200|Protective Agents|protective agents|mesh-ancestor
154243898|NCT05868200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243899|NCT05868200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154243900|NCT05868200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154243901|NCT05865080|Ketamine|ketamine|mesh-list
154243902|NCT05865080|Analgesics|analgesics|mesh-ancestor
154243903|NCT05865080|Sensory System Agents|sensory system agents|mesh-ancestor
154243904|NCT05865080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243905|NCT05865080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243906|NCT05865080|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154243907|NCT05865080|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154243908|NCT05865080|Anesthetics, General|anesthetics, general|mesh-ancestor
154243909|NCT05865080|Anesthetics|anesthetics|mesh-ancestor
154243910|NCT05865080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243911|NCT05865080|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154243912|NCT05865080|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154243913|NCT05865080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243914|NCT05865080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243915|NCT05863286|Botulinum Toxins|botulinum toxins|mesh-list
154243916|NCT05863286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154243917|NCT05863286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154243918|NCT05863286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154243919|NCT05863286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154253993|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243920|NCT05863286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243921|NCT05863286|Cholinergic Agents|cholinergic agents|mesh-ancestor
154243922|NCT05863286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243923|NCT05863286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243924|NCT05863286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154243925|NCT05863286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154243927|NCT05768373|Cariostatic Agents|cariostatic agents|mesh-ancestor
154243928|NCT05768373|Protective Agents|protective agents|mesh-ancestor
154243929|NCT05768373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243930|NCT05734690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154243931|NCT05734690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154243932|NCT05734690|Adrenergic Agents|adrenergic agents|mesh-ancestor
154243933|NCT05734690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243934|NCT05734690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243935|NCT05734690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243936|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154243939|NCT05642572|Antibodies|antibodies|mesh-list
154243940|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
154243941|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154243942|NCT05642572|Lexatumumab|lexatumumab|mesh-list
154243943|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
154243944|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243945|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243946|NCT05642572|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154243947|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154243948|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118095|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154243949|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243950|NCT05642572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154243951|NCT05642572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154243952|NCT05642572|Growth Substances|growth substances|mesh-ancestor
154243953|NCT05642572|Growth Inhibitors|growth inhibitors|mesh-ancestor
154243954|NCT05518799|Midazolam|midazolam|mesh-list
154243955|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154243956|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154243957|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243958|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243959|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154243960|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154243961|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154243962|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154243963|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
154243964|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
154243965|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
154243966|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
154243967|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154243968|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243969|NCT05447702|Paclitaxel|paclitaxel|mesh-list
154243970|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
154243971|NCT05447702|Apatinib|apatinib|mesh-list
154243972|NCT05447702|Epirubicin|epirubicin|mesh-list
154243973|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154243974|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154243975|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
154243976|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
154243977|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
154243978|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154243979|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154243980|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
154243981|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243982|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154243983|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154243984|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
154243985|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154243986|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154243987|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154243988|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154243989|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154243990|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154243991|NCT05418010|Natalizumab|natalizumab|mesh-list
154243992|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
154243993|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243994|NCT05391971|Bupivacaine|bupivacaine|mesh-list
154243995|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
154243997|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154243998|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154243999|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
154244000|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244001|NCT05178550|Heparin|heparin|mesh-list
154244002|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
154244003|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154244004|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154244005|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244006|NCT05168566|Maleic acid|maleic acid|mesh-list
154244007|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244008|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244009|NCT05085782|Propranolol|propranolol|mesh-list
154244010|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154158118|NCT04904588|Melphalan|melphalan|mesh-list
154244011|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154244013|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244014|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244015|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244016|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154244017|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154244019|NCT04732195|Pilocarpine|pilocarpine|mesh-list
154244020|NCT04732195|Miotics|miotics|mesh-ancestor
154244021|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
154244022|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244023|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244024|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154244025|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154244026|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
154244027|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244028|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244029|NCT04704921|Ranibizumab|ranibizumab|mesh-list
154244030|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154244031|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154244032|NCT04704921|Growth Substances|growth substances|mesh-ancestor
154244033|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244034|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
154244035|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244036|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
154244037|NCT04703426|Sargramostim|sargramostim|mesh-list
154244038|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244039|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244040|NCT04703426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244041|NCT04703426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244042|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
154244043|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244044|NCT04681482|Apixaban|apixaban|mesh-list
154244045|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154244046|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
154244047|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154244048|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
154244049|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244050|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244051|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
154244052|NCT04635644|Morphine|morphine|mesh-list
154244053|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154244054|NCT04635644|Narcotics|narcotics|mesh-ancestor
154244055|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244056|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244057|NCT04635644|Analgesics|analgesics|mesh-ancestor
154244058|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
154244059|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244060|NCT04580277|Tofacitinib|tofacitinib|mesh-list
154244061|NCT04580277|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154118214|NCT00322621|Analgesics|analgesics|mesh-ancestor
154244062|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154244063|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244064|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244065|NCT04571229|Mifamurtide|mifamurtide|mesh-list
154244066|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154244067|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
154244068|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244069|NCT04535713|Gemcitabine|gemcitabine|mesh-list
154244070|NCT04535713|Docetaxel|docetaxel|mesh-list
154244071|NCT04535713|Doxorubicin|doxorubicin|mesh-list
154244073|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154244074|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
154244075|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244076|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244077|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
154244078|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
154244079|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
154244080|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154244081|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154244082|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154244083|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244084|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244085|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244086|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
154244087|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154244089|NCT04526132|Analgesics|analgesics|mesh-ancestor
154244090|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
154244091|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244092|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244093|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154244094|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154244095|NCT04514653|Ranibizumab|ranibizumab|mesh-list
154244096|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154244097|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154244098|NCT04514653|Growth Substances|growth substances|mesh-ancestor
154244099|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244100|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
154244101|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244102|NCT04505670|Donepezil|donepezil|mesh-list
154244103|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
154244104|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154244105|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244106|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244107|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
154244108|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244109|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244110|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
154244111|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
154244112|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
154244113|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154244114|NCT04505670|Protective Agents|protective agents|mesh-ancestor
154244115|NCT04493320|Levodopa|levodopa|mesh-list
154244116|NCT04493320|Carbidopa|carbidopa|mesh-list
154244117|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154244118|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154244119|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154244120|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
154244121|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244122|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244123|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244124|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154244125|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244126|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154244127|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
154244128|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
154244129|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
154244130|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244131|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244132|NCT04417166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244133|NCT04417166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244134|NCT04189744|Metronidazole|metronidazole|mesh-list
154244135|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
154244136|NCT04189744|Piperaquine|piperaquine|mesh-list
154244137|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
154244138|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154244139|NCT04189744|Artenimol|artenimol|mesh-list
154244140|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154244141|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154244142|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154244143|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154244144|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
154244145|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154244146|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541118|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
154244147|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244148|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154244149|NCT04175470|Tocotrienols|tocotrienols|mesh-list
154244150|NCT04175470|Vitamin E|vitamin e|mesh-list
154244151|NCT04175470|Tocopherols|tocopherols|mesh-list
154244152|NCT04175470|Bevacizumab|bevacizumab|mesh-list
154118312|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
154244153|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244154|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244155|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154244156|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154244157|NCT04175470|Growth Substances|growth substances|mesh-ancestor
154244158|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244159|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
154244160|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
154244161|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244163|NCT04175470|Vitamins|vitamins|mesh-ancestor
154244164|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
154244165|NCT04165330|Nivolumab|nivolumab|mesh-list
154244166|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244167|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244168|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244169|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244170|NCT04115878|Oxybutynin|oxybutynin|mesh-list
154244171|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154244172|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154244173|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154244174|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154244175|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244176|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
154244177|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244178|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244179|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
154244180|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
154244181|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244182|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154244183|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154244184|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
154244185|NCT04115878|Urological Agents|urological agents|mesh-ancestor
154244186|NCT03900884|Letrozole|letrozole|mesh-list
154244187|NCT03900884|Venetoclax|venetoclax|mesh-list
154244188|NCT03900884|Palbociclib|palbociclib|mesh-list
154244189|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244190|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154244191|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154244192|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244193|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244194|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154244195|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
154244196|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244197|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244198|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154244199|NCT03761030|Levodopa|levodopa|mesh-list
154244200|NCT03761030|Carbidopa|carbidopa|mesh-list
154244201|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154244202|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154244203|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154244204|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
154244205|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244206|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244207|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244208|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154244209|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244210|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154244211|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
154244212|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
154244213|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
154244214|NCT03742505|Vitamin D|vitamin d|mesh-list
154244215|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154244216|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244217|NCT03742505|Vitamins|vitamins|mesh-ancestor
154244218|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
154244219|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154244220|NCT03663205|Cisplatin|cisplatin|mesh-list
154244221|NCT03663205|Carboplatin|carboplatin|mesh-list
154244222|NCT03663205|Pemetrexed|pemetrexed|mesh-list
154244223|NCT03663205|Tislelizumab|tislelizumab|mesh-list
154244224|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244225|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244226|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244227|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154244228|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154244229|NCT03663205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244230|NCT03572088|Terlipressin|terlipressin|mesh-list
154244231|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154244232|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154244233|NCT03560934|Dronabinol|dronabinol|mesh-list
154244234|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
154244235|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244236|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154244237|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154244238|NCT03560934|Analgesics|analgesics|mesh-ancestor
154244239|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
154244240|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244241|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154244242|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154244243|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244244|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244245|NCT03560934|Hormones|hormones|mesh-ancestor
154244246|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244247|NCT03527472|Memantine|memantine|mesh-list
154244248|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154244249|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154244250|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
154244251|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244252|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244253|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244254|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154244255|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154244256|NCT03388788|CGP 12177|cgp 12177|mesh-list
154244257|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154244258|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154244259|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
154244260|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244261|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244262|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244263|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154244264|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154244265|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154244266|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154244267|NCT03240081|Estradiol|estradiol|mesh-list
154244268|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154244269|NCT03240081|Estrogens|estrogens|mesh-ancestor
154244270|NCT03240081|Hormones|hormones|mesh-ancestor
154244271|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244272|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244273|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154244274|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
154244275|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154244276|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154244277|NCT03236857|Venetoclax|venetoclax|mesh-list
154244278|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244279|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154244280|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
154244281|NCT03097120|Estrogens|estrogens|mesh-list
154244282|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154244283|NCT03097120|Hormones|hormones|mesh-ancestor
154244284|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244285|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244286|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154244287|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154244288|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154244289|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
154244290|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154244291|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154244292|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154244293|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154244294|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154244295|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244297|NCT03003520|Prednisolone|prednisolone|mesh-list
154244298|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
154244299|NCT03003520|Rituximab|rituximab|mesh-list
154244300|NCT03003520|Doxorubicin|doxorubicin|mesh-list
154244301|NCT03003520|Vincristine|vincristine|mesh-list
154244302|NCT03003520|Lenalidomide|lenalidomide|mesh-list
154244303|NCT03003520|Durvalumab|durvalumab|mesh-list
154244304|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154244305|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
154244306|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244307|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154244308|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154244309|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
154158411|NCT04549467|Tenofovir|tenofovir|mesh-list
154393021|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244310|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244311|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244312|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154244313|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244314|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154244315|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154244316|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154244318|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154244319|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
154244321|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244322|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154244323|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154244324|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
154244325|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
154244326|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
154244327|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154244328|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154244329|NCT03003520|Growth Substances|growth substances|mesh-ancestor
154244330|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
154244331|NCT02989597|Dexamethasone|dexamethasone|mesh-list
154244332|NCT02989597|Sufentanil|sufentanil|mesh-list
154244333|NCT02989597|Ketamine|ketamine|mesh-list
154244334|NCT02989597|Remifentanil|remifentanil|mesh-list
154244335|NCT02989597|Methadone|methadone|mesh-list
154244336|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154244337|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
154244338|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
154244339|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244340|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244341|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154244342|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
154244343|NCT02989597|Hormones|hormones|mesh-ancestor
154244344|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244345|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154244346|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244347|NCT02989597|Analgesics|analgesics|mesh-ancestor
154244348|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
154244349|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154244350|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154244351|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
154244352|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
154244353|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244354|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154244355|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154244356|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244357|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244358|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154244359|NCT02989597|Narcotics|narcotics|mesh-ancestor
154244360|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154244361|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
154244362|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
154244363|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154244364|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154244365|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154244366|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154244367|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244368|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244369|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244370|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154244371|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
154244372|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154244373|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
154244374|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
154244375|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154244376|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
154244377|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244378|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154244379|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154244380|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
154244381|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244382|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158498|NCT04440176|Vaccines|vaccines|mesh-list
154244383|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154244384|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991267|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
154244385|NCT02768701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244386|NCT02621944|Melatonin|melatonin|mesh-list
154244387|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
154244388|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244389|NCT02621944|Protective Agents|protective agents|mesh-ancestor
154244390|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244391|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244392|NCT02586025|Docetaxel|docetaxel|mesh-list
154244393|NCT02586025|Trastuzumab|trastuzumab|mesh-list
154244394|NCT02586025|Pertuzumab|pertuzumab|mesh-list
154244395|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244396|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
154244397|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
154244398|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
154244399|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244400|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244401|NCT02465164|Oxytocin|oxytocin|mesh-list
154244402|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
154118546|NCT00675428|Natalizumab|natalizumab|mesh-list
154244403|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154244404|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244405|NCT01955512|Clopidogrel|clopidogrel|mesh-list
154244406|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154244407|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154244408|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154244409|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154244410|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
154244411|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244412|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244413|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244414|NCT00227617|Leucovorin|leucovorin|mesh-list
154244415|NCT00227617|Bevacizumab|bevacizumab|mesh-list
154244416|NCT00227617|Fluorouracil|fluorouracil|mesh-list
154244417|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
154244418|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244419|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244420|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154244421|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154244422|NCT00227617|Growth Substances|growth substances|mesh-ancestor
154244423|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244424|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
154244425|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
154244426|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244427|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154244428|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154244429|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
154244430|NCT00227617|Antidotes|antidotes|mesh-ancestor
154244431|NCT00227617|Protective Agents|protective agents|mesh-ancestor
154244432|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
154244433|NCT00227617|Vitamins|vitamins|mesh-ancestor
154244434|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
154244435|NCT05710081|Broncho-Vaxom|broncho-vaxom|mesh-list
154244436|NCT05710081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154244437|NCT05710081|Immunologic Factors|immunologic factors|mesh-ancestor
154244438|NCT05710081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244439|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
154244440|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154244441|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
154244442|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244443|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244444|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154244445|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
154244446|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154244447|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
154244448|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244449|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244450|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154244451|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
154244452|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
154244453|NCT05703191|Protective Agents|protective agents|mesh-ancestor
154244454|NCT05657470|Tenecteplase|tenecteplase|mesh-list
154244455|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154244456|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154393022|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
154244457|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244458|NCT05639686|Remifentanil|remifentanil|mesh-list
154244459|NCT05639686|Anesthetics|anesthetics|mesh-list
154244460|NCT05639686|Propofol|propofol|mesh-list
154244462|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
154244463|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244464|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244465|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154244466|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154244467|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
154244468|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154244469|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154244470|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244471|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
154244472|NCT05639686|Coagulants|coagulants|mesh-ancestor
154244473|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154244474|NCT05639686|Narcotics|narcotics|mesh-ancestor
154244475|NCT05639686|Analgesics|analgesics|mesh-ancestor
154244476|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
154244477|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244478|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154244479|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154244480|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154244481|NCT05586074|Cytarabine|cytarabine|mesh-list
154244482|NCT05586074|Fludarabine|fludarabine|mesh-list
154244483|NCT05586074|Azacitidine|azacitidine|mesh-list
154244484|NCT05586074|Decitabine|decitabine|mesh-list
154244485|NCT05586074|Idarubicin|idarubicin|mesh-list
154244486|NCT05586074|Lenograstim|lenograstim|mesh-list
154244487|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118647|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
154244488|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154244489|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
154244490|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244491|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154244492|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
154244493|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244494|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
154244495|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154244496|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244497|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154244498|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154244499|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154244500|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154244501|NCT05541146|Paclitaxel|paclitaxel|mesh-list
154244502|NCT05541146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154244503|NCT05541146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244504|NCT05541146|Tubulin Modulators|tubulin modulators|mesh-ancestor
154244505|NCT05541146|Antimitotic Agents|antimitotic agents|mesh-ancestor
154244506|NCT05541146|Mitosis Modulators|mitosis modulators|mesh-ancestor
154244507|NCT05541146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244508|NCT05532358|Midazolam|midazolam|mesh-list
154244509|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
154244510|NCT05532358|Caffeine|caffeine|mesh-list
154244511|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154244512|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154244513|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244514|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244515|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154244516|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154244517|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154244518|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154244519|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
154244521|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
154244522|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
154244523|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244524|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244525|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154244526|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154244527|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244528|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154244529|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154244530|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
154244531|NCT05532358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154244532|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154244533|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154244534|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
154244535|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154244536|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
154244537|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154244538|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154244539|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154244541|NCT05525416|Nitroprusside|nitroprusside|mesh-list
154244542|NCT05525416|Phentolamine|phentolamine|mesh-list
154244543|NCT05525416|Phenylephrine|phenylephrine|mesh-list
154244544|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
154244545|NCT05525416|Norepinephrine|norepinephrine|mesh-list
154244546|NCT05525416|Synephrine|synephrine|mesh-list
154244547|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154244548|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154244549|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
154244550|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244551|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244552|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244553|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154244554|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154244555|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
154244556|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154244557|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
154244558|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
154244559|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244560|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
154244561|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154244562|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
154244563|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
154244564|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154244565|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154244566|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154244567|NCT05525416|Protective Agents|protective agents|mesh-ancestor
154244568|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154244569|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154244570|NCT05491512|Carboplatin|carboplatin|mesh-list
154244571|NCT05491512|Fluorouracil|fluorouracil|mesh-list
154244572|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244573|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
154244574|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244575|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154244576|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154244577|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
154244578|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244579|NCT05449405|Chlorpheniramine|chlorpheniramine|mesh-list
154244580|NCT05449405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244581|NCT05449405|Antipruritics|antipruritics|mesh-ancestor
154244582|NCT05449405|Dermatologic Agents|dermatologic agents|mesh-ancestor
154244583|NCT05449405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154244584|NCT05449405|Histamine Antagonists|histamine antagonists|mesh-ancestor
154244585|NCT05449405|Histamine Agents|histamine agents|mesh-ancestor
154244586|NCT05449405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244587|NCT05449405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244588|NCT05449405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154244589|NCT05394740|Leucovorin|leucovorin|mesh-list
154244590|NCT05394740|Capecitabine|capecitabine|mesh-list
154244591|NCT05394740|Fluorouracil|fluorouracil|mesh-list
154244592|NCT05394740|Nivolumab|nivolumab|mesh-list
154244593|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
154244594|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154244595|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
154244596|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244597|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244598|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154244599|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
154244600|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244601|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244602|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244603|NCT05394740|Antidotes|antidotes|mesh-ancestor
154244604|NCT05394740|Protective Agents|protective agents|mesh-ancestor
154244605|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
154244606|NCT05394740|Vitamins|vitamins|mesh-ancestor
154244607|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
154244608|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154244609|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154244610|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244611|NCT05273996|Bupropion|bupropion|mesh-list
154244612|NCT05273996|Sertraline|sertraline|mesh-list
154244613|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154244617|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154244618|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154244619|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154244620|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244621|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
154244622|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244623|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244624|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154244625|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154244626|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244627|NCT05273996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154244628|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
154244629|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154244630|NCT05262244|Bevacizumab|bevacizumab|mesh-list
154244631|NCT05262244|Vedolizumab|vedolizumab|mesh-list
154244632|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244633|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244634|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154244635|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154244636|NCT05262244|Growth Substances|growth substances|mesh-ancestor
154244637|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244638|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
154244639|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154244640|NCT05244213|Paclitaxel|paclitaxel|mesh-list
154244641|NCT05244213|Carboplatin|carboplatin|mesh-list
154244642|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154244643|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244644|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
154244645|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
154244646|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
154244647|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244648|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154244649|NCT05231148|Calcium|calcium|mesh-list
154244650|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154244651|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244652|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154244653|NCT05169112|Leuprolide|leuprolide|mesh-list
154244654|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154244655|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
154244656|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154244657|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244658|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154244659|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244660|NCT05097209|Cisplatin|cisplatin|mesh-list
154244661|NCT05097209|Gemcitabine|gemcitabine|mesh-list
154244662|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244663|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154244664|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
154244665|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244666|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
154244667|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154244668|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244669|NCT04991974|Buprenorphine|buprenorphine|mesh-list
154244670|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154244672|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154244673|NCT04991974|Narcotics|narcotics|mesh-ancestor
154244674|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244675|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244676|NCT04991974|Analgesics|analgesics|mesh-ancestor
154244677|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
154244678|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244679|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154244683|NCT04917692|Empagliflozin|empagliflozin|mesh-list
154244684|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154244685|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244686|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154244687|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244688|NCT04881747|Lasmiditan|lasmiditan|mesh-list
154244689|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154244690|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
154244691|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393023|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
154244692|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244693|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244694|NCT04862949|Bevacizumab|bevacizumab|mesh-list
154244695|NCT04862949|Atezolizumab|atezolizumab|mesh-list
154244696|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244697|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244698|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154244699|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154244700|NCT04862949|Growth Substances|growth substances|mesh-ancestor
154244701|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244702|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
154244703|NCT04862949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244704|NCT04862949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244705|NCT04781959|Lenograstim|lenograstim|mesh-list
154244706|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154244707|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
154244708|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244709|NCT04729608|Paclitaxel|paclitaxel|mesh-list
154244710|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154244711|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244712|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
154244713|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
154244714|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
154244715|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244716|NCT04652245|Fluticasone|fluticasone|mesh-list
154244718|NCT04652245|Azelastine|azelastine|mesh-list
154244719|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154244720|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154244721|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
154244722|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244723|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244724|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154244725|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
154244726|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
154244727|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154244728|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154244729|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244730|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244731|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154244732|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154244733|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
154244734|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
154244735|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244736|NCT04642287|Fluorouracil|fluorouracil|mesh-list
154244737|NCT04642287|Calcipotriene|calcipotriene|mesh-list
154244738|NCT04642287|Petrolatum|petrolatum|mesh-list
154244739|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
154244740|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244741|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154244742|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244744|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
154244745|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244746|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
154244747|NCT04642287|Emollients|emollients|mesh-ancestor
154244748|NCT04635735|Ipilimumab|ipilimumab|mesh-list
154244749|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244750|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244751|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244752|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244753|NCT04595513|Sirolimus|sirolimus|mesh-list
154244754|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154244755|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154244756|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154244757|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244758|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
154244759|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154244760|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
154244761|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244763|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244764|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244765|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
154244766|NCT04487652|Vitamins|vitamins|mesh-ancestor
154244767|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
154244768|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244769|NCT04429334|Nangibotide|nangibotide|mesh-list
154244770|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154244771|NCT04408443|Vitamin D|vitamin d|mesh-list
154244772|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
154244773|NCT04408443|Vitamins|vitamins|mesh-ancestor
154244774|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
154244775|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244776|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154244777|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154244778|NCT04405739|Molnupiravir|molnupiravir|mesh-list
154244779|NCT04405739|Antiviral Agents|antiviral agents|mesh-ancestor
154244780|NCT04405739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154244781|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
154244782|NCT04396457|Pemetrexed|pemetrexed|mesh-list
154244783|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244784|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244785|NCT04396457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154244786|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244787|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244788|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154244789|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154244790|NCT04377204|Lidocaine|lidocaine|mesh-list
154244791|NCT04377204|Bupivacaine|bupivacaine|mesh-list
154244792|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
154244793|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
154244794|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244795|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244796|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
154244797|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244798|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154244799|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154244800|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154244801|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154244802|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244803|NCT04346589|Antibodies|antibodies|mesh-list
154244804|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
154244805|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154244806|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
154244807|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244808|NCT05934097|Prednisone|prednisone|mesh-list
154244809|NCT05934097|Cyclophosphamide|cyclophosphamide|mesh-list
154244810|NCT05934097|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154244811|NCT05934097|Rituximab|rituximab|mesh-list
154244812|NCT05934097|Doxorubicin|doxorubicin|mesh-list
154244813|NCT05934097|Vincristine|vincristine|mesh-list
154244814|NCT05934097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154244815|NCT05934097|Immunologic Factors|immunologic factors|mesh-ancestor
154244816|NCT05934097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244817|NCT05934097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154244818|NCT05934097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154244819|NCT05934097|Alkylating Agents|alkylating agents|mesh-ancestor
154244820|NCT05934097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118956|NCT00942201|Dexamethasone|dexamethasone|mesh-list
154244821|NCT05934097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244822|NCT05934097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154244823|NCT05934097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154244824|NCT05934097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154244825|NCT05934097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154244826|NCT05934097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154244827|NCT05934097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244828|NCT05934097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154244830|NCT05934097|Hormones|hormones|mesh-ancestor
154244831|NCT05934097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244832|NCT05934097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154244833|NCT05934097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154244834|NCT05934097|Tubulin Modulators|tubulin modulators|mesh-ancestor
153991720|NCT00797017|Fentanyl|fentanyl|mesh-list
154244835|NCT05934097|Antimitotic Agents|antimitotic agents|mesh-ancestor
154244836|NCT05934097|Mitosis Modulators|mitosis modulators|mesh-ancestor
154244837|NCT05934071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154244838|NCT05934071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244839|NCT05934071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154244840|NCT05934071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244841|NCT05933863|Antibodies|antibodies|mesh-list
154244842|NCT05933863|Immunologic Factors|immunologic factors|mesh-ancestor
154244843|NCT05933863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244845|NCT05933759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154244846|NCT05933759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244847|NCT05933486|Pregabalin|pregabalin|mesh-list
154244848|NCT05933486|Analgesics|analgesics|mesh-ancestor
154244849|NCT05933486|Sensory System Agents|sensory system agents|mesh-ancestor
154244850|NCT05933486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244851|NCT05933486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244852|NCT05933486|Anticonvulsants|anticonvulsants|mesh-ancestor
154244853|NCT05933486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154244854|NCT05933486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154244855|NCT05933486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244856|NCT05933486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154244857|NCT05933486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154244858|NCT05933486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154244859|NCT05933486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244860|NCT05933486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154244861|NCT05933447|Moxifloxacin|moxifloxacin|mesh-list
154244862|NCT05933447|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154244863|NCT05933447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154244864|NCT05933447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154244865|NCT05933447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154244866|NCT05933447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154244867|NCT05933447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244868|NCT05933447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119009|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244869|NCT05933447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244870|NCT05933447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154244871|NCT05933447|Contraceptive Agents|contraceptive agents|mesh-ancestor
154244872|NCT05933447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154244873|NCT05933447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244874|NCT05933447|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154244875|NCT05933447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154244876|NCT05933447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154244877|NCT05933213|Mescaline|mescaline|mesh-list
154244878|NCT05933213|Glucocorticoids|glucocorticoids|mesh-list
154244879|NCT05933213|Hormones|hormones|mesh-ancestor
154244880|NCT05933213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244881|NCT05933213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244882|NCT05933213|Hallucinogens|hallucinogens|mesh-ancestor
154244883|NCT05933213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154244884|NCT05933213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154244885|NCT05933213|Serotonin Agents|serotonin agents|mesh-ancestor
154244886|NCT05933213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244887|NCT05933213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244888|NCT05933031|Lansoprazole|lansoprazole|mesh-list
154244889|NCT05933031|Dexlansoprazole|dexlansoprazole|mesh-list
154244890|NCT05933031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154244891|NCT05933031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154244892|NCT05933031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154244893|NCT05933031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244894|NCT05933031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244895|NCT05932849|Benralizumab|benralizumab|mesh-list
154244896|NCT05932849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154244897|NCT05932849|Respiratory System Agents|respiratory system agents|mesh-ancestor
154244898|NCT05932550|Maraviroc|maraviroc|mesh-list
154244899|NCT05932550|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154244900|NCT05932550|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154244901|NCT05932550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244902|NCT05932550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154244903|NCT05932550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154244904|NCT05932550|Antiviral Agents|antiviral agents|mesh-ancestor
154244905|NCT05932550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154244906|NCT05932550|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154244907|NCT05932524|Dexamethasone|dexamethasone|mesh-list
154244908|NCT05932524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154244909|NCT05932524|Antiemetics|antiemetics|mesh-ancestor
153991792|NCT00988637|Calcitriol|calcitriol|mesh-list
154244910|NCT05932524|Autonomic Agents|autonomic agents|mesh-ancestor
154244911|NCT05932524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244912|NCT05932524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244913|NCT05932524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154244914|NCT05932524|Glucocorticoids|glucocorticoids|mesh-ancestor
154244916|NCT05932524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154244917|NCT05932524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154244918|NCT05932524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154244919|NCT05932407|Vortioxetine|vortioxetine|mesh-list
154244920|NCT05932407|Antidepressive Agents|antidepressive agents|mesh-ancestor
154244921|NCT05932407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154244922|NCT05932407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154244923|NCT05932407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154244924|NCT05932407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244925|NCT05932407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244926|NCT05932407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154244927|NCT05932407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154244928|NCT05932407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154244929|NCT05932407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244930|NCT05932407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244931|NCT05932407|Serotonin Agents|serotonin agents|mesh-ancestor
154244932|NCT05932407|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154244933|NCT05932407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154244934|NCT05932407|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154244935|NCT05932407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154244936|NCT05932316|Albuterol|albuterol|mesh-list
154244937|NCT05932316|Bronchodilator Agents|bronchodilator agents|mesh-list
154244938|NCT05932316|Autonomic Agents|autonomic agents|mesh-ancestor
154244939|NCT05932316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244940|NCT05932316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244941|NCT05932316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154244942|NCT05932316|Respiratory System Agents|respiratory system agents|mesh-ancestor
154244943|NCT05932316|Tocolytic Agents|tocolytic agents|mesh-ancestor
154244944|NCT05932316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154244945|NCT05932316|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154244946|NCT05932316|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154244947|NCT05932316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154244948|NCT05932316|Adrenergic Agents|adrenergic agents|mesh-ancestor
154244949|NCT05932316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244950|NCT05932316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244951|NCT05932277|Fexofenadine|fexofenadine|mesh-list
154244952|NCT05932277|Flurbiprofen|flurbiprofen|mesh-list
154244953|NCT05932277|Midazolam|midazolam|mesh-list
154244954|NCT05932277|Caffeine|caffeine|mesh-list
154244955|NCT05932277|Bupropion|bupropion|mesh-list
154244956|NCT05932277|Omeprazole|omeprazole|mesh-list
154244957|NCT05932277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154244958|NCT05932277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154244959|NCT05932277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154244960|NCT05932277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154244961|NCT05932277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154244962|NCT05932277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154244963|NCT05932277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154244964|NCT05932277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154244965|NCT05932277|Anesthetics, General|anesthetics, general|mesh-ancestor
154244966|NCT05932277|Anesthetics|anesthetics|mesh-ancestor
154244967|NCT05932277|GABA Modulators|gaba modulators|mesh-ancestor
154244968|NCT05932277|GABA Agents|gaba agents|mesh-ancestor
154244969|NCT05932277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154244970|NCT05932277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154244971|NCT05932277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154244972|NCT05932277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154244973|NCT05932277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154244974|NCT05932277|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154244975|NCT05932277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154244976|NCT05932277|Purinergic Agents|purinergic agents|mesh-ancestor
154244977|NCT05932277|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154244978|NCT05932277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154244979|NCT05932277|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154244980|NCT05932277|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154244981|NCT05932277|Antidepressive Agents|antidepressive agents|mesh-ancestor
154244982|NCT05932277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154244983|NCT05932277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154244984|NCT05932277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154244985|NCT05932277|Dopamine Agents|dopamine agents|mesh-ancestor
154244986|NCT05932277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154159086|NCT03179904|Anastrozole|anastrozole|mesh-list
154244987|NCT05932277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154244988|NCT05932277|Analgesics|analgesics|mesh-ancestor
154244989|NCT05932277|Sensory System Agents|sensory system agents|mesh-ancestor
154244990|NCT05932277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154244991|NCT05932277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154244992|NCT05932277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154244993|NCT05932277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154244994|NCT05932277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154244995|NCT05932277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154244996|NCT05932277|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154244997|NCT05932277|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154244998|NCT05932277|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154244999|NCT05932277|Histamine Antagonists|histamine antagonists|mesh-ancestor
154245000|NCT05932277|Histamine Agents|histamine agents|mesh-ancestor
154245002|NCT05932264|Fluzoparib|fluzoparib|mesh-list
154245003|NCT05932264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245004|NCT05932264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154245005|NCT05932264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119143|NCT00804960|Letrozole|letrozole|mesh-list
154245006|NCT05932264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245007|NCT05932264|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154245008|NCT05932186|Anesthetics|anesthetics|mesh-list
154245009|NCT05932186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245010|NCT05932186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245011|NCT05931822|Fluorides|fluorides|mesh-list
154245012|NCT05931822|Fluorides, Topical|fluorides, topical|mesh-list
154245013|NCT05931822|Cariostatic Agents|cariostatic agents|mesh-ancestor
154245014|NCT05931822|Protective Agents|protective agents|mesh-ancestor
154245015|NCT05931822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245016|NCT05931757|Blinatumomab|blinatumomab|mesh-list
154245017|NCT05931757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245018|NCT05931744|Prednisone|prednisone|mesh-list
154245019|NCT05931744|Budesonide|budesonide|mesh-list
154245020|NCT05931744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245021|NCT05931744|Glucocorticoids|glucocorticoids|mesh-ancestor
154245022|NCT05931744|Hormones|hormones|mesh-ancestor
154245023|NCT05931744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245024|NCT05931744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245025|NCT05931744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154245026|NCT05931744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245027|NCT05931744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154245028|NCT05931744|Autonomic Agents|autonomic agents|mesh-ancestor
154245029|NCT05931744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245030|NCT05931744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154245031|NCT05931744|Respiratory System Agents|respiratory system agents|mesh-ancestor
154245032|NCT05931458|Infliximab|infliximab|mesh-list
154245033|NCT05931458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154245034|NCT05931458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245035|NCT05931458|Dermatologic Agents|dermatologic agents|mesh-ancestor
154245036|NCT05931458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154245037|NCT05931458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154245038|NCT05931328|Pomalidomide|pomalidomide|mesh-list
154245039|NCT05931328|Thiotepa|thiotepa|mesh-list
154245040|NCT05931328|Immunologic Factors|immunologic factors|mesh-ancestor
154245041|NCT05931328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245042|NCT05931328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154245043|NCT05931328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154245044|NCT05931328|Growth Substances|growth substances|mesh-ancestor
154245045|NCT05931328|Growth Inhibitors|growth inhibitors|mesh-ancestor
154245046|NCT05931328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245047|NCT05931328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154245048|NCT05931328|Alkylating Agents|alkylating agents|mesh-ancestor
154245049|NCT05931328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245050|NCT05931328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154245051|NCT05931328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154245052|NCT05931263|Cytarabine|cytarabine|mesh-list
154245053|NCT05931263|Carmustine|carmustine|mesh-list
154245054|NCT05931263|Melphalan|melphalan|mesh-list
154245055|NCT05931263|Etoposide|etoposide|mesh-list
154245056|NCT05931263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154245057|NCT05931263|Alkylating Agents|alkylating agents|mesh-ancestor
154245058|NCT05931263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245059|NCT05931263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245060|NCT05931263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154245061|NCT05931263|Antimetabolites|antimetabolites|mesh-ancestor
154245062|NCT05931263|Antiviral Agents|antiviral agents|mesh-ancestor
154245064|NCT05931263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154245065|NCT05931263|Immunologic Factors|immunologic factors|mesh-ancestor
154245066|NCT05931263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245067|NCT05931263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154245068|NCT05931263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154245069|NCT05931263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154245070|NCT05931263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245071|NCT05931263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154245072|NCT05931224|Antihypertensive Agents|antihypertensive agents|mesh-list
154245073|NCT05931042|Trastuzumab|trastuzumab|mesh-list
154245074|NCT05931042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245075|NCT05931042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245076|NCT05931029|Ubiquinone|ubiquinone|mesh-list
154245077|NCT05931029|Idebenone|idebenone|mesh-list
154245078|NCT05931029|Antioxidants|antioxidants|mesh-ancestor
154245079|NCT05931029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245080|NCT05931029|Protective Agents|protective agents|mesh-ancestor
154245081|NCT05931029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245082|NCT05931029|Micronutrients|micronutrients|mesh-ancestor
154245083|NCT05930912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154245084|NCT05930912|Sertraline|sertraline|mesh-list
154245085|NCT05930912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154245086|NCT05930912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154245087|NCT05930912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245088|NCT05930912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245089|NCT05930912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245090|NCT05930912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245091|NCT05930912|Analgesics|analgesics|mesh-ancestor
154245092|NCT05930912|Sensory System Agents|sensory system agents|mesh-ancestor
154245093|NCT05930912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245094|NCT05930912|Antidepressive Agents|antidepressive agents|mesh-ancestor
154245095|NCT05930912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154245096|NCT05930912|Dopamine Agents|dopamine agents|mesh-ancestor
154245097|NCT05930912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154245098|NCT05930912|Serotonin Agents|serotonin agents|mesh-ancestor
154245099|NCT05930236|Methylprednisolone|methylprednisolone|mesh-list
154245100|NCT05930236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154245101|NCT05930236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154245102|NCT05930236|Prednisolone|prednisolone|mesh-list
154245103|NCT05930236|Prednisolone acetate|prednisolone acetate|mesh-list
154245104|NCT05930236|Lidocaine|lidocaine|mesh-list
154245105|NCT05930236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154245106|NCT05930236|Prednisolone phosphate|prednisolone phosphate|mesh-list
154245107|NCT05930236|Anesthetics, Local|anesthetics, local|mesh-ancestor
154245108|NCT05930236|Anesthetics|anesthetics|mesh-ancestor
154245109|NCT05930236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245110|NCT05930236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245111|NCT05930236|Sensory System Agents|sensory system agents|mesh-ancestor
154245112|NCT05930236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245113|NCT05930236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154245114|NCT05930236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154245115|NCT05930236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154245116|NCT05930236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245117|NCT05930236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245118|NCT05930236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245119|NCT05930236|Antiemetics|antiemetics|mesh-ancestor
154245120|NCT05930236|Autonomic Agents|autonomic agents|mesh-ancestor
154245121|NCT05930236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154245122|NCT05930236|Glucocorticoids|glucocorticoids|mesh-ancestor
154245123|NCT05930236|Hormones|hormones|mesh-ancestor
154245124|NCT05930236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245125|NCT05930236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154245126|NCT05930236|Protective Agents|protective agents|mesh-ancestor
154245127|NCT05930236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154245128|NCT05930236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245129|NCT05930080|Celecoxib|celecoxib|mesh-list
154245130|NCT05930080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154245131|NCT05930080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154245132|NCT05930080|Analgesics|analgesics|mesh-ancestor
154245133|NCT05930080|Sensory System Agents|sensory system agents|mesh-ancestor
153992020|NCT00689559|Aripiprazole|aripiprazole|mesh-list
154245134|NCT05930080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245135|NCT05930080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245136|NCT05930080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245138|NCT05930080|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154245139|NCT05930080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154245140|NCT05930080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245141|NCT05930080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245142|NCT05930002|Ivermectin|ivermectin|mesh-list
154245143|NCT05930002|Colchicine|colchicine|mesh-list
154245144|NCT05930002|Gout Suppressants|gout suppressants|mesh-ancestor
154245145|NCT05930002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154245146|NCT05930002|Tubulin Modulators|tubulin modulators|mesh-ancestor
154245147|NCT05930002|Antimitotic Agents|antimitotic agents|mesh-ancestor
154245148|NCT05930002|Mitosis Modulators|mitosis modulators|mesh-ancestor
154245149|NCT05930002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245150|NCT05930002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245151|NCT05930002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154245152|NCT05930002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245153|NCT05929092|Cyclophosphamide|cyclophosphamide|mesh-list
154245154|NCT05929092|Busulfan|busulfan|mesh-list
154245155|NCT05929092|Fludarabine|fludarabine|mesh-list
154245156|NCT05929092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154245157|NCT05929092|Immunologic Factors|immunologic factors|mesh-ancestor
154245158|NCT05929092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245159|NCT05929092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154245160|NCT05929092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154245161|NCT05929092|Alkylating Agents|alkylating agents|mesh-ancestor
154245162|NCT05929092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245163|NCT05929092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245164|NCT05929092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154245165|NCT05928897|Disitamab vedotin|disitamab vedotin|mesh-list
154245166|NCT05928897|Immunoconjugates|immunoconjugates|mesh-ancestor
154245167|NCT05928897|Immunologic Factors|immunologic factors|mesh-ancestor
154245168|NCT05928897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245169|NCT05925894|Anesthetics|anesthetics|mesh-list
154245170|NCT05925894|Mydriatics|mydriatics|mesh-list
154245171|NCT05925894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245172|NCT05925894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245173|NCT05925894|Autonomic Agents|autonomic agents|mesh-ancestor
154245174|NCT05925894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245175|NCT05909618|Nivolumab|nivolumab|mesh-list
154245176|NCT05909618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154245177|NCT05909618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245178|NCT05909618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245179|NCT05909618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154245180|NCT05909618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245181|NCT05902117|Arginine Vasopressin|arginine vasopressin|mesh-list
154245182|NCT05902117|Hemostatics|hemostatics|mesh-ancestor
154245183|NCT05902117|Coagulants|coagulants|mesh-ancestor
154245184|NCT05902117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153348985|NCT03011645|Ziprasidone|ziprasidone|mesh-list
154245185|NCT05902117|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154245186|NCT05902117|Natriuretic Agents|natriuretic agents|mesh-ancestor
154245187|NCT05902117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245188|NCT05899010|Progesterone|progesterone|mesh-list
154245189|NCT05899010|Progestins|progestins|mesh-ancestor
154245190|NCT05899010|Hormones|hormones|mesh-ancestor
154245191|NCT05899010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245192|NCT05899010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245193|NCT05877573|Capecitabine|capecitabine|mesh-list
154245194|NCT05877573|Oxaliplatin|oxaliplatin|mesh-list
154245195|NCT05877573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154245196|NCT05877573|Antimetabolites|antimetabolites|mesh-ancestor
154245197|NCT05877573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245198|NCT05877573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245199|NCT05872542|Listerine|listerine|mesh-list
154245200|NCT05872542|Fluorides|fluorides|mesh-list
154245201|NCT05872542|Sodium Fluoride|sodium fluoride|mesh-list
154245202|NCT05872542|Fluorides, Topical|fluorides, topical|mesh-list
154245203|NCT05872542|Cariostatic Agents|cariostatic agents|mesh-ancestor
154245204|NCT05872542|Protective Agents|protective agents|mesh-ancestor
154245205|NCT05872542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245206|NCT05872542|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154245207|NCT05872542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245208|NCT05870709|Valsartan|valsartan|mesh-list
154245209|NCT05870709|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154159319|NCT02681302|Nivolumab|nivolumab|mesh-list
154245210|NCT05870709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154245211|NCT05870709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154245212|NCT05870709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154245213|NCT05870709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245214|NCT05870514|Propofol|propofol|mesh-list
154245215|NCT05870514|Fospropofol|fospropofol|mesh-list
154245216|NCT05870514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154245217|NCT05870514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245218|NCT05870514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245219|NCT05870514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154245220|NCT05870514|Anesthetics, General|anesthetics, general|mesh-ancestor
154245221|NCT05870514|Anesthetics|anesthetics|mesh-ancestor
154245222|NCT05851560|Hyaluronic Acid|hyaluronic acid|mesh-list
154245223|NCT05851560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154245224|NCT05851560|Immunologic Factors|immunologic factors|mesh-ancestor
154245225|NCT05851560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245226|NCT05851560|Viscosupplements|viscosupplements|mesh-ancestor
154245227|NCT05851560|Protective Agents|protective agents|mesh-ancestor
154245228|NCT05803148|Midodrine|midodrine|mesh-list
154245229|NCT05803148|Sympathomimetics|sympathomimetics|mesh-ancestor
154245230|NCT05803148|Autonomic Agents|autonomic agents|mesh-ancestor
154245231|NCT05803148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245232|NCT05803148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245233|NCT05803148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154245234|NCT05803148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154245235|NCT05803148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154245236|NCT05803148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154245237|NCT05803148|Adrenergic Agents|adrenergic agents|mesh-ancestor
154245238|NCT05803148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245239|NCT05803148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245240|NCT05802849|Acetazolamide|acetazolamide|mesh-list
154245241|NCT05802849|Anticonvulsants|anticonvulsants|mesh-ancestor
154245242|NCT05802849|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154245243|NCT05802849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245244|NCT05802849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245245|NCT05802849|Diuretics|diuretics|mesh-ancestor
154245246|NCT05802849|Natriuretic Agents|natriuretic agents|mesh-ancestor
154245247|NCT05802849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245248|NCT05748366|Analgesics|analgesics|mesh-list
154245249|NCT05748366|Sensory System Agents|sensory system agents|mesh-ancestor
154245250|NCT05748366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245251|NCT05748366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245252|NCT05738161|Cisplatin|cisplatin|mesh-list
154245253|NCT05738161|Gemcitabine|gemcitabine|mesh-list
154245254|NCT05738161|Magrolimab|magrolimab|mesh-list
154245255|NCT05738161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245256|NCT05738161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154245257|NCT05738161|Antimetabolites|antimetabolites|mesh-ancestor
154245258|NCT05738161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245259|NCT05738161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245260|NCT05705804|Atorvastatin|atorvastatin|mesh-list
154245261|NCT05705804|Pitavastatin|pitavastatin|mesh-list
154245262|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154245263|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154245264|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
154245265|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245266|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154245267|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154245268|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245269|NCT05636787|Melphalan|melphalan|mesh-list
154245270|NCT05636787|Treosulfan|treosulfan|mesh-list
154245271|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154245272|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
154245273|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245274|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245275|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154245276|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154245277|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
154245278|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245279|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
154245280|NCT05631912|Fludarabine|fludarabine|mesh-list
154245281|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
154245282|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154245283|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
154245284|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245285|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154393024|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154119431|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
154245286|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154245287|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
154245288|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245289|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245290|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154245291|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154245292|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
154245294|NCT05615948|Analgesics|analgesics|mesh-ancestor
154245295|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
154245296|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245297|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245298|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245299|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154245300|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154245301|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
154245302|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
154245303|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245304|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154245305|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154245306|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245307|NCT05614349|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154245308|NCT05614349|Antiviral Agents|antiviral agents|mesh-ancestor
154245309|NCT05614349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245310|NCT05595460|Carboplatin|carboplatin|mesh-list
154245311|NCT05595460|Etoposide|etoposide|mesh-list
154245312|NCT05595460|Atezolizumab|atezolizumab|mesh-list
154245313|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245314|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154245315|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154245316|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154245317|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245318|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245319|NCT05595460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154245320|NCT05595460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245321|NCT05594667|Psilocybin|psilocybin|mesh-list
154245322|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
154245323|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245324|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154245325|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
154245326|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245327|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245328|NCT05589818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154245329|NCT05589818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245330|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154245331|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154245332|NCT05571319|Metformin|metformin|mesh-list
154245333|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154245334|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245335|NCT05542615|Pirfenidone|pirfenidone|mesh-list
154245336|NCT05542615|Analgesics|analgesics|mesh-ancestor
154245337|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
154245338|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245339|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245340|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154245341|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154245342|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245343|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154245344|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245345|NCT05532163|Natalizumab|natalizumab|mesh-list
154245346|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
154245347|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245348|NCT05393271|Midazolam|midazolam|mesh-list
154245349|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154245350|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154245351|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245352|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245353|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154245354|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154245355|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154245356|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154245357|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
154245358|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
154245359|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
154245360|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
154245361|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245362|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245363|NCT05332561|Trastuzumab|trastuzumab|mesh-list
154245364|NCT05332561|Atezolizumab|atezolizumab|mesh-list
154245366|NCT05332561|Olaparib|olaparib|mesh-list
154245367|NCT05332561|Ipatasertib|ipatasertib|mesh-list
154245368|NCT05332561|Inavolisib|inavolisib|mesh-list
154245369|NCT05332561|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154245370|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245371|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245372|NCT05332561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154245373|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245374|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154245375|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245376|NCT05332561|Immunoconjugates|immunoconjugates|mesh-ancestor
154245377|NCT05332561|Immunologic Factors|immunologic factors|mesh-ancestor
154245378|NCT05332561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245379|NCT05332561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154245380|NCT05332561|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154245381|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154245382|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
154245383|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154245384|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154245385|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154245386|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245387|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245388|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154245389|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154245390|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154245391|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245392|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245393|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154245394|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245395|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245396|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
154245397|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245398|NCT05291130|Vitamin E|vitamin e|mesh-list
154245399|NCT05291130|Vitamins|vitamins|mesh-ancestor
154245400|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
154245401|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245402|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
154245403|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245404|NCT05291130|Protective Agents|protective agents|mesh-ancestor
154245405|NCT05243797|Lenalidomide|lenalidomide|mesh-list
154245406|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
154245407|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245408|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154245409|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154245410|NCT05243797|Growth Substances|growth substances|mesh-ancestor
154245411|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
154245412|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245413|NCT05206266|Turmeric extract|turmeric extract|mesh-list
154245414|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
154245415|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245416|NCT05206266|Protective Agents|protective agents|mesh-ancestor
154245417|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245418|NCT05169268|Aripiprazole|aripiprazole|mesh-list
154245419|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
154245420|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
154245421|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154245422|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154245423|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154245424|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245425|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245426|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
154245427|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
154245428|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245429|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245430|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154245431|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153992318|NCT05796401|Hematinics|hematinics|mesh-ancestor
154245432|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
154245433|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154245434|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154245435|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154245436|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154245437|NCT05166746|Clindamycin|clindamycin|mesh-list
154245438|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
154245439|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
154245440|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154245441|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245442|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154245443|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245444|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245445|NCT05160298|Ropivacaine|ropivacaine|mesh-list
154245446|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
154245447|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
154245448|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245449|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245450|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
154245451|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245452|NCT05155579|Vaccines|vaccines|mesh-list
154245453|NCT05155579|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154245454|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
154245455|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245456|NCT05143281|Dexamethasone|dexamethasone|mesh-list
154245457|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
154245458|NCT05143281|BB 1101|bb 1101|mesh-list
154245459|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245460|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
154245461|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
154245462|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245463|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245464|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154245465|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
154245466|NCT05143281|Hormones|hormones|mesh-ancestor
154245467|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245468|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154245469|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245470|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
154245471|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245472|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245473|NCT05117710|Ebselen|ebselen|mesh-list
154245474|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154245475|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154245476|NCT05117710|Analgesics|analgesics|mesh-ancestor
154245477|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
154245478|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245479|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245480|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245481|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154245482|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154245483|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154245484|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
154245485|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245486|NCT05117710|Protective Agents|protective agents|mesh-ancestor
154245487|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154245488|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245489|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154245490|NCT05105022|Propofol|propofol|mesh-list
154245491|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154245492|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245493|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245494|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154245495|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
154245496|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
154245497|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
154245498|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154245499|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
154245500|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245501|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
154245502|NCT05099718|Protective Agents|protective agents|mesh-ancestor
154245503|NCT05096468|Pregabalin|pregabalin|mesh-list
154245504|NCT05096468|Ketamine|ketamine|mesh-list
154245505|NCT05096468|Esketamine|esketamine|mesh-list
154245506|NCT05096468|Analgesics|analgesics|mesh-ancestor
154245507|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
154245508|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245509|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245510|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154245513|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
154245514|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245515|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154245516|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154245517|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245518|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245519|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
154245520|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154245521|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245522|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154245523|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154245524|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154245525|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154245526|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
154245527|NCT05084365|Sulforaphane|sulforaphane|mesh-list
154245528|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154245529|NCT05084365|Protective Agents|protective agents|mesh-ancestor
154245530|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245531|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245532|NCT05079789|Amiloride|amiloride|mesh-list
154245533|NCT05079789|Furosemide|furosemide|mesh-list
154245534|NCT05079789|Diuretics|diuretics|mesh-ancestor
154245535|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
154245536|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245537|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154245538|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245539|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245540|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154245541|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154245542|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154245543|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154245544|NCT05025423|Venetoclax|venetoclax|mesh-list
154245545|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154245546|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245547|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154245548|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
154245549|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245550|NCT05023993|Niacinamide|niacinamide|mesh-list
154245551|NCT05023993|Niacin|niacin|mesh-list
154245552|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
154245553|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
154245554|NCT05023993|Vitamins|vitamins|mesh-ancestor
154245555|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
154245556|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245557|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154245558|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
154245559|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245560|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154245561|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
154245562|NCT05021926|Lidocaine|lidocaine|mesh-list
154245563|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
154245564|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
154245565|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
154245566|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245567|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245568|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
154245569|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245570|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154245571|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154245572|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154245573|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245574|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245575|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154245576|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
154245577|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
154245578|NCT05021926|Protective Agents|protective agents|mesh-ancestor
154245579|NCT05021913|Lidocaine|lidocaine|mesh-list
154245580|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
154245581|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
154245582|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
154159685|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154245583|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245584|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245585|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
154245586|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245587|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154245588|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154245589|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154245590|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245591|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245592|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154245593|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
154245594|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
154245595|NCT05021913|Protective Agents|protective agents|mesh-ancestor
154245596|NCT04999241|Infliximab|infliximab|mesh-list
154245597|NCT04999241|Mesalamine|mesalamine|mesh-list
154245598|NCT04999241|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154245599|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245600|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
154245601|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154245602|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154245603|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154245604|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154245605|NCT04999241|Analgesics|analgesics|mesh-ancestor
154245606|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
154245607|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245608|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245609|NCT04992065|Evolocumab|evolocumab|mesh-list
154245610|NCT04992065|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154245611|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154245612|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154245613|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
154245614|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245615|NCT04992065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154245616|NCT04992065|Protease Inhibitors|protease inhibitors|mesh-ancestor
154245617|NCT04992065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245618|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154245619|NCT04906096|GDC-0084|gdc-0084|mesh-list
154245620|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245621|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245622|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
154245623|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
154245624|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245625|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
154245626|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154245627|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154245628|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245629|NCT04898114|Urological Agents|urological agents|mesh-ancestor
154245630|NCT04898114|Analgesics|analgesics|mesh-ancestor
154245631|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
154245632|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245633|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245634|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
154245635|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245636|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154245637|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
154245638|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154245639|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245640|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154245641|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
154245642|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154245644|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
154245645|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
154245646|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154245647|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
154245648|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154119785|NCT00942747|Sirolimus|sirolimus|mesh-list
154245649|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245650|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154245651|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154245652|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154245653|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154245654|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154245655|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245656|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
154245657|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154245658|NCT04867707|Zanamivir|zanamivir|mesh-list
154245659|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
154245660|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245661|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245662|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245663|NCT04860661|Esketamine|esketamine|mesh-list
154245664|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
154245665|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154245666|NCT04853199|Quercetin|quercetin|mesh-list
154245667|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
154245668|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245669|NCT04853199|Protective Agents|protective agents|mesh-ancestor
154245670|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245671|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154245672|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154245673|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245674|NCT04801485|Inositol|inositol|mesh-list
154245675|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
154245676|NCT04801485|Vitamins|vitamins|mesh-ancestor
154245677|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
154245678|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245679|NCT04753970|Cilostazol|cilostazol|mesh-list
154245680|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154245681|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
154245682|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245683|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245684|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154245685|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
154245686|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154245687|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154245688|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245689|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154245690|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
154245691|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154245692|NCT04753970|Protective Agents|protective agents|mesh-ancestor
154245693|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154245694|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154245696|NCT04741204|Metformin|metformin|mesh-list
154245697|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154245698|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245699|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154245700|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154119830|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
154245701|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245702|NCT04725188|Docetaxel|docetaxel|mesh-list
154245703|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
154245704|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245705|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
154245706|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
154245707|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
154245708|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245709|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245710|NCT04725188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154245711|NCT04723394|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154245712|NCT04723394|Antiviral Agents|antiviral agents|mesh-ancestor
154245713|NCT04723394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245714|NCT04718792|Psilocybin|psilocybin|mesh-list
154245715|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
154245716|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245717|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154245718|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154245719|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154245720|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245721|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
154245722|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154245723|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154245724|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245725|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
154245726|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154245727|NCT04613206|Vaccines|vaccines|mesh-list
154245728|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
154245729|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245730|NCT04590508|Xanthohumol|xanthohumol|mesh-list
154245731|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245732|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154245733|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154245735|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245736|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
154245737|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
154245738|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154245739|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
154245740|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245741|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
154245742|NCT04557527|Protective Agents|protective agents|mesh-ancestor
154245743|NCT04543383|Thrombin|thrombin|mesh-list
154245744|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
154245745|NCT04543383|Coagulants|coagulants|mesh-ancestor
154245746|NCT04532606|Anesthetics|anesthetics|mesh-list
154245747|NCT04532606|Propofol|propofol|mesh-list
154245748|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245749|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245750|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154245751|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154245752|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
154245753|NCT04513145|Ropivacaine|ropivacaine|mesh-list
154245754|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
154245755|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
154245756|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245757|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245758|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
154245759|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245760|NCT04460885|Insulin|insulin|mesh-list
154245761|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154245762|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
154245763|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154245764|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245765|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
154245766|NCT04417192|Olaparib|olaparib|mesh-list
154245767|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245768|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245769|NCT04417192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154254019|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
154245770|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245771|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154245773|NCT04409002|Niraparib|niraparib|mesh-list
154245774|NCT04409002|Dostarlimab|dostarlimab|mesh-list
154245775|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154245776|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245777|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245778|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245779|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154245780|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154245781|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245782|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245783|NCT04388384|Neratinib|neratinib|mesh-list
154245784|NCT04388384|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154245785|NCT04388384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154245786|NCT04388384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245787|NCT04388384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245788|NCT04343885|Docetaxel|docetaxel|mesh-list
154245789|NCT04343885|Pluvicto|pluvicto|mesh-list
154245790|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245791|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
154245792|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
154245793|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
154245794|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245795|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154245796|NCT04338061|Teriflunomide|teriflunomide|mesh-list
154245797|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154245798|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154245799|NCT04338061|Analgesics|analgesics|mesh-ancestor
154119929|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
154245800|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
154245801|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245802|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245803|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245804|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154245805|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154245806|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
154245807|NCT04310995|Nicorandil|nicorandil|mesh-list
154245808|NCT04310995|Diltiazem|diltiazem|mesh-list
154245810|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154245811|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154245812|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154245813|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154245814|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154245815|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245816|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154245817|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245818|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
154245819|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154245820|NCT04310995|Diuretics|diuretics|mesh-ancestor
154245821|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
154245822|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154245823|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154245824|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
154245825|NCT04310995|Vitamins|vitamins|mesh-ancestor
154245826|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
154245827|NCT04302324|Clarithromycin|clarithromycin|mesh-list
154245828|NCT04302324|Dexamethasone|dexamethasone|mesh-list
154245829|NCT04302324|Daratumumab|daratumumab|mesh-list
154245830|NCT04302324|Pomalidomide|pomalidomide|mesh-list
154245831|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245832|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
154245833|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
154245834|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245835|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245836|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154245837|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
154245838|NCT04302324|Hormones|hormones|mesh-ancestor
154245839|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245840|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154245841|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245842|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154245843|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154254022|NCT01236482|Oxytocin|oxytocin|mesh-list
154245845|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245846|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245847|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154245848|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154245849|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
154245850|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154245851|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154245852|NCT04302324|Growth Substances|growth substances|mesh-ancestor
154245853|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
154245854|NCT04270175|Dexamethasone|dexamethasone|mesh-list
154245855|NCT04270175|Daratumumab|daratumumab|mesh-list
154245856|NCT04270175|Pomalidomide|pomalidomide|mesh-list
154245857|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245858|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
154245859|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
154245860|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245861|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245862|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154245863|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
154245864|NCT04270175|Hormones|hormones|mesh-ancestor
154245865|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245866|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154245867|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245868|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
154245869|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154245870|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154245871|NCT04270175|Growth Substances|growth substances|mesh-ancestor
154245872|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
154245873|NCT04267549|Paclitaxel|paclitaxel|mesh-list
154245874|NCT04267549|Apatinib|apatinib|mesh-list
154245875|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154245876|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245877|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
154245878|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
154245879|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
154245880|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245881|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154245882|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245883|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
154245884|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
154245885|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154245886|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
154245887|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245888|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
154245889|NCT04262336|Protective Agents|protective agents|mesh-ancestor
154245890|NCT04262336|Antidotes|antidotes|mesh-ancestor
154245891|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
154245892|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245893|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
154245894|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154245895|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154245896|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
154245897|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
154245898|NCT04242238|Avelumab|avelumab|mesh-list
154245899|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245900|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245901|NCT04235959|Tirzepatide|tirzepatide|mesh-list
154245902|NCT04235959|Incretins|incretins|mesh-ancestor
154245903|NCT04235959|Hormones|hormones|mesh-ancestor
154245904|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245905|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245906|NCT04235101|Trastuzumab|trastuzumab|mesh-list
154245907|NCT04235101|Niraparib|niraparib|mesh-list
154245908|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154245909|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245910|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154245911|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245912|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245913|NCT04182360|Carbetocin|carbetocin|mesh-list
154245914|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
154245915|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154245916|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254023|NCT01236482|Ergonovine|ergonovine|mesh-list
154245917|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
154245918|NCT04147533|Dasatinib|dasatinib|mesh-list
154245919|NCT04147533|Nilotinib|nilotinib|mesh-list
154245920|NCT04147533|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154245921|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154245922|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245923|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245924|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245925|NCT04112368|Estradiol|estradiol|mesh-list
154245926|NCT04112368|Progesterone|progesterone|mesh-list
154245927|NCT04112368|Estrogens|estrogens|mesh-ancestor
154245928|NCT04112368|Hormones|hormones|mesh-ancestor
154245929|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245930|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245931|NCT04112368|Progestins|progestins|mesh-ancestor
154245932|NCT04088188|Cisplatin|cisplatin|mesh-list
154245933|NCT04088188|Gemcitabine|gemcitabine|mesh-list
154245934|NCT04088188|Ivosidenib|ivosidenib|mesh-list
154245935|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245936|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154245937|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
154245938|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245939|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245940|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
154245941|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
154245942|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245943|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245944|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245945|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
154245946|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
154245947|NCT04062123|Fentanyl|fentanyl|mesh-list
154245948|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
154245949|NCT04062123|Propofol|propofol|mesh-list
154245950|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154245951|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154245952|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245953|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154245954|NCT04062123|Analgesics|analgesics|mesh-ancestor
154245955|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
154245956|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154245957|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154245958|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154245959|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154245960|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
154245961|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154245962|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245964|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
154245965|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
154245966|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154245967|NCT04062123|Narcotics|narcotics|mesh-ancestor
154245968|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154245969|NCT03992261|Halobetasol|halobetasol|mesh-list
154245970|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154245971|NCT03991884|Prednisone|prednisone|mesh-list
154245972|NCT03991884|Cortisone|cortisone|mesh-list
154245973|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
154245974|NCT03991884|Doxorubicin|doxorubicin|mesh-list
154245975|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154245976|NCT03991884|Etoposide|etoposide|mesh-list
154245977|NCT03991884|Vincristine|vincristine|mesh-list
154245978|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
154245979|NCT03991884|Daunorubicin|daunorubicin|mesh-list
154245980|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
154245981|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154245982|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154245983|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
154245984|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154245985|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154245986|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154245987|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
154245988|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154245989|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154245990|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154245991|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154245992|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154245993|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154245994|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154245995|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154245996|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
154245997|NCT03991884|Hormones|hormones|mesh-ancestor
154245998|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154245999|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246000|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246001|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
154246002|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
154246003|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
154246004|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
154246005|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246006|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246007|NCT03991884|Immunotoxins|immunotoxins|mesh-ancestor
154246008|NCT03991884|Immunoconjugates|immunoconjugates|mesh-ancestor
154246009|NCT03978039|Immunomodulating Agents|immunomodulating agents|mesh-list
154246010|NCT03978039|Immunologic Factors|immunologic factors|mesh-ancestor
154246011|NCT03978039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246012|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
154246013|NCT03890289|Idelalisib|idelalisib|mesh-list
154246014|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246015|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246016|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246017|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246018|NCT03800602|Metformin|metformin|mesh-list
154246019|NCT03800602|Nivolumab|nivolumab|mesh-list
154246020|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154246021|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246022|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246023|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246024|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246025|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246026|NCT03779191|Bevacizumab|bevacizumab|mesh-list
154246027|NCT03779191|Alectinib|alectinib|mesh-list
154246028|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246029|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246030|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154246031|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154246032|NCT03779191|Growth Substances|growth substances|mesh-ancestor
154246033|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246034|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
154246035|NCT03779191|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154246036|NCT03779191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154246037|NCT03779191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393025|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154246038|NCT03779191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246039|NCT03775902|Nicorandil|nicorandil|mesh-list
154246041|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154246042|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
154246043|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
154246044|NCT03775902|Vitamins|vitamins|mesh-ancestor
154246045|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
154246046|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246047|NCT03743662|Bevacizumab|bevacizumab|mesh-list
154246048|NCT03743662|Nivolumab|nivolumab|mesh-list
154246049|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246050|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246051|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154246052|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154246053|NCT03743662|Growth Substances|growth substances|mesh-ancestor
154246054|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246055|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
154246056|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246057|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246058|NCT03651206|Niraparib|niraparib|mesh-list
154246059|NCT03651206|Dostarlimab|dostarlimab|mesh-list
154246060|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154246061|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246062|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246063|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246064|NCT03485417|Aripiprazole|aripiprazole|mesh-list
154246065|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154246066|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
154246067|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154246068|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154246069|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154246070|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154246071|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246072|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
154246073|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
154246074|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154246075|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246076|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154246077|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154246078|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
154246079|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154246080|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154246081|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154246082|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154246084|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
154246085|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154246086|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154246087|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154246088|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154246089|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246090|NCT03485274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154246091|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154246092|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154246093|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246094|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154246095|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
154246096|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154246097|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154246098|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154246099|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154246100|NCT03434028|Norepinephrine|norepinephrine|mesh-list
154246101|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154246102|NCT03434028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154246103|NCT03434028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154246104|NCT03434028|Adrenergic Agents|adrenergic agents|mesh-ancestor
154246105|NCT03434028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154246106|NCT03434028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246107|NCT03434028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246108|NCT03434028|Sympathomimetics|sympathomimetics|mesh-ancestor
154246109|NCT03434028|Autonomic Agents|autonomic agents|mesh-ancestor
154246110|NCT03434028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246112|NCT03393845|Fulvestrant|fulvestrant|mesh-list
154246113|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246114|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246115|NCT03393845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246116|NCT03393845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246117|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246118|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154246119|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154246120|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
154246121|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246122|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246124|NCT03391427|Ketamine|ketamine|mesh-list
154246125|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
154246126|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
154246127|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154246128|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246129|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
154246130|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246131|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154246132|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154246133|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154246134|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154246135|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246136|NCT03391427|Analgesics|analgesics|mesh-ancestor
154246137|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154246138|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154246139|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
154246140|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154246141|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154246142|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154246143|NCT03290950|Dexamethasone|dexamethasone|mesh-list
154246144|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
154246145|NCT03290950|Lenalidomide|lenalidomide|mesh-list
154246146|NCT03290950|Daratumumab|daratumumab|mesh-list
154246147|NCT03290950|BB 1101|bb 1101|mesh-list
154246148|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246149|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
154246150|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
154246151|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246152|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246153|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154246154|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
154246155|NCT03290950|Hormones|hormones|mesh-ancestor
154246156|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246157|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246158|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246159|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
154246160|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246161|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246162|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
154246163|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154246164|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154246165|NCT03290950|Growth Substances|growth substances|mesh-ancestor
154246166|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
154246167|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
154246168|NCT03264404|Azacitidine|azacitidine|mesh-list
154246169|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246170|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246171|NCT03264404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246172|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246173|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246174|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
154246175|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246176|NCT03241745|Nivolumab|nivolumab|mesh-list
154246177|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246178|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246179|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246180|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246181|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
154246182|NCT03129555|Apixaban|apixaban|mesh-list
154246183|NCT03129555|Edoxaban|edoxaban|mesh-list
154246184|NCT03129555|Dabigatran|dabigatran|mesh-list
154160302|NCT00684515|Aspirin|aspirin|mesh-list
154246185|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153993056|NCT05329454|Ibuprofen|ibuprofen|mesh-list
154246187|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154246188|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
154246189|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246190|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246191|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
154246192|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
154246193|NCT03129490|Apixaban|apixaban|mesh-list
154246194|NCT03129490|Edoxaban|edoxaban|mesh-list
154246195|NCT03129490|Dabigatran|dabigatran|mesh-list
154246196|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154246197|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
154246198|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154246199|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
154246200|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246201|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246202|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
154246203|NCT03121014|Methotrexate|methotrexate|mesh-list
154246204|NCT03121014|Fludarabine|fludarabine|mesh-list
154246205|NCT03121014|Busulfan|busulfan|mesh-list
154246206|NCT03121014|Tacrolimus|tacrolimus|mesh-list
154246207|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
154246208|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154246209|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
154246210|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154246211|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246212|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246213|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
154246214|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246216|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246217|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246218|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154246219|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246220|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
154246221|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246222|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154246223|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154246224|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
154246225|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246226|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246227|NCT03118570|Vitamin D|vitamin d|mesh-list
154246228|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
154246229|NCT03118570|Calcium|calcium|mesh-list
154246230|NCT03118570|Vitamins|vitamins|mesh-ancestor
154246231|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
154246232|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246233|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154246234|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154246235|NCT03076320|Adapalene|adapalene|mesh-list
154246236|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154246237|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246238|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154246239|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154246240|NCT03076320|Analgesics|analgesics|mesh-ancestor
154246241|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
154246242|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246243|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246244|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246245|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246246|NCT03066739|Remifentanil|remifentanil|mesh-list
154246247|NCT03066739|Naloxone|naloxone|mesh-list
154246248|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154246249|NCT03066739|Narcotics|narcotics|mesh-ancestor
154246250|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154246251|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246252|NCT03066739|Analgesics|analgesics|mesh-ancestor
154246253|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
154246254|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246255|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154246256|NCT03033303|Isotretinoin|isotretinoin|mesh-list
154246257|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246258|NCT03009981|Prednisone|prednisone|mesh-list
154246259|NCT03009981|Leuprolide|leuprolide|mesh-list
154246260|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
154246261|NCT03009981|Bicalutamide|bicalutamide|mesh-list
154246262|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246263|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
154246264|NCT03009981|Hormones|hormones|mesh-ancestor
154246265|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246266|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246267|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246268|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246269|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154246270|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
154246271|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154246272|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154246273|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246274|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246275|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
154246276|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154246277|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
154246278|NCT02971683|Abatacept|abatacept|mesh-list
154246279|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246280|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246281|NCT02971683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246282|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246283|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246284|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
154246285|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246286|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246287|NCT02921022|Paclitaxel|paclitaxel|mesh-list
154246288|NCT02921022|Gemcitabine|gemcitabine|mesh-list
154246289|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246290|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246291|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
154246292|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
154246293|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
154246294|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246295|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246296|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
154246297|NCT02899299|Carboplatin|carboplatin|mesh-list
154246298|NCT02899299|Nivolumab|nivolumab|mesh-list
154246299|NCT02899299|Pemetrexed|pemetrexed|mesh-list
154246300|NCT02899299|Ipilimumab|ipilimumab|mesh-list
154246301|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246302|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246303|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246304|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246305|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246306|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154246307|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154246308|NCT02899195|Durvalumab|durvalumab|mesh-list
154246309|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246310|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246311|NCT02833233|Nivolumab|nivolumab|mesh-list
154246312|NCT02833233|Ipilimumab|ipilimumab|mesh-list
154246313|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246314|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246315|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246316|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246317|NCT02814916|Dalbavancin|dalbavancin|mesh-list
154246318|NCT02814916|Teicoplanin|teicoplanin|mesh-list
154246319|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154246320|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246321|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
154246322|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154246323|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
154246324|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246325|NCT02804594|Expectorants|expectorants|mesh-ancestor
154246326|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
154246327|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154246328|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
154246329|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246330|NCT02804594|Protective Agents|protective agents|mesh-ancestor
154246331|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246332|NCT02804594|Antidotes|antidotes|mesh-ancestor
154246333|NCT02728050|Cytarabine|cytarabine|mesh-list
154246334|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154246335|NCT02728050|Sorafenib|sorafenib|mesh-list
154393026|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
154246336|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
154246337|NCT02728050|Cladribine|cladribine|mesh-list
154246338|NCT02728050|Lenograstim|lenograstim|mesh-list
153993207|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
154246339|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246341|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246342|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246343|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
154246344|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246345|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246346|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
154246347|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246348|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154246349|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154246350|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246351|NCT02728050|Analgesics|analgesics|mesh-ancestor
154246352|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
154246353|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246354|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154246355|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246356|NCT02581943|Paclitaxel|paclitaxel|mesh-list
154246357|NCT02581943|Carboplatin|carboplatin|mesh-list
154246358|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
154246359|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154246360|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246361|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246362|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
154246363|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
154246364|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
154246365|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246366|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246367|NCT02581943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246369|NCT02527200|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154246370|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154246371|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246372|NCT02527200|Incretins|incretins|mesh-ancestor
154246373|NCT02527200|Hormones|hormones|mesh-ancestor
154246374|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246375|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
154246376|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154246377|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154246378|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246379|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
154246380|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154246381|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246382|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
154246383|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
154246384|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246385|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
154246386|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246387|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246388|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246389|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
154246390|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246391|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246392|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246393|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246394|NCT02414269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246395|NCT02341989|Carboplatin|carboplatin|mesh-list
154246396|NCT02341989|Etoposide|etoposide|mesh-list
154246397|NCT02341989|Bleomycin|bleomycin|mesh-list
154246398|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246399|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246400|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154246401|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246402|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246403|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246404|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154246405|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154246406|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154246407|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246408|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
154246409|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246410|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246411|NCT02267603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153993301|NCT02619747|Antacids|antacids|mesh-ancestor
154246412|NCT02267603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246414|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
154246415|NCT02244125|Pomalidomide|pomalidomide|mesh-list
154246416|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246417|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
154246418|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246419|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246420|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246421|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
154246422|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246423|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246424|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246425|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246426|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
154246427|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
154246428|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246429|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154246430|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
154246432|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246433|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246434|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154246435|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154246436|NCT02244125|Growth Substances|growth substances|mesh-ancestor
154246437|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
154246439|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154246440|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154246441|NCT02243878|Growth Substances|growth substances|mesh-ancestor
154246442|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246443|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
154246444|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246445|NCT02199236|Capecitabine|capecitabine|mesh-list
154246446|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246447|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
154246448|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246449|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246450|NCT01935089|Interferons|interferons|mesh-list
154246451|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
154246452|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
154246453|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154246454|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246455|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
154246456|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246457|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
154246458|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246459|NCT01803152|Gemcitabine|gemcitabine|mesh-list
154246460|NCT01803152|Imiquimod|imiquimod|mesh-list
154246461|NCT01803152|Vaccines|vaccines|mesh-list
154246462|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
154246463|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246464|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246465|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
154246466|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246467|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246468|NCT01803152|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154246469|NCT01803152|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154246470|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154246471|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
154246472|NCT01773707|Abatacept|abatacept|mesh-list
154246473|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246474|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246475|NCT01773707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246476|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246477|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246478|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
154246479|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246480|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246481|NCT01628640|Interferons|interferons|mesh-list
154246482|NCT01628640|Interferon-beta|interferon-beta|mesh-list
154246483|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246484|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
154246485|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246486|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
154120623|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
154246487|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246489|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246491|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154246492|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154246493|NCT01334944|Analgesics|analgesics|mesh-ancestor
154246494|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
154246495|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246496|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246497|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246498|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246499|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154246500|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246501|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246502|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
154246503|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246504|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
154246505|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246506|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246507|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246508|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
154246509|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246510|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246511|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246513|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
154246514|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154246515|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154246516|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246517|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154246518|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246519|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
154246520|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
154246521|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154246522|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154246523|NCT00719888|Cyclosporine|cyclosporine|mesh-list
154246524|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
154246525|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
154246526|NCT00719888|Thiotepa|thiotepa|mesh-list
154246527|NCT00719888|Fludarabine|fludarabine|mesh-list
154246528|NCT00719888|Cyclosporins|cyclosporins|mesh-list
154246529|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246530|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
154246531|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246532|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120658|NCT00812448|Protective Agents|protective agents|mesh-ancestor
154246533|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246534|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
154246535|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246536|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246537|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246538|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246539|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
154246540|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246541|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246542|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154246543|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154246544|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154246545|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
154246546|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154246547|NCT00571727|Mecasermin|mecasermin|mesh-list
154246548|NCT00571727|Growth Substances|growth substances|mesh-ancestor
154246549|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246550|NCT00427349|Octreotide|octreotide|mesh-list
154246551|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
154246552|NCT00427349|Imetelstat|imetelstat|mesh-list
154246553|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154246554|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246555|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246556|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154246557|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246558|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993444|NCT02618733|Clopidogrel|clopidogrel|mesh-list
154246559|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154246560|NCT00200174|Exemestane|exemestane|mesh-list
154246561|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246562|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154393027|NCT02393482|Vitamins|vitamins|mesh-ancestor
154246563|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154246564|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246565|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246566|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154246567|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
154246568|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246569|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246570|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154246571|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154246572|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154246573|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154246574|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
154246575|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
154246576|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246577|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246578|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154246579|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154246580|NCT00195091|Growth Substances|growth substances|mesh-ancestor
154246581|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246582|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
154246583|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246584|NCT00098787|Leucovorin|leucovorin|mesh-list
154246585|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
154246586|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
154246587|NCT00098787|Bevacizumab|bevacizumab|mesh-list
154246588|NCT00098787|Fluorouracil|fluorouracil|mesh-list
154246589|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
154246590|NCT00098787|Irinotecan|irinotecan|mesh-list
154246591|NCT00098787|Camptothecin|camptothecin|mesh-list
154246592|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
154246593|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246594|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246595|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154246596|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154246597|NCT00098787|Growth Substances|growth substances|mesh-ancestor
154246598|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246599|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
154246600|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
154246601|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246602|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246603|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246604|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
154246605|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154246606|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246607|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246608|NCT00098787|Antidotes|antidotes|mesh-ancestor
154246609|NCT00098787|Protective Agents|protective agents|mesh-ancestor
154246610|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
154246611|NCT00098787|Vitamins|vitamins|mesh-ancestor
154246612|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
154246613|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246614|NCT00074165|Cytarabine|cytarabine|mesh-list
154246615|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
154246616|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
154246617|NCT00074165|Rituximab|rituximab|mesh-list
154246618|NCT00074165|Carboplatin|carboplatin|mesh-list
154246619|NCT00074165|Etoposide|etoposide|mesh-list
154246620|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
154246621|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246622|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
154246623|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246624|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246625|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246626|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
154246627|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246628|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246629|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246630|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246631|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246632|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154246633|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246634|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246635|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246636|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
154246637|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
154246638|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246639|NCT00074165|Antidotes|antidotes|mesh-ancestor
154246640|NCT00074165|Protective Agents|protective agents|mesh-ancestor
154246641|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
154246642|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
154246643|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154246644|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
154246645|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
154246646|NCT00059930|Leucovorin|leucovorin|mesh-list
154246647|NCT00059930|Dexamethasone|dexamethasone|mesh-list
154246648|NCT00059930|Fluorouracil|fluorouracil|mesh-list
154246649|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
154246650|NCT00059930|Floxuridine|floxuridine|mesh-list
154246651|NCT00059930|Calcium|calcium|mesh-list
154246652|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
154246653|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246654|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
154246655|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
154246656|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246657|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246658|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154246659|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
154246661|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246662|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246663|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246664|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154246665|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
154246666|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246667|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246668|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246669|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
154246670|NCT00059930|Antidotes|antidotes|mesh-ancestor
154246671|NCT00059930|Protective Agents|protective agents|mesh-ancestor
154246672|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
154246673|NCT00059930|Vitamins|vitamins|mesh-ancestor
154246674|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
154246675|NCT00057876|Gemcitabine|gemcitabine|mesh-list
154246676|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246677|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
154246678|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246679|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246680|NCT00057837|Cisplatin|cisplatin|mesh-list
154246681|NCT00057837|Irinotecan|irinotecan|mesh-list
154246682|NCT00057837|Etoposide|etoposide|mesh-list
154246683|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
154246684|NCT00057837|Topotecan|topotecan|mesh-list
154246685|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
154246686|NCT00057837|Camptothecin|camptothecin|mesh-list
154246687|NCT00057837|Lenograstim|lenograstim|mesh-list
154246688|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246689|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154246690|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246691|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246692|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246693|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246694|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154246695|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154246696|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
154246697|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246698|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
154246699|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246700|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
154246701|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
154246702|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
154246703|NCT00046930|Cytarabine|cytarabine|mesh-list
154246704|NCT00046930|Daunorubicin|daunorubicin|mesh-list
154246705|NCT00046930|Molgramostim|molgramostim|mesh-list
154246706|NCT00046930|Lenograstim|lenograstim|mesh-list
154246707|NCT00046930|Sargramostim|sargramostim|mesh-list
154246708|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246709|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
154246710|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246711|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246712|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
154246713|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246714|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246715|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
154246716|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246717|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154246718|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154246719|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154246720|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246721|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246723|NCT00042939|Irinotecan|irinotecan|mesh-list
154246724|NCT00042939|Cetuximab|cetuximab|mesh-list
154246725|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246726|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
154246727|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
154246728|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
154246729|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246730|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154246731|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246732|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246733|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246734|NCT00008385|Selenium|selenium|mesh-list
154246735|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
154246736|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246737|NCT00008385|Protective Agents|protective agents|mesh-ancestor
154246738|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246739|NCT00008385|Trace Elements|trace elements|mesh-ancestor
154246740|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
154246741|NCT00003927|Paclitaxel|paclitaxel|mesh-list
154246742|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
154246743|NCT00003927|Doxorubicin|doxorubicin|mesh-list
154246744|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154246745|NCT00003927|Amifostine|amifostine|mesh-list
154246746|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246747|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246748|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
154246749|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
154246750|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
154246751|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246752|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246753|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
154246754|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246755|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246756|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246757|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
154246758|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246759|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154246760|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154246761|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246762|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246763|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154246764|NCT00003927|Protective Agents|protective agents|mesh-ancestor
154246765|NCT00003910|Prednisone|prednisone|mesh-list
154246766|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
154246767|NCT00003910|Methotrexate|methotrexate|mesh-list
154246768|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246769|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
154246770|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246771|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246772|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246773|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
154246774|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246775|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246776|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246777|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246778|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
154246779|NCT00003910|Hormones|hormones|mesh-ancestor
154246780|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246781|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246782|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154246783|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
154246784|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154246785|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246786|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
154246787|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246788|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246789|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154246790|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154246791|NCT00003907|Cisplatin|cisplatin|mesh-list
154246792|NCT00003907|Doxorubicin|doxorubicin|mesh-list
154160884|NCT00489489|Analgesics|analgesics|mesh-ancestor
154246793|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154246794|NCT00003907|Mitomycins|mitomycins|mesh-list
154246795|NCT00003907|Mitomycin|mitomycin|mesh-list
154246796|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246797|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154246798|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154246799|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154246800|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246801|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246802|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
154246803|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154246804|NCT04331067|Paclitaxel|paclitaxel|mesh-list
154246805|NCT04331067|Carboplatin|carboplatin|mesh-list
154246806|NCT04331067|Nivolumab|nivolumab|mesh-list
154246807|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154246808|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246809|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
154246810|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
154246811|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
154246812|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246813|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246814|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246815|NCT04329221|Calcitriol|calcitriol|mesh-list
154246816|NCT04329221|Fluorouracil|fluorouracil|mesh-list
154246817|NCT04329221|Calcipotriene|calcipotriene|mesh-list
154246818|NCT04329221|Petrolatum|petrolatum|mesh-list
154246819|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
154246820|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246821|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246822|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246823|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246824|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
154246825|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246826|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246827|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154246828|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154246829|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154246830|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154246831|NCT04329221|Vitamins|vitamins|mesh-ancestor
154246832|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
154246833|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154246834|NCT04329221|Emollients|emollients|mesh-ancestor
154246835|NCT04316013|Lidocaine|lidocaine|mesh-list
154246836|NCT04316013|Propofol|propofol|mesh-list
154246837|NCT04316013|Sevoflurane|sevoflurane|mesh-list
154246838|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
154246839|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
154246840|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154246841|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246842|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
154246843|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246844|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154246845|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154246846|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154246847|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154246848|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246849|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154246850|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154246851|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
154246852|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154246853|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154246854|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154246855|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
154246856|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154246857|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246858|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246859|NCT04264897|Metformin|metformin|mesh-list
154246860|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154246861|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246862|NCT04225026|Manganese|manganese|mesh-list
154246863|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
154246864|NCT04225026|Trace Elements|trace elements|mesh-ancestor
154246865|NCT04225026|Micronutrients|micronutrients|mesh-ancestor
154246866|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246867|NCT04225026|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154246868|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
154246875|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246876|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154246877|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246878|NCT04111627|Analgesics|analgesics|mesh-ancestor
154246879|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
154246880|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246881|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
154246882|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154246883|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
154246884|NCT04090710|Nivolumab|nivolumab|mesh-list
154246885|NCT04090710|Ipilimumab|ipilimumab|mesh-list
154254047|NCT01140308|Vitamins|vitamins|mesh-ancestor
154246886|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246887|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246888|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246889|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246890|NCT03982277|Rifampin|rifampin|mesh-list
154246891|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154246892|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
154246893|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154246894|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246895|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
154246896|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154246897|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246898|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246899|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154246900|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154246901|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154246902|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154246903|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154246904|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154246905|NCT03955978|Dostarlimab|dostarlimab|mesh-list
154246906|NCT03955978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246907|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
154246908|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
154246909|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154246910|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
154246911|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246912|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154246913|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154246914|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
154246915|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246916|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246917|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154246918|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246919|NCT03918499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246926|NCT03711474|Dexamethasone|dexamethasone|mesh-list
154246927|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154246928|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
154246929|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
154246930|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154246931|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246932|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154246933|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
154246934|NCT03711474|Hormones|hormones|mesh-ancestor
154246935|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246936|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154246937|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246938|NCT03482024|Tirzepatide|tirzepatide|mesh-list
154246939|NCT03482024|Incretins|incretins|mesh-ancestor
154246940|NCT03482024|Hormones|hormones|mesh-ancestor
154161043|NCT01034878|Sunitinib|sunitinib|mesh-list
154393028|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
154246941|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246942|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246943|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
154246944|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154246945|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154246946|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154246947|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
154246948|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
154246949|NCT03418532|Osimertinib|osimertinib|mesh-list
154246950|NCT03418532|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154246951|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154246952|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154246953|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246954|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246955|NCT03417401|Plasminogen|plasminogen|mesh-list
154246956|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154246957|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154246958|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154246959|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246960|NCT03322631|Tirzepatide|tirzepatide|mesh-list
154246961|NCT03322631|Incretins|incretins|mesh-ancestor
154246962|NCT03322631|Hormones|hormones|mesh-ancestor
154246963|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154246964|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246965|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
154246966|NCT03290612|Vitamins|vitamins|mesh-ancestor
154246967|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
154246968|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246969|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
154246970|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246971|NCT03290612|Protective Agents|protective agents|mesh-ancestor
154246972|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154246973|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154246974|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246975|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154246976|NCT03057795|Nivolumab|nivolumab|mesh-list
154246977|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154246978|NCT03057795|Antibodies|antibodies|mesh-list
154246979|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
154246980|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154246981|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
154246982|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
154246983|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246984|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246985|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154246986|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246987|NCT03057795|Immunotoxins|immunotoxins|mesh-ancestor
154246988|NCT03018704|Topiramate|topiramate|mesh-list
154246989|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
154246990|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154246991|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154246992|NCT02978612|Capecitabine|capecitabine|mesh-list
154246993|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154246994|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
154246995|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154246996|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154246997|NCT02970500|Methylphenidate|methylphenidate|mesh-list
154246998|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154246999|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247000|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154247001|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154247002|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154247003|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247004|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
154247005|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247006|NCT02617407|Listerine|listerine|mesh-list
154247007|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
154247008|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
154247009|NCT02617407|Protective Agents|protective agents|mesh-ancestor
154247010|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247011|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154247012|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247013|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
154247014|NCT02537509|Vitamin D|vitamin d|mesh-list
154247015|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154247023|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154247024|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154247025|NCT02490878|Growth Substances|growth substances|mesh-ancestor
154247026|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247027|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
154247028|NCT02332850|Dexamethasone|dexamethasone|mesh-list
154247029|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247030|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
154247031|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
154247032|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247033|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247034|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247035|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
154247036|NCT02332850|Hormones|hormones|mesh-ancestor
154247037|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247038|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154247039|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247040|NCT02205762|Cytarabine|cytarabine|mesh-list
154247041|NCT02205762|Prednisone|prednisone|mesh-list
154247042|NCT02205762|Indomethacin|indomethacin|mesh-list
154247043|NCT02205762|Methotrexate|methotrexate|mesh-list
154247044|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
154247045|NCT02205762|Vinblastine|vinblastine|mesh-list
154247046|NCT02205762|Cladribine|cladribine|mesh-list
154247047|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
154247048|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154247049|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
154247050|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154247051|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247052|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
154247053|NCT02205762|Hormones|hormones|mesh-ancestor
154247054|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247055|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247056|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154247057|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247058|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154247059|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
154247060|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154247061|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154247062|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
154247063|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247064|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
154247065|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247066|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154247067|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247068|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
154247069|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247070|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154247071|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
154247072|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247073|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154247074|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
154247075|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247076|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247077|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154247078|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154247079|NCT02205762|Analgesics|analgesics|mesh-ancestor
154247080|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
154247081|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247082|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
154247083|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
154247084|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154247141|NCT00385606|Gemcitabine|gemcitabine|mesh-list
154247142|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247143|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154247144|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
154247145|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247146|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154247147|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154247148|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247149|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154247150|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154247151|NCT00385606|Analgesics|analgesics|mesh-ancestor
154247152|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
154247153|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247154|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247155|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247156|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247158|NCT03721744|Gemcitabine|gemcitabine|mesh-list
154247159|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154247160|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247161|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154247162|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247163|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247164|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247165|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154247166|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
154247167|NCT01589354|Ropivacaine|ropivacaine|mesh-list
154247168|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
154247169|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
154247170|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247171|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247172|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
154247173|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247174|NCT01583660|Acetaminophen|acetaminophen|mesh-list
154247175|NCT01583660|Celecoxib|celecoxib|mesh-list
154247176|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154247177|NCT01583660|Oxycodone|oxycodone|mesh-list
154247178|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154247179|NCT01583660|Analgesics|analgesics|mesh-ancestor
154247180|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
154247181|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121226|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
154247182|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247183|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
154247184|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154247185|NCT01583660|Narcotics|narcotics|mesh-ancestor
154247186|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247187|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154247188|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247189|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247190|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154247191|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154247192|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247193|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247194|NCT01583816|Resiquimod|resiquimod|mesh-list
154247195|NCT01583816|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154247196|NCT01583816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247197|NCT01583816|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154247198|NCT01583816|Immunologic Factors|immunologic factors|mesh-ancestor
154247199|NCT01583816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247200|NCT01089218|Amoxicillin|amoxicillin|mesh-list
154247201|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
154247202|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
154247203|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154247204|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247205|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247206|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154247207|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247208|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247209|NCT03957668|Lactulose|lactulose|mesh-list
154247210|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154247211|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247212|NCT03957668|Laxatives|laxatives|mesh-ancestor
154247213|NCT01089452|Amlodipine|amlodipine|mesh-list
154247214|NCT01089452|Olmesartan|olmesartan|mesh-list
154247215|NCT01089452|Perindopril|perindopril|mesh-list
154247216|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154247217|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154247218|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154247219|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247220|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154247221|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247222|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
154247223|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154121273|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
154247224|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154247225|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154247226|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
154247227|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247228|NCT04880980|Itraconazole|itraconazole|mesh-list
154247229|NCT04880980|Terbinafine|terbinafine|mesh-list
154247230|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
154247231|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247232|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154247233|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154247234|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247235|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247236|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154247237|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
154247238|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247239|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247240|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154247241|NCT01583504|Anesthetics|anesthetics|mesh-list
154247242|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
154247243|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247244|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247245|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
154247246|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247248|NCT01583036|Ezogabine|ezogabine|mesh-list
154247249|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154247250|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154247251|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247252|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247253|NCT01583036|Protective Agents|protective agents|mesh-ancestor
154247254|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247255|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
154247256|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154247257|NCT01091792|Bevacizumab|bevacizumab|mesh-list
154247258|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154247259|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247260|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154247261|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154247262|NCT01091792|Growth Substances|growth substances|mesh-ancestor
154121318|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247263|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247264|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
154247265|NCT03510910|Acetaminophen|acetaminophen|mesh-list
154247266|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154247267|NCT03510910|Analgesics|analgesics|mesh-ancestor
154247268|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
154247269|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247270|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247271|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
154247272|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
154247273|NCT01091870|Citric Acid|citric acid|mesh-list
154247274|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
154247275|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
154247276|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154247277|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
154247278|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
154247279|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247280|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
154247281|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154247282|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154247283|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247284|NCT01091870|Urological Agents|urological agents|mesh-ancestor
154247285|NCT03509350|Vitamins|vitamins|mesh-list
154247286|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
154247287|NCT03509350|Thiamine|thiamine|mesh-list
154247288|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
154247289|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154247290|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154247291|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154247292|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
154247293|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247294|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247295|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
154247296|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247297|NCT03509350|Protective Agents|protective agents|mesh-ancestor
154247298|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
154247299|NCT03478696|Budesonide|budesonide|mesh-list
154247300|NCT03478696|Albuterol|albuterol|mesh-list
154247301|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
154247302|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
154247303|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154247304|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247305|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154247306|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
154247307|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247308|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247309|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154247310|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
154247311|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
154247312|NCT03478696|Hormones|hormones|mesh-ancestor
154247313|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247314|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154247315|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154247316|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154247317|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
154247318|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121359|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247319|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247320|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
154247321|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154247322|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
154247323|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
154247324|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154247325|NCT00072176|Sirolimus|sirolimus|mesh-list
154247326|NCT00072176|Temsirolimus|temsirolimus|mesh-list
154247327|NCT00072176|MTOR Inhibitors|mtor inhibitors|mesh-list
154247328|NCT00072176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154247329|NCT00072176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247330|NCT00072176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247331|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247332|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
154247333|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247334|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247335|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247336|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247337|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154247338|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
154247339|NCT00071396|Rituximab|rituximab|mesh-list
154247340|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
154247341|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154247342|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247343|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
154247344|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247345|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247346|NCT03472534|Diacerein|diacerein|mesh-list
154247347|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247348|NCT03725020|Fluorides|fluorides|mesh-list
154247349|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
154247350|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
154247351|NCT03725020|Protective Agents|protective agents|mesh-ancestor
154247352|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247353|NCT03721432|Pregabalin|pregabalin|mesh-list
154247354|NCT03721432|Analgesics|analgesics|mesh-ancestor
154247355|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
154247356|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247357|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247358|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
154247359|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154247360|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154247361|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247362|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154247363|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154247364|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154247365|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247366|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154247367|NCT03469336|Betamethasone|betamethasone|mesh-list
154247368|NCT03469336|Calcipotriene|calcipotriene|mesh-list
154121414|NCT00821496|Norinyl|norinyl|mesh-list
154247369|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247370|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
154247371|NCT03469336|Hormones|hormones|mesh-ancestor
154247372|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247373|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247374|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154247375|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
154247376|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
154247377|NCT03719560|Cytarabine|cytarabine|mesh-list
154247378|NCT03719560|Methotrexate|methotrexate|mesh-list
154247379|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154247380|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
154247381|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154247382|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247383|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154247384|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
154255885|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154247385|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247386|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247387|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
154247388|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247389|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154247390|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247391|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
154247392|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247393|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154247394|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
154247395|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247397|NCT03469258|Pancreatin|pancreatin|mesh-list
154247398|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247399|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
154247400|NCT00066170|Modafinil|modafinil|mesh-list
154247401|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154247402|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247403|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154247404|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154247405|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154247406|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247407|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154247408|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154247409|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
154247410|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
154247411|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247412|NCT00065468|Interferons|interferons|mesh-list
154247413|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
154247414|NCT00065468|Sirolimus|sirolimus|mesh-list
154247415|NCT00065468|Temsirolimus|temsirolimus|mesh-list
154247416|NCT00065468|MTOR Inhibitors|mtor inhibitors|mesh-list
154247417|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247418|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
154247419|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247420|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
154247421|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247422|NCT00065468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154247423|NCT00065468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247424|NCT00065468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247425|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247426|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247427|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154247428|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
154247429|NCT00071006|Axitinib|axitinib|mesh-list
154247430|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247431|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154247432|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247433|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247434|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154247435|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154247436|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247437|NCT00094107|Axitinib|axitinib|mesh-list
154247438|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247439|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154247440|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247441|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247442|NCT00102063|Aripiprazole|aripiprazole|mesh-list
154247443|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
154247444|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154247445|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154247446|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154247447|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247448|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247449|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
154247450|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
154247451|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247452|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247453|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154121512|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154247454|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154247455|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
154247456|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154247457|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154247458|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154247459|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154247460|NCT00065156|Lenalidomide|lenalidomide|mesh-list
154247461|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
154247462|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247463|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154247464|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154247465|NCT00065156|Growth Substances|growth substances|mesh-ancestor
154247466|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
154247467|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247468|NCT01094210|Fluorides|fluorides|mesh-list
154247469|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
154247470|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
154247471|NCT01094210|Protective Agents|protective agents|mesh-ancestor
154247472|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247473|NCT01094444|Vitamin K|vitamin k|mesh-list
154247474|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
154247475|NCT01094444|Vitamins|vitamins|mesh-ancestor
154247476|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
154247477|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247478|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154247479|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154247480|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247481|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
154247482|NCT01094444|Coagulants|coagulants|mesh-ancestor
154247483|NCT00078819|Etanercept|etanercept|mesh-list
154247484|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154247485|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154247486|NCT00078819|Analgesics|analgesics|mesh-ancestor
154247487|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
154247488|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247489|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247490|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247491|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247492|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247493|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247494|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
154247495|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154247496|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154247497|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247498|NCT00098865|Thalidomide|thalidomide|mesh-list
154247499|NCT00098865|Temozolomide|temozolomide|mesh-list
154247500|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154247501|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
154247502|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247503|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247504|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247505|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
154247506|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247507|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
154247508|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247509|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247510|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154247511|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154247512|NCT00098865|Growth Substances|growth substances|mesh-ancestor
154247513|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
154247514|NCT01084863|Paclitaxel|paclitaxel|mesh-list
154247515|NCT01084863|Trastuzumab|trastuzumab|mesh-list
154247516|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154247517|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247518|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
154247519|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247520|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247521|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247522|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154247523|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
154247524|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154247525|NCT03719404|Eusol|eusol|mesh-list
154247526|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154247527|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247528|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
154247529|NCT03720886|Teriparatide|teriparatide|mesh-list
154247530|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154247531|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247532|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154247533|NCT00077649|Ribavirin|ribavirin|mesh-list
154247534|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154247535|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
154247536|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
154247537|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154247538|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
154247539|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247540|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
154247541|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247542|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
154121593|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
154247543|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247544|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247545|NCT00038948|Cyclosporine|cyclosporine|mesh-list
154247547|NCT00038948|Tacrolimus|tacrolimus|mesh-list
154247548|NCT00038948|Cyclosporins|cyclosporins|mesh-list
154247549|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247550|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
154247551|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247552|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154247553|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247554|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247555|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
154247556|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247557|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
154247558|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247559|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247560|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154247561|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247562|NCT01096940|Simvastatin|simvastatin|mesh-list
154247563|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154247564|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154247565|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
154247566|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247567|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154247568|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154247569|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247570|NCT02530424|Trastuzumab|trastuzumab|mesh-list
154247571|NCT02530424|Pertuzumab|pertuzumab|mesh-list
154247572|NCT02530424|Fulvestrant|fulvestrant|mesh-list
154247573|NCT02530424|Palbociclib|palbociclib|mesh-list
154247574|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154247575|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247576|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154247577|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154247578|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154247579|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
154247580|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247581|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247582|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154247583|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247584|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247585|NCT01088763|Dexamethasone|dexamethasone|mesh-list
154247586|NCT01088763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154247587|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247588|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
154247589|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
154247590|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247591|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247592|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247593|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
154247594|NCT01088763|Hormones|hormones|mesh-ancestor
154247595|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247596|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154247597|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247598|NCT01088763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154247599|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247600|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247601|NCT01094600|Secretin|secretin|mesh-list
154247602|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247603|NCT01094600|Hormones|hormones|mesh-ancestor
154247604|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247605|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247606|NCT01097252|Cisplatin|cisplatin|mesh-list
154247607|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247608|NCT00054704|Riluzole|riluzole|mesh-list
154247609|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
154247610|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154247611|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154247612|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247613|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247614|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247615|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154247616|NCT00054704|Protective Agents|protective agents|mesh-ancestor
154247617|NCT01092572|Simvastatin|simvastatin|mesh-list
154247618|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154247619|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154247621|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247622|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154247623|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154247624|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247625|NCT00031694|Paclitaxel|paclitaxel|mesh-list
154247626|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
154247627|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154247628|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247629|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
154247630|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247631|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247632|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247633|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154247634|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
154247635|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247636|NCT03953066|Melatonin|melatonin|mesh-list
154247637|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
154247638|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247639|NCT03953066|Protective Agents|protective agents|mesh-ancestor
154247640|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247641|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247642|NCT00093795|Paclitaxel|paclitaxel|mesh-list
154247643|NCT00093795|Docetaxel|docetaxel|mesh-list
154247644|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
154247645|NCT00093795|Gemcitabine|gemcitabine|mesh-list
154247646|NCT00093795|Doxorubicin|doxorubicin|mesh-list
154247647|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154247648|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247649|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
154247650|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247651|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247652|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247653|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247654|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
154247655|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247656|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247657|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154247658|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
154247659|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154247660|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154247661|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
154247662|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154247663|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154247664|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154247665|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247666|NCT01092806|Tacrolimus|tacrolimus|mesh-list
154247667|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247668|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
154247669|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247670|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154247671|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247672|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247673|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
154247674|NCT01094912|Narcotics|narcotics|mesh-ancestor
154247675|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247676|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247677|NCT01094912|Analgesics|analgesics|mesh-ancestor
154247678|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
154247679|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247680|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
154247681|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
154247682|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247683|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
154247684|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247685|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247686|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154247687|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
154247688|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247689|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247690|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154121748|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
154247691|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154247692|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154247693|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
154247694|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247695|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247696|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247698|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154247699|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
154247700|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247701|NCT01088919|Pioglitazone|pioglitazone|mesh-list
154247702|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
154247703|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154247704|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247705|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154247706|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247707|NCT03802916|Deferiprone|deferiprone|mesh-list
154247708|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154247709|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
154247710|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
154247711|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247712|NCT03720340|Oprelvekin|oprelvekin|mesh-list
154247713|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247714|NCT01094990|Dexamethasone|dexamethasone|mesh-list
154247715|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247716|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
154247717|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
154247718|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247719|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247720|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247721|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
154247722|NCT01094990|Hormones|hormones|mesh-ancestor
154247723|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247724|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154247725|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247726|NCT01584050|Folic Acid|folic acid|mesh-list
154247727|NCT01584050|Hematinics|hematinics|mesh-ancestor
154247728|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
154247729|NCT01584050|Vitamins|vitamins|mesh-ancestor
154247730|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
154247731|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247732|NCT03952832|Leflunomide|leflunomide|mesh-list
154247733|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247734|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247735|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247736|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
154247737|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247738|NCT01311076|Insulin|insulin|mesh-list
154247739|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154247740|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
154247741|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154247742|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247743|NCT01098344|Gemcitabine|gemcitabine|mesh-list
154247744|NCT01098344|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
154247745|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154247746|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
154247747|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247748|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247749|NCT01098344|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154247750|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247751|NCT01098656|Lenalidomide|lenalidomide|mesh-list
154247752|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
154247753|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247754|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154247755|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154247756|NCT01098656|Growth Substances|growth substances|mesh-ancestor
154247757|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
154247758|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247759|NCT00076011|Mitogens|mitogens|mesh-list
154247760|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
154247761|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247762|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247763|NCT00076011|Growth Substances|growth substances|mesh-ancestor
154247764|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247765|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
154247766|NCT03465436|Lasmiditan|lasmiditan|mesh-list
154247767|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247768|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247769|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154247771|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247772|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247773|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247774|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247775|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154247777|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247778|NCT01098890|Plasminogen|plasminogen|mesh-list
154247779|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154247780|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154247781|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154247782|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247783|NCT00053846|Buspirone|buspirone|mesh-list
154247784|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154247785|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154247786|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247787|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247788|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154247789|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154247790|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
154247791|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247792|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247793|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
154247794|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154247795|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154247796|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154247797|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247798|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
154247799|NCT00090987|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154247800|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154247801|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247802|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247803|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247804|NCT03489304|Zaleplon|zaleplon|mesh-list
154247805|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
154247806|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154247807|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247808|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247809|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
154247810|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
154247811|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247812|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247813|NCT03718624|Paclitaxel|paclitaxel|mesh-list
154247814|NCT03718624|Apatinib|apatinib|mesh-list
154247815|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154247816|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247817|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
154247818|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247819|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247820|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247821|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154247822|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247823|NCT03543358|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154247824|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
154247825|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
154247826|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247827|NCT03485950|Meropenem|meropenem|mesh-list
154247828|NCT03485950|Tazobactam|tazobactam|mesh-list
154247829|NCT03485950|Piperacillin|piperacillin|mesh-list
154247830|NCT03485950|Cefepime|cefepime|mesh-list
154247831|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154247832|NCT03485950|Ceftolozane|ceftolozane|mesh-list
154247833|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247834|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247835|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154247836|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247837|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247838|NCT00060944|Dexamethasone|dexamethasone|mesh-list
154247839|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
154247840|NCT00060944|Trabectedin|trabectedin|mesh-list
154247841|NCT00060944|BB 1101|bb 1101|mesh-list
154247842|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247843|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
154247844|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
154247845|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247846|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247847|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247848|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
154247850|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154247851|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154247852|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247853|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
154247854|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247855|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247856|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154247857|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
154247858|NCT03956732|Vitamin D|vitamin d|mesh-list
154247859|NCT03956732|Caseins|caseins|mesh-list
154247860|NCT03956732|Vitamins|vitamins|mesh-ancestor
154247861|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
154247862|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247863|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154247864|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
154247865|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
154247866|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247867|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
154247868|NCT01093274|Cathartics|cathartics|mesh-ancestor
154247869|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154247870|NCT01584206|Ezetimibe|ezetimibe|mesh-list
154247871|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154121926|NCT00530842|Hormones|hormones|mesh-ancestor
154247872|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154247873|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
154247874|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247875|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154247876|NCT03541252|Cisplatin|cisplatin|mesh-list
154247877|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247878|NCT00031460|Acyclovir|acyclovir|mesh-list
154247879|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
154247880|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247881|NCT03540160|Serlopitant|serlopitant|mesh-list
154247882|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154247883|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247884|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247885|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247886|NCT01095302|Docetaxel|docetaxel|mesh-list
154247887|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247888|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
154247889|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247890|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247891|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247892|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154247893|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
154247894|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154247895|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154247896|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
154247897|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247898|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247899|NCT03457636|Doxycycline|doxycycline|mesh-list
154247900|NCT03457636|Adapalene|adapalene|mesh-list
154247901|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154247902|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154247903|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154247904|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247905|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
154247906|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154247907|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154247908|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
154247909|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154247910|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154247911|NCT03457636|Analgesics|analgesics|mesh-ancestor
154121970|NCT03879772|Hormones|hormones|mesh-ancestor
154247912|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
154247913|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247914|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247915|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154247916|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247917|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
154247919|NCT01099436|Docetaxel|docetaxel|mesh-list
154247920|NCT01099436|Doxorubicin|doxorubicin|mesh-list
154247921|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154247922|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154247923|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
154247924|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247925|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154247926|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154247927|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
154247928|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247929|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154247930|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154247931|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154247932|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154247933|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154247934|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154247935|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154247936|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154247937|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247938|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154247939|NCT01099514|Nilotinib|nilotinib|mesh-list
154247940|NCT01099514|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154247941|NCT01099514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154247942|NCT01099514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154247943|NCT01099514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247944|NCT01099592|Citalopram|citalopram|mesh-list
154247945|NCT01099592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154247946|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154247947|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154247948|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247949|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247950|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
154247951|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247952|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154247953|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
154247954|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154247955|NCT01099748|Methadone|methadone|mesh-list
154247956|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154247957|NCT01099748|Narcotics|narcotics|mesh-ancestor
154247958|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247959|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247960|NCT01099748|Analgesics|analgesics|mesh-ancestor
154247961|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
154247962|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247963|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
154247964|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
154247965|NCT03481816|Vaccines|vaccines|mesh-list
154247966|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
154247967|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247968|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
154247969|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154247970|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
154247971|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154247972|NCT03956888|Expectorants|expectorants|mesh-ancestor
154247973|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
154247974|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154247975|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
154247976|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247977|NCT03956888|Protective Agents|protective agents|mesh-ancestor
154247978|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247979|NCT03956888|Antidotes|antidotes|mesh-ancestor
154247980|NCT03955406|Anesthetics|anesthetics|mesh-list
154247981|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247982|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247983|NCT03538054|Levomethorphan|levomethorphan|mesh-list
154247985|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
154247986|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
154247987|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154247988|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154247989|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154247990|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154247991|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154247992|NCT03538054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154247994|NCT03538054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154247995|NCT03538054|Analgesics|analgesics|mesh-ancestor
154247996|NCT03538054|Sensory System Agents|sensory system agents|mesh-ancestor
154247997|NCT03538054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154247998|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154247999|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
154248000|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248001|NCT00050960|Paclitaxel|paclitaxel|mesh-list
154248002|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154248003|NCT00050960|Carboplatin|carboplatin|mesh-list
154248004|NCT00050960|Bexarotene|bexarotene|mesh-list
154248005|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154248006|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248007|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
154248008|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
154248009|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
154248010|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248011|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
154248012|NCT00097773|Tobramycin|tobramycin|mesh-list
154248013|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154248014|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248015|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154248016|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154248017|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248018|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248019|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248020|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154248021|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154248022|NCT03480022|Liraglutide|liraglutide|mesh-list
154248023|NCT03480022|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154248024|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154248025|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248026|NCT03480022|Incretins|incretins|mesh-ancestor
154248027|NCT03480022|Hormones|hormones|mesh-ancestor
154248028|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248029|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
154248030|NCT01093820|Hematinics|hematinics|mesh-ancestor
154248031|NCT00049322|Bevacizumab|bevacizumab|mesh-list
154248032|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248033|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248034|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154248035|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154248036|NCT00049322|Growth Substances|growth substances|mesh-ancestor
154248037|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248038|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
154248039|NCT00008138|Paclitaxel|paclitaxel|mesh-list
154248040|NCT00008138|Carboplatin|carboplatin|mesh-list
154248041|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154248042|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248043|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
154248044|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
154248045|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
154248046|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248047|NCT03436732|LMB-100|lmb-100|mesh-list
154248048|NCT03436732|Immunoconjugates|immunoconjugates|mesh-ancestor
154248049|NCT03436732|Immunologic Factors|immunologic factors|mesh-ancestor
154248050|NCT03436732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248051|NCT01100060|Azithromycin|azithromycin|mesh-list
154248052|NCT01100060|Chloroquine|chloroquine|mesh-list
154248053|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154248054|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154248055|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248056|NCT01100060|Amebicides|amebicides|mesh-ancestor
154248057|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154248058|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154248059|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
154248060|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248061|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154248062|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154248063|NCT01100060|Analgesics|analgesics|mesh-ancestor
154248064|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
154248065|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248066|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994934|NCT04203368|Adenosine|adenosine|mesh-list
154248068|NCT01100060|Filaricides|filaricides|mesh-ancestor
154248069|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
154248070|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
154248071|NCT01100216|Nicotine|nicotine|mesh-list
154248072|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154393029|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154248074|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248075|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248076|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154248077|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154248078|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
154248079|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248080|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248081|NCT01100294|Vaccines|vaccines|mesh-list
154248082|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
154248083|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248084|NCT03436420|Calcium|calcium|mesh-list
154248085|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154248086|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248087|NCT01100372|Gemcitabine|gemcitabine|mesh-list
154248088|NCT01100372|Doxorubicin|doxorubicin|mesh-list
154122151|NCT01062529|Somatostatin|somatostatin|mesh-list
154248089|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154248090|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154248091|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
154248092|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248093|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248094|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154248095|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154248096|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154248097|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248098|NCT00027560|Cyclosporine|cyclosporine|mesh-list
154248099|NCT00027560|Fludarabine|fludarabine|mesh-list
154248100|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
154248101|NCT00027560|Melphalan|melphalan|mesh-list
154248102|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
154248103|NCT00027560|Cyclosporins|cyclosporins|mesh-list
154248104|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248105|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154248106|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
154248107|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248108|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154248109|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
154248110|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248111|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248112|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
154248113|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248114|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
154248115|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248116|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154248117|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154248118|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
154248119|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154248120|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248121|NCT02529878|Paclitaxel|paclitaxel|mesh-list
154248122|NCT02529878|Apatinib|apatinib|mesh-list
154248123|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154248124|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248125|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
154248126|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
154248127|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
154248128|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248129|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154248130|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248131|NCT03451006|Metformin|metformin|mesh-list
154248132|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154248133|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248134|NCT05625854|Cocaine|cocaine|mesh-list
154248135|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
154248136|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
154248137|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154248138|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248139|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
154248140|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248141|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154248142|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154248143|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154248144|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154248145|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248147|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248149|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
154248150|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154248151|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
154248152|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154248153|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248154|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
154248155|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
154248156|NCT03449758|Chloroquine|chloroquine|mesh-list
154248157|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
154248158|NCT03449758|Methotrexate|methotrexate|mesh-list
154248159|NCT03449758|Azathioprine|azathioprine|mesh-list
154248160|NCT03449758|Leflunomide|leflunomide|mesh-list
154248161|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154248162|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
154248163|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154248164|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248165|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154248166|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
154248167|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248168|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248169|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
154248170|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248171|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154248172|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154248173|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
154248174|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248175|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154248176|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
154248177|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154248178|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154248179|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248180|NCT03449758|Amebicides|amebicides|mesh-ancestor
154248181|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154248182|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154248183|NCT03449758|Analgesics|analgesics|mesh-ancestor
154248184|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
154248185|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122228|NCT04988152|Sotrovimab|sotrovimab|mesh-list
154248186|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248187|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248188|NCT03449446|Firsocostat|firsocostat|mesh-list
154248189|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248190|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248191|NCT03716596|Antibodies|antibodies|mesh-list
154248192|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
154248193|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248194|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
154248195|NCT05650840|Calcium|calcium|mesh-list
154248196|NCT05650840|Charcoal|charcoal|mesh-list
154248197|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154248198|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248199|NCT05650840|Antacids|antacids|mesh-ancestor
154248200|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248201|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248202|NCT05650840|Antidotes|antidotes|mesh-ancestor
154248203|NCT05650840|Protective Agents|protective agents|mesh-ancestor
154248204|NCT03722914|Benzonatate|benzonatate|mesh-list
154248205|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
154248206|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
154248207|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
154248208|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154248209|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154248210|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248211|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
154248213|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248214|NCT03444766|Nivolumab|nivolumab|mesh-list
154248215|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248216|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248217|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154248218|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248219|NCT03526432|Bevacizumab|bevacizumab|mesh-list
154393030|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
154248220|NCT03526432|Atezolizumab|atezolizumab|mesh-list
154248221|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248222|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248223|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154248224|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154248225|NCT03526432|Growth Substances|growth substances|mesh-ancestor
154248226|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248227|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
154248228|NCT03526432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154248229|NCT03526432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248230|NCT01310842|Nicotine|nicotine|mesh-list
154248231|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154248232|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
154248233|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248234|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248235|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154248236|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154248237|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
154248238|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248239|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248240|NCT03722290|Metformin|metformin|mesh-list
154248241|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154248242|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248243|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154248244|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154248245|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154248246|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154248247|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248248|NCT03717688|Incretins|incretins|mesh-ancestor
154248249|NCT03717688|Hormones|hormones|mesh-ancestor
154248250|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248251|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
154248252|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248253|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248254|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154248255|NCT02953678|Prednisone|prednisone|mesh-list
154248256|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
154248257|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154248258|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154248259|NCT02953678|Prednisolone|prednisolone|mesh-list
154248260|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
154248261|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154248262|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
154248263|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248264|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
154248265|NCT02953678|Hormones|hormones|mesh-ancestor
154248266|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248267|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248268|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154248269|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248270|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
154248271|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
154248272|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248273|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248274|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154248275|NCT02953678|Protective Agents|protective agents|mesh-ancestor
154248276|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
154248277|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
154248278|NCT00090753|Hematinics|hematinics|mesh-ancestor
154248279|NCT00048932|Abatacept|abatacept|mesh-list
154248280|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154248281|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248282|NCT00048932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248283|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248284|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154248285|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
154248286|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248287|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248288|NCT00073983|Gemcitabine|gemcitabine|mesh-list
154248289|NCT00073983|Docetaxel|docetaxel|mesh-list
154248290|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154248291|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
153995165|NCT04515134|Ubiquinone|ubiquinone|mesh-list
154248292|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248293|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248294|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
154248295|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
154248296|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
154248297|NCT02952820|Lemborexant|lemborexant|mesh-list
154248298|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154393031|NCT03346057|Rocuronium|rocuronium|mesh-list
154248299|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248300|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248301|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154248302|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154248303|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154248304|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248305|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
154248306|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248307|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
154248308|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
154248309|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154248310|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
154248311|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154122368|NCT05732051|Niacin|niacin|mesh-list
154248312|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248313|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154248314|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154248315|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154248316|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154248317|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248318|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
154248319|NCT01085487|Coagulants|coagulants|mesh-ancestor
154248320|NCT01089309|Spironolactone|spironolactone|mesh-list
154248321|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154248322|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
154248323|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248324|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248325|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154248326|NCT01089309|Diuretics|diuretics|mesh-ancestor
154248327|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
154248328|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
154248329|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
154248330|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
154248331|NCT01085721|Ephedrine|ephedrine|mesh-list
154248332|NCT01085721|Guaifenesin|guaifenesin|mesh-list
154248333|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154248334|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154248335|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154248336|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
154248337|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248338|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248339|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154248340|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
154248341|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
154248342|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154248343|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154248344|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
154248345|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
154248346|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248347|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248348|NCT01085721|Expectorants|expectorants|mesh-ancestor
154248349|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154248350|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154248351|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
154248352|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154248353|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154248354|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
153620111|NCT01989507|Nicotine|nicotine|mesh-list
154248355|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
154248356|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
154248357|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
154248358|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154248359|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
154248360|NCT00006392|Vitamins|vitamins|mesh-list
154248361|NCT00006392|Vitamin E|vitamin e|mesh-list
154248362|NCT00006392|Tocopherols|tocopherols|mesh-list
154248363|NCT00006392|Tocotrienols|tocotrienols|mesh-list
154248364|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
154248365|NCT00006392|Selenium|selenium|mesh-list
154248366|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
154248367|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248368|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
154248369|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248370|NCT00006392|Protective Agents|protective agents|mesh-ancestor
154248371|NCT00006392|Trace Elements|trace elements|mesh-ancestor
154248372|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154248373|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154248374|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154248375|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154248376|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248377|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248378|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248379|NCT01089621|Analgesics|analgesics|mesh-ancestor
154248380|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
154248381|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248382|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
154248383|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154248384|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
154248385|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154248386|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154248387|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154248388|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154248389|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248390|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248391|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248392|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
154248393|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154248394|NCT00379769|Metformin|metformin|mesh-list
154248395|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
154248396|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154248397|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248398|NCT00006164|Ribavirin|ribavirin|mesh-list
154248399|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154248400|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
154248401|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
154248402|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248403|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
154248404|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248405|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
154248406|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248407|NCT00378599|Interferons|interferons|mesh-list
154248408|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
154248409|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
154248410|NCT00378599|Ribavirin|ribavirin|mesh-list
154248411|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154248412|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248413|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
154248414|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248415|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
154248416|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248417|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
154248418|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248419|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154248420|NCT01046981|Metronidazole|metronidazole|mesh-list
154248421|NCT01046981|Cefazolin|cefazolin|mesh-list
154248422|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154248423|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248424|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
154248425|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154248426|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154248427|NCT00378209|Dexamethasone|dexamethasone|mesh-list
154248428|NCT00378209|Lenalidomide|lenalidomide|mesh-list
154248429|NCT00378209|Bortezomib|bortezomib|mesh-list
154254056|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154248430|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248432|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
154248433|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248434|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248435|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248436|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
154248437|NCT00378209|Hormones|hormones|mesh-ancestor
154248438|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248439|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153995317|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
154248440|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248441|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
154248442|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154248443|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154248444|NCT00378209|Growth Substances|growth substances|mesh-ancestor
154248445|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
154248446|NCT01047059|Bevacizumab|bevacizumab|mesh-list
154248447|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154248448|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248449|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248450|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154248451|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154248452|NCT01047059|Growth Substances|growth substances|mesh-ancestor
154248453|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248454|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
154248455|NCT01047059|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154248456|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154248457|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248458|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248460|NCT00377819|Alendronate|alendronate|mesh-list
154248461|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154248462|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248463|NCT00377429|Catumaxomab|catumaxomab|mesh-list
154248464|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248465|NCT01047215|Aripiprazole|aripiprazole|mesh-list
154248466|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154248467|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
154248468|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154248469|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154248470|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154248471|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154248472|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248473|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
154248474|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
154248475|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248476|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248477|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154248478|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154248479|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
154248480|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154248481|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154248482|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154248483|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154248484|NCT03715582|Trimetazidine|trimetazidine|mesh-list
154248485|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
154248486|NCT00376961|Prednisone|prednisone|mesh-list
154248487|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
154248488|NCT00376961|Rituximab|rituximab|mesh-list
154248489|NCT00376961|Doxorubicin|doxorubicin|mesh-list
154248490|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154248491|NCT00376961|Vincristine|vincristine|mesh-list
154248492|NCT00376961|Bortezomib|bortezomib|mesh-list
154248493|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154248494|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
154248495|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248496|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248497|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154248498|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
154248499|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248500|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248501|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154248503|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154248504|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154248505|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154248506|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248507|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248508|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
154248509|NCT00376961|Hormones|hormones|mesh-ancestor
154248510|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248511|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154248512|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154248513|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
154248514|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
154248515|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
154248516|NCT00376259|Adefovir|adefovir|mesh-list
154248517|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154248518|NCT00376259|Telbivudine|telbivudine|mesh-list
154248519|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
154248520|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248521|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154248522|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154248523|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248524|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248525|NCT03715348|Thrombin|thrombin|mesh-list
154248526|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
154248527|NCT03715348|Coagulants|coagulants|mesh-ancestor
154248528|NCT01324505|Semaglutide|semaglutide|mesh-list
154248529|NCT01324505|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154248530|NCT01324505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154248531|NCT01324505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248532|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
154248533|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154248534|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154248535|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248536|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248537|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248538|NCT00365105|Vitamin D|vitamin d|mesh-list
154248539|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
154248540|NCT00365105|Calcium|calcium|mesh-list
154248541|NCT00365105|Vitamins|vitamins|mesh-ancestor
154248542|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
154248543|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248544|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154248545|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154248546|NCT01049633|Aspirin|aspirin|mesh-list
154248547|NCT01049633|Sirolimus|sirolimus|mesh-list
154248548|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154248549|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
154248550|NCT01049633|Clotrimazole|clotrimazole|mesh-list
154248551|NCT01049633|Miconazole|miconazole|mesh-list
154248552|NCT01049633|Trimethoprim|trimethoprim|mesh-list
154248553|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
154248554|NCT01049633|Valganciclovir|valganciclovir|mesh-list
154248555|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
154248556|NCT01049633|Heparin|heparin|mesh-list
154248557|NCT01049633|Enoxaparin|enoxaparin|mesh-list
154248558|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
154248559|NCT01049633|Tacrolimus|tacrolimus|mesh-list
154248560|NCT01049633|Basiliximab|basiliximab|mesh-list
154248561|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154248562|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154248563|NCT01049633|Analgesics|analgesics|mesh-ancestor
154248564|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
154248565|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248566|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248567|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248568|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248569|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154248570|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154248571|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248572|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154248573|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154248574|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248575|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
154248576|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154248577|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
154248578|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154248579|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248580|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154248581|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248582|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
154248583|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154248584|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154248585|NCT01049633|Protective Agents|protective agents|mesh-ancestor
154248586|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
154248587|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154248588|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
154248589|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154248590|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
154248591|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154248592|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154248593|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154248594|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154248595|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154248596|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154248597|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154248598|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154248599|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154248600|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
154248601|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248602|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154248603|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154248604|NCT00399893|Octreotide|octreotide|mesh-list
154248605|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248606|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154248607|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248608|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
154248609|NCT01049711|Hematinics|hematinics|mesh-ancestor
154248610|NCT00048542|Adalimumab|adalimumab|mesh-list
154248611|NCT00048542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154248612|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248613|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248614|NCT03814590|Vaccines|vaccines|mesh-list
154248615|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
154248616|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248617|NCT01583244|Abatacept|abatacept|mesh-list
154248618|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154248619|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248620|NCT01583244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248621|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248622|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154248623|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
154248624|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248625|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248626|NCT01085526|Immunomodulating Agents|immunomodulating agents|mesh-list
154248627|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
154248628|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248629|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
154248630|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154248631|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248632|NCT01102946|Ranibizumab|ranibizumab|mesh-list
154248633|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154248634|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154248635|NCT01102946|Growth Substances|growth substances|mesh-ancestor
154248636|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248637|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
154248638|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248639|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154248640|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
154248641|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248642|NCT01101386|Voriconazole|voriconazole|mesh-list
154248643|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
154248644|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248645|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154248646|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154248647|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248648|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248649|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154248650|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
154248651|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248652|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248653|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154248654|NCT00005906|Octreotide|octreotide|mesh-list
154248655|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248656|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154248657|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248658|NCT01103336|Nicorandil|nicorandil|mesh-list
154248659|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154248660|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154248661|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
154248662|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
154248663|NCT01103336|Vitamins|vitamins|mesh-ancestor
154248664|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
154248665|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248666|NCT03950960|Itraconazole|itraconazole|mesh-list
154248667|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
154248668|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248669|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154248670|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154248671|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248672|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162756|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
154393032|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
154248673|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154248674|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
154248675|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248676|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248677|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154248678|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
154248679|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154248680|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154248681|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248682|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
154248683|NCT03954860|Coagulants|coagulants|mesh-ancestor
154248685|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
154248686|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248687|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154248688|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154248689|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154248690|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154248691|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
154248692|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
154248693|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248694|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248695|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248696|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
154248697|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
154248698|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248699|NCT00004088|Pamidronate|pamidronate|mesh-list
154248700|NCT00004088|Interferons|interferons|mesh-list
154248701|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
154248702|NCT00004088|Thalidomide|thalidomide|mesh-list
154248703|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
154248704|NCT00004088|Melphalan|melphalan|mesh-list
154248705|NCT00004088|Busulfan|busulfan|mesh-list
154248706|NCT00004088|Lenograstim|lenograstim|mesh-list
154248707|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154248708|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
154248709|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248710|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248711|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154248712|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
154248713|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248714|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248715|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154248716|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
154248717|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248718|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154248719|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
154248720|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154248721|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154248722|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154248723|NCT00004088|Growth Substances|growth substances|mesh-ancestor
154248724|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
154248725|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154248726|NCT03439072|Glucagon|glucagon|mesh-list
154248727|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154248728|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248729|NCT03439072|Hormones|hormones|mesh-ancestor
154248730|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122770|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
154248731|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248732|NCT03439072|Incretins|incretins|mesh-ancestor
154248733|NCT00078312|Modafinil|modafinil|mesh-list
154248734|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154248735|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248736|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154248737|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154248738|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154248739|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248740|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154248741|NCT01085838|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154248742|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154248743|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248744|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248745|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248746|NCT00003896|Paclitaxel|paclitaxel|mesh-list
154248747|NCT00003896|Doxorubicin|doxorubicin|mesh-list
154248748|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154248749|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154248750|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248751|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
154248752|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
154248753|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
154248754|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248755|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154248756|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154248757|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154248758|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248759|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154248760|NCT03712540|Rifampin|rifampin|mesh-list
154248761|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154248762|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
154248763|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154248764|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248765|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
154248766|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154248767|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248768|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248769|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154248770|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154248771|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154248772|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154248773|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154248774|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154248775|NCT05472220|Carboplatin|carboplatin|mesh-list
154248776|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
154248777|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248778|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248779|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248780|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
154248781|NCT00003782|Docetaxel|docetaxel|mesh-list
154248782|NCT00003782|Doxorubicin|doxorubicin|mesh-list
154248783|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154248784|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
154248785|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248786|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248787|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154248788|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
154248789|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248790|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248791|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154248792|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
154248793|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
154248794|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
154248795|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154248796|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154248797|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154248798|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248800|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248801|NCT03714490|Capecitabine|capecitabine|mesh-list
154248802|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
154248803|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154248804|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
154248805|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248806|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248807|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
154248808|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154248809|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248810|NCT03407170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154248811|NCT03407170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248812|NCT01103648|Simvastatin|simvastatin|mesh-list
154248813|NCT01103648|Ezetimibe|ezetimibe|mesh-list
154248814|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154248815|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154248816|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154248817|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
154248818|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248840|NCT00003656|Interferons|interferons|mesh-list
154393033|NCT03346057|Neostigmine|neostigmine|mesh-list
154248841|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
154248842|NCT00003656|Tretinoin|tretinoin|mesh-list
154248843|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248844|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
154248845|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248846|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
154248847|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248848|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
154248849|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
154248850|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
154248851|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248852|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
154248853|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248854|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248855|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154248856|NCT03948620|Penicillins|penicillins|mesh-list
154248857|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154248858|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248859|NCT03416374|Dexamethasone|dexamethasone|mesh-list
154248860|NCT03416374|Lenalidomide|lenalidomide|mesh-list
154248861|NCT03416374|Bortezomib|bortezomib|mesh-list
154248862|NCT03416374|Ixazomib|ixazomib|mesh-list
154248863|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248864|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
154248865|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
154248866|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248867|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248868|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248869|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
154248870|NCT03416374|Hormones|hormones|mesh-ancestor
154248871|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248872|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154248873|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248874|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
154248875|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154254072|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
154248876|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154248877|NCT03416374|Growth Substances|growth substances|mesh-ancestor
154248878|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
154248879|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
154248880|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248881|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248882|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
154248883|NCT00077766|Hematinics|hematinics|mesh-ancestor
154248884|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
154248885|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
154248886|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154248887|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248888|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248889|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
154248890|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154248891|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154248892|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248893|NCT03388138|Ketotifen|ketotifen|mesh-list
154248894|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
154248895|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
154248896|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154248897|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
154248898|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
154248899|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154248900|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248901|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248902|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154248903|NCT01101620|Simendan|simendan|mesh-list
154248904|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154248905|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
154248906|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154248907|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154248908|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248909|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248910|NCT01101620|Protective Agents|protective agents|mesh-ancestor
154248911|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248912|NCT02952898|Diclofenac|diclofenac|mesh-list
153995832|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
153995833|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
153995834|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
154248913|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154248914|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154248915|NCT02952898|Analgesics|analgesics|mesh-ancestor
154248916|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
154248917|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248918|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248919|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248920|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154248921|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154248922|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248923|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248924|NCT01101698|Vitamin D|vitamin d|mesh-list
154248925|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
154248926|NCT01101698|Vitamins|vitamins|mesh-list
154248927|NCT01101698|Vitamin K|vitamin k|mesh-list
154248928|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
154248929|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
154248930|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248931|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154248932|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154248933|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154248934|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154248935|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248936|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
154248937|NCT01101698|Coagulants|coagulants|mesh-ancestor
154248938|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
154248939|NCT00045734|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154248940|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154248941|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248942|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248943|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248944|NCT05513768|Protein C|protein c|mesh-list
154248945|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
154248946|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154248947|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154248948|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248949|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
154248950|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154248951|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154248952|NCT03387046|Prednisolone|prednisolone|mesh-list
154248953|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
154248954|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154248955|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
154248956|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154248957|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
154248958|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
154248959|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154248960|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248961|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248962|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
154248964|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154248965|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154248966|NCT03387046|Protective Agents|protective agents|mesh-ancestor
154248967|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154248968|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248969|NCT01101776|Interferons|interferons|mesh-list
154248970|NCT01101776|Interferon-beta|interferon-beta|mesh-list
154248971|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
154248972|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248973|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
154248974|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248975|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
154248976|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154248977|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154248978|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154248979|NCT00045110|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154248980|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154248981|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154248982|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248983|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154248984|NCT03353740|Edetic Acid|edetic acid|mesh-list
154248985|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154248986|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
154248987|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
154248988|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154248989|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
154248990|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154248991|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154248992|NCT04814602|Proglumide|proglumide|mesh-list
154248993|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154248994|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154248995|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
154248996|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154248997|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154248998|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154248999|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
154249000|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
154249001|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154249002|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154249003|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249004|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154249005|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249006|NCT00399035|Leucovorin|leucovorin|mesh-list
154249007|NCT00399035|Capecitabine|capecitabine|mesh-list
154249008|NCT00399035|Fluorouracil|fluorouracil|mesh-list
154249009|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
154249010|NCT00399035|Cediranib|cediranib|mesh-list
154249011|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
154249012|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154249013|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
154249014|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249015|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249016|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154249017|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
154249018|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249019|NCT00399035|Antidotes|antidotes|mesh-ancestor
154249020|NCT00399035|Protective Agents|protective agents|mesh-ancestor
154249022|NCT00399035|Vitamins|vitamins|mesh-ancestor
154249023|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
154249024|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154249025|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249026|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154249027|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249028|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249029|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154249030|NCT00073749|Immunotoxins|immunotoxins|mesh-ancestor
154249031|NCT00073749|Immunoconjugates|immunoconjugates|mesh-ancestor
154249032|NCT00073749|Immunologic Factors|immunologic factors|mesh-ancestor
154249033|NCT00073749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249034|NCT03960801|Remifentanil|remifentanil|mesh-list
154249035|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154249036|NCT03960801|Narcotics|narcotics|mesh-ancestor
154249037|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249038|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249039|NCT03960801|Analgesics|analgesics|mesh-ancestor
154249040|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
154249041|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249042|NCT01583439|Ritonavir|ritonavir|mesh-list
154249043|NCT01583439|Lopinavir|lopinavir|mesh-list
154249044|NCT01583439|Tenofovir|tenofovir|mesh-list
154249045|NCT01583439|Lamivudine|lamivudine|mesh-list
154249046|NCT01583439|Emtricitabine|emtricitabine|mesh-list
154249047|NCT01583439|Zidovudine|zidovudine|mesh-list
154249048|NCT01583439|Efavirenz|efavirenz|mesh-list
154249049|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154249050|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154249051|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154249052|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
154249053|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249054|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249055|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154249056|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
154249057|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249058|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154249059|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154249060|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154249061|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154249062|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
154249063|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153995982|NCT00965081|Analgesics|analgesics|mesh-ancestor
154249064|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154249065|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154249066|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154249067|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154249068|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
154249069|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
154249070|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249071|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154249073|NCT00398567|Neratinib|neratinib|mesh-list
154249074|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249075|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249076|NCT00398567|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154249077|NCT00398567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154249078|NCT00398567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249079|NCT00398567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249080|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154249081|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154249082|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154249083|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249084|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249085|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154249086|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154249087|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154249088|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154249089|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
154249090|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249091|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249092|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154249093|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154249094|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
154249096|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154249097|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
154249098|NCT05841992|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154249099|NCT05841992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154249100|NCT05841992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249101|NCT05841849|Aprepitant|aprepitant|mesh-list
154249102|NCT05841849|Fosaprepitant|fosaprepitant|mesh-list
154249103|NCT05841849|Palonosetron|palonosetron|mesh-list
154249104|NCT05841849|Antiemetics|antiemetics|mesh-ancestor
154249105|NCT05841849|Autonomic Agents|autonomic agents|mesh-ancestor
154249106|NCT05841849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249107|NCT05841849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249108|NCT05841849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249109|NCT05841849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154249110|NCT05841849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249111|NCT05841849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249112|NCT05841849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154249113|NCT05841849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154249114|NCT05841849|Serotonin Agents|serotonin agents|mesh-ancestor
154249115|NCT05841771|Azacitidine|azacitidine|mesh-list
154249116|NCT05841771|Decitabine|decitabine|mesh-list
154249117|NCT05841771|Venetoclax|venetoclax|mesh-list
154249118|NCT05841771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154249119|NCT05841771|Antimetabolites|antimetabolites|mesh-ancestor
154249120|NCT05841771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249121|NCT05841771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249122|NCT05841771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249123|NCT05841654|Antihypertensive Agents|antihypertensive agents|mesh-list
154249124|NCT05841654|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154249125|NCT05841654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154249126|NCT05841654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154249127|NCT05841654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249128|NCT05841641|Hemostatics|hemostatics|mesh-list
154249129|NCT05841641|Coagulants|coagulants|mesh-ancestor
154249130|NCT05841589|Chlorhexidine|chlorhexidine|mesh-list
154249131|NCT05841589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154249132|NCT05841589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249133|NCT05841589|Disinfectants|disinfectants|mesh-ancestor
154249134|NCT05841446|Apixaban|apixaban|mesh-list
154249135|NCT05841446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154249136|NCT05841446|Antithrombins|antithrombins|mesh-ancestor
154249137|NCT05841446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154249138|NCT05841446|Protease Inhibitors|protease inhibitors|mesh-ancestor
154249139|NCT05841446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249140|NCT05841446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249141|NCT05841446|Anticoagulants|anticoagulants|mesh-ancestor
154249142|NCT05841394|Esomeprazole|esomeprazole|mesh-list
154249143|NCT05841394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154249144|NCT05841394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249145|NCT05841394|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154249146|NCT05841394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249147|NCT05841394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249148|NCT05841381|Paclitaxel|paclitaxel|mesh-list
154249149|NCT05841381|Trastuzumab|trastuzumab|mesh-list
154249150|NCT05841381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154249151|NCT05841381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249152|NCT05841381|Tubulin Modulators|tubulin modulators|mesh-ancestor
154249153|NCT05841381|Antimitotic Agents|antimitotic agents|mesh-ancestor
154249154|NCT05841381|Mitosis Modulators|mitosis modulators|mesh-ancestor
154249155|NCT05841381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123174|NCT00756275|Nicotine|nicotine|mesh-list
154249156|NCT05841381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249157|NCT05841303|Ascorbic Acid|ascorbic acid|mesh-list
154249158|NCT05841303|Antioxidants|antioxidants|mesh-ancestor
154249159|NCT05841303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249160|NCT05841303|Protective Agents|protective agents|mesh-ancestor
154249161|NCT05841303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249162|NCT05841303|Vitamins|vitamins|mesh-ancestor
154249163|NCT05841303|Micronutrients|micronutrients|mesh-ancestor
154249164|NCT05841251|Phenylephrine|phenylephrine|mesh-list
154249165|NCT05841251|Oxymetazoline|oxymetazoline|mesh-list
154249166|NCT05841251|Tranexamic Acid|tranexamic acid|mesh-list
154249167|NCT05841251|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154249168|NCT05841251|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154249169|NCT05841251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249170|NCT05841251|Hemostatics|hemostatics|mesh-ancestor
154249171|NCT05841251|Coagulants|coagulants|mesh-ancestor
154249172|NCT05841251|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154249173|NCT05841251|Mydriatics|mydriatics|mesh-ancestor
154249174|NCT05841251|Autonomic Agents|autonomic agents|mesh-ancestor
154249175|NCT05841251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249176|NCT05841251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249177|NCT05841251|Sympathomimetics|sympathomimetics|mesh-ancestor
154249178|NCT05841251|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154249179|NCT05841251|Nasal Decongestants|nasal decongestants|mesh-ancestor
154249180|NCT05841251|Respiratory System Agents|respiratory system agents|mesh-ancestor
154249181|NCT05841251|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154249182|NCT05841251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154249183|NCT05841251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154249184|NCT05841251|Adrenergic Agents|adrenergic agents|mesh-ancestor
154249185|NCT05841251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249186|NCT05841251|Protective Agents|protective agents|mesh-ancestor
154249187|NCT05841147|Tirofiban|tirofiban|mesh-list
154249188|NCT05841147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154249189|NCT05841147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154249190|NCT05841147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249191|NCT05841147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154249192|NCT05841043|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154249193|NCT05841043|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154249194|NCT05840913|Epinephrine|epinephrine|mesh-list
154249195|NCT05840913|Carticaine|carticaine|mesh-list
154249196|NCT05840913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154249197|NCT05840913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154249198|NCT05840913|Adrenergic Agents|adrenergic agents|mesh-ancestor
154249199|NCT05840913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249200|NCT05840913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249201|NCT05840913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249202|NCT05840913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154249203|NCT05840913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154249204|NCT05840913|Autonomic Agents|autonomic agents|mesh-ancestor
154249205|NCT05840913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249206|NCT05840913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154249207|NCT05840913|Respiratory System Agents|respiratory system agents|mesh-ancestor
154249208|NCT05840913|Mydriatics|mydriatics|mesh-ancestor
154249209|NCT05840913|Sympathomimetics|sympathomimetics|mesh-ancestor
154249210|NCT05840913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154249211|NCT05840913|Anesthetics, Local|anesthetics, local|mesh-ancestor
153996133|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154249212|NCT05840913|Anesthetics|anesthetics|mesh-ancestor
154249213|NCT05840913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249214|NCT05840913|Sensory System Agents|sensory system agents|mesh-ancestor
154249217|NCT05840796|Caseins|caseins|mesh-list
154249218|NCT05840796|Chelating Agents|chelating agents|mesh-ancestor
154249219|NCT05840796|Sequestering Agents|sequestering agents|mesh-ancestor
154249220|NCT05840796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249221|NCT05840068|Metformin|metformin|mesh-list
154249222|NCT05840068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154249223|NCT05840068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249224|NCT05782816|Oxytocin|oxytocin|mesh-list
154249225|NCT05782816|Oxytocics|oxytocics|mesh-ancestor
154249226|NCT05782816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154249227|NCT05782816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249228|NCT05768932|Paclitaxel|paclitaxel|mesh-list
154249229|NCT05768932|Carboplatin|carboplatin|mesh-list
154249230|NCT05768932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154249231|NCT05768932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249232|NCT05768932|Tubulin Modulators|tubulin modulators|mesh-ancestor
154249233|NCT05768932|Antimitotic Agents|antimitotic agents|mesh-ancestor
154249234|NCT05768932|Mitosis Modulators|mitosis modulators|mesh-ancestor
154249235|NCT05768932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249236|NCT05637398|Colchicine|colchicine|mesh-list
154249237|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
154249238|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249239|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
154249240|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
154249241|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
154249242|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249243|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249244|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
154249245|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154249246|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154249247|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154249248|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154249249|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249250|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
154249251|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249252|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249253|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154249254|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249256|NCT05583071|Methotrexate|methotrexate|mesh-list
154249257|NCT05583071|Lenalidomide|lenalidomide|mesh-list
154249258|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249259|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249260|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
154249261|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249262|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249263|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154249264|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
154249265|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154249266|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154249267|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
154249268|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249269|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
154249270|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249271|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154249272|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154249273|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154249274|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154249275|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154249276|NCT05583071|Growth Substances|growth substances|mesh-ancestor
154249277|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
154249278|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154249279|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154249280|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249281|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
154249282|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
154249283|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154249284|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154249285|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
154249286|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249287|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249288|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249289|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
154249290|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
154249291|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249292|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
154249293|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154249294|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
154249295|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
154249296|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154249297|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154249298|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154249299|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154249300|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249301|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
154249302|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249303|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249304|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154249305|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249306|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
154249307|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154249308|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154249309|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154249310|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154249311|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249312|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
154249313|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249314|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249315|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154249316|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249317|NCT05249569|Avelumab|avelumab|mesh-list
154249318|NCT05249569|Bavituximab|bavituximab|mesh-list
154249319|NCT05249569|Axitinib|axitinib|mesh-list
154249320|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249321|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249322|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154249323|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249324|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249325|NCT05212662|Cysteamine|cysteamine|mesh-list
154249326|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154249327|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249328|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154249329|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249330|NCT05096663|Vitamins|vitamins|mesh-list
154249331|NCT05096663|Folic Acid|folic acid|mesh-list
154249332|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
154249333|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
154249334|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
154249335|NCT05096663|Dexamethasone|dexamethasone|mesh-list
154249336|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
154249337|NCT05096663|Gemcitabine|gemcitabine|mesh-list
154249338|NCT05096663|Docetaxel|docetaxel|mesh-list
154249339|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
154249340|NCT05096663|Pemetrexed|pemetrexed|mesh-list
154249341|NCT05096663|Ramucirumab|ramucirumab|mesh-list
154249342|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154249343|NCT05096663|Antibodies|antibodies|mesh-list
154249344|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
154249345|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154249346|NCT05096663|Lexatumumab|lexatumumab|mesh-list
154249347|NCT05096663|BB 1101|bb 1101|mesh-list
154249348|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
154249349|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249350|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
154249351|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249352|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
154249353|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
154249354|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249355|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249356|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
154249357|NCT05096663|Hormones|hormones|mesh-ancestor
154249358|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154249359|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154249360|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249361|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
154249362|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249363|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249364|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154249365|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
154249366|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
154249367|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
154249369|NCT05096663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154249370|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154249371|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154249372|NCT05096663|Hematinics|hematinics|mesh-ancestor
154249373|NCT05096663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154249374|NCT05096663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154249375|NCT05096663|Growth Substances|growth substances|mesh-ancestor
154249376|NCT05096663|Growth Inhibitors|growth inhibitors|mesh-ancestor
154249377|NCT04982796|Psilocybin|psilocybin|mesh-list
154249378|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
154249379|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249380|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154249381|NCT04941911|Octreotide|octreotide|mesh-list
154249382|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249383|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154249384|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249385|NCT04779879|Sotrovimab|sotrovimab|mesh-list
154249386|NCT04779879|Antiviral Agents|antiviral agents|mesh-ancestor
154249387|NCT04779879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249388|NCT04768101|Corticosterone|corticosterone|mesh-list
154249389|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249390|NCT04599075|Insulin|insulin|mesh-list
154249391|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154249392|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154249393|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249394|NCT04574583|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154249396|NCT04574583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249397|NCT04523363|Metformin|metformin|mesh-list
154249398|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154249399|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249400|NCT04495894|Ketorolac|ketorolac|mesh-list
154249401|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154249402|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154249403|NCT04495894|Analgesics|analgesics|mesh-ancestor
154249404|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
154249405|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249406|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249407|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249408|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249409|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154249410|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249411|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249412|NCT04478721|Meropenem|meropenem|mesh-list
154249413|NCT04478721|Temocillin|temocillin|mesh-list
154249414|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154249415|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249416|NCT04283500|Buprenorphine|buprenorphine|mesh-list
154249417|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154249418|NCT04283500|Naloxone|naloxone|mesh-list
154249419|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154249420|NCT04283500|Narcotics|narcotics|mesh-ancestor
154249421|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249422|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249423|NCT04283500|Analgesics|analgesics|mesh-ancestor
154249424|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
154249425|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249426|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154249427|NCT04223791|Islatravir|islatravir|mesh-list
154249428|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
154249429|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249430|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249431|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249432|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154249433|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154249434|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154249435|NCT03982030|Dalbavancin|dalbavancin|mesh-list
153996358|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249436|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154249437|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249438|NCT03915067|Botulinum Toxins|botulinum toxins|mesh-list
154249439|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154249440|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154249441|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154249442|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154249443|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249444|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
154249445|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249446|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249447|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154249448|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249450|NCT03903133|Antioxidants|antioxidants|mesh-list
154249451|NCT03903133|Vitamins|vitamins|mesh-ancestor
154249452|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
154249453|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249454|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249455|NCT03903133|Protective Agents|protective agents|mesh-ancestor
154249456|NCT03841305|Liver Extracts|liver extracts|mesh-list
154249457|NCT03841305|Hematinics|hematinics|mesh-ancestor
154249458|NCT03727633|Idarubicin|idarubicin|mesh-list
154249459|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
154249460|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154249461|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249462|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154249463|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154249464|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249465|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249466|NCT03694002|Paclitaxel|paclitaxel|mesh-list
154249467|NCT03694002|Carboplatin|carboplatin|mesh-list
154249468|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154249469|NCT03694002|Ramucirumab|ramucirumab|mesh-list
154249470|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154249472|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
154249473|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154249474|NCT03694002|Lexatumumab|lexatumumab|mesh-list
154249475|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154249476|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249477|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
154249478|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
154249479|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
154249480|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249481|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
154249482|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249483|NCT03694002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154249484|NCT03694002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154249485|NCT03694002|Growth Substances|growth substances|mesh-ancestor
154249486|NCT03694002|Growth Inhibitors|growth inhibitors|mesh-ancestor
154249487|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
154249488|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249489|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249490|NCT03447314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154249491|NCT03447314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249492|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154249493|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
154249494|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249495|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154249496|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249497|NCT03364530|Gemcitabine|gemcitabine|mesh-list
154249498|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
154249499|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154249500|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
154249501|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249502|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249503|NCT03289910|Carboplatin|carboplatin|mesh-list
154249504|NCT03289910|Topotecan|topotecan|mesh-list
154249505|NCT03289910|Veliparib|veliparib|mesh-list
154249506|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249507|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154249508|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154249509|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249510|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249511|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154249512|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
154249513|NCT03253133|Oxycodone|oxycodone|mesh-list
154249514|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249515|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154249516|NCT03253133|Narcotics|narcotics|mesh-ancestor
154249517|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249518|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249520|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
154249521|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249523|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
154249524|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154249525|NCT03091660|Vaccines|vaccines|mesh-list
154249526|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
154249527|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
154249528|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249529|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154249530|NCT03091595|Drospirenone|drospirenone|mesh-list
154249531|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154249532|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154249533|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
153973726|NCT06248229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249534|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154249535|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249536|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154249537|NCT03091595|Diuretics|diuretics|mesh-ancestor
154249538|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
154249539|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154249540|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154249541|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154249542|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
154249543|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154249545|NCT03091595|Estrogens|estrogens|mesh-ancestor
154249546|NCT03091595|Hormones|hormones|mesh-ancestor
154249547|NCT01925131|Prednisone|prednisone|mesh-list
154249548|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
154249549|NCT01925131|Vincristine|vincristine|mesh-list
154249550|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154249551|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154249552|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
154249553|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249554|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249555|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154249556|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
154249557|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249558|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249559|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154249560|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249561|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
154249562|NCT01925131|Hormones|hormones|mesh-ancestor
154249563|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154249564|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154249565|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154249566|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
154249567|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
154249568|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
154249569|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249570|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154249571|NCT01925131|Immunotoxins|immunotoxins|mesh-ancestor
154249572|NCT01925131|Immunoconjugates|immunoconjugates|mesh-ancestor
154249573|NCT01698918|Dexamethasone|dexamethasone|mesh-list
154249574|NCT01698918|Everolimus|everolimus|mesh-list
154249575|NCT01698918|Letrozole|letrozole|mesh-list
154249576|NCT01698918|Exemestane|exemestane|mesh-list
154249577|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249578|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
154249579|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
154249580|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249581|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249582|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249583|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
154249584|NCT01698918|Hormones|hormones|mesh-ancestor
154249585|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154249586|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154249587|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249588|NCT01698918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154249589|NCT01698918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154249590|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249591|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249592|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154249593|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
154249594|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154249595|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154249596|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154249597|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
154249598|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
154249599|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
154249600|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154249601|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154249602|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249603|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249604|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249605|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249606|NCT00840177|Cytarabine|cytarabine|mesh-list
154249607|NCT00840177|Idarubicin|idarubicin|mesh-list
154249608|NCT00840177|Pravastatin|pravastatin|mesh-list
154249609|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154249610|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
154249611|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249612|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249613|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
154249614|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249615|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154249616|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
154249617|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249618|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154249619|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154249621|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249622|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154249623|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154249624|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154249625|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154249626|NCT01347580|Ticagrelor|ticagrelor|mesh-list
154249627|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154249628|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154249629|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154249630|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154249631|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
154249632|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249633|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249634|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249635|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
154249636|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154249637|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249638|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154249639|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154249640|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249641|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249642|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249643|NCT03352414|Alvimopan|alvimopan|mesh-list
154249644|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249645|NCT00364793|Emtricitabine|emtricitabine|mesh-list
154249646|NCT00364793|Efavirenz|efavirenz|mesh-list
154249647|NCT00364793|Didanosine|didanosine|mesh-list
154249648|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
154249649|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249650|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154249651|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154249652|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249653|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249654|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154249655|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154249656|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154249657|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154249658|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154249659|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154249660|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154249661|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154249662|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
154249663|NCT03351478|Empagliflozin|empagliflozin|mesh-list
154249664|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154249665|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153996581|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
154249666|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249668|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249669|NCT00363545|Vaccines|vaccines|mesh-list
154249670|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
154249671|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249672|NCT03351244|BI 409306|bi 409306|mesh-list
154249673|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154249674|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249675|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249676|NCT03386032|Desonide|desonide|mesh-list
154249677|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249678|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
154249679|NCT00077610|Hematinics|hematinics|mesh-ancestor
154249680|NCT00066222|Etoposide|etoposide|mesh-list
154249681|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249682|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154249683|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154249684|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154249685|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249686|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249687|NCT00397943|Vaccines|vaccines|mesh-list
154249688|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
154249689|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249690|NCT00066066|Amoxicillin|amoxicillin|mesh-list
154249691|NCT00066066|Metronidazole|metronidazole|mesh-list
154249692|NCT00066066|Doxycycline|doxycycline|mesh-list
154249693|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154249694|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249695|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154249696|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154249697|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
154249698|NCT00363467|Busulfan|busulfan|mesh-list
154249699|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
154249700|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249701|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154249702|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
154249703|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249704|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154249705|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249706|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154249707|NCT00397631|Pioglitazone|pioglitazone|mesh-list
154249708|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154249709|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154249710|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249711|NCT00397631|Incretins|incretins|mesh-ancestor
154249712|NCT00397631|Hormones|hormones|mesh-ancestor
154249713|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154249714|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154249715|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
154249716|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249717|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249718|NCT00077376|Carboplatin|carboplatin|mesh-list
154249719|NCT00077376|Trastuzumab|trastuzumab|mesh-list
154249720|NCT00077376|Epothilone B|epothilone b|mesh-list
154249721|NCT00077376|Epothilones|epothilones|mesh-list
154249722|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249723|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249724|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
154249725|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
154249726|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
154249727|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249728|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
154249729|NCT01088724|Rituximab|rituximab|mesh-list
154249730|NCT01088724|Doxorubicin|doxorubicin|mesh-list
154249731|NCT01088724|Fludarabine|fludarabine|mesh-list
153973727|NCT06248229|Adrenergic Agents|adrenergic agents|mesh-ancestor
154249732|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154249733|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
154249734|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249735|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249736|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154249737|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
154249738|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249739|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249740|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153996661|NCT00623545|Exenatide|exenatide|mesh-list
154249741|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249742|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154249743|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154249744|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154249745|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249746|NCT03957174|Rivastigmine|rivastigmine|mesh-list
154249747|NCT03957174|Reboxetine|reboxetine|mesh-list
154249748|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154249749|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249750|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249751|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
154249752|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249753|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249754|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154249755|NCT03957174|Protective Agents|protective agents|mesh-ancestor
154249756|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
154249757|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154249758|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154249759|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154249760|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154249761|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
154249762|NCT00363311|Dutasteride|dutasteride|mesh-list
154249763|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154249764|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154249765|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249766|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249767|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
154249768|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154249769|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249770|NCT00362609|Pantoprazole|pantoprazole|mesh-list
154249771|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154249772|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249773|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154249774|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249775|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249776|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
154249777|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
154249778|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249779|NCT02534753|Protective Agents|protective agents|mesh-ancestor
154249780|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249781|NCT02534753|Vitamins|vitamins|mesh-ancestor
154249782|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
154123788|NCT00821262|Propofol|propofol|mesh-list
154249783|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
154249784|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154249785|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249786|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154249787|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
154249788|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154249789|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249790|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249791|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249792|NCT00362297|Valacyclovir|valacyclovir|mesh-list
154249793|NCT00362297|Acyclovir|acyclovir|mesh-list
154249794|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
154249795|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249796|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
154249797|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249798|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
154249799|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
154249800|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249801|NCT00090402|Protective Agents|protective agents|mesh-ancestor
154249802|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249803|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
154249804|NCT00090402|Vitamins|vitamins|mesh-ancestor
154249805|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
154249806|NCT00361283|Atorvastatin|atorvastatin|mesh-list
154249807|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154249808|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154249809|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
154249810|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249811|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154249812|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154249813|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249814|NCT00077064|Captopril|captopril|mesh-list
154249815|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154249816|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
154249817|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249818|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249819|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154393034|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154249821|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154249822|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154249823|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
154249824|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249825|NCT02534363|Aripiprazole|aripiprazole|mesh-list
154249826|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154249827|NCT02534363|Ziprasidone|ziprasidone|mesh-list
154249828|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
154123877|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249829|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154249830|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154249831|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154249832|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249833|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249834|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
154249835|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
154249836|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254095|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154249837|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249838|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154249839|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154249840|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
154249841|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154249842|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154249843|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154249844|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154249845|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
154249846|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154249847|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249848|NCT01088958|Micronutrients|micronutrients|mesh-list
154249849|NCT01088958|Trace Elements|trace elements|mesh-list
154249850|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249851|NCT03404518|Acetaminophen|acetaminophen|mesh-list
154249852|NCT03404518|Ibuprofen|ibuprofen|mesh-list
154249853|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154249854|NCT03404518|Hydrocodone|hydrocodone|mesh-list
154249855|NCT03404518|Narcotics|narcotics|mesh-list
154249856|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154249857|NCT03404518|Analgesics|analgesics|mesh-ancestor
154249858|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
154249859|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249860|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249861|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
154249862|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154249863|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249864|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249865|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154249866|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249867|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249868|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154249869|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249870|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
154249871|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
154249872|NCT03404206|Ibuprofen|ibuprofen|mesh-list
154249873|NCT03404206|Naproxen|naproxen|mesh-list
154249874|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154249875|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154249876|NCT03404206|Analgesics|analgesics|mesh-ancestor
154249877|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
154249878|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249879|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249880|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249881|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249882|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154249883|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249884|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249885|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
154249886|NCT00394901|Pregabalin|pregabalin|mesh-list
154249887|NCT00394901|Analgesics|analgesics|mesh-ancestor
154249888|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
154249889|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249890|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249891|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
154249892|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154249893|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154249894|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249895|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154249896|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154249897|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154249898|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249899|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154249900|NCT03349060|Abrocitinib|abrocitinib|mesh-list
154249901|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154249902|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249903|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249904|NCT03348904|Paclitaxel|paclitaxel|mesh-list
154249905|NCT03348904|Carboplatin|carboplatin|mesh-list
154249906|NCT03348904|Gemcitabine|gemcitabine|mesh-list
154249907|NCT03348904|Nivolumab|nivolumab|mesh-list
154249908|NCT03348904|Pemetrexed|pemetrexed|mesh-list
154249909|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154249910|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249911|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154249912|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
154249913|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
154249914|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249915|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154249917|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249918|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154249919|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249920|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154249921|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154249922|NCT00359021|Etravirine|etravirine|mesh-list
154249923|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154249924|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154249925|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249926|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249927|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
154249928|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154249929|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154249930|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154249931|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154249932|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154249933|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249934|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
154249935|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249936|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249937|NCT01052597|Curcumin|curcumin|mesh-list
154249938|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154249939|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154249940|NCT01052597|Analgesics|analgesics|mesh-ancestor
154249941|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
154249942|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249943|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249944|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249945|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249946|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249947|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249948|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249949|NCT01051115|Dasatinib|dasatinib|mesh-list
154249950|NCT01051115|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154249951|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154249952|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154249953|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249954|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249955|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
154249956|NCT00076752|Promethazine|promethazine|mesh-list
154249957|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
154249958|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
154249959|NCT00076752|Rituximab|rituximab|mesh-list
154249960|NCT00076752|Fludarabine|fludarabine|mesh-list
154249961|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
154249962|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154249963|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
154249964|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154249965|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154249966|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154249967|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
154249968|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154249969|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154249970|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154249971|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154249972|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154249973|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
154249974|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154249975|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
154249976|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
154249977|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154249978|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154249979|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
154249980|NCT00076752|Hormones|hormones|mesh-ancestor
154249981|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154249982|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154249983|NCT00076752|Protective Agents|protective agents|mesh-ancestor
154249984|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154249985|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154123991|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
154249986|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154249987|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
154249988|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
154249989|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
154249990|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154249991|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
154249992|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
154249993|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154249994|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154249995|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
154249996|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
154249997|NCT03384940|Trastuzumab|trastuzumab|mesh-list
154249998|NCT03384940|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154249999|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250000|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250001|NCT03384940|Immunoconjugates|immunoconjugates|mesh-ancestor
154250002|NCT03384940|Immunologic Factors|immunologic factors|mesh-ancestor
154250003|NCT03384940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250004|NCT00075582|Dactinomycin|dactinomycin|mesh-list
154250005|NCT00075582|Cactinomycin|cactinomycin|mesh-list
154250006|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
154250007|NCT00075582|Vincristine|vincristine|mesh-list
154250008|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250009|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
154250010|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250011|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250012|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154250013|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
154250014|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250015|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250016|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154250017|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154250018|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
154250019|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
154250020|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
154250021|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250022|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250023|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154250024|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154250025|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250026|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154250027|NCT00063258|Paclitaxel|paclitaxel|mesh-list
154250028|NCT00063258|Carboplatin|carboplatin|mesh-list
154250029|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154250030|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154250031|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250032|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
154250033|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
154250034|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
154250035|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250036|NCT00063258|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154250037|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154250038|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250039|NCT00088530|Prednisone|prednisone|mesh-list
153996964|NCT02836548|Vorinostat|vorinostat|mesh-list
154250040|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
154250041|NCT00088530|Rituximab|rituximab|mesh-list
154250042|NCT00088530|Gemcitabine|gemcitabine|mesh-list
154250043|NCT00088530|Etoposide|etoposide|mesh-list
154250044|NCT00088530|Vincristine|vincristine|mesh-list
154250045|NCT00088530|Vinorelbine|vinorelbine|mesh-list
154250046|NCT00088530|Pixantrone|pixantrone|mesh-list
154250047|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250048|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
154250049|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250050|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250051|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154250052|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
154250053|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250054|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250055|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154250056|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250057|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154250058|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
154250059|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250060|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
154250061|NCT00088530|Hormones|hormones|mesh-ancestor
154250062|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250063|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154250064|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154250065|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154250066|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154250067|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250068|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
154250069|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
154250070|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
154250071|NCT00359801|Insulin|insulin|mesh-list
154250072|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154250073|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154250074|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250075|NCT03990701|Metomidate|metomidate|mesh-list
154250076|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154250077|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250078|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250079|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
154250080|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
154250081|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154250082|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154250083|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154250084|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250085|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154250086|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154250087|NCT01051271|Midazolam|midazolam|mesh-list
154250088|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154250089|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154250090|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250091|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250092|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154250093|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154250094|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154250095|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154250096|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
154250097|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
154250098|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
154250099|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
154250100|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250101|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250102|NCT01051427|Hemostatics|hemostatics|mesh-list
154250103|NCT01051427|Surgiflo|surgiflo|mesh-list
154250104|NCT01051427|Coagulants|coagulants|mesh-ancestor
154250105|NCT01052909|Glimepiride|glimepiride|mesh-list
154250106|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154124118|NCT04094909|Paclitaxel|paclitaxel|mesh-list
154250107|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154250108|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250109|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250110|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
154250111|NCT00045032|Trastuzumab|trastuzumab|mesh-list
154250112|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250113|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250114|NCT01052987|Tranilast|tranilast|mesh-list
154250115|NCT01052987|Allopurinol|allopurinol|mesh-list
154250116|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
154250117|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250118|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250119|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
154250120|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250121|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154250122|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
154250123|NCT01052987|Protective Agents|protective agents|mesh-ancestor
154250124|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250125|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154250126|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154250127|NCT01052987|Analgesics|analgesics|mesh-ancestor
154250128|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
154250129|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250130|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250131|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154250132|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154250133|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154250134|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154250135|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
154250136|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
154250137|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250138|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154250139|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154250140|NCT02533973|Calcipotriene|calcipotriene|mesh-list
154250141|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250142|NCT01053065|Atorvastatin|atorvastatin|mesh-list
154250143|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
154250144|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
154250145|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154250146|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154250147|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
154250148|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250149|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154250150|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154250151|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250152|NCT01051583|Bevacizumab|bevacizumab|mesh-list
154250153|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250154|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250155|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154250156|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154250157|NCT01051583|Growth Substances|growth substances|mesh-ancestor
154250158|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250159|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
154250161|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154250162|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250163|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
154250164|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250165|NCT00356915|Itraconazole|itraconazole|mesh-list
154250166|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154250167|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
154250168|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250169|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154250170|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154250171|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250172|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250173|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154250174|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
154250175|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250176|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250177|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154250178|NCT00356759|Warfarin|warfarin|mesh-list
154250179|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
154250180|NCT00356603|Sumatriptan|sumatriptan|mesh-list
154250181|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154250182|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154250183|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154250184|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
154250185|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250186|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250187|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250188|NCT01052051|Vitamin D|vitamin d|mesh-list
154250189|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
153997112|NCT05877079|Menthol|menthol|mesh-list
154250190|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
154250191|NCT01052051|Calcium|calcium|mesh-list
154250192|NCT01052051|Vitamins|vitamins|mesh-ancestor
154250193|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
154250194|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250195|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154250196|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154250197|NCT01052051|Antacids|antacids|mesh-ancestor
154250198|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250199|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154250200|NCT00002558|Paclitaxel|paclitaxel|mesh-list
154250201|NCT00002558|Etoposide|etoposide|mesh-list
154250202|NCT00002558|Carboplatin|carboplatin|mesh-list
154250203|NCT00002558|Ifosfamide|ifosfamide|mesh-list
154250204|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154250205|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250206|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
154250207|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
154250208|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
154250209|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250210|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154250211|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154250212|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250213|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154250214|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
154250215|NCT00001880|Cyclosporine|cyclosporine|mesh-list
154250216|NCT00001880|Methotrexate|methotrexate|mesh-list
154250217|NCT00001880|Cyclosporins|cyclosporins|mesh-list
154250218|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154250219|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
154250220|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154250221|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250222|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154250223|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
154250224|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250225|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250226|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250227|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250228|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154250229|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250230|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
154250231|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250232|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154250233|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
154250234|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250235|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154250236|NCT01096472|Octenidine|octenidine|mesh-list
154250237|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250238|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154250239|NCT05627648|Mitogens|mitogens|mesh-list
154250240|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
154250241|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250242|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
154250243|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154250244|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154250245|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250246|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154250247|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154250248|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
154250249|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250250|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250251|NCT01104896|Nicotine|nicotine|mesh-list
154250252|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154250253|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
154250254|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250255|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250256|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154250257|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154250258|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
154250259|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250260|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250261|NCT00043550|Sertraline|sertraline|mesh-list
154250262|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154250263|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
154250264|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154250265|NCT00043550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154250266|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154250267|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154250268|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250269|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250270|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
154250271|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250272|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154250273|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154250274|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154250275|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250276|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250277|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250278|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
154250280|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250281|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250282|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154250283|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154250284|NCT01105208|Cephalexin|cephalexin|mesh-list
154250285|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250286|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250287|NCT01105286|Vitamin D|vitamin d|mesh-list
154250288|NCT01105286|Calcipotriene|calcipotriene|mesh-list
154250289|NCT01105286|Vitamins|vitamins|mesh-ancestor
154250290|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
154250291|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124296|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250292|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154250293|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250294|NCT00041132|Leucovorin|leucovorin|mesh-list
154250295|NCT00041132|Cytarabine|cytarabine|mesh-list
154250296|NCT00041132|Dexamethasone|dexamethasone|mesh-list
154250297|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
154250298|NCT00041132|Rituximab|rituximab|mesh-list
154250299|NCT00041132|Doxorubicin|doxorubicin|mesh-list
154250300|NCT00041132|Methotrexate|methotrexate|mesh-list
154250301|NCT00041132|Vincristine|vincristine|mesh-list
154250302|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
154250303|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250304|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
154250305|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250306|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250307|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154250308|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
154250309|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250310|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250311|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154250312|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250313|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
154250314|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
154250315|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250316|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154250317|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
154250318|NCT00041132|Hormones|hormones|mesh-ancestor
154250319|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250320|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154250321|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250322|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154250323|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154250324|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154250325|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250326|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154250327|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
154250328|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154250329|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154250330|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
154250331|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250332|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154250333|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154250334|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
154250335|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250336|NCT00041132|Antidotes|antidotes|mesh-ancestor
154250337|NCT00041132|Protective Agents|protective agents|mesh-ancestor
153997258|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
154250338|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
154250339|NCT00041132|Vitamins|vitamins|mesh-ancestor
154250340|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
153730622|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
154250341|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154250342|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
154250343|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
154124340|NCT02597699|Lidocaine|lidocaine|mesh-list
154250344|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
154250345|NCT00040664|Ritonavir|ritonavir|mesh-list
154250346|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
154250347|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154250348|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154250349|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
154250350|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250351|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250352|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154250353|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154250354|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
154250355|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250356|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154250357|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154250358|NCT02952586|Avelumab|avelumab|mesh-list
154250359|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250360|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250361|NCT01096706|Aspirin|aspirin|mesh-list
154250362|NCT01096706|Fluconazole|fluconazole|mesh-list
154250363|NCT01096706|Substance P|substance p|mesh-list
154250364|NCT01096706|Neurokinin A|neurokinin a|mesh-list
154250365|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154250366|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154250367|NCT01096706|Analgesics|analgesics|mesh-ancestor
154250368|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
154250369|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250370|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250371|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250372|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250373|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154250374|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154250375|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250376|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154250377|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154250378|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250379|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
154250380|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
154250381|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250382|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154124395|NCT04089605|BB 1101|bb 1101|mesh-list
154250383|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154250384|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154250385|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
154250386|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250387|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154250388|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154250389|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250390|NCT01102478|Losartan|losartan|mesh-list
154250391|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154250392|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154250393|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154250394|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154250395|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154250396|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250397|NCT01102478|Diuretics|diuretics|mesh-ancestor
154250398|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
154250399|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250400|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154250401|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154250402|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154250403|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154250404|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
154250405|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250406|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154250407|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250408|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154250409|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250410|NCT03384316|Vaccines|vaccines|mesh-list
154250411|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
154250412|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997328|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154250414|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154250415|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250416|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154250417|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154393035|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154250418|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
154250419|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154250421|NCT00356525|Gemcitabine|gemcitabine|mesh-list
154250422|NCT00356525|Pemetrexed|pemetrexed|mesh-list
154250423|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250424|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154250425|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
154250426|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250427|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250428|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154250429|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154250430|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
154250431|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250432|NCT01052129|Naproxen|naproxen|mesh-list
154250433|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154250434|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154250435|NCT01052129|Analgesics|analgesics|mesh-ancestor
154250436|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
154250437|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250438|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250439|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250440|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250441|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
154250442|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154250443|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250444|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250445|NCT01053377|Oseltamivir|oseltamivir|mesh-list
154250446|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
154250447|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250448|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250449|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250450|NCT03991559|Manganese|manganese|mesh-list
154250451|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154250452|NCT03991559|Antibodies|antibodies|mesh-list
154250453|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
154250454|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
154250455|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250456|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250457|NCT03991559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250458|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250459|NCT03991559|Trace Elements|trace elements|mesh-ancestor
154250460|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
154250461|NCT03949634|Paclitaxel|paclitaxel|mesh-list
154250462|NCT03949634|Docetaxel|docetaxel|mesh-list
154250463|NCT03949634|Doxorubicin|doxorubicin|mesh-list
154250464|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154250465|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250466|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
154250467|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
154250468|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
154250469|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250470|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154250471|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154250472|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154250473|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250474|NCT01108874|Metaraminol|metaraminol|mesh-list
154250475|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
154250476|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
154250477|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250478|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250479|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154250480|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154250481|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154250482|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154250483|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154250484|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250485|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250486|NCT03383614|Emodepside|emodepside|mesh-list
154250487|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154250488|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250490|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250491|NCT00356135|Clopidogrel|clopidogrel|mesh-list
154250492|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154250493|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154250494|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154250495|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154393036|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154250496|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154250497|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
154250498|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250499|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250500|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250501|NCT01052363|Bevacizumab|bevacizumab|mesh-list
154250502|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250503|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250504|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154250505|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154250506|NCT01052363|Growth Substances|growth substances|mesh-ancestor
154250507|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250508|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
154250509|NCT01053611|Remifentanil|remifentanil|mesh-list
154250510|NCT01053611|Propofol|propofol|mesh-list
154250511|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154250512|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250513|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250514|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154250515|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
154250516|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
154250517|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154250518|NCT01053611|Narcotics|narcotics|mesh-ancestor
154124530|NCT00521014|Cytarabine|cytarabine|mesh-list
154250519|NCT01053611|Analgesics|analgesics|mesh-ancestor
154250520|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
154250521|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250522|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
154250523|NCT00350519|Hematinics|hematinics|mesh-ancestor
154250524|NCT01053689|Glimepiride|glimepiride|mesh-list
154250525|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154250526|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154250527|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250528|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250529|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
154250530|NCT01111448|Sirolimus|sirolimus|mesh-list
154250531|NCT01111448|Temsirolimus|temsirolimus|mesh-list
154250532|NCT01111448|MTOR Inhibitors|mtor inhibitors|mesh-list
154250533|NCT01111448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154250534|NCT01111448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250535|NCT01111448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250536|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250537|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
154250538|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250539|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250540|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250541|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250542|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154250543|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
154250544|NCT03382912|Nivolumab|nivolumab|mesh-list
154250545|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250546|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250547|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154250548|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250549|NCT03942926|Sirolimus|sirolimus|mesh-list
154250550|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250551|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250552|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154250553|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250554|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
154250555|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250556|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
154250557|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250558|NCT00350207|Bromides|bromides|mesh-list
154250559|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
154250560|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154250561|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154250562|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
154250563|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250564|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250565|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154250566|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
154250567|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
154250568|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154250569|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
154250570|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250571|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250572|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154250573|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154250574|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154250575|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
154250576|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
154250577|NCT03946826|Halometasone|halometasone|mesh-list
154250578|NCT03946826|Petrolatum|petrolatum|mesh-list
154250579|NCT03946826|Emollients|emollients|mesh-ancestor
154250580|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250581|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250582|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
154250583|NCT03946826|Hormones|hormones|mesh-ancestor
154250584|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250585|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250586|NCT01311622|Warfarin|warfarin|mesh-list
154250587|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
154250588|NCT00349973|Dipyridamole|dipyridamole|mesh-list
154250589|NCT00349973|Olanzapine|olanzapine|mesh-list
154250590|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
154250591|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
154250592|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250593|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250594|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154250595|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154250596|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154250597|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250598|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154250599|NCT00349973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154250600|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154250601|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154250602|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250603|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250604|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
154250605|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154250606|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250607|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154250608|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
154250609|NCT01111682|Mannitol|mannitol|mesh-list
154250610|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154250611|NCT01111682|Diuretics|diuretics|mesh-ancestor
154250612|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
154250613|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250614|NCT04464122|Somatostatin|somatostatin|mesh-list
154250615|NCT04464122|Hormones|hormones|mesh-ancestor
154250616|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250617|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250618|NCT01111994|Clindamycin|clindamycin|mesh-list
154250619|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
154250620|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
154250621|NCT01111994|Tretinoin|tretinoin|mesh-list
154250622|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250623|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250624|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154250625|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250626|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250627|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250628|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
154250629|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250630|NCT03187262|Daratumumab|daratumumab|mesh-list
154250632|NCT03944252|Cetuximab|cetuximab|mesh-list
154250633|NCT03944252|Avelumab|avelumab|mesh-list
154250634|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250635|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250636|NCT01209026|Fluticasone|fluticasone|mesh-list
154250637|NCT01209026|Xhance|xhance|mesh-list
154250638|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
154250639|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154250640|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250641|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154250642|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
154250643|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250644|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250645|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154250646|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
154250647|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250648|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154250649|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250650|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250651|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154250652|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154250653|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250654|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250655|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250656|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154250657|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
154250658|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154250659|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154250660|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154250661|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154250662|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154250663|NCT01107470|Hormones|hormones|mesh-ancestor
154250664|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250665|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250666|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154250667|NCT01109264|Chlorambucil|chlorambucil|mesh-list
154250668|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154250669|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
154250670|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250671|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250672|NCT01311700|Metoprolol|metoprolol|mesh-list
154250673|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154250674|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154250675|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
154250676|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
154250677|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250678|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250679|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154250680|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154250681|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154250682|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
154250683|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250684|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250685|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
154250686|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
154250687|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154250688|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154250689|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250690|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250691|NCT01107782|Urological Agents|urological agents|mesh-ancestor
154250692|NCT01107938|Esomeprazole|esomeprazole|mesh-list
154250693|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154250694|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154250695|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154250696|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250697|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250698|NCT02950558|Ropivacaine|ropivacaine|mesh-list
154250699|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
154250700|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
154250701|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250702|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250703|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
154250704|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250705|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
154250706|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154250707|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
154250708|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250709|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250710|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154250711|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
154250712|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
154250713|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154250714|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
154250715|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250716|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250717|NCT01209416|Acipimox|acipimox|mesh-list
154250718|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154250719|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
154250720|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250721|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154250722|NCT00349349|Ofatumumab|ofatumumab|mesh-list
154250723|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250724|NCT01112462|Acetaminophen|acetaminophen|mesh-list
154250725|NCT01112462|Phenylephrine|phenylephrine|mesh-list
154250726|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
154250727|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154250728|NCT01112462|Analgesics|analgesics|mesh-ancestor
154250729|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
154250730|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250731|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250732|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
154250733|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154250734|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
154250735|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
154250736|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
154250737|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154250738|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
154250739|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
154250740|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154250741|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154250742|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154250743|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
154250744|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250745|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250746|NCT01112462|Protective Agents|protective agents|mesh-ancestor
154250747|NCT02950480|Zafirlukast|zafirlukast|mesh-list
154250748|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154250749|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
154250750|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154250751|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
154250752|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250753|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250754|NCT01109030|Pioglitazone|pioglitazone|mesh-list
154250755|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
154250756|NCT01109030|Dexetimide|dexetimide|mesh-list
154250757|NCT01109030|Citalopram|citalopram|mesh-list
154250758|NCT01109030|Escitalopram|escitalopram|mesh-list
154250759|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154250760|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250761|NCT01109030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154250762|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154250763|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154250764|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250765|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250766|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
154250767|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154250768|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
154250769|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154250770|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154250771|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154250772|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
154250773|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
154250774|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250775|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154250776|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154250777|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
154250778|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154250779|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154250780|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250781|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154250782|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154250783|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
154250784|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
154250785|NCT05494528|Entecavir|entecavir|mesh-list
154250786|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
154250787|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250788|NCT03987815|Nivolumab|nivolumab|mesh-list
154250789|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997702|NCT05335460|Capecitabine|capecitabine|mesh-list
154250790|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250791|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154250792|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393037|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250794|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
154250795|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250796|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
154250797|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154250798|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154250799|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250800|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
154250801|NCT02257580|Coagulants|coagulants|mesh-ancestor
154250802|NCT01055795|Bevacizumab|bevacizumab|mesh-list
154250803|NCT01055795|Everolimus|everolimus|mesh-list
154250804|NCT01055795|Panobinostat|panobinostat|mesh-list
154250805|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250806|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250807|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154250808|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154250809|NCT01055795|Growth Substances|growth substances|mesh-ancestor
154250810|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250811|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
154250812|NCT01055795|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154250813|NCT01055795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154250814|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250815|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250816|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250817|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
154250818|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154250819|NCT03943784|Propranolol|propranolol|mesh-list
154250820|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154250821|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154250822|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
154250823|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154250824|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250825|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250826|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154250827|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154250828|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
154250829|NCT00347009|Adefovir|adefovir|mesh-list
154250830|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154250831|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
154250832|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250833|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154250834|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154250835|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250836|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250837|NCT01209650|Afatinib|afatinib|mesh-list
154250838|NCT01209650|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154124837|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154250839|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154250840|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250841|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250842|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250843|NCT01947140|Romidepsin|romidepsin|mesh-list
154250844|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154250845|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250846|NCT01947140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154250847|NCT01947140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250848|NCT01947140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250849|NCT00346775|Beclomethasone|beclomethasone|mesh-list
154250850|NCT00346775|Flunisolide|flunisolide|mesh-list
154250851|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250852|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
154250853|NCT00346775|Hormones|hormones|mesh-ancestor
154250854|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250855|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250856|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154250857|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
154250858|NCT01108562|Lidocaine|lidocaine|mesh-list
154250859|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
154250860|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
154250861|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250862|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250863|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
154250864|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250865|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154250866|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154250867|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154250868|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154250869|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250871|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154250872|NCT01112540|Narcotics|narcotics|mesh-ancestor
154250873|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250874|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250875|NCT01112540|Analgesics|analgesics|mesh-ancestor
154250876|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
154250877|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250878|NCT03400852|Cosyntropin|cosyntropin|mesh-list
154250879|NCT03400852|Hormones|hormones|mesh-ancestor
154250880|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250881|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250882|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
154250883|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
154250884|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250885|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
154250886|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
154250887|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250888|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250889|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
154250890|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
154250891|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250892|NCT01056497|Protective Agents|protective agents|mesh-ancestor
154250893|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250894|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
154250895|NCT01056497|Vitamins|vitamins|mesh-ancestor
154250896|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
154250897|NCT03398356|Metformin|metformin|mesh-list
154250898|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154250899|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250900|NCT00346151|Sirolimus|sirolimus|mesh-list
154250901|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
154250902|NCT00346151|Abatacept|abatacept|mesh-list
154250903|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
154250904|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154250905|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
154250906|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
154250907|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250908|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250909|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154250910|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250911|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
154250912|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250913|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
154250914|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250915|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250916|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154250917|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
154250918|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
154250919|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250920|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154250921|NCT00346151|Hormones|hormones|mesh-ancestor
154250922|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250923|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154250924|NCT00346151|Protective Agents|protective agents|mesh-ancestor
154250925|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154250926|NCT00346151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250927|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250928|NCT03940976|Afatinib|afatinib|mesh-list
154250929|NCT03940976|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154250930|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154250931|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250932|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250933|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250934|NCT01109498|Cyclosporine|cyclosporine|mesh-list
154250935|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
154250936|NCT01109498|Cyclosporins|cyclosporins|mesh-list
154250937|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154250938|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250939|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250940|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
154250941|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250942|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
154250943|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250944|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
154250945|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250946|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154250947|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154250948|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250949|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154250950|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
154250951|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154250953|NCT00130286|Hormones|hormones|mesh-list
154250954|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154250955|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250956|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154250957|NCT03940664|Formaldehyde|formaldehyde|mesh-list
154250958|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
154250959|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250960|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
154250961|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
154250962|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154250963|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
154250964|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
154250965|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250966|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250967|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154250968|NCT03941990|Analgesics|analgesics|mesh-ancestor
154250969|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
154250970|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250971|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
154250972|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154250973|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154250974|NCT03374488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154250975|NCT03374488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154250976|NCT01209728|Ethanol|ethanol|mesh-list
154250977|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154250978|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154250979|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154250980|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250981|NCT00345683|Vaccines|vaccines|mesh-list
154250982|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
154250983|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250984|NCT01211912|Acetaminophen|acetaminophen|mesh-list
154250985|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154250986|NCT01211912|Analgesics|analgesics|mesh-ancestor
154250987|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
154250988|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154250989|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250990|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
154250991|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
154250992|NCT03943472|Fludarabine|fludarabine|mesh-list
154250993|NCT03943472|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154250994|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154250995|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
154250996|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154250997|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154250998|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154250999|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
154251000|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251001|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251002|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154251003|NCT03943472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154251004|NCT01056731|Aliskiren|aliskiren|mesh-list
154251005|NCT01056731|Renin Inhibitors|renin inhibitors|mesh-ancestor
154251006|NCT01056731|Protease Inhibitors|protease inhibitors|mesh-ancestor
154251007|NCT01056731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251008|NCT01056731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251009|NCT01114490|Anacetrapib|anacetrapib|mesh-list
154251010|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154251011|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154251012|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
154251013|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251014|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154251015|NCT01209806|Simethicone|simethicone|mesh-list
154251016|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
154251017|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154251018|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154393038|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251019|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
154251021|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
154251022|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251023|NCT01209806|Emollients|emollients|mesh-ancestor
154251024|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
154251025|NCT01209806|Antacids|antacids|mesh-ancestor
154251026|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251027|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154251028|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
154251029|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251030|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
154251031|NCT01209806|Protective Agents|protective agents|mesh-ancestor
154251032|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
154251033|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153973728|NCT06248229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154125083|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
154251034|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251035|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154251036|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251037|NCT01109654|Cetrorelix|cetrorelix|mesh-list
154251038|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154251039|NCT01109654|Hormones|hormones|mesh-ancestor
154251040|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251041|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251042|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154251043|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
154251044|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154251045|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
154251046|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
154251047|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251048|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154251049|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154251050|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251051|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251052|NCT01054001|Urological Agents|urological agents|mesh-ancestor
154251053|NCT01057355|Ethanol|ethanol|mesh-list
154251054|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154251055|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251056|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251057|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251058|NCT01057511|Progesterone|progesterone|mesh-list
154251059|NCT01057511|Progestins|progestins|mesh-ancestor
154251060|NCT01057511|Hormones|hormones|mesh-ancestor
154251061|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251062|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251063|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154251064|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251065|NCT01210040|Folic Acid|folic acid|mesh-list
154251066|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
154251067|NCT01210040|Hematinics|hematinics|mesh-ancestor
154251068|NCT01210040|Vitamins|vitamins|mesh-ancestor
154251069|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
154251070|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251071|NCT01054313|Sirolimus|sirolimus|mesh-list
154251072|NCT01054313|Prednisone|prednisone|mesh-list
154251073|NCT01054313|Docetaxel|docetaxel|mesh-list
154251074|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251075|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
154251076|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
154251077|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
154251078|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251079|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251080|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
154251081|NCT01054313|Hormones|hormones|mesh-ancestor
154251082|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251083|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251084|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154251085|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154251086|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251087|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154251088|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
154251090|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
154251091|NCT01114958|Cisplatin|cisplatin|mesh-list
154251092|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251093|NCT03742115|Dexamethasone|dexamethasone|mesh-list
154251094|NCT03742115|Etoposide|etoposide|mesh-list
154251095|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
154251096|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251098|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
154251099|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251100|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251101|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251102|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
154251103|NCT03742115|Hormones|hormones|mesh-ancestor
154251104|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251105|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154251106|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251107|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154251108|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154125138|NCT00744497|Dasatinib|dasatinib|mesh-list
154251109|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154251110|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251111|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251112|NCT01115036|Panobinostat|panobinostat|mesh-list
154251113|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251114|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154251115|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251116|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251117|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154251118|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154251119|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154251120|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251121|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251122|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
154251123|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251124|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251125|NCT03942068|Paclitaxel|paclitaxel|mesh-list
154251126|NCT03942068|Apatinib|apatinib|mesh-list
154251127|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154251128|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154251129|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251130|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
154251131|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
154251132|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
154251133|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251134|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154251135|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251136|NCT01112852|Terlipressin|terlipressin|mesh-list
154251137|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154251138|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154251139|NCT01112852|Somatostatin|somatostatin|mesh-list
154251140|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154251141|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251142|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251143|NCT01112852|Hormones|hormones|mesh-ancestor
154251144|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251145|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251146|NCT01054469|Ropivacaine|ropivacaine|mesh-list
154251147|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
154251148|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
154251149|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251150|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251151|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
154251152|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251153|NCT03940430|Lactoferrin|lactoferrin|mesh-list
154125188|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251154|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251155|NCT00355121|Vaccines|vaccines|mesh-list
154251156|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
154251157|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251158|NCT02533349|Pantoprazole|pantoprazole|mesh-list
154251159|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154251160|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251161|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154251162|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251163|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251164|NCT01115426|Losartan|losartan|mesh-list
154251165|NCT01115426|Ramipril|ramipril|mesh-list
154251166|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154251167|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154251168|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154251169|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154251170|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251171|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154251173|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251174|NCT03942458|Clopidogrel|clopidogrel|mesh-list
154251175|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154251176|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154251177|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154251178|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154251179|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
154251180|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251181|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251182|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251183|NCT01115504|Thiamine|thiamine|mesh-list
154251184|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
154251185|NCT01115504|Vitamins|vitamins|mesh-ancestor
154251186|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
154251187|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251188|NCT00343889|Vaccines|vaccines|mesh-list
154251189|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
154251190|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251191|NCT03939884|Diclofenac|diclofenac|mesh-list
154251192|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154251193|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154251194|NCT03939884|Analgesics|analgesics|mesh-ancestor
154251195|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
154251196|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251197|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251198|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251199|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154251200|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154251201|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251202|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251203|NCT01054547|Anesthetics|anesthetics|mesh-list
154251204|NCT01054547|Ropivacaine|ropivacaine|mesh-list
154251205|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251206|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251207|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
154251208|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
154251209|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251210|NCT01115894|Naltrexone|naltrexone|mesh-list
154251211|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154251212|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154251213|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251214|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
154251215|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251216|NCT01115972|Valsartan|valsartan|mesh-list
154251217|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154251218|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154251219|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154251220|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251221|NCT01116050|Misoprostol|misoprostol|mesh-list
153354892|NCT00610688|Vitamin D|vitamin d|mesh-list
154251222|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154251223|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
154251224|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154251225|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251226|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154251227|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251228|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
154251229|NCT01054781|Rituximab|rituximab|mesh-list
154251230|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154251231|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251232|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
154251233|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251234|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154251235|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
154251236|NCT01311778|Fentanyl|fentanyl|mesh-list
154251237|NCT01311778|Cannabidiol|cannabidiol|mesh-list
154251238|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154251239|NCT01311778|Narcotics|narcotics|mesh-ancestor
154251240|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251241|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251242|NCT01311778|Analgesics|analgesics|mesh-ancestor
154251243|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
154251244|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251245|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154251246|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154251247|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
154251248|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
154251249|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
154251250|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
154251251|NCT00354341|Hematinics|hematinics|mesh-ancestor
154251252|NCT03708718|Prednisolone|prednisolone|mesh-list
154251253|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251254|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
154251255|NCT03708718|Hormones|hormones|mesh-ancestor
154251256|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251257|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251258|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154251259|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251260|NCT00354107|Cytarabine|cytarabine|mesh-list
154251261|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
154251262|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154251263|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154251264|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154251265|NCT00354107|Carboplatin|carboplatin|mesh-list
154251266|NCT00354107|Methotrexate|methotrexate|mesh-list
154251267|NCT00354107|Etoposide|etoposide|mesh-list
154251268|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
154251269|NCT00354107|Ifosfamide|ifosfamide|mesh-list
154251270|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154251271|NCT00354107|Antibodies|antibodies|mesh-list
154251272|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154251273|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
154251274|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251275|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251276|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154251277|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
154251278|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154251279|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154251280|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
154251281|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251282|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
154251283|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251284|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154251285|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154251286|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154251287|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154251288|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154251289|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154254125|NCT03331666|Evolocumab|evolocumab|mesh-list
154251290|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154251291|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
154251292|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251293|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251294|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154251295|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
154251296|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154251297|NCT00354107|Immunotoxins|immunotoxins|mesh-ancestor
154251298|NCT00354107|Immunoconjugates|immunoconjugates|mesh-ancestor
154251299|NCT00354029|Ketamine|ketamine|mesh-list
154251300|NCT00354029|Analgesics|analgesics|mesh-ancestor
154251301|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
154125348|NCT00956163|Fluorides|fluorides|mesh-list
154251302|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251303|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251304|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154251305|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154251306|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
154251307|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
154251308|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251309|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154251310|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154251311|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251312|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251313|NCT00353873|Fluticasone|fluticasone|mesh-list
154251315|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154251316|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251317|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154251318|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
154251319|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251320|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251321|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154251322|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
154251324|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154251325|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154251326|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154251327|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154251328|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
154251329|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251330|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251331|NCT01058057|Atorvastatin|atorvastatin|mesh-list
154251332|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154251333|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154251334|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
154251335|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251336|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154251337|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154251338|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251339|NCT03796676|Abrocitinib|abrocitinib|mesh-list
154251340|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154251341|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251342|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251343|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154251344|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154251345|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154251346|NCT00339833|Analgesics|analgesics|mesh-ancestor
154251347|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
154251348|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251349|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251350|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251351|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154251352|NCT01058291|Apomorphine|apomorphine|mesh-list
154251353|NCT01058291|Emetics|emetics|mesh-ancestor
154251354|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251355|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
154251356|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251357|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251358|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
154251359|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
154251360|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251361|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251362|NCT01055249|Ibuprofen|ibuprofen|mesh-list
154251363|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
154251364|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154251366|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154251367|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154251368|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154251369|NCT01055249|Analgesics|analgesics|mesh-ancestor
154251370|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
154251371|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251372|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251373|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251374|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154251375|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154251376|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251377|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251378|NCT01055327|Lamotrigine|lamotrigine|mesh-list
154251379|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
154251380|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154251381|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251382|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251383|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154251384|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251385|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154251386|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154251387|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251388|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154251389|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154251390|NCT03793556|Omeprazole|omeprazole|mesh-list
154251391|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154251392|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165454|NCT00786305|Amikacin|amikacin|mesh-list
154251393|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154251394|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251395|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251396|NCT01113164|Ondansetron|ondansetron|mesh-list
154251397|NCT01113164|Sertraline|sertraline|mesh-list
154251398|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
154251399|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
154251400|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251401|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251402|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251403|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
154251404|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
154251405|NCT01113164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154251406|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154251407|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
154251408|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251409|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251410|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
154251411|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154251412|NCT01113164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154251413|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154251414|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251415|NCT01210430|Vitamins|vitamins|mesh-list
154251416|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
154251417|NCT01210430|Losartan|losartan|mesh-list
154251418|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
154251419|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251420|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
154251421|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251422|NCT01210430|Protective Agents|protective agents|mesh-ancestor
154251423|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154251424|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154251425|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154251426|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154251428|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
154251429|NCT01210742|Protective Agents|protective agents|mesh-ancestor
154251430|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251431|NCT01116128|Prednisone|prednisone|mesh-list
154251432|NCT01116128|Melphalan|melphalan|mesh-list
154251433|NCT01116128|Dasatinib|dasatinib|mesh-list
154251434|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251435|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
154251436|NCT01116128|Hormones|hormones|mesh-ancestor
153624013|NCT03607175|Hormones|hormones|mesh-ancestor
154251437|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251438|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251439|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154251440|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251441|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154251442|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
154251443|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251444|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154251445|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154251446|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
154251447|NCT01116128|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154251448|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154251449|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251450|NCT03390166|Vaccines|vaccines|mesh-list
154251451|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
154125470|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251452|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251453|NCT01116206|Prucalopride|prucalopride|mesh-list
154251454|NCT01116206|Laxatives|laxatives|mesh-ancestor
154251455|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251456|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154251457|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154251458|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
154251459|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251460|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251461|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251462|NCT01210976|Simendan|simendan|mesh-list
154251463|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154251464|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251465|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154251466|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154251467|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393039|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154251468|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251469|NCT01210976|Protective Agents|protective agents|mesh-ancestor
154251470|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251471|NCT03828539|Topiramate|topiramate|mesh-list
154251472|NCT03828539|Erenumab|erenumab|mesh-list
154251473|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154251474|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
154251475|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154251476|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251477|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154251478|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251479|NCT03828539|Analgesics|analgesics|mesh-ancestor
154251480|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
154251481|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251482|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
154251483|NCT01109888|Cetrorelix|cetrorelix|mesh-list
154251484|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154251485|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
154125504|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
154251486|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154251487|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251488|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
154251489|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251490|NCT03336502|Posaconazole|posaconazole|mesh-list
154251491|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
154251492|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251493|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154251494|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154251495|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154251496|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154251497|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154251498|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251499|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251500|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154251501|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
154251502|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251503|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251504|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
154251505|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154254129|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
154251506|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154251507|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
154251508|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251509|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154251510|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154251511|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251512|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251513|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
154251514|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251515|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154251516|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154251517|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251518|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251519|NCT01055405|Urological Agents|urological agents|mesh-ancestor
154251520|NCT01055483|Panobinostat|panobinostat|mesh-list
154251521|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251522|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154251523|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251524|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251525|NCT03370510|Oxytocin|oxytocin|mesh-list
154251526|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
154251527|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154251528|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251529|NCT03985865|Quinine|quinine|mesh-list
154251530|NCT03985865|Denatonium|denatonium|mesh-list
154251531|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
154251532|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154251533|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154251534|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998451|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251535|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154251536|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251537|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154251538|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251539|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393040|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251541|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
154251542|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
154251543|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251544|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
154251545|NCT01116596|Acetaminophen|acetaminophen|mesh-list
154251546|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154251547|NCT01116596|Analgesics|analgesics|mesh-ancestor
154251548|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
154251549|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251550|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251551|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
154251552|NCT00351611|Pregabalin|pregabalin|mesh-list
154251553|NCT00351611|Analgesics|analgesics|mesh-ancestor
154251554|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
154251555|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251556|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251557|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
154251558|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154251559|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251560|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251561|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154251562|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154251563|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154251564|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251565|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154251566|NCT01211210|Fluorouracil|fluorouracil|mesh-list
154251567|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
154251568|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
154251569|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251570|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154251571|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251572|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154251573|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
154251574|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251575|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
154251576|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154251577|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251578|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251579|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154251580|NCT01208012|Liraglutide|liraglutide|mesh-list
154251581|NCT01208012|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154251582|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154251583|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251584|NCT01208012|Incretins|incretins|mesh-ancestor
154251585|NCT01208012|Hormones|hormones|mesh-ancestor
154251586|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251587|NCT03939806|Oxytocin|oxytocin|mesh-list
154251588|NCT03939806|Carbetocin|carbetocin|mesh-list
154251589|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
154251590|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154251591|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251592|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
154251593|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154251594|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251595|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154251596|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
154251597|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154251598|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251599|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251600|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251601|NCT00337727|Dexamethasone|dexamethasone|mesh-list
154251602|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
154251603|NCT00337727|Ondansetron|ondansetron|mesh-list
154251604|NCT00337727|Aprepitant|aprepitant|mesh-list
154251605|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
154251606|NCT00337727|BB 1101|bb 1101|mesh-list
154251607|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251608|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
154251609|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
154251610|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251611|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251612|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251613|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
154251615|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154251616|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154251618|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
154251619|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251620|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251621|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
154251622|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
154125672|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
154251623|NCT00337727|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154251624|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154251625|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
154251626|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251627|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154251628|NCT03987893|Lactulose|lactulose|mesh-list
154251629|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154251630|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251631|NCT03987893|Laxatives|laxatives|mesh-ancestor
154251632|NCT01208480|Carboplatin|carboplatin|mesh-list
154251633|NCT01208480|Docetaxel|docetaxel|mesh-list
154251634|NCT01208480|Bevacizumab|bevacizumab|mesh-list
154251635|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251636|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
154251637|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
154251638|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
154125674|NCT00851370|Omalizumab|omalizumab|mesh-list
154251639|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251640|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154251641|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154251642|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154251643|NCT01208480|Growth Substances|growth substances|mesh-ancestor
154251644|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251645|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
154251646|NCT04774120|Propofol|propofol|mesh-list
154251647|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154251648|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251649|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251650|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154251651|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
154251652|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
154251653|NCT01117220|Ziprasidone|ziprasidone|mesh-list
154251654|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154251655|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
154251656|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251657|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251658|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251659|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154251660|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154251661|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251662|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154251663|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154251664|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
154251665|NCT05236972|Capecitabine|capecitabine|mesh-list
154251666|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
154251667|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154251668|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
154251669|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251670|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251671|NCT01114100|Sertraline|sertraline|mesh-list
154251672|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
154251673|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154251674|NCT01114100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154251675|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154251676|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251677|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251678|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251679|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
154251680|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251681|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154251682|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251683|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154251684|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154251685|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251686|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251687|NCT01110590|Urological Agents|urological agents|mesh-ancestor
154251688|NCT01117298|Tadalafil|tadalafil|mesh-list
154251689|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251691|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154251692|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251693|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251694|NCT01117298|Urological Agents|urological agents|mesh-ancestor
154251695|NCT01117376|Erythromycin|erythromycin|mesh-list
154251696|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
154251697|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154251698|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
154251699|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
154251700|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154251701|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251702|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251703|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154251704|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251705|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251706|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154251707|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251708|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
154251709|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251710|NCT01213238|Bevacizumab|bevacizumab|mesh-list
154251711|NCT01213238|Capecitabine|capecitabine|mesh-list
154251712|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
154251713|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154251714|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251715|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154251716|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154251717|NCT01213238|Growth Substances|growth substances|mesh-ancestor
154251718|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251719|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
154251720|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154251721|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
154251722|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251723|NCT01110668|Nilotinib|nilotinib|mesh-list
154251724|NCT01110668|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154251725|NCT01110668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154251726|NCT01110668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251727|NCT01110668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251728|NCT01110824|Carvedilol|carvedilol|mesh-list
154251729|NCT01110824|Enalapril|enalapril|mesh-list
154251730|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154251731|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154251732|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
154251733|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251734|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251735|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251736|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154251737|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
154251738|NCT01110824|Protective Agents|protective agents|mesh-ancestor
154251739|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154251740|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251741|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154251742|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251743|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154251744|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154251745|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154251746|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
154251747|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251748|NCT03936140|Iloprost|iloprost|mesh-list
154251749|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154251750|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251751|NCT01117610|Ropivacaine|ropivacaine|mesh-list
154251752|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
154251753|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
154251754|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251755|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251756|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
154251757|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998672|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251758|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
154251759|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154251760|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165827|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
154251761|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251762|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154251763|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251764|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154251766|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154251767|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251768|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154251769|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
154251770|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154251771|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251772|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251773|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251774|NCT03368170|Mesdopetam|mesdopetam|mesh-list
154251775|NCT03368170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154251776|NCT03368170|Dopamine Agents|dopamine agents|mesh-ancestor
154251777|NCT03368170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251778|NCT03368170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251779|NCT03368170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251780|NCT01121744|Sirolimus|sirolimus|mesh-list
154251781|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154251782|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251783|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154251784|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251785|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
154251786|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154251787|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
154251788|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251789|NCT01121822|Vaccines|vaccines|mesh-list
154251790|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
154251791|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251792|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
154251793|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154251794|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154251795|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251796|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
154251797|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
154251798|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154251799|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251800|NCT01216046|Ivacaftor|ivacaftor|mesh-list
154251801|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154251802|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251803|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251804|NCT01216124|Docetaxel|docetaxel|mesh-list
154251805|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
154251806|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251807|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
154251808|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
154251809|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
154251810|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251811|NCT01219010|Siltuximab|siltuximab|mesh-list
154251812|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251813|NCT01118234|Rituximab|rituximab|mesh-list
154251814|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154251815|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251816|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
154251817|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251818|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154251819|NCT00324155|Ipilimumab|ipilimumab|mesh-list
154251820|NCT00324155|Dacarbazine|dacarbazine|mesh-list
154125831|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251821|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154251822|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251823|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154251824|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251825|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154251826|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
154251827|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
154251828|NCT03937544|Fludarabine|fludarabine|mesh-list
154251829|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154251830|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
154251831|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251832|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154251833|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154251834|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
154251835|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251836|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251837|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154251838|NCT01122056|Interferons|interferons|mesh-list
154251839|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
154251840|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251841|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
154251842|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251843|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154251844|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
154251845|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251846|NCT01219088|Morphine|morphine|mesh-list
154251847|NCT01219088|Bupivacaine|bupivacaine|mesh-list
154251848|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
154251849|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
154251850|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251851|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251852|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
154251853|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154251854|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154251855|NCT01219088|Narcotics|narcotics|mesh-ancestor
154251856|NCT01219088|Analgesics|analgesics|mesh-ancestor
154251857|NCT01122134|Artesunate|artesunate|mesh-list
154251858|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
154251859|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154251860|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154251861|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251862|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251863|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
154251864|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
154251865|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154251866|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
154251867|NCT01118702|Methylphenidate|methylphenidate|mesh-list
154251868|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154251869|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251870|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154251871|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154251872|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251873|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251874|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
154251875|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251876|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154251877|NCT01118936|Antacids|antacids|mesh-ancestor
154251878|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251879|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154251880|NCT01119014|Aripiprazole|aripiprazole|mesh-list
154251881|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154251882|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
154251883|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154251884|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154251885|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154251886|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251887|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251888|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
154251889|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
154251890|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973729|NCT06248229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154251891|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251892|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154251893|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154251894|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
154251895|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154251896|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154251897|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154251898|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154251899|NCT01219244|Resveratrol|resveratrol|mesh-list
154251900|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
154251901|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251902|NCT01219244|Protective Agents|protective agents|mesh-ancestor
154251903|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251904|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251905|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154251906|NCT01119482|Vaccines|vaccines|mesh-list
154251907|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
154251908|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251909|NCT01119638|Risperidone|risperidone|mesh-list
154251911|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154251912|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
154251913|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154251914|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251915|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251916|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154251917|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154251918|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154251919|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154251920|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154251921|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
154251922|NCT01119638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154251923|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154251924|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154251925|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154251926|NCT03338998|Siponimod|siponimod|mesh-list
154251927|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154251928|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251929|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154251930|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
154251931|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251932|NCT03935984|Calcitonin|calcitonin|mesh-list
154251933|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
154251934|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154251935|NCT03935984|Katacalcin|katacalcin|mesh-list
154251936|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154251937|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251938|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154251939|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251940|NCT01219400|Vildagliptin|vildagliptin|mesh-list
154251941|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154251942|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251943|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154251944|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
154251945|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251946|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251947|NCT01124630|Leucovorin|leucovorin|mesh-list
154251948|NCT01124630|Fluorouracil|fluorouracil|mesh-list
154251949|NCT01124630|Irinotecan|irinotecan|mesh-list
154251950|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
154251951|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251952|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154251953|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251954|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154251955|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
154125983|NCT00968565|Citric Acid|citric acid|mesh-list
154251956|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251957|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154251958|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154251959|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251960|NCT01124630|Antidotes|antidotes|mesh-ancestor
154251961|NCT01124630|Protective Agents|protective agents|mesh-ancestor
154251962|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
154251964|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
154251965|NCT05683054|Adalimumab|adalimumab|mesh-list
154251966|NCT05683054|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154251967|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154251968|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154251969|NCT01120106|Simendan|simendan|mesh-list
154251970|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154251971|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
154251972|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154251973|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154251974|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251975|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251976|NCT01120106|Protective Agents|protective agents|mesh-ancestor
154251977|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251978|NCT01122368|Micafungin|micafungin|mesh-list
154251979|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
154251980|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154251981|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
154251982|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
154251983|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
154166064|NCT01095211|Vitamins|vitamins|mesh-ancestor
154251984|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251985|NCT01216826|Everolimus|everolimus|mesh-list
154251986|NCT01216826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154251987|NCT01216826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154251988|NCT01216826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154251989|NCT01216826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154251990|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154251991|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
154251992|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154251993|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154251994|NCT01120340|Mesalamine|mesalamine|mesh-list
154251995|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154251996|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154251997|NCT01120340|Analgesics|analgesics|mesh-ancestor
154251998|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
154126045|NCT00849030|Tamoxifen|tamoxifen|mesh-list
154251999|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252000|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252001|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252002|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252003|NCT01214408|Pantoprazole|pantoprazole|mesh-list
154252004|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154252005|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252006|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154252007|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252008|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252009|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
154252010|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154252011|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154252012|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
154252013|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252014|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154252015|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154252016|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252017|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252018|NCT01216904|Nicotine|nicotine|mesh-list
154252019|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154252020|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
154252021|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252022|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252023|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154252024|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154252025|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
154252026|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252027|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252028|NCT01125020|Gemcitabine|gemcitabine|mesh-list
154252029|NCT01125020|Doxorubicin|doxorubicin|mesh-list
154252030|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
154252031|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252032|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154252033|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
154252034|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252035|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154252036|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154252037|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154252038|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252039|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
154252040|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252041|NCT01125254|Amlodipine|amlodipine|mesh-list
154252042|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154252043|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154252044|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154252045|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252046|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154252047|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252048|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
154252049|NCT03710434|Lansoprazole|lansoprazole|mesh-list
154252050|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
154252051|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154252052|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252053|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154252054|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252055|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252056|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154252057|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
154252058|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154252059|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154252060|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252061|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252062|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
154126083|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
154252063|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252064|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154252065|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154252066|NCT05682586|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154252067|NCT05682586|Antiviral Agents|antiviral agents|mesh-ancestor
154252068|NCT05682586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252069|NCT01217138|Epinephrine|epinephrine|mesh-list
154252070|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154252071|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154252072|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
154252073|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252074|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252075|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252076|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154252077|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154252078|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
154252079|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252080|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154252081|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
154252082|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
154252083|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
154252084|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154252085|NCT03710356|Danazol|danazol|mesh-list
154252086|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154252087|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
154252088|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252089|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252090|NCT01217294|Morphine|morphine|mesh-list
154252091|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154252092|NCT01217294|Narcotics|narcotics|mesh-ancestor
154252093|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154252094|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252095|NCT01217294|Analgesics|analgesics|mesh-ancestor
154252096|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
154252097|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252098|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
154252099|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154252100|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252101|NCT03361228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154252102|NCT03361228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252104|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
154252105|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
154252106|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252107|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252108|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252109|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
154252110|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
154252111|NCT01121042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154252112|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154252113|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
154252114|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252115|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252116|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154252117|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154252118|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
154252119|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154252120|NCT01217450|Cetuximab|cetuximab|mesh-list
154252121|NCT01217450|Antibodies|antibodies|mesh-list
154252122|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
154252123|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154252124|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
154252125|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252126|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252127|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154252128|NCT01219556|Olmesartan|olmesartan|mesh-list
154252129|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154252130|NCT01219556|Diuretics|diuretics|mesh-ancestor
154252131|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
154252132|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252133|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154252134|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154252135|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252136|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154252137|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154252139|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154252140|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252141|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154252142|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252144|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154252145|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
154252146|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
154252147|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154252148|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154252149|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252150|NCT05175508|Azacitidine|azacitidine|mesh-list
154252151|NCT05175508|Tretinoin|tretinoin|mesh-list
154252152|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154252153|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
154252154|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252155|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252156|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252157|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
154252158|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
154252159|NCT01125410|Clindamycin|clindamycin|mesh-list
154252160|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
154252161|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
154252162|NCT01125410|Dequalinium|dequalinium|mesh-list
154252163|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252164|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252165|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154252166|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252167|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252168|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154252169|NCT01328834|Tacrolimus|tacrolimus|mesh-list
154252170|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154252171|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
153730641|NCT00141960|Famotidine|famotidine|mesh-list
154252172|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252173|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154252174|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252175|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252176|NCT01121354|Cefazolin|cefazolin|mesh-list
154252177|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252178|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252179|NCT01122602|Aspirin|aspirin|mesh-list
154252180|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154252181|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252182|NCT01122602|Analgesics|analgesics|mesh-ancestor
154252183|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
154252184|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252185|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252186|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252187|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252188|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154252189|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154252190|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252191|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154252192|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154252193|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252194|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
154252195|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154252196|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154252197|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252198|NCT03359590|Incretins|incretins|mesh-ancestor
154252199|NCT03359590|Hormones|hormones|mesh-ancestor
154252200|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252201|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154252202|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
154252203|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252204|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252205|NCT01219712|Simendan|simendan|mesh-list
154252206|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154393041|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252207|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
154252208|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154252209|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154252210|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126243|NCT00850122|Cefazolin|cefazolin|mesh-list
154252211|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252212|NCT01219712|Protective Agents|protective agents|mesh-ancestor
154252213|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252215|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252216|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252217|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252218|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252219|NCT05682196|Rituximab|rituximab|mesh-list
154252220|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154252221|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252222|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
154252223|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252224|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252225|NCT03936374|Omeprazole|omeprazole|mesh-list
154252226|NCT03936374|Linrodostat|linrodostat|mesh-list
154252227|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154252228|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252229|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154252230|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252231|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252232|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154252233|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
154252234|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154252235|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
154252236|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154252237|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252238|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154252239|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154252240|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252241|NCT01215578|Sunitinib|sunitinib|mesh-list
154254135|NCT04828538|Vitamin D|vitamin d|mesh-list
154252242|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252243|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154252244|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154252245|NCT01215578|Growth Substances|growth substances|mesh-ancestor
154252246|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252247|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
154252248|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252249|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252250|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252251|NCT01120418|Besifloxacin|besifloxacin|mesh-list
154252252|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252253|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252254|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154252255|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154252256|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126299|NCT00855660|Riociguat|riociguat|mesh-list
154252257|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252258|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252259|NCT05577988|Aspirin|aspirin|mesh-list
154252260|NCT05577988|Clopidogrel|clopidogrel|mesh-list
154252261|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154252262|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252263|NCT05577988|Analgesics|analgesics|mesh-ancestor
154252264|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
154252265|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252266|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252267|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252268|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252269|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154252270|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154252271|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252272|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154252273|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154252274|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252275|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
154252276|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154252277|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154252278|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154252279|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
154252280|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252281|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
154252282|NCT01222052|Docetaxel|docetaxel|mesh-list
154252283|NCT01222052|Fluorouracil|fluorouracil|mesh-list
154252284|NCT01222052|Epirubicin|epirubicin|mesh-list
154252285|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154252286|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
154252287|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252288|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252289|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154252290|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
154252291|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252292|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252293|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154252294|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
154252295|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
154252296|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
154252297|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
154252298|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154252299|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154252300|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154252301|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154252302|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252303|NCT03710044|Cyclosporine|cyclosporine|mesh-list
154252304|NCT03710044|Cyclosporins|cyclosporins|mesh-list
154252305|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252306|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252307|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154252308|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
154252309|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252310|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
154252311|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252312|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
154252313|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252314|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154252315|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
154252316|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
154252317|NCT03706300|Ephedrine|ephedrine|mesh-list
154252318|NCT03706300|Guaifenesin|guaifenesin|mesh-list
154252319|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154252320|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154252321|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
154252322|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252323|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252324|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154252325|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
154252326|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
154252327|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154252328|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154252329|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
154252330|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
154252331|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252332|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252333|NCT03706300|Expectorants|expectorants|mesh-ancestor
154252334|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154252335|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154252336|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
154252337|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154252338|NCT05155540|Plasminogen|plasminogen|mesh-list
154252339|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154252340|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154252341|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154252342|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252343|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154252344|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252345|NCT05360758|Ibrutinib|ibrutinib|mesh-list
154252346|NCT05360758|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154252347|NCT05360758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252348|NCT05360758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252349|NCT05360758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252350|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
154252351|NCT01222442|AZD-3199|azd-3199|mesh-list
154252352|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252353|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999283|NCT00835939|Lidocaine|lidocaine|mesh-list
154393042|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
154252354|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154252355|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154252356|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252357|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252358|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252359|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252360|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154252361|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154252362|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154252363|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
154252364|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252365|NCT03706222|Grazoprevir|grazoprevir|mesh-list
154252366|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154252367|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
154252368|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252369|NCT01222676|Gemcitabine|gemcitabine|mesh-list
154252370|NCT01222676|Sorafenib|sorafenib|mesh-list
154252371|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154252372|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252373|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154252374|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
154252375|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252376|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252377|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252378|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154252379|NCT05681728|Paclitaxel|paclitaxel|mesh-list
154252380|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
154252381|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
154252382|NCT05681728|Epirubicin|epirubicin|mesh-list
154126412|NCT00854646|ON 01910|on 01910|mesh-list
154252383|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154252384|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252385|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
154252386|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
154252387|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
154252388|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252389|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154252390|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
154252391|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252392|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252393|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154252394|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
154252395|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154252396|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154252397|NCT05681728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154252398|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154252399|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154252400|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154252401|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252403|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154252404|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
154252405|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252406|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252407|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154252408|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252409|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154252410|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154252411|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154252412|NCT01220102|Adapalene|adapalene|mesh-list
154252413|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154126452|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
154252414|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
154252415|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154252416|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252417|NCT01220102|Analgesics|analgesics|mesh-ancestor
154252418|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
154252419|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252420|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252421|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252422|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252423|NCT05133310|Simvastatin|simvastatin|mesh-list
154252424|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154252425|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154252426|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
154393043|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393044|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154252427|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252428|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154252429|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154252430|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252431|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154252432|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252433|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252434|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252435|NCT01222910|Valacyclovir|valacyclovir|mesh-list
154252436|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
154252437|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252438|NCT04533568|Ibuprofen|ibuprofen|mesh-list
154252439|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154252440|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154252441|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252442|NCT04533568|Analgesics|analgesics|mesh-ancestor
154252443|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
154252444|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252445|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252446|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252447|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252448|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154252449|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252450|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252451|NCT01312324|Docetaxel|docetaxel|mesh-list
154252452|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252453|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
154252454|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
154252455|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
154252456|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252458|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154252459|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
154252460|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252461|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252462|NCT01127672|Betamethasone|betamethasone|mesh-list
154252463|NCT01127672|Lidocaine|lidocaine|mesh-list
154252464|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252465|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
154252466|NCT01127672|Hormones|hormones|mesh-ancestor
154252467|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252468|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252469|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154252470|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
154252471|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
154252472|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
154252473|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154252474|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
154252475|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252476|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154252477|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154252478|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154252479|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154252480|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252481|NCT01220258|Azithromycin|azithromycin|mesh-list
154252482|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154252483|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154252484|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252485|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252486|NCT01223534|Isoniazid|isoniazid|mesh-list
154252487|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
154252488|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252489|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252490|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154252491|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154252492|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
154252493|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252494|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154252495|NCT01223612|Ranibizumab|ranibizumab|mesh-list
154252496|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154252497|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154252498|NCT01223612|Growth Substances|growth substances|mesh-ancestor
154252499|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252500|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
154252501|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252502|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154252503|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154252504|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252505|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154252506|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
154252507|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252509|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154252510|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252511|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
154252512|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252513|NCT01223690|Clarithromycin|clarithromycin|mesh-list
154252514|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252515|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730650|NCT00134693|Prednisolone|prednisolone|mesh-list
154252517|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252518|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252519|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154252520|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154252521|NCT05381350|Vaccines|vaccines|mesh-list
154252522|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
154252523|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252524|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
154252525|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
154252526|NCT01223768|Vitamins|vitamins|mesh-ancestor
154252527|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
154252528|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252529|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
154252530|NCT01126112|Panitumumab|panitumumab|mesh-list
154252531|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154252532|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252533|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
154252534|NCT01123538|Progesterone|progesterone|mesh-list
154252535|NCT01123538|Progestins|progestins|mesh-ancestor
154252536|NCT01123538|Hormones|hormones|mesh-ancestor
154252537|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252538|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252539|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
154252540|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
154252541|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154252542|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154252543|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154252544|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
154252545|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154252546|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154252547|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154252548|NCT01220570|Sirolimus|sirolimus|mesh-list
154252549|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154252550|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252551|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252552|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154252553|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252554|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
154252555|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154252556|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
154252557|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252558|NCT04682860|Scopolamine|scopolamine|mesh-list
154252559|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154252560|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154252561|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
154126610|NCT00959517|Amebicides|amebicides|mesh-ancestor
154252562|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
154252563|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252564|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252565|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252566|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
154252567|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154252568|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
154252569|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252570|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252571|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154252572|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
154252573|NCT01127906|Oxycodone|oxycodone|mesh-list
154252574|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154252575|NCT01127906|Narcotics|narcotics|mesh-ancestor
154252576|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154252577|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252578|NCT01127906|Analgesics|analgesics|mesh-ancestor
154252579|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
154252580|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252581|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154252582|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
154252583|NCT01127984|Coagulants|coagulants|mesh-ancestor
154252584|NCT01220648|Interferons|interferons|mesh-list
154252585|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
154252586|NCT01220648|Nilotinib|nilotinib|mesh-list
154252587|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252588|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
154252589|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252590|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
154252591|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252592|NCT01220648|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154252593|NCT01220648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252594|NCT01220648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252595|NCT01220648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252596|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154252597|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154252599|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154252600|NCT01218386|Estrogens|estrogens|mesh-ancestor
154252601|NCT01218386|Hormones|hormones|mesh-ancestor
154252602|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252603|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252604|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154252605|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
154252606|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154252607|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154252608|NCT03933098|Vaccines|vaccines|mesh-list
154252609|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
154252610|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252611|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
154252612|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154252613|NCT01224392|Capecitabine|capecitabine|mesh-list
154252614|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154252615|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
154252616|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252617|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252618|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
154252619|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154252620|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154252621|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252622|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252623|NCT01224470|Analgesics|analgesics|mesh-ancestor
154252624|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
154252625|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252626|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154252627|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154252628|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154252629|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
154252630|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252631|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252632|NCT03740516|Apremilast|apremilast|mesh-list
154252633|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154252634|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252635|NCT03740516|Analgesics|analgesics|mesh-ancestor
154252636|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
154252637|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252638|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252639|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252640|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252641|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154252642|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154252643|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126661|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
154252644|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252645|NCT03933956|Empagliflozin|empagliflozin|mesh-list
154252646|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154252647|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393045|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
154252648|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154252649|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252650|NCT01218620|Tolbutamide|tolbutamide|mesh-list
154252651|NCT01218620|Rifampin|rifampin|mesh-list
154252652|NCT01218620|Ketoconazole|ketoconazole|mesh-list
154252653|NCT01218620|Midazolam|midazolam|mesh-list
154252654|NCT01218620|Levomethorphan|levomethorphan|mesh-list
154252655|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
154252656|NCT01218620|Omeprazole|omeprazole|mesh-list
154252657|NCT01218620|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154252658|NCT01218620|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154252659|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154252660|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154252661|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154252662|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252663|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154252664|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154252665|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154252666|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154252667|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
154252668|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
154252669|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
154252670|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
154252671|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252672|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252673|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154252674|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252675|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154252676|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252677|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154252678|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
154252679|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154252680|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252681|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
154252682|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154252683|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154252684|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154252685|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154252686|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154252687|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154252688|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154252689|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
154252690|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154252691|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154252692|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154252693|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
154252694|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252695|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154252696|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
154252697|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
154252698|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154252699|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154252700|NCT01218620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154252701|NCT01218620|Narcotics|narcotics|mesh-ancestor
154252702|NCT01218620|Analgesics|analgesics|mesh-ancestor
154252703|NCT01218620|Sensory System Agents|sensory system agents|mesh-ancestor
154252704|NCT01218620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252705|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154252706|NCT00323297|Bosentan|bosentan|mesh-list
154252707|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
154252708|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252709|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
154252710|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154252711|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154252712|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252713|NCT00323297|Urological Agents|urological agents|mesh-ancestor
154126748|NCT05179239|Cisplatin|cisplatin|mesh-list
154252714|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154252715|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154252716|NCT01218698|Losartan|losartan|mesh-list
154252717|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154252718|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154252719|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154252720|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154252721|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252722|NCT01224860|Losartan|losartan|mesh-list
154252724|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154252725|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154252726|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154252727|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154252728|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252729|NCT00323063|Gemcitabine|gemcitabine|mesh-list
154252730|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
154252731|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154252732|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
154252733|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625814|NCT02012569|Coagulants|coagulants|mesh-ancestor
154252734|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252735|NCT00323063|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154252736|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252737|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252738|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
154252739|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
154252740|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154252741|NCT01328990|Amodiaquine|amodiaquine|mesh-list
154252742|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
154252743|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154252744|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154252745|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252746|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154252747|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252748|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252749|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154252750|NCT01225094|Curcumin|curcumin|mesh-list
154252751|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154252752|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252753|NCT01225094|Analgesics|analgesics|mesh-ancestor
154252754|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
154252755|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252756|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252757|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252758|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252759|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252760|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252761|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252762|NCT00322049|Vaccines|vaccines|mesh-list
154252763|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
154252764|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252765|NCT01124240|Temozolomide|temozolomide|mesh-list
154252766|NCT01124240|Procarbazine|procarbazine|mesh-list
154252767|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154252768|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
154252769|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252770|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252771|NCT01124318|Lactulose|lactulose|mesh-list
154252772|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252773|NCT01221116|Simendan|simendan|mesh-list
154252774|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154252775|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
154252776|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154252777|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154252778|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252779|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252780|NCT01221116|Protective Agents|protective agents|mesh-ancestor
154252781|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252782|NCT03929744|Midazolam|midazolam|mesh-list
154252783|NCT03929744|Atorvastatin|atorvastatin|mesh-list
154252784|NCT03929744|Simvastatin|simvastatin|mesh-list
154252785|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154252786|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154252787|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154252788|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252789|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154252790|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154252791|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154252792|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154252793|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
154252794|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
154252795|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
154393046|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154252796|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
154252797|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252798|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252799|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154252800|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154252801|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
154252802|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154252803|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154252804|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252805|NCT01225406|Tenofovir|tenofovir|mesh-list
154252806|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
154252807|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252808|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154252809|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154252810|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252811|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252813|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154252814|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
154252815|NCT01126814|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154252816|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252817|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252818|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252819|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252820|NCT01225484|Ropivacaine|ropivacaine|mesh-list
154252821|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
154252822|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
154252823|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154252824|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252825|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
154252826|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252827|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154252828|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154252829|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154252830|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154252831|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252832|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
154252833|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252834|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252835|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154252836|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252837|NCT01128998|Sorafenib|sorafenib|mesh-list
154252838|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252839|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252840|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252841|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252842|NCT00321893|Budesonide|budesonide|mesh-list
154252843|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252844|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154252845|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
154252846|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252847|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252848|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154252849|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
154252850|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
154252851|NCT00321893|Hormones|hormones|mesh-ancestor
154252852|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252853|NCT01225874|Cytarabine|cytarabine|mesh-list
154252854|NCT01225874|Dexamethasone|dexamethasone|mesh-list
154252855|NCT01225874|Prednisone|prednisone|mesh-list
154252856|NCT01225874|Methotrexate|methotrexate|mesh-list
154252857|NCT01225874|Vincristine|vincristine|mesh-list
154252858|NCT01225874|Daunorubicin|daunorubicin|mesh-list
154252859|NCT01225874|Asparaginase|asparaginase|mesh-list
154252860|NCT01225874|Pegaspargase|pegaspargase|mesh-list
154252861|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252862|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
154252863|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
154252864|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252865|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252866|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252867|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
154252868|NCT01225874|Hormones|hormones|mesh-ancestor
154252869|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154252870|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154252872|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154252873|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
154252874|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154252875|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154252876|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
154252877|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252878|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
154252879|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252880|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154252881|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154252882|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
154252883|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252884|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154252885|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
154252886|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252887|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154252888|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
154252889|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
154252890|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
154252891|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154252892|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154252893|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154252894|NCT03928340|Metformin|metformin|mesh-list
154252895|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154252896|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252897|NCT00371345|Dasatinib|dasatinib|mesh-list
154252898|NCT00371345|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154252899|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252900|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252901|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252902|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252903|NCT01226186|Morphine|morphine|mesh-list
154252904|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154252905|NCT01226186|Narcotics|narcotics|mesh-ancestor
154252906|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154252907|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252908|NCT01226186|Analgesics|analgesics|mesh-ancestor
154252909|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
154252910|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252911|NCT01228214|Aspirin|aspirin|mesh-list
154252912|NCT01228214|Amiloride|amiloride|mesh-list
154252913|NCT01228214|Clopidogrel|clopidogrel|mesh-list
154252914|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154252915|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252916|NCT01228214|Analgesics|analgesics|mesh-ancestor
154252917|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
154252918|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252919|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252920|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252921|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252922|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154252923|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154252924|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252925|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154252926|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154252927|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252928|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
154252929|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154252930|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154252931|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154252932|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
154252933|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154252934|NCT01228214|Diuretics|diuretics|mesh-ancestor
154252935|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
154252936|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154252937|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154252938|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154252939|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153999867|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153999868|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153999869|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999870|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252940|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154252942|NCT00321737|Lansoprazole|lansoprazole|mesh-list
154252943|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154252944|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154252945|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154252946|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252947|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252948|NCT01126892|Nilotinib|nilotinib|mesh-list
154252949|NCT01126892|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154252950|NCT01126892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154252951|NCT01126892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252952|NCT01126892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252954|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154252955|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
154252956|NCT03740438|Chrysarobin|chrysarobin|mesh-list
154252957|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154252958|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154252959|NCT03740438|Analgesics|analgesics|mesh-ancestor
154252960|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
154252961|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154252962|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154252963|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154252964|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154252965|NCT01129154|Panitumumab|panitumumab|mesh-list
154252966|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154252967|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252968|NCT01047995|Ritonavir|ritonavir|mesh-list
154252969|NCT01047995|Darunavir|darunavir|mesh-list
154252970|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
154252971|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154252972|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154252973|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
154252974|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252975|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252976|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154252977|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154252978|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
154252979|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154252980|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154252981|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154252982|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154252983|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154252984|NCT01129310|Capecitabine|capecitabine|mesh-list
154252985|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
154252986|NCT01129310|Irinotecan|irinotecan|mesh-list
154252987|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154252988|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
154252989|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154252990|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154252991|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154252992|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154252993|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154252994|NCT01129388|Omeprazole|omeprazole|mesh-list
154252995|NCT01129388|Clopidogrel|clopidogrel|mesh-list
154252996|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154252997|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154252998|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154252999|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154253000|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
154253001|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253002|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253003|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253004|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154253005|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253006|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154253007|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253008|NCT01228292|Heparin|heparin|mesh-list
154253009|NCT01228292|Calcium heparin|calcium heparin|mesh-list
154253010|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
154253011|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154253012|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154253013|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253014|NCT03924596|Boswellic acid|boswellic acid|mesh-list
154253015|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154253016|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154253017|NCT03924596|Analgesics|analgesics|mesh-ancestor
154253018|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
154253019|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253020|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253021|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253022|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154253023|NCT00320801|Buprenorphine|buprenorphine|mesh-list
154253024|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154253025|NCT00320801|Narcotics|narcotics|mesh-ancestor
154253026|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253027|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253028|NCT00320801|Analgesics|analgesics|mesh-ancestor
154253029|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
154253030|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253031|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154253032|NCT01127204|Lamivudine|lamivudine|mesh-list
154127042|NCT00265759|Letrozole|letrozole|mesh-list
154253033|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154253034|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154253035|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253036|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253037|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
154253038|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253039|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154253040|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154253041|NCT01228370|Silodosin|silodosin|mesh-list
154253042|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154253043|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154253044|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154253045|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
154253046|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253047|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253048|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253049|NCT01228370|Urological Agents|urological agents|mesh-ancestor
154253050|NCT01221740|Milnacipran|milnacipran|mesh-list
154253051|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
154253052|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154253053|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154253054|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154253055|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253056|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253057|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253058|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154253059|NCT01221740|Analgesics|analgesics|mesh-ancestor
154253060|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
154253061|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253062|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
154253063|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154253064|NCT00320489|Olanzapine|olanzapine|mesh-list
154253065|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
154253066|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
154253067|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253068|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253069|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253070|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154253071|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154253072|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253073|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154253074|NCT00320489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154127099|NCT00792818|Ibuprofen|ibuprofen|mesh-list
154253075|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154253076|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154253077|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253078|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253079|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
154253080|NCT01127282|Vitamins|vitamins|mesh-list
154253081|NCT01127282|Vitamin A|vitamin a|mesh-list
154253082|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
154253083|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253084|NCT01127360|Bevacizumab|bevacizumab|mesh-list
154253085|NCT01127360|Ranibizumab|ranibizumab|mesh-list
154253086|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154253087|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253088|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154253089|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154253090|NCT01127360|Growth Substances|growth substances|mesh-ancestor
154253091|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253092|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
154253093|NCT01228604|Methylphenidate|methylphenidate|mesh-list
154253094|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154253095|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253096|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154253097|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154253098|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154253099|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253100|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
154253101|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127142|NCT00917345|Captopril|captopril|mesh-list
154253103|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154253104|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253105|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
154253106|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253107|NCT01221896|Choline|choline|mesh-list
154253108|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
154253109|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154253110|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
154253111|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253112|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253113|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154253114|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
154253115|NCT03923114|Exenatide|exenatide|mesh-list
154253116|NCT03923114|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154253117|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253118|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253119|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154253120|NCT03923114|Incretins|incretins|mesh-ancestor
154253121|NCT03923114|Hormones|hormones|mesh-ancestor
154253122|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253123|NCT00320411|Lapatinib|lapatinib|mesh-list
154253124|NCT00320411|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154253125|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253126|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253127|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253128|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253129|NCT01132040|Primidone|primidone|mesh-list
154253130|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
154253131|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
154253132|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
154253133|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253134|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253135|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253136|NCT01226966|Liraglutide|liraglutide|mesh-list
154253137|NCT01226966|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154253138|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253139|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253140|NCT01226966|Incretins|incretins|mesh-ancestor
154253141|NCT01226966|Hormones|hormones|mesh-ancestor
154253142|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253143|NCT03923036|Cetuximab|cetuximab|mesh-list
154253144|NCT03923036|Panitumumab|panitumumab|mesh-list
154253145|NCT03923036|Aflibercept|aflibercept|mesh-list
154253146|NCT03923036|Capecitabine|capecitabine|mesh-list
154253147|NCT03923036|Irinotecan|irinotecan|mesh-list
154253148|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
154253149|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154253150|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154253151|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154253152|NCT03923036|Growth Substances|growth substances|mesh-ancestor
154253153|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253154|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
154253155|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154253156|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
154253157|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253158|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154253159|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154253160|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253161|NCT01129856|Dexamethasone|dexamethasone|mesh-list
154253162|NCT01129856|Citric Acid|citric acid|mesh-list
154253164|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154253165|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154253166|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154253167|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253168|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
154253169|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
154253170|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253171|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253172|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253173|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
154253175|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253176|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154253177|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253178|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
154253179|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154253180|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
154253181|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
154253182|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253183|NCT01129934|Promethazine|promethazine|mesh-list
154253184|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
154253185|NCT01129934|Morphine|morphine|mesh-list
154253186|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154253187|NCT01129934|Narcotics|narcotics|mesh-ancestor
154253188|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253189|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253190|NCT01129934|Analgesics|analgesics|mesh-ancestor
154253191|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
154253192|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253193|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
154253194|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154253195|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154253196|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
154253197|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
154253198|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253199|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253200|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154253201|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154253202|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154253203|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
154253204|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
154253205|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
154253206|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
154253207|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253208|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
154253209|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154253210|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
154253211|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253212|NCT01131572|Expectorants|expectorants|mesh-ancestor
154253213|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
154253214|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154253215|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
154253216|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127249|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
154253217|NCT01131572|Protective Agents|protective agents|mesh-ancestor
154253218|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253219|NCT01131572|Antidotes|antidotes|mesh-ancestor
154253220|NCT01132196|Valproic Acid|valproic acid|mesh-list
154253221|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
154253222|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253223|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253224|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
154253225|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253226|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253227|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
154253228|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154253229|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253230|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154253231|NCT01228994|Baclofen|baclofen|mesh-list
154253232|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154253233|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253234|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154253235|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253236|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154253237|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
154253238|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
154253239|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253240|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253241|NCT03927170|Metformin|metformin|mesh-list
154253242|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154253243|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253244|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253245|NCT03927170|Incretins|incretins|mesh-ancestor
154253246|NCT03927170|Hormones|hormones|mesh-ancestor
154253247|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253248|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154253249|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
154253250|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253251|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253252|NCT01227200|Tramadol|tramadol|mesh-list
154253253|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154253254|NCT01227200|Narcotics|narcotics|mesh-ancestor
154253255|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253256|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253257|NCT01227200|Analgesics|analgesics|mesh-ancestor
154253258|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
154253259|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253260|NCT01227356|Interferons|interferons|mesh-list
154253261|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
154253262|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253263|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
154253264|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253265|NCT01227356|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154253266|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253267|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253268|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253269|NCT01132352|Levetiracetam|levetiracetam|mesh-list
154253270|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
154253271|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
154253272|NCT01131728|Naproxen|naproxen|mesh-list
154253273|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
154253274|NCT01131728|Ephedrine|ephedrine|mesh-list
154253275|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154253276|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154253277|NCT01131728|Analgesics|analgesics|mesh-ancestor
154253278|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
154127313|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154127347|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253279|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253280|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253281|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253282|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154253283|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
154253284|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154253285|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253286|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253287|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154253288|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
154253289|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154253290|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
154253291|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
154253292|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154253293|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154253294|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
154253295|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
154253296|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253297|NCT01132586|Cytarabine|cytarabine|mesh-list
154253298|NCT01132586|Lenalidomide|lenalidomide|mesh-list
154253299|NCT01132586|Idarubicin|idarubicin|mesh-list
154253300|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154253301|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
154253302|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253303|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253304|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
154253305|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253306|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154253307|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
154253308|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253309|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154253310|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154253311|NCT01132586|Growth Substances|growth substances|mesh-ancestor
154253312|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
154253313|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154253314|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154393047|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154253316|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253317|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
154253318|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154253319|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253320|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253321|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
154253322|NCT01227590|Ritonavir|ritonavir|mesh-list
154253323|NCT01227590|Lopinavir|lopinavir|mesh-list
154253324|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154253325|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154253326|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
154253327|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253328|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253329|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154253330|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154253331|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
154253332|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253333|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154253334|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154253335|NCT03927248|Nivolumab|nivolumab|mesh-list
154253336|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154253337|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253338|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154253339|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253340|NCT03926780|Warfarin|warfarin|mesh-list
154253341|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
154253342|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
154253343|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154253344|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
154253345|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154253346|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
154253347|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253348|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253349|NCT03926936|Fulvestrant|fulvestrant|mesh-list
154253350|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154253351|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253352|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154253353|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154253354|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
154253355|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253356|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253357|NCT03920618|Tenofovir|tenofovir|mesh-list
154253358|NCT03920618|Entecavir|entecavir|mesh-list
154253359|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
154253360|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253361|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154253362|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154253363|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253364|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253365|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154253366|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154253367|NCT01131806|Fluticasone|fluticasone|mesh-list
154253368|NCT01131806|Xhance|xhance|mesh-list
154253369|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154253370|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154253371|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253372|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154253373|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
154253374|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253375|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253376|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154253377|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
154253378|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
154253379|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154253380|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154253381|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154253382|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154253383|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
154253384|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253385|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253386|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
154253387|NCT01131806|Hormones|hormones|mesh-ancestor
154167487|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
154253388|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253390|NCT01229930|Paclitaxel|paclitaxel|mesh-list
154253391|NCT01229930|Carboplatin|carboplatin|mesh-list
154253392|NCT01229930|Cediranib|cediranib|mesh-list
154253393|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154253394|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253396|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
154253397|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
154253398|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253399|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253400|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253401|NCT03920150|Vitamin D|vitamin d|mesh-list
154253402|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
154253403|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
154253404|NCT03920150|Vitamins|vitamins|mesh-list
154253405|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
154253406|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253407|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154253408|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154253409|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
154253410|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154253411|NCT01130324|Telavancin|telavancin|mesh-list
154253412|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154253413|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253414|NCT01229774|Diclofenac|diclofenac|mesh-list
154253415|NCT01229774|Etoricoxib|etoricoxib|mesh-list
154253416|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154253417|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154253418|NCT01229774|Analgesics|analgesics|mesh-ancestor
154253419|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
154253420|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253421|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253422|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253423|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154253424|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154253425|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253426|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253427|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154253428|NCT03918590|Nepafenac|nepafenac|mesh-list
154253429|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154253430|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154253431|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154253432|NCT03918590|Analgesics|analgesics|mesh-ancestor
154253433|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
154253434|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253435|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253436|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253437|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154253438|NCT03918590|Laxatives|laxatives|mesh-ancestor
154253439|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253440|NCT00320255|Apixaban|apixaban|mesh-list
154253441|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154253442|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
154253443|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154253444|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
154253445|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253446|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253447|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
154253448|NCT01231802|Leucovorin|leucovorin|mesh-list
154253449|NCT01231802|Capecitabine|capecitabine|mesh-list
154253450|NCT01231802|Fluorouracil|fluorouracil|mesh-list
154253451|NCT01231802|Eniluracil|eniluracil|mesh-list
154253452|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154253453|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
154253454|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253455|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253456|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154253457|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
154253458|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253459|NCT01231802|Antidotes|antidotes|mesh-ancestor
154253460|NCT01231802|Protective Agents|protective agents|mesh-ancestor
154253461|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
154253462|NCT01231802|Vitamins|vitamins|mesh-ancestor
154253463|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
154253464|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253465|NCT01231880|Piperaquine|piperaquine|mesh-list
154253466|NCT01231880|Artenimol|artenimol|mesh-list
154253467|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
154253468|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154253469|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154253470|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253471|NCT01232036|Metformin|metformin|mesh-list
154253472|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253473|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127524|NCT00783926|Vaccines|vaccines|mesh-list
154253474|NCT01130636|Oseltamivir|oseltamivir|mesh-list
154253475|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
154253476|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253477|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253478|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253480|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
154253481|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
154253482|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154253483|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
154253484|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154253485|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
154253486|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253487|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253488|NCT01134536|Tapentadol|tapentadol|mesh-list
154253489|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154253490|NCT01134536|Narcotics|narcotics|mesh-ancestor
154253491|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253492|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253493|NCT01134536|Analgesics|analgesics|mesh-ancestor
154253494|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
154253495|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253496|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154253497|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154253498|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154253499|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253500|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
154253501|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253502|NCT01134692|Norfloxacin|norfloxacin|mesh-list
154253503|NCT01134692|Propranolol|propranolol|mesh-list
154253504|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154253505|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154253506|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
154253507|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253508|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253509|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253510|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154253511|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154253512|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
154253513|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154253514|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253515|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154253516|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154253517|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253518|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253519|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154253520|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154253521|NCT01134848|Morphine|morphine|mesh-list
154253522|NCT01134848|Secretin|secretin|mesh-list
154253523|NCT01134848|Neostigmine|neostigmine|mesh-list
154253524|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154253525|NCT01134848|Narcotics|narcotics|mesh-ancestor
154253526|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253527|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253528|NCT01134848|Analgesics|analgesics|mesh-ancestor
154253529|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
154253530|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253531|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154253532|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253533|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253534|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
154253535|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253536|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154253537|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
154253538|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253539|NCT01134848|Hormones|hormones|mesh-ancestor
154253540|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253541|NCT03926000|Pregabalin|pregabalin|mesh-list
154253542|NCT03926000|Analgesics|analgesics|mesh-ancestor
154253543|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
154253544|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253545|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253546|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
154253547|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154253548|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154253549|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253550|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154253551|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154253552|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154253553|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253554|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154253555|NCT01134926|Misoprostol|misoprostol|mesh-list
154253556|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154253557|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
154253558|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154253559|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253560|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154253561|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253562|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
154253563|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
154253564|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154253565|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154253566|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253567|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
154253568|NCT01228136|Coagulants|coagulants|mesh-ancestor
154253570|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127605|NCT00973323|Warfarin|warfarin|mesh-list
154253571|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154253572|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154253573|NCT03140176|Growth Substances|growth substances|mesh-ancestor
154253574|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253575|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
154253576|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253577|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253578|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253579|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
154253580|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
154253581|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253582|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
154253583|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154253584|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154253585|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154253586|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154253587|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
154253588|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154253589|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253590|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253591|NCT01230476|Cetuximab|cetuximab|mesh-list
154253592|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154253593|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253594|NCT01135472|Esomeprazole|esomeprazole|mesh-list
154253595|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154253596|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253597|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154253598|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253599|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253600|NCT01133210|Maraviroc|maraviroc|mesh-list
154253601|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154253602|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154253603|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253604|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154253605|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154253606|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
154253607|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127630|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
154253608|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154253609|NCT01135550|Dexamethasone|dexamethasone|mesh-list
154253610|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
154253611|NCT01135550|BB 1101|bb 1101|mesh-list
154253612|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154253613|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
154253614|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
154253615|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154253616|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253617|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253619|NCT01135550|Hormones|hormones|mesh-ancestor
154253620|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154253621|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154253622|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253624|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253625|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253626|NCT05401370|Methylene Blue|methylene blue|mesh-list
154253627|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253628|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253629|NCT01131026|Amoxicillin|amoxicillin|mesh-list
154253630|NCT01131026|Levofloxacin|levofloxacin|mesh-list
154253631|NCT01131026|Lansoprazole|lansoprazole|mesh-list
154253632|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
154253633|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154253634|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253635|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154253636|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154253637|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154253638|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253639|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253640|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253641|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154253642|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154253643|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154253644|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154253645|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154253646|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
154253647|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154253648|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253649|NCT01133366|Warfarin|warfarin|mesh-list
154253650|NCT01133366|Mipomersen|mipomersen|mesh-list
154253651|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
154253652|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154253653|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154253654|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
154253655|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253656|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154253657|NCT01232270|Propofol|propofol|mesh-list
154253658|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154253659|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154253660|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253661|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154253662|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
154253663|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
154253664|NCT05400902|Apatinib|apatinib|mesh-list
154253665|NCT05400902|Tislelizumab|tislelizumab|mesh-list
154253666|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154253667|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253668|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253669|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253670|NCT05400902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154253671|NCT01233206|Metformin|metformin|mesh-list
154253672|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154253673|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154253674|NCT00369941|Tenofovir|tenofovir|mesh-list
154253675|NCT00369941|Emtricitabine|emtricitabine|mesh-list
154253676|NCT00369941|Efavirenz|efavirenz|mesh-list
154253677|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154253678|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
154253679|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
154253680|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154253681|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154253682|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154253683|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253684|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154253685|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154253686|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154253687|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154253688|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154253689|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154253690|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154253691|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154167786|NCT00058123|Poly ICLC|poly iclc|mesh-list
154393048|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154393049|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154393050|NCT03166306|Bevacizumab|bevacizumab|mesh-list
154393051|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154393052|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393053|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154393054|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154393055|NCT03166306|Growth Substances|growth substances|mesh-ancestor
154393056|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393057|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
154393059|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393060|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393061|NCT02398552|Sunitinib|sunitinib|mesh-list
154393062|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393063|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154393064|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154393065|NCT02398552|Growth Substances|growth substances|mesh-ancestor
154393066|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393067|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
154393068|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154393069|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393070|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393071|NCT03345979|Aripiprazole|aripiprazole|mesh-list
154393072|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154393073|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
154393074|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
154393075|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154393076|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154393077|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154393078|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393079|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393080|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
154393081|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
154393082|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393083|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393084|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154393085|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154393086|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
154393087|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154393088|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154393089|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154393090|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154393091|NCT02696434|Naltrexone|naltrexone|mesh-list
154393092|NCT02696434|Buprenorphine|buprenorphine|mesh-list
154393093|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154393094|NCT02696434|Narcotics|narcotics|mesh-ancestor
154393095|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393096|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393097|NCT02696434|Analgesics|analgesics|mesh-ancestor
154393098|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
154393099|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393100|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154393101|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154393102|NCT03709147|Metformin|metformin|mesh-list
154393103|NCT03709147|Carboplatin|carboplatin|mesh-list
154393104|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
154393105|NCT03709147|Pemetrexed|pemetrexed|mesh-list
154393106|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393107|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154393108|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393109|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154393110|NCT03709147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154393111|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393112|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393113|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154393114|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154393115|NCT02398474|Ropivacaine|ropivacaine|mesh-list
154393116|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
154393117|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
154393118|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393119|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393120|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
154393121|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172169|NCT00640835|Buprenorphine|buprenorphine|mesh-list
154393123|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
154393124|NCT03710317|Carbetocin|carbetocin|mesh-list
154393125|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154393126|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154254164|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393127|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393128|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
154393129|NCT03710317|Coagulants|coagulants|mesh-ancestor
154127811|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
154393130|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154393131|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
154393132|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154393133|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393134|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154393135|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393136|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
154393137|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
154393138|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154393139|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154393140|NCT02392780|Prednisolone|prednisolone|mesh-list
154393141|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
154393142|NCT02392780|Cannabidiol|cannabidiol|mesh-list
154393143|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154393144|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
154393145|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154393146|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393147|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
154393148|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
154393149|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393150|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393151|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393152|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
154393153|NCT02392780|Hormones|hormones|mesh-ancestor
154393154|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393155|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154393156|NCT02392780|Protective Agents|protective agents|mesh-ancestor
154393157|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154393158|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393159|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
154393160|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393161|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393162|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154393163|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154393164|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393165|NCT02392702|Ivacaftor|ivacaftor|mesh-list
154393166|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154393167|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154393168|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393169|NCT02392468|BI 409306|bi 409306|mesh-list
154393170|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154393171|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393172|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393173|NCT02397928|Carboplatin|carboplatin|mesh-list
154393174|NCT02397928|Pemetrexed|pemetrexed|mesh-list
154393175|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393176|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393177|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393178|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154393179|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154393180|NCT03734627|Acetaminophen|acetaminophen|mesh-list
154393181|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
154393182|NCT03734627|Octreotide|octreotide|mesh-list
154393183|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393184|NCT03734627|Analgesics|analgesics|mesh-ancestor
154393185|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
154393186|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393187|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393188|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
154393189|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393190|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154393191|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393192|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393193|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154393194|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393195|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154393196|NCT02397772|Albendazole|albendazole|mesh-list
154393197|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
154393198|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154393199|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393200|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
154393201|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154393202|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154393203|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
154393204|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
154393205|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
154393206|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393207|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393208|NCT03592277|Vitamins|vitamins|mesh-list
154393209|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
154393210|NCT03592277|Thiamine|thiamine|mesh-list
154393211|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
154393212|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393213|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
154393214|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393215|NCT03592277|Protective Agents|protective agents|mesh-ancestor
154393216|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
154393217|NCT03106402|Bromfenac|bromfenac|mesh-list
154393218|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154393219|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393220|NCT03106402|Analgesics|analgesics|mesh-ancestor
154393221|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
154393222|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393223|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393224|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393225|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154393226|NCT03734159|Ropivacaine|ropivacaine|mesh-list
154393227|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
154393228|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
154393229|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393230|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393231|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
154393232|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393233|NCT02397382|Midazolam|midazolam|mesh-list
154393234|NCT02397382|Levomethorphan|levomethorphan|mesh-list
154393235|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
154393236|NCT02397382|Caffeine|caffeine|mesh-list
154393237|NCT02397382|Omeprazole|omeprazole|mesh-list
154393238|NCT02397382|Warfarin|warfarin|mesh-list
154393239|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154393240|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154393241|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393242|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393243|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154393244|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154393245|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154393246|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154393247|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
154393248|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
154393249|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
154393250|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
154393251|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393252|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393253|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
154393254|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154393255|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154393256|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393257|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154393258|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154393259|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
154393260|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154393261|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393262|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154393263|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
154393264|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
153358213|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393265|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154393266|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154393267|NCT02397382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154393268|NCT02397382|Narcotics|narcotics|mesh-ancestor
154393269|NCT02397382|Analgesics|analgesics|mesh-ancestor
154393270|NCT02397382|Sensory System Agents|sensory system agents|mesh-ancestor
154393271|NCT02397382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393272|NCT02697916|Aspirin|aspirin|mesh-list
154172328|NCT00459537|Terbinafine|terbinafine|mesh-list
154393273|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154393274|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393275|NCT02697916|Analgesics|analgesics|mesh-ancestor
154393276|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
154393277|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393278|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393279|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393280|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154393281|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154393282|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154393283|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393284|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154393285|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154393286|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393287|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
154393289|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
154393290|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393291|NCT02392156|Factor VIII|factor viii|mesh-list
154393292|NCT02392156|Coagulants|coagulants|mesh-ancestor
154393293|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
154393294|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154393295|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154393296|NCT03359473|GSK2881078|gsk2881078|mesh-list
154393297|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
154393298|NCT03359473|Hormones|hormones|mesh-ancestor
154393299|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393300|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393301|NCT03632304|Anesthetics|anesthetics|mesh-list
154393302|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393303|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393304|NCT02397538|Amlodipine|amlodipine|mesh-list
154393305|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154393306|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154393307|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154393308|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154393309|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393310|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154393311|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393312|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
154393313|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154393314|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154393315|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
154393316|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154393317|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154393318|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393319|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154393320|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154393321|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393322|NCT03359395|Alfentanil|alfentanil|mesh-list
154393323|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154393324|NCT03359395|Narcotics|narcotics|mesh-ancestor
154393325|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393326|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393327|NCT03359395|Analgesics|analgesics|mesh-ancestor
154393328|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
154393329|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393330|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154393331|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
154393332|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
154393333|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
154393334|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154393335|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
154393336|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393337|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393338|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154393339|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
154393340|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
154393341|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154393342|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
154393343|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393344|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393345|NCT03093402|Dronabinol|dronabinol|mesh-list
154393346|NCT03093402|Lenabasum|lenabasum|mesh-list
154393347|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154393348|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154393349|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393350|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393351|NCT03093402|Hormones|hormones|mesh-ancestor
154393352|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393353|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393354|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
154393355|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154393356|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393357|NCT03093402|Analgesics|analgesics|mesh-ancestor
154393358|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
154393359|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393360|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
154128053|NCT00868062|Polygeline|polygeline|mesh-list
154393361|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393362|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
154393363|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
154393364|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393365|NCT03733379|Amoxicillin|amoxicillin|mesh-list
154393366|NCT03733379|Metronidazole|metronidazole|mesh-list
154393367|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154393368|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393369|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154393370|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154393371|NCT05733676|Calcium|calcium|mesh-list
154393372|NCT05733676|Fluorides|fluorides|mesh-list
154393373|NCT05733676|Caseins|caseins|mesh-list
154393374|NCT05733676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154393375|NCT05733676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393376|NCT05733676|Cariostatic Agents|cariostatic agents|mesh-ancestor
154393377|NCT05733676|Protective Agents|protective agents|mesh-ancestor
154393378|NCT05733676|Chelating Agents|chelating agents|mesh-ancestor
154393379|NCT05733676|Sequestering Agents|sequestering agents|mesh-ancestor
154393380|NCT05733676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128080|NCT00801086|Tempol|tempol|mesh-list
154393381|NCT03343639|Serlopitant|serlopitant|mesh-list
154393382|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154393383|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393384|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393385|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393386|NCT04479748|Dexamethasone|dexamethasone|mesh-list
154393387|NCT04479748|Prednisolone|prednisolone|mesh-list
154393388|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154393389|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
154393390|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154393391|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
154393392|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154393393|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
154393394|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393395|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
154393396|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
154393397|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393398|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393399|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393400|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
154393401|NCT04479748|Hormones|hormones|mesh-ancestor
154128085|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
154393402|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393403|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154393404|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393405|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154393406|NCT04479748|Protective Agents|protective agents|mesh-ancestor
154393407|NCT02690974|Valsartan|valsartan|mesh-list
154393408|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154393409|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154393410|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154393411|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154393412|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393413|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154393414|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393415|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154393416|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
154393417|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393418|NCT03584009|Venetoclax|venetoclax|mesh-list
154393419|NCT03584009|Fulvestrant|fulvestrant|mesh-list
154393420|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393421|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154393422|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154393423|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154172473|NCT00468585|Bevacizumab|bevacizumab|mesh-list
154393424|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
154393425|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393426|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393427|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
154393428|NCT03709927|Fosfomycin|fosfomycin|mesh-list
154393429|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154393430|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393431|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154393432|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154393433|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393434|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393435|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393436|NCT04167462|Deucravacitinib|deucravacitinib|mesh-list
154393437|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393438|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154393439|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393440|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393441|NCT04160520|Morphine|morphine|mesh-list
154393442|NCT04160520|Pramipexole|pramipexole|mesh-list
154393443|NCT04160520|Dexpramipexole|dexpramipexole|mesh-list
154393444|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154393445|NCT04160520|Narcotics|narcotics|mesh-ancestor
154393446|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393447|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393448|NCT04160520|Analgesics|analgesics|mesh-ancestor
154393449|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
154393450|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393451|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
154393452|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393453|NCT04160520|Protective Agents|protective agents|mesh-ancestor
154393454|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154393455|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154393456|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
154393457|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
154393458|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393459|NCT03583385|Metformin|metformin|mesh-list
154393460|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154393461|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393462|NCT05288335|Methamphetamine|methamphetamine|mesh-list
154393463|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154393464|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393465|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
154393466|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
154393467|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393468|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
154393469|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393470|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393471|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
154393472|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154393473|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154393474|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154393475|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154393476|NCT04792801|Choline|choline|mesh-list
154393477|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
154393478|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154393479|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
154393480|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393481|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393482|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154393483|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
154393484|NCT05420922|Lenvatinib|lenvatinib|mesh-list
154393485|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154393486|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393487|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154393488|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393489|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393490|NCT05420922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154393491|NCT03582215|Salicylates|salicylates|mesh-list
154393492|NCT03582215|Avobenzone|avobenzone|mesh-list
154393493|NCT03582215|Homosalate|homosalate|mesh-list
154393494|NCT03582215|Oxybenzone|oxybenzone|mesh-list
154393495|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
154393496|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
154393497|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
154393498|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154393499|NCT03582215|Protective Agents|protective agents|mesh-ancestor
154393500|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393501|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393502|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154393503|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393505|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
154393506|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393507|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393508|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154393509|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154393510|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393511|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393512|NCT05175703|Paclitaxel|paclitaxel|mesh-list
154393513|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154393514|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393515|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
154393516|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
154393517|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
154393518|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393519|NCT04102800|Benralizumab|benralizumab|mesh-list
154393520|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154393521|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
154393522|NCT03323346|Disulfiram|disulfiram|mesh-list
154393523|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154393524|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154393525|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393526|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393527|NCT05628571|Fluorides|fluorides|mesh-list
154393528|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
154393529|NCT05628571|Protective Agents|protective agents|mesh-ancestor
154393530|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393531|NCT05255016|Riboflavin|riboflavin|mesh-list
154393532|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
154393533|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
154393534|NCT05255016|Vitamins|vitamins|mesh-ancestor
154393535|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
154393536|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393537|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154393538|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393539|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154393540|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154393541|NCT05178888|Palbociclib|palbociclib|mesh-list
154393542|NCT05178888|Adagrasib|adagrasib|mesh-list
154393543|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393544|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154393545|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393546|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393547|NCT03342001|Calcitonin|calcitonin|mesh-list
154393548|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
154393549|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154393550|NCT03342001|Katacalcin|katacalcin|mesh-list
154393551|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154393552|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393553|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154393554|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
154393555|NCT03579719|Itraconazole|itraconazole|mesh-list
154393556|NCT03579719|Balovaptan|balovaptan|mesh-list
154393557|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
154393558|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393559|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154393560|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154393561|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393562|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393563|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154393564|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
154393565|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393566|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393567|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154393568|NCT03579719|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154393569|NCT03579719|Natriuretic Agents|natriuretic agents|mesh-ancestor
154393571|NCT03631602|Clotrimazole|clotrimazole|mesh-list
154393572|NCT03631602|Miconazole|miconazole|mesh-list
154393573|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393574|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154393575|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154393576|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154393577|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393578|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393579|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154393580|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
154393581|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393582|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393583|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154393584|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154393585|NCT02688088|Midazolam|midazolam|mesh-list
154393586|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
154393587|NCT02688088|Caffeine|caffeine|mesh-list
154393588|NCT02688088|Warfarin|warfarin|mesh-list
154393589|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154393590|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154393591|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393592|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393593|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154393594|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154393595|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154393596|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154393597|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
154393598|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
154393599|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
154393600|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
154393601|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393602|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393603|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
154393604|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154393605|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154393606|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393607|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154393608|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154393609|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
154393610|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
154393611|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
154393612|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154393613|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154393614|NCT03641651|Frovatriptan|frovatriptan|mesh-list
154393615|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154393616|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
154393617|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393618|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393619|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393620|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
154393621|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154393622|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393623|NCT05666219|Aminophylline|aminophylline|mesh-list
154393624|NCT05666219|Theophylline|theophylline|mesh-list
154393625|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154393626|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
154393627|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393628|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393629|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154393630|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
154393631|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154393632|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393633|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393634|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
154393635|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154393636|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154393637|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
154393638|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393639|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154393640|NCT05666219|Protective Agents|protective agents|mesh-ancestor
154393641|NCT02949271|Fentanyl|fentanyl|mesh-list
154393642|NCT02949271|Ropivacaine|ropivacaine|mesh-list
154393643|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
154393644|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
154393645|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393646|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393647|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
154172699|NCT00628355|Lidocaine|lidocaine|mesh-list
154393648|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393649|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154393650|NCT02949271|Narcotics|narcotics|mesh-ancestor
154393651|NCT02949271|Analgesics|analgesics|mesh-ancestor
154393652|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154393653|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154393654|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
154393655|NCT03339583|Zopiclone|zopiclone|mesh-list
154393656|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154393657|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393658|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393659|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
154393660|NCT03639779|Antidotes|antidotes|mesh-ancestor
154393661|NCT03639779|Protective Agents|protective agents|mesh-ancestor
154393662|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393663|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
154393664|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393665|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
154393666|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154393667|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393668|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
154393669|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
154393670|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
154393671|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154393672|NCT05173441|Antibodies|antibodies|mesh-list
154393673|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
154393674|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393675|NCT03708133|Nifurtimox|nifurtimox|mesh-list
154393676|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154393677|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154393678|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154393679|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393680|NCT05075161|Pirfenidone|pirfenidone|mesh-list
154393681|NCT05075161|Analgesics|analgesics|mesh-ancestor
154393682|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
154128363|NCT00870480|Finasteride|finasteride|mesh-list
154393683|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393684|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393685|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154393686|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393687|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393688|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154393689|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393690|NCT05095831|Pancrelipase|pancrelipase|mesh-list
154393691|NCT05095831|Pancreatin|pancreatin|mesh-list
154393692|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393693|NCT03638869|Methadone|methadone|mesh-list
154393694|NCT03638869|D-methadone|d-methadone|mesh-list
154393695|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154393696|NCT03638869|Narcotics|narcotics|mesh-ancestor
154393697|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393698|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393699|NCT03638869|Analgesics|analgesics|mesh-ancestor
154393700|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
154393701|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393702|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
154393703|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
154393704|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393705|NCT03091920|Praliciguat|praliciguat|mesh-list
154393706|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154393707|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
154393708|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393709|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393710|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
154393711|NCT03338569|Vitamins|vitamins|mesh-ancestor
154393712|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
154128381|NCT00616902|Vitamins|vitamins|mesh-ancestor
154393713|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393714|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
154393715|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393716|NCT03338569|Protective Agents|protective agents|mesh-ancestor
154393717|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
154393718|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154393719|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393720|NCT03337477|Insulin|insulin|mesh-list
154393721|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154393722|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154393723|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393724|NCT03707899|Amlodipine|amlodipine|mesh-list
154393725|NCT03707899|Telmisartan|telmisartan|mesh-list
154393726|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154393727|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154393728|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154393729|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154393730|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154393731|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393732|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154393733|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393734|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
154393735|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154393736|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154393737|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
154393738|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154393739|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154393740|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393741|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154393742|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154393743|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
154393744|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154393745|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393746|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154393747|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393748|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393749|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
154393750|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154393751|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154393752|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393753|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
154393754|NCT03706339|Coagulants|coagulants|mesh-ancestor
154393755|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154393756|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
154393757|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154393758|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154393759|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154393760|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393761|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128456|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393762|NCT03639558|Promethazine|promethazine|mesh-list
154393763|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
154393764|NCT03639558|Haloperidol|haloperidol|mesh-list
154393765|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
154393766|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
154393767|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
154393768|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
154393769|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393770|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393771|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393772|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154393773|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154393774|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393775|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154393776|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154393777|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
154393778|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393779|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393780|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154393781|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
154393782|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393783|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154393784|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
154393785|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
154393786|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154393787|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154393788|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154393789|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
154393790|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
154393791|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
154393792|NCT01353508|Valsartan|valsartan|mesh-list
154393793|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154393794|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154393795|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154393796|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154393797|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393799|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
154393800|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
154172849|NCT00449787|Naproxen|naproxen|mesh-list
154393801|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393802|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393803|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393804|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154393805|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154393806|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
154393807|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393808|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393810|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393811|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
154393812|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
154393813|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393814|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393815|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154393816|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
154393817|NCT04911361|Hormones|hormones|mesh-ancestor
153973730|NCT06248229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154393818|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393819|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154393820|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393821|NCT03087786|Nicotine|nicotine|mesh-list
154393822|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154393823|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
154393824|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393825|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393826|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154393827|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154393828|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
154393829|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393830|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393831|NCT03635957|Folic Acid|folic acid|mesh-list
154393832|NCT03635957|Methotrexate|methotrexate|mesh-list
154393833|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154393834|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
154393835|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154393836|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128513|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393837|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154393838|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
154393839|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393840|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393841|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393842|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393843|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154393844|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154393845|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
154393846|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154393847|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154393848|NCT03635957|Hematinics|hematinics|mesh-ancestor
154393849|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
154393850|NCT03635957|Vitamins|vitamins|mesh-ancestor
154393851|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
154393852|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154393853|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154393854|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393855|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
154393856|NCT02684344|Tamsulosin|tamsulosin|mesh-list
154393857|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154393858|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154393859|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154393860|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
154393861|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393862|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393863|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393864|NCT02684344|Urological Agents|urological agents|mesh-ancestor
154393865|NCT03974100|Denosumab|denosumab|mesh-list
154393866|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154393867|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393868|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
154393869|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
154393870|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
154393871|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
154393872|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154393873|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393874|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154393875|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154393876|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154393878|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
154393879|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
154393880|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154393881|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154393882|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154393883|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393884|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393885|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154393886|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154393887|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154393888|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393889|NCT01374568|Incretins|incretins|mesh-ancestor
154393890|NCT01374568|Hormones|hormones|mesh-ancestor
154393891|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393892|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154393893|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
154393894|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154393895|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393896|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
154393897|NCT01312441|Vitamin D|vitamin d|mesh-list
154393898|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154393899|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393900|NCT01312441|Vitamins|vitamins|mesh-ancestor
154393901|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
154393902|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154393903|NCT02682784|Oxytocin|oxytocin|mesh-list
154393904|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
154393905|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154393906|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393907|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
154393908|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
154393909|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154393910|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
154393911|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393912|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
154393913|NCT03705949|Protective Agents|protective agents|mesh-ancestor
154393914|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154393915|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154393916|NCT03162562|Oregovomab|oregovomab|mesh-list
154393917|NCT03162562|Poly ICLC|poly iclc|mesh-list
154393918|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
154393919|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
154393920|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393921|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154393922|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393923|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
154393924|NCT03164590|Ketamine|ketamine|mesh-list
154393925|NCT03164590|Bupivacaine|bupivacaine|mesh-list
154393926|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
154393927|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
154393928|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154393929|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393930|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
154393931|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393932|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154393933|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154393934|NCT03164590|Analgesics|analgesics|mesh-ancestor
154393935|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154393936|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154393937|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154393938|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
154393939|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393940|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393941|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154393942|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154393943|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
154393944|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154393945|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154393947|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
154393948|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154393949|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
154393950|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
154393951|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393952|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393953|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
154393954|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393955|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393956|NCT05119075|Protective Agents|protective agents|mesh-ancestor
154393957|NCT03387852|Fluticasone|fluticasone|mesh-list
154393958|NCT03387852|Xhance|xhance|mesh-list
154393959|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154393960|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154393961|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154393962|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154393963|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154393964|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
154393965|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154393966|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393967|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154393968|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
154393969|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154393970|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154393971|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154393972|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154393973|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154393974|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
154393975|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154393976|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154393977|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
154393978|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
154393979|NCT03387852|Hormones|hormones|mesh-ancestor
154393980|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393981|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
154393982|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
154393983|NCT02679274|Testosterone|testosterone|mesh-list
154393984|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
154393985|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
154393986|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154393987|NCT02679274|Androgens|androgens|mesh-ancestor
154393988|NCT02679274|Hormones|hormones|mesh-ancestor
154393989|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154393990|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154393991|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154393992|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154393993|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
154393994|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154393995|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154393996|NCT03620929|Estradiol|estradiol|mesh-list
154393997|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154393998|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
154393999|NCT03620929|Estrogens|estrogens|mesh-ancestor
154394000|NCT03620929|Hormones|hormones|mesh-ancestor
154394001|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394002|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394003|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154394004|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
154394005|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154394006|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154394007|NCT03620929|Progestins|progestins|mesh-ancestor
154394008|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
154394009|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394010|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394011|NCT04969861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154394012|NCT04969861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394013|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154394015|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394016|NCT02678416|Acetaminophen|acetaminophen|mesh-list
154394017|NCT02678416|Morphine|morphine|mesh-list
154394018|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154394019|NCT02678416|Narcotics|narcotics|mesh-ancestor
154394020|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394021|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394022|NCT02678416|Analgesics|analgesics|mesh-ancestor
154394023|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
154173071|NCT00445341|Alvocidib|alvocidib|mesh-list
154394024|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173081|NCT00444951|Vaccines|vaccines|mesh-list
154394025|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154394026|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
154394027|NCT03164668|Menthol|menthol|mesh-list
154394028|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
154394029|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
154394030|NCT03164512|Cannabidiol|cannabidiol|mesh-list
154394031|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
154394032|NCT02680756|Ferric maltol|ferric maltol|mesh-list
154394033|NCT02680756|Hematinics|hematinics|mesh-ancestor
154394034|NCT03631836|Bevacizumab|bevacizumab|mesh-list
154394035|NCT03631836|Antibodies|antibodies|mesh-list
154394036|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154394037|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394038|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394039|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154394040|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154394041|NCT03631836|Growth Substances|growth substances|mesh-ancestor
154394042|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394043|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
154394044|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
154394045|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154394046|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154394047|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
154128707|NCT00877110|Topotecan|topotecan|mesh-list
154394048|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154394049|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
154394050|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394051|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394052|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154394053|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
154394054|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154394055|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154394056|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154394057|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
154394058|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394059|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394060|NCT03670706|Analgesics|analgesics|mesh-list
154394061|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
154394062|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394063|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394064|NCT03114280|Carboplatin|carboplatin|mesh-list
154394065|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394066|NCT01312363|Rivastigmine|rivastigmine|mesh-list
154394067|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154394068|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394069|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394070|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
154394071|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394072|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394073|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154394074|NCT01312363|Protective Agents|protective agents|mesh-ancestor
154394075|NCT03161678|Clopidogrel|clopidogrel|mesh-list
154394076|NCT03161678|Ticagrelor|ticagrelor|mesh-list
154394077|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154128741|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
154394078|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154394079|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154394080|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154394081|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
154394082|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394083|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394084|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394085|NCT03674606|Aspirin|aspirin|mesh-list
153738609|NCT00089245|Iodine|iodine|mesh-list
154394086|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154394087|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154394088|NCT03674606|Analgesics|analgesics|mesh-ancestor
154394089|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
154394090|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394091|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394092|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394093|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154394094|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154394095|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154394096|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394097|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154394098|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154173146|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154394099|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394100|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
154394101|NCT02677324|Venetoclax|venetoclax|mesh-list
154394102|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394103|NCT03163966|Methotrexate|methotrexate|mesh-list
154394104|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154394105|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
154394106|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154394107|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394108|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154394109|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
154394110|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394111|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394112|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
154394113|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394114|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154394115|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154394116|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
154394117|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154394118|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154394119|NCT03678116|Caffeine|caffeine|mesh-list
154394120|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154394121|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394122|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154394123|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394124|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394125|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154394126|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154394127|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
154394128|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394129|NCT03678038|Triamcinolone|triamcinolone|mesh-list
154394130|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154394131|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154394132|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154394133|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394134|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
154394135|NCT03678038|Hormones|hormones|mesh-ancestor
154394136|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394137|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394138|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154394139|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
154394140|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394141|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394142|NCT03163420|Diclofenac|diclofenac|mesh-list
154394143|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154394144|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154394145|NCT03163420|Analgesics|analgesics|mesh-ancestor
154394146|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
154394147|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128821|NCT04045730|Gemcitabine|gemcitabine|mesh-list
154394148|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394149|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394150|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154394151|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154394152|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394153|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394154|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
154394155|NCT04440436|Fludarabine|fludarabine|mesh-list
154394156|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154394157|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
154394158|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394159|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154394160|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154394161|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
154394162|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394163|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394164|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154394165|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154394166|NCT05405686|Hormones|hormones|mesh-ancestor
154394167|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394168|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394169|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154394170|NCT04711122|Cephalosporins|cephalosporins|mesh-list
154394171|NCT04711122|Third Generation Cephalosporins|third generation cephalosporins|mesh-list
154394172|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394173|NCT04711122|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154394174|NCT05272696|Paclitaxel|paclitaxel|mesh-list
154394175|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
154394176|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154394177|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394178|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
154394179|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
154394180|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
154394181|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394182|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394183|NCT05272696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154394184|NCT05563116|Calcium|calcium|mesh-list
154394185|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154394186|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394187|NCT03520946|Ramucirumab|ramucirumab|mesh-list
154394188|NCT03520946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154394189|NCT03520946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154394190|NCT03520946|Growth Substances|growth substances|mesh-ancestor
154394191|NCT03520946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394192|NCT03520946|Growth Inhibitors|growth inhibitors|mesh-ancestor
154394193|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394194|NCT03674060|Sorafenib|sorafenib|mesh-list
154394195|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394196|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394197|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394198|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394199|NCT03163576|Niacin|niacin|mesh-list
154394200|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154394201|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
154394202|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394203|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154394204|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
154394205|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
154394206|NCT03163576|Vitamins|vitamins|mesh-ancestor
154394207|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
154394208|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394209|NCT01810718|Nilotinib|nilotinib|mesh-list
154394210|NCT01810718|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154394211|NCT01810718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394212|NCT01810718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394213|NCT01810718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394214|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
154394215|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394216|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394217|NCT03673280|Morphine|morphine|mesh-list
154394218|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154394219|NCT03673280|Narcotics|narcotics|mesh-ancestor
154394220|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394221|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394222|NCT03673280|Analgesics|analgesics|mesh-ancestor
154394223|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
154394224|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394225|NCT05420220|Axitinib|axitinib|mesh-list
154394226|NCT05420220|Antibodies|antibodies|mesh-list
154128903|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
154394227|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
154394228|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394229|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394230|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394231|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394232|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394233|NCT01382004|Azithromycin|azithromycin|mesh-list
154394234|NCT01382004|Penicillins|penicillins|mesh-list
154394235|NCT01382004|Penicillin G|penicillin g|mesh-list
154394236|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154394237|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
154394238|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154394239|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394240|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
154394241|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154394242|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154394243|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394244|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
154394245|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
154394246|NCT01381848|Doripenem|doripenem|mesh-list
154394247|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154173300|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
154394248|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394249|NCT04546620|Prednisolone|prednisolone|mesh-list
154394250|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154394251|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
154394252|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154394253|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
154394254|NCT04546620|Prednisone|prednisone|mesh-list
154394255|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
154394256|NCT04546620|Rituximab|rituximab|mesh-list
154394257|NCT04546620|Doxorubicin|doxorubicin|mesh-list
154394258|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154394259|NCT04546620|Vincristine|vincristine|mesh-list
154394260|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
154394261|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154394262|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
154394263|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154394264|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
154394265|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394266|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154394267|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154394268|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
154394269|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394270|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394271|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154394272|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394273|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154394274|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154394275|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154394276|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394277|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154394278|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
154394279|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
154394280|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
154394281|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394282|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
154394283|NCT04546620|Hormones|hormones|mesh-ancestor
154394284|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394285|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154394286|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
154394287|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
154394288|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394289|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154394290|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154394291|NCT04546620|Protective Agents|protective agents|mesh-ancestor
154394292|NCT04546620|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154394293|NCT04546620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394294|NCT04058210|Ivacaftor|ivacaftor|mesh-list
154394295|NCT04058210|Elexacaftor|elexacaftor|mesh-list
154394296|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154394297|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154394298|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394299|NCT02250300|Ixazomib|ixazomib|mesh-list
154394300|NCT02250300|Glycine|glycine|mesh-list
154394301|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394302|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
154394303|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394304|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394305|NCT02250300|Glycine Agents|glycine agents|mesh-ancestor
154394306|NCT02250300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394307|NCT02250300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394308|NCT03020966|Acetaminophen|acetaminophen|mesh-list
154394309|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154394310|NCT03020966|Analgesics|analgesics|mesh-ancestor
154394311|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
154394312|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394313|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394314|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
154394315|NCT04051268|Vaccines|vaccines|mesh-list
154394316|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
154394317|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394318|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
154394319|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154394320|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154394321|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394322|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
154394323|NCT04595786|Coagulants|coagulants|mesh-ancestor
154394324|NCT01381614|Bevacizumab|bevacizumab|mesh-list
154394325|NCT01381614|Sunitinib|sunitinib|mesh-list
154394326|NCT01381614|Sorafenib|sorafenib|mesh-list
154394327|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394328|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394329|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154394330|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154394331|NCT01381614|Growth Substances|growth substances|mesh-ancestor
154394332|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394333|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
154394334|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394335|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394336|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394337|NCT01381536|Belimumab|belimumab|mesh-list
154394338|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154394339|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
154394340|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394341|NCT03162406|Vitamin D|vitamin d|mesh-list
154394342|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
154394343|NCT03162406|Vitamins|vitamins|mesh-ancestor
154394344|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
154394345|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394346|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154394347|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154394348|NCT02946385|Vaccines|vaccines|mesh-list
154394349|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
154394350|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394351|NCT05676190|Immunomodulating Agents|immunomodulating agents|mesh-list
154394352|NCT05676190|Immunologic Factors|immunologic factors|mesh-ancestor
154394353|NCT05676190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394354|NCT02694718|Capecitabine|capecitabine|mesh-list
154394355|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
154394356|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154394357|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
154394358|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394359|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394360|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154394361|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154394362|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
154394363|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154394364|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
154394365|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154394366|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
154394367|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394368|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394369|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
154394370|NCT05681221|Calcium|calcium|mesh-list
154394371|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154394372|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394373|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
154394374|NCT04303507|Chloroquine|chloroquine|mesh-list
154394375|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
154129048|NCT00872274|Sumatriptan|sumatriptan|mesh-list
154129067|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154394376|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154394377|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154394378|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394379|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394380|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394381|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739034|NCT00472225|Rituximab|rituximab|mesh-list
154394382|NCT04303507|Amebicides|amebicides|mesh-ancestor
154394383|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
154394384|NCT03202537|Lansoprazole|lansoprazole|mesh-list
154394385|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154394386|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154394387|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154394388|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394389|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394390|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154394391|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394392|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394393|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394394|NCT04138615|Morphine|morphine|mesh-list
154394395|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154394396|NCT04138615|Narcotics|narcotics|mesh-ancestor
154394397|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394398|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394399|NCT04138615|Analgesics|analgesics|mesh-ancestor
154394400|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
154394401|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394403|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154394404|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394405|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
154394406|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154394407|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394408|NCT03018938|Insulin|insulin|mesh-list
154394409|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154394410|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394411|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394412|NCT04776499|Perphenazine|perphenazine|mesh-list
154394413|NCT04776499|Riociguat|riociguat|mesh-list
154394414|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
154394415|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
154394416|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394417|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154394418|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154394419|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394420|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394421|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154394422|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154394423|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
154394424|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394425|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
154394426|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
154394427|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
154394428|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394429|NCT03668054|Bevacizumab|bevacizumab|mesh-list
154394430|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394431|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394432|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154394433|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154394434|NCT03668054|Growth Substances|growth substances|mesh-ancestor
154394435|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394436|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
154394437|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
154394438|NCT03623048|Propolis|propolis|mesh-list
154394439|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154394440|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394441|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
154394442|NCT03016598|Oxytocin|oxytocin|mesh-list
154394443|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
154394444|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154394445|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394446|NCT03017846|Cantharidin|cantharidin|mesh-list
154394447|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394448|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394449|NCT03638401|Morphine|morphine|mesh-list
154394450|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154394451|NCT03638401|Narcotics|narcotics|mesh-ancestor
154394452|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394453|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394454|NCT03638401|Analgesics|analgesics|mesh-ancestor
154394455|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
154394456|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394457|NCT03666650|Edoxaban|edoxaban|mesh-list
154394458|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154394459|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
154394460|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154394461|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
154394462|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394463|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394464|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
154394465|NCT02942485|Metronidazole|metronidazole|mesh-list
154394466|NCT02942485|Tinidazole|tinidazole|mesh-list
154394467|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394468|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154394469|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154394470|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154394471|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
154394472|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394473|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154394474|NCT03666494|Fentanyl|fentanyl|mesh-list
154394475|NCT03666494|Ketamine|ketamine|mesh-list
154394476|NCT03666494|Propofol|propofol|mesh-list
154394477|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154394478|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394479|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394480|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154394482|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
154394483|NCT03666494|Analgesics|analgesics|mesh-ancestor
154394484|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
154394485|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394486|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154394487|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154129151|NCT00657020|Nicotine|nicotine|mesh-list
154394488|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154394489|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394490|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394491|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154394492|NCT03666494|Narcotics|narcotics|mesh-ancestor
154394493|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154394494|NCT03666884|Cyclosporine|cyclosporine|mesh-list
154394495|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154394496|NCT03666884|Cyclosporins|cyclosporins|mesh-list
154394497|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154394498|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394499|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394500|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154394501|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
154394502|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394503|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
154394504|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394505|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
154394506|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129178|NCT00878124|Ubiquinone|ubiquinone|mesh-list
154394507|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154394508|NCT02942407|Warfarin|warfarin|mesh-list
154394509|NCT02942407|Apixaban|apixaban|mesh-list
154394510|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
154394511|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154394512|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
154394513|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154394514|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
154394515|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394516|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394517|NCT02921035|Interferons|interferons|mesh-list
154394518|NCT02921035|Interferon-beta|interferon-beta|mesh-list
154394519|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
154394520|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394521|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
154394522|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394523|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
154394524|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394525|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154394526|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154394527|NCT03667352|Fentanyl|fentanyl|mesh-list
154394528|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154394529|NCT03667352|Narcotics|narcotics|mesh-ancestor
154394530|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394531|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394532|NCT03667352|Analgesics|analgesics|mesh-ancestor
154394533|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
154394534|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394535|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154394536|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154394537|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
154394538|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
154394539|NCT03320941|Licogliflozin|licogliflozin|mesh-list
154394540|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154394541|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394542|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394543|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394544|NCT03559699|Mitapivat|mitapivat|mesh-list
154394545|NCT03559699|Enzyme Activators|enzyme activators|mesh-ancestor
154394546|NCT03559699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394547|NCT02573233|Fluticasone|fluticasone|mesh-list
154394548|NCT02573233|Xhance|xhance|mesh-list
154394549|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
154394550|NCT02573233|Budesonide|budesonide|mesh-list
154394551|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
154394552|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154173599|NCT00427635|Esomeprazole|esomeprazole|mesh-list
154394553|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394554|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154394556|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394557|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394558|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154394559|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
154394560|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
154394561|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154394562|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
154394563|NCT02573233|Hormones|hormones|mesh-ancestor
154394564|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394565|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154394566|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154394567|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154394568|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
154394569|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394570|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394571|NCT03867487|Empagliflozin|empagliflozin|mesh-list
154394572|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154394573|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394574|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394575|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394576|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
154394577|NCT01569048|Remifentanil|remifentanil|mesh-list
154394578|NCT01569048|Propofol|propofol|mesh-list
154394579|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154394580|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394581|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394582|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154394583|NCT01569048|Analgesics|analgesics|mesh-ancestor
154394584|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
154394585|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394586|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154394587|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154394588|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154394589|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
154394590|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394591|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394592|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154394593|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
154394594|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
154394595|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154394596|NCT01569048|Narcotics|narcotics|mesh-ancestor
154394597|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154394598|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
154129240|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394599|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154394600|NCT01380912|Prednisolone|prednisolone|mesh-list
154394601|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
154394602|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154394603|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
154394604|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394605|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
154394606|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
154394607|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394608|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394609|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154394611|NCT01380912|Hormones|hormones|mesh-ancestor
154394612|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394613|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154394614|NCT01380912|Protective Agents|protective agents|mesh-ancestor
154394615|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154394616|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394617|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154394618|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154394619|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154394620|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154394621|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394622|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394623|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394624|NCT03315793|Analgesics|analgesics|mesh-ancestor
154394625|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
154173686|NCT03894540|Paclitaxel|paclitaxel|mesh-list
154394626|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394627|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
154394628|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154394629|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
154394630|NCT01569204|Dexamethasone|dexamethasone|mesh-list
154394631|NCT01569204|Prednisone|prednisone|mesh-list
154394632|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
154394633|NCT01569204|Dacarbazine|dacarbazine|mesh-list
154394634|NCT01569204|Doxorubicin|doxorubicin|mesh-list
154394635|NCT01569204|Etoposide|etoposide|mesh-list
154394636|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154394637|NCT01569204|Procarbazine|procarbazine|mesh-list
154394638|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154394639|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
154394640|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394641|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154394642|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154394643|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
154394644|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394645|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394646|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154394647|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394648|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
154394649|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
154394650|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394651|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154394652|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
154394653|NCT01569204|Hormones|hormones|mesh-ancestor
154394654|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394655|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154394656|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154394657|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154394658|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154394659|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394660|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154394661|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394662|NCT01569204|Immunotoxins|immunotoxins|mesh-ancestor
154394663|NCT01569204|Immunoconjugates|immunoconjugates|mesh-ancestor
154394664|NCT02676466|Losartan|losartan|mesh-list
154394665|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154394666|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154394667|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154394668|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154394669|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394670|NCT04439890|Carboplatin|carboplatin|mesh-list
154394671|NCT04439890|Pemetrexed|pemetrexed|mesh-list
154394672|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394673|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394674|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394675|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154394676|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154394677|NCT02324725|Naltrexone|naltrexone|mesh-list
154394678|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154394679|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154394680|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394681|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
154394682|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394684|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154394685|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
154394686|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154394687|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394688|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394689|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154394690|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154394691|NCT01380678|Growth Substances|growth substances|mesh-ancestor
154394692|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394693|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
154394694|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
154394695|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394696|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394697|NCT01380600|Molgramostim|molgramostim|mesh-list
154394698|NCT01380600|Sargramostim|sargramostim|mesh-list
154394699|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
154394700|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394701|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394702|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
154394703|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
154394704|NCT03264118|Coagulants|coagulants|mesh-ancestor
154394705|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
154394706|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394707|NCT02674204|Atorvastatin|atorvastatin|mesh-list
154129349|NCT00978549|Docetaxel|docetaxel|mesh-list
154394708|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154394709|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154394710|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
154394711|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394712|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154394713|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154394714|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394715|NCT05675644|Drospirenone|drospirenone|mesh-list
154394716|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154394717|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
154394718|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394719|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394720|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154394721|NCT05675644|Diuretics|diuretics|mesh-ancestor
154394722|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
154394723|NCT02579044|Everolimus|everolimus|mesh-list
154394724|NCT02579044|Lonafarnib|lonafarnib|mesh-list
154394725|NCT02579044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154394726|NCT02579044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394727|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394728|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394729|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154394730|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
154394731|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394732|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394733|NCT03525379|Resveratrol|resveratrol|mesh-list
154394734|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
154394735|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394736|NCT03525379|Protective Agents|protective agents|mesh-ancestor
154394737|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394738|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394739|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154394740|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154394741|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154394742|NCT03476551|Diuretics|diuretics|mesh-ancestor
154394743|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
154394744|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394745|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154394746|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154394747|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394748|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154394749|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154394750|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394751|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394752|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394753|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
154394754|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394755|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394756|NCT01380522|Metronidazole|metronidazole|mesh-list
154394757|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394758|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154394759|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154394760|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154394761|NCT02913326|Warfarin|warfarin|mesh-list
154394762|NCT02913326|Dabigatran|dabigatran|mesh-list
154394763|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
154394764|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
154129426|NCT00613938|Oxycodone|oxycodone|mesh-list
154394765|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154394766|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
154394767|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394768|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394769|NCT03725891|Aspirin|aspirin|mesh-list
154394770|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154394771|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154394772|NCT03725891|Analgesics|analgesics|mesh-ancestor
154394773|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
154394774|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394775|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394776|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394777|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154394778|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154394779|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154394780|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394781|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154394782|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154394783|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394784|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
154394785|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
154129455|NCT00805064|Hormones|hormones|mesh-ancestor
154129474|NCT00873756|Growth Substances|growth substances|mesh-ancestor
154394786|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
154129475|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394787|NCT03751163|Hydroquinone|hydroquinone|mesh-list
154394788|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154394789|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154394790|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394791|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
154394792|NCT03751163|Coagulants|coagulants|mesh-ancestor
154394793|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154394794|NCT03751163|Protective Agents|protective agents|mesh-ancestor
154394795|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394796|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
154394797|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
154394798|NCT03639545|Metformin|metformin|mesh-list
154394799|NCT03639545|Empagliflozin|empagliflozin|mesh-list
154394800|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394801|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394802|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154394803|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394804|NCT03181386|Warfarin|warfarin|mesh-list
154394805|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
154394806|NCT03181386|Dabigatran|dabigatran|mesh-list
154394807|NCT03181386|Apixaban|apixaban|mesh-list
154394808|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
154394809|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154394810|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
154394811|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154394812|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
154394813|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394814|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394815|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
154394816|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394817|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
154394818|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154394819|NCT03639467|Gemcitabine|gemcitabine|mesh-list
154394820|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394821|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154394822|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
154394823|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394824|NCT01382706|Docetaxel|docetaxel|mesh-list
154394825|NCT01382706|Lapatinib|lapatinib|mesh-list
154394826|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394827|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
154394828|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
153740179|NCT00151125|Oprelvekin|oprelvekin|mesh-list
154394829|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
154394830|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394831|NCT01382706|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154394832|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394833|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394834|NCT03665402|Isoniazid|isoniazid|mesh-list
154394835|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
154394836|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154394837|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129495|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129535|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
154394838|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154394839|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154394840|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
154394841|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394842|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154394843|NCT01380288|Rivastigmine|rivastigmine|mesh-list
154394844|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154394845|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394846|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394847|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
154394848|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394849|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394850|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154394851|NCT01380288|Protective Agents|protective agents|mesh-ancestor
154394852|NCT03110484|Pemetrexed|pemetrexed|mesh-list
154394853|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154394854|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394855|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394856|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394857|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154394858|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154394859|NCT03110484|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154394860|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394861|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
154394862|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394863|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394864|NCT03110328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154394865|NCT03110328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394866|NCT00002874|Bicalutamide|bicalutamide|mesh-list
154394867|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
154394868|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
154394869|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394870|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394871|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394872|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154394873|NCT03001076|Ezetimibe|ezetimibe|mesh-list
154394874|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154394875|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154394876|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
154394877|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394878|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154394879|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394880|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394881|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394882|NCT03555305|Insulin|insulin|mesh-list
154394883|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154394884|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
154394885|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154394886|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394887|NCT05422716|Baclofen|baclofen|mesh-list
154394888|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154394889|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394890|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154394891|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394892|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154394893|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
154394894|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
154394895|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394896|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394897|NCT03728777|Resveratrol|resveratrol|mesh-list
154394898|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
154394899|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394900|NCT03728777|Protective Agents|protective agents|mesh-ancestor
154394901|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394902|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394903|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154394905|NCT05421936|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154394906|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394907|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394908|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394909|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394910|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154394911|NCT01382472|Simvastatin|simvastatin|mesh-list
154394912|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154394913|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154394914|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
154394915|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394916|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154394917|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154394918|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394919|NCT03552029|Quizartinib|quizartinib|mesh-list
154394920|NCT03552029|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154394921|NCT03552029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394922|NCT03552029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394923|NCT03552029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394924|NCT03725423|Apatinib|apatinib|mesh-list
154394925|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394926|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154394927|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394928|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394929|NCT06171594|Chlorhexidine|chlorhexidine|mesh-list
154394930|NCT06171594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154394931|NCT06171594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394932|NCT06171594|Disinfectants|disinfectants|mesh-ancestor
154394933|NCT06171243|Lidocaine|lidocaine|mesh-list
154394934|NCT06171243|Tetracaine|tetracaine|mesh-list
154394935|NCT06171243|Anesthetics, Local|anesthetics, local|mesh-ancestor
154394936|NCT06171243|Anesthetics|anesthetics|mesh-ancestor
154394937|NCT06171243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394938|NCT06171243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394939|NCT06171243|Sensory System Agents|sensory system agents|mesh-ancestor
154129589|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
154394940|NCT06171243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394941|NCT06171243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154394942|NCT06171243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154394943|NCT06171243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154394944|NCT06171243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154394945|NCT06171243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394946|NCT06171217|Hydroxyurea|hydroxyurea|mesh-list
154394947|NCT06171217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394948|NCT06171217|Antisickling Agents|antisickling agents|mesh-ancestor
154394949|NCT06171217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154394950|NCT06171217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394951|NCT06171217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154394952|NCT06171087|Domperidone|domperidone|mesh-list
154394953|NCT06171087|Antiemetics|antiemetics|mesh-ancestor
154394954|NCT06171087|Autonomic Agents|autonomic agents|mesh-ancestor
154394955|NCT06171087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154394956|NCT06171087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394957|NCT06171087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154394958|NCT06171087|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154394959|NCT06171087|Dopamine Agents|dopamine agents|mesh-ancestor
154394960|NCT06171087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154394961|NCT06171087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394962|NCT06170983|Azithromycin|azithromycin|mesh-list
154394963|NCT06170983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154394964|NCT06170983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154394965|NCT06170710|Antibodies|antibodies|mesh-list
154394966|NCT06170710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154394967|NCT06170710|Immunologic Factors|immunologic factors|mesh-ancestor
154394968|NCT06170710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394969|NCT06170593|Triamcinolone|triamcinolone|mesh-list
154394970|NCT06170593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394971|NCT06170593|Glucocorticoids|glucocorticoids|mesh-ancestor
154394972|NCT06170593|Hormones|hormones|mesh-ancestor
153740373|NCT02950441|Niacin|niacin|mesh-list
154394973|NCT06170593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154394974|NCT06170593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394976|NCT06170359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154394977|NCT06170359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394978|NCT06170008|Petrolatum|petrolatum|mesh-list
154394979|NCT06170008|Emollients|emollients|mesh-ancestor
154394980|NCT06170008|Dermatologic Agents|dermatologic agents|mesh-ancestor
154394981|NCT06169956|Nivolumab|nivolumab|mesh-list
154394982|NCT06169956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394983|NCT06169956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394984|NCT06169956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154394985|NCT06169956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394986|NCT06169904|Atezolizumab|atezolizumab|mesh-list
154394987|NCT06169904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154394988|NCT06169904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154394989|NCT06169904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154394990|NCT06169904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154394991|NCT06169891|Betamethasone|betamethasone|mesh-list
154394992|NCT06169891|Antibodies|antibodies|mesh-list
154394993|NCT06169891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154394994|NCT06169891|Immunologic Factors|immunologic factors|mesh-ancestor
154394995|NCT06169891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154394996|NCT06169891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154394997|NCT06169891|Glucocorticoids|glucocorticoids|mesh-ancestor
154174046|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129684|NCT00725543|Infliximab|infliximab|mesh-list
154394999|NCT06169891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395000|NCT06169891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154395001|NCT06169891|Respiratory System Agents|respiratory system agents|mesh-ancestor
154395002|NCT06169813|Nicotine|nicotine|mesh-list
154395003|NCT06169813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154395004|NCT06169813|Autonomic Agents|autonomic agents|mesh-ancestor
154395005|NCT06169813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395006|NCT06169813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395007|NCT06169813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154395008|NCT06169813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154395009|NCT06169813|Cholinergic Agents|cholinergic agents|mesh-ancestor
154395010|NCT06169813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395011|NCT06169813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395012|NCT06168812|Glipizide|glipizide|mesh-list
154395013|NCT06168812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154395014|NCT06168812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395015|NCT06155383|Capecitabine|capecitabine|mesh-list
154395016|NCT06155383|Oxaliplatin|oxaliplatin|mesh-list
154395017|NCT06155383|Disitamab vedotin|disitamab vedotin|mesh-list
154395018|NCT06155383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154395019|NCT06155383|Antimetabolites|antimetabolites|mesh-ancestor
154395020|NCT06155383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395021|NCT06155383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395022|NCT06155383|Immunoconjugates|immunoconjugates|mesh-ancestor
154395023|NCT06155383|Immunologic Factors|immunologic factors|mesh-ancestor
154395024|NCT06155383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395025|NCT06147583|Insulin|insulin|mesh-list
154395026|NCT06147583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154395027|NCT06147583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395028|NCT06105918|Fluorides|fluorides|mesh-list
154395029|NCT06105918|Cariostatic Agents|cariostatic agents|mesh-ancestor
154395030|NCT06105918|Protective Agents|protective agents|mesh-ancestor
154395031|NCT06105918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395032|NCT06099769|Mifepristone|mifepristone|mesh-list
154395033|NCT06099769|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154395034|NCT06099769|Abortifacient Agents|abortifacient agents|mesh-ancestor
154395035|NCT06099769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154395036|NCT06099769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395037|NCT06099769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154395038|NCT06099769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154395039|NCT06099769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154395040|NCT06099769|Contraceptive Agents|contraceptive agents|mesh-ancestor
154395041|NCT06099769|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154395042|NCT06099769|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154395043|NCT06099769|Hormone Antagonists|hormone antagonists|mesh-ancestor
154254183|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395044|NCT06099769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395045|NCT06099769|Luteolytic Agents|luteolytic agents|mesh-ancestor
154395046|NCT06099769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154395047|NCT06099769|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154395048|NCT06040268|Fluticasone|fluticasone|mesh-list
154395049|NCT06040268|Norflurane|norflurane|mesh-list
154395050|NCT06040268|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154395051|NCT06040268|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154129721|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
154129737|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
154395052|NCT06040268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395053|NCT06040268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154395054|NCT06040268|Autonomic Agents|autonomic agents|mesh-ancestor
154395055|NCT06040268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395056|NCT06040268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395057|NCT06040268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154395058|NCT06040268|Respiratory System Agents|respiratory system agents|mesh-ancestor
154395059|NCT06040268|Dermatologic Agents|dermatologic agents|mesh-ancestor
154395060|NCT06040268|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154395061|NCT06040268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154395062|NCT06040268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154395063|NCT06040268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154395064|NCT06040268|Adrenergic Agents|adrenergic agents|mesh-ancestor
154395065|NCT06040268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395066|NCT06040268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395067|NCT06040268|Glucocorticoids|glucocorticoids|mesh-ancestor
154395068|NCT06040268|Hormones|hormones|mesh-ancestor
154395069|NCT06040268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395070|NCT06040268|Sympathomimetics|sympathomimetics|mesh-ancestor
154395071|NCT06040268|Anesthetics|anesthetics|mesh-ancestor
154395072|NCT06040268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129758|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
154395074|NCT05950113|Cyclophosphamide|cyclophosphamide|mesh-list
154395075|NCT05950113|Fludarabine|fludarabine|mesh-list
154395076|NCT05950113|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154395077|NCT05950113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395078|NCT05950113|Immunologic Factors|immunologic factors|mesh-ancestor
154395079|NCT05950113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395080|NCT05950113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395081|NCT05950113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395082|NCT05950113|Alkylating Agents|alkylating agents|mesh-ancestor
154395083|NCT05950113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395084|NCT05950113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395085|NCT05950113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395086|NCT05950113|Antimetabolites|antimetabolites|mesh-ancestor
154395087|NCT05950113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154395088|NCT05950113|Antiviral Agents|antiviral agents|mesh-ancestor
154395089|NCT05950113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395090|NCT05859009|Propranolol|propranolol|mesh-list
154395091|NCT05859009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154395092|NCT05859009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154395093|NCT05859009|Adrenergic Agents|adrenergic agents|mesh-ancestor
154395094|NCT05859009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395095|NCT05859009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395096|NCT05859009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395097|NCT05859009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154395098|NCT05859009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154395099|NCT05859009|Vasodilator Agents|vasodilator agents|mesh-ancestor
154395100|NCT05849129|Ascorbic Acid|ascorbic acid|mesh-list
154395101|NCT05849129|Vitamins|vitamins|mesh-ancestor
154395102|NCT05849129|Micronutrients|micronutrients|mesh-ancestor
154129759|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395103|NCT05849129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395104|NCT05849129|Antioxidants|antioxidants|mesh-ancestor
154395105|NCT05849129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395106|NCT05849129|Protective Agents|protective agents|mesh-ancestor
154395107|NCT05846659|Pembrolizumab|pembrolizumab|mesh-list
154395108|NCT05846659|Nivolumab|nivolumab|mesh-list
154395109|NCT05846659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154395110|NCT05846659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395111|NCT05846659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395112|NCT05846659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395113|NCT05776927|Fluticasone|fluticasone|mesh-list
154395114|NCT05776927|Xhance|xhance|mesh-list
154395115|NCT05776927|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154395116|NCT05776927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395117|NCT05776927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154395118|NCT05776927|Autonomic Agents|autonomic agents|mesh-ancestor
154395119|NCT05776927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395120|NCT05776927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395121|NCT05776927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154395122|NCT05776927|Respiratory System Agents|respiratory system agents|mesh-ancestor
154395123|NCT05776927|Dermatologic Agents|dermatologic agents|mesh-ancestor
154395124|NCT05776927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154395125|NCT05776927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154395126|NCT05776927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154395127|NCT05776927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154395128|NCT05776927|Adrenergic Agents|adrenergic agents|mesh-ancestor
154395129|NCT05776927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395130|NCT05776927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395131|NCT05714345|Cyclophosphamide|cyclophosphamide|mesh-list
154395132|NCT05714345|Fludarabine|fludarabine|mesh-list
154395133|NCT05714345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395134|NCT05714345|Immunologic Factors|immunologic factors|mesh-ancestor
154395135|NCT05714345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395136|NCT05714345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395137|NCT05714345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395138|NCT05714345|Alkylating Agents|alkylating agents|mesh-ancestor
154395139|NCT05714345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395140|NCT05714345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395141|NCT05714345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395142|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154395143|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154395144|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
154395145|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395146|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154395147|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395148|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154395149|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395150|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154395151|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154395152|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
154395153|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395154|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154395155|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395156|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154395157|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395158|NCT05676931|Docetaxel|docetaxel|mesh-list
154395159|NCT05676931|Quemliclustat|quemliclustat|mesh-list
154395160|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395161|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
154395162|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
154395163|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154395164|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395165|NCT05676931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154395166|NCT05676931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395167|NCT05662943|Aflibercept|aflibercept|mesh-list
154129824|NCT00652028|Midazolam|midazolam|mesh-list
154395168|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154395169|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154395170|NCT05662943|Growth Substances|growth substances|mesh-ancestor
154395171|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395172|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
154395173|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395174|NCT05659381|Cisplatin|cisplatin|mesh-list
154395175|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395176|NCT05614648|Clonidine|clonidine|mesh-list
154395177|NCT05614648|Analgesics|analgesics|mesh-ancestor
154395178|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
154395179|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395180|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395181|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154395182|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
154395183|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
154395184|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154129861|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
154129873|NCT00733421|Tramadol|tramadol|mesh-list
154395185|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154395186|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154395187|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
154395188|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395189|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395190|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
154395191|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395192|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395193|NCT05613413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154395194|NCT05613413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395195|NCT05577364|Prednisone|prednisone|mesh-list
154395196|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
154395197|NCT05577364|Doxorubicin|doxorubicin|mesh-list
154395198|NCT05577364|Vincristine|vincristine|mesh-list
154129875|NCT00733421|Narcotics|narcotics|mesh-ancestor
154129886|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154395199|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395200|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
154395201|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395202|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395203|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395204|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
154395205|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395206|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395207|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395208|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154395209|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154395210|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154395211|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395212|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395213|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
154395214|NCT05577364|Hormones|hormones|mesh-ancestor
154395215|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395216|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154395217|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154395218|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
154395219|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
154395220|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
154395221|NCT05548426|Linezolid|linezolid|mesh-list
154395222|NCT05548426|Penicillins|penicillins|mesh-list
154395223|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154395224|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395225|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154395226|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395227|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129917|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
154129919|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395228|NCT05534529|Rezafungin|rezafungin|mesh-list
154395229|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
154395230|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395231|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
154395232|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
154395233|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395234|NCT05514197|Protective Agents|protective agents|mesh-ancestor
154395235|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395236|NCT05514197|Vitamins|vitamins|mesh-ancestor
154395237|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
154395238|NCT05513313|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154395239|NCT05513313|Antiviral Agents|antiviral agents|mesh-ancestor
154395240|NCT05513313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395241|NCT05511909|Lofexidine|lofexidine|mesh-list
154395242|NCT05511909|Buspirone|buspirone|mesh-list
154395243|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154395244|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154395245|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154395246|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395247|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154395248|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154395249|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
154129938|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154395250|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129939|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
154395251|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395252|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154395253|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154395254|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
154395255|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395256|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154395257|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154395258|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154395259|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
154395260|NCT05496075|Orlistat|orlistat|mesh-list
154395261|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395262|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395263|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154254186|NCT04939636|Vitamin D|vitamin d|mesh-list
154395264|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154395265|NCT05493735|Lidocaine|lidocaine|mesh-list
154395266|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
154395267|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
154395268|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154395269|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395270|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
154395271|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395272|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154129940|NCT00810524|Lamivudine|lamivudine|mesh-list
154129960|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154395273|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154395274|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154395275|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154395276|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395277|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
154395278|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
154395279|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154395280|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154395281|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395282|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
154395283|NCT05474027|Coagulants|coagulants|mesh-ancestor
154395284|NCT05443178|Isoniazid|isoniazid|mesh-list
154395285|NCT05443178|Ethambutol|ethambutol|mesh-list
154395286|NCT05443178|Chloroquine|chloroquine|mesh-list
154395287|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
154395288|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154395289|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395290|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395291|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154395292|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154395293|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
154395294|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154395296|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154395297|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154395298|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
154395299|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395300|NCT05432466|Celiprolol|celiprolol|mesh-list
154395301|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154129990|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395302|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154395303|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
154395304|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
154395305|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395306|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395307|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
154395308|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154395309|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154395310|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154395311|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
154395312|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395313|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395314|NCT05403749|Aflibercept|aflibercept|mesh-list
154395315|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154395316|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154395317|NCT05403749|Growth Substances|growth substances|mesh-ancestor
154395318|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395319|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
154395320|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395321|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
154395322|NCT05400122|Fludarabine|fludarabine|mesh-list
154395323|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
154395324|NCT05400122|Vactosertib|vactosertib|mesh-list
154395325|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395326|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
154395327|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395328|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395329|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395330|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
154395331|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395332|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395333|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395334|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154395335|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
154395336|NCT05400122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154395337|NCT05400122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395338|NCT05395104|Cefiderocol|cefiderocol|mesh-list
154395339|NCT05395104|Midazolam|midazolam|mesh-list
154395340|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154395341|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154395342|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154395343|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395344|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154130015|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395345|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154395346|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154395347|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154395348|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
154395349|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
154395350|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
154395351|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
154395352|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395353|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395354|NCT05395104|Siderophores|siderophores|mesh-ancestor
154395355|NCT05395104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154395356|NCT05395104|Chelating Agents|chelating agents|mesh-ancestor
154395357|NCT05395104|Sequestering Agents|sequestering agents|mesh-ancestor
154395358|NCT05395104|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154395359|NCT05395104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154395360|NCT05395104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130050|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154395361|NCT05389462|Gemcitabine|gemcitabine|mesh-list
154395362|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154395363|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
154395364|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395365|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395366|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
154395367|NCT05380713|Durvalumab|durvalumab|mesh-list
154395368|NCT05380713|Tremelimumab|tremelimumab|mesh-list
154174438|NCT01003002|Levodopa|levodopa|mesh-list
154395369|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395370|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
154395371|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395372|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395373|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395374|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
154395375|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395376|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395377|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395378|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395379|NCT05351788|Carboplatin|carboplatin|mesh-list
154395380|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395381|NCT05327491|Sotorasib|sotorasib|mesh-list
154395382|NCT05327491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154395383|NCT05327491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395384|NCT05327491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395385|NCT05327491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395386|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
154395387|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154395388|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154395389|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395390|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
154395391|NCT05321199|Coagulants|coagulants|mesh-ancestor
154395392|NCT05300282|Gemcitabine|gemcitabine|mesh-list
154395393|NCT05300282|Atezolizumab|atezolizumab|mesh-list
154395394|NCT05300282|Vinorelbine|vinorelbine|mesh-list
154395395|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154395396|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154395397|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
154395398|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395399|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395400|NCT05300282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154395401|NCT05300282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395402|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154395403|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
154395404|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
154395405|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
154395406|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395407|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
154130095|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395408|NCT05281276|Celecoxib|celecoxib|mesh-list
154395409|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154395410|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154395411|NCT05281276|Analgesics|analgesics|mesh-ancestor
154395413|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395414|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395415|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395416|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395417|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154395418|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154395419|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395420|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395421|NCT05280769|Lobeline|lobeline|mesh-list
154395422|NCT05280769|Nicotine|nicotine|mesh-list
154395423|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154395424|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
154395425|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395426|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395427|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154395428|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154395429|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
154395430|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395431|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395432|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
154395433|NCT05279040|Ivacaftor|ivacaftor|mesh-list
154395434|NCT05279040|Elexacaftor|elexacaftor|mesh-list
154395435|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154395436|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154395437|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395438|NCT05269628|Dronabinol|dronabinol|mesh-list
154395439|NCT05269628|Cannabidiol|cannabidiol|mesh-list
154395440|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
154395441|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
154395442|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395443|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154395444|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154395445|NCT05269628|Analgesics|analgesics|mesh-ancestor
154130132|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
154395446|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
154395447|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395448|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154395449|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154395450|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395451|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395452|NCT05269628|Hormones|hormones|mesh-ancestor
154395453|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395454|NCT05261490|Doxorubicin|doxorubicin|mesh-list
154395455|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154395456|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154395457|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395458|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154395459|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154395460|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395461|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395462|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
154395463|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154395464|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395465|NCT05183737|Propolis|propolis|mesh-list
154395466|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395467|NCT05180799|Pembrolizumab|pembrolizumab|mesh-list
154395468|NCT05180799|Nivolumab|nivolumab|mesh-list
154395469|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395470|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395471|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154130140|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
154395472|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395473|NCT05154487|Fulvestrant|fulvestrant|mesh-list
154395474|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154395475|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395476|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154395477|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154395478|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
154395479|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395480|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395481|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154395482|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154395483|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154395485|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395486|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395487|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395488|NCT05086393|Analgesics|analgesics|mesh-ancestor
154395489|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
154395490|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395491|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
154395492|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154395493|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
154395494|NCT05068791|Levomethorphan|levomethorphan|mesh-list
154395495|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
154395496|NCT05068791|Psilocybin|psilocybin|mesh-list
154395497|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
154395498|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395499|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154395500|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
154395501|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
154395502|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154395503|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154395504|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395505|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395506|NCT05068791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154395507|NCT05068791|Narcotics|narcotics|mesh-ancestor
154395508|NCT05068791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154395509|NCT05068791|Analgesics|analgesics|mesh-ancestor
154395510|NCT05068791|Sensory System Agents|sensory system agents|mesh-ancestor
154395511|NCT05068791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395512|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
154395513|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154395514|NCT04983940|Testosterone|testosterone|mesh-list
154395515|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
154395516|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
154395517|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154395518|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395519|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
154395520|NCT04983940|Hormones|hormones|mesh-ancestor
154395521|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395522|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395523|NCT04983940|Androgens|androgens|mesh-ancestor
154395524|NCT04979806|Meropenem|meropenem|mesh-list
154395525|NCT04979806|Cefepime|cefepime|mesh-list
154395526|NCT04979806|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
154395527|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154395528|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395529|NCT04958122|Penicillins|penicillins|mesh-list
154395530|NCT04958122|Cefixime|cefixime|mesh-list
154395531|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154395532|NCT04958122|Penicillin G|penicillin g|mesh-list
154395533|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
154395534|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154395535|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395536|NCT04958122|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154395537|NCT04958122|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154395538|NCT04951492|Olaparib|olaparib|mesh-list
154395539|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154395540|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395541|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395542|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395543|NCT04927975|Upadacitinib|upadacitinib|mesh-list
154395544|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154395545|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154395546|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395547|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395548|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395549|NCT04900038|Lamivudine|lamivudine|mesh-list
154395550|NCT04900038|Dolutegravir|dolutegravir|mesh-list
154395551|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154395552|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154395553|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395554|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395555|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
154395556|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395557|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154395558|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154395559|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154395560|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154395561|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
154395562|NCT04880434|Fludarabine|fludarabine|mesh-list
154395563|NCT04880434|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154395564|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395565|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
154395566|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395567|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395568|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395569|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
154395570|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395571|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395572|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395573|NCT04880434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395574|NCT04850599|Pomalidomide|pomalidomide|mesh-list
154395575|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154395576|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
154395577|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395578|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154395579|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154395580|NCT04850599|Growth Substances|growth substances|mesh-ancestor
154395581|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
154395582|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395583|NCT04824638|Vaccines|vaccines|mesh-list
154395584|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
154395585|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395586|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
154395587|NCT04784052|Rituximab|rituximab|mesh-list
154395588|NCT04784052|Fludarabine|fludarabine|mesh-list
154395589|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
154395590|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154395591|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395592|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
154395593|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395594|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395595|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395596|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
154395597|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130235|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
154395598|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395599|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395600|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395601|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
154395602|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154395603|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
154395604|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395605|NCT04685590|Dasatinib|dasatinib|mesh-list
154395606|NCT04685590|Quercetin|quercetin|mesh-list
154395607|NCT04685590|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154395608|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154395609|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395610|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395611|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395612|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
154395613|NCT04685590|Protective Agents|protective agents|mesh-ancestor
154395614|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395615|NCT04648202|Pembrolizumab|pembrolizumab|mesh-list
154395616|NCT04648202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395617|NCT04648202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395618|NCT04648202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154395619|NCT04648202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395620|NCT04631484|Niacinamide|niacinamide|mesh-list
154395622|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
154395623|NCT04631484|Riboflavin|riboflavin|mesh-list
154395624|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
154395625|NCT04631484|Vitamins|vitamins|mesh-ancestor
154395626|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
154395627|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395628|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154395629|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
154395630|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395631|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154395632|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
154395633|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154130289|NCT00875784|Sumatriptan|sumatriptan|mesh-list
154395634|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
154395635|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
154395636|NCT04578535|Antibodies|antibodies|mesh-list
154395637|NCT04578535|gamma-Globulins|gamma-globulins|mesh-list
154395638|NCT04578535|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154395639|NCT04578535|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154395640|NCT04578535|Immunoglobulin G|immunoglobulin g|mesh-list
154395641|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
154395642|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395643|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
154395644|NCT04566887|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154395645|NCT04566887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154395646|NCT04566887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395647|NCT04566887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395648|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395649|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
154395650|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154395651|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395652|NCT04551521|Trastuzumab|trastuzumab|mesh-list
154395653|NCT04551521|Atezolizumab|atezolizumab|mesh-list
154395654|NCT04551521|Pertuzumab|pertuzumab|mesh-list
154395655|NCT04551521|Vemurafenib|vemurafenib|mesh-list
154395656|NCT04551521|Ipatasertib|ipatasertib|mesh-list
154395657|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154395658|NCT04551521|Alectinib|alectinib|mesh-list
154395659|NCT04551521|Inavolisib|inavolisib|mesh-list
154395660|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395661|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395662|NCT04551521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154395663|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395664|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
154395665|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395666|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154395667|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395668|NCT04551521|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154395669|NCT04551521|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154395670|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
154395671|NCT04545762|Fludarabine|fludarabine|mesh-list
154395672|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
154395673|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395674|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
154395675|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395676|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395677|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395678|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
154395679|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395680|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395681|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395682|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154395683|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
154395684|NCT04522973|Ethanol|ethanol|mesh-list
154395685|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154395686|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395687|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154395688|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395689|NCT04470908|Rifabutin|rifabutin|mesh-list
154395690|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
154395691|NCT04470908|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154395692|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154395693|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395694|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395695|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395696|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154395697|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395698|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154395699|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
154395700|NCT04439149|GSK2636771|gsk2636771|mesh-list
154395701|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395702|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154395703|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130392|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395704|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395705|NCT04419766|ethyl-3-(N-n-butyl-N-acetyl)aminopropionate|ethyl-3-(n-n-butyl-n-acetyl)aminopropionate|mesh-list
154395706|NCT04419766|Insect Repellents|insect repellents|mesh-ancestor
154395707|NCT04419766|Protective Agents|protective agents|mesh-ancestor
154395708|NCT04419766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395709|NCT04416633|Durvalumab|durvalumab|mesh-list
154395710|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395711|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395712|NCT04413266|Curcumin|curcumin|mesh-list
154395713|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154395714|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154395715|NCT04413266|Analgesics|analgesics|mesh-ancestor
154395716|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
154395717|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395718|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395719|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395720|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395721|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395722|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395723|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395724|NCT04337970|Axitinib|axitinib|mesh-list
154395725|NCT04337970|Talazoparib|talazoparib|mesh-list
154395726|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395727|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154395728|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395729|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395730|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154395731|NCT04318080|Tislelizumab|tislelizumab|mesh-list
154395732|NCT04318080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395733|NCT04318080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395734|NCT04254549|Rifaximin|rifaximin|mesh-list
154395735|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154395736|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395737|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154395738|NCT04227288|Betamethasone|betamethasone|mesh-list
154395739|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
154395740|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154395741|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
154395742|NCT04227288|Calcipotriene|calcipotriene|mesh-list
154395743|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154395744|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395745|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
154395747|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154130411|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
154395748|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395749|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154395750|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154395751|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
154395752|NCT04134091|Tocopherols|tocopherols|mesh-list
154395753|NCT04134091|alpha-Tocopherol|alpha-tocopherol|mesh-list
154395754|NCT04134091|Methyltestosterone|methyltestosterone|mesh-list
154395755|NCT04134091|Testosterone|testosterone|mesh-list
154395756|NCT04134091|Testosterone undecanoate|testosterone undecanoate|mesh-list
154395757|NCT04134091|Testosterone enanthate|testosterone enanthate|mesh-list
154395758|NCT04134091|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154395759|NCT04134091|Androgens|androgens|mesh-ancestor
154395760|NCT04134091|Hormones|hormones|mesh-ancestor
154395761|NCT04134091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395762|NCT04134091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395763|NCT04134091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154395764|NCT04134091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395765|NCT04134091|Anabolic Agents|anabolic agents|mesh-ancestor
154395766|NCT04134091|Antioxidants|antioxidants|mesh-ancestor
154395767|NCT04134091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395768|NCT04134091|Protective Agents|protective agents|mesh-ancestor
154395769|NCT04134091|Vitamins|vitamins|mesh-ancestor
154395770|NCT04134091|Micronutrients|micronutrients|mesh-ancestor
154395771|NCT04115644|Triamcinolone|triamcinolone|mesh-list
154395772|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154395773|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154395774|NCT04115644|Ketorolac|ketorolac|mesh-list
154395775|NCT04115644|Bupivacaine|bupivacaine|mesh-list
154395776|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154395777|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
154395778|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
154395779|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154395780|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395781|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
154130436|NCT02541708|Vitamins|vitamins|mesh-ancestor
154395782|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395783|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395784|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
154395785|NCT04115644|Hormones|hormones|mesh-ancestor
154395786|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395787|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395788|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
154395789|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395790|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395791|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154395792|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154395793|NCT04115644|Analgesics|analgesics|mesh-ancestor
154395794|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395795|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154395796|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154395797|NCT04113382|Laxatives|laxatives|mesh-ancestor
154395798|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154395799|NCT04078568|Aspirin|aspirin|mesh-list
154395800|NCT04078568|Prednisolone|prednisolone|mesh-list
154395801|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
154395802|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154395803|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
154395804|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154395805|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154395806|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154395807|NCT04078568|Analgesics|analgesics|mesh-ancestor
154395808|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
154395809|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395810|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395811|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395812|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395813|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154395814|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154395815|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395816|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154395817|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154395818|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130509|NCT00886002|Buprenorphine|buprenorphine|mesh-list
154395819|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
154395820|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
154395821|NCT04078568|Hormones|hormones|mesh-ancestor
154395822|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395823|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154395824|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395825|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
154395826|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154395827|NCT04057456|Nabilone|nabilone|mesh-list
154395828|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
154395829|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
154395830|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395831|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395832|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154395833|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154395834|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154395835|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154395836|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154395837|NCT04010539|Azithromycin|azithromycin|mesh-list
154395838|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
154395839|NCT04010539|Gepotidacin|gepotidacin|mesh-list
154395840|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154395841|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154395842|NCT04010539|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154395843|NCT04010539|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154395844|NCT04010539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154395845|NCT04010539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395846|NCT04010539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395847|NCT04010539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395848|NCT03977194|Paclitaxel|paclitaxel|mesh-list
154395849|NCT03977194|Carboplatin|carboplatin|mesh-list
154395850|NCT03977194|Atezolizumab|atezolizumab|mesh-list
154395851|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154395852|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395853|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
154395854|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
154395855|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
154395856|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395857|NCT03977194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154395858|NCT03977194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395859|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
154395860|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154395861|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154395862|NCT03942887|Prednisolone|prednisolone|mesh-list
154395863|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
153754668|NCT04392037|Hormones|hormones|mesh-ancestor
154395864|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
154395865|NCT03942887|Rituximab|rituximab|mesh-list
154395866|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154395867|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
154395868|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154395869|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
154395870|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395871|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395872|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395873|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
154395874|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395875|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395876|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154395877|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395878|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395879|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
154395880|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
154395881|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395882|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154395883|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
154395884|NCT03942887|Hormones|hormones|mesh-ancestor
154395885|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154395886|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154395887|NCT03942887|Protective Agents|protective agents|mesh-ancestor
154395888|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154395889|NCT03831503|Antibodies|antibodies|mesh-list
154395890|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
154395891|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395892|NCT03785405|Valsartan|valsartan|mesh-list
154395893|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154395894|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154130571|NCT00612534|Dsuvia|dsuvia|mesh-list
154395895|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154174949|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
154395896|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154395897|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395898|NCT03673462|Vaccines|vaccines|mesh-list
154395899|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
154395900|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395901|NCT03522831|Albuterol|albuterol|mesh-list
154395902|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154395903|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
154395904|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395905|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395906|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154395907|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
154395908|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
154395909|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154395910|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154395911|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154395912|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154395913|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
154395914|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395915|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395916|NCT03464292|Capsaicin|capsaicin|mesh-list
154395917|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
154395918|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
154395919|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
154395920|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395921|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395922|NCT03348969|Mitomycins|mitomycins|mesh-list
154395923|NCT03348969|Mitomycin|mitomycin|mesh-list
154395924|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154395925|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395926|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
154395927|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130582|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
154395928|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154395929|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395930|NCT03307785|Paclitaxel|paclitaxel|mesh-list
154395931|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154395932|NCT03307785|Bevacizumab|bevacizumab|mesh-list
154395933|NCT03307785|Carboplatin|carboplatin|mesh-list
154395934|NCT03307785|Pemetrexed|pemetrexed|mesh-list
154395935|NCT03307785|Niraparib|niraparib|mesh-list
154395936|NCT03307785|Dostarlimab|dostarlimab|mesh-list
154395937|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154395938|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395939|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
154395940|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
154395941|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
154395942|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395943|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395944|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154395945|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154395946|NCT03307785|Growth Substances|growth substances|mesh-ancestor
154395947|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395948|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
154395949|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395950|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154395951|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154395952|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154395953|NCT03199040|Durvalumab|durvalumab|mesh-list
154395954|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154395955|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395956|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
154395957|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154395958|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154395959|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154395960|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154395961|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395962|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
154395963|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154395964|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395965|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154395966|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395967|NCT03159897|Doxorubicin|doxorubicin|mesh-list
154395968|NCT03159897|Bleomycin|bleomycin|mesh-list
154175022|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154175025|NCT04374461|Expectorants|expectorants|mesh-ancestor
154395969|NCT03159897|Dacarbazine|dacarbazine|mesh-list
154395970|NCT03159897|Vinblastine|vinblastine|mesh-list
154395971|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154395972|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154395973|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154395974|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154395975|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395976|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395977|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154395978|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
154395979|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154395980|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
154395981|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
154395982|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
154395983|NCT03079999|Aspirin|aspirin|mesh-list
154395984|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154395985|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154395986|NCT03079999|Analgesics|analgesics|mesh-ancestor
154395987|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
154395988|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154395989|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154395990|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154395991|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154395992|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154395993|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154395994|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154395995|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154395996|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154395997|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154395998|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
154396000|NCT02879409|Metformin|metformin|mesh-list
154396001|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
154396002|NCT02879409|Pioglitazone|pioglitazone|mesh-list
154396003|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154396004|NCT02879409|Liraglutide|liraglutide|mesh-list
154396005|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154396006|NCT02879409|Gliclazide|gliclazide|mesh-list
154396007|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154396008|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396009|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154396010|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396011|NCT02879409|Incretins|incretins|mesh-ancestor
154396012|NCT02879409|Hormones|hormones|mesh-ancestor
154396013|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396014|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154396015|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
154396016|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396017|NCT02879409|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154396018|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154396019|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154396020|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396021|NCT02621398|Paclitaxel|paclitaxel|mesh-list
154396022|NCT02621398|Carboplatin|carboplatin|mesh-list
154396023|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
154396024|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154396025|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154396026|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396027|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
154396028|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
154396029|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
154396030|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396031|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396032|NCT02621398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154396033|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154396034|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154396035|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396036|NCT02427620|Cytarabine|cytarabine|mesh-list
154396037|NCT02427620|Dexamethasone|dexamethasone|mesh-list
154396038|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
154396039|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
154396040|NCT02427620|Rituximab|rituximab|mesh-list
154396041|NCT02427620|Doxorubicin|doxorubicin|mesh-list
154396042|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154396043|NCT02427620|Methotrexate|methotrexate|mesh-list
154396044|NCT02427620|Vincristine|vincristine|mesh-list
154175097|NCT04118387|Diuretics|diuretics|mesh-ancestor
154396045|NCT02427620|Daunorubicin|daunorubicin|mesh-list
154396046|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154396047|NCT02427620|Antibodies|antibodies|mesh-list
154396048|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
154396049|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154396050|NCT02427620|BB 1101|bb 1101|mesh-list
154396051|NCT02427620|Ibrutinib|ibrutinib|mesh-list
154396052|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154396053|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
154396054|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396055|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396056|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154396057|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
154396058|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396059|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396060|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154396061|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154396062|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
154396063|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
154396064|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396065|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154396066|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
154396067|NCT02427620|Hormones|hormones|mesh-ancestor
154396068|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396069|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154396070|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
154396071|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396072|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154396073|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154396074|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154396075|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154396076|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
154396077|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154396078|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154396079|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
154396080|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
154396081|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154396082|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154396083|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
154396084|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396085|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154396086|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
154396087|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
154396088|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
154396089|NCT02427620|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154396090|NCT02427620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396092|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
154396093|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154396094|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154396095|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154396096|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396097|NCT01837277|Efavirenz|efavirenz|mesh-list
154396098|NCT01837277|Dolutegravir|dolutegravir|mesh-list
154396099|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154396100|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154396101|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396102|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396103|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
154396104|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396105|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154396106|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154396107|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154396108|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154396109|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154396110|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154396111|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154396112|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154396113|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154396114|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154396115|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154396116|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396117|NCT01658878|Nivolumab|nivolumab|mesh-list
154396118|NCT01658878|Ipilimumab|ipilimumab|mesh-list
154396120|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396121|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396122|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154396123|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396124|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396125|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396126|NCT01624285|Sorafenib|sorafenib|mesh-list
154396127|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396128|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396129|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396130|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396131|NCT01523002|Artesunate|artesunate|mesh-list
154396132|NCT01523002|Pyronaridine|pyronaridine|mesh-list
154396133|NCT01523002|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154396134|NCT01523002|Metoprolol|metoprolol|mesh-list
154396135|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154396136|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154396137|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
154396138|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
154396139|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396140|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396141|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154396142|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154396143|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154396144|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
154396145|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396146|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396148|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154396149|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154396150|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396151|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396152|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
154396153|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
154396154|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154396155|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
154396156|NCT01471106|Dasatinib|dasatinib|mesh-list
154396157|NCT01471106|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154396158|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396159|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396160|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396161|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396162|NCT00489307|Dexamethasone|dexamethasone|mesh-list
154396163|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154396164|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
154396165|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
154396166|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396167|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396168|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154396169|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
154396170|NCT00489307|Hormones|hormones|mesh-ancestor
154396171|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396172|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154396173|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396174|NCT00349310|Pramipexole|pramipexole|mesh-list
154396175|NCT00349310|Dexpramipexole|dexpramipexole|mesh-list
154396176|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
154396177|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396178|NCT00349310|Protective Agents|protective agents|mesh-ancestor
154396179|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396180|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154396181|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154396182|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
154396183|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
154396184|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396185|NCT00267917|Fenoterol|fenoterol|mesh-list
154396186|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154396187|NCT00267917|Ipratropium|ipratropium|mesh-list
154396188|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154396189|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
154396190|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396191|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396192|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154175296|NCT03039413|Copper|copper|mesh-list
154396193|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
154396194|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
154396195|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
154396196|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154396197|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154396198|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154396199|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154396200|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
154396201|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396202|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396203|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154396204|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
154396205|NCT00171002|Amlodipine|amlodipine|mesh-list
154396206|NCT00171002|Valsartan|valsartan|mesh-list
154396207|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154396208|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154396209|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154396210|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396211|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154396212|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396213|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
154396214|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154396215|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154396216|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
154396217|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
153742016|NCT02952157|Lidocaine|lidocaine|mesh-list
154396218|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154396219|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154396220|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154396221|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365876|NCT02449902|Hormones|hormones|mesh-ancestor
154396222|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154396223|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154396224|NCT03521141|Nicotine|nicotine|mesh-list
154396225|NCT03521141|Varenicline|varenicline|mesh-list
154396226|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154396227|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
154396228|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396229|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396230|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154396231|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154396232|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
154396233|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396234|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396235|NCT03725267|Melatonin|melatonin|mesh-list
154396236|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
154396237|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396238|NCT03725267|Protective Agents|protective agents|mesh-ancestor
154396239|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396240|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396241|NCT02997176|Talazoparib|talazoparib|mesh-list
154396242|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154396243|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396244|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396245|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396246|NCT03000452|Durvalumab|durvalumab|mesh-list
154396247|NCT03000452|Daratumumab|daratumumab|mesh-list
154396248|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396249|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396250|NCT03664388|Clopidogrel|clopidogrel|mesh-list
154396251|NCT03664388|Ticagrelor|ticagrelor|mesh-list
154396252|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154396253|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154396254|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154396255|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154396256|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
154396257|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396258|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396259|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396260|NCT01373164|Gemcitabine|gemcitabine|mesh-list
154396261|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154396262|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
154396263|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396264|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396265|NCT02999984|Busulfan|busulfan|mesh-list
154396266|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
154396267|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396268|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154396269|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
154396270|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396271|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154396272|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396273|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154396274|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154396275|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
154396276|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396277|NCT03312907|Rituximab|rituximab|mesh-list
154396278|NCT03312907|Belimumab|belimumab|mesh-list
154254207|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
154396279|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154396280|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396281|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396282|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
154396283|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396284|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396285|NCT02999672|Trastuzumab|trastuzumab|mesh-list
154396286|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154396287|NCT02999672|Maytansine|maytansine|mesh-list
154396288|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396289|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396290|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154396291|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
154396292|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
154396293|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
154396294|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396295|NCT02999672|Immunotoxins|immunotoxins|mesh-ancestor
154396296|NCT02999672|Immunoconjugates|immunoconjugates|mesh-ancestor
154396297|NCT02999672|Immunologic Factors|immunologic factors|mesh-ancestor
154396298|NCT02999672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396299|NCT03664622|Ketamine|ketamine|mesh-list
154396300|NCT03664622|Morphine|morphine|mesh-list
154396301|NCT03664622|Analgesics|analgesics|mesh-ancestor
154396302|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
154396303|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396304|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396305|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154396306|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154396307|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
154396308|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
154396309|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396310|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154396311|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154396312|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396313|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396314|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154396315|NCT03664622|Narcotics|narcotics|mesh-ancestor
154396316|NCT04056182|Lofexidine|lofexidine|mesh-list
154396317|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154396318|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154396319|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396320|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
154396321|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396322|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154396323|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154396324|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154396325|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
154396326|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396327|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396328|NCT03573323|Ixekizumab|ixekizumab|mesh-list
154396329|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
154396330|NCT04058054|Biafine|biafine|mesh-list
154396331|NCT04058054|Histamine|histamine|mesh-list
154396332|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
154396333|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
154396334|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396335|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396336|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396337|NCT04058054|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154396338|NCT04058054|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154396339|NCT04058054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154396340|NCT04498286|Antibodies|antibodies|mesh-list
154396341|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
154396342|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396343|NCT01069172|Dipivefrin|dipivefrin|mesh-list
154396344|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154396345|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
154396346|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396347|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396348|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396349|NCT03724955|Estradiol|estradiol|mesh-list
154396350|NCT03724955|Estrogens|estrogens|mesh-ancestor
154396351|NCT03724955|Hormones|hormones|mesh-ancestor
154396352|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396353|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396354|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
154396355|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
154396356|NCT04220008|Busulfan|busulfan|mesh-list
154396357|NCT04220008|Rituximab|rituximab|mesh-list
154396358|NCT04220008|Gemcitabine|gemcitabine|mesh-list
154396359|NCT04220008|Vorinostat|vorinostat|mesh-list
154396360|NCT04220008|Clofarabine|clofarabine|mesh-list
154396361|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154396362|NCT04220008|Tacrolimus|tacrolimus|mesh-list
154396363|NCT04220008|Antibodies|antibodies|mesh-list
154396364|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
154396365|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154396366|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154396367|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
154396368|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396369|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396370|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154396371|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
154396372|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396373|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396374|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154396375|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154396376|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
154396377|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154396378|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396379|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154396380|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154396381|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
154396382|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154396383|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396384|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154396385|NCT03721991|Butyric Acid|butyric acid|mesh-list
154396386|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396387|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396388|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396389|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
154396390|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
154396391|NCT02911688|Vitamin E|vitamin e|mesh-list
154396392|NCT02911688|Tocopherols|tocopherols|mesh-list
154396393|NCT02911688|Tocotrienols|tocotrienols|mesh-list
154396394|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
154396395|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
154396396|NCT02911688|Vitamins|vitamins|mesh-ancestor
154396397|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
154396398|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396399|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
154396400|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396401|NCT02911688|Protective Agents|protective agents|mesh-ancestor
154396402|NCT05580250|Metformin|metformin|mesh-list
154396403|NCT05580250|Simvastatin|simvastatin|mesh-list
154396404|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154396405|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396406|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154396407|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154396408|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
154396409|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396410|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154396411|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154396412|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396413|NCT03431948|Nivolumab|nivolumab|mesh-list
154396414|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396415|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175475|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
154396416|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153973731|NCT06248229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154396417|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396418|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
154396419|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154396420|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
154396421|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
154396422|NCT03662516|Estradiol|estradiol|mesh-list
154396423|NCT03662516|Abrocitinib|abrocitinib|mesh-list
154396424|NCT03662516|Estrogens|estrogens|mesh-ancestor
154396426|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396427|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396428|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154396429|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154396430|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154396431|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154396432|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154396433|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396434|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396435|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396436|NCT03728465|Nivolumab|nivolumab|mesh-list
154396437|NCT03728465|Ipilimumab|ipilimumab|mesh-list
154396438|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396439|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396440|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154396441|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131099|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
154396442|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
154396443|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154396444|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
154396445|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396446|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154396447|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
154396448|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154396449|NCT02994056|Velpatasvir|velpatasvir|mesh-list
154396450|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
154396451|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396452|NCT03728153|Fluoxetine|fluoxetine|mesh-list
154396453|NCT03728153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154396454|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154396455|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154396456|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396457|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396458|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
154396459|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396460|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154396461|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
154396462|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154396463|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154396464|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154396465|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396466|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
154396467|NCT04056806|Terlipressin|terlipressin|mesh-list
154396468|NCT04056806|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154396469|NCT04056806|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154396470|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154396471|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396472|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154396473|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154396474|NCT03305575|Bupivacaine|bupivacaine|mesh-list
154396475|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
154396476|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
154396477|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
154396478|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396479|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396480|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
154396481|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396482|NCT02993822|Maleic acid|maleic acid|mesh-list
154396483|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396484|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396485|NCT02391844|Oxycodone|oxycodone|mesh-list
154396486|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154396487|NCT02391844|Narcotics|narcotics|mesh-ancestor
154396488|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396489|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396490|NCT02391844|Analgesics|analgesics|mesh-ancestor
154396491|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
154396492|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396493|NCT02391688|Fexofenadine|fexofenadine|mesh-list
154396494|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
154396495|NCT02391688|Midazolam|midazolam|mesh-list
154396496|NCT02391688|Levomethorphan|levomethorphan|mesh-list
154396497|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
154396498|NCT02391688|Caffeine|caffeine|mesh-list
154396500|NCT02391688|Omeprazole|omeprazole|mesh-list
154396501|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154396502|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154396503|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973744|NCT06248099|Adrenergic Agents|adrenergic agents|mesh-ancestor
154396504|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396505|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154396506|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154396507|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154396508|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154396509|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
154396510|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
154396511|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
154396512|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
154396513|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396514|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396515|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154396516|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154396517|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396518|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154396519|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154396520|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
154396521|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154396522|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154396523|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154396524|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154396525|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
154131176|NCT00642278|Canagliflozin|canagliflozin|mesh-list
154396526|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154396527|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154396528|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154396529|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
154396530|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154396531|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154396532|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
154396533|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
154396534|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154396535|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154396536|NCT02391688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154396537|NCT02391688|Narcotics|narcotics|mesh-ancestor
154396538|NCT02391688|Analgesics|analgesics|mesh-ancestor
154396539|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
154396540|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396541|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154396542|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154396543|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154396544|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396545|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154396546|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154131209|NCT00815048|Atropine|atropine|mesh-list
154396547|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154396548|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154396549|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
154396550|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
154396551|NCT01068860|Insulin|insulin|mesh-list
154396552|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154396553|NCT01068860|Metformin|metformin|mesh-list
154396554|NCT01068860|Glimepiride|glimepiride|mesh-list
154396555|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
154396556|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
154396557|NCT01068860|Glyburide|glyburide|mesh-list
154396558|NCT01068860|Glipizide|glipizide|mesh-list
154396559|NCT01068860|Troglitazone|troglitazone|mesh-list
154396560|NCT01068860|Tolbutamide|tolbutamide|mesh-list
154396561|NCT01068860|Acetohexamide|acetohexamide|mesh-list
154396562|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
154396563|NCT01068860|Tolazamide|tolazamide|mesh-list
154396564|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
154396565|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154396566|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154396567|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396568|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154396569|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154396570|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
154396571|NCT04056650|Caffeine|caffeine|mesh-list
154396572|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154396573|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254222|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
154131219|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396574|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154396575|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396576|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396577|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154396578|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154396579|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
154396580|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396582|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154396583|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
154396584|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
154396585|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154396586|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396587|NCT03158090|Octreotide|octreotide|mesh-list
154396588|NCT03158090|Lanreotide|lanreotide|mesh-list
154396589|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154396590|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154396591|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396592|NCT02670538|Cariprazine|cariprazine|mesh-list
154396593|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154396594|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154396595|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396596|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396597|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154396598|NCT03727763|Cetuximab|cetuximab|mesh-list
154396599|NCT03727763|Vemurafenib|vemurafenib|mesh-list
154396600|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396601|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396602|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396603|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396604|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396605|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154396606|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
154396607|NCT02991482|Gemcitabine|gemcitabine|mesh-list
154396608|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
154396609|NCT02991482|Vinorelbine|vinorelbine|mesh-list
154396610|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154396611|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
153368965|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396612|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396613|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396614|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154396615|NCT02991482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154396616|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154396617|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
154396618|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
154396619|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
154396620|NCT02391142|Lidocaine|lidocaine|mesh-list
154396621|NCT02391142|Ropivacaine|ropivacaine|mesh-list
154396622|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
154396623|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
154396624|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396625|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396626|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
154396627|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396628|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154396629|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154396630|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154396631|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154396632|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396633|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154396634|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
154396635|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396636|NCT04479202|Bentonite|bentonite|mesh-list
154396637|NCT04479202|Antidotes|antidotes|mesh-ancestor
154396638|NCT04479202|Protective Agents|protective agents|mesh-ancestor
154396639|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396640|NCT01372618|Pasireotide|pasireotide|mesh-list
154396641|NCT01372618|Hormones|hormones|mesh-ancestor
154396642|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396643|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396644|NCT03304873|Retapamulin|retapamulin|mesh-list
154396645|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154396646|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396647|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
154396648|NCT04526509|Fludarabine|fludarabine|mesh-list
154396650|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
154396651|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396652|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396653|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154396654|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
154396655|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396656|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396657|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154396658|NCT03660020|Anesthetics|anesthetics|mesh-list
154396659|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
154396660|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396661|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396662|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
154396663|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396664|NCT03661892|Dronabinol|dronabinol|mesh-list
154396665|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
154396666|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396667|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154396668|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154396669|NCT03661892|Analgesics|analgesics|mesh-ancestor
154396670|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
154396671|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396672|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154396673|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154396674|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396675|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396676|NCT03661892|Hormones|hormones|mesh-ancestor
154396677|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396678|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154396679|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154396680|NCT03658850|Diuretics|diuretics|mesh-ancestor
154396681|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
154396682|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396683|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154396684|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154396685|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396686|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
154396687|NCT03659162|Clotrimazole|clotrimazole|mesh-list
154396688|NCT03659162|Miconazole|miconazole|mesh-list
154396689|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396690|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154396691|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154396692|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154396693|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396694|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396695|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154396696|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
154396697|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396698|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396699|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154396700|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154396701|NCT03659084|Deferasirox|deferasirox|mesh-list
154396702|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154396703|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
154396704|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
154396705|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396706|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154396707|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154396708|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154396709|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
154396710|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396711|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154396712|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154396713|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396714|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154396715|NCT02921750|Laxatives|laxatives|mesh-ancestor
154396716|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154396717|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154396718|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396719|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
154396720|NCT03622502|Remifentanil|remifentanil|mesh-list
154396721|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154396722|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396723|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370437|NCT00364143|Irinotecan|irinotecan|mesh-list
154396724|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154396725|NCT03622502|Analgesics|analgesics|mesh-ancestor
154396726|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
154396727|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396728|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154396729|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154396730|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154396731|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
154396732|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396733|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396734|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154396735|NCT03622502|Narcotics|narcotics|mesh-ancestor
154396736|NCT04397354|Dexamethasone|dexamethasone|mesh-list
154396737|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
154396738|NCT04397354|BB 1101|bb 1101|mesh-list
154396739|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154396740|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
154396741|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
154396742|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396743|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396744|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154396745|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
154396746|NCT04397354|Hormones|hormones|mesh-ancestor
154396747|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396748|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154396749|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396750|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
154396751|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396752|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396753|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153370607|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370645|NCT01229228|Naproxen|naproxen|mesh-list
154396754|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154396755|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154396756|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
154396757|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396758|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154396759|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154396760|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396761|NCT01068158|Ivermectin|ivermectin|mesh-list
154396762|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154396763|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396764|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154396765|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
154396766|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396767|NCT01067846|Cycloserine|cycloserine|mesh-list
154396768|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154396769|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396770|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154396771|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
154396772|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154396773|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
154396774|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396775|NCT03874234|GSK3186899|gsk3186899|mesh-list
154396776|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396777|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396778|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396779|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
154396780|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154396781|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396782|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154396783|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154396784|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396785|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396786|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396787|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
154396788|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154396789|NCT05275777|Paclitaxel|paclitaxel|mesh-list
154396790|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
154396791|NCT05275777|Doxorubicin|doxorubicin|mesh-list
154396792|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154396793|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396794|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131445|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131450|NCT01073059|Ertapenem|ertapenem|mesh-list
154396795|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
154396796|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
154396797|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396798|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154396799|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
154396800|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396801|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396802|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154396803|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
154396804|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154396805|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154396806|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154396807|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154396808|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396809|NCT05672212|Sufentanil|sufentanil|mesh-list
154396810|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154396811|NCT05672212|Narcotics|narcotics|mesh-ancestor
154396812|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396813|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396814|NCT05672212|Analgesics|analgesics|mesh-ancestor
154396815|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
154396816|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396817|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154396818|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154396819|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
154396820|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
154396821|NCT02390674|Cyclosporine|cyclosporine|mesh-list
154396822|NCT02390674|Cyclosporins|cyclosporins|mesh-list
154396823|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396824|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396825|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154396826|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
154396827|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396828|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
154396829|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131476|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396830|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
154396831|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396832|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154396833|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154396834|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396835|NCT02663674|Fluconazole|fluconazole|mesh-list
154396836|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
154396837|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396838|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154396839|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154396840|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396841|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396842|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154396843|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
154396844|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396845|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396846|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154396847|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154396848|NCT03657212|Zolpidem|zolpidem|mesh-list
154396849|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154396850|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154396851|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396852|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396853|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154396854|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
154396855|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
154396856|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396857|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396858|NCT03310411|Sumatriptan|sumatriptan|mesh-list
154396859|NCT03310411|Lasmiditan|lasmiditan|mesh-list
154396860|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154396861|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154396862|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154396863|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
154175928|NCT00833339|Mifepristone|mifepristone|mesh-list
154396864|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973745|NCT06248099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154396865|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396866|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396867|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
154396868|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
154396869|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154396870|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396871|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396872|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
154396873|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154396874|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396875|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396876|NCT02390440|Bupivacaine|bupivacaine|mesh-list
154396877|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
154396878|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
154396879|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154396880|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396881|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
154131532|NCT00884676|Sunitinib|sunitinib|mesh-list
154396882|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396883|NCT02199691|Vaccines|vaccines|mesh-list
154396884|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
154396885|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396886|NCT02389972|Dasatinib|dasatinib|mesh-list
154396887|NCT02389972|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154396888|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396889|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396890|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396891|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396892|NCT02389582|Enoxaparin|enoxaparin|mesh-list
154396893|NCT02389582|Dabigatran|dabigatran|mesh-list
154396894|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
154396895|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154396896|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154131547|NCT00891384|Lenalidomide|lenalidomide|mesh-list
154131562|NCT00609336|Docetaxel|docetaxel|mesh-list
154396897|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396898|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
154396899|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154396900|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
154396901|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396902|NCT02906930|Semaglutide|semaglutide|mesh-list
154396903|NCT02906930|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154396904|NCT02906930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154396905|NCT02906930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396906|NCT02389426|Bosentan|bosentan|mesh-list
154396907|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154396908|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154396909|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396910|NCT02389348|Artefenomel|artefenomel|mesh-list
154396911|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
154396912|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154396913|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154396914|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396915|NCT02387242|Rifampin|rifampin|mesh-list
154396916|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154396917|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
154396918|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154396919|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131581|NCT04397406|Fentanyl|fentanyl|mesh-list
154396920|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
154396921|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154396922|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396923|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396924|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154396925|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154396926|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154396927|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154396928|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154396929|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154396930|NCT03656588|Iodine|iodine|mesh-list
154396931|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
154396932|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154396933|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
154396934|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154396935|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154396936|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396937|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
154396938|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
154396939|NCT03656588|Trace Elements|trace elements|mesh-ancestor
154396940|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
154396941|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396943|NCT02387086|Thalidomide|thalidomide|mesh-list
154396944|NCT02387086|Gefitinib|gefitinib|mesh-list
154396945|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154396946|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154396947|NCT02387086|Analgesics|analgesics|mesh-ancestor
154396948|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
154396949|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154396950|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396951|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154396952|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154396953|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154396954|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154396955|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396956|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154396957|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154396958|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396959|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
154396960|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154396961|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
154396962|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
154396963|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154396964|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154396965|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154396966|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154396967|NCT02387086|Growth Substances|growth substances|mesh-ancestor
154396968|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
154396969|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396970|NCT02387086|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154396971|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154396972|NCT02383030|Fulvestrant|fulvestrant|mesh-list
154396973|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154396974|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396975|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154396976|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154396977|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
154396978|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396979|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396980|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154396981|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
154396982|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396983|NCT02983604|Fulvestrant|fulvestrant|mesh-list
154396984|NCT02983604|Exemestane|exemestane|mesh-list
154396985|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154396986|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154396987|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154396988|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154396989|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
154396990|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154396991|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154396992|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154396993|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154396994|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154396995|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154396996|NCT03656432|Fluorides|fluorides|mesh-list
154396997|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
154396998|NCT03656432|Protective Agents|protective agents|mesh-ancestor
154396999|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397000|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
154397001|NCT02386462|Propofol|propofol|mesh-list
154397002|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154397003|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154397004|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397005|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154397006|NCT02386462|Analgesics|analgesics|mesh-ancestor
154254231|NCT01145846|Cytarabine|cytarabine|mesh-list
154397007|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
154397008|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397009|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154397010|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154397011|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154397012|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
154176070|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
154397013|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397014|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397015|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154397016|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
154397017|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
154397018|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
154397019|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
154397020|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397021|NCT02382328|Protective Agents|protective agents|mesh-ancestor
154397022|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397023|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
154397024|NCT02382328|Vitamins|vitamins|mesh-ancestor
154397025|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
154397026|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154397027|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154397028|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397029|NCT02388490|Immunotoxins|immunotoxins|mesh-ancestor
154397030|NCT02388490|Immunoconjugates|immunoconjugates|mesh-ancestor
154397031|NCT02388490|Immunologic Factors|immunologic factors|mesh-ancestor
154397032|NCT02388490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397033|NCT02382094|Bicalutamide|bicalutamide|mesh-list
154397034|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
154397035|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
154397036|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397037|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397038|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397039|NCT02386150|Vaccines|vaccines|mesh-list
154397040|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
154397041|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397042|NCT02377180|Anesthetics|anesthetics|mesh-list
154397043|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
154397044|NCT02377180|Capsaicin|capsaicin|mesh-list
154397045|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154397046|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397047|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
154397048|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397049|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
154397050|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
154397051|NCT03656042|Lenograstim|lenograstim|mesh-list
154397052|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154397053|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
154397054|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397055|NCT03655964|Olmesartan|olmesartan|mesh-list
154397056|NCT03655964|Nebivolol|nebivolol|mesh-list
154397057|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
154397058|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154397059|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154397060|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397061|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
153372999|NCT01404260|Carboplatin|carboplatin|mesh-list
154397062|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154397063|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154397064|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154397065|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
154397066|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397067|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397068|NCT02982590|Warfarin|warfarin|mesh-list
154397069|NCT02982590|Apixaban|apixaban|mesh-list
154397070|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
154397071|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154397072|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
154397073|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154397074|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
154397075|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397076|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397078|NCT02381548|Adavosertib|adavosertib|mesh-list
154397079|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397080|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397081|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397082|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154397083|NCT02381314|Ipilimumab|ipilimumab|mesh-list
154397084|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154397085|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397086|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154397087|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397088|NCT02386072|Mirabegron|mirabegron|mesh-list
154397089|NCT02386072|Oxybutynin|oxybutynin|mesh-list
154397090|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154397091|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154397092|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154397093|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154131733|NCT00888108|Docetaxel|docetaxel|mesh-list
154397094|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
154397095|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397096|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397097|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397098|NCT02386072|Urological Agents|urological agents|mesh-ancestor
154397099|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
154397100|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
154397101|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397102|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154397103|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
154397104|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
154397105|NCT02381470|Amoxicillin|amoxicillin|mesh-list
154397106|NCT02381470|Rifampin|rifampin|mesh-list
154397107|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154397108|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
154397109|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
154397110|NCT02381470|Cefadroxil|cefadroxil|mesh-list
154397111|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397112|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397113|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154397114|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
154397115|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
154397116|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154397117|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397118|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397119|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154397120|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154397121|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154397122|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154397123|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154397124|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154397125|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154397126|NCT02381158|Beclomethasone|beclomethasone|mesh-list
154397127|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397128|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
154397129|NCT02381158|Hormones|hormones|mesh-ancestor
154397130|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397131|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397132|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154397133|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
154397134|NCT02381080|Voriconazole|voriconazole|mesh-list
154397135|NCT02381080|Erythromycin|erythromycin|mesh-list
154397136|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
154397137|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154397138|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
154397139|NCT02381080|Ibrutinib|ibrutinib|mesh-list
154397140|NCT02381080|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154397141|NCT02381080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154397142|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397143|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397144|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
153743164|NCT00528619|Pemetrexed|pemetrexed|mesh-list
154397145|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397146|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154397147|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154397148|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154397149|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
154397150|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397151|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397152|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154397153|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397154|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154397155|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154397156|NCT04694248|Aspirin|aspirin|mesh-list
154397157|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
154397158|NCT04694248|Anticoagulants|anticoagulants|mesh-list
154397159|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154397160|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154131792|NCT00888342|Ethanol|ethanol|mesh-list
154397161|NCT04694248|Analgesics|analgesics|mesh-ancestor
154397162|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
154397163|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397164|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397165|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397166|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397167|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154397168|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154397169|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397170|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154397171|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154397172|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397173|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
154397174|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154397175|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
154397176|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154397177|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
154397178|NCT02376478|Folic Acid|folic acid|mesh-list
154397179|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
154397180|NCT02376478|Adalimumab|adalimumab|mesh-list
154397181|NCT02376478|Infliximab|infliximab|mesh-list
154397182|NCT02376478|Etanercept|etanercept|mesh-list
154397183|NCT02376478|Methotrexate|methotrexate|mesh-list
154397184|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
154397185|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
154397186|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154397187|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
154397188|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154397189|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397190|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154397191|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
154397192|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397193|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397194|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
154397195|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397196|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397197|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
154397198|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397199|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154397200|NCT02376478|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154397201|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397202|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154397203|NCT02376478|Hematinics|hematinics|mesh-ancestor
154397204|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
154397205|NCT02376478|Vitamins|vitamins|mesh-ancestor
154397206|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
154397207|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154397208|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154397209|NCT02376478|Analgesics|analgesics|mesh-ancestor
154397210|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
154397211|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397212|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397213|NCT02385448|Dienogest|dienogest|mesh-list
154397214|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154397215|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154397216|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154397217|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
154397218|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154397219|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397220|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154397221|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154397222|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154397223|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154397224|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
154397225|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397226|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154397227|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397228|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154397229|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154397230|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154397231|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153375518|NCT01562678|Incretins|incretins|mesh-ancestor
154397232|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154397233|NCT02376400|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154397234|NCT02376400|Antiviral Agents|antiviral agents|mesh-ancestor
154397235|NCT02376400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397237|NCT02385058|Piperazine|piperazine|mesh-list
154397238|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
154397239|NCT02385058|DMP 777|dmp 777|mesh-list
154397240|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
154397241|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
154397242|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154397243|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397244|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
154397245|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
154397246|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
154397247|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397248|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397249|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397250|NCT02376088|Methimazole|methimazole|mesh-list
154397251|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
154397252|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
154397253|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397254|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397255|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
154397256|NCT03310021|Apixaban|apixaban|mesh-list
154397257|NCT03310021|Edoxaban|edoxaban|mesh-list
154397258|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154397259|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
154397260|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154397261|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
154397262|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397263|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397264|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
154397265|NCT03333109|Erenumab|erenumab|mesh-list
154397266|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154397267|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397268|NCT03333109|Analgesics|analgesics|mesh-ancestor
154397269|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
154397270|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397271|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397272|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154397273|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154397274|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154397275|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
154397276|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
154397277|NCT01312831|Vitamins|vitamins|mesh-ancestor
154397278|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
154397279|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397280|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
154397281|NCT01312831|Hematinics|hematinics|mesh-ancestor
154397282|NCT04431193|Oxytocin|oxytocin|mesh-list
154397283|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
154397284|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154397285|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397286|NCT03293485|Imipenem|imipenem|mesh-list
154397287|NCT03293485|Relebactam|relebactam|mesh-list
154397288|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
154397289|NCT03293485|Cilastatin|cilastatin|mesh-list
154397290|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397291|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397292|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
154397293|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397294|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397295|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154397296|NCT03309943|Propranolol|propranolol|mesh-list
154397297|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154397298|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154397299|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
154397300|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397301|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397302|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397303|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154397304|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154397305|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
154397306|NCT01732627|Vaccines|vaccines|mesh-list
154131933|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
154176369|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154397307|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
154397308|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397309|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154397310|NCT03331315|Celecoxib|celecoxib|mesh-list
154397311|NCT03331315|Ketorolac|ketorolac|mesh-list
154397312|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154397313|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154397315|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
154397316|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397317|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397318|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397319|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397320|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154397321|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154397322|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397323|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397324|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
154397325|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
154397326|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397327|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397328|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397329|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
154397330|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
154397331|NCT02661490|Vaccines|vaccines|mesh-list
154397332|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
154397333|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397334|NCT03287791|Azelaic acid|azelaic acid|mesh-list
154397335|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
154397336|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154397337|NCT03287791|Protective Agents|protective agents|mesh-ancestor
154397338|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397339|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
154397340|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397341|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154397342|NCT03287635|Hormones|hormones|mesh-ancestor
154397343|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397344|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397345|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
154397346|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154397347|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397348|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397349|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
154397350|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154397351|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397352|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
154397353|NCT02385136|Temozolomide|temozolomide|mesh-list
154397354|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154397355|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
154397356|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397357|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397358|NCT02940691|Grazoprevir|grazoprevir|mesh-list
154397359|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154397360|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
154397361|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397362|NCT04949269|Deucravacitinib|deucravacitinib|mesh-list
154397363|NCT04949269|Famotidine|famotidine|mesh-list
154397364|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154397365|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154397366|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154397367|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
154397368|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
154397369|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397370|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397371|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397372|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
154397373|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154397374|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397375|NCT02379754|Gentamicins|gentamicins|mesh-list
154397376|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397377|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397378|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154397379|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397380|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397381|NCT01313377|Gemcitabine|gemcitabine|mesh-list
154397382|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
154397383|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154397384|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
154397385|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397386|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397387|NCT02384746|Fulvestrant|fulvestrant|mesh-list
154397389|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154397390|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397391|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154397392|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154397393|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
154397394|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397395|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397396|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
154397397|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397398|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397399|NCT02375464|Octreotide|octreotide|mesh-list
154397400|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154397401|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154397402|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397403|NCT03113344|Amoxicillin|amoxicillin|mesh-list
154397404|NCT03113344|Azithromycin|azithromycin|mesh-list
154397405|NCT03113344|Meropenem|meropenem|mesh-list
154397406|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
154397407|NCT03113344|Penicillins|penicillins|mesh-list
154397408|NCT03113344|Imipenem|imipenem|mesh-list
154397409|NCT03113344|Erythromycin|erythromycin|mesh-list
154397410|NCT03113344|Ceftazidime|ceftazidime|mesh-list
154397411|NCT03113344|Ampicillin|ampicillin|mesh-list
154397412|NCT03113344|Cephalosporins|cephalosporins|mesh-list
154397413|NCT03113344|Acyclovir|acyclovir|mesh-list
154397414|NCT03113344|Ganciclovir|ganciclovir|mesh-list
154397415|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
154397416|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397417|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397418|NCT03113344|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154397419|NCT03113344|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154397420|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397421|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397422|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154397423|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154397424|NCT03113266|Antibodies|antibodies|mesh-list
154397425|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154397426|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
154397427|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397428|NCT02379676|Clopidogrel|clopidogrel|mesh-list
154397429|NCT02379676|Ticagrelor|ticagrelor|mesh-list
154397430|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154397431|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154397432|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154397433|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154397434|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
154397435|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397436|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397437|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397438|NCT02378740|Ketamine|ketamine|mesh-list
154397439|NCT02378740|Analgesics|analgesics|mesh-ancestor
154397440|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
154397441|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397442|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397443|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154397444|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154397445|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
154397446|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
154397447|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154397448|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154397449|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154397450|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397451|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397452|NCT01411267|Cytarabine|cytarabine|mesh-list
154397453|NCT01411267|Methotrexate|methotrexate|mesh-list
154397454|NCT01411267|Etoposide|etoposide|mesh-list
154397455|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
154397456|NCT01411267|Quizartinib|quizartinib|mesh-list
154397457|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154397458|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
154397459|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154397460|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397461|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154397462|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
154397463|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397464|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397465|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154397466|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397467|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154397468|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397469|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
154397470|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397471|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154397472|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154397473|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154397474|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154397475|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
154397476|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397477|NCT01411267|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154397478|NCT01411267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154397479|NCT03113110|Empagliflozin|empagliflozin|mesh-list
154397480|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154397481|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397482|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154397483|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397484|NCT02383888|BI 425809|bi 425809|mesh-list
154397485|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
154397486|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
154397487|NCT03130959|Nivolumab|nivolumab|mesh-list
154397488|NCT03130959|Ipilimumab|ipilimumab|mesh-list
154397489|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154397490|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397491|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154397492|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397493|NCT01370031|Charcoal|charcoal|mesh-list
154397494|NCT01370031|Antidotes|antidotes|mesh-ancestor
154397495|NCT01370031|Protective Agents|protective agents|mesh-ancestor
154397496|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397497|NCT02373514|Acetaminophen|acetaminophen|mesh-list
154397498|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154397499|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154397500|NCT02373514|Analgesics|analgesics|mesh-ancestor
154397501|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
154397502|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397503|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397504|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
154397505|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154397506|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397507|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397508|NCT01364493|Capecitabine|capecitabine|mesh-list
154397509|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
154397510|NCT01364493|Trastuzumab|trastuzumab|mesh-list
154397511|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154397512|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
154397513|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397514|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397515|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154397516|NCT01370187|Montelukast|montelukast|mesh-list
154397517|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154397518|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
154397519|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154397520|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
154397521|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397522|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397523|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154397524|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154397525|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397526|NCT04483960|Nafamostat|nafamostat|mesh-list
154397527|NCT04483960|Enoxaparin|enoxaparin|mesh-list
154397528|NCT04483960|Dalteparin|dalteparin|mesh-list
154397529|NCT04483960|Tinzaparin|tinzaparin|mesh-list
154397530|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154397531|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
154397532|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154397533|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154397534|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397535|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154397536|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154397537|NCT04483960|Analgesics|analgesics|mesh-ancestor
154397538|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
154397539|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397540|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397541|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397542|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397543|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
154397544|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397545|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154397546|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154397547|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154397548|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397549|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
154397550|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
154397551|NCT01370343|Cyclosporine|cyclosporine|mesh-list
154397552|NCT01370343|Cyclosporins|cyclosporins|mesh-list
154397553|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
154397554|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397555|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132197|NCT00986505|Lidocaine|lidocaine|mesh-list
154397556|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397557|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
154397558|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397559|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
154397560|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397561|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
154397562|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397563|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154397564|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
154397565|NCT01370343|Vitamins|vitamins|mesh-ancestor
154397566|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
154397567|NCT01368003|Dutasteride|dutasteride|mesh-list
154397568|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154397569|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154397570|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397571|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397572|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
154397573|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397574|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397575|NCT01364571|Vaccines|vaccines|mesh-list
154397576|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
154397577|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397578|NCT02377648|Everolimus|everolimus|mesh-list
154397579|NCT02377648|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154397580|NCT02377648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154397581|NCT02377648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132211|NCT03667443|Vitamins|vitamins|mesh-ancestor
154397582|NCT02377648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397583|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397584|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
154397585|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397586|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397587|NCT02371408|Ribavirin|ribavirin|mesh-list
154397588|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
154397589|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
154397590|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397591|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
154397592|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397593|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
154397594|NCT01364805|Gemcitabine|gemcitabine|mesh-list
154397595|NCT01364805|Vitamins|vitamins|mesh-ancestor
154397596|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
154397597|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397598|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154397599|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
154397600|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397601|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397602|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
154397603|NCT01364805|Protective Agents|protective agents|mesh-ancestor
154397604|NCT01370889|Resveratrol|resveratrol|mesh-list
154397605|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
154397606|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397607|NCT01370889|Protective Agents|protective agents|mesh-ancestor
154397608|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397609|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397610|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154397611|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154397612|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154397613|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397614|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154397615|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397616|NCT02371096|Rituximab|rituximab|mesh-list
154397617|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154397618|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397619|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
154397620|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397621|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397622|NCT04420455|Enoximone|enoximone|mesh-list
154397623|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154397624|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
154397625|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154397626|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154397627|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397628|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397629|NCT04420455|Protective Agents|protective agents|mesh-ancestor
154397630|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397631|NCT01364961|Resveratrol|resveratrol|mesh-list
154397632|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
154397633|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397634|NCT01364961|Protective Agents|protective agents|mesh-ancestor
154397635|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397636|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397637|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154397638|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
154397639|NCT02370862|Neostigmine|neostigmine|mesh-list
154397640|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154397641|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397642|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397643|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
154397644|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397645|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397646|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154397647|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
154397648|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397649|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154397650|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154397651|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154397652|NCT02373280|Amoxicillin|amoxicillin|mesh-list
153757594|NCT00204321|Sirolimus|sirolimus|mesh-list
154397653|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
154397654|NCT02373280|Metronidazole|metronidazole|mesh-list
154397655|NCT02373280|Clarithromycin|clarithromycin|mesh-list
154397656|NCT02373280|Esomeprazole|esomeprazole|mesh-list
154397657|NCT02373280|Bismuth|bismuth|mesh-list
154397658|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154397659|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397660|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397661|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154397662|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154397663|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154254245|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154397664|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397665|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397666|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154397667|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
154397668|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154397669|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397670|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154397671|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154397672|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154397673|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154397674|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154397675|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154397676|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154397677|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154397678|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154397679|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154397680|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154397681|NCT02373280|Antacids|antacids|mesh-ancestor
154397682|NCT02370550|Cyclosporine|cyclosporine|mesh-list
153972261|NCT04215237|Atorvastatin|atorvastatin|mesh-list
153972326|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154397684|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
154397685|NCT02370550|Calcium|calcium|mesh-list
154397686|NCT02370550|Cyclosporins|cyclosporins|mesh-list
154397687|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154397688|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397689|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397690|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
154397691|NCT02370550|Hormones|hormones|mesh-ancestor
154397692|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397693|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154397694|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397695|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397696|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397697|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397698|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
154397699|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
154397700|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397701|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
154132312|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
154397702|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397703|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154397704|NCT02370550|Antacids|antacids|mesh-ancestor
154397705|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154397706|NCT02365402|Entecavir|entecavir|mesh-list
154397707|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
154397708|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397709|NCT02364934|Propofol|propofol|mesh-list
154397710|NCT02364934|Sevoflurane|sevoflurane|mesh-list
154397711|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154397712|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154397713|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397714|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154397715|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
154397716|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
154397717|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154397718|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154397719|NCT02372656|Metformin|metformin|mesh-list
154397720|NCT02372656|Simvastatin|simvastatin|mesh-list
154397721|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154397722|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397723|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154397724|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154397725|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
154397726|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397727|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154397728|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154397729|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397730|NCT03123939|Tisagenlecleucel|tisagenlecleucel|mesh-list
154397731|NCT03123939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154397732|NCT03123939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397733|NCT01368627|Sirolimus|sirolimus|mesh-list
154397734|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397735|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397736|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154397737|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397738|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
154397739|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397740|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
154397741|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397742|NCT02358681|Ketorolac|ketorolac|mesh-list
154397743|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154397744|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154397745|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154397746|NCT02358681|Analgesics|analgesics|mesh-ancestor
154397747|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
154397748|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397749|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397750|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397751|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397752|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154397753|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397754|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397755|NCT03123861|Gabapentin|gabapentin|mesh-list
154397756|NCT03123861|Analgesics|analgesics|mesh-ancestor
154397757|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
154397758|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397759|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397760|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
154397761|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154397762|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154397763|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154397764|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154397765|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154397766|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154397767|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397768|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397769|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
154397770|NCT01368783|Ritonavir|ritonavir|mesh-list
154397771|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154397772|NCT01368783|Tenofovir|tenofovir|mesh-list
154397773|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154397774|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154397775|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
154397776|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397777|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397778|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154397779|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154397780|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
154397781|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397782|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154397783|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154397784|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154397785|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154397786|NCT01509339|Vancomycin|vancomycin|mesh-list
154397787|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397788|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397789|NCT03123471|Apremilast|apremilast|mesh-list
154397790|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154397791|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154397792|NCT03123471|Analgesics|analgesics|mesh-ancestor
154397793|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
154397794|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397795|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397796|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397797|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397798|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154397799|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154132430|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397800|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397801|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397802|NCT02661178|Emodepside|emodepside|mesh-list
154397803|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154397804|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397805|NCT01365117|Insulin|insulin|mesh-list
154397806|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154397807|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154397808|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397809|NCT02372812|Dexamethasone|dexamethasone|mesh-list
154397810|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397811|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
154397812|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
154397813|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397814|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397815|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154397816|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
154397817|NCT02372812|Hormones|hormones|mesh-ancestor
154397818|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397819|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154397820|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397821|NCT02365012|Midodrine|midodrine|mesh-list
154397822|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
154397823|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
154397824|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397825|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397826|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154397827|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154397828|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154397829|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154397830|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
154397831|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729971|NCT00132119|Nalmefene|nalmefene|mesh-list
154397832|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397833|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154397834|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397835|NCT01365351|Hormones|hormones|mesh-list
154397836|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397837|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397838|NCT01372449|Memantine|memantine|mesh-list
154397839|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154397840|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154397841|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
154397842|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397843|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397844|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397845|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154397846|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154397847|NCT04666389|Atorvastatin|atorvastatin|mesh-list
154132455|NCT00904176|Digoxin|digoxin|mesh-list
154397848|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154397849|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154397850|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
154397851|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397852|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154397853|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154397854|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397855|NCT02372110|Caffeine|caffeine|mesh-list
154397856|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154397857|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397858|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154397859|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397860|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397861|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154397862|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154397863|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
154397864|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397865|NCT02372188|Caffeine|caffeine|mesh-list
154397866|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154397867|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397868|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154397869|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397870|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397871|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154397872|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154397873|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
154397874|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397875|NCT01371435|Paroxetine|paroxetine|mesh-list
154397876|NCT01371435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154397877|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154397878|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154397879|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397880|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154397881|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
154397882|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397883|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154397884|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
154397885|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154397886|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154397887|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154397888|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397889|NCT01369719|Deferasirox|deferasirox|mesh-list
154397890|NCT01369719|Deferoxamine|deferoxamine|mesh-list
154397891|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154397892|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
154397893|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
154397894|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397895|NCT01369719|Siderophores|siderophores|mesh-ancestor
154397896|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
154397897|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154397898|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
154397899|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397900|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
154397901|NCT02369380|Protective Agents|protective agents|mesh-ancestor
154397902|NCT02038816|Azacitidine|azacitidine|mesh-list
154397903|NCT02038816|Deferasirox|deferasirox|mesh-list
154397904|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154397905|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
154397906|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397907|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397908|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397909|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154397910|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
154397911|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
154397912|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
154397913|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154397914|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397915|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
154397917|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
154397918|NCT02359162|Gemcitabine|gemcitabine|mesh-list
154397919|NCT02359162|Doxorubicin|doxorubicin|mesh-list
154397920|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
154397922|NCT02359162|Vincristine|vincristine|mesh-list
154397923|NCT02359162|Pegaspargase|pegaspargase|mesh-list
154397924|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397925|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
154397926|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397927|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154397928|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154397929|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
154397930|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397931|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154397932|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154397933|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154397934|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
154397935|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153380583|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154397936|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154397937|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154397938|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397939|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154397940|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
154397941|NCT02359162|Hormones|hormones|mesh-ancestor
154397942|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397943|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154397944|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154397945|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
154397946|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
154397947|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
154397948|NCT03634605|Tetracycline|tetracycline|mesh-list
154397949|NCT03634605|Lidocaine|lidocaine|mesh-list
154397950|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
154397951|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
154397952|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154397953|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397954|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
154397955|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154397956|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154397957|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154397958|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154397959|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154132557|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
154397960|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397961|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154397962|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397963|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154397964|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397965|NCT02363764|Dimercaprol|dimercaprol|mesh-list
154397966|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
154397967|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
154397968|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397969|NCT03654794|Tacrolimus|tacrolimus|mesh-list
154397970|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154397971|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
154397972|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397973|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154397974|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397975|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397976|NCT03654170|BI 425809|bi 425809|mesh-list
154397977|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
154397978|NCT02369146|UB-421|ub-421|mesh-list
154132573|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154397979|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154397980|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
154397981|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397982|NCT02363452|Lamivudine|lamivudine|mesh-list
154397983|NCT02363452|Zidovudine|zidovudine|mesh-list
154397984|NCT02363452|Abacavir|abacavir|mesh-list
154397985|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154397986|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154397987|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154397988|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154397989|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
154397990|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154397991|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154397992|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154397993|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
154397994|NCT03634137|Afamelanotide|afamelanotide|mesh-list
154397995|NCT03634137|alpha-MSH|alpha-msh|mesh-list
154397996|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
154397997|NCT03634137|Hormones|hormones|mesh-ancestor
154397998|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154397999|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398000|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
154398001|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154398002|NCT02358694|Antibodies|antibodies|mesh-list
154398003|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
154398004|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398005|NCT04473807|Sotalol|sotalol|mesh-list
154398006|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154398007|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154398008|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
154398009|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398010|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398011|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398012|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154398013|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
154398014|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
154398015|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398016|NCT02323659|Interferons|interferons|mesh-list
154398017|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
154398018|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
154398019|NCT02323659|Methotrexate|methotrexate|mesh-list
154398020|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154398021|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
154398022|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154398023|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398024|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154398025|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
154398026|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398027|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398028|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
154398029|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398030|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154398031|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154398032|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
154398033|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398034|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154398035|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
154398036|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398037|NCT03634059|Apatinib|apatinib|mesh-list
154398038|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398039|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154398040|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398041|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398042|NCT02358304|Calcitonin|calcitonin|mesh-list
154398043|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
154398044|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154398045|NCT02358304|Katacalcin|katacalcin|mesh-list
154398046|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154398047|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398048|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154398049|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
154398050|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
154398051|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154398052|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154398053|NCT02362906|Azithromycin|azithromycin|mesh-list
154398054|NCT02362906|Erythromycin|erythromycin|mesh-list
154398055|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
154398056|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154398057|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
154398058|NCT02362906|Cephalosporins|cephalosporins|mesh-list
154398059|NCT02362906|Second Generation Cephalosporins|second generation cephalosporins|mesh-list
154398060|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154398061|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398062|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398063|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154398064|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398065|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398066|NCT02362906|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154398067|NCT03085914|Leucovorin|leucovorin|mesh-list
154398068|NCT03085914|Paclitaxel|paclitaxel|mesh-list
154398069|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154398070|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
154398071|NCT03085914|Carboplatin|carboplatin|mesh-list
154398072|NCT03085914|Gemcitabine|gemcitabine|mesh-list
154398073|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
154398074|NCT03085914|Fluorouracil|fluorouracil|mesh-list
154398075|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
154398076|NCT03085914|Pemetrexed|pemetrexed|mesh-list
154398077|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154398078|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398079|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
154398080|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
154398081|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
154398082|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398083|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154398084|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
154398085|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398086|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398087|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154398088|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
154398089|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154398090|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154398091|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
154398092|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132692|NCT00627458|Vaccines|vaccines|mesh-list
154398093|NCT03085914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154398094|NCT03085914|Antidotes|antidotes|mesh-ancestor
154398095|NCT03085914|Protective Agents|protective agents|mesh-ancestor
154398096|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
154398097|NCT03085914|Vitamins|vitamins|mesh-ancestor
154398098|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
154398099|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398100|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154398101|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154398102|NCT02467608|Isoniazid|isoniazid|mesh-list
154398103|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
154398104|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154398105|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398106|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154398107|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154398108|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
154398109|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398110|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154398111|NCT02368288|Entecavir|entecavir|mesh-list
154398112|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
154398113|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398114|NCT02368054|Epinephrine|epinephrine|mesh-list
154398115|NCT02368054|Racepinephrine|racepinephrine|mesh-list
154398116|NCT02368054|Bupivacaine|bupivacaine|mesh-list
154398117|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
154398118|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
154398119|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
154398120|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398121|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398122|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
154398123|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398124|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154398125|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154398126|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
154398127|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398128|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398129|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154398130|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153729892|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
154398131|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
154398132|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154398133|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
154398134|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
154398135|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
154398136|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154398137|NCT02357602|Tenofovir|tenofovir|mesh-list
154398138|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
154398139|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398140|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154398141|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154398142|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398143|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398144|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154398145|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154398146|NCT01379196|Azithromycin|azithromycin|mesh-list
154398147|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154398148|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398149|NCT01382238|Dolutegravir|dolutegravir|mesh-list
154398150|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154398151|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154398152|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398153|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398154|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154398155|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154398156|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
154398157|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398158|NCT03112564|Fentanyl|fentanyl|mesh-list
154398159|NCT03112564|Sevoflurane|sevoflurane|mesh-list
154398160|NCT03112564|Rocuronium|rocuronium|mesh-list
154398161|NCT03112564|Cisatracurium|cisatracurium|mesh-list
154398162|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154398163|NCT03112564|Narcotics|narcotics|mesh-ancestor
154398164|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398165|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398166|NCT03112564|Analgesics|analgesics|mesh-ancestor
154398167|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
154398168|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398169|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154398170|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154398171|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
154398172|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
154398173|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154398174|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154398175|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154398176|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154398177|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154398178|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
154398179|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
154398180|NCT01379976|Vitamins|vitamins|mesh-ancestor
154398181|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
154398182|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398183|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
154398184|NCT01379898|Doxazosin|doxazosin|mesh-list
154398185|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
154398186|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154398187|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154398188|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154398189|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154398190|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
154398191|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398192|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398193|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398194|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
154398195|NCT02362516|BI 425809|bi 425809|mesh-list
154398196|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
154398197|NCT02367664|Vaccines|vaccines|mesh-list
154398198|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
154398199|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398200|NCT05421000|Anesthetics|anesthetics|mesh-list
154398201|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398202|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398203|NCT02357212|Adenosine|adenosine|mesh-list
154398204|NCT02357212|Analgesics|analgesics|mesh-ancestor
154398205|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
154398206|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398207|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132795|NCT00927498|Immunotoxins|immunotoxins|mesh-ancestor
154398208|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154398209|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
154398210|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154398211|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
154398212|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
154398213|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398214|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398215|NCT01382160|Adalimumab|adalimumab|mesh-list
154398216|NCT01382160|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154398217|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154398218|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398219|NCT00735748|Tramadol|tramadol|mesh-list
154398220|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154398221|NCT00735748|Narcotics|narcotics|mesh-ancestor
154398222|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398223|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398224|NCT00735748|Analgesics|analgesics|mesh-ancestor
154398225|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
154398226|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398227|NCT02367196|Rituximab|rituximab|mesh-list
154398228|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154398229|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398230|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
154398231|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398232|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398233|NCT05418504|Anesthetics|anesthetics|mesh-list
154398234|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398235|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398236|NCT03408886|Vancomycin|vancomycin|mesh-list
154398237|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154398238|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398239|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
154398240|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154398241|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
154398242|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154398243|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398244|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154398245|NCT04013334|Nivolumab|nivolumab|mesh-list
154398246|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154398247|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398248|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154398249|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398250|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154398251|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
154398252|NCT02366884|Clotrimazole|clotrimazole|mesh-list
154398253|NCT02366884|Miconazole|miconazole|mesh-list
154398254|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
154398255|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398256|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154132848|NCT00604188|Buprenorphine|buprenorphine|mesh-list
154398257|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154398258|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154398259|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398260|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398261|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154398262|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
154398263|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398264|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398265|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154398266|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154398267|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154398268|NCT02361502|Mirabegron|mirabegron|mesh-list
154398269|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154398270|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154398271|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154398272|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
154398273|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398274|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398275|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398276|NCT02361502|Urological Agents|urological agents|mesh-ancestor
154398277|NCT02367118|Prednisone|prednisone|mesh-list
154398278|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154398279|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
154398280|NCT02367118|Hormones|hormones|mesh-ancestor
154398281|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398282|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398283|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154398284|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398285|NCT00979212|Paclitaxel|paclitaxel|mesh-list
154398286|NCT00979212|Carboplatin|carboplatin|mesh-list
154398287|NCT00979212|Panitumumab|panitumumab|mesh-list
154398288|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154398289|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398290|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
154398291|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
154398292|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
154398293|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398294|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154398295|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
154398296|NCT02361190|Testosterone|testosterone|mesh-list
154398297|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
154398298|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
154398299|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154398300|NCT02361190|Androgens|androgens|mesh-ancestor
154398301|NCT02361190|Hormones|hormones|mesh-ancestor
154398302|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398303|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398304|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154398305|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398306|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
154398307|NCT02361112|Capecitabine|capecitabine|mesh-list
154398308|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154398309|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
154398310|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398311|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398312|NCT02360956|Olmesartan|olmesartan|mesh-list
154398313|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154398314|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
154398315|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154398316|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154398317|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398318|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154398319|NCT02360800|Hemostatics|hemostatics|mesh-list
154398320|NCT02360800|Coagulants|coagulants|mesh-ancestor
154398321|NCT03501966|Acetazolamide|acetazolamide|mesh-list
154398322|NCT03501966|Diuretics|diuretics|mesh-list
154398323|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
154398324|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398325|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
154398326|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154398327|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398328|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398329|NCT02355184|Leronlimab|leronlimab|mesh-list
154398330|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154398331|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154398332|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398333|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154398334|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154398335|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
154398336|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398337|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
154398338|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154398339|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
154398340|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398341|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
154398342|NCT03477630|Protective Agents|protective agents|mesh-ancestor
154398343|NCT02981342|Gemcitabine|gemcitabine|mesh-list
154398344|NCT02981342|Capecitabine|capecitabine|mesh-list
154398345|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154398346|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
154398347|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398348|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398349|NCT02360644|Vitamin D|vitamin d|mesh-list
154398350|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
154398351|NCT02360644|Vitamins|vitamins|mesh-ancestor
154398352|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
154398353|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398354|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154398355|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154398356|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
154398357|NCT02365948|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154398358|NCT02365948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153972926|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154398359|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154398360|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
154398361|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398362|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398363|NCT02354950|Cabotegravir|cabotegravir|mesh-list
154398364|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154398365|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154398366|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398367|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398368|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154398369|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154398370|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
154398371|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398372|NCT02980874|Triamcinolone|triamcinolone|mesh-list
154398373|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154398374|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154398375|NCT02980874|Aflibercept|aflibercept|mesh-list
154398376|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154398377|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154398378|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
154398379|NCT02980874|Hormones|hormones|mesh-ancestor
154398380|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398381|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398382|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154398383|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
154398384|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398385|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398386|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154398387|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154398388|NCT02980874|Growth Substances|growth substances|mesh-ancestor
154398389|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
154398390|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398391|NCT02354872|Nicotine|nicotine|mesh-list
154398392|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154398393|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
154398394|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398395|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398396|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154398397|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154398398|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
154398399|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398400|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398401|NCT02354638|Nicotine|nicotine|mesh-list
154398402|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154398403|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
154398404|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398405|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398406|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154398407|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154398408|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
154398409|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398410|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398411|NCT02360254|Insulin|insulin|mesh-list
154398412|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154398413|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398414|NCT03112642|Anesthetics|anesthetics|mesh-list
154398415|NCT03112642|Bupivacaine|bupivacaine|mesh-list
154398416|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
154398417|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398418|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398419|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
154398420|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398421|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154398422|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154398423|NCT01377324|Estradiol|estradiol|mesh-list
154398424|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154398425|NCT01377324|Estrogens|estrogens|mesh-ancestor
154398426|NCT01377324|Hormones|hormones|mesh-ancestor
154398427|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398428|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398429|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154398430|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
154398431|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154398432|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154398433|NCT02359942|Citric Acid|citric acid|mesh-list
154398434|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
154398435|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
153973014|NCT03824587|Calcium|calcium|mesh-list
154398436|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154398437|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
154398438|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
154398439|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398440|NCT02354560|Erythromycin|erythromycin|mesh-list
154398441|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
154398442|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154398443|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
154398444|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154398445|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398446|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398447|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154398448|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398449|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398450|NCT01378884|Domperidone|domperidone|mesh-list
154398451|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
154398452|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
154398453|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398454|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398455|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398456|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154398457|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
154398458|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133062|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154398459|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398460|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
154398461|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154398462|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
154398463|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398464|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398465|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154398466|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
154398467|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
154398468|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154398469|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
154398470|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398471|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398472|NCT02354170|Mifepristone|mifepristone|mesh-list
154398473|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154398474|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
154398475|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154398476|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398477|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154398478|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154398479|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154398480|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
154398481|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154398482|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154398483|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154398484|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398485|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
154398486|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154398487|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154398488|NCT02927964|Ibrutinib|ibrutinib|mesh-list
154133096|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
154398489|NCT02927964|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154398490|NCT02927964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154398491|NCT02927964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398492|NCT02927964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398493|NCT01377246|Octreotide|octreotide|mesh-list
154398494|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398495|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154398496|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398497|NCT02353936|Afatinib|afatinib|mesh-list
154398498|NCT02353936|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154398499|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154398500|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398501|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398502|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398503|NCT02353858|Fluorouracil|fluorouracil|mesh-list
154398504|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
154398505|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398506|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154398507|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973084|NCT04101682|Bupivacaine|bupivacaine|mesh-list
154398508|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154398509|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
154398510|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398511|NCT02353702|Ropivacaine|ropivacaine|mesh-list
154398512|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
154398513|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
154398514|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398515|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398516|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
154398517|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398518|NCT02532660|Dexetimide|dexetimide|mesh-list
154398519|NCT02532660|Citalopram|citalopram|mesh-list
154398520|NCT02532660|Escitalopram|escitalopram|mesh-list
154398521|NCT02532660|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154398522|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154398523|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154398524|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398525|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398526|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
154398527|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398528|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154398529|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154398530|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
154398531|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
154398532|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398533|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153382970|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
154398534|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154398535|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
154398536|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154398537|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
154398538|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154398539|NCT01377168|Naltrexone|naltrexone|mesh-list
154398540|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154398541|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154398542|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398543|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
154398544|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398545|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
154398546|NCT02892149|Hematinics|hematinics|mesh-ancestor
154398547|NCT02348398|Topotecan|topotecan|mesh-list
154398548|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154398549|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154398550|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398551|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398552|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398553|NCT05278338|Denosumab|denosumab|mesh-list
154398554|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154398555|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398556|NCT03721757|Nivolumab|nivolumab|mesh-list
154398557|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154398558|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398559|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154398560|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398561|NCT03727607|Propofol|propofol|mesh-list
154398562|NCT03727607|Desflurane|desflurane|mesh-list
154398563|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154398564|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133149|NCT04006353|Rifampin|rifampin|mesh-list
154398565|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398566|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154398567|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
154398568|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
154398569|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154398570|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
154398571|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154398572|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154398573|NCT03157414|Empagliflozin|empagliflozin|mesh-list
154398574|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154398575|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398576|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154398577|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398578|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154398579|NCT03147196|Bicalutamide|bicalutamide|mesh-list
154398580|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
154398581|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
154398582|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398583|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398584|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398585|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154398586|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154398587|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154398588|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154398589|NCT03153436|Inositol|inositol|mesh-list
154398590|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
154398591|NCT03153436|Vitamins|vitamins|mesh-ancestor
154398592|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
154398593|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398594|NCT03544229|Maleic acid|maleic acid|mesh-list
154398595|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513576|NCT01421212|Antibodies|antibodies|mesh-list
154398596|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398597|NCT02351908|Tenofovir|tenofovir|mesh-list
154398598|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154398599|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
154398600|NCT02351908|Dolutegravir|dolutegravir|mesh-list
154398601|NCT02351908|Cobicistat|cobicistat|mesh-list
154398602|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154398603|NCT02351908|Elvitegravir|elvitegravir|mesh-list
154398604|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
154398605|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398606|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154398607|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154398608|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398609|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398610|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154398611|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154398612|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154398613|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154398614|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154398615|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154398616|NCT01371240|Secretin|secretin|mesh-list
154398617|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398618|NCT01371240|Hormones|hormones|mesh-ancestor
154398619|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398620|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398621|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154398622|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154398623|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398624|NCT03723941|Etoposide|etoposide|mesh-list
154398625|NCT03723941|Mitotane|mitotane|mesh-list
154398626|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398627|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154398628|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154398629|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154398630|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398631|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398632|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154398633|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
154398634|NCT03721679|Nivolumab|nivolumab|mesh-list
154398635|NCT03721679|Atezolizumab|atezolizumab|mesh-list
154398636|NCT03721679|Durvalumab|durvalumab|mesh-list
154398637|NCT03721679|Poly ICLC|poly iclc|mesh-list
154398638|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154398639|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398640|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154398641|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398642|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
154398643|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
154398644|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398645|NCT03639948|Carboplatin|carboplatin|mesh-list
154398646|NCT03639948|Docetaxel|docetaxel|mesh-list
154398647|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
154398648|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398649|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
154398650|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
154398651|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
154398652|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398653|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154398654|NCT03639948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154133258|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398655|NCT03510455|Infigratinib|infigratinib|mesh-list
153973235|NCT00618501|Vitamins|vitamins|mesh-ancestor
154398656|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398658|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154398659|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154398660|NCT03509675|Analgesics|analgesics|mesh-ancestor
154398661|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
154398662|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398663|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398664|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154398665|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398666|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154398667|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398668|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398669|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
154398670|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
154398671|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154398672|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154398673|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398674|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398675|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398676|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398677|NCT02353078|Sucralfate|sucralfate|mesh-list
154398678|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154398679|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398680|NCT03509207|Vorinostat|vorinostat|mesh-list
154398681|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398682|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154398683|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398684|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398685|NCT03727295|Idebenone|idebenone|mesh-list
154398686|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
154398687|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398688|NCT03727295|Protective Agents|protective agents|mesh-ancestor
154398689|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398690|NCT01378650|Cilostazol|cilostazol|mesh-list
154398691|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154398692|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
154398693|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398694|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398695|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154398696|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
154398697|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154398698|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154398699|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398700|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154398701|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
154398702|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154398703|NCT01378650|Protective Agents|protective agents|mesh-ancestor
154398704|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154398705|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154398706|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398708|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
154398709|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154398710|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398711|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
154398712|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398713|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398714|NCT03723785|Insulin|insulin|mesh-list
154398715|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154398716|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154398717|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398718|NCT03543137|Nicotine|nicotine|mesh-list
154398719|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154398720|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
154398721|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398722|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398723|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154398724|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154398725|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
154398726|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133284|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398727|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383693|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398728|NCT02343484|Ethanol|ethanol|mesh-list
154398729|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154398730|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398731|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398732|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398733|NCT03073980|Acetaminophen|acetaminophen|mesh-list
154398734|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154398735|NCT03073980|Analgesics|analgesics|mesh-ancestor
154398736|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
154398737|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398738|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398739|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
154398740|NCT03930186|Apremilast|apremilast|mesh-list
154398741|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154398742|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154398743|NCT03930186|Analgesics|analgesics|mesh-ancestor
154398744|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
154398745|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398746|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398747|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154398748|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154398749|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154398750|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154398751|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398752|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398753|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154398754|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154398755|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154398756|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154398757|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398758|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398759|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398760|NCT02351440|Analgesics|analgesics|mesh-ancestor
154398761|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
154398762|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398763|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
154398764|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154398765|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
154398766|NCT03504917|Balovaptan|balovaptan|mesh-list
154398767|NCT03504917|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154398768|NCT03504917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254255|NCT05173688|Propofol|propofol|mesh-list
154398770|NCT03504917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398771|NCT02351128|Lanreotide|lanreotide|mesh-list
154398772|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398773|NCT02343250|Valsartan|valsartan|mesh-list
154398774|NCT02343250|Cilnidipine|cilnidipine|mesh-list
154398775|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154398776|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154398777|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154398778|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398779|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154398780|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154398781|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154398782|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398783|NCT03565211|Progesterone|progesterone|mesh-list
154398784|NCT03565211|Progestins|progestins|mesh-ancestor
154398785|NCT03565211|Hormones|hormones|mesh-ancestor
154398786|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398787|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398788|NCT03723395|Repaglinide|repaglinide|mesh-list
154398789|NCT03723395|Tolbutamide|tolbutamide|mesh-list
154398790|NCT03723395|Itraconazole|itraconazole|mesh-list
154398791|NCT03723395|Rifampin|rifampin|mesh-list
154398792|NCT03723395|Tucatinib|tucatinib|mesh-list
154398793|NCT03723395|Digoxin|digoxin|mesh-list
154398794|NCT03723395|Midazolam|midazolam|mesh-list
154398795|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
154398796|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154398797|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154398798|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398799|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398800|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154398801|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154398802|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154398803|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154398804|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
154398805|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
154398806|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
154398807|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
154398808|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398809|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398810|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
154398811|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398812|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154398813|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154398814|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398815|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154398816|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
154398817|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398818|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154398819|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154398820|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
154398821|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154398822|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
154398823|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154398824|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154398825|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154398826|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154398827|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154398828|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153745376|NCT04610658|Nivolumab|nivolumab|mesh-list
154398829|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154398830|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154398831|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154398832|NCT03723395|Protective Agents|protective agents|mesh-ancestor
154398833|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154398834|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398835|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154398836|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154398837|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
154398838|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154398839|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154398840|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154398841|NCT03531905|Ezetimibe|ezetimibe|mesh-list
154398842|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154398843|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154398844|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
154398845|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398846|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154398847|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398848|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154398849|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398850|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154398851|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154398852|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398853|NCT02346682|Clonazepam|clonazepam|mesh-list
154398854|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154398855|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154398856|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154398857|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154398858|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398859|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398860|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398861|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154398862|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
154398863|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154398864|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
154398865|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
154398866|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
154398867|NCT05764512|Endorphins|endorphins|mesh-list
154398868|NCT05764512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398869|NCT05764512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398870|NCT05764512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398871|NCT02342392|Ranibizumab|ranibizumab|mesh-list
153973452|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153973453|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973454|NCT02582203|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153973455|NCT05035927|Psilocybin|psilocybin|mesh-list
153973456|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
154398872|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154398873|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154398874|NCT02342392|Growth Substances|growth substances|mesh-ancestor
154398875|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398876|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
154398877|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398878|NCT02342002|Misoprostol|misoprostol|mesh-list
154398879|NCT02342002|Mifepristone|mifepristone|mesh-list
154398880|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154398881|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
154398882|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154398883|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398884|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154398885|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398886|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
154398887|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154398888|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154398889|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154398890|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154398891|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
154398892|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154398893|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154398894|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
154398895|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398896|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
154398897|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154398898|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154398900|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154398901|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398902|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154398903|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154398904|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398905|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398906|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398907|NCT02345902|Haloperidol|haloperidol|mesh-list
154398908|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
154398909|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
154398910|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
154398911|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154398912|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398913|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154398914|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154398915|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154398916|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154398917|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154398918|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154398919|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
154398920|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398921|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398922|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154398923|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
154398924|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
154398925|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154398926|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154398927|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398928|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398929|NCT02345980|Urological Agents|urological agents|mesh-ancestor
154398930|NCT02345746|Leucovorin|leucovorin|mesh-list
154398931|NCT02345746|Folic Acid|folic acid|mesh-list
154398932|NCT02345746|Fluorouracil|fluorouracil|mesh-list
154398933|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
154398934|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
154398935|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
154398936|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398937|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154398938|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398939|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154398940|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
154398941|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398942|NCT02345746|Antidotes|antidotes|mesh-ancestor
154398943|NCT02345746|Protective Agents|protective agents|mesh-ancestor
154398944|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
154398945|NCT02345746|Vitamins|vitamins|mesh-ancestor
154398946|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
154398947|NCT02345746|Hematinics|hematinics|mesh-ancestor
154398948|NCT03794778|Paclitaxel|paclitaxel|mesh-list
154398949|NCT03794778|Carboplatin|carboplatin|mesh-list
154398950|NCT03794778|Doxorubicin|doxorubicin|mesh-list
154398951|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154398952|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154398953|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154398954|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
154398955|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154398956|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133530|NCT00930072|Clonidine|clonidine|mesh-list
154398957|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398958|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154398959|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154398960|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154398961|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398962|NCT03790332|Ibrutinib|ibrutinib|mesh-list
154398963|NCT03790332|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154398964|NCT03790332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154398965|NCT03790332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154398966|NCT03790332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398967|NCT02341300|Iron|iron|mesh-list
154398968|NCT02341300|Trace Elements|trace elements|mesh-ancestor
154398969|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
154398970|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398971|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153731761|NCT00139256|Hormones|hormones|mesh-ancestor
154398972|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154398973|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154398974|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154398975|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154398976|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
154398977|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154398978|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154398979|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398980|NCT02345590|Eplerenone|eplerenone|mesh-list
154398981|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154398982|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
154398983|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154398984|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398985|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154398986|NCT02345590|Diuretics|diuretics|mesh-ancestor
154398987|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
154398988|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154398989|NCT03723083|Thalidomide|thalidomide|mesh-list
154398990|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154398991|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
154398992|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154398993|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
154398994|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154398995|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154398996|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154398997|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154398998|NCT03723083|Growth Substances|growth substances|mesh-ancestor
154398999|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
154399000|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399001|NCT03562481|Lidocaine|lidocaine|mesh-list
154399002|NCT03562481|Epinephrine|epinephrine|mesh-list
154399003|NCT03562481|Racepinephrine|racepinephrine|mesh-list
154399004|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
154399005|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154399006|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
154399007|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399008|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399009|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
154399010|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399011|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154399012|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154399013|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154399014|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154399015|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133604|NCT00926718|Rocuronium|rocuronium|mesh-list
154399016|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154399017|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154399018|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
154399019|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399020|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154399021|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154399022|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
154399023|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154399024|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
154399025|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
154399026|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
154399027|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154399028|NCT03726593|Artesunate|artesunate|mesh-list
154399029|NCT03726593|Mefloquine|mefloquine|mesh-list
154399030|NCT03726593|Atovaquone|atovaquone|mesh-list
154399031|NCT03726593|Pyronaridine|pyronaridine|mesh-list
154399032|NCT03726593|Proguanil|proguanil|mesh-list
154399033|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154399034|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
154399035|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154399036|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154133633|NCT00827450|Caffeine|caffeine|mesh-list
154399037|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399038|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399039|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
154399040|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
154399041|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154399042|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
154399043|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399044|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399045|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
154399046|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
154399047|NCT03197064|Aprepitant|aprepitant|mesh-list
154399048|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
154399049|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
154399050|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399051|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399052|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399053|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154399054|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399055|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399056|NCT02345044|Eplerenone|eplerenone|mesh-list
154399057|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154399058|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
154399059|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399060|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399061|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154399062|NCT02345044|Diuretics|diuretics|mesh-ancestor
154399063|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
154133644|NCT00930306|Midazolam|midazolam|mesh-list
154399064|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154399065|NCT02349802|Exenatide|exenatide|mesh-list
154399066|NCT02349802|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154399067|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154399068|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399069|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154399070|NCT02349802|Incretins|incretins|mesh-ancestor
154399071|NCT02349802|Hormones|hormones|mesh-ancestor
154399072|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399073|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
154399074|NCT03145714|Anesthetics|anesthetics|mesh-list
154399075|NCT03145714|Propofol|propofol|mesh-list
154399076|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399077|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399078|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154399079|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154399080|NCT03145714|Analgesics|analgesics|mesh-ancestor
154399081|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
154133672|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154399082|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399083|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154399084|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154399085|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154399086|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
154399087|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399088|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399089|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154399090|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
154399091|NCT02349958|Doxorubicin|doxorubicin|mesh-list
154399092|NCT02349958|Cisplatin|cisplatin|mesh-list
154399093|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154399094|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399095|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154399096|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154399097|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399098|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399099|NCT04872426|Insulin|insulin|mesh-list
154399100|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154399101|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399103|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
154399104|NCT02344888|Prednisolone|prednisolone|mesh-list
154399105|NCT02344888|Citric Acid|citric acid|mesh-list
154399106|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
154399107|NCT02344888|Clomiphene|clomiphene|mesh-list
154399108|NCT02344888|Enclomiphene|enclomiphene|mesh-list
154399109|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
154399110|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
154399111|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154399112|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
154399113|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
154399114|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399115|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399116|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
154399117|NCT02344888|Hormones|hormones|mesh-ancestor
154399118|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399119|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399120|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154399121|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399122|NCT02344888|Hematinics|hematinics|mesh-ancestor
154399123|NCT02344888|Vitamins|vitamins|mesh-ancestor
154399124|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
154133710|NCT00927030|Melatonin|melatonin|mesh-list
154399125|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154399126|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
154399127|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154399128|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
154399129|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154399130|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154399131|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154399132|NCT03497429|Niraparib|niraparib|mesh-list
154399133|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154399134|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399135|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399136|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399137|NCT03146104|Propofol|propofol|mesh-list
154399138|NCT03146104|Isoflurane|isoflurane|mesh-list
154399139|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154399140|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399141|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399142|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154399143|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
154399144|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
154399145|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154399146|NCT03497039|Diclofenac|diclofenac|mesh-list
154399147|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154399148|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154399149|NCT03497039|Analgesics|analgesics|mesh-ancestor
154399150|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
154399151|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399152|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399153|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399154|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154399155|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154399156|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399157|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399158|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
154399159|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154399160|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154399161|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
154399162|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399163|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399164|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399165|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
154399166|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
154399167|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399168|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
154399169|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154399170|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
154399171|NCT02349490|Hemostatics|hemostatics|mesh-list
154399172|NCT02349490|Coagulants|coagulants|mesh-ancestor
154399173|NCT03720899|Nicotine|nicotine|mesh-list
154399174|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154399175|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
154399176|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399177|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399178|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154399179|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154399180|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
154399181|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399182|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399183|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
154399184|NCT03145480|Ibrutinib|ibrutinib|mesh-list
154399185|NCT03145480|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154399186|NCT03145480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154399187|NCT03145480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399188|NCT03145480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399189|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399190|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399191|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
154399192|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399193|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399194|NCT03726515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154399195|NCT03726515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399196|NCT03071094|Nivolumab|nivolumab|mesh-list
154399197|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399198|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399199|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154399200|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399201|NCT03148990|Vaccines|vaccines|mesh-list
154399202|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
154399203|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399204|NCT04477642|Abatacept|abatacept|mesh-list
154399205|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154399206|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399207|NCT04477642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399208|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399209|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399210|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
154399211|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399212|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154399213|NCT02344732|Polymyxins|polymyxins|mesh-list
154399214|NCT02344732|Neomycin|neomycin|mesh-list
154399215|NCT02344732|Polymyxin B|polymyxin b|mesh-list
154399216|NCT02344732|Dexamethasone|dexamethasone|mesh-list
154399217|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154399218|NCT02344732|Homatropine|homatropine|mesh-list
154399219|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399220|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
154399221|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
154399222|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399223|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399224|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399225|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
154399226|NCT02344732|Hormones|hormones|mesh-ancestor
154399227|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399228|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154399229|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399230|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154399231|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154399232|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399233|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154399234|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399235|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399236|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
154399237|NCT03720665|Caffeine|caffeine|mesh-list
154399238|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154399239|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399240|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154399241|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399242|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399243|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154399244|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154399245|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
154399246|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399248|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399249|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973830|NCT06247488|Oxycodone|oxycodone|mesh-list
154399250|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154399251|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399252|NCT02344264|Ropivacaine|ropivacaine|mesh-list
154399253|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
154399254|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
154399255|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399256|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399257|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
154399258|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399259|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
154399260|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
154399261|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
154399262|NCT02339662|Gabapentin|gabapentin|mesh-list
154399263|NCT02339662|Amitriptyline|amitriptyline|mesh-list
154399264|NCT02339662|Analgesics|analgesics|mesh-ancestor
154399265|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
154399266|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399267|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399268|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
154399269|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154399270|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154399271|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399272|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154399273|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154399274|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154399275|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399276|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399277|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
154399278|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154399279|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
154399280|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154399281|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154399282|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154399283|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154399284|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
154399285|NCT02343718|Sirolimus|sirolimus|mesh-list
154399286|NCT02343718|Temsirolimus|temsirolimus|mesh-list
154399287|NCT02343718|MTOR Inhibitors|mtor inhibitors|mesh-list
154399288|NCT02343718|Vinblastine|vinblastine|mesh-list
154399289|NCT02343718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154399290|NCT02343718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399291|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399292|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399293|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
154399294|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399295|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399296|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154399297|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399298|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154399299|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
154399300|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154399301|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
154399302|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
154399303|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
154399304|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154399305|NCT03148522|Mirtazapine|mirtazapine|mesh-list
154399306|NCT03148522|Escitalopram|escitalopram|mesh-list
154399307|NCT03148522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154399308|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154399309|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133888|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399310|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399311|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399312|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
154399313|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399314|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399315|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
154399316|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154399317|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154399318|NCT03148522|Analgesics|analgesics|mesh-ancestor
154399319|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
154399320|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
154399321|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154399322|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
154399323|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
154399324|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154399325|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154399326|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399327|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154399328|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154399329|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154399330|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
154399331|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154399332|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154399333|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154399335|NCT03148444|Roxithromycin|roxithromycin|mesh-list
154399336|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154399337|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399338|NCT03148132|Bevacizumab|bevacizumab|mesh-list
154399339|NCT03148132|Ranibizumab|ranibizumab|mesh-list
153385442|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154399340|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399341|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399342|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154399343|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154399344|NCT03148132|Growth Substances|growth substances|mesh-ancestor
154399345|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399346|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
154399347|NCT02339350|Methotrexate|methotrexate|mesh-list
154399348|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154399349|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
154399350|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154399351|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399352|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154399353|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
154399354|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399355|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399356|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
154399357|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399358|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154399359|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399360|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
154399361|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154399362|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154399363|NCT02339428|Diclofenac|diclofenac|mesh-list
154399364|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154399365|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154399366|NCT02339428|Analgesics|analgesics|mesh-ancestor
154399367|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
154399368|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399369|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399370|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399371|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385597|NCT00553202|Hormones|hormones|mesh-ancestor
154399372|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154399373|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399374|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399375|NCT02337322|Ritonavir|ritonavir|mesh-list
154399376|NCT02337322|Darunavir|darunavir|mesh-list
154399377|NCT02337322|Dolutegravir|dolutegravir|mesh-list
154399378|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154399379|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154399380|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
154399381|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399382|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399383|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154399384|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154399385|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
154133975|NCT00933582|Naproxen|naproxen|mesh-list
154399386|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399387|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154399388|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154399389|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154399390|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154399391|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
154399392|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154399393|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
154399394|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399395|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
154399396|NCT02337166|Protective Agents|protective agents|mesh-ancestor
154399397|NCT03148288|Vitamin D|vitamin d|mesh-list
154399398|NCT03148288|Vitamins|vitamins|mesh-ancestor
154399399|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
154399400|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399401|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154399402|NCT02039362|Tenofovir|tenofovir|mesh-list
154399403|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
154399404|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399405|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154399406|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154399407|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133988|NCT00938730|Warfarin|warfarin|mesh-list
154399408|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399409|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154399410|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154399411|NCT02339116|Bevacizumab|bevacizumab|mesh-list
154399412|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
154399413|NCT02339116|Irinotecan|irinotecan|mesh-list
154399414|NCT02339116|Fluorouracil|fluorouracil|mesh-list
154399415|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399416|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399417|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154399418|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154399419|NCT02339116|Growth Substances|growth substances|mesh-ancestor
154399420|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399421|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
154399422|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154399423|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154399424|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399425|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399426|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
154399427|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154399428|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399429|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
154399430|NCT04824274|Fentanyl|fentanyl|mesh-list
154399431|NCT04824274|Morphine|morphine|mesh-list
154399432|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154399433|NCT04824274|Narcotics|narcotics|mesh-ancestor
154399434|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399435|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399436|NCT04824274|Analgesics|analgesics|mesh-ancestor
153385782|NCT03007719|Fluorides|fluorides|mesh-list
154399437|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
154399438|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399439|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154399440|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154399441|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
154399442|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
154399443|NCT02509494|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154399444|NCT02509494|Antiviral Agents|antiviral agents|mesh-ancestor
154399445|NCT02509494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399446|NCT02348788|Chloroquine|chloroquine|mesh-list
154399447|NCT02348788|Lumefantrine|lumefantrine|mesh-list
154399448|NCT02348788|Artemether|artemether|mesh-list
154399449|NCT02348788|Primaquine|primaquine|mesh-list
154399450|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154399451|NCT02348788|Amebicides|amebicides|mesh-ancestor
154399452|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154399453|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154399454|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399455|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
154399456|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154399457|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154399458|NCT02338570|Everolimus|everolimus|mesh-list
154399459|NCT02338570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154399460|NCT02338570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154399461|NCT02338570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134033|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154399462|NCT02338570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399463|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399464|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
154399465|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399466|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399467|NCT02336854|Tacrolimus|tacrolimus|mesh-list
154399468|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399469|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
154399470|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399471|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154399472|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399473|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974052|NCT05949541|Everolimus|everolimus|mesh-list
154399474|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154399475|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
154399476|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399477|NCT02332174|Rufinamide|rufinamide|mesh-list
154399478|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
154399479|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154399480|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154399481|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154399482|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399483|NCT03493451|Tislelizumab|tislelizumab|mesh-list
154399484|NCT03493451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399485|NCT03493451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399486|NCT03726125|Insulin|insulin|mesh-list
154399487|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154399488|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
154399489|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154399490|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399491|NCT02336308|Ketamine|ketamine|mesh-list
154399492|NCT02336308|Analgesics|analgesics|mesh-ancestor
154399493|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
154399494|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399495|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399496|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154399497|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154399498|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
154399499|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
154399500|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399501|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154399502|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154399503|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399504|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399505|NCT02336386|Dexamethasone|dexamethasone|mesh-list
154399506|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
154399507|NCT02336386|Doxorubicin|doxorubicin|mesh-list
154399508|NCT02336386|Bortezomib|bortezomib|mesh-list
154399509|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399510|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
154399511|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399512|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154399513|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154399514|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
154399515|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399516|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399517|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154399518|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399519|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
154399520|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
154399521|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399522|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399523|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
154399524|NCT02336386|Hormones|hormones|mesh-ancestor
154399525|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399526|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154399527|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399528|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154399529|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154399530|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154399531|NCT02337712|Etoposide|etoposide|mesh-list
154399532|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399533|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154399534|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154399535|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154134112|NCT00823862|Ribavirin|ribavirin|mesh-list
154399536|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399537|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399538|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154399539|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154399540|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154399541|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
154399542|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399543|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399544|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399545|NCT03492281|Urological Agents|urological agents|mesh-ancestor
154399546|NCT02336152|Anesthetics|anesthetics|mesh-list
154399547|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399548|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399550|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154399551|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154399552|NCT02331862|Prednisolone|prednisolone|mesh-list
154399553|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
154399554|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154399555|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
154399556|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399557|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
154399558|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
154399559|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399560|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399561|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399562|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
154399564|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399565|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154399566|NCT02331862|Protective Agents|protective agents|mesh-ancestor
154399567|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154399568|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399569|NCT03525119|Vaccines|vaccines|mesh-list
154399570|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
154399571|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399572|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
154399573|NCT05230654|Aprepitant|aprepitant|mesh-list
154399574|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
154399575|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
154399576|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399577|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399578|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399579|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154399580|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399581|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399582|NCT02039518|Gemcitabine|gemcitabine|mesh-list
154399583|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154399584|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
154399585|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399586|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399587|NCT03722381|Amlodipine|amlodipine|mesh-list
154399588|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154399589|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154399590|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154399591|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399592|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154399593|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399594|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
154399595|NCT04352608|Vaccines|vaccines|mesh-list
154399596|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
154399597|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399598|NCT03722303|Cortisone|cortisone|mesh-list
154399599|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399600|NCT03558503|Mitomycins|mitomycins|mesh-list
154399601|NCT03558503|Mitomycin|mitomycin|mesh-list
154399602|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154399603|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399604|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
154399605|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399606|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154399607|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399608|NCT02331706|Interferons|interferons|mesh-list
154399609|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
154399610|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
154399611|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399612|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
154399613|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399614|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
154399615|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399616|NCT03489863|Ticagrelor|ticagrelor|mesh-list
154399617|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154399618|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154399619|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154399620|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153974199|NCT05827159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134188|NCT05361057|Cytarabine|cytarabine|mesh-list
153974200|NCT05827159|Anticonvulsants|anticonvulsants|mesh-ancestor
153731760|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
154399621|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154399622|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
154399623|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399624|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399625|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399627|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
154399628|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154399629|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399630|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
154399631|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154399632|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154399633|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399634|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399635|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154399636|NCT03489551|Haloperidol|haloperidol|mesh-list
154399637|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
154399638|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
154399639|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399640|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399641|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399642|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154399643|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154399644|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399645|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154399646|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154399647|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
154399648|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399649|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399650|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154399651|NCT05762952|Dapagliflozin|dapagliflozin|mesh-list
154399652|NCT05762952|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154399653|NCT05762952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399654|NCT05762952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154399655|NCT05762952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399656|NCT02335684|Methamphetamine|methamphetamine|mesh-list
154399657|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154399658|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399659|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
154399660|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
154399661|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399662|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
154399663|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399664|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399665|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
154399666|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154399667|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154399668|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154399669|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154399670|NCT05198388|Endorphins|endorphins|mesh-list
154399671|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399672|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399673|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399674|NCT04210180|Varenicline|varenicline|mesh-list
154399675|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154399676|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154399677|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
154399678|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134255|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154399679|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399680|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399681|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154399682|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
154399683|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399684|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154399685|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154399686|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154399687|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399688|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399689|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154399690|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974275|NCT05681039|Atezolizumab|atezolizumab|mesh-list
153974276|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399691|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399692|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
154399693|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399694|NCT03105310|Interferons|interferons|mesh-list
154399695|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
154399697|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399698|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
154399699|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399700|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
154399701|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399702|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154399703|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154399704|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
154399705|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399706|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154399707|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
154399708|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399709|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399710|NCT03144466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154399711|NCT03144466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399712|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154399713|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154399714|NCT03105466|Tacrolimus|tacrolimus|mesh-list
154399715|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399716|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
154399717|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399718|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154399719|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399720|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399721|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154399722|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399723|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154399724|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399725|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
154399726|NCT03105466|Hormones|hormones|mesh-ancestor
154399727|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399728|NCT02335372|Acetic Acid|acetic acid|mesh-list
154399729|NCT02335372|Proflavine|proflavine|mesh-list
154399730|NCT02335372|Retinol acetate|retinol acetate|mesh-list
154399731|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154399732|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399733|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154399734|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
154399735|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399736|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154399737|NCT02335372|Protective Agents|protective agents|mesh-ancestor
154399738|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399739|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154399740|NCT02334904|Risperidone|risperidone|mesh-list
154399741|NCT02334904|Aripiprazole|aripiprazole|mesh-list
154399742|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154399743|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
154399744|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399745|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399746|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399747|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154399748|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154399749|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399750|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154399751|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153386635|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
154399752|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
154399753|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
154399754|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
154399755|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154399756|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154399757|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154399758|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154399759|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154399760|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154399761|NCT03437447|Praziquantel|praziquantel|mesh-list
154399762|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
154399763|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154399764|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399765|NCT03720041|Dexamethasone|dexamethasone|mesh-list
154399766|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
154399767|NCT03720041|Lenalidomide|lenalidomide|mesh-list
154399769|NCT03720041|BB 1101|bb 1101|mesh-list
154399770|NCT03720041|Glycine|glycine|mesh-list
154399771|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399772|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
154399773|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
154399774|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399775|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399776|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399777|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
154399778|NCT03720041|Hormones|hormones|mesh-ancestor
154399779|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399780|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154399781|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399782|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
154399783|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399784|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399785|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
154399786|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154399787|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154399788|NCT03720041|Growth Substances|growth substances|mesh-ancestor
154399789|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
154399790|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
154399791|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399792|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
154399793|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154134352|NCT00537381|Hormones|hormones|mesh-ancestor
154399794|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
154399795|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399796|NCT02334670|Fluconazole|fluconazole|mesh-list
154399797|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
154399798|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399799|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154399800|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154399801|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399802|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399803|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154399804|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
154399805|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399806|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399807|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154399808|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154399809|NCT02974868|PF-06700841|pf-06700841|mesh-list
154399810|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154399811|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399812|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399813|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
154399814|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154399815|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
154399816|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399817|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
154399818|NCT05076526|Protective Agents|protective agents|mesh-ancestor
154399819|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
154399820|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154399821|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399822|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154399823|NCT03143998|Grazoprevir|grazoprevir|mesh-list
154399824|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
154399825|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399826|NCT02334046|Remifentanil|remifentanil|mesh-list
154399827|NCT02334046|Sevoflurane|sevoflurane|mesh-list
154399828|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154399829|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154399830|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
154399831|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
154399832|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399833|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399834|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154399835|NCT02334046|Narcotics|narcotics|mesh-ancestor
154399836|NCT02334046|Analgesics|analgesics|mesh-ancestor
154399837|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
154399838|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399839|NCT02330380|Adalimumab|adalimumab|mesh-list
154399840|NCT02330380|Etanercept|etanercept|mesh-list
154399841|NCT02330380|Methotrexate|methotrexate|mesh-list
154399842|NCT02330380|Ustekinumab|ustekinumab|mesh-list
154399843|NCT02330380|Acitretin|acitretin|mesh-list
154399844|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154399845|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
154399846|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154399847|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399848|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154399849|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
154399850|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399851|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399852|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
154399853|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399854|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154399855|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399856|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
154399857|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154399858|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154399859|NCT02330380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154399860|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154399861|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154399862|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154399863|NCT02330380|Analgesics|analgesics|mesh-ancestor
154399864|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
154399865|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399866|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154399867|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
154399868|NCT02333890|Chloroquine|chloroquine|mesh-list
154399869|NCT02333890|Amebicides|amebicides|mesh-ancestor
154399870|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154399871|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154399872|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399873|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
154399874|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154399875|NCT02330302|Ropivacaine|ropivacaine|mesh-list
154399876|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
154399877|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
154399878|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399879|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399880|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
154399881|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399882|NCT03143530|Ropivacaine|ropivacaine|mesh-list
154399883|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
154399884|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
154399885|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399886|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399887|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
154399888|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399889|NCT01065818|Telbivudine|telbivudine|mesh-list
154399890|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
154399891|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399892|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154399893|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399894|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399895|NCT02318277|Durvalumab|durvalumab|mesh-list
154399896|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399897|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399898|NCT03143452|Lidocaine|lidocaine|mesh-list
154399899|NCT03143452|Tetracaine|tetracaine|mesh-list
154399900|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154399901|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
154399902|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
154399903|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399904|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399905|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
154399906|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399907|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154399908|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154399909|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154399910|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154399911|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399913|NCT01063868|Oxycodone|oxycodone|mesh-list
154399914|NCT01063868|Tapentadol|tapentadol|mesh-list
154399915|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154399916|NCT01063868|Narcotics|narcotics|mesh-ancestor
154399917|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399918|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399919|NCT01063868|Analgesics|analgesics|mesh-ancestor
154399920|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
154399921|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399922|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154399923|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154399924|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154399925|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399926|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
154399927|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399928|NCT04993924|Cetrorelix|cetrorelix|mesh-list
154399929|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154399930|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
154399931|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154399932|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399933|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
154399934|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154399935|NCT02330068|Citalopram|citalopram|mesh-list
154399936|NCT02330068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154399937|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154399938|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154399939|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399940|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399941|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
154399942|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399943|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154399944|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
154399945|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154399946|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
154399947|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154399948|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399949|NCT01312857|Panitumumab|panitumumab|mesh-list
154399950|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154399951|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399952|NCT02974010|Cycloserine|cycloserine|mesh-list
154399953|NCT02974010|Ketamine|ketamine|mesh-list
154399954|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154399955|NCT02974010|Analgesics|analgesics|mesh-ancestor
154399956|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
154399957|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154399958|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399959|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154399960|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154399961|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
154399962|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
154399963|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154399964|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154399965|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154399966|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154399967|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399968|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154399969|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399970|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154399971|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
154399972|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154399973|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
154399974|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154399975|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154399976|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154399977|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154399978|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154399979|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154399980|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
154399981|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154399982|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154399983|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
154399985|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154399986|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
154399987|NCT01061606|Sirolimus|sirolimus|mesh-list
154399988|NCT01061606|Temsirolimus|temsirolimus|mesh-list
154399989|NCT01061606|MTOR Inhibitors|mtor inhibitors|mesh-list
153974569|NCT04937816|Empagliflozin|empagliflozin|mesh-list
154399990|NCT01061606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154399991|NCT01061606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154399992|NCT01061606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154399993|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154399994|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
154399995|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154399996|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154399997|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154134564|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
154399998|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154399999|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154400000|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
154400001|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
154400002|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154400003|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154400004|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400005|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
154400006|NCT02329756|Coagulants|coagulants|mesh-ancestor
154400007|NCT02329288|Triamcinolone|triamcinolone|mesh-list
154400008|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154400009|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154400010|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154400011|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400012|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
154400013|NCT02329288|Hormones|hormones|mesh-ancestor
154400014|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400015|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400016|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400017|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
154400018|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400019|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400020|NCT02329054|Favipiravir|favipiravir|mesh-list
154400021|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
154400022|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400023|NCT03122457|C 1027|c 1027|mesh-list
154400024|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154400025|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
154400026|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154400027|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400028|NCT04407988|Letrozole|letrozole|mesh-list
154400029|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400030|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154400031|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154400032|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400033|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400034|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154400035|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
154400036|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400037|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400038|NCT02329132|Ranibizumab|ranibizumab|mesh-list
154400039|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154400040|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154400041|NCT02329132|Growth Substances|growth substances|mesh-ancestor
154400042|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400043|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
154400044|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400045|NCT04342078|Vitamin D|vitamin d|mesh-list
154400046|NCT04342078|Vitamins|vitamins|mesh-ancestor
154400047|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
154400048|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400049|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154400050|NCT02332954|Vortioxetine|vortioxetine|mesh-list
154400051|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
154400052|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154400053|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154400054|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154400055|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400056|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400057|NCT02332954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154400059|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400060|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400061|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400062|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
154400063|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154400064|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154400065|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154400066|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154400067|NCT01372761|CKD732|ckd732|mesh-list
154400068|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154400069|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154400070|NCT01372761|Growth Substances|growth substances|mesh-ancestor
154400071|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400072|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
154400073|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400074|NCT03873675|Hormones|hormones|mesh-list
154400075|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
154400076|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400077|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400078|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154400079|NCT05173857|Paclitaxel|paclitaxel|mesh-list
154400080|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154400081|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400082|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
154400083|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
154400084|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
154400085|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400086|NCT03142516|Leucovorin|leucovorin|mesh-list
154400087|NCT03142516|Folic Acid|folic acid|mesh-list
154400088|NCT03142516|Fluorouracil|fluorouracil|mesh-list
154400089|NCT03142516|Irinotecan|irinotecan|mesh-list
154400090|NCT03142516|Panitumumab|panitumumab|mesh-list
154400091|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
154400092|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
154400093|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400094|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154400095|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400096|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400097|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
154400098|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400099|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154400100|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154400101|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400102|NCT03142516|Antidotes|antidotes|mesh-ancestor
154400103|NCT03142516|Protective Agents|protective agents|mesh-ancestor
154400104|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
154400105|NCT03142516|Vitamins|vitamins|mesh-ancestor
154400106|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
154400107|NCT03142516|Hematinics|hematinics|mesh-ancestor
154400108|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154400109|NCT03482453|Mobocertinib|mobocertinib|mesh-list
154400110|NCT03482453|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154400111|NCT03482453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400112|NCT03482453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400113|NCT03482453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400114|NCT03719729|Rifaximin|rifaximin|mesh-list
154400115|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154400116|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400117|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154400118|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
154400119|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
154400120|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
154400121|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400122|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400123|NCT03714113|Antibodies|antibodies|mesh-list
154400124|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
154400125|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400126|NCT03472547|Diacerein|diacerein|mesh-list
154400127|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400128|NCT00799396|Aspirin|aspirin|mesh-list
154400129|NCT00799396|Clopidogrel|clopidogrel|mesh-list
154400130|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154400131|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154254289|NCT04188028|Paroxetine|paroxetine|mesh-list
154400132|NCT00799396|Analgesics|analgesics|mesh-ancestor
154400133|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
154400134|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400135|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400136|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400137|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154400138|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154400139|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154400140|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400141|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154400142|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154400143|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400144|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
154400145|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154400146|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154400147|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154400148|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
154400149|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400150|NCT03469349|Actovegin|actovegin|mesh-list
154400151|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154400152|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400153|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154400154|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154400155|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
154400156|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400157|NCT03469349|Protective Agents|protective agents|mesh-ancestor
154400158|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154400159|NCT03467945|Metformin|metformin|mesh-list
154400160|NCT03467945|Gliclazide|gliclazide|mesh-list
154400161|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154400162|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400163|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154400164|NCT03719261|Eusol|eusol|mesh-list
154400165|NCT03719261|Chitosan|chitosan|mesh-list
154400166|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154400167|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154400168|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
154400169|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400170|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154400171|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
154400172|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
154400173|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
154400174|NCT03719261|Coagulants|coagulants|mesh-ancestor
154400175|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
154400176|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400177|NCT00069238|Prednisone|prednisone|mesh-list
154400178|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
154400179|NCT00069238|Doxorubicin|doxorubicin|mesh-list
154400180|NCT00069238|Etoposide|etoposide|mesh-list
154400181|NCT00069238|Vincristine|vincristine|mesh-list
154400182|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
154400183|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400184|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
154400185|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400186|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154400187|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154400188|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
154400189|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400190|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400191|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154400192|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154400193|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154400194|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154400195|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400196|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400197|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
154400198|NCT00069238|Hormones|hormones|mesh-ancestor
154400199|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400200|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154400201|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154400202|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
154400203|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
154400204|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
154400205|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154400206|NCT03639155|Glycine|glycine|mesh-list
154400207|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
154400208|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400209|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400210|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974792|NCT04512105|Venetoclax|venetoclax|mesh-list
153974793|NCT04512105|Pitavastatin|pitavastatin|mesh-list
153974794|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400212|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
154400213|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
154400214|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400215|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400216|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
154400217|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400218|NCT03073200|Etanercept|etanercept|mesh-list
154400219|NCT03073200|Ixekizumab|ixekizumab|mesh-list
154400220|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154400221|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154400222|NCT03073200|Analgesics|analgesics|mesh-ancestor
154400223|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
154400224|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400225|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400226|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400227|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134793|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
154400228|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154400229|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400230|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
154400231|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
154400232|NCT01569984|Bevacizumab|bevacizumab|mesh-list
154400233|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154400234|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400235|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154400236|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154400237|NCT01569984|Growth Substances|growth substances|mesh-ancestor
154400238|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400239|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
154400240|NCT02328118|Triamcinolone|triamcinolone|mesh-list
154400241|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154400242|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154400243|NCT02328118|Ranibizumab|ranibizumab|mesh-list
154400244|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154400245|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154400246|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154400247|NCT02328118|Growth Substances|growth substances|mesh-ancestor
154400248|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400249|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154400250|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400251|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400252|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
154400253|NCT02328118|Hormones|hormones|mesh-ancestor
154400254|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400255|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400256|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
154400257|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400258|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400259|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
154400260|NCT02602314|Nilotinib|nilotinib|mesh-list
154400261|NCT02602314|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154400262|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400263|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400264|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400265|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400266|NCT05079880|Caffeine|caffeine|mesh-list
154400267|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
154400268|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400269|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154400270|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400271|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154400272|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400273|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154400274|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154400275|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
154400276|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400277|NCT03716765|Vitamin D|vitamin d|mesh-list
154400278|NCT03716765|Vitamins|vitamins|mesh-ancestor
154400279|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
153974876|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
153974877|NCT04360473|Ketamine|ketamine|mesh-list
153974878|NCT04360473|Anesthetics|anesthetics|mesh-list
153974879|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974880|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974881|NCT04360473|Analgesics|analgesics|mesh-ancestor
153974882|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
153974883|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974885|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154400280|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400281|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154400283|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154400284|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400285|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
154400286|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154400287|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154400288|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154400289|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400290|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400291|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
154400292|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400293|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400294|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154400295|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400296|NCT02918318|Esketamine|esketamine|mesh-list
154400297|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
154400298|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154400299|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
154400300|NCT04926454|Bupivacaine|bupivacaine|mesh-list
154400301|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
154400302|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
154400303|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400304|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400305|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
154400306|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400307|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154400308|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154400309|NCT04926454|Analgesics|analgesics|mesh-ancestor
154400310|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154400311|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154400312|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154400313|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
154400314|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400315|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400316|NCT03652376|Benralizumab|benralizumab|mesh-list
154400317|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154400318|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
154400319|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
154400320|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154400321|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400322|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
154400323|NCT01372839|Atorvastatin|atorvastatin|mesh-list
154400324|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154400325|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154400326|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
154400327|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400328|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154400329|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154400330|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400331|NCT01065350|Ketamine|ketamine|mesh-list
154400332|NCT01065350|Propofol|propofol|mesh-list
154400333|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154400334|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400335|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400336|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154400337|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
154400338|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
154400339|NCT01065350|Analgesics|analgesics|mesh-ancestor
154400340|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
154400341|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400342|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154400343|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154400344|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154400345|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400346|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400347|NCT02914977|Daunorubicin|daunorubicin|mesh-list
154400348|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154400349|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400350|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153974942|NCT04282044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400351|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154400352|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400353|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400354|NCT03718715|Metformin|metformin|mesh-list
154400355|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134905|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154400356|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400357|NCT05079022|Aflutinib|aflutinib|mesh-list
154400358|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400359|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400360|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400361|NCT05078788|Triamcinolone|triamcinolone|mesh-list
154400362|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400363|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
154400364|NCT05078788|Hormones|hormones|mesh-ancestor
154400365|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400366|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400367|NCT02032654|Floxacillin|floxacillin|mesh-list
154400368|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154400369|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400370|NCT04734886|Vitamin D|vitamin d|mesh-list
154400371|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
154400372|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
154400373|NCT04734886|Vitamins|vitamins|mesh-list
154400374|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
154400375|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400376|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154400377|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154400378|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154400379|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
154400380|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154400381|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154400382|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
154400383|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154400384|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
154400385|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400386|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400387|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
154400388|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154400389|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
154400390|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400391|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400392|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
154400393|NCT03114969|Hormones|hormones|mesh-ancestor
154400394|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400395|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
154400396|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154400397|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
154400398|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400399|NCT03144778|Durvalumab|durvalumab|mesh-list
154400400|NCT03144778|Ipilimumab|ipilimumab|mesh-list
154400401|NCT03144778|Tremelimumab|tremelimumab|mesh-list
154400402|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
154400403|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154400404|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
154400405|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154400406|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400407|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
154400408|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400409|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154400410|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400411|NCT03142360|Beraprost|beraprost|mesh-list
154400412|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154400413|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
154400414|NCT05124678|Isoniazid|isoniazid|mesh-list
154400415|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
154400416|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154400417|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400418|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154400419|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154400420|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
154400421|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975015|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975016|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
154134998|NCT00842114|Hormones|hormones|mesh-ancestor
153975017|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
153975018|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
153975019|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400422|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154400424|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
154400425|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154400426|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
154400427|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400428|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400429|NCT03144856|Apatinib|apatinib|mesh-list
154400430|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400431|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400432|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400433|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400434|NCT04949022|Insulin|insulin|mesh-list
154400435|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154400436|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400437|NCT02327338|Ibuprofen|ibuprofen|mesh-list
154400438|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154400439|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154400440|NCT02327338|Analgesics|analgesics|mesh-ancestor
154400441|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
154400442|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400443|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400444|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400445|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154400446|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154400447|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400448|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400449|NCT02327416|Entecavir|entecavir|mesh-list
154400450|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154400451|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
154400452|NCT02327416|Adefovir|adefovir|mesh-list
154400453|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154400454|NCT02327416|Molgramostim|molgramostim|mesh-list
154400455|NCT02327416|Sargramostim|sargramostim|mesh-list
154400456|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
154400457|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400458|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
154400459|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400460|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154135022|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400461|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154400462|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400463|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400464|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400465|NCT02926950|Metformin|metformin|mesh-list
154400466|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154400467|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154400468|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400469|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154400470|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400471|NCT01064414|Canagliflozin|canagliflozin|mesh-list
154400472|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154400473|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400474|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154400475|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400476|NCT03433703|Lenvatinib|lenvatinib|mesh-list
154400477|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400478|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400479|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400480|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400481|NCT01374633|Sevoflurane|sevoflurane|mesh-list
154400482|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154400483|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154135061|NCT00843908|Imidacloprid|imidacloprid|mesh-list
154400484|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
154400485|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
154400486|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400487|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400488|NCT01178814|Lenalidomide|lenalidomide|mesh-list
154400489|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
154400490|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400491|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154400492|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154400493|NCT01178814|Growth Substances|growth substances|mesh-ancestor
154400494|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
154400495|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400496|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
154400497|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
154400498|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400499|NCT05762484|Clindamycin|clindamycin|mesh-list
154400500|NCT05762484|Clindamycin palmitate|clindamycin palmitate|mesh-list
154400501|NCT05762484|Clindamycin phosphate|clindamycin phosphate|mesh-list
154400502|NCT05762484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154400503|NCT05762484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400504|NCT05762484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154400505|NCT05762484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400506|NCT05762484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400507|NCT03462641|Flumazenil|flumazenil|mesh-list
154400508|NCT03462641|Antidotes|antidotes|mesh-ancestor
154400509|NCT03462641|Protective Agents|protective agents|mesh-ancestor
154400510|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400511|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
154400512|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
154400513|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400514|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400515|NCT05761704|Anticoagulants|anticoagulants|mesh-list
154400516|NCT03652142|Nivolumab|nivolumab|mesh-list
154400517|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154400518|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400519|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154400520|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400521|NCT04629378|Amoxicillin|amoxicillin|mesh-list
154400522|NCT04629378|Meropenem|meropenem|mesh-list
154400523|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
154400524|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
154400525|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
154400526|NCT04629378|Bedaquiline|bedaquiline|mesh-list
154400527|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154400528|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154400529|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400530|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154400531|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400532|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400533|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
154400534|NCT03651674|Olanzapine|olanzapine|mesh-list
154400535|NCT03651674|Clozapine|clozapine|mesh-list
154400536|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
154400537|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
154400538|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400539|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400540|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154400541|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154400542|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154400543|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400544|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154400545|NCT03651674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154400546|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154400547|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400548|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400549|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400550|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
154400551|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154400552|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
154400553|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
154400554|NCT01061840|Molgramostim|molgramostim|mesh-list
154400555|NCT01061840|Vaccines|vaccines|mesh-list
154400556|NCT01061840|Sargramostim|sargramostim|mesh-list
154400557|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
154400558|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400559|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400560|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154400561|NCT02926638|Rilotumumab|rilotumumab|mesh-list
154400562|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154400563|NCT02926638|Antibodies|antibodies|mesh-list
154400564|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
154400565|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154400566|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
154400567|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400568|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400569|NCT02926638|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154400570|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400571|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400572|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400573|NCT03650582|Glucagon|glucagon|mesh-list
154400574|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154400575|NCT03650582|Hormones|hormones|mesh-ancestor
154400576|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400577|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400578|NCT02903030|Silicon|silicon|mesh-list
154400579|NCT02903030|Trace Elements|trace elements|mesh-ancestor
154400580|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
154400581|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400582|NCT02969408|Albuterol|albuterol|mesh-list
154400583|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154400584|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
154400585|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400586|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400587|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154400588|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
154400589|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
154400590|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154400591|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154400592|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154400593|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154400594|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
154400595|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400596|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400597|NCT05180214|Ketorolac|ketorolac|mesh-list
154400598|NCT05180214|Bupivacaine|bupivacaine|mesh-list
154400599|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
154400600|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
154400601|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135185|NCT00620750|Naltrexone|naltrexone|mesh-list
154400602|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400603|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
154400604|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400605|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154400606|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154400607|NCT05180214|Analgesics|analgesics|mesh-ancestor
154400608|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400609|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154400610|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154400611|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400612|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400613|NCT01060124|Fentanyl|fentanyl|mesh-list
154400614|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154400615|NCT01060124|Narcotics|narcotics|mesh-ancestor
154400616|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400617|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400618|NCT01060124|Analgesics|analgesics|mesh-ancestor
154400619|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
154400620|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400621|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154400622|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154400623|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
154400624|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
154400625|NCT03461003|Losartan|losartan|mesh-list
154400626|NCT03461003|Amlodipine|amlodipine|mesh-list
154400627|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154400628|NCT03461003|Lisinopril|lisinopril|mesh-list
154400629|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154400630|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154400631|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400632|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400633|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154029124|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
154400634|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400635|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
154400636|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154400637|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154400638|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154400640|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
154400641|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154400642|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154400643|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
154400644|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400645|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154400646|NCT03461003|Protective Agents|protective agents|mesh-ancestor
154400647|NCT03650348|Atezolizumab|atezolizumab|mesh-list
154400648|NCT03650348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154400649|NCT03650348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400650|NCT03650348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154400651|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400652|NCT05761470|Paclitaxel|paclitaxel|mesh-list
154400653|NCT05761470|Fluzoparib|fluzoparib|mesh-list
154400654|NCT05761470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154400655|NCT05761470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400656|NCT05761470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154400657|NCT05761470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154400658|NCT05761470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154400659|NCT05761470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400660|NCT05761470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154400661|NCT05761470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400662|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
154400663|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
154400664|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154400665|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154400666|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400667|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154400668|NCT02904902|Adalimumab|adalimumab|mesh-list
154400669|NCT02904902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154400670|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400671|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154400672|NCT03650270|Phenytoin|phenytoin|mesh-list
154400673|NCT03650270|Midazolam|midazolam|mesh-list
154400674|NCT03650270|Phenobarbital|phenobarbital|mesh-list
154400675|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154400676|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154400677|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400678|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400679|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154400680|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154400681|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154400682|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154400683|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
154400684|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
154400685|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
154400686|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
154400687|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400688|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400689|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
154400690|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154400691|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154400692|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400693|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154400694|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154400695|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154400696|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154400697|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154400698|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154400699|NCT05204628|Crizotinib|crizotinib|mesh-list
154400700|NCT05204628|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154400701|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400702|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400703|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400704|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400705|NCT03650738|Paclitaxel|paclitaxel|mesh-list
154400706|NCT03650738|Carboplatin|carboplatin|mesh-list
154400707|NCT03650738|Apatinib|apatinib|mesh-list
154400708|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154400709|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400710|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154400711|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154400712|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154400713|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400714|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400715|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400716|NCT02904200|Silicon|silicon|mesh-list
154400717|NCT02904200|Trace Elements|trace elements|mesh-ancestor
154400718|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
154400719|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400720|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154400721|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
154400722|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400723|NCT03621800|Menthol|menthol|mesh-list
154400724|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
154400725|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
154400726|NCT03649334|Ketorolac|ketorolac|mesh-list
154400727|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154400728|NCT03649334|Fentanyl|fentanyl|mesh-list
154400729|NCT03649334|Ketamine|ketamine|mesh-list
154400730|NCT03649334|Analgesics|analgesics|mesh-ancestor
154400731|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
154400732|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400733|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400734|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154400735|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154400736|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
154400737|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
154400738|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400739|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154400740|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154400741|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400742|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400743|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154400744|NCT03649334|Narcotics|narcotics|mesh-ancestor
154400745|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154400746|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154400747|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154400748|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154400749|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154400750|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154400751|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400752|NCT02901548|Durvalumab|durvalumab|mesh-list
154400753|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154400754|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400755|NCT03457727|Omeprazole|omeprazole|mesh-list
154400756|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154400757|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154400758|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154400759|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400760|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400761|NCT03648554|Dulaglutide|dulaglutide|mesh-list
154400762|NCT03648554|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154400763|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154400764|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400765|NCT03648320|Immunomodulating Agents|immunomodulating agents|mesh-list
154400766|NCT03648320|Immunologic Factors|immunologic factors|mesh-ancestor
154400767|NCT03648320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400768|NCT05284994|Osimertinib|osimertinib|mesh-list
154400769|NCT05284994|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154400770|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400771|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400772|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400773|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400774|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154400775|NCT03068754|Hormones|hormones|mesh-ancestor
154400776|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154400777|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400778|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
154400779|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154400780|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
154400781|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400782|NCT03430895|Durvalumab|durvalumab|mesh-list
154400783|NCT03430895|Tremelimumab|tremelimumab|mesh-list
154400785|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400786|NCT03452189|Vancomycin|vancomycin|mesh-list
154400787|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154400788|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400789|NCT00603954|Fludarabine|fludarabine|mesh-list
154400790|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
154400791|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154400792|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400793|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154400794|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
154400795|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400796|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400797|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
154400798|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400799|NCT03427619|Picibanil|picibanil|mesh-list
154400800|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400801|NCT03712475|Pregabalin|pregabalin|mesh-list
154400802|NCT03712475|Analgesics|analgesics|mesh-ancestor
154400803|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
154400804|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400805|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400806|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
154400807|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154400808|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400809|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400810|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154400811|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154400812|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154400813|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400814|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154400815|NCT02435433|Ramucirumab|ramucirumab|mesh-list
154400816|NCT02435433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154400817|NCT02435433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154400818|NCT02435433|Growth Substances|growth substances|mesh-ancestor
154400819|NCT02435433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400820|NCT02435433|Growth Inhibitors|growth inhibitors|mesh-ancestor
154400821|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400822|NCT01372371|Vancomycin|vancomycin|mesh-list
154400823|NCT01372371|Gentamicins|gentamicins|mesh-list
154400824|NCT01372371|Cefuroxime|cefuroxime|mesh-list
154400825|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
154400826|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154400827|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400828|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154400829|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400830|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400831|NCT03120351|Lidocaine|lidocaine|mesh-list
154400832|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
154400833|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
154400834|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400835|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400836|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
154400837|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400838|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154400839|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154400840|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154400841|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400842|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400843|NCT05165355|Aflutinib|aflutinib|mesh-list
154400844|NCT05165355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154400845|NCT05165355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400846|NCT05165355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400847|NCT01374789|Panitumumab|panitumumab|mesh-list
154400848|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154400849|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400850|NCT02354703|Ondansetron|ondansetron|mesh-list
154400851|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
154400852|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
154135442|NCT04420299|Bemiparin|bemiparin|mesh-list
154400853|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400854|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400855|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154400856|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
154400857|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
154400858|NCT02354703|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154400859|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154400860|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
154400861|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400862|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400863|NCT05008887|Fluorouracil|fluorouracil|mesh-list
154400864|NCT05008887|Methotrexate|methotrexate|mesh-list
154400865|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
154400866|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400867|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154400868|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154400869|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400870|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
154176478|NCT04042805|Lenvatinib|lenvatinib|mesh-list
154400871|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400872|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154400873|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
154400874|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154400875|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
154400876|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400877|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154400878|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154400879|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154400880|NCT01376193|Naratriptan|naratriptan|mesh-list
154400881|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154400882|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154400883|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154400884|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
154400885|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400886|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400887|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400888|NCT04944771|Rabeprazole|rabeprazole|mesh-list
154400889|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154400890|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154400891|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154400892|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400893|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400894|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
154400895|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154400896|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
154400897|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400898|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154400899|NCT05197101|Oxytocin|oxytocin|mesh-list
154400900|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
154400901|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154400902|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400903|NCT01375101|Quercetin|quercetin|mesh-list
154400904|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
154400905|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400906|NCT01375101|Protective Agents|protective agents|mesh-ancestor
154400907|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400908|NCT03633591|Tolcapone|tolcapone|mesh-list
154400909|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154400910|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154400911|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154400912|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400913|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400914|NCT01376271|Paroxetine|paroxetine|mesh-list
154400915|NCT01376271|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154400916|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154400917|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400918|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400919|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400920|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
154400921|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400922|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154400923|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
154400924|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154400925|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154400926|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154400927|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400928|NCT04885881|Lidocaine|lidocaine|mesh-list
154400929|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
154400930|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
154400931|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400932|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400933|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
154400934|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400935|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154400936|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154400937|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154400938|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154400939|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400940|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
154400942|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
154400943|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153975613|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154400944|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400945|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400946|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154400947|NCT04820205|Analgesics|analgesics|mesh-ancestor
154400948|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
154400949|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400950|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154400951|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154400952|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154400953|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
154400954|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400955|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400956|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154400957|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154400958|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
154400959|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
154400960|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154400961|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154400962|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154400963|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154400964|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154400965|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
154400966|NCT01375335|Dobutamine|dobutamine|mesh-list
154400967|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154400968|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
154400969|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
154400970|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400971|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400972|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154400973|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154400974|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154400975|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
154400976|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154400977|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400978|NCT01375335|Protective Agents|protective agents|mesh-ancestor
154400979|NCT01373463|Carboplatin|carboplatin|mesh-list
154400980|NCT01373463|Pemetrexed|pemetrexed|mesh-list
154400981|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135563|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
154400982|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154400983|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154400984|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154400985|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154400986|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154400987|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154400988|NCT03113409|Naltrexone|naltrexone|mesh-list
154400989|NCT03113409|Buprenorphine|buprenorphine|mesh-list
154400990|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154400991|NCT03113409|Narcotics|narcotics|mesh-ancestor
154400992|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154400993|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154400994|NCT03113409|Analgesics|analgesics|mesh-ancestor
154400995|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
154400996|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154400997|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154400998|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154400999|NCT05193747|Anesthetics|anesthetics|mesh-list
154401000|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401001|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401003|NCT03634293|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154401004|NCT03634293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154401005|NCT03634293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154401006|NCT03634293|Antimetabolites|antimetabolites|mesh-ancestor
154401007|NCT03634293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401008|NCT03634293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153733168|NCT05142865|Carboplatin|carboplatin|mesh-list
154401009|NCT03634293|Protease Inhibitors|protease inhibitors|mesh-ancestor
153975614|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135593|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975615|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975624|NCT05566301|Clopidogrel|clopidogrel|mesh-list
153975625|NCT05566301|Ticagrelor|ticagrelor|mesh-list
153975626|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153975627|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153975634|NCT05553704|Metformin|metformin|mesh-list
154401010|NCT03634293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401011|NCT03634293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154401012|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
154401013|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401014|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401015|NCT03633747|Propranolol|propranolol|mesh-list
154401016|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154401017|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154401018|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
154401019|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401020|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401021|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401022|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154401023|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154401024|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
154401025|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154401026|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154401027|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154401028|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154401030|NCT01373697|Ketoprofen|ketoprofen|mesh-list
154401031|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154401032|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154401033|NCT01373697|Analgesics|analgesics|mesh-ancestor
154401034|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
154401035|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401036|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401037|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401038|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401039|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154401040|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401041|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401042|NCT01375881|Ritonavir|ritonavir|mesh-list
154401043|NCT01375881|Darunavir|darunavir|mesh-list
154401044|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154401045|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154401046|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
154401047|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401048|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401049|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154401050|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154401051|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
154401052|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401053|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154401054|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154401055|NCT04690023|Ropivacaine|ropivacaine|mesh-list
154401056|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
154401057|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
154401058|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401059|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401060|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
154401061|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401062|NCT03066804|Valsartan|valsartan|mesh-list
154401063|NCT03066804|Enalapril|enalapril|mesh-list
154401064|NCT03066804|Enalaprilat|enalaprilat|mesh-list
154401065|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154401066|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154401067|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154401068|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154401069|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401070|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154401072|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401073|NCT03629262|Sufentanil|sufentanil|mesh-list
154401074|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
154401075|NCT03629262|Dsuvia|dsuvia|mesh-list
154401076|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154401077|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401078|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401079|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154401080|NCT03629262|Analgesics|analgesics|mesh-ancestor
154401081|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
154401082|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975686|NCT05209867|Cannabidiol|cannabidiol|mesh-list
154401083|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154401084|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154401085|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154401086|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
154401087|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401088|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401089|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154401090|NCT03629262|Narcotics|narcotics|mesh-ancestor
154401091|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154401092|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154401093|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
154401094|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
154401095|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
154401096|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154401097|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154401098|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
154401099|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401100|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154401101|NCT05207904|Paclitaxel|paclitaxel|mesh-list
154401102|NCT05207904|Carboplatin|carboplatin|mesh-list
154401103|NCT05207904|Tislelizumab|tislelizumab|mesh-list
154401104|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154401105|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401106|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154401107|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
154401108|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
154401109|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401110|NCT05207904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401111|NCT03118947|Pimavanserin|pimavanserin|mesh-list
154401112|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154401113|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154401114|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154401115|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154401116|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401117|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401118|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154401119|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154401120|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154401121|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
154401122|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401123|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401124|NCT03953079|Sunitinib|sunitinib|mesh-list
154401125|NCT03953079|Aflibercept|aflibercept|mesh-list
154401126|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401127|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154401128|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154401129|NCT03953079|Growth Substances|growth substances|mesh-ancestor
154401130|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401131|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
154401132|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154401133|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401134|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401135|NCT03794427|Anesthetics|anesthetics|mesh-list
154401136|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401137|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401138|NCT03410901|Antibodies|antibodies|mesh-list
154401139|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
154401140|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401141|NCT03357939|Adalimumab|adalimumab|mesh-list
154401142|NCT03357939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154401143|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401144|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401145|NCT03567057|Amantadine|amantadine|mesh-list
154401146|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154401147|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154401148|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
154401149|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401150|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
154401151|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401152|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401153|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401154|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154401155|NCT03567057|Analgesics|analgesics|mesh-ancestor
154401156|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
154401157|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401158|NCT03057600|Paclitaxel|paclitaxel|mesh-list
154401159|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154401160|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401161|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
154401162|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
154401163|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
154401164|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401165|NCT04382937|Ribavirin|ribavirin|mesh-list
154401166|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154401167|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
154401168|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401169|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
154401170|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401171|NCT05206890|Fluzoparib|fluzoparib|mesh-list
154401172|NCT05206890|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154401173|NCT05206890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401174|NCT05206890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401175|NCT05206890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401176|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
154401177|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401178|NCT03107091|Terlipressin|terlipressin|mesh-list
154401179|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154401180|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154401181|NCT03849768|Gefitinib|gefitinib|mesh-list
154401182|NCT03849768|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154401183|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154401184|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401185|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401186|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401187|NCT03189693|Anesthetics|anesthetics|mesh-list
154401188|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401189|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401190|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
154401191|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401192|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401193|NCT03065400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154401194|NCT03065400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401195|NCT05734716|Epoetin Alfa|epoetin alfa|mesh-list
154401196|NCT05734716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154401197|NCT05734716|Hematinics|hematinics|mesh-ancestor
154401198|NCT05733000|Thioctic Acid|thioctic acid|mesh-list
154401199|NCT05733000|Hydroxychloroquine|hydroxychloroquine|mesh-list
154401200|NCT05733000|Gemcitabine|gemcitabine|mesh-list
154401201|NCT05733000|Fluorouracil|fluorouracil|mesh-list
154401202|NCT05733000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154401203|NCT05733000|Antimetabolites|antimetabolites|mesh-ancestor
154401204|NCT05733000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401205|NCT05733000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401206|NCT05733000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154401207|NCT05733000|Immunologic Factors|immunologic factors|mesh-ancestor
154401208|NCT05733000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401209|NCT05733000|Antimalarials|antimalarials|mesh-ancestor
154401210|NCT05733000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154401211|NCT05733000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154401212|NCT05733000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401213|NCT05733000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401214|NCT05733000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401215|NCT05733000|Antioxidants|antioxidants|mesh-ancestor
154401216|NCT05733000|Protective Agents|protective agents|mesh-ancestor
154401217|NCT05733000|Vitamin B Complex|vitamin b complex|mesh-ancestor
153975836|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401219|NCT05733000|Micronutrients|micronutrients|mesh-ancestor
154401220|NCT03417180|Remifentanil|remifentanil|mesh-list
154401221|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154401222|NCT03417180|Narcotics|narcotics|mesh-ancestor
153975837|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975838|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
153975839|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
153975840|NCT04326673|Testosterone|testosterone|mesh-list
153975841|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
153975842|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
153975843|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153975844|NCT04326673|Androgens|androgens|mesh-ancestor
153975845|NCT04326673|Hormones|hormones|mesh-ancestor
153975847|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401223|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401224|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401225|NCT03417180|Analgesics|analgesics|mesh-ancestor
154401226|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
154401227|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401228|NCT03085095|Leuprolide|leuprolide|mesh-list
154401229|NCT03085095|Relugolix|relugolix|mesh-list
154401230|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154401231|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
154401232|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154401233|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401234|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401235|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401236|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
154401237|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
154401238|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401239|NCT02811783|Naloxone|naloxone|mesh-list
154401240|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154401241|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401242|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
154401243|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401244|NCT03106077|Maytansine|maytansine|mesh-list
154401245|NCT03106077|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154401246|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154401247|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401248|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
154401249|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
154401250|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
154401251|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401252|NCT03106077|Immunoconjugates|immunoconjugates|mesh-ancestor
154401253|NCT03106077|Immunologic Factors|immunologic factors|mesh-ancestor
154401254|NCT03106077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401255|NCT03648008|Morphine|morphine|mesh-list
154401256|NCT03648008|Hydromorphone|hydromorphone|mesh-list
154401257|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154401258|NCT03648008|Narcotics|narcotics|mesh-ancestor
154401259|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401260|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401261|NCT03648008|Analgesics|analgesics|mesh-ancestor
154401262|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
154401263|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401264|NCT05054751|Fulvestrant|fulvestrant|mesh-list
154401265|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401266|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401267|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154401268|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154401269|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
154401270|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401271|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401272|NCT00604617|Interferons|interferons|mesh-list
154401273|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
154401274|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401275|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
154401276|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401277|NCT03426995|Cantharidin|cantharidin|mesh-list
154401278|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401279|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401280|NCT05200299|Leucovorin|leucovorin|mesh-list
154401281|NCT05200299|Capecitabine|capecitabine|mesh-list
154401282|NCT05200299|Fluorouracil|fluorouracil|mesh-list
154401283|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
154401284|NCT05200299|Irinotecan|irinotecan|mesh-list
154401285|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
154401286|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154401287|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
154401288|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401289|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401290|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154401291|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
154401292|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401293|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154401294|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154401295|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401296|NCT05200299|Antidotes|antidotes|mesh-ancestor
154401297|NCT05200299|Protective Agents|protective agents|mesh-ancestor
154401298|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
154401299|NCT05200299|Vitamins|vitamins|mesh-ancestor
154401300|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
154401301|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
154401302|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401303|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401304|NCT03322566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154401305|NCT03322566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401306|NCT03822975|Heparin|heparin|mesh-list
154401307|NCT03822975|Calcium heparin|calcium heparin|mesh-list
154401308|NCT03822975|Bivalirudin|bivalirudin|mesh-list
154401309|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
154401310|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154401311|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154401312|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401313|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
154401314|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154401315|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
154401316|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401317|NCT05178225|Ubiquinone|ubiquinone|mesh-list
154401318|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
154401319|NCT05178225|Anticoagulants|anticoagulants|mesh-list
154401320|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
154401321|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401322|NCT05178225|Vitamins|vitamins|mesh-ancestor
154401323|NCT02969018|PF-06700841|pf-06700841|mesh-list
154401324|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154401325|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401326|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401327|NCT03255096|Rituximab|rituximab|mesh-list
154401328|NCT03255096|Venetoclax|venetoclax|mesh-list
154401329|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401330|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401331|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
154401332|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401333|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401334|NCT01319721|Mitomycins|mitomycins|mesh-list
154401335|NCT01319721|Mitomycin|mitomycin|mesh-list
154401336|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154401337|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401338|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
154401339|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401340|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154401341|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401342|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
154401343|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
154401344|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154401345|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154401346|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401347|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401348|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401349|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401350|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
154401351|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
154401352|NCT05139849|Vasopressins|vasopressins|mesh-list
154401353|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401354|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
154401355|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
154401356|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135935|NCT02544698|Vaccines|vaccines|mesh-list
154401357|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401358|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401360|NCT05139849|Hormones|hormones|mesh-ancestor
154401361|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401362|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154401363|NCT05139849|Protective Agents|protective agents|mesh-ancestor
154401364|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
154401365|NCT05139849|Coagulants|coagulants|mesh-ancestor
154401366|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154401367|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154401368|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
154401369|NCT03315741|Pirfenidone|pirfenidone|mesh-list
154401370|NCT03315741|Analgesics|analgesics|mesh-ancestor
154401371|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
154401372|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401373|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401374|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154401375|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154401376|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401377|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401378|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401379|NCT05077449|Fulvestrant|fulvestrant|mesh-list
154401380|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401381|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401382|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154401383|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154401384|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
154401385|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401386|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401387|NCT03632733|Tetracycline|tetracycline|mesh-list
154401388|NCT03632733|Clotrimazole|clotrimazole|mesh-list
154401389|NCT03632733|Miconazole|miconazole|mesh-list
154401390|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154401391|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401392|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154401393|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135967|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401394|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401395|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154401396|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
154401397|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154401398|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154401399|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154401400|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
154401401|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401402|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401403|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154401404|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154401405|NCT03259425|Nivolumab|nivolumab|mesh-list
154401406|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401407|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401408|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154401409|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401410|NCT03061188|Nivolumab|nivolumab|mesh-list
154401411|NCT03061188|Veliparib|veliparib|mesh-list
154401412|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401413|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401414|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154401415|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401416|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154401417|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401418|NCT05588453|Temozolomide|temozolomide|mesh-list
154401419|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154401420|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
154401421|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401422|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401423|NCT05186454|Dexamethasone|dexamethasone|mesh-list
154401424|NCT05186454|Midazolam|midazolam|mesh-list
154401425|NCT05186454|Morphine|morphine|mesh-list
154401426|NCT05186454|Bupivacaine|bupivacaine|mesh-list
154401427|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401428|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
154401429|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
154401430|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401431|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401432|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401433|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
154401435|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401436|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401437|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401438|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
154401439|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
154401440|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401441|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
154401442|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154401443|NCT05186454|Narcotics|narcotics|mesh-ancestor
154401444|NCT05186454|Analgesics|analgesics|mesh-ancestor
154401445|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154401446|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154401447|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154401448|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154401449|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154401450|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153976066|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
153976140|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
154401451|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
154401452|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
154401453|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
154401454|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401455|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401456|NCT02113878|Cisplatin|cisplatin|mesh-list
154401457|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401458|NCT05162898|Lenvatinib|lenvatinib|mesh-list
154401459|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401460|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154401461|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401462|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401463|NCT05113290|Sorafenib|sorafenib|mesh-list
154401464|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401465|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154401466|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401467|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401468|NCT03461952|Nivolumab|nivolumab|mesh-list
154401469|NCT03461952|Ipilimumab|ipilimumab|mesh-list
154401470|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401471|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401472|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154401473|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401474|NCT03619824|Gemcitabine|gemcitabine|mesh-list
154401475|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401476|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154401477|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
154401478|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401479|NCT01759836|Atorvastatin|atorvastatin|mesh-list
154401480|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154401481|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154401482|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
154401483|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401484|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154401485|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154401486|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401487|NCT03447821|Rifamycins|rifamycins|mesh-list
154401488|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
154401489|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154401490|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401491|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401492|NCT05630339|Vitamin D|vitamin d|mesh-list
154401493|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
154401494|NCT05630339|Vitamins|vitamins|mesh-ancestor
154401495|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
154401496|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401497|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154401498|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154401499|NCT03447353|Acetaminophen|acetaminophen|mesh-list
154401500|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154401501|NCT03447353|Hydrocodone|hydrocodone|mesh-list
154401503|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154401504|NCT03447353|Analgesics|analgesics|mesh-ancestor
154401505|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
154401506|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401507|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401508|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
154401509|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154401510|NCT03447353|Narcotics|narcotics|mesh-ancestor
154401511|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401512|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
154401513|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
154401514|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154401515|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154401516|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154401517|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154401518|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
154401519|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
154401520|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401521|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401522|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154401523|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401524|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401525|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154401526|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154401527|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136107|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154401528|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154401529|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154401530|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154401531|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401532|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
154401533|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401534|NCT00710970|Tamoxifen|tamoxifen|mesh-list
154401535|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154401536|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154401537|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
154401538|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401539|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401540|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401541|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401542|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154401543|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154401544|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154401545|NCT03421379|Glucagon|glucagon|mesh-list
154401546|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154401547|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401548|NCT03421379|Hormones|hormones|mesh-ancestor
154401549|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401550|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401551|NCT03421379|Incretins|incretins|mesh-ancestor
154401552|NCT03712241|Indomethacin|indomethacin|mesh-list
154401553|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154401554|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154401555|NCT03712241|Analgesics|analgesics|mesh-ancestor
154401556|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
154401557|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401558|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401559|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401560|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401561|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
154401562|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
154401563|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154401564|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154401565|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401566|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401567|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
154401568|NCT02675946|Cetuximab|cetuximab|mesh-list
154401569|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401570|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401571|NCT02675946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154401572|NCT02675946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401573|NCT02900378|Valsartan|valsartan|mesh-list
154401575|NCT02900378|Enalaprilat|enalaprilat|mesh-list
154401576|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154401577|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154401578|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154401579|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154401580|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401581|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154401582|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
154401583|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401584|NCT03058692|Vaccines|vaccines|mesh-list
154401585|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
154401586|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401587|NCT03647150|Amoxicillin|amoxicillin|mesh-list
154401588|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154401589|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401590|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
154401591|NCT03056352|Promethazine|promethazine|mesh-list
154401592|NCT03056352|Metoclopramide|metoclopramide|mesh-list
154401593|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154401594|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154401595|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401596|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401597|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
154401598|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
154401599|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
154401600|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401601|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
154401602|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
154401603|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401604|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154401605|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
154401606|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
154401607|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401608|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401609|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154401610|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
154401611|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
154401612|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154401613|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154401614|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
154401615|NCT04360980|Colchicine|colchicine|mesh-list
154401616|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
154401617|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401618|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
154401619|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
154401620|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
154401621|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401622|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401623|NCT03647072|Famotidine|famotidine|mesh-list
154401624|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154401625|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401626|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154401627|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
154401628|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
154401629|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401630|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401631|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401632|NCT05284136|Prednisolone|prednisolone|mesh-list
154401633|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401634|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
154401635|NCT05284136|Hormones|hormones|mesh-ancestor
154401636|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401637|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401638|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401639|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401640|NCT03646916|Dexamethasone|dexamethasone|mesh-list
154401641|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
154401642|NCT03646916|BB 1101|bb 1101|mesh-list
154401643|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401644|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
154401645|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
154401646|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401647|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401648|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401649|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
154401650|NCT03646916|Hormones|hormones|mesh-ancestor
154401651|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401652|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401653|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401654|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
154401655|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401656|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401657|NCT04305756|Enoxaparin|enoxaparin|mesh-list
154401658|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
154401659|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154401660|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154401661|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401662|NCT03645980|Sorafenib|sorafenib|mesh-list
154401663|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401664|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154401665|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401666|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401667|NCT04315038|Anesthetics|anesthetics|mesh-list
154401668|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401669|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401670|NCT03645200|Apatinib|apatinib|mesh-list
154401671|NCT03645200|Fluzoparib|fluzoparib|mesh-list
154401672|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401673|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153976299|NCT04099732|Dabigatran|dabigatran|mesh-list
154401674|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401675|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401676|NCT03645200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154401678|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154401679|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
154401680|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401681|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401682|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401683|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154401684|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154401685|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401686|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154401687|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154401688|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
154401689|NCT03645668|Meropenem|meropenem|mesh-list
154401690|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154401691|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401692|NCT03712163|Ketotifen|ketotifen|mesh-list
154401693|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
154401694|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
154401695|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154401696|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
154401697|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
154401698|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401699|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401700|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401701|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154401702|NCT01311167|Dexamethasone|dexamethasone|mesh-list
154401703|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401704|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
154401705|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
154401706|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401707|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401708|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401709|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
154401710|NCT01311167|Hormones|hormones|mesh-ancestor
154401711|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401712|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401713|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401714|NCT04233840|Nivolumab|nivolumab|mesh-list
154401715|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401716|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401717|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154401718|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401719|NCT02896400|Nicotine|nicotine|mesh-list
154401720|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154401721|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
154401722|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401723|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401724|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154401725|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154401726|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
154401727|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516706|NCT01437696|Vitamin D|vitamin d|mesh-list
154401728|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401729|NCT03404843|Fasudil|fasudil|mesh-list
154401730|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154401731|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154401732|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401733|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154401734|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401735|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
154401736|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154401737|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401738|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
154401739|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154401740|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401741|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401742|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154401743|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154401744|NCT05284448|Protective Agents|protective agents|mesh-ancestor
154401745|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401746|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
154401747|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154401748|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
154401749|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
154401750|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401751|NCT03444155|Folic Acid|folic acid|mesh-list
154401752|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
154401753|NCT03444155|Vitamins|vitamins|mesh-ancestor
154401754|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
154401755|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401756|NCT03444155|Hematinics|hematinics|mesh-ancestor
154401757|NCT02898116|Durvalumab|durvalumab|mesh-list
154401758|NCT02898116|Ensartinib|ensartinib|mesh-list
154401759|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154401760|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401761|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154401762|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471451|NCT05055024|Mazindol|mazindol|mesh-list
154401763|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401764|NCT03717701|Metformin|metformin|mesh-list
154401765|NCT03717701|Esomeprazole|esomeprazole|mesh-list
154401766|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154401767|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401768|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154401769|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401770|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154401771|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401772|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401773|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
154401774|NCT03422159|Thiamine|thiamine|mesh-list
154401775|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
154401776|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154401777|NCT03422159|Vitamins|vitamins|mesh-ancestor
154401778|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
154401779|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401780|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401781|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
154401782|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401783|NCT03422159|Protective Agents|protective agents|mesh-ancestor
154401784|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
154401785|NCT04538040|Tenofovir|tenofovir|mesh-list
154401786|NCT04538040|Emtricitabine|emtricitabine|mesh-list
154401787|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154401788|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
154401789|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401790|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154401791|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154401792|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401793|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401794|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154401795|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154401796|NCT02297412|Minocycline|minocycline|mesh-list
154401797|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154401798|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401799|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
154401800|NCT03644576|Ephedrine|ephedrine|mesh-list
154401801|NCT03644576|Ozanimod|ozanimod|mesh-list
154401802|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154401803|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
154401804|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401805|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401806|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154401807|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
154401808|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
154401809|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154401810|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154401811|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
154401812|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
154401813|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401814|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401815|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154401816|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154401817|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
154401818|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154401819|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154401820|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153976440|NCT01000610|Rituximab|rituximab|mesh-list
154401821|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154401822|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154401823|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154401824|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154401825|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154401826|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154401827|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401828|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401829|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401831|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401832|NCT01180374|Dronabinol|dronabinol|mesh-list
154401833|NCT01180374|Cannabidiol|cannabidiol|mesh-list
154401834|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
154401835|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
154401836|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401837|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154401838|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154401839|NCT01180374|Analgesics|analgesics|mesh-ancestor
154401840|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
154401841|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401842|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154401843|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154401844|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401845|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401846|NCT01180374|Hormones|hormones|mesh-ancestor
154401847|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401848|NCT03418571|Gontivimab|gontivimab|mesh-list
154401849|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
154401850|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401851|NCT03715517|Morphine|morphine|mesh-list
154401852|NCT03715517|Hydromorphone|hydromorphone|mesh-list
154401853|NCT03715517|Bupivacaine|bupivacaine|mesh-list
154401854|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154401855|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
154401856|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
154401857|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401858|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401859|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
154401860|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401861|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154401862|NCT03715517|Narcotics|narcotics|mesh-ancestor
154401863|NCT03715517|Analgesics|analgesics|mesh-ancestor
154401864|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
154401865|NCT03717467|Analgesics|analgesics|mesh-ancestor
154401866|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
154401867|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401868|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401869|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
154401870|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401872|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
154401873|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154401874|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154401875|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401876|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154401877|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
154401878|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154401879|NCT01318122|Pioglitazone|pioglitazone|mesh-list
154401880|NCT01318122|Alogliptin|alogliptin|mesh-list
154401881|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154401882|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401883|NCT01318122|Incretins|incretins|mesh-ancestor
154401884|NCT01318122|Hormones|hormones|mesh-ancestor
154401885|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401886|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154401887|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
154401888|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401889|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401890|NCT02954159|Vedolizumab|vedolizumab|mesh-list
154401891|NCT02954159|Tacrolimus|tacrolimus|mesh-list
154401892|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154401893|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
154401894|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401895|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154401896|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401897|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976511|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
154401898|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401899|NCT03763422|Temozolomide|temozolomide|mesh-list
154401900|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154401901|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
154401902|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401903|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401904|NCT03440411|Dexamethasone|dexamethasone|mesh-list
154401905|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
154401906|NCT03440411|Pomalidomide|pomalidomide|mesh-list
154401907|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154401908|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
154401909|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401910|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154401911|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154401912|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
154401913|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401914|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154401915|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154401916|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401917|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
154401918|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
154401919|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401920|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401921|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
154401922|NCT03440411|Hormones|hormones|mesh-ancestor
154401923|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154401924|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154401925|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154401926|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154401927|NCT03440411|Growth Substances|growth substances|mesh-ancestor
154401928|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
154401929|NCT03714737|Vaccines|vaccines|mesh-list
154401930|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
154401931|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401932|NCT03389555|Vitamins|vitamins|mesh-list
154401933|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
154401934|NCT03389555|Thiamine|thiamine|mesh-list
154401935|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
154401936|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
154401937|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401938|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154401939|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
154401940|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401941|NCT03389555|Protective Agents|protective agents|mesh-ancestor
154401942|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
154401943|NCT03395639|Heparin|heparin|mesh-list
154401944|NCT03395639|Enoxaparin|enoxaparin|mesh-list
154401945|NCT03395639|Warfarin|warfarin|mesh-list
154401946|NCT03395639|Edoxaban|edoxaban|mesh-list
154401947|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
154401948|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154401949|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154401950|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401951|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154401952|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
154401953|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154401954|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
154401955|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401956|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
154401957|NCT03353922|Tolperisone|tolperisone|mesh-list
154401958|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154401959|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
154401960|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154401961|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154401962|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401963|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154401964|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154401965|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154401966|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401967|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
154401968|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154401969|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401970|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154401971|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401972|NCT05467553|Tenofovir|tenofovir|mesh-list
154401973|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154401974|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
154401975|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154401976|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154401977|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154401978|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154401979|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401980|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154401981|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154401982|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154401983|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154401984|NCT02942004|Pregnanolone|pregnanolone|mesh-list
154401985|NCT02942004|Brexanolone|brexanolone|mesh-list
154401986|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
154401987|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154401988|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154401989|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154401990|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
154401991|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
154401992|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
154401993|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401994|NCT03414359|Lidocaine|lidocaine|mesh-list
154401995|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
154401996|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
154401997|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
154401998|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154401999|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402000|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
154402001|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402002|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154402003|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154402004|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154402005|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154402006|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402007|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
154402008|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
154402009|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402010|NCT02583048|Dolutegravir|dolutegravir|mesh-list
154402011|NCT02583048|Bedaquiline|bedaquiline|mesh-list
154402012|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154402013|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154402014|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402015|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402016|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154402017|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154402018|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
154402019|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402020|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
154402021|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154402022|NCT03274687|Androgens|androgens|mesh-list
154402023|NCT03274687|Hormones|hormones|mesh-ancestor
154402024|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154402025|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402026|NCT02542956|Bupivacaine|bupivacaine|mesh-list
154402027|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
154402028|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
154402029|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402030|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402031|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
154402032|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402033|NCT03274453|Ketamine|ketamine|mesh-list
154402034|NCT03274453|Analgesics|analgesics|mesh-ancestor
154402035|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
154402036|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402037|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402038|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154402039|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154402040|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
154402041|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
154402042|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402043|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154402044|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154402045|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402046|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402047|NCT02313870|Clobetasol|clobetasol|mesh-list
154402048|NCT02313870|Methotrexate|methotrexate|mesh-list
153976663|NCT02389465|Dexetimide|dexetimide|mesh-list
154402049|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154402051|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154402052|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402053|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154402054|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
154402055|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402056|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402057|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
154402058|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402059|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154402060|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154402061|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
154402062|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402063|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154402064|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402065|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
154402066|NCT02313870|Hormones|hormones|mesh-ancestor
154402067|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154402068|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
154402069|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154402070|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402071|NCT01942122|Analgesics|analgesics|mesh-ancestor
154402072|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
154402073|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402074|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402075|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402076|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402077|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154402078|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402079|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402080|NCT02236806|Ramipril|ramipril|mesh-list
154402081|NCT02236806|Bisoprolol|bisoprolol|mesh-list
154402082|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154402083|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
154402084|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402085|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402086|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154402087|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
154402088|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
154402089|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402090|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402091|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154402092|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154402093|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154402094|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402095|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402096|NCT01578954|Lenalidomide|lenalidomide|mesh-list
154402097|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
154402098|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402099|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154402100|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154402101|NCT01578954|Growth Substances|growth substances|mesh-ancestor
154402102|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
154402103|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402104|NCT00659646|Levofloxacin|levofloxacin|mesh-list
154402105|NCT00659646|Ofloxacin|ofloxacin|mesh-list
154402106|NCT00659646|Gentamicins|gentamicins|mesh-list
154402107|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154402108|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402109|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154402110|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154402111|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154402112|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402113|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402114|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402115|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154402116|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154402117|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154402118|NCT02236572|Everolimus|everolimus|mesh-list
154402119|NCT02236572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154402120|NCT02236572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154402121|NCT02236572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402122|NCT02236572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402123|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154402124|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
154402125|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402126|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402128|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154402129|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
154402130|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
154402131|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402132|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402133|NCT03414047|Prexasertib|prexasertib|mesh-list
154402134|NCT03414047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154402135|NCT03414047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402136|NCT03414047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402137|NCT05448677|Bevacizumab|bevacizumab|mesh-list
154402138|NCT05448677|Atezolizumab|atezolizumab|mesh-list
154402139|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154402140|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402141|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154402142|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154402143|NCT05448677|Growth Substances|growth substances|mesh-ancestor
154402144|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402145|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
154402146|NCT05448677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154402147|NCT05448677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402148|NCT05222646|Metoclopramide|metoclopramide|mesh-list
154402149|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
154402150|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
154402151|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402152|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402153|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154402154|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154402155|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154402156|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
154402157|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402158|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402159|NCT05222334|Bupivacaine|bupivacaine|mesh-list
154402160|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
154402161|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
154402162|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402163|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402164|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
154402165|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402166|NCT04465266|Tolperisone|tolperisone|mesh-list
154402167|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154402168|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402169|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154402170|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402171|NCT04434300|Daptomycin|daptomycin|mesh-list
154402172|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154402173|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402174|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
154402175|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
154402176|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154402177|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154402178|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402179|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402180|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402181|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402182|NCT05178654|Nirmatrelvir|nirmatrelvir|mesh-list
154402183|NCT05178654|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154402184|NCT05178654|Protease Inhibitors|protease inhibitors|mesh-ancestor
154402185|NCT05178654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402186|NCT05178654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402187|NCT05178654|Antiviral Agents|antiviral agents|mesh-ancestor
154402188|NCT05178654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402189|NCT04108962|Benralizumab|benralizumab|mesh-list
154402190|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154402191|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
154402192|NCT04865796|Lactoferrin|lactoferrin|mesh-list
154402193|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402194|NCT04811118|Docetaxel|docetaxel|mesh-list
154402195|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402196|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154402197|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154402198|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154402199|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402200|NCT05221164|Aspirin|aspirin|mesh-list
154402201|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154402202|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402203|NCT05221164|Analgesics|analgesics|mesh-ancestor
154402204|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
154402205|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402206|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402207|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402208|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402209|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154402210|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154402211|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402212|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154402213|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154402214|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402215|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
154402216|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
154402217|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154402218|NCT03627546|Velpatasvir|velpatasvir|mesh-list
154402219|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
154402220|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402221|NCT04620798|Antibodies|antibodies|mesh-list
154402222|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
154402223|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402224|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
154402225|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
154402226|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154402227|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154402228|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402229|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402230|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402231|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402232|NCT04765644|Celecoxib|celecoxib|mesh-list
154402233|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154402234|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402235|NCT04765644|Analgesics|analgesics|mesh-ancestor
154402236|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
154402237|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402238|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402239|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402240|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402241|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154402242|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154402243|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402244|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402245|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
154402246|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154136852|NCT00994617|Losartan|losartan|mesh-list
154402247|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154402248|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154402249|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154402250|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402251|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
154402252|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402253|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402254|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154402255|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402256|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154402257|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154402258|NCT05197374|Estradiol|estradiol|mesh-list
154402259|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154402260|NCT05197374|Estrogens|estrogens|mesh-ancestor
154402261|NCT05197374|Hormones|hormones|mesh-ancestor
154402262|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154402263|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402264|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154402265|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
154402266|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154402267|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154402268|NCT02951819|Dexamethasone|dexamethasone|mesh-list
154402269|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
154402270|NCT02951819|Bortezomib|bortezomib|mesh-list
154402271|NCT02951819|Daratumumab|daratumumab|mesh-list
154402272|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154402274|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402275|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402276|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154402277|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
154136865|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154402278|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402279|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402280|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154402281|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402282|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
154402283|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
154402284|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402285|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154402286|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
154402287|NCT02951819|Hormones|hormones|mesh-ancestor
154402288|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154402289|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154402290|NCT05191290|Heparin|heparin|mesh-list
154402291|NCT05191290|Calcium heparin|calcium heparin|mesh-list
154402292|NCT05191290|Citric Acid|citric acid|mesh-list
154402293|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
154402294|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
154402295|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154402296|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
154402297|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
154402298|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402299|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154402300|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154402301|NCT05627544|Anesthetics|anesthetics|mesh-list
154402302|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402303|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402304|NCT03383783|Listerine|listerine|mesh-list
154402305|NCT03383783|Fluorides|fluorides|mesh-list
154402306|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
154402307|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
154402308|NCT03383783|Protective Agents|protective agents|mesh-ancestor
154402309|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402310|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154402311|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402312|NCT03627390|Molybdenum|molybdenum|mesh-list
154402313|NCT03627390|Trace Elements|trace elements|mesh-ancestor
154402314|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
154402315|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402316|NCT03709745|Ranibizumab|ranibizumab|mesh-list
154402317|NCT03709745|Aflibercept|aflibercept|mesh-list
154402318|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154402319|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154402320|NCT03709745|Growth Substances|growth substances|mesh-ancestor
154402321|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402322|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
154402323|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402324|NCT05570526|Melatonin|melatonin|mesh-list
154402325|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
154402326|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402327|NCT05570526|Protective Agents|protective agents|mesh-ancestor
154402328|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402329|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402330|NCT03707639|Apatinib|apatinib|mesh-list
154402331|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402332|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154402333|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402334|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402335|NCT03334721|Gabapentin|gabapentin|mesh-list
154402336|NCT03334721|Analgesics|analgesics|mesh-ancestor
154402337|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
154402338|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402339|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402340|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
154402341|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154402342|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154402343|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402344|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154402345|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153976965|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
154402346|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154402347|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402348|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402349|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
154402350|NCT05706090|Fentanyl|fentanyl|mesh-list
154402351|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
154402352|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402353|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402354|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154402355|NCT05706090|Narcotics|narcotics|mesh-ancestor
154402356|NCT05706090|Analgesics|analgesics|mesh-ancestor
154402357|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
154402358|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402359|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154402360|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154402361|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
154402362|NCT03380429|Albuterol|albuterol|mesh-list
154402363|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154402364|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
154402365|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402366|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402367|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154402368|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
154402369|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
154402370|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154402371|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154402372|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154402373|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154402374|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402375|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402376|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402377|NCT01313143|Esmolol|esmolol|mesh-list
154402378|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154402379|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154402380|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154402381|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402382|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402383|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402384|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402385|NCT05071794|Propofol|propofol|mesh-list
154402386|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154402387|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402388|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402389|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154402390|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
154402392|NCT03280537|Omalizumab|omalizumab|mesh-list
154402393|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154402394|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154402395|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
154402396|NCT05029050|Clonidine|clonidine|mesh-list
154402397|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
154402398|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154402399|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402400|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402401|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402402|NCT05029050|Analgesics|analgesics|mesh-ancestor
154402403|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
154402404|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136983|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402405|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154402406|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154402407|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154402408|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402409|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402410|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402411|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154402412|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
154402413|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
154402414|NCT04690231|Etoposide|etoposide|mesh-list
154402415|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
154402416|NCT04690231|Apatinib|apatinib|mesh-list
154402417|NCT04690231|Ifosfamide|ifosfamide|mesh-list
154402418|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
154402419|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154402420|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402421|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154402422|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153977116|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154402423|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402424|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402425|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154402426|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154402427|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
154402428|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154402429|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154402430|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154402431|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
154402432|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402433|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154402434|NCT04234945|Doxycycline|doxycycline|mesh-list
154402435|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154402436|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402437|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
154402438|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154402439|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154402440|NCT03316807|Vaccines|vaccines|mesh-list
154402441|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
154402442|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402443|NCT03379259|Tislelizumab|tislelizumab|mesh-list
154402444|NCT03379259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154402445|NCT03379259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402446|NCT03328897|Omalizumab|omalizumab|mesh-list
154402447|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154402448|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154402449|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
154402450|NCT04918758|Sucralfate|sucralfate|mesh-list
154402451|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154402452|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154402453|NCT03378635|Glucagon|glucagon|mesh-list
154402454|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154402455|NCT03378635|Hormones|hormones|mesh-ancestor
154402456|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154402457|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402458|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154402459|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154402460|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402461|NCT01182727|Analgesics|analgesics|mesh-ancestor
154402462|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
154402463|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402464|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402465|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402466|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402467|NCT03334409|Vitamins|vitamins|mesh-list
154402468|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
154402469|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
154402470|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402471|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
154402472|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402473|NCT03334409|Protective Agents|protective agents|mesh-ancestor
154402474|NCT02891915|Amoxicillin|amoxicillin|mesh-list
154402475|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
154402476|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
154402477|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154402478|NCT02891915|Cefdinir|cefdinir|mesh-list
154402479|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154402480|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402481|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154402482|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402483|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402484|NCT02891915|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154402485|NCT02891915|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154402486|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
154402487|NCT03051217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154402488|NCT03051217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402489|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154402490|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
154402491|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402492|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402493|NCT05035303|Epinephrine|epinephrine|mesh-list
154402494|NCT05035303|Norepinephrine|norepinephrine|mesh-list
154402495|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154402496|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154402497|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402498|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402499|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402500|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402501|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154402502|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154402503|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
154402504|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402505|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154402506|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
154402507|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
154402508|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
154402509|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154402510|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154402511|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
154402512|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402513|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
154402514|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154402515|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402516|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154402517|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
154402518|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154402519|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402520|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402521|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402522|NCT04580394|Oxybutynin|oxybutynin|mesh-list
154402523|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154402524|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154402525|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154402526|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154402527|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402528|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402529|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402530|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402531|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
154402532|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
154402533|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402534|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154402535|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154402536|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
154402537|NCT04580394|Urological Agents|urological agents|mesh-ancestor
154402539|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154402540|NCT04385173|Temozolomide|temozolomide|mesh-list
154402541|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154402542|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
154402543|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402544|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402545|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
154402546|NCT03707249|Hematinics|hematinics|mesh-ancestor
154402547|NCT05682911|Simvastatin|simvastatin|mesh-list
154402548|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154402549|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154402550|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
154402551|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402552|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154402553|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154402554|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402555|NCT04625088|Atropine|atropine|mesh-list
154402556|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154402557|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154402558|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154402559|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
154402560|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402561|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402562|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154402563|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
154402564|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
154402565|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
154402566|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154402567|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154402568|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
154402569|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402570|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977190|NCT00627731|Hormones|hormones|mesh-ancestor
154402571|NCT03568422|Paclitaxel|paclitaxel|mesh-list
154402572|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154402573|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402574|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
154402575|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
154402576|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
154402577|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402578|NCT02547493|Abatacept|abatacept|mesh-list
154402579|NCT02547493|Vaccines|vaccines|mesh-list
154402580|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154402581|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
154402582|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402583|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154402584|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402585|NCT02547493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154402586|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402587|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154402588|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402589|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
154402590|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154402591|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402592|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
154402593|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
154402594|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402595|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402596|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402597|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
154402598|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
154402599|NCT03257995|Maleic acid|maleic acid|mesh-list
154402600|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402601|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402602|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154402603|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154402604|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
154402605|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402606|NCT03049488|Antacids|antacids|mesh-ancestor
154402607|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402608|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154402609|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
154402610|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154402611|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402612|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402614|NCT04484922|Analgesics|analgesics|mesh-ancestor
154402615|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
154402616|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402617|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154402618|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154402619|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154402620|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402621|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402622|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402623|NCT04446390|Listerine|listerine|mesh-list
154402624|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
154402625|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
154402626|NCT04446390|Protective Agents|protective agents|mesh-ancestor
154402627|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402628|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154402629|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402630|NCT02338921|Metformin|metformin|mesh-list
154402631|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
154402632|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154402633|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154402634|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402635|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154402636|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402637|NCT02338921|Incretins|incretins|mesh-ancestor
154402638|NCT02338921|Hormones|hormones|mesh-ancestor
154402639|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154402640|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154402641|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
154402642|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402643|NCT01313845|Amantadine|amantadine|mesh-list
154402644|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154402645|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154402646|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
154402647|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402648|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
154402649|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402650|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402651|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402652|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402653|NCT01313845|Analgesics|analgesics|mesh-ancestor
154402654|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
154402655|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402656|NCT04745845|Norepinephrine|norepinephrine|mesh-list
154402657|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154402658|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154402659|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402660|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402661|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402662|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402663|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
154402664|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
154402665|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402666|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154402667|NCT03196986|Bevacizumab|bevacizumab|mesh-list
154402668|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154402669|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402670|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154402671|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154402672|NCT03196986|Growth Substances|growth substances|mesh-ancestor
154402673|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402674|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
154402675|NCT04051632|Insulin|insulin|mesh-list
154402676|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154402677|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402678|NCT03043560|Ezogabine|ezogabine|mesh-list
154402679|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
154402680|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154402681|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402682|NCT02145403|Tacrolimus|tacrolimus|mesh-list
154402683|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154402684|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
154402685|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402686|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154402687|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137257|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
154402688|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402690|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154402691|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402692|NCT02899988|Analgesics|analgesics|mesh-ancestor
154402693|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
154402694|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402695|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402696|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402697|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402698|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154402699|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154402700|NCT03646526|Amitriptyline|amitriptyline|mesh-list
154402701|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154402702|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
154402703|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154402704|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402705|NCT03646526|Analgesics|analgesics|mesh-ancestor
154402706|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
154402707|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402708|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402709|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154402710|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154402711|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154402712|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402713|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402714|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402715|NCT03646370|Tenofovir|tenofovir|mesh-list
154402716|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
154402717|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402718|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153977415|NCT00627575|Phenytoin|phenytoin|mesh-list
154402719|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154402720|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402721|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402722|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154402723|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154402724|NCT03646292|Pioglitazone|pioglitazone|mesh-list
154402725|NCT03646292|Empagliflozin|empagliflozin|mesh-list
154402726|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154402727|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402728|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154402729|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402730|NCT03345407|Albuterol|albuterol|mesh-list
154402731|NCT03345407|Nemiralisib|nemiralisib|mesh-list
154402732|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154402733|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
154402734|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402735|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402736|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154402737|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
154402738|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
154402739|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154402740|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154402741|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154402742|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154402743|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402744|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402745|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402746|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154402747|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402748|NCT03626298|Niacinamide|niacinamide|mesh-list
154402749|NCT03626298|Niacin|niacin|mesh-list
154402750|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
154402751|NCT03626298|Adapalene|adapalene|mesh-list
154402752|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
154402753|NCT03626298|Vitamins|vitamins|mesh-ancestor
154402754|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
154402755|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402756|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154402757|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
154031283|NCT06320990|Tamoxifen|tamoxifen|mesh-list
154402758|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402759|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154402760|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
154402761|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154402762|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402763|NCT03626298|Analgesics|analgesics|mesh-ancestor
154402764|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
154402765|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402766|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402767|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402768|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
154402769|NCT03644264|Sevelamer|sevelamer|mesh-list
154402770|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
154402771|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
154402772|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402773|NCT03240133|Berotralstat|berotralstat|mesh-list
154402774|NCT03240133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154402775|NCT03240133|Protease Inhibitors|protease inhibitors|mesh-ancestor
154402776|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402777|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402778|NCT03814356|Methylphenidate|methylphenidate|mesh-list
154402779|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154402780|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402781|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154402782|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154137358|NCT00920465|Misoprostol|misoprostol|mesh-list
154402783|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154402784|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402785|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
154402786|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402787|NCT03707171|Liraglutide|liraglutide|mesh-list
154402788|NCT03707171|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154402789|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154402790|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402791|NCT03707171|Incretins|incretins|mesh-ancestor
154402792|NCT03707171|Hormones|hormones|mesh-ancestor
154402793|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154402794|NCT03372083|Deferasirox|deferasirox|mesh-list
154402795|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154402796|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
154402797|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
154402798|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402799|NCT03044886|Vitamin D|vitamin d|mesh-list
154402800|NCT03044886|Vitamins|vitamins|mesh-ancestor
154402801|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
154402802|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402803|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154402804|NCT02961764|Dalbavancin|dalbavancin|mesh-list
154402805|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154402806|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402807|NCT03371459|Albuterol|albuterol|mesh-list
154402808|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154402809|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
154402810|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402811|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402812|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154402813|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
154402814|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
154402815|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154402816|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154402817|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154402818|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154402819|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
154402820|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154402821|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402822|NCT03371381|Nivolumab|nivolumab|mesh-list
154402823|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154402824|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402825|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154402826|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402827|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
154402828|NCT03044730|Capecitabine|capecitabine|mesh-list
154402829|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154402830|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402831|NCT03044730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154402832|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402833|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154402834|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
154402835|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154402836|NCT02961374|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154402837|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154402838|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402839|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402840|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402841|NCT04783233|Chitosan|chitosan|mesh-list
154402842|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154402843|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154402844|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154402845|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
154402846|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402847|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154402848|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
154402849|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
154402850|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
154402851|NCT04783233|Coagulants|coagulants|mesh-ancestor
154402852|NCT02951429|Pirfenidone|pirfenidone|mesh-list
154402853|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
154402854|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
154402855|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154402856|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154402857|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402858|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402859|NCT02951429|Urological Agents|urological agents|mesh-ancestor
154402860|NCT02951429|Analgesics|analgesics|mesh-ancestor
154402861|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
154402862|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402863|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402864|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154402865|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154402866|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402868|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402869|NCT04622709|Furosemide|furosemide|mesh-list
154402870|NCT04622709|Diuretics|diuretics|mesh-list
154402871|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154402872|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
154402873|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402874|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154402875|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402876|NCT05214807|Chitosan|chitosan|mesh-list
154402877|NCT05214807|Hylan|hylan|mesh-list
154402878|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154402879|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154402880|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
154402881|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402882|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154402883|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
154402884|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
154402885|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
154402886|NCT05214807|Coagulants|coagulants|mesh-ancestor
154402887|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
154402888|NCT05214807|Protective Agents|protective agents|mesh-ancestor
154402889|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402890|NCT02454855|Melatonin|melatonin|mesh-list
154402891|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
154402892|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402893|NCT02454855|Protective Agents|protective agents|mesh-ancestor
154402894|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402895|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402896|NCT03343067|Norethindrone|norethindrone|mesh-list
154402897|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
154402898|NCT03343067|Estradiol|estradiol|mesh-list
154402899|NCT03343067|Estrogens|estrogens|mesh-ancestor
154402900|NCT03343067|Hormones|hormones|mesh-ancestor
154402901|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154402902|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402903|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154402904|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
154402905|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154402906|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154402907|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154402908|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154402909|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154402910|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154402911|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154402912|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402913|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
154402914|NCT04707183|Lidocaine|lidocaine|mesh-list
154402915|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
154402916|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
154402917|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154402918|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402919|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
154402920|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154402921|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154402922|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154402923|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154402924|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154402925|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402926|NCT04703205|Ivermectin|ivermectin|mesh-list
154402927|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154402928|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402929|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
154402930|NCT03706781|Benzydamine|benzydamine|mesh-list
154402931|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154402932|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402933|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154402934|NCT03706703|Carboplatin|carboplatin|mesh-list
154402935|NCT03706703|Docetaxel|docetaxel|mesh-list
154402936|NCT03706703|Pemetrexed|pemetrexed|mesh-list
154402937|NCT03706703|Endostar protein|endostar protein|mesh-list
154402938|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402939|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
154402940|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
154402941|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
153977574|NCT04070755|Minocycline|minocycline|mesh-list
154402942|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402943|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154402944|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154402945|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154402946|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154402947|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154402948|NCT03706703|Growth Substances|growth substances|mesh-ancestor
154402949|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402950|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
154402951|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154402952|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
154402953|NCT03706547|Fludarabine|fludarabine|mesh-list
154402954|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154402955|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
154402956|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402957|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154402958|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154402959|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
154402960|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402961|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402962|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154402963|NCT05682209|Octreotide|octreotide|mesh-list
154402964|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154402965|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154402966|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154402967|NCT03708497|Misoprostol|misoprostol|mesh-list
154402968|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
154402969|NCT03708497|Carbetocin|carbetocin|mesh-list
154402970|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154402971|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154402972|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154402973|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
154402974|NCT03708497|Coagulants|coagulants|mesh-ancestor
154402975|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154402976|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
154402977|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154402978|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402979|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154402980|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154402981|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
154402982|NCT05681975|Antibodies|antibodies|mesh-list
154402983|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
154402984|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154402985|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
154402986|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
154402987|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154402988|NCT05216744|Doxycycline|doxycycline|mesh-list
154402989|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
154402990|NCT05216744|Cefixime|cefixime|mesh-list
154402991|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154402992|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154402993|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
154402994|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154402995|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154402996|NCT05216744|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154402997|NCT05216744|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154402998|NCT05681897|Minoxidil|minoxidil|mesh-list
154402999|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154403000|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
154403001|NCT01345058|Lacosamide|lacosamide|mesh-list
154403002|NCT01345058|Levetiracetam|levetiracetam|mesh-list
154403003|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
154403004|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
154403005|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154403006|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154403007|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403008|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403009|NCT03642236|Ibrutinib|ibrutinib|mesh-list
154403010|NCT03642236|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154403011|NCT03642236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403012|NCT03642236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977641|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154403013|NCT03642236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403014|NCT01345292|Listerine|listerine|mesh-list
154403015|NCT01345292|Fluorides|fluorides|mesh-list
154403016|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
154403017|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
154403018|NCT01345292|Protective Agents|protective agents|mesh-ancestor
154403019|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403020|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154403021|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403022|NCT03340961|Doxycycline|doxycycline|mesh-list
154403023|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154403024|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403025|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
154403026|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154403027|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154403028|NCT03643874|Albuterol|albuterol|mesh-list
154403029|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154403030|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
154403031|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403032|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403033|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154403034|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
154403035|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
154403036|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154403037|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154403038|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154403039|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154403040|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154403041|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403042|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403043|NCT03254485|Praliciguat|praliciguat|mesh-list
154403044|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154403045|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
154403046|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403047|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154403049|NCT00769327|Nilotinib|nilotinib|mesh-list
154403050|NCT00769327|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154403051|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403052|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403053|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403054|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403055|NCT01068704|Letrozole|letrozole|mesh-list
154403056|NCT01068704|Lapatinib|lapatinib|mesh-list
154403057|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403058|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154403059|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154403060|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403061|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403062|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154403063|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
154403064|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403065|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403066|NCT01068704|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154403067|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403068|NCT03339401|Brincidofovir|brincidofovir|mesh-list
154403069|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
154403070|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403071|NCT05179525|Risperidone|risperidone|mesh-list
154403072|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154403073|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
154403074|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403075|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403076|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403077|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154403078|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154403079|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403080|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154403081|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154403082|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
154403083|NCT03370289|Vaccines|vaccines|mesh-list
154403084|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
154403085|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403086|NCT01344824|Bevacizumab|bevacizumab|mesh-list
154403087|NCT01344824|Carboplatin|carboplatin|mesh-list
154403088|NCT01344824|Pemetrexed|pemetrexed|mesh-list
154403089|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154403090|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403091|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403092|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153977713|NCT02576353|Analgesics|analgesics|mesh-ancestor
154403093|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154403094|NCT01344824|Growth Substances|growth substances|mesh-ancestor
154403095|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403096|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
154403097|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403098|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403099|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154403100|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154403101|NCT01344824|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154403102|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403103|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154403104|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
154403105|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403106|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
154403107|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154403108|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154403109|NCT05137496|Prednisolone|prednisolone|mesh-list
154403110|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
154403111|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154403112|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
154403113|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403114|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
154403115|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
154403116|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403117|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403118|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154403119|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
154403120|NCT05137496|Hormones|hormones|mesh-ancestor
154403121|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403122|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154403123|NCT05137496|Protective Agents|protective agents|mesh-ancestor
154403124|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154403125|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403126|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154403127|NCT02959892|Amphetamine|amphetamine|mesh-list
154403128|NCT02959892|Naxagolide|naxagolide|mesh-list
154403129|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154403130|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403131|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
154403132|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
154403133|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403134|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
154403135|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403136|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403137|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
154403138|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154403139|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154403140|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403141|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154403142|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
154403143|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
154403144|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154403145|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403146|NCT05179213|Azacitidine|azacitidine|mesh-list
154403147|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154403148|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
154403149|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403150|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403151|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403152|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
154403153|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154403154|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403155|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154403156|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403157|NCT03367793|Metronidazole|metronidazole|mesh-list
154403158|NCT03367793|Methamphetamine|methamphetamine|mesh-list
154403159|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154403160|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403161|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
154403162|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
154403163|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403164|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
154403165|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403166|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403167|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
154403168|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154403169|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154403170|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403171|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154403172|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403173|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154403174|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154403175|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154403176|NCT05178511|Ensartinib|ensartinib|mesh-list
154403177|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403178|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403179|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403180|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403181|NCT05571163|Sotorasib|sotorasib|mesh-list
154403182|NCT05571163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154403183|NCT05571163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403184|NCT05571163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403185|NCT05571163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403186|NCT03532555|Zinc|zinc|mesh-list
154403187|NCT03532555|Trace Elements|trace elements|mesh-ancestor
154403188|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
154403189|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403190|NCT03993457|Bupropion|bupropion|mesh-list
154403191|NCT03993457|Escitalopram|escitalopram|mesh-list
154403192|NCT03993457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154403193|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154403194|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403195|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403196|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403197|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
154403198|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403199|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154403200|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
154403201|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154403202|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154403203|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
154403204|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154403205|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154403206|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403207|NCT04677439|Flumatinib|flumatinib|mesh-list
154403208|NCT04677439|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154403209|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403210|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403211|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403212|NCT02777424|Thrombin|thrombin|mesh-list
154403213|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
154403214|NCT02777424|Coagulants|coagulants|mesh-ancestor
154403215|NCT01347073|Glycerol|glycerol|mesh-list
154403216|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154403217|NCT01347073|Protective Agents|protective agents|mesh-ancestor
154403218|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403219|NCT01315236|Amikacin|amikacin|mesh-list
154403220|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154403221|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403222|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154403223|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
154403224|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
154403225|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403226|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
154403227|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403228|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403229|NCT03364049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154403230|NCT03364049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403231|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
154403232|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154403233|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403234|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154403235|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403236|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
154403237|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
154403238|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154403239|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154403240|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403241|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403242|NCT03710369|Urological Agents|urological agents|mesh-ancestor
154403244|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154403245|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154403246|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403247|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154403248|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154403249|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403250|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403251|NCT03707795|Betamethasone|betamethasone|mesh-list
154403252|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
154137825|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403253|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154403254|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
154403255|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
154403256|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
154403257|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154403258|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403259|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
154403260|NCT03707795|Hormones|hormones|mesh-ancestor
154403261|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403262|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403263|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154403264|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
154403265|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154403266|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
154403267|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403268|NCT03042312|Pluvicto|pluvicto|mesh-list
154403269|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154403270|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403271|NCT05171231|Hemostatics|hemostatics|mesh-list
154403272|NCT05171231|Coagulants|coagulants|mesh-ancestor
154403273|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154403274|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403275|NCT03360071|Immunomodulating Agents|immunomodulating agents|mesh-list
154403276|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
154403277|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403278|NCT05681429|Acetaminophen|acetaminophen|mesh-list
154403279|NCT05681429|Parecoxib|parecoxib|mesh-list
154403280|NCT05681429|Lidocaine|lidocaine|mesh-list
154403281|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
154403282|NCT05681429|Sevoflurane|sevoflurane|mesh-list
154403283|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154403284|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403285|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403286|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154403287|NCT05681429|Analgesics|analgesics|mesh-ancestor
154403288|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
154403289|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403290|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154403291|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154403292|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154403293|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
154403294|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403295|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403296|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
154403297|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154137879|NCT01016002|Temoporfin|temoporfin|mesh-list
154403298|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154403299|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
154403300|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
154403301|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
154403302|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154403303|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154403304|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154403305|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403306|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154403307|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154403308|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403309|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154403310|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403311|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154403312|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
153977956|NCT01014143|Triclosan|triclosan|mesh-list
154403313|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154403314|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154403315|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403316|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
154403317|NCT02949011|Oseltamivir|oseltamivir|mesh-list
154403318|NCT02949011|Baloxavir|baloxavir|mesh-list
154403319|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
154403320|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403321|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403322|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403323|NCT03705533|Telmisartan|telmisartan|mesh-list
154403324|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154403325|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154403326|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154403327|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403328|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
154403329|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
154403330|NCT03357341|Albuterol|albuterol|mesh-list
154403331|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154403332|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
154403333|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403334|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403335|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154403336|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
154403337|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
154403338|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154403339|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154403340|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154403341|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154403342|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
154403343|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403344|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403345|NCT05177237|Endostar protein|endostar protein|mesh-list
154403346|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154403347|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154403348|NCT05177237|Growth Substances|growth substances|mesh-ancestor
154403349|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403350|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
154403351|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403352|NCT04507373|Simvastatin|simvastatin|mesh-list
154403353|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154403354|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154403355|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
154403356|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403357|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154403358|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154403359|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403360|NCT01312337|Gefitinib|gefitinib|mesh-list
154137922|NCT03775421|Macitentan|macitentan|mesh-list
154403361|NCT01312337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154403362|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403363|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403364|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403365|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403366|NCT05551949|Estradiol|estradiol|mesh-list
154403367|NCT05551949|Estrogens|estrogens|mesh-ancestor
154403368|NCT05551949|Hormones|hormones|mesh-ancestor
154403369|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403370|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403371|NCT05283954|Ivermectin|ivermectin|mesh-list
154403372|NCT05283954|Albendazole|albendazole|mesh-list
154403373|NCT05283954|Prednisolone|prednisolone|mesh-list
154403374|NCT05283954|Fluoxetine|fluoxetine|mesh-list
154403375|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403376|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403377|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
154403378|NCT05283954|Hormones|hormones|mesh-ancestor
154403379|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403380|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154403381|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403382|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403383|NCT05283954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154403384|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154403385|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403386|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978013|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
154403387|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
154403388|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154403389|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
154403390|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154403391|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154403392|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154403393|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403394|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154403395|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403396|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
154403397|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
154403398|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154403399|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154403400|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
154403401|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
154403402|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
154403403|NCT01312415|Morphine|morphine|mesh-list
154403404|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
154403405|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154403406|NCT01312415|Narcotics|narcotics|mesh-ancestor
154403407|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403408|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403409|NCT01312415|Analgesics|analgesics|mesh-ancestor
154403410|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
154403411|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403412|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
154403413|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
154403414|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
154403415|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154403417|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
154403418|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403419|NCT01312493|Panitumumab|panitumumab|mesh-list
154403420|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403421|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403422|NCT05309694|Copper|copper|mesh-list
154403423|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
154403424|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154403425|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403426|NCT05309694|Trace Elements|trace elements|mesh-ancestor
154403427|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
154403428|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
154403429|NCT05268510|Olaparib|olaparib|mesh-list
154403430|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403431|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403432|NCT05268510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154403433|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403434|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154403435|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403436|NCT05438303|Celecoxib|celecoxib|mesh-list
154403437|NCT05438303|Midazolam|midazolam|mesh-list
154403438|NCT05438303|Omeprazole|omeprazole|mesh-list
154403439|NCT05438303|Dabigatran|dabigatran|mesh-list
154403440|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154403441|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154403442|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403443|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403444|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154403445|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154403446|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154403447|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154403448|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
154403449|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
154403450|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
154403451|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
154403452|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403453|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403454|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154403455|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154403456|NCT05438303|Analgesics|analgesics|mesh-ancestor
154403457|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
154403458|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403459|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403460|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154403461|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153978087|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
154403462|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154403463|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403464|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154403465|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154403466|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154403467|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
154403468|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154138030|NCT01000857|Paroxetine|paroxetine|mesh-list
154403469|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
154403470|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
154403471|NCT05432141|Vaccines|vaccines|mesh-list
154403472|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
154403473|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403474|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
154403475|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403476|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154403477|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403478|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403479|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
154403480|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403481|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403482|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154403483|NCT04906889|Lidocaine|lidocaine|mesh-list
154403484|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
154403485|NCT04906889|Remifentanil|remifentanil|mesh-list
154403486|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
154403487|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
154403488|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403489|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403490|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
154403491|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403492|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154403493|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154403494|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154403495|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403496|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403497|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154403498|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154403500|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154403501|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154403502|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154403503|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
154403504|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403505|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154403506|NCT04906889|Narcotics|narcotics|mesh-ancestor
154403507|NCT02948777|Evolocumab|evolocumab|mesh-list
154403508|NCT02948777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154403509|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154403510|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154403511|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
154403512|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403513|NCT02948777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154403514|NCT02948777|Protease Inhibitors|protease inhibitors|mesh-ancestor
154403515|NCT02948777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403516|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154403517|NCT04868747|Lidocaine|lidocaine|mesh-list
154403518|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
154403519|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
154403520|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403521|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403522|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
154403523|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138088|NCT00482170|Etanercept|etanercept|mesh-list
154403524|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154403525|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154403526|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154403527|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403528|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403529|NCT05330273|Efavirenz|efavirenz|mesh-list
154403530|NCT05330273|Lumefantrine|lumefantrine|mesh-list
154403531|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154403532|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154403533|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403534|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403535|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
154403536|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403537|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154403538|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154403539|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154403540|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154403541|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154403542|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154403543|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
154403544|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154403545|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154403546|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154403547|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
154403548|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403549|NCT05254847|Capecitabine|capecitabine|mesh-list
154403550|NCT05254847|Lenvatinib|lenvatinib|mesh-list
154403551|NCT05254847|Tislelizumab|tislelizumab|mesh-list
154403552|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154403553|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
154403554|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403555|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403556|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403557|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403558|NCT05254847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403559|NCT05249699|Isoniazid|isoniazid|mesh-list
154138145|NCT01004601|Docetaxel|docetaxel|mesh-list
154403560|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
154403561|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154403562|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403563|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154403564|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154403565|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
154403566|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403567|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154403568|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154403569|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154403570|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154403571|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403572|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403573|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154403574|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403575|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403576|NCT02943473|Ibrutinib|ibrutinib|mesh-list
154403577|NCT02943473|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154403578|NCT02943473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154403579|NCT02943473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403580|NCT02943473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403581|NCT03629873|Cytarabine|cytarabine|mesh-list
154403582|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
154403583|NCT03629873|Carmustine|carmustine|mesh-list
154403584|NCT03629873|Etoposide|etoposide|mesh-list
154403585|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154403586|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
154403587|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403588|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154403589|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154403590|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
154403591|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403592|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403593|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154403594|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154403595|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154403596|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154403597|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403598|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154403599|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
154403600|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
154403601|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403602|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
154403603|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154403604|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403605|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403606|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
154403607|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
154403608|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154403609|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154403610|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403611|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154253692|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154403612|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403613|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658680|NCT02539537|Leucovorin|leucovorin|mesh-list
154403614|NCT04258631|Hydromorphone|hydromorphone|mesh-list
154403615|NCT04258631|Bupivacaine|bupivacaine|mesh-list
154403616|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
154403617|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
154403618|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403619|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403620|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
154403621|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403622|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154403623|NCT04258631|Narcotics|narcotics|mesh-ancestor
154403624|NCT04258631|Analgesics|analgesics|mesh-ancestor
154403625|NCT03638063|Adenosine|adenosine|mesh-list
154403626|NCT03638063|Capsaicin|capsaicin|mesh-list
154403627|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
154403628|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
154403629|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
154403630|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403631|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403632|NCT03638063|Analgesics|analgesics|mesh-ancestor
154403633|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154403634|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
154403635|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154403636|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
154403637|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
154403638|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403639|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403640|NCT04869371|Prednisone|prednisone|mesh-list
154403641|NCT04869371|Docetaxel|docetaxel|mesh-list
154403642|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154403643|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403644|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
154403645|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
154403646|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
154403647|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403648|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403649|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
154403650|NCT04869371|Hormones|hormones|mesh-ancestor
154403651|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403652|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403653|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154403654|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
154403655|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154403656|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
154403657|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154403658|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154403659|NCT03320057|Mifepristone|mifepristone|mesh-list
154403660|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154403661|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
154403662|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154403663|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403664|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154403665|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154403666|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154403667|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
154403668|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154403669|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154403670|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
154403671|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403672|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
154403673|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154403674|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154403675|NCT04741139|Acetaminophen|acetaminophen|mesh-list
154403676|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
154403677|NCT04741139|Promethazine|promethazine|mesh-list
154403678|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154403679|NCT04741139|Analgesics|analgesics|mesh-ancestor
154403680|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
154403681|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403682|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403683|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
154403684|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154403685|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154403686|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403687|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
154403688|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
154403689|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
154403690|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
154403691|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154403692|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154403693|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
154403694|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
154403695|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403696|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403697|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154403698|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
154403699|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
154403700|NCT04853147|Dexamethasone|dexamethasone|mesh-list
154403701|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
154403702|NCT04853147|Palonosetron|palonosetron|mesh-list
154403703|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
154403705|NCT04853147|BB 1101|bb 1101|mesh-list
154403706|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403707|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
154403708|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
154403709|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403710|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403711|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154403712|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
154403713|NCT04853147|Hormones|hormones|mesh-ancestor
154403714|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403715|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154403716|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403717|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
154403718|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403719|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403720|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154403721|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154403722|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
154403723|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403724|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154403725|NCT04689347|Leucovorin|leucovorin|mesh-list
154403726|NCT04689347|Bevacizumab|bevacizumab|mesh-list
154403727|NCT04689347|Fluorouracil|fluorouracil|mesh-list
154403728|NCT04689347|Irinotecan|irinotecan|mesh-list
154403729|NCT04689347|Temozolomide|temozolomide|mesh-list
154403730|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403731|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403732|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154403733|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154403734|NCT04689347|Growth Substances|growth substances|mesh-ancestor
154403735|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403736|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
154403737|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
154403738|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403739|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154403740|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154403741|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
154403742|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154403743|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154403744|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403745|NCT04689347|Antidotes|antidotes|mesh-ancestor
154403746|NCT04689347|Protective Agents|protective agents|mesh-ancestor
154403747|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
154403748|NCT04689347|Vitamins|vitamins|mesh-ancestor
154403749|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
154403750|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154403751|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
154403752|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154403753|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
154403754|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403755|NCT02420795|TIC10 compound|tic10 compound|mesh-list
154403756|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403757|NCT02384759|Aflibercept|aflibercept|mesh-list
154403758|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154403759|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154403760|NCT02384759|Growth Substances|growth substances|mesh-ancestor
154403761|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403762|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
154403763|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403764|NCT05276687|Vancomycin|vancomycin|mesh-list
154403765|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
154403766|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154403767|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403768|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154403769|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
154403770|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154403771|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403772|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154403773|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403774|NCT03332771|Metformin|metformin|mesh-list
154403775|NCT03332771|Glimepiride|glimepiride|mesh-list
154403776|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154403777|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154403778|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403779|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154403780|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154403781|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
154403782|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154403783|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403784|NCT03625830|Paclitaxel|paclitaxel|mesh-list
154403785|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154403786|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403787|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
154403788|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
154403789|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
154403790|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403791|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
154403792|NCT04108104|Prazosin|prazosin|mesh-list
154403793|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154403794|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154403795|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154403796|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154403797|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
154403798|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403799|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403800|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403801|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
154403802|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
154403803|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154403804|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154403805|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
154403806|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
154403807|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154403808|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
153658975|NCT00398554|Hormones|hormones|mesh-ancestor
154403809|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154403810|NCT05304468|Cisplatin|cisplatin|mesh-list
154403811|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403812|NCT03039192|Esketamine|esketamine|mesh-list
154403813|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
154403814|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154403815|NCT03698279|Vaccines|vaccines|mesh-list
154403816|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
154403817|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403818|NCT03038880|Ranibizumab|ranibizumab|mesh-list
154403819|NCT03038880|Faricimab|faricimab|mesh-list
154403820|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154403821|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154403822|NCT03038880|Growth Substances|growth substances|mesh-ancestor
154403823|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403824|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
154403825|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403826|NCT03035916|Anesthetics|anesthetics|mesh-list
154403827|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154403828|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403829|NCT01702571|Trastuzumab|trastuzumab|mesh-list
154403830|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154403831|NCT01702571|Maytansine|maytansine|mesh-list
154403832|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403833|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403834|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153978462|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
154403835|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
154403836|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
154403837|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
154403838|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403840|NCT01702571|Immunoconjugates|immunoconjugates|mesh-ancestor
154403841|NCT01702571|Immunologic Factors|immunologic factors|mesh-ancestor
154403842|NCT01702571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403843|NCT01578239|Octreotide|octreotide|mesh-list
154403844|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154403845|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154403846|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154403847|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403848|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154403849|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403850|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154403851|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403852|NCT01220531|Cyclosporine|cyclosporine|mesh-list
154403853|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
154403854|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
154403855|NCT01220531|Prednisolone|prednisolone|mesh-list
154403856|NCT01220531|Tacrolimus|tacrolimus|mesh-list
154403857|NCT01220531|Cyclosporins|cyclosporins|mesh-list
154254327|NCT03523000|Analgesics|analgesics|mesh-ancestor
154403858|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154403859|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
154403860|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154403861|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
154403862|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403863|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154403864|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403865|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403866|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
154403867|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403868|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
154403869|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154403870|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154403871|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403872|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154403873|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
154403874|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154403875|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403876|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
154403877|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
154403878|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403879|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154403880|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
154403881|NCT01220531|Hormones|hormones|mesh-ancestor
154403882|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154403883|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154403884|NCT01220531|Protective Agents|protective agents|mesh-ancestor
154403885|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154403886|NCT05255471|Olaparib|olaparib|mesh-list
154403887|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154403888|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403889|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403890|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403891|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
154403892|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403893|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403894|NCT03241927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154403895|NCT03241927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403896|NCT02941523|Carboplatin|carboplatin|mesh-list
154403897|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403898|NCT03666143|Tislelizumab|tislelizumab|mesh-list
154403899|NCT03666143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403900|NCT03666143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403901|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
154403902|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154403903|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154403904|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403905|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154403906|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154403907|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403908|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403909|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403910|NCT00360425|Hematinics|hematinics|mesh-ancestor
154403911|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154403912|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154403913|NCT02938585|Factor VIII|factor viii|mesh-list
154403914|NCT02938585|Coagulants|coagulants|mesh-ancestor
154403915|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154403916|NCT00233597|Hematinics|hematinics|mesh-ancestor
154403917|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154403918|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154403919|NCT04282811|Venetoclax|venetoclax|mesh-list
154403920|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403921|NCT03229759|Octenidine|octenidine|mesh-list
154403922|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154403923|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154403924|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
154403925|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154403926|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403927|NCT03476681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154403928|NCT03476681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403929|NCT03620825|Indomethacin|indomethacin|mesh-list
154403930|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154403931|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154403932|NCT03620825|Analgesics|analgesics|mesh-ancestor
154403934|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154403935|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403936|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154403937|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154403938|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
154403939|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
154403940|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154403941|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154403942|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403943|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403944|NCT01496118|Panobinostat|panobinostat|mesh-list
154403945|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154403946|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154403947|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403948|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403949|NCT03329573|Paroxetine|paroxetine|mesh-list
154403950|NCT03329573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154403951|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154403952|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403953|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403954|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403955|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
154403956|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403957|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154403958|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
154403959|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154403960|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154403961|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154403962|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403963|NCT00492349|Varenicline|varenicline|mesh-list
154403964|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154403965|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154403966|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
154403967|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403968|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403969|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403970|NCT03308825|Vaccines|vaccines|mesh-list
154403971|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
154403972|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403973|NCT04235855|Liver Extracts|liver extracts|mesh-list
154403974|NCT04235855|Hematinics|hematinics|mesh-ancestor
154403975|NCT03328325|Vaccines|vaccines|mesh-list
154403976|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
154403977|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403978|NCT03476603|Irbesartan|irbesartan|mesh-list
154403979|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154403980|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154403981|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154403982|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403983|NCT03476525|Fluoxetine|fluoxetine|mesh-list
154403984|NCT03476525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154403985|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154403986|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154403987|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154403988|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154403989|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
154403990|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154403991|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154403992|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
154403993|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154403994|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154403995|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154403996|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154403997|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
154403998|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154403999|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404000|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404001|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154404002|NCT03665545|Poly I-C|poly i-c|mesh-list
154404003|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
154404004|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154404005|NCT03665545|Poly ICLC|poly iclc|mesh-list
154404006|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404007|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404008|NCT03665545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154404009|NCT03665545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404010|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
154404011|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
154404012|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404013|NCT03665545|Laxatives|laxatives|mesh-ancestor
154404014|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404015|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
154404016|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404017|NCT03305081|Copper|copper|mesh-list
154404018|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
154404019|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154404020|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
154404021|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154404022|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404023|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154404024|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154404025|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154404026|NCT03305081|Trace Elements|trace elements|mesh-ancestor
154404027|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
154404028|NCT04079881|Insulin|insulin|mesh-list
154404029|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154404030|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154404031|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404032|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
154404033|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154404034|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
154404035|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404036|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
154404037|NCT03223909|Protective Agents|protective agents|mesh-ancestor
154404038|NCT03733925|Golimumab|golimumab|mesh-list
154404039|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154404040|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404041|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154404042|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
154404043|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404044|NCT03649711|Aspirin|aspirin|mesh-list
154404045|NCT03649711|Clopidogrel|clopidogrel|mesh-list
154404046|NCT03649711|Ticagrelor|ticagrelor|mesh-list
154404047|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404048|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404049|NCT03649711|Analgesics|analgesics|mesh-ancestor
154404050|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
154404051|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404052|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404053|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404054|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404055|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154404056|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154404057|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404058|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154404059|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154404060|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404061|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
154404062|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154404063|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154404064|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154404065|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
154404066|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404067|NCT03273257|Riociguat|riociguat|mesh-list
154404068|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
154404069|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404070|NCT04270877|Naltrexone|naltrexone|mesh-list
154404071|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154404072|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154404073|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404074|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
154404075|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404076|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154404077|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154404078|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154404079|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154404080|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404081|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404082|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001304|NCT02806362|Ritonavir|ritonavir|mesh-list
154404083|NCT03271151|Analgesics|analgesics|mesh-ancestor
154404084|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
154404085|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404086|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
154404087|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154404088|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
154404089|NCT03301649|Ivermectin|ivermectin|mesh-list
154404090|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154404091|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404092|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154404093|NCT01144416|Hormones|hormones|mesh-ancestor
154404094|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404095|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404096|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
154404097|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154404098|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
154404099|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
154404100|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404101|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404102|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404103|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404104|NCT00335777|Analgesics|analgesics|mesh-ancestor
154404105|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
154404106|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404107|NCT03764137|Panitumumab|panitumumab|mesh-list
154404108|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404109|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404110|NCT03625518|Oxytocin|oxytocin|mesh-list
154404111|NCT03625518|Dinoprostone|dinoprostone|mesh-list
154404112|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
154404113|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154404114|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404115|NCT00972738|Loratadine|loratadine|mesh-list
154404116|NCT00972738|Montelukast|montelukast|mesh-list
154404117|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154404118|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
154404119|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154404120|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
154404121|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404122|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404123|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154404124|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154404125|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404126|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
154404127|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
154404128|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154404129|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154404130|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154404131|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
154404132|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
154404133|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978763|NCT04291118|Budesonide|budesonide|mesh-list
154404135|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154404136|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404137|NCT04701281|Capecitabine|capecitabine|mesh-list
154404138|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154404139|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
154404140|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404141|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404142|NCT03882918|Gaboxadol|gaboxadol|mesh-list
154404143|NCT03882918|Analgesics|analgesics|mesh-ancestor
154404144|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
154404145|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404146|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404147|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
154404148|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
154404149|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
154404150|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404151|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404152|NCT04180397|Furosemide|furosemide|mesh-list
154404153|NCT04180397|Diuretics|diuretics|mesh-ancestor
154404154|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
154404155|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404156|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154404157|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154404158|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404160|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
154404161|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
154404162|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404163|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404164|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
154404165|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404166|NCT00803790|Vitamin D|vitamin d|mesh-list
154404167|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
154404168|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
154404169|NCT00803790|Alendronate|alendronate|mesh-list
154404170|NCT00803790|Vitamins|vitamins|mesh-list
154404171|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
154404172|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404173|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154404174|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154404175|NCT00442338|Aminophylline|aminophylline|mesh-list
154404176|NCT00442338|Theophylline|theophylline|mesh-list
154404177|NCT00442338|Montelukast|montelukast|mesh-list
154404178|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154404179|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
154404180|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154404181|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
154404182|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404183|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404184|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154404185|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154404186|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404187|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154404188|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
154404189|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404190|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154404191|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154404192|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404193|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154404194|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154404195|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
154404196|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404197|NCT00442338|Protective Agents|protective agents|mesh-ancestor
154404198|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
154404199|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154404200|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154404201|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404202|NCT02316834|Talazoparib|talazoparib|mesh-list
154404203|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154404204|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404205|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404206|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404207|NCT00250458|Rizatriptan|rizatriptan|mesh-list
154404208|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154404209|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
154404210|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404211|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404212|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404213|NCT01965132|Adalimumab|adalimumab|mesh-list
154404214|NCT01965132|Infliximab|infliximab|mesh-list
154404215|NCT01965132|Golimumab|golimumab|mesh-list
154404216|NCT01965132|Etanercept|etanercept|mesh-list
154404217|NCT01965132|Abatacept|abatacept|mesh-list
154404218|NCT01965132|Upadacitinib|upadacitinib|mesh-list
154404219|NCT01965132|Ustekinumab|ustekinumab|mesh-list
154404220|NCT01965132|Ixekizumab|ixekizumab|mesh-list
154404221|NCT01965132|Tofacitinib|tofacitinib|mesh-list
154404222|NCT01965132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404223|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404224|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
154404225|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404226|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032784|NCT04809974|Niacinamide|niacinamide|mesh-list
154404227|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154404228|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404229|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
154404230|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404231|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404232|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404233|NCT01965132|Analgesics|analgesics|mesh-ancestor
154404234|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
154404235|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404236|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154404237|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154404238|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659675|NCT00069550|Donepezil|donepezil|mesh-list
154404239|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154404240|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154404241|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404243|NCT01667133|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154404244|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154404245|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404246|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404247|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404248|NCT01498770|Olanzapine|olanzapine|mesh-list
154404249|NCT01498770|Risperidone|risperidone|mesh-list
154404250|NCT01498770|Aripiprazole|aripiprazole|mesh-list
154404251|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154404252|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154404253|NCT01498770|Ziprasidone|ziprasidone|mesh-list
154404254|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154404255|NCT01498770|Clozapine|clozapine|mesh-list
154404256|NCT01498770|Asenapine|asenapine|mesh-list
154404257|NCT01498770|Amisulpride|amisulpride|mesh-list
154404258|NCT01498770|Iloperidone|iloperidone|mesh-list
154404259|NCT01498770|Sertindole|sertindole|mesh-list
154404260|NCT01498770|Zotepine|zotepine|mesh-list
154404261|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154404262|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
154404263|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404264|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404265|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404266|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154404267|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154404268|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404269|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154404270|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154404271|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
154404272|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
154404273|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
154404274|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404275|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404276|NCT01498770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154404277|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154404278|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154404279|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
154404280|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
154404281|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154404282|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154404283|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154404284|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154404285|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154404286|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154404287|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154404289|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
154404290|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
154404291|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154404292|NCT00140946|Montelukast|montelukast|mesh-list
154404293|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404294|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404295|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
154404296|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154404297|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154404298|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
154404299|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404300|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154404301|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154404302|NCT00095004|Rizatriptan|rizatriptan|mesh-list
154404303|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404304|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404305|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404306|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154404307|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
154404308|NCT00967746|Etonogestrel|etonogestrel|mesh-list
154404309|NCT00967746|Desogestrel|desogestrel|mesh-list
154404310|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154404311|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
154404312|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154404313|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404314|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154404315|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154404316|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154404317|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154404318|NCT00967746|Progestins|progestins|mesh-ancestor
154404319|NCT00967746|Hormones|hormones|mesh-ancestor
153659790|NCT00070213|Protective Agents|protective agents|mesh-ancestor
154404320|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404321|NCT00092118|Montelukast|montelukast|mesh-list
154404322|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154404323|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
154404324|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154404325|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
154404326|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404327|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404328|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154404329|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154404330|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404331|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154404332|NCT00920634|Hormones|hormones|mesh-ancestor
154404333|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404334|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404335|NCT00092040|Alendronate|alendronate|mesh-list
154404336|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
154404337|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404338|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404339|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154404340|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154404341|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154404342|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154404343|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
154404344|NCT05224128|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154404345|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154404346|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404347|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404348|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404349|NCT05416827|Dexamethasone|dexamethasone|mesh-list
154404350|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404351|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
154404352|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
154404353|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404354|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404355|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404356|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
154404357|NCT05416827|Hormones|hormones|mesh-ancestor
154404358|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404359|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154404360|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404361|NCT05076513|Niraparib|niraparib|mesh-list
154404362|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154404363|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404364|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404365|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404366|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
154404367|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154404368|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404369|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154404370|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404371|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
154404372|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154404373|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154404374|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154404375|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154404376|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404377|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
154404378|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404379|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404380|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154404381|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404382|NCT05418309|Paclitaxel|paclitaxel|mesh-list
154404383|NCT05418309|Tislelizumab|tislelizumab|mesh-list
154404384|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154404385|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404386|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
154404387|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
154404388|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
154404389|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404390|NCT05418309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404391|NCT05137548|Tenofovir|tenofovir|mesh-list
154404392|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
154404393|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404394|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154404395|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154404396|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404397|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404398|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154404399|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154404400|NCT05091294|Anesthetics|anesthetics|mesh-list
154404401|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
154404402|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404403|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404404|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
154404405|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404406|NCT05417997|Clarithromycin|clarithromycin|mesh-list
154404407|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
154404408|NCT05417997|Favipiravir|favipiravir|mesh-list
154404409|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
154404410|NCT05417997|Enoxaparin|enoxaparin|mesh-list
154404411|NCT05417997|Lansoprazole|lansoprazole|mesh-list
154404412|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404413|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
154404414|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
154404415|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404416|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404417|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404418|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
154404419|NCT05417997|Hormones|hormones|mesh-ancestor
154404420|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404421|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154404422|NCT05417997|Protective Agents|protective agents|mesh-ancestor
154404423|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154404424|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404425|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154404426|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404427|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404428|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154404429|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154404430|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
154404431|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154404432|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154404433|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154404434|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154404435|NCT05417997|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154404436|NCT05417997|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154404437|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
154404438|NCT03856788|Bupivacaine|bupivacaine|mesh-list
154404439|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
154404440|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
154404441|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404442|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404443|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
154404444|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404445|NCT03242759|Pirfenidone|pirfenidone|mesh-list
154404446|NCT03242759|Nintedanib|nintedanib|mesh-list
154404447|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404448|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154404449|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404450|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404451|NCT03242759|Analgesics|analgesics|mesh-ancestor
154404452|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
154404453|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404454|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404455|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404456|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404457|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404458|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404459|NCT03625050|Celecoxib|celecoxib|mesh-list
154404460|NCT03625050|Esomeprazole|esomeprazole|mesh-list
154404461|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404462|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404463|NCT03625050|Analgesics|analgesics|mesh-ancestor
154404464|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
154404465|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404466|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404467|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404468|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404469|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154404470|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154404471|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404472|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404473|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154404474|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404475|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154404476|NCT03257813|Timolol|timolol|mesh-list
154404477|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154404478|NCT03257813|Dorzolamide|dorzolamide|mesh-list
154404479|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154404480|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154404481|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
154404482|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404483|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404484|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404485|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154404486|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154404487|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154404488|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154404489|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154404490|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154404491|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404492|NCT03210259|Adalimumab|adalimumab|mesh-list
154404493|NCT03210259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154404494|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404495|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404496|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
154404497|NCT04319757|Fludarabine|fludarabine|mesh-list
154404498|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154404499|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
154404500|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404501|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404502|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154404503|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
154404504|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404505|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404506|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154404507|NCT05180461|Ivermectin|ivermectin|mesh-list
154404508|NCT05180461|Emodepside|emodepside|mesh-list
154404509|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154404510|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404511|NCT02496611|Exenatide|exenatide|mesh-list
154254391|NCT01048229|Rasagiline|rasagiline|mesh-list
154404512|NCT02496611|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154404514|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404515|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154404516|NCT02496611|Incretins|incretins|mesh-ancestor
154404517|NCT02496611|Hormones|hormones|mesh-ancestor
154404518|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404519|NCT03237481|Bupivacaine|bupivacaine|mesh-list
154404520|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154404521|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
154404522|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404523|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404524|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
154404525|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404526|NCT03704220|Warfarin|warfarin|mesh-list
154404527|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
154404528|NCT03222349|Diazepam|diazepam|mesh-list
154404529|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154404530|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
154404531|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
154404532|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
154404533|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404534|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404535|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404536|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154404537|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404538|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154404539|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154404540|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154404541|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154404542|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154404543|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154404544|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
154404545|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
154404546|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
154404547|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
154404548|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404549|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404550|NCT02927925|Daratumumab|daratumumab|mesh-list
154404551|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404552|NCT03208933|Pirfenidone|pirfenidone|mesh-list
154404553|NCT03208933|Analgesics|analgesics|mesh-ancestor
154404554|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
154404555|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404556|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404557|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404558|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404559|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404560|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404561|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404562|NCT02415036|Melphalan|melphalan|mesh-list
154404563|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154404564|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
154404565|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404566|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404567|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154404568|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154404569|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
154404570|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404571|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
154404572|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154404573|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
154404574|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404575|NCT02117700|Expectorants|expectorants|mesh-ancestor
154404576|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
154404577|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154404578|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
154404579|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404580|NCT02117700|Protective Agents|protective agents|mesh-ancestor
154404581|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404583|NCT02932579|Acetaminophen|acetaminophen|mesh-list
154404584|NCT02932579|Ibuprofen|ibuprofen|mesh-list
154404585|NCT02932579|Oxycodone|oxycodone|mesh-list
154404586|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404587|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404588|NCT02932579|Analgesics|analgesics|mesh-ancestor
154404589|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
153660134|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
154404590|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404591|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404592|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404593|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404594|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154404595|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404596|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404597|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154404598|NCT02932579|Narcotics|narcotics|mesh-ancestor
154404599|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404600|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
154404601|NCT04748757|Annexin A5|annexin a5|mesh-list
154404602|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404603|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404604|NCT03207451|Aspirin|aspirin|mesh-list
154404605|NCT03207451|Clopidogrel|clopidogrel|mesh-list
154404606|NCT03207451|Vorapaxar|vorapaxar|mesh-list
154404607|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404608|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404609|NCT03207451|Analgesics|analgesics|mesh-ancestor
154404610|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
154404611|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404612|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404613|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404614|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404615|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154404616|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154404617|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404618|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154404619|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154404620|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404621|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
154404622|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154404623|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154404624|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154404625|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
154404626|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404627|NCT05089123|Vaccines|vaccines|mesh-list
154404628|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
154404629|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404630|NCT02361125|Methylphenidate|methylphenidate|mesh-list
154404631|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154404632|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404633|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154404634|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154404635|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154404636|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404637|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
154404638|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404639|NCT03701256|Atracurium|atracurium|mesh-list
154404640|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154404641|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154404642|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154404643|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404644|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404645|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154404646|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154404647|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
154404648|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404649|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404650|NCT04780581|Dexamethasone|dexamethasone|mesh-list
154404651|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
154404652|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154404653|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154404654|NCT04780581|Prednisolone|prednisolone|mesh-list
154404655|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
153660272|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
154404656|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154404657|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
154404658|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404659|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
154404660|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
154404661|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404662|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404663|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404665|NCT04780581|Hormones|hormones|mesh-ancestor
154404666|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404667|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154404668|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404669|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154404670|NCT04780581|Protective Agents|protective agents|mesh-ancestor
154404671|NCT01526135|Gemcitabine|gemcitabine|mesh-list
154404672|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154404673|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
154404674|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404675|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404676|NCT05417139|Immunomodulating Agents|immunomodulating agents|mesh-list
154404677|NCT05417139|Immunologic Factors|immunologic factors|mesh-ancestor
154404678|NCT05417139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404679|NCT03701022|Apatinib|apatinib|mesh-list
154404680|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404681|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154404682|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404683|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404684|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
154404685|NCT04221165|Narcotics|narcotics|mesh-ancestor
154404686|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404687|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404688|NCT04221165|Analgesics|analgesics|mesh-ancestor
154404689|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
154404690|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404691|NCT03255629|Glucagon|glucagon|mesh-list
154404692|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154404693|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404694|NCT03255629|Hormones|hormones|mesh-ancestor
154404695|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404696|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404697|NCT03255629|Incretins|incretins|mesh-ancestor
154404698|NCT01143779|Telbivudine|telbivudine|mesh-list
154404699|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
154404700|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404701|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154404702|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404703|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404704|NCT03703596|Docetaxel|docetaxel|mesh-list
154404705|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404706|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
154404707|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
154404708|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
154404709|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404710|NCT01137773|Insulin|insulin|mesh-list
154404711|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154404712|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154404713|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404714|NCT03698292|Metoclopramide|metoclopramide|mesh-list
154404715|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
154404716|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
154404717|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404718|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404719|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404720|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154404721|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154404722|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
154404723|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404724|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404725|NCT04613271|Azithromycin|azithromycin|mesh-list
154404726|NCT04613271|Favipiravir|favipiravir|mesh-list
154404727|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154404728|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404729|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
154404730|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154404731|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404732|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404733|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154404735|NCT03094611|Immunoconjugates|immunoconjugates|mesh-ancestor
154404736|NCT03094611|Immunologic Factors|immunologic factors|mesh-ancestor
154404737|NCT03094611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404738|NCT03631953|Trametinib|trametinib|mesh-list
154404739|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404740|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154404741|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404742|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404743|NCT01030575|Inositol|inositol|mesh-list
154404744|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
154404745|NCT01030575|Vitamins|vitamins|mesh-ancestor
154404746|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
154404747|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404748|NCT04215471|Antibodies|antibodies|mesh-list
154404749|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
154404750|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
154404751|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404752|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
154404753|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154404754|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154404755|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
154404756|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404757|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404758|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404759|NCT03106987|Olaparib|olaparib|mesh-list
154404760|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154404761|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404762|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404763|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404764|NCT02932267|Adapalene|adapalene|mesh-list
154404765|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404766|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404767|NCT02932267|Analgesics|analgesics|mesh-ancestor
154404768|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
154404769|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404770|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404771|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404772|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404773|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154404774|NCT03217591|Praliciguat|praliciguat|mesh-list
154404775|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154404776|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
154404777|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404778|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404779|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
154404780|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
154404781|NCT03697824|Fludarabine|fludarabine|mesh-list
154404782|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154404783|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
154404784|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404785|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404786|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154404787|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
153660471|NCT04729595|Tempol|tempol|mesh-list
154404788|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404789|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404790|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154404791|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404792|NCT03697824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154404793|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154404794|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154404795|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404796|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154404797|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404798|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404799|NCT03697746|Acetaminophen|acetaminophen|mesh-list
154404800|NCT03697746|Ibuprofen|ibuprofen|mesh-list
154404801|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154404802|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404803|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404804|NCT03697746|Analgesics|analgesics|mesh-ancestor
154404806|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404807|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404808|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404809|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154404810|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154404811|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660528|NCT00075595|Vitamins|vitamins|mesh-ancestor
154254398|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154404812|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404813|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
154404814|NCT03697668|Piperaquine|piperaquine|mesh-list
154404815|NCT03697668|Artenimol|artenimol|mesh-list
154404816|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
154404817|NCT03697668|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154404818|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154404819|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404820|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404821|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404822|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
154404823|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154404824|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154404825|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404826|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
154404827|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154404828|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
154404829|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404830|NCT03702738|Expectorants|expectorants|mesh-ancestor
154404831|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
154404832|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154404833|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
154404834|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404835|NCT03702738|Protective Agents|protective agents|mesh-ancestor
154404836|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404837|NCT03702738|Antidotes|antidotes|mesh-ancestor
154404838|NCT03697044|Irinotecan|irinotecan|mesh-list
154404839|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154404840|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154404841|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404842|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404843|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404844|NCT03699774|Firuglipel|firuglipel|mesh-list
154404845|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154404846|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154404847|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154404848|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
154404849|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404850|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154404851|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154404852|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404853|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154404854|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404855|NCT03699696|Propofol|propofol|mesh-list
154404856|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154404857|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404858|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404859|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154404860|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
154404861|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
154404862|NCT03702426|Norfloxacin|norfloxacin|mesh-list
154404863|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154404864|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404865|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154404866|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154404867|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404868|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404869|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404870|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154404871|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154404872|NCT00265941|Cetuximab|cetuximab|mesh-list
154404873|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404874|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404875|NCT03699384|Azacitidine|azacitidine|mesh-list
154404876|NCT03699384|Avelumab|avelumab|mesh-list
154404877|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154404878|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
153979523|NCT04183881|Brodalumab|brodalumab|mesh-list
154404879|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404880|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404881|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404882|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404883|NCT03201211|Vaccines|vaccines|mesh-list
154404884|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
154404885|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404886|NCT04472949|Carboplatin|carboplatin|mesh-list
154404887|NCT04472949|Etoposide|etoposide|mesh-list
154404888|NCT04472949|Durvalumab|durvalumab|mesh-list
154404889|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404890|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154404891|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154404892|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154404893|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404894|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404895|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404896|NCT03696186|Phenobarbital|phenobarbital|mesh-list
154404897|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
154404898|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154404899|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404900|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404901|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154404902|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154404903|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404904|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404905|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
154404906|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
154404907|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154404908|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154404909|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154404910|NCT03698916|Celecoxib|celecoxib|mesh-list
154404911|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154404912|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154404913|NCT03698916|Analgesics|analgesics|mesh-ancestor
154404914|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
154404915|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404916|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404917|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404918|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660708|NCT00077116|Immunotoxins|immunotoxins|mesh-ancestor
154404919|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154404920|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154404921|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404922|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404923|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
154404924|NCT03695952|Nivolumab|nivolumab|mesh-list
154404925|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154404926|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404927|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404928|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404929|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
154404930|NCT03695640|Analgesics|analgesics|mesh-ancestor
154404931|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
154404932|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404933|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404934|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
154404935|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154404936|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154404937|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
154404938|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154404939|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154404940|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404941|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154404942|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
154404943|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154404944|NCT03698682|Levofloxacin|levofloxacin|mesh-list
154404945|NCT03698682|Ofloxacin|ofloxacin|mesh-list
154404946|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154404947|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154404948|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153660732|NCT00077233|Leucovorin|leucovorin|mesh-list
154404949|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154404950|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153979595|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
154404951|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404952|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404953|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404954|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154404955|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154404956|NCT03029832|Atezolizumab|atezolizumab|mesh-list
154404957|NCT03029832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154404958|NCT03029832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404959|NCT03029832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154404960|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404961|NCT03701880|Bisoprolol|bisoprolol|mesh-list
154404962|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154404963|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
154404964|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
154404965|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404966|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404967|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154404968|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153660767|NCT00077311|Hematinics|hematinics|mesh-ancestor
154404969|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154404970|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
154404971|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154404972|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404973|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
154404974|NCT03692754|Dexamethasone|dexamethasone|mesh-list
154404975|NCT03692754|Atorvastatin|atorvastatin|mesh-list
154404976|NCT03692754|Calcium|calcium|mesh-list
154404977|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154404978|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
154404979|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
154404980|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154404981|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154404982|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154404983|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
154404984|NCT03692754|Hormones|hormones|mesh-ancestor
154404985|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154404986|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154404987|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154404988|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154404989|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154404990|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154404991|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154404992|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
154404993|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154404994|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154404995|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154404996|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154404997|NCT04224558|Acetaminophen|acetaminophen|mesh-list
154404998|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
154404999|NCT04224558|Promethazine|promethazine|mesh-list
154405000|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
154405001|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154405002|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
154405003|NCT04224558|Fludarabine|fludarabine|mesh-list
154405004|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
154405005|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154405006|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
154405007|NCT04224558|Antibodies|antibodies|mesh-list
154405008|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
154405009|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154405010|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154405011|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154405012|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
154405013|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405014|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154405015|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154405016|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
154405017|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405018|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405019|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154405020|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154405021|NCT04224558|Analgesics|analgesics|mesh-ancestor
154405022|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
154405023|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405024|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
154405025|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405026|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
154405027|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
154405028|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154405029|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
154405030|NCT04224558|Hormones|hormones|mesh-ancestor
154405031|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405032|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154405033|NCT04224558|Protective Agents|protective agents|mesh-ancestor
154405034|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154405035|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154405036|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154405037|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405038|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
154405039|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
154405040|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154405041|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
154405042|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
154405043|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405044|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154405045|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
154405046|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405047|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
154405048|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
154405049|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405050|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
154405051|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
154405052|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405053|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405054|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154405055|NCT05598411|Hormones|hormones|mesh-ancestor
154405056|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405057|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154405058|NCT05598411|Protective Agents|protective agents|mesh-ancestor
154405059|NCT03688230|Cetuximab|cetuximab|mesh-list
154405060|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405061|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405062|NCT03694236|Durvalumab|durvalumab|mesh-list
154405063|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405064|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405065|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
154405066|NCT03692286|Calcium|calcium|mesh-list
154405067|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154405068|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405069|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154405070|NCT03694080|Calcium|calcium|mesh-list
154405071|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154405072|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405073|NCT04203498|Nabiximols|nabiximols|mesh-list
154405074|NCT04203498|Analgesics|analgesics|mesh-ancestor
154405075|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
154405076|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405077|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405078|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
154405079|NCT03691896|Vitamin D|vitamin d|mesh-list
154405080|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154405081|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405082|NCT03691896|Vitamins|vitamins|mesh-ancestor
154405083|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
154405084|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154405085|NCT03691818|Ibuprofen|ibuprofen|mesh-list
154405086|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154405087|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154405088|NCT03691818|Analgesics|analgesics|mesh-ancestor
154405089|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
154405090|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405091|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405092|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405093|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154405094|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154405095|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405096|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405097|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154405098|NCT03687606|Menotropins|menotropins|mesh-list
154405099|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154405100|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405101|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154405102|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
154405103|NCT04059978|Remifentanil|remifentanil|mesh-list
154405104|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154405105|NCT04059978|Narcotics|narcotics|mesh-ancestor
154405106|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405107|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405109|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
154405110|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405111|NCT03199963|Tamoxifen|tamoxifen|mesh-list
154405112|NCT03199963|Afimoxifene|afimoxifene|mesh-list
154405113|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154405114|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
154405115|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405116|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405117|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154405118|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405119|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154405120|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154405121|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154405122|NCT03636685|Paclitaxel|paclitaxel|mesh-list
154405123|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154405124|NCT03636685|Carboplatin|carboplatin|mesh-list
154405125|NCT03636685|Pemetrexed|pemetrexed|mesh-list
154405126|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154405127|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405128|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405129|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405130|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405131|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405132|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405133|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154405134|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154405135|NCT03883581|Quinidine|quinidine|mesh-list
154405136|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
154405137|NCT03883581|Levomethorphan|levomethorphan|mesh-list
154405138|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
154405139|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
154405140|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
154405141|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154405142|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154405143|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405144|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405145|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405146|NCT03883581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154405147|NCT03883581|Narcotics|narcotics|mesh-ancestor
154405148|NCT03883581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405149|NCT03883581|Analgesics|analgesics|mesh-ancestor
154405150|NCT03883581|Sensory System Agents|sensory system agents|mesh-ancestor
154405151|NCT03883581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405152|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154405153|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154405154|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405155|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154405156|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
154405157|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154405158|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154405159|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405160|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405161|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154405162|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154405163|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
153661052|NCT00079261|Hormones|hormones|mesh-ancestor
154405164|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154405165|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154405166|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154405167|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154405168|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154405169|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
154405170|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154405171|NCT03824535|Fluorides|fluorides|mesh-list
154405172|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154405173|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405174|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
154405175|NCT03824535|Protective Agents|protective agents|mesh-ancestor
154405176|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405177|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
154405178|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
154405179|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405181|NCT03113643|Venetoclax|venetoclax|mesh-list
154405182|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154405183|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
154405184|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405185|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405186|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405187|NCT03091491|Nivolumab|nivolumab|mesh-list
154405188|NCT03091491|Ipilimumab|ipilimumab|mesh-list
154405189|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405190|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405191|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154405192|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405193|NCT04733235|Progesterone|progesterone|mesh-list
154405194|NCT04733235|Hormones|hormones|mesh-ancestor
154405195|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405196|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405197|NCT04733235|Progestins|progestins|mesh-ancestor
154405198|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
154405199|NCT03029208|Hematinics|hematinics|mesh-ancestor
154405200|NCT05212623|Vaccines|vaccines|mesh-list
154405201|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
153661075|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405202|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405203|NCT03693222|Morphine|morphine|mesh-list
154405204|NCT03693222|Tramadol|tramadol|mesh-list
154405205|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154405206|NCT03693222|Narcotics|narcotics|mesh-ancestor
154405207|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405208|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405209|NCT03693222|Analgesics|analgesics|mesh-ancestor
154405210|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
154405211|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405212|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
154405213|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154405214|NCT03693066|Disinfectants|disinfectants|mesh-list
154405215|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154405216|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405217|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405218|NCT03631641|Nivolumab|nivolumab|mesh-list
154405219|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405220|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405221|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154405222|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405223|NCT03631875|Ketamine|ketamine|mesh-list
154405224|NCT03631875|Propofol|propofol|mesh-list
154405225|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154405226|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405227|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405228|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154405229|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
154405230|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
154405231|NCT03631875|Analgesics|analgesics|mesh-ancestor
154405232|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
154405233|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405234|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154405235|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154405236|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154405237|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405238|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405239|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154405240|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
154405241|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405242|NCT01568775|Aliskiren|aliskiren|mesh-list
154405243|NCT01568775|Renin Inhibitors|renin inhibitors|mesh-ancestor
154405244|NCT01568775|Protease Inhibitors|protease inhibitors|mesh-ancestor
154405245|NCT01568775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405246|NCT01568775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405247|NCT04941261|Vaccines|vaccines|mesh-list
154405248|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
154405249|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405250|NCT05597709|Insulin|insulin|mesh-list
154405251|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154405252|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405253|NCT02917629|Pioglitazone|pioglitazone|mesh-list
154405254|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154405255|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405256|NCT05417841|Insulin|insulin|mesh-list
153661199|NCT00080080|Docetaxel|docetaxel|mesh-list
154405257|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154405258|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
154405259|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
154405260|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154405261|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154405262|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405263|NCT03691038|Pregabalin|pregabalin|mesh-list
154405264|NCT03691038|Analgesics|analgesics|mesh-ancestor
154405265|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
154405266|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405267|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405268|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
154405269|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154405270|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154405271|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405272|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154405273|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154405274|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154405275|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405276|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154405277|NCT02927847|Nicotine|nicotine|mesh-list
154405278|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154405279|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
154405280|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405281|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405282|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154405283|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154405284|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
154405285|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405286|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405287|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154405288|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
154405289|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405290|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405291|NCT01568853|Norepinephrine|norepinephrine|mesh-list
154405292|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153661257|NCT00080275|Vitamins|vitamins|mesh-ancestor
154405293|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154405294|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405295|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405296|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405297|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405298|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
154405299|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
154405300|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405301|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154405302|NCT02960438|Quetmolimab|quetmolimab|mesh-list
154405303|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154405304|NCT03690414|Atropine|atropine|mesh-list
154405305|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154405306|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154405307|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154405308|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154405309|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154405310|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
154405311|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405312|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405313|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154405314|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
154405315|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
154405316|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
154405317|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154405318|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154405319|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
154405320|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405321|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405322|NCT02959970|Dapsone|dapsone|mesh-list
154405323|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405324|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
154405325|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154405326|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154405327|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154405328|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405329|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405330|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
154405331|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154405333|NCT03681990|Chlorhexidine|chlorhexidine|mesh-list
153661295|NCT03506373|Ixazomib|ixazomib|mesh-list
153661321|NCT00080665|Docetaxel|docetaxel|mesh-list
154405334|NCT03681990|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154405335|NCT03681990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154405336|NCT03681990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405337|NCT03681990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405338|NCT03681990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405339|NCT03681990|Disinfectants|disinfectants|mesh-ancestor
154405340|NCT03681990|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405341|NCT02740335|Protein C|protein c|mesh-list
154405342|NCT02740335|Protein S|protein s|mesh-list
154405343|NCT02740335|Thrombin|thrombin|mesh-list
154405344|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
154405345|NCT02740335|Coagulants|coagulants|mesh-ancestor
154405346|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
154405347|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154405348|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154405349|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405350|NCT01568931|Coal Tar|coal tar|mesh-list
154405351|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
154405352|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405353|NCT05279859|Gilteritinib|gilteritinib|mesh-list
154405354|NCT05279859|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154405355|NCT05279859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154405356|NCT05279859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405357|NCT05279859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405358|NCT05475717|Alprostadil|alprostadil|mesh-list
154405359|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154405360|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
154405361|NCT05475717|Urological Agents|urological agents|mesh-ancestor
154405362|NCT05133687|Bupivacaine|bupivacaine|mesh-list
154405363|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
154405364|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
154405365|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405366|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405367|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
154405368|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405369|NCT03685032|Dexamethasone|dexamethasone|mesh-list
154405370|NCT03685032|Ondansetron|ondansetron|mesh-list
154405371|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405372|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
154405373|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
154405374|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405375|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405376|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154405377|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
154405378|NCT03685032|Hormones|hormones|mesh-ancestor
154405379|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405380|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154405381|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405382|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
154405383|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405384|NCT03685032|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154405385|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154405386|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
154405387|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405388|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405389|NCT03689010|Azelaic acid|azelaic acid|mesh-list
154405390|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405391|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405392|NCT03680976|CXA-10|cxa-10|mesh-list
154405393|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405394|NCT05387343|Vaccines|vaccines|mesh-list
154405395|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
154405396|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405397|NCT04220775|Atezolizumab|atezolizumab|mesh-list
154405398|NCT04220775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154405399|NCT04220775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405400|NCT04220775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405401|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405402|NCT01381887|Canagliflozin|canagliflozin|mesh-list
154405403|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154405404|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405405|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154405406|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405407|NCT04877379|Ceftibuten|ceftibuten|mesh-list
154405408|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154405409|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405410|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
154405411|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405412|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405413|NCT03684330|Vitamin D|vitamin d|mesh-list
154405414|NCT03684330|Vitamins|vitamins|mesh-ancestor
154405415|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
154405416|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405417|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154405418|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
154405419|NCT01381809|Hematinics|hematinics|mesh-ancestor
154405420|NCT03677466|Tenecteplase|tenecteplase|mesh-list
154405421|NCT03677466|Streptokinase|streptokinase|mesh-list
154405422|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154405423|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154405424|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405425|NCT03447132|Fulvestrant|fulvestrant|mesh-list
154405426|NCT03447132|Goserelin|goserelin|mesh-list
154405427|NCT03447132|Palbociclib|palbociclib|mesh-list
154405428|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154405429|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405430|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154405431|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154405432|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
154405433|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405434|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405435|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154405436|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405437|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405438|NCT04133623|Ibuprofen|ibuprofen|mesh-list
154405439|NCT04133623|Ketorolac|ketorolac|mesh-list
154405440|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154405441|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154405442|NCT04133623|Analgesics|analgesics|mesh-ancestor
154405443|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
154405444|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405445|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405446|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405447|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154405448|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154405449|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405450|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405451|NCT03188185|Naltrexone|naltrexone|mesh-list
154405452|NCT03188185|Buprenorphine|buprenorphine|mesh-list
154405453|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154405454|NCT03188185|Narcotics|narcotics|mesh-ancestor
154405455|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405456|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405457|NCT03188185|Analgesics|analgesics|mesh-ancestor
154405458|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
154405459|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405460|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154405461|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154405462|NCT03679182|Olanzapine|olanzapine|mesh-list
154405463|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
154405464|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
154405465|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405466|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405467|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154405468|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154405469|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154405470|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405471|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154405472|NCT03679182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154405473|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154405474|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154405475|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405477|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
154405478|NCT03184987|Albuterol|albuterol|mesh-list
154405479|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154405480|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
154405481|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405482|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405483|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154405484|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
154405485|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
154405486|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154405487|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154405488|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154405489|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154405490|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405491|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405492|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405494|NCT03026166|Ipilimumab|ipilimumab|mesh-list
154405495|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154405496|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405497|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405498|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154405499|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405500|NCT03026166|Immunoconjugates|immunoconjugates|mesh-ancestor
154405501|NCT03026166|Immunologic Factors|immunologic factors|mesh-ancestor
154405502|NCT03026166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405503|NCT03026088|Bisoprolol|bisoprolol|mesh-list
154405504|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154405505|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
154405506|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
154405507|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405508|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405509|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154405510|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154405511|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154405512|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405513|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405514|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405515|NCT03678792|Morphine|morphine|mesh-list
154405516|NCT03678792|Buprenorphine|buprenorphine|mesh-list
154405517|NCT03678792|Tramadol|tramadol|mesh-list
154405518|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154405519|NCT03678792|Naloxone|naloxone|mesh-list
154405520|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154405521|NCT03678792|Narcotics|narcotics|mesh-ancestor
154405522|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405523|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405524|NCT03678792|Analgesics|analgesics|mesh-ancestor
154405525|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
154405526|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405527|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154405528|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154405529|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154405530|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154405531|NCT03678090|Plasminogen|plasminogen|mesh-list
154405532|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154405533|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154405534|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154405535|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405536|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154405537|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154405538|NCT03678012|Hematinics|hematinics|mesh-ancestor
154405539|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154405540|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154405541|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154405542|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405543|NCT03676296|Puerarin|puerarin|mesh-list
154405544|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
154405545|NCT03676140|Azithromycin|azithromycin|mesh-list
154405546|NCT03676140|Ivermectin|ivermectin|mesh-list
154405547|NCT03676140|Albendazole|albendazole|mesh-list
154405548|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
154405549|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154405550|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405551|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154405552|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
154405553|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
154405554|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154405555|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154405556|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405557|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405558|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405559|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405560|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405562|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
154405563|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154405564|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405565|NCT04059198|Tenofovir|tenofovir|mesh-list
154405566|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
154405567|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405568|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154405569|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154405570|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405571|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405572|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154405573|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154405574|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
154405575|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405576|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405577|NCT04058964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154405578|NCT04058964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405579|NCT03675594|Cobalt|cobalt|mesh-list
154405580|NCT03675594|Chromium|chromium|mesh-list
154405581|NCT03675594|Trace Elements|trace elements|mesh-ancestor
154405582|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
154405583|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405584|NCT03671538|Pemetrexed|pemetrexed|mesh-list
154405585|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405586|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405587|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405588|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154405589|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154405590|NCT05420467|Paclitaxel|paclitaxel|mesh-list
154405591|NCT05420467|Docetaxel|docetaxel|mesh-list
154405592|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154405593|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
154405594|NCT05420467|Carboplatin|carboplatin|mesh-list
154405595|NCT05420467|Trastuzumab|trastuzumab|mesh-list
154405596|NCT05420467|Epirubicin|epirubicin|mesh-list
154405597|NCT05420467|Pertuzumab|pertuzumab|mesh-list
153661679|NCT05568082|Itraconazole|itraconazole|mesh-list
154405598|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154405599|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405600|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405601|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405602|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405603|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405604|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154405605|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
154405606|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405607|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154405608|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154405609|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
154405610|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154405611|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405612|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154405613|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154405614|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154405615|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405616|NCT03022578|Lomustine|lomustine|mesh-list
154405617|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154405618|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
154405619|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405620|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405621|NCT03671070|Epinephrine|epinephrine|mesh-list
154405622|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154405623|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154405624|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405625|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405626|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405627|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405628|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154405629|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154405630|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
154405631|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405633|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
154405634|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
154405635|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
154405636|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154405637|NCT03670758|Protein S|protein s|mesh-list
154405638|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
154405639|NCT03674658|Propafenone|propafenone|mesh-list
154405640|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154405641|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154405642|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154405643|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154405644|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405645|NCT03623256|Fentanyl|fentanyl|mesh-list
154405646|NCT03623256|Bupivacaine|bupivacaine|mesh-list
154405647|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
154405648|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
154405649|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405650|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405651|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
154405652|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405653|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154405654|NCT03623256|Narcotics|narcotics|mesh-ancestor
154405655|NCT03623256|Analgesics|analgesics|mesh-ancestor
154405656|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153661761|NCT03151434|Narcotics|narcotics|mesh-ancestor
154405657|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154405658|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
154405659|NCT03082014|Losartan|losartan|mesh-list
154405660|NCT03082014|Atenolol|atenolol|mesh-list
154405661|NCT03082014|Amlodipine|amlodipine|mesh-list
154405662|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154405663|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154405664|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154405665|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405666|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154405667|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405668|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
154405669|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154405670|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154405671|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154405672|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
154405673|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
154405674|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405675|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154405676|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154405677|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154405678|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405679|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405680|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
154405681|NCT03670212|Yohimbine|yohimbine|mesh-list
154405682|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405683|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
154405684|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
154405685|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405686|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405687|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154405688|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154405689|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154405690|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405691|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405692|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405693|NCT03670212|Urological Agents|urological agents|mesh-ancestor
154405694|NCT03165955|Paclitaxel|paclitaxel|mesh-list
154405695|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154405696|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405697|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405698|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405699|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405700|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405701|NCT05263921|Ritonavir|ritonavir|mesh-list
154405702|NCT05263921|Nirmatrelvir|nirmatrelvir|mesh-list
154405703|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154405704|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154405705|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
154405706|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405707|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405709|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154405710|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
154405711|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405712|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154405713|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154405714|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154405715|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405716|NCT03673332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405717|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405718|NCT03165721|Guadecitabine|guadecitabine|mesh-list
154405719|NCT03165721|Azacitidine|azacitidine|mesh-list
154405720|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405721|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154405722|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
154405723|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405724|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405725|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
154405726|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
154405727|NCT02224872|Fludarabine|fludarabine|mesh-list
154405728|NCT02224872|Tacrolimus|tacrolimus|mesh-list
154405729|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
154405730|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154405731|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
154405732|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405733|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154405734|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154405735|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
154405736|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405737|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405738|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154405739|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154405740|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405741|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154405742|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154405743|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
154405744|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154405745|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405746|NCT02187198|Buprenorphine|buprenorphine|mesh-list
154405747|NCT02187198|Naloxone|naloxone|mesh-list
154405748|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154405749|NCT02187198|Narcotics|narcotics|mesh-ancestor
154405750|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405751|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405752|NCT02187198|Analgesics|analgesics|mesh-ancestor
154405753|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
154405754|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405755|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154405756|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
154405757|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154405758|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405759|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405760|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154405761|NCT04969705|Analgesics|analgesics|mesh-ancestor
154405762|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
153661924|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
154405763|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405764|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154405765|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154405766|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154405767|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405768|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405769|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405770|NCT03676374|Prucalopride|prucalopride|mesh-list
154405771|NCT03676374|Laxatives|laxatives|mesh-ancestor
154405772|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154405773|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154405774|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154405776|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405777|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405778|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405779|NCT03021642|Tepotinib|tepotinib|mesh-list
153980488|NCT04065529|Zinc|zinc|mesh-list
154405780|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405781|NCT03023046|Prednisone|prednisone|mesh-list
154405782|NCT03023046|Cortisone|cortisone|mesh-list
154405783|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
154405784|NCT03023046|Rituximab|rituximab|mesh-list
154405785|NCT03023046|Doxorubicin|doxorubicin|mesh-list
154405786|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154405787|NCT03023046|Etoposide|etoposide|mesh-list
154405788|NCT03023046|Vincristine|vincristine|mesh-list
154405789|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
154405790|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
154405791|NCT03023046|Daunorubicin|daunorubicin|mesh-list
154405792|NCT03023046|Dasatinib|dasatinib|mesh-list
154405793|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
153661968|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405794|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154405795|NCT03023046|Antibodies|antibodies|mesh-list
154405796|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
154405797|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154405798|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154405799|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
154405800|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405801|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154405802|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154405803|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
154405804|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405805|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405806|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154405807|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154405808|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154405809|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154405810|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405811|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405812|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
154405813|NCT03023046|Hormones|hormones|mesh-ancestor
154405814|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405815|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154405816|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154405817|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405818|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405819|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405820|NCT03023046|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154405821|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154405822|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
154405823|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405824|NCT03668262|Atracurium|atracurium|mesh-list
154405825|NCT03668262|Cisatracurium|cisatracurium|mesh-list
154405826|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154405827|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154405828|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154405829|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405830|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405831|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154405832|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154405833|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
154405834|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405835|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405836|NCT03668964|Vitamin D|vitamin d|mesh-list
154405837|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
154405838|NCT03668964|Vitamins|vitamins|mesh-list
154405839|NCT03668964|Vitamin E|vitamin e|mesh-list
154405840|NCT03668964|Tocopherols|tocopherols|mesh-list
154405841|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
154405842|NCT03668964|Vitamin A|vitamin a|mesh-list
154405843|NCT03668964|Riboflavin|riboflavin|mesh-list
154405844|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
154405845|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
154405846|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405847|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154405848|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154405849|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
154405850|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405851|NCT03668964|Protective Agents|protective agents|mesh-ancestor
154405852|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154405853|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405854|NCT03668730|Paclitaxel|paclitaxel|mesh-list
154405855|NCT03668730|Fluorouracil|fluorouracil|mesh-list
153980502|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
154405856|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154405857|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405858|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405859|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405860|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405861|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405862|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
154405863|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153662038|NCT00137995|Cytarabine|cytarabine|mesh-list
154405864|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154405865|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
154405866|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405867|NCT03021018|Lorazepam|lorazepam|mesh-list
154405868|NCT03021018|Brivaracetam|brivaracetam|mesh-list
154405869|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
154405870|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
154405871|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
154405872|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405873|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405874|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154405875|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154405876|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154405877|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154405878|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154405879|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154405880|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
154405881|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
154405882|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405883|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405884|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
154405885|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154405886|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154405887|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405888|NCT02509507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154405889|NCT02509507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405890|NCT03175549|Apremilast|apremilast|mesh-list
154405891|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154405892|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154405893|NCT03175549|Analgesics|analgesics|mesh-ancestor
154405894|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
154405895|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405896|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405897|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405898|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154405899|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154405900|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154405901|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405902|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405903|NCT01314937|Mebendazole|mebendazole|mesh-list
154405904|NCT01314937|Piperazine|piperazine|mesh-list
154405905|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
154405906|NCT01314937|DMP 777|dmp 777|mesh-list
154405907|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
154405908|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
154405909|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154405910|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154405911|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405912|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405913|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405914|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405915|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405916|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405917|NCT04718155|Atorvastatin|atorvastatin|mesh-list
154405918|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154405919|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154405920|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
154405921|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405922|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154405923|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154405924|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405925|NCT04668859|Midodrine|midodrine|mesh-list
154405926|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
154405927|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
154405928|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405929|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405930|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154405931|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154405932|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154405934|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405935|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405936|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405937|NCT02924688|Fluticasone|fluticasone|mesh-list
154405938|NCT02924688|Albuterol|albuterol|mesh-list
154405939|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154405940|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154405941|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153662158|NCT00138970|Daclizumab|daclizumab|mesh-list
154405942|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154405943|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
154405944|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154405945|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405946|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154405947|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
154405948|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
154405949|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154405950|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154405951|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154405952|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154405953|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154405954|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154405955|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405956|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
154405957|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154405958|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
154405959|NCT02924688|Hormones|hormones|mesh-ancestor
154405960|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405961|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
154405962|NCT03668418|Camptothecin|camptothecin|mesh-list
154405963|NCT03668418|Docetaxel|docetaxel|mesh-list
154405964|NCT03668418|Gemcitabine|gemcitabine|mesh-list
154405965|NCT03668418|Fluorouracil|fluorouracil|mesh-list
154405966|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
154405967|NCT03668418|Irinotecan|irinotecan|mesh-list
154405968|NCT03668418|Epirubicin|epirubicin|mesh-list
154405969|NCT03668418|Taxane|taxane|mesh-list
154405970|NCT03668418|Antimetabolites|antimetabolites|mesh-list
154405971|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154405972|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405973|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405974|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405975|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405976|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154405977|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154405978|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154405979|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
154405980|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405981|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154405982|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154405983|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154405984|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154405985|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154405986|NCT03011892|Triamcinolone|triamcinolone|mesh-list
154405987|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154405988|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
154405989|NCT03011892|Hormones|hormones|mesh-ancestor
154405990|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154405991|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154405992|NCT02125513|Paclitaxel|paclitaxel|mesh-list
154405993|NCT02125513|Carboplatin|carboplatin|mesh-list
154405994|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154405995|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154405996|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
154405997|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
154405998|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
154405999|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406000|NCT03666546|Methamphetamine|methamphetamine|mesh-list
154406001|NCT03666546|Lactulose|lactulose|mesh-list
154406002|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406003|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154406004|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406005|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
154406006|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
154406007|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406008|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
154406009|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406010|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406011|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154406012|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154406013|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154406014|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154406015|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154406016|NCT03012828|Moxidectin|moxidectin|mesh-list
154406017|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
154406018|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154406019|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406020|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
154406021|NCT03666390|Midazolam|midazolam|mesh-list
154406022|NCT03666390|Ketamine|ketamine|mesh-list
154406023|NCT03666390|Analgesics|analgesics|mesh-ancestor
154406024|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
154406025|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406026|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406027|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154406028|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154406029|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
154406030|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
154406031|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406032|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154406033|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154406034|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406035|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406036|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154406037|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154406038|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154406039|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154406040|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154406041|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
154406042|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
154406043|NCT03003390|Enoxaparin|enoxaparin|mesh-list
154406044|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
154406045|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154406046|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154406047|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406048|NCT03003000|Ibuprofen|ibuprofen|mesh-list
154406049|NCT03003000|Caffeine|caffeine|mesh-list
154406050|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154406051|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406052|NCT03003000|Analgesics|analgesics|mesh-ancestor
154406053|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
154406054|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406055|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406056|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406057|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406058|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154406059|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406060|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406061|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154406062|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154406063|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154406064|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154406065|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
154406066|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406067|NCT03665766|Cycloserine|cycloserine|mesh-list
154406068|NCT03665766|Tacrolimus|tacrolimus|mesh-list
154406069|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154406070|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
154406071|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406072|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154406073|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406074|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406075|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154406076|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406077|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154406078|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
154406079|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154406080|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
154406081|NCT03637361|Methadone|methadone|mesh-list
154406082|NCT03637361|D-methadone|d-methadone|mesh-list
154406083|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154406084|NCT03637361|Narcotics|narcotics|mesh-ancestor
154406085|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406086|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406087|NCT03637361|Analgesics|analgesics|mesh-ancestor
154406088|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
154406089|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406090|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
154406091|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
154406092|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406093|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
154406094|NCT00038675|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154406095|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154406096|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406097|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406098|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406099|NCT03254459|Morphine|morphine|mesh-list
154406100|NCT03254459|Oxycodone|oxycodone|mesh-list
154406101|NCT03254459|Buprenorphine|buprenorphine|mesh-list
154406102|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154406103|NCT03254459|Narcotics|narcotics|mesh-ancestor
154406104|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406105|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406106|NCT03254459|Analgesics|analgesics|mesh-ancestor
154406107|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
154406108|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406109|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154406110|NCT03620591|Lidocaine|lidocaine|mesh-list
154406111|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
154406112|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
154406113|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406114|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406115|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
154406116|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406117|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154406118|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154406119|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154406120|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154406121|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406123|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
154406124|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
154406125|NCT05178953|Trace Elements|trace elements|mesh-ancestor
154406126|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
153662398|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
154406127|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406128|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154406129|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406130|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406131|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154406132|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154406133|NCT05178953|Protective Agents|protective agents|mesh-ancestor
154406134|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
154406135|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154406136|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
154406137|NCT05178953|Astringents|astringents|mesh-ancestor
154406138|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
154406139|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
154406140|NCT02736617|Ibrutinib|ibrutinib|mesh-list
154406141|NCT02736617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154406142|NCT02736617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154406143|NCT02736617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406144|NCT02736617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406145|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154406146|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406147|NCT03251963|Enoxaparin|enoxaparin|mesh-list
154406148|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
154406149|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
154406150|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154406151|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154406152|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406154|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406155|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406156|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
154406157|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154406158|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406159|NCT03249935|Azithromycin|azithromycin|mesh-list
154406160|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154406161|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406163|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154406164|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
154406165|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154406166|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406167|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154406168|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406169|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
154406170|NCT03000348|Cysteamine|cysteamine|mesh-list
154406171|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154406172|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406173|NCT03664986|Bupivacaine|bupivacaine|mesh-list
154406174|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
154406175|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
154406176|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406177|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406178|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
154406179|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406180|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
154406181|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154406182|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406183|NCT03492918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154406184|NCT03492918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406185|NCT03247673|Bevacizumab|bevacizumab|mesh-list
154406186|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154406187|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406188|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154406189|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154406190|NCT03247673|Growth Substances|growth substances|mesh-ancestor
154406191|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406192|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
154406193|NCT03665610|Ozanimod|ozanimod|mesh-list
154406194|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154406195|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406196|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154406197|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
154406198|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406199|NCT03664908|Antibodies|antibodies|mesh-list
154406200|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
154406201|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406202|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154406203|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154406204|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
154406205|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406206|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154406207|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154406208|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
154406209|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
154406210|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406211|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406212|NCT03664440|Nevirapine|nevirapine|mesh-list
154406213|NCT03664440|Rilpivirine|rilpivirine|mesh-list
154406214|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154406215|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154406216|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406217|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406218|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
154406219|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406220|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154406221|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154406222|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154034788|NCT05299567|Azithromycin|azithromycin|mesh-list
154406223|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154406224|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154406225|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154406226|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406227|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
154406228|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
154406229|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154406230|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154406231|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
154406232|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406233|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980945|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
154406234|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406235|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406236|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154406237|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406238|NCT03240575|Fluticasone|fluticasone|mesh-list
154406239|NCT03240575|Xhance|xhance|mesh-list
154406240|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
154406241|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154406242|NCT03240575|Olodaterol|olodaterol|mesh-list
154406243|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406244|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154406245|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
154406246|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406247|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406248|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154406249|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
154406250|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
154406251|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154406252|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
154406253|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154406254|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
154406255|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406256|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406257|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154406258|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154406259|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154406260|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
154406261|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
153499580|NCT00004266|Nifedipine|nifedipine|mesh-list
154406262|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154406263|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406264|NCT04034225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154406265|NCT04034225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406266|NCT03690947|Ranibizumab|ranibizumab|mesh-list
154406267|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154406268|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154406269|NCT03690947|Growth Substances|growth substances|mesh-ancestor
154406270|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406271|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
154406272|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406273|NCT02999178|Nintedanib|nintedanib|mesh-list
154406274|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406275|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154406276|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406277|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406278|NCT02999100|Oxytocin|oxytocin|mesh-list
154406279|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
154406280|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154406281|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406282|NCT02749370|Etanercept|etanercept|mesh-list
154406283|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154406284|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406285|NCT02749370|Analgesics|analgesics|mesh-ancestor
154406286|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
154406287|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406288|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406289|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406290|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406291|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406292|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154406293|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
154406294|NCT03617900|Acetaminophen|acetaminophen|mesh-list
154406295|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406297|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
154406298|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406299|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406300|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
154406301|NCT05384366|Paclitaxel|paclitaxel|mesh-list
154406302|NCT05384366|Carboplatin|carboplatin|mesh-list
154406303|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154406304|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406305|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
154406306|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
154406307|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
154406308|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406310|NCT03616808|Coagulants|coagulants|mesh-ancestor
154406311|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
154406312|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154406313|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406314|NCT03617510|Analgesics|analgesics|mesh-ancestor
154406315|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
154406316|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406317|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406318|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406319|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406320|NCT03617432|Prednisone|prednisone|mesh-list
154406321|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
154406322|NCT03617432|Doxorubicin|doxorubicin|mesh-list
154406323|NCT03617432|Etoposide|etoposide|mesh-list
154406324|NCT03617432|Vincristine|vincristine|mesh-list
154406325|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154406326|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
154406327|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406328|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406329|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154406330|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
154406331|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406332|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406333|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154406334|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154406335|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154406336|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154406337|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406338|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406339|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
154406340|NCT03617432|Hormones|hormones|mesh-ancestor
154406341|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154406342|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154406343|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154406344|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
154406345|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
154406346|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
154406347|NCT02996682|Ribavirin|ribavirin|mesh-list
154406348|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154406349|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
153662720|NCT00142480|Capecitabine|capecitabine|mesh-list
154406350|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406351|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
154406352|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406353|NCT02873702|Lansoprazole|lansoprazole|mesh-list
154406354|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
154406355|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154406356|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406357|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154406358|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406359|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406360|NCT03616262|Lidocaine|lidocaine|mesh-list
154406361|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
154406362|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
154406363|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406364|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406365|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
154406366|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406367|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154406368|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154406369|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154406370|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154406371|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406372|NCT03615950|Vitamin D|vitamin d|mesh-list
154406373|NCT03615950|Vitamins|vitamins|mesh-ancestor
154406374|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
154406375|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406376|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154406377|NCT02911116|Ustekinumab|ustekinumab|mesh-list
154406378|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
154406379|NCT03664050|Letrozole|letrozole|mesh-list
154406380|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406381|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154406382|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154406383|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406384|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406385|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154406386|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
154406387|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154406388|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406389|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154406390|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154406391|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
154406392|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154406393|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406394|NCT04494438|Rituximab|rituximab|mesh-list
154406395|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154406396|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406397|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
154406398|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406399|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406400|NCT04057482|Dequalinium|dequalinium|mesh-list
154406401|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154406402|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406403|NCT03662412|Sirolimus|sirolimus|mesh-list
154406404|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154406405|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406406|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154406407|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406408|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
154406409|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154406410|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
154406411|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406412|NCT02870972|Berotralstat|berotralstat|mesh-list
154406413|NCT02870972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154406414|NCT02870972|Protease Inhibitors|protease inhibitors|mesh-ancestor
154406415|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406416|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406417|NCT03214367|Insulin|insulin|mesh-list
154406418|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154406419|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
154406420|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
154406421|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154406422|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406423|NCT03662958|Leuprolide|leuprolide|mesh-list
154406424|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154406425|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
154406426|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154406427|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406428|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154406429|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406430|NCT03231371|Adenosine|adenosine|mesh-list
154406431|NCT03231371|Analgesics|analgesics|mesh-ancestor
154406432|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
154406433|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406434|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406435|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154406436|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
154406437|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154406438|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
154406439|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
154406440|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406441|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406442|NCT03663114|Lenvatinib|lenvatinib|mesh-list
154406443|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406444|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154406445|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406446|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406447|NCT03526679|Lenvatinib|lenvatinib|mesh-list
154406448|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406449|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154406450|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406451|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406452|NCT04057326|Pancreatin|pancreatin|mesh-list
154406453|NCT04057326|Pancrelipase|pancrelipase|mesh-list
154406454|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406455|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154406456|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154406457|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154406458|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
154406459|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406460|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406461|NCT05384210|Gabapentin|gabapentin|mesh-list
154406462|NCT05384210|Milnacipran|milnacipran|mesh-list
154406463|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
154406464|NCT05384210|Analgesics|analgesics|mesh-ancestor
154406465|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
154406466|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406467|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406468|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
154406469|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154406470|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154406471|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406472|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154406473|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154406474|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154406475|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406476|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406477|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
154406478|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154406479|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154406480|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154406481|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406482|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
154406483|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
154406484|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154406485|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
154406486|NCT02032394|Povidone|povidone|mesh-list
154406487|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154406488|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406489|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
154406490|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
154406491|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
154406492|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
154406493|NCT03239483|Dapivirine|dapivirine|mesh-list
154406494|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154406495|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154406496|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
154406497|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406498|NCT01068912|Favipiravir|favipiravir|mesh-list
154406499|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
154406500|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406501|NCT04056702|Ivacaftor|ivacaftor|mesh-list
154406502|NCT04056702|Elexacaftor|elexacaftor|mesh-list
154406503|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154406504|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153662959|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154406505|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406506|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
154406507|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154406508|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406509|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406510|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406511|NCT03612440|Analgesics|analgesics|mesh-ancestor
154406512|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
154406513|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406514|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154406515|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154406516|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154406517|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
154406518|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406519|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406520|NCT03662724|Venetoclax|venetoclax|mesh-list
154406521|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406522|NCT03662568|Ritonavir|ritonavir|mesh-list
154406523|NCT03662568|Tenofovir|tenofovir|mesh-list
154406524|NCT03662568|Entecavir|entecavir|mesh-list
154406525|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154406526|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154406527|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
154406528|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406529|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406530|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154406531|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154406532|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
154406533|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406534|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154406535|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154406536|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154406537|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154406538|NCT02993250|Simeprevir|simeprevir|mesh-list
154406539|NCT02993250|Odalasvir|odalasvir|mesh-list
154406540|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
154406541|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406542|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
154406543|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406544|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406545|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154406546|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154406547|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154406548|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154406549|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406550|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
154406551|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406552|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406553|NCT05383820|Ketorolac|ketorolac|mesh-list
153663027|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
154406554|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154406555|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406556|NCT05383820|Analgesics|analgesics|mesh-ancestor
154406557|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
154406558|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406559|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406560|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406561|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406562|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154406563|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406564|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406565|NCT03611504|Hemostatics|hemostatics|mesh-list
154406566|NCT03611504|Coagulants|coagulants|mesh-ancestor
154406567|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154406568|NCT02954510|Hematinics|hematinics|mesh-ancestor
154406569|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154406570|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154406571|NCT02032784|Octreotide|octreotide|mesh-list
154406572|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406573|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154406574|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406575|NCT03611426|Thrombin|thrombin|mesh-list
154406576|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
154406577|NCT03611426|Coagulants|coagulants|mesh-ancestor
154406578|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154406579|NCT03658746|Amoxicillin|amoxicillin|mesh-list
154406580|NCT03658746|Metronidazole|metronidazole|mesh-list
154406581|NCT03658746|Clarithromycin|clarithromycin|mesh-list
154406582|NCT03658746|Levofloxacin|levofloxacin|mesh-list
154406583|NCT03658746|Ofloxacin|ofloxacin|mesh-list
154406584|NCT03658746|Tetracycline|tetracycline|mesh-list
154406585|NCT03658746|Tinidazole|tinidazole|mesh-list
154406586|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154406587|NCT03658746|Furazolidone|furazolidone|mesh-list
154406588|NCT03658746|Bismuth|bismuth|mesh-list
154406589|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154406590|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406591|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
154406592|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154406593|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154406594|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154406595|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406596|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406597|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154406598|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154406599|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154406600|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154406601|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154406602|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406603|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154406605|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406606|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154406607|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154406608|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154406609|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
153981247|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406610|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
154406611|NCT02990910|Narcotics|narcotics|mesh-ancestor
154406612|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406613|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406614|NCT02990910|Analgesics|analgesics|mesh-ancestor
154406615|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
154406616|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406617|NCT04056000|Caffeine|caffeine|mesh-list
154406618|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154406619|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406620|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154406621|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406622|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406623|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154406624|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154406625|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
154406626|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406627|NCT03611348|Latanoprost|latanoprost|mesh-list
154406628|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154406629|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154406630|NCT02033018|Aflibercept|aflibercept|mesh-list
154406631|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154406632|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154406633|NCT02033018|Growth Substances|growth substances|mesh-ancestor
154406634|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406635|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
154406636|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406637|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
154406638|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406639|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406640|NCT03658590|Dexamethasone|dexamethasone|mesh-list
154406641|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406642|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
154406643|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
154406644|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406645|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406646|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406647|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
154406648|NCT03658590|Hormones|hormones|mesh-ancestor
154406649|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154406650|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154406651|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406652|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
154406653|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
154406654|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154406655|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154406656|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406657|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406658|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406659|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406660|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
154406661|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406662|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154406663|NCT02033408|Amoxicillin|amoxicillin|mesh-list
154406664|NCT02033408|Metronidazole|metronidazole|mesh-list
154406665|NCT02033408|Vancomycin|vancomycin|mesh-list
154406666|NCT02033408|Doxycycline|doxycycline|mesh-list
154406667|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
154406668|NCT02033408|Gentamicins|gentamicins|mesh-list
154406669|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406670|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154406671|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154406672|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
154406673|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154406674|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154406675|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406676|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406677|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406678|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154406679|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154406680|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154406681|NCT03610880|Yimitasvir|yimitasvir|mesh-list
154406682|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
154406683|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406684|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
154406685|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154406686|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153663188|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
154406687|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154406688|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154406689|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406690|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
154406691|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406692|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406693|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154406694|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406695|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154406696|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154406697|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
154406698|NCT02560298|Paclitaxel|paclitaxel|mesh-list
154406699|NCT02560298|Cisplatin|cisplatin|mesh-list
154406700|NCT02560298|Carboplatin|carboplatin|mesh-list
154406701|NCT02560298|Capecitabine|capecitabine|mesh-list
154406702|NCT02560298|Fluorouracil|fluorouracil|mesh-list
154406703|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154406704|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154406705|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406706|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
154406707|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
154406708|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
154406709|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406710|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154406711|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
154406712|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154406713|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
154406714|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406715|NCT01330615|Lidocaine|lidocaine|mesh-list
154406716|NCT01330615|Prilocaine|prilocaine|mesh-list
154406717|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154406718|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
154406719|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
154406720|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406721|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406722|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
154406723|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406724|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154406725|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154406726|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154406727|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154406728|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406729|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154406730|NCT05034029|Metformin|metformin|mesh-list
154406731|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154406732|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406733|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154406734|NCT03237065|Hematinics|hematinics|mesh-ancestor
154406735|NCT03620461|Gemcitabine|gemcitabine|mesh-list
154406736|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154406737|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154406738|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
154406739|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406740|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406741|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
154406742|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154406743|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154406744|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
154406745|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406746|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406747|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406748|NCT01314781|Urological Agents|urological agents|mesh-ancestor
154406749|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154406750|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154406751|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153663261|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
154406752|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154406753|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406754|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154406755|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406756|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406757|NCT02863328|Semaglutide|semaglutide|mesh-list
154406758|NCT02863328|Empagliflozin|empagliflozin|mesh-list
154406759|NCT02863328|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154406760|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153981419|NCT02653209|Hormones|hormones|mesh-ancestor
154406761|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406762|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154406763|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406764|NCT03040141|Oseltamivir|oseltamivir|mesh-list
154406765|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
154406766|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406767|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663302|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154406768|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406769|NCT02937701|Infliximab|infliximab|mesh-list
154406770|NCT02937701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154406771|NCT02937701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406772|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
154406773|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406774|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406775|NCT05186623|Ustekinumab|ustekinumab|mesh-list
154406776|NCT05186623|Vedolizumab|vedolizumab|mesh-list
154406777|NCT05186623|Tofacitinib|tofacitinib|mesh-list
154406778|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
154406779|NCT05186623|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154406780|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154406781|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406782|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406783|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406784|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
154406785|NCT04602845|Midazolam|midazolam|mesh-list
154406786|NCT04602845|Fentanyl|fentanyl|mesh-list
154406787|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154406788|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154406789|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406790|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406791|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153663324|NCT00393393|Hylan|hylan|mesh-list
154406792|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154406793|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154406794|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154406795|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
154406796|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
154406797|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
154406798|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
154406799|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406800|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406801|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154406802|NCT04602845|Narcotics|narcotics|mesh-ancestor
154406803|NCT04602845|Analgesics|analgesics|mesh-ancestor
154406804|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
154406805|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406806|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154406807|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406808|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406809|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406810|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154406811|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406812|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
154406813|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154406814|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406815|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154406816|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154406817|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406818|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406819|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406820|NCT03168919|Temozolomide|temozolomide|mesh-list
154406821|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153663367|NCT04713319|Calcium|calcium|mesh-list
154406822|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
154406823|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406824|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406825|NCT03205163|Factor VIII|factor viii|mesh-list
154406826|NCT03205163|Coagulants|coagulants|mesh-ancestor
154406827|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
154406828|NCT03638947|Povidone|povidone|mesh-list
154406829|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
154406830|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
154406831|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153981470|NCT02652741|Enalaprilat|enalaprilat|mesh-list
154406832|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406833|NCT03502681|Avelumab|avelumab|mesh-list
154406834|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154406835|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406836|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
154406837|NCT04938817|Lenvatinib|lenvatinib|mesh-list
154406838|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154406839|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406840|NCT04938817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154406841|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406842|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154406843|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406844|NCT04485325|Etanercept|etanercept|mesh-list
154406845|NCT04485325|Tofacitinib|tofacitinib|mesh-list
154406846|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154406847|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154406848|NCT04485325|Analgesics|analgesics|mesh-ancestor
154406849|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
154406850|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406851|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406852|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406853|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406854|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406855|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154406856|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
154406857|NCT04485325|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154406858|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154406859|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406860|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406861|NCT03610178|Insulin|insulin|mesh-list
154406862|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154406863|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154406864|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406865|NCT02033798|Tamsulosin|tamsulosin|mesh-list
154406866|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154406867|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154406868|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154406869|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
154406870|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406871|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406872|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406873|NCT02033798|Urological Agents|urological agents|mesh-ancestor
154406874|NCT02887183|Valsartan|valsartan|mesh-list
154406875|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154406876|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154406877|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154406878|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154406879|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406880|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
154406881|NCT03660306|Anesthetics|anesthetics|mesh-list
154406882|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406883|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406884|NCT03660306|Narcotics|narcotics|mesh-ancestor
154406885|NCT03660306|Analgesics|analgesics|mesh-ancestor
154406886|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
154406887|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154406888|NCT01067352|Hormones|hormones|mesh-list
154406889|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154406890|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406891|NCT02920242|Rifaximin|rifaximin|mesh-list
154406892|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154406893|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406894|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406895|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154406896|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154406897|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154406898|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154406899|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406900|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406901|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
154406902|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406903|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154406904|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154406905|NCT03659682|Semaglutide|semaglutide|mesh-list
154406906|NCT03659682|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153739166|NCT02964104|Insulin|insulin|mesh-list
154406907|NCT03659682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154406908|NCT03659682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406910|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154406911|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154406912|NCT03203447|Bevacizumab|bevacizumab|mesh-list
154406913|NCT03203447|Ranibizumab|ranibizumab|mesh-list
154406914|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154406915|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154406916|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406917|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154406918|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154406919|NCT03203447|Growth Substances|growth substances|mesh-ancestor
154406920|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406921|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
154406922|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154406923|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
154406924|NCT03203447|Hormones|hormones|mesh-ancestor
154406925|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154406926|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154406927|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
154406928|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406929|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406930|NCT01068678|Insulin|insulin|mesh-list
154406931|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154406932|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
154406933|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154406934|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406935|NCT03202511|Tenofovir|tenofovir|mesh-list
154406936|NCT03202511|Emtricitabine|emtricitabine|mesh-list
154406937|NCT03202511|Probenecid|probenecid|mesh-list
154406938|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
154406939|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154406940|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154406941|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154406942|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154406943|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406944|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154406945|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154406946|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
154406947|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
154406948|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154406949|NCT03637049|Midazolam|midazolam|mesh-list
154406950|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154406951|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153663672|NCT00062816|Ribavirin|ribavirin|mesh-list
154406952|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406953|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406954|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154406955|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154406956|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154406957|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154406958|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
154406959|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
154406960|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
154406961|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
154406962|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154406963|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406964|NCT03636971|Mannitol|mannitol|mesh-list
154406965|NCT03636971|Sorbitol|sorbitol|mesh-list
154406966|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
154406967|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154406968|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
154406969|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406970|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
154406971|NCT03636971|Protective Agents|protective agents|mesh-ancestor
154406972|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154406973|NCT03636971|Diuretics|diuretics|mesh-ancestor
154406974|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
154406975|NCT03636971|Cathartics|cathartics|mesh-ancestor
154406976|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154406977|NCT03610100|Gemcitabine|gemcitabine|mesh-list
154406978|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154406979|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
154406980|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406981|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406982|NCT03657966|Paclitaxel|paclitaxel|mesh-list
154406983|NCT03657966|Carboplatin|carboplatin|mesh-list
154406984|NCT03657966|Gemcitabine|gemcitabine|mesh-list
154406985|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154406986|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154406987|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
154406988|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
154406989|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
154406990|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154406991|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154406992|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
154406993|NCT03659292|Anesthetics|anesthetics|mesh-list
154406994|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154406995|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154406996|NCT03659058|Colchicine|colchicine|mesh-list
154406997|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154406998|NCT03659058|Antioxidants|antioxidants|mesh-list
154406999|NCT03659058|Silymarin|silymarin|mesh-list
154407000|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
154407001|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407002|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
154407003|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
154407004|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
154407005|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407006|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407007|NCT03659058|Protective Agents|protective agents|mesh-ancestor
154407008|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407009|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154407010|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407011|NCT03635905|Gabapentin|gabapentin|mesh-list
153663754|NCT00009581|Acetylcholine|acetylcholine|mesh-list
154407012|NCT03635905|Analgesics|analgesics|mesh-ancestor
154407013|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
154407014|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407015|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407016|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
154407017|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154407018|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154407019|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407020|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154407021|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154407022|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154407023|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407024|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407025|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
154407026|NCT02960113|Scopolamine|scopolamine|mesh-list
154407027|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154407028|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154407029|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
154407030|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
154407031|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407032|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407033|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407034|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
154407035|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154407036|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
154407037|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407038|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407039|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154407040|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
154407041|NCT04458324|Buspirone|buspirone|mesh-list
154407042|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154407043|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154407044|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407045|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407046|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154407047|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154407048|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
154407049|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407050|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407051|NCT03657420|Dexamethasone|dexamethasone|mesh-list
154407052|NCT03657420|Pomalidomide|pomalidomide|mesh-list
154407053|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154407054|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
154407055|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
154407056|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407057|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407058|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407059|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
153739296|NCT00509470|Amlodipine|amlodipine|mesh-list
154407060|NCT03657420|Hormones|hormones|mesh-ancestor
154407061|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154407062|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154407063|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407064|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
154407065|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154407066|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154407067|NCT03657420|Growth Substances|growth substances|mesh-ancestor
154407068|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
154407069|NCT02984982|Anticoagulants|anticoagulants|mesh-list
154407070|NCT02984982|Atorvastatin|atorvastatin|mesh-list
154407071|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154407072|NCT02984982|Ezetimibe|ezetimibe|mesh-list
154407073|NCT02984982|Alirocumab|alirocumab|mesh-list
154407074|NCT02984982|Fenofibrate|fenofibrate|mesh-list
154407075|NCT02984982|Bezafibrate|bezafibrate|mesh-list
154407076|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154407077|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154407078|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
154407079|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663836|NCT00009815|Antidotes|antidotes|mesh-ancestor
154407080|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154407081|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154407082|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407083|NCT02984982|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154407084|NCT02984982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154407085|NCT02984982|Protease Inhibitors|protease inhibitors|mesh-ancestor
154407086|NCT03656484|Metronidazole|metronidazole|mesh-list
154407087|NCT03656484|Tetracycline|tetracycline|mesh-list
154407088|NCT03656484|Melatonin|melatonin|mesh-list
154407089|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
154407090|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407091|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154407092|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154407093|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154407094|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
154407095|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407096|NCT03656484|Protective Agents|protective agents|mesh-ancestor
154407097|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407098|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407099|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154407100|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
154407101|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
154407102|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154407103|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407104|NCT04309578|Capecitabine|capecitabine|mesh-list
154407105|NCT04309578|Trastuzumab|trastuzumab|mesh-list
154407106|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407107|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154407108|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
154407109|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254436|NCT01062191|Laxatives|laxatives|mesh-ancestor
154407110|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407112|NCT03656952|PF-06700841|pf-06700841|mesh-list
154407113|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154407114|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407115|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154407116|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154407117|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407118|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407119|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407120|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154407121|NCT02981472|Vitamin K|vitamin k|mesh-list
154407122|NCT02981472|Heparin|heparin|mesh-list
154407123|NCT02981472|Enoxaparin|enoxaparin|mesh-list
154407124|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154407125|NCT02981472|Tinzaparin|tinzaparin|mesh-list
154407126|NCT02981472|Dalteparin|dalteparin|mesh-list
154407127|NCT02981472|Warfarin|warfarin|mesh-list
154407128|NCT02981472|Apixaban|apixaban|mesh-list
154407129|NCT02981472|Vitamins|vitamins|mesh-ancestor
154407130|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
154407131|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407132|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
154407133|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154407134|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154407135|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407136|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154407137|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
154407138|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154407139|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
154407140|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407141|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154407142|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
154407143|NCT02981472|Coagulants|coagulants|mesh-ancestor
154407144|NCT03656172|Chrysarobin|chrysarobin|mesh-list
154407145|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154407146|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154407147|NCT03656172|Analgesics|analgesics|mesh-ancestor
154407148|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
154407149|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407150|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407151|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663906|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
154407152|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407153|NCT03656094|Docetaxel|docetaxel|mesh-list
154407154|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
154407155|NCT03656094|Pemetrexed|pemetrexed|mesh-list
154407156|NCT03656094|Vinorelbine|vinorelbine|mesh-list
154407157|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407158|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
154407159|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
154407160|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
154407161|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407162|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407163|NCT03656094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154407164|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407165|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154407166|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154407167|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154407168|NCT04298034|Labetalol|labetalol|mesh-list
154407169|NCT04298034|Nifedipine|nifedipine|mesh-list
154407170|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154407171|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154407172|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407173|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154407174|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407175|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
154407176|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
154407177|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154407178|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154407179|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154407180|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
154407181|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407182|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154407183|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
154407184|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
154407185|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407186|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154407187|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154407189|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
154407190|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407191|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407192|NCT02982720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154407193|NCT02982720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407194|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
154407195|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407196|NCT00849667|Carboplatin|carboplatin|mesh-list
154407197|NCT00849667|Taxane|taxane|mesh-list
154407198|NCT00849667|Farletuzumab|farletuzumab|mesh-list
154407199|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664206|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154407200|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154407201|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
154407202|NCT03201419|Coagulants|coagulants|mesh-ancestor
154407203|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154407204|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
154407205|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407206|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154407207|NCT02924389|Dolutegravir|dolutegravir|mesh-list
154407208|NCT02924389|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
154407209|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154407210|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154407211|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407212|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407213|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
154407214|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407215|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154407216|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154407217|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154407218|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154407219|NCT01315093|Heparin|heparin|mesh-list
154407220|NCT01315093|Calcium heparin|calcium heparin|mesh-list
154407221|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154407222|NCT01315093|Tinzaparin|tinzaparin|mesh-list
154407223|NCT01315093|Dalteparin|dalteparin|mesh-list
154407224|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
154407225|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154407226|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154407227|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407228|NCT01331707|Everolimus|everolimus|mesh-list
154407229|NCT01331707|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154407230|NCT01331707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154407231|NCT01331707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407232|NCT01331707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407233|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664260|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
154407234|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
154407235|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407236|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407237|NCT03953807|Dexamethasone|dexamethasone|mesh-list
154407238|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154407239|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
154407240|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
154407241|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407242|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407243|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407244|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
154407245|NCT03953807|Hormones|hormones|mesh-ancestor
154407246|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154407247|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154407248|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407249|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
154407250|NCT03662711|Olodaterol|olodaterol|mesh-list
154407251|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
154407252|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407253|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407254|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154407255|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
154407256|NCT02923531|Nivolumab|nivolumab|mesh-list
154407257|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407258|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407259|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154407260|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407261|NCT02934503|Carboplatin|carboplatin|mesh-list
154407262|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
154407263|NCT02934503|Etoposide|etoposide|mesh-list
154407264|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407265|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407266|NCT02934503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154407267|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407268|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154407269|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154407270|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154407271|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407272|NCT04563247|Antibodies|antibodies|mesh-list
154407273|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
154407274|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407275|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
154407276|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154407277|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407278|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407279|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154407280|NCT01314209|Analgesics|analgesics|mesh-ancestor
154407281|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
154407282|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407283|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154407284|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154407285|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154407286|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
154407287|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407288|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981995|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154407290|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154407291|NCT03636659|Amebicides|amebicides|mesh-ancestor
154407292|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154407293|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154407294|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407295|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154407296|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
154407297|NCT04892173|Cetuximab|cetuximab|mesh-list
154407298|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407299|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407300|NCT03198767|Licogliflozin|licogliflozin|mesh-list
154407301|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
154407302|NCT03198767|Psyllium|psyllium|mesh-list
154407303|NCT03198767|Calcium|calcium|mesh-list
154407304|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154407305|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407306|NCT03198767|Antacids|antacids|mesh-ancestor
154407307|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407308|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407309|NCT03198767|Cathartics|cathartics|mesh-ancestor
154407310|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154407311|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154407312|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
154407313|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
154407314|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154407315|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
154407316|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407317|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407318|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154407319|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
154407320|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154407321|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154407322|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154407323|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
154407324|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407325|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407326|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154407327|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154407328|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154407329|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
154407330|NCT01331785|Midodrine|midodrine|mesh-list
154407331|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
154407332|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
154407333|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407334|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407335|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154407336|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154407337|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154407338|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154407339|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
154407340|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407341|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407342|NCT01382589|Afamelanotide|afamelanotide|mesh-list
154407343|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
154407344|NCT03671759|Caffeine|caffeine|mesh-list
154407345|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154407346|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407347|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154407348|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407349|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407350|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154407351|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154407352|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
154407353|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407354|NCT01384227|Proflavine|proflavine|mesh-list
154407355|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154407356|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407357|NCT01382511|Simvastatin|simvastatin|mesh-list
154407358|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154407359|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154407360|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
154407361|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407362|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153664497|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
153664507|NCT00845988|Aripiprazole|aripiprazole|mesh-list
154407363|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154407364|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407365|NCT03684447|Propofol|propofol|mesh-list
154407366|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154407367|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407368|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407369|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154407370|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
154407371|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
154407372|NCT04505059|Anesthetics|anesthetics|mesh-list
154407373|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407374|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407375|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154407376|NCT04217135|Hydralazine|hydralazine|mesh-list
154407377|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154407378|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
154407379|NCT01337401|Cediranib|cediranib|mesh-list
154407380|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407381|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154407382|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407383|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407384|NCT04178603|Insulin|insulin|mesh-list
154407385|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153461715|NCT01076868|Primaquine|primaquine|mesh-list
154407386|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407387|NCT01333891|Nitroprusside|nitroprusside|mesh-list
154407388|NCT01333891|Phenylephrine|phenylephrine|mesh-list
154407389|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
154407390|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154407391|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
154407392|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
154407393|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407394|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407395|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
154407396|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154407397|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
154407398|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
154407399|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154407400|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153664593|NCT00276978|Aripiprazole|aripiprazole|mesh-list
154407401|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154407402|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
154407403|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407404|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407405|NCT01333891|Protective Agents|protective agents|mesh-ancestor
154407406|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154407407|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
154407408|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154407409|NCT04853875|Amoxicillin|amoxicillin|mesh-list
154407410|NCT04853875|Metronidazole|metronidazole|mesh-list
154407411|NCT04853875|Clarithromycin|clarithromycin|mesh-list
154407412|NCT04853875|Tetracycline|tetracycline|mesh-list
154407413|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154407414|NCT04853875|Bismuth|bismuth|mesh-list
154407415|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154407416|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407417|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154407418|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154407419|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154407420|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407421|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407422|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154407423|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154407424|NCT04853875|Antacids|antacids|mesh-ancestor
154407425|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407426|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154407427|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154407428|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154407429|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407430|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
154407431|NCT03196505|Bupivacaine|bupivacaine|mesh-list
154407432|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
154407433|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
154407434|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407435|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407436|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
153982068|NCT04285268|Rituximab|rituximab|mesh-list
154407437|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407438|NCT01334047|Vaccines|vaccines|mesh-list
154407439|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
154407440|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407441|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
154407442|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154407443|NCT03196349|Warfarin|warfarin|mesh-list
154407444|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
154407445|NCT03196349|Apixaban|apixaban|mesh-list
154407446|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
154407447|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154407448|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
154407449|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154407450|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
154407451|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407452|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407453|NCT01331941|Paclitaxel|paclitaxel|mesh-list
154407454|NCT01331941|Trebananib|trebananib|mesh-list
154407455|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154407456|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407457|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
154407458|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
154407459|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
154407460|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407461|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154407462|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154407463|NCT01331941|Growth Substances|growth substances|mesh-ancestor
154407464|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407465|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
154407466|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
154407467|NCT02886715|Tazarotene|tazarotene|mesh-list
154407468|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
154407469|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
154407470|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
154407471|NCT02886715|Vitamins|vitamins|mesh-ancestor
154407472|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
154407473|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407474|NCT01337791|Telbivudine|telbivudine|mesh-list
154407475|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
154407476|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407477|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154407478|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407479|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407480|NCT01334203|Ranolazine|ranolazine|mesh-list
154407481|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154407482|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154407483|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407484|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
154407485|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154407486|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
154407487|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154407488|NCT01569165|Fluorides|fluorides|mesh-list
154407489|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
154407490|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
154407491|NCT01569165|Protective Agents|protective agents|mesh-ancestor
154407492|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407493|NCT02535091|Cenobamate|cenobamate|mesh-list
154407494|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
154407495|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154407496|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154407497|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154407498|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
154407499|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407500|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154407501|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154407502|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407503|NCT01382199|Lactoferrin|lactoferrin|mesh-list
154407504|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407505|NCT01381497|Naproxen|naproxen|mesh-list
154407506|NCT01381497|Sumatriptan|sumatriptan|mesh-list
154407507|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154407508|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154407509|NCT01381497|Analgesics|analgesics|mesh-ancestor
154407510|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
153665075|NCT00015899|Lonafarnib|lonafarnib|mesh-list
154407511|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407512|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407513|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982149|NCT00964886|Benztropine|benztropine|mesh-list
154407514|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407515|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
154407516|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154407518|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407519|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154407520|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154407521|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154407522|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
154407523|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407524|NCT03635827|Xenon|xenon|mesh-list
154407525|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154407526|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
154407527|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
154407528|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407529|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407530|NCT01338103|Rituximab|rituximab|mesh-list
154407531|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407532|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407533|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
154407534|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407535|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407536|NCT03621761|Modafinil|modafinil|mesh-list
154407537|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154407538|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407539|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154407540|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154407541|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154407542|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407543|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
154407544|NCT03318861|Fludarabine|fludarabine|mesh-list
154407545|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154407546|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
154407547|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407548|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407549|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154407550|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
154407551|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407552|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407553|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154407554|NCT03084315|Nicotine|nicotine|mesh-list
154407555|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153665147|NCT00274989|Rituximab|rituximab|mesh-list
154407556|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
154407557|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407558|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407559|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154407560|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154407561|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
154407562|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407563|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407564|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
154407565|NCT03187301|Apomorphine|apomorphine|mesh-list
154407566|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154407567|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407568|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154407569|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154407570|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407571|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407572|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407573|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407574|NCT03187301|Emetics|emetics|mesh-ancestor
154407575|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
154407576|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407577|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407578|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
154407579|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
154407580|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407581|NCT01381185|Aspirin|aspirin|mesh-list
154407582|NCT01381185|Clopidogrel|clopidogrel|mesh-list
154407583|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154407584|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154407585|NCT01381185|Analgesics|analgesics|mesh-ancestor
154407586|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
154407587|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407588|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982226|NCT04284722|Metformin|metformin|mesh-list
154407589|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154407590|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407591|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154407592|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154407593|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407594|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154407595|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154407596|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407598|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154407599|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154407600|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154407601|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
154407602|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407603|NCT02946047|Ixazomib|ixazomib|mesh-list
154407604|NCT02946047|Glycine|glycine|mesh-list
154407605|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407606|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154407607|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407608|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407609|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
154407610|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407611|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407612|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
154407613|NCT05421897|Temozolomide|temozolomide|mesh-list
154407614|NCT05421897|Irinotecan|irinotecan|mesh-list
154407615|NCT05421897|Topotecan|topotecan|mesh-list
154407616|NCT05421897|Dinutuximab|dinutuximab|mesh-list
154407617|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154407618|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
154407619|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407620|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407621|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154407622|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
154407623|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407624|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407625|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154407626|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154407627|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154407628|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407629|NCT03077919|Ropivacaine|ropivacaine|mesh-list
154407630|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
154407631|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
154407632|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407633|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407634|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
154407635|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407636|NCT01380951|Telbivudine|telbivudine|mesh-list
154407637|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
154407638|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407639|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154407640|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407641|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407642|NCT01377597|Ranibizumab|ranibizumab|mesh-list
154407643|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154407644|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154407645|NCT01377597|Growth Substances|growth substances|mesh-ancestor
154407646|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407647|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
154407648|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407649|NCT03204695|Clopidogrel|clopidogrel|mesh-list
154407650|NCT03204695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154407651|NCT03204695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154407652|NCT03204695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154407653|NCT03204695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154407654|NCT03204695|Purinergic Agents|purinergic agents|mesh-ancestor
154407655|NCT03204695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407656|NCT03204695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407657|NCT03204695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407658|NCT03287375|Cisplatin|cisplatin|mesh-list
154407659|NCT03287375|Doxorubicin|doxorubicin|mesh-list
154407660|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
154407661|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739894|NCT00511225|Vitamins|vitamins|mesh-ancestor
154407662|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154407664|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154407665|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407666|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407667|NCT03881059|Ustekinumab|ustekinumab|mesh-list
154407668|NCT03881059|Deucravacitinib|deucravacitinib|mesh-list
154407669|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
154407670|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154407671|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407672|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407673|NCT01338337|Azacitidine|azacitidine|mesh-list
154407674|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154407675|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
154407676|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407677|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407678|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407679|NCT03083847|Chloroquine|chloroquine|mesh-list
154407680|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154407681|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
154407682|NCT03083847|Amebicides|amebicides|mesh-ancestor
154407683|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154407684|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154407685|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407686|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
154407687|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407688|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154407689|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154407690|NCT03083847|Analgesics|analgesics|mesh-ancestor
154407691|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
154407692|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407693|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407694|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154407695|NCT03083847|Filaricides|filaricides|mesh-ancestor
154407696|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
154407697|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
154407698|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154407699|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407700|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407701|NCT03082677|Ixazomib|ixazomib|mesh-list
154407702|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407703|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
154407704|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407705|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407706|NCT03136055|Paclitaxel|paclitaxel|mesh-list
154407707|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
154407708|NCT03136055|Irinotecan|irinotecan|mesh-list
154407709|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154407711|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
154407712|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
154407713|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
154407714|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407715|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407716|NCT03136055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154407717|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154407718|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154407719|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407720|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
154407721|NCT03221309|Narcotics|narcotics|mesh-ancestor
154407722|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407723|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407724|NCT03221309|Analgesics|analgesics|mesh-ancestor
154407725|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
154407726|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407727|NCT03426657|Durvalumab|durvalumab|mesh-list
154407728|NCT03426657|Tremelimumab|tremelimumab|mesh-list
154407729|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407730|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407731|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
154407732|NCT02858180|Ledipasvir|ledipasvir|mesh-list
154407733|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
154407734|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407735|NCT03609086|Melatonin|melatonin|mesh-list
154407736|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
154407737|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407738|NCT03609086|Protective Agents|protective agents|mesh-ancestor
154407739|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407740|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407741|NCT00730717|Adalimumab|adalimumab|mesh-list
154407742|NCT00730717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154407743|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154407744|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154407745|NCT01332409|Fluticasone|fluticasone|mesh-list
154407746|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154407747|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154407748|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154407749|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154407750|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
154407751|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407752|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407753|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154407754|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
154407755|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
154407756|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154407757|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154407758|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154407759|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154407760|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
154407761|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407762|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407763|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
154407764|NCT01332409|Hormones|hormones|mesh-ancestor
154407765|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154407766|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
154407767|NCT03181451|Ferric maltol|ferric maltol|mesh-list
154407768|NCT03181451|Hematinics|hematinics|mesh-ancestor
154407769|NCT03495973|Ustekinumab|ustekinumab|mesh-list
154407770|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
154407771|NCT00480805|Losartan|losartan|mesh-list
154407772|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154407773|NCT00480805|Ramipril|ramipril|mesh-list
154407774|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154407775|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154407776|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154407777|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154407778|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407779|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407780|NCT00480805|Diuretics|diuretics|mesh-ancestor
154407781|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
154407782|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154407783|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154407784|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154407785|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
154407786|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407788|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154407789|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
154407790|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407791|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407792|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407793|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154407794|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154407795|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
154407796|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
154407797|NCT03179891|Diazepam|diazepam|mesh-list
154407798|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154407799|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
154407800|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
154407801|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
154407802|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407803|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407804|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407805|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154407806|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407807|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154407808|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154407809|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154407810|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154407811|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154407812|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154407813|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
154407815|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
154407816|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
154407817|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407818|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407819|NCT01334671|Atorvastatin|atorvastatin|mesh-list
154407820|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154407821|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154407822|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
154407823|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407824|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154407825|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154407826|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407827|NCT01332565|Dolutegravir|dolutegravir|mesh-list
154407828|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154407829|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154407830|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407831|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407832|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154407833|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154407834|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
154407835|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407836|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154407837|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154407838|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407839|NCT02736227|Everolimus|everolimus|mesh-list
154407840|NCT02736227|Tacrolimus|tacrolimus|mesh-list
154407841|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154407842|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
154407843|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407844|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154407845|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407846|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407847|NCT02736227|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154407848|NCT02736227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154407849|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407850|NCT01334905|Mirabegron|mirabegron|mesh-list
154407851|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154407852|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154407853|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154407854|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
154407855|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407856|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665952|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154407857|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407858|NCT01334905|Urological Agents|urological agents|mesh-ancestor
154407859|NCT01335139|Immunomodulating Agents|immunomodulating agents|mesh-list
154407860|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
154407861|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407862|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
154407864|NCT05030129|Pyridoxine|pyridoxine|mesh-list
154407865|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
154407866|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
154407867|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
154407868|NCT05030129|Vitamins|vitamins|mesh-ancestor
154407869|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
154407870|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407871|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
154407872|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154407873|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
154407874|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154407875|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154407876|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154407877|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
154407878|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154407879|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407880|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
154407881|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
154407882|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
154407883|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
154407884|NCT01339039|Plerixafor|plerixafor|mesh-list
153982515|NCT05930808|Sympatholytics|sympatholytics|mesh-ancestor
154407885|NCT01339039|Bevacizumab|bevacizumab|mesh-list
154407886|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154407887|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407888|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154407889|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154407890|NCT01339039|Growth Substances|growth substances|mesh-ancestor
154407891|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407892|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154407893|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154407894|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154407895|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
154407896|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407897|NCT03176459|Bupivacaine|bupivacaine|mesh-list
154407898|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
154407899|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
154407900|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407901|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407902|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
154407903|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407904|NCT01332955|Ribavirin|ribavirin|mesh-list
154407905|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154407906|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
154407907|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407908|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
154407909|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407910|NCT05224895|Anesthetics|anesthetics|mesh-list
154407911|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154407912|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407913|NCT01335373|Metronidazole|metronidazole|mesh-list
154407914|NCT01335373|Miconazole|miconazole|mesh-list
154407915|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666057|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154407916|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154407917|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154407918|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154407919|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
154407920|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154407921|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154407922|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407923|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407924|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154407925|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
154407926|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154407927|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407928|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154407929|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154407930|NCT01333267|Hormones|hormones|mesh-list
154407931|NCT01333267|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
154407932|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
154407933|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
154407934|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
154407935|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
154407936|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154407937|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407938|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154407939|NCT01333267|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
154407940|NCT01335529|Interferons|interferons|mesh-list
154407942|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
154407943|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
154407944|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154407945|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407946|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
154407947|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407948|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
154407949|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407950|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
154407951|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407952|NCT00308347|Losartan|losartan|mesh-list
154407953|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154407954|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154407955|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154407956|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154407957|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407958|NCT02186834|Dexamethasone|dexamethasone|mesh-list
154407959|NCT02186834|Doxorubicin|doxorubicin|mesh-list
154407960|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154407961|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982591|NCT05343455|Doxycycline|doxycycline|mesh-list
154407962|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
154407963|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
154407964|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154407965|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407966|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407967|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
154407968|NCT02186834|Hormones|hormones|mesh-ancestor
154407969|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154407970|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154407971|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407972|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154407973|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154407974|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154407975|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407976|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407977|NCT04335890|Vaccines|vaccines|mesh-list
154407978|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
154407979|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407980|NCT01379157|Imipenem|imipenem|mesh-list
154407981|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154407982|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154407983|NCT01538966|Octreotide|octreotide|mesh-list
154407984|NCT01538966|Lanreotide|lanreotide|mesh-list
154407985|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154407986|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154407987|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154407988|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
154407989|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154407990|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154407991|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154407992|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154407993|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154407994|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154407995|NCT01377285|Protective Agents|protective agents|mesh-ancestor
154407996|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154407997|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
154407998|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154407999|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
154408000|NCT02905266|Nivolumab|nivolumab|mesh-list
154408001|NCT02905266|Ipilimumab|ipilimumab|mesh-list
154408002|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154408003|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036557|NCT02777411|Vaccines|vaccines|mesh-list
154408004|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154408005|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408006|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
154408007|NCT01380717|Calcium|calcium|mesh-list
154408008|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154408009|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154408010|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154408011|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408012|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154408013|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
154408014|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408015|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408016|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
154408017|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408018|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154408019|NCT03080493|Acetaminophen|acetaminophen|mesh-list
154408020|NCT03080493|Ibuprofen|ibuprofen|mesh-list
154408021|NCT03080493|Gabapentin|gabapentin|mesh-list
154408022|NCT03080493|Codeine|codeine|mesh-list
154408023|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154408024|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154408025|NCT03080493|Analgesics|analgesics|mesh-ancestor
154408026|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
154408027|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408028|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408029|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
154408030|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154408031|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408032|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408033|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154408034|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408035|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982661|NCT05007392|Dotinurad|dotinurad|mesh-list
154408037|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154408038|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154408039|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408040|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154408041|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154408042|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154408043|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408044|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
154408045|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154408046|NCT03080493|Narcotics|narcotics|mesh-ancestor
154408047|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
154408048|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
154408049|NCT03080493|Laxatives|laxatives|mesh-ancestor
154408050|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408051|NCT01339910|Vidarabine|vidarabine|mesh-list
154408052|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
154408053|NCT01339910|Melphalan|melphalan|mesh-list
154408054|NCT01339910|Busulfan|busulfan|mesh-list
154408055|NCT01339910|Fludarabine|fludarabine|mesh-list
154408056|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
154408057|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408058|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
154408059|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408060|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408061|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154408062|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
154408063|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408064|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408065|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154408066|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408067|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
154408068|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
154408069|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408070|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
154408071|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154408072|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
154408073|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408074|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408075|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154408076|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
154408077|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154408078|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
154408079|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408080|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408081|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154408082|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
154408083|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
154408084|NCT03655392|Protective Agents|protective agents|mesh-ancestor
154408085|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
154408086|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408087|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
154408088|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408089|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408090|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154408091|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
154408092|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408093|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408094|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154408095|NCT04203290|Bupivacaine|bupivacaine|mesh-list
154408096|NCT04203290|Sevoflurane|sevoflurane|mesh-list
154408097|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
154408098|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
154408099|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666518|NCT00022074|Gabapentin|gabapentin|mesh-list
154408100|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408101|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
154408102|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408103|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154408104|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154408105|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
154408106|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154408107|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408108|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408109|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
154408110|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408111|NCT03654612|Apatinib|apatinib|mesh-list
154408112|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408113|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154408114|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408115|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408116|NCT01066104|Omalizumab|omalizumab|mesh-list
154408117|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154408118|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154408119|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154408120|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
154408121|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
154408122|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408123|NCT02736968|Auranofin|auranofin|mesh-list
154408124|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408125|NCT03608306|Methamphetamine|methamphetamine|mesh-list
154408126|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154408127|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408128|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
154408129|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
154408130|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408131|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
154408132|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408133|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408134|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
154408135|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154408136|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154408137|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154408138|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154408139|NCT03654144|Dienogest|dienogest|mesh-list
154408140|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
154408141|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
154408142|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154408143|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154408144|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408145|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154408146|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154408147|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153666598|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408148|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154408149|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
154408150|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408151|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154408152|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408153|NCT02591615|Paclitaxel|paclitaxel|mesh-list
154408155|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
154408156|NCT02591615|Pemetrexed|pemetrexed|mesh-list
154408157|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408158|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408159|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
154408160|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
154408161|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
154408162|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408163|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154408164|NCT02591615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154408165|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408166|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154408167|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154408168|NCT03077607|Itraconazole|itraconazole|mesh-list
154408169|NCT03077607|Rifampin|rifampin|mesh-list
154408170|NCT03077607|Talazoparib|talazoparib|mesh-list
154408171|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
154408172|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408173|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154408174|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154408175|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408176|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408177|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154408178|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
154408179|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408180|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408181|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154408182|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154408183|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
154408184|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154408185|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
154408186|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154408187|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154408188|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154408189|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154408190|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154408191|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154408192|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154408193|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154408194|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408195|NCT04215588|Hemostatics|hemostatics|mesh-list
154408196|NCT04215588|Coagulants|coagulants|mesh-ancestor
154408197|NCT01377051|Maleic acid|maleic acid|mesh-list
154408198|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408199|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408201|NCT03217175|Pancrelipase|pancrelipase|mesh-list
154408202|NCT03217175|Pancreatin|pancreatin|mesh-list
154408203|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408204|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408205|NCT03217175|Hormones|hormones|mesh-ancestor
154408206|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408207|NCT01379079|Aspirin|aspirin|mesh-list
154408208|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
154408209|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
154408210|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
154408211|NCT01379079|Calcium|calcium|mesh-list
154408212|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154408213|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408214|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154408215|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154408216|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154408217|NCT01379079|Analgesics|analgesics|mesh-ancestor
154408218|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
154408219|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408220|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408221|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408222|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154408223|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154408224|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408225|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154408226|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154408227|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408228|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
154408229|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
154408230|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154408231|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408232|NCT01379001|Scopolamine|scopolamine|mesh-list
154408233|NCT01379001|Donepezil|donepezil|mesh-list
154408234|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154408235|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154408236|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408237|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408238|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
154408239|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408240|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408241|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
154408242|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154408243|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
154408244|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
154408245|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408246|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408247|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
154408248|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154408249|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154408250|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
154408251|NCT03172325|Folic Acid|folic acid|mesh-list
154408252|NCT03172325|Prednisolone|prednisolone|mesh-list
154408253|NCT03172325|Adalimumab|adalimumab|mesh-list
154408254|NCT03172325|Methotrexate|methotrexate|mesh-list
154408255|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154408256|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
154408257|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154408258|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408259|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408261|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408262|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408263|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408264|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408265|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154408266|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408267|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
154408268|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408269|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154408270|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408271|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
154408272|NCT03172325|Hormones|hormones|mesh-ancestor
154408273|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408274|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154408275|NCT03172325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154408276|NCT03172325|Hematinics|hematinics|mesh-ancestor
154408277|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
154408278|NCT03172325|Vitamins|vitamins|mesh-ancestor
154408279|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
154408280|NCT03653520|Diazepam|diazepam|mesh-list
154408281|NCT03653520|Tramadol|tramadol|mesh-list
154408282|NCT03653520|Ondansetron|ondansetron|mesh-list
154408283|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
154408284|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
154408285|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408286|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408287|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408288|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
154408289|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408290|NCT03653520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154408291|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154408292|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
154408293|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408294|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408295|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154408296|NCT03653520|Narcotics|narcotics|mesh-ancestor
154408297|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408298|NCT03653520|Analgesics|analgesics|mesh-ancestor
154408299|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
154408300|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154408301|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
154408302|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154408303|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154408304|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154408305|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154408306|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154408307|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154408308|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154408309|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
154408311|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
154408312|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
154408313|NCT01208090|Ponesimod|ponesimod|mesh-list
154408314|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154408315|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408316|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408317|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
154408318|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408319|NCT01380483|Doxycycline|doxycycline|mesh-list
154408320|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154408321|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408322|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
154408323|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154408324|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154408325|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
154408326|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154408327|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154408328|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
154408329|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408330|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408331|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408332|NCT01378845|Bosentan|bosentan|mesh-list
154408333|NCT01378845|Alprostadil|alprostadil|mesh-list
153667025|NCT00024531|Calcium|calcium|mesh-list
154408334|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154408335|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154408336|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408337|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154408339|NCT01378845|Urological Agents|urological agents|mesh-ancestor
154408340|NCT04904549|Vaccines|vaccines|mesh-list
154408341|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
154408342|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408343|NCT03607916|Morphine|morphine|mesh-list
154408344|NCT03607916|Prilocaine|prilocaine|mesh-list
154408345|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154408346|NCT03607916|Narcotics|narcotics|mesh-ancestor
154408347|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408348|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408349|NCT03607916|Analgesics|analgesics|mesh-ancestor
154408350|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
154408351|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408352|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
154408353|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
154408354|NCT01141712|Cytarabine|cytarabine|mesh-list
154408355|NCT01141712|Etoposide|etoposide|mesh-list
154408356|NCT01141712|Melphalan|melphalan|mesh-list
154408357|NCT01141712|Carmustine|carmustine|mesh-list
154408358|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408359|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408360|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154408361|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154408362|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408363|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408364|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408365|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
154408366|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
154408367|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408368|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408369|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
154408370|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408371|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154408372|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
154408373|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154408374|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
154408375|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154408376|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
154408377|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408378|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
154036928|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
154408380|NCT02015351|Bevacizumab|bevacizumab|mesh-list
154408381|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154408382|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408383|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154408384|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154408385|NCT02015351|Growth Substances|growth substances|mesh-ancestor
154408386|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667161|NCT00025428|Doxorubicin|doxorubicin|mesh-list
154408387|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
154408388|NCT03604796|Acetaminophen|acetaminophen|mesh-list
154408389|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154408390|NCT03604796|Analgesics|analgesics|mesh-ancestor
154408391|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
154408392|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408393|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408394|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
154408395|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
154408396|NCT02237534|Calcium|calcium|mesh-list
154408397|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154408398|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408399|NCT02237534|Antacids|antacids|mesh-ancestor
154408400|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408401|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408402|NCT03606902|Fentanyl|fentanyl|mesh-list
154408403|NCT03606902|Bupivacaine|bupivacaine|mesh-list
154408404|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
154408405|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
154408406|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408407|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408408|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
154408409|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408410|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154408411|NCT03606902|Narcotics|narcotics|mesh-ancestor
154408412|NCT03606902|Analgesics|analgesics|mesh-ancestor
154408414|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154408415|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
154408416|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
154408417|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408418|NCT03606824|Pitavastatin|pitavastatin|mesh-list
154408419|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154408420|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154408421|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154408422|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
154408423|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408424|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408425|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154408426|NCT03604016|Tenofovir|tenofovir|mesh-list
154408427|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
154408428|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408429|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154408430|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154408431|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408432|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408433|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154408434|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154408435|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
154408436|NCT01064622|Gemcitabine|gemcitabine|mesh-list
154408437|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408438|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
154408439|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408440|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408441|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408442|NCT01063764|Levetiracetam|levetiracetam|mesh-list
154408443|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
154408444|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
154408445|NCT04053972|Lenvatinib|lenvatinib|mesh-list
154408446|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408447|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154408448|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408449|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408450|NCT01380249|Bromides|bromides|mesh-list
154408451|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
154408452|NCT04054518|Durvalumab|durvalumab|mesh-list
154408453|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154408454|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408456|NCT03652896|Hematinics|hematinics|mesh-ancestor
154408457|NCT04565847|Albuterol|albuterol|mesh-list
154408458|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154408459|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
154408460|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408461|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408462|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154408463|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
154408464|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
154408465|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154408466|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154408467|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154408468|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154408469|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
154408470|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408471|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408472|NCT03075891|Doxycycline|doxycycline|mesh-list
154408473|NCT03075891|Ivermectin|ivermectin|mesh-list
154408474|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154408475|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408476|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
154408477|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154408478|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154408479|NCT02013167|Blinatumomab|blinatumomab|mesh-list
154408480|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408481|NCT01378533|Paclitaxel|paclitaxel|mesh-list
154408482|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
154408483|NCT01378533|Carboplatin|carboplatin|mesh-list
154408484|NCT01378533|Epirubicin|epirubicin|mesh-list
154408485|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408486|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408487|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
154408488|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
154408489|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
154408490|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408491|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408492|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
154408493|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408494|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408495|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154408496|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
154408497|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154408498|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154408499|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154408500|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154408501|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408502|NCT02630199|Paclitaxel|paclitaxel|mesh-list
154408503|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408504|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408505|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
154408506|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
154408507|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
154408508|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408509|NCT02588781|Pemetrexed|pemetrexed|mesh-list
154408510|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408511|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408512|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408513|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154408514|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154408515|NCT01063062|Methotrexate|methotrexate|mesh-list
154408516|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154408517|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
154408518|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154408519|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408520|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408521|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
153667446|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408522|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408523|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408524|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408525|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408526|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154408527|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408528|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
154408529|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408530|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154408531|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
154408532|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
154408533|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408534|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408535|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154408536|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
154408537|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
154408538|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408539|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408540|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408541|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154408542|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
154408543|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154408544|NCT04483115|Tadalafil|tadalafil|mesh-list
154408545|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
154408546|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154408547|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154408548|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408549|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408550|NCT04483115|Urological Agents|urological agents|mesh-ancestor
154408551|NCT04054362|Paclitaxel|paclitaxel|mesh-list
154408552|NCT04054362|Gemcitabine|gemcitabine|mesh-list
154408553|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154408554|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408555|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408556|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
154408557|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
154408558|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
154408559|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408560|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408561|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
154408562|NCT04467281|Daratumumab|daratumumab|mesh-list
154408563|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408565|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
154408566|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408567|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154408568|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154408569|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154408570|NCT02973048|Bupivacaine|bupivacaine|mesh-list
154408571|NCT02973048|Prilocaine|prilocaine|mesh-list
154408572|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
154408573|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
154408574|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408575|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408576|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
154408577|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408578|NCT04054206|Ibudilast|ibudilast|mesh-list
154408579|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154408580|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
154408581|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408582|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408583|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154408584|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
154408585|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154408586|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408587|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408588|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154408589|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
154408590|NCT03603938|Losartan|losartan|mesh-list
154408591|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154408592|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154408593|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154408594|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153667492|NCT00392522|Analgesics|analgesics|mesh-ancestor
154408595|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408596|NCT03652116|Meperidine|meperidine|mesh-list
154408597|NCT03652116|Bupivacaine|bupivacaine|mesh-list
154408598|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
154408599|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
154408600|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408601|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408602|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
154408603|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408605|NCT03652116|Narcotics|narcotics|mesh-ancestor
154408606|NCT03652116|Analgesics|analgesics|mesh-ancestor
154408607|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154408608|NCT02232087|Fluticasone|fluticasone|mesh-list
154408609|NCT02232087|Xhance|xhance|mesh-list
154408610|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154408611|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154408612|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408613|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154408614|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
154408615|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408616|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408617|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154408618|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
154408619|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408620|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154408621|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154408622|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154408623|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154408624|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
154408625|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408626|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408627|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
154408628|NCT02232087|Hormones|hormones|mesh-ancestor
154408629|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408630|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
154408631|NCT03603626|Pregabalin|pregabalin|mesh-list
154408632|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408633|NCT03603626|Analgesics|analgesics|mesh-ancestor
154408634|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
154408635|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408636|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
154408637|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154408638|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154408639|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408640|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154408642|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154408643|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408644|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154408645|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
154408646|NCT02972502|Promethazine|promethazine|mesh-list
154408647|NCT02972502|Haloperidol|haloperidol|mesh-list
154408648|NCT02972502|Metoclopramide|metoclopramide|mesh-list
154408649|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
154408650|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154408651|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154408652|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408653|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408654|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
154408655|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
154408656|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
154408657|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408658|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
154408659|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
154408660|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408661|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154408662|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
154408663|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
154408664|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408665|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408666|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154408667|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
154408668|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408669|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154408670|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154408671|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154408672|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154408673|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
154408674|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154408675|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154408676|NCT03606590|Sorafenib|sorafenib|mesh-list
154408677|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408678|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154408679|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408680|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408682|NCT03163667|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154408683|NCT03163667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154408684|NCT03163667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408685|NCT03163667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408686|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408687|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
154408688|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408689|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408690|NCT03603548|Tacrolimus|tacrolimus|mesh-list
154408691|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408692|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
154408693|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408694|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154408695|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408696|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408697|NCT03954782|Nintedanib|nintedanib|mesh-list
154408698|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408699|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154408700|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408701|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408702|NCT03651726|Palmidrol|palmidrol|mesh-list
154408703|NCT03651726|Dronabinol|dronabinol|mesh-list
154408704|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
154408705|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408706|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154408707|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154408708|NCT03651726|Analgesics|analgesics|mesh-ancestor
154408709|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
154408710|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408711|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154408712|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154408713|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408714|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408715|NCT03651726|Hormones|hormones|mesh-ancestor
153667681|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
154408716|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408717|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154408718|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408719|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408720|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
154408721|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408722|NCT00107250|Paclitaxel|paclitaxel|mesh-list
154408723|NCT00107250|Carboplatin|carboplatin|mesh-list
154408724|NCT00107250|Capecitabine|capecitabine|mesh-list
154408725|NCT00107250|Cediranib|cediranib|mesh-list
154408726|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408727|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408728|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
154408729|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
154408730|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
154408731|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408732|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408733|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
154408734|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408735|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154408736|NCT03167411|Exenatide|exenatide|mesh-list
154408737|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
154408738|NCT03167411|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154408739|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154408740|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408741|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154408742|NCT03167411|Incretins|incretins|mesh-ancestor
154408743|NCT03167411|Hormones|hormones|mesh-ancestor
153973746|NCT06248099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408744|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408745|NCT02237768|Dirithromycin|dirithromycin|mesh-list
154408746|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154408747|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408748|NCT05461833|Octylonium|octylonium|mesh-list
154408749|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154408750|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154408751|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408752|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154408753|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408754|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408755|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
154408756|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
154408757|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408758|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154408759|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154408760|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
154408761|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408762|NCT01560585|Isotretinoin|isotretinoin|mesh-list
154408763|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408764|NCT01376427|Dexamethasone|dexamethasone|mesh-list
154408765|NCT01376427|Methotrexate|methotrexate|mesh-list
154408766|NCT01376427|Vincristine|vincristine|mesh-list
154408767|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408768|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
154408769|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
154408770|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408771|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408772|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408773|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
154408774|NCT01376427|Hormones|hormones|mesh-ancestor
154408775|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408776|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154408777|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667785|NCT00028860|Paclitaxel|paclitaxel|mesh-list
154408778|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154408779|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
154408780|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154408781|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154408782|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
154408783|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408784|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
154408785|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408786|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154408787|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408788|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
154408789|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408790|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154408791|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408792|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
154408793|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
154408794|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
154408795|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154408796|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408797|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408799|NCT05462535|Amlodipine|amlodipine|mesh-list
154408800|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
154408801|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154408802|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154408803|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973747|NCT06248099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408804|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408805|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154408806|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408807|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
154408808|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154408809|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154408810|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154408811|NCT05462535|Diuretics|diuretics|mesh-ancestor
154408812|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
154408813|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154408814|NCT05764317|Amlodipine|amlodipine|mesh-list
154408815|NCT05764317|Perindopril|perindopril|mesh-list
154408816|NCT05764317|Atorvastatin|atorvastatin|mesh-list
154408817|NCT05764317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154408818|NCT05764317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154408819|NCT05764317|Antimetabolites|antimetabolites|mesh-ancestor
154408820|NCT05764317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408821|NCT05764317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154408822|NCT05764317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154408823|NCT05764317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408824|NCT05764317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154408825|NCT05764317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154408826|NCT05764317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154408827|NCT05764317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154408828|NCT05764317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408829|NCT05764317|Vasodilator Agents|vasodilator agents|mesh-ancestor
154408830|NCT05764317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154408831|NCT05764317|Protease Inhibitors|protease inhibitors|mesh-ancestor
154408832|NCT05461365|Insulin|insulin|mesh-list
153667927|NCT00030030|Silymarin|silymarin|mesh-list
154408833|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154408834|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154408835|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408836|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154408837|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408838|NCT02317991|Paclitaxel|paclitaxel|mesh-list
154408839|NCT02317991|Ramucirumab|ramucirumab|mesh-list
154408840|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408841|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408842|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154408843|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154408844|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154408845|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408846|NCT02317991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154408847|NCT02317991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154408848|NCT02317991|Growth Substances|growth substances|mesh-ancestor
154408849|NCT02317991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408850|NCT02317991|Growth Inhibitors|growth inhibitors|mesh-ancestor
154408851|NCT03602690|Ritonavir|ritonavir|mesh-list
154408852|NCT03602690|Darunavir|darunavir|mesh-list
154408853|NCT03602690|Dolutegravir|dolutegravir|mesh-list
154408854|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154408855|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154408856|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
154408857|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408858|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408859|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154408860|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154408861|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
154408862|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408863|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154408864|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154408865|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154408866|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154408867|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154408868|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408869|NCT02978495|Paclitaxel|paclitaxel|mesh-list
154408870|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
154408871|NCT02978495|Carboplatin|carboplatin|mesh-list
154408872|NCT02978495|Doxorubicin|doxorubicin|mesh-list
154408873|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154408874|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408875|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
154408876|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
154408877|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
154408878|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408879|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154408880|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
154408881|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408882|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154408883|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154408884|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
154408885|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154408886|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154408887|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154408888|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154408889|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408890|NCT02237690|Doxorubicin|doxorubicin|mesh-list
154408891|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154408892|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154408893|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408894|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154408895|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154408896|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408897|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408898|NCT04788017|Ziresovir|ziresovir|mesh-list
154408899|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
154408900|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408901|NCT03600974|Domperidone|domperidone|mesh-list
154408903|NCT03600974|Esomeprazole|esomeprazole|mesh-list
154408904|NCT03600974|Omeprazole|omeprazole|mesh-list
154408905|NCT03600974|Rabeprazole|rabeprazole|mesh-list
154408906|NCT03600974|Pantoprazole|pantoprazole|mesh-list
154408907|NCT03600974|Lansoprazole|lansoprazole|mesh-list
154408908|NCT03600974|Mosapride|mosapride|mesh-list
154408909|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154408910|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154408911|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154408912|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154408913|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154408914|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408915|NCT03600974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154408916|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154408917|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154408918|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
154408919|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408920|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154408921|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
154408922|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154408923|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
154408924|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408925|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
154408926|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154408927|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
154408928|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154408929|NCT03075267|Budesonide|budesonide|mesh-list
154408930|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
154408931|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
154408932|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154408933|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154408934|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
154408935|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408936|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983565|NCT00961220|Carmustine|carmustine|mesh-list
154408937|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154408938|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
154408939|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
154408940|NCT03075267|Hormones|hormones|mesh-ancestor
154408941|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154408942|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154408943|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154408944|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154408945|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
154408946|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408947|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408948|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154408949|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154408950|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154408951|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
154408952|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
154408953|NCT03600506|Sympatholytics|sympatholytics|mesh-list
154408954|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154408955|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154408956|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408957|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154408958|NCT03600506|Analgesics|analgesics|mesh-ancestor
154408959|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
154408960|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408961|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154408962|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154408963|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154408964|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
154408965|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408966|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408967|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
154408968|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
154408969|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154408970|NCT03074331|Velpatasvir|velpatasvir|mesh-list
154408971|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
154408972|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154408973|NCT02237924|Endostar protein|endostar protein|mesh-list
154254453|NCT01146002|Guanfacine|guanfacine|mesh-list
154408974|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154408975|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154408976|NCT02237924|Growth Substances|growth substances|mesh-ancestor
154408977|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408978|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
154408979|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154408980|NCT03825302|Mannitol|mannitol|mesh-list
154408981|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
154408982|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154408983|NCT03825302|Diuretics|diuretics|mesh-ancestor
154408984|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
154408985|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154408986|NCT03825302|Miotics|miotics|mesh-ancestor
154408987|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
154408988|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154408989|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154408990|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154408991|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
154408992|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154408993|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154408994|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
154408995|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154408996|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154408997|NCT02238392|Adenosine|adenosine|mesh-list
154408998|NCT02238392|Analgesics|analgesics|mesh-ancestor
154408999|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
154409000|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409001|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409002|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153668370|NCT00031746|Caseins|caseins|mesh-list
153668491|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409003|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
154409004|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154409005|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
154409006|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
154409007|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409008|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409009|NCT02260193|Glycine|glycine|mesh-list
154409010|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
154409011|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409012|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409013|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409015|NCT02849678|Ropivacaine|ropivacaine|mesh-list
154409016|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
154409017|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
154409018|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409019|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409020|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
154409021|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409022|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154409023|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154409024|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154409025|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409026|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409027|NCT04295577|Niraparib|niraparib|mesh-list
154409028|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154409029|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409030|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409031|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409032|NCT02238158|Ipratropium|ipratropium|mesh-list
154409033|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154409034|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
154409035|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409036|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409037|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154409038|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
154409039|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154409040|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
154409041|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409042|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409043|NCT02238314|Ritonavir|ritonavir|mesh-list
154409044|NCT02238314|Tipranavir|tipranavir|mesh-list
154409045|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154409046|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154409047|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154409048|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
154409049|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409050|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409051|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154409052|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154409053|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
154409054|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409055|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154409056|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154409057|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154409058|NCT02238470|Warfarin|warfarin|mesh-list
154409059|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
154409060|NCT02238470|Dabigatran|dabigatran|mesh-list
154409061|NCT02238470|Apixaban|apixaban|mesh-list
154409062|NCT02238470|Anticoagulants|anticoagulants|mesh-list
154409063|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154409064|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
154409065|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154409066|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
154409067|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409068|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409069|NCT03586934|Acetaminophen|acetaminophen|mesh-list
154409070|NCT03586934|Celecoxib|celecoxib|mesh-list
154409071|NCT03586934|Ketorolac|ketorolac|mesh-list
154409072|NCT03586934|Meloxicam|meloxicam|mesh-list
154409073|NCT03586934|Morphine|morphine|mesh-list
154409074|NCT03586934|Oxycodone|oxycodone|mesh-list
154409075|NCT03586934|Tramadol|tramadol|mesh-list
154409076|NCT03586934|Hydrocodone|hydrocodone|mesh-list
154409077|NCT03586934|Ropivacaine|ropivacaine|mesh-list
154409078|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154409079|NCT03586934|Narcotics|narcotics|mesh-ancestor
154409080|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409081|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409082|NCT03586934|Analgesics|analgesics|mesh-ancestor
154409083|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
154409084|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409085|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
154409086|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
154409087|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154409088|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
154409089|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154409090|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154409091|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154409092|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154409093|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154409094|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409095|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409096|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
154409097|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
154409098|NCT03586154|Ketamine|ketamine|mesh-list
154409099|NCT03586154|Bupivacaine|bupivacaine|mesh-list
154409100|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
154409101|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
154409102|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409103|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409104|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
154409105|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409106|NCT03586154|Analgesics|analgesics|mesh-ancestor
154409107|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154409108|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154409109|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
154409110|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154409111|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154409112|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409113|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409114|NCT03629847|Everolimus|everolimus|mesh-list
154409115|NCT03629847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154409116|NCT03629847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154409117|NCT03629847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409118|NCT03629847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409119|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154409120|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
154409121|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409122|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409123|NCT01314833|Paclitaxel|paclitaxel|mesh-list
154409124|NCT01314833|Docetaxel|docetaxel|mesh-list
154409125|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
154409126|NCT01314833|Fluorouracil|fluorouracil|mesh-list
154409127|NCT01314833|Epirubicin|epirubicin|mesh-list
154409128|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154409129|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409130|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
154409131|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
154409132|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
154409133|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409134|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154409135|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
154409136|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409137|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154409138|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154409139|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
154409140|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154409141|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
154409142|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154409143|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154409144|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154409145|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154409146|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409147|NCT03579836|Gemcitabine|gemcitabine|mesh-list
154409148|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154409149|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
154409150|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409151|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409152|NCT02737826|Buprenorphine|buprenorphine|mesh-list
154409153|NCT02737826|Gabapentin|gabapentin|mesh-list
154409154|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154409155|NCT02737826|Narcotics|narcotics|mesh-ancestor
154409156|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409157|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409158|NCT02737826|Analgesics|analgesics|mesh-ancestor
154409159|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
154409160|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409161|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154409162|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
154409163|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154409164|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154409165|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154409166|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154409167|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154409168|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668647|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154409169|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409170|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
154409172|NCT03367715|Ipilimumab|ipilimumab|mesh-list
154409173|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154409174|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409175|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154409176|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409177|NCT04064931|Niacin|niacin|mesh-list
154409178|NCT04064931|Vitamins|vitamins|mesh-ancestor
154409179|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
154409180|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409181|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154409182|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
154409183|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409184|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154409185|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
154409186|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
154409187|NCT03577652|Ticagrelor|ticagrelor|mesh-list
154409188|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154409189|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154409190|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154409191|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154409192|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
154409193|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409194|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409195|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409196|NCT03620513|Lidocaine|lidocaine|mesh-list
154409197|NCT03620513|Phenylephrine|phenylephrine|mesh-list
154409199|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
154409200|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
154409201|NCT03620513|Ephedrine|ephedrine|mesh-list
154409202|NCT03620513|Anesthetics|anesthetics|mesh-list
154409203|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
154409204|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409205|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409206|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
154409207|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409208|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154409209|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153668686|NCT00033267|Sirolimus|sirolimus|mesh-list
154409210|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154409211|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409212|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409213|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154409214|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154409215|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
154409216|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409217|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
154409218|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
154409219|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154409220|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
154409221|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154409222|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
154409223|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154409224|NCT03620513|Protective Agents|protective agents|mesh-ancestor
154409225|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154409226|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154409227|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154409228|NCT03585062|Paclitaxel|paclitaxel|mesh-list
154409229|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154409230|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409231|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
154409232|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154409233|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
154409234|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409235|NCT03584360|Calcitriol|calcitriol|mesh-list
154409236|NCT03584360|Betamethasone|betamethasone|mesh-list
154409237|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
154409238|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154409239|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
154409240|NCT03584360|Calcipotriene|calcipotriene|mesh-list
154409241|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154409242|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154409243|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
154409244|NCT03584360|Hormones|hormones|mesh-ancestor
154409245|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409246|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409247|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154409248|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
154409249|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
154409250|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154409251|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154409252|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409253|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409254|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154409255|NCT03584360|Vitamins|vitamins|mesh-ancestor
153668700|NCT00033306|Irinotecan|irinotecan|mesh-list
154409256|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
154409257|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154409258|NCT03579758|Gemcitabine|gemcitabine|mesh-list
154409259|NCT03579758|Capecitabine|capecitabine|mesh-list
154409260|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409261|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154409262|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
154409263|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409264|NCT03577574|Anesthetics|anesthetics|mesh-list
154409265|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409266|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409267|NCT01330901|Ustekinumab|ustekinumab|mesh-list
154409268|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
154409269|NCT02428647|Zinc|zinc|mesh-list
154409270|NCT02428647|Trace Elements|trace elements|mesh-ancestor
154409271|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
154409272|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409273|NCT01071395|Amantadine|amantadine|mesh-list
154409274|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154409275|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154409276|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
154409277|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409278|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
154409279|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409280|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409281|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409282|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154409283|NCT01071395|Analgesics|analgesics|mesh-ancestor
154409284|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
154409285|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409286|NCT02970942|Semaglutide|semaglutide|mesh-list
154409287|NCT02970942|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154409288|NCT02970942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154409289|NCT02970942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409290|NCT03577496|Peppermint oil|peppermint oil|mesh-list
154409291|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
154409292|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
154409293|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409294|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409295|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154409296|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
154409297|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
154409298|NCT03582878|Sirolimus|sirolimus|mesh-list
154409299|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154409300|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409301|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154409302|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
154409303|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154409304|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409305|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409306|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409307|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
154409308|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154409309|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
154409310|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409311|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
154409312|NCT02238704|Iron|iron|mesh-list
154409313|NCT02238704|Folic Acid|folic acid|mesh-list
154409314|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
154409315|NCT02238704|Calcium|calcium|mesh-list
154409316|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154409317|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409318|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154409319|NCT02238704|Trace Elements|trace elements|mesh-ancestor
154409320|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
154409321|NCT02238704|Hematinics|hematinics|mesh-ancestor
154409322|NCT02238704|Vitamins|vitamins|mesh-ancestor
154409323|NCT01331135|Sirolimus|sirolimus|mesh-list
154409324|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154409325|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409326|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154409327|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409328|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
154409329|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154409330|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
154409331|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409332|NCT03577184|Metformin|metformin|mesh-list
154409333|NCT03577184|Vildagliptin|vildagliptin|mesh-list
154409334|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154409335|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409336|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154409337|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
154409338|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409339|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409340|NCT02849171|Choline|choline|mesh-list
154409341|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
154409342|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154409343|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
154409344|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409345|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154409346|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154409347|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
154409348|NCT02238860|Tenofovir|tenofovir|mesh-list
154409349|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
154409351|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154409352|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154409353|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409354|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409355|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154409356|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154409357|NCT01333709|Folfirinox|folfirinox|mesh-list
154409358|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409359|NCT00493961|Hormones|hormones|mesh-list
154409360|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409361|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409362|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154409363|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154409364|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154409365|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409366|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409367|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409368|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409369|NCT02903238|Analgesics|analgesics|mesh-ancestor
154409370|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
154409371|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409372|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
154409373|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154409374|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
154409375|NCT01329809|Molgramostim|molgramostim|mesh-list
154409376|NCT01329809|Sargramostim|sargramostim|mesh-list
154409377|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
154409378|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409379|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409380|NCT02847260|Treprostinil|treprostinil|mesh-list
154409381|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154409382|NCT01331447|Exemestane|exemestane|mesh-list
154409383|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409384|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154409385|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154409386|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409387|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409388|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154409389|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
153973748|NCT06247995|Capecitabine|capecitabine|mesh-list
154409390|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409391|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984013|NCT01006265|Ponesimod|ponesimod|mesh-list
154409393|NCT02968563|Idelalisib|idelalisib|mesh-list
154409394|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154409395|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409396|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409397|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409398|NCT01329887|Ketanserin|ketanserin|mesh-list
154409399|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154409400|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154409401|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154409402|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
154409403|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409404|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409405|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409406|NCT01334099|Tremelimumab|tremelimumab|mesh-list
154409407|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409408|NCT01331525|Ipilimumab|ipilimumab|mesh-list
154409409|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154409410|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409411|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154409412|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409413|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154409414|NCT01334177|Cetuximab|cetuximab|mesh-list
154409415|NCT01334177|Antibodies|antibodies|mesh-list
154409416|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
154409417|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154409418|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
154409419|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409420|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409421|NCT05762523|Vaccines|vaccines|mesh-list
154409422|NCT05762523|Immunologic Factors|immunologic factors|mesh-ancestor
154409423|NCT05762523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409424|NCT02796261|Eflornithine|eflornithine|mesh-list
154409425|NCT02796261|Lomustine|lomustine|mesh-list
154409426|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154409427|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
154409428|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409429|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409430|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154409431|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154409432|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154409433|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409434|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154409435|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409436|NCT02904096|Lidocaine|lidocaine|mesh-list
154409437|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
154409438|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
154409439|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409440|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409441|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
154409442|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409443|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154409444|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154409445|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154409446|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409447|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409448|NCT02586675|Tamoxifen|tamoxifen|mesh-list
154409449|NCT02586675|Goserelin|goserelin|mesh-list
154409450|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154409451|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
154409452|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409453|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409454|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154409455|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409456|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154409457|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154409458|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154409459|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
154409460|NCT03648528|Vitamin D|vitamin d|mesh-list
154409461|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154409462|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409463|NCT03648528|Vitamins|vitamins|mesh-ancestor
154409464|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
153984085|NCT02871323|Durvalumab|durvalumab|mesh-list
154409465|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154409467|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409468|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409469|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
154409470|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409471|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154409472|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154409473|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154409474|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
154409475|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409476|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409477|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154409478|NCT01813929|Metformin|metformin|mesh-list
154409479|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154409480|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409481|NCT01502085|Dexamethasone|dexamethasone|mesh-list
154409482|NCT01502085|Vorinostat|vorinostat|mesh-list
154409483|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154409484|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
154409485|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
154409486|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409487|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409488|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154409489|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
154409490|NCT01502085|Hormones|hormones|mesh-ancestor
154409491|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409492|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154409493|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409494|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154409495|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409496|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409497|NCT03648684|Caffeine|caffeine|mesh-list
154409498|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154409499|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409500|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154409501|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409502|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409503|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154409504|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153669256|NCT00035958|Hormones|hormones|mesh-ancestor
154409505|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
154409506|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409507|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154409508|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154409509|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409510|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409511|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154409512|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409513|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409514|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
154409515|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409516|NCT02901054|Ondansetron|ondansetron|mesh-list
154409517|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
154409518|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
154409519|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409520|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409521|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154409522|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
154409523|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
154409524|NCT02901054|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154409525|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154409526|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
154409527|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669329|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
153669397|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
154409528|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409529|NCT03647670|Midazolam|midazolam|mesh-list
154409530|NCT03647670|Abrocitinib|abrocitinib|mesh-list
154409531|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154409532|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154409533|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409534|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409535|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154409536|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154409537|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154409538|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154409539|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
154409540|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
154409541|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
154409542|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
154409543|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409544|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409545|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154409546|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409547|NCT02966340|Prazosin|prazosin|mesh-list
154409548|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154409549|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154409550|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154409551|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154409552|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
154409553|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409554|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409555|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409556|NCT05284734|Anesthetics|anesthetics|mesh-list
154409557|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409558|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409559|NCT03629379|Ustekinumab|ustekinumab|mesh-list
154409560|NCT03629379|Vedolizumab|vedolizumab|mesh-list
154409561|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
154409562|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154409563|NCT05055999|Atezolizumab|atezolizumab|mesh-list
154409564|NCT05055999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154409565|NCT05055999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409566|NCT05055999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154409567|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409568|NCT03578900|Citric Acid|citric acid|mesh-list
154409569|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
154409570|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
154409571|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154409572|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
154409573|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
154409574|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409575|NCT02550002|Aflibercept|aflibercept|mesh-list
154409576|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154409577|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154409578|NCT02550002|Growth Substances|growth substances|mesh-ancestor
154409579|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409580|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
154409581|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409582|NCT03574376|Bupivacaine|bupivacaine|mesh-list
154409583|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
154409584|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
154409585|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409586|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409587|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
154409588|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409589|NCT03576794|Prednisolone|prednisolone|mesh-list
154409590|NCT03576794|Leflunomide|leflunomide|mesh-list
154409591|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154409592|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
154409594|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409595|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409596|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154409597|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409598|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409599|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409600|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154409601|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
154409602|NCT03578822|Aspirin|aspirin|mesh-list
154409603|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154409604|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154409605|NCT03578822|Analgesics|analgesics|mesh-ancestor
154409606|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
154409607|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409608|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409609|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154409610|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154409611|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153984310|NCT00689611|Bupropion|bupropion|mesh-list
154409612|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154409613|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409614|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154409615|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154409616|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409617|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
154409618|NCT03576638|Levodopa|levodopa|mesh-list
154409619|NCT03576638|Carbidopa|carbidopa|mesh-list
154409620|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154409621|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154409622|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154409623|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
154409624|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409625|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409626|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409627|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154409628|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409629|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154409630|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
154409631|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
154409632|NCT04284657|Citric Acid|citric acid|mesh-list
154409633|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
154409634|NCT04284657|Pravastatin|pravastatin|mesh-list
154409635|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
154409636|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154409637|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
154409638|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
154409639|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254462|NCT01146626|Vitamin D|vitamin d|mesh-list
154409641|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154409642|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
154409643|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154409644|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154409645|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409646|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
154409647|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154409648|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409649|NCT03574220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154409650|NCT03574220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409651|NCT04876677|Beclomethasone|beclomethasone|mesh-list
154409652|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
154409653|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
154409654|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154409655|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
154409656|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409657|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409658|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154409659|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
154409660|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154409661|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154409662|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154409663|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
154409664|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409665|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409666|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154409667|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
154409668|NCT04876677|Hormones|hormones|mesh-ancestor
154409669|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409670|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154409671|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154409672|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154409673|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
154409674|NCT03578432|Everolimus|everolimus|mesh-list
154409675|NCT03578432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154409676|NCT03578432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154409677|NCT03578432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409678|NCT03578432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409679|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154409680|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
154409681|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409682|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409683|NCT03578354|Atenolol|atenolol|mesh-list
154409684|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
154409685|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154409686|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154409687|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
154409688|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
154409689|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409690|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409691|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154409692|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154409693|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154409694|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
154409695|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409696|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409697|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154409698|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409699|NCT05204979|Misoprostol|misoprostol|mesh-list
154409700|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154409701|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
154409702|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154409703|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409704|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154409705|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154409706|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
154409707|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154409708|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409709|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154409711|NCT02239952|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154409712|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154409713|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409714|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409715|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409716|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154409717|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154409718|NCT02239952|Growth Substances|growth substances|mesh-ancestor
154409719|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409720|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
154409721|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154409722|NCT03647280|Epirubicin|epirubicin|mesh-list
154409723|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409724|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409725|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154409726|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154409727|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154409728|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409729|NCT03578042|Losartan|losartan|mesh-list
154409730|NCT03578042|Amlodipine|amlodipine|mesh-list
154409731|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154409732|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154409733|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154409734|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409735|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409736|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154409737|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409738|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
154409739|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154409740|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154409741|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154409742|NCT03578042|Diuretics|diuretics|mesh-ancestor
154409743|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
154409744|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154409745|NCT03646500|Remifentanil|remifentanil|mesh-list
154409746|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154409747|NCT03646500|Narcotics|narcotics|mesh-ancestor
154409748|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409749|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409750|NCT03646500|Analgesics|analgesics|mesh-ancestor
154409751|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
154409752|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409753|NCT03574064|Glucagon|glucagon|mesh-list
154409754|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154409755|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154409756|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154409757|NCT03574064|Hormones|hormones|mesh-ancestor
154409758|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409759|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409760|NCT03574064|Incretins|incretins|mesh-ancestor
154409761|NCT03573986|Bevacizumab|bevacizumab|mesh-list
154409762|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154409763|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409764|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154409765|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154409766|NCT03573986|Growth Substances|growth substances|mesh-ancestor
154409767|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409768|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
154409769|NCT03959592|Carotenoids|carotenoids|mesh-list
154409770|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
154409771|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409772|NCT03959592|Protective Agents|protective agents|mesh-ancestor
154409773|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409774|NCT04087395|Lidocaine|lidocaine|mesh-list
154409775|NCT04087395|Anesthetics|anesthetics|mesh-list
154409776|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
154409777|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669734|NCT00847418|Esketamine|esketamine|mesh-list
154409778|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409779|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
154409780|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409781|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154409782|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154409783|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154409784|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409785|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409786|NCT03573596|Dasatinib|dasatinib|mesh-list
154409787|NCT03573596|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154409788|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154409789|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409790|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409791|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409792|NCT03621618|Dobutamine|dobutamine|mesh-list
154409793|NCT03621618|Norepinephrine|norepinephrine|mesh-list
154409794|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154409795|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154409796|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
154409797|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409798|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409799|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409800|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
154409801|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
154409802|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409803|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154409804|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154409805|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154409806|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154409807|NCT03621618|Protective Agents|protective agents|mesh-ancestor
154409808|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
154409809|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154409810|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154409811|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
154409812|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409813|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154409814|NCT01569945|Clomiphene|clomiphene|mesh-list
154409815|NCT01569945|Menotropins|menotropins|mesh-list
154409816|NCT01569945|Estradiol|estradiol|mesh-list
154409817|NCT01569945|Estrogens|estrogens|mesh-ancestor
154409818|NCT01569945|Hormones|hormones|mesh-ancestor
154409819|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409820|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409821|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154409822|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
154409823|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154409824|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154409825|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154409826|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154409827|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154409828|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
154409829|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154409830|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
154409831|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154409832|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154253693|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154409833|NCT03645876|Capecitabine|capecitabine|mesh-list
154409834|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
154409835|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154409836|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
154409837|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409838|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409839|NCT03646266|Bromides|bromides|mesh-list
154409840|NCT03646266|Rocuronium|rocuronium|mesh-list
154409841|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
154409842|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154409843|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154409844|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154409845|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409846|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409847|NCT04052178|Capsaicin|capsaicin|mesh-list
154409848|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
154409849|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
154409850|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
154409851|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409852|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409853|NCT03645642|Midodrine|midodrine|mesh-list
154409854|NCT03645642|Diuretics|diuretics|mesh-list
154409855|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
154409856|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409857|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
154409858|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
154409859|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409860|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154409861|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154409862|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154409863|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154409864|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
154409865|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154409866|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409867|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154409868|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
154409869|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409870|NCT01345188|Ranolazine|ranolazine|mesh-list
154409871|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154409872|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154409873|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409874|NCT03852459|Ibuprofen|ibuprofen|mesh-list
154409875|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154409876|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154409877|NCT03852459|Analgesics|analgesics|mesh-ancestor
154409878|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
154409879|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409880|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409881|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154409882|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154409883|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154409884|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409885|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409886|NCT03580902|Buprenorphine|buprenorphine|mesh-list
154409887|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154409888|NCT03580902|Naloxone|naloxone|mesh-list
154409889|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154409890|NCT03580902|Narcotics|narcotics|mesh-ancestor
154409891|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409892|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409893|NCT03580902|Analgesics|analgesics|mesh-ancestor
154409894|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
154409895|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409896|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154409897|NCT02896296|Buprenorphine|buprenorphine|mesh-list
154409898|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154409899|NCT02896296|Narcotics|narcotics|mesh-ancestor
154409900|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154409901|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409902|NCT02896296|Analgesics|analgesics|mesh-ancestor
154409903|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
154409904|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409905|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154253694|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154409906|NCT03740919|Insulin|insulin|mesh-list
154409907|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154409908|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
154409909|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
154409910|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154409911|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409912|NCT01335685|Prednisone|prednisone|mesh-list
154409913|NCT01335685|Melphalan|melphalan|mesh-list
154409914|NCT01335685|Ixazomib|ixazomib|mesh-list
154409915|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154409916|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
154409917|NCT01335685|Hormones|hormones|mesh-ancestor
154409918|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154409919|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409920|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154409921|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409922|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154409923|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
154409924|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409925|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154409926|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154409927|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
154409928|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
154409929|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409930|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
154409931|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154254468|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
154409932|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409933|NCT04462965|Temozolomide|temozolomide|mesh-list
154409934|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154409935|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
154409936|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409937|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409938|NCT01339663|Aldesleukin|aldesleukin|mesh-list
154409939|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
154409940|NCT01339663|Interleukin-2|interleukin-2|mesh-list
154409941|NCT01339663|Vaccines|vaccines|mesh-list
154409942|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
154409943|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409944|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154409945|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154409946|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154409947|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
154409948|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409949|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409950|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154409951|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154409952|NCT01339663|Analgesics|analgesics|mesh-ancestor
154409953|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
154409954|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154409955|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154409956|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154409957|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
154409958|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409959|NCT00092599|Ezetimibe|ezetimibe|mesh-list
153669973|NCT00277043|Paclitaxel|paclitaxel|mesh-list
154409960|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154409961|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154409962|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
154409963|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409964|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154409965|NCT03737565|Tryptophan|tryptophan|mesh-list
154409966|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154409967|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
154409968|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154409970|NCT02889133|Dextrans|dextrans|mesh-list
154409971|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
154409972|NCT02889133|Trace Elements|trace elements|mesh-ancestor
154409973|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
154409974|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154409975|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
154409976|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
154409977|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
154409978|NCT02889133|Hematinics|hematinics|mesh-ancestor
154409979|NCT01333423|Roscovitine|roscovitine|mesh-list
154409980|NCT01333423|Doxorubicin|doxorubicin|mesh-list
154409981|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153984660|NCT00745693|BQ 788|bq 788|mesh-list
154409982|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154409983|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154409984|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154409985|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154409986|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154409987|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409988|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
154409989|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154409990|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154409992|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154409993|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154409994|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154409995|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154409996|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154409997|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154409998|NCT00092209|Diuretics|diuretics|mesh-ancestor
154409999|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
154410000|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410001|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154410002|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154410003|NCT01339741|Vitamin D|vitamin d|mesh-list
154410004|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
154410005|NCT01339741|Vitamins|vitamins|mesh-ancestor
154410006|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
154410007|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410008|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154410009|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154410010|NCT00003777|Fluorouracil|fluorouracil|mesh-list
154410011|NCT00003777|Amifostine|amifostine|mesh-list
154410012|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410013|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
154410014|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410015|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154410016|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410017|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
154410018|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410019|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154410020|NCT00003777|Protective Agents|protective agents|mesh-ancestor
154410021|NCT01339819|Dabigatran|dabigatran|mesh-list
154410022|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
154410023|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
154410024|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154410025|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
154410026|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410027|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410028|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
154410029|NCT02963922|Liraglutide|liraglutide|mesh-list
154410030|NCT02963922|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154410031|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154410032|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410033|NCT02963922|Incretins|incretins|mesh-ancestor
154410034|NCT02963922|Hormones|hormones|mesh-ancestor
153670078|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410035|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410036|NCT00090181|Diclofenac|diclofenac|mesh-list
154410037|NCT00090181|Etoricoxib|etoricoxib|mesh-list
154410038|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154410039|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154410040|NCT00090181|Analgesics|analgesics|mesh-ancestor
154410041|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
154410042|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410043|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410044|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410045|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410046|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154410047|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410048|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410049|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154410050|NCT03619785|Acetaminophen|acetaminophen|mesh-list
154410051|NCT03619785|Ibuprofen|ibuprofen|mesh-list
154410052|NCT03619785|Ketorolac|ketorolac|mesh-list
154410053|NCT03619785|Fentanyl|fentanyl|mesh-list
154410054|NCT03619785|Ketamine|ketamine|mesh-list
154410055|NCT03619785|Morphine|morphine|mesh-list
154410056|NCT03619785|Gabapentin|gabapentin|mesh-list
154410057|NCT03619785|Hydromorphone|hydromorphone|mesh-list
154410058|NCT03619785|Hydrocodone|hydrocodone|mesh-list
154410059|NCT03619785|Bupivacaine|bupivacaine|mesh-list
154410060|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
154410061|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
154410062|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410063|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410064|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
154410065|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410066|NCT03619785|Analgesics|analgesics|mesh-ancestor
154410067|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154410068|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154410069|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
154410070|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154410071|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154410072|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670131|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
154410073|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410074|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154410075|NCT03619785|Narcotics|narcotics|mesh-ancestor
154410076|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154410077|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154410078|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
154410079|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154410080|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410081|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410082|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154410083|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410084|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
154410085|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154410087|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154410088|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
154410089|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
154410090|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
154410091|NCT02881567|Daclizumab|daclizumab|mesh-list
154410092|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410093|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
154410094|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410095|NCT05184517|Cyclosporine|cyclosporine|mesh-list
154410096|NCT05184517|Cyclosporins|cyclosporins|mesh-list
154410097|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410098|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410099|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410100|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
154410101|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410102|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
154410103|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154410104|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410105|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410106|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153670193|NCT00275951|Cetuximab|cetuximab|mesh-list
154410107|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
154410108|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154410109|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154410110|NCT02962284|Prednisolone|prednisolone|mesh-list
154410111|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
154410112|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
154410113|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154410114|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
154410115|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410116|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
154410117|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
154410118|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410119|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410120|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154410121|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
154410122|NCT02962284|Hormones|hormones|mesh-ancestor
154410123|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410124|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154410125|NCT02962284|Protective Agents|protective agents|mesh-ancestor
154410126|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154410127|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410128|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154410129|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410130|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410131|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
154410132|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154410133|NCT03642600|Folic Acid|folic acid|mesh-list
154410134|NCT03642600|Inositol|inositol|mesh-list
154410135|NCT03642600|Liraglutide|liraglutide|mesh-list
154410136|NCT03642600|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154253695|NCT01133444|Finasteride|finasteride|mesh-list
154410137|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154410138|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410139|NCT03642600|Incretins|incretins|mesh-ancestor
154410140|NCT03642600|Hormones|hormones|mesh-ancestor
154410141|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410142|NCT03642600|Hematinics|hematinics|mesh-ancestor
154410143|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
154410144|NCT03642600|Vitamins|vitamins|mesh-ancestor
154410145|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
154410146|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
154410147|NCT01069692|Hematinics|hematinics|mesh-ancestor
154410148|NCT05183178|Ticagrelor|ticagrelor|mesh-list
154410149|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154410150|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154410151|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154410152|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154410153|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154410154|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
154410155|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410156|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410157|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410158|NCT03161093|Naproxen|naproxen|mesh-list
154410159|NCT03161093|Fasinumab|fasinumab|mesh-list
154410160|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154410161|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154410162|NCT03161093|Analgesics|analgesics|mesh-ancestor
154410163|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
154410164|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410165|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410166|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410167|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410168|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
154410169|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154410170|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410171|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410172|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
154410173|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154410174|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
154410175|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410176|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410177|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154410178|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
154410179|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154410180|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
154410181|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410182|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410183|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154410184|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
154410185|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
154410186|NCT03573284|Protective Agents|protective agents|mesh-ancestor
154410187|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
154410188|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410189|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410190|NCT01334333|Tacrolimus|tacrolimus|mesh-list
154410191|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410192|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
154410193|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410194|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154410195|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410196|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410197|NCT03573050|Rivastigmine|rivastigmine|mesh-list
154410198|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154410199|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410200|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410201|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
154410202|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410203|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410204|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154410205|NCT03573050|Protective Agents|protective agents|mesh-ancestor
154410206|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
154410207|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154410208|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154410209|NCT02847494|Dexamethasone|dexamethasone|mesh-list
154410210|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
153984829|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
154410211|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154410212|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154410213|NCT02847494|Prednisolone|prednisolone|mesh-list
154410214|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
154410215|NCT02847494|Metoclopramide|metoclopramide|mesh-list
154410216|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154410217|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
154410218|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410219|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
154410220|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
154410221|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410222|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410223|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154410224|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
154410226|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410227|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154410228|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410229|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154410230|NCT02847494|Protective Agents|protective agents|mesh-ancestor
154410231|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154410232|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154410233|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
154410234|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973749|NCT06247995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154410235|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410237|NCT02554253|Propofol|propofol|mesh-list
154410238|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154410239|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410240|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410241|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154410242|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
154410243|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
154410244|NCT02554253|Analgesics|analgesics|mesh-ancestor
154410245|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
154410246|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410247|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154410248|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154410249|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154410250|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410251|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410252|NCT02239484|Tadalafil|tadalafil|mesh-list
154410253|NCT02239484|Tamsulosin|tamsulosin|mesh-list
154410254|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
154410255|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154410256|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154410257|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410258|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410259|NCT02239484|Urological Agents|urological agents|mesh-ancestor
154410260|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154410261|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154410262|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154410263|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
154410264|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410265|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410266|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
154410267|NCT03575234|Nivolumab|nivolumab|mesh-list
154410268|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410269|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
154410270|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410271|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410272|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154410273|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
154410274|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410275|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410276|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154410277|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410278|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154410279|NCT04508855|Heparin|heparin|mesh-list
154410280|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154410281|NCT04508855|Tinzaparin|tinzaparin|mesh-list
154410282|NCT04508855|Dalteparin|dalteparin|mesh-list
154410283|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
153984903|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
154410284|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154410285|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154410286|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410287|NCT03575078|Olaparib|olaparib|mesh-list
154410288|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154410289|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410290|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410291|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410292|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
154410293|NCT03157583|Glycerol|glycerol|mesh-list
154410294|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154410295|NCT03157583|Protective Agents|protective agents|mesh-ancestor
154410296|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410297|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410298|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154410299|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
154410300|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154410301|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154410302|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410303|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
154410304|NCT03570710|Coagulants|coagulants|mesh-ancestor
154410305|NCT01337765|Dactolisib|dactolisib|mesh-list
154410306|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410308|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154410309|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153973750|NCT06247995|Antimetabolites|antimetabolites|mesh-ancestor
154410310|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154410311|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154410312|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410313|NCT04475705|Propofol|propofol|mesh-list
154410314|NCT04475705|Sevoflurane|sevoflurane|mesh-list
154410315|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154410316|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410317|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410318|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154410319|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
154410320|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
154410321|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154410322|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154410323|NCT03158311|Fluticasone|fluticasone|mesh-list
154410324|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
154410325|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154410326|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410327|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154410328|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
154410329|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410330|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410331|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154410332|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
154410333|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410334|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154410335|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
154410336|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154410337|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
154410338|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410339|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410340|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154410341|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154410342|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154410343|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
154410344|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154410345|NCT02244866|Hormones|hormones|mesh-ancestor
154027522|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154410346|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410347|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410348|NCT01334567|Tenofovir|tenofovir|mesh-list
154410349|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
154410350|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154410351|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154410352|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154410353|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410354|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410355|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154410356|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154410357|NCT04398329|Bupivacaine|bupivacaine|mesh-list
154410358|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154410359|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
154410360|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410361|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410362|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
154410363|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410364|NCT00449111|Losartan|losartan|mesh-list
154410365|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154410366|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154410367|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154410368|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154410369|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410370|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
154410371|NCT03568916|Apixaban|apixaban|mesh-list
154410372|NCT03568916|Dabigatran|dabigatran|mesh-list
154410373|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154410374|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
154410375|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154410376|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
154410377|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410378|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410379|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
154410380|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
154410382|NCT01334645|Coagulants|coagulants|mesh-ancestor
154410383|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154410384|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154410385|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
154410386|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410387|NCT03571490|Ropivacaine|ropivacaine|mesh-list
154410388|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154410389|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
154410390|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410391|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410392|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
154410393|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410394|NCT01331993|Naproxen|naproxen|mesh-list
154410395|NCT01331993|Esomeprazole|esomeprazole|mesh-list
154410396|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154410397|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154410398|NCT01331993|Analgesics|analgesics|mesh-ancestor
154410399|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
154410400|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410401|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410402|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410403|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410404|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
154410405|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154410406|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410407|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410408|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154410409|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154410410|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154410411|NCT01338077|Omeprazole|omeprazole|mesh-list
154410412|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154410413|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154410414|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154410415|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410416|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410417|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
154410418|NCT03570320|Narcotics|narcotics|mesh-ancestor
154410419|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410420|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410421|NCT03570320|Analgesics|analgesics|mesh-ancestor
154410422|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
154410423|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410424|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
154410425|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154410426|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410427|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410428|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154410429|NCT04266665|Analgesics|analgesics|mesh-ancestor
154410430|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
154410431|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410432|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154410433|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154410434|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154410435|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
154410436|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410437|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410438|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
154410439|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154410440|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154410441|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154410442|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
154410443|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410444|NCT01338311|Albuterol|albuterol|mesh-list
154410445|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154410446|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
154410447|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410448|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410449|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154410450|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
154410451|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
154410452|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154410453|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154254473|NCT02924324|Ropivacaine|ropivacaine|mesh-list
154410454|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154410455|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154410456|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
154410457|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410458|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410459|NCT01334879|Ranibizumab|ranibizumab|mesh-list
154410460|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154410461|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154410462|NCT01334879|Growth Substances|growth substances|mesh-ancestor
154410463|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410464|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
154410465|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410466|NCT01315795|Lanreotide|lanreotide|mesh-list
154410467|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410468|NCT03570164|Sevoflurane|sevoflurane|mesh-list
154410469|NCT03570164|Desflurane|desflurane|mesh-list
154410470|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154410471|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154410472|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
154410473|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
154410474|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410475|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410476|NCT01315951|Petrolatum|petrolatum|mesh-list
154410477|NCT01315951|Emollients|emollients|mesh-ancestor
154410478|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410479|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
154410480|NCT05184049|Epalrestat|epalrestat|mesh-list
154410481|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
154410482|NCT05184049|Vitamins|vitamins|mesh-ancestor
154410483|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
154410484|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410485|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410486|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410487|NCT01336543|Cisplatin|cisplatin|mesh-list
154410488|NCT01336543|Gemcitabine|gemcitabine|mesh-list
154410489|NCT01336543|Etoposide|etoposide|mesh-list
154410490|NCT01336543|Pemetrexed|pemetrexed|mesh-list
154410491|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410492|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154410493|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
154410494|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410495|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154410496|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154410497|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154410498|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410499|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153670907|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154410500|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154410501|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154410502|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
154410503|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410504|NCT01336621|Ezogabine|ezogabine|mesh-list
154410505|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
154410506|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154410507|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410508|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
154410509|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
154410510|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154410511|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
154410512|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410513|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410514|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154410515|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
154410516|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154410517|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154410518|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154410519|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
154410520|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410521|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410522|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410523|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410524|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154410525|NCT01340521|Clomiphene|clomiphene|mesh-list
154410526|NCT01340521|Enclomiphene|enclomiphene|mesh-list
154410527|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
154410528|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154410529|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
154410530|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410531|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410532|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154410533|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
154410534|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154410535|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154410536|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154410537|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154410538|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
154410539|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410540|NCT01340599|Protective Agents|protective agents|mesh-ancestor
154410541|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410542|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154410543|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154410544|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410545|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154410546|NCT01335035|Deferasirox|deferasirox|mesh-list
153670959|NCT04859296|Dronabinol|dronabinol|mesh-list
154410547|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154410548|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
154410549|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
154410550|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410551|NCT01340677|Canagliflozin|canagliflozin|mesh-list
154410552|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154410553|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410554|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154410555|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410556|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
154410557|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154410558|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154410559|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
154410560|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154410561|NCT01340833|Dabrafenib|dabrafenib|mesh-list
154410562|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410563|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154410564|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410565|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410566|NCT01332383|Naratriptan|naratriptan|mesh-list
154410567|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154410568|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154410569|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154410570|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
154410571|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410572|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410573|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410574|NCT01342237|Carboplatin|carboplatin|mesh-list
154410575|NCT01342237|Etoposide|etoposide|mesh-list
154410576|NCT01342237|Melphalan|melphalan|mesh-list
154410577|NCT01342237|Topotecan|topotecan|mesh-list
154410578|NCT01342237|Thiotepa|thiotepa|mesh-list
154410579|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410580|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154410581|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154410582|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154410583|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410584|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410585|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154410586|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
154410587|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154410588|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410589|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
154410590|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410591|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154410592|NCT01337323|Fluticasone|fluticasone|mesh-list
154410593|NCT01337323|Xhance|xhance|mesh-list
154410594|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410595|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154410596|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
154410597|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410598|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410599|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154410600|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
154410601|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410602|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154410603|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
154410604|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
154410605|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
154410606|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410607|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
154410608|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154410609|NCT04830943|Protective Agents|protective agents|mesh-ancestor
154410610|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410611|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
154410613|NCT03067610|Cisplatin|cisplatin|mesh-list
154410614|NCT03067610|Carboplatin|carboplatin|mesh-list
154410615|NCT03067610|Cetuximab|cetuximab|mesh-list
154410616|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154410617|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410618|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
154410619|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
154410620|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
154410621|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410622|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410623|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
154410624|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
154410625|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154410626|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
154410627|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410628|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410629|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154410630|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
154410631|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154410632|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154410633|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154410634|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
154410635|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671153|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
154410636|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410637|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410638|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410639|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154410640|NCT05182957|Lenalidomide|lenalidomide|mesh-list
154410641|NCT05182957|Azacitidine|azacitidine|mesh-list
154410642|NCT05182957|Antibodies|antibodies|mesh-list
154410643|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
154410644|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154410645|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
154410646|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410647|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154410648|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154410649|NCT05182957|Growth Substances|growth substances|mesh-ancestor
154410650|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
154410651|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410652|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154410653|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
154410654|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410655|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410656|NCT00092651|Simvastatin|simvastatin|mesh-list
154410657|NCT00092651|Ezetimibe|ezetimibe|mesh-list
154410658|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154410659|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154410660|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154410661|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
154410662|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410663|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154410664|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154410665|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410666|NCT04889599|Docetaxel|docetaxel|mesh-list
154410667|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410668|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
154410669|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
153671248|NCT03356873|Vitamins|vitamins|mesh-list
153671274|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
154410670|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
154410671|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410672|NCT01342627|Sorafenib|sorafenib|mesh-list
154410673|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410674|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154410675|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410676|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410677|NCT03160703|Fluorides|fluorides|mesh-list
154410678|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
154410679|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
154410680|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
154410681|NCT03160703|Protective Agents|protective agents|mesh-ancestor
154410682|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410683|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
154410684|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
154410685|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154410686|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154410687|NCT01332617|Prednisolone|prednisolone|mesh-list
154410688|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
154410689|NCT01332617|Diclofenac|diclofenac|mesh-list
154410690|NCT01332617|Bortezomib|bortezomib|mesh-list
154410691|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154410692|NCT01332617|Simvastatin|simvastatin|mesh-list
154410693|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154410694|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
154410695|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410696|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410697|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
154410698|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
154410699|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410700|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410701|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154410702|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
154410703|NCT01332617|Hormones|hormones|mesh-ancestor
154410704|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410705|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154410706|NCT01332617|Protective Agents|protective agents|mesh-ancestor
154410707|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154410708|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154410709|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154410710|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
154410711|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410712|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154410713|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154410714|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410715|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154410716|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154410717|NCT01332617|Analgesics|analgesics|mesh-ancestor
154410718|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
154410719|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410720|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154410721|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154410722|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
154410723|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154410724|NCT03569696|Nivolumab|nivolumab|mesh-list
154410725|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410726|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410727|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154410728|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410729|NCT00092573|Ezetimibe|ezetimibe|mesh-list
154410730|NCT00092573|Fenofibrate|fenofibrate|mesh-list
154410731|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154410732|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154410733|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
154410734|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410735|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154410736|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154410737|NCT01342939|Incretins|incretins|mesh-list
154410738|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154410739|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410740|NCT01342939|Hormones|hormones|mesh-ancestor
154410741|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410742|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154410743|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
154410744|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410745|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410746|NCT03569540|Glyburide|glyburide|mesh-list
154410747|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154410748|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410749|NCT05708690|Tranexamic Acid|tranexamic acid|mesh-list
154410750|NCT05708690|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154410751|NCT05708690|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154410752|NCT05708690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410753|NCT05708690|Hemostatics|hemostatics|mesh-ancestor
154410754|NCT05708690|Coagulants|coagulants|mesh-ancestor
154410755|NCT04851821|Quercetin|quercetin|mesh-list
154410756|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
154410757|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410759|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410760|NCT02247128|Aspirin|aspirin|mesh-list
154410761|NCT02247128|Clopidogrel|clopidogrel|mesh-list
154410762|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154410763|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154410764|NCT02247128|Analgesics|analgesics|mesh-ancestor
154410765|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
154410766|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410767|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410768|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410769|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410770|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154410771|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154410772|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410773|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154410774|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154410775|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410776|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
154410777|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154410778|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154410779|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154410780|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
154410781|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410782|NCT01339481|Abatacept|abatacept|mesh-list
154410783|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154410784|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410785|NCT01339481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410786|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410787|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410788|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
154410789|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410790|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410791|NCT01344031|Fulvestrant|fulvestrant|mesh-list
154410792|NCT01344031|Anastrozole|anastrozole|mesh-list
154410793|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154410794|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410795|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154410796|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154410797|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
154410798|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410799|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410800|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154410801|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154410802|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410803|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410804|NCT01332929|Bevacizumab|bevacizumab|mesh-list
154410805|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410806|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410807|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154410808|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154410809|NCT01332929|Growth Substances|growth substances|mesh-ancestor
154410810|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410811|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
154410813|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154410814|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410815|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154410816|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154410817|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154410818|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410819|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
154410820|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410821|NCT05708534|Abatacept|abatacept|mesh-list
154410822|NCT05708534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154410823|NCT05708534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410824|NCT05708534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410825|NCT05708534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410826|NCT05708534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410827|NCT05708534|Immunologic Factors|immunologic factors|mesh-ancestor
154039335|NCT06260969|Tirofiban|tirofiban|mesh-list
154410828|NCT05708534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410830|NCT03000374|Leucovorin|leucovorin|mesh-list
154410831|NCT03000374|Fluorouracil|fluorouracil|mesh-list
154410832|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
154410833|NCT03000374|Panitumumab|panitumumab|mesh-list
154410834|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
154410835|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410836|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154410837|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410838|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410839|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
154410840|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410841|NCT03000374|Antidotes|antidotes|mesh-ancestor
154410842|NCT03000374|Protective Agents|protective agents|mesh-ancestor
154410843|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
154410844|NCT03000374|Vitamins|vitamins|mesh-ancestor
154410845|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
154410846|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410847|NCT03566576|Docetaxel|docetaxel|mesh-list
154410848|NCT03566576|Pemetrexed|pemetrexed|mesh-list
154410849|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410850|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
154410851|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
154410852|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153671529|NCT05770960|Codeine|codeine|mesh-list
153671579|NCT05757011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410853|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410854|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410855|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154410856|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154410857|NCT04377997|Heparin|heparin|mesh-list
154410858|NCT04377997|Calcium heparin|calcium heparin|mesh-list
154410859|NCT04377997|Enoxaparin|enoxaparin|mesh-list
154410860|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154410861|NCT04377997|Tinzaparin|tinzaparin|mesh-list
154410862|NCT04377997|Dalteparin|dalteparin|mesh-list
154410863|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
154410864|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154410865|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154410866|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410867|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
154410868|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410869|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410870|NCT04758949|Nivolumab|nivolumab|mesh-list
154410871|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410872|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410873|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154410874|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410875|NCT03566030|Tenofovir|tenofovir|mesh-list
154410876|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
154410877|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154410878|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154410879|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154410880|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671580|NCT05750875|Loratadine|loratadine|mesh-list
154410881|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410882|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154410883|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154410884|NCT01333085|Paclitaxel|paclitaxel|mesh-list
154410885|NCT01333085|Carboplatin|carboplatin|mesh-list
153985503|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
154410886|NCT01333085|Everolimus|everolimus|mesh-list
154410887|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154410888|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410889|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
154410890|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
154410891|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
154410892|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410893|NCT01333085|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154410894|NCT01333085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154410895|NCT01333085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410896|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410897|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
154410898|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410899|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154410900|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154410901|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
154410902|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039403|NCT06260046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154410903|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410904|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154410905|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
154410906|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154410907|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154410908|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154410909|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
154410910|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154410911|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410912|NCT03565406|Nivolumab|nivolumab|mesh-list
154410913|NCT03565406|Ipilimumab|ipilimumab|mesh-list
154410914|NCT03565406|Mocetinostat|mocetinostat|mesh-list
154410915|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154410916|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410917|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154410918|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410919|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154410920|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410921|NCT04734379|Fasudil|fasudil|mesh-list
154410922|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154410923|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154410924|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410925|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154410926|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410927|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
154410928|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154410929|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410930|NCT01339871|Vorinostat|vorinostat|mesh-list
154410931|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154410932|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154410933|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410934|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410935|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
154410936|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154410937|NCT03564704|Cytarabine|cytarabine|mesh-list
154410938|NCT03564704|Dexamethasone|dexamethasone|mesh-list
154410939|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
154410940|NCT03564704|Methotrexate|methotrexate|mesh-list
154410941|NCT03564704|Etoposide|etoposide|mesh-list
154410942|NCT03564704|Vincristine|vincristine|mesh-list
154410943|NCT03564704|Doxorubicin|doxorubicin|mesh-list
154410944|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
154410945|NCT03564704|Idarubicin|idarubicin|mesh-list
154410946|NCT03564704|Pegaspargase|pegaspargase|mesh-list
154410947|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410948|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
154410949|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410950|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154410951|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154410952|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
154410953|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154410954|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671671|NCT05112848|Vaccines|vaccines|mesh-list
154410955|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154410956|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154410957|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
154410958|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
154410959|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410960|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154410961|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
154410962|NCT03564704|Hormones|hormones|mesh-ancestor
154410963|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154410964|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154410965|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154410966|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
154410967|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154410968|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154410969|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
154410970|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
154410971|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410972|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154410973|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154410974|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154410975|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154410976|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154410977|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
154410978|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154410979|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
154410980|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
154410981|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
154410982|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154410983|NCT03564548|Morphine|morphine|mesh-list
154410984|NCT03564548|Oxycodone|oxycodone|mesh-list
154410985|NCT03564548|Hydromorphone|hydromorphone|mesh-list
154410986|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154410987|NCT03564548|Narcotics|narcotics|mesh-ancestor
154410988|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154410989|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410990|NCT03564548|Analgesics|analgesics|mesh-ancestor
154410991|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
154410992|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154410993|NCT05353010|Tacrolimus|tacrolimus|mesh-list
153671694|NCT04892511|Urapidil|urapidil|mesh-list
154410994|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154410995|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
154410996|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154410997|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154410998|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154410999|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411000|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154411001|NCT05352854|Pilocarpine|pilocarpine|mesh-list
154411002|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154411003|NCT05352854|Miotics|miotics|mesh-ancestor
154411004|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
154411005|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411006|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411007|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154411008|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154411009|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
154411010|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411011|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411012|NCT01841177|Milrinone|milrinone|mesh-list
154411013|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154411014|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154411015|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
154411016|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154411017|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154411018|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411019|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411020|NCT01841177|Protective Agents|protective agents|mesh-ancestor
154411021|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411022|NCT02838134|Rocuronium|rocuronium|mesh-list
154411023|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154411024|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154411025|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154411026|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411027|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411028|NCT03150589|Ranibizumab|ranibizumab|mesh-list
154411029|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154411030|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154411031|NCT03150589|Growth Substances|growth substances|mesh-ancestor
154411032|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411033|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
154411034|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411035|NCT05340452|Clarithromycin|clarithromycin|mesh-list
154411036|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153671739|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
154411037|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411038|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154411039|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411040|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411041|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154411042|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154411043|NCT03145207|Lidocaine|lidocaine|mesh-list
154411044|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
154411045|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
154411046|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411047|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411048|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
154411049|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411050|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154411051|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154411052|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154411053|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411054|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411055|NCT02836652|Aspirin|aspirin|mesh-list
154411056|NCT02836652|Warfarin|warfarin|mesh-list
154411057|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154411058|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154411059|NCT02836652|Analgesics|analgesics|mesh-ancestor
154411060|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
154411061|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411062|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411063|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411064|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411065|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154411066|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154411067|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411068|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154411069|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154411070|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411071|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
154411072|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
154411073|NCT02836496|Prednisone|prednisone|mesh-list
154411074|NCT02836496|Prednisolone|prednisolone|mesh-list
154411075|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411076|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
154411077|NCT02836496|Hormones|hormones|mesh-ancestor
154411078|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411079|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411080|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154411081|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411082|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
154411083|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154411084|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411085|NCT05250661|Propolis|propolis|mesh-list
154411086|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411087|NCT04044781|BPN14770|bpn14770|mesh-list
154411088|NCT04044781|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154411089|NCT04044781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154411090|NCT04044781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411091|NCT04044781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411092|NCT01345279|Paclitaxel|paclitaxel|mesh-list
154411093|NCT01345279|Topotecan|topotecan|mesh-list
154411094|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154411095|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411096|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
154411097|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
154411098|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
154411099|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411100|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154411101|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154411102|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411103|NCT02833844|Evolocumab|evolocumab|mesh-list
154411104|NCT02833844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154411105|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154411106|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154411107|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
154411108|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411109|NCT02833844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154411110|NCT02833844|Protease Inhibitors|protease inhibitors|mesh-ancestor
154411111|NCT02833844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411112|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154411114|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411115|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154411116|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
154411117|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411118|NCT01333631|Valproic Acid|valproic acid|mesh-list
154411119|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
154411120|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411121|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411122|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
154411123|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411124|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411125|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
154411126|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154411127|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411128|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154411129|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
154411130|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154411131|NCT04611763|Analgesics|analgesics|mesh-ancestor
154411132|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
154411133|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411134|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411135|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154411136|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154411137|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411138|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411139|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154411140|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411141|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411142|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
154411143|NCT01341782|Calcitriol|calcitriol|mesh-list
154411144|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
154411145|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154411146|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411147|NCT01341782|Vitamins|vitamins|mesh-ancestor
154411148|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
154411149|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154411150|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411151|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
154411152|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154411153|NCT01341782|Protective Agents|protective agents|mesh-ancestor
154411154|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154411155|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411156|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411157|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154411158|NCT02250157|Irinotecan|irinotecan|mesh-list
154411159|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154411160|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154411161|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411162|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411163|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411164|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
154411165|NCT03564158|Meropenem|meropenem|mesh-list
154411166|NCT03564158|Vaborbactam|vaborbactam|mesh-list
154411167|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154411168|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411169|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154411170|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154411171|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411172|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411173|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411174|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154411175|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
154411176|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154411177|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154411178|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154411179|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411180|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411181|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
154411182|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411183|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411184|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153985806|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
154411185|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411186|NCT01345981|Lidocaine|lidocaine|mesh-list
154411187|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
154411188|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
154411189|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411190|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411191|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
154411192|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411193|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154411194|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154411195|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154411196|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411197|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411198|NCT00871351|Atorvastatin|atorvastatin|mesh-list
154411199|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154411201|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154411202|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154411203|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
154411204|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411205|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154411206|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154411207|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411208|NCT04920331|Erenumab|erenumab|mesh-list
154411209|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154411210|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672046|NCT02573831|Oxycodone|oxycodone|mesh-list
154411211|NCT04920331|Analgesics|analgesics|mesh-ancestor
154411212|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
154411213|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411214|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411215|NCT02745080|Adalimumab|adalimumab|mesh-list
154411216|NCT02745080|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154411217|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411218|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411219|NCT01346137|Meloxicam|meloxicam|mesh-list
154411220|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154411221|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154411222|NCT01346137|Analgesics|analgesics|mesh-ancestor
154411223|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
154411224|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411225|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411226|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411227|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411228|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154411229|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154411230|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411231|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411232|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
154411233|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411234|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
154411235|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154411236|NCT00442897|Atorvastatin|atorvastatin|mesh-list
154411237|NCT00442897|Simvastatin|simvastatin|mesh-list
154411238|NCT00442897|Ezetimibe|ezetimibe|mesh-list
154411239|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154411240|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154411241|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
154411242|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411243|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154411244|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154411245|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411246|NCT01346215|Heparin|heparin|mesh-list
154411247|NCT01346215|Calcium heparin|calcium heparin|mesh-list
154411248|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
154411249|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154411250|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154411251|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411252|NCT02834390|Cytarabine|cytarabine|mesh-list
154411253|NCT02834390|Daunorubicin|daunorubicin|mesh-list
154411254|NCT02834390|Idarubicin|idarubicin|mesh-list
154411255|NCT02834390|Quizartinib|quizartinib|mesh-list
154411256|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154411257|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
153985897|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
154411258|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411259|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411260|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
154411261|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411262|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154411263|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
154411264|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411265|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154411266|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154411267|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154411268|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411269|NCT02834390|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154411270|NCT02834390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154411272|NCT01317433|Cetuximab|cetuximab|mesh-list
154411273|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154411274|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411275|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154411276|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411277|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
154411278|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154411279|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154411280|NCT01317511|Caseins|caseins|mesh-list
154411281|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
154411282|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
154411283|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411284|NCT01356602|Triamcinolone|triamcinolone|mesh-list
154411285|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154411286|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154411287|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154411288|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154411289|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411290|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
154411291|NCT01356602|Hormones|hormones|mesh-ancestor
154411292|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411293|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411294|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154411295|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
154411296|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411297|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411298|NCT01347853|Ketorolac|ketorolac|mesh-list
154411299|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154411300|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154411301|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154411302|NCT01347853|Analgesics|analgesics|mesh-ancestor
154411303|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
154411304|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411305|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411306|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411307|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411308|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154411309|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411310|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411311|NCT01346917|Lidocaine|lidocaine|mesh-list
154411312|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
154411313|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
154411314|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411315|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411316|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
154411317|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411318|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154411319|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154411320|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154411321|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411322|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411323|NCT01348009|Cisplatin|cisplatin|mesh-list
154411324|NCT01348009|Capecitabine|capecitabine|mesh-list
154411325|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411326|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154411327|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
154411328|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411329|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
154411330|NCT01343173|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154411331|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154411332|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411333|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411334|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411336|NCT01348243|Lidocaine|lidocaine|mesh-list
154411337|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
154411338|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
154411339|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411340|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411341|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
154411342|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411343|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154411344|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154411345|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154411346|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411347|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411348|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154411350|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154411351|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
154411352|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411353|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
154411354|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
154411355|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154411356|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411357|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411358|NCT03772951|Clozapine|clozapine|mesh-list
154411359|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154411360|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
154411361|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411362|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411363|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411364|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154411365|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154411366|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411367|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154411368|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
154411369|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
154411370|NCT01343329|Propranolol|propranolol|mesh-list
154411371|NCT01343329|Esmolol|esmolol|mesh-list
154411372|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154411373|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154411374|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
154411375|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411376|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411377|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411378|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154411379|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154411380|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
154411381|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154411382|NCT01317589|Fentanyl|fentanyl|mesh-list
154411383|NCT01317589|Methadone|methadone|mesh-list
154411384|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154411385|NCT01317589|Narcotics|narcotics|mesh-ancestor
154411386|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411387|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411388|NCT01317589|Analgesics|analgesics|mesh-ancestor
154411389|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
154411390|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411391|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154411392|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154411393|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
154411394|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
154411395|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
154411396|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
154411397|NCT02825420|Trabectedin|trabectedin|mesh-list
154411398|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154411399|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
154411400|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411401|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411402|NCT02829944|Ketorolac|ketorolac|mesh-list
154411403|NCT02829944|Ropivacaine|ropivacaine|mesh-list
154411404|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
154411405|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
154411406|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411407|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411408|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
154411409|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411410|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154411411|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154411412|NCT02829944|Analgesics|analgesics|mesh-ancestor
154411413|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411414|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411415|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154411416|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411417|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411418|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
154411419|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154411420|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411421|NCT04014530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154411422|NCT04014530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411423|NCT03563534|Fluorides|fluorides|mesh-list
154411424|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
154411425|NCT03563534|Protective Agents|protective agents|mesh-ancestor
154411426|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411427|NCT03563144|Leucovorin|leucovorin|mesh-list
154411428|NCT03563144|Paclitaxel|paclitaxel|mesh-list
154411429|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
154411430|NCT03563144|Bevacizumab|bevacizumab|mesh-list
154411431|NCT03563144|Gemcitabine|gemcitabine|mesh-list
154411432|NCT03563144|Capecitabine|capecitabine|mesh-list
154411433|NCT03563144|Fluorouracil|fluorouracil|mesh-list
154411434|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
154411435|NCT03563144|Avelumab|avelumab|mesh-list
154411436|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154411437|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411438|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
154411439|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
154411440|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
154411441|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411442|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154411443|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
154411444|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411445|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411446|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154411447|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
154411448|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154411449|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154411450|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154411451|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154411452|NCT03563144|Growth Substances|growth substances|mesh-ancestor
154411453|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
154411454|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154411455|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
154411456|NCT03563144|Antidotes|antidotes|mesh-ancestor
154411457|NCT03563144|Protective Agents|protective agents|mesh-ancestor
154411458|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
154411459|NCT03563144|Vitamins|vitamins|mesh-ancestor
154411460|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
154411461|NCT01338818|Methylphenidate|methylphenidate|mesh-list
154411462|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154411463|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411464|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154411465|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154411466|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411467|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411468|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
154411469|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411470|NCT02823470|Ivacaftor|ivacaftor|mesh-list
154411471|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154411472|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411473|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411474|NCT03562754|Heparin|heparin|mesh-list
154411475|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
154411476|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411477|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154411478|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153360958|NCT01490723|Tacrolimus|tacrolimus|mesh-list
154411479|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
154411480|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
154411481|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
153986106|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
154411482|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411483|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411484|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
154411486|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154411487|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411488|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154411489|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154411490|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154411491|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411492|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411493|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411494|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154411495|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154411496|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154411497|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154411499|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
154411500|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
154411501|NCT01354964|Vitamins|vitamins|mesh-list
154411502|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
154411503|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411504|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154411505|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154411506|NCT02259998|Dipyridamole|dipyridamole|mesh-list
154411507|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154411508|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411509|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411510|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154411511|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
154411512|NCT02035904|Morphine|morphine|mesh-list
154411513|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
154411514|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154411515|NCT02035904|Narcotics|narcotics|mesh-ancestor
154411516|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411517|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411518|NCT02035904|Analgesics|analgesics|mesh-ancestor
154411519|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
154411520|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411521|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
154411522|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
154411523|NCT04110080|Anesthetics|anesthetics|mesh-list
154411524|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411525|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411526|NCT02035982|Rivastigmine|rivastigmine|mesh-list
154411527|NCT02035982|Donepezil|donepezil|mesh-list
154411528|NCT02035982|Galantamine|galantamine|mesh-list
154411529|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154411530|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411531|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411532|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
154411533|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411534|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411535|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
154411536|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154411537|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
154411538|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411539|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154411540|NCT02035982|Protective Agents|protective agents|mesh-ancestor
154411541|NCT05707832|Amphotericin B|amphotericin b|mesh-list
154411542|NCT05707832|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154411543|NCT05707832|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
154411544|NCT05707832|Amebicides|amebicides|mesh-ancestor
154411545|NCT05707832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154411546|NCT05707832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154411547|NCT05707832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411548|NCT05707832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154411549|NCT05707832|Antifungal Agents|antifungal agents|mesh-ancestor
154411550|NCT05707832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154411551|NCT05707832|Protease Inhibitors|protease inhibitors|mesh-ancestor
154411552|NCT05707832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411553|NCT05707832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411554|NCT05707832|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154411555|NCT05707832|Protective Agents|protective agents|mesh-ancestor
154411556|NCT05707832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411557|NCT05707832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986179|NCT00756847|Paclitaxel|paclitaxel|mesh-list
154411558|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
154411559|NCT02822222|Cathartics|cathartics|mesh-ancestor
154411560|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154411561|NCT02821910|Metformin|metformin|mesh-list
154411562|NCT02821910|Empagliflozin|empagliflozin|mesh-list
154411563|NCT02821910|Linagliptin|linagliptin|mesh-list
154411564|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154411565|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411566|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154254483|NCT05137574|Ketamine|ketamine|mesh-list
154411567|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411569|NCT02821910|Hormones|hormones|mesh-ancestor
154411570|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411571|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154411572|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
154411573|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411574|NCT03819452|Vitamin D|vitamin d|mesh-list
154411575|NCT03819452|Vitamins|vitamins|mesh-ancestor
154411576|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
154411577|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411578|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154411579|NCT03138655|Vedolizumab|vedolizumab|mesh-list
154411580|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154411581|NCT05707520|Mycophenolic Acid|mycophenolic acid|mesh-list
154411582|NCT05707520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154411583|NCT05707520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411584|NCT05707520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154411585|NCT05707520|Antitubercular Agents|antitubercular agents|mesh-ancestor
154411586|NCT05707520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154411587|NCT05707520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411588|NCT05707520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411589|NCT05707520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411590|NCT04412785|Cyclosporine|cyclosporine|mesh-list
154411591|NCT04412785|Cyclosporins|cyclosporins|mesh-list
154411592|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411593|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411594|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154411595|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
154411596|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411597|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
154411598|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411599|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154411600|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411601|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154411602|NCT01352611|Baclofen|baclofen|mesh-list
154411603|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154411604|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411605|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154411606|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411607|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154411608|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
154411609|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
154411610|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411611|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411612|NCT02819804|Nivolumab|nivolumab|mesh-list
154411613|NCT02819804|Dasatinib|dasatinib|mesh-list
154411614|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154411615|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411616|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154411617|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411618|NCT02819804|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154411619|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154411620|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411621|NCT02819726|Rituximab|rituximab|mesh-list
154411622|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154411623|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411624|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
154411625|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411626|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411627|NCT02816138|Nicotine|nicotine|mesh-list
154411628|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154411629|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
154411630|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986252|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411631|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411632|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154411633|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154411634|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
154411635|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411636|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411637|NCT02036060|Prednisone|prednisone|mesh-list
154411638|NCT02036060|Docetaxel|docetaxel|mesh-list
154411639|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411640|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
154411641|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
154411642|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
154411643|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411644|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411645|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
154411647|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411648|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411649|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154411650|NCT02036528|Doxycycline|doxycycline|mesh-list
154411651|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
154411652|NCT02036528|Gentamicins|gentamicins|mesh-list
154411653|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154411654|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411655|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
154411656|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154411657|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154411658|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154411659|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154411660|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411661|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411662|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411663|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154411664|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154411665|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154411666|NCT02880865|Vaccines|vaccines|mesh-list
154411667|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
154411668|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411669|NCT03635125|Metoprolol|metoprolol|mesh-list
154411670|NCT03635125|Nebivolol|nebivolol|mesh-list
154411671|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154411672|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154411673|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
154411674|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
154411675|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411676|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411677|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154411678|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154411679|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154411680|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
154411681|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411682|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411683|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
154411684|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154411685|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154411686|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154411687|NCT01854385|Sumatriptan|sumatriptan|mesh-list
154411688|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154411689|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154411690|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154411691|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
154411692|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411693|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411694|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411695|NCT02047838|Hormones|hormones|mesh-list
154411696|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153673049|NCT00049179|Immunoconjugates|immunoconjugates|mesh-ancestor
154411697|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411698|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411699|NCT01318681|Fluticasone|fluticasone|mesh-list
154411700|NCT01318681|Xhance|xhance|mesh-list
154411701|NCT01318681|Cetirizine|cetirizine|mesh-list
154411702|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411703|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154411704|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
153986327|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
154411705|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411706|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411707|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154411708|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
154411709|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
154411710|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154254484|NCT05137574|Propofol|propofol|mesh-list
154411711|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154411712|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154411713|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
154411714|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
154411715|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411716|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411718|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154411719|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154411720|NCT03604159|Narcotics|narcotics|mesh-ancestor
154411721|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411722|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411723|NCT03604159|Analgesics|analgesics|mesh-ancestor
154411724|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
154411725|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411726|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154411727|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154411728|NCT01353235|Prednisolone|prednisolone|mesh-list
153673093|NCT00049374|Oblimersen|oblimersen|mesh-list
154411729|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411730|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
154411731|NCT01353235|Hormones|hormones|mesh-ancestor
154411732|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411733|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411734|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154411735|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411736|NCT02048228|Clopidogrel|clopidogrel|mesh-list
154411737|NCT02048228|Ticagrelor|ticagrelor|mesh-list
154411738|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154411739|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154411740|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154411741|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154411742|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
154411743|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411744|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411745|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411746|NCT03046927|Vitamin D|vitamin d|mesh-list
154411747|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
154411748|NCT03046927|Vitamins|vitamins|mesh-ancestor
154411749|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
154411750|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411751|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154411752|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154411753|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
154411754|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154411755|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
154411756|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411757|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411758|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154411759|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
154411760|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154411761|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154411762|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154411763|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
154411764|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153673119|NCT00049413|Rituximab|rituximab|mesh-list
153673176|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673177|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673178|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
153673202|NCT00049569|Antidotes|antidotes|mesh-ancestor
154411765|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411766|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
154411767|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
154411768|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411769|NCT02048384|Metformin|metformin|mesh-list
154411770|NCT02048384|Sirolimus|sirolimus|mesh-list
154411771|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154411772|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411773|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154411774|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411775|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154411776|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411777|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
154411778|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154411779|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
154411780|NCT01353391|Metformin|metformin|mesh-list
153986410|NCT04085770|Vitamins|vitamins|mesh-ancestor
154411781|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154411782|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411785|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411786|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
154411787|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411788|NCT03009487|Amlodipine|amlodipine|mesh-list
154411789|NCT03009487|Olmesartan|olmesartan|mesh-list
154411790|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154411791|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
154411792|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154411793|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154411794|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154411795|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411796|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411797|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154411798|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411799|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
154411800|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154411801|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154411802|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
154411803|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154411804|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154411805|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411806|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154411807|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154411808|NCT02048540|Bevacizumab|bevacizumab|mesh-list
154411809|NCT02048540|Docetaxel|docetaxel|mesh-list
154411810|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
154411811|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154411812|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411813|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154411814|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154411815|NCT02048540|Growth Substances|growth substances|mesh-ancestor
154411816|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411817|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
154411818|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
154411819|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
154411820|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
154411821|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411822|NCT01353469|Insulin|insulin|mesh-list
154411823|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154411824|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154411825|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411826|NCT03562130|Teduglutide|teduglutide|mesh-list
153673217|NCT00022178|Epirubicin|epirubicin|mesh-list
154411827|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154411828|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154411829|NCT03562130|Protective Agents|protective agents|mesh-ancestor
154411830|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411831|NCT02050178|Paclitaxel|paclitaxel|mesh-list
154411832|NCT02050178|Gemcitabine|gemcitabine|mesh-list
154411833|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154411834|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411835|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
154411836|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
154411837|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
154411838|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411839|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154411840|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
154411841|NCT02048852|Menthol|menthol|mesh-list
154411842|NCT02048852|Nicotine|nicotine|mesh-list
154411843|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154411844|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
154411845|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411846|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411847|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154411848|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154411849|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
154411850|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411851|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254490|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
154411852|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
154411853|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154411854|NCT02048930|Budesonide|budesonide|mesh-list
154411855|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411856|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154411857|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
154411858|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411859|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411860|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154411861|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154411862|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
154411863|NCT02048930|Hormones|hormones|mesh-ancestor
154411864|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411865|NCT02049320|Remifentanil|remifentanil|mesh-list
153673266|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411866|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154411867|NCT02049320|Narcotics|narcotics|mesh-ancestor
154411868|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411869|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411870|NCT02049320|Analgesics|analgesics|mesh-ancestor
154411871|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
153673358|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673359|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673360|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
154411872|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411873|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
154411874|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154411875|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411876|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
154411877|NCT02050802|Macitentan|macitentan|mesh-list
154411878|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154411879|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411880|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154411881|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154411882|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411883|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411884|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411885|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154411886|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154411887|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154411888|NCT02051738|Mebendazole|mebendazole|mesh-list
154411889|NCT02051738|Piperazine|piperazine|mesh-list
154411890|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
154411891|NCT02051738|DMP 777|dmp 777|mesh-list
154411892|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
154411893|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
154411894|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154411895|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411896|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154411897|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154411898|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154411899|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411900|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411901|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411902|NCT02050958|Ibuprofen|ibuprofen|mesh-list
154411903|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154411904|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154411905|NCT02050958|Analgesics|analgesics|mesh-ancestor
153673361|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
153673362|NCT00050271|Vitamins|vitamins|mesh-ancestor
154411906|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
154411907|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411908|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411909|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411910|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154411911|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154411912|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411913|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411914|NCT02037464|Capsaicin|capsaicin|mesh-list
154411915|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
154411916|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
154411917|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
154411918|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411919|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411920|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
154411921|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154411922|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411923|NCT02051894|Dobutamine|dobutamine|mesh-list
154411924|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154411925|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
154411926|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
154411927|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411928|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411929|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154411930|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154411931|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154411932|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
154411933|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411934|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411935|NCT02051894|Protective Agents|protective agents|mesh-ancestor
154411936|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154411937|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
154411938|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411939|NCT01357681|Protective Agents|protective agents|mesh-ancestor
154411940|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411941|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154411942|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154411943|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411944|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154411946|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154411947|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154411948|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411949|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154411950|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
154411951|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
154411952|NCT03561740|Capecitabine|capecitabine|mesh-list
154411953|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154411954|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
154411955|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411956|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411957|NCT01357759|Gimsilumab|gimsilumab|mesh-list
154411958|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154411959|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
154411960|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154411961|NCT02052128|Onapristone|onapristone|mesh-list
154411962|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154411963|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154411964|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
154411965|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154411966|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411967|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
154411968|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154411969|NCT01349413|Esomeprazole|esomeprazole|mesh-list
154411970|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154411971|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154411972|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154411973|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154411974|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411975|NCT01349647|Vaccines|vaccines|mesh-list
154411976|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
154411977|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411978|NCT06273540|Cocaine|cocaine|mesh-list
154411979|NCT06273540|Anesthetics, Local|anesthetics, local|mesh-ancestor
154411980|NCT06273540|Anesthetics|anesthetics|mesh-ancestor
154411981|NCT06273540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153673562|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
154411982|NCT06273540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411983|NCT06273540|Sensory System Agents|sensory system agents|mesh-ancestor
154411984|NCT06273540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411985|NCT06273540|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154411986|NCT06273540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154411987|NCT06273540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154411988|NCT06273540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154411989|NCT06273540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154411990|NCT06273540|Dopamine Agents|dopamine agents|mesh-ancestor
154411991|NCT06273540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154411992|NCT06273462|Palmidrol|palmidrol|mesh-list
154411993|NCT06273462|Analgesics|analgesics|mesh-ancestor
154411994|NCT06273462|Sensory System Agents|sensory system agents|mesh-ancestor
154411995|NCT06273462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154411996|NCT06273462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154411997|NCT06273462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154411998|NCT06273462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154411999|NCT06273462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412001|NCT06273462|Antiviral Agents|antiviral agents|mesh-ancestor
154412002|NCT06273462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412003|NCT06273462|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154412004|NCT06273462|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154412005|NCT06273462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412006|NCT06273462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412007|NCT06273462|Hormones|hormones|mesh-ancestor
154412008|NCT06273462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412009|NCT06273254|Valsartan|valsartan|mesh-list
154412010|NCT06273254|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154412011|NCT06273254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154412012|NCT06273254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154412013|NCT06273254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154412014|NCT06273254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412015|NCT06273215|Midazolam|midazolam|mesh-list
154412016|NCT06273215|Dabigatran|dabigatran|mesh-list
154412017|NCT06273215|Atorvastatin|atorvastatin|mesh-list
154412018|NCT06273215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154412019|NCT06273215|Pitavastatin|pitavastatin|mesh-list
154412020|NCT06273215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154412021|NCT06273215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154412022|NCT06273215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412023|NCT06273215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412024|NCT06273215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154412025|NCT06273215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154412026|NCT06273215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154412027|NCT06273215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154412028|NCT06273215|Anesthetics, General|anesthetics, general|mesh-ancestor
154412029|NCT06273215|Anesthetics|anesthetics|mesh-ancestor
154412030|NCT06273215|GABA Modulators|gaba modulators|mesh-ancestor
154412031|NCT06273215|GABA Agents|gaba agents|mesh-ancestor
154412032|NCT06273215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412033|NCT06273215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412034|NCT06273215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154412035|NCT06273215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154412036|NCT06273215|Antimetabolites|antimetabolites|mesh-ancestor
154412037|NCT06273215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154412038|NCT06273215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154412039|NCT06273215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412040|NCT06273215|Antithrombins|antithrombins|mesh-ancestor
154412041|NCT06273215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154412042|NCT06273215|Protease Inhibitors|protease inhibitors|mesh-ancestor
154412043|NCT06273215|Anticoagulants|anticoagulants|mesh-ancestor
154412044|NCT06273176|Anesthetics|anesthetics|mesh-list
154412045|NCT06273176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412046|NCT06273176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412047|NCT06273111|Simvastatin|simvastatin|mesh-list
154412048|NCT06273111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153673640|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
154412049|NCT06273111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154412050|NCT06273111|Antimetabolites|antimetabolites|mesh-ancestor
154412051|NCT06273111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412052|NCT06273111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154412053|NCT06273111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154412054|NCT06273111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412055|NCT06273020|Cerebrolysin|cerebrolysin|mesh-list
154412056|NCT06273020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154412057|NCT06273020|Protective Agents|protective agents|mesh-ancestor
154412058|NCT06273020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412059|NCT06273020|Nootropic Agents|nootropic agents|mesh-ancestor
154412060|NCT06272916|Magnesium Sulfate|magnesium sulfate|mesh-list
154412061|NCT06272916|Aminophylline|aminophylline|mesh-list
154412062|NCT06272916|Analgesics|analgesics|mesh-ancestor
154412063|NCT06272916|Sensory System Agents|sensory system agents|mesh-ancestor
154412064|NCT06272916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412065|NCT06272916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412066|NCT06272916|Anesthetics|anesthetics|mesh-ancestor
154412067|NCT06272916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412068|NCT06272916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154412069|NCT06272916|Anticonvulsants|anticonvulsants|mesh-ancestor
154412070|NCT06272916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154412071|NCT06272916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154412072|NCT06272916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412073|NCT06272916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154412074|NCT06272916|Tocolytic Agents|tocolytic agents|mesh-ancestor
154412075|NCT06272916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154412076|NCT06272916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154412077|NCT06272916|Autonomic Agents|autonomic agents|mesh-ancestor
154412078|NCT06272916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154412079|NCT06272916|Respiratory System Agents|respiratory system agents|mesh-ancestor
154412080|NCT06272916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154412081|NCT06272916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154412082|NCT06272916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412083|NCT06272916|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154412084|NCT06272916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153673809|NCT00024323|Cisplatin|cisplatin|mesh-list
154412085|NCT06272916|Purinergic Agents|purinergic agents|mesh-ancestor
154412086|NCT06272916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412087|NCT06272916|Protective Agents|protective agents|mesh-ancestor
154412088|NCT06272903|Anesthetics|anesthetics|mesh-list
154412089|NCT06272903|Benzocaine|benzocaine|mesh-list
154412090|NCT06272903|Anesthetics, Local|anesthetics, local|mesh-list
154412091|NCT06272903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412092|NCT06272903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412093|NCT06272903|Sensory System Agents|sensory system agents|mesh-ancestor
154412094|NCT06272903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412095|NCT06272695|Volagidemab|volagidemab|mesh-list
154412096|NCT06272695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154412097|NCT06272695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412098|NCT06272500|Acetic Acid|acetic acid|mesh-list
154412099|NCT06272500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412100|NCT06272500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412101|NCT06272409|Desloratadine|desloratadine|mesh-list
154412102|NCT06272409|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154412103|NCT06272409|Cholinergic Agents|cholinergic agents|mesh-ancestor
154412104|NCT06272409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412105|NCT06272409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412106|NCT06272409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412107|NCT06272409|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154412108|NCT06272409|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154412109|NCT06272409|Histamine Antagonists|histamine antagonists|mesh-ancestor
154412110|NCT06272409|Histamine Agents|histamine agents|mesh-ancestor
154412111|NCT06272383|Dexamethasone|dexamethasone|mesh-list
154412112|NCT06272383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412113|NCT06272383|Antiemetics|antiemetics|mesh-ancestor
154412114|NCT06272383|Autonomic Agents|autonomic agents|mesh-ancestor
154412115|NCT06272383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412116|NCT06272383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412117|NCT06272383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154412118|NCT06272383|Glucocorticoids|glucocorticoids|mesh-ancestor
154412119|NCT06272383|Hormones|hormones|mesh-ancestor
154412120|NCT06272383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412121|NCT06272383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154412122|NCT06272383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412123|NCT06272370|Azithromycin|azithromycin|mesh-list
154412124|NCT06272370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412125|NCT06272370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412126|NCT06272357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154412127|NCT06272227|Denosumab|denosumab|mesh-list
154412128|NCT06272227|Alfacalcidol|alfacalcidol|mesh-list
154412129|NCT06272227|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154412130|NCT06272227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154412131|NCT06272227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412132|NCT06272227|Vitamins|vitamins|mesh-ancestor
154412133|NCT06272227|Micronutrients|micronutrients|mesh-ancestor
154412134|NCT06272032|Leukotriene Antagonists|leukotriene antagonists|mesh-list
154412135|NCT06272032|Histamine Antagonists|histamine antagonists|mesh-list
154412136|NCT06272032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154412137|NCT06272032|Histamine Agents|histamine agents|mesh-ancestor
154412138|NCT06272032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412139|NCT06272032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412140|NCT06272032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412141|NCT06272032|Hormone Antagonists|hormone antagonists|mesh-ancestor
154412142|NCT06272032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412143|NCT06272032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154412144|NCT06272032|Respiratory System Agents|respiratory system agents|mesh-ancestor
154412145|NCT06271837|Trastuzumab|trastuzumab|mesh-list
154412146|NCT06271837|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154412147|NCT06271837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412148|NCT06271837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412149|NCT06271837|Immunoconjugates|immunoconjugates|mesh-ancestor
154412150|NCT06271837|Immunologic Factors|immunologic factors|mesh-ancestor
154412151|NCT06271837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412152|NCT06271772|Moxifloxacin|moxifloxacin|mesh-list
154412153|NCT06271772|Difluprednate|difluprednate|mesh-list
154412154|NCT06271772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412155|NCT06271772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412156|NCT06271772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154412157|NCT06271772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154412158|NCT06271772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412159|NCT06271772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412160|NCT06271772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412161|NCT06271772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412162|NCT06271772|Glucocorticoids|glucocorticoids|mesh-ancestor
154412164|NCT06271772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412165|NCT06271707|Bupivacaine|bupivacaine|mesh-list
154412166|NCT06271707|Anesthetics, Local|anesthetics, local|mesh-ancestor
154412167|NCT06271707|Anesthetics|anesthetics|mesh-ancestor
154412168|NCT06271707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412169|NCT06271707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412170|NCT06271707|Sensory System Agents|sensory system agents|mesh-ancestor
154412171|NCT06271707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412172|NCT06271681|Vaccines|vaccines|mesh-list
154412173|NCT06271681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154412174|NCT06271681|Immunologic Factors|immunologic factors|mesh-ancestor
154412175|NCT06271681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412176|NCT06271590|Sirolimus|sirolimus|mesh-list
154412177|NCT06271590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412178|NCT06271590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412179|NCT06271590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154412180|NCT06271590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412181|NCT06271590|Antifungal Agents|antifungal agents|mesh-ancestor
154412182|NCT06271590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154412183|NCT06271590|Immunologic Factors|immunologic factors|mesh-ancestor
154412184|NCT06271590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412185|NCT06271564|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154412186|NCT06271564|Hematinics|hematinics|mesh-ancestor
154412187|NCT06271564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154412188|NCT06271564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154412189|NCT06269770|Tramadol|tramadol|mesh-list
154412190|NCT06269770|Tapentadol|tapentadol|mesh-list
154412191|NCT06269770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154412192|NCT06269770|Narcotics|narcotics|mesh-ancestor
154412193|NCT06269770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412194|NCT06269770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412195|NCT06269770|Analgesics|analgesics|mesh-ancestor
154412196|NCT06269770|Sensory System Agents|sensory system agents|mesh-ancestor
154412197|NCT06269770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412198|NCT06269770|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154412199|NCT06269770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154412200|NCT06269770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154412201|NCT06269770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412202|NCT06269770|Adrenergic Agents|adrenergic agents|mesh-ancestor
154412203|NCT06269770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412204|NCT06268015|Leucovorin|leucovorin|mesh-list
154412205|NCT06268015|Bevacizumab|bevacizumab|mesh-list
154412206|NCT06268015|Panitumumab|panitumumab|mesh-list
154412207|NCT06268015|Fluorouracil|fluorouracil|mesh-list
154412208|NCT06268015|Oxaliplatin|oxaliplatin|mesh-list
154412209|NCT06268015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412210|NCT06268015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412211|NCT06268015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154412212|NCT06268015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154412213|NCT06268015|Growth Substances|growth substances|mesh-ancestor
154412214|NCT06268015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412215|NCT06268015|Growth Inhibitors|growth inhibitors|mesh-ancestor
154412216|NCT06268015|Antimetabolites|antimetabolites|mesh-ancestor
154412217|NCT06268015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412218|NCT06268015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154412219|NCT06268015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154412220|NCT06268015|Immunologic Factors|immunologic factors|mesh-ancestor
154412221|NCT06268015|Antidotes|antidotes|mesh-ancestor
154412222|NCT06268015|Protective Agents|protective agents|mesh-ancestor
154412223|NCT06268015|Vitamin B Complex|vitamin b complex|mesh-ancestor
154412224|NCT06268015|Vitamins|vitamins|mesh-ancestor
154412225|NCT06268015|Micronutrients|micronutrients|mesh-ancestor
154412226|NCT06264596|Epinephrine|epinephrine|mesh-list
154412227|NCT06264596|Racepinephrine|racepinephrine|mesh-list
154412228|NCT06264596|Epinephryl borate|epinephryl borate|mesh-list
154412229|NCT06264596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154412230|NCT06264596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154412231|NCT06264596|Adrenergic Agents|adrenergic agents|mesh-ancestor
154412232|NCT06264596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412233|NCT06264596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412234|NCT06264596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412235|NCT06264596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154412236|NCT06264596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154412237|NCT06264596|Autonomic Agents|autonomic agents|mesh-ancestor
154412238|NCT06264596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412239|NCT06264596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154412240|NCT06264596|Respiratory System Agents|respiratory system agents|mesh-ancestor
154412241|NCT06264596|Mydriatics|mydriatics|mesh-ancestor
154412242|NCT06264596|Sympathomimetics|sympathomimetics|mesh-ancestor
154412243|NCT06264596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154412244|NCT06264531|Bevacizumab|bevacizumab|mesh-list
154412245|NCT06264531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412246|NCT06264531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511061|NCT01404689|Analgesics|analgesics|mesh-ancestor
154412247|NCT06264531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154412248|NCT06264531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154412249|NCT06264531|Growth Substances|growth substances|mesh-ancestor
154412250|NCT06264531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412251|NCT06264531|Growth Inhibitors|growth inhibitors|mesh-ancestor
154412252|NCT06258811|Paclitaxel|paclitaxel|mesh-list
154412253|NCT06258811|Tislelizumab|tislelizumab|mesh-list
154412254|NCT06258811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154412255|NCT06258811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412256|NCT06258811|Tubulin Modulators|tubulin modulators|mesh-ancestor
154412257|NCT06258811|Antimitotic Agents|antimitotic agents|mesh-ancestor
154412258|NCT06258811|Mitosis Modulators|mitosis modulators|mesh-ancestor
154412259|NCT06258811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412260|NCT06258811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412261|NCT06249048|Pembrolizumab|pembrolizumab|mesh-list
154412262|NCT06249048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412263|NCT06249048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412264|NCT06249048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154412265|NCT06249048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412266|NCT06248515|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154412267|NCT06248515|Immunoconjugates|immunoconjugates|mesh-ancestor
154412268|NCT06248515|Immunologic Factors|immunologic factors|mesh-ancestor
154412269|NCT06248515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412270|NCT06241560|Pirfenidone|pirfenidone|mesh-list
154412271|NCT06241560|Analgesics|analgesics|mesh-ancestor
154412272|NCT06241560|Sensory System Agents|sensory system agents|mesh-ancestor
154412273|NCT06241560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412274|NCT06241560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674219|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412275|NCT06241560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154412276|NCT06241560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154412277|NCT06241560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412278|NCT06241560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154412279|NCT06241560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412280|NCT06228560|Omalizumab|omalizumab|mesh-list
154412281|NCT06228560|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154412282|NCT06228560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154412283|NCT06228560|Respiratory System Agents|respiratory system agents|mesh-ancestor
154412284|NCT06178588|Camptothecin|camptothecin|mesh-list
154412285|NCT06178588|Irinotecan|irinotecan|mesh-list
154412286|NCT06178588|Immunoconjugates|immunoconjugates|mesh-list
154412287|NCT06178588|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154412288|NCT06178588|Immunologic Factors|immunologic factors|mesh-ancestor
154412289|NCT06178588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254502|NCT04971746|Pirfenidone|pirfenidone|mesh-list
154412290|NCT06178588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154412292|NCT06178588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154412293|NCT06178588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154412294|NCT06178588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412295|NCT06178588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412296|NCT06157151|Pembrolizumab|pembrolizumab|mesh-list
154412297|NCT06157151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412298|NCT06157151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412299|NCT06157151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154412300|NCT06157151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412301|NCT06157008|Anesthetics|anesthetics|mesh-list
154412302|NCT06157008|Anesthetics, General|anesthetics, general|mesh-list
154412303|NCT06157008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412304|NCT06157008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412305|NCT06136897|Trastuzumab|trastuzumab|mesh-list
154412306|NCT06136897|Pertuzumab|pertuzumab|mesh-list
154412307|NCT06136897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154412308|NCT06136897|Antibodies|antibodies|mesh-list
154412309|NCT06136897|Immunoglobulins|immunoglobulins|mesh-list
154412310|NCT06136897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154412311|NCT06136897|Immunologic Factors|immunologic factors|mesh-ancestor
154412312|NCT06136897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412313|NCT06136897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412314|NCT06136897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412315|NCT06134466|Caseins|caseins|mesh-list
154412316|NCT06134466|Chelating Agents|chelating agents|mesh-ancestor
154412317|NCT06134466|Sequestering Agents|sequestering agents|mesh-ancestor
154412318|NCT06134466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412319|NCT06078501|Misoprostol|misoprostol|mesh-list
154412320|NCT06078501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154412321|NCT06078501|Abortifacient Agents|abortifacient agents|mesh-ancestor
154412322|NCT06078501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154412323|NCT06078501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412324|NCT06078501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154412325|NCT06078501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154412326|NCT06078501|Oxytocics|oxytocics|mesh-ancestor
154412327|NCT06061809|Bevacizumab|bevacizumab|mesh-list
154412328|NCT06061809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412329|NCT06061809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412330|NCT06061809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154412331|NCT06061809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154412332|NCT06061809|Growth Substances|growth substances|mesh-ancestor
154412333|NCT06061809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412334|NCT06061809|Growth Inhibitors|growth inhibitors|mesh-ancestor
154412335|NCT06049589|Chlorhexidine|chlorhexidine|mesh-list
154412336|NCT06049589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154412337|NCT06049589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412338|NCT06049589|Disinfectants|disinfectants|mesh-ancestor
154412339|NCT06047171|Cyclophosphamide|cyclophosphamide|mesh-list
154412340|NCT06047171|Rituximab|rituximab|mesh-list
154412341|NCT06047171|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154412342|NCT06047171|Glucocorticoids|glucocorticoids|mesh-list
154412343|NCT06047171|Immunologic Factors|immunologic factors|mesh-ancestor
154412344|NCT06047171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412345|NCT06047171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154412346|NCT06047171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154412347|NCT06047171|Alkylating Agents|alkylating agents|mesh-ancestor
154412348|NCT06047171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412349|NCT06047171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412350|NCT06047171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154412351|NCT06047171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412352|NCT06047171|Hormones|hormones|mesh-ancestor
154412353|NCT06047171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412354|NCT06040190|Thioctic Acid|thioctic acid|mesh-list
154412355|NCT06040190|Clonazepam|clonazepam|mesh-list
154412356|NCT06040190|Capsaicin|capsaicin|mesh-list
154412357|NCT06040190|Antipruritics|antipruritics|mesh-ancestor
154412358|NCT06040190|Dermatologic Agents|dermatologic agents|mesh-ancestor
154412359|NCT06040190|Sensory System Agents|sensory system agents|mesh-ancestor
154412360|NCT06040190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412361|NCT06040190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412362|NCT06040190|Antioxidants|antioxidants|mesh-ancestor
154254503|NCT04971746|Nintedanib|nintedanib|mesh-list
154412363|NCT06040190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412364|NCT06040190|Protective Agents|protective agents|mesh-ancestor
154412365|NCT06040190|Vitamin B Complex|vitamin b complex|mesh-ancestor
154412366|NCT06040190|Vitamins|vitamins|mesh-ancestor
154412367|NCT06040190|Micronutrients|micronutrients|mesh-ancestor
154412368|NCT06040190|Anticonvulsants|anticonvulsants|mesh-ancestor
154412369|NCT06040190|GABA Modulators|gaba modulators|mesh-ancestor
154412370|NCT06040190|GABA Agents|gaba agents|mesh-ancestor
154412371|NCT06040190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412372|NCT06025097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154412373|NCT06025097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412374|NCT06025097|Glucocorticoids|glucocorticoids|mesh-ancestor
154412375|NCT06025097|Hormones|hormones|mesh-ancestor
154412376|NCT06025097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412377|NCT06025097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412378|NCT06025097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154412379|NCT06025097|Protective Agents|protective agents|mesh-ancestor
154412380|NCT06025097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154412381|NCT06025097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412382|NCT06016634|Alendronate|alendronate|mesh-list
154412383|NCT06016634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154412384|NCT06016634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412385|NCT06011265|Mirabegron|mirabegron|mesh-list
154412386|NCT06011265|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154412387|NCT06011265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154412388|NCT06011265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154412389|NCT06011265|Adrenergic Agents|adrenergic agents|mesh-ancestor
154412390|NCT06011265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412391|NCT06011265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412392|NCT06011265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412393|NCT06011265|Urological Agents|urological agents|mesh-ancestor
154412394|NCT05997693|Ticagrelor|ticagrelor|mesh-list
154412395|NCT05997693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154412396|NCT05997693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154412397|NCT05997693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154412398|NCT05997693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154412399|NCT05997693|Purinergic Agents|purinergic agents|mesh-ancestor
154412400|NCT05997693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412401|NCT05997693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412402|NCT05997693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412403|NCT05995353|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154412404|NCT05995353|Immunologic Factors|immunologic factors|mesh-ancestor
154412405|NCT05995353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412406|NCT05981131|BCG Vaccine|bcg vaccine|mesh-list
154412407|NCT05981131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154412408|NCT05981131|Immunologic Factors|immunologic factors|mesh-ancestor
154412409|NCT05981131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412410|NCT05957510|Carboplatin|carboplatin|mesh-list
154412411|NCT05957510|Etoposide|etoposide|mesh-list
154412412|NCT05957510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412413|NCT05957510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154412414|NCT05957510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154412415|NCT05957510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154412416|NCT05957510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412417|NCT05957510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412418|NCT05945147|Midazolam|midazolam|mesh-list
154412419|NCT05945147|Ketamine|ketamine|mesh-list
154412420|NCT05945147|Analgesics|analgesics|mesh-ancestor
154412421|NCT05945147|Sensory System Agents|sensory system agents|mesh-ancestor
154412422|NCT05945147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412423|NCT05945147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412424|NCT05945147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154412425|NCT05945147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154412426|NCT05945147|Anesthetics, General|anesthetics, general|mesh-ancestor
154412427|NCT05945147|Anesthetics|anesthetics|mesh-ancestor
154412428|NCT05945147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412429|NCT05945147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154412430|NCT05945147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154412431|NCT05945147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412432|NCT05945147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254506|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412433|NCT05945147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154412434|NCT05945147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154412435|NCT05945147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154412436|NCT05945147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154412437|NCT05945147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154412438|NCT05945147|GABA Modulators|gaba modulators|mesh-ancestor
154412439|NCT05945147|GABA Agents|gaba agents|mesh-ancestor
154412440|NCT05944952|Buprenorphine|buprenorphine|mesh-list
154412441|NCT05944952|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154412442|NCT05944952|Naloxone|naloxone|mesh-list
154412443|NCT05944952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154412444|NCT05944952|Narcotics|narcotics|mesh-ancestor
154412445|NCT05944952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412446|NCT05944952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412447|NCT05944952|Analgesics|analgesics|mesh-ancestor
154412448|NCT05944952|Sensory System Agents|sensory system agents|mesh-ancestor
154412449|NCT05944952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412450|NCT05944952|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154412451|NCT05936203|Insulin|insulin|mesh-list
154412452|NCT05936203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154412453|NCT05936203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412454|NCT05933057|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154412455|NCT05933057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154412456|NCT05933057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412457|NCT05933057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412458|NCT05896800|Nitric Oxide|nitric oxide|mesh-list
154412459|NCT05896800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154412460|NCT05896800|Autonomic Agents|autonomic agents|mesh-ancestor
154412461|NCT05896800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412462|NCT05896800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412463|NCT05896800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154412464|NCT05896800|Respiratory System Agents|respiratory system agents|mesh-ancestor
154412465|NCT05896800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154412466|NCT05896800|Antioxidants|antioxidants|mesh-ancestor
153674622|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412467|NCT05896800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412468|NCT05896800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412469|NCT05896800|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154412470|NCT05896800|Vasodilator Agents|vasodilator agents|mesh-ancestor
154412471|NCT05896800|Gasotransmitters|gasotransmitters|mesh-ancestor
154412472|NCT05896800|Protective Agents|protective agents|mesh-ancestor
154412473|NCT05896384|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154412474|NCT05896384|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154412475|NCT05896384|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154412476|NCT05896384|Contraceptive Agents|contraceptive agents|mesh-ancestor
154412477|NCT05896384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154412478|NCT05896384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412479|NCT05896384|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154412480|NCT05896384|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154412481|NCT05896384|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154412482|NCT05896384|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154412483|NCT05896384|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154412484|NCT05896384|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154412485|NCT05896384|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154412486|NCT05896384|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154412487|NCT05848687|Dexamethasone|dexamethasone|mesh-list
154412488|NCT05848687|Methotrexate|methotrexate|mesh-list
154412489|NCT05848687|Bortezomib|bortezomib|mesh-list
154412490|NCT05848687|Asparaginase|asparaginase|mesh-list
154412491|NCT05848687|Mercaptopurine|mercaptopurine|mesh-list
154412492|NCT05848687|Mitoxantrone|mitoxantrone|mesh-list
154412493|NCT05848687|Vorinostat|vorinostat|mesh-list
154412494|NCT05848687|Blinatumomab|blinatumomab|mesh-list
154412495|NCT05848687|Pegaspargase|pegaspargase|mesh-list
154412496|NCT05848687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412497|NCT05848687|Antiemetics|antiemetics|mesh-ancestor
154412498|NCT05848687|Autonomic Agents|autonomic agents|mesh-ancestor
154412499|NCT05848687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412500|NCT05848687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412501|NCT05848687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154412502|NCT05848687|Glucocorticoids|glucocorticoids|mesh-ancestor
154412503|NCT05848687|Hormones|hormones|mesh-ancestor
154412504|NCT05848687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412505|NCT05848687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154412506|NCT05848687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412507|NCT05848687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154412508|NCT05848687|Abortifacient Agents|abortifacient agents|mesh-ancestor
154412509|NCT05848687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154412510|NCT05848687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154412511|NCT05848687|Antimetabolites|antimetabolites|mesh-ancestor
154412512|NCT05848687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412513|NCT05848687|Dermatologic Agents|dermatologic agents|mesh-ancestor
154412514|NCT05848687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412515|NCT05848687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154412516|NCT05848687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154412517|NCT05848687|Immunologic Factors|immunologic factors|mesh-ancestor
154412518|NCT05848687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154412519|NCT05848687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154412520|NCT05848687|Analgesics|analgesics|mesh-ancestor
153774264|NCT00219011|Aliskiren|aliskiren|mesh-list
154412521|NCT05848687|Sensory System Agents|sensory system agents|mesh-ancestor
154412522|NCT05848687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154412523|NCT05848687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154412524|NCT05848687|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154412525|NCT05827081|Letrozole|letrozole|mesh-list
154412526|NCT05827081|Leuprolide|leuprolide|mesh-list
154412527|NCT05827081|Exemestane|exemestane|mesh-list
154412528|NCT05827081|Goserelin|goserelin|mesh-list
154412529|NCT05827081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412530|NCT05827081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154412531|NCT05827081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154412532|NCT05827081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412533|NCT05827081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412534|NCT05827081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154412535|NCT05827081|Hormone Antagonists|hormone antagonists|mesh-ancestor
154412536|NCT05827081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412537|NCT05827081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412538|NCT05827081|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154412539|NCT05827081|Fertility Agents|fertility agents|mesh-ancestor
154412540|NCT05827081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154412541|NCT05827081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154412542|NCT05815927|Pembrolizumab|pembrolizumab|mesh-list
154412543|NCT05815927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412544|NCT05815927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412545|NCT05815927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154412546|NCT05815927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412547|NCT05814432|Amphotericin B|amphotericin b|mesh-list
154412548|NCT05814432|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154412549|NCT05814432|Amebicides|amebicides|mesh-ancestor
154412550|NCT05814432|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154412551|NCT05814432|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154412552|NCT05814432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412553|NCT05814432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412554|NCT05814432|Antifungal Agents|antifungal agents|mesh-ancestor
154412555|NCT05785429|Colchicine|colchicine|mesh-list
154412556|NCT05785429|Gout Suppressants|gout suppressants|mesh-ancestor
154412557|NCT05785429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154412558|NCT05785429|Tubulin Modulators|tubulin modulators|mesh-ancestor
154412559|NCT05785429|Antimitotic Agents|antimitotic agents|mesh-ancestor
154412560|NCT05785429|Mitosis Modulators|mitosis modulators|mesh-ancestor
154412561|NCT05785429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412562|NCT05785429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412563|NCT05757557|Nitric Oxide|nitric oxide|mesh-list
154412564|NCT05757557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154412565|NCT05757557|Autonomic Agents|autonomic agents|mesh-ancestor
154412566|NCT05757557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412567|NCT05757557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412568|NCT05757557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154412569|NCT05757557|Respiratory System Agents|respiratory system agents|mesh-ancestor
154412570|NCT05757557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154412571|NCT05757557|Antioxidants|antioxidants|mesh-ancestor
154412572|NCT05757557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412573|NCT05757557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412574|NCT05757557|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154412575|NCT05757557|Vasodilator Agents|vasodilator agents|mesh-ancestor
154412576|NCT05757557|Gasotransmitters|gasotransmitters|mesh-ancestor
154412577|NCT05757557|Protective Agents|protective agents|mesh-ancestor
154412578|NCT05727969|Dexmedetomidine|dexmedetomidine|mesh-list
154412579|NCT05727969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154412580|NCT05727969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412581|NCT05727969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412582|NCT05727969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154412584|NCT05727969|Sensory System Agents|sensory system agents|mesh-ancestor
153674890|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
154412585|NCT05727969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412586|NCT05727969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154412587|NCT05727969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154412588|NCT05727969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154412589|NCT05727969|Adrenergic Agents|adrenergic agents|mesh-ancestor
154412590|NCT05727969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412591|NCT05727969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412592|NCT05704166|Pirfenidone|pirfenidone|mesh-list
154412593|NCT05704166|Analgesics|analgesics|mesh-ancestor
154412594|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
154412595|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412596|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412597|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154412598|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154412599|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412600|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154412601|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412602|NCT05703373|Micronutrients|micronutrients|mesh-list
154412603|NCT05703373|Trace Elements|trace elements|mesh-list
154412604|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412606|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154412607|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
154412608|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154412609|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154412610|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412611|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154412612|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154412613|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154412614|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412615|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154412616|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154412617|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154412618|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
154412619|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412620|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412621|NCT05668949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154412622|NCT05668949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412623|NCT05659368|Tirzepatide|tirzepatide|mesh-list
154412624|NCT05659368|Incretins|incretins|mesh-ancestor
154412625|NCT05659368|Hormones|hormones|mesh-ancestor
154412626|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412627|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412628|NCT05649956|Letrozole|letrozole|mesh-list
154412629|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412630|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154412631|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154412632|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412633|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412634|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154412635|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
154412636|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412637|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412638|NCT05644184|Vaccines|vaccines|mesh-list
154412639|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
154412640|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412641|NCT05615636|Lenalidomide|lenalidomide|mesh-list
154412642|NCT05615636|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154412643|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
154412644|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412645|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154412646|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154412647|NCT05615636|Growth Substances|growth substances|mesh-ancestor
154412648|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
154412649|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412650|NCT05615636|Immunoconjugates|immunoconjugates|mesh-ancestor
154412651|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
154412652|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412653|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412654|NCT05614739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154412655|NCT05614739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412656|NCT05605899|Prednisone|prednisone|mesh-list
154412657|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
154412658|NCT05605899|Rituximab|rituximab|mesh-list
154412659|NCT05605899|Doxorubicin|doxorubicin|mesh-list
154412660|NCT05605899|Fludarabine|fludarabine|mesh-list
154412661|NCT05605899|Etoposide|etoposide|mesh-list
154412662|NCT05605899|Vincristine|vincristine|mesh-list
154412663|NCT05605899|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154412664|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154412665|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
154412666|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412667|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154412668|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154412669|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
154412670|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412671|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412672|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154412673|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412674|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154412675|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154412676|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154412677|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412678|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412679|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
154412681|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412682|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154412683|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154412684|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
154412685|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
154412686|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
154412687|NCT05601440|Gemcitabine|gemcitabine|mesh-list
154412688|NCT05601440|Fulvestrant|fulvestrant|mesh-list
154412689|NCT05601440|Niraparib|niraparib|mesh-list
154412690|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154412691|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
154412692|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412693|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412694|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154412695|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154412696|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154412697|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
154412698|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412699|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412700|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154412701|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412702|NCT05590923|Dexamethasone|dexamethasone|mesh-list
154412703|NCT05590923|Olanzapine|olanzapine|mesh-list
154412704|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412705|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
154412706|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
154412707|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412708|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412709|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154412710|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
154412711|NCT05590923|Hormones|hormones|mesh-ancestor
154412712|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412713|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154412714|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412715|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154412716|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154412717|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412718|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154412719|NCT05590923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154412720|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154412721|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675087|NCT00028886|Thalidomide|thalidomide|mesh-list
154412722|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412723|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412724|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
154412725|NCT05562466|Budesonide|budesonide|mesh-list
154412726|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412727|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154412728|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
154412729|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412730|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412731|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154412732|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
154412733|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
154412734|NCT05562466|Hormones|hormones|mesh-ancestor
154412735|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412736|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154412737|NCT05561673|Vaccines|vaccines|mesh-list
154412738|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
154412739|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412740|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154412741|NCT05561673|Antacids|antacids|mesh-ancestor
154412742|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412743|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154412744|NCT05553834|Cemiplimab|cemiplimab|mesh-list
154412745|NCT05553834|Alirocumab|alirocumab|mesh-list
154412746|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412747|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412748|NCT05553834|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154412749|NCT05553834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153744975|NCT02916121|Folic Acid|folic acid|mesh-list
154412750|NCT05553834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154412751|NCT05553834|Antimetabolites|antimetabolites|mesh-ancestor
154412752|NCT05553834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412753|NCT05553834|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154412754|NCT05553834|Protease Inhibitors|protease inhibitors|mesh-ancestor
154412755|NCT05553834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412756|NCT05553834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154412757|NCT05521880|Oritavancin|oritavancin|mesh-list
154412758|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412759|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412760|NCT05519254|Lactoferrin|lactoferrin|mesh-list
154412761|NCT05519254|Muramidase|muramidase|mesh-list
154412762|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412763|NCT05513625|Pritelivir|pritelivir|mesh-list
154412764|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
154412765|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412766|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412767|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412768|NCT05502237|Paclitaxel|paclitaxel|mesh-list
154412769|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154412770|NCT05502237|Carboplatin|carboplatin|mesh-list
154412771|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
154412772|NCT05502237|Pemetrexed|pemetrexed|mesh-list
154412773|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154412774|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412775|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
154412776|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
154412777|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
154412778|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412779|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412780|NCT05502237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154412781|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412782|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154412783|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154412784|NCT05486416|Propofol|propofol|mesh-list
154412785|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154412786|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154412787|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412788|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154412789|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
154412790|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
154412791|NCT05480800|Vaccines|vaccines|mesh-list
154412792|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
154412793|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412794|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
154412795|NCT05476770|Cytarabine|cytarabine|mesh-list
154412796|NCT05476770|Dexamethasone|dexamethasone|mesh-list
154412797|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
154412798|NCT05476770|Methotrexate|methotrexate|mesh-list
154412799|NCT05476770|Fludarabine|fludarabine|mesh-list
154412800|NCT05476770|Vincristine|vincristine|mesh-list
154412801|NCT05476770|Azacitidine|azacitidine|mesh-list
154412802|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412803|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
154412804|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
154412805|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412806|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412807|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154412808|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
154412809|NCT05476770|Hormones|hormones|mesh-ancestor
154412810|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412811|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154412812|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412813|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154412814|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
154412815|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154412816|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154412817|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
154412818|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412819|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
154412820|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412821|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154412822|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154412823|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
153987434|NCT05857085|Semaglutide|semaglutide|mesh-list
154412824|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154412825|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154412826|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
154412827|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412828|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154412829|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
154412830|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
154412831|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
154412832|NCT05461131|Azithromycin|azithromycin|mesh-list
154412833|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412834|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412835|NCT05449171|Vitamin D|vitamin d|mesh-list
154412836|NCT05449171|Vitamins|vitamins|mesh-list
154412837|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
154412838|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
154412839|NCT05449171|Pyridoxal|pyridoxal|mesh-list
154412840|NCT05449171|Pyridoxine|pyridoxine|mesh-list
154412841|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
154412842|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
154412843|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412844|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154412845|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154412846|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
154412847|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
154412848|NCT05449171|Protective Agents|protective agents|mesh-ancestor
154412849|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
154412850|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
154412851|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412852|NCT05384951|Vitamin D|vitamin d|mesh-list
154412853|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
154412854|NCT05384951|Vitamins|vitamins|mesh-ancestor
154412855|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
154412856|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412857|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154412858|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154412859|NCT05382091|Naltrexone|naltrexone|mesh-list
154412860|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154412861|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154412862|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412863|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
154412864|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412865|NCT05381948|Aflibercept|aflibercept|mesh-list
154412866|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154412867|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154412868|NCT05381948|Growth Substances|growth substances|mesh-ancestor
154412869|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412870|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
154412871|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412872|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154412873|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154412874|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
154412876|NCT05358886|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154412877|NCT05358886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154412878|NCT05358886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412879|NCT05358886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412880|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
154412881|NCT05352672|Cemiplimab|cemiplimab|mesh-list
154412882|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412883|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412884|NCT05352672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154412885|NCT05352672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412886|NCT05316935|Letrozole|letrozole|mesh-list
154412887|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154412888|NCT05316935|Cyproterone|cyproterone|mesh-list
154412889|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
154412890|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412891|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154412892|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154412893|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412894|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412895|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154412896|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
154412897|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154412898|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412899|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153987508|NCT05733715|Pembrolizumab|pembrolizumab|mesh-list
154412900|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154412901|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154412902|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
154412903|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154412904|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154412905|NCT05316935|Estrogens|estrogens|mesh-ancestor
154412907|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
154412908|NCT05312645|Diclofenac|diclofenac|mesh-list
154412909|NCT05312645|Petrolatum|petrolatum|mesh-list
154412910|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154412911|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154412912|NCT05312645|Analgesics|analgesics|mesh-ancestor
154412913|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
154412914|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412915|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412916|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412917|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154412918|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154412919|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412920|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412921|NCT05312645|Emollients|emollients|mesh-ancestor
154412922|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
154412923|NCT05306041|Inavolisib|inavolisib|mesh-list
154412924|NCT05306041|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154412925|NCT05306041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412926|NCT05306041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412927|NCT05289193|Nivolumab|nivolumab|mesh-list
154412928|NCT05289193|Ipilimumab|ipilimumab|mesh-list
154412929|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412930|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154254517|NCT00369161|Tacrolimus|tacrolimus|mesh-list
154412931|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154412932|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412933|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
154412934|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
154412935|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412936|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154412937|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154412938|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412939|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
154412940|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
154412941|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154412942|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412943|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
154412944|NCT05265325|Darbepoetin alfa|darbepoetin alfa|mesh-list
154412945|NCT05265325|Hematinics|hematinics|mesh-ancestor
154412946|NCT05257629|Nicotine|nicotine|mesh-list
154412947|NCT05257629|Varenicline|varenicline|mesh-list
154412948|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154412949|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
154412950|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154412951|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412952|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154412953|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154412954|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
154412955|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154412956|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412957|NCT05234112|Acetic Acid|acetic acid|mesh-list
154412958|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154412959|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412960|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154412961|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154412962|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412963|NCT05205577|Iodine|iodine|mesh-list
154412964|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154412965|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154412966|NCT05205577|Trace Elements|trace elements|mesh-ancestor
154412967|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
154412968|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412969|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154412970|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154412971|NCT05192798|Paclitaxel|paclitaxel|mesh-list
154412972|NCT05192798|Bevacizumab|bevacizumab|mesh-list
154412973|NCT05192798|Apatinib|apatinib|mesh-list
154412974|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154412975|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154412976|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154412977|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
154412978|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
154412979|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
154412980|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154412981|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154412982|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154412983|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154412984|NCT05192798|Growth Substances|growth substances|mesh-ancestor
154412985|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154412986|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
154412987|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154412988|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154412989|NCT05191706|Dexamethasone|dexamethasone|mesh-list
154412990|NCT05191706|Prednisolone|prednisolone|mesh-list
154412991|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154412992|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
154412993|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154412994|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
154412995|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154412996|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
154412997|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154412998|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
154412999|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
154413000|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413001|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413002|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154413003|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
154413004|NCT05191706|Hormones|hormones|mesh-ancestor
154254535|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
154413005|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413006|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413007|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413008|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154413009|NCT05191706|Protective Agents|protective agents|mesh-ancestor
154413010|NCT05180097|Dexamethasone|dexamethasone|mesh-list
154413011|NCT05180097|Gemcitabine|gemcitabine|mesh-list
154413012|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
154413013|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154413014|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413015|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413016|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
154413017|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
154413018|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413019|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413020|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154413021|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
154413022|NCT05180097|Hormones|hormones|mesh-ancestor
154413023|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413024|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413025|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413026|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
154413027|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413028|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413029|NCT05180097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413030|NCT05180097|Immunotoxins|immunotoxins|mesh-ancestor
154413031|NCT05180097|Immunoconjugates|immunoconjugates|mesh-ancestor
154413032|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
154413033|NCT05178043|Nivolumab|nivolumab|mesh-list
154413034|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413035|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413036|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413037|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413038|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
154413039|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154413040|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
154413041|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154413042|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413043|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154413044|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154413045|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154413046|NCT05163808|BPN14770|bpn14770|mesh-list
154413047|NCT05163808|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154413048|NCT05163808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154413049|NCT05163808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413050|NCT05163808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413051|NCT05155293|Aflibercept|aflibercept|mesh-list
154413052|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154413053|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154413054|NCT05155293|Growth Substances|growth substances|mesh-ancestor
154413055|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413056|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
154413057|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413059|NCT05089630|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
154413060|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
154413061|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413062|NCT05089630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154413063|NCT05084508|Vaccines|vaccines|mesh-list
154413064|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154413065|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
154413066|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413067|NCT05075603|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154413068|NCT05075603|Tisagenlecleucel|tisagenlecleucel|mesh-list
154413069|NCT05075603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413070|NCT05075603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413071|NCT05074810|Sotorasib|sotorasib|mesh-list
154413072|NCT05074810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413073|NCT05074810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413074|NCT05074810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413075|NCT05074810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413076|NCT05073003|Vaccines|vaccines|mesh-list
154413077|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
154413078|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413079|NCT05053087|Ropivacaine|ropivacaine|mesh-list
154413080|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
154413081|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
154413082|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154413083|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413084|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
154413085|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413086|NCT05049057|Erenumab|erenumab|mesh-list
154413087|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154413088|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413089|NCT05049057|Analgesics|analgesics|mesh-ancestor
154413090|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
154413091|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413092|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413093|NCT05039281|Atezolizumab|atezolizumab|mesh-list
154413094|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154413095|NCT05039281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413096|NCT05039281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413097|NCT05039281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413098|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413099|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
154413100|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413101|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
154413102|NCT05005182|Luspatercept|luspatercept|mesh-list
154413103|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154413104|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413105|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
154413106|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413107|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413108|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154413109|NCT05005182|Hematinics|hematinics|mesh-ancestor
154413110|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
154413111|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413112|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
154413113|NCT04977453|Lenvatinib|lenvatinib|mesh-list
154413114|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413115|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413116|NCT04977453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413117|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413118|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154413119|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413120|NCT04975152|Cemiplimab|cemiplimab|mesh-list
154413121|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413122|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413123|NCT04905407|Azacitidine|azacitidine|mesh-list
154413124|NCT04905407|Venetoclax|venetoclax|mesh-list
154413125|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413126|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
153987735|NCT04289779|Atezolizumab|atezolizumab|mesh-list
154413127|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413129|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413130|NCT04880863|Docetaxel|docetaxel|mesh-list
154413131|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
154413132|NCT04880863|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
154413133|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413134|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413135|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413136|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
154254547|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
154413137|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413138|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413139|NCT04880863|Immunoconjugates|immunoconjugates|mesh-ancestor
154413140|NCT04880863|Immunologic Factors|immunologic factors|mesh-ancestor
154413141|NCT04880863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413142|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
154413143|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413144|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413145|NCT04847466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413146|NCT04847466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413148|NCT04845035|Methotrexate|methotrexate|mesh-list
154413149|NCT04845035|Dasatinib|dasatinib|mesh-list
154413150|NCT04845035|Ponatinib|ponatinib|mesh-list
154413151|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154413152|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
154413153|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154413154|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413155|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413156|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
154413157|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413158|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413159|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
154413160|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413161|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154413162|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413163|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
154413164|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413165|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154413166|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
154413167|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413168|NCT04845035|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154413169|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154413170|NCT04840862|Rifabutin|rifabutin|mesh-list
154413171|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154413172|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413173|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154413174|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
154413175|NCT04821622|Talazoparib|talazoparib|mesh-list
154413176|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154413177|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413178|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413179|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413180|NCT04817644|Semaglutide|semaglutide|mesh-list
154413181|NCT04817644|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154413182|NCT04817644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154413183|NCT04817644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413184|NCT04784715|Trastuzumab|trastuzumab|mesh-list
154413185|NCT04784715|Pertuzumab|pertuzumab|mesh-list
154413186|NCT04784715|Taxane|taxane|mesh-list
154413187|NCT04784715|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154413188|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413189|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413190|NCT04784715|Immunoconjugates|immunoconjugates|mesh-ancestor
154413191|NCT04784715|Immunologic Factors|immunologic factors|mesh-ancestor
154413192|NCT04784715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413193|NCT04781387|REP 3123|rep 3123|mesh-list
154413194|NCT04781387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154413195|NCT04781387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413196|NCT04780464|Prednisone|prednisone|mesh-list
154413197|NCT04780464|Prednisolone|prednisolone|mesh-list
154413198|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
154413199|NCT04780464|Doxorubicin|doxorubicin|mesh-list
154413200|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154413201|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413202|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
154413203|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413204|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413205|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413206|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
154413207|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413208|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413209|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154413210|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154413211|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413212|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154413213|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413214|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413215|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
154413216|NCT04780464|Hormones|hormones|mesh-ancestor
154413217|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413218|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413219|NCT04777396|Semaglutide|semaglutide|mesh-list
154413220|NCT04777396|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154413221|NCT04777396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154413222|NCT04777396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413223|NCT04761198|Nivolumab|nivolumab|mesh-list
154413224|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413225|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413226|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413227|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413228|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154413229|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
154413230|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413231|NCT04738838|Oxytocin|oxytocin|mesh-list
154413232|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
154413233|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154413234|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413235|NCT04732247|Oxytocin|oxytocin|mesh-list
154413236|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
154413237|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154413238|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413239|NCT04697719|Aspirin|aspirin|mesh-list
154413240|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154413241|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154413242|NCT04697719|Analgesics|analgesics|mesh-ancestor
154413243|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
154413244|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413245|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413246|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413247|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413248|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154413249|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154413250|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413251|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154413252|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154413253|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413254|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
154413255|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154413256|NCT04591743|Nicotine|nicotine|mesh-list
154413257|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154413258|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
154413259|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413260|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413261|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154413262|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154413263|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
154413264|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154413265|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413266|NCT04564898|Trifluridine|trifluridine|mesh-list
154413267|NCT04564898|Bevacizumab|bevacizumab|mesh-list
154413268|NCT04564898|Capecitabine|capecitabine|mesh-list
154413269|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413270|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413271|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154413272|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154413273|NCT04564898|Growth Substances|growth substances|mesh-ancestor
154413274|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987885|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413275|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
154413276|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413277|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
154413278|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413279|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
154413280|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413281|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154413282|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
154413283|NCT04550832|Bedaquiline|bedaquiline|mesh-list
154413284|NCT04550832|Delpazolid|delpazolid|mesh-list
154413285|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154413286|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413287|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413288|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154413289|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413290|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413291|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413292|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
154413293|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154413294|NCT04515186|Miltefosine|miltefosine|mesh-list
154413295|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154413296|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
154413297|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413298|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413299|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154413300|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154413301|NCT04499248|Bimatoprost|bimatoprost|mesh-list
154413302|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154413303|NCT04434092|Eculizumab|eculizumab|mesh-list
154413304|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154413305|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413306|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
154413307|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413308|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
154413309|NCT04432506|Fludarabine|fludarabine|mesh-list
154413310|NCT04432506|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154413311|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154413312|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413313|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
154413314|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413315|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413316|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413317|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
154413318|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413319|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413320|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154413321|NCT04432506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413322|NCT04259138|Vedolizumab|vedolizumab|mesh-list
154413323|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154413324|NCT04258943|Bosutinib|bosutinib|mesh-list
154413325|NCT04258943|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154413326|NCT04258943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154413327|NCT04258943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413328|NCT04258943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413329|NCT04216563|Asciminib|asciminib|mesh-list
154413330|NCT04216563|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154413331|NCT04216563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154413332|NCT04216563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413333|NCT04216563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413334|NCT04182334|TEMPO|tempo|mesh-list
154413335|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
154413336|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413337|NCT04182334|Protective Agents|protective agents|mesh-ancestor
154413338|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413339|NCT04169763|Nelfinavir|nelfinavir|mesh-list
154413340|NCT04169763|Cisplatin|cisplatin|mesh-list
154413341|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413342|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154413343|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154413344|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
154413345|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413346|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413347|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154413348|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154413349|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
154413350|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987964|NCT01996436|Verapamil|verapamil|mesh-list
154413351|NCT04162015|Carboplatin|carboplatin|mesh-list
154413352|NCT04162015|Nivolumab|nivolumab|mesh-list
154413353|NCT04162015|Pemetrexed|pemetrexed|mesh-list
154413354|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413355|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413356|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153676596|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154413357|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413358|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413359|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154413360|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154413361|NCT04120974|Insulin|insulin|mesh-list
154413362|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154413363|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413364|NCT04107805|Midazolam|midazolam|mesh-list
154413365|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154413366|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154413367|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154413368|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413369|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154413370|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154413371|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154413372|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154413373|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
154413374|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
154413375|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
154413376|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
154413377|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154413378|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413379|NCT04085887|Panitumumab|panitumumab|mesh-list
154413380|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413381|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413382|NCT04031508|SMOFlipid|smoflipid|mesh-list
154413383|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154413384|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154413385|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154413386|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154413387|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413388|NCT04011241|Itraconazole|itraconazole|mesh-list
154413389|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
154413390|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413391|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154413392|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154413393|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413394|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413395|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154413396|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
154413397|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413398|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413399|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154413400|NCT03986268|Vitamin D|vitamin d|mesh-list
154413401|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
154413402|NCT03986268|Vitamins|vitamins|mesh-ancestor
154413403|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
154413404|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413405|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154413406|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154413407|NCT03983954|Durvalumab|durvalumab|mesh-list
154413408|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
154413409|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154413410|NCT03983954|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
154413411|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
154413412|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413413|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413414|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
154413415|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413416|NCT03901573|Atezolizumab|atezolizumab|mesh-list
154413417|NCT03901573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413418|NCT03901573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413419|NCT03901573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413420|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413421|NCT03817320|Leucovorin|leucovorin|mesh-list
154413422|NCT03817320|Cytarabine|cytarabine|mesh-list
154413423|NCT03817320|Dexamethasone|dexamethasone|mesh-list
154413424|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
154413425|NCT03817320|Doxorubicin|doxorubicin|mesh-list
154413426|NCT03817320|Methotrexate|methotrexate|mesh-list
154413427|NCT03817320|Vincristine|vincristine|mesh-list
154413428|NCT03817320|Asparaginase|asparaginase|mesh-list
154413429|NCT03817320|Ixazomib|ixazomib|mesh-list
154413430|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413431|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
154413432|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
154413433|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413434|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413435|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154413436|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
154413437|NCT03817320|Hormones|hormones|mesh-ancestor
154413438|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413439|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413440|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413441|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154413442|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413443|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154413444|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413445|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413446|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154413447|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
154413448|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154413449|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413450|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
154413451|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
154413452|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154413453|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413454|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
154413455|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413456|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154413457|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
154413458|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413459|NCT03817320|Antidotes|antidotes|mesh-ancestor
154413460|NCT03817320|Protective Agents|protective agents|mesh-ancestor
154413461|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
154413462|NCT03817320|Vitamins|vitamins|mesh-ancestor
154413463|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
154413464|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413465|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413466|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413467|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
154413468|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
154413469|NCT03799445|Nivolumab|nivolumab|mesh-list
154413470|NCT03799445|Ipilimumab|ipilimumab|mesh-list
154413471|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413472|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413473|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413474|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413475|NCT03782376|Ustekinumab|ustekinumab|mesh-list
154413476|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
154413477|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
154413478|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413479|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
154413480|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413481|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413482|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
154413483|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
154413484|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413485|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
154413486|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413488|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413489|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
154413490|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413491|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413492|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154413493|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413494|NCT03752723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413495|NCT03683433|Azacitidine|azacitidine|mesh-list
154413496|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413497|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
154413498|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413499|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413500|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413501|NCT03664830|Plerixafor|plerixafor|mesh-list
154413503|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154413504|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
154413505|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413506|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
154413507|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413508|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413509|NCT03634241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413510|NCT03634241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413511|NCT03581942|Ibrutinib|ibrutinib|mesh-list
154413512|NCT03581942|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154413513|NCT03581942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154413514|NCT03581942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413515|NCT03581942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413516|NCT03543189|Nivolumab|nivolumab|mesh-list
154413517|NCT03543189|Androgens|androgens|mesh-list
154413518|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413519|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413520|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413521|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413522|NCT03543189|Hormones|hormones|mesh-ancestor
154413523|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413524|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413525|NCT03494569|Fludarabine|fludarabine|mesh-list
154413526|NCT03494569|Melphalan|melphalan|mesh-list
154413527|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
154413528|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154413529|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677220|NCT00064857|Pycnogenols|pycnogenols|mesh-list
154413530|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413531|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413532|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
154413533|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413534|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413535|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
154413536|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154413537|NCT03449537|Caseins|caseins|mesh-list
154413538|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
154413539|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
154413540|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413541|NCT03436992|Resveratrol|resveratrol|mesh-list
154413542|NCT03436992|Antioxidants|antioxidants|mesh-list
154413543|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413544|NCT03436992|Protective Agents|protective agents|mesh-ancestor
154413545|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413546|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413547|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154413548|NCT03357224|Atezolizumab|atezolizumab|mesh-list
154413549|NCT03357224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413550|NCT03357224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413551|NCT03357224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413552|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413553|NCT03333915|Pamiparib|pamiparib|mesh-list
154413554|NCT03333915|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154413555|NCT03333915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413556|NCT03333915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413557|NCT03333915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413558|NCT03177291|Pirfenidone|pirfenidone|mesh-list
154413559|NCT03177291|Paclitaxel|paclitaxel|mesh-list
154413560|NCT03177291|Carboplatin|carboplatin|mesh-list
154413561|NCT03177291|Pemetrexed|pemetrexed|mesh-list
154413562|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413563|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413564|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413565|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413566|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
154413567|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413568|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413569|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154413570|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154413571|NCT03177291|Analgesics|analgesics|mesh-ancestor
154413572|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
154413573|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413574|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677272|NCT00065130|Insulin|insulin|mesh-list
154413575|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154413576|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154413577|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413578|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413579|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
154413580|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
154413581|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154413582|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154413583|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413584|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413585|NCT03142568|Urological Agents|urological agents|mesh-ancestor
154413586|NCT03142321|Vedolizumab|vedolizumab|mesh-list
154413587|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154413588|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
154413589|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154413590|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154413591|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413592|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
154413593|NCT03128866|Coagulants|coagulants|mesh-ancestor
154413594|NCT03063619|Tamoxifen|tamoxifen|mesh-list
154413595|NCT03063619|Afimoxifene|afimoxifene|mesh-list
154413596|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154413597|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
154413598|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413599|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413600|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413601|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413602|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154413603|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154413604|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154413605|NCT03037385|Pralsetinib|pralsetinib|mesh-list
154413606|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413607|NCT03013933|Cyclosporine|cyclosporine|mesh-list
154413608|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154413609|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154413610|NCT03013933|Verapamil|verapamil|mesh-list
154413611|NCT03013933|Antibodies|antibodies|mesh-list
154413612|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
154413613|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154413614|NCT03013933|Cyclosporins|cyclosporins|mesh-list
154413615|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
154413616|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
154413617|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413618|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413619|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413620|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413621|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413622|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
154413623|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413624|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
154413625|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413626|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154413627|NCT03013933|Immunotoxins|immunotoxins|mesh-ancestor
154413628|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154413629|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154413630|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154413631|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154413632|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
154413633|NCT02996825|Gemcitabine|gemcitabine|mesh-list
154413634|NCT02996825|Maytansine|maytansine|mesh-list
154413635|NCT02996825|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154413636|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413637|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
154413638|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413639|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413640|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413641|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413642|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413643|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154413644|NCT02996825|Immunoconjugates|immunoconjugates|mesh-ancestor
154413645|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
154413646|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413647|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
154413648|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413649|NCT02976337|Naloxone|naloxone|mesh-list
154413650|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154413651|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413652|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
153677424|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
154413653|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413654|NCT02964078|Aldesleukin|aldesleukin|mesh-list
154413655|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
154413656|NCT02964078|Interleukin-2|interleukin-2|mesh-list
154413657|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413658|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413659|NCT02964078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413660|NCT02964078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413661|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154413662|NCT02964078|Analgesics|analgesics|mesh-ancestor
154413663|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
154413664|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413665|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413666|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154413667|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154413668|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
154413669|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413671|NCT02945800|Gemcitabine|gemcitabine|mesh-list
154413672|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413673|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413674|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413675|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413676|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
154413677|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413678|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413679|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
154413680|NCT02892591|Oxycodone|oxycodone|mesh-list
154413681|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154413682|NCT02892591|Narcotics|narcotics|mesh-ancestor
154413683|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154413684|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413685|NCT02892591|Analgesics|analgesics|mesh-ancestor
154413686|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
154413687|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413688|NCT02865928|Bupivacaine|bupivacaine|mesh-list
154413690|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
154413691|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154413692|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413693|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
154413694|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413695|NCT02793375|Montelukast|montelukast|mesh-list
154413696|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154413697|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
154413698|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154413699|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
154413700|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413701|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413702|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154413703|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154413704|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413705|NCT02734290|Paclitaxel|paclitaxel|mesh-list
154413706|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
154413707|NCT02734290|Capecitabine|capecitabine|mesh-list
154413708|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413709|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413710|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413711|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413712|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
154413713|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413714|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413715|NCT02734290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413716|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413717|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
154413718|NCT02721888|Liraglutide|liraglutide|mesh-list
154413719|NCT02721888|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154413720|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154413721|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413722|NCT02721888|Incretins|incretins|mesh-ancestor
154413723|NCT02721888|Hormones|hormones|mesh-ancestor
154253696|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154413724|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413725|NCT02652260|Tenofovir|tenofovir|mesh-list
154413726|NCT02652260|Lamivudine|lamivudine|mesh-list
154413727|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154413728|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
154413729|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413730|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154413731|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154413732|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413733|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413734|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154413735|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154413736|NCT02505893|Sirolimus|sirolimus|mesh-list
154413737|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154413738|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413739|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154413740|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413741|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
154413742|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413743|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
154413744|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413745|NCT02446236|Rituximab|rituximab|mesh-list
154413746|NCT02446236|Lenalidomide|lenalidomide|mesh-list
154413747|NCT02446236|Ibrutinib|ibrutinib|mesh-list
154413748|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413749|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413750|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
154413751|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413752|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413753|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154413754|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154413755|NCT02446236|Growth Substances|growth substances|mesh-ancestor
154413756|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
154413757|NCT02446236|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154413758|NCT02446236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154042274|NCT00537979|Vitamins|vitamins|mesh-ancestor
154413759|NCT02446236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413760|NCT02446236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413761|NCT02441803|Cytarabine|cytarabine|mesh-list
154413762|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
154413763|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
154413764|NCT02441803|Busulfan|busulfan|mesh-list
154413765|NCT02441803|Fludarabine|fludarabine|mesh-list
154413766|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
154413767|NCT02441803|Decitabine|decitabine|mesh-list
154413768|NCT02441803|Idarubicin|idarubicin|mesh-list
154413769|NCT02441803|Clofarabine|clofarabine|mesh-list
154413770|NCT02441803|Tacrolimus|tacrolimus|mesh-list
154413771|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
154413772|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154413773|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413774|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
154413775|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413776|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413777|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413778|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
154413779|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413780|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413781|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154413782|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154413783|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
154413784|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
154413785|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413786|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154413787|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413788|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154413789|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154413790|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
154413791|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154413792|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413793|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154413794|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
154413795|NCT02337829|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154413796|NCT02337829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154413797|NCT02337829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413798|NCT02337829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988408|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
154413799|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413800|NCT02120352|Rilpivirine|rilpivirine|mesh-list
154413801|NCT02120352|Cabotegravir|cabotegravir|mesh-list
154413802|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154413803|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154413804|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413805|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413806|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
154413807|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413808|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154413809|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154413810|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154413811|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154413812|NCT02091141|Trastuzumab|trastuzumab|mesh-list
154413813|NCT02091141|Atezolizumab|atezolizumab|mesh-list
154413814|NCT02091141|Pertuzumab|pertuzumab|mesh-list
154413815|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154413816|NCT02091141|Vemurafenib|vemurafenib|mesh-list
154413817|NCT02091141|Alectinib|alectinib|mesh-list
154413818|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413819|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413820|NCT02091141|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154413821|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154413822|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413823|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413824|NCT02091141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154413825|NCT02083692|Metformin|metformin|mesh-list
154413826|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154413827|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413828|NCT02040857|Tamoxifen|tamoxifen|mesh-list
154413829|NCT02040857|Letrozole|letrozole|mesh-list
154413830|NCT02040857|Palbociclib|palbociclib|mesh-list
154413831|NCT02040857|Anastrozole|anastrozole|mesh-list
154413832|NCT02040857|Exemestane|exemestane|mesh-list
154413833|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154413834|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413835|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154413836|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413837|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413838|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154413839|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154413840|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413841|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413842|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413843|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154413844|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154413845|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154413846|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154413847|NCT01992146|Naloxone|naloxone|mesh-list
154413848|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154413849|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413850|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
154413851|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413852|NCT01961063|Busulfan|busulfan|mesh-list
154413853|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
154413854|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413855|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413856|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
154413857|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413858|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413859|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413860|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154413861|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154413862|NCT01909245|Gastrins|gastrins|mesh-list
154413863|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
153677803|NCT05019794|Infigratinib|infigratinib|mesh-list
154413864|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413865|NCT01909245|Hormones|hormones|mesh-ancestor
154413866|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413867|NCT01093612|Copper|copper|mesh-list
154413868|NCT01093612|Trastuzumab|trastuzumab|mesh-list
154413869|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154413870|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413871|NCT01093612|Trace Elements|trace elements|mesh-ancestor
154413872|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
154413873|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413874|NCT00676715|Interferons|interferons|mesh-list
154413875|NCT00676715|Interferon-beta|interferon-beta|mesh-list
154413876|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
154413877|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413878|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
154413879|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154413880|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
154413881|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413882|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
154413883|NCT00641381|Carmustine|carmustine|mesh-list
154413884|NCT00641381|Etoposide|etoposide|mesh-list
154413885|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154413886|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
154413887|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413888|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154413889|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413890|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
154413891|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413892|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413893|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154413894|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413895|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413896|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154413897|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413898|NCT00516373|Olaparib|olaparib|mesh-list
154413899|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154413900|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413901|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413902|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413903|NCT00379041|Prednisone|prednisone|mesh-list
154413904|NCT00379041|Doxorubicin|doxorubicin|mesh-list
154413905|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154413906|NCT00379041|Bleomycin|bleomycin|mesh-list
154413907|NCT00379041|Vincristine|vincristine|mesh-list
154413908|NCT00379041|Vinblastine|vinblastine|mesh-list
154413909|NCT00379041|Procarbazine|procarbazine|mesh-list
154413910|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
154413911|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154413912|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413913|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413914|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154413915|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413916|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413917|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413918|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
154413919|NCT00379041|Hormones|hormones|mesh-ancestor
154413920|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413921|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413922|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413923|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413924|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413925|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413926|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
154413927|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
154413928|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413929|NCT00378105|Dexamethasone|dexamethasone|mesh-list
154413930|NCT00378105|Lenalidomide|lenalidomide|mesh-list
154413931|NCT00378105|Bortezomib|bortezomib|mesh-list
154413932|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413933|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
154413934|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
154413935|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154413936|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413937|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154413938|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
154413939|NCT00378105|Hormones|hormones|mesh-ancestor
154413940|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413941|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413942|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413943|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
154413944|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154413945|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154413946|NCT00378105|Growth Substances|growth substances|mesh-ancestor
154413947|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
154413948|NCT00005584|Prednisone|prednisone|mesh-list
154413949|NCT00005584|Epirubicin|epirubicin|mesh-list
154413950|NCT00005584|Bleomycin|bleomycin|mesh-list
154413951|NCT00005584|Vinblastine|vinblastine|mesh-list
154413952|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413953|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
154413954|NCT00005584|Hormones|hormones|mesh-ancestor
154413955|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413956|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413957|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413958|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413959|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154413960|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413961|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154413962|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413963|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413964|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413965|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413966|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413967|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
154413968|NCT00002462|Cobalt|cobalt|mesh-list
154413969|NCT00002462|Prednisone|prednisone|mesh-list
154413970|NCT00002462|Doxorubicin|doxorubicin|mesh-list
154413971|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154413972|NCT00002462|Bleomycin|bleomycin|mesh-list
154413973|NCT00002462|Vincristine|vincristine|mesh-list
154413974|NCT00002462|Vinblastine|vinblastine|mesh-list
154413975|NCT00002462|Procarbazine|procarbazine|mesh-list
154413976|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
154413977|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154413978|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154413979|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154413980|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154413981|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154413982|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154413983|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154413984|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
154413985|NCT00002462|Hormones|hormones|mesh-ancestor
153678141|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413986|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154413987|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154413988|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154413989|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154413990|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
154413991|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
154413992|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
154413993|NCT00002462|Trace Elements|trace elements|mesh-ancestor
154413994|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
154413995|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
154413996|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154413997|NCT02806232|Praziquantel|praziquantel|mesh-list
154413998|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
154413999|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154414000|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414001|NCT02908087|Liraglutide|liraglutide|mesh-list
154414002|NCT02908087|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154414003|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154414004|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414005|NCT02908087|Incretins|incretins|mesh-ancestor
154414006|NCT02908087|Hormones|hormones|mesh-ancestor
154414007|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414008|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
154414009|NCT02053766|Propofol|propofol|mesh-list
154414010|NCT02053766|Sevoflurane|sevoflurane|mesh-list
154414011|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154414012|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414013|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414014|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414015|NCT02053766|Analgesics|analgesics|mesh-ancestor
154414016|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
154414017|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414018|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154414019|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154414020|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154414021|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
154414022|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414023|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414024|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154414025|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
154414026|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
154414027|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154414028|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154414030|NCT02053922|Oxytocin|oxytocin|mesh-list
154414031|NCT02053922|Carbetocin|carbetocin|mesh-list
154414032|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154414033|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
154414034|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154414035|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414036|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154414037|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414038|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
154414039|NCT02054000|Tirofiban|tirofiban|mesh-list
154414040|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154414041|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154414042|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414043|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154414044|NCT02054078|Bevacizumab|bevacizumab|mesh-list
154414045|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154414046|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414047|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154414048|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154414049|NCT02054078|Growth Substances|growth substances|mesh-ancestor
154414050|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414051|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
154414052|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
154414053|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154414054|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154414055|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154414056|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154414057|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414058|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
154414059|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414060|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414061|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154414062|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414063|NCT01336595|Cobalt|cobalt|mesh-list
154414064|NCT01336595|Triamcinolone|triamcinolone|mesh-list
153678386|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
153678387|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678390|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154414065|NCT01336595|Trace Elements|trace elements|mesh-ancestor
154414066|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
154414067|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414068|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414069|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
154414070|NCT01336595|Hormones|hormones|mesh-ancestor
154414071|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414072|NCT01336751|Insulin|insulin|mesh-list
154414073|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154414074|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
154414075|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
154414076|NCT01336751|Protamines|protamines|mesh-list
154414077|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154414078|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414079|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
154414080|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414081|NCT01336751|Coagulants|coagulants|mesh-ancestor
154414082|NCT01336829|Rilpivirine|rilpivirine|mesh-list
154414083|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154414084|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154414085|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414086|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414087|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
154414088|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414089|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154414090|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154414091|NCT02960490|Quetmolimab|quetmolimab|mesh-list
154414092|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414093|NCT05184179|Olmesartan|olmesartan|mesh-list
154414094|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154414095|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154414096|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154414097|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154414098|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
154414099|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414100|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154414101|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154414102|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414103|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153988711|NCT02557789|Lefamulin|lefamulin|mesh-list
154414104|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154414106|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154414107|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
154414108|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414109|NCT01065012|Udenafil|udenafil|mesh-list
154414110|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154414111|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154414112|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414113|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414114|NCT01315691|Amikacin|amikacin|mesh-list
154414115|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154414116|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414117|NCT05654090|Sulbactam|sulbactam|mesh-list
154414118|NCT05654090|Cefoperazone|cefoperazone|mesh-list
154414119|NCT05654090|Sulperazone|sulperazone|mesh-list
154414120|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154414121|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414122|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154414123|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414124|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414125|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154414126|NCT02054468|Remifentanil|remifentanil|mesh-list
154414127|NCT02054468|Propofol|propofol|mesh-list
154414128|NCT02054468|Rocuronium|rocuronium|mesh-list
154414129|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154414130|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414131|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414132|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154414133|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
154414134|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
154414135|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154414136|NCT02054468|Narcotics|narcotics|mesh-ancestor
154414137|NCT02054468|Analgesics|analgesics|mesh-ancestor
154414138|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
154414139|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414140|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154414141|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154414142|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154414143|NCT03640650|Triamcinolone|triamcinolone|mesh-list
154414144|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154414145|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154414146|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154414147|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154414148|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154414149|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154414150|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
154414152|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414153|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678429|NCT00072072|Analgesics|analgesics|mesh-ancestor
154414154|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154414155|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
154414156|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414157|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414158|NCT05183555|Edotreotide|edotreotide|mesh-list
154414159|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154414160|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414161|NCT02052908|Naproxen|naproxen|mesh-list
154414162|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154414163|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414164|NCT02052908|Analgesics|analgesics|mesh-ancestor
154414165|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
154414166|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414167|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414168|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414169|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414170|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
154414171|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154414172|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414173|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414174|NCT01336985|Irinotecan|irinotecan|mesh-list
154414175|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154414176|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154414177|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414178|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414179|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414180|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154414181|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
154414182|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
154414183|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414184|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
154414185|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414186|NCT03635411|Niacinamide|niacinamide|mesh-list
154414187|NCT03635411|Niacin|niacin|mesh-list
154414188|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
154414189|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
154414190|NCT03635411|Vitamins|vitamins|mesh-ancestor
154414191|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
154414192|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414193|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154414194|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
154414195|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414196|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154414197|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
154414198|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154414199|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414200|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
154414201|NCT02748512|Hormones|hormones|mesh-ancestor
154414202|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414203|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414204|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
154414205|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
154414206|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
154414207|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414209|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
154414210|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414211|NCT01316549|Fludarabine|fludarabine|mesh-list
154414212|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414213|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154414214|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
154414215|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414216|NCT01341743|Entecavir|entecavir|mesh-list
154414217|NCT01341743|Adefovir|adefovir|mesh-list
154414218|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154414219|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
154414220|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414221|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154414222|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154414223|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414224|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414225|NCT01341275|Vaccines|vaccines|mesh-list
154414226|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
154414227|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414228|NCT01353937|Plerixafor|plerixafor|mesh-list
154414229|NCT01353937|Becaplermin|becaplermin|mesh-list
154414230|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154414231|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154414232|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
154414233|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414234|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
154414235|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154414236|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154414237|NCT01353937|Growth Substances|growth substances|mesh-ancestor
154414238|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414239|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154414240|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154414241|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
154414242|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414243|NCT02053298|Timolol|timolol|mesh-list
154414244|NCT02053298|Dorzolamide|dorzolamide|mesh-list
154414245|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154414246|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154414247|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154414248|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414249|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414250|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414251|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154414252|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154414253|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154414254|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414255|NCT02054936|Warfarin|warfarin|mesh-list
154414256|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
154414257|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
154414258|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154414259|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
154414260|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154414261|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
154414262|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414263|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414264|NCT04782791|Nivolumab|nivolumab|mesh-list
154414265|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154414266|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414267|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154414268|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414269|NCT01341353|Amiodarone|amiodarone|mesh-list
154414270|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
154414271|NCT01341353|Calcium|calcium|mesh-list
154414272|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154414273|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414274|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154414275|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
154414276|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154414277|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154414278|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414279|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154414280|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154414281|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154414283|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154414284|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154414285|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154414286|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
154414287|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154414288|NCT02056184|Adalimumab|adalimumab|mesh-list
154414289|NCT02056184|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154414290|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414291|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414292|NCT02800928|Aticaprant|aticaprant|mesh-list
154414293|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154414294|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414295|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
154414296|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414297|NCT02056418|Prednisone|prednisone|mesh-list
154414298|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
154414299|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414300|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
154414301|NCT02056418|Hormones|hormones|mesh-ancestor
154414302|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414303|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414304|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154414305|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414306|NCT02055014|Liraglutide|liraglutide|mesh-list
154414307|NCT02055014|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154414308|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154414309|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414310|NCT02055014|Incretins|incretins|mesh-ancestor
154414311|NCT02055014|Hormones|hormones|mesh-ancestor
154414312|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414313|NCT02055170|Finasteride|finasteride|mesh-list
154414314|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154414315|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154414316|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414317|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414318|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154414319|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414320|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414321|NCT02055170|Urological Agents|urological agents|mesh-ancestor
154414322|NCT04490993|Epirubicin|epirubicin|mesh-list
154414323|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154414324|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414325|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154414326|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154414327|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414328|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414329|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
154414330|NCT02055482|Hematinics|hematinics|mesh-ancestor
154414331|NCT02059460|Terlipressin|terlipressin|mesh-list
154414332|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154414333|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154414334|NCT02055716|Sulforaphane|sulforaphane|mesh-list
154414335|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154414336|NCT02055716|Protective Agents|protective agents|mesh-ancestor
154414337|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414338|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414339|NCT04739735|Anesthetics|anesthetics|mesh-list
154414340|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414341|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414342|NCT02059616|Amlodipine|amlodipine|mesh-list
154414343|NCT02059616|Candesartan|candesartan|mesh-list
154414344|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
154414345|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154414346|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154414347|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154414348|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414349|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154414350|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414351|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
154414352|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154414353|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154414354|NCT02059694|Lidocaine|lidocaine|mesh-list
154414355|NCT02059694|Epinephrine|epinephrine|mesh-list
154414356|NCT02059694|Racepinephrine|racepinephrine|mesh-list
154414357|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
154414358|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
154414359|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
154414360|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414361|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414362|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
154414363|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414364|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154414365|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154414366|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154414367|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154414368|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414369|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154414370|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153678865|NCT00068484|Bortezomib|bortezomib|mesh-list
154414371|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
154414372|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414373|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154414374|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154414375|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
154414376|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154414377|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
154414378|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
154414379|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
154414380|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154414381|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154414382|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
154414383|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414384|NCT02056730|Calcium|calcium|mesh-list
154414385|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154414386|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414387|NCT05162573|Pluvicto|pluvicto|mesh-list
154414388|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153678883|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154414389|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414390|NCT01337219|Tobramycin|tobramycin|mesh-list
154414391|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154414392|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414393|NCT03560804|Olmesartan|olmesartan|mesh-list
154414394|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
154414395|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154414396|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154414397|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154414398|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414399|NCT03560804|Diuretics|diuretics|mesh-ancestor
154414400|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
154414401|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414402|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154414403|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154414404|NCT03150719|Ivacaftor|ivacaftor|mesh-list
154414405|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154414406|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154414407|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414408|NCT02059772|Ranibizumab|ranibizumab|mesh-list
154414409|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154414410|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154414411|NCT02059772|Growth Substances|growth substances|mesh-ancestor
154414412|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414413|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
154414414|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414415|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154414416|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154414417|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414418|NCT01344083|Analgesics|analgesics|mesh-ancestor
154414419|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
154414420|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414421|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414422|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414423|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414424|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154414425|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154414426|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154414427|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
153678974|NCT00206986|Clonidine|clonidine|mesh-list
154414428|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
154414429|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414430|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414431|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
154414432|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154414433|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
154414434|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414435|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414436|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154414437|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
154414438|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414439|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414440|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154414441|NCT00982111|Pemetrexed|pemetrexed|mesh-list
154414442|NCT00982111|Necitumumab|necitumumab|mesh-list
154414443|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414444|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414445|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414446|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154414447|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154414448|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154414449|NCT02957682|Alirocumab|alirocumab|mesh-list
154414450|NCT02957682|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154414451|NCT02957682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154414452|NCT02957682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154414453|NCT02957682|Antimetabolites|antimetabolites|mesh-ancestor
154414454|NCT02957682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414455|NCT02957682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154414456|NCT02957682|Protease Inhibitors|protease inhibitors|mesh-ancestor
154414457|NCT02957682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414458|NCT02957682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154414459|NCT03057951|Empagliflozin|empagliflozin|mesh-list
154414460|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154414461|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414462|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154414463|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414464|NCT02060318|Infliximab|infliximab|mesh-list
154414465|NCT02060318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154414466|NCT02060318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414467|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
154414468|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414469|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414470|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
154414471|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154414472|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154414473|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
154414474|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414475|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989086|NCT00769405|Calcium|calcium|mesh-list
154414476|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414477|NCT01318837|Urological Agents|urological agents|mesh-ancestor
154414478|NCT01350037|Remifentanil|remifentanil|mesh-list
154414479|NCT01350037|Alfentanil|alfentanil|mesh-list
154414480|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154414481|NCT01350037|Narcotics|narcotics|mesh-ancestor
154414482|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414483|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414484|NCT01350037|Analgesics|analgesics|mesh-ancestor
154414485|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
154414486|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414487|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154414488|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
154414489|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
154414490|NCT02060006|Meloxicam|meloxicam|mesh-list
154414491|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154414492|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154414493|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414494|NCT02060006|Analgesics|analgesics|mesh-ancestor
154414495|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
154414496|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414497|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414498|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414499|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414500|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154414501|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414502|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414503|NCT03620435|Atezolizumab|atezolizumab|mesh-list
154414504|NCT03620435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154414505|NCT03620435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414506|NCT03620435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154414507|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414508|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
154414509|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
154414510|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414511|NCT04686773|Vaccines|vaccines|mesh-list
154414512|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
154414513|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414514|NCT02956278|Allopurinol|allopurinol|mesh-list
154414515|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
154414516|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414517|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414518|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
154414519|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414520|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154414521|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
154414522|NCT02956278|Protective Agents|protective agents|mesh-ancestor
154414523|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414524|NCT02060396|Aspirin|aspirin|mesh-list
154414525|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154414526|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414527|NCT02060396|Analgesics|analgesics|mesh-ancestor
154414528|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
154414529|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414530|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414531|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414532|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414533|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154414534|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154414535|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414536|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154414537|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154414538|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414539|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
154414540|NCT01358071|Doxorubicin|doxorubicin|mesh-list
154414541|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154414542|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154414543|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414544|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154414545|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154414546|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414547|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414548|NCT02058212|Vitamin E|vitamin e|mesh-list
154414549|NCT02058212|Selenium|selenium|mesh-list
154253697|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154414550|NCT02058212|Vitamins|vitamins|mesh-ancestor
154414551|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
154414552|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414553|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
154414554|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414555|NCT02058212|Protective Agents|protective agents|mesh-ancestor
154414556|NCT02058212|Trace Elements|trace elements|mesh-ancestor
154414557|NCT02058446|Amlodipine|amlodipine|mesh-list
154414558|NCT02058446|Valsartan|valsartan|mesh-list
154414559|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154414560|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154414561|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154414562|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154414563|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414564|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154414565|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414566|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
154414567|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154414569|NCT01354405|Lanreotide|lanreotide|mesh-list
154414570|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414571|NCT03363035|Enoxaparin|enoxaparin|mesh-list
154414572|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
154414573|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154414574|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
153679126|NCT00208039|Calfactant|calfactant|mesh-list
154414575|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154414576|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
154414577|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414578|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414579|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
154414580|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154414581|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154414582|NCT02060552|Diacerein|diacerein|mesh-list
154414583|NCT02060552|Colchicine|colchicine|mesh-list
154414584|NCT02060552|Febuxostat|febuxostat|mesh-list
154414585|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
154414586|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414587|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
154414588|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
154414589|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
154414590|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414591|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414592|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414593|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
154414594|NCT05384574|Vitamin D|vitamin d|mesh-list
154414595|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154414596|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414597|NCT05384574|Vitamins|vitamins|mesh-ancestor
154414598|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
154414599|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154414600|NCT04355585|Colchicine|colchicine|mesh-list
154414601|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
154414602|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414603|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
154414604|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
154414605|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
154414606|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414607|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414608|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154414609|NCT02031744|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154414610|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154414611|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414612|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414613|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414614|NCT04653389|Immunomodulating Agents|immunomodulating agents|mesh-list
154414615|NCT04653389|Immunologic Factors|immunologic factors|mesh-ancestor
154414616|NCT04653389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414617|NCT01344395|Ketorolac|ketorolac|mesh-list
154414618|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154414619|NCT01344395|Ropivacaine|ropivacaine|mesh-list
154414620|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
154414621|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
154414622|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414623|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414624|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
154414625|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414626|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154414627|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414628|NCT01344395|Analgesics|analgesics|mesh-ancestor
154414629|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414630|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414631|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154414632|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414633|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414634|NCT02291445|Peppermint oil|peppermint oil|mesh-list
154414635|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
154414636|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
154414637|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414638|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414639|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414640|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
154414641|NCT02062112|Laxatives|laxatives|mesh-list
154414642|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414643|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
154414645|NCT01342289|Fludarabine|fludarabine|mesh-list
154414646|NCT01342289|Tacrolimus|tacrolimus|mesh-list
154414647|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154414648|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
154414649|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414650|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414651|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154414652|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
154414653|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414654|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414655|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154414656|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154414657|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414658|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154414659|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153679254|NCT00208585|Sertraline|sertraline|mesh-list
154414660|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
154414661|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154414662|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414663|NCT02062190|Resveratrol|resveratrol|mesh-list
154414664|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
154414665|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414666|NCT02062190|Protective Agents|protective agents|mesh-ancestor
154414667|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414668|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414669|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154414670|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
154414671|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154414672|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154414673|NCT01354483|Prednisolone|prednisolone|mesh-list
154414674|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
154414675|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
154414676|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154414677|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
154414678|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414679|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
154414680|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
154414681|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414682|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414683|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414684|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
154414685|NCT01354483|Hormones|hormones|mesh-ancestor
154414686|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414687|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154414688|NCT01354483|Protective Agents|protective agents|mesh-ancestor
154414689|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154414690|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414691|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
154414692|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154414693|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414694|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414695|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
154414696|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154414697|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414698|NCT03618264|Dexamethasone|dexamethasone|mesh-list
154414699|NCT03618264|Ropivacaine|ropivacaine|mesh-list
154414700|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989315|NCT02634021|Midazolam|midazolam|mesh-list
154414701|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
154414702|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
154414703|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679307|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154414704|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414705|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414706|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
154414707|NCT03618264|Hormones|hormones|mesh-ancestor
154414708|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414709|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154414710|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414711|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
154414712|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
154414713|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414714|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
154414715|NCT03617016|Domperidone|domperidone|mesh-list
154414716|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
154414717|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
154414718|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414719|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414720|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414721|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154414722|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
154414723|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414724|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414725|NCT02060786|Clopidogrel|clopidogrel|mesh-list
154414726|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154414727|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154414728|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154414729|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154414730|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
154414731|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414732|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414733|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414734|NCT03153137|Macitentan|macitentan|mesh-list
154414735|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154414736|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154414737|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414738|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154414739|NCT03617484|Bortezomib|bortezomib|mesh-list
154414740|NCT03617484|Ibrutinib|ibrutinib|mesh-list
154414741|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414742|NCT03617484|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154414743|NCT03617484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154414744|NCT03617484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414745|NCT03617484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414746|NCT01344473|Caseins|caseins|mesh-list
154414747|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
154414748|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
154414749|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414750|NCT03618108|Azithromycin|azithromycin|mesh-list
154414751|NCT03618108|Doxycycline|doxycycline|mesh-list
154414752|NCT03618108|Rifabutin|rifabutin|mesh-list
154414753|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154414754|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414755|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
154414756|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154414757|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154414758|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154414759|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
154414760|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154414761|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154414762|NCT02236728|Pramipexole|pramipexole|mesh-list
154414763|NCT02236728|Dexpramipexole|dexpramipexole|mesh-list
154414764|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
154414765|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414766|NCT02236728|Protective Agents|protective agents|mesh-ancestor
154414767|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414768|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154414769|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154414770|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
154414771|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
154414772|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414773|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154414774|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
154414775|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414776|NCT01342679|Dasatinib|dasatinib|mesh-list
154414777|NCT01342679|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154414778|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154414779|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414780|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414781|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414782|NCT01342835|Propofol|propofol|mesh-list
154414783|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154414784|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414785|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414786|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154414787|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
154414788|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
154414789|NCT01344863|Trastuzumab|trastuzumab|mesh-list
154414790|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154414791|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414792|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
154414793|NCT03139279|Propofol|propofol|mesh-list
154414794|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154414795|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414796|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414797|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414798|NCT03139279|Analgesics|analgesics|mesh-ancestor
154414799|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
154414800|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414801|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153679458|NCT00209521|Propofol|propofol|mesh-list
154414802|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154414803|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154414804|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
154414805|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414806|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414807|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154414808|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
154414809|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
154414810|NCT02562599|Raltitrexed|raltitrexed|mesh-list
154414811|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414812|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154414813|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
154414814|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414815|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154414816|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414817|NCT03311958|Nivolumab|nivolumab|mesh-list
154414818|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154414819|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414820|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154414821|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414822|NCT01370642|Ribavirin|ribavirin|mesh-list
154414823|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
154414824|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414825|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
154414826|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414827|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
154414828|NCT03138967|Bromides|bromides|mesh-list
154414829|NCT03138967|Rocuronium|rocuronium|mesh-list
154414830|NCT03138967|Neostigmine|neostigmine|mesh-list
154414831|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
154414832|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154414833|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154414834|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154414835|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414836|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414837|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154414838|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414839|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414840|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
154414841|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414842|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154414843|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
154414844|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154414845|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154414846|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154414847|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
154414848|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
154414849|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414850|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
154414851|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989464|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
154414852|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414853|NCT01358383|Naproxen|naproxen|mesh-list
154414854|NCT01358383|Esomeprazole|esomeprazole|mesh-list
154414855|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154414856|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414857|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154414858|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414859|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414860|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154414861|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414862|NCT01358383|Analgesics|analgesics|mesh-ancestor
154414863|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
154414864|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414865|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414866|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414867|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414868|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
154414869|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154414870|NCT03560336|Liraglutide|liraglutide|mesh-list
154414871|NCT03560336|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154414872|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154414873|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414874|NCT03560336|Incretins|incretins|mesh-ancestor
154414875|NCT03560336|Hormones|hormones|mesh-ancestor
154414876|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414877|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
154414878|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154414879|NCT03615768|Clindamycin|clindamycin|mesh-list
154414880|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
154414881|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
154414882|NCT03615768|Adapalene|adapalene|mesh-list
154414883|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154414884|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414885|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154414886|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414887|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414888|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154414889|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414890|NCT03615768|Analgesics|analgesics|mesh-ancestor
154414891|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
154414892|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414893|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414894|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154414895|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154414896|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
154414897|NCT02061644|Anesthetics|anesthetics|mesh-list
154414898|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414899|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414900|NCT03793400|Bevacizumab|bevacizumab|mesh-list
154414901|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154414902|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414903|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154414904|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154414905|NCT03793400|Growth Substances|growth substances|mesh-ancestor
154414906|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414907|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
154414908|NCT01318369|Diazepam|diazepam|mesh-list
154414909|NCT01318369|Dronabinol|dronabinol|mesh-list
154414910|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
154414911|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414912|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154414913|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154414914|NCT01318369|Analgesics|analgesics|mesh-ancestor
154414915|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
154414916|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154414917|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154414918|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154414919|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414920|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414921|NCT01318369|Hormones|hormones|mesh-ancestor
154414922|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154414923|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154414924|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
154414925|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
154414926|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
154414927|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154414928|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154414929|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154414930|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154414931|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154414932|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154414933|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154414934|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154414935|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
154414936|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
154414937|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
154414938|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
154414939|NCT03479684|Warfarin|warfarin|mesh-list
154414940|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
154414942|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154414943|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154414944|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154414945|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
154414946|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414947|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414948|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414949|NCT03614052|Urological Agents|urological agents|mesh-ancestor
154414950|NCT02062892|Sirolimus|sirolimus|mesh-list
154414951|NCT02062892|Everolimus|everolimus|mesh-list
154414952|NCT02062892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154414953|NCT02062892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154414954|NCT02062892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414955|NCT02062892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414956|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154414957|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
154414958|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414959|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154414960|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154414961|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414962|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154414963|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
154414964|NCT02063360|Ritonavir|ritonavir|mesh-list
154414965|NCT02063360|Darunavir|darunavir|mesh-list
154414966|NCT02063360|Fostemsavir|fostemsavir|mesh-list
154414967|NCT02063360|Etravirine|etravirine|mesh-list
154414968|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154414969|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154414970|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
154414971|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154414972|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414973|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154414974|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154414975|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
154414976|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154414977|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154414978|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154414979|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154414980|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154414981|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154414982|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154414983|NCT03614832|Clopidogrel|clopidogrel|mesh-list
154414984|NCT03614832|Ticagrelor|ticagrelor|mesh-list
154414985|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154414986|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154414987|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154414988|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154414989|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
154414990|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154414991|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154414992|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154414993|NCT05210595|Clopidogrel|clopidogrel|mesh-list
154414994|NCT05210595|Ticagrelor|ticagrelor|mesh-list
154414995|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154414996|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154414997|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154414998|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154414999|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
154415000|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415001|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415002|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415003|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
154415004|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154415005|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
154415006|NCT02061800|Melphalan|melphalan|mesh-list
154415007|NCT02061800|Busulfan|busulfan|mesh-list
154415008|NCT02061800|Thiotepa|thiotepa|mesh-list
154415009|NCT02061800|Fludarabine|fludarabine|mesh-list
154415010|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
154415011|NCT02061800|Tacrolimus|tacrolimus|mesh-list
154415012|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154415013|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
154254622|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415014|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415015|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154415016|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154415017|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
154415018|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415019|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415020|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154415021|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154415022|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415023|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415024|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
154415025|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
154415026|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415027|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154415028|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
154415029|NCT02061800|Hormones|hormones|mesh-ancestor
154415030|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415031|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154415032|NCT02061800|Protective Agents|protective agents|mesh-ancestor
154415033|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154415034|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415035|NCT01350817|Docetaxel|docetaxel|mesh-list
154415036|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154415037|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415038|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
154415039|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
154415040|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
154415041|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415042|NCT01350817|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154415043|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154415044|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415045|NCT01986075|Amphetamine|amphetamine|mesh-list
154415046|NCT01986075|Adderall|adderall|mesh-list
154415047|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154415048|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415049|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
154415050|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
154415051|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415052|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
154415053|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415054|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415055|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
154415056|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154415057|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154415058|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154415059|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154415060|NCT02061878|Bexarotene|bexarotene|mesh-list
154415061|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415062|NCT00394355|Fluticasone|fluticasone|mesh-list
154415063|NCT00394355|Xhance|xhance|mesh-list
154415064|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
154415065|NCT00394355|Montelukast|montelukast|mesh-list
154415066|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415067|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154415068|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
154415069|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415070|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415071|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154415072|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
154415073|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
154415074|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154415075|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154415076|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
154415077|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153989686|NCT02631603|Hormones|hormones|mesh-ancestor
154415078|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154415079|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154415080|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415082|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
154415083|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154415084|NCT02797808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154415085|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154415086|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154415087|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415088|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415089|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
154415090|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415091|NCT02796560|Travoprost|travoprost|mesh-list
154415092|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154415093|NCT01316081|Vitamins|vitamins|mesh-list
154415094|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
154415095|NCT01316081|Vitamin E|vitamin e|mesh-list
154415096|NCT01316081|Tocopherols|tocopherols|mesh-list
154415097|NCT01316081|Tocotrienols|tocotrienols|mesh-list
154415098|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
154415099|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
154415100|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415101|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
154415102|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415103|NCT01316081|Protective Agents|protective agents|mesh-ancestor
154415104|NCT02062034|Vitamins|vitamins|mesh-list
154415105|NCT02062034|Vitamin E|vitamin e|mesh-list
154415106|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
154415107|NCT02062034|Ubiquinone|ubiquinone|mesh-list
154415108|NCT02062034|Antioxidants|antioxidants|mesh-list
154415109|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
154415110|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415111|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415112|NCT02062034|Protective Agents|protective agents|mesh-ancestor
154415113|NCT00344487|Ritonavir|ritonavir|mesh-list
154415114|NCT00344487|Lopinavir|lopinavir|mesh-list
154415115|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154415116|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154415117|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
154415118|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415119|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415120|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154415121|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154415122|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
154415123|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415124|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154415125|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154415126|NCT03789968|Tenofovir|tenofovir|mesh-list
154415127|NCT03789968|Emtricitabine|emtricitabine|mesh-list
154415128|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154415129|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
154415130|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415131|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154415132|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154415133|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415134|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415135|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154415136|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154415137|NCT05089643|Capecitabine|capecitabine|mesh-list
154415138|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154415139|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
154415140|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415141|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415142|NCT02871492|Acyclovir|acyclovir|mesh-list
154415143|NCT02871492|Pritelivir|pritelivir|mesh-list
154415144|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
154415145|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415146|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415147|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415148|NCT03613974|Lidocaine|lidocaine|mesh-list
154415149|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
154415150|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
154415151|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415152|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415153|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
154415154|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415155|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154415156|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154415157|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154415158|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154415159|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415160|NCT01343225|Ritonavir|ritonavir|mesh-list
154415161|NCT01343225|Darunavir|darunavir|mesh-list
154415162|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
154415163|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154415164|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154415165|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154415166|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
154415167|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415168|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415169|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154415170|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154415171|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
154415172|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415173|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154415174|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154415175|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154415176|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154415177|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154415178|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154415179|NCT01370408|Dexamethasone|dexamethasone|mesh-list
154415180|NCT01370408|Ondansetron|ondansetron|mesh-list
154415181|NCT01370408|Palonosetron|palonosetron|mesh-list
154415182|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415183|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
154415184|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
154415185|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680461|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
154415186|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415187|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154415188|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
154415189|NCT01370408|Hormones|hormones|mesh-ancestor
154415190|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415191|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154415192|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415193|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
154415194|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
154415195|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154415196|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154415197|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
154415198|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415199|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415200|NCT04769388|Carboplatin|carboplatin|mesh-list
154415201|NCT04769388|Pemetrexed|pemetrexed|mesh-list
154415202|NCT04769388|Osimertinib|osimertinib|mesh-list
154415203|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415204|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415205|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415206|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154415207|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154415208|NCT04769388|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154415209|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154415210|NCT03294109|Bupivacaine|bupivacaine|mesh-list
154415211|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
154415212|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
154415213|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415214|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415215|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
154415216|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415217|NCT01345643|Chrysarobin|chrysarobin|mesh-list
154415218|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154415219|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154415220|NCT01345643|Analgesics|analgesics|mesh-ancestor
154415221|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
154415222|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415223|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415224|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415225|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154415226|NCT02065466|Paclitaxel|paclitaxel|mesh-list
154415227|NCT02065466|Bevacizumab|bevacizumab|mesh-list
154415228|NCT02065466|Temozolomide|temozolomide|mesh-list
154415229|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154415230|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415231|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
154415232|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
154415233|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
154415234|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415235|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415236|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154415237|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154415238|NCT02065466|Growth Substances|growth substances|mesh-ancestor
154415239|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415240|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
154415241|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154415242|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
154415243|NCT05208801|Morphine|morphine|mesh-list
154415244|NCT05208801|Bupivacaine|bupivacaine|mesh-list
154415245|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
154415246|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
154415247|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415248|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415249|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
154415250|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415251|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154415252|NCT05208801|Narcotics|narcotics|mesh-ancestor
154415253|NCT05208801|Analgesics|analgesics|mesh-ancestor
154415254|NCT02064140|Rocuronium|rocuronium|mesh-list
154415255|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154415256|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154415257|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154415258|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415259|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415260|NCT05190627|Loratadine|loratadine|mesh-list
154415261|NCT05190627|Sirolimus|sirolimus|mesh-list
154415262|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154415263|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415264|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154415265|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415266|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
154415267|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154415268|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
154415269|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415270|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415271|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
154415272|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
154415273|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154415274|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154415275|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154415276|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
154415277|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
154415278|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415279|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
154415280|NCT01343303|Naproxen|naproxen|mesh-list
154415281|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154415282|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154415283|NCT01343303|Analgesics|analgesics|mesh-ancestor
154415284|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
154415285|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680626|NCT00217828|Citalopram|citalopram|mesh-list
154415286|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415287|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415288|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154415289|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
154415290|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154415291|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415292|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415293|NCT01343381|Heparin|heparin|mesh-list
154415294|NCT01343381|Calcium heparin|calcium heparin|mesh-list
154415295|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
154415296|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154415297|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154415298|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415299|NCT03620149|Denosumab|denosumab|mesh-list
154415300|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154415301|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415302|NCT02064374|Metformin|metformin|mesh-list
154415303|NCT02064374|Dolutegravir|dolutegravir|mesh-list
154415304|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154415305|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415306|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154415307|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154415308|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415309|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415310|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154415311|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154415312|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
154415313|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415314|NCT01355263|Vitamin A|vitamin a|mesh-list
154415315|NCT01355263|Vitamins|vitamins|mesh-ancestor
154415316|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
154415317|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415318|NCT03613428|Prednisone|prednisone|mesh-list
154415319|NCT03613428|Vincristine|vincristine|mesh-list
154415320|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415321|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
154415322|NCT03613428|Hormones|hormones|mesh-ancestor
154415323|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415324|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415325|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154415326|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415327|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154415328|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
154415329|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
154415330|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
154415331|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415332|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
154415333|NCT02064530|Bupivacaine|bupivacaine|mesh-list
154415334|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
154415335|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
154415336|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415337|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415338|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
154415339|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415340|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154415341|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154415342|NCT02064530|Analgesics|analgesics|mesh-ancestor
154415343|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154415344|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154415345|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154415346|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
154415347|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415348|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415349|NCT04519437|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154415350|NCT04519437|Antiviral Agents|antiviral agents|mesh-ancestor
154415351|NCT04519437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415352|NCT01359085|Pregabalin|pregabalin|mesh-list
154415353|NCT01359085|Analgesics|analgesics|mesh-ancestor
154415354|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
154415355|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415356|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415357|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
154415358|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154415359|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154415360|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415361|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154415362|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154415363|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154415364|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415365|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154415366|NCT01351285|Remifentanil|remifentanil|mesh-list
154415367|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154415368|NCT01351285|Narcotics|narcotics|mesh-ancestor
154415369|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415370|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415371|NCT01351285|Analgesics|analgesics|mesh-ancestor
154415372|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
154415373|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415374|NCT02032290|Clopidogrel|clopidogrel|mesh-list
154415375|NCT02032290|Ticagrelor|ticagrelor|mesh-list
154415376|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154415377|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154415378|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154415379|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154415380|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
154415381|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154254630|NCT02655692|Ketamine|ketamine|mesh-list
154415382|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415383|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415385|NCT03379428|Ibrutinib|ibrutinib|mesh-list
154415386|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415387|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415388|NCT03379428|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154415389|NCT03379428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154415390|NCT03379428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680768|NCT00219154|Aliskiren|aliskiren|mesh-list
154415391|NCT03379428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415392|NCT03628131|Carboplatin|carboplatin|mesh-list
154415393|NCT03628131|Etoposide|etoposide|mesh-list
154415394|NCT03628131|Ifosfamide|ifosfamide|mesh-list
154415395|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415396|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154415397|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154415398|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154415399|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415400|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415401|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154415402|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
154415403|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
154415404|NCT03560024|Growth Substances|growth substances|mesh-ancestor
154415405|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415406|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
154415407|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415408|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415409|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154415410|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154415411|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
154415412|NCT03612492|Lidocaine|lidocaine|mesh-list
154415413|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
154415414|NCT03612492|Anesthetics|anesthetics|mesh-list
154415415|NCT03612492|Esmolol|esmolol|mesh-list
154415416|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415417|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415418|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
154415419|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415420|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154415421|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154415422|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154415423|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154415424|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415425|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154415426|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154415427|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
154415428|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415429|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154415430|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
154415431|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154415432|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154415433|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154415434|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
154415435|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154415436|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415437|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154415438|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154415439|NCT01351597|Docetaxel|docetaxel|mesh-list
154415440|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
154415441|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415442|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
154415443|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
154415444|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
154415445|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415446|NCT02793128|Mitomycins|mitomycins|mesh-list
154415447|NCT02793128|Mitomycin|mitomycin|mesh-list
154415448|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154415449|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415450|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
153990060|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154415451|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254631|NCT02655692|Analgesics|analgesics|mesh-ancestor
154415452|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154415453|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415454|NCT03612180|Metoprolol|metoprolol|mesh-list
154415455|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154415456|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154415457|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
154415458|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
154415459|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415460|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415461|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154415462|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154415463|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154415464|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
154415465|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415466|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415467|NCT04400799|Enoxaparin|enoxaparin|mesh-list
154415468|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
154415469|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154415470|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154415471|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415472|NCT01359241|Insulin|insulin|mesh-list
154415473|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154415474|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415475|NCT02068196|Ipilimumab|ipilimumab|mesh-list
154415476|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415477|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415478|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154415479|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415480|NCT03142451|Minocycline|minocycline|mesh-list
154415481|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154415482|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415483|NCT04065789|Dexamethasone|dexamethasone|mesh-list
154415484|NCT04065789|Lenalidomide|lenalidomide|mesh-list
154415485|NCT04065789|Daratumumab|daratumumab|mesh-list
154415486|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415487|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
154415488|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
154415489|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415490|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415491|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154415492|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
154415493|NCT04065789|Hormones|hormones|mesh-ancestor
154415494|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415495|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154415496|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415497|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
154415498|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154415499|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154415500|NCT04065789|Growth Substances|growth substances|mesh-ancestor
154415501|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
154415502|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
154415503|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
154415504|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415505|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
154415506|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415507|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415508|NCT02064842|Ritonavir|ritonavir|mesh-list
154415509|NCT02064842|Simeprevir|simeprevir|mesh-list
154415510|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154415511|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154415512|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
154415513|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415514|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415515|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154415516|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154415517|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
154415518|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415519|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154415520|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154415521|NCT04192266|Estradiol|estradiol|mesh-list
154415522|NCT04192266|Estrogens|estrogens|mesh-ancestor
154415523|NCT04192266|Hormones|hormones|mesh-ancestor
154415524|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415525|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415526|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
154415527|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154415528|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415529|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415530|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154415531|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154415532|NCT01359397|Bevacizumab|bevacizumab|mesh-list
154415533|NCT01359397|Trastuzumab|trastuzumab|mesh-list
154415534|NCT01359397|Docetaxel|docetaxel|mesh-list
154415535|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
154415536|NCT01359397|Capecitabine|capecitabine|mesh-list
154415537|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415538|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415539|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154415540|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154415541|NCT01359397|Growth Substances|growth substances|mesh-ancestor
154415542|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415543|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
154415544|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
154415545|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
154415546|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
154415547|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415548|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154415549|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
154415550|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154415551|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153681244|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
153681245|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154415552|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154415553|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
154415554|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415555|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415556|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415557|NCT05250245|Urological Agents|urological agents|mesh-ancestor
154415558|NCT01347983|Methotrexate|methotrexate|mesh-list
154415559|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154415560|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
154415561|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154415562|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415563|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154415564|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
154415565|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415566|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415567|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
154415568|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415569|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154415570|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154415571|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
154415572|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154415573|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154415574|NCT05249933|Benzocaine|benzocaine|mesh-list
154415575|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
154415576|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
154415577|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415578|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415579|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
154415580|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415581|NCT02032836|Iloprost|iloprost|mesh-list
154415582|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154415583|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
154415584|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
154415585|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
154415586|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
154415587|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415588|NCT02465593|Capecitabine|capecitabine|mesh-list
154415589|NCT02465593|Fluorouracil|fluorouracil|mesh-list
154415590|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154415591|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
154415592|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415593|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415594|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154415595|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
154415596|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415597|NCT02068898|Nilotinib|nilotinib|mesh-list
154415598|NCT02068898|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154415599|NCT02068898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154253698|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415600|NCT02068898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415601|NCT02068898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415602|NCT03611322|Semaglutide|semaglutide|mesh-list
154415603|NCT03611322|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154415604|NCT03611322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154415605|NCT03611322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415606|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154415607|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415608|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
154415609|NCT02424019|Hormones|hormones|mesh-ancestor
154415610|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415611|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415612|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
154415613|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415614|NCT03611244|Benzocaine|benzocaine|mesh-list
154415615|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
154415616|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
154415617|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415618|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415619|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
154415620|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415621|NCT01359709|Nicotine|nicotine|mesh-list
154415622|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154415623|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
154415624|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415625|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415626|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154415627|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154415628|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
154415629|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415630|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415631|NCT02826486|Leucovorin|leucovorin|mesh-list
154415632|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
154415633|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415634|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415635|NCT02826486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154415636|NCT02826486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415637|NCT02826486|Antidotes|antidotes|mesh-ancestor
154415638|NCT02826486|Protective Agents|protective agents|mesh-ancestor
154415639|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415640|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
154415641|NCT02826486|Vitamins|vitamins|mesh-ancestor
154415642|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
154415643|NCT02825940|Gemcitabine|gemcitabine|mesh-list
154415644|NCT02825940|Atezolizumab|atezolizumab|mesh-list
154415645|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415646|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154415647|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
154415648|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415649|NCT02825940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154415650|NCT02825940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415651|NCT02304991|Glycerol|glycerol|mesh-list
154415652|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154415653|NCT02304991|Protective Agents|protective agents|mesh-ancestor
154415654|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415655|NCT02069132|Warfarin|warfarin|mesh-list
154415656|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
154415657|NCT01352065|Bosentan|bosentan|mesh-list
154415658|NCT01352065|Ambrisentan|ambrisentan|mesh-list
154415659|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154415660|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154254637|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
154415661|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415662|NCT01356043|Niacin|niacin|mesh-list
154415663|NCT01356043|Amlodipine|amlodipine|mesh-list
154415664|NCT01356043|Telmisartan|telmisartan|mesh-list
154415665|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154415666|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154415667|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154415668|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415669|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154415670|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415671|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
154415672|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154415673|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153990281|NCT00781573|Clopidogrel|clopidogrel|mesh-list
154415674|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153681428|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
154415675|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
154415676|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154415677|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
154415678|NCT01356043|Vitamins|vitamins|mesh-ancestor
154415679|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
154415680|NCT02065388|Warfarin|warfarin|mesh-list
154415681|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
154415682|NCT01317563|Vitamin A|vitamin a|mesh-list
154415683|NCT01317563|Selenium|selenium|mesh-list
154415684|NCT01317563|Vitamins|vitamins|mesh-ancestor
154415685|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
154415686|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415687|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
154415688|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415689|NCT01317563|Protective Agents|protective agents|mesh-ancestor
154415690|NCT01317563|Trace Elements|trace elements|mesh-ancestor
154415691|NCT02067338|Morphine|morphine|mesh-list
154415692|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
154415693|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154415694|NCT02067338|Narcotics|narcotics|mesh-ancestor
154415695|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415696|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415697|NCT02067338|Analgesics|analgesics|mesh-ancestor
154415698|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
154415699|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415700|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
154415701|NCT02067338|Coagulants|coagulants|mesh-ancestor
154415702|NCT01352143|Thrombin|thrombin|mesh-list
154415703|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
154415704|NCT01352143|Coagulants|coagulants|mesh-ancestor
154415705|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
154415706|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
154415707|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
154415708|NCT05188495|Trastuzumab|trastuzumab|mesh-list
154415709|NCT05188495|Pertuzumab|pertuzumab|mesh-list
154415710|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415711|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415712|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
154415713|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415714|NCT01356121|Midazolam|midazolam|mesh-list
154415715|NCT01356121|Propofol|propofol|mesh-list
154415716|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154415717|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415718|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415719|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154415720|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
154415721|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
154415722|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154415723|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154415724|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154415725|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154415726|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
154415727|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
154415728|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415729|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415730|NCT01336608|Fluticasone|fluticasone|mesh-list
154415731|NCT01336608|Xhance|xhance|mesh-list
154415732|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415733|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154415734|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
154415735|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415736|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415737|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154415738|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
154415739|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
154415740|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154415741|NCT03628521|Carboplatin|carboplatin|mesh-list
154415742|NCT03628521|Gemcitabine|gemcitabine|mesh-list
154415744|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154415745|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415746|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154415747|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
153990355|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154415748|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415749|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415750|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154415751|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154415752|NCT03628521|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154415753|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154415754|NCT05697003|Fluticasone|fluticasone|mesh-list
154415755|NCT05697003|Xhance|xhance|mesh-list
154415756|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154415757|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154415758|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415759|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154415760|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
154415761|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415762|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415763|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154415764|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
154415765|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
154415766|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154415767|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154415768|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154415769|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154415770|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
154415771|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415772|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415773|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
154415774|NCT05697003|Hormones|hormones|mesh-ancestor
154415775|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415776|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
154415777|NCT02069522|Carotenoids|carotenoids|mesh-list
154415778|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
154415779|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415780|NCT02069522|Protective Agents|protective agents|mesh-ancestor
154415781|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415782|NCT01361425|Methyldopa|methyldopa|mesh-list
154415783|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154415784|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
154415785|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
154415786|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415787|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415788|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154415789|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154415790|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154415791|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
154415792|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415793|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415794|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154415795|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154415796|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154415797|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
154415798|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415799|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415800|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415801|NCT01356355|Urological Agents|urological agents|mesh-ancestor
154415802|NCT01356433|Vitamins|vitamins|mesh-list
154415803|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
154415804|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
154415805|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415806|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
154415807|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415808|NCT01356433|Protective Agents|protective agents|mesh-ancestor
154415809|NCT03691727|Tirofiban|tirofiban|mesh-list
154044334|NCT02645240|Heparin|heparin|mesh-list
154415810|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154415811|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154415812|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415813|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154415814|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154415815|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
154415816|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154415817|NCT01356511|Dexamethasone|dexamethasone|mesh-list
154415818|NCT01356511|Prednisone|prednisone|mesh-list
154415819|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154415820|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
154415821|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
154415822|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415823|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415824|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154415825|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
153990428|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415826|NCT01356511|Hormones|hormones|mesh-ancestor
154415827|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415828|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154415829|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415830|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
154415831|NCT02069990|Vitamin D|vitamin d|mesh-list
154415832|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154415833|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415834|NCT02069990|Vitamins|vitamins|mesh-ancestor
154415835|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
154415836|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154415837|NCT05076409|Fluconazole|fluconazole|mesh-list
154415838|NCT05076409|BI 425809|bi 425809|mesh-list
154415839|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
154415840|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415841|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154415842|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154415843|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415844|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415845|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154415846|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
154415847|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154415848|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415849|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154415850|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154415851|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
154415852|NCT02076386|Dolutegravir|dolutegravir|mesh-list
154415853|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154415854|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154415855|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415856|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415857|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154415858|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154415859|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
154415860|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415861|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
154415862|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154415863|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415864|NCT02072330|Amlodipine|amlodipine|mesh-list
154415865|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154415866|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154415867|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154415868|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153681746|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154415869|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154415870|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415871|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154415872|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415873|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
154415874|NCT02072330|Diuretics|diuretics|mesh-ancestor
154415875|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
154415876|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154415877|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154415878|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154415879|NCT02072408|Aflibercept|aflibercept|mesh-list
154415880|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154415881|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154415882|NCT02072408|Growth Substances|growth substances|mesh-ancestor
154415883|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415885|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415886|NCT02070458|Cytarabine|cytarabine|mesh-list
154415887|NCT02070458|Etoposide|etoposide|mesh-list
154415888|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
154415889|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
154415890|NCT02070458|Ixazomib|ixazomib|mesh-list
154415891|NCT02070458|Glycine|glycine|mesh-list
154415892|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
154415893|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154415894|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415895|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154415896|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154415897|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415898|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415899|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154415900|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
153990503|NCT00927758|Hormones|hormones|mesh-ancestor
154415901|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
154415902|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415903|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154415904|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
154415905|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415906|NCT02070458|Analgesics|analgesics|mesh-ancestor
154415907|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
154415908|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415909|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
154415910|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
154415911|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154415912|NCT03131479|Licogliflozin|licogliflozin|mesh-list
154415913|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154415914|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415915|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154415916|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415917|NCT02077010|Milrinone|milrinone|mesh-list
154415918|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154415919|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154415920|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
154415921|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154415922|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154415923|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415924|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415925|NCT02077010|Protective Agents|protective agents|mesh-ancestor
154415926|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415927|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
154415928|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154415929|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
154415930|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682020|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
154415931|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
154415932|NCT01319461|Protective Agents|protective agents|mesh-ancestor
154415933|NCT02072720|Bevacizumab|bevacizumab|mesh-list
154415934|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154415935|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154415936|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154415937|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154415938|NCT02072720|Growth Substances|growth substances|mesh-ancestor
154415939|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415940|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
154415941|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
154415942|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154415943|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
154415944|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
154415945|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415946|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415947|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154415948|NCT01356745|Analgesics|analgesics|mesh-ancestor
154415949|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
154415950|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415951|NCT02072798|Cefuroxime|cefuroxime|mesh-list
154415952|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
154415953|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154415954|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415955|NCT04943549|Bupivacaine|bupivacaine|mesh-list
154415956|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
154415958|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415959|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415960|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
154415961|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415962|NCT04252105|Antioxidants|antioxidants|mesh-list
154415963|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415964|NCT04252105|Protective Agents|protective agents|mesh-ancestor
154415965|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415966|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
154415967|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
154415968|NCT02077322|Coagulants|coagulants|mesh-ancestor
154415969|NCT02077400|Cefazolin|cefazolin|mesh-list
154415970|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154415971|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154415972|NCT02077478|Remifentanil|remifentanil|mesh-list
154415973|NCT02077478|Propofol|propofol|mesh-list
154415974|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154415975|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154415976|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415977|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154415978|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
154415979|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
154415980|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154415981|NCT02077478|Narcotics|narcotics|mesh-ancestor
154415982|NCT02077478|Analgesics|analgesics|mesh-ancestor
154415983|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
154415984|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154415985|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
154415986|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
154415987|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154415988|NCT02077556|Prednisolone|prednisolone|mesh-list
154415989|NCT02077556|Everolimus|everolimus|mesh-list
154415990|NCT02077556|Tacrolimus|tacrolimus|mesh-list
154415991|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154415992|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
154415993|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154415994|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154415995|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154415996|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154415997|NCT02077556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154415998|NCT02077556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154415999|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416000|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154416001|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154416002|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
154416003|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154416004|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416005|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416006|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
154416007|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
154416008|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416009|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416010|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
154416011|NCT02077556|Hormones|hormones|mesh-ancestor
154416012|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416013|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154416014|NCT02077556|Protective Agents|protective agents|mesh-ancestor
154416015|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154416016|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
154416017|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154416018|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154416019|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416020|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
154416021|NCT02930941|Coagulants|coagulants|mesh-ancestor
154416022|NCT02077634|Prednisone|prednisone|mesh-list
154416023|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
154416024|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416025|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
154416026|NCT02077634|Hormones|hormones|mesh-ancestor
154416027|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416028|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416029|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154416030|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416031|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154416032|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416033|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416034|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
154416035|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154416036|NCT01365403|Carbamazepine|carbamazepine|mesh-list
153682159|NCT00402766|Pemetrexed|pemetrexed|mesh-list
154416037|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
154416038|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
154416039|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154416040|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416041|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416042|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154416043|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416044|NCT01365403|Analgesics|analgesics|mesh-ancestor
154416045|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
154416046|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416047|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154416048|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154416049|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416050|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154416051|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154416052|NCT01352663|Insulin|insulin|mesh-list
153748284|NCT00533611|Niacin|niacin|mesh-list
154416053|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
154416054|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416055|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416056|NCT01362361|Nintedanib|nintedanib|mesh-list
154416057|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416058|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154416059|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416060|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416061|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
154416062|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154416063|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416064|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416065|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416066|NCT02077712|Analgesics|analgesics|mesh-ancestor
154416067|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
154416068|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416069|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154416070|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154416071|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154416072|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
154416073|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416074|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416075|NCT02073734|Dexamethasone|dexamethasone|mesh-list
154416076|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416077|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
154416078|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
154416079|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416080|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416081|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416082|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
154416083|NCT02073734|Hormones|hormones|mesh-ancestor
154416084|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416085|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154416086|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416087|NCT02071004|Aspirin|aspirin|mesh-list
154416088|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154416089|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416090|NCT02071004|Analgesics|analgesics|mesh-ancestor
154416091|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
154416092|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416093|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416094|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416095|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154416096|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154416097|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154416098|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416099|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154416100|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154416101|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416102|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
154416103|NCT02071160|Melatonin|melatonin|mesh-list
154416105|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416106|NCT02071160|Protective Agents|protective agents|mesh-ancestor
154416107|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416108|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416109|NCT03131713|Acetaminophen|acetaminophen|mesh-list
154416110|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416111|NCT03131713|Analgesics|analgesics|mesh-ancestor
154416112|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
154416113|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416114|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416115|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
154416116|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
154416117|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416118|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416119|NCT03514121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154416120|NCT03514121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416121|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
154416122|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
154416123|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
154416124|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154416125|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416126|NCT02930005|Analgesics|analgesics|mesh-ancestor
154416127|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
154416128|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416129|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416130|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416131|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154416132|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154416133|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416134|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416135|NCT01349387|Metformin|metformin|mesh-list
154416136|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416137|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416138|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
154416139|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
154416140|NCT01361269|Clindamycin|clindamycin|mesh-list
154416141|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
154416142|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
154416143|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
154416144|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154416145|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416146|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154416147|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416148|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416149|NCT01353209|Letrozole|letrozole|mesh-list
154416150|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416151|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154416152|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154416153|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416154|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416155|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154416156|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
154416157|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416158|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416159|NCT03637491|Avelumab|avelumab|mesh-list
154416160|NCT03637491|Talazoparib|talazoparib|mesh-list
154416161|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416162|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416163|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154416164|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416165|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416166|NCT01363063|Ketorolac|ketorolac|mesh-list
154416167|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154416168|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154416169|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416170|NCT01363063|Analgesics|analgesics|mesh-ancestor
154416171|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
154416172|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416173|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416174|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416175|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154416176|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154416177|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416178|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416179|NCT04550455|Cladribine|cladribine|mesh-list
154416180|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416181|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154416182|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
154416183|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416184|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154416185|NCT01349699|Deferasirox|deferasirox|mesh-list
154416186|NCT01349699|Hematinics|hematinics|mesh-ancestor
154416187|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154416188|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
154416189|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
154416190|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416191|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154416192|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154416193|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
154416194|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416195|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416196|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416197|NCT03628443|Mitogens|mitogens|mesh-list
154416198|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
154416199|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416200|NCT01365871|Anesthetics|anesthetics|mesh-list
154416201|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416202|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416203|NCT01349777|Clopidogrel|clopidogrel|mesh-list
154416204|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154416205|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154416206|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154416207|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154416208|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
154416209|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416210|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416211|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416212|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
154416213|NCT04700007|Promethazine|promethazine|mesh-list
154416214|NCT04700007|Morphine|morphine|mesh-list
154416215|NCT04700007|Capsaicin|capsaicin|mesh-list
154416216|NCT04700007|Histamine|histamine|mesh-list
154416217|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-list
154416218|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154416219|NCT04700007|Narcotics|narcotics|mesh-ancestor
154416220|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416221|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416222|NCT04700007|Analgesics|analgesics|mesh-ancestor
154416223|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
154416224|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416225|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
154416226|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
154416227|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154416228|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154416229|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
154416230|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
154416231|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
154416232|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
154416233|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416234|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154416235|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
154416236|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416237|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416238|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154416239|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
154416240|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
154416241|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416242|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416243|NCT01318655|Naloxegol|naloxegol|mesh-list
154416244|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154416245|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416246|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
154416247|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416248|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
154416249|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416250|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
154416251|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154416252|NCT01350089|Ethanol|ethanol|mesh-list
154416253|NCT01350089|Caffeine|caffeine|mesh-list
153682655|NCT03928366|Propofol|propofol|mesh-list
154416254|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154416255|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416256|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416257|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416258|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154416259|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154416260|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416261|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416262|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154416263|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154416264|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
154416265|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416266|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154416267|NCT03296553|Valganciclovir|valganciclovir|mesh-list
154416268|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
154416269|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416270|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
154416271|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154416272|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416273|NCT01370707|Metformin|metformin|mesh-list
154416274|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416275|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416276|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154416277|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416278|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
154416279|NCT01363609|Liraglutide|liraglutide|mesh-list
154416280|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416281|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416282|NCT01363609|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154416283|NCT01363609|Incretins|incretins|mesh-ancestor
154416284|NCT01363609|Hormones|hormones|mesh-ancestor
154416285|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416286|NCT03060447|Vesatolimod|vesatolimod|mesh-list
154416287|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
154416288|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416289|NCT04623567|Metformin|metformin|mesh-list
154416290|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416291|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416292|NCT01712789|Dexamethasone|dexamethasone|mesh-list
154416293|NCT01712789|Pomalidomide|pomalidomide|mesh-list
154416294|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416295|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
154416296|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
154416297|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416298|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416299|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416300|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
154416301|NCT01712789|Hormones|hormones|mesh-ancestor
154416302|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416303|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154416304|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416305|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
154416306|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154416307|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154416308|NCT01712789|Growth Substances|growth substances|mesh-ancestor
154416309|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
154416310|NCT01350323|Bevacizumab|bevacizumab|mesh-list
154416311|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416312|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416313|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154416314|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154416315|NCT01350323|Growth Substances|growth substances|mesh-ancestor
154416316|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416317|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
154416318|NCT03074318|Avelumab|avelumab|mesh-list
154416319|NCT03074318|Trabectedin|trabectedin|mesh-list
154416320|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154416321|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416322|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416323|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154416324|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
154416325|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416326|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
154416327|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416328|NCT02071316|Esomeprazole|esomeprazole|mesh-list
154416329|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
154416330|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154416331|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154416332|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416333|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
154416334|NCT02071316|Coagulants|coagulants|mesh-ancestor
154416335|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154416336|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416337|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154416338|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416339|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154416340|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154416341|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416342|NCT02074280|Rifaximin|rifaximin|mesh-list
154416343|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682774|NCT00045539|Vitamins|vitamins|mesh-ancestor
154416344|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416345|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416346|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154416347|NCT02077946|Liraglutide|liraglutide|mesh-list
154416348|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416349|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416350|NCT02077946|Incretins|incretins|mesh-ancestor
154416351|NCT02077946|Hormones|hormones|mesh-ancestor
154416352|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416353|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154416354|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
154416355|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416356|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416357|NCT02077946|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154416358|NCT03559790|Tenofovir|tenofovir|mesh-list
154416359|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
154416360|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416361|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154416362|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154416363|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416364|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416365|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154416366|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154416367|NCT02079974|Pravastatin|pravastatin|mesh-list
154416368|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154416369|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154416370|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
154416371|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416372|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154416373|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154416374|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416375|NCT01353755|Immunomodulating Agents|immunomodulating agents|mesh-list
154416376|NCT01353755|Immunologic Factors|immunologic factors|mesh-ancestor
154416377|NCT01353755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416378|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154416379|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
154416380|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416381|NCT01317953|Protective Agents|protective agents|mesh-ancestor
154416382|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416383|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154416384|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154416385|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416386|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154416387|NCT02078336|Atropine|atropine|mesh-list
154416388|NCT02078336|Midazolam|midazolam|mesh-list
154416389|NCT02078336|Droperidol|droperidol|mesh-list
154416390|NCT02078336|Lorazepam|lorazepam|mesh-list
154416391|NCT02078336|Biperiden|biperiden|mesh-list
154416392|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154416393|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154416394|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416395|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416396|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154416397|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154416398|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154416399|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154416400|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
154416401|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
154416402|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
154416403|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
154416404|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416405|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416406|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154416407|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154416408|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
154416409|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416410|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154416411|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
154416412|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
154416413|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
154416414|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154416415|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154416416|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
154416417|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
154416418|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
154416419|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416420|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154416421|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154416422|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154416423|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154416424|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154416425|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
154416426|NCT01353833|Aldesleukin|aldesleukin|mesh-list
154416427|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416428|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154416429|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154416430|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
154416431|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416433|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416434|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416435|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154416436|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416437|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
154416438|NCT01350713|Povidone|povidone|mesh-list
154416439|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
154416440|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
154416441|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154416442|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416443|NCT02075294|Entecavir|entecavir|mesh-list
154416444|NCT02075294|Adefovir|adefovir|mesh-list
154416445|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154416446|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
154416447|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416448|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154416449|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154416450|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416451|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416452|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154416453|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
154416454|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154416455|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154416456|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154416457|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416458|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416459|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154416460|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154416461|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154416462|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416463|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416464|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154416465|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154416466|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154416467|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
154416468|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416469|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416470|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154416471|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154416472|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
154416474|NCT01358045|Diclofenac|diclofenac|mesh-list
154416475|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154416476|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416477|NCT01358045|Analgesics|analgesics|mesh-ancestor
154416478|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
154416479|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416480|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416481|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416482|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154416483|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154416484|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416485|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416486|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154416487|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154416488|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154416489|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154416490|NCT01358045|Vitamins|vitamins|mesh-ancestor
154416491|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
154416492|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154416493|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
154416494|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154416495|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
154416496|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416497|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416498|NCT01357811|Digoxin|digoxin|mesh-list
154416499|NCT01357811|Eliglustat|eliglustat|mesh-list
154416500|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154416501|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154416502|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416503|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416504|NCT01357811|Protective Agents|protective agents|mesh-ancestor
154416505|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416507|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
154416508|NCT04300985|Anesthetics|anesthetics|mesh-list
154416509|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416510|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416511|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154416512|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416513|NCT04300985|Analgesics|analgesics|mesh-ancestor
154416514|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
154416515|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416516|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154416517|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154416518|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154416519|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
154416520|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416521|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416522|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154416523|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
154416524|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154416525|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154416526|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154416527|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
154416528|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154416529|NCT02079194|Aspirin|aspirin|mesh-list
154416530|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154416531|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416533|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
154416534|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416535|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416536|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416537|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154416538|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154416539|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154416540|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416541|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154416542|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154416543|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416544|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
154416545|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
154416546|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154416547|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
154416548|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416549|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416550|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154416551|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
154416552|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154416553|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
154416554|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416555|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416556|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154416557|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
154416558|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
154416559|NCT01351493|Protective Agents|protective agents|mesh-ancestor
154416560|NCT01318187|Acetaminophen|acetaminophen|mesh-list
154416561|NCT01318187|Morphine|morphine|mesh-list
154416562|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154416563|NCT01318187|Narcotics|narcotics|mesh-ancestor
154416564|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416565|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416566|NCT01318187|Analgesics|analgesics|mesh-ancestor
154416567|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
154416568|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416569|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416570|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
154416571|NCT01358435|Insulin|insulin|mesh-list
154416572|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154416573|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
154416574|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
154416575|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
154416576|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416577|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416578|NCT01318265|Ketoconazole|ketoconazole|mesh-list
153991176|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154416579|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
154416580|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416581|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153683137|NCT00131404|Hormones|hormones|mesh-ancestor
153814310|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814311|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814312|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
153775542|NCT05887609|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154416582|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154416583|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416584|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416585|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154416586|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
154416587|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416588|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416589|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154416590|NCT01354457|Epratuzumab|epratuzumab|mesh-list
154416591|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416592|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416593|NCT02079350|Polygeline|polygeline|mesh-list
154416594|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
154416595|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
154416596|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
154416597|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154416598|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
154416599|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154416600|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154416601|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416602|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154416603|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416604|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154416605|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416606|NCT03060980|Empagliflozin|empagliflozin|mesh-list
154416607|NCT03060980|Glimepiride|glimepiride|mesh-list
154416608|NCT03060980|Exenatide|exenatide|mesh-list
154416609|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154416610|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416611|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416612|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416613|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154416614|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154416615|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
154416616|NCT03060980|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154416617|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154416618|NCT03060980|Incretins|incretins|mesh-ancestor
154416619|NCT03060980|Hormones|hormones|mesh-ancestor
154416620|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416621|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
154416622|NCT01358591|Calcium|calcium|mesh-list
154416623|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154416624|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416625|NCT01358591|Antacids|antacids|mesh-ancestor
154416626|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416627|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416628|NCT02081144|Nicotine|nicotine|mesh-list
154416629|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154416630|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
154416631|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775551|NCT05887609|Immunoconjugates|immunoconjugates|mesh-ancestor
153775605|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775606|NCT05402111|Olanzapine|olanzapine|mesh-list
154416632|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416633|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154416634|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154416635|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
154416636|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416637|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416638|NCT02083328|Mannitol|mannitol|mesh-list
154416639|NCT02083328|Caffeine|caffeine|mesh-list
154416640|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154416641|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416642|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154416643|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416644|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416645|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154416646|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154416647|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
154416648|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416649|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154416650|NCT02083328|Diuretics|diuretics|mesh-ancestor
154416651|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
154416652|NCT02079506|Candesartan|candesartan|mesh-list
154416653|NCT02079506|Candesartan cilexetil|candesartan cilexetil|mesh-list
154416654|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154416655|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154416656|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154416657|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
154416658|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416659|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154416660|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154416661|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416662|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154416663|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154416664|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154416665|NCT02940548|Amlodipine|amlodipine|mesh-list
154416666|NCT02940548|Nifedipine|nifedipine|mesh-list
154416667|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154416668|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154416669|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154416670|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416671|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154416672|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416673|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
154416675|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154416676|NCT01366183|Paclitaxel|paclitaxel|mesh-list
154416677|NCT01366183|Carboplatin|carboplatin|mesh-list
154416678|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154416679|NCT01366183|Lenograstim|lenograstim|mesh-list
154416680|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154416681|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416682|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
154416683|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
154416684|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
154416685|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416686|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154416687|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
153775679|NCT05136846|Pemetrexed|pemetrexed|mesh-list
154416688|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416689|NCT03134183|Misoprostol|misoprostol|mesh-list
154416690|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154416691|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
154416692|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154416693|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416694|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154416695|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416696|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
154416697|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
154416698|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416699|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416700|NCT02083484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154416701|NCT02083484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416702|NCT01354613|Amlodipine|amlodipine|mesh-list
154416703|NCT01354613|Dobutamine|dobutamine|mesh-list
154416704|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154416705|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154416706|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154416707|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416708|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154416709|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416710|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
154416711|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154416712|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
154416713|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
154416714|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416715|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154416716|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154416717|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154416718|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
154416719|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416720|NCT01354613|Protective Agents|protective agents|mesh-ancestor
154416721|NCT02083640|Palbociclib|palbociclib|mesh-list
154416722|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416723|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154416724|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416725|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416726|NCT01352039|Heparin|heparin|mesh-list
154416727|NCT01352039|Calcium heparin|calcium heparin|mesh-list
154416728|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
154416729|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154416730|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154416731|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416732|NCT04419337|Metformin|metformin|mesh-list
154416733|NCT04419337|Pioglitazone|pioglitazone|mesh-list
154416734|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154416735|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153775680|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153814336|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154416736|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416737|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416738|NCT01359059|Pregabalin|pregabalin|mesh-list
154416739|NCT01359059|Analgesics|analgesics|mesh-ancestor
154416740|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
154416741|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416742|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416743|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
154416744|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154416745|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154416746|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416747|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154416748|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154416749|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154416750|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416751|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154416752|NCT05189093|Antibodies|antibodies|mesh-list
154416753|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154416754|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
154416755|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416756|NCT01371331|Tacrolimus|tacrolimus|mesh-list
154416757|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154416758|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
154416759|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416760|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154416761|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416762|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416763|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
154416764|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154416765|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416766|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
154416767|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416768|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
154416769|NCT03133793|Vitamins|vitamins|mesh-ancestor
154416770|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
154416771|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416772|NCT03133481|Ropivacaine|ropivacaine|mesh-list
154416773|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154416774|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
154416775|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154416776|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416777|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
154416778|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416779|NCT01366651|Doripenem|doripenem|mesh-list
154416780|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154416781|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154416782|NCT05124509|Vaccines|vaccines|mesh-list
154416783|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
154416784|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416785|NCT02864316|Nivolumab|nivolumab|mesh-list
154416786|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416787|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416788|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154416789|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416790|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
154416791|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154416792|NCT02862600|Perhexiline|perhexiline|mesh-list
154416793|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154416794|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154416795|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416796|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154416797|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416798|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
154416799|NCT01354925|Insulin|insulin|mesh-list
153991396|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416800|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416801|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416802|NCT03556345|Trastuzumab|trastuzumab|mesh-list
154416803|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416804|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416805|NCT03610230|Iron|iron|mesh-list
154416806|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154416807|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
154416808|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154416809|NCT03610230|Trace Elements|trace elements|mesh-ancestor
154416810|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
153776438|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776439|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776440|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
154416811|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416812|NCT03610230|Hematinics|hematinics|mesh-ancestor
154416813|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
154416814|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154416815|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416816|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416817|NCT05188859|Pemetrexed|pemetrexed|mesh-list
154416818|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416819|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416820|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416821|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154416822|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154416824|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154416825|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154416826|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416827|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
154416828|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
154416829|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
154416830|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416831|NCT02792192|Atezolizumab|atezolizumab|mesh-list
154416832|NCT02792192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154416833|NCT02792192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416834|NCT02792192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416835|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416836|NCT03609996|Ranibizumab|ranibizumab|mesh-list
154416837|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154416838|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154416839|NCT03609996|Growth Substances|growth substances|mesh-ancestor
154416840|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416841|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
154416842|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416843|NCT02088008|Valsartan|valsartan|mesh-list
154416844|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154416845|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154416846|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154416847|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416848|NCT01361789|Dexamethasone|dexamethasone|mesh-list
154416849|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
154416850|NCT01361789|Etoricoxib|etoricoxib|mesh-list
154416851|NCT01361789|Parecoxib|parecoxib|mesh-list
154416852|NCT01361789|Valdecoxib|valdecoxib|mesh-list
154416853|NCT01361789|BB 1101|bb 1101|mesh-list
154416854|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416855|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
154416856|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
154416857|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416858|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416859|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416860|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
154416861|NCT01361789|Hormones|hormones|mesh-ancestor
154416862|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416863|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154416864|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416865|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
154416866|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416867|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416868|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154416869|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416870|NCT01361789|Analgesics|analgesics|mesh-ancestor
154416871|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
154416872|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154416873|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154416874|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154416875|NCT02964507|Fulvestrant|fulvestrant|mesh-list
154416876|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154416877|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416878|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154416879|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154416880|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
154416881|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416882|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416883|NCT02083874|Cannabidiol|cannabidiol|mesh-list
154416884|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
154416885|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
154416886|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154416887|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416888|NCT05188781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154416889|NCT05188781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416890|NCT03634735|Thiamine|thiamine|mesh-list
154416891|NCT03634735|Vitamins|vitamins|mesh-ancestor
154416892|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
154045425|NCT00995917|Vitamin K|vitamin k|mesh-list
154416893|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416894|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
154416895|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154416896|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
154416897|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154416898|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154416899|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416900|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
154416901|NCT02084342|Coagulants|coagulants|mesh-ancestor
154416902|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154416903|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
154416904|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416905|NCT01371487|Trametinib|trametinib|mesh-list
154416906|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416907|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154416908|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416909|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416910|NCT02084420|Pantoprazole|pantoprazole|mesh-list
154416911|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154416912|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154416913|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154416914|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416915|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416916|NCT01367431|Xanthohumol|xanthohumol|mesh-list
154416917|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416918|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154416919|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154416920|NCT01367431|Growth Substances|growth substances|mesh-ancestor
154416921|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416922|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
154416923|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
154416924|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154416925|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416926|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
154416927|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416928|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
154416929|NCT01364701|Tadalafil|tadalafil|mesh-list
154416930|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
153776753|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
153814340|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
154416931|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154416932|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154416933|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416934|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416935|NCT01364701|Urological Agents|urological agents|mesh-ancestor
154416936|NCT02440464|Fludarabine|fludarabine|mesh-list
154416937|NCT02440464|Bortezomib|bortezomib|mesh-list
154416938|NCT02440464|Melphalan|melphalan|mesh-list
154416939|NCT02440464|Ixazomib|ixazomib|mesh-list
154416940|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416941|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416942|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154416943|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
154416944|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416945|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154416946|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
154416947|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154416948|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
154416949|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416950|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
154416951|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154416952|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416953|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
154416954|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416956|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154416957|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154416958|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416959|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416960|NCT02084576|Ketorolac|ketorolac|mesh-list
154416961|NCT02084576|Nepafenac|nepafenac|mesh-list
154416962|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154416963|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154416964|NCT02084576|Analgesics|analgesics|mesh-ancestor
154416965|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
154416966|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416967|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416968|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154416969|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154416970|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154416971|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416972|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416973|NCT03131453|Umibecestat|umibecestat|mesh-list
154416974|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154416975|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416976|NCT02084654|Exenatide|exenatide|mesh-list
154416977|NCT02084654|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154416978|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154416979|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416980|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154416981|NCT02084654|Incretins|incretins|mesh-ancestor
154416982|NCT02084654|Hormones|hormones|mesh-ancestor
154416983|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154416984|NCT01367743|Epinephrine|epinephrine|mesh-list
154416985|NCT01367743|Norepinephrine|norepinephrine|mesh-list
154416986|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154416987|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154416988|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154416989|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
154416990|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154416991|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154416992|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154416993|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154416994|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154416995|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
154416996|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154416997|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154416998|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
154416999|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
154417000|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
154417001|NCT02084732|Sorafenib|sorafenib|mesh-list
154417002|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417003|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154417004|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417005|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417006|NCT02780401|Vaccines|vaccines|mesh-list
154417007|NCT02780401|Sargramostim|sargramostim|mesh-list
154417008|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
154417009|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417010|NCT02533232|Minocycline|minocycline|mesh-list
154417011|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154417012|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417013|NCT02673151|Edetic Acid|edetic acid|mesh-list
154417014|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154417015|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
154417016|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
154417017|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417018|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
154417019|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154417020|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154417021|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154417022|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
154417023|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154417024|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154417025|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417026|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154417027|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154417028|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
154417030|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154417031|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417032|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417033|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417034|NCT02082236|Sufentanil|sufentanil|mesh-list
154417035|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154417036|NCT02082236|Narcotics|narcotics|mesh-ancestor
154417037|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417038|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417039|NCT02082236|Analgesics|analgesics|mesh-ancestor
154417040|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
154417041|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417042|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154417043|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154417044|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
154417045|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
154417046|NCT03557996|Listerine|listerine|mesh-list
154417047|NCT03557996|Fluorides|fluorides|mesh-list
154417048|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
154417049|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
154417050|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
154417051|NCT03557996|Protective Agents|protective agents|mesh-ancestor
154417052|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417053|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154417054|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417055|NCT02296801|Letrozole|letrozole|mesh-list
154417056|NCT02296801|Palbociclib|palbociclib|mesh-list
154417057|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417058|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154417059|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154417060|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417061|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417062|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154417063|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
153814341|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
154417064|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777294|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153777295|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153777348|NCT00564772|Lopinavir|lopinavir|mesh-list
154417065|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417066|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154417067|NCT02859324|Nivolumab|nivolumab|mesh-list
154417068|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154417069|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417070|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154417071|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417072|NCT02085590|Vaccines|vaccines|mesh-list
154417073|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
154417074|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
154417075|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417076|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154417077|NCT02143063|Cocaine|cocaine|mesh-list
154417078|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
154417079|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
154417080|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417081|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417082|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
154417083|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417084|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154417085|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154417086|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154417087|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154417088|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417089|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
154417090|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417091|NCT02088866|Lidocaine|lidocaine|mesh-list
154417092|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
154417093|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
154417094|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417095|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417096|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
153777543|NCT00252408|Hormones|hormones|mesh-list
154417097|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417098|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154417099|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154417100|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154417101|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154417102|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417103|NCT02859246|Guaifenesin|guaifenesin|mesh-list
154417104|NCT02859246|Expectorants|expectorants|mesh-ancestor
154417105|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
154417106|NCT02088944|Infliximab|infliximab|mesh-list
154417107|NCT02088944|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154417108|NCT02088944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154417109|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
154417110|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154417111|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154417112|NCT02073097|Acyclovir|acyclovir|mesh-list
154417113|NCT02073097|Prednisone|prednisone|mesh-list
154417114|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
154417115|NCT02073097|Rituximab|rituximab|mesh-list
154417116|NCT02073097|Doxorubicin|doxorubicin|mesh-list
154417117|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154417118|NCT02073097|Vincristine|vincristine|mesh-list
154417119|NCT02073097|Lenograstim|lenograstim|mesh-list
154417120|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154417121|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
154417122|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417124|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154417125|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
154417126|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417127|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417128|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154417129|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154417130|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154417131|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154417132|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154417133|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417134|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154417135|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
154417136|NCT02073097|Hormones|hormones|mesh-ancestor
154417137|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154417138|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154417139|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154417140|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
153814345|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154417141|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
154417142|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
154417143|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154417144|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
154417145|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417146|NCT02791490|Metformin|metformin|mesh-list
154417147|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154417148|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154417149|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417150|NCT02791490|Incretins|incretins|mesh-ancestor
154417151|NCT02791490|Hormones|hormones|mesh-ancestor
154417152|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154417153|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154417154|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
154417155|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417156|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417157|NCT02085824|Enoxaparin|enoxaparin|mesh-list
154417158|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
154417159|NCT02085824|Dabigatran|dabigatran|mesh-list
154417160|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154417161|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
154417162|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154417163|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
154417164|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417165|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417166|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
154417167|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154417168|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154417169|NCT01368445|Azelastine|azelastine|mesh-list
154417170|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154417171|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
154417172|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417173|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991771|NCT00794755|Vitamins|vitamins|mesh-ancestor
154417174|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154417175|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
154417176|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154417177|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417178|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417179|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154417180|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153777659|NCT04598542|Hormones|hormones|mesh-ancestor
153814346|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
153777862|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
153777863|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417181|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154417182|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
154417183|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
154417184|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417186|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
154417187|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
154417188|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417189|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417190|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
154417191|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417192|NCT01368523|Nilotinib|nilotinib|mesh-list
154417193|NCT01368523|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154417194|NCT01368523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154417195|NCT01368523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417196|NCT01368523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417197|NCT01368757|Lenalidomide|lenalidomide|mesh-list
154417198|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
154417199|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417200|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154417201|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154417202|NCT01368757|Growth Substances|growth substances|mesh-ancestor
154417203|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
154417204|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417205|NCT02086292|Lidocaine|lidocaine|mesh-list
154417206|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
154417207|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
154417208|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417209|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417210|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
154417211|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417212|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154417213|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154417214|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154417215|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154417216|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417217|NCT02425644|Teriflunomide|teriflunomide|mesh-list
154417218|NCT02425644|Ponesimod|ponesimod|mesh-list
154417219|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154417220|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154417221|NCT02425644|Analgesics|analgesics|mesh-ancestor
154417222|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
154417223|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417224|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417225|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154417226|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154417227|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154417228|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
154417229|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154417230|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417231|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
154417232|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154417233|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
154417234|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154417235|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
154417236|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417237|NCT02086526|Metformin|metformin|mesh-list
154417238|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154417239|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417240|NCT04180995|Axitinib|axitinib|mesh-list
154417241|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417242|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154417243|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417244|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417245|NCT02089178|Remifentanil|remifentanil|mesh-list
154417246|NCT02089178|Anesthetics|anesthetics|mesh-list
154417247|NCT02089178|Propofol|propofol|mesh-list
154417248|NCT02089178|Sevoflurane|sevoflurane|mesh-list
154417249|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417250|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417251|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154417252|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154417253|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
154417254|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154417255|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154417256|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154417257|NCT02089178|Narcotics|narcotics|mesh-ancestor
154417258|NCT02089178|Analgesics|analgesics|mesh-ancestor
154417259|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
154417260|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417261|NCT02089256|Liraglutide|liraglutide|mesh-list
154417262|NCT02089256|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154417263|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154417264|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417265|NCT02089256|Incretins|incretins|mesh-ancestor
154417266|NCT02089256|Hormones|hormones|mesh-ancestor
154417267|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154417268|NCT02861664|Fluorides|fluorides|mesh-list
154417269|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
154417270|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
154417271|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
154417272|NCT02861664|Protective Agents|protective agents|mesh-ancestor
154417273|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417275|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
154417276|NCT02086838|Hematinics|hematinics|mesh-list
154417277|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
154417278|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
154417279|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
154417280|NCT02236962|Pioglitazone|pioglitazone|mesh-list
154417281|NCT02236962|Ephedrine|ephedrine|mesh-list
154417282|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154417283|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417284|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154417285|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
154417286|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
154417287|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417288|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154417289|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
154417290|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417291|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417292|NCT04431375|Tenofovir|tenofovir|mesh-list
154417293|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
154417294|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417295|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154417296|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154417297|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417298|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417299|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154417300|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154417301|NCT02086994|Misoprostol|misoprostol|mesh-list
154417302|NCT02086994|Carbetocin|carbetocin|mesh-list
154417303|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154417304|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
154417305|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154417306|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417307|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154417308|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154417309|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
154417310|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154417311|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154417312|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417313|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154417314|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417315|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417316|NCT03284853|Latanoprost|latanoprost|mesh-list
154417317|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154417318|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154417319|NCT02087384|Vaccines|vaccines|mesh-list
154417320|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
154417321|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417322|NCT02087462|Vitamins|vitamins|mesh-list
154417323|NCT02087462|Thiamine|thiamine|mesh-list
154417324|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
154417325|NCT02087462|Diclofenac|diclofenac|mesh-list
154417326|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
154417327|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417328|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154417329|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154417330|NCT02087462|Analgesics|analgesics|mesh-ancestor
154417331|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
154417332|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417333|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154417334|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154417335|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154417336|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417337|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417338|NCT02087540|Telmisartan|telmisartan|mesh-list
153814348|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
153814349|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
154417339|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154417340|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154417341|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154417342|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
154417343|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417344|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154417345|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154417346|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417347|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154417348|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154417349|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154417350|NCT03206463|Dronabinol|dronabinol|mesh-list
154417351|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
154417352|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417353|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154417354|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154417355|NCT03206463|Analgesics|analgesics|mesh-ancestor
154417356|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
154417357|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417358|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154417359|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154417360|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417361|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417362|NCT03206463|Hormones|hormones|mesh-ancestor
154417363|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154417364|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
154417365|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154417366|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
154417367|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417368|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
154417369|NCT02091674|Protective Agents|protective agents|mesh-ancestor
154417370|NCT01218555|Lenalidomide|lenalidomide|mesh-list
154417371|NCT01218555|Everolimus|everolimus|mesh-list
154417372|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
154417373|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417374|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154417375|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154417376|NCT01218555|Growth Substances|growth substances|mesh-ancestor
154417377|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
154417378|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417379|NCT01218555|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154417380|NCT01218555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154417381|NCT01218555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417382|NCT01218555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417383|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154417384|NCT02091830|Acetaminophen|acetaminophen|mesh-list
154417385|NCT02091830|Cortisone|cortisone|mesh-list
154417386|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154417387|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154417388|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154417389|NCT02091830|Analgesics|analgesics|mesh-ancestor
154417390|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
154417391|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417392|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417393|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
153778135|NCT04591600|Ivermectin|ivermectin|mesh-list
154417394|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154417395|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
154417396|NCT01111305|Reslizumab|reslizumab|mesh-list
154417397|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154417398|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
154417399|NCT01111305|Filaricides|filaricides|mesh-ancestor
154417400|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
154417401|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
153991998|NCT00912483|Calcium heparin|calcium heparin|mesh-list
154417402|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154417403|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417404|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154417405|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417406|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417407|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154417408|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154417409|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417410|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417411|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154417412|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154417413|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417414|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417415|NCT02091908|Lactitol|lactitol|mesh-list
154417416|NCT02091908|Vaccines|vaccines|mesh-list
154417417|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
154417418|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417419|NCT02091908|Cathartics|cathartics|mesh-ancestor
154417420|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154417422|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
154417423|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
154417424|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417425|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417426|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
154417427|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417428|NCT01372111|Cisplatin|cisplatin|mesh-list
154417429|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417430|NCT03125941|Dexamethasone|dexamethasone|mesh-list
154417431|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154417432|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
154417433|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
154417434|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417435|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417436|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153387527|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814351|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417437|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
154417438|NCT03125941|Hormones|hormones|mesh-ancestor
154417439|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154417440|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154417441|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417442|NCT02092142|Vaccines|vaccines|mesh-list
154417443|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
154417444|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417445|NCT02095886|BMS-955176|bms-955176|mesh-list
154417446|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154417447|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154417448|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
154417449|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417450|NCT01372579|Carboplatin|carboplatin|mesh-list
154417451|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417452|NCT02090036|Lumefantrine|lumefantrine|mesh-list
154417453|NCT02090036|Artemether|artemether|mesh-list
154417454|NCT02090036|Primaquine|primaquine|mesh-list
154417455|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154417456|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
154417457|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154417458|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154417459|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417460|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154417461|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154417462|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417463|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
154417464|NCT02092376|Vitamin D|vitamin d|mesh-list
154417465|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154417466|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417467|NCT02092376|Vitamins|vitamins|mesh-ancestor
154417468|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
154417469|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154417470|NCT05452928|Valacyclovir|valacyclovir|mesh-list
154417471|NCT05452928|Acyclovir|acyclovir|mesh-list
154417472|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
154417473|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417474|NCT03125395|Ivacaftor|ivacaftor|mesh-list
154417475|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154417476|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154417477|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417478|NCT01369303|Tenofovir|tenofovir|mesh-list
154417479|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
154417480|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417481|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154417482|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154417484|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417485|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154417486|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154417487|NCT02092532|Aflibercept|aflibercept|mesh-list
154417488|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154417489|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154417490|NCT02092532|Growth Substances|growth substances|mesh-ancestor
154417491|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417492|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
154417493|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417494|NCT02092766|Artesunate|artesunate|mesh-list
154417495|NCT02092766|Quinine|quinine|mesh-list
154417496|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
154417497|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154417498|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154417499|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417500|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417501|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
154417502|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
154417503|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154417504|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
154417505|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154417506|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417507|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154417508|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417509|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154417510|NCT02092766|Analgesics|analgesics|mesh-ancestor
154417511|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
154417512|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154417513|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
154417514|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154417515|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
154417516|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417517|NCT02721069|Diazepam|diazepam|mesh-list
154417518|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154417519|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
154417520|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
154417521|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
154417522|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417523|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417524|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154417525|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154417526|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417527|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154417528|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154417529|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154417530|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154417531|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154417532|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154417533|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
154417534|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
154417535|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
154417536|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
154417537|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417538|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417539|NCT02093000|Bevacizumab|bevacizumab|mesh-list
154417540|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154417541|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417542|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154417543|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154417544|NCT02093000|Growth Substances|growth substances|mesh-ancestor
154417545|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417546|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
154417547|NCT00261807|Daptomycin|daptomycin|mesh-list
154417548|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154417549|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417550|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
154417551|NCT02090504|Oxazepam|oxazepam|mesh-list
154417552|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154417553|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154417554|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
154417555|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
154417556|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417557|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417558|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154417559|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154417560|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154417561|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154417562|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
154417563|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
154417564|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417565|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417566|NCT01567059|Cytarabine|cytarabine|mesh-list
154417567|NCT01567059|Decitabine|decitabine|mesh-list
154417568|NCT01567059|Azacitidine|azacitidine|mesh-list
154417569|NCT01567059|Tosedostat|tosedostat|mesh-list
154417570|NCT01567059|Glycine|glycine|mesh-list
154417571|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154417572|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
154417573|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417574|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417575|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
154417576|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417578|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
154417579|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417580|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417581|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
154417582|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417583|NCT02090738|Amoxicillin|amoxicillin|mesh-list
154417584|NCT02090738|Clarithromycin|clarithromycin|mesh-list
154417585|NCT02090738|Acetazolamide|acetazolamide|mesh-list
154417586|NCT02090738|Esomeprazole|esomeprazole|mesh-list
154417587|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154417588|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417589|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154417590|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154417591|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154417592|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417593|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417594|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154417595|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154417596|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154417597|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
154417598|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154417599|NCT02090738|Diuretics|diuretics|mesh-ancestor
154417600|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
154417601|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417602|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
154417603|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154417604|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154417605|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154417606|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154417607|NCT03441555|Venetoclax|venetoclax|mesh-list
154417608|NCT03441555|Alvocidib|alvocidib|mesh-list
154417609|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417610|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
154417611|NCT03441555|Growth Substances|growth substances|mesh-ancestor
154417612|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417613|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154417614|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417615|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417616|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154417617|NCT03346239|Escitalopram|escitalopram|mesh-list
154417618|NCT03346239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154417619|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154417620|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154417621|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417622|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417623|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
154417624|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417625|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
154417626|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154417627|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417628|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417629|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154417630|NCT05218161|Analgesics|analgesics|mesh-ancestor
154417631|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
154417632|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417633|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153736447|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736449|NCT02420847|Doxorubicin|doxorubicin|mesh-list
154417634|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154417635|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154417636|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
154417637|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417638|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417639|NCT02861586|Vaccines|vaccines|mesh-list
154417640|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
154417641|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417642|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154417643|NCT02099240|Amoxicillin|amoxicillin|mesh-list
154417644|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
154417645|NCT02099240|Azithromycin|azithromycin|mesh-list
154417646|NCT02099240|Vancomycin|vancomycin|mesh-list
154417647|NCT02099240|Clarithromycin|clarithromycin|mesh-list
154417648|NCT02099240|Doxycycline|doxycycline|mesh-list
154417649|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
154417650|NCT02099240|Levofloxacin|levofloxacin|mesh-list
154417651|NCT02099240|Ofloxacin|ofloxacin|mesh-list
154417652|NCT02099240|Minocycline|minocycline|mesh-list
154417653|NCT02099240|Rifampin|rifampin|mesh-list
154417654|NCT02099240|Clindamycin|clindamycin|mesh-list
154417655|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
154417656|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
154417657|NCT02099240|Gentamicins|gentamicins|mesh-list
154417658|NCT02099240|Isoniazid|isoniazid|mesh-list
154417659|NCT02099240|Meropenem|meropenem|mesh-list
154417660|NCT02099240|Tazobactam|tazobactam|mesh-list
154417661|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
154417662|NCT02099240|Linezolid|linezolid|mesh-list
154417663|NCT02099240|Cycloserine|cycloserine|mesh-list
154417664|NCT02099240|Piperacillin|piperacillin|mesh-list
154417665|NCT02099240|Metronidazole|metronidazole|mesh-list
154417666|NCT02099240|Penicillins|penicillins|mesh-list
154417667|NCT02099240|Imipenem|imipenem|mesh-list
154417668|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
154417669|NCT02099240|Amikacin|amikacin|mesh-list
154417670|NCT02099240|Erythromycin|erythromycin|mesh-list
154417671|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
154417672|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154417673|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
154417674|NCT02099240|Colistin|colistin|mesh-list
154417675|NCT02099240|Ceftazidime|ceftazidime|mesh-list
154417676|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154417677|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
154417678|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
154417679|NCT02099240|Ampicillin|ampicillin|mesh-list
154417680|NCT02099240|Mupirocin|mupirocin|mesh-list
154417681|NCT02099240|Rifapentine|rifapentine|mesh-list
154417682|NCT02099240|Rifabutin|rifabutin|mesh-list
154417683|NCT02099240|Cefepime|cefepime|mesh-list
154417684|NCT02099240|Cefuroxime|cefuroxime|mesh-list
154417685|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
154417686|NCT02099240|Fosfomycin|fosfomycin|mesh-list
154417687|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154417688|NCT02099240|Paromomycin|paromomycin|mesh-list
154417689|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
154417690|NCT02099240|Aztreonam|aztreonam|mesh-list
154417691|NCT02099240|Polymyxins|polymyxins|mesh-list
154417692|NCT02099240|Neomycin|neomycin|mesh-list
154417693|NCT02099240|Sulbactam|sulbactam|mesh-list
154417694|NCT02099240|Bacitracin|bacitracin|mesh-list
154417695|NCT02099240|Cefotaxime|cefotaxime|mesh-list
154417696|NCT02099240|Cefoxitin|cefoxitin|mesh-list
154417697|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
154417698|NCT02099240|Cefixime|cefixime|mesh-list
154417699|NCT02099240|Polymyxin B|polymyxin b|mesh-list
154417700|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
154417701|NCT02099240|Cefdinir|cefdinir|mesh-list
154417702|NCT02099240|Penicillin G|penicillin g|mesh-list
154417703|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154417704|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
154417705|NCT02099240|Norfloxacin|norfloxacin|mesh-list
154417706|NCT02099240|Cloxacillin|cloxacillin|mesh-list
154417707|NCT02099240|Cefprozil|cefprozil|mesh-list
154417708|NCT02099240|Cephalosporins|cephalosporins|mesh-list
154417709|NCT02099240|Oxacillin|oxacillin|mesh-list
154417710|NCT02099240|Streptomycin|streptomycin|mesh-list
154417711|NCT02099240|Nafcillin|nafcillin|mesh-list
154417712|NCT02099240|Ticarcillin|ticarcillin|mesh-list
154417713|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
154417714|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
154417715|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
154417716|NCT02099240|Sultamicillin|sultamicillin|mesh-list
154417717|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
154417718|NCT02099240|Cefpodoxime Proxetil|cefpodoxime proxetil|mesh-list
154417719|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
154417720|NCT02099240|Ceftibuten|ceftibuten|mesh-list
154417721|NCT02099240|Ethionamide|ethionamide|mesh-list
154417722|NCT02099240|Kanamycin|kanamycin|mesh-list
154417723|NCT02099240|Penicillin V|penicillin v|mesh-list
154417724|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
154417726|NCT02099240|Lincomycin|lincomycin|mesh-list
154417727|NCT02099240|Dirithromycin|dirithromycin|mesh-list
154417728|NCT02099240|Demeclocycline|demeclocycline|mesh-list
154417729|NCT02099240|Cefotetan|cefotetan|mesh-list
154417730|NCT02099240|Cefaclor|cefaclor|mesh-list
154417731|NCT02099240|Capreomycin|capreomycin|mesh-list
154417732|NCT02099240|Mafenide|mafenide|mesh-list
154417733|NCT02099240|Tobramycin|tobramycin|mesh-list
154417734|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
153736454|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
153779109|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154417735|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
154417736|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
154417737|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
154417738|NCT02099240|Netilmicin|netilmicin|mesh-list
154417739|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
154417740|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
154417741|NCT02099240|Virginiamycin|virginiamycin|mesh-list
154417742|NCT02099240|Novobiocin|novobiocin|mesh-list
154417743|NCT02099240|Enoxacin|enoxacin|mesh-list
154417744|NCT02099240|Methicillin|methicillin|mesh-list
154417745|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154417746|NCT02099240|Bacampicillin|bacampicillin|mesh-list
154417747|NCT02099240|Carbenicillin|carbenicillin|mesh-list
154417748|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
154417749|NCT02099240|Mezlocillin|mezlocillin|mesh-list
154417750|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
154417751|NCT02099240|Cefamandole|cefamandole|mesh-list
154417752|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
154417753|NCT02099240|Cefonicid|cefonicid|mesh-list
154417754|NCT02099240|Cefmetazole|cefmetazole|mesh-list
154417755|NCT02099240|Loracarbef|loracarbef|mesh-list
154417756|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
154417757|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
154417758|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
154417759|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
154417760|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
154417761|NCT02099240|Methacycline|methacycline|mesh-list
154417762|NCT02099240|Tetracycline|tetracycline|mesh-list
154417763|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
154417764|NCT02099240|Dalfopristin|dalfopristin|mesh-list
154417765|NCT02099240|Spectinomycin|spectinomycin|mesh-list
154417766|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154417767|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
154417768|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
154417769|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154417770|NCT02099240|Methenamine|methenamine|mesh-list
154417771|NCT02099240|Sulperazone|sulperazone|mesh-list
154417772|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
154417773|NCT02099240|Cinoxacin|cinoxacin|mesh-list
154417774|NCT02099240|Trimethoprim|trimethoprim|mesh-list
154417775|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
154417776|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
154417777|NCT02099240|Procaine|procaine|mesh-list
154417778|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153779298|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
154417779|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154417780|NCT02099240|Cilastatin|cilastatin|mesh-list
154417781|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417782|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
154417783|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154417784|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154417785|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417786|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417787|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417788|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154417789|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
154417790|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154417791|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417792|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154417793|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154417794|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154417795|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154417796|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154417797|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154417798|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
154417799|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154417800|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154417801|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154417802|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154417803|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
154417804|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154417805|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154417806|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154417807|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154417808|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154417809|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154417810|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154417811|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154417812|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154417813|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
154417814|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154417815|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154417816|NCT02099240|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154254691|NCT03916406|Midazolam|midazolam|mesh-list
154417817|NCT02099240|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154417818|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153814360|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154417819|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154417820|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154417821|NCT02099240|Analgesics|analgesics|mesh-ancestor
154417822|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
154417823|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417824|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154417825|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154417826|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
154417827|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154417828|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154417829|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154417830|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
154417831|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
154417832|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
154417833|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417834|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154417835|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154417836|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154417837|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154417838|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
154417839|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
154417840|NCT05215743|Antioxidants|antioxidants|mesh-list
154417841|NCT05215743|Deferoxamine|deferoxamine|mesh-list
154417842|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
154417843|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417844|NCT05215743|Expectorants|expectorants|mesh-ancestor
154417845|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
154417846|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154417847|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417848|NCT05215743|Protective Agents|protective agents|mesh-ancestor
154417849|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417850|NCT05215743|Siderophores|siderophores|mesh-ancestor
154417851|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154417852|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
154417853|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
154417854|NCT02099396|Gemcitabine|gemcitabine|mesh-list
154417855|NCT02099396|Docetaxel|docetaxel|mesh-list
154417856|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154417857|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
154417858|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417859|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417860|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
154417861|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
154417862|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
154417863|NCT05215665|Lenvatinib|lenvatinib|mesh-list
154417864|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417865|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154417866|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417867|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417868|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
154417869|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154417870|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154417871|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
154417872|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154417873|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154417874|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154417875|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417876|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417877|NCT05217069|Leucovorin|leucovorin|mesh-list
154417878|NCT05217069|Folic Acid|folic acid|mesh-list
154417879|NCT05217069|Irinotecan|irinotecan|mesh-list
154417880|NCT05217069|Cetuximab|cetuximab|mesh-list
154417881|NCT05217069|Avelumab|avelumab|mesh-list
154417882|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
154417883|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154417884|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154417886|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417887|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417888|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154417889|NCT05217069|Antidotes|antidotes|mesh-ancestor
154417890|NCT05217069|Protective Agents|protective agents|mesh-ancestor
154417891|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417892|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
154417893|NCT05217069|Vitamins|vitamins|mesh-ancestor
154417894|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
154417896|NCT02065635|Propofol|propofol|mesh-list
154417897|NCT02065635|Sevoflurane|sevoflurane|mesh-list
154417898|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154417899|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417900|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417901|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154417902|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
154417903|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
154417904|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154417905|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154417906|NCT03628053|Blinatumomab|blinatumomab|mesh-list
154417907|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154417908|NCT03628053|Tisagenlecleucel|tisagenlecleucel|mesh-list
154417909|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417910|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154417911|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154417912|NCT03628053|Immunotoxins|immunotoxins|mesh-ancestor
154417913|NCT03628053|Immunoconjugates|immunoconjugates|mesh-ancestor
154417914|NCT03628053|Immunologic Factors|immunologic factors|mesh-ancestor
154417915|NCT03628053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417916|NCT02100176|Dopamine|dopamine|mesh-list
154417917|NCT02100176|Rotigotine|rotigotine|mesh-list
154417918|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
154417919|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
154417920|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417921|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417922|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417923|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154417924|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
154417925|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
154417926|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417927|NCT02100176|Protective Agents|protective agents|mesh-ancestor
154417928|NCT02250482|Factor VIII|factor viii|mesh-list
154417929|NCT02250482|Coagulants|coagulants|mesh-ancestor
154417930|NCT04967079|Trametinib|trametinib|mesh-list
154417931|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417932|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154417933|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417934|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417935|NCT03556592|Metoprolol|metoprolol|mesh-list
154417936|NCT03556592|Midazolam|midazolam|mesh-list
154417937|NCT03556592|Caffeine|caffeine|mesh-list
154417938|NCT03556592|Omeprazole|omeprazole|mesh-list
154417939|NCT03556592|Warfarin|warfarin|mesh-list
154417940|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154417941|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154417942|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154417943|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417944|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154417945|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154417946|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154417947|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154417948|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
154417949|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
154417950|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
154417951|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
154417952|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154417953|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154417954|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
154417955|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154417956|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154417957|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417958|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154417959|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154417960|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
154417961|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154417962|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154417963|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154417964|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154417965|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154417967|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
153779916|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153779917|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154417968|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154417969|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154417970|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154417971|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154417972|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
154417973|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
154417975|NCT04964193|Cyproterone|cyproterone|mesh-list
154417976|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
154417977|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154417978|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154417979|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154417980|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
154417981|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154417982|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417983|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154417984|NCT04964193|Estrogens|estrogens|mesh-ancestor
154417985|NCT04964193|Hormones|hormones|mesh-ancestor
154417986|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154417987|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
154417988|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
154417989|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417990|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154417991|NCT02100488|Insulin|insulin|mesh-list
154417992|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154417993|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154417994|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154417995|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
154417996|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154417997|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154417998|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154417999|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
154418000|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154418001|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418002|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418003|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418004|NCT04865497|Vaccines|vaccines|mesh-list
154418005|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
154418006|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418007|NCT05665725|Siltuximab|siltuximab|mesh-list
154418008|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154418009|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418010|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
154418011|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418012|NCT02098148|Xenon|xenon|mesh-list
154418013|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154418014|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
154418015|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
154418016|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154418017|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418018|NCT05168527|Paclitaxel|paclitaxel|mesh-list
154418019|NCT05168527|Gemcitabine|gemcitabine|mesh-list
154418020|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154418021|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418022|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
154418023|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
154418024|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
154418025|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418026|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154418027|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
154418028|NCT02098460|Cilostazol|cilostazol|mesh-list
154418029|NCT02098460|Atorvastatin|atorvastatin|mesh-list
154418030|NCT02098460|Probucol|probucol|mesh-list
154418031|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154418032|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154418033|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
154418034|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418035|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154418036|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154418037|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418038|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154418039|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
154418040|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418041|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418042|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154418043|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
154418044|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154418045|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154418046|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154418047|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
154418048|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154418049|NCT02098460|Protective Agents|protective agents|mesh-ancestor
154418050|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154418051|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154418053|NCT02095574|Venetoclax|venetoclax|mesh-list
154418054|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418055|NCT02095730|Vitamins|vitamins|mesh-list
154418056|NCT02095730|Riboflavin|riboflavin|mesh-list
154418057|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
154418058|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
154418059|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418060|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154418061|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
154418062|NCT02102438|Paclitaxel|paclitaxel|mesh-list
154418063|NCT02102438|Carboplatin|carboplatin|mesh-list
154418064|NCT02102438|Trastuzumab|trastuzumab|mesh-list
154418065|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154418066|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418067|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
154418068|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
154418069|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
154418070|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418071|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154418072|NCT02098616|Asunaprevir|asunaprevir|mesh-list
154418073|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
154418074|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418075|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418076|NCT02102516|Ketorolac|ketorolac|mesh-list
154418077|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154418078|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154418079|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154418080|NCT02102516|Analgesics|analgesics|mesh-ancestor
154418081|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
154418082|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418083|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418084|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418085|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418086|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154418087|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418088|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418089|NCT02106182|Silodosin|silodosin|mesh-list
154418090|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154418091|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154418092|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154418093|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
154418094|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418095|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418096|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418097|NCT02106182|Urological Agents|urological agents|mesh-ancestor
154418098|NCT01369693|Lobeline|lobeline|mesh-list
154418099|NCT01369693|Nicotine|nicotine|mesh-list
154418100|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154418101|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
154418102|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418103|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418104|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154418105|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154418106|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
154418107|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418108|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780186|NCT00228020|Cyclosporine|cyclosporine|mesh-list
154418109|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
154418110|NCT02102594|Bortezomib|bortezomib|mesh-list
154418111|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418112|NCT02102672|Trimetazidine|trimetazidine|mesh-list
154418113|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
154418115|NCT02106338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154418116|NCT02106338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418117|NCT04249323|Prednisone|prednisone|mesh-list
154418118|NCT04249323|Cortisone|cortisone|mesh-list
154418119|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418120|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
154418121|NCT04249323|Hormones|hormones|mesh-ancestor
154418122|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418123|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418124|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154418125|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418126|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154418127|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154418128|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418129|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418130|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154418131|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
154418132|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418133|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418134|NCT02102828|Aspirin|aspirin|mesh-list
154418135|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154418136|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154418137|NCT02102828|Analgesics|analgesics|mesh-ancestor
154418138|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
154418139|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418140|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418141|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418142|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418143|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154418144|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154418145|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418146|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154418147|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154418148|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418149|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
154418150|NCT01372423|Lubiprostone|lubiprostone|mesh-list
154418151|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154418152|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154418153|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418154|NCT02106650|Leucovorin|leucovorin|mesh-list
154418155|NCT02106650|Folic Acid|folic acid|mesh-list
154418156|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
153814366|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154418157|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
154418158|NCT02106650|Vitamins|vitamins|mesh-ancestor
154418159|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
154418160|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418161|NCT02106650|Antidotes|antidotes|mesh-ancestor
154418162|NCT02106650|Protective Agents|protective agents|mesh-ancestor
154418163|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
154418164|NCT02106650|Hematinics|hematinics|mesh-ancestor
154418165|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154418166|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418167|NCT01376011|Quercetin|quercetin|mesh-list
154418168|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
154418169|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418170|NCT01376011|Protective Agents|protective agents|mesh-ancestor
154418171|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418172|NCT02106806|Zinc|zinc|mesh-list
154418173|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
154418174|NCT02106806|Trace Elements|trace elements|mesh-ancestor
154418175|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
154418176|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418177|NCT02106806|Astringents|astringents|mesh-ancestor
154418178|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
154418179|NCT02966119|Aspirin|aspirin|mesh-list
154418180|NCT02966119|Clopidogrel|clopidogrel|mesh-list
154418181|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154418182|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154418183|NCT02966119|Analgesics|analgesics|mesh-ancestor
154418184|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
154418185|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418186|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418187|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418188|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418189|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154418190|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154418191|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418192|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154418193|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154418194|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418196|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154418197|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154418198|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154418199|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
154418200|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418201|NCT02101892|Amitriptyline|amitriptyline|mesh-list
154418202|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154418203|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
154418204|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154418205|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154418206|NCT02101892|Analgesics|analgesics|mesh-ancestor
154418207|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
154418208|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418209|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418210|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154418211|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153814367|NCT00451620|Glyburide|glyburide|mesh-list
153814370|NCT00445497|Amoxicillin|amoxicillin|mesh-list
154418212|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154418213|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418214|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
154418215|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418216|NCT03634111|Morphine|morphine|mesh-list
154418217|NCT03634111|Ropivacaine|ropivacaine|mesh-list
154418218|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154418219|NCT03634111|Narcotics|narcotics|mesh-ancestor
154418220|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154418221|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418222|NCT03634111|Analgesics|analgesics|mesh-ancestor
154418223|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
154418224|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418225|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154418226|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
154418227|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154418228|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154418229|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154418230|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
154418231|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418232|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418233|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154418234|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154418235|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
154418236|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418237|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
154418238|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154418239|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
154418240|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154418241|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418242|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154418243|NCT02250794|Insulin|insulin|mesh-list
154418244|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154418245|NCT02250794|Metformin|metformin|mesh-list
154418246|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
154418247|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154418248|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
154418249|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154418250|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418251|NCT02250794|Incretins|incretins|mesh-ancestor
154418252|NCT02250794|Hormones|hormones|mesh-ancestor
154418253|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418254|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154418255|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
154418256|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418257|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418258|NCT02103374|Terbutaline|terbutaline|mesh-list
154418259|NCT02103374|Ipratropium|ipratropium|mesh-list
154418260|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154418261|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
154418262|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992822|NCT01147016|Paclitaxel|paclitaxel|mesh-list
153814373|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
154418263|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418264|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154418265|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
154418266|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154418267|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
154418268|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418269|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418270|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
154418271|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
154418272|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154418273|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154418274|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154418275|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154418277|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
154418278|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154418279|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418280|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
154418281|NCT03117361|Dexamethasone|dexamethasone|mesh-list
154418282|NCT03117361|Bortezomib|bortezomib|mesh-list
154418283|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418284|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
154418285|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
154418286|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418287|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418288|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418289|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
154418290|NCT03117361|Hormones|hormones|mesh-ancestor
154418291|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418292|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154418293|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418294|NCT03053427|Gabapentin|gabapentin|mesh-list
154418295|NCT03053427|Analgesics|analgesics|mesh-ancestor
154418296|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
154418297|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418298|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418299|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
154418300|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154418301|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154418302|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154418303|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154418304|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154418305|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154418306|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418307|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418308|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
154418309|NCT02107118|Complement Factor H|complement factor h|mesh-list
154418310|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154418311|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154418312|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
154418313|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418314|NCT05081089|Lumefantrine|lumefantrine|mesh-list
154418315|NCT05081089|Artemether|artemether|mesh-list
154418316|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
154418317|NCT05081089|Primaquine|primaquine|mesh-list
154418318|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
154418319|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154418320|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154418321|NCT05081089|Amodiaquine|amodiaquine|mesh-list
154418322|NCT05081089|Tafenoquine|tafenoquine|mesh-list
154418323|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
154418324|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154418325|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153780583|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154418326|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418327|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154418328|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418329|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418330|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154418331|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154418332|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154418333|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418334|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154418335|NCT03554408|Antibodies|antibodies|mesh-list
154418336|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
154418337|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154418338|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
154418339|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418340|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418342|NCT02103686|Analgesics|analgesics|mesh-ancestor
154418343|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
154418344|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418345|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418346|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
154418347|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154418348|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154418349|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418350|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154418351|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154418352|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154418353|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154418354|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154418355|NCT02110082|Cetuximab|cetuximab|mesh-list
154418356|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154418357|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418358|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154418359|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
154418360|NCT02103764|Desogestrel|desogestrel|mesh-list
154418361|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154418362|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154418363|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154418364|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
154418365|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154418366|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418367|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154418368|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154418369|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154418370|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154418371|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418372|NCT02103764|Progestins|progestins|mesh-ancestor
154418373|NCT02103764|Hormones|hormones|mesh-ancestor
154418374|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418375|NCT02110316|Voriconazole|voriconazole|mesh-list
153814375|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153814376|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418376|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
154418377|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418378|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154418379|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154418380|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418381|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418382|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154418383|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
154418384|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418385|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418386|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154418387|NCT02110394|Rituximab|rituximab|mesh-list
154418388|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154418389|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154418390|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418391|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
154418392|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418393|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418394|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154418395|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
154418396|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418397|NCT02373241|Losartan|losartan|mesh-list
154418398|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154418399|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154418400|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154418401|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154418402|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418403|NCT05656131|Fluzoparib|fluzoparib|mesh-list
154418404|NCT05656131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154418405|NCT05656131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418406|NCT05656131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418407|NCT05656131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418408|NCT02103998|Iodine|iodine|mesh-list
154418409|NCT02103998|Hormones|hormones|mesh-list
154418410|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418411|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418412|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154418413|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418414|NCT02103998|Trace Elements|trace elements|mesh-ancestor
154418415|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
154418416|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
154418417|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154418418|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154418419|NCT01941589|Prednisolone|prednisolone|mesh-list
154418420|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
154418421|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
154418422|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154418423|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154418425|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154418426|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
154418427|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418428|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
154418429|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
154418430|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418431|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418432|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418433|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
154418434|NCT01941589|Hormones|hormones|mesh-ancestor
154418435|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418436|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154418437|NCT01941589|Protective Agents|protective agents|mesh-ancestor
154418438|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154418439|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418440|NCT01845649|Estradiol|estradiol|mesh-list
154418441|NCT01845649|Estrogens|estrogens|mesh-ancestor
154418442|NCT01845649|Hormones|hormones|mesh-ancestor
154418443|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418444|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418445|NCT01345929|Levofloxacin|levofloxacin|mesh-list
154418446|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154418447|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418448|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154418449|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154418450|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154418451|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418452|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418453|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418454|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154418455|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154418456|NCT02107742|Lidocaine|lidocaine|mesh-list
154418457|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
154418458|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
154418459|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154418460|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418461|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
154418462|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418463|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154418464|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154418465|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154418466|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154418467|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418468|NCT02250872|Cisplatin|cisplatin|mesh-list
154418469|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418470|NCT01374139|Bosutinib|bosutinib|mesh-list
154418471|NCT01374139|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154418472|NCT01374139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154418473|NCT01374139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418474|NCT01374139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418475|NCT02110784|Piperaquine|piperaquine|mesh-list
154418476|NCT02110784|Artenimol|artenimol|mesh-list
154418477|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
154418478|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154418479|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154418480|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418481|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
154418482|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154418483|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154418484|NCT04988425|Prednisolone|prednisolone|mesh-list
153993041|NCT04256252|Rituximab|rituximab|mesh-list
154418485|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
154418487|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154418488|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154418489|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
154418490|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
154418491|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418492|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418493|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
154418494|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
154418495|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418496|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418497|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
154418498|NCT04988425|Hormones|hormones|mesh-ancestor
154418499|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418500|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154418501|NCT04988425|Protective Agents|protective agents|mesh-ancestor
154418502|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153780796|NCT00415311|Lectins|lectins|mesh-list
153814381|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814382|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153814383|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154418503|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418504|NCT01343901|Bevacizumab|bevacizumab|mesh-list
154418505|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154418506|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418507|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154418508|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154418509|NCT01343901|Growth Substances|growth substances|mesh-ancestor
154418510|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418511|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
154418513|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154418514|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418515|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154418516|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418517|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418518|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154418519|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154418520|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
154418521|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418522|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154418523|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418524|NCT02104700|Tenofovir|tenofovir|mesh-list
154418525|NCT02104700|Emtricitabine|emtricitabine|mesh-list
154418526|NCT02104700|Rilpivirine|rilpivirine|mesh-list
154418527|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
154418528|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418529|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154418530|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154418531|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418532|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418533|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154418534|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154418535|NCT02104778|Dexamethasone|dexamethasone|mesh-list
154418536|NCT02104778|Epinephrine|epinephrine|mesh-list
154418537|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418538|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
154418539|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
153780886|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
153780887|NCT00257751|Aprotinin|aprotinin|mesh-list
154418540|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418541|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418542|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418543|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
154418544|NCT02104778|Hormones|hormones|mesh-ancestor
154418545|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418546|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154418547|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418548|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154418549|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154418550|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
154418551|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418552|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418553|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154418554|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154418555|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154418556|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
154418557|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
154418558|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
153993160|NCT02621385|Midazolam|midazolam|mesh-list
154418559|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154418560|NCT02108366|Oseltamivir|oseltamivir|mesh-list
154418561|NCT02108366|Celecoxib|celecoxib|mesh-list
154418562|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154418563|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154418564|NCT02108366|Analgesics|analgesics|mesh-ancestor
154418565|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
154418566|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418567|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418568|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418569|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418570|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154418571|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154418572|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418573|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418574|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
154418575|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418576|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154418577|NCT05706207|Antibodies|antibodies|mesh-list
154418578|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
154418579|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154418580|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
154418581|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418582|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418583|NCT02105090|Anesthetics|anesthetics|mesh-list
154418584|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
154418585|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154418586|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418587|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418588|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
154418589|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
154418590|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154418591|NCT03553628|Propolis|propolis|mesh-list
154418592|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154418593|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418594|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
154418595|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
154418596|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154418597|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
154418598|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154418599|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418600|NCT02112032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154418601|NCT02112032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418602|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
154418603|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418604|NCT01343823|Ecallantide|ecallantide|mesh-list
154418605|NCT01343823|Analgesics|analgesics|mesh-ancestor
154418606|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
154418607|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418608|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418609|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154418610|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154418611|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418612|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418613|NCT02251184|Aspirin|aspirin|mesh-list
154418614|NCT02251184|Dipyridamole|dipyridamole|mesh-list
154418615|NCT02251184|Lansoprazole|lansoprazole|mesh-list
154418616|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
154418617|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
154418618|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154418619|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154418620|NCT02251184|Analgesics|analgesics|mesh-ancestor
154418621|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
154418622|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418623|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418624|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418625|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418626|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154418627|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153780971|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418628|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418629|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154418630|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154418631|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418632|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
154418633|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154418634|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418635|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154418636|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154418637|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
154418638|NCT02108756|Pantoprazole|pantoprazole|mesh-list
154418639|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154418640|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418641|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154418642|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418643|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418644|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
154418645|NCT05547399|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154418646|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154418647|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418648|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418650|NCT01318083|Glimepiride|glimepiride|mesh-list
154418651|NCT01318083|Alogliptin|alogliptin|mesh-list
154418652|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154418653|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154418654|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418655|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154418656|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
154418657|NCT01318083|Incretins|incretins|mesh-ancestor
154418658|NCT01318083|Hormones|hormones|mesh-ancestor
154418659|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418660|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154418661|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
154418662|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418663|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418664|NCT02109224|Ibrutinib|ibrutinib|mesh-list
154418665|NCT02109224|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154418666|NCT02109224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154418667|NCT02109224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418668|NCT02109224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418669|NCT02105714|Formaldehyde|formaldehyde|mesh-list
154418670|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
154418671|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418672|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154418673|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154418674|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418675|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154418676|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418677|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
154418678|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418679|NCT03817515|Sirolimus|sirolimus|mesh-list
154418680|NCT03817515|Temsirolimus|temsirolimus|mesh-list
154418681|NCT03817515|MTOR Inhibitors|mtor inhibitors|mesh-list
154418682|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154418683|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418684|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154418685|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418686|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
154418687|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154418688|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
153814404|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
154418689|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418690|NCT03817515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154418691|NCT03817515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418692|NCT03817515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418693|NCT02105870|Abciximab|abciximab|mesh-list
154418694|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
154418695|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154418696|NCT02112422|Dexamethasone|dexamethasone|mesh-list
154418697|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
154418698|NCT02112422|BB 1101|bb 1101|mesh-list
154418699|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418700|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
154418701|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
154418702|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418703|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418704|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418705|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
154418706|NCT02112422|Hormones|hormones|mesh-ancestor
154418707|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418708|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154418709|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418711|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418712|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418713|NCT02106104|Glimepiride|glimepiride|mesh-list
154418714|NCT02106104|Linagliptin|linagliptin|mesh-list
154418715|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154418716|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154418717|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418718|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154418719|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
154418720|NCT02106104|Incretins|incretins|mesh-ancestor
154418721|NCT02106104|Hormones|hormones|mesh-ancestor
154418722|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418723|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154418724|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
154418725|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418726|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418727|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154418728|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154418729|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418730|NCT01376323|Incretins|incretins|mesh-ancestor
154418731|NCT01376323|Hormones|hormones|mesh-ancestor
154418732|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418733|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154418734|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
154418735|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418736|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418737|NCT02113904|Adalimumab|adalimumab|mesh-list
154418738|NCT02113904|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154418739|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418740|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418741|NCT05432115|Amoxicillin|amoxicillin|mesh-list
154418742|NCT05432115|Tetracycline|tetracycline|mesh-list
154418743|NCT05432115|Esomeprazole|esomeprazole|mesh-list
154418744|NCT05432115|Bismuth|bismuth|mesh-list
154418745|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154418746|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418747|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154418748|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418749|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154418750|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781026|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418751|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418752|NCT05432115|Antacids|antacids|mesh-ancestor
154418753|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154418754|NCT02114528|Amiodarone|amiodarone|mesh-list
154418755|NCT02114528|Sotalol|sotalol|mesh-list
154418756|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154418757|NCT02114528|Mexiletine|mexiletine|mesh-list
154418758|NCT02114528|Procainamide|procainamide|mesh-list
154418759|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
154418760|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154418761|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154418762|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418763|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154418764|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154418765|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154418766|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418767|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154418768|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154418769|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154418770|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154418771|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154418772|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
154418773|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418774|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418775|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
154418776|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
154418777|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418778|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154418779|NCT01376401|Prednisone|prednisone|mesh-list
154418780|NCT01376401|Bortezomib|bortezomib|mesh-list
154418781|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154418782|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418783|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
154418784|NCT01376401|Hormones|hormones|mesh-ancestor
154418785|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418786|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418787|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154418788|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418789|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154418790|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
154418791|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418792|NCT02119520|Atorvastatin|atorvastatin|mesh-list
154418793|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154418794|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154418795|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
154418796|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418797|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154418798|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154418799|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418800|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
154418801|NCT03961789|Narcotics|narcotics|mesh-ancestor
153781027|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781047|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781065|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
154418802|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154418803|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418804|NCT03961789|Analgesics|analgesics|mesh-ancestor
154418805|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
154418806|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418807|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154418808|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
154418809|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
154418810|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418811|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418812|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154418813|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154418814|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154418815|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
154418816|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418817|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154418818|NCT01376713|Dacarbazine|dacarbazine|mesh-list
154418820|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154418821|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154418822|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
154418823|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418824|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418825|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
154418826|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418827|NCT01368536|Amlodipine|amlodipine|mesh-list
154418828|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
154418829|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154418830|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154418831|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154418832|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418833|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154418834|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418835|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
154418836|NCT01368536|Diuretics|diuretics|mesh-ancestor
154418837|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
154418838|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154418839|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
154418840|NCT05103735|Remifentanil|remifentanil|mesh-list
154418841|NCT05103735|Propofol|propofol|mesh-list
154418842|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154418843|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154418844|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418845|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154418846|NCT05103735|Analgesics|analgesics|mesh-ancestor
154418847|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
154418848|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418849|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154418850|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154418851|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154418852|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
154418853|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418854|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418855|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153781084|NCT00258102|Levofloxacin|levofloxacin|mesh-list
153993418|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
154418856|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
154418857|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
154418858|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154418859|NCT05103735|Narcotics|narcotics|mesh-ancestor
154418860|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
154418861|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154418862|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154418863|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418864|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418865|NCT01319929|Hormones|hormones|mesh-ancestor
154418866|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418867|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418868|NCT03633565|Prednisolone|prednisolone|mesh-list
154418869|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154418871|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154418872|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
154418873|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
154418874|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154418875|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
154418876|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
154418877|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154418878|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
154418879|NCT03633565|Hormones|hormones|mesh-ancestor
154418880|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418881|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418882|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154418883|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418884|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
154418885|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
154418886|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418887|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418888|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154418889|NCT03633565|Protective Agents|protective agents|mesh-ancestor
154418890|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
154418891|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154418892|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781085|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154418893|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418894|NCT03633565|Urological Agents|urological agents|mesh-ancestor
154418895|NCT02120066|Plasminogen|plasminogen|mesh-list
154418896|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154418897|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154418898|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154418899|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418900|NCT01373359|Misoprostol|misoprostol|mesh-list
154418901|NCT01373359|Oxytocin|oxytocin|mesh-list
154418902|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
154418903|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154418904|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418905|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154418906|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
154418907|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154418908|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418909|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
154418910|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154418911|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418912|NCT02251964|Rituximab|rituximab|mesh-list
154418913|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154418914|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418915|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
154418916|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418917|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418918|NCT04739995|Naltrexone|naltrexone|mesh-list
154418919|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154418920|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154418921|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418922|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
154418923|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418924|NCT02120612|Naloxone|naloxone|mesh-list
154418925|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154418926|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418927|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
153993490|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154418928|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154418929|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
154418930|NCT02115152|Capecitabine|capecitabine|mesh-list
154418931|NCT02115152|Fluorouracil|fluorouracil|mesh-list
154418932|NCT02115152|Epirubicin|epirubicin|mesh-list
154418933|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154418934|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
154418935|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418936|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154418937|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154418938|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
154418939|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418940|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418941|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154418942|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154418943|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
154418945|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154418946|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154418947|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418948|NCT02115464|Metformin|metformin|mesh-list
154418949|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154418950|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418951|NCT02858076|Aflibercept|aflibercept|mesh-list
154418952|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
154418953|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154418954|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154418955|NCT02858076|Growth Substances|growth substances|mesh-ancestor
154418956|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418957|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
154418958|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154418959|NCT01319695|Hormones|hormones|mesh-list
154418960|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154418961|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154418962|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418963|NCT04594759|Isotretinoin|isotretinoin|mesh-list
154418964|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
154418965|NCT02123498|Omeprazole|omeprazole|mesh-list
154418966|NCT02123498|Pantoprazole|pantoprazole|mesh-list
154418967|NCT02123498|Ranitidine|ranitidine|mesh-list
154418968|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154418969|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154418970|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154418971|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154418972|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418973|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418974|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154418975|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
154418976|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
154418977|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154418978|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154418979|NCT02115776|Amoxicillin|amoxicillin|mesh-list
154418980|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
154418981|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
154418982|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
154418983|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154418984|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418985|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154418986|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
154418987|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154418988|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418989|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418990|NCT02123654|Asunaprevir|asunaprevir|mesh-list
154418991|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
154418992|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781216|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154418993|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154418994|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
154418995|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154418996|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154418997|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154418998|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154418999|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154419000|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
153993560|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
154419001|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154419002|NCT03609294|Linagliptin|linagliptin|mesh-list
154419003|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154419004|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419005|NCT03609294|Incretins|incretins|mesh-ancestor
154419006|NCT03609294|Hormones|hormones|mesh-ancestor
154419007|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419008|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154419009|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
154419010|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419011|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419012|NCT01917552|Capecitabine|capecitabine|mesh-list
154419013|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154419014|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
154419015|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419016|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419017|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
154419018|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
154419019|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154419020|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419021|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419022|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
154419023|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154419024|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419025|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419027|NCT03119701|Interferon-beta|interferon-beta|mesh-list
154419028|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
154419029|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419030|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
154419031|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419032|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
154419033|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419034|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154419035|NCT03717129|Tenofovir|tenofovir|mesh-list
154419036|NCT03717129|Emtricitabine|emtricitabine|mesh-list
154419037|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154419038|NCT03717129|Cobicistat|cobicistat|mesh-list
154419039|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154419040|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154419041|NCT03717129|Elvitegravir|elvitegravir|mesh-list
154419042|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
154419043|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419044|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154419045|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154419046|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419047|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419048|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154419049|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154419050|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154419051|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154419052|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154419053|NCT03627039|Metformin|metformin|mesh-list
154419054|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
154419055|NCT03627039|Empagliflozin|empagliflozin|mesh-list
154419056|NCT03627039|Canagliflozin|canagliflozin|mesh-list
154419057|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154419058|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419059|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154419060|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419061|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
154419062|NCT01374373|Hematinics|hematinics|mesh-ancestor
154419063|NCT02116556|Rifaximin|rifaximin|mesh-list
154419064|NCT02116556|Prednisone|prednisone|mesh-list
154419065|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154419066|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
154419067|NCT02116556|Hormones|hormones|mesh-ancestor
154419068|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419069|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419070|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154419071|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419072|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154419073|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419074|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419075|NCT03634345|Fluconazole|fluconazole|mesh-list
154419076|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
154419077|NCT03634345|Abrocitinib|abrocitinib|mesh-list
154419078|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
153993638|NCT00798343|Vaccines|vaccines|mesh-list
154419079|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419080|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154419081|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154419082|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419083|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419084|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154419085|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
154419086|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419087|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419088|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154419089|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154419090|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154419091|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154419092|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419093|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154419094|NCT03634345|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154419095|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154419096|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154419097|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419098|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
154419099|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154419100|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
154419101|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154419102|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154419103|NCT03553238|Cytarabine|cytarabine|mesh-list
154419104|NCT03553238|Dexamethasone|dexamethasone|mesh-list
154419105|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
154419106|NCT03553238|Methotrexate|methotrexate|mesh-list
154419107|NCT03553238|Etoposide|etoposide|mesh-list
154419108|NCT03553238|Vincristine|vincristine|mesh-list
154419109|NCT03553238|Doxorubicin|doxorubicin|mesh-list
154419110|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
154419111|NCT03553238|Idarubicin|idarubicin|mesh-list
154419112|NCT03553238|Pegaspargase|pegaspargase|mesh-list
154419113|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154419114|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
154419115|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419116|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154419117|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154419118|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
154419119|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419120|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419121|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154419122|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154419123|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
153781334|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153618531|NCT02828358|Cytarabine|cytarabine|mesh-list
154419124|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
154419125|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419126|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419127|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
154419128|NCT03553238|Hormones|hormones|mesh-ancestor
154419129|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419130|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154419131|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154419132|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
154419133|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154419134|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154419135|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
154419136|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
154419137|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419138|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154419139|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154419140|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154419141|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154419142|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154419143|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
154419144|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419145|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
154419146|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
154419147|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
154419148|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154419149|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
154419150|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153993717|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419151|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419152|NCT01373593|Lidocaine|lidocaine|mesh-list
154419153|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
154419154|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
154419155|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419156|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419157|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
154419158|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419159|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154419160|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154419161|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154419162|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154419163|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419165|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419166|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419167|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419168|NCT02116790|Naproxen|naproxen|mesh-list
154419169|NCT02116790|Levodopa|levodopa|mesh-list
154419170|NCT02116790|Carbidopa|carbidopa|mesh-list
153781371|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419171|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154419172|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154419173|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154419174|NCT02116790|Analgesics|analgesics|mesh-ancestor
154419175|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
154419176|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419177|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419178|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154419179|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154419180|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
154419181|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154419182|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419183|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419184|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154419185|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154419186|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
154419187|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419188|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154419189|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154419190|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
154419191|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
154419192|NCT02859961|Leronlimab|leronlimab|mesh-list
154419193|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
154419194|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154419195|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154419196|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419197|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154419198|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154419199|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
154419200|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419201|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
154419202|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419203|NCT02124200|Nicotine|nicotine|mesh-list
154419204|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154419205|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
154419206|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419207|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419208|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154419209|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154419210|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
154419211|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419212|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419213|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
154419214|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
154419215|NCT04503993|Antibodies|antibodies|mesh-list
154419216|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
153781415|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419217|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
154419218|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419219|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
154419220|NCT02116868|Nicardipine|nicardipine|mesh-list
154419221|NCT02116868|Urapidil|urapidil|mesh-list
154419222|NCT02116868|Remifentanil|remifentanil|mesh-list
154419223|NCT02116868|Esmolol|esmolol|mesh-list
154419224|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154419225|NCT02116868|Narcotics|narcotics|mesh-ancestor
153993795|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
154419226|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419227|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419228|NCT02116868|Analgesics|analgesics|mesh-ancestor
154419229|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
154419230|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419231|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154419232|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154419233|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154419234|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
154419235|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419236|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419237|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154419238|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154419239|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154419240|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
154419241|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154419242|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
154419243|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154419244|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154419245|NCT02679781|Midazolam|midazolam|mesh-list
154419246|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154419247|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154419248|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419249|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419250|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154419251|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154419252|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154419253|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154419254|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
154419255|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
154419256|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
154419257|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
154419258|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419259|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419260|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
154419261|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154419262|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419263|NCT04373031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154419264|NCT04373031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419265|NCT02121782|Vaccines|vaccines|mesh-list
154419266|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
154419267|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419268|NCT03553082|Propofol|propofol|mesh-list
154419269|NCT03553082|Sevoflurane|sevoflurane|mesh-list
154419270|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154419271|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419272|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781418|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814416|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154419273|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154419274|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
154419275|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
154419276|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154419277|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154419278|NCT03318393|Heparin|heparin|mesh-list
154419279|NCT03318393|Calcium heparin|calcium heparin|mesh-list
154419280|NCT03318393|Bivalirudin|bivalirudin|mesh-list
154419281|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
154419282|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154419283|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154419284|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419285|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
154419286|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154419287|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
154419288|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419289|NCT03110029|Efinaconazole|efinaconazole|mesh-list
154419290|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
154419291|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419292|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
154419293|NCT03552146|Propofol|propofol|mesh-list
154419294|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154419295|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419296|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419297|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154419298|NCT03552146|Analgesics|analgesics|mesh-ancestor
154419299|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
154419300|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419301|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154419302|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154419303|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154419304|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
154419305|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419306|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419307|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154419308|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
154419309|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
154419310|NCT01374763|Oxycodone|oxycodone|mesh-list
154419311|NCT01374763|Naloxone|naloxone|mesh-list
154419312|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154419313|NCT01374763|Narcotics|narcotics|mesh-ancestor
154419314|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419315|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419316|NCT01374763|Analgesics|analgesics|mesh-ancestor
154419317|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
154419318|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419319|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154419320|NCT03608514|Terlipressin|terlipressin|mesh-list
154419321|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154419322|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154419323|NCT02117726|Midazolam|midazolam|mesh-list
154419324|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
154419325|NCT02117726|Propofol|propofol|mesh-list
154419326|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154419327|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419328|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419329|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154419330|NCT02117726|Analgesics|analgesics|mesh-ancestor
154419331|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
154419332|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419333|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154419334|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154419335|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154419336|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
154419337|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419338|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419339|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154419340|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
154419341|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
154419342|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154419343|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154419344|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154419345|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154419346|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
154419347|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
154419348|NCT02733432|Fluconazole|fluconazole|mesh-list
154419349|NCT02733432|Rezafungin|rezafungin|mesh-list
154419350|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
154419351|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419352|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154419353|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154419354|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419355|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419356|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154419357|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
154419358|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419359|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419360|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154419361|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154419362|NCT03634189|Cannabidiol|cannabidiol|mesh-list
154419363|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
154419364|NCT03608046|Irinotecan|irinotecan|mesh-list
154419365|NCT03608046|Cetuximab|cetuximab|mesh-list
154419366|NCT03608046|Avelumab|avelumab|mesh-list
154419367|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154419368|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154419369|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419370|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419371|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419372|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153814419|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781487|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154419373|NCT02122484|Colchicine|colchicine|mesh-list
154419374|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
154419375|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154419376|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
154419377|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
154419378|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
154419379|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419380|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419381|NCT03606018|Insulin|insulin|mesh-list
154419382|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154419383|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
154419384|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154419385|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419386|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
154419387|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
154419388|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154419389|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154419390|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419391|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419392|NCT01373749|Urological Agents|urological agents|mesh-ancestor
154419393|NCT03605940|Methoxsalen|methoxsalen|mesh-list
154419394|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154419395|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
154419396|NCT03607734|Amoxicillin|amoxicillin|mesh-list
154419397|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154419398|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419399|NCT02035488|Tobramycin|tobramycin|mesh-list
154419400|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154419401|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419402|NCT03602430|Vitamin D|vitamin d|mesh-list
154419403|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
154419404|NCT03602430|Vitamins|vitamins|mesh-ancestor
154419405|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
154419406|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419407|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154419408|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154419409|NCT02260544|Doxorubicin|doxorubicin|mesh-list
154419410|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154419411|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154419412|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419413|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154419414|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154419415|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781488|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153814420|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419416|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419417|NCT05470647|Interleukin-4|interleukin-4|mesh-list
154419418|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154419419|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
154419420|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419421|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419422|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154419423|NCT04409665|Ketamine|ketamine|mesh-list
154419424|NCT04409665|Analgesics|analgesics|mesh-ancestor
154419425|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
154419426|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419427|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419428|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154419429|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154419430|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
154419431|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
154419432|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419433|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154419434|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154419435|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419436|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419437|NCT02854800|Varenicline|varenicline|mesh-list
154419438|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154419439|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154419440|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
154419441|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419442|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419443|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419444|NCT03552770|Bevacizumab|bevacizumab|mesh-list
154419445|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154419446|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419447|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154419448|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154419449|NCT03552770|Growth Substances|growth substances|mesh-ancestor
154419450|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419451|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
154419452|NCT02931539|Valganciclovir|valganciclovir|mesh-list
154419453|NCT02931539|Ganciclovir|ganciclovir|mesh-list
154419454|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153994092|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419455|NCT02931539|Cidofovir|cidofovir|mesh-list
154419456|NCT02931539|Foscarnet|foscarnet|mesh-list
154419457|NCT02931539|Maribavir|maribavir|mesh-list
154419458|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
154419459|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419460|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154419461|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419462|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419463|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154419464|NCT03602118|Phenobarbital|phenobarbital|mesh-list
154419465|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
154419466|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154419467|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419468|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419469|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154419470|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154419471|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419472|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419473|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
154419474|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
154419475|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154419476|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154419477|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154419478|NCT02125682|Atorvastatin|atorvastatin|mesh-list
154419479|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154419480|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154419481|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
154419482|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419483|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154419484|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154419485|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419486|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
154419487|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154419488|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154419489|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154419490|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419491|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
154419492|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419493|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419494|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154419495|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419497|NCT02131220|Saruplase|saruplase|mesh-list
154419498|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154419499|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154419500|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419501|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154419502|NCT04042077|Vancomycin|vancomycin|mesh-list
154419503|NCT04042077|Tazobactam|tazobactam|mesh-list
154419504|NCT04042077|Linezolid|linezolid|mesh-list
153814422|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816317|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419505|NCT04042077|Piperacillin|piperacillin|mesh-list
154419506|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154419507|NCT04042077|Tigecycline|tigecycline|mesh-list
154419508|NCT04042077|Delafloxacin|delafloxacin|mesh-list
154419509|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154419510|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419511|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154419512|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419513|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419514|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154419515|NCT03557359|Nivolumab|nivolumab|mesh-list
154419516|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154419517|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419518|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154419519|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419520|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154419521|NCT02127320|Ezetimibe|ezetimibe|mesh-list
154419522|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154419523|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154419524|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
154419525|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419526|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154419527|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154419528|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419529|NCT03522415|Methotrexate|methotrexate|mesh-list
154419530|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154419531|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
154419532|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154419533|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419534|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154419535|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
154419536|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419537|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419538|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
154419539|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419540|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154419541|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154419542|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
154419543|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154419544|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154419545|NCT04226833|Entrectinib|entrectinib|mesh-list
154419546|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154419547|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419548|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419549|NCT02131298|Itraconazole|itraconazole|mesh-list
154419550|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153781538|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781539|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
154419551|NCT02131298|Palbociclib|palbociclib|mesh-list
154419552|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
154419553|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419554|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154419555|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154419556|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419557|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419558|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154419559|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
154419560|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419561|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419562|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154419563|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419564|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154419565|NCT01375387|Lacosamide|lacosamide|mesh-list
154419566|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
154419567|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154419568|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154419569|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154419570|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419571|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
154419572|NCT02853318|Bevacizumab|bevacizumab|mesh-list
154419573|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
154419574|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154419575|NCT02853318|Antibodies|antibodies|mesh-list
154419576|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
154419577|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154419578|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
154419579|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
154419580|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154419581|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
154419582|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419583|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154419584|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154419585|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
154419586|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419587|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419588|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154419589|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154419590|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154419591|NCT02853318|Growth Substances|growth substances|mesh-ancestor
154419592|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
154419593|NCT02853318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154419594|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
154419595|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154419596|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154419597|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
153781540|NCT00478777|Hormones|hormones|mesh-ancestor
153814424|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154419598|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
154419599|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419600|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419601|NCT03604224|Canagliflozin|canagliflozin|mesh-list
154419602|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154419603|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419604|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154419605|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419606|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154419607|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
154419608|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419609|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154419610|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154419611|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419613|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154419614|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
154419615|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419616|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419617|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419618|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154419619|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154419620|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419621|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154419622|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
154419623|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
154419624|NCT02127788|Micafungin|micafungin|mesh-list
154419625|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
154419626|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419627|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
154419628|NCT02131688|Analgesics|analgesics|mesh-ancestor
154419629|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
154419630|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419631|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419632|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419633|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154419634|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154419635|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419636|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419637|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154419638|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154419639|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
154419640|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419641|NCT02126462|Antacids|antacids|mesh-ancestor
154419642|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419643|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419644|NCT03113071|Decitabine|decitabine|mesh-list
154419645|NCT03113071|Digoxin|digoxin|mesh-list
154419646|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154419647|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
154419648|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419649|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419650|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419651|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154419652|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154419653|NCT03113071|Protective Agents|protective agents|mesh-ancestor
154419654|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419655|NCT03050307|Lansoprazole|lansoprazole|mesh-list
154419656|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
153618846|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154419657|NCT03050307|Bismuth|bismuth|mesh-list
154419658|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154419659|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419660|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154419661|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419662|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419663|NCT03050307|Antacids|antacids|mesh-ancestor
154419664|NCT02127866|Beclomethasone|beclomethasone|mesh-list
154419665|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
154419666|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
154419667|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154419668|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
154419669|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419670|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419671|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154419672|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
154419673|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154419674|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154419675|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153994243|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
154419676|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
154419677|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419678|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419679|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154419680|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154419681|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154419682|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
154419683|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154419685|NCT02127866|Hormones|hormones|mesh-ancestor
154419686|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419687|NCT03550508|Antibodies|antibodies|mesh-list
154419688|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154419689|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
154419690|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419691|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
154419692|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154419693|NCT03607578|Protective Agents|protective agents|mesh-ancestor
154419694|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419695|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
154419696|NCT05760079|Lactoferrin|lactoferrin|mesh-list
154419697|NCT05760079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419698|NCT03603834|Leucovorin|leucovorin|mesh-list
154419699|NCT03603834|Fluorouracil|fluorouracil|mesh-list
154419700|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
154419701|NCT03603834|Irinotecan|irinotecan|mesh-list
154419702|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
154419703|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419704|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154419705|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618873|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
153545886|NCT06297772|Immunologic Factors|immunologic factors|mesh-ancestor
154419706|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154419707|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
154419708|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419709|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154419710|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154419711|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419712|NCT03603834|Antidotes|antidotes|mesh-ancestor
154419713|NCT03603834|Protective Agents|protective agents|mesh-ancestor
154419714|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
154419715|NCT03603834|Vitamins|vitamins|mesh-ancestor
154419716|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
154419717|NCT03601338|Bemiparin|bemiparin|mesh-list
154419718|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
154419719|NCT02128022|Glyburide|glyburide|mesh-list
154419720|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154419721|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419722|NCT03256045|Dexamethasone|dexamethasone|mesh-list
154419723|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
154419724|NCT03256045|Panobinostat|panobinostat|mesh-list
154419725|NCT03256045|Ichthammol|ichthammol|mesh-list
154419726|NCT03256045|BB 1101|bb 1101|mesh-list
154419727|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154419728|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
154419729|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
154419730|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419731|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419732|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419733|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
154419734|NCT03256045|Hormones|hormones|mesh-ancestor
154419735|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419736|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154419737|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419738|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
154419739|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419740|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419741|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154419742|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
154419743|NCT03603756|Paclitaxel|paclitaxel|mesh-list
154419744|NCT03603756|Irinotecan|irinotecan|mesh-list
154419745|NCT03603756|Apatinib|apatinib|mesh-list
154419746|NCT03603756|Nedaplatin|nedaplatin|mesh-list
154419747|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154419748|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419749|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
154419750|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
154419751|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
154419752|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419753|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154419754|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154419755|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419756|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154419757|NCT02372409|Doxorubicin|doxorubicin|mesh-list
154419758|NCT02372409|Etoposide|etoposide|mesh-list
154419759|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
154419760|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154419761|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419762|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154419763|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153545888|NCT06297772|Alkylating Agents|alkylating agents|mesh-ancestor
153781571|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781572|NCT00266253|Metformin|metformin|mesh-list
154419764|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419765|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419766|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154419767|NCT03626259|Losartan|losartan|mesh-list
154419768|NCT03626259|Amlodipine|amlodipine|mesh-list
154419769|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154419770|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154419771|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154419772|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419773|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154419774|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419775|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
154419776|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154419777|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154419778|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154419779|NCT03601260|Allopurinol|allopurinol|mesh-list
154419780|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
154419781|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419782|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419783|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
154419784|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154419785|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154419786|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
154419787|NCT03601260|Protective Agents|protective agents|mesh-ancestor
154419788|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419789|NCT05193253|Liver Extracts|liver extracts|mesh-list
154419790|NCT05193253|Hematinics|hematinics|mesh-ancestor
154419791|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
154419792|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154419793|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154419794|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
154419795|NCT02132000|Tamoxifen|tamoxifen|mesh-list
154419796|NCT02132000|Toremifene|toremifene|mesh-list
154419797|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154419798|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
154419799|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419800|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419801|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154419802|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419803|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154419804|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154419805|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154419806|NCT03118765|Bromides|bromides|mesh-list
154419807|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154419808|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
154419809|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154419810|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
154419811|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419812|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419813|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154419814|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
154419815|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
154419816|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154419817|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
154419818|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419819|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419820|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
154419821|NCT02128100|Leucovorin|leucovorin|mesh-list
154419822|NCT02128100|Fluorouracil|fluorouracil|mesh-list
154419823|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
154419824|NCT02128100|Irinotecan|irinotecan|mesh-list
154419825|NCT02128100|Folfirinox|folfirinox|mesh-list
154419826|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
154419827|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419828|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153994393|NCT02864849|Capecitabine|capecitabine|mesh-list
154419829|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419830|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154419831|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
154419832|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419833|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154419834|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154419835|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419836|NCT02128100|Antidotes|antidotes|mesh-ancestor
154419837|NCT02128100|Protective Agents|protective agents|mesh-ancestor
154419838|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
154419839|NCT02128100|Vitamins|vitamins|mesh-ancestor
154419840|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
154419841|NCT03603366|Aspirin|aspirin|mesh-list
154419842|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154419843|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154419844|NCT03603366|Analgesics|analgesics|mesh-ancestor
154419845|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
154419846|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419847|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419848|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154419849|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154419850|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154419851|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154419852|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419853|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154419854|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154419855|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419856|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
154419857|NCT02128178|Enoxaparin|enoxaparin|mesh-list
154419858|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
154419859|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
154419860|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154419861|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154419862|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419863|NCT03600870|Midodrine|midodrine|mesh-list
153566771|NCT06233344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566780|NCT06233266|Ticagrelor|ticagrelor|mesh-list
154419864|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
154419865|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
154419866|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419867|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419868|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154419869|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154419870|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154419871|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154419872|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
154419873|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419874|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419875|NCT02128334|Leuprolide|leuprolide|mesh-list
154419876|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154419877|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
154419878|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154419879|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419880|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154419881|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419882|NCT01375699|Doxorubicin|doxorubicin|mesh-list
154419883|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154419884|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
154419885|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154419886|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419887|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154419888|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154419889|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419890|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419891|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
154419892|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154419893|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154419894|NCT01375699|Urological Agents|urological agents|mesh-ancestor
154419895|NCT01373983|Ziconotide|ziconotide|mesh-list
154419896|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154419897|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154419898|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419899|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154419900|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814441|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154419901|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154419902|NCT01373983|Protective Agents|protective agents|mesh-ancestor
154419903|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994539|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419904|NCT01373983|Analgesics|analgesics|mesh-ancestor
154419905|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
154419906|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419907|NCT05812612|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154419908|NCT05812612|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154419909|NCT05812612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419910|NCT05812521|Methylene Blue|methylene blue|mesh-list
154419911|NCT05812521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419912|NCT05812521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419914|NCT05812430|Cisplatin|cisplatin|mesh-list
154419915|NCT05812430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154419916|NCT05812430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419917|NCT05812430|Tubulin Modulators|tubulin modulators|mesh-ancestor
154419918|NCT05812430|Antimitotic Agents|antimitotic agents|mesh-ancestor
154419919|NCT05812430|Mitosis Modulators|mitosis modulators|mesh-ancestor
154419920|NCT05812430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419921|NCT05812404|Fexuprazan|fexuprazan|mesh-list
154419922|NCT05812404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419923|NCT03607110|Fentanyl|fentanyl|mesh-list
154419924|NCT03607110|Ketamine|ketamine|mesh-list
154419925|NCT03607110|Analgesics|analgesics|mesh-ancestor
154419926|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
154419927|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154419928|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419929|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154419930|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154419931|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
154419932|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
154419933|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419934|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154419935|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154419936|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419937|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419938|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154419939|NCT03607110|Narcotics|narcotics|mesh-ancestor
154419940|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154419941|NCT05811793|Bevacizumab|bevacizumab|mesh-list
154419942|NCT05811793|Tislelizumab|tislelizumab|mesh-list
153566883|NCT06233032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154419943|NCT05811793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154419944|NCT05811793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419945|NCT05811793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154419946|NCT05811793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154419947|NCT05811793|Growth Substances|growth substances|mesh-ancestor
154419948|NCT05811793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419949|NCT05811793|Growth Inhibitors|growth inhibitors|mesh-ancestor
154419950|NCT05811507|Testosterone|testosterone|mesh-list
154419951|NCT05811507|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154419952|NCT05811507|Androgens|androgens|mesh-ancestor
154419953|NCT05811507|Hormones|hormones|mesh-ancestor
154419954|NCT05811507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154419955|NCT05811507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419956|NCT05811507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154419957|NCT05811507|Immunologic Factors|immunologic factors|mesh-ancestor
154419958|NCT05811221|Anesthetics|anesthetics|mesh-list
154419959|NCT05811221|Esketamine|esketamine|mesh-list
154419960|NCT05811221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154419961|NCT05811221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419962|NCT05811221|Antidepressive Agents|antidepressive agents|mesh-ancestor
154419963|NCT05811221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154419964|NCT05811000|Donepezil|donepezil|mesh-list
154419965|NCT05811000|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154419966|NCT05811000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419967|NCT05811000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419968|NCT05811000|Cholinergic Agents|cholinergic agents|mesh-ancestor
154419969|NCT05811000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154419970|NCT05811000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419971|NCT05811000|Nootropic Agents|nootropic agents|mesh-ancestor
154419972|NCT05810909|Calcium Carbonate|calcium carbonate|mesh-list
154419973|NCT05810909|Calcium|calcium|mesh-list
154419974|NCT05810909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154419975|NCT05810909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419976|NCT05810909|Antacids|antacids|mesh-ancestor
154419977|NCT05810909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419978|NCT05810909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154419979|NCT05810350|Pemetrexed|pemetrexed|mesh-list
154419980|NCT05810350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419981|NCT05810350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154419982|NCT05810350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154419983|NCT05810350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154419984|NCT05810350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153566884|NCT06233032|Adrenergic Agents|adrenergic agents|mesh-ancestor
153814446|NCT00425243|Zolpidem|zolpidem|mesh-list
154419985|NCT05793489|Silybin|silybin|mesh-list
154419986|NCT05793489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154419987|NCT05793489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419988|NCT05793489|Protective Agents|protective agents|mesh-ancestor
154419989|NCT05793489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154419991|NCT05754853|Docetaxel|docetaxel|mesh-list
154419992|NCT05754853|Gemcitabine|gemcitabine|mesh-list
154419993|NCT05754853|Pemetrexed|pemetrexed|mesh-list
154419994|NCT05754853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154419995|NCT05754853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154419996|NCT05754853|Tubulin Modulators|tubulin modulators|mesh-ancestor
154419997|NCT05754853|Antimitotic Agents|antimitotic agents|mesh-ancestor
154419998|NCT05754853|Mitosis Modulators|mitosis modulators|mesh-ancestor
154419999|NCT05754853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420000|NCT05754853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154420001|NCT05754853|Antimetabolites|antimetabolites|mesh-ancestor
154420002|NCT05754853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420003|NCT05754853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154420004|NCT05754853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154420005|NCT05747625|Panitumumab|panitumumab|mesh-list
154420006|NCT05747625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420007|NCT05747625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420008|NCT05742347|Protective Agents|protective agents|mesh-list
154420009|NCT05742347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420010|NCT05692869|Propranolol|propranolol|mesh-list
154420011|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
154420012|NCT05692869|Ephedrine|ephedrine|mesh-list
154420013|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154420014|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154420015|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420016|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420017|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420018|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420019|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154420020|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154420021|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
154420022|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154420023|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
154420024|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420025|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154420026|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
154420027|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
154420028|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154420029|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154420030|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
154420031|NCT05655468|Dronedarone|dronedarone|mesh-list
154420032|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154420033|NCT05644353|Mirikizumab|mirikizumab|mesh-list
154420034|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154420035|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420036|NCT05644353|Analgesics|analgesics|mesh-ancestor
154420037|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
153814447|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153566943|NCT06232694|Venetoclax|venetoclax|mesh-list
154420038|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420039|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420040|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420041|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420042|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154420043|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154420044|NCT05563389|Atorvastatin|atorvastatin|mesh-list
154420045|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154420046|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154420047|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
154420048|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420049|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154420050|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154420051|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420052|NCT05511766|Allopurinol|allopurinol|mesh-list
154420053|NCT05511766|Atorvastatin|atorvastatin|mesh-list
153994611|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
154420054|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154420055|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154420056|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
154420057|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420058|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154420059|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154420061|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
154420062|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420063|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154420064|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
154420065|NCT05511766|Protective Agents|protective agents|mesh-ancestor
154420066|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420067|NCT05466734|Cilostazol|cilostazol|mesh-list
154420068|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154420069|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
154420070|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420071|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420072|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154420073|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154420074|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154420075|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420076|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420077|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154420078|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
154420079|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154420080|NCT05466734|Protective Agents|protective agents|mesh-ancestor
153566944|NCT06232694|Idarubicin|idarubicin|mesh-list
153387532|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153814450|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816333|NCT00466518|Incretins|incretins|mesh-ancestor
154420081|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154420082|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154420083|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420084|NCT05420402|Propofol|propofol|mesh-list
154420085|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154420086|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420087|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420088|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154420089|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
154420090|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
154420091|NCT05417087|Vortioxetine|vortioxetine|mesh-list
154420092|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
154420093|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420094|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154420095|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154420096|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420097|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420098|NCT05417087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154420099|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154420100|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154420101|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420102|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420103|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
154420104|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154420105|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154420106|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154420107|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154420108|NCT05416957|Vortioxetine|vortioxetine|mesh-list
154420109|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
154420110|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420111|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154420112|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154420113|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420114|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420115|NCT05416957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154420116|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154420117|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154420118|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420119|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420120|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
154420121|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154420122|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154420123|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154420124|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154420125|NCT05416762|Vortioxetine|vortioxetine|mesh-list
154420126|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
154420127|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420128|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154420129|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154420130|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048645|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566994|NCT06195540|Heparin|heparin|mesh-list
154420131|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420132|NCT05416762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154420133|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154420134|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154420135|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420136|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420137|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
154420138|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154420139|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154420140|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154420141|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154420142|NCT05365802|FAPI-46|fapi-46|mesh-list
154420143|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154420144|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420145|NCT05358639|Olaparib|olaparib|mesh-list
154420146|NCT05358639|Navitoclax|navitoclax|mesh-list
154420147|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154420148|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420149|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420150|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420151|NCT05330871|Vaccines|vaccines|mesh-list
154420152|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
154420153|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420154|NCT05314153|Brexanolone|brexanolone|mesh-list
154420155|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
154420156|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420157|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420158|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420159|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
154420160|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
154420161|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
154420162|NCT05283408|Esketamine|esketamine|mesh-list
154420163|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154420164|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420165|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420166|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420167|NCT05283408|Analgesics|analgesics|mesh-ancestor
154420168|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
154420169|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420170|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154420171|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153457683|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420172|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154420173|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420174|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420175|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420176|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
154420177|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420178|NCT05240755|Cannabidiol|cannabidiol|mesh-list
154420179|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
154420180|NCT05229315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154420181|NCT05229315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420182|NCT05229315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420183|NCT05229315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420184|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154420185|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154420186|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154420187|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420188|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420189|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420190|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154420191|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154420192|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154420193|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420194|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420195|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420196|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153994760|NCT02612259|Tryptophan|tryptophan|mesh-list
154420197|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154420198|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
154420199|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154420200|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154420201|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
154420202|NCT05208931|Mitogens|mitogens|mesh-list
154420204|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154420205|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420206|NCT05208931|Growth Substances|growth substances|mesh-ancestor
154420207|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420208|NCT05191862|Cilostazol|cilostazol|mesh-list
154420209|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154420210|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
154420211|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420212|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420213|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154420214|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
154420215|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154420216|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420217|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420218|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154420219|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
154420220|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154420221|NCT05191862|Protective Agents|protective agents|mesh-ancestor
154420222|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154420223|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154420224|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420225|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
154420226|NCT05189704|Narcotics|narcotics|mesh-ancestor
154420227|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420228|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420229|NCT05189704|Analgesics|analgesics|mesh-ancestor
154420230|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
154420231|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420232|NCT05100160|Gabapentin|gabapentin|mesh-list
154420233|NCT05100160|Analgesics|analgesics|mesh-ancestor
154420234|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
154420235|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420236|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420237|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
154420238|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154420239|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154420240|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420241|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420242|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154420243|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154420244|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420245|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420246|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
154420247|NCT05052931|Paclitaxel|paclitaxel|mesh-list
154420248|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
154420249|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154420250|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420251|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
154420252|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
154420253|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154420254|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420255|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
154420256|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154420257|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
153567082|NCT06080399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567083|NCT06080399|Autonomic Agents|autonomic agents|mesh-ancestor
154420258|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420259|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420260|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154420261|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
154420262|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154420263|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
154420264|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420265|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420266|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154420267|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
154420268|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
154420269|NCT05052229|Protective Agents|protective agents|mesh-ancestor
154420270|NCT05020769|Osimertinib|osimertinib|mesh-list
154420271|NCT05020769|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154420272|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154420274|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420275|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420276|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154420277|NCT05002738|Desogestrel|desogestrel|mesh-list
154420278|NCT05002738|Estradiol|estradiol|mesh-list
154420279|NCT05002738|Estrogens|estrogens|mesh-ancestor
154420280|NCT05002738|Hormones|hormones|mesh-ancestor
154420281|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154420282|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420283|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154420284|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
154420285|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154420286|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154420287|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154420288|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154420289|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154420290|NCT05002738|Progestins|progestins|mesh-ancestor
154420291|NCT04990284|Levodopa|levodopa|mesh-list
154420292|NCT04990284|Opicapone|opicapone|mesh-list
154420293|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154420294|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154420295|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
154420296|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420297|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420298|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420299|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154420300|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420301|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
154420302|NCT04955158|Ketamine|ketamine|mesh-list
154420303|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154420304|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420305|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420306|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420307|NCT04955158|Analgesics|analgesics|mesh-ancestor
154420308|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
154420309|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420310|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154420311|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154420312|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154420313|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420314|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420315|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420316|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154420317|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154420318|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
154420319|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
154420320|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154420321|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154420322|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
154420323|NCT04928391|Nalbuphine|nalbuphine|mesh-list
154420324|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154420325|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420326|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420327|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420328|NCT04928391|Analgesics|analgesics|mesh-ancestor
154420329|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
154420330|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420331|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154420332|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154420333|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154420334|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420335|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420336|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420337|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154420338|NCT04928391|Narcotics|narcotics|mesh-ancestor
154420339|NCT04928352|Bupivacaine|bupivacaine|mesh-list
154420340|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
154420341|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
154420342|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153361985|NCT05945771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567140|NCT05921370|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420343|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420344|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
153994910|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
154420345|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420346|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
154420347|NCT04928300|Ketamine|ketamine|mesh-list
154420348|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154420349|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420350|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420351|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420352|NCT04928300|Analgesics|analgesics|mesh-ancestor
154420353|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
154420354|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420355|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154420356|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154420357|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154420358|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420359|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420360|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420361|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154420362|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154420363|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
154420364|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
154420365|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154420366|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154420367|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
154420368|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154420369|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420370|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420371|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
154420372|NCT04910464|Coagulants|coagulants|mesh-ancestor
154420373|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
154420374|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154420375|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420376|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420377|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
154420378|NCT04905901|Coagulants|coagulants|mesh-ancestor
154420379|NCT04901988|Nivolumab|nivolumab|mesh-list
154420380|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420381|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567141|NCT05921370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420382|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154420383|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420384|NCT04899687|Levomethorphan|levomethorphan|mesh-list
154420385|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
154420386|NCT04899687|Fluoxetine|fluoxetine|mesh-list
154420387|NCT04899687|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154420388|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154420389|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154420390|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420391|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420392|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
154420393|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420394|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154420395|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
154420396|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420397|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154420398|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154420399|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420400|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
154420401|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
154420402|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154420403|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154420404|NCT04899687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154420405|NCT04899687|Narcotics|narcotics|mesh-ancestor
154420406|NCT04899687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420407|NCT04899687|Analgesics|analgesics|mesh-ancestor
154420408|NCT04899687|Sensory System Agents|sensory system agents|mesh-ancestor
154420409|NCT04899687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420410|NCT04823845|Adapalene|adapalene|mesh-list
154420411|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154420412|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420413|NCT04823845|Analgesics|analgesics|mesh-ancestor
154420414|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
154420415|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420416|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420417|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420418|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420419|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
154420421|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154420422|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420423|NCT04789070|Sirolimus|sirolimus|mesh-list
154420424|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154420425|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154420427|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567163|NCT05888311|Charcoal|charcoal|mesh-list
154420428|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
154420429|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154420430|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
154420431|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420432|NCT04756427|Citric Acid|citric acid|mesh-list
154420433|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
154420434|NCT04756427|Anticoagulants|anticoagulants|mesh-list
154420435|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154420436|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
154420437|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
154420438|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420439|NCT04722601|Azacitidine|azacitidine|mesh-list
154420440|NCT04722601|Venetoclax|venetoclax|mesh-list
154420441|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
154420442|NCT04722601|Cc-486|cc-486|mesh-list
154420443|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154420444|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
154420445|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420446|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420447|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420448|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420449|NCT04692844|Propranolol|propranolol|mesh-list
154420450|NCT04692844|Primidone|primidone|mesh-list
154420451|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154420452|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154420453|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420454|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420455|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420456|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420457|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154420458|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154420459|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
154420460|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
154420461|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
154420462|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
154420463|NCT04657003|Tirzepatide|tirzepatide|mesh-list
154420464|NCT04657003|Incretins|incretins|mesh-ancestor
154420465|NCT04657003|Hormones|hormones|mesh-ancestor
154420466|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154420467|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420468|NCT04624906|Rituximab|rituximab|mesh-list
154420469|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154420470|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
154420471|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420472|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420473|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
154420474|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420475|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420476|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154420477|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
154420478|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420479|NCT04624906|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154420480|NCT04624906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154420481|NCT04624906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420482|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
154420483|NCT04546399|Leucovorin|leucovorin|mesh-list
154420484|NCT04546399|Folic Acid|folic acid|mesh-list
154420485|NCT04546399|Cytarabine|cytarabine|mesh-list
154420486|NCT04546399|Dexamethasone|dexamethasone|mesh-list
154420487|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
154420488|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
154420489|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153995060|NCT00811993|Bevacizumab|bevacizumab|mesh-list
154420490|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154420491|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154420492|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
154420493|NCT04546399|Nivolumab|nivolumab|mesh-list
154420494|NCT04546399|Methotrexate|methotrexate|mesh-list
154420495|NCT04546399|Etoposide|etoposide|mesh-list
154420497|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
154420498|NCT04546399|Asparaginase|asparaginase|mesh-list
154420499|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
154420500|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
154420501|NCT04546399|Pegaspargase|pegaspargase|mesh-list
154420502|NCT04546399|Thioguanine|thioguanine|mesh-list
154420503|NCT04546399|Blinatumomab|blinatumomab|mesh-list
154420504|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154420505|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
154420506|NCT04546399|Antibodies|antibodies|mesh-list
154420507|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
154420508|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154420509|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154420510|NCT04546399|BB 1101|bb 1101|mesh-list
154420511|NCT04546399|Calcium|calcium|mesh-list
154420512|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
154420513|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
154420514|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154420515|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
154420516|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420517|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420518|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154420519|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
153731767|NCT00161304|Testosterone|testosterone|mesh-list
153814461|NCT00451971|Leflunomide|leflunomide|mesh-list
154420520|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420521|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420522|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154420523|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420524|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
154420525|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
154420526|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420527|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154420528|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
154420529|NCT04546399|Hormones|hormones|mesh-ancestor
154420530|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154420531|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154420532|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
154420533|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420534|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154420535|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154420536|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154420537|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154420538|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
154420539|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154420540|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154420541|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
154420542|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
154420543|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154420544|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154420545|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154420546|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154420547|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154420548|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
154420549|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154420550|NCT04546399|Antidotes|antidotes|mesh-ancestor
154420551|NCT04546399|Protective Agents|protective agents|mesh-ancestor
154420552|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
154420553|NCT04546399|Vitamins|vitamins|mesh-ancestor
154420554|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
154420555|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
154420556|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
154420557|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
154420558|NCT04546399|Hematinics|hematinics|mesh-ancestor
154420559|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
154420560|NCT04540120|Dapansutrile|dapansutrile|mesh-list
154420561|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420562|NCT04480086|Navitoclax|navitoclax|mesh-list
154420563|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420564|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154420565|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154420566|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154420567|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154420568|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154420569|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420570|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995145|NCT04384562|Reboxetine|reboxetine|mesh-list
154420571|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420572|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154420573|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154420574|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154420575|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420576|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420577|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420578|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154420579|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154420580|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
154420581|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154420582|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154420583|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
154420584|NCT04426825|Bevacizumab|bevacizumab|mesh-list
154420585|NCT04426825|Atezolizumab|atezolizumab|mesh-list
154420586|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420587|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420588|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154420589|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154420590|NCT04426825|Growth Substances|growth substances|mesh-ancestor
154420591|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420592|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
154420593|NCT04426825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154420594|NCT04426825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420595|NCT04418479|Aspirin|aspirin|mesh-list
154420596|NCT04418479|Clopidogrel|clopidogrel|mesh-list
154420597|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154420598|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420599|NCT04418479|Analgesics|analgesics|mesh-ancestor
154420600|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
154420601|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420602|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420603|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420604|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420605|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154420606|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420607|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420608|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154420609|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154420610|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420611|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
153567246|NCT05773664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420612|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154420613|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154420614|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154420615|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
154420616|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420617|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154420618|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154420619|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420620|NCT04408508|Amoxicillin|amoxicillin|mesh-list
154420621|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154420622|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154420623|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
154420624|NCT04181515|Yohimbine|yohimbine|mesh-list
154420625|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420626|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
154420627|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
154420628|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420629|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420630|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154420631|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154420632|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154420633|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420634|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420635|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420636|NCT04181515|Urological Agents|urological agents|mesh-ancestor
154420637|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
154420638|NCT04180969|Yohimbine|yohimbine|mesh-list
154420639|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420640|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
154420641|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
154420642|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420643|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420644|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154420645|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153995211|NCT03960554|Denosumab|denosumab|mesh-list
154420646|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154420647|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420648|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420649|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420650|NCT04180969|Urological Agents|urological agents|mesh-ancestor
154420651|NCT04123470|Atezolizumab|atezolizumab|mesh-list
154420652|NCT04123470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154420653|NCT04123470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420654|NCT04123470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420655|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420656|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
153457720|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420657|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154420658|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420659|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154420660|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420661|NCT04060108|Methamphetamine|methamphetamine|mesh-list
154420662|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154420663|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420664|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
154420665|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
154420666|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420667|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
154420668|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420669|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420670|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420671|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154420672|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154420673|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154420674|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154420676|NCT04017598|Trace Elements|trace elements|mesh-ancestor
154420677|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
154420678|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420679|NCT04014803|Aspirin|aspirin|mesh-list
154420680|NCT04014803|Clopidogrel|clopidogrel|mesh-list
154420681|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154420682|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154420683|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420684|NCT04014803|Analgesics|analgesics|mesh-ancestor
154420685|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
154420686|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420687|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420688|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420689|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420690|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154420691|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420692|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420693|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154420694|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154420695|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420696|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
154420697|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153814465|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
154420698|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154420699|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154420700|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
154420701|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420702|NCT03945903|Golimumab|golimumab|mesh-list
154420703|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154420704|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420705|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154420706|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
154420707|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420708|NCT03937219|Nivolumab|nivolumab|mesh-list
154420709|NCT03937219|Ipilimumab|ipilimumab|mesh-list
154420710|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420711|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420712|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154420713|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420714|NCT03869268|Aspirin|aspirin|mesh-list
154420715|NCT03869268|Ticagrelor|ticagrelor|mesh-list
154420716|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154420717|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153995287|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154420719|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
154420720|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420721|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420722|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420723|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420724|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154420725|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420726|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420727|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154420728|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154420729|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420730|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
154420731|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154420732|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154420733|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154420734|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
154420735|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420736|NCT03843463|Dexetimide|dexetimide|mesh-list
154420737|NCT03843463|Citalopram|citalopram|mesh-list
154420738|NCT03843463|Escitalopram|escitalopram|mesh-list
154420739|NCT03843463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154420740|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154420741|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154420742|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420743|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420744|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
154420745|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420746|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154420747|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154420748|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
154420749|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
154420750|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420751|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154420752|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154420753|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
153567317|NCT05698381|Acetic Acid|acetic acid|mesh-list
153567333|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567334|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567335|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154420754|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154420755|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
154420756|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420757|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
154420758|NCT03643796|Ketamine|ketamine|mesh-list
154420759|NCT03643796|Remifentanil|remifentanil|mesh-list
154420760|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154420761|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420762|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420763|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420764|NCT03643796|Analgesics|analgesics|mesh-ancestor
154420765|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
154420766|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420767|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154420768|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154420769|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154420770|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420771|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420772|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420773|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154420774|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154420775|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
154420776|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
154420777|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154420778|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154420779|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154420780|NCT03643796|Narcotics|narcotics|mesh-ancestor
154420781|NCT03623854|Nivolumab|nivolumab|mesh-list
154420782|NCT03623854|Relatlimab|relatlimab|mesh-list
154420783|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
154420784|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
154420785|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420786|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420787|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154420788|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420789|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
154420790|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420791|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154420792|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154420793|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420794|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
154420795|NCT03530215|Immunomodulating Agents|immunomodulating agents|mesh-list
153814468|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154420796|NCT03530215|Immunologic Factors|immunologic factors|mesh-ancestor
154420797|NCT03530215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420798|NCT03475277|Ketamine|ketamine|mesh-list
154420799|NCT03475277|Analgesics|analgesics|mesh-ancestor
154420800|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
154420801|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420802|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420803|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154420804|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154420805|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
154420806|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
154420807|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420808|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154420809|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154420810|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420811|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420812|NCT03472274|Durvalumab|durvalumab|mesh-list
154420813|NCT03472274|Tremelimumab|tremelimumab|mesh-list
154420814|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420815|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420816|NCT03436433|Lacosamide|lacosamide|mesh-list
154420817|NCT03436433|Levetiracetam|levetiracetam|mesh-list
154420818|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
154420819|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
154420820|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154420821|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154420822|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154420823|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420824|NCT03405090|Fentanyl|fentanyl|mesh-list
154420825|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
154420826|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154420827|NCT03405090|Narcotics|narcotics|mesh-ancestor
154420828|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420829|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420830|NCT03405090|Analgesics|analgesics|mesh-ancestor
154420831|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
154420832|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420833|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154420834|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154420835|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
154420836|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
154420837|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
154420838|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154420839|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
154420840|NCT03284307|Midazolam|midazolam|mesh-list
153567392|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154420841|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
154420842|NCT03284307|Ketamine|ketamine|mesh-list
154420843|NCT03284307|Propofol|propofol|mesh-list
154420844|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154420845|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420846|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420847|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420848|NCT03284307|Analgesics|analgesics|mesh-ancestor
154420849|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
154420850|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420851|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154420852|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154420853|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154420854|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
154420855|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420856|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420857|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154420858|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
154420859|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
154420860|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154420861|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154420862|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153995433|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
154420863|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154420864|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154420865|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154420866|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420867|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
154420868|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
154420869|NCT03279289|Leucovorin|leucovorin|mesh-list
154420870|NCT03279289|Folic Acid|folic acid|mesh-list
154420871|NCT03279289|Fluorouracil|fluorouracil|mesh-list
154420872|NCT03279289|Irinotecan|irinotecan|mesh-list
154420873|NCT03279289|Aflibercept|aflibercept|mesh-list
154420874|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
154420875|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
154420876|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420877|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154420878|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420879|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154420880|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
154420881|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420882|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154420883|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154420884|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420885|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154420886|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154420887|NCT03279289|Growth Substances|growth substances|mesh-ancestor
154420888|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
153567393|NCT05602038|Morphine|morphine|mesh-list
153814472|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153816412|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816413|NCT00466791|Methylphenidate|methylphenidate|mesh-list
154420889|NCT03279289|Antidotes|antidotes|mesh-ancestor
154420890|NCT03279289|Protective Agents|protective agents|mesh-ancestor
154420891|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
154420892|NCT03279289|Vitamins|vitamins|mesh-ancestor
154420893|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
154420894|NCT03279289|Hematinics|hematinics|mesh-ancestor
154420895|NCT03186456|Aspirin|aspirin|mesh-list
154420896|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154420897|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420898|NCT03186456|Analgesics|analgesics|mesh-ancestor
154420899|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
154420900|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420901|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420902|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420903|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154420904|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154420905|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420906|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420907|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154420908|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154420909|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420910|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
154420911|NCT03184935|Decitabine|decitabine|mesh-list
154420912|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154420913|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
154420914|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420915|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420916|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420917|NCT03176498|Aspirin|aspirin|mesh-list
154420918|NCT03176498|Atorvastatin|atorvastatin|mesh-list
154420919|NCT03176498|Calcium|calcium|mesh-list
154420920|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154420921|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420922|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154420923|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154420924|NCT03176498|Analgesics|analgesics|mesh-ancestor
154420925|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
154420926|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154420927|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154420928|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816420|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
153567479|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154420929|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154420930|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154420931|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420932|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154420933|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154420934|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420935|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
154420936|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154420937|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154420938|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
154420939|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154420940|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153995507|NCT00813241|Celecoxib|celecoxib|mesh-list
154420941|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
154420942|NCT03126591|Olaratumab|olaratumab|mesh-list
154420943|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154420944|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420945|NCT03126591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154420946|NCT03126591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420947|NCT03085004|Ethanol|ethanol|mesh-list
154420948|NCT03085004|Paclitaxel|paclitaxel|mesh-list
154420949|NCT03085004|Gemcitabine|gemcitabine|mesh-list
154420950|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154420951|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420952|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
154420953|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
154420954|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154420955|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420956|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154420957|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
154420958|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154420959|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154420960|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420961|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420962|NCT03059862|Tryptophan|tryptophan|mesh-list
154420963|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154420964|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
154420965|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154420966|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154420967|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420968|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420969|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420970|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154420971|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
154420972|NCT02916862|Calcium|calcium|mesh-list
154420973|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153816428|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154420974|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420975|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154420976|NCT02891447|Cisplatin|cisplatin|mesh-list
154420977|NCT02891447|Mitomycins|mitomycins|mesh-list
154420978|NCT02891447|Mitomycin|mitomycin|mesh-list
154420979|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154420980|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154420981|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
154420982|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420983|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154420984|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154420985|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
154420986|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154420987|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154420988|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154420989|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
154420990|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154420991|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154420992|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420993|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
154420994|NCT02680626|Ropivacaine|ropivacaine|mesh-list
154420995|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
154420996|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
154420997|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154420998|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154420999|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
154421000|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421001|NCT02680626|Analgesics|analgesics|mesh-ancestor
154421002|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154421003|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
154421004|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154421005|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421006|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421007|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154421008|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
154421009|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154421010|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
154421011|NCT02494583|Capecitabine|capecitabine|mesh-list
154421012|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421013|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154421014|NCT02494583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154421015|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421016|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154421017|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
154421019|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
154421020|NCT02359331|Metronidazole|metronidazole|mesh-list
154421021|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154421022|NCT02359331|Tetracycline|tetracycline|mesh-list
154421023|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
154421024|NCT02359331|Bismuth|bismuth|mesh-list
154421025|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154421026|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154421027|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154421028|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421029|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421030|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421031|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154421032|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154421033|NCT02359331|Antacids|antacids|mesh-ancestor
154421034|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154421035|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154421036|NCT02322814|Paclitaxel|paclitaxel|mesh-list
154421037|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154421038|NCT02322814|Atezolizumab|atezolizumab|mesh-list
154421039|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154421040|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421041|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
154421042|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
154421043|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
154421044|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421045|NCT02322814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154421046|NCT02322814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154421047|NCT01837862|Mebendazole|mebendazole|mesh-list
154421048|NCT01837862|Piperazine|piperazine|mesh-list
154421049|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
154421050|NCT01837862|Bevacizumab|bevacizumab|mesh-list
154421051|NCT01837862|Carboplatin|carboplatin|mesh-list
154421052|NCT01837862|Irinotecan|irinotecan|mesh-list
154421053|NCT01837862|Vincristine|vincristine|mesh-list
154421054|NCT01837862|Temozolomide|temozolomide|mesh-list
154421055|NCT01837862|DMP 777|dmp 777|mesh-list
154421056|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154421057|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421058|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154421059|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154421060|NCT01837862|Growth Substances|growth substances|mesh-ancestor
154421061|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421062|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
154421063|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154421064|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154421065|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387535|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421066|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421067|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154421068|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
154421069|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
154421070|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
154421071|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154421072|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
154421073|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
154421074|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
154421075|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154421076|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421077|NCT01675219|Mitomycins|mitomycins|mesh-list
154421078|NCT01675219|Mitomycin|mitomycin|mesh-list
154421079|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154421080|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421081|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
154421082|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421083|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154421084|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421085|NCT01333033|Leucovorin|leucovorin|mesh-list
154421086|NCT01333033|Paclitaxel|paclitaxel|mesh-list
154421087|NCT01333033|Carboplatin|carboplatin|mesh-list
154421088|NCT01333033|Fluorouracil|fluorouracil|mesh-list
154421089|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
154421090|NCT01333033|Calcium|calcium|mesh-list
154421091|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
154421092|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154421093|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421094|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
154421095|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
154421096|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
154421097|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421098|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154421099|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421100|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
154421101|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154421102|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421103|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
154421104|NCT01333033|Antidotes|antidotes|mesh-ancestor
154421105|NCT01333033|Protective Agents|protective agents|mesh-ancestor
153814476|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421106|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
154421108|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
154421109|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
154421110|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154421111|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421112|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421113|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421114|NCT00778063|Analgesics|analgesics|mesh-ancestor
154421115|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
154421116|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421117|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154421118|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154421119|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154421120|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
154421121|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421122|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421123|NCT00547196|Cyclosporine|cyclosporine|mesh-list
154421124|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
154421125|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
154421126|NCT00547196|Melphalan|melphalan|mesh-list
154421127|NCT00547196|Busulfan|busulfan|mesh-list
154421128|NCT00547196|Fludarabine|fludarabine|mesh-list
154421129|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
154421130|NCT00547196|Cyclosporins|cyclosporins|mesh-list
154421131|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421132|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
154421133|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421134|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421135|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154421136|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
154421137|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421138|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421139|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154421140|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154421141|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
154421142|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421143|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
154421144|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421145|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
154421146|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154421147|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154421148|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154421149|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
154421150|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154421151|NCT00330941|Lidocaine|lidocaine|mesh-list
154421152|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
154421153|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
154421154|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421155|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421156|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
154421157|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421158|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154421159|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154421160|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154421161|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421162|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421163|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
154421164|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154421165|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
154421166|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421167|NCT03149107|Expectorants|expectorants|mesh-ancestor
154421168|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
154421169|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154421170|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
154421171|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421172|NCT03149107|Protective Agents|protective agents|mesh-ancestor
154421173|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421174|NCT03149107|Antidotes|antidotes|mesh-ancestor
154421176|NCT03135301|Letrozole|letrozole|mesh-list
154421177|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154421178|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421179|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421180|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154421181|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154049690|NCT00615875|Naproxen|naproxen|mesh-list
154421182|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421183|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421184|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154421185|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
154421186|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154421188|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
154421189|NCT03602898|Busulfan|busulfan|mesh-list
154421190|NCT03602898|Methotrexate|methotrexate|mesh-list
154421191|NCT03602898|Fludarabine|fludarabine|mesh-list
154421192|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
154421193|NCT03602898|Tacrolimus|tacrolimus|mesh-list
154421194|NCT03602898|Cyclosporins|cyclosporins|mesh-list
154421195|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154421196|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421197|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
154421198|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421199|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421200|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154421201|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
154421202|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421203|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421204|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154421205|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154421206|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
154421207|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154421208|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154421209|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
154421210|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
154421211|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421212|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154421213|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154421214|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154421215|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
154421216|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421217|NCT02983747|Loxoprofen|loxoprofen|mesh-list
154421218|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154421219|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421220|NCT02983747|Analgesics|analgesics|mesh-ancestor
154421221|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
154421222|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421223|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421224|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154421225|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421226|NCT05759845|Topiramate|topiramate|mesh-list
154421227|NCT05759845|Amitriptyline|amitriptyline|mesh-list
154421228|NCT05759845|Anticonvulsants|anticonvulsants|mesh-ancestor
154421229|NCT05759845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154421230|NCT05759845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421231|NCT05759845|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153567834|NCT04860713|Aspirin|aspirin|mesh-list
154421232|NCT05759845|Antidepressive Agents|antidepressive agents|mesh-ancestor
154421233|NCT05759845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154421234|NCT05759845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421235|NCT05759845|Analgesics|analgesics|mesh-ancestor
154421236|NCT05759845|Sensory System Agents|sensory system agents|mesh-ancestor
154421237|NCT05759845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421238|NCT05759845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154421239|NCT05759845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154421240|NCT05759845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421241|NCT05759845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421242|NCT05759845|Adrenergic Agents|adrenergic agents|mesh-ancestor
154421243|NCT05759845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421244|NCT00799110|Imiquimod|imiquimod|mesh-list
154421245|NCT00799110|Vaccines|vaccines|mesh-list
154421246|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
154421247|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421248|NCT00799110|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154421249|NCT00799110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421250|NCT00799110|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154421251|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154421252|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421253|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
154421254|NCT05199727|Tadalafil|tadalafil|mesh-list
154421255|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
154421256|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154421257|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154421258|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421259|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421260|NCT05199727|Urological Agents|urological agents|mesh-ancestor
154421262|NCT02132234|Infliximab|infliximab|mesh-list
154421263|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
154421264|NCT02132234|Etanercept|etanercept|mesh-list
154421265|NCT02132234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154421266|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154421267|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421268|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
154421269|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154421270|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154421271|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421272|NCT02132234|Analgesics|analgesics|mesh-ancestor
154421273|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
154421274|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421275|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421276|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421277|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
154421278|NCT02132390|Toremifene|toremifene|mesh-list
154421279|NCT02132390|Goserelin|goserelin|mesh-list
154421280|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154421281|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421282|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154421283|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154421284|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
154421285|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154421286|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421287|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154421288|NCT02128646|Ketorolac|ketorolac|mesh-list
154421289|NCT02128646|Bupivacaine|bupivacaine|mesh-list
154421290|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
154421291|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
154421292|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421293|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421294|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
154421295|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421296|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154421297|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421298|NCT02128646|Analgesics|analgesics|mesh-ancestor
154421299|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154421300|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421301|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154421302|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421303|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421304|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154421305|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
154421306|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
154421307|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421308|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421309|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
154421310|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154421311|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421312|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
154421313|NCT05198947|Ivermectin|ivermectin|mesh-list
154421314|NCT05198947|Permethrin|permethrin|mesh-list
154421315|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154421316|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421317|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421318|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421319|NCT01367834|Hormones|hormones|mesh-list
154421320|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154421321|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421322|NCT03106753|Bupivacaine|bupivacaine|mesh-list
154421323|NCT03106753|Terbutaline|terbutaline|mesh-list
154421324|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
154421325|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
154421326|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421327|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421328|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
154421329|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421330|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154421331|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
154421332|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154421333|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
154421334|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
154421335|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
154421336|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154421337|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154421338|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154421339|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154421340|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
154421341|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421342|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421343|NCT02133014|Fluorouracil|fluorouracil|mesh-list
154421344|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
154421345|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421346|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154421347|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421348|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421349|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
154421350|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421351|NCT05759455|Vitamin D|vitamin d|mesh-list
154421352|NCT05759455|Vitamins|vitamins|mesh-ancestor
154421353|NCT05759455|Micronutrients|micronutrients|mesh-ancestor
154421354|NCT05759455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421355|NCT05759455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154421356|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154421357|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154421358|NCT02129114|Estradiol|estradiol|mesh-list
154421359|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154421360|NCT02129114|Estrogens|estrogens|mesh-ancestor
154421361|NCT02129114|Hormones|hormones|mesh-ancestor
154421362|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567965|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815085|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421363|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421364|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154421365|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
154421366|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154421367|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154421368|NCT02136992|Pirfenidone|pirfenidone|mesh-list
154421369|NCT02136992|Analgesics|analgesics|mesh-ancestor
154421370|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
154421371|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421372|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421373|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154421374|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421375|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154421376|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421377|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421378|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
154421379|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154421380|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421381|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154421382|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154421383|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421384|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421385|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421386|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154421387|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154421388|NCT02129270|Lidocaine|lidocaine|mesh-list
154421389|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
154421390|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
154421391|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421392|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421393|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
154421394|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421395|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154421396|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154421397|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154421398|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421399|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421400|NCT02133326|Acetaminophen|acetaminophen|mesh-list
154421402|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421403|NCT02133326|Analgesics|analgesics|mesh-ancestor
154421404|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
154421405|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421406|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421408|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154421409|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154421410|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421411|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154421412|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421413|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421414|NCT02137616|Olanzapine|olanzapine|mesh-list
154421415|NCT02137616|Risperidone|risperidone|mesh-list
154421416|NCT02137616|Aripiprazole|aripiprazole|mesh-list
154421417|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154421418|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154421419|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
154421420|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421421|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421422|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421423|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154421424|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154421425|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421426|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154421427|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154421428|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
154421429|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
154421430|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
154421431|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421432|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154421433|NCT02137616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154421434|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154421435|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421436|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
154421437|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
154421438|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154421439|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154421440|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154421441|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154421442|NCT02133638|Propofol|propofol|mesh-list
154421443|NCT02133638|Sevoflurane|sevoflurane|mesh-list
154421444|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154421445|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421446|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421447|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154421448|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
154421449|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
154421450|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154421451|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154421452|NCT02545283|Cytarabine|cytarabine|mesh-list
153568050|NCT04404387|Vitamins|vitamins|mesh-ancestor
153568090|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421453|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154421454|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
154421455|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421456|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421457|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
154421458|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421459|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421460|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
154421461|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421462|NCT02137928|Carboplatin|carboplatin|mesh-list
154421463|NCT02137928|Etoposide|etoposide|mesh-list
154421464|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
154421465|NCT02137928|Vincristine|vincristine|mesh-list
154421466|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421467|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154421468|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154421469|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154421470|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996038|NCT04283435|Hormones|hormones|mesh-ancestor
154421471|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421472|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
154421473|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
154421474|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
154421476|NCT02138084|Fostemsavir|fostemsavir|mesh-list
154421477|NCT02138084|Rifabutin|rifabutin|mesh-list
154421478|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154421479|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154421480|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
154421481|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421482|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421484|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154421485|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
154421486|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421487|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154421488|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154421489|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154421490|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154421491|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
154421492|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154421493|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154421494|NCT02129582|Methotrexate|methotrexate|mesh-list
154421495|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
154421496|NCT02129582|Fludarabine|fludarabine|mesh-list
154421497|NCT02129582|Busulfan|busulfan|mesh-list
154421498|NCT02129582|Tacrolimus|tacrolimus|mesh-list
154421499|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
154421500|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154421501|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
154421502|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154421503|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
154421504|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154421505|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421506|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154421507|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
154421508|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421509|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421510|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
154421511|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421512|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154421513|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421514|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
154421515|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421516|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154421517|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154421518|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
154421519|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154421520|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154421521|NCT02138396|Fentanyl|fentanyl|mesh-list
154421522|NCT02138396|Naltrexone|naltrexone|mesh-list
154421523|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154421524|NCT02138396|Narcotics|narcotics|mesh-ancestor
154421525|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421526|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421527|NCT02138396|Analgesics|analgesics|mesh-ancestor
154421528|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
154421529|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421530|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154421531|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154421532|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
154421533|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
154421534|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154421535|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154421536|NCT04560881|Vaccines|vaccines|mesh-list
153568200|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154421537|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
154421538|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421539|NCT02875613|Avelumab|avelumab|mesh-list
154421540|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154421541|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421542|NCT02815267|Minocycline|minocycline|mesh-list
154421543|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154421544|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421545|NCT02130440|Resveratrol|resveratrol|mesh-list
154421546|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
154421547|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421548|NCT02130440|Protective Agents|protective agents|mesh-ancestor
154421549|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421550|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421551|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154421553|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421554|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154421555|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154421556|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154421557|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154421558|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421560|NCT02138708|Acetylcholine|acetylcholine|mesh-list
154421561|NCT02138708|Analgesics|analgesics|mesh-ancestor
154421562|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
154421563|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421564|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421565|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154421566|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
154421567|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154421568|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
154421569|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
154421570|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421571|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421572|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154421573|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
154421574|NCT03633175|Progesterone|progesterone|mesh-list
154421575|NCT03633175|Progestins|progestins|mesh-ancestor
154421576|NCT03633175|Hormones|hormones|mesh-ancestor
154421577|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154421578|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421579|NCT02539693|Lidocaine|lidocaine|mesh-list
154421580|NCT02539693|Clonidine|clonidine|mesh-list
154421581|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
154421582|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
154421583|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421584|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421585|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
154421586|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421587|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154421588|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154421589|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154421590|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421591|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421592|NCT02539693|Analgesics|analgesics|mesh-ancestor
154421593|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154421594|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
154421595|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
154421596|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154421597|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154421598|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154421599|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154421600|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421601|NCT05062135|Progesterone|progesterone|mesh-list
154421602|NCT05062135|Progestins|progestins|mesh-ancestor
154421603|NCT05062135|Hormones|hormones|mesh-ancestor
154421604|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154421605|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421606|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154421607|NCT02134106|Polymyxins|polymyxins|mesh-list
154421608|NCT02134106|Doripenem|doripenem|mesh-list
154421609|NCT02134106|Polymyxin B|polymyxin b|mesh-list
154421610|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154421611|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421612|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
154421613|NCT01354301|Everolimus|everolimus|mesh-list
154421614|NCT01354301|Tacrolimus|tacrolimus|mesh-list
154421615|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
154421616|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421617|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
154421618|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421619|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154421620|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814489|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154421621|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421622|NCT01354301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154421623|NCT01354301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154421624|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421625|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154421626|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154421627|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
154421628|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154421629|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421630|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
154421631|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154421632|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154421633|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
154421634|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421635|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154421636|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154421637|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
154421638|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421639|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421640|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154421642|NCT01343277|Trabectedin|trabectedin|mesh-list
154421643|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154421644|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
154421645|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421646|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421647|NCT04856293|Crizotinib|crizotinib|mesh-list
154421648|NCT04856293|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154421649|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154421650|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421651|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421652|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421653|NCT02253212|Carboplatin|carboplatin|mesh-list
154421654|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421655|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
154421656|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
154421657|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
154421658|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153568320|NCT03767582|Nivolumab|nivolumab|mesh-list
153362398|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421659|NCT01355939|Protective Agents|protective agents|mesh-ancestor
154421660|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421661|NCT01356017|Amlodipine|amlodipine|mesh-list
154421662|NCT01356017|Telmisartan|telmisartan|mesh-list
154421663|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154421664|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154421665|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421666|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421667|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154421668|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421669|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
154421670|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154421671|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154421672|NCT02139098|Amitriptyline|amitriptyline|mesh-list
154421673|NCT02139098|Zolpidem|zolpidem|mesh-list
154421674|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154421675|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154421676|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421677|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421678|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154421679|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
154421680|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
154421681|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421682|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421683|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154421684|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
154421685|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154421686|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421687|NCT02139098|Analgesics|analgesics|mesh-ancestor
154421688|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
154421689|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421690|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154421691|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154421692|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421693|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
154421694|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154421695|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
154421696|NCT02487979|Immunotoxins|immunotoxins|mesh-list
154421697|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154421698|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
154421699|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421700|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154421701|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421702|NCT02130830|Lidocaine|lidocaine|mesh-list
154421703|NCT02130830|Prilocaine|prilocaine|mesh-list
154421704|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
154421705|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
154421706|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050215|NCT04213781|Narcotics|narcotics|mesh-ancestor
154421707|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421708|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
154421709|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421710|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154421711|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154421712|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154421713|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421714|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421715|NCT01360151|Ranibizumab|ranibizumab|mesh-list
154421716|NCT01360151|Verteporfin|verteporfin|mesh-list
154421717|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154421718|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154421719|NCT01360151|Growth Substances|growth substances|mesh-ancestor
154421720|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421721|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
154421722|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421723|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154421724|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154421725|NCT01363037|Maraviroc|maraviroc|mesh-list
154421726|NCT01363037|Dapivirine|dapivirine|mesh-list
154421727|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154421728|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154421729|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421730|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154421731|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154421732|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
154421733|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421734|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154421735|NCT01363115|Vitamin D|vitamin d|mesh-list
154421736|NCT01363115|Calcium|calcium|mesh-list
154421737|NCT01363115|Vitamins|vitamins|mesh-ancestor
154421738|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
154421739|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421740|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154421741|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154421742|NCT01356329|Heparin|heparin|mesh-list
154421743|NCT01356329|Enoxaparin|enoxaparin|mesh-list
154421744|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
154421745|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154421746|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154421747|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421748|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
154421749|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154421750|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
154421751|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421752|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
154421753|NCT05579522|Protective Agents|protective agents|mesh-ancestor
154421754|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154421755|NCT01363193|Heparin|heparin|mesh-list
154421756|NCT01363193|Calcium heparin|calcium heparin|mesh-list
154421757|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
154421758|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154421759|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154421760|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421761|NCT01319279|Hydrocodone|hydrocodone|mesh-list
154421762|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154421763|NCT01319279|Narcotics|narcotics|mesh-ancestor
154421764|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421765|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421766|NCT01319279|Analgesics|analgesics|mesh-ancestor
154421767|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
154421768|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421769|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
154421770|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
154421771|NCT01363271|Vancomycin|vancomycin|mesh-list
154421772|NCT01363271|Linezolid|linezolid|mesh-list
154421773|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154421774|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421775|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154421776|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421777|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421778|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154421779|NCT02134886|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154421780|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154421781|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421782|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421783|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421785|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154421786|NCT01360463|Narcotics|narcotics|mesh-ancestor
154421787|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421788|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421789|NCT01360463|Analgesics|analgesics|mesh-ancestor
154421790|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
154421791|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421792|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
154421793|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
154421794|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154421795|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421796|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154421797|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153568398|NCT03339349|Enoxaparin|enoxaparin|mesh-list
154421798|NCT03103087|Norethindrone|norethindrone|mesh-list
154421799|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
154421800|NCT03103087|Estradiol|estradiol|mesh-list
154421801|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154421802|NCT03103087|Relugolix|relugolix|mesh-list
154421803|NCT03103087|Estrogens|estrogens|mesh-ancestor
154421804|NCT03103087|Hormones|hormones|mesh-ancestor
154421805|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154421806|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421807|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154421808|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
154421809|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154421810|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154421811|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154421812|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154421813|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154421814|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
154421815|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
154421816|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
154421817|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154421818|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
154421819|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
154421820|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421821|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421822|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154421823|NCT05579288|Analgesics|analgesics|mesh-ancestor
154421824|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
154421825|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421826|NCT02134964|Dapansutrile|dapansutrile|mesh-list
154421827|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154421828|NCT01363583|Epoprostenol|epoprostenol|mesh-list
154421829|NCT01363583|Tezosentan|tezosentan|mesh-list
154421830|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154421831|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154421832|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
154421833|NCT02135120|Morphine|morphine|mesh-list
154421834|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421835|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421836|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154421837|NCT02135120|Narcotics|narcotics|mesh-ancestor
154421838|NCT02135120|Analgesics|analgesics|mesh-ancestor
154421839|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
154421840|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421841|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
154421842|NCT03131999|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154421843|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154421844|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421845|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421846|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421847|NCT01319357|Saxagliptin|saxagliptin|mesh-list
153814499|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814500|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
153814501|NCT00446316|Antacids|antacids|mesh-list
153568564|NCT02768337|Afatinib|afatinib|mesh-list
154421848|NCT01319357|Incretins|incretins|mesh-ancestor
154421849|NCT01319357|Hormones|hormones|mesh-ancestor
154421850|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154421851|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421852|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154421853|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
154421854|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421855|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421856|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154421857|NCT02135354|Azithromycin|azithromycin|mesh-list
154421858|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154421859|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421860|NCT02055053|Bupivacaine|bupivacaine|mesh-list
154421861|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
154421862|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
154421863|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421864|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421865|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
154421866|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421867|NCT02135510|Metoclopramide|metoclopramide|mesh-list
154421868|NCT02135510|Palonosetron|palonosetron|mesh-list
154421869|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
154421870|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
154421871|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421872|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421873|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154421874|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154421875|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154421876|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
154421877|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421878|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421879|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154421880|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154421881|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
154421882|NCT03548714|Ethanol|ethanol|mesh-list
154421883|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154421884|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154421885|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421886|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421887|NCT02135588|Plasminogen|plasminogen|mesh-list
154421888|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154421889|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154421890|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154421891|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421892|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
154421893|NCT01491763|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154421894|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154421895|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421896|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421897|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421898|NCT01363817|Dexamethasone|dexamethasone|mesh-list
154421899|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154421900|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
154421901|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
154421902|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421903|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421904|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154421905|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
154421906|NCT01363817|Hormones|hormones|mesh-ancestor
154421907|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154421908|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154421909|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421910|NCT02140268|Midazolam|midazolam|mesh-list
154421911|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154421912|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154421913|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421914|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421915|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154421916|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154421917|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154421918|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154421919|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
154421920|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
154421921|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
154421922|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
154421923|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421924|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996485|NCT00901394|Folic Acid|folic acid|mesh-list
154421925|NCT05578352|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154421926|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154421927|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421928|NCT03602508|Mirabegron|mirabegron|mesh-list
154421929|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
154421930|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154421931|NCT03602508|Fesoterodine|fesoterodine|mesh-list
154421932|NCT03602508|Oxybutynin|oxybutynin|mesh-list
154421933|NCT03602508|Darifenacin|darifenacin|mesh-list
154421934|NCT03602508|Propiverine|propiverine|mesh-list
154421935|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154421936|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154421937|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154421938|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
154421939|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421940|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421941|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421942|NCT03602508|Urological Agents|urological agents|mesh-ancestor
154421943|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154421944|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154421945|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
154421946|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
154421947|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
154421948|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421949|NCT03549728|Lenograstim|lenograstim|mesh-list
154421950|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154421951|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
154421952|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421953|NCT01356797|Fentanyl|fentanyl|mesh-list
154421954|NCT01356797|Bupivacaine|bupivacaine|mesh-list
154421955|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
154421956|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
154421957|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
153814504|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154421958|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154421959|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421960|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
154421961|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421962|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154421963|NCT01356797|Narcotics|narcotics|mesh-ancestor
154421964|NCT01356797|Analgesics|analgesics|mesh-ancestor
154421965|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154421966|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154421967|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
154421968|NCT02238132|Ipratropium|ipratropium|mesh-list
154421969|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154421970|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
154421971|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154421972|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154421973|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154421974|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
154421975|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154421976|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
154421977|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154421978|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421979|NCT05200429|Ivacaftor|ivacaftor|mesh-list
154421980|NCT05200429|Elexacaftor|elexacaftor|mesh-list
154421981|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154421982|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154421983|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421984|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154421985|NCT02135822|Paclitaxel|paclitaxel|mesh-list
154421986|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154421987|NCT02135822|Gemcitabine|gemcitabine|mesh-list
154421988|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154421989|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154421990|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
154421991|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
154421992|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
154421993|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154421994|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154421995|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
154421996|NCT02238210|Ipratropium|ipratropium|mesh-list
154421997|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154421998|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
154421999|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422000|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422001|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154422002|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
154422003|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154422004|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
154422005|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422006|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422007|NCT02978456|Sirolimus|sirolimus|mesh-list
154422008|NCT02978456|Temsirolimus|temsirolimus|mesh-list
154422009|NCT02978456|MTOR Inhibitors|mtor inhibitors|mesh-list
154422010|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153568711|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
154422011|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422012|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154422013|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422014|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
154422015|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154422016|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
154422017|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422018|NCT02978456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154422019|NCT02978456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422020|NCT02978456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422022|NCT05736913|Immunologic Factors|immunologic factors|mesh-ancestor
154422023|NCT05736913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422024|NCT03598452|Ganciclovir|ganciclovir|mesh-list
154422025|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154422026|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
154422027|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422028|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154422029|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422030|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422031|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154422032|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154422033|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154422034|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154422035|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422036|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422037|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422038|NCT03549026|Analgesics|analgesics|mesh-ancestor
154422039|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
154422040|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422041|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
154422042|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154422043|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
154422044|NCT03101371|Iodine|iodine|mesh-list
154422045|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
154422046|NCT03101371|Povidone|povidone|mesh-list
154422047|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154422048|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422049|NCT03101371|Trace Elements|trace elements|mesh-ancestor
154422050|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
154422051|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422052|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
154422053|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
154422054|NCT03588078|Azacitidine|azacitidine|mesh-list
154422055|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154422056|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
154422057|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422058|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422059|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422060|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154422061|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
154422062|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154422063|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
154422064|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154422065|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422066|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154422067|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154422068|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422069|NCT05494190|Docetaxel|docetaxel|mesh-list
154422070|NCT05494190|Capecitabine|capecitabine|mesh-list
154422071|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568761|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422072|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
154422073|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
154422074|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
154422075|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996635|NCT00901628|Analgesics|analgesics|mesh-ancestor
154422076|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154422077|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
154422079|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154422080|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
154422081|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154422082|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422083|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422085|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422086|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422087|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
154422088|NCT03862170|Cefazolin|cefazolin|mesh-list
154422089|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154422090|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422091|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154422092|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154422093|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422094|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422095|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422096|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154422097|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154422098|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154422099|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
154422100|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
154422101|NCT05577806|Progestins|progestins|mesh-ancestor
154422102|NCT05577806|Hormones|hormones|mesh-ancestor
154422103|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154422104|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422105|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
154422106|NCT03548948|Iron|iron|mesh-list
154422107|NCT03548948|Trace Elements|trace elements|mesh-ancestor
154422108|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
154422109|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422110|NCT02238444|Aspirin|aspirin|mesh-list
154422111|NCT02238444|Heparin|heparin|mesh-list
154422112|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154422113|NCT02238444|Tinzaparin|tinzaparin|mesh-list
154422114|NCT02238444|Dalteparin|dalteparin|mesh-list
154422115|NCT02238444|Dipyridamole|dipyridamole|mesh-list
154422116|NCT02238444|Warfarin|warfarin|mesh-list
154422117|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154422118|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422119|NCT02238444|Analgesics|analgesics|mesh-ancestor
154422120|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
154422121|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422122|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422123|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422124|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422125|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154422126|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154422127|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422128|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153814510|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422129|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154422130|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422131|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
154422132|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
154422133|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154422134|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
154422135|NCT03131687|Dulaglutide|dulaglutide|mesh-list
154422136|NCT03131687|Tirzepatide|tirzepatide|mesh-list
154422137|NCT03131687|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154422138|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154422139|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422140|NCT03131687|Incretins|incretins|mesh-ancestor
154422141|NCT03131687|Hormones|hormones|mesh-ancestor
154422142|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154422143|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
154422144|NCT03579888|Fludarabine|fludarabine|mesh-list
154422145|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154422146|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
154422147|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422148|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422149|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154422150|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
154422151|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422152|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422153|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154422154|NCT05344027|Mitotane|mitotane|mesh-list
154422155|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154422156|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422157|NCT05430698|Antibodies|antibodies|mesh-list
154422158|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
154422159|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422161|NCT03585894|Sumatriptan|sumatriptan|mesh-list
154422162|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154422163|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422164|NCT03585894|Analgesics|analgesics|mesh-ancestor
154422165|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
154422166|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422167|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422168|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422169|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422170|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154422171|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422172|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422173|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154422174|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154422175|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154422176|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
154422177|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422178|NCT04912921|Palmidrol|palmidrol|mesh-list
154422179|NCT04912921|Curcumin|curcumin|mesh-list
154422180|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153814511|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154422181|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422182|NCT04912921|Analgesics|analgesics|mesh-ancestor
154422183|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
154422184|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422185|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422186|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422187|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422188|NCT04912921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422189|NCT04912921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422190|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422191|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
154422192|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422193|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154422194|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154422195|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422196|NCT04912921|Hormones|hormones|mesh-ancestor
154422197|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154422198|NCT05420324|Paclitaxel|paclitaxel|mesh-list
154422199|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
154422200|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154422201|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422202|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
154422203|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
154422204|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
154422205|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422206|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154422207|NCT05420324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154422208|NCT02238288|Acetaminophen|acetaminophen|mesh-list
154422209|NCT02238288|Lidocaine|lidocaine|mesh-list
154422210|NCT02238288|Epinephrine|epinephrine|mesh-list
154422211|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
154422212|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
154422213|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
154422214|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422215|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422216|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
154422217|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422218|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154422219|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154422220|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154422221|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154422222|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422223|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422224|NCT02238288|Analgesics|analgesics|mesh-ancestor
154422225|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
154422226|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154422227|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154422228|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
154422229|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422230|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154422231|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154422232|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
154422234|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154422235|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
154422236|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
154422237|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154422238|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153568802|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154422239|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154422240|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
154422241|NCT02238288|Coagulants|coagulants|mesh-ancestor
154422242|NCT01561040|Vitamin D|vitamin d|mesh-list
154422243|NCT01561040|Vitamin A|vitamin a|mesh-list
154422244|NCT01561040|Vitamins|vitamins|mesh-ancestor
154422245|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
154422246|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422247|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154422248|NCT03590496|Calcium|calcium|mesh-list
154422249|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154422250|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422251|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
154422252|NCT05577260|Bupivacaine|bupivacaine|mesh-list
154422253|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
154422254|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
154422255|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422256|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422257|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
154422258|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422259|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154422260|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422261|NCT05577260|Analgesics|analgesics|mesh-ancestor
154422262|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154422263|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154422264|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154422265|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
154422266|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422267|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422268|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
154422269|NCT03760562|Hormones|hormones|mesh-ancestor
154422270|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154422271|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422272|NCT01357031|Amitriptyline|amitriptyline|mesh-list
154422273|NCT01357031|Melatonin|melatonin|mesh-list
154422274|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
154422275|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422276|NCT01357031|Protective Agents|protective agents|mesh-ancestor
154422277|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422278|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422279|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154422280|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
154422281|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154422282|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422283|NCT01357031|Analgesics|analgesics|mesh-ancestor
154422284|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
154422285|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422286|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154422287|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154422288|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154422289|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
154422290|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568804|NCT01049347|Analgesics|analgesics|mesh-ancestor
153814512|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153457775|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154422291|NCT01357109|Bosentan|bosentan|mesh-list
154422292|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154422293|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154422294|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422295|NCT02253446|Diclofenac|diclofenac|mesh-list
154422296|NCT02253446|Piroxicam|piroxicam|mesh-list
154422297|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154422298|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154422299|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422300|NCT02253446|Analgesics|analgesics|mesh-ancestor
154422301|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
154422302|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422303|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422304|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422305|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422306|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154422307|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422308|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422310|NCT05417893|Everolimus|everolimus|mesh-list
154422311|NCT05417893|MTOR Inhibitors|mtor inhibitors|mesh-list
154422312|NCT05417893|Temsirolimus|temsirolimus|mesh-list
154422313|NCT05417893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154422314|NCT05417893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422315|NCT05417893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422316|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154422317|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
154422318|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422319|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422320|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154422321|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422322|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154422323|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
154422324|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154422325|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154422326|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422327|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422328|NCT01563224|Baclofen|baclofen|mesh-list
154422329|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154422330|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422331|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154422332|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422333|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154422334|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
154422335|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
154422336|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422337|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422338|NCT01369979|Imidacloprid|imidacloprid|mesh-list
154422339|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
154422340|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422341|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422342|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422343|NCT03577860|Bupivacaine|bupivacaine|mesh-list
154422344|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
154422345|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
154422346|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422347|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422348|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
154422349|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422350|NCT03577782|Vedolizumab|vedolizumab|mesh-list
154422351|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154422352|NCT03577626|Hemay005|hemay005|mesh-list
154422353|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
154422354|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154422355|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154422356|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422357|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422358|NCT03412799|Paclitaxel|paclitaxel|mesh-list
154422359|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154422360|NCT03412799|Gemcitabine|gemcitabine|mesh-list
154422361|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154422362|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422363|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
154422364|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
154422365|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
154422366|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422367|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154422368|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
154422369|NCT03579732|Aspirin|aspirin|mesh-list
154422370|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154422371|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422372|NCT03579732|Analgesics|analgesics|mesh-ancestor
154422373|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
154422374|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422375|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422376|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422378|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154422379|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154422380|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422381|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154422382|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154422383|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422385|NCT02259816|Amlodipine|amlodipine|mesh-list
154422386|NCT02259816|Telmisartan|telmisartan|mesh-list
154422387|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154422388|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154422389|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154422390|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422391|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154422392|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422393|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
154422394|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153568836|NCT00099086|Docetaxel|docetaxel|mesh-list
153814515|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422395|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154422396|NCT01567735|Simeprevir|simeprevir|mesh-list
154422397|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
154422398|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422399|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
154422400|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422401|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422402|NCT04631471|Ibudilast|ibudilast|mesh-list
154422403|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154422404|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
154422405|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422406|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422407|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154422408|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
154422409|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154422410|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422411|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422412|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154422413|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
154422414|NCT03577392|Capecitabine|capecitabine|mesh-list
154422415|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
154422416|NCT03577392|Endostatins|endostatins|mesh-list
154422417|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154422418|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
154422419|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422420|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422421|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154422422|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154422423|NCT03577392|Growth Substances|growth substances|mesh-ancestor
154422424|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422425|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
154422426|NCT03579576|Ribavirin|ribavirin|mesh-list
154422427|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
154422428|NCT03579576|Velpatasvir|velpatasvir|mesh-list
154422429|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
154422430|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422431|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
154422432|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422433|NCT01364519|Fluticasone|fluticasone|mesh-list
154422434|NCT01364519|Xhance|xhance|mesh-list
154422435|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422436|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154422437|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
154422438|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422439|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422440|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154422441|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
154422442|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
154422443|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154422444|NCT03577158|Insulin|insulin|mesh-list
154422445|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154422446|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422447|NCT02253914|Ritonavir|ritonavir|mesh-list
154422448|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154422449|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154422450|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
154422451|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422452|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422453|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154422454|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154422455|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
154422456|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422457|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154422458|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154422460|NCT01364675|Enalapril|enalapril|mesh-list
154422461|NCT01364675|Simvastatin|simvastatin|mesh-list
154422462|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154422463|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422464|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154422465|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154422466|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
154422467|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422468|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154422469|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154422470|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422471|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154422472|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
154422473|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154422474|NCT02253758|Propofol|propofol|mesh-list
154422475|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154422476|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422477|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422478|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154422479|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
154422480|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
154422481|NCT03547232|Indomethacin|indomethacin|mesh-list
154422482|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154422483|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422484|NCT03547232|Analgesics|analgesics|mesh-ancestor
154422485|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
154422486|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422487|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422488|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422489|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422490|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
154422491|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
154422492|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154422493|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154422494|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422495|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422496|NCT02250534|Nicotine|nicotine|mesh-list
154422497|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154422498|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
154422499|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422500|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422501|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154422502|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154422503|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
154422504|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422505|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422506|NCT01370135|Ranibizumab|ranibizumab|mesh-list
154422507|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154422508|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154422509|NCT01370135|Growth Substances|growth substances|mesh-ancestor
154422510|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422511|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
154422512|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422513|NCT05266586|Ezetimibe|ezetimibe|mesh-list
154422514|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154422515|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154422516|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
154422517|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422518|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154422519|NCT01370291|Risperidone|risperidone|mesh-list
154422520|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154422521|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
154422522|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422523|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422524|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422525|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154422526|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154422527|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422528|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154422529|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154422531|NCT05575544|Morphine|morphine|mesh-list
154422532|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154422533|NCT05575544|Narcotics|narcotics|mesh-ancestor
154422534|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422535|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422537|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
154422538|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422539|NCT05179772|Olanzapine|olanzapine|mesh-list
154422540|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
154422541|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
154422542|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422543|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422544|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154422545|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154422546|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154422547|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422548|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154422549|NCT05179772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154422550|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154422551|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154422552|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422553|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422554|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
154422555|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
154422556|NCT01364987|Peficitinib|peficitinib|mesh-list
154422557|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153814520|NCT00340574|Antacids|antacids|mesh-ancestor
153569024|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422558|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422559|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154422560|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
154422561|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154422562|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422563|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422564|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422565|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154422566|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
154422567|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422568|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
154422569|NCT01365923|Remifentanil|remifentanil|mesh-list
154422570|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154422571|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422572|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422573|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422574|NCT01365923|Analgesics|analgesics|mesh-ancestor
154422575|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
154422576|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422577|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154422578|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154422579|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154422580|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154422581|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422582|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422583|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154422584|NCT01365923|Narcotics|narcotics|mesh-ancestor
154422585|NCT01370915|Vitamins|vitamins|mesh-list
154422586|NCT01370915|Pregabalin|pregabalin|mesh-list
154422587|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
154422588|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422589|NCT01370915|Analgesics|analgesics|mesh-ancestor
154422590|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
154422591|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422592|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
154422593|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154422594|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154422595|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422596|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154422597|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154422598|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154422599|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422601|NCT05574998|Paclitaxel|paclitaxel|mesh-list
154422602|NCT05574998|Cisplatin|cisplatin|mesh-list
153813988|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154422603|NCT05574998|Carboplatin|carboplatin|mesh-list
154422604|NCT05574998|Pemetrexed|pemetrexed|mesh-list
154422605|NCT05574998|Endostar protein|endostar protein|mesh-list
154422606|NCT05574998|Endostatins|endostatins|mesh-list
154422607|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154422608|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422609|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
154422610|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
154422611|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
154422612|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422613|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422614|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154422615|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154422616|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154422617|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154422618|NCT05574998|Growth Substances|growth substances|mesh-ancestor
154422619|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422620|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
154422622|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154422623|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
154422624|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154422625|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422626|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154422627|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154422628|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
154422629|NCT03547700|Ixazomib|ixazomib|mesh-list
154422630|NCT03547700|Romidepsin|romidepsin|mesh-list
154422631|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422632|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
154422633|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422634|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422635|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154422636|NCT03547700|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154422637|NCT02239458|Saxagliptin|saxagliptin|mesh-list
154422638|NCT02239458|Incretins|incretins|mesh-ancestor
154422639|NCT02239458|Hormones|hormones|mesh-ancestor
154422640|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154422641|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422642|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154422643|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
154422644|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422645|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422646|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154422647|NCT03128411|Bosutinib|bosutinib|mesh-list
154422648|NCT03128411|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154422649|NCT03128411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154422650|NCT03128411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422651|NCT03128411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422652|NCT03578874|Capecitabine|capecitabine|mesh-list
154422653|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
154422654|NCT03578874|Sorafenib|sorafenib|mesh-list
154422655|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154422656|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
154422657|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422658|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422659|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154422660|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422661|NCT01366001|Buprenorphine|buprenorphine|mesh-list
154422662|NCT01366001|ALKS-33|alks-33|mesh-list
154422663|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154422664|NCT01366001|Narcotics|narcotics|mesh-ancestor
154422665|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422666|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422667|NCT01366001|Analgesics|analgesics|mesh-ancestor
154422668|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
154422669|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422670|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154422671|NCT03574584|Semaglutide|semaglutide|mesh-list
154422672|NCT03574584|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154422673|NCT03574584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154422674|NCT03574584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422675|NCT01365065|Vorinostat|vorinostat|mesh-list
154422676|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422677|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154422678|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422679|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422680|NCT03576456|Alprazolam|alprazolam|mesh-list
154422681|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154422682|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422683|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422684|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154422685|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154422686|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154422687|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
154422688|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
154422689|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422690|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422691|NCT05572190|Hydrocodone|hydrocodone|mesh-list
154422692|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154422693|NCT05572190|Narcotics|narcotics|mesh-ancestor
154422694|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422695|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422696|NCT05572190|Analgesics|analgesics|mesh-ancestor
154422697|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
154422698|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422699|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
154422700|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
154422701|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154422702|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154422703|NCT03124199|Rifaximin|rifaximin|mesh-list
154422704|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154422705|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422706|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154422707|NCT03578640|Grazoprevir|grazoprevir|mesh-list
154422708|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
154422709|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422710|NCT04465916|Tenofovir|tenofovir|mesh-list
154422711|NCT04465916|Entecavir|entecavir|mesh-list
154422712|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
154422713|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422714|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154422715|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154422716|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422717|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422718|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154422719|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154422720|NCT01366235|Chloroquine|chloroquine|mesh-list
154422721|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154422722|NCT01366235|Amebicides|amebicides|mesh-ancestor
154422723|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154422724|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154422725|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422726|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
154422727|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422728|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154422729|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422730|NCT01366235|Analgesics|analgesics|mesh-ancestor
154422731|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
154422732|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422733|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422734|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422735|NCT01366235|Filaricides|filaricides|mesh-ancestor
154422736|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
154422737|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
154422738|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
154422739|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154422740|NCT04871165|Antibodies|antibodies|mesh-list
154422741|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
154422742|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422743|NCT01366313|Acetaminophen|acetaminophen|mesh-list
154422744|NCT01366313|Morphine|morphine|mesh-list
154422745|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154422746|NCT01366313|Narcotics|narcotics|mesh-ancestor
154422747|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422748|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422749|NCT01366313|Analgesics|analgesics|mesh-ancestor
153997334|NCT04537715|Rifampin|rifampin|mesh-list
154422750|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
154422751|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422752|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422753|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
154422754|NCT02253524|Metoclopramide|metoclopramide|mesh-list
154422755|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
153569122|NCT04648358|Hormones|hormones|mesh-ancestor
153569148|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153569149|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153569150|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
154422756|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
154422757|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
154422758|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422759|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422760|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154422761|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154422762|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154422763|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
154422764|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422765|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422766|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154422767|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
154422768|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
154422769|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154422770|NCT02253602|Hematinics|hematinics|mesh-ancestor
154422771|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154422772|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154422773|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
154422774|NCT03575520|Doxorubicin|doxorubicin|mesh-list
154422775|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154422776|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
154422777|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422778|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422779|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154422780|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
154422781|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422782|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422783|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154422784|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154422785|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154422786|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154422787|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422788|NCT01366391|Metformin|metformin|mesh-list
154422789|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154422790|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422791|NCT04408586|Topiramate|topiramate|mesh-list
154422792|NCT04408586|Phentermine|phentermine|mesh-list
154422793|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
154422794|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154422795|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422796|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154422797|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
154422798|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154422799|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
154422800|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
154422801|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422802|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
154422803|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422804|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422805|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154422806|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
154422807|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
154422808|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422809|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153569152|NCT04560725|Choline|choline|mesh-list
154422810|NCT02239614|Antacids|antacids|mesh-ancestor
154422811|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422812|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154422813|NCT03572400|Gemcitabine|gemcitabine|mesh-list
154422814|NCT03572400|Durvalumab|durvalumab|mesh-list
154422815|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154422816|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
154422817|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422818|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422819|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154422820|NCT02253836|Ritonavir|ritonavir|mesh-list
154422821|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154422822|NCT02253836|Tipranavir|tipranavir|mesh-list
154422823|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154422824|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154422825|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
154422826|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422827|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997394|NCT04025359|Hormones|hormones|mesh-ancestor
154422828|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154422829|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154422830|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
154422831|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422832|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154422833|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154422834|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154422835|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154422837|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154422838|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154422839|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
154422840|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422841|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422842|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422843|NCT04039022|Levomethorphan|levomethorphan|mesh-list
154422844|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
154422845|NCT04039022|Bupropion|bupropion|mesh-list
154422846|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154422847|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
154422848|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154422849|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154422850|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154422851|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154422852|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422853|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
154422854|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422855|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422856|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154422857|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154422858|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422859|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
153569171|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422860|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
154422861|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154422862|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154422863|NCT04039022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154422864|NCT04039022|Narcotics|narcotics|mesh-ancestor
154422865|NCT04039022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154422866|NCT04039022|Analgesics|analgesics|mesh-ancestor
154422867|NCT04039022|Sensory System Agents|sensory system agents|mesh-ancestor
154422868|NCT04039022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422869|NCT00109772|Lenalidomide|lenalidomide|mesh-list
154422870|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
154422871|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422872|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154422873|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154422874|NCT00109772|Growth Substances|growth substances|mesh-ancestor
154422875|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
154422876|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422877|NCT03572010|Fesoterodine|fesoterodine|mesh-list
154422878|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154422879|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154422880|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
154422881|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422882|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422883|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422884|NCT03572010|Urological Agents|urological agents|mesh-ancestor
154422885|NCT01560104|Paclitaxel|paclitaxel|mesh-list
154422886|NCT01560104|Carboplatin|carboplatin|mesh-list
154422887|NCT01560104|Veliparib|veliparib|mesh-list
154422888|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154422889|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422890|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
154422891|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
154422892|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
154422893|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422894|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154422895|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422896|NCT00101972|Antibodies|antibodies|mesh-list
154422897|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154422898|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
154422899|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422900|NCT02245932|Resveratrol|resveratrol|mesh-list
154422901|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
154422902|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422903|NCT02245932|Protective Agents|protective agents|mesh-ancestor
154422904|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422905|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422906|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154422907|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154422908|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154422909|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422910|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422911|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422912|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154422913|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
154422914|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
154422915|NCT04944368|Paraproteins|paraproteins|mesh-list
153814529|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
153569202|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154422916|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
154422917|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422918|NCT03546530|Interferons|interferons|mesh-list
154422919|NCT03546530|Resveratrol|resveratrol|mesh-list
154422920|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422921|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
154422922|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422923|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
154422924|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422925|NCT03546530|Protective Agents|protective agents|mesh-ancestor
154422926|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422927|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422928|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154422929|NCT01366547|Lamivudine|lamivudine|mesh-list
154422930|NCT01366547|Abacavir|abacavir|mesh-list
154422931|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
154422932|NCT01366547|Dolutegravir|dolutegravir|mesh-list
154422933|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154422934|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154422935|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422936|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422937|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
154422938|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422939|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154422940|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154422941|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154422942|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154422943|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
154422944|NCT05190341|Ibuprofen|ibuprofen|mesh-list
154422945|NCT05190341|Ketorolac|ketorolac|mesh-list
154422946|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154422947|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154422948|NCT05190341|Analgesics|analgesics|mesh-ancestor
154422949|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
154422950|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422951|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422952|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422953|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154422954|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154422955|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422956|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422957|NCT04347239|Leronlimab|leronlimab|mesh-list
154422958|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154422959|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154422960|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422961|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154422962|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154422963|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
154422964|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154422965|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
154422966|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154422967|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154422968|NCT00109928|Prednisolone|prednisolone|mesh-list
154422969|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
154422970|NCT00109928|Gemcitabine|gemcitabine|mesh-list
154422971|NCT00109928|Etoposide|etoposide|mesh-list
154422972|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154422973|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
154422974|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154422975|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154422976|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
154422977|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997546|NCT00566098|Melphalan|melphalan|mesh-list
154422978|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153569203|NCT04523818|Capecitabine|capecitabine|mesh-list
154422979|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154422980|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154422981|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154422982|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154422983|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
154422984|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
154422985|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154422986|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422987|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154422988|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
154422990|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154422991|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154422992|NCT00109928|Protective Agents|protective agents|mesh-ancestor
154422993|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154422994|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154422995|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154422996|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
154422997|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154422998|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154422999|NCT00109850|Irinotecan|irinotecan|mesh-list
154423000|NCT00109850|Cetuximab|cetuximab|mesh-list
154423001|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423002|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154423003|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154423004|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423005|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423006|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423007|NCT03318770|Dasatinib|dasatinib|mesh-list
154423008|NCT03318770|Blinatumomab|blinatumomab|mesh-list
154423009|NCT03318770|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154423010|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154423011|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423012|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423013|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423014|NCT01065519|Umirolimus|umirolimus|mesh-list
154423015|NCT01065519|Everolimus|everolimus|mesh-list
154423016|NCT01065519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154423017|NCT01065519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154423018|NCT01065519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423019|NCT01065519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423020|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154423021|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
154423022|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423023|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423024|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423025|NCT01810016|Poly I-C|poly i-c|mesh-list
154423026|NCT01810016|Ipilimumab|ipilimumab|mesh-list
154423027|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154423028|NCT01810016|Vaccines|vaccines|mesh-list
154423029|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154423030|NCT01810016|Poly ICLC|poly iclc|mesh-list
154423031|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
154423032|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423033|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423034|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423035|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154423036|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423037|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154423038|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
154423039|NCT01810016|Laxatives|laxatives|mesh-ancestor
154423040|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154423041|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
154423042|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423043|NCT02254148|Metoprolol|metoprolol|mesh-list
154423044|NCT02254148|Digoxin|digoxin|mesh-list
154423045|NCT02254148|Midazolam|midazolam|mesh-list
154423046|NCT02254148|Caffeine|caffeine|mesh-list
154423047|NCT02254148|Omeprazole|omeprazole|mesh-list
154423048|NCT02254148|Warfarin|warfarin|mesh-list
154423049|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154423050|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154423051|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423052|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423053|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154423054|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154423055|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154423056|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154423057|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
154423058|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
154423059|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
154423060|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
154423061|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423062|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423063|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
154423064|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154423065|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154423067|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154423068|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154423069|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
154423070|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154423071|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154423072|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153387539|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423073|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154423074|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154423075|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
154423076|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
154423077|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423078|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154423079|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154423080|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154423081|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
154423082|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154423083|NCT02254148|Protective Agents|protective agents|mesh-ancestor
154423084|NCT02842866|Vaccines|vaccines|mesh-list
154423085|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
154423086|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423087|NCT01316913|Bromides|bromides|mesh-list
154423088|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
154423089|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154423090|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
154423091|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423092|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423093|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154423094|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
154423095|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
154423096|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154423097|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
154423098|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423099|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423100|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
154423101|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
154423102|NCT02875067|Lenalidomide|lenalidomide|mesh-list
154423103|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423104|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423105|NCT02875067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154423106|NCT02875067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423107|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
154423108|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423109|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154423110|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154423111|NCT02875067|Growth Substances|growth substances|mesh-ancestor
154423112|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
154423113|NCT03570294|Atosiban|atosiban|mesh-list
154423114|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
154423115|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423116|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423117|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
154423118|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154423119|NCT02143622|Cetuximab|cetuximab|mesh-list
154423120|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423121|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423122|NCT02781506|Nivolumab|nivolumab|mesh-list
153569369|NCT03511118|Hydrocodone|hydrocodone|mesh-list
154423123|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423124|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423125|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154423126|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997683|NCT02833116|Hormones|hormones|mesh-ancestor
154423127|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154423128|NCT03571230|Amoxicillin|amoxicillin|mesh-list
154423130|NCT03571230|Clarithromycin|clarithromycin|mesh-list
154423131|NCT03571230|Levofloxacin|levofloxacin|mesh-list
154423132|NCT03571230|Tetracycline|tetracycline|mesh-list
154423133|NCT03571230|Tinidazole|tinidazole|mesh-list
154423134|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154423135|NCT03571230|Furazolidone|furazolidone|mesh-list
154423136|NCT03571230|Bismuth|bismuth|mesh-list
154423137|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154423138|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423139|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
154423140|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154423141|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154423142|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154423143|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423144|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423145|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154423146|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154423147|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154423148|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154423149|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154423150|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423151|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154423152|NCT03571230|Antacids|antacids|mesh-ancestor
154423153|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154423154|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154423155|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154423156|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154423157|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
154423158|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154423159|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154423160|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
154423161|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423162|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423163|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154423164|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
154423165|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154423166|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154423167|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154423168|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
154423169|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423170|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423171|NCT02143934|Chloroquine|chloroquine|mesh-list
154423172|NCT02143934|Lumefantrine|lumefantrine|mesh-list
154423173|NCT02143934|Artemether|artemether|mesh-list
154423174|NCT02143934|Primaquine|primaquine|mesh-list
154423175|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154423176|NCT02143934|Amebicides|amebicides|mesh-ancestor
154423177|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154423178|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154423179|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423180|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
154423181|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423182|NCT03096847|Letrozole|letrozole|mesh-list
154423183|NCT03096847|Goserelin|goserelin|mesh-list
154423184|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423185|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154423186|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154423187|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423188|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423189|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154423190|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
154423191|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423192|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423193|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154423194|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
154423195|NCT03545516|Bupivacaine|bupivacaine|mesh-list
154423196|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
154423197|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
154423198|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423199|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423200|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
154423201|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423202|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154423203|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154423204|NCT03545516|Analgesics|analgesics|mesh-ancestor
154423205|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154423206|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154423208|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
154423209|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423210|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423211|NCT02846532|Aspirin|aspirin|mesh-list
154423212|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
154423213|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154423214|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
154423215|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154423216|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
154423217|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423218|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423219|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
154423220|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154423221|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154423222|NCT02846532|Analgesics|analgesics|mesh-ancestor
154423223|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
154423224|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423225|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423226|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423227|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423228|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154423229|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154423230|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154423231|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154423232|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
154423233|NCT01371461|Paroxetine|paroxetine|mesh-list
154423234|NCT01371461|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154423235|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154423236|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423237|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423238|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423239|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
154423240|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423241|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154423242|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
154423243|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154423244|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154423245|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154423246|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423247|NCT05324423|Colchicine|colchicine|mesh-list
154423248|NCT05324423|Febuxostat|febuxostat|mesh-list
154423249|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
154423250|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423251|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
154423252|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
154423253|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
154423254|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423255|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814544|NCT00446472|Becaplermin|becaplermin|mesh-list
154423256|NCT00842348|Lanreotide|lanreotide|mesh-list
154423257|NCT00842348|Somatostatin|somatostatin|mesh-list
154423258|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423259|NCT00842348|Hormones|hormones|mesh-ancestor
154423260|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423261|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423262|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
154423263|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154423264|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154423265|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154423266|NCT02144246|Norgestimate|norgestimate|mesh-list
154423267|NCT02144246|Norgestrel|norgestrel|mesh-list
154423268|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154423269|NCT02144246|Estradiol|estradiol|mesh-list
154423270|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154423271|NCT02144246|Estrogens|estrogens|mesh-ancestor
154423272|NCT02144246|Hormones|hormones|mesh-ancestor
154423273|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423274|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423275|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154423276|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
154423277|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153997837|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
154423278|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154423279|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154423280|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154423281|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154423282|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154423283|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423284|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154423285|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154423286|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423287|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423288|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423289|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154423291|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
154423292|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
154423293|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
154423294|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423295|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
154423296|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154423297|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
154423298|NCT03569046|Bupivacaine|bupivacaine|mesh-list
154423299|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
154423300|NCT03569046|Anesthetics|anesthetics|mesh-list
154423301|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
154423302|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423303|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423304|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
154423305|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423306|NCT02935595|Ketamine|ketamine|mesh-list
154423307|NCT02935595|Analgesics|analgesics|mesh-ancestor
154423308|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
154423309|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423310|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423311|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154423312|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154423313|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
154423314|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
154423315|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423316|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154423317|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154423318|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423319|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423320|NCT02817347|Tazobactam|tazobactam|mesh-list
154423321|NCT02817347|Piperacillin|piperacillin|mesh-list
154423322|NCT02817347|Dexamethasone|dexamethasone|mesh-list
154423323|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
154423324|NCT02817347|BB 1101|bb 1101|mesh-list
154423325|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423326|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
154423327|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
154423328|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423329|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423330|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154423331|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
154423332|NCT02817347|Hormones|hormones|mesh-ancestor
154423333|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423334|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154423335|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423336|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
154423337|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423338|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423339|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154423340|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423341|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154423342|NCT01373021|Fentanyl|fentanyl|mesh-list
154423343|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
154423344|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154423345|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423346|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423347|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154423348|NCT01373021|Analgesics|analgesics|mesh-ancestor
154423349|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
154423350|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423351|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154423352|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154423353|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154423354|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
154423355|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423356|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423357|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154423359|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153569552|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423360|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154423361|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
154423362|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
154423363|NCT03568578|Entecavir|entecavir|mesh-list
154423364|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
154423365|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423366|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
154423367|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154423368|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423369|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
154423370|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423371|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
154423372|NCT02140736|Hematinics|hematinics|mesh-ancestor
154423373|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
154423374|NCT05417035|Androgens|androgens|mesh-ancestor
154423375|NCT05417035|Hormones|hormones|mesh-ancestor
154423376|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423377|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423378|NCT03095287|Factor VIII|factor viii|mesh-list
154423379|NCT03095287|Coagulants|coagulants|mesh-ancestor
154423380|NCT01335581|Tretinoin|tretinoin|mesh-list
154423381|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423382|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
154423383|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
154423384|NCT05204563|Imipenem|imipenem|mesh-list
154423385|NCT05204563|Relebactam|relebactam|mesh-list
154423386|NCT05204563|Cilastatin|cilastatin|mesh-list
154423387|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154423388|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423389|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
154423390|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423391|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423392|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154423393|NCT02140814|Niacinamide|niacinamide|mesh-list
154423395|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
154423396|NCT02140814|Vitamins|vitamins|mesh-ancestor
154423397|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
154423398|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423399|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
154423400|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154423401|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
154423402|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423403|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154423404|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
154423405|NCT03015090|Theophylline|theophylline|mesh-list
154423406|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154423407|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
154423408|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423409|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423410|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154423411|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
154423412|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154423413|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423414|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423415|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
154423416|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154423417|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154423418|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
153569553|NCT03120780|Analgesics|analgesics|mesh-ancestor
154423419|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423420|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
154423421|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154423422|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154423423|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423424|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
154423425|NCT02620748|Coagulants|coagulants|mesh-ancestor
154423426|NCT02144792|Verapamil|verapamil|mesh-list
154423427|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154423428|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153997987|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
154423429|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423430|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423431|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154423432|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423433|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
154423434|NCT03566394|Gabapentin|gabapentin|mesh-list
154423435|NCT03566394|Analgesics|analgesics|mesh-ancestor
154423436|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
154423437|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423438|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423439|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
154423440|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154423441|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154423442|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423443|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154423444|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154423445|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154423446|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423447|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423448|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
154423449|NCT00033293|Prednisone|prednisone|mesh-list
154423450|NCT00033293|Cortisone|cortisone|mesh-list
154423451|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
154423452|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
154423453|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154423454|NCT00033293|Antibodies|antibodies|mesh-list
154423455|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
154423456|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154423457|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
154423458|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154423459|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
154423460|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423461|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423462|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154423463|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
154423464|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423465|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423466|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154423467|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423468|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
154423469|NCT00033293|Hormones|hormones|mesh-ancestor
153973751|NCT06247995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423470|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423471|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154423472|NCT03566316|Amlodipine|amlodipine|mesh-list
154423473|NCT03566316|Telmisartan|telmisartan|mesh-list
154423474|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154423475|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154423476|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154423477|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154423478|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423479|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423480|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154423481|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423482|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
154423483|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154423484|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154423485|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
154423486|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154423487|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154423488|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423489|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154423490|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154423491|NCT02145104|Valsartan|valsartan|mesh-list
154423492|NCT02145104|Cilnidipine|cilnidipine|mesh-list
154423493|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154423494|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154423495|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154423496|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423497|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154423498|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423499|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154423500|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423501|NCT02145338|Trimethoprim|trimethoprim|mesh-list
154423502|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
154423503|NCT02145338|Cephalexin|cephalexin|mesh-list
154423504|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154423505|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423506|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
154423507|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154423508|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154423509|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154423510|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423511|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423512|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154423513|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153814558|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
153569676|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423514|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154423515|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154423517|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423518|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154423519|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423520|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423521|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
154423522|NCT03565458|Empagliflozin|empagliflozin|mesh-list
154423523|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154423524|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423525|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154423526|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423527|NCT03565302|Terbutaline|terbutaline|mesh-list
154423528|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
154423529|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154423530|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
154423531|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423532|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423533|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154423534|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
154423535|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154423536|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154423537|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154423538|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
154423539|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423540|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423541|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
154423542|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
154423543|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154423544|NCT01372007|Lanreotide|lanreotide|mesh-list
154423545|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423546|NCT01373411|Ticagrelor|ticagrelor|mesh-list
154423547|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154423548|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154423549|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154423550|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154423551|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
154423552|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423553|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423554|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423555|NCT03567408|Bivalirudin|bivalirudin|mesh-list
154423556|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
153816443|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154423557|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154423558|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
154423559|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423560|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423561|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
154423562|NCT05354076|Doxorubicin|doxorubicin|mesh-list
154423563|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154423564|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154423565|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423566|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154423567|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154423568|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423569|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423570|NCT05192681|Docetaxel|docetaxel|mesh-list
154423571|NCT05192681|Tislelizumab|tislelizumab|mesh-list
154423572|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423573|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
154423574|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
154423575|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
154423576|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423577|NCT05192681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423579|NCT02039674|Bevacizumab|bevacizumab|mesh-list
154423580|NCT02039674|Carboplatin|carboplatin|mesh-list
154423581|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
154423582|NCT02039674|Pemetrexed|pemetrexed|mesh-list
154423583|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154423584|NCT02039674|Ipilimumab|ipilimumab|mesh-list
154423585|NCT02039674|Gefitinib|gefitinib|mesh-list
154423586|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154423587|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423588|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
154423589|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
154423590|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
154423591|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423592|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423593|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154423594|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154423595|NCT02039674|Growth Substances|growth substances|mesh-ancestor
154423596|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423597|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
154423598|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154423599|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423600|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154423601|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154423602|NCT02039674|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154423603|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154423604|NCT03099187|Pirfenidone|pirfenidone|mesh-list
154423605|NCT03099187|Analgesics|analgesics|mesh-ancestor
154423606|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
154423607|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423608|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423609|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154423610|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154423611|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423612|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423613|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423614|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
154423615|NCT04162756|Fludarabine|fludarabine|mesh-list
154423616|NCT04162756|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154423617|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154423618|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
154423619|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423620|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423621|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154423622|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
154423623|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423624|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423625|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154423626|NCT04162756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423627|NCT04544267|Vaccines|vaccines|mesh-list
154423628|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
154423629|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423630|NCT01373333|Amifampridine|amifampridine|mesh-list
154423631|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154423632|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423633|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423634|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154423635|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423636|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423637|NCT01368341|Amoxicillin|amoxicillin|mesh-list
154423638|NCT01368341|Doxycycline|doxycycline|mesh-list
154423639|NCT01368341|Penicillin V|penicillin v|mesh-list
154423640|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154423641|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423642|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
154423643|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154423644|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154423645|NCT01368419|Endostar protein|endostar protein|mesh-list
154423646|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153569759|NCT01685489|Docetaxel|docetaxel|mesh-list
153569761|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154423647|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154423648|NCT01368419|Growth Substances|growth substances|mesh-ancestor
154423649|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052153|NCT04038346|Naproxen|naproxen|mesh-list
154423650|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
154423651|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423653|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
154423654|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423655|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154423656|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154423657|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423658|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423659|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154423660|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
154423661|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423662|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423663|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154423664|NCT04439578|Rifampin|rifampin|mesh-list
154423665|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154423666|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
154423667|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154423668|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423669|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
154423670|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154423671|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423672|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423673|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154423674|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154423675|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154423676|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154423677|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154423678|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154423679|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
154423680|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154423681|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154423682|NCT03110848|Prednisolone|prednisolone|mesh-list
154423683|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
154423684|NCT03110848|Atorvastatin|atorvastatin|mesh-list
154423685|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154423686|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
154423687|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
153814567|NCT00452556|Docetaxel|docetaxel|mesh-list
154423688|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154423689|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154423690|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
154423691|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423692|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154423693|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154423694|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423695|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423696|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
154423697|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
154423698|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423699|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423700|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154423701|NCT03110848|Hormones|hormones|mesh-ancestor
154423702|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423703|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154423704|NCT03110848|Protective Agents|protective agents|mesh-ancestor
154423705|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154423706|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423707|NCT03139474|Hormones|hormones|mesh-list
154423708|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
154423709|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423710|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423711|NCT01368887|Niacinamide|niacinamide|mesh-list
154423712|NCT01368887|Niacin|niacin|mesh-list
154423713|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
154423714|NCT01368887|Calcipotriene|calcipotriene|mesh-list
154423715|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
154423716|NCT01368887|Vitamins|vitamins|mesh-ancestor
154423717|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
154423718|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423719|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154423720|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
154423721|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154254724|NCT03912974|Escitalopram|escitalopram|mesh-list
154423722|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154423723|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
154423724|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
154423725|NCT01369043|Vitamins|vitamins|mesh-list
154423726|NCT01369043|Vitamin E|vitamin e|mesh-list
154423728|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423729|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
154423730|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423731|NCT01369043|Protective Agents|protective agents|mesh-ancestor
154423732|NCT04477096|Emtricitabine|emtricitabine|mesh-list
154423733|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
154423734|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423735|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154423736|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153814580|NCT00452556|Hormones|hormones|mesh-ancestor
154423737|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423738|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423739|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154423740|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154423741|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
154423742|NCT01369121|Hormones|hormones|mesh-ancestor
154423743|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423744|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423745|NCT03868150|Amiodarone|amiodarone|mesh-list
154423746|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154423747|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
154423748|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154423749|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423750|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423751|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154423752|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154423753|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154423754|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423755|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154423756|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154423757|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154423758|NCT03521687|Apremilast|apremilast|mesh-list
154423759|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154423760|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154423761|NCT03521687|Analgesics|analgesics|mesh-ancestor
154423762|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
154423763|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423764|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423765|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423766|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423767|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154423768|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154423769|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423770|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423771|NCT03141658|Ketamine|ketamine|mesh-list
154423772|NCT03141658|Analgesics|analgesics|mesh-ancestor
154423773|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
154423774|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423775|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423776|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154423777|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154423778|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
154423779|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
154423780|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569845|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154423781|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154423782|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154423783|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423784|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423785|NCT03498131|Melatonin|melatonin|mesh-list
154423786|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
154423787|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423788|NCT03498131|Protective Agents|protective agents|mesh-ancestor
154423789|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423790|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423791|NCT01319825|Milnacipran|milnacipran|mesh-list
154423792|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
154423793|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154423794|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154423795|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153998356|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423796|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423797|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423798|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423799|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154423800|NCT01319825|Analgesics|analgesics|mesh-ancestor
154423801|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
154423802|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423803|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
154423804|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154423805|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
154423806|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
154423807|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423808|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423809|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
154423810|NCT01369277|Vitamins|vitamins|mesh-ancestor
154423811|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
154423812|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423813|NCT02983006|Nivolumab|nivolumab|mesh-list
154423814|NCT02983006|DS-8273a|ds-8273a|mesh-list
154423815|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423816|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423817|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154423818|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423819|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
154423820|NCT03811756|Vitamins|vitamins|mesh-ancestor
154423821|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
154423822|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423823|NCT03141268|Lactulose|lactulose|mesh-list
154423824|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154423825|NCT03316781|Adalimumab|adalimumab|mesh-list
154423826|NCT03316781|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154423827|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423828|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423829|NCT01319903|Antibodies|antibodies|mesh-list
154423830|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154423831|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
154423832|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815093|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423833|NCT02839200|Zolpidem|zolpidem|mesh-list
154423834|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154423835|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154423836|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423837|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423838|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154423839|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
154423840|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
154423841|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423842|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423843|NCT01369667|Vitamin D|vitamin d|mesh-list
154423844|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
154423845|NCT01369667|Vitamins|vitamins|mesh-ancestor
154423846|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
154423847|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423848|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154423849|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154423850|NCT03564912|Capecitabine|capecitabine|mesh-list
154423851|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
154423852|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154423853|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
154423854|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423855|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423856|NCT05760053|Cisplatin|cisplatin|mesh-list
154423857|NCT05760053|Carboplatin|carboplatin|mesh-list
154423858|NCT05760053|Etoposide|etoposide|mesh-list
154423859|NCT05760053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423860|NCT05760053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154423861|NCT05760053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154423862|NCT05760053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154423863|NCT05760053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423864|NCT05760053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423865|NCT03118739|Febuxostat|febuxostat|mesh-list
154423866|NCT03118739|Verinurad|verinurad|mesh-list
154423867|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
154423868|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423869|NCT03181126|Venetoclax|venetoclax|mesh-list
154423870|NCT03181126|Navitoclax|navitoclax|mesh-list
154423871|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423872|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154423873|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423874|NCT04799548|Tislelizumab|tislelizumab|mesh-list
154423875|NCT04799548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423876|NCT04799548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423877|NCT01375985|Radavirsen|radavirsen|mesh-list
154423878|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
154423879|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154423880|NCT02654080|Vaccines|vaccines|mesh-list
154423881|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
154423882|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423883|NCT03140332|Sorafenib|sorafenib|mesh-list
154423884|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423885|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154423886|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423887|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423888|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
154423889|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423890|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423891|NCT02835690|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569971|NCT01690507|Cytarabine|cytarabine|mesh-list
153569978|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423892|NCT02835690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423893|NCT02832167|Nivolumab|nivolumab|mesh-list
154423894|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423895|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423896|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154423897|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423898|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
154423899|NCT04941040|Anesthetics|anesthetics|mesh-list
154423900|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423901|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423902|NCT04941040|Narcotics|narcotics|mesh-ancestor
154423903|NCT04941040|Analgesics|analgesics|mesh-ancestor
154423904|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
154423905|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154423906|NCT00913705|Carboplatin|carboplatin|mesh-list
154423907|NCT00913705|Paclitaxel|paclitaxel|mesh-list
154423908|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154423909|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423910|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154423911|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
154423912|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
154423913|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
154423914|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423915|NCT04934410|Midazolam|midazolam|mesh-list
154423916|NCT04934410|Etomidate|etomidate|mesh-list
154423917|NCT04934410|Sevoflurane|sevoflurane|mesh-list
154423918|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154423919|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154423920|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154423921|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423922|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154423923|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154423924|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154423925|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154423926|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
154423927|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
154423928|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
154423929|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
154423930|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423931|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423932|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154423933|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154423934|NCT02787239|Rituximab|rituximab|mesh-list
154423935|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423936|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423937|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
154423938|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423939|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154423940|NCT03140956|Levodopa|levodopa|mesh-list
154423941|NCT03140956|Carbidopa|carbidopa|mesh-list
153569979|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
154423942|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154423943|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154423944|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
154423945|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423946|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423947|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423948|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154423949|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423951|NCT02681237|Cediranib|cediranib|mesh-list
154423952|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154423953|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423954|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423955|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423956|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154423957|NCT02674529|Escitalopram|escitalopram|mesh-list
154423958|NCT02674529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154423959|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154423960|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423961|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423962|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423963|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
154423964|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423965|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154423966|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154423967|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423968|NCT03632317|Everolimus|everolimus|mesh-list
154423969|NCT03632317|Panobinostat|panobinostat|mesh-list
154423970|NCT03632317|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154423971|NCT03632317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154423972|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154423973|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423974|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154423975|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
154423976|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423977|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423978|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154423979|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
154423980|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154423981|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154423982|NCT02653963|Triamcinolone|triamcinolone|mesh-list
154423983|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154423984|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
154423985|NCT02653963|Hormones|hormones|mesh-ancestor
154423986|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154423987|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154423988|NCT03097861|Lubiprostone|lubiprostone|mesh-list
154423989|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154423990|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154423991|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423992|NCT01376141|Sumatriptan|sumatriptan|mesh-list
154423993|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154423994|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154423995|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154423996|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
154423997|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154423998|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154423999|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424000|NCT01816139|Estradiol|estradiol|mesh-list
154424001|NCT01816139|Estrogens|estrogens|mesh-ancestor
154424002|NCT01816139|Hormones|hormones|mesh-ancestor
154424003|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424004|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424005|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
154424006|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154424007|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154424008|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154424009|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154424010|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424011|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
154424012|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424013|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424015|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424016|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154424017|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154424018|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424019|NCT05041673|Metformin|metformin|mesh-list
154424021|NCT05041673|Empagliflozin|empagliflozin|mesh-list
154424022|NCT05041673|Vildagliptin|vildagliptin|mesh-list
154424023|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154424024|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424025|NCT05041673|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154424026|NCT05041673|Incretins|incretins|mesh-ancestor
154424027|NCT05041673|Hormones|hormones|mesh-ancestor
154424028|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424029|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154424030|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424031|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154424032|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
154424033|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424034|NCT03907540|Belumosudil|belumosudil|mesh-list
154424035|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424036|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424037|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424038|NCT05759429|Melatonin|melatonin|mesh-list
154424039|NCT05759429|Antioxidants|antioxidants|mesh-ancestor
154424040|NCT05759429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424041|NCT05759429|Protective Agents|protective agents|mesh-ancestor
154424042|NCT05759429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424043|NCT05759429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424044|NCT04005209|Ketamine|ketamine|mesh-list
154424045|NCT04005209|Analgesics|analgesics|mesh-ancestor
154424046|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
154424047|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424048|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424049|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154424050|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154424051|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
154424052|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
154424053|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424054|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154424055|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154424056|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424057|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424058|NCT03904108|Ramucirumab|ramucirumab|mesh-list
154424059|NCT03904108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154424060|NCT03904108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154424061|NCT03904108|Growth Substances|growth substances|mesh-ancestor
154424062|NCT03904108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424063|NCT03904108|Growth Inhibitors|growth inhibitors|mesh-ancestor
154424064|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424065|NCT02833350|Folic Acid|folic acid|mesh-list
154424066|NCT02833350|Adalimumab|adalimumab|mesh-list
154424067|NCT02833350|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154424068|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154424069|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154424070|NCT02833350|Hematinics|hematinics|mesh-ancestor
154424071|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
154424072|NCT02833350|Vitamins|vitamins|mesh-ancestor
154424073|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
154424074|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424075|NCT03137134|Crizotinib|crizotinib|mesh-list
154424076|NCT03137134|Esomeprazole|esomeprazole|mesh-list
154424077|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154424078|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424079|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154424080|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424081|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814585|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
154424082|NCT03137134|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154424083|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424084|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424085|NCT03137368|Tamoxifen|tamoxifen|mesh-list
154424086|NCT03137368|Exemestane|exemestane|mesh-list
154424087|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154424088|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
154052605|NCT01897454|Leucovorin|leucovorin|mesh-list
154424089|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424090|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424091|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153998652|NCT02839538|Anesthetics|anesthetics|mesh-list
154424093|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154424094|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154424095|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154424096|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154424097|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154424098|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424099|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424100|NCT03138616|Vitamin D|vitamin d|mesh-list
154424101|NCT03138616|Vitamins|vitamins|mesh-ancestor
154424102|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
154424103|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424104|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154424105|NCT03137290|Neostigmine|neostigmine|mesh-list
154424106|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154424107|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424108|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424109|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
154424110|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424111|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424112|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154424113|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
154424114|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424115|NCT03782818|Olaparib|olaparib|mesh-list
154424116|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154424117|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424118|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424119|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424120|NCT05391724|Brincidofovir|brincidofovir|mesh-list
154424121|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
154424122|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424123|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
154424124|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154424125|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424126|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424127|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154424128|NCT03355534|Analgesics|analgesics|mesh-ancestor
154424129|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
154424130|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424131|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153570130|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154424132|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154424133|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154424134|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
154424135|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424136|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424137|NCT05385562|Triamcinolone|triamcinolone|mesh-list
154424138|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154424139|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154424140|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
154424141|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154424142|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154424143|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
154424144|NCT05385562|Hormones|hormones|mesh-ancestor
154424145|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424146|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424147|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424148|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
154424149|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424150|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424151|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154424152|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
154424153|NCT05385562|Protective Agents|protective agents|mesh-ancestor
154424154|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
154424155|NCT01343043|Fludarabine|fludarabine|mesh-list
154424156|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424157|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
154424158|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424159|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052682|NCT01815359|Leucovorin|leucovorin|mesh-list
154424160|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154424162|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424163|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424164|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154424165|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154424166|NCT03139708|Phenylephrine|phenylephrine|mesh-list
154424167|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
154424168|NCT03139708|Tropicamide|tropicamide|mesh-list
154424169|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154424170|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
154424171|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
154424172|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424173|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424174|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
153387801|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424175|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154424176|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
154424177|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
154424178|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154424179|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154424180|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154424181|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
154424182|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424183|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424184|NCT03139708|Protective Agents|protective agents|mesh-ancestor
154424185|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154424186|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154424187|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154424188|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154424189|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
154424190|NCT03548987|Semaglutide|semaglutide|mesh-list
154424191|NCT03548987|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154424192|NCT03548987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154424193|NCT03548987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424194|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154424195|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154424196|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
154424197|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424198|NCT05330364|Cladribine|cladribine|mesh-list
154424199|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424200|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424201|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
154424202|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424203|NCT05087368|Vaccines|vaccines|mesh-list
154424204|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
154424205|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424206|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154424207|NCT05087134|Choline|choline|mesh-list
154424208|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
154424209|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154424210|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
154424211|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424212|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424213|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154424214|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
154424215|NCT03048747|Tolvaptan|tolvaptan|mesh-list
154424216|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154424217|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424218|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
154424219|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424220|NCT05086822|Irinotecan|irinotecan|mesh-list
154424221|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154424222|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154424223|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424224|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424225|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424226|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154424227|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154424228|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424229|NCT04051827|Midazolam|midazolam|mesh-list
154424230|NCT04051827|Mobocertinib|mobocertinib|mesh-list
154424231|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154424232|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154424233|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424234|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424235|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154424236|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154424237|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154424238|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154424239|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
154424240|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
154424241|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
153998805|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
154424242|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
154424243|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424244|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424245|NCT04051827|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154424246|NCT04051827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424247|NCT04051827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424248|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
154424249|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424250|NCT02123823|Everolimus|everolimus|mesh-list
154424251|NCT02123823|Exemestane|exemestane|mesh-list
154424252|NCT02123823|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154424253|NCT02123823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424254|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424255|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424256|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424257|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
154424258|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424259|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424260|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154424261|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154424262|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154424263|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
154424264|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424265|NCT05085652|Anesthetics|anesthetics|mesh-list
154424266|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424267|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424268|NCT03136510|Apixaban|apixaban|mesh-list
154424269|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154424270|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
154424271|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154424272|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
154424273|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424274|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424275|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
154424276|NCT05692245|Dexamethasone|dexamethasone|mesh-list
154424277|NCT05692245|Ondansetron|ondansetron|mesh-list
154424278|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153814588|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
154424279|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
154424280|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
154424281|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424282|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424283|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424284|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
154424285|NCT05692245|Hormones|hormones|mesh-ancestor
154424286|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424287|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154424288|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424289|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
154424290|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
154424291|NCT05692245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154424292|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154424293|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
154424294|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424295|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424296|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
154424297|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154424298|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154424299|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154424300|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154424301|NCT05085106|Analgesics|analgesics|mesh-ancestor
154424302|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
154424303|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424304|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424305|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154424306|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154424307|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
154424308|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
154424310|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154424311|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424312|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424313|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424314|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154424315|NCT00159796|Olanzapine|olanzapine|mesh-list
154424316|NCT00159796|Asenapine|asenapine|mesh-list
154424317|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
154424318|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
154424319|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424320|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424321|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424322|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154424323|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154424324|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424325|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154424326|NCT00159796|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154424327|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154424328|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154424329|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424330|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424331|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
154424332|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154424333|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154424334|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424335|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
154424336|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154424338|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
154424339|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154424340|NCT03327844|Calcium|calcium|mesh-list
154424341|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154424342|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424343|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154424344|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424345|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
154424346|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154424347|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154424348|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154424349|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154424350|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424351|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424352|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424353|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154424354|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154424355|NCT05008510|Camptothecin|camptothecin|mesh-list
154424356|NCT05008510|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154424357|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
154424358|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
154424359|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424360|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154424361|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424362|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154424363|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154424364|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424365|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424366|NCT05194995|Cetuximab|cetuximab|mesh-list
154424367|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154424368|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424369|NCT05187039|Anesthetics|anesthetics|mesh-list
154424370|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424371|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814593|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153816465|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457797|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
154424372|NCT03136666|Candesartan|candesartan|mesh-list
154424373|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
154424374|NCT03136666|Nifedipine|nifedipine|mesh-list
154424375|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154424376|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154424377|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154424378|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424379|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154424380|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154424381|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154424382|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424383|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
154424384|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
154424385|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154424386|NCT03255083|Osimertinib|osimertinib|mesh-list
154424387|NCT03255083|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154424388|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424389|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424390|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424391|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424392|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
154424393|NCT03735537|Teriparatide|teriparatide|mesh-list
154424394|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154424395|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154424396|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424397|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154424398|NCT04531059|Metronidazole|metronidazole|mesh-list
154424399|NCT04531059|Minocycline|minocycline|mesh-list
154424400|NCT04531059|Tetracycline|tetracycline|mesh-list
154424401|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
154424402|NCT04531059|Esomeprazole|esomeprazole|mesh-list
154424403|NCT04531059|Bismuth|bismuth|mesh-list
154424404|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424405|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424406|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154424407|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154424408|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154424409|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154424410|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424411|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154424412|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424413|NCT04531059|Antacids|antacids|mesh-ancestor
154424414|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154424415|NCT04531059|Diuretics|diuretics|mesh-ancestor
153570278|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424416|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
154424417|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424418|NCT04531059|Expectorants|expectorants|mesh-ancestor
154424419|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
154424420|NCT05090176|Povidone|povidone|mesh-list
154424421|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
154424422|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
154424423|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
154424424|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154424425|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154424426|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424427|NCT04558294|Ketanserin|ketanserin|mesh-list
154424428|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154424429|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
154424430|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424431|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154424432|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154424433|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
154424434|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424435|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424436|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154424437|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154424438|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154424439|NCT03378466|Heparin|heparin|mesh-list
154424440|NCT03378466|Calcium heparin|calcium heparin|mesh-list
154424441|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
154424442|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154424443|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154424444|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424445|NCT05077540|Misoprostol|misoprostol|mesh-list
154424446|NCT05077540|Oxytocin|oxytocin|mesh-list
154424447|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
154424448|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154424449|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424450|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154424451|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
154424452|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154424453|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424454|NCT03097315|Triamcinolone|triamcinolone|mesh-list
154424455|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154424456|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154424457|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154424458|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154424459|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
154424461|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424462|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424463|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424464|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
154424465|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999030|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
154424466|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424467|NCT05530707|Niacinamide|niacinamide|mesh-list
154424469|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
154424470|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
154424471|NCT05530707|Vitamins|vitamins|mesh-ancestor
154424472|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
154424473|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424474|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154424475|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
154424476|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424477|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154424478|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
154424479|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154424480|NCT03093415|Grazoprevir|grazoprevir|mesh-list
154424481|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154424482|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
154424483|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424484|NCT01358526|Oxycodone|oxycodone|mesh-list
154424485|NCT01358526|Naloxone|naloxone|mesh-list
154424486|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154424487|NCT01358526|Narcotics|narcotics|mesh-ancestor
154424488|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424489|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424490|NCT01358526|Analgesics|analgesics|mesh-ancestor
154424491|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
154424492|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424493|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154424494|NCT01310010|Dasatinib|dasatinib|mesh-list
154424495|NCT01310010|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154424496|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424497|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424498|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424499|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424500|NCT02830776|Bimatoprost|bimatoprost|mesh-list
154424501|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154424502|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154424503|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154424504|NCT03563664|Danazol|danazol|mesh-list
154424505|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154424506|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
153363302|NCT03217838|Venetoclax|venetoclax|mesh-list
153814596|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424507|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424508|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424509|NCT03041181|Gemcitabine|gemcitabine|mesh-list
154424510|NCT03041181|Docetaxel|docetaxel|mesh-list
154424511|NCT03041181|Nivolumab|nivolumab|mesh-list
154424512|NCT03041181|Pemetrexed|pemetrexed|mesh-list
154424513|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154424514|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
154424515|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424516|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424517|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
154424518|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
154424519|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
154424520|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154424521|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154424522|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424523|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154424524|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154424525|NCT02828124|Nivolumab|nivolumab|mesh-list
154424526|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154424527|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424528|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154424529|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424530|NCT02829996|Latanoprost|latanoprost|mesh-list
154424531|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154424532|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154424533|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
154424534|NCT05385549|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154424535|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424536|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424537|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424538|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424539|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153999102|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154424540|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424541|NCT03929679|Semaglutide|semaglutide|mesh-list
154424542|NCT03929679|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154424543|NCT03929679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154424544|NCT03929679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424545|NCT05197062|Aticaprant|aticaprant|mesh-list
154424546|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154424547|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424548|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
154424549|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424550|NCT05000736|Fulvestrant|fulvestrant|mesh-list
154424551|NCT05000736|Palbociclib|palbociclib|mesh-list
154424552|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154424553|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153570325|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154424554|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424555|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154424556|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154424557|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
154424558|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424559|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424560|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424561|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424562|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424563|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154424564|NCT03828162|Anticoagulants|anticoagulants|mesh-list
154424565|NCT03563040|Methoxsalen|methoxsalen|mesh-list
154424566|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154424567|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
154424568|NCT03094416|Esomeprazole|esomeprazole|mesh-list
154424569|NCT03094416|Omeprazole|omeprazole|mesh-list
154424570|NCT03094416|Rabeprazole|rabeprazole|mesh-list
154424571|NCT03094416|Pantoprazole|pantoprazole|mesh-list
154424572|NCT03094416|Lansoprazole|lansoprazole|mesh-list
154424573|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
154424574|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154424575|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154424576|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424577|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424578|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424579|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
154424580|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154424581|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
154424582|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154424583|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424585|NCT01338870|Hormones|hormones|mesh-ancestor
154424586|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424587|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154424588|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
154424589|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424590|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424591|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
154424592|NCT01338870|Vitamins|vitamins|mesh-ancestor
154424593|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
154424594|NCT02824224|Tamoxifen|tamoxifen|mesh-list
154424595|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154424596|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
154424597|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424598|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424599|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154424600|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814597|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
154424601|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154424602|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154424603|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154424604|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
154424605|NCT01338792|Pemetrexed|pemetrexed|mesh-list
154424606|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424607|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424608|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424609|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154424610|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154424611|NCT01314105|Carboplatin|carboplatin|mesh-list
154424612|NCT01314105|Nintedanib|nintedanib|mesh-list
154424613|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424614|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424615|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424616|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424617|NCT01966471|Maytansine|maytansine|mesh-list
154424618|NCT01966471|Docetaxel|docetaxel|mesh-list
154424619|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154424620|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
154424621|NCT01966471|Doxorubicin|doxorubicin|mesh-list
154424622|NCT01966471|Fluorouracil|fluorouracil|mesh-list
154424623|NCT01966471|Trastuzumab|trastuzumab|mesh-list
154424624|NCT01966471|Epirubicin|epirubicin|mesh-list
154424625|NCT01966471|Pertuzumab|pertuzumab|mesh-list
154424626|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154424627|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424628|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
154424629|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
154424630|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
154424631|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424632|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424633|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
154424634|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424635|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154424636|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154424637|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
154424638|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154424639|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154424640|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154424641|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154424642|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424643|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
154424644|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154424645|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154424646|NCT01966471|Immunotoxins|immunotoxins|mesh-ancestor
154424647|NCT01966471|Immunoconjugates|immunoconjugates|mesh-ancestor
154424648|NCT04188847|Apatinib|apatinib|mesh-list
154424649|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424650|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424651|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424652|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424653|NCT05255107|Riboflavin|riboflavin|mesh-list
154424654|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
154424655|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
154424656|NCT05255107|Vitamins|vitamins|mesh-ancestor
154424657|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
154424658|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053211|NCT00822237|Vaccines|vaccines|mesh-list
154424659|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154424660|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
154424661|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154424662|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154424663|NCT03227471|Ivacaftor|ivacaftor|mesh-list
154424664|NCT03227471|Elexacaftor|elexacaftor|mesh-list
154424665|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154424666|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154424667|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424668|NCT01354314|Fluconazole|fluconazole|mesh-list
154424669|NCT01354314|Paroxetine|paroxetine|mesh-list
154424670|NCT01354314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154424671|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154424672|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154424673|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424674|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424675|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
154424676|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424677|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154424678|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
154424679|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154424680|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154424681|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154424682|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424683|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
154424684|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424685|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154424686|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154424687|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
154424688|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424689|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154424690|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154424692|NCT04509336|Baclofen|baclofen|mesh-list
154424693|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154424694|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424695|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153570518|NCT05291455|Lacosamide|lacosamide|mesh-list
154424696|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424697|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154424698|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
154424699|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
154424700|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424701|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424702|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154424703|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154424704|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
154424705|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
154424706|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154424707|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154424708|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
154424709|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
154424710|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154424711|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424712|NCT03194321|Tacrolimus|tacrolimus|mesh-list
154424713|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424714|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
154424715|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424716|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154424717|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424718|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424719|NCT01374581|Artesunate|artesunate|mesh-list
154424720|NCT01374581|Lumefantrine|lumefantrine|mesh-list
154424721|NCT01374581|Artemether|artemether|mesh-list
154424722|NCT01374581|Amodiaquine|amodiaquine|mesh-list
154424723|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154424724|NCT01374581|Quinine|quinine|mesh-list
154424725|NCT01374581|Clindamycin|clindamycin|mesh-list
154424726|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
154424727|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
154424728|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
154424729|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154424730|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154424731|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424732|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570556|NCT05291052|Lenvatinib|lenvatinib|mesh-list
153816490|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424733|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
154424734|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
154424735|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154424736|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
154424737|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154424738|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154424739|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424740|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424741|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154424742|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424743|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154424744|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424745|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154424746|NCT01374581|Analgesics|analgesics|mesh-ancestor
154424747|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
154424748|NCT01354938|Clarithromycin|clarithromycin|mesh-list
154424749|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154424750|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424751|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154424752|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424753|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424754|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154424755|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154424756|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154424757|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
154424758|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154424759|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424760|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424761|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154424762|NCT01374737|Analgesics|analgesics|mesh-ancestor
154424763|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
154424764|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424765|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154424766|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154424767|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154424768|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
154424769|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424770|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424771|NCT03631615|Antibodies|antibodies|mesh-list
154424772|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
154424773|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424774|NCT01376453|Fluorouracil|fluorouracil|mesh-list
154424775|NCT01376453|Sorafenib|sorafenib|mesh-list
154424776|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
154424777|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424778|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153816491|NCT00354302|Vitamins|vitamins|mesh-ancestor
154424779|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424780|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424781|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
154424782|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424783|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154424784|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424785|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154424786|NCT01568125|Incretins|incretins|mesh-list
154424787|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424788|NCT01568125|Hormones|hormones|mesh-ancestor
154424789|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424790|NCT02288897|Temozolomide|temozolomide|mesh-list
154424791|NCT02288897|Dacarbazine|dacarbazine|mesh-list
154424792|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154424793|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154424794|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
154424795|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424796|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424797|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154424798|NCT05707572|Methylprednisolone|methylprednisolone|mesh-list
154424799|NCT05707572|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154424800|NCT05707572|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154424801|NCT05707572|Prednisolone|prednisolone|mesh-list
154424802|NCT05707572|Prednisolone acetate|prednisolone acetate|mesh-list
154424803|NCT05707572|Lidocaine|lidocaine|mesh-list
154424804|NCT05707572|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154424805|NCT05707572|Prednisolone phosphate|prednisolone phosphate|mesh-list
154424806|NCT05707572|Anesthetics, Local|anesthetics, local|mesh-ancestor
154424807|NCT05707572|Anesthetics|anesthetics|mesh-ancestor
154424808|NCT05707572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424809|NCT05707572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424810|NCT05707572|Sensory System Agents|sensory system agents|mesh-ancestor
154424811|NCT05707572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424812|NCT05707572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154424813|NCT05707572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154424814|NCT05707572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154424815|NCT05707572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154424816|NCT05707572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424817|NCT05707572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154424818|NCT05707572|Antiemetics|antiemetics|mesh-ancestor
154424819|NCT05707572|Autonomic Agents|autonomic agents|mesh-ancestor
154424820|NCT05707572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424821|NCT05707572|Glucocorticoids|glucocorticoids|mesh-ancestor
154424822|NCT05707572|Hormones|hormones|mesh-ancestor
154424823|NCT05707572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424824|NCT05707572|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154424825|NCT05707572|Protective Agents|protective agents|mesh-ancestor
154424826|NCT05707572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154424827|NCT05707572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424828|NCT02035800|Adalimumab|adalimumab|mesh-list
154424829|NCT02035800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154424830|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154424831|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154424832|NCT01568749|Acetaminophen|acetaminophen|mesh-list
154424833|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154424834|NCT01568749|Analgesics|analgesics|mesh-ancestor
154424835|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
154424836|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424837|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424838|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
154424839|NCT02819310|Laxatives|laxatives|mesh-list
154424840|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424841|NCT03633773|Immunomodulating Agents|immunomodulating agents|mesh-list
153816504|NCT00354380|Amodiaquine|amodiaquine|mesh-list
154424842|NCT03633773|Immunologic Factors|immunologic factors|mesh-ancestor
154424843|NCT03633773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424844|NCT01375361|Albuterol|albuterol|mesh-list
154424845|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154424846|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
154424847|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424848|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424849|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154424850|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
154424851|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
154424852|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154424853|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154424854|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154424855|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154424856|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
154424857|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424858|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424859|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154424860|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154424861|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
154424862|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424863|NCT01376765|Antacids|antacids|mesh-ancestor
154424864|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424865|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154424866|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
154424867|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
154424868|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154424869|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424870|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154424871|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424872|NCT01358201|Cytarabine|cytarabine|mesh-list
154424873|NCT01358201|Dexamethasone|dexamethasone|mesh-list
154424874|NCT01358201|Methotrexate|methotrexate|mesh-list
154424875|NCT01358201|Vincristine|vincristine|mesh-list
154424876|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154424877|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
154424878|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
154424879|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424880|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570624|NCT05292742|Pertuzumab|pertuzumab|mesh-list
154424882|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
154424883|NCT01358201|Hormones|hormones|mesh-ancestor
154424884|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424885|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154424886|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424887|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154424888|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
154424889|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154424890|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154424891|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
154424892|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424893|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
154424894|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424895|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154424896|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154424897|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
154424898|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154424899|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154424900|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154424901|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
154424902|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
154424903|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
154424904|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
154424905|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424906|NCT04726475|Cannabidiol|cannabidiol|mesh-list
154424907|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
154424908|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154424909|NCT03091777|Metronidazole|metronidazole|mesh-list
154424910|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154424911|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154424912|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153999479|NCT02818140|Ropivacaine|ropivacaine|mesh-list
154424913|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154424914|NCT05392361|Gabapentin|gabapentin|mesh-list
154424916|NCT05392361|Analgesics|analgesics|mesh-ancestor
154424917|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
154424918|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424919|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424920|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
154424921|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154424922|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154424923|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424924|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154424925|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154424926|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154424927|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424928|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424929|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
154424930|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154424931|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154424932|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154424933|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
154424934|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
154424935|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
154424936|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154424937|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154424938|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424939|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154424940|NCT05335655|Analgesics|analgesics|mesh-ancestor
154424941|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
154424942|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424943|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154424944|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154424945|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154424946|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
154424947|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154424948|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424949|NCT04589351|Ezetimibe|ezetimibe|mesh-list
154424950|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154424951|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154424952|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
154424953|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424954|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154424955|NCT02818998|Aflibercept|aflibercept|mesh-list
154424956|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154424957|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154424958|NCT02818998|Growth Substances|growth substances|mesh-ancestor
154424959|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424960|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
154424961|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424962|NCT02821416|Benralizumab|benralizumab|mesh-list
154424963|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154424964|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
154424965|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154424966|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154424967|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424968|NCT03108521|Incretins|incretins|mesh-ancestor
154424969|NCT03108521|Hormones|hormones|mesh-ancestor
154424970|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154424971|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154424972|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
154424973|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424974|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424975|NCT04500509|Diclofenac|diclofenac|mesh-list
154424976|NCT04500509|Dinoprostone|dinoprostone|mesh-list
154424977|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154424978|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154424979|NCT04500509|Analgesics|analgesics|mesh-ancestor
154424980|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
154424981|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154424982|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424983|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154424984|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570669|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154424985|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154424986|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154424987|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154424988|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
154424989|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154424990|NCT05760599|Bevacizumab|bevacizumab|mesh-list
154424991|NCT05760599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154424992|NCT05760599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154424993|NCT05760599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154424994|NCT05760599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154424995|NCT05760599|Growth Substances|growth substances|mesh-ancestor
154424996|NCT05760599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154424997|NCT05760599|Growth Inhibitors|growth inhibitors|mesh-ancestor
154424998|NCT04441073|Lidocaine|lidocaine|mesh-list
154424999|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
154425000|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
154425001|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425002|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425003|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
154425004|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425005|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154425006|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154425007|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154425008|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154425009|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425010|NCT02817828|Drospirenone|drospirenone|mesh-list
154425011|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154425012|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425013|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425014|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425015|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154425016|NCT02817828|Diuretics|diuretics|mesh-ancestor
154425017|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
154425018|NCT03632681|Insulin|insulin|mesh-list
154425019|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154425020|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154425021|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425022|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
154425023|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154425024|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153570699|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
154425025|NCT03796650|Vancomycin|vancomycin|mesh-list
154425026|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154425027|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425028|NCT05597527|Apatinib|apatinib|mesh-list
154425029|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425030|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154425031|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425032|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425033|NCT05198141|Letrozole|letrozole|mesh-list
154425034|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425035|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154425036|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154425037|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425038|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425039|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154425040|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425041|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425042|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425043|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
154425044|NCT02813694|Lefamulin|lefamulin|mesh-list
154425045|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154425046|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425047|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154425048|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154425049|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425050|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425051|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425052|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
154425053|NCT03632161|Bupivacaine|bupivacaine|mesh-list
154425054|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
154425055|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
154425056|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425057|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425058|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
154425059|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425060|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154425061|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153999630|NCT00962741|Etanercept|etanercept|mesh-list
154425062|NCT03632161|Analgesics|analgesics|mesh-ancestor
154425063|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154425064|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154425065|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154425066|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
154425067|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425068|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425069|NCT03103919|Rotigotine|rotigotine|mesh-list
154425070|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
154425071|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
154425072|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425073|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425074|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425075|NCT04173325|Nivolumab|nivolumab|mesh-list
154425076|NCT04173325|Irinotecan|irinotecan|mesh-list
154425077|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154425078|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425079|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154425080|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425081|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154425082|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154425083|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425084|NCT02810964|Sulforaphane|sulforaphane|mesh-list
154425085|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154425086|NCT02810964|Protective Agents|protective agents|mesh-ancestor
154425087|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425088|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425089|NCT04073147|Venetoclax|venetoclax|mesh-list
154425090|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
154425091|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425092|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154425093|NCT02707159|Paclitaxel|paclitaxel|mesh-list
154425094|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154425095|NCT02707159|Gemcitabine|gemcitabine|mesh-list
154425096|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154425097|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425098|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
154425099|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
154425100|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
154425101|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425102|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154425103|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
154425104|NCT04113187|Propranolol|propranolol|mesh-list
153731776|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425105|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154425106|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154425107|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
154425108|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425109|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425110|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425111|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154425112|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154425113|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
154425114|NCT03103763|Warfarin|warfarin|mesh-list
154425115|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
154425116|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154425117|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154425118|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154425119|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
154425120|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425121|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154425122|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154425123|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425124|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
154425125|NCT04011475|Olodaterol|olodaterol|mesh-list
154425126|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154425127|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
154425128|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425129|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425130|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154425131|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
154425132|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
154425133|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154425134|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
154425135|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425136|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425138|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154425139|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
154425140|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425141|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154425142|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425143|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425144|NCT03632915|Lacosamide|lacosamide|mesh-list
154425145|NCT03632915|Phenytoin|phenytoin|mesh-list
154425146|NCT03632915|Ketamine|ketamine|mesh-list
154425147|NCT03632915|Levetiracetam|levetiracetam|mesh-list
154425148|NCT03632915|Valproic Acid|valproic acid|mesh-list
154425149|NCT03632915|Phenobarbital|phenobarbital|mesh-list
154425150|NCT03632915|Analgesics|analgesics|mesh-ancestor
154425151|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
154425152|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425153|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425154|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154425155|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154425156|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
154425157|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
154425158|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425159|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154425160|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154425161|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425162|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425163|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
154425164|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
154425165|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425166|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
154425167|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
154425168|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154425169|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154425170|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154425171|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154425172|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154425173|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154425174|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154425175|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154425177|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154425178|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154425179|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
154425180|NCT05649605|Testosterone|testosterone|mesh-list
154425181|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
154425182|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
154425183|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154425184|NCT05649605|Androgens|androgens|mesh-ancestor
154425185|NCT05649605|Hormones|hormones|mesh-ancestor
154425186|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425187|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425188|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154425189|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425190|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
154425191|NCT05640479|Pregabalin|pregabalin|mesh-list
154425192|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
154425193|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154425194|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425195|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425196|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154425197|NCT05640479|Analgesics|analgesics|mesh-ancestor
154425198|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
154425199|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425200|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154425201|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154425202|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154425203|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
154425204|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425205|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425206|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
154425207|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154425208|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154425209|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154425210|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154425211|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154425212|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154425213|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
154425214|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154425215|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154425216|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425217|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
154425218|NCT05309525|Coagulants|coagulants|mesh-ancestor
154425219|NCT02810418|Paclitaxel|paclitaxel|mesh-list
154425220|NCT02810418|LMB-100|lmb-100|mesh-list
154425221|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154425222|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425223|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
154425224|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
154425225|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
154425226|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425227|NCT02810418|Immunoconjugates|immunoconjugates|mesh-ancestor
154425228|NCT02810418|Immunologic Factors|immunologic factors|mesh-ancestor
154425229|NCT02810418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425230|NCT02959541|Leucovorin|leucovorin|mesh-list
154425231|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
154425232|NCT02959541|Antidotes|antidotes|mesh-ancestor
154425233|NCT02959541|Protective Agents|protective agents|mesh-ancestor
154425234|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425235|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
154425236|NCT02959541|Vitamins|vitamins|mesh-ancestor
154425237|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
154425238|NCT05705700|Dutasteride|dutasteride|mesh-list
154425239|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154425240|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154425241|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425242|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425243|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425244|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425245|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425246|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
154425247|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154425248|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425249|NCT02260050|Epinastine|epinastine|mesh-list
153731827|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
154425250|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154425251|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
154425252|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
154425253|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425254|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425255|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425256|NCT02036736|Propofol|propofol|mesh-list
154425257|NCT02036736|Anesthetics|anesthetics|mesh-list
154425258|NCT02036736|Desflurane|desflurane|mesh-list
154425259|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154425260|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425261|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425262|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154425263|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
154425264|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154425265|NCT05693688|Atosiban|atosiban|mesh-list
154425266|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425267|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425268|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425269|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
154425270|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154425271|NCT02047422|Metolazone|metolazone|mesh-list
154425272|NCT02047422|Furosemide|furosemide|mesh-list
154425273|NCT02047422|Spironolactone|spironolactone|mesh-list
154425274|NCT02047422|Diuretics|diuretics|mesh-ancestor
154425275|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
154425276|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425277|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154425278|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154425279|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425280|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154425281|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425282|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425283|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154425284|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154425285|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153999854|NCT02807922|Zopiclone|zopiclone|mesh-list
154425286|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
154425287|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154425288|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154425289|NCT02048358|Prednisolone|prednisolone|mesh-list
154425290|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
154425291|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154425292|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
154425293|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425294|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
154425295|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
154425296|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425297|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425298|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154425299|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
154425300|NCT02048358|Hormones|hormones|mesh-ancestor
154425301|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425302|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154425303|NCT02048358|Protective Agents|protective agents|mesh-ancestor
154425304|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154425305|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425306|NCT02928029|Dexamethasone|dexamethasone|mesh-list
154425307|NCT02928029|Bortezomib|bortezomib|mesh-list
154425308|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154425309|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425310|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
154425311|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
154425312|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425313|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425314|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154425315|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
154425316|NCT02928029|Hormones|hormones|mesh-ancestor
154425317|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425318|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154425319|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425320|NCT02050074|Metformin|metformin|mesh-list
154425321|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154425322|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154425323|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425324|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154425326|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
154425327|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425328|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154425329|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
154425330|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154425331|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
154425332|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
154425333|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425334|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425335|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154425336|NCT02050152|Analgesics|analgesics|mesh-ancestor
154425337|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
154425338|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425339|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
154425340|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
154425341|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154425342|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154425343|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
154425344|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425345|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
154425346|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154425347|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425348|NCT05212025|Gemcitabine|gemcitabine|mesh-list
154425349|NCT05212025|Adavosertib|adavosertib|mesh-list
154425350|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154425351|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
154425352|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425353|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425354|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425355|NCT02051868|Paclitaxel|paclitaxel|mesh-list
154425356|NCT02051868|Carboplatin|carboplatin|mesh-list
154425357|NCT02051868|Fluorouracil|fluorouracil|mesh-list
154425358|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154425359|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425360|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
154425361|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
154425362|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
154425363|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425365|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154425366|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154425367|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
154425368|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425369|NCT04696757|Capecitabine|capecitabine|mesh-list
154425370|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154425371|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
154425372|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425373|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425374|NCT02049294|Omalizumab|omalizumab|mesh-list
154425375|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154425376|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154425377|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
154425378|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
154425379|NCT02051946|Diuretics|diuretics|mesh-ancestor
154425380|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
154425381|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425382|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425383|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425384|NCT02049606|Nabumetone|nabumetone|mesh-list
154425385|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154425386|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154425387|NCT02049606|Analgesics|analgesics|mesh-ancestor
154425388|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
154425389|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425390|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425391|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425392|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154425393|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154425394|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154425395|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425396|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425397|NCT02037516|Neostigmine|neostigmine|mesh-list
154425398|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154425399|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053958|NCT04115982|Vitamin D|vitamin d|mesh-list
153570847|NCT05273242|Artesunate|artesunate|mesh-list
154425400|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425401|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
154425402|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425403|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425404|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154425405|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
154425406|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425407|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154425408|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
154425409|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154425410|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154425411|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154425412|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154425413|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425414|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
154425415|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425416|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425417|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154425418|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425419|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154425420|NCT02037672|Metformin|metformin|mesh-list
154425421|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154425422|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425423|NCT02049762|Aspirin|aspirin|mesh-list
154425424|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154425425|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154425426|NCT02049762|Analgesics|analgesics|mesh-ancestor
154425427|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
154425428|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425429|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425430|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425431|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154425432|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154425433|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154425434|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000003|NCT00857155|Clopidogrel|clopidogrel|mesh-list
154425435|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154425436|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154425437|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425438|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
154425439|NCT03561558|Ibuprofen|ibuprofen|mesh-list
154425440|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154425441|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154425442|NCT03561558|Analgesics|analgesics|mesh-ancestor
154425443|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
154425444|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425445|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425446|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425447|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154425448|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154425449|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425450|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425451|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
154425452|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154425453|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425454|NCT03099161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154425455|NCT03099161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425456|NCT04639115|Ozanimod|ozanimod|mesh-list
154425457|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154425458|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425459|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154425460|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
154425461|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425462|NCT04260659|Lidocaine|lidocaine|mesh-list
154425463|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
154425464|NCT04260659|Fentanyl|fentanyl|mesh-list
154425465|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
154425466|NCT04260659|Ketamine|ketamine|mesh-list
154425467|NCT04260659|Remifentanil|remifentanil|mesh-list
154425468|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
154425469|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
154425470|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425471|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425472|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
154425473|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425474|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154425475|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154425476|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154425477|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154425478|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425479|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154425480|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154425482|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153814609|NCT00452634|Irinotecan|irinotecan|mesh-list
154425483|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154425484|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154425485|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
154425486|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425487|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154425488|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154425489|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
154425490|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154425491|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154425492|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154425493|NCT04260659|Narcotics|narcotics|mesh-ancestor
154425494|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154425495|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
154425496|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154425497|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154425498|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
154425499|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154425500|NCT04148495|Acetaminophen|acetaminophen|mesh-list
154425501|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154425502|NCT04148495|Analgesics|analgesics|mesh-ancestor
154425503|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
154425504|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425505|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425506|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
154425507|NCT05051189|Fentanyl|fentanyl|mesh-list
154425508|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154425509|NCT05051189|Narcotics|narcotics|mesh-ancestor
154425510|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425511|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425512|NCT05051189|Analgesics|analgesics|mesh-ancestor
154425513|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
154425514|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425515|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154425516|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154425517|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
154425518|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
154425519|NCT00446225|Carboplatin|carboplatin|mesh-list
154425520|NCT00446225|Docetaxel|docetaxel|mesh-list
154425521|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154425522|NCT00446225|Gemcitabine|gemcitabine|mesh-list
154425523|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425524|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
154425525|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
154425526|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570925|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570958|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153570959|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
153570960|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570961|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425527|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425528|NCT00446225|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154425529|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154425530|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425531|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154425532|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
154425533|NCT03080935|Evolocumab|evolocumab|mesh-list
154425534|NCT03080935|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154425535|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154425536|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154425537|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
154425538|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425539|NCT03080935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154425540|NCT03080935|Protease Inhibitors|protease inhibitors|mesh-ancestor
154425541|NCT03080935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425542|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154425543|NCT04479449|Otaplimastat|otaplimastat|mesh-list
154425544|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154425545|NCT04479449|Protective Agents|protective agents|mesh-ancestor
154425546|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425547|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
154425548|NCT01383655|Analgesics|analgesics|mesh-ancestor
154425549|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
154425550|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425551|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425552|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
154425553|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425554|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154425555|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
154425556|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154425557|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154425558|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425559|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154425560|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
154425561|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154425562|NCT01568281|Anastrozole|anastrozole|mesh-list
154425563|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154425564|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425565|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154425566|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154425567|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425568|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425569|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154425570|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425571|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425572|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425573|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
154425574|NCT02921789|Prednisone|prednisone|mesh-list
154425575|NCT02921789|Tacrolimus|tacrolimus|mesh-list
154425576|NCT02921789|Basiliximab|basiliximab|mesh-list
154425577|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425578|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
154425579|NCT02921789|Hormones|hormones|mesh-ancestor
154425580|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425581|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425582|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154425583|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425584|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154425586|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154425587|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425588|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425589|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154425590|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154425591|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
154425592|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154425593|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425594|NCT01568333|Decitabine|decitabine|mesh-list
154425595|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154425596|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
154425597|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425598|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425599|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425600|NCT03437005|Ketoconazole|ketoconazole|mesh-list
154425601|NCT03437005|Desonide|desonide|mesh-list
154425602|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
154425603|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425604|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154425605|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154425606|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425607|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425608|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154425609|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425610|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425611|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425612|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154425613|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425614|NCT03943823|Estrogens|estrogens|mesh-list
154425615|NCT03943823|Hormones|hormones|mesh-ancestor
154425616|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425617|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425618|NCT02419742|Paclitaxel|paclitaxel|mesh-list
154425619|NCT02419742|Docetaxel|docetaxel|mesh-list
154425620|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
154425621|NCT02419742|Carboplatin|carboplatin|mesh-list
154425622|NCT02419742|Doxorubicin|doxorubicin|mesh-list
154425623|NCT02419742|Trastuzumab|trastuzumab|mesh-list
154425624|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154425625|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425626|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
154425627|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
154425628|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
154425629|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425630|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154425631|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
154425632|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425633|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154425634|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154425635|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
154425636|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154425637|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154425638|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153816580|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425639|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154425640|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425641|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154425642|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
154425643|NCT02409290|Levofloxacin|levofloxacin|mesh-list
154425644|NCT02409290|Isoniazid|isoniazid|mesh-list
154425645|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
154425646|NCT02409290|Ethambutol|ethambutol|mesh-list
154425647|NCT02409290|Bedaquiline|bedaquiline|mesh-list
154425648|NCT02409290|Clofazimine|clofazimine|mesh-list
154425649|NCT02409290|Kanamycin|kanamycin|mesh-list
154425650|NCT02409290|Prothionamide|prothionamide|mesh-list
154425651|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154425652|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425653|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154425654|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154425655|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425656|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425657|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425658|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154000237|NCT02858297|Triamcinolone|triamcinolone|mesh-list
154425659|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154425660|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154425661|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
154425662|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154425663|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154425664|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
154425665|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154425666|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425667|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
154425668|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154425669|NCT02898077|Paclitaxel|paclitaxel|mesh-list
154425670|NCT02898077|Ramucirumab|ramucirumab|mesh-list
154425671|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154425672|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425673|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
154425674|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
154425675|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
154425676|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425677|NCT02898077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154425678|NCT02898077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154425679|NCT02898077|Growth Substances|growth substances|mesh-ancestor
154425680|NCT02898077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425681|NCT02898077|Growth Inhibitors|growth inhibitors|mesh-ancestor
154425682|NCT02145884|Timolol|timolol|mesh-list
154425683|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425684|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154425685|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154425686|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
154425687|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425688|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425689|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154425690|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154425691|NCT03544814|Cisplatin|cisplatin|mesh-list
153570973|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154425692|NCT03544814|Pemetrexed|pemetrexed|mesh-list
154425693|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425694|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425695|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425696|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154425697|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154425698|NCT03097133|Esketamine|esketamine|mesh-list
154425699|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
154425700|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154425701|NCT02148380|Carboplatin|carboplatin|mesh-list
154425702|NCT02148380|Pemetrexed|pemetrexed|mesh-list
154425703|NCT02148380|Gefitinib|gefitinib|mesh-list
154425704|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425705|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425706|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425707|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154425708|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154425709|NCT02148380|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154425710|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154425711|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154425712|NCT02146118|Silybin|silybin|mesh-list
154425713|NCT02146118|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154425714|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154425715|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425716|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425717|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425718|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154425719|NCT02146118|Protective Agents|protective agents|mesh-ancestor
154425720|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425721|NCT02142140|Methylphenidate|methylphenidate|mesh-list
154425722|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154425723|NCT02142140|Adderall|adderall|mesh-list
154425724|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154425725|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
154425726|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154425727|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425728|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154425729|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154425730|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255026|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571006|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154425731|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425732|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
154425734|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154425735|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
154425736|NCT02142218|Nivolumab|nivolumab|mesh-list
154425737|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154425738|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425739|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154425740|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425741|NCT02142296|Aflibercept|aflibercept|mesh-list
154425742|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154425743|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154425744|NCT02142296|Growth Substances|growth substances|mesh-ancestor
154425745|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425746|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
154425747|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425748|NCT02142530|Belinostat|belinostat|mesh-list
154425749|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425750|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154425751|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425752|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425753|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
154425754|NCT01383343|Leucovorin|leucovorin|mesh-list
154425755|NCT01383343|Folic Acid|folic acid|mesh-list
154425756|NCT01383343|Bevacizumab|bevacizumab|mesh-list
154425757|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154425758|NCT01383343|Fluorouracil|fluorouracil|mesh-list
154425759|NCT01383343|Irinotecan|irinotecan|mesh-list
154425760|NCT01383343|Sorafenib|sorafenib|mesh-list
154425761|NCT01383343|Camptothecin|camptothecin|mesh-list
154425762|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
154425763|NCT01383343|Antibodies|antibodies|mesh-list
154425764|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
154425765|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154425766|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
154425767|NCT01383343|Calcium|calcium|mesh-list
154425768|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
154425769|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425770|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154425771|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154425772|NCT01383343|Growth Substances|growth substances|mesh-ancestor
154425773|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425774|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
154425775|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
154425776|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154425777|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154425778|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
154425779|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425780|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154425781|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154425782|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153571010|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
154425783|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154425784|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425785|NCT01383343|Antidotes|antidotes|mesh-ancestor
154425786|NCT01383343|Protective Agents|protective agents|mesh-ancestor
154425787|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
154425788|NCT01383343|Vitamins|vitamins|mesh-ancestor
154425789|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
154425790|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154425791|NCT01383343|Hematinics|hematinics|mesh-ancestor
154425792|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154425793|NCT03631147|Rifaximin|rifaximin|mesh-list
154425794|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154425795|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425796|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154425797|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
154425798|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154425799|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154425800|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425801|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154425802|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425803|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154425804|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
154425805|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154425806|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425807|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000382|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
154425808|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425809|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154425810|NCT05344495|Midazolam|midazolam|mesh-list
154425811|NCT05344495|Bupivacaine|bupivacaine|mesh-list
154425812|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
154425813|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
154425814|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425815|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425816|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
154425817|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425818|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154425819|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154425820|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154425821|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154425822|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154425823|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154425824|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
154425825|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
154425826|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
154425827|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425828|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425829|NCT05960565|Glucagon|glucagon|mesh-list
154425830|NCT05960565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154425831|NCT05960565|Hormones|hormones|mesh-ancestor
153814617|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153571077|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
154425832|NCT05960565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425833|NCT05960565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425834|NCT05960227|Dextrans|dextrans|mesh-list
154425835|NCT05960227|Iron-Dextran Complex|iron-dextran complex|mesh-list
154425836|NCT05960227|Anticoagulants|anticoagulants|mesh-ancestor
154425837|NCT05960227|Plasma Substitutes|plasma substitutes|mesh-ancestor
154425838|NCT05960227|Blood Substitutes|blood substitutes|mesh-ancestor
154425839|NCT05960227|Hematinics|hematinics|mesh-ancestor
154425840|NCT05960110|Fluorides|fluorides|mesh-list
154425841|NCT05960110|Fluorides, Topical|fluorides, topical|mesh-list
154425842|NCT05960110|Cariostatic Agents|cariostatic agents|mesh-ancestor
154425843|NCT05960110|Protective Agents|protective agents|mesh-ancestor
154425844|NCT05960110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425845|NCT05959889|Montelukast|montelukast|mesh-list
154425846|NCT05959889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154425847|NCT05959889|Respiratory System Agents|respiratory system agents|mesh-ancestor
154425848|NCT05959889|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154425849|NCT05959889|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425850|NCT05959889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425851|NCT05959889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425852|NCT05959889|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154425853|NCT05959889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154425854|NCT05959889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425856|NCT05959863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154425857|NCT05959863|Protease Inhibitors|protease inhibitors|mesh-ancestor
154425858|NCT05959863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425859|NCT05959863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425860|NCT05959863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154425861|NCT05959759|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154425862|NCT05959759|Dermatologic Agents|dermatologic agents|mesh-ancestor
154425863|NCT05959759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154425864|NCT05959759|Immunologic Factors|immunologic factors|mesh-ancestor
154425865|NCT05959759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425866|NCT05959616|Ciprofloxacin|ciprofloxacin|mesh-list
154425867|NCT05959616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154425868|NCT05959616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425869|NCT05959616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154425870|NCT05959616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154425871|NCT05959616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425872|NCT05959616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425873|NCT05959616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425874|NCT05959616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154255027|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153571078|NCT05030025|Dolutegravir|dolutegravir|mesh-list
154425875|NCT05959616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154425876|NCT05959603|Vancomycin|vancomycin|mesh-list
154425877|NCT05959603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154425878|NCT05959603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425879|NCT05958914|Calcitonin|calcitonin|mesh-list
154000454|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
154425880|NCT05958914|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154425881|NCT05958914|Katacalcin|katacalcin|mesh-list
154425882|NCT05958914|Enkephalins|enkephalins|mesh-list
154425883|NCT05958914|Vasodilator Agents|vasodilator agents|mesh-ancestor
154425884|NCT05958914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154425885|NCT05958914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425886|NCT05958914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154425887|NCT05958914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425888|NCT05958914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425889|NCT05958810|Lumefantrine|lumefantrine|mesh-list
154425891|NCT05958810|Primaquine|primaquine|mesh-list
154425892|NCT05958810|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154425893|NCT05958810|Antimalarials|antimalarials|mesh-ancestor
154425894|NCT05958810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154425895|NCT05958810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154425896|NCT05958810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425897|NCT05958797|Chloroquine|chloroquine|mesh-list
154425898|NCT05958797|Primaquine|primaquine|mesh-list
154425899|NCT05958797|Amebicides|amebicides|mesh-ancestor
154425900|NCT05958797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154425901|NCT05958797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154425902|NCT05958797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425903|NCT05958797|Antimalarials|antimalarials|mesh-ancestor
154425904|NCT05958797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154425905|NCT05958758|Psilocybin|psilocybin|mesh-list
154425906|NCT05958758|Hallucinogens|hallucinogens|mesh-ancestor
154425907|NCT05958758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425908|NCT05958758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154425909|NCT05958719|Azacitidine|azacitidine|mesh-list
154425910|NCT05958719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154425911|NCT05958719|Antimetabolites|antimetabolites|mesh-ancestor
154425912|NCT05958719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425913|NCT05958719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425914|NCT05958719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425915|NCT05958290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154425916|NCT05958290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425917|NCT05955885|Flurbiprofen|flurbiprofen|mesh-list
154425918|NCT05955885|Benzydamine|benzydamine|mesh-list
154425919|NCT05955885|Analgesics|analgesics|mesh-ancestor
154425920|NCT05955885|Sensory System Agents|sensory system agents|mesh-ancestor
154425921|NCT05955885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425922|NCT05955885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425923|NCT05955885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154425924|NCT05955885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154425925|NCT05955885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425926|NCT05955885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154425927|NCT05955885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154425928|NCT05955885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425929|NCT05955885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425930|NCT05952752|Dexamethasone|dexamethasone|mesh-list
154425931|NCT05952752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425932|NCT05952752|Antiemetics|antiemetics|mesh-ancestor
154425933|NCT05952752|Autonomic Agents|autonomic agents|mesh-ancestor
154425934|NCT05952752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425935|NCT05952752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425936|NCT05952752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154425937|NCT05952752|Glucocorticoids|glucocorticoids|mesh-ancestor
154425938|NCT05952752|Hormones|hormones|mesh-ancestor
154425939|NCT05952752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425940|NCT05952752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154425941|NCT05952752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425942|NCT05914857|Dapagliflozin|dapagliflozin|mesh-list
154425943|NCT05914857|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154425944|NCT05914857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425945|NCT05914857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154425946|NCT05914857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425947|NCT05909696|Rocuronium|rocuronium|mesh-list
154425948|NCT05909696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154425949|NCT05909696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154425950|NCT05909696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154425951|NCT05909696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425952|NCT05909696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425953|NCT05907811|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154425954|NCT05907811|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154425955|NCT05907811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425956|NCT05907811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425957|NCT05901350|Levodopa|levodopa|mesh-list
154425958|NCT05901350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154425959|NCT05901350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154425960|NCT05901350|Dopamine Agents|dopamine agents|mesh-ancestor
154425961|NCT05901350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154425962|NCT05901350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425963|NCT05901350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425964|NCT05894018|Fluzoparib|fluzoparib|mesh-list
154425965|NCT05894018|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154425966|NCT05894018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154425967|NCT05894018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425968|NCT05894018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154425969|NCT05870462|Semaglutide|semaglutide|mesh-list
154425970|NCT05870462|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154425971|NCT05870462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154425972|NCT05870462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425973|NCT05822440|Itraconazole|itraconazole|mesh-list
154425974|NCT05822440|Antifungal Agents|antifungal agents|mesh-ancestor
154425975|NCT05822440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154425976|NCT05822440|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154425977|NCT05822440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154425978|NCT05822440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816617|NCT00426101|Etoposide|etoposide|mesh-list
153571143|NCT04899843|Astringents|astringents|mesh-ancestor
154425979|NCT05822440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154425980|NCT05822440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154425981|NCT05822440|Hormone Antagonists|hormone antagonists|mesh-ancestor
154425982|NCT05822440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154425983|NCT05822440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425984|NCT05822440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154425985|NCT05805839|Corticosterone|corticosterone|mesh-list
154425986|NCT05805839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154425988|NCT05790252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154425989|NCT05790252|Narcotics|narcotics|mesh-ancestor
154425990|NCT05790252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154425991|NCT05790252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154425992|NCT05790252|Analgesics|analgesics|mesh-ancestor
154425993|NCT05790252|Sensory System Agents|sensory system agents|mesh-ancestor
154425994|NCT05790252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154425995|NCT05790252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154425996|NCT05757999|Magnesium Sulfate|magnesium sulfate|mesh-list
154425997|NCT05757999|Analgesics|analgesics|mesh-ancestor
154425998|NCT05757999|Sensory System Agents|sensory system agents|mesh-ancestor
154425999|NCT05757999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426000|NCT05757999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426001|NCT05757999|Anesthetics|anesthetics|mesh-ancestor
154426002|NCT05757999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426003|NCT05757999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154426004|NCT05757999|Anticonvulsants|anticonvulsants|mesh-ancestor
154426005|NCT05757999|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154426006|NCT05757999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154426007|NCT05757999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426008|NCT05757999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154426009|NCT05757999|Tocolytic Agents|tocolytic agents|mesh-ancestor
154426010|NCT05757999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154426011|NCT05729646|Oxaliplatin|oxaliplatin|mesh-list
154426012|NCT05729646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426013|NCT05557136|Ether|ether|mesh-list
154426014|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154426015|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
154426016|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
154426017|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426018|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426019|NCT05502081|Remdesivir|remdesivir|mesh-list
154426020|NCT05502081|Favipiravir|favipiravir|mesh-list
154426021|NCT05502081|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154426022|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
154426023|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426024|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
154426025|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426026|NCT05494385|Gabapentin|gabapentin|mesh-list
154426027|NCT05494385|Analgesics|analgesics|mesh-ancestor
154426028|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
153571145|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
154426029|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426030|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426031|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
154426032|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154426033|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154426034|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426035|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154426036|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154426037|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154426038|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154426039|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426040|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
154426041|NCT05455294|Venetoclax|venetoclax|mesh-list
154426042|NCT05455294|Decitabine|decitabine|mesh-list
154426043|NCT05455294|Navitoclax|navitoclax|mesh-list
154426044|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426045|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154426046|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
154426047|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426048|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426049|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154426050|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426051|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426052|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154426053|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154426054|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
154426055|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426056|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154426057|NCT05201300|Propofol|propofol|mesh-list
154426058|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154426059|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426060|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426061|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154426062|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
154426063|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
154426064|NCT05119439|Misoprostol|misoprostol|mesh-list
154426065|NCT05119439|Mifepristone|mifepristone|mesh-list
154426066|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154426067|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
154426068|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154426069|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426070|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154426071|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154426072|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
154426073|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153731832|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
153457964|NCT03592836|Diuretics|diuretics|mesh-list
153814621|NCT03277599|Tramadol|tramadol|mesh-list
154426074|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154426075|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154426076|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154426077|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
154426078|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154426079|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154426080|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
154426081|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426082|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
154426083|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154426084|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154426085|NCT05020392|Vidarabine|vidarabine|mesh-list
154426086|NCT05020392|Fludarabine|fludarabine|mesh-list
154426087|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
154426088|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426089|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154426090|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
154426091|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426092|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426093|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
154426094|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426095|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
154426096|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426097|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154426098|NCT04992468|Hormones|hormones|mesh-ancestor
154426099|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426100|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426101|NCT04975100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154426102|NCT04975100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154426103|NCT04975100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154000687|NCT05974241|Dopamine Agents|dopamine agents|mesh-ancestor
154426104|NCT04975100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426105|NCT04975100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154426106|NCT04975100|Serotonin Agents|serotonin agents|mesh-ancestor
154426107|NCT04975100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426108|NCT04970342|Alprazolam|alprazolam|mesh-list
154426109|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426110|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154426111|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154426112|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426113|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154426114|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426115|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154426116|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154426117|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
154426118|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
154426119|NCT04959981|Osimertinib|osimertinib|mesh-list
154426120|NCT04959981|Sotorasib|sotorasib|mesh-list
154426121|NCT04959981|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154426122|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153814622|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153457971|NCT03596502|Anticoagulants|anticoagulants|mesh-list
154426123|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426124|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426125|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426126|NCT04959981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154426127|NCT04959981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426128|NCT04901377|Dienogest|dienogest|mesh-list
154426129|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154426130|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154426131|NCT04901377|Estradiol|estradiol|mesh-list
154426132|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154426133|NCT04901377|Estrogens|estrogens|mesh-ancestor
154426134|NCT04901377|Hormones|hormones|mesh-ancestor
154426135|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426136|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426137|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154426138|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
154426139|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154426140|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154426141|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154426142|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154426143|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154426144|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
154426145|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154426146|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426147|NCT04795245|Afatinib|afatinib|mesh-list
154426148|NCT04795245|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154426149|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154426150|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426151|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426152|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426153|NCT04654507|Dexamethasone|dexamethasone|mesh-list
154426154|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426155|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
154426156|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
154426157|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426158|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426159|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154426160|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
154426161|NCT04654507|Hormones|hormones|mesh-ancestor
154426162|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426163|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154426164|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426165|NCT04646655|Enoxaparin|enoxaparin|mesh-list
154426166|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
154426167|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154426168|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154426169|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426170|NCT04629443|Azacitidine|azacitidine|mesh-list
154426171|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154426172|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
154426173|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426174|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426175|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426176|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
154426177|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154426178|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
154426179|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426180|NCT04627922|Expectorants|expectorants|mesh-ancestor
154426181|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
154426182|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154426183|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
154426184|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426185|NCT04627922|Protective Agents|protective agents|mesh-ancestor
154426186|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426187|NCT04627922|Antidotes|antidotes|mesh-ancestor
154426188|NCT04577716|Listerine|listerine|mesh-list
154426189|NCT04577716|Fluorides|fluorides|mesh-list
154426190|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
154426191|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
154426192|NCT04577716|Protective Agents|protective agents|mesh-ancestor
154426193|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426194|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154426195|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426196|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
154426197|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426198|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426199|NCT04521413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154426200|NCT04521413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426201|NCT04516057|Nabilone|nabilone|mesh-list
154426202|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
154426203|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
154426204|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426205|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426206|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154426207|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154426208|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154426209|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426210|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154426212|NCT04424641|Immunoglobulins|immunoglobulins|mesh-list
154426213|NCT04424641|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154426214|NCT04424641|Immunoglobulin G|immunoglobulin g|mesh-list
154426215|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154426216|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
154426217|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426218|NCT04393103|Atropine|atropine|mesh-list
154426219|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154426220|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154426221|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154426222|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154426223|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
154426224|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426225|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426226|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154426227|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
154426228|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
154426229|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
154426230|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154426231|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154426232|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
154426233|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154426234|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426235|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154426236|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154426237|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154426238|NCT04334629|Ibuprofen|ibuprofen|mesh-list
154426239|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154426240|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154426241|NCT04334629|Analgesics|analgesics|mesh-ancestor
154426242|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
154426243|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426244|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426245|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426246|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154426247|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154426248|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426249|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426250|NCT04296890|Maytansine|maytansine|mesh-list
154426251|NCT04296890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154426252|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154426253|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426254|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
154426255|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
154426256|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
154426257|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426258|NCT04296890|Immunoconjugates|immunoconjugates|mesh-ancestor
154426259|NCT04296890|Immunologic Factors|immunologic factors|mesh-ancestor
154426260|NCT04296890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426261|NCT04276090|Dexamethasone|dexamethasone|mesh-list
154426262|NCT04276090|Floxuridine|floxuridine|mesh-list
154426263|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426264|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
154426265|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
154426266|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426267|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426268|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154426269|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
154426270|NCT04276090|Hormones|hormones|mesh-ancestor
154426271|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426272|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154426273|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426274|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154426275|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
154426276|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426277|NCT04273139|Venetoclax|venetoclax|mesh-list
154426278|NCT04273139|Ibrutinib|ibrutinib|mesh-list
154254740|NCT01144676|Dapivirine|dapivirine|mesh-list
154426280|NCT04273139|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154426281|NCT04273139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154426282|NCT04273139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426283|NCT04273139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426284|NCT04081688|Atezolizumab|atezolizumab|mesh-list
154426285|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154426286|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
154426287|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
154426288|NCT04081688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154426289|NCT04081688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457981|NCT04197882|Molgramostim|molgramostim|mesh-list
153814627|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
153571229|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153571230|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571233|NCT04669587|Palbociclib|palbociclib|mesh-list
154426290|NCT04081688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426291|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426292|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
154426293|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426294|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
154426295|NCT04064814|Flunarizine|flunarizine|mesh-list
154426296|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
154426297|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426298|NCT04064814|Protective Agents|protective agents|mesh-ancestor
154426299|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426300|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
154426301|NCT04064814|Vitamins|vitamins|mesh-ancestor
154426302|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
154426303|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
154426304|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154426305|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154426306|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154426307|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154426308|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
154426309|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
154426310|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154426311|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
154426312|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
154426313|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154426314|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426315|NCT03846388|Hormones|hormones|mesh-list
154426316|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154426317|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426318|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426319|NCT03675815|Ritonavir|ritonavir|mesh-list
154426320|NCT03675815|Darunavir|darunavir|mesh-list
154426321|NCT03675815|Tenofovir|tenofovir|mesh-list
154426322|NCT03675815|Lamivudine|lamivudine|mesh-list
154426323|NCT03675815|Emtricitabine|emtricitabine|mesh-list
154426324|NCT03675815|Dolutegravir|dolutegravir|mesh-list
154426325|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154426326|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154426327|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154426328|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
154426329|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426330|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426331|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154426332|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154426333|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
154426334|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426335|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154426336|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154426337|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154426338|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154426339|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153626782|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426340|NCT03669133|Vitamin E|vitamin e|mesh-list
154426341|NCT03669133|Vitamins|vitamins|mesh-ancestor
154426342|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
154426343|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426344|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
154426345|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426346|NCT03669133|Protective Agents|protective agents|mesh-ancestor
154426347|NCT03647969|Nivolumab|nivolumab|mesh-list
154426348|NCT03647969|Ipilimumab|ipilimumab|mesh-list
154426349|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426350|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426351|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154426352|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426353|NCT03644186|Paclitaxel|paclitaxel|mesh-list
154426354|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154426355|NCT03644186|Trastuzumab|trastuzumab|mesh-list
154426356|NCT03644186|Letrozole|letrozole|mesh-list
154426357|NCT03644186|Palbociclib|palbociclib|mesh-list
154426358|NCT03644186|Pertuzumab|pertuzumab|mesh-list
154426359|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154426360|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426361|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154426362|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154426363|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154426364|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426365|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426366|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154426367|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154426368|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426369|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154426370|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
154426371|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426372|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426373|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154426374|NCT03593759|Prednisone|prednisone|mesh-list
154426375|NCT03593759|Prednisolone|prednisolone|mesh-list
154426376|NCT03593759|Methotrexate|methotrexate|mesh-list
154426377|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426378|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
154426379|NCT03593759|Hormones|hormones|mesh-ancestor
154426380|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814628|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426381|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426382|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154426383|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426384|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154426385|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
154426386|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154426387|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154426388|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
154426389|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426390|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
154426391|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426392|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154426393|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426394|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
154426395|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154426396|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154426397|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
154426398|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154426399|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426400|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426401|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154426402|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
154426403|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426404|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426405|NCT03347292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154426406|NCT03347292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426407|NCT03182426|Liraglutide|liraglutide|mesh-list
154426409|NCT03182426|Etanercept|etanercept|mesh-list
154426410|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
154426411|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154426412|NCT03182426|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154426413|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154426414|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426415|NCT03182426|Incretins|incretins|mesh-ancestor
154426416|NCT03182426|Hormones|hormones|mesh-ancestor
154426417|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426418|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154426419|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154426420|NCT03182426|Analgesics|analgesics|mesh-ancestor
154426421|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
153814629|NCT00452829|Folic Acid|folic acid|mesh-list
154426422|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426423|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426424|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154426425|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154426426|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426427|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
154426428|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426429|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426430|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154426431|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154426432|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
154426433|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426434|NCT03078946|Midazolam|midazolam|mesh-list
154426435|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
154426436|NCT03078946|Morphine|morphine|mesh-list
154426437|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154426438|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426439|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426440|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154426441|NCT03078946|Analgesics|analgesics|mesh-ancestor
154426442|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
154426443|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426444|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154426445|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154426446|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154426447|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
154426448|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154426449|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426450|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154426451|NCT03078946|Narcotics|narcotics|mesh-ancestor
154426452|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154426453|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154426454|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154426455|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154426456|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154426457|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
154426458|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
154426459|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
154426460|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
154426461|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154426462|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154426463|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426464|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154426465|NCT02694978|Hematinics|hematinics|mesh-ancestor
154426466|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154426467|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154426468|NCT02663518|Rituximab|rituximab|mesh-list
154426469|NCT02663518|Nivolumab|nivolumab|mesh-list
154426470|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
154426471|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426472|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426473|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
154426474|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426475|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154426476|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153571300|NCT04490707|Lenalidomide|lenalidomide|mesh-list
153814655|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153816658|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816659|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
153816660|NCT00426179|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153457997|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
153457998|NCT03591744|Doxorubicin|doxorubicin|mesh-list
153457999|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153458000|NCT03591744|Lenalidomide|lenalidomide|mesh-list
153458001|NCT03591744|Bortezomib|bortezomib|mesh-list
153458002|NCT03591744|Daratumumab|daratumumab|mesh-list
153458003|NCT03591744|Ichthammol|ichthammol|mesh-list
154426477|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426478|NCT02563002|Bevacizumab|bevacizumab|mesh-list
154426479|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
154426480|NCT02563002|Cetuximab|cetuximab|mesh-list
154426481|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426482|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426483|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154426484|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154426485|NCT02563002|Growth Substances|growth substances|mesh-ancestor
154426486|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426487|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
154426488|NCT02563002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154426489|NCT02563002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426491|NCT02454933|Osimertinib|osimertinib|mesh-list
154426492|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426493|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426494|NCT02454933|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154426495|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154426496|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426497|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426498|NCT02430480|Goserelin|goserelin|mesh-list
154426499|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154426500|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426501|NCT02207439|Nelfinavir|nelfinavir|mesh-list
154426502|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154426503|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154426504|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
154426505|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426506|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426508|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154426509|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
154426510|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426511|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
154426512|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154426513|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426514|NCT01205048|Lidocaine|lidocaine|mesh-list
154426515|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
154426516|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
154426517|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426518|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426519|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
154426520|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426521|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154426522|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154426523|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153814937|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
153814938|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426524|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154426525|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426526|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154426527|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154426528|NCT01052779|Hematinics|hematinics|mesh-ancestor
154426529|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154426530|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154426531|NCT00785525|Lenograstim|lenograstim|mesh-list
154426532|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154426533|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
154426534|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426535|NCT00591370|Temozolomide|temozolomide|mesh-list
154426536|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154426537|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
154426538|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426539|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426540|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154426541|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426542|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426543|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
154426544|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154426545|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
154426546|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426547|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
154426548|NCT02782676|Protective Agents|protective agents|mesh-ancestor
154426549|NCT03033095|Etanercept|etanercept|mesh-list
154426550|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154426551|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154426552|NCT03033095|Analgesics|analgesics|mesh-ancestor
154426553|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
154001130|NCT02232152|Protective Agents|protective agents|mesh-ancestor
154426554|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426555|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426556|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426557|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154426558|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154426559|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426560|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
154426561|NCT02142920|Gedatolisib|gedatolisib|mesh-list
154426562|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154426563|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426564|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426565|NCT01383785|Abciximab|abciximab|mesh-list
154426566|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
154426567|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154426568|NCT02146976|Propofol|propofol|mesh-list
153814939|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814940|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154426569|NCT02146976|Sevoflurane|sevoflurane|mesh-list
154426570|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154426571|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426572|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426573|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154426574|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
154426575|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
154426576|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154426577|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154426578|NCT02147054|Rocuronium|rocuronium|mesh-list
154426579|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154426580|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154426581|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154426582|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426583|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426584|NCT00107978|Vancomycin|vancomycin|mesh-list
154426585|NCT00107978|Telavancin|telavancin|mesh-list
154426586|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154426587|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426588|NCT02781818|Triamcinolone|triamcinolone|mesh-list
154426589|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154426590|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154426591|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154426592|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426593|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
154426594|NCT02781818|Hormones|hormones|mesh-ancestor
154426595|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426596|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426597|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426598|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
154426599|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426600|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426601|NCT02149628|Propofol|propofol|mesh-list
154426602|NCT02149628|Desflurane|desflurane|mesh-list
154426603|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154426604|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426605|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426606|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154426607|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
154426608|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
154426609|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154426610|NCT02927873|Vaccines|vaccines|mesh-list
154426611|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
154426612|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426613|NCT02460419|Capecitabine|capecitabine|mesh-list
154426614|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154426615|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
154426616|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426617|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426618|NCT01568411|Itraconazole|itraconazole|mesh-list
154426619|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
154426620|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426621|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154426622|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154426623|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426624|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426625|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154426626|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
154001208|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
154426627|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426628|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426629|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154426630|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154426631|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
154426632|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
154426633|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426634|NCT03631901|Diazepam|diazepam|mesh-list
154426635|NCT03631901|Melatonin|melatonin|mesh-list
154426636|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
154426637|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426638|NCT03631901|Protective Agents|protective agents|mesh-ancestor
154426639|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426640|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426641|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154426642|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
154426643|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
154426644|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
154426645|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426646|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154426647|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154426648|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154426649|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154426650|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154426651|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154426652|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154426653|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154426654|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
154426655|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
154426656|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
154426657|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
154426658|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154426659|NCT01383395|Cilostazol|cilostazol|mesh-list
154426660|NCT01383395|Simvastatin|simvastatin|mesh-list
154426661|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154426662|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154426663|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
154426664|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426665|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153814944|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154426666|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154426667|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426668|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154426669|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
154426670|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426671|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426672|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154426673|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
154426674|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154426675|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154426676|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154426677|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
154426678|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154426679|NCT01383395|Protective Agents|protective agents|mesh-ancestor
154426680|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154426681|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154426682|NCT05084651|Itraconazole|itraconazole|mesh-list
154426683|NCT05084651|Lumefantrine|lumefantrine|mesh-list
154426684|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
154426685|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426686|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154426687|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154426688|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426689|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426690|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154426691|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
154426692|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426693|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426694|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154426695|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
154426696|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154426697|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154426698|NCT02781584|Firsocostat|firsocostat|mesh-list
154426699|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426700|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426701|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
154426702|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154426703|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
154426704|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426705|NCT02147678|Remifentanil|remifentanil|mesh-list
154426706|NCT02147678|Propofol|propofol|mesh-list
154426707|NCT02147678|Etomidate|etomidate|mesh-list
154426708|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
154426709|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426710|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426711|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154426712|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154426713|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
154426714|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154426715|NCT02147678|Narcotics|narcotics|mesh-ancestor
154426716|NCT02147678|Analgesics|analgesics|mesh-ancestor
154426717|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
154426718|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426719|NCT02151344|Vaccines|vaccines|mesh-list
154426720|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
153814945|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153360224|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153365208|NCT04370288|Expectorants|expectorants|mesh-ancestor
154426721|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426722|NCT02155634|Lenalidomide|lenalidomide|mesh-list
154426723|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
154426724|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426725|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154426726|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154426727|NCT02155634|Growth Substances|growth substances|mesh-ancestor
154426728|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
154426729|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426730|NCT02151812|Paclitaxel|paclitaxel|mesh-list
154426731|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154426732|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154426733|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426734|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154426735|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
154426736|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
154426737|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426738|NCT02151968|Anesthetics|anesthetics|mesh-list
154426739|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
154426740|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426741|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426742|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
154426743|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426744|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154426745|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
154426746|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154426747|NCT02255084|Menthol|menthol|mesh-list
154426748|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
154426749|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
154426750|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154426751|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154426752|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
154426753|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426754|NCT02255162|Cytarabine|cytarabine|mesh-list
154426755|NCT02255162|Lenalidomide|lenalidomide|mesh-list
154426756|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154426757|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
154426758|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426759|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426760|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
154426761|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426762|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426763|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
154426764|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426765|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154426766|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154426767|NCT02255162|Growth Substances|growth substances|mesh-ancestor
154426768|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
154426769|NCT02152514|Sufentanil|sufentanil|mesh-list
154426770|NCT02152514|Morphine|morphine|mesh-list
154426771|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154426772|NCT02152514|Narcotics|narcotics|mesh-ancestor
154426773|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154426774|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426775|NCT02152514|Analgesics|analgesics|mesh-ancestor
154426776|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
154426777|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426778|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154426779|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154426780|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
154426781|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
154426782|NCT02261090|Pramipexole|pramipexole|mesh-list
154426783|NCT02261090|Dexpramipexole|dexpramipexole|mesh-list
154426784|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
154426785|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426786|NCT02261090|Protective Agents|protective agents|mesh-ancestor
154426787|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426788|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154426789|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154426790|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
154426791|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
154426792|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154426793|NCT01307423|Thalidomide|thalidomide|mesh-list
154426794|NCT01307423|Apremilast|apremilast|mesh-list
154426795|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154426796|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154426797|NCT01307423|Analgesics|analgesics|mesh-ancestor
154426798|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
154426799|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426800|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426801|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426802|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154426804|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154426805|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426806|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426807|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426808|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
154426809|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
154426810|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154426811|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426812|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154426813|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154426814|NCT01307423|Growth Substances|growth substances|mesh-ancestor
154426815|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
154426816|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426817|NCT02156336|Ranolazine|ranolazine|mesh-list
154426818|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154426819|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154426820|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426821|NCT03542240|Curcumin|curcumin|mesh-list
153814946|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154426822|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154426823|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154426824|NCT03542240|Analgesics|analgesics|mesh-ancestor
154426825|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
154426826|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426827|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426828|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426829|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154426830|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426831|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426832|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426833|NCT00911183|Prednisone|prednisone|mesh-list
154426834|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
154426835|NCT00911183|Rituximab|rituximab|mesh-list
154426836|NCT00911183|Doxorubicin|doxorubicin|mesh-list
154426837|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154426838|NCT00911183|Vincristine|vincristine|mesh-list
154426839|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426840|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
154426841|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426842|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154426843|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154426844|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
154426845|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426846|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426847|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154426848|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426849|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154426850|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154426851|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154426852|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426853|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426854|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
154426855|NCT00911183|Hormones|hormones|mesh-ancestor
154426856|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426857|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154426858|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154426859|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
154426860|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
154426861|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
154426862|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
154426863|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154426864|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426865|NCT05420441|Chitosan|chitosan|mesh-list
154426866|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154426867|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153365266|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
154426868|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
154426869|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426870|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154426871|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
154426872|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
154426873|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
154426874|NCT05420441|Coagulants|coagulants|mesh-ancestor
154426875|NCT05598593|Cytarabine|cytarabine|mesh-list
154426876|NCT05598593|Fludarabine|fludarabine|mesh-list
154426877|NCT05598593|Busulfan|busulfan|mesh-list
154426878|NCT05598593|Thiotepa|thiotepa|mesh-list
154426879|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426880|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154426881|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
154426882|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426883|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426884|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
154426885|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426886|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
154426887|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426888|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
154426889|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154426890|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154426891|NCT05337449|Fluorides|fluorides|mesh-list
154426892|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
154426893|NCT05337449|Protective Agents|protective agents|mesh-ancestor
154426894|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426895|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
154426896|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154426897|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154426898|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154426899|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426900|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
154426901|NCT02150720|Coagulants|coagulants|mesh-ancestor
154426902|NCT02153060|Dexamethasone|dexamethasone|mesh-list
154426903|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
154426904|NCT02153060|BB 1101|bb 1101|mesh-list
154426905|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426906|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
154426907|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
154426908|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154426909|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426910|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154426911|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
154426912|NCT02153060|Hormones|hormones|mesh-ancestor
154426913|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426914|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154426915|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426916|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
154426917|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426918|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426919|NCT02156570|Ribavirin|ribavirin|mesh-list
154426920|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
154426921|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
154426922|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426923|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
154426924|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426925|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
154426926|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154426927|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426928|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
154426929|NCT02156726|Fludarabine|fludarabine|mesh-list
154426930|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154426931|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
154426932|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426934|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154426935|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
154426936|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426937|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426938|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154426939|NCT02153450|Metformin|metformin|mesh-list
154426940|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154426941|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426942|NCT05598281|Sotorasib|sotorasib|mesh-list
154426943|NCT05598281|Digoxin|digoxin|mesh-list
154426944|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154426945|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154426946|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426947|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426948|NCT05598281|Protective Agents|protective agents|mesh-ancestor
154426949|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426950|NCT05598281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154426951|NCT05598281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154426952|NCT05598281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154426953|NCT03092375|Ribavirin|ribavirin|mesh-list
154426954|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
154426955|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426956|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
154426957|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426958|NCT01995513|Prednisone|prednisone|mesh-list
154426959|NCT01995513|Prednisolone|prednisolone|mesh-list
154426960|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
154426961|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154426962|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
154426963|NCT01995513|Hormones|hormones|mesh-ancestor
154426964|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426965|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426966|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154426967|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814947|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154426968|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154426969|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154426970|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154426971|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
154426972|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154426973|NCT03180359|Vaccines|vaccines|mesh-list
154426974|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
154426975|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426976|NCT01304511|Ganirelix|ganirelix|mesh-list
154426977|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
154426978|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154426979|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426980|NCT00103610|Plerixafor|plerixafor|mesh-list
154426981|NCT00103610|Lenograstim|lenograstim|mesh-list
154426982|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154426983|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
154426984|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426985|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154426986|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154426987|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
154426988|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154426989|NCT02156960|Denosumab|denosumab|mesh-list
154426990|NCT02156960|Teriparatide|teriparatide|mesh-list
154426991|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154426992|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426993|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154426994|NCT02153606|Glycerol|glycerol|mesh-list
154426995|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154426996|NCT02153606|Protective Agents|protective agents|mesh-ancestor
154426997|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154426998|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
154426999|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154427000|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154427001|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154427002|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427003|NCT04687631|Bevacizumab|bevacizumab|mesh-list
154427004|NCT04687631|Cetuximab|cetuximab|mesh-list
154427005|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154427006|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001579|NCT02797704|Growth Substances|growth substances|mesh-ancestor
154001662|NCT02939183|Hormones|hormones|mesh-ancestor
154427007|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154427008|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154427009|NCT04687631|Growth Substances|growth substances|mesh-ancestor
154427010|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427011|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
154427012|NCT04833023|Olanzapine|olanzapine|mesh-list
154427013|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
154427014|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
154427015|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427016|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427017|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154427018|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154427019|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154427020|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427021|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154427022|NCT04833023|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154427023|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154427024|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154427025|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427026|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427028|NCT03091439|Dalbavancin|dalbavancin|mesh-list
154427029|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154427030|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427031|NCT03631823|Temozolomide|temozolomide|mesh-list
154427032|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154427033|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
154427034|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427035|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427036|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
154427037|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154427038|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
154427039|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154427040|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
154427041|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427042|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427043|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
154427044|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
154427045|NCT02154074|Isoflurane|isoflurane|mesh-list
154427046|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
154427047|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427048|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427049|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154427050|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427051|NCT02154074|Analgesics|analgesics|mesh-ancestor
154427052|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
154427053|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427054|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154427055|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154427056|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154427057|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
154427058|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427059|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427060|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154427061|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
154427062|NCT05460455|Antibodies|antibodies|mesh-list
154427063|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154427064|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
154427065|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427066|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154427067|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
154427068|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427069|NCT01382147|Daunorubicin|daunorubicin|mesh-list
154427070|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
154427071|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154427072|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427073|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154427074|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154427075|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427076|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427077|NCT01382147|Analgesics|analgesics|mesh-ancestor
154427078|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
154427079|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427080|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427082|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
154427083|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427084|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
154427085|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427086|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427087|NCT04429685|Ketamine|ketamine|mesh-list
154427088|NCT04429685|Analgesics|analgesics|mesh-ancestor
154427089|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
154427090|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427091|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427092|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154427093|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154427094|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
154427095|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
154427096|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427097|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154427098|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154427099|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427100|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427101|NCT01384279|Metformin|metformin|mesh-list
154427102|NCT01384279|Topiramate|topiramate|mesh-list
154427103|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154427104|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427105|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
154427106|NCT01381601|Bevacizumab|bevacizumab|mesh-list
154427107|NCT01381601|Sunitinib|sunitinib|mesh-list
154427108|NCT01381601|Sorafenib|sorafenib|mesh-list
154427109|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154427110|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427111|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154427112|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154427113|NCT01381601|Growth Substances|growth substances|mesh-ancestor
153814955|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
154427114|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427115|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
154427116|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154427117|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427118|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427119|NCT02823353|Fenofibrate|fenofibrate|mesh-list
154427120|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154427121|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
154427122|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427123|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154427124|NCT04509193|Warfarin|warfarin|mesh-list
154427125|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
154427126|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
154427127|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154427128|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
154427129|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154427130|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
154427131|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427132|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427133|NCT04173949|Ramipril|ramipril|mesh-list
154427134|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154427135|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
154427136|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427137|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427138|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154427139|NCT01382017|Lacosamide|lacosamide|mesh-list
154427140|NCT01382017|Carbamazepine|carbamazepine|mesh-list
154427141|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
154427142|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154427143|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154427144|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154427145|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427146|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
154427147|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154427148|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427149|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427150|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154427151|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427152|NCT01382017|Analgesics|analgesics|mesh-ancestor
154427153|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
154427154|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001727|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
154427156|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154427157|NCT01381523|Naproxen|naproxen|mesh-list
154427158|NCT01381523|Sumatriptan|sumatriptan|mesh-list
154427159|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154427160|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427161|NCT01381523|Analgesics|analgesics|mesh-ancestor
154427162|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
154427163|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427164|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814956|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153814957|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153814958|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154427165|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427166|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427167|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
154427168|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154427169|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427170|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427171|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154427172|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154427173|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154427174|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
154427175|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427176|NCT04233047|Fostemsavir|fostemsavir|mesh-list
154427177|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154427178|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154427179|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
154427180|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427181|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154427182|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154427183|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427184|NCT01381445|Clobetasol|clobetasol|mesh-list
154427185|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427186|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
154427187|NCT01381445|Hormones|hormones|mesh-ancestor
154427188|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427189|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427190|NCT03083639|Esomeprazole|esomeprazole|mesh-list
154427191|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154427192|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154427193|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154427194|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427195|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427196|NCT02927431|Oseltamivir|oseltamivir|mesh-list
154427197|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
154427198|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427199|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427200|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427201|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
154427202|NCT05027893|Cefixime|cefixime|mesh-list
154427203|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153458004|NCT03591744|BB 1101|bb 1101|mesh-list
153458005|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571314|NCT04464577|Fluconazole|fluconazole|mesh-list
153571315|NCT04464577|Bupropion|bupropion|mesh-list
153571316|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154427204|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427205|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154427206|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154427207|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427208|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427209|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427210|NCT05027893|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154427211|NCT05027893|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154427212|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
154427213|NCT04113083|Provitamins|provitamins|mesh-ancestor
154427214|NCT04113083|Vitamins|vitamins|mesh-ancestor
154427215|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
154427216|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427217|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154427218|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
154427219|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427220|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
154427221|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154427222|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
154427223|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427224|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
154427225|NCT04989361|Protective Agents|protective agents|mesh-ancestor
154427226|NCT01381289|Ivacaftor|ivacaftor|mesh-list
154427227|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154427228|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154427229|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427231|NCT04899193|Hormones|hormones|mesh-ancestor
154427232|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427233|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427234|NCT01381705|Rituximab|rituximab|mesh-list
154427235|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154427236|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427237|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
154427238|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427239|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427240|NCT04401709|Gemcitabine|gemcitabine|mesh-list
154427241|NCT04401709|Capecitabine|capecitabine|mesh-list
154427242|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154427243|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
154427244|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427245|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427246|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
154427247|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
154427248|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427249|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
154427250|NCT01381627|Remifentanil|remifentanil|mesh-list
154427251|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154254743|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
154427252|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427253|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427254|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427255|NCT01381627|Analgesics|analgesics|mesh-ancestor
154427256|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
154427257|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427258|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154427259|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154427260|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154427261|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154427262|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427263|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427264|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154427265|NCT01381627|Narcotics|narcotics|mesh-ancestor
154427266|NCT00974571|Cetirizine|cetirizine|mesh-list
154427267|NCT00974571|Montelukast|montelukast|mesh-list
154427268|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154427269|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
154427270|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154427271|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427272|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427273|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427274|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154427275|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154427276|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427277|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154427278|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154427279|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154427280|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
154427281|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
153571317|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
153571318|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154427282|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427283|NCT02766608|Budesonide|budesonide|mesh-list
154427284|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
154427285|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154427286|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427287|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154427288|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
154427289|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427290|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427291|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154427292|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
154427293|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
154427294|NCT02766608|Hormones|hormones|mesh-ancestor
154427295|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427296|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154427297|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154427298|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154427299|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
154427300|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427301|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427302|NCT01382407|Cetuximab|cetuximab|mesh-list
154427303|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154427304|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427305|NCT02235857|Dextrans|dextrans|mesh-list
154427306|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
154427307|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
154427308|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
154427309|NCT03317119|Trifluridine|trifluridine|mesh-list
154427310|NCT03317119|Trametinib|trametinib|mesh-list
154427311|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427312|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154427313|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427314|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427315|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
154427316|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
154427317|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427318|NCT04356495|Ciclesonide|ciclesonide|mesh-list
154427319|NCT04356495|Interferons|interferons|mesh-list
153365402|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154427320|NCT04356495|Interferon-beta|interferon-beta|mesh-list
154427321|NCT04356495|Telmisartan|telmisartan|mesh-list
154427322|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
154427323|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427324|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427325|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
154427326|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427327|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154427328|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154427329|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154427330|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427331|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
154427333|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427334|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154427335|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
154427336|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154427337|NCT02154230|Calcium|calcium|mesh-list
154427338|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154427339|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427340|NCT02157428|Flumazenil|flumazenil|mesh-list
154427341|NCT02157428|Antidotes|antidotes|mesh-ancestor
154427342|NCT02157428|Protective Agents|protective agents|mesh-ancestor
154427343|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427344|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
154427345|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
154427346|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427347|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427348|NCT00960141|Loratadine|loratadine|mesh-list
154427349|NCT00960141|Montelukast|montelukast|mesh-list
154427350|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154427351|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
154427352|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154427353|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427354|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427355|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427356|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154427357|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154427358|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427359|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
154427360|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
154427361|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154427362|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154427363|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154427364|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
154427365|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
154427366|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427367|NCT00759655|Factor VIII|factor viii|mesh-list
154427368|NCT00759655|Coagulants|coagulants|mesh-ancestor
154427369|NCT02255006|Glyburide|glyburide|mesh-list
154427370|NCT02255006|Celecoxib|celecoxib|mesh-list
154427371|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154427372|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427373|NCT02255006|Analgesics|analgesics|mesh-ancestor
154427374|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
154427375|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427376|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427377|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427378|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427379|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154427380|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154427381|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427382|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427383|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154427384|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
154427385|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154427386|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427387|NCT03396471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154427388|NCT03396471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427389|NCT00103142|Sargramostim|sargramostim|mesh-list
154427390|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
154427391|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427392|NCT00943683|Montelukast|montelukast|mesh-list
154427393|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154427394|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
154427395|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154427396|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427397|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427398|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427399|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154427400|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154427401|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427402|NCT03542006|Brinzolamide|brinzolamide|mesh-list
154427403|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154427404|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427405|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427406|NCT02154464|Acetaminophen|acetaminophen|mesh-list
154427407|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427408|NCT02154464|Analgesics|analgesics|mesh-ancestor
154427409|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
154427410|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427411|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427412|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
154427413|NCT00911547|Beclomethasone|beclomethasone|mesh-list
154427414|NCT00911547|Montelukast|montelukast|mesh-list
154427415|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154427416|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
154427417|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154427418|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427419|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427420|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427421|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154427422|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154427423|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427424|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427425|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
154427427|NCT02159690|Prednisone|prednisone|mesh-list
154427428|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
154427429|NCT02159690|Dutasteride|dutasteride|mesh-list
154427430|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427431|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
154427432|NCT02159690|Hormones|hormones|mesh-ancestor
154427433|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427434|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427435|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154427436|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427437|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154427438|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427439|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427440|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427441|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154427442|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154427443|NCT02157818|Midazolam|midazolam|mesh-list
154427444|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
154427445|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154427446|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427447|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427448|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427449|NCT02157818|Analgesics|analgesics|mesh-ancestor
154427450|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
154427451|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427452|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154427453|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154427454|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154427455|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
154427456|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427457|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427458|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154427459|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154427460|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154427461|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154427462|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154427463|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
154427464|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
154427465|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
154427466|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
154427467|NCT00899379|Rizatriptan|rizatriptan|mesh-list
154427468|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154427469|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
154427470|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427471|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427472|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427473|NCT04326439|Cytarabine|cytarabine|mesh-list
154427474|NCT04326439|Etoposide|etoposide|mesh-list
154427475|NCT04326439|Daunorubicin|daunorubicin|mesh-list
154427476|NCT04326439|Sorafenib|sorafenib|mesh-list
154427477|NCT04326439|Asparaginase|asparaginase|mesh-list
154427478|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
154427479|NCT04326439|Calicheamicins|calicheamicins|mesh-list
154427480|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154427481|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427482|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154427483|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154427484|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427485|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427486|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154427487|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
154427488|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
154427489|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427490|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154427491|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
154427492|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427493|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154427494|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154427495|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154427496|NCT04326439|Immunotoxins|immunotoxins|mesh-ancestor
154427497|NCT04326439|Immunoconjugates|immunoconjugates|mesh-ancestor
154427498|NCT03541928|Valacyclovir|valacyclovir|mesh-list
154427499|NCT03541928|Leuprolide|leuprolide|mesh-list
154427500|NCT03541928|Bicalutamide|bicalutamide|mesh-list
154427501|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154427502|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
154427503|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154427504|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427505|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154427506|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427507|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
154427508|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427509|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427510|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
154427511|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427512|NCT00145795|Ritonavir|ritonavir|mesh-list
154427513|NCT00145795|Lopinavir|lopinavir|mesh-list
154427514|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154427515|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154427516|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
154427517|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427518|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427519|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154427520|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154427521|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
154427522|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427523|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154427524|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154427525|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154427526|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
154427527|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427528|NCT00898677|Sumatriptan|sumatriptan|mesh-list
154427529|NCT00898677|Rizatriptan|rizatriptan|mesh-list
154427530|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154427531|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154427532|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154427533|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
154427534|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427535|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427536|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427537|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
154427538|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154427539|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427540|NCT02154776|Letrozole|letrozole|mesh-list
154427541|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427542|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154427543|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154427544|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427545|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427547|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427548|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427549|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427550|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154427551|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
154427552|NCT03388749|Annamycin|annamycin|mesh-list
154427553|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153814963|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154427554|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427555|NCT02770820|Aldesleukin|aldesleukin|mesh-list
154427556|NCT02770820|Interleukin-2|interleukin-2|mesh-list
154427557|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427558|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427559|NCT02770820|Analgesics|analgesics|mesh-ancestor
154427560|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
154427561|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427562|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427563|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154427564|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154427565|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
154427566|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427567|NCT02154854|Tacrolimus|tacrolimus|mesh-list
154427568|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154427569|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
154427570|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427571|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154427572|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427573|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427574|NCT02160080|Interferons|interferons|mesh-list
154427575|NCT02160080|Ribavirin|ribavirin|mesh-list
154427576|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
154427577|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427578|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
154427579|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427580|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
154427581|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427582|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
154427583|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427584|NCT05422183|Lenvatinib|lenvatinib|mesh-list
154427585|NCT05422183|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154427586|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427587|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154427588|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427589|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427590|NCT02160158|Fesoterodine|fesoterodine|mesh-list
154427591|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154427592|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154427593|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
154427594|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427595|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427596|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427597|NCT02160158|Urological Agents|urological agents|mesh-ancestor
154427598|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154427599|NCT02160236|Tenoxicam|tenoxicam|mesh-list
154427600|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154427601|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427602|NCT02160236|Analgesics|analgesics|mesh-ancestor
154427603|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
154427604|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427605|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427606|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427607|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427608|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154427609|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427610|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427611|NCT02154932|Misoprostol|misoprostol|mesh-list
154427612|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154427613|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
154427614|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154427615|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427616|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154427617|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154427618|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
154427619|NCT02158286|Acetaminophen|acetaminophen|mesh-list
154427620|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427621|NCT02158286|Analgesics|analgesics|mesh-ancestor
154427622|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
154427623|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427624|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427625|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
154427626|NCT01377415|Bupivacaine|bupivacaine|mesh-list
154427627|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
154427628|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
154427629|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427630|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427631|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
154427632|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427633|NCT02155088|Paclitaxel|paclitaxel|mesh-list
154427634|NCT02155088|Gemcitabine|gemcitabine|mesh-list
154427635|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154427636|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814966|NCT00447759|Ibuprofen|ibuprofen|mesh-list
154427637|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
154427638|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
154427639|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
154427640|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427641|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154427642|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
154427643|NCT02160548|Atropine|atropine|mesh-list
154427644|NCT02160548|Albuterol|albuterol|mesh-list
154427645|NCT02160548|Pralidoxime|pralidoxime|mesh-list
154427646|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154427647|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154427648|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154427649|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
154427650|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427651|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427652|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154427653|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
154427654|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
154427655|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
154427656|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154427657|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154427658|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
154427659|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427660|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427661|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
154427662|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154427663|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154427664|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154427665|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154427666|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
154427667|NCT02160548|Antidotes|antidotes|mesh-ancestor
154427668|NCT02160548|Protective Agents|protective agents|mesh-ancestor
154427669|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
154427670|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
154427671|NCT02158598|Vitamin D|vitamin d|mesh-list
154427672|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
154427673|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
154427674|NCT02158598|Vitamins|vitamins|mesh-list
154427675|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
154427676|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002254|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
154427677|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153814967|NCT00447759|Celecoxib|celecoxib|mesh-list
153814968|NCT00447759|Diclofenac|diclofenac|mesh-list
154427678|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154427679|NCT03082729|Apremilast|apremilast|mesh-list
154427680|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154427681|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427682|NCT03082729|Analgesics|analgesics|mesh-ancestor
154427683|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
154427684|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427685|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427686|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427687|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427688|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154427689|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154427690|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427691|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427692|NCT02160704|Enclomiphene|enclomiphene|mesh-list
154427693|NCT02160704|Clomiphene|clomiphene|mesh-list
154427694|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
154427695|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154427696|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427697|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427698|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427699|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154427700|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
154427701|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154427702|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154427703|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154427704|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
154427705|NCT03542552|Nifedipine|nifedipine|mesh-list
154427706|NCT03542552|Analgesics|analgesics|mesh-ancestor
154427707|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
154427708|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427709|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427710|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
154427711|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427712|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154427713|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
154427714|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154427715|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154427716|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814970|NCT00447759|Meloxicam|meloxicam|mesh-list
154427717|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154427718|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
154427719|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154427720|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
154427721|NCT02155166|Ibuprofen|ibuprofen|mesh-list
154427722|NCT02155166|Lidocaine|lidocaine|mesh-list
154427723|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
154427724|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
154427725|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427726|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427727|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
154427728|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427729|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154427730|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154427731|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154427732|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154427733|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427734|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154427735|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427736|NCT02155166|Analgesics|analgesics|mesh-ancestor
154427737|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427738|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427739|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154427740|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427741|NCT00398931|Alendronate|alendronate|mesh-list
154427742|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427743|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154427744|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154427745|NCT00920361|Hormones|hormones|mesh-ancestor
154427746|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427747|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427748|NCT00651807|Etonogestrel|etonogestrel|mesh-list
154427749|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154427750|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
154427751|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154427752|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427753|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154427754|NCT02158910|Donepezil|donepezil|mesh-list
154427755|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154427756|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427757|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427758|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
154427759|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427760|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427761|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
154427762|NCT03077659|Paclitaxel|paclitaxel|mesh-list
154427763|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154427764|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365554|NCT00928694|Fenofibrate|fenofibrate|mesh-list
154427765|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
154427766|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
154427767|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
154427768|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427769|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
154427770|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154427771|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427772|NCT05052723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154427773|NCT05052723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427774|NCT02807883|Blinatumomab|blinatumomab|mesh-list
154427775|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427776|NCT04051047|Gemcitabine|gemcitabine|mesh-list
154427777|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154427778|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
154427779|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427780|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427781|NCT00102440|Allopurinol|allopurinol|mesh-list
154427782|NCT00102440|Febuxostat|febuxostat|mesh-list
154427783|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
154427784|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427785|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427786|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
154427787|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427788|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154427789|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
154427790|NCT00102440|Protective Agents|protective agents|mesh-ancestor
154427791|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427792|NCT05224167|Melatonin|melatonin|mesh-list
154427793|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
154427794|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
154427795|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427796|NCT05224167|Protective Agents|protective agents|mesh-ancestor
154427797|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427798|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427799|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
154427800|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154427801|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154427802|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
154427803|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
154427804|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427805|NCT01377259|Anesthetics|anesthetics|mesh-list
154427806|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427807|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427808|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154427809|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154427810|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154427811|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427812|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427813|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154427814|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154427815|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427816|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
154427817|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427818|NCT03909607|Ketamine|ketamine|mesh-list
154427819|NCT03909607|Analgesics|analgesics|mesh-ancestor
154427820|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
154427821|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427822|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427823|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153760010|NCT00187707|Gabapentin|gabapentin|mesh-list
154427824|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154427825|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
154427826|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
154427827|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427828|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154427829|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154427830|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427831|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427832|NCT03902509|Pirfenidone|pirfenidone|mesh-list
154427833|NCT03902509|Analgesics|analgesics|mesh-ancestor
154427834|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
154427835|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427836|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427837|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154427838|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427839|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427841|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427842|NCT02166632|Bupivacaine|bupivacaine|mesh-list
154427843|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
154427844|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
154427845|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427846|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427847|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
154427848|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427849|NCT02161952|Pirfenidone|pirfenidone|mesh-list
154427850|NCT02161952|Analgesics|analgesics|mesh-ancestor
154427851|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
154427852|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427853|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427854|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154427855|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427856|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427857|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427858|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427859|NCT04050735|Ethanol|ethanol|mesh-list
154427860|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154427861|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427862|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427863|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427864|NCT04784559|Remdesivir|remdesivir|mesh-list
154427865|NCT04784559|Favipiravir|favipiravir|mesh-list
154427866|NCT04784559|Dexamethasone|dexamethasone|mesh-list
154427867|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427868|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
154427869|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
154427870|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427871|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427872|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154427873|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
154427874|NCT04784559|Hormones|hormones|mesh-ancestor
154427875|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427876|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154427877|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427878|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
154427879|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427880|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
154427881|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154427882|NCT03704181|Colchicine|colchicine|mesh-list
154427883|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
154427884|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427885|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
154427886|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
154427887|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
154427888|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427889|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427890|NCT03625011|Gabapentin|gabapentin|mesh-list
154427891|NCT03625011|Analgesics|analgesics|mesh-ancestor
154427892|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
154427893|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427894|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427895|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
154427896|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154427897|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154427898|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427899|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154427900|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154427901|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154427902|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427903|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427904|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
154427905|NCT03625167|Petrolatum|petrolatum|mesh-list
154427906|NCT03625167|Emollients|emollients|mesh-ancestor
154427907|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154427908|NCT04718727|Olanzapine|olanzapine|mesh-list
154427909|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
154427910|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
154427911|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427912|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427913|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154427914|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154427915|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154427916|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427917|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154427918|NCT04718727|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154427919|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154427920|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154427921|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427922|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427924|NCT03701529|Anesthetics|anesthetics|mesh-list
154427925|NCT03701529|Propofol|propofol|mesh-list
154427926|NCT03701529|Sevoflurane|sevoflurane|mesh-list
154427927|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427928|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427929|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154427930|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154427931|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
154427932|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154427933|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154427934|NCT04553133|Letrozole|letrozole|mesh-list
154427935|NCT04553133|Fulvestrant|fulvestrant|mesh-list
154427936|NCT04553133|Palbociclib|palbociclib|mesh-list
154427937|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427938|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154427939|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154427940|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427941|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427942|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154427943|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
154427944|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154427945|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427946|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154427947|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154427948|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154427949|NCT03701451|Decitabine|decitabine|mesh-list
154427950|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154427951|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
154427952|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427953|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427954|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154427955|NCT03703089|Paclitaxel|paclitaxel|mesh-list
154427956|NCT03703089|Gemcitabine|gemcitabine|mesh-list
154427957|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154427958|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427959|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
154427960|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
154427961|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
154427962|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427963|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154427964|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
154427965|NCT02807844|Spartalizumab|spartalizumab|mesh-list
154427966|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154427967|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427968|NCT02807844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154427969|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154427970|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
154427971|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154427972|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154427973|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154427974|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154427975|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
154427976|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154427977|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427979|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
154427980|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
154427981|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154427982|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427983|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
154427984|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427985|NCT03561402|Teriflunomide|teriflunomide|mesh-list
154427986|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154427987|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154427988|NCT03561402|Analgesics|analgesics|mesh-ancestor
154427989|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
154427990|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154427991|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427992|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154427993|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154427994|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154427995|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
154427997|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154427998|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154427999|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
154428000|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428001|NCT02052258|Oxytocin|oxytocin|mesh-list
154428002|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
154428003|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154428004|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428005|NCT02053818|Sufentanil|sufentanil|mesh-list
154428006|NCT02053818|Remifentanil|remifentanil|mesh-list
154428007|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154428008|NCT02053818|Narcotics|narcotics|mesh-ancestor
154428009|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428010|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428011|NCT02053818|Analgesics|analgesics|mesh-ancestor
154428012|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
154428013|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428014|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154428015|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154428016|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
154428017|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
154428018|NCT03702387|Anesthetics|anesthetics|mesh-list
154428019|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428020|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428021|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
154428022|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
154428023|NCT03031899|Coagulants|coagulants|mesh-ancestor
154428024|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
154428025|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428026|NCT03700905|Nivolumab|nivolumab|mesh-list
154428027|NCT03700905|Ipilimumab|ipilimumab|mesh-list
154428028|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154428029|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428030|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154428031|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428032|NCT03700749|Iodine|iodine|mesh-list
154428033|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
154428034|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154428035|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
154428036|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
154428037|NCT03700749|Povidone|povidone|mesh-list
154428038|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154428039|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428040|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
154428041|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154428042|NCT03700749|Trace Elements|trace elements|mesh-ancestor
154428043|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
154428044|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428045|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
154428046|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
154002634|NCT02787018|Hormones|hormones|mesh-ancestor
154428047|NCT03086369|Paclitaxel|paclitaxel|mesh-list
154428048|NCT03086369|Gemcitabine|gemcitabine|mesh-list
154428049|NCT03086369|Olaratumab|olaratumab|mesh-list
154428050|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154428051|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428052|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
154428053|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
154428054|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
154428055|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428056|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154428057|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
154428059|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428060|NCT05326373|Fluorides|fluorides|mesh-list
154428061|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
154428062|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
154428063|NCT05326373|Protective Agents|protective agents|mesh-ancestor
154428064|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428065|NCT02166944|Tamoxifen|tamoxifen|mesh-list
154428066|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154428067|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
154428068|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154428069|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428070|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154428071|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428072|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154428073|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154428074|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154428076|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154428077|NCT02162264|Donepezil|donepezil|mesh-list
154428078|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154428079|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428080|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428081|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428082|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428083|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428084|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
154428085|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
154428086|NCT03700515|Hematinics|hematinics|mesh-ancestor
154428087|NCT03700359|Etoposide|etoposide|mesh-list
154428088|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154428089|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428090|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154428091|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154428092|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428093|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428094|NCT02167178|Polygeline|polygeline|mesh-list
154428095|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
154428096|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
154428097|NCT03625089|Atorvastatin|atorvastatin|mesh-list
154428098|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154428099|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154428100|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
154428101|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428102|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154428103|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154428104|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428105|NCT01378949|Morphine|morphine|mesh-list
154428106|NCT01378949|Bupivacaine|bupivacaine|mesh-list
154428107|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
154428108|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
154428109|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428110|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428111|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
154428112|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428113|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154428114|NCT01378949|Narcotics|narcotics|mesh-ancestor
154428115|NCT01378949|Analgesics|analgesics|mesh-ancestor
154428116|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
154428117|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154428118|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428119|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428120|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154428121|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154428122|NCT01381055|Protective Agents|protective agents|mesh-ancestor
154428123|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428124|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
154428125|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154428126|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
154428127|NCT03122613|Curcumin|curcumin|mesh-list
154428128|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154428129|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154428130|NCT03122613|Analgesics|analgesics|mesh-ancestor
154428131|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
154428132|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428133|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428134|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154428135|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428136|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428137|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428138|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428139|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
154428140|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154428141|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154428142|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428144|NCT03540368|Coagulants|coagulants|mesh-ancestor
154428145|NCT02255396|Estradiol|estradiol|mesh-list
154428146|NCT02255396|Estrogens|estrogens|mesh-ancestor
154428147|NCT02255396|Hormones|hormones|mesh-ancestor
154428148|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154428149|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428150|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
154428151|NCT02163980|Ropivacaine|ropivacaine|mesh-list
154428152|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154428153|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428154|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428155|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154428156|NCT02163980|Analgesics|analgesics|mesh-ancestor
154428157|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
154428158|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428159|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154428160|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154428161|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154428162|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
154428163|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428164|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428165|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
154428166|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
154428167|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154428168|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154428169|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
154428170|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428171|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428172|NCT01569035|Warfarin|warfarin|mesh-list
154428173|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
154428174|NCT03841565|Dexamethasone|dexamethasone|mesh-list
154428175|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
154428176|NCT03841565|Daratumumab|daratumumab|mesh-list
154428177|NCT03841565|Pomalidomide|pomalidomide|mesh-list
154428178|NCT03841565|Ichthammol|ichthammol|mesh-list
154428179|NCT03841565|BB 1101|bb 1101|mesh-list
154428180|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154428181|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
154428182|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
154428183|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428184|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428185|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154428186|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
154428187|NCT03841565|Hormones|hormones|mesh-ancestor
154428188|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154428189|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154428190|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428191|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428192|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428193|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428194|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
154428195|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154428196|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154428197|NCT03841565|Growth Substances|growth substances|mesh-ancestor
154428198|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
154002783|NCT00869869|Melatonin|melatonin|mesh-list
154428199|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
154428200|NCT02162966|Colistin|colistin|mesh-list
154428201|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154428202|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428203|NCT01595321|Leucovorin|leucovorin|mesh-list
154428204|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
154428205|NCT01595321|Fluorouracil|fluorouracil|mesh-list
154428206|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
154428207|NCT01595321|Irinotecan|irinotecan|mesh-list
154428208|NCT01595321|Folfirinox|folfirinox|mesh-list
154428209|NCT01595321|Vaccines|vaccines|mesh-list
154428210|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
154428211|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428212|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154428213|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428214|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154428215|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
154255028|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154428216|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428217|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428218|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154428220|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154428221|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154428222|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154428223|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428224|NCT01595321|Antidotes|antidotes|mesh-ancestor
154428225|NCT01595321|Protective Agents|protective agents|mesh-ancestor
154428226|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
154428227|NCT01595321|Vitamins|vitamins|mesh-ancestor
154428228|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
154428229|NCT02164214|Etanercept|etanercept|mesh-list
154428230|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154428231|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154428232|NCT02164214|Analgesics|analgesics|mesh-ancestor
154428233|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
154428234|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428235|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428236|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154428237|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428238|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154428239|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154428240|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
154428241|NCT03722849|Adenosine|adenosine|mesh-list
154428242|NCT03722849|Capsaicin|capsaicin|mesh-list
154428243|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
154428244|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154428245|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
154428246|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428247|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428248|NCT03722849|Analgesics|analgesics|mesh-ancestor
154428249|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154428250|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
154428251|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154428252|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
154428253|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
154428254|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428255|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428256|NCT02170844|Dabigatran|dabigatran|mesh-list
154428257|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
154428258|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428259|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428260|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428261|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428262|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
154428263|NCT02170922|Dabigatran|dabigatran|mesh-list
154428264|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
154428265|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428266|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428267|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428268|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428269|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
154428270|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
154428271|NCT02167958|Fludarabine|fludarabine|mesh-list
154428272|NCT02167958|Tacrolimus|tacrolimus|mesh-list
154428273|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154428274|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
154428275|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428276|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428277|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154428278|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
154428279|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428280|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428281|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154428282|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154428284|NCT01384331|NuvaRing|nuvaring|mesh-list
154428285|NCT01384331|Desogestrel|desogestrel|mesh-list
154428286|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154428287|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
154428288|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154428289|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428290|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154428291|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154428292|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154428293|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154428294|NCT01384331|Progestins|progestins|mesh-ancestor
154428295|NCT01384331|Hormones|hormones|mesh-ancestor
154428296|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154428297|NCT03699423|Atropine|atropine|mesh-list
154428298|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154428299|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154428300|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154428301|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154428302|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154428303|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
154428304|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428305|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428306|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154428307|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
154428308|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
154428309|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
154428310|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154428311|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154428312|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428313|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428314|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428315|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
154428316|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154428317|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428318|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428319|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153814987|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153814988|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
154428320|NCT02164448|Analgesics|analgesics|mesh-ancestor
154428321|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
154428322|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428323|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154428324|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154428325|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154428326|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
154428327|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428328|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428329|NCT01380509|Metronidazole|metronidazole|mesh-list
154428330|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428331|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154428332|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154428333|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154428334|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154428335|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154428336|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154428337|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
154428338|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428339|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154428340|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154428341|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428342|NCT00976131|Ubiquinone|ubiquinone|mesh-list
154428343|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
154428344|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
154428345|NCT00976131|Doxorubicin|doxorubicin|mesh-list
154428346|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154428347|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
154428348|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428349|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428350|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154428351|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
154002929|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
154428352|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428353|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428354|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153571319|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153571320|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154428355|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154428356|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154428357|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154428358|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428359|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
154428360|NCT00976131|Vitamins|vitamins|mesh-ancestor
154428361|NCT01384253|Trastuzumab|trastuzumab|mesh-list
154428362|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154428363|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428364|NCT03631277|Calcium|calcium|mesh-list
154428365|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154428366|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428367|NCT02171000|Dabigatran|dabigatran|mesh-list
154428368|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
154428369|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428370|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428371|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428372|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428373|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
154428374|NCT02164604|Ranibizumab|ranibizumab|mesh-list
154428375|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154428376|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154428377|NCT02164604|Growth Substances|growth substances|mesh-ancestor
154428378|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428379|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
154428380|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428381|NCT04571645|Heparin|heparin|mesh-list
154428382|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
154428383|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154428384|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154428385|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428386|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
154428387|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154428388|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
154428389|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
154428390|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814989|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428391|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428392|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154428393|NCT04050267|Analgesics|analgesics|mesh-ancestor
154428394|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
154428395|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428396|NCT02759120|Doxycycline|doxycycline|mesh-list
154428397|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154428398|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154428399|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
154428400|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
154428401|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154428402|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154428403|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154428404|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
154428405|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154428406|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
154428407|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154428408|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154428409|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154428410|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
154428411|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154428412|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428413|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154428414|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154428415|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154428416|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154428417|NCT01569113|Estrogens|estrogens|mesh-ancestor
154428418|NCT01569113|Hormones|hormones|mesh-ancestor
154428419|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154428420|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154428421|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154003005|NCT06167707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003006|NCT06167642|Ofatumumab|ofatumumab|mesh-list
154003007|NCT06167642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428422|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154428423|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154428425|NCT03699033|Carboplatin|carboplatin|mesh-list
154428426|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154428427|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428428|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
154428429|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
154428430|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
154428431|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428432|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
154428433|NCT03697239|Paclitaxel|paclitaxel|mesh-list
154428434|NCT03697239|Gemcitabine|gemcitabine|mesh-list
154428435|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154428436|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154428437|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428438|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
154428439|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
154428440|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
154428441|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428442|NCT03697239|Vitamins|vitamins|mesh-ancestor
154428443|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
154428444|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428445|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154428446|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
154428447|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
154428448|NCT03697239|Protective Agents|protective agents|mesh-ancestor
154428449|NCT01380431|Lisinopril|lisinopril|mesh-list
154428450|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154428451|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428452|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428453|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428454|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154428455|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154428456|NCT01380431|Protective Agents|protective agents|mesh-ancestor
154428457|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428458|NCT03697161|Gaboxadol|gaboxadol|mesh-list
154428459|NCT03697161|Analgesics|analgesics|mesh-ancestor
154428460|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
154428461|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428462|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428463|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
154428464|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
154428465|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
154428466|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428467|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428468|NCT02171156|Nintedanib|nintedanib|mesh-list
154428469|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428470|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154428471|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428472|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428473|NCT01380353|Diclofenac|diclofenac|mesh-list
154428474|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154428475|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154428476|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154428477|NCT01380353|Analgesics|analgesics|mesh-ancestor
154428478|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
154428479|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428480|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428481|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154428482|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428483|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154428484|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428485|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428486|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
154428487|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154428488|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
154428489|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428490|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
154428491|NCT02168426|Protective Agents|protective agents|mesh-ancestor
154428492|NCT01380275|Docetaxel|docetaxel|mesh-list
153365912|NCT02229461|Naproxen|naproxen|mesh-list
154428493|NCT01380275|Irinotecan|irinotecan|mesh-list
154428494|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428495|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
154428496|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
154003079|NCT06157541|Pembrolizumab|pembrolizumab|mesh-list
154428497|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
154428498|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428499|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154428500|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154428501|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428502|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
154428503|NCT02171390|Testosterone|testosterone|mesh-list
154428504|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
154428505|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
154428506|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154428507|NCT02171390|Androgens|androgens|mesh-ancestor
154428509|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154428510|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428511|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154428512|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428513|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
154428514|NCT01378481|Vorinostat|vorinostat|mesh-list
154428515|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428516|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154428517|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428518|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428520|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
154428521|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428522|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428523|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428524|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428525|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
154428526|NCT03502031|Losartan|losartan|mesh-list
154428527|NCT03502031|Valsartan|valsartan|mesh-list
154428528|NCT03502031|Enalapril|enalapril|mesh-list
154428529|NCT03502031|Enalaprilat|enalaprilat|mesh-list
154428530|NCT03502031|Lisinopril|lisinopril|mesh-list
154428531|NCT03502031|Perindopril|perindopril|mesh-list
154428532|NCT03502031|Spironolactone|spironolactone|mesh-list
154428533|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154428534|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154428535|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154428536|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428537|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154428538|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154428539|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
154428540|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814991|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428541|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428542|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154428543|NCT03502031|Diuretics|diuretics|mesh-ancestor
154428544|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
154428545|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154428546|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428547|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428548|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154428549|NCT03502031|Protective Agents|protective agents|mesh-ancestor
154428550|NCT02171546|Fexofenadine|fexofenadine|mesh-list
154428551|NCT02171546|Quinidine|quinidine|mesh-list
154428552|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
154428553|NCT02171546|Dabigatran|dabigatran|mesh-list
154428554|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
154428555|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428556|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428557|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428558|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428559|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
154428560|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154428561|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154428562|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154428563|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
154428564|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
154428565|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428566|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428567|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154428568|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154428569|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154428570|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154428571|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
154428572|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154003164|NCT05882604|Mesna|mesna|mesh-list
154428574|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428575|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154428576|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154428577|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428578|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154428579|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154428580|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154428581|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154428582|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154428583|NCT02171624|Quinidine|quinidine|mesh-list
154428584|NCT02171624|Dabigatran|dabigatran|mesh-list
154428585|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
154428586|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428587|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428588|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428589|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428590|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
154428591|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154057159|NCT00642161|Hormones|hormones|mesh-ancestor
154428592|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154428593|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
154428594|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428595|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428596|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154428597|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
154428598|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154428599|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154428600|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428601|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154428602|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154428603|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428604|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154428605|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154428606|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154428607|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154428608|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154428609|NCT03705195|Gliclazide|gliclazide|mesh-list
154428610|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154428611|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428612|NCT00101192|Cetuximab|cetuximab|mesh-list
154428613|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428614|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154428615|NCT03688269|Dexamethasone|dexamethasone|mesh-list
154428616|NCT03688269|Ropivacaine|ropivacaine|mesh-list
154428617|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154428618|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
154428619|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
154428620|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428621|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428622|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154428623|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
154428624|NCT03688269|Hormones|hormones|mesh-ancestor
154428625|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154428626|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154428627|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428628|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
154428629|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
154428630|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428631|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
154428632|NCT03688191|Sirolimus|sirolimus|mesh-list
154428633|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154428634|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428635|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154428636|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428637|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
154428638|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154428639|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
154428640|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428641|NCT02164838|Axitinib|axitinib|mesh-list
154428642|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428643|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154428644|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428645|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428646|NCT02171702|Afatinib|afatinib|mesh-list
154003233|NCT05610969|Midazolam|midazolam|mesh-list
154428647|NCT02171702|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154428648|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154428649|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428650|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428651|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428652|NCT02171780|Olodaterol|olodaterol|mesh-list
154428653|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154428654|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
154428655|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428656|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428657|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154428658|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
154428659|NCT02172014|Midazolam|midazolam|mesh-list
154428660|NCT02172014|Fentanyl|fentanyl|mesh-list
154428661|NCT02172014|Citric Acid|citric acid|mesh-list
154428662|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
154428663|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154428664|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154428665|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428666|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428667|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154428668|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154428669|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154428670|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154428671|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
154428672|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
154428673|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
154428674|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
154428675|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428676|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428677|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154428678|NCT02172014|Narcotics|narcotics|mesh-ancestor
154428679|NCT02172014|Analgesics|analgesics|mesh-ancestor
154428680|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
154428681|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428682|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
154428683|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154428684|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
154428685|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
154428686|NCT02172170|Empagliflozin|empagliflozin|mesh-list
154428687|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154428688|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428689|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154428690|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428691|NCT02255942|Zinc|zinc|mesh-list
154428692|NCT02255942|Iron|iron|mesh-list
154428693|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
154428694|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
154428695|NCT02255942|Trace Elements|trace elements|mesh-ancestor
154428696|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
154428697|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428698|NCT02255942|Astringents|astringents|mesh-ancestor
154428699|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
154428700|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
154428701|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154428702|NCT02255942|Protective Agents|protective agents|mesh-ancestor
154428703|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
154428704|NCT03029247|Hematinics|hematinics|mesh-ancestor
154428705|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
154428706|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154428707|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154428708|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428709|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154428710|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154428711|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428712|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428713|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428714|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154428715|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
154428716|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154428717|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428718|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154428719|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154428720|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154428721|NCT03624309|Docetaxel|docetaxel|mesh-list
154428722|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428723|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731834|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154428724|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
154428725|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
154428726|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428727|NCT03692013|Losartan|losartan|mesh-list
154428728|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154428729|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154428730|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154428731|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154428732|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428733|NCT03695835|Immunomodulating Agents|immunomodulating agents|mesh-list
154428734|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
154428735|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428736|NCT03687255|Tazobactam|tazobactam|mesh-list
154428737|NCT03687255|Piperacillin|piperacillin|mesh-list
154428738|NCT03687255|Cefepime|cefepime|mesh-list
154428739|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154428740|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
154428741|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154428742|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428743|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154428744|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428745|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428746|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
154428747|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154428748|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
154428749|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428750|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
154428751|NCT03691467|Protective Agents|protective agents|mesh-ancestor
154428752|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154428753|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428754|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428755|NCT02165930|Naltrexone|naltrexone|mesh-list
154428756|NCT02165930|Oxycodone|oxycodone|mesh-list
154428757|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154428758|NCT02165930|Narcotics|narcotics|mesh-ancestor
154428759|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428760|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428761|NCT02165930|Analgesics|analgesics|mesh-ancestor
154428762|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
154428763|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428764|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154428765|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154428766|NCT03694977|Spartalizumab|spartalizumab|mesh-list
154428767|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154428768|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428769|NCT03694977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154428770|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428771|NCT02172248|Metformin|metformin|mesh-list
154428772|NCT02172248|Empagliflozin|empagliflozin|mesh-list
154428773|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154428774|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428775|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154428776|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428777|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
154428778|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154428779|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
154428780|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428781|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428782|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154428783|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
154428784|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
154428785|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154428786|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428787|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428788|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428789|NCT02169596|Ticagrelor|ticagrelor|mesh-list
154428790|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154428791|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154428792|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154428793|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154428794|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
154428795|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428796|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428797|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428798|NCT02169752|Ambrisentan|ambrisentan|mesh-list
154428799|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154428800|NCT02172404|Ipratropium|ipratropium|mesh-list
154428801|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154428802|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
154428803|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428804|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428805|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154428806|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
154428807|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154428808|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428809|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428810|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428811|NCT00109538|Lonafarnib|lonafarnib|mesh-list
154428812|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428813|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428814|NCT02172482|Bromides|bromides|mesh-list
154428815|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
154428816|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154428817|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
154428818|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428819|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428820|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154428821|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
154428822|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
154428823|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154428824|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428825|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428826|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428827|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
154428828|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
154428829|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154428830|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
154428831|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428832|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428833|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154428834|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
154428835|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
154428836|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154428837|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428838|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428839|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428840|NCT00106808|Pioglitazone|pioglitazone|mesh-list
154428841|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154428842|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428843|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
154428844|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154428845|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
154428846|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428847|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
154428848|NCT02166554|Protective Agents|protective agents|mesh-ancestor
154428849|NCT03687021|Progesterone|progesterone|mesh-list
154428850|NCT03687021|Progestins|progestins|mesh-ancestor
154428851|NCT03687021|Hormones|hormones|mesh-ancestor
154428852|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154428853|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428854|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
154428855|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154428856|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154428857|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
154428858|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428859|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428860|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154428861|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
154428862|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
154428863|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154428864|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
154428865|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428866|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428867|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153571321|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154428868|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154428869|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154428870|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
154428871|NCT02174900|Lumefantrine|lumefantrine|mesh-list
154428872|NCT02174900|Artemether|artemether|mesh-list
154428873|NCT02174900|Primaquine|primaquine|mesh-list
154428874|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154428876|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154428877|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154428878|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428879|NCT02170610|Pantoprazole|pantoprazole|mesh-list
154428880|NCT02170610|Dabigatran|dabigatran|mesh-list
154428881|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154428882|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154428883|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154428884|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428885|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428886|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
154428887|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428888|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428889|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
154428890|NCT02173106|Cyclosporine|cyclosporine|mesh-list
154428891|NCT02173106|Cyclosporins|cyclosporins|mesh-list
154428892|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428893|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428894|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154428895|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
154428896|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428897|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
154428898|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428899|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
154428900|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428901|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154428902|NCT03932721|Evolocumab|evolocumab|mesh-list
154428903|NCT03932721|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154428904|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154428905|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154428906|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
154255029|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154428907|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428908|NCT03932721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428909|NCT03932721|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428910|NCT03932721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428911|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154428912|NCT00106340|Metformin|metformin|mesh-list
154428913|NCT00106340|Glimepiride|glimepiride|mesh-list
154428914|NCT00106340|Vildagliptin|vildagliptin|mesh-list
154428915|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154428916|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428917|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154428918|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154428919|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
154428920|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154428921|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428922|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428923|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428924|NCT03538496|Bupivacaine|bupivacaine|mesh-list
154428925|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
154428926|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
154428927|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154428928|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428929|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
154428930|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428931|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
154428932|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154428933|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154428934|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428935|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
154428936|NCT03686787|Coagulants|coagulants|mesh-ancestor
154428937|NCT03694587|Ibuprofen|ibuprofen|mesh-list
154428938|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154428939|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154428940|NCT03694587|Analgesics|analgesics|mesh-ancestor
154428941|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
154428942|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428943|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428944|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154428945|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428946|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154003531|NCT04780932|Macitentan|macitentan|mesh-list
154428947|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428948|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428949|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154428950|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154428952|NCT02170766|Dabigatran|dabigatran|mesh-list
154428953|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154428954|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154428955|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154428956|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428957|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428958|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
154428959|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154428960|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
154428961|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
154428962|NCT04156659|Tisagenlecleucel|tisagenlecleucel|mesh-list
154428963|NCT04156659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154428964|NCT04156659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154428965|NCT03694119|Phenelzine|phenelzine|mesh-list
154428966|NCT03694119|Ozanimod|ozanimod|mesh-list
154428967|NCT03694119|Tyramine|tyramine|mesh-list
154428968|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154428969|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428970|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154428971|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
154428972|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428973|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
154428974|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154428975|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154428976|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428977|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
154428978|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
154428979|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154428980|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154428981|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154428982|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154428983|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
154428984|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154428985|NCT02178254|Fosfomycin|fosfomycin|mesh-list
154428986|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154428987|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428988|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
154428989|NCT02173262|Lenograstim|lenograstim|mesh-list
154428990|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154428991|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
154428992|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154428993|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154428994|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154428995|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154428996|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154428997|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154428998|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154428999|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429000|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154429001|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154429002|NCT02173418|Ropivacaine|ropivacaine|mesh-list
154429003|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
154429004|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
154429005|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429006|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429007|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
154429008|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429009|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
154429010|NCT03932331|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154429011|NCT03932331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154429012|NCT03932331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429013|NCT03932331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429014|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429015|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
154429016|NCT02178488|Vitamin D|vitamin d|mesh-list
154429017|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154429018|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429019|NCT02178488|Vitamins|vitamins|mesh-ancestor
154429020|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
154429021|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154429022|NCT02173652|Linagliptin|linagliptin|mesh-list
154429023|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154429024|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429025|NCT02173652|Incretins|incretins|mesh-ancestor
154429026|NCT02173652|Hormones|hormones|mesh-ancestor
154429027|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429028|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154429029|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
154429030|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429031|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429032|NCT02173730|Pantoprazole|pantoprazole|mesh-list
154429033|NCT02173730|Dabigatran|dabigatran|mesh-list
154429034|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154429035|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154429036|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154429037|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429038|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429039|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
154429040|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154429041|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
154429042|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
154429043|NCT02175446|Bevacizumab|bevacizumab|mesh-list
154429044|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154429045|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429046|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154429047|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154429048|NCT02175446|Growth Substances|growth substances|mesh-ancestor
154429049|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429050|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
154429052|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154429053|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
154429054|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429055|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429056|NCT03686163|Mitogens|mitogens|mesh-list
154429057|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154429058|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429059|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
154429060|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
154429061|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154429062|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
154429063|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429064|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429065|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154429066|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154429067|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154429068|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154429069|NCT02173886|Bupropion|bupropion|mesh-list
154429070|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154429071|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
154429072|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154429073|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154429074|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154429075|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429076|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429077|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
154429078|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429079|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429080|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154429081|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154429082|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429083|NCT02173964|Pinaverium|pinaverium|mesh-list
154429084|NCT02173964|Bromides|bromides|mesh-list
154429085|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
154429086|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154429087|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429088|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429089|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154429090|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429091|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
154429092|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
154429093|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429094|NCT02175602|Sertraline|sertraline|mesh-list
154429095|NCT02175602|Escitalopram|escitalopram|mesh-list
154003678|NCT04471727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429096|NCT02175602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154429097|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154429098|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429099|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429101|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
154429102|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429103|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
154429104|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154429105|NCT03686085|Dinoprostone|dinoprostone|mesh-list
154429106|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
154429107|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429108|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429109|NCT03693885|Oxytocin|oxytocin|mesh-list
154429110|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
154429111|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429112|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429113|NCT02174120|Propofol|propofol|mesh-list
154429114|NCT02174120|Etomidate|etomidate|mesh-list
154429115|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154057682|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
154429116|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429117|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429118|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154429119|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
154429120|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
154429121|NCT02175914|Erythromycin|erythromycin|mesh-list
154429122|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
154429123|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154429124|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
154429125|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154429126|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429127|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154429128|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154429129|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429130|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429131|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
154429132|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154429133|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154429134|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429135|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
154429136|NCT02753816|Coagulants|coagulants|mesh-ancestor
154429137|NCT02179034|Menthol|menthol|mesh-list
154429138|NCT02179034|Nicotine|nicotine|mesh-list
154429139|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154429140|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
154429141|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429142|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429143|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154429144|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154429145|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
154429146|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429147|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429148|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
154429149|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
154429150|NCT02174588|Midazolam|midazolam|mesh-list
154429151|NCT02174588|Propofol|propofol|mesh-list
154429152|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154429153|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429154|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429155|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154429156|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
154429157|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
154429158|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154429159|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154429160|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154429161|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154429162|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
154429163|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
154429164|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429165|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429166|NCT03693573|Bevacizumab|bevacizumab|mesh-list
154429167|NCT03693573|Atezolizumab|atezolizumab|mesh-list
154429168|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154429169|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429170|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154003758|NCT04164069|Leucovorin|leucovorin|mesh-list
154429171|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154429172|NCT03693573|Growth Substances|growth substances|mesh-ancestor
154429173|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429174|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
154429175|NCT03693573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154429176|NCT03693573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429177|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154429178|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
154429179|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154429180|NCT02176304|Prednisolone|prednisolone|mesh-list
154429181|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
154429182|NCT02176304|Lidocaine|lidocaine|mesh-list
154429183|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154429184|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
154429185|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
154429186|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
154429187|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429188|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429189|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
154429190|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429191|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154429192|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154429193|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154429194|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429195|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429196|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429197|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
154429198|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
154429199|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154429200|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
154429201|NCT02176304|Hormones|hormones|mesh-ancestor
153814999|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154429202|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429203|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154429204|NCT02176304|Protective Agents|protective agents|mesh-ancestor
154429205|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154429206|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429207|NCT02176460|Colchicine|colchicine|mesh-list
154429208|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
154429209|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429210|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
154429211|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
154429212|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
154429213|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429214|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429215|NCT02256254|Simvastatin|simvastatin|mesh-list
154429216|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154429217|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154429218|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
154429219|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429220|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154429221|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154429222|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429223|NCT02182076|Nintedanib|nintedanib|mesh-list
154429224|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429225|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154429226|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429227|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429228|NCT02179268|Sertraline|sertraline|mesh-list
154429229|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154429230|NCT02179268|Citalopram|citalopram|mesh-list
154429231|NCT02179268|Reboxetine|reboxetine|mesh-list
154429232|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
154429233|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154429234|NCT02179268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154429235|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154429236|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429237|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429238|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429239|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
154429240|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429241|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154429242|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154429243|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154429245|NCT02182154|Nintedanib|nintedanib|mesh-list
154429246|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429247|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154429248|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429249|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429250|NCT02182232|Paclitaxel|paclitaxel|mesh-list
154429251|NCT02182232|Carboplatin|carboplatin|mesh-list
154429252|NCT02182232|Nintedanib|nintedanib|mesh-list
154429253|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154429254|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429255|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
154429256|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
154429257|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
154429258|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429259|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154429260|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429261|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
154429262|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154429263|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429264|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154429265|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154429266|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429267|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429268|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429269|NCT02176850|Telmisartan|telmisartan|mesh-list
154429270|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154429271|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154429272|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154429273|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429274|NCT03537326|Budesonide|budesonide|mesh-list
154429275|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429276|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154429277|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
154429278|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429279|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429280|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154429281|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
154429282|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
154429283|NCT03537326|Hormones|hormones|mesh-ancestor
154429284|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815001|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
153815002|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360229|NCT00809276|Fludarabine|fludarabine|mesh-list
154429285|NCT02182544|Ketotifen|ketotifen|mesh-list
154429286|NCT02182544|Epinastine|epinastine|mesh-list
154429287|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
154429288|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
154429289|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154429290|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
154429291|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
154429292|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429293|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429294|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429295|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154429296|NCT02179658|Vancomycin|vancomycin|mesh-list
154429297|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
154429298|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154429299|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429300|NCT02177318|Bromides|bromides|mesh-list
154429301|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
154429302|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154429303|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
154429304|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429305|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429306|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154429307|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
154429308|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
154429309|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154429310|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
154429311|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429312|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429313|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
154429314|NCT02177396|Valsartan|valsartan|mesh-list
154429315|NCT02177396|Telmisartan|telmisartan|mesh-list
154429316|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154429317|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154429318|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154429319|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429320|NCT02030054|Atorvastatin|atorvastatin|mesh-list
154429321|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154429322|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154429323|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154429324|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
154429325|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429326|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154429327|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154429328|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429329|NCT02182622|Prednisone|prednisone|mesh-list
153815004|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154429330|NCT02182622|Docetaxel|docetaxel|mesh-list
154429331|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429332|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
154429333|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
154429334|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
154429335|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429336|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429337|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
154429338|NCT02182622|Hormones|hormones|mesh-ancestor
154429339|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429340|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429341|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154429342|NCT02182700|Bromides|bromides|mesh-list
154429343|NCT02182700|Albuterol|albuterol|mesh-list
154429344|NCT02182700|Ipratropium|ipratropium|mesh-list
154429345|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
154429346|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154429347|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
154429348|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429349|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429350|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154429351|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
154429352|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
154429353|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429354|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154429355|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154429356|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154429357|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
154429358|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429359|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429360|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154429361|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
154429362|NCT02182778|Cisplatin|cisplatin|mesh-list
154429363|NCT02182778|Gemcitabine|gemcitabine|mesh-list
154429364|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429365|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154429366|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
154429367|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429368|NCT03688971|Ketoconazole|ketoconazole|mesh-list
154429369|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
154429370|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429371|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154429372|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154429373|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429374|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429375|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154429376|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
154429377|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429378|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429379|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154429380|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
154429381|NCT02179814|Promethazine|promethazine|mesh-list
154429382|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154429383|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154429384|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429385|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429386|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
154429387|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
154429388|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
154429389|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429390|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
154429391|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
154429392|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154429394|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
154429395|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
154429396|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429397|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429398|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154429399|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
154429400|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
154429401|NCT02179970|Plerixafor|plerixafor|mesh-list
154429402|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154429403|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154429404|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
154429405|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429406|NCT03537950|Cannabidiol|cannabidiol|mesh-list
154429407|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
153815006|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
154429408|NCT02182856|Bromides|bromides|mesh-list
154429409|NCT02182856|Albuterol|albuterol|mesh-list
154429410|NCT02182856|Ipratropium|ipratropium|mesh-list
154429411|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
154429412|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154429413|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
154429414|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429415|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429416|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154429417|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
154429419|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429420|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154429421|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154429422|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154429423|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
154429424|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429425|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429426|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154429427|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
154429428|NCT02183012|Ibuprofen|ibuprofen|mesh-list
154429429|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154429430|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429431|NCT02183012|Analgesics|analgesics|mesh-ancestor
154429432|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
154429433|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429434|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429435|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429436|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429437|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154429438|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429439|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429440|NCT02180048|Caffeine|caffeine|mesh-list
154429441|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154429442|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429443|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154429444|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429445|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429446|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154429447|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154429448|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
154429449|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429450|NCT03688659|Vancomycin|vancomycin|mesh-list
154429451|NCT03688659|Gentamicins|gentamicins|mesh-list
154429452|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154429453|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429454|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154429455|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429456|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429457|NCT03683043|Leuprolide|leuprolide|mesh-list
154429458|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154429459|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
154429460|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429461|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429462|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154429463|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429464|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154429465|NCT02180204|Tenecteplase|tenecteplase|mesh-list
154429466|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154429467|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154429468|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429469|NCT02183090|Meloxicam|meloxicam|mesh-list
154429470|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154429471|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429472|NCT02183090|Analgesics|analgesics|mesh-ancestor
154429473|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
154429474|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429475|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429476|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429477|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429478|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154429479|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154429480|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429481|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429482|NCT02177552|Carboplatin|carboplatin|mesh-list
154429483|NCT02177552|Docetaxel|docetaxel|mesh-list
154429484|NCT02177552|Capecitabine|capecitabine|mesh-list
154429485|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
154429486|NCT02177552|Epirubicin|epirubicin|mesh-list
154429487|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429488|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
154429489|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
154429491|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429492|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153815008|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
153815009|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429493|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
154429494|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154429495|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154429496|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154429497|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429498|NCT03682653|Azithromycin|azithromycin|mesh-list
154429499|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154429500|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429501|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
154429502|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154429503|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154429504|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429505|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
154429506|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
154429507|NCT04062279|Autoantibodies|autoantibodies|mesh-list
154429508|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
154429509|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429510|NCT02183246|Porfiromycin|porfiromycin|mesh-list
154429511|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154429512|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429513|NCT02183324|Linagliptin|linagliptin|mesh-list
154429514|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154429515|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429516|NCT02183324|Incretins|incretins|mesh-ancestor
154429517|NCT02183324|Hormones|hormones|mesh-ancestor
154429518|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429519|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154429520|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
154429521|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429522|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429523|NCT02183402|Linagliptin|linagliptin|mesh-list
154429524|NCT02183402|Digoxin|digoxin|mesh-list
154429525|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154429526|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154429527|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429528|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429529|NCT02183402|Protective Agents|protective agents|mesh-ancestor
154429530|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429531|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154429532|NCT02183402|Incretins|incretins|mesh-ancestor
154429533|NCT02183402|Hormones|hormones|mesh-ancestor
154429534|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429535|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154429536|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
154429537|NCT02183480|Linagliptin|linagliptin|mesh-list
154429538|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154429539|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429540|NCT02183480|Incretins|incretins|mesh-ancestor
154429541|NCT02183480|Hormones|hormones|mesh-ancestor
154004144|NCT02771093|Alogliptin|alogliptin|mesh-list
154429542|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429543|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154429544|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
154429545|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429546|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429547|NCT05141864|Lidocaine|lidocaine|mesh-list
154429548|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
154429549|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
154429550|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429551|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429552|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
154429553|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429554|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154429555|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154429556|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154429557|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429558|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429559|NCT02180516|Meloxicam|meloxicam|mesh-list
154429560|NCT02180516|Etodolac|etodolac|mesh-list
154429561|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154429562|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154429563|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429565|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
154429566|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429567|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429568|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429569|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154429570|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154429571|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429572|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429573|NCT02183636|Pioglitazone|pioglitazone|mesh-list
154429574|NCT02183636|Linagliptin|linagliptin|mesh-list
154429575|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154429576|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429577|NCT02183636|Incretins|incretins|mesh-ancestor
154429578|NCT02183636|Hormones|hormones|mesh-ancestor
154429579|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429580|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154429581|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
154429582|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429583|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429584|NCT02183948|Oxytocin|oxytocin|mesh-list
154429585|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
154429586|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429587|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429588|NCT02184104|Caffeine|caffeine|mesh-list
154429589|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154429590|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429591|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154429592|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429593|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429594|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154429595|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154429596|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
154429597|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429598|NCT02184260|Dipyrone|dipyrone|mesh-list
154429599|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154429600|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429601|NCT02184260|Analgesics|analgesics|mesh-ancestor
154429602|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
154429603|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815014|NCT00447915|Vitamins|vitamins|mesh-ancestor
154429604|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429605|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429606|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429607|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
154429608|NCT03684837|Vitamin D|vitamin d|mesh-list
154429609|NCT03684837|Vitamins|vitamins|mesh-ancestor
154429610|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
154429611|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429612|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154429613|NCT03808155|Tamsulosin|tamsulosin|mesh-list
154429614|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154429615|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154429616|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154429617|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
154429618|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429619|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429620|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429621|NCT03808155|Urological Agents|urological agents|mesh-ancestor
154429622|NCT02752958|Fluorides|fluorides|mesh-list
154429623|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
154429624|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
154429625|NCT02752958|Protective Agents|protective agents|mesh-ancestor
154429626|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429627|NCT02181218|Dexamethasone|dexamethasone|mesh-list
154429628|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
154429629|NCT02181218|Gemcitabine|gemcitabine|mesh-list
154429630|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
154429631|NCT02181218|Romidepsin|romidepsin|mesh-list
154429632|NCT02181218|BB 1101|bb 1101|mesh-list
154429633|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429634|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
154429635|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
154429636|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429637|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058203|NCT00648869|Metformin|metformin|mesh-list
154429638|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154429639|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
154429640|NCT02181218|Hormones|hormones|mesh-ancestor
154429641|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429642|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154429643|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429644|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
154429645|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429646|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429647|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154429648|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
153577500|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429649|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154429650|NCT02181218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154429651|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154429652|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
154429653|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154429654|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
154429655|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429656|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429657|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154429658|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154429659|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429660|NCT03682497|Spironolactone|spironolactone|mesh-list
154429661|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154429662|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
154429663|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429664|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429665|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154429666|NCT03682497|Diuretics|diuretics|mesh-ancestor
154429667|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
154429668|NCT02185898|Menthol|menthol|mesh-list
154429669|NCT02185898|Nicotine|nicotine|mesh-list
154429670|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154429671|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
154429672|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429673|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429674|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154429675|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154429676|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
154429677|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429678|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429679|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
154429680|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
154429681|NCT02805660|Durvalumab|durvalumab|mesh-list
154429682|NCT02805660|Mocetinostat|mocetinostat|mesh-list
154429683|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154429684|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429685|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154429686|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429687|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429688|NCT02186132|Atropine|atropine|mesh-list
154429689|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154429690|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154429691|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154004260|NCT00587717|Simvastatin|simvastatin|mesh-list
154429692|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
154429693|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429694|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429695|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154429696|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
154429697|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
154429698|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
154429699|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154429700|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154429701|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
154429702|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429703|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429704|NCT03536780|Gemcitabine|gemcitabine|mesh-list
154429705|NCT03536780|Avelumab|avelumab|mesh-list
154429706|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154429707|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
154429708|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429709|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429710|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154429711|NCT02052336|Clarithromycin|clarithromycin|mesh-list
154429712|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154429713|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154429714|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154429715|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429716|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429717|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154429718|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154429719|NCT02181920|Dipyrone|dipyrone|mesh-list
154429720|NCT02181920|Diclofenac|diclofenac|mesh-list
154429721|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154429722|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429723|NCT02181920|Analgesics|analgesics|mesh-ancestor
154429724|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
154429725|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429726|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429727|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429728|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429729|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154429730|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429731|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429732|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
154429733|NCT02185118|Sevoflurane|sevoflurane|mesh-list
154429734|NCT02185118|Isoflurane|isoflurane|mesh-list
154429735|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154429736|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154429737|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
154429738|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
154429739|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429740|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429741|NCT02186366|Buspirone|buspirone|mesh-list
154429742|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154429743|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154429744|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429745|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429746|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154429747|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154429748|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
154429749|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429750|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429751|NCT02053974|Spironolactone|spironolactone|mesh-list
154429752|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154429753|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
154429754|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154429755|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429756|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154429757|NCT02053974|Diuretics|diuretics|mesh-ancestor
154429758|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
154429759|NCT02185196|Vitamin D|vitamin d|mesh-list
154429760|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
154429761|NCT02185196|Vitamins|vitamins|mesh-ancestor
154429762|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
154429763|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429764|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154429765|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154429766|NCT02052492|Vitamin D|vitamin d|mesh-list
154429767|NCT02052492|Vitamins|vitamins|mesh-ancestor
154429768|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
154429769|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429770|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154429771|NCT02181998|Heparin|heparin|mesh-list
154429772|NCT02181998|Enoxaparin|enoxaparin|mesh-list
154429773|NCT02181998|Tenecteplase|tenecteplase|mesh-list
154429774|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
154429775|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154429776|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154429777|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429778|NCT02054052|Bevacizumab|bevacizumab|mesh-list
154429779|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154429780|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429781|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154429782|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154429783|NCT02054052|Growth Substances|growth substances|mesh-ancestor
154429784|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429785|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
154429786|NCT02185352|Cisplatin|cisplatin|mesh-list
154429787|NCT02185352|Etoposide|etoposide|mesh-list
154429788|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429789|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154429790|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154429791|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154429792|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429793|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429794|NCT02052726|Vaccines|vaccines|mesh-list
154429795|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
154429796|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429797|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
154429798|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154429799|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429800|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429801|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429802|NCT02185430|Analgesics|analgesics|mesh-ancestor
154429803|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
154429804|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429805|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154429806|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154429807|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154429808|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
154429809|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429810|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429811|NCT03536390|Methylphenidate|methylphenidate|mesh-list
154429812|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154429813|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429814|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154429815|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154429816|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429817|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429818|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
154429819|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429820|NCT03561870|Olaparib|olaparib|mesh-list
154429821|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154429822|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429823|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429824|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429825|NCT02186990|Propofol|propofol|mesh-list
154429826|NCT02186990|Etomidate|etomidate|mesh-list
154429827|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154429828|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429829|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429830|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154429831|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
154429832|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
154429833|NCT05657028|Lidocaine|lidocaine|mesh-list
154429834|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
154429835|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
154429836|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
154429837|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429838|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429839|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
154429840|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429841|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154429842|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154429843|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154429844|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429845|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429846|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154429847|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429848|NCT05657028|Analgesics|analgesics|mesh-ancestor
154429849|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154429850|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154429851|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154429852|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
154429853|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429854|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
154429855|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154429856|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429857|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429858|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429859|NCT02187068|Analgesics|analgesics|mesh-ancestor
154429860|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
154429861|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429862|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154429863|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154429864|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154429865|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
154429866|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429867|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429868|NCT02054442|Methotrexate|methotrexate|mesh-list
154429869|NCT02054442|Cetuximab|cetuximab|mesh-list
154429870|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154429871|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
154429872|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154429873|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429874|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154429875|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
154429876|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429877|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429878|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
154429879|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429880|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154429881|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154429882|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
154429883|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429884|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154429885|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154429886|NCT02054676|Ibuprofen|ibuprofen|mesh-list
154429887|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154429888|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429889|NCT02054676|Analgesics|analgesics|mesh-ancestor
154429890|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
154429891|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429892|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429893|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429894|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429895|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154429896|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429897|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429898|NCT02256956|Amitriptyline|amitriptyline|mesh-list
154429899|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154429900|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154429901|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
154429902|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154429903|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429904|NCT02256956|Analgesics|analgesics|mesh-ancestor
154429905|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
154429906|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429907|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429908|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154429909|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154429910|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429911|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429912|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
154429913|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429914|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154429915|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154429916|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
154429917|NCT02256956|Urological Agents|urological agents|mesh-ancestor
154429919|NCT02187536|Simvastatin|simvastatin|mesh-list
154429920|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154429921|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154429922|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
154429923|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429924|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154429925|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154429926|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429927|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154429928|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154429929|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154429930|NCT02256722|Propranolol|propranolol|mesh-list
154429931|NCT02256722|Bisoprolol|bisoprolol|mesh-list
154429932|NCT02256722|Acipimox|acipimox|mesh-list
154429933|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154429935|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
154429936|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429937|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429938|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154429939|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
154429940|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154429941|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154429942|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154429943|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
154429944|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429945|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429946|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154429947|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154429948|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154429949|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154429950|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
154429951|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
154429952|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154429953|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154429954|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
154429955|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154429956|NCT02187614|Acetaminophen|acetaminophen|mesh-list
154429957|NCT02187614|Diclofenac|diclofenac|mesh-list
154429958|NCT02187614|Morphine|morphine|mesh-list
154429959|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154429960|NCT02187614|Narcotics|narcotics|mesh-ancestor
154429961|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154429962|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429963|NCT02187614|Analgesics|analgesics|mesh-ancestor
154429964|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
154429965|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154429966|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154429967|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
154429968|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154429969|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154429970|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154429971|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154429972|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973752|NCT06247995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429973|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429974|NCT02030678|Irinotecan|irinotecan|mesh-list
154429975|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154429976|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154429977|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429978|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429979|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154429980|NCT02054988|Caffeine|caffeine|mesh-list
154429981|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154429982|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429983|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154429984|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154429985|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429986|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154429987|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154429988|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
154429989|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429990|NCT02191124|Mirtazapine|mirtazapine|mesh-list
154429991|NCT02191124|Paroxetine|paroxetine|mesh-list
154429992|NCT02191124|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154429993|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154429994|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154429995|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154429996|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154429997|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
154429998|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154429999|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154430000|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
154430001|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154430002|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154430003|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154430004|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430005|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154430006|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
154430007|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
154430008|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154430009|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154430010|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430011|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154430012|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154430013|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154430014|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
154430015|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154430016|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154430017|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154430018|NCT02193698|Dexamethasone|dexamethasone|mesh-list
154430019|NCT02193698|Lenalidomide|lenalidomide|mesh-list
154430020|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430021|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
154430022|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
154430023|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430024|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430025|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154430026|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
154430027|NCT02193698|Hormones|hormones|mesh-ancestor
153782037|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154430028|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430029|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154430030|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430031|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
154430032|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154430033|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154430034|NCT02193698|Growth Substances|growth substances|mesh-ancestor
154430035|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
154430036|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154430037|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154430038|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430039|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430040|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
154430041|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430042|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154430043|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154430044|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154430045|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154430046|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430047|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430048|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430049|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
154430050|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154430051|NCT02191280|Quercetin|quercetin|mesh-list
154430052|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
154430053|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430054|NCT02191280|Protective Agents|protective agents|mesh-ancestor
154430055|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430056|NCT02055378|Atropine|atropine|mesh-list
154430057|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154430058|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154430059|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154430060|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
154430061|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430062|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430063|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154430064|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
154430065|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
154430066|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
154430067|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154430068|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154430069|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
154430070|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430071|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430072|NCT04558190|Ubiquinone|ubiquinone|mesh-list
154430073|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154430074|NCT04558190|Albuterol|albuterol|mesh-list
154430075|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154430076|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
154430077|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430078|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973753|NCT06247956|Paclitaxel|paclitaxel|mesh-list
153782038|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154430079|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154430080|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
154430081|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
154430082|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154430083|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154430084|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154430085|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154430086|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
154430087|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430088|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430089|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154430090|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154430091|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154430092|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
154430093|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154430094|NCT03676959|Antibodies|antibodies|mesh-list
154430095|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
154430096|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154430097|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
154430098|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430099|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430100|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154430101|NCT03755973|Hormones|hormones|mesh-ancestor
154430102|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430103|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430104|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154430105|NCT02056938|Basiliximab|basiliximab|mesh-list
154430106|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
154430107|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430108|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154430109|NCT02191670|Tenecteplase|tenecteplase|mesh-list
154430110|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154430111|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154430112|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430113|NCT02057094|Caseins|caseins|mesh-list
154430114|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
154430115|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
154430116|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430117|NCT02917941|Dexamethasone|dexamethasone|mesh-list
154430118|NCT02917941|Lenalidomide|lenalidomide|mesh-list
154430119|NCT02917941|Ixazomib|ixazomib|mesh-list
154430120|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430121|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
154430122|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
154430123|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430124|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430125|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154430126|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
154430127|NCT02917941|Hormones|hormones|mesh-ancestor
154430128|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430129|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154430130|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430131|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
154430132|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154004714|NCT02937116|Etoposide|etoposide|mesh-list
154430133|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154430134|NCT02917941|Growth Substances|growth substances|mesh-ancestor
154430135|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
154430136|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
154430137|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430138|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430139|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
154430140|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154430141|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430142|NCT02191748|Triamcinolone|triamcinolone|mesh-list
154430143|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430144|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
154430145|NCT02191748|Hormones|hormones|mesh-ancestor
154430146|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430147|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430148|NCT02191826|Tolcapone|tolcapone|mesh-list
154430149|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154430150|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154430151|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154430152|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430153|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430155|NCT01333956|Analgesics|analgesics|mesh-ancestor
154430156|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
154430157|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430158|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430159|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
154430160|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154430161|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154430162|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430163|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154430164|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154430165|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154430166|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430167|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154430168|NCT02055924|Ibrutinib|ibrutinib|mesh-list
154430169|NCT02055924|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154430170|NCT02055924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154430171|NCT02055924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430172|NCT02055924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430173|NCT02057328|Telmisartan|telmisartan|mesh-list
154430174|NCT02057328|Nebivolol|nebivolol|mesh-list
154430175|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154430176|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154430177|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154430178|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430179|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
154430180|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154430181|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154430182|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154430183|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
154430184|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430185|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430186|NCT02057484|Tacrolimus|tacrolimus|mesh-list
154430187|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154430188|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
154430189|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430190|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154430191|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430192|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430193|NCT02192060|Triclosan|triclosan|mesh-list
154430194|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154430195|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430196|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154430197|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154430198|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
154430199|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430200|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154430201|NCT02188394|Bupivacaine|bupivacaine|mesh-list
154430202|NCT02188394|Anesthetics|anesthetics|mesh-list
154430203|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
154430204|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430205|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430207|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430208|NCT01333722|Acetaminophen|acetaminophen|mesh-list
154430209|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153782047|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154430210|NCT01333722|Hydrocodone|hydrocodone|mesh-list
154430211|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154430212|NCT01333722|Analgesics|analgesics|mesh-ancestor
154430213|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
154430214|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430215|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430216|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
154430217|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154430218|NCT01333722|Narcotics|narcotics|mesh-ancestor
154430219|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430220|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
154430221|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
154430222|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154430223|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430224|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154430225|NCT02188472|Trimethoprim|trimethoprim|mesh-list
154430226|NCT02188472|Penicillins|penicillins|mesh-list
154430227|NCT02188472|Penicillin V|penicillin v|mesh-list
154430228|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154430229|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430230|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
154430231|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154430232|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154430233|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154430234|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430235|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430236|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154430237|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154430238|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154430239|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430240|NCT02188550|Everolimus|everolimus|mesh-list
154430241|NCT02188550|Letrozole|letrozole|mesh-list
154430242|NCT02188550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154430243|NCT02188550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154430244|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430245|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430246|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154430247|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
154430248|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430249|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430250|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154430251|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153571322|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430252|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154430253|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
154430254|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430255|NCT02059590|Isavuconazole|isavuconazole|mesh-list
154430256|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
154430257|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430258|NCT02192294|Bosutinib|bosutinib|mesh-list
154430259|NCT02192294|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154430260|NCT02192294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154430261|NCT02192294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430262|NCT02192294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430263|NCT02057796|Efavirenz|efavirenz|mesh-list
154430264|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154430265|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154430266|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154430267|NCT02057796|Rifampin|rifampin|mesh-list
154430268|NCT02057796|Isoniazid|isoniazid|mesh-list
154430269|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
154430270|NCT02057796|Ethambutol|ethambutol|mesh-list
154430271|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154430272|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154430273|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430274|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430275|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
154430276|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430277|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154004863|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430278|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154430279|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154430280|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154430281|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154430282|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154430283|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153782056|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
153782057|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
153782058|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782059|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782060|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153782061|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153782062|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430284|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154430285|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154430286|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
154430287|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430288|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
154430289|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154430290|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154430291|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154430292|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154430293|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154430294|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
154430295|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154430297|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154430298|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
154430299|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
154430300|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154430301|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154430302|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430303|NCT03560856|Fulvestrant|fulvestrant|mesh-list
154430304|NCT03560856|Palbociclib|palbociclib|mesh-list
154430305|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154430306|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430307|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154430308|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154430309|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
154430310|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430311|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430312|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154430313|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430314|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430315|NCT03676413|Fluticasone|fluticasone|mesh-list
154430316|NCT03676413|Xhance|xhance|mesh-list
154430317|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154430318|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154430319|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430320|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154430321|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
154430322|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430323|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430324|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154430325|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
154430326|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
154430327|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154430328|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154430329|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154430330|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154430331|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
154430332|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430333|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430334|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
154430335|NCT03676413|Hormones|hormones|mesh-ancestor
154430336|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430337|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
154430338|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154430339|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154430340|NCT01370694|Prednisolone|prednisolone|mesh-list
154430341|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
154430342|NCT01370694|Vincristine|vincristine|mesh-list
154430343|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154430344|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
154430345|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430346|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154430347|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154430348|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
154430349|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004936|NCT02543671|Vitamin D|vitamin d|mesh-list
154430350|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430351|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154430352|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154430353|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
154430354|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
154430355|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
154430356|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430357|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
154430358|NCT01370694|Hormones|hormones|mesh-ancestor
154430359|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430360|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154430361|NCT02256878|Amitriptyline|amitriptyline|mesh-list
154430362|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154430363|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
154430364|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154430365|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154430366|NCT02256878|Analgesics|analgesics|mesh-ancestor
154430367|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
154430368|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430369|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430370|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153782065|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
154430371|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154430372|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154430373|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430374|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
154430375|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430376|NCT02058186|Vitamin D|vitamin d|mesh-list
154430377|NCT02058186|Vitamins|vitamins|mesh-ancestor
154430378|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
154430379|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430380|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154430381|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
154430382|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154430383|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154430384|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430385|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
154430386|NCT03676023|Coagulants|coagulants|mesh-ancestor
154430387|NCT02260206|Colchicine|colchicine|mesh-list
154430388|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
154430389|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154430390|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
154430391|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
154430392|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
154430393|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430394|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430395|NCT02058576|Tamsulosin|tamsulosin|mesh-list
154430396|NCT02058576|Dutasteride|dutasteride|mesh-list
154430397|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154430398|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154430399|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154430400|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
154430401|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430402|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430403|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430404|NCT02058576|Urological Agents|urological agents|mesh-ancestor
154430405|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154430406|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154430407|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430408|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
154430409|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430410|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154430411|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
154430412|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
154430413|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430414|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430415|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154430416|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154430417|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154430418|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
154430419|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430420|NCT03675555|Dexamethasone|dexamethasone|mesh-list
154430421|NCT03675555|Mirtazapine|mirtazapine|mesh-list
154430422|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154430423|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430424|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
154430425|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
154430426|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430427|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430428|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154430429|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
154430430|NCT03675555|Hormones|hormones|mesh-ancestor
154430431|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430432|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154430433|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430434|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
154430435|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154430436|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154430437|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
154430438|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
154430439|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430440|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430441|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154430442|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154430443|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430444|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154430445|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154430446|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154430447|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
154430448|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154430449|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154430450|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
154430451|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154430453|NCT02194166|Docetaxel|docetaxel|mesh-list
154430454|NCT02194166|Trastuzumab|trastuzumab|mesh-list
154430455|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154430456|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430457|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
154430458|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
154430459|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
154430460|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430461|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154430462|NCT02194322|Olcegepant|olcegepant|mesh-list
154430463|NCT02194322|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154430464|NCT02194322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430465|NCT02194322|Analgesics|analgesics|mesh-ancestor
154430466|NCT02194322|Sensory System Agents|sensory system agents|mesh-ancestor
154430467|NCT02194322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430468|NCT02194322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430469|NCT02193308|Amlodipine|amlodipine|mesh-list
154430470|NCT02193308|Telmisartan|telmisartan|mesh-list
154430471|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154430472|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154430473|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154430474|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154430475|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430476|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154430477|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430478|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
154430479|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154430480|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154430481|NCT02060604|Ketorolac|ketorolac|mesh-list
154430482|NCT02060604|Ranibizumab|ranibizumab|mesh-list
154430483|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154430484|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154430485|NCT02060604|Growth Substances|growth substances|mesh-ancestor
154430486|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430487|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
154430488|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430489|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154430490|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154430491|NCT02060604|Analgesics|analgesics|mesh-ancestor
154430492|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
154430493|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430494|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430495|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154430496|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154005120|NCT02842814|Hormones|hormones|mesh-ancestor
154430497|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430498|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430499|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
154430500|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154430501|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430502|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154430503|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154430504|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430505|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154430506|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430507|NCT02194556|Gemcitabine|gemcitabine|mesh-list
154430508|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154430509|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
154430510|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430511|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430512|NCT02030912|Amoxicillin|amoxicillin|mesh-list
154430513|NCT02030912|Minocycline|minocycline|mesh-list
154430514|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430515|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430517|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154430518|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430519|NCT02797080|Interferons|interferons|mesh-list
154430520|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
154430521|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430522|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
154430523|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430524|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
154430525|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154430526|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
154430527|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430528|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430529|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154430530|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
154430531|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
154430532|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154430533|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
154430534|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430535|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430536|NCT02915835|Riociguat|riociguat|mesh-list
154430537|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
154430538|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430539|NCT01370616|Amoxicillin|amoxicillin|mesh-list
154430540|NCT01370616|Tazobactam|tazobactam|mesh-list
154430541|NCT01370616|Piperacillin|piperacillin|mesh-list
154430542|NCT01370616|Ertapenem|ertapenem|mesh-list
154430543|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154430544|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430545|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430546|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153782074|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
153815022|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430547|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430548|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430549|NCT02688881|Sirolimus|sirolimus|mesh-list
154430550|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430551|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430552|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154430553|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430554|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
154430555|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154430556|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
154430557|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430558|NCT02197286|Vitamin D|vitamin d|mesh-list
154430559|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
154430560|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
154430561|NCT02197286|Vitamins|vitamins|mesh-list
154430562|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
154430563|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430564|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154430565|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154430566|NCT02197442|Valsartan|valsartan|mesh-list
154430567|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154430568|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154430569|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154005157|NCT04273529|Thalidomide|thalidomide|mesh-list
154430570|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430571|NCT03534674|Vitamin D|vitamin d|mesh-list
154430572|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
154430573|NCT03534674|Vitamins|vitamins|mesh-ancestor
154430574|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
154430575|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430576|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154430577|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154430578|NCT02063334|Vitamin D|vitamin d|mesh-list
154430579|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
154430580|NCT02063334|Vitamins|vitamins|mesh-ancestor
154430581|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
154430582|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430583|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154430584|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154430585|NCT02916927|Ketamine|ketamine|mesh-list
154430586|NCT02916927|Analgesics|analgesics|mesh-ancestor
154430587|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
154430588|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430589|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430590|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154430591|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154430592|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
154430593|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
154430594|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430595|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154430596|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154430597|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430598|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430599|NCT02197598|Nalmefene|nalmefene|mesh-list
154430600|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154430601|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430602|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
154430603|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430604|NCT02196662|Mesalamine|mesalamine|mesh-list
154430605|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154430606|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154430607|NCT02196662|Analgesics|analgesics|mesh-ancestor
154430608|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
154430609|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430610|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430611|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430612|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154430613|NCT02195180|Leucovorin|leucovorin|mesh-list
154430614|NCT02195180|Gemcitabine|gemcitabine|mesh-list
154430615|NCT02195180|Fluorouracil|fluorouracil|mesh-list
154430616|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
154430617|NCT02195180|Asparaginase|asparaginase|mesh-list
154430618|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154430619|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
154430620|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430621|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430622|NCT02195180|Antidotes|antidotes|mesh-ancestor
154430623|NCT02195180|Protective Agents|protective agents|mesh-ancestor
154430624|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430625|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
154430626|NCT02195180|Vitamins|vitamins|mesh-ancestor
154430627|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
154430628|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154430629|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
154430630|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
154430631|NCT03623529|Giapreza|giapreza|mesh-list
154430632|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
154430633|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154430634|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154430635|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
154430636|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430637|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430638|NCT02197676|Guadecitabine|guadecitabine|mesh-list
154430639|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430640|NCT02916693|Mirabegron|mirabegron|mesh-list
154430641|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154430642|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154430643|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154430644|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154005230|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154430645|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430646|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430647|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430648|NCT02916693|Urological Agents|urological agents|mesh-ancestor
154430649|NCT02195336|Paclitaxel|paclitaxel|mesh-list
154430650|NCT02195336|Bevacizumab|bevacizumab|mesh-list
154430651|NCT02195336|Carboplatin|carboplatin|mesh-list
154430652|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154430653|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430654|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154430655|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154430656|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154430657|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430658|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154430659|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154430660|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154430661|NCT02195336|Growth Substances|growth substances|mesh-ancestor
154430662|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430663|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
154430664|NCT03679065|Acetaminophen|acetaminophen|mesh-list
154430665|NCT03679065|Dexamethasone|dexamethasone|mesh-list
154430666|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
154430667|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154430668|NCT03679065|BB 1101|bb 1101|mesh-list
154430669|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430670|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
154430671|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
154430672|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430673|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430674|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154430675|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
154430676|NCT03679065|Hormones|hormones|mesh-ancestor
154430677|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430678|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154430679|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430680|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
154430681|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430682|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430683|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154430684|NCT03679065|Analgesics|analgesics|mesh-ancestor
154430685|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
154430686|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
154430687|NCT02196740|Metronidazole|metronidazole|mesh-list
154430688|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
154430689|NCT02196740|Clindamycin|clindamycin|mesh-list
154430690|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
154430691|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
154430692|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
154430693|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430694|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430695|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154430696|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154430697|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154430698|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154430699|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430700|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430701|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430702|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154430703|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154430704|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154430705|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154430706|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154430708|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
154430709|NCT02195492|Protective Agents|protective agents|mesh-ancestor
154430710|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430711|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
154430712|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154430713|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430714|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154430715|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
154430716|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430717|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430718|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430719|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430720|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
154430721|NCT02919345|Glyburide|glyburide|mesh-list
154430722|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154430723|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430724|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154430725|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430727|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154430728|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154430729|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154430730|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154430731|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
154430732|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
154430733|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430734|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430735|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430736|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
154430737|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
154430738|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
154430739|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430740|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430741|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
154430742|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430743|NCT03674463|Immunomodulating Agents|immunomodulating agents|mesh-list
154430744|NCT03674463|Immunologic Factors|immunologic factors|mesh-ancestor
154430745|NCT03674463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430746|NCT03674385|Vitamin E|vitamin e|mesh-list
154430747|NCT03674385|Metformin|metformin|mesh-list
154430748|NCT03674385|Clomiphene|clomiphene|mesh-list
154430749|NCT03674385|Enclomiphene|enclomiphene|mesh-list
154430750|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
154430751|NCT03674385|Vitamins|vitamins|mesh-ancestor
154430752|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
154430753|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430754|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154430755|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430756|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
154430757|NCT03674385|Protective Agents|protective agents|mesh-ancestor
154430758|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154430759|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
154430760|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430761|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154430762|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
154430763|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154430764|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154430765|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154430766|NCT02574455|Gemcitabine|gemcitabine|mesh-list
154430767|NCT02574455|Capecitabine|capecitabine|mesh-list
154430768|NCT02574455|Vinorelbine|vinorelbine|mesh-list
154430769|NCT02574455|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154430770|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154430771|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
154430772|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430773|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430774|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154430775|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
154430776|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
154430777|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
154430778|NCT02574455|Immunoconjugates|immunoconjugates|mesh-ancestor
154430779|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
154430780|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430781|NCT02197988|Fentanyl|fentanyl|mesh-list
154430782|NCT02197988|Bupivacaine|bupivacaine|mesh-list
154430783|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
154430784|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
154430785|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430786|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430787|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
154430788|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430789|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154430790|NCT02197988|Narcotics|narcotics|mesh-ancestor
154430791|NCT02197988|Analgesics|analgesics|mesh-ancestor
154430792|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154430793|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154430794|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
154430795|NCT03672357|Liver Extracts|liver extracts|mesh-list
154430796|NCT03672357|Hematinics|hematinics|mesh-ancestor
154430797|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154430798|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
154430799|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430800|NCT03674073|Vaccines|vaccines|mesh-list
154430801|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
154430802|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430803|NCT03673995|Inositol|inositol|mesh-list
154430804|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
154430805|NCT03673995|Vitamins|vitamins|mesh-ancestor
154430806|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
154430807|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430808|NCT01378091|Prednisone|prednisone|mesh-list
154430809|NCT01378091|Docetaxel|docetaxel|mesh-list
154430810|NCT01378091|Lenalidomide|lenalidomide|mesh-list
154430811|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430812|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
154430813|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
154430814|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
154430815|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430816|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430817|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
154430818|NCT01378091|Hormones|hormones|mesh-ancestor
154430819|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154430820|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154254749|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
154430821|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154430822|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
154430823|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154430824|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154430825|NCT01378091|Growth Substances|growth substances|mesh-ancestor
154430826|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
154430827|NCT02794974|Anesthetics|anesthetics|mesh-list
154430828|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430829|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430830|NCT02063568|Oxytocin|oxytocin|mesh-list
153782091|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153782092|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153360233|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154430831|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
154430832|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154430833|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430834|NCT02257502|Aflibercept|aflibercept|mesh-list
154430835|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154430836|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154430837|NCT02257502|Growth Substances|growth substances|mesh-ancestor
154430838|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430839|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
154430840|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430841|NCT02450123|Sunitinib|sunitinib|mesh-list
154430842|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430843|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154430844|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154430845|NCT02450123|Growth Substances|growth substances|mesh-ancestor
154430846|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430847|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
154430848|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154430849|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430850|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430851|NCT02063802|Metformin|metformin|mesh-list
154430852|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154430853|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430854|NCT03672045|Carbetocin|carbetocin|mesh-list
154430855|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
154430856|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154430857|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430858|NCT02198300|Clopidogrel|clopidogrel|mesh-list
154430859|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154430860|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154430861|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154430862|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154430863|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
154430864|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154430865|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430866|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430867|NCT03560232|Clindamycin|clindamycin|mesh-list
154430868|NCT03560232|Gentamicins|gentamicins|mesh-list
154430869|NCT03560232|Cefazolin|cefazolin|mesh-list
154430870|NCT03560232|Tazobactam|tazobactam|mesh-list
154430871|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
154430872|NCT03560232|Piperacillin|piperacillin|mesh-list
154430873|NCT03560232|Ampicillin|ampicillin|mesh-list
154430874|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154430875|NCT03560232|Sulbactam|sulbactam|mesh-list
154430876|NCT03560232|Sultamicillin|sultamicillin|mesh-list
154430877|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430878|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430879|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154430880|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430881|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430882|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154430883|NCT03560232|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154430884|NCT03560232|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154430885|NCT02201342|Udenafil|udenafil|mesh-list
154430886|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154430887|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154430888|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430889|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430890|NCT02201576|Bortezomib|bortezomib|mesh-list
154430891|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
154430892|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154430893|NCT02201576|Antibodies|antibodies|mesh-list
154430894|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
154430895|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154430896|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430897|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
154430898|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430899|NCT02198378|Acetaminophen|acetaminophen|mesh-list
154430900|NCT02198378|Morphine|morphine|mesh-list
154430901|NCT02198378|Entonox|entonox|mesh-list
154430902|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154430903|NCT02198378|Narcotics|narcotics|mesh-ancestor
154430904|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430905|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430906|NCT02198378|Analgesics|analgesics|mesh-ancestor
154430907|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
154430908|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430909|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154430910|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
154430911|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154430912|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
154430913|NCT02063100|Losartan|losartan|mesh-list
154430914|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154430915|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154430916|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154430917|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154430918|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430919|NCT02198846|Insulin|insulin|mesh-list
154430920|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154430921|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430922|NCT02198924|Celecoxib|celecoxib|mesh-list
154430923|NCT02198924|Parecoxib|parecoxib|mesh-list
154430924|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154430925|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154430926|NCT02198924|Analgesics|analgesics|mesh-ancestor
154430927|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
154430928|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430929|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430930|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430931|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154430932|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154430933|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154430934|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430935|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430936|NCT05462093|Liver Extracts|liver extracts|mesh-list
154430937|NCT05462093|Hematinics|hematinics|mesh-ancestor
154430938|NCT02064348|Semaglutide|semaglutide|mesh-list
154430939|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
154430940|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154430941|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154430942|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154430943|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154430944|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154430945|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430946|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430947|NCT02064348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430948|NCT02064348|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154430949|NCT02064348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154005531|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430950|NCT02202200|Palbociclib|palbociclib|mesh-list
154430951|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430952|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154430954|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430955|NCT02064504|Fluticasone|fluticasone|mesh-list
154430956|NCT02064504|Xhance|xhance|mesh-list
154430957|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154430958|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154430959|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
154430960|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430961|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430962|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154430963|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
154430964|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
154430965|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154430966|NCT02067936|Remifentanil|remifentanil|mesh-list
154430967|NCT02067936|Propofol|propofol|mesh-list
154430968|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154430969|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430970|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430971|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154430972|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
154430973|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
154430974|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154430975|NCT02067936|Narcotics|narcotics|mesh-ancestor
154430976|NCT02067936|Analgesics|analgesics|mesh-ancestor
154430977|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
154430978|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430979|NCT01377545|Anesthetics|anesthetics|mesh-list
154430980|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
154430981|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154430982|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154430983|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
154430984|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154430985|NCT01379807|Docetaxel|docetaxel|mesh-list
154430986|NCT01379807|Panitumumab|panitumumab|mesh-list
154430987|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154430988|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
154430989|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
154430990|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
154430991|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154430992|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154430993|NCT02202512|Naproxen|naproxen|mesh-list
154430994|NCT02202512|Cimetidine|cimetidine|mesh-list
154430995|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154430996|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154430997|NCT02202512|Analgesics|analgesics|mesh-ancestor
154430998|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
154430999|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431000|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431001|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154431002|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154431003|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
154431004|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154431005|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431006|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431007|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154431008|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154431009|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154431010|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
154431011|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
154431012|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431013|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153782104|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387568|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154431014|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154431015|NCT02065752|Metformin|metformin|mesh-list
154431016|NCT02065752|Canagliflozin|canagliflozin|mesh-list
154431017|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431018|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431019|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154431020|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431021|NCT02206490|Naltrexone|naltrexone|mesh-list
154431022|NCT02206490|Levomethorphan|levomethorphan|mesh-list
154431023|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
154005607|NCT02767674|Epirubicin|epirubicin|mesh-list
154431024|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154431025|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154431026|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431027|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
154431028|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431029|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
154431030|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
154431031|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154431032|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154431033|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431034|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431035|NCT02206490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154431037|NCT02206490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431038|NCT02206490|Analgesics|analgesics|mesh-ancestor
154431039|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
154431040|NCT02068170|Azithromycin|azithromycin|mesh-list
154431041|NCT02068170|Clarithromycin|clarithromycin|mesh-list
154431042|NCT02068170|Levofloxacin|levofloxacin|mesh-list
154431043|NCT02068170|Erythromycin|erythromycin|mesh-list
154431044|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
154431045|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154431046|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
154431047|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154431048|NCT02068170|Itraconazole|itraconazole|mesh-list
154431049|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154431051|NCT02068170|Ketoconazole|ketoconazole|mesh-list
154431052|NCT02068170|Voriconazole|voriconazole|mesh-list
154431053|NCT02068170|Sunitinib|sunitinib|mesh-list
154431054|NCT02068170|Methadone|methadone|mesh-list
154431055|NCT02068170|Haloperidol|haloperidol|mesh-list
154431056|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
154431057|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154431058|NCT02068170|Tacrolimus|tacrolimus|mesh-list
154431059|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154431060|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
154431061|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431062|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154431063|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431064|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431065|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431066|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431067|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154431068|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154431069|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387571|NCT00000225|Narcotics|narcotics|mesh-ancestor
153782109|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154431070|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154431071|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
154431072|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154431073|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154431074|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154431075|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154431076|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154431077|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154431078|NCT02068170|Growth Substances|growth substances|mesh-ancestor
154431079|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
154431080|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154431081|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154431082|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154431083|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154431084|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
154431085|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154431086|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154431087|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154431088|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431089|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154431090|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154431091|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154431092|NCT02068170|Narcotics|narcotics|mesh-ancestor
154431093|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431094|NCT02068170|Analgesics|analgesics|mesh-ancestor
154431095|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
154431096|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431097|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
154431098|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
154431099|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154431100|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154431101|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
154431102|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
154431103|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154431104|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154431105|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154431106|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154431107|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154431108|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
154431109|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431110|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154431111|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
154431112|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154431113|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154431114|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
154431115|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
154431116|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431117|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571323|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
153571324|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571325|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458014|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154431118|NCT02206646|Tenecteplase|tenecteplase|mesh-list
154431119|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154431120|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154431121|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431122|NCT02419417|Nivolumab|nivolumab|mesh-list
154254751|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
154431123|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154431124|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431125|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154431126|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431127|NCT02068404|Nifedipine|nifedipine|mesh-list
154431128|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154431129|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154431130|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431131|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154431132|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431133|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
154431134|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
154431135|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154431136|NCT02068482|Rifaximin|rifaximin|mesh-list
154431137|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431138|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431139|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154431140|NCT02206802|Minoxidil|minoxidil|mesh-list
154431141|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154431142|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
154431143|NCT02065986|Tenofovir|tenofovir|mesh-list
154431144|NCT02065986|Emtricitabine|emtricitabine|mesh-list
154431145|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154431146|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
154431147|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431148|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154431149|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154431150|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782112|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431151|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431152|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154431153|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154431154|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154431155|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
154431156|NCT02068560|Coagulants|coagulants|mesh-ancestor
154431157|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154431158|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
154431159|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431160|NCT01377103|Testosterone|testosterone|mesh-list
154431161|NCT01377103|Androgens|androgens|mesh-ancestor
154431162|NCT01377103|Hormones|hormones|mesh-ancestor
154431163|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431164|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431165|NCT01377025|Sorafenib|sorafenib|mesh-list
154431166|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431167|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154431168|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431169|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431170|NCT02342275|Propranolol|propranolol|mesh-list
154431171|NCT02342275|Atenolol|atenolol|mesh-list
154431172|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154431173|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154005764|NCT04246502|Capecitabine|capecitabine|mesh-list
154431174|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
154431175|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431176|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431177|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431178|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154431179|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154431180|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
154431181|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
154431182|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
154431183|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431184|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154431185|NCT01827553|Gemcitabine|gemcitabine|mesh-list
154431186|NCT01827553|Folfirinox|folfirinox|mesh-list
154431187|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154431188|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
154431189|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431190|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431191|NCT02207348|Liraglutide|liraglutide|mesh-list
154431192|NCT02207348|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154431193|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431194|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431195|NCT02207348|Incretins|incretins|mesh-ancestor
154431196|NCT02207348|Hormones|hormones|mesh-ancestor
154431197|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431198|NCT02066454|Apixaban|apixaban|mesh-list
154431199|NCT02066454|Anticoagulants|anticoagulants|mesh-list
154431200|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154431201|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
154431202|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154431203|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
154431204|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431205|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431206|NCT02207426|Tobramycin|tobramycin|mesh-list
154431207|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431208|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431209|NCT00777491|Cisplatin|cisplatin|mesh-list
154431210|NCT00777491|Gemcitabine|gemcitabine|mesh-list
154431211|NCT00777491|Fluorouracil|fluorouracil|mesh-list
154431212|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431213|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154431214|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
154431215|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431216|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154431217|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
154431218|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431219|NCT02199392|Lenvatinib|lenvatinib|mesh-list
154431220|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431221|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154431222|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431223|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431224|NCT03559920|Propofol|propofol|mesh-list
154431225|NCT03559920|Anesthetics|anesthetics|mesh-list
154431226|NCT03559920|Sevoflurane|sevoflurane|mesh-list
154431227|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153387572|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782114|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431228|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431229|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431230|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154431231|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
154431232|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154431233|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154431234|NCT02203760|Gemcitabine|gemcitabine|mesh-list
154431235|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154431236|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
154431237|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431238|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431239|NCT03703271|Methotrexate|methotrexate|mesh-list
154431240|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154431241|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
154431242|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154431243|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431244|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154431245|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
154431246|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431247|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431248|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
154431249|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431250|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154431251|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154431252|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
154431253|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154431254|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154431255|NCT03532802|Metoprolol|metoprolol|mesh-list
154431256|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154431257|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154431258|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
154431259|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
154431260|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431261|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431262|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154431263|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154431264|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154431265|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
154431266|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431267|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431268|NCT03430531|Lidocaine|lidocaine|mesh-list
154431269|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
154431270|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
153782119|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360234|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154431271|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431272|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431273|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
154431274|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431275|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154431276|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154431277|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154431278|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154431279|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431280|NCT02066532|Trastuzumab|trastuzumab|mesh-list
154431281|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154431282|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431283|NCT04088513|Aspirin|aspirin|mesh-list
154431284|NCT04088513|Clopidogrel|clopidogrel|mesh-list
154431285|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154431286|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154431287|NCT04088513|Analgesics|analgesics|mesh-ancestor
154431288|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
154431289|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431290|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431291|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154431292|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154431293|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154431294|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154431295|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431296|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154431297|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154431298|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431299|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
154431300|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154431301|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154431302|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154431303|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
154431304|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431305|NCT02207660|Fluorouracil|fluorouracil|mesh-list
154431306|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431307|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
154431308|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431309|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154431310|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154431311|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
154431312|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431313|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
154431314|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154431315|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431316|NCT02069418|Alovudine|alovudine|mesh-list
154431317|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154431318|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154431319|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431320|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
154431321|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431322|NCT02208128|Bevacizumab|bevacizumab|mesh-list
154431323|NCT02208128|Sunitinib|sunitinib|mesh-list
154431324|NCT02208128|Everolimus|everolimus|mesh-list
154431325|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154431326|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431327|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154431328|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154431329|NCT02208128|Growth Substances|growth substances|mesh-ancestor
154431330|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431331|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
154431332|NCT02208128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154431333|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154431334|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431335|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431336|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154431337|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
154431338|NCT02066610|Selenium|selenium|mesh-list
154431339|NCT02066610|Selenious Acid|selenious acid|mesh-list
154431340|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
154431341|NCT02066610|Selenic Acid|selenic acid|mesh-list
154431342|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
154431343|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431345|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431346|NCT02066610|Trace Elements|trace elements|mesh-ancestor
154431347|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
154431348|NCT03077711|Trimethoprim|trimethoprim|mesh-list
154431349|NCT03077711|Methenamine|methenamine|mesh-list
154431350|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
153782121|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
154431351|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
154431352|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154431353|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431354|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
154431355|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154431356|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154431357|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154431358|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431359|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431360|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154431361|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154431362|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154431363|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431364|NCT04374019|Artesunate|artesunate|mesh-list
154431365|NCT04374019|Ivermectin|ivermectin|mesh-list
154431366|NCT04374019|Camostat|camostat|mesh-list
154431367|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
154431368|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154431369|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154431370|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431371|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431372|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
154431373|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
154431374|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154431375|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
154431376|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
154431377|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431378|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431379|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154431380|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154431381|NCT02069808|Leuprolide|leuprolide|mesh-list
154431382|NCT02069808|Menotropins|menotropins|mesh-list
154431383|NCT02069808|Ganirelix|ganirelix|mesh-list
154431384|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154431385|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
154431386|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154431387|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431388|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154431389|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431390|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
154431391|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431392|NCT03673605|Warfarin|warfarin|mesh-list
154431393|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
154431394|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
154431395|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154431396|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
154431397|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154431398|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
154431399|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431400|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431401|NCT02069886|Deferasirox|deferasirox|mesh-list
154431402|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154431403|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
154431404|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
154431405|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431406|NCT04311463|Paroxetine|paroxetine|mesh-list
154431407|NCT04311463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154431408|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154431409|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154431410|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431411|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431412|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
154431413|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431414|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154431415|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
154431416|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154431417|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154431418|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154431420|NCT02065128|Capsaicin|capsaicin|mesh-list
154431421|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
154431422|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
154431423|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
154431424|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431425|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431426|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
154431427|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154431428|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
154431429|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431430|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
154431431|NCT03677895|Protective Agents|protective agents|mesh-ancestor
154431432|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154431433|NCT04295005|Empagliflozin|empagliflozin|mesh-list
154431434|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431435|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431436|NCT04295005|Incretins|incretins|mesh-ancestor
154431437|NCT04295005|Hormones|hormones|mesh-ancestor
154431438|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431439|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154431440|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
153367097|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
154431441|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431442|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431443|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154431444|NCT03174353|Lanreotide|lanreotide|mesh-list
154431445|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431446|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154431447|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431448|NCT04080947|Montelukast|montelukast|mesh-list
154431449|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154431450|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
154431451|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154431452|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
154431453|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431454|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431455|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154431456|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154431457|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431458|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
154431459|NCT02066688|Vitamin D|vitamin d|mesh-list
154431460|NCT02066688|Folic Acid|folic acid|mesh-list
154431461|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
154431462|NCT02066688|Calcium|calcium|mesh-list
154431463|NCT02066688|Vitamins|vitamins|mesh-ancestor
154431464|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
154431465|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431466|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154431467|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154431468|NCT02066688|Hematinics|hematinics|mesh-ancestor
154431469|NCT03671733|Liraglutide|liraglutide|mesh-list
154431470|NCT03671733|Exenatide|exenatide|mesh-list
154431471|NCT03671733|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154431472|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431473|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006060|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431474|NCT03671733|Incretins|incretins|mesh-ancestor
154431475|NCT03671733|Hormones|hormones|mesh-ancestor
154431476|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431477|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154431478|NCT03119363|Methamphetamine|methamphetamine|mesh-list
154431479|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154431480|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367127|NCT02249585|Iodine|iodine|mesh-list
154431481|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
154431482|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
154431483|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431484|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
154431485|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431486|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431487|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
154431488|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154431489|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154431490|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154431491|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154431492|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
154431493|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154431494|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431495|NCT03671655|Paclitaxel|paclitaxel|mesh-list
154431496|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154431497|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431498|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
154431499|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
154431500|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
154431501|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431502|NCT02200094|Telmisartan|telmisartan|mesh-list
154431503|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154431504|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154431505|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154431506|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431507|NCT01370538|Esomeprazole|esomeprazole|mesh-list
154431508|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154431509|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154431510|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154431511|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431512|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431513|NCT03248297|Amoxicillin|amoxicillin|mesh-list
154431514|NCT03248297|Azithromycin|azithromycin|mesh-list
154431515|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431516|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431517|NCT02208596|Pentazocine|pentazocine|mesh-list
154431518|NCT02208596|Propofol|propofol|mesh-list
154431519|NCT02208596|Etomidate|etomidate|mesh-list
154431520|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154431521|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431522|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431523|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154431524|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
154431525|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
154431526|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154431527|NCT02208596|Narcotics|narcotics|mesh-ancestor
154431528|NCT02208596|Analgesics|analgesics|mesh-ancestor
154431529|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
154431530|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431531|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154431532|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154431533|NCT02070120|Mitomycins|mitomycins|mesh-list
154431534|NCT02070120|Mitomycin|mitomycin|mesh-list
154431535|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154431536|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431537|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
154431538|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431539|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154431540|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431541|NCT02200172|Melatonin|melatonin|mesh-list
154431542|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
154431543|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431544|NCT02200172|Protective Agents|protective agents|mesh-ancestor
154431545|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431546|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431547|NCT03673137|Gemcitabine|gemcitabine|mesh-list
154431548|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154006140|NCT04222842|Vorolanib|vorolanib|mesh-list
154431549|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
154431550|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431551|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431552|NCT02066844|Betamethasone|betamethasone|mesh-list
154431553|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
154431554|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154431555|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
154431556|NCT02066844|Lidocaine|lidocaine|mesh-list
154431557|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154431558|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
154431559|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
154431560|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431561|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431562|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
154431563|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782128|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153360235|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
154431564|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154431565|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154431566|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154431568|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431569|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154431570|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
154431571|NCT02066844|Hormones|hormones|mesh-ancestor
154431572|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431573|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154431574|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
154431575|NCT03669783|Dactinomycin|dactinomycin|mesh-list
154431576|NCT03669783|Carboplatin|carboplatin|mesh-list
154431577|NCT03669783|Doxorubicin|doxorubicin|mesh-list
154431578|NCT03669783|Etoposide|etoposide|mesh-list
154431579|NCT03669783|Vincristine|vincristine|mesh-list
154431580|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431581|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154431582|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154431583|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154431584|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431585|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431586|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154431587|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431588|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431589|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154431590|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154431591|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
154431592|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
154431593|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
154431594|NCT02067078|Dexamethasone|dexamethasone|mesh-list
154431595|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
154431596|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154431597|NCT02067078|Clonidine|clonidine|mesh-list
154431598|NCT02067078|Epinephrine|epinephrine|mesh-list
154431599|NCT02067078|Racepinephrine|racepinephrine|mesh-list
154431600|NCT02067078|Ropivacaine|ropivacaine|mesh-list
154431601|NCT02067078|Bupivacaine|bupivacaine|mesh-list
154431602|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
154431603|NCT02067078|BB 1101|bb 1101|mesh-list
153782129|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153387573|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782130|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154431604|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154431605|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
154431606|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
154431607|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431608|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431609|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154431610|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
154431611|NCT02067078|Hormones|hormones|mesh-ancestor
154431612|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431613|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154431614|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431615|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
154431616|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431617|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431618|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
154431619|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
154431620|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431621|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
154006208|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154431622|NCT02067078|Analgesics|analgesics|mesh-ancestor
154431623|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154431624|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
154431625|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154431626|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154431627|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154431628|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
154431629|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431630|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154431631|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154431632|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154431633|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
154431634|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
154431635|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
154431636|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154431637|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154431638|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154431639|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154431640|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154431641|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
154431643|NCT05461235|Tislelizumab|tislelizumab|mesh-list
154431644|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154431645|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431646|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154431647|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431648|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154431649|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154431650|NCT02070198|Hormones|hormones|mesh-ancestor
154431651|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431652|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431653|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
154431654|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154431655|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
154431656|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154431657|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154431658|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154431659|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431660|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154431661|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154431662|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154431663|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154431664|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431665|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431666|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431667|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
154431668|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154431669|NCT02204852|Iloprost|iloprost|mesh-list
154431670|NCT02204852|Eptifibatide|eptifibatide|mesh-list
154431671|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154431672|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
154431673|NCT02070510|Semaglutide|semaglutide|mesh-list
154431674|NCT02070510|Lisinopril|lisinopril|mesh-list
154431675|NCT02070510|Warfarin|warfarin|mesh-list
154431676|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
154431677|NCT02070510|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154431678|NCT02070510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431679|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431680|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154431681|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
154431682|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431683|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431684|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154431685|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154431686|NCT02070510|Protective Agents|protective agents|mesh-ancestor
154431687|NCT02200562|Ipilimumab|ipilimumab|mesh-list
154431688|NCT02200562|Dabrafenib|dabrafenib|mesh-list
154431689|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154431690|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431691|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154431692|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431693|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154431694|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431695|NCT02200640|Losartan|losartan|mesh-list
154431696|NCT02200640|Telmisartan|telmisartan|mesh-list
154006286|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
154431697|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154431698|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154431699|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154431700|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154431701|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431702|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
154431703|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154431704|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
154431705|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431706|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154431707|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
154431708|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154431709|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
154431710|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154431711|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431712|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154431713|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154431715|NCT02067780|Levofloxacin|levofloxacin|mesh-list
154431716|NCT02067780|Ofloxacin|ofloxacin|mesh-list
154431717|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154431718|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431719|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431720|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154431721|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154431722|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431723|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431724|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431725|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154431726|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154431727|NCT02205164|Aprepitant|aprepitant|mesh-list
154431728|NCT02205164|Palonosetron|palonosetron|mesh-list
154431729|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
154431730|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
154431731|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431732|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431733|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782139|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
154431734|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154431735|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431736|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431737|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154431738|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154431739|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
154431740|NCT02071212|Ticagrelor|ticagrelor|mesh-list
154431741|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154431742|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154431743|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154431744|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154431745|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
154431746|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431747|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431748|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431749|NCT02072382|Metformin|metformin|mesh-list
154431750|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431751|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431752|NCT02205242|Azithromycin|azithromycin|mesh-list
154431753|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431754|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431755|NCT02071368|Metformin|metformin|mesh-list
154431756|NCT02071368|Canagliflozin|canagliflozin|mesh-list
154431757|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431758|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431759|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154431760|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431761|NCT03402841|Olaparib|olaparib|mesh-list
154431762|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154431763|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431764|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431765|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431766|NCT02205398|Cetuximab|cetuximab|mesh-list
154431767|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154431768|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431769|NCT02220608|Bortezomib|bortezomib|mesh-list
154431771|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154431772|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
154431773|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431774|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431775|NCT03630367|Dexamethasone|dexamethasone|mesh-list
154431776|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154431777|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
154431778|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
154431779|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431780|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431781|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154431782|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
154431783|NCT03630367|Hormones|hormones|mesh-ancestor
154431784|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431785|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154431786|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431788|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154431789|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154431790|NCT02258282|Analgesics|analgesics|mesh-ancestor
154431791|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
154431792|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431793|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431794|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154431795|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154431796|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154431797|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154431798|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
154431799|NCT02076594|Docetaxel|docetaxel|mesh-list
154431800|NCT02076594|Capecitabine|capecitabine|mesh-list
154431801|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
154431802|NCT02076594|Epirubicin|epirubicin|mesh-list
154431803|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431804|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
154431805|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
154431806|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
154431807|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431808|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154431809|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
154431810|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154431811|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154431812|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154431813|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431814|NCT04175509|Acetaminophen|acetaminophen|mesh-list
154431815|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154431816|NCT04175509|Analgesics|analgesics|mesh-ancestor
154431817|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
154431818|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431819|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431820|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
154431821|NCT02220842|Atezolizumab|atezolizumab|mesh-list
154431822|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
154431823|NCT02220842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154431824|NCT02220842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431825|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154431826|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431827|NCT02205554|Tramadol|tramadol|mesh-list
154431828|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154431829|NCT02205554|Narcotics|narcotics|mesh-ancestor
154431830|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431831|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431832|NCT02205554|Analgesics|analgesics|mesh-ancestor
154431833|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
154431834|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431835|NCT02076750|Vitamin D|vitamin d|mesh-list
154431836|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
154431837|NCT02076750|Vitamins|vitamins|mesh-ancestor
154431838|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
154431839|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431840|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154431841|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154431842|NCT05262608|Olaparib|olaparib|mesh-list
154431843|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154431844|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431845|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431846|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431847|NCT01380457|Dronabinol|dronabinol|mesh-list
154431848|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
154431849|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431850|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154431851|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154431852|NCT01380457|Analgesics|analgesics|mesh-ancestor
154431853|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
154431854|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431855|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154431856|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154431857|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431858|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431859|NCT01380457|Hormones|hormones|mesh-ancestor
154431860|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154431861|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154431862|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431863|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431864|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431865|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154431867|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
154431868|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431869|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431870|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154431871|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154431872|NCT02076828|Zinc|zinc|mesh-list
154431873|NCT02076828|Glycine|glycine|mesh-list
154431874|NCT02076828|Trace Elements|trace elements|mesh-ancestor
154431875|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
154431876|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431877|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
154431878|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154431879|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431880|NCT02221154|Folic Acid|folic acid|mesh-list
154431881|NCT02221154|Hematinics|hematinics|mesh-ancestor
154431882|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
154431883|NCT02221154|Vitamins|vitamins|mesh-ancestor
154431884|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
154431885|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431886|NCT02079870|Semaglutide|semaglutide|mesh-list
154431887|NCT02079870|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154431888|NCT02079870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154431889|NCT02079870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431890|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
154431891|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154431892|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431893|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154431894|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154431895|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431896|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431897|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431898|NCT03787849|Anesthetics|anesthetics|mesh-list
154431899|NCT03787849|Propofol|propofol|mesh-list
154431900|NCT03787849|Sevoflurane|sevoflurane|mesh-list
154431901|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431902|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431903|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154431904|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154431905|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
154431906|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154431907|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154431908|NCT03671265|Apatinib|apatinib|mesh-list
154431909|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431910|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154431911|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431912|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431913|NCT02881957|Vitamin D|vitamin d|mesh-list
154431914|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
154431915|NCT02881957|Vitamins|vitamins|mesh-ancestor
154431916|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
154431917|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431918|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154431919|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154431920|NCT02206022|Remifentanil|remifentanil|mesh-list
154431921|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154431922|NCT02206022|Narcotics|narcotics|mesh-ancestor
154431923|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154431924|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431926|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
154431927|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431928|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
154431929|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154431930|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
154431931|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431932|NCT02073552|Protective Agents|protective agents|mesh-ancestor
154431933|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431934|NCT02073552|Vitamins|vitamins|mesh-ancestor
154431935|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
154431936|NCT02073552|Laxatives|laxatives|mesh-ancestor
154431937|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154431938|NCT02210156|Micronutrients|micronutrients|mesh-list
154431939|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431940|NCT02080026|Chloroquine|chloroquine|mesh-list
154431941|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154431942|NCT02080026|Atovaquone|atovaquone|mesh-list
154431943|NCT02080026|Proguanil|proguanil|mesh-list
154431944|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154431945|NCT02080026|Amebicides|amebicides|mesh-ancestor
154431946|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154431947|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154431948|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431949|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
154431950|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154431951|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154431952|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154431953|NCT02080026|Analgesics|analgesics|mesh-ancestor
154431954|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
154431955|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431956|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431957|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154431958|NCT02080026|Filaricides|filaricides|mesh-ancestor
154431959|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
154431960|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
154431961|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431962|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431963|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
154431964|NCT02206178|Acetaminophen|acetaminophen|mesh-list
154431965|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
154431966|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154431967|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154431968|NCT02206178|Analgesics|analgesics|mesh-ancestor
154431969|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
154431970|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154431971|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431972|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
154431973|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
154431974|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154431975|NCT02206178|Expectorants|expectorants|mesh-ancestor
154431976|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
154431977|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154431978|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
154431979|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431980|NCT02206178|Protective Agents|protective agents|mesh-ancestor
154431981|NCT02206178|Antidotes|antidotes|mesh-ancestor
154431982|NCT02080104|Oxytocin|oxytocin|mesh-list
154431983|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
154431984|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154431985|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431986|NCT02211326|Warfarin|warfarin|mesh-list
154431987|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
154431988|NCT02691793|Sunitinib|sunitinib|mesh-list
154431989|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154431990|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154431991|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154431992|NCT02691793|Growth Substances|growth substances|mesh-ancestor
154431993|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154431994|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
154431995|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154431996|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154431997|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154431998|NCT02221622|Pregnanolone|pregnanolone|mesh-list
154431999|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154432000|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
154432001|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432003|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
154432004|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154432005|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
154432006|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432007|NCT02080182|Expectorants|expectorants|mesh-ancestor
154432008|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
154432009|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154432010|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
154432011|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432012|NCT02080182|Protective Agents|protective agents|mesh-ancestor
154432013|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432014|NCT02080182|Antidotes|antidotes|mesh-ancestor
154432015|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
154432016|NCT02750930|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154432017|NCT02750930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154432018|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432020|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154432021|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154432022|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
154432023|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432024|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432025|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154432026|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154432027|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
154432028|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432029|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
154432030|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154432031|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154432032|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432033|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
154432034|NCT02080494|Coagulants|coagulants|mesh-ancestor
154432035|NCT02213744|Gemcitabine|gemcitabine|mesh-list
154432036|NCT02213744|Capecitabine|capecitabine|mesh-list
154432037|NCT02213744|Trastuzumab|trastuzumab|mesh-list
154432038|NCT02213744|Vinorelbine|vinorelbine|mesh-list
154432039|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154432040|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
154432041|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432042|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432043|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432044|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154432045|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154432046|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154432047|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154432048|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
154432049|NCT01378741|Propofol|propofol|mesh-list
154432050|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154432051|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432052|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432053|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154432054|NCT01378741|Analgesics|analgesics|mesh-ancestor
154432055|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
154432056|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432057|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154432058|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154432059|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154432060|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432061|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432062|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432063|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154432064|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
154432065|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
154432066|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
154432067|NCT02461849|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154432068|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154432069|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432070|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432071|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432072|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
154432073|NCT02225054|Ropivacaine|ropivacaine|mesh-list
153783589|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154432074|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154006668|NCT00798759|Travoprost|travoprost|mesh-list
154432075|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432076|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432077|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154432079|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
154432080|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432081|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154432082|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154432083|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154432084|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432085|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432086|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432087|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
154432088|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
154432089|NCT02080728|Ropivacaine|ropivacaine|mesh-list
154432090|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
154432092|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432093|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432094|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
154432095|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432096|NCT03078907|Selexipag|selexipag|mesh-list
154432097|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154432098|NCT02225210|Midazolam|midazolam|mesh-list
154432099|NCT02225210|Fentanyl|fentanyl|mesh-list
154432100|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
154432101|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154432102|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432103|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432104|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154432105|NCT02225210|Analgesics|analgesics|mesh-ancestor
154432106|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
154432107|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432108|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154432109|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154432110|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154432111|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432112|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432113|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432114|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154432115|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154432116|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154432117|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154432118|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154432119|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
154432120|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
154432121|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
154432122|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
154432123|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154432124|NCT02225210|Narcotics|narcotics|mesh-ancestor
154432125|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
154432126|NCT02217020|Irinotecan|irinotecan|mesh-list
154432127|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387574|NCT00000225|Analgesics|analgesics|mesh-ancestor
153782151|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153782152|NCT00267306|Visilizumab|visilizumab|mesh-list
154432128|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154432129|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154432130|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432131|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432132|NCT03249714|Ofatumumab|ofatumumab|mesh-list
154432133|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154432134|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432135|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
154432136|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432137|NCT02925117|Upadacitinib|upadacitinib|mesh-list
154432138|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154432139|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154432140|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432141|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432142|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154432143|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
154432144|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154432145|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432146|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
154432147|NCT02225756|Cyclosporine|cyclosporine|mesh-list
154432148|NCT02225756|Cyclosporins|cyclosporins|mesh-list
154432149|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432150|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432151|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154432152|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
154432153|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432154|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
154432155|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432156|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
154432157|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154432158|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154432159|NCT02225834|Atorvastatin|atorvastatin|mesh-list
154432160|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154432161|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154432162|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
154432163|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432164|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154432165|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154432166|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432167|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
154432168|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432169|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
154432170|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154432171|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432172|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154432173|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154432174|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432175|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432176|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432177|NCT02074800|Siltuximab|siltuximab|mesh-list
154432178|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154432179|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432180|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
154432181|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432182|NCT04504045|Metformin|metformin|mesh-list
154432183|NCT04504045|Efavirenz|efavirenz|mesh-list
154432184|NCT04504045|Losartan|losartan|mesh-list
154432185|NCT04504045|Metoprolol|metoprolol|mesh-list
154432186|NCT04504045|Midazolam|midazolam|mesh-list
154432187|NCT04504045|Caffeine|caffeine|mesh-list
154432188|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154432189|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432190|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154432191|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154432192|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432193|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154432194|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154432195|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154432196|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154432197|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
154432198|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
154432199|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
154432200|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
154432201|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432202|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432203|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154432204|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154432205|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154432206|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154432207|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154432208|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154432209|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432210|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154432211|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154432212|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
154432213|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154432214|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154432215|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
154432216|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432217|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154432218|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154432219|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154432220|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154432221|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154432222|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154432223|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
154432224|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
154432225|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432226|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154432227|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154432229|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432230|NCT03283488|Megestrol|megestrol|mesh-list
154432231|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
154432232|NCT03283488|Mirtazapine|mirtazapine|mesh-list
154432233|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
154432234|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154432235|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154432236|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
154432237|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
154432238|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432239|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432240|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432241|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154432242|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154432243|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432244|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154432245|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154432246|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154432247|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432248|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154432249|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154432250|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
154432251|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154432252|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154432253|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154432254|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154432255|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
154432256|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154432257|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154432258|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154432259|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153782168|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432260|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432261|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
154432262|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154432264|NCT02258204|Analgesics|analgesics|mesh-ancestor
154432265|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
154432266|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432267|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432268|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154432269|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154432270|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
154432271|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
154432272|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432273|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154432274|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154432275|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432276|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432277|NCT02226068|Cyclosporine|cyclosporine|mesh-list
154432278|NCT02226068|Cyclosporins|cyclosporins|mesh-list
154432279|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432280|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432281|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154432282|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
154432283|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432284|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
154432285|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432286|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
154432287|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154432288|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154432289|NCT02220218|Metformin|metformin|mesh-list
154432290|NCT02220218|Canagliflozin|canagliflozin|mesh-list
154432291|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154432292|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432293|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154432294|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432295|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154432296|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154432297|NCT02222480|Diuretics|diuretics|mesh-ancestor
154432298|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
154432299|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432300|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154432301|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154432302|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432303|NCT03670875|Curcumin|curcumin|mesh-list
154432304|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154432305|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154432306|NCT03670875|Analgesics|analgesics|mesh-ancestor
154432307|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
154432308|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432309|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432310|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154432311|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154432313|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432314|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432315|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
154432316|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154432317|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432318|NCT02220296|Insulin|insulin|mesh-list
154432319|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154432320|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
154432321|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154432322|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432323|NCT02074878|Sunitinib|sunitinib|mesh-list
154432324|NCT02074878|Crizotinib|crizotinib|mesh-list
154432325|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432326|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154432327|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154432328|NCT02074878|Growth Substances|growth substances|mesh-ancestor
154432329|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432330|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
154432331|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154432332|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432333|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432334|NCT02074878|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154432335|NCT03075163|Ondansetron|ondansetron|mesh-list
154432336|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
154432337|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
154432338|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432339|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432340|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154432341|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
154432342|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
154432343|NCT03075163|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154432344|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154432345|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
154432346|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432347|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432348|NCT02220530|Midazolam|midazolam|mesh-list
154432349|NCT02220530|Fentanyl|fentanyl|mesh-list
154432350|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154432351|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154432352|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432353|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432354|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154432355|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154432356|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154432357|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154432358|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
154432359|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
154432360|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
154432361|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
154432362|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432363|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432364|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154432365|NCT02220530|Narcotics|narcotics|mesh-ancestor
154432366|NCT02220530|Analgesics|analgesics|mesh-ancestor
154432367|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
154432368|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432369|NCT02078232|Pancrelipase|pancrelipase|mesh-list
154432370|NCT02078232|Pancreatin|pancreatin|mesh-list
154432371|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154432372|NCT02075034|ON 01910|on 01910|mesh-list
154432373|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432374|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154432375|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432376|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432377|NCT02078388|Doxorubicin|doxorubicin|mesh-list
154432378|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154432379|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432380|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154432381|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154432382|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432383|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432384|NCT02222636|Fentanyl|fentanyl|mesh-list
154432385|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
154432386|NCT02222636|Anesthetics|anesthetics|mesh-list
154432387|NCT02222636|Sevoflurane|sevoflurane|mesh-list
154432388|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432389|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432390|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153367568|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153782184|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432391|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154432392|NCT02222636|Analgesics|analgesics|mesh-ancestor
154432393|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
154432394|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432395|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154432396|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154432397|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154432398|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432399|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432400|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432401|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154432402|NCT02222636|Narcotics|narcotics|mesh-ancestor
154432403|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154432404|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154432405|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
154432406|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154432407|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154432408|NCT04058145|Plerixafor|plerixafor|mesh-list
154432409|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
154432410|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432411|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432412|NCT04058145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154432413|NCT04058145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432414|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154432415|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154432416|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
154432417|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154432418|NCT02230982|Nintedanib|nintedanib|mesh-list
154432419|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432420|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154432421|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432422|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432423|NCT02075112|Genistein|genistein|mesh-list
154432424|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432425|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154432426|NCT02075112|Protective Agents|protective agents|mesh-ancestor
154432427|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432428|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154432429|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973754|NCT06247956|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153782189|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782190|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432430|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432431|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
154432432|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154432433|NCT02075112|Estrogens|estrogens|mesh-ancestor
154432434|NCT02075112|Hormones|hormones|mesh-ancestor
154432435|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154432436|NCT02223026|Metformin|metformin|mesh-list
154432437|NCT02223026|Linagliptin|linagliptin|mesh-list
154432438|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154432439|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432440|NCT02223026|Incretins|incretins|mesh-ancestor
154432441|NCT02223026|Hormones|hormones|mesh-ancestor
154432442|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154432443|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154432444|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
154432445|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432446|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432447|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154432448|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154432450|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154432451|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154432452|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432453|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432454|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432455|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432456|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154432457|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154432458|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
154432459|NCT02231294|Pramipexole|pramipexole|mesh-list
154432460|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
154432461|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432462|NCT02231294|Protective Agents|protective agents|mesh-ancestor
154432463|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432464|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154432465|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154432466|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
154432467|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
154432468|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432469|NCT02223416|Teriparatide|teriparatide|mesh-list
154432470|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154432471|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432472|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154432473|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
154432474|NCT02082054|Atropine|atropine|mesh-list
154432475|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
154432476|NCT02082054|Ephedrine|ephedrine|mesh-list
154432477|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154432478|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154432479|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154432480|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
154432481|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432482|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432483|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154432484|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
154432485|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
154432486|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
154432487|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154432488|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154432489|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
154432490|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432491|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432492|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
154432493|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154432494|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154432495|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
154432496|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432497|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
154432498|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
154432499|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154432500|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
154432501|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
154432502|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154432503|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154432504|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154432505|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
154432506|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432507|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432508|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154432509|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
154432510|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
154432511|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154432512|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432513|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154432514|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154432515|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154432516|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432517|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
154432518|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432519|NCT02226926|Aspirin|aspirin|mesh-list
154432520|NCT02226926|Dipyridamole|dipyridamole|mesh-list
154432521|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
154432522|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154432523|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154432524|NCT02226926|Analgesics|analgesics|mesh-ancestor
154432525|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
154432526|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432527|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432528|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154432529|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154432530|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154432531|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154432532|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432533|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154254756|NCT01147718|Digoxin|digoxin|mesh-list
154432534|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154432536|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
154432537|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154432538|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
154432539|NCT02924883|Trastuzumab|trastuzumab|mesh-list
154432540|NCT02924883|Atezolizumab|atezolizumab|mesh-list
154432541|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154432542|NCT02924883|Maytansine|maytansine|mesh-list
154432543|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432544|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432545|NCT02924883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154432546|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432547|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154432548|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
154432549|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
154432550|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
154432551|NCT02924883|Immunotoxins|immunotoxins|mesh-ancestor
154432552|NCT02924883|Immunoconjugates|immunoconjugates|mesh-ancestor
154432553|NCT02924883|Immunologic Factors|immunologic factors|mesh-ancestor
154432554|NCT02924883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432555|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
154432556|NCT02075970|Hematinics|hematinics|mesh-ancestor
154432557|NCT02231450|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154432558|NCT02231450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154432559|NCT02231450|Serotonin Agents|serotonin agents|mesh-ancestor
154432560|NCT02231450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432561|NCT02231450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432562|NCT02231450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432563|NCT02227082|Olaparib|olaparib|mesh-list
154432564|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154432565|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432566|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432567|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432568|NCT01369680|Ketamine|ketamine|mesh-list
154432569|NCT01369680|Analgesics|analgesics|mesh-ancestor
154432570|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
154432571|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432572|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432573|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154432574|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154432575|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
154432576|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
154432577|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154432578|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154432579|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154432580|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432581|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432582|NCT04780321|Antibodies|antibodies|mesh-list
154432583|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154432584|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
154432585|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432586|NCT01378039|Budesonide|budesonide|mesh-list
154432587|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154432588|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154432589|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
154432590|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432591|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432592|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154432593|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154432594|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
154432595|NCT01378039|Hormones|hormones|mesh-ancestor
154432596|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154432598|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154432599|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
154432600|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432601|NCT01377961|Protective Agents|protective agents|mesh-ancestor
154432602|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432603|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154432604|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154432605|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432606|NCT03558750|Rituximab|rituximab|mesh-list
154432607|NCT03558750|Nivolumab|nivolumab|mesh-list
154432608|NCT03558750|Lenalidomide|lenalidomide|mesh-list
154432609|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432610|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432611|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
154432612|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432613|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154432614|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154432615|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432616|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154432617|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154432618|NCT03558750|Growth Substances|growth substances|mesh-ancestor
154432619|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
154432620|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154432621|NCT02751320|Citric Acid|citric acid|mesh-list
154432622|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
154432623|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
154432624|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154432625|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
154432626|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
154432627|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432628|NCT03559764|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154432629|NCT03559764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154432630|NCT03559764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432631|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
154432632|NCT04931641|Trace Elements|trace elements|mesh-ancestor
154432633|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
154432634|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432635|NCT02083536|Docetaxel|docetaxel|mesh-list
154432636|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432637|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
154432638|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
154432639|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
154432640|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432641|NCT02231606|Methamphetamine|methamphetamine|mesh-list
154432642|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154432643|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432644|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
154432645|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
154432646|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154432647|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
154432648|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432649|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432650|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
154432651|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154432652|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154432653|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154432654|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154432655|NCT02231684|Semaglutide|semaglutide|mesh-list
154432656|NCT02231684|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154432657|NCT02231684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154432658|NCT02231684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432659|NCT02227550|Vitamin K|vitamin k|mesh-list
154432660|NCT02227550|Warfarin|warfarin|mesh-list
154432661|NCT02227550|Apixaban|apixaban|mesh-list
154432662|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
154432663|NCT02227550|Fluindione|fluindione|mesh-list
154432664|NCT02227550|Vitamins|vitamins|mesh-ancestor
154432665|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
154432666|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432667|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
154432668|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154432669|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
154432670|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154432671|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
154432672|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432673|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432674|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154432675|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154432676|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
154432677|NCT02227550|Coagulants|coagulants|mesh-ancestor
154432678|NCT02206035|Methotrexate|methotrexate|mesh-list
154432679|NCT02206035|Tacrolimus|tacrolimus|mesh-list
154432680|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154432681|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
154432682|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154432683|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432684|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154432685|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
154432686|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432687|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154432688|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
154432689|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154432690|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154432691|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154432692|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
154432693|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154432694|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154432695|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154432696|NCT02258828|Memantine|memantine|mesh-list
154432697|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154432698|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154432699|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
154432700|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154432701|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432702|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432703|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154432704|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154432705|NCT02083068|Vaccines|vaccines|mesh-list
154432706|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154432707|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
154432708|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154432709|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154432710|NCT02228252|Caseins|caseins|mesh-list
154432711|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
154432712|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
154432713|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154432714|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
153828025|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
154387713|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154387714|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387715|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154387716|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
154387717|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387718|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154387719|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
154387720|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
154387721|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154387722|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154387723|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
154387724|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387725|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154387726|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
154387727|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
154387728|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
154387729|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154387730|NCT03180346|Laxatives|laxatives|mesh-ancestor
154387731|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387732|NCT01356225|Ketorolac|ketorolac|mesh-list
154387733|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154387734|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154387735|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154387736|NCT01356225|Analgesics|analgesics|mesh-ancestor
154387737|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
154387738|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387739|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387740|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387741|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154387742|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154387743|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387753|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
154387754|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
154387755|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
154387756|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387757|NCT02220309|Pramipexole|pramipexole|mesh-list
154387758|NCT02220309|Dexpramipexole|dexpramipexole|mesh-list
154387759|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
153828043|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153828044|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828045|NCT00483158|Finafloxacin|finafloxacin|mesh-list
153368052|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153368053|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153368054|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368055|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368056|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153368057|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153577730|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577737|NCT01719601|Tapentadol|tapentadol|mesh-list
154387760|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387761|NCT02220309|Protective Agents|protective agents|mesh-ancestor
154387762|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387763|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154387764|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154387765|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
154387766|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
154387767|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387768|NCT02419534|Diltiazem|diltiazem|mesh-list
154387769|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154387770|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154387771|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387772|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387773|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154387774|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387775|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
154260683|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260684|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260685|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
153733401|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368065|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
153577754|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577755|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153577756|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153577757|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577758|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387776|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154387777|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
154387778|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387779|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154387780|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
154387781|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387782|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387783|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154387784|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154387785|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387786|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
154387787|NCT01358409|Nebivolol|nebivolol|mesh-list
154387788|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154387789|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
154387790|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154387791|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154387792|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154387793|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
154387794|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387795|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387796|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387797|NCT02423590|Carboplatin|carboplatin|mesh-list
154387798|NCT02423590|Gemcitabine|gemcitabine|mesh-list
154387799|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387800|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154387801|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
154387802|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387803|NCT01362309|Cycloserine|cycloserine|mesh-list
154387804|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154387805|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387806|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154387807|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
154387824|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828060|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828061|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153828062|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828063|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
153828064|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153577760|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577761|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153577762|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153577763|NCT01719627|Maraviroc|maraviroc|mesh-list
153577764|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153577765|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153577766|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577767|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153577768|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154387825|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154387826|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154387827|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
154387828|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154387829|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154387830|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154387831|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154387832|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154387833|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154387834|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154387835|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154387836|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154387837|NCT01356381|Vildagliptin|vildagliptin|mesh-list
154387838|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154387839|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387840|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154387841|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
154387842|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387843|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387844|NCT03117166|Lidocaine|lidocaine|mesh-list
154387845|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
154387846|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
154387847|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387848|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387849|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
154387850|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387851|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154387852|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154387853|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153733406|NCT00507091|Protective Agents|protective agents|mesh-ancestor
153863792|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
153828090|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154387854|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387855|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387856|NCT03302286|Mannitol|mannitol|mesh-list
154387857|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154387858|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154387859|NCT03302286|Diuretics|diuretics|mesh-ancestor
154387860|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
154387861|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387862|NCT01356615|Heparin|heparin|mesh-list
154387863|NCT01356615|Calcium heparin|calcium heparin|mesh-list
154387864|NCT01356615|Enoxaparin|enoxaparin|mesh-list
154387870|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154387871|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154387872|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387873|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
154387874|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
154387875|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154387876|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154387877|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387878|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387879|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387880|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154387881|NCT04583592|Gabexate|gabexate|mesh-list
154387882|NCT04583592|Camostat|camostat|mesh-list
154387883|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
154387884|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387885|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387886|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154387887|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154387888|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
154387889|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
154387890|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154387891|NCT02418988|Estrogens|estrogens|mesh-ancestor
154387892|NCT02418988|Hormones|hormones|mesh-ancestor
154387893|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387894|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387895|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387896|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387897|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154387898|NCT01356927|Etonogestrel|etonogestrel|mesh-list
154387899|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154387900|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
154387901|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387902|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387903|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154387904|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154387905|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387906|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387907|NCT03439670|Prednisone|prednisone|mesh-list
154387908|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387909|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
154387910|NCT03439670|Hormones|hormones|mesh-ancestor
154387911|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387912|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387913|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387914|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387915|NCT02930343|Folic Acid|folic acid|mesh-list
154387916|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
154387917|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
154387918|NCT02930343|Prednisolone|prednisolone|mesh-list
154387919|NCT02930343|Methotrexate|methotrexate|mesh-list
154387920|NCT02930343|Leflunomide|leflunomide|mesh-list
154387921|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
154387922|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154387923|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
154387924|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387925|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387926|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154387927|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
154387928|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387929|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387930|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
153403177|NCT04139304|Hormones|hormones|mesh-ancestor
153863825|NCT04610541|Remdesivir|remdesivir|mesh-list
154387931|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387932|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154387933|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154387934|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
154387935|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154387936|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154387952|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828120|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
153828121|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153368122|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
154387953|NCT02930343|Analgesics|analgesics|mesh-ancestor
154387954|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
154387955|NCT03686618|Secretin|secretin|mesh-list
154387956|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387957|NCT03686618|Hormones|hormones|mesh-ancestor
154387958|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387959|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387960|NCT02426866|Efavirenz|efavirenz|mesh-list
154387961|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154387962|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154387963|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387964|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387965|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
154387966|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387967|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154387968|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154387969|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154387970|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154387971|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154387972|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154387973|NCT02423824|Liraglutide|liraglutide|mesh-list
154387974|NCT02423824|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154387975|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154387976|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387977|NCT02423824|Incretins|incretins|mesh-ancestor
154387978|NCT02423824|Hormones|hormones|mesh-ancestor
154387979|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387980|NCT01012167|Galantamine|galantamine|mesh-list
154387981|NCT01012167|Oxytocin|oxytocin|mesh-list
154387982|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
154387983|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387984|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387985|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154387986|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387987|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387988|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
154387989|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387990|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154387991|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
154387992|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387993|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
154387994|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
154387995|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388006|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154388007|NCT02422966|Acetaminophen|acetaminophen|mesh-list
154388008|NCT02422966|Ibuprofen|ibuprofen|mesh-list
154388009|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154388010|NCT02422966|Analgesics|analgesics|mesh-ancestor
154388011|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
154388012|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388013|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388014|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
154388015|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154388016|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388017|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388018|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154388019|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388020|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388021|NCT02422888|Ticagrelor|ticagrelor|mesh-list
154388022|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154388023|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154388024|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154388025|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153828122|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153828123|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733407|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
153733408|NCT00507091|Vitamins|vitamins|mesh-ancestor
153404261|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
154388026|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154388027|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
154388028|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388029|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388030|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388031|NCT03633552|Temozolomide|temozolomide|mesh-list
154388032|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154388033|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
154388034|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388035|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388036|NCT05760456|Metformin|metformin|mesh-list
154388037|NCT05760456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154388038|NCT05760456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388039|NCT02418130|Inositol|inositol|mesh-list
154388040|NCT02418130|Thiamine|thiamine|mesh-list
154388041|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154388042|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
154388043|NCT02418130|Vitamins|vitamins|mesh-ancestor
154388044|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
154388045|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388046|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154388047|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388048|NCT03391765|Tilavonemab|tilavonemab|mesh-list
154388049|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
154388050|NCT02802228|Ifetroban|ifetroban|mesh-list
154388051|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154388052|NCT02801448|Sulforaphane|sulforaphane|mesh-list
154388053|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154388054|NCT02801448|Protective Agents|protective agents|mesh-ancestor
154388055|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388056|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388057|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
154388058|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
154388059|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154388060|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828126|NCT00483795|Citric Acid|citric acid|mesh-list
153828141|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828142|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783787|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153783788|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388061|NCT03674177|Vaccines|vaccines|mesh-list
154388062|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
153749852|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
154388068|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388069|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154388071|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154388072|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
154388073|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388074|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388075|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154388076|NCT02417896|Diuretics|diuretics|mesh-ancestor
154388077|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
154388078|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154388079|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154388080|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388081|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154388082|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388083|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
154388084|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154388085|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
154388086|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154388087|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154388088|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
154388089|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388090|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
154388091|NCT03116776|Protective Agents|protective agents|mesh-ancestor
154388092|NCT02505204|Clonidine|clonidine|mesh-list
154388093|NCT02505204|Analgesics|analgesics|mesh-ancestor
154388094|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
154388095|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388096|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388097|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154388098|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
154388099|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
154388100|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154388101|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153403239|NCT04091750|Nivolumab|nivolumab|mesh-list
154388102|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154388103|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
154388104|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388105|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388106|NCT01359423|Cilostazol|cilostazol|mesh-list
154388107|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154388108|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
154388109|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388110|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388111|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154388112|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
154388113|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154388114|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154388115|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388116|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154388117|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
154388118|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153828149|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828150|NCT05644210|Analgesics|analgesics|mesh-ancestor
153828151|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
153828152|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828153|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154388119|NCT01359423|Protective Agents|protective agents|mesh-ancestor
154388120|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154388121|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154388122|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388123|NCT01363089|Ketorolac|ketorolac|mesh-list
154388124|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154388125|NCT01363089|Phenylephrine|phenylephrine|mesh-list
154388126|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
154388127|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154388128|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154388129|NCT01363089|Analgesics|analgesics|mesh-ancestor
154388130|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
154388131|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388146|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
154388148|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
154388149|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154388150|NCT01363089|Protective Agents|protective agents|mesh-ancestor
154388151|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154388152|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154388153|NCT03681548|Doxorubicin|doxorubicin|mesh-list
154388154|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154388155|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154388156|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388157|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154388158|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154388159|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388160|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388161|NCT02417506|Ibuprofen|ibuprofen|mesh-list
154388162|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154388163|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154388164|NCT02417506|Analgesics|analgesics|mesh-ancestor
154388165|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
154388166|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388167|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388168|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388169|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388170|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154388171|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388172|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388173|NCT05188911|Prednisone|prednisone|mesh-list
154388174|NCT05188911|Androgens|androgens|mesh-list
154388175|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388176|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
154388177|NCT05188911|Hormones|hormones|mesh-ancestor
154388178|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388179|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388180|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154388181|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388182|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154388183|NCT03676946|Antibodies|antibodies|mesh-list
154388184|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
154388185|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154388186|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
154388187|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388188|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404399|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404400|NCT00354991|Diuretics|diuretics|mesh-ancestor
154388189|NCT01363167|Vitamin D|vitamin d|mesh-list
154388190|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
154388191|NCT01363167|Vitamins|vitamins|mesh-ancestor
154388192|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
154388193|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388232|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
154388233|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388234|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
154388235|NCT02426164|Hormones|hormones|mesh-ancestor
154388236|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388237|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154388238|NCT02426164|Protective Agents|protective agents|mesh-ancestor
154388239|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154388240|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154388241|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
154388242|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388243|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388244|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154388245|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154388246|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154388247|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
154388248|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
154388249|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
154388250|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154388251|NCT03745157|Insulin|insulin|mesh-list
154388252|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
154388253|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154388254|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388255|NCT02426008|Mitogens|mitogens|mesh-list
154388256|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415249|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154388257|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388258|NCT04050371|Tenofovir|tenofovir|mesh-list
154388259|NCT04050371|Emtricitabine|emtricitabine|mesh-list
154388260|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
154388261|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388262|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154388263|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154388264|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388265|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388266|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154388267|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154388268|NCT04447287|Buprenorphine|buprenorphine|mesh-list
154388269|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154388270|NCT04447287|ASP8062|asp8062|mesh-list
154388271|NCT04447287|Naloxone|naloxone|mesh-list
154388272|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154388273|NCT04447287|Narcotics|narcotics|mesh-ancestor
154388274|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388275|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388290|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388291|NCT01879319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154388292|NCT01879319|Protease Inhibitors|protease inhibitors|mesh-ancestor
154388293|NCT01879319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388294|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154388295|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
154388296|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388297|NCT04165122|Valacyclovir|valacyclovir|mesh-list
154388298|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
154388299|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388300|NCT02422030|Atorvastatin|atorvastatin|mesh-list
154388301|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
154388302|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154388303|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154388304|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
154388305|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388306|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154388307|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154388308|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388309|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
154388310|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388312|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154388313|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828192|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153368190|NCT01098500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153783794|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153783796|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
153368191|NCT01098500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368192|NCT01098500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577769|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
153577770|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577771|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153577772|NCT01719705|Pregabalin|pregabalin|mesh-list
153577773|NCT01719705|Analgesics|analgesics|mesh-ancestor
153577774|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
154388314|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154388315|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154388316|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154388317|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388318|NCT02422108|Denosumab|denosumab|mesh-list
154388319|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154388320|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388321|NCT01359657|Dexamethasone|dexamethasone|mesh-list
154388322|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
154388323|NCT01359657|Lenalidomide|lenalidomide|mesh-list
154388324|NCT01359657|Bortezomib|bortezomib|mesh-list
154388325|NCT01359657|BB 1101|bb 1101|mesh-list
154388326|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154388327|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388328|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
154388329|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
154388330|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388331|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388332|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388333|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
154388334|NCT01359657|Hormones|hormones|mesh-ancestor
154388335|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388336|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154388337|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134522|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
154388356|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
154388357|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388358|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388359|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388360|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154388361|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154388362|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388363|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154388364|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154388366|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388367|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388368|NCT03177850|Acetazolamide|acetazolamide|mesh-list
154388369|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
154388370|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154388371|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388372|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388373|NCT03177850|Diuretics|diuretics|mesh-ancestor
154388374|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
154388375|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388376|NCT03102918|Cannabidiol|cannabidiol|mesh-list
154388377|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
154388378|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
154388379|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154388380|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154388381|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154388382|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154388383|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388384|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
154388385|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388386|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388387|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154388388|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388389|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154388390|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
154388391|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154388392|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
154388393|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154388394|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388421|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
154388422|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
154388423|NCT03106948|Penicillamine|penicillamine|mesh-list
154388424|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
154388425|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388426|NCT03106948|Protective Agents|protective agents|mesh-ancestor
154388427|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388428|NCT03106948|Vitamins|vitamins|mesh-ancestor
154388429|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
154388430|NCT03106948|Antidotes|antidotes|mesh-ancestor
154134602|NCT00825188|Diuretics|diuretics|mesh-ancestor
154388431|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
154388432|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
154388433|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388434|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
154388435|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154388436|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388437|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
154388438|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388439|NCT01363557|Gefitinib|gefitinib|mesh-list
154388440|NCT01363557|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153828193|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828194|NCT01307020|Analgesics|analgesics|mesh-ancestor
153828195|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
153828196|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828206|NCT00483743|Budesonide|budesonide|mesh-list
154388441|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154388442|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388452|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154388453|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
154388454|NCT02416258|Calcipotriene|calcipotriene|mesh-list
154388455|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154388456|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388457|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
154388458|NCT02416258|Hormones|hormones|mesh-ancestor
154388459|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388460|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388461|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154388462|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
154388463|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
154388464|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
154388465|NCT02410720|Cathartics|cathartics|mesh-ancestor
154388466|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388467|NCT02416570|Clarithromycin|clarithromycin|mesh-list
154388468|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154388469|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388470|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154388471|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388472|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388473|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154388474|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154388475|NCT05328336|Paclitaxel|paclitaxel|mesh-list
154388476|NCT05328336|Tislelizumab|tislelizumab|mesh-list
154388477|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154388478|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388479|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154388480|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154388481|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154388482|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388483|NCT05328336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154388484|NCT02873754|Bupropion|bupropion|mesh-list
154388485|NCT02873754|Nicotine|nicotine|mesh-list
154388486|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154388487|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
154388488|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388489|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388490|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154388491|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154388492|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
154388493|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388494|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368215|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388495|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154388496|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
154388497|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154388498|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154388499|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154388500|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154388501|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
154388502|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154388503|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154388504|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388505|NCT03669614|Gallium citrate|gallium citrate|mesh-list
154134674|NCT00840242|Nicotine|nicotine|mesh-list
154388506|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388508|NCT05200260|Niraparib|niraparib|mesh-list
154388521|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388522|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154388524|NCT04792320|Antidotes|antidotes|mesh-ancestor
153404753|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
154388525|NCT04792320|Protective Agents|protective agents|mesh-ancestor
154388526|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388527|NCT03176758|Anesthetics|anesthetics|mesh-list
154388528|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
154388529|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388530|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388531|NCT03177070|Methylene Blue|methylene blue|mesh-list
154388532|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388533|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388534|NCT03680612|Cefepime|cefepime|mesh-list
154388535|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
154388536|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154388537|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388538|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154388539|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388540|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388541|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
154388542|NCT02410096|Miotics|miotics|mesh-ancestor
154388543|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
154388544|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388545|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388546|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154388547|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154388548|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
154388549|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154388550|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154388551|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
153828213|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
153828214|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
153828215|NCT00483743|Hormones|hormones|mesh-ancestor
153828216|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828217|NCT00483782|Paclitaxel|paclitaxel|mesh-list
153828218|NCT00483782|Bevacizumab|bevacizumab|mesh-list
153828219|NCT00483782|Carboplatin|carboplatin|mesh-list
153828220|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153828221|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828222|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
153828223|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
154388552|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388553|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388554|NCT04046939|Pramipexole|pramipexole|mesh-list
154388555|NCT04046939|Dexpramipexole|dexpramipexole|mesh-list
154388556|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
154388557|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388558|NCT04046939|Protective Agents|protective agents|mesh-ancestor
154388559|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388560|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
154388561|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388562|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154388563|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154388564|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
154388565|NCT05188131|Diclofenac|diclofenac|mesh-list
154388566|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154388567|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154388568|NCT05188131|Analgesics|analgesics|mesh-ancestor
154388569|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
154388570|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388571|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388589|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154388590|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388591|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
154388592|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
154388593|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154388594|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154388595|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388596|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388597|NCT01360671|Urological Agents|urological agents|mesh-ancestor
154388598|NCT02955797|Vaccines|vaccines|mesh-list
154388599|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
154388600|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388601|NCT03680378|Cefepime|cefepime|mesh-list
154388602|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154388603|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388604|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154388605|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
154388606|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154388607|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153828237|NCT01306162|Dronedarone|dronedarone|mesh-list
154388608|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
154388609|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388610|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388611|NCT03176524|Glucagon|glucagon|mesh-list
154388612|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153404798|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154388613|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388614|NCT03176524|Hormones|hormones|mesh-ancestor
154388615|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388616|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388617|NCT03176524|Incretins|incretins|mesh-ancestor
154388618|NCT03676088|Mitogens|mitogens|mesh-list
154388619|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
154388620|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388621|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
154388622|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154388623|NCT02414464|Calcium|calcium|mesh-list
154388624|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154388625|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750411|NCT00160043|Vatalanib|vatalanib|mesh-list
154388655|NCT03672812|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154388657|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388658|NCT03672812|Incretins|incretins|mesh-ancestor
154388659|NCT03672812|Hormones|hormones|mesh-ancestor
154388660|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388661|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154388662|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388663|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
154388664|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154388665|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388666|NCT05007652|Plerixafor|plerixafor|mesh-list
154388667|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154388693|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154388694|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154388695|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388696|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
154388697|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154388698|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154388699|NCT03675854|Cefazolin|cefazolin|mesh-list
154388700|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154388701|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388702|NCT01360827|Cisplatin|cisplatin|mesh-list
154388703|NCT01360827|Fluorouracil|fluorouracil|mesh-list
154388704|NCT01360827|Cetuximab|cetuximab|mesh-list
154388705|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388706|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
154388707|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388708|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154388709|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154388710|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
154388711|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388712|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154388713|NCT03171610|Fentanyl|fentanyl|mesh-list
154388714|NCT03171610|Sufentanil|sufentanil|mesh-list
154388715|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154388716|NCT03171610|Narcotics|narcotics|mesh-ancestor
154388726|NCT01364181|Udenafil|udenafil|mesh-list
154388727|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154388728|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154388729|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388730|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388731|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
154388732|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154388733|NCT03679442|Antidotes|antidotes|mesh-list
154388734|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388735|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
154388736|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388737|NCT03679442|Expectorants|expectorants|mesh-ancestor
154388738|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
154388739|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154388740|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
154388741|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388742|NCT03679442|Protective Agents|protective agents|mesh-ancestor
154388743|NCT01367535|Naltrexone|naltrexone|mesh-list
154388744|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
154388745|NCT01367535|Paroxetine|paroxetine|mesh-list
154388746|NCT01367535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153864478|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864479|NCT04599699|Androgens|androgens|mesh-list
154388747|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154388748|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154388749|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388750|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388751|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
154388752|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388753|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154388754|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
154388755|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154388756|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154388757|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154388758|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388759|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154388760|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
153368269|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153368270|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
153368271|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368272|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153368273|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
153368274|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153577775|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817769|NCT06110793|Fulvestrant|fulvestrant|mesh-list
153817770|NCT06110793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388761|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388762|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154388763|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
154388764|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
154388765|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154388766|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154388767|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388768|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388769|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388770|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388771|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
154388772|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154388773|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388774|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
154388775|NCT04482712|Sirolimus|sirolimus|mesh-list
154388776|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154388777|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388778|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154388779|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388780|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
154388781|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750557|NCT00544999|Cytarabine|cytarabine|mesh-list
154388803|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154388804|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388805|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388807|NCT04039919|Anticonvulsants|anticonvulsants|mesh-ancestor
154388808|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
154388809|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154388810|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388811|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
154388812|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388813|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
154388814|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154388815|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388816|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154388817|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388818|NCT01364415|Pasireotide|pasireotide|mesh-list
154388819|NCT01364415|Hormones|hormones|mesh-ancestor
154388820|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388821|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388822|NCT03176446|Anesthetics|anesthetics|mesh-list
154388823|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
154388824|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388825|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388826|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
154388827|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388828|NCT03176212|Milk fat globule|milk fat globule|mesh-list
154388829|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388830|NCT04035473|Paclitaxel|paclitaxel|mesh-list
154388831|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154388832|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388866|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
154388867|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154388868|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388869|NCT02408302|Midazolam|midazolam|mesh-list
154388870|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154388871|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153733410|NCT05148910|Copper|copper|mesh-list
153404962|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388872|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388873|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388874|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154135050|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
154388892|NCT02408146|Analgesics|analgesics|mesh-ancestor
154388893|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
154388894|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388895|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154388896|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154388897|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
154388898|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
154388899|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388900|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154388901|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154388902|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388903|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388904|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154388905|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154388906|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783808|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
154388907|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
154388908|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
154388909|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388910|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
154388911|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
154388912|NCT02408146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154388913|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154388914|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
154388915|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388916|NCT03175666|Leucovorin|leucovorin|mesh-list
154388917|NCT03175666|Paclitaxel|paclitaxel|mesh-list
154388918|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
154388919|NCT03175666|Bevacizumab|bevacizumab|mesh-list
154388920|NCT03175666|Capecitabine|capecitabine|mesh-list
154388921|NCT03175666|Fluorouracil|fluorouracil|mesh-list
154388922|NCT03175666|Avelumab|avelumab|mesh-list
154388923|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154388924|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388925|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
154388926|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
154388927|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
154388928|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388929|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154388930|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
154388931|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388932|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388933|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154388934|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
154388935|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153750724|NCT00191178|Insulin|insulin|mesh-list
154388944|NCT03175666|Protective Agents|protective agents|mesh-ancestor
154388945|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
154388947|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
154388948|NCT03101358|Paclitaxel|paclitaxel|mesh-list
154388949|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154135121|NCT00844142|Etanercept|etanercept|mesh-list
154388950|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154388951|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388952|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
154388953|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
154388954|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
154388955|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388956|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
154388957|NCT03171220|Fludarabine|fludarabine|mesh-list
154388958|NCT03171220|Interleukin-2|interleukin-2|mesh-list
154388959|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154388960|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
154388961|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388962|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388963|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154388964|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
154388965|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388966|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388967|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154388968|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154388969|NCT03171220|Analgesics|analgesics|mesh-ancestor
154388970|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
154388971|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388973|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
154388974|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388975|NCT03170596|Tazarotene|tazarotene|mesh-list
154388976|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
154388977|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
154388978|NCT03173326|Anesthetics|anesthetics|mesh-list
154388979|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388980|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388981|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
154388982|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154388983|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154388984|NCT02403856|Prednisolone|prednisolone|mesh-list
154388985|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
154388986|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154388987|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
154388988|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388989|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
154388990|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
154388991|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388992|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388993|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388994|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
154388995|NCT02403856|Hormones|hormones|mesh-ancestor
154388996|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388997|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154388998|NCT02403856|Protective Agents|protective agents|mesh-ancestor
154388999|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154389000|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389001|NCT03170284|Bevacizumab|bevacizumab|mesh-list
154389002|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389003|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389031|NCT03169738|Fluorouracil|fluorouracil|mesh-list
154389032|NCT03169738|Nivolumab|nivolumab|mesh-list
154389033|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
154389034|NCT03169738|Fulvestrant|fulvestrant|mesh-list
154389035|NCT03169738|Avelumab|avelumab|mesh-list
154389036|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389037|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389038|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154389039|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
154389040|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389041|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154389042|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154389043|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
154389044|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154389045|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389046|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154389047|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154389048|NCT03169738|Growth Substances|growth substances|mesh-ancestor
154389049|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
154389050|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154389051|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
154389052|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154389053|NCT03169738|Antidotes|antidotes|mesh-ancestor
154389054|NCT03169738|Protective Agents|protective agents|mesh-ancestor
154389062|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389064|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
154389065|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
154389066|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
154389067|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389068|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389069|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154389070|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154389071|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389072|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389073|NCT02403544|Capecitabine|capecitabine|mesh-list
154389074|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
154389075|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154389076|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
154389077|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389078|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389079|NCT02411344|Pertuzumab|pertuzumab|mesh-list
154260687|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260688|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154389080|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389081|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389083|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154389084|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
154389085|NCT02407366|Carboplatin|carboplatin|mesh-list
154389086|NCT02407366|Pemetrexed|pemetrexed|mesh-list
154389087|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389088|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389089|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389090|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154389091|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154389092|NCT03738137|Lidocaine|lidocaine|mesh-list
154389093|NCT03738137|Midazolam|midazolam|mesh-list
154389094|NCT03738137|Sufentanil|sufentanil|mesh-list
154389095|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
154389096|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
154389097|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389098|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389099|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
154389100|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389101|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154389102|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154389103|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154389104|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389105|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389106|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154389107|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154389108|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154389109|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154389110|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154389111|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154389112|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
154389113|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
154389114|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
154389115|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389116|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154389117|NCT03738137|Narcotics|narcotics|mesh-ancestor
154389118|NCT03738137|Analgesics|analgesics|mesh-ancestor
154389119|NCT02407210|Olmesartan|olmesartan|mesh-list
154389120|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154389121|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154389122|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154389123|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154389139|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154389140|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154389141|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
154389142|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154389143|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389144|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389145|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389146|NCT03738059|Analgesics|analgesics|mesh-ancestor
154389147|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
154389148|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389149|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154389150|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154389151|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154389152|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
154389153|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389154|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389155|NCT05233462|Bupivacaine|bupivacaine|mesh-list
153828330|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
153828331|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828332|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828333|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153828334|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
153828335|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153828336|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153828337|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153828338|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828339|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
153828343|NCT01303627|Remifentanil|remifentanil|mesh-list
153817771|NCT06110793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153817772|NCT06110793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389156|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
154389157|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
154389158|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389159|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389160|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
154389161|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389162|NCT02700412|Cannabidiol|cannabidiol|mesh-list
154389163|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
154389164|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
154389165|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154389166|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154389167|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154389168|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389169|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389170|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
154389171|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389172|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389173|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154389174|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389175|NCT02288832|Azithromycin|azithromycin|mesh-list
154389176|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154389177|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389179|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154389180|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750955|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389192|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389193|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154389194|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154389195|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154389196|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389197|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154389198|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
154389199|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389200|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154389201|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154389202|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389203|NCT03665441|Antidotes|antidotes|mesh-ancestor
154389204|NCT03665441|Protective Agents|protective agents|mesh-ancestor
154389205|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
154389206|NCT03665441|Vitamins|vitamins|mesh-ancestor
154389207|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
154389208|NCT03169660|Aflibercept|aflibercept|mesh-list
154389209|NCT03169660|Mitogens|mitogens|mesh-list
154389210|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
154389211|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
154389212|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389213|NCT03169660|Growth Substances|growth substances|mesh-ancestor
154389214|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389215|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154389216|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154389217|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
154389218|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389219|NCT02401828|Dolutegravir|dolutegravir|mesh-list
154389220|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154389221|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154389222|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389223|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389224|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154389225|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154389226|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
154389227|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389228|NCT02401594|Enoxaparin|enoxaparin|mesh-list
154389229|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
154389230|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154389231|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
154389232|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154389233|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
154389234|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389235|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389236|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
154389237|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154389238|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154389239|NCT02406508|Sorafenib|sorafenib|mesh-list
154389240|NCT02406508|Melphalan|melphalan|mesh-list
154389241|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389242|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368388|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783835|NCT00262236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783836|NCT00237302|Topiramate|topiramate|mesh-list
154389243|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389244|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389245|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154389246|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
154389247|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154389257|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
154389258|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154389259|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154389260|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389261|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389262|NCT03169582|Urological Agents|urological agents|mesh-ancestor
154389263|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
154389264|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154389265|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154389266|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154389267|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389268|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389269|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
154389270|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389271|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389272|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154389273|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389274|NCT03169504|Fluticasone|fluticasone|mesh-list
154389275|NCT03169504|Xhance|xhance|mesh-list
154389276|NCT03169504|Bromides|bromides|mesh-list
154389277|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
154389278|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154389279|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154389280|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
154389281|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389282|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389283|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154389284|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
154389285|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
154389286|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154389287|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
154389288|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154389289|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
153828373|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153817773|NCT06110793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817774|NCT06110793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817775|NCT06110793|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153817776|NCT06110793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153817777|NCT06110793|Hormone Antagonists|hormone antagonists|mesh-ancestor
153817778|NCT06110793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817779|NCT06110793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817780|NCT06097676|Gabapentin|gabapentin|mesh-list
153817781|NCT06097676|Alprazolam|alprazolam|mesh-list
153459147|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153459148|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459149|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153459150|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459151|NCT04747080|Dexamethasone|dexamethasone|mesh-list
153459152|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
153459153|NCT04747080|BB 1101|bb 1101|mesh-list
153459154|NCT04747080|Tacrolimus|tacrolimus|mesh-list
154389290|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389291|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389292|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
154389293|NCT03169426|Carvedilol|carvedilol|mesh-list
154389294|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154389295|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154389296|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
154389297|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389298|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389299|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389300|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154389301|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
154389302|NCT03169426|Protective Agents|protective agents|mesh-ancestor
154389303|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154389304|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389305|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154389306|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
154389307|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154389308|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154389309|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
154389310|NCT03169348|Ledipasvir|ledipasvir|mesh-list
154389311|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154389317|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389319|NCT03631355|Coagulants|coagulants|mesh-ancestor
154389320|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
154389321|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154389322|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368406|NCT02980094|Vitamin E|vitamin e|mesh-list
153368407|NCT02980094|Tocopherols|tocopherols|mesh-list
153368408|NCT02980094|Tocotrienols|tocotrienols|mesh-list
154389323|NCT03679052|Clonidine|clonidine|mesh-list
153368409|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
154389324|NCT03679052|Mirtazapine|mirtazapine|mesh-list
153368410|NCT02980094|Selenium|selenium|mesh-list
153783837|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
154389325|NCT03679052|Analgesics|analgesics|mesh-ancestor
154389326|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
153783838|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154389327|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389328|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389329|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154389330|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
154135493|NCT00992355|Analgesics|analgesics|mesh-ancestor
154389331|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
154389332|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154389334|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154389335|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
154389336|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389337|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405264|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389338|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
154389339|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154389340|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154389341|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
154389342|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
154389343|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154389344|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154389345|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389346|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154389347|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154389348|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154389349|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154389350|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154389351|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
154389352|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154389353|NCT03540914|Acetazolamide|acetazolamide|mesh-list
154389354|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
154389355|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154389356|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389357|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389358|NCT03540914|Diuretics|diuretics|mesh-ancestor
154389359|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
154389360|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389361|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
154389362|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154389363|NCT03629249|Growth Substances|growth substances|mesh-ancestor
154389364|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389365|NCT03671174|Aspirin|aspirin|mesh-list
154389366|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
154389367|NCT03671174|Prednisone|prednisone|mesh-list
154389368|NCT03671174|Heparin|heparin|mesh-list
154389369|NCT03671174|Enoxaparin|enoxaparin|mesh-list
154389370|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154389371|NCT03671174|Tinzaparin|tinzaparin|mesh-list
154389372|NCT03671174|Dalteparin|dalteparin|mesh-list
154389373|NCT03671174|Nadroparin|nadroparin|mesh-list
154389374|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154389375|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
154389376|NCT03671174|Hormones|hormones|mesh-ancestor
154389377|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389378|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389379|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154389380|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389381|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154389382|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389393|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
154389394|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
154389395|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
154389396|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154389397|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154389398|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389399|NCT03172234|Amantadine|amantadine|mesh-list
154389400|NCT03172234|Gabapentin|gabapentin|mesh-list
154389401|NCT03172234|Analgesics|analgesics|mesh-ancestor
154389402|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
154389403|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389404|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389405|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
154389406|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154389407|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154389408|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389410|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154389411|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154389412|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389413|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389414|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
154389415|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154389416|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154389417|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
154389418|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389419|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
154389420|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389421|NCT03709849|Citric Acid|citric acid|mesh-list
154389422|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
154389423|NCT03709849|Clomiphene|clomiphene|mesh-list
154389424|NCT03709849|Enclomiphene|enclomiphene|mesh-list
154389425|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
154389426|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
154389427|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154389428|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
154389429|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
154389430|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389431|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154389432|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
154389433|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389434|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389435|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154389436|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
154389437|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154389438|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154389439|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154389440|NCT05343325|Paclitaxel|paclitaxel|mesh-list
154389441|NCT05343325|Cisplatin|cisplatin|mesh-list
154389442|NCT05343325|Tislelizumab|tislelizumab|mesh-list
154389443|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154389444|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154389445|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389446|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
154389447|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
154389448|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
154389449|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389470|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389471|NCT03365011|Analgesics|analgesics|mesh-ancestor
154389472|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
154389473|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389474|NCT03627767|Abrocitinib|abrocitinib|mesh-list
154389475|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154389476|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389477|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389478|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154389479|NCT03732365|Cefazolin|cefazolin|mesh-list
154389480|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135647|NCT00853268|Oxycodone|oxycodone|mesh-list
154389481|NCT03732287|Anesthetics|anesthetics|mesh-list
154389482|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389483|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389484|NCT02142738|Paclitaxel|paclitaxel|mesh-list
154389485|NCT02142738|Carboplatin|carboplatin|mesh-list
154389486|NCT02142738|Gemcitabine|gemcitabine|mesh-list
154389487|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
154389488|NCT02142738|Pemetrexed|pemetrexed|mesh-list
154389489|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154389490|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389491|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154389492|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154389493|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154389494|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389495|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154389496|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
154389497|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389498|NCT02142738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154389499|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389500|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154389501|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154389502|NCT03617861|Secretin|secretin|mesh-list
153368447|NCT00363519|Hormones|hormones|mesh-ancestor
154389503|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368448|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368449|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154389504|NCT03617861|Hormones|hormones|mesh-ancestor
154182192|NCT05868525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389523|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
154389524|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389525|NCT03096288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154389526|NCT03096288|Protease Inhibitors|protease inhibitors|mesh-ancestor
154389527|NCT03096288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368450|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
153368451|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368452|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389528|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154389529|NCT03731897|Lidocaine|lidocaine|mesh-list
154389530|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
154389531|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
154389532|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389533|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389534|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
154389535|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389536|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154389537|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154389538|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154389539|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389540|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389541|NCT02072148|Cisplatin|cisplatin|mesh-list
154389542|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389545|NCT03095508|Menthol|menthol|mesh-list
154389546|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
154389547|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
154389548|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154389549|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
154389550|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154389551|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154389552|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
154389553|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389554|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389555|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
154389556|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154389557|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389558|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389559|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154389560|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154389571|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154389572|NCT03731429|Lidocaine|lidocaine|mesh-list
154389573|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
154389574|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
154389575|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389576|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389577|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
154389578|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389579|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154389580|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154389581|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154389582|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389583|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389584|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154389585|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
154389586|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
154389587|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389588|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
154389589|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154389590|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154389591|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389592|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
154389593|NCT03653429|Coagulants|coagulants|mesh-ancestor
154389594|NCT03731117|Furosemide|furosemide|mesh-list
154389595|NCT03731117|Diuretics|diuretics|mesh-ancestor
154389596|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
154389597|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389598|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154389599|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389600|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389601|NCT03735251|Metoprolol|metoprolol|mesh-list
154389602|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154389603|NCT03735251|Diuretics|diuretics|mesh-list
154389604|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
154389605|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389606|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154389607|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154389608|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
154389609|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
154389610|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389611|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154389612|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154389613|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154389614|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
154389615|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389616|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865040|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154389617|NCT03098550|Nivolumab|nivolumab|mesh-list
154389618|NCT03098550|Daratumumab|daratumumab|mesh-list
154389619|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389620|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389621|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154389622|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389623|NCT03095118|Daratumumab|daratumumab|mesh-list
153751387|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
154389633|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389634|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154389635|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154389636|NCT03115762|Growth Substances|growth substances|mesh-ancestor
154389637|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389638|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
154389640|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154389641|NCT03168958|Narcotics|narcotics|mesh-ancestor
154389642|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389643|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389644|NCT03168958|Analgesics|analgesics|mesh-ancestor
154389645|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
154389646|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389647|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
154389648|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
154389649|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
154389650|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154389651|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389652|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389653|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389654|NCT03632460|Analgesics|analgesics|mesh-ancestor
154389655|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
154389656|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389657|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154389658|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154389659|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154389660|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
154389661|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389662|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389663|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
154389664|NCT05418660|Nivolumab|nivolumab|mesh-list
154389665|NCT05418660|Atezolizumab|atezolizumab|mesh-list
154389666|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389667|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389668|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154389669|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389670|NCT03364309|Ixekizumab|ixekizumab|mesh-list
154389671|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
154389672|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154389673|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154389674|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389675|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
154389676|NCT05166096|Aspirin|aspirin|mesh-list
154389677|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154389678|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389679|NCT05166096|Analgesics|analgesics|mesh-ancestor
154389680|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
154389681|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389682|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389683|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154389684|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154389685|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154389686|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154389687|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389688|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153751452|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389699|NCT03700788|Calcium|calcium|mesh-list
154389700|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154389701|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389702|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154389703|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389704|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
154389705|NCT03334903|Gabapentin|gabapentin|mesh-list
153865165|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389706|NCT03334903|Analgesics|analgesics|mesh-ancestor
154389707|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
154389708|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389709|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389710|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
154389711|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154389712|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154389713|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389714|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154389715|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153368488|NCT02322320|Growth Substances|growth substances|mesh-ancestor
153368489|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
153368490|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368491|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
154389716|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154389717|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389718|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389719|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
154389720|NCT03168100|Dexamethasone|dexamethasone|mesh-list
154389721|NCT03168100|Lenalidomide|lenalidomide|mesh-list
154389722|NCT03168100|Bortezomib|bortezomib|mesh-list
154389723|NCT03168100|Elotuzumab|elotuzumab|mesh-list
154389724|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154389725|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
153368492|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153368493|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368494|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153368495|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368496|NCT01127438|Fospropofol|fospropofol|mesh-list
154389726|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
154389727|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389728|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389729|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154389730|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
154389731|NCT03168100|Hormones|hormones|mesh-ancestor
154389732|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389733|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154389734|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389735|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
154389736|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154389737|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154389738|NCT03168100|Growth Substances|growth substances|mesh-ancestor
154389739|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
154389740|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154389741|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154389742|NCT03709381|Cosyntropin|cosyntropin|mesh-list
154389743|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
154389744|NCT03709381|Hormones|hormones|mesh-ancestor
154389745|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389746|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389747|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389748|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389749|NCT01353664|Romidepsin|romidepsin|mesh-list
154389750|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154389751|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389752|NCT01353664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154389753|NCT01353664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389754|NCT01353664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389755|NCT02395744|Paclitaxel|paclitaxel|mesh-list
154389775|NCT02694328|Olanzapine|olanzapine|mesh-list
154389776|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
154389777|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
154389778|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389779|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368497|NCT01127438|Propofol|propofol|mesh-list
154389780|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783851|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154389781|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154389782|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154389783|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389784|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154389785|NCT02694328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154389786|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154389787|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389788|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389789|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389790|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
154389791|NCT02395510|Vortioxetine|vortioxetine|mesh-list
154389792|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
154389793|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154389794|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154389795|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154389796|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389798|NCT02395510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154389799|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154389800|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389801|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389802|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389803|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
154389804|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154389805|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153751582|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389818|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389819|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154389820|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
154389822|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389823|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154389824|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
154389825|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389826|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389827|NCT02399566|Pemetrexed|pemetrexed|mesh-list
154389828|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154389829|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389830|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389831|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389832|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154389833|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154389834|NCT02399566|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154389835|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154389836|NCT03167164|Leucovorin|leucovorin|mesh-list
154389837|NCT03167164|Paclitaxel|paclitaxel|mesh-list
154389838|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
154389839|NCT03167164|Bevacizumab|bevacizumab|mesh-list
154389840|NCT03167164|Capecitabine|capecitabine|mesh-list
154389841|NCT03167164|Fluorouracil|fluorouracil|mesh-list
153368513|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153368514|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
154389842|NCT03167164|Avelumab|avelumab|mesh-list
154389843|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153368515|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154389844|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389845|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
154389846|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
154389847|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
154389848|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389849|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154389850|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
154389851|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389852|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153368516|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368518|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154389853|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154389854|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
154389855|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154389856|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389857|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154389858|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154389859|NCT03167164|Growth Substances|growth substances|mesh-ancestor
154389860|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
154389861|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154389862|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
154389864|NCT03167164|Protective Agents|protective agents|mesh-ancestor
154389865|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
154389866|NCT03167164|Vitamins|vitamins|mesh-ancestor
154389867|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
154389868|NCT03334747|Lumefantrine|lumefantrine|mesh-list
154389869|NCT03334747|Artemether|artemether|mesh-list
154389870|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154389883|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154389884|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154389885|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389886|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154389887|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154389888|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
154389889|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389890|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389891|NCT02394496|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154389892|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153865527|NCT00562289|Analgesics|analgesics|mesh-ancestor
154389893|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389894|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389895|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154389896|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
154389897|NCT02394418|Propofol|propofol|mesh-list
154389898|NCT02394418|Sevoflurane|sevoflurane|mesh-list
154389899|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154389900|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389901|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389902|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389903|NCT02394418|Analgesics|analgesics|mesh-ancestor
154389904|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
153783855|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783856|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
153415251|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389905|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389906|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154389907|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154389908|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154389909|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154389910|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154389911|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389912|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154389913|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
154389914|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
154389915|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154389916|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154389917|NCT06336395|Cytarabine|cytarabine|mesh-list
154389918|NCT06336395|Dexamethasone|dexamethasone|mesh-list
154389919|NCT06336395|Prednisolone|prednisolone|mesh-list
154389920|NCT06336395|Cyclophosphamide|cyclophosphamide|mesh-list
154389921|NCT06336395|Rituximab|rituximab|mesh-list
154389922|NCT06336395|Doxorubicin|doxorubicin|mesh-list
154389923|NCT06336395|Methotrexate|methotrexate|mesh-list
154389924|NCT06336395|Fludarabine|fludarabine|mesh-list
154389925|NCT06336395|Vincristine|vincristine|mesh-list
154389926|NCT06336395|Asparaginase|asparaginase|mesh-list
154389927|NCT06336395|Dasatinib|dasatinib|mesh-list
154389928|NCT06336395|Mercaptopurine|mercaptopurine|mesh-list
154389929|NCT06336395|Thioguanine|thioguanine|mesh-list
154389930|NCT06336395|Pegaspargase|pegaspargase|mesh-list
154389931|NCT06336395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154389932|NCT06336395|Immunologic Factors|immunologic factors|mesh-ancestor
154389933|NCT06336395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389935|NCT06336395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154389936|NCT06336395|Alkylating Agents|alkylating agents|mesh-ancestor
153751696|NCT00185562|Adalimumab|adalimumab|mesh-list
154389965|NCT06336395|Tubulin Modulators|tubulin modulators|mesh-ancestor
154389966|NCT06336395|Antimitotic Agents|antimitotic agents|mesh-ancestor
154389967|NCT06336395|Mitosis Modulators|mitosis modulators|mesh-ancestor
154389968|NCT06336395|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154389969|NCT06336395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154389970|NCT06336291|Lomustine|lomustine|mesh-list
154389971|NCT06336291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154389972|NCT06336291|Alkylating Agents|alkylating agents|mesh-ancestor
154389973|NCT06336291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389974|NCT06336291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389975|NCT06336213|Ampicillin|ampicillin|mesh-list
154389976|NCT06336213|Sulbactam|sulbactam|mesh-list
154389977|NCT06336213|Sultamicillin|sultamicillin|mesh-list
154389978|NCT06336213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154389979|NCT06336213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389980|NCT06336213|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154389990|NCT06336174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389991|NCT06336174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389992|NCT06336174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154389993|NCT06336174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154389994|NCT06336174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154389995|NCT06336174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154389996|NCT06336174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389997|NCT06336174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154389998|NCT06336174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154389999|NCT06336174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390000|NCT06336174|Antipyretics|antipyretics|mesh-ancestor
154390001|NCT06336174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154390002|NCT06336174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154390003|NCT06336174|Antimetabolites|antimetabolites|mesh-ancestor
154390004|NCT06336174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154390005|NCT06336174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153406087|NCT05426525|Empagliflozin|empagliflozin|mesh-list
154390006|NCT06336174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154390007|NCT06336174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154390008|NCT06336174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154390009|NCT06336174|Purinergic Agents|purinergic agents|mesh-ancestor
154390010|NCT06336174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390012|NCT06336161|Propofol|propofol|mesh-list
154390013|NCT06336161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154390014|NCT06336161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390015|NCT06336161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390016|NCT06336161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154390017|NCT06336161|Anesthetics, General|anesthetics, general|mesh-ancestor
154390018|NCT06336161|Anesthetics|anesthetics|mesh-ancestor
154390019|NCT06336161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154390020|NCT06336161|Narcotics|narcotics|mesh-ancestor
154390021|NCT06336161|Analgesics|analgesics|mesh-ancestor
154390022|NCT06336161|Sensory System Agents|sensory system agents|mesh-ancestor
154390023|NCT06336161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390024|NCT06336161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154390025|NCT06335914|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154390026|NCT06335914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154390027|NCT06335914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390028|NCT06335797|Bisacodyl|bisacodyl|mesh-list
154390029|NCT06335797|Cathartics|cathartics|mesh-ancestor
154390030|NCT06335797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154390031|NCT06335797|Laxatives|laxatives|mesh-ancestor
154390032|NCT06335537|Potassium Citrate|potassium citrate|mesh-list
154390033|NCT06335537|Diuretics|diuretics|mesh-ancestor
154390034|NCT06335537|Natriuretic Agents|natriuretic agents|mesh-ancestor
154390035|NCT06335537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390036|NCT06335537|Expectorants|expectorants|mesh-ancestor
154390037|NCT06335537|Respiratory System Agents|respiratory system agents|mesh-ancestor
154390038|NCT06335407|Dexmedetomidine|dexmedetomidine|mesh-list
154390039|NCT06335407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154390040|NCT06335407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390041|NCT06335407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390042|NCT06335407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154390043|NCT06335407|Analgesics|analgesics|mesh-ancestor
154390044|NCT06335407|Sensory System Agents|sensory system agents|mesh-ancestor
154390045|NCT06335407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390046|NCT06335407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154390047|NCT06335407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153751803|NCT00185952|Nifedipine|nifedipine|mesh-list
154390060|NCT06335316|Anesthetics, Local|anesthetics, local|mesh-ancestor
154390061|NCT06335316|Anesthetics|anesthetics|mesh-ancestor
154390062|NCT06335316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390063|NCT06335316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390064|NCT06335316|Sensory System Agents|sensory system agents|mesh-ancestor
154390065|NCT06335316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390066|NCT06335316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154390067|NCT06335316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154390068|NCT06335316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154390069|NCT06335316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154390070|NCT06335316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390071|NCT06335160|Mebendazole|mebendazole|mesh-list
154390072|NCT06335160|Piperazine|piperazine|mesh-list
154390073|NCT06335160|Piperazine citrate|piperazine citrate|mesh-list
154390074|NCT06335160|DMP 777|dmp 777|mesh-list
154390075|NCT06335160|Antinematodal Agents|antinematodal agents|mesh-ancestor
154390076|NCT06335160|Anthelmintics|anthelmintics|mesh-ancestor
154390077|NCT06335160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154390078|NCT06335160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390079|NCT06335160|Tubulin Modulators|tubulin modulators|mesh-ancestor
154390080|NCT06335160|Antimitotic Agents|antimitotic agents|mesh-ancestor
154390081|NCT06335160|Mitosis Modulators|mitosis modulators|mesh-ancestor
154390082|NCT06335160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368547|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368548|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153368549|NCT02481375|Iron|iron|mesh-list
153368550|NCT02481375|Trace Elements|trace elements|mesh-list
153368551|NCT02481375|Micronutrients|micronutrients|mesh-list
153368552|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390083|NCT06335160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390084|NCT06335160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390085|NCT06335134|Metformin|metformin|mesh-list
154390086|NCT06335134|Digoxin|digoxin|mesh-list
154390087|NCT06335134|Warfarin|warfarin|mesh-list
154390088|NCT06335134|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154390089|NCT06335134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154390090|NCT06335134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260689|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260690|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
154260691|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260692|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260693|NCT03851432|Metformin|metformin|mesh-list
154390091|NCT06335134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154390092|NCT06335134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154390093|NCT06335134|Antimetabolites|antimetabolites|mesh-ancestor
154390094|NCT06335134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390095|NCT06335134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154390096|NCT06335134|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154390097|NCT06335134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390098|NCT06335134|Anticoagulants|anticoagulants|mesh-ancestor
154390099|NCT06335134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154390100|NCT06335134|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154390101|NCT06335134|Protective Agents|protective agents|mesh-ancestor
154390102|NCT06335108|Anesthetics|anesthetics|mesh-list
154390103|NCT06335108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390104|NCT06335108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368553|NCT01164098|Rituximab|rituximab|mesh-list
154390105|NCT06335069|FAPI-46|fapi-46|mesh-list
154390106|NCT06335069|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154390107|NCT06335069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390108|NCT06334991|Rituximab|rituximab|mesh-list
154390109|NCT06334991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153751864|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
154390116|NCT06334965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154390117|NCT06334965|Antimetabolites|antimetabolites|mesh-ancestor
153368554|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368555|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368556|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
154390118|NCT06334965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390119|NCT06334965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154390120|NCT06334965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154390121|NCT06334965|Nootropic Agents|nootropic agents|mesh-ancestor
154390122|NCT06334822|Caffeine|caffeine|mesh-list
154390123|NCT06334822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154390124|NCT06334822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390125|NCT06334822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154390126|NCT06334822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390127|NCT06334822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390128|NCT06334822|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154390129|NCT06334822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154390130|NCT06334822|Purinergic Agents|purinergic agents|mesh-ancestor
154390131|NCT06334822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390132|NCT06334757|Bevacizumab|bevacizumab|mesh-list
154390133|NCT06334757|Carboplatin|carboplatin|mesh-list
154390134|NCT06334757|Pemetrexed|pemetrexed|mesh-list
154390135|NCT06334757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390136|NCT06334757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390137|NCT06334757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154390138|NCT06334757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154390139|NCT06334757|Growth Substances|growth substances|mesh-ancestor
154390140|NCT06334757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390141|NCT06334757|Growth Inhibitors|growth inhibitors|mesh-ancestor
154390142|NCT06334757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390143|NCT06334757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390144|NCT06334757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154390145|NCT06334757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154390146|NCT06334705|Calcium|calcium|mesh-list
154390147|NCT06334705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154390148|NCT06334705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390149|NCT06334575|Budesonide|budesonide|mesh-list
154390150|NCT06334575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154390151|NCT06334575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154390152|NCT06334575|Autonomic Agents|autonomic agents|mesh-ancestor
154390153|NCT06334575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390154|NCT06334575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390155|NCT06334575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154390156|NCT06334575|Respiratory System Agents|respiratory system agents|mesh-ancestor
154390157|NCT06334575|Glucocorticoids|glucocorticoids|mesh-ancestor
154390158|NCT06334575|Hormones|hormones|mesh-ancestor
154260694|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154260695|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390159|NCT06334575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154390160|NCT06334562|Neostigmine|neostigmine|mesh-list
154390161|NCT06334562|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154390162|NCT06334562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390163|NCT06334562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390164|NCT06334562|Cholinergic Agents|cholinergic agents|mesh-ancestor
154390165|NCT06334562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390166|NCT06334562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390167|NCT06334562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154390168|NCT06334562|Autonomic Agents|autonomic agents|mesh-ancestor
154390169|NCT06334562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390170|NCT06334549|Phenylephrine|phenylephrine|mesh-list
153368572|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368573|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153368574|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
153368575|NCT01129778|Omeprazole|omeprazole|mesh-list
153368576|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153368577|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
153368578|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153368579|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368580|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390171|NCT06334549|Oxymetazoline|oxymetazoline|mesh-list
154390172|NCT06334549|Norepinephrine|norepinephrine|mesh-list
154390173|NCT06334549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154390174|NCT06334549|Ephedrine|ephedrine|mesh-list
154390175|NCT06334549|Pseudoephedrine|pseudoephedrine|mesh-list
154390176|NCT06334549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154390177|NCT06334549|Mydriatics|mydriatics|mesh-ancestor
154390178|NCT06334549|Autonomic Agents|autonomic agents|mesh-ancestor
153751928|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154390187|NCT06334549|Adrenergic Agents|adrenergic agents|mesh-ancestor
154390188|NCT06334549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390189|NCT06334549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390190|NCT06334549|Protective Agents|protective agents|mesh-ancestor
154390191|NCT06334549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154390192|NCT06334549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154390193|NCT06334549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154390194|NCT06334497|Valganciclovir|valganciclovir|mesh-list
154390196|NCT06334497|Antiviral Agents|antiviral agents|mesh-ancestor
154390197|NCT06334497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390198|NCT06334497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154390199|NCT06334497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390200|NCT06334497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390201|NCT06334497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390202|NCT06334419|Gaboxadol|gaboxadol|mesh-list
154390203|NCT06334419|Analgesics|analgesics|mesh-ancestor
154390204|NCT06334419|Sensory System Agents|sensory system agents|mesh-ancestor
154390205|NCT06334419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390206|NCT06334419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390207|NCT06334419|Anticonvulsants|anticonvulsants|mesh-ancestor
154390208|NCT06334419|GABA Agonists|gaba agonists|mesh-ancestor
154390209|NCT06334419|GABA Agents|gaba agents|mesh-ancestor
154390210|NCT06334419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390211|NCT06334419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390212|NCT06334393|1018 oligonucleotide|1018 oligonucleotide|mesh-list
154390213|NCT06334393|MEDI9197|medi9197|mesh-list
154390214|NCT06334393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154390215|NCT06334393|Immunologic Factors|immunologic factors|mesh-ancestor
154390216|NCT06334393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390217|NCT06334315|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154390218|NCT06334315|Desogestrel|desogestrel|mesh-list
153415253|NCT00367471|Carboplatin|carboplatin|mesh-list
153828570|NCT00484601|Ifosfamide|ifosfamide|mesh-list
153459155|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153459156|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
153459157|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
153459158|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577780|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577781|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153577783|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153577784|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390219|NCT06334315|Estradiol|estradiol|mesh-list
154390220|NCT06334315|Estrogens|estrogens|mesh-ancestor
154390221|NCT06334315|Hormones|hormones|mesh-ancestor
153577785|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153577786|NCT01719770|Rocuronium|rocuronium|mesh-list
154390222|NCT06334315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154390223|NCT06334315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390224|NCT06334315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154390225|NCT06334315|Contraceptive Agents|contraceptive agents|mesh-ancestor
154390226|NCT06334315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154390227|NCT06334315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154390228|NCT06334315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154390229|NCT06334315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154390230|NCT06334315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154390231|NCT06334315|Progestins|progestins|mesh-ancestor
154390232|NCT06334198|Tramadol|tramadol|mesh-list
154390233|NCT06334198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154390234|NCT06334198|Narcotics|narcotics|mesh-ancestor
154390235|NCT06334198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390236|NCT06334198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390238|NCT06334198|Sensory System Agents|sensory system agents|mesh-ancestor
154390239|NCT06334198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390246|NCT06333041|Cannabidiol|cannabidiol|mesh-list
154390271|NCT06330168|Anesthetics|anesthetics|mesh-ancestor
154390272|NCT06330168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390273|NCT06330168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390274|NCT06330168|Sensory System Agents|sensory system agents|mesh-ancestor
154390275|NCT06330168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390276|NCT06330168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154390277|NCT06330168|Narcotics|narcotics|mesh-ancestor
154390278|NCT06330168|Analgesics|analgesics|mesh-ancestor
154390279|NCT06330168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154390280|NCT06330168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154390281|NCT06330168|Anesthetics, General|anesthetics, general|mesh-ancestor
154390282|NCT06330168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154390283|NCT06330168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154390284|NCT06330168|Vasodilator Agents|vasodilator agents|mesh-ancestor
154390285|NCT06330038|Propofol|propofol|mesh-list
154390286|NCT06330038|Anesthetics|anesthetics|mesh-list
154390287|NCT06330038|Sevoflurane|sevoflurane|mesh-list
154390288|NCT06330038|Desflurane|desflurane|mesh-list
154390289|NCT06330038|Isoflurane|isoflurane|mesh-list
154390290|NCT06330038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154390291|NCT06330038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390292|NCT06330038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390293|NCT06330038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153577787|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154390294|NCT06330038|Anesthetics, General|anesthetics, general|mesh-ancestor
154390295|NCT06330038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154390296|NCT06330038|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154390297|NCT06329661|Cyclosporine|cyclosporine|mesh-list
154390298|NCT06329661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154390299|NCT06329661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154390300|NCT06329661|Cyclosporins|cyclosporins|mesh-list
154390301|NCT06329661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390302|NCT06329661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390303|NCT06329661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154390304|NCT06329661|Immunologic Factors|immunologic factors|mesh-ancestor
154390305|NCT06329661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390306|NCT06329661|Antifungal Agents|antifungal agents|mesh-ancestor
154390307|NCT06329661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390308|NCT06329661|Dermatologic Agents|dermatologic agents|mesh-ancestor
154390309|NCT06329661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154390310|NCT06329661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154136470|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154390311|NCT06328673|Pembrolizumab|pembrolizumab|mesh-list
154390312|NCT06328673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390313|NCT06328673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390314|NCT06328673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154390315|NCT06328673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390347|NCT06319820|Antimetabolites|antimetabolites|mesh-ancestor
154390348|NCT06319820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390349|NCT06319820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390350|NCT06318403|Estrogens|estrogens|mesh-list
154390351|NCT06318403|Hormones|hormones|mesh-ancestor
154390352|NCT06318403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154390353|NCT06318403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390359|NCT06313047|Doxorubicin|doxorubicin|mesh-list
154390360|NCT06313047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154390361|NCT06313047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390362|NCT06313047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154390363|NCT06313047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154390364|NCT06313047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390365|NCT06313047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390366|NCT06304974|Paclitaxel|paclitaxel|mesh-list
154390367|NCT06304974|Docetaxel|docetaxel|mesh-list
153415254|NCT00367471|Trastuzumab|trastuzumab|mesh-list
154390368|NCT06304974|Irinotecan|irinotecan|mesh-list
154390369|NCT06304974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154390370|NCT06304974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390371|NCT06304974|Tubulin Modulators|tubulin modulators|mesh-ancestor
154390372|NCT06304974|Antimitotic Agents|antimitotic agents|mesh-ancestor
154390373|NCT06304974|Mitosis Modulators|mitosis modulators|mesh-ancestor
154390374|NCT06304974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752129|NCT05807659|Alkylating Agents|alkylating agents|mesh-ancestor
154390396|NCT06267001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390397|NCT06256510|Midazolam|midazolam|mesh-list
154390398|NCT06256510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154390399|NCT06256510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154390400|NCT06256510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260696|NCT01192490|Lidocaine|lidocaine|mesh-list
154260697|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154260698|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
153866048|NCT04618601|Diuretics|diuretics|mesh-ancestor
154390401|NCT06256510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390402|NCT06256510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154390403|NCT06256510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154390404|NCT06256510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154390405|NCT06256510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154390406|NCT06256510|Anesthetics, General|anesthetics, general|mesh-ancestor
154390407|NCT06256510|Anesthetics|anesthetics|mesh-ancestor
154390408|NCT06256510|GABA Modulators|gaba modulators|mesh-ancestor
154390409|NCT06256510|GABA Agents|gaba agents|mesh-ancestor
154390410|NCT06256510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390411|NCT06256510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390456|NCT06220604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390457|NCT06211764|Gemcitabine|gemcitabine|mesh-list
154390458|NCT06211764|Mitomycins|mitomycins|mesh-list
154390459|NCT06211764|Mitomycin|mitomycin|mesh-list
154390460|NCT06211764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154390461|NCT06211764|Antimetabolites|antimetabolites|mesh-ancestor
154390462|NCT06211764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390463|NCT06211764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390464|NCT06211764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154390465|NCT06211764|Alkylating Agents|alkylating agents|mesh-ancestor
154390466|NCT06211764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154390467|NCT06211764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390468|NCT06203977|Colchicine|colchicine|mesh-list
154390469|NCT06203977|Gout Suppressants|gout suppressants|mesh-ancestor
154390470|NCT06203977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415255|NCT00367471|Lapatinib|lapatinib|mesh-list
153820849|NCT00465075|Estrogens|estrogens|mesh-list
154390471|NCT06203977|Tubulin Modulators|tubulin modulators|mesh-ancestor
154390472|NCT06203977|Antimitotic Agents|antimitotic agents|mesh-ancestor
154390473|NCT06203977|Mitosis Modulators|mitosis modulators|mesh-ancestor
154390474|NCT06203977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390475|NCT06203977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390476|NCT06200103|Edetic Acid|edetic acid|mesh-list
154390477|NCT06200103|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154390478|NCT06200103|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154390479|NCT06200103|Pluvicto|pluvicto|mesh-list
154390480|NCT06200103|Chelating Agents|chelating agents|mesh-ancestor
154390481|NCT06200103|Sequestering Agents|sequestering agents|mesh-ancestor
154390482|NCT06200103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390483|NCT06200103|Anticoagulants|anticoagulants|mesh-ancestor
154390484|NCT06200103|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154390485|NCT06200103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154390495|NCT06188520|Palbociclib|palbociclib|mesh-list
154390496|NCT06188520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390511|NCT06167317|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154390512|NCT06167317|Immunoconjugates|immunoconjugates|mesh-ancestor
154390513|NCT06167317|Immunologic Factors|immunologic factors|mesh-ancestor
154390514|NCT06167317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390515|NCT06166849|Fluorides|fluorides|mesh-list
154390516|NCT06166849|Cariostatic Agents|cariostatic agents|mesh-ancestor
154390517|NCT06166849|Protective Agents|protective agents|mesh-ancestor
154390518|NCT06166849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390541|NCT06145074|Propranolol|propranolol|mesh-list
154390542|NCT06145074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154390543|NCT06145074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154390544|NCT06145074|Adrenergic Agents|adrenergic agents|mesh-ancestor
154390545|NCT06145074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390546|NCT06145074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390547|NCT06145074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390548|NCT06145074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154390549|NCT06145074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153820850|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154390550|NCT06145074|Vasodilator Agents|vasodilator agents|mesh-ancestor
154390551|NCT06143878|Deucravacitinib|deucravacitinib|mesh-list
154390552|NCT06143878|Dermatologic Agents|dermatologic agents|mesh-ancestor
154390553|NCT06143878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390554|NCT06143878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390555|NCT06143878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390556|NCT06143670|Listerine|listerine|mesh-list
154390557|NCT06143670|Fluorides|fluorides|mesh-list
154390558|NCT06143670|Sodium Fluoride|sodium fluoride|mesh-list
154390559|NCT06143670|Tin Fluorides|tin fluorides|mesh-list
154260699|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260700|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390560|NCT06143670|Cariostatic Agents|cariostatic agents|mesh-ancestor
154390561|NCT06143670|Protective Agents|protective agents|mesh-ancestor
154390562|NCT06143670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752309|NCT05464654|Hormones|hormones|mesh-ancestor
154390573|NCT06122649|Analgesics|analgesics|mesh-ancestor
154390574|NCT06122649|Sensory System Agents|sensory system agents|mesh-ancestor
154390575|NCT06122649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390576|NCT06122649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390577|NCT06122649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154390578|NCT06122649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154390579|NCT06122649|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154390580|NCT06122649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154390581|NCT06122649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390582|NCT06122649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390583|NCT06120140|Chlorhexidine|chlorhexidine|mesh-list
154390584|NCT06120140|Doxycycline|doxycycline|mesh-list
154390585|NCT06120140|Minocycline|minocycline|mesh-list
154390586|NCT06120140|Clindamycin|clindamycin|mesh-list
154390587|NCT06120140|Clindamycin palmitate|clindamycin palmitate|mesh-list
154390588|NCT06120140|Clindamycin phosphate|clindamycin phosphate|mesh-list
154390589|NCT06120140|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154390590|NCT06120140|Lazertinib|lazertinib|mesh-list
154390591|NCT06120140|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154390592|NCT06120140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390593|NCT06120140|Disinfectants|disinfectants|mesh-ancestor
154390594|NCT06120140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154390595|NCT06120140|Antimalarials|antimalarials|mesh-ancestor
154390596|NCT06120140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154390597|NCT06120140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154390598|NCT06120140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154390599|NCT06120140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390600|NCT06120140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390601|NCT06120140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390602|NCT06120140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390603|NCT06120140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390604|NCT06118411|Upadacitinib|upadacitinib|mesh-list
154390605|NCT06118411|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154390606|NCT06118411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390607|NCT06118411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390608|NCT06118411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390609|NCT06118411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136774|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
154390610|NCT06117774|AMG 757|amg 757|mesh-list
154390611|NCT06117774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390612|NCT06103838|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154390613|NCT06103838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154390614|NCT06103838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390615|NCT06100744|Adalimumab|adalimumab|mesh-list
154390616|NCT06100744|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154390617|NCT06100744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154390618|NCT06100744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154390622|NCT06086275|Buprenorphine|buprenorphine|mesh-list
154390623|NCT06086275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154390624|NCT06086275|Narcotics|narcotics|mesh-ancestor
154390625|NCT06086275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390626|NCT06086275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390637|NCT06071767|Vesatolimod|vesatolimod|mesh-list
154390638|NCT06071767|Antiviral Agents|antiviral agents|mesh-ancestor
154390639|NCT06071767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390650|NCT06027840|Varenicline|varenicline|mesh-list
154390651|NCT06027840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154390652|NCT06027840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154390653|NCT06027840|Cholinergic Agents|cholinergic agents|mesh-ancestor
154390654|NCT06027840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390655|NCT06027840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390656|NCT06027840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390657|NCT06022029|Cemiplimab|cemiplimab|mesh-list
154390658|NCT06022029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390659|NCT06022029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390660|NCT06016855|Copper|copper|mesh-list
154390661|NCT06016855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154390662|NCT06016855|Trace Elements|trace elements|mesh-ancestor
154390663|NCT06016855|Micronutrients|micronutrients|mesh-ancestor
154390664|NCT06016855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390665|NCT06016855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154390666|NCT06016855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390667|NCT06016517|Adalimumab|adalimumab|mesh-list
154390668|NCT06016517|Upadacitinib|upadacitinib|mesh-list
154390669|NCT06016517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154390670|NCT06016517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154390671|NCT06016517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154390672|NCT06016517|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154390673|NCT06016517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390674|NCT06016517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390675|NCT06016517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390680|NCT05998863|Magnesium citrate|magnesium citrate|mesh-list
154390681|NCT05998863|Cathartics|cathartics|mesh-ancestor
154390682|NCT05998863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154390683|NCT05997485|Ritonavir|ritonavir|mesh-list
154390684|NCT05997485|Nirmatrelvir|nirmatrelvir|mesh-list
154390685|NCT05997485|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154390686|NCT05997485|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154390687|NCT05997485|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154390688|NCT05997485|Protease Inhibitors|protease inhibitors|mesh-ancestor
154390689|NCT05997485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390690|NCT05997485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390691|NCT05997485|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154390692|NCT05997485|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154390728|NCT05965492|Antipyretics|antipyretics|mesh-ancestor
154390729|NCT05965492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154390730|NCT05965492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154390731|NCT05965492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390732|NCT05965492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390733|NCT05965492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154390734|NCT05965492|Narcotics|narcotics|mesh-ancestor
154390735|NCT05965492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390736|NCT05965492|Anticonvulsants|anticonvulsants|mesh-ancestor
154390737|NCT05965492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154390738|NCT05965492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154390739|NCT05965492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154390740|NCT05965492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154390741|NCT05965492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154390742|NCT05965492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390743|NCT05965492|Antimanic Agents|antimanic agents|mesh-ancestor
154390744|NCT05965492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153752511|NCT03712397|Irinotecan|irinotecan|mesh-list
154136959|NCT00492232|Zolpidem|zolpidem|mesh-list
153368716|NCT01168934|Crizotinib|crizotinib|mesh-list
154390761|NCT05961709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390762|NCT05947760|Magnesium Sulfate|magnesium sulfate|mesh-list
154390763|NCT05947760|Analgesics|analgesics|mesh-ancestor
154390764|NCT05947760|Sensory System Agents|sensory system agents|mesh-ancestor
154390765|NCT05947760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390766|NCT05947760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390767|NCT05947760|Anesthetics|anesthetics|mesh-ancestor
154390768|NCT05947760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390769|NCT05947760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154390770|NCT05947760|Anticonvulsants|anticonvulsants|mesh-ancestor
154390771|NCT05947760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154390772|NCT05947760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154390773|NCT05947760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390774|NCT05947760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154390775|NCT05947760|Tocolytic Agents|tocolytic agents|mesh-ancestor
154390776|NCT05947760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154390777|NCT05945927|Trastuzumab|trastuzumab|mesh-list
154390778|NCT05945927|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154390779|NCT05945927|Maytansine|maytansine|mesh-list
154390780|NCT05945927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390781|NCT05945927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390782|NCT05945927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154390783|NCT05945927|Tubulin Modulators|tubulin modulators|mesh-ancestor
154390784|NCT05945927|Antimitotic Agents|antimitotic agents|mesh-ancestor
154390785|NCT05945927|Mitosis Modulators|mitosis modulators|mesh-ancestor
154390786|NCT05945927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390787|NCT05945927|Immunotoxins|immunotoxins|mesh-ancestor
154390788|NCT05945927|Immunoconjugates|immunoconjugates|mesh-ancestor
154390789|NCT05945927|Immunologic Factors|immunologic factors|mesh-ancestor
154390790|NCT05945927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390792|NCT05913388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390793|NCT05913388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390794|NCT05913388|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154390795|NCT05913388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390798|NCT05902754|Sulforaphane|sulforaphane|mesh-list
154390799|NCT05902754|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154390800|NCT05902754|Protective Agents|protective agents|mesh-ancestor
154390801|NCT05902754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390802|NCT05902754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390815|NCT05900336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390828|NCT05896033|Menthol|menthol|mesh-list
154390829|NCT05896033|Antipruritics|antipruritics|mesh-ancestor
154390830|NCT05896033|Dermatologic Agents|dermatologic agents|mesh-ancestor
154390832|NCT05894239|Inavolisib|inavolisib|mesh-list
154390833|NCT05894239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390834|NCT05894239|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154136999|NCT02586311|Amlodipine|amlodipine|mesh-list
154390835|NCT05894239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390836|NCT05894239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390838|NCT05882877|Dermatologic Agents|dermatologic agents|mesh-ancestor
154390844|NCT05868577|Anesthetics|anesthetics|mesh-list
154390845|NCT05868577|Anesthetics, Local|anesthetics, local|mesh-list
154390846|NCT05868577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390847|NCT05868577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390848|NCT05868577|Sensory System Agents|sensory system agents|mesh-ancestor
154390849|NCT05868577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390875|NCT05802303|Estrogens|estrogens|mesh-ancestor
154390876|NCT05802303|Hormones|hormones|mesh-ancestor
154390877|NCT05802303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154390878|NCT05802303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390879|NCT05802303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154390880|NCT05802303|Contraceptive Agents|contraceptive agents|mesh-ancestor
154390881|NCT05802303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154390882|NCT05802303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154390883|NCT05801224|Nitric Oxide|nitric oxide|mesh-list
154390884|NCT05801224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154390885|NCT05801224|Autonomic Agents|autonomic agents|mesh-ancestor
154390886|NCT05801224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390887|NCT05801224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390888|NCT05801224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154390889|NCT05801224|Respiratory System Agents|respiratory system agents|mesh-ancestor
154390890|NCT05801224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154390891|NCT05801224|Antioxidants|antioxidants|mesh-ancestor
154390892|NCT05801224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390893|NCT05801224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390894|NCT05801224|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154390895|NCT05801224|Vasodilator Agents|vasodilator agents|mesh-ancestor
154390896|NCT05801224|Gasotransmitters|gasotransmitters|mesh-ancestor
154390897|NCT05801224|Protective Agents|protective agents|mesh-ancestor
154390898|NCT05798481|Acetylcysteine|acetylcysteine|mesh-list
154390899|NCT05798481|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154390900|NCT05798481|Antiviral Agents|antiviral agents|mesh-ancestor
154390901|NCT05798481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390902|NCT05798481|Expectorants|expectorants|mesh-ancestor
154390903|NCT05798481|Respiratory System Agents|respiratory system agents|mesh-ancestor
154390904|NCT05798481|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154390905|NCT05798481|Antioxidants|antioxidants|mesh-ancestor
154390906|NCT05798481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390907|NCT05798481|Protective Agents|protective agents|mesh-ancestor
154390908|NCT05798481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390909|NCT05798481|Antidotes|antidotes|mesh-ancestor
154390910|NCT05788289|Lenalidomide|lenalidomide|mesh-list
154390911|NCT05788289|Immunologic Factors|immunologic factors|mesh-ancestor
154390912|NCT05788289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390913|NCT05788289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154390914|NCT05788289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154390915|NCT05788289|Growth Substances|growth substances|mesh-ancestor
154390916|NCT05788289|Growth Inhibitors|growth inhibitors|mesh-ancestor
154390917|NCT05788289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390918|NCT05784402|Semaglutide|semaglutide|mesh-list
154390919|NCT05784402|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154390920|NCT05784402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154390921|NCT05784402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390922|NCT05782907|Upadacitinib|upadacitinib|mesh-list
154390923|NCT05782907|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154390924|NCT05782907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390925|NCT05782907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390926|NCT05782907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390927|NCT05782907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154390946|NCT05756764|Topiramate|topiramate|mesh-list
154390947|NCT05756764|Phentermine|phentermine|mesh-list
154390948|NCT05756764|Diethylpropion|diethylpropion|mesh-list
154390949|NCT05756764|Naltrexone|naltrexone|mesh-list
154390950|NCT05756764|Bupropion|bupropion|mesh-list
154390951|NCT05756764|Glucagon|glucagon|mesh-list
154390952|NCT05756764|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154390953|NCT05756764|Tirzepatide|tirzepatide|mesh-list
154390954|NCT05756764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154390955|NCT05756764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154390956|NCT05756764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390957|NCT05756764|Sensory System Agents|sensory system agents|mesh-ancestor
154390958|NCT05756764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390959|NCT05756764|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154390960|NCT05756764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154390961|NCT05756764|Incretins|incretins|mesh-ancestor
154390962|NCT05756764|Hormones|hormones|mesh-ancestor
154390963|NCT05756764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154390964|NCT05756764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154390965|NCT05756764|Antidepressive Agents|antidepressive agents|mesh-ancestor
154390966|NCT05756764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154390967|NCT05756764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154390968|NCT05756764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154390969|NCT05756764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154390970|NCT05756764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390971|NCT05756764|Dopamine Agents|dopamine agents|mesh-ancestor
154390972|NCT05756764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390973|NCT05756764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154390974|NCT05756764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154390975|NCT05756764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390976|NCT05756764|Anticonvulsants|anticonvulsants|mesh-ancestor
154390977|NCT05756764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154390978|NCT05756764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154390979|NCT05756764|Appetite Depressants|appetite depressants|mesh-ancestor
154390980|NCT05756764|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154390981|NCT05756764|Sympathomimetics|sympathomimetics|mesh-ancestor
154390982|NCT05756764|Autonomic Agents|autonomic agents|mesh-ancestor
154390983|NCT05756764|Adrenergic Agents|adrenergic agents|mesh-ancestor
154390984|NCT05740566|Topotecan|topotecan|mesh-list
154390985|NCT05740566|Amrubicin|amrubicin|mesh-list
154137150|NCT00873392|Nicotine|nicotine|mesh-list
154390986|NCT05740566|AMG 757|amg 757|mesh-list
154390987|NCT05740566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154390988|NCT05740566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154390989|NCT05740566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390990|NCT05740566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390991|NCT05740566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820862|NCT00434486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390992|NCT05734105|Sunitinib|sunitinib|mesh-list
154390993|NCT05734105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390994|NCT05734105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154390995|NCT05734105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154390996|NCT05734105|Growth Substances|growth substances|mesh-ancestor
154390997|NCT05734105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391025|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
154391026|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391027|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391028|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391029|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154391030|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154391031|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
154391032|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
154391033|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391034|NCT05674656|Dolutegravir|dolutegravir|mesh-list
154391035|NCT05674656|Rilpivirine|rilpivirine|mesh-list
153403984|NCT01726582|Vitamins|vitamins|mesh-ancestor
153406911|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154391036|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
154391037|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154391038|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154391039|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391040|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391041|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154391042|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154391043|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
154391044|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154391045|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154391046|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154391089|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391090|NCT05630781|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153828752|NCT04513704|Semaglutide|semaglutide|mesh-list
154391091|NCT05630781|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154391092|NCT05630781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154391093|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391095|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391096|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154391097|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154391098|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154391099|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154391100|NCT05627557|Acetaminophen|acetaminophen|mesh-list
154391101|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
154391102|NCT05627557|Promethazine|promethazine|mesh-list
154391103|NCT05627557|Prednisone|prednisone|mesh-list
154391104|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
154391105|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
154391106|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391117|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
154391118|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
154391119|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
154391120|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391121|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154391122|NCT05627557|Protective Agents|protective agents|mesh-ancestor
154391123|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391124|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154391125|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154391126|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154391127|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
154391128|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
154391129|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154391130|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
154391131|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
154391132|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391133|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391134|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154391135|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
154391136|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
154391137|NCT05604131|Deferiprone|deferiprone|mesh-list
154391138|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154391139|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
154391140|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
154391141|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391142|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
154391143|NCT05603910|Lenvatinib|lenvatinib|mesh-list
154391144|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391145|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391146|NCT05603910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391147|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391148|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154391149|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391150|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154391151|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
154391152|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154391153|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
154391154|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154391155|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391156|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154391157|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391158|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391159|NCT05554328|Olaparib|olaparib|mesh-list
154391160|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154391161|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391162|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391163|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391164|NCT05554224|Liver Extracts|liver extracts|mesh-list
154391165|NCT05554224|Hematinics|hematinics|mesh-ancestor
154391166|NCT05538897|Megestrol|megestrol|mesh-list
154391167|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
154391168|NCT05538897|Ipatasertib|ipatasertib|mesh-list
154391169|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154391170|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154391171|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154391187|NCT05516914|Tislelizumab|tislelizumab|mesh-list
154391188|NCT05516914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391189|NCT05516914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391190|NCT05516914|Antimetabolites|antimetabolites|mesh-ancestor
154391191|NCT05516914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391192|NCT05516914|Tubulin Modulators|tubulin modulators|mesh-ancestor
154391193|NCT05516914|Antimitotic Agents|antimitotic agents|mesh-ancestor
154391194|NCT05516914|Mitosis Modulators|mitosis modulators|mesh-ancestor
154391195|NCT05516914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391196|NCT05502562|Semaglutide|semaglutide|mesh-list
154391197|NCT05502562|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154391198|NCT05502562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154391199|NCT05502562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391200|NCT05491356|Plasminogen|plasminogen|mesh-list
154391201|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154391202|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153578049|NCT01730222|Paclitaxel|paclitaxel|mesh-list
154391203|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154391204|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391205|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
154391206|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391207|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391208|NCT05484622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391209|NCT05484622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391210|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
154391211|NCT05470283|Fludarabine|fludarabine|mesh-list
154391212|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
154391213|NCT05470283|Furosemide|furosemide|mesh-list
154391214|NCT05470283|Acetazolamide|acetazolamide|mesh-list
154391215|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154391216|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
154391217|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391218|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154391219|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154391220|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
154391221|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391222|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391223|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154391224|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391225|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
154391226|NCT05470283|Diuretics|diuretics|mesh-ancestor
154391227|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
154391228|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154391229|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154391259|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
154391260|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154391261|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154391262|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154391263|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
154391264|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391265|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154391266|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154391267|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
154391268|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391269|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391270|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154391271|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154260701|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
154260702|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260703|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154391272|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
154391273|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154391274|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391275|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
154391276|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154391277|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391278|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154391279|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154391310|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
154391311|NCT05389423|Rituximab|rituximab|mesh-list
154391312|NCT05389423|Doxorubicin|doxorubicin|mesh-list
154391313|NCT05389423|Etoposide|etoposide|mesh-list
154391314|NCT05389423|Vincristine|vincristine|mesh-list
154391315|NCT05389423|Pomalidomide|pomalidomide|mesh-list
154391316|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154391317|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
154391318|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391319|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154391320|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154391321|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
154391322|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391323|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391324|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154391325|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391326|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154391327|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154391328|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154391329|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391330|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391331|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
154391332|NCT05389423|Hormones|hormones|mesh-ancestor
154391333|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391334|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391335|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391336|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
154391337|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
153753097|NCT04641247|Niraparib|niraparib|mesh-list
154391355|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391356|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154391357|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154391359|NCT05383352|Antidotes|antidotes|mesh-ancestor
154391360|NCT05383352|Protective Agents|protective agents|mesh-ancestor
154391361|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
154391362|NCT05383352|Vitamins|vitamins|mesh-ancestor
154391363|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
154391364|NCT05383352|Hematinics|hematinics|mesh-ancestor
154391365|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391366|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
154391367|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391368|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391369|NCT05382325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391370|NCT05382325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391372|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154391373|NCT05382286|Carboplatin|carboplatin|mesh-list
154391374|NCT05382286|Gemcitabine|gemcitabine|mesh-list
154391375|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
154391376|NCT05382286|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154391377|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391378|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391379|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
154391380|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
154391381|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
154391382|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391383|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391384|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
154391385|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391386|NCT05382286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391387|NCT05382286|Immunoconjugates|immunoconjugates|mesh-ancestor
154391388|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
154391389|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391390|NCT05378750|Diuretics|diuretics|mesh-list
154391391|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
154391392|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391393|NCT05372614|Trastuzumab|trastuzumab|mesh-list
154391394|NCT05372614|Camptothecin|camptothecin|mesh-list
154391395|NCT05372614|Maleic acid|maleic acid|mesh-list
154391396|NCT05372614|Neratinib|neratinib|mesh-list
154391397|NCT05372614|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154391398|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
154391399|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391423|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154391424|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154391425|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154391426|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154391427|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154391428|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154391429|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
154391430|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
154391431|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
154391432|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
154391433|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391434|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391435|NCT05361395|Carboplatin|carboplatin|mesh-list
154391436|NCT05361395|Etoposide|etoposide|mesh-list
154391437|NCT05361395|Atezolizumab|atezolizumab|mesh-list
154391438|NCT05361395|Durvalumab|durvalumab|mesh-list
154391439|NCT05361395|AMG 757|amg 757|mesh-list
154137604|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
154391440|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391441|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391442|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154391443|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154391444|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391445|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391446|NCT05361395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391447|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391448|NCT05329766|Leucovorin|leucovorin|mesh-list
154391449|NCT05329766|Fluorouracil|fluorouracil|mesh-list
154391450|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
154391467|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391468|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391470|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
154391471|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391472|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391473|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391474|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391475|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154391476|NCT05308446|Nivolumab|nivolumab|mesh-list
154391477|NCT05308446|Cetuximab|cetuximab|mesh-list
154391478|NCT05308446|Antibodies|antibodies|mesh-list
154391479|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
154391480|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154391481|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
154391482|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391483|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391484|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391485|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391486|NCT05292586|Beclomethasone|beclomethasone|mesh-list
154391487|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
154391488|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154391489|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
154391490|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391491|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391492|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154391493|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
154391494|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154391495|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154391496|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154391497|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
154391498|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391499|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391500|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391501|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
154391502|NCT05292586|Hormones|hormones|mesh-ancestor
153404053|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
153409097|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391503|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578101|NCT01726400|Ribavirin|ribavirin|mesh-list
154391504|NCT05291039|Adalimumab|adalimumab|mesh-list
154391505|NCT05291039|Infliximab|infliximab|mesh-list
154391506|NCT05291039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154391507|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391508|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154391509|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
154391518|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391519|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
154391520|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391521|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154391524|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154391525|NCT05284747|Evolocumab|evolocumab|mesh-list
154391526|NCT05284747|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154391527|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154391528|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154391529|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
154391530|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391531|NCT05284747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154391532|NCT05284747|Protease Inhibitors|protease inhibitors|mesh-ancestor
154391533|NCT05284747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391534|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154391535|NCT05279092|Dexamethasone|dexamethasone|mesh-list
154391536|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
154391537|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154391538|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154391539|NCT05279092|Prednisolone|prednisolone|mesh-list
154391540|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
154391541|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
154391542|NCT05279092|Bupivacaine|bupivacaine|mesh-list
154391543|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154391544|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
154391545|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154391546|NCT05279092|BB 1101|bb 1101|mesh-list
154391547|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391548|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
154391549|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
154391550|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391551|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820896|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
154391552|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391553|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
154391554|NCT05279092|Hormones|hormones|mesh-ancestor
154391555|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391556|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391557|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391558|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
154391559|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
154391560|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154391561|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
154391562|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154391563|NCT05279092|Protective Agents|protective agents|mesh-ancestor
154391564|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
154391565|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391566|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391567|NCT05259839|Dexamethasone|dexamethasone|mesh-list
154391568|NCT05259839|Lenalidomide|lenalidomide|mesh-list
154391569|NCT05259839|Daratumumab|daratumumab|mesh-list
154391570|NCT05259839|Pomalidomide|pomalidomide|mesh-list
154391571|NCT05259839|Nirogacestat|nirogacestat|mesh-list
154391572|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391573|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
154391574|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
154391575|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391576|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391577|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391578|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
154391579|NCT05259839|Hormones|hormones|mesh-ancestor
154391597|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
154391598|NCT05191797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391599|NCT05191797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391600|NCT05191797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391601|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391602|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
153360884|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391603|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391604|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
154391605|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391606|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391607|NCT05179603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391608|NCT05179603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391609|NCT05177055|Methamphetamine|methamphetamine|mesh-list
154391610|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154391611|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391612|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
154391613|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
154391614|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391615|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
154391616|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391617|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391618|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
154391619|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154391620|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154391621|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154391622|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154391623|NCT05166577|Valganciclovir|valganciclovir|mesh-list
154391624|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
154391625|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391626|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391627|NCT05166577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391628|NCT05166577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391629|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
154391630|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820900|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391631|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
154391632|NCT05145309|Cathartics|cathartics|mesh-ancestor
154391633|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391634|NCT05120960|Osimertinib|osimertinib|mesh-list
154391635|NCT05120960|Tepotinib|tepotinib|mesh-list
154391655|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
154391656|NCT05101096|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154391657|NCT05101096|Immunoconjugates|immunoconjugates|mesh-ancestor
154391658|NCT05101096|Immunologic Factors|immunologic factors|mesh-ancestor
154391659|NCT05101096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391660|NCT05094336|Docetaxel|docetaxel|mesh-list
154391661|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391662|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154391663|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154391664|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154391665|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391667|NCT05063565|Tremelimumab|tremelimumab|mesh-list
154391668|NCT05063565|Immunomodulating Agents|immunomodulating agents|mesh-list
154391669|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
154391670|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391671|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391672|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391673|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
154391674|NCT05061420|Cetuximab|cetuximab|mesh-list
154391675|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391676|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391677|NCT05061420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391678|NCT05061420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391679|NCT05052385|Ibrutinib|ibrutinib|mesh-list
154391680|NCT05052385|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154391681|NCT05052385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154391682|NCT05052385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391683|NCT05052385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391684|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
154391685|NCT05018585|Vitamin D|vitamin d|mesh-list
154391686|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154391687|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154391688|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
154391689|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391690|NCT05018585|Antacids|antacids|mesh-ancestor
154391725|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154391726|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391727|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154391728|NCT04973124|Analgesics|analgesics|mesh-ancestor
154391729|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
154391730|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869435|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409964|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154391739|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391740|NCT04963296|Acetaminophen|acetaminophen|mesh-list
154391741|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
154391742|NCT04963296|Promethazine|promethazine|mesh-list
154391743|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
154391744|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
154391745|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154391746|NCT04963296|Analgesics|analgesics|mesh-ancestor
154391747|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
154391748|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391749|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391750|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
154391751|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391752|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
154391753|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
154391754|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391755|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
154391757|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391758|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154391759|NCT04963296|Protective Agents|protective agents|mesh-ancestor
154391760|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391761|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391762|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154391763|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154391764|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154391765|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
154391766|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
154391767|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154391768|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
154391769|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
154391770|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391771|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415257|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391772|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154391773|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
154391774|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
154391775|NCT04949828|Pancrelipase|pancrelipase|mesh-list
154391776|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391777|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154391778|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154391779|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154391780|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391781|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
154391782|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391783|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391784|NCT04935177|Antibodies|antibodies|mesh-list
154391785|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
154391786|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154391787|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
154391788|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154391789|NCT04935177|Eculizumab|eculizumab|mesh-list
154391790|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
154391791|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391792|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154391793|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154391794|NCT04933539|Dexamethasone|dexamethasone|mesh-list
154391795|NCT04933539|Daratumumab|daratumumab|mesh-list
154391796|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391797|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
154391824|NCT04914897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391825|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391826|NCT04903314|Cenobamate|cenobamate|mesh-list
154391827|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
154391828|NCT04892953|Paclitaxel|paclitaxel|mesh-list
154391829|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154391830|NCT04892953|Carboplatin|carboplatin|mesh-list
154391831|NCT04892953|Gemcitabine|gemcitabine|mesh-list
154391832|NCT04892953|Pemetrexed|pemetrexed|mesh-list
154391833|NCT04892953|Durvalumab|durvalumab|mesh-list
154391834|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
154391835|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154391836|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
154391837|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391838|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410600|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410603|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
154391839|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154391840|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154391841|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154391842|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391843|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391844|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
154391845|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391846|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154391847|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154391848|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391849|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
154391850|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391874|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391875|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154391876|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391877|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
154391878|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391879|NCT04791553|Cenobamate|cenobamate|mesh-list
154391880|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
154391881|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154391882|NCT04785287|Nivolumab|nivolumab|mesh-list
154391883|NCT04785287|Antibodies|antibodies|mesh-list
154391884|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
154391885|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154391886|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
154391887|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391888|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391889|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391890|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391892|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154391893|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391894|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391895|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
154391896|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
154391897|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
154391898|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391899|NCT04757636|Aflibercept|aflibercept|mesh-list
154391900|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154391901|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154391902|NCT04757636|Growth Substances|growth substances|mesh-ancestor
154391903|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391904|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
154391905|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391906|NCT04757610|Ranibizumab|ranibizumab|mesh-list
154391907|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154391908|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154391909|NCT04757610|Growth Substances|growth substances|mesh-ancestor
154391910|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391911|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
154391912|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391920|NCT04704661|Trastuzumab|trastuzumab|mesh-list
154391921|NCT04704661|Camptothecin|camptothecin|mesh-list
154391922|NCT04704661|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154391923|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
154391924|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391925|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391926|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
154391927|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391928|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391929|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153925560|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153925561|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153925562|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925563|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369013|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
153925565|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925566|NCT04283487|Levan|levan|mesh-list
153925567|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925568|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
153925569|NCT04283331|Propoxycaine|propoxycaine|mesh-list
153925570|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
153925571|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
153925572|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925573|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925574|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
153925575|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925576|NCT02657473|Tobramycin|tobramycin|mesh-list
153925577|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153925578|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925579|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925581|NCT02652637|Neomycin|neomycin|mesh-list
153925582|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925583|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925584|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153925585|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153925586|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153925587|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925588|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925589|NCT00649675|Meloxicam|meloxicam|mesh-list
153925590|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153925591|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153925592|NCT00649675|Analgesics|analgesics|mesh-ancestor
153925593|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
153925594|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925595|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925596|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153925597|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153925598|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153925599|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153925600|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925601|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925602|NCT02860923|Exenatide|exenatide|mesh-list
153925603|NCT02860923|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153925604|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153925605|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828984|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925618|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
153925619|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
153925620|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925621|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153925622|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
153925623|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153925624|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153925625|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153925626|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925627|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153925628|NCT02652325|Iodine|iodine|mesh-list
153925629|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
153925630|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
153925631|NCT02652325|Povidone|povidone|mesh-list
153925632|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153925633|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925634|NCT02652325|Trace Elements|trace elements|mesh-ancestor
153925635|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
153925636|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925637|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
153925638|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
153925639|NCT00960687|Fenofibrate|fenofibrate|mesh-list
153925640|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
153925641|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153925642|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
153925643|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925644|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153925645|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153925647|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925648|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153925649|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369043|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
153415259|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
153925650|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925651|NCT01120626|Donepezil|donepezil|mesh-list
153925652|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153925653|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925654|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925656|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925657|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925658|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
153925659|NCT00650377|Finasteride|finasteride|mesh-list
153925660|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153404146|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870508|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153870509|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153925661|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153925662|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925663|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925664|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
153925665|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925666|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925667|NCT00650377|Urological Agents|urological agents|mesh-ancestor
153925668|NCT02649751|Roscovitine|roscovitine|mesh-list
153925669|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925670|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
153925671|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683288|NCT00132184|Vitamin D|vitamin d|mesh-list
153925682|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925684|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153925685|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153925686|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153925687|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153925688|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
153925689|NCT00924508|Hormones|hormones|mesh-ancestor
153925690|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925691|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925692|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153925693|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
153925694|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925695|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925696|NCT00650923|Temozolomide|temozolomide|mesh-list
153925697|NCT00650923|Aflibercept|aflibercept|mesh-list
153925698|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
153829014|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153829021|NCT00485810|Olanzapine|olanzapine|mesh-list
153925699|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153925700|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
153925701|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925702|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925703|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153925704|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153925705|NCT00650923|Growth Substances|growth substances|mesh-ancestor
153925706|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925707|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
153925708|NCT00637858|Lycopene|lycopene|mesh-list
153925709|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153925710|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
153925711|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925712|NCT00637858|Protective Agents|protective agents|mesh-ancestor
153925713|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925714|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153925715|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153925716|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925717|NCT02657161|Vaccines|vaccines|mesh-list
153925718|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
153925719|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925720|NCT01139580|Calcipotriene|calcipotriene|mesh-list
153925721|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
153925722|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
153925723|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
153925724|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
153925725|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
153925726|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
153829023|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
153578554|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153925727|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925728|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153925729|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
153925730|NCT04251832|Antidotes|antidotes|mesh-ancestor
153925731|NCT04251832|Protective Agents|protective agents|mesh-ancestor
153925732|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925733|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
153683351|NCT00080418|Paclitaxel|paclitaxel|mesh-list
153925762|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153925763|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925764|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153925765|NCT00625170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153925766|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153404176|NCT00006436|Hormones|hormones|mesh-ancestor
153925767|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925768|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925769|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925770|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
153925771|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153925772|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
153925773|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153925774|NCT00599755|Carboplatin|carboplatin|mesh-list
153925775|NCT00599755|Gemcitabine|gemcitabine|mesh-list
153925776|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925777|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153925778|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
153925779|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925780|NCT04251364|Acetazolamide|acetazolamide|mesh-list
153925793|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925795|NCT02648425|Cisplatin|cisplatin|mesh-list
153925796|NCT02648425|Capecitabine|capecitabine|mesh-list
153925797|NCT02648425|Fluorouracil|fluorouracil|mesh-list
153925798|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925799|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153925800|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
153925801|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925802|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153925803|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
153925804|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925805|NCT02648425|Antidotes|antidotes|mesh-ancestor
153925806|NCT02648425|Protective Agents|protective agents|mesh-ancestor
153925807|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
153925808|NCT02648425|Vitamins|vitamins|mesh-ancestor
153925809|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
153925810|NCT02648503|Atropine|atropine|mesh-list
153925811|NCT02648503|Rocuronium|rocuronium|mesh-list
153925812|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153925813|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153925814|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153925815|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
153925816|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925817|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925818|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153925819|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
153925820|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
153925821|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
153925822|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153925823|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153925824|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
153925825|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925826|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925827|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153925828|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153925829|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153925830|NCT05253508|Lidocaine|lidocaine|mesh-list
153925831|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
153925832|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
153925833|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925834|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925835|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
153925836|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925837|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153925838|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153925839|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153925840|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925841|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925842|NCT04524130|Lidocaine|lidocaine|mesh-list
153925843|NCT04524130|Ketamine|ketamine|mesh-list
153925853|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925854|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925855|NCT04524130|Analgesics|analgesics|mesh-ancestor
153925856|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153925857|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153925858|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
153925859|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153925860|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153925861|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411703|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153411707|NCT00003783|Leucovorin|leucovorin|mesh-list
153925862|NCT00649831|Amoxicillin|amoxicillin|mesh-list
153925863|NCT00649831|Azithromycin|azithromycin|mesh-list
153925864|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925865|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925866|NCT02648659|Amoxicillin|amoxicillin|mesh-list
153925867|NCT02648659|Metronidazole|metronidazole|mesh-list
153925868|NCT02648659|Clarithromycin|clarithromycin|mesh-list
153925869|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925870|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925871|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153925872|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153925873|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153925874|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925875|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925876|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153925877|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153925878|NCT01125930|Tretinoin|tretinoin|mesh-list
153925879|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925880|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
153925881|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
153925882|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
153925883|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925884|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153925885|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925886|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925887|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
153925888|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925889|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925890|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153925891|NCT00651235|Losartan|losartan|mesh-list
153925892|NCT00651235|Propranolol|propranolol|mesh-list
153925893|NCT00651235|Atenolol|atenolol|mesh-list
153925894|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153925895|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153925896|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153925897|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153925898|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925899|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153925900|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153925901|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
153925902|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925903|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925904|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
153925905|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
153925906|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
153925907|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925929|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925931|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
153925932|NCT00631618|Sunitinib|sunitinib|mesh-list
153925933|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925934|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153925935|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153925936|NCT00631618|Growth Substances|growth substances|mesh-ancestor
153925937|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925938|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
153925939|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153925940|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925941|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925942|NCT04431778|Ethosuximide|ethosuximide|mesh-list
153925943|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
153925944|NCT04669132|Olanzapine|olanzapine|mesh-list
153925945|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
153925946|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
153925947|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925948|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925949|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153925950|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153925951|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153820921|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153579033|NCT01736878|Sorafenib|sorafenib|mesh-list
153925952|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925953|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153925954|NCT04669132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153404198|NCT03331835|Brodalumab|brodalumab|mesh-list
153411769|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411770|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
153925955|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153925956|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925957|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925958|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683608|NCT00133822|Risperidone|risperidone|mesh-list
153925982|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153925983|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153925984|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925985|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153925986|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153925987|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925988|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
153925989|NCT00912964|Mirabegron|mirabegron|mesh-list
153925990|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153925991|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153925992|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153925993|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
153925994|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925995|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925996|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925997|NCT00912964|Urological Agents|urological agents|mesh-ancestor
153925998|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
153925999|NCT02641639|Combretastatin|combretastatin|mesh-list
153926000|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153926001|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926002|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
153926003|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
153926004|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
153926005|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926006|NCT02647567|Caffeine|caffeine|mesh-list
153926007|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153926008|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579259|NCT01738373|Plerixafor|plerixafor|mesh-list
153926009|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153683643|NCT00047138|Carboplatin|carboplatin|mesh-list
153926039|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
153926040|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926041|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926042|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153926043|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
153926044|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
153926045|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153926046|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926047|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153926048|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153926049|NCT00910897|Growth Substances|growth substances|mesh-ancestor
153926050|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
153926052|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
153926053|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926081|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
153926082|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153926083|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
153926084|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926085|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
153926086|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
153926087|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926088|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683669|NCT00080847|Prednisone|prednisone|mesh-list
153926089|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926090|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
153926091|NCT02647255|Hormones|hormones|mesh-ancestor
153926092|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926093|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153926094|NCT02647255|Protective Agents|protective agents|mesh-ancestor
153926095|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153926096|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926097|NCT04329442|Tenofovir|tenofovir|mesh-list
153926098|NCT04329442|Emtricitabine|emtricitabine|mesh-list
153926099|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
153926118|NCT00652639|Clonazepam|clonazepam|mesh-list
153926119|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
153926120|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
153926121|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
153926122|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926123|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926124|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926125|NCT02644915|Edaravone|edaravone|mesh-list
153926126|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153926127|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
153926128|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926129|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153926130|NCT02644915|Protective Agents|protective agents|mesh-ancestor
153926131|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926132|NCT00651703|Imiquimod|imiquimod|mesh-list
153926133|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153926134|NCT00651703|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153926135|NCT00651703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926136|NCT00651703|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153926137|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
153926138|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926139|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153926140|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926141|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
153926142|NCT02964585|Canagliflozin|canagliflozin|mesh-list
153926143|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153926144|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926145|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153926146|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926147|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153926148|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
153926149|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926150|NCT00651781|Bortezomib|bortezomib|mesh-list
153926151|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926152|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
153926153|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153926154|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153926174|NCT00957801|Protective Agents|protective agents|mesh-ancestor
153926175|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153926176|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926177|NCT00957801|Androgens|androgens|mesh-ancestor
153926178|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
153926179|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
153926180|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153926181|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153926182|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926183|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
153926184|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
153926187|NCT02646709|Analgesics|analgesics|mesh-ancestor
153926188|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
153926189|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926190|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926191|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153926192|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153926193|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
153926194|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
153926195|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153926196|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153926197|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153926198|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829158|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926199|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926200|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153926201|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153926202|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153926203|NCT00651859|Bimatoprost|bimatoprost|mesh-list
153926204|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153926205|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153926206|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153926207|NCT02955823|Dexamethasone|dexamethasone|mesh-list
153926208|NCT02955823|Rituximab|rituximab|mesh-list
153926209|NCT02955823|Lenalidomide|lenalidomide|mesh-list
153926210|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926211|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
153926212|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
153683846|NCT00134641|Gemcitabine|gemcitabine|mesh-list
153926222|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
153926223|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153404245|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
153871275|NCT04562103|Epinephrine|epinephrine|mesh-list
153926224|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153926225|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153926226|NCT02955823|Growth Substances|growth substances|mesh-ancestor
153926227|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
153926228|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153926229|NCT02646397|Fosinopril|fosinopril|mesh-list
153926230|NCT02646397|Benidipine|benidipine|mesh-list
153926231|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153926232|NCT02646397|Diuretics|diuretics|mesh-ancestor
153926233|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
153926234|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926235|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153926236|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153683808|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
153926237|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926238|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153926239|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
153926240|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926241|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153829160|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
153926242|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153926243|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
153926245|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153926246|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926247|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
153926248|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153926249|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153926250|NCT00911170|Bevacizumab|bevacizumab|mesh-list
153926251|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153926252|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926253|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153926254|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153926255|NCT00911170|Growth Substances|growth substances|mesh-ancestor
153926256|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926257|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
153926258|NCT00910975|Interferons|interferons|mesh-list
153926260|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
153926261|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
153926262|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153926263|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926264|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
153926265|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926266|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
153926267|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926268|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
153926269|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926270|NCT01167881|Glimepiride|glimepiride|mesh-list
153926271|NCT01167881|Empagliflozin|empagliflozin|mesh-list
153926272|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153926273|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153926274|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926275|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153926276|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
153926277|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153683905|NCT00134953|Rivastigmine|rivastigmine|mesh-list
153926302|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153926303|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
153926304|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926305|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153926306|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153926307|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
153926308|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926309|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926310|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153926311|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153926312|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153926313|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683882|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926314|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926315|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153926316|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153926317|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
153404264|NCT00356954|Protective Agents|protective agents|mesh-ancestor
153871392|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
153926318|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
153926319|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
153926321|NCT02646319|Temsirolimus|temsirolimus|mesh-list
153926322|NCT02646319|MTOR Inhibitors|mtor inhibitors|mesh-list
153926323|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153926324|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926325|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153926326|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926327|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
153926328|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153926341|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153926343|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
153926344|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153926345|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153926346|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153926347|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153926348|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926349|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926350|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
153926351|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926352|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926353|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153926354|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926355|NCT00912340|Trastuzumab|trastuzumab|mesh-list
153926356|NCT00912340|Everolimus|everolimus|mesh-list
153926357|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153926358|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926359|NCT00912340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153926360|NCT00912340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153926361|NCT00912340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926362|NCT00912340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926363|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153926364|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
153926365|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926366|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
153926367|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153926368|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153926369|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153926370|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926371|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926372|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
153926373|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926374|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926375|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153926376|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926377|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153926378|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153926379|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926380|NCT01119846|Incretins|incretins|mesh-ancestor
153926381|NCT01119846|Hormones|hormones|mesh-ancestor
153926382|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926383|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153926384|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
153926385|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683957|NCT00135187|Dexamethasone|dexamethasone|mesh-list
153926386|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926403|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926404|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926405|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153926406|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153926407|NCT00654121|Insulin|insulin|mesh-list
153926408|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153926409|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153926410|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926411|NCT01166945|Amoxicillin|amoxicillin|mesh-list
153926412|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
153926413|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
153926414|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153926415|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153926416|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926417|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153926418|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926419|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926420|NCT02639533|Pregabalin|pregabalin|mesh-list
153926421|NCT02639533|Analgesics|analgesics|mesh-ancestor
153926422|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
153926423|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926424|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926425|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
153926426|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153926427|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926428|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369218|NCT02504775|Acetaminophen|acetaminophen|mesh-list
153829193|NCT00490880|Gemcitabine|gemcitabine|mesh-list
153926429|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153926430|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153926431|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153926432|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153926433|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153926434|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
153926435|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153926436|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153926437|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926438|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
153926439|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
153926440|NCT00910000|Carboplatin|carboplatin|mesh-list
153926441|NCT00910000|Gemcitabine|gemcitabine|mesh-list
153926442|NCT00910000|Vorinostat|vorinostat|mesh-list
153926443|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926444|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153926445|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
153926458|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926459|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926460|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153926461|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
153926462|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153926463|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153926464|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153926465|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153926466|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
153926467|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
153926468|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926469|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153926470|NCT00652873|Cabergoline|cabergoline|mesh-list
153926471|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153926472|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153926473|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
153926474|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
153926475|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926476|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926477|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926478|NCT00652171|Lamotrigine|lamotrigine|mesh-list
153926479|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
153926480|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153926481|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926482|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926483|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153926484|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926485|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153926486|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580525|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153926487|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153926488|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153926489|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153926490|NCT01119768|Esomeprazole|esomeprazole|mesh-list
153926491|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153926492|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926493|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153926494|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926495|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926496|NCT01165307|Naproxen|naproxen|mesh-list
153926497|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
153926498|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
153926499|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
153926500|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153926501|NCT01165307|Estradiol|estradiol|mesh-list
153926502|NCT01165307|Estrogens|estrogens|mesh-ancestor
153926503|NCT01165307|Hormones|hormones|mesh-ancestor
153926504|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926505|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926506|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153926507|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153926518|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926519|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926520|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153926522|NCT02639143|Ticagrelor|ticagrelor|mesh-list
153926523|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153926524|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153926525|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153926526|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153926527|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
153926528|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926529|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926530|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926531|NCT02644057|Dobutamine|dobutamine|mesh-list
153926532|NCT02644057|Milrinone|milrinone|mesh-list
153926533|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153926534|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
153926535|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
153926536|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926537|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926538|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153926539|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153926540|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153926541|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
153926542|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926543|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926544|NCT02644057|Protective Agents|protective agents|mesh-ancestor
153926545|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153926546|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
153926547|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153926548|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153926549|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926550|NCT00654277|Ondansetron|ondansetron|mesh-list
153926551|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
153926552|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
153926553|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926554|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926555|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926556|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
153926557|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
153926558|NCT00654277|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153926559|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153926560|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
153926561|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926562|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926563|NCT01124838|Prednisone|prednisone|mesh-list
153926564|NCT01124838|Adalimumab|adalimumab|mesh-list
153926565|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926566|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
153926567|NCT01124838|Hormones|hormones|mesh-ancestor
153926568|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926569|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926570|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153926590|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926591|NCT04282941|Ibuprofen|ibuprofen|mesh-list
153926592|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153926593|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153926594|NCT04282941|Analgesics|analgesics|mesh-ancestor
153926595|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
153926596|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926597|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926598|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926599|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153926600|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153926601|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926602|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404339|NCT02360215|Memantine|memantine|mesh-list
153871594|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153926603|NCT00910858|Lenalidomide|lenalidomide|mesh-list
153926604|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
153926605|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
153926606|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926607|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153684183|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153926608|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153926609|NCT00910858|Growth Substances|growth substances|mesh-ancestor
153926610|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
153926611|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926612|NCT00910858|Hematinics|hematinics|mesh-ancestor
153926613|NCT02859285|Estradiol|estradiol|mesh-list
153926614|NCT02859285|Estrogens|estrogens|mesh-ancestor
153926615|NCT02859285|Hormones|hormones|mesh-ancestor
153926616|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926617|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926618|NCT04260412|Psyllium|psyllium|mesh-list
153926619|NCT04260412|Cathartics|cathartics|mesh-ancestor
153926620|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926621|NCT04476550|Lenograstim|lenograstim|mesh-list
153926622|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153926623|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
153926624|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926626|NCT00598975|Cetuximab|cetuximab|mesh-list
153926627|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
153926635|NCT01124604|Tapentadol|tapentadol|mesh-list
153926636|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153926637|NCT01124604|Narcotics|narcotics|mesh-ancestor
153926638|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153926639|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926640|NCT01124604|Analgesics|analgesics|mesh-ancestor
153926641|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
153926642|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926643|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153926644|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153926645|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926646|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926647|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
153926648|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926649|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153926650|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
153926651|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153926652|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
153926653|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153926654|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926655|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153926656|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153926657|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926658|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
153926659|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
153926660|NCT01124448|Growth Substances|growth substances|mesh-ancestor
153926661|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926662|NCT02638909|Ceritinib|ceritinib|mesh-list
153926663|NCT02638909|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153926664|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153926665|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926666|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926667|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926668|NCT02643823|Methotrexate|methotrexate|mesh-list
153926669|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
153926670|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153926671|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
153926672|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153926673|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926674|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153926675|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
153926676|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926677|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926678|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
153926679|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926680|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153926681|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153404350|NCT01349192|Minocycline|minocycline|mesh-list
153871657|NCT01088243|Mesalamine|mesalamine|mesh-list
153926682|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
153926683|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153926684|NCT02638831|Ketorolac|ketorolac|mesh-list
153926685|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153926686|NCT02638831|Ketoprofen|ketoprofen|mesh-list
153926687|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153926688|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153926689|NCT02638831|Analgesics|analgesics|mesh-ancestor
153926690|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
153926691|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926692|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926712|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153926713|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
153926714|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
153926715|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
153926716|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926717|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926718|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153926719|NCT00909532|Ivacaftor|ivacaftor|mesh-list
153926720|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153926721|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926722|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926723|NCT01136382|Budesonide|budesonide|mesh-list
153926724|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926725|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153926726|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
153926727|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926728|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926729|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153926730|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
153926731|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
153926732|NCT01136382|Hormones|hormones|mesh-ancestor
153926733|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926734|NCT02731729|Nivolumab|nivolumab|mesh-list
153926735|NCT02731729|Ipilimumab|ipilimumab|mesh-list
153926736|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153926737|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369284|NCT01149434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581588|NCT05996133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153926738|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153926739|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581589|NCT05996133|Adrenergic Agents|adrenergic agents|mesh-ancestor
153926740|NCT02645461|Palmidrol|palmidrol|mesh-list
153926741|NCT02645461|Riluzole|riluzole|mesh-list
153926742|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
153926743|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153926744|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153926745|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926746|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926794|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
153926795|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926796|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153926797|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153926798|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
153926799|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926800|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926801|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153926802|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153926804|NCT00910624|Ribavirin|ribavirin|mesh-list
153926805|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153926806|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
153926807|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926808|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
153926809|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926810|NCT00654667|Resveratrol|resveratrol|mesh-list
153926811|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
153926812|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926813|NCT00654667|Protective Agents|protective agents|mesh-ancestor
153926814|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926815|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926816|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153926817|NCT01123980|Insulin|insulin|mesh-list
153926818|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153926819|NCT01123980|Metformin|metformin|mesh-list
153926820|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
153926821|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
153871759|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
153926822|NCT01123980|Glimepiride|glimepiride|mesh-list
153926823|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
153926824|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153926825|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153926826|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926827|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153926828|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153926829|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
153926830|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153926831|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153926832|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153926833|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153926834|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
153926835|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926836|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153926837|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153926838|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926839|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153926841|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
153926842|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926843|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926844|NCT02857959|Penicillins|penicillins|mesh-list
153926845|NCT02857959|Penicillin G|penicillin g|mesh-list
153926846|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153926847|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
153926848|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153926849|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926850|NCT02643433|Vaccines|vaccines|mesh-list
153926863|NCT04164745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153926864|NCT04164745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926865|NCT01198522|Gemcitabine|gemcitabine|mesh-list
153926866|NCT01198522|Antibodies|antibodies|mesh-list
153926867|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153926868|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
153926869|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926870|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153926871|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
153926872|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926873|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926874|NCT02638285|Clomiphene|clomiphene|mesh-list
153926875|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153926876|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
153926877|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926878|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926879|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153926880|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
153926881|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153829258|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926882|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153926883|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153926884|NCT01134250|Paclitaxel|paclitaxel|mesh-list
153926885|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153926886|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926887|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
153926888|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
153926889|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
153926890|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926891|NCT01118520|Amlodipine|amlodipine|mesh-list
153926892|NCT01118520|Perindopril|perindopril|mesh-list
153926893|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153926894|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153926895|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926896|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926897|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153926898|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926899|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
153926900|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153926901|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
153926902|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926903|NCT01135992|Insulin|insulin|mesh-list
153926904|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153926905|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
153412643|NCT02446483|Rabeprazole|rabeprazole|mesh-list
153926906|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153926907|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926909|NCT03734770|Progestins|progestins|mesh-ancestor
153926910|NCT03734770|Hormones|hormones|mesh-ancestor
153926911|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926912|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926913|NCT00959049|Vaccines|vaccines|mesh-list
153926943|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153926944|NCT01123356|Growth Substances|growth substances|mesh-ancestor
153926945|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
153926946|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926947|NCT00630357|Levetiracetam|levetiracetam|mesh-list
153926948|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
153926949|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
153926950|NCT02858817|Atovaquone|atovaquone|mesh-list
153926951|NCT02858817|Proguanil|proguanil|mesh-list
153926952|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153926953|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926954|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
153926955|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153926956|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153926957|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926958|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926959|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
153926960|NCT02883192|Ondansetron|ondansetron|mesh-list
153369312|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153926983|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926985|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153926986|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926987|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
153926988|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
153926989|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926990|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926991|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153926992|NCT00632554|Protective Agents|protective agents|mesh-ancestor
153926993|NCT03082209|Bevacizumab|bevacizumab|mesh-list
153926994|NCT03082209|Venetoclax|venetoclax|mesh-list
153926995|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153926996|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926997|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153926998|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153926999|NCT03082209|Growth Substances|growth substances|mesh-ancestor
153927000|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927001|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
153927003|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
153927004|NCT02224144|Calcitriol|calcitriol|mesh-list
153927005|NCT02224144|Vitamins|vitamins|mesh-ancestor
153927006|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
153927007|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927008|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153927009|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153927010|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153927011|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927012|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927013|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153927052|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153927053|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
153927083|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153927084|NCT00955305|Paclitaxel|paclitaxel|mesh-list
153927085|NCT00955305|Bevacizumab|bevacizumab|mesh-list
153927086|NCT00955305|Carboplatin|carboplatin|mesh-list
153927087|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153927088|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927089|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
153927090|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
153927091|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
153927092|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927093|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153927094|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153369336|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153927095|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153927096|NCT00955305|Growth Substances|growth substances|mesh-ancestor
153927097|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927098|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
153927107|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
153927108|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404418|NCT02112578|Cholinergic Agents|cholinergic agents|mesh-ancestor
153872137|NCT00171834|Epothilone B|epothilone b|mesh-list
153927109|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927110|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153927112|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153927113|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
153927114|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927115|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
153927116|NCT04204083|Protective Agents|protective agents|mesh-ancestor
153927117|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
153927118|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
153927119|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153927120|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153927121|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927122|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927123|NCT00598585|Urological Agents|urological agents|mesh-ancestor
153927124|NCT02635243|Glucagon|glucagon|mesh-list
153927125|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927126|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153927127|NCT02635243|Hormones|hormones|mesh-ancestor
153927128|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927129|NCT00953667|Niacin|niacin|mesh-list
153927130|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153927131|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
153927132|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927133|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153927134|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
153927135|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
153927136|NCT00953667|Vitamins|vitamins|mesh-ancestor
153927137|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
153927138|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927139|NCT02857491|Ranibizumab|ranibizumab|mesh-list
153927140|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153927141|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153927142|NCT02857491|Growth Substances|growth substances|mesh-ancestor
153927143|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927144|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
153927145|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927146|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
153927147|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
153927148|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153927149|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
153927150|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927151|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927152|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153927153|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
153927154|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927155|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927156|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153829305|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
153829306|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829307|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153581870|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153927157|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153927158|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153927159|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
153927160|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927161|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927162|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927164|NCT02856867|Fluorouracil|fluorouracil|mesh-list
153927165|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
153927166|NCT02856867|Nintedanib|nintedanib|mesh-list
153927167|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
153927183|NCT00630513|Sulbactam|sulbactam|mesh-list
153927184|NCT00630513|Sultamicillin|sultamicillin|mesh-list
153927185|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927186|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927187|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153927188|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927189|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927190|NCT05287360|Apatinib|apatinib|mesh-list
153927191|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927192|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153927193|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927194|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927195|NCT00954447|Linagliptin|linagliptin|mesh-list
153927196|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153927197|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927198|NCT00954447|Incretins|incretins|mesh-ancestor
153412852|NCT02437669|Hydromorphone|hydromorphone|mesh-list
153927199|NCT00954447|Hormones|hormones|mesh-ancestor
153927200|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927201|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153927202|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
153927203|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927204|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927205|NCT00903760|Decitabine|decitabine|mesh-list
153927206|NCT00903760|Clofarabine|clofarabine|mesh-list
153927207|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153927208|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
153927209|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927210|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927211|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927212|NCT05177614|Micronutrients|micronutrients|mesh-list
153927214|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927215|NCT04202536|Tenofovir|tenofovir|mesh-list
153927216|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
153927217|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927218|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153927219|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153927220|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927221|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927222|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153927223|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153927224|NCT02794402|Exenatide|exenatide|mesh-list
153927225|NCT02794402|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153927226|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153927227|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927228|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153927229|NCT02794402|Incretins|incretins|mesh-ancestor
153927239|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153927241|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927242|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927243|NCT00903682|Efavirenz|efavirenz|mesh-list
153927244|NCT00903682|Etravirine|etravirine|mesh-list
153927245|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153927246|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153927247|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927248|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927249|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
153927250|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927251|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153927252|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153927253|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153927254|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153927255|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153927256|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153927257|NCT00655603|Pancrelipase|pancrelipase|mesh-list
153927258|NCT00655603|Hormones|hormones|mesh-list
153927259|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927260|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927261|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153927262|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153927263|NCT00655681|Pamidronate|pamidronate|mesh-list
153927264|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153927265|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927266|NCT04221568|Fentanyl|fentanyl|mesh-list
153927267|NCT04221568|Bupivacaine|bupivacaine|mesh-list
153927268|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
153927269|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
153927270|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
153927271|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927272|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927273|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
153927274|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927275|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153927276|NCT04221568|Narcotics|narcotics|mesh-ancestor
153927277|NCT04221568|Analgesics|analgesics|mesh-ancestor
153927278|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153927279|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153927280|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
153927281|NCT01135524|Buprenorphine|buprenorphine|mesh-list
153927282|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153927283|NCT01135524|Narcotics|narcotics|mesh-ancestor
153927284|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927285|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927286|NCT01135524|Analgesics|analgesics|mesh-ancestor
153927287|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
153927288|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927289|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153927290|NCT00948675|Paclitaxel|paclitaxel|mesh-list
153927291|NCT00948675|Bevacizumab|bevacizumab|mesh-list
153927292|NCT00948675|Carboplatin|carboplatin|mesh-list
153927293|NCT00948675|Pemetrexed|pemetrexed|mesh-list
153684910|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927306|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927307|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153927308|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153927309|NCT02642497|Ketamine|ketamine|mesh-list
153927310|NCT02642497|Analgesics|analgesics|mesh-ancestor
153927311|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
153927312|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829335|NCT00486876|Tofisopam|tofisopam|mesh-list
153927313|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927314|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153927315|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153927316|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
153927317|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
153927318|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927319|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153927320|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153927321|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927322|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927323|NCT04273581|Thalidomide|thalidomide|mesh-list
153927324|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153927325|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
153927326|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927327|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
153927328|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927329|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927330|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153927331|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153927332|NCT04273581|Growth Substances|growth substances|mesh-ancestor
153927333|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
153927334|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927335|NCT01110408|Amoxicillin|amoxicillin|mesh-list
153927336|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
153927337|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
153927338|NCT01110408|Cefepime|cefepime|mesh-list
153927339|NCT01110408|Doripenem|doripenem|mesh-list
153927340|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153927341|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927342|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927343|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153927344|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927345|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927346|NCT00953043|Lubiprostone|lubiprostone|mesh-list
153927347|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153927348|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927349|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927350|NCT02850484|Budesonide|budesonide|mesh-list
153927351|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
153927352|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153927353|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153927354|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
153927367|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927368|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
153927369|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153927370|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
153927371|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153927372|NCT00948441|Ethanol|ethanol|mesh-list
153927373|NCT00948441|Heparin|heparin|mesh-list
153927374|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
153927375|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153927376|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153927377|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927378|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153927379|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260704|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153927380|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927381|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927382|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
153927383|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153927384|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927385|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927386|NCT00630903|Methoxsalen|methoxsalen|mesh-list
153927387|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153927388|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
153927389|NCT02883426|Vaccines|vaccines|mesh-list
153927390|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
153927391|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927392|NCT02849314|Immunomodulating Agents|immunomodulating agents|mesh-list
153927393|NCT02849314|Immunologic Factors|immunologic factors|mesh-ancestor
153927394|NCT02849314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927395|NCT02849236|Ropivacaine|ropivacaine|mesh-list
153927396|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
153927397|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
153927398|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927399|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927400|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
153927401|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927402|NCT02856789|Hemostatics|hemostatics|mesh-list
153927403|NCT02856789|Coagulants|coagulants|mesh-ancestor
153927404|NCT01117350|Metformin|metformin|mesh-list
153927405|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
153927406|NCT01117350|Liraglutide|liraglutide|mesh-list
153927407|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153927408|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927409|NCT01117350|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153927410|NCT01117350|Incretins|incretins|mesh-ancestor
153927411|NCT01117350|Hormones|hormones|mesh-ancestor
153927412|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927413|NCT00952731|Tamoxifen|tamoxifen|mesh-list
153927414|NCT00952731|Afimoxifene|afimoxifene|mesh-list
153927415|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153927427|NCT04202224|Analgesics|analgesics|mesh-ancestor
153927428|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
153927429|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927430|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927431|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
153927432|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153927433|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153927434|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927435|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153927436|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927437|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927438|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153927439|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
153927440|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927442|NCT02848612|Calcium heparin|calcium heparin|mesh-list
153927443|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
153927444|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153927445|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153927446|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927447|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153927448|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153927449|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153927450|NCT04235062|Furosemide|furosemide|mesh-list
153927451|NCT04235062|Calcium|calcium|mesh-list
153927452|NCT04235062|Diuretics|diuretics|mesh-list
153927453|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153927454|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153829365|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153927455|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927456|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
153927457|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927458|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927459|NCT02848768|Sunitinib|sunitinib|mesh-list
153927460|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927461|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153927462|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153927463|NCT02848768|Growth Substances|growth substances|mesh-ancestor
153927464|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927465|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
153927466|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153927467|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927468|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927469|NCT02848300|Bimatoprost|bimatoprost|mesh-list
153927470|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153927471|NCT00953745|Aripiprazole|aripiprazole|mesh-list
153927472|NCT00953745|Escitalopram|escitalopram|mesh-list
153927473|NCT00953745|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153927474|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153927475|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927476|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927509|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153927510|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
153927511|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153927512|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
153927513|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153927514|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927515|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153927516|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153927517|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927519|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153927538|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
153927539|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927540|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153927541|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
153927542|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153927543|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153927544|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927545|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927546|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153927547|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
153927548|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927549|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927550|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153927551|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153927552|NCT00902668|Lovastatin|lovastatin|mesh-list
153927553|NCT00902668|L 647318|l 647318|mesh-list
153927554|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
153927555|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153927556|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153927557|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
153927558|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927559|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153927560|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153927561|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927562|NCT00433420|Paclitaxel|paclitaxel|mesh-list
153927563|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
153927564|NCT00433420|Fluorouracil|fluorouracil|mesh-list
153927565|NCT00433420|Epirubicin|epirubicin|mesh-list
153927566|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153927567|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927568|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
153927569|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
153927570|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153927571|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927572|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153927573|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
153927574|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927575|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685204|NCT00082485|Baclofen|baclofen|mesh-list
153927588|NCT04202068|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153927589|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927590|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927591|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153927592|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927593|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927594|NCT02850250|Cefuroxime|cefuroxime|mesh-list
153927595|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
153927596|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927597|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927599|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153927600|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927601|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153927602|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927603|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927604|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153927605|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153927606|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
153927607|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927608|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927609|NCT02846506|Metformin|metformin|mesh-list
153927610|NCT02846506|Canagliflozin|canagliflozin|mesh-list
153927611|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153927612|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927613|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153927614|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927615|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
153927616|NCT02846428|Docetaxel|docetaxel|mesh-list
153927617|NCT02846428|Capecitabine|capecitabine|mesh-list
153927618|NCT02846428|Fluorouracil|fluorouracil|mesh-list
153927619|NCT02846428|Epirubicin|epirubicin|mesh-list
153927620|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153927621|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
153927622|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927623|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927624|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153927625|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
153927626|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927627|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927628|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153927629|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
153927630|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
153927631|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
153927632|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153927633|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
153927634|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153927635|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153927636|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153927637|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927651|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
153927652|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927653|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927654|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153927655|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927657|NCT02845804|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153927658|NCT02845804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153927659|NCT02845804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927660|NCT02845804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927661|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153927662|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
153927663|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927664|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927665|NCT02844634|Tenofovir|tenofovir|mesh-list
153927666|NCT02844634|Emtricitabine|emtricitabine|mesh-list
153927667|NCT02844634|Doxycycline|doxycycline|mesh-list
153927668|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
153927669|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927670|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153927671|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153927672|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927673|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927674|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153927675|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153927676|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927677|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
153927678|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153927679|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153927680|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153927681|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
153927682|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927683|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927684|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927685|NCT00952419|Vaccines|vaccines|mesh-list
153927686|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
153927687|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413246|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153927689|NCT02844322|Bortezomib|bortezomib|mesh-list
153927690|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153927691|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927692|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
153927693|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927694|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927695|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153927696|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153927697|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927698|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153927699|NCT00630981|Escitalopram|escitalopram|mesh-list
153685320|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
153927732|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153927733|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927734|NCT00952341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153927735|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153927736|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
153927738|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927739|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927740|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
153927741|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153927759|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927760|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
153927761|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927762|NCT04410328|Aspirin|aspirin|mesh-list
153927763|NCT04410328|Dipyridamole|dipyridamole|mesh-list
153927764|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153927765|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153927766|NCT04410328|Analgesics|analgesics|mesh-ancestor
153927767|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
153927768|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927769|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927770|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153927771|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927772|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153927773|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153927774|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927775|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153927776|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153927777|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927778|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
153927779|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153927780|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
153927781|NCT02852577|Clonazepam|clonazepam|mesh-list
153927782|NCT02852577|Paroxetine|paroxetine|mesh-list
153927783|NCT02852577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153927784|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153927785|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927786|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927787|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927788|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
153927789|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927790|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153927791|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
153927792|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153927793|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153927794|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153927795|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927796|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
153927797|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
153927798|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
153927799|NCT04201990|Apatinib|apatinib|mesh-list
153927810|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927812|NCT00901186|Ranibizumab|ranibizumab|mesh-list
153927813|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153927814|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153927815|NCT00901186|Growth Substances|growth substances|mesh-ancestor
153927816|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927817|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
153927818|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927819|NCT05040880|Telmisartan|telmisartan|mesh-list
153927820|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153872706|NCT02211950|Acarbose|acarbose|mesh-list
153927821|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153927822|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153927823|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927825|NCT04073290|Lactulose|lactulose|mesh-list
153927826|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927827|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927828|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153927829|NCT03936790|Fentanyl|fentanyl|mesh-list
153927830|NCT03936790|Ropivacaine|ropivacaine|mesh-list
153829460|NCT00487032|Protective Agents|protective agents|mesh-ancestor
153927831|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
153927832|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
153927833|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927834|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927835|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
153927836|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927837|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153927838|NCT03936790|Narcotics|narcotics|mesh-ancestor
153927839|NCT03936790|Analgesics|analgesics|mesh-ancestor
153927840|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153927841|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153927842|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
153927843|NCT04782700|Prednisone|prednisone|mesh-list
153927844|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153927845|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
153927846|NCT04782700|Hormones|hormones|mesh-ancestor
153927847|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927848|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927849|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153927850|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927851|NCT00885703|Fluconazole|fluconazole|mesh-list
153927852|NCT00885703|Amphotericin B|amphotericin b|mesh-list
153927853|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153927854|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
153927855|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
153927856|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
153927857|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927858|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153927859|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153927860|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927861|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927862|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153927863|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
153685482|NCT00152035|Amphetamine|amphetamine|mesh-list
153927887|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
153927888|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927889|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927890|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153927891|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927892|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153927893|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153927894|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927895|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153927896|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927897|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
153927898|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153927899|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153927900|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153927901|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
153927902|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927903|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153927904|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
153927905|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153927906|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
153927907|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
153927908|NCT00901576|Methylphenidate|methylphenidate|mesh-list
153927909|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153927910|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927911|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153927912|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153927925|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153927926|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
153927927|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260705|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154260706|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927928|NCT00655915|Betamethasone|betamethasone|mesh-list
153927929|NCT00655915|Lidocaine|lidocaine|mesh-list
153927930|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
153927931|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
153927932|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927933|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927934|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
153927935|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927936|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153927937|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153927938|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153927939|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927940|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927941|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583879|NCT01758120|Hormones|hormones|mesh-ancestor
153927942|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
153927943|NCT00655915|Hormones|hormones|mesh-ancestor
153927944|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927945|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153927946|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
153927947|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
153927948|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153927949|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927950|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927951|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153927952|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153927953|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685527|NCT00152308|Sirolimus|sirolimus|mesh-list
153927954|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927955|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927956|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927957|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153927958|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153927959|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927960|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927961|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153927962|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
153927963|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153927965|NCT00656773|Morphine|morphine|mesh-list
153927966|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153927967|NCT00656773|Narcotics|narcotics|mesh-ancestor
153927968|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927969|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927970|NCT00656773|Analgesics|analgesics|mesh-ancestor
153927971|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
153927972|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927973|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153927974|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153928006|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153928007|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928008|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928009|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153928010|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153928011|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153928012|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153928013|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
153928014|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
153928015|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
153928016|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
153928017|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928018|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928019|NCT00599521|Adapalene|adapalene|mesh-list
153928020|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153928033|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153928034|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
153928035|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
153928036|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
153928037|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
153928038|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153928039|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928040|NCT02642263|Carbetocin|carbetocin|mesh-list
153872889|NCT00637468|Aspirin|aspirin|mesh-list
153928041|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
153928042|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153928043|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928044|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
153928045|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928046|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
153928048|NCT02636803|Albendazole|albendazole|mesh-list
153928049|NCT02636803|Oxfendazole|oxfendazole|mesh-list
153928050|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
153928051|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153928052|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928053|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
153928054|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153928055|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153928056|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
153928057|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
153928058|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
153928059|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928060|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928061|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
153928062|NCT02634463|Olanzapine|olanzapine|mesh-list
153928063|NCT02634463|Risperidone|risperidone|mesh-list
153928064|NCT02634463|Aripiprazole|aripiprazole|mesh-list
153928065|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153928066|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153928067|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
153928068|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928069|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928070|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928071|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153928072|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153928073|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928074|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153928075|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153928076|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
153928077|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
153928078|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
153928079|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928080|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928081|NCT02634463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153928082|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153928083|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153928084|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
153928085|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
153928086|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153928087|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153928113|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
153928115|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
153928116|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928117|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153928118|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153928119|NCT00884221|Menotropins|menotropins|mesh-list
153928120|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153928121|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
153928122|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153928123|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928125|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153928126|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153928127|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
153928128|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928129|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
153928130|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928131|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928132|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928133|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928134|NCT02153632|Analgesics|analgesics|mesh-ancestor
153928135|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
153928136|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928159|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153928160|NCT00651274|Ezetimibe|ezetimibe|mesh-list
153928161|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153928162|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153928163|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
153928164|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928166|NCT00212836|Olanzapine|olanzapine|mesh-list
153928167|NCT00212836|Asenapine|asenapine|mesh-list
153928168|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
153928169|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
153928170|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928171|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928172|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928173|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153928174|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153928175|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928176|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153928177|NCT00212836|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153928178|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153928179|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153928180|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928181|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928182|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
153928183|NCT00805324|Desloratadine|desloratadine|mesh-list
153928184|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153928185|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
153928186|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928187|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928188|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928219|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928220|NCT03612466|Antacids|antacids|mesh-ancestor
153928221|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928222|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928223|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153928224|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153928225|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
153928226|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928227|NCT00142558|Indomethacin|indomethacin|mesh-list
153928228|NCT00142558|Etoricoxib|etoricoxib|mesh-list
153928229|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928230|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928231|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928232|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153928233|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928234|NCT00142558|Analgesics|analgesics|mesh-ancestor
153928257|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928258|NCT02841982|Analgesics|analgesics|mesh-ancestor
153928259|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
153928260|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928261|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
153928262|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
153928263|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
153928264|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153928265|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928266|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928267|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928268|NCT02843698|Analgesics|analgesics|mesh-ancestor
153928269|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
153928270|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928271|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153928272|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153928273|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153928274|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
153928275|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360928|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
153928276|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928278|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928279|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
153928280|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
153928281|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153928282|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153928283|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928284|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153928285|NCT00895414|Doxorubicin|doxorubicin|mesh-list
153928286|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153928287|NCT00895414|Enalapril|enalapril|mesh-list
153928288|NCT00895414|Enalaprilat|enalaprilat|mesh-list
153928304|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928305|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260707|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928306|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153928307|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
153928308|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153928309|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153928310|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153928311|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153928312|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153928313|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153928314|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153928315|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928316|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
153928317|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
153928318|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153928319|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153928320|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
153928321|NCT01328626|Venetoclax|venetoclax|mesh-list
153928322|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928323|NCT02840812|Nemonoxacin|nemonoxacin|mesh-list
153928324|NCT02840812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928325|NCT02840812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928326|NCT01212770|Thalidomide|thalidomide|mesh-list
153928327|NCT01212770|Apremilast|apremilast|mesh-list
153928328|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153928329|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928330|NCT01212770|Analgesics|analgesics|mesh-ancestor
153928331|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
153685910|NCT00050648|Daclizumab|daclizumab|mesh-list
153928332|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928333|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928334|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928335|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928336|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153928337|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153928338|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928339|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584678|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584679|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
153928340|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153928341|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
153928342|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
153928343|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928344|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928345|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153685963|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153928369|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153928370|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
153928371|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928372|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
153928373|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153928374|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153928375|NCT04318652|Prednisolone|prednisolone|mesh-list
153928376|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
153928377|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153928378|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153928379|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
153928380|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928381|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
153928382|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
153928383|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928384|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928385|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928386|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
153928387|NCT04318652|Hormones|hormones|mesh-ancestor
153928388|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928389|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153928390|NCT04318652|Protective Agents|protective agents|mesh-ancestor
153928391|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153928392|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928393|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153928394|NCT02633995|Anesthetics|anesthetics|mesh-list
153928395|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928396|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928397|NCT02633683|Gabapentin|gabapentin|mesh-list
153928398|NCT02633683|Analgesics|analgesics|mesh-ancestor
153873137|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928399|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
153928417|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928418|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928419|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928420|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153928421|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153928422|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928423|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153928424|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153928425|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
153928426|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928427|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928428|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153928429|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153928430|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
153928431|NCT05404724|Itraconazole|itraconazole|mesh-list
153928432|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
153928433|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829599|NCT00487422|Prucalopride|prucalopride|mesh-list
153928434|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153928435|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153928436|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928437|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928438|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153928439|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
153928440|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928441|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928442|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153928443|NCT02633761|Misoprostol|misoprostol|mesh-list
153928444|NCT02633761|Mifepristone|mifepristone|mesh-list
153928445|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153928446|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
153928447|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153928448|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928449|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153928450|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928451|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
153928452|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153928453|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153928454|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153928470|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928471|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153928472|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928473|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
153928474|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153820967|NCT02957474|Omeprazole|omeprazole|mesh-list
153928475|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928476|NCT00657397|Methadone|methadone|mesh-list
153928477|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153928478|NCT00657397|Narcotics|narcotics|mesh-ancestor
153928479|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928480|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928481|NCT00657397|Analgesics|analgesics|mesh-ancestor
153928482|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
153928483|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928484|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
153928485|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
153928486|NCT04160611|Midazolam|midazolam|mesh-list
153928487|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153928488|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153928489|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928490|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928491|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153928492|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153928493|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153928494|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153928495|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
153928496|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
153928497|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
153928498|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
153928499|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928500|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928501|NCT04161001|Amlodipine|amlodipine|mesh-list
153928502|NCT04161001|Olmesartan|olmesartan|mesh-list
154260709|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928503|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153928504|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
153928505|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153928506|NCT04161001|Ezetimibe|ezetimibe|mesh-list
153928507|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153928508|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153928509|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153928510|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928511|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153928540|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153928541|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
153928543|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153928544|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928545|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
153928546|NCT02636101|Hormones|hormones|mesh-ancestor
153928547|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928548|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928549|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153928550|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
153928551|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
153928552|NCT00657475|Heparin|heparin|mesh-list
153686121|NCT00154687|Paclitaxel|paclitaxel|mesh-list
153928553|NCT00657475|Calcium heparin|calcium heparin|mesh-list
153928567|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928568|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928569|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153928570|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
153928571|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153928572|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153928573|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928574|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928575|NCT00661219|Urological Agents|urological agents|mesh-ancestor
153928576|NCT00665743|Naproxen|naproxen|mesh-list
153928577|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153928578|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928579|NCT00665743|Analgesics|analgesics|mesh-ancestor
153928580|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
153928581|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928582|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928583|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928584|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928585|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
153928586|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153928587|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928588|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928589|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153928590|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
153928591|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153928592|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153928593|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928594|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928595|NCT00661297|Urological Agents|urological agents|mesh-ancestor
153928596|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
153928597|NCT00879775|Caffeine|caffeine|mesh-list
153928598|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153928599|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928600|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153928601|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928602|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928603|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153928604|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153928605|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
153928606|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928607|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
153928608|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928609|NCT00894790|Celecoxib|celecoxib|mesh-list
153928610|NCT00894790|Diclofenac|diclofenac|mesh-list
153928611|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153928612|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153414035|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153873371|NCT02214966|Telmisartan|telmisartan|mesh-list
153928621|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928622|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928623|NCT00665977|Triamcinolone|triamcinolone|mesh-list
153928624|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153928625|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153928626|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153928627|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928628|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
154191181|NCT05941741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928630|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928631|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928632|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153928633|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
153928634|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928635|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928636|NCT00666055|Ritonavir|ritonavir|mesh-list
153928637|NCT00666055|Lopinavir|lopinavir|mesh-list
153928638|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153928639|NCT00666055|Tenofovir|tenofovir|mesh-list
153928640|NCT00666055|Lamivudine|lamivudine|mesh-list
153928641|NCT00666055|Emtricitabine|emtricitabine|mesh-list
153928642|NCT00666055|Zidovudine|zidovudine|mesh-list
153928643|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
153928644|NCT00666055|Maraviroc|maraviroc|mesh-list
153928645|NCT00666055|Efavirenz|efavirenz|mesh-list
153928646|NCT00666055|Etravirine|etravirine|mesh-list
153928647|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153928648|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153928649|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
153928650|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928651|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928652|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153928653|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153928654|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
153928655|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928656|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153928657|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153928658|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153928659|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153928660|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
153928661|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153928662|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153928663|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153928664|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153928665|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153928666|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153928667|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153928668|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153928669|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153928670|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153928671|NCT00661375|Sorafenib|sorafenib|mesh-list
153928672|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928673|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153928674|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928675|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928676|NCT00911287|Oxymorphone|oxymorphone|mesh-list
153928677|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153928678|NCT00911287|Narcotics|narcotics|mesh-ancestor
153686299|NCT00083538|Growth Substances|growth substances|mesh-ancestor
153928712|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928713|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928714|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928716|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
153586282|NCT01771289|Docetaxel|docetaxel|mesh-list
153928717|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
153928718|NCT02839486|Vancomycin|vancomycin|mesh-list
153928719|NCT02839486|Cefoxitin|cefoxitin|mesh-list
153686361|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
153928743|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928744|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928745|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
153360937|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586398|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928747|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
153928748|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
153928749|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153928750|NCT00878995|Androgens|androgens|mesh-ancestor
154260710|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260711|NCT01192724|Aspirin|aspirin|mesh-list
153928751|NCT00878995|Hormones|hormones|mesh-ancestor
153928752|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928753|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928754|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153928755|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928756|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
153928757|NCT02837146|Methotrexate|methotrexate|mesh-list
153928758|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153928759|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
153928760|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153928761|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928762|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153928763|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
153928764|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928765|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928766|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
153928767|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928768|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153928769|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153928770|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
153928771|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928783|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928784|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928785|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928786|NCT00657943|Insulin|insulin|mesh-list
153928787|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153928789|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
153928790|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
153928791|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153928792|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
153928793|NCT00657943|Protamines|protamines|mesh-list
153928794|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153928795|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928796|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
153928797|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928798|NCT00657943|Coagulants|coagulants|mesh-ancestor
153928799|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
153928800|NCT04249804|Analgesics|analgesics|mesh-ancestor
153928801|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
153928802|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928803|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928804|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
153928805|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928806|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153928807|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
153928808|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153928809|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153928810|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928811|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153928812|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
153928813|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153928814|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
153928815|NCT02631109|Doxorubicin|doxorubicin|mesh-list
153928816|NCT02631109|Etoposide|etoposide|mesh-list
153928817|NCT02631109|Pegaspargase|pegaspargase|mesh-list
153928818|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153928819|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928820|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153928821|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153928822|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928823|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928824|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153928825|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928826|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
153928827|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
153928828|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928829|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928830|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928831|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
153928832|NCT02631109|Hormones|hormones|mesh-ancestor
153414343|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
153414344|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153414345|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
153414347|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153414348|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
153414349|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
153414351|NCT02577601|Estradiol|estradiol|mesh-list
153928833|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928834|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153928835|NCT02631109|Protective Agents|protective agents|mesh-ancestor
153928866|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928867|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153928868|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
153928869|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928870|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928871|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153928872|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153928873|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928874|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928875|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928876|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
153928877|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153928878|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928879|NCT00658099|Insulin|insulin|mesh-list
153686519|NCT00157729|Vitamins|vitamins|mesh-ancestor
153928888|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
153928889|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153928890|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153928891|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928892|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928893|NCT00658177|Urological Agents|urological agents|mesh-ancestor
153928894|NCT00658255|Budesonide|budesonide|mesh-list
153928895|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
153928896|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928897|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153928898|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
153928899|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928900|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928901|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153928902|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
153928903|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
153928904|NCT00658255|Hormones|hormones|mesh-ancestor
153928905|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928906|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153369716|NCT05857982|Glucocorticoids|glucocorticoids|mesh-ancestor
153829675|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928907|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153928908|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153928909|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
153928910|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928911|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928912|NCT02836288|Ketamine|ketamine|mesh-list
153928913|NCT02836288|Analgesics|analgesics|mesh-ancestor
153928914|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
153928915|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928916|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928917|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153928918|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153928919|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
153928920|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
153928921|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928922|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153928923|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153928924|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928925|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928926|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153928927|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
153928928|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153873865|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873866|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153873867|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153873883|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153873884|NCT04577885|Rifampin|rifampin|mesh-list
153873885|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153873886|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
153873887|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873888|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873889|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
153873891|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928929|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153928930|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153928931|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587012|NCT01777919|Copper|copper|mesh-list
153928932|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928933|NCT01208402|Esmolol|esmolol|mesh-list
153928934|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153928935|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153928936|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153928937|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
153928938|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928939|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928940|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928941|NCT01208324|Estrogens|estrogens|mesh-list
153928942|NCT01208324|Hormones|hormones|mesh-ancestor
153928943|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928944|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928945|NCT02838940|Cefazolin|cefazolin|mesh-list
153928974|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
153928975|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928976|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153928977|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
153928978|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
153928979|NCT02838472|Vitamins|vitamins|mesh-ancestor
153928980|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
153928981|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928982|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
153928983|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928984|NCT02838472|Protective Agents|protective agents|mesh-ancestor
153928985|NCT00666991|Paclitaxel|paclitaxel|mesh-list
153928986|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153928987|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928988|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
153928989|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
153928990|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
153928991|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928992|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153928993|NCT00667147|Paclitaxel|paclitaxel|mesh-list
153928994|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928995|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153929003|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
153929004|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
153929005|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
153929006|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929008|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
153929009|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929010|NCT02838238|Capecitabine|capecitabine|mesh-list
153929011|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153929012|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
153929013|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929014|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929015|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154260713|NCT01192724|Clopidogrel|clopidogrel|mesh-list
154260714|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154260715|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154260716|NCT01192724|Analgesics|analgesics|mesh-ancestor
154260717|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
153360944|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154260718|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260719|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260720|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260721|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260722|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154260723|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153404903|NCT00003213|Dexamethasone|dexamethasone|mesh-list
153873943|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153873944|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873945|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873946|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
153873947|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153873948|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
153873949|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153873950|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873951|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153873952|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153929016|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929018|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153929019|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153929020|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929021|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
153929022|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929024|NCT01206764|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153929025|NCT01206764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153929026|NCT01206764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929027|NCT01206764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929028|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929029|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
153929030|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929031|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929032|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
153929033|NCT00667927|Busulfan|busulfan|mesh-list
153929034|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929035|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
153929036|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929037|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929038|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153929039|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
153587224|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
153929040|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929041|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929042|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153929043|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153929044|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
153929045|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153414714|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
153414715|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153414716|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153414717|NCT02207400|Listerine|listerine|mesh-list
153874015|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874016|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874017|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153874019|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
153929046|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153929047|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929048|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929049|NCT00668005|Urological Agents|urological agents|mesh-ancestor
153929050|NCT00668239|Triamcinolone|triamcinolone|mesh-list
153929051|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929052|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
153929053|NCT00668239|Hormones|hormones|mesh-ancestor
153929054|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929055|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929056|NCT02631499|Epirubicin|epirubicin|mesh-list
153929057|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
153929058|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153929059|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929060|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153929061|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153587331|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153929062|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929063|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929101|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929102|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929125|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153929126|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153929127|NCT00894322|Exenatide|exenatide|mesh-list
153929128|NCT00894322|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153929129|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153929130|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929131|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153929132|NCT00894322|Incretins|incretins|mesh-ancestor
153929133|NCT00894322|Hormones|hormones|mesh-ancestor
153929134|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929135|NCT00633412|Esomeprazole|esomeprazole|mesh-list
153929136|NCT00633412|Ranitidine|ranitidine|mesh-list
153929137|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153929138|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153929139|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153929140|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153929141|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929142|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829748|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
153929143|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153929144|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
153929145|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
153929146|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929147|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929148|NCT00659113|Tegafur|tegafur|mesh-list
153929149|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929150|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153929151|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
153929152|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929153|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
153929154|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153929155|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
153929156|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929170|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929171|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
153929172|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153929173|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153929174|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929175|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154260724|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260725|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154260726|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154260727|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260729|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154260730|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153404951|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153874088|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874089|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153874090|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153874091|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153874092|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
153874093|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153874094|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153874095|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
153414792|NCT00366067|Phenytoin|phenytoin|mesh-list
153414793|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
153414794|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153414795|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153414796|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874114|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
153929176|NCT00669487|Lamivudine|lamivudine|mesh-list
153929177|NCT00669487|Stavudine|stavudine|mesh-list
153929178|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153929179|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153929180|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929181|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929182|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
153929183|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929184|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153929185|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153929186|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
153929187|NCT00669565|Bavituximab|bavituximab|mesh-list
153929188|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153929189|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929190|NCT00669643|Rifampin|rifampin|mesh-list
153929191|NCT00669643|Dapsone|dapsone|mesh-list
153929192|NCT00669643|Clofazimine|clofazimine|mesh-list
153929193|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153929194|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
153929195|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929196|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929197|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
153929198|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153929199|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929200|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929201|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153929202|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153929203|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154260731|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154260732|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
154260733|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260734|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154260735|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
154260736|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154260737|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
154260738|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
154007678|NCT00602693|Allopurinol|allopurinol|mesh-list
154260739|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154260740|NCT01192724|Protective Agents|protective agents|mesh-ancestor
154260741|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153929204|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153929205|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153929206|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153929207|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
153929208|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153929209|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153929210|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153929211|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929212|NCT00669721|Heparin|heparin|mesh-list
153929213|NCT00669721|Calcium heparin|calcium heparin|mesh-list
153929214|NCT00669721|Nadroparin|nadroparin|mesh-list
153929215|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
153929216|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153929217|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153929218|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929219|NCT00894166|Bupropion|bupropion|mesh-list
153929254|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153929255|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929256|NCT00670423|Sirolimus|sirolimus|mesh-list
153929257|NCT00670423|Bortezomib|bortezomib|mesh-list
153929258|NCT00670423|Tacrolimus|tacrolimus|mesh-list
153929259|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929268|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153929270|NCT00659659|Benralizumab|benralizumab|mesh-list
153929271|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153929272|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
153929273|NCT00670501|Vitamin D|vitamin d|mesh-list
153929274|NCT00670501|Teriparatide|teriparatide|mesh-list
153929275|NCT00670501|Calcium|calcium|mesh-list
153929276|NCT00670501|Vitamins|vitamins|mesh-ancestor
153929277|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
153929278|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929279|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153929280|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153929281|NCT00663247|Mesalamine|mesalamine|mesh-list
153929282|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153929283|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153929284|NCT00663247|Analgesics|analgesics|mesh-ancestor
153929285|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
153929286|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929287|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929288|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929289|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929290|NCT01163747|Methotrexate|methotrexate|mesh-list
153929291|NCT01163747|Vaccines|vaccines|mesh-list
153929292|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153929293|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
153929294|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929295|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153929296|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
153929297|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153929298|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153929299|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
153402602|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153402761|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
153929300|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929301|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929302|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
153929303|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929304|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153929305|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929306|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929307|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153929308|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153929309|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
153929310|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929311|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153929312|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153929313|NCT05657015|Simvastatin|simvastatin|mesh-list
153929314|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153929315|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153929316|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
153929317|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929318|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153929319|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153929320|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929321|NCT02887313|Leucovorin|leucovorin|mesh-list
153929322|NCT02887313|Fluorouracil|fluorouracil|mesh-list
153929323|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
153929324|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
153929325|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929348|NCT01206140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929349|NCT01206140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929350|NCT01162421|Adalimumab|adalimumab|mesh-list
153929351|NCT01162421|Methotrexate|methotrexate|mesh-list
153929352|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153929353|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
153929354|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588206|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153929355|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929356|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153929357|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
153929358|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929359|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929360|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
153929361|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929362|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153929363|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929364|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
153929365|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929366|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153929367|NCT01162421|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153929368|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929369|NCT02885441|Ketorolac|ketorolac|mesh-list
153929370|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153929371|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153929372|NCT02885441|Analgesics|analgesics|mesh-ancestor
153929373|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
153929374|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929375|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929376|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153686949|NCT00160537|Levocetirizine|levocetirizine|mesh-list
153929377|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929378|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153929412|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929413|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153929414|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153929415|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153929416|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153929417|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153687064|NCT00161239|Prednisone|prednisone|mesh-list
153588247|NCT01786538|Antidotes|antidotes|mesh-ancestor
153929427|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929428|NCT01161407|Antacids|antacids|mesh-ancestor
153929429|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929430|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153929431|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154260742|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153929432|NCT01161173|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153929433|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153929434|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929435|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929436|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929437|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153929438|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153929439|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153929440|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153929441|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153929442|NCT01159769|Analgesics|analgesics|mesh-ancestor
153929443|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
153929444|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929445|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929446|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929447|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929448|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153929449|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153687034|NCT00044577|Tenofovir|tenofovir|mesh-list
153929450|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153929451|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
153929452|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
153929453|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929454|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929455|NCT01185821|Siponimod|siponimod|mesh-list
153929456|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153929457|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588374|NCT01787669|Hormones|hormones|mesh-ancestor
153929458|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929459|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
153929460|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929462|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929463|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
153929464|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929465|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929466|NCT00891904|Cetuximab|cetuximab|mesh-list
153929467|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153929468|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929469|NCT02834260|Dexamethasone|dexamethasone|mesh-list
153929470|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929471|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
153929472|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
153929473|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929474|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929475|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153929476|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
153929477|NCT02834260|Hormones|hormones|mesh-ancestor
153929478|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929479|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153929480|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929481|NCT01157351|Olanzapine|olanzapine|mesh-list
153929482|NCT01157351|Risperidone|risperidone|mesh-list
153929483|NCT01157351|Aripiprazole|aripiprazole|mesh-list
153929484|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153929515|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
153929516|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929517|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929518|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153929519|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
153929520|NCT02831686|Hormones|hormones|mesh-ancestor
154191182|NCT05941741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153821007|NCT00481572|Terlipressin|terlipressin|mesh-list
153929521|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929522|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153929523|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687101|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
153929525|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929526|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929527|NCT00633490|Apatinib|apatinib|mesh-list
153929546|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153929547|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929548|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153929549|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153929550|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260745|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153929552|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153929553|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153929554|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153929555|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
153929556|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929557|NCT02833480|Fluticasone|fluticasone|mesh-list
153929558|NCT02833480|Budesonide|budesonide|mesh-list
153929559|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
153929560|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929561|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153929562|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
153929563|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929564|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929565|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153929566|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
153929567|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
153929568|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153929569|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
153929570|NCT02833480|Hormones|hormones|mesh-ancestor
153929571|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929572|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153929573|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153929574|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153929575|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
153929576|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929577|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929578|NCT04201054|Fluconazole|fluconazole|mesh-list
153369920|NCT04893291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153929579|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
153929580|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929581|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153687211|NCT00405457|Cyclosporine|cyclosporine|mesh-list
153929614|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929616|NCT02832778|Lamivudine|lamivudine|mesh-list
153929617|NCT02832778|Emtricitabine|emtricitabine|mesh-list
153929618|NCT02832778|Zidovudine|zidovudine|mesh-list
153929619|NCT02832778|Efavirenz|efavirenz|mesh-list
153687278|NCT00162487|Albuterol|albuterol|mesh-list
153929630|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
153929631|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153929632|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153929633|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153929634|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153929635|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153929636|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153929637|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
153929638|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929639|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153929640|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153929641|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153929642|NCT01185509|Trastuzumab|trastuzumab|mesh-list
153588540|NCT01788982|Nintedanib|nintedanib|mesh-list
153929643|NCT01185509|Vinorelbine|vinorelbine|mesh-list
153929644|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153929645|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929646|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153929647|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
153929648|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
153929649|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
153929650|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929651|NCT04247230|Tetracaine|tetracaine|mesh-list
153929652|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
153929653|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
153929654|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929655|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929656|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
153929657|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929658|NCT02832700|Caseins|caseins|mesh-list
153929659|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
153929660|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
153929661|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929662|NCT02831842|Bevacizumab|bevacizumab|mesh-list
153929663|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154260746|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929664|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929665|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153929666|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153929667|NCT02831842|Growth Substances|growth substances|mesh-ancestor
153929668|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588695|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153929669|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
153929671|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153929672|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929674|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929675|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929676|NCT02828566|Ketamine|ketamine|mesh-list
153929677|NCT02828566|Analgesics|analgesics|mesh-ancestor
153929678|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
153929679|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929680|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929681|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153929682|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153687309|NCT00162604|Cefuroxime|cefuroxime|mesh-list
153929708|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153929709|NCT02828176|Anesthetics|anesthetics|mesh-list
153929710|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929711|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929712|NCT00633568|Cisplatin|cisplatin|mesh-list
153929713|NCT00633568|Docetaxel|docetaxel|mesh-list
153929714|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929715|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
153929716|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
153929717|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
153929718|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929719|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
153929720|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153929721|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153929722|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929723|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
153929724|NCT02829346|Coagulants|coagulants|mesh-ancestor
153929725|NCT05210764|Ketamine|ketamine|mesh-list
153929726|NCT05210764|Anesthetics|anesthetics|mesh-list
153929727|NCT05210764|Propofol|propofol|mesh-list
153929728|NCT05210764|Sevoflurane|sevoflurane|mesh-list
153929729|NCT05210764|Esketamine|esketamine|mesh-list
153929730|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191183|NCT05941585|Cytarabine|cytarabine|mesh-list
154191184|NCT05941585|Venetoclax|venetoclax|mesh-list
153929742|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929743|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153929744|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153929745|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
153929748|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153929749|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153929750|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
153929751|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929752|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929753|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929754|NCT04243954|Morphine|morphine|mesh-list
153929755|NCT04243954|Hydromorphone|hydromorphone|mesh-list
153929756|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153929757|NCT04243954|Narcotics|narcotics|mesh-ancestor
153929758|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929759|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929760|NCT04243954|Analgesics|analgesics|mesh-ancestor
153929761|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
153929762|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929763|NCT02827942|Amoxicillin|amoxicillin|mesh-list
153929764|NCT02827942|Metronidazole|metronidazole|mesh-list
153929765|NCT02827942|Clarithromycin|clarithromycin|mesh-list
153929766|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929767|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929768|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153929769|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153929770|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153929771|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929772|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929773|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153929774|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153929775|NCT00889252|Ketotifen|ketotifen|mesh-list
154260747|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
154260748|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153929776|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
153929777|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
153929778|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153929779|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
153929780|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
153929781|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929782|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929783|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929784|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153929785|NCT00670813|Modafinil|modafinil|mesh-list
153929786|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153929787|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929788|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153929789|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153929790|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153929791|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929792|NCT01110330|Ketoconazole|ketoconazole|mesh-list
153687428|NCT00163150|Atorvastatin|atorvastatin|mesh-list
153929810|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
153929811|NCT04308954|Flumazenil|flumazenil|mesh-list
153929812|NCT04308954|Antidotes|antidotes|mesh-ancestor
153929813|NCT04308954|Protective Agents|protective agents|mesh-ancestor
153929814|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687458|NCT00163345|Hormones|hormones|mesh-ancestor
153929815|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
153929816|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
153929817|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929818|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929819|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
153929820|NCT00596947|Prednisone|prednisone|mesh-list
153929821|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
153929822|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153929823|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153929824|NCT00596947|Prednisolone|prednisolone|mesh-list
153929825|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
153929826|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153929827|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
153929828|NCT00596947|Tacrolimus|tacrolimus|mesh-list
153929829|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
153929830|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153929831|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929832|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
153929833|NCT00596947|Hormones|hormones|mesh-ancestor
153929834|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929835|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829955|NCT00506844|Irinotecan|irinotecan|mesh-list
153829956|NCT00506844|Cetuximab|cetuximab|mesh-list
153829957|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589149|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589150|NCT01801046|Analgesics|analgesics|mesh-ancestor
153929836|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153929837|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929838|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929839|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
153929840|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153929841|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929842|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929843|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153929844|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153929845|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
153929846|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929847|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929848|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
153929849|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
153929873|NCT00888940|Ecallantide|ecallantide|mesh-list
153929874|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
153929875|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153929876|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153929877|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929878|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
153929879|NCT00888940|Coagulants|coagulants|mesh-ancestor
153929880|NCT00888940|Analgesics|analgesics|mesh-ancestor
153929881|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
153929882|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929883|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929884|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153929885|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153405133|NCT03256799|Ivacaftor|ivacaftor|mesh-list
153929886|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929887|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929888|NCT02826070|Adefovir|adefovir|mesh-list
153929889|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153929890|NCT02826070|Telbivudine|telbivudine|mesh-list
153929891|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
153687468|NCT00163423|Ciclesonide|ciclesonide|mesh-list
153929892|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929893|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153929894|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153929895|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929896|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929897|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
153929898|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
153929899|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929900|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929912|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929913|NCT04157803|Acetic Acid|acetic acid|mesh-list
153929914|NCT04157803|Retinol acetate|retinol acetate|mesh-list
153929915|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929916|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929917|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153929918|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
153929919|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929920|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153929921|NCT04157803|Protective Agents|protective agents|mesh-ancestor
153929922|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929924|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
153929925|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929926|NCT00660283|Temozolomide|temozolomide|mesh-list
153929927|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153929928|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
153929929|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929930|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459375|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929931|NCT00663949|Captopril|captopril|mesh-list
153929932|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
153929933|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153929934|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929935|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929936|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153929937|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153929938|NCT00663949|Protective Agents|protective agents|mesh-ancestor
153929939|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929940|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
153929941|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153929942|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
153929943|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153929944|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
153929945|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153929946|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153929947|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153929948|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929949|NCT00888238|Incretins|incretins|mesh-ancestor
153929950|NCT00888238|Hormones|hormones|mesh-ancestor
153929951|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929952|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153929953|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
153929954|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929955|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929956|NCT05660356|Hormones|hormones|mesh-list
153929957|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929958|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929959|NCT02825914|Caseins|caseins|mesh-list
153929960|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
153929961|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
153929962|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929963|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
153929981|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929983|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
153929984|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153929985|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929986|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929987|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
153929988|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929989|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929990|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
153929991|NCT04153201|Antimalarials|antimalarials|mesh-list
153929992|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153929993|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153929994|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929995|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929996|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929997|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929999|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
153930000|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
153930001|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930002|NCT04153123|Epinephrine|epinephrine|mesh-list
153930003|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153930004|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153930005|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
153930006|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930007|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930008|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930009|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153930010|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153930011|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
153930012|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930013|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154191185|NCT05941585|Mitoxantrone|mitoxantrone|mesh-list
153930014|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
153930015|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
153930016|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
153930017|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153930018|NCT00671593|Phenol|phenol|mesh-list
153930019|NCT00671593|Glycerol|glycerol|mesh-list
153930020|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153930021|NCT00671593|Protective Agents|protective agents|mesh-ancestor
153930022|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930044|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687626|NCT00053612|Vitamin A|vitamin a|mesh-list
153930045|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930046|NCT01205126|Oxycodone|oxycodone|mesh-list
153930047|NCT01205126|Hydromorphone|hydromorphone|mesh-list
153930048|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153930049|NCT01205126|Narcotics|narcotics|mesh-ancestor
153930050|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930051|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930052|NCT01205126|Analgesics|analgesics|mesh-ancestor
153930054|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930055|NCT02629627|Metformin|metformin|mesh-list
153930056|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930057|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930058|NCT00946647|Azacitidine|azacitidine|mesh-list
153930059|NCT00946647|Panobinostat|panobinostat|mesh-list
153930060|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153930061|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
153930062|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930063|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930064|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930065|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153930066|NCT04157491|Antibodies|antibodies|mesh-list
153930067|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
153930068|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930069|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153930070|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153930071|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153930072|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153930073|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930074|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830004|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930075|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930076|NCT00660751|Analgesics|analgesics|mesh-ancestor
153930077|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
153687708|NCT00045123|Tarenflurbil|tarenflurbil|mesh-list
153930084|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930085|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153930086|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930088|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153930089|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
153930090|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930091|NCT00672295|Paclitaxel|paclitaxel|mesh-list
153930092|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153930093|NCT00672295|Carboplatin|carboplatin|mesh-list
153930094|NCT00672295|Dasatinib|dasatinib|mesh-list
153930095|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153930096|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930097|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930098|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930099|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
153930100|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930101|NCT00672295|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153930102|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153930103|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930104|NCT00665041|Quinagolide|quinagolide|mesh-list
153930105|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
153930106|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
153930107|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930108|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930109|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930110|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
153930111|NCT04152655|Idebenone|idebenone|mesh-list
153930112|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
153930113|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930114|NCT04152655|Vitamins|vitamins|mesh-ancestor
153930115|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
153930116|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930117|NCT04152655|Protective Agents|protective agents|mesh-ancestor
153930118|NCT00665119|Remifentanil|remifentanil|mesh-list
153930119|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153930120|NCT00665119|Narcotics|narcotics|mesh-ancestor
153687698|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930121|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930122|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930123|NCT00665119|Analgesics|analgesics|mesh-ancestor
153930124|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
153930125|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930126|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153930127|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153930128|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153930129|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153930130|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930131|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930132|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930133|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
153930134|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930135|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
153930136|NCT00672763|Vitamin D|vitamin d|mesh-list
153930137|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
153930138|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
153930139|NCT00672763|Vitamins|vitamins|mesh-list
153930140|NCT00672763|Calcium|calcium|mesh-list
153930141|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
153930142|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930143|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153930144|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153930145|NCT04154449|Insulin|insulin|mesh-list
153930146|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930154|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153930155|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153930156|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
153930157|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
153930158|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930159|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153930160|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153930161|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930162|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930163|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153930164|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
153930165|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
153930166|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153930167|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153930168|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153930169|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
154260749|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154260750|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930170|NCT00672919|Pioglitazone|pioglitazone|mesh-list
153930171|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930172|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930173|NCT01109316|Insulin|insulin|mesh-list
153930174|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153930175|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
153930176|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
153930177|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930178|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930179|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153930180|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153930181|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
153930182|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153930183|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
153930184|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153930185|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930186|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153930187|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153930188|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930189|NCT00675961|Naltrexone|naltrexone|mesh-list
153930190|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153930191|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153930192|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930193|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
153930194|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930195|NCT00887068|Azacitidine|azacitidine|mesh-list
153687774|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
153589935|NCT01810315|Hormones|hormones|mesh-ancestor
153930196|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153930197|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
153930198|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930199|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930200|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930201|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153930202|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
153930203|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930204|NCT00886834|Misoprostol|misoprostol|mesh-list
153930205|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153930206|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
153930207|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153930208|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930209|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153930210|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930211|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
153930212|NCT00880009|Letrozole|letrozole|mesh-list
153930213|NCT00880009|Bosutinib|bosutinib|mesh-list
153930214|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930215|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153930221|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153930222|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930223|NCT00880009|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153930224|NCT00880009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153590196|NCT01812122|Glimepiride|glimepiride|mesh-list
153930225|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153930226|NCT00676039|Citalopram|citalopram|mesh-list
153930227|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153930228|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153930229|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153930230|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930231|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930232|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930233|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153930234|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
153930235|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930236|NCT00676039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153930237|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
153930238|NCT01104636|Varenicline|varenicline|mesh-list
153930239|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153930240|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153930241|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
153930242|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930243|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930244|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930245|NCT04931602|Vitamin D|vitamin d|mesh-list
153930246|NCT04931602|Vitamins|vitamins|mesh-ancestor
153930247|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
153930248|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930249|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153930250|NCT04157257|Tenofovir|tenofovir|mesh-list
153930251|NCT04157257|Entecavir|entecavir|mesh-list
153930252|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
153930253|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930254|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153930255|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153930256|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930257|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930258|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153930259|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153930260|NCT04152889|Docetaxel|docetaxel|mesh-list
153930261|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930262|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930263|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930264|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
153930265|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930266|NCT00602511|Thalidomide|thalidomide|mesh-list
153930267|NCT00602511|Bortezomib|bortezomib|mesh-list
153930268|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687848|NCT00165373|Endostatins|endostatins|mesh-list
153930269|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153930270|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
153930271|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930272|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
153930273|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153930274|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930275|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153930276|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153930277|NCT00602511|Growth Substances|growth substances|mesh-ancestor
153930278|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
153930279|NCT02826616|Trimetazidine|trimetazidine|mesh-list
153370136|NCT02889159|Imiquimod|imiquimod|mesh-list
153930280|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
153930281|NCT00676117|Loxoprofen|loxoprofen|mesh-list
153930282|NCT00676117|Esomeprazole|esomeprazole|mesh-list
153930283|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153930291|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
153930292|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930293|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930294|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153930295|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153930296|NCT01104558|Bisoprolol|bisoprolol|mesh-list
153930297|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153930298|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
153930299|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
153930300|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930301|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930302|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153930303|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153930304|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153930305|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
153930306|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930307|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930308|NCT00602589|Levofloxacin|levofloxacin|mesh-list
153930309|NCT00602589|Ofloxacin|ofloxacin|mesh-list
153360983|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153930310|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153930311|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930312|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153930313|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153930314|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153930315|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930316|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930317|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930318|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153930319|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153930320|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
153930321|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
153930322|NCT02856087|Remifentanil|remifentanil|mesh-list
153930323|NCT02856087|Naloxone|naloxone|mesh-list
153930324|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153930325|NCT02856087|Narcotics|narcotics|mesh-ancestor
153424724|NCT03404167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930326|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930327|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930328|NCT02856087|Analgesics|analgesics|mesh-ancestor
153930329|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
153930330|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930331|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153930332|NCT00676429|Ziprasidone|ziprasidone|mesh-list
153930333|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153930334|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
153930335|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930336|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930337|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930338|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153930339|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153930340|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930341|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930342|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153930343|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
153930344|NCT02629315|Formaldehyde|formaldehyde|mesh-list
153930345|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
153930346|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930347|NCT01204658|Vaccines|vaccines|mesh-list
153930348|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153930349|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
153930350|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930387|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153930388|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
153590527|NCT01813955|Papaverine|papaverine|mesh-list
153930389|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688043|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930422|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930423|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930424|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
153357370|NCT00744848|Bupivacaine|bupivacaine|mesh-list
153930425|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930426|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930427|NCT01203878|Imiquimod|imiquimod|mesh-list
153930428|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153930429|NCT01203878|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153688082|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
153930444|NCT00625794|Nicotine|nicotine|mesh-list
153930445|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153930446|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
153930447|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930448|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930449|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153930450|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153930451|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
153930452|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930453|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930454|NCT01203098|Enoxaparin|enoxaparin|mesh-list
153930455|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
153930456|NCT01203098|Edoxaban|edoxaban|mesh-list
153930457|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
153930458|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153930459|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153930460|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930461|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153930462|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
153930463|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153930464|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
153930465|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930466|NCT05032794|Bisacodyl|bisacodyl|mesh-list
153930467|NCT05032794|Cathartics|cathartics|mesh-ancestor
153930468|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930469|NCT05032794|Laxatives|laxatives|mesh-ancestor
153930470|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153930471|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930472|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153360985|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
153930473|NCT01108458|Pertuzumab|pertuzumab|mesh-list
153930474|NCT01108458|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153930475|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153930476|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930477|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930478|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930479|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153930480|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153930481|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930482|NCT00680485|Ketoconazole|ketoconazole|mesh-list
153930483|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
153930484|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930485|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153930486|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153930487|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930488|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930489|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153930490|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
153688124|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
153930506|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153930507|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153930508|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
153930509|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930510|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153930511|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153930512|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930513|NCT01201850|Bevacizumab|bevacizumab|mesh-list
153930514|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153930515|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930516|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153930517|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153930518|NCT01201850|Growth Substances|growth substances|mesh-ancestor
153930519|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930520|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
153930522|NCT05660122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930523|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
153930524|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153930525|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153930526|NCT02825056|Morphine|morphine|mesh-list
153930527|NCT02825056|Bupivacaine|bupivacaine|mesh-list
153930528|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
153930529|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
153930530|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930531|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930532|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
153930533|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930534|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153930535|NCT02825056|Narcotics|narcotics|mesh-ancestor
153930536|NCT02825056|Analgesics|analgesics|mesh-ancestor
153930537|NCT02826772|Androgens|androgens|mesh-list
153930538|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
153930539|NCT02826772|Hormones|hormones|mesh-ancestor
153930540|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153930541|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930542|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
153930543|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
153930544|NCT00674011|Bevacizumab|bevacizumab|mesh-list
153930545|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153930546|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930547|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153930548|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153930549|NCT00674011|Growth Substances|growth substances|mesh-ancestor
153930566|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153930567|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
153930568|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930569|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930570|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930571|NCT00674167|Docetaxel|docetaxel|mesh-list
153930572|NCT00674167|Capecitabine|capecitabine|mesh-list
153930573|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930574|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930575|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930576|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
153930577|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930578|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153930579|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
153930580|NCT00912145|Alprazolam|alprazolam|mesh-list
153930581|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153930582|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930583|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930584|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154260751|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930585|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153930586|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930587|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
153930588|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
153590697|NCT01814501|Protective Agents|protective agents|mesh-ancestor
153930589|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930590|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930591|NCT02824510|Insulin|insulin|mesh-list
153930592|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153930593|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
153930594|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930595|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930596|NCT00674245|Pantoprazole|pantoprazole|mesh-list
153930597|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153930598|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930599|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153930600|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930601|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930602|NCT00878215|Liver Extracts|liver extracts|mesh-list
153930603|NCT00878215|Hematinics|hematinics|mesh-ancestor
153930604|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
153930605|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930606|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
153930607|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153930608|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153930609|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370240|NCT02620865|Analgesics|analgesics|mesh-ancestor
153370241|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
153830183|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688249|NCT00407251|Epothilone B|epothilone b|mesh-list
153930622|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930623|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930624|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153930625|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
153930626|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153930627|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930628|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
153930629|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
153930630|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153830184|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930631|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153930632|NCT00674557|Growth Substances|growth substances|mesh-ancestor
153930633|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
153930634|NCT00677521|Acarbose|acarbose|mesh-list
153930635|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153930636|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930637|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930638|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930639|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930640|NCT00674713|Ondansetron|ondansetron|mesh-list
153930641|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153930642|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
153930643|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
153930644|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930645|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930646|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930647|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
153930648|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
153830185|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153830186|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
153830187|NCT00496301|Gemcitabine|gemcitabine|mesh-list
153830188|NCT00496301|Capecitabine|capecitabine|mesh-list
153830189|NCT00496301|Sorafenib|sorafenib|mesh-list
153930649|NCT00674713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153930650|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153930652|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930653|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930654|NCT04241380|Heparin|heparin|mesh-list
153930655|NCT04241380|Anticoagulants|anticoagulants|mesh-list
153930656|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153930657|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153930658|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153930659|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930660|NCT02824354|Nalmefene|nalmefene|mesh-list
153930661|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153930662|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930663|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
153930664|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930665|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
153930666|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153930667|NCT02823496|Protective Agents|protective agents|mesh-ancestor
153930668|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930669|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
154260752|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
153428832|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930670|NCT00677755|Misoprostol|misoprostol|mesh-list
153930671|NCT00677755|Mifepristone|mifepristone|mesh-list
153930672|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153930673|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
153930684|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153930685|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153930686|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
153930687|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818048|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930688|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
153930689|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153930690|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153930691|NCT00674947|huB3F6-SPDB-DM4 immunoconjugate|hub3f6-spdb-dm4 immunoconjugate|mesh-list
153930692|NCT00674947|Immunoconjugates|immunoconjugates|mesh-ancestor
153930693|NCT00674947|Immunologic Factors|immunologic factors|mesh-ancestor
153930694|NCT00674947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930695|NCT02824042|Itraconazole|itraconazole|mesh-list
153930696|NCT02824042|Maytansine|maytansine|mesh-list
153930697|NCT02824042|Anetumab ravtansine|anetumab ravtansine|mesh-list
153930698|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
153930699|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930700|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153930701|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153930702|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930703|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930704|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153930705|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
153930706|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153930707|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930708|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153930709|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153930710|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930711|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930712|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930713|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
153930714|NCT02824042|Immunoconjugates|immunoconjugates|mesh-ancestor
153930715|NCT02824042|Immunologic Factors|immunologic factors|mesh-ancestor
153821041|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
153821042|NCT04697745|Hormones|hormones|mesh-ancestor
153930716|NCT00675181|Melatonin|melatonin|mesh-list
153930717|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
153930718|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930719|NCT00675181|Protective Agents|protective agents|mesh-ancestor
153930720|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930721|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930722|NCT04241458|Midazolam|midazolam|mesh-list
153930723|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153930724|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153930725|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930726|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930727|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153930728|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153930729|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930730|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153930731|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
153930732|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
153930733|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
153930734|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
153930735|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930736|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930750|NCT02822482|Cetuximab|cetuximab|mesh-list
153930751|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153930752|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930753|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
153930754|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
153930755|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153930756|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930757|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930758|NCT04240834|Aspirin|aspirin|mesh-list
153930759|NCT04240834|Ticagrelor|ticagrelor|mesh-list
153930760|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153930761|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153930762|NCT04240834|Analgesics|analgesics|mesh-ancestor
153405338|NCT00376727|Cetuximab|cetuximab|mesh-list
153930763|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
153930764|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930765|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930766|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153930767|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153930768|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153930769|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153930770|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930771|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153930772|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153930773|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930774|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
153930775|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153930776|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153930777|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153930778|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
153930779|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930780|NCT01200758|Prednisone|prednisone|mesh-list
153930781|NCT01200758|Prednisolone|prednisolone|mesh-list
153930782|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
153930783|NCT01200758|Rituximab|rituximab|mesh-list
153930784|NCT01200758|Doxorubicin|doxorubicin|mesh-list
153930785|NCT01200758|Vincristine|vincristine|mesh-list
153930786|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153930787|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
153930788|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930789|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153930790|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153930791|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
153930792|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930793|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930794|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153930795|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153930796|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153930797|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153930798|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153688439|NCT00169078|Chloroquine|chloroquine|mesh-list
153930815|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930817|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153930818|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
153930819|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153930820|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153930821|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153930822|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153930823|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930824|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
153930825|NCT02821858|Odalasvir|odalasvir|mesh-list
153930826|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
153930827|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930828|NCT00876343|Aripiprazole|aripiprazole|mesh-list
153930829|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
153930830|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930831|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153930832|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153930833|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930834|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930835|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
153930836|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
153930837|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930838|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930839|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153930840|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153930841|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
153930842|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153930843|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153930844|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153930845|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153930846|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
153930847|NCT02627989|Diflucortolone|diflucortolone|mesh-list
153930848|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153930849|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
153930850|NCT02627989|Hormones|hormones|mesh-ancestor
153930851|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153930852|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930853|NCT00675649|Golimumab|golimumab|mesh-list
153930854|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153930855|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153930856|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370310|NCT01499953|PENTA|penta|mesh-list
153930870|NCT00678145|Morphine|morphine|mesh-list
153930871|NCT00678145|Naloxone|naloxone|mesh-list
153930872|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930873|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153930874|NCT00678145|Narcotics|narcotics|mesh-ancestor
153930875|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930876|NCT00678145|Analgesics|analgesics|mesh-ancestor
153930877|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
153930878|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930879|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153930880|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153930881|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
153930882|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930883|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930884|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153930885|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153930886|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
153930887|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153930888|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
153930889|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
153930890|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
153930891|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153930892|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153930893|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
153930894|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
153930895|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
153930896|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930897|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930898|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
153930899|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930900|NCT02690506|Pregabalin|pregabalin|mesh-list
153930901|NCT02690506|Analgesics|analgesics|mesh-ancestor
153930902|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
153930903|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930904|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930905|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
153930906|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153930907|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153930908|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930909|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153930910|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153930911|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153930912|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930913|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930914|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
153930915|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930916|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930917|NCT04239586|Glyburide|glyburide|mesh-list
153930935|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153930936|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153930938|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
153930939|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930940|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930941|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590986|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
153930942|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153930943|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930944|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153930945|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
153930946|NCT04148833|Paclitaxel|paclitaxel|mesh-list
153930947|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153930948|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930949|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930950|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930951|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
153930952|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930953|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153930955|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154260753|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930956|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153930958|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
153930959|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930960|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930961|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
153930962|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153930963|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930964|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930965|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153930966|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153930967|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153930968|NCT04964622|Ibuprofen|ibuprofen|mesh-list
153930969|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153930970|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153930971|NCT04964622|Analgesics|analgesics|mesh-ancestor
153930972|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
153930973|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930974|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930975|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688620|NCT00170677|Topotecan|topotecan|mesh-list
153930988|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930989|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153930990|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
153930991|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153930992|NCT02821390|Nepafenac|nepafenac|mesh-list
153930993|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153930994|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
153930995|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153930996|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153930997|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153930998|NCT02821390|Analgesics|analgesics|mesh-ancestor
153930999|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
153931000|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931001|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931002|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931003|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931004|NCT02821312|DA-8010|da-8010|mesh-list
153931005|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153931006|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153591110|NCT01817400|Aspirin|aspirin|mesh-list
153931007|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
153931008|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931009|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931010|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931011|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
153931012|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153931013|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
153931014|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931015|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931016|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153931017|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
153931018|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153931019|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
153931020|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688603|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931021|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931022|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153931023|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
153931024|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
153931025|NCT02821156|Protective Agents|protective agents|mesh-ancestor
153931026|NCT02820922|Anesthetics|anesthetics|mesh-list
153931027|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931028|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931029|NCT00633958|Alovudine|alovudine|mesh-list
153931030|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
153931031|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931032|NCT02820688|Bupivacaine|bupivacaine|mesh-list
153931033|NCT02820688|Prilocaine|prilocaine|mesh-list
153931034|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
153931035|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
153931036|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931037|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435832|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153931038|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
153688676|NCT00171028|Valsartan|valsartan|mesh-list
153931051|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931052|NCT02818816|Laxatives|laxatives|mesh-ancestor
153931053|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153931054|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
153931055|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
153931056|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153931057|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931058|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931059|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153931060|NCT02820610|Analgesics|analgesics|mesh-ancestor
153931061|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
153931062|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931063|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153931064|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153931065|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153931066|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
153931067|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931068|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931069|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
153931070|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153931071|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
153931072|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153931073|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153931074|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153931075|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
153459515|NCT06125834|Maytansine|maytansine|mesh-list
153931076|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153931077|NCT04745728|Prednisone|prednisone|mesh-list
153931078|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
153931079|NCT04745728|Rituximab|rituximab|mesh-list
153931080|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153931081|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
153931082|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931083|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931084|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153931085|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
153931086|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931087|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931088|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153931089|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153931090|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931091|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
153931092|NCT04745728|Hormones|hormones|mesh-ancestor
153931093|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931094|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153931095|NCT05659186|Tislelizumab|tislelizumab|mesh-list
153931096|NCT05659186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153931097|NCT05659186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931098|NCT01107444|Docetaxel|docetaxel|mesh-list
153931099|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931131|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153931132|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
153931133|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931134|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931135|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153931136|NCT01102374|Vitamin D|vitamin d|mesh-list
153931137|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
153931138|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
153931139|NCT01102374|Vitamins|vitamins|mesh-list
153931140|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
153931141|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931154|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931155|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931156|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153931157|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931159|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
153931160|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931161|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153931162|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
153931163|NCT05658640|Hormones|hormones|mesh-ancestor
153931164|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931165|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153931166|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153931167|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
153931168|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
153931169|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931170|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153931171|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931172|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
153931173|NCT02818270|Albuterol|albuterol|mesh-list
153459549|NCT06125353|Melatonin|melatonin|mesh-list
153931174|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153931175|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
153931176|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931177|NCT02818270|Expectorants|expectorants|mesh-ancestor
153931178|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
153931179|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153931180|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
153931181|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931182|NCT02818270|Protective Agents|protective agents|mesh-ancestor
153931183|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931184|NCT02818270|Antidotes|antidotes|mesh-ancestor
153931185|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153931186|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
153931187|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931188|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153931189|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
153931190|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153931191|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153931192|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153931193|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153931194|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
153931195|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931196|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
153931197|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153931198|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931199|NCT02879760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153931200|NCT02879760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931201|NCT02818348|Darunavir|darunavir|mesh-list
153931202|NCT02818348|Cobicistat|cobicistat|mesh-list
153931203|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
153931204|NCT02818348|Etravirine|etravirine|mesh-list
153688840|NCT00171691|Diclofenac|diclofenac|mesh-list
153931214|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153931215|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153931216|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153931217|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153931218|NCT00634192|Tobramycin|tobramycin|mesh-list
153931219|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931220|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931221|NCT00684463|Palonosetron|palonosetron|mesh-list
153931222|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
153931223|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
153931224|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931225|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931226|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153931227|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153931228|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153931229|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
153931230|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931231|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931232|NCT00678457|Ondansetron|ondansetron|mesh-list
153931233|NCT00678457|Olanzapine|olanzapine|mesh-list
153931234|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
153931235|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
153931236|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931237|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931238|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153931239|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
153931240|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
153931241|NCT00678457|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153931242|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153931243|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
153931244|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931245|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931246|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153931247|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153931248|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405435|NCT00356395|Ramipril|ramipril|mesh-list
153931249|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153931250|NCT00678457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153931251|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153931252|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153931253|NCT00678613|Norfloxacin|norfloxacin|mesh-list
153931254|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931255|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931256|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153931257|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153931258|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931259|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931260|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931261|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153931262|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153931263|NCT00678769|Sirolimus|sirolimus|mesh-list
153931264|NCT00678769|Temsirolimus|temsirolimus|mesh-list
153931265|NCT00678769|MTOR Inhibitors|mtor inhibitors|mesh-list
153931266|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153931267|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931268|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688901|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
153931283|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931284|NCT02817100|Itraconazole|itraconazole|mesh-list
153931285|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
153931286|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931287|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153931288|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153931289|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931290|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931291|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153931292|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
153931293|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931294|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931295|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153931296|NCT00684853|Bevacizumab|bevacizumab|mesh-list
153931297|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153931298|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931299|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153931300|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153931301|NCT00684853|Growth Substances|growth substances|mesh-ancestor
153931302|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931303|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
153931304|NCT02816476|Daratumumab|daratumumab|mesh-list
153931305|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931306|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
153931307|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153931308|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931309|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931310|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153931311|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153931312|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153931313|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
153931314|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931315|NCT00685009|Hormones|hormones|mesh-list
153931316|NCT00685009|Progesterone|progesterone|mesh-list
153931317|NCT00685009|Estrogens|estrogens|mesh-list
153931318|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931319|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931322|NCT00679237|Glimepiride|glimepiride|mesh-list
153931323|NCT00679237|Ezetimibe|ezetimibe|mesh-list
153931324|NCT00679237|Diuretics|diuretics|mesh-list
153931325|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153931326|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931327|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153931328|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153931329|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
153931330|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931360|NCT04238962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153931361|NCT04238962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931362|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153931363|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
153931364|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931366|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153931367|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
153931368|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931369|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931370|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931371|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153931372|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153931373|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931374|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153931393|NCT04425538|Infliximab|infliximab|mesh-list
153931394|NCT04425538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153931395|NCT04425538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931396|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
153931397|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153931398|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931400|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153931401|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153931402|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153931403|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153931404|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
153931405|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830436|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830437|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153830438|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153830439|NCT00497354|Anesthetics|anesthetics|mesh-list
153830440|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
153830441|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931406|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931407|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931408|NCT00681967|Gefitinib|gefitinib|mesh-list
153931409|NCT00681967|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153931410|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153931411|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931412|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931413|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931414|NCT04239118|Hemostatics|hemostatics|mesh-list
153931415|NCT04239118|Coagulants|coagulants|mesh-ancestor
153931416|NCT04139941|Antibodies|antibodies|mesh-list
153931417|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
153931418|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
153931419|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931420|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
153931421|NCT00875017|Sevelamer|sevelamer|mesh-list
153931422|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
153931423|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
153931424|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931425|NCT00679705|Atosiban|atosiban|mesh-list
153931426|NCT00679705|Ritodrine|ritodrine|mesh-list
153931427|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
153931428|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931429|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931430|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
153931431|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153830442|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821085|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153361032|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931450|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
153931451|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153931452|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153931453|NCT04329832|Azithromycin|azithromycin|mesh-list
153931454|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
153931455|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931456|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931457|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
153931458|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153931459|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153931460|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931461|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931462|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931463|NCT04237246|Tacrolimus|tacrolimus|mesh-list
153931464|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153931465|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
153931466|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931467|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153931468|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931469|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931471|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
153931472|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931473|NCT02814058|Zolpidem|zolpidem|mesh-list
153931474|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154260755|NCT01292720|Vitamin D|vitamin d|mesh-list
153931475|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153931476|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931477|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931478|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153931479|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
153931480|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
153931481|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931482|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931483|NCT00680173|Interferons|interferons|mesh-list
153931484|NCT00680173|Ribavirin|ribavirin|mesh-list
153931485|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
153931486|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
153931487|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153931488|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931489|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
153931501|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931502|NCT00682279|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153931503|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153931505|NCT02811484|Exenatide|exenatide|mesh-list
153931506|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153931507|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931508|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153931509|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931510|NCT02811484|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153931511|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153931512|NCT02811484|Incretins|incretins|mesh-ancestor
153931513|NCT02811484|Hormones|hormones|mesh-ancestor
153931514|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931515|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
153931516|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931517|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931518|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153931519|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153931520|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931521|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931522|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931523|NCT00922597|Factor VIII|factor viii|mesh-list
153931524|NCT00922597|Coagulants|coagulants|mesh-ancestor
153931525|NCT00874939|Donepezil|donepezil|mesh-list
153931526|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153931527|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931528|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931529|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
153931530|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931531|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931532|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
153931533|NCT00634348|Aripiprazole|aripiprazole|mesh-list
153931534|NCT00634348|Ziprasidone|ziprasidone|mesh-list
153931535|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
153931536|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153931537|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153931538|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153931539|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931540|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931541|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
153931542|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
153931543|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931544|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931545|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153931546|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153931547|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
153931548|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153931549|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153370511|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
153931550|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153689185|NCT02963779|Analgesics|analgesics|mesh-ancestor
153931563|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153931564|NCT02811016|Budesonide|budesonide|mesh-list
153931565|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931566|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153931567|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
153931568|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931569|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931570|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153931571|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
153931572|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
153931573|NCT02811016|Hormones|hormones|mesh-ancestor
153931574|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931575|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
153931576|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153931577|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931578|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931579|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153931580|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153931581|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931582|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931583|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931584|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153931585|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
153931586|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153931587|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931588|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153931589|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153931590|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153931591|NCT04237480|Vitamin D|vitamin d|mesh-list
153931592|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
153931593|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
153931594|NCT04237480|Vitamins|vitamins|mesh-list
153931595|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
153931596|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931597|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153931598|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153931599|NCT02810782|Morphine|morphine|mesh-list
153931600|NCT02810782|Phenobarbital|phenobarbital|mesh-list
153931601|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
153931602|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153931603|NCT02810782|Narcotics|narcotics|mesh-ancestor
153818173|NCT05417165|Vaccines|vaccines|mesh-list
153931604|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931605|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931606|NCT02810782|Analgesics|analgesics|mesh-ancestor
153931607|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
153931608|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931609|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
153931610|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153931611|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153931612|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153931613|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931614|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931649|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153931650|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153931651|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931652|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931653|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153931654|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
153931655|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931656|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931657|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153931658|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153931659|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
153931660|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931661|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
153931669|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153931670|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153931671|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
153931672|NCT04237090|Promethazine|promethazine|mesh-list
153931673|NCT04237090|Cetirizine|cetirizine|mesh-list
153931674|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153931675|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153931676|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931677|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931678|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
153931679|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
153931680|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
153931681|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931682|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
153931683|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
153931684|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260756|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
154260757|NCT01292720|Vitamins|vitamins|mesh-ancestor
154260758|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
153931685|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153931686|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
153931687|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
153931688|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931689|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931690|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153931691|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
153931692|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
153689278|NCT00175435|Vaccines|vaccines|mesh-list
153931693|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153931694|NCT00690781|Caseins|caseins|mesh-list
153931695|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
153931696|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
153931697|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931698|NCT00682825|Anesthetics|anesthetics|mesh-list
153931699|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
153931700|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931701|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931702|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
153931703|NCT00912379|Chrysarobin|chrysarobin|mesh-list
153931704|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153931705|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153931706|NCT00912379|Analgesics|analgesics|mesh-ancestor
153931707|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
153931708|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931709|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931710|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931711|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931712|NCT02809378|Remifentanil|remifentanil|mesh-list
153931714|NCT02809378|Palonosetron|palonosetron|mesh-list
153931715|NCT02809378|Propofol|propofol|mesh-list
153931716|NCT02809378|Sevoflurane|sevoflurane|mesh-list
153931717|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153931718|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931719|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931720|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153931721|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
153931722|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
153931723|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153931724|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153931725|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153931726|NCT02809378|Narcotics|narcotics|mesh-ancestor
153931727|NCT02809378|Analgesics|analgesics|mesh-ancestor
153931728|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
153931744|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
153931745|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
153931746|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
153931747|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931748|NCT01185353|Methotrexate|methotrexate|mesh-list
153931749|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153931750|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
153931751|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153931752|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931753|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153931754|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
153931755|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931756|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931757|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
153931758|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931759|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153931760|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153931761|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
153931762|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931763|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153931764|NCT00683137|Valdecoxib|valdecoxib|mesh-list
153931765|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153931766|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153931767|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931768|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931769|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153931770|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153931771|NCT00683137|Analgesics|analgesics|mesh-ancestor
153931772|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
153931773|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931774|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931775|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931776|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931777|NCT02809456|Nicorandil|nicorandil|mesh-list
153931778|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153931779|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153931780|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
153931781|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
153931782|NCT02809456|Vitamins|vitamins|mesh-ancestor
153931783|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
153931784|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931785|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
153931786|NCT05576740|Hormones|hormones|mesh-list
153931787|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689425|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
153931807|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931808|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153931809|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153931810|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
153931811|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
153931812|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
153931813|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931814|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
153931815|NCT00687661|Diphosphonates|diphosphonates|mesh-list
153931816|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153931817|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931818|NCT00687817|Paclitaxel|paclitaxel|mesh-list
153931819|NCT00687817|Carboplatin|carboplatin|mesh-list
153931820|NCT00687817|Bavituximab|bavituximab|mesh-list
153931821|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153931822|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931823|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
153931824|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
153931825|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
153931826|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931827|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153931828|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
153931829|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153931830|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931831|NCT02625805|Methylphenidate|methylphenidate|mesh-list
153931832|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153931833|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931834|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153591447|NCT01820026|Cefoxitin|cefoxitin|mesh-list
153931835|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153931836|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153931837|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931838|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
153931839|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931840|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
153931841|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153689483|NCT00176527|Interferons|interferons|mesh-list
153931856|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931857|NCT02812654|Doxorubicin|doxorubicin|mesh-list
153931858|NCT02812654|Ifosfamide|ifosfamide|mesh-list
153931859|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153931860|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931861|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153931862|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153931863|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931864|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931865|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153931866|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
153931867|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
153931868|NCT02809066|Calcium|calcium|mesh-list
153931869|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153931870|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931871|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153931872|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
153931873|NCT01097694|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153439968|NCT00002875|Vincristine|vincristine|mesh-list
153440212|NCT00003661|Melphalan|melphalan|mesh-list
153931874|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153931875|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931876|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931877|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931878|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
153931879|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931880|NCT02808676|Vitamin D|vitamin d|mesh-list
153931881|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
153931882|NCT02808676|Vitamins|vitamins|mesh-ancestor
153931883|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
153931884|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931885|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153931886|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153931887|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153931888|NCT00690937|Sevelamer|sevelamer|mesh-list
153931889|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
153931890|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
153931891|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931892|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153931893|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153931894|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
153931895|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153931896|NCT00689143|Sargramostim|sargramostim|mesh-list
153931897|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
153931898|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931899|NCT00912457|Donepezil|donepezil|mesh-list
153931900|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153931901|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931902|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931912|NCT02625103|Clozapine|clozapine|mesh-list
153931913|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153931914|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
153931915|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931916|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931917|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689502|NCT00398489|Tamoxifen|tamoxifen|mesh-list
153931920|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931921|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153931923|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
153931924|NCT01155479|Rasagiline|rasagiline|mesh-list
153931925|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153931926|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931927|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931928|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153931929|NCT01155479|Protective Agents|protective agents|mesh-ancestor
153931930|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931931|NCT02807272|Tipifarnib|tipifarnib|mesh-list
153931932|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931933|NCT02807194|Anesthetics|anesthetics|mesh-list
153931934|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931935|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931936|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153931937|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
153931938|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153931939|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153931940|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153931941|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931942|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821114|NCT00436943|Bupropion|bupropion|mesh-list
153931943|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
153931944|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153931945|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
153931946|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931947|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
153931948|NCT02625727|Protective Agents|protective agents|mesh-ancestor
153931949|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153931950|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
153931951|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931952|NCT01155167|Lidocaine|lidocaine|mesh-list
153931953|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
153931954|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
153931955|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
153931956|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931957|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931958|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
153931959|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931960|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153931961|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153931962|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153931963|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153931964|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931965|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
153931968|NCT01106586|Ritonavir|ritonavir|mesh-list
153931969|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153931970|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153931979|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153931980|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153931982|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153931983|NCT00683995|Narcotics|narcotics|mesh-ancestor
153931984|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931985|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931986|NCT00683995|Analgesics|analgesics|mesh-ancestor
153931987|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
153931988|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931989|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153931990|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153931991|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
153931993|NCT02884817|Listerine|listerine|mesh-list
153931994|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153931995|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931996|NCT02806804|Vaccines|vaccines|mesh-list
153931997|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
153931998|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931999|NCT02879292|Anesthetics|anesthetics|mesh-list
153932000|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932001|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932002|NCT02806648|Palbociclib|palbociclib|mesh-list
153932003|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932004|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932005|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932006|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932007|NCT00689845|Cytarabine|cytarabine|mesh-list
153932008|NCT00689845|Prednisone|prednisone|mesh-list
153932009|NCT00689845|Prednisolone|prednisolone|mesh-list
153932010|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
153932011|NCT00689845|Ifosfamide|ifosfamide|mesh-list
153932012|NCT00689845|Rituximab|rituximab|mesh-list
153932013|NCT00689845|Doxorubicin|doxorubicin|mesh-list
153932014|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153932015|NCT00689845|Methotrexate|methotrexate|mesh-list
153932016|NCT00689845|Etoposide|etoposide|mesh-list
153932017|NCT00689845|Vincristine|vincristine|mesh-list
153932018|NCT00689845|Bleomycin|bleomycin|mesh-list
153932019|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
153932020|NCT00689845|Vindesine|vindesine|mesh-list
153932021|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932022|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
153932023|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932024|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153932025|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153932026|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
153932027|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932028|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932029|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153932030|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932031|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153932032|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153932033|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153932034|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932035|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153932036|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
153932037|NCT00689845|Hormones|hormones|mesh-ancestor
153932038|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932039|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153932056|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
153932057|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153932058|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932059|NCT02806492|Phenylephrine|phenylephrine|mesh-list
153932060|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
153932061|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153932062|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
153443056|NCT02058966|Entacapone|entacapone|mesh-list
153932063|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
153932064|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932065|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932066|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
153932067|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153932068|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
153932069|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
153370718|NCT01229462|Timolol|timolol|mesh-list
153932070|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153932071|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153932072|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153932073|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
153932074|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932075|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932076|NCT02806492|Protective Agents|protective agents|mesh-ancestor
153932077|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153932078|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
153932079|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153932080|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
153932081|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932082|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932083|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153932084|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
153932085|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153932086|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153932087|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153932088|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
153932089|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932090|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932091|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153932092|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153932093|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153932094|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153932095|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153932096|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932097|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
153932117|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932118|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932119|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932120|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
153932121|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932122|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932123|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
153932124|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
153932125|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153932126|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153932127|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153932128|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
153932129|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
153932130|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932131|NCT00684229|Anesthetics|anesthetics|mesh-list
153932132|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932133|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932134|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
153932135|NCT00874237|Loxapine|loxapine|mesh-list
153932136|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153932137|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932138|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153932139|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153932140|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932141|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932142|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932143|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932144|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153932145|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153932146|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932147|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153932148|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153932149|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
153932150|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932151|NCT02805946|Posaconazole|posaconazole|mesh-list
153932152|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
153444457|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153444458|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
153444459|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689784|NCT00057122|Rifampin|rifampin|mesh-list
153932165|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
153932166|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
153932167|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932168|NCT02805868|Siltuximab|siltuximab|mesh-list
153932169|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153932170|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932171|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
153932172|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932173|NCT00684385|Gefitinib|gefitinib|mesh-list
153932174|NCT00684385|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153932175|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932176|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932177|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932178|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932179|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
153932180|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153932181|NCT02690038|Antibodies|antibodies|mesh-list
153932182|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
153932183|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153932184|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
153932185|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932186|NCT00691795|Clonidine|clonidine|mesh-list
153932187|NCT00691795|Fentanyl|fentanyl|mesh-list
153932188|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153932189|NCT00691795|Narcotics|narcotics|mesh-ancestor
153932190|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932191|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932192|NCT00691795|Analgesics|analgesics|mesh-ancestor
153932193|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
153932194|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932195|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153932196|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153932197|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
153932198|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
153932199|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153932200|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
153932201|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
153932202|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153932203|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153932204|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153932205|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
153932206|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932207|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932208|NCT02805556|Fostemsavir|fostemsavir|mesh-list
153932209|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153932210|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153932211|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
153932212|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932213|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153932214|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153932230|NCT05538052|Lidocaine|lidocaine|mesh-list
153932231|NCT05538052|Tramadol|tramadol|mesh-list
153932232|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
153932233|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
153932234|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932235|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932236|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
153932237|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932238|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153932239|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153932240|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153932241|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153932242|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932243|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153932244|NCT05538052|Narcotics|narcotics|mesh-ancestor
153932245|NCT05538052|Analgesics|analgesics|mesh-ancestor
153932246|NCT05298475|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
153932247|NCT05298475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153932248|NCT05298475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153932249|NCT05298475|Antimetabolites|antimetabolites|mesh-ancestor
153821222|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
153932250|NCT05298475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405763|NCT05920980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153446138|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153446139|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153446142|NCT00001997|Zidovudine|zidovudine|mesh-list
153932251|NCT05298475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153932252|NCT05298475|Protease Inhibitors|protease inhibitors|mesh-ancestor
153932253|NCT05298475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932254|NCT05298475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153932255|NCT00691951|Budesonide|budesonide|mesh-list
153932256|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
153932257|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153932258|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153932259|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
153932260|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932261|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932262|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153932263|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
153932264|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
153932265|NCT00691951|Hormones|hormones|mesh-ancestor
153932266|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932267|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153932268|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153932269|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153932270|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
153932271|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932272|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932273|NCT04316351|Pemetrexed|pemetrexed|mesh-list
153932274|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932282|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932283|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932284|NCT02625337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153932285|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932286|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932287|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932288|NCT04236310|Trastuzumab|trastuzumab|mesh-list
153932289|NCT04236310|Anastrozole|anastrozole|mesh-list
153932290|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932291|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932292|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153932293|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153932294|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153932295|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932296|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932297|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153932298|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
153932299|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932300|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932301|NCT02621515|Nivolumab|nivolumab|mesh-list
153932302|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932303|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932304|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153830722|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
153932305|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932306|NCT02803918|Metformin|metformin|mesh-list
153932307|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153932308|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932309|NCT02805010|Abatacept|abatacept|mesh-list
153932310|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153932311|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932312|NCT02805010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932313|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932314|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932315|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
153932316|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932317|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153932318|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
153932319|NCT02800408|Provitamins|provitamins|mesh-ancestor
153932320|NCT02800408|Vitamins|vitamins|mesh-ancestor
153932321|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
153932322|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453270|NCT01777854|Omeprazole|omeprazole|mesh-list
153932323|NCT00692263|Tramadol|tramadol|mesh-list
153932324|NCT00692263|Escitalopram|escitalopram|mesh-list
153932325|NCT00692263|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153932326|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153932327|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153932328|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932329|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932330|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
153932331|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932332|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932333|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153932334|NCT00692263|Narcotics|narcotics|mesh-ancestor
153932335|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932336|NCT00692263|Analgesics|analgesics|mesh-ancestor
153932337|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
153932338|NCT00694759|Metformin|metformin|mesh-list
153932339|NCT00694759|Pioglitazone|pioglitazone|mesh-list
153932340|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153689959|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153932353|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153932354|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153932356|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
153932357|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932358|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932359|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153932360|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153932361|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153932362|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153932363|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932364|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153689947|NCT04729491|Azithromycin|azithromycin|mesh-list
153932365|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153932366|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932367|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
153932368|NCT02621359|Doxycycline|doxycycline|mesh-list
153932369|NCT02621359|Levofloxacin|levofloxacin|mesh-list
153932370|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
153932371|NCT02621359|Omeprazole|omeprazole|mesh-list
153932373|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153932374|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153932375|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932376|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932377|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153932378|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932379|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
153932380|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153932381|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153932382|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153932383|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153932384|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153932385|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932386|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153932387|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153932388|NCT01152437|Cetuximab|cetuximab|mesh-list
153932389|NCT01152437|Afatinib|afatinib|mesh-list
153932390|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932391|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932392|NCT01152437|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153932393|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932394|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932395|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932396|NCT02800174|Clopidogrel|clopidogrel|mesh-list
153932397|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153932398|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932399|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932400|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153932401|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153690026|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
153932414|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932416|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
153932417|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932418|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454815|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
153932419|NCT01151579|Albuterol|albuterol|mesh-list
153932420|NCT01151579|Ipratropium|ipratropium|mesh-list
153932421|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153932422|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
153932423|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932424|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932425|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153932426|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
153932427|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
153932428|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153932429|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153932430|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153932431|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153932432|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
153932433|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932434|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932435|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153932436|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
153932437|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
153932438|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153932439|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
153932440|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932441|NCT01097616|Suvorexant|suvorexant|mesh-list
153932442|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153932443|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153932444|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932445|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932446|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153932447|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932448|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932450|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
153932451|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932452|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153932453|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153932454|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932455|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932456|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153932457|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
153932458|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932459|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932460|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153932461|NCT02803216|Amoxicillin|amoxicillin|mesh-list
153932462|NCT02803216|Clarithromycin|clarithromycin|mesh-list
153932463|NCT02803216|Omeprazole|omeprazole|mesh-list
153932474|NCT02799316|Antibodies|antibodies|mesh-list
153932475|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
153932476|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932477|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
153932478|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153932479|NCT02799238|Temozolomide|temozolomide|mesh-list
153932480|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153932481|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
153932482|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932483|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932484|NCT02620813|Tretinoin|tretinoin|mesh-list
153932485|NCT02620813|Isotretinoin|isotretinoin|mesh-list
153932486|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
153932487|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932488|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
153932489|NCT00692731|Caffeine|caffeine|mesh-list
153932490|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153932491|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932492|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153932493|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932494|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932495|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153932496|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153361504|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932497|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
153932498|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932499|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
153932500|NCT02624401|Ketamine|ketamine|mesh-list
153932501|NCT02624401|Propofol|propofol|mesh-list
153932502|NCT02624401|Sevoflurane|sevoflurane|mesh-list
153457255|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153932504|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153932505|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932506|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932507|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153932508|NCT02624401|Analgesics|analgesics|mesh-ancestor
153932509|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
153932510|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932511|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153932512|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153932513|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153932514|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
153932515|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932516|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932517|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153932518|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
153932520|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153932521|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153932522|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153932523|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153932524|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153932525|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
153932526|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153932527|NCT02802748|Letrozole|letrozole|mesh-list
153932528|NCT02802748|Vinorelbine|vinorelbine|mesh-list
153932541|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932542|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
153932543|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153932544|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153932545|NCT02798068|Prednisolone|prednisolone|mesh-list
153361560|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153932546|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
153932547|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153932548|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
153932549|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153932550|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
153932551|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
153932552|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932553|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932554|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153932555|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
153932556|NCT02798068|Hormones|hormones|mesh-ancestor
153932557|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932558|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153932559|NCT02798068|Protective Agents|protective agents|mesh-ancestor
153932560|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153932561|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932562|NCT00593827|Epothilones|epothilones|mesh-list
153932563|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
153932564|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
153932565|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932566|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932567|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932568|NCT04135885|Folic Acid|folic acid|mesh-list
153932569|NCT04135885|Hematinics|hematinics|mesh-ancestor
153932570|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
153932571|NCT04135885|Vitamins|vitamins|mesh-ancestor
153932572|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
153932573|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932574|NCT00693043|Lidocaine|lidocaine|mesh-list
153932575|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
153932576|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
153932577|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932578|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932579|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
153932580|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932581|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153932582|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153932583|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153932584|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153932585|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932586|NCT00695929|Simendan|simendan|mesh-list
153932587|NCT00695929|Milrinone|milrinone|mesh-list
153932588|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154260759|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260760|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153932589|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
153690212|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153932599|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932601|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
153932602|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
153932603|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932604|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932605|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
153932606|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932607|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153932608|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153932609|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153932610|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153932611|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932612|NCT00693121|Amantadine|amantadine|mesh-list
153932613|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153932614|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153932615|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
153932616|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932617|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
153932618|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932619|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932620|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932621|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153932622|NCT00693121|Analgesics|analgesics|mesh-ancestor
153932623|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
153932624|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932625|NCT02620423|Leucovorin|leucovorin|mesh-list
153932626|NCT02620423|Gemcitabine|gemcitabine|mesh-list
153932627|NCT02620423|Fluorouracil|fluorouracil|mesh-list
153932628|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
153932629|NCT02620423|Irinotecan|irinotecan|mesh-list
153932630|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153932631|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
153932632|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932633|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932634|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932635|NCT02620423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153932636|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932637|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
153932638|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932639|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153932640|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153932641|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932642|NCT02620423|Antidotes|antidotes|mesh-ancestor
153821616|NCT00439400|Doxycycline|doxycycline|mesh-list
153932643|NCT02620423|Protective Agents|protective agents|mesh-ancestor
153932644|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
153932645|NCT02620423|Vitamins|vitamins|mesh-ancestor
153932646|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
153932647|NCT00696007|Gemcitabine|gemcitabine|mesh-list
153932648|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932649|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153932650|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
153932651|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932652|NCT02624089|Ropivacaine|ropivacaine|mesh-list
153932653|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
153932654|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
153932667|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153932668|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932669|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153932670|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932672|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153932673|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153932674|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153932675|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
153932676|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932677|NCT00693199|Urological Agents|urological agents|mesh-ancestor
153932678|NCT02795884|Cisplatin|cisplatin|mesh-list
153932679|NCT02795884|Pemetrexed|pemetrexed|mesh-list
153932680|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153932682|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932683|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932684|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932685|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153932686|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153932687|NCT02795884|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153932688|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932689|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153932690|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
153932691|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
153932692|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932694|NCT02795572|Vitamins|vitamins|mesh-list
153932695|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
153932696|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
153932697|NCT02795572|Pyridoxal|pyridoxal|mesh-list
153932698|NCT02795572|Pyridoxine|pyridoxine|mesh-list
153932699|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
153932700|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
153932701|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932702|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153932703|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
153932704|NCT02801188|Bupivacaine|bupivacaine|mesh-list
153932705|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
153932706|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
153932707|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932708|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932709|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
153932710|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932711|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153932712|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153932713|NCT02801188|Analgesics|analgesics|mesh-ancestor
153932714|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153932715|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153932716|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153932717|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
153690346|NCT00184171|Budesonide|budesonide|mesh-list
153932747|NCT01150097|Tacrolimus|tacrolimus|mesh-list
153932748|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932749|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
153932750|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932751|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153932752|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932753|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932754|NCT01150097|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153932755|NCT01150097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932756|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932757|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153932758|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153932759|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
153932760|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932761|NCT01149863|Plerixafor|plerixafor|mesh-list
153932762|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153932777|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153932778|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932780|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
153932781|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932782|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153932783|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153932784|NCT00872989|Docetaxel|docetaxel|mesh-list
153932785|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932786|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
153932787|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
153932788|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932789|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932790|NCT02794714|Rocuronium|rocuronium|mesh-list
153932791|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153932792|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153932793|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153932794|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932795|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932796|NCT01148771|Ertapenem|ertapenem|mesh-list
153932797|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153932798|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932800|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153932801|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932802|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153932803|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932804|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932805|NCT00693355|Butyric Acid|butyric acid|mesh-list
153932806|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
153932807|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
153932808|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932809|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932810|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932811|NCT00693433|Sirolimus|sirolimus|mesh-list
153932812|NCT00693433|Dexamethasone|dexamethasone|mesh-list
153932813|NCT00693433|Temsirolimus|temsirolimus|mesh-list
153932814|NCT00693433|MTOR Inhibitors|mtor inhibitors|mesh-list
153932815|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153932816|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
153932817|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
153821690|NCT00476346|Vitamin D|vitamin d|mesh-list
153932818|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932819|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932820|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153932821|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
153932833|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153932834|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
153932835|NCT05414422|Ketamine|ketamine|mesh-list
153932836|NCT05414422|Analgesics|analgesics|mesh-ancestor
153932837|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
153932838|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932839|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932840|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153932841|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153932842|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
153932843|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
153932844|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932845|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153932846|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153932847|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932848|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932849|NCT00872599|Fenofibrate|fenofibrate|mesh-list
153932850|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153932851|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
153932852|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932853|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153932854|NCT02623621|Bevacizumab|bevacizumab|mesh-list
153932855|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932856|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932857|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153932858|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153932859|NCT02623621|Growth Substances|growth substances|mesh-ancestor
153932860|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932861|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
153932862|NCT00693589|Folic Acid|folic acid|mesh-list
153932863|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
153932864|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
153932865|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153932866|NCT00693589|Vitamins|vitamins|mesh-ancestor
153932867|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
153932868|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932869|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153932870|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153932871|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
153932872|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932873|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153932874|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153932875|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932876|NCT00693589|Hematinics|hematinics|mesh-ancestor
153932877|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
153932878|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
153932879|NCT01148537|Buprenorphine|buprenorphine|mesh-list
153932880|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153932881|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153932882|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690510|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153932901|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153405940|NCT05823337|Micronutrients|micronutrients|mesh-ancestor
153932903|NCT02793544|Sirolimus|sirolimus|mesh-list
153932904|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
153932905|NCT02793544|Busulfan|busulfan|mesh-list
153932906|NCT02793544|Fludarabine|fludarabine|mesh-list
153932907|NCT02793544|Mesna|mesna|mesh-list
153932908|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932909|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
153932910|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932911|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153932912|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153932913|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
153932914|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932915|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821795|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932916|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153932917|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153932918|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153932919|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
153932920|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153932921|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932922|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932923|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
153932924|NCT02793544|Protective Agents|protective agents|mesh-ancestor
153932925|NCT02793388|Primaquine|primaquine|mesh-list
153932926|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
153932927|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153932928|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153932929|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932930|NCT02689882|Niacinamide|niacinamide|mesh-list
153932931|NCT02689882|Niacin|niacin|mesh-list
153932932|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
153932933|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
153932934|NCT02689882|Vitamins|vitamins|mesh-ancestor
153932935|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
153932936|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932937|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153932938|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
153932939|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932940|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153932941|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
153932942|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153932943|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153932959|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153932960|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932961|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932962|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153932963|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
153932964|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932965|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932966|NCT02789332|Paclitaxel|paclitaxel|mesh-list
153932967|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153932968|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
153932969|NCT02789332|Carboplatin|carboplatin|mesh-list
153932971|NCT02789332|Olaparib|olaparib|mesh-list
153932972|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153932973|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932974|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
153932975|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
153932976|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932977|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932978|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932979|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
153932980|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932981|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153932982|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153932983|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
153932984|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153932985|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153932986|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153932987|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153932988|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932989|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153932990|NCT02792140|Naltrexone|naltrexone|mesh-list
153932991|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153932992|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153932993|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932995|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932996|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
153932997|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932998|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932999|NCT02791594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153933000|NCT02791594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933001|NCT04234516|Morphine|morphine|mesh-list
153933002|NCT04234516|Buprenorphine|buprenorphine|mesh-list
153933003|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153933004|NCT04234516|Naloxone|naloxone|mesh-list
153933032|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153933033|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933034|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
153933035|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153933036|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153830921|NCT05148312|Budesonide|budesonide|mesh-list
153933037|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153933038|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
153933039|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933040|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
153933041|NCT02620345|Progestins|progestins|mesh-ancestor
153933042|NCT02620345|Hormones|hormones|mesh-ancestor
153933043|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933044|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933045|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
153933046|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
153933047|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153933048|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153933049|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933050|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
153933051|NCT02790580|Doxorubicin|doxorubicin|mesh-list
153933052|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153933069|NCT02790580|Growth Substances|growth substances|mesh-ancestor
153933070|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
153933071|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153933072|NCT02788864|Piperaquine|piperaquine|mesh-list
153933073|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
153933074|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153933075|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153933076|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933077|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
153933078|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153933079|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
153933080|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153933081|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933082|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
153933083|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
153933084|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
153933085|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153370983|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153933086|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821871|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
153361858|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153821889|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153933087|NCT00693979|Paclitaxel|paclitaxel|mesh-list
153933088|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153933089|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933090|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
153933091|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
153933092|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
153933093|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933094|NCT04232800|Riboflavin|riboflavin|mesh-list
153933095|NCT04232800|Vitamins|vitamins|mesh-ancestor
153933096|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
153933097|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933098|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
153933099|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153933100|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
153933101|NCT01148225|Adalimumab|adalimumab|mesh-list
153933102|NCT01148225|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153933103|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153933104|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933105|NCT02788240|Meropenem|meropenem|mesh-list
153933106|NCT02788240|Terlipressin|terlipressin|mesh-list
153933107|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933108|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933109|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153933110|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153933111|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
153933112|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
153933127|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933128|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933129|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933130|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153933131|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933133|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933134|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153933135|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153933136|NCT03641326|Growth Substances|growth substances|mesh-ancestor
153933137|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933138|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
153933139|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153933140|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933141|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933142|NCT00870727|Aripiprazole|aripiprazole|mesh-list
153933143|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
153933144|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153933145|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153933146|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153933147|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821895|NCT00440804|Ibuprofen|ibuprofen|mesh-list
153371018|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
153371019|NCT01242644|Ketorolac|ketorolac|mesh-list
153821914|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153821915|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821916|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153933148|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821917|NCT00440843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153821918|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153821919|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821920|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821921|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821922|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
153933149|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
153821923|NCT00438789|Eculizumab|eculizumab|mesh-list
153821926|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
153933150|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
153933151|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933152|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933153|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153933154|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153933155|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
153933156|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153933157|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153933158|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153933159|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153933160|NCT02787928|Hydromorphone|hydromorphone|mesh-list
153933161|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153933162|NCT02787928|Narcotics|narcotics|mesh-ancestor
153933163|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933164|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933165|NCT02787928|Analgesics|analgesics|mesh-ancestor
153933166|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
153933167|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933168|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
153933169|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153933170|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933171|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933172|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
153933173|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690795|NCT00187447|Analgesics|analgesics|mesh-ancestor
153933187|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153933188|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933189|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933190|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153933191|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153933192|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153933193|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153933194|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153933195|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153933196|NCT01147055|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153933197|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153933199|NCT02623231|Escitalopram|escitalopram|mesh-list
153933200|NCT02623231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153933201|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153821940|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821941|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153821942|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153821943|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153821944|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821945|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821946|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153821947|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153361903|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361905|NCT02504892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153361906|NCT02504892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153361909|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153933202|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933203|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933204|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933205|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
153933206|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933207|NCT02623153|Docetaxel|docetaxel|mesh-list
153933208|NCT02623153|Capecitabine|capecitabine|mesh-list
153933209|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
153933210|NCT02623153|Tegafur|tegafur|mesh-list
153933211|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933212|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
153933213|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
153933215|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933216|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153933217|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
153933218|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
153933219|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933220|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933221|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153933222|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153933223|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933224|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933225|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933226|NCT02884037|Rifaximin|rifaximin|mesh-list
153933227|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933228|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933229|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933230|NCT04233502|Melatonin|melatonin|mesh-list
153933231|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
153933232|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933233|NCT04233502|Protective Agents|protective agents|mesh-ancestor
153933234|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933235|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933236|NCT00696475|Diazoxide|diazoxide|mesh-list
153933237|NCT00696475|Choline|choline|mesh-list
153933254|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933255|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153933256|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
153933257|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933258|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821948|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
153821949|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153821950|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153821951|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153821952|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821953|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
153821954|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
153821970|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821971|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
153821972|NCT00441155|Nilotinib|nilotinib|mesh-list
153933259|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153933260|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153933261|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
153933262|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
153933263|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153933264|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153933265|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933266|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933267|NCT00625079|Urological Agents|urological agents|mesh-ancestor
153933268|NCT02786992|Misoprostol|misoprostol|mesh-list
153933270|NCT02786992|Carbetocin|carbetocin|mesh-list
153933271|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
153933272|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153933273|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933274|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153933275|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
153933276|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153933277|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933278|NCT04232644|Amphetamine|amphetamine|mesh-list
153933279|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
153933280|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153933281|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933282|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
153933283|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
153933284|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933285|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
153933286|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933287|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933288|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
153933289|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153933290|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153933291|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933292|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153933293|NCT03557788|Rifaximin|rifaximin|mesh-list
153933294|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933295|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933296|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933309|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153933310|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933311|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933312|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153933313|NCT00869089|Apremilast|apremilast|mesh-list
153933314|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153933315|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153933317|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
153933318|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933319|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933320|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153933321|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933322|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153933323|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153933324|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933325|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933326|NCT02616367|Bupivacaine|bupivacaine|mesh-list
153933327|NCT02616367|Ropivacaine|ropivacaine|mesh-list
153933328|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
153933329|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
153933330|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933331|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933332|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
153933333|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933334|NCT04200040|Dacarbazine|dacarbazine|mesh-list
153933335|NCT04200040|Molgramostim|molgramostim|mesh-list
153933336|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153933337|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
153933338|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933339|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933340|NCT04232722|Sorafenib|sorafenib|mesh-list
153933341|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933342|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153933343|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933344|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933346|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153933347|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933348|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
153933349|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153933350|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933351|NCT02787226|Bupivacaine|bupivacaine|mesh-list
153933352|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
153933353|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
153933354|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933355|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933356|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
153933357|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933358|NCT00697567|Vaccines|vaccines|mesh-list
153933359|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
153361936|NCT05946486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361937|NCT05946148|Empagliflozin|empagliflozin|mesh-list
153361991|NCT05945745|Immunologic Factors|immunologic factors|mesh-ancestor
153362114|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
153822158|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822160|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153362115|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153362116|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362117|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362118|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362119|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
153362121|NCT05554276|Antibodies|antibodies|mesh-list
153933360|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933376|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153933377|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153933378|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
153933379|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
153933380|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933381|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933382|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933383|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
153933384|NCT00870103|Hormones|hormones|mesh-ancestor
153933385|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933386|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153933387|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933388|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933389|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933390|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153933391|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153933392|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933393|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933394|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153933395|NCT03365752|Anesthetics|anesthetics|mesh-list
153933396|NCT03365752|Mepivacaine|mepivacaine|mesh-list
153933397|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
153933398|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
153933399|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933400|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933401|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
153933402|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
153933403|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933404|NCT02785666|Ribavirin|ribavirin|mesh-list
153933405|NCT02785666|Grazoprevir|grazoprevir|mesh-list
153406081|NCT05438316|Ramipril|ramipril|mesh-list
153933406|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153933407|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
153933408|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933409|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
153933410|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933411|NCT01145417|Pregabalin|pregabalin|mesh-list
153933412|NCT01145417|Analgesics|analgesics|mesh-ancestor
153933413|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
153933414|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822222|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822223|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822224|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153822225|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153822226|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362227|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153362228|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362229|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822274|NCT00478374|Doxorubicin|doxorubicin|mesh-list
153933415|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822275|NCT00478374|Sorafenib|sorafenib|mesh-list
153933416|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
153933417|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153933418|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933419|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933420|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153933421|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153933438|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933439|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933440|NCT00696631|Dronedarone|dronedarone|mesh-list
153933441|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153933442|NCT02615977|Ethanol|ethanol|mesh-list
153933443|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153933444|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933445|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933446|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933447|NCT01189487|Ampicillin|ampicillin|mesh-list
153933448|NCT01189487|Sulbactam|sulbactam|mesh-list
153933449|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933450|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933451|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153933452|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933453|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933454|NCT02621905|Itraconazole|itraconazole|mesh-list
153933455|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153933456|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
153933457|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933458|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153933459|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153933460|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933461|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933462|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153933463|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
153933464|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933465|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933466|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153822276|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153362233|NCT04512365|Dronabinol|dronabinol|mesh-list
153822316|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153822317|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
153822318|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153822319|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153822320|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153362299|NCT03933631|Miotics|miotics|mesh-ancestor
153362300|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153362301|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153362302|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
153362303|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362304|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362305|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153408737|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
153933467|NCT01106352|Docetaxel|docetaxel|mesh-list
153933468|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153933469|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933470|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
153933471|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
153933472|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
153933473|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933474|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
153933475|NCT01144403|Rituximab|rituximab|mesh-list
153933476|NCT01144403|Fludarabine|fludarabine|mesh-list
153933477|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
153933478|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153933479|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
153933485|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933486|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153933487|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153933488|NCT01144403|Analgesics|analgesics|mesh-ancestor
153933489|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
153933490|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933491|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153933492|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153933493|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933495|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153933496|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153933497|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933498|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153933499|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153933500|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933501|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933502|NCT02883647|Tenofovir|tenofovir|mesh-list
153933503|NCT02883647|Entecavir|entecavir|mesh-list
153933504|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
153933505|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933506|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153933507|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153933508|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933509|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933510|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153933511|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153362306|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371160|NCT01739699|Acetaminophen|acetaminophen|mesh-list
153822341|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153822342|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153822343|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153822345|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933512|NCT02621827|Calcifediol|calcifediol|mesh-list
153933513|NCT02621827|Vitamins|vitamins|mesh-ancestor
153933514|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
153933515|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933516|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153933517|NCT01143389|Riboflavin|riboflavin|mesh-list
153933518|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
153933519|NCT01143389|Vitamins|vitamins|mesh-ancestor
153933520|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
153933521|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933522|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153933523|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
153933524|NCT00868231|Bromides|bromides|mesh-list
153933525|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
153933526|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153933527|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
153933528|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933529|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933530|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153933531|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
153933532|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
153933533|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153933534|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
153933535|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933536|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933537|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
153933538|NCT04231864|Durvalumab|durvalumab|mesh-list
153933539|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
153933540|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153933541|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
153933542|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153933543|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933544|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
153933545|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933546|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153933547|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153933548|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153933549|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153691165|NCT00189787|Tacrolimus|tacrolimus|mesh-list
153933570|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933571|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
153933572|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933573|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153933574|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153933575|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153933576|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933577|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933578|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153933579|NCT02786446|Analgesics|analgesics|mesh-ancestor
153933580|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153933581|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933582|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
153933583|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153933584|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933585|NCT02619019|Dexamethasone|dexamethasone|mesh-list
153933586|NCT02619019|Meperidine|meperidine|mesh-list
153933587|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153933588|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
153933589|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
153933590|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933591|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933592|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933594|NCT02619019|Hormones|hormones|mesh-ancestor
153933595|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933596|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153933597|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933598|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153933599|NCT02619019|Narcotics|narcotics|mesh-ancestor
153933600|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933601|NCT02619019|Analgesics|analgesics|mesh-ancestor
153933614|NCT00864721|Growth Substances|growth substances|mesh-ancestor
153933615|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933616|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
153933617|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153822388|NCT00443573|Protein C|protein c|mesh-list
153933618|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933619|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933620|NCT05308420|Morphine|morphine|mesh-list
153933621|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933622|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933623|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153933624|NCT05308420|Narcotics|narcotics|mesh-ancestor
153933625|NCT05308420|Analgesics|analgesics|mesh-ancestor
153933626|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
153933627|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933628|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
153933629|NCT02897050|Docetaxel|docetaxel|mesh-list
153933630|NCT02897050|Capecitabine|capecitabine|mesh-list
153933631|NCT02897050|Fluorouracil|fluorouracil|mesh-list
153933632|NCT02897050|Epirubicin|epirubicin|mesh-list
153933633|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153933634|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
153933635|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933636|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933637|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153933638|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
153933639|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933640|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933641|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153933642|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
153933643|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
153933644|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
153933645|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153933646|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
153933647|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153933648|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153933649|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153933650|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933652|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
153933653|NCT01095666|Pioglitazone|pioglitazone|mesh-list
153933654|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153933655|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933656|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153933657|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933658|NCT01100658|Methylphenidate|methylphenidate|mesh-list
153933659|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153933660|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933661|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153933662|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153933663|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933664|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933665|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
153933685|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153933686|NCT02786212|Analgesics|analgesics|mesh-ancestor
153933687|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
153933688|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933689|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153933690|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153933691|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153933692|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
153933693|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933694|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933696|NCT05273710|Hematinics|hematinics|mesh-ancestor
153933697|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
153933698|NCT05273710|Vitamins|vitamins|mesh-ancestor
153933699|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
153933700|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933701|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
153933702|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
153933703|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153933704|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933705|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153933706|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153933707|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933708|NCT01100502|Immunotoxins|immunotoxins|mesh-ancestor
153933709|NCT01100502|Immunoconjugates|immunoconjugates|mesh-ancestor
153933710|NCT01100502|Immunologic Factors|immunologic factors|mesh-ancestor
153933711|NCT01100502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933712|NCT02784340|Dexamethasone|dexamethasone|mesh-list
153933713|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
153933714|NCT02784340|Bupivacaine|bupivacaine|mesh-list
153933715|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153933716|NCT02784340|BB 1101|bb 1101|mesh-list
153933717|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153933718|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
153933719|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
153933720|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933721|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822455|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933744|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933746|NCT01094808|Pregabalin|pregabalin|mesh-list
153933747|NCT01094808|Analgesics|analgesics|mesh-ancestor
153933748|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
153933749|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933750|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933751|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
153933752|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153933753|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933754|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933755|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153933756|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153933757|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153933758|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933759|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153933760|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153933761|NCT00864253|Dacarbazine|dacarbazine|mesh-list
153933762|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933763|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153933764|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
153933765|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933766|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153933767|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153933768|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
153933769|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933770|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691396|NCT00190918|Pemetrexed|pemetrexed|mesh-list
153822532|NCT00441519|Aspirin|aspirin|mesh-list
153691365|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933787|NCT05342272|Betaine|betaine|mesh-list
153933788|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933789|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933790|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
153933791|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153933793|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933794|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153933795|NCT04230460|Ethanol|ethanol|mesh-list
153933796|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153933797|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933798|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933799|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933800|NCT02783638|Pregabalin|pregabalin|mesh-list
153933801|NCT02783638|Analgesics|analgesics|mesh-ancestor
153933802|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
153933803|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933804|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933805|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
153933806|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153933807|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933808|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933809|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153933810|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153933811|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153933812|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933813|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153933814|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153933815|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153933816|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
153933817|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153933818|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153933820|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153933821|NCT04230070|Estrogens|estrogens|mesh-ancestor
153933822|NCT04230070|Hormones|hormones|mesh-ancestor
153933823|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933824|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933825|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153933826|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
153933827|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153933828|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153933829|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153933830|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153933846|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153933847|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153933848|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153933849|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153933850|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153933851|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153933853|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153933854|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933855|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153933856|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933857|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933858|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153933859|NCT01293682|Vitamins|vitamins|mesh-ancestor
153933860|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
153933861|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153933862|NCT00864097|Diclofenac|diclofenac|mesh-list
153933863|NCT00864097|Tanezumab|tanezumab|mesh-list
153933864|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153933866|NCT00864097|Analgesics|analgesics|mesh-ancestor
153933867|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
153933868|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933869|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933870|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153933871|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933872|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153933873|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933874|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933875|NCT02782624|Empagliflozin|empagliflozin|mesh-list
153933876|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153933877|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933878|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153933879|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933880|NCT02781766|Thrombin|thrombin|mesh-list
153933881|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
153933882|NCT02781766|Coagulants|coagulants|mesh-ancestor
153933883|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
153933884|NCT00887536|Bevacizumab|bevacizumab|mesh-list
153933885|NCT00887536|Docetaxel|docetaxel|mesh-list
153933886|NCT00887536|Doxorubicin|doxorubicin|mesh-list
153933887|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153933888|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
153933889|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362582|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933898|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153933899|NCT00887536|Growth Substances|growth substances|mesh-ancestor
153933900|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
153933901|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
153933902|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
153933903|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
153933904|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153933905|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153933906|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153933907|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933908|NCT02614339|Metformin|metformin|mesh-list
153933909|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153933910|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933912|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153933913|NCT02618395|Narcotics|narcotics|mesh-ancestor
153933914|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933915|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933916|NCT02618395|Analgesics|analgesics|mesh-ancestor
153933917|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
153933918|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933919|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
153933920|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
153933921|NCT01183013|Pioglitazone|pioglitazone|mesh-list
153933922|NCT01183013|Linagliptin|linagliptin|mesh-list
153933923|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153933924|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933925|NCT01183013|Incretins|incretins|mesh-ancestor
153933926|NCT01183013|Hormones|hormones|mesh-ancestor
153933927|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933928|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153933929|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
153933930|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933931|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933932|NCT04229212|Cimetidine|cimetidine|mesh-list
153933933|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153933934|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933935|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153933936|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
153933937|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
153933938|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933939|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933941|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153933942|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153933943|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933944|NCT02615041|Meropenem|meropenem|mesh-list
153933945|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933946|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933947|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153933948|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153933949|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153933950|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933951|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933952|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933953|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933954|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153933963|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153933964|NCT05298163|Vitamins|vitamins|mesh-ancestor
153933965|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
153933966|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153933967|NCT01141283|Buprenorphine|buprenorphine|mesh-list
153933968|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153933969|NCT01141283|Narcotics|narcotics|mesh-ancestor
153933970|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933971|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933972|NCT01141283|Analgesics|analgesics|mesh-ancestor
153933973|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
153933974|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933975|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153933976|NCT05340946|Anesthetics|anesthetics|mesh-list
153933977|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933978|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933979|NCT00863707|Regadenoson|regadenoson|mesh-list
153933980|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153933981|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153933982|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
153933983|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
153933984|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933985|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933986|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933987|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
153933988|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
153933989|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153933990|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933991|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153933992|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153406219|NCT05139238|Nifedipine|nifedipine|mesh-list
153933993|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933994|NCT02780830|Ibrutinib|ibrutinib|mesh-list
153933995|NCT02780830|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153933996|NCT02780830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153933997|NCT02780830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933998|NCT02780830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933999|NCT04187807|Melatonin|melatonin|mesh-list
153934000|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
153934001|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934002|NCT04187807|Protective Agents|protective agents|mesh-ancestor
153934003|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934004|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934005|NCT01094184|Paclitaxel|paclitaxel|mesh-list
153934006|NCT01094184|Docetaxel|docetaxel|mesh-list
153934007|NCT01094184|Bevacizumab|bevacizumab|mesh-list
153934008|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153934009|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934010|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
153934011|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
153934012|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
153934013|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934014|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153934015|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153934016|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153934017|NCT01094184|Growth Substances|growth substances|mesh-ancestor
153934018|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934019|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
153934034|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153934036|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
153934038|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
153934039|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
153934040|NCT02618317|Minocycline|minocycline|mesh-list
153934041|NCT02618317|Heparin|heparin|mesh-list
153934042|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
153934043|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934044|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153934045|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153934046|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153934047|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934048|NCT01140503|Apremilast|apremilast|mesh-list
153934049|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934050|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934051|NCT01140503|Analgesics|analgesics|mesh-ancestor
153934052|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
153934053|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934054|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934055|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934056|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934057|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153934058|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153934059|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934060|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934061|NCT02689726|Imiquimod|imiquimod|mesh-list
153934062|NCT02689726|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153934063|NCT02689726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934064|NCT02689726|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153934065|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
153934066|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934067|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153934068|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934069|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
153934070|NCT00863317|Montelukast|montelukast|mesh-list
153934071|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153934072|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
153934073|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153934074|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
153934075|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934076|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934077|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153934090|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
153934091|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
153934092|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153934093|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153934094|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153934095|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153934096|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
153934097|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934098|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934099|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153934100|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
153934101|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153934102|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153934103|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153934104|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
153934105|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934106|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934107|NCT01078974|Dexamethasone|dexamethasone|mesh-list
153934109|NCT01078974|Pomalidomide|pomalidomide|mesh-list
153934110|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934111|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
153934112|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
153934113|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934114|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934115|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153934116|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
153934117|NCT01078974|Hormones|hormones|mesh-ancestor
153934118|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934119|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153934120|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934121|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153934122|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
153934123|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934124|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153934125|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153934126|NCT01078974|Growth Substances|growth substances|mesh-ancestor
153934127|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
153934128|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
153934129|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
153934130|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934131|NCT02878200|Piperaquine|piperaquine|mesh-list
153934132|NCT02878200|Artenimol|artenimol|mesh-list
153934133|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
153934134|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153934135|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153934136|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934137|NCT04302012|Mydriatics|mydriatics|mesh-list
153934138|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
153934139|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934140|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691752|NCT00193570|Docetaxel|docetaxel|mesh-list
153934172|NCT00866359|Analgesics|analgesics|mesh-ancestor
153934173|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
153934174|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934175|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934176|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934177|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934178|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153934179|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153934194|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153934196|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153934197|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
153934198|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
153934199|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153934200|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934201|NCT01198574|Vitamins|vitamins|mesh-list
153934202|NCT01198574|Folic Acid|folic acid|mesh-list
153934203|NCT01198574|Vitamin A|vitamin a|mesh-list
153934204|NCT01198574|Iron|iron|mesh-list
153934205|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
153934206|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
153934207|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934208|NCT01198574|Trace Elements|trace elements|mesh-ancestor
153934209|NCT01198574|Hematinics|hematinics|mesh-ancestor
153362817|NCT00895934|Vorinostat|vorinostat|mesh-list
153934210|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
153934211|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
153934212|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934213|NCT01198574|Protective Agents|protective agents|mesh-ancestor
153934214|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153934215|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406266|NCT05090384|Hormones|hormones|mesh-ancestor
153934216|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153934217|NCT01198028|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153934218|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153934219|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934220|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934221|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934222|NCT01092780|Modafinil|modafinil|mesh-list
153934223|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153934224|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934225|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153934226|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153934227|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153934228|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934229|NCT05338606|Bimatoprost|bimatoprost|mesh-list
153934230|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153934231|NCT01092546|Flutemetamol|flutemetamol|mesh-list
153934232|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153934233|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934235|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
153934236|NCT02779582|Progesterone|progesterone|mesh-list
153934237|NCT02779582|Progestins|progestins|mesh-ancestor
153934238|NCT02779582|Hormones|hormones|mesh-ancestor
153691846|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
153934255|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
153934257|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153934258|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934259|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934260|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934261|NCT04227886|Capecitabine|capecitabine|mesh-list
153934262|NCT04227886|Irinotecan|irinotecan|mesh-list
153934263|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153934264|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
153362818|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
153934265|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934266|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934267|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153934268|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153934269|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934270|NCT02200978|Cytarabine|cytarabine|mesh-list
153934271|NCT02200978|Methotrexate|methotrexate|mesh-list
153934272|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
153934273|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
153934274|NCT02200978|Tretinoin|tretinoin|mesh-list
153934275|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
153934276|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153934277|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
153934278|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153934279|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934280|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153934281|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
153934282|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934283|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934284|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153934285|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934286|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153934287|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153934288|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
153934289|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934290|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153934291|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
153934292|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934293|NCT02200978|Analgesics|analgesics|mesh-ancestor
153934294|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
153362840|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
153934300|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934301|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934302|NCT02779192|Analgesics|analgesics|mesh-ancestor
153934303|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
153934304|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934305|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934306|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934307|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934308|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153934309|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153934322|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934323|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153934324|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934325|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934326|NCT01091454|Cisplatin|cisplatin|mesh-list
153934327|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934328|NCT01140347|Ramucirumab|ramucirumab|mesh-list
153934329|NCT01140347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153934330|NCT01140347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153934331|NCT01140347|Growth Substances|growth substances|mesh-ancestor
153934332|NCT01140347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934333|NCT01140347|Growth Inhibitors|growth inhibitors|mesh-ancestor
153934334|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934335|NCT04227652|Ibuprofen|ibuprofen|mesh-list
153934336|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934337|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934338|NCT04227652|Analgesics|analgesics|mesh-ancestor
153934339|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
153934340|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934341|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934342|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934343|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934344|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934345|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934346|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934347|NCT02883569|Ibuprofen|ibuprofen|mesh-list
153934348|NCT02883569|Aceclofenac|aceclofenac|mesh-list
153934349|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
153934350|NCT02883569|Tramadol|tramadol|mesh-list
153934351|NCT02883569|Codeine|codeine|mesh-list
153822896|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822900|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
153934352|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934353|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934354|NCT02883569|Analgesics|analgesics|mesh-ancestor
153934355|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
153934356|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934357|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934358|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934359|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934360|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934361|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934362|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934363|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153934395|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153934397|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934398|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153934399|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153934400|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153934401|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934402|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153934403|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153934404|NCT01197560|Growth Substances|growth substances|mesh-ancestor
153934405|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
153934406|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153692030|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
153934422|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
153934423|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153934424|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934425|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
153934426|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
153934427|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
153934428|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
153934429|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153934430|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153934431|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
153934432|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
153934433|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934434|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934435|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934436|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153934437|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
153934438|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153934439|NCT01194830|Linagliptin|linagliptin|mesh-list
153934440|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153934441|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934442|NCT01194830|Incretins|incretins|mesh-ancestor
153934443|NCT01194830|Hormones|hormones|mesh-ancestor
153934444|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934445|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153934446|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
153934447|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934448|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934449|NCT02778178|Clonidine|clonidine|mesh-list
153934450|NCT02778178|Ropivacaine|ropivacaine|mesh-list
153934451|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
153934452|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
153934453|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934454|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934455|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
153934456|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934457|NCT02778178|Analgesics|analgesics|mesh-ancestor
153934458|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153934459|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
153934460|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
153934461|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153934462|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153934463|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153934464|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
153934465|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934466|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934467|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
153934469|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934484|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
153934485|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934486|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934487|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934488|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934489|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934490|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153823013|NCT00455936|Gefitinib|gefitinib|mesh-list
153934491|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934492|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934493|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
153934494|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
153934495|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
153934496|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934497|NCT00951015|Efavirenz|efavirenz|mesh-list
153934498|NCT00951015|Dolutegravir|dolutegravir|mesh-list
153934499|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153934500|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153934501|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934502|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934503|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
153934504|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934505|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153934506|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153934507|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153934508|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153934509|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153823084|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934510|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153934511|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153934512|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153934513|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153934514|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153934515|NCT02777866|Bupivacaine|bupivacaine|mesh-list
153934516|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
153934517|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
153934518|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934519|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934520|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
153934521|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934522|NCT00626262|Esomeprazole|esomeprazole|mesh-list
153934523|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153934524|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153934525|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153934526|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934527|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934539|NCT02777788|Cisplatin|cisplatin|mesh-list
153934540|NCT02777788|Nedaplatin|nedaplatin|mesh-list
153934541|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153934542|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934543|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
153934544|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
153934545|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
153934546|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934547|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153934548|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
153934549|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934550|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153934551|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153934552|NCT01076166|Clarithromycin|clarithromycin|mesh-list
153934553|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153934554|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934555|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153934556|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934557|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934558|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153934559|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153934560|NCT02777710|Durvalumab|durvalumab|mesh-list
153934561|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153934562|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934563|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153934564|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
153934565|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934566|NCT00602901|Naproxen|naproxen|mesh-list
153934567|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934568|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934569|NCT00602901|Analgesics|analgesics|mesh-ancestor
153934570|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
153934571|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934572|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934573|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934574|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934575|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
153934576|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934577|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934578|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934579|NCT01076088|Metformin|metformin|mesh-list
153934580|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153934581|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153934582|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934583|NCT01076088|Incretins|incretins|mesh-ancestor
153934584|NCT01076088|Hormones|hormones|mesh-ancestor
153934585|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934586|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153934587|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
153934588|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934589|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934590|NCT02777320|Acetaminophen|acetaminophen|mesh-list
153934591|NCT02777320|Ibuprofen|ibuprofen|mesh-list
153934592|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934593|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934594|NCT02777320|Analgesics|analgesics|mesh-ancestor
153934595|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
153934617|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934618|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934619|NCT02776228|Brotizolam|brotizolam|mesh-list
153934620|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153934621|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934622|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934623|NCT01192178|Fluticasone|fluticasone|mesh-list
153934624|NCT01192178|Xhance|xhance|mesh-list
153934625|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153934626|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153934627|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934628|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153934629|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
153934630|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934631|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934632|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153934633|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
153934634|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
153934635|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153934636|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153934637|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153934638|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153934639|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
153934640|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934641|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934642|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
153934643|NCT01192178|Hormones|hormones|mesh-ancestor
153934644|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934645|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
153934646|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
153934647|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153934663|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153934665|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934666|NCT04225780|Ganciclovir|ganciclovir|mesh-list
153934667|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153934668|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
153934669|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934670|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153934671|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934672|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934673|NCT04045171|Tacrolimus|tacrolimus|mesh-list
153934674|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153934675|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
153934676|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934677|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153934678|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934679|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934681|NCT01075152|Zidovudine|zidovudine|mesh-list
153934682|NCT01075152|Efavirenz|efavirenz|mesh-list
153934683|NCT01075152|Stavudine|stavudine|mesh-list
153934684|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153934685|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153934686|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934687|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934688|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
153934689|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934690|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153934691|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153934692|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
153934693|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153934694|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153934695|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153934696|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153934697|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153934698|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153934699|NCT04134637|Bupivacaine|bupivacaine|mesh-list
153934700|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
153934701|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
153934702|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934703|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934704|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
153692311|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153934722|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153934723|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153934724|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
153934725|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934726|NCT02775292|Aldesleukin|aldesleukin|mesh-list
153934727|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
153934728|NCT02775292|Nivolumab|nivolumab|mesh-list
153934729|NCT02775292|Fludarabine|fludarabine|mesh-list
153934730|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
153934731|NCT02775292|Interleukin-2|interleukin-2|mesh-list
153934732|NCT02775292|Vaccines|vaccines|mesh-list
153934733|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
153934734|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934735|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153934736|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934737|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153934738|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
153934739|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934740|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934741|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153934742|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153934743|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153934744|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153934745|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
153934746|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934747|NCT02775292|Analgesics|analgesics|mesh-ancestor
153934748|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
153934749|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934750|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153934751|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153934752|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
153934753|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934754|NCT00862849|Insulin|insulin|mesh-list
153934755|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153934756|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
153934757|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153934758|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934760|NCT01090050|Sumatriptan|sumatriptan|mesh-list
153934761|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934762|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934763|NCT01090050|Analgesics|analgesics|mesh-ancestor
153934764|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
153934773|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153934774|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153934775|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153934776|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
153934777|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934779|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934780|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153934781|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934782|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934783|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
153934784|NCT04225468|Narcotics|narcotics|mesh-ancestor
153934785|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934786|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934787|NCT04225468|Analgesics|analgesics|mesh-ancestor
153934788|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
153934789|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934790|NCT02855307|Insulin|insulin|mesh-list
153934791|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153934792|NCT02855307|Hormones|hormones|mesh-list
153934793|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153934794|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934795|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934796|NCT01077960|Hormones|hormones|mesh-list
153934797|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934798|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934799|NCT04269369|Fluorouracil|fluorouracil|mesh-list
153934800|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
153934801|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934802|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153934803|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934804|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153934805|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
153934806|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934807|NCT02776540|Aspirin|aspirin|mesh-list
153934808|NCT02776540|Clopidogrel|clopidogrel|mesh-list
153934809|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934810|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934811|NCT02776540|Analgesics|analgesics|mesh-ancestor
153934812|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
153934813|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934814|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934815|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934816|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934817|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153934818|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153934819|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934820|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153934821|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934822|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934823|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
153934824|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153934825|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153934826|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153934827|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
153934828|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934850|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
153934851|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
153934852|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
153934853|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934854|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153934855|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
153934856|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934857|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934858|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153934859|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
153934860|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153934861|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153934862|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153934863|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153934864|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934866|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
153934867|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
153934868|NCT02877888|Protective Agents|protective agents|mesh-ancestor
153934869|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934870|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153934871|NCT02772640|Ezetimibe|ezetimibe|mesh-list
153934872|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153934873|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153934874|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
153934875|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934876|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153934877|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153934878|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934879|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153934880|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
153934881|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934882|NCT00866281|Midostaurin|midostaurin|mesh-list
153934883|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934884|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153934885|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934910|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153934912|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
153934913|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
153934914|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934915|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153934916|NCT02771392|Tetracaine|tetracaine|mesh-list
153934917|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153934918|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
153934919|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
153934920|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363252|NCT01556633|Oseltamivir|oseltamivir|mesh-list
153934921|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934922|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
153934923|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934925|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
153934926|NCT02771704|Fluorides|fluorides|mesh-list
153934927|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
153934928|NCT02771704|Protective Agents|protective agents|mesh-ancestor
153934929|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934930|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153934931|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934932|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
153934933|NCT02771704|Trace Elements|trace elements|mesh-ancestor
153934934|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
153934935|NCT02771314|Osimertinib|osimertinib|mesh-list
153934936|NCT02771314|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153934956|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
153934957|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934958|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934959|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
153934960|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934961|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153934962|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153934963|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153934964|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153934965|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934966|NCT02770378|Ritonavir|ritonavir|mesh-list
153934967|NCT02770378|Itraconazole|itraconazole|mesh-list
153934968|NCT02770378|Minocycline|minocycline|mesh-list
153934969|NCT02770378|Celecoxib|celecoxib|mesh-list
153934970|NCT02770378|Temozolomide|temozolomide|mesh-list
153934971|NCT02770378|Auranofin|auranofin|mesh-list
153934972|NCT02770378|Captopril|captopril|mesh-list
153934973|NCT02770378|Disulfiram|disulfiram|mesh-list
153934974|NCT02770378|Aprepitant|aprepitant|mesh-list
153934975|NCT02770378|Sertraline|sertraline|mesh-list
153934976|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153934977|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153934978|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
153934979|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731403|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153934980|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934981|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153934982|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153934983|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
153934984|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934985|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153934986|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153934987|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153934988|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
153934989|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934990|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934991|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935016|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153935017|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153935018|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153935019|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153935020|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153935021|NCT02770222|Rifampin|rifampin|mesh-list
153935022|NCT02770222|Selexipag|selexipag|mesh-list
153935023|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
153935024|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153935025|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
153935026|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153935027|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935028|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
153935029|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153935030|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935031|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935032|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153935033|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153935034|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153935035|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153935036|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153935037|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153935038|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153692622|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935058|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935059|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
153935060|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935061|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
153935062|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935063|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153935064|NCT02769910|Capsaicin|capsaicin|mesh-list
153935065|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
153935066|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
153935067|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
153935068|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935069|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935070|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153935071|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153935072|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153935073|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153935074|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
153935075|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935076|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153935077|NCT02876484|Cathartics|cathartics|mesh-ancestor
153935078|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935079|NCT02876094|Celecoxib|celecoxib|mesh-list
153935080|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153935081|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935082|NCT02876094|Analgesics|analgesics|mesh-ancestor
153935083|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
153935084|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935085|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935086|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935087|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935088|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153935089|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153935090|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935091|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935122|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153935123|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935124|NCT01074450|Pramipexole|pramipexole|mesh-list
153935125|NCT01074450|Dexpramipexole|dexpramipexole|mesh-list
153935126|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
153935127|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935128|NCT01074450|Protective Agents|protective agents|mesh-ancestor
153935129|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935130|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153935131|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153935132|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
153935134|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935135|NCT02768116|Sirolimus|sirolimus|mesh-list
153935146|NCT02768116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153935147|NCT02768116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935148|NCT02768116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935149|NCT00635284|Sirolimus|sirolimus|mesh-list
153935150|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153935151|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935152|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153935153|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935154|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
153935155|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153935156|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
153935157|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935158|NCT04131595|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153935159|NCT04131595|Antiviral Agents|antiviral agents|mesh-ancestor
153935160|NCT04131595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935161|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
153935162|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
153935163|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153935164|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153935165|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
153935166|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831563|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153831590|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153935167|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935168|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935169|NCT00699049|Urological Agents|urological agents|mesh-ancestor
153935170|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153935171|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
153935172|NCT04131283|Epinephrine|epinephrine|mesh-list
153935173|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153935174|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153935175|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
153935176|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935177|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935178|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935179|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153935180|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153935181|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
153935182|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935183|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153935184|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
153935185|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
153935186|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
153935187|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153935188|NCT00943761|Interferons|interferons|mesh-list
153935189|NCT00943761|Ribavirin|ribavirin|mesh-list
153935190|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935191|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
153935192|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935193|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
153935194|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935195|NCT02617771|Vitamin D|vitamin d|mesh-list
153935196|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
153935197|NCT02617771|Vitamins|vitamins|mesh-ancestor
153935198|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
153935199|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935200|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153935236|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153935237|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935238|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935239|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153935240|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935241|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153935273|NCT00866047|Immunologic Factors|immunologic factors|mesh-ancestor
153935274|NCT00866047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935275|NCT01706692|Cyclosporine|cyclosporine|mesh-list
153935277|NCT01706692|Infliximab|infliximab|mesh-list
153935278|NCT01706692|Etanercept|etanercept|mesh-list
153935279|NCT01706692|Methotrexate|methotrexate|mesh-list
153935280|NCT01706692|Ustekinumab|ustekinumab|mesh-list
153935281|NCT01706692|Cyclosporins|cyclosporins|mesh-list
153935282|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153935283|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
153935284|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153935285|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935286|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153935287|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
153935288|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935289|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935305|NCT01706692|Analgesics|analgesics|mesh-ancestor
153935306|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
153935307|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935308|NCT00869323|Rituximab|rituximab|mesh-list
153935309|NCT00869323|Bortezomib|bortezomib|mesh-list
153935310|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153935311|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935312|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
153935313|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935314|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935315|NCT02767102|Melatonin|melatonin|mesh-list
153935316|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
153935317|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935318|NCT02767102|Protective Agents|protective agents|mesh-ancestor
153935319|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935320|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935321|NCT02774902|Clarithromycin|clarithromycin|mesh-list
153935322|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153935323|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935324|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153935325|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935326|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935327|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153935328|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153935329|NCT02767024|Nitroprusside|nitroprusside|mesh-list
153935330|NCT02767024|Dobutamine|dobutamine|mesh-list
153935331|NCT02767024|Furosemide|furosemide|mesh-list
153935332|NCT02767024|Diuretics|diuretics|mesh-ancestor
153935333|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
153935334|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935335|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153935336|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935337|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935338|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153935339|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
153935340|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
153935341|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935342|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153935343|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153935344|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153935345|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
153935346|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935347|NCT02767024|Protective Agents|protective agents|mesh-ancestor
153935348|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153935381|NCT01191944|Pramipexole|pramipexole|mesh-list
153935382|NCT01191944|Dexpramipexole|dexpramipexole|mesh-list
153935383|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
153935384|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935385|NCT01191944|Protective Agents|protective agents|mesh-ancestor
153935386|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935387|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153935388|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153935389|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
153935390|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
153935391|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935422|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153935423|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153935425|NCT05655338|Metronidazole|metronidazole|mesh-list
153935426|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
153935427|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153935428|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153935429|NCT01132313|Ribavirin|ribavirin|mesh-list
153935430|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
153935431|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935432|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
153935433|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935435|NCT00422565|Paclitaxel|paclitaxel|mesh-list
153935436|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153693053|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
153935450|NCT04316936|Prednisolone|prednisolone|mesh-list
153935451|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153935452|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
153935453|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153935454|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
153935455|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153935456|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
153935457|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935458|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
153935459|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
153935460|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935461|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935462|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935463|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
153935464|NCT04316936|Hormones|hormones|mesh-ancestor
153935465|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935466|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153935467|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935468|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153935469|NCT04316936|Protective Agents|protective agents|mesh-ancestor
153935470|NCT00861757|Tadalafil|tadalafil|mesh-list
153935471|NCT00861757|Tamsulosin|tamsulosin|mesh-list
153935472|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
153935473|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153935474|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153935475|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935476|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935477|NCT00861757|Urological Agents|urological agents|mesh-ancestor
153935478|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153935479|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153935480|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153935481|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
153935482|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935483|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935484|NCT02762812|Infliximab|infliximab|mesh-list
153935485|NCT02762812|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153935486|NCT02762812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935487|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
153935488|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935489|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935490|NCT02762890|Iodine|iodine|mesh-list
153935491|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153935492|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935493|NCT02762890|Trace Elements|trace elements|mesh-ancestor
153935494|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
153935495|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935496|NCT02613715|Ethanol|ethanol|mesh-list
153935497|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153935498|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935499|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935500|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935511|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935512|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935513|NCT00637325|Trastuzumab|trastuzumab|mesh-list
153935514|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153935515|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935517|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
153935518|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153935519|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153935520|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935521|NCT04663282|Insulin|insulin|mesh-list
153935522|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153935523|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935524|NCT01130597|Spironolactone|spironolactone|mesh-list
153935525|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153935526|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
153935527|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935528|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935529|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153935530|NCT01130597|Diuretics|diuretics|mesh-ancestor
153935531|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
153935532|NCT00939003|Adalimumab|adalimumab|mesh-list
153935533|NCT00939003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153935534|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935535|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935536|NCT01188668|Aripiprazole|aripiprazole|mesh-list
153935537|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153935538|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
153935539|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153935540|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153935541|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153935542|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935543|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935544|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
153935545|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
153935546|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935547|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935548|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153935549|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153935550|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
153935551|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153935552|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153935553|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153935554|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153935555|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153935556|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153935557|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935558|NCT01130051|Colchicine|colchicine|mesh-list
153935559|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
153935560|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935561|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
153935562|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
153371710|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
153935563|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
153693163|NCT02968160|Telmisartan|telmisartan|mesh-list
153935578|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
153935579|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
153935580|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935581|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153935582|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153935583|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
153693153|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
153935585|NCT00865189|Protective Agents|protective agents|mesh-ancestor
153935586|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
153935587|NCT00865189|Vitamins|vitamins|mesh-ancestor
153935588|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
153935589|NCT00865189|Hematinics|hematinics|mesh-ancestor
153935590|NCT00698269|Insulin|insulin|mesh-list
153935591|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153935592|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
153935593|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
153935594|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153935595|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
153935596|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
153935597|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153935598|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153935599|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935600|NCT01182194|Drospirenone|drospirenone|mesh-list
153935601|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153935602|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153935603|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153935604|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153935605|NCT01182194|Estradiol|estradiol|mesh-list
153935606|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153935607|NCT01182194|Estrogens|estrogens|mesh-ancestor
153935608|NCT01182194|Hormones|hormones|mesh-ancestor
153935609|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935610|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935611|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153935612|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
153406626|NCT04194528|Analgesics|analgesics|mesh-ancestor
153935613|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153935614|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153935615|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153935616|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153935617|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153935618|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
153935619|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153935620|NCT01182194|Diuretics|diuretics|mesh-ancestor
153935621|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
153935622|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153935623|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153935624|NCT01181726|Norethindrone|norethindrone|mesh-list
153935640|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153935641|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
153935642|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935643|NCT00603759|Celecoxib|celecoxib|mesh-list
153823748|NCT01327651|Tenofovir|tenofovir|mesh-list
153935644|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153935645|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935646|NCT00603759|Analgesics|analgesics|mesh-ancestor
153935647|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
153935648|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935649|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935650|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935651|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935652|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153935653|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153935654|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935655|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935656|NCT04130815|Furosemide|furosemide|mesh-list
153935657|NCT04130815|Diuretics|diuretics|mesh-ancestor
153693223|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
153935658|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
153935659|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935660|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153935661|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935662|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935663|NCT04256265|Risdiplam|risdiplam|mesh-list
153935664|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153935665|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935666|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935667|NCT04312061|Tramadol|tramadol|mesh-list
153935668|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153935669|NCT04312061|Narcotics|narcotics|mesh-ancestor
153935670|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935671|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935672|NCT04312061|Analgesics|analgesics|mesh-ancestor
153935673|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
153935674|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935675|NCT00860743|Antioxidants|antioxidants|mesh-list
153935676|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935677|NCT00860743|Protective Agents|protective agents|mesh-ancestor
153935678|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935679|NCT01186796|Fulvestrant|fulvestrant|mesh-list
153935680|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153935681|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935682|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153935706|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935707|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935708|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935709|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935710|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153935711|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153935712|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935713|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153935714|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153935715|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935717|NCT02882789|Delpazolid|delpazolid|mesh-list
153935718|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
153935719|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153935720|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935721|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153935722|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935723|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935724|NCT00940017|Voriconazole|voriconazole|mesh-list
153935725|NCT00940017|Anidulafungin|anidulafungin|mesh-list
153935726|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
153935727|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935728|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153935729|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153935730|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935731|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935759|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153935760|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935761|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
153935762|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
153935763|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153935764|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153935765|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935766|NCT00848497|Urological Agents|urological agents|mesh-ancestor
153935767|NCT02763592|Lidocaine|lidocaine|mesh-list
153935768|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
153935769|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
153935770|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935771|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935772|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
153935773|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935774|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153693394|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
153935789|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153935790|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153935791|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153935792|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153935793|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
153935794|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935795|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935796|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935798|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
153935799|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
153935800|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
153935801|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935802|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693375|NCT00223639|Topiramate|topiramate|mesh-list
153935803|NCT00699361|Pantoprazole|pantoprazole|mesh-list
153935804|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153935805|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935806|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153935807|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935808|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935809|NCT01185704|Cetrorelix|cetrorelix|mesh-list
153935810|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153935811|NCT01185704|Hormones|hormones|mesh-list
153935812|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153935813|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935814|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935815|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153935816|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
153935817|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153935818|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
153935819|NCT01128959|Carbamazepine|carbamazepine|mesh-list
153935820|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
153935821|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
153935822|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153935823|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935824|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935825|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153935826|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935827|NCT01128959|Analgesics|analgesics|mesh-ancestor
153935828|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
153935829|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935830|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153935858|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153935859|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935861|NCT01128569|Xhance|xhance|mesh-list
153935862|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935863|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153935864|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
153935865|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935866|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935867|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153935868|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
153935869|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
153935870|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153935872|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935873|NCT02883179|Lidocaine|lidocaine|mesh-list
153935874|NCT02883179|Prilocaine|prilocaine|mesh-list
153935875|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153935889|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153935890|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935891|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153935892|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153935893|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935894|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935895|NCT00637403|Megestrol|megestrol|mesh-list
153935896|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
153831725|NCT03871361|Abatacept|abatacept|mesh-list
153935897|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153935898|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153935899|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153935900|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
153935901|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153935902|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935903|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153935904|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153935905|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153935906|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935907|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
153935908|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153935909|NCT01185080|Adenosine|adenosine|mesh-list
153935910|NCT01185080|Analgesics|analgesics|mesh-ancestor
153935911|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
153935912|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935913|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935914|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153935915|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
153935916|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153935917|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
153935918|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
153935919|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935920|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935921|NCT01181102|Enoxaparin|enoxaparin|mesh-list
153935922|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
153935923|NCT01181102|Edoxaban|edoxaban|mesh-list
153935924|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
153935925|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153935926|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153935927|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935928|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153935929|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
153935930|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153935931|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
153935932|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935933|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
153935951|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
153935952|NCT02760316|Hormones|hormones|mesh-ancestor
153935953|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935954|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935955|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153935956|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935957|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
153935958|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
153935959|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935960|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935961|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153935962|NCT02760316|Protective Agents|protective agents|mesh-ancestor
153935963|NCT00858403|Dasatinib|dasatinib|mesh-list
153935964|NCT00858403|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153935965|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153935966|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935967|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935968|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935969|NCT02760472|SMOFlipid|smoflipid|mesh-list
153935970|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153935971|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153935972|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153935973|NCT00858247|Vitamin D|vitamin d|mesh-list
153935974|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
153935975|NCT00858247|Vitamins|vitamins|mesh-ancestor
153935976|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
153935977|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935978|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153935979|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153935980|NCT04222348|Metformin|metformin|mesh-list
153935981|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
153935982|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153935983|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935984|NCT04222114|Catumaxomab|catumaxomab|mesh-list
153935985|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935986|NCT00838435|Verapamil|verapamil|mesh-list
153935987|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153935988|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153935989|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935990|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693600|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
153936015|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
153936016|NCT02757196|Hormones|hormones|mesh-ancestor
153936017|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936018|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153936019|NCT02757196|Protective Agents|protective agents|mesh-ancestor
153936020|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153936021|NCT04403698|Alendronate|alendronate|mesh-list
153936022|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153936023|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936024|NCT02759926|Quinine|quinine|mesh-list
153936025|NCT02759926|Denatonium|denatonium|mesh-list
153936026|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
153936027|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153936028|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153936029|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936030|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153936031|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936032|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153936033|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936034|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153936035|NCT02759926|Analgesics|analgesics|mesh-ancestor
153831736|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153936036|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
153936037|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
153936038|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936039|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
153936040|NCT04221256|Escitalopram|escitalopram|mesh-list
153936041|NCT04221256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153693656|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936073|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153936075|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936076|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
153936077|NCT02759614|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153936078|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936079|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693708|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
153936101|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153936102|NCT02756728|Melphalan|melphalan|mesh-list
153936103|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153936104|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
153936105|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936106|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936107|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153936108|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153936109|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
153936110|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936111|NCT04586920|Itraconazole|itraconazole|mesh-list
153936112|NCT04586920|Midazolam|midazolam|mesh-list
153936113|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153936115|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936116|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936117|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153936118|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153936119|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153936120|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153936121|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
153936122|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
153936123|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
153936124|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
153936125|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936126|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936127|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
153936128|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936129|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153936130|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153936131|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693751|NCT00225121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936152|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153936153|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153936155|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936156|NCT02758990|Protective Agents|protective agents|mesh-ancestor
153936157|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153936158|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153936159|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936160|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153936161|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153936162|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
153936163|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936164|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
153936165|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153936166|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
153936167|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153936168|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
153936170|NCT02756104|Vitamins|vitamins|mesh-ancestor
153936171|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
153936172|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936173|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153936174|NCT02756026|Micronutrients|micronutrients|mesh-list
153936175|NCT02756026|Trace Elements|trace elements|mesh-list
153936176|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936177|NCT02755714|Bromides|bromides|mesh-list
153936178|NCT02755714|Ipratropium|ipratropium|mesh-list
153936179|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
153936180|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153936181|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
153936182|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936183|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936184|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153936185|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
153936186|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153936187|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
153936188|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936189|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936191|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153936192|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153693812|NCT00225433|Ganirelix|ganirelix|mesh-list
153936211|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936213|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
153936214|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936215|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936216|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153936217|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
153936218|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936219|NCT02752204|Rituximab|rituximab|mesh-list
153936220|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936221|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936222|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
153936223|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936224|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936225|NCT04220398|Hormones|hormones|mesh-list
153406722|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
153936226|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936227|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936228|NCT04220632|Prednisone|prednisone|mesh-list
153936229|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
153936230|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153936231|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153936232|NCT04220632|Prednisolone|prednisolone|mesh-list
153936233|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
153936234|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153936235|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
153936236|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936237|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
153936238|NCT04220632|Hormones|hormones|mesh-ancestor
153936239|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936240|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936241|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153936242|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936243|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
153936244|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
153936245|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936246|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153936247|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153936248|NCT04220632|Protective Agents|protective agents|mesh-ancestor
153936249|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153936268|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153936269|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936270|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936271|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153936272|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
153936273|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936274|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936275|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936276|NCT02695810|Metformin|metformin|mesh-list
153936277|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
153936278|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153936279|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936280|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153936281|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936282|NCT02753764|Prednisone|prednisone|mesh-list
153936283|NCT02753764|AZD7624|azd7624|mesh-list
153936284|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936285|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
153936286|NCT02753764|Hormones|hormones|mesh-ancestor
153936287|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936288|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936289|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153936290|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936291|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936292|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371840|NCT04246619|Pregabalin|pregabalin|mesh-list
153936293|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936294|NCT02695654|Clonidine|clonidine|mesh-list
153936295|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
153936296|NCT02695654|Analgesics|analgesics|mesh-ancestor
153936297|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
153936298|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936299|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936300|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153936301|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
153936302|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
153936303|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153936304|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153936305|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153936306|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
153693912|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
153936334|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936335|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936336|NCT02753218|Midazolam|midazolam|mesh-list
153936337|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153936338|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153936339|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936340|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406765|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
153936341|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153936342|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153936343|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153936344|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153936345|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
153936346|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
153936347|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
153936348|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
153936349|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936350|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936351|NCT05429554|Vildagliptin|vildagliptin|mesh-list
153936352|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153936353|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936355|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
153936356|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936357|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936358|NCT05429086|Propofol|propofol|mesh-list
153936359|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153936360|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936361|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936362|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153936363|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
153936364|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
153936365|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
153936366|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153936367|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153936368|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936369|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
153936370|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153936371|NCT01184846|Antibodies|antibodies|mesh-list
153936372|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
153936373|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936374|NCT01191086|Topiramate|topiramate|mesh-list
153936375|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
153936376|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153936377|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936378|NCT05318560|Lidocaine|lidocaine|mesh-list
153936379|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
153936380|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
153936381|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936382|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936383|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
153936384|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936385|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153936386|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153936387|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153936388|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936389|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936390|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
153936391|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153936392|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153936393|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153936394|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936395|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936396|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
153936397|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936398|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936399|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153936400|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936401|NCT01086384|Fluticasone|fluticasone|mesh-list
153936402|NCT01086384|Xhance|xhance|mesh-list
153936404|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153936405|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
153936406|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936407|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936408|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153936409|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
153936410|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
153936411|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153936412|NCT00635986|Fentanyl|fentanyl|mesh-list
153936413|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153936414|NCT00635986|Narcotics|narcotics|mesh-ancestor
153406799|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936415|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936416|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936417|NCT00635986|Analgesics|analgesics|mesh-ancestor
153936418|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
153936419|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371866|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
153936420|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153936421|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153936422|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
153936423|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
153936424|NCT04799626|Levofloxacin|levofloxacin|mesh-list
153936425|NCT04799626|Meropenem|meropenem|mesh-list
153936426|NCT04799626|Tazobactam|tazobactam|mesh-list
153936427|NCT04799626|Piperacillin|piperacillin|mesh-list
153936428|NCT04799626|Tigecycline|tigecycline|mesh-list
153936429|NCT04799626|Biapenem|biapenem|mesh-list
153936455|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936457|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
153936458|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
153936459|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936460|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936461|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
153936462|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936463|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153936464|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153936465|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153936466|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936467|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936468|NCT04217668|Isosorbide|isosorbide|mesh-list
153936469|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153936470|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153936471|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153936472|NCT04217668|Diuretics|diuretics|mesh-ancestor
153936473|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
153936474|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694099|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
153936505|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
153936506|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936507|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
153936508|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153936509|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936510|NCT02750254|Plerixafor|plerixafor|mesh-list
153936511|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
153936512|NCT02750254|Melphalan|melphalan|mesh-list
153936513|NCT02750254|Busulfan|busulfan|mesh-list
153936514|NCT02750254|Fludarabine|fludarabine|mesh-list
153936515|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
153936516|NCT02750254|Azacitidine|azacitidine|mesh-list
153936517|NCT02750254|Lenograstim|lenograstim|mesh-list
153936518|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153936519|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
153936555|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
153936556|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936557|NCT00605787|Protective Agents|protective agents|mesh-ancestor
153936558|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936559|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153936560|NCT00936117|Posaconazole|posaconazole|mesh-list
153936561|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
153936562|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936563|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153936564|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153936581|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936583|NCT01082874|Analgesics|analgesics|mesh-ancestor
153936584|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
153936585|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936586|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936587|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936588|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153936589|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
153936590|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
153936591|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153936592|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153936593|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153936594|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
153406816|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
153936595|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936596|NCT00607503|Terbutaline|terbutaline|mesh-list
153936597|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153936598|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
153936599|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936600|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936601|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153936602|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
153936603|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
153936604|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
153936605|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153936606|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153936607|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153936608|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153936609|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
153936610|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936611|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936612|NCT04217512|Pantoprazole|pantoprazole|mesh-list
153936613|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153936614|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153936615|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153936616|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936617|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936618|NCT01079988|Cyclosporine|cyclosporine|mesh-list
153936619|NCT01079988|Methotrexate|methotrexate|mesh-list
153936620|NCT01079988|Cyclosporins|cyclosporins|mesh-list
153936630|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936631|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153936632|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153936633|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
153936634|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371903|NCT02618343|Ondansetron|ondansetron|mesh-list
153936635|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153936636|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
153936637|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936638|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153936640|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153936641|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
153936642|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153936643|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
153936644|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936645|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936646|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
153936648|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
153936649|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
153936650|NCT01074216|Vitamins|vitamins|mesh-list
153936651|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
153936652|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936653|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153936654|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153936655|NCT00636142|Infliximab|infliximab|mesh-list
153936656|NCT00636142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153936657|NCT00636142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936658|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
153936659|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153936660|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936661|NCT02499562|Entecavir|entecavir|mesh-list
153936662|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
153936663|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936664|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
153936665|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153936666|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153936667|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936668|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153936669|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936670|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
153936671|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936672|NCT02875002|Belinostat|belinostat|mesh-list
153936673|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936674|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153936675|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936676|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936677|NCT02749396|Interferons|interferons|mesh-list
153936678|NCT02749396|Interferon-beta|interferon-beta|mesh-list
153936679|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
153936680|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
153936681|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936682|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
153936683|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936684|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
153936685|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936686|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153936700|NCT02749162|Hormones|hormones|mesh-ancestor
153936701|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936702|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153936703|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936705|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
153936706|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936707|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
153936708|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153936709|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153936710|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153936711|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936712|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936713|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153936714|NCT02749162|Narcotics|narcotics|mesh-ancestor
153936715|NCT02749162|Analgesics|analgesics|mesh-ancestor
153936716|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153936717|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
153936718|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153936719|NCT02041234|Liraglutide|liraglutide|mesh-list
153936720|NCT02041234|Empagliflozin|empagliflozin|mesh-list
153936721|NCT02041234|Linagliptin|linagliptin|mesh-list
153936722|NCT02041234|Canagliflozin|canagliflozin|mesh-list
153936723|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153936724|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153936725|NCT02041234|Orlistat|orlistat|mesh-list
153936726|NCT02041234|Incretins|incretins|mesh-list
153936727|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153936728|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936729|NCT02041234|Hormones|hormones|mesh-ancestor
153936730|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936731|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
153936732|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936733|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936734|NCT02041234|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153936735|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153936736|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153936737|NCT02695732|Carvedilol|carvedilol|mesh-list
153936738|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153936739|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153936740|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
153936741|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371935|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
153936742|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936743|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936744|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153936745|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
153936746|NCT02695732|Protective Agents|protective agents|mesh-ancestor
153936747|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153936748|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936749|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153936750|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
153694345|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153936768|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936769|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153936770|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153936771|NCT02748772|Growth Substances|growth substances|mesh-ancestor
153936772|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
153936773|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936774|NCT04216888|Ketamine|ketamine|mesh-list
153936775|NCT04216888|Analgesics|analgesics|mesh-ancestor
153936776|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
153936777|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694348|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
153936778|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936779|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153936780|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153936782|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
153936783|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936784|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153936785|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153936786|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936787|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936788|NCT02746744|Rituximab|rituximab|mesh-list
153936789|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153936790|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936791|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936792|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
153936793|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936794|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936795|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153936796|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153936797|NCT02748304|Aspirin|aspirin|mesh-list
153936798|NCT02748304|Sorafenib|sorafenib|mesh-list
153936799|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153936800|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153936801|NCT02748304|Analgesics|analgesics|mesh-ancestor
153936802|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
153936803|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936804|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365906|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
153936805|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936806|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936807|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153936808|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153936841|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153936842|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153936844|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
153936845|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936846|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936847|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936848|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936849|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153936850|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153936851|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694428|NCT00075543|Docetaxel|docetaxel|mesh-list
153694468|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153936874|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936876|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
153936877|NCT00857389|Busulfan|busulfan|mesh-list
153936878|NCT00857389|Thiotepa|thiotepa|mesh-list
153936879|NCT00857389|Methotrexate|methotrexate|mesh-list
153936880|NCT00857389|Clofarabine|clofarabine|mesh-list
153936881|NCT00857389|Tacrolimus|tacrolimus|mesh-list
153936882|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
153936883|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153936884|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153936885|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
153936886|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936887|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936888|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153936889|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
153936890|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936891|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936892|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153936893|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153936894|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
153936895|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153936896|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153936897|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
153936898|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
153936899|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936900|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153936901|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153936902|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153936903|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
153936904|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153936905|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371981|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
153694510|NCT00229216|Tinidazole|tinidazole|mesh-list
153936924|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153936925|NCT02874768|Analgesics|analgesics|mesh-ancestor
153936926|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
153936927|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936928|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153936929|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153936930|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153936931|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
153936932|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936933|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936934|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153936935|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
153936937|NCT00857233|Memantine|memantine|mesh-list
153936938|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153936939|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153936940|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
153936941|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936942|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936943|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936944|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153936945|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153936946|NCT02740426|Pirarubicin|pirarubicin|mesh-list
153936947|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936948|NCT02743546|Ibrutinib|ibrutinib|mesh-list
153936949|NCT02743546|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153936950|NCT02743546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936951|NCT02743546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936952|NCT02743546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936953|NCT02743234|Vancomycin|vancomycin|mesh-list
153936954|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
153936955|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153936956|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936957|NCT02740270|Spartalizumab|spartalizumab|mesh-list
153936958|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153936959|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936960|NCT02740270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936977|NCT00856609|Hormones|hormones|mesh-ancestor
153936978|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936979|NCT02739958|Propofol|propofol|mesh-list
153936980|NCT02739958|Isoflurane|isoflurane|mesh-list
153936981|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153936982|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936983|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936984|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153936985|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
153936986|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
153936987|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153936988|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
153936989|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153936990|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
153936991|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936992|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
153936993|NCT02739880|Protective Agents|protective agents|mesh-ancestor
153936994|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
153936995|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153366292|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
153366293|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153366294|NCT02777372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153366295|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153366296|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366297|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826354|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153826356|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826373|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
153936996|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153936997|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153694579|NCT00229567|Analgesics|analgesics|mesh-ancestor
153936998|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936999|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937000|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
153937001|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937002|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937003|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153937004|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937005|NCT00856375|Irinotecan|irinotecan|mesh-list
153937006|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
153937007|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153937008|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153937009|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937010|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937011|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937012|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153937013|NCT01070784|Budesonide|budesonide|mesh-list
153937014|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
153937015|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153937016|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937017|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153937018|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
153937019|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937031|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937033|NCT00837577|Voglibose|voglibose|mesh-list
153937034|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153937035|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937036|NCT00837577|Incretins|incretins|mesh-ancestor
153937037|NCT00837577|Hormones|hormones|mesh-ancestor
153937038|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937039|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153937040|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
153937041|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937042|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937043|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153937044|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153937045|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
153937046|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937047|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153937048|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
153937049|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153937050|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
153937051|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153937052|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937053|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153937054|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153937055|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937056|NCT00848107|Treprostinil|treprostinil|mesh-list
153937057|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153937058|NCT04030741|Metronidazole|metronidazole|mesh-list
153937059|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937060|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153937061|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153937062|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153937063|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153372011|NCT02322788|Terbutaline|terbutaline|mesh-list
153372012|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153372013|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
153372014|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937064|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153937065|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937066|NCT00856297|Vaccines|vaccines|mesh-list
153937067|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
153937068|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937069|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
153937070|NCT02736604|Anesthetics|anesthetics|mesh-list
153937071|NCT02736604|Sevoflurane|sevoflurane|mesh-list
153937072|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937073|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694643|NCT00229996|Leuprolide|leuprolide|mesh-list
153937074|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153937075|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153937076|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
153937077|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153937078|NCT02736604|Analgesics|analgesics|mesh-ancestor
153937079|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
153937080|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937081|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
153937103|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
153937104|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
153937105|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937106|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153937107|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153937108|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937109|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937110|NCT02736448|Capecitabine|capecitabine|mesh-list
153831948|NCT02174666|Formononetin|formononetin|mesh-list
153831949|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
153831950|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831951|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153831952|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153937111|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937112|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
153937113|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937114|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937115|NCT00703651|Vaccines|vaccines|mesh-list
153937116|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
153831953|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153831957|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831958|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831959|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
153937117|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937118|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
153937119|NCT01046136|Guaifenesin|guaifenesin|mesh-list
153937120|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153937121|NCT01046136|Expectorants|expectorants|mesh-ancestor
153937122|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
153937123|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153937124|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153937125|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
153937126|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937127|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937128|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937129|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
153937130|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153937131|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
153937132|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
153937134|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
153937135|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153937136|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153937162|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
153937163|NCT02738632|Diuretics|diuretics|mesh-ancestor
153937164|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
153937165|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153937166|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153937167|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153937168|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153937169|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153937170|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937171|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153937172|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153937173|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153937174|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937175|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
153937176|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937177|NCT00703807|Everolimus|everolimus|mesh-list
153937178|NCT00703807|Topotecan|topotecan|mesh-list
153937179|NCT00703807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153937180|NCT00703807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937181|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191186|NCT05941585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153366417|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
153366506|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153366507|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366508|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826525|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
153826526|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826527|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153826528|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
153826529|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153826530|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826531|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
153826532|NCT01324141|Protective Agents|protective agents|mesh-ancestor
153826533|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153937182|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937183|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937184|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
153937185|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937186|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937187|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153937188|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153937189|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153937190|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937191|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937192|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937193|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153937194|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
153937195|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153937196|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153937197|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937198|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
153937199|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937200|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937215|NCT01070316|Everolimus|everolimus|mesh-list
153937216|NCT01070316|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153937217|NCT01070316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937218|NCT01070316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937219|NCT01070316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937220|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937221|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
153937222|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937223|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937251|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937253|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937254|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937255|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937256|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937257|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153937258|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937259|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
153937260|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153937261|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153826547|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153826548|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153826549|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
153826550|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
153826551|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826552|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826553|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826554|NCT00471653|Temozolomide|temozolomide|mesh-list
153826555|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153826556|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
153826557|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366546|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366547|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
153366548|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937262|NCT05626348|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153937263|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937264|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
153937265|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153937266|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153937267|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937268|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
153937269|NCT02737696|Narcotics|narcotics|mesh-ancestor
153937270|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694858|NCT02967380|Antidotes|antidotes|mesh-ancestor
153937278|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
153937279|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937280|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937281|NCT02737228|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153937282|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937283|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937284|NCT01126541|Rituximab|rituximab|mesh-list
153937285|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153937286|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937287|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
153937288|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937289|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153937290|NCT02737150|Anesthetics|anesthetics|mesh-list
153937291|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937292|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937293|NCT02735356|Itraconazole|itraconazole|mesh-list
153937294|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
153937295|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694867|NCT00075855|Hormones|hormones|mesh-ancestor
153937296|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153937297|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153937298|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937299|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937300|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153937301|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
153937302|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937303|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937304|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153937306|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153937307|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153826562|NCT00494598|Sufentanil|sufentanil|mesh-list
153826563|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153826564|NCT00494598|Narcotics|narcotics|mesh-ancestor
153826565|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153826566|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826567|NCT00494598|Analgesics|analgesics|mesh-ancestor
153826568|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
153826592|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826593|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153826594|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
153826595|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
153937308|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937309|NCT00637481|Atorvastatin|atorvastatin|mesh-list
153937310|NCT00637481|Calcium|calcium|mesh-list
153937311|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153937312|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937313|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153937314|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153937315|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
153937316|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937317|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153937318|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153937319|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937320|NCT00637559|Esomeprazole|esomeprazole|mesh-list
153937321|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153937322|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153937323|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153937324|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937325|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937326|NCT00836875|Voriconazole|voriconazole|mesh-list
153937327|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
153937328|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937329|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153937330|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153937331|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937332|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937333|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153937334|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
153694905|NCT00231595|Topiramate|topiramate|mesh-list
153937348|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153937349|NCT02732236|Rituximab|rituximab|mesh-list
153937350|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153937351|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937352|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
153937353|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937354|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153937355|NCT01121549|Exemestane|exemestane|mesh-list
153937356|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937357|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153937358|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153937359|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937360|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937361|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153937362|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
153937363|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937364|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937365|NCT00847405|Sumatriptan|sumatriptan|mesh-list
153937366|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153937367|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153937368|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153937370|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937371|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937372|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937373|NCT02731846|Fluticasone|fluticasone|mesh-list
153937374|NCT02731846|Xhance|xhance|mesh-list
153937375|NCT02731846|Albuterol|albuterol|mesh-list
153937376|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937377|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153937378|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
153937379|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937380|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937381|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153937382|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
153937383|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937384|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153937385|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
153937386|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153937387|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153937388|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153937389|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153937390|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
153937391|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937392|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937393|NCT04248712|Loratadine|loratadine|mesh-list
153937394|NCT04248712|Famotidine|famotidine|mesh-list
153937395|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153937396|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153937419|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153937420|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153937421|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
153937422|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153937423|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153937424|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153937425|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153937426|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153937428|NCT02731378|Dextrans|dextrans|mesh-list
153937429|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
153937430|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
153937431|NCT02731378|Trace Elements|trace elements|mesh-ancestor
153937432|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
153937433|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937434|NCT02731378|Hematinics|hematinics|mesh-ancestor
153937435|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
153937436|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
153937437|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
153937438|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153937439|NCT02731534|Hematinics|hematinics|mesh-ancestor
153937440|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
153937441|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
153695022|NCT00063869|Etanercept|etanercept|mesh-list
153937442|NCT02734420|Coagulants|coagulants|mesh-ancestor
153937443|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
153937444|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937446|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153937447|NCT00704275|Cyclosporins|cyclosporins|mesh-list
153937448|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937449|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937471|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937472|NCT00627354|Prednisone|prednisone|mesh-list
153937473|NCT00627354|Etoposide|etoposide|mesh-list
153937474|NCT00627354|Vinorelbine|vinorelbine|mesh-list
153937475|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
153937476|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937477|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
153937478|NCT00627354|Hormones|hormones|mesh-ancestor
153937479|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937480|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937481|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153937482|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937483|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153937484|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153937485|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153937486|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937487|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937488|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
153937489|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
153937490|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
153937491|NCT00627354|Analgesics|analgesics|mesh-ancestor
153937492|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
153937493|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937494|NCT00704431|Darapladib|darapladib|mesh-list
153937495|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153937496|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937497|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937498|NCT02734186|Praziquantel|praziquantel|mesh-list
153937499|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
153937500|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153937501|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937502|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153937503|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
153937531|NCT00855595|Metronidazole|metronidazole|mesh-list
153937532|NCT00855595|Doxycycline|doxycycline|mesh-list
153937533|NCT00855595|Azelaic acid|azelaic acid|mesh-list
153937534|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937535|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153937536|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153937537|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153937538|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
153937539|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937540|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937541|NCT05433532|Azacitidine|azacitidine|mesh-list
153937542|NCT05433532|Venetoclax|venetoclax|mesh-list
153937543|NCT05433532|Flumatinib|flumatinib|mesh-list
153937544|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937545|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
153937546|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937547|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937548|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937549|NCT05433532|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153937550|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937551|NCT00855439|Exenatide|exenatide|mesh-list
153937552|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153937585|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
153937586|NCT02733874|Hormones|hormones|mesh-ancestor
153937587|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937588|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937589|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153937590|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
153937591|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937592|NCT02730364|Acetaminophen|acetaminophen|mesh-list
153937593|NCT02730364|Pheniramine|pheniramine|mesh-list
153937629|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153937630|NCT00704665|Methocarbamol|methocarbamol|mesh-list
153937631|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153937632|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937633|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153937634|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937635|NCT00913315|Tamsulosin|tamsulosin|mesh-list
153937636|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153937699|NCT04724928|Immunomodulating Agents|immunomodulating agents|mesh-list
153937700|NCT04724928|Immunologic Factors|immunologic factors|mesh-ancestor
153937701|NCT04724928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937702|NCT02728492|Paclitaxel|paclitaxel|mesh-list
153937703|NCT02728492|Carboplatin|carboplatin|mesh-list
153937704|NCT02728492|Gemcitabine|gemcitabine|mesh-list
153937705|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153937706|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937707|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
153937708|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
153937709|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
153937710|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937711|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937712|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
153937713|NCT02726308|Dexamethasone|dexamethasone|mesh-list
153937714|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937715|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
153937716|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
153937717|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937718|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937752|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153937754|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937755|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
153937756|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937780|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937781|NCT00854581|Interferons|interferons|mesh-list
153937782|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
153937783|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
153937785|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153937786|NCT00854581|Valproic Acid|valproic acid|mesh-list
153937787|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937788|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
153937789|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937790|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
153937791|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937792|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
153937793|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937794|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153937795|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153937796|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937797|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153937798|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153937799|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
153937800|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
153937801|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937802|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
153937803|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153937804|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937805|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153937806|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153937807|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937808|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937809|NCT00833911|Tramadol|tramadol|mesh-list
153937836|NCT02719834|Acetaminophen|acetaminophen|mesh-list
153937837|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153937838|NCT02719834|Analgesics|analgesics|mesh-ancestor
153937839|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
153937840|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937841|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937842|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
153937843|NCT02719210|Mannitol|mannitol|mesh-list
153937844|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153937845|NCT02719210|Diuretics|diuretics|mesh-ancestor
153937846|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
153937847|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937848|NCT02719132|Metformin|metformin|mesh-list
153937849|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
153937850|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153937851|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937852|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153937853|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937854|NCT02718976|Lidocaine|lidocaine|mesh-list
153937855|NCT02718976|Epinephrine|epinephrine|mesh-list
153937856|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153937857|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
153937858|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
153937890|NCT02717884|Cytarabine|cytarabine|mesh-list
153937891|NCT02717884|Tretinoin|tretinoin|mesh-list
153407018|NCT02969681|Vitamins|vitamins|mesh-ancestor
153937892|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
153937893|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937894|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
153937895|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937896|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937897|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
153937898|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937899|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937900|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
153937932|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937934|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
153937935|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372158|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153937936|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937937|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
153937938|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832109|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
153832110|NCT05146713|Propolis|propolis|mesh-list
153832111|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153826881|NCT01244334|Prednisolone|prednisolone|mesh-list
153366932|NCT02485158|Amphetamine|amphetamine|mesh-list
153366933|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
153366934|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153366935|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366936|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
153366937|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
153366938|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937939|NCT02882477|Expectorants|expectorants|mesh-ancestor
153937940|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
153937941|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153937942|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
153937943|NCT02882477|Protective Agents|protective agents|mesh-ancestor
153937944|NCT02882477|Antidotes|antidotes|mesh-ancestor
153937945|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153937982|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937983|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937984|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
153937997|NCT00765310|Protective Agents|protective agents|mesh-ancestor
153937998|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937999|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
153938000|NCT00765310|Vitamins|vitamins|mesh-ancestor
153938001|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
153938002|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
153938003|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153938004|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938005|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938006|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153938007|NCT02715154|Analgesics|analgesics|mesh-ancestor
153938008|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
153938009|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938010|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153938011|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153938012|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153938013|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
153938014|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938015|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938016|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153938017|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
153938018|NCT02715232|Lynestrenol|lynestrenol|mesh-list
153938019|NCT02715232|Estradiol|estradiol|mesh-list
153938020|NCT02715232|Testosterone|testosterone|mesh-list
153938021|NCT02715232|Cyproterone|cyproterone|mesh-list
153938022|NCT02715232|Estrogens|estrogens|mesh-ancestor
153938023|NCT02715232|Hormones|hormones|mesh-ancestor
153938024|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938025|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938026|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153938027|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
153938028|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153938029|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153938030|NCT02715232|Androgens|androgens|mesh-ancestor
153938031|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153938032|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938033|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
153938034|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
153938035|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
153938036|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153938037|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153938038|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153938039|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153938040|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153938041|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
153938042|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938044|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153938045|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153938046|NCT02714842|Analgesics|analgesics|mesh-ancestor
153938047|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
153938048|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695629|NCT00097734|Ertapenem|ertapenem|mesh-list
153938058|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938059|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938060|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938061|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
153938062|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153938063|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938064|NCT04000906|Paclitaxel|paclitaxel|mesh-list
153938065|NCT04000906|Cisplatin|cisplatin|mesh-list
153938066|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153938067|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938068|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
153938069|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
153938070|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
153938071|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938072|NCT00636766|Metformin|metformin|mesh-list
153938073|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
153938074|NCT00636766|Rimonabant|rimonabant|mesh-list
153938075|NCT00636766|Atorvastatin|atorvastatin|mesh-list
153938076|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153938077|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938078|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153938079|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153938080|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
153938081|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938082|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153938083|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153938084|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938085|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153938086|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153938087|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153938088|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938089|NCT00636766|Hormones|hormones|mesh-ancestor
153938090|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938091|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153938092|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153938093|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153938094|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938095|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938096|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153938097|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153938098|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153938099|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
153372202|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
153827048|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827049|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938100|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938101|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938102|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153938103|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153938104|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
153938105|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153938106|NCT00611416|Caffeine|caffeine|mesh-list
153938107|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153938108|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938109|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153938110|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938111|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938130|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
153938131|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153938132|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153938133|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153938134|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153938135|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
153938136|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938137|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938138|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
153938139|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153938140|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938141|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153938142|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
153938143|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938144|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938145|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938146|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938147|NCT02712502|Amoxicillin|amoxicillin|mesh-list
153938148|NCT02712502|Levofloxacin|levofloxacin|mesh-list
153938149|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
153938150|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
153938151|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153938152|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938153|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938154|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153938155|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153938156|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153938157|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938158|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938159|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938160|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153938161|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153938162|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153938163|NCT02712346|Ambrisentan|ambrisentan|mesh-list
153938164|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153938165|NCT02711410|Clopidogrel|clopidogrel|mesh-list
153695752|NCT00236548|Risperidone|risperidone|mesh-list
153938197|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938198|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153938199|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153938200|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938201|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153938202|NCT02710552|Amlodipine|amlodipine|mesh-list
153938203|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
153938204|NCT02710552|Perindopril|perindopril|mesh-list
153938206|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153938207|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153695807|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
153938237|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938238|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938240|NCT00611728|Sunitinib|sunitinib|mesh-list
153938241|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153938242|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153938243|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938244|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938245|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938246|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153938247|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153938248|NCT00611728|Growth Substances|growth substances|mesh-ancestor
153938249|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938250|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
153695849|NCT00065117|Vitamins|vitamins|mesh-ancestor
153938264|NCT04189666|Melatonin|melatonin|mesh-list
153938265|NCT04189666|Rivastigmine|rivastigmine|mesh-list
153938267|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938268|NCT04189666|Protective Agents|protective agents|mesh-ancestor
153938269|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938270|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938271|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153938272|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938273|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
153938274|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938275|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153938276|NCT00937521|Antipyretics|antipyretics|mesh-list
153938277|NCT00937521|Vaccines|vaccines|mesh-list
153938278|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
153372228|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938279|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938280|NCT02709382|Tazobactam|tazobactam|mesh-list
153938281|NCT02709382|Cefepime|cefepime|mesh-list
153938282|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938283|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938284|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153938285|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938286|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938287|NCT02708992|Azithromycin|azithromycin|mesh-list
153938288|NCT02708992|Cefixime|cefixime|mesh-list
153938289|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938290|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938291|NCT02708992|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153938292|NCT02708992|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153938293|NCT00611962|Paclitaxel|paclitaxel|mesh-list
153938294|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
153938295|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153938296|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938297|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
153938298|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
153938299|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
153938300|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938301|NCT00606099|Adefovir|adefovir|mesh-list
153938302|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153938303|NCT00606099|Telbivudine|telbivudine|mesh-list
153938304|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
153938305|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938306|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153938307|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153938308|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938309|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938310|NCT00935883|Eculizumab|eculizumab|mesh-list
153938311|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153695892|NCT00237250|Vildagliptin|vildagliptin|mesh-list
153938347|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938349|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
153938350|NCT05378919|Vitamins|vitamins|mesh-ancestor
153938351|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
153938387|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
153938388|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153938389|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153938390|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
153938391|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
153938392|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938393|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410060|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153938459|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938460|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938462|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
153938463|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938464|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
153938465|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
153938466|NCT00606411|Topiramate|topiramate|mesh-list
153938467|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
153938468|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153938469|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938470|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
153938471|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153938472|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938473|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
153938474|NCT01120691|Albuterol|albuterol|mesh-list
153938475|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
153938476|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153938477|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
153938478|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938504|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938505|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938507|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938509|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938510|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
153938511|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153938512|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153938513|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153938514|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938515|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938516|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153938517|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
153938518|NCT05263882|Gemcitabine|gemcitabine|mesh-list
153938519|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153938520|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
153938521|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938522|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938523|NCT02724904|Methotrexate|methotrexate|mesh-list
153938524|NCT02724904|Fludarabine|fludarabine|mesh-list
153938525|NCT02724904|Thiotepa|thiotepa|mesh-list
153938526|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153938527|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
153938528|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153696115|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
153938555|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938556|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938557|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153938558|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938559|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938560|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153938561|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153938562|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
153938563|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153938564|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153938565|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
153938566|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938567|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938568|NCT00935259|Simvastatin|simvastatin|mesh-list
153938569|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153938570|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153938571|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
153938572|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938573|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153938607|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938609|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938610|NCT00605397|Trastuzumab|trastuzumab|mesh-list
153938611|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153938612|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938613|NCT00625547|Levodopa|levodopa|mesh-list
153938644|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153938645|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
153938646|NCT01124045|Hormones|hormones|mesh-ancestor
153372275|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153938647|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938648|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938649|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153938650|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938651|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
153938652|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
153938653|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938654|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153938655|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153938666|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153938667|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153938668|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153938669|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938670|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153938672|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
153938673|NCT00606957|Vitamins|vitamins|mesh-ancestor
153938674|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
153938675|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938676|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153938677|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153938678|NCT00934947|Propranolol|propranolol|mesh-list
153938679|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153938680|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153938681|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
153938682|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938683|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938684|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938685|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153938686|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153938687|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
153938688|NCT02723578|Pemetrexed|pemetrexed|mesh-list
153938689|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153938690|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938691|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938692|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938693|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153938694|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153938695|NCT02723578|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153938696|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938697|NCT04189198|Bupivacaine|bupivacaine|mesh-list
153938698|NCT04189198|Carticaine|carticaine|mesh-list
153938699|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
153938700|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
153938701|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938702|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938703|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
153938704|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938705|NCT00608361|Dasatinib|dasatinib|mesh-list
153938706|NCT00608361|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153938707|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938708|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938709|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938710|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938711|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
153696304|NCT00098397|Romidepsin|romidepsin|mesh-list
153938713|NCT00934791|Prednisone|prednisone|mesh-list
153938714|NCT00934791|Tacrolimus|tacrolimus|mesh-list
153938715|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153938716|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
153938717|NCT00934791|Hormones|hormones|mesh-ancestor
153938718|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938719|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938720|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153696295|NCT00414349|Analgesics|analgesics|mesh-list
153938728|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153938729|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
153938730|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938731|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938732|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
153938733|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153938735|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153938736|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153938737|NCT00607035|Diuretics|diuretics|mesh-ancestor
153938738|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
153938739|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938740|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153938741|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153938742|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938743|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153938744|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153938745|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
153938746|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
153938747|NCT02723266|Protective Agents|protective agents|mesh-ancestor
153938748|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938749|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
153938750|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153938751|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938752|NCT02722954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153938753|NCT02722954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938754|NCT00625859|Bupropion|bupropion|mesh-list
153938755|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153938756|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
153938757|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153372300|NCT01324700|Escitalopram|escitalopram|mesh-list
153372301|NCT01324700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153372302|NCT01324700|Serotonin|serotonin|mesh-list
153367850|NCT01083368|Growth Substances|growth substances|mesh-ancestor
153938758|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153938759|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153938760|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153938761|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938762|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
153938763|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938764|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938765|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153938766|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153938767|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938768|NCT02691195|Ropivacaine|ropivacaine|mesh-list
153938769|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
153938770|NCT02691195|Anesthetics|anesthetics|mesh-list
153938771|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938772|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938773|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
153938774|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938775|NCT03808090|Calcium|calcium|mesh-list
153938776|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153938777|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938778|NCT01111019|Hormones|hormones|mesh-list
153938779|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938780|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938781|NCT02883400|Spironolactone|spironolactone|mesh-list
153938782|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153938783|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
153696356|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153938794|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
153938795|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938796|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938797|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153938798|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
153938800|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938801|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367862|NCT02387580|Artefenomel|artefenomel|mesh-list
153938802|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938803|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153938804|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153938805|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153832237|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153832238|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153832239|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832240|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827882|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827883|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153827884|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153367878|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153367879|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827901|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153827902|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
153827903|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827904|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827905|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153827906|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827907|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
153938806|NCT01119287|Analgesics|analgesics|mesh-ancestor
153938807|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
153938808|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153938809|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153938810|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153938811|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153938812|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
153938813|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
153938814|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938815|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938816|NCT01110707|Hormones|hormones|mesh-list
153938817|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153938818|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938819|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938820|NCT01119131|Vitamin D|vitamin d|mesh-list
153938821|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
153938822|NCT01119131|Calcium|calcium|mesh-list
153938823|NCT01119131|Vitamins|vitamins|mesh-ancestor
153938824|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
153938825|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938826|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153938827|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153938828|NCT00636922|Everolimus|everolimus|mesh-list
153938829|NCT00636922|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153938830|NCT00636922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938831|NCT00636922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938832|NCT00636922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938833|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938834|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
153938835|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938836|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938837|NCT02722096|Lidocaine|lidocaine|mesh-list
153938838|NCT02722096|Ropivacaine|ropivacaine|mesh-list
153938839|NCT02722096|Anesthetics|anesthetics|mesh-list
153938840|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
153938841|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938842|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938843|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
153938844|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938845|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153938846|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153938847|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153696422|NCT00239746|Ibuprofen|ibuprofen|mesh-list
153938864|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938865|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938866|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153938868|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153938869|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938870|NCT04829422|Lazertinib|lazertinib|mesh-list
153938871|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938872|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938873|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938874|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153938875|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153938876|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153938877|NCT00612898|Lamivudine|lamivudine|mesh-list
153938878|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153938879|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153938880|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938881|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938882|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
153938883|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938884|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153938885|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153938886|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
153938887|NCT01118663|Edetic Acid|edetic acid|mesh-list
153938888|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153938889|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
153938890|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
153938891|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938892|NCT01118663|Expectorants|expectorants|mesh-ancestor
153938893|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
153938894|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153938895|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
153938896|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938897|NCT01118663|Protective Agents|protective agents|mesh-ancestor
153938898|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938899|NCT01118663|Antidotes|antidotes|mesh-ancestor
153938900|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
153938901|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153938902|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
153938903|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
153938904|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153938905|NCT01118351|Sunitinib|sunitinib|mesh-list
153938939|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
153938940|NCT00613132|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153938941|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938942|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938943|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938944|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938945|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
153938946|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938958|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938959|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938960|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153938961|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153938962|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153938963|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153938964|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153938965|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153938966|NCT04120870|Ketamine|ketamine|mesh-list
153938967|NCT04120870|Etomidate|etomidate|mesh-list
153938968|NCT04120870|Analgesics|analgesics|mesh-ancestor
153938969|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
153938970|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938971|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938972|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153938973|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153938974|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
153938975|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
153938976|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938977|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153938978|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153938979|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938980|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938981|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153938982|NCT03747562|Gabapentin|gabapentin|mesh-list
153938983|NCT03747562|Analgesics|analgesics|mesh-ancestor
153938984|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
153938985|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938986|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938987|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
153938988|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153938989|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153938990|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938991|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153407210|NCT01566240|Paclitaxel|paclitaxel|mesh-list
153938992|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153938993|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153938994|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938995|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938996|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
153938997|NCT01109849|Methylphenidate|methylphenidate|mesh-list
153938998|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
153938999|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939000|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153939001|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939002|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939003|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939004|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
153939005|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939006|NCT01061736|Folic Acid|folic acid|mesh-list
153939007|NCT01061736|Methotrexate|methotrexate|mesh-list
153939008|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153939009|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
153939035|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153939036|NCT02874378|Analgesics|analgesics|mesh-ancestor
153939037|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
153939038|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939039|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153939040|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153939041|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153939042|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
153939043|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939044|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939045|NCT01117181|Methylphenidate|methylphenidate|mesh-list
153939046|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153939047|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939048|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153898573|NCT00607711|Ifosfamide|ifosfamide|mesh-list
153939049|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939050|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832280|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832281|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939051|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939052|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
153939053|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939054|NCT02881619|Etodolac|etodolac|mesh-list
153939055|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153939056|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153939057|NCT02881619|Analgesics|analgesics|mesh-ancestor
153939058|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
153939076|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153939077|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
153939078|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153939079|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939080|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153939082|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939083|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939084|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
153939085|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939086|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153939087|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939088|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
153939089|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939090|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153939091|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
153939093|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939094|NCT04303884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153939095|NCT04303884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939096|NCT01040130|Olodaterol|olodaterol|mesh-list
153939097|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153939098|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
153939099|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939100|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939101|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153939102|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
153939103|NCT00932451|Crizotinib|crizotinib|mesh-list
153939104|NCT00932451|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153939105|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153939106|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939107|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939108|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939109|NCT05297682|Propofol|propofol|mesh-list
153939110|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
153939111|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939112|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939113|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153939114|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153939143|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153939144|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153939145|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939146|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153939147|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153939148|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939149|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153939150|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939151|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
153939152|NCT01059864|Atorvastatin|atorvastatin|mesh-list
153939153|NCT01059864|Tofacitinib|tofacitinib|mesh-list
153939154|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153832296|NCT00500864|Analgesics|analgesics|mesh-ancestor
153832297|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
153832298|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832299|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832300|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
153832301|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898662|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898663|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898668|NCT04321070|Clindamycin|clindamycin|mesh-list
153939155|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153939156|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
153939157|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696756|NCT00098982|Vitamins|vitamins|mesh-ancestor
153939177|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153939178|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939179|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153939180|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939181|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939182|NCT03398824|Metformin|metformin|mesh-list
153939183|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153939184|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939185|NCT01033734|Oseltamivir|oseltamivir|mesh-list
153939186|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
153939187|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939188|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939189|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939190|NCT03792256|Cytarabine|cytarabine|mesh-list
153939191|NCT03792256|Prednisone|prednisone|mesh-list
153939192|NCT03792256|Prednisolone|prednisolone|mesh-list
153939193|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
153939194|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153939195|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153939196|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153939197|NCT03792256|Doxorubicin|doxorubicin|mesh-list
153939198|NCT03792256|Methotrexate|methotrexate|mesh-list
153939199|NCT03792256|Vincristine|vincristine|mesh-list
153939200|NCT03792256|Palbociclib|palbociclib|mesh-list
153939201|NCT03792256|Pegaspargase|pegaspargase|mesh-list
153939202|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153939203|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939204|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153939205|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153939206|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898702|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898703|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898704|NCT04262635|Capecitabine|capecitabine|mesh-list
153898705|NCT04262635|Cetuximab|cetuximab|mesh-list
153898706|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153898707|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
153898708|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898709|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440008|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
153440009|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153440010|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440011|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153440012|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153440013|NCT00003091|Interferons|interferons|mesh-list
153939207|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939208|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939217|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153939219|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
153939220|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153939221|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939222|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
153939223|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939224|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153939225|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
153939226|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939227|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153939228|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
153939229|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
153939230|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
153939231|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153939232|NCT00613288|Testosterone|testosterone|mesh-list
153939233|NCT00613288|Androgens|androgens|mesh-ancestor
153939234|NCT00613288|Hormones|hormones|mesh-ancestor
154260761|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153939235|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939236|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939238|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153939239|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
153939240|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939241|NCT03711838|Expectorants|expectorants|mesh-ancestor
153939242|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
153939243|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153939244|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
153939245|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939246|NCT03711838|Protective Agents|protective agents|mesh-ancestor
153939247|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939248|NCT03711838|Antidotes|antidotes|mesh-ancestor
153939249|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
153939250|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
153939251|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153939252|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153939253|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939254|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939255|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939256|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939257|NCT01115855|Eplerenone|eplerenone|mesh-list
153939258|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153939259|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
153939260|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939261|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939262|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153939263|NCT01115855|Diuretics|diuretics|mesh-ancestor
153939264|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
153939265|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153939266|NCT03615508|Phenylephrine|phenylephrine|mesh-list
153939267|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
153372389|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372390|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
153832319|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832320|NCT01247909|Gentamicins|gentamicins|mesh-list
153832321|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
153832322|NCT01247909|Penicillins|penicillins|mesh-list
153832323|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153939268|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153939269|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
153939270|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
153939271|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939272|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939273|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
153696851|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939280|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
153939281|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939282|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939283|NCT03615508|Protective Agents|protective agents|mesh-ancestor
153939284|NCT02880995|Amisulpride|amisulpride|mesh-list
153939285|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153939286|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153939287|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939288|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939289|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153939290|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153939291|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
153939292|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939293|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939294|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153939295|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
153939296|NCT03522064|Carboplatin|carboplatin|mesh-list
153939297|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
153939298|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153696894|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
153939300|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
153939301|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
153939302|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153939303|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939304|NCT03522064|Androgens|androgens|mesh-ancestor
153939305|NCT03522064|Hormones|hormones|mesh-ancestor
153898732|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440093|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440094|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153440095|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440096|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153939306|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939307|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939308|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153939309|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
153939310|NCT04310579|Midazolam|midazolam|mesh-list
153939311|NCT04310579|Oxycodone|oxycodone|mesh-list
153939312|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154260762|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153939314|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153939315|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153939316|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939317|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939318|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153939319|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153939320|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153939321|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153939322|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
153939323|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
153939324|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
153939325|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
153939326|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939327|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939328|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153939329|NCT04310579|Narcotics|narcotics|mesh-ancestor
153939330|NCT04310579|Analgesics|analgesics|mesh-ancestor
153939331|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
153939332|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939333|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
153939334|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153939335|NCT04310579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153939336|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939337|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939338|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
153939339|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153939340|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153939341|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153696912|NCT00066794|Cyclosporins|cyclosporins|mesh-list
153939354|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
153939355|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939356|NCT03638128|Denosumab|denosumab|mesh-list
153939357|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153939358|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939359|NCT05345236|Aflibercept|aflibercept|mesh-list
153939360|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153939361|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153939362|NCT05345236|Growth Substances|growth substances|mesh-ancestor
153939363|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939364|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
153939365|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939366|NCT02692534|Cocaine|cocaine|mesh-list
153939367|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
153939368|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
153939369|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939370|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939371|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
153939372|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939373|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153939374|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153939375|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939376|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939377|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939378|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
153939379|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939380|NCT00614536|Rabeprazole|rabeprazole|mesh-list
153939381|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153939382|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153939383|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153939384|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939385|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939386|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
153939387|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
153939389|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153939390|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939391|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939392|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939393|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939394|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153939395|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
153939396|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153939397|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
153939398|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939399|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939400|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153939401|NCT04142086|Vaccines|vaccines|mesh-list
153939402|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
153939403|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939404|NCT03664882|Fexofenadine|fexofenadine|mesh-list
153939405|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153696980|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
153939426|NCT03800836|Atezolizumab|atezolizumab|mesh-list
153939427|NCT03800836|Ipatasertib|ipatasertib|mesh-list
153939428|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153939429|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939430|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
153939431|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
153939432|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
153939433|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939434|NCT03800836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153939435|NCT03800836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153939436|NCT03800836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153939437|NCT03800836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939438|NCT00932373|Trastuzumab|trastuzumab|mesh-list
153939439|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153939440|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153939441|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939442|NCT00932373|Immunotoxins|immunotoxins|mesh-ancestor
153939443|NCT00932373|Immunoconjugates|immunoconjugates|mesh-ancestor
153939444|NCT00932373|Immunologic Factors|immunologic factors|mesh-ancestor
153939445|NCT00932373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939446|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
153939447|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
153697048|NCT00244153|Narcotics|narcotics|mesh-ancestor
153939448|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
153939449|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939450|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
153939451|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153939452|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
153939453|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939454|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
153939455|NCT04265001|Protective Agents|protective agents|mesh-ancestor
153939456|NCT00608595|Celecoxib|celecoxib|mesh-list
153939457|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153939458|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153939459|NCT00608595|Analgesics|analgesics|mesh-ancestor
153939470|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153939472|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939473|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153939474|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939475|NCT01055496|Dexamethasone|dexamethasone|mesh-list
153939476|NCT01055496|Prednisone|prednisone|mesh-list
153939477|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
153939478|NCT01055496|Rituximab|rituximab|mesh-list
153939479|NCT01055496|Gemcitabine|gemcitabine|mesh-list
153939480|NCT01055496|Vincristine|vincristine|mesh-list
153939481|NCT01055496|Cisplatin|cisplatin|mesh-list
153939482|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153939483|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939484|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
153939485|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939486|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939487|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153939488|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
153939489|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939490|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939491|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153939492|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939493|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
153939494|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
153939495|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939496|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153939497|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
153939498|NCT01055496|Hormones|hormones|mesh-ancestor
153939499|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939500|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153939501|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153939502|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153939503|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
153939504|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153939505|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
153939506|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
153939507|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
153939508|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153939509|NCT01055496|Immunotoxins|immunotoxins|mesh-ancestor
153939510|NCT01055496|Immunoconjugates|immunoconjugates|mesh-ancestor
153939511|NCT03436498|Insulin|insulin|mesh-list
153939512|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153939513|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
153939514|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
153939515|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153939516|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153939517|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939518|NCT00609531|Citalopram|citalopram|mesh-list
153939519|NCT00609531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153697098|NCT00244348|Fluorouracil|fluorouracil|mesh-list
153939530|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153939531|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939533|NCT01052844|Analgesics|analgesics|mesh-ancestor
153939534|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
153939535|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939536|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939537|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
153939538|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153939539|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153939540|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939541|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153939542|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153939543|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153939544|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939545|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939546|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
153939547|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
153939548|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153939549|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939551|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153939552|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939553|NCT00934089|Latanoprost|latanoprost|mesh-list
153939554|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153939555|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153939556|NCT01032174|Azithromycin|azithromycin|mesh-list
153939557|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153939558|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939559|NCT02704780|Misoprostol|misoprostol|mesh-list
153939560|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153939561|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
153939562|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153939563|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939564|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153939565|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153939566|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
153939567|NCT02704546|Methylphenidate|methylphenidate|mesh-list
153939568|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153939569|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939570|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153939571|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939572|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939573|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939574|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
153939575|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939576|NCT01032018|Bupropion|bupropion|mesh-list
153939577|NCT01032018|Citalopram|citalopram|mesh-list
153939578|NCT01032018|Sertraline|sertraline|mesh-list
153939579|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153939580|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
153939581|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153939593|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
153697193|NCT00244972|Sorafenib|sorafenib|mesh-list
153939595|NCT00927069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153939596|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939597|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260763|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154260764|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939598|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
153939599|NCT01031628|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153939600|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153939601|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939602|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939603|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939604|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
153939605|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939606|NCT00608673|Betamethasone|betamethasone|mesh-list
153939608|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153939609|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
153939610|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
153939611|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153939612|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939613|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
153939614|NCT00608673|Hormones|hormones|mesh-ancestor
153939615|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939616|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939617|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153939618|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
153939619|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153939620|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153939621|NCT00608673|Analgesics|analgesics|mesh-ancestor
153939622|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
153939623|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939624|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939625|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
153939626|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939627|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
153939628|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153939629|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939630|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939631|NCT04263519|Tacrolimus|tacrolimus|mesh-list
153939632|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939633|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
153899116|NCT03906136|Adalimumab|adalimumab|mesh-list
153939634|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939635|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153939636|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939637|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939638|NCT00637767|Melphalan|melphalan|mesh-list
153939639|NCT00637767|Antibodies|antibodies|mesh-list
153939640|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153939641|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
153697224|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
153939662|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939663|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939664|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939665|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153939666|NCT00627250|Analgesics|analgesics|mesh-ancestor
153939667|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
153939668|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939669|NCT04300374|Anesthetics|anesthetics|mesh-list
153939671|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939672|NCT02703376|Prednisone|prednisone|mesh-list
153939673|NCT02703376|Prednisolone|prednisolone|mesh-list
153939674|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939675|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
153939676|NCT02703376|Hormones|hormones|mesh-ancestor
153939677|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939678|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939679|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153939680|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939681|NCT00610077|Letrozole|letrozole|mesh-list
153939682|NCT00610077|Clomiphene|clomiphene|mesh-list
153939683|NCT00610077|Enclomiphene|enclomiphene|mesh-list
153939684|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
153939685|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939686|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939687|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153939688|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153939689|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939690|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153939691|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
153939692|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939693|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939694|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153939695|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
153939696|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153939709|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939710|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939711|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939712|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939714|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
153939715|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939716|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
153939717|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153939718|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
153939719|NCT03172780|Diclofenac|diclofenac|mesh-list
153939720|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153939721|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153939722|NCT03172780|Analgesics|analgesics|mesh-ancestor
153939723|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
153939724|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939725|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939726|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939727|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939728|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153939729|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939730|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939731|NCT05011617|Anesthetics|anesthetics|mesh-list
153939732|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939733|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939734|NCT00926367|Clindamycin|clindamycin|mesh-list
153939735|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
153939736|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
153939737|NCT00926367|Adapalene|adapalene|mesh-list
153939738|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153939739|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153939740|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939741|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153939742|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939743|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939744|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
153939745|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153939746|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153939747|NCT00926367|Analgesics|analgesics|mesh-ancestor
153939748|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
153939749|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939750|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939751|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939752|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939754|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153939755|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697338|NCT00245791|Levofloxacin|levofloxacin|mesh-list
153939764|NCT01114529|Tacrolimus|tacrolimus|mesh-list
153939765|NCT01114529|Cyclosporins|cyclosporins|mesh-list
153939766|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939767|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
153939768|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939769|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153939770|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939771|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939772|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
153939773|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939774|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
153939775|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939776|NCT01114529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153939777|NCT01114529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153939778|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939779|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153440557|NCT00003157|Gemcitabine|gemcitabine|mesh-list
153440558|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440559|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440560|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
153440561|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899205|NCT06268652|Tubulin Modulators|tubulin modulators|mesh-ancestor
153899206|NCT06268652|Antimitotic Agents|antimitotic agents|mesh-ancestor
153899207|NCT06268652|Mitosis Modulators|mitosis modulators|mesh-ancestor
153899208|NCT06268587|Analgesics|analgesics|mesh-list
153899227|NCT06268457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153899228|NCT06268457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939780|NCT00926289|Telmisartan|telmisartan|mesh-list
153939781|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154260765|NCT02939014|Immunotoxins|immunotoxins|mesh-ancestor
154260766|NCT02939014|Immunoconjugates|immunoconjugates|mesh-ancestor
154260767|NCT02939014|Immunologic Factors|immunologic factors|mesh-ancestor
153939782|NCT00926289|Diuretics|diuretics|mesh-ancestor
153939783|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
153939784|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939785|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153939786|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939787|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939788|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153939789|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153939790|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
153939791|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153939792|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
153939793|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
153939794|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153939796|NCT04309643|Estrogens|estrogens|mesh-ancestor
153939797|NCT04309643|Hormones|hormones|mesh-ancestor
153939798|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939799|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939800|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153939801|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153939802|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153939803|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153939804|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153939805|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153939806|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153939807|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153939808|NCT04259073|Pregabalin|pregabalin|mesh-list
153939809|NCT04259073|Analgesics|analgesics|mesh-ancestor
153939810|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
153939811|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939812|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939813|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
153939814|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153939815|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697418|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153939816|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939817|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153939818|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153939819|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153939820|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697411|NCT00067535|Cocaine|cocaine|mesh-list
153939837|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939838|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153440581|NCT00003733|Carboplatin|carboplatin|mesh-list
153440582|NCT00003733|Topotecan|topotecan|mesh-list
153440583|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440584|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899234|NCT06268431|Oxytocics|oxytocics|mesh-ancestor
153899235|NCT06268431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153899236|NCT06268431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899237|NCT06268327|Gemcitabine|gemcitabine|mesh-list
153899238|NCT06268327|Capecitabine|capecitabine|mesh-list
153899239|NCT06268327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939839|NCT00925899|Melatonin|melatonin|mesh-list
153939840|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
153939841|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939842|NCT00925899|Protective Agents|protective agents|mesh-ancestor
153939843|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939844|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939845|NCT02601586|Oxycodone|oxycodone|mesh-list
153939846|NCT02601586|Levodopa|levodopa|mesh-list
153939847|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153939848|NCT02601586|Narcotics|narcotics|mesh-ancestor
153939849|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939850|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939851|NCT02601586|Analgesics|analgesics|mesh-ancestor
153939852|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
153939853|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939854|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153939855|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153939856|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
153939857|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939858|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939859|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153939860|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
153939861|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939862|NCT00610389|Immunomodulating Agents|immunomodulating agents|mesh-list
153939863|NCT00610389|Immunologic Factors|immunologic factors|mesh-ancestor
153939864|NCT00610389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939865|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153939867|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153939868|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153939869|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
153939870|NCT01030536|Immunotoxins|immunotoxins|mesh-ancestor
153939871|NCT01030536|Immunoconjugates|immunoconjugates|mesh-ancestor
153939872|NCT01030536|Immunologic Factors|immunologic factors|mesh-ancestor
153939873|NCT01030536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939874|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939875|NCT01030458|Amlodipine|amlodipine|mesh-list
153939876|NCT01030458|Valsartan|valsartan|mesh-list
153939877|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153939878|NCT01030458|Bisoprolol|bisoprolol|mesh-list
153939879|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153939880|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153939881|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153899240|NCT06268327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153939882|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697469|NCT00424801|Diuretics|diuretics|mesh-ancestor
153939913|NCT01114139|Hematinics|hematinics|mesh-ancestor
153939914|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153939915|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153939916|NCT01027884|Idebenone|idebenone|mesh-list
153939917|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
153939918|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939919|NCT01027884|Protective Agents|protective agents|mesh-ancestor
153939920|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939921|NCT02699008|Clopidogrel|clopidogrel|mesh-list
153832498|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153939922|NCT02699008|Ticagrelor|ticagrelor|mesh-list
153939923|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153939924|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153939925|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153939926|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153939944|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153939945|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
153939946|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939947|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939948|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
153939949|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939950|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153939951|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939952|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
153939953|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939954|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153939955|NCT00627666|Antidotes|antidotes|mesh-ancestor
153939956|NCT00627666|Protective Agents|protective agents|mesh-ancestor
153939957|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
153939958|NCT00627666|Vitamins|vitamins|mesh-ancestor
153939959|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
153939960|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
153939961|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153939962|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153697568|NCT00247585|Ethanol|ethanol|mesh-list
153939963|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153939964|NCT01022580|Calfactant|calfactant|mesh-list
153939965|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
153939967|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153939968|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939969|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939970|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153939971|NCT02698930|Analgesics|analgesics|mesh-ancestor
153939972|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
153939973|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939974|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153939975|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153939976|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153939977|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832499|NCT00509613|Sirolimus|sirolimus|mesh-list
153440628|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153440629|NCT00004087|Antibodies|antibodies|mesh-list
153899286|NCT06268093|Growth Substances|growth substances|mesh-ancestor
153899287|NCT06268093|Growth Inhibitors|growth inhibitors|mesh-ancestor
153899288|NCT06268093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899289|NCT06268080|Anesthetics|anesthetics|mesh-list
153899290|NCT06268080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899291|NCT06268080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899292|NCT06267872|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153899293|NCT06267872|MEDI9197|medi9197|mesh-list
153939978|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939979|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939980|NCT01107353|Imipramine|imipramine|mesh-list
153939981|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153939982|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
153939983|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153939984|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153697570|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939994|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
153939995|NCT02702206|Hormones|hormones|mesh-ancestor
153939996|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939997|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939998|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
153939999|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153940000|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
153940001|NCT02702206|Protective Agents|protective agents|mesh-ancestor
153940002|NCT04216186|Ubiquinone|ubiquinone|mesh-list
153940003|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
153940004|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153940005|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153940006|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153940007|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940008|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940009|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
153940010|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940011|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940012|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
153940013|NCT04216186|Vitamins|vitamins|mesh-ancestor
153940014|NCT01989598|Trametinib|trametinib|mesh-list
153940015|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940016|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153940017|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940018|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940019|NCT04214938|Lidocaine|lidocaine|mesh-list
153940020|NCT04214938|Xylometazoline|xylometazoline|mesh-list
153940021|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
153940022|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
153899294|NCT06267872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153440635|NCT00003757|Rituximab|rituximab|mesh-list
153899297|NCT06267872|Antacids|antacids|mesh-ancestor
153899298|NCT06267872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899299|NCT06267872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153899300|NCT06267820|Ketorolac|ketorolac|mesh-list
153899301|NCT06267820|Bupivacaine|bupivacaine|mesh-list
153899302|NCT06267820|Anesthetics, Local|anesthetics, local|mesh-ancestor
153899303|NCT06267820|Anesthetics|anesthetics|mesh-ancestor
153899304|NCT06267820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940023|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940024|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940025|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
153940026|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940027|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153940028|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153940029|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153940030|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940031|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940032|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
153940033|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153940034|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
153940035|NCT00615160|Dacarbazine|dacarbazine|mesh-list
153940036|NCT00615160|Vatalanib|vatalanib|mesh-list
153940037|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153940038|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
153940039|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940040|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940041|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153940042|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940043|NCT01112267|Acetaminophen|acetaminophen|mesh-list
153940045|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940046|NCT01112267|Analgesics|analgesics|mesh-ancestor
153940047|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
153940048|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940049|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940064|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
153940065|NCT02698306|Hormones|hormones|mesh-ancestor
153940066|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940067|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153940068|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940069|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153940070|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940071|NCT02698306|Analgesics|analgesics|mesh-ancestor
153940072|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
153940073|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940074|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153940075|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940076|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940077|NCT02698228|Morphine|morphine|mesh-list
153940078|NCT02698228|Bupivacaine|bupivacaine|mesh-list
153940079|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
153940080|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
153940081|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940082|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940083|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
153940084|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940085|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153899305|NCT06267820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940086|NCT02698228|Narcotics|narcotics|mesh-ancestor
153940087|NCT02698228|Analgesics|analgesics|mesh-ancestor
153940088|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
153940089|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153940090|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153940091|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940092|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
153940093|NCT02702128|Coagulants|coagulants|mesh-ancestor
153940094|NCT00610545|Atorvastatin|atorvastatin|mesh-list
153940095|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153940096|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153940097|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
153940098|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940099|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153940100|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153940101|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940102|NCT00193414|Gemcitabine|gemcitabine|mesh-list
153940103|NCT00193414|Pemetrexed|pemetrexed|mesh-list
153940104|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153940105|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
153940106|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940107|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940108|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940109|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153940110|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153940111|NCT04260711|Interferons|interferons|mesh-list
153940112|NCT04260711|Teriflunomide|teriflunomide|mesh-list
153940113|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
153940145|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
153940146|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940147|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
153940148|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940149|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940150|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153940151|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153940152|NCT04956705|Vitamin D|vitamin d|mesh-list
153940153|NCT04956705|Calcium|calcium|mesh-list
153940154|NCT04956705|Vitamins|vitamins|mesh-ancestor
153940155|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
153940156|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940157|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940158|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153940159|NCT02705950|Baclofen|baclofen|mesh-list
153940160|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153940184|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
153940185|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
153440717|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440718|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
153440719|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
153940186|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
153940187|NCT02701348|Letrozole|letrozole|mesh-list
153940188|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153697799|NCT00249847|Paroxetine|paroxetine|mesh-list
153940189|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940190|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153940191|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940192|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940193|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153940194|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
153940195|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940196|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940197|NCT05324800|Turmeric extract|turmeric extract|mesh-list
153940198|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
153940199|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940200|NCT05324800|Protective Agents|protective agents|mesh-ancestor
153940201|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940202|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
153940203|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153940204|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940205|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940206|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260768|NCT02939014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940207|NCT00930579|Metformin|metformin|mesh-list
153940208|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940209|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940210|NCT02700568|Axitinib|axitinib|mesh-list
153940211|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940212|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153940227|NCT02705482|Durvalumab|durvalumab|mesh-list
153940228|NCT02705482|Tremelimumab|tremelimumab|mesh-list
153940229|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153940230|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940231|NCT02705638|Rituximab|rituximab|mesh-list
153940232|NCT02705638|Lenalidomide|lenalidomide|mesh-list
153940233|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153940234|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940235|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
153940236|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940237|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940238|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153940239|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153940240|NCT02705638|Growth Substances|growth substances|mesh-ancestor
153372675|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440743|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440744|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440745|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
153440746|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440747|NCT00004123|Doxorubicin|doxorubicin|mesh-list
153940241|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
153440748|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153440749|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440750|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440751|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440752|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153899401|NCT06266962|Sympathomimetics|sympathomimetics|mesh-ancestor
153940242|NCT02691910|Chloroquine|chloroquine|mesh-list
153940243|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153940244|NCT02691910|Primaquine|primaquine|mesh-list
153940245|NCT02691910|Amebicides|amebicides|mesh-ancestor
153940246|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153940247|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153940248|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940249|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
153940250|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940251|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153940252|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940253|NCT02691910|Analgesics|analgesics|mesh-ancestor
153940254|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
153940255|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940256|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940257|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940258|NCT02691910|Filaricides|filaricides|mesh-ancestor
153940259|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
153940260|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
153940261|NCT02705014|Hormones|hormones|mesh-list
153940262|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940263|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940264|NCT02704624|Vitamin D|vitamin d|mesh-list
153940265|NCT02704624|Vitamins|vitamins|mesh-ancestor
153940266|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
153940267|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940268|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153940270|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
153940271|NCT02700022|Doxorubicin|doxorubicin|mesh-list
153940272|NCT02700022|Etoposide|etoposide|mesh-list
153940273|NCT02700022|Vincristine|vincristine|mesh-list
153697847|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
153940291|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153940292|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153940293|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
153940294|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
153940295|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
153940296|NCT02699710|Folic Acid|folic acid|mesh-list
153940297|NCT02699710|Methotrexate|methotrexate|mesh-list
153940298|NCT02699710|Rabeprazole|rabeprazole|mesh-list
153940299|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153940300|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
153940301|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153940302|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940303|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153940304|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
153940305|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940306|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940307|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
153940308|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940309|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153940310|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153940311|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
153940312|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940313|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153820983|NCT00465231|Analgesics|analgesics|mesh-ancestor
153820984|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153940314|NCT02699710|Hematinics|hematinics|mesh-ancestor
153940315|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
153940316|NCT02699710|Vitamins|vitamins|mesh-ancestor
153940317|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
153940318|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153940319|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153940320|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153940321|NCT03140488|Oxytocin|oxytocin|mesh-list
153940322|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
153940323|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153940324|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940325|NCT00616408|Octreotide|octreotide|mesh-list
153940326|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153940327|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153940328|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940329|NCT02691754|Acetaminophen|acetaminophen|mesh-list
153940330|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940344|NCT00637078|Amlodipine|amlodipine|mesh-list
153940345|NCT00637078|Spironolactone|spironolactone|mesh-list
153940346|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153940347|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153940348|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940349|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940350|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940351|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940353|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153940354|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
153940355|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940356|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153940357|NCT00637078|Diuretics|diuretics|mesh-ancestor
153940358|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
153940359|NCT00625781|Insulin|insulin|mesh-list
153940360|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153940361|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
153940362|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940363|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940364|NCT01027650|Dexamethasone|dexamethasone|mesh-list
153940365|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940366|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
153940367|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
153940368|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940369|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940370|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153940371|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
153940372|NCT01027650|Hormones|hormones|mesh-ancestor
153940373|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940374|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153940375|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940376|NCT00616876|Lactulose|lactulose|mesh-list
153940377|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153940378|NCT01106027|Eculizumab|eculizumab|mesh-list
153940379|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153940380|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153940381|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
153940382|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940383|NCT01027416|Tamoxifen|tamoxifen|mesh-list
153940384|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153940385|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
153940386|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940387|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940388|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153940389|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940390|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153940391|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153940407|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940408|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940409|NCT00627744|Incretins|incretins|mesh-ancestor
153940410|NCT00627744|Hormones|hormones|mesh-ancestor
153940411|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940412|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153940413|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
153940414|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899441|NCT06265870|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153940415|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940416|NCT01105091|Epoprostenol|epoprostenol|mesh-list
153940417|NCT01105091|Tezosentan|tezosentan|mesh-list
153940418|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153940419|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153940420|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
153940421|NCT00628056|Perhexiline|perhexiline|mesh-list
153940422|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153940423|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940424|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940425|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940426|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940427|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
153940428|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
153940429|NCT00924729|Besifloxacin|besifloxacin|mesh-list
153940430|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153940431|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153940432|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153940433|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940434|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153940435|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153940436|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940437|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940438|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940440|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153940441|NCT01099709|Narcotics|narcotics|mesh-ancestor
153940442|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940443|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940444|NCT01099709|Analgesics|analgesics|mesh-ancestor
153940445|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
153940446|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940447|NCT04907019|Rifampin|rifampin|mesh-list
153940448|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153940449|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
153940450|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153940451|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940469|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940470|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940471|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153940472|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
153940473|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940474|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940476|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
153940477|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153940478|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940479|NCT01104779|Cariprazine|cariprazine|mesh-list
153940480|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153940481|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153440873|NCT00004177|Antibodies|antibodies|mesh-list
153940482|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940483|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940484|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153940485|NCT00918957|Tobramycin|tobramycin|mesh-list
153940486|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153940487|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940488|NCT04308161|Vitamin D|vitamin d|mesh-list
153940489|NCT04308161|Miconazole|miconazole|mesh-list
153940490|NCT04308161|Vitamins|vitamins|mesh-ancestor
153940491|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
153940492|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940493|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153940494|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
153940495|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940496|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153940497|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153940498|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940499|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940500|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153940501|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
153940502|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940503|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153940504|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153940516|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940517|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940518|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940520|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153940521|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
153940522|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940523|NCT04253223|Volagidemab|volagidemab|mesh-list
153940524|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940525|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940526|NCT00918879|Saxagliptin|saxagliptin|mesh-list
153940527|NCT00918879|Incretins|incretins|mesh-ancestor
153940528|NCT00918879|Hormones|hormones|mesh-ancestor
153940529|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940530|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940531|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153940532|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
153940533|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940534|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940535|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940536|NCT01026792|Sirolimus|sirolimus|mesh-list
153940537|NCT01026792|Temsirolimus|temsirolimus|mesh-list
153940538|NCT01026792|MTOR Inhibitors|mtor inhibitors|mesh-list
153940539|NCT01026792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153899589|NCT06155981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899590|NCT06155981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153440938|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
153440939|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440940|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153440941|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
153440942|NCT00003217|Hormones|hormones|mesh-ancestor
153440943|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153440944|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153440945|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440946|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440947|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153940540|NCT01026792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940541|NCT01026792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940542|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153940543|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
153940544|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940545|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940546|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153940547|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940548|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153940549|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
153940550|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
153940551|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153940552|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940553|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940554|NCT04300686|Adalimumab|adalimumab|mesh-list
153940555|NCT04300686|Antibodies|antibodies|mesh-list
153940556|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
153940557|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
153940558|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940559|NCT04300686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153940560|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940561|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940562|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153940563|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
153940564|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940565|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940566|NCT01098539|Incretins|incretins|mesh-ancestor
153940567|NCT01098539|Hormones|hormones|mesh-ancestor
153940568|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698144|NCT00251485|Cetuximab|cetuximab|mesh-list
153940582|NCT01098305|Varenicline|varenicline|mesh-list
153940583|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153940584|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153940585|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
153940586|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940587|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940588|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940589|NCT00833833|Aspirin|aspirin|mesh-list
153940590|NCT00833833|Dexamethasone|dexamethasone|mesh-list
153899591|NCT06155981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153899592|NCT06155981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153899593|NCT06155981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153899595|NCT06155981|Dopamine Agents|dopamine agents|mesh-ancestor
153940591|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
153940592|NCT00833833|Pomalidomide|pomalidomide|mesh-list
153940593|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153940594|NCT00833833|BB 1101|bb 1101|mesh-list
153940595|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940596|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
153940597|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
153940598|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940599|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940600|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153940601|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
153940602|NCT00833833|Hormones|hormones|mesh-ancestor
153940603|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940604|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153940605|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940606|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
153940607|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940608|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940609|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153940610|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940611|NCT00833833|Analgesics|analgesics|mesh-ancestor
153940612|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
153940613|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940614|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153940615|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153940616|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153940617|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153940618|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
153940619|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
153940620|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153940621|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153940622|NCT00833833|Growth Substances|growth substances|mesh-ancestor
153940623|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
153940624|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
153940625|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940626|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
153940627|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153940628|NCT02612545|Piperaquine|piperaquine|mesh-list
153940629|NCT02612545|Artenimol|artenimol|mesh-list
153940644|NCT01097057|Etoposide|etoposide|mesh-list
153940645|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
153940646|NCT01097057|Ifosfamide|ifosfamide|mesh-list
153940647|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
153940648|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
153940649|NCT01097057|Antibodies|antibodies|mesh-list
153940650|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
153940651|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153940652|NCT01097057|Lenograstim|lenograstim|mesh-list
153940653|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
153940654|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940655|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940656|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940657|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153940658|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153940659|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153940660|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940661|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940662|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153940663|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153940664|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
153940665|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153940666|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153940667|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
153940668|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940669|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
153940670|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
153940671|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
153940672|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
153940673|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
153940674|NCT02612701|Nicotine|nicotine|mesh-list
153940675|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153940676|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
153940677|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940678|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940679|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153940680|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153940681|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
153940682|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940683|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940684|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
153940685|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153441040|NCT00385021|Protective Agents|protective agents|mesh-ancestor
153441041|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
153441043|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
153441044|NCT00004201|Carboplatin|carboplatin|mesh-list
153441045|NCT00004201|Gemcitabine|gemcitabine|mesh-list
153441046|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940686|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153940687|NCT01096667|Diuretics|diuretics|mesh-ancestor
153940688|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
153940689|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940690|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153940691|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940692|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698265|NCT00100308|Heparin|heparin|mesh-list
153940702|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940703|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940704|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940706|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
153940707|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153940708|NCT02872428|Valproic Acid|valproic acid|mesh-list
153940709|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
153940710|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940711|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940712|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
153940713|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940714|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940715|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
153940716|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153940717|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940718|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153940719|NCT02873364|Vitamin D|vitamin d|mesh-list
153940720|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
153940721|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
153940722|NCT02873364|Vitamins|vitamins|mesh-list
153940723|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
153940724|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940725|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153940726|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940727|NCT00628290|Cannabidiol|cannabidiol|mesh-list
153940728|NCT00628290|Amisulpride|amisulpride|mesh-list
153940729|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
153940730|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153940731|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153940732|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940733|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940734|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153940735|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153940736|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
153940737|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940738|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372912|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372913|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153940739|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153940740|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
153940741|NCT04559412|Etanercept|etanercept|mesh-list
153940742|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153940743|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940744|NCT04559412|Analgesics|analgesics|mesh-ancestor
153940745|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
153940746|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940747|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940748|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940749|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940750|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153940751|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153940752|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
153940753|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153940754|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940755|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940756|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940774|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153940775|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940776|NCT00704899|Analgesics|analgesics|mesh-ancestor
153940777|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
153940778|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940779|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940780|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153940781|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153940782|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940783|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940784|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
153940785|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940786|NCT01104701|Exenatide|exenatide|mesh-list
153940787|NCT01104701|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153940788|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153698385|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153940789|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940790|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153940791|NCT01104701|Incretins|incretins|mesh-ancestor
153441055|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
153940793|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940795|NCT00833755|Analgesics|analgesics|mesh-ancestor
153940796|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
153940797|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940798|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940799|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153940800|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153940801|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
153940802|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
153940803|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940804|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153940805|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153940806|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940807|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940808|NCT01021332|Tamsulosin|tamsulosin|mesh-list
153940809|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
153940810|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153940811|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153940812|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153940831|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940832|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
153940833|NCT00923091|Diuretics|diuretics|mesh-ancestor
153940834|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
153940835|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153940836|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153940837|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153940839|NCT00853957|Aliskiren|aliskiren|mesh-list
153940840|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153940841|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153940842|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940843|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940844|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940845|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940846|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
153940847|NCT00853957|Renin Inhibitors|renin inhibitors|mesh-ancestor
153940848|NCT00853957|Protease Inhibitors|protease inhibitors|mesh-ancestor
153940849|NCT00853957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940850|NCT01021020|Colchicine|colchicine|mesh-list
153899721|NCT05991518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899722|NCT05976763|Rituximab|rituximab|mesh-list
153899723|NCT05976763|Zanubrutinib|zanubrutinib|mesh-list
153899724|NCT05976763|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153940851|NCT01021020|Probenecid|probenecid|mesh-list
153940852|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
153940853|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940854|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
153940855|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
153940856|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
153940857|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940858|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940859|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
153940860|NCT00833053|Infliximab|infliximab|mesh-list
153940861|NCT00833053|Methotrexate|methotrexate|mesh-list
153940862|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153940863|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
153940864|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153940865|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940866|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153940881|NCT01020786|Pemetrexed|pemetrexed|mesh-list
153940882|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940883|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940884|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940885|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153940886|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153940887|NCT00918645|Calcium|calcium|mesh-list
153940888|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940889|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940890|NCT01020474|Pregabalin|pregabalin|mesh-list
153940891|NCT01020474|Analgesics|analgesics|mesh-ancestor
153940892|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
153940893|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940894|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940895|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
153940896|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153940897|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940898|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940899|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940900|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153940901|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153940902|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940903|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153940904|NCT02872818|Metformin|metformin|mesh-list
153940905|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153940906|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153940907|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153940908|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
153940909|NCT02872818|Estradiol|estradiol|mesh-list
153940910|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153940911|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940912|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940913|NCT02872818|Estrogens|estrogens|mesh-ancestor
153940914|NCT02872818|Hormones|hormones|mesh-ancestor
153899727|NCT05976763|Immunologic Factors|immunologic factors|mesh-ancestor
153899752|NCT05934942|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153899753|NCT05934942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153899754|NCT05934942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899755|NCT05924776|Immunomodulating Agents|immunomodulating agents|mesh-list
153899756|NCT05924776|Immunologic Factors|immunologic factors|mesh-ancestor
153899757|NCT05924776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899758|NCT05895136|Enoxaparin|enoxaparin|mesh-list
153940915|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940916|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153940917|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
153940918|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153940919|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153940920|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153940921|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153940922|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153940923|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153940924|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153940925|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940926|NCT00922779|Ribavirin|ribavirin|mesh-list
153940942|NCT04203771|Analgesics|analgesics|mesh-ancestor
153940943|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
153940944|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940945|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940946|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940947|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940948|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153940949|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940950|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940951|NCT01025232|Ranibizumab|ranibizumab|mesh-list
153940952|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153940953|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153940954|NCT01025232|Growth Substances|growth substances|mesh-ancestor
153940955|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940956|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
153940957|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940958|NCT04300452|Carbetocin|carbetocin|mesh-list
153940959|NCT04300452|Ergonovine|ergonovine|mesh-list
153940960|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
153940961|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153940962|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940963|NCT01025154|Cytarabine|cytarabine|mesh-list
153940964|NCT01025154|Clofarabine|clofarabine|mesh-list
153940965|NCT01025154|Idarubicin|idarubicin|mesh-list
153940966|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153940967|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
153410551|NCT00003375|Vincristine|vincristine|mesh-list
153441157|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441158|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441159|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441160|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441161|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441162|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441163|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441164|NCT00004237|Analgesics|analgesics|mesh-ancestor
153441165|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
153441166|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899798|NCT05870917|Antiemetics|antiemetics|mesh-ancestor
153940968|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940969|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940970|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
153940971|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940972|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153940973|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
153940974|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940975|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153940976|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153940977|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153940978|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940979|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
153940980|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153940981|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940982|NCT04252365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153940983|NCT04252365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940984|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
153940985|NCT04252443|Analgesics|analgesics|mesh-list
153940986|NCT04252443|Narcotics|narcotics|mesh-ancestor
153940999|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941000|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153941001|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941002|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
153941003|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
153941004|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941005|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941006|NCT00853723|Teriparatide|teriparatide|mesh-list
153941007|NCT00853723|Hormones|hormones|mesh-list
153941008|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
153941009|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
153941010|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153941011|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941012|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153941013|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153941014|NCT00918255|Adalimumab|adalimumab|mesh-list
153941015|NCT00918255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153941016|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153941017|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941018|NCT01096589|Monensin|monensin|mesh-list
153941019|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
153899799|NCT05870917|Autonomic Agents|autonomic agents|mesh-ancestor
153899800|NCT05870917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941020|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941021|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153941022|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153941023|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
153941024|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
153941025|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
153941026|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941027|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941028|NCT01096589|Ionophores|ionophores|mesh-ancestor
153941029|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941030|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
153941031|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153941032|NCT04252521|Ketoprofen|ketoprofen|mesh-list
153941033|NCT04252521|Metoclopramide|metoclopramide|mesh-list
153941034|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
153941035|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
153941036|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941037|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941038|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153941039|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153941040|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153941041|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
153941042|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941043|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941044|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153941045|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153941046|NCT04252521|Analgesics|analgesics|mesh-ancestor
153941047|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
153941048|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153698623|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
153941071|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153941072|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153941073|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153941074|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941075|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441176|NCT00003913|Busulfan|busulfan|mesh-list
153941076|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
153941077|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941078|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941079|NCT05252325|Lidocaine|lidocaine|mesh-list
153941080|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
153941081|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
153941082|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
153941083|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941084|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941085|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
153941086|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698683|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941087|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153941088|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153941089|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153941090|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941091|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941092|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153941093|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
153941094|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
153941095|NCT05252325|Protective Agents|protective agents|mesh-ancestor
153941097|NCT01024920|Nintedanib|nintedanib|mesh-list
153941098|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941099|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153941100|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153941101|NCT01024920|Growth Substances|growth substances|mesh-ancestor
153941119|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153941120|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941121|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941123|NCT00705445|Trace Elements|trace elements|mesh-list
153941124|NCT00705445|Micronutrients|micronutrients|mesh-list
153941125|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941126|NCT02879981|Trimethoprim|trimethoprim|mesh-list
153941127|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
153941128|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
153941129|NCT02879981|Guaifenesin|guaifenesin|mesh-list
153941130|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153941131|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153941132|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941133|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
153941134|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153941135|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153941136|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153941137|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941138|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941139|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153941140|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153941141|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153941142|NCT02879981|Expectorants|expectorants|mesh-ancestor
153941143|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
153941144|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153941145|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153941146|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
153941147|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941148|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941149|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
153941150|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153941151|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
153941152|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
153941153|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941154|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
153941155|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153941156|NCT04307693|Ritonavir|ritonavir|mesh-list
153941157|NCT04307693|Lopinavir|lopinavir|mesh-list
153941158|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
153941159|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153941160|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153941179|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153941180|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153941181|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
153941182|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941183|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941185|NCT01019694|Ipratropium|ipratropium|mesh-list
153941186|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153941187|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
153899855|NCT05775861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153941188|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941189|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941190|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153941191|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
153941192|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
153941193|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153941194|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153941195|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153941196|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153941197|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
153941198|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941199|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941200|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153941201|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
153941202|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153941203|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153941204|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153941205|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941206|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941207|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941208|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941209|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
153941210|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153941211|NCT01095653|Metformin|metformin|mesh-list
153941212|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
153941213|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153941214|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698794|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941239|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941241|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153941242|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941243|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941244|NCT00920829|Naltrexone|naltrexone|mesh-list
153941245|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153941246|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153941247|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941248|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
153941249|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941250|NCT05010876|Icatibant|icatibant|mesh-list
153441273|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153441316|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441317|NCT00003301|Irinotecan|irinotecan|mesh-list
153441318|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153441319|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441320|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441321|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441322|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441323|NCT00003307|Amifostine|amifostine|mesh-list
153441324|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153441325|NCT00003307|Protective Agents|protective agents|mesh-ancestor
153441326|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441327|NCT00004327|Octreotide|octreotide|mesh-list
153941251|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153941252|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153941253|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153941254|NCT05010876|Analgesics|analgesics|mesh-ancestor
153941255|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
153941256|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941257|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941258|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153941259|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941260|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153941261|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153941274|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
153941275|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941276|NCT02878265|Trace Elements|trace elements|mesh-ancestor
153941277|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
153941278|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941279|NCT02878265|Protective Agents|protective agents|mesh-ancestor
153941280|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153941281|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941282|NCT00831181|Leucovorin|leucovorin|mesh-list
153941283|NCT00831181|Fluorouracil|fluorouracil|mesh-list
153941284|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
153941285|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
153941286|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941287|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153941288|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941289|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941290|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
153941291|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941292|NCT00831181|Antidotes|antidotes|mesh-ancestor
153941293|NCT00831181|Protective Agents|protective agents|mesh-ancestor
153941294|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
153941295|NCT00831181|Vitamins|vitamins|mesh-ancestor
153941296|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
153941297|NCT01023672|Modafinil|modafinil|mesh-list
153941298|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153941299|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941300|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153941301|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153941302|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153941303|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941304|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153941305|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153941306|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
153941307|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941308|NCT00705835|Antacids|antacids|mesh-ancestor
153941309|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941310|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153941311|NCT00702637|Modafinil|modafinil|mesh-list
153941312|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153941313|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941314|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153407899|NCT03472469|Narcotics|narcotics|mesh-ancestor
153941315|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153941316|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153941317|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941318|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153941319|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153941320|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153941321|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941322|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941323|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
153698904|NCT00070343|Oblimersen|oblimersen|mesh-list
153941345|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153941346|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153941347|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153941348|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941349|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941350|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941351|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941353|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
153941354|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941355|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
153941356|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153899955|NCT05683977|Durvalumab|durvalumab|mesh-list
153941357|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
153941358|NCT04255017|Ritonavir|ritonavir|mesh-list
153941359|NCT04255017|Lopinavir|lopinavir|mesh-list
153941360|NCT04255017|Oseltamivir|oseltamivir|mesh-list
153941361|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153941362|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153941363|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
153941364|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941365|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373155|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
153373156|NCT02685267|Hormones|hormones|mesh-ancestor
153373157|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373158|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833097|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153833098|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
153833099|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153833100|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153441354|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
153441355|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441356|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941366|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153941367|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153941368|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
153941369|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941370|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153941371|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153941372|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153941373|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
153941374|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
153941375|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941376|NCT01017120|Tazarotene|tazarotene|mesh-list
153941377|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
153941378|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
153941390|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941391|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
153941392|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941393|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
153941394|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941395|NCT02996110|Nivolumab|nivolumab|mesh-list
153941396|NCT02996110|Ipilimumab|ipilimumab|mesh-list
153941397|NCT02996110|Relatlimab|relatlimab|mesh-list
153941398|NCT02996110|Linrodostat|linrodostat|mesh-list
153941399|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153941400|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941401|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153941402|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941403|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941404|NCT01103063|Azithromycin|azithromycin|mesh-list
153941405|NCT01103063|Chloroquine|chloroquine|mesh-list
153941406|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
153941407|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
153941408|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153941409|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153941410|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941411|NCT01103063|Amebicides|amebicides|mesh-ancestor
153941412|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153941413|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153941414|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
153899984|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941415|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941416|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153941417|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941418|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941419|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153941420|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
153941421|NCT02987998|Etoposide|etoposide|mesh-list
153941422|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941423|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153941424|NCT02987998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153941425|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941426|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153941427|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153941428|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153941429|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941430|NCT04213378|Paclitaxel|paclitaxel|mesh-list
153941431|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153941432|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153941433|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941434|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941435|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941436|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941437|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941438|NCT04213924|Ibuprofen|ibuprofen|mesh-list
153941439|NCT04213924|Lidocaine|lidocaine|mesh-list
153941440|NCT04213924|Bupivacaine|bupivacaine|mesh-list
153941441|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
153941442|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
153941443|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941444|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941445|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
153941454|NCT04213924|Analgesics|analgesics|mesh-ancestor
153941455|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153941456|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941457|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153941458|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941459|NCT00616720|Interferons|interferons|mesh-list
153699056|NCT00257491|Telmisartan|telmisartan|mesh-list
153941460|NCT00616720|Aldesleukin|aldesleukin|mesh-list
153941461|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
153941462|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941463|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
153941464|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941465|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153941466|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153941467|NCT01091675|Etoricoxib|etoricoxib|mesh-list
153941468|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153941469|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153941470|NCT01091675|Analgesics|analgesics|mesh-ancestor
153941471|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
153941472|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941473|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941474|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153941475|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941476|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153941477|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153941478|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941479|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941480|NCT02739412|Aldesleukin|aldesleukin|mesh-list
153941481|NCT02739412|Interleukin-2|interleukin-2|mesh-list
153941482|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941483|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153941484|NCT02739412|Analgesics|analgesics|mesh-ancestor
153941485|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
153941486|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941487|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941488|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153941489|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153941490|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
153941491|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941492|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
153941493|NCT04213612|Doxorubicin|doxorubicin|mesh-list
153941494|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153941495|NCT04213612|Vincristine|vincristine|mesh-list
153941496|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941497|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
153941498|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941499|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941500|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153941501|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
153941502|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941503|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941504|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153941505|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153941506|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153941507|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153941508|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941529|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941530|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941531|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153941532|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
153941533|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941534|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833135|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833136|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
153833137|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
153833138|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833139|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833140|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
153833141|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153441397|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441398|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441399|NCT00004885|Leucovorin|leucovorin|mesh-list
153441400|NCT00004885|Fluorouracil|fluorouracil|mesh-list
153441401|NCT00004885|Irinotecan|irinotecan|mesh-list
153941535|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153941537|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153941538|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153941540|NCT00918333|Panobinostat|panobinostat|mesh-list
153941541|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153941542|NCT00918333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153941543|NCT00918333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153941544|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941545|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941546|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941547|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
153941548|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941549|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941550|NCT01090973|Panobinostat|panobinostat|mesh-list
153941551|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153941552|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941553|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941554|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941555|NCT02607904|Cannabidiol|cannabidiol|mesh-list
153941556|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
153941557|NCT05295394|Lamivudine|lamivudine|mesh-list
153941558|NCT05295394|Dolutegravir|dolutegravir|mesh-list
153941559|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153941560|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153941561|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941562|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941563|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
153941564|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941585|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153941586|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941587|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941589|NCT02497300|Spironolactone|spironolactone|mesh-list
153941590|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153941591|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
153941592|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153941593|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941594|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153941595|NCT02497300|Diuretics|diuretics|mesh-ancestor
153941596|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
153941597|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153941598|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153941599|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941600|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941601|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153941602|NCT04254471|Carboplatin|carboplatin|mesh-list
153441402|NCT00004885|Calcium|calcium|mesh-list
153441403|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
153941603|NCT04254471|Etoposide|etoposide|mesh-list
153941604|NCT04254471|Rabeprazole|rabeprazole|mesh-list
153941605|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941606|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153941607|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153941608|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153941609|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833146|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153833147|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833148|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
153833149|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153833150|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
153833151|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941610|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941611|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153941612|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153941613|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153941614|NCT00631527|Sunitinib|sunitinib|mesh-list
153941616|NCT00631527|Goserelin|goserelin|mesh-list
153941617|NCT00631527|Bicalutamide|bicalutamide|mesh-list
153941618|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941619|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153941634|NCT00620620|Zaleplon|zaleplon|mesh-list
153941635|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
153833152|NCT00512265|Expectorants|expectorants|mesh-ancestor
153900032|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153941636|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153941637|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941638|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941639|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
153941640|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
153941641|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941642|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941643|NCT00916383|Donepezil|donepezil|mesh-list
153941644|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153941645|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941646|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941647|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
153941648|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941649|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941650|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
153941651|NCT00617500|Hormones|hormones|mesh-list
153941652|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153941653|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941654|NCT04209478|Morphine|morphine|mesh-list
153941655|NCT04209478|Tramadol|tramadol|mesh-list
153941656|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153941657|NCT04209478|Narcotics|narcotics|mesh-ancestor
153941658|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941659|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941660|NCT04209478|Analgesics|analgesics|mesh-ancestor
153941661|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
153941662|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900034|NCT05610163|Leucovorin|leucovorin|mesh-list
153833154|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153833155|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
153941663|NCT05252715|Vaccines|vaccines|mesh-list
153941664|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
153941665|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941666|NCT04209166|Norepinephrine|norepinephrine|mesh-list
153941667|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153941668|NCT04209166|Serotonin|serotonin|mesh-list
153941669|NCT04209166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153941670|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
153941671|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
153941672|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153941673|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153941674|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153941675|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941676|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941677|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153699248|NCT00423761|Midazolam|midazolam|mesh-list
153941700|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153941701|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941702|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153941703|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153941704|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941705|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153941706|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153941707|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153941708|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
153941709|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153941710|NCT00175162|Protective Agents|protective agents|mesh-ancestor
153941711|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941712|NCT04213222|Bevacizumab|bevacizumab|mesh-list
153941713|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153941714|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941715|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153941716|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153941717|NCT04213222|Growth Substances|growth substances|mesh-ancestor
153941718|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941719|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
153941720|NCT00621166|Ritonavir|ritonavir|mesh-list
153941721|NCT00621166|Lopinavir|lopinavir|mesh-list
153941722|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153941723|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153941724|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
153941725|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941726|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941727|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153941728|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153941754|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153941755|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699354|NCT00259636|Zonisamide|zonisamide|mesh-list
153941756|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
153941757|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153941758|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153941759|NCT00621400|Growth Substances|growth substances|mesh-ancestor
153941760|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
153833160|NCT00513396|Isoniazid|isoniazid|mesh-list
153941761|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153941762|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
153941763|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941764|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153941765|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941766|NCT04208854|Vinorelbine|vinorelbine|mesh-list
153833162|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833163|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833164|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153833165|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153833166|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
153833167|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410713|NCT00004845|Naproxen|naproxen|mesh-list
153941767|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153941768|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941769|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941770|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941771|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941772|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941773|NCT01090427|Ustekinumab|ustekinumab|mesh-list
153941774|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
153941775|NCT04208776|Propranolol|propranolol|mesh-list
153941776|NCT04208776|Midodrine|midodrine|mesh-list
153941777|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153941778|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153941779|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
153941780|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941788|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941789|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153941790|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153941791|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153941792|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153941793|NCT02879435|Bupivacaine|bupivacaine|mesh-list
153941794|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
153941795|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
153941796|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941797|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941798|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
153941799|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941801|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
153941802|NCT02879513|Epirubicin|epirubicin|mesh-list
153941803|NCT02879513|Fluorouracil|fluorouracil|mesh-list
153941804|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153941805|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941806|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941807|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941808|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941809|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941810|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941811|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
153941812|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941813|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941814|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153941815|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
153941816|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153941817|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153941818|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153941819|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153941820|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941821|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
153941822|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153941823|NCT00621478|Diazepam|diazepam|mesh-list
153941824|NCT00621478|Lorazepam|lorazepam|mesh-list
153941825|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
153941826|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
153941827|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
153941828|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941829|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941830|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153941831|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153941832|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941833|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153941834|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153941835|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153941836|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
153941837|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
153941838|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941839|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941840|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153941841|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153941842|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153941843|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153941844|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
153941845|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
153941846|NCT00621556|Secretin|secretin|mesh-list
153941847|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153941848|NCT00621556|Hormones|hormones|mesh-ancestor
153699407|NCT00105144|Micafungin|micafungin|mesh-list
153941859|NCT04308551|Aspirin|aspirin|mesh-list
153941860|NCT04308551|Indobufen|indobufen|mesh-list
153941861|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153941862|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153941863|NCT04308551|Analgesics|analgesics|mesh-ancestor
153941864|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
153941865|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941866|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941867|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153941868|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941869|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153941870|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153941871|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941872|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153941873|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153941874|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941875|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
153941876|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
153941877|NCT04306913|Esmolol|esmolol|mesh-list
153941878|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153941879|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153941880|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153941881|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
153941882|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941883|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941884|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941885|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153941886|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
153941887|NCT02299414|Nifedipine|nifedipine|mesh-list
153941888|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153941889|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941890|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941891|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153941892|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941893|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
153941894|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
153941895|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153941896|NCT01016262|Mesalamine|mesalamine|mesh-list
153941897|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153941898|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153941899|NCT01016262|Analgesics|analgesics|mesh-ancestor
153941900|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
153941901|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941902|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941903|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153941904|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941905|NCT00625937|Docetaxel|docetaxel|mesh-list
153941906|NCT00625937|Tegafur|tegafur|mesh-list
153941907|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941908|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941909|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941922|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153941923|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941924|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941925|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153941926|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941927|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154260769|NCT05177926|Tenofovir|tenofovir|mesh-list
154260770|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
153941928|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
153941930|NCT01009554|Fluorides|fluorides|mesh-list
153941931|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
153941932|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
153941933|NCT01009554|Protective Agents|protective agents|mesh-ancestor
153941934|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941935|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153941936|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941937|NCT04211896|Nivolumab|nivolumab|mesh-list
153941938|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153941939|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833190|NCT00504959|Growth Substances|growth substances|mesh-ancestor
153941940|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153941941|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941942|NCT04188184|Epinephrine|epinephrine|mesh-list
153941943|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
153941944|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153941945|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153941946|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941947|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
153941948|NCT04188184|Coagulants|coagulants|mesh-ancestor
153941949|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153941950|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153941951|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
153941952|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941953|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941954|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153941955|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153941956|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
153941957|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941958|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153941959|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
153941960|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
153941961|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
153941962|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153941963|NCT01006590|Metformin|metformin|mesh-list
153941964|NCT01006590|Saxagliptin|saxagliptin|mesh-list
153941965|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153941966|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941967|NCT01006590|Incretins|incretins|mesh-ancestor
153941968|NCT01006590|Hormones|hormones|mesh-ancestor
153941969|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153941970|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153941971|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
153941972|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941973|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941986|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941987|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941988|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941989|NCT00618124|Capecitabine|capecitabine|mesh-list
153941990|NCT00618124|Sunitinib|sunitinib|mesh-list
153941991|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153941992|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
153941993|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941994|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941995|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153941996|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153941997|NCT00618124|Growth Substances|growth substances|mesh-ancestor
153941998|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941999|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
153942000|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942001|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942002|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
153942003|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153942004|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942005|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153942006|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942007|NCT01882660|Decitabine|decitabine|mesh-list
153942008|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153942009|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
153942010|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942011|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408053|NCT01640184|Vitamin D|vitamin d|mesh-list
153942012|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942013|NCT01001832|Abatacept|abatacept|mesh-list
153942014|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153942015|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942016|NCT01001832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942017|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942018|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942019|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
153942020|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942021|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942022|NCT01001598|Danazol|danazol|mesh-list
153942023|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153942024|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
153942025|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153942026|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942027|NCT01006356|Hydromorphone|hydromorphone|mesh-list
153942028|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153942029|NCT01006356|Narcotics|narcotics|mesh-ancestor
153942030|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942031|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942032|NCT01006356|Analgesics|analgesics|mesh-ancestor
153942033|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
153942034|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942035|NCT01089725|Tanezumab|tanezumab|mesh-list
153942036|NCT01089725|Analgesics|analgesics|mesh-ancestor
153942037|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
153942065|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153942066|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
153942067|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942068|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942069|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942070|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
153942071|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942072|NCT00618280|Nicotine|nicotine|mesh-list
153942073|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153942074|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
153942075|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942076|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942077|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153942078|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153942079|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
153942080|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942081|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942082|NCT01101191|Oxycodone|oxycodone|mesh-list
153942083|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153942084|NCT01101191|Narcotics|narcotics|mesh-ancestor
153942099|NCT01812616|Nabiximols|nabiximols|mesh-list
153942100|NCT01812616|Analgesics|analgesics|mesh-ancestor
153942101|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
153942102|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942103|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942104|NCT00618358|Thrombin|thrombin|mesh-list
153942105|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
153942106|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
153942107|NCT00618358|Coagulants|coagulants|mesh-ancestor
153942108|NCT01178762|Azithromycin|azithromycin|mesh-list
153942109|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153942110|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942111|NCT03563560|Cytarabine|cytarabine|mesh-list
153942112|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
153942113|NCT03563560|Alvocidib|alvocidib|mesh-list
153942114|NCT03563560|Daunorubicin|daunorubicin|mesh-list
153942115|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153942116|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
153942117|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942118|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942119|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
153942120|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942121|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942122|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
153942123|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942124|NCT03563560|Analgesics|analgesics|mesh-ancestor
153942125|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
153942126|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260771|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260772|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153900164|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942127|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153942128|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153942129|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942130|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
153942131|NCT03563560|Growth Substances|growth substances|mesh-ancestor
153942132|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942133|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153833215|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833216|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
153833217|NCT00513630|Metformin|metformin|mesh-list
153833218|NCT00513630|Glipizide|glipizide|mesh-list
153833219|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153833220|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833221|NCT02275247|Ropivacaine|ropivacaine|mesh-list
153900208|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153900209|NCT05205109|Pembrolizumab|pembrolizumab|mesh-list
153900210|NCT05205109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153441589|NCT00003385|Paclitaxel|paclitaxel|mesh-list
153942134|NCT01178138|Prazosin|prazosin|mesh-list
153942135|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153942136|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153942137|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153942138|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153942139|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
153942140|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942141|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942142|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942143|NCT01190228|Vaccines|vaccines|mesh-list
153942144|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
153942145|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942146|NCT01009086|Ustekinumab|ustekinumab|mesh-list
153942168|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942170|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153942171|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942172|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153942173|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153942174|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153942175|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942176|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
153942177|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942178|NCT01189604|Propofol|propofol|mesh-list
153942179|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153942180|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942181|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942182|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153942183|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
153942184|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
153942185|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
153942186|NCT02697058|Leucovorin|leucovorin|mesh-list
153942187|NCT02697058|Fluorouracil|fluorouracil|mesh-list
153942188|NCT02697058|Calcium|calcium|mesh-list
153942189|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
153942190|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153942191|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942192|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153942193|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
153942194|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942195|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153942196|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942197|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942198|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
153942217|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153942218|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942219|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942220|NCT01955980|Budesonide|budesonide|mesh-list
153942221|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942222|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153942223|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
153942224|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942225|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942226|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153942227|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
153942228|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
153942229|NCT01955980|Hormones|hormones|mesh-ancestor
153942230|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153942231|NCT02870478|Atropine|atropine|mesh-list
153942232|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153942233|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153942234|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153942235|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153942236|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153942237|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
153942238|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942239|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942240|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153942241|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
153942242|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
153942243|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
153942244|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153942245|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153942246|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
153942247|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942248|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942249|NCT04296162|Capecitabine|capecitabine|mesh-list
153942250|NCT04296162|Trastuzumab|trastuzumab|mesh-list
153942251|NCT04296162|Vinorelbine|vinorelbine|mesh-list
153942252|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153942253|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
153942254|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942255|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942256|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942257|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153942267|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942269|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942270|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153942271|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153942272|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153942273|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942274|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942275|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
153942276|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942277|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153942278|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153833243|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153833244|NCT00513786|Growth Substances|growth substances|mesh-ancestor
153833245|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900265|NCT05089734|Immunoconjugates|immunoconjugates|mesh-ancestor
153900266|NCT05089734|Immunologic Factors|immunologic factors|mesh-ancestor
153900267|NCT05089734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900268|NCT05060003|Atezolizumab|atezolizumab|mesh-list
153900269|NCT05060003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153900270|NCT05060003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900271|NCT05060003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900272|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900273|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
153900274|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
153942279|NCT00622570|Pentobarbital|pentobarbital|mesh-list
153942280|NCT00622570|Thiopental|thiopental|mesh-list
153942281|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
153942282|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153942283|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942284|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942285|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153942286|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
153942287|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
153942288|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
153942289|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
153942290|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942291|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942292|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153942293|NCT00890266|Riboflavin|riboflavin|mesh-list
153942294|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
153942295|NCT00890266|Vitamins|vitamins|mesh-ancestor
153942296|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
153942297|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942298|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153942299|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
153942300|NCT01176968|Eplerenone|eplerenone|mesh-list
153942301|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153942302|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
153942303|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153942304|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942305|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153942306|NCT01176968|Diuretics|diuretics|mesh-ancestor
153942307|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
153942308|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153942309|NCT02697370|Factor VIII|factor viii|mesh-list
153942310|NCT02697370|Coagulants|coagulants|mesh-ancestor
153942311|NCT02691442|Epinephrine|epinephrine|mesh-list
153942312|NCT02691442|Ropivacaine|ropivacaine|mesh-list
153942313|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
153942314|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
153942315|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
153942316|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942317|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942318|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
153942319|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942320|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153942321|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153942322|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
153373322|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900291|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153900292|NCT04984577|Edaravone|edaravone|mesh-list
153900293|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153900294|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
153900295|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900296|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153900297|NCT04984577|Protective Agents|protective agents|mesh-ancestor
153900298|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900299|NCT04978493|Ustekinumab|ustekinumab|mesh-list
153900300|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
153942323|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942324|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942336|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153942337|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942340|NCT02687854|Vitamins|vitamins|mesh-ancestor
153942341|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
153942342|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942343|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153942344|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
153942345|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153942346|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
153942347|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942348|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942350|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153942351|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153942352|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
153942353|NCT02687854|Coagulants|coagulants|mesh-ancestor
153942354|NCT01005966|Listerine|listerine|mesh-list
153942355|NCT01005966|Fluorides|fluorides|mesh-list
153942356|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
153942357|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
153942358|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
153942359|NCT01005966|Protective Agents|protective agents|mesh-ancestor
153942360|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942361|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153942362|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942363|NCT00628680|Heparin|heparin|mesh-list
153942364|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
153942365|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153942366|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153942367|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942368|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
153942369|NCT00603304|Urological Agents|urological agents|mesh-ancestor
153942370|NCT01176032|Losartan|losartan|mesh-list
153942371|NCT01176032|Amlodipine|amlodipine|mesh-list
153942372|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153942373|NCT01176032|Aliskiren|aliskiren|mesh-list
153942374|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153942375|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153942376|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153942377|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942378|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153942379|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942380|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
153942381|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153942382|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153942383|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153942384|NCT01176032|Diuretics|diuretics|mesh-ancestor
153942385|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
153942386|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153942387|NCT01176032|Renin Inhibitors|renin inhibitors|mesh-ancestor
153942388|NCT01176032|Protease Inhibitors|protease inhibitors|mesh-ancestor
153942389|NCT01176032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942390|NCT01008618|Fentanyl|fentanyl|mesh-list
153942391|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153942392|NCT01008618|Narcotics|narcotics|mesh-ancestor
153942403|NCT01001208|Methotrexate|methotrexate|mesh-list
153942404|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153942405|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
153942406|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153942407|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942408|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153942409|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
153942410|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942411|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942412|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
153942413|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942414|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153942415|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942416|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
153942417|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260773|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153942418|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153942419|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153942420|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153942421|NCT01001208|Analgesics|analgesics|mesh-ancestor
153942422|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
153942423|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942424|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942425|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942426|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153942427|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
153942428|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942430|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153942431|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153942432|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153942433|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
153942434|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942435|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153942436|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942437|NCT01182350|Bevacizumab|bevacizumab|mesh-list
153942438|NCT01182350|Temozolomide|temozolomide|mesh-list
153942439|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153942440|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942441|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942442|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153942443|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153942444|NCT01182350|Growth Substances|growth substances|mesh-ancestor
153942445|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942446|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
153942447|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153942448|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
153942449|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942450|NCT01182350|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153942451|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942452|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942453|NCT00603538|Paclitaxel|paclitaxel|mesh-list
153942454|NCT00603538|Carboplatin|carboplatin|mesh-list
153942455|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153942456|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942457|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
153942470|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153942471|NCT02537860|Narcotics|narcotics|mesh-ancestor
153942472|NCT02537860|Analgesics|analgesics|mesh-ancestor
153942473|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153942474|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153942475|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
153942477|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153942478|NCT01162304|Narcotics|narcotics|mesh-ancestor
153942479|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942480|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942481|NCT01162304|Analgesics|analgesics|mesh-ancestor
153942482|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
153942483|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942484|NCT04515394|Cetuximab|cetuximab|mesh-list
153942485|NCT04515394|Tepotinib|tepotinib|mesh-list
153942486|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942487|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942488|NCT04206176|Ticagrelor|ticagrelor|mesh-list
153942489|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153942490|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153942491|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153942492|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153942493|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
153942494|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833282|NCT00512850|Hematinics|hematinics|mesh-ancestor
153833283|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
153942495|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942496|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942497|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153942498|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942500|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153942501|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153942502|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153408193|NCT05641818|Vitamin D|vitamin d|mesh-list
153942503|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153942504|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
153942505|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942506|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942507|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942508|NCT04314674|Mannitol|mannitol|mesh-list
153942509|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153942510|NCT04314674|Diuretics|diuretics|mesh-ancestor
153942511|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
153942512|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700112|NCT00415831|Levodopa|levodopa|mesh-list
153942513|NCT00639262|Temozolomide|temozolomide|mesh-list
153942515|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153942516|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
153942517|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942518|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942519|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942520|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942545|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942546|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
153942547|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942548|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942549|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153942550|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
153942551|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153942552|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153942553|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153942554|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153942555|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942556|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942557|NCT01008150|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153942558|NCT01008150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942559|NCT04186936|Simethicone|simethicone|mesh-list
153942560|NCT04186936|Loperamide|loperamide|mesh-list
153942561|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
153942562|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942563|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
153942564|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942565|NCT04186936|Emollients|emollients|mesh-ancestor
153942566|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833303|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
153833304|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942567|NCT02689180|Furosemide|furosemide|mesh-list
153942568|NCT02689180|Diuretics|diuretics|mesh-ancestor
153942569|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
153942570|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942571|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153700140|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
153942586|NCT01007448|Bexarotene|bexarotene|mesh-list
153942587|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942588|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153942589|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
153942590|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942591|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
153942592|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942593|NCT04294056|Propofol|propofol|mesh-list
153942594|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153942595|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942596|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942597|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153942598|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
153942599|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
153942600|NCT04186702|Ranibizumab|ranibizumab|mesh-list
153942601|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153942602|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153942603|NCT04186702|Growth Substances|growth substances|mesh-ancestor
153942604|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942605|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
153942606|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942607|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
153942608|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
153942609|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153942610|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153942611|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942612|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
153942615|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153942616|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
153942617|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153942618|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942619|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153942620|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942621|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
153942622|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153942623|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153942624|NCT00638482|Diuretics|diuretics|mesh-ancestor
153942625|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
153942626|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942627|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153942628|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153942629|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942630|NCT00638560|Vitamins|vitamins|mesh-list
153942631|NCT00638560|Vitamin E|vitamin e|mesh-list
153942645|NCT02684812|Coagulants|coagulants|mesh-ancestor
153942646|NCT01004250|Bevacizumab|bevacizumab|mesh-list
153942647|NCT01004250|Pemetrexed|pemetrexed|mesh-list
153942648|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942649|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942650|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153942651|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153942652|NCT01004250|Growth Substances|growth substances|mesh-ancestor
153942653|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942654|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
153942655|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942656|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942657|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153942658|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153942659|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153942660|NCT02688634|Amoxicillin|amoxicillin|mesh-list
153942661|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942662|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
153942663|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153942664|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
153942665|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942666|NCT00639496|Expectorants|expectorants|mesh-ancestor
153942667|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
153942668|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153942669|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
153942670|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942671|NCT00639496|Protective Agents|protective agents|mesh-ancestor
153942672|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942673|NCT00639496|Antidotes|antidotes|mesh-ancestor
153942674|NCT00639574|Nefopam|nefopam|mesh-list
153900418|NCT04709380|Sorafenib|sorafenib|mesh-list
153942675|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153942676|NCT00639574|Analgesics|analgesics|mesh-ancestor
153942677|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
153942678|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942679|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942680|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
153942681|NCT02685046|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153942682|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942683|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942684|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942685|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942686|NCT01004172|Bevacizumab|bevacizumab|mesh-list
153942687|NCT01004172|Trastuzumab|trastuzumab|mesh-list
153942688|NCT01004172|Carboplatin|carboplatin|mesh-list
153942689|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942690|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942691|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153942692|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153833333|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833334|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
153700249|NCT00106548|Methotrexate|methotrexate|mesh-list
153942707|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
153942708|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942709|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942710|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942711|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942712|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153942713|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153942714|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942715|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153942716|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153942717|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942718|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
153942719|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153942720|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153833335|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942721|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153942722|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
153942723|NCT02685670|Fludarabine|fludarabine|mesh-list
153942724|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942725|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
153942726|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942727|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942728|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153942729|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
153942730|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942731|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942732|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153942733|NCT02687932|Valsartan|valsartan|mesh-list
153942734|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153942735|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153942736|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153942737|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153942738|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833336|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942739|NCT00641602|Esomeprazole|esomeprazole|mesh-list
153942740|NCT00641602|Lansoprazole|lansoprazole|mesh-list
153942741|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
153942742|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153942743|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942744|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153942745|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942746|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942747|NCT02682862|Bromides|bromides|mesh-list
153942748|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
153942749|NCT02682862|Olodaterol|olodaterol|mesh-list
153942750|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153942751|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
153942752|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700310|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
153942776|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
153942777|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
153942778|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942779|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942780|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942781|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153942782|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
153942783|NCT02680600|Cefepime|cefepime|mesh-list
153942784|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153942785|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942786|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153942787|NCT04182724|Paclitaxel|paclitaxel|mesh-list
153942788|NCT04182724|Apatinib|apatinib|mesh-list
153942789|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153942790|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942791|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
153942792|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
153942793|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
153942794|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942795|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942796|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942797|NCT04184518|Durvalumab|durvalumab|mesh-list
153942798|NCT04184518|Cediranib|cediranib|mesh-list
153942799|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942800|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942801|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942802|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942803|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942822|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
153942823|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942824|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942825|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
153942826|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942827|NCT01161446|Antibodies|antibodies|mesh-list
153942828|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
154260774|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408264|NCT04243616|Paclitaxel|paclitaxel|mesh-list
153942829|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
153942830|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942831|NCT00641680|Fluticasone|fluticasone|mesh-list
153942832|NCT00641680|Xhance|xhance|mesh-list
153942833|NCT00641680|Budesonide|budesonide|mesh-list
153942834|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942835|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153942836|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
153942837|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942838|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942839|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153942840|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
153942841|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
153942842|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153942843|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
153942844|NCT00641680|Hormones|hormones|mesh-ancestor
153942845|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153942846|NCT01174004|Pimavanserin|pimavanserin|mesh-list
153942847|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153942848|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153942849|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153942850|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153942851|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942852|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942853|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153942854|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153942855|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153942856|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
153942857|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942858|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942859|NCT01173692|Minocycline|minocycline|mesh-list
153942860|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153942861|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942862|NCT00641758|Pycnogenols|pycnogenols|mesh-list
153942888|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942889|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942890|NCT01101035|Allopurinol|allopurinol|mesh-list
153942891|NCT01101035|Febuxostat|febuxostat|mesh-list
153942892|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
153942893|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942894|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942895|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
153833374|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833375|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153833376|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153942896|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942897|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153942898|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
153942899|NCT01101035|Protective Agents|protective agents|mesh-ancestor
153942900|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942901|NCT01160822|Naproxen|naproxen|mesh-list
153942902|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153942903|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153942904|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153942905|NCT01160822|Analgesics|analgesics|mesh-ancestor
153942906|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
153942907|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942908|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942909|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942923|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942924|NCT04296240|Capecitabine|capecitabine|mesh-list
153942925|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
153942926|NCT04296240|Antiemetics|antiemetics|mesh-list
153942927|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153942928|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
153942929|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942930|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942931|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
153942932|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942933|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942934|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942935|NCT04205058|Caffeine|caffeine|mesh-list
153942936|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153942937|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942938|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153942939|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942940|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942941|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153942942|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153942944|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942945|NCT04183738|Ritonavir|ritonavir|mesh-list
153942946|NCT04183738|Darunavir|darunavir|mesh-list
153942947|NCT04183738|Dolutegravir|dolutegravir|mesh-list
153942948|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153942949|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153942951|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942952|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942953|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153942954|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153942955|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
153942956|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942957|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153942958|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153942959|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153942960|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153942961|NCT02682082|Bupivacaine|bupivacaine|mesh-list
153942962|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
153942963|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
153942964|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942965|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942966|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
153942967|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942968|NCT00640432|Celecoxib|celecoxib|mesh-list
153942969|NCT00640432|Diclofenac|diclofenac|mesh-list
153942970|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153700528|NCT00106821|Bromides|bromides|mesh-list
153942986|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942987|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153942988|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153942989|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942991|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942992|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153942993|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
153942994|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942995|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942996|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153942997|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
153942998|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
153942999|NCT00641212|Hormones|hormones|mesh-ancestor
153943000|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943001|NCT04183192|Reslizumab|reslizumab|mesh-list
153943002|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153943003|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
153943004|NCT02681848|Nicotine|nicotine|mesh-list
153943005|NCT02681848|Varenicline|varenicline|mesh-list
153943006|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153943007|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
153943008|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943009|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943010|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153943011|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153943012|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
153943013|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943014|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943015|NCT00997386|Melphalan|melphalan|mesh-list
153943016|NCT00997386|Busulfan|busulfan|mesh-list
153943017|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
153943018|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153943019|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
153943020|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943021|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943022|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153943023|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943024|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
153943025|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833382|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373446|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373447|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373448|NCT05327621|Pamiparib|pamiparib|mesh-list
153373449|NCT05327621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153373450|NCT05327621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373451|NCT05327621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943026|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153943027|NCT02679820|Copper|copper|mesh-list
153943028|NCT02679820|Trace Elements|trace elements|mesh-ancestor
153943029|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
153943050|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943051|NCT05663398|Ibuprofen|ibuprofen|mesh-list
153943052|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153943053|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153943054|NCT05663398|Analgesics|analgesics|mesh-ancestor
153943055|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
153943056|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943057|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943058|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943059|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153943060|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153943061|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943062|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943063|NCT00640744|Atorvastatin|atorvastatin|mesh-list
153943064|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153943065|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153943066|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
153943067|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943068|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153943069|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153943070|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943071|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
153943072|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153943073|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153943074|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943075|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
153943076|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
153943077|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153943078|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
153943079|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
153943080|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153943081|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153943082|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943083|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
153943104|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
153943105|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153943106|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943107|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
153943108|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
153943109|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
153943110|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943111|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943112|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
153943113|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943114|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153943115|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153943116|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
153943117|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153943119|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943120|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153943121|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
153943122|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943123|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943124|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153943125|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
153943126|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
153943127|NCT00641446|Hormones|hormones|mesh-ancestor
153943128|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943129|NCT02677948|Ibrutinib|ibrutinib|mesh-list
153943130|NCT02677948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153943131|NCT02677948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153943132|NCT02677948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943133|NCT02677948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943134|NCT05663164|Thiamine|thiamine|mesh-list
153943135|NCT05663164|Vitamins|vitamins|mesh-ancestor
153943136|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
153943137|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943138|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
153943139|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
153943140|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153943163|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153943164|NCT04180072|Growth Substances|growth substances|mesh-ancestor
153943165|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943166|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
153943167|NCT04180072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153943168|NCT04180072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943169|NCT02678650|Anesthetics|anesthetics|mesh-list
153943170|NCT02678650|Propofol|propofol|mesh-list
153943171|NCT02678650|Isoflurane|isoflurane|mesh-list
153943172|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943173|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943174|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153943175|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153943176|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
153943177|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153943178|NCT04180150|Entecavir|entecavir|mesh-list
153441934|NCT00005641|Leucovorin|leucovorin|mesh-list
153373474|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943179|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
153943180|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943181|NCT02678338|Magrolimab|magrolimab|mesh-list
153943182|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153943183|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943184|NCT00642226|Triamcinolone|triamcinolone|mesh-list
153943185|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943186|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
153943187|NCT00642226|Hormones|hormones|mesh-ancestor
153943188|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943189|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943190|NCT02675530|Ketamine|ketamine|mesh-list
153943191|NCT02675530|Analgesics|analgesics|mesh-ancestor
153943201|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153943202|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943203|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943204|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
153943205|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153943206|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
153943207|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
153943208|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943209|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943210|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943211|NCT02678260|Spartalizumab|spartalizumab|mesh-list
153943212|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153943213|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943214|NCT02678260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153943215|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943216|NCT04179604|Simendan|simendan|mesh-list
153943217|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153943218|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
153943219|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153943220|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153943221|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943222|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943223|NCT04179604|Protective Agents|protective agents|mesh-ancestor
153943224|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943225|NCT02675140|Vitamins|vitamins|mesh-list
153943226|NCT02675140|Vitamin A|vitamin a|mesh-list
153943227|NCT02675140|Albendazole|albendazole|mesh-list
153943228|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
153943229|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
153943230|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943231|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
153943232|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943233|NCT02675140|Protective Agents|protective agents|mesh-ancestor
153943234|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153943235|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943236|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
153943237|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153943238|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943239|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
153943240|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153943241|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153943242|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
153943243|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
153943244|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
153943245|NCT02674906|Heparin|heparin|mesh-list
153943246|NCT02674906|Calcium heparin|calcium heparin|mesh-list
153943247|NCT02674906|Anticoagulants|anticoagulants|mesh-list
153943248|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361223|NCT00825266|Bosentan|bosentan|mesh-list
153943249|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153943250|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153943251|NCT01160744|Carboplatin|carboplatin|mesh-list
153943252|NCT01160744|Gemcitabine|gemcitabine|mesh-list
153943253|NCT01160744|Pemetrexed|pemetrexed|mesh-list
153943254|NCT01160744|Ramucirumab|ramucirumab|mesh-list
153943255|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153943256|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943271|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943273|NCT01160354|Clofarabine|clofarabine|mesh-list
153943274|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153943275|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
153943276|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943277|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943278|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153943279|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153943280|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
153943281|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943282|NCT04178512|Dexamethasone|dexamethasone|mesh-list
153943283|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
153943284|NCT04178512|Fentanyl|fentanyl|mesh-list
153943285|NCT04178512|BB 1101|bb 1101|mesh-list
153943286|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943287|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
153943288|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
153943289|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943290|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943291|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153943292|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
153943293|NCT04178512|Hormones|hormones|mesh-ancestor
153943294|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943295|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153943296|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943297|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
153943298|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943299|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943300|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153943301|NCT04178512|Narcotics|narcotics|mesh-ancestor
153943302|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943303|NCT04178512|Analgesics|analgesics|mesh-ancestor
153943304|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
153943305|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153943306|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153943307|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
153943308|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
153943309|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
153943310|NCT01160198|Chelating Agents|chelating agents|mesh-list
153943311|NCT01160198|Glycine|glycine|mesh-list
153943312|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
153943313|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943314|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
153943315|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943316|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943330|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943331|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153943332|NCT05351086|Analgesics|analgesics|mesh-ancestor
153943333|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
153943334|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943335|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153943336|NCT02885168|Phenylephrine|phenylephrine|mesh-list
153943337|NCT02885168|Protein C|protein c|mesh-list
153943338|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
153943339|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153943340|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
153943341|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
153943342|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943343|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943344|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
153943345|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153943346|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
153943347|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
153943348|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153943349|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153943350|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153943351|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
153943352|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361342|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153361343|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153361344|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943353|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943354|NCT02885168|Protective Agents|protective agents|mesh-ancestor
153943355|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
153943356|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153943357|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153943358|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943359|NCT01159574|Clarithromycin|clarithromycin|mesh-list
153943360|NCT01159574|Dexamethasone|dexamethasone|mesh-list
153373497|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
153943361|NCT01159574|Pomalidomide|pomalidomide|mesh-list
153943362|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943363|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
153943364|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
153943365|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943366|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943367|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153943368|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
153943369|NCT01159574|Hormones|hormones|mesh-ancestor
153943370|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943371|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153943372|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943373|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153943374|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943375|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153943376|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943377|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943378|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153943379|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153943380|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
153943381|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153943397|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153943398|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153943399|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943401|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153943402|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
153943403|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943404|NCT01172288|Expectorants|expectorants|mesh-ancestor
153943405|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
153943406|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153943407|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
153943408|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943409|NCT01172288|Protective Agents|protective agents|mesh-ancestor
153943410|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943411|NCT01172288|Antidotes|antidotes|mesh-ancestor
153943412|NCT02676622|Aldesleukin|aldesleukin|mesh-list
153943413|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
153943414|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
153943415|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943416|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
153943417|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943418|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153943419|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153943420|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
153943421|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943422|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943423|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153943424|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153943425|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153943426|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
153943427|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943428|NCT00644020|Fluorouracil|fluorouracil|mesh-list
153943429|NCT00644020|Mitomycins|mitomycins|mesh-list
153943430|NCT00644020|Mitomycin|mitomycin|mesh-list
153943431|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
153943432|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943433|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153943434|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943435|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943436|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
153408406|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153361473|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943437|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943438|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153943439|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
153943440|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153943441|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943452|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
153943454|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
153943455|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153943456|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153943457|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943458|NCT02672488|Metformin|metformin|mesh-list
153943459|NCT02672488|Sorafenib|sorafenib|mesh-list
153943460|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153943461|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373520|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153373521|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153943462|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943463|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153943464|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943465|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943466|NCT02537392|Folic Acid|folic acid|mesh-list
153943467|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
153943468|NCT02537392|Vitamins|vitamins|mesh-ancestor
153943469|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
153943470|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943471|NCT02537392|Hematinics|hematinics|mesh-ancestor
153943472|NCT02673814|Durvalumab|durvalumab|mesh-list
153943473|NCT02673814|Bavituximab|bavituximab|mesh-list
153943474|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153943475|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943476|NCT00644176|Azithromycin|azithromycin|mesh-list
153943477|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153943478|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943479|NCT04178200|Lidocaine|lidocaine|mesh-list
153943480|NCT04178200|Bupivacaine|bupivacaine|mesh-list
153943481|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153943482|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
153943483|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
153943484|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943485|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943486|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
153943487|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943488|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153943489|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153943490|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153943491|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153943492|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943493|NCT02537158|Sorafenib|sorafenib|mesh-list
153373522|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
153373523|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943494|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943495|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153943496|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943497|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943498|NCT02676154|Fesoterodine|fesoterodine|mesh-list
153373525|NCT04172961|Cyclosporine|cyclosporine|mesh-list
153943499|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153943500|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153943501|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
153943502|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943503|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943504|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943505|NCT02676154|Urological Agents|urological agents|mesh-ancestor
153943506|NCT02676310|Bimatoprost|bimatoprost|mesh-list
153943522|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943524|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153943525|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
153943526|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943527|NCT04176328|Teicoplanin|teicoplanin|mesh-list
153943528|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153943529|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943530|NCT04177342|Fentanyl|fentanyl|mesh-list
153943531|NCT04177342|Oxycodone|oxycodone|mesh-list
153943532|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153943533|NCT04177342|Narcotics|narcotics|mesh-ancestor
153943534|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408443|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
153361531|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
153361532|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
153943535|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943536|NCT04177342|Analgesics|analgesics|mesh-ancestor
153943537|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
153943538|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943539|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153943540|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153943541|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
153943542|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
153943543|NCT04175158|Bevacizumab|bevacizumab|mesh-list
153943544|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
153943545|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153943546|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943547|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153943548|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153943549|NCT04175158|Growth Substances|growth substances|mesh-ancestor
153943550|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943551|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
153943552|NCT02671318|Sirolimus|sirolimus|mesh-list
153943553|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153943554|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943555|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153943556|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943557|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
153943558|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943559|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
153943560|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943561|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
153943562|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
153943563|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
153943564|NCT02668588|Octreotide|octreotide|mesh-list
153943565|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153900659|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153900660|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900661|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701126|NCT00272935|Hormones|hormones|mesh-ancestor
153943583|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943584|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153943585|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153943586|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
153943587|NCT02670616|Prednisolone|prednisolone|mesh-list
153943588|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
153943589|NCT02670616|Rituximab|rituximab|mesh-list
153943590|NCT02670616|Doxorubicin|doxorubicin|mesh-list
153943591|NCT02670616|Vincristine|vincristine|mesh-list
153943592|NCT02670616|Ibrutinib|ibrutinib|mesh-list
153943593|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943594|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
153943595|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943596|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153943597|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153943598|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
153943599|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943600|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943601|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153943602|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153943603|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153943604|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153943605|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153943606|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943607|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153943608|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
153943609|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
153943610|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
153943611|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943612|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
153943613|NCT02670616|Hormones|hormones|mesh-ancestor
153943614|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943615|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153943616|NCT02670616|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153943617|NCT02670616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153943618|NCT00645502|Risperidone|risperidone|mesh-list
153943619|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153943620|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
153943621|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361592|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153943622|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900671|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153900672|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153900673|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153900674|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153943637|NCT00644956|Urological Agents|urological agents|mesh-ancestor
153943638|NCT04175002|Progesterone|progesterone|mesh-list
153943639|NCT04175002|Progestins|progestins|mesh-ancestor
153943640|NCT04175002|Hormones|hormones|mesh-ancestor
153943641|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943642|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943643|NCT02670772|Tenofovir|tenofovir|mesh-list
153943644|NCT02670772|Stavudine|stavudine|mesh-list
153943645|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
153943646|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943647|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153943648|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153943649|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943650|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943651|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153943652|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153943653|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
153943654|NCT04294992|Ondansetron|ondansetron|mesh-list
153943655|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
153943656|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
153943657|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943658|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943659|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153943660|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
153943661|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
153943662|NCT04294992|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153943663|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153943664|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
153943665|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943666|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943667|NCT00628914|Dexetimide|dexetimide|mesh-list
153943668|NCT00628914|Eszopiclone|eszopiclone|mesh-list
153943669|NCT00628914|Citalopram|citalopram|mesh-list
153943670|NCT00628914|Escitalopram|escitalopram|mesh-list
153943671|NCT00628914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153943672|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153943673|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153943674|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943675|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943676|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
153943677|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943678|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153943679|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153943680|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
153943681|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
153943682|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943683|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153943696|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153943697|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153943698|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943699|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943700|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153943701|NCT00645580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153943702|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153943703|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153943704|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943705|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943706|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
153943707|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153943708|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
153943709|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153943710|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153943711|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943712|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153943713|NCT02670304|Aspirin|aspirin|mesh-list
153943714|NCT02670304|Letrozole|letrozole|mesh-list
153943715|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153943716|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153943717|NCT02670304|Analgesics|analgesics|mesh-ancestor
153943718|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
153408538|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
153821673|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943719|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943720|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943721|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943722|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153943723|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153943724|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153943725|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943726|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153943727|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153943728|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943730|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943731|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153943732|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153943733|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153943734|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
153943735|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943736|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
153943737|NCT02671708|Busulfan|busulfan|mesh-list
153943738|NCT02671708|Idarubicin|idarubicin|mesh-list
153943739|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943740|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
153943741|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943742|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153943743|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153943744|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
153943745|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943756|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
153943757|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
153943758|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943759|NCT00998946|Hematinics|hematinics|mesh-ancestor
153943760|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943761|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153943762|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943763|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943764|NCT01158404|LY900009|ly900009|mesh-list
153943765|NCT01158404|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153943766|NCT01158404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943767|NCT01158404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943768|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153943769|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153943770|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153943771|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
153943772|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943773|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153943774|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153943775|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943776|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
153943777|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
153943778|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153943779|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153943780|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943781|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943782|NCT00645034|Urological Agents|urological agents|mesh-ancestor
153943783|NCT04173832|Amantadine|amantadine|mesh-list
153943784|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153943785|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153943786|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
153943787|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943788|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
153943789|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943790|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943791|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943792|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153943793|NCT04173832|Analgesics|analgesics|mesh-ancestor
153943794|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
153943795|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943796|NCT00645658|Testosterone|testosterone|mesh-list
153943797|NCT00645658|Androgens|androgens|mesh-ancestor
153943798|NCT00645658|Hormones|hormones|mesh-ancestor
153361702|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153943799|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943800|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943801|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
153943802|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
153943803|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943804|NCT02666170|Protective Agents|protective agents|mesh-ancestor
153943805|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943806|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
153943807|NCT02666170|Vitamins|vitamins|mesh-ancestor
153943808|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
153943809|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
153943810|NCT02667262|Narcotics|narcotics|mesh-ancestor
153943811|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943832|NCT02537080|Nimodipine|nimodipine|mesh-list
153943833|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153943834|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153943835|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153943836|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943837|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153943838|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943839|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
153943840|NCT02667496|Sargramostim|sargramostim|mesh-list
153943841|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
153943842|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943843|NCT00645112|Azithromycin|azithromycin|mesh-list
153943844|NCT00645112|Cefdinir|cefdinir|mesh-list
153943845|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153943846|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943847|NCT00645112|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153943848|NCT00645112|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153943849|NCT02666092|Antibodies|antibodies|mesh-list
153943850|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
153943851|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943852|NCT00645814|Adalimumab|adalimumab|mesh-list
153943853|NCT00645814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153943854|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943855|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153943856|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153943857|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
153943858|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153943859|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
153943860|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153943861|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943862|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153943863|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153943864|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943866|NCT00645892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153943867|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943868|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153943881|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153943882|NCT00910390|Growth Substances|growth substances|mesh-ancestor
153943883|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943884|NCT02665936|Dexamethasone|dexamethasone|mesh-list
153943885|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
153943886|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
153943887|NCT02665936|BB 1101|bb 1101|mesh-list
153943888|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943889|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
153943890|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
153833572|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
153373641|NCT03349281|Hormones|hormones|mesh-ancestor
153373642|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153442193|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
153442194|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442195|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
153943891|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943892|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943893|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153943894|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
153943895|NCT02665936|Hormones|hormones|mesh-ancestor
153943896|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943897|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153943898|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943899|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
153943900|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943901|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821801|NCT00438321|Goserelin|goserelin|mesh-list
153943902|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
153943903|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
153943904|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943905|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
153943906|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
153943907|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153943908|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943909|NCT04292886|Tamoxifen|tamoxifen|mesh-list
153943910|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943911|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153943912|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
153943913|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943914|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153943915|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943916|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153943917|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153943918|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153943919|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
153943920|NCT04292418|Tacrolimus|tacrolimus|mesh-list
153943921|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153943922|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
153943923|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943924|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153943925|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943926|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943927|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153943928|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943929|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153943930|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
153943931|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153943932|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943953|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153943954|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
153943955|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943956|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943957|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153943958|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153943959|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
153943960|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
153943962|NCT02669368|Analgesics|analgesics|mesh-ancestor
153943963|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
153943964|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943965|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943966|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
153943967|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833612|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442213|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442214|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442215|NCT02106156|Interferons|interferons|mesh-list
153442216|NCT02106156|Ribavirin|ribavirin|mesh-list
153442217|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
153442218|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
153442219|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153442220|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442221|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
153442222|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442223|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
153442224|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442225|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
153442226|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943968|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153943969|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
153943970|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153943971|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153943972|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943973|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153943974|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
153943975|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153943976|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153943977|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153943978|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153943979|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
153943980|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
153943981|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153944002|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153944003|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153944004|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944005|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153944006|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153944007|NCT02665702|Growth Substances|growth substances|mesh-ancestor
153944008|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944009|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
153944011|NCT00646750|Melphalan|melphalan|mesh-list
153944012|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153944013|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944014|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
153944015|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944016|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944017|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153944018|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
153944019|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944020|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153944021|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153944023|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
153944024|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153944025|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944026|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153944027|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
153944028|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944029|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944030|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153944031|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
153944032|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
153944033|NCT00646516|Hormones|hormones|mesh-ancestor
153944034|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944035|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153538572|NCT01529125|Nevirapine|nevirapine|mesh-list
153944057|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153944059|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153944060|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
153944061|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944062|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944063|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153944064|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
153944065|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
153944066|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153944067|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
153944068|NCT00646594|Hormones|hormones|mesh-ancestor
153944069|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944070|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153944071|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153944072|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153944073|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944074|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944075|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944076|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
153944077|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153944078|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
153944079|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944080|NCT00647140|Levodopa|levodopa|mesh-list
153944081|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
153944082|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944083|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944084|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944085|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153944086|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153944087|NCT00647218|Paclitaxel|paclitaxel|mesh-list
153944088|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153701676|NCT00108849|Estrogens|estrogens|mesh-ancestor
153944125|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944138|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153944139|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
153944140|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153944141|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153944143|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153944144|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944145|NCT00648778|Loxapine|loxapine|mesh-list
153944146|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153944147|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153944148|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944149|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944150|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153944151|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153944152|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
153944153|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944154|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944156|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153944157|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153944158|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
153833619|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
153373687|NCT03206151|Hematinics|hematinics|mesh-ancestor
153373688|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153373689|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
153373690|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153373691|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373692|NCT01841021|Immunotoxins|immunotoxins|mesh-ancestor
153373693|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
153373694|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900849|NCT03345784|Cisplatin|cisplatin|mesh-list
153944159|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944160|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153944161|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153944162|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944163|NCT04172740|Calcium|calcium|mesh-list
153944164|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153944165|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944166|NCT02663596|Vancomycin|vancomycin|mesh-list
153944167|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153944168|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944169|NCT00647530|Capecitabine|capecitabine|mesh-list
153944170|NCT00647530|Fluorouracil|fluorouracil|mesh-list
153944171|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
153944172|NCT00647530|Panitumumab|panitumumab|mesh-list
153944173|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153944174|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
153944175|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944176|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944177|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153944178|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
153944179|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944180|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153944181|NCT00647608|Propranolol|propranolol|mesh-list
153944182|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153944183|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153944184|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944185|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944186|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944187|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944214|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153944215|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944216|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944217|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944218|NCT02660008|Glucagon|glucagon|mesh-list
153944219|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153944220|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153944221|NCT02660008|Hormones|hormones|mesh-ancestor
153944222|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944223|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944225|NCT00649168|Bromocriptine|bromocriptine|mesh-list
153944226|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153944227|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153944228|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
153944229|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944230|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944231|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
153944232|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
153944233|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900860|NCT03345576|Hormones|hormones|mesh-ancestor
153944234|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944235|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
153944253|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944254|NCT00647686|Analgesics|analgesics|mesh-ancestor
153944255|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
153944256|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944257|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153944258|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153944259|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
153944260|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
153944261|NCT02663050|Diclofenac|diclofenac|mesh-list
153944262|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153944263|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153944264|NCT02663050|Analgesics|analgesics|mesh-ancestor
153944265|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
153944266|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944267|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944268|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944269|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944270|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153944271|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361907|NCT02504892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944272|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944273|NCT00648856|Sertraline|sertraline|mesh-list
153944274|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
153944275|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153944276|NCT00648856|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153944277|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153944278|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944279|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944280|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944281|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
153944282|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944283|NCT01171976|Ranibizumab|ranibizumab|mesh-list
153944284|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153944285|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153944286|NCT01171976|Growth Substances|growth substances|mesh-ancestor
153944287|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944288|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
153944289|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944290|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
153944291|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944292|NCT00647842|Fentanyl|fentanyl|mesh-list
153944293|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153944325|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153944327|NCT04291794|Propofol|propofol|mesh-list
153944328|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153944329|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944330|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944331|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153944332|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
153944333|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
153944334|NCT02662660|Acetaminophen|acetaminophen|mesh-list
153944355|NCT00647920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153944356|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944357|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944358|NCT00830869|Ixazomib|ixazomib|mesh-list
153944359|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944360|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
153944361|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944362|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944363|NCT02662504|Cisplatin|cisplatin|mesh-list
153944364|NCT02662504|Pemetrexed|pemetrexed|mesh-list
153944365|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153944366|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944367|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944368|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944369|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153944370|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153944371|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
153944372|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153944374|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
153944375|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153944376|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944377|NCT02659228|Anesthetics|anesthetics|mesh-list
153944378|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
153944379|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944380|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944381|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
153944382|NCT00844519|Maraviroc|maraviroc|mesh-list
153944383|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153944384|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153944385|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944386|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153944387|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153944388|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
153944389|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944390|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153944391|NCT00702793|Varenicline|varenicline|mesh-list
153944392|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153701958|NCT00280969|Efavirenz|efavirenz|mesh-list
153944465|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153944467|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153944468|NCT00995670|Sevoflurane|sevoflurane|mesh-list
153944469|NCT00995670|Simvastatin|simvastatin|mesh-list
153361955|NCT05946122|Antimetabolites|antimetabolites|mesh-ancestor
153361959|NCT05946122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944470|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944491|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153944492|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
153944493|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153944494|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153944495|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944496|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153944497|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153944498|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153944499|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
153944500|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944501|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944502|NCT00648076|Valproic Acid|valproic acid|mesh-list
153944503|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
153944504|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944505|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944506|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
153944507|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944508|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944509|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
153944510|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153944511|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944512|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153944513|NCT00649012|Pioglitazone|pioglitazone|mesh-list
153944514|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153944515|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944516|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
153944517|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153944518|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153944519|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944520|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
153944521|NCT04170088|Coagulants|coagulants|mesh-ancestor
153944522|NCT00648154|Letrozole|letrozole|mesh-list
153944524|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153944525|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153944526|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944527|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944540|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
153900881|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
153944541|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944542|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153944543|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153944544|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153944545|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944546|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944547|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
153944548|NCT02661100|Poly ICLC|poly iclc|mesh-list
153944549|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153944550|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944551|NCT02661100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153944552|NCT02661100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944553|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
153944554|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
153944555|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944556|NCT00601354|Orlistat|orlistat|mesh-list
153944557|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944558|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944559|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153944560|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153944561|NCT02660866|Vorapaxar|vorapaxar|mesh-list
153944562|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153944563|NCT00853099|Adalimumab|adalimumab|mesh-list
153944564|NCT00853099|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153944565|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944566|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944567|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153944568|NCT00648310|Estrogens|estrogens|mesh-list
153944569|NCT00648310|Hormones|hormones|mesh-ancestor
153944570|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944571|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944572|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153944573|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153944574|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
153944575|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944576|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944577|NCT00648310|Urological Agents|urological agents|mesh-ancestor
153944579|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153944580|NCT00702871|Sucralfate|sucralfate|mesh-list
153944581|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153944582|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153944583|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153944584|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
153944585|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
153944586|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944587|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944588|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944599|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153944600|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153944601|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944602|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153944604|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153944605|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153944606|NCT00992394|Analgesics|analgesics|mesh-ancestor
153442322|NCT02124564|Lacosamide|lacosamide|mesh-list
153944607|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
153944608|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944609|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944610|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944611|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944612|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153944613|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153944614|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
153944615|NCT00829933|Warfarin|warfarin|mesh-list
153944616|NCT00829933|Edoxaban|edoxaban|mesh-list
153944617|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
153944618|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153944619|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
153944620|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153944621|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
153944622|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944623|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944624|NCT01170962|Ribavirin|ribavirin|mesh-list
153944625|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153944626|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
153944627|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944628|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
153944629|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944630|NCT00843193|Fluticasone|fluticasone|mesh-list
153944631|NCT00843193|Xhance|xhance|mesh-list
153944632|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944633|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153944634|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
153944635|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944636|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944637|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153944638|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
153944639|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
153944640|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153944641|NCT00853021|Aldesleukin|aldesleukin|mesh-list
153944642|NCT00853021|Bevacizumab|bevacizumab|mesh-list
153944643|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153944644|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944645|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153944646|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153944647|NCT00853021|Growth Substances|growth substances|mesh-ancestor
153944648|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944649|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
153944650|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153944651|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153944652|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
153944653|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944674|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944675|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
154260775|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260776|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153944676|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944677|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944678|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
153944679|NCT01156376|Listerine|listerine|mesh-list
153944680|NCT01156376|Fluorides|fluorides|mesh-list
153944681|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
153944682|NCT01156376|Protective Agents|protective agents|mesh-ancestor
153944683|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944684|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153944685|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944686|NCT01156142|Doxepin|doxepin|mesh-list
153944687|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153944688|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153944689|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944690|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944691|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153944692|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
153944693|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153944694|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
153944695|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
153944696|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944697|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944698|NCT00842257|Panitumumab|panitumumab|mesh-list
153944699|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153944700|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944701|NCT00706069|Capecitabine|capecitabine|mesh-list
153944702|NCT00706069|Vinorelbine|vinorelbine|mesh-list
153944703|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153944704|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
153944705|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944726|NCT00852397|Apixaban|apixaban|mesh-list
153944727|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153944728|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
153944729|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153944730|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
153944731|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944732|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944733|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
153944734|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
153944735|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153944736|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
153944737|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944738|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
153944739|NCT00852241|Protective Agents|protective agents|mesh-ancestor
153944740|NCT02612233|Pregabalin|pregabalin|mesh-list
153373796|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153373797|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
153373798|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442415|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
153442416|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442417|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442418|NCT02121756|Dipyridamole|dipyridamole|mesh-list
153442419|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153442420|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442421|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733432|NCT05148169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153733433|NCT05148169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153944741|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153944742|NCT02612233|Analgesics|analgesics|mesh-ancestor
153944743|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
153944744|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944745|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944746|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
153944747|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153944748|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944749|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944750|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153944751|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153944752|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153944753|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944754|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153944755|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153944756|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153944757|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944758|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
153944759|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
153944786|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944787|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944789|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
153944790|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362360|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362361|NCT03740100|MTOR Inhibitors|mtor inhibitors|mesh-list
153362362|NCT03740100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153362363|NCT03740100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944791|NCT04117243|Misoprostol|misoprostol|mesh-list
153944792|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
153944793|NCT04117243|Oxytocin|oxytocin|mesh-list
153944794|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
153944795|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153944796|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944797|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153944798|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153944799|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944800|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
153944801|NCT04117243|Coagulants|coagulants|mesh-ancestor
153944802|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153944803|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
153944804|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153944805|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153944806|NCT01169558|Bevacizumab|bevacizumab|mesh-list
153944807|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153944808|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944809|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153944810|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153944844|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153944845|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153944846|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
153944847|NCT00839527|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153944848|NCT00839527|Incretins|incretins|mesh-ancestor
153944849|NCT00839527|Hormones|hormones|mesh-ancestor
153944850|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944851|NCT00706927|Timolol|timolol|mesh-list
153944852|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153944853|NCT00706927|Latanoprost|latanoprost|mesh-list
153944854|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153944855|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153944875|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944876|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153944877|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
153944878|NCT00707083|Hormones|hormones|mesh-ancestor
153944879|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944880|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153944881|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944882|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153944883|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
153944884|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153944885|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153944886|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
153944887|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944888|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
153944889|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944890|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153944891|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153944892|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
153944893|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944894|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153944895|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153944896|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
153944897|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
153944898|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
153944899|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
153944900|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153944901|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944902|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944903|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153944904|NCT05500261|Analgesics|analgesics|mesh-ancestor
153944905|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
153944906|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944907|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153944908|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153944910|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944930|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944931|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153944932|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153944933|NCT00649324|Diuretics|diuretics|mesh-ancestor
153944934|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
153944935|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944936|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153944937|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944938|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944939|NCT00648388|Cilostazol|cilostazol|mesh-list
153944940|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153944941|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
153944942|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944943|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944944|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153944945|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
153944946|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153944947|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153944948|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944949|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153944950|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
153944951|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153944952|NCT00648388|Protective Agents|protective agents|mesh-ancestor
153944953|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153944954|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153944955|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944956|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
153944957|NCT02658760|Bupivacaine|bupivacaine|mesh-list
153944958|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
153944959|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
153944960|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944961|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944962|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
153702530|NCT00110604|Folic Acid|folic acid|mesh-list
153944979|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153944980|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
153944981|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
153944982|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153373826|NCT04950621|Propofol|propofol|mesh-list
153944983|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153944984|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153944985|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153944986|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
153944987|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
153944988|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944989|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944990|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153944991|NCT02536690|Narcotics|narcotics|mesh-ancestor
153944992|NCT02536690|Analgesics|analgesics|mesh-ancestor
153944993|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
153944994|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944995|NCT00649090|Exemestane|exemestane|mesh-list
153944996|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944997|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153944998|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153944999|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945000|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945001|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153945002|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
153945003|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945004|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945005|NCT00838903|Metformin|metformin|mesh-list
153945006|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153945007|NCT00838903|Glimepiride|glimepiride|mesh-list
153945008|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
153945009|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153945010|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153945011|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945012|NCT00838903|Incretins|incretins|mesh-ancestor
153945013|NCT00838903|Hormones|hormones|mesh-ancestor
153945014|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945015|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153945016|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
153945017|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822585|NCT02274051|Kinetin|kinetin|mesh-list
153945018|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945019|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153945020|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153945021|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
153945022|NCT00838903|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153945032|NCT00649402|Benazepril|benazepril|mesh-list
153945033|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153945034|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153945035|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945036|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945037|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945038|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945039|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
153945040|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153945041|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
153945042|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945043|NCT00649480|Balsalazide|balsalazide|mesh-list
153945044|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153945045|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153945046|NCT00649480|Analgesics|analgesics|mesh-ancestor
153945047|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
153945048|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945049|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945050|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945051|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153945052|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153945053|NCT02656342|Cycloserine|cycloserine|mesh-list
153945054|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153945055|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945056|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153945057|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
153945058|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153945059|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
153945060|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945061|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
153945062|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
153945063|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945064|NCT00650416|Carvedilol|carvedilol|mesh-list
153945065|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153945066|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153945067|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
153945068|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945069|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945070|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945071|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153945072|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
153945073|NCT00650416|Protective Agents|protective agents|mesh-ancestor
153945074|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153945075|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945076|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945077|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
153945078|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153945079|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153442537|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373851|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153373852|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
153373853|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373854|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373855|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373856|NCT04457219|Hemostatics|hemostatics|mesh-list
153945080|NCT00649948|Metformin|metformin|mesh-list
153945081|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153945082|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945083|NCT04167982|Isotretinoin|isotretinoin|mesh-list
153945084|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153945085|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
153945086|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153945087|NCT00649558|Pioglitazone|pioglitazone|mesh-list
153945105|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945107|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373857|NCT04457219|Coagulants|coagulants|mesh-ancestor
153945108|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153945109|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153945110|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945111|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945112|NCT02658214|Leucovorin|leucovorin|mesh-list
153945113|NCT02658214|Folic Acid|folic acid|mesh-list
153945114|NCT02658214|Paclitaxel|paclitaxel|mesh-list
153945115|NCT02658214|Etoposide|etoposide|mesh-list
153945116|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153945117|NCT02658214|Carboplatin|carboplatin|mesh-list
153945119|NCT02658214|Fluorouracil|fluorouracil|mesh-list
153945120|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
153945122|NCT02658214|Tremelimumab|tremelimumab|mesh-list
153945123|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
153945124|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153945125|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945126|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
153945127|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
153945128|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
153945129|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945130|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153945131|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
153945132|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945133|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702729|NCT00110877|Darunavir|darunavir|mesh-list
153945134|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
153945135|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153945136|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153945137|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945138|NCT02658214|Antidotes|antidotes|mesh-ancestor
153945139|NCT02658214|Protective Agents|protective agents|mesh-ancestor
153945140|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
153945141|NCT02658214|Vitamins|vitamins|mesh-ancestor
153945142|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
153945143|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153945144|NCT02658214|Hematinics|hematinics|mesh-ancestor
153945145|NCT04169230|Citalopram|citalopram|mesh-list
153945146|NCT04169230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153945147|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153945148|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945168|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
153945169|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945170|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
153945171|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
153945172|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945173|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945174|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153945175|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
153945176|NCT02651350|Hormones|hormones|mesh-ancestor
153945177|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945178|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153945179|NCT02651350|Protective Agents|protective agents|mesh-ancestor
153945180|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153945181|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945182|NCT02658292|Naftifine|naftifine|mesh-list
153945183|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
153945184|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945185|NCT02651038|Micafungin|micafungin|mesh-list
153945186|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
153945187|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945188|NCT00650026|Adalimumab|adalimumab|mesh-list
153945189|NCT00650026|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153945190|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945191|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153945192|NCT00838513|Eculizumab|eculizumab|mesh-list
153945193|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153945194|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153945195|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
153945196|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945197|NCT00649636|Fluoxetine|fluoxetine|mesh-list
153945198|NCT00649636|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153945199|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153945200|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945201|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945202|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945203|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
153945236|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
153945237|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945238|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945239|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
153945241|NCT02657512|Protective Agents|protective agents|mesh-ancestor
153945242|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945243|NCT00818779|Amlodipine|amlodipine|mesh-list
153945244|NCT00818779|Aliskiren|aliskiren|mesh-list
153945245|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153945256|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
154260777|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153945257|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153945258|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945259|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945260|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945261|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945262|NCT00600028|Thalidomide|thalidomide|mesh-list
153945263|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153945264|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
153945265|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945266|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
153945267|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153945268|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945269|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153945270|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153945271|NCT00600028|Growth Substances|growth substances|mesh-ancestor
153945272|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
153945273|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945275|NCT02650102|Risperidone|risperidone|mesh-list
153945276|NCT02650102|Aripiprazole|aripiprazole|mesh-list
153945277|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153945278|NCT02650102|Ziprasidone|ziprasidone|mesh-list
153945279|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153945280|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
153945281|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945282|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945283|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945284|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153945285|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153945286|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945287|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153945288|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153945289|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
153945290|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
153945291|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
153945292|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945293|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153945294|NCT02650102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153945295|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153945296|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945297|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
153945298|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
153945299|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153945300|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153945301|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153945302|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153945303|NCT00650182|Fentanyl|fentanyl|mesh-list
153945304|NCT00650182|Naltrexone|naltrexone|mesh-list
153945305|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153945306|NCT00650182|Narcotics|narcotics|mesh-ancestor
153945307|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945308|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945309|NCT00650182|Analgesics|analgesics|mesh-ancestor
153945310|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
153945329|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945331|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153945332|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
153945333|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153945334|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153945335|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153945336|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153945337|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
153945338|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
153945339|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833829|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833830|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833831|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833832|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153833833|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153833834|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442584|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153442585|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153442586|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153442587|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945340|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153945341|NCT00910780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153945342|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153945343|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945344|NCT02656810|Teriparatide|teriparatide|mesh-list
153945345|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945346|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945347|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153945349|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153945350|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153945351|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945352|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153945353|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
153945354|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945355|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945356|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153945357|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
153945358|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
153945359|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153945360|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153945361|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153945362|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153945363|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
153945364|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945365|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945366|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
153945388|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153945389|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
153945390|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945391|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945392|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153945393|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153945394|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153945395|NCT00649870|Valacyclovir|valacyclovir|mesh-list
153945396|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
153945397|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945398|NCT04167280|Ipratropium|ipratropium|mesh-list
153945399|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153945400|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
153945401|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945402|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945403|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153945404|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
153945405|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153945406|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
153945407|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945408|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945409|NCT02648854|Metformin|metformin|mesh-list
153945410|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153945411|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945412|NCT02652598|Tolcapone|tolcapone|mesh-list
153945413|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153945414|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153945415|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153945416|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945417|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945418|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153945419|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945420|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945421|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
153702975|NCT00077948|Metoprolol|metoprolol|mesh-list
153945439|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153945441|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153945442|NCT02644720|Dexamethasone|dexamethasone|mesh-list
153945443|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945444|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
153945445|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
153945446|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945447|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945448|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153945449|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
153945450|NCT02644720|Hormones|hormones|mesh-ancestor
153945451|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945452|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153945453|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945454|NCT03542266|Azacitidine|azacitidine|mesh-list
153945456|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153945457|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
153945458|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945459|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945460|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945461|NCT00652600|Propranolol|propranolol|mesh-list
153945462|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153945463|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153945464|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
153945465|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945466|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945467|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945468|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153945469|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153945470|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
153945471|NCT04166578|Lidocaine|lidocaine|mesh-list
153945472|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
153945473|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
153945474|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945475|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945476|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
153945477|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945478|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153945479|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153945480|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153945481|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945507|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
153945508|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945509|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945511|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153945512|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153945513|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153945514|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
153945515|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153945516|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945517|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153945518|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153945519|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153945520|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945522|NCT02644486|Sevelamer|sevelamer|mesh-list
153945523|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153945524|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153945525|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153945526|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945527|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
153945528|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
153945529|NCT00827359|Everolimus|everolimus|mesh-list
153945553|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945555|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
153945556|NCT02613247|Protective Agents|protective agents|mesh-ancestor
153945557|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945558|NCT02641132|Mitomycins|mitomycins|mesh-list
153945559|NCT02641132|Mitomycin|mitomycin|mesh-list
153945560|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153945561|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945562|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
153945563|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945564|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153945565|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945566|NCT00653614|Drospirenone|drospirenone|mesh-list
153442623|NCT02116530|Hormones|hormones|mesh-ancestor
153945567|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153945568|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
153945569|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945570|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945571|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153945573|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
153945574|NCT02644252|Tocotrienols|tocotrienols|mesh-list
153945575|NCT02644252|Vitamin E|vitamin e|mesh-list
153945576|NCT02644252|Tocopherols|tocopherols|mesh-list
153945577|NCT02644252|Carboplatin|carboplatin|mesh-list
153945578|NCT02644252|Vinorelbine|vinorelbine|mesh-list
153945579|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945580|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153822905|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153945581|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
153703133|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
153945595|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945596|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
153945597|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153945598|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945599|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945600|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
153945601|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153945602|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153945603|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945604|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153945605|NCT00818389|Protective Agents|protective agents|mesh-ancestor
153945606|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153945608|NCT02640976|Menotropins|menotropins|mesh-list
153945609|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153945610|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945611|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153945612|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
153945613|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
153945614|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945615|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
153945616|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
153945617|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945618|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153945619|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153945620|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945621|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153945622|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945623|NCT02640898|Docetaxel|docetaxel|mesh-list
153945624|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945625|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
153945626|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
153945627|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
153945628|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945629|NCT02535910|Vitamin D|vitamin d|mesh-list
153945630|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
153945631|NCT02535910|Calcifediol|calcifediol|mesh-list
153945632|NCT02535910|Vitamins|vitamins|mesh-ancestor
153945633|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
153945634|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442685|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442686|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153442687|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153442706|NCT02085252|Leuprolide|leuprolide|mesh-list
153945635|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153945636|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945637|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153945638|NCT00849901|Fluoxetine|fluoxetine|mesh-list
153945639|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153945640|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153945641|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153703180|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153945661|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945662|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945663|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945664|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153945665|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153945666|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153945667|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
153945668|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945669|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153945670|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153945671|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945672|NCT04166890|Epinephrine|epinephrine|mesh-list
153945673|NCT04166890|Carticaine|carticaine|mesh-list
153945674|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153945675|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153945676|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
153945677|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945678|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945679|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945680|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153945681|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153945682|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
153945683|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945684|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153945685|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
153945686|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
153945687|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
153945688|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153901280|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901281|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901282|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901283|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
153901284|NCT02697344|Hormones|hormones|mesh-ancestor
153901285|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901286|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153901287|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901288|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
153901289|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153945689|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
153945690|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
153945691|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945692|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
153945693|NCT00652912|Clonazepam|clonazepam|mesh-list
153945708|NCT00817531|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153945709|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153945710|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945711|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945712|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945714|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
153945715|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153945716|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153945717|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153945718|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945719|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153945720|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153945721|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945722|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945723|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945724|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153945725|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153945726|NCT02640508|Lenvatinib|lenvatinib|mesh-list
153945727|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945728|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153945729|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945730|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945731|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
153945732|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153945733|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153945734|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945735|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
153945736|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
153945737|NCT02643550|Cetuximab|cetuximab|mesh-list
153945738|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153945739|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945740|NCT00817063|Alitretinoin|alitretinoin|mesh-list
153945741|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945742|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
153945743|NCT04313270|Evolocumab|evolocumab|mesh-list
153901291|NCT02697344|Growth Substances|growth substances|mesh-ancestor
153945744|NCT04313270|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153945745|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153945746|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153945747|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
153945748|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945749|NCT04313270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153945750|NCT04313270|Protease Inhibitors|protease inhibitors|mesh-ancestor
153945751|NCT04313270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945752|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153945753|NCT00826267|Trastuzumab|trastuzumab|mesh-list
153945754|NCT00826267|Lapatinib|lapatinib|mesh-list
153945755|NCT00826267|Afatinib|afatinib|mesh-list
153945788|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153945790|NCT00986154|Dalteparin|dalteparin|mesh-list
153945792|NCT00986154|Edoxaban|edoxaban|mesh-list
153945793|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
153945794|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153703357|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
153945819|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
153945820|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
153945821|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
153945822|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153945823|NCT02613091|Clemastine|clemastine|mesh-list
153945824|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
153945825|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
153945826|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153945827|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
153945828|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
153945829|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945830|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945831|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945833|NCT02646904|Beclomethasone|beclomethasone|mesh-list
153945834|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945835|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
153945836|NCT02646904|Hormones|hormones|mesh-ancestor
153945837|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945838|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945839|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153945840|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
153945841|NCT00848965|Fluticasone|fluticasone|mesh-list
153945842|NCT00848965|Xhance|xhance|mesh-list
153945843|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945844|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153945845|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
153945846|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945847|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945866|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
153945867|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945868|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153945869|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945870|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153945871|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
153945872|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153945873|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153945874|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945875|NCT00654160|Antidotes|antidotes|mesh-ancestor
153945876|NCT00654160|Protective Agents|protective agents|mesh-ancestor
153945877|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
153945878|NCT00654160|Vitamins|vitamins|mesh-ancestor
153945879|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
153945880|NCT02642380|Dexamethasone|dexamethasone|mesh-list
153945881|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
153945882|NCT02642380|BB 1101|bb 1101|mesh-list
153945883|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945884|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
153945885|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
153945886|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945887|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945888|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153945889|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
153945890|NCT02642380|Hormones|hormones|mesh-ancestor
153945891|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945892|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153945893|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945894|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
153945895|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945896|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945897|NCT01154036|Atorvastatin|atorvastatin|mesh-list
153945898|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153945899|NCT01154036|Ezetimibe|ezetimibe|mesh-list
153945900|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153945901|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153945902|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
153945903|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945904|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153945905|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153945920|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153945922|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153945923|NCT00816595|Growth Substances|growth substances|mesh-ancestor
153945924|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
153945925|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153945926|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945927|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
153945928|NCT01166438|Trospium chloride|trospium chloride|mesh-list
153945929|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
153945930|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153945931|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153945932|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153945933|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945934|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945935|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
154260779|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
153945936|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945937|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945938|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153945939|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945940|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153945941|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153945942|NCT01166438|Urological Agents|urological agents|mesh-ancestor
153945943|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
153945945|NCT00707707|Paclitaxel|paclitaxel|mesh-list
153945946|NCT00707707|Olaparib|olaparib|mesh-list
153945947|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153945948|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374020|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
153374021|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374022|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153374023|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153374024|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
153442772|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442773|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945949|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
153945950|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
153945951|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
153945952|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945953|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153945954|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945955|NCT01153958|Metronidazole|metronidazole|mesh-list
153945956|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
153945957|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945958|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153945959|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153945960|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153945961|NCT00707785|Vitamin A|vitamin a|mesh-list
153945962|NCT00707785|Vitamins|vitamins|mesh-ancestor
153945963|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
153945964|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945965|NCT00599638|Pregabalin|pregabalin|mesh-list
153945966|NCT00599638|Analgesics|analgesics|mesh-ancestor
153945967|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
153703514|NCT00291538|Bortezomib|bortezomib|mesh-list
153945973|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945974|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945975|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153945976|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153945977|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945978|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153945979|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
153945980|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
153945981|NCT02642146|Calcium|calcium|mesh-list
153945982|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
153945983|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945984|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945985|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945986|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945987|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945988|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153945989|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153945990|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153945991|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
153945992|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945993|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153945994|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153945995|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945996|NCT00653302|Metformin|metformin|mesh-list
153945997|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
153945998|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153945999|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946000|NCT02638870|Amitriptyline|amitriptyline|mesh-list
153946001|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153946002|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
153946003|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153442774|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
153946004|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153946005|NCT02638870|Analgesics|analgesics|mesh-ancestor
153946006|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
153946007|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946008|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946009|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153946010|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153946011|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946012|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946013|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
153946014|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946015|NCT02641990|Exenatide|exenatide|mesh-list
153946016|NCT02641990|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153946017|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153946018|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946019|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153946020|NCT02641990|Incretins|incretins|mesh-ancestor
153946021|NCT02641990|Hormones|hormones|mesh-ancestor
153946022|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946023|NCT00653380|Doxycycline|doxycycline|mesh-list
153946024|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946025|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946026|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
153946027|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153946028|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153946029|NCT02646592|Alfentanil|alfentanil|mesh-list
153946030|NCT02646592|Propofol|propofol|mesh-list
153946031|NCT02646592|Sevoflurane|sevoflurane|mesh-list
153946032|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153946033|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946034|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946035|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153946058|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946060|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
153946061|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946062|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946063|NCT01166282|Adalimumab|adalimumab|mesh-list
153946064|NCT01166282|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153946065|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153946066|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153946067|NCT01153724|Fluconazole|fluconazole|mesh-list
153946068|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
153946069|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946070|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153946071|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153946072|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946073|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946074|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153946075|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
153946076|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946077|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946078|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153946079|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153946080|NCT02884388|Anesthetics|anesthetics|mesh-list
153946081|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946082|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946083|NCT02885948|Naloxone|naloxone|mesh-list
153374069|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374070|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834001|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
153946084|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153946085|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946086|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
153703633|NCT00275119|Fluorouracil|fluorouracil|mesh-list
153946119|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153946120|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946121|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153946122|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153946123|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946124|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946126|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946141|NCT04292184|Antidotes|antidotes|mesh-ancestor
153946142|NCT04292184|Protective Agents|protective agents|mesh-ancestor
153946143|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946144|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
153946145|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946146|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
153946147|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946148|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946149|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
153946150|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
153946151|NCT01147640|Metronidazole|metronidazole|mesh-list
153946152|NCT01147640|Meropenem|meropenem|mesh-list
153946153|NCT01147640|Tazobactam|tazobactam|mesh-list
153946154|NCT01147640|Ceftolozane|ceftolozane|mesh-list
153823303|NCT00457964|Everolimus|everolimus|mesh-list
153946155|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946156|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946157|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153946158|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153946159|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153946160|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946161|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946162|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153946163|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946164|NCT01121900|Trazodone|trazodone|mesh-list
153946165|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153946166|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153946167|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946168|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946169|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153946170|NCT01121900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153946171|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153946172|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946173|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946174|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946175|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
153946176|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153946177|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
153946178|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153946179|NCT01121666|Hormones|hormones|mesh-ancestor
153946180|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946181|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946182|NCT00984126|Factor VIII|factor viii|mesh-list
153703773|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
153946184|NCT02868996|Kallikreins|kallikreins|mesh-list
153946185|NCT02868996|Coagulants|coagulants|mesh-ancestor
153946186|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153946187|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
153946209|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946210|NCT00982644|Insulin|insulin|mesh-list
153946211|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153946212|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
153946213|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153946214|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946215|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153946216|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153946217|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153946218|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
153901419|NCT00992238|Flavoxate|flavoxate|mesh-list
153946219|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946220|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153946221|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153946222|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946223|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
153946224|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153946225|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153946226|NCT02867904|Prednisolone|prednisolone|mesh-list
153946227|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
153946228|NCT02867904|Bupivacaine|bupivacaine|mesh-list
153946229|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153946230|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
153946231|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153946232|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
153946233|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
153946234|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946235|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946236|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153946237|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
153946238|NCT02867904|Hormones|hormones|mesh-ancestor
153946239|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946240|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153946263|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153946264|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
153946265|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946266|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946267|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153946268|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
153946269|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153946270|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363334|NCT03217292|Narcotics|narcotics|mesh-ancestor
153363335|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946271|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946272|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153946273|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153946274|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153946275|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
153946276|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
153946277|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946278|NCT04291092|Immunomodulating Agents|immunomodulating agents|mesh-list
153946279|NCT04291092|Immunologic Factors|immunologic factors|mesh-ancestor
153946280|NCT04291092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946282|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946283|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153946284|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946285|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946286|NCT04290390|Itraconazole|itraconazole|mesh-list
153946287|NCT04290390|Rifampin|rifampin|mesh-list
153946288|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153946289|NCT04290390|Estradiol|estradiol|mesh-list
153946290|NCT04290390|Estrogens|estrogens|mesh-ancestor
153946291|NCT04290390|Hormones|hormones|mesh-ancestor
153946292|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946293|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946307|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153946308|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
153946309|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946310|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
153946311|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153946312|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153946313|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153946314|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153946315|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153946316|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153946317|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153946318|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153946320|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
153946321|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153946322|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
153946323|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946324|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946325|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153946326|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
153946327|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153946328|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
153946329|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946331|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153946332|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
153946333|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
153946334|NCT04290858|Protective Agents|protective agents|mesh-ancestor
153946335|NCT05326555|Imidacloprid|imidacloprid|mesh-list
153946336|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
153946337|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946338|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946339|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946340|NCT02610829|Vitamin E|vitamin e|mesh-list
153946341|NCT02610829|Tocopherols|tocopherols|mesh-list
153946342|NCT02610829|Tocotrienols|tocotrienols|mesh-list
153946343|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
153946344|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
153946345|NCT02610829|Vitamins|vitamins|mesh-ancestor
153946346|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
153946347|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946348|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
153946349|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946350|NCT02610829|Protective Agents|protective agents|mesh-ancestor
153946351|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
153946352|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153946353|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153946354|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153946391|NCT00812461|Nalmefene|nalmefene|mesh-list
153946413|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153946414|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
153946415|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946416|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946417|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153946418|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
153946419|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153946421|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946422|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946423|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153946424|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
153946425|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
153946426|NCT04166812|Protective Agents|protective agents|mesh-ancestor
153946427|NCT00708799|Azithromycin|azithromycin|mesh-list
153946428|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946429|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946430|NCT02610127|Factor VIII|factor viii|mesh-list
153946431|NCT02610127|Coagulants|coagulants|mesh-ancestor
153946432|NCT00814333|Thrombin|thrombin|mesh-list
153946433|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
153946434|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
153946435|NCT00814333|Coagulants|coagulants|mesh-ancestor
153946436|NCT00813943|Temozolomide|temozolomide|mesh-list
153946437|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153946438|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
153946439|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946440|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946441|NCT00821509|Disinfectants|disinfectants|mesh-list
153946442|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946443|NCT00913861|Fentanyl|fentanyl|mesh-list
153946444|NCT00913861|Propofol|propofol|mesh-list
153946476|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
153946477|NCT00709267|Vitamins|vitamins|mesh-ancestor
153946478|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
153946479|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946480|NCT00591565|Acamprosate|acamprosate|mesh-list
153946481|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153946482|NCT00978120|Vaccines|vaccines|mesh-list
153946483|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
153946484|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946486|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153946487|NCT01133678|Cisplatin|cisplatin|mesh-list
153946488|NCT01133678|Cetuximab|cetuximab|mesh-list
153946489|NCT01133678|Everolimus|everolimus|mesh-list
153946490|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153946491|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946492|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
153946493|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
153946494|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
153946522|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946523|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
153946524|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946525|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153946526|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153946527|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946528|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153946529|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153946530|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153946531|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946532|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153946533|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
153946534|NCT00655018|Tocopherols|tocopherols|mesh-list
153946535|NCT00655018|Vitamin E|vitamin e|mesh-list
153946536|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
153946537|NCT00655018|Vitamins|vitamins|mesh-ancestor
153946538|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
153946539|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946540|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
153946572|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153946573|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153946575|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946576|NCT01133522|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153946577|NCT01133522|Protease Inhibitors|protease inhibitors|mesh-ancestor
153946578|NCT01133522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946579|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153946580|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
153946581|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153946582|NCT00655252|Everolimus|everolimus|mesh-list
153946594|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823554|NCT00495339|Levofloxacin|levofloxacin|mesh-list
153946595|NCT02645656|Curcumin|curcumin|mesh-list
153946596|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153946597|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153946598|NCT02645656|Analgesics|analgesics|mesh-ancestor
153946599|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
153946600|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946601|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946602|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153946603|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153946604|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946605|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946606|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946607|NCT01132820|Cediranib|cediranib|mesh-list
153946608|NCT01132820|Maleic acid|maleic acid|mesh-list
153946609|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946610|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946611|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946612|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153946613|NCT00655330|Valsartan|valsartan|mesh-list
153946614|NCT00655330|Probucol|probucol|mesh-list
153946615|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153946616|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153946617|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153946618|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946619|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153946620|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153946621|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
153946622|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153946623|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
153946624|NCT00655330|Protective Agents|protective agents|mesh-ancestor
153946625|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946626|NCT00655408|Iron|iron|mesh-list
153946627|NCT00655408|Trace Elements|trace elements|mesh-ancestor
153946628|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
153946629|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946630|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
153946631|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153946632|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153946633|NCT04163536|Prednisolone|prednisolone|mesh-list
153946634|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
153946635|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153946636|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
153946637|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153946639|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
153946640|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946641|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946642|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153946643|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
153946644|NCT04163536|Hormones|hormones|mesh-ancestor
153946645|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946646|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153946647|NCT04163536|Protective Agents|protective agents|mesh-ancestor
153946680|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153946681|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153946682|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
153946684|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946685|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153946686|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153946687|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946688|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704246|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
153946722|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153946723|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153946724|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153946725|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153946726|NCT02634970|Ranibizumab|ranibizumab|mesh-list
153946727|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153946728|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153946729|NCT02634970|Growth Substances|growth substances|mesh-ancestor
153946730|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946731|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
153946740|NCT00885352|Hormones|hormones|mesh-ancestor
153409191|NCT04948489|Norethindrone|norethindrone|mesh-list
153823666|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
153946741|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946742|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153946743|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
153946744|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946745|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946746|NCT00656032|Cinacalcet|cinacalcet|mesh-list
153946747|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153946748|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946749|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153946750|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
153946751|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946752|NCT00885118|Empagliflozin|empagliflozin|mesh-list
153946753|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153946754|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946755|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153946756|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946757|NCT00656812|Rituximab|rituximab|mesh-list
153946758|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153946759|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946760|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
153946761|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946762|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153946763|NCT00656110|Ethanol|ethanol|mesh-list
153946764|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
153946765|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153946766|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153946767|NCT00656110|Prednisolone|prednisolone|mesh-list
153946768|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
153946769|NCT00656110|Lidocaine|lidocaine|mesh-list
153946770|NCT00656110|Bupivacaine|bupivacaine|mesh-list
153946771|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153946772|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
153946773|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
153946774|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
153946775|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946776|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946777|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
153946778|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946779|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153946780|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153946781|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153946782|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946783|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946784|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153946785|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
153946786|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
153946787|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153946788|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
153946790|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946791|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153946792|NCT00656110|Protective Agents|protective agents|mesh-ancestor
153946793|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153946794|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946795|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153946796|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946797|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153946798|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
153946799|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153946826|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946827|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946828|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153946830|NCT04159870|Norfloxacin|norfloxacin|mesh-list
153946831|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946832|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946833|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153946834|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153946835|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153946836|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363773|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
153363774|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153363775|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153823790|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
153823791|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153823792|NCT00461747|Thalidomide|thalidomide|mesh-list
153823793|NCT00461747|Dexamethasone|dexamethasone|mesh-list
153901600|NCT05936268|Colchicine|colchicine|mesh-list
153946837|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946838|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946839|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153946840|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153946841|NCT00657514|Ranolazine|ranolazine|mesh-list
153946842|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153946843|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946844|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946845|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
153946846|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153946878|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946879|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946880|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153946881|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153946882|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
153946883|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153946884|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153946885|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153946886|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153946887|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
153946888|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153946889|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946902|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153946903|NCT00657748|Triacetin|triacetin|mesh-list
153946904|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
153946905|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
153946906|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153946907|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946908|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946909|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
153946910|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153946911|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946912|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946913|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
153946914|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946915|NCT04161586|Prilocaine|prilocaine|mesh-list
153946916|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
153946917|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
153946918|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946919|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946920|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
153946921|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946922|NCT02636218|Ketamine|ketamine|mesh-list
153946923|NCT02636218|Analgesics|analgesics|mesh-ancestor
153946924|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
153946925|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946926|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946927|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153946928|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153946929|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
153946930|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
153946931|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153704516|NCT00292123|Analgesics|analgesics|mesh-ancestor
153946932|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153946933|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153946934|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946935|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946936|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
153946937|NCT04161508|Neostigmine|neostigmine|mesh-list
153823990|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153823991|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
153363948|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
153363949|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363950|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363951|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153363952|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153363953|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153363954|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
153946938|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153946939|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946940|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946941|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
153946942|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946943|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946944|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153946945|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
153946946|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946947|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153946948|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153946949|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153946950|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
153704491|NCT00301483|Chrysarobin|chrysarobin|mesh-list
153946963|NCT04162834|Papaverine|papaverine|mesh-list
153946964|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153946965|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946966|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946967|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
153946968|NCT04162834|Urological Agents|urological agents|mesh-ancestor
153946969|NCT00657904|Bicalutamide|bicalutamide|mesh-list
153946970|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
153946971|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
153946972|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946973|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946974|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946975|NCT02633878|Progesterone|progesterone|mesh-list
153946976|NCT02633878|Progestins|progestins|mesh-ancestor
153946977|NCT02633878|Hormones|hormones|mesh-ancestor
153946978|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946979|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946980|NCT00597766|Triamcinolone|triamcinolone|mesh-list
153946981|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153946982|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153946983|NCT00597766|Lidocaine|lidocaine|mesh-list
153946984|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153946985|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
153946986|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
153946987|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946988|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946989|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
153946990|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946991|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153946992|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153946993|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153946994|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946995|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946996|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153946997|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
153946999|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947000|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947001|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
153947002|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947003|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
153947004|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153824072|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824073|NCT00497328|Expectorants|expectorants|mesh-ancestor
153364029|NCT03001661|Dinoprostone|dinoprostone|mesh-list
153364030|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
153364031|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153364032|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364033|NCT03006965|Factor VIII|factor viii|mesh-list
153364035|NCT03006965|Coagulants|coagulants|mesh-ancestor
153364036|NCT04379102|Anesthetics|anesthetics|mesh-list
153364037|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
153947005|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947006|NCT00657982|Everolimus|everolimus|mesh-list
153947008|NCT00657982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153947009|NCT00657982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947010|NCT00657982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947011|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947012|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
153947013|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947014|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947015|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
153947037|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
153947038|NCT01079741|Laxatives|laxatives|mesh-ancestor
153947039|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947040|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
153947041|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947042|NCT01079741|Emollients|emollients|mesh-ancestor
153947043|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
153947044|NCT02877641|Vitamin D|vitamin d|mesh-list
153947045|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
153947046|NCT02877641|Vitamins|vitamins|mesh-list
153947047|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
153947048|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947049|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153947050|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153947051|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
153947052|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153947053|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947054|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
153947055|NCT02867046|Dexamethasone|dexamethasone|mesh-list
153947056|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153947057|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
153947058|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
153947059|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947060|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947061|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947062|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
153947063|NCT02867046|Hormones|hormones|mesh-ancestor
153947064|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947065|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153947066|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947067|NCT02865174|Heparin|heparin|mesh-list
153947068|NCT02865174|Enoxaparin|enoxaparin|mesh-list
153947069|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153947070|NCT02865174|Tinzaparin|tinzaparin|mesh-list
153947071|NCT02865174|Dalteparin|dalteparin|mesh-list
153947072|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
153947086|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153947087|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153947088|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947089|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947090|NCT00879814|Vaccines|vaccines|mesh-list
153947091|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
153947092|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947093|NCT02633176|Docetaxel|docetaxel|mesh-list
153947094|NCT02633176|Capecitabine|capecitabine|mesh-list
153947095|NCT02633176|Cetuximab|cetuximab|mesh-list
153947096|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947097|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
153824099|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824100|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153824101|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153824102|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824103|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
153824104|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153364091|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153364092|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153947098|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
153947099|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
153947100|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947101|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947102|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
153947103|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947104|NCT04156984|Golimumab|golimumab|mesh-list
153947105|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153947106|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153947107|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947108|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
153947109|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947110|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153947111|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
153947112|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947113|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153947114|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
153947115|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947116|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947117|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153947118|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153947119|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153947120|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
153947121|NCT01132664|Capecitabine|capecitabine|mesh-list
153947122|NCT01132664|Trastuzumab|trastuzumab|mesh-list
153947123|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947124|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
153947125|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947126|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947127|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947128|NCT01078805|Teriparatide|teriparatide|mesh-list
153947129|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153947130|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947131|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153947132|NCT00820027|Ibuprofen|ibuprofen|mesh-list
153947133|NCT00820027|Etoricoxib|etoricoxib|mesh-list
153947134|NCT00820027|Morphine|morphine|mesh-list
153947167|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947169|NCT01076153|Clarithromycin|clarithromycin|mesh-list
153947170|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153947171|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947172|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153947173|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947174|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704726|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153947187|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153947188|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
153947189|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947190|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947191|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153947192|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947193|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
153947194|NCT01075763|Interferons|interferons|mesh-list
153947195|NCT01075763|Interferon-beta|interferon-beta|mesh-list
153947196|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
153947197|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947198|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
153364158|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364159|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153364160|NCT03007121|Narcotics|narcotics|mesh-ancestor
153824185|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824186|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824187|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153824188|NCT00497562|Narcotics|narcotics|mesh-ancestor
153824189|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824190|NCT00497562|Analgesics|analgesics|mesh-ancestor
153824191|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
153824192|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824193|NCT00497562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153824221|NCT00466388|Cevimeline|cevimeline|mesh-list
153947199|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947200|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
153947201|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947202|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153947203|NCT00881530|Metformin|metformin|mesh-list
153947204|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153947205|NCT00881530|Empagliflozin|empagliflozin|mesh-list
153947206|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153947207|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947208|NCT00881530|Incretins|incretins|mesh-ancestor
153947209|NCT00881530|Hormones|hormones|mesh-ancestor
153947210|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947211|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153947212|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
153947213|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947214|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947215|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153947216|NCT02632474|Tenofovir|tenofovir|mesh-list
153947217|NCT02632474|Lamivudine|lamivudine|mesh-list
153947218|NCT02632474|Efavirenz|efavirenz|mesh-list
153947219|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
153947220|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947221|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153947222|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153947223|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947224|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947225|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153947226|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153947227|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153947228|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153947229|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153947230|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153947231|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153947232|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153947233|NCT04156750|Metformin|metformin|mesh-list
153947234|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153947235|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947237|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153947238|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
153947264|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947265|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947266|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153947267|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153947268|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947269|NCT00661336|Melphalan|melphalan|mesh-list
153947270|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
153364289|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
153364290|NCT02464410|Narcotics|narcotics|mesh-ancestor
153364291|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364292|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364293|NCT02464410|Analgesics|analgesics|mesh-ancestor
153364294|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
153364295|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364296|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
153364299|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364300|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364301|NCT03405272|Antibodies|antibodies|mesh-list
153364302|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153364303|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
153364304|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364305|NCT03405194|Efavirenz|efavirenz|mesh-list
153947271|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153947272|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
153947273|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947274|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947275|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153947276|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947277|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
153947278|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947279|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
153947280|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947281|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947282|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153947283|NCT00661336|Protective Agents|protective agents|mesh-ancestor
153947284|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
153947285|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947286|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947287|NCT04158700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153947307|NCT04156204|Tacrolimus|tacrolimus|mesh-list
153947308|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947309|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
153947310|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947311|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153947312|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947313|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947314|NCT02631694|Propranolol|propranolol|mesh-list
153947315|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153947316|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153947317|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
153947318|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947319|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947320|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947321|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153947322|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153947323|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
153947324|NCT00658840|Capecitabine|capecitabine|mesh-list
153947325|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947326|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
153947327|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947328|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947329|NCT00658918|Ciclesonide|ciclesonide|mesh-list
153947330|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
153947331|NCT00658918|Hormones|hormones|mesh-ancestor
153901770|NCT05833776|Narcotics|narcotics|mesh-ancestor
153443215|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
153443216|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153443217|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153947332|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947333|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947334|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153364388|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
153364389|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364390|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364391|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153364392|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364393|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153364394|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153364395|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364396|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153824422|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824423|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
153824424|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824425|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824426|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153824468|NCT01327573|Eculizumab|eculizumab|mesh-list
153947335|NCT02876081|Afatinib|afatinib|mesh-list
153947336|NCT02876081|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153947337|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153947338|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947339|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947340|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947341|NCT02631616|Somatostatin|somatostatin|mesh-list
153947342|NCT02631616|Hormones|hormones|mesh-ancestor
153947343|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947375|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947376|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947377|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
153947378|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947380|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153947381|NCT01077323|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153947382|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947383|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153947384|NCT01077323|Incretins|incretins|mesh-ancestor
153947385|NCT01077323|Hormones|hormones|mesh-ancestor
153704943|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153947408|NCT04287426|Narcotics|narcotics|mesh-ancestor
153947409|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947410|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947411|NCT04287426|Analgesics|analgesics|mesh-ancestor
153947412|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
153947413|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947414|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153947415|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153947416|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153947417|NCT04047576|Sirolimus|sirolimus|mesh-list
153947418|NCT04047576|Prednisone|prednisone|mesh-list
153947419|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153947420|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
153947421|NCT04047576|Hormones|hormones|mesh-ancestor
153947422|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947423|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947424|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153947425|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947426|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153947427|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947428|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153947429|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
153947430|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947431|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
153364463|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
153364464|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364465|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364466|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153364467|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153364468|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364469|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153947432|NCT00976950|Ritonavir|ritonavir|mesh-list
153947433|NCT00976950|Tipranavir|tipranavir|mesh-list
153947434|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153947435|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153947436|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
153947437|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704982|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153947491|NCT06199895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153947492|NCT06199895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947493|NCT06199895|Tubulin Modulators|tubulin modulators|mesh-ancestor
153947494|NCT06199895|Antimitotic Agents|antimitotic agents|mesh-ancestor
153947495|NCT06199895|Mitosis Modulators|mitosis modulators|mesh-ancestor
153947513|NCT06199791|Anticonvulsants|anticonvulsants|mesh-ancestor
153947514|NCT06199791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153947515|NCT06199791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153947516|NCT06199791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947517|NCT06199791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153947518|NCT06199791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947519|NCT06199791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153947520|NCT06199791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153947521|NCT06199791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947522|NCT06199791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153947523|NCT06199791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153947524|NCT06199700|Esketamine|esketamine|mesh-list
153947525|NCT06199700|Antidepressive Agents|antidepressive agents|mesh-ancestor
153947526|NCT06199700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153947527|NCT06199596|Caseins|caseins|mesh-list
153947528|NCT06199596|Chelating Agents|chelating agents|mesh-ancestor
153947529|NCT06199596|Sequestering Agents|sequestering agents|mesh-ancestor
153947530|NCT06199596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947531|NCT06199557|Mercaptopurine|mercaptopurine|mesh-list
153947532|NCT06199557|Hydroxyurea|hydroxyurea|mesh-list
153947533|NCT06199557|Valproic Acid|valproic acid|mesh-list
153947534|NCT06199557|Antimetabolites|antimetabolites|mesh-ancestor
153947535|NCT06199557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947536|NCT06199557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947537|NCT06199557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947538|NCT06199557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947539|NCT06199557|Immunologic Factors|immunologic factors|mesh-ancestor
153947540|NCT06199557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947541|NCT06199557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153947542|NCT06199557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947543|NCT06199557|Antisickling Agents|antisickling agents|mesh-ancestor
153947544|NCT06199557|Anticonvulsants|anticonvulsants|mesh-ancestor
153947545|NCT06199557|GABA Agents|gaba agents|mesh-ancestor
153947546|NCT06199557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947547|NCT06199557|Antimanic Agents|antimanic agents|mesh-ancestor
153947548|NCT06199557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153947549|NCT06199557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947550|NCT06199557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153947551|NCT06199544|Metformin|metformin|mesh-list
153947552|NCT06199544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153947586|NCT06199102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153947588|NCT06199076|Oxytocics|oxytocics|mesh-ancestor
153947589|NCT06199076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153947590|NCT06199076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947591|NCT06199011|Esketamine|esketamine|mesh-list
153947592|NCT06199011|Antidepressive Agents|antidepressive agents|mesh-ancestor
153947593|NCT06199011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153947594|NCT06198842|Treosulfan|treosulfan|mesh-list
153947610|NCT06198465|Mitosis Modulators|mitosis modulators|mesh-ancestor
153409455|NCT00359359|Sagopilone|sagopilone|mesh-list
153461731|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
153824591|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824592|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153824593|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824595|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
153824596|NCT00592111|Etoposide|etoposide|mesh-list
153824597|NCT00592111|Vincristine|vincristine|mesh-list
153824598|NCT00592111|Doxorubicin|doxorubicin|mesh-list
153364563|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153947611|NCT06198465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947612|NCT06198465|Antimetabolites|antimetabolites|mesh-ancestor
153947613|NCT06198465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947614|NCT06198465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947615|NCT06198465|Immunologic Factors|immunologic factors|mesh-ancestor
153947616|NCT06198465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947617|NCT06198387|Hormones|hormones|mesh-list
153947618|NCT06198387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947619|NCT06198387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947620|NCT06195891|Fludarabine|fludarabine|mesh-list
153947621|NCT06195891|Melphalan|melphalan|mesh-list
153947622|NCT06195891|Mechlorethamine|mechlorethamine|mesh-list
153947623|NCT06195891|Thiotepa|thiotepa|mesh-list
153947624|NCT06195891|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153947625|NCT06195891|Tacrolimus|tacrolimus|mesh-list
153947626|NCT06195891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947627|NCT06195891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947628|NCT06195891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947629|NCT06195891|Immunologic Factors|immunologic factors|mesh-ancestor
153947630|NCT06195891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947631|NCT06195891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153947632|NCT06195891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947633|NCT06195891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153947634|NCT06195891|Alkylating Agents|alkylating agents|mesh-ancestor
153947635|NCT06195891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153947636|NCT06180616|Tirzepatide|tirzepatide|mesh-list
153947637|NCT06180616|Incretins|incretins|mesh-ancestor
153947638|NCT06180616|Hormones|hormones|mesh-ancestor
153947639|NCT06180616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947640|NCT06180616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947641|NCT06153251|Cyclophosphamide|cyclophosphamide|mesh-list
153947642|NCT06153251|Fludarabine|fludarabine|mesh-list
153947643|NCT06153251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947644|NCT06153251|Immunologic Factors|immunologic factors|mesh-ancestor
153947645|NCT06153251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947646|NCT06153251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153947647|NCT06153251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153947648|NCT06153251|Alkylating Agents|alkylating agents|mesh-ancestor
153947649|NCT06153251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947650|NCT06153251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947651|NCT06153251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153947652|NCT06109558|Osimertinib|osimertinib|mesh-list
153947653|NCT06109558|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153947654|NCT06109558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153947667|NCT06075771|Carbidopa|carbidopa|mesh-list
153947668|NCT06075771|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153947669|NCT06075771|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153947670|NCT06075771|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153947671|NCT06075771|Dopamine Agents|dopamine agents|mesh-ancestor
153947672|NCT06075771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947673|NCT06075771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947674|NCT06075771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947675|NCT06075771|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153947676|NCT06075771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947677|NCT06075771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153824638|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824640|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824641|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824642|NCT04377295|Ranibizumab|ranibizumab|mesh-list
153824643|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153824644|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824645|NCT04377295|Growth Substances|growth substances|mesh-ancestor
153364645|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364646|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364672|NCT02218463|Estradiol|estradiol|mesh-list
153947678|NCT06075771|Immunologic Factors|immunologic factors|mesh-ancestor
153947679|NCT06075771|Dopamine Agonists|dopamine agonists|mesh-ancestor
153947680|NCT06054776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153947681|NCT06054776|Obinutuzumab|obinutuzumab|mesh-list
153947682|NCT06054776|Acalabrutinib|acalabrutinib|mesh-list
153947683|NCT06054776|Antibodies|antibodies|mesh-list
153947684|NCT06054776|Immunoglobulins|immunoglobulins|mesh-list
153705271|NCT00303745|Irinotecan|irinotecan|mesh-list
153947685|NCT06054776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153947686|NCT06054776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153947687|NCT06054776|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153947688|NCT06054776|Immunologic Factors|immunologic factors|mesh-ancestor
153947689|NCT06054776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947690|NCT06054776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947691|NCT06054776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153947692|NCT06054776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947693|NCT06054776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947695|NCT06040840|Epinephrine|epinephrine|mesh-list
153947696|NCT06040840|Anesthetics, Local|anesthetics, local|mesh-ancestor
153947697|NCT06040840|Anesthetics|anesthetics|mesh-ancestor
153947698|NCT06040840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947699|NCT06040840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947700|NCT06040840|Sensory System Agents|sensory system agents|mesh-ancestor
153947701|NCT06040840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947702|NCT06040840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153947703|NCT06040840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153947704|NCT06040840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153947705|NCT06040840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153947706|NCT06040840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947707|NCT06040840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153947708|NCT06040840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153947709|NCT06040840|Adrenergic Agents|adrenergic agents|mesh-ancestor
153947710|NCT06040840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947711|NCT06040840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153947712|NCT06040840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153947713|NCT06040840|Autonomic Agents|autonomic agents|mesh-ancestor
153947714|NCT06040840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153705225|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
153947737|NCT06011772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947738|NCT06011772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947739|NCT06011772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947740|NCT06011772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153947741|NCT06011772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153947742|NCT06011772|Growth Substances|growth substances|mesh-ancestor
153947743|NCT06011772|Growth Inhibitors|growth inhibitors|mesh-ancestor
153947744|NCT06011772|Antimetabolites|antimetabolites|mesh-ancestor
153947745|NCT06011772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947746|NCT06011772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947747|NCT06011772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947748|NCT06011772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153947749|NCT06011772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153947750|NCT06011772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947751|NCT06011772|Antidotes|antidotes|mesh-ancestor
153947752|NCT06011772|Protective Agents|protective agents|mesh-ancestor
153947753|NCT06011772|Vitamin B Complex|vitamin b complex|mesh-ancestor
153364757|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364758|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153364759|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153364760|NCT02248571|Growth Substances|growth substances|mesh-ancestor
153364761|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364762|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
153364763|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153364765|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364766|NCT02248571|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153364767|NCT02248571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153364768|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824783|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153824785|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
153947754|NCT06011772|Vitamins|vitamins|mesh-ancestor
153947755|NCT06011772|Micronutrients|micronutrients|mesh-ancestor
153947756|NCT06011772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153947757|NCT05973487|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
153947758|NCT05973487|Antioxidants|antioxidants|mesh-ancestor
153947759|NCT05973487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947760|NCT05973487|Protective Agents|protective agents|mesh-ancestor
153947761|NCT05973487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947762|NCT05973487|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153947763|NCT05973487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947764|NCT05955157|Tegafur|tegafur|mesh-list
153947765|NCT05955157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947766|NCT05955157|Antimetabolites|antimetabolites|mesh-ancestor
153947767|NCT05955157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947768|NCT05955157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947769|NCT05945875|Panitumumab|panitumumab|mesh-list
153947770|NCT05945875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947805|NCT05818553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947807|NCT05818553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947808|NCT05804032|Dexamethasone|dexamethasone|mesh-list
153947809|NCT05804032|Lenalidomide|lenalidomide|mesh-list
153947810|NCT05804032|Bortezomib|bortezomib|mesh-list
153947811|NCT05804032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153947812|NCT05804032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153947840|NCT05737784|Sensory System Agents|sensory system agents|mesh-ancestor
153947841|NCT05737784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947842|NCT05709821|Pembrolizumab|pembrolizumab|mesh-list
153947843|NCT05709821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947844|NCT05709821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947845|NCT05709821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153947846|NCT05709821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947847|NCT05704595|Diuretics|diuretics|mesh-list
153947848|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
153947849|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947850|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
153947851|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
153947852|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153947853|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153947854|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947855|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153947856|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947857|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947887|NCT05584267|Immunologic Factors|immunologic factors|mesh-ancestor
153947888|NCT05584267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947889|NCT05513391|Vaccines|vaccines|mesh-list
153947890|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
153947891|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947892|NCT05485805|Naproxen|naproxen|mesh-list
153947893|NCT05485805|Caffeine|caffeine|mesh-list
153824965|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824966|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
153824967|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824968|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153824969|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
153824973|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153824974|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
153824976|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
153947894|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153947895|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947896|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153947897|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947898|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947899|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153947900|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153947901|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
153947902|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947903|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153947936|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947937|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153947938|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947939|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947940|NCT05296278|Bevacizumab|bevacizumab|mesh-list
153947941|NCT05296278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947942|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947943|NCT05296278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153947944|NCT05296278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153947945|NCT05296278|Growth Substances|growth substances|mesh-ancestor
153705478|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
153947981|NCT05256225|Pertuzumab|pertuzumab|mesh-list
153947982|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153947983|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947984|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
153947985|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
153947986|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
153947987|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705518|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153948000|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
153948001|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948002|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153948003|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153948004|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153948005|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
153948006|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153948007|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948008|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153948009|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
153948010|NCT05171166|Leucovorin|leucovorin|mesh-list
153948011|NCT05171166|Fluorouracil|fluorouracil|mesh-list
153948012|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
153948013|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
153948014|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
153948015|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948016|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948017|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948018|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948019|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
153948020|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948021|NCT05171166|Antidotes|antidotes|mesh-ancestor
153948022|NCT05171166|Protective Agents|protective agents|mesh-ancestor
153948023|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
153948024|NCT05171166|Vitamins|vitamins|mesh-ancestor
153948025|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
153948026|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153948027|NCT05171166|Estrogens|estrogens|mesh-ancestor
153948028|NCT05171166|Hormones|hormones|mesh-ancestor
153365011|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153365012|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365013|NCT02241356|Methamphetamine|methamphetamine|mesh-list
153365014|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153365015|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365035|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
153365036|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365037|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
153948029|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948030|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948041|NCT05103605|Osimertinib|osimertinib|mesh-list
153948042|NCT05103605|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948043|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948044|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948045|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948046|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948047|NCT05090566|Dexamethasone|dexamethasone|mesh-list
153948048|NCT05090566|Lenalidomide|lenalidomide|mesh-list
153948049|NCT05090566|Nirogacestat|nirogacestat|mesh-list
153948086|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
153948087|NCT05024773|Protective Agents|protective agents|mesh-ancestor
153948088|NCT05024513|Fluorouracil|fluorouracil|mesh-list
153948089|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
153948090|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
153705620|NCT00082667|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948102|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948103|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948104|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
153948105|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153948106|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948107|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
153948108|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948109|NCT04903470|Bisacodyl|bisacodyl|mesh-list
153948110|NCT04903470|Cathartics|cathartics|mesh-ancestor
153948111|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153948112|NCT04903470|Laxatives|laxatives|mesh-ancestor
153948113|NCT04791176|Lenvatinib|lenvatinib|mesh-list
153948114|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948115|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948116|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948117|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948119|NCT04760275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153948120|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153948121|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153948122|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948123|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153948124|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
153948125|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948126|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153948127|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
153948128|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153948129|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153948130|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153948131|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948132|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
153948133|NCT04714372|Fludarabine|fludarabine|mesh-list
153948134|NCT04714372|Daratumumab|daratumumab|mesh-list
153948135|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948136|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
153948142|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948143|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153948144|NCT04710030|Valacyclovir|valacyclovir|mesh-list
153948145|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
153948146|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153948147|NCT04700176|Dexamethasone|dexamethasone|mesh-list
153948148|NCT04700176|Daratumumab|daratumumab|mesh-list
153948149|NCT04700176|Pomalidomide|pomalidomide|mesh-list
153825127|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825128|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
153825129|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825130|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153825131|NCT00468533|Aripiprazole|aripiprazole|mesh-list
153825132|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
153825133|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825134|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153365171|NCT01623869|Growth Substances|growth substances|mesh-ancestor
153365172|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825194|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
153948150|NCT04700176|Tretinoin|tretinoin|mesh-list
153948151|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948152|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
153948153|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
153948154|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948155|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948156|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153948157|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
153948158|NCT04700176|Hormones|hormones|mesh-ancestor
153948159|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705665|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
153948199|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948200|NCT04537637|Semaglutide|semaglutide|mesh-list
153948201|NCT04537637|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153948202|NCT04537637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153948203|NCT04537637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948204|NCT04533880|Calcium|calcium|mesh-list
153948205|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153948206|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948234|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
153948235|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153948236|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948237|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948238|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153948239|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153948240|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
153948241|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153948242|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153948243|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
153948244|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948245|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948246|NCT04447755|Lenvatinib|lenvatinib|mesh-list
153948247|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948248|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948249|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948250|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948251|NCT04396535|Docetaxel|docetaxel|mesh-list
153948252|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948253|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948254|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948255|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948287|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153948288|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948289|NCT04112160|Ketorolac|ketorolac|mesh-list
153948290|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153948291|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153948292|NCT04112160|Analgesics|analgesics|mesh-ancestor
153948293|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
153948294|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948295|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948296|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948297|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153705814|NCT00307723|Bevacizumab|bevacizumab|mesh-list
153948312|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153365285|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365305|NCT02244632|Bevacizumab|bevacizumab|mesh-list
153365306|NCT02244632|Fluorouracil|fluorouracil|mesh-list
153365307|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
153365309|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365310|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948314|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948315|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948316|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
153948317|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948318|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153948319|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948320|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
153948321|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948322|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153948323|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153948324|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948325|NCT04082754|Antibodies|antibodies|mesh-list
153948326|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153948327|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
153948328|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948329|NCT03989414|Dexamethasone|dexamethasone|mesh-list
153948330|NCT03989414|Bortezomib|bortezomib|mesh-list
153948331|NCT03989414|Daratumumab|daratumumab|mesh-list
153948332|NCT03989414|Elotuzumab|elotuzumab|mesh-list
153948333|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948334|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
153948335|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
153948336|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948337|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948338|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153948339|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
153948340|NCT03989414|Hormones|hormones|mesh-ancestor
153948341|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948342|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948343|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948344|NCT03981614|Trifluridine|trifluridine|mesh-list
153948345|NCT03981614|Palbociclib|palbociclib|mesh-list
153948346|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948347|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948348|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948349|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948350|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
153948351|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
153948352|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153948353|NCT03965689|Paclitaxel|paclitaxel|mesh-list
153948354|NCT03965689|Carboplatin|carboplatin|mesh-list
153948355|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153948356|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153948357|NCT03965689|Pevonedistat|pevonedistat|mesh-list
153948367|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
153948368|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153948369|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
153948370|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948371|NCT03932162|Insulin|insulin|mesh-list
153948372|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153948373|NCT03932162|Mitogens|mitogens|mesh-list
153948374|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153948375|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948376|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948377|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948378|NCT03896217|Simvastatin|simvastatin|mesh-list
153948379|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153948380|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153948381|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
153948382|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948383|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153365398|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153365399|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153365400|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153365403|NCT02224313|Estradiol|estradiol|mesh-list
153365404|NCT02224313|Progesterone|progesterone|mesh-list
153365405|NCT02224313|Estrogens|estrogens|mesh-ancestor
153825437|NCT01243827|Protective Agents|protective agents|mesh-ancestor
153948384|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153948385|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948386|NCT03862157|Azacitidine|azacitidine|mesh-list
153948387|NCT03862157|Venetoclax|venetoclax|mesh-list
153948388|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153948389|NCT03862157|Pevonedistat|pevonedistat|mesh-list
153948390|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948391|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
153948392|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948393|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948394|NCT03858322|Paclitaxel|paclitaxel|mesh-list
153948395|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
153948396|NCT03858322|Carboplatin|carboplatin|mesh-list
153948397|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948398|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948399|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948400|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948401|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948402|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948403|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948404|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
153948405|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948406|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948407|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153948408|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
153948409|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153948410|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
153948411|NCT03765229|Entinostat|entinostat|mesh-list
153948412|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948413|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948414|NCT03765229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948415|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948416|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153948417|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948418|NCT03727971|Omalizumab|omalizumab|mesh-list
153948419|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153948420|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153948421|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
153948422|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
153948423|NCT03713593|Lenvatinib|lenvatinib|mesh-list
153705924|NCT00308503|SR 46349B|sr 46349b|mesh-list
153948449|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153948450|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153948451|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153948452|NCT03668041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153948453|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153948454|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153948455|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948456|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153948457|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
153948458|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153948459|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
153948460|NCT03643744|Celecoxib|celecoxib|mesh-list
153948461|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153948462|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153948463|NCT03643744|Analgesics|analgesics|mesh-ancestor
153948464|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
153948465|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948466|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260780|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260782|NCT01193270|Vitamins|vitamins|mesh-ancestor
154260783|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
154260784|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948467|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948468|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948469|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153948470|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153948471|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948472|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948473|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
153948474|NCT03610490|Fludarabine|fludarabine|mesh-list
153948511|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
153948512|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948513|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706062|NCT00309517|Leucovorin|leucovorin|mesh-list
153948529|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
153948530|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153948531|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948533|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948534|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948535|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948536|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948537|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
153948538|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153948539|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153948540|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948541|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
153948542|NCT03475342|Coagulants|coagulants|mesh-ancestor
153948543|NCT03412773|Sorafenib|sorafenib|mesh-list
153948544|NCT03412773|Tislelizumab|tislelizumab|mesh-list
153948545|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948546|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948547|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948548|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948549|NCT03412773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948550|NCT03410043|Osimertinib|osimertinib|mesh-list
153948551|NCT03410043|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948552|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948553|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948554|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948555|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948556|NCT03392246|Osimertinib|osimertinib|mesh-list
153948557|NCT03392246|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948558|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948559|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948560|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948561|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948562|NCT03175432|Bevacizumab|bevacizumab|mesh-list
153948563|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153948564|NCT03175432|Atezolizumab|atezolizumab|mesh-list
153948565|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
153948566|NCT03175432|Antibodies|antibodies|mesh-list
153948567|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
153948568|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153948569|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
153948570|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948571|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153948572|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153948573|NCT03175432|Growth Substances|growth substances|mesh-ancestor
153948574|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948600|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948602|NCT03138499|Immunoconjugates|immunoconjugates|mesh-ancestor
153948603|NCT03138499|Immunologic Factors|immunologic factors|mesh-ancestor
153948604|NCT03138499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948605|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
153948606|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948607|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948608|NCT03085719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153826120|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153826121|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826122|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826123|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826124|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153826126|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153826127|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826128|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153826129|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153366104|NCT01656629|Vitamin D|vitamin d|mesh-list
153366105|NCT01656629|Alendronate|alendronate|mesh-list
153366106|NCT01656629|Teriparatide|teriparatide|mesh-list
153366107|NCT01656629|Calcium|calcium|mesh-list
153366108|NCT01656629|Vitamins|vitamins|mesh-ancestor
153948609|NCT03085719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948610|NCT03083353|Isradipine|isradipine|mesh-list
153948611|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153948612|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153948613|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153948614|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948615|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153948616|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948617|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
153948618|NCT03049306|Propranolol|propranolol|mesh-list
153948619|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153948620|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153948621|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
153948622|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706131|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
153948649|NCT02954874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948650|NCT02954874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948651|NCT02915523|Avelumab|avelumab|mesh-list
153948652|NCT02915523|Entinostat|entinostat|mesh-list
153948653|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948654|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948655|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153948656|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948657|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948658|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
153948659|NCT02890355|Leucovorin|leucovorin|mesh-list
153948660|NCT02890355|Folic Acid|folic acid|mesh-list
153948661|NCT02890355|Fluorouracil|fluorouracil|mesh-list
153948662|NCT02890355|Irinotecan|irinotecan|mesh-list
153948663|NCT02890355|Veliparib|veliparib|mesh-list
153948664|NCT02890355|Camptothecin|camptothecin|mesh-list
153706239|NCT00310336|Ribavirin|ribavirin|mesh-list
153948665|NCT02890355|Calcium|calcium|mesh-list
153948666|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
153948667|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153948668|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948678|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948679|NCT02890355|Antidotes|antidotes|mesh-ancestor
153948680|NCT02890355|Protective Agents|protective agents|mesh-ancestor
153948681|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
153948682|NCT02890355|Vitamins|vitamins|mesh-ancestor
153948683|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
153948684|NCT02890355|Hematinics|hematinics|mesh-ancestor
153948685|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153948686|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948687|NCT02888743|Durvalumab|durvalumab|mesh-list
153948688|NCT02888743|Ipilimumab|ipilimumab|mesh-list
153948689|NCT02888743|Tremelimumab|tremelimumab|mesh-list
153948690|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
153948691|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153948692|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
153826203|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826204|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
153826205|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366187|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153366188|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153366189|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366190|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153366191|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
153948693|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948694|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948695|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
153948696|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948697|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948698|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948699|NCT02844816|Atezolizumab|atezolizumab|mesh-list
153948700|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153948701|NCT02844816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948702|NCT02844816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948703|NCT02844816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948704|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948705|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
153948706|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948707|NCT02595424|Carboplatin|carboplatin|mesh-list
153948708|NCT02595424|Capecitabine|capecitabine|mesh-list
153948709|NCT02595424|Etoposide|etoposide|mesh-list
153948710|NCT02595424|Temozolomide|temozolomide|mesh-list
153948711|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948712|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948713|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
153948714|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948715|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948716|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153948717|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153948718|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948719|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153948720|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
153948721|NCT02581930|Ibrutinib|ibrutinib|mesh-list
153948722|NCT02581930|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948723|NCT02581930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948724|NCT02581930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948725|NCT02581930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948726|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153948727|NCT02568553|Lenalidomide|lenalidomide|mesh-list
153948728|NCT02568553|Blinatumomab|blinatumomab|mesh-list
153948729|NCT02568553|Antibodies|antibodies|mesh-list
153948730|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
153948731|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153948732|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
153948733|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153948734|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
153948746|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
153948747|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948748|NCT02513563|Paclitaxel|paclitaxel|mesh-list
153948749|NCT02513563|Carboplatin|carboplatin|mesh-list
153948750|NCT02513563|Adavosertib|adavosertib|mesh-list
153948751|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948752|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948753|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948754|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948755|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948756|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948757|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948758|NCT02496585|Prednisone|prednisone|mesh-list
153948759|NCT02496585|Nintedanib|nintedanib|mesh-list
153948760|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948761|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
153826357|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826358|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153948763|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948764|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948765|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948766|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948767|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948768|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948769|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948770|NCT02466971|Cisplatin|cisplatin|mesh-list
153948771|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948772|NCT02443545|Deferiprone|deferiprone|mesh-list
153948773|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153948774|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
153948775|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
153948776|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948777|NCT02388906|Nivolumab|nivolumab|mesh-list
153948778|NCT02388906|Ipilimumab|ipilimumab|mesh-list
153948779|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948780|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948781|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948782|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948783|NCT02375555|Dexamethasone|dexamethasone|mesh-list
153948784|NCT02375555|Lenalidomide|lenalidomide|mesh-list
153948785|NCT02375555|Bortezomib|bortezomib|mesh-list
153948786|NCT02375555|Elotuzumab|elotuzumab|mesh-list
153948787|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948788|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
153948789|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
153948790|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948791|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948792|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153948793|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
153948794|NCT02375555|Hormones|hormones|mesh-ancestor
153948795|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948796|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948797|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948798|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
153948799|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153948826|NCT02299999|Epirubicin|epirubicin|mesh-list
153948827|NCT02299999|Olaparib|olaparib|mesh-list
153948828|NCT02299999|Mitomycins|mitomycins|mesh-list
153948829|NCT02299999|Mitomycin|mitomycin|mesh-list
153948830|NCT02299999|Bicalutamide|bicalutamide|mesh-list
153948831|NCT02299999|Taxane|taxane|mesh-list
153948832|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948833|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948834|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948835|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948836|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948837|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948838|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948839|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
153948840|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948841|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948842|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153948843|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
153948844|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153948845|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948846|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153948847|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153948848|NCT02299999|Growth Substances|growth substances|mesh-ancestor
153948849|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
153409782|NCT04359199|Cisplatin|cisplatin|mesh-list
153366415|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948850|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948851|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
153948852|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153948853|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153948854|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153948855|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948856|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153948857|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
153948873|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948874|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153948875|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
153948876|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948877|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948878|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153948879|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948880|NCT02251548|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948881|NCT02251548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948882|NCT02251548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731463|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
153948883|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153948884|NCT02193282|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948885|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948886|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948887|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948888|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948889|NCT02152982|Temozolomide|temozolomide|mesh-list
153948890|NCT02152982|Veliparib|veliparib|mesh-list
153948891|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153706476|NCT00312013|Nadroparin|nadroparin|mesh-list
153948892|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
153948893|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948894|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948895|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153948896|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948897|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
153948898|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
153948899|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153948900|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948901|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948902|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
153948903|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153948904|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153948905|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948907|NCT02117167|Durvalumab|durvalumab|mesh-list
153948908|NCT02117167|Olaparib|olaparib|mesh-list
153948909|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948910|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948911|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948912|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153948913|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153948914|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948929|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
153948930|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948931|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948932|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153948933|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
153948934|NCT02106988|Hormones|hormones|mesh-ancestor
153948935|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948936|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948937|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948938|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948939|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153948940|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153948941|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948942|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948943|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153948944|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
153948945|NCT02101788|Tamoxifen|tamoxifen|mesh-list
153948946|NCT02101788|Paclitaxel|paclitaxel|mesh-list
153948947|NCT02101788|Doxorubicin|doxorubicin|mesh-list
153948948|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153948949|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153948950|NCT02101788|Letrozole|letrozole|mesh-list
153948951|NCT02101788|Topotecan|topotecan|mesh-list
153948952|NCT02101788|Trametinib|trametinib|mesh-list
153948953|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153948954|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948955|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948956|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948957|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948958|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948959|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948960|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153948961|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153948962|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153733539|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
153948963|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948964|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153948965|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153948966|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153948967|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
153948968|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948969|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948970|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153948971|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948972|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153948973|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153948974|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153948975|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153949001|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153949002|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949004|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
153949005|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
153949006|NCT01864018|Ixazomib|ixazomib|mesh-list
153949007|NCT01864018|Ichthammol|ichthammol|mesh-list
153949008|NCT01864018|BB 1101|bb 1101|mesh-list
153949009|NCT01864018|Glycine|glycine|mesh-list
153949010|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949011|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
153949012|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949013|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949014|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153949015|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
153949016|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949017|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949018|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153949019|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949020|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
153949021|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
153949022|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949023|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153949024|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
153949025|NCT01864018|Hormones|hormones|mesh-ancestor
153949026|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949027|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153949028|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
153949029|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706536|NCT00312325|Hormones|hormones|mesh-ancestor
153949045|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949046|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153949047|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949048|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153949049|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
153949050|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153949051|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949052|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949053|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
153949054|NCT01844505|Nivolumab|nivolumab|mesh-list
153949055|NCT01844505|Ipilimumab|ipilimumab|mesh-list
153949056|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949057|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949058|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153949059|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949060|NCT01796171|Rituximab|rituximab|mesh-list
153949061|NCT01796171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949062|NCT01796171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949063|NCT01796171|Immunologic Factors|immunologic factors|mesh-ancestor
153949064|NCT01796171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949065|NCT01796171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949066|NCT01620944|Ritonavir|ritonavir|mesh-list
153949067|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153949068|NCT01620944|Tenofovir|tenofovir|mesh-list
153949069|NCT01620944|Lamivudine|lamivudine|mesh-list
153949070|NCT01620944|Emtricitabine|emtricitabine|mesh-list
153949071|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153949072|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153949073|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
153949074|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949075|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949076|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153949077|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153949078|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
153949079|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949080|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153949081|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153949082|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153949083|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153949084|NCT01522976|Lenalidomide|lenalidomide|mesh-list
153949085|NCT01522976|Azacitidine|azacitidine|mesh-list
153949086|NCT01522976|Vorinostat|vorinostat|mesh-list
153949087|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
153949088|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949089|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949090|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949091|NCT01522976|Growth Substances|growth substances|mesh-ancestor
153949109|NCT01371981|Sorafenib|sorafenib|mesh-list
153949110|NCT01371981|Asparaginase|asparaginase|mesh-list
153949111|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949112|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949113|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153949114|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153949115|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949116|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706690|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
153949117|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153949118|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
153949119|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
153949120|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949121|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949123|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949124|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153949125|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949126|NCT01371981|Analgesics|analgesics|mesh-ancestor
153949127|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
153949128|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949129|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
153949130|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
153949131|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949132|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949133|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949134|NCT01345851|Paclitaxel|paclitaxel|mesh-list
153949135|NCT01345851|Carboplatin|carboplatin|mesh-list
153949136|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949137|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949138|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949139|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949140|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949141|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949142|NCT01274338|Interferons|interferons|mesh-list
153949143|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
153949144|NCT01274338|Interferon alpha-2|interferon alpha-2|mesh-list
153949145|NCT01274338|Ipilimumab|ipilimumab|mesh-list
153949146|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949147|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
153949148|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949149|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949150|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153949151|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949152|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
153949171|NCT01199575|Rituximab|rituximab|mesh-list
153949172|NCT01199575|Lenalidomide|lenalidomide|mesh-list
153949173|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949174|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949175|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
153949176|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949177|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949178|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949179|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949180|NCT01199575|Growth Substances|growth substances|mesh-ancestor
153949181|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949182|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
153949183|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
153949184|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949185|NCT01169922|Ethanol|ethanol|mesh-list
153949186|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153949187|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949188|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153949189|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949190|NCT01169337|Lenalidomide|lenalidomide|mesh-list
153949191|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
153949192|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949193|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153706766|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949194|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949195|NCT01169337|Growth Substances|growth substances|mesh-ancestor
153949196|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949197|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949198|NCT01064648|Cisplatin|cisplatin|mesh-list
153949199|NCT01064648|Pemetrexed|pemetrexed|mesh-list
153949200|NCT01064648|Cediranib|cediranib|mesh-list
153949201|NCT01064648|Maleic acid|maleic acid|mesh-list
153949202|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949203|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949204|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949205|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153949206|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153949207|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153949247|NCT00977574|Epothilones|epothilones|mesh-list
153949248|NCT00977574|Epothilone B|epothilone b|mesh-list
153949270|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949271|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
153949272|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153949273|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949274|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949275|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
153949276|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949277|NCT00977574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153949278|NCT00977574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949280|NCT00972478|Cortisone|cortisone|mesh-list
153949281|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
153949282|NCT00972478|Rituximab|rituximab|mesh-list
153949283|NCT00972478|Doxorubicin|doxorubicin|mesh-list
153949284|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153949285|NCT00972478|Vincristine|vincristine|mesh-list
153949286|NCT00972478|Vorinostat|vorinostat|mesh-list
153949287|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153949288|NCT00972478|Antibodies|antibodies|mesh-list
153949289|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
153949290|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153949291|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949292|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
153949293|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949294|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949295|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153949296|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
153949297|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949298|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949299|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153949300|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949301|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153949302|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153949303|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949304|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949321|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949322|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949323|NCT00843882|Hematinics|hematinics|mesh-ancestor
153949324|NCT00769379|Trastuzumab|trastuzumab|mesh-list
153949325|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153949326|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949327|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949328|NCT00750841|Cediranib|cediranib|mesh-list
153949329|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949330|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153949331|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949332|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949333|NCT00658814|Azacitidine|azacitidine|mesh-list
153949334|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
153949335|NCT00658814|Calicheamicins|calicheamicins|mesh-list
153949336|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153949337|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
153949338|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949339|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949340|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733690|NCT00507793|Sirolimus|sirolimus|mesh-list
153949341|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949342|NCT00658814|Immunotoxins|immunotoxins|mesh-ancestor
153949343|NCT00658814|Immunoconjugates|immunoconjugates|mesh-ancestor
153949344|NCT00658814|Immunologic Factors|immunologic factors|mesh-ancestor
153949345|NCT00658814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949346|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949347|NCT00644228|Dexamethasone|dexamethasone|mesh-list
153949348|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
153949349|NCT00644228|Lenalidomide|lenalidomide|mesh-list
153949350|NCT00644228|Bortezomib|bortezomib|mesh-list
153949351|NCT00644228|Ichthammol|ichthammol|mesh-list
153949352|NCT00644228|BB 1101|bb 1101|mesh-list
153949353|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949354|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
153949355|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
153949356|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949357|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949358|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153949359|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
153949360|NCT00644228|Hormones|hormones|mesh-ancestor
153949361|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949362|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153949363|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949375|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153949376|NCT00470223|Methotrexate|methotrexate|mesh-list
153949377|NCT00470223|Etoposide|etoposide|mesh-list
153949378|NCT00470223|Ifosfamide|ifosfamide|mesh-list
153949379|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949380|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949381|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153949382|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153949383|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949384|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949385|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153949386|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
153949387|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153949388|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949389|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153949390|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
153949391|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
153949392|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153949393|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949394|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
153949395|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949396|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153949397|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949398|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153949399|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
153949400|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153949401|NCT00324805|Bevacizumab|bevacizumab|mesh-list
153949402|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153949403|NCT00324805|Cisplatin|cisplatin|mesh-list
153949404|NCT00324805|Gemcitabine|gemcitabine|mesh-list
153949405|NCT00324805|Docetaxel|docetaxel|mesh-list
153949406|NCT00324805|Pemetrexed|pemetrexed|mesh-list
153949407|NCT00324805|Vinorelbine|vinorelbine|mesh-list
153949408|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
153949409|NCT00324805|Antibodies|antibodies|mesh-list
153949410|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
153949411|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153949412|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
153949413|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949414|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949415|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949416|NCT00324805|Growth Substances|growth substances|mesh-ancestor
153409965|NCT04592419|Aflibercept|aflibercept|mesh-list
153949417|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949418|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949419|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
153949420|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153949422|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949423|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949424|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949425|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949426|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949427|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153706984|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949428|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153949450|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949451|NCT00819091|Linagliptin|linagliptin|mesh-list
153949452|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153949453|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949454|NCT00819091|Incretins|incretins|mesh-ancestor
153949455|NCT00819091|Hormones|hormones|mesh-ancestor
153949456|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949457|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153949458|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
153949459|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949460|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949461|NCT00819013|Vaccines|vaccines|mesh-list
153949462|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
153949463|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949464|NCT04868461|Caseins|caseins|mesh-list
153949465|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
153949466|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
153949467|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949468|NCT02865642|Escitalopram|escitalopram|mesh-list
153949469|NCT02865642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153949470|NCT02865642|Serotonin|serotonin|mesh-list
153949471|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153949472|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153949473|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949474|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949475|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
153949476|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949477|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153949478|NCT03762564|Paclitaxel|paclitaxel|mesh-list
153949479|NCT03762564|Ramucirumab|ramucirumab|mesh-list
153949480|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949493|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153949494|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949495|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153949496|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153949497|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
153949498|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949499|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707062|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
153949500|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153949501|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153949502|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949503|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949504|NCT02864628|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153949506|NCT02864628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949507|NCT01120028|Sirolimus|sirolimus|mesh-list
153949508|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
153949509|NCT01120028|Tacrolimus|tacrolimus|mesh-list
153949510|NCT01120028|Basiliximab|basiliximab|mesh-list
153949511|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949512|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
153949513|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949514|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153949515|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949516|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949517|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153949518|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949519|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949520|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949521|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
153949522|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949523|NCT00878800|Doxorubicin|doxorubicin|mesh-list
153949524|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153949525|NCT00878800|Belinostat|belinostat|mesh-list
153949526|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949527|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949528|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153949529|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153949530|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949531|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949532|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153949533|NCT00662272|Vaccines|vaccines|mesh-list
153949534|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
153949535|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949536|NCT04158856|Trastuzumab|trastuzumab|mesh-list
153949537|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949538|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949539|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
153949540|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153949541|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153949542|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153949560|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949562|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153949563|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153949564|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153949565|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
153949566|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
153949567|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
153949568|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
153949569|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949570|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949571|NCT01145066|Borage oil|borage oil|mesh-list
153949572|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949573|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
153949574|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
153949575|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153949576|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153949577|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949578|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949579|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949580|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949581|NCT00637442|Galantamine|galantamine|mesh-list
153949582|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153949583|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949584|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949585|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
153949586|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949587|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949588|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153949589|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
153949590|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949591|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
153949592|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153949593|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153949594|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153949595|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153949596|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949597|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
153949598|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949612|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949614|NCT02863614|Lorazepam|lorazepam|mesh-list
153949615|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153949616|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153949617|NCT02863614|Analgesics|analgesics|mesh-ancestor
153949618|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
153949619|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949620|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949621|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949622|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949623|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153949624|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949625|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260785|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
153367140|NCT00988832|Infliximab|infliximab|mesh-list
153949626|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
153949627|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
153949628|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
153949629|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153949630|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153949631|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153949632|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153949633|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153949634|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153949635|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
153949636|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
153949637|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949638|NCT00974922|Vitamin D|vitamin d|mesh-list
153949639|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
153949641|NCT00974922|Vitamins|vitamins|mesh-ancestor
153949642|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
153949643|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949644|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153949645|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153949646|NCT00974922|Renin Inhibitors|renin inhibitors|mesh-ancestor
153949647|NCT00974922|Protease Inhibitors|protease inhibitors|mesh-ancestor
153949648|NCT00974922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949649|NCT00974922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949651|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153949652|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153949653|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153949654|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
153949655|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
153949656|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949657|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949658|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949659|NCT00969150|Milnacipran|milnacipran|mesh-list
153949660|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
153707150|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
153949672|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949674|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153949675|NCT00974220|Narcotics|narcotics|mesh-ancestor
153949676|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153949677|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949678|NCT00974220|Analgesics|analgesics|mesh-ancestor
153949679|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
153949680|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949681|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153949682|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153949683|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
153949684|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
153949685|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
153949686|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153949687|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153949688|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949689|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153949690|NCT00971178|Analgesics|analgesics|mesh-ancestor
153949691|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
153949692|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949693|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153949694|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153949695|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153949696|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
153949697|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949698|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949699|NCT00970944|Amantadine|amantadine|mesh-list
153949700|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153949701|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153949702|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
153949703|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949704|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
153949705|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949706|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949707|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949708|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153949709|NCT00970944|Analgesics|analgesics|mesh-ancestor
153949710|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
153949711|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949712|NCT05780723|Mesalamine|mesalamine|mesh-list
153949713|NCT05780723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153949715|NCT05780723|Analgesics|analgesics|mesh-ancestor
153949716|NCT05780723|Sensory System Agents|sensory system agents|mesh-ancestor
153949717|NCT05780723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949718|NCT05780723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949719|NCT05780723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949720|NCT05780723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949721|NCT05780515|Immunoglobulins|immunoglobulins|mesh-list
153949722|NCT05780515|Immunoglobulin G|immunoglobulin g|mesh-list
153949758|NCT05779410|Cholecalciferol|cholecalciferol|mesh-list
153949759|NCT05779410|Vitamins|vitamins|mesh-list
153949760|NCT05779410|Micronutrients|micronutrients|mesh-ancestor
153949780|NCT05779059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949781|NCT05779059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949782|NCT05779059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949783|NCT05778422|Anesthetics|anesthetics|mesh-list
153949784|NCT05778422|Anesthetics, Local|anesthetics, local|mesh-list
153949785|NCT05778422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153949786|NCT05778422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949787|NCT05778422|Sensory System Agents|sensory system agents|mesh-ancestor
153949788|NCT05778422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949790|NCT05739929|Gout Suppressants|gout suppressants|mesh-ancestor
153949791|NCT05739929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949792|NCT05739929|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949793|NCT05739929|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949794|NCT05739929|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949795|NCT05739929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949796|NCT05739929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949797|NCT05712265|Fluvoxamine|fluvoxamine|mesh-list
153949798|NCT05712265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153949799|NCT05712265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153949800|NCT05712265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153949801|NCT05712265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949802|NCT05712265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153949803|NCT05712265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153949804|NCT05712265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153949805|NCT05712265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153949806|NCT05712265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949807|NCT05712265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949808|NCT05712265|Serotonin Agents|serotonin agents|mesh-ancestor
153949809|NCT05712265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153949810|NCT05712265|Antidepressive Agents|antidepressive agents|mesh-ancestor
153949811|NCT05712265|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153949812|NCT05712265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153949813|NCT05712265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949830|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949831|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949833|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
153949834|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
153949835|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153949836|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949837|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
153949838|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949839|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153949840|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153949841|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153949842|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153949843|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949844|NCT05598957|Vitamin D|vitamin d|mesh-list
153949845|NCT05598957|Vitamins|vitamins|mesh-ancestor
153949846|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
153949847|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949848|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153949849|NCT05567068|Mesalamine|mesalamine|mesh-list
153949850|NCT05567068|Atorvastatin|atorvastatin|mesh-list
153949851|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153949852|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153949853|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
153949854|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949855|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153949856|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153949857|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731464|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153949858|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153949859|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153949860|NCT05567068|Analgesics|analgesics|mesh-ancestor
153949861|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
153949862|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949863|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949864|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949865|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949866|NCT05565001|Cromakalim|cromakalim|mesh-list
153949867|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153949868|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153707431|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
153949900|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949901|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
153949902|NCT05311033|Coagulants|coagulants|mesh-ancestor
153949903|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
153949904|NCT05281562|Vitamins|vitamins|mesh-ancestor
153949905|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
153949906|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949907|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
153949908|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949909|NCT05281562|Protective Agents|protective agents|mesh-ancestor
153949910|NCT05276596|Norepinephrine|norepinephrine|mesh-list
153949911|NCT05276596|Ephedrine|ephedrine|mesh-list
153949912|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153949913|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153949914|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
153949915|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949916|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949917|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949918|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
153949919|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
153949920|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949921|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153949922|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153949923|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
153949924|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153949925|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
153949926|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949927|NCT05241262|Expectorants|expectorants|mesh-ancestor
153949928|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
153949929|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153949930|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
153707411|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949964|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153949965|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949966|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
153949967|NCT04903054|Prednisone|prednisone|mesh-list
153949968|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
153949969|NCT04903054|Tacrolimus|tacrolimus|mesh-list
153949970|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
153949971|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153949972|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949973|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
153949974|NCT04903054|Hormones|hormones|mesh-ancestor
153949975|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949976|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949977|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153949978|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949979|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949980|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
153949981|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153949982|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949983|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949984|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949985|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153949986|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
153949987|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153949988|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949989|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
153949990|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
153949991|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950001|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153950002|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153950003|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950004|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950005|NCT04834557|Protective Agents|protective agents|mesh-ancestor
153950006|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950007|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153950008|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950010|NCT04825093|Vitamins|vitamins|mesh-ancestor
153950011|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
153950012|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950013|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153950014|NCT04793152|Vancomycin|vancomycin|mesh-list
153950015|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153950016|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950017|NCT04770493|Lamotrigine|lamotrigine|mesh-list
153950018|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
153950019|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153950020|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153707589|NCT00312598|Aripiprazole|aripiprazole|mesh-list
153950021|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950023|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950024|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153950025|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153950026|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950027|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950028|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153950029|NCT04741464|Tinzaparin|tinzaparin|mesh-list
153950030|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153950031|NCT04741464|Dalteparin|dalteparin|mesh-list
153950032|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
153950033|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153950034|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153950035|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950036|NCT04663555|Dexamethasone|dexamethasone|mesh-list
153950037|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950038|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
153950039|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
153950040|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950041|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950042|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950043|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
153950044|NCT04663555|Hormones|hormones|mesh-ancestor
153950045|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153950046|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153950047|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950048|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153950049|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153950050|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153950051|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950052|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950053|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
153950054|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950055|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950056|NCT04496024|Ofloxacin|ofloxacin|mesh-list
153950057|NCT04496024|Levofloxacin|levofloxacin|mesh-list
153950094|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
153950095|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
153950133|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950134|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153707622|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950149|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950150|NCT03657810|Acetaminophen|acetaminophen|mesh-list
153950151|NCT03657810|Promethazine|promethazine|mesh-list
153950152|NCT03657810|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153950153|NCT03657810|Hydrocodone|hydrocodone|mesh-list
153950155|NCT03657810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153950156|NCT03657810|Analgesics|analgesics|mesh-ancestor
153950157|NCT03657810|Sensory System Agents|sensory system agents|mesh-ancestor
153950158|NCT03657810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950159|NCT03657810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950160|NCT03657810|Antipyretics|antipyretics|mesh-ancestor
153950161|NCT03657810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153950162|NCT03657810|Narcotics|narcotics|mesh-ancestor
153950163|NCT03657810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950164|NCT03657810|Antitussive Agents|antitussive agents|mesh-ancestor
153950165|NCT03657810|Respiratory System Agents|respiratory system agents|mesh-ancestor
153950166|NCT03657810|Antipruritics|antipruritics|mesh-ancestor
153950167|NCT03657810|Dermatologic Agents|dermatologic agents|mesh-ancestor
153950168|NCT03657810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153950169|NCT03657810|Histamine Antagonists|histamine antagonists|mesh-ancestor
153950170|NCT03657810|Histamine Agents|histamine agents|mesh-ancestor
153950171|NCT03657810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950172|NCT03657810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950173|NCT03657810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153950174|NCT03657810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153950175|NCT03657810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950176|NCT03657810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950177|NCT03640026|Tacrolimus|tacrolimus|mesh-list
153950178|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153950179|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
153950180|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950181|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153950182|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950183|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950185|NCT03544736|Carboplatin|carboplatin|mesh-list
153950186|NCT03544736|Nivolumab|nivolumab|mesh-list
153950187|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153950188|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950189|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
153950190|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
153950191|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
153950192|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950193|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153707660|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950214|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153950215|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153950216|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153950217|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153950218|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153950219|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153950220|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153950221|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
153950222|NCT03094637|Azacitidine|azacitidine|mesh-list
153950223|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153950224|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950225|NCT03094637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153950226|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950227|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153950228|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
153950229|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950230|NCT03055507|Acetaminophen|acetaminophen|mesh-list
153950231|NCT03055507|Ibuprofen|ibuprofen|mesh-list
153950232|NCT03055507|Oxycodone|oxycodone|mesh-list
153950233|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153950234|NCT03055507|Analgesics|analgesics|mesh-ancestor
153950235|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
153950236|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950237|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950238|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
153950239|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153950240|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950241|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950242|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153950243|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950244|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950245|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153950246|NCT03055507|Narcotics|narcotics|mesh-ancestor
153950247|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950248|NCT03038256|Capecitabine|capecitabine|mesh-list
153950269|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153950270|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153950271|NCT02587195|Analgesics|analgesics|mesh-ancestor
153950272|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
153950273|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950274|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950275|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439929|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
153950276|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950277|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153950278|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
153950279|NCT02582008|Bupropion|bupropion|mesh-list
153950280|NCT02582008|Nicotine|nicotine|mesh-list
153950281|NCT02582008|Varenicline|varenicline|mesh-list
153950282|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153950283|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
153950284|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950285|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950286|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153950287|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153950288|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
153734120|NCT04697641|Z 338|z 338|mesh-list
153950289|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950290|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950291|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153950292|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
153950293|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950294|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153950295|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153950296|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950297|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
153950298|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153950299|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153950300|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950301|NCT02502799|Methylphenidate|methylphenidate|mesh-list
153950318|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153950319|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153950321|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153950322|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153950323|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
153950324|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950325|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153950326|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153950327|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950328|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
153950329|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153950330|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
153950331|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153950332|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950333|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153950334|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153950335|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153950336|NCT00408447|Fludarabine|fludarabine|mesh-list
153950337|NCT00408447|Busulfan|busulfan|mesh-list
153950338|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
153950339|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950340|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950341|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153950342|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
153950343|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950344|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
153950345|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153950346|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153950347|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153950348|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153950349|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153950350|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950351|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
153950352|NCT00970632|Tadalafil|tadalafil|mesh-list
153950353|NCT00970632|Tamsulosin|tamsulosin|mesh-list
153950354|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
153729830|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729831|NCT00139971|Gemcitabine|gemcitabine|mesh-list
153729832|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153729833|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
153707829|NCT05999474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729842|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950355|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153950356|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153950357|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950358|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950359|NCT00970632|Urological Agents|urological agents|mesh-ancestor
153950360|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153950361|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153950362|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153950363|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
153950364|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950365|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950367|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153950368|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950369|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
153950370|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950371|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950372|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
153950373|NCT00965094|Everolimus|everolimus|mesh-list
153950374|NCT00965094|Tacrolimus|tacrolimus|mesh-list
153950375|NCT00965094|Basiliximab|basiliximab|mesh-list
153950376|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153950377|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
153950378|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950379|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153950380|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950381|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950382|NCT00965094|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153950383|NCT00965094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153950384|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950385|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153950386|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153950387|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
153950388|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153950391|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153950392|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153950393|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950394|NCT01131182|Incretins|incretins|mesh-ancestor
153950395|NCT01131182|Hormones|hormones|mesh-ancestor
153950396|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153950397|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153950398|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
153950399|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950400|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950401|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
153950402|NCT01131104|Tadalafil|tadalafil|mesh-list
153950403|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153950404|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
153950405|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
153950406|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153950407|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950408|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950409|NCT01131104|Urological Agents|urological agents|mesh-ancestor
153950410|NCT04264884|Daratumumab|daratumumab|mesh-list
153950411|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950412|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153950413|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153950424|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
153950425|NCT00629928|Esomeprazole|esomeprazole|mesh-list
153950426|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153950427|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950428|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153950429|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950430|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950431|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
153950432|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
153950433|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153950434|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153950435|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950436|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950437|NCT00964782|Urological Agents|urological agents|mesh-ancestor
153950438|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153950439|NCT02882984|Gefitinib|gefitinib|mesh-list
153950440|NCT02882984|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153950441|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153950442|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950443|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950444|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950445|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153950446|NCT00966654|Incretins|incretins|mesh-ancestor
153950447|NCT00966654|Hormones|hormones|mesh-ancestor
153950448|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153950449|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950450|NCT00625196|Fluticasone|fluticasone|mesh-list
153950451|NCT00625196|Xhance|xhance|mesh-list
153950452|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950453|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153950454|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
153950455|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950456|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950457|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153950458|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
153950459|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
153950460|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153950461|NCT03262116|Insulin|insulin|mesh-list
153950462|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153950463|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
153950464|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
153950465|NCT03262116|Pancrelipase|pancrelipase|mesh-list
153950466|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153950467|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950468|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950469|NCT01130168|Amlodipine|amlodipine|mesh-list
153950470|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153950471|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153950472|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950473|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950504|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
153950505|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153950506|NCT01117766|Pregabalin|pregabalin|mesh-list
153950507|NCT01117766|Analgesics|analgesics|mesh-ancestor
153950508|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
153950509|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950510|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950511|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
153950512|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153950513|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950514|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950515|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153950516|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153950517|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153950518|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950549|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153950550|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
153950551|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950552|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950553|NCT01128842|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153950554|NCT01128842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153950555|NCT01128842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950556|NCT00625274|Esomeprazole|esomeprazole|mesh-list
153950557|NCT00625274|Pantoprazole|pantoprazole|mesh-list
153950558|NCT00625274|Lansoprazole|lansoprazole|mesh-list
153950559|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
153950560|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153950561|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950562|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153950563|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950572|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950573|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950574|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153950575|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950576|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153410246|NCT00002823|Etoposide|etoposide|mesh-list
153898940|NCT05768191|Insulin|insulin|mesh-list
153950577|NCT04669041|Ezetimibe|ezetimibe|mesh-list
153950578|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153950579|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153950580|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
153950581|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950582|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153950583|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153950584|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950585|NCT05132595|Ketorolac|ketorolac|mesh-list
153950586|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153950587|NCT05132595|Esketamine|esketamine|mesh-list
153950588|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153950589|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153950590|NCT05132595|Analgesics|analgesics|mesh-ancestor
153950591|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
153950592|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950593|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950594|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950595|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950596|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153950597|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950598|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950599|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
153950600|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950601|NCT01074047|Azacitidine|azacitidine|mesh-list
153950602|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153950603|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
153357594|NCT01274624|Leucovorin|leucovorin|mesh-list
153950604|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950606|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950607|NCT05226117|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153950608|NCT05226117|Immunoconjugates|immunoconjugates|mesh-ancestor
153950609|NCT05226117|Immunologic Factors|immunologic factors|mesh-ancestor
153950610|NCT05226117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950611|NCT01142726|Methotrexate|methotrexate|mesh-list
153950612|NCT01142726|Abatacept|abatacept|mesh-list
153950613|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153950614|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
153950615|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153950616|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950617|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153950618|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
153950619|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950620|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950621|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
153950622|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950623|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153950624|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153950625|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
153950626|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950627|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153950628|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153950643|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153950644|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153950645|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950646|NCT00915681|Silybin|silybin|mesh-list
153950647|NCT00915681|Protective Agents|protective agents|mesh-ancestor
153950648|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950649|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153950650|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950651|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
153950652|NCT01128296|Gemcitabine|gemcitabine|mesh-list
153950653|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153950654|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
153950655|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950656|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950657|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
153950658|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153950659|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153950660|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950661|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410263|NCT00361621|Vincristine|vincristine|mesh-list
153899080|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153950662|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950663|NCT05082909|Probenecid|probenecid|mesh-list
153950664|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
153950665|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
153950666|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950667|NCT04240509|Tenofovir|tenofovir|mesh-list
153950668|NCT04240509|Emtricitabine|emtricitabine|mesh-list
153950669|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
153950670|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950671|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153950672|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153950673|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950674|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950675|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153950676|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153950677|NCT01115738|Clopidogrel|clopidogrel|mesh-list
153950678|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153950679|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153950680|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153950681|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153950682|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153950683|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
153950684|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950685|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950686|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950687|NCT00632073|Maleic acid|maleic acid|mesh-list
153950703|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950704|NCT04539873|Colchicine|colchicine|mesh-list
153950705|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
153950706|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950707|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
153950708|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
153950709|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
153950710|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950711|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950712|NCT02861040|Vincristine|vincristine|mesh-list
153950713|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153950714|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950715|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
153950716|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
153950717|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
153950718|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950719|NCT04282902|Pirfenidone|pirfenidone|mesh-list
153950720|NCT04282902|Analgesics|analgesics|mesh-ancestor
153950721|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
153950722|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950723|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950724|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153950725|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153950726|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950727|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950728|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950729|NCT02860962|Levomethorphan|levomethorphan|mesh-list
153950730|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
153950731|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
153950732|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
153950733|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153950734|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153950735|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950736|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950737|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950738|NCT02860962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153950739|NCT02860962|Narcotics|narcotics|mesh-ancestor
153950740|NCT02860962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950741|NCT02860962|Analgesics|analgesics|mesh-ancestor
153950742|NCT02860962|Sensory System Agents|sensory system agents|mesh-ancestor
153950743|NCT02860962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950744|NCT00878722|Idarubicin|idarubicin|mesh-list
153950745|NCT00878722|Belinostat|belinostat|mesh-list
153950746|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153950757|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950759|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153950760|NCT00659386|Antibodies|antibodies|mesh-list
153950761|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
153950762|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153950763|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
153950764|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950765|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153950766|NCT04155814|Hematinics|hematinics|mesh-ancestor
153950767|NCT04158076|Amlodipine|amlodipine|mesh-list
153950768|NCT04158076|Telmisartan|telmisartan|mesh-list
153950769|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153950770|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153950771|NCT04158076|Ezetimibe|ezetimibe|mesh-list
153950772|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153950773|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153950774|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950775|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950776|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153950777|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950778|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
153950779|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153950780|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153950781|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
153950782|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153950783|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153950784|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950785|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153902445|NCT00400725|Clobetasol|clobetasol|mesh-list
153950786|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153950787|NCT00961350|Aspirin|aspirin|mesh-list
153950788|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153950789|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153950790|NCT00961350|Analgesics|analgesics|mesh-ancestor
153950791|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
153950792|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950793|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950794|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950795|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950796|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153950797|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153950798|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950799|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153950800|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153950801|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950802|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
153950803|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
153950804|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153950805|NCT04032184|Fluorides|fluorides|mesh-list
153950806|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
153950807|NCT04032184|Protective Agents|protective agents|mesh-ancestor
153950819|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
153950820|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950821|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950822|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950823|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729843|NCT04726631|Insulin|insulin|mesh-list
153950825|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950826|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950827|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
153950828|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153950829|NCT00963924|Cycloserine|cycloserine|mesh-list
153950830|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153950831|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950832|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153950833|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
153950834|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153950835|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
153950836|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950837|NCT04155658|Fluorides|fluorides|mesh-list
153950838|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
153950839|NCT04155658|Protective Agents|protective agents|mesh-ancestor
153950840|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950841|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
153950842|NCT02861976|Narcotics|narcotics|mesh-ancestor
153950843|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950844|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950845|NCT02861976|Analgesics|analgesics|mesh-ancestor
153950846|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
153950847|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950848|NCT00666484|Prednisolone|prednisolone|mesh-list
153950849|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
153950850|NCT00666484|Doxorubicin|doxorubicin|mesh-list
153950851|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153950852|NCT00666484|Etoposide|etoposide|mesh-list
153950853|NCT00666484|Vincristine|vincristine|mesh-list
153950854|NCT00666484|Procarbazine|procarbazine|mesh-list
153950855|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153950856|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
153950857|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950858|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950859|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153950860|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
153950861|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950862|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950863|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153950864|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153950865|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153950866|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153950867|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950868|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153950869|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
153950870|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
153950871|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
153950872|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708371|NCT05721027|Ibuprofen|ibuprofen|mesh-list
153950887|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153950888|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950889|NCT00965562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153950890|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153950891|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950892|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950893|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950894|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
153950895|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153950896|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
153950897|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950898|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153950899|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153950900|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950901|NCT00659698|Pancrelipase|pancrelipase|mesh-list
153950902|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950903|NCT00666796|Ethanol|ethanol|mesh-list
153950904|NCT00666796|Gabapentin|gabapentin|mesh-list
153950905|NCT00666796|Analgesics|analgesics|mesh-ancestor
153950906|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
153950907|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950908|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950909|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
153950910|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153950911|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153950912|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950913|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950914|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153950915|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153950916|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950917|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950918|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
153950919|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153950920|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950921|NCT00912093|Icatibant|icatibant|mesh-list
153950922|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153950923|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153950924|NCT00912093|Analgesics|analgesics|mesh-ancestor
153950925|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
153950926|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950927|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950928|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950929|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950930|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153950931|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153950947|NCT02631460|Pemetrexed|pemetrexed|mesh-list
153950948|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950949|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950950|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950951|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153950952|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153950953|NCT04282824|Edetic Acid|edetic acid|mesh-list
153950954|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153902476|NCT00931801|Emtricitabine|emtricitabine|mesh-list
153950955|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
153950956|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
153950957|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950958|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
153950959|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153950960|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153950961|NCT00663286|Clindamycin|clindamycin|mesh-list
153950962|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
153950963|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
153950964|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153950965|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153950966|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950967|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153950968|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950969|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950970|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
153950971|NCT03237702|Carotenoids|carotenoids|mesh-list
153950972|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
153950973|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950974|NCT03237702|Protective Agents|protective agents|mesh-ancestor
153950975|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950976|NCT00667108|Gabapentin|gabapentin|mesh-list
153950977|NCT00667108|Analgesics|analgesics|mesh-ancestor
153950978|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
153950979|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950980|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950981|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
153950982|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153950983|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153950984|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950985|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950986|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153950987|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153950988|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950989|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950990|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
153951005|NCT04283058|Anesthetics|anesthetics|mesh-list
153951006|NCT04283058|Analgesics|analgesics|mesh-ancestor
153951007|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
153951008|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951009|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951010|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153951011|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153951012|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
153951013|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951014|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153951015|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153951016|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951017|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951018|NCT00631995|Vaccines|vaccines|mesh-list
153951019|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
153951020|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951021|NCT00663442|Methylphenidate|methylphenidate|mesh-list
153951022|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153951023|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951024|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153951025|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153951026|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153951027|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951028|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
153951029|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951030|NCT00912015|Tramadol|tramadol|mesh-list
153951031|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153951032|NCT00912015|Narcotics|narcotics|mesh-ancestor
153951033|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951034|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951035|NCT00912015|Analgesics|analgesics|mesh-ancestor
153951036|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
153951037|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951039|NCT00960804|Analgesics|analgesics|mesh-ancestor
153951040|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
153951041|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951042|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951043|NCT01126580|Metformin|metformin|mesh-list
153951044|NCT01126580|Dulaglutide|dulaglutide|mesh-list
153951045|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153951046|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951047|NCT01126580|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153951048|NCT00911157|Heparin|heparin|mesh-list
153951049|NCT00911157|Calcium heparin|calcium heparin|mesh-list
153951050|NCT00911157|PENTA|penta|mesh-list
153951051|NCT00911157|Fondaparinux|fondaparinux|mesh-list
153951069|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153951070|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153951071|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153951072|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153951073|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153951074|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153951075|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153951077|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
153951078|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153951079|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
153951080|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153951081|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
153951082|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951083|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
153951084|NCT04204278|Protective Agents|protective agents|mesh-ancestor
153951085|NCT00625430|Fludarabine|fludarabine|mesh-list
153951086|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
153951087|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951088|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951089|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
153951090|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951091|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951092|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
153951093|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951094|NCT04282746|Ketamine|ketamine|mesh-list
153951095|NCT04282746|Analgesics|analgesics|mesh-ancestor
153951096|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
153951097|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951098|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951099|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153951100|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153951101|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
153951102|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
153951103|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951104|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153951105|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153951106|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708598|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153951123|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951125|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951127|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951128|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
153951129|NCT01126424|Oxybutynin|oxybutynin|mesh-list
153951130|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153951131|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153951132|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
153951133|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951134|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951135|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951136|NCT01126424|Urological Agents|urological agents|mesh-ancestor
153951137|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
153951138|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
153951139|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951140|NCT01126268|Retapamulin|retapamulin|mesh-list
153951141|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951142|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951143|NCT04284150|Midazolam|midazolam|mesh-list
153951144|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
153951145|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153951146|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951147|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951148|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153951149|NCT04284150|Analgesics|analgesics|mesh-ancestor
153951150|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
153734631|NCT06052839|Pembrolizumab|pembrolizumab|mesh-list
153951151|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951152|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153951153|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153951154|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153951155|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
153951156|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951157|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951158|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153951159|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153951160|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153951161|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153951162|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153951163|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
153951164|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
153951165|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
153951166|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
153951167|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
153951168|NCT03311334|Nivolumab|nivolumab|mesh-list
153951181|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951182|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
153951183|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951184|NCT00959946|Capecitabine|capecitabine|mesh-list
153951185|NCT00959946|Bosutinib|bosutinib|mesh-list
153951186|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951187|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
153951188|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951189|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951190|NCT00959946|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153951191|NCT00959946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153951192|NCT00959946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951193|NCT00667264|Ropivacaine|ropivacaine|mesh-list
153951194|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
153951195|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
153951196|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951197|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951198|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
153951199|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951201|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153951202|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951203|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153951204|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153951205|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951206|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951207|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153951208|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
153951209|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951210|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951211|NCT04282200|Ketorolac|ketorolac|mesh-list
153951212|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153951213|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153951214|NCT04282200|Analgesics|analgesics|mesh-ancestor
153951215|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
153951216|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951217|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951218|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951219|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951220|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153951221|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951222|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951223|NCT00667498|Metformin|metformin|mesh-list
153951224|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153951225|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440720|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951226|NCT02860650|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153951246|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153951247|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153951248|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951249|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951250|NCT00663598|Urological Agents|urological agents|mesh-ancestor
153951251|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153951252|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153951253|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153734738|NCT05891171|Carboplatin|carboplatin|mesh-list
153734798|NCT05867251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951254|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
153951255|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951256|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153951257|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153951258|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951259|NCT01076543|Sirolimus|sirolimus|mesh-list
153951260|NCT01076543|Lenalidomide|lenalidomide|mesh-list
153951261|NCT01076543|Temsirolimus|temsirolimus|mesh-list
153951262|NCT01076543|MTOR Inhibitors|mtor inhibitors|mesh-list
153951263|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
153951264|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951265|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153951266|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153951267|NCT01076543|Growth Substances|growth substances|mesh-ancestor
153951268|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
153951269|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951270|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951271|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951272|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153951273|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
153951274|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951275|NCT01076543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153951276|NCT01076543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951277|NCT01076543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951278|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
153951279|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951280|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951292|NCT02860494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951293|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951294|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
153951295|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951296|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951297|NCT00663832|Panobinostat|panobinostat|mesh-list
153951298|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951299|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153951300|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951301|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951302|NCT04281576|Capecitabine|capecitabine|mesh-list
153951303|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
153951304|NCT04281576|Trastuzumab|trastuzumab|mesh-list
153951305|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951306|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
153951307|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951308|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951309|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153951310|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
153951311|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951312|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951313|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153951314|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153951315|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951316|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951317|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951318|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153951319|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153951320|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153951321|NCT04304807|Melatonin|melatonin|mesh-list
153951322|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951323|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
153951324|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951325|NCT04304807|Protective Agents|protective agents|mesh-ancestor
153951327|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951328|NCT04280874|Dinoprostone|dinoprostone|mesh-list
153951329|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
153951330|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153951331|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951332|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153951333|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153951334|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
153951335|NCT04157998|Metoclopramide|metoclopramide|mesh-list
153951336|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
153951337|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
153951338|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951339|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951340|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153951341|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153951342|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153951357|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153951358|NCT00957528|Androgens|androgens|mesh-ancestor
153951359|NCT00957528|Hormones|hormones|mesh-ancestor
153951360|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951361|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951362|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153951363|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951364|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
153951365|NCT02857062|Emollients|emollients|mesh-list
153951366|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
153951367|NCT00958776|Peramivir|peramivir|mesh-list
153951368|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
153951369|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951370|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951371|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951372|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
153951373|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951374|NCT02858856|Mitogens|mitogens|mesh-ancestor
153951375|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
153951376|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951377|NCT02858622|Fentanyl|fentanyl|mesh-list
153951378|NCT02858622|Meperidine|meperidine|mesh-list
153951379|NCT02858622|Bupivacaine|bupivacaine|mesh-list
153951380|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
153951381|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
153951382|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951383|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951384|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
153951385|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951386|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153951387|NCT02858622|Narcotics|narcotics|mesh-ancestor
153951388|NCT02858622|Analgesics|analgesics|mesh-ancestor
153951389|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153951390|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153951391|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
153951392|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
153951393|NCT02191566|Tegafur|tegafur|mesh-list
153951394|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951395|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951396|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
153951397|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951398|NCT00596830|Paclitaxel|paclitaxel|mesh-list
153951399|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153951400|NCT00596830|Carboplatin|carboplatin|mesh-list
153951401|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153951402|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951403|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
153951404|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
153951405|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
153951406|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951407|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153951408|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
153951434|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
153951435|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951436|NCT02819856|Protective Agents|protective agents|mesh-ancestor
153951437|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153951438|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951439|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153951440|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
153951441|NCT02630290|Ropivacaine|ropivacaine|mesh-list
153951442|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153951443|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951444|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951445|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153951446|NCT02630290|Analgesics|analgesics|mesh-ancestor
153951447|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
153951448|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951449|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153951450|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153951451|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153951452|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
153951453|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951454|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951455|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
153951456|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
153951457|NCT00668356|Didanosine|didanosine|mesh-list
153951458|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
153708958|NCT04872790|Cortisone|cortisone|mesh-list
153951471|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951472|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153951473|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153951474|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951475|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153951476|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
153951477|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951478|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153951479|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153951480|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951481|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
153951482|NCT00952614|Hormones|hormones|mesh-ancestor
153951483|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951484|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951485|NCT00911859|Prednisone|prednisone|mesh-list
153951486|NCT00911859|Bortezomib|bortezomib|mesh-list
153951487|NCT00911859|Melphalan|melphalan|mesh-list
153951488|NCT00911859|Siltuximab|siltuximab|mesh-list
153951489|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153951490|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951491|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
153951492|NCT00911859|Hormones|hormones|mesh-ancestor
153951493|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951494|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951495|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153951496|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951497|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153951498|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
153951499|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951500|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153951501|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951502|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
153951503|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
153951504|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153951505|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951506|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153951507|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951509|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153951510|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
153951511|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
153951512|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153951513|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951514|NCT00596752|Alprostadil|alprostadil|mesh-list
153951515|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153951516|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
153951517|NCT00596752|Urological Agents|urological agents|mesh-ancestor
153951518|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153951519|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951520|NCT00958074|Vorinostat|vorinostat|mesh-list
153951521|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951549|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
153951550|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153951551|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
153951552|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153951553|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
153899542|NCT06191692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951554|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951555|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951556|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
153951557|NCT04338165|Evolocumab|evolocumab|mesh-list
153951558|NCT04338165|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153951559|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153951560|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153951561|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
153951562|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951563|NCT04338165|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153951564|NCT04338165|Protease Inhibitors|protease inhibitors|mesh-ancestor
153951565|NCT04338165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729845|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
153951575|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951576|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951577|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951578|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951579|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153951580|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153951581|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951582|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153951583|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153951584|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951585|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
153951586|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153951587|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153951588|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
153951589|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153951590|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153951591|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153951592|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153951593|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153951594|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
153951595|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951596|NCT00913783|Clomipramine|clomipramine|mesh-list
153951597|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153951598|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
153951599|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153951600|NCT00913783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153951601|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153951602|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153951603|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951604|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951605|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
153951606|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951607|NCT00661102|Capecitabine|capecitabine|mesh-list
153951608|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951609|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
153951610|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951611|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951613|NCT00669370|Capecitabine|capecitabine|mesh-list
153951614|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951615|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
153951616|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
153951617|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
153951618|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951619|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951620|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
153951621|NCT00665314|Plerixafor|plerixafor|mesh-list
153951622|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153951623|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153951624|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
153951625|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951626|NCT04154722|Azithromycin|azithromycin|mesh-list
153951627|NCT04154722|Meropenem|meropenem|mesh-list
153951628|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951629|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951630|NCT02631928|Insulin|insulin|mesh-list
153951631|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153951632|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
153951646|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951647|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951648|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951649|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153951650|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153951651|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
153951652|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
153951653|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
153951654|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951656|NCT04669717|Azithromycin|azithromycin|mesh-list
153951657|NCT04669717|Metronidazole|metronidazole|mesh-list
153951658|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951659|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951660|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153951661|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153951662|NCT00809341|Prednisone|prednisone|mesh-list
153951663|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
153951664|NCT00809341|Ifosfamide|ifosfamide|mesh-list
153951665|NCT00809341|Rituximab|rituximab|mesh-list
153951666|NCT00809341|Carboplatin|carboplatin|mesh-list
153951667|NCT00809341|Doxorubicin|doxorubicin|mesh-list
153951668|NCT00809341|Etoposide|etoposide|mesh-list
153951669|NCT00809341|Vincristine|vincristine|mesh-list
153951670|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951671|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
153951672|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951673|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951674|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153951675|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
153951676|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951677|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951678|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153951679|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153951680|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153951681|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153951682|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153951683|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951684|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951685|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
153951686|NCT00809341|Hormones|hormones|mesh-ancestor
153951687|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951688|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153951689|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153951690|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
153951691|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
153951692|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
153951693|NCT02609581|Immunomodulating Agents|immunomodulating agents|mesh-list
153951694|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
153951695|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951704|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951705|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
153951706|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951708|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951709|NCT00811057|Indomethacin|indomethacin|mesh-list
153951710|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
153951711|NCT00811057|Nifedipine|nifedipine|mesh-list
153951712|NCT00811057|Analgesics|analgesics|mesh-ancestor
153951713|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
153951714|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951715|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951716|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
153951717|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951718|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153951719|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
153951720|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153951721|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153951722|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951723|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153951724|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
153951725|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153951726|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
153951727|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153951728|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153951729|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951730|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951731|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
153410481|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
153899649|NCT06117722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153951732|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153951733|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951735|NCT00879970|Pioglitazone|pioglitazone|mesh-list
153951736|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
153951737|NCT00879970|Vitamins|vitamins|mesh-ancestor
153951738|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
153951739|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951740|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153951741|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153951742|NCT00808639|Doxorubicin|doxorubicin|mesh-list
153951743|NCT00808639|Methotrexate|methotrexate|mesh-list
153951744|NCT00808639|Vinblastine|vinblastine|mesh-list
153951745|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951746|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153951747|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153951748|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153951749|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951750|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951751|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153951752|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
153951753|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153951754|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951755|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951756|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
153951757|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
153951758|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153951759|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951760|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
153951761|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951762|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153709247|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153951774|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951775|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951776|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951777|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
153951778|NCT03007329|Exenatide|exenatide|mesh-list
153951779|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153951780|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951781|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153951782|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951783|NCT03007329|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153951784|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153951785|NCT03007329|Incretins|incretins|mesh-ancestor
153951786|NCT03007329|Hormones|hormones|mesh-ancestor
153951787|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951788|NCT04072341|Propolis|propolis|mesh-list
153951789|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951790|NCT04030039|Interferons|interferons|mesh-list
153951791|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951792|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
153951793|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951794|NCT02628574|Gemcitabine|gemcitabine|mesh-list
153951795|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
153951796|NCT02628574|Nivolumab|nivolumab|mesh-list
153951797|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951798|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
153951799|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951800|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951801|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153951802|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153951803|NCT00596362|Bevacizumab|bevacizumab|mesh-list
153951804|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153951805|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951806|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153951807|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153951808|NCT00596362|Growth Substances|growth substances|mesh-ancestor
153951809|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951810|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
153951811|NCT00907803|Tecovirimat|tecovirimat|mesh-list
153951812|NCT00907803|Antiviral Agents|antiviral agents|mesh-ancestor
153951813|NCT00907803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260786|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410498|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
153951814|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
153951815|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951816|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951817|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153951818|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153951819|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735116|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153951820|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951821|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951822|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153951823|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153951824|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153951843|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951845|NCT00671320|Valdecoxib|valdecoxib|mesh-list
153951846|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153951847|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153951848|NCT00671320|Analgesics|analgesics|mesh-ancestor
153951849|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
153951850|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951851|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951852|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951853|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951854|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153951855|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951856|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951857|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153951858|NCT00676468|Montelukast|montelukast|mesh-list
153951859|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153951860|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
153951861|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153951862|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
153951863|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951864|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951865|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153709453|NCT03821792|Hormones|hormones|mesh-ancestor
153951866|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153951867|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951868|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153951869|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153951870|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153951871|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951873|NCT00676702|Pancrelipase|pancrelipase|mesh-list
153951874|NCT00676702|Pancreatin|pancreatin|mesh-list
153951875|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153951876|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153951877|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153951878|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951879|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
153951896|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153951897|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153951899|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
153951900|NCT00908583|Rituximab|rituximab|mesh-list
153951901|NCT00908583|Bortezomib|bortezomib|mesh-list
153951902|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153951903|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
153951904|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153951905|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951906|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
153951907|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951908|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951909|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951910|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
153951911|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
153951912|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951913|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153951914|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
153951915|NCT00908583|Hormones|hormones|mesh-ancestor
153951916|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899734|NCT05976763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899735|NCT05950997|Obinutuzumab|obinutuzumab|mesh-list
153899736|NCT05950997|Acalabrutinib|acalabrutinib|mesh-list
153951917|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153951918|NCT00908583|Protective Agents|protective agents|mesh-ancestor
153951919|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153951920|NCT00671632|Triazolam|triazolam|mesh-list
153951921|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153951922|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153951923|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153951924|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951925|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951926|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153951927|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
153951928|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
153951929|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951930|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951931|NCT04153708|Antibodies|antibodies|mesh-list
153951932|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
153951933|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
153951934|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
153951935|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951936|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
153951937|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153951938|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153951939|NCT00676936|Prednisolone|prednisolone|mesh-list
153709431|NCT03840915|Paclitaxel|paclitaxel|mesh-list
153951962|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951964|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
153951965|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153951966|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153951967|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153951968|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951969|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153951970|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153951971|NCT01125566|Trastuzumab|trastuzumab|mesh-list
153951972|NCT01125566|Vinorelbine|vinorelbine|mesh-list
153951973|NCT01125566|Afatinib|afatinib|mesh-list
153951974|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153951975|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951976|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153951977|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
153951978|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
153951979|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
153951980|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951981|NCT01125566|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153951982|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153951983|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951984|NCT04031872|Capecitabine|capecitabine|mesh-list
153951985|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153951986|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
153951987|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951988|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951989|NCT00670696|Tetracaine|tetracaine|mesh-list
153951990|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
153951991|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
153709492|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952008|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952009|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
153952010|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952011|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952012|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153952013|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
153952014|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952015|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952016|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153952017|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153952018|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153952019|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153952020|NCT00911716|Growth Substances|growth substances|mesh-ancestor
153952021|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
153952022|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
154260788|NCT01189214|Memantine|memantine|mesh-list
153952023|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952024|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952025|NCT00595582|Curcumin|curcumin|mesh-list
153952026|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153952027|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153952028|NCT00595582|Analgesics|analgesics|mesh-ancestor
153952029|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
153952030|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952031|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952032|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153952033|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952034|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952035|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952036|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952037|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
153952038|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153952039|NCT00680446|Antibodies|antibodies|mesh-list
153952040|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
153952041|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
153952042|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952043|NCT00672022|Miglustat|miglustat|mesh-list
153952044|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952045|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952046|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153952047|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153952048|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
153952049|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952050|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153952066|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153952067|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153952068|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153952069|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952070|NCT00680680|Dutasteride|dutasteride|mesh-list
153952071|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153952072|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153952073|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952074|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952075|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
153952076|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952077|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952078|NCT00808015|Varenicline|varenicline|mesh-list
153952079|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153952080|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153952081|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
153952082|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952083|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952084|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952086|NCT00680758|Everolimus|everolimus|mesh-list
153952087|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153952088|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952089|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
153952090|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952091|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952092|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952093|NCT00680758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153952094|NCT00680758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153952095|NCT00680758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952096|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952097|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
153952098|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952099|NCT00678106|Dalbavancin|dalbavancin|mesh-list
153952100|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153952101|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952102|NCT00810199|Methotrexate|methotrexate|mesh-list
153952103|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153952104|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
153952105|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153952106|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952107|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153952108|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
153952131|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952132|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153952133|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153952134|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153952135|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153952136|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153952137|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952138|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153952139|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
153952140|NCT00877006|Hormones|hormones|mesh-ancestor
153952141|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952142|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153952143|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153952144|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
153952145|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952146|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952147|NCT00678184|Atorvastatin|atorvastatin|mesh-list
153952148|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153952149|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153952150|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
153952151|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952152|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153952153|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153952154|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952155|NCT00876928|Vitamin D|vitamin d|mesh-list
153952156|NCT00876928|Vitamins|vitamins|mesh-ancestor
153952157|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
153952158|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952159|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153952160|NCT02627950|Metoclopramide|metoclopramide|mesh-list
153952161|NCT02627950|Ticagrelor|ticagrelor|mesh-list
153952178|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
153952179|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
153952180|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
153952181|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952182|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952183|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153952184|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153952185|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952186|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153952187|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153952188|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153952189|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
153952190|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
153952191|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952192|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952193|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153952194|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153952195|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952196|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952197|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153952198|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952199|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952200|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
153952201|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952202|NCT00681226|Ramipril|ramipril|mesh-list
153952203|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153952204|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
153952205|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952206|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952207|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153952208|NCT00678964|Carboplatin|carboplatin|mesh-list
153952209|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153952210|NCT00678964|Vinorelbine|vinorelbine|mesh-list
153952211|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952212|NCT00678964|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153952213|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153952214|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952215|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952216|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153952217|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
153952229|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952231|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153952232|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
153952233|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952234|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952235|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153952236|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153952237|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153952238|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729846|NCT04726631|Protamines|protamines|mesh-list
153952240|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153952241|NCT02626936|Glucagon|glucagon|mesh-list
153952242|NCT02626936|Hormones|hormones|mesh-list
153952243|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153952244|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952245|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952246|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153952247|NCT00912262|Capsaicin|capsaicin|mesh-list
153952248|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
153952249|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952250|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
153952251|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952252|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952253|NCT00906945|Cytarabine|cytarabine|mesh-list
153952254|NCT00906945|Plerixafor|plerixafor|mesh-list
153952255|NCT00906945|Etoposide|etoposide|mesh-list
153952256|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
153952257|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153952258|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952259|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153952260|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153952261|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952262|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952263|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153952264|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
153952265|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
153952266|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952267|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952268|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
153952269|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952270|NCT00906945|Analgesics|analgesics|mesh-ancestor
153952271|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
153952272|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952273|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153952274|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153952275|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153952276|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
153952277|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
153952278|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153952279|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153952280|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952281|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
153952282|NCT02627560|Coagulants|coagulants|mesh-ancestor
153952283|NCT00681460|Metformin|metformin|mesh-list
153952293|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153952295|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153952296|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
153952297|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952298|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952299|NCT00590317|Ondansetron|ondansetron|mesh-list
153952300|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
153952301|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
153952302|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
153952303|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952304|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952305|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153952306|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
153952307|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952308|NCT00590317|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153952309|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153952310|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
153952311|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952312|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952313|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153952314|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153952315|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952316|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153952317|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153410604|NCT00003549|Fluorouracil|fluorouracil|mesh-list
153952318|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
153952319|NCT01139762|Tadalafil|tadalafil|mesh-list
153952320|NCT01139762|Finasteride|finasteride|mesh-list
153952321|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
153952322|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153952323|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153952324|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952325|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952326|NCT01139762|Urological Agents|urological agents|mesh-ancestor
153952327|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153952328|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153952329|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
153952330|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952331|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952333|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
153952334|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153952335|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153952336|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
153952337|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952338|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952339|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153952340|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
153952341|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
153952342|NCT00805285|Hormones|hormones|mesh-ancestor
153952343|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952344|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
153952345|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
153952346|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952347|NCT02606773|Protective Agents|protective agents|mesh-ancestor
153709832|NCT02703220|Finasteride|finasteride|mesh-list
153952370|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952371|NCT00805207|Androgens|androgens|mesh-ancestor
153952372|NCT00805207|Progestins|progestins|mesh-ancestor
153952374|NCT00805675|Telbivudine|telbivudine|mesh-list
153952375|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
153952376|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952377|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153952378|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153952379|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952380|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952381|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153952382|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153952383|NCT03958201|Rocuronium|rocuronium|mesh-list
153952384|NCT03958201|Neostigmine|neostigmine|mesh-list
153952385|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153952386|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153952387|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153952388|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952389|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729847|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153952390|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153952391|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952392|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952393|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
153952394|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952395|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153952396|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
153952397|NCT00589303|Metoprolol|metoprolol|mesh-list
153952398|NCT00589303|Amiodarone|amiodarone|mesh-list
153952399|NCT00589303|Verapamil|verapamil|mesh-list
153952400|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153952401|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153952413|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153952414|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952415|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153952416|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153952417|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153952418|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952419|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153952420|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153952421|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154260790|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154260791|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
154260792|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260793|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260794|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952422|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153952423|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153952424|NCT02607943|Insulin|insulin|mesh-list
153952425|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153952426|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
153952427|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153952428|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952429|NCT02606617|Mosapride|mosapride|mesh-list
153952430|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153952431|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153952432|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
153952433|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952434|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952435|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952436|NCT00914095|Methylphenidate|methylphenidate|mesh-list
153952437|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153952438|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952439|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153952440|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153952441|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952442|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952443|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
153952444|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952445|NCT05745337|Metoprolol|metoprolol|mesh-list
153952446|NCT05745337|Verapamil|verapamil|mesh-list
153952447|NCT05745337|Diltiazem|diltiazem|mesh-list
153952448|NCT05745337|Calcium Channel Blockers|calcium channel blockers|mesh-list
153952449|NCT05745337|Calcium|calcium|mesh-list
153952450|NCT05745337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153952451|NCT05745337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153952452|NCT05745337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952453|NCT05745337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153952454|NCT05745337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153952455|NCT05745337|Sympatholytics|sympatholytics|mesh-ancestor
153952456|NCT05745337|Autonomic Agents|autonomic agents|mesh-ancestor
153952457|NCT05745337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952458|NCT05745337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153952459|NCT05745337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153952460|NCT05745337|Adrenergic Agents|adrenergic agents|mesh-ancestor
153952461|NCT05745337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709952|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
153952483|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153952484|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952485|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952486|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
153952487|NCT05751967|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153952488|NCT05751967|Fenofibrate|fenofibrate|mesh-list
153952489|NCT05751967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153952490|NCT05751967|Antimetabolites|antimetabolites|mesh-ancestor
153952491|NCT05751967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952492|NCT05751967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153952493|NCT05751967|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153952494|NCT05751967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153952495|NCT02857920|Bevacizumab|bevacizumab|mesh-list
153952496|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153952497|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952498|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153952499|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153952500|NCT02857920|Growth Substances|growth substances|mesh-ancestor
153952501|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952502|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
154260795|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154260796|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154260798|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
154260799|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154260800|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
153952503|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
153952504|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153952505|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952506|NCT02607631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153952507|NCT02607631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952508|NCT02857842|Prednisolone|prednisolone|mesh-list
153952509|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153952510|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
153952511|NCT02857842|Hormones|hormones|mesh-ancestor
153952512|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952513|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952514|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153710012|NCT01220583|Cisplatin|cisplatin|mesh-list
153952529|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952530|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952532|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
153952533|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952534|NCT05697211|Ferric maltol|ferric maltol|mesh-list
153952535|NCT05697211|Hematinics|hematinics|mesh-ancestor
153952536|NCT00957996|Peramivir|peramivir|mesh-list
153952537|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
153952538|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952539|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952540|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952541|NCT02606539|Leucovorin|leucovorin|mesh-list
153952542|NCT02606539|Folic Acid|folic acid|mesh-list
153952543|NCT02606539|Methotrexate|methotrexate|mesh-list
153952544|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
153952545|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153952546|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
153952547|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153952548|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952549|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153952550|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
153952551|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952552|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952553|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952554|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952555|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153952556|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952557|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
153952558|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952559|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153952560|NCT02606539|Antidotes|antidotes|mesh-ancestor
153952561|NCT02606539|Protective Agents|protective agents|mesh-ancestor
153952562|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
153952563|NCT02606539|Vitamins|vitamins|mesh-ancestor
153952564|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
153952565|NCT02606539|Hematinics|hematinics|mesh-ancestor
153952566|NCT00589693|Imipenem|imipenem|mesh-list
153952567|NCT00589693|Doripenem|doripenem|mesh-list
153952568|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
153952569|NCT00589693|Cilastatin|cilastatin|mesh-list
153952570|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153952571|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952572|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
153952573|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952574|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952575|NCT02606383|Ketoconazole|ketoconazole|mesh-list
153952576|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
153952577|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952606|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153952607|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
153952608|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
153952609|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900039|NCT05610163|Calcium|calcium|mesh-list
153952610|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153952611|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
153710203|NCT00425152|Vitamins|vitamins|mesh-ancestor
153952613|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952614|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153952615|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153952616|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
153952617|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153952618|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153952619|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
153952620|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952621|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952622|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153952638|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952640|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153952641|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952642|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153952643|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153952644|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952645|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952646|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
153952647|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952648|NCT04269954|Heparin|heparin|mesh-list
153952649|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153952650|NCT04269954|Tinzaparin|tinzaparin|mesh-list
153952651|NCT04269954|Dalteparin|dalteparin|mesh-list
153952652|NCT04269954|Batroxobin|batroxobin|mesh-list
153952653|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
153952654|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153952655|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153952656|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952657|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
153952658|NCT04269954|Coagulants|coagulants|mesh-ancestor
153952659|NCT00630630|Levetiracetam|levetiracetam|mesh-list
153952660|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
153952661|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
153952662|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
153952663|NCT02854722|Vitamin D|vitamin d|mesh-list
153952664|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
153952665|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
153952666|NCT02854722|Vitamins|vitamins|mesh-list
153952667|NCT02854722|Calcium|calcium|mesh-list
153952668|NCT02854722|Deferasirox|deferasirox|mesh-list
153952669|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
153952670|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952671|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153952672|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153952673|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153952674|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
153952675|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
153952676|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952677|NCT00800683|Linagliptin|linagliptin|mesh-list
153952678|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153952679|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952680|NCT00800683|Incretins|incretins|mesh-ancestor
153952681|NCT00800683|Hormones|hormones|mesh-ancestor
153952682|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710179|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952696|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153952697|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153952698|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952700|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153952701|NCT00923533|Diuretics|diuretics|mesh-ancestor
153952702|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
153952703|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952704|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153952705|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952706|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952707|NCT00906399|Interferons|interferons|mesh-list
153952708|NCT00906399|Interferon-beta|interferon-beta|mesh-list
153952709|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
153952710|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260801|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153952711|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
153952712|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952713|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
153952714|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952715|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153952716|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153952717|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153952718|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952719|NCT00947856|Immunotoxins|immunotoxins|mesh-ancestor
153952720|NCT00947856|Immunoconjugates|immunoconjugates|mesh-ancestor
153952721|NCT00947856|Immunologic Factors|immunologic factors|mesh-ancestor
153952722|NCT00947856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952723|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153952724|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952725|NCT00907335|Tretinoin|tretinoin|mesh-list
153952726|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153952727|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952728|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
153952729|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952730|NCT00947154|Aripiprazole|aripiprazole|mesh-list
153952731|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
153952732|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153952733|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153952734|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153952735|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952736|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952737|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
153952738|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
153952739|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902746|NCT01217814|Protective Agents|protective agents|mesh-ancestor
153952740|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952741|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153952742|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153952743|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
153952744|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153952755|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
153952756|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952758|NCT00951912|Daidzein|daidzein|mesh-list
153952759|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153952760|NCT00951912|Protective Agents|protective agents|mesh-ancestor
153952761|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952762|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952763|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153952764|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952765|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952766|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
153952767|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153952768|NCT00951912|Estrogens|estrogens|mesh-ancestor
153952769|NCT00951912|Hormones|hormones|mesh-ancestor
153952770|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952771|NCT02882594|Anesthetics|anesthetics|mesh-list
153952772|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952773|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952774|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153952775|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
153952776|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153952777|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
153952778|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153952779|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952780|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153952781|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153952782|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952783|NCT01123070|Rituximab|rituximab|mesh-list
153952784|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153952785|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952786|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
153952787|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952788|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952789|NCT02857686|Anesthetics|anesthetics|mesh-list
153952790|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952791|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952792|NCT03198741|Aspirin|aspirin|mesh-list
153952793|NCT03198741|Clopidogrel|clopidogrel|mesh-list
153441497|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441498|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153952794|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153952795|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153952796|NCT03198741|Analgesics|analgesics|mesh-ancestor
153952797|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
153952798|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952799|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952800|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153952801|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952802|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153952803|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153952804|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952805|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153952806|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153952807|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952808|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
153710300|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
153952820|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153952821|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
153952822|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
153952823|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153952824|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
153952825|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952826|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952827|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
153952828|NCT00946998|Sertraline|sertraline|mesh-list
153952829|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
153952830|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153952831|NCT00946998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153952832|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153952833|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952834|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952835|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952836|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
153952837|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952838|NCT01138826|Amlodipine|amlodipine|mesh-list
153952839|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153952840|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153952841|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952842|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952843|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153952844|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952846|NCT00906087|Timolol|timolol|mesh-list
153952847|NCT00906087|Dorzolamide|dorzolamide|mesh-list
153952848|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153952849|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153952850|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153952851|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
153952852|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952853|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952854|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952855|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153952856|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153952857|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153952858|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153952859|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952860|NCT03525795|Ipilimumab|ipilimumab|mesh-list
153952861|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
153952862|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153952863|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952864|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153952865|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952866|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952867|NCT02420574|Albendazole|albendazole|mesh-list
153952868|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
153952869|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153952882|NCT02855502|Hormones|hormones|mesh-ancestor
154260802|NCT01193504|Prednisolone|prednisolone|mesh-list
154260803|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153952883|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952884|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952885|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153952886|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952887|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
153952888|NCT02853864|Propofol|propofol|mesh-list
153952889|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153952890|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952891|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952892|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153952893|NCT02853864|Analgesics|analgesics|mesh-ancestor
153952894|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
153952895|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952896|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153952897|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153952898|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153952899|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
153952900|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952901|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952902|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153952903|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
153952904|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
153952905|NCT00907257|Tretinoin|tretinoin|mesh-list
153952906|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153952907|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952908|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952909|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
153952910|NCT01138046|Paclitaxel|paclitaxel|mesh-list
153952911|NCT01138046|Lapatinib|lapatinib|mesh-list
153952912|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153952913|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952914|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
153952915|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952916|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952917|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952918|NCT01138046|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153952919|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153952920|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952922|NCT00876460|Nintedanib|nintedanib|mesh-list
153952923|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952924|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
153952925|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952926|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952927|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952928|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153952929|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952930|NCT01137812|Metformin|metformin|mesh-list
153952931|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153952932|NCT01137812|Canagliflozin|canagliflozin|mesh-list
153952933|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153545817|NCT06300099|Dexmedetomidine|dexmedetomidine|mesh-list
153952961|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
153952962|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952963|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
153952964|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153952965|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952966|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
153952967|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
153952968|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153952969|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153952970|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952971|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153952972|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952973|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952974|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153952975|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
153952976|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153952977|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153952978|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952990|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153952991|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
153952992|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260804|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
154260805|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260806|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
154260807|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
153952993|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952994|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153952995|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952997|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153952998|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153952999|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953000|NCT00681928|Letrozole|letrozole|mesh-list
153953001|NCT00681928|Anastrozole|anastrozole|mesh-list
153953002|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953003|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153953004|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153953005|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953006|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953007|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153953008|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
153953009|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953010|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953011|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153953012|NCT00594646|Tenofovir|tenofovir|mesh-list
153953013|NCT00594646|Emtricitabine|emtricitabine|mesh-list
153953014|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153953015|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
153953016|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
153953017|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953018|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153953019|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153953020|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953021|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953022|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153953023|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153953024|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153953025|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153953026|NCT00680134|Tavaborole|tavaborole|mesh-list
153953027|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
153953028|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953029|NCT00680212|Beta Carotene|beta carotene|mesh-list
153953030|NCT00680212|Carotenoids|carotenoids|mesh-list
153953031|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
153953032|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953033|NCT00680212|Protective Agents|protective agents|mesh-ancestor
153953034|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953035|NCT00680212|Provitamins|provitamins|mesh-ancestor
153953036|NCT00680212|Vitamins|vitamins|mesh-ancestor
153953037|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
153953038|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
153953039|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153953040|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153953063|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953064|NCT00950742|Trastuzumab|trastuzumab|mesh-list
153953066|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153953067|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953068|NCT00950742|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153953069|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153953070|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953071|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953072|NCT04310228|Favipiravir|favipiravir|mesh-list
153953073|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
153953074|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953075|NCT00955110|Oxymorphone|oxymorphone|mesh-list
153953076|NCT00955110|Oxycodone|oxycodone|mesh-list
153953077|NCT00955110|Hydromorphone|hydromorphone|mesh-list
153953078|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153953079|NCT00955110|Narcotics|narcotics|mesh-ancestor
153953080|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953081|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953082|NCT00955110|Analgesics|analgesics|mesh-ancestor
153953083|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
153953084|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953085|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153953086|NCT05056142|Anesthetics|anesthetics|mesh-list
153953087|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953088|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953089|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153953090|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153953091|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153953092|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953093|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953094|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153953103|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953105|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
153953106|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153953107|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
153953108|NCT02881346|Calcipotriene|calcipotriene|mesh-list
153953109|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153953110|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153953111|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
153953112|NCT02881346|Hormones|hormones|mesh-ancestor
153953113|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953114|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953115|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153953116|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
153953117|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
153953118|NCT00630708|Losartan|losartan|mesh-list
153953119|NCT00630708|Benazepril|benazepril|mesh-list
153953120|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153953121|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153953122|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153953123|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153953124|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953125|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153953126|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
153953127|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953128|NCT01111292|Inositol|inositol|mesh-list
153953129|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
153953130|NCT01111292|Vitamins|vitamins|mesh-ancestor
153953131|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
153953132|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953133|NCT02853630|Metformin|metformin|mesh-list
153953134|NCT02853630|Vildagliptin|vildagliptin|mesh-list
153953135|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953136|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953137|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153953138|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
153953139|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953140|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953141|NCT04309838|Treprostinil|treprostinil|mesh-list
153953142|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153953143|NCT05367206|Paclitaxel|paclitaxel|mesh-list
153953144|NCT05367206|Carboplatin|carboplatin|mesh-list
153953145|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153953146|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153953147|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953148|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153953149|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153953150|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153953151|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953152|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
153953153|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153953154|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153953155|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
153953156|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953157|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953158|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953159|NCT00944658|Apremilast|apremilast|mesh-list
153953170|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953171|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953172|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153953173|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153953174|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153953175|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
153953176|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953177|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953178|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153953179|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
153953180|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153953181|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153953182|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153953183|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
153953184|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953185|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953186|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
153953187|NCT01110200|Hormones|hormones|mesh-ancestor
153953188|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953189|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
153953190|NCT01136954|Zonisamide|zonisamide|mesh-list
153953191|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
153953192|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153953193|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953194|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953195|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153953196|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953197|NCT01108094|Itraconazole|itraconazole|mesh-list
153953198|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
153953199|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953200|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153953201|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153953202|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953203|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953204|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153953205|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
153953206|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953207|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953208|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153953209|NCT00954174|Paclitaxel|paclitaxel|mesh-list
153953210|NCT00954174|Carboplatin|carboplatin|mesh-list
153953211|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153953212|NCT00954174|Ifosfamide|ifosfamide|mesh-list
153953213|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
153953214|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153953215|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953216|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
153953217|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
153953218|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
153953219|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953220|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153953238|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953239|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953240|NCT00949884|Losartan|losartan|mesh-list
153953241|NCT00949884|Olmesartan|olmesartan|mesh-list
153953242|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153953243|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153953244|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153953245|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153953246|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153953247|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953248|NCT00949650|Pemetrexed|pemetrexed|mesh-list
153953249|NCT00949650|Afatinib|afatinib|mesh-list
153953250|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953251|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953252|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953253|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153953254|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153953255|NCT00949650|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153953256|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153953257|NCT03082755|Gabapentin|gabapentin|mesh-list
153953258|NCT03082755|Analgesics|analgesics|mesh-ancestor
153953259|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
153953260|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953261|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953262|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
153953263|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153953264|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153953265|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900329|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153953266|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153953267|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153953268|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153953269|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953270|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953271|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
153953272|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
153953273|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153953274|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
153953275|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953276|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153953277|NCT00904215|Telmisartan|telmisartan|mesh-list
153953278|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153953279|NCT00904215|Diuretics|diuretics|mesh-ancestor
153953280|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
153953289|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
153953290|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953291|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153953292|NCT05293665|Vaccines|vaccines|mesh-list
153953293|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
153953294|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953295|NCT00905307|Aripiprazole|aripiprazole|mesh-list
153953296|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
153953297|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153953298|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153953299|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153953300|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953301|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953302|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
153953303|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
153953304|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953305|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953306|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153953307|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153953308|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
153953309|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153953310|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153953311|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153953312|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153953313|NCT00904839|Bevacizumab|bevacizumab|mesh-list
153953314|NCT00904839|Nintedanib|nintedanib|mesh-list
153953315|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153953316|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953317|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153953318|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153953319|NCT00904839|Growth Substances|growth substances|mesh-ancestor
153953320|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953321|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
153953322|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153953323|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953324|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953325|NCT04985955|Tofacitinib|tofacitinib|mesh-list
153953326|NCT04985955|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153953327|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153953328|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953329|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953330|NCT02821923|Erythritol|erythritol|mesh-list
153953331|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
153953332|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
153953333|NCT00903357|Montelukast|montelukast|mesh-list
153953334|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153953335|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
153953336|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153953337|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
153953338|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953339|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953340|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153953341|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153953342|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953343|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
153441768|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
153953344|NCT00903357|Protective Agents|protective agents|mesh-ancestor
153953345|NCT00903357|Vitamins|vitamins|mesh-ancestor
153953356|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953358|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153953359|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153953360|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953361|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153953362|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153953363|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
153953364|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153953365|NCT01730313|Pyridoxine|pyridoxine|mesh-list
153953366|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
153953367|NCT01730313|Phenytoin|phenytoin|mesh-list
153953368|NCT01730313|Valproic Acid|valproic acid|mesh-list
153953369|NCT01730313|Vitamins|vitamins|mesh-ancestor
153953370|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
153953371|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953372|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
153953373|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
153953374|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953375|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953376|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
153953377|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953378|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
153953379|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153953380|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953381|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153953382|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153953383|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153953384|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953385|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153953386|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153953387|NCT02849379|Immunomodulating Agents|immunomodulating agents|mesh-list
153953388|NCT02849379|Immunologic Factors|immunologic factors|mesh-ancestor
153953389|NCT02849379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953390|NCT01104662|Vancomycin|vancomycin|mesh-list
153953391|NCT01104662|Penicillins|penicillins|mesh-list
153953392|NCT01104662|Daptomycin|daptomycin|mesh-list
153953393|NCT01104662|Cloxacillin|cloxacillin|mesh-list
153953394|NCT01104662|Oxacillin|oxacillin|mesh-list
153953395|NCT01104662|Nafcillin|nafcillin|mesh-list
153953396|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153953397|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953398|NCT05062785|Insulin|insulin|mesh-list
153953399|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953400|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953401|NCT01103960|Amlodipine|amlodipine|mesh-list
153953402|NCT01103960|Telmisartan|telmisartan|mesh-list
153953403|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153953404|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153953405|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953406|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953407|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153953408|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953439|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953440|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953442|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953443|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953444|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153953445|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953446|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
153953447|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153953448|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
153953449|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953450|NCT01106846|Ketamine|ketamine|mesh-list
153953451|NCT01106846|Analgesics|analgesics|mesh-ancestor
153953471|NCT05034783|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153953473|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953474|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153953475|NCT05034783|Incretins|incretins|mesh-ancestor
153953476|NCT05034783|Hormones|hormones|mesh-ancestor
153953477|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953478|NCT00902577|Misonidazole|misonidazole|mesh-list
153953479|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953480|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153953481|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153953482|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953483|NCT04202367|Bupivacaine|bupivacaine|mesh-list
153953484|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
153953485|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
153953486|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953487|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953488|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
153953489|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953490|NCT02846493|Dexamethasone|dexamethasone|mesh-list
153953491|NCT02846493|Bromocriptine|bromocriptine|mesh-list
153953492|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153953493|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
153953494|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
153953495|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953496|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953497|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153953498|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
153953499|NCT02846493|Hormones|hormones|mesh-ancestor
153953500|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953501|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153953502|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953503|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153953504|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153711025|NCT03352427|Everolimus|everolimus|mesh-list
153953518|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953519|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153953521|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953522|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953523|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153953524|NCT04286529|Calcitriol|calcitriol|mesh-list
153953525|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153953526|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953527|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153953528|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953529|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953530|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153953531|NCT04286529|Vitamins|vitamins|mesh-ancestor
153953532|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
153953533|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153953534|NCT01103180|Escitalopram|escitalopram|mesh-list
153953535|NCT01103180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153953536|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153953537|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953538|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953539|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953540|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
153953541|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953542|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
153953543|NCT00625898|Bevacizumab|bevacizumab|mesh-list
153953544|NCT00625898|Carboplatin|carboplatin|mesh-list
153953545|NCT00625898|Docetaxel|docetaxel|mesh-list
153953546|NCT00625898|Fluorouracil|fluorouracil|mesh-list
153953547|NCT00625898|Trastuzumab|trastuzumab|mesh-list
153953548|NCT00625898|Epirubicin|epirubicin|mesh-list
153953549|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153953550|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
153953551|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953552|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153953553|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153953554|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
153953555|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953556|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953557|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153953558|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153953559|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153953560|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153953561|NCT00625898|Growth Substances|growth substances|mesh-ancestor
153953562|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
153953563|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
153953564|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
153953565|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
153953567|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153953582|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153953584|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953585|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953586|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153953587|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153953588|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
153953589|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953590|NCT02844621|Omeprazole|omeprazole|mesh-list
153953591|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153953592|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153953593|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153953594|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953595|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953596|NCT00941304|Oxycodone|oxycodone|mesh-list
153953597|NCT00941304|Buprenorphine|buprenorphine|mesh-list
153953598|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153953599|NCT00941304|Narcotics|narcotics|mesh-ancestor
153953600|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953601|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953602|NCT00941304|Analgesics|analgesics|mesh-ancestor
153953603|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
153953604|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953605|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153953606|NCT02846025|Folic Acid|folic acid|mesh-list
153953607|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
153953608|NCT02846025|Antioxidants|antioxidants|mesh-list
153953609|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953610|NCT02846025|Protective Agents|protective agents|mesh-ancestor
153953611|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953612|NCT02846025|Hematinics|hematinics|mesh-ancestor
153953613|NCT02846025|Vitamins|vitamins|mesh-ancestor
153953614|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
153953615|NCT02880410|Temozolomide|temozolomide|mesh-list
153953616|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153953617|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
153953618|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953619|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953620|NCT02879006|Omalizumab|omalizumab|mesh-list
153953621|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153953622|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153953623|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
153953624|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153953625|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153953626|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953627|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153953628|NCT02857218|Hematinics|hematinics|mesh-ancestor
153953629|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153953630|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153711136|NCT00317200|Paclitaxel|paclitaxel|mesh-list
153953641|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953642|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953643|NCT04956302|Dexamethasone|dexamethasone|mesh-list
153953644|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
153953646|NCT04956302|Daratumumab|daratumumab|mesh-list
153953647|NCT04956302|Panobinostat|panobinostat|mesh-list
153953648|NCT04956302|Ichthammol|ichthammol|mesh-list
153953649|NCT04956302|BB 1101|bb 1101|mesh-list
153953650|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153953651|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153953652|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
153953653|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
153953654|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953655|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953656|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153953657|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
153953658|NCT04956302|Hormones|hormones|mesh-ancestor
153953659|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953660|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153953661|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953662|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
153953663|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953671|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
153953672|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153953673|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953674|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153733429|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
153900503|NCT04569032|Immunotoxins|immunotoxins|mesh-ancestor
153953675|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153953676|NCT02848443|Growth Substances|growth substances|mesh-ancestor
153953677|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953678|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
153953679|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153953680|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953681|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
153953682|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
153953683|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953684|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
153953685|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153953686|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953687|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953688|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153953689|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153953690|NCT00632697|Protective Agents|protective agents|mesh-ancestor
153953691|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953692|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
153953693|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153953694|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
153953695|NCT02848209|Phenol|phenol|mesh-list
153953696|NCT02848209|Croton Oil|croton oil|mesh-list
153953697|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153953698|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953699|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
153953700|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153953701|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153953702|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
153953703|NCT05337969|Metformin|metformin|mesh-list
153953723|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953724|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
153953725|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153953726|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953727|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153953728|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153953729|NCT02844309|Growth Substances|growth substances|mesh-ancestor
153953730|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
153953731|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953732|NCT02845713|Ivermectin|ivermectin|mesh-list
153953733|NCT02845713|Albendazole|albendazole|mesh-list
153953734|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
153953735|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153953736|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953737|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
153953738|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
153953739|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153953740|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153953741|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
153953742|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
153953743|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
153953744|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953745|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953746|NCT02845713|Filaricides|filaricides|mesh-ancestor
153953747|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
153953748|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153953749|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953750|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153953751|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
153953752|NCT00902265|Coagulants|coagulants|mesh-ancestor
153953753|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153953754|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
153953755|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953756|NCT02848287|Ropivacaine|ropivacaine|mesh-list
153953757|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
153953758|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
153953759|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953760|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953761|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
153953762|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953763|NCT05337657|Letrozole|letrozole|mesh-list
153953764|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953765|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153953766|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153953767|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953768|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953769|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153953770|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
153711257|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
153953783|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953784|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953785|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953786|NCT02847429|Crenolanib|crenolanib|mesh-list
153953787|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953788|NCT04750005|Listerine|listerine|mesh-list
153953789|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153953790|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953791|NCT05336721|Capecitabine|capecitabine|mesh-list
153953792|NCT05336721|Chiauranib|chiauranib|mesh-list
153953793|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153953794|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
153953795|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953796|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953797|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153953798|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953799|NCT00653913|Ezetimibe|ezetimibe|mesh-list
153953800|NCT00653913|Pitavastatin|pitavastatin|mesh-list
153953801|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153953802|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153953803|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
153953804|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953805|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153953806|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153953807|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953808|NCT00652431|Niacin|niacin|mesh-list
153953809|NCT00652431|Niacinamide|niacinamide|mesh-list
153953810|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
153953811|NCT00652431|Simvastatin|simvastatin|mesh-list
153953813|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153953814|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153953815|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153953816|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
153953817|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953818|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153953819|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153953820|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953821|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
153953822|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
153953824|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
153953825|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953826|NCT00380523|Etoricoxib|etoricoxib|mesh-list
153953827|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153953828|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153953829|NCT00380523|Analgesics|analgesics|mesh-ancestor
153953830|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
153953831|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953832|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711327|NCT00329368|Vitamins|vitamins|mesh-ancestor
153953847|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153953848|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153953849|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953850|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
153953851|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
153953852|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153953853|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153953854|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153953855|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
153953856|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
153953857|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953858|NCT02842281|Levan|levan|mesh-list
153953859|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953860|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
153953861|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153953862|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953863|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953864|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153953865|NCT02842437|Analgesics|analgesics|mesh-ancestor
153953866|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
153441961|NCT00005641|Antidotes|antidotes|mesh-ancestor
153953867|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953868|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153953869|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153953870|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153953871|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
153953872|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953873|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953874|NCT00157911|Simvastatin|simvastatin|mesh-list
153953875|NCT00157911|Ezetimibe|ezetimibe|mesh-list
153953876|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153953877|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153953878|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
153953879|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953880|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153953881|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153953882|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953883|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153953884|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153953885|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
153953886|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
153953888|NCT02842125|Capecitabine|capecitabine|mesh-list
153953889|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153731475|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
153953890|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711418|NCT00329914|Hormones|hormones|mesh-ancestor
153953900|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
153953901|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
153953902|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953903|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953904|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153953905|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153953906|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153953907|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953908|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153953909|NCT00156117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153953910|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153953911|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953912|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953913|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953914|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
153953915|NCT00140985|Losartan|losartan|mesh-list
153953916|NCT00140985|Amlodipine|amlodipine|mesh-list
153953917|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153953918|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153953919|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953920|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953921|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153953922|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953923|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
153953924|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153953925|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153953926|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153953927|NCT00140907|Losartan|losartan|mesh-list
153953928|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153953929|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153953930|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153953931|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153953932|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953933|NCT00132717|Atorvastatin|atorvastatin|mesh-list
153953934|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153953935|NCT00132717|Simvastatin|simvastatin|mesh-list
153953936|NCT00132717|Ezetimibe|ezetimibe|mesh-list
153953937|NCT00132717|Pravastatin|pravastatin|mesh-list
153953938|NCT00132717|Lovastatin|lovastatin|mesh-list
153953939|NCT00132717|L 647318|l 647318|mesh-list
153953940|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
153953941|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153953942|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153953943|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
153953944|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953945|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153953946|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153953947|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953948|NCT00127179|Finasteride|finasteride|mesh-list
153953949|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953950|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953951|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153953952|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153953953|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953954|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
153953955|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153711447|NCT00093093|Ribavirin|ribavirin|mesh-list
153953971|NCT02852382|Analgesics|analgesics|mesh-ancestor
153953972|NCT00630942|Minocycline|minocycline|mesh-list
153953973|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153953974|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953975|NCT00602550|Zidovudine|zidovudine|mesh-list
153953976|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
153953977|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953978|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153953979|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153953980|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953981|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
153953982|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953983|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153953984|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153953985|NCT00602706|Melphalan|melphalan|mesh-list
153953986|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
153953987|NCT00602706|Sargramostim|sargramostim|mesh-list
153953988|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153953989|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
153953990|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953991|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953992|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153953993|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153953994|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
153953995|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953996|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153953997|NCT00602706|Analgesics|analgesics|mesh-ancestor
153953998|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
153953999|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954000|NCT00604344|Insulin|insulin|mesh-list
153954001|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153954002|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
153954003|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
153954004|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
153954005|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
153954006|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954007|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954008|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
153954009|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
153954010|NCT02851914|Serotonin|serotonin|mesh-list
153954011|NCT02851914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153954012|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153954013|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153954014|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
153954015|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711510|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
153954022|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
153954023|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153954024|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954025|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
153954026|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954027|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153954028|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153954029|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153954030|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153954031|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954032|NCT00938886|Naltrexone|naltrexone|mesh-list
153954033|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153954034|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154260808|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954035|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954036|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
153954037|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954039|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
153954040|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
153954041|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954042|NCT00602862|Bevacizumab|bevacizumab|mesh-list
153954043|NCT00602862|Sorafenib|sorafenib|mesh-list
153954044|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153954045|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954046|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153954047|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153954048|NCT00602862|Growth Substances|growth substances|mesh-ancestor
153954049|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954050|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
153954051|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153954052|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954053|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954054|NCT00942708|Fluoxetine|fluoxetine|mesh-list
153954055|NCT00942708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153954056|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153954057|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153954058|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954059|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954060|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
153954061|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954062|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153954063|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
153954064|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153954065|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153954066|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153954067|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954068|NCT00942084|Acyclovir|acyclovir|mesh-list
153954069|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
153954070|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954071|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
153954072|NCT00941928|Fludarabine|fludarabine|mesh-list
153954073|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
153954074|NCT00941928|Interleukin-2|interleukin-2|mesh-list
153954075|NCT00941928|Epratuzumab|epratuzumab|mesh-list
153954076|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954077|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
153954078|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954079|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954080|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153954081|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
153711568|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
153954104|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
153954105|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954106|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153954107|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954108|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
153954109|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954110|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153954111|NCT02852694|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153954112|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954114|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954115|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954116|NCT00937560|Paclitaxel|paclitaxel|mesh-list
153954117|NCT00937560|Bevacizumab|bevacizumab|mesh-list
153954118|NCT00937560|Carboplatin|carboplatin|mesh-list
153954119|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153954120|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954121|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
153954122|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
153954123|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
153954124|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954125|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153954126|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153954127|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153954128|NCT00937560|Growth Substances|growth substances|mesh-ancestor
153954129|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954130|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
153954131|NCT04268394|Metformin|metformin|mesh-list
153954132|NCT04268394|Itraconazole|itraconazole|mesh-list
153954133|NCT04268394|Rifampin|rifampin|mesh-list
153954134|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
153954145|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
153954146|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954147|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954148|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
153954149|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954150|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153954151|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954152|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
153954153|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954154|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153954155|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153954156|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153954157|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153954158|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153954159|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153954160|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153954161|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153954162|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
153954163|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
153954164|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
153954165|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
153954166|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954167|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153954168|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153954169|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153954170|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153954171|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
153954172|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954173|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153954174|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153954175|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153954176|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
153954177|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954178|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153954179|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153954180|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
153954181|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711783|NCT00325000|Amitriptyline|amitriptyline|mesh-list
153954182|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
153954183|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153954184|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153954185|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153954186|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153954187|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153954188|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153954189|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153954190|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153954191|NCT04268394|Protective Agents|protective agents|mesh-ancestor
153954192|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153954193|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153954194|NCT04268394|Analgesics|analgesics|mesh-ancestor
153954195|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
153954196|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954197|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954205|NCT00594568|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
153954206|NCT00594568|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153954207|NCT00594568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954208|NCT00594568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954209|NCT04143802|Dulaglutide|dulaglutide|mesh-list
153954210|NCT04143802|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153954211|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954212|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954213|NCT00682630|Artesunate|artesunate|mesh-list
153954214|NCT00682630|Pyronaridine|pyronaridine|mesh-list
153954215|NCT00682630|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154260809|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954216|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
153954217|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153954218|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153954219|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954220|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954221|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
153954222|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
153954223|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153954224|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
153954225|NCT00875056|Vorinostat|vorinostat|mesh-list
153954226|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954227|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153954228|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954229|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954230|NCT00685594|Vitamin D|vitamin d|mesh-list
153954231|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
153954232|NCT00685594|Vitamins|vitamins|mesh-ancestor
153954233|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
153954234|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954235|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153954236|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153954237|NCT00685672|Epinephrine|epinephrine|mesh-list
153954238|NCT00685672|Racepinephrine|racepinephrine|mesh-list
153954239|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
153954240|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153954241|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153954242|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
153954243|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954244|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954245|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954246|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153954247|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153954248|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
153954249|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954250|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153954251|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
153954252|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
153954253|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
153954254|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153954255|NCT00683176|Choline|choline|mesh-list
153954256|NCT00683176|Fenofibrate|fenofibrate|mesh-list
153954257|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153954258|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
153954259|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954260|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153954261|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
153954262|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954263|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
153954277|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
153954278|NCT00685828|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153954279|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153954280|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954281|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954282|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954283|NCT00685906|Ticagrelor|ticagrelor|mesh-list
153954284|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
153954285|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153954286|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153954287|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153954288|NCT00685906|Estradiol|estradiol|mesh-list
153954289|NCT00685906|Estrogens|estrogens|mesh-ancestor
153954290|NCT00685906|Hormones|hormones|mesh-ancestor
153954291|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954292|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954293|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153954294|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
153954295|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153954296|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153954297|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153954298|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153954299|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153954300|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153954301|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153954302|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153954303|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153954304|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
153954305|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954306|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954307|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153954308|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153954309|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153954310|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153954311|NCT04139824|Naproxen|naproxen|mesh-list
153954312|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153954313|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153954314|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153954315|NCT04139824|Analgesics|analgesics|mesh-ancestor
153954316|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
153954317|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954318|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954319|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954320|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
153954321|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153954322|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954331|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153954332|NCT00686140|Analgesics|analgesics|mesh-ancestor
153954333|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
153954334|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954335|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954336|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954337|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954338|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153954339|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153954340|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954341|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954342|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
153954343|NCT00686218|Panobinostat|panobinostat|mesh-list
153954344|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153954345|NCT00686218|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153954346|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153954347|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954348|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954349|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954350|NCT00683956|Propofol|propofol|mesh-list
153954351|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
153954352|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153954353|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954354|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153954355|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153954356|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
153954357|NCT02850744|Temozolomide|temozolomide|mesh-list
153954358|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153954359|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
153954360|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954361|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954362|NCT04139668|Naltrexone|naltrexone|mesh-list
153954363|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153954364|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153954365|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954366|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
153954367|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954368|NCT04266756|Selexipag|selexipag|mesh-list
153954369|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153954370|NCT00606060|Factor VIII|factor viii|mesh-list
153954371|NCT00606060|Coagulants|coagulants|mesh-ancestor
153954372|NCT00875524|Vaccines|vaccines|mesh-list
153954373|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
153954374|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954375|NCT01094288|Docetaxel|docetaxel|mesh-list
153954376|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954377|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
153954378|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
153954379|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
153954380|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954381|NCT05380986|Apatinib|apatinib|mesh-list
153954382|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954383|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153954384|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954385|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954386|NCT00684112|Gabapentin|gabapentin|mesh-list
153954387|NCT00684112|Analgesics|analgesics|mesh-ancestor
153954388|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
153711881|NCT00093522|Fludarabine|fludarabine|mesh-list
153954399|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712008|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
153954402|NCT00684190|Lesogaberan|lesogaberan|mesh-list
153954403|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153954404|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954405|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153954406|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954407|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954408|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153954409|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
153954410|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
153954411|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954412|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954413|NCT00684268|Silybin|silybin|mesh-list
153954414|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153954415|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954416|NCT00684268|Protective Agents|protective agents|mesh-ancestor
153954417|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954418|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
153954419|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954420|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954421|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153954422|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153954423|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954424|NCT00874120|Phenylephrine|phenylephrine|mesh-list
153954425|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
153954426|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153954427|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
153954428|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
153954429|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954430|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954431|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
153954432|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153954433|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
153954434|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
153954435|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153954436|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153954437|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153954438|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
153954439|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954440|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954441|NCT00874120|Protective Agents|protective agents|mesh-ancestor
153954442|NCT00939822|Simvastatin|simvastatin|mesh-list
153954443|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153954444|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153954445|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
153954446|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954447|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153954448|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153954449|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954450|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153954451|NCT00685126|Albuterol|albuterol|mesh-list
153954458|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
153954459|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153954460|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153954461|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153954462|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153954463|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
153954464|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954465|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954467|NCT00687388|Doxazosin|doxazosin|mesh-list
153954468|NCT00687388|Prazosin|prazosin|mesh-list
153954469|NCT00687388|Tamsulosin|tamsulosin|mesh-list
153954470|NCT00687388|Alfuzosin|alfuzosin|mesh-list
153954471|NCT00687388|Terazosin|terazosin|mesh-list
153954472|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
153954473|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154260810|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954474|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153954475|NCT00687388|Analgesics|analgesics|mesh-ancestor
153954476|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
153954477|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954478|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954479|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954480|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954481|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153954482|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153954483|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954484|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954485|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153954486|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153954487|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
153954488|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954489|NCT00687388|Urological Agents|urological agents|mesh-ancestor
153954490|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153954491|NCT00939510|Lenalidomide|lenalidomide|mesh-list
153954492|NCT00939510|Sargramostim|sargramostim|mesh-list
153954493|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
153954494|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954495|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153954496|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153954497|NCT00939510|Growth Substances|growth substances|mesh-ancestor
153954498|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
153954499|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954500|NCT00687466|Insulin|insulin|mesh-list
153954501|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954502|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954503|NCT04266288|Ketamine|ketamine|mesh-list
153954504|NCT04266288|Analgesics|analgesics|mesh-ancestor
153954505|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
153954506|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954507|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954508|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153954509|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153954510|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
153954511|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
153954512|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153954513|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153954514|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153954515|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954516|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954517|NCT00687622|Trametinib|trametinib|mesh-list
153954518|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954519|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712009|NCT00325936|Cilnidipine|cilnidipine|mesh-list
153954529|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153954530|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153954531|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
153954532|NCT00935532|Insulin|insulin|mesh-list
153954533|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153954534|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
153954535|NCT00935532|Exenatide|exenatide|mesh-list
153954536|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954537|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954538|NCT00935532|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153954539|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153954540|NCT00935532|Incretins|incretins|mesh-ancestor
153954541|NCT00935532|Hormones|hormones|mesh-ancestor
153954542|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954543|NCT04138420|Bevacizumab|bevacizumab|mesh-list
153954544|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153954545|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954546|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153954547|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153954548|NCT04138420|Growth Substances|growth substances|mesh-ancestor
153954549|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954550|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
153954551|NCT05378646|Interferons|interferons|mesh-list
153954552|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
153954553|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954555|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954556|NCT01093586|Cyclosporine|cyclosporine|mesh-list
153900852|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442253|NCT02105454|Ribavirin|ribavirin|mesh-list
153954557|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
153954558|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
153954559|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153954560|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153954561|NCT01093586|Prednisolone|prednisolone|mesh-list
153954562|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
153954563|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
153954564|NCT01093586|Busulfan|busulfan|mesh-list
153954565|NCT01093586|Cyclosporins|cyclosporins|mesh-list
153954566|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
153954567|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153954568|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153954569|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
153954570|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954571|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
153954572|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954573|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954574|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153954575|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
153954576|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954577|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954578|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153954579|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954580|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
153954581|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954582|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
153954583|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153954584|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153954585|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153954586|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
153954598|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153954599|NCT04266132|Bupivacaine|bupivacaine|mesh-list
153954600|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
153954601|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
153954602|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153954603|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954604|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
153954605|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954606|NCT02625454|Acetaminophen|acetaminophen|mesh-list
153954607|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153954608|NCT02625454|Analgesics|analgesics|mesh-ancestor
153954609|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
153954610|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954611|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954612|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
153954613|NCT00606450|Thalidomide|thalidomide|mesh-list
153954614|NCT00606450|Apremilast|apremilast|mesh-list
153954615|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153954616|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153954617|NCT00606450|Analgesics|analgesics|mesh-ancestor
153954618|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
153954619|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954620|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954621|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954622|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954623|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153954624|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153954625|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954626|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954627|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954628|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
153954629|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
153954630|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153954631|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954632|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153954633|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153954634|NCT00606450|Growth Substances|growth substances|mesh-ancestor
153954635|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
153954636|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954637|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153954638|NCT04138888|Olmesartan|olmesartan|mesh-list
153954639|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153954640|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153442271|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
153954641|NCT04138888|Diuretics|diuretics|mesh-ancestor
153954642|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
153954643|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954644|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153954645|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153954646|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954647|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153954648|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153954649|NCT01098110|Asenapine|asenapine|mesh-list
153954650|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153954669|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954671|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
153954672|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954673|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954674|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
153954675|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954676|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153954677|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
153954678|NCT00688480|Protective Agents|protective agents|mesh-ancestor
153954679|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954680|NCT01092728|Dasatinib|dasatinib|mesh-list
153954681|NCT01092728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153954682|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153954683|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954684|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954685|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954686|NCT00688558|Simvastatin|simvastatin|mesh-list
153954687|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
153954688|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153954689|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153954690|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
153954691|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954692|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153954693|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153954694|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954695|NCT02625376|Resveratrol|resveratrol|mesh-list
153954696|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
153954697|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954698|NCT02625376|Protective Agents|protective agents|mesh-ancestor
153954699|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954700|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954701|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153954702|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
153954703|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153954704|NCT04153084|Cathartics|cathartics|mesh-ancestor
153954705|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954706|NCT04153084|Laxatives|laxatives|mesh-ancestor
153954712|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954713|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954714|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954716|NCT04152694|Ceftaroline|ceftaroline|mesh-list
153954717|NCT04152694|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153954718|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153954719|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954720|NCT00873730|Etanercept|etanercept|mesh-list
153954721|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153954722|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153954723|NCT00873730|Analgesics|analgesics|mesh-ancestor
153954724|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
153954725|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954726|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954727|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954728|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954729|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954730|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954731|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
153954732|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153954733|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153954734|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153954735|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
153954736|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954737|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154260811|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
154260812|NCT01193504|Hormones|hormones|mesh-ancestor
153411237|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
153954738|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153954739|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954740|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
153954741|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153954742|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
153954743|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153954744|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954745|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153954746|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153954747|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153954748|NCT00672568|Capsaicin|capsaicin|mesh-list
153954749|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
153954750|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
153954751|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
153954752|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954753|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954754|NCT00604032|Tretinoin|tretinoin|mesh-list
153954755|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954756|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
153954757|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
153954758|NCT00874432|Lisinopril|lisinopril|mesh-list
153954759|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153954760|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153954761|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
153954762|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954763|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153954764|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153954765|NCT00874432|Protective Agents|protective agents|mesh-ancestor
153954766|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954767|NCT00935220|Linagliptin|linagliptin|mesh-list
153954768|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954769|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954770|NCT00935220|Incretins|incretins|mesh-ancestor
153954771|NCT00935220|Hormones|hormones|mesh-ancestor
153954772|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954773|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153954774|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
153954775|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954804|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954805|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153954806|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153954807|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153954808|NCT00689806|Lovastatin|lovastatin|mesh-list
153954809|NCT00689806|L 647318|l 647318|mesh-list
153954810|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
153903439|NCT04203511|Paclitaxel|paclitaxel|mesh-list
153954811|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153954812|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153954813|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
153954814|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954815|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153954816|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153954817|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954818|NCT04204044|Folic Acid|folic acid|mesh-list
153954819|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
153954820|NCT04204044|Inositol|inositol|mesh-list
153954821|NCT04204044|Metformin|metformin|mesh-list
153954822|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954823|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954824|NCT04204044|Hematinics|hematinics|mesh-ancestor
153954825|NCT04204044|Vitamins|vitamins|mesh-ancestor
153954826|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
153954827|NCT00594880|Interferons|interferons|mesh-list
153954828|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
153954849|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153954850|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153954851|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
153954852|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954853|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954854|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153954855|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153954856|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411267|NCT00004173|Paclitaxel|paclitaxel|mesh-list
153954857|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954858|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
153954859|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153954860|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153954861|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153954862|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
153954863|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954864|NCT00871780|Natalizumab|natalizumab|mesh-list
153954865|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
153954866|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954867|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
153954868|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153954869|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153954870|NCT00694408|Prednisolone|prednisolone|mesh-list
153954871|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
153954872|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
153954873|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153954874|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153954875|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153954876|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153954877|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
153954878|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954879|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
153954880|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
153954881|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954882|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712374|NCT00093912|Nitroprusside|nitroprusside|mesh-list
153954889|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153954890|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954891|NCT04136782|Paclitaxel|paclitaxel|mesh-list
153954892|NCT04136782|Docetaxel|docetaxel|mesh-list
153954893|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153954894|NCT04136782|Carboplatin|carboplatin|mesh-list
153954895|NCT04136782|Epirubicin|epirubicin|mesh-list
153954896|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153954897|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954898|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
153954899|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
153954900|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
153954901|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954902|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153954903|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153954904|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153954905|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954906|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
153954907|NCT04137640|Docetaxel|docetaxel|mesh-list
153954908|NCT04137640|Letrozole|letrozole|mesh-list
153954909|NCT04137640|Epirubicin|epirubicin|mesh-list
153954910|NCT04137640|Palbociclib|palbociclib|mesh-list
153954911|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954912|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
153954913|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954914|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954915|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153954916|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
153954917|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954918|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954919|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153954920|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
153954921|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
153954922|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
153954923|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153954924|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153954925|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954926|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153954927|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
153954928|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954929|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153954930|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153954931|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153954932|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153954934|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954935|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954936|NCT02629042|Prednisolone|prednisolone|mesh-list
153954937|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260813|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260814|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153954938|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954939|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
153954940|NCT02629042|Hormones|hormones|mesh-ancestor
153954941|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954942|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153954943|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954944|NCT00692614|Triamcinolone|triamcinolone|mesh-list
153954945|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153954946|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153954947|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153954948|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954949|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
153954950|NCT00692614|Hormones|hormones|mesh-ancestor
153954951|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954952|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954987|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153954988|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153954989|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954990|NCT00912574|Molgramostim|molgramostim|mesh-list
153954991|NCT00912574|Sargramostim|sargramostim|mesh-list
153955001|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
153955002|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955003|NCT04137328|Liraglutide|liraglutide|mesh-list
153712657|NCT00086528|XL647|xl647|mesh-list
153955004|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153955005|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955006|NCT04137328|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153955007|NCT04137328|Incretins|incretins|mesh-ancestor
153955009|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955010|NCT00693004|Donepezil|donepezil|mesh-list
153955011|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153955012|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955013|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955014|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
153955015|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955016|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955017|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
153955018|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
153955019|NCT00695344|Everolimus|everolimus|mesh-list
153955020|NCT00695344|Azathioprine|azathioprine|mesh-list
153955021|NCT00695344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153955022|NCT00695344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153955023|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955024|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955025|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955026|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
153955027|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955028|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955029|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153955030|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153955031|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
153955032|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153955033|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955034|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
153955035|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153955036|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955037|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
153955038|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153955039|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955040|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
153955041|NCT00607542|Baclofen|baclofen|mesh-list
153955042|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153955043|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955044|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153955045|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955046|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153955047|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
153955048|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
153955049|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260815|NCT01193504|Protective Agents|protective agents|mesh-ancestor
153955050|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955051|NCT00936858|Everolimus|everolimus|mesh-list
153955052|NCT00936858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153955053|NCT00936858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153955054|NCT00936858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955055|NCT00936858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955056|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955057|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
153955084|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
153955085|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955086|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955087|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955088|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153955089|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955090|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153955091|NCT05377788|Lazertinib|lazertinib|mesh-list
153955092|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153955093|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955094|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955095|NCT00674050|Fluticasone|fluticasone|mesh-list
153955096|NCT00674050|Albuterol|albuterol|mesh-list
153955097|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955098|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153955099|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153955100|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
153955101|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955102|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153955103|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153955104|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
153712606|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
153955117|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153955118|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955119|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955120|NCT00872170|Urological Agents|urological agents|mesh-ancestor
153955121|NCT00936702|Paclitaxel|paclitaxel|mesh-list
153955122|NCT00936702|Carboplatin|carboplatin|mesh-list
153955123|NCT00936702|Everolimus|everolimus|mesh-list
153955124|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153955125|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955126|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
153955127|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153955128|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153955129|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955130|NCT00936702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153955131|NCT00936702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153955132|NCT00936702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955133|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955134|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
153955135|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955136|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153955137|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
153955138|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153955139|NCT00607932|Protective Agents|protective agents|mesh-ancestor
153955140|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955141|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955142|NCT00674596|Ramipril|ramipril|mesh-list
153955143|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153955144|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
153955145|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955146|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955147|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153955148|NCT00674674|Topotecan|topotecan|mesh-list
153955149|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153955150|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153955151|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955152|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712778|NCT00124644|Cytarabine|cytarabine|mesh-list
153955153|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955154|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153955155|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
153955156|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955157|NCT04265508|Hemostatics|hemostatics|mesh-list
153411327|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
153901081|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
153955158|NCT04265508|Coagulants|coagulants|mesh-ancestor
153955159|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153955160|NCT02623738|Latanoprost|latanoprost|mesh-list
153955161|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153955162|NCT00607074|Albendazole|albendazole|mesh-list
153955163|NCT00607074|Anthelmintics|anthelmintics|mesh-list
153955164|NCT00607074|Secnidazole|secnidazole|mesh-list
153955165|NCT00607074|Metronidazole|metronidazole|mesh-list
153955166|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153712653|NCT00321490|Analgesics|analgesics|mesh-ancestor
153955185|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955186|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153955188|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153955189|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
153955190|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153955191|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955192|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153955193|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153955194|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153955196|NCT00674752|Analgesics|analgesics|mesh-ancestor
153955197|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
153955198|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955199|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955200|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
153955201|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153955202|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153955203|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153955204|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153955205|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153955206|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153955207|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955208|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955209|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
153955210|NCT00607152|Allopurinol|allopurinol|mesh-list
153955211|NCT00607152|Rasburicase|rasburicase|mesh-list
153955212|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
153955213|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955214|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955215|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
153955216|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955217|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153955218|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
153955219|NCT00607152|Protective Agents|protective agents|mesh-ancestor
153955220|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955221|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
153955222|NCT00696748|Testosterone|testosterone|mesh-list
153955235|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955236|NCT02621554|Protective Agents|protective agents|mesh-ancestor
153955237|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955238|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955239|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153955241|NCT02623036|Lisinopril|lisinopril|mesh-list
153955242|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153955243|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
153955244|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955245|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955246|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153955247|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153955248|NCT02623036|Protective Agents|protective agents|mesh-ancestor
153955249|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955250|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153955251|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153955252|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955253|NCT00696826|Incretins|incretins|mesh-ancestor
153955254|NCT00696826|Hormones|hormones|mesh-ancestor
153955255|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955256|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153955257|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
153955258|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955259|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955260|NCT01092182|Prednisone|prednisone|mesh-list
154260816|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154260817|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260818|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154260819|NCT03848780|Desflurane|desflurane|mesh-list
154260820|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153955261|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
153955262|NCT01092182|Rituximab|rituximab|mesh-list
153955263|NCT01092182|Doxorubicin|doxorubicin|mesh-list
153955264|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153955265|NCT01092182|Etoposide|etoposide|mesh-list
153955266|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
153955267|NCT01092182|Vincristine|vincristine|mesh-list
153955268|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955269|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
153955270|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955271|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955272|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153955273|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
153955274|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955275|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955276|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153955277|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955278|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153955279|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153955280|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153955281|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955282|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153955283|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
153955284|NCT01092182|Hormones|hormones|mesh-ancestor
153955285|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712763|NCT00086801|Vinblastine|vinblastine|mesh-list
153955299|NCT02878772|Vinpocetine|vinpocetine|mesh-list
153955300|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153712895|NCT00322114|Lycopene|lycopene|mesh-list
153955301|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153955302|NCT02878772|Analgesics|analgesics|mesh-ancestor
153955303|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
153955304|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955305|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955306|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153955307|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955308|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153955309|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153955310|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955311|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153955312|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153955313|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955314|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
153955315|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153955316|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
153955317|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153955318|NCT02878772|Protective Agents|protective agents|mesh-ancestor
153955319|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
153955320|NCT02623114|Methylphenidate|methylphenidate|mesh-list
153955321|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153955322|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153955323|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955324|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153955325|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153955326|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153955327|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955328|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
153955329|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955330|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153955331|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
153955333|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
153955334|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153955335|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
153955336|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955337|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260822|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
154260823|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260824|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260825|NCT05599802|Vaccines|vaccines|mesh-list
153955338|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153955339|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
153955340|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153955341|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153955342|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153955343|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
153955344|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955345|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955346|NCT00871234|Etravirine|etravirine|mesh-list
153712835|NCT00086879|Carmustine|carmustine|mesh-list
153955364|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955365|NCT04267146|Nivolumab|nivolumab|mesh-list
153955366|NCT04267146|Temozolomide|temozolomide|mesh-list
153955367|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955368|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955369|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153955370|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955371|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153955372|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
153955373|NCT02621320|Vitamin D|vitamin d|mesh-list
153955374|NCT02621320|Vitamins|vitamins|mesh-ancestor
153955375|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
153955376|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955377|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153955378|NCT01097330|Amiodarone|amiodarone|mesh-list
153955379|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153955381|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153955382|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153955383|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955384|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153955385|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153955386|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153955387|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955388|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153955389|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153955390|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153955391|NCT00934440|Bevacizumab|bevacizumab|mesh-list
153955392|NCT00934440|Azacitidine|azacitidine|mesh-list
153955393|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955394|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955395|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153955396|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153955397|NCT00934440|Growth Substances|growth substances|mesh-ancestor
153955398|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955399|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
153955400|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153955401|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
153955445|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153955447|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955448|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955449|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153955450|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
153955451|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153955452|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153955453|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153955456|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153955457|NCT00696514|Vitamin D|vitamin d|mesh-list
153955458|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
153955459|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
153955460|NCT00696514|Vitamins|vitamins|mesh-list
153955461|NCT00696514|Folic Acid|folic acid|mesh-list
153955462|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
153955463|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
153955464|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955465|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153955466|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153955467|NCT00696514|Hematinics|hematinics|mesh-ancestor
153955468|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
153955469|NCT04263870|Capecitabine|capecitabine|mesh-list
153955470|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
153955471|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153955472|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
153955473|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955474|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955475|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
153955476|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955477|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
153955478|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
153955479|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
153955480|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
153955481|NCT00871000|Antidotes|antidotes|mesh-ancestor
153955482|NCT00871000|Protective Agents|protective agents|mesh-ancestor
153955483|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955484|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
153955485|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
153955486|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955487|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153955488|NCT01096784|Mecasermin|mecasermin|mesh-list
153955489|NCT01096784|Growth Substances|growth substances|mesh-ancestor
153955490|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955491|NCT00696592|Bevacizumab|bevacizumab|mesh-list
153955492|NCT00696592|Verteporfin|verteporfin|mesh-list
153955493|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955494|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955495|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153955496|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153955497|NCT00696592|Growth Substances|growth substances|mesh-ancestor
153955498|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955499|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
153955500|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153955501|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
153955502|NCT02622022|Morphine|morphine|mesh-list
153955503|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153955504|NCT02622022|Narcotics|narcotics|mesh-ancestor
153955505|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153955506|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955507|NCT02622022|Analgesics|analgesics|mesh-ancestor
153955508|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
153955509|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955510|NCT00934050|Inositol|inositol|mesh-list
153955531|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
153955532|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153955533|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955534|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955535|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153955536|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153955537|NCT00864916|Protective Agents|protective agents|mesh-ancestor
153955538|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955539|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
153955540|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153955541|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
153955542|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
153955543|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955545|NCT00864682|Propofol|propofol|mesh-list
153955546|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
153955547|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
153955548|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153955549|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955550|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
153955551|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955552|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153955553|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153955554|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153955555|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153955556|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955557|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153955558|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153955559|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
154260827|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260828|NCT00051558|Alendronate|alendronate|mesh-list
153955560|NCT00931944|Dexpramipexole|dexpramipexole|mesh-list
153955561|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
153955562|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955563|NCT00931944|Protective Agents|protective agents|mesh-ancestor
153955564|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955565|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
153955566|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955586|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955588|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153955589|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
153955590|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153955591|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153955592|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
153955593|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153955594|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153955595|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955596|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
153955597|NCT02616874|Romidepsin|romidepsin|mesh-list
153955598|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153955599|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955600|NCT02616874|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153955601|NCT02616874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955602|NCT02616874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955603|NCT04133428|Valsartan|valsartan|mesh-list
153955604|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153955605|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153955606|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153955607|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153955608|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955609|NCT00869050|Capecitabine|capecitabine|mesh-list
153955610|NCT00869050|Temozolomide|temozolomide|mesh-list
153955611|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153955612|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
153955613|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955614|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955615|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153955616|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
153955618|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153955619|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153955620|NCT04133506|Analgesics|analgesics|mesh-ancestor
153955621|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
153955634|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
153955635|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955636|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153955637|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955638|NCT04872218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955639|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955640|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955641|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955642|NCT00698464|Pasireotide|pasireotide|mesh-list
153955643|NCT00698464|Hormones|hormones|mesh-ancestor
153955644|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955645|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955646|NCT04933682|Rifampin|rifampin|mesh-list
153955647|NCT04933682|Fluconazole|fluconazole|mesh-list
153955648|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153955649|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
153955650|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153955651|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955652|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
153955653|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153955654|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955655|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955656|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153955657|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153955658|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153955659|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153955660|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154260829|NCT00051558|Teriparatide|teriparatide|mesh-list
154260830|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154260831|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260832|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154260833|NCT03848234|Estradiol|estradiol|mesh-list
154260834|NCT03848234|Estrogens|estrogens|mesh-ancestor
153955661|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153955662|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
153955663|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153955664|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153955665|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153955666|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
153955667|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955668|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955669|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153955670|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153955671|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
153955672|NCT00927186|Teriparatide|teriparatide|mesh-list
153955673|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153955674|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955675|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153955677|NCT00593554|Thiotepa|thiotepa|mesh-list
153955678|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
153955679|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153955680|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955681|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955705|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153955706|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153955707|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955708|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153955710|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153955711|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955712|NCT00696982|Incretins|incretins|mesh-ancestor
153955713|NCT00696982|Hormones|hormones|mesh-ancestor
153955714|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955715|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153955716|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
153955717|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955718|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955719|NCT01087736|Topiramate|topiramate|mesh-list
153955720|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
153955721|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153955722|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955723|NCT04262388|Durvalumab|durvalumab|mesh-list
153955724|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955725|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955726|NCT00608712|Esomeprazole|esomeprazole|mesh-list
153955727|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153955728|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153955729|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153955730|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955731|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955732|NCT01079936|Lenalidomide|lenalidomide|mesh-list
153955733|NCT01079936|Melphalan|melphalan|mesh-list
153955734|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
153955735|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955743|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955745|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955746|NCT00931710|Losartan|losartan|mesh-list
153955747|NCT00931710|Amlodipine|amlodipine|mesh-list
153713354|NCT00332020|Enoxaparin|enoxaparin|mesh-list
153955748|NCT00931710|Valsartan|valsartan|mesh-list
153955749|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153955750|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153955751|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153955752|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153955753|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955754|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154260835|NCT03848234|Hormones|hormones|mesh-ancestor
153411454|NCT00004233|Vitamins|vitamins|mesh-ancestor
153955755|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955756|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
153955757|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153955758|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153955759|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153955761|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
153955762|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153955763|NCT01100528|Interferons|interferons|mesh-list
153955764|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
153955765|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
153955766|NCT01100528|Dacarbazine|dacarbazine|mesh-list
153955767|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955768|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
153955769|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955770|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
153955771|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955772|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153955773|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
153955774|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955775|NCT01079234|Insulin|insulin|mesh-list
153955776|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153955777|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
153955778|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
153955779|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153955780|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955781|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
153955782|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153955783|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
153955784|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955785|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955786|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153955787|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
153955788|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153955789|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
153955790|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955791|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955792|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153955793|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
153955794|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
153955795|NCT00931632|Protective Agents|protective agents|mesh-ancestor
153955796|NCT00608790|Albuterol|albuterol|mesh-list
153955797|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153955798|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
153955799|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955800|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955801|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153713276|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955818|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153955819|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955820|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955821|NCT04992156|Palbociclib|palbociclib|mesh-list
153955822|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713417|NCT05831761|Lidocaine|lidocaine|mesh-list
153955823|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153955824|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955825|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955826|NCT00608946|Copper|copper|mesh-list
153955827|NCT00608946|Trace Elements|trace elements|mesh-ancestor
153955828|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
153955829|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955830|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
153955831|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
153955832|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153955833|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153955834|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955835|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955836|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955837|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955838|NCT00926328|Triclosan|triclosan|mesh-list
153955839|NCT00926328|Fluorides|fluorides|mesh-list
153955840|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
153955841|NCT00926328|Protective Agents|protective agents|mesh-ancestor
153955842|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260836|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260837|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955843|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153955844|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955845|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153955846|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153955847|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
153955848|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955849|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153955850|NCT04203732|Anesthetics|anesthetics|mesh-list
153955851|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153955852|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955853|NCT00863512|Gemcitabine|gemcitabine|mesh-list
153955854|NCT00863512|Docetaxel|docetaxel|mesh-list
153955855|NCT00863512|Pemetrexed|pemetrexed|mesh-list
153955856|NCT00863512|Vinorelbine|vinorelbine|mesh-list
153955857|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955858|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153955859|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
153713342|NCT00126633|Bevacizumab|bevacizumab|mesh-list
153955887|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
153955888|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153955889|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
153955890|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153955891|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
153955892|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
153955893|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955894|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955895|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153955896|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
153955897|NCT04263402|Hormones|hormones|mesh-ancestor
153955898|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955899|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153955900|NCT04263402|Protective Agents|protective agents|mesh-ancestor
153955901|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153955902|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955903|NCT00868192|Bevacizumab|bevacizumab|mesh-list
153955904|NCT00868192|Pemetrexed|pemetrexed|mesh-list
153713396|NCT00332137|Urological Agents|urological agents|mesh-ancestor
153955918|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
153955919|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153955920|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153955921|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955922|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955923|NCT02615782|Urological Agents|urological agents|mesh-ancestor
153955924|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153955925|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153955926|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153955927|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
153955928|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955929|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955931|NCT00930930|Everolimus|everolimus|mesh-list
153955932|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153955933|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955934|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
153955935|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
153955936|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
153955937|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955938|NCT00930930|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153955939|NCT00930930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153955940|NCT00930930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955941|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955942|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
153955943|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955944|NCT00698776|Lenalidomide|lenalidomide|mesh-list
153955945|NCT00698776|KRN 7000|krn 7000|mesh-list
153955946|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
153955947|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955948|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153955949|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153955950|NCT00698776|Growth Substances|growth substances|mesh-ancestor
153955951|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
154260838|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154260839|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260840|NCT01195298|Bevacizumab|bevacizumab|mesh-list
154260841|NCT01195298|Capecitabine|capecitabine|mesh-list
153955952|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955953|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153955954|NCT04122040|Roxithromycin|roxithromycin|mesh-list
153955955|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153955956|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955957|NCT04258956|Avelumab|avelumab|mesh-list
153955958|NCT04258956|Axitinib|axitinib|mesh-list
153955959|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955960|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955961|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153955962|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955963|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955964|NCT00862654|Ketoconazole|ketoconazole|mesh-list
153955965|NCT00862654|Clobetasol|clobetasol|mesh-list
153955985|NCT00867490|Candesartan|candesartan|mesh-list
153955986|NCT00867490|Candesartan cilexetil|candesartan cilexetil|mesh-list
153955987|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153955988|NCT00867490|Aliskiren|aliskiren|mesh-list
153955989|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153955990|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153955991|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153955992|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955993|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153955994|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955995|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
153955996|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153955997|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153955998|NCT00867490|Renin Inhibitors|renin inhibitors|mesh-ancestor
153955999|NCT00867490|Protease Inhibitors|protease inhibitors|mesh-ancestor
153956000|NCT00867490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956001|NCT00867490|Diuretics|diuretics|mesh-ancestor
153956002|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
153956003|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153956004|NCT00697060|Docetaxel|docetaxel|mesh-list
153956005|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956006|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
153956007|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
153956008|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
153956009|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956010|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
153956011|NCT00867334|Panitumumab|panitumumab|mesh-list
153956012|NCT00867334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153956013|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956014|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956015|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956016|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956017|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956018|NCT00925704|Calcitriol|calcitriol|mesh-list
153956019|NCT00925704|Sevelamer|sevelamer|mesh-list
153713504|NCT05776017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153956037|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956038|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
153956039|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956040|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956041|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153956042|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
153956043|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
153956044|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956045|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
153956046|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153956047|NCT00609960|Midazolam|midazolam|mesh-list
153956048|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153956049|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956050|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956051|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956052|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153956053|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956054|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153411504|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
153901429|NCT05940909|Amlodipine|amlodipine|mesh-list
153956055|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153956056|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
153956058|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
153956060|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956061|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956062|NCT04879134|Apomorphine|apomorphine|mesh-list
153956063|NCT04879134|Emetics|emetics|mesh-ancestor
153956064|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956065|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
153956066|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956067|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153956068|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
153956069|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
153956070|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956071|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956072|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
153956073|NCT04134130|Testosterone|testosterone|mesh-list
153956074|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
153956075|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
153956076|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153956077|NCT04134130|Androgens|androgens|mesh-ancestor
153956078|NCT04134130|Hormones|hormones|mesh-ancestor
153956089|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
153956090|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
153956091|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956092|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956093|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956094|NCT00610038|Glyburide|glyburide|mesh-list
153956095|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153956096|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956097|NCT02619526|Carvedilol|carvedilol|mesh-list
153956098|NCT02619526|Nebivolol|nebivolol|mesh-list
153956099|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153956100|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153956101|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
153956102|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956103|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956104|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956105|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153956106|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
153956107|NCT02619526|Protective Agents|protective agents|mesh-ancestor
153956108|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153956109|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153956110|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153956111|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
153956112|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153956113|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153956114|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153956115|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153956116|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153956117|NCT04119622|Capecitabine|capecitabine|mesh-list
153956118|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
153956119|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153956120|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
153956121|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956122|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956123|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
153956124|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153956125|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
153956126|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956128|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153956129|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
153956130|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956131|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956132|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153956134|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
153956135|NCT00866788|Promethazine|promethazine|mesh-list
153956136|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153956137|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
153956138|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153956148|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956149|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
154260842|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154260843|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956150|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
153956151|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153956152|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
153956153|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956154|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956155|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
153956156|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
153956157|NCT04132570|Budesonide|budesonide|mesh-list
153956158|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153956159|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153956160|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
153956161|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956162|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956163|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153956164|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
153956165|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
153956166|NCT04132570|Hormones|hormones|mesh-ancestor
153956167|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153956168|NCT00699244|Anesthetics|anesthetics|mesh-list
153956169|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956170|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956171|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153956172|NCT00699322|Glimepiride|glimepiride|mesh-list
153956173|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153956174|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956175|NCT00699322|Incretins|incretins|mesh-ancestor
153956176|NCT00699322|Hormones|hormones|mesh-ancestor
153956177|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153956178|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153956179|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
153956180|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956181|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956182|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153956183|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153956184|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
153956186|NCT00860470|Trace Elements|trace elements|mesh-list
153956187|NCT00860470|Folic Acid|folic acid|mesh-list
153956188|NCT00860470|Micronutrients|micronutrients|mesh-list
153956189|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956190|NCT00860470|Hematinics|hematinics|mesh-ancestor
153956191|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
153956192|NCT00860470|Vitamins|vitamins|mesh-ancestor
153956193|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
153956194|NCT00923364|Fludarabine|fludarabine|mesh-list
153956195|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
153956196|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153956197|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153956198|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
153713797|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
153956199|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956200|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956201|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153956202|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
153956203|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956205|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153956225|NCT02878538|Deferiprone|deferiprone|mesh-list
153956226|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153956227|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
153956228|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
153956229|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956230|NCT04134598|Tamoxifen|tamoxifen|mesh-list
153956231|NCT04134598|Letrozole|letrozole|mesh-list
153956232|NCT04134598|Anastrozole|anastrozole|mesh-list
153956233|NCT04134598|Exemestane|exemestane|mesh-list
153956234|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956235|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153956236|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153956237|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956238|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956239|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153956240|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
154260844|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154260845|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154260846|NCT01195298|Growth Substances|growth substances|mesh-ancestor
154260847|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260848|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
153956241|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153956242|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956243|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153956244|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153956245|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153956246|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153956247|NCT04134052|Midazolam|midazolam|mesh-list
153956248|NCT04134052|Ketamine|ketamine|mesh-list
153956249|NCT04134052|Analgesics|analgesics|mesh-ancestor
153956250|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
153956251|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956252|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956253|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153956254|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153956255|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
153956256|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
153956257|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956258|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153956259|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153956260|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956293|NCT00799903|Darapladib|darapladib|mesh-list
153956294|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153956295|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956296|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956297|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
153956298|NCT01075256|Calcium|calcium|mesh-list
153956299|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153956300|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956301|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153956302|NCT02876432|Diclofenac|diclofenac|mesh-list
153956325|NCT00923130|Growth Substances|growth substances|mesh-ancestor
153956326|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956327|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
153956328|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153956329|NCT04258098|Metronidazole|metronidazole|mesh-list
153956330|NCT04258098|Streptomycin|streptomycin|mesh-list
153956331|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956332|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153956333|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153956334|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153956335|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956336|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956337|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
153956338|NCT02605915|Carboplatin|carboplatin|mesh-list
153956339|NCT02605915|Docetaxel|docetaxel|mesh-list
153956340|NCT02605915|Doxorubicin|doxorubicin|mesh-list
153956341|NCT02605915|Trastuzumab|trastuzumab|mesh-list
153956342|NCT02605915|Atezolizumab|atezolizumab|mesh-list
153956343|NCT02605915|Pertuzumab|pertuzumab|mesh-list
153956344|NCT02605915|Maytansine|maytansine|mesh-list
153713944|NCT02898207|Olaparib|olaparib|mesh-list
153956345|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153956346|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153956347|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
153956348|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956349|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956350|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153956351|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
153956352|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956353|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713847|NCT03643822|Hormones|hormones|mesh-ancestor
153956381|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956382|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153956383|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153956384|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154260849|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154260850|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
153956385|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
153956386|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956387|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956388|NCT01075100|Carboplatin|carboplatin|mesh-list
153956389|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956390|NCT02876354|Vitamin K|vitamin k|mesh-list
153956391|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
153956392|NCT02876354|Vitamins|vitamins|mesh-ancestor
153956393|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
153956394|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956395|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153956396|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153956397|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956398|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
153956399|NCT02876354|Coagulants|coagulants|mesh-ancestor
153956400|NCT00626678|Prednisone|prednisone|mesh-list
153956401|NCT00626678|Azathioprine|azathioprine|mesh-list
153956402|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153956403|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
153956404|NCT00626678|Hormones|hormones|mesh-ancestor
153956426|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153956427|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153956428|NCT00859222|Growth Substances|growth substances|mesh-ancestor
153956429|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956430|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
153956431|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153956432|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956433|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956434|NCT00858988|Rifaximin|rifaximin|mesh-list
153956435|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153956436|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956437|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153956438|NCT00858832|Methylergonovine|methylergonovine|mesh-list
153956439|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
153956440|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153956441|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956442|NCT01071512|Natalizumab|natalizumab|mesh-list
153956443|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
153956444|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956445|NCT00626834|Vigabatrin|vigabatrin|mesh-list
153956446|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
153956447|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956448|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956449|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
153956450|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956451|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956452|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
153956453|NCT04255992|Vitamin D|vitamin d|mesh-list
153956454|NCT04255992|Calcium|calcium|mesh-list
153956455|NCT04255992|Vitamins|vitamins|mesh-ancestor
153956456|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
153956457|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956466|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
153729848|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729849|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
153714090|NCT05952596|Immunologic Factors|immunologic factors|mesh-ancestor
153956467|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153956468|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153956469|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956470|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956471|NCT00610350|Protective Agents|protective agents|mesh-ancestor
153956472|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956473|NCT01071200|Hormones|hormones|mesh-list
153956474|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153956475|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153956476|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956477|NCT04255836|Durvalumab|durvalumab|mesh-list
153956478|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956479|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956480|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
153956481|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
153956482|NCT00699478|Vitamins|vitamins|mesh-ancestor
153956483|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
153733464|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956484|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956485|NCT01070888|Budesonide|budesonide|mesh-list
153956486|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
153956487|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153956488|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153956489|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
153956490|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956491|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956492|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153956493|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
153956494|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
153956495|NCT01070888|Hormones|hormones|mesh-ancestor
153956496|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153956497|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153956498|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153956499|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153956500|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
153956501|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956502|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956503|NCT00857896|Fesoterodine|fesoterodine|mesh-list
153956504|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153956505|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153956506|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
153956507|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956508|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956509|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956510|NCT00857896|Urological Agents|urological agents|mesh-ancestor
153956511|NCT00857818|Risperidone|risperidone|mesh-list
153956512|NCT00857818|Aripiprazole|aripiprazole|mesh-list
153956513|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153956514|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153956515|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
153956516|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956517|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956518|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956519|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153956520|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956534|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956535|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956536|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153956537|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
153956538|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
153956539|NCT02618668|Analgesics|analgesics|mesh-ancestor
153956540|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
153956541|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956542|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153956543|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153956544|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153956545|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956546|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956547|NCT01074944|Eliglustat|eliglustat|mesh-list
153956548|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956549|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956550|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
153956551|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956552|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153956553|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153956554|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956555|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956556|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153956557|NCT01074554|Azithromycin|azithromycin|mesh-list
153956558|NCT01074554|Levofloxacin|levofloxacin|mesh-list
153956559|NCT01074554|Rifampin|rifampin|mesh-list
153956560|NCT01074554|Ethambutol|ethambutol|mesh-list
153956561|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956562|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153956563|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
153956564|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153956565|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153956566|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153956567|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956568|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956569|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714167|NCT05951361|Triamcinolone|triamcinolone|mesh-list
153956570|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153956571|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153956572|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
153956573|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153956574|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153956575|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153956576|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153956577|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153956578|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153714059|NCT01946477|Dexamethasone|dexamethasone|mesh-list
153956588|NCT00857584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153956589|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153956590|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153956591|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956592|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956593|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
153956594|NCT00798967|Teduglutide|teduglutide|mesh-list
153956595|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153956596|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153956597|NCT00798967|Protective Agents|protective agents|mesh-ancestor
153956598|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956599|NCT04132102|Afatinib|afatinib|mesh-list
153956600|NCT04132102|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153956601|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956602|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956603|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956604|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956605|NCT02618356|Raltitrexed|raltitrexed|mesh-list
153956606|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153956607|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
153956608|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956609|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956610|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153956611|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956612|NCT00697996|Rituximab|rituximab|mesh-list
153956613|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956614|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956615|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
153956616|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956617|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956618|NCT04118842|Rifampin|rifampin|mesh-list
153956619|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153956620|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
153956621|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153956622|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956623|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
153956624|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153956625|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956626|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956627|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153956628|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153956629|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153956630|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153956631|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153956632|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153956633|NCT00699634|Nabilone|nabilone|mesh-list
153956634|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
153956635|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
153956636|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956637|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956638|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153956639|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153956640|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956641|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956642|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956653|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
153956654|NCT04113889|Metformin|metformin|mesh-list
153956655|NCT04113889|Pioglitazone|pioglitazone|mesh-list
153956656|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153956657|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956658|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
153956659|NCT04113889|Vitamins|vitamins|mesh-ancestor
153956660|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
153956661|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
153956662|NCT00796861|Sunitinib|sunitinib|mesh-list
153956663|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956664|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153956665|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153956666|NCT00796861|Growth Substances|growth substances|mesh-ancestor
153956667|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956668|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
153956669|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956670|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956671|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956672|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
153956673|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
153956674|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956675|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956676|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956677|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
153956678|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956679|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956680|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956681|NCT00914797|Terbutaline|terbutaline|mesh-list
153956682|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153956683|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
153956684|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956685|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956686|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153956687|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
153956688|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
153956689|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
153956690|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153956691|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153956692|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153956693|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153956694|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
153956695|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956696|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956697|NCT00798655|Cisplatin|cisplatin|mesh-list
153956698|NCT00798655|Panitumumab|panitumumab|mesh-list
153956699|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956700|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956701|NCT00914641|Apixaban|apixaban|mesh-list
153956702|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153956703|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
153956704|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153956705|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
153956706|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956707|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956723|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
153956724|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
153956725|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
153956726|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956727|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153956728|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
153956729|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956730|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956731|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153956732|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
153956733|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153956734|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956735|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153956736|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153956737|NCT00856492|Growth Substances|growth substances|mesh-ancestor
153956738|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
153956739|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153956740|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153956741|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153956742|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956743|NCT04111159|Propofol|propofol|mesh-list
153956744|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956745|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956746|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956747|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153956748|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
153956749|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
153956750|NCT00697372|Sirolimus|sirolimus|mesh-list
153956751|NCT00697372|Everolimus|everolimus|mesh-list
153956752|NCT00697372|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153956753|NCT00697372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956754|NCT00697372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956755|NCT00697372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956756|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153956757|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
153956758|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956759|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956760|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153956761|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956762|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153956763|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
153956764|NCT04111003|Anesthetics|anesthetics|mesh-list
153956765|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956766|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956767|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
153956768|NCT00856180|Bevacizumab|bevacizumab|mesh-list
153956785|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956786|NCT00900627|Paclitaxel|paclitaxel|mesh-list
153956787|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153956788|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956789|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
153956790|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
153956791|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
153956792|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956793|NCT00866320|Sorafenib|sorafenib|mesh-list
153956795|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956796|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956797|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956798|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
153956799|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956800|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956801|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956802|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153956803|NCT04115449|Analgesics|analgesics|mesh-ancestor
153956804|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
153956805|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956806|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153956807|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153956808|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153956809|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
153956810|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956811|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956812|NCT04133974|Methadone|methadone|mesh-list
153956813|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153956814|NCT04133974|Narcotics|narcotics|mesh-ancestor
153956815|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956816|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956817|NCT04133974|Analgesics|analgesics|mesh-ancestor
153956818|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
153956819|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956820|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
153956821|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
153956822|NCT03679611|Neostigmine|neostigmine|mesh-list
153956823|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153956824|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956825|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956852|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153956853|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
153956854|NCT00869440|Midazolam|midazolam|mesh-list
153956855|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153956856|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956857|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956858|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956859|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153956860|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956861|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956862|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154260851|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260852|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154260853|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153956863|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
153956864|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
153956865|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
153956866|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
153956867|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956868|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956869|NCT00895947|Interferons|interferons|mesh-list
153956870|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
153956871|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956872|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
153956873|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714373|NCT05379491|Linaclotide|linaclotide|mesh-list
153956884|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956886|NCT00588445|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153956887|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956889|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956890|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956891|NCT00092781|Celecoxib|celecoxib|mesh-list
153956892|NCT00092781|Etoricoxib|etoricoxib|mesh-list
153956893|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153956894|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153956895|NCT00092781|Analgesics|analgesics|mesh-ancestor
153956896|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
153956897|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956898|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956899|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153956900|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956901|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153956902|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153956903|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956904|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956905|NCT00092703|Diclofenac|diclofenac|mesh-list
153956906|NCT00092703|Etoricoxib|etoricoxib|mesh-list
153956907|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153956908|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153956909|NCT00092703|Analgesics|analgesics|mesh-ancestor
153956910|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
153956911|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956912|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956913|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153956914|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956915|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153956916|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956917|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956918|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153956919|NCT00699946|Olanzapine|olanzapine|mesh-list
153956920|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
153956921|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
153956922|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956923|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956924|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153956925|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153956926|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956927|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956928|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956929|NCT00699946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153956930|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153956931|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153956932|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956933|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956934|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
153956935|NCT00796315|Doxylamine|doxylamine|mesh-list
153956936|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
153956937|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
153956953|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956955|NCT00855166|Hormones|hormones|mesh-ancestor
153956956|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443200|NCT02036502|Lenalidomide|lenalidomide|mesh-list
153956957|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153956958|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
153956959|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956960|NCT00854620|Sorafenib|sorafenib|mesh-list
153956961|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956962|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956963|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956964|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956965|NCT00793585|Allopurinol|allopurinol|mesh-list
153956966|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
153956967|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956968|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956969|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
153956970|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956971|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153956972|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
153956973|NCT00793585|Protective Agents|protective agents|mesh-ancestor
153956974|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956975|NCT02013141|Telavancin|telavancin|mesh-list
153956976|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153956977|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956978|NCT04107103|Nivolumab|nivolumab|mesh-list
153956979|NCT04107103|Pemetrexed|pemetrexed|mesh-list
153956980|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956981|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956982|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153956983|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956984|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956985|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153956986|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153956987|NCT02617810|Midazolam|midazolam|mesh-list
153956988|NCT02617810|Warfarin|warfarin|mesh-list
153956989|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153956990|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956991|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956992|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956993|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153714484|NCT05049902|Expectorants|expectorants|mesh-ancestor
153957012|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
153957013|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153957014|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
153957015|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957016|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
153957017|NCT02614612|Hormones|hormones|mesh-ancestor
153957018|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957019|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957020|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153957021|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957022|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
153957023|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
153957024|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957025|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957026|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153957027|NCT02614612|Protective Agents|protective agents|mesh-ancestor
153957028|NCT00900159|Eszopiclone|eszopiclone|mesh-list
153957029|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153957030|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957031|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957032|NCT01689909|Zolpidem|zolpidem|mesh-list
153957033|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153957034|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153957035|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957036|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957037|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153957038|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
153957039|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
153957040|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957041|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957042|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153957043|NCT00854308|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153957044|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153957045|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957046|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957047|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957048|NCT00592852|Fluoxetine|fluoxetine|mesh-list
153957049|NCT00592852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153957050|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153957076|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153957077|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153957078|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153957079|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
153957080|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957081|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957082|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153957083|NCT03172377|Adalimumab|adalimumab|mesh-list
153957084|NCT03172377|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153957085|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957086|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957087|NCT02617654|Liraglutide|liraglutide|mesh-list
153957088|NCT02617654|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153957089|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153957090|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957091|NCT02617654|Incretins|incretins|mesh-ancestor
153957092|NCT02617654|Hormones|hormones|mesh-ancestor
153729850|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729852|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
153729853|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729854|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
153729855|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729862|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153729863|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729864|NCT00140166|Pyridoxine|pyridoxine|mesh-list
153729865|NCT00140166|Niacinamide|niacinamide|mesh-list
153729866|NCT00140166|Niacin|niacin|mesh-list
153729867|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
153729868|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
153729869|NCT00140166|Vitamins|vitamins|mesh-ancestor
153729870|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
153729871|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729872|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153729873|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
153729874|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729875|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153729876|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
153957093|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957094|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
153957095|NCT00700024|Testosterone|testosterone|mesh-list
153957096|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
153957097|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
153957098|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153957099|NCT00700024|Androgens|androgens|mesh-ancestor
153957100|NCT00700024|Hormones|hormones|mesh-ancestor
153957101|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957102|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957103|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153957104|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957105|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
153957106|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
153957107|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153957108|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957109|NCT00796003|Decitabine|decitabine|mesh-list
153957110|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153957111|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
153957112|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957113|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957114|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957115|NCT04110535|Midazolam|midazolam|mesh-list
153957116|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153957117|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153957118|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957119|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957120|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153957121|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153957122|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957123|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153957124|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
154260854|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
153957125|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
153957126|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
153957127|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
153957128|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957129|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957130|NCT04025203|Ibuprofen|ibuprofen|mesh-list
153957131|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
153957132|NCT04025203|Gabapentin|gabapentin|mesh-list
153957133|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153957134|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153957135|NCT04025203|Analgesics|analgesics|mesh-ancestor
153957136|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
153957137|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729877|NCT03095274|Durvalumab|durvalumab|mesh-list
153957138|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957139|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957140|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957160|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
153957161|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957162|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
153957163|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957164|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
153957165|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957166|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153957167|NCT00899847|Acetaminophen|acetaminophen|mesh-list
153957168|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
153957169|NCT00899847|Promethazine|promethazine|mesh-list
153957170|NCT00899847|Cyclosporine|cyclosporine|mesh-list
153957171|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
153957172|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
153957173|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153957174|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
153957175|NCT00899847|Melphalan|melphalan|mesh-list
153957176|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
153957177|NCT00899847|Cyclosporins|cyclosporins|mesh-list
153957178|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
153957179|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153957180|NCT00899847|Lenograstim|lenograstim|mesh-list
153957181|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957182|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
153957183|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957184|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957185|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153957186|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
153957187|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957188|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957189|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153957190|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153957191|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957192|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
153957193|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957194|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
153957195|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153957196|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153957197|NCT00899847|Analgesics|analgesics|mesh-ancestor
153957198|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
153957217|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957218|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153957219|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
153957220|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
153957221|NCT00899847|Hormones|hormones|mesh-ancestor
153957222|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957223|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153957224|NCT00899847|Protective Agents|protective agents|mesh-ancestor
153957225|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153957226|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153957227|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
153957228|NCT04117750|Vitamin D|vitamin d|mesh-list
153957229|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
153957230|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153957231|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957232|NCT04117750|Vitamins|vitamins|mesh-ancestor
153957233|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
153957234|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153957235|NCT04117750|Antacids|antacids|mesh-ancestor
153957236|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957237|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901843|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901844|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153901850|NCT05444777|Analgesics|analgesics|mesh-ancestor
153901851|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
153957238|NCT04131322|Adalimumab|adalimumab|mesh-list
153957239|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153957240|NCT04131322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153957241|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957242|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957243|NCT02840175|Adalimumab|adalimumab|mesh-list
153957244|NCT02840175|Etanercept|etanercept|mesh-list
153957245|NCT02840175|Abatacept|abatacept|mesh-list
153957246|NCT02840175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153957247|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957248|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957249|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153957250|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153957251|NCT02840175|Analgesics|analgesics|mesh-ancestor
153957252|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
153957253|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957254|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957255|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957256|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957257|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
153957270|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
153957271|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957272|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
153957273|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957274|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153957275|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957276|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957277|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153957278|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957279|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153957280|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
153957281|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153957282|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957284|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957285|NCT02842983|Esmolol|esmolol|mesh-list
153957286|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153957287|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153957288|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
153957289|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957290|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957291|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957292|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153957293|NCT02839785|Ibuprofen|ibuprofen|mesh-list
153957294|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153957296|NCT02839785|Analgesics|analgesics|mesh-ancestor
153957297|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
153957298|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957299|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957300|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957301|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957302|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153957303|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957304|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957305|NCT02843061|Rituximab|rituximab|mesh-list
153957306|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153957307|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957308|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
153957309|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957310|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957311|NCT02839239|Vitamin D|vitamin d|mesh-list
153957312|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
153957313|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
153957314|NCT02839239|Vitamins|vitamins|mesh-list
153957315|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
153957316|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957317|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153957318|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153957349|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153957350|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
153957351|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153957352|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
153957353|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957355|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153957356|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153957357|NCT04260828|Analgesics|analgesics|mesh-ancestor
153957358|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
153957359|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957360|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957361|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957362|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957363|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153957384|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153957385|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957386|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153957387|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957388|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957390|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153957391|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153957392|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153957393|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
153957394|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
153957395|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957396|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957397|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957398|NCT00894543|Escitalopram|escitalopram|mesh-list
153957399|NCT00894543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153957400|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153957401|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957402|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957403|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957404|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
153957405|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957406|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153957407|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153957408|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957409|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153957410|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153957411|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957412|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957413|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
153957414|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957415|NCT00853372|Sunitinib|sunitinib|mesh-list
153957448|NCT04260516|Antidotes|antidotes|mesh-ancestor
153957449|NCT00921024|Ceftazidime|ceftazidime|mesh-list
153957450|NCT00921024|Ceftolozane|ceftolozane|mesh-list
153957451|NCT00921024|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153957452|NCT00921024|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153957453|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153957454|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957455|NCT00928668|Olodaterol|olodaterol|mesh-list
153957456|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153957457|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
153957458|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957459|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957468|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957469|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957470|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
153957471|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153957472|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957473|NCT00703300|Bortezomib|bortezomib|mesh-list
153957474|NCT00703300|Decitabine|decitabine|mesh-list
153957475|NCT00703300|Azacitidine|azacitidine|mesh-list
153957476|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957477|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153957478|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
153957479|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957480|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957481|NCT00703378|Docetaxel|docetaxel|mesh-list
153957482|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957483|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
153957484|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
153957485|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
153957486|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957487|NCT00852202|Cariprazine|cariprazine|mesh-list
153957488|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153957489|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153957490|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957491|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957492|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957493|NCT01074008|Ritonavir|ritonavir|mesh-list
153957494|NCT01074008|Ribavirin|ribavirin|mesh-list
153957495|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153957496|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153957497|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153957498|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
153957499|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957500|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957501|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153957502|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153957503|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
153957504|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957505|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153957506|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153957507|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
153957508|NCT02613052|Propofol|propofol|mesh-list
153957509|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153957510|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957511|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715144|NCT00333346|Analgesics|analgesics|mesh-ancestor
153957512|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153957513|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
153957514|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
153957515|NCT01073930|Bisacodyl|bisacodyl|mesh-list
153957516|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
153957517|NCT01073930|Cathartics|cathartics|mesh-ancestor
153957518|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957519|NCT01073930|Laxatives|laxatives|mesh-ancestor
153957520|NCT01073618|Voriconazole|voriconazole|mesh-list
153957521|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
153957522|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957523|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153957524|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153957525|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957526|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957527|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153957528|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
153957534|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957535|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957536|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153957537|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153957538|NCT00851890|Interferons|interferons|mesh-list
153957539|NCT00851890|Ribavirin|ribavirin|mesh-list
153957540|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957541|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
153957542|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957543|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
153957544|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957545|NCT00592072|Decanoic acid|decanoic acid|mesh-list
153957546|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
153957547|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957548|NCT00626288|Mesalamine|mesalamine|mesh-list
153957549|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153957550|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153957551|NCT00626288|Analgesics|analgesics|mesh-ancestor
153957552|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
153957553|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957554|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957555|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957556|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957557|NCT00792571|Epoprostenol|epoprostenol|mesh-list
153957558|NCT00792571|Beraprost|beraprost|mesh-list
154260855|NCT01296074|Hormones|hormones|mesh-ancestor
153411908|NCT00003849|Rituximab|rituximab|mesh-list
153957559|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153957560|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
153957561|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153957562|NCT00794365|Varenicline|varenicline|mesh-list
153957563|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153957564|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153957565|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
153957566|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957567|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957568|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957569|NCT01067144|Gabapentin|gabapentin|mesh-list
153957570|NCT01067144|Lorazepam|lorazepam|mesh-list
153957571|NCT01067144|Analgesics|analgesics|mesh-ancestor
153957572|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
153957573|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957574|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957575|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
153957576|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153957577|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153957578|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957579|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957580|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153957581|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153957582|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957583|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957584|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
153957585|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
153957586|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
153957587|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957588|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153957589|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
153957590|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
153957591|NCT01078298|Varenicline|varenicline|mesh-list
153957592|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153957595|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957596|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957597|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957598|NCT00788593|Pancreatin|pancreatin|mesh-list
153957599|NCT00788593|Pancrelipase|pancrelipase|mesh-list
153957600|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957615|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
153957616|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153957617|NCT02875886|Amiloride|amiloride|mesh-list
153957618|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153957619|NCT02875886|Diuretics|diuretics|mesh-ancestor
153957620|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
153957621|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957622|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153957623|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957624|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957625|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153957626|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153445672|NCT00001049|Zidovudine|zidovudine|mesh-list
153957627|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153957628|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153957629|NCT00793819|Silodosin|silodosin|mesh-list
153957630|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153957631|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153957632|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153957633|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
153957634|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957635|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957636|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957637|NCT00793819|Urological Agents|urological agents|mesh-ancestor
153957638|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153957639|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957640|NCT00894387|Aliskiren|aliskiren|mesh-list
153957641|NCT00894387|Renin Inhibitors|renin inhibitors|mesh-ancestor
153957642|NCT00894387|Protease Inhibitors|protease inhibitors|mesh-ancestor
153957643|NCT00894387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957644|NCT00894387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957645|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
153957646|NCT02836821|Rifampin|rifampin|mesh-list
153957647|NCT02836821|Apatinib|apatinib|mesh-list
153411915|NCT00004575|Bradykinin|bradykinin|mesh-list
153901961|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901962|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957648|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957649|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153957650|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957651|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957652|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153957653|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
153957654|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153957655|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957656|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
153957657|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153957658|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153715199|NCT00421096|Gemcitabine|gemcitabine|mesh-list
153957689|NCT00892437|Cobicistat|cobicistat|mesh-list
153957690|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153957691|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153957692|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957693|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957694|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
153957695|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957696|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153957697|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153957698|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153715256|NCT00334360|Buspirone|buspirone|mesh-list
153957704|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153957706|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957707|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957708|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957709|NCT02836509|Acetaminophen|acetaminophen|mesh-list
153957710|NCT02836509|Ibuprofen|ibuprofen|mesh-list
153957711|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153957712|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153957713|NCT02836509|Analgesics|analgesics|mesh-ancestor
153957714|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
153957715|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957716|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957717|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957718|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957719|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153957720|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957721|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957722|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
153957723|NCT05306379|Simvastatin|simvastatin|mesh-list
153957724|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153957725|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153957726|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
153957727|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957728|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153957729|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153957730|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957731|NCT05304663|Lomustine|lomustine|mesh-list
153957732|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153957733|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
153957734|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957735|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957736|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
153957737|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153957738|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957739|NCT04109755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153957740|NCT04109755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957741|NCT04248309|Progesterone|progesterone|mesh-list
153957742|NCT04248309|Progestins|progestins|mesh-ancestor
153957743|NCT04248309|Hormones|hormones|mesh-ancestor
153957744|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957745|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957746|NCT00892281|Doxycycline|doxycycline|mesh-list
153957747|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153957748|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957749|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
153957751|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153957752|NCT02836353|Rifaximin|rifaximin|mesh-list
153957753|NCT02836353|Somatostatin|somatostatin|mesh-list
153957754|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153957755|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957756|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957757|NCT02836353|Hormones|hormones|mesh-ancestor
153957758|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957759|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957760|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
153957761|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153957762|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957763|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957764|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153957765|NCT02836431|Analgesics|analgesics|mesh-ancestor
153957777|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957779|NCT00784693|Analgesics|analgesics|mesh-ancestor
153957780|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
153957781|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957782|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957783|NCT00915811|Fludarabine|fludarabine|mesh-list
153957784|NCT00915811|Busulfan|busulfan|mesh-list
153957785|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
153957786|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153957787|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957788|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957789|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957790|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
153957791|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957792|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
153957793|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153957794|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153957795|NCT00892047|Aripiprazole|aripiprazole|mesh-list
153957796|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153957797|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
153957798|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957799|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153957800|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153957801|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957802|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957803|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
153957804|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
153957805|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957806|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957807|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153957808|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153957809|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
153957810|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153957811|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153957812|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153957813|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153957814|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153957815|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153904242|NCT01254227|Deferasirox|deferasirox|mesh-list
153957816|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957817|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153957818|NCT02835729|Cytarabine|cytarabine|mesh-list
153957819|NCT02835729|Idarubicin|idarubicin|mesh-list
153957820|NCT02835729|Tryptophan|tryptophan|mesh-list
153957821|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153957822|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
153957823|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957824|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957825|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
153957826|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957838|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957839|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957840|NCT00787267|Dasatinib|dasatinib|mesh-list
153957841|NCT00787267|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153957842|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153957843|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733470|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153902038|NCT04781374|Neratinib|neratinib|mesh-list
153957844|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957845|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957846|NCT02838615|Dexamethasone|dexamethasone|mesh-list
153957847|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957848|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
153957849|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
153957850|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957851|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957852|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957853|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
153957854|NCT02838615|Hormones|hormones|mesh-ancestor
153957855|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957856|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153957857|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957858|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
153957859|NCT02838225|Docetaxel|docetaxel|mesh-list
153957860|NCT02838225|Doxorubicin|doxorubicin|mesh-list
153957861|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153957862|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957863|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
153957864|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957865|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957866|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153957867|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
153957868|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957869|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957870|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153957871|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
153957872|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
153957873|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
153957874|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153957875|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153957876|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153957877|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957878|NCT00928434|Leuprolide|leuprolide|mesh-list
153957879|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153957880|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
153957881|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153957882|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957883|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153957884|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957885|NCT04248621|Goserelin|goserelin|mesh-list
153957886|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153957887|NCT04248621|Leuprolide|leuprolide|mesh-list
153957888|NCT04248621|Flutamide|flutamide|mesh-list
153957889|NCT04248621|Bicalutamide|bicalutamide|mesh-list
153957890|NCT04248621|Androgens|androgens|mesh-list
153715428|NCT00334789|Belinostat|belinostat|mesh-list
153957911|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
153957912|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957913|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957914|NCT02835183|Insulin|insulin|mesh-list
153957915|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153957916|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957917|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
153957918|NCT02602483|Ibuprofen|ibuprofen|mesh-list
153957919|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153957920|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153957921|NCT02602483|Analgesics|analgesics|mesh-ancestor
153957922|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
153957923|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957924|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957925|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957926|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957927|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153957928|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957929|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957930|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
153957931|NCT02602483|Protective Agents|protective agents|mesh-ancestor
153957932|NCT02602483|Vitamins|vitamins|mesh-ancestor
153957933|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
153957934|NCT00784147|Ibalizumab|ibalizumab|mesh-list
153957935|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153957936|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153411969|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
153443497|NCT02023866|Cysteamine|cysteamine|mesh-list
153957937|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153957938|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
153957939|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957940|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
153957941|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957942|NCT04260360|Docetaxel|docetaxel|mesh-list
153957943|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957944|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
153715502|NCT00342862|Alefacept|alefacept|mesh-list
153957955|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153957956|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
153957957|NCT04254822|Protective Agents|protective agents|mesh-ancestor
153957958|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153957959|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957960|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153957961|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
153957962|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153957963|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153957964|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
153957965|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153957966|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957968|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
153957969|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153957970|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
153957971|NCT04255056|Epirubicin|epirubicin|mesh-list
153957972|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957973|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
153957974|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957975|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153957976|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153957977|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
153957978|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957979|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957980|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153957981|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153957982|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153957983|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153957984|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957985|NCT00783835|Methylphenidate|methylphenidate|mesh-list
153957986|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153957987|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957988|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153957989|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153957990|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957991|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957992|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
153957993|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957994|NCT04254744|Sevoflurane|sevoflurane|mesh-list
153957995|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153957996|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153957997|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
153957998|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
153957999|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958000|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958001|NCT02831361|Metformin|metformin|mesh-list
153958002|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153958003|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958004|NCT04103905|Antibodies|antibodies|mesh-list
153715549|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
153958022|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153958023|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
153958024|NCT02828163|Triamcinolone|triamcinolone|mesh-list
153958025|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153958026|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153958027|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153958028|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153958029|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
153958030|NCT02828163|Hormones|hormones|mesh-ancestor
153958031|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958032|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958033|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411993|NCT00363584|Capecitabine|capecitabine|mesh-list
153443527|NCT01967628|Vitamin D|vitamin d|mesh-list
153958034|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
153958035|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958036|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958037|NCT02833155|Exemestane|exemestane|mesh-list
153715675|NCT00127920|Bevacizumab|bevacizumab|mesh-list
153958038|NCT02833155|Entinostat|entinostat|mesh-list
153958039|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958040|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153958041|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153958042|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958043|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958044|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153958045|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
153958046|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958047|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958048|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153958049|NCT04672460|Talazoparib|talazoparib|mesh-list
153958050|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153958051|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958052|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958053|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958054|NCT00847912|Fluorouracil|fluorouracil|mesh-list
153958055|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
153958056|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958057|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153958058|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958059|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958060|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
153958061|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958062|NCT00850564|Hormones|hormones|mesh-list
153958063|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
153958076|NCT00703690|Fenofibrate|fenofibrate|mesh-list
153958077|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153958078|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
153958079|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958080|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153958081|NCT05297968|Oseltamivir|oseltamivir|mesh-list
153958082|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
153958083|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958084|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958085|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958086|NCT02613130|Fluorides|fluorides|mesh-list
153958087|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
153958088|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
153958089|NCT02613130|Protective Agents|protective agents|mesh-ancestor
153958090|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958091|NCT00849472|Paclitaxel|paclitaxel|mesh-list
153958092|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
153958093|NCT00849472|Doxorubicin|doxorubicin|mesh-list
153958094|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153958095|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958096|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153958097|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153958098|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153958099|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958100|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958101|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
153958102|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904337|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153904338|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904339|NCT01253135|Petrolatum|petrolatum|mesh-list
153958103|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153958104|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153958105|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
153958106|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153958107|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153958108|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153958109|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153958110|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715747|NCT00344110|Protease Inhibitors|protease inhibitors|mesh-ancestor
153958111|NCT00782509|Olodaterol|olodaterol|mesh-list
153958112|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153958113|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
153958114|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260856|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260857|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260858|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153902158|NCT04049851|Moxidectin|moxidectin|mesh-list
153958115|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958116|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153958117|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
153958118|NCT00701428|Losartan|losartan|mesh-list
153958119|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153958120|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153958121|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153958122|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153958123|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958124|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153958141|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958142|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958143|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958144|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958145|NCT04254042|Perindopril|perindopril|mesh-list
153958146|NCT04254042|Zofenopril|zofenopril|mesh-list
153958147|NCT04254042|Captopril|captopril|mesh-list
153958148|NCT04254042|Calcium|calcium|mesh-list
153958149|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153958150|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958151|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153958152|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
153958153|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958154|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958155|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153958156|NCT00918138|Metformin|metformin|mesh-list
153958157|NCT00918138|Saxagliptin|saxagliptin|mesh-list
153958158|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153958159|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958160|NCT00918138|Incretins|incretins|mesh-ancestor
153958161|NCT00918138|Hormones|hormones|mesh-ancestor
153958162|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958163|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153958164|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
153958165|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958166|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958167|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153958168|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153958169|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958170|NCT00782275|Sirolimus|sirolimus|mesh-list
153958171|NCT00782275|Bevacizumab|bevacizumab|mesh-list
153958172|NCT00782275|Temsirolimus|temsirolimus|mesh-list
153958173|NCT00782275|MTOR Inhibitors|mtor inhibitors|mesh-list
153958174|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153958175|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958176|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958177|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958178|NCT00782275|Growth Substances|growth substances|mesh-ancestor
153904340|NCT01253135|Emollients|emollients|mesh-ancestor
153958179|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958180|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958181|NCT00782275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958182|NCT00782275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958183|NCT00782275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958184|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958185|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
153958193|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
153958194|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153958195|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153958196|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
153958197|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958198|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153958199|NCT05176314|Pirtobrutinib|pirtobrutinib|mesh-list
153958200|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153958201|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153958202|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
154260859|NCT01296074|Protective Agents|protective agents|mesh-ancestor
154260860|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154260861|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260862|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
154260863|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
154260865|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
154260866|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154260867|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154260868|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260869|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154260870|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260871|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260872|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154260873|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
154260874|NCT01195376|Dactolisib|dactolisib|mesh-list
154260875|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260876|NCT01189526|Ranibizumab|ranibizumab|mesh-list
154260877|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154260878|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154260879|NCT01189526|Growth Substances|growth substances|mesh-ancestor
154260880|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260881|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
154260882|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260883|NCT01296230|Hormones|hormones|mesh-list
154260884|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260885|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260886|NCT01580696|Molgramostim|molgramostim|mesh-list
154260887|NCT01580696|Vaccines|vaccines|mesh-list
154260888|NCT01580696|Sargramostim|sargramostim|mesh-list
154260889|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
154260890|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007832|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260891|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260892|NCT01197014|Losartan|losartan|mesh-list
154260893|NCT01197014|Amlodipine|amlodipine|mesh-list
154260894|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154260895|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153733475|NCT05148637|Fentanyl|fentanyl|mesh-list
154260896|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154260897|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260898|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154260899|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260900|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
154260901|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154260902|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154260903|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154260904|NCT01195454|Insulin|insulin|mesh-list
154260905|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154260906|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
154260907|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154260908|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260909|NCT01197170|Bevacizumab|bevacizumab|mesh-list
154260910|NCT01197170|Everolimus|everolimus|mesh-list
154260911|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154260912|NCT01197170|Sorafenib|sorafenib|mesh-list
154260913|NCT01197170|Anastrozole|anastrozole|mesh-list
154260914|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154260915|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260916|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154260917|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154260918|NCT01197170|Growth Substances|growth substances|mesh-ancestor
154260919|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260920|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
154260921|NCT01197170|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154260922|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154260923|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260924|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260925|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958203|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958204|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153958205|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153958206|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958207|NCT05176314|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153958208|NCT05176314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958209|NCT00920556|Bortezomib|bortezomib|mesh-list
153958210|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958211|NCT00781885|Beraprost|beraprost|mesh-list
153958212|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153958213|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
153958214|NCT04901676|Leronlimab|leronlimab|mesh-list
153958215|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154260926|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
154260927|NCT01197170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154260928|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154260929|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154260930|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154260931|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154260932|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154260933|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260934|NCT05516966|Dulaglutide|dulaglutide|mesh-list
154260935|NCT05516966|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154260936|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154260937|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260938|NCT01195766|Ofatumumab|ofatumumab|mesh-list
154260939|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260940|NCT03850886|Niacinamide|niacinamide|mesh-list
154260942|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
154260943|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154260944|NCT03850886|Vitamins|vitamins|mesh-ancestor
154260945|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
154260946|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260947|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
154260948|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154260949|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
154260950|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260951|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154260952|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
154260953|NCT03251482|Apixaban|apixaban|mesh-list
154260954|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154260955|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
154260956|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154260957|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
154260958|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733545|NCT05143762|Hormones|hormones|mesh-ancestor
153733560|NCT00424281|PENTA|penta|mesh-list
153958216|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153958217|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958218|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153958219|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153958220|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
153958221|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958222|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
154260959|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260960|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
154260961|NCT03732248|Sirolimus|sirolimus|mesh-list
154260962|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154007906|NCT04267991|Tacrolimus|tacrolimus|mesh-list
154260963|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260964|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154260965|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260966|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
154260967|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154260968|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
154260969|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260970|NCT00310037|Bortezomib|bortezomib|mesh-list
154260971|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260972|NCT01196234|Paclitaxel|paclitaxel|mesh-list
154260973|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154260974|NCT01196234|Carboplatin|carboplatin|mesh-list
154260975|NCT01196234|Gefitinib|gefitinib|mesh-list
154260976|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154260977|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260978|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
154260979|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
154260980|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
154260981|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260982|NCT01196234|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154260983|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154260984|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260985|NCT00309959|Paclitaxel|paclitaxel|mesh-list
154260986|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154260987|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154260988|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260989|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
154260990|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
154260991|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
153733579|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
153733590|NCT02276677|Oxytocin|oxytocin|mesh-list
153958223|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153958224|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958226|NCT02603965|Trace Elements|trace elements|mesh-ancestor
153958227|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
153958228|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260992|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260993|NCT03238924|Oxytocin|oxytocin|mesh-list
154260994|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
154260995|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154260996|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260997|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
154260998|NCT01190384|Antioxidants|antioxidants|mesh-list
153733615|NCT00156897|Orlistat|orlistat|mesh-list
153958229|NCT00918684|Escitalopram|escitalopram|mesh-list
153958230|NCT00918684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153958231|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153958232|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153958233|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958234|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958235|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
153958236|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958237|NCT00919854|Ritonavir|ritonavir|mesh-list
153958238|NCT00919854|Darunavir|darunavir|mesh-list
153958239|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153958240|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153958241|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
153958242|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958243|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958244|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153958245|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153958246|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
153958247|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958248|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153958249|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153958251|NCT04669782|Vitamin K|vitamin k|mesh-list
153958252|NCT04669782|Vitamins|vitamins|mesh-ancestor
153958253|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
153958254|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715794|NCT00344422|Hormones|hormones|mesh-ancestor
153958272|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958273|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958274|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958275|NCT04247373|Ropivacaine|ropivacaine|mesh-list
153958276|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
153958277|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
153958278|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958279|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958280|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
153958281|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958282|NCT02832999|Liraglutide|liraglutide|mesh-list
153958283|NCT02832999|Vildagliptin|vildagliptin|mesh-list
153958284|NCT02832999|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153958285|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153958286|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958287|NCT02832999|Incretins|incretins|mesh-ancestor
153958289|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958290|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153958291|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
153958292|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958293|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958294|NCT04245033|Piperaquine|piperaquine|mesh-list
153958295|NCT04245033|Artenimol|artenimol|mesh-list
153958296|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
153958297|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153958298|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153958299|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958300|NCT00915018|Paclitaxel|paclitaxel|mesh-list
153958301|NCT00915018|Trastuzumab|trastuzumab|mesh-list
153958302|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153958303|NCT00915018|Neratinib|neratinib|mesh-list
153958304|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153958305|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958306|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154260999|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261000|NCT01190384|Protective Agents|protective agents|mesh-ancestor
154261001|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261002|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154261003|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261005|NCT02532413|Poly I-C|poly i-c|mesh-list
154261006|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
154261007|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261008|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
154261009|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
154261010|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261011|NCT01190462|Cetuximab|cetuximab|mesh-list
154261012|NCT01190462|Simvastatin|simvastatin|mesh-list
154261013|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261014|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261015|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154261016|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154261017|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
154261018|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261019|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154261020|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154261021|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261022|NCT01198106|Cinnarizine|cinnarizine|mesh-list
154261023|NCT01198106|Scopolamine|scopolamine|mesh-list
154261024|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154261025|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154261026|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
154261027|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
154261028|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261029|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261030|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154261031|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
154261032|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154261033|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
154261034|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958307|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
153958308|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154261035|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261036|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154261037|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
154261038|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154261039|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261040|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154261041|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154261042|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
154261043|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
154261045|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154261046|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
154261047|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261048|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261049|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154261050|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154261051|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
154261052|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261053|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261054|NCT03850652|Iron|iron|mesh-list
154261055|NCT03850652|Trace Elements|trace elements|mesh-ancestor
154261056|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
154261057|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261058|NCT01198184|Sirolimus|sirolimus|mesh-list
154261059|NCT01198184|Temsirolimus|temsirolimus|mesh-list
154261060|NCT01198184|MTOR Inhibitors|mtor inhibitors|mesh-list
154261061|NCT01198184|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154261062|NCT01198184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154261063|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261064|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261065|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958309|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958310|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153958311|NCT00915018|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153958323|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153958324|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
153958325|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958326|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958328|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153958329|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154261066|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
154261067|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261068|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261069|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261070|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261071|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154261072|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
154261073|NCT01198184|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154261075|NCT00333359|Analgesics|analgesics|mesh-ancestor
154261076|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
154261077|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261078|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261079|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
154261080|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154261081|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154261082|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261083|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154261084|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154261085|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154261086|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261087|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261088|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
154261089|NCT03246724|Midazolam|midazolam|mesh-list
154261090|NCT03246724|Triazolam|triazolam|mesh-list
154261091|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154261092|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154261093|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733687|NCT00157053|Factor VIII|factor viii|mesh-list
153733688|NCT00157053|Coagulants|coagulants|mesh-ancestor
153958330|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958331|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
153958332|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
153958333|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
153958334|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958335|NCT02829879|Listerine|listerine|mesh-list
153958336|NCT02829879|Fluorides|fluorides|mesh-list
153958337|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
153958338|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
153958339|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
153958340|NCT02829879|Protective Agents|protective agents|mesh-ancestor
153958341|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958342|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153958343|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958344|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
154261094|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261095|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154261096|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154261097|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154261098|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154261099|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
154261100|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
154261101|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
154261102|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
154261103|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261104|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261105|NCT01196546|Metformin|metformin|mesh-list
154261106|NCT01196546|Vildagliptin|vildagliptin|mesh-list
154261107|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261108|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261109|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154261110|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
154261111|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261112|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261113|NCT01293266|Propofol|propofol|mesh-list
154261114|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154261115|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261116|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261117|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154261118|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
154261120|NCT03948646|Bromides|bromides|mesh-list
154261121|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
154261122|NCT01198340|Ropivacaine|ropivacaine|mesh-list
154261123|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
154261124|NCT01198340|Anesthetics|anesthetics|mesh-list
153733725|NCT00507949|Megestrol|megestrol|mesh-list
153958345|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153958346|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958347|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958348|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153958349|NCT05246007|Analgesics|analgesics|mesh-ancestor
153958350|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
153958351|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958352|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153958353|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153958354|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153958355|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
153958356|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958357|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958358|NCT00914940|Fludarabine|fludarabine|mesh-list
153958359|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
154261125|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261126|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261127|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
154261128|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261129|NCT01347112|Varenicline|varenicline|mesh-list
154261130|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154261131|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154261132|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
154261133|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261134|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261135|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261136|NCT00308711|Misoprostol|misoprostol|mesh-list
154261137|NCT00308711|Dinoprostone|dinoprostone|mesh-list
154261138|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154261139|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
153958360|NCT00914940|Thiotepa|thiotepa|mesh-list
153958361|NCT00914940|Tacrolimus|tacrolimus|mesh-list
153958362|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958363|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153958364|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
153958365|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958366|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958367|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
153958368|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958369|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153958370|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958371|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153958372|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
153958373|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153958374|NCT00835978|Axitinib|axitinib|mesh-list
153958375|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715916|NCT00128037|Mitomycins|mitomycins|mesh-list
153958407|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958408|NCT00701740|Isotretinoin|isotretinoin|mesh-list
153958409|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
153958410|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
153958411|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
153445978|NCT00001889|Dobutamine|dobutamine|mesh-list
153958412|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153716045|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958413|NCT00701740|Protective Agents|protective agents|mesh-ancestor
153958414|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958415|NCT04938882|Lidocaine|lidocaine|mesh-list
153958416|NCT04938882|Ropivacaine|ropivacaine|mesh-list
153958417|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
153958418|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
153958449|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
153958450|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958451|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958452|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153958453|NCT04303598|Tenofovir|tenofovir|mesh-list
153958454|NCT04303598|Lamivudine|lamivudine|mesh-list
153958455|NCT04303598|Efavirenz|efavirenz|mesh-list
153958456|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
153958457|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958458|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153958459|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153958460|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958475|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
153958476|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153958477|NCT00827242|Tadalafil|tadalafil|mesh-list
154261140|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154261141|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261142|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154261143|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154261145|NCT01198496|Losartan|losartan|mesh-list
154261146|NCT01198496|Amlodipine|amlodipine|mesh-list
154261147|NCT01198496|Valsartan|valsartan|mesh-list
154261148|NCT01198496|Telmisartan|telmisartan|mesh-list
154261149|NCT01198496|Candesartan|candesartan|mesh-list
154261150|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
154261151|NCT01198496|Olmesartan|olmesartan|mesh-list
154261152|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154261153|NCT01198496|Spironolactone|spironolactone|mesh-list
154261154|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154261155|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154261156|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261157|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261158|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154261159|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261160|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
154261161|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154261162|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154261163|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154261164|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154261165|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
154261166|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261167|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154261168|NCT01198496|Diuretics|diuretics|mesh-ancestor
154261169|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
154261170|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
154261171|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154261172|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
154261173|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261174|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261175|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
154261176|NCT03846284|Bupivacaine|bupivacaine|mesh-list
153443721|NCT01984242|Growth Substances|growth substances|mesh-ancestor
153958478|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
153958479|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153958480|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153958481|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958482|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958483|NCT00827242|Urological Agents|urological agents|mesh-ancestor
153958484|NCT01077362|Ustekinumab|ustekinumab|mesh-list
153958485|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
153729879|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153958486|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
153958487|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153958488|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
153958489|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958490|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904498|NCT02867878|Analgesics|analgesics|mesh-ancestor
153958491|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153958492|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
153958493|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
153958494|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153958495|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
153958496|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958497|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958498|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
153958499|NCT00785785|Nilotinib|nilotinib|mesh-list
153958500|NCT00785785|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153958501|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958502|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958503|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958504|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958505|NCT00707278|Capecitabine|capecitabine|mesh-list
153958506|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
153958507|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153958508|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
153958509|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958510|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958511|NCT01077284|Allopurinol|allopurinol|mesh-list
153958512|NCT01077284|Febuxostat|febuxostat|mesh-list
153958513|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
153958514|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958515|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958516|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
153958517|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153958539|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
153958540|NCT04103125|Protective Agents|protective agents|mesh-ancestor
153958541|NCT00826618|Ranibizumab|ranibizumab|mesh-list
153958542|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958543|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958544|NCT00826618|Growth Substances|growth substances|mesh-ancestor
153958545|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958546|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958547|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958548|NCT02876822|Vitamin D|vitamin d|mesh-list
153958549|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
153958550|NCT02876822|Vitamins|vitamins|mesh-ancestor
153958551|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
153958552|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958553|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153958554|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153958555|NCT00826540|Bevacizumab|bevacizumab|mesh-list
153958556|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153958557|NCT00826540|Sorafenib|sorafenib|mesh-list
153958558|NCT00826540|Antibodies|antibodies|mesh-list
153958559|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
153716209|NCT00346801|Celecoxib|celecoxib|mesh-list
153958560|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153958561|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958562|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958563|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958564|NCT00826540|Growth Substances|growth substances|mesh-ancestor
153958565|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958566|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958567|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
153958568|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958569|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958570|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261178|NCT03846284|Anesthetics|anesthetics|mesh-list
154261179|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
154261180|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261181|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261182|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
154261183|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261184|NCT03846284|Analgesics|analgesics|mesh-ancestor
154261185|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154261186|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
154261187|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154261188|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008123|NCT02827682|Anesthetics|anesthetics|mesh-list
154261189|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261190|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154261191|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
154261192|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154261193|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154261194|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154261195|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261196|NCT01066169|Lactitol|lactitol|mesh-list
154261197|NCT01066169|Cathartics|cathartics|mesh-ancestor
154261198|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154261199|NCT05572060|Metformin|metformin|mesh-list
154261200|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261201|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261202|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
154261203|NCT05431244|Gemcitabine|gemcitabine|mesh-list
154261204|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154261205|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
154261206|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261207|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261211|NCT01199432|Epirubicin|epirubicin|mesh-list
154261219|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261220|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154261221|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
154261222|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154261223|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154261224|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154261225|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154261226|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261227|NCT05064020|Tenofovir|tenofovir|mesh-list
154261228|NCT05064020|Emtricitabine|emtricitabine|mesh-list
154261229|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154261230|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
154261231|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261232|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154261233|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154261234|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261235|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261236|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154261237|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154261238|NCT05058560|Tislelizumab|tislelizumab|mesh-list
154261239|NCT05058560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261240|NCT05058560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261241|NCT01293422|Rifampin|rifampin|mesh-list
154261242|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154261243|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
154261244|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261245|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261246|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
154261247|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154261248|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261249|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261260|NCT01566734|Cefazolin|cefazolin|mesh-list
154261261|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261262|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008193|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154261263|NCT00050778|Interferons|interferons|mesh-list
154261264|NCT00050778|Interferon-beta|interferon-beta|mesh-list
154261265|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
154261266|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
154261267|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261268|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
154261269|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261270|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261271|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
154261272|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261273|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154261274|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154261275|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
154261276|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154261277|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
154261278|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154261279|NCT00050622|Methylphenidate|methylphenidate|mesh-list
154261280|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154261281|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261282|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154261283|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154261284|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261285|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902308|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153958580|NCT00626600|Narcotics|narcotics|mesh-ancestor
153958581|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958582|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958583|NCT00626600|Analgesics|analgesics|mesh-ancestor
153958584|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
153958585|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958586|NCT00707512|Natalizumab|natalizumab|mesh-list
153958587|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
153958588|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958589|NCT00704548|Simvastatin|simvastatin|mesh-list
153958590|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153958591|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153958592|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
153958593|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958594|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153958595|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153958596|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958597|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153958598|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153958599|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153958600|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153958601|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958602|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958603|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958604|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153958605|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
153958606|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153958607|NCT00846040|Fallypride|fallypride|mesh-list
153958608|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153958609|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153958610|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
153958611|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958612|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958613|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958614|NCT02611336|Tadalafil|tadalafil|mesh-list
153958615|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
153958616|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153958617|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153958618|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958619|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958620|NCT02611336|Urological Agents|urological agents|mesh-ancestor
153958621|NCT00704704|Thalidomide|thalidomide|mesh-list
153958622|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958623|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
153958624|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958625|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
153958626|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153958627|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958628|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958629|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958630|NCT00704704|Growth Substances|growth substances|mesh-ancestor
153958631|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958632|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958633|NCT00707824|Nalbuphine|nalbuphine|mesh-list
153958634|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153958656|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153958658|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
153958659|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958660|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958661|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153958662|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153958663|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153958664|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958665|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
153958666|NCT05208333|Albendazole|albendazole|mesh-list
153958667|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
153958668|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153958669|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958670|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
153958671|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153958672|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153958673|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
154261306|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261307|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154261308|NCT01097148|Atracurium|atracurium|mesh-list
154261309|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154261310|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154261311|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154261312|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261313|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261314|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154261315|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154261316|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
154261317|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261318|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261319|NCT01199276|Sevoflurane|sevoflurane|mesh-list
154261320|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154261321|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154261322|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
154261323|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
154261324|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261325|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261326|NCT01202084|Fluticasone|fluticasone|mesh-list
154261327|NCT01202084|Xhance|xhance|mesh-list
154261328|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
154261329|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154261330|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154261331|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
154261332|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261333|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261334|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154261349|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153733983|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153958674|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
153958675|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
153958676|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958677|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958678|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153958680|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153958681|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153958682|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153958683|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
153958684|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958685|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153958686|NCT02829333|Anesthetics|anesthetics|mesh-list
153958687|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958688|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958700|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958701|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
153958702|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153958703|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153958704|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
153958705|NCT02829177|Protective Agents|protective agents|mesh-ancestor
153958706|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958707|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
153958708|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153958709|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153716372|NCT00347425|Olanzapine|olanzapine|mesh-list
153958710|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153958711|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153958712|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958713|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
153958714|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958715|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958716|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153958717|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958718|NCT04244097|Bupivacaine|bupivacaine|mesh-list
153958719|NCT04244097|Neostigmine|neostigmine|mesh-list
153958720|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
153958721|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
153958722|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958723|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958724|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
153958725|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958726|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153958727|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958728|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958729|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
153958730|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958731|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153958732|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
153958733|NCT00785629|Calcium|calcium|mesh-list
153958734|NCT00785629|Sevelamer|sevelamer|mesh-list
153958735|NCT00785629|Calcium acetate|calcium acetate|mesh-list
153958736|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153958737|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958738|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
153958739|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
153958740|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958741|NCT00915733|Aspirin|aspirin|mesh-list
153958742|NCT00915733|Cilostazol|cilostazol|mesh-list
153958743|NCT00915733|Clopidogrel|clopidogrel|mesh-list
153958744|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153958745|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153958746|NCT00915733|Analgesics|analgesics|mesh-ancestor
153958747|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
153958748|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958749|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958750|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153958751|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153958766|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153958767|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
154261350|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154261351|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261352|NCT01202240|Ketoconazole|ketoconazole|mesh-list
154261353|NCT01202240|Tofacitinib|tofacitinib|mesh-list
154261354|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
154261355|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261356|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154261357|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154261358|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261359|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261360|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154261361|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
154261362|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261363|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261364|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154261365|NCT01202240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154261366|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154261367|NCT01204112|Rifampin|rifampin|mesh-list
154261368|NCT01204112|Tofacitinib|tofacitinib|mesh-list
154261369|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154261370|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
154261371|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261372|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261373|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
154261374|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154261375|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261376|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261377|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154261378|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154261379|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154261380|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154261381|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154261382|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154261386|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154261387|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154261388|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154261389|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
154261390|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154261391|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261392|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154261393|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154261394|NCT01204190|Progestins|progestins|mesh-ancestor
154261396|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261397|NCT01204268|Sevoflurane|sevoflurane|mesh-list
154261398|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154261399|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154261400|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
154261401|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
154261402|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261403|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261404|NCT02965898|Vitamin D|vitamin d|mesh-list
154261405|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
154261406|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
154261407|NCT02965898|Vitamins|vitamins|mesh-list
154261408|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
154261409|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261410|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154261418|NCT03844178|Tetracaine|tetracaine|mesh-list
154261437|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261438|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154261439|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154261440|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
154261441|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261442|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154261443|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154261444|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154261445|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154261446|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
154261447|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154261448|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154261449|NCT03981029|Folic Acid|folic acid|mesh-list
154261450|NCT03981029|Hematinics|hematinics|mesh-ancestor
154261451|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
154261452|NCT03981029|Vitamins|vitamins|mesh-ancestor
154261453|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
154261454|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261455|NCT02654132|Dexamethasone|dexamethasone|mesh-list
154261456|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
154261457|NCT02654132|Pomalidomide|pomalidomide|mesh-list
154261458|NCT02654132|Elotuzumab|elotuzumab|mesh-list
154261459|NCT02654132|BB 1101|bb 1101|mesh-list
154261460|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154261461|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
154261462|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
154261463|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261464|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261465|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154261466|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
154261467|NCT02654132|Hormones|hormones|mesh-ancestor
154261469|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154261478|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
154261479|NCT01064141|Vaccines|vaccines|mesh-list
154261480|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
154261481|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261482|NCT03837470|Furosemide|furosemide|mesh-list
154261483|NCT03837470|Diuretics|diuretics|mesh-ancestor
154261484|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
154261485|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261486|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154261487|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261488|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261489|NCT01199900|Prednisone|prednisone|mesh-list
154261490|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154261491|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
154261492|NCT01199900|Hormones|hormones|mesh-ancestor
154261493|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261494|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261495|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154261496|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261497|NCT01200056|Atorvastatin|atorvastatin|mesh-list
154261498|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154261499|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154261500|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
154261501|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261502|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154261503|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154261504|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261505|NCT01200212|Bevacizumab|bevacizumab|mesh-list
154261506|NCT01200212|Taxane|taxane|mesh-list
154261507|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261508|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261509|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154261510|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154261511|NCT01200212|Growth Substances|growth substances|mesh-ancestor
154261512|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261513|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
154261516|NCT03978845|Anesthetics|anesthetics|mesh-list
154261517|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261518|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261519|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
154261520|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261521|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154261522|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154261523|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154261524|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261525|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261526|NCT02387996|Nivolumab|nivolumab|mesh-list
154261527|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261528|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261529|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154261530|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261531|NCT01204580|Metformin|metformin|mesh-list
154261532|NCT01204580|Glimepiride|glimepiride|mesh-list
154261533|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261534|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261535|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154261536|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154261537|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
154261538|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154261539|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154261540|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154261541|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154261542|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
154261543|NCT03229486|Neostigmine|neostigmine|mesh-list
154261544|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154261545|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261546|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261547|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
154261553|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154261554|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154261555|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154261557|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
154261558|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261559|NCT03833570|Protective Agents|protective agents|mesh-ancestor
154261560|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008486|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261561|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261562|NCT01779050|Paclitaxel|paclitaxel|mesh-list
154261563|NCT01779050|Docetaxel|docetaxel|mesh-list
154261564|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
154261565|NCT01779050|Carboplatin|carboplatin|mesh-list
154261566|NCT01779050|Doxorubicin|doxorubicin|mesh-list
154261567|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154261568|NCT01779050|Fluorouracil|fluorouracil|mesh-list
154261569|NCT01779050|Trastuzumab|trastuzumab|mesh-list
154261570|NCT01779050|Epirubicin|epirubicin|mesh-list
154261571|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154261572|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261573|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
154261574|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
154261575|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
154261576|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261577|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154261578|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
154261579|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261580|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154261581|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154261582|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
154261583|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153958768|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
153958769|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153958770|NCT00915733|Protective Agents|protective agents|mesh-ancestor
153958771|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153958772|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153958773|NCT00913770|Buprenorphine|buprenorphine|mesh-list
153958774|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153958775|NCT00913770|Narcotics|narcotics|mesh-ancestor
153958776|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958777|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958778|NCT00913770|Analgesics|analgesics|mesh-ancestor
153958779|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
154261584|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154261585|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154261586|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154261587|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261588|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
154261589|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154261590|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261591|NCT03841136|Etoposide|etoposide|mesh-list
154261592|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154261593|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261594|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154261595|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154261596|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261597|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261598|NCT05669768|Tamoxifen|tamoxifen|mesh-list
154261599|NCT05669768|Pamiparib|pamiparib|mesh-list
154261600|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154261601|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
154261602|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261603|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261604|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154261605|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261606|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154261607|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154261608|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154261609|NCT05669768|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154261610|NCT05669768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261611|NCT05669768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261612|NCT00306527|Vaccines|vaccines|mesh-list
154261613|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
154261614|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261615|NCT01066247|Midazolam|midazolam|mesh-list
154261616|NCT01066247|Morphine|morphine|mesh-list
154261617|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154261622|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
154261623|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261624|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154261625|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154261626|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154261627|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154261628|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154261629|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154261630|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
154261631|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
154261632|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
154261633|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
154261634|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261635|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261636|NCT00306293|Valacyclovir|valacyclovir|mesh-list
154261637|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
154261638|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261639|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
154261640|NCT03980951|Narcotics|narcotics|mesh-ancestor
154261641|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261642|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261643|NCT03980951|Analgesics|analgesics|mesh-ancestor
154261644|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
154261645|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261646|NCT02532491|Risperidone|risperidone|mesh-list
154261647|NCT02532491|Aripiprazole|aripiprazole|mesh-list
154261648|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154261649|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
154261650|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261651|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261652|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261653|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154261654|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154261664|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154261665|NCT01066403|Pergolide|pergolide|mesh-list
154261666|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
154261667|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
154261668|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261669|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261670|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261671|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154261672|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154261673|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261674|NCT00294671|Diflunisal|diflunisal|mesh-list
154261675|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154261676|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154261677|NCT00294671|Analgesics|analgesics|mesh-ancestor
154261678|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
154261679|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261680|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261681|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154261682|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154261683|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154261684|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261685|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261686|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154261687|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154261688|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261689|NCT03980249|Carvedilol|carvedilol|mesh-list
154261690|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154261691|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154261692|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
154261693|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261705|NCT01495598|Pomalidomide|pomalidomide|mesh-list
154261706|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
154261707|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261708|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154261709|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154261710|NCT01495598|Growth Substances|growth substances|mesh-ancestor
154261711|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
154261712|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261713|NCT01297166|Calcitriol|calcitriol|mesh-list
154261714|NCT01297166|Calcipotriene|calcipotriene|mesh-list
154261715|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
154261716|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154261717|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261718|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154261719|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261720|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261721|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154261722|NCT01297166|Vitamins|vitamins|mesh-ancestor
154261723|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
154261724|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154261725|NCT01202474|Insulin|insulin|mesh-list
154261726|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154261727|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
154261728|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
154261729|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261730|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261731|NCT05667818|Norfloxacin|norfloxacin|mesh-list
154261732|NCT05667818|Amlodipine|amlodipine|mesh-list
154261733|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154261734|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154261735|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261738|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261748|NCT01205204|Clonidine|clonidine|mesh-list
154261749|NCT01205204|Fentanyl|fentanyl|mesh-list
154261750|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154261751|NCT01205204|Narcotics|narcotics|mesh-ancestor
154261752|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261753|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261754|NCT01205204|Analgesics|analgesics|mesh-ancestor
154261755|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
154261756|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261757|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154261758|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153958780|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958781|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153958782|NCT00912912|Sunitinib|sunitinib|mesh-list
153958783|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716422|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153958784|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958785|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958786|NCT00912912|Growth Substances|growth substances|mesh-ancestor
153958787|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958788|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958789|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958790|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958791|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958793|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
153958794|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958795|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958796|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958797|NCT00784927|Dexamethasone|dexamethasone|mesh-list
153958798|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
153958799|NCT00784927|Rituximab|rituximab|mesh-list
153958800|NCT00784927|Lenalidomide|lenalidomide|mesh-list
153958801|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958802|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
153958803|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958804|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153958805|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153958806|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
153958807|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958808|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958809|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153958810|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153958832|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958833|NCT04203342|Ketoconazole|ketoconazole|mesh-list
153958834|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
153958835|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958836|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153958837|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153958838|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958839|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958840|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153958841|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
153958842|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958843|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958844|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153958845|NCT04834206|Docetaxel|docetaxel|mesh-list
153958846|NCT04834206|Fluorouracil|fluorouracil|mesh-list
153958847|NCT04834206|Nedaplatin|nedaplatin|mesh-list
153958848|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958849|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153958850|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153958851|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153958852|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958853|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
154261760|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
153958854|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153958855|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958856|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
153958857|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958858|NCT00631722|Haloperidol|haloperidol|mesh-list
153958859|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
153958860|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
153958861|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
153716432|NCT00347542|Vitamin D|vitamin d|mesh-list
153958880|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
153958881|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
153958882|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153958883|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
153958884|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958885|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958887|NCT00779467|Bupivacaine|bupivacaine|mesh-list
153958888|NCT00779467|Neostigmine|neostigmine|mesh-list
153958889|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
153958890|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
153958891|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958892|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958893|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
153958894|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958895|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153958896|NCT00779467|Narcotics|narcotics|mesh-ancestor
153958897|NCT00779467|Analgesics|analgesics|mesh-ancestor
153958898|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153958899|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153958900|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
153958901|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153958902|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958903|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958904|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
153958905|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958906|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153958907|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
153958908|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
153958909|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
153958910|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958911|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
153958912|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958913|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958914|NCT00778921|Amlodipine|amlodipine|mesh-list
153958915|NCT00778921|Aliskiren|aliskiren|mesh-list
153958916|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153958917|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153958936|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153958937|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958938|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958939|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153958940|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
153958941|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958942|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958943|NCT00632268|Leucovorin|leucovorin|mesh-list
153958944|NCT00632268|Everolimus|everolimus|mesh-list
153958945|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958946|NCT00632268|Antidotes|antidotes|mesh-ancestor
153958947|NCT00632268|Protective Agents|protective agents|mesh-ancestor
153958948|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958949|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
153958950|NCT00632268|Vitamins|vitamins|mesh-ancestor
153958951|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
153958952|NCT00632268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153958953|NCT00632268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958954|NCT00632268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958955|NCT00632268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958956|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958957|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
153958958|NCT04145076|Citalopram|citalopram|mesh-list
153958959|NCT04145076|Tianeptine|tianeptine|mesh-list
153958960|NCT04145076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153958961|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153958962|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261761|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154261762|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
154261763|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
154261764|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154261765|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154261766|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154261767|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
154261768|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904832|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154261769|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261770|NCT01205282|Pioglitazone|pioglitazone|mesh-list
154261771|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261772|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261773|NCT01205360|Fentanyl|fentanyl|mesh-list
154261774|NCT01205360|Bupivacaine|bupivacaine|mesh-list
154261775|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
154261776|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
154261777|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261778|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261779|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
154261780|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261781|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154261782|NCT01205360|Narcotics|narcotics|mesh-ancestor
154261783|NCT01205360|Analgesics|analgesics|mesh-ancestor
154261784|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154008733|NCT04239560|Boron|boron|mesh-list
154261785|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154261786|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
154261787|NCT01200914|Heparin|heparin|mesh-list
154261788|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
154261789|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154261790|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154261791|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261792|NCT01205516|Morphine|morphine|mesh-list
154261793|NCT01205516|Methadone|methadone|mesh-list
154261794|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154261803|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
154261804|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154261805|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154261806|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154261807|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154261808|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261809|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
154261810|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154261811|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261812|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154261813|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261814|NCT01201070|Antithrombins|antithrombins|mesh-list
154261815|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
154261816|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154261817|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
154261818|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261819|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261820|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
154261821|NCT01205672|Metformin|metformin|mesh-list
154261822|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261823|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261824|NCT01205750|Insulin|insulin|mesh-list
154261825|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154261826|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261827|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261828|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
154261829|NCT03012386|Citric Acid|citric acid|mesh-list
154261830|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
154261831|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
154261832|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154261833|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
154261834|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
154261846|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154261847|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154261848|NCT01205984|Prednisolone|prednisolone|mesh-list
154261849|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
154261850|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154261851|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
154261852|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154261853|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
154261854|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
154261855|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154261856|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261857|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154261858|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
154261859|NCT01205984|Hormones|hormones|mesh-ancestor
154261860|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261861|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154261862|NCT01205984|Protective Agents|protective agents|mesh-ancestor
154261863|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154261864|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261865|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261866|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261867|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154261868|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261869|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261870|NCT01297946|Hormones|hormones|mesh-list
154261871|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261872|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261873|NCT03211858|Insulin|insulin|mesh-list
153958963|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958964|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958965|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
153958966|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958967|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153958968|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
153958969|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153958970|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153958971|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
153958972|NCT00707902|Lidocaine|lidocaine|mesh-list
153958973|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
153958992|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958993|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958994|NCT00833794|Analgesics|analgesics|mesh-ancestor
153958995|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
153958996|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958997|NCT00778375|Cytarabine|cytarabine|mesh-list
154261874|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154261875|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
154261876|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
154261877|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
154261878|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154261879|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154261880|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261881|NCT01298180|Hormones|hormones|mesh-list
154261882|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154261883|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261884|NCT03211156|Amoxicillin|amoxicillin|mesh-list
154261885|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261886|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261887|NCT01298258|Aliskiren|aliskiren|mesh-list
154261888|NCT01298258|Renin Inhibitors|renin inhibitors|mesh-ancestor
154261889|NCT01298258|Protease Inhibitors|protease inhibitors|mesh-ancestor
154261890|NCT01298258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261891|NCT01298258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261892|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
154261893|NCT01298336|Clarithromycin|clarithromycin|mesh-list
154261894|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261895|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261896|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154261897|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154261898|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261899|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261921|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261922|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261923|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
154261924|NCT03236506|Grazoprevir|grazoprevir|mesh-list
154261925|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154261926|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
154261927|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261928|NCT01298882|Diacerein|diacerein|mesh-list
154261929|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154261930|NCT01206530|Leucovorin|leucovorin|mesh-list
154261931|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
154261932|NCT01206530|Bevacizumab|bevacizumab|mesh-list
154261933|NCT01206530|Fluorouracil|fluorouracil|mesh-list
154261934|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
154261935|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154261936|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261937|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154261938|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154261939|NCT01206530|Growth Substances|growth substances|mesh-ancestor
154261940|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734574|NCT06120972|Olaparib|olaparib|mesh-list
153734575|NCT06120972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153958998|NCT00778375|Decitabine|decitabine|mesh-list
153958999|NCT00778375|Clofarabine|clofarabine|mesh-list
153959000|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153959001|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
153959002|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959003|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959004|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
153959005|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959006|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959007|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
153959008|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959010|NCT04102267|Epinephrine|epinephrine|mesh-list
153959011|NCT04102267|Bupivacaine|bupivacaine|mesh-list
153959012|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
153959013|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
153959014|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959015|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959016|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
153959017|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959018|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153959019|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153959020|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
153959021|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959022|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959023|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153959024|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153959025|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
153959026|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153959027|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
153959028|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
153959029|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
153959030|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154261942|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
154261943|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261944|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154261945|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154261946|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
154261947|NCT01206530|Antidotes|antidotes|mesh-ancestor
154261948|NCT01206530|Protective Agents|protective agents|mesh-ancestor
154261949|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
154261950|NCT01206530|Vitamins|vitamins|mesh-ancestor
154261951|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
154261952|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
154261953|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154261954|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154261955|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154261956|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261957|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154261958|NCT03209518|Leuprolide|leuprolide|mesh-list
154261959|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154261960|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
154261961|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154261962|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261963|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154261964|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261965|NCT01201538|Nilotinib|nilotinib|mesh-list
154261966|NCT01201538|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154261967|NCT01201538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154261968|NCT01201538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261969|NCT01201538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261970|NCT05282420|Ranibizumab|ranibizumab|mesh-list
154261971|NCT05282420|Aflibercept|aflibercept|mesh-list
153959059|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959060|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959061|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153959062|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153959064|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
153959065|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959066|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959067|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
153959068|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
153959069|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153959070|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153959071|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153959072|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
153959073|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154261972|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154261973|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154261974|NCT05282420|Growth Substances|growth substances|mesh-ancestor
154261975|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261976|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
154261977|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261978|NCT00304031|Temozolomide|temozolomide|mesh-list
154261979|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154261980|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
154261981|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261982|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154261983|NCT01567124|Moxonidine|moxonidine|mesh-list
154261984|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154261985|NCT01299194|Atorvastatin|atorvastatin|mesh-list
154261986|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154261987|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154261988|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
154261989|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154261990|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154261991|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154261992|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154261993|NCT03827408|Midazolam|midazolam|mesh-list
154261994|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
154261995|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154261996|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154261997|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154261998|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154261999|NCT03827408|Analgesics|analgesics|mesh-ancestor
154262000|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
154262001|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262002|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154262003|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154262004|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154262005|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
153959075|NCT00916123|Docetaxel|docetaxel|mesh-list
154262010|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154262011|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154262012|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154262013|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
154262014|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
154262015|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
154262016|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
154262017|NCT00332189|Verapamil|verapamil|mesh-list
154262018|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154262019|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154262020|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154262021|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262022|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154262023|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262024|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
154262025|NCT01206998|Progesterone|progesterone|mesh-list
154262026|NCT01206998|Progestins|progestins|mesh-ancestor
154262027|NCT01206998|Hormones|hormones|mesh-ancestor
154262028|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262029|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262030|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154262031|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154262032|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154262035|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262058|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262059|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262060|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262061|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262062|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262063|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262064|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262065|NCT01201928|Insulin|insulin|mesh-list
154262066|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154262067|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262068|NCT00303719|Cyclosporine|cyclosporine|mesh-list
154262069|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
154262070|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
154262071|NCT00303719|Fludarabine|fludarabine|mesh-list
154262072|NCT00303719|Cyclosporins|cyclosporins|mesh-list
154262073|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154262074|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262075|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
154262076|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262077|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262078|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154262079|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
154262080|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262081|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262082|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154262107|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262108|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262109|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
154262110|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262111|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262112|NCT00331409|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154262113|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154262114|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154262115|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154262116|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
154262117|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262118|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154262119|NCT01064921|Vorinostat|vorinostat|mesh-list
153734766|NCT05886972|Anesthetics, General|anesthetics, general|mesh-ancestor
153734767|NCT05886972|Anesthetics|anesthetics|mesh-ancestor
153734768|NCT05878522|Moxifloxacin|moxifloxacin|mesh-list
153959076|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959077|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
153959078|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
153959079|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
153959080|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959081|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153959093|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959094|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959095|NCT00833638|Urological Agents|urological agents|mesh-ancestor
153959096|NCT01041404|Capecitabine|capecitabine|mesh-list
153959097|NCT01041404|Fluorouracil|fluorouracil|mesh-list
153959098|NCT01041404|Trastuzumab|trastuzumab|mesh-list
153959099|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959100|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153959101|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
153959102|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959103|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959104|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
153959105|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959106|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959107|NCT00777049|Panobinostat|panobinostat|mesh-list
153959108|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959109|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153959110|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959111|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959113|NCT00774787|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153959114|NCT00774787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959115|NCT00774787|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153959116|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
153959117|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959118|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153959119|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959120|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
153959121|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
153959122|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959123|NCT01040780|Gefitinib|gefitinib|mesh-list
153959124|NCT01040780|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153959125|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153959126|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959127|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959128|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262120|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262121|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154262122|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262123|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262124|NCT01299662|Poly ICLC|poly iclc|mesh-list
154262125|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
154262126|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
154262127|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262128|NCT00303485|Vitamin D|vitamin d|mesh-list
154262129|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
154262130|NCT00303485|Calcium|calcium|mesh-list
154262131|NCT00303485|Vitamins|vitamins|mesh-ancestor
154262132|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
154262133|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262134|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154262135|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154262136|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
154262137|NCT03983915|Remifentanil|remifentanil|mesh-list
154262138|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154262139|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262140|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262141|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154262142|NCT03983915|Analgesics|analgesics|mesh-ancestor
154262143|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
154262144|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734781|NCT05869136|Hyaluronic Acid|hyaluronic acid|mesh-list
153959129|NCT04303988|Bevacizumab|bevacizumab|mesh-list
153959130|NCT04303988|Carboplatin|carboplatin|mesh-list
153959131|NCT04303988|Temozolomide|temozolomide|mesh-list
153959132|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959133|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959134|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153959135|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153959136|NCT04303988|Growth Substances|growth substances|mesh-ancestor
153959137|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959138|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
153959139|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153959140|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
153959141|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959142|NCT01059812|Insulin|insulin|mesh-list
153959143|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153959144|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
153959150|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959152|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153959153|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153959154|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959155|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
153959156|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
153959157|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
154262145|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154262146|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154262147|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154262148|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
154262149|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262150|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262151|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154262152|NCT03983915|Narcotics|narcotics|mesh-ancestor
154262153|NCT01300754|Lidocaine|lidocaine|mesh-list
154262154|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
154262155|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
154262156|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262157|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262158|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
154262159|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262160|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154262161|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154009092|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262162|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153959158|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959159|NCT00888381|Vaccines|vaccines|mesh-list
153959160|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
153959161|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959162|NCT00833560|Dexamethasone|dexamethasone|mesh-list
153959163|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
153959164|NCT00833560|Bortezomib|bortezomib|mesh-list
153959165|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959166|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
153959167|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959168|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959169|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153959170|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
153959171|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959172|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959173|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153959174|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153959175|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
153959176|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
153959177|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959178|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153959179|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
153959180|NCT00833560|Hormones|hormones|mesh-ancestor
153959181|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959182|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153959183|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
153959184|NCT04242927|Niacin|niacin|mesh-list
153959185|NCT04242927|Niacinamide|niacinamide|mesh-list
153959186|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
153959187|NCT04242927|Vitamins|vitamins|mesh-ancestor
153959188|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
153959189|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959190|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153959191|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
153959192|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959193|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154262163|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154262164|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262166|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262167|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154262168|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262169|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262170|NCT03840122|Anesthetics|anesthetics|mesh-list
154262171|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
154262172|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262173|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262174|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
154262175|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262176|NCT01314274|Bevacizumab|bevacizumab|mesh-list
154262177|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154262178|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262179|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154262180|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154262219|NCT01203488|Vitamins|vitamins|mesh-ancestor
154262220|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
154262221|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262222|NCT01314352|Desloratadine|desloratadine|mesh-list
154262223|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154262224|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
154262225|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262226|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262227|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262228|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154262229|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154262230|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
154262231|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
154262232|NCT03818282|Paclitaxel|paclitaxel|mesh-list
154262233|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154009167|NCT04240496|Clozapine|clozapine|mesh-list
154262234|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262235|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
154262236|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
154262237|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
154262238|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262239|NCT01300364|Citalopram|citalopram|mesh-list
154262240|NCT01300364|Reboxetine|reboxetine|mesh-list
154262241|NCT01300364|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154262242|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154262243|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154262244|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262245|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262246|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
154262247|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262248|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154262249|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
154262250|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154262251|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154262252|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
154262254|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154262255|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154262256|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
154262257|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262258|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154262259|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262260|NCT05622890|Maytansine|maytansine|mesh-list
154262261|NCT05622890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154262262|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154262263|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262264|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
154262265|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
154262266|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
154262267|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262268|NCT05622890|Immunoconjugates|immunoconjugates|mesh-ancestor
154262269|NCT05622890|Immunologic Factors|immunologic factors|mesh-ancestor
154262270|NCT05622890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262271|NCT00303329|Deferasirox|deferasirox|mesh-list
154262272|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154262273|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
154262274|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
154262275|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262276|NCT01300988|Aprepitant|aprepitant|mesh-list
154262277|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
154262278|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
154262279|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
154262280|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262281|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262282|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262283|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154262284|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262285|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262286|NCT01064999|Capecitabine|capecitabine|mesh-list
154262287|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
154262292|NCT03818048|Propofol|propofol|mesh-list
154262294|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154262295|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262296|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262297|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154262298|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
154262299|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
154262300|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154262301|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154262302|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154262303|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154262304|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154262305|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262306|NCT00329849|Vaccines|vaccines|mesh-list
154262307|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
154262308|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262309|NCT05655806|Aminophylline|aminophylline|mesh-list
154262310|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154262311|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
154262312|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262313|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262314|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154262315|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
154262316|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154262317|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154262318|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262319|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262320|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154262321|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154262322|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
154262323|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262324|NCT05655806|Protective Agents|protective agents|mesh-ancestor
153959194|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
153959195|NCT00887679|Escitalopram|escitalopram|mesh-list
153959196|NCT00887679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153959197|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153959198|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153959199|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959200|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959201|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
153959202|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262326|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
154262327|NCT01300676|Estrogens|estrogens|mesh-ancestor
154262328|NCT01300676|Hormones|hormones|mesh-ancestor
154262329|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262330|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262331|NCT01300676|Progestins|progestins|mesh-ancestor
154262332|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
154262333|NCT00329303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154262334|NCT00329303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262335|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262336|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
154262337|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262338|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262339|NCT03806816|Melatonin|melatonin|mesh-list
154262340|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
154262341|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262342|NCT03806816|Protective Agents|protective agents|mesh-ancestor
153734992|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153959203|NCT04241523|Lenvatinib|lenvatinib|mesh-list
153959204|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959205|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153959206|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959207|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959208|NCT00833482|Ritonavir|ritonavir|mesh-list
153959209|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153959210|NCT00833482|Voriconazole|voriconazole|mesh-list
153959211|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153959212|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153959238|NCT00833248|Bicalutamide|bicalutamide|mesh-list
153959239|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153959240|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959241|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
153959242|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
153959243|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959244|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959245|NCT00702130|Pravastatin|pravastatin|mesh-list
153959246|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153959247|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153959248|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
153959249|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959250|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153959251|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153959252|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959253|NCT00823264|Charcoal|charcoal|mesh-list
153959254|NCT00823264|Antidotes|antidotes|mesh-ancestor
153959255|NCT00823264|Protective Agents|protective agents|mesh-ancestor
153959256|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959257|NCT04241211|Denosumab|denosumab|mesh-list
153959258|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153959259|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959260|NCT00702442|Droperidol|droperidol|mesh-list
153716824|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959296|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959297|NCT00832624|Incretins|incretins|mesh-ancestor
153959298|NCT00832624|Hormones|hormones|mesh-ancestor
153959318|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262343|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262344|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262346|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262347|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154262348|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262349|NCT02532569|Vaccines|vaccines|mesh-list
154262350|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
154262351|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262352|NCT01302002|Metformin|metformin|mesh-list
154262353|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154262354|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262355|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154262356|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
154262357|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
154262358|NCT03814616|Artesunate|artesunate|mesh-list
154262359|NCT03814616|Pyronaridine|pyronaridine|mesh-list
154262360|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
154262361|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154262362|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154262363|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262364|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262365|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
154262366|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
154262367|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154262368|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
154262369|NCT00302159|Temozolomide|temozolomide|mesh-list
154262370|NCT00302159|Valproic Acid|valproic acid|mesh-list
154262371|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154262392|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
154262393|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
154262394|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262395|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
154262396|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262397|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
154262398|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262399|NCT00302003|Cytarabine|cytarabine|mesh-list
154262400|NCT00302003|Dexamethasone|dexamethasone|mesh-list
154262401|NCT00302003|Prednisone|prednisone|mesh-list
154262402|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
154262403|NCT00302003|Ifosfamide|ifosfamide|mesh-list
154262404|NCT00302003|Doxorubicin|doxorubicin|mesh-list
154262405|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154262406|NCT00302003|Etoposide|etoposide|mesh-list
154262407|NCT00302003|Vincristine|vincristine|mesh-list
154262408|NCT00302003|Vinorelbine|vinorelbine|mesh-list
154262409|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
154262410|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262411|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
154262412|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262413|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262414|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154262415|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
154262416|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262417|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262418|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154262419|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262420|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
154262421|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
154262422|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262423|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153735060|NCT05355441|Analgesics|analgesics|mesh-ancestor
153959320|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
153959321|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153959322|NCT00822172|Protective Agents|protective agents|mesh-ancestor
153959323|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153959324|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153959325|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959326|NCT00832000|Mexiletine|mexiletine|mesh-list
153959327|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153959328|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153959329|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154262424|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
154262425|NCT00302003|Hormones|hormones|mesh-ancestor
154262426|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262427|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154262428|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154262429|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154262430|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154262431|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262432|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154262433|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154262434|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
154262435|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
154262436|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262437|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
154262438|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
154262439|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
154262440|NCT00036270|Tamoxifen|tamoxifen|mesh-list
154262441|NCT00036270|Exemestane|exemestane|mesh-list
154262442|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154262443|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
153446570|NCT00002351|Indinavir|indinavir|mesh-list
154262444|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262445|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262446|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154262447|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262448|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154262449|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154262450|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154262451|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154262452|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154262453|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262454|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262464|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262466|NCT00301067|Temozolomide|temozolomide|mesh-list
154262467|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154262468|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
154262469|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262470|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262471|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154262472|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262473|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154262474|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154262475|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154262476|NCT00301067|Vitamins|vitamins|mesh-ancestor
154262477|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
154262478|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154262479|NCT03979859|Nafithromycin|nafithromycin|mesh-list
154262480|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154262481|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262482|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154262483|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262484|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262485|NCT03955458|Bupivacaine|bupivacaine|mesh-list
154262486|NCT03955458|Ropivacaine|ropivacaine|mesh-list
154262487|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
154262488|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
154262489|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262490|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262491|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
154262492|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262493|NCT00007020|Cholic Acids|cholic acids|mesh-list
154262494|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262495|NCT00300755|Pantoprazole|pantoprazole|mesh-list
154262496|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154262497|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262498|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154262499|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735135|NCT05306301|Ponatinib|ponatinib|mesh-list
154262500|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262501|NCT00033540|Gemcitabine|gemcitabine|mesh-list
154262502|NCT00033540|Capecitabine|capecitabine|mesh-list
154262503|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154262504|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
154262505|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262506|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262507|NCT00300365|Aspirin|aspirin|mesh-list
154262509|NCT00300365|Pioglitazone|pioglitazone|mesh-list
154262510|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154262511|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154262512|NCT00300365|Analgesics|analgesics|mesh-ancestor
154262513|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
154262514|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262515|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262516|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262517|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262518|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154262519|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154262520|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262521|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154262522|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154262523|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262524|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
154262531|NCT00300365|Vitamins|vitamins|mesh-ancestor
154262551|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262552|NCT01095822|Valsartan|valsartan|mesh-list
154262553|NCT01095822|Aliskiren|aliskiren|mesh-list
154262554|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154262555|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154262556|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154262557|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262558|NCT01095822|Renin Inhibitors|renin inhibitors|mesh-ancestor
154262559|NCT01095822|Protease Inhibitors|protease inhibitors|mesh-ancestor
154262560|NCT01095822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262561|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
154262562|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154262563|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154262564|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262565|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
154262566|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262567|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262568|NCT00300053|Lenograstim|lenograstim|mesh-list
154262569|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154262570|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
154262571|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959330|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153959331|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959332|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
153959333|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
153959334|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959335|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
153959336|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959337|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
153959338|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
153959339|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
153959340|NCT04166292|Lidocaine|lidocaine|mesh-list
153959341|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
153959342|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
153959343|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959344|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959345|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
153959346|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959347|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153959348|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153959349|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153959350|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153959371|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
153959372|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
153959373|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959374|NCT00768469|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153959375|NCT00768469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153959376|NCT00768469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959378|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153959379|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959380|NCT02825121|Trace Elements|trace elements|mesh-ancestor
153959381|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
153959382|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959383|NCT02825199|Caffeine|caffeine|mesh-list
153959384|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153959385|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959386|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153959387|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959388|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959389|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153959390|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153959391|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
153959392|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959393|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
153959394|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959395|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959396|NCT02824965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153959397|NCT02824965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959398|NCT00886743|Oprelvekin|oprelvekin|mesh-list
153959399|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959400|NCT02826759|Insulin|insulin|mesh-list
153959401|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153716970|NCT00093509|Doxorubicin|doxorubicin|mesh-list
153959420|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
153959421|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153959422|NCT02823483|Protective Agents|protective agents|mesh-ancestor
153959423|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959424|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
153959425|NCT04848597|Paclitaxel|paclitaxel|mesh-list
153959426|NCT04848597|Antibodies|antibodies|mesh-list
153959427|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153959428|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153959429|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959430|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
153959431|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
153959432|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
153959433|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959434|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959435|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
153959436|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153959438|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959439|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959440|NCT02823405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153959441|NCT02823405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959442|NCT02823249|Erythritol|erythritol|mesh-list
154262604|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
154262605|NCT03954756|Apatinib|apatinib|mesh-list
154262606|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262607|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154262608|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262609|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262610|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
154262611|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154262612|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154262613|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262614|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154262615|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154262616|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
154262617|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262618|NCT00326885|Catumaxomab|catumaxomab|mesh-list
154262619|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262620|NCT00326495|Cetuximab|cetuximab|mesh-list
154262621|NCT00326495|Sorafenib|sorafenib|mesh-list
154262622|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154262623|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262624|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154262625|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262626|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262627|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
154262628|NCT00326417|Fludarabine|fludarabine|mesh-list
153959443|NCT02823249|Tryptophan|tryptophan|mesh-list
153959444|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153959445|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
153959446|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153959447|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
153959448|NCT00768079|Benralizumab|benralizumab|mesh-list
153959449|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153959450|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
153959451|NCT02603575|Caspofungin|caspofungin|mesh-list
153959452|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
153959453|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
153959454|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
153959455|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153959456|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
153959457|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
153959458|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959459|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959461|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
153959476|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
153959477|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153959478|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959479|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959480|NCT02822157|Paclitaxel|paclitaxel|mesh-list
153959481|NCT02822157|Carboplatin|carboplatin|mesh-list
153959482|NCT02822157|Gemcitabine|gemcitabine|mesh-list
154262629|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262630|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
153735300|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153959483|NCT02822157|Doxorubicin|doxorubicin|mesh-list
153959484|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153959485|NCT02822157|Topotecan|topotecan|mesh-list
153959486|NCT02822157|Olaparib|olaparib|mesh-list
153959487|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153959488|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959489|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
153959490|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
153959491|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
153959492|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959493|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153959494|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
153959495|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153959496|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153959497|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153959498|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959499|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153959500|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153959501|NCT02822937|Triazolam|triazolam|mesh-list
153959502|NCT02822937|Methylphenidate|methylphenidate|mesh-list
153959503|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153959504|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959505|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153959506|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153959507|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153959508|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959509|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
153959510|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959511|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153959512|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153959513|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153959514|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959515|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153959516|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
153959517|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
153959518|NCT04200885|Dexamethasone|dexamethasone|mesh-list
153959519|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153959520|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153959521|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153959544|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959545|NCT02821689|Pirfenidone|pirfenidone|mesh-list
153959546|NCT02821689|Analgesics|analgesics|mesh-ancestor
153959547|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
153959548|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959549|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959550|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153959551|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153959552|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153959553|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959554|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959556|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
153959557|NCT05659407|Rituximab|rituximab|mesh-list
153959558|NCT05659407|Belimumab|belimumab|mesh-list
153959559|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959560|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959561|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
153959562|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959563|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959564|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959565|NCT00766675|Acetaminophen|acetaminophen|mesh-list
153959566|NCT00766675|Tramadol|tramadol|mesh-list
153959567|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153959568|NCT00766675|Analgesics|analgesics|mesh-ancestor
153959569|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
153959570|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959571|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959572|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
153959573|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153959574|NCT00766675|Narcotics|narcotics|mesh-ancestor
154262631|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262632|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262633|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154262634|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
154262635|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262636|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262637|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154262638|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154262639|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262640|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
154262641|NCT01060787|Hormones|hormones|mesh-ancestor
154262642|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262643|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262644|NCT01065467|Panobinostat|panobinostat|mesh-list
154262645|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262646|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154262647|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262648|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262649|NCT01065545|Clofarabine|clofarabine|mesh-list
154262650|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154262651|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
153717145|NCT00402909|Nateglinide|nateglinide|mesh-list
153959593|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959594|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153959595|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959596|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959598|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959599|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
153959600|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
153959601|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
153959602|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153959603|NCT00773383|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153959604|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153959605|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959606|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959607|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959608|NCT02818881|Methamphetamine|methamphetamine|mesh-list
153959609|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153959610|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959611|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
153959612|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
153959613|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959614|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
153959615|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959616|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959617|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
153959618|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153959619|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153959620|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153959621|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154262652|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262653|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262654|NCT03979469|Fentanyl|fentanyl|mesh-list
154262655|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
154262656|NCT03979469|Ketamine|ketamine|mesh-list
154262657|NCT03979469|Remifentanil|remifentanil|mesh-list
154262658|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154262659|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262660|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262661|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154262662|NCT03979469|Analgesics|analgesics|mesh-ancestor
154262663|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
154262664|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262665|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154262666|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154262667|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154262668|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
154262669|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262670|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262671|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154262672|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154262673|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
154262674|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
154262675|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154262676|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154262677|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154262678|NCT03979469|Narcotics|narcotics|mesh-ancestor
154262679|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154262680|NCT01060865|Aliskiren|aliskiren|mesh-list
154262681|NCT01060865|Renin Inhibitors|renin inhibitors|mesh-ancestor
154262682|NCT01060865|Protease Inhibitors|protease inhibitors|mesh-ancestor
154009622|NCT02743104|Analgesics|analgesics|mesh-ancestor
154262683|NCT01060865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262684|NCT01060865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262685|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
154262690|NCT01065701|Analgesics|analgesics|mesh-ancestor
154262691|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
154262692|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262693|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154262694|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154262695|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154262696|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
154262697|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262698|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262699|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
154262700|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262701|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
154262702|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262703|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262704|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154262705|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
154262706|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
154262707|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
154262708|NCT01065857|Citric Acid|citric acid|mesh-list
154262709|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
154262710|NCT01065857|Antacids|antacids|mesh-ancestor
154262711|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262712|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262713|NCT01065857|Cathartics|cathartics|mesh-ancestor
154262714|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
154262715|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154262716|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
154262717|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
154262718|NCT00297479|Nicotine|nicotine|mesh-list
154262719|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154262720|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
154262721|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262722|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262723|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154262728|NCT00688870|Vaccines|vaccines|mesh-list
154262731|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262732|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154262733|NCT02532335|Cathartics|cathartics|mesh-ancestor
154262734|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262735|NCT03216226|Glucagon|glucagon|mesh-list
154262736|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262737|NCT03216226|Hormones|hormones|mesh-ancestor
154262738|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262739|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262740|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
154262741|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
154262742|NCT00290771|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154262743|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154262744|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262745|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262746|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262747|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
154262748|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153735410|NCT04882202|Acetaminophen|acetaminophen|mesh-list
153959623|NCT02818803|Miconazole|miconazole|mesh-list
153959624|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959625|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
153959626|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153959627|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153959628|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959629|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959630|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153717217|NCT00094640|Olanzapine|olanzapine|mesh-list
153959651|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153959652|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
153959653|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
153959654|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153959655|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959656|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
153959657|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959658|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153959659|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959660|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153959661|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
153959662|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
153959663|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
153959664|NCT02820051|Lidocaine|lidocaine|mesh-list
153959665|NCT02820051|Midazolam|midazolam|mesh-list
153959666|NCT02820051|Nalbuphine|nalbuphine|mesh-list
153959667|NCT02820051|Propofol|propofol|mesh-list
153959668|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
153959669|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
153959670|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959671|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959672|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
153959673|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959674|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153959675|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153959676|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153959677|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154262749|NCT00290693|Docetaxel|docetaxel|mesh-list
154262750|NCT00290693|Capecitabine|capecitabine|mesh-list
154262751|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262752|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
154262753|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
154262754|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
154262755|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262756|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154262757|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
154262758|NCT06292052|Immunomodulating Agents|immunomodulating agents|mesh-list
154262759|NCT06292052|Immunologic Factors|immunologic factors|mesh-ancestor
154262760|NCT06292052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262762|NCT06291948|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154262763|NCT06291948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262764|NCT06291948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262765|NCT06291831|Ritonavir|ritonavir|mesh-list
154262766|NCT06291831|Nirmatrelvir|nirmatrelvir|mesh-list
154262767|NCT06291831|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154262768|NCT06291831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154262769|NCT06291831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154262770|NCT06291831|Protease Inhibitors|protease inhibitors|mesh-ancestor
154262771|NCT06291831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262772|NCT06291831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262773|NCT06291831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154262774|NCT06291831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153735426|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
153959678|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959679|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153959680|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153717330|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
153959681|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
153959682|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153959695|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
153959696|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959697|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153959698|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153959699|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959700|NCT00766363|Rivastigmine|rivastigmine|mesh-list
153959701|NCT00766363|Donepezil|donepezil|mesh-list
153959702|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153959703|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959704|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959705|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
153959706|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959707|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959708|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
153959709|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153959710|NCT00766363|Protective Agents|protective agents|mesh-ancestor
154262775|NCT06291831|Antiviral Agents|antiviral agents|mesh-ancestor
154262776|NCT06291831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262777|NCT06291831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154262778|NCT06291831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154262780|NCT06291727|Mepivacaine|mepivacaine|mesh-list
154262781|NCT06291727|Anesthetics, Local|anesthetics, local|mesh-ancestor
154262782|NCT06291727|Anesthetics|anesthetics|mesh-ancestor
154262783|NCT06291727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262784|NCT06291727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262785|NCT06291727|Sensory System Agents|sensory system agents|mesh-ancestor
154262786|NCT06291727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262787|NCT06291675|Hormones|hormones|mesh-list
154262788|NCT06291675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262789|NCT06291675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262790|NCT06291623|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154262791|NCT06291623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262792|NCT06291376|Ravulizumab|ravulizumab|mesh-list
154262793|NCT06291376|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154262794|NCT06291376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262795|NCT06291376|Immunologic Factors|immunologic factors|mesh-ancestor
154262796|NCT06291376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262797|NCT06291337|Ibuprofen|ibuprofen|mesh-list
153959711|NCT02636946|Bimatoprost|bimatoprost|mesh-list
153959712|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153959713|NCT02819661|Morphine|morphine|mesh-list
153959714|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959715|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959716|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153959717|NCT02819661|Narcotics|narcotics|mesh-ancestor
153959718|NCT02819661|Analgesics|analgesics|mesh-ancestor
153959719|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
153959720|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959721|NCT00765817|Exenatide|exenatide|mesh-list
153959722|NCT00765817|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153959723|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153959724|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959725|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153959726|NCT00765817|Incretins|incretins|mesh-ancestor
153959727|NCT00765817|Hormones|hormones|mesh-ancestor
153959728|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959729|NCT02818491|Dexamethasone|dexamethasone|mesh-list
153959730|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
153959731|NCT02818491|Ropivacaine|ropivacaine|mesh-list
153959732|NCT02818491|BB 1101|bb 1101|mesh-list
153959733|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153959734|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
153959735|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
153959736|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959737|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959738|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153959739|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
153959740|NCT02818491|Hormones|hormones|mesh-ancestor
153959741|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959742|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153959743|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959744|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
153959745|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959746|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959747|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
153959748|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
153959749|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959750|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
153959771|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153959772|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153959773|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959774|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153959775|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153959776|NCT00772447|Vancomycin|vancomycin|mesh-list
153959777|NCT00772447|Daptomycin|daptomycin|mesh-list
153959778|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153959779|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959780|NCT06279104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153959781|NCT06279104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959782|NCT06279104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959783|NCT06279104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959784|NCT06278948|Cysteamine|cysteamine|mesh-list
153959785|NCT06278948|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153959786|NCT06278948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959787|NCT06278896|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153959788|NCT06278896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153959789|NCT06278896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959790|NCT06278896|Antitubercular Agents|antitubercular agents|mesh-ancestor
153959791|NCT06278870|Trastuzumab|trastuzumab|mesh-list
153959792|NCT06278870|Pertuzumab|pertuzumab|mesh-list
153959793|NCT06278870|Taxane|taxane|mesh-list
153959794|NCT06278870|Disitamab vedotin|disitamab vedotin|mesh-list
153959795|NCT06278870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959796|NCT06278870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959797|NCT06278870|Immunoconjugates|immunoconjugates|mesh-ancestor
153959798|NCT06278870|Immunologic Factors|immunologic factors|mesh-ancestor
153959799|NCT06278870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959800|NCT06278857|Dostarlimab|dostarlimab|mesh-list
153959801|NCT06278857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959802|NCT06278792|Diuretics|diuretics|mesh-list
153959803|NCT06278792|Natriuretic Agents|natriuretic agents|mesh-ancestor
153959804|NCT06278792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959805|NCT06278727|Angiotensin II|angiotensin ii|mesh-list
153959806|NCT06278727|Giapreza|giapreza|mesh-list
153959821|NCT06278402|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153959822|NCT06278402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153959823|NCT06278402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959824|NCT06278402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959826|NCT06278051|Rivaroxaban|rivaroxaban|mesh-list
153959827|NCT06278051|Anticoagulants|anticoagulants|mesh-ancestor
153959828|NCT06278051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153959829|NCT06278051|Antithrombins|antithrombins|mesh-ancestor
153959830|NCT06278051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153959831|NCT06278051|Protease Inhibitors|protease inhibitors|mesh-ancestor
153959832|NCT06278051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717487|NCT00095966|Sorafenib|sorafenib|mesh-list
153959833|NCT06278051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959834|NCT06277804|Cyclophosphamide|cyclophosphamide|mesh-list
153959835|NCT06277804|Fludarabine|fludarabine|mesh-list
153959836|NCT06277804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959837|NCT06277804|Immunologic Factors|immunologic factors|mesh-ancestor
153959838|NCT06277804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959839|NCT06277804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959840|NCT06277804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153959841|NCT06277804|Alkylating Agents|alkylating agents|mesh-ancestor
153959842|NCT06277804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959843|NCT06277804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959844|NCT06277804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153959845|NCT06277635|Silymarin|silymarin|mesh-list
153959846|NCT06277635|Antioxidants|antioxidants|mesh-ancestor
153959847|NCT06277635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959848|NCT06277635|Protective Agents|protective agents|mesh-ancestor
153959849|NCT06277635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959850|NCT06277284|Penicillins|penicillins|mesh-list
153959851|NCT06277284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153959852|NCT06277284|Antibodies|antibodies|mesh-list
153959853|NCT06277284|Immunoglobulins|immunoglobulins|mesh-list
153959854|NCT06277284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153959855|NCT06277284|Immunologic Factors|immunologic factors|mesh-ancestor
153959856|NCT06277284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959857|NCT06277284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959858|NCT06277284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153959859|NCT06277284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959860|NCT06277219|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
153959861|NCT06277219|Immunologic Factors|immunologic factors|mesh-ancestor
153959862|NCT06277219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959863|NCT06277167|Interferons|interferons|mesh-list
153959864|NCT06277167|Interferon-alpha|interferon-alpha|mesh-list
153959865|NCT06277167|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153959866|NCT06277167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153959881|NCT06277154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959882|NCT06277154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153959883|NCT06277154|Alkylating Agents|alkylating agents|mesh-ancestor
153959885|NCT06277024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959886|NCT06277024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153959887|NCT06277024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959888|NCT06277024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959889|NCT06276933|Thalidomide|thalidomide|mesh-list
153959890|NCT06276933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959891|NCT06276933|Immunologic Factors|immunologic factors|mesh-ancestor
153959892|NCT06276933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959893|NCT06276933|Leprostatic Agents|leprostatic agents|mesh-ancestor
153959894|NCT06276933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153959895|NCT06276933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959896|NCT06276933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153959897|NCT06276933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153959898|NCT06276933|Growth Substances|growth substances|mesh-ancestor
153959899|NCT06276933|Growth Inhibitors|growth inhibitors|mesh-ancestor
153959900|NCT06276933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959901|NCT06276868|Letrozole|letrozole|mesh-list
153959902|NCT06276868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959903|NCT06276868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153959904|NCT06276868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153959905|NCT06276868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959906|NCT06276868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717552|NCT01726452|Carboplatin|carboplatin|mesh-list
153959907|NCT06276868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153959908|NCT06276868|Hormone Antagonists|hormone antagonists|mesh-ancestor
153959909|NCT06276868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959910|NCT06276868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959911|NCT06276556|Allopurinol|allopurinol|mesh-list
153959912|NCT06276556|Antimetabolites|antimetabolites|mesh-ancestor
153959913|NCT06276556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959914|NCT06276556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959915|NCT06276556|Gout Suppressants|gout suppressants|mesh-ancestor
153959916|NCT06276556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959917|NCT06276556|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153959918|NCT06276556|Antioxidants|antioxidants|mesh-ancestor
153959919|NCT06276556|Protective Agents|protective agents|mesh-ancestor
153959920|NCT06276556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959921|NCT06276543|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153959922|NCT06276543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959923|NCT06276504|Pembrolizumab|pembrolizumab|mesh-list
153959924|NCT06276504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959925|NCT06276504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959926|NCT06276504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153959942|NCT06276010|Heparin|heparin|mesh-list
153959943|NCT06276010|Calcium heparin|calcium heparin|mesh-list
153959944|NCT06276010|Anticoagulants|anticoagulants|mesh-ancestor
153959945|NCT06276010|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153959946|NCT06276010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153959947|NCT06276010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959948|NCT06276010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153959949|NCT06276010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153959950|NCT06276010|Analgesics|analgesics|mesh-ancestor
153959951|NCT06276010|Sensory System Agents|sensory system agents|mesh-ancestor
153959953|NCT06276010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959954|NCT06276010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153959955|NCT06276010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959956|NCT06276010|Protease Inhibitors|protease inhibitors|mesh-ancestor
153959957|NCT06276010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959958|NCT06276010|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153959959|NCT06276010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153959960|NCT06276010|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153959961|NCT06276010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959962|NCT06276010|Immunologic Factors|immunologic factors|mesh-ancestor
153959964|NCT06275555|Calcium heparin|calcium heparin|mesh-list
153959965|NCT06275555|Bivalirudin|bivalirudin|mesh-list
153959966|NCT06275555|Anticoagulants|anticoagulants|mesh-ancestor
153959967|NCT06275555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153959968|NCT06275555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153959969|NCT06275555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959970|NCT06275555|Antithrombins|antithrombins|mesh-ancestor
153959971|NCT06275555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153959972|NCT06275555|Protease Inhibitors|protease inhibitors|mesh-ancestor
153959973|NCT06275555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959974|NCT06272461|Lidocaine|lidocaine|mesh-list
153959975|NCT06272461|Ketamine|ketamine|mesh-list
153959976|NCT06272461|Anesthetics, Local|anesthetics, local|mesh-ancestor
153959977|NCT06272461|Anesthetics|anesthetics|mesh-ancestor
153959978|NCT06272461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959979|NCT06272461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959980|NCT06272461|Sensory System Agents|sensory system agents|mesh-ancestor
153959981|NCT06272461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959982|NCT06272461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153959983|NCT06272461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153717549|NCT01726452|Leucovorin|leucovorin|mesh-list
153960002|NCT06265441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153960003|NCT06265441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960004|NCT06265441|Sensory System Agents|sensory system agents|mesh-ancestor
153960005|NCT06265441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960007|NCT06260683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153960008|NCT06260683|Autonomic Agents|autonomic agents|mesh-ancestor
153960009|NCT06260683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960010|NCT06260683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960011|NCT06260683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153960012|NCT06260683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153960013|NCT06260683|Cholinergic Agents|cholinergic agents|mesh-ancestor
153960014|NCT06260683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960015|NCT06260683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960016|NCT06255951|Itraconazole|itraconazole|mesh-list
153960017|NCT06255951|Rifampin|rifampin|mesh-list
153960018|NCT06255951|Antifungal Agents|antifungal agents|mesh-ancestor
153960019|NCT06255951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960020|NCT06255951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153960021|NCT06255951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153960022|NCT06255951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960023|NCT06255951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960024|NCT06255951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153960025|NCT06255951|Hormone Antagonists|hormone antagonists|mesh-ancestor
153960026|NCT06255951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960027|NCT06255951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960028|NCT06255951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153960029|NCT06255951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153960030|NCT06255951|Antitubercular Agents|antitubercular agents|mesh-ancestor
153960031|NCT06255951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153960032|NCT06255951|Leprostatic Agents|leprostatic agents|mesh-ancestor
153960033|NCT06255951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153960034|NCT06255951|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153960035|NCT06255951|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153717608|NCT00096512|Sorafenib|sorafenib|mesh-list
153960044|NCT06233695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960045|NCT06233695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153960046|NCT06233695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960047|NCT06220162|Azacitidine|azacitidine|mesh-list
153960048|NCT06220162|Venetoclax|venetoclax|mesh-list
154262799|NCT06291337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154262800|NCT06291337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154262801|NCT06291337|Analgesics|analgesics|mesh-ancestor
154262802|NCT06291337|Sensory System Agents|sensory system agents|mesh-ancestor
154262803|NCT06291337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262804|NCT06291337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262805|NCT06291337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262806|NCT06291337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262807|NCT06291337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154262808|NCT06291337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262809|NCT06291337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262810|NCT06291337|Gout Suppressants|gout suppressants|mesh-ancestor
154262811|NCT06291285|Decitabine|decitabine|mesh-list
154262812|NCT06291285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154262813|NCT06291285|Antimetabolites|antimetabolites|mesh-ancestor
154262814|NCT06291285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262815|NCT06291285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262816|NCT06291285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262817|NCT06291272|Psyllium|psyllium|mesh-list
154262818|NCT06291272|Cathartics|cathartics|mesh-ancestor
154262819|NCT06291272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154262820|NCT06291220|Obinutuzumab|obinutuzumab|mesh-list
154262821|NCT06291220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154262822|NCT06291220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262823|NCT06291181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154262824|NCT06291181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153735473|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153960049|NCT06220162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960050|NCT06220162|Antimetabolites|antimetabolites|mesh-ancestor
153960051|NCT06220162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960052|NCT06220162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717734|NCT00431080|Paclitaxel|paclitaxel|mesh-list
153960061|NCT06214910|Antimetabolites|antimetabolites|mesh-ancestor
153960062|NCT06214910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960063|NCT06214910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153960064|NCT06214910|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153960065|NCT06214910|Leprostatic Agents|leprostatic agents|mesh-ancestor
153960074|NCT06181305|Letrozole|letrozole|mesh-list
153960075|NCT06181305|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153960076|NCT06181305|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153960077|NCT06181305|Estradiol|estradiol|mesh-list
153960078|NCT06181305|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153960079|NCT06181305|Estrogens|estrogens|mesh-ancestor
153960080|NCT06181305|Hormones|hormones|mesh-ancestor
153960081|NCT06181305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154262825|NCT06291155|Canagliflozin|canagliflozin|mesh-list
154262826|NCT06291155|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154262827|NCT06291155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262828|NCT06291155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154262829|NCT06291155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262830|NCT06291116|Rotigotine|rotigotine|mesh-list
154262831|NCT06291116|Dopamine Agonists|dopamine agonists|mesh-ancestor
154262832|NCT06291116|Dopamine Agents|dopamine agents|mesh-ancestor
154262833|NCT06291116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154262834|NCT06291116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262835|NCT06291116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262837|NCT06291103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153960082|NCT06181305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960083|NCT06181305|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153960084|NCT06181305|Contraceptive Agents|contraceptive agents|mesh-ancestor
153960085|NCT06181305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153960086|NCT06181305|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153960087|NCT06181305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960088|NCT06181305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153960089|NCT06181305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153960090|NCT06181305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960091|NCT06181305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960092|NCT06181305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153960093|NCT06181305|Hormone Antagonists|hormone antagonists|mesh-ancestor
153960094|NCT06135493|Losartan|losartan|mesh-list
153960095|NCT06135493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153960096|NCT06135493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153960097|NCT06135493|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153960098|NCT06135493|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153960099|NCT06135493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960100|NCT06115499|Paclitaxel|paclitaxel|mesh-list
153960101|NCT06115499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153960102|NCT06115499|Gemcitabine|gemcitabine|mesh-list
153960103|NCT06115499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153960104|NCT06115499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960105|NCT06115499|Tubulin Modulators|tubulin modulators|mesh-ancestor
153960106|NCT06115499|Antimitotic Agents|antimitotic agents|mesh-ancestor
153960107|NCT06115499|Mitosis Modulators|mitosis modulators|mesh-ancestor
153960108|NCT06115499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960109|NCT06115499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960110|NCT06115499|Antimetabolites|antimetabolites|mesh-ancestor
153960111|NCT06109779|Gemcitabine|gemcitabine|mesh-list
153960112|NCT06109779|Capecitabine|capecitabine|mesh-list
153960113|NCT06109779|Tegafur|tegafur|mesh-list
153960114|NCT06109779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960115|NCT06109779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960116|NCT06109779|Antimetabolites|antimetabolites|mesh-ancestor
153717657|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
153960140|NCT06087328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960141|NCT06087328|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153960142|NCT06087328|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153960143|NCT06087328|Cholinergic Agents|cholinergic agents|mesh-ancestor
153960144|NCT06087328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960145|NCT06087328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960147|NCT06074185|Bromides|bromides|mesh-list
153960148|NCT06074185|Ipratropium|ipratropium|mesh-list
153960149|NCT06074185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153960150|NCT06074185|Antiemetics|antiemetics|mesh-ancestor
153960151|NCT06074185|Autonomic Agents|autonomic agents|mesh-ancestor
153960152|NCT06074185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960153|NCT06074185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262838|NCT06291103|Immunologic Factors|immunologic factors|mesh-ancestor
154262839|NCT06291103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262840|NCT06291103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154262841|NCT06291103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262842|NCT06291103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262844|NCT06291077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154262845|NCT06291077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262846|NCT06291077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154262847|NCT06291077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262848|NCT06291077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262849|NCT06291077|Immunologic Factors|immunologic factors|mesh-ancestor
154262850|NCT06291077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262851|NCT06291077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262852|NCT06291064|Cyclophosphamide|cyclophosphamide|mesh-list
154262853|NCT06291064|Carboplatin|carboplatin|mesh-list
154262854|NCT06291064|Docetaxel|docetaxel|mesh-list
154262855|NCT06291064|Capecitabine|capecitabine|mesh-list
154262856|NCT06291064|Epirubicin|epirubicin|mesh-list
154262857|NCT06291064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154262858|NCT06291064|Immunologic Factors|immunologic factors|mesh-ancestor
154262859|NCT06291064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262860|NCT06291064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154262861|NCT06291064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154262862|NCT06291064|Alkylating Agents|alkylating agents|mesh-ancestor
154262863|NCT06291064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262864|NCT06291064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262865|NCT06291064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154262866|NCT06291064|Tubulin Modulators|tubulin modulators|mesh-ancestor
154262867|NCT06291064|Antimitotic Agents|antimitotic agents|mesh-ancestor
154262868|NCT06291064|Mitosis Modulators|mitosis modulators|mesh-ancestor
154262869|NCT06291064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960154|NCT06074185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153960155|NCT06074185|Glucocorticoids|glucocorticoids|mesh-ancestor
153960156|NCT06074185|Hormones|hormones|mesh-ancestor
153960157|NCT06074185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960158|NCT06074185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960159|NCT06074185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960160|NCT06074185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960161|NCT06074185|Anticonvulsants|anticonvulsants|mesh-ancestor
153960162|NCT06074185|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154262870|NCT06291064|Antimetabolites|antimetabolites|mesh-ancestor
154262871|NCT06291064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154262872|NCT06291064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154262873|NCT06291064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154262874|NCT06291064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262875|NCT06291012|Amoxicillin|amoxicillin|mesh-list
154262876|NCT06291012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154262877|NCT06291012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262878|NCT06290713|Tadalafil|tadalafil|mesh-list
154262879|NCT06290713|Vasodilator Agents|vasodilator agents|mesh-ancestor
154262880|NCT06290713|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154262881|NCT06290713|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154262882|NCT06290713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262883|NCT06290713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262884|NCT06290713|Urological Agents|urological agents|mesh-ancestor
154262885|NCT06290531|Anesthetics|anesthetics|mesh-list
154262886|NCT06290531|Benzocaine|benzocaine|mesh-list
154262887|NCT06290531|Anesthetics, Local|anesthetics, local|mesh-list
154262888|NCT06290531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735545|NCT04694183|Antimetabolites|antimetabolites|mesh-ancestor
153960163|NCT06074185|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153960164|NCT06074185|Respiratory System Agents|respiratory system agents|mesh-ancestor
153960165|NCT06074185|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153960166|NCT06074185|Cholinergic Agents|cholinergic agents|mesh-ancestor
153960203|NCT06049797|Antidepressive Agents|antidepressive agents|mesh-ancestor
153960204|NCT06049797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153960205|NCT06049797|Sympatholytics|sympatholytics|mesh-ancestor
153960253|NCT05918328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960254|NCT05918328|Tubulin Modulators|tubulin modulators|mesh-ancestor
153960255|NCT05918328|Antimitotic Agents|antimitotic agents|mesh-ancestor
153960256|NCT05918328|Mitosis Modulators|mitosis modulators|mesh-ancestor
153960257|NCT05918328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960258|NCT05918328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960259|NCT05906914|Cytarabine|cytarabine|mesh-list
153960260|NCT05906914|Cladribine|cladribine|mesh-list
153960261|NCT05906914|Homoharringtonine|homoharringtonine|mesh-list
153960262|NCT05906914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960263|NCT05906914|Antimetabolites|antimetabolites|mesh-ancestor
153960264|NCT05906914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960265|NCT05906914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960266|NCT05906914|Antiviral Agents|antiviral agents|mesh-ancestor
153960267|NCT05906914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960268|NCT05906914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153960269|NCT05906914|Immunologic Factors|immunologic factors|mesh-ancestor
153960270|NCT05906914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960271|NCT05906914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153960272|NCT05906914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153960273|NCT05906914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960274|NCT05903131|Levonorgestrel|levonorgestrel|mesh-list
153960275|NCT05903131|Progestins|progestins|mesh-list
153960277|NCT05903131|Contraceptive Agents|contraceptive agents|mesh-ancestor
153960278|NCT05903131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153717934|NCT00131040|Aprotinin|aprotinin|mesh-list
153960279|NCT05903131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960280|NCT05903131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153960281|NCT05903131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153960283|NCT05903131|Hormones|hormones|mesh-ancestor
153960284|NCT05903131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960285|NCT05873751|Vaccines|vaccines|mesh-list
153960286|NCT05873751|Immunologic Factors|immunologic factors|mesh-ancestor
153960287|NCT05873751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960288|NCT05871424|Buprenorphine|buprenorphine|mesh-list
153960289|NCT05871424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153960290|NCT05871424|Narcotics|narcotics|mesh-ancestor
153960291|NCT05871424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153960292|NCT05871424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960293|NCT05871424|Analgesics|analgesics|mesh-ancestor
153960294|NCT05871424|Sensory System Agents|sensory system agents|mesh-ancestor
153960295|NCT05871424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960296|NCT05871424|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153960297|NCT05844046|Bevacizumab|bevacizumab|mesh-list
153960298|NCT05844046|Durvalumab|durvalumab|mesh-list
153960299|NCT05844046|Tremelimumab|tremelimumab|mesh-list
153960300|NCT05844046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960301|NCT05844046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960302|NCT05844046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153960303|NCT05844046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153960304|NCT05844046|Growth Substances|growth substances|mesh-ancestor
153960305|NCT05844046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960306|NCT05844046|Growth Inhibitors|growth inhibitors|mesh-ancestor
153960307|NCT05843786|Interferons|interferons|mesh-list
153960308|NCT05843786|Interferon-gamma|interferon-gamma|mesh-list
153960309|NCT05843786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960338|NCT05751226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960339|NCT05718856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153960340|NCT05718856|Antibodies|antibodies|mesh-list
153960341|NCT05718856|Immunoglobulins|immunoglobulins|mesh-list
153960342|NCT05718856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153960343|NCT05718856|Immunologic Factors|immunologic factors|mesh-ancestor
153960344|NCT05718856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960345|NCT05718856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960346|NCT05700630|Vorinostat|vorinostat|mesh-list
153960347|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960348|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153960349|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960350|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718005|NCT00097760|Natalizumab|natalizumab|mesh-list
153717913|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960386|NCT05533632|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153960388|NCT05533632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717957|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
153960415|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960416|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153960417|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153960418|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153960419|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153960420|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
153960421|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960422|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153960423|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153718078|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153960424|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960425|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960426|NCT05480072|Hormones|hormones|mesh-ancestor
153960427|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960428|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
153960429|NCT05474690|Carboplatin|carboplatin|mesh-list
153960430|NCT05474690|Docetaxel|docetaxel|mesh-list
153960431|NCT05474690|Trastuzumab|trastuzumab|mesh-list
153960432|NCT05474690|Epirubicin|epirubicin|mesh-list
153960433|NCT05474690|Pertuzumab|pertuzumab|mesh-list
153960434|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153960435|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
153960436|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960437|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153960438|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153960439|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
153960440|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960441|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960442|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153960455|NCT05405595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262889|NCT06290531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262890|NCT06290531|Sensory System Agents|sensory system agents|mesh-ancestor
154262891|NCT06290531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262892|NCT06290505|Durvalumab|durvalumab|mesh-list
154262893|NCT06290505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154262894|NCT06290505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262895|NCT06290219|Zinc|zinc|mesh-list
154262896|NCT06290219|Ethanol|ethanol|mesh-list
154262897|NCT06290219|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
154262898|NCT06290219|Hyaluronic Acid|hyaluronic acid|mesh-list
154262899|NCT06290219|Trace Elements|trace elements|mesh-ancestor
154262900|NCT06290219|Micronutrients|micronutrients|mesh-ancestor
154262901|NCT06290219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262902|NCT06290219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154262903|NCT06290219|Immunologic Factors|immunologic factors|mesh-ancestor
154262904|NCT06290219|Viscosupplements|viscosupplements|mesh-ancestor
153960456|NCT05371223|Gemcitabine|gemcitabine|mesh-list
153960457|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153960458|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960459|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
153960460|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960461|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960462|NCT05310591|Nivolumab|nivolumab|mesh-list
153960463|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960464|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960465|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153960466|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960467|NCT05296837|Doxycycline|doxycycline|mesh-list
153960468|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153960469|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960470|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
153960471|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153960472|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153960473|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153960474|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
153960475|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960476|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
153960477|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960478|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960479|NCT05277402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153960480|NCT05277402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960481|NCT05259800|Peppermint oil|peppermint oil|mesh-list
153960482|NCT05259800|Mineral Oil|mineral oil|mesh-list
153960483|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
153960484|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
153960485|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960486|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960487|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153960488|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
153960489|NCT05259800|Emollients|emollients|mesh-ancestor
153960490|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
153960491|NCT05252416|Carboplatin|carboplatin|mesh-list
153960492|NCT05252416|Fulvestrant|fulvestrant|mesh-list
153960493|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960494|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960495|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153960497|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
153960498|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960499|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960500|NCT05247125|Melatonin|melatonin|mesh-list
153960501|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960502|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
153960503|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960504|NCT05247125|Protective Agents|protective agents|mesh-ancestor
153718053|NCT00432757|Ketotifen|ketotifen|mesh-list
153960536|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153960537|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153960538|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153960539|NCT05184101|Heparin|heparin|mesh-list
153960540|NCT05184101|Calcium heparin|calcium heparin|mesh-list
153960541|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
153960542|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153960543|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153960544|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960545|NCT05173896|Tadalafil|tadalafil|mesh-list
153960546|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
153960547|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153960548|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153960570|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
153960571|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
153960572|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
153960573|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153960574|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153960575|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960576|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960577|NCT05149768|Immunotoxins|immunotoxins|mesh-ancestor
153960578|NCT05149768|Immunoconjugates|immunoconjugates|mesh-ancestor
153960579|NCT05149768|Immunologic Factors|immunologic factors|mesh-ancestor
153960580|NCT05149768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960581|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
153960582|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153960583|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
153960584|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960585|NCT05142735|Expectorants|expectorants|mesh-ancestor
153960586|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
153960587|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153960588|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
153960589|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960590|NCT05142735|Protective Agents|protective agents|mesh-ancestor
153960591|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960592|NCT05142735|Antidotes|antidotes|mesh-ancestor
153960593|NCT05093517|Volagidemab|volagidemab|mesh-list
153960594|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153960595|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960596|NCT05092165|Methylene Blue|methylene blue|mesh-list
153960597|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960598|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960599|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
153960600|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960601|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960628|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
153960629|NCT05027594|Hormones|hormones|mesh-ancestor
153960630|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960631|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960632|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960633|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
153960634|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153960635|NCT05010772|Venetoclax|venetoclax|mesh-list
153960636|NCT05010772|Decitabine|decitabine|mesh-list
153960637|NCT05010772|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153960638|NCT05010772|Ivosidenib|ivosidenib|mesh-list
153960639|NCT05010772|Gilteritinib|gilteritinib|mesh-list
153960640|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960641|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960642|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
153960643|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960645|NCT05010772|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153960646|NCT05010772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153960647|NCT04986605|Methoxsalen|methoxsalen|mesh-list
153960648|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153718215|NCT00131391|Hormones|hormones|mesh-ancestor
153960676|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
153960677|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
153960678|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153960679|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153960680|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154262905|NCT06290219|Protective Agents|protective agents|mesh-ancestor
154009842|NCT02731950|Bupivacaine|bupivacaine|mesh-list
154262906|NCT06290219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154262907|NCT06290219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262908|NCT06290219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262909|NCT06290219|Disinfectants|disinfectants|mesh-ancestor
154262915|NCT06290102|Fluticasone|fluticasone|mesh-list
154262917|NCT06290102|Albuterol|albuterol|mesh-list
154262918|NCT06290102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154262919|NCT06290102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154262920|NCT06290102|Autonomic Agents|autonomic agents|mesh-ancestor
154262921|NCT06290102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262922|NCT06290102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262923|NCT06290102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154262924|NCT06290102|Respiratory System Agents|respiratory system agents|mesh-ancestor
154262925|NCT06290102|Dermatologic Agents|dermatologic agents|mesh-ancestor
154262926|NCT06290102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154262927|NCT06290102|Tocolytic Agents|tocolytic agents|mesh-ancestor
154262928|NCT06290102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154262929|NCT06290102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154262930|NCT06290102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154262931|NCT06290102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154262932|NCT06290102|Adrenergic Agents|adrenergic agents|mesh-ancestor
154262933|NCT06290102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905515|NCT02879097|Bevacizumab|bevacizumab|mesh-list
154262934|NCT06290102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960681|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153960682|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960683|NCT04895488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153960684|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153960685|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153960686|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960687|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960688|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
153960689|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153960690|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153960691|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153960692|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153960693|NCT04740008|Nicotine|nicotine|mesh-list
153960694|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153960695|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
153960696|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960697|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960698|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153960718|NCT04699188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960719|NCT04686786|PF-06372865|pf-06372865|mesh-list
153960720|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
153960721|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
153960722|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960723|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960724|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960725|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153960726|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
153960727|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153960728|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
153960729|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153960730|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960731|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153960732|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153960733|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960734|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960735|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153960736|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153960737|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153960738|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
153960739|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
153960740|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
153960741|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153960742|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
153960743|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960745|NCT04635241|Calcium heparin|calcium heparin|mesh-list
153960746|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
153960747|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153960748|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153960749|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960750|NCT04630808|Latanoprost|latanoprost|mesh-list
153960751|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153960752|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153960753|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
153960754|NCT04617938|Narcotics|narcotics|mesh-ancestor
153960755|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153960774|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960775|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153960776|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960777|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960778|NCT04541173|Bevacizumab|bevacizumab|mesh-list
153960779|NCT04541173|Atezolizumab|atezolizumab|mesh-list
153960780|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960781|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960782|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153960783|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153960784|NCT04541173|Growth Substances|growth substances|mesh-ancestor
153960785|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960786|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
153960787|NCT04541173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153960788|NCT04541173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960789|NCT04537286|Paclitaxel|paclitaxel|mesh-list
153960790|NCT04537286|Cisplatin|cisplatin|mesh-list
153960791|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153960792|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960793|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
153960794|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
153960795|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
153960796|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960797|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
153960798|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153960799|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
153960800|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960801|NCT04520139|Expectorants|expectorants|mesh-ancestor
153960802|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
153960803|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153960804|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
153960805|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960806|NCT04520139|Protective Agents|protective agents|mesh-ancestor
153960807|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903016|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960808|NCT04520139|Antidotes|antidotes|mesh-ancestor
153960809|NCT04514029|Dexamethasone|dexamethasone|mesh-list
153960810|NCT04514029|Simvastatin|simvastatin|mesh-list
153960811|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153960812|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
153960813|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
153718362|NCT00098501|EKB 569|ekb 569|mesh-list
153960824|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
153960825|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960826|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153960827|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153960828|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960829|NCT04458116|Curcumin|curcumin|mesh-list
153960830|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153960831|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153960832|NCT04458116|Analgesics|analgesics|mesh-ancestor
153960833|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
153960834|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960835|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960836|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153960837|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153960838|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960839|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960840|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960841|NCT04411758|Propolis|propolis|mesh-list
153960842|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960843|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153960844|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153960845|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960846|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960847|NCT04378647|Immunotoxins|immunotoxins|mesh-ancestor
153960848|NCT04378647|Immunoconjugates|immunoconjugates|mesh-ancestor
153960849|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
153960850|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960851|NCT04306315|Brodalumab|brodalumab|mesh-list
153960852|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
153960853|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
153960854|NCT04267887|Prednisone|prednisone|mesh-list
153960855|NCT04267887|Cortisone|cortisone|mesh-list
153960856|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
153960857|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
153960858|NCT04267887|Hormones|hormones|mesh-list
153960859|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153960860|NCT04267887|Androgens|androgens|mesh-list
153960861|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
153960862|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153960863|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
153960864|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960865|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960866|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960867|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960868|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153960869|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960870|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960871|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
153960872|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153960873|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
153960874|NCT04267887|Protective Agents|protective agents|mesh-ancestor
153960875|NCT04267887|Vitamins|vitamins|mesh-ancestor
153960876|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
153960877|NCT04267887|Estrogens|estrogens|mesh-ancestor
153960878|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
153960903|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153960904|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153960905|NCT04126200|Growth Substances|growth substances|mesh-ancestor
153960906|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
153960907|NCT04126200|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153960908|NCT04126200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960909|NCT04126200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960910|NCT04100135|Clopidogrel|clopidogrel|mesh-list
153960911|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153960912|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153960913|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153960914|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154262936|NCT06290063|Anticonvulsants|anticonvulsants|mesh-ancestor
154262937|NCT06289946|Nitroglycerin|nitroglycerin|mesh-list
154262938|NCT06289946|Vasodilator Agents|vasodilator agents|mesh-ancestor
154262939|NCT06289868|Hepatitis A Antibodies|hepatitis a antibodies|mesh-list
154262940|NCT06289868|Immunologic Factors|immunologic factors|mesh-ancestor
154262941|NCT06289868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262942|NCT06289829|Remifentanil|remifentanil|mesh-list
154262943|NCT06289829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154262944|NCT06289829|Narcotics|narcotics|mesh-ancestor
153735611|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
153413908|NCT04326764|Panobinostat|panobinostat|mesh-list
153960915|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153960916|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
153960917|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960918|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960919|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960920|NCT04094688|Vitamin D|vitamin d|mesh-list
153960921|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
153960922|NCT04094688|Leucovorin|leucovorin|mesh-list
153960923|NCT04094688|Bevacizumab|bevacizumab|mesh-list
153960924|NCT04094688|Fluorouracil|fluorouracil|mesh-list
153960925|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
153960926|NCT04094688|Irinotecan|irinotecan|mesh-list
153960927|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
153960928|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960929|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960935|NCT04094688|Vitamins|vitamins|mesh-ancestor
153960936|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
153960937|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153960938|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153960939|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
153960940|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960941|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960942|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153960943|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
153960944|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153960945|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153960946|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960947|NCT04094688|Antidotes|antidotes|mesh-ancestor
153960948|NCT04094688|Protective Agents|protective agents|mesh-ancestor
153960949|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
153960950|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153960951|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153960952|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960953|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153960954|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
153960955|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960957|NCT04077736|Interleukin-2|interleukin-2|mesh-list
153960958|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960959|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153960960|NCT04077736|Analgesics|analgesics|mesh-ancestor
153960961|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
153960962|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960963|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960964|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153960965|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153960966|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
153960967|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960968|NCT04003805|Nicotine|nicotine|mesh-list
153960969|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153960970|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
153960971|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960972|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960973|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153960974|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153960975|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
154262945|NCT06289829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262946|NCT06289829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262947|NCT06289829|Analgesics|analgesics|mesh-ancestor
154262948|NCT06289829|Sensory System Agents|sensory system agents|mesh-ancestor
154262949|NCT06289829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262950|NCT06289790|Lidocaine|lidocaine|mesh-list
154262951|NCT06289790|Anesthetics, Local|anesthetics, local|mesh-ancestor
154262952|NCT06289790|Anesthetics|anesthetics|mesh-ancestor
154262953|NCT06289790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154262954|NCT06289790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262955|NCT06289790|Sensory System Agents|sensory system agents|mesh-ancestor
154262956|NCT06289790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154262957|NCT06289790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154262958|NCT06289790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154262959|NCT06289790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154262960|NCT06289790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154262961|NCT06289790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262962|NCT06289751|Paclitaxel|paclitaxel|mesh-list
154262963|NCT06289751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154262964|NCT06289751|Cisplatin|cisplatin|mesh-list
154262965|NCT06289751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154262966|NCT06289751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262967|NCT06289751|Tubulin Modulators|tubulin modulators|mesh-ancestor
154262968|NCT06289751|Antimitotic Agents|antimitotic agents|mesh-ancestor
154262969|NCT06289751|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735619|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153960976|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960977|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960978|NCT03998735|Lobeline|lobeline|mesh-list
153960979|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153960980|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
153960981|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960982|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960983|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153960984|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153960985|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
153960986|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960987|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960988|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
153960989|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
153960990|NCT03983850|Sirolimus|sirolimus|mesh-list
153960991|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
153960992|NCT03983850|Busulfan|busulfan|mesh-list
153960993|NCT03983850|Fludarabine|fludarabine|mesh-list
153960994|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153960995|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
153960996|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960997|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444557|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153960998|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153960999|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
153961000|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961011|NCT03899987|Interferons|interferons|mesh-list
153961012|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
153961013|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
153961014|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153961015|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961016|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
153961017|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961018|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153961019|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153961020|NCT03899987|Analgesics|analgesics|mesh-ancestor
153961021|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
153961022|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961023|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961024|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961025|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961026|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153961027|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153961028|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961029|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153961030|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153961031|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961033|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
153961034|NCT03889912|Cemiplimab|cemiplimab|mesh-list
153961035|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961036|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961037|NCT03875235|Durvalumab|durvalumab|mesh-list
153961038|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961039|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961040|NCT03862859|Warfarin|warfarin|mesh-list
153961041|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
153961042|NCT03858231|Acetaminophen|acetaminophen|mesh-list
153961043|NCT03858231|Ibuprofen|ibuprofen|mesh-list
153961044|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153961045|NCT03858231|Analgesics|analgesics|mesh-ancestor
153961046|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
153961047|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961048|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961049|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
153961050|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153961051|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961052|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961053|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153961054|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961055|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961056|NCT03841058|Abaloparatide|abaloparatide|mesh-list
153961057|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153961058|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961059|NCT03836287|Bromides|bromides|mesh-list
153961060|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
153961061|NCT03824522|BAX 855|bax 855|mesh-list
153961062|NCT03824522|Coagulants|coagulants|mesh-ancestor
153961063|NCT03769155|Nivolumab|nivolumab|mesh-list
153961064|NCT03769155|Ipilimumab|ipilimumab|mesh-list
153961065|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961066|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961067|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153961068|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961104|NCT03600883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718753|NCT04244058|Amantadine|amantadine|mesh-list
153961105|NCT03579316|Olaparib|olaparib|mesh-list
153961106|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153961107|NCT03579316|Adavosertib|adavosertib|mesh-list
153961134|NCT03576378|Analgesics|analgesics|mesh-ancestor
153961135|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
153961136|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961137|NCT03537534|Lidocaine|lidocaine|mesh-list
153961138|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
153961139|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
153961140|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961141|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961142|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
154262970|NCT06289751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262971|NCT06289647|Azithromycin|azithromycin|mesh-list
154262972|NCT06289647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154262973|NCT06289647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154262974|NCT06289478|Tranexamic Acid|tranexamic acid|mesh-list
154262975|NCT06289478|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154262976|NCT06289478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154262977|NCT06289478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262978|NCT06289478|Hemostatics|hemostatics|mesh-ancestor
154262979|NCT06289478|Coagulants|coagulants|mesh-ancestor
153961143|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961144|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153961145|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153961146|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153961147|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153961148|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961149|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
153961150|NCT03516981|Lenvatinib|lenvatinib|mesh-list
153961151|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961152|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961153|NCT03516981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153718708|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
153961164|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
153961165|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153961166|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153961167|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153961168|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961169|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961170|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153961171|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153961172|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153961173|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153961174|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
153961175|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961176|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961177|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153961178|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153961179|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
153961180|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153961181|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153961182|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
153961183|NCT03343197|Ivosidenib|ivosidenib|mesh-list
153961184|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961185|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961186|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961187|NCT03291847|Buprenorphine|buprenorphine|mesh-list
153961188|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153961189|NCT03291847|Naloxone|naloxone|mesh-list
153961190|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153961191|NCT03291847|Narcotics|narcotics|mesh-ancestor
153961192|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961193|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961194|NCT03291847|Analgesics|analgesics|mesh-ancestor
153961195|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
153961196|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961197|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153961198|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
153961199|NCT03267277|Antidotes|antidotes|mesh-ancestor
153961200|NCT03267277|Protective Agents|protective agents|mesh-ancestor
153961201|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961202|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
153961203|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961204|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
153444642|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961205|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153961206|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961207|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
153961208|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
153961209|NCT03221751|Prazosin|prazosin|mesh-list
153961210|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153961211|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153961212|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153961213|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153961214|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
153961215|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718754|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153961225|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153961226|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153961227|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153961228|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
153961229|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961230|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961231|NCT03137303|Albuterol|albuterol|mesh-list
153961232|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153961233|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
153961234|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961235|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961236|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153961237|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
153961238|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
153961239|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153961240|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153961241|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153961242|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153961243|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
153961244|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961245|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961246|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
153961247|NCT03105336|Fludarabine|fludarabine|mesh-list
153961248|NCT03105336|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153961249|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961250|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
153961251|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961252|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961253|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961254|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
153961255|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961256|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961257|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961258|NCT03105336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961259|NCT03040999|Cisplatin|cisplatin|mesh-list
153961260|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
153961261|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961262|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961263|NCT03040999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153961264|NCT03040999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961265|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
153961266|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961267|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961268|NCT03010176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153961269|NCT03010176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961270|NCT02988297|RNS60|rns60|mesh-list
153961271|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153961272|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153961273|NCT02988297|Analgesics|analgesics|mesh-ancestor
153961274|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
153961275|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961276|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961277|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718819|NCT00132600|Bacitracin|bacitracin|mesh-list
153961289|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
153961290|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961291|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961292|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
154262981|NCT06288516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154262982|NCT06288516|Respiratory System Agents|respiratory system agents|mesh-ancestor
154262983|NCT06288191|Nivolumab|nivolumab|mesh-list
154262984|NCT06288191|Relatlimab|relatlimab|mesh-list
154262985|NCT06288191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154262986|NCT06288191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262987|NCT06288191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154262988|NCT06288191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262989|NCT06285890|Azacitidine|azacitidine|mesh-list
154262990|NCT06285890|Venetoclax|venetoclax|mesh-list
154262991|NCT06285890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154262992|NCT06285890|Antimetabolites|antimetabolites|mesh-ancestor
154262993|NCT06285890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154262994|NCT06285890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154262995|NCT06285890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154262996|NCT06285760|Diuretics|diuretics|mesh-list
154262997|NCT06285760|Natriuretic Agents|natriuretic agents|mesh-ancestor
154262998|NCT06285760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154262999|NCT06285422|Cyclophosphamide|cyclophosphamide|mesh-list
154263000|NCT06285422|Fludarabine|fludarabine|mesh-list
154263001|NCT06285422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154263002|NCT06285422|Immunologic Factors|immunologic factors|mesh-ancestor
154263003|NCT06285422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263004|NCT06285422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263005|NCT06285422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961293|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961294|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961295|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961296|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
153961297|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961298|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961299|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
153961300|NCT02945566|Capecitabine|capecitabine|mesh-list
153961301|NCT02945566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961302|NCT02945566|Antimetabolites|antimetabolites|mesh-ancestor
153961303|NCT02945566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961304|NCT02945566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961305|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153961306|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153961307|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961308|NCT02876510|Aldesleukin|aldesleukin|mesh-list
153961309|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
153961310|NCT02876510|Fludarabine|fludarabine|mesh-list
153961311|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
153961312|NCT02876510|Atezolizumab|atezolizumab|mesh-list
153961313|NCT02876510|Interleukin-2|interleukin-2|mesh-list
153961314|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961315|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
154263006|NCT06285422|Alkylating Agents|alkylating agents|mesh-ancestor
154263007|NCT06285422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263008|NCT06285422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263009|NCT06285422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154263010|NCT06284434|Epinephrine|epinephrine|mesh-list
154263011|NCT06284434|Bupivacaine|bupivacaine|mesh-list
154263012|NCT06284434|Anesthetics, Local|anesthetics, local|mesh-ancestor
154263013|NCT06284434|Anesthetics|anesthetics|mesh-ancestor
154263014|NCT06284434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154263015|NCT06284434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263016|NCT06284434|Sensory System Agents|sensory system agents|mesh-ancestor
154263017|NCT06284434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263018|NCT06284434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154263019|NCT06284434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154263020|NCT06284434|Adrenergic Agents|adrenergic agents|mesh-ancestor
154263021|NCT06284434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263022|NCT06284434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961316|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961317|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961318|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961319|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
153961320|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961321|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961327|NCT02876510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153961328|NCT02876510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961329|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153961331|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
153961332|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961333|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153961334|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153961335|NCT02769962|Olaparib|olaparib|mesh-list
153961336|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153961337|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961338|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961339|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961340|NCT02766582|Paclitaxel|paclitaxel|mesh-list
153961341|NCT02766582|Carboplatin|carboplatin|mesh-list
153961342|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
153961343|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153961344|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961345|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153961346|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153961347|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153718885|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
153961363|NCT02682641|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153961364|NCT02682641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961365|NCT02682641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961366|NCT02682641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961367|NCT02553161|Escitalopram|escitalopram|mesh-list
153961368|NCT02553161|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153961369|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153961370|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153961371|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961372|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961373|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
153961374|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961375|NCT02536742|Fulvestrant|fulvestrant|mesh-list
153961376|NCT02536742|Palbociclib|palbociclib|mesh-list
153961377|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153961378|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961379|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153961380|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153961381|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
153961382|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961383|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961384|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961385|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961386|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961387|NCT02420860|Lenalidomide|lenalidomide|mesh-list
153961388|NCT02420860|Elotuzumab|elotuzumab|mesh-list
153961389|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
153961390|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961391|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153961392|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153961393|NCT02420860|Growth Substances|growth substances|mesh-ancestor
153961394|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
153961395|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961396|NCT02396979|Methadone|methadone|mesh-list
153961397|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153961398|NCT02396979|Narcotics|narcotics|mesh-ancestor
153961399|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961400|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961402|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
153961403|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961404|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
153961405|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
153961406|NCT02276495|Ketorolac|ketorolac|mesh-list
153961407|NCT02276495|Clonidine|clonidine|mesh-list
153961408|NCT02276495|Epinephrine|epinephrine|mesh-list
153961409|NCT02276495|Ropivacaine|ropivacaine|mesh-list
153961410|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
153961411|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
153961412|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961413|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961414|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
153961415|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718951|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153961428|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153961429|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153961430|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153961431|NCT02276495|Analgesics|analgesics|mesh-ancestor
153961432|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961433|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961434|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153961435|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961436|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153961437|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
153961438|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153961439|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
153961440|NCT02157324|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153961441|NCT02157324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961442|NCT02157324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961443|NCT02157324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961444|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961445|NCT02091960|Trastuzumab|trastuzumab|mesh-list
153961446|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961447|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961449|NCT02043678|Prednisolone|prednisolone|mesh-list
153961450|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153961451|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961452|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
153961453|NCT02043678|Hormones|hormones|mesh-ancestor
153961454|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961455|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961456|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153961457|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961458|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
153961459|NCT02029443|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153961460|NCT02029443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961461|NCT02029443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961462|NCT02029443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961463|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961464|NCT02015013|Plerixafor|plerixafor|mesh-list
153961465|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153961466|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153961467|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
153961468|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961469|NCT02012088|Prednisone|prednisone|mesh-list
153961470|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
153961471|NCT02012088|Rituximab|rituximab|mesh-list
153961472|NCT02012088|Doxorubicin|doxorubicin|mesh-list
153719128|NCT00135876|Dalteparin|dalteparin|mesh-list
153961473|NCT02012088|Vincristine|vincristine|mesh-list
153961474|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961475|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
153961476|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961477|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719017|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153961503|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961504|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153961505|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153961506|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153961507|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961508|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961509|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961510|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
153961511|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961512|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961513|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
153961514|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961515|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153961516|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
153961517|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
153961519|NCT01505569|Carboplatin|carboplatin|mesh-list
153961520|NCT01505569|Melphalan|melphalan|mesh-list
153961521|NCT01505569|Busulfan|busulfan|mesh-list
153961522|NCT01505569|Ifosfamide|ifosfamide|mesh-list
153961523|NCT01505569|Thiotepa|thiotepa|mesh-list
153961524|NCT01505569|Lenograstim|lenograstim|mesh-list
153961525|NCT01505569|Mesna|mesna|mesh-list
153961526|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153961527|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719077|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961545|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153961546|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153961547|NCT01396408|Growth Substances|growth substances|mesh-ancestor
153961548|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961549|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
153961550|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961551|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961552|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961553|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961554|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
153961555|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153961556|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961557|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153961558|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
153961560|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153961561|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
153961562|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961563|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961564|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153961565|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961566|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153961567|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153961568|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153961569|NCT01139970|Temozolomide|temozolomide|mesh-list
153961570|NCT01139970|Veliparib|veliparib|mesh-list
153961571|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961572|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
153961573|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961574|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961575|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153961576|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903334|NCT00916357|Insulin|insulin|mesh-list
153903339|NCT00916279|Paclitaxel|paclitaxel|mesh-list
153961577|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
153961578|NCT00937924|Promethazine|promethazine|mesh-list
153961579|NCT00937924|Midazolam|midazolam|mesh-list
153961580|NCT00937924|Meperidine|meperidine|mesh-list
153961581|NCT00937924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153961582|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153961583|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961584|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719129|NCT00135876|Tinzaparin|tinzaparin|mesh-list
153961600|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
153961601|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153961602|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153961603|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
153961604|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
153961605|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153961606|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
153961607|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153961608|NCT00937924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153961609|NCT00937924|Narcotics|narcotics|mesh-ancestor
153961610|NCT00937924|Analgesics|analgesics|mesh-ancestor
153961611|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
153961612|NCT00792948|Leucovorin|leucovorin|mesh-list
153961613|NCT00792948|Folic Acid|folic acid|mesh-list
153961614|NCT00792948|Cytarabine|cytarabine|mesh-list
153961615|NCT00792948|Sirolimus|sirolimus|mesh-list
153961616|NCT00792948|Dexamethasone|dexamethasone|mesh-list
153961617|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
153961618|NCT00792948|Prednisone|prednisone|mesh-list
153961619|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
153961620|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153961621|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153961622|NCT00792948|Prednisolone|prednisolone|mesh-list
153961623|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
153961624|NCT00792948|Cortisone|cortisone|mesh-list
153961625|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
153961626|NCT00792948|Doxorubicin|doxorubicin|mesh-list
153961627|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153961628|NCT00792948|Methotrexate|methotrexate|mesh-list
153961629|NCT00792948|Etoposide|etoposide|mesh-list
153961630|NCT00792948|Vincristine|vincristine|mesh-list
153961631|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
153961634|NCT00792948|Tacrolimus|tacrolimus|mesh-list
153961635|NCT00792948|Lenograstim|lenograstim|mesh-list
153961636|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153961637|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
153961638|NCT00792948|BB 1101|bb 1101|mesh-list
153961639|NCT00792948|Calcium|calcium|mesh-list
153961640|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
153961641|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961642|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
153961643|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961644|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961645|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961646|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
153961647|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961648|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961649|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961650|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961651|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
153961652|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
153719185|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719244|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961702|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961703|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
153961704|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961705|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961706|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961707|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153961708|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153961709|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153961710|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961711|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153961713|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961718|NCT00268385|Vorinostat|vorinostat|mesh-list
153961719|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961720|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
153961721|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961722|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263023|NCT06284434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154263024|NCT06284434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154263025|NCT06284434|Autonomic Agents|autonomic agents|mesh-ancestor
154263026|NCT06284434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154263027|NCT06284434|Respiratory System Agents|respiratory system agents|mesh-ancestor
154263028|NCT06284434|Mydriatics|mydriatics|mesh-ancestor
154263029|NCT06284434|Sympathomimetics|sympathomimetics|mesh-ancestor
154263030|NCT06284434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154263031|NCT06281418|Granisetron|granisetron|mesh-list
154263032|NCT06281418|Antiemetics|antiemetics|mesh-ancestor
154263033|NCT06281418|Autonomic Agents|autonomic agents|mesh-ancestor
154263034|NCT06281418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263035|NCT06281418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263036|NCT06281418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263037|NCT06281418|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154263038|NCT06281418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154263039|NCT06281418|Serotonin Agents|serotonin agents|mesh-ancestor
154263040|NCT06281418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263041|NCT06281418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263042|NCT06280495|Bevacizumab|bevacizumab|mesh-list
154263043|NCT06280495|Fluorouracil|fluorouracil|mesh-list
154263044|NCT06280495|Oxaliplatin|oxaliplatin|mesh-list
154263045|NCT06280495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263046|NCT06280495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263047|NCT06280495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154263048|NCT06280495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263049|NCT06280495|Growth Substances|growth substances|mesh-ancestor
154263050|NCT06280495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263051|NCT06280495|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263052|NCT06280495|Antimetabolites|antimetabolites|mesh-ancestor
154263053|NCT06280495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263054|NCT06280495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263055|NCT06280495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961723|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153961724|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961725|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153961726|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
153961727|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961728|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153961729|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154263056|NCT06280495|Immunologic Factors|immunologic factors|mesh-ancestor
154263057|NCT06246110|Paclitaxel|paclitaxel|mesh-list
154263058|NCT06246110|Carboplatin|carboplatin|mesh-list
154263059|NCT06246110|Pembrolizumab|pembrolizumab|mesh-list
154010001|NCT00925093|Vancomycin|vancomycin|mesh-list
154263060|NCT06246110|Pemetrexed|pemetrexed|mesh-list
154263061|NCT06246110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154263062|NCT06246110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263063|NCT06246110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154263064|NCT06246110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154263065|NCT06246110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154263066|NCT06246110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263067|NCT06246110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263068|NCT06246110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263069|NCT06246110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263070|NCT06246110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154263071|NCT06246110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154263072|NCT06216249|Edetic Acid|edetic acid|mesh-list
154263073|NCT06216249|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154263074|NCT06216249|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154263075|NCT06216249|Pluvicto|pluvicto|mesh-list
154263076|NCT06216249|Chelating Agents|chelating agents|mesh-ancestor
154263077|NCT06216249|Sequestering Agents|sequestering agents|mesh-ancestor
153961730|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153961731|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
153961732|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153961733|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961734|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153961735|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153961736|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153961737|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153961738|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153961739|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153447305|NCT00002531|Hormones|hormones|mesh-ancestor
153961740|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153961741|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153961742|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153961743|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
153961744|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153961745|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153961746|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153961747|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961748|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961761|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153961762|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961763|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961764|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153961765|NCT02817477|Narcotics|narcotics|mesh-ancestor
153961766|NCT02819115|Vaccines|vaccines|mesh-list
153961767|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
153961768|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961769|NCT04099069|Anesthetics|anesthetics|mesh-list
153961770|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154263078|NCT06216249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263079|NCT06216249|Anticoagulants|anticoagulants|mesh-ancestor
154263080|NCT06216249|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154263081|NCT06216249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154263082|NCT06175390|FAPI-46|fapi-46|mesh-list
154263083|NCT06175390|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154263084|NCT06175390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961771|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961772|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153961773|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153961774|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153961775|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961776|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961777|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153961778|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153961779|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719451|NCT00133731|Heparin|heparin|mesh-list
153961780|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
153961781|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961782|NCT04101019|Lidocaine|lidocaine|mesh-list
153961783|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
153961784|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
153961785|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961786|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961787|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
153961788|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961789|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153961790|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153961791|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153961792|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153961793|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961794|NCT02817321|Morphine|morphine|mesh-list
153961795|NCT02817321|Ropivacaine|ropivacaine|mesh-list
153961796|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153961797|NCT02817321|Narcotics|narcotics|mesh-ancestor
153961798|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961799|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961800|NCT02817321|Analgesics|analgesics|mesh-ancestor
153961801|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
153961802|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961803|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
153961804|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
153961805|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
153961806|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153961807|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961808|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153961809|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153719350|NCT00136266|Vitamin D|vitamin d|mesh-list
153961827|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153961828|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961829|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153961830|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
153961831|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153961832|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961833|NCT04480125|Azacitidine|azacitidine|mesh-list
153961834|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961835|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
153961836|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961837|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961838|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961839|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
153961840|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153961841|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
153961842|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961843|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
153961844|NCT00705796|Testosterone|testosterone|mesh-list
153961845|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
153961846|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
153961847|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153961849|NCT00705796|Hormones|hormones|mesh-ancestor
153961850|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961851|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961852|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153961853|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961854|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
153961855|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
153961856|NCT00843778|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153961857|NCT00843778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961858|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961859|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
153961860|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961861|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961863|NCT05631249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153961864|NCT05631249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961865|NCT05631249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961866|NCT05631249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719406|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961886|NCT01039688|Tofacitinib|tofacitinib|mesh-list
153961887|NCT01039688|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153961888|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961889|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961890|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961891|NCT02237508|Budesonide|budesonide|mesh-list
153961892|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
153961893|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153961894|NCT02237508|Charcoal|charcoal|mesh-list
153961895|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961896|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153961897|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
153961898|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961899|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961900|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153961901|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
153961902|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
153961903|NCT02237508|Hormones|hormones|mesh-ancestor
153961904|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961905|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153961906|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153961907|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153961908|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
153961909|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961910|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961911|NCT02237508|Antidotes|antidotes|mesh-ancestor
153961912|NCT02237508|Protective Agents|protective agents|mesh-ancestor
153961913|NCT02809755|Lidocaine|lidocaine|mesh-list
153961914|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
153961915|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
153961916|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961917|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961918|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
153961919|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961920|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153961921|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153961922|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153719465|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
153961931|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
153961932|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153961933|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153961934|NCT02812719|Analgesics|analgesics|mesh-ancestor
153961935|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
153961936|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961937|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961938|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961939|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961940|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153961941|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961942|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961943|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
153961944|NCT02876978|Fludarabine|fludarabine|mesh-list
153961945|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961946|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
153961947|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961948|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961949|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961950|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
153961951|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961952|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961953|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961955|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153961956|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
153961957|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
153961958|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153961959|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961960|NCT05642715|Varenicline|varenicline|mesh-list
153961961|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153961962|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153961963|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
153961964|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961965|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961966|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961967|NCT02874326|Octreotide|octreotide|mesh-list
153961968|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153961969|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153961970|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961971|NCT02812641|Bevacizumab|bevacizumab|mesh-list
153961972|NCT02812641|Cisplatin|cisplatin|mesh-list
153961973|NCT02812641|Fluorouracil|fluorouracil|mesh-list
153961974|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961975|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961976|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153961977|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153961978|NCT02812641|Growth Substances|growth substances|mesh-ancestor
153961979|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961980|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
153961981|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
153961982|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961983|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961984|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961985|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
153961986|NCT01058096|Cariprazine|cariprazine|mesh-list
153961987|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153961988|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153961989|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962011|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962012|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962013|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153962014|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
153962015|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962016|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962017|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153962018|NCT02562378|Doxorubicin|doxorubicin|mesh-list
153962019|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153962020|NCT02562378|Trastuzumab|trastuzumab|mesh-list
153962021|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153962022|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962023|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153962024|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153962025|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962026|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962027|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153962028|NCT00842530|Vaccines|vaccines|mesh-list
153962029|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
153962030|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962031|NCT05580510|Empagliflozin|empagliflozin|mesh-list
153962032|NCT05580510|Valsartan|valsartan|mesh-list
153962033|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153962034|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153962035|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153962036|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153962037|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962038|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154263085|NCT06157255|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154263086|NCT06138691|Ketamine|ketamine|mesh-list
153444917|NCT01645709|Verapamil|verapamil|mesh-list
153962039|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153962040|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962041|NCT02811627|Memantine|memantine|mesh-list
153962042|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153962045|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962046|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962047|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962048|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153962049|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153962051|NCT00634413|Theophylline|theophylline|mesh-list
153962052|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962053|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153962054|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
153962055|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962056|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962057|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153962058|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
153962059|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
153962060|NCT00634413|Hormones|hormones|mesh-ancestor
153962061|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962062|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153962063|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962064|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962065|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
153962066|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153962067|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153962068|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
153962069|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962070|NCT02815059|Prednisone|prednisone|mesh-list
153962071|NCT02815059|Dasatinib|dasatinib|mesh-list
153962072|NCT02815059|Ibrutinib|ibrutinib|mesh-list
153962073|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962074|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
153962075|NCT02815059|Hormones|hormones|mesh-ancestor
153962076|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962077|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962078|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153962080|NCT02815059|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153962081|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153962082|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962083|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962084|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
153962085|NCT00819910|Fenofibrate|fenofibrate|mesh-list
153962086|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153962087|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962088|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153962089|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
153905844|NCT01198548|Bevacizumab|bevacizumab|mesh-list
153962090|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962091|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153962092|NCT02808117|Micronutrients|micronutrients|mesh-list
153962093|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962094|NCT04321395|Vigabatrin|vigabatrin|mesh-list
153962095|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
153962096|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962097|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962098|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
153962099|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962100|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962101|NCT02814669|Atezolizumab|atezolizumab|mesh-list
153962102|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153962103|NCT02814669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153962104|NCT02814669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962105|NCT02814669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153962106|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962107|NCT02808741|Olorofim|olorofim|mesh-list
153962108|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
153962109|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962110|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153962111|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154263087|NCT06138691|Analgesics|analgesics|mesh-ancestor
153962112|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153962113|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153962114|NCT02807415|Ivacaftor|ivacaftor|mesh-list
153719657|NCT00136773|Amlodipine|amlodipine|mesh-list
153962123|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962124|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153962125|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153962126|NCT00634491|Acetazolamide|acetazolamide|mesh-list
153962127|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
153962128|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153962129|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962130|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962131|NCT00634491|Diuretics|diuretics|mesh-ancestor
153962132|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
153962133|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962134|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
153962135|NCT02807103|Rituximab|rituximab|mesh-list
153962136|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153962137|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
153962138|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962139|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962140|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153962141|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
153962142|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962143|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962144|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153962145|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153962146|NCT02806791|Lenograstim|lenograstim|mesh-list
153962147|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153962148|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
153962149|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962150|NCT00830128|Pregabalin|pregabalin|mesh-list
153962151|NCT00830128|Analgesics|analgesics|mesh-ancestor
153962152|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
153962153|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962154|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962155|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
153962156|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153962157|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962158|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962159|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153962160|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153962161|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153962162|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962163|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962164|NCT00771667|Ustekinumab|ustekinumab|mesh-list
153962165|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
153962166|NCT03893175|Acetaminophen|acetaminophen|mesh-list
153962167|NCT03893175|Ibuprofen|ibuprofen|mesh-list
153962168|NCT03893175|Oxycodone|oxycodone|mesh-list
153962169|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153962170|NCT03893175|Analgesics|analgesics|mesh-ancestor
153962171|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
153962172|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962173|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962174|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
153962175|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153962176|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962177|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962178|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153962179|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962180|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719719|NCT00104468|Troxacitabine|troxacitabine|mesh-list
153962197|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153962198|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153962199|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153962200|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153962201|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
153962202|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153962203|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153962204|NCT05461339|Ranibizumab|ranibizumab|mesh-list
153962206|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153962207|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
154263088|NCT06138691|Sensory System Agents|sensory system agents|mesh-ancestor
154263089|NCT06138691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263090|NCT06138691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263091|NCT06138691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154263092|NCT06138691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154263093|NCT06138691|Anesthetics, General|anesthetics, general|mesh-ancestor
154263095|NCT06138691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154263096|NCT06138691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154263097|NCT06138691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154263098|NCT06138691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263099|NCT06138691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263100|NCT06131554|Vaccines|vaccines|mesh-list
154263101|NCT06131554|Immunologic Factors|immunologic factors|mesh-ancestor
154263102|NCT06131554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263103|NCT06094010|Baloxavir|baloxavir|mesh-list
154263104|NCT06094010|Antiviral Agents|antiviral agents|mesh-ancestor
154263105|NCT06094010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263106|NCT06094010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263107|NCT06094010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263108|NCT06091085|Acetazolamide|acetazolamide|mesh-list
154263109|NCT06091085|Anticonvulsants|anticonvulsants|mesh-ancestor
154263110|NCT06091085|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154263111|NCT06091085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263112|NCT06091085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263113|NCT06091085|Diuretics|diuretics|mesh-ancestor
153962208|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962209|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153962210|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153962211|NCT05461339|Growth Substances|growth substances|mesh-ancestor
153962212|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
153962213|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962214|NCT03409848|Nivolumab|nivolumab|mesh-list
153962215|NCT03409848|Ipilimumab|ipilimumab|mesh-list
153962216|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153962217|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962218|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153962219|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962220|NCT00763555|Calcitriol|calcitriol|mesh-list
153962221|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153962222|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962223|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153962224|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962225|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962226|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153962227|NCT00763555|Vitamins|vitamins|mesh-ancestor
154263115|NCT06091085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263116|NCT06076018|Morphine|morphine|mesh-list
154263117|NCT06076018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154263118|NCT06076018|Narcotics|narcotics|mesh-ancestor
154263119|NCT06076018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962228|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
153962229|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153962230|NCT02804373|Oxytocin|oxytocin|mesh-list
153962231|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
153962232|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153962233|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962234|NCT00763321|Acetaminophen|acetaminophen|mesh-list
153962235|NCT00763321|Hydrocodone|hydrocodone|mesh-list
153962236|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153962237|NCT00763321|Analgesics|analgesics|mesh-ancestor
153719780|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
153962268|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962269|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
153962270|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962271|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153962272|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153962273|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153962274|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153962275|NCT00763009|Dipyridamole|dipyridamole|mesh-list
153962276|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153962277|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962278|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962279|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153962280|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
153962281|NCT02799459|Anesthetics|anesthetics|mesh-list
153962282|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962292|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962293|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153962294|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
153962295|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962296|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962297|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153962298|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153962300|NCT00841672|Amlodipine|amlodipine|mesh-list
153962301|NCT00841672|Aliskiren|aliskiren|mesh-list
153962302|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153962303|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153962304|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962305|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962306|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153962307|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962308|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
153962309|NCT00841672|Renin Inhibitors|renin inhibitors|mesh-ancestor
153962310|NCT00841672|Protease Inhibitors|protease inhibitors|mesh-ancestor
153962311|NCT00841672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962313|NCT05549115|Clarithromycin|clarithromycin|mesh-list
153962314|NCT05549115|Levofloxacin|levofloxacin|mesh-list
153962315|NCT05549115|Ofloxacin|ofloxacin|mesh-list
153962316|NCT05549115|Furazolidone|furazolidone|mesh-list
153962317|NCT05549115|Bismuth|bismuth|mesh-list
153962318|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153962319|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962320|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153962321|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962322|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962323|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153962324|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153962325|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153962326|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153962327|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153962328|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962329|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153962330|NCT05549115|Antacids|antacids|mesh-ancestor
154263120|NCT06076018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962331|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153905916|NCT02877615|S44819|s44819|mesh-list
153962332|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153962333|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153962334|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153962335|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153962336|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153962337|NCT04236219|Rasburicase|rasburicase|mesh-list
153962338|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
153962339|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962340|NCT00908232|Dexamethasone|dexamethasone|mesh-list
153962341|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
153962342|NCT00908232|Lenalidomide|lenalidomide|mesh-list
153962343|NCT00908232|Bortezomib|bortezomib|mesh-list
153962344|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153962345|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
153962346|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962347|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962348|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153962349|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
153962350|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962351|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962352|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153962380|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962381|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962382|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962383|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962385|NCT05472753|Protective Agents|protective agents|mesh-ancestor
153962386|NCT05472753|Trace Elements|trace elements|mesh-ancestor
153962387|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
153962388|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962389|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153962390|NCT02799147|Fludarabine|fludarabine|mesh-list
153962391|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
153962392|NCT02799147|Busulfan|busulfan|mesh-list
153962393|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153962394|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962395|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153962396|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
153962397|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962398|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153962399|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
153962400|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962401|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
153962415|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153962416|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153962418|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
153962419|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962420|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962421|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962422|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962423|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153962424|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153962425|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962426|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962427|NCT00906282|Carboplatin|carboplatin|mesh-list
153962428|NCT00906282|Pemetrexed|pemetrexed|mesh-list
153962429|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962430|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962431|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962432|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153962433|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153962434|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
153962435|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153962436|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962437|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153962438|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962439|NCT02798367|Melatonin|melatonin|mesh-list
153962440|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
153962441|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962442|NCT02798367|Protective Agents|protective agents|mesh-ancestor
153905929|NCT01251653|Gemcitabine|gemcitabine|mesh-list
153962443|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962444|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962446|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153962447|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153962448|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
153962449|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962450|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153962451|NCT00907374|Benazepril|benazepril|mesh-list
153962452|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153962453|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
153962454|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962455|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962456|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153962457|NCT02805231|Vitamin D|vitamin d|mesh-list
153962458|NCT02805231|Vitamins|vitamins|mesh-ancestor
153962459|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
153962460|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962475|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153962476|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153962477|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
153962478|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153962479|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962480|NCT02640222|Vitamin K|vitamin k|mesh-list
153962481|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
153962482|NCT02640222|Apixaban|apixaban|mesh-list
153962483|NCT02640222|Dabigatran|dabigatran|mesh-list
153962484|NCT02640222|Vitamins|vitamins|mesh-ancestor
153962485|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
153962486|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962487|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153962488|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
153962489|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153962490|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
153962491|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962492|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962493|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
153962494|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153962495|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153962496|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
153962497|NCT02640222|Coagulants|coagulants|mesh-ancestor
153962498|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153962499|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
153962500|NCT00818662|Antibodies|antibodies|mesh-list
153962501|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
153962502|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153962503|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153962504|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
153962505|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
153962506|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962507|NCT03983031|Rituximab|rituximab|mesh-list
153962508|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153962509|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962510|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
153962511|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962512|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962513|NCT00703066|Vaccines|vaccines|mesh-list
153962514|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
153962515|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962516|NCT00762073|Budesonide|budesonide|mesh-list
153962517|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962518|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153962519|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
153962520|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962521|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720065|NCT00135057|Insulin|insulin|mesh-list
153962530|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962531|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962532|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962533|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
153962534|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962535|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153962536|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
153962537|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962538|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153962539|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153962540|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962541|NCT02797587|Nicotine|nicotine|mesh-list
153962542|NCT02797587|Varenicline|varenicline|mesh-list
153962543|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154263121|NCT06076018|Analgesics|analgesics|mesh-ancestor
154263122|NCT06076018|Sensory System Agents|sensory system agents|mesh-ancestor
153445055|NCT00379691|Protective Agents|protective agents|mesh-ancestor
153962544|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
153962545|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962546|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962547|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153962548|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153962549|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
153962550|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962551|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962552|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153962553|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153962554|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153962555|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962556|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962557|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962558|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153962559|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153962560|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
153962561|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962562|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962563|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153962564|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153962565|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
153962566|NCT00761527|Desloratadine|desloratadine|mesh-list
153962567|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153962568|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
153962569|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962570|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962571|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962572|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153962573|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153962574|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
153962575|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
153962576|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
153962577|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153962578|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153962579|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153962580|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153962581|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962582|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962583|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
153962584|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720119|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
153962605|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
153962606|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153962607|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962608|NCT05805098|Cytarabine|cytarabine|mesh-list
153962609|NCT05805098|Venetoclax|venetoclax|mesh-list
153962610|NCT05805098|Homoharringtonine|homoharringtonine|mesh-list
153962611|NCT05805098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153962612|NCT05805098|Antimetabolites|antimetabolites|mesh-ancestor
153962613|NCT05805098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962614|NCT05805098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962615|NCT05805098|Antiviral Agents|antiviral agents|mesh-ancestor
153962616|NCT05805098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962617|NCT05805098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153962618|NCT05805098|Immunologic Factors|immunologic factors|mesh-ancestor
153962619|NCT05805098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962620|NCT05805098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153962621|NCT05805098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153962622|NCT05805098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962623|NCT05804734|Vitamin K|vitamin k|mesh-list
153962624|NCT05804734|Anticoagulants|anticoagulants|mesh-list
153962625|NCT05804734|Vitamins|vitamins|mesh-ancestor
153962626|NCT05804734|Micronutrients|micronutrients|mesh-ancestor
153962627|NCT05804734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962628|NCT05804734|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153962629|NCT05804734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153962630|NCT05804734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962631|NCT05804734|Hemostatics|hemostatics|mesh-ancestor
154263123|NCT06076018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263124|NCT06067893|Dexmedetomidine|dexmedetomidine|mesh-list
153962632|NCT05804734|Coagulants|coagulants|mesh-ancestor
153962633|NCT05804721|Aripiprazole|aripiprazole|mesh-list
153962634|NCT05804721|Antidepressive Agents|antidepressive agents|mesh-ancestor
153962635|NCT05804721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962636|NCT05804721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153962637|NCT05804721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153962638|NCT05804721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962639|NCT05804721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962640|NCT05804721|Dopamine Agonists|dopamine agonists|mesh-ancestor
153962641|NCT05804721|Dopamine Agents|dopamine agents|mesh-ancestor
153962642|NCT05804721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962643|NCT05804721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962655|NCT05804630|Anesthetics, Local|anesthetics, local|mesh-ancestor
153962656|NCT05804630|Sensory System Agents|sensory system agents|mesh-ancestor
153962657|NCT05804630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962658|NCT05804630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153962659|NCT05804630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153962660|NCT05804630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153962661|NCT05804630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962662|NCT05804630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962663|NCT05804591|Pregabalin|pregabalin|mesh-list
153962664|NCT05804591|Analgesics|analgesics|mesh-ancestor
153962665|NCT05804591|Sensory System Agents|sensory system agents|mesh-ancestor
153962666|NCT05804591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962667|NCT05804591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962668|NCT05804591|Anticonvulsants|anticonvulsants|mesh-ancestor
153962669|NCT05804591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153962670|NCT05804591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962671|NCT05804591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962672|NCT05804591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153962673|NCT05804591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153962674|NCT05804591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153962675|NCT05804591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962676|NCT05804591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962678|NCT05804305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153962679|NCT05804305|Abortifacient Agents|abortifacient agents|mesh-ancestor
153962680|NCT05804305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153962681|NCT05804305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962682|NCT05804305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153962683|NCT05804305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153962684|NCT05804305|Oxytocics|oxytocics|mesh-ancestor
153962685|NCT05803863|Atropine|atropine|mesh-list
153962686|NCT05803863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153962687|NCT05803863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153962688|NCT05803863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153962689|NCT05803863|Autonomic Agents|autonomic agents|mesh-ancestor
153962690|NCT05803863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962691|NCT05803863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962692|NCT05803863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153962693|NCT05803863|Respiratory System Agents|respiratory system agents|mesh-ancestor
153962694|NCT05803863|Mydriatics|mydriatics|mesh-ancestor
153962695|NCT05803863|Parasympatholytics|parasympatholytics|mesh-ancestor
153962696|NCT05803863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153962697|NCT05803863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153962698|NCT05803863|Cholinergic Agents|cholinergic agents|mesh-ancestor
153962699|NCT05803863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962700|NCT05803863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962701|NCT05803746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153962702|NCT05803746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153962703|NCT05803746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962704|NCT05803642|Haloperidol|haloperidol|mesh-list
153962705|NCT05803642|Olanzapine|olanzapine|mesh-list
153962706|NCT05803642|Haloperidol decanoate|haloperidol decanoate|mesh-list
153962712|NCT05803642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153962713|NCT05803642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153962714|NCT05803642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962715|NCT05803642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962716|NCT05803642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153962717|NCT05803642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154263125|NCT06067893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153906042|NCT01248065|Vitamin D|vitamin d|mesh-list
153962718|NCT05803642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962719|NCT05803642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962720|NCT05803642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962721|NCT05803642|Serotonin Agents|serotonin agents|mesh-ancestor
153962722|NCT05803642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153962723|NCT05803642|Dopamine Agents|dopamine agents|mesh-ancestor
153962724|NCT05803642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153962725|NCT05803590|Chlorhexidine|chlorhexidine|mesh-list
153962726|NCT05803590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153962727|NCT05803590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962728|NCT05803590|Disinfectants|disinfectants|mesh-ancestor
153962729|NCT05803135|Tofacitinib|tofacitinib|mesh-list
153962730|NCT05803135|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153962731|NCT05803135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153962732|NCT05803135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962733|NCT05803135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962734|NCT05803070|Cetirizine|cetirizine|mesh-list
153962735|NCT05803070|Betamethasone|betamethasone|mesh-list
153962736|NCT05803070|Betamethasone Valerate|betamethasone valerate|mesh-list
153962737|NCT05803070|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153962738|NCT05803070|Betamethasone benzoate|betamethasone benzoate|mesh-list
153962739|NCT05803070|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153962740|NCT05803070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962741|NCT05803070|Glucocorticoids|glucocorticoids|mesh-ancestor
153962742|NCT05803070|Hormones|hormones|mesh-ancestor
153962743|NCT05803070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962744|NCT05803070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962745|NCT05803070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153962746|NCT05803070|Respiratory System Agents|respiratory system agents|mesh-ancestor
153962747|NCT05803070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153962748|NCT05803070|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153962749|NCT05803070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153962750|NCT05803070|Histamine Antagonists|histamine antagonists|mesh-ancestor
153962751|NCT05803070|Histamine Agents|histamine agents|mesh-ancestor
153962752|NCT05803070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962753|NCT05803070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962754|NCT05803031|Tea Tree Oil|tea tree oil|mesh-list
153962755|NCT05803031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153962756|NCT05803031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962757|NCT05802992|Dexamethasone|dexamethasone|mesh-list
153962758|NCT05802992|Dexamethasone acetate|dexamethasone acetate|mesh-list
153962759|NCT05802992|Lenalidomide|lenalidomide|mesh-list
153962760|NCT05802992|Colchicine|colchicine|mesh-list
153962761|NCT05802992|BB 1101|bb 1101|mesh-list
153962762|NCT05802992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962763|NCT05802992|Antiemetics|antiemetics|mesh-ancestor
153962764|NCT05802992|Autonomic Agents|autonomic agents|mesh-ancestor
153962765|NCT05802992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962766|NCT05802992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962767|NCT05802992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153962768|NCT05802992|Glucocorticoids|glucocorticoids|mesh-ancestor
153962769|NCT05802992|Hormones|hormones|mesh-ancestor
153962770|NCT05802992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962771|NCT05802992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153962772|NCT05802992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962773|NCT05802992|Protease Inhibitors|protease inhibitors|mesh-ancestor
153962774|NCT05802992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962775|NCT05802992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962776|NCT05802992|Immunologic Factors|immunologic factors|mesh-ancestor
153962794|NCT05802888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153962795|NCT05802888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153962796|NCT05802888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962797|NCT05802888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962799|NCT05802888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153962800|NCT05802862|Insulin|insulin|mesh-list
153962801|NCT05802862|Insulin Aspart|insulin aspart|mesh-list
153962802|NCT05802862|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153962803|NCT05802862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153962804|NCT05802862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962805|NCT05800574|Cisplatin|cisplatin|mesh-list
153962806|NCT05800574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263126|NCT06067893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962807|NCT05776290|Hyaluronic Acid|hyaluronic acid|mesh-list
153962808|NCT05776290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153962809|NCT05776290|Immunologic Factors|immunologic factors|mesh-ancestor
153962810|NCT05776290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962811|NCT05776290|Viscosupplements|viscosupplements|mesh-ancestor
153962812|NCT05776290|Protective Agents|protective agents|mesh-ancestor
153962813|NCT05765227|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153962814|NCT05765227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153962815|NCT05765227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962816|NCT05758948|Formaldehyde|formaldehyde|mesh-list
153962817|NCT05758948|Disinfectants|disinfectants|mesh-ancestor
153962818|NCT05758948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962819|NCT05728775|Propofol|propofol|mesh-list
153962820|NCT05728775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153962821|NCT05728775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962822|NCT05728775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729882|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
153962823|NCT05728775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153962824|NCT05728775|Anesthetics, General|anesthetics, general|mesh-ancestor
153962825|NCT05728775|Anesthetics|anesthetics|mesh-ancestor
153962826|NCT05705089|Warfarin|warfarin|mesh-list
153962827|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
153962828|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
153962829|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153962830|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
153962831|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153962832|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
153962833|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962834|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962835|NCT05672901|Estradiol|estradiol|mesh-list
153962836|NCT05672901|Estrogens|estrogens|mesh-ancestor
153962837|NCT05672901|Hormones|hormones|mesh-ancestor
153720371|NCT00436423|Gemcitabine|gemcitabine|mesh-list
153962858|NCT05646693|Serotonin Agents|serotonin agents|mesh-ancestor
153962859|NCT05646693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962860|NCT05646693|Antacids|antacids|mesh-ancestor
153962861|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153962862|NCT05616624|Gemcitabine|gemcitabine|mesh-list
153962863|NCT05616624|Docetaxel|docetaxel|mesh-list
153962864|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153962865|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
153962866|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962867|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962868|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
153962869|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
153962870|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
153962871|NCT05601817|Tocopherols|tocopherols|mesh-list
153962872|NCT05601817|Vitamin E|vitamin e|mesh-list
153962873|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
153962874|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
153962875|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962876|NCT05601817|Protective Agents|protective agents|mesh-ancestor
153962877|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962878|NCT05601817|Vitamins|vitamins|mesh-ancestor
153962879|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
153962880|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153962881|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153962882|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962883|NCT05484349|Clonidine|clonidine|mesh-list
153962884|NCT05484349|Tizanidine|tizanidine|mesh-list
153962885|NCT05484349|Analgesics|analgesics|mesh-ancestor
153962886|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
153962887|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962888|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962889|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
153962890|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153962891|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153962907|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
153962908|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962909|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153962910|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153962911|NCT05449548|Growth Substances|growth substances|mesh-ancestor
153962912|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
153962913|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962915|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153962916|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962917|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263127|NCT06067893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962918|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
153962919|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962920|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962921|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
153962922|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153962923|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153962924|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962925|NCT05350085|Midazolam|midazolam|mesh-list
153962926|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153962927|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153962928|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962929|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962930|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153962931|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153962932|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962933|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153962934|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
153962935|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
153962936|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
153962937|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
153962938|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962939|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962940|NCT05313308|Midazolam|midazolam|mesh-list
153962941|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153962942|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153962943|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962944|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962945|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153962946|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153962947|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962948|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153962949|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
153962950|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
153962962|NCT05163223|Capecitabine|capecitabine|mesh-list
153962963|NCT05163223|Sargramostim|sargramostim|mesh-list
153962964|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153962965|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962966|NCT05163223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153962967|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962968|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153962969|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
153962970|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
153962971|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962972|NCT05101122|Dronabinol|dronabinol|mesh-list
153962973|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153962974|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153962975|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153962976|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962977|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720637|NCT00439426|Capecitabine|capecitabine|mesh-list
153962978|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
153962979|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962980|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962981|NCT05101122|Hallucinogens|hallucinogens|mesh-ancestor
153962982|NCT05101122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962983|NCT05101122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153962984|NCT05101122|Analgesics|analgesics|mesh-ancestor
153962985|NCT05101122|Sensory System Agents|sensory system agents|mesh-ancestor
153962986|NCT05101122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962987|NCT05101122|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153962988|NCT05101122|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153962989|NCT05101122|Hormones|hormones|mesh-ancestor
153962990|NCT05101122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962991|NCT05087771|Naltrexone|naltrexone|mesh-list
153962992|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153962993|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153962994|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962995|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
153962996|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962997|NCT05084235|Empagliflozin|empagliflozin|mesh-list
153962998|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153962999|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263129|NCT06067893|Analgesics|analgesics|mesh-ancestor
154263130|NCT06067893|Sensory System Agents|sensory system agents|mesh-ancestor
153963000|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153963001|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963002|NCT05048901|Lanreotide|lanreotide|mesh-list
153963003|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963004|NCT05042973|Empagliflozin|empagliflozin|mesh-list
153963005|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153963006|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963007|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153963008|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963009|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153963010|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153963011|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963012|NCT04954365|Amisulpride|amisulpride|mesh-list
153963027|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
153963028|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963029|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963030|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153963031|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
153963032|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963033|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963034|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153963035|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963036|NCT04920617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153963037|NCT04860804|Aspirin|aspirin|mesh-list
153963038|NCT04860804|Ketamine|ketamine|mesh-list
153963039|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153963040|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153963041|NCT04860804|Analgesics|analgesics|mesh-ancestor
153963042|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
153963043|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963044|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963045|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963046|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963047|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153963048|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153963049|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963050|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153963051|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153963052|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963053|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
153963054|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153963055|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153963056|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
153963057|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
153963058|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963059|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153963060|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153963061|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963062|NCT04817345|Plerixafor|plerixafor|mesh-list
153963063|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153963064|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153963065|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
153963066|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963067|NCT04764396|Heparin|heparin|mesh-list
153963068|NCT04764396|Calcium heparin|calcium heparin|mesh-list
153963069|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
153963070|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153963071|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153963072|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963089|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153963091|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
153963092|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963093|NCT04505735|Corticosterone|corticosterone|mesh-list
153963094|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963095|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
153963096|NCT04460872|Testosterone|testosterone|mesh-list
153963097|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
153963098|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
153963099|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153963101|NCT04460872|Hormones|hormones|mesh-ancestor
153963102|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963103|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963104|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153963105|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906145|NCT01079949|Hormones|hormones|mesh-ancestor
153963106|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
153963107|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
153963108|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
153963109|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
153963110|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963111|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963112|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
153963113|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963114|NCT04413617|Tofacitinib|tofacitinib|mesh-list
153963115|NCT04413617|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153963116|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963117|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963118|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963119|NCT04218565|Golimumab|golimumab|mesh-list
153963120|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153963121|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963122|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963123|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
153963124|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963125|NCT04129502|Carboplatin|carboplatin|mesh-list
153720780|NCT00440128|Docetaxel|docetaxel|mesh-list
153963126|NCT04129502|Pemetrexed|pemetrexed|mesh-list
153963127|NCT04129502|Mobocertinib|mobocertinib|mesh-list
153963128|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963129|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963130|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963148|NCT04045028|Atezolizumab|atezolizumab|mesh-list
153963149|NCT04045028|Daratumumab|daratumumab|mesh-list
153963150|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963151|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963152|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
153963153|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963154|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963155|NCT04045028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153963156|NCT04045028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963157|NCT03990623|Liver Extracts|liver extracts|mesh-list
153963158|NCT03990623|Hematinics|hematinics|mesh-ancestor
153963159|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153963160|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153963161|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
153963162|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153963163|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963164|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153963165|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153963166|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153963167|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963168|NCT03867500|Niacin|niacin|mesh-list
153963169|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153963170|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
153963171|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963172|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153963173|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
153963174|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
153963175|NCT03867500|Vitamins|vitamins|mesh-ancestor
153963176|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
153963177|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963178|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
153963179|NCT03743402|Narcotics|narcotics|mesh-ancestor
153963180|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963181|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963182|NCT03743402|Analgesics|analgesics|mesh-ancestor
153963183|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
153963184|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963185|NCT03562416|Nintedanib|nintedanib|mesh-list
153963186|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963198|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963199|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153729883|NCT00131768|Protective Agents|protective agents|mesh-ancestor
153963200|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735801|NCT04134260|Hormones|hormones|mesh-list
153445232|NCT00281879|Cytarabine|cytarabine|mesh-list
153445233|NCT00281879|Cyclosporine|cyclosporine|mesh-list
153963201|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963203|NCT03301896|Spartalizumab|spartalizumab|mesh-list
153963204|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153963205|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963206|NCT03301896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963207|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963208|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
153963209|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963210|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963211|NCT03260322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153963212|NCT03260322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963213|NCT03218085|Tenofovir|tenofovir|mesh-list
153963214|NCT03218085|Emtricitabine|emtricitabine|mesh-list
153963215|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
153963216|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963217|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153963218|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153963219|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963220|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963221|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153963222|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153963223|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
153963224|NCT03197077|Desogestrel|desogestrel|mesh-list
153963225|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
153963226|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153963227|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153963228|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153963229|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963230|NCT03197077|Hormones|hormones|mesh-ancestor
153963231|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963232|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153963233|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153963234|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153963235|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153963236|NCT03197077|Progestins|progestins|mesh-ancestor
153963237|NCT03078855|Vitamin D|vitamin d|mesh-list
153963238|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
153963239|NCT03078855|Rituximab|rituximab|mesh-list
153963240|NCT03078855|Vitamins|vitamins|mesh-ancestor
153963241|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
153963242|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963243|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963244|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963245|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
153963246|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963247|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153963302|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963303|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963304|NCT02437071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153963305|NCT02437071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963306|NCT02341274|Tacrolimus|tacrolimus|mesh-list
153963307|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963308|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
153963309|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963310|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153963311|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963312|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963313|NCT02231879|Plerixafor|plerixafor|mesh-list
153963314|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153963315|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153963316|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
153963317|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963318|NCT01968460|Pramipexole|pramipexole|mesh-list
153963319|NCT01968460|Rasagiline|rasagiline|mesh-list
153963320|NCT01968460|Dexpramipexole|dexpramipexole|mesh-list
153963321|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
153963322|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963323|NCT01968460|Protective Agents|protective agents|mesh-ancestor
153963324|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963325|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153963326|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153963327|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
153963328|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
153963329|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963330|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153963331|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963332|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153963333|NCT01527747|Saxagliptin|saxagliptin|mesh-list
153963334|NCT01527747|Incretins|incretins|mesh-ancestor
153963335|NCT01527747|Hormones|hormones|mesh-ancestor
153963336|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963337|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963338|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153963351|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963352|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153963354|NCT00816556|Estradiol|estradiol|mesh-list
153963355|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153963356|NCT00816556|Estrogens|estrogens|mesh-ancestor
153963357|NCT00816556|Hormones|hormones|mesh-ancestor
153963358|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963359|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963360|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153963361|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
153963362|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153963363|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153963364|NCT04100473|Insulin|insulin|mesh-list
153963365|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153963366|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
153963367|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153963368|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963369|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153963370|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153963371|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963372|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153963373|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153963374|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153963375|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153963376|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963377|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
153963378|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963379|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963380|NCT00760669|Infliximab|infliximab|mesh-list
153963381|NCT00760669|Methotrexate|methotrexate|mesh-list
153963382|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153963383|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
153963384|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153963385|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963386|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153963387|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
153963388|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963389|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963390|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
153963391|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963392|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153963393|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963394|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
153963395|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963396|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153963397|NCT00760669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153963398|NCT00760669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963399|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153963400|NCT02796183|Bevacizumab|bevacizumab|mesh-list
153963401|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963402|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963425|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153963427|NCT02795949|Aztreonam|aztreonam|mesh-list
153963428|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153963429|NCT02795949|beta-Lactams|beta-lactams|mesh-list
153963430|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153963431|NCT02795949|Trimethoprim|trimethoprim|mesh-list
153963432|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
153963433|NCT02795949|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
153963434|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963435|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
154263131|NCT06067893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963436|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153963437|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153963438|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963439|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963440|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963441|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153963442|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153963443|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153963444|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153963445|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
153963446|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153963447|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153963448|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153963449|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153963450|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153963451|NCT02795949|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153963452|NCT00769483|Gemcitabine|gemcitabine|mesh-list
153963453|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153963454|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153963455|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
153963456|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963457|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720995|NCT00107822|Tetracaine|tetracaine|mesh-list
153963468|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
153963469|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963470|NCT02794389|Protective Agents|protective agents|mesh-ancestor
153963471|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963472|NCT02794389|Antidotes|antidotes|mesh-ancestor
153963473|NCT02601703|Tacrolimus|tacrolimus|mesh-list
153963474|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963475|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
153963476|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963477|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153963478|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963479|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963480|NCT04234191|Buprenorphine|buprenorphine|mesh-list
153963481|NCT04234191|Hydromorphone|hydromorphone|mesh-list
153963482|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153963483|NCT04234191|Naloxone|naloxone|mesh-list
153963484|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153963485|NCT04234191|Narcotics|narcotics|mesh-ancestor
153963486|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963487|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963488|NCT04234191|Analgesics|analgesics|mesh-ancestor
153963489|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
153963490|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963491|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153963492|NCT02801799|Ropivacaine|ropivacaine|mesh-list
153963493|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
153963494|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
153963495|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963496|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963497|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
153963498|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963499|NCT02690103|Ribavirin|ribavirin|mesh-list
153721159|NCT00404586|Xhance|xhance|mesh-list
153963501|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963502|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
153963503|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963504|NCT02790099|Morphine|morphine|mesh-list
153963505|NCT02790099|Bupivacaine|bupivacaine|mesh-list
153963506|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
153963507|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
153963508|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963509|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963510|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
153963511|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963512|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153963513|NCT02790099|Narcotics|narcotics|mesh-ancestor
153963514|NCT02790099|Analgesics|analgesics|mesh-ancestor
153963515|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
153963516|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153963517|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
153963518|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963519|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
153963520|NCT02790177|Protective Agents|protective agents|mesh-ancestor
153963521|NCT04100083|Spironolactone|spironolactone|mesh-list
153963522|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153963523|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906266|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
153963524|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963539|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963540|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963541|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153963542|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
153963544|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963545|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153963546|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963547|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963548|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
153963549|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
153963550|NCT02793843|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153963551|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153963552|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
153963553|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963554|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
153963555|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
153963556|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963557|NCT02793687|Protective Agents|protective agents|mesh-ancestor
153963558|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963559|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153963560|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153963561|NCT02801487|Cisplatin|cisplatin|mesh-list
153963562|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963563|NCT02793765|Docetaxel|docetaxel|mesh-list
153963564|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963565|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
153963566|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
153963567|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
153963568|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963569|NCT02793219|Docetaxel|docetaxel|mesh-list
153963570|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963571|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
153963572|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
153963573|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
153963574|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963575|NCT02801409|Anesthetics|anesthetics|mesh-list
153963576|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963577|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963578|NCT03787251|Apatinib|apatinib|mesh-list
153963579|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963580|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963581|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963582|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963583|NCT02789865|Metronidazole|metronidazole|mesh-list
153963584|NCT02789865|Levofloxacin|levofloxacin|mesh-list
153963585|NCT02789865|Ertapenem|ertapenem|mesh-list
153963586|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963587|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153963603|NCT02792673|Protective Agents|protective agents|mesh-ancestor
153963604|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
153963605|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153963606|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
153963607|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963608|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963609|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
153963610|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963611|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
153963612|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963613|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963614|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153963615|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
153963616|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963617|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963618|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153963619|NCT02791737|Coal Tar|coal tar|mesh-list
153963620|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
153963621|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
153963622|NCT02535936|Anesthetics|anesthetics|mesh-list
154263132|NCT06067893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153447847|NCT05749367|Ropivacaine|ropivacaine|mesh-list
154263133|NCT06067893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153963623|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963624|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963625|NCT05332470|Lamivudine|lamivudine|mesh-list
153963626|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153963627|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153963628|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963629|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963630|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
153963631|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963632|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153963633|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153963634|NCT02791815|Selexipag|selexipag|mesh-list
153963635|NCT02791815|Midazolam|midazolam|mesh-list
153963636|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153963637|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153963638|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963639|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963640|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153963641|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153963642|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153963643|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153963644|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
153963645|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
153963647|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
153963661|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153963662|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
153963663|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153963664|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153963665|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963666|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
153963667|NCT04202484|Tegafur|tegafur|mesh-list
153963668|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963669|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153963670|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
153963671|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963672|NCT02790957|Plerixafor|plerixafor|mesh-list
153963673|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153963674|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153963675|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
153963676|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963677|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153963678|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
153963679|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153963680|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153963681|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963682|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153963683|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153963684|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153963685|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963686|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
153963687|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963688|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
153963689|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153963690|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963691|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153963692|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963693|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
153963694|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963695|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963696|NCT03753243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153963697|NCT03753243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963698|NCT00632580|Ropivacaine|ropivacaine|mesh-list
153963699|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
153963700|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
153963701|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963702|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963703|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
153963704|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263135|NCT06067893|Adrenergic Agents|adrenergic agents|mesh-ancestor
153445400|NCT00521885|Enoxaparin|enoxaparin|mesh-list
153963705|NCT02789397|Rituximab|rituximab|mesh-list
153963718|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153963719|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153963720|NCT00816166|Analgesics|analgesics|mesh-ancestor
153963721|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
153963722|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963723|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721399|NCT03278314|Ivacaftor|ivacaftor|mesh-list
153963724|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963725|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963726|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153963727|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153963728|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963729|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153963730|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153963731|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963732|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
153963733|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153963734|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153963735|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153963736|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
153963737|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963738|NCT02788851|Guanfacine|guanfacine|mesh-list
153963739|NCT02788851|Methylphenidate|methylphenidate|mesh-list
153963740|NCT02788851|Amphetamine|amphetamine|mesh-list
153963741|NCT02788851|Adderall|adderall|mesh-list
153963742|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
153963743|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153963744|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153963745|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963746|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153963747|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153963748|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153963749|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963750|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
153963751|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963752|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
153963753|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
153963754|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963755|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
153963756|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153963757|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153963758|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153963759|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153963760|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153963761|NCT02786823|Folic Acid|folic acid|mesh-list
153963762|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
153963763|NCT02786823|Metformin|metformin|mesh-list
153963764|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153963765|NCT02786823|Vitamins|vitamins|mesh-ancestor
153963766|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
153963767|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963775|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963776|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963778|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963779|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153963780|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963781|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963782|NCT00815308|Paclitaxel|paclitaxel|mesh-list
153963783|NCT00815308|Cetuximab|cetuximab|mesh-list
153963784|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153963785|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963786|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
153963787|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
153963788|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
153963789|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963790|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963791|NCT01039376|Ofatumumab|ofatumumab|mesh-list
153963792|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963794|NCT02610712|Analgesics|analgesics|mesh-ancestor
153963795|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
153963796|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963797|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963798|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153963799|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153963800|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
153963801|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
153963802|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963803|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153963804|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153963805|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963806|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963807|NCT00905034|Dexamethasone|dexamethasone|mesh-list
153963808|NCT00905034|Rituximab|rituximab|mesh-list
153963809|NCT00905034|Methotrexate|methotrexate|mesh-list
153963810|NCT00905034|Vincristine|vincristine|mesh-list
153963811|NCT00905034|Asparaginase|asparaginase|mesh-list
153963812|NCT00905034|Pegaspargase|pegaspargase|mesh-list
153963813|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963814|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
153963815|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
153963816|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963817|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963818|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153963819|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
153963820|NCT00905034|Hormones|hormones|mesh-ancestor
153963821|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963822|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153963823|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963824|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963825|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
153963826|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963827|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153963828|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
153963829|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153963830|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153963831|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
153963832|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963833|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
153963834|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963835|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153721353|NCT00443794|Atenolol|atenolol|mesh-list
153963855|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153963856|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153963857|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
153963858|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
153963859|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963860|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963861|NCT02611492|Cytarabine|cytarabine|mesh-list
153963862|NCT02611492|Dexamethasone|dexamethasone|mesh-list
153963863|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153963864|NCT02611492|Methotrexate|methotrexate|mesh-list
153963865|NCT02611492|Vincristine|vincristine|mesh-list
153963866|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
153963867|NCT02611492|Nilotinib|nilotinib|mesh-list
153963868|NCT02611492|Lenograstim|lenograstim|mesh-list
153963869|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963870|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
153963871|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
153963872|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963873|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963874|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153963875|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
153963876|NCT02611492|Hormones|hormones|mesh-ancestor
153963877|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963878|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153963879|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963880|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153963881|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
153963882|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153963883|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153963884|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
153963885|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963886|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
153963887|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963888|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153963889|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963890|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
154263136|NCT06067893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445485|NCT00000929|Nonoxynol|nonoxynol|mesh-list
153721425|NCT00444223|Fluorides|fluorides|mesh-list
153963921|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
153963922|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
153963923|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
153963924|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963925|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
153963926|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
153963927|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153963928|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963929|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153963930|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153963931|NCT00903630|Doxorubicin|doxorubicin|mesh-list
153963932|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153963933|NCT00903630|Lenalidomide|lenalidomide|mesh-list
153963934|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153963935|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963936|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153963960|NCT04302584|Coagulants|coagulants|mesh-ancestor
153963961|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153963962|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
153963964|NCT00703144|Piperacillin|piperacillin|mesh-list
153963965|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153963966|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153963967|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963968|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153963969|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963970|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963972|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
153963973|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153963974|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153963975|NCT01054820|Analgesics|analgesics|mesh-ancestor
153963976|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
153963977|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963978|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963979|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963980|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963981|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153963982|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963983|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963984|NCT02874248|Drospirenone|drospirenone|mesh-list
153963985|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153963986|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
153963987|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963988|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964003|NCT05758012|Carbetocin|carbetocin|mesh-list
153964004|NCT05758012|Oxytocics|oxytocics|mesh-ancestor
153964005|NCT05758012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964006|NCT05758012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964007|NCT02786667|Rotigotine|rotigotine|mesh-list
153964008|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
153964009|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
153964010|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964011|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964012|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964013|NCT00913276|Propofol|propofol|mesh-list
153964014|NCT00913276|Sevoflurane|sevoflurane|mesh-list
153964015|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153964016|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964017|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964018|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153964019|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
153964020|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
153964021|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153964022|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153964023|NCT04302116|Prednisolone|prednisolone|mesh-list
153964024|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153964025|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
153964026|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153447970|NCT04330547|Analgesics|analgesics|mesh-list
153964027|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
153964028|NCT04302116|Vigabatrin|vigabatrin|mesh-list
153964029|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153964030|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
153964031|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964032|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
153964034|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964035|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964036|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153964037|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964038|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
153964039|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
153964040|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964041|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153964042|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153964043|NCT04302116|Protective Agents|protective agents|mesh-ancestor
153964044|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
153964045|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964046|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964047|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
153964048|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964049|NCT05756998|Copper|copper|mesh-list
153964050|NCT05756998|Trace Elements|trace elements|mesh-ancestor
153964051|NCT05756998|Micronutrients|micronutrients|mesh-ancestor
153964052|NCT05756998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964068|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153964069|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
153964070|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964071|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153964073|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153964074|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
153964075|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964076|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964077|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153964078|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153964079|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
153964080|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964081|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964082|NCT02785653|Sevoflurane|sevoflurane|mesh-list
153964083|NCT02785653|Rocuronium|rocuronium|mesh-list
153964084|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153964085|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153964086|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
153964087|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
153964088|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964089|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964090|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153964091|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153964092|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153964093|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964094|NCT02787447|Gefitinib|gefitinib|mesh-list
153964095|NCT02787447|Thymalfasin|thymalfasin|mesh-list
153964096|NCT02787447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153964097|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964098|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964099|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964100|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964101|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153964102|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
153964103|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964104|NCT00904722|Rituximab|rituximab|mesh-list
153964105|NCT00904722|Pidilizumab|pidilizumab|mesh-list
153964106|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964107|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964108|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
153964109|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964110|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964111|NCT02909361|Fulvestrant|fulvestrant|mesh-list
153964112|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153964121|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
153964122|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
153964123|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964124|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964125|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964126|NCT04301024|Analgesics|analgesics|mesh-ancestor
153964127|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
153964128|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964129|NCT01340430|Trastuzumab|trastuzumab|mesh-list
153415084|NCT02625181|Meclizine|meclizine|mesh-list
153445537|NCT00000953|Acyclovir|acyclovir|mesh-list
153964130|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964131|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964132|NCT01029782|Cefazolin|cefazolin|mesh-list
153964133|NCT01029782|Cephalexin|cephalexin|mesh-list
153964134|NCT01029782|Probenecid|probenecid|mesh-list
153964135|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153964136|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964137|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
153964138|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
153964139|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964140|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153964141|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153964142|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153964143|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964144|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
153964145|NCT02849730|Fentanyl|fentanyl|mesh-list
153964146|NCT02849730|Analgesics|analgesics|mesh-list
153964147|NCT02849730|Ropivacaine|ropivacaine|mesh-list
153964148|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
153964149|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
153964150|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964151|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964152|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
153964153|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964154|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153964155|NCT02849730|Narcotics|narcotics|mesh-ancestor
153964156|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153964157|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153964158|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
153964159|NCT02849340|Immunomodulating Agents|immunomodulating agents|mesh-list
153964160|NCT02849340|Immunologic Factors|immunologic factors|mesh-ancestor
153964161|NCT02849340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964162|NCT03936192|Meloxicam|meloxicam|mesh-list
153964163|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153964164|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964165|NCT03936192|Analgesics|analgesics|mesh-ancestor
153964166|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
153964167|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964168|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964169|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964170|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964171|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153964172|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153964173|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964174|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964175|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153964176|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964177|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153964178|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964179|NCT02786979|Aspirin|aspirin|mesh-list
153964187|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964188|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964189|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153964190|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153964191|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964192|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153964193|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153964194|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964195|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
153964196|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
153964197|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
153964198|NCT02689869|Ibrutinib|ibrutinib|mesh-list
153964199|NCT02689869|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153964200|NCT02689869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964201|NCT02689869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964202|NCT02689869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964203|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964204|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964205|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
153964206|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
153964207|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964208|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964209|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153964210|NCT00221988|Levetiracetam|levetiracetam|mesh-list
153964211|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
153964212|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
153964213|NCT02341911|Carboplatin|carboplatin|mesh-list
153964214|NCT02341911|Gemcitabine|gemcitabine|mesh-list
153964215|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964216|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153964217|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
153964218|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964219|NCT02847000|Decitabine|decitabine|mesh-list
153964220|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
153964221|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153964222|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
153964223|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964224|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964225|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964226|NCT02784327|Ropivacaine|ropivacaine|mesh-list
153964227|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
153964228|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
153964229|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964230|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964231|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
153964232|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964233|NCT02845050|Cisplatin|cisplatin|mesh-list
153964234|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964235|NCT02690922|Dexamethasone|dexamethasone|mesh-list
153964236|NCT02690922|Prednisone|prednisone|mesh-list
153964237|NCT02690922|Methotrexate|methotrexate|mesh-list
153964238|NCT02690922|Dasatinib|dasatinib|mesh-list
153964239|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964240|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
153964241|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
153964242|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964243|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964244|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153964245|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
153964246|NCT02690922|Hormones|hormones|mesh-ancestor
153745628|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964247|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964267|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964269|NCT04202406|Codeine|codeine|mesh-list
153964270|NCT04202406|Caffeine|caffeine|mesh-list
153964271|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964272|NCT04202406|Analgesics|analgesics|mesh-ancestor
153964273|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
153964274|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964275|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964276|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
153964277|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153964278|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153964279|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964280|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964281|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153964282|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153964283|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
153964284|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964285|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153964286|NCT04202406|Narcotics|narcotics|mesh-ancestor
153964287|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964288|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
153964289|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
153964290|NCT02846766|Lenvatinib|lenvatinib|mesh-list
153964291|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964292|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964293|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964294|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964295|NCT00839956|Bortezomib|bortezomib|mesh-list
153964296|NCT00839956|Vorinostat|vorinostat|mesh-list
153964297|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964298|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153964299|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964300|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964301|NCT00839800|Terbutaline|terbutaline|mesh-list
153964327|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964328|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964329|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964331|NCT00913666|Interferon-beta|interferon-beta|mesh-list
153964332|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
153964333|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964334|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
153964335|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964336|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
153964337|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964338|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153964339|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153964340|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964341|NCT02601157|Aspirin|aspirin|mesh-list
153964342|NCT02601157|Clopidogrel|clopidogrel|mesh-list
153964343|NCT02601157|Ticagrelor|ticagrelor|mesh-list
153964344|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153964345|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153964346|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964347|NCT02601157|Analgesics|analgesics|mesh-ancestor
153964348|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
153964349|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721872|NCT00454480|Azacitidine|azacitidine|mesh-list
153964375|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153964376|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153964377|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153964378|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153964379|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153964380|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964381|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153964382|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964383|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
153964384|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153964385|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153964386|NCT00902304|Diuretics|diuretics|mesh-ancestor
153964387|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
153964388|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153964389|NCT02784795|Carboplatin|carboplatin|mesh-list
153964390|NCT02784795|Gemcitabine|gemcitabine|mesh-list
153964391|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964392|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153964393|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
153964394|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964395|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153964396|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
153964397|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964419|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
153964420|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153964421|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153964422|NCT00638079|Megestrol|megestrol|mesh-list
153964423|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
153964424|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153964425|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153964426|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153964427|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
153964428|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964429|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964430|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153964431|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153964432|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153964433|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964434|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
153964435|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153964436|NCT00759031|Listerine|listerine|mesh-list
153964437|NCT00759031|Triclosan|triclosan|mesh-list
153964438|NCT00759031|Fluorides|fluorides|mesh-list
153964439|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
153964440|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
153964441|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
153964442|NCT00759031|Protective Agents|protective agents|mesh-ancestor
153964443|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964444|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153964445|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964446|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153964447|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153964448|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
153964449|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263137|NCT06067893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263138|NCT06046482|Docetaxel|docetaxel|mesh-list
153964450|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153964451|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
153964452|NCT04197219|Axitinib|axitinib|mesh-list
153964475|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
153964476|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153964477|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153964478|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153964479|NCT02512497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153964480|NCT02512497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964483|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
153964484|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964485|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153964486|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153964487|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153964488|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964489|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964490|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
153964491|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153964492|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153964493|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
153964494|NCT02784015|Melphalan|melphalan|mesh-list
153964495|NCT02784015|Ifosfamide|ifosfamide|mesh-list
153964496|NCT02784015|Thiotepa|thiotepa|mesh-list
153964497|NCT02784015|Carboplatin|carboplatin|mesh-list
153964498|NCT02784015|Doxorubicin|doxorubicin|mesh-list
153964499|NCT02784015|Etoposide|etoposide|mesh-list
153964500|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153964501|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
153964502|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964503|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964504|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153964505|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
153964506|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964530|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153964531|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
153964532|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153964533|NCT02601235|Protective Agents|protective agents|mesh-ancestor
153964534|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153964535|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153964536|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964537|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153964538|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
153964539|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
153964540|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153964541|NCT02783937|Lenograstim|lenograstim|mesh-list
153964542|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153964543|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
153964544|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964545|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
153964546|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153964548|NCT02846142|Estrogens|estrogens|mesh-ancestor
153964549|NCT02846142|Hormones|hormones|mesh-ancestor
153722186|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964550|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964551|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964552|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153964553|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
153964554|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964555|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153964556|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153964557|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153964570|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153964571|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
153964572|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964573|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153964574|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153964575|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153964576|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153964577|NCT05242926|Docetaxel|docetaxel|mesh-list
153964578|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964579|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
153964580|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
154263139|NCT06046482|Pembrolizumab|pembrolizumab|mesh-list
154263140|NCT06046482|Cetuximab|cetuximab|mesh-list
154263141|NCT06046482|Magrolimab|magrolimab|mesh-list
153964581|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
153964582|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964583|NCT02782221|Hormones|hormones|mesh-list
153964584|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964585|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964586|NCT04231617|Glyburide|glyburide|mesh-list
153964587|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153964588|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964589|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153964590|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153964591|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153964592|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964593|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964594|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153964595|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153964596|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153964597|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
153964598|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964599|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964600|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153964601|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153964602|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
153964603|NCT02845908|Leucovorin|leucovorin|mesh-list
153964604|NCT02845908|Fluorouracil|fluorouracil|mesh-list
153964605|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
153964606|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
153964607|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964608|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153964609|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964610|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153964611|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
153964612|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964613|NCT02845908|Antidotes|antidotes|mesh-ancestor
153964614|NCT02845908|Protective Agents|protective agents|mesh-ancestor
153964615|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
153964616|NCT02845908|Vitamins|vitamins|mesh-ancestor
153964617|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
153964618|NCT02784483|Atezolizumab|atezolizumab|mesh-list
153964619|NCT02784483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153964620|NCT02784483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964621|NCT02784483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964622|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964634|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
153964635|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964636|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
153964637|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964638|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
153964639|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153964640|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153964641|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153964642|NCT00757627|Etoricoxib|etoricoxib|mesh-list
153964643|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153964644|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964645|NCT00757627|Analgesics|analgesics|mesh-ancestor
153964646|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
153964647|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964648|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964649|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964650|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964651|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153964652|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153964653|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964654|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964655|NCT02600455|Abatacept|abatacept|mesh-list
153964656|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153964657|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964658|NCT02600455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964659|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964660|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154263142|NCT06046482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964661|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
153964662|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964663|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964664|NCT01023308|Dexamethasone|dexamethasone|mesh-list
153964665|NCT01023308|Bortezomib|bortezomib|mesh-list
153964666|NCT01023308|Panobinostat|panobinostat|mesh-list
153964667|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964668|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
153964669|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
153964670|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964671|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964672|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153964673|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
153964674|NCT01023308|Hormones|hormones|mesh-ancestor
153964675|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964676|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153964677|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964678|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153964679|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964680|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964681|NCT02781909|Ibuprofen|ibuprofen|mesh-list
153964682|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153964683|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964684|NCT02781909|Analgesics|analgesics|mesh-ancestor
153964685|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
153964686|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964687|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964688|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964689|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964690|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153964701|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964702|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
153964703|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153964704|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153964705|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964706|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
153964707|NCT02781597|Coagulants|coagulants|mesh-ancestor
153964708|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153964711|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153964712|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153964713|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964714|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
153964715|NCT01029392|Vitamin D|vitamin d|mesh-list
153964716|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
153964717|NCT01029392|Vitamins|vitamins|mesh-ancestor
153964718|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
153964719|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964720|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153964721|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153964722|NCT02781753|Interferons|interferons|mesh-list
153964723|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
153964724|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
153964725|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964726|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
153964727|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964728|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
153964729|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964730|NCT00903006|Dasatinib|dasatinib|mesh-list
153964731|NCT00903006|Fulvestrant|fulvestrant|mesh-list
153964732|NCT00903006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153964733|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964734|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964735|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964736|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964737|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153964738|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153964739|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153964740|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
153964741|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964742|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964743|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
153964744|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153964745|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
153964746|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263144|NCT06046482|Antimitotic Agents|antimitotic agents|mesh-ancestor
153964747|NCT00839332|Gemcitabine|gemcitabine|mesh-list
153964748|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153964749|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
153964750|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964751|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964752|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
153964753|NCT04095169|Complement C3|complement c3|mesh-list
153964754|NCT04095169|Complement C3d|complement c3d|mesh-list
153964755|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
153722261|NCT00110747|Lidocaine|lidocaine|mesh-list
153964780|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964781|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964782|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964783|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153964784|NCT04229355|Estrogens|estrogens|mesh-ancestor
153964785|NCT04229355|Hormones|hormones|mesh-ancestor
153964786|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964787|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964788|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153964789|NCT04229355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964790|NCT02848170|Olmesartan|olmesartan|mesh-list
153964791|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153964792|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153964793|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153964794|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153964795|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964796|NCT05341401|Prednisolone|prednisolone|mesh-list
153964797|NCT05341401|Budesonide|budesonide|mesh-list
153964798|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964799|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
153964800|NCT05341401|Hormones|hormones|mesh-ancestor
153964801|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964802|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964803|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153964835|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153964836|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153964837|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153964838|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
153964839|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964840|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964841|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153964842|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153964843|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153964845|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964846|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964847|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153722381|NCT00144144|Giapreza|giapreza|mesh-list
153964857|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964858|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964860|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964861|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153964862|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
153964863|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964864|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964865|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153964866|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
153964867|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
153964868|NCT05325489|Hormones|hormones|mesh-ancestor
153964869|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964870|NCT00902538|Amlodipine|amlodipine|mesh-list
153964871|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153964872|NCT00902538|Olmesartan|olmesartan|mesh-list
153964873|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153964874|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153964875|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153964876|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153964877|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964878|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153964879|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263145|NCT06046482|Mitosis Modulators|mitosis modulators|mesh-ancestor
154263146|NCT06046482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964880|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
153964882|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
153964883|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153964884|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153964885|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153964886|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
153964887|NCT02780505|Vitamins|vitamins|mesh-ancestor
153964888|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
153964889|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964890|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
153964891|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964892|NCT02780505|Protective Agents|protective agents|mesh-ancestor
153964893|NCT02690844|Clonazepam|clonazepam|mesh-list
153964894|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
153964895|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
153964896|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
153964897|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964898|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964899|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964900|NCT04201860|Hemostatics|hemostatics|mesh-list
153964901|NCT04201860|Coagulants|coagulants|mesh-ancestor
153964902|NCT02847702|Naproxen|naproxen|mesh-list
153964903|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153964904|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964905|NCT02847702|Analgesics|analgesics|mesh-ancestor
153964906|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
153964907|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964908|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964909|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153964910|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964911|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
153964923|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964925|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153964926|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
153964927|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964928|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153964929|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153964930|NCT04793568|Interferons|interferons|mesh-list
153964931|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
153964932|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964933|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
153964934|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964935|NCT05339217|Aldesleukin|aldesleukin|mesh-list
153964936|NCT05339217|Interleukin-2|interleukin-2|mesh-list
153964937|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964938|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964939|NCT05339217|Analgesics|analgesics|mesh-ancestor
153964940|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
153964941|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964942|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964943|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153964944|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153964945|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
153964946|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964947|NCT04793490|Acetaminophen|acetaminophen|mesh-list
153964948|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964949|NCT04793490|Analgesics|analgesics|mesh-ancestor
153964950|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
153964951|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964952|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964953|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
153964954|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
153964955|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153964956|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153964957|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964958|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153964959|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153964960|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964961|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964962|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964963|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153964965|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964966|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964967|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153964968|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153964969|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153964970|NCT05319093|Ozanimod|ozanimod|mesh-list
153964971|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153964972|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965009|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153965010|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
153965011|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
153965012|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965013|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965035|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153965036|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153965038|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
153965039|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965040|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965041|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153965042|NCT04095013|Narcotics|narcotics|mesh-ancestor
153965043|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153965044|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153965045|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
153965046|NCT02779881|Caseins|caseins|mesh-list
153965047|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
153965048|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
153965049|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965050|NCT00651378|Atorvastatin|atorvastatin|mesh-list
153965051|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153965052|NCT00651378|Ezetimibe|ezetimibe|mesh-list
153965053|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153965054|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153965055|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
153965056|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965057|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153965058|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153965059|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965060|NCT00747643|Varenicline|varenicline|mesh-list
153965061|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153965062|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153965063|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
153965064|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965065|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965066|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965067|NCT00627692|Prucalopride|prucalopride|mesh-list
153965101|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153965102|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153965103|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
153965104|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
153965105|NCT02599675|Vitamin D|vitamin d|mesh-list
153965106|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
153965107|NCT02599675|Vitamins|vitamins|mesh-ancestor
153965108|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
153722640|NCT00348244|Analgesics|analgesics|mesh-ancestor
153965131|NCT00212784|Asenapine|asenapine|mesh-list
153965132|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
153965133|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
153965134|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965135|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965136|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965137|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153965138|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965139|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965140|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965141|NCT00212784|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153965142|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153965143|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153965144|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965145|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965146|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
153965147|NCT00751933|Vaccines|vaccines|mesh-list
153965148|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
153415350|NCT04146571|Ensartinib|ensartinib|mesh-list
153965149|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965151|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
153965152|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965153|NCT02778945|Rocuronium|rocuronium|mesh-list
153965154|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153965155|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153965156|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153722781|NCT00111449|Etanercept|etanercept|mesh-list
153965157|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965158|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965159|NCT02721342|Ramipril|ramipril|mesh-list
153965160|NCT02721342|Irbesartan|irbesartan|mesh-list
153965161|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153965162|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
153965172|NCT02779101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965173|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
153965174|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
153965175|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
153965176|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965177|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965178|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965179|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153965180|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965181|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965182|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965183|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153965184|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
153965185|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965186|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965187|NCT05335278|Nintedanib|nintedanib|mesh-list
153965188|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965189|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153965190|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965191|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965192|NCT00092898|Ezetimibe|ezetimibe|mesh-list
153965193|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153965194|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153965195|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
153965196|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965197|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153965198|NCT04094467|Leuprolide|leuprolide|mesh-list
153965199|NCT04094467|Cetrorelix|cetrorelix|mesh-list
153965200|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153965201|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
153965202|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153965203|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965204|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153965205|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965206|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
153965207|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965208|NCT00092820|Ezetimibe|ezetimibe|mesh-list
153965209|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153965210|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153965211|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
153965212|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965213|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153965214|NCT00092742|Diclofenac|diclofenac|mesh-list
153965215|NCT00092742|Etoricoxib|etoricoxib|mesh-list
153965216|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153965217|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965218|NCT00092742|Analgesics|analgesics|mesh-ancestor
153965219|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
153965220|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965221|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965222|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965223|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153965224|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153965225|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722732|NCT00349180|Enoxaparin|enoxaparin|mesh-list
153965245|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153965246|NCT02598427|Trastuzumab|trastuzumab|mesh-list
153965247|NCT02598427|Pertuzumab|pertuzumab|mesh-list
153965248|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263147|NCT06046482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263148|NCT06046482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263149|NCT05976464|Magnesium Sulfate|magnesium sulfate|mesh-list
154263150|NCT05976464|Analgesics|analgesics|mesh-ancestor
154263151|NCT05976464|Sensory System Agents|sensory system agents|mesh-ancestor
154263152|NCT05976464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263153|NCT05976464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263154|NCT05976464|Anesthetics|anesthetics|mesh-ancestor
154263155|NCT05976464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154263156|NCT05976464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154263157|NCT05976464|Anticonvulsants|anticonvulsants|mesh-ancestor
154263158|NCT05976464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154263159|NCT05976464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154263160|NCT05976464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263161|NCT05976464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154263162|NCT05976464|Tocolytic Agents|tocolytic agents|mesh-ancestor
153965249|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965250|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153965251|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153965252|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153965253|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
153965254|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965255|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153906624|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153448213|NCT03933293|Ezetimibe|ezetimibe|mesh-list
153965256|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153965257|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965258|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
153965259|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
153965260|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
153965261|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965262|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
153965263|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153965264|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965265|NCT01028222|Dacarbazine|dacarbazine|mesh-list
153965266|NCT01028222|Nilotinib|nilotinib|mesh-list
153965267|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153965268|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
153965269|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965270|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965271|NCT01028222|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153965272|NCT01028222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153965273|NCT01028222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965274|NCT00586495|Sorafenib|sorafenib|mesh-list
153965275|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965276|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153965277|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965278|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965279|NCT02776137|Docetaxel|docetaxel|mesh-list
153965280|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965299|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965300|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153965301|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153965302|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153722930|NCT00350311|Nicotine|nicotine|mesh-list
153965303|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
153965304|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263163|NCT05976464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153965305|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965307|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965308|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
153965309|NCT02776059|Hormones|hormones|mesh-ancestor
153965310|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965311|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965312|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153965313|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965314|NCT00774930|Lanreotide|lanreotide|mesh-list
153965315|NCT00774930|Somatostatin|somatostatin|mesh-list
153965316|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965317|NCT00774930|Hormones|hormones|mesh-ancestor
153965318|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965319|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965320|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153965321|NCT02841774|Pravastatin|pravastatin|mesh-list
153965322|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153965323|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153965324|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
153965325|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965326|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153965327|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153965328|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965329|NCT02772237|Riboflavin|riboflavin|mesh-list
153965330|NCT02772237|Vitamins|vitamins|mesh-ancestor
153965331|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
153965332|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965333|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
153965334|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153722856|NCT00350038|Irbesartan|irbesartan|mesh-list
153965342|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965343|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965344|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
153965345|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153965346|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965347|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965348|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965349|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153965350|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153965351|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965352|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965353|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
153965354|NCT03205956|Levodopa|levodopa|mesh-list
153965355|NCT03205956|Carbidopa|carbidopa|mesh-list
153965356|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153965357|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153965358|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
153965359|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965360|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965361|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965362|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153965363|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965364|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
153965365|NCT02840994|Nivolumab|nivolumab|mesh-list
153965366|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153965367|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965368|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153965369|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965371|NCT02771457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153965372|NCT02771457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965373|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
153965374|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153723008|NCT00111956|Etanercept|etanercept|mesh-list
153965375|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153965376|NCT02843802|Immunomodulating Agents|immunomodulating agents|mesh-list
153965377|NCT02843802|Immunologic Factors|immunologic factors|mesh-ancestor
153965378|NCT02843802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965379|NCT02771379|Idebenone|idebenone|mesh-list
153965380|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
153965381|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965382|NCT02771379|Protective Agents|protective agents|mesh-ancestor
153965383|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965384|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
153965385|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965386|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
153965387|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153965388|NCT02844114|Cisplatin|cisplatin|mesh-list
153965389|NCT02844114|Gemcitabine|gemcitabine|mesh-list
153965390|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965391|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153965392|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
153965393|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965394|NCT02696733|Cephalosporins|cephalosporins|mesh-list
153965395|NCT02696733|Lidocaine|lidocaine|mesh-list
153965396|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
153965397|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
153965398|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965399|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965400|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
153965401|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965402|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153965403|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153965415|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965416|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153965418|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965419|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965420|NCT01034462|Milnacipran|milnacipran|mesh-list
153965421|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
153965422|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153965423|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153965424|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153965425|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965426|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965427|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965428|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
153965429|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965430|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965431|NCT01034462|Analgesics|analgesics|mesh-ancestor
153965432|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
153906671|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
153906672|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
153965433|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965434|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153965435|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
153965436|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965437|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
153965438|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965439|NCT02774811|Bimatoprost|bimatoprost|mesh-list
153965440|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153965441|NCT00817050|Fluticasone|fluticasone|mesh-list
153965442|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
153965444|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153965445|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
153965446|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965447|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965448|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153965449|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153965450|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
153965451|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153965452|NCT04224831|Mitogens|mitogens|mesh-list
153965453|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
153965454|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965455|NCT00816972|Loratadine|loratadine|mesh-list
153965456|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
153965457|NCT00816972|Oxybutynin|oxybutynin|mesh-list
153965458|NCT00816972|Desloratadine|desloratadine|mesh-list
153965459|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
153965460|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
153965461|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965462|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965463|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153965464|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153965465|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
153965466|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722979|NCT00350662|Deferiprone|deferiprone|mesh-list
154263164|NCT05964413|Vilobelimab|vilobelimab|mesh-list
153965500|NCT02774187|Fluorouracil|fluorouracil|mesh-list
153965501|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
153965502|NCT02774187|Sorafenib|sorafenib|mesh-list
153965503|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
153965504|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965505|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723049|NCT00401609|Carboplatin|carboplatin|mesh-list
153965516|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965517|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
153965518|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153965519|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965520|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965521|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965522|NCT02773797|Analgesics|analgesics|mesh-ancestor
153965523|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
153965524|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965525|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153723153|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153965526|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153965528|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
153965529|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965530|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965531|NCT02773875|Pancrelipase|pancrelipase|mesh-list
153965532|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965533|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
153965534|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153965535|NCT02768961|Ledipasvir|ledipasvir|mesh-list
153965536|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
153965537|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965538|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
153965539|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153965540|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153965541|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153965542|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153965543|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965544|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
153965545|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965546|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965547|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153965548|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965549|NCT02768805|Vaccines|vaccines|mesh-list
153965550|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
153965551|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965552|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153965553|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
153965554|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153965555|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
153965556|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965557|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
153965558|NCT02773251|Protective Agents|protective agents|mesh-ancestor
153965559|NCT02773251|Laxatives|laxatives|mesh-ancestor
153965560|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965561|NCT02768649|Risperidone|risperidone|mesh-list
153965562|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153965563|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
153965564|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965565|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965566|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965567|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153965568|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965569|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965570|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965571|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153965593|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965594|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965596|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965597|NCT02768415|Apatinib|apatinib|mesh-list
153965598|NCT02768415|Vinorelbine|vinorelbine|mesh-list
153965599|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965600|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153965601|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965602|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965603|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154263165|NCT05964413|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154263167|NCT05964413|Immunologic Factors|immunologic factors|mesh-ancestor
154263168|NCT05964413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965604|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
153965605|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
153965606|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
153965607|NCT02773095|Lactitol|lactitol|mesh-list
153965608|NCT02773095|Cathartics|cathartics|mesh-ancestor
153965609|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965610|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
153965611|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153965612|NCT02768571|Protective Agents|protective agents|mesh-ancestor
153965613|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965614|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
153965615|NCT02767713|Dexamethasone|dexamethasone|mesh-list
153965616|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965617|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
153965618|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
153965619|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965620|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965621|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965622|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
153965623|NCT02767713|Hormones|hormones|mesh-ancestor
153965624|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965625|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153965626|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965627|NCT02767245|Thiamine|thiamine|mesh-list
153965641|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
153965642|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965643|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965644|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965645|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153965646|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153965647|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153965648|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965649|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153965650|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153965651|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965652|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
153965653|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153965654|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153965655|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
153965656|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153965657|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153965658|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153965659|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153965660|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153965661|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
153965662|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965663|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153965664|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153965665|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
153965666|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
153965667|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153965668|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153965669|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153965671|NCT02767479|Esomeprazole|esomeprazole|mesh-list
153965672|NCT02767479|Rabeprazole|rabeprazole|mesh-list
153965673|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153965674|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965675|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153965676|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723302|NCT00112658|Vitamins|vitamins|mesh-ancestor
153965677|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965679|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153965680|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153965681|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153965682|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153965683|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153965684|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153965685|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965686|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965687|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153965688|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153965689|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965690|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
153965691|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723203|NCT00351910|Amitriptyline|amitriptyline|mesh-list
153965701|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153965703|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965704|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965705|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
153965706|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
153965707|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965708|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965709|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965710|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153965711|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965712|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965713|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965714|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153448369|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448370|NCT00003101|Vincristine|vincristine|mesh-list
153448371|NCT00003101|Busulfan|busulfan|mesh-list
153965715|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
153965716|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965717|NCT02767089|Prednisone|prednisone|mesh-list
153965718|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965719|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
153965720|NCT02767089|Hormones|hormones|mesh-ancestor
153965721|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965722|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965723|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153965724|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965725|NCT02766855|Cysteamine|cysteamine|mesh-list
153965726|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153965727|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965728|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153965729|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153965730|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
153965731|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965732|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965733|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153965734|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153965735|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153965736|NCT02762253|Riboflavin|riboflavin|mesh-list
153965737|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
153965738|NCT02762253|Vitamins|vitamins|mesh-ancestor
153965739|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
153965740|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965741|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153965742|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
153965743|NCT00746941|Mefloquine|mefloquine|mesh-list
153965744|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
153965745|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153965746|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153965747|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965748|NCT04532463|Fluconazole|fluconazole|mesh-list
153965749|NCT04532463|Amphotericin B|amphotericin b|mesh-list
153965750|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153965751|NCT04532463|Flucytosine|flucytosine|mesh-list
153965752|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
153965753|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965754|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153965755|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153965756|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723261|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153965776|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965778|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153965779|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965780|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965781|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965782|NCT00746785|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153965783|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153965784|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153965785|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965786|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965788|NCT04090021|Amoxicillin|amoxicillin|mesh-list
153965789|NCT04090021|Metronidazole|metronidazole|mesh-list
153965790|NCT04090021|Clarithromycin|clarithromycin|mesh-list
153965791|NCT04090021|Levofloxacin|levofloxacin|mesh-list
153965792|NCT04090021|Rifabutin|rifabutin|mesh-list
153965793|NCT04090021|Esomeprazole|esomeprazole|mesh-list
153965794|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153965795|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965796|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153965797|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153965798|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153965799|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965800|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153965801|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965802|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965803|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153965804|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153965805|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153965806|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153965807|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153965808|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153965809|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965810|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153965831|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
153965832|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153965833|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153965834|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
153965835|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153965837|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153965838|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153965839|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
153965840|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965841|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965842|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965843|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153965844|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
153965845|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
153965846|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153965847|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
153965848|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153965849|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
153965850|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965851|NCT02761395|Deferasirox|deferasirox|mesh-list
153965852|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153965853|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
153965854|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
153965855|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965856|NCT02761317|Bisacodyl|bisacodyl|mesh-list
153965857|NCT02761317|Cathartics|cathartics|mesh-ancestor
153965858|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965859|NCT02761317|Laxatives|laxatives|mesh-ancestor
153965860|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153965861|NCT00746551|Hematinics|hematinics|mesh-ancestor
153965862|NCT02696577|Aspirin|aspirin|mesh-list
153965863|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153965864|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965865|NCT02696577|Analgesics|analgesics|mesh-ancestor
153965866|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
153965891|NCT04223739|Landiolol|landiolol|mesh-list
153965892|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153965893|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
153965894|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153965895|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153965896|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965897|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153965898|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153729884|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965900|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965901|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153965902|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154263169|NCT05964140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154263170|NCT05964140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965903|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153965904|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153965905|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153965906|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
153965907|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965908|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965909|NCT02765373|Letrozole|letrozole|mesh-list
153965910|NCT02765373|Anastrozole|anastrozole|mesh-list
153965911|NCT02765373|Exemestane|exemestane|mesh-list
153965912|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965913|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153965914|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153965915|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965927|NCT02760615|Omeprazole|omeprazole|mesh-list
153965928|NCT02760615|Vedolizumab|vedolizumab|mesh-list
153965929|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153965930|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153965931|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965932|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965933|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153965934|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965935|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965936|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153965937|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
153965938|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
153965939|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
153965940|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
153965941|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965942|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965943|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153965944|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153965945|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153965946|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153965947|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153965948|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153965949|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965950|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153965951|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153965952|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
153965953|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153965954|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965955|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153965956|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
153965957|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
153965958|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153965959|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153965960|NCT02760615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153965961|NCT02760615|Narcotics|narcotics|mesh-ancestor
153965962|NCT02760615|Analgesics|analgesics|mesh-ancestor
153965963|NCT02760615|Sensory System Agents|sensory system agents|mesh-ancestor
153965964|NCT02760615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965965|NCT02760459|Dexamethasone|dexamethasone|mesh-list
153965966|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965967|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
153965968|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
153965969|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965970|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965972|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
153965973|NCT02760459|Hormones|hormones|mesh-ancestor
153965974|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965975|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153965976|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965977|NCT02765217|Amoxicillin|amoxicillin|mesh-list
153965978|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
153965979|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
153965980|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153965993|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153965994|NCT02760381|Protective Agents|protective agents|mesh-ancestor
153965995|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965996|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
153965997|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153965998|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965999|NCT02760225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153966000|NCT02760225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966001|NCT00744757|Decitabine|decitabine|mesh-list
153966002|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966003|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
153966004|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966005|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966006|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966007|NCT00917527|Atorvastatin|atorvastatin|mesh-list
153966008|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153966009|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153966010|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
153966011|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966012|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153966013|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153966014|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966015|NCT00745849|Esomeprazole|esomeprazole|mesh-list
153966016|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153966017|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153966018|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153966019|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966020|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966021|NCT02759991|Vaccines|vaccines|mesh-list
153966022|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
153966023|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966024|NCT04112277|Morphine|morphine|mesh-list
153966025|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153966026|NCT04112277|Narcotics|narcotics|mesh-ancestor
153966027|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966028|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966029|NCT04112277|Analgesics|analgesics|mesh-ancestor
153966030|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
153966031|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966032|NCT00749203|Midazolam|midazolam|mesh-list
153966033|NCT00749203|Ketamine|ketamine|mesh-list
153966034|NCT00749203|Analgesics|analgesics|mesh-ancestor
153966035|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
153966036|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966037|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966038|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153966039|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153966040|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
153966041|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
153966042|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723544|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
153966080|NCT02764125|Carbidopa|carbidopa|mesh-list
153966081|NCT02764125|Entacapone|entacapone|mesh-list
153723615|NCT00426049|Everolimus|everolimus|mesh-list
153966103|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966105|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966106|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966107|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966108|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153966109|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
153966110|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153966111|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966112|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
153966113|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966114|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153966115|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153966116|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
153966117|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966118|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153966119|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153966120|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153966121|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153966122|NCT02763969|Interferons|interferons|mesh-list
153966123|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
153966124|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
153966125|NCT02763969|Ustekinumab|ustekinumab|mesh-list
153966126|NCT02763969|Famotidine|famotidine|mesh-list
153966127|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966128|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
153966129|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966130|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
153735832|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
153904484|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153904486|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
153966131|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966132|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966133|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153966134|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153966163|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153966164|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153966165|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
153966166|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966167|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966168|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153966169|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153966170|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153966171|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153966172|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
153966173|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
153966174|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966175|NCT02762955|Adalimumab|adalimumab|mesh-list
153966176|NCT02762955|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153966177|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966178|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966179|NCT04191681|Valsartan|valsartan|mesh-list
153966180|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153723692|NCT00444418|Naltrexone|naltrexone|mesh-list
153966202|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153966203|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966204|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966205|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153966206|NCT02757495|Analgesics|analgesics|mesh-ancestor
153966207|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
153966208|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966209|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153966210|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153966211|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153966212|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
153966213|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966214|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966215|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
153966216|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966217|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
153966218|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
153966219|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966220|NCT02752113|Metformin|metformin|mesh-list
153966221|NCT02752113|Empagliflozin|empagliflozin|mesh-list
153966222|NCT02752113|Linagliptin|linagliptin|mesh-list
153966223|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153966224|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966225|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153966226|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966227|NCT02752113|Incretins|incretins|mesh-ancestor
153966228|NCT02752113|Hormones|hormones|mesh-ancestor
153966229|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966230|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153966231|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
153723737|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
153966247|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153966248|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153966249|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966250|NCT02755857|Itraconazole|itraconazole|mesh-list
153966251|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
153966252|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966253|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153966254|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153448439|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966255|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966256|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966257|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153966258|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
153966259|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263172|NCT05945485|Immunologic Factors|immunologic factors|mesh-ancestor
153415592|NCT02244164|Liraglutide|liraglutide|mesh-list
153966260|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966261|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153966262|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
153966264|NCT02755545|Salicylates|salicylates|mesh-list
153966265|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153966266|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153966267|NCT02755545|Analgesics|analgesics|mesh-ancestor
153966268|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
153966269|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966270|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966271|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729885|NCT01248949|Paclitaxel|paclitaxel|mesh-list
153966272|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966273|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966274|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966275|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
153966276|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
153966277|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153966278|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966279|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966280|NCT02695797|Prednisolone|prednisolone|mesh-list
153966281|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966282|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
153966283|NCT02695797|Hormones|hormones|mesh-ancestor
153966284|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966285|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966286|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153966287|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966288|NCT02755311|Cisplatin|cisplatin|mesh-list
153966289|NCT02755311|Carboplatin|carboplatin|mesh-list
153966290|NCT02755311|Fluorouracil|fluorouracil|mesh-list
153966318|NCT04090801|Minoxidil|minoxidil|mesh-list
153966319|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153966320|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966321|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966322|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966323|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153966324|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
153966325|NCT04089631|Capecitabine|capecitabine|mesh-list
153966326|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966327|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
153966328|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966329|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966330|NCT00917059|Bupropion|bupropion|mesh-list
153966331|NCT00917059|Escitalopram|escitalopram|mesh-list
153966332|NCT00917059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153966333|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153966334|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153966335|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966336|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966337|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
153966338|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723846|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
153966366|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966367|NCT04220073|Antibodies|antibodies|mesh-list
153448450|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
153966368|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153966369|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
153966370|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966371|NCT05429151|Acyclovir|acyclovir|mesh-list
153966372|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
153966373|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966374|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
153966375|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153966376|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153966377|NCT04219995|Prednisolone|prednisolone|mesh-list
153966378|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
153966379|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153966380|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
153966381|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966382|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
153966383|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
154263173|NCT05945485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263174|NCT05932693|Menthol|menthol|mesh-list
154263175|NCT05932693|Antipruritics|antipruritics|mesh-ancestor
154263176|NCT05932693|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966384|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723902|NCT00446173|Busulfan|busulfan|mesh-list
153966452|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966453|NCT02752971|Diclofenac|diclofenac|mesh-list
153966454|NCT02752971|Bupivacaine|bupivacaine|mesh-list
153966455|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
153966456|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
153966457|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966458|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966459|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
153966460|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966461|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153966462|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153966463|NCT02752971|Analgesics|analgesics|mesh-ancestor
153966464|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966494|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966495|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153966497|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
153966498|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153966499|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153966500|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966501|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
153966503|NCT04218981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153966504|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153966505|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153966506|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966507|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966508|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
153966509|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966510|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153966524|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966525|NCT04218435|Valsartan|valsartan|mesh-list
153966526|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153966527|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153966528|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153966529|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153966530|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966531|NCT04138875|Rituximab|rituximab|mesh-list
153966532|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153966533|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153966534|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153966535|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966536|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
153966537|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966538|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966539|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153966540|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
153966541|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966542|NCT04138875|Immunotoxins|immunotoxins|mesh-ancestor
153966543|NCT04138875|Immunoconjugates|immunoconjugates|mesh-ancestor
153966544|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153966545|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
153966546|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966547|NCT02695563|Lactoferrin|lactoferrin|mesh-list
153966548|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966549|NCT02747823|Bevacizumab|bevacizumab|mesh-list
153966550|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153966551|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966552|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153966553|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153966554|NCT02747823|Growth Substances|growth substances|mesh-ancestor
153966555|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966556|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
153966557|NCT02747511|Haloperidol|haloperidol|mesh-list
153966558|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
154263177|NCT05919823|Xanomeline|xanomeline|mesh-list
153966559|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
153966560|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
153966561|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966562|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966563|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153966564|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153966565|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153966566|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966567|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153966568|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153966569|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
153729887|NCT01248949|Carboplatin|carboplatin|mesh-list
153966570|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966599|NCT02742051|Fluorouracil|fluorouracil|mesh-list
153966600|NCT02742051|Everolimus|everolimus|mesh-list
153966601|NCT02742051|Letrozole|letrozole|mesh-list
153966602|NCT02742051|Epirubicin|epirubicin|mesh-list
153966603|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153966604|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
153966605|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966606|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966607|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153966608|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
153966609|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966610|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906873|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
153966611|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153966612|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
153966613|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966614|NCT02742051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153966615|NCT02742051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153966616|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966617|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153966618|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153966619|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153966620|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
153966621|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966622|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153724130|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966636|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966637|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153966639|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966640|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
153966641|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
153966642|NCT02745873|Vitamins|vitamins|mesh-ancestor
153966643|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
153966644|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724268|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153966645|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
153966646|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966647|NCT02745873|Protective Agents|protective agents|mesh-ancestor
153966648|NCT02745639|Capecitabine|capecitabine|mesh-list
153966649|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
153966650|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966651|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
153966652|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966653|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966654|NCT02745717|Cyclosporine|cyclosporine|mesh-list
153966655|NCT02745717|Cyclosporins|cyclosporins|mesh-list
153966656|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
153966657|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153966658|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966659|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966660|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153966661|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
153966662|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966663|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
153966664|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966665|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966666|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966667|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153966668|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
153966669|NCT02745561|Endostatins|endostatins|mesh-list
153966670|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966671|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153966672|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153966673|NCT02745561|Growth Substances|growth substances|mesh-ancestor
153966674|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966675|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
153966676|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
153966677|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153906892|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
153966678|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966679|NCT02745093|Misoprostol|misoprostol|mesh-list
153966680|NCT02745093|Mifepristone|mifepristone|mesh-list
153966681|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153966682|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
153966683|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153966695|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
153966696|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966697|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
153966698|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153966699|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153966701|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153966702|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
153966703|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966704|NCT02741115|Udenafil|udenafil|mesh-list
153966705|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153966706|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153966707|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966708|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966709|NCT02740803|Listerine|listerine|mesh-list
153966710|NCT02740803|Fluorides|fluorides|mesh-list
153966711|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
153966712|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
153966713|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
153966714|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
153966715|NCT02740803|Protective Agents|protective agents|mesh-ancestor
153966716|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966717|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153966718|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966719|NCT02740647|Amoxicillin|amoxicillin|mesh-list
153966720|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
153966721|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
153966722|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153966723|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153966724|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966725|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153966726|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966727|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966728|NCT03737253|Menotropins|menotropins|mesh-list
153966729|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153966731|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966732|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966733|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153966734|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
153966735|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153966736|NCT00812968|Lenalidomide|lenalidomide|mesh-list
153966737|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
153966738|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966739|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153966740|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153966741|NCT00812968|Growth Substances|growth substances|mesh-ancestor
153966742|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
153966743|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966744|NCT02744703|Capecitabine|capecitabine|mesh-list
153966745|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153724241|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
153966756|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966757|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966759|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153966760|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153966761|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966762|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153966763|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153966764|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966765|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
153966766|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153966767|NCT02744625|Propofol|propofol|mesh-list
154263178|NCT05919823|Trospium chloride|trospium chloride|mesh-list
153966768|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153966769|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966770|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966771|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153966772|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
153966773|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
153966774|NCT02610556|Cisplatin|cisplatin|mesh-list
153966775|NCT02610556|Docetaxel|docetaxel|mesh-list
153966776|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966777|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
153966778|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
153966779|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
153966780|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966781|NCT02740101|Oxytocin|oxytocin|mesh-list
153966782|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
153966783|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153966784|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966785|NCT02612116|Ticagrelor|ticagrelor|mesh-list
153966786|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153966787|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153966788|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153966789|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153966790|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
153966791|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357765|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
153966792|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966793|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966795|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153966796|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153966797|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
153966798|NCT00813592|Pasireotide|pasireotide|mesh-list
153966799|NCT00813592|Hormones|hormones|mesh-ancestor
153966800|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966801|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966802|NCT02739633|Paclitaxel|paclitaxel|mesh-list
153966803|NCT02739633|genexol-PM|genexol-pm|mesh-list
153966804|NCT02739633|Gemcitabine|gemcitabine|mesh-list
153966805|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153966806|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966807|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
153966808|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
153966809|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
153966832|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966833|NCT02739399|Protective Agents|protective agents|mesh-ancestor
153966834|NCT02743065|Doxorubicin|doxorubicin|mesh-list
153966835|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153966836|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966837|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153966838|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153966839|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966840|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966841|NCT06179056|Azithromycin|azithromycin|mesh-list
153966842|NCT06179056|Doxycycline|doxycycline|mesh-list
153966843|NCT06179056|Acetylcysteine|acetylcysteine|mesh-list
153966844|NCT06179056|Salicylic Acid|salicylic acid|mesh-list
153966845|NCT06179056|Salicylates|salicylates|mesh-list
153966846|NCT06179056|Isotretinoin|isotretinoin|mesh-list
153966847|NCT06179056|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153966848|NCT06179056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153966849|NCT06179056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966850|NCT06179056|Antimalarials|antimalarials|mesh-ancestor
153966851|NCT06179056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153966852|NCT06179056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153966853|NCT06179056|Antiviral Agents|antiviral agents|mesh-ancestor
153966854|NCT06179056|Expectorants|expectorants|mesh-ancestor
153966855|NCT06179056|Respiratory System Agents|respiratory system agents|mesh-ancestor
153966856|NCT06179056|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153966857|NCT06179056|Antioxidants|antioxidants|mesh-ancestor
153966858|NCT06179056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966859|NCT06179056|Protective Agents|protective agents|mesh-ancestor
153966860|NCT06179056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966861|NCT06179056|Antidotes|antidotes|mesh-ancestor
153966862|NCT06179056|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966863|NCT06179056|Antifungal Agents|antifungal agents|mesh-ancestor
153966864|NCT06179056|Keratolytic Agents|keratolytic agents|mesh-ancestor
153966889|NCT06178848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966890|NCT06178848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153966891|NCT06178848|Anesthetics, General|anesthetics, general|mesh-ancestor
153966893|NCT06178835|Epoetin Alfa|epoetin alfa|mesh-list
153966894|NCT06178835|Hematinics|hematinics|mesh-ancestor
153966895|NCT06178627|Amphotericin B|amphotericin b|mesh-list
153966896|NCT06178627|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153966897|NCT06178627|Flucytosine|flucytosine|mesh-list
153966898|NCT06178627|Amebicides|amebicides|mesh-ancestor
153966899|NCT06178627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153966900|NCT06178627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153966901|NCT06178627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966902|NCT06178627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153966903|NCT06178627|Antifungal Agents|antifungal agents|mesh-ancestor
153966904|NCT06178627|Antimetabolites|antimetabolites|mesh-ancestor
153966905|NCT06178627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966906|NCT06178523|Sildenafil Citrate|sildenafil citrate|mesh-list
153966907|NCT06178523|Citric Acid|citric acid|mesh-list
153966908|NCT06178523|Sodium Citrate|sodium citrate|mesh-list
153966909|NCT06178523|Clomiphene|clomiphene|mesh-list
153966910|NCT06178523|Enclomiphene|enclomiphene|mesh-list
153966911|NCT06178523|Zuclomiphene|zuclomiphene|mesh-list
153966912|NCT06178523|Anticoagulants|anticoagulants|mesh-ancestor
153966913|NCT06178523|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153966914|NCT06178523|Chelating Agents|chelating agents|mesh-ancestor
153966915|NCT06178523|Sequestering Agents|sequestering agents|mesh-ancestor
153966916|NCT06178523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966917|NCT06178523|Vasodilator Agents|vasodilator agents|mesh-ancestor
153966918|NCT06178523|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153966931|NCT06178445|Pembrolizumab|pembrolizumab|mesh-list
153966932|NCT06178445|Trastuzumab|trastuzumab|mesh-list
153966933|NCT06178445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153966934|NCT06178445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966935|NCT06178445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153966936|NCT06178445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966937|NCT06173466|Dexamethasone|dexamethasone|mesh-list
153966938|NCT06173466|Bupivacaine|bupivacaine|mesh-list
153966939|NCT06173466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966940|NCT06173466|Antiemetics|antiemetics|mesh-ancestor
153966941|NCT06173466|Autonomic Agents|autonomic agents|mesh-ancestor
153966942|NCT06173466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966943|NCT06173466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966944|NCT06173466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153966945|NCT06173466|Glucocorticoids|glucocorticoids|mesh-ancestor
153966946|NCT06173466|Hormones|hormones|mesh-ancestor
153966947|NCT06173466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966948|NCT06173466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153966949|NCT06173466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966950|NCT06173466|Anesthetics, Local|anesthetics, local|mesh-ancestor
153966951|NCT06173466|Anesthetics|anesthetics|mesh-ancestor
153966952|NCT06173466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966953|NCT06173466|Sensory System Agents|sensory system agents|mesh-ancestor
153966954|NCT06169046|Clenbuterol|clenbuterol|mesh-list
153966955|NCT06169046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153966956|NCT06169046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153966957|NCT06169046|Adrenergic Agents|adrenergic agents|mesh-ancestor
153966958|NCT06169046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966959|NCT06169046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966960|NCT06169046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966961|NCT06169046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153966962|NCT06169046|Autonomic Agents|autonomic agents|mesh-ancestor
153966963|NCT06169046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966964|NCT06169046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153966965|NCT06169046|Respiratory System Agents|respiratory system agents|mesh-ancestor
153966966|NCT06169046|Sympathomimetics|sympathomimetics|mesh-ancestor
153966967|NCT06166498|Artesunate|artesunate|mesh-list
153966968|NCT06166498|Pyrimethamine|pyrimethamine|mesh-list
153966969|NCT06166498|Sulfadoxine|sulfadoxine|mesh-list
153966970|NCT06166498|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153966971|NCT06166498|Antimalarials|antimalarials|mesh-ancestor
153966972|NCT06166498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153966973|NCT06166498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153966974|NCT06166498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966975|NCT06166498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966976|NCT06166498|Antiviral Agents|antiviral agents|mesh-ancestor
153966977|NCT06166498|Schistosomicides|schistosomicides|mesh-ancestor
153966978|NCT06166498|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153904741|NCT00624026|Memantine|memantine|mesh-list
153966979|NCT06166498|Anthelmintics|anthelmintics|mesh-ancestor
153966980|NCT06166498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153967001|NCT06150014|Antiviral Agents|antiviral agents|mesh-ancestor
153967002|NCT06150014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967003|NCT06150014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153967004|NCT06150014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153967005|NCT06150014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967006|NCT06150014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967007|NCT06150014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153967008|NCT06150014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153967009|NCT06135103|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153967010|NCT06135103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153967011|NCT06135103|Vasodilator Agents|vasodilator agents|mesh-ancestor
153967012|NCT06114407|Tofacitinib|tofacitinib|mesh-list
153967013|NCT06114407|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153967014|NCT06114407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967015|NCT06114407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967016|NCT06114407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967017|NCT06111443|Dapagliflozin|dapagliflozin|mesh-list
153967018|NCT06111443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153967019|NCT06111443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967020|NCT06111443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153967021|NCT06111443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967023|NCT06077877|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153967024|NCT06077877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967025|NCT06077877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967026|NCT06077877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967027|NCT06069869|Iron|iron|mesh-list
153967028|NCT06069869|Trace Elements|trace elements|mesh-list
153967029|NCT06069869|Micronutrients|micronutrients|mesh-list
153967030|NCT06069869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967031|NCT06017479|Levofloxacin|levofloxacin|mesh-list
153967032|NCT06017479|Fosfomycin|fosfomycin|mesh-list
153967033|NCT06017479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153967034|NCT06017479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967035|NCT06017479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153724533|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
153967060|NCT05932667|Fulvestrant|fulvestrant|mesh-list
153967061|NCT05932667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153967062|NCT05932667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967063|NCT05932667|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153967064|NCT05932667|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153967065|NCT05932667|Hormone Antagonists|hormone antagonists|mesh-ancestor
153967066|NCT05932667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967067|NCT05932667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967068|NCT05917340|Aspirin|aspirin|mesh-list
153967069|NCT05917340|Moxifloxacin|moxifloxacin|mesh-list
153967070|NCT05917340|Rifampin|rifampin|mesh-list
153967071|NCT05917340|Isoniazid|isoniazid|mesh-list
153967072|NCT05917340|Pyrazinamide|pyrazinamide|mesh-list
153967073|NCT05917340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153967074|NCT05917340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153967075|NCT05917340|Analgesics|analgesics|mesh-ancestor
153967076|NCT05917340|Sensory System Agents|sensory system agents|mesh-ancestor
153967077|NCT05917340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967078|NCT05917340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967079|NCT05917340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967080|NCT05917340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967081|NCT05917340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153967082|NCT05917340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153967083|NCT05917340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967109|NCT05902819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967110|NCT05901051|Amoxicillin|amoxicillin|mesh-list
153967111|NCT05901051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153967112|NCT05901051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967113|NCT05798156|Rituximab|rituximab|mesh-list
153967114|NCT05798156|Obinutuzumab|obinutuzumab|mesh-list
153967115|NCT05798156|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153967116|NCT05798156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967117|NCT05798156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967118|NCT05798156|Immunologic Factors|immunologic factors|mesh-ancestor
153967119|NCT05798156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967120|NCT05798156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967121|NCT05798156|Immunoconjugates|immunoconjugates|mesh-ancestor
153967122|NCT05778825|Minoxidil|minoxidil|mesh-list
153967123|NCT05778825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153967124|NCT05778825|Vasodilator Agents|vasodilator agents|mesh-ancestor
153967125|NCT05774899|Lenvatinib|lenvatinib|mesh-list
153967126|NCT05774899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967127|NCT05774899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967128|NCT05774899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967129|NCT05774899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967130|NCT05767047|Apremilast|apremilast|mesh-list
153967131|NCT05767047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153724639|NCT00401804|Hormones|hormones|mesh-ancestor
153967164|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
153967165|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967166|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153967167|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
153967168|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153967169|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
153967170|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
153967171|NCT05661149|Insulin|insulin|mesh-list
153724686|NCT00460369|Artesunate|artesunate|mesh-list
153967185|NCT05438329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153907001|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
153967186|NCT05438329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967187|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153967188|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153967189|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967190|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153967191|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153967192|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153967193|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967194|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
153967195|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967196|NCT05315648|Anesthetics|anesthetics|mesh-list
153967197|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153967198|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967199|NCT05304455|Heparin|heparin|mesh-list
153967200|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153967201|NCT05304455|Tinzaparin|tinzaparin|mesh-list
153967202|NCT05304455|Dalteparin|dalteparin|mesh-list
153967203|NCT05304455|Dipyridamole|dipyridamole|mesh-list
153967204|NCT05304455|Apixaban|apixaban|mesh-list
153967205|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
153967206|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153967207|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153967208|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967209|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153967210|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
153967211|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153967212|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
153967213|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967214|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153967215|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153967216|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
153967217|NCT05279937|Lidocaine|lidocaine|mesh-list
153967218|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153967219|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
153967220|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
153967221|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153967222|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967223|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
153967224|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967225|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153967226|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153967227|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153967228|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153967229|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967230|NCT05238883|Tislelizumab|tislelizumab|mesh-list
153967252|NCT05153668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967254|NCT05153668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967255|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967256|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
153967257|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967258|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967259|NCT05119855|Vaccines|vaccines|mesh-list
154263179|NCT05919823|Parasympatholytics|parasympatholytics|mesh-ancestor
153967260|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
153967261|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967262|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
153967263|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153967264|NCT05058872|Estradiol|estradiol|mesh-list
153967265|NCT05058872|Estrogens|estrogens|mesh-ancestor
153967266|NCT05058872|Hormones|hormones|mesh-ancestor
153967267|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967268|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967269|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153967270|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
153967271|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153967272|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153967273|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153967274|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153967275|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153967276|NCT05042128|Paclitaxel|paclitaxel|mesh-list
153967277|NCT05042128|Gemcitabine|gemcitabine|mesh-list
153967278|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153967279|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967280|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
153967281|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
153967282|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724802|NCT03273595|Paclitaxel|paclitaxel|mesh-list
153967297|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967298|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153967299|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153967300|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
153967301|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967302|NCT05033080|Ivacaftor|ivacaftor|mesh-list
153967303|NCT05033080|Elexacaftor|elexacaftor|mesh-list
153967304|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153967305|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153967306|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967307|NCT05022901|Melphalan|melphalan|mesh-list
153967308|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153967309|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
153967310|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967311|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967312|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153967313|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967314|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
153967315|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967316|NCT04989946|Nivolumab|nivolumab|mesh-list
153967318|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967319|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967320|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153967321|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967322|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
153967323|NCT04965090|Lazertinib|lazertinib|mesh-list
153967324|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967325|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967326|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967327|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967328|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967329|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
153967330|NCT04933084|Narcotics|narcotics|mesh-ancestor
153967331|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153967332|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967333|NCT04933084|Analgesics|analgesics|mesh-ancestor
153967334|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
153967335|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967336|NCT04833907|Prednisone|prednisone|mesh-list
153967337|NCT04833907|Levetiracetam|levetiracetam|mesh-list
153967338|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967339|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
153967340|NCT04833907|Hormones|hormones|mesh-ancestor
153967341|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967342|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967371|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153967372|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967373|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967374|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967375|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967377|NCT04664972|Docetaxel|docetaxel|mesh-list
153967378|NCT04664972|Doxorubicin|doxorubicin|mesh-list
153967379|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967380|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
153967381|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967382|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967383|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153967384|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
153967385|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967386|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967387|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153967388|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
153967389|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
153967427|NCT04592744|Norepinephrine|norepinephrine|mesh-list
153967428|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
153967429|NCT04592744|Giapreza|giapreza|mesh-list
153967430|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
153967431|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153967468|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967469|NCT04526236|Methadone|methadone|mesh-list
153967470|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153967471|NCT04526236|Narcotics|narcotics|mesh-ancestor
153967472|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724988|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
153967547|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967582|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967583|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153967584|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153967585|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
153967586|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967599|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
153967600|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967601|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153967602|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
153967603|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967604|NCT03692325|Nivolumab|nivolumab|mesh-list
153967605|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967606|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967607|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153967608|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967609|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
153967610|NCT03642509|Apixaban|apixaban|mesh-list
153967611|NCT03642509|Edoxaban|edoxaban|mesh-list
153967612|NCT03642509|Dabigatran|dabigatran|mesh-list
153967613|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153967614|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
153967615|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153967616|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
153967617|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967618|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967619|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
153967620|NCT03640481|Belumosudil|belumosudil|mesh-list
153967621|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967622|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745630|NCT03433755|Protease Inhibitors|protease inhibitors|mesh-ancestor
153967623|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967625|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967626|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967627|NCT03454451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153725243|NCT00465205|Valacyclovir|valacyclovir|mesh-list
153967628|NCT03454451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967629|NCT03384654|Cytarabine|cytarabine|mesh-list
153967630|NCT03384654|Prednisone|prednisone|mesh-list
153967631|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
153967632|NCT03384654|Doxorubicin|doxorubicin|mesh-list
153967633|NCT03384654|Methotrexate|methotrexate|mesh-list
153967634|NCT03384654|Vincristine|vincristine|mesh-list
153967635|NCT03384654|Asparaginase|asparaginase|mesh-list
153967636|NCT03384654|Daratumumab|daratumumab|mesh-list
153967637|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
153967638|NCT03384654|Pegaspargase|pegaspargase|mesh-list
153967639|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967640|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
153967641|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967642|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263181|NCT05919823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967643|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153967644|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
153967645|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967646|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967647|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153967648|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153967684|NCT03153202|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153967685|NCT03153202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967686|NCT03153202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967687|NCT03108131|Atezolizumab|atezolizumab|mesh-list
153967688|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153967689|NCT03108131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153967690|NCT03108131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967691|NCT03108131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967692|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967693|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
153967694|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967695|NCT03088878|Ibrutinib|ibrutinib|mesh-list
153967696|NCT03088878|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153967726|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967727|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967728|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967729|NCT03015610|Lansoprazole|lansoprazole|mesh-list
153967730|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
153967731|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153967732|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153967733|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153967734|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967735|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967736|NCT03005860|Fentanyl|fentanyl|mesh-list
153967737|NCT03005860|Propofol|propofol|mesh-list
153967738|NCT03005860|Sevoflurane|sevoflurane|mesh-list
153967739|NCT03005860|Atracurium|atracurium|mesh-list
153967740|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153967741|NCT03005860|Narcotics|narcotics|mesh-ancestor
153967742|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153967743|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967764|NCT02928224|Fluorouracil|fluorouracil|mesh-list
153967765|NCT02928224|Irinotecan|irinotecan|mesh-list
153967766|NCT02928224|Cetuximab|cetuximab|mesh-list
153967767|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
153967768|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
153967769|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967770|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153967771|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967772|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967773|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
153967774|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967775|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153967776|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967777|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967778|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153729888|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153967779|NCT02928224|Antidotes|antidotes|mesh-ancestor
153967780|NCT02928224|Protective Agents|protective agents|mesh-ancestor
153967781|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
153967782|NCT02928224|Vitamins|vitamins|mesh-ancestor
153967783|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
153967784|NCT02928224|Hematinics|hematinics|mesh-ancestor
153967785|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153967786|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153967787|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153967788|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153967789|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967790|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967791|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
153967792|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967793|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153967794|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153967795|NCT02788474|Nintedanib|nintedanib|mesh-list
153967796|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725296|NCT03272503|Pimozide|pimozide|mesh-list
153967806|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154263182|NCT05919823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263183|NCT05919823|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153967807|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
153967808|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967809|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967811|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153967812|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
153448721|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
153967813|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967814|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967815|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153967816|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967817|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
153967818|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967819|NCT02631746|Nivolumab|nivolumab|mesh-list
153967820|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967821|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967822|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153967823|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967824|NCT02293655|Methylphenidate|methylphenidate|mesh-list
153967825|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153967826|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967827|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153967828|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153967829|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153967830|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967831|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
153967832|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967833|NCT02166463|Prednisone|prednisone|mesh-list
153967834|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
153967835|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153967836|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153967837|NCT02166463|Prednisolone|prednisolone|mesh-list
153967838|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
153967839|NCT02166463|Cortisone|cortisone|mesh-list
153967840|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
153967841|NCT02166463|Doxorubicin|doxorubicin|mesh-list
153967842|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153967843|NCT02166463|Etoposide|etoposide|mesh-list
153967844|NCT02166463|Vincristine|vincristine|mesh-list
153967845|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
153967846|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153967848|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
153967849|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153967850|NCT02166463|Antibodies|antibodies|mesh-list
153967851|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
153967852|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153967853|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153967854|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
153967855|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
153967856|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967857|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
153967858|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967859|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967860|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153967861|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
153967862|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967896|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
153967897|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967898|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967899|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967900|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153967901|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153967902|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
153967903|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967904|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153967905|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
153967906|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
153967940|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153967941|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
153907146|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967942|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967943|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967944|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153967946|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967947|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153967948|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725451|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153967963|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153967964|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153967965|NCT00135226|Analgesics|analgesics|mesh-ancestor
153967966|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
153967967|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967968|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967969|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967970|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967971|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153967972|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153967973|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967974|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153967975|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153967976|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967977|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
153967978|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153967979|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
153967980|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967981|NCT02742675|Leuprolide|leuprolide|mesh-list
153967982|NCT02742675|Goserelin|goserelin|mesh-list
153967983|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153967984|NCT02742675|Flutamide|flutamide|mesh-list
153967985|NCT02742675|Bicalutamide|bicalutamide|mesh-list
153967986|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153967987|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
153967988|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153967989|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967990|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153967991|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967992|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
153967993|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
153967994|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967995|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
153967996|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153967997|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
153967998|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153967999|NCT00812812|Paroxetine|paroxetine|mesh-list
153968000|NCT00812812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153968001|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153968002|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968003|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968004|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968005|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
153968006|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725496|NCT00117260|Estradiol|estradiol|mesh-list
153968028|NCT02738931|Dolutegravir|dolutegravir|mesh-list
153968029|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153968030|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153968031|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968032|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968033|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
153968034|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968035|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153968036|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153968037|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153968038|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153968039|NCT02738619|Vitamin D|vitamin d|mesh-list
153968040|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
153968041|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
153968042|NCT02738619|Vitamins|vitamins|mesh-list
153968043|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
153968044|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968045|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153968046|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153968047|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
153968048|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153968049|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968050|NCT04016116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153415922|NCT02653183|Laxatives|laxatives|mesh-ancestor
153968051|NCT04016116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968052|NCT02736591|Hormones|hormones|mesh-list
153968053|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
153968054|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968055|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968056|NCT02736513|Osimertinib|osimertinib|mesh-list
153968057|NCT02736513|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153968058|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153968059|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968078|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
153968079|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968081|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968082|NCT00913822|Desipramine|desipramine|mesh-list
153968083|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153968084|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
153968085|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153968086|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968087|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968088|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153968089|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153968090|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968091|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968092|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968093|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968094|NCT02736123|Nivolumab|nivolumab|mesh-list
153968095|NCT02736123|Ipilimumab|ipilimumab|mesh-list
153968096|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153968097|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968098|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153968099|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968100|NCT00744055|Prazosin|prazosin|mesh-list
153968101|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153968102|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153968103|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153968104|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153968105|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968106|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968107|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968108|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968109|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
153968110|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153968111|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153968112|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968113|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
153968114|NCT02738073|Coagulants|coagulants|mesh-ancestor
153968115|NCT03967483|Indomethacin|indomethacin|mesh-list
153968116|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153968117|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153968147|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968148|NCT01026818|Urological Agents|urological agents|mesh-ancestor
153968149|NCT02593747|Loratadine|loratadine|mesh-list
153968150|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
153968151|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
153968152|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153968153|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153968154|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153968155|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
153968156|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
153968157|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968158|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968159|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968160|NCT00743509|Sirolimus|sirolimus|mesh-list
153968161|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
153968192|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968193|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153968194|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968196|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968197|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968198|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
153968199|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
153968200|NCT00734929|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153968201|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153968202|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
153968203|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968204|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153968206|NCT00734851|Sunitinib|sunitinib|mesh-list
153725713|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
153968236|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
153968237|NCT02737605|Esketamine|esketamine|mesh-list
153968238|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153968239|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968240|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153968241|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153968242|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968243|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968244|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968245|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
153968246|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153968247|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
153968248|NCT02737371|Clotrimazole|clotrimazole|mesh-list
153968249|NCT02737371|Miconazole|miconazole|mesh-list
153968250|NCT02737371|Olorofim|olorofim|mesh-list
153968251|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968286|NCT02737059|Narcotics|narcotics|mesh-ancestor
153968306|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968308|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
153968309|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968310|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
153968311|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968312|NCT00743197|Aspirin|aspirin|mesh-list
153968313|NCT00743197|Lisinopril|lisinopril|mesh-list
153968314|NCT00743197|Simvastatin|simvastatin|mesh-list
153907170|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
153968315|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153968316|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153968317|NCT00743197|Analgesics|analgesics|mesh-ancestor
153968318|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
153968319|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968320|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968321|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153968322|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153968323|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153968324|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153968325|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968326|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153968327|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153968328|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968329|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
153968330|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153968331|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153968332|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
153968333|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153968334|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153968335|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153968336|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
153968337|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153968338|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153968339|NCT00743197|Protective Agents|protective agents|mesh-ancestor
153968340|NCT02731287|Timolol|timolol|mesh-list
153562887|NCT01659684|Antibodies|antibodies|mesh-list
153968368|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968370|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
153968371|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153968372|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153968373|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153968374|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153968375|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
153968376|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153968377|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968378|NCT04188951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153968379|NCT04188951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968380|NCT00739297|Montelukast|montelukast|mesh-list
153968381|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153968415|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153968416|NCT02730117|Protective Agents|protective agents|mesh-ancestor
154263184|NCT05919823|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154263185|NCT05919823|Cholinergic Agents|cholinergic agents|mesh-ancestor
153904912|NCT00980980|Mupirocin|mupirocin|mesh-list
153968417|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
153968418|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153968419|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
153968420|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153968421|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153968422|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968442|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153968443|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
153968444|NCT02593669|Hormones|hormones|mesh-ancestor
153968445|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968446|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153968447|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968448|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153968449|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153968451|NCT02729961|Antibodies|antibodies|mesh-list
153968452|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
153968453|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153968454|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
153907185|NCT03931057|Midazolam|midazolam|mesh-list
153968455|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
153968456|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968457|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968458|NCT02729961|Immunotoxins|immunotoxins|mesh-ancestor
153968459|NCT02729961|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153968460|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153968461|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968462|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968463|NCT02735031|Exenatide|exenatide|mesh-list
153968464|NCT02735031|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153968465|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153968466|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968467|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153968468|NCT02735031|Incretins|incretins|mesh-ancestor
153968469|NCT02735031|Hormones|hormones|mesh-ancestor
153968470|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968471|NCT02595541|Milrinone|milrinone|mesh-list
153968472|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
153968473|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
153968474|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153968475|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153968476|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968477|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968503|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968504|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968506|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153968507|NCT00811954|Darunavir|darunavir|mesh-list
153968508|NCT00811954|Tenofovir|tenofovir|mesh-list
153968509|NCT00811954|Emtricitabine|emtricitabine|mesh-list
153968510|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
153745631|NCT03433755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968511|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153968512|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153968513|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153968514|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
153968515|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968516|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968517|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153968518|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153968519|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
153968520|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968521|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153968522|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153968523|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153968524|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153968541|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968542|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153968543|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153968544|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153907206|NCT02845843|Ritonavir|ritonavir|mesh-list
153968545|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968546|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
153968547|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153968549|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968550|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153968551|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968552|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968553|NCT00743119|Dronabinol|dronabinol|mesh-list
153968554|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
153968555|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968556|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153968557|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153968558|NCT00743119|Analgesics|analgesics|mesh-ancestor
153968559|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
153968560|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968561|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153968562|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153968563|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968564|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968565|NCT00743119|Hormones|hormones|mesh-ancestor
153968566|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968567|NCT02610010|Cisplatin|cisplatin|mesh-list
153968568|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968569|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
153968570|NCT02610088|Gliclazide|gliclazide|mesh-list
153968571|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153968572|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968573|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153968574|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968575|NCT02734407|Aflibercept|aflibercept|mesh-list
153968576|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153968577|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153968578|NCT02734407|Growth Substances|growth substances|mesh-ancestor
153968579|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968580|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
153968593|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153968594|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153968596|NCT05297422|Ketamine|ketamine|mesh-list
153968597|NCT05297422|Ropivacaine|ropivacaine|mesh-list
153968598|NCT05297422|Analgesics|analgesics|mesh-ancestor
153968599|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
153968600|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968601|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968602|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153968603|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153968604|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
153968605|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
153968606|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968607|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153968608|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153968609|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968610|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968611|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
153968612|NCT00813124|Fludarabine|fludarabine|mesh-list
153968613|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
153968614|NCT00813124|Azacitidine|azacitidine|mesh-list
153968615|NCT00813124|Busulfan|busulfan|mesh-list
153968616|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
153968617|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153968618|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968619|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153968620|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
153968621|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968622|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153968623|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
153968624|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968625|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968626|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
153907211|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
153968627|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153968628|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153968629|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153968630|NCT02728869|Vaccines|vaccines|mesh-list
153968631|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
153968632|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968633|NCT02594761|Trastuzumab|trastuzumab|mesh-list
153968634|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153968635|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968636|NCT02728947|Rotigotine|rotigotine|mesh-list
153968637|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
153968638|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
153968639|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968640|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968641|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968642|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153968657|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153968659|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
153968660|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
153968661|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968662|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968663|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
153968664|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968665|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153968666|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153968667|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153968668|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968669|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968670|NCT02596555|Dabigatran|dabigatran|mesh-list
153968671|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
153968672|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153968673|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
153968674|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968675|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968676|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
153968677|NCT02733471|Lidocaine|lidocaine|mesh-list
153968678|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
153968679|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
153968680|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968681|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968682|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
153968683|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968684|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153968685|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153968686|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153968687|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968688|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968689|NCT02733237|Oxytocin|oxytocin|mesh-list
153968690|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
153968691|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153968692|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968693|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
153968694|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
153968695|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
153968696|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968697|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968698|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
153968699|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968700|NCT00811720|Nalmefene|nalmefene|mesh-list
153968701|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153968702|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968703|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
153968720|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968721|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968722|NCT02609152|Esmolol|esmolol|mesh-list
153968723|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153968724|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153968725|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153968726|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968727|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968728|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968729|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968730|NCT02733393|Lidocaine|lidocaine|mesh-list
153968732|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
153968733|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968734|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968735|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
153904998|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
153968736|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968737|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153968738|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153968739|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153968740|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968741|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968742|NCT00809926|Valsartan|valsartan|mesh-list
153968743|NCT00809926|Aliskiren|aliskiren|mesh-list
153968744|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153968745|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153968746|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153968747|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968748|NCT00809926|Renin Inhibitors|renin inhibitors|mesh-ancestor
153968749|NCT00809926|Protease Inhibitors|protease inhibitors|mesh-ancestor
153968750|NCT00809926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968751|NCT02728245|Dienogest|dienogest|mesh-list
153968752|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153968753|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
153968754|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153968755|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968756|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153968757|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153968758|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153968759|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153968788|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153968789|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
153968790|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
153968791|NCT02608606|Tacrolimus|tacrolimus|mesh-list
153968792|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153968793|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
153968794|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968795|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153968796|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968797|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968798|NCT02608918|BMS-955176|bms-955176|mesh-list
153907249|NCT05337085|Analgesics|analgesics|mesh-ancestor
153968799|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153968800|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153968801|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
153968802|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968804|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968839|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
153968840|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968841|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968842|NCT02720991|Misoprostol|misoprostol|mesh-list
153968843|NCT02720991|Mifepristone|mifepristone|mesh-list
153968844|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153968845|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
153968862|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153968863|NCT02720601|Capecitabine|capecitabine|mesh-list
153968864|NCT02720601|Irinotecan|irinotecan|mesh-list
153968865|NCT02720601|Camptothecin|camptothecin|mesh-list
153968866|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153968867|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
153968868|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968869|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968870|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153968871|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153968872|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968873|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153968874|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
153968875|NCT00590590|Promethazine|promethazine|mesh-list
153968876|NCT00590590|Lidocaine|lidocaine|mesh-list
153968877|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
153968878|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
153968879|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968880|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968881|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
153968882|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968883|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153968884|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153968885|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153968886|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154263186|NCT05919823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263187|NCT05919823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968887|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968888|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153968889|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153968890|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
153968891|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
153968892|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153968893|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153968894|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
153968895|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
153968896|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968897|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153968898|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
153968899|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
153968900|NCT02720367|Gemcitabine|gemcitabine|mesh-list
153968901|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153968902|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
153968932|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
153968933|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
153907271|NCT01723579|Estradiol|estradiol|mesh-list
153968934|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968935|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968936|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
153968937|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968938|NCT02725359|Analgesics|analgesics|mesh-ancestor
153968939|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
153968940|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153968941|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153968942|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
153968943|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
153968944|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153968945|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153968946|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153968947|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968948|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968949|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968960|NCT00806494|Fesoterodine|fesoterodine|mesh-list
153968961|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153968962|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153968963|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
153968964|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968965|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968966|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968967|NCT00806494|Urological Agents|urological agents|mesh-ancestor
153968968|NCT00806416|Vitamin D|vitamin d|mesh-list
153968969|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
153968970|NCT00806416|Alendronate|alendronate|mesh-list
153968971|NCT00806416|Vitamins|vitamins|mesh-ancestor
153968972|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
153968973|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968974|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153968975|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153968976|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153968977|NCT00811252|Vortioxetine|vortioxetine|mesh-list
153968978|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153968979|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153968980|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968981|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968982|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968983|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968984|NCT00811252|Analgesics|analgesics|mesh-ancestor
153968985|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
153968986|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968987|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
153968988|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153968989|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
153968990|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153968991|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153968992|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968993|NCT00811252|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153968994|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
153905050|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
153968995|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153968996|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153968997|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153968998|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153968999|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153969000|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
153969001|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969002|NCT00736957|Acetaminophen|acetaminophen|mesh-list
153969003|NCT00736957|Tramadol|tramadol|mesh-list
153969004|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153969005|NCT00736957|Analgesics|analgesics|mesh-ancestor
153969006|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
153969007|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969008|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969009|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
153969010|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153969011|NCT00736957|Narcotics|narcotics|mesh-ancestor
153969012|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969013|NCT05294523|Rocuronium|rocuronium|mesh-list
153969014|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153969015|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153969016|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153969026|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153969027|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153969028|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969029|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969031|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153969032|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969033|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969034|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969035|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153969036|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
153969037|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153969038|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969039|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
153969040|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153969041|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153969042|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
153969043|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969044|NCT02723487|Bupivacaine|bupivacaine|mesh-list
153969045|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
153969046|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
153969047|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969048|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969049|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
153969050|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969051|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
153969052|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
153969053|NCT02717871|Levofloxacin|levofloxacin|mesh-list
153969055|NCT02717871|Gentamicins|gentamicins|mesh-list
153969056|NCT02717871|Cefazolin|cefazolin|mesh-list
153969057|NCT02717871|Tobramycin|tobramycin|mesh-list
153969058|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
153969059|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
153969060|NCT02717871|Besifloxacin|besifloxacin|mesh-list
153969061|NCT02717871|Prednisolone|prednisolone|mesh-list
153969062|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153969063|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
153969064|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153969065|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
153969066|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153969067|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153969068|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
153969069|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
153969070|NCT02717871|Mydriatics|mydriatics|mesh-list
153969071|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153969072|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
153969073|NCT02717871|Hormones|hormones|mesh-ancestor
153969074|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153969075|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969076|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153969077|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969078|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
153969079|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
153969080|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969081|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153969082|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153969083|NCT02717871|Protective Agents|protective agents|mesh-ancestor
153969084|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153969091|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153969092|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153969093|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153969094|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153969095|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153969097|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153969098|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153969099|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
153969100|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969101|NCT02723253|Raltitrexed|raltitrexed|mesh-list
153969102|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969103|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153969104|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
153969105|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969106|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153969107|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969108|NCT00730405|Albaconazole|albaconazole|mesh-list
153969109|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
153969110|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969111|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
153969112|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153969113|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969114|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
153726743|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
153969115|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969116|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
153969117|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
153969118|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153969119|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
153969120|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
153969121|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969122|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969123|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153969125|NCT00736645|Finasteride|finasteride|mesh-list
153969126|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153969127|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153969128|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969129|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969130|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
153969131|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153969132|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969133|NCT00736645|Urological Agents|urological agents|mesh-ancestor
153969134|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
153969135|NCT00736645|Protective Agents|protective agents|mesh-ancestor
153969136|NCT00736645|Trace Elements|trace elements|mesh-ancestor
153969137|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
153969138|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
153969139|NCT00736489|AZD-3199|azd-3199|mesh-list
153969140|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153969141|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
153969142|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969143|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969144|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153969145|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
153969146|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153969147|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153969148|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153969149|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
153969150|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726642|NCT00483301|Sorafenib|sorafenib|mesh-list
153969161|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153969162|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
153969163|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153969164|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969165|NCT04087915|Evolocumab|evolocumab|mesh-list
153969166|NCT04087915|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153969167|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153969168|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153969169|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
153969170|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969171|NCT04087915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153969173|NCT04087915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969174|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153969175|NCT02715687|Amiodarone|amiodarone|mesh-list
153969177|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
153969178|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153969179|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153969180|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969181|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153969182|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153969183|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153969184|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969185|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153969186|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153969187|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153969188|NCT02715531|Leucovorin|leucovorin|mesh-list
153969189|NCT02715531|Paclitaxel|paclitaxel|mesh-list
153969190|NCT02715531|Bevacizumab|bevacizumab|mesh-list
153969191|NCT02715531|Gemcitabine|gemcitabine|mesh-list
153969192|NCT02715531|Capecitabine|capecitabine|mesh-list
153969193|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
153969194|NCT02715531|Atezolizumab|atezolizumab|mesh-list
153969195|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153969196|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969197|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
153969198|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
153969199|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
153969200|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969201|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153969202|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153969203|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153969204|NCT02715531|Growth Substances|growth substances|mesh-ancestor
153969205|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969206|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
153969207|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153969208|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
153969209|NCT02715531|Antidotes|antidotes|mesh-ancestor
153969210|NCT02715531|Protective Agents|protective agents|mesh-ancestor
153969211|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
153969212|NCT02715531|Vitamins|vitamins|mesh-ancestor
153969213|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
153969214|NCT02715531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153969215|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
153726708|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
153969224|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153969225|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
153969226|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
153969227|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969228|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153969229|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153969230|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969231|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969232|NCT00914056|Lactulose|lactulose|mesh-list
153969233|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153969234|NCT00730171|Linaclotide|linaclotide|mesh-list
153969235|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153969236|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
153969237|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969238|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153969239|NCT04787835|Anesthetics|anesthetics|mesh-list
153969240|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
153969241|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969242|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969243|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
153969244|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969245|NCT00730015|Linaclotide|linaclotide|mesh-list
153969246|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153969247|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
153969248|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969250|NCT00806026|Pregabalin|pregabalin|mesh-list
153969251|NCT00806026|Pramipexole|pramipexole|mesh-list
153969252|NCT00806026|Dexpramipexole|dexpramipexole|mesh-list
153969253|NCT00806026|Analgesics|analgesics|mesh-ancestor
153969254|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
153969255|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969256|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969257|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
153969258|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153969259|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153969260|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969261|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153969262|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153969263|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153726900|NCT02274337|Abivertinib|abivertinib|mesh-list
153969264|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969265|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153969266|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
153969267|NCT00806026|Protective Agents|protective agents|mesh-ancestor
153969268|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153969269|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153969270|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
153969271|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
153969272|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969273|NCT04227093|Acetazolamide|acetazolamide|mesh-list
153969274|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
153969275|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153969276|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969277|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969278|NCT04227093|Diuretics|diuretics|mesh-ancestor
153969279|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
153969280|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969282|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153969305|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969306|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153969307|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153969309|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969310|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
153969311|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
153969312|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
153969313|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969314|NCT02713893|Econazole|econazole|mesh-list
153969315|NCT02713893|Benzydamine|benzydamine|mesh-list
153969316|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153969317|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
153969318|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969319|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153969320|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153969321|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969322|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969323|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153969324|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
153969325|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153969326|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969327|NCT00729937|Clindamycin|clindamycin|mesh-list
153969328|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
153969329|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
153969330|NCT00729937|Cephalexin|cephalexin|mesh-list
153969331|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153969332|NCT00729937|Trimethoprim|trimethoprim|mesh-list
153969333|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
153969334|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153449025|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153969335|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969336|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153969350|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
153969351|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
153969352|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153969353|NCT00729859|Acyline|acyline|mesh-list
153969354|NCT00729859|Androgens|androgens|mesh-ancestor
153969355|NCT00729859|Hormones|hormones|mesh-ancestor
153969356|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153969357|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969358|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153969359|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969360|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
153969361|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153969362|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153969363|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905180|NCT01203852|Metoprolol|metoprolol|mesh-list
153969364|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969365|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153969366|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
153969367|NCT00810394|Sorafenib|sorafenib|mesh-list
153969368|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969369|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153969370|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969371|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969372|NCT00736333|Doxorubicin|doxorubicin|mesh-list
153969373|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153969374|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153969375|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969376|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153969377|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153969378|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969379|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969380|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153969381|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
153969382|NCT00736255|Nicotine|nicotine|mesh-list
153969383|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153969384|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
153969385|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969386|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969387|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153969388|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153969389|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
153969390|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969391|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969392|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153969393|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153969394|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153969395|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153969396|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
153969397|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153969413|NCT05754736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727037|NCT00486421|Hormones|hormones|mesh-ancestor
153969414|NCT05754736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153969415|NCT05754736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153969417|NCT05754736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969418|NCT05754736|Growth Inhibitors|growth inhibitors|mesh-ancestor
153969419|NCT00742027|Panobinostat|panobinostat|mesh-list
153969420|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969421|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153969422|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969423|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969424|NCT02609698|Aspirin|aspirin|mesh-list
153969425|NCT02609698|Clopidogrel|clopidogrel|mesh-list
153969426|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153969427|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153969428|NCT02609698|Analgesics|analgesics|mesh-ancestor
153969429|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
153969430|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969431|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969432|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153969433|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153969434|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153969435|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153969436|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969437|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153969438|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153969439|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969440|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
153969441|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153969442|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153969443|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153969444|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
153969445|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969446|NCT05750134|Pancrelipase|pancrelipase|mesh-list
153969447|NCT05750134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153969448|NCT05749822|Fenofibrate|fenofibrate|mesh-list
153969449|NCT05749822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153969450|NCT05749822|Antimetabolites|antimetabolites|mesh-ancestor
154263188|NCT05919823|Urological Agents|urological agents|mesh-ancestor
153969451|NCT05749822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969452|NCT05749822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153969453|NCT02713191|Midazolam|midazolam|mesh-list
153969454|NCT02713191|Fentanyl|fentanyl|mesh-list
153969455|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
153969456|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153969457|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969458|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969469|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153969470|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153969471|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153969472|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153969473|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153969474|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
153969475|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
153969476|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
153969477|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
153969478|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153969479|NCT02713191|Narcotics|narcotics|mesh-ancestor
153969480|NCT00611169|Tirofiban|tirofiban|mesh-list
153969481|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153969482|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153969483|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969484|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153969485|NCT05754502|Trastuzumab|trastuzumab|mesh-list
153969486|NCT05754502|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153969487|NCT05754502|Maytansine|maytansine|mesh-list
153969488|NCT05754502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153969489|NCT05754502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969490|NCT05754502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153969491|NCT05754502|Tubulin Modulators|tubulin modulators|mesh-ancestor
153969492|NCT05754502|Antimitotic Agents|antimitotic agents|mesh-ancestor
153969493|NCT05754502|Mitosis Modulators|mitosis modulators|mesh-ancestor
153969494|NCT05754502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969495|NCT05754502|Immunotoxins|immunotoxins|mesh-ancestor
153969496|NCT05754502|Immunoconjugates|immunoconjugates|mesh-ancestor
153969497|NCT05754502|Immunologic Factors|immunologic factors|mesh-ancestor
153969498|NCT05754502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969499|NCT02712957|Naproxen|naproxen|mesh-list
153969500|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153969501|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153969502|NCT02712957|Analgesics|analgesics|mesh-ancestor
153969503|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
153969504|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969505|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969506|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153969507|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153969508|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
153969509|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153969510|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969511|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969512|NCT04226625|Propofol|propofol|mesh-list
153969513|NCT04226625|Desflurane|desflurane|mesh-list
153969514|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153969515|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969516|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969517|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153969518|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
153969519|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
153969520|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153969521|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
153969522|NCT02777619|Propofol|propofol|mesh-list
153969523|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153727005|NCT00486187|Metformin|metformin|mesh-list
153969532|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153969533|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
153969534|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969535|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969536|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153969537|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
153969538|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
153969539|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153969540|NCT00636831|Cefazolin|cefazolin|mesh-list
153969541|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969542|NCT04193631|Cannabidiol|cannabidiol|mesh-list
153969543|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
153969544|NCT04856631|Cetuximab|cetuximab|mesh-list
153969545|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153969546|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969547|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
153969548|NCT00808210|Infliximab|infliximab|mesh-list
153969549|NCT00808210|Methotrexate|methotrexate|mesh-list
153969550|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
153969551|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153969552|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
153969553|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153969554|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969555|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153969556|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
153969557|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969558|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969559|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
153969560|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969561|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153969562|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153969563|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
153969564|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153969565|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153969566|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153969567|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
153969568|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
153969569|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969570|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153969571|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
153969572|NCT00808210|Hormones|hormones|mesh-ancestor
153969573|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153969574|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153969575|NCT00808210|Protective Agents|protective agents|mesh-ancestor
153969576|NCT00808210|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153969577|NCT02777229|Tenofovir|tenofovir|mesh-list
153969578|NCT02777229|Lamivudine|lamivudine|mesh-list
153969579|NCT02777229|Efavirenz|efavirenz|mesh-list
153969580|NCT02777229|Dolutegravir|dolutegravir|mesh-list
153969581|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
153969582|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969583|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153969584|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153969585|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969586|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969587|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153969588|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153969589|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153727069|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
153969606|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969607|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
153969608|NCT02777151|Atoltivimab|atoltivimab|mesh-list
153969609|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
153969610|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969611|NCT02711865|Antibodies|antibodies|mesh-list
153969612|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
153969613|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969614|NCT02711943|Levofloxacin|levofloxacin|mesh-list
153969615|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153969616|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969617|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153969618|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153969619|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153969620|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969621|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969622|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969623|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153969624|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153969625|NCT02776761|Vaccines|vaccines|mesh-list
153969626|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
153969627|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969628|NCT00736099|Pioglitazone|pioglitazone|mesh-list
153969629|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153969630|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969631|NCT02711241|Dipyrone|dipyrone|mesh-list
153969632|NCT02711241|Papaverine|papaverine|mesh-list
153969633|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153969634|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153905258|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
153969635|NCT02711241|Analgesics|analgesics|mesh-ancestor
153969636|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
153969637|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969638|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969639|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153969640|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153969641|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
153969642|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153969643|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969644|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727137|NCT00487123|Valsartan|valsartan|mesh-list
153969652|NCT02710539|Amlodipine|amlodipine|mesh-list
153969653|NCT02710539|Perindopril|perindopril|mesh-list
153969654|NCT02710539|Indapamide|indapamide|mesh-list
153969655|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153969656|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153969657|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153969658|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969659|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153969660|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969661|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
153969662|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153969663|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
153969664|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969665|NCT02710539|Diuretics|diuretics|mesh-ancestor
153969666|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
153969667|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153969668|NCT00735709|Vortioxetine|vortioxetine|mesh-list
153969669|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
153969670|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153969671|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153969672|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153969673|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969674|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969675|NCT00735709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153969676|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153969677|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153969678|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969679|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969680|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
153969681|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153969682|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153969683|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153969684|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153969685|NCT02776527|Apatinib|apatinib|mesh-list
153969686|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969687|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153969688|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969689|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969690|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
153969691|NCT00729157|Aflibercept|aflibercept|mesh-list
153969692|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
153969693|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153969694|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153969695|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153969696|NCT00729157|Growth Substances|growth substances|mesh-ancestor
153969697|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969699|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969700|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969701|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153969702|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
153969703|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
153969704|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969705|NCT02710305|Lidocaine|lidocaine|mesh-list
153969706|NCT02710305|Scopolamine|scopolamine|mesh-list
153969707|NCT02710305|Bromides|bromides|mesh-list
153969708|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153969709|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
153969710|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
153969711|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969712|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969732|NCT02708511|Trace Elements|trace elements|mesh-ancestor
153969733|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
154263189|NCT05919823|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153969734|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969735|NCT00728689|Tecovirimat|tecovirimat|mesh-list
153969736|NCT00728689|Antiviral Agents|antiviral agents|mesh-ancestor
153969737|NCT00728689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969738|NCT02596243|Vaccines|vaccines|mesh-list
153969739|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
153969740|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969741|NCT02717091|Paclitaxel|paclitaxel|mesh-list
153969742|NCT02717091|Gemcitabine|gemcitabine|mesh-list
153969743|NCT02717091|Folfirinox|folfirinox|mesh-list
153969744|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153969745|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969746|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
153969747|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
153969748|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
153969749|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969750|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153969751|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
153969752|NCT00726895|Quinine|quinine|mesh-list
153969753|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
153969754|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153969755|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153969756|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969757|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153969758|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969759|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153969760|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969761|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153969762|NCT00726895|Analgesics|analgesics|mesh-ancestor
153969763|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
153969764|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153969765|NCT02593201|Cefazolin|cefazolin|mesh-list
153969766|NCT02593201|Ceftazidime|ceftazidime|mesh-list
153969767|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153969768|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969769|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
153969770|NCT02593201|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153969791|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
153969792|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969793|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153969794|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153969795|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153969796|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153969797|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969799|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153969800|NCT02716857|Narcotics|narcotics|mesh-ancestor
153969801|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969802|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969803|NCT02716857|Analgesics|analgesics|mesh-ancestor
153969804|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
153969805|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969806|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153969807|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
153969808|NCT00917761|Entecavir|entecavir|mesh-list
153969809|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
153969810|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449184|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153969811|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
153969812|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969813|NCT02709603|Scopolamine|scopolamine|mesh-list
153969814|NCT02709603|Bromides|bromides|mesh-list
153969815|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153969816|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
153969817|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153969818|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
153969819|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
153969820|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969821|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969822|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153969823|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
153969824|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153969825|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
153969851|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
153969852|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
153969853|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153969854|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
153969855|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263190|NCT05919823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154263191|NCT05919823|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153969856|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
153969857|NCT02709525|Protective Agents|protective agents|mesh-ancestor
153969858|NCT05087589|Tofacitinib|tofacitinib|mesh-list
153969859|NCT05087589|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153969860|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153969861|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969862|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969863|NCT00612651|Temozolomide|temozolomide|mesh-list
153969865|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153969866|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
153969867|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969868|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969869|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969870|NCT00918307|Varenicline|varenicline|mesh-list
153969871|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153969872|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153969873|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
153969909|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969911|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153727410|NCT01243060|Zolpidem|zolpidem|mesh-list
153969933|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153969934|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
153969935|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969936|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153969937|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153969938|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
153969939|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969940|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969941|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153969942|NCT04153929|Semaglutide|semaglutide|mesh-list
153969943|NCT04153929|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153969944|NCT04153929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153969945|NCT04153929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969946|NCT00914368|Clopidogrel|clopidogrel|mesh-list
153969947|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153969948|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153969949|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153969950|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153969951|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
153969952|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969953|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969954|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969955|NCT02607982|Paclitaxel|paclitaxel|mesh-list
153969956|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
153969957|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153969958|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969959|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
153969960|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
153969979|NCT04856475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969980|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
153969981|NCT02608060|Hematinics|hematinics|mesh-ancestor
153969982|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
153969983|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153969984|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153969985|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969986|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
153969987|NCT04085575|Coagulants|coagulants|mesh-ancestor
153969988|NCT00585169|Memantine|memantine|mesh-list
153969989|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153969990|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153969991|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
153969992|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969993|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969994|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969995|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153969996|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153969997|NCT00807742|Nicotine|nicotine|mesh-list
153969998|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153969999|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
154263192|NCT05919823|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153970000|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970001|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970002|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153970003|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153970004|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
153970005|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970006|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970008|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153970009|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970010|NCT05738434|Apatinib|apatinib|mesh-list
153970011|NCT05738434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970012|NCT05738434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153970013|NCT05738434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970014|NCT05738434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970015|NCT00803452|Azithromycin|azithromycin|mesh-list
153970016|NCT00803452|Doxycycline|doxycycline|mesh-list
153970035|NCT05737342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970037|NCT05737342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153970038|NCT00914212|Sibutramine|sibutramine|mesh-list
153970039|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
153970040|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153970041|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
153970042|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153970043|NCT04456023|Tisagenlecleucel|tisagenlecleucel|mesh-list
153970044|NCT04456023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970045|NCT04456023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970046|NCT04188483|Selenium|selenium|mesh-list
153970047|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
153970048|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970049|NCT04188483|Protective Agents|protective agents|mesh-ancestor
153970050|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970051|NCT04188483|Trace Elements|trace elements|mesh-ancestor
153970052|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
153970053|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153970054|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
153970055|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970056|NCT00717067|Ritonavir|ritonavir|mesh-list
153970057|NCT00717067|Saquinavir|saquinavir|mesh-list
153970058|NCT00717067|Maraviroc|maraviroc|mesh-list
153970059|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153970060|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153970061|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
153970062|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970063|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970064|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153970065|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153970066|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
153970067|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970068|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153970069|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153970070|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153970071|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153970072|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153970073|NCT04393311|Urinastatin|urinastatin|mesh-list
153727556|NCT00491725|Metformin|metformin|mesh-list
153970107|NCT04356339|Interferon-beta|interferon-beta|mesh-list
153970108|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
153970109|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970110|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
153970111|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970112|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
153727621|NCT01243528|Vitamin D|vitamin d|mesh-list
153970122|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970124|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153970125|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970126|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970127|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153970128|NCT03460522|Immunotoxins|immunotoxins|mesh-ancestor
153970129|NCT03460522|Immunoconjugates|immunoconjugates|mesh-ancestor
153970130|NCT03460522|Immunologic Factors|immunologic factors|mesh-ancestor
153970131|NCT03460522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970132|NCT02605720|Piperaquine|piperaquine|mesh-list
153970133|NCT02605720|Artenimol|artenimol|mesh-list
153970134|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
153970135|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153905388|NCT01108809|Telmisartan|telmisartan|mesh-list
153970136|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153970137|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970138|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
153970139|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153970140|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
153970141|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970142|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
153970143|NCT04188561|Protective Agents|protective agents|mesh-ancestor
153970144|NCT00588952|Ketamine|ketamine|mesh-list
153970145|NCT00588952|Analgesics|analgesics|mesh-ancestor
153970146|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
153970147|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970148|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970149|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153970150|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153970151|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
153970152|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
153970153|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153970154|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153970155|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153970156|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970157|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970158|NCT04885257|Methylphenidate|methylphenidate|mesh-list
153970159|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153970160|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970161|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153727784|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970162|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153970163|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970164|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970165|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
153970166|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970167|NCT00802360|Menotropins|menotropins|mesh-list
153970168|NCT00802360|Progesterone|progesterone|mesh-list
153970169|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153970170|NCT00802360|Ganirelix|ganirelix|mesh-list
153970171|NCT00802360|Progestins|progestins|mesh-ancestor
153970172|NCT00802360|Hormones|hormones|mesh-ancestor
153970173|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970174|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970175|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
153970198|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970199|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153970200|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970201|NCT02692599|Vaccines|vaccines|mesh-list
153970202|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
153970203|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970204|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153970205|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
153970206|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970207|NCT02606266|Valganciclovir|valganciclovir|mesh-list
153970208|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
153970209|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970210|NCT04115020|Naltrexone|naltrexone|mesh-list
153970211|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153970212|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153970213|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970214|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
153970215|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970216|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
153970217|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970218|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970219|NCT03292666|Warfarin|warfarin|mesh-list
153970220|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
153970221|NCT03292666|Dabigatran|dabigatran|mesh-list
153970222|NCT03292666|Apixaban|apixaban|mesh-list
153970223|NCT03292666|Anticoagulants|anticoagulants|mesh-list
153970224|NCT03292666|Edoxaban|edoxaban|mesh-list
153970225|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153970226|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
153970227|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153970228|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
153970229|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727715|NCT00493129|Interleukin-2|interleukin-2|mesh-list
153970250|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153970251|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
153970252|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970253|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153970254|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153970255|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153970256|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153970257|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
153970258|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153970259|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
153970260|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970261|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
153970262|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970263|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970264|NCT03868839|Telmisartan|telmisartan|mesh-list
153970265|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153970266|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153970267|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153970268|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970269|NCT00589420|Docetaxel|docetaxel|mesh-list
153970270|NCT00589420|Sorafenib|sorafenib|mesh-list
153970271|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970272|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
153970273|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
153970274|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153970275|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970276|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153970277|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970278|NCT04114630|Erenumab|erenumab|mesh-list
153970279|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153970280|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970281|NCT04114630|Analgesics|analgesics|mesh-ancestor
153729889|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970312|NCT00613665|Vaccines|vaccines|mesh-list
153970313|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
153970314|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970315|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153970316|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970317|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970318|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
153970319|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153970320|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970335|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
153970336|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153970337|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153970338|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970339|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970340|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
153970341|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970342|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970343|NCT00614679|Tigecycline|tigecycline|mesh-list
153970344|NCT00614679|Heparin|heparin|mesh-list
153970345|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
153970346|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153970347|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153970348|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970349|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153970350|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970351|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153970352|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970353|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153970354|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153970355|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970356|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153970357|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970358|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
153970359|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153970360|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970361|NCT01024946|Everolimus|everolimus|mesh-list
153905418|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153970363|NCT01024946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153970364|NCT01024946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970365|NCT01024946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970366|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153970367|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
153970368|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970369|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970371|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153970372|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
153970373|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970374|NCT00627536|Mitogens|mitogens|mesh-list
153970375|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
153970376|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970405|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153970406|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970407|NCT03611751|Apremilast|apremilast|mesh-list
153970408|NCT03611751|Deucravacitinib|deucravacitinib|mesh-list
153970409|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153970410|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153970411|NCT03611751|Analgesics|analgesics|mesh-ancestor
153970412|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
153970413|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970414|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970415|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153970416|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153970417|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153970418|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153970419|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970420|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970421|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
153970422|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153970423|NCT00613743|Morphine|morphine|mesh-list
153970432|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153970433|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
153970434|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970435|NCT00614757|Expectorants|expectorants|mesh-ancestor
153970436|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
153970437|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153970438|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
153970439|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970440|NCT00614757|Protective Agents|protective agents|mesh-ancestor
153970441|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970442|NCT00614757|Antidotes|antidotes|mesh-ancestor
153970444|NCT02692365|Trace Elements|trace elements|mesh-ancestor
153970445|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
153970446|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970447|NCT03492099|Buprenorphine|buprenorphine|mesh-list
153970448|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153970449|NCT03492099|Narcotics|narcotics|mesh-ancestor
153970450|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153970451|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970452|NCT03492099|Analgesics|analgesics|mesh-ancestor
153970453|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
153970454|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970455|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153970456|NCT03481959|Methylphenidate|methylphenidate|mesh-list
153970457|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153970458|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729890|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
153970459|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153970460|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153970461|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970462|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970464|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970465|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153970466|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153970467|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153970468|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
153970469|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970470|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153905429|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970471|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153970472|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970473|NCT03462069|Empagliflozin|empagliflozin|mesh-list
153970474|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153970475|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153970476|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970477|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153970478|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970479|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153970480|NCT03414723|Ramipril|ramipril|mesh-list
153970481|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153970482|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
153970483|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970484|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970485|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153727968|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
153970489|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153970490|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153970491|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153970493|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
153970494|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970495|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153970496|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970497|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970498|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153970499|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153970500|NCT00720499|Bromides|bromides|mesh-list
153970501|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
153970502|NCT00720499|Olodaterol|olodaterol|mesh-list
153970503|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153970504|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
153970505|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970506|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970507|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153449296|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
153970508|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
153970509|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
153970510|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153970511|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
153970512|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970513|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970514|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
153970515|NCT00724243|Infliximab|infliximab|mesh-list
153970516|NCT00724243|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153970517|NCT00724243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153970518|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
153970519|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153970520|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153970521|NCT02590705|Lidocaine|lidocaine|mesh-list
153970522|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
153970523|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
153970524|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153970525|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728093|NCT00127478|Atrasentan|atrasentan|mesh-list
153970526|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
153970527|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970528|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153970529|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153970530|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153970531|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970532|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970533|NCT00720343|Choline|choline|mesh-list
153970534|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
153970535|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153970536|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
153970537|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970538|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153970539|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153970540|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
153970541|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
153970542|NCT00720109|Leucovorin|leucovorin|mesh-list
153970543|NCT00720109|Folic Acid|folic acid|mesh-list
153970544|NCT00720109|Cytarabine|cytarabine|mesh-list
153970545|NCT00720109|Dexamethasone|dexamethasone|mesh-list
153970546|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
153970547|NCT00720109|Prednisone|prednisone|mesh-list
153970548|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
153970549|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153970550|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153970551|NCT00720109|Prednisolone|prednisolone|mesh-list
153970552|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
153970553|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
153970554|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153970555|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153970566|NCT00720109|Asparaginase|asparaginase|mesh-list
153970567|NCT00720109|Dasatinib|dasatinib|mesh-list
153970568|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
153970569|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
153970570|NCT00720109|Pegaspargase|pegaspargase|mesh-list
153970571|NCT00720109|Lenograstim|lenograstim|mesh-list
153970572|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153970573|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
153970574|NCT00720109|BB 1101|bb 1101|mesh-list
153970575|NCT00720109|Calcium|calcium|mesh-list
153970576|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
153970577|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153970578|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
153970579|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970580|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153970581|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153970582|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
153970583|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970584|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970585|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153970586|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153970587|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
153970589|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970590|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153970591|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
153970592|NCT00720109|Hormones|hormones|mesh-ancestor
153970593|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970594|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153970595|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
153970596|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970597|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153970598|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153970599|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153728166|NCT00497107|Vitamins|vitamins|mesh-ancestor
153970600|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
153970601|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970602|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153970603|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
153970604|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
153970605|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153970606|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153970607|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153970608|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153970609|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153970610|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
153970611|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970612|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153970613|NCT00720109|Antidotes|antidotes|mesh-ancestor
153970614|NCT00720109|Protective Agents|protective agents|mesh-ancestor
153970615|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
153970616|NCT00720109|Vitamins|vitamins|mesh-ancestor
153970617|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
153970618|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
153970619|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
153970620|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
153970621|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153970622|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153970623|NCT00720109|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153970624|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153970625|NCT00720109|Hematinics|hematinics|mesh-ancestor
153728051|NCT00495547|Azacitidine|azacitidine|mesh-list
153970630|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153905510|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905513|NCT02879097|Paclitaxel|paclitaxel|mesh-list
153970632|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
153970633|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153970634|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153970635|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970636|NCT01015118|Paclitaxel|paclitaxel|mesh-list
153970637|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153970638|NCT01015118|Carboplatin|carboplatin|mesh-list
153970639|NCT01015118|Nintedanib|nintedanib|mesh-list
153970640|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153970641|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970642|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
153970643|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
153970644|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
153970645|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970646|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153970647|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970648|NCT02415153|Pomalidomide|pomalidomide|mesh-list
153970649|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
153970650|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970651|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153970652|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153970653|NCT02415153|Growth Substances|growth substances|mesh-ancestor
153970654|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
153970655|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970656|NCT00628160|Terlipressin|terlipressin|mesh-list
153970657|NCT00628160|Dopamine|dopamine|mesh-list
153970658|NCT00628160|Norepinephrine|norepinephrine|mesh-list
153970659|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
153970660|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153970661|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153970662|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970663|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970664|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970666|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
153970667|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970668|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153970669|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153970670|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153970671|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
153970672|NCT00628160|Protective Agents|protective agents|mesh-ancestor
153970673|NCT02274285|Vaccines|vaccines|mesh-list
153970674|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
153970675|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970676|NCT00614835|Gemcitabine|gemcitabine|mesh-list
153970677|NCT00614835|Docetaxel|docetaxel|mesh-list
153970678|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153970679|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
153970680|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970681|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970682|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
153970683|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
153970684|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
153970686|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
153970687|NCT00715429|Vitamins|vitamins|mesh-ancestor
153970688|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
153970689|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970690|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153970691|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153970692|NCT02606032|Metronidazole|metronidazole|mesh-list
153970693|NCT02606032|Doxycycline|doxycycline|mesh-list
153970694|NCT02606032|Terbinafine|terbinafine|mesh-list
153970695|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970696|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153970697|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153970698|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153970699|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
153970700|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
153970701|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970702|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970708|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970709|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153970710|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
153970711|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
153970712|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905522|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970713|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970714|NCT00715117|Naltrexone|naltrexone|mesh-list
153970715|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153970716|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153970717|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970718|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
153970719|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970720|NCT00723229|Acyclovir|acyclovir|mesh-list
153970721|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
153970722|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970723|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
153970724|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153970725|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970726|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970727|NCT01030718|Dasatinib|dasatinib|mesh-list
153970728|NCT01030718|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153970729|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153970730|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970731|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970732|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970733|NCT00722761|Drospirenone|drospirenone|mesh-list
153970734|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153970735|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153970736|NCT00722761|Estradiol|estradiol|mesh-list
153970737|NCT00722761|Estrogens|estrogens|mesh-ancestor
153970738|NCT00722761|Hormones|hormones|mesh-ancestor
153970739|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970740|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970741|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153970742|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
153970743|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970744|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153970745|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153970746|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153970747|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153970748|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
153970749|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153970750|NCT00722761|Diuretics|diuretics|mesh-ancestor
153970751|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
153970752|NCT00628238|Rituximab|rituximab|mesh-list
153970753|NCT00628238|Lenalidomide|lenalidomide|mesh-list
153970754|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970755|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970756|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
153970757|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970758|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153970759|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153970760|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153970761|NCT00628238|Growth Substances|growth substances|mesh-ancestor
153970762|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
153970763|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153970764|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153970765|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
153970766|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970767|NCT01019486|Regadenoson|regadenoson|mesh-list
153970768|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153970769|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153970770|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153970771|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
153970772|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
153728186|NCT04599894|Pregabalin|pregabalin|mesh-list
153970774|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970775|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970776|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153970778|NCT02803203|Osimertinib|osimertinib|mesh-list
153970779|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970780|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970781|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153970782|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153970783|NCT02803203|Growth Substances|growth substances|mesh-ancestor
153970784|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970785|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
153447057|NCT00002177|Nelfinavir|nelfinavir|mesh-list
153970786|NCT02803203|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153970787|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153970788|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970789|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970790|NCT00714493|Infliximab|infliximab|mesh-list
153970791|NCT00714493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153970792|NCT00714493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153970793|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
153970794|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153970795|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153970796|NCT01013870|Atorvastatin|atorvastatin|mesh-list
153970797|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153970798|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153970799|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
153731511|NCT00154089|Protective Agents|protective agents|mesh-ancestor
153970800|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970801|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153970802|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153970803|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970804|NCT00628316|Caffeine|caffeine|mesh-list
153970805|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153970806|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970807|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153970808|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970809|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970810|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153970811|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153970812|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
153970813|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970814|NCT01018862|Azelastine|azelastine|mesh-list
153970815|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153970816|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
153970817|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970818|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970819|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153970820|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
153970821|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153970822|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970823|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970824|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153970825|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153970826|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153970827|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
153970828|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
153970829|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970830|NCT01018394|Nicotine|nicotine|mesh-list
153970831|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153970832|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
153970833|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970834|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970836|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153970837|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
153970838|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970839|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970841|NCT04301336|Folic Acid|folic acid|mesh-list
153970842|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
153970843|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
153970844|NCT04301336|Morphine|morphine|mesh-list
153970845|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
153970846|NCT04301336|Simvastatin|simvastatin|mesh-list
153970868|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
153970869|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153970870|NCT00627848|Rivastigmine|rivastigmine|mesh-list
153970871|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153970872|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970873|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970874|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
153970875|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970876|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970877|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153970878|NCT00627848|Protective Agents|protective agents|mesh-ancestor
153970879|NCT04299854|Dinoprostone|dinoprostone|mesh-list
153970880|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
153970881|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970882|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970883|NCT01017146|Tazarotene|tazarotene|mesh-list
153970884|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
153970885|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
153970886|NCT02872064|Verteporfin|verteporfin|mesh-list
153970887|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153970888|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
153970889|NCT01010750|Amphetamine|amphetamine|mesh-list
153970890|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153970891|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153970892|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970893|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
153970894|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
153970895|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970896|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
153970897|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970898|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970899|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
153970900|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153728339|NCT00402623|Quercetin|quercetin|mesh-list
153970922|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
153970923|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970924|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970925|NCT02871986|Estrogens|estrogens|mesh-list
153970926|NCT02871986|Hormones|hormones|mesh-ancestor
153970927|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970928|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970929|NCT00722137|Prednisone|prednisone|mesh-list
153970930|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
153970931|NCT00722137|Rituximab|rituximab|mesh-list
153970932|NCT00722137|Doxorubicin|doxorubicin|mesh-list
153970933|NCT00722137|Vincristine|vincristine|mesh-list
153970934|NCT00722137|Bortezomib|bortezomib|mesh-list
153970935|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153970936|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
153970937|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970938|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153970939|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153970940|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
153970941|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970942|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970943|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153970944|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970945|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153970946|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153970947|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153970948|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970949|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153970950|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
153970968|NCT00796666|Urological Agents|urological agents|mesh-ancestor
153970969|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153970970|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153970971|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153970972|NCT00799708|Estradiol|estradiol|mesh-list
153970973|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153970974|NCT00799708|Estrogens|estrogens|mesh-ancestor
153970975|NCT00799708|Hormones|hormones|mesh-ancestor
153970976|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970977|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970978|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153970979|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
153970980|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970981|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153728546|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
153970982|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
153970983|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
153970984|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
153970985|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153970986|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153970987|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970988|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970989|NCT00796510|Urological Agents|urological agents|mesh-ancestor
153970990|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153970991|NCT04111432|Vaccines|vaccines|mesh-list
153970992|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
153447106|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970993|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970994|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
153970995|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153970996|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153970997|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970998|NCT00588640|Methadone|methadone|mesh-list
153970999|NCT00588640|D-methadone|d-methadone|mesh-list
153971000|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153971001|NCT00588640|Narcotics|narcotics|mesh-ancestor
153971002|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971003|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971004|NCT00588640|Analgesics|analgesics|mesh-ancestor
153971005|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
153971006|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971030|NCT04115800|Sirolimus|sirolimus|mesh-list
153971031|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153971032|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971033|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153971034|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971035|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
153971036|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153971037|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
153971038|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971039|NCT04115410|Cisplatin|cisplatin|mesh-list
153971040|NCT04115410|Carboplatin|carboplatin|mesh-list
153971041|NCT04115410|Gemcitabine|gemcitabine|mesh-list
153971042|NCT04115410|Docetaxel|docetaxel|mesh-list
153971043|NCT04115410|Pemetrexed|pemetrexed|mesh-list
153971044|NCT04115410|Vinorelbine|vinorelbine|mesh-list
153971045|NCT04115410|Gefitinib|gefitinib|mesh-list
153971046|NCT04115410|Mitomycins|mitomycins|mesh-list
153971047|NCT04115410|Mitomycin|mitomycin|mesh-list
153971048|NCT04115410|Osimertinib|osimertinib|mesh-list
153971049|NCT04115410|Afatinib|afatinib|mesh-list
153971050|NCT04115410|Vinblastine|vinblastine|mesh-list
153971051|NCT04115410|Crizotinib|crizotinib|mesh-list
153971052|NCT04115410|Ceritinib|ceritinib|mesh-list
153971053|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
153971054|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153971055|NCT04115410|Alectinib|alectinib|mesh-list
153971056|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153971057|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
153971058|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971059|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
153971060|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
153971061|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
153971062|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728495|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
153971133|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153971134|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971135|NCT05310643|Nivolumab|nivolumab|mesh-list
153971136|NCT05310643|Ipilimumab|ipilimumab|mesh-list
153971137|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153971138|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971139|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153971140|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971141|NCT00918853|Pancrelipase|pancrelipase|mesh-list
153971169|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153971170|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
153971171|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971172|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971173|NCT04298372|Lenalidomide|lenalidomide|mesh-list
153971174|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
153971175|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971176|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153971177|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153971178|NCT04298372|Growth Substances|growth substances|mesh-ancestor
153971179|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
153971180|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971182|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153971183|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153971184|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
153971185|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971186|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971187|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971188|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
153971189|NCT00718549|Rituximab|rituximab|mesh-list
153447126|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153728625|NCT00499720|Aztreonam|aztreonam|mesh-list
153971213|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971214|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971215|NCT00919243|Prednisone|prednisone|mesh-list
153971216|NCT00919243|Allopurinol|allopurinol|mesh-list
153971217|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153971218|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
153971219|NCT00919243|Hormones|hormones|mesh-ancestor
153971220|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153971221|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971222|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153971223|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971224|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
153971225|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971226|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971227|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
153971228|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153971229|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153971230|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
153971231|NCT00919243|Protective Agents|protective agents|mesh-ancestor
153971232|NCT00794950|Sunitinib|sunitinib|mesh-list
153971233|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971234|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153971235|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153971236|NCT00794950|Growth Substances|growth substances|mesh-ancestor
153971237|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971238|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
153971239|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153971240|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728675|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153971269|NCT00798694|Travoprost|travoprost|mesh-list
153971270|NCT00798694|Latanoprost|latanoprost|mesh-list
153971271|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153971272|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153971273|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153971274|NCT00718315|Erythromycin|erythromycin|mesh-list
153971275|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
153971276|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153971277|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
153971278|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
153971279|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153971280|NCT00718315|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153971281|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153971282|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971283|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971284|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971320|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153971321|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
153971322|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
153971323|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971348|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971349|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153971350|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
153971351|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971352|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153971353|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
153971354|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971355|NCT02643303|Durvalumab|durvalumab|mesh-list
153971356|NCT02643303|Tremelimumab|tremelimumab|mesh-list
153971357|NCT02643303|Poly ICLC|poly iclc|mesh-list
153971358|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153971359|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971360|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
153971361|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
153971362|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971363|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
153971364|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153971365|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153971366|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971367|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
153971368|NCT00615147|Coagulants|coagulants|mesh-ancestor
153971369|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153971370|NCT01029717|Minocycline|minocycline|mesh-list
153971371|NCT01029717|Rifampin|rifampin|mesh-list
153971372|NCT01029717|Heparin|heparin|mesh-list
153971373|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971374|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153971402|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971403|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153971404|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971405|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
153971406|NCT00789958|Gemcitabine|gemcitabine|mesh-list
153971407|NCT00789958|Capecitabine|capecitabine|mesh-list
153971408|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153971409|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
153971410|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971411|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971412|NCT00789880|Vitamin D|vitamin d|mesh-list
153971413|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
153971414|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
153971415|NCT00789880|Vitamins|vitamins|mesh-list
153971416|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
153449495|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153449497|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
153971417|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971448|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971449|NCT00792298|Suvorexant|suvorexant|mesh-list
153971450|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153971451|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153971452|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971453|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971454|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153971487|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
153971488|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153971489|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971490|NCT00787930|Valproic Acid|valproic acid|mesh-list
153971491|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
153971492|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971493|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971494|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
153971495|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971496|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728951|NCT00503152|Valsartan|valsartan|mesh-list
153971527|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153971528|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
153971529|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153971530|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
153971531|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971532|NCT00482157|Vitamin D|vitamin d|mesh-list
153971533|NCT00482157|Calcitriol|calcitriol|mesh-list
153971534|NCT00482157|Vitamins|vitamins|mesh-ancestor
153971535|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
153971536|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971537|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153971538|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153971539|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153971540|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153971556|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153971558|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
153971559|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971560|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153971561|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153971562|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
153971563|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153971564|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
153971565|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
153971566|NCT02707575|Ranibizumab|ranibizumab|mesh-list
153971567|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153971568|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153971569|NCT02707575|Growth Substances|growth substances|mesh-ancestor
153971570|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971571|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
153971572|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971573|NCT00919399|Tamoxifen|tamoxifen|mesh-list
153971574|NCT00919399|Exemestane|exemestane|mesh-list
153971575|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153971576|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
153971577|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153971578|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971579|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153416783|NCT05448937|Eugenol|eugenol|mesh-list
153971580|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729145|NCT00503932|Capecitabine|capecitabine|mesh-list
153971581|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153971583|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153971584|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153971585|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153971586|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971587|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971588|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153449508|NCT00004187|Capecitabine|capecitabine|mesh-list
153971589|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153971590|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971591|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153971592|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153971593|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153971594|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971595|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
153971596|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971635|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971666|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153971668|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971669|NCT04105426|Protective Agents|protective agents|mesh-ancestor
153971670|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971671|NCT02704923|Atropine|atropine|mesh-list
153971672|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153971707|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971709|NCT02587273|Fentanyl|fentanyl|mesh-list
153971710|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153971732|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971733|NCT02703363|Minocycline|minocycline|mesh-list
153971734|NCT02703363|Celecoxib|celecoxib|mesh-list
153971735|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153971736|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153971737|NCT02703363|Analgesics|analgesics|mesh-ancestor
153971738|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
153971739|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971740|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971741|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153971742|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153971743|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153971744|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153971745|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971746|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971747|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153971748|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971749|NCT00615381|Insulin|insulin|mesh-list
153971750|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153971751|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153971752|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971753|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
153971754|NCT00785980|Quinine|quinine|mesh-list
153971755|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153971756|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971757|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153971758|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153971759|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971760|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971761|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971762|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153971763|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153971764|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
153729205|NCT01248403|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153971798|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
153971799|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971800|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971801|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153971802|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153971803|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
153971804|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447208|NCT00002255|Zidovudine|zidovudine|mesh-list
153971806|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153971821|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971822|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971823|NCT02702817|Naproxen|naproxen|mesh-list
153971824|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153971825|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153971826|NCT02702817|Analgesics|analgesics|mesh-ancestor
153971827|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
153971828|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971829|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971830|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153971831|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153971832|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
153971833|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153971834|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971835|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971836|NCT02702739|Ribavirin|ribavirin|mesh-list
153971837|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
153971838|NCT02702739|Simeprevir|simeprevir|mesh-list
153971839|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
153971840|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971841|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
153971842|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971843|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
153971844|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971845|NCT02602444|Ticagrelor|ticagrelor|mesh-list
153971846|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153971847|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153971848|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153971849|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153971850|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
153971851|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971852|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971853|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971854|NCT02702661|Anesthetics|anesthetics|mesh-list
153971855|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
153971856|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
153971857|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971858|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971859|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
153971860|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971861|NCT02702349|Penicillins|penicillins|mesh-list
153971862|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153971863|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971864|NCT04104334|Remifentanil|remifentanil|mesh-list
153971865|NCT04104334|Desflurane|desflurane|mesh-list
153971866|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
153971867|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971868|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971886|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
153971887|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
153971888|NCT00784810|Acetaminophen|acetaminophen|mesh-list
153971889|NCT00784810|Oxycodone|oxycodone|mesh-list
153971890|NCT00784810|Codeine|codeine|mesh-list
153971891|NCT00784810|Naloxone|naloxone|mesh-list
153971892|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153971893|NCT00784810|Analgesics|analgesics|mesh-ancestor
153971894|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
153971895|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971896|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971897|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
153971898|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153971899|NCT00784810|Narcotics|narcotics|mesh-ancestor
153971900|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971901|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153971902|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
153971903|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
153971904|NCT02603770|Lovastatin|lovastatin|mesh-list
153971905|NCT02603770|L 647318|l 647318|mesh-list
153971906|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
153971907|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153971908|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153971909|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
153971910|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971911|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154263194|NCT05900388|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154263195|NCT05900388|Antithrombins|antithrombins|mesh-ancestor
153971912|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153971913|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971914|NCT04081909|Fentanyl|fentanyl|mesh-list
153971915|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
153971916|NCT04081909|Ketamine|ketamine|mesh-list
153971917|NCT04081909|Remifentanil|remifentanil|mesh-list
153971918|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153971919|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971920|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971921|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153971922|NCT04081909|Analgesics|analgesics|mesh-ancestor
153971923|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
153971924|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971925|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153971926|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153971927|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153971928|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
153971929|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971965|NCT00919555|Tretinoin|tretinoin|mesh-list
153971966|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153971967|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971968|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971969|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
153971970|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
153972002|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153972003|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
153972004|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
153972005|NCT02586259|Hormones|hormones|mesh-ancestor
153972006|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153972007|NCT00775606|Ritonavir|ritonavir|mesh-list
153972008|NCT00775606|Lopinavir|lopinavir|mesh-list
153972009|NCT00775606|Efavirenz|efavirenz|mesh-list
153972010|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153972011|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153972012|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
153972013|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729454|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153791530|NCT06300970|Artesunate|artesunate|mesh-list
153791610|NCT06300216|Octreotide|octreotide|mesh-list
153338235|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
153791768|NCT06285409|Oxytocin|oxytocin|mesh-list
153791828|NCT06218303|Letrozole|letrozole|mesh-list
153731322|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792199|NCT05768854|Diphosphonates|diphosphonates|mesh-list
153792272|NCT05720273|Calcitriol|calcitriol|mesh-list
153731323|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731324|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153792944|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153793030|NCT04270409|Anesthetics|anesthetics|mesh-ancestor
153729497|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
153805503|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153805870|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153806089|NCT00329628|Enoxaparin|enoxaparin|mesh-list
153806693|NCT00335088|Iodine|iodine|mesh-list
153806756|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153807667|NCT00425217|Rituximab|rituximab|mesh-list
153808019|NCT00343239|Fluorouracil|fluorouracil|mesh-list
153808099|NCT00347802|Bimatoprost|bimatoprost|mesh-list
153808318|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
153355253|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808834|NCT05849779|Anesthetics|anesthetics|mesh-ancestor
153809288|NCT04209543|Hormones|hormones|mesh-ancestor
153809511|NCT03206671|Hormones|hormones|mesh-ancestor
153356302|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
153809882|NCT00316433|Irinotecan|irinotecan|mesh-list
153809952|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
153810475|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731392|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153731393|NCT00137813|Growth Substances|growth substances|mesh-ancestor
153357365|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153357366|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
153731394|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731395|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
153731396|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731397|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
153731398|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736460|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357386|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
153731399|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731400|NCT00137852|Celecoxib|celecoxib|mesh-list
153731401|NCT00137852|Irinotecan|irinotecan|mesh-list
153731402|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357390|NCT03830606|Paclitaxel|paclitaxel|mesh-list
153357394|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
153357395|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
153731419|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731421|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153731422|NCT00153933|Lenalidomide|lenalidomide|mesh-list
153731423|NCT00153933|Bortezomib|bortezomib|mesh-list
153731424|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
153731425|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731426|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153731427|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153731428|NCT00153933|Growth Substances|growth substances|mesh-ancestor
153731429|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
153731430|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731431|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
153731432|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731433|NCT00153972|Levodopa|levodopa|mesh-list
153731434|NCT00153972|Cabergoline|cabergoline|mesh-list
153731435|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153731455|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153731457|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731458|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
153731459|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
153731460|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731461|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731462|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357578|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731465|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731466|NCT00404222|Acetaminophen|acetaminophen|mesh-list
153731467|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153731468|NCT00404222|Hydrocodone|hydrocodone|mesh-list
153731469|NCT00404222|Oxycodone|oxycodone|mesh-list
153731470|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731471|NCT00404222|Analgesics|analgesics|mesh-ancestor
153731472|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
153731473|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357600|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153730760|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153730761|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153730762|NCT04725357|Analgesics|analgesics|mesh-ancestor
153730763|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
153730764|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730765|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730766|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730767|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730768|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153730769|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153730770|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730771|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730772|NCT00135122|Prednisolone|prednisolone|mesh-list
153730773|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153730774|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
153730775|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153730777|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153730778|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
153730779|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730780|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
153730781|NCT00135122|Hormones|hormones|mesh-ancestor
153730782|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153730783|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730784|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153730816|NCT00135434|Lopinavir|lopinavir|mesh-list
153730817|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153730818|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153730819|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153784141|NCT00269880|Heparin|heparin|mesh-list
153730850|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730851|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153730852|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153730853|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
153730854|NCT00152724|Aspirin|aspirin|mesh-list
153730855|NCT00152724|Celecoxib|celecoxib|mesh-list
153730856|NCT00152724|Indomethacin|indomethacin|mesh-list
153730857|NCT00152724|Nitroprusside|nitroprusside|mesh-list
153730858|NCT00152724|Acetylcholine|acetylcholine|mesh-list
153730859|NCT00152724|Capsaicin|capsaicin|mesh-list
153567886|NCT04822350|Avelumab|avelumab|mesh-list
153730860|NCT00152724|Clopidogrel|clopidogrel|mesh-list
153730861|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153730862|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153730863|NCT00152724|Analgesics|analgesics|mesh-ancestor
153730864|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
153730865|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784185|NCT04537780|Montelukast|montelukast|mesh-list
153730894|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730896|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153730898|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730899|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730900|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153730901|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153730902|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
153730903|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731520|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731521|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731522|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730934|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
153730936|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153730965|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
153730966|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
153730967|NCT00135863|Tinzaparin|tinzaparin|mesh-list
153730968|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153449638|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730969|NCT00135863|Dalteparin|dalteparin|mesh-list
153730995|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730996|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730997|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730998|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153730999|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153731000|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731001|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731002|NCT00406146|Artesunate|artesunate|mesh-list
153731003|NCT00406146|Lumefantrine|lumefantrine|mesh-list
153731004|NCT00406146|Artemether|artemether|mesh-list
153731005|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153731006|NCT00406146|Amodiaquine|amodiaquine|mesh-list
153731007|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
153731008|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153731009|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153731010|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731011|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731012|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
153731013|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
153731014|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153731015|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
153731016|NCT00136058|Alendronate|alendronate|mesh-list
153731017|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
153731018|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153784350|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
153731050|NCT00152997|Protective Agents|protective agents|mesh-ancestor
153731053|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153731055|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
153731056|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731057|NCT00136292|Daptomycin|daptomycin|mesh-list
153731058|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153731059|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731060|NCT00159471|Gemcitabine|gemcitabine|mesh-list
153731061|NCT00159471|Capecitabine|capecitabine|mesh-list
153731062|NCT00159471|Docetaxel|docetaxel|mesh-list
153731063|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153731064|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
153731065|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731066|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731067|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731068|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
153731084|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731085|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731086|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153731088|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
153731089|NCT00159510|Protective Agents|protective agents|mesh-ancestor
153731090|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731091|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
153731092|NCT00136409|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153731094|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731095|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731096|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731097|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153731099|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731100|NCT00136448|Cytarabine|cytarabine|mesh-list
153731101|NCT00136448|Interleukin-2|interleukin-2|mesh-list
153731102|NCT00136448|Daunorubicin|daunorubicin|mesh-list
153908005|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
153731103|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153731104|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
153731105|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731106|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731107|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
153731108|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731109|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153731110|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
153731111|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731112|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731524|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
153731114|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
153731115|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731117|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153731118|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153731119|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731120|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153731121|NCT00153153|Laxatives|laxatives|mesh-ancestor
153731122|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731123|NCT00136487|Celecoxib|celecoxib|mesh-list
153731124|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731126|NCT00136487|Analgesics|analgesics|mesh-ancestor
153731127|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
153731128|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731129|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731130|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731140|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731141|NCT00153192|Analgesics|analgesics|mesh-ancestor
153731142|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
153782226|NCT04673812|Fentanyl|fentanyl|mesh-list
153731143|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731144|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153731145|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153731146|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731147|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731148|NCT00153192|Hormones|hormones|mesh-ancestor
153731149|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731150|NCT00136526|Docetaxel|docetaxel|mesh-list
153731151|NCT00136526|Fosfestrol|fosfestrol|mesh-list
153731160|NCT00136526|Hormones|hormones|mesh-ancestor
153731161|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731162|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731163|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153731164|NCT00136565|Prednisone|prednisone|mesh-list
153731165|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
153731166|NCT00136565|Doxorubicin|doxorubicin|mesh-list
153731168|NCT00136565|Bleomycin|bleomycin|mesh-list
153731169|NCT00136565|Vindesine|vindesine|mesh-list
153357812|NCT01301183|Growth Substances|growth substances|mesh-ancestor
153731170|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153731173|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731174|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153731175|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
153731176|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731213|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731214|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
153731215|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731216|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548284|NCT04886154|Vaccines|vaccines|mesh-list
153731217|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
153548593|NCT04706130|Artesunate|artesunate|mesh-list
153548818|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
153548966|NCT04529954|Valproic Acid|valproic acid|mesh-list
153731218|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153731219|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731220|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153731221|NCT00159705|Pregabalin|pregabalin|mesh-list
153731222|NCT00159705|Analgesics|analgesics|mesh-ancestor
153731223|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
153731224|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731225|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731226|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
153731227|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153731228|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153553864|NCT01595334|Cetrorelix|cetrorelix|mesh-list
153554143|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153554219|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731243|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731244|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153731245|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153555490|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
153555563|NCT02702492|Niacin|niacin|mesh-list
153555649|NCT02158234|Cisplatin|cisplatin|mesh-list
153731246|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
153731247|NCT00137033|Celecoxib|celecoxib|mesh-list
153731248|NCT00137033|Naproxen|naproxen|mesh-list
153556009|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153556307|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153556378|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
153556454|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153556529|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153560758|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
153561057|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
153561281|NCT01651715|Antibodies|antibodies|mesh-list
153561656|NCT01653171|Emollients|emollients|mesh-ancestor
153561733|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
153561804|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562095|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
153562396|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153565058|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565189|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153565258|NCT05837286|Cortisone|cortisone|mesh-list
153565336|NCT05781308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565515|NCT04404881|Bevacizumab|bevacizumab|mesh-list
153566447|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
153566534|NCT06234748|Cisplatin|cisplatin|mesh-list
153566651|NCT06234046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783062|NCT00268593|Hormones|hormones|mesh-ancestor
153783149|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332555|NCT03375385|Analgesics|analgesics|mesh-ancestor
153332781|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333305|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153333384|NCT02185339|Rocuronium|rocuronium|mesh-list
153333456|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333605|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333839|NCT03828032|Mannitol|mannitol|mesh-list
153334592|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
153334670|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153334824|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
153335002|NCT01451840|Analgesics|analgesics|mesh-ancestor
153343654|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343728|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350973|NCT04100824|Nimodipine|nimodipine|mesh-list
153351347|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153351572|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
153351648|NCT00407888|Trastuzumab|trastuzumab|mesh-list
153351723|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153784796|NCT05841160|Moxifloxacin|moxifloxacin|mesh-list
153731263|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731264|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
153368688|NCT02384850|Folic Acid|folic acid|mesh-list
153731265|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153784829|NCT05815758|Histamine Agents|histamine agents|mesh-ancestor
153439898|NCT00003595|Prednisone|prednisone|mesh-list
153442171|NCT00005797|Busulfan|busulfan|mesh-list
153444687|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
153453195|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
153456601|NCT01473732|Everolimus|everolimus|mesh-list
153783686|NCT00236717|Valproic Acid|valproic acid|mesh-list
153731273|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731274|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
153731275|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153360695|NCT01365611|Analgesics|analgesics|mesh-ancestor
153731277|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731278|NCT00159900|Urological Agents|urological agents|mesh-ancestor
153731279|NCT00159978|Alovudine|alovudine|mesh-list
153731280|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
153733840|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
153733842|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733843|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153733844|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733845|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733878|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153733879|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153733880|NCT00466609|Fluoxetine|fluoxetine|mesh-list
153733881|NCT00466609|Clomipramine|clomipramine|mesh-list
153733882|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
153733883|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153733884|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153733885|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153733886|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733887|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784958|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733967|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733968|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
153733969|NCT00148902|Docetaxel|docetaxel|mesh-list
153733970|NCT00148902|Lapatinib|lapatinib|mesh-list
153733971|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733972|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
153733973|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
153733974|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
153733975|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733976|NCT00148902|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153733977|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153733978|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733979|NCT05507645|Saruplase|saruplase|mesh-list
153733980|NCT05507645|Anticoagulants|anticoagulants|mesh-list
153733981|NCT05507645|Clopidogrel|clopidogrel|mesh-list
153733982|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734018|NCT00467545|Telbivudine|telbivudine|mesh-list
153734019|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
153734020|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734021|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153412496|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
153734049|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734050|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734051|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153734052|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
153734053|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
153734054|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
153734055|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153734056|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153734057|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
153734119|NCT04697641|Pantoprazole|pantoprazole|mesh-list
153734157|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734194|NCT06183073|Dexmedetomidine|dexmedetomidine|mesh-list
153734195|NCT06183073|Bupivacaine|bupivacaine|mesh-list
153734196|NCT06183073|Anesthetics, Local|anesthetics, local|mesh-ancestor
153734197|NCT06183073|Anesthetics|anesthetics|mesh-ancestor
153734198|NCT06183073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734199|NCT06183073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734267|NCT06246786|Dermatologic Agents|dermatologic agents|mesh-ancestor
153734268|NCT06246786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734269|NCT06246786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153734270|NCT06246695|Itraconazole|itraconazole|mesh-list
153734271|NCT06246695|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153734301|NCT06246513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153734302|NCT06246513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734304|NCT06246461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153734305|NCT06246461|Antimetabolites|antimetabolites|mesh-ancestor
153734306|NCT06246461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734307|NCT06246461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734308|NCT06246422|Tranexamic Acid|tranexamic acid|mesh-list
153734309|NCT06246422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153734310|NCT06246422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153734311|NCT06246422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734442|NCT06243809|Hormones|hormones|mesh-ancestor
153734443|NCT06243809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734444|NCT06243809|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153734445|NCT06243809|Protease Inhibitors|protease inhibitors|mesh-ancestor
153734446|NCT06243809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734447|NCT06243809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734448|NCT06241781|Gemcitabine|gemcitabine|mesh-list
153734449|NCT06241781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153734481|NCT06231212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734482|NCT06231212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734483|NCT06231212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734484|NCT06231212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734485|NCT06231212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153734486|NCT06231212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734487|NCT06231212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734489|NCT06227429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734490|NCT06227429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734491|NCT06217562|Vasopressins|vasopressins|mesh-list
153734492|NCT06217562|Arginine Vasopressin|arginine vasopressin|mesh-list
153734493|NCT06217562|Hemostatics|hemostatics|mesh-ancestor
153734696|NCT05956899|Ondansetron|ondansetron|mesh-list
153734697|NCT05956899|Palonosetron|palonosetron|mesh-list
153734698|NCT05956899|Antiemetics|antiemetics|mesh-ancestor
153734699|NCT05956899|Autonomic Agents|autonomic agents|mesh-ancestor
153785151|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153734761|NCT05886972|Propofol|propofol|mesh-list
153734762|NCT05886972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153734763|NCT05886972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785190|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
153734874|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734875|NCT05643560|Factor VIII|factor viii|mesh-list
153734876|NCT05643560|Coagulants|coagulants|mesh-ancestor
153734877|NCT05624996|Paclitaxel|paclitaxel|mesh-list
153735052|NCT05355441|Acetaminophen|acetaminophen|mesh-list
153735053|NCT05355441|Ibuprofen|ibuprofen|mesh-list
153735054|NCT05355441|Morphine|morphine|mesh-list
153735055|NCT05355441|Tramadol|tramadol|mesh-list
153735056|NCT05355441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153735057|NCT05355441|Narcotics|narcotics|mesh-ancestor
153735122|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
153735124|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153735125|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153735126|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153735127|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153735128|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153735129|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153735130|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
153735131|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
153735132|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153735133|NCT05314569|Narcotics|narcotics|mesh-ancestor
153735195|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735197|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735198|NCT05180240|Cannabidiol|cannabidiol|mesh-list
153735199|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
153735200|NCT05136560|Dexamethasone|dexamethasone|mesh-list
153735201|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
153735202|NCT05136560|BB 1101|bb 1101|mesh-list
153735203|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735204|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
153735205|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
153735206|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785266|NCT00239096|Losartan|losartan|mesh-list
153735250|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153735251|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153735252|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153735253|NCT05098067|Ondansetron|ondansetron|mesh-list
153735254|NCT05098067|Metoclopramide|metoclopramide|mesh-list
153735255|NCT05098067|Capsaicin|capsaicin|mesh-list
153735256|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
153735257|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
153735258|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735259|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735260|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153735261|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
153735262|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
153735263|NCT05098067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153735264|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153735265|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
153735266|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735267|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735268|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
153735269|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153735270|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153735271|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
153735272|NCT05092373|Paclitaxel|paclitaxel|mesh-list
153413157|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
153735357|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153735358|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153735360|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
153735361|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413303|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
153735396|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153753903|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
153753904|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
153785364|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
153754172|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754173|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
153754174|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754175|NCT02904031|Antidotes|antidotes|mesh-ancestor
153754176|NCT02904031|Protective Agents|protective agents|mesh-ancestor
153754177|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
153754179|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
153754180|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754181|NCT02904109|Mannitol|mannitol|mesh-list
153754182|NCT02904109|Triflusal|triflusal|mesh-list
153754183|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153754184|NCT02904109|Diuretics|diuretics|mesh-ancestor
153754185|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
153754186|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754187|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153754188|NCT00178113|Lycopene|lycopene|mesh-list
153754189|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754190|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
153754191|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754192|NCT00178113|Protective Agents|protective agents|mesh-ancestor
153754193|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754194|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153754195|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153754196|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754197|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
153754238|NCT05995912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754239|NCT05995912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754240|NCT05995912|Gout Suppressants|gout suppressants|mesh-ancestor
153754241|NCT05995912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153754242|NCT05995912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754243|NCT05995912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754244|NCT05995912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153754246|NCT05995691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153754247|NCT05995691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754248|NCT05995691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754249|NCT05995522|Vitamin K|vitamin k|mesh-list
153754250|NCT05995522|Vitamin K 2|vitamin k 2|mesh-list
153754251|NCT05995522|Vitamins|vitamins|mesh-ancestor
153754252|NCT05995522|Micronutrients|micronutrients|mesh-ancestor
153754253|NCT05995522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754254|NCT05995522|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153754255|NCT05995522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153754256|NCT05995522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754257|NCT05995522|Hemostatics|hemostatics|mesh-ancestor
153754258|NCT05995522|Coagulants|coagulants|mesh-ancestor
153754259|NCT05995054|Obinutuzumab|obinutuzumab|mesh-list
153754260|NCT05995054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754261|NCT05995054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754262|NCT05994742|Pyridoxine|pyridoxine|mesh-list
153754263|NCT05994742|Vitamin B 6|vitamin b 6|mesh-list
153754264|NCT05994742|Azithromycin|azithromycin|mesh-list
153754265|NCT05994742|Rifampin|rifampin|mesh-list
153754266|NCT05994742|Isoniazid|isoniazid|mesh-list
153754267|NCT05994742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153754268|NCT05994742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754293|NCT05994599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754294|NCT05994547|Midazolam|midazolam|mesh-list
153754295|NCT05994547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153754296|NCT05994547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153754350|NCT05864417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754417|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
153754418|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153754453|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754454|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
153754455|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153754456|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754457|NCT05284591|Daratumumab|daratumumab|mesh-list
153754458|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754459|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
153754553|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
153754554|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153754715|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153754716|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
153754717|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754718|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
153754719|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153754720|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
153754869|NCT02635672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754871|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
153754874|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
153754875|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754876|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153754877|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153754908|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153754910|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153754911|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153754912|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
153754913|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754914|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153754915|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153754916|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754917|NCT00799864|Tenofovir|tenofovir|mesh-list
153754918|NCT00799864|Lamivudine|lamivudine|mesh-list
153754952|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
153754953|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
153754954|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
153754955|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754956|NCT02903251|Oxytocin|oxytocin|mesh-list
153754957|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
153754958|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153754959|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754960|NCT00168467|Ramipril|ramipril|mesh-list
153755021|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755023|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
153755024|NCT02902354|Nifedipine|nifedipine|mesh-list
153755025|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153755026|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755027|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755028|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153755029|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755030|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
153755031|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
153755032|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153755033|NCT00168623|Vitamin A|vitamin a|mesh-list
153755034|NCT00168623|Vitamins|vitamins|mesh-ancestor
153755063|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755065|NCT00168779|Valsartan|valsartan|mesh-list
153755066|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153755067|NCT00168779|Telmisartan|telmisartan|mesh-list
153785657|NCT01644799|Idelalisib|idelalisib|mesh-list
153755080|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755081|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755112|NCT02901145|Nivolumab|nivolumab|mesh-list
153755113|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755114|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
153755115|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755116|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755117|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153755118|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
153755119|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755120|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755121|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153755122|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755123|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153755124|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
153755125|NCT02901301|Capecitabine|capecitabine|mesh-list
153755126|NCT02901301|Trastuzumab|trastuzumab|mesh-list
153755127|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755154|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755155|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755156|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153755157|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755158|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755159|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755160|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153755161|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
153755165|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153755166|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
153755167|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
153755168|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
153755169|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
153755170|NCT00169130|Doxorubicin|doxorubicin|mesh-list
153755171|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755172|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
153755173|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755174|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755175|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153755176|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
153755205|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
153755206|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755207|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153755208|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153755209|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755210|NCT00178698|Interferons|interferons|mesh-list
153755211|NCT00178698|Gemcitabine|gemcitabine|mesh-list
153755338|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755340|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755370|NCT02897830|Growth Substances|growth substances|mesh-ancestor
153755371|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
153755372|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
153755373|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755374|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755375|NCT02897557|Pancrelipase|pancrelipase|mesh-list
153755376|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755377|NCT02897596|Grazoprevir|grazoprevir|mesh-list
153755378|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
153785776|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
153755531|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755532|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755533|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153755534|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755535|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755643|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755644|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153755645|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
153755646|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755647|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755648|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153755649|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153755650|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153755651|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153755652|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755653|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153755654|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153755743|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
153755744|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153755745|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
153755746|NCT00170729|Hormones|hormones|mesh-ancestor
153755747|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153755748|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755749|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153755750|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755751|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
153755752|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
153755753|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755809|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153755810|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755811|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755812|NCT00170963|Amlodipine|amlodipine|mesh-list
153755813|NCT00170963|Valsartan|valsartan|mesh-list
153755814|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755815|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153755816|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755867|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263196|NCT05900388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153755869|NCT05349448|Analgesics|analgesics|mesh-ancestor
153755870|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
153755871|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755929|NCT01330030|Protective Agents|protective agents|mesh-ancestor
153755930|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755932|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153755933|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
153755934|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755935|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756077|NCT00171860|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756078|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756079|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756080|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756081|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756082|NCT00553930|Interferons|interferons|mesh-list
153756083|NCT00553930|Ribavirin|ribavirin|mesh-list
153756108|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756110|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756111|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756112|NCT02240407|Acetaminophen|acetaminophen|mesh-list
153756113|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
153756146|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153756147|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
153756148|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
153756149|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756150|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153756151|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
153756152|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
153756153|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
153756154|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153756155|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756156|NCT00197613|Lamivudine|lamivudine|mesh-list
153756157|NCT00197613|Zidovudine|zidovudine|mesh-list
153756158|NCT00197613|Efavirenz|efavirenz|mesh-list
153756191|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153756193|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
153756194|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
153756195|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756196|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
153756197|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756383|NCT00198237|Capecitabine|capecitabine|mesh-list
153756384|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756385|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
153756386|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756387|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756388|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756389|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756510|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756511|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756513|NCT02072863|Melphalan|melphalan|mesh-list
153756514|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756515|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
153756516|NCT02072863|Hormones|hormones|mesh-ancestor
153756517|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756518|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756519|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153756520|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756547|NCT02057380|Bortezomib|bortezomib|mesh-list
153756548|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153756549|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153756550|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756551|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
153756552|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756553|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756554|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756555|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756556|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
153756557|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
153756558|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756559|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756560|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153756611|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153756644|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756645|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756646|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
153756647|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153756648|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
153756649|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
153756650|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153756651|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153756652|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153756653|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
153756654|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756717|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
153756718|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756719|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756720|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153756721|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
153756722|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153756723|NCT01930357|Vaccines|vaccines|mesh-list
153756724|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
153756725|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756726|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
153756727|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153756728|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756729|NCT01903954|Ribavirin|ribavirin|mesh-list
153756730|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153756731|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
153756732|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756733|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
153756734|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756735|NCT01893190|Nimodipine|nimodipine|mesh-list
153756736|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153756737|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153756738|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153756795|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756796|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
153756797|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756798|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153756799|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756800|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
153756801|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756973|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153756974|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153756975|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153756976|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153756977|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153757203|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153757254|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757255|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757256|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757257|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153757258|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153757259|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757260|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153757261|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153757262|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
153757297|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757298|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757299|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153757300|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153757301|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
153757302|NCT00555334|Lamivudine|lamivudine|mesh-list
153757303|NCT00555334|Entecavir|entecavir|mesh-list
153757304|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153757305|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153757323|NCT00174707|Methotrexate|methotrexate|mesh-list
153757324|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757325|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
153757326|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757357|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
153757358|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153757359|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757360|NCT00174863|SR 31747|sr 31747|mesh-list
153757361|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757362|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757363|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154263197|NCT05900388|Protease Inhibitors|protease inhibitors|mesh-ancestor
153757364|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
153757365|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757399|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757400|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757401|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757443|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757444|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153757445|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153757446|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
153757447|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757448|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757449|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
153757450|NCT04676776|Mifepristone|mifepristone|mesh-list
153757451|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153757452|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
153757453|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153757454|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757455|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153757456|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153757484|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
153757485|NCT00555607|Hormones|hormones|mesh-ancestor
153757486|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757487|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757488|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153757489|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757490|NCT00199368|Istradefylline|istradefylline|mesh-list
153757491|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153757492|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153757493|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153757494|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
153757495|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757496|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757497|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757498|NCT04675528|Paclitaxel|paclitaxel|mesh-list
153757499|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757500|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757501|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757529|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153757530|NCT04675372|Analgesics|analgesics|mesh-ancestor
153757531|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
153757532|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757533|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153757534|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153757535|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153757536|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
153757537|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757538|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757539|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153757621|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153757622|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153757623|NCT04230187|Growth Substances|growth substances|mesh-ancestor
153757624|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757625|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
153757627|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757628|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757629|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757630|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
153757631|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153757632|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153757633|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757635|NCT04230187|Protective Agents|protective agents|mesh-ancestor
153757636|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
153757637|NCT04230187|Vitamins|vitamins|mesh-ancestor
153757638|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
153757639|NCT00175643|Imiquimod|imiquimod|mesh-list
153757640|NCT00175643|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153757668|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
153757669|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757670|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447579|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757671|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757672|NCT00554086|Bicalutamide|bicalutamide|mesh-list
153757673|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
153757674|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
153757675|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757760|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153757761|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757762|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153757763|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153757764|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757765|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
153757766|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786465|NCT02219191|Puerarin|puerarin|mesh-list
153757855|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153908324|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
153757856|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757857|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757858|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757859|NCT00176540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153757860|NCT00176540|Narcotics|narcotics|mesh-ancestor
153757861|NCT00176540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757862|NCT00176540|Analgesics|analgesics|mesh-ancestor
153757863|NCT00176540|Sensory System Agents|sensory system agents|mesh-ancestor
153757864|NCT00176540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757866|NCT00176618|Sulindac|sulindac|mesh-list
153786503|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758186|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153758187|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153758188|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153758189|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153758190|NCT00204984|Hydralazine|hydralazine|mesh-list
153758191|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153758192|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
153758193|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758256|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153758344|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
153786640|NCT00264927|Satavaptan|satavaptan|mesh-list
153758447|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
153758448|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153758450|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
153758451|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
153758452|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758453|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758454|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
153758455|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758456|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153758457|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153758458|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153758459|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758460|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758559|NCT04652284|Rifabutin|rifabutin|mesh-list
153758560|NCT04652284|Tinidazole|tinidazole|mesh-list
153758561|NCT04652284|Esomeprazole|esomeprazole|mesh-list
153758562|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758563|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758687|NCT00559741|Protective Agents|protective agents|mesh-ancestor
153758688|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
153758689|NCT00559741|Vitamins|vitamins|mesh-ancestor
153758690|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
153758691|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153758692|NCT00178763|Interferons|interferons|mesh-list
153758693|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
153758694|NCT00178763|Cisplatin|cisplatin|mesh-list
153758695|NCT00178763|Gemcitabine|gemcitabine|mesh-list
153758696|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758697|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153758698|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
153758699|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758700|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
153758755|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758756|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
153758757|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758758|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
153758839|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153758841|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
153758843|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758844|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758845|NCT00560326|Tacrolimus|tacrolimus|mesh-list
153758846|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758847|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
153758848|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758849|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153758850|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758851|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758852|NCT00560443|Ketorolac|ketorolac|mesh-list
153758853|NCT00560443|Tramadol|tramadol|mesh-list
153786748|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
153758871|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153758872|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153758873|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758874|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758875|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
153758876|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758877|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758878|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153758879|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758880|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153758881|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153758882|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
153758883|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
153758884|NCT00201318|Lamivudine|lamivudine|mesh-list
153758885|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
153758886|NCT00201318|Doxorubicin|doxorubicin|mesh-list
153758887|NCT00201318|Vincristine|vincristine|mesh-list
153758888|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758889|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
153758890|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758891|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758892|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153758893|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
153758894|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758895|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758896|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153758897|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153758898|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153758899|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153758900|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758901|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153758902|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
153758903|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
153758904|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
153758905|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153758906|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153758907|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
153758908|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758909|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153758910|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153758911|NCT00201357|Thalidomide|thalidomide|mesh-list
153758912|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758913|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
153758914|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758915|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
153758916|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758917|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758918|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153758919|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153758920|NCT00201357|Growth Substances|growth substances|mesh-ancestor
153758921|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
153758922|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758923|NCT00201396|Leucovorin|leucovorin|mesh-list
153758924|NCT00201396|Fluorouracil|fluorouracil|mesh-list
153758959|NCT00560599|Mupirocin|mupirocin|mesh-list
153758960|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153758961|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758962|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
153758963|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
153758964|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758965|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153758966|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447646|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
153758967|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758968|NCT04635553|Praziquantel|praziquantel|mesh-list
153758969|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
153758970|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153758971|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758972|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153758973|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153758974|NCT04634656|Lidocaine|lidocaine|mesh-list
153758975|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
153758976|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
153758977|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758978|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758979|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
153758980|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758981|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153758982|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153758983|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153758984|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758985|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758986|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
153758987|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153786860|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759040|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759041|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759042|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
153759043|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759075|NCT00201747|Mitomycin|mitomycin|mesh-list
153759076|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759077|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759078|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
153759079|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759080|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153759081|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759082|NCT00179738|Lenalidomide|lenalidomide|mesh-list
153759083|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
153759084|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786912|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153759108|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
153759109|NCT00201786|Pentostatin|pentostatin|mesh-list
153759110|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759111|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153759112|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759113|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759114|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
153759115|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759116|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
153759117|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759118|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759119|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759120|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
153759121|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759122|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759123|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759124|NCT04630444|Riluzole|riluzole|mesh-list
153759125|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
153759126|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153759127|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153759128|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759129|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759130|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759131|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153759132|NCT04630444|Protective Agents|protective agents|mesh-ancestor
153759133|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
153759134|NCT00186810|Busulfan|busulfan|mesh-list
153759135|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759136|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
153759137|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759138|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759139|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759140|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
153447674|NCT00002747|Trace Elements|trace elements|mesh-ancestor
153759141|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759142|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759143|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759144|NCT04630288|Clopidogrel|clopidogrel|mesh-list
153759145|NCT04630288|Ticagrelor|ticagrelor|mesh-list
153759146|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153759147|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153759163|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153759164|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
153759165|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759167|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
153759168|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759169|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759170|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759171|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
153759172|NCT00561067|Hormones|hormones|mesh-ancestor
153759173|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759174|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153759200|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
153759201|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759202|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759203|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759204|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
153759205|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759206|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759207|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759216|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759217|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
153759218|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759219|NCT00201981|Protective Agents|protective agents|mesh-ancestor
153759220|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759221|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759222|NCT00180011|Omalizumab|omalizumab|mesh-list
153759223|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153759224|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153759225|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
153759226|NCT00186966|Cytarabine|cytarabine|mesh-list
153759227|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
153759228|NCT00186966|Melphalan|melphalan|mesh-list
153759229|NCT00186966|Busulfan|busulfan|mesh-list
153759230|NCT00186966|Fludarabine|fludarabine|mesh-list
153759231|NCT00186966|Etoposide|etoposide|mesh-list
153759232|NCT00186966|Daunorubicin|daunorubicin|mesh-list
153759233|NCT00186966|Thioguanine|thioguanine|mesh-list
153759234|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759235|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
153759236|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787019|NCT00244361|Rituximab|rituximab|mesh-list
153759260|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
153759261|NCT00180050|Hormones|hormones|mesh-ancestor
153759262|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759263|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153759264|NCT00575302|Hormones|hormones|mesh-ancestor
153759265|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759266|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759267|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153759268|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153759269|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
153759270|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759271|NCT00180089|Budesonide|budesonide|mesh-list
153759272|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759273|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153759274|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
153759275|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759295|NCT00180128|Daunorubicin|daunorubicin|mesh-list
153759296|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
153759297|NCT00180128|Idarubicin|idarubicin|mesh-list
153759298|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759299|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
153759300|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759301|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759302|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
153759303|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759304|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759305|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
153759317|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153759318|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153759320|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382897|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153759321|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759322|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759323|NCT00575848|Glycine|glycine|mesh-list
153759324|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
153759325|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759326|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759327|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759328|NCT00576238|Betamethasone|betamethasone|mesh-list
153759329|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
153759330|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153759331|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
153759344|NCT00576433|Rituximab|rituximab|mesh-list
153759345|NCT00576433|Methotrexate|methotrexate|mesh-list
153759346|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153759347|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759348|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
153759349|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759350|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759351|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153759352|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
153759353|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153759354|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759355|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
153759356|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759357|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
153759358|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759359|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153759360|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759361|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153759362|NCT00576511|Prucalopride|prucalopride|mesh-list
153759363|NCT00576511|Laxatives|laxatives|mesh-ancestor
153759364|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759365|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153759366|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153759367|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
153759368|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759369|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759370|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759371|NCT00576550|Betamethasone|betamethasone|mesh-list
153759372|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
153759373|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153759374|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
153759375|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153759376|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759377|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
153759378|NCT00576550|Hormones|hormones|mesh-ancestor
153759379|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759416|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153759417|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153759418|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759419|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153759420|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153759421|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759423|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153759424|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
153759425|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153759426|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
153759427|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
153759428|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153759429|NCT00202020|Protective Agents|protective agents|mesh-ancestor
153759430|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153759431|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153759432|NCT00577018|Prucalopride|prucalopride|mesh-list
153759433|NCT00577018|Laxatives|laxatives|mesh-ancestor
153759434|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759435|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153759436|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153447721|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
153759437|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
153759438|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759439|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759440|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759441|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
153759442|NCT04578847|Dasatinib|dasatinib|mesh-list
153759443|NCT04578847|Nilotinib|nilotinib|mesh-list
153759444|NCT04578847|Bosutinib|bosutinib|mesh-list
153759445|NCT04578847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153759446|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153759447|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759448|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759449|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759450|NCT00577057|Capecitabine|capecitabine|mesh-list
153759451|NCT00577057|Fluorouracil|fluorouracil|mesh-list
153759536|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
153759537|NCT00187083|Hormones|hormones|mesh-ancestor
153759538|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759539|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153759540|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759549|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153759550|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759551|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
153759552|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759553|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153759554|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759555|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759556|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759557|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759558|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759559|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759560|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153759561|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759583|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759584|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
153759585|NCT00187122|Cytarabine|cytarabine|mesh-list
153759586|NCT00187122|Dexamethasone|dexamethasone|mesh-list
153759587|NCT00187122|Prednisone|prednisone|mesh-list
153759588|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
153759589|NCT00187122|Methotrexate|methotrexate|mesh-list
153759590|NCT00187122|Etoposide|etoposide|mesh-list
153759591|NCT00187122|Vincristine|vincristine|mesh-list
153759592|NCT00187122|Asparaginase|asparaginase|mesh-list
153759593|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
153759594|NCT00187122|Daunorubicin|daunorubicin|mesh-list
153759595|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759596|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
153759597|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759598|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759599|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759600|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
153759601|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759602|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759603|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759604|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759605|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
153759606|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
153759607|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759608|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759609|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
153759610|NCT00187122|Hormones|hormones|mesh-ancestor
153759611|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759612|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153759613|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153759614|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
153759621|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153759622|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759624|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759625|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
153759626|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759627|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759628|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759629|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759630|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759631|NCT00180635|Pimagedine|pimagedine|mesh-list
153759632|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759633|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759634|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
153759653|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759654|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759655|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153759656|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153759657|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
153759658|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
153759659|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153759660|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153759661|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153759662|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759663|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759664|NCT00187161|Cytarabine|cytarabine|mesh-list
153759665|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
153759666|NCT00187161|Doxorubicin|doxorubicin|mesh-list
153759667|NCT00187161|Methotrexate|methotrexate|mesh-list
153759668|NCT00187161|Etoposide|etoposide|mesh-list
153759669|NCT00187161|Vincristine|vincristine|mesh-list
153759670|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759671|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
153759672|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759673|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759674|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759675|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
153759676|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759677|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759678|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759679|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759680|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759681|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759702|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153759703|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153759704|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153759705|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
153908547|NCT04246567|Analgesics|analgesics|mesh-ancestor
153759706|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153759707|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153759708|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
153759709|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759710|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
153787340|NCT00274677|Lamotrigine|lamotrigine|mesh-list
153759722|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153759723|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
153759724|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153759725|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759726|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759727|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759728|NCT00180791|Carboplatin|carboplatin|mesh-list
153759729|NCT00180791|Etoposide|etoposide|mesh-list
153759730|NCT00180791|Melphalan|melphalan|mesh-list
153759731|NCT00180791|Thiotepa|thiotepa|mesh-list
153759732|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759733|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759734|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759735|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759762|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759764|NCT00202176|Ipratropium|ipratropium|mesh-list
153759765|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
153759766|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153759767|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
153759768|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759769|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759770|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153759771|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
153759772|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153759773|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
153759774|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759775|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759777|NCT00580060|Sargramostim|sargramostim|mesh-list
153759778|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
153759779|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759780|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417642|NCT02973763|Aflutinib|aflutinib|mesh-list
153759781|NCT00180908|Doxorubicin|doxorubicin|mesh-list
153759782|NCT00180908|Etoposide|etoposide|mesh-list
153759783|NCT00180908|Methotrexate|methotrexate|mesh-list
153759784|NCT00180908|Ifosfamide|ifosfamide|mesh-list
153759785|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759789|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759790|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759791|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153759792|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
153759793|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153759794|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759795|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759796|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
153759797|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
153759798|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153759799|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759800|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
153759801|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759802|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153759803|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759804|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759815|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759816|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759817|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153759818|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
153759819|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759821|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
153759822|NCT00581425|Imiquimod|imiquimod|mesh-list
153759823|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759824|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
153759825|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759826|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
153759827|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759828|NCT00581425|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153759829|NCT00581425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759830|NCT00581425|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153759831|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153759832|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
153759833|NCT00209079|Docetaxel|docetaxel|mesh-list
153759834|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
153759835|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759836|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759837|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759838|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759839|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759840|NCT00209079|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153759841|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153759842|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759843|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
153759844|NCT04576975|Ketamine|ketamine|mesh-list
153759845|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153759846|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153759847|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759848|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153759849|NCT04576975|Analgesics|analgesics|mesh-ancestor
153759850|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
153759851|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759852|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153759853|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153759854|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153759855|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
153759856|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759881|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759882|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759883|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759884|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759885|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
153759886|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759888|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
153417675|NCT02192190|Analgesics|analgesics|mesh-ancestor
153447809|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
153759889|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759890|NCT00582634|Docetaxel|docetaxel|mesh-list
153759891|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759892|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759893|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759894|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759934|NCT00583063|Sunitinib|sunitinib|mesh-list
153759935|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759936|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153759937|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153759938|NCT00583063|Growth Substances|growth substances|mesh-ancestor
153759939|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759940|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
153759941|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153759942|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759943|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759944|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153759945|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759946|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759947|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
153759948|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759949|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
153759950|NCT00181298|Memantine|memantine|mesh-list
153759951|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153759952|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153759967|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153759968|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153759969|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
153759970|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759971|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759972|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759973|NCT00583258|Urological Agents|urological agents|mesh-ancestor
153759974|NCT00181532|Celecoxib|celecoxib|mesh-list
153759975|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153759976|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153759977|NCT00181532|Analgesics|analgesics|mesh-ancestor
153759978|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
153759979|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759980|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759981|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759982|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759983|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153759984|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153759985|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759986|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759987|NCT04576390|Ondansetron|ondansetron|mesh-list
153759988|NCT04576390|Palonosetron|palonosetron|mesh-list
153759989|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
153759990|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
153759991|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759992|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597090|NCT01866553|Nilotinib|nilotinib|mesh-list
153759993|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759994|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
153759995|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
153760004|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153760005|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153760006|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153760007|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760008|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
153760009|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760036|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760037|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153760038|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153760039|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760040|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760041|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153760042|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
153760043|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760044|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760045|NCT00181688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153760046|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153760048|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153760049|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760050|NCT00181727|Valproic Acid|valproic acid|mesh-list
153760051|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
153760052|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760053|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760054|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
153760055|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760056|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760057|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
153760058|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760102|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153760103|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760104|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760105|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760106|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153760107|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
153760108|NCT00182039|Metoprolol|metoprolol|mesh-list
153760109|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153760110|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153760111|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
153760112|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
153760113|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760114|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760115|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153760116|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153760117|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153760118|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
153760119|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760120|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760121|NCT00584389|Rimonabant|rimonabant|mesh-list
153760122|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153760123|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153760124|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153760125|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760126|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760127|NCT00584389|Hormones|hormones|mesh-ancestor
153787584|NCT00247052|Analgesics|analgesics|mesh-ancestor
153760195|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153760196|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153760197|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153760198|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760199|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760201|NCT00585442|Calcitriol|calcitriol|mesh-list
153760202|NCT00585442|Vitamins|vitamins|mesh-ancestor
153760203|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
153760204|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760205|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153760206|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153760207|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153760208|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153760209|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760210|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153760211|NCT00585520|Progesterone|progesterone|mesh-list
153760212|NCT00585520|Progestins|progestins|mesh-ancestor
153760213|NCT00585520|Hormones|hormones|mesh-ancestor
153787647|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153760293|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359657|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760295|NCT04575415|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153760296|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787698|NCT00247481|Docetaxel|docetaxel|mesh-list
153760325|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760327|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153760328|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
153760329|NCT00182312|Caffeine|caffeine|mesh-list
153760330|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
153760331|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760332|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153760344|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760345|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760348|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760349|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153760350|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153760351|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760352|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760353|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760389|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153760390|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760391|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153760433|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
153760434|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153760435|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760436|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760437|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153760438|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153760439|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153760440|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153760441|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153760442|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153760444|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153760445|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153760446|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787817|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
153760492|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760494|NCT00182507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153760495|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153760496|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153760497|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760498|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760499|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
153760500|NCT00209742|Leucovorin|leucovorin|mesh-list
153760501|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
153760502|NCT00209742|Tegafur|tegafur|mesh-list
153760503|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
153760504|NCT00209742|Antidotes|antidotes|mesh-ancestor
153760505|NCT00209742|Protective Agents|protective agents|mesh-ancestor
153760506|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760507|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
153760508|NCT00209742|Vitamins|vitamins|mesh-ancestor
153760509|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
153760510|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153760511|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
153760525|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760526|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760527|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760528|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
153760529|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
153760565|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760566|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153760567|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787907|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153760679|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760680|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760681|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760682|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153760683|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153760684|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153760685|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760739|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153760740|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
153760741|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153760742|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153760743|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760744|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153760745|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
153760746|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153760762|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153760763|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
153760764|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760765|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447894|NCT05215691|Morphine|morphine|mesh-list
153760766|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153760767|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760768|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153760799|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
153760800|NCT00590629|Vitamins|vitamins|mesh-ancestor
153760801|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
153760802|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760803|NCT00590785|Tamoxifen|tamoxifen|mesh-list
153760804|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
153760805|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
153760806|NCT00590785|Doxorubicin|doxorubicin|mesh-list
153760807|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153760824|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153760825|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153760826|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153760827|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153788031|NCT00278967|Bisacodyl|bisacodyl|mesh-list
153760847|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153760848|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153760849|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153760850|NCT00476593|Dexamethasone|dexamethasone|mesh-list
153760851|NCT00476593|Diclofenac|diclofenac|mesh-list
153760852|NCT00476593|Lactitol|lactitol|mesh-list
153760853|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153760854|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760855|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
153760856|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
153760857|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760858|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760859|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153760860|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
153760861|NCT00476593|Hormones|hormones|mesh-ancestor
153760862|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760876|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
153760877|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
153760878|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760879|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760880|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
153760881|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760882|NCT00183404|Olanzapine|olanzapine|mesh-list
153760883|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
153760884|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
153760885|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760886|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760887|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153760888|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153760889|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760890|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760891|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760892|NCT00183404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153760893|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153760894|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153760895|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788076|NCT00249431|Sertraline|sertraline|mesh-list
153760946|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153760947|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450412|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
153760948|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760949|NCT00476008|Memantine|memantine|mesh-list
153760950|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153760996|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760997|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760999|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
153761000|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761001|NCT02963402|Adalimumab|adalimumab|mesh-list
153761002|NCT02963402|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153761003|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153761004|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153761005|NCT00210327|Bortezomib|bortezomib|mesh-list
153761006|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761007|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
153761008|NCT00425516|Docetaxel|docetaxel|mesh-list
153761009|NCT00425516|Fluorouracil|fluorouracil|mesh-list
153761010|NCT00425516|Epirubicin|epirubicin|mesh-list
153761035|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761036|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153761037|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153761038|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761039|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761040|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153761042|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
153761058|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761059|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761060|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153761061|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761062|NCT00475735|Methylphenidate|methylphenidate|mesh-list
153761063|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153761064|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761065|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153761066|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153761067|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761068|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761069|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
153761070|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761072|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761073|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761089|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
153450435|NCT00386399|Mitomycin|mitomycin|mesh-list
153761090|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761092|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153761093|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761094|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
153761095|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761096|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153761097|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
153761098|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153761099|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153761100|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153761113|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761114|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761115|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
153761117|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
153761118|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761119|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
153761120|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
153761121|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153761122|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153761123|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
153761124|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
153761125|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761126|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761127|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153761128|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
153761129|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
153761130|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153761131|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153761132|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
153761133|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
153761134|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153761135|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
153761136|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153761137|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761138|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153761139|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153761140|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153761141|NCT00183989|Rituximab|rituximab|mesh-list
153908772|NCT02820259|Tacrolimus|tacrolimus|mesh-list
153761142|NCT00183989|Fludarabine|fludarabine|mesh-list
153761143|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
153761144|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153761145|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761146|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
153761190|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761191|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
153761192|NCT00210600|Hematinics|hematinics|mesh-ancestor
153761194|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153761195|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153761196|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153761197|NCT00217386|Analgesics|analgesics|mesh-ancestor
153761198|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
153761199|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761200|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736463|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761201|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153761202|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153761203|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153761204|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153761205|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
153761254|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761255|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153761256|NCT00217542|Protective Agents|protective agents|mesh-ancestor
153761257|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153761258|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153761259|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153761260|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761261|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761262|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761263|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153761311|NCT00184613|Insulin|insulin|mesh-list
153761312|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153761313|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
153761314|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
153761315|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761316|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761317|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
153761368|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
153761369|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761370|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761371|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
153761372|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788393|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
153761396|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761397|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761399|NCT00185120|Olmesartan|olmesartan|mesh-list
153761400|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153761401|NCT00185120|Benazepril|benazepril|mesh-list
153761402|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153761403|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153761404|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761405|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761406|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153761407|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761408|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
153761441|NCT00185237|Estradiol|estradiol|mesh-list
153761442|NCT00185237|Estrogens|estrogens|mesh-ancestor
153761443|NCT00185237|Hormones|hormones|mesh-ancestor
153761444|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761445|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761446|NCT00218166|Triazolam|triazolam|mesh-list
153761447|NCT00218166|Tiagabine|tiagabine|mesh-list
153761448|NCT00218166|Baclofen|baclofen|mesh-list
153761467|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761468|NCT00185315|Iloprost|iloprost|mesh-list
153761469|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153761470|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
153761471|NCT00409019|Tenofovir|tenofovir|mesh-list
153761472|NCT00409019|Adefovir|adefovir|mesh-list
153761473|NCT00409019|Telbivudine|telbivudine|mesh-list
153761474|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
153761475|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761520|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153761522|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
153761523|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
153761524|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153761525|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
153761526|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153761527|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
153761528|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
153761529|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761530|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761531|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153761532|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
153761533|NCT00185510|Hormones|hormones|mesh-ancestor
153761578|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761579|NCT00185705|Telmisartan|telmisartan|mesh-list
153761580|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153761581|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153761582|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153761583|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761584|NCT00211341|Vitamin A|vitamin a|mesh-list
153761585|NCT00211341|Vitamins|vitamins|mesh-ancestor
153761586|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
153761587|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761588|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
153761613|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153761614|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761615|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761616|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153761617|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153761618|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153761619|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761631|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598737|NCT04757584|Nadolol|nadolol|mesh-list
153761633|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
153761634|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761635|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153761636|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153761637|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153761638|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761639|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761640|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153761641|NCT00218517|Protective Agents|protective agents|mesh-ancestor
153761642|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761643|NCT00211419|Triamcinolone|triamcinolone|mesh-list
153761644|NCT00211419|Anecortave|anecortave|mesh-list
153761645|NCT00211419|Verteporfin|verteporfin|mesh-list
153761646|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153761647|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
153761673|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153761674|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153761675|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761676|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761678|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153761679|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
153761680|NCT00186797|Fludarabine|fludarabine|mesh-list
153761681|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153761682|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
153761691|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153761692|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
153761693|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761694|NCT00211653|Expectorants|expectorants|mesh-ancestor
153761695|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
153761696|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153761697|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
153761698|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761699|NCT00211653|Protective Agents|protective agents|mesh-ancestor
153761700|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761701|NCT00211653|Antidotes|antidotes|mesh-ancestor
153761703|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153761704|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761734|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
153761735|NCT00187070|Hormones|hormones|mesh-ancestor
153761736|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761737|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153761738|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153761739|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153761740|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761741|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761742|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153761743|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
153761744|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153761745|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153761746|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
153761747|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
153761748|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153761749|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153761758|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
153761759|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153761760|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153761800|NCT00212043|Gemcitabine|gemcitabine|mesh-list
153761895|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761896|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761897|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761898|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
153761899|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761900|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153761901|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
153761902|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761903|NCT00219570|Clindamycin|clindamycin|mesh-list
153761904|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
153761905|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
153761906|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
153761907|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153761908|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761909|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153761910|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788795|NCT00252317|Captopril|captopril|mesh-list
153761935|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153761936|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
153761937|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761938|NCT00188630|Expectorants|expectorants|mesh-ancestor
153761939|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
153761940|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153761941|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
153761952|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761953|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761954|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153761955|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153761956|NCT00188669|Protective Agents|protective agents|mesh-ancestor
153843216|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153761957|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761958|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
153761959|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153761962|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
153761963|NCT00409214|Talaporfin|talaporfin|mesh-list
153761964|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761965|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153761966|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
153761967|NCT02963051|Copper|copper|mesh-list
153761968|NCT02963051|Disulfiram|disulfiram|mesh-list
153761969|NCT02963051|Trace Elements|trace elements|mesh-ancestor
153761970|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
153761971|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761972|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153761973|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153761974|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761975|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762005|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
153762006|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762007|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762026|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
153762027|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762029|NCT00212589|Protective Agents|protective agents|mesh-ancestor
153762030|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
153762031|NCT00212589|Vitamins|vitamins|mesh-ancestor
153762032|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
153762033|NCT00212589|Hematinics|hematinics|mesh-ancestor
153762034|NCT00188825|Basiliximab|basiliximab|mesh-list
153762035|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762036|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
153762037|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762038|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
153788879|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
153762087|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762088|NCT00219921|Morphine|morphine|mesh-list
153762089|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153762090|NCT00219921|Narcotics|narcotics|mesh-ancestor
153762091|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762169|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762170|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762171|NCT00220155|Gemcitabine|gemcitabine|mesh-list
153762172|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762173|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
153762174|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762175|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762176|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
153762180|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
153762181|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762182|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153762183|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450533|NCT05894200|Fluorides|fluorides|mesh-list
153762184|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
153762194|NCT00189683|Capecitabine|capecitabine|mesh-list
153789001|NCT01680406|Amebicides|amebicides|mesh-ancestor
153762219|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762220|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153762221|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153762222|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
153762223|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153762224|NCT00213096|ST 1435|st 1435|mesh-list
153762225|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
153762226|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
153762227|NCT00213096|Estradiol|estradiol|mesh-list
153762228|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153762229|NCT00213096|Estrogens|estrogens|mesh-ancestor
153762230|NCT00213096|Hormones|hormones|mesh-ancestor
153762231|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153762232|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762233|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153762234|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153762235|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153762236|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153762237|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153762238|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
153762239|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153762240|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153762241|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
153762242|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762243|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762284|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153762285|NCT00220311|Fludarabine|fludarabine|mesh-list
153762286|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
153762287|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762288|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762289|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
153762290|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762291|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762292|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
153762293|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762294|NCT00189917|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153762295|NCT00189917|Antiviral Agents|antiviral agents|mesh-ancestor
153762296|NCT00189917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762297|NCT00189956|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153762298|NCT00189956|Antiviral Agents|antiviral agents|mesh-ancestor
153762299|NCT00189956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762326|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153762327|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762328|NCT00189995|Haloperidol|haloperidol|mesh-list
153762329|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
153762330|NCT00189995|Clozapine|clozapine|mesh-list
153762331|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
153762332|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
153762333|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762334|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762335|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153762336|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153762337|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153762338|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762339|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762340|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153762341|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
153762342|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762343|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762344|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153762345|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153762347|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
153762348|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
153762349|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
153762350|NCT00213291|Hematinics|hematinics|mesh-ancestor
153762351|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
153762352|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153762353|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
153762354|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762355|NCT00190034|Expectorants|expectorants|mesh-ancestor
153762356|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
153762357|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153762358|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
153762359|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762360|NCT00190034|Protective Agents|protective agents|mesh-ancestor
153450560|NCT05892913|Mydriatics|mydriatics|mesh-ancestor
153762361|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762362|NCT00190034|Antidotes|antidotes|mesh-ancestor
153762399|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153762400|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
153762401|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762402|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762403|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153762405|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153762406|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762407|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762408|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153762409|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762410|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762412|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153762413|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
153762414|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153762415|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762440|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
153762441|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153762453|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153762454|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153762455|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762456|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762457|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762458|NCT00190502|Antibodies|antibodies|mesh-list
153762459|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
153762460|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599560|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
153762461|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153762462|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153762463|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153762464|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762465|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450589|NCT05861258|Minocycline|minocycline|mesh-list
153762466|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762467|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762468|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762470|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
153762471|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762472|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
153762473|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762502|NCT00213564|Methotrexate|methotrexate|mesh-list
153762503|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153762504|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
153762521|NCT00122876|Talaporfin|talaporfin|mesh-list
153762522|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762523|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153762524|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
153762525|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153762526|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153762527|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762528|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762529|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599633|NCT01876849|Exenatide|exenatide|mesh-list
153762556|NCT00220818|Lansoprazole|lansoprazole|mesh-list
153762557|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
153762558|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153762559|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263199|NCT05900388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263200|NCT05900388|Anticoagulants|anticoagulants|mesh-ancestor
153762560|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153762571|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762573|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762574|NCT00190853|Analgesics|analgesics|mesh-ancestor
153762575|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
153762576|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762577|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
153762578|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762579|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
153762580|NCT00190892|Carbamazepine|carbamazepine|mesh-list
153762581|NCT00190892|Olanzapine|olanzapine|mesh-list
153762582|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
153762583|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
153762584|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762585|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762586|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153762587|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153762588|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789386|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
153762648|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153762649|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153762650|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762651|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762652|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762653|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762654|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762655|NCT00191087|Analgesics|analgesics|mesh-ancestor
153762656|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
153762657|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762658|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
153908928|NCT02817217|Valsartan|valsartan|mesh-list
153762659|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762660|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
153762661|NCT00191126|Gemcitabine|gemcitabine|mesh-list
153762662|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762663|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762664|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
153762665|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762666|NCT00221052|Diclofenac|diclofenac|mesh-list
153762667|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153762668|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153762669|NCT00221052|Analgesics|analgesics|mesh-ancestor
153762670|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
153762671|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599779|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
153762672|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762673|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153762674|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153762675|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153762676|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762677|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762678|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153762679|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153762696|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762697|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
153762698|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762699|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762735|NCT06116461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153762736|NCT06116461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762737|NCT06116461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153762755|NCT06116214|Disinfectants|disinfectants|mesh-ancestor
153762783|NCT06115408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153762784|NCT06115408|Hormone Antagonists|hormone antagonists|mesh-ancestor
153762785|NCT06115408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153762786|NCT06115408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153762787|NCT06115408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762788|NCT06112808|Nivolumab|nivolumab|mesh-list
153762789|NCT06112808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153762791|NCT06112808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153762792|NCT06112808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762806|NCT06111573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153762807|NCT06111573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762808|NCT06111573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762810|NCT06108193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153762811|NCT06108193|Vasodilator Agents|vasodilator agents|mesh-ancestor
153762812|NCT06097611|Tranexamic Acid|tranexamic acid|mesh-list
153789518|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
153762844|NCT05925686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762845|NCT05925686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762847|NCT05925686|Sensory System Agents|sensory system agents|mesh-ancestor
153762848|NCT05925686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762849|NCT05913232|Timolol|timolol|mesh-list
153762850|NCT05913232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153762851|NCT05913232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153762852|NCT05913232|Adrenergic Agents|adrenergic agents|mesh-ancestor
153762853|NCT05913232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789563|NCT01686217|Peficitinib|peficitinib|mesh-list
153762883|NCT05855798|Analgesics|analgesics|mesh-ancestor
153762884|NCT05855798|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153762885|NCT05855798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153762886|NCT05855798|Anesthetics, General|anesthetics, general|mesh-ancestor
153762887|NCT05855798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153762888|NCT05855798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153762889|NCT05855798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762890|NCT05855798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762891|NCT05855798|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153762892|NCT05855798|Anticonvulsants|anticonvulsants|mesh-ancestor
153762893|NCT05855798|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153762894|NCT05855798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762895|NCT05855798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153762896|NCT05855798|Tocolytic Agents|tocolytic agents|mesh-ancestor
153762897|NCT05855798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153762898|NCT06319196|Nivolumab|nivolumab|mesh-list
153762899|NCT06319196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153762900|NCT06319196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762901|NCT06319196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153762902|NCT06319196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762903|NCT06319183|Albuterol|albuterol|mesh-list
153762904|NCT06319183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153762905|NCT06319183|Autonomic Agents|autonomic agents|mesh-ancestor
153762906|NCT06319183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762907|NCT06319183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762908|NCT06319183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153762909|NCT06319183|Respiratory System Agents|respiratory system agents|mesh-ancestor
153762910|NCT06319183|Tocolytic Agents|tocolytic agents|mesh-ancestor
153762911|NCT06319183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153762912|NCT06319183|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153762933|NCT06319170|Serotonin Agents|serotonin agents|mesh-ancestor
153762934|NCT06319027|Chelating Agents|chelating agents|mesh-list
153762935|NCT06319027|Sequestering Agents|sequestering agents|mesh-ancestor
153762936|NCT06319027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762937|NCT06318988|Polidocanol|polidocanol|mesh-list
153762938|NCT06318988|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153762939|NCT06318988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153762940|NCT06318897|Paclitaxel|paclitaxel|mesh-list
153762941|NCT06318897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153762942|NCT06318897|Cyclophosphamide|cyclophosphamide|mesh-list
153762943|NCT06318897|Carboplatin|carboplatin|mesh-list
153762944|NCT06318897|Doxorubicin|doxorubicin|mesh-list
153762945|NCT06318897|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153762946|NCT06318897|Pembrolizumab|pembrolizumab|mesh-list
153762947|NCT06318897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153762948|NCT06318897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762996|NCT06318481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762998|NCT06318442|Semaglutide|semaglutide|mesh-list
153763065|NCT06317662|Cyclophosphamide|cyclophosphamide|mesh-list
153763066|NCT06317662|Doxorubicin|doxorubicin|mesh-list
153763067|NCT06317662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153763068|NCT06317662|Methotrexate|methotrexate|mesh-list
153763069|NCT06317662|Vincristine|vincristine|mesh-list
154263201|NCT05878405|Anti-Infective Agents|anti-infective agents|mesh-list
153763070|NCT06317662|Daunorubicin|daunorubicin|mesh-list
153763071|NCT06317662|Venetoclax|venetoclax|mesh-list
153763104|NCT06317662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763105|NCT06317662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153763106|NCT06317662|Protease Inhibitors|protease inhibitors|mesh-ancestor
153763107|NCT06317662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763108|NCT06317662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153763109|NCT06317662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153763110|NCT06317662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763111|NCT06317662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153763112|NCT06317662|Abortifacient Agents|abortifacient agents|mesh-ancestor
153763113|NCT06317662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153763114|NCT06317662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153763115|NCT06317662|Antimetabolites|antimetabolites|mesh-ancestor
153763116|NCT06317662|Dermatologic Agents|dermatologic agents|mesh-ancestor
153763117|NCT06317662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153763118|NCT06317662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153763119|NCT06317662|Antiviral Agents|antiviral agents|mesh-ancestor
153763120|NCT06317662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763121|NCT06317662|Antidotes|antidotes|mesh-ancestor
153763122|NCT06317662|Protective Agents|protective agents|mesh-ancestor
153763123|NCT06317662|Vitamin B Complex|vitamin b complex|mesh-ancestor
153763124|NCT06317662|Vitamins|vitamins|mesh-ancestor
153763125|NCT06317662|Micronutrients|micronutrients|mesh-ancestor
153763126|NCT06317662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153763127|NCT06317662|Tubulin Modulators|tubulin modulators|mesh-ancestor
153763128|NCT06317662|Antimitotic Agents|antimitotic agents|mesh-ancestor
153763129|NCT06317662|Mitosis Modulators|mitosis modulators|mesh-ancestor
153763130|NCT06317662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153763131|NCT06317649|Azacitidine|azacitidine|mesh-list
153763185|NCT06317311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763187|NCT06317298|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153763188|NCT06317298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153763189|NCT06317298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763190|NCT06317298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763191|NCT06317298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763192|NCT06317298|Immunologic Factors|immunologic factors|mesh-ancestor
153763193|NCT06317298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763194|NCT06317298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763195|NCT06317220|Vedolizumab|vedolizumab|mesh-list
153763196|NCT06317220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763197|NCT06317142|Acipimox|acipimox|mesh-list
153763249|NCT06316960|Immunologic Factors|immunologic factors|mesh-ancestor
153763250|NCT06316960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763251|NCT06316960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763252|NCT06316960|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153763253|NCT06316960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153763254|NCT06316960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153763265|NCT06316570|Analgesics|analgesics|mesh-ancestor
153763266|NCT06316570|Sensory System Agents|sensory system agents|mesh-ancestor
153763267|NCT06316570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763268|NCT06316570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763269|NCT06316570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763270|NCT06316570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763271|NCT06316570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153763291|NCT06315205|Letrozole|letrozole|mesh-list
153763292|NCT06315205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763293|NCT06315205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153763294|NCT06315205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153763295|NCT06315205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763296|NCT06315205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763297|NCT06315205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153763298|NCT06315205|Hormone Antagonists|hormone antagonists|mesh-ancestor
153763299|NCT06315205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763300|NCT06315205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763301|NCT06313515|Methamphetamine|methamphetamine|mesh-list
153763302|NCT06313515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153763303|NCT06313515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763304|NCT06313515|Sympathomimetics|sympathomimetics|mesh-ancestor
153763305|NCT06313515|Autonomic Agents|autonomic agents|mesh-ancestor
153763306|NCT06313515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763307|NCT06313515|Dopamine Agents|dopamine agents|mesh-ancestor
153763308|NCT06313515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263202|NCT05878405|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153763309|NCT06313515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763310|NCT06313515|Adrenergic Agents|adrenergic agents|mesh-ancestor
153763311|NCT06313515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153763312|NCT06313515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153763313|NCT06313515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153763314|NCT06313515|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153763315|NCT06313242|Laxatives|laxatives|mesh-list
153763316|NCT06313242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763317|NCT06311422|Lithium Carbonate|lithium carbonate|mesh-list
153763318|NCT06311422|Antidepressive Agents|antidepressive agents|mesh-ancestor
153763336|NCT06293326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763338|NCT06289504|Semaglutide|semaglutide|mesh-list
153763339|NCT06289504|Warfarin|warfarin|mesh-list
153763340|NCT06289504|Atorvastatin|atorvastatin|mesh-list
153789884|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
153763372|NCT06276231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763373|NCT06276231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153763374|NCT06276231|Autonomic Agents|autonomic agents|mesh-ancestor
153763392|NCT06260566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763393|NCT06260566|Protective Agents|protective agents|mesh-ancestor
153763394|NCT06260566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763395|NCT06260566|Antidotes|antidotes|mesh-ancestor
153763396|NCT06254911|Atezolizumab|atezolizumab|mesh-list
153763397|NCT06254911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153763398|NCT06254911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153450711|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153763399|NCT06254911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763400|NCT06254911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763401|NCT06254911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763402|NCT06254911|Immunologic Factors|immunologic factors|mesh-ancestor
153763403|NCT06254911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763404|NCT06249152|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153763405|NCT06249152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153763406|NCT06244004|Ascorbic Acid|ascorbic acid|mesh-list
153763407|NCT06244004|Methyltestosterone|methyltestosterone|mesh-list
153763408|NCT06244004|Hormones|hormones|mesh-list
153763409|NCT06244004|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153763432|NCT06241118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153763433|NCT06241118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153763452|NCT06227117|Alkylating Agents|alkylating agents|mesh-ancestor
153763453|NCT06227117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763454|NCT06227117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763455|NCT06227117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153763456|NCT06227117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153763457|NCT06227117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153763458|NCT06227117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763459|NCT06227117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763460|NCT06227117|Immunoconjugates|immunoconjugates|mesh-ancestor
153763462|NCT06225999|Fluorouracil|fluorouracil|mesh-list
153763463|NCT06225999|Oxaliplatin|oxaliplatin|mesh-list
153763464|NCT06225999|Irinotecan|irinotecan|mesh-list
153763465|NCT06225999|Antimetabolites|antimetabolites|mesh-ancestor
153763466|NCT06225999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763467|NCT06225999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153763468|NCT06225999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763469|NCT06225999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763470|NCT06225999|Immunologic Factors|immunologic factors|mesh-ancestor
153763471|NCT06225999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763472|NCT06225999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153763473|NCT06225999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763474|NCT06225999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763475|NCT06225999|Antidotes|antidotes|mesh-ancestor
153763476|NCT06225999|Protective Agents|protective agents|mesh-ancestor
153763477|NCT06225999|Vitamin B Complex|vitamin b complex|mesh-ancestor
153763478|NCT06225999|Vitamins|vitamins|mesh-ancestor
153763479|NCT06225999|Micronutrients|micronutrients|mesh-ancestor
153763480|NCT06225622|Bevacizumab|bevacizumab|mesh-list
153763481|NCT06225622|Cetuximab|cetuximab|mesh-list
153763560|NCT06179303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153763561|NCT06179303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763562|NCT06179303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763597|NCT06152653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763598|NCT06152653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763599|NCT06152653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153763622|NCT06151574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763623|NCT06151574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790068|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763642|NCT06136585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763643|NCT06136585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763644|NCT06136585|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153763646|NCT06136585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763647|NCT06132113|Carboplatin|carboplatin|mesh-list
153600760|NCT01886209|Hormones|hormones|mesh-ancestor
153763648|NCT06132113|Etoposide|etoposide|mesh-list
153763649|NCT06132113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763650|NCT06132113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153763651|NCT06132113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153763652|NCT06132113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763670|NCT06108947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153763671|NCT06108947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763672|NCT06108947|Antipyretics|antipyretics|mesh-ancestor
153763673|NCT06108947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763674|NCT06108947|Antifungal Agents|antifungal agents|mesh-ancestor
153763675|NCT06108947|Keratolytic Agents|keratolytic agents|mesh-ancestor
153763676|NCT06108947|Dermatologic Agents|dermatologic agents|mesh-ancestor
153763677|NCT06107036|Moxifloxacin|moxifloxacin|mesh-list
153763678|NCT06107036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153763679|NCT06107036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763680|NCT06107036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153763681|NCT06107036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763682|NCT06107036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763683|NCT06107036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763684|NCT06107036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763689|NCT06091657|Dexamethasone|dexamethasone|mesh-list
153763690|NCT06091657|Ketamine|ketamine|mesh-list
153763691|NCT06091657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763692|NCT06091657|Antiemetics|antiemetics|mesh-ancestor
153763693|NCT06091657|Autonomic Agents|autonomic agents|mesh-ancestor
153763694|NCT06091657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763695|NCT06091657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763696|NCT06091657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763697|NCT06091657|Glucocorticoids|glucocorticoids|mesh-ancestor
153763698|NCT06091657|Hormones|hormones|mesh-ancestor
153763699|NCT06091657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153790106|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153763727|NCT06077500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153763728|NCT06077500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153763729|NCT06077500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763730|NCT06077500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763731|NCT06077500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763732|NCT06077500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153763733|NCT06077500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763734|NCT06075095|Budesonide|budesonide|mesh-list
153763735|NCT06075095|Glycopyrrolate|glycopyrrolate|mesh-list
153763736|NCT06075095|Formoterol Fumarate|formoterol fumarate|mesh-list
153763737|NCT06075095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763738|NCT06075095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153763739|NCT06075095|Autonomic Agents|autonomic agents|mesh-ancestor
153763740|NCT06075095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763741|NCT06075095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763742|NCT06075095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153763743|NCT06075095|Respiratory System Agents|respiratory system agents|mesh-ancestor
153763744|NCT06075095|Glucocorticoids|glucocorticoids|mesh-ancestor
153763745|NCT06075095|Hormones|hormones|mesh-ancestor
153763746|NCT06075095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763747|NCT06075095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153763748|NCT06075095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153763749|NCT06075095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153763750|NCT06075095|Adrenergic Agents|adrenergic agents|mesh-ancestor
153763751|NCT06075095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763752|NCT06075095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763753|NCT06075095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153763754|NCT06075095|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153763755|NCT06075095|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153763756|NCT06075095|Cholinergic Agents|cholinergic agents|mesh-ancestor
153763757|NCT06074263|Dexamethasone|dexamethasone|mesh-list
153763758|NCT06074263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763759|NCT06074263|Antiemetics|antiemetics|mesh-ancestor
153736467|NCT02397720|Azacitidine|azacitidine|mesh-list
153763760|NCT06074263|Autonomic Agents|autonomic agents|mesh-ancestor
153763761|NCT06074263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763762|NCT06074263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763763|NCT06074263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763764|NCT06074263|Glucocorticoids|glucocorticoids|mesh-ancestor
153450790|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
153763765|NCT06074263|Hormones|hormones|mesh-ancestor
153763766|NCT06074263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763767|NCT06074263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153763768|NCT06074263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763769|NCT06073184|Tirzepatide|tirzepatide|mesh-list
153763770|NCT06073184|Progestins|progestins|mesh-list
153763771|NCT06073184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763805|NCT06047977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763807|NCT06047977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153763808|NCT06047977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153763809|NCT06047977|Analgesics|analgesics|mesh-ancestor
153763810|NCT06047977|Sensory System Agents|sensory system agents|mesh-ancestor
153763811|NCT06047977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763812|NCT06045806|Cyclophosphamide|cyclophosphamide|mesh-list
153763813|NCT06045806|Fludarabine|fludarabine|mesh-list
153763814|NCT06045806|Lenalidomide|lenalidomide|mesh-list
153763815|NCT06045806|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
153763816|NCT06045806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763817|NCT06045806|Immunologic Factors|immunologic factors|mesh-ancestor
153763818|NCT06045806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763819|NCT06045806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763820|NCT06045806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153763821|NCT06045806|Alkylating Agents|alkylating agents|mesh-ancestor
153763822|NCT06045806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763823|NCT06045806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763824|NCT06045806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153763825|NCT06045806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153763826|NCT06045806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153763827|NCT06045806|Growth Substances|growth substances|mesh-ancestor
153763828|NCT06045806|Growth Inhibitors|growth inhibitors|mesh-ancestor
153763829|NCT06045806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763830|NCT06032923|Niacinamide|niacinamide|mesh-list
153763832|NCT06032923|Nicotinic Acids|nicotinic acids|mesh-list
153763833|NCT06032923|Vitamin B Complex|vitamin b complex|mesh-ancestor
153763834|NCT06032923|Vitamins|vitamins|mesh-ancestor
153763848|NCT06013020|Aspirin|aspirin|mesh-list
153763849|NCT06013020|Rivaroxaban|rivaroxaban|mesh-list
153763850|NCT06013020|Clopidogrel|clopidogrel|mesh-list
153763851|NCT06013020|Ticagrelor|ticagrelor|mesh-list
153763852|NCT06013020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153763853|NCT06013020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153763854|NCT06013020|Analgesics|analgesics|mesh-ancestor
153763878|NCT06012760|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153763879|NCT06012760|Hematinics|hematinics|mesh-ancestor
153763908|NCT05926960|Ipilimumab|ipilimumab|mesh-list
153763909|NCT05926960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763910|NCT05926960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763911|NCT05926960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153763912|NCT05926960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763913|NCT05918718|Methotrexate|methotrexate|mesh-list
153763914|NCT05918718|Letrozole|letrozole|mesh-list
153763915|NCT05918718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153763916|NCT05918718|Abortifacient Agents|abortifacient agents|mesh-ancestor
153763917|NCT05918718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153763918|NCT05918718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763919|NCT05918718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153763920|NCT05918718|Antimetabolites|antimetabolites|mesh-ancestor
153763921|NCT05918718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763922|NCT05918718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763923|NCT05918718|Dermatologic Agents|dermatologic agents|mesh-ancestor
153763924|NCT05918718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763925|NCT05918718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153763926|NCT05918718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763927|NCT05918718|Immunologic Factors|immunologic factors|mesh-ancestor
153763928|NCT05918718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763929|NCT05918718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153763930|NCT05918718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153763931|NCT05918718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153763932|NCT05918718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153790273|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763957|NCT05848011|Docetaxel|docetaxel|mesh-list
153763958|NCT05848011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763959|NCT05848011|Tubulin Modulators|tubulin modulators|mesh-ancestor
153763960|NCT05848011|Antimitotic Agents|antimitotic agents|mesh-ancestor
153763961|NCT05848011|Mitosis Modulators|mitosis modulators|mesh-ancestor
153763962|NCT05848011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763963|NCT05848011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763964|NCT05848011|Glucocorticoids|glucocorticoids|mesh-ancestor
153763965|NCT05848011|Hormones|hormones|mesh-ancestor
153763966|NCT05848011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763967|NCT05848011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763968|NCT05848011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153763990|NCT05774951|Tamoxifen|tamoxifen|mesh-list
153763991|NCT05774951|Letrozole|letrozole|mesh-list
153763992|NCT05774951|Anastrozole|anastrozole|mesh-list
153763993|NCT05774951|Exemestane|exemestane|mesh-list
153763994|NCT05774951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763995|NCT05774951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153763996|NCT05774951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153763997|NCT05774951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763998|NCT05774951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763999|NCT05774951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153764000|NCT05774951|Hormone Antagonists|hormone antagonists|mesh-ancestor
153764001|NCT05774951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764002|NCT05774951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764003|NCT05774951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153764004|NCT05774951|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153764005|NCT05774951|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153764006|NCT05774951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153764045|NCT05761171|Prednisolone phosphate|prednisolone phosphate|mesh-list
153764046|NCT05761171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764047|NCT05761171|Glucocorticoids|glucocorticoids|mesh-ancestor
153764048|NCT05761171|Hormones|hormones|mesh-ancestor
153764049|NCT05761171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764050|NCT05761171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764051|NCT05761171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153764052|NCT05761171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764053|NCT05761171|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153764054|NCT05761171|Abortifacient Agents|abortifacient agents|mesh-ancestor
153764055|NCT05761171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153764056|NCT05761171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153764057|NCT05761171|Antimetabolites|antimetabolites|mesh-ancestor
153764058|NCT05761171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764059|NCT05761171|Dermatologic Agents|dermatologic agents|mesh-ancestor
153781937|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764103|NCT05724134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764104|NCT05724134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153764105|NCT05724134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153764106|NCT05724134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764108|NCT05707377|Tacrolimus|tacrolimus|mesh-list
153764109|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764110|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
153764111|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764187|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764200|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764201|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764202|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764203|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
153764204|NCT05564390|Cytarabine|cytarabine|mesh-list
153764205|NCT05564390|Azacitidine|azacitidine|mesh-list
153764206|NCT05564390|Daunorubicin|daunorubicin|mesh-list
153764207|NCT05564390|Venetoclax|venetoclax|mesh-list
153764208|NCT05564390|Gilteritinib|gilteritinib|mesh-list
153764209|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153764210|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
153790500|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
153764261|NCT05513001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764263|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153764264|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153764265|NCT05476926|Ranibizumab|ranibizumab|mesh-list
153764266|NCT05476926|Faricimab|faricimab|mesh-list
153764267|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153764268|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153764269|NCT05476926|Growth Substances|growth substances|mesh-ancestor
153764310|NCT05425940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764311|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764312|NCT05415215|Trastuzumab|trastuzumab|mesh-list
153764313|NCT05415215|Pertuzumab|pertuzumab|mesh-list
153764314|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153764315|NCT05415215|Maytansine|maytansine|mesh-list
153764316|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764317|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764318|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764319|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
153764320|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764321|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764322|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764323|NCT05415215|Immunotoxins|immunotoxins|mesh-ancestor
153764324|NCT05415215|Immunoconjugates|immunoconjugates|mesh-ancestor
153764325|NCT05415215|Immunologic Factors|immunologic factors|mesh-ancestor
153764326|NCT05415215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764327|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
153764328|NCT05395195|Hematinics|hematinics|mesh-ancestor
153764329|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
153764330|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
153764331|NCT05382338|Lomustine|lomustine|mesh-list
153764332|NCT05382338|Cisplatin|cisplatin|mesh-list
153764333|NCT05382338|Vincristine|vincristine|mesh-list
153764334|NCT05382338|Mesna|mesna|mesh-list
153764335|NCT05382338|Antidotes|antidotes|mesh-list
153764336|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764416|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
153764432|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764433|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764434|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764435|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764436|NCT05265299|Aspirin|aspirin|mesh-list
153764437|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153764438|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153764478|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764479|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764480|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764481|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764482|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764485|NCT05103332|Amlodipine|amlodipine|mesh-list
153764486|NCT05103332|Olmesartan|olmesartan|mesh-list
153764487|NCT05103332|Indapamide|indapamide|mesh-list
153764488|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153764489|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153764490|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153764491|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764492|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153764493|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764494|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
153764495|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153764496|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153764497|NCT05103332|Diuretics|diuretics|mesh-ancestor
153764498|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
153764499|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153764500|NCT05088876|Acetaminophen|acetaminophen|mesh-list
153764501|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153764579|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153764580|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764581|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153764706|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153764707|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153764708|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764709|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764710|NCT04665856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764711|NCT04665856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764712|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
153764713|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764714|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764715|NCT04657991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263204|NCT05878405|Analgesics|analgesics|mesh-list
154263205|NCT05878405|Methylene Blue|methylene blue|mesh-list
154263206|NCT05878405|Sensory System Agents|sensory system agents|mesh-ancestor
153764716|NCT04657991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764717|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
153764718|NCT04624633|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153764719|NCT04624633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764720|NCT04624633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764721|NCT04624633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764722|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764723|NCT04624243|Risperidone|risperidone|mesh-list
153764724|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153764725|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
153450872|NCT04723134|Antidotes|antidotes|mesh-ancestor
153764726|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153764727|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764728|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764729|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153764775|NCT04573920|Atrasentan|atrasentan|mesh-list
153764776|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764777|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153764778|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153764779|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764780|NCT04551430|Nivolumab|nivolumab|mesh-list
153764781|NCT04551430|Ipilimumab|ipilimumab|mesh-list
153764782|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764783|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764784|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764785|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764786|NCT04550936|Isavuconazole|isavuconazole|mesh-list
153764787|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
153764788|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764789|NCT04536467|Goserelin|goserelin|mesh-list
153764790|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153764819|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
153764820|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153764821|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764822|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153764823|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764824|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
153764825|NCT04488081|Cyclosporine|cyclosporine|mesh-list
153764827|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
153764828|NCT04488081|Dexamethasone|dexamethasone|mesh-list
153764829|NCT04488081|Celecoxib|celecoxib|mesh-list
153764830|NCT04488081|Apremilast|apremilast|mesh-list
153764831|NCT04488081|Icatibant|icatibant|mesh-list
153764832|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
153764869|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153764870|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
153764871|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
153764872|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
153764873|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153764874|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153764875|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
153909223|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
153764876|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153764877|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153764878|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153764879|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153764880|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153764881|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153764882|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153764883|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
153764884|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153764885|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
153764886|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764887|NCT04481035|Expectorants|expectorants|mesh-ancestor
153764888|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
153764889|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153764940|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
153764941|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764943|NCT04389632|Pembrolizumab|pembrolizumab|mesh-list
153764956|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764957|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153764959|NCT04355572|Vitamins|vitamins|mesh-ancestor
153764960|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
153764961|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263207|NCT05878405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764962|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153764964|NCT04336189|Piperaquine|piperaquine|mesh-list
153764965|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
153764984|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
153764985|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
153764986|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764987|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764988|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153764989|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
153764990|NCT04307576|Hormones|hormones|mesh-ancestor
153764991|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764992|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153764993|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764994|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153764995|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153764996|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153764997|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764998|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764999|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153765000|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
153765001|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153765002|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153765003|NCT04307576|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153765004|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765005|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765006|NCT04307576|Immunotoxins|immunotoxins|mesh-ancestor
153765007|NCT04307576|Immunoconjugates|immunoconjugates|mesh-ancestor
153765008|NCT04307576|Immunologic Factors|immunologic factors|mesh-ancestor
153765009|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765010|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
153765011|NCT04294810|Atezolizumab|atezolizumab|mesh-list
153765012|NCT04294810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153909231|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765013|NCT04294810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765014|NCT04294810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765015|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765016|NCT04251416|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153765017|NCT04251416|Immunoconjugates|immunoconjugates|mesh-ancestor
153765018|NCT04251416|Immunologic Factors|immunologic factors|mesh-ancestor
153765019|NCT04251416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765020|NCT04227847|Azacitidine|azacitidine|mesh-list
153765021|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765067|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359754|NCT04201457|Protective Agents|protective agents|mesh-ancestor
153765068|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765069|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765070|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153765071|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
153791010|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765108|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
153765109|NCT03889743|Hormones|hormones|mesh-ancestor
153765110|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765111|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765112|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765113|NCT03847649|Prednisone|prednisone|mesh-list
153765114|NCT03847649|Durvalumab|durvalumab|mesh-list
153765115|NCT03847649|Tremelimumab|tremelimumab|mesh-list
153765116|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765117|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
153765118|NCT03847649|Hormones|hormones|mesh-ancestor
153765119|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765120|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765121|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765122|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765123|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765124|NCT03837899|Durvalumab|durvalumab|mesh-list
153765125|NCT03837899|Tremelimumab|tremelimumab|mesh-list
153765126|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153765127|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765128|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765129|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
153765130|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765131|NCT03834883|Ibutilide|ibutilide|mesh-list
153765132|NCT03834883|Progesterone|progesterone|mesh-list
153765133|NCT03834883|Progestins|progestins|mesh-ancestor
153765134|NCT03834883|Hormones|hormones|mesh-ancestor
153791050|NCT01602640|Fentanyl|fentanyl|mesh-list
153791051|NCT01602640|Morphine|morphine|mesh-list
153765181|NCT03768063|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153765182|NCT03684980|Leucovorin|leucovorin|mesh-list
153765183|NCT03684980|Rituximab|rituximab|mesh-list
153765184|NCT03684980|Methotrexate|methotrexate|mesh-list
153450956|NCT04497012|Trace Elements|trace elements|mesh-ancestor
153765185|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765186|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765187|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
153765188|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765189|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765190|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153765191|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
153765192|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153765193|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765194|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
153765195|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765196|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
153765197|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765198|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153765307|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153765308|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153765309|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
153765310|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
153765311|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765312|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
153765313|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153765314|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
153765355|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153765356|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153765357|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
153765358|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765359|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765360|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765362|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765363|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
153765364|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765365|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765366|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765367|NCT02576509|Nivolumab|nivolumab|mesh-list
153765368|NCT02576509|Sorafenib|sorafenib|mesh-list
153765369|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765370|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765371|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153791224|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153765414|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153765415|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
153765416|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765417|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153765418|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
153765419|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153765420|NCT02157883|Itraconazole|itraconazole|mesh-list
153765421|NCT02157883|Osimertinib|osimertinib|mesh-list
153765422|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
153765423|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765424|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153765425|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153765426|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765427|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765428|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153765429|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
153765430|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791271|NCT01603498|Prednisolone|prednisolone|mesh-list
153765473|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765474|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153765475|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153765476|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765477|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
153765478|NCT00638898|Melphalan|melphalan|mesh-list
153765479|NCT00638898|Busulfan|busulfan|mesh-list
153765480|NCT00638898|Topotecan|topotecan|mesh-list
153765481|NCT00638898|Lenograstim|lenograstim|mesh-list
153906712|NCT01064635|Letrozole|letrozole|mesh-list
153765482|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153765483|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
153765484|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765564|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765565|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765566|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
153765567|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765568|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765569|NCT05501821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765570|NCT05501821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765571|NCT05487586|Ceftazidime|ceftazidime|mesh-list
153765615|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153765616|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153765617|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765618|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765619|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
153765620|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153765621|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153765622|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153765623|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
153765624|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
153765625|NCT05296512|Lenvatinib|lenvatinib|mesh-list
153765626|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765627|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765628|NCT05296512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765629|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765672|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765673|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
153765674|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765675|NCT05162053|Clopidogrel|clopidogrel|mesh-list
153765676|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153765677|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153765709|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153765711|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
153765712|NCT04920344|Cisplatin|cisplatin|mesh-list
153765713|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765714|NCT04885634|Semaglutide|semaglutide|mesh-list
153765715|NCT04885634|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153765716|NCT04885634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153765717|NCT04885634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765718|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
153765719|NCT04862221|Promethazine|promethazine|mesh-list
153765720|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
153765721|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153765774|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153765775|NCT04692831|Pertuzumab|pertuzumab|mesh-list
153765776|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765795|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765797|NCT04585737|Tenofovir|tenofovir|mesh-list
153765798|NCT04585737|Lamivudine|lamivudine|mesh-list
153765799|NCT04585737|Emtricitabine|emtricitabine|mesh-list
153765800|NCT04585737|Dolutegravir|dolutegravir|mesh-list
153765801|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153765802|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
153765803|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765804|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153765805|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153765806|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765807|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765808|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153765809|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153765810|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153765811|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153765812|NCT04397458|Dexamethasone|dexamethasone|mesh-list
153765813|NCT04397458|Bupivacaine|bupivacaine|mesh-list
153765814|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765815|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
153765816|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
153765817|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765818|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765819|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153765820|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
153765821|NCT04397458|Hormones|hormones|mesh-ancestor
153735842|NCT04111315|Ibuprofen|ibuprofen|mesh-list
153765822|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765823|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765824|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765825|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
153765826|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
153765827|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153765828|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
153765829|NCT04383743|Cisplatin|cisplatin|mesh-list
153765830|NCT04383743|Doxorubicin|doxorubicin|mesh-list
153765831|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153765832|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
153765833|NCT04383743|Methotrexate|methotrexate|mesh-list
153765834|NCT04383743|Daunorubicin|daunorubicin|mesh-list
153765835|NCT04383743|Vinblastine|vinblastine|mesh-list
153765836|NCT04383743|Lenograstim|lenograstim|mesh-list
153765837|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765838|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153765839|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153765840|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153765841|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765842|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765843|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765844|NCT04383743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765845|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153765846|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
153765847|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153765848|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765865|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765866|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765867|NCT04332874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765868|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765893|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765894|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765895|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153765896|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153765897|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765898|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153765899|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153765900|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
153765901|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153765902|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765903|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765904|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
153765905|NCT04195568|Antacids|antacids|mesh-ancestor
153765906|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765907|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153765925|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
153765926|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153765927|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153765928|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153765929|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
153765930|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153765931|NCT04056468|Mobocertinib|mobocertinib|mesh-list
153765932|NCT04056468|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153765933|NCT04056468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765934|NCT04056468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765935|NCT04056468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765952|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765953|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765954|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153765955|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153765956|NCT03796273|Ketoconazole|ketoconazole|mesh-list
153765957|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
153765958|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765959|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153765960|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153765961|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765962|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765963|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153765964|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906774|NCT01073163|Rituximab|rituximab|mesh-list
153765970|NCT03782207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765971|NCT03782207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765972|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765973|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153765974|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153765975|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
153765976|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153765977|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765978|NCT03713294|Dexamethasone|dexamethasone|mesh-list
153765979|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
153765980|NCT03713294|Pomalidomide|pomalidomide|mesh-list
153765981|NCT03713294|Elotuzumab|elotuzumab|mesh-list
153765982|NCT03713294|Ichthammol|ichthammol|mesh-list
153765983|NCT03713294|BB 1101|bb 1101|mesh-list
153781938|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765984|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765985|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
153765986|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
153765987|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765988|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791691|NCT06294561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766005|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153766006|NCT03605342|Narcotics|narcotics|mesh-ancestor
153766007|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766008|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766009|NCT03605342|Analgesics|analgesics|mesh-ancestor
153766010|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
153766011|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766012|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153766013|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153766014|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153766015|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
153766016|NCT03596450|Semaglutide|semaglutide|mesh-list
153766017|NCT03596450|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153766018|NCT03596450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153766019|NCT03596450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766020|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
153766021|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
153766022|NCT03579875|Busulfan|busulfan|mesh-list
153766023|NCT03579875|Rituximab|rituximab|mesh-list
153766024|NCT03579875|Fludarabine|fludarabine|mesh-list
153766025|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153766026|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
153766027|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766028|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153766029|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153766030|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
153766031|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766032|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766047|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
153766048|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766049|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766050|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153766051|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153766052|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766053|NCT03389620|Dexamethasone|dexamethasone|mesh-list
153766054|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153766055|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
153766056|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
153766057|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766058|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766059|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791745|NCT06293287|Enoxaparin|enoxaparin|mesh-list
153766085|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153766086|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153766088|NCT03235245|Ipilimumab|ipilimumab|mesh-list
153766089|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766090|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766091|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153766092|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766108|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
153766109|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766110|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153766111|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153766112|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153766113|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766114|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766115|NCT03088059|Durvalumab|durvalumab|mesh-list
153766116|NCT03088059|Palbociclib|palbociclib|mesh-list
153451081|NCT03864042|Caffeine|caffeine|mesh-list
153766117|NCT03088059|Niraparib|niraparib|mesh-list
153766118|NCT03088059|Afatinib|afatinib|mesh-list
153766119|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766120|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766121|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153766122|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766150|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766151|NCT02595866|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153766152|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
153766153|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766165|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766167|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
153766169|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766170|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766171|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
153766172|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766173|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153766174|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153766175|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766176|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766177|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
153766178|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766179|NCT02420717|Leucovorin|leucovorin|mesh-list
153766180|NCT02420717|Cytarabine|cytarabine|mesh-list
153766181|NCT02420717|Dexamethasone|dexamethasone|mesh-list
153766182|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
153766183|NCT02420717|Prednisone|prednisone|mesh-list
153766216|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153766217|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
153766218|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766219|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153766229|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153766231|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766232|NCT02420717|Antidotes|antidotes|mesh-ancestor
153766233|NCT02420717|Protective Agents|protective agents|mesh-ancestor
153766234|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
153766236|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
153766237|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153766238|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
153766239|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
153766240|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153766266|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
153766267|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766268|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766269|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
153766270|NCT02188368|Hormones|hormones|mesh-ancestor
153766271|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766272|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153766273|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766274|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153766275|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766276|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153766277|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153766278|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153766279|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153766280|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153766281|NCT02188368|Growth Substances|growth substances|mesh-ancestor
153766282|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
153766283|NCT02074839|Ivosidenib|ivosidenib|mesh-list
153766284|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766285|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766294|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153766295|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153766296|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
153766297|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766298|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766299|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153766300|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766330|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
153766331|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153766332|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153766333|NCT01375140|Growth Substances|growth substances|mesh-ancestor
153766334|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
153766335|NCT01130077|Poly ICLC|poly iclc|mesh-list
153766336|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
153766337|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
153766338|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766339|NCT01063647|Treosulfan|treosulfan|mesh-list
153766340|NCT01063647|Busulfan|busulfan|mesh-list
153766341|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153766342|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
153766343|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766344|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766345|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153766346|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
153766397|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153766398|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
153766399|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153766400|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766401|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
153909409|NCT02809963|Diuretics|diuretics|mesh-ancestor
153766443|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766444|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153766445|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153766446|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766447|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766448|NCT00191399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153766449|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766450|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766451|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766452|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766453|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
153766454|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153766455|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
153766456|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153766457|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153766458|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766459|NCT00191438|Gemcitabine|gemcitabine|mesh-list
153766460|NCT00191438|Capecitabine|capecitabine|mesh-list
153766461|NCT00191438|Docetaxel|docetaxel|mesh-list
153766462|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766463|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
153766464|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766465|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766466|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
153766467|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
153766468|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
153766469|NCT00221286|Interferons|interferons|mesh-list
153766514|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153766516|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
153766517|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766518|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153766519|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153766520|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153766521|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766522|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766523|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766524|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
153766525|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766526|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766527|NCT00191555|Haloperidol|haloperidol|mesh-list
153766532|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766533|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909447|NCT04303377|Evolocumab|evolocumab|mesh-list
153766534|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766535|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153766565|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
153766566|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766567|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
154263208|NCT05878405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766568|NCT00221442|Zonisamide|zonisamide|mesh-list
153766569|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
153766570|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153766571|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766572|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766573|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153766574|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766575|NCT00123578|Pentobarbital|pentobarbital|mesh-list
153766576|NCT00123578|Lorazepam|lorazepam|mesh-list
153766577|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
153766578|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
153766624|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153766625|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766626|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766628|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153766629|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766674|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153766676|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766677|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766678|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153766679|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
153766716|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766717|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153766764|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766766|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153766767|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153766768|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766769|NCT00475033|Vaccines|vaccines|mesh-list
153909458|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
153766770|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153766771|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
153766772|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766773|NCT00192062|Gemcitabine|gemcitabine|mesh-list
153766774|NCT00192062|Vinorelbine|vinorelbine|mesh-list
153766775|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766788|NCT00215007|Levofloxacin|levofloxacin|mesh-list
153766789|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153603985|NCT01915082|Azithromycin|azithromycin|mesh-list
153766880|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153766881|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153766882|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153766883|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
153766884|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766885|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766886|NCT02277730|Protective Agents|protective agents|mesh-ancestor
153766900|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766901|NCT00215124|Lenograstim|lenograstim|mesh-list
153766933|NCT00215241|Sertraline|sertraline|mesh-list
153766934|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153766935|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
153766936|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766937|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766938|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766939|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153766940|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153766941|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766942|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766943|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153792459|NCT05482789|Exenatide|exenatide|mesh-list
153767044|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
153767045|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767046|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767047|NCT00215514|Fluorouracil|fluorouracil|mesh-list
153767049|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767050|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
153767051|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767052|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767053|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153909496|NCT01040403|Bromides|bromides|mesh-list
153767054|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
153767055|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792524|NCT05387603|Capecitabine|capecitabine|mesh-list
153767063|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153767064|NCT00215592|Zonisamide|zonisamide|mesh-list
153767104|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767105|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153767106|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153767107|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153767108|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153767109|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
153767110|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767111|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767112|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153767113|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153767114|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
153767115|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767116|NCT00192803|Candesartan|candesartan|mesh-list
153767117|NCT00192803|Candesartan cilexetil|candesartan cilexetil|mesh-list
153767118|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153767119|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153767120|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153767121|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767123|NCT00192842|Gemcitabine|gemcitabine|mesh-list
153767124|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767125|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
153767126|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767127|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767128|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153767129|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153767130|NCT00192842|Analgesics|analgesics|mesh-ancestor
153767131|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
153767132|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767133|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767134|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767135|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767158|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767159|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767160|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153767161|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153767162|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767218|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153767219|NCT00193154|Growth Substances|growth substances|mesh-ancestor
153767220|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767221|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
153767222|NCT00193154|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153767223|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153767224|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767225|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767226|NCT00193193|Paclitaxel|paclitaxel|mesh-list
153767227|NCT00193193|Carboplatin|carboplatin|mesh-list
153767228|NCT00193193|Estramustine|estramustine|mesh-list
153767279|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153767280|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767281|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767282|NCT00222534|Diuretics|diuretics|mesh-ancestor
153767283|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
153767284|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767313|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767314|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767316|NCT00193466|Fludarabine|fludarabine|mesh-list
153767317|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153767318|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767319|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
153767320|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767321|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767322|NCT00215748|Dexamethasone|dexamethasone|mesh-list
153767323|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767324|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
153767325|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
153767326|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767327|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767328|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153767329|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
153767331|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767332|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153767333|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767334|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
153767335|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
153767336|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451221|NCT02333370|Tamoxifen|tamoxifen|mesh-list
153767337|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
153767338|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767339|NCT00193544|Thalidomide|thalidomide|mesh-list
153767340|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
153767341|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767342|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
153767343|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767344|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
153767345|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153767346|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767347|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153767348|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153767349|NCT00193544|Growth Substances|growth substances|mesh-ancestor
153767350|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
153767351|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767352|NCT00215865|Ribavirin|ribavirin|mesh-list
153767353|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153767354|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
153767355|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767366|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153767367|NCT00193583|Carboplatin|carboplatin|mesh-list
153767368|NCT00193583|Topotecan|topotecan|mesh-list
153767369|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767370|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153767371|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767372|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767373|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767374|NCT00215982|Capecitabine|capecitabine|mesh-list
153767404|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767405|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767406|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767407|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767408|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767409|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
153767410|NCT00216177|Adalimumab|adalimumab|mesh-list
153767411|NCT00216177|Infliximab|infliximab|mesh-list
153767412|NCT00216177|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153767413|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767414|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767415|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
153767416|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153767417|NCT00216216|Pemetrexed|pemetrexed|mesh-list
153767418|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767419|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767420|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767421|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153909548|NCT02811289|Mirabegron|mirabegron|mesh-list
153767525|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153767526|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767527|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767528|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767529|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767530|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767531|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153767532|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153767570|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153767571|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767572|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153767573|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767574|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153767575|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153767576|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767577|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153767578|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153767580|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767581|NCT00223548|Mesna|mesna|mesh-list
153767582|NCT00223548|Protective Agents|protective agents|mesh-ancestor
153767583|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767584|NCT00125060|Simvastatin|simvastatin|mesh-list
153767585|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153767586|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154263209|NCT05878405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767587|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
153767588|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767589|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153767590|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153767591|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767592|NCT00223626|Topiramate|topiramate|mesh-list
153767593|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
153792881|NCT04652544|Vitamin D|vitamin d|mesh-list
153767658|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767659|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767660|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767661|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153767662|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
153767663|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153767665|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153767666|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767667|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767668|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153767669|NCT00125255|Lidocaine|lidocaine|mesh-list
153767670|NCT00125255|Tetracaine|tetracaine|mesh-list
153767671|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
153767672|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
153767673|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767674|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767675|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
153767676|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767677|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153767719|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767720|NCT00125411|Docetaxel|docetaxel|mesh-list
153767721|NCT00125411|Satraplatin|satraplatin|mesh-list
153767722|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767723|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767724|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767725|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767726|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767727|NCT00206505|Docetaxel|docetaxel|mesh-list
153767728|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767729|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767759|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153767760|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153767761|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153767762|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153767763|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
153767764|NCT00206622|Estradiol|estradiol|mesh-list
153767765|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153767766|NCT00206622|Estrogens|estrogens|mesh-ancestor
153767767|NCT00206622|Hormones|hormones|mesh-ancestor
153767768|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767769|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767770|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153339517|NCT01942694|Vitamin D|vitamin d|mesh-list
153767847|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
153767848|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767849|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767850|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153767851|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153767852|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
153767853|NCT00125567|Levodopa|levodopa|mesh-list
153767854|NCT00125567|Carbidopa|carbidopa|mesh-list
153767855|NCT00125567|Entacapone|entacapone|mesh-list
153793057|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
153767900|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
153767901|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767902|NCT00125645|Irbesartan|irbesartan|mesh-list
153767903|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153767904|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153767905|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153767906|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767907|NCT00125684|Morphine|morphine|mesh-list
153767908|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153767909|NCT00125684|Narcotics|narcotics|mesh-ancestor
153767910|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767911|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767912|NCT00125684|Analgesics|analgesics|mesh-ancestor
153767913|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
153767914|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767915|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
153767916|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767917|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
153767918|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153767919|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153767920|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767921|NCT00194597|Urological Agents|urological agents|mesh-ancestor
153767922|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
153767923|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
153767924|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
153767925|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153767926|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153793104|NCT04209686|Paclitaxel|paclitaxel|mesh-list
153767961|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767963|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153767964|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153767965|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153767966|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153767967|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
153767968|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767969|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767970|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153767971|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153767972|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
153767973|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767974|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153767975|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153767976|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153767977|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153767978|NCT00194753|Paclitaxel|paclitaxel|mesh-list
153767979|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
153767980|NCT00194753|Doxorubicin|doxorubicin|mesh-list
153767981|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153767982|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767983|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767984|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767985|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793155|NCT04015700|Coal Tar|coal tar|mesh-list
153768022|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153768023|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153768024|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768025|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
153768026|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768027|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153768028|NCT00125996|Hematinics|hematinics|mesh-ancestor
153768029|NCT00206934|Dexetimide|dexetimide|mesh-list
153768030|NCT00206934|Citalopram|citalopram|mesh-list
153768031|NCT00206934|Escitalopram|escitalopram|mesh-list
153768032|NCT00206934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153768033|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153768034|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153768035|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768036|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768037|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
153768038|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768039|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153768040|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153768041|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
153768042|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
153768043|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793221|NCT03795194|Ampicillin|ampicillin|mesh-list
153768098|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153768099|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768100|NCT00402467|Enoxaparin|enoxaparin|mesh-list
153768101|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
153768102|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
153768103|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153768104|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
153768105|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153768116|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
153768117|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768118|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793252|NCT03756896|Hormones|hormones|mesh-ancestor
153768136|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
153768137|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768138|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768139|NCT00402545|Docetaxel|docetaxel|mesh-list
153768140|NCT00402545|Fluorouracil|fluorouracil|mesh-list
153768141|NCT00402545|Cetuximab|cetuximab|mesh-list
153768142|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768143|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
153768144|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
153768145|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
153768146|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451338|NCT00003671|Vitamins|vitamins|mesh-ancestor
153768147|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
153768148|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768149|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768150|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
153768151|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768152|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153768153|NCT00126074|Tedisamil|tedisamil|mesh-list
153768154|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153768155|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153768156|NCT00126074|Protective Agents|protective agents|mesh-ancestor
153768157|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768158|NCT00195104|Cytarabine|cytarabine|mesh-list
153768159|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
153768160|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768161|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
153768162|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768163|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768164|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
153768165|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768166|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768167|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
153768168|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768169|NCT00413088|Bemiparin|bemiparin|mesh-list
153768170|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
153768171|NCT00409760|Amlodipine|amlodipine|mesh-list
153768172|NCT00409760|Valsartan|valsartan|mesh-list
153768193|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768194|NCT00126230|Docetaxel|docetaxel|mesh-list
153768195|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768196|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
153768197|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
153768198|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
153768214|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768215|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
153768216|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768217|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
153768218|NCT00207402|Interferons|interferons|mesh-list
153768220|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
153768221|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768222|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
153768223|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768224|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
153768253|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768254|NCT00471328|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153768255|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
153768256|NCT00126308|Mannitol|mannitol|mesh-list
153768257|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153768258|NCT00126308|Diuretics|diuretics|mesh-ancestor
153768259|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
153768260|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768261|NCT00195377|Etanercept|etanercept|mesh-list
153768262|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153768263|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153768264|NCT00195377|Analgesics|analgesics|mesh-ancestor
153768265|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
153768266|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768267|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768268|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768269|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768270|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768285|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768286|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768287|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768288|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768289|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768290|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768291|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
153768292|NCT00195455|Estradiol|estradiol|mesh-list
153768293|NCT00195455|Estrogens|estrogens|mesh-ancestor
153768294|NCT00195455|Hormones|hormones|mesh-ancestor
153768295|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153768296|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768298|NCT00126347|Betaine|betaine|mesh-list
153768299|NCT00126347|Hematinics|hematinics|mesh-ancestor
153768300|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
153768301|NCT00126347|Vitamins|vitamins|mesh-ancestor
153768328|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768329|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153768330|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768331|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153768332|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153768333|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153768334|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153768344|NCT00207558|Hematinics|hematinics|mesh-ancestor
153768345|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
153768346|NCT00207558|Vitamins|vitamins|mesh-ancestor
153768347|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
153768348|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768349|NCT00195572|Leucovorin|leucovorin|mesh-list
153768350|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
153768351|NCT00195572|Antidotes|antidotes|mesh-ancestor
153768352|NCT00195572|Protective Agents|protective agents|mesh-ancestor
153768353|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768354|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
153768355|NCT00195572|Vitamins|vitamins|mesh-ancestor
153768356|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
153768357|NCT00202280|Folic Acid|folic acid|mesh-list
153768358|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
153768359|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
153768360|NCT00202280|Vitamins|vitamins|mesh-ancestor
153768361|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
153768362|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768363|NCT00202280|Hematinics|hematinics|mesh-ancestor
153768383|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768384|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768385|NCT00195689|Adalimumab|adalimumab|mesh-list
153768386|NCT00195689|Antibodies|antibodies|mesh-list
153768387|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153768388|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
153768389|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768390|NCT00195689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153768391|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768392|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768393|NCT00470275|Cytarabine|cytarabine|mesh-list
153768394|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768395|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
153768396|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768397|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768398|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
153768399|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768400|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768401|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
153768402|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768417|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768418|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
153768419|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
153768420|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153768421|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768422|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768423|NCT00470158|Iron|iron|mesh-list
153768424|NCT00470158|Zinc|zinc|mesh-list
153768425|NCT00470158|Trace Elements|trace elements|mesh-ancestor
153768426|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
153768427|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263210|NCT05878405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263211|NCT05872555|Antipsychotic Agents|antipsychotic agents|mesh-list
153768429|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
153768430|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153768431|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768447|NCT00207675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153768448|NCT00207675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768449|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
153768450|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768451|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768452|NCT00202358|Atenolol|atenolol|mesh-list
153768453|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153768454|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153768455|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
153768456|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
153768457|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768458|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768459|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153768460|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153768461|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153768462|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
153768463|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768464|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768473|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
153768474|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768475|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153768476|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153768477|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768479|NCT00207753|Albendazole|albendazole|mesh-list
153768480|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153768481|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768482|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
153768483|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
153768484|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153768485|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153768486|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
153768487|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
153768488|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
153768489|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768490|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768491|NCT00202397|Riluzole|riluzole|mesh-list
153768492|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
153768493|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153768494|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153768495|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768496|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768497|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768498|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153768499|NCT00202397|Protective Agents|protective agents|mesh-ancestor
153768516|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768517|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
153768518|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768519|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768520|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
153768521|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153768522|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768523|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768524|NCT00477529|Docetaxel|docetaxel|mesh-list
153768525|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768526|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
153768527|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
153768528|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
153768529|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768530|NCT00472693|Bevacizumab|bevacizumab|mesh-list
153768531|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153768542|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768543|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
153768544|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768545|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768546|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154263212|NCT05872555|Antidepressive Agents|antidepressive agents|mesh-list
154263213|NCT05872555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768547|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
153768548|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768549|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
153768550|NCT00202514|Valproic Acid|valproic acid|mesh-list
153768551|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
153768552|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768553|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768554|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
153768555|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768556|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768557|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
153768558|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153768559|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768560|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768561|NCT00207831|Tegafur|tegafur|mesh-list
153768562|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768563|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
153768564|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768565|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768566|NCT00195923|Clindamycin|clindamycin|mesh-list
153768567|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
153768583|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768584|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153768585|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768587|NCT00202553|Perindopril|perindopril|mesh-list
153768588|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153768589|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
153768590|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768591|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768592|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153768593|NCT00202592|Perindopril|perindopril|mesh-list
153768594|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153768617|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768618|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768619|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768621|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153768622|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153768623|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768624|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153768625|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153768626|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768627|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
153768628|NCT00202787|Leucovorin|leucovorin|mesh-list
153768629|NCT00202787|Cetuximab|cetuximab|mesh-list
153768630|NCT00202787|Fluorouracil|fluorouracil|mesh-list
153768631|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
153768632|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153768633|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768634|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
153768635|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768636|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768637|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768638|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
153768639|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768640|NCT00202787|Antidotes|antidotes|mesh-ancestor
153768641|NCT00202787|Protective Agents|protective agents|mesh-ancestor
153768642|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
153768643|NCT00202787|Vitamins|vitamins|mesh-ancestor
153768644|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
153768645|NCT00424437|Insulin|insulin|mesh-list
153768674|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
153768675|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153768676|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
153768690|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768691|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153768692|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153768703|NCT00203060|Protective Agents|protective agents|mesh-ancestor
153768704|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768705|NCT00226122|Indomethacin|indomethacin|mesh-list
153768706|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153768707|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153768708|NCT00226122|Analgesics|analgesics|mesh-ancestor
153768709|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
153768710|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768711|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768712|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768713|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768714|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
153768715|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
153768716|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153768717|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153768718|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768719|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768721|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
153768722|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153768723|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153768724|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768725|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
153768726|NCT00208065|Ephedrine|ephedrine|mesh-list
153768727|NCT00208065|Almotriptan|almotriptan|mesh-list
153768728|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153768729|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
153768730|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768731|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768732|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153768733|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
153768734|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
153768735|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153768736|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153768737|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
153768738|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
153768739|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768740|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768741|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153768742|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
153768743|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
153768744|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
153768745|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153768746|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
153768747|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
153768748|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793695|NCT00334815|Antibodies|antibodies|mesh-list
153768785|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768786|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153768787|NCT00203177|Protective Agents|protective agents|mesh-ancestor
153768788|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768789|NCT00208143|Risperidone|risperidone|mesh-list
153768790|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153768791|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153768792|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
153768793|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768794|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768795|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768796|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153768797|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153768798|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768799|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768800|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153768801|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
153768802|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
153768803|NCT00196586|Interferons|interferons|mesh-list
153768805|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
153768806|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
153768807|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153768808|NCT00196586|Interleukin-2|interleukin-2|mesh-list
153768809|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768810|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
153768811|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731530|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
153768812|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
153605937|NCT01935674|Ritonavir|ritonavir|mesh-list
153768825|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768826|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768827|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
153768828|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
153768829|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263214|NCT05872555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154263215|NCT05872555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768830|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768831|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153768832|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153768833|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
153768834|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153768835|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153768836|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153768837|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153768838|NCT00226356|Betaine|betaine|mesh-list
153768839|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768840|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
153768862|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768863|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153768864|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
153768865|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768866|NCT00196625|Ritonavir|ritonavir|mesh-list
153768867|NCT00196625|Amprenavir|amprenavir|mesh-list
153768868|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153768869|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153768870|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
153768871|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768872|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768873|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153768884|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768885|NCT00208260|Leucovorin|leucovorin|mesh-list
153768886|NCT00208260|Fluorouracil|fluorouracil|mesh-list
153768887|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
153768888|NCT00208260|Folfirinox|folfirinox|mesh-list
153768889|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
153768890|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768891|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768892|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768893|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768894|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
153768895|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768896|NCT00208260|Antidotes|antidotes|mesh-ancestor
153768897|NCT00208260|Protective Agents|protective agents|mesh-ancestor
153768898|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
153768899|NCT00208260|Vitamins|vitamins|mesh-ancestor
153768900|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
153768901|NCT00226473|Dacarbazine|dacarbazine|mesh-list
153768903|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768904|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153768905|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
153768914|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
153768915|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768916|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768917|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153768918|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
153768919|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153768920|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
153768921|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
153768922|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768923|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768924|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153768925|NCT00196664|Paroxetine|paroxetine|mesh-list
153768926|NCT00196664|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153768927|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153768928|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153768929|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768930|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768931|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
153768932|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768933|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153768934|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
153768935|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768936|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153768937|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153768938|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263216|NCT05872555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263217|NCT05862285|Ipatasertib|ipatasertib|mesh-list
153768955|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
153768956|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768957|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153768958|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768959|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
153768960|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
153768961|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153768962|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153768963|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768964|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768965|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768966|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768967|NCT00410657|Prednisone|prednisone|mesh-list
153768968|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
153768969|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153768970|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153768971|NCT00410657|Prednisolone|prednisolone|mesh-list
153768972|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
153768973|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
153768974|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153768975|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
153768976|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768977|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
153768978|NCT00410657|Hormones|hormones|mesh-ancestor
153768979|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153768980|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768981|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153768982|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768983|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
153768984|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
153768985|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768994|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768995|NCT00410696|Lenograstim|lenograstim|mesh-list
153768996|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153768997|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
153769015|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769016|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769017|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769018|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
153769019|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769020|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769021|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153769022|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153769023|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153769024|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153769025|NCT00203372|Growth Substances|growth substances|mesh-ancestor
153769026|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
153769027|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
153769028|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
153769029|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
153769030|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153769031|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153769032|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153769033|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769034|NCT00226551|Isoproterenol|isoproterenol|mesh-list
153769035|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153769036|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153769037|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
153769038|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769039|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769040|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769041|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153769042|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
153769043|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909877|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
153769044|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153769045|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
153769046|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153769047|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
153769048|NCT00226551|Protective Agents|protective agents|mesh-ancestor
153769049|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
153769050|NCT00196859|Capecitabine|capecitabine|mesh-list
153769051|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263218|NCT05862285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769052|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
153769053|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769054|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769077|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153769078|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153769079|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769080|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153769081|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769082|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
153769083|NCT00226668|Hormones|hormones|mesh-ancestor
153745635|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153359846|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769084|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769085|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769086|NCT00208572|Citalopram|citalopram|mesh-list
153769087|NCT00208572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153769088|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153769089|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153769090|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769091|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769092|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
153769093|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769094|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153769095|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
153769096|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769097|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
153769098|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153769099|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153769100|NCT00226707|Analgesics|analgesics|mesh-ancestor
153769101|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
153769102|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769103|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769104|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769105|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769106|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
153769107|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769108|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
153769109|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153769110|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909884|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769111|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769141|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769142|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769143|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153769144|NCT00203567|Analgesics|analgesics|mesh-ancestor
153769145|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
153769146|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769147|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153769148|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153769149|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769150|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153769151|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153769152|NCT00226746|Paclitaxel|paclitaxel|mesh-list
153769153|NCT00226746|Gemcitabine|gemcitabine|mesh-list
153769154|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153769155|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769156|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
153769157|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
153769158|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
153769190|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769191|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769192|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
153769193|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769194|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769195|NCT00226824|Galantamine|galantamine|mesh-list
153769196|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153769197|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769198|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769199|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
153769200|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909885|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
153769201|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769202|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153769203|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
153769204|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769205|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
153769206|NCT00197249|Vaccines|vaccines|mesh-list
153769207|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
153769214|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769215|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153769216|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153769217|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769218|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769219|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153769220|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
153769221|NCT00226902|Chrysarobin|chrysarobin|mesh-list
153769222|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153769223|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153769224|NCT00226902|Analgesics|analgesics|mesh-ancestor
153769225|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
153769226|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769227|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769228|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769229|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769230|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153769231|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
153769232|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769233|NCT00226980|Thalidomide|thalidomide|mesh-list
153769234|NCT00226980|Capecitabine|capecitabine|mesh-list
153769235|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153769236|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
153769237|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769238|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769239|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769240|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
153769241|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769242|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
153451603|NCT04564469|Furosemide|furosemide|mesh-list
153769243|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153769244|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769245|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153769246|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153769247|NCT00226980|Growth Substances|growth substances|mesh-ancestor
153769248|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
153769249|NCT00203801|Artesunate|artesunate|mesh-list
153769250|NCT00203801|Lumefantrine|lumefantrine|mesh-list
153769251|NCT00203801|Artemether|artemether|mesh-list
153769252|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
153769253|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
153769254|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153769255|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153769256|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
153769257|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153769258|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153769259|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769260|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769261|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
153769305|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153769306|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153769307|NCT00204074|Estradiol|estradiol|mesh-list
153769308|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153769309|NCT00204074|Estrogens|estrogens|mesh-ancestor
153769310|NCT00204074|Hormones|hormones|mesh-ancestor
153909903|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153769311|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769312|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769313|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153769314|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
153769315|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153769316|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153769317|NCT00227292|Escitalopram|escitalopram|mesh-list
153769318|NCT00227292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153769319|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153769320|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153769341|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
153769342|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769344|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
153769345|NCT00227331|Amoxicillin|amoxicillin|mesh-list
153769346|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153769347|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769348|NCT00197561|Selenium|selenium|mesh-list
153769349|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
153769350|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769351|NCT00197561|Protective Agents|protective agents|mesh-ancestor
153769352|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769353|NCT00197561|Trace Elements|trace elements|mesh-ancestor
153769354|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
153769355|NCT00227409|Edetic Acid|edetic acid|mesh-list
153769356|NCT00227409|Calcium|calcium|mesh-list
153769357|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
153769358|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153769359|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769360|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
153769361|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153769362|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
153769363|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
153769364|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769365|NCT00227409|Antidotes|antidotes|mesh-ancestor
153769366|NCT00227409|Protective Agents|protective agents|mesh-ancestor
153769367|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153769399|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769402|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769403|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
153769404|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769405|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153769406|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769407|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769408|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
153769409|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153769410|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769411|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153769412|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
153769413|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153769414|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769415|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769416|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769417|NCT00204269|Testosterone|testosterone|mesh-list
153769418|NCT00204269|Androgens|androgens|mesh-ancestor
153769419|NCT00204269|Hormones|hormones|mesh-ancestor
153769420|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769421|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769422|NCT00197756|Vitamins|vitamins|mesh-list
153769423|NCT00197756|Vitamin A|vitamin a|mesh-list
153769424|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
153769425|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
153769426|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769427|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
153769428|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769429|NCT00197756|Protective Agents|protective agents|mesh-ancestor
153769430|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153769431|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769432|NCT00227565|Carboplatin|carboplatin|mesh-list
153769433|NCT00227565|Pemetrexed|pemetrexed|mesh-list
153769434|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769435|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769436|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769454|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769455|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153769456|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153769457|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769476|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769477|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
153769478|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
153769479|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153769480|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769481|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153769482|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153769483|NCT00227682|Growth Substances|growth substances|mesh-ancestor
153769484|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
153769485|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
154263219|NCT05862285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154263220|NCT05862285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769486|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769487|NCT00227682|Protective Agents|protective agents|mesh-ancestor
153769489|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
153769490|NCT00230763|Timolol|timolol|mesh-list
153769491|NCT00230763|Latanoprost|latanoprost|mesh-list
153769492|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153769493|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153769494|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
153769495|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769511|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
153769512|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769513|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769514|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
153769515|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769516|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769517|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
153769518|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153769519|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769520|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769521|NCT00197912|Celecoxib|celecoxib|mesh-list
153769522|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
153769523|NCT00197912|Interleukin-2|interleukin-2|mesh-list
153769524|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
153769525|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769526|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769527|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769528|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769529|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
153769530|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769531|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769572|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769573|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153769574|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769575|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769577|NCT00230958|Ribavirin|ribavirin|mesh-list
153769578|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
153769579|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
153769580|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153769581|NCT00230958|Taribavirin|taribavirin|mesh-list
153769582|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769583|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
153769584|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769585|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
153769586|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769587|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
153769588|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769589|NCT00227955|Imipramine|imipramine|mesh-list
153769590|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153769591|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
153769592|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769593|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153769594|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153769595|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153794306|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153769631|NCT00231075|Carboplatin|carboplatin|mesh-list
153769632|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153769633|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359847|NCT03733314|Quetmolimab|quetmolimab|mesh-list
153769634|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
153769635|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
153769636|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
153769637|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769638|NCT00198146|Daclizumab|daclizumab|mesh-list
153769639|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769640|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
153769641|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769642|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153769643|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769644|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
153769645|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769647|NCT02962518|Triamcinolone|triamcinolone|mesh-list
153769648|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769659|NCT00231192|Repaglinide|repaglinide|mesh-list
153769660|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769661|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769662|NCT00204698|Rabeprazole|rabeprazole|mesh-list
153769663|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153769664|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769665|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153769666|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769667|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769668|NCT00204737|Prednisone|prednisone|mesh-list
153769669|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769670|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
153769671|NCT00204737|Hormones|hormones|mesh-ancestor
153769672|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769673|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769674|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153769675|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769676|NCT00198380|Gefitinib|gefitinib|mesh-list
153769677|NCT00198380|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153769678|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153769679|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769690|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153769691|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153769692|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153769693|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769694|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769695|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769696|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153769697|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
153769698|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769699|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153769700|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153769701|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
153769702|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
153769703|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769704|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769706|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769707|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153769708|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769709|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
153769710|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769711|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769712|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153769713|NCT00198536|Protective Agents|protective agents|mesh-ancestor
153769714|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769715|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769716|NCT00409994|Sirolimus|sirolimus|mesh-list
153769717|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153769718|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769719|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153769733|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153769734|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
153769735|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769736|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153769737|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153769738|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769739|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769740|NCT00198614|Metoprolol|metoprolol|mesh-list
153769741|NCT00198614|Carvedilol|carvedilol|mesh-list
153769742|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153769743|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153769744|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
153769745|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
153769767|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153769769|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153769770|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451669|NCT01948908|Midazolam|midazolam|mesh-list
153769771|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153769772|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769773|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154263221|NCT05862285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769774|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153769775|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769776|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153769777|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769778|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
153769779|NCT02963324|Ivermectin|ivermectin|mesh-list
153769780|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153769781|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769782|NCT00228540|Modafinil|modafinil|mesh-list
153769783|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153769784|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769785|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153769786|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153769787|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153769788|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769789|NCT00231621|Topiramate|topiramate|mesh-list
153769790|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
153769791|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769792|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769793|NCT00474526|Vaccines|vaccines|mesh-list
153769794|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153769795|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
153769796|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769797|NCT00231660|Topiramate|topiramate|mesh-list
153769815|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769816|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
153769817|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153769818|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769819|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769820|NCT00231855|Docetaxel|docetaxel|mesh-list
153769821|NCT00231855|Topotecan|topotecan|mesh-list
153769822|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769823|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
153769838|NCT00199004|Daunorubicin|daunorubicin|mesh-list
153769839|NCT00199004|Asparaginase|asparaginase|mesh-list
153769840|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
153769841|NCT00199004|Thioguanine|thioguanine|mesh-list
153769842|NCT00199004|Vindesine|vindesine|mesh-list
153769843|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769844|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
153769845|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769846|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769847|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769848|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
153451670|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153769849|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769850|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769851|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153769852|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769853|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
153769854|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
153769855|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769856|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769857|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
153769858|NCT00199004|Hormones|hormones|mesh-ancestor
153769867|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
153769868|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769869|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153769870|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153769871|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
153769872|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769873|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153769874|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
153769875|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
153769876|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
153769877|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153769878|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153769879|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153769880|NCT00228852|Fludarabine|fludarabine|mesh-list
153769881|NCT00228852|Busulfan|busulfan|mesh-list
153769882|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769883|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769884|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769885|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
153769886|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769887|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
153769888|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769889|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153769890|NCT00204776|Capecitabine|capecitabine|mesh-list
153769891|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
153769892|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153769893|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
153769894|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769895|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769918|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769919|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769920|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769921|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
153769922|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769923|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769924|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153769984|NCT00410930|Immunologic Factors|immunologic factors|mesh-ancestor
153769985|NCT00410930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769987|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153769988|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769989|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
153769990|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153769991|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153769992|NCT00232011|Analgesics|analgesics|mesh-ancestor
153769993|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
153769994|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769995|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769996|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769997|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769998|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
153769999|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770000|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
153770001|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153770002|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844645|NCT04885686|Formaldehyde|formaldehyde|mesh-list
153770003|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770004|NCT00232050|Omalizumab|omalizumab|mesh-list
153770005|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153770006|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153770007|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153770008|NCT00232089|Tegaserod|tegaserod|mesh-list
153770009|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153770025|NCT00229125|Lorazepam|lorazepam|mesh-list
153770026|NCT00229125|Analgesics|analgesics|mesh-ancestor
153770027|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
153770028|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770060|NCT00232167|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153770061|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770062|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770063|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770064|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770065|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
153770066|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770067|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153770089|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770091|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
153770092|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770093|NCT00232284|Sertraline|sertraline|mesh-list
153770094|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770116|NCT00205751|Dexamethasone|dexamethasone|mesh-list
153770117|NCT00205751|Prednisone|prednisone|mesh-list
153770118|NCT00205751|Melphalan|melphalan|mesh-list
153770119|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384756|NCT00377091|PENTA|penta|mesh-list
153770120|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
153770121|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
153770122|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770123|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770135|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
153770136|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
153770137|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153770138|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770139|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153907181|NCT04136743|Hormones|hormones|mesh-ancestor
153770140|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153770141|NCT00205751|Growth Substances|growth substances|mesh-ancestor
153770142|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
153770144|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770145|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770146|NCT00229476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153770147|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770148|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770149|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770150|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770151|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
153770152|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770153|NCT00205946|Bupropion|bupropion|mesh-list
153770154|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153770155|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770156|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770157|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153770166|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770168|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
153770169|NCT00229515|Temsirolimus|temsirolimus|mesh-list
153770170|NCT00229515|MTOR Inhibitors|mtor inhibitors|mesh-list
153770171|NCT00229515|Tirofiban|tirofiban|mesh-list
153770172|NCT00229515|Abciximab|abciximab|mesh-list
153770173|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153770174|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770175|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153770176|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770177|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
153770178|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770179|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
153770180|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770181|NCT00229515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153770182|NCT00229515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770183|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770202|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
153770203|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770204|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770205|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
153770206|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153770207|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770208|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770209|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153770210|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770211|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770212|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770213|NCT00229593|ST 1435|st 1435|mesh-list
153770214|NCT00229593|Testosterone|testosterone|mesh-list
153770215|NCT00229593|Androgens|androgens|mesh-ancestor
153770216|NCT00229593|Hormones|hormones|mesh-ancestor
153770217|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770218|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770219|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153770220|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
153770221|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153770222|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153770223|NCT00229632|Idebenone|idebenone|mesh-list
153770224|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
153770225|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770226|NCT00229632|Protective Agents|protective agents|mesh-ancestor
153770227|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770228|NCT00206180|Esomeprazole|esomeprazole|mesh-list
153770229|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153910026|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770230|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770231|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153770232|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770233|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770234|NCT00206219|Methotrexate|methotrexate|mesh-list
153770235|NCT00206219|Gefitinib|gefitinib|mesh-list
153770236|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153770237|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
153770238|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153770239|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794739|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
154263222|NCT05852223|Pembrolizumab|pembrolizumab|mesh-list
154263223|NCT05852223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153770271|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153770273|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153770274|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770275|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153770276|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
153770277|NCT00411164|Hydromorphone|hydromorphone|mesh-list
153770278|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153770279|NCT00411164|Narcotics|narcotics|mesh-ancestor
153770280|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770281|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770282|NCT00411164|Analgesics|analgesics|mesh-ancestor
153770283|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
153731537|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153731538|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
153731539|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731540|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731541|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731542|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153731543|NCT00138515|Vildagliptin|vildagliptin|mesh-list
153731544|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153731545|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731546|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153770284|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770285|NCT00411203|Tamoxifen|tamoxifen|mesh-list
153770286|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153770287|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
153770288|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770289|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770290|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770291|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770292|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153770293|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153770294|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153770295|NCT00411281|Cytarabine|cytarabine|mesh-list
153770296|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153770297|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
153770309|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153770310|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770311|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770312|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770313|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770314|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153770315|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153770316|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
153770331|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770333|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770334|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
153770335|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
153770336|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
153770337|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770338|NCT00206492|Tamoxifen|tamoxifen|mesh-list
153770339|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153770340|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
153770341|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770342|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910059|NCT02795299|Vitamins|vitamins|mesh-ancestor
153770343|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770344|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770345|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153770346|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153770347|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153770348|NCT00206570|Estradiol|estradiol|mesh-list
153770349|NCT00206570|Estrogens|estrogens|mesh-ancestor
153770350|NCT00206570|Hormones|hormones|mesh-ancestor
153770351|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770352|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770353|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
153735851|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153770354|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153770355|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
153770356|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770357|NCT01056159|Albuterol|albuterol|mesh-list
153770358|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153770359|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
153770378|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770379|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153770380|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770381|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770382|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770383|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153770384|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
153770385|NCT00206765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153770386|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770387|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770388|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153770389|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770390|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153770405|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770406|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770408|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770409|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770410|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770411|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153770412|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
153770413|NCT00206999|Imipramine|imipramine|mesh-list
153770414|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153770427|NCT00207077|Cetuximab|cetuximab|mesh-list
153770428|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153770429|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153770430|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770431|NCT00207077|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153770432|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153770433|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770434|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770435|NCT00207116|Cetuximab|cetuximab|mesh-list
153770436|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153770437|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770438|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
153770439|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153770440|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153770441|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770442|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153770443|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153770444|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
153770445|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770446|NCT00207155|Cetuximab|cetuximab|mesh-list
153770447|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153770448|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770449|NCT00232947|Vaccines|vaccines|mesh-list
153770450|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
153770451|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770452|NCT00413712|Adenosine|adenosine|mesh-list
153770453|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
153770454|NCT00413712|Calcium|calcium|mesh-list
153770455|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153770456|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770457|NCT00413712|Analgesics|analgesics|mesh-ancestor
153770458|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
153770459|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770460|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153770461|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
153770462|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153770463|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
153770464|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
153794928|NCT00293787|Timolol|timolol|mesh-list
153770469|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
153770470|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153770471|NCT00207311|Interferons|interferons|mesh-list
153770472|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
153770473|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
153770474|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153418666|NCT03032965|Adenosine|adenosine|mesh-list
153770476|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770477|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
153770495|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770496|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770497|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
153770499|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
153770500|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
153770501|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770502|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770503|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770504|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770505|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153770506|NCT00207428|Analgesics|analgesics|mesh-ancestor
153770507|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
153770508|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910094|NCT03826303|Ethanol|ethanol|mesh-list
153770509|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153770510|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770511|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770512|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153770513|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153770514|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
153770515|NCT00230334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153770516|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153770517|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770518|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770519|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770520|NCT00207584|Doxycycline|doxycycline|mesh-list
153770521|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153770522|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770523|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
153770524|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153770525|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153770527|NCT00207662|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153770528|NCT00207662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153770529|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
153770530|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770542|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770544|NCT00230373|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153770545|NCT00230373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770546|NCT00230373|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153770547|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
153770548|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770549|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153770550|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770551|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
153770552|NCT00230451|Paclitaxel|paclitaxel|mesh-list
153770553|NCT00230451|Fluorouracil|fluorouracil|mesh-list
153770554|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153770555|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770556|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
153770557|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
153770558|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
153770559|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770560|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
153770561|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153770562|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770563|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
153770564|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770582|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770584|NCT00230490|Pradefovir|pradefovir|mesh-list
153770585|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
153770586|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770587|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153770588|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153770589|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770590|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770591|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153770592|NCT01089556|Pregabalin|pregabalin|mesh-list
153770593|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153770594|NCT01089556|Analgesics|analgesics|mesh-ancestor
153770613|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153770614|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770615|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
153770617|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153770618|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770619|NCT00424541|Aliskiren|aliskiren|mesh-list
153770620|NCT00424541|Renin Inhibitors|renin inhibitors|mesh-ancestor
153770621|NCT00424541|Protease Inhibitors|protease inhibitors|mesh-ancestor
153770622|NCT00424541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770623|NCT00424541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770624|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153770625|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153770626|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
153770627|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770628|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770629|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153770630|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
153770631|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153770632|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153770633|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153770634|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
153770635|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910117|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153770636|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770637|NCT00424580|Montelukast|montelukast|mesh-list
153770638|NCT00424580|Desloratadine|desloratadine|mesh-list
153770639|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153770640|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
153770670|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153770671|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153770672|NCT00237198|Letrozole|letrozole|mesh-list
153770673|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770674|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153770675|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153770676|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770677|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770678|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153770679|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
153770680|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770681|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770682|NCT00233610|Tamoxifen|tamoxifen|mesh-list
153770683|NCT00233610|Bicalutamide|bicalutamide|mesh-list
153770684|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153770685|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
153770686|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770687|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770688|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770689|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770690|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153770691|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153770692|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153770693|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
153770694|NCT00208130|Topiramate|topiramate|mesh-list
153770695|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
153770696|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153770697|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770698|NCT00237237|Vildagliptin|vildagliptin|mesh-list
153770699|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153770710|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770711|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770712|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
153770713|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
153770714|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770715|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770716|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153770717|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153770718|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
153770719|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153770720|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153770721|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153770722|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153770723|NCT01087723|Heparin|heparin|mesh-list
153770724|NCT01087723|Bivalirudin|bivalirudin|mesh-list
153770725|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
153770726|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153770740|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770741|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770742|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770743|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153770744|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
153770745|NCT01085812|Milnacipran|milnacipran|mesh-list
153770746|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
153770747|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153770748|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770749|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770750|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770751|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770752|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770753|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770754|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770755|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153770757|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
153770758|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770759|NCT01085734|Bevacizumab|bevacizumab|mesh-list
153770760|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153770761|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770762|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153770776|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770777|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153770778|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153770779|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
153770780|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770781|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910151|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770782|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
153770783|NCT00208442|Diuretics|diuretics|mesh-ancestor
153770784|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
153770785|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770786|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153770787|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770788|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770789|NCT00233766|Sirolimus|sirolimus|mesh-list
153770790|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153770791|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770792|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153770793|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770794|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
153770795|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770796|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
153770797|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770798|NCT00208520|Lamotrigine|lamotrigine|mesh-list
153770799|NCT00208520|Carbamazepine|carbamazepine|mesh-list
153770800|NCT00208520|Levetiracetam|levetiracetam|mesh-list
153770811|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770812|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153770813|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
153770814|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153770815|NCT00208520|Analgesics|analgesics|mesh-ancestor
153770816|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
153770817|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770818|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153770819|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153770820|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153770821|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770822|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770823|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153770824|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770836|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770837|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153770838|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
153770839|NCT00233805|Sirolimus|sirolimus|mesh-list
153770840|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153770841|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910159|NCT02797717|Hormones|hormones|mesh-ancestor
153770842|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153770843|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770844|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
153770845|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770846|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
153770847|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770848|NCT01084135|Rivastigmine|rivastigmine|mesh-list
153770849|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154263224|NCT05852223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263225|NCT05852223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153770850|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770851|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770852|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
153770853|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770854|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770855|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153770856|NCT01084135|Protective Agents|protective agents|mesh-ancestor
153770857|NCT01083316|Dexamethasone|dexamethasone|mesh-list
153770859|NCT01083316|Melphalan|melphalan|mesh-list
153770860|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153770861|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
153770862|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
153770863|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770864|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770865|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770866|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
153770867|NCT01083316|Hormones|hormones|mesh-ancestor
153770868|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770869|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770870|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770871|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153770872|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
153770873|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770874|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153770875|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770896|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153770897|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770899|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153770900|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
153770901|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770902|NCT01081873|Leuprolide|leuprolide|mesh-list
153770903|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153770904|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
153770905|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153770906|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770907|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770908|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770909|NCT00237471|Insulin|insulin|mesh-list
153770910|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153770911|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770912|NCT00237510|Terazosin|terazosin|mesh-list
153770913|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153770914|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153770915|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153770916|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
153770917|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770918|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770919|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770920|NCT00237510|Urological Agents|urological agents|mesh-ancestor
153770921|NCT01081795|Topiramate|topiramate|mesh-list
153770922|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
153770923|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153770924|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770925|NCT00233961|Lenograstim|lenograstim|mesh-list
153770926|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153770927|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
153770928|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770929|NCT00234000|Azacitidine|azacitidine|mesh-list
153770930|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
153770931|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153770932|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
153770933|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770934|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770935|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770936|NCT00234117|Rabeprazole|rabeprazole|mesh-list
153770937|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153770938|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770939|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153770940|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735854|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
153907331|NCT03691090|Cisplatin|cisplatin|mesh-list
153770941|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770942|NCT00209144|Insulin|insulin|mesh-list
153770943|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153770944|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770945|NCT00209222|Cytarabine|cytarabine|mesh-list
153770946|NCT00209222|Dexamethasone|dexamethasone|mesh-list
153770947|NCT00209222|Prednisone|prednisone|mesh-list
153770948|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
153770970|NCT00209222|Hormones|hormones|mesh-ancestor
153770971|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770972|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770973|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153770974|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153770975|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153770976|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153770977|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770978|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153770979|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
153770980|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
153770981|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
153770982|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153770983|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
153770984|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
153770985|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770986|NCT00234195|Bupropion|bupropion|mesh-list
153770987|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153770988|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770989|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770990|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153770991|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770992|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770993|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770994|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
153770995|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770996|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770997|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153770998|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153770999|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771000|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153771001|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
153771002|NCT00209261|Coagulants|coagulants|mesh-ancestor
153771003|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153771004|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
153771005|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771006|NCT00209300|Mesalamine|mesalamine|mesh-list
153771007|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153771008|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153771009|NCT00209300|Analgesics|analgesics|mesh-ancestor
153771010|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
153771011|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771012|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771013|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153771014|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153771015|NCT00234234|Adalimumab|adalimumab|mesh-list
153771030|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153771031|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153771032|NCT00411437|Oxybutynin|oxybutynin|mesh-list
153771033|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153771034|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153771035|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
153771036|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771037|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771038|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771039|NCT00411437|Urological Agents|urological agents|mesh-ancestor
153771040|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
153771041|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
153771042|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771043|NCT00234312|Sertraline|sertraline|mesh-list
153771044|NCT00234312|Escitalopram|escitalopram|mesh-list
153795355|NCT06059118|Androgens|androgens|mesh-ancestor
153771060|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771061|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771062|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771064|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153771066|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153771067|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771068|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153771069|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153771070|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771071|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771072|NCT00209495|Dexamethasone|dexamethasone|mesh-list
153771073|NCT00209495|Pregabalin|pregabalin|mesh-list
153771103|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
153771104|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
153771105|NCT00234390|Hormones|hormones|mesh-ancestor
153771106|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153771107|NCT00209534|Fospropofol|fospropofol|mesh-list
153771108|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153771109|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771110|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771111|NCT00209573|Fospropofol|fospropofol|mesh-list
153771112|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153771113|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771114|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771115|NCT00209612|Paclitaxel|paclitaxel|mesh-list
153771116|NCT00209612|Irinotecan|irinotecan|mesh-list
153771117|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153771122|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771123|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153771124|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153771125|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771126|NCT01081249|Oxytocin|oxytocin|mesh-list
153771127|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
153771128|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153771129|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771130|NCT00234429|Gefitinib|gefitinib|mesh-list
153771131|NCT00234429|Raltitrexed|raltitrexed|mesh-list
153771132|NCT00234429|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153771133|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153795434|NCT05964647|Ketanserin|ketanserin|mesh-list
153771159|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771161|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153771162|NCT02961855|Analgesics|analgesics|mesh-ancestor
153771163|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153771164|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153771165|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771166|NCT00209690|Cisplatin|cisplatin|mesh-list
153771167|NCT00209690|Docetaxel|docetaxel|mesh-list
153771168|NCT00209690|Fluorouracil|fluorouracil|mesh-list
153771169|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771170|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
153771171|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
153771172|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
153771173|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771174|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
153771175|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153771176|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153771177|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
153771178|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771224|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
153771225|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771226|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153771227|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153771228|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771229|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771230|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
153771231|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771232|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771233|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153771234|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153771235|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771244|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771245|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735855|NCT04079712|Nivolumab|nivolumab|mesh-list
153907378|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
153771246|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
153910280|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
153771247|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153771248|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153771249|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153771250|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771251|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771252|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
153771253|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771254|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771255|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153771256|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771258|NCT01084330|Irinotecan|irinotecan|mesh-list
153771259|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771291|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771292|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153771293|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153771294|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771295|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771296|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153771297|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
153771298|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153771299|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771300|NCT01086748|Risperidone|risperidone|mesh-list
153771318|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153781952|NCT04557397|Rifampin|rifampin|mesh-list
153781953|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
153781954|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781955|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153781956|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153781957|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781958|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781959|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153781960|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
153781961|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781962|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781963|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153781964|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153781965|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
153781966|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153781967|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
153781968|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153781969|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153781970|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153781971|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153771342|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
153771343|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153771344|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153771345|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771346|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
153771347|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153771348|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153771349|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771350|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
153771351|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
153771352|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153771353|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
153771354|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
153771355|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153771356|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153771357|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153771358|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153771359|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
153771360|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
153771361|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153771384|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771385|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771386|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
153771387|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
153771388|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
153771390|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771391|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
153771392|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153771393|NCT00210002|Hematinics|hematinics|mesh-ancestor
153771394|NCT02277886|Esomeprazole|esomeprazole|mesh-list
153771395|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153771396|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153771397|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153771398|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771399|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771400|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153771401|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153771402|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153771403|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153771404|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153771405|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153771406|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153771407|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
153771408|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771409|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771410|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771411|NCT00210041|Gemcitabine|gemcitabine|mesh-list
153771412|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771413|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153771414|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
153771415|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771416|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
153771417|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153771418|NCT04991662|Phenylephrine|phenylephrine|mesh-list
153771419|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
153771420|NCT04991662|Norepinephrine|norepinephrine|mesh-list
153771421|NCT04991662|Metaraminol|metaraminol|mesh-list
153771422|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153771423|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
153771424|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
153771435|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771436|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771437|NCT04991662|Protective Agents|protective agents|mesh-ancestor
153771439|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153771440|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
153771441|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153771442|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771443|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153771444|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771445|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153771446|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153771447|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153771448|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
153771449|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153771450|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
153771451|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
153795679|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
153771468|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
153771469|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
153771470|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771471|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771472|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771474|NCT04996771|Etoposide|etoposide|mesh-list
153771475|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
153771476|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452075|NCT01862328|Pevonedistat|pevonedistat|mesh-list
153771477|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153771478|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153771479|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153771480|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771481|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771482|NCT00210314|Cytarabine|cytarabine|mesh-list
153771483|NCT00210314|Methotrexate|methotrexate|mesh-list
153771484|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153771485|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
153771486|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153771503|NCT00413829|Ranibizumab|ranibizumab|mesh-list
153771504|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153771505|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153771506|NCT00413829|Growth Substances|growth substances|mesh-ancestor
153771507|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771508|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
153771509|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771510|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
153771512|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153771513|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
153771514|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771515|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153771516|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153771517|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
153771518|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771519|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771520|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153771521|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153771522|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153771523|NCT02210182|Pentamidine|pentamidine|mesh-list
153771524|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
153795744|NCT05419011|Vaccines|vaccines|mesh-list
153771541|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
153771542|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771543|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153771544|NCT02210260|Narcotics|narcotics|mesh-ancestor
153771545|NCT02210260|Analgesics|analgesics|mesh-ancestor
153771569|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153771571|NCT04570345|Analgesics|analgesics|mesh-ancestor
153771572|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
153771573|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771574|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771575|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153771576|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910386|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
153771577|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153771578|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153771579|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771580|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153771581|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153771582|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771583|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
153771584|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153771585|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153771586|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153771587|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
153771588|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771589|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
153771590|NCT00234819|Estrogens|estrogens|mesh-list
153771591|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153771592|NCT00234819|Hormones|hormones|mesh-ancestor
153771593|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153771594|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771595|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153771611|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153771612|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153771613|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153771614|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771616|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
153771617|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771618|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153771619|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771620|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153771621|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153771631|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
153771632|NCT00210743|Hematinics|hematinics|mesh-ancestor
153771633|NCT04569916|Irinotecan|irinotecan|mesh-list
153771634|NCT04569916|Apatinib|apatinib|mesh-list
153771635|NCT04569916|Antibodies|antibodies|mesh-list
153771636|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
153771637|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771638|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153771639|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153771640|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418823|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
153771641|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771642|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771643|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153771644|NCT00210782|Topiramate|topiramate|mesh-list
153771645|NCT00210782|Phenytoin|phenytoin|mesh-list
153771646|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
153771647|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153771648|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910390|NCT02788123|Pantoprazole|pantoprazole|mesh-list
153771649|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153771650|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153771651|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771652|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771676|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
153771678|NCT00237900|Fluorouracil|fluorouracil|mesh-list
153771679|NCT00237900|Gefitinib|gefitinib|mesh-list
153771680|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
153771681|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771682|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153771683|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771684|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153771685|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
153771686|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771687|NCT00237900|Antidotes|antidotes|mesh-ancestor
153771688|NCT00237900|Protective Agents|protective agents|mesh-ancestor
153771689|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
153771690|NCT00237900|Vitamins|vitamins|mesh-ancestor
153771691|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
153771692|NCT00237900|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153771693|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153771694|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771695|NCT00210821|Topiramate|topiramate|mesh-list
153771696|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
153771697|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153771698|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771699|NCT00237939|Aripiprazole|aripiprazole|mesh-list
153771700|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
153771701|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771702|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153771703|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153771737|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771738|NCT00210938|Doripenem|doripenem|mesh-list
153771739|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153771740|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771741|NCT02278081|Lansoprazole|lansoprazole|mesh-list
153771742|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
153771788|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153771789|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
153771790|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771791|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
153771792|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
153771793|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
153452136|NCT01898130|Antibodies|antibodies|mesh-list
153771794|NCT00238173|Carboplatin|carboplatin|mesh-list
153771795|NCT00238173|Etoposide|etoposide|mesh-list
153771796|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
153771797|NCT00238173|Mannitol|mannitol|mesh-list
153771798|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153771799|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153771806|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771807|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153771808|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153771809|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153771810|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153771811|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771812|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
153771813|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771814|NCT00238173|Expectorants|expectorants|mesh-ancestor
153771815|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
153771816|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153771817|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
153771818|NCT00238173|Protective Agents|protective agents|mesh-ancestor
153771819|NCT00238173|Antidotes|antidotes|mesh-ancestor
153771820|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153771821|NCT00238173|Diuretics|diuretics|mesh-ancestor
153771822|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
154263226|NCT05852223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771823|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
153771824|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153771828|NCT00211133|Hematinics|hematinics|mesh-ancestor
153771829|NCT00238212|Sorafenib|sorafenib|mesh-list
153771830|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771831|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153771832|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771833|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771834|NCT00211250|Valproic Acid|valproic acid|mesh-list
153771835|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
153771836|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771837|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771838|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
153771839|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771840|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771841|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
153771842|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153771843|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771844|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771845|NCT00238251|Temozolomide|temozolomide|mesh-list
153771846|NCT00238251|Gefitinib|gefitinib|mesh-list
153771847|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153771848|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
153910442|NCT02785393|Doxazosin|doxazosin|mesh-list
153771849|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771850|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771851|NCT00238251|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153771852|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153771853|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771854|NCT04566718|Metformin|metformin|mesh-list
153771855|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153771856|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771857|NCT02210884|Vitamin D|vitamin d|mesh-list
153771858|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
153771859|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
153771860|NCT02210884|Vitamins|vitamins|mesh-list
153771861|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
153771862|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771863|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153771864|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153771865|NCT00238290|Trastuzumab|trastuzumab|mesh-list
153771866|NCT00238290|Letrozole|letrozole|mesh-list
153771867|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153771868|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771869|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153771892|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
153771893|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771894|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153771895|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
153771896|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153771897|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153771898|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153771899|NCT00238329|Growth Substances|growth substances|mesh-ancestor
153771900|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
153771901|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
153771902|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
153771903|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771905|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153771906|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153771907|NCT00211367|Growth Substances|growth substances|mesh-ancestor
153771908|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771909|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
153771951|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771952|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153771953|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153771955|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153771956|NCT02894593|Ethanol|ethanol|mesh-list
153771957|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
153771958|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153771959|NCT02894593|Listerine|listerine|mesh-list
153771960|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
153771961|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153771962|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771963|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771964|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771965|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
153771966|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772012|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772014|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153772015|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153772016|NCT00211484|Growth Substances|growth substances|mesh-ancestor
153772017|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772018|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
153772019|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772020|NCT05428072|Aspirin|aspirin|mesh-list
153772021|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153772022|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153772023|NCT05428072|Analgesics|analgesics|mesh-ancestor
153772024|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
153772025|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772026|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772027|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772028|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772029|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153772030|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153772031|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772032|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153772068|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772069|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772071|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772072|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772073|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153772074|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772075|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153772076|NCT05427175|Methotrexate|methotrexate|mesh-list
153772077|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153772078|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
153731548|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772079|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153772080|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772081|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153772082|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
153772083|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772084|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772085|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772086|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772087|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153772088|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153772089|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
153772090|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772091|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153910484|NCT02782273|Analgesics|analgesics|mesh-ancestor
153772092|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
153772093|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153772094|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153772095|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153772096|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772097|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772140|NCT00211796|Valproic Acid|valproic acid|mesh-list
153772141|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
153772142|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772143|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772144|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
153772145|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772146|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772154|NCT00238797|Gefitinib|gefitinib|mesh-list
153772155|NCT00238797|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153772156|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153772157|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772158|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772159|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772160|NCT05426044|Metformin|metformin|mesh-list
153772161|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153772162|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772163|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
153772164|NCT05425654|Busulfan|busulfan|mesh-list
153772165|NCT05425654|Carmustine|carmustine|mesh-list
153772166|NCT05425654|Rituximab|rituximab|mesh-list
153772167|NCT05425654|Methotrexate|methotrexate|mesh-list
153772169|NCT05425654|Lenalidomide|lenalidomide|mesh-list
153772170|NCT05425654|Procarbazine|procarbazine|mesh-list
153772171|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153772172|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
153772173|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772174|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772175|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153772176|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
153772177|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772178|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772179|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153772180|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153772181|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153772182|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
153772183|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153772184|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153772228|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772229|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772230|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772231|NCT04669366|Sunitinib|sunitinib|mesh-list
153772232|NCT04669366|Axitinib|axitinib|mesh-list
153772233|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772234|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153772235|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153772236|NCT04669366|Growth Substances|growth substances|mesh-ancestor
153772240|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772241|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772243|NCT04721301|Nivolumab|nivolumab|mesh-list
153772244|NCT04721301|Ipilimumab|ipilimumab|mesh-list
153772245|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153772246|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772247|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153772248|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772249|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153772250|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153772251|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153772252|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153772253|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
153772254|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772255|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153772256|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
153772257|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153772258|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772259|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153772260|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
153772261|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772262|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772263|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772264|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772265|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
153772266|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153772267|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
153772268|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772269|NCT00556465|Expectorants|expectorants|mesh-ancestor
153772270|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
153772271|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153772272|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
153772273|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772274|NCT00556465|Protective Agents|protective agents|mesh-ancestor
153772275|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772276|NCT00556465|Antidotes|antidotes|mesh-ancestor
153772277|NCT04668469|Acetaminophen|acetaminophen|mesh-list
153772278|NCT04668469|Vitamins|vitamins|mesh-list
153772279|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
153772280|NCT04668469|Zinc|zinc|mesh-list
153772281|NCT04668469|Azithromycin|azithromycin|mesh-list
153772282|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
153772283|NCT04668469|Ivermectin|ivermectin|mesh-list
153772303|NCT04668469|Protective Agents|protective agents|mesh-ancestor
153772304|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153772305|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153772307|NCT04668469|Coagulants|coagulants|mesh-ancestor
153772308|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
154263228|NCT05809986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772309|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153772310|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772311|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153772312|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
153772313|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772314|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772315|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772316|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772317|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
153772318|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153772319|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772320|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153772321|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
153772322|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772323|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772324|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772325|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772326|NCT00211952|Celecoxib|celecoxib|mesh-list
153772327|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153772328|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153772341|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
153772342|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
153910540|NCT04229719|Protective Agents|protective agents|mesh-ancestor
153772351|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153772352|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772353|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772354|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772355|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
153772356|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153772357|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153772358|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
153772359|NCT00212030|Nicorandil|nicorandil|mesh-list
153772360|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153772361|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153772362|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
153772363|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
153772364|NCT00212030|Vitamins|vitamins|mesh-ancestor
153772365|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
153772366|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772367|NCT00212069|Carboplatin|carboplatin|mesh-list
153772368|NCT00212069|Gemcitabine|gemcitabine|mesh-list
153772369|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772370|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153772371|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
153772372|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772373|NCT00212108|Celecoxib|celecoxib|mesh-list
153772374|NCT00212108|Gefitinib|gefitinib|mesh-list
153772375|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153772376|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153772377|NCT00212108|Analgesics|analgesics|mesh-ancestor
153772378|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
153772379|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772380|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772381|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772382|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772383|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153772384|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153772385|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772386|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772387|NCT00212108|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153772388|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153772389|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772390|NCT00212186|Selenium|selenium|mesh-list
153772391|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
153772392|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772393|NCT00212186|Protective Agents|protective agents|mesh-ancestor
153772394|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772395|NCT00212186|Trace Elements|trace elements|mesh-ancestor
153772396|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
153772397|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153772398|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153772399|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
153796335|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
154263230|NCT05790486|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154263231|NCT05790486|Autonomic Agents|autonomic agents|mesh-ancestor
153907567|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
153772407|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153772408|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153772429|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153772430|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772431|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772433|NCT00239343|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153772434|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153772435|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772436|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772437|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772438|NCT00411593|Bevacizumab|bevacizumab|mesh-list
153772439|NCT00411593|Bortezomib|bortezomib|mesh-list
153772440|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153772441|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772442|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153772443|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153772444|NCT00411593|Growth Substances|growth substances|mesh-ancestor
153772445|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772446|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
153772447|NCT00239382|Meloxicam|meloxicam|mesh-list
153772448|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153772449|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153772450|NCT00239382|Analgesics|analgesics|mesh-ancestor
153772451|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
153772452|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772453|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772454|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772455|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772456|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153772457|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153772458|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772459|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772460|NCT00239421|Fluticasone|fluticasone|mesh-list
153772471|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
153772472|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772473|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153772474|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153772475|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153772476|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153772477|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
153772478|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772479|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772480|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
153772481|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153772482|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
153772484|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153772485|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
153772486|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772487|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772488|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153772489|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
153772490|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
153772491|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153772492|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
153772493|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772494|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772495|NCT00239499|Fluticasone|fluticasone|mesh-list
153772496|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
153772497|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153796395|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
153772519|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
153772520|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772521|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772523|NCT00222573|Clopidogrel|clopidogrel|mesh-list
153772524|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153772525|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153772540|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
153772541|NCT00212654|Landiolol|landiolol|mesh-list
153772542|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153772543|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153772544|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
153772545|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772546|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772547|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772548|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153772549|NCT00239538|Valsartan|valsartan|mesh-list
153772550|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153772551|NCT00239538|Telmisartan|telmisartan|mesh-list
153772552|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153772553|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153772554|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153772555|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772556|NCT00239538|Diuretics|diuretics|mesh-ancestor
153772557|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
153772558|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772559|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153772560|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772561|NCT00212810|Topiramate|topiramate|mesh-list
153772562|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
153772563|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153772564|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772579|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153772580|NCT00213200|Narcotics|narcotics|mesh-ancestor
153772581|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772582|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772583|NCT00213200|Analgesics|analgesics|mesh-ancestor
153772584|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
153772599|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
153772600|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772601|NCT00239889|Calcitonin|calcitonin|mesh-list
153772602|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
153772603|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153772605|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153772606|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772607|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153772608|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
153772609|NCT00239967|Rimonabant|rimonabant|mesh-list
153772610|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153772611|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153772612|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153772613|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772614|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772615|NCT00239967|Hormones|hormones|mesh-ancestor
153772616|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153772617|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772618|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
153772619|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153772620|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772621|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
153772622|NCT00213512|Rituximab|rituximab|mesh-list
153772623|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153772624|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772625|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
153772626|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772627|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772628|NCT00213551|Antioxidants|antioxidants|mesh-list
153772629|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772630|NCT00213551|Protective Agents|protective agents|mesh-ancestor
153772631|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772632|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153772633|NCT00213590|Cyclosporine|cyclosporine|mesh-list
153772634|NCT00213590|Cyclosporins|cyclosporins|mesh-list
153772635|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772636|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772637|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452351|NCT01851720|Analgesics|analgesics|mesh-ancestor
153772638|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
153772639|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772683|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153772684|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153418987|NCT05821972|Ketamine|ketamine|mesh-list
153907626|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153772685|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772712|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772713|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153772714|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
153772715|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772716|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772717|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772718|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772719|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153772720|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153772721|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
153772722|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772723|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153772724|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
153772725|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153772726|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772727|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772728|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153772729|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153772730|NCT00243789|Protective Agents|protective agents|mesh-ancestor
153772731|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772741|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772743|NCT00240318|Calcium|calcium|mesh-list
153772744|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153772745|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772746|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153772747|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153772748|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
153609940|NCT05409365|Antibodies|antibodies|mesh-list
153772749|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772750|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153772751|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153772752|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772753|NCT00243945|Rotigotine|rotigotine|mesh-list
153772754|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
153772755|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
153772756|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772757|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910655|NCT05340985|Provitamins|provitamins|mesh-ancestor
153772758|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772770|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772772|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
153772773|NCT00214331|Gentamicins|gentamicins|mesh-list
153772774|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772775|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772776|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153772777|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153772778|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772779|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772780|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772781|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153772782|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153772783|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153772784|NCT00243984|Topiramate|topiramate|mesh-list
153772785|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
153772786|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153772787|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772788|NCT00214370|Fentanyl|fentanyl|mesh-list
153772789|NCT00214370|Propofol|propofol|mesh-list
153772790|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153772791|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772792|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772793|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153772794|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
153772795|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
153772796|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153772803|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
153772804|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153772805|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
153419004|NCT05821972|Anesthetics|anesthetics|mesh-ancestor
153772806|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772807|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772808|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153772809|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
153772810|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
153772811|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153772812|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
153772813|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772814|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772815|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
153772816|NCT00244023|Testosterone|testosterone|mesh-list
153772817|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
153772818|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
153772819|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153772820|NCT00244023|Androgens|androgens|mesh-ancestor
153772821|NCT00244023|Hormones|hormones|mesh-ancestor
153772822|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153772823|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772824|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153772825|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772826|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
153772828|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153772829|NCT00240474|Telmisartan|telmisartan|mesh-list
153772841|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153772843|NCT00214604|Pravastatin|pravastatin|mesh-list
153772844|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153772845|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153772846|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
153772847|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772848|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153772849|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153772850|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772851|NCT00214643|Clindamycin|clindamycin|mesh-list
153772852|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
153772853|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
153772854|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
153772855|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772856|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772857|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153772858|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772859|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772860|NCT00414531|Atorvastatin|atorvastatin|mesh-list
153772861|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153772862|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153772863|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
153772864|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772865|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153772883|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772884|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
153772885|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153772886|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153772887|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
153772888|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772889|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772890|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153772891|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153772892|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
153772893|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772894|NCT00214877|Methylene Blue|methylene blue|mesh-list
153772895|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772896|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772897|NCT00214955|Fentanyl|fentanyl|mesh-list
153772898|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153772899|NCT00214955|Narcotics|narcotics|mesh-ancestor
153772900|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772901|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772903|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
153772904|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772905|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153772906|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153772907|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
153449289|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772945|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153772947|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772948|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153772949|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153772950|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153772951|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772952|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772953|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772954|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772955|NCT00244296|Analgesics|analgesics|mesh-ancestor
153772956|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
153772957|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772958|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
153772959|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153772960|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
153772961|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153772962|NCT00215228|Escitalopram|escitalopram|mesh-list
153772963|NCT00215228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153772964|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153772965|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772966|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772967|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772968|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
153772969|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772970|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772971|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
153772972|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153772973|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153772975|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
153772976|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
153773048|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
153773049|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
153773050|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
153773051|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773053|NCT00215501|Fluorouracil|fluorouracil|mesh-list
153773054|NCT00215501|Irinotecan|irinotecan|mesh-list
153773055|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773056|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153773057|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
153773058|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773059|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773060|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
153773061|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773062|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153773097|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153773098|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773099|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
153773100|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773101|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773102|NCT00411866|Ketoconazole|ketoconazole|mesh-list
153773103|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
153773104|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773105|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153773106|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153773107|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773108|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773109|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153773110|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
153773111|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773112|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773113|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153773115|NCT04667299|Metronidazole|metronidazole|mesh-list
153773116|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
153773117|NCT04667299|Rabeprazole|rabeprazole|mesh-list
153773118|NCT04667299|Bismuth|bismuth|mesh-list
153773119|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773120|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153773121|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773122|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153449314|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449316|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773123|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153773124|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153773125|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773126|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153773127|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773155|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773156|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773157|NCT00244530|Nifedipine|nifedipine|mesh-list
153773158|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153773159|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153773160|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773161|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153773162|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773163|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
153773164|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
153773165|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153773166|NCT00411905|Bortezomib|bortezomib|mesh-list
153773167|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773168|NCT00240864|Acetaminophen|acetaminophen|mesh-list
153773169|NCT00240864|Ibuprofen|ibuprofen|mesh-list
153773170|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153773171|NCT00240864|Analgesics|analgesics|mesh-ancestor
153773172|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
153773173|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773174|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773175|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
153773176|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153773177|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773178|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773179|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153773180|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773181|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773182|NCT00557011|Amphetamine|amphetamine|mesh-list
153773183|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153773184|NCT00557011|Adderall|adderall|mesh-list
153773185|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153773186|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773187|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
153773188|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
153773189|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773190|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
153773191|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773192|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610373|NCT01946555|Buprenorphine|buprenorphine|mesh-list
153773193|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
153773194|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153745760|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773195|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153773215|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
153773216|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773217|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773218|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153773219|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
153773220|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
153773222|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773223|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153773224|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153773225|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153796910|NCT01672255|Fluoxetine|fluoxetine|mesh-list
153773238|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153773240|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773241|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773242|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153773243|NCT00215774|Flecainide|flecainide|mesh-list
153773244|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153773245|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153773246|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153773247|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153449342|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153773248|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773250|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773251|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153773258|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773259|NCT00215891|Interferons|interferons|mesh-list
153773260|NCT00215891|Ribavirin|ribavirin|mesh-list
153773261|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773262|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
153773263|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773264|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
153773265|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773266|NCT02961816|Pyridoxine|pyridoxine|mesh-list
153773267|NCT02961816|Dexamethasone|dexamethasone|mesh-list
153773268|NCT02961816|Rituximab|rituximab|mesh-list
153610447|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
153773269|NCT02961816|Gemcitabine|gemcitabine|mesh-list
153773270|NCT02961816|Melphalan|melphalan|mesh-list
153773271|NCT02961816|Busulfan|busulfan|mesh-list
153773272|NCT02961816|Panobinostat|panobinostat|mesh-list
153773273|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773274|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
153773275|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
153773276|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773277|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773278|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773279|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
153773280|NCT02961816|Hormones|hormones|mesh-ancestor
153773281|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773282|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153773283|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773284|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153773285|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
153773286|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773287|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153773288|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
153773289|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773290|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153773291|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
153773292|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153796967|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153773357|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773359|NCT04664803|Cefetamet|cefetamet|mesh-list
153773375|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773376|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153773377|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153773378|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797036|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153773391|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
153773392|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773393|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773394|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153773395|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
153773396|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153773397|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153773398|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773399|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773400|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
153773402|NCT00241137|Valsartan|valsartan|mesh-list
153773403|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153773404|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153773405|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153745885|NCT02914327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773406|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773407|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153773408|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
153773409|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
153773410|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773411|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153773412|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153773413|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773414|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153773415|NCT04664530|Esketamine|esketamine|mesh-list
153773416|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
153449362|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773417|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773439|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153773440|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
153773441|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153773442|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153773443|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773444|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
153773445|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153773446|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773447|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153773448|NCT00244920|Protective Agents|protective agents|mesh-ancestor
153773449|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153773450|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153773451|NCT00244920|Growth Substances|growth substances|mesh-ancestor
153773452|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
153773453|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
153773454|NCT00216515|Galantamine|galantamine|mesh-list
153773455|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153773456|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773457|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773458|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
153773459|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773460|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773491|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153745931|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
153773492|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773493|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773494|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153773495|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
153773496|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
153773497|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153773498|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153773499|NCT00241254|Prednisolone|prednisolone|mesh-list
153773500|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
153773501|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
153773502|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153773503|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
153773504|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773505|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
153773506|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773507|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773508|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153773509|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
153773510|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773511|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773512|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153773513|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773514|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
153773515|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
153773516|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773517|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773518|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
153773519|NCT00241254|Hormones|hormones|mesh-ancestor
153359880|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773520|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773521|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153773523|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153773524|NCT00216632|Risperidone|risperidone|mesh-list
153773525|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153773526|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
153773527|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773528|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773567|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153773568|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773570|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
153773571|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153773572|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
153773573|NCT00216827|Calcipotriene|calcipotriene|mesh-list
153773574|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153773575|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773576|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
153773577|NCT00216827|Hormones|hormones|mesh-ancestor
153773578|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797188|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
153773622|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773623|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153773624|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773625|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
153773626|NCT04660786|Hormones|hormones|mesh-ancestor
153773627|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773628|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773629|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
153773630|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773631|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773632|NCT00217178|Folic Acid|folic acid|mesh-list
153773633|NCT00217178|Vitamins|vitamins|mesh-ancestor
153773634|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
153773635|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773636|NCT00217178|Hematinics|hematinics|mesh-ancestor
153773637|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
153773638|NCT00241449|Tamoxifen|tamoxifen|mesh-list
153773639|NCT00241449|Fulvestrant|fulvestrant|mesh-list
153773640|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153773641|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
153773642|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610839|NCT01949675|Vaccines|vaccines|mesh-list
153773643|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773644|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153773645|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773646|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153773680|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773682|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
153773683|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153773684|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
153773685|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773686|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773687|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153773688|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
153773689|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
153773690|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153773691|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
153773692|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773693|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773694|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
153773695|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
153773696|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153773697|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153773698|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
153773699|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
153773700|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773701|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773702|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
153773703|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153773704|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153773705|NCT00558181|Prednisolone|prednisolone|mesh-list
153773706|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
153773707|NCT00558181|Rituximab|rituximab|mesh-list
153773708|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153773709|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
153773710|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153773711|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773759|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773760|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773762|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773763|NCT00217373|Interferons|interferons|mesh-list
153773764|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
153773765|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
153773766|NCT00217373|Metronidazole|metronidazole|mesh-list
153773767|NCT00217373|Vaccines|vaccines|mesh-list
153773768|NCT00217373|Sargramostim|sargramostim|mesh-list
153773769|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
153773814|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773816|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153773817|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773818|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773819|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153773820|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153773821|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773822|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
153773824|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773825|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773826|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
153773838|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773839|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773841|NCT00217568|Docetaxel|docetaxel|mesh-list
153773842|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773843|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
153773844|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
153773845|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
153773846|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773847|NCT04646161|Misoprostol|misoprostol|mesh-list
153773883|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773884|NCT04645303|Triamcinolone|triamcinolone|mesh-list
153773885|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153773886|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153773887|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
153773888|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153773906|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
153773907|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773908|NCT04644484|Vaccines|vaccines|mesh-list
153773909|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
153773910|NCT04644484|Antibodies|antibodies|mesh-list
153773911|NCT04644484|gamma-Globulins|gamma-globulins|mesh-list
153773912|NCT04644484|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153773913|NCT04644484|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153773914|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
153773915|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773916|NCT04644250|Paclitaxel|paclitaxel|mesh-list
153773917|NCT04644250|Carboplatin|carboplatin|mesh-list
153773918|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153773919|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773920|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
153773921|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
153773922|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
153385891|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153773923|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773924|NCT00245739|Darunavir|darunavir|mesh-list
153773925|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153773926|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153773927|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
153773928|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773929|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773930|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153773931|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153773932|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
153773933|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773934|NCT00558883|Acarbose|acarbose|mesh-list
153359883|NCT03323463|Fluorouracil|fluorouracil|mesh-list
153773935|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153773936|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773937|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773938|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153773939|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773977|NCT00218075|Carbidopa|carbidopa|mesh-list
153773978|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153773979|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153773980|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
153773981|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773982|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773983|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773984|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153773985|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773986|NCT00218114|Valproic Acid|valproic acid|mesh-list
153773987|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
153773988|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773989|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773990|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
153773991|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773992|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773993|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
153773994|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153773995|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773996|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773997|NCT00424788|Natalizumab|natalizumab|mesh-list
153773999|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774001|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153774002|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153774003|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774004|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
153774005|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774006|NCT04642846|Fluorides|fluorides|mesh-list
153774007|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
153774008|NCT04642846|Protective Agents|protective agents|mesh-ancestor
153774009|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774038|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153774039|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774040|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
153774041|NCT00218309|Hydromorphone|hydromorphone|mesh-list
153774074|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774075|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153774076|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153774077|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153774078|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153774079|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
153774080|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774081|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774082|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
153774083|NCT00559312|Hormones|hormones|mesh-ancestor
153774084|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774085|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
153774086|NCT00559351|Fluorouracil|fluorouracil|mesh-list
153774087|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774088|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
153774089|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774090|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153774091|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774092|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
153774093|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774094|NCT00218504|Dronabinol|dronabinol|mesh-list
153774095|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
153774096|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611268|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153774097|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153774098|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774100|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
153774101|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774102|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153774103|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153774104|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774105|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774106|NCT00218504|Hormones|hormones|mesh-ancestor
153774107|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774108|NCT00559429|Docetaxel|docetaxel|mesh-list
153774109|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
153774110|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774111|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
153774112|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
153797533|NCT00265811|Cetuximab|cetuximab|mesh-list
153774149|NCT00559546|Montelukast|montelukast|mesh-list
153774150|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153774151|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774152|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153774153|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
153774154|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774155|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774156|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153774157|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153774158|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774159|NCT00246207|Methylphenidate|methylphenidate|mesh-list
153774160|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153774161|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774162|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153774163|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153774191|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154263232|NCT05790486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774192|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153774193|NCT00218855|Growth Substances|growth substances|mesh-ancestor
153774194|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
153774195|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774196|NCT00246246|Risperidone|risperidone|mesh-list
153774197|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153774198|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
153774199|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774200|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774201|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774202|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153774203|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153774204|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774205|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153774206|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153774207|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
153774208|NCT00242190|Gemcitabine|gemcitabine|mesh-list
153774209|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
153774210|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153774234|NCT04629118|Sirolimus|sirolimus|mesh-list
153774235|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153774236|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774237|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153774238|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774239|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
153774240|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774241|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
153774242|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774243|NCT00561496|Tenofovir|tenofovir|mesh-list
153774244|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
153774245|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774280|NCT00246363|Protective Agents|protective agents|mesh-ancestor
153774281|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774282|NCT00219050|Aliskiren|aliskiren|mesh-list
153774283|NCT00219050|Renin Inhibitors|renin inhibitors|mesh-ancestor
153774284|NCT00219050|Protease Inhibitors|protease inhibitors|mesh-ancestor
153774285|NCT00219050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774286|NCT00219050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774287|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
153774288|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153774289|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153774290|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
153774291|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774292|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774293|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774294|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
153774295|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
153774296|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774297|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
153774298|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153774299|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774300|NCT00219089|Aliskiren|aliskiren|mesh-list
153774301|NCT00219089|Renin Inhibitors|renin inhibitors|mesh-ancestor
153774302|NCT00219089|Protease Inhibitors|protease inhibitors|mesh-ancestor
153774303|NCT00219089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774304|NCT00219089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774305|NCT00246402|Acipimox|acipimox|mesh-list
153774306|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153774307|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
153774308|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774309|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153774310|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
153774311|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153774312|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774313|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153774314|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
153774315|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153774316|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
153774317|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153774318|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774356|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774357|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
153774358|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774359|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774360|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153774362|NCT04627363|Bevacizumab|bevacizumab|mesh-list
153774363|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153774364|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774365|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153774366|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153774367|NCT04627363|Growth Substances|growth substances|mesh-ancestor
153774368|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774369|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
153774396|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774397|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153774399|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774400|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774401|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153774402|NCT00246636|Fenofibrate|fenofibrate|mesh-list
153774403|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153774404|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
153746567|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774405|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774406|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153774407|NCT00219440|Metformin|metformin|mesh-list
153774408|NCT00219440|Pioglitazone|pioglitazone|mesh-list
153774409|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153774410|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774411|NCT00246675|Furosemide|furosemide|mesh-list
153774412|NCT00246675|Diuretics|diuretics|mesh-ancestor
153774413|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
153774414|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774415|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153774416|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153774435|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153774436|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774437|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
153774438|NCT00242463|Nandrolone|nandrolone|mesh-list
153774439|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
153774440|NCT00242463|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
153774441|NCT00242463|Androgens|androgens|mesh-ancestor
153359884|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774442|NCT00242463|Hormones|hormones|mesh-ancestor
153774443|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774444|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774445|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
153797704|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153774468|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153774469|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153774491|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153774492|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153774493|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153774494|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153774495|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774496|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153774497|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153774498|NCT00242541|Octreotide|octreotide|mesh-list
153774499|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153774500|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153774501|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774502|NCT04625608|Acetaminophen|acetaminophen|mesh-list
153774503|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774504|NCT04625608|Analgesics|analgesics|mesh-ancestor
153774505|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
153774506|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774507|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774508|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
153774509|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
153774510|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153774511|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
153774512|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
153774513|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774514|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774515|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774516|NCT00219713|Analgesics|analgesics|mesh-ancestor
153774517|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
154263233|NCT05790486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774544|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774546|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153774547|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153774548|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153774549|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774550|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774551|NCT00219869|Galantamine|galantamine|mesh-list
153774552|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153774553|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774554|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774555|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
153774556|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774557|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774558|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153774559|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
153774560|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774561|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
153774562|NCT04624360|Dexamethasone|dexamethasone|mesh-list
153774563|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774564|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
153774565|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
153774566|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774567|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774568|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153774569|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
153774570|NCT04624360|Hormones|hormones|mesh-ancestor
153774571|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774572|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153774573|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774574|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
153774575|NCT00219908|Analgesics|analgesics|mesh-ancestor
153774576|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
153774577|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774578|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774579|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774580|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153774581|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153774582|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774583|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774604|NCT00242775|Hormones|hormones|mesh-ancestor
153774605|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774606|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153774607|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153774608|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153774609|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
153774610|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774611|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774612|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
153774613|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
153774614|NCT04623619|Vitamins|vitamins|mesh-ancestor
153774615|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
153774616|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774617|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
153774618|NCT00562198|Carbidopa|carbidopa|mesh-list
153774619|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153774620|NCT00562198|Entacapone|entacapone|mesh-list
153774621|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153774622|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153774623|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
153774624|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774625|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774626|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745637|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774627|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153774628|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774629|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153774630|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
153774631|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
153774632|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153774634|NCT00220064|Fluorouracil|fluorouracil|mesh-list
153774635|NCT00220064|Irinotecan|irinotecan|mesh-list
153774636|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
153774637|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774638|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153774639|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774640|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774642|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774643|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153774644|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153774645|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774646|NCT00220064|Antidotes|antidotes|mesh-ancestor
153774647|NCT00220064|Protective Agents|protective agents|mesh-ancestor
153774648|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
153774649|NCT00220064|Vitamins|vitamins|mesh-ancestor
153774650|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
153774651|NCT00220103|Capecitabine|capecitabine|mesh-list
153774652|NCT00220103|Epirubicin|epirubicin|mesh-list
153774653|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774670|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774671|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774672|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774673|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774689|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611868|NCT03649659|Fluorides|fluorides|mesh-list
153774690|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774691|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774692|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
153774693|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774694|NCT00220220|Amlodipine|amlodipine|mesh-list
153774695|NCT00220220|Olmesartan|olmesartan|mesh-list
153774696|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153774697|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153774698|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153774699|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153774700|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774701|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153774702|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774703|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
153774704|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153774705|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153774706|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
153774707|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153774708|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
153774709|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774710|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774711|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153774728|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774729|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774730|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153774731|NCT04622956|Methotrexate|methotrexate|mesh-list
153774732|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153774733|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
153774734|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153774735|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774736|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153774738|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774739|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774740|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774741|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774742|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153774743|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774744|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
153774745|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746882|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774746|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153774747|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
153774748|NCT04622566|Lenvatinib|lenvatinib|mesh-list
153774749|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153774750|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774751|NCT04622566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153774752|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774765|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774766|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774767|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
153774785|NCT04621669|Calcium|calcium|mesh-list
153774786|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153774787|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774788|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153774789|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153774790|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153774791|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
153774792|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774793|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153774794|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153774795|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774796|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153774797|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153774798|NCT04621669|Protective Agents|protective agents|mesh-ancestor
153774799|NCT00412646|Etravirine|etravirine|mesh-list
153774800|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153774801|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153774802|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774803|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774804|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
153774805|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774806|NCT00243009|Cyclosporine|cyclosporine|mesh-list
153774807|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
153774808|NCT00243009|Fludarabine|fludarabine|mesh-list
153774809|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
153774810|NCT00243009|Cyclosporins|cyclosporins|mesh-list
153774811|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774812|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153774813|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
153774814|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774815|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774816|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
153746910|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
153774817|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774818|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774819|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
153774820|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774821|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774822|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774823|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153774824|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153774825|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153774826|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
153774827|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153774850|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153774851|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774852|NCT00562705|Hormones|hormones|mesh-list
153774868|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774869|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
153774870|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774871|NCT04620616|Menthol|menthol|mesh-list
153774872|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
153774873|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774874|NCT00220532|Folic Acid|folic acid|mesh-list
153774875|NCT00220532|Riboflavin|riboflavin|mesh-list
153774876|NCT00220532|Hematinics|hematinics|mesh-ancestor
153774877|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
153774878|NCT00220532|Vitamins|vitamins|mesh-ancestor
153774879|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
153774893|NCT00243204|Docetaxel|docetaxel|mesh-list
153774894|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774895|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
153774896|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
153774897|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
153774898|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774899|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153774900|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774901|NCT04620031|Propofol|propofol|mesh-list
153774902|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153774903|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774904|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774905|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153774906|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
153774907|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
153774908|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153774910|NCT00220649|Leucovorin|leucovorin|mesh-list
153774911|NCT00220649|Gemcitabine|gemcitabine|mesh-list
153774912|NCT00220649|Fluorouracil|fluorouracil|mesh-list
153774913|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
153774914|NCT00220649|Irinotecan|irinotecan|mesh-list
153774915|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153774916|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
153774917|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774918|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774919|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774921|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774922|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153774923|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153774924|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774925|NCT00220649|Antidotes|antidotes|mesh-ancestor
153798055|NCT00416039|Midazolam|midazolam|mesh-list
153774972|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153774973|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153774974|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774975|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
153774976|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774977|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774978|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
153774990|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774991|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774992|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
153774993|NCT00220922|Ethanol|ethanol|mesh-list
153774994|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153774995|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774996|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774997|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774998|NCT00221000|Methoxsalen|methoxsalen|mesh-list
153774999|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153775000|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775001|NCT00243477|Escitalopram|escitalopram|mesh-list
153775002|NCT00243477|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153775003|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153775004|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153775015|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775017|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153775018|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775019|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775020|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153775021|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775022|NCT04617613|Amoxicillin|amoxicillin|mesh-list
153775023|NCT04617613|Metronidazole|metronidazole|mesh-list
153775024|NCT04617613|Clarithromycin|clarithromycin|mesh-list
153775025|NCT04617613|Omeprazole|omeprazole|mesh-list
153775026|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153775027|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775028|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153775029|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153775030|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153775031|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775032|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153775033|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775034|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775035|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153775036|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153775037|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153775038|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
153775039|NCT04617652|Analgesics|analgesics|mesh-ancestor
153775040|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
153775041|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775042|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775043|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
153775044|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775045|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153775046|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
153775047|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153775048|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419305|NCT04966663|Nivolumab|nivolumab|mesh-list
153775049|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775064|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775066|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153775084|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
153775085|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
153775086|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775087|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775088|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775089|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
153775090|NCT00247650|Letrozole|letrozole|mesh-list
153775091|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775092|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153775093|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153775094|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775095|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775096|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153775097|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
153775098|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775099|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775100|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153775101|NCT00563017|Risperidone|risperidone|mesh-list
153775102|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153775103|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
153775104|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775105|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775106|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775107|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153775108|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153775109|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775110|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153775111|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153775112|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
153775113|NCT00563056|Fluticasone|fluticasone|mesh-list
153775114|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
153775115|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153775116|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
153775117|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745638|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
153775118|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775119|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153775120|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
153775121|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153775138|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153775139|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775140|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775141|NCT00563212|Interferons|interferons|mesh-list
153775142|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
153775143|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775144|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
153775145|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775146|NCT00563251|Azithromycin|azithromycin|mesh-list
153775147|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153775148|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775149|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153775150|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153775151|NCT00251082|Estradiol|estradiol|mesh-list
153775152|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153775153|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
153775154|NCT00251082|Estrogens|estrogens|mesh-ancestor
153775155|NCT00251082|Hormones|hormones|mesh-ancestor
153775156|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775157|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775158|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153775159|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
153775160|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153775161|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153775162|NCT00251082|Progestins|progestins|mesh-ancestor
153775163|NCT00221624|Ribavirin|ribavirin|mesh-list
153775164|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153775165|NCT00221624|Amantadine|amantadine|mesh-list
153775166|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
153775167|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419324|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
153907954|NCT00966940|Travoprost|travoprost|mesh-list
153775168|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
153775169|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775170|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153775171|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153775172|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
153775173|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775174|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775175|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153775176|NCT00221624|Analgesics|analgesics|mesh-ancestor
153775177|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
153775178|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775179|NCT06178211|Paclitaxel|paclitaxel|mesh-list
153775180|NCT06178211|Carboplatin|carboplatin|mesh-list
153775181|NCT06178211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153775182|NCT06178211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775183|NCT06178211|Tubulin Modulators|tubulin modulators|mesh-ancestor
153775184|NCT06178211|Antimitotic Agents|antimitotic agents|mesh-ancestor
153775185|NCT06178211|Mitosis Modulators|mitosis modulators|mesh-ancestor
153775186|NCT06178211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775187|NCT06178159|Pertuzumab|pertuzumab|mesh-list
153775188|NCT06178159|Disitamab vedotin|disitamab vedotin|mesh-list
153775189|NCT06178159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775207|NCT06178146|Immunologic Factors|immunologic factors|mesh-ancestor
153775208|NCT06178146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153775209|NCT06178146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775210|NCT06178146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775211|NCT06178146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153612412|NCT01954043|Rifampin|rifampin|mesh-list
153775212|NCT06178146|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153775213|NCT06178146|Antitubercular Agents|antitubercular agents|mesh-ancestor
153775214|NCT06178146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153775215|NCT06178146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775216|NCT06178146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153775217|NCT06178068|Bronchodilator Agents|bronchodilator agents|mesh-list
153775218|NCT06178068|Autonomic Agents|autonomic agents|mesh-ancestor
153775241|NCT06177522|Mitosis Modulators|mitosis modulators|mesh-ancestor
153775242|NCT06177522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775243|NCT06177522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153775244|NCT06177522|Antimetabolites|antimetabolites|mesh-ancestor
153775245|NCT06177496|Sorafenib|sorafenib|mesh-list
153775246|NCT06177496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775247|NCT06177496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153775248|NCT06177496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775260|NCT06177288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775261|NCT06177288|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153775262|NCT06177288|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153775263|NCT06177288|Growth Substances|growth substances|mesh-ancestor
153775264|NCT06177288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775265|NCT06177288|Growth Inhibitors|growth inhibitors|mesh-ancestor
153775267|NCT06177249|Immunologic Factors|immunologic factors|mesh-ancestor
153775268|NCT06177249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775269|NCT06177197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153775270|NCT06177171|Olaparib|olaparib|mesh-list
153775271|NCT06177171|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153775272|NCT06177171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153775273|NCT06177171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775274|NCT06177171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775275|NCT06177171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775276|NCT06177171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153775277|NCT06177171|Antimetabolites|antimetabolites|mesh-ancestor
153775278|NCT06177119|Amoxicillin|amoxicillin|mesh-list
153775279|NCT06177119|Metronidazole|metronidazole|mesh-list
153775280|NCT06177119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153775281|NCT06177119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775282|NCT06177119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153775339|NCT06176781|Edaravone|edaravone|mesh-list
153775340|NCT06176781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153775341|NCT06176781|Antioxidants|antioxidants|mesh-ancestor
153775342|NCT06176781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775343|NCT06176781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153775344|NCT06176781|Protective Agents|protective agents|mesh-ancestor
153775345|NCT06176781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775347|NCT06176729|Lenalidomide|lenalidomide|mesh-list
153775348|NCT06176729|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153775349|NCT06176729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775350|NCT06176729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775351|NCT06176729|Immunologic Factors|immunologic factors|mesh-ancestor
153775352|NCT06176729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775373|NCT06170463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775390|NCT06166394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775391|NCT06166394|Sensory System Agents|sensory system agents|mesh-ancestor
153775392|NCT06166394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775393|NCT06160713|Itraconazole|itraconazole|mesh-list
153775394|NCT06160713|Antifungal Agents|antifungal agents|mesh-ancestor
153775395|NCT06160713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775396|NCT06160713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153775397|NCT06160713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153775398|NCT06160713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775399|NCT06160713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775400|NCT06160713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153775401|NCT06160713|Hormone Antagonists|hormone antagonists|mesh-ancestor
153775402|NCT06160713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775403|NCT06160713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775404|NCT06160713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153775405|NCT06155318|Edotreotide|edotreotide|mesh-list
153775406|NCT06155318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153775407|NCT06155318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775408|NCT06154174|Amoxicillin|amoxicillin|mesh-list
153775409|NCT06154174|Choline|choline|mesh-list
153775410|NCT06154174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153775411|NCT06154174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775412|NCT06154174|Lipotropic Agents|lipotropic agents|mesh-ancestor
153775413|NCT06154174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153775414|NCT06154174|Antimetabolites|antimetabolites|mesh-ancestor
153775415|NCT06154174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775416|NCT06154174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775417|NCT06154174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153775418|NCT06154174|Nootropic Agents|nootropic agents|mesh-ancestor
153775419|NCT06140186|Betamethasone|betamethasone|mesh-list
153775420|NCT06140186|Betamethasone Valerate|betamethasone valerate|mesh-list
153798442|NCT00269867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775450|NCT06083948|Phenylephrine|phenylephrine|mesh-list
153775451|NCT06083948|Oxymetazoline|oxymetazoline|mesh-list
153775452|NCT06083948|Norepinephrine|norepinephrine|mesh-list
153775453|NCT06083948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153775454|NCT06083948|Mydriatics|mydriatics|mesh-ancestor
153775455|NCT06083948|Autonomic Agents|autonomic agents|mesh-ancestor
153775456|NCT06083948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775457|NCT06083948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775458|NCT06083948|Sympathomimetics|sympathomimetics|mesh-ancestor
153775459|NCT06083948|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153775460|NCT06083948|Nasal Decongestants|nasal decongestants|mesh-ancestor
153775461|NCT06083948|Respiratory System Agents|respiratory system agents|mesh-ancestor
153775462|NCT06083948|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153775463|NCT06083948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153775464|NCT06083948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153775465|NCT06083948|Adrenergic Agents|adrenergic agents|mesh-ancestor
153775466|NCT06083948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775467|NCT06083948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775468|NCT06083948|Protective Agents|protective agents|mesh-ancestor
153775469|NCT06082492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153775470|NCT06082492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153775471|NCT06082492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775472|NCT06081998|Histamine|histamine|mesh-list
153775473|NCT06081998|Histamine Agonists|histamine agonists|mesh-ancestor
153775474|NCT06081998|Histamine Agents|histamine agents|mesh-ancestor
153775475|NCT06081998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775476|NCT06081998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775477|NCT06081998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775478|NCT06062810|Crizotinib|crizotinib|mesh-list
153775479|NCT06062810|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153775480|NCT06062810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153775481|NCT06062810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775483|NCT06062810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775484|NCT06056050|Vaccines|vaccines|mesh-list
153775485|NCT06056050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153775486|NCT06056050|Immunologic Factors|immunologic factors|mesh-ancestor
153775487|NCT06056050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775488|NCT06035744|Pembrolizumab|pembrolizumab|mesh-list
153775489|NCT06035744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775490|NCT06035744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775512|NCT06015750|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775513|NCT06015750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775514|NCT06015750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153775515|NCT06015750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798500|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775562|NCT05837845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153775563|NCT05837845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153775564|NCT05837845|Adrenergic Agents|adrenergic agents|mesh-ancestor
153775565|NCT05739292|Vaccines|vaccines|mesh-list
153775566|NCT05739292|Immunologic Factors|immunologic factors|mesh-ancestor
153775567|NCT05739292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775568|NCT05677282|Azithromycin|azithromycin|mesh-list
153775578|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
153775579|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
153775580|NCT05654662|Protective Agents|protective agents|mesh-ancestor
153775581|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775582|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153775583|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775584|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
153775585|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775586|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153775587|NCT05497453|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153775588|NCT05497453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153775589|NCT05497453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775590|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775591|NCT05497453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775592|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775593|NCT05439772|Ondansetron|ondansetron|mesh-list
153775594|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
153775595|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
153775596|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775597|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775598|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775599|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
153775600|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775601|NCT05439772|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153775602|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153775613|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775614|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775615|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775616|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153775617|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775618|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153775619|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153775620|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
153775622|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
153775623|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775624|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775625|NCT05402111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153775626|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153775627|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153775628|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
153775629|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
153775630|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153775631|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153775632|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153775633|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153775634|NCT05362292|Mirabegron|mirabegron|mesh-list
153775635|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153775636|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153775637|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153775638|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153775639|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
153775640|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775641|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775642|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775643|NCT05362292|Urological Agents|urological agents|mesh-ancestor
153775644|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153775645|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153775693|NCT05136846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153775694|NCT05136846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153775695|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775696|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
153775697|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775698|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153775699|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
153775700|NCT05136846|Urological Agents|urological agents|mesh-ancestor
153775701|NCT05130463|Empagliflozin|empagliflozin|mesh-list
153775702|NCT05130463|Linagliptin|linagliptin|mesh-list
153775703|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153775704|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775705|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153345309|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
153775743|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153775744|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153775745|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153775746|NCT05089708|Trifarotene|trifarotene|mesh-list
153775747|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775748|NCT05088980|Lidocaine|lidocaine|mesh-list
153775749|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
153775750|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
153775751|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775752|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775753|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
153775754|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775755|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153798709|NCT00271427|Selenium|selenium|mesh-list
153775780|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
153775781|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153775782|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
153775783|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775784|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775785|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
153775786|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153775787|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153775788|NCT04981678|Buprenorphine|buprenorphine|mesh-list
153775789|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153775790|NCT04981678|Narcotics|narcotics|mesh-ancestor
153775791|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775792|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775793|NCT04981678|Analgesics|analgesics|mesh-ancestor
153775794|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
153775795|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775796|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153775797|NCT04970901|Obinutuzumab|obinutuzumab|mesh-list
153775798|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153775815|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747573|NCT00180102|Amsacrine|amsacrine|mesh-list
153775816|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775817|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153775819|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
153775820|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775821|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153775822|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153775854|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775855|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
153775856|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775857|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775858|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153775859|NCT04681105|Analgesics|analgesics|mesh-ancestor
153775877|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153775878|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153775879|NCT04614974|Famotidine|famotidine|mesh-list
153775880|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153775881|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263235|NCT05790486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153419418|NCT04503460|Hormones|hormones|mesh-ancestor
153775882|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153775883|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
153775884|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
153775885|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775886|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775908|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153775909|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
153775910|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775911|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153775912|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153775913|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
153775914|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775915|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775916|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153775917|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775939|NCT04392011|Midazolam|midazolam|mesh-list
153775940|NCT04392011|Levomethorphan|levomethorphan|mesh-list
153775941|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
153775942|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153775943|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153775944|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775945|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775946|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153775947|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153775948|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153775949|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153775950|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
153775951|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
153775952|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
153775953|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
153775954|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775955|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775956|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
153775957|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
153775958|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153775959|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153775960|NCT04392011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153775961|NCT04392011|Narcotics|narcotics|mesh-ancestor
153775962|NCT04392011|Analgesics|analgesics|mesh-ancestor
153775989|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
153775990|NCT04144933|Ketamine|ketamine|mesh-list
153775991|NCT04144933|Gabapentin|gabapentin|mesh-list
153775993|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
153775994|NCT04144933|Ondansetron|ondansetron|mesh-list
153775995|NCT04144933|Sevoflurane|sevoflurane|mesh-list
153775996|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153775997|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775998|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
153775999|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
153776000|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776001|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776002|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153776003|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
153776004|NCT04144933|Hormones|hormones|mesh-ancestor
153776005|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153776006|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153776007|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776008|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
153776009|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
153776010|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776011|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
153776012|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153776013|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153776014|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153776015|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153776016|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776017|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153776018|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776019|NCT04144933|Analgesics|analgesics|mesh-ancestor
153776020|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153776021|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153419440|NCT04150042|Ethanol|ethanol|mesh-list
153776022|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153776023|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
153776024|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776025|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153776026|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153776027|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
153776028|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153776029|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153776030|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
153776031|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153776032|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153776033|NCT04144933|Narcotics|narcotics|mesh-ancestor
153776034|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
153776064|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776065|NCT04082572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153776066|NCT04082572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776077|NCT03978598|Etonogestrel|etonogestrel|mesh-list
153776078|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153776079|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
153776080|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153776081|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776082|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153776083|NCT03951649|Acetaminophen|acetaminophen|mesh-list
153776084|NCT03951649|Caffeine|caffeine|mesh-list
153776085|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776086|NCT03951649|Analgesics|analgesics|mesh-ancestor
153776087|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
153776088|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776089|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776090|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
153776091|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153776092|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153776093|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776094|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776095|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153776096|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153776097|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
153776098|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776099|NCT03949855|Rituximab|rituximab|mesh-list
153776100|NCT03949855|Belimumab|belimumab|mesh-list
153776101|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776102|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776110|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776111|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776112|NCT03918915|Atropine|atropine|mesh-list
153776113|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153776114|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153776127|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776128|NCT03913455|Carboplatin|carboplatin|mesh-list
153776129|NCT03913455|Guadecitabine|guadecitabine|mesh-list
153776130|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776131|NCT03894891|Docetaxel|docetaxel|mesh-list
153776132|NCT03894891|Nivolumab|nivolumab|mesh-list
153776133|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776134|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776135|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776136|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776137|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776138|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776139|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153776140|NCT03883412|Liraglutide|liraglutide|mesh-list
153776141|NCT03883412|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153776142|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153776143|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776144|NCT03883412|Incretins|incretins|mesh-ancestor
153776145|NCT03883412|Hormones|hormones|mesh-ancestor
153776146|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153776147|NCT03864614|Zuranolone|zuranolone|mesh-list
153776148|NCT03864614|Antidepressive Agents|antidepressive agents|mesh-ancestor
153776149|NCT03864614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153776150|NCT03840837|Rivastigmine|rivastigmine|mesh-list
153776151|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153776153|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776154|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
153776155|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776156|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776157|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153776158|NCT03840837|Protective Agents|protective agents|mesh-ancestor
153776159|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
153776160|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776161|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776162|NCT03834493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153776163|NCT03834493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776164|NCT03770416|Nivolumab|nivolumab|mesh-list
153776165|NCT03770416|Ibrutinib|ibrutinib|mesh-list
153776166|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776167|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776168|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153776169|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776170|NCT03770416|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153776179|NCT03631043|Growth Substances|growth substances|mesh-ancestor
153776180|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
153776181|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776183|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153776184|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153776185|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153776186|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
153776201|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776203|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
153776204|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776205|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776206|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776207|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153776208|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
153776209|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153776210|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776211|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776212|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776213|NCT03564093|Analgesics|analgesics|mesh-ancestor
153776214|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
153776215|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776216|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153776217|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153776218|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153776219|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
153776220|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776221|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776222|NCT03482479|Naltrexone|naltrexone|mesh-list
153776223|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153776224|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153776225|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776226|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
153776227|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776228|NCT03449108|Aldesleukin|aldesleukin|mesh-list
153776229|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
153776230|NCT03449108|Nivolumab|nivolumab|mesh-list
153776231|NCT03449108|Fludarabine|fludarabine|mesh-list
153776232|NCT03449108|Ipilimumab|ipilimumab|mesh-list
153776233|NCT03449108|Interleukin-2|interleukin-2|mesh-list
153776234|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776235|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
153776236|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776237|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776238|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153776243|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776244|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153776245|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776246|NCT03449108|Analgesics|analgesics|mesh-ancestor
153776247|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
153776248|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776249|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153776250|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153776251|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
153776258|NCT03342404|Hematinics|hematinics|mesh-ancestor
153776259|NCT03277196|Ivacaftor|ivacaftor|mesh-list
153776261|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153776262|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776263|NCT03272698|Ketamine|ketamine|mesh-list
153776264|NCT03272698|Analgesics|analgesics|mesh-ancestor
153776265|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
153776266|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745640|NCT03283150|Propofol|propofol|mesh-list
153776267|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776268|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153776269|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153747889|NCT04689100|Antidotes|antidotes|mesh-ancestor
153776270|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
153776271|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
153776272|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776273|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153776274|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153776275|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776276|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776277|NCT03213457|Norethindrone|norethindrone|mesh-list
153776278|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
153776279|NCT03213457|Estradiol|estradiol|mesh-list
153776280|NCT03213457|Estrogens|estrogens|mesh-ancestor
153776281|NCT03213457|Hormones|hormones|mesh-ancestor
153776282|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153776283|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776284|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153776285|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
153776286|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153776287|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153776288|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153776289|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153776290|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153776291|NCT03198078|Aripiprazole|aripiprazole|mesh-list
153776292|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
153776293|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
153776294|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153776295|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153776296|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153776297|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776298|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776299|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
153776300|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
153776301|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776302|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776303|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153776304|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153776305|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
153776306|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153776307|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153776327|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153776328|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153776329|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
153776330|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776331|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776332|NCT02938442|Paclitaxel|paclitaxel|mesh-list
153776333|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153776334|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
153776335|NCT02938442|Doxorubicin|doxorubicin|mesh-list
153776336|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153776337|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153776338|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
153776343|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776344|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776345|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776346|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
153776347|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776348|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776349|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153776350|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
153776351|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153776352|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153776353|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153776354|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153776356|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153776357|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
153776358|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
153776359|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776360|NCT02910531|Protective Agents|protective agents|mesh-ancestor
153776361|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776371|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776372|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776373|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776374|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776375|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776376|NCT02883062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153776377|NCT02883062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776378|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
153776379|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776380|NCT02808650|Prexasertib|prexasertib|mesh-list
153776381|NCT02808650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776382|NCT02808650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776383|NCT02808650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776384|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
153776386|NCT02727803|Busulfan|busulfan|mesh-list
153776387|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
153776388|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153776389|NCT02727803|Rituximab|rituximab|mesh-list
153776390|NCT02727803|Fludarabine|fludarabine|mesh-list
153776391|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
153776392|NCT02727803|Clofarabine|clofarabine|mesh-list
153776393|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153776394|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153776395|NCT02727803|Antibodies|antibodies|mesh-list
153776396|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
153776397|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153776398|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776399|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
153776400|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776401|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776402|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153776403|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
153776404|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776405|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776406|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153776407|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153776408|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
153776409|NCT02630693|Tamoxifen|tamoxifen|mesh-list
153776410|NCT02630693|Fulvestrant|fulvestrant|mesh-list
153776411|NCT02630693|Palbociclib|palbociclib|mesh-list
153776412|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153776413|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153776414|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
153776415|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153776416|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799201|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153776453|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
153776454|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153776455|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153776456|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776457|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776458|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776459|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776460|NCT02484859|Metoprolol|metoprolol|mesh-list
153776461|NCT02484859|Remifentanil|remifentanil|mesh-list
153776462|NCT02484859|Tramadol|tramadol|mesh-list
153776463|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153776464|NCT02484859|Narcotics|narcotics|mesh-ancestor
153776465|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776466|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776467|NCT02484859|Analgesics|analgesics|mesh-ancestor
153776468|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
153776469|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776470|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153776471|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153776472|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
153776473|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
153776474|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153799282|NCT00274001|Nevirapine|nevirapine|mesh-list
153776529|NCT02229084|Doxorubicin|doxorubicin|mesh-list
153776530|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153776531|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
153776532|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776533|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776534|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776535|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776536|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776537|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776538|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776548|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776549|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153776550|NCT02213497|Paclitaxel|paclitaxel|mesh-list
153776551|NCT02213497|Carboplatin|carboplatin|mesh-list
153776565|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153776566|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153776567|NCT01750073|Antibodies|antibodies|mesh-list
153776568|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
153776569|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153613737|NCT01964157|Ceritinib|ceritinib|mesh-list
153776570|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776571|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776573|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776574|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776575|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776576|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776577|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
153776578|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776579|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776580|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153776581|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
153776582|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153776583|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153776584|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153776585|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153776586|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776587|NCT01723774|Anastrozole|anastrozole|mesh-list
153776588|NCT01723774|Goserelin|goserelin|mesh-list
153776589|NCT01723774|Palbociclib|palbociclib|mesh-list
153776590|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153776591|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776592|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153776593|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153776594|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776595|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776596|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153776597|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
153776598|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153776599|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776600|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776601|NCT01674140|Tamoxifen|tamoxifen|mesh-list
153776602|NCT01674140|Everolimus|everolimus|mesh-list
153776603|NCT01674140|Letrozole|letrozole|mesh-list
153776604|NCT01674140|Anastrozole|anastrozole|mesh-list
153776605|NCT01674140|Leuprolide|leuprolide|mesh-list
153776606|NCT01674140|Exemestane|exemestane|mesh-list
153776607|NCT01674140|Goserelin|goserelin|mesh-list
153776608|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776609|NCT01674140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153776610|NCT01674140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776611|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776612|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776613|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
153776614|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776615|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776627|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153776629|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799367|NCT00274235|Mefloquine|mefloquine|mesh-list
153776661|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153776662|NCT00439049|Naltrexone|naltrexone|mesh-list
153776663|NCT00439049|Modafinil|modafinil|mesh-list
153776664|NCT00439049|Amphetamine|amphetamine|mesh-list
153776665|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
153776666|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153776667|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153776668|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776669|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
153776671|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153776672|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153776673|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153799425|NCT00274391|Amiloride|amiloride|mesh-list
153776697|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776698|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
153776699|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153776700|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
153776701|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776702|NCT04615702|Acetaminophen|acetaminophen|mesh-list
153776703|NCT04615702|Metronidazole|metronidazole|mesh-list
153776704|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
153776705|NCT04615702|Imipenem|imipenem|mesh-list
153776706|NCT04615702|Diclofenac|diclofenac|mesh-list
153776707|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153776708|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
153776709|NCT04615702|Secretin|secretin|mesh-list
153776710|NCT04615702|Bilirubin|bilirubin|mesh-list
153776711|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776712|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776713|NCT04615702|Analgesics|analgesics|mesh-ancestor
153776714|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
153776715|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776716|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
153776717|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776718|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153776719|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153776720|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153776721|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153776722|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776723|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153776724|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776725|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776726|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153776727|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153776728|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776729|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153776730|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153776731|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153776732|NCT04615702|Narcotics|narcotics|mesh-ancestor
153776733|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776734|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153776735|NCT04615702|Hormones|hormones|mesh-ancestor
153776736|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153776737|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
153776738|NCT04615702|Protective Agents|protective agents|mesh-ancestor
153776739|NCT04615351|Metformin|metformin|mesh-list
153776740|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153776756|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
153776757|NCT04614259|Bupivacaine|bupivacaine|mesh-list
153776758|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
153776759|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
153776760|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776761|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776762|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
153776763|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776765|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
153776766|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776767|NCT00412763|Protective Agents|protective agents|mesh-ancestor
153776768|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776769|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
153776781|NCT00563485|Urological Agents|urological agents|mesh-ancestor
153776782|NCT00251277|Rituximab|rituximab|mesh-list
153776783|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776784|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776785|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
153776786|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776787|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776788|NCT00412802|Enoxaparin|enoxaparin|mesh-list
153776789|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
153776790|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
153776791|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153776792|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153776793|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776794|NCT00563524|Fezakinumab|fezakinumab|mesh-list
153776795|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
153776796|NCT04613869|Hydromorphone|hydromorphone|mesh-list
153776797|NCT04613869|Esketamine|esketamine|mesh-list
153776798|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153776800|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776801|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776802|NCT04613869|Analgesics|analgesics|mesh-ancestor
153776803|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
153776818|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153776819|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776820|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153776822|NCT04613167|Alirocumab|alirocumab|mesh-list
153776823|NCT04613167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153776824|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153776825|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153776826|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
153776827|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776828|NCT04613167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153776829|NCT04613167|Protease Inhibitors|protease inhibitors|mesh-ancestor
153776830|NCT04613167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776831|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153776832|NCT04613284|Durvalumab|durvalumab|mesh-list
153776833|NCT04613284|Endostar protein|endostar protein|mesh-list
153776834|NCT04613284|Endostatins|endostatins|mesh-list
153776835|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776836|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776837|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153776838|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153776839|NCT04613284|Growth Substances|growth substances|mesh-ancestor
153776840|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776841|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
153776842|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153776843|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
153776844|NCT00248118|Bupropion|bupropion|mesh-list
153776845|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153776846|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
153776847|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153776848|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153776849|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153799533|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
153748454|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
153776890|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
153776891|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776892|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776893|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153776894|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
153776895|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776896|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776897|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153776898|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
153776899|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153776900|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776901|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153776902|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153776903|NCT04612582|Growth Substances|growth substances|mesh-ancestor
153776904|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
153776905|NCT00248157|Octreotide|octreotide|mesh-list
153776906|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153776907|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153776908|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776909|NCT00251472|Paclitaxel|paclitaxel|mesh-list
153776910|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776911|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776912|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776913|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776914|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776915|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776916|NCT00222053|Diphosphonates|diphosphonates|mesh-list
153776917|NCT00222053|Thalidomide|thalidomide|mesh-list
153776918|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776919|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
153776933|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
153776947|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153776948|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153776949|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776950|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776951|NCT04611724|Folfirinox|folfirinox|mesh-list
153908264|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153776952|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776954|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153776955|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
153776956|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776957|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776958|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776959|NCT00563836|Catumaxomab|catumaxomab|mesh-list
153776960|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153776961|NCT00563875|Aspirin|aspirin|mesh-list
153776962|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153776963|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776964|NCT00563875|Analgesics|analgesics|mesh-ancestor
153776965|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
153776966|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776967|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776968|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153776969|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776970|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153776971|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153776972|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776973|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153776974|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153776975|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776976|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
153776977|NCT04611685|Parecoxib|parecoxib|mesh-list
153776978|NCT04611685|Loxoprofen|loxoprofen|mesh-list
153776979|NCT04611685|Tramadol|tramadol|mesh-list
153776980|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153776992|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776993|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153776994|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776995|NCT00563914|Amodiaquine|amodiaquine|mesh-list
153776996|NCT00563914|Ferroquine|ferroquine|mesh-list
153776997|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
153776998|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153776999|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153777000|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777001|NCT00563953|Doxorubicin|doxorubicin|mesh-list
153777002|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153777003|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777004|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153777005|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153777022|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777023|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153777024|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153777026|NCT04611373|Acetazolamide|acetazolamide|mesh-list
153777027|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
153777028|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153777029|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777030|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777031|NCT04611373|Diuretics|diuretics|mesh-ancestor
153777032|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
153777033|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777034|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153777035|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
153777036|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
153777037|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
153777038|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153777039|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777040|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153777041|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153777042|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
153777043|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153777058|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153777059|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153777060|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777061|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
153777062|NCT04610164|Coagulants|coagulants|mesh-ancestor
153777064|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153777065|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153777066|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777067|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777069|NCT00222482|Valproic Acid|valproic acid|mesh-list
153777070|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
153777071|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777072|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777073|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
153777074|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777075|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777076|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
153777077|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153777078|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777095|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153777096|NCT00564148|Growth Substances|growth substances|mesh-ancestor
153777097|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777098|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
153777099|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
153777100|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153777101|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777102|NCT04609540|Trastuzumab|trastuzumab|mesh-list
153777103|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153777117|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777118|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153777119|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153777120|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153777121|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777122|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153777123|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153777124|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777125|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
153777126|NCT00564460|Finasteride|finasteride|mesh-list
153777127|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153777128|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153777129|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777130|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777131|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
153777132|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777133|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777134|NCT00564460|Urological Agents|urological agents|mesh-ancestor
153777135|NCT04609033|Ketamine|ketamine|mesh-list
153777136|NCT04609033|Morphine|morphine|mesh-list
153777137|NCT04609033|Bupivacaine|bupivacaine|mesh-list
153777138|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
153777139|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
153777140|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777141|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777142|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
153777143|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777144|NCT04609033|Analgesics|analgesics|mesh-ancestor
153777145|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153777146|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153777147|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
153777148|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153799782|NCT00315744|Xhance|xhance|mesh-list
153777162|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777170|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777172|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
153777173|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153777174|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
153777175|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777176|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777177|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153777178|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
153777179|NCT00222833|Aripiprazole|aripiprazole|mesh-list
153777180|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
153777181|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777182|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153777183|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153777184|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777185|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777186|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
153777187|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
153777188|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263236|NCT05790486|Cholinergic Agents|cholinergic agents|mesh-ancestor
154263237|NCT05790486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908318|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
153777189|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777190|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153777191|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153777192|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
153777193|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153777194|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153777195|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153777196|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153777197|NCT00564538|Tacrolimus|tacrolimus|mesh-list
153777198|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
153777199|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153777200|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777201|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
153777202|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777203|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153777204|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777205|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777206|NCT00251706|Amiodarone|amiodarone|mesh-list
153777207|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153777208|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
153777209|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153777210|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153777211|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777212|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153777213|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153777214|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153777215|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799826|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153777249|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777250|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153777251|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
153777252|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
153777254|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777255|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153777256|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153777257|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153777258|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
153777259|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777260|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777261|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153777262|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
153777263|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
153777264|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
153777265|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153777266|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153777267|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777268|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777269|NCT00251784|Urological Agents|urological agents|mesh-ancestor
153777270|NCT00248430|Aldesleukin|aldesleukin|mesh-list
153777271|NCT00248430|Melphalan|melphalan|mesh-list
153777272|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153777273|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
153777274|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777275|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777276|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153777277|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777278|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
153777279|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777280|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153777281|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153777282|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
153777283|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777299|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153777300|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153777301|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
153777302|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153777303|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
153777327|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153777328|NCT04605952|Antibodies|antibodies|mesh-list
153777329|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
153748780|NCT00536653|Vitamin D|vitamin d|mesh-list
153777330|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
153777331|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777332|NCT04605562|Palbociclib|palbociclib|mesh-list
153777333|NCT04605562|Antibodies|antibodies|mesh-list
153777334|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
153777335|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
153777336|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777337|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777338|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153777339|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777340|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777341|NCT00251901|Esomeprazole|esomeprazole|mesh-list
153777342|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153777343|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777359|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153777360|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153777362|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153777363|NCT00251940|Glyburide|glyburide|mesh-list
153777364|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153777365|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777366|NCT04604938|Losartan|losartan|mesh-list
153777367|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153777368|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153777369|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153777370|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153777412|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153777413|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777414|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153777415|NCT04603729|Protective Agents|protective agents|mesh-ancestor
153777416|NCT04603573|Listerine|listerine|mesh-list
153777417|NCT04603573|Fluorides|fluorides|mesh-list
153777418|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
153777419|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
153777420|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
153777421|NCT04603573|Protective Agents|protective agents|mesh-ancestor
153799999|NCT00279617|Levetiracetam|levetiracetam|mesh-list
153777438|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777440|NCT04603456|Antacids|antacids|mesh-ancestor
153748820|NCT00156884|Cisplatin|cisplatin|mesh-list
153777441|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777442|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777443|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
153777444|NCT00252291|Miotics|miotics|mesh-ancestor
153777445|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
153777446|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777447|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777448|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153777449|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153777450|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
153777451|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153777452|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153777453|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
153777454|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777455|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777456|NCT00565240|Letrozole|letrozole|mesh-list
153777457|NCT00565240|NuvaRing|nuvaring|mesh-list
153777458|NCT00565240|Desogestrel|desogestrel|mesh-list
153777459|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777460|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153777461|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153777462|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777463|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777464|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153614633|NCT01969357|Incretins|incretins|mesh-ancestor
153777465|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
153777466|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777467|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777476|NCT00565240|Hormones|hormones|mesh-ancestor
153777477|NCT04602247|Fesoterodine|fesoterodine|mesh-list
153777478|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153777479|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153777480|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
153777481|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777482|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777483|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777507|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153777508|NCT04601701|Growth Substances|growth substances|mesh-ancestor
153777509|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777510|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
153777511|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777513|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
153777514|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777515|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777516|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
153777517|NCT04601701|Hormones|hormones|mesh-ancestor
153777518|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777519|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153777520|NCT00252369|Infliximab|infliximab|mesh-list
153777521|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153777522|NCT00252369|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153777523|NCT00252369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777524|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
153777525|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777526|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153777527|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
153777528|NCT00252369|Coagulants|coagulants|mesh-ancestor
153777529|NCT00565318|Benphothiamine|benphothiamine|mesh-list
153777530|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153777531|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
153777532|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800100|NCT00316563|Hormones|hormones|mesh-ancestor
153777557|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153777558|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153777559|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777560|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153777561|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
153777562|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777563|NCT04601116|Atorvastatin|atorvastatin|mesh-list
153777564|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153777565|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153777566|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
153777567|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777568|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153777569|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153777570|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777571|NCT00249132|Risperidone|risperidone|mesh-list
153777572|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153777573|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
153777574|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777575|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777576|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777577|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153777578|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153777579|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777580|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777581|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153777582|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
153777583|NCT04600492|Riociguat|riociguat|mesh-list
153777584|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
153777585|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777586|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
153777587|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359905|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153777588|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777589|NCT00414687|Iloprost|iloprost|mesh-list
153777590|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153777591|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
153777592|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
153777593|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153777607|NCT00565591|Albuterol|albuterol|mesh-list
153777608|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153777609|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
153735863|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153777610|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777611|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777612|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153777613|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
153777614|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
153614777|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
153777615|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153777616|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153777617|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153777618|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153777619|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
153800149|NCT00316680|Vaccines|vaccines|mesh-list
153777643|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
153777644|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153777645|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777646|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153777647|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153777648|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153777649|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153777650|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
153777651|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777652|NCT04598542|Triamcinolone|triamcinolone|mesh-list
153777660|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777661|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777662|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777663|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
153777664|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777665|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777666|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153777667|NCT04995263|Caffeine|caffeine|mesh-list
153777668|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153777669|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777670|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153777671|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777672|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777673|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153777682|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153777683|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
153777684|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777685|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777686|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777687|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153777689|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777690|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777691|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153777692|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
153777693|NCT00565981|Fludarabine|fludarabine|mesh-list
153777694|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
153777695|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
153777696|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777697|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153777698|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
153777699|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777700|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777701|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
153777702|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777703|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153777704|NCT04952519|Amantadine|amantadine|mesh-list
153777705|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153777706|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153777707|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
153777708|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777709|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
153777710|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777711|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777712|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777713|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153777714|NCT04952519|Analgesics|analgesics|mesh-ancestor
153777715|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
153777716|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777717|NCT00414921|Clonidine|clonidine|mesh-list
153419696|NCT00374647|Sirolimus|sirolimus|mesh-list
153777718|NCT00414921|Methylphenidate|methylphenidate|mesh-list
153777719|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153777720|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777734|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153777735|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153777736|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
153777737|NCT04597762|Cyclosporine|cyclosporine|mesh-list
153777738|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
153777739|NCT04597762|Cyclosporins|cyclosporins|mesh-list
153777740|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777741|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777742|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777743|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
153777744|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777745|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
153777746|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777747|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
153777748|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153777749|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153777750|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777751|NCT00249210|Levofloxacin|levofloxacin|mesh-list
153777752|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153777753|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800264|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
153777779|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777780|NCT00566332|Fludarabine|fludarabine|mesh-list
153777787|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153777788|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
153777789|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777790|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153777791|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153777792|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153777793|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153777794|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777795|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
153777796|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777797|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777799|NCT04595929|Docetaxel|docetaxel|mesh-list
153777800|NCT04595929|Fluorouracil|fluorouracil|mesh-list
153777801|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
153777802|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777803|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
153777804|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
153777805|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
153800327|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
153777827|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153777828|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
153777829|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153777830|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777831|NCT04595812|Coagulants|coagulants|mesh-ancestor
153777832|NCT00249366|Lorazepam|lorazepam|mesh-list
153777833|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
153777834|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
153777835|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
153777836|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777837|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777838|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777839|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153777840|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777842|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153777843|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777844|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
153777845|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
153777846|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749209|NCT00182871|Hormones|hormones|mesh-ancestor
153359907|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
153777847|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777848|NCT04635683|Lenalidomide|lenalidomide|mesh-list
153777849|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
153777850|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777851|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153777874|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153777875|NCT00253110|Haloperidol|haloperidol|mesh-list
153777876|NCT00253110|Risperidone|risperidone|mesh-list
153908484|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
153777877|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
153777878|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153777879|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
153777880|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777881|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777882|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777883|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153777884|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153800382|NCT00416897|Hormones|hormones|mesh-ancestor
153777902|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
153777916|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153777917|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153777918|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777919|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
153777920|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
153777921|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777922|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777923|NCT00566761|Triamcinolone|triamcinolone|mesh-list
153777924|NCT00566761|Bevacizumab|bevacizumab|mesh-list
153777925|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153777926|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777927|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153777928|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153777929|NCT00566761|Growth Substances|growth substances|mesh-ancestor
153777930|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777931|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
153777932|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777933|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
153777934|NCT00566761|Hormones|hormones|mesh-ancestor
153777935|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777936|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153777937|NCT00566800|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153777938|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153777939|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777940|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777941|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777942|NCT04593706|Dexamethasone|dexamethasone|mesh-list
153777943|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
153777944|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153777945|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153777946|NCT04593706|Prednisolone|prednisolone|mesh-list
153777947|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
153777948|NCT04593706|Triamcinolone|triamcinolone|mesh-list
153777949|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153777950|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153777951|NCT04593706|Betamethasone|betamethasone|mesh-list
153777952|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
153777953|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153777954|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
153777955|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
153777956|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
153777957|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153777958|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
153777959|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153778001|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778003|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153778004|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
153778005|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778006|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778007|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778008|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153778009|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778010|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778011|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778012|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153778013|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
153778014|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153778015|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153778016|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153778017|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778018|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778019|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735864|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153778020|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778021|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153778049|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778050|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778051|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
153778052|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778064|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778065|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778066|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153778074|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778075|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153778076|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778078|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
153778079|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778080|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153778081|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153778082|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778083|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778084|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778085|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
153778086|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778088|NCT04592029|Bevacizumab|bevacizumab|mesh-list
153778089|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153778090|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778091|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778092|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153778093|NCT04592029|Growth Substances|growth substances|mesh-ancestor
153778094|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778095|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
153778096|NCT00253227|Galantamine|galantamine|mesh-list
153778097|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153778098|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778099|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778100|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
153778101|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778102|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778103|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153778104|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
153778105|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778106|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
153778107|NCT04591444|Fluorides|fluorides|mesh-list
153778108|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
153778109|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
153778110|NCT04591444|Protective Agents|protective agents|mesh-ancestor
153778111|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778112|NCT04591327|Anesthetics|anesthetics|mesh-list
153778113|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778114|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778115|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153778116|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153778117|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
153778118|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778119|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153778120|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778142|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778143|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778144|NCT00253344|Docetaxel|docetaxel|mesh-list
153778145|NCT00253344|Lenalidomide|lenalidomide|mesh-list
153778146|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778147|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
153778148|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
153778149|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
153778150|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778151|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
153778152|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778153|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778154|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153778155|NCT00253344|Growth Substances|growth substances|mesh-ancestor
153778156|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
153778157|NCT00567463|Fluticasone|fluticasone|mesh-list
154263238|NCT05790486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749423|NCT00158483|Acyclovir|acyclovir|mesh-list
153778158|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778159|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153778160|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
153778161|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778162|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778163|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153778164|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
153778165|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
153778166|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153778167|NCT00253422|Fulvestrant|fulvestrant|mesh-list
153778168|NCT00253422|Anastrozole|anastrozole|mesh-list
153778169|NCT00253422|Exemestane|exemestane|mesh-list
153778170|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153778171|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778172|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153778173|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153778174|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
153778175|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153778176|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778177|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153778178|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153778179|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778180|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778181|NCT04590625|Carboplatin|carboplatin|mesh-list
153778182|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153778183|NCT04590625|Apatinib|apatinib|mesh-list
153778184|NCT04590625|Cisplatin|cisplatin|mesh-list
153778185|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778186|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778187|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153778188|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778189|NCT00253461|Topotecan|topotecan|mesh-list
153778190|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153778191|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153778192|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153778222|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
153778223|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778224|NCT00253500|Epirubicin|epirubicin|mesh-list
153778225|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153778226|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778227|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153778228|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153778229|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778230|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778231|NCT04588987|Apatinib|apatinib|mesh-list
153778232|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778233|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153778234|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778235|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778236|NCT00253539|Tamoxifen|tamoxifen|mesh-list
153778237|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153778238|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
153778239|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153778240|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778241|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153778242|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778243|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153778244|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153778245|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153778246|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
153778247|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778248|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
153778249|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
153778250|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
153778251|NCT00567775|Insulin|insulin|mesh-list
153778252|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153778253|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153778254|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778255|NCT00567814|Oxazepam|oxazepam|mesh-list
153778256|NCT00567814|Metyrapone|metyrapone|mesh-list
153778276|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778277|NCT00253578|Sorafenib|sorafenib|mesh-list
153778278|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778303|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153778304|NCT04587115|Narcotics|narcotics|mesh-ancestor
153778305|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778306|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778307|NCT04587115|Analgesics|analgesics|mesh-ancestor
153778308|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
153778309|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778310|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153778311|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
153778312|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778313|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778314|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153778315|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778328|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153778329|NCT00253773|Analgesics|analgesics|mesh-ancestor
153778330|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
153778331|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778332|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778333|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
153778334|NCT00403286|Fluticasone|fluticasone|mesh-list
153778335|NCT00403286|Xhance|xhance|mesh-list
153778336|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
153778337|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153778338|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778339|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153778340|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
153778341|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778342|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778343|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153778353|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153778354|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153778355|NCT04585867|Bupivacaine|bupivacaine|mesh-list
153615526|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
153778356|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
153778357|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
153778358|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778360|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
153778361|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778362|NCT00253851|Heparin|heparin|mesh-list
153778363|NCT00253851|Calcium heparin|calcium heparin|mesh-list
153778364|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
153778365|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153778366|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153778367|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778368|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153778369|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153778370|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153778371|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
153778372|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778373|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153778374|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153778375|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778376|NCT04585438|Diclofenac|diclofenac|mesh-list
153749533|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778377|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153778378|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153778379|NCT04585438|Analgesics|analgesics|mesh-ancestor
153778380|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
153778381|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778382|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778394|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778395|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
153778396|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153778397|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778398|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153778399|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
153778400|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153778401|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778402|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778403|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778405|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154263239|NCT05780151|Insulin Glargine|insulin glargine|mesh-list
154263240|NCT05780151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154263241|NCT05780151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263242|NCT05769478|Amifampridine|amifampridine|mesh-list
154263243|NCT05769478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154263244|NCT05769478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263245|NCT05769478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778406|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153778407|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153778408|NCT04585321|Analgesics|analgesics|mesh-ancestor
153778409|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
153778410|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778411|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778412|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778413|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153778414|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153778415|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778416|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778417|NCT00412997|Panobinostat|panobinostat|mesh-list
153778418|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778457|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778458|NCT04584580|Heparin|heparin|mesh-list
153778459|NCT04584580|Enoxaparin|enoxaparin|mesh-list
153778460|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153778461|NCT04584580|Tinzaparin|tinzaparin|mesh-list
153778462|NCT04584580|Dalteparin|dalteparin|mesh-list
153778463|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
153778464|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153778465|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153778466|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778467|NCT00250029|Capecitabine|capecitabine|mesh-list
153778468|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
153778469|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153778470|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
153778471|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778472|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778473|NCT00223418|Aripiprazole|aripiprazole|mesh-list
153778474|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
153778475|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778476|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153800836|NCT00284024|Domperidone|domperidone|mesh-list
153778490|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153778491|NCT04584736|Ezetimibe|ezetimibe|mesh-list
153778492|NCT04584736|Pitavastatin|pitavastatin|mesh-list
153778493|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153778494|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153778495|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
153778496|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778497|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153778498|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153778499|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778500|NCT00250068|Rubitecan|rubitecan|mesh-list
153778501|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778502|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153615676|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
153778503|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153778504|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778505|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778506|NCT04584307|Pomalidomide|pomalidomide|mesh-list
153778507|NCT04584307|Elotuzumab|elotuzumab|mesh-list
153778520|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153778521|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
153778523|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153778524|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153778525|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153778526|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153778527|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
153778528|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778529|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778530|NCT04583410|Nicotine|nicotine|mesh-list
153778531|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153778532|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
153778533|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778534|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778535|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153778536|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153778537|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
153778538|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778539|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778540|NCT00254007|Citalopram|citalopram|mesh-list
153778541|NCT00254007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153778542|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153778543|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778544|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778545|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778546|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
153778637|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153749673|NCT00537472|Anesthetics|anesthetics|mesh-list
153778638|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153778639|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153778640|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
153778641|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
153778642|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153778643|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153778644|NCT00223691|Diuretics|diuretics|mesh-ancestor
153778645|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
153778646|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153778647|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153778648|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153778649|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
153778650|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153778651|NCT00223691|Protective Agents|protective agents|mesh-ancestor
153778652|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
153778653|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153778654|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153778655|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153778656|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153778657|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153778658|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
153778659|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
153778660|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153778661|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153778662|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
153778663|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
153778664|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153778685|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153778686|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778687|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778688|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778689|NCT04582786|Morphine|morphine|mesh-list
153778690|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153778691|NCT04582786|Narcotics|narcotics|mesh-ancestor
153778692|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778693|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778694|NCT04582786|Analgesics|analgesics|mesh-ancestor
153778695|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
153778696|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778697|NCT00223769|Oxandrolone|oxandrolone|mesh-list
153778708|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778709|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778710|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778711|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153778712|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153778713|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153778714|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
153778715|NCT00254046|Etravirine|etravirine|mesh-list
153778716|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153778717|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153778718|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778719|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778720|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
153778721|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778722|NCT00223925|Maribavir|maribavir|mesh-list
153778723|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
153778724|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778725|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
153749732|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
153778726|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153778727|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778728|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
153778729|NCT04581967|Doxorubicin|doxorubicin|mesh-list
153778775|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153778776|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
153778777|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
153801105|NCT00319566|Hormones|hormones|mesh-ancestor
153778787|NCT00415116|Carboplatin|carboplatin|mesh-list
153778788|NCT00415116|Docetaxel|docetaxel|mesh-list
153778789|NCT00415116|Lenalidomide|lenalidomide|mesh-list
153778790|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778791|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
153778792|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
153778793|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
153778794|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778795|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
153778796|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778797|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778798|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153778799|NCT00415116|Growth Substances|growth substances|mesh-ancestor
153778800|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
153778801|NCT00568750|Dasatinib|dasatinib|mesh-list
153778802|NCT00568750|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153778803|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153778804|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778805|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778806|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778807|NCT00568789|Zolpidem|zolpidem|mesh-list
153778808|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153778809|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153778810|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778811|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778812|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153778813|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
153778814|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
153778815|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778816|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778817|NCT00254202|Iloperidone|iloperidone|mesh-list
153778818|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153778819|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778820|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778821|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778822|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778823|NCT00568984|Metformin|metformin|mesh-list
153778824|NCT00568984|Repaglinide|repaglinide|mesh-list
153778825|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153778826|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778827|NCT00254241|Risperidone|risperidone|mesh-list
153778828|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153778838|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153586926|NCT01776853|Levan|levan|mesh-list
153778839|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
153778840|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
153778841|NCT00224315|Risperidone|risperidone|mesh-list
153778842|NCT00224315|Ziprasidone|ziprasidone|mesh-list
153778843|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153778844|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
153778845|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778846|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778847|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778848|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153778849|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778850|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778862|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
153778863|NCT00224354|Immunotoxins|immunotoxins|mesh-list
153778864|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778865|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153778866|NCT00224354|Analgesics|analgesics|mesh-ancestor
153778867|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
153778868|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778869|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778870|NCT00224354|Immunoconjugates|immunoconjugates|mesh-ancestor
153778871|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
153778874|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
153778875|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778876|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778877|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153778878|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153778879|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
153778880|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778881|NCT00569335|Bevacizumab|bevacizumab|mesh-list
153778882|NCT00569335|Irinotecan|irinotecan|mesh-list
153778883|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153778884|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778885|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778886|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153778887|NCT00569335|Growth Substances|growth substances|mesh-ancestor
153778888|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778889|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
153778890|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153778891|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153778892|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778893|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778894|NCT00254319|Bevacizumab|bevacizumab|mesh-list
153778910|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153778911|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153778912|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778913|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778914|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778915|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153778916|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153778918|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
153749870|NCT00183885|Mitomycins|mitomycins|mesh-list
153778919|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778920|NCT00569920|Dexamethasone|dexamethasone|mesh-list
153778921|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
153778922|NCT00569920|BB 1101|bb 1101|mesh-list
153778923|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778924|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
153778925|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
153778926|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778927|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778928|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153778929|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
153778930|NCT00569920|Hormones|hormones|mesh-ancestor
153778931|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153778942|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153778943|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778944|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153778945|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778946|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778947|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778948|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153778949|NCT00570193|Ranibizumab|ranibizumab|mesh-list
153778950|NCT00570193|Verteporfin|verteporfin|mesh-list
153778951|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778952|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153778953|NCT00570193|Growth Substances|growth substances|mesh-ancestor
153778971|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153778972|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153778973|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153778974|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
153778975|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153778976|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
153778977|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778978|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778979|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153778980|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
153778981|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
153778982|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153778983|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
153778984|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778985|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778986|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
153735867|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908763|NCT02822131|Sevelamer|sevelamer|mesh-list
153778987|NCT00254436|Hematinics|hematinics|mesh-ancestor
153778989|NCT00224588|Analgesics|analgesics|mesh-ancestor
153778990|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
153778991|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778992|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778993|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153778994|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153778995|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
153778996|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
153778997|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778998|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153778999|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153779000|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779001|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779002|NCT00570622|Pioglitazone|pioglitazone|mesh-list
153779003|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153779004|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779005|NCT00254475|Valsartan|valsartan|mesh-list
153779006|NCT00254475|Simvastatin|simvastatin|mesh-list
153779007|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153779008|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153779009|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
153779010|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779096|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
153779097|NCT00571675|Prednisone|prednisone|mesh-list
153779098|NCT00571675|Docetaxel|docetaxel|mesh-list
153779099|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779100|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
153779101|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
153779102|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
153779103|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779104|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779105|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
153779106|NCT00571675|Hormones|hormones|mesh-ancestor
153779107|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779115|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153779116|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
153779117|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779118|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153779119|NCT00254709|Sirolimus|sirolimus|mesh-list
153779120|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153779121|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779122|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153801314|NCT00417404|Vitamins|vitamins|mesh-list
153779131|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153779132|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779133|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779134|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779135|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
153779136|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
153779137|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779138|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779139|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153779140|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153779141|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
153779142|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153779143|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153779144|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153779145|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153779146|NCT00571870|Cetrorelix|cetrorelix|mesh-list
153779147|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153779148|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
153779149|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153779150|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779151|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
153779152|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779153|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153779154|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
153779155|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779156|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153779157|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153419899|NCT02832115|Lidocaine|lidocaine|mesh-list
153779158|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779159|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779160|NCT00572026|Methylphenidate|methylphenidate|mesh-list
153779161|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153779162|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779163|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153779164|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153779165|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779166|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779167|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
153779168|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779169|NCT00572065|Cytarabine|cytarabine|mesh-list
153779170|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
153779171|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153779172|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
153779181|NCT00234897|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153779182|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779183|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781981|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779184|NCT00572182|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
153779185|NCT00572182|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153779186|NCT00572182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779187|NCT00572182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779189|NCT00572299|Prednisone|prednisone|mesh-list
153779190|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779191|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
153779192|NCT00572299|Hormones|hormones|mesh-ancestor
153779193|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779224|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779225|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153779226|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
153779227|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779228|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779229|NCT00413270|Nilotinib|nilotinib|mesh-list
153779230|NCT00413270|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153779231|NCT00413270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153779232|NCT00413270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779233|NCT00413270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779234|NCT00572689|Exenatide|exenatide|mesh-list
153801432|NCT00287378|Omalizumab|omalizumab|mesh-list
153779272|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779273|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153779274|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153779275|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153779276|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153779277|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
153779278|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153779279|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153779280|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153779281|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153750081|NCT00541840|Sorafenib|sorafenib|mesh-list
153779282|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153779283|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153779284|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
153779285|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779286|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153779287|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779288|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779289|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779290|NCT00225056|Docetaxel|docetaxel|mesh-list
153779302|NCT00225173|Doxorubicin|doxorubicin|mesh-list
153779303|NCT00225173|Etoposide|etoposide|mesh-list
153779304|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
153779305|NCT00225173|Vincristine|vincristine|mesh-list
153779306|NCT00225173|Vinorelbine|vinorelbine|mesh-list
153779307|NCT00225173|Bleomycin|bleomycin|mesh-list
153779308|NCT00225173|Vinblastine|vinblastine|mesh-list
153779309|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153779310|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
153779311|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779312|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153779313|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153779314|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
153779315|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359915|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153779316|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779343|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779344|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153779345|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153779346|NCT00235014|Verapamil|verapamil|mesh-list
153779347|NCT00235014|Trandolapril|trandolapril|mesh-list
153779348|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153779349|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153779350|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779351|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779352|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153779353|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779354|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
153750152|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153779355|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153779356|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
153779383|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153779384|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779386|NCT00573664|Analgesics|analgesics|mesh-ancestor
153779387|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
153779388|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779389|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779390|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
153779391|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153779392|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779442|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779443|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779444|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779493|NCT00235092|Paclitaxel|paclitaxel|mesh-list
153779494|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801618|NCT00288002|Docetaxel|docetaxel|mesh-list
153779536|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
153779537|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779538|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779540|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153779541|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779542|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779543|NCT03453346|Ribavirin|ribavirin|mesh-list
153779544|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
153779545|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
153779546|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779547|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
153779548|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779549|NCT00575068|Galiximab|galiximab|mesh-list
153616738|NCT06158126|Tenofovir|tenofovir|mesh-list
153779550|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779551|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779552|NCT00575224|Interferons|interferons|mesh-list
153779553|NCT00575224|Ribavirin|ribavirin|mesh-list
153779554|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779555|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
153779556|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779573|NCT00225875|Rituximab|rituximab|mesh-list
153779574|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153779575|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779576|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
153779588|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779589|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779591|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
153779592|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779593|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153779594|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
153779595|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779596|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153779597|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153779598|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779599|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153779600|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153779601|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154263246|NCT05769478|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153779602|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779603|NCT00235248|Aspirin|aspirin|mesh-list
153779604|NCT00235248|Warfarin|warfarin|mesh-list
153779605|NCT00235248|Clopidogrel|clopidogrel|mesh-list
153779606|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153779607|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153779608|NCT00235248|Analgesics|analgesics|mesh-ancestor
153779609|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
153779610|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779611|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779612|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779613|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153779614|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153779615|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153779616|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779617|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153779618|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153779619|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779621|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153779622|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153779623|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153779624|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
153779633|NCT03451435|Expectorants|expectorants|mesh-ancestor
153779634|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
153779635|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153779636|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
153779637|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779638|NCT03451435|Protective Agents|protective agents|mesh-ancestor
153779644|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
153779645|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779646|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
153779647|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779648|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
153779649|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153779650|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153779651|NCT00255450|Hematinics|hematinics|mesh-ancestor
153779652|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153779653|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153779654|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
153779655|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153779656|NCT04573855|Antibodies|antibodies|mesh-list
153779657|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
153779658|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779659|NCT00226109|Spironolactone|spironolactone|mesh-list
153779660|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153779661|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
153779662|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779663|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779664|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153779665|NCT00226109|Diuretics|diuretics|mesh-ancestor
153779666|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
153779667|NCT04573426|Acetaminophen|acetaminophen|mesh-list
153779668|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153779669|NCT04573426|Analgesics|analgesics|mesh-ancestor
153779670|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
153779671|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779672|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779673|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
153779674|NCT00235287|Candesartan|candesartan|mesh-list
153779675|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
153779676|NCT00235287|Enalapril|enalapril|mesh-list
153779677|NCT00235287|Enalaprilat|enalaprilat|mesh-list
153779678|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153779679|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153779680|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153779681|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779682|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153779683|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
153779684|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779685|NCT00255489|Gefitinib|gefitinib|mesh-list
153779686|NCT00255489|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153779687|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153779688|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779689|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779690|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779692|NCT04573153|Sorbitol|sorbitol|mesh-list
153779693|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
153779694|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153779695|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153779696|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779697|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801752|NCT00321165|Taurolidine|taurolidine|mesh-list
153779733|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153779734|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779735|NCT00255567|Paromomycin|paromomycin|mesh-list
153779736|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153779737|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153779738|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779739|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153779740|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153779741|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
153779742|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153779743|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
153779744|NCT03450967|Durvalumab|durvalumab|mesh-list
153779745|NCT03450967|Tremelimumab|tremelimumab|mesh-list
153801817|NCT00288548|Metoprolol|metoprolol|mesh-list
153779777|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153779788|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
153779789|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153779790|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779791|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
153779792|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779793|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
153779794|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779795|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153779797|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153779798|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153779817|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779818|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153779819|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
153779820|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779821|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779822|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153779823|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
153779824|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
153779825|NCT00413387|Hormones|hormones|mesh-ancestor
153779826|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779827|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153779828|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153779829|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153779830|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
153779831|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779832|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779833|NCT00413426|Darifenacin|darifenacin|mesh-list
153779834|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153779835|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153779836|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
153779837|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779838|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779839|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779840|NCT00413426|Urological Agents|urological agents|mesh-ancestor
153779841|NCT00255762|Paclitaxel|paclitaxel|mesh-list
153779842|NCT00255762|Bevacizumab|bevacizumab|mesh-list
153779843|NCT00255762|Carboplatin|carboplatin|mesh-list
153779856|NCT00255762|Growth Substances|growth substances|mesh-ancestor
153779857|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779858|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
153779859|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
153779860|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153779861|NCT02277457|Crizotinib|crizotinib|mesh-list
153779862|NCT02277457|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153779863|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153779864|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779865|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779866|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779867|NCT00255879|Olanzapine|olanzapine|mesh-list
153779886|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153779888|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
153779889|NCT00413504|PENTA|penta|mesh-list
153779890|NCT00413504|Fondaparinux|fondaparinux|mesh-list
153779891|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153779892|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
153779893|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153779894|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
153779895|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779896|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779897|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
153779898|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153779899|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153779900|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153779901|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779902|NCT04721223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153779903|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779904|NCT00226538|Rifampin|rifampin|mesh-list
153779905|NCT00226538|Fluconazole|fluconazole|mesh-list
153779906|NCT00226538|Diclofenac|diclofenac|mesh-list
153779907|NCT00226538|Phenytoin|phenytoin|mesh-list
153779932|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153779933|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153779934|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153779935|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
153779936|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779937|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153779938|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153779939|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
153779940|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153779941|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153779942|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779943|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153779944|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
153779945|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153779972|NCT00226967|Octreotide|octreotide|mesh-list
153779973|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153779974|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153779975|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779976|NCT00199381|Istradefylline|istradefylline|mesh-list
153779977|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153779978|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153779979|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153779980|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
153779981|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486520|NCT01822548|Metformin|metformin|mesh-list
153779982|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779983|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779985|NCT00227084|Coagulants|coagulants|mesh-ancestor
153779986|NCT00227123|Risperidone|risperidone|mesh-list
153779987|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153779988|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153779989|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
153779990|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779991|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779992|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779993|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153617178|NCT05761327|Curcumin|curcumin|mesh-list
153779994|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779995|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779996|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779997|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153779998|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
153779999|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
153780000|NCT00235521|Iloprost|iloprost|mesh-list
153780001|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153780002|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
153780003|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
153780004|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153780005|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153780006|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153780007|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780008|NCT00227357|Buprenorphine|buprenorphine|mesh-list
153780009|NCT00227357|Methadone|methadone|mesh-list
153908974|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153780024|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780025|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780026|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153780027|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153780054|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
153780055|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
153780056|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
153780057|NCT00235794|Sirolimus|sirolimus|mesh-list
153780058|NCT00235794|Temsirolimus|temsirolimus|mesh-list
153780059|NCT00235794|MTOR Inhibitors|mtor inhibitors|mesh-list
153780060|NCT00235794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153780061|NCT00235794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780062|NCT00235794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780063|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153780064|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
153780065|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780066|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780067|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780068|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780069|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153780081|NCT00227708|Docetaxel|docetaxel|mesh-list
153780082|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780083|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
153387626|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
153780084|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
153780085|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
153780098|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780099|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153780100|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153780101|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153780102|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
153780103|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780104|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780106|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153780107|NCT00256347|Narcotics|narcotics|mesh-ancestor
153780108|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780109|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780110|NCT00256347|Analgesics|analgesics|mesh-ancestor
153780111|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
153780112|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780113|NCT00227747|Capecitabine|capecitabine|mesh-list
153780114|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
153780115|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780116|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
153780117|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780118|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780119|NCT00235950|Clopidogrel|clopidogrel|mesh-list
153780120|NCT00235950|Atorvastatin|atorvastatin|mesh-list
153780121|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153780122|NCT00235950|Simvastatin|simvastatin|mesh-list
153780123|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153780124|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153780125|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
153780126|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780127|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153780128|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153780129|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780130|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153780131|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153780132|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153780133|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153780163|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780165|NCT00236028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153780166|NCT00236028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780167|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
153780168|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780169|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780170|NCT00256542|Lidocaine|lidocaine|mesh-list
153780171|NCT00256542|Heparin|heparin|mesh-list
153780172|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
153780173|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
153780174|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780175|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780197|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780198|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750666|NCT00545857|Pioglitazone|pioglitazone|mesh-list
153780233|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153780234|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153780236|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153780237|NCT00236145|Narcotics|narcotics|mesh-ancestor
153780238|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780239|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780240|NCT00236145|Analgesics|analgesics|mesh-ancestor
153780241|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
153780242|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780243|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153780244|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153780245|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
153780246|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
153780247|NCT00228254|Vitamin A|vitamin a|mesh-list
153780248|NCT00228254|Vitamins|vitamins|mesh-ancestor
153780260|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780261|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780262|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
153780263|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
153780264|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780265|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780266|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153780267|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153780268|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
153780269|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153780270|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153780271|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153780272|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153780273|NCT00193609|Capecitabine|capecitabine|mesh-list
153780274|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
153780275|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780276|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
153780277|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780278|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780279|NCT00228410|Vancomycin|vancomycin|mesh-list
153780280|NCT00228410|Tigecycline|tigecycline|mesh-list
153780281|NCT00228410|Aztreonam|aztreonam|mesh-list
153780282|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780283|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780284|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153780285|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780286|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780287|NCT00193180|Docetaxel|docetaxel|mesh-list
153780288|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
153780289|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780290|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
153780291|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
153780292|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
153781982|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780293|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780294|NCT00193180|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153780295|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153780296|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780297|NCT00193063|Gemcitabine|gemcitabine|mesh-list
153780298|NCT00193063|Trastuzumab|trastuzumab|mesh-list
153780313|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153780314|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780315|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780316|NCT00191854|Paclitaxel|paclitaxel|mesh-list
153780317|NCT00191854|Carboplatin|carboplatin|mesh-list
153780318|NCT00191854|Gemcitabine|gemcitabine|mesh-list
153780319|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153780320|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780321|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
153780322|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
153780323|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
153780324|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780325|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780353|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450734|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153780354|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780355|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780356|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153780391|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780393|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780394|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780395|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780396|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153780417|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780418|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153780419|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153780420|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780421|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153780422|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153780423|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
153780424|NCT00236223|Dexamethasone|dexamethasone|mesh-list
153780434|NCT00236223|Hormones|hormones|mesh-ancestor
153780435|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780436|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153780437|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780438|NCT00236223|Analgesics|analgesics|mesh-ancestor
153780439|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
153617625|NCT05030272|Nicotine|nicotine|mesh-list
153780440|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153780441|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153780442|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
153780443|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
153780444|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780445|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153780446|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153780447|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780448|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780449|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
153780462|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780463|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780465|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780466|NCT00191152|Gemcitabine|gemcitabine|mesh-list
153780467|NCT00191152|Capecitabine|capecitabine|mesh-list
153780468|NCT00191152|Docetaxel|docetaxel|mesh-list
153780469|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780470|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
153780471|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780472|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780473|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
153780474|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
153780475|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
153780476|NCT00257049|Levofloxacin|levofloxacin|mesh-list
153780477|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153780478|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780479|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780480|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153780481|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153780482|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780483|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780484|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780485|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153780486|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153780487|NCT01059188|Docetaxel|docetaxel|mesh-list
153780488|NCT01059188|Cetuximab|cetuximab|mesh-list
153780489|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780490|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
153780491|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
153780492|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
153780493|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780494|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153780495|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153780496|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153780497|NCT00236301|Estradiol|estradiol|mesh-list
153450775|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153450776|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780498|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153780499|NCT00236301|Estrogens|estrogens|mesh-ancestor
153780500|NCT00236301|Hormones|hormones|mesh-ancestor
153780501|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780502|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802341|NCT05313620|Adalimumab|adalimumab|mesh-list
153780546|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153780547|NCT00229775|Amebicides|amebicides|mesh-ancestor
153780548|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153780549|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153780550|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780567|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780568|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780570|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
153780571|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780572|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780573|NCT00236457|Risperidone|risperidone|mesh-list
153780574|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153780575|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
153780576|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780593|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780595|NCT00236535|Acetaminophen|acetaminophen|mesh-list
153780596|NCT00236535|Tramadol|tramadol|mesh-list
153780597|NCT00236535|Hydrocodone|hydrocodone|mesh-list
153780598|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153780599|NCT00236535|Analgesics|analgesics|mesh-ancestor
153780600|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
153780601|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780602|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780603|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
153780604|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153780605|NCT00236535|Narcotics|narcotics|mesh-ancestor
153780606|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780607|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
153780608|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
153780609|NCT00193219|Leucovorin|leucovorin|mesh-list
153780610|NCT00193219|Bevacizumab|bevacizumab|mesh-list
153780611|NCT00193219|Cetuximab|cetuximab|mesh-list
153780612|NCT00193219|Fluorouracil|fluorouracil|mesh-list
153780613|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
153780614|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153780615|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780616|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153780617|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153780618|NCT00193219|Growth Substances|growth substances|mesh-ancestor
153780619|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780620|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
153780621|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
153780622|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780623|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780682|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780690|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780691|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780692|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153780693|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
153780724|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780725|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153780726|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153780728|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153780729|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153780730|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153780731|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
153780732|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
153780733|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780734|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780735|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780736|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
153780762|NCT04709172|Cefditoren|cefditoren|mesh-list
153780763|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780764|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780765|NCT00199784|Phenylephrine|phenylephrine|mesh-list
153780766|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
153780767|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153780768|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
153780769|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
153780770|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780771|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780772|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
153780773|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153780774|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
153780775|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
153780776|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153780777|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153780778|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153780779|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
153780780|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780781|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780782|NCT00199784|Protective Agents|protective agents|mesh-ancestor
153780783|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153780784|NCT00236769|Norelgestromin|norelgestromin|mesh-list
153780785|NCT00236769|Estradiol|estradiol|mesh-list
153780805|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780807|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153780808|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153750995|NCT00184821|Annexin A5|annexin a5|mesh-list
153780809|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780810|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153780811|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153780812|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
153780813|NCT00236808|Levofloxacin|levofloxacin|mesh-list
153780814|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153780815|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780816|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780817|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153780818|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153780819|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780820|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780821|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780822|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153780823|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153802541|NCT04572295|Fulvestrant|fulvestrant|mesh-list
153780908|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
153780909|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
153780910|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780911|NCT00236886|Topiramate|topiramate|mesh-list
153780912|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
153780913|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780914|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780915|NCT00257790|Tobramycin|tobramycin|mesh-list
153780916|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780917|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780918|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
153780919|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153780920|NCT00236964|Hematinics|hematinics|mesh-ancestor
153780921|NCT00200252|Oxytocin|oxytocin|mesh-list
153780922|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
153780923|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153780924|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780925|NCT00177307|Bevacizumab|bevacizumab|mesh-list
153780992|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153780993|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780994|NCT00200447|Carbidopa|carbidopa|mesh-list
153780995|NCT00200447|Levodopa|levodopa|mesh-list
153780996|NCT00200447|Entacapone|entacapone|mesh-list
153780997|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
153780998|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153780999|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153781000|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
153781001|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781002|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781003|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781004|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153781005|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781006|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153781007|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
153781008|NCT00237120|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153781009|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153781010|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781011|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450839|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781012|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781013|NCT00175825|Brivaracetam|brivaracetam|mesh-list
153781014|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
153781015|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
153781016|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
153781017|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781018|NCT04710329|Protective Agents|protective agents|mesh-ancestor
153781048|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781049|NCT00174265|Olanzapine|olanzapine|mesh-list
153781050|NCT00174265|Asenapine|asenapine|mesh-list
153781051|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
153781052|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
153781053|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781054|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781055|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781056|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153781057|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153781058|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153781059|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153802652|NCT04338763|Gemcitabine|gemcitabine|mesh-list
153781103|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153781104|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781106|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153781107|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781108|NCT00258297|Gefitinib|gefitinib|mesh-list
153781140|NCT00201305|Protective Agents|protective agents|mesh-ancestor
153781141|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781142|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
153781144|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
153781145|NCT00265551|Olanzapine|olanzapine|mesh-list
153781146|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
153781147|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
153781148|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781149|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781150|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781151|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153781152|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153781153|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153781154|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153781186|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153781187|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781188|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781190|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781191|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781192|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153618383|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
153781193|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781194|NCT00265746|Metformin|metformin|mesh-list
153781195|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153781196|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781226|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781227|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781228|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
153781229|NCT00201695|Hormones|hormones|mesh-ancestor
153781230|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781231|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153781232|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781233|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153781234|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153781235|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153781273|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781274|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
153781275|NCT00258765|Docetaxel|docetaxel|mesh-list
153781276|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359933|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153781277|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
153781278|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
153781279|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
153781280|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781281|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154263247|NCT05769478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154263248|NCT05769478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263249|NCT05761951|Pembrolizumab|pembrolizumab|mesh-list
154263250|NCT05761951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263251|NCT05761951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263252|NCT05761951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153781282|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781284|NCT00410540|Hydromorphone|hydromorphone|mesh-list
153781285|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153781286|NCT00410540|Narcotics|narcotics|mesh-ancestor
153781287|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153781348|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153781349|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153781350|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781351|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153781352|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153781353|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153781354|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153781356|NCT00171340|Letrozole|letrozole|mesh-list
153781357|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781358|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153781359|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153781360|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781361|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781362|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153781391|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153781392|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153781393|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153781394|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153781395|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153781396|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
153781397|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153781398|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153781399|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
153781400|NCT00171223|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153781401|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153781402|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781403|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781404|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781405|NCT00202124|Tryptophan|tryptophan|mesh-list
153781406|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153781433|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781434|NCT00266136|Cytarabine|cytarabine|mesh-list
153781435|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
153781436|NCT00266136|Daunorubicin|daunorubicin|mesh-list
153781437|NCT00266136|Thioguanine|thioguanine|mesh-list
153781563|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153781564|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781565|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
153781566|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618841|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153618842|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
153566814|NCT06233201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566816|NCT06233201|Protease Inhibitors|protease inhibitors|mesh-ancestor
153566817|NCT06233201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566818|NCT06233201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566819|NCT06233162|Febuxostat|febuxostat|mesh-list
153566820|NCT06233162|Gout Suppressants|gout suppressants|mesh-ancestor
153566821|NCT06233162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153566822|NCT06233149|Esomeprazole|esomeprazole|mesh-list
153566823|NCT06233149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153566824|NCT06233149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153566825|NCT06233149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153566826|NCT06233149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909228|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566827|NCT06233149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566828|NCT06233097|Esomeprazole|esomeprazole|mesh-list
153566829|NCT06233097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153566830|NCT06233097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153566831|NCT06233097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153566832|NCT06233097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566833|NCT06233097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566834|NCT06233084|Desogestrel|desogestrel|mesh-list
153802828|NCT03901339|Vinorelbine|vinorelbine|mesh-list
153566867|NCT06233045|Dapagliflozin|dapagliflozin|mesh-list
153566868|NCT06233045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153566869|NCT06233045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566870|NCT06233045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153566871|NCT06233045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566873|NCT06233032|Dexmedetomidine|dexmedetomidine|mesh-list
153566874|NCT06233032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153566875|NCT06233032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566876|NCT06233032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566877|NCT06233032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153566878|NCT06233032|Analgesics|analgesics|mesh-ancestor
153566879|NCT06233032|Sensory System Agents|sensory system agents|mesh-ancestor
153566880|NCT06233032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566881|NCT06233032|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153566917|NCT06232902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153566918|NCT06232902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153567039|NCT06132477|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153567040|NCT06132477|Incretins|incretins|mesh-ancestor
153567041|NCT06132477|Hormones|hormones|mesh-ancestor
153567042|NCT06132477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567043|NCT06132477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567044|NCT06132477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153567045|NCT06118333|Gemcitabine|gemcitabine|mesh-list
153567046|NCT06118333|Capecitabine|capecitabine|mesh-list
153567047|NCT06118333|Docetaxel|docetaxel|mesh-list
153567048|NCT06118333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153567049|NCT06118333|Antimetabolites|antimetabolites|mesh-ancestor
153567050|NCT06118333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567051|NCT06118333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567052|NCT06118333|Tubulin Modulators|tubulin modulators|mesh-ancestor
153567053|NCT06118333|Antimitotic Agents|antimitotic agents|mesh-ancestor
153567054|NCT06118333|Mitosis Modulators|mitosis modulators|mesh-ancestor
153567055|NCT06116955|Midazolam|midazolam|mesh-list
153567340|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
153567341|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567342|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567343|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
153567344|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567345|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153567346|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153813470|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153567347|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
153567348|NCT05658575|Dapansutrile|dapansutrile|mesh-list
153567349|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153567350|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153567351|NCT05656027|Aceclidine|aceclidine|mesh-list
153567421|NCT05579249|Naltrexone|naltrexone|mesh-list
153567422|NCT05579249|Bupropion|bupropion|mesh-list
153567423|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153567424|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153567425|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567426|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
153567427|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567428|NCT05579249|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153567429|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153567430|NCT05579249|Incretins|incretins|mesh-ancestor
153567431|NCT05579249|Hormones|hormones|mesh-ancestor
153567432|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567445|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
153567446|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153567447|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153567448|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153420198|NCT03123614|Hormones|hormones|mesh-ancestor
153567449|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
153567450|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
153567451|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
153567452|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567453|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153567454|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
153567455|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567456|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567457|NCT05542446|Colistin|colistin|mesh-list
153567458|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153567459|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567460|NCT05541640|Lidocaine|lidocaine|mesh-list
153567461|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
153567462|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
153567463|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567464|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567465|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
153567466|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567467|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153567468|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153567469|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153567532|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153567533|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567534|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153567535|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
153567536|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153567537|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
153567538|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
153567539|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567540|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567541|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567542|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567543|NCT05367492|Varenicline|varenicline|mesh-list
153567544|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153567545|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153567546|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
153567580|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153567581|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153567583|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567628|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153567629|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153567630|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567631|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567714|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153567715|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567716|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567718|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153567719|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153567720|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567721|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567722|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567723|NCT05020457|Paclitaxel|paclitaxel|mesh-list
153567724|NCT05020457|Docetaxel|docetaxel|mesh-list
153567725|NCT05020457|Cisplatin|cisplatin|mesh-list
153567726|NCT05020457|Pemetrexed|pemetrexed|mesh-list
153567727|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153567728|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567729|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
153567730|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
153567731|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803010|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567814|NCT04883281|Paclitaxel|paclitaxel|mesh-list
153781601|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567815|NCT04883281|Carboplatin|carboplatin|mesh-list
153567816|NCT04883281|Cetuximab|cetuximab|mesh-list
153567817|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153567844|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153567845|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153567846|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567847|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153567848|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153567849|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567850|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
153735874|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153567851|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153567852|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153567853|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
153567854|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
153567855|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567856|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153567857|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153567858|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567859|NCT04860635|Celecoxib|celecoxib|mesh-list
153567860|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153567861|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567862|NCT04860635|Analgesics|analgesics|mesh-ancestor
153567863|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
153567864|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567865|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567901|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153567902|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
153567903|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153567904|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567905|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153567927|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567928|NCT04682366|Urological Agents|urological agents|mesh-ancestor
153567930|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
153567931|NCT04679818|Narcotics|narcotics|mesh-ancestor
153567932|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567933|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567934|NCT04679818|Analgesics|analgesics|mesh-ancestor
153567935|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
153567936|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567937|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153568030|NCT04466475|Antibodies|antibodies|mesh-list
153568031|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
153568032|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153568033|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
153568034|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568035|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568036|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153568037|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
153568038|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781985|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153568039|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153568070|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568072|NCT04386811|Vitamins|vitamins|mesh-ancestor
153568073|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
153568074|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153568075|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
153568076|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
153803130|NCT03004287|Melphalan|melphalan|mesh-list
153568128|NCT04250805|Ropivacaine|ropivacaine|mesh-list
153568129|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
153568130|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
153568155|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568157|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153568158|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153568159|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568160|NCT04245085|Paclitaxel|paclitaxel|mesh-list
153568161|NCT04245085|Bevacizumab|bevacizumab|mesh-list
153568162|NCT04245085|Carboplatin|carboplatin|mesh-list
153568163|NCT04245085|Pemetrexed|pemetrexed|mesh-list
153568164|NCT04245085|Atezolizumab|atezolizumab|mesh-list
153568165|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153568166|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568167|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
153568168|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
153568169|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
153568170|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568171|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568172|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568173|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568174|NCT04245085|Growth Substances|growth substances|mesh-ancestor
154263253|NCT05761951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263255|NCT05739955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263256|NCT05727163|Leucovorin|leucovorin|mesh-list
154263257|NCT05727163|Dexamethasone|dexamethasone|mesh-list
154263258|NCT05727163|Anisodamine|anisodamine|mesh-list
154263259|NCT05727163|Bevacizumab|bevacizumab|mesh-list
154263260|NCT05727163|Fluorouracil|fluorouracil|mesh-list
154263261|NCT05727163|Oxaliplatin|oxaliplatin|mesh-list
153568175|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568258|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
153568282|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153568283|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568284|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568285|NCT03813147|Cytarabine|cytarabine|mesh-list
153568286|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
153568287|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153568288|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153568289|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153568290|NCT03813147|Methotrexate|methotrexate|mesh-list
153568291|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
153568292|NCT03813147|Azacitidine|azacitidine|mesh-list
153568293|NCT03813147|Fludarabine|fludarabine|mesh-list
153568294|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153568295|NCT03813147|Pevonedistat|pevonedistat|mesh-list
153568296|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153568297|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
153568298|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153568299|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568300|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153568301|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
153568302|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568303|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568304|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
153568305|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153568306|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568342|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568344|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
153568345|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568346|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153568384|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568385|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568415|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153568416|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153568417|NCT03245489|Analgesics|analgesics|mesh-ancestor
153568418|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
153568419|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568459|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
153568460|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
153568461|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
153568462|NCT03109080|Olaparib|olaparib|mesh-list
153568463|NCT03109080|Adenosine|adenosine|mesh-list
153568464|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153568465|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568466|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568467|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568468|NCT03109080|Analgesics|analgesics|mesh-ancestor
153568469|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
153568470|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751547|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
153568471|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568472|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153568473|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
153568474|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153568475|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
153568476|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
153568477|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568478|NCT03016819|Dacarbazine|dacarbazine|mesh-list
154263262|NCT05727163|Irinotecan|irinotecan|mesh-list
154263263|NCT05727163|Levoleucovorin|levoleucovorin|mesh-list
153451042|NCT03954366|Rucaparib|rucaparib|mesh-list
153568479|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153568480|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
153568519|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153568520|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153568521|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568522|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568523|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153568524|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
153568525|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153568526|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568527|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
153568528|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568529|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
153568530|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
153568531|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
153568532|NCT02853500|Doxorubicin|doxorubicin|mesh-list
153568533|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153568534|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568535|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153568536|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153568537|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568538|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568539|NCT02841371|Edetic Acid|edetic acid|mesh-list
153568540|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
153568541|NCT02841371|Antidotes|antidotes|mesh-ancestor
153568542|NCT02841371|Protective Agents|protective agents|mesh-ancestor
153751620|NCT00162383|Dapsone|dapsone|mesh-list
153803321|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
153568624|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568625|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
153568626|NCT02543255|Hormones|hormones|mesh-ancestor
153568627|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568628|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568629|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153568630|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568631|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153568632|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
153568633|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153568634|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153568635|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568636|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568638|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153568670|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568671|NCT01932125|Growth Substances|growth substances|mesh-ancestor
153568672|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568673|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
153568674|NCT01922076|Adavosertib|adavosertib|mesh-list
153568675|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568676|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568677|NCT01868269|Dexamethasone|dexamethasone|mesh-list
153568678|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
153568679|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
153568680|NCT01868269|Rituximab|rituximab|mesh-list
153568681|NCT01868269|BB 1101|bb 1101|mesh-list
153568682|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153359940|NCT02861573|Hormones|hormones|mesh-ancestor
153568683|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
153568684|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568685|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568686|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153568687|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
153568688|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568689|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568690|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153568691|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568692|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
153568693|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
153568694|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568695|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153568696|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
153568697|NCT01868269|Hormones|hormones|mesh-ancestor
153909375|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568698|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568699|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153568700|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
153568701|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568702|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568703|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
153568704|NCT01742299|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153568705|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153568706|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568707|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568732|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153803413|NCT00289406|Amlodipine|amlodipine|mesh-list
153568757|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568758|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153568759|NCT01366092|Analgesics|analgesics|mesh-ancestor
153568856|NCT05356741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568857|NCT05356741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568858|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153568859|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153568860|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568898|NCT05282277|Progestins|progestins|mesh-ancestor
153568899|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153568900|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153568901|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568902|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153568903|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153568924|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568925|NCT05203445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568926|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568927|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153568928|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568929|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
153568930|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
153568931|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153568933|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803473|NCT00323583|Vitamins|vitamins|mesh-ancestor
153568958|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568975|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568976|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
153568977|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153568978|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153568979|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
153568980|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568981|NCT04967469|Calcitriol|calcitriol|mesh-list
153568982|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
153568983|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153568984|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153568985|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568986|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153568987|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153568988|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568989|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153568990|NCT04967469|Vitamins|vitamins|mesh-ancestor
153568991|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
153568992|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153568993|NCT04958226|Midazolam|midazolam|mesh-list
153568994|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153568995|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153568996|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568997|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568998|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153568999|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153569000|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153803519|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569135|NCT04562129|Aldesleukin|aldesleukin|mesh-list
153569220|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569221|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
153569222|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569223|NCT04390763|Paclitaxel|paclitaxel|mesh-list
153569224|NCT04390763|Gemcitabine|gemcitabine|mesh-list
154263264|NCT05727163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263265|NCT05727163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569226|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153569227|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569256|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
153569257|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569258|NCT04330729|Aspirin|aspirin|mesh-list
153569259|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153569260|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153569261|NCT04330729|Analgesics|analgesics|mesh-ancestor
153569262|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
153569263|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569264|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569265|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569266|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569267|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153569268|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153569269|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569270|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153569271|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153569272|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569273|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
153569314|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
153569315|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569344|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153569345|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
153569409|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153569410|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153569411|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153569412|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153569413|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153569414|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569416|NCT03511118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153569417|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153569418|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153569453|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153569454|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
153569455|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
153569485|NCT03442556|Docetaxel|docetaxel|mesh-list
153569486|NCT03442556|Rucaparib|rucaparib|mesh-list
153569487|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569488|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
153569489|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
153569490|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
153569491|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569492|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153569493|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569607|NCT02734004|Bevacizumab|bevacizumab|mesh-list
153569609|NCT02734004|Olaparib|olaparib|mesh-list
153569610|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569611|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569612|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153569613|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153569614|NCT02734004|Growth Substances|growth substances|mesh-ancestor
153569615|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569634|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569635|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
153569636|NCT02641847|Gemcitabine|gemcitabine|mesh-list
153569637|NCT02641847|Docetaxel|docetaxel|mesh-list
153569638|NCT02641847|Doxorubicin|doxorubicin|mesh-list
153569639|NCT02641847|Epirubicin|epirubicin|mesh-list
153569640|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569641|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
153569642|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569643|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569644|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569645|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
153569646|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569647|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569648|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153569734|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153569735|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153569736|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153569737|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
153569738|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569739|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569740|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569742|NCT01684982|Everolimus|everolimus|mesh-list
153569743|NCT01684982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153569744|NCT01684982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569745|NCT01684982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569746|NCT01684982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569747|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569748|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
153569749|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569750|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569751|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153569752|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569859|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153569860|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569861|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569863|NCT01690065|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153569864|NCT01690065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569865|NCT01690065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569866|NCT01690065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569867|NCT01690091|Metformin|metformin|mesh-list
153569868|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153569869|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569870|NCT01690104|Rifampin|rifampin|mesh-list
153569871|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153569872|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
153569873|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153569874|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569875|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
153569876|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153569877|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569878|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569879|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153569880|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153569881|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153569882|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153569883|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153569884|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153569885|NCT01690221|Diltiazem|diltiazem|mesh-list
153569905|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569906|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569907|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153569908|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
153569909|NCT01690325|Bevacizumab|bevacizumab|mesh-list
153569910|NCT01690325|Docetaxel|docetaxel|mesh-list
153569921|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153569922|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569923|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153569924|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153569925|NCT01690325|Growth Substances|growth substances|mesh-ancestor
153569926|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
153569927|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
153569928|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
153569929|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
153569930|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153569931|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153569932|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153569933|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569934|NCT01690338|Bromides|bromides|mesh-list
153569935|NCT01690338|Rocuronium|rocuronium|mesh-list
153569936|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
153569937|NCT01690338|Cisatracurium|cisatracurium|mesh-list
153569938|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
153569939|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153569976|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
153569977|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570001|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153570002|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153570003|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
153570004|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153570005|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570006|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153570007|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153570008|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570009|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570010|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570011|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153570012|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153570013|NCT01690572|Paclitaxel|paclitaxel|mesh-list
153570014|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
153570015|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153570016|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570017|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
153570018|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
153570019|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570020|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570021|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153570022|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
153570023|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570024|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
153570025|NCT01690572|Protective Agents|protective agents|mesh-ancestor
153570026|NCT01690598|Topotecan|topotecan|mesh-list
153570027|NCT01690598|Veliparib|veliparib|mesh-list
153570028|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153570064|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570065|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
153570066|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570067|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153803859|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570343|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
153570344|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570345|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570346|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
153570347|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
153570348|NCT01693159|Coagulants|coagulants|mesh-ancestor
153570349|NCT01693276|Paclitaxel|paclitaxel|mesh-list
153570350|NCT01693276|Gemcitabine|gemcitabine|mesh-list
153570351|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153570352|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153570353|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570354|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
153570355|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
153570356|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570419|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153570420|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803926|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153570455|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570456|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153570457|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153570458|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570459|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570460|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153570461|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153570462|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
153570463|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
153570464|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153570465|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570466|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570467|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153570469|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
153570470|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570471|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153570472|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153570473|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154263266|NCT05727163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153572919|NCT03026972|Vaccines|vaccines|mesh-list
153570474|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
153570475|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570476|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570477|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153570524|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570526|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570527|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570528|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153570529|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153570530|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570531|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
153570532|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
153570533|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153570534|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153570535|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153570536|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153570537|NCT05291195|Eusol|eusol|mesh-list
153570538|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
153570539|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570540|NCT05291104|Folic Acid|folic acid|mesh-list
153570541|NCT05291104|Choline|choline|mesh-list
153570542|NCT05291104|Hematinics|hematinics|mesh-ancestor
153570543|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
153752035|NCT00163553|Meperidine|meperidine|mesh-list
153570551|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153570552|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153570674|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153570675|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153570676|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153570677|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570678|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570679|NCT05294887|Bisoprolol|bisoprolol|mesh-list
153570680|NCT05294887|Diltiazem|diltiazem|mesh-list
153570681|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153570682|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153570683|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
153570684|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570685|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570686|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570687|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153570688|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
153570722|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
153570723|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570724|NCT05294536|Liraglutide|liraglutide|mesh-list
153570725|NCT05294536|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153570726|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153570727|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570728|NCT05294536|Incretins|incretins|mesh-ancestor
153570729|NCT05294536|Hormones|hormones|mesh-ancestor
153626779|NCT02018991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570896|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570897|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153570899|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570900|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570901|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
153570902|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570903|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153570904|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570905|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
153570906|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570907|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153570908|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
153570909|NCT05267431|Protective Agents|protective agents|mesh-ancestor
153570910|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153570911|NCT05266248|Caffeine|caffeine|mesh-list
153570912|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153570913|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570914|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153570915|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570916|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571008|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
153571009|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
153571043|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153571044|NCT05129137|Analgesics|analgesics|mesh-ancestor
153571045|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
153571046|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571047|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571048|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
153571049|NCT05110898|Olmesartan|olmesartan|mesh-list
153571050|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153571051|NCT05110898|Indapamide|indapamide|mesh-list
153571101|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571382|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153571383|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153571384|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153571385|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153571386|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571387|NCT04310150|Hemostatics|hemostatics|mesh-list
153571388|NCT04310150|Coagulants|coagulants|mesh-ancestor
153571389|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153571390|NCT04294147|Erenumab|erenumab|mesh-list
153571391|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153571392|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571393|NCT04294147|Analgesics|analgesics|mesh-ancestor
153571394|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
153571395|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571396|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571397|NCT04264637|Azelastine|azelastine|mesh-list
153571431|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153571432|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153571433|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153571434|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571435|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571436|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571437|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153571438|NCT04157881|Rabeprazole|rabeprazole|mesh-list
153571439|NCT04157881|Dabigatran|dabigatran|mesh-list
153571454|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153571455|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
153571456|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571457|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571466|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153571467|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571468|NCT04082676|Bupivacaine|bupivacaine|mesh-list
153571469|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
153571487|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153571488|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
153571489|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
153571491|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
153571492|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571493|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
153571494|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
153571495|NCT03993249|Nivolumab|nivolumab|mesh-list
153571496|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571497|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571498|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153571499|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571500|NCT03990883|Lidocaine|lidocaine|mesh-list
153571501|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
153571529|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571530|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153571531|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571532|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571533|NCT05802433|Vitamin D|vitamin d|mesh-list
153571534|NCT05802433|Cholecalciferol|cholecalciferol|mesh-list
153571535|NCT05802433|Vitamins|vitamins|mesh-ancestor
153571536|NCT05802433|Micronutrients|micronutrients|mesh-ancestor
153571537|NCT05802433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571538|NCT05802433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153571539|NCT05802433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153571693|NCT05797597|Aspirin|aspirin|mesh-list
153571694|NCT05797597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154263267|NCT05727163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263268|NCT05727163|Growth Substances|growth substances|mesh-ancestor
153909600|NCT04278040|Melphalan|melphalan|mesh-list
153571695|NCT05797597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153571696|NCT05797597|Analgesics|analgesics|mesh-ancestor
153571697|NCT05797597|Sensory System Agents|sensory system agents|mesh-ancestor
153571698|NCT05797597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571699|NCT05797597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571700|NCT05797597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571701|NCT05797597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571702|NCT05797597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153571703|NCT05797597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153571704|NCT05797597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571705|NCT05797597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153571706|NCT05797597|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153571707|NCT05797597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571839|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571840|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571841|NCT05161468|Triamcinolone|triamcinolone|mesh-list
153571842|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153571843|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153571845|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
153571948|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
153571950|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153571951|NCT04545554|Vitamin D|vitamin d|mesh-list
153571952|NCT04545554|Calcium|calcium|mesh-list
153571953|NCT04545554|Vitamins|vitamins|mesh-ancestor
153571954|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
153571985|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153571986|NCT04042051|Maytansine|maytansine|mesh-list
153571987|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571988|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571989|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153571990|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
153571991|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
153571992|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
153571993|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571994|NCT04042051|Immunotoxins|immunotoxins|mesh-ancestor
153572052|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153572053|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153572054|NCT03642132|Growth Substances|growth substances|mesh-ancestor
153572055|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572056|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
153572057|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153572058|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572059|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572060|NCT03632330|Midazolam|midazolam|mesh-list
153572061|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
153572062|NCT03632330|Propofol|propofol|mesh-list
153572063|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153572064|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572065|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572066|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153572067|NCT03632330|Analgesics|analgesics|mesh-ancestor
153572093|NCT03572764|Daunorubicin|daunorubicin|mesh-list
153572094|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572095|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
153572096|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572097|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572098|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
153572099|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572100|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572101|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
153572102|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572103|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153572104|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153572105|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153572106|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572164|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572165|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153572166|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153572195|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153909633|NCT02808247|Ifosfamide|ifosfamide|mesh-list
153572197|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572198|NCT02160353|Prednisolone|prednisolone|mesh-list
153572199|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
153572200|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153572201|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
153572202|NCT02160353|Hormones|hormones|mesh-ancestor
153572203|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153572204|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572205|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153572206|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572207|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153572208|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572209|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572210|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
153572211|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153572212|NCT02152358|Acyclovir|acyclovir|mesh-list
153804305|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153572278|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153572279|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153572280|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
153572281|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572282|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153572283|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153572284|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572285|NCT03870880|Risperidone|risperidone|mesh-list
153572286|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153572287|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
153572288|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572289|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572290|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572291|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153572292|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153572293|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572294|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153572347|NCT03770299|Gemcitabine|gemcitabine|mesh-list
153572348|NCT03770299|Nivolumab|nivolumab|mesh-list
153572349|NCT03770299|Pemetrexed|pemetrexed|mesh-list
153572350|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153572351|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572352|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
153572353|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
153572354|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
153572355|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572356|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572357|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
153572358|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572359|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153572360|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572361|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153572362|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153572363|NCT03760835|Dexamethasone|dexamethasone|mesh-list
153572364|NCT03760835|Prednisone|prednisone|mesh-list
153572365|NCT03760835|Prednisolone|prednisolone|mesh-list
153572366|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
153572367|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153572368|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153572394|NCT03727750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572395|NCT03715829|PF-06700841|pf-06700841|mesh-list
153572396|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153572397|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572398|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572399|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
153572400|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
153572401|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153572402|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153572403|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572404|NCT03704441|Bupivacaine|bupivacaine|mesh-list
153572405|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
153572406|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
153572584|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153572585|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572586|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
153909675|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153572587|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
153572588|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
153572675|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572676|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
153572677|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153572678|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
153572679|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153572680|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
153572681|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572682|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572683|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
153572685|NCT04895046|Dostarlimab|dostarlimab|mesh-list
153572686|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153572687|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572688|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572773|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572774|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153572775|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572777|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
153572778|NCT02333292|Grazoprevir|grazoprevir|mesh-list
153572779|NCT02333292|Ledipasvir|ledipasvir|mesh-list
153572833|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572834|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
153572866|NCT03164889|Molgramostim|molgramostim|mesh-list
153572867|NCT03164889|Sargramostim|sargramostim|mesh-list
153572868|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
153572869|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572870|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
153572871|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572872|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572873|NCT03133260|Aspirin|aspirin|mesh-list
153572874|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153572875|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153572876|NCT03133260|Analgesics|analgesics|mesh-ancestor
153572877|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
153572878|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572879|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572880|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153572881|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153572882|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153781610|NCT00231140|Thalidomide|thalidomide|mesh-list
153572917|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572918|NCT03126812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153573006|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153573007|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153573008|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
153573009|NCT02865187|Vitamin D|vitamin d|mesh-list
153573010|NCT02865187|Vitamins|vitamins|mesh-ancestor
153573011|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
153573012|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573013|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153573014|NCT02787551|Metformin|metformin|mesh-list
153573015|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
153573016|NCT02787551|Pioglitazone|pioglitazone|mesh-list
153573017|NCT02787551|Liraglutide|liraglutide|mesh-list
153573018|NCT02787551|Exenatide|exenatide|mesh-list
153573117|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573118|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573539|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573899|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153573900|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
153573901|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
153573902|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573903|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573904|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153573905|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
153573906|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573907|NCT01696799|Econazole|econazole|mesh-list
153573908|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
153573909|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573910|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153573911|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153573912|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573914|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153573915|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
153574440|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574441|NCT01700010|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153574442|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153574454|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574456|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153574488|NCT01700400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153574489|NCT01700400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153574490|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153574491|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
153574492|NCT01700413|Idarubicin|idarubicin|mesh-list
153574493|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153574494|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574495|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153574496|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153574497|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574659|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574660|NCT01701453|Clopidogrel|clopidogrel|mesh-list
153574662|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153574663|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153574664|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153574665|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153574666|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153574667|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
153574697|NCT01701518|Hormones|hormones|mesh-ancestor
153574698|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574699|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153574700|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574701|NCT01701583|Omalizumab|omalizumab|mesh-list
153574702|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153574703|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153574704|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
153574705|NCT01701739|Digoxin|digoxin|mesh-list
153574706|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153574707|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153574708|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574709|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574710|NCT01701739|Protective Agents|protective agents|mesh-ancestor
153574711|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574712|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
153574713|NCT01701778|Sevoflurane|sevoflurane|mesh-list
153574714|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
153574748|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574749|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153574751|NCT01701882|Emtricitabine|emtricitabine|mesh-list
153574752|NCT01701882|Rilpivirine|rilpivirine|mesh-list
153574753|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
153574754|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574755|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153574756|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153574849|NCT01702506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804572|NCT00326664|Cediranib|cediranib|mesh-list
153575057|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
153575059|NCT01703910|Cetuximab|cetuximab|mesh-list
153575060|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153575061|NCT01703910|Sorafenib|sorafenib|mesh-list
153575062|NCT01703910|Topotecan|topotecan|mesh-list
153575144|NCT01704508|Piperaquine|piperaquine|mesh-list
153575145|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153575146|NCT01704508|Artenimol|artenimol|mesh-list
153575147|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
153575148|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153575149|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153575150|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575151|NCT01704534|Ustekinumab|ustekinumab|mesh-list
153575152|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
153575153|NCT01704612|Ropivacaine|ropivacaine|mesh-list
153575154|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
153575155|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
153575156|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575214|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153575215|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
153575216|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575265|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153575266|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575267|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153575268|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153575269|NCT01705002|Growth Substances|growth substances|mesh-ancestor
153575270|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575271|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
153575272|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153575273|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
153575274|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575275|NCT01705041|Liver Extracts|liver extracts|mesh-list
153575276|NCT01705041|Hematinics|hematinics|mesh-ancestor
153575409|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575410|NCT01706055|Interferons|interferons|mesh-list
153575411|NCT01706055|Interferon-beta|interferon-beta|mesh-list
153575412|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
153575413|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575414|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
153575415|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575416|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
153575485|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153575487|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
153575488|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575489|NCT01706627|Protective Agents|protective agents|mesh-ancestor
153575490|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575491|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575492|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
153575493|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153575494|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575495|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153575496|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153576492|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576494|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153576495|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576496|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153576497|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576498|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752609|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
153576499|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153576500|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153576501|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
153576502|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577070|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577071|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577072|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577073|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
153577905|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
153577906|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153577907|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153577908|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577909|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577910|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577911|NCT01723852|Vitamin D|vitamin d|mesh-list
153577912|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
153577913|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
153577914|NCT01723852|Vitamins|vitamins|mesh-list
153577915|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
153577916|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577917|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153577918|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153577919|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
153577920|NCT01724229|Clotrimazole|clotrimazole|mesh-list
153577921|NCT01724229|Miconazole|miconazole|mesh-list
153577922|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577923|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153577924|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153577925|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154263269|NCT05727163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263270|NCT05727163|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263271|NCT05727163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154263272|NCT05727163|Antiemetics|antiemetics|mesh-ancestor
154263273|NCT05727163|Autonomic Agents|autonomic agents|mesh-ancestor
153577926|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577927|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577928|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153577929|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
153577930|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153577931|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577932|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153577933|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153577934|NCT01724450|Carvedilol|carvedilol|mesh-list
153577935|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153577936|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153577937|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
153577938|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577939|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577940|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578401|NCT01732250|Meropenem|meropenem|mesh-list
153578402|NCT01732250|Colistin|colistin|mesh-list
153578403|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153578404|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578405|NCT01732276|Gefitinib|gefitinib|mesh-list
153578406|NCT01732276|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153578407|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153578408|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578409|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578410|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578412|NCT01732328|Calcium|calcium|mesh-list
153578413|NCT01732328|Vitamins|vitamins|mesh-ancestor
153578414|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
153578415|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578416|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153578417|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153578418|NCT01732367|Tenofovir|tenofovir|mesh-list
153578419|NCT01732367|Lamivudine|lamivudine|mesh-list
153578420|NCT01732367|Adefovir|adefovir|mesh-list
153578421|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
153578451|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578452|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153578454|NCT01732744|Castor Oil|castor oil|mesh-list
153578455|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153578456|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
153578457|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578458|NCT01732744|Cathartics|cathartics|mesh-ancestor
153578459|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578460|NCT01732861|Lenalidomide|lenalidomide|mesh-list
153578461|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
153578462|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578463|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153578464|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153578465|NCT01732861|Growth Substances|growth substances|mesh-ancestor
153578466|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
153578467|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578468|NCT01733017|Lycopene|lycopene|mesh-list
153578469|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578470|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
153578471|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578472|NCT01733017|Protective Agents|protective agents|mesh-ancestor
153578473|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578474|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153578475|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153578476|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578478|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153578479|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578480|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153578481|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
153578482|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153578484|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578485|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
153578486|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153578487|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752700|NCT01359956|Interferons|interferons|mesh-list
153578488|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578489|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578503|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153578504|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578505|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153578506|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578507|NCT01733134|Tolvaptan|tolvaptan|mesh-list
153578508|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153578509|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578510|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
153578511|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578512|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
153804844|NCT00297323|Topiramate|topiramate|mesh-list
153578543|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153578544|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578546|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
153578547|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578548|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578549|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578561|NCT01733589|Etoposide|etoposide|mesh-list
153578562|NCT01733589|Cisplatin|cisplatin|mesh-list
153578563|NCT01733589|Endostatins|endostatins|mesh-list
153578564|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153578565|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578591|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153578592|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578593|NCT01733966|Amoxicillin|amoxicillin|mesh-list
153578594|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
153578595|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
153578596|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153578597|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
153578598|NCT01733966|Secnidazole|secnidazole|mesh-list
153578599|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153578600|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578601|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578602|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578603|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153578604|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153578605|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153578606|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153578607|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153578608|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578609|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153578610|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153578611|NCT01733979|Iron|iron|mesh-list
153578612|NCT01733979|Trace Elements|trace elements|mesh-ancestor
153578613|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
153578624|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578643|NCT01734057|Hormones|hormones|mesh-ancestor
153578644|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578645|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153578646|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578647|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153578648|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
153578649|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752771|NCT00192855|Entacapone|entacapone|mesh-list
153578650|NCT01734096|Candesartan|candesartan|mesh-list
153578651|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
153578652|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153578653|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153578654|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153578655|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578656|NCT01734252|Argatroban|argatroban|mesh-list
153578657|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
153578658|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153578659|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
153578660|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578661|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578662|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
153578663|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153578664|NCT01734330|Nicotine|nicotine|mesh-list
153578665|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153578666|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
153578667|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578668|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578669|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153578670|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153578671|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
153578672|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578673|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578674|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153578675|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
153578676|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153578677|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
153578678|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578679|NCT01734408|Antacids|antacids|mesh-ancestor
153578688|NCT01734564|Poly ICLC|poly iclc|mesh-list
153578689|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
153578690|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
153578691|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578705|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578706|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153578708|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578709|NCT01734954|Midazolam|midazolam|mesh-list
153578710|NCT01734954|Analgesics|analgesics|mesh-list
153578711|NCT01734954|Anesthetics|anesthetics|mesh-list
153578712|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
153578713|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
153752833|NCT00193167|Topotecan|topotecan|mesh-list
153578714|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578715|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578716|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153578717|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153578718|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153578719|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153578720|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153578721|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153578722|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
153578723|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
153578725|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578726|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578727|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
153578728|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578729|NCT01735006|Vaccines|vaccines|mesh-list
153578730|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
153578731|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578732|NCT01735019|Remifentanil|remifentanil|mesh-list
153578733|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153578734|NCT01735019|Narcotics|narcotics|mesh-ancestor
153578735|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578736|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578737|NCT01735019|Analgesics|analgesics|mesh-ancestor
153578738|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
153578739|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578740|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
153578741|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153578742|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
153578743|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578744|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
153578745|NCT01735058|Protective Agents|protective agents|mesh-ancestor
153578746|NCT01735071|Bevacizumab|bevacizumab|mesh-list
153578747|NCT01735071|Carboplatin|carboplatin|mesh-list
153578748|NCT01735071|Trabectedin|trabectedin|mesh-list
153578749|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153578774|NCT01735227|Pantoprazole|pantoprazole|mesh-list
153578775|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153578776|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153752903|NCT00553189|Topotecan|topotecan|mesh-list
153578777|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153578778|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578779|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578780|NCT01735240|Ketoconazole|ketoconazole|mesh-list
153578810|NCT01735370|Etodolac|etodolac|mesh-list
153578811|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154263274|NCT05727163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909878|NCT04273984|Misoprostol|misoprostol|mesh-list
153578812|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578813|NCT01735370|Analgesics|analgesics|mesh-ancestor
153578814|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
153578815|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578816|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578817|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578818|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578819|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153578820|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153578821|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578822|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578823|NCT01735383|Etodolac|etodolac|mesh-list
153578824|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153578825|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578826|NCT01735383|Analgesics|analgesics|mesh-ancestor
153578827|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
153578828|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578829|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578830|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578831|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578832|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153578833|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153578834|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578861|NCT01735747|Nedaplatin|nedaplatin|mesh-list
153578862|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153578863|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578864|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
153578865|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
153578866|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
153578909|NCT01736033|Tamsulosin|tamsulosin|mesh-list
153578910|NCT01736033|Finasteride|finasteride|mesh-list
153578911|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153578912|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153578913|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153578914|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
153578915|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578916|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578917|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578918|NCT01736033|Urological Agents|urological agents|mesh-ancestor
153578919|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153578920|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153578921|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578922|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
153578923|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578924|NCT01736150|Sevelamer|sevelamer|mesh-list
153578925|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
153578926|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
153578927|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578956|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578957|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153578958|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153578959|NCT01736449|Growth Substances|growth substances|mesh-ancestor
153578960|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578961|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
153578962|NCT01736488|Atenolol|atenolol|mesh-list
153578963|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153578964|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153578965|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
153578989|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153578990|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578991|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
153578992|NCT01736670|Hormones|hormones|mesh-ancestor
153578993|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578994|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578995|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805213|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
153579013|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153579014|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153579015|NCT01736800|Temozolomide|temozolomide|mesh-list
153579016|NCT01736800|Topotecan|topotecan|mesh-list
154263277|NCT05727163|Hormones|hormones|mesh-ancestor
154263278|NCT05727163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263279|NCT05727163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154263280|NCT05727163|Antimetabolites|antimetabolites|mesh-ancestor
154263281|NCT05727163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420572|NCT03109015|Sunitinib|sunitinib|mesh-list
153579041|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579042|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153579043|NCT01736891|Protective Agents|protective agents|mesh-ancestor
153579044|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579046|NCT01737008|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153579047|NCT01737008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153579048|NCT01737008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579049|NCT01737008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579050|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
153579051|NCT01737073|Narcotics|narcotics|mesh-ancestor
153579052|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579053|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579054|NCT01737073|Analgesics|analgesics|mesh-ancestor
153579055|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
153579056|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579057|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
153579058|NCT01737086|Astringents|astringents|mesh-ancestor
153579059|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579060|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579061|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
153579062|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153753018|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153579063|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579064|NCT01737177|Rituximab|rituximab|mesh-list
153579080|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579082|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153579083|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153579085|NCT01737203|Urological Agents|urological agents|mesh-ancestor
153579086|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
153579087|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153579088|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579089|NCT01737294|Capsaicin|capsaicin|mesh-list
153579090|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
153579091|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579092|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
153579093|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805267|NCT00301301|Rituximab|rituximab|mesh-list
153805312|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
153579174|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579175|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579177|NCT01738035|Budesonide|budesonide|mesh-list
153579178|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351914|NCT00410150|Albuterol|albuterol|mesh-list
153579210|NCT01738100|Narcotics|narcotics|mesh-ancestor
153579211|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579212|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579213|NCT01738100|Analgesics|analgesics|mesh-ancestor
153579214|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
153579215|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579216|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153579217|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153579218|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153579219|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153579220|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
153579221|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579222|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420583|NCT03115177|Cefazolin|cefazolin|mesh-list
153909906|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579223|NCT01738178|Caffeine|caffeine|mesh-list
153579224|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153579225|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579226|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153579227|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579228|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579229|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153579230|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153579231|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
153579232|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579233|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
153579234|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153579235|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
153579236|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579237|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
153579238|NCT01738243|Protective Agents|protective agents|mesh-ancestor
153579240|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153579248|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579250|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153579251|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579252|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579253|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
153579254|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579268|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579270|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579271|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153579272|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579273|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579274|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
153579275|NCT01738542|Bosentan|bosentan|mesh-list
153579276|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153579277|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579278|NCT01738724|Goserelin|goserelin|mesh-list
153579279|NCT01738724|Dienogest|dienogest|mesh-list
153579280|NCT01738724|Desogestrel|desogestrel|mesh-list
153579281|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153579282|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579283|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153579284|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
153579285|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153579286|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579287|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153579288|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153579289|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153579290|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153579291|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
153579292|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579293|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153579294|NCT01738724|Progestins|progestins|mesh-ancestor
153579295|NCT01738724|Hormones|hormones|mesh-ancestor
153579297|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
153579298|NCT01738763|Vitamins|vitamins|mesh-ancestor
153579299|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
153579300|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579301|NCT01738802|Micronutrients|micronutrients|mesh-list
153579302|NCT01738802|Trace Elements|trace elements|mesh-list
153579303|NCT01738802|Antioxidants|antioxidants|mesh-list
153579304|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745642|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579305|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579306|NCT01738802|Protective Agents|protective agents|mesh-ancestor
153579307|NCT01738815|Valproic Acid|valproic acid|mesh-list
153579308|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
153579309|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579310|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579311|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
153579312|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579313|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579314|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
153579316|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579318|NCT01738867|Naltrexone|naltrexone|mesh-list
153579330|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153579331|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153579332|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579353|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579355|NCT01739127|Aripiprazole|aripiprazole|mesh-list
153579356|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153579357|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153579358|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
153579359|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579360|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579361|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579362|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153579363|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153579364|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579365|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153579366|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153579367|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
153579368|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
153579369|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
153579370|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153579371|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153579372|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153579373|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153579374|NCT01739192|Bupropion|bupropion|mesh-list
153579375|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153579376|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
153579377|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153579378|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153579379|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153579396|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579397|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153579417|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153579419|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
153579420|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579421|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579422|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579423|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579424|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153579425|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153579426|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579427|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153579428|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153579429|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579430|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
153579431|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153579432|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153579433|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153579434|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
153579435|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579436|NCT01739582|Enclomiphene|enclomiphene|mesh-list
153579449|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
153579450|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153579451|NCT01739673|Riboflavin|riboflavin|mesh-list
153579452|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
153579453|NCT01739673|Vitamins|vitamins|mesh-ancestor
153579454|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
153579455|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579456|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153579457|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579458|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
153579459|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
153579460|NCT01739855|Calcium|calcium|mesh-list
153579461|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153579462|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579463|NCT01739855|Antacids|antacids|mesh-ancestor
153579495|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579496|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579497|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263282|NCT05727163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263283|NCT05727163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153579499|NCT01739985|Hormones|hormones|mesh-ancestor
153579500|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579501|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153579502|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579510|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
153579511|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579512|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153579513|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153579514|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153579515|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579516|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153579517|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153579518|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153579548|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579550|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
153579551|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579552|NCT01740518|Protective Agents|protective agents|mesh-ancestor
153579553|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579554|NCT01740518|Vitamins|vitamins|mesh-ancestor
153579555|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
153579556|NCT01740921|Aspirin|aspirin|mesh-list
153579557|NCT01740921|Liraglutide|liraglutide|mesh-list
153579558|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153579559|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153579560|NCT01740921|Analgesics|analgesics|mesh-ancestor
153579561|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
153579562|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579563|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579564|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579598|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579599|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579601|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579602|NCT01741038|Cetuximab|cetuximab|mesh-list
153579603|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153579604|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579605|NCT01741077|Folic Acid|folic acid|mesh-list
153579606|NCT01741077|Hematinics|hematinics|mesh-ancestor
153579607|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
153579608|NCT01741077|Vitamins|vitamins|mesh-ancestor
153579609|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
153579610|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579611|NCT01741142|Escitalopram|escitalopram|mesh-list
153579612|NCT01741142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153579613|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153579614|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153579615|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579616|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579617|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
153579618|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579619|NCT01741181|Vitamin D|vitamin d|mesh-list
153579620|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
153579621|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
153579622|NCT01741181|Vitamins|vitamins|mesh-list
153579623|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
153579624|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579676|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153579677|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153579678|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153579679|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
153579680|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579681|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579682|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579683|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153579685|NCT01741558|Methotrexate|methotrexate|mesh-list
153579686|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153579687|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
153579688|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153579689|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579691|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
153579710|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579711|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153579712|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153579713|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153579714|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
153579728|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579729|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579730|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153579731|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579732|NCT01741831|Darunavir|darunavir|mesh-list
153579733|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153579734|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153579735|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
153579736|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753400|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753467|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
153579737|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579738|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153579739|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153579740|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
153579741|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579742|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
153579743|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153579744|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579745|NCT01742247|Palmidrol|palmidrol|mesh-list
153579746|NCT01742247|Analgesics|analgesics|mesh-ancestor
153579747|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
153579748|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579749|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579758|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579759|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579761|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579762|NCT01742273|Vitamin K|vitamin k|mesh-list
153579763|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
153579764|NCT01742273|Vitamins|vitamins|mesh-ancestor
153579765|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
153579766|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579767|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153579768|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153579769|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579770|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
153579771|NCT01742273|Coagulants|coagulants|mesh-ancestor
153579772|NCT01742338|Prednisone|prednisone|mesh-list
153579773|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
153579774|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153579775|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153579776|NCT01742338|Prednisolone|prednisolone|mesh-list
153579777|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
153579778|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153579779|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
153579780|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579781|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
153579782|NCT01742338|Hormones|hormones|mesh-ancestor
153579783|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579784|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579785|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153579786|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579787|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
153579806|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
153579807|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
153579808|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
153579809|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153579810|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153579811|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153579812|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153579813|NCT01742429|Amoxicillin|amoxicillin|mesh-list
153579814|NCT01742429|Metronidazole|metronidazole|mesh-list
153579815|NCT01742429|Levofloxacin|levofloxacin|mesh-list
153579827|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579828|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579829|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579830|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153579831|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153579834|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153579835|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
153579836|NCT01742533|Hormones|hormones|mesh-list
153579837|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579838|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579839|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
153579840|NCT01742624|Tacrolimus|tacrolimus|mesh-list
153579841|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153579842|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
153579843|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579844|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153579845|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579846|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579847|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153579848|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579849|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153579850|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
153579851|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153579852|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579853|NCT01742637|Adapalene|adapalene|mesh-list
153579854|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153579864|NCT01742663|Diclofenac|diclofenac|mesh-list
153579865|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153579866|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153579867|NCT01742663|Analgesics|analgesics|mesh-ancestor
153579868|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
153579869|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579870|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579871|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579872|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579873|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153579874|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579875|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579877|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153579878|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
153579879|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579891|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579892|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153753553|NCT05259631|Propofol|propofol|mesh-list
153579893|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
153579894|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
153579895|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153579896|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153579898|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579900|NCT01742689|Coagulants|coagulants|mesh-ancestor
153579901|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153579902|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
153579903|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
153579904|NCT01742702|Bisoprolol|bisoprolol|mesh-list
153579905|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
153579906|NCT01742702|Albuterol|albuterol|mesh-list
153579907|NCT01742702|Caseins|caseins|mesh-list
153579908|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153579909|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
153579910|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579911|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579912|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153579913|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
153579914|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
153579915|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153579916|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153579917|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153579918|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153579919|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
153579920|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579921|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579922|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
153579923|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
153579924|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
153579925|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153579926|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
153579927|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153579928|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154263284|NCT05727163|Immunologic Factors|immunologic factors|mesh-ancestor
153579929|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153579930|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579931|NCT01742767|Pemetrexed|pemetrexed|mesh-list
153579932|NCT01742767|Cisplatin|cisplatin|mesh-list
153805911|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579959|NCT01742988|Venetoclax|venetoclax|mesh-list
153579960|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153579961|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579962|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
153579963|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579964|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579965|NCT01743014|Ramipril|ramipril|mesh-list
153579966|NCT01743014|Clopidogrel|clopidogrel|mesh-list
153579967|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153579968|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153579969|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153579970|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153579971|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
153579972|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579973|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579974|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579975|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153579976|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
153579977|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579978|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153579980|NCT01743066|Vitamins|vitamins|mesh-ancestor
153579981|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
153579982|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579983|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
153579984|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579985|NCT01743066|Protective Agents|protective agents|mesh-ancestor
153579986|NCT01743079|Lamivudine|lamivudine|mesh-list
153579987|NCT01743079|Telbivudine|telbivudine|mesh-list
153580043|NCT01743300|Sunitinib|sunitinib|mesh-list
153580044|NCT01743300|Midazolam|midazolam|mesh-list
153580045|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153359924|NCT02861573|Prednisone|prednisone|mesh-list
153580046|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153580094|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153580121|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580123|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
153580124|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580125|NCT01743820|Primaquine|primaquine|mesh-list
153580126|NCT01743820|Piperaquine|piperaquine|mesh-list
153580127|NCT01743820|Artenimol|artenimol|mesh-list
153580128|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
153580129|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153580130|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153580132|NCT01743885|Propranolol|propranolol|mesh-list
153580133|NCT01743885|Acebutolol|acebutolol|mesh-list
153580134|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153580135|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153580146|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153580147|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
153580148|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153580149|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
153580150|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153580151|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
153580152|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580153|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580154|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
153580155|NCT01743911|Tadalafil|tadalafil|mesh-list
153580184|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153580185|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580186|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580187|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153580188|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
153580189|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
153580190|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
153580191|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
153580192|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580193|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580194|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153580195|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153580196|NCT01744184|Analgesics|analgesics|mesh-ancestor
153580197|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
153910041|NCT02795299|Methotrexate|methotrexate|mesh-list
153580198|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580199|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153580200|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153580215|NCT01744249|Octreotide|octreotide|mesh-list
153580216|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580247|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
153580248|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
153580249|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153580250|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153580252|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153580253|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580254|NCT01744379|Lesinurad|lesinurad|mesh-list
153580255|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
153580256|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580257|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
153580258|NCT01744444|Gabapentin|gabapentin|mesh-list
153580283|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580284|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153580285|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
153580286|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580287|NCT01744587|Protective Agents|protective agents|mesh-ancestor
153580288|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580289|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153580290|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153580291|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580292|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153580293|NCT01744262|Anesthetics|anesthetics|mesh-list
153580294|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580295|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580296|NCT01744756|Bevacizumab|bevacizumab|mesh-list
153580297|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153580298|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580299|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153580300|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153580301|NCT01744756|Growth Substances|growth substances|mesh-ancestor
153580302|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580303|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
153580305|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153580306|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
153580307|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
153580308|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580309|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580310|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153580311|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153580312|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153683244|NCT00403858|Lactulose|lactulose|mesh-list
153580313|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580314|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580315|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580317|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
153580318|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
153580319|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580320|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580321|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
153580322|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580323|NCT01744626|Rituximab|rituximab|mesh-list
153580324|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153580325|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580326|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
153580327|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580355|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580356|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153580357|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153580358|NCT01745302|Gefitinib|gefitinib|mesh-list
153580359|NCT01745302|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153580360|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580361|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580362|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580363|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580364|NCT01745328|Amoxicillin|amoxicillin|mesh-list
153580365|NCT01745328|Levofloxacin|levofloxacin|mesh-list
153580366|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153580367|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451798|NCT01921140|Olaparib|olaparib|mesh-list
153580368|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153580369|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153580370|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153580371|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580372|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580373|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580374|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153580375|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153580376|NCT01745549|Insulin|insulin|mesh-list
153580377|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153580378|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153580379|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580380|NCT01745562|Alprazolam|alprazolam|mesh-list
153580381|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153580382|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580383|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580384|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153580385|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580386|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580387|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
153580388|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
153580389|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580390|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580391|NCT01745575|Alprazolam|alprazolam|mesh-list
153580392|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153580393|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580394|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580443|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
153580445|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153580446|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153580447|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580448|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
153580449|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153580450|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153580451|NCT01745640|Growth Substances|growth substances|mesh-ancestor
153580452|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
153580461|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153580462|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
153580463|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580464|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153580481|NCT01745770|Analgesics|analgesics|mesh-ancestor
153580482|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
153580483|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580484|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580485|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580486|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580487|NCT01745809|Dimercaprol|dimercaprol|mesh-list
153580488|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
153580489|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
153580490|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580491|NCT01745835|Bisacodyl|bisacodyl|mesh-list
153580492|NCT01745835|Cathartics|cathartics|mesh-ancestor
153580493|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580494|NCT01745835|Laxatives|laxatives|mesh-ancestor
153580495|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
153580496|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
153580497|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153580498|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153360366|NCT04155164|Metformin|metformin|mesh-list
153580500|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
153580501|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153580502|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153580503|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153580504|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153580505|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580506|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683370|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153580507|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153580508|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153580509|NCT01746251|Afatinib|afatinib|mesh-list
153580510|NCT01746251|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153580511|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580512|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580513|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580514|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580515|NCT01746277|Docetaxel|docetaxel|mesh-list
153580516|NCT01746277|Pemetrexed|pemetrexed|mesh-list
153580517|NCT01746277|Gefitinib|gefitinib|mesh-list
153580518|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580519|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
153580543|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580544|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153580545|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153580546|NCT01746641|Remifentanil|remifentanil|mesh-list
153580587|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153580588|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580589|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580591|NCT01746771|Trastuzumab|trastuzumab|mesh-list
153580592|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153580593|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580594|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
153580595|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
153580596|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
153580597|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580598|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153580599|NCT01746823|Cyclosporine|cyclosporine|mesh-list
153580600|NCT01746823|Cyclosporins|cyclosporins|mesh-list
153580601|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806455|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580628|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
153580629|NCT01746992|Pirarubicin|pirarubicin|mesh-list
153580630|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153580631|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
153580632|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580633|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580634|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153580635|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
153580636|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580643|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580644|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
153580645|NCT01746992|Hormones|hormones|mesh-ancestor
153580646|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153580647|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153580648|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153580649|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
153580650|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153580651|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153580652|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
153580653|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
153580654|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153580655|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153580656|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153580658|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153580659|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153580695|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580696|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153580737|NCT01747564|Urological Agents|urological agents|mesh-ancestor
153580739|NCT01747590|Alprazolam|alprazolam|mesh-list
153580740|NCT01747590|Caffeine|caffeine|mesh-list
153580741|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153580742|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580743|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153580744|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580745|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580746|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153580747|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153580748|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
153580749|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580750|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153580751|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153580752|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580753|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153580787|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580788|NCT01747668|Tocopherols|tocopherols|mesh-list
153580789|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
153580790|NCT01747668|Vitamin E|vitamin e|mesh-list
153580791|NCT01747668|Vitamins|vitamins|mesh-ancestor
153580792|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
153580793|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580794|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
153580795|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580796|NCT01747668|Protective Agents|protective agents|mesh-ancestor
153580797|NCT01747707|Docetaxel|docetaxel|mesh-list
153580798|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580799|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
153580800|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
153580801|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
153580802|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580803|NCT01747720|Vitamin D|vitamin d|mesh-list
153580804|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
153580805|NCT01747720|Vitamins|vitamins|mesh-ancestor
153580806|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
153580807|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580808|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153580809|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153580810|NCT01747746|Enoxaparin|enoxaparin|mesh-list
153580811|NCT01747746|Warfarin|warfarin|mesh-list
153580812|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
153580813|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
153580814|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153580815|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
153580816|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153580817|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
153580818|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580819|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580820|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153580821|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153580822|NCT01747798|Auranofin|auranofin|mesh-list
153580823|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580824|NCT01747993|Tamsulosin|tamsulosin|mesh-list
153580825|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153580826|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153580851|NCT01748253|Amlodipine|amlodipine|mesh-list
153580852|NCT01748253|Telmisartan|telmisartan|mesh-list
153580853|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153580854|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153580855|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153580856|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153683513|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
153580857|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580858|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153580859|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580860|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153580861|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153580862|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153580863|NCT01748279|Atorvastatin|atorvastatin|mesh-list
153580864|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
153580865|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153580866|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153580867|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
153580868|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580869|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153580870|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153580871|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580872|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153580873|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
153580874|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580875|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580877|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
153580878|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153580879|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153580880|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153580881|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580882|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580883|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153580884|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153580885|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153580886|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153580887|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
153580888|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153580889|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153580890|NCT01748344|Cetirizine|cetirizine|mesh-list
153580891|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153580928|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
153580929|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
153580930|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
153580931|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580932|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580934|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
153580935|NCT01748487|BB 1101|bb 1101|mesh-list
153580936|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580937|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
153580938|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
153580939|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580940|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580941|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580942|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
153580943|NCT01748487|Hormones|hormones|mesh-ancestor
153580944|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153580945|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153580946|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580947|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
153580948|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580949|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580950|NCT01748500|Pantoprazole|pantoprazole|mesh-list
153580951|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153580952|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580997|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153580998|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580999|NCT01748721|Antibodies|antibodies|mesh-list
153581000|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153581001|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
153581002|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581003|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153581004|NCT01748747|Resiquimod|resiquimod|mesh-list
153581005|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153581006|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
153581025|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
153581032|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
153581033|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
153581034|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581035|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581036|NCT01749072|Vinorelbine|vinorelbine|mesh-list
153581038|NCT01749072|Gefitinib|gefitinib|mesh-list
153581039|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153581040|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581041|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
153581042|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
153581043|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
153581044|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581045|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581046|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
153581047|NCT01749072|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153581048|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153581049|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581050|NCT01749085|Ketoconazole|ketoconazole|mesh-list
153581051|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
153581052|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581053|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153581054|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153581055|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581056|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581057|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153581058|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
153581059|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581060|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581061|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153581062|NCT01749098|Ketamine|ketamine|mesh-list
153581063|NCT01749098|Analgesics|analgesics|mesh-ancestor
153581064|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
153581065|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581066|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581067|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153581068|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154263285|NCT05727163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153581108|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153683692|NCT00080847|Hormones|hormones|mesh-ancestor
153581109|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
153581110|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581111|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153581112|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153581113|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
153581114|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
153581115|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581116|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153581117|NCT01749228|Etodolac|etodolac|mesh-list
153581118|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153581119|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581120|NCT01749228|Analgesics|analgesics|mesh-ancestor
153581121|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
153581122|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581123|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581124|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581125|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581126|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153581127|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153581128|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581142|NCT01749371|Vitamins|vitamins|mesh-list
153581143|NCT01749371|Vitamin E|vitamin e|mesh-list
153581144|NCT01749371|Tocopherols|tocopherols|mesh-list
153581145|NCT01749371|Tocotrienols|tocotrienols|mesh-list
153581146|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
153581147|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
153581148|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581150|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581151|NCT01749371|Protective Agents|protective agents|mesh-ancestor
153581152|NCT01749384|Bevacizumab|bevacizumab|mesh-list
153581153|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153581154|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
153581155|NCT01749384|Antibodies|antibodies|mesh-list
153581170|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
153581171|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581172|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581173|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581174|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581175|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
153581176|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581177|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153581178|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581179|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
153581180|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153581181|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153581182|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153581183|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153581184|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581185|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
153581186|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581187|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581188|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153581189|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581190|NCT01749475|Midazolam|midazolam|mesh-list
153581191|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153581192|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153581193|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581194|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581195|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153581196|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153581197|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153581198|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153581199|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
153581200|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
153581201|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
153581202|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
153581203|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806936|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
153581230|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153581231|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
153581232|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
153581233|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581234|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581235|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153581236|NCT01749579|Narcotics|narcotics|mesh-ancestor
153581237|NCT01749579|Analgesics|analgesics|mesh-ancestor
153581238|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
153581239|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581241|NCT01750060|Naltrexone|naltrexone|mesh-list
153581242|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153581243|NCT01750060|Narcotics|narcotics|mesh-ancestor
153581244|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581245|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581246|NCT01750060|Analgesics|analgesics|mesh-ancestor
153581247|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
153581248|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581249|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153581250|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153581251|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
153581252|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
153581253|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153581254|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153581255|NCT01750099|Lidocaine|lidocaine|mesh-list
153581256|NCT01750099|Epinephrine|epinephrine|mesh-list
153581257|NCT01750099|Fentanyl|fentanyl|mesh-list
153581258|NCT01750099|Bupivacaine|bupivacaine|mesh-list
153581259|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
153581260|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
153581261|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581262|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581263|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
153581264|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581265|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153848974|NCT06087211|Magnesium Sulfate|magnesium sulfate|mesh-list
153581266|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153581267|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153581268|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153581269|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581270|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153581272|NCT01750099|Analgesics|analgesics|mesh-ancestor
153581273|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153581274|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153581275|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
153581276|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153807002|NCT00336921|Alfuzosin|alfuzosin|mesh-list
153581297|NCT06176560|Sensory System Agents|sensory system agents|mesh-ancestor
153581298|NCT06176560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581299|NCT06176560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581300|NCT06176560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581301|NCT06176560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581302|NCT06176534|Capecitabine|capecitabine|mesh-list
153581303|NCT06176534|Vinorelbine|vinorelbine|mesh-list
153581304|NCT06176534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581305|NCT06176534|Antimetabolites|antimetabolites|mesh-ancestor
153581306|NCT06176534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581307|NCT06176534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581308|NCT06176534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153581309|NCT06176534|Tubulin Modulators|tubulin modulators|mesh-ancestor
153581310|NCT06176534|Antimitotic Agents|antimitotic agents|mesh-ancestor
153581311|NCT06176534|Mitosis Modulators|mitosis modulators|mesh-ancestor
153581312|NCT06176508|Tofacitinib|tofacitinib|mesh-list
153581313|NCT06176508|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153581314|NCT06176508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153581315|NCT06176508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581316|NCT06176508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581317|NCT06176222|Dexmedetomidine|dexmedetomidine|mesh-list
153581318|NCT06176222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153581319|NCT06176222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581320|NCT06176222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581321|NCT06176222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581322|NCT06176222|Analgesics|analgesics|mesh-ancestor
153581323|NCT06176222|Sensory System Agents|sensory system agents|mesh-ancestor
153581324|NCT06176222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581325|NCT06176222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153581326|NCT06176222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153581327|NCT06176222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153581328|NCT06176222|Adrenergic Agents|adrenergic agents|mesh-ancestor
154263286|NCT05727163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154263287|NCT05727163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581329|NCT06176222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581330|NCT06176222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581332|NCT06176157|Ergocalciferols|ergocalciferols|mesh-list
153581335|NCT06176157|Micronutrients|micronutrients|mesh-ancestor
153581336|NCT06176157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581337|NCT06176157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153581338|NCT06176157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153581340|NCT06176144|Desflurane|desflurane|mesh-list
153581341|NCT06176144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153581342|NCT06176144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153581343|NCT06176144|Anesthetics, General|anesthetics, general|mesh-ancestor
153581344|NCT06176144|Anesthetics|anesthetics|mesh-ancestor
153581345|NCT06176144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581346|NCT06176144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581347|NCT06175806|Ondansetron|ondansetron|mesh-list
153581348|NCT06175806|Granisetron|granisetron|mesh-list
153581349|NCT06175806|Antiemetics|antiemetics|mesh-ancestor
153581350|NCT06175806|Autonomic Agents|autonomic agents|mesh-ancestor
153581351|NCT06175806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581352|NCT06175806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581399|NCT06175702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153581400|NCT06175702|Tubulin Modulators|tubulin modulators|mesh-ancestor
153581401|NCT06175702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153581402|NCT06175702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153581403|NCT06175702|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153807117|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
153581442|NCT06168214|Bismuth|bismuth|mesh-list
153581443|NCT06168214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153581444|NCT06168214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581445|NCT06168214|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153581446|NCT06168214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581447|NCT06168214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581448|NCT06168214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153581449|NCT06168214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153581450|NCT06168214|Antacids|antacids|mesh-ancestor
153581451|NCT06168214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153581452|NCT06168214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153581453|NCT06168214|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153581454|NCT06168214|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153581455|NCT06168214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153581456|NCT06168214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153581457|NCT06168214|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153581458|NCT06162611|Levonorgestrel|levonorgestrel|mesh-list
153581459|NCT06162611|Etonogestrel|etonogestrel|mesh-list
153581460|NCT06162611|Desogestrel|desogestrel|mesh-list
153581461|NCT06162611|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153581501|NCT06109402|Pemetrexed|pemetrexed|mesh-list
153581502|NCT06109402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153581503|NCT06109402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581504|NCT06109402|Tubulin Modulators|tubulin modulators|mesh-ancestor
153581505|NCT06109402|Antimitotic Agents|antimitotic agents|mesh-ancestor
153581506|NCT06109402|Mitosis Modulators|mitosis modulators|mesh-ancestor
153581507|NCT06109402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581508|NCT06109402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581509|NCT06109402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153581510|NCT06109402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153581511|NCT06100432|Vitamins|vitamins|mesh-list
153581512|NCT06100432|Vitamin E|vitamin e|mesh-list
153581513|NCT06100432|Beta Carotene|beta carotene|mesh-list
153581514|NCT06100432|Carotenoids|carotenoids|mesh-list
153581515|NCT06100432|Micronutrients|micronutrients|mesh-ancestor
153581574|NCT05996133|Autonomic Agents|autonomic agents|mesh-ancestor
153581575|NCT05996133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581576|NCT05996133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581577|NCT05996133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153581578|NCT05996133|Glucocorticoids|glucocorticoids|mesh-ancestor
153581579|NCT05996133|Hormones|hormones|mesh-ancestor
153581580|NCT05996133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581595|NCT05996133|Respiratory System Agents|respiratory system agents|mesh-ancestor
153581596|NCT05996133|Mydriatics|mydriatics|mesh-ancestor
153581597|NCT05996133|Sympathomimetics|sympathomimetics|mesh-ancestor
153452019|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153581598|NCT05996133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153581599|NCT05975307|Carboplatin|carboplatin|mesh-list
153581633|NCT05898724|Protective Agents|protective agents|mesh-ancestor
153581634|NCT05898724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581635|NCT05846789|Carboplatin|carboplatin|mesh-list
153581636|NCT05846789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581637|NCT05806515|Carboplatin|carboplatin|mesh-list
153581638|NCT05806515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581699|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581701|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581702|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581704|NCT05533892|Tislelizumab|tislelizumab|mesh-list
153581705|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
153581706|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581707|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153581708|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581709|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581710|NCT05533892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581711|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153581712|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
153581713|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581714|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
153581715|NCT05501665|Paclitaxel|paclitaxel|mesh-list
153581716|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153581717|NCT05501665|Carboplatin|carboplatin|mesh-list
153581718|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
153581719|NCT05501665|Nivolumab|nivolumab|mesh-list
153581720|NCT05501665|Pemetrexed|pemetrexed|mesh-list
153581721|NCT05501665|Ipilimumab|ipilimumab|mesh-list
153581722|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153581723|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153581724|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581725|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
153581726|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
153581727|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
153581728|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581729|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581730|NCT05501665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153581731|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581732|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153581733|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153581734|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153581735|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
153581736|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
153581737|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581738|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153581739|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153807331|NCT00308477|Dexamethasone|dexamethasone|mesh-list
153581769|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581770|NCT05366777|Analgesics|analgesics|mesh-ancestor
153581771|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
153581772|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581773|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581774|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
153581775|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153581776|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581777|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581778|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153581779|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581780|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581781|NCT05335915|Nicotine|nicotine|mesh-list
153581782|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153581783|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
153581784|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581785|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684154|NCT00146341|Telmisartan|telmisartan|mesh-list
153581787|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153581788|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
153581789|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581790|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581791|NCT05295784|Caffeine|caffeine|mesh-list
153581792|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
153581793|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263289|NCT05727163|Protective Agents|protective agents|mesh-ancestor
153581794|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153581795|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581796|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153581797|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581798|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153581799|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153581800|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
153581801|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581802|NCT05289687|Daratumumab|daratumumab|mesh-list
153581803|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153581843|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581844|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153581845|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581846|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
153581847|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581848|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581849|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581850|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
153581851|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153581852|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581853|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
153581854|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153581855|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153581856|NCT05231629|Growth Substances|growth substances|mesh-ancestor
153581857|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
153581858|NCT05173298|Bevacizumab|bevacizumab|mesh-list
153581859|NCT05173298|Atezolizumab|atezolizumab|mesh-list
153581860|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581861|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581862|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153581863|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153581864|NCT05173298|Growth Substances|growth substances|mesh-ancestor
153581894|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581895|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153581896|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153581897|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153581898|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153581899|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581900|NCT05106296|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153581901|NCT05106296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153581903|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153581904|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153581905|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
153581906|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153581907|NCT05106192|Bexarotene|bexarotene|mesh-list
153581908|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153581909|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581919|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581921|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
153581922|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153581923|NCT05103007|Estrogens|estrogens|mesh-ancestor
153581924|NCT05103007|Hormones|hormones|mesh-ancestor
153581925|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581926|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581927|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153581928|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581953|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581954|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
153581955|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
153581956|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581957|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581958|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153581959|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
153581960|NCT04965155|Hormones|hormones|mesh-ancestor
153581961|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581962|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153581963|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581964|NCT04946734|Aspirin|aspirin|mesh-list
153581965|NCT04946734|Clopidogrel|clopidogrel|mesh-list
154263290|NCT05727163|Vitamin B Complex|vitamin b complex|mesh-ancestor
154263291|NCT05727163|Vitamins|vitamins|mesh-ancestor
153581966|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153581967|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581968|NCT04946734|Analgesics|analgesics|mesh-ancestor
153581969|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
153581970|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581971|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581972|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581983|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153581984|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
153581985|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581986|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153807502|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582011|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582012|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153582013|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
153582014|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
153582015|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153582016|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582017|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582018|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153582019|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153582020|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153582021|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153582022|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153582023|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153582024|NCT04919382|Temozolomide|temozolomide|mesh-list
153582025|NCT04919382|Atezolizumab|atezolizumab|mesh-list
153582026|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153582027|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153582028|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
153582029|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582030|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582031|NCT04919382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582032|NCT04919382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582033|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
153582034|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582055|NCT04733547|Diuretics|diuretics|mesh-ancestor
153582056|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
153582057|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582072|NCT04622319|Immunologic Factors|immunologic factors|mesh-ancestor
153582073|NCT04622319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582074|NCT04543591|Ravulizumab|ravulizumab|mesh-list
153582075|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153582076|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153582077|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
153582078|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582080|NCT04518306|Telmisartan|telmisartan|mesh-list
153582082|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153684308|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
153582083|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153582084|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153582085|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582086|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153582087|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582088|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
153582099|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153582100|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582101|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
153582102|NCT04450212|Coagulants|coagulants|mesh-ancestor
153582104|NCT04408118|Bevacizumab|bevacizumab|mesh-list
153582105|NCT04408118|Atezolizumab|atezolizumab|mesh-list
153582106|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582107|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582108|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582109|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582110|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582111|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582112|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582113|NCT04408118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153582115|NCT04408118|Growth Substances|growth substances|mesh-ancestor
153582116|NCT04408118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582117|NCT04408118|Growth Inhibitors|growth inhibitors|mesh-ancestor
153582118|NCT04408118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582119|NCT04385368|Durvalumab|durvalumab|mesh-list
153582120|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582121|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582122|NCT04380636|Paclitaxel|paclitaxel|mesh-list
153582123|NCT04380636|Etoposide|etoposide|mesh-list
153582124|NCT04380636|Carboplatin|carboplatin|mesh-list
153582125|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
153582126|NCT04380636|Pemetrexed|pemetrexed|mesh-list
153582127|NCT04380636|Durvalumab|durvalumab|mesh-list
153582128|NCT04380636|Olaparib|olaparib|mesh-list
153807610|NCT00338910|Hormones|hormones|mesh-ancestor
153582141|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153582142|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153582143|NCT04323280|Dexamethasone|dexamethasone|mesh-list
153582144|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582145|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
153582146|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
153582147|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582148|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582149|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153582150|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
153582151|NCT04323280|Hormones|hormones|mesh-ancestor
153582152|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582153|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153582154|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582166|NCT04221438|Alovudine|alovudine|mesh-list
153582167|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
153582168|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582169|NCT04181749|Aspirin|aspirin|mesh-list
153582170|NCT04181749|Atorvastatin|atorvastatin|mesh-list
153582171|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153582172|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582174|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
153582175|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582176|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582177|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582178|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582179|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153582180|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153582181|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582182|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153582183|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153582184|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582185|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
153582186|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153582187|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153582188|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
153582189|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153582190|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153582191|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
153582192|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153582193|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
153582194|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582195|NCT04161755|Atezolizumab|atezolizumab|mesh-list
153582196|NCT04161755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582197|NCT04161755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582198|NCT04161755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582199|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582214|NCT04151563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582215|NCT04151563|Growth Inhibitors|growth inhibitors|mesh-ancestor
153582216|NCT04142242|Vaccines|vaccines|mesh-list
153582217|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
153582218|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582219|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
153582220|NCT04123366|Olaparib|olaparib|mesh-list
153582221|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582222|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582233|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582234|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452164|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
153582235|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153582236|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
153582237|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582238|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582239|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153582240|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582241|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153582242|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153582243|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582244|NCT04023331|Copper|copper|mesh-list
153582245|NCT04023331|Trace Elements|trace elements|mesh-ancestor
153582246|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
153582247|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582248|NCT04023305|Sevoflurane|sevoflurane|mesh-list
153582249|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153582250|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153582251|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
153582252|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
153582253|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684503|NCT00147784|Interferons|interferons|mesh-list
153582254|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582255|NCT03912259|Emollients|emollients|mesh-list
153582257|NCT03871829|Dexamethasone|dexamethasone|mesh-list
153582258|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
153582259|NCT03871829|BB 1101|bb 1101|mesh-list
153582260|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582261|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
153582262|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
153582263|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582264|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582265|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153582266|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
153582267|NCT03871829|Hormones|hormones|mesh-ancestor
153582268|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582269|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153582270|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582271|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
153807731|NCT00421122|Hormones|hormones|mesh-ancestor
153582307|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
153582308|NCT03742986|Doxorubicin|doxorubicin|mesh-list
153582309|NCT03742986|Nivolumab|nivolumab|mesh-list
153582310|NCT03742986|Trastuzumab|trastuzumab|mesh-list
153582311|NCT03742986|Pertuzumab|pertuzumab|mesh-list
153582312|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582313|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582314|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582315|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582316|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582317|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582318|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153582319|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
153582320|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582321|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582322|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153582323|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
153582324|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153849130|NCT06078228|Atropine|atropine|mesh-list
153582325|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153582326|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153582327|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153582328|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582329|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582330|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582331|NCT03736720|Leucovorin|leucovorin|mesh-list
153582332|NCT03736720|Fluorouracil|fluorouracil|mesh-list
153582351|NCT03703167|Ibrutinib|ibrutinib|mesh-list
153582352|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582353|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582354|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
153582355|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582356|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582357|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153582358|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153582392|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153582393|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582394|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153582395|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582396|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582398|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
153582399|NCT03551691|Omeprazole|omeprazole|mesh-list
153582400|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153582401|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153582402|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153582403|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582404|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582405|NCT03493425|Cisplatin|cisplatin|mesh-list
153582406|NCT03493425|Carboplatin|carboplatin|mesh-list
153582407|NCT03493425|Docetaxel|docetaxel|mesh-list
153582408|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582409|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582410|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582411|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582412|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582413|NCT03373383|Padsevonil|padsevonil|mesh-list
153582414|NCT03373383|Anticonvulsants|anticonvulsants|mesh-ancestor
153582415|NCT03320018|Minocycline|minocycline|mesh-list
153582416|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582417|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582418|NCT03250975|Azithromycin|azithromycin|mesh-list
153582433|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153582434|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
153582435|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582436|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153582437|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153582438|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153582439|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582441|NCT03169972|BAX 855|bax 855|mesh-list
153582468|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153582470|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582471|NCT02939872|Aspirin|aspirin|mesh-list
153582472|NCT02939872|Clopidogrel|clopidogrel|mesh-list
153582473|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153582474|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582475|NCT02939872|Analgesics|analgesics|mesh-ancestor
153582476|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
153582477|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582478|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582479|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582480|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582489|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153582490|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153582491|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
153582492|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582494|NCT02856438|Lenalidomide|lenalidomide|mesh-list
153582495|NCT02856438|Elotuzumab|elotuzumab|mesh-list
153582496|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582497|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
153582498|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
153582499|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807888|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
153582516|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
153582517|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582518|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582519|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582520|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582521|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153582522|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153582523|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582524|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153582525|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153582526|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582527|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
153582528|NCT02626715|Vidarabine|vidarabine|mesh-list
153582529|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
153582530|NCT02626715|Fludarabine|fludarabine|mesh-list
153582531|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
153582532|NCT02626715|Thiotepa|thiotepa|mesh-list
153582533|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153582534|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
153582535|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420928|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
153582536|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582537|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153582538|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
153582539|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582541|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582542|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582543|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153582544|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
153582545|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153582547|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582564|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582565|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582566|NCT02153437|Sotalol|sotalol|mesh-list
153582567|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153582568|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153582569|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
153582570|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582571|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582572|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582573|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153582575|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
153582591|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153582592|NCT01718743|Growth Substances|growth substances|mesh-ancestor
153582593|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
153582594|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582595|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582596|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
153582597|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582598|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
153582599|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582600|NCT01605084|Ritonavir|ritonavir|mesh-list
153582601|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153582602|NCT01605084|Darunavir|darunavir|mesh-list
153582603|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153582604|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153582605|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
153582606|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582607|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582608|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153582609|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153582618|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582619|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582620|NCT01502917|Antibodies|antibodies|mesh-list
153582621|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153582622|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
153582623|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582624|NCT01458366|Carboplatin|carboplatin|mesh-list
153582625|NCT01458366|Etoposide|etoposide|mesh-list
153582626|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
153582627|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153582628|NCT01458366|Ofatumumab|ofatumumab|mesh-list
153582629|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582630|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582631|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153582632|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153582633|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582634|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582635|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153582636|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
153582637|NCT00968760|Cytarabine|cytarabine|mesh-list
153582638|NCT00968760|Etoposide|etoposide|mesh-list
153582639|NCT00968760|Melphalan|melphalan|mesh-list
153582640|NCT00968760|Interleukin-2|interleukin-2|mesh-list
153582641|NCT00968760|Carmustine|carmustine|mesh-list
153582642|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582643|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582644|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153582645|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153582646|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582647|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582658|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582659|NCT00968760|Analgesics|analgesics|mesh-ancestor
153582660|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
153582661|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582663|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582664|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582665|NCT00364286|Dasatinib|dasatinib|mesh-list
153582666|NCT00364286|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153582667|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153582668|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582669|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582670|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582671|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
153582672|NCT00328614|Goserelin|goserelin|mesh-list
153582673|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
153582674|NCT00328614|Bicalutamide|bicalutamide|mesh-list
153582675|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
153582676|NCT00328614|Androgens|androgens|mesh-list
153582696|NCT00328614|Analgesics|analgesics|mesh-ancestor
153582697|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
153582698|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582700|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153582701|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582702|NCT01750359|Analgesics|analgesics|mesh-ancestor
153582703|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
153582704|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582705|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582706|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582707|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582708|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582709|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582710|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582711|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153582712|NCT01750385|Cephalosporins|cephalosporins|mesh-list
153582713|NCT01750385|Second Generation Cephalosporins|second generation cephalosporins|mesh-list
153582714|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582715|NCT01750385|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153582716|NCT01750437|Esomeprazole|esomeprazole|mesh-list
153582717|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153582718|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153582719|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153582720|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582721|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582722|NCT01750463|Chrysarobin|chrysarobin|mesh-list
153582723|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153582724|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582725|NCT01750463|Analgesics|analgesics|mesh-ancestor
153582726|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
153582727|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582728|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582729|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582822|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153582823|NCT01750983|Growth Substances|growth substances|mesh-ancestor
153582824|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
153582825|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582826|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582827|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582828|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582829|NCT01751009|Vitamins|vitamins|mesh-list
153582830|NCT01751009|Vitamin A|vitamin a|mesh-list
153582831|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
153582832|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
153582833|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582834|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
153808156|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153582873|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153582875|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582876|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582878|NCT01751347|Bupivacaine|bupivacaine|mesh-list
153582879|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
153582880|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
153582881|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153582882|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582883|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
153582884|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582885|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154263293|NCT05727163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154263294|NCT05727163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154263295|NCT05727163|Adrenergic Agents|adrenergic agents|mesh-ancestor
153582886|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153582887|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153582888|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153582889|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582890|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
153582903|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582904|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582906|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
153582907|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153582908|NCT01751828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153582909|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153582910|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153582911|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582912|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582913|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
153582914|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582915|NCT01751854|Escitalopram|escitalopram|mesh-list
153781629|NCT00231335|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153582916|NCT01751854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153582917|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153582918|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153582929|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
153582930|NCT01752010|Immunomodulating Agents|immunomodulating agents|mesh-list
153582931|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582933|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
153582934|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582936|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153582937|NCT01752075|Growth Substances|growth substances|mesh-ancestor
153582938|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
153582939|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582940|NCT01752153|Silymarin|silymarin|mesh-list
153582941|NCT01752153|Deferoxamine|deferoxamine|mesh-list
153582942|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
153582943|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582944|NCT01752153|Protective Agents|protective agents|mesh-ancestor
153582945|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582946|NCT01752153|Siderophores|siderophores|mesh-ancestor
153582947|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153582948|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
153582949|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
153582950|NCT01752205|Paclitaxel|paclitaxel|mesh-list
153582951|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153582952|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582953|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582954|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582955|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582956|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582957|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582958|NCT01752205|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153808244|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
153582983|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
153582997|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582998|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153583000|NCT01752543|Conivaptan|conivaptan|mesh-list
153583001|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153583002|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583003|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
153583004|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583005|NCT01752686|Carboplatin|carboplatin|mesh-list
153583006|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583007|NCT01752699|Methadone|methadone|mesh-list
153583008|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153583009|NCT01752699|Narcotics|narcotics|mesh-ancestor
154263296|NCT05727163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583010|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583011|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583012|NCT01752699|Analgesics|analgesics|mesh-ancestor
153583013|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
153583014|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583015|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
153583016|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
153583017|NCT01752790|Azathioprine|azathioprine|mesh-list
153583018|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583019|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
153583020|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583039|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153583040|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153583041|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
153583047|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583049|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
153685020|NCT00150280|Ibuprofen|ibuprofen|mesh-list
153583050|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583051|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153583052|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153583053|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
153583054|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583055|NCT01753102|Estradiol|estradiol|mesh-list
153583056|NCT01753102|Estrogens|estrogens|mesh-ancestor
153583057|NCT01753102|Hormones|hormones|mesh-ancestor
153583058|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583059|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583060|NCT01753128|Imipramine|imipramine|mesh-list
153583061|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153583062|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
153583063|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153583064|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153583065|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153583066|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153583067|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583068|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
153583069|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583070|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583071|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153583072|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
153583073|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153583074|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153583075|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153583076|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153583077|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583078|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
153583079|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583080|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583081|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153583091|NCT01753453|Lenograstim|lenograstim|mesh-list
153583092|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153583093|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
153583094|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583095|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153583096|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153583097|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
153583098|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583099|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153583100|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153583101|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
153583102|NCT01753752|Chitosan|chitosan|mesh-list
153583103|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153583104|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153583105|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153583106|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
153583107|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583108|NCT01753752|Expectorants|expectorants|mesh-ancestor
153583109|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
153583110|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153583128|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583130|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
153583131|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583132|NCT01754116|Cabotegravir|cabotegravir|mesh-list
153583134|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153583135|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153583136|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583137|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583138|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153583139|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153583140|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153583141|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153583142|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
153583144|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
153583145|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
153583146|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583147|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583148|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153583149|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153583150|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583151|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153583152|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153583153|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
153583154|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583155|NCT01754181|Insulin|insulin|mesh-list
153583156|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583157|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583158|NCT01754220|Montelukast|montelukast|mesh-list
153583159|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153583160|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
153583161|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153583162|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
153583163|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583164|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583165|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153583166|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153583167|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583206|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153583207|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583208|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
153583209|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583210|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153583211|NCT01754831|Fluorides|fluorides|mesh-list
153583212|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
153685134|NCT00049556|Gefitinib|gefitinib|mesh-list
153583213|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
153583214|NCT01754831|Protective Agents|protective agents|mesh-ancestor
153583215|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583217|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153583218|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583219|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583221|NCT01754870|Lenalidomide|lenalidomide|mesh-list
153583222|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153583245|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
153583246|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
153583247|NCT01754961|Vitamins|vitamins|mesh-list
153583248|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
153583249|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583250|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153583251|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153583252|NCT01754974|Ribavirin|ribavirin|mesh-list
153583253|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153583254|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
153583255|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583256|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
153583257|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583258|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
153583259|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
153583260|NCT01755078|Calcium|calcium|mesh-list
153583261|NCT01755078|Sevelamer|sevelamer|mesh-list
153583262|NCT01755078|Calcium acetate|calcium acetate|mesh-list
153583263|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153583264|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583265|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153583266|NCT01755078|Antacids|antacids|mesh-ancestor
153583267|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583268|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153583269|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
153583270|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
153736470|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153583272|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
153583273|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
153583274|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583286|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153583313|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583315|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
153583316|NCT01755338|Hormones|hormones|mesh-ancestor
153583317|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583318|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153583319|NCT01755338|Protective Agents|protective agents|mesh-ancestor
153583320|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153583321|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583322|NCT01755377|Benzonidazole|benzonidazole|mesh-list
153583323|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583324|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
153583325|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583326|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153583327|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153583328|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153583329|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583365|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583366|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153583367|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153583368|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583369|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153583370|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153583371|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583373|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153583374|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153583375|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153583376|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
153583377|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583379|NCT01755559|Lumefantrine|lumefantrine|mesh-list
153583380|NCT01755559|Artemether|artemether|mesh-list
153583381|NCT01755559|Piperaquine|piperaquine|mesh-list
153583382|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153583383|NCT01755559|Amodiaquine|amodiaquine|mesh-list
153583384|NCT01755559|Artenimol|artenimol|mesh-list
153583385|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
153583386|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153583387|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153583388|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583389|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583390|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
153583391|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
153583392|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153583393|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
153583394|NCT01755572|Liraglutide|liraglutide|mesh-list
153583417|NCT01754792|Inositol|inositol|mesh-list
153583418|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
153583419|NCT01754792|Vitamins|vitamins|mesh-ancestor
153583420|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
153583421|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583422|NCT01755676|Orlistat|orlistat|mesh-list
153583423|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583424|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583425|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153583426|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153583427|NCT01755728|Acetaminophen|acetaminophen|mesh-list
153583428|NCT01755728|Ibuprofen|ibuprofen|mesh-list
153583429|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153583430|NCT01755728|Analgesics|analgesics|mesh-ancestor
153583431|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
153583432|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583433|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583434|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
153583476|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153583477|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153583478|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583479|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583480|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153583481|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153583482|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
153421049|NCT06288334|Cetirizine|cetirizine|mesh-list
153583483|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583484|NCT01756170|Paclitaxel|paclitaxel|mesh-list
153583485|NCT01756170|Cisplatin|cisplatin|mesh-list
153583486|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153583487|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583488|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
153583489|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
153583503|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685353|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153583504|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
153583505|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583506|NCT01756404|Canagliflozin|canagliflozin|mesh-list
153583507|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153583508|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583509|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583510|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583511|NCT01756417|Metformin|metformin|mesh-list
153583518|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153583519|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153583520|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
153583521|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583522|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583523|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583524|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153583525|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
153583526|NCT01756430|Protective Agents|protective agents|mesh-ancestor
153583527|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153583528|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153583529|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153583530|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
153583531|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153583532|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153583533|NCT01756443|Lidocaine|lidocaine|mesh-list
153583534|NCT01756443|Epinephrine|epinephrine|mesh-list
153583535|NCT01756443|Racepinephrine|racepinephrine|mesh-list
153583536|NCT01756443|Bupivacaine|bupivacaine|mesh-list
153583537|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
153583538|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
153583539|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
153583540|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583541|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583542|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
153583543|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583544|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153583545|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153583546|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153583547|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153583548|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583549|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153583550|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153583551|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
153583552|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583553|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153583554|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153583555|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
153583590|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
153583591|NCT01756547|Diuretics|diuretics|mesh-ancestor
153583592|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
153583593|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583594|NCT01756547|Expectorants|expectorants|mesh-ancestor
153583595|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
153583596|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
153583597|NCT01756612|Hematinics|hematinics|mesh-ancestor
153583598|NCT01756638|Prednisolone|prednisolone|mesh-list
153583599|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583600|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
153583602|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153808745|NCT06163755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153583637|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153583638|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153583639|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153583640|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
153583641|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
153583642|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
153583643|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
153583644|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583672|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153583673|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583674|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153583675|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153583676|NCT01756989|Growth Substances|growth substances|mesh-ancestor
153583677|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
153583678|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
153583679|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153583680|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153583681|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153583682|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
153583683|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583684|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583685|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583686|NCT01757106|Sevoflurane|sevoflurane|mesh-list
153583687|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153583688|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153583689|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
153583690|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
153583691|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583692|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583694|NCT01757236|Rifampin|rifampin|mesh-list
153583695|NCT01757236|Clindamycin|clindamycin|mesh-list
153583696|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
153583697|NCT01757236|Linezolid|linezolid|mesh-list
153583698|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153583699|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
153583700|NCT01757236|Trimethoprim|trimethoprim|mesh-list
153583701|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
153583702|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153583703|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583704|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153583705|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
153583706|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
153583707|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153583717|NCT01757236|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153583718|NCT01757236|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153583719|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153583720|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
153583721|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153583722|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153583723|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153583724|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153583725|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153583726|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153583727|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
153583728|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153808826|NCT05879146|Nirogacestat|nirogacestat|mesh-list
153583745|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153583746|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153583747|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
153583748|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583749|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583750|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583751|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
153583752|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153583753|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583755|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153583756|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583757|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
153583758|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583759|NCT01757457|Abciximab|abciximab|mesh-list
153583760|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
153583761|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153583762|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
153583763|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153583764|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583765|NCT01757587|Insulin|insulin|mesh-list
153583766|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153583767|NCT01757587|Metformin|metformin|mesh-list
153583768|NCT01757587|Vildagliptin|vildagliptin|mesh-list
153583798|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153583799|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
153583801|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583802|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583803|NCT01757769|Urological Agents|urological agents|mesh-ancestor
153583804|NCT01757795|Otaplimastat|otaplimastat|mesh-list
153583805|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153583806|NCT01757795|Protective Agents|protective agents|mesh-ancestor
153583807|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583808|NCT01757808|Ranolazine|ranolazine|mesh-list
153583809|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153583810|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153583811|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583836|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583902|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583950|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583951|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153583953|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583954|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583955|NCT01758393|Prednisone|prednisone|mesh-list
153583956|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583958|NCT01758393|Hormones|hormones|mesh-ancestor
153781631|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153583959|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360013|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583960|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583987|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583988|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583989|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
153583990|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583991|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153584024|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153584025|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584026|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584027|NCT01758978|Hydrocodone|hydrocodone|mesh-list
153584028|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153584029|NCT01758978|Narcotics|narcotics|mesh-ancestor
153584030|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584031|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584032|NCT01758978|Analgesics|analgesics|mesh-ancestor
153584033|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
153584034|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584036|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
153584037|NCT01759030|Rituximab|rituximab|mesh-list
153584038|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153584039|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584040|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
153584041|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584042|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584043|NCT01759108|Rebamipide|rebamipide|mesh-list
153849353|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685608|NCT00152620|Prednisolone|prednisolone|mesh-list
153584044|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153584045|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584046|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
153584047|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584048|NCT01759108|Protective Agents|protective agents|mesh-ancestor
153584049|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584050|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584051|NCT01759394|Maleic acid|maleic acid|mesh-list
153584052|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584053|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584072|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153584073|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153584074|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584076|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153584077|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
153584078|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
153584086|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584087|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153584088|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584089|NCT01759589|Remifentanil|remifentanil|mesh-list
153584090|NCT01759589|Propofol|propofol|mesh-list
153584091|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
153584092|NCT01759589|Anesthetics|anesthetics|mesh-list
153584096|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584097|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
153584098|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153584099|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153584100|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153584101|NCT01759589|Narcotics|narcotics|mesh-ancestor
153584102|NCT01759589|Analgesics|analgesics|mesh-ancestor
153584103|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
153584104|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584105|NCT01759706|Dexamethasone|dexamethasone|mesh-list
153584106|NCT01759706|Sufentanil|sufentanil|mesh-list
153584107|NCT01759706|Diazepam|diazepam|mesh-list
153584108|NCT01759706|Ondansetron|ondansetron|mesh-list
153584109|NCT01759706|Anesthetics|anesthetics|mesh-list
153584110|NCT01759706|Ropivacaine|ropivacaine|mesh-list
153584111|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584113|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
153584114|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584115|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584116|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584117|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
153584118|NCT01759706|Hormones|hormones|mesh-ancestor
153584119|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584133|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
153584134|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153584135|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153584136|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
153584137|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
153584138|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
153584139|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153584140|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153584141|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153584142|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153584143|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153584144|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153584145|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
153584146|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
153584147|NCT01759719|Chromium|chromium|mesh-list
153584148|NCT01759719|Trace Elements|trace elements|mesh-ancestor
153584149|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
153584170|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153584171|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153584172|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
153584173|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584174|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584175|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153584176|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153584177|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
153584178|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584179|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153584180|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153584181|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153584182|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584183|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153584184|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
153584185|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153584186|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
153584188|NCT01759940|Ropivacaine|ropivacaine|mesh-list
153584189|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
153584190|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
153584191|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584192|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584193|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
153584194|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584195|NCT01760018|Desflurane|desflurane|mesh-list
153584196|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153584197|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
153584198|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
153584199|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584200|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584201|NCT01760096|Cyclosporine|cyclosporine|mesh-list
153584202|NCT01760096|Levamisole|levamisole|mesh-list
153584226|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584227|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584228|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153584229|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
153584230|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584232|NCT01760148|Ribavirin|ribavirin|mesh-list
153584233|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
153584234|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
153685733|NCT00043758|Tolvaptan|tolvaptan|mesh-list
153584235|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584236|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
153584237|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584238|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
153584239|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584240|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
153584241|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584242|NCT01760161|Ropivacaine|ropivacaine|mesh-list
153584243|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
153584244|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
153584245|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584246|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584247|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
153584248|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584249|NCT01760174|Bupivacaine|bupivacaine|mesh-list
153584250|NCT01760174|Ropivacaine|ropivacaine|mesh-list
153584251|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
153584252|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
153584253|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584254|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584255|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
153584256|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584257|NCT01760252|Capecitabine|capecitabine|mesh-list
153584258|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
153584259|NCT01760252|Irinotecan|irinotecan|mesh-list
153584260|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153584261|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
153584262|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584263|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584264|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153584265|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153584266|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584267|NCT01760278|Cetrorelix|cetrorelix|mesh-list
153584268|NCT01760278|Hormones|hormones|mesh-list
153584269|NCT01760278|Progesterone|progesterone|mesh-list
153584270|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153584271|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584272|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584303|NCT01760564|Miglustat|miglustat|mesh-list
153584304|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809203|NCT04771156|Ketorolac|ketorolac|mesh-list
153584370|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584371|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153584372|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153584373|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389586|NCT00002517|Dexamethasone|dexamethasone|mesh-list
153584374|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584375|NCT01760694|Antidotes|antidotes|mesh-ancestor
153584388|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584389|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
153584390|NCT01760798|Teriparatide|teriparatide|mesh-list
153584391|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153584392|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584393|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153584395|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153584396|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584397|NCT01760824|Amoxicillin|amoxicillin|mesh-list
153584398|NCT01760824|Metronidazole|metronidazole|mesh-list
153584399|NCT01760824|Clarithromycin|clarithromycin|mesh-list
153584400|NCT01760824|Tetracycline|tetracycline|mesh-list
153584401|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153584402|NCT01760824|Esomeprazole|esomeprazole|mesh-list
153584403|NCT01760824|Bismuth|bismuth|mesh-list
153584404|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584405|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584406|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153584407|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153584408|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153584409|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584410|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153584411|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584412|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584413|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153364272|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
153584414|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153584415|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153584416|NCT01760824|Antacids|antacids|mesh-ancestor
153584417|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153584418|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584419|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
153584420|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153584421|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584422|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584423|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584424|NCT01760967|Analgesics|analgesics|mesh-ancestor
153584425|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
153584426|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584427|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153584428|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153584429|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153584430|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
153584431|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584432|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584433|NCT01760980|Exemestane|exemestane|mesh-list
153809298|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
153584462|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
153584463|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584464|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153584465|NCT01761149|Remifentanil|remifentanil|mesh-list
153584466|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153584467|NCT01761149|Narcotics|narcotics|mesh-ancestor
153584468|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584469|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584470|NCT01761149|Analgesics|analgesics|mesh-ancestor
153584471|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
153584472|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584473|NCT01761201|Levofloxacin|levofloxacin|mesh-list
153584474|NCT01761201|Ofloxacin|ofloxacin|mesh-list
153584475|NCT01761201|Isoniazid|isoniazid|mesh-list
153584476|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153584477|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584478|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584479|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153584480|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153584481|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584482|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584483|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584484|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153584485|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153584486|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
153584487|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153584489|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
153584490|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153584491|NCT01761214|Amoxicillin|amoxicillin|mesh-list
153584492|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
153584493|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
153584494|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
153584495|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153584496|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
153584584|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584585|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153584586|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
153584587|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584592|NCT01761994|Nafamostat|nafamostat|mesh-list
153584593|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153584594|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584595|NCT01761994|Analgesics|analgesics|mesh-ancestor
153584596|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
153584597|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584598|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584599|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584600|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584601|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
153584602|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
153584603|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584605|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153584606|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153584607|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153584608|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153584609|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
153584610|NCT01762046|Metformin|metformin|mesh-list
153584611|NCT01762046|Glipizide|glipizide|mesh-list
153584612|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153584613|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584614|NCT01762150|Gemcitabine|gemcitabine|mesh-list
153584615|NCT01762150|Sorafenib|sorafenib|mesh-list
153584616|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584617|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153584618|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
153584619|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584643|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809460|NCT03342196|Fludarabine|fludarabine|mesh-list
153584700|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584701|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584702|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153584703|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153584704|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153584705|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
153584723|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584724|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584725|NCT01762540|Hormones|hormones|mesh-ancestor
153584726|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584727|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153584735|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
153584736|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584737|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
153584738|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584739|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
153584740|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584741|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153584742|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153584743|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584744|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153584745|NCT01762657|Cyclosporine|cyclosporine|mesh-list
153584746|NCT01762657|Lansoprazole|lansoprazole|mesh-list
153584747|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
153584748|NCT01762657|Cyclosporins|cyclosporins|mesh-list
153584749|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584750|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584751|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153584752|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
153584753|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584754|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
153584755|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584756|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
153584757|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584758|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153584759|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153584760|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584761|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153584762|NCT01762670|Metronidazole|metronidazole|mesh-list
153584763|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584764|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584765|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153584766|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153584767|NCT01762787|Aspirin|aspirin|mesh-list
153584768|NCT01762787|Prednisolone|prednisolone|mesh-list
153584769|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153584770|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
153584771|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153809611|NCT02580994|Carboplatin|carboplatin|mesh-list
153584844|NCT01762995|Antacids|antacids|mesh-ancestor
153584845|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584846|NCT01762995|Trace Elements|trace elements|mesh-ancestor
153584847|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
153584848|NCT01763021|Rifampin|rifampin|mesh-list
153584849|NCT01763021|Ibrutinib|ibrutinib|mesh-list
153584850|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153584851|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
153686097|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
153584852|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584854|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
153584855|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153584856|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584857|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584858|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153584859|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153584860|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153584861|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153584862|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153584871|NCT01763385|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153584872|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153584873|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584892|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153584893|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153584894|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
153584895|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584896|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
153584897|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584898|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584899|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153584900|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
153584901|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
153584902|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153584903|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153584904|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153584905|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153584906|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
153584907|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584908|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686152|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153584909|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
153584911|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584912|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
153584913|NCT01763476|Paclitaxel|paclitaxel|mesh-list
153584914|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153584915|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584916|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
153584917|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
153584918|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
153584919|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584920|NCT01763541|Anastrozole|anastrozole|mesh-list
153584921|NCT01763541|Leuprolide|leuprolide|mesh-list
153584922|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153584923|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584924|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153584925|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153584937|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153584938|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
153584939|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153584940|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
153809691|NCT01524926|Crizotinib|crizotinib|mesh-list
153584972|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584973|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584974|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584976|NCT01763788|Necitumumab|necitumumab|mesh-list
153584977|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584978|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153584979|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
153584980|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584981|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153584982|NCT01764087|Paclitaxel|paclitaxel|mesh-list
153584983|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
153584984|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153584985|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584986|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
153584987|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
153585028|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585029|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153585030|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153585033|NCT01763424|Niacinamide|niacinamide|mesh-list
153585034|NCT01763424|Niacin|niacin|mesh-list
153585035|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
153585036|NCT01763424|Calcipotriene|calcipotriene|mesh-list
153585071|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585072|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585073|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
153686188|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
153585074|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585076|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585077|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585078|NCT01764828|Gemcitabine|gemcitabine|mesh-list
153585079|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153585080|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
153585081|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585082|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585083|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153585085|NCT01764867|Mirtazapine|mirtazapine|mesh-list
153585086|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
153585087|NCT01764867|Trazodone|trazodone|mesh-list
153585089|NCT01764867|Bupropion|bupropion|mesh-list
153585090|NCT01764867|Fluoxetine|fluoxetine|mesh-list
153585091|NCT01764867|Paroxetine|paroxetine|mesh-list
153585092|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153585093|NCT01764867|Sertraline|sertraline|mesh-list
153585094|NCT01764867|Escitalopram|escitalopram|mesh-list
153585095|NCT01764867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153585096|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153585097|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585098|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585099|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585100|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
153809832|NCT00349362|Testosterone|testosterone|mesh-list
153585134|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153585135|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153585136|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
153585137|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153585138|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153585139|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
153585140|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585141|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585142|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585143|NCT01764893|Urological Agents|urological agents|mesh-ancestor
153585145|NCT01765010|Vitamin D|vitamin d|mesh-list
153585146|NCT01765010|Calcitriol|calcitriol|mesh-list
153585147|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
153585148|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153585149|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153585150|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585151|NCT01765010|Vitamins|vitamins|mesh-ancestor
153585152|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
153585153|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153585154|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153585155|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585156|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585157|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153585158|NCT01765023|Metformin|metformin|mesh-list
153585159|NCT01765023|Atorvastatin|atorvastatin|mesh-list
153585160|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153809879|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585201|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153585202|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
153585203|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585204|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585205|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585206|NCT01765556|Ketoconazole|ketoconazole|mesh-list
153585207|NCT01765556|Vemurafenib|vemurafenib|mesh-list
153585208|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
153585209|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585210|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153585211|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153585212|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809933|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153585223|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153585224|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154263298|NCT05727163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154263299|NCT05727163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154263300|NCT05727163|Analgesics|analgesics|mesh-ancestor
154263301|NCT05727163|Sensory System Agents|sensory system agents|mesh-ancestor
154263302|NCT05727163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263303|NCT05727163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154263304|NCT05727163|Parasympatholytics|parasympatholytics|mesh-ancestor
153585225|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585226|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153585227|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585228|NCT01765738|Minocycline|minocycline|mesh-list
153585230|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585231|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545898|NCT06297499|Antipruritics|antipruritics|mesh-ancestor
153585232|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153585233|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
153585234|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
153585235|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153585236|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585237|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585238|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153585253|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
153585254|NCT01765829|Risperidone|risperidone|mesh-list
153585255|NCT01765829|Aripiprazole|aripiprazole|mesh-list
153585256|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153585257|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153585258|NCT01765829|Ziprasidone|ziprasidone|mesh-list
153585259|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
153585260|NCT01765829|Clozapine|clozapine|mesh-list
153585261|NCT01765829|Asenapine|asenapine|mesh-list
153585262|NCT01765829|Amisulpride|amisulpride|mesh-list
153585263|NCT01765829|Perphenazine|perphenazine|mesh-list
153585264|NCT01765829|Sertindole|sertindole|mesh-list
153585265|NCT01765829|Sulpiride|sulpiride|mesh-list
153585266|NCT01765829|Clopenthixol|clopenthixol|mesh-list
153585267|NCT01765829|Clothiapine|clothiapine|mesh-list
153585268|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153585269|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
153585270|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585271|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585272|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585273|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153585274|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585275|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153585276|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153585277|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
153585278|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
153585279|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
153585280|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585281|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153585282|NCT01765829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153585283|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153585284|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585285|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
153585286|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
153585287|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153809976|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
153585299|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
153585300|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585301|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585303|NCT01765881|Dinoprostone|dinoprostone|mesh-list
153585313|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585315|NCT01766063|Interferon-beta|interferon-beta|mesh-list
153585316|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
153686428|NCT00157261|Tenecteplase|tenecteplase|mesh-list
153585317|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585318|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
153585319|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263305|NCT05727163|Vasodilator Agents|vasodilator agents|mesh-ancestor
154263306|NCT05727163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154263307|NCT05727163|Antioxidants|antioxidants|mesh-ancestor
154263308|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
154263309|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154263310|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
154263311|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263312|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
154263313|NCT05694286|Protective Agents|protective agents|mesh-ancestor
154263314|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154263315|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263316|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263317|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154263318|NCT05687032|Immunotoxins|immunotoxins|mesh-ancestor
154263319|NCT05687032|Immunoconjugates|immunoconjugates|mesh-ancestor
153585320|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
153585321|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585322|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153585323|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
153585324|NCT01766089|Remifentanil|remifentanil|mesh-list
153585325|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153585326|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585327|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585328|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153585330|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
153585331|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585332|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153585333|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153585334|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153585335|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
153585336|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585337|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585338|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153585339|NCT01766089|Narcotics|narcotics|mesh-ancestor
153585340|NCT01766154|Tirofiban|tirofiban|mesh-list
153585341|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153585342|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153585343|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585344|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153585345|NCT01766180|Resveratrol|resveratrol|mesh-list
153585346|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
153585347|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585348|NCT01766180|Protective Agents|protective agents|mesh-ancestor
153585349|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585350|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585351|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153585352|NCT01766245|Semaglutide|semaglutide|mesh-list
153686499|NCT00157651|Warfarin|warfarin|mesh-list
153585353|NCT01766245|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153585354|NCT01766245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153585355|NCT01766245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585356|NCT01766258|Carbidopa|carbidopa|mesh-list
153585357|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153585358|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153585359|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
153585360|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810045|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153585396|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
153585397|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585399|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153585400|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154263320|NCT05687032|Immunologic Factors|immunologic factors|mesh-ancestor
154263321|NCT05687032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746960|NCT00152399|Hormones|hormones|mesh-ancestor
153585401|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
153585402|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585403|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153585404|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153585405|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
153585406|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153585407|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585408|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153585409|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
153585410|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585411|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585412|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585413|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686572|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153585414|NCT01766583|Lenalidomide|lenalidomide|mesh-list
153585415|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
153585416|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585417|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153585418|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153585419|NCT01766583|Growth Substances|growth substances|mesh-ancestor
153585420|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
153585421|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585422|NCT01766609|Triamcinolone|triamcinolone|mesh-list
153585432|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
153585433|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585434|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585435|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
153585436|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
153585437|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
153585438|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585439|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153585440|NCT01766843|Charcoal|charcoal|mesh-list
153585441|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153585442|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
153585443|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585444|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585445|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153810107|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
153585462|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
153585463|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153585464|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585465|NCT01767090|Leuprolide|leuprolide|mesh-list
153585466|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153585467|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
153585468|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153585469|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585470|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153585471|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585472|NCT01767259|Valsartan|valsartan|mesh-list
153585473|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153585474|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153585475|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153585476|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153585477|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585478|NCT01767259|Diuretics|diuretics|mesh-ancestor
153585479|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
153585480|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585481|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153585482|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585483|NCT01767272|Fexofenadine|fexofenadine|mesh-list
153585484|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153585485|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153585486|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153585487|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
153585494|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153585495|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153585496|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153585497|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585498|NCT01767298|Diuretics|diuretics|mesh-ancestor
153585499|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
153585500|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585501|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153585502|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585503|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
153585504|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
153585505|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153585506|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
153585507|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585508|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810164|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153585533|NCT01767454|Dabrafenib|dabrafenib|mesh-list
153585534|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153585535|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585536|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153585537|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585538|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153585539|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585540|NCT01767532|Cephalexin|cephalexin|mesh-list
153585541|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585542|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585543|NCT01767545|Dexamethasone|dexamethasone|mesh-list
153585544|NCT01767545|Bevacizumab|bevacizumab|mesh-list
153585545|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153585546|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585547|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153585548|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153585549|NCT01767545|Growth Substances|growth substances|mesh-ancestor
153585550|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585551|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
153585552|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153585553|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
153585554|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
153585569|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153585570|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585571|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585572|NCT01767714|Plerixafor|plerixafor|mesh-list
153585573|NCT01767714|Lenograstim|lenograstim|mesh-list
153585574|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153585592|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585593|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153585594|NCT01767610|Infliximab|infliximab|mesh-list
153585595|NCT01767610|Fenofibrate|fenofibrate|mesh-list
153585596|NCT01767610|Pitavastatin|pitavastatin|mesh-list
153585597|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153585598|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
153585599|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585600|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153585601|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153585602|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153585603|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585604|NCT01767610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153585605|NCT01767610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153585606|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
153585607|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153585608|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585609|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153585610|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153585611|NCT01768078|Betamethasone|betamethasone|mesh-list
153585612|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585613|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
153585614|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153585615|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
153585616|NCT01768078|Hormones|hormones|mesh-ancestor
153585627|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
153585628|NCT01768182|Vitamins|vitamins|mesh-ancestor
153585629|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
153585630|NCT01768182|Hematinics|hematinics|mesh-ancestor
153585631|NCT01768195|Entecavir|entecavir|mesh-list
153585632|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
153585633|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747196|NCT02935855|Warfarin|warfarin|mesh-list
153585634|NCT01768208|Saxagliptin|saxagliptin|mesh-list
153585635|NCT01768208|Incretins|incretins|mesh-ancestor
153585636|NCT01768208|Hormones|hormones|mesh-ancestor
153585637|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585638|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585639|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153585640|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
153585641|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585642|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585643|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153585644|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153585676|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585677|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585678|NCT01768299|Misoprostol|misoprostol|mesh-list
153585679|NCT01768299|Mifepristone|mifepristone|mesh-list
153585680|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153585681|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
153585682|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153585692|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153585693|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153585694|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
153585695|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585696|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
153585712|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153585713|NCT01768351|Calcitriol|calcitriol|mesh-list
153585714|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153585715|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585716|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153585717|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585718|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585719|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153585720|NCT01768351|Vitamins|vitamins|mesh-ancestor
153585721|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
153686782|NCT00159679|Analgesics|analgesics|mesh-ancestor
153585722|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153585723|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153585724|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153585725|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585726|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153585727|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
153585728|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153585729|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153585730|NCT01768377|Lidocaine|lidocaine|mesh-list
153585731|NCT01768377|Midazolam|midazolam|mesh-list
153585732|NCT01768377|Fentanyl|fentanyl|mesh-list
153585733|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
153585734|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
153585735|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585736|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585737|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
153585738|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585739|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153585740|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153585741|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153585742|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585743|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585744|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153585745|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153585746|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153585758|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
153585759|NCT01768390|Protective Agents|protective agents|mesh-ancestor
153585760|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585761|NCT01768455|Glimepiride|glimepiride|mesh-list
153585762|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153585763|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153585764|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585765|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153585766|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
153585800|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585801|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153585802|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153585803|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
153585839|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585840|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585841|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153585843|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
153585844|NCT01768884|Protective Agents|protective agents|mesh-ancestor
153585845|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
153585846|NCT01768897|Cytarabine|cytarabine|mesh-list
153585847|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
153585848|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153585849|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
153585850|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585851|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585852|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
153585853|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585854|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153585855|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
153585856|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585857|NCT01768897|Analgesics|analgesics|mesh-ancestor
153585858|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
153585901|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153585902|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585903|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153585904|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585905|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585906|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153585908|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
153585909|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585911|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153585912|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153585913|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585914|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585915|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153585916|NCT01769183|Protective Agents|protective agents|mesh-ancestor
153585917|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585918|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585919|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810518|NCT00319787|Gefitinib|gefitinib|mesh-list
153585961|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585963|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
153585964|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585965|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
153585966|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
153585968|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
153585969|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
153585970|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153585971|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585972|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585973|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153585974|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585975|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585976|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
153585977|NCT01769677|Hydrocodone|hydrocodone|mesh-list
153585978|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153585979|NCT01769677|Narcotics|narcotics|mesh-ancestor
153585981|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585982|NCT01769677|Analgesics|analgesics|mesh-ancestor
153585983|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
153585984|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585985|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
153585986|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
153585987|NCT01769703|Dabigatran|dabigatran|mesh-list
153585988|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
153585989|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153585990|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
153585991|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585992|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585993|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
153586017|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586019|NCT01769820|Dexamethasone|dexamethasone|mesh-list
153586020|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586055|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153586056|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
153586059|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153586060|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586061|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
153586062|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153586063|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153586064|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
153586066|NCT01769911|Etoposide|etoposide|mesh-list
153586067|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
153586068|NCT01769911|Melphalan|melphalan|mesh-list
153586069|NCT01769911|Carmustine|carmustine|mesh-list
153586070|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153586071|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153586072|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586073|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153586074|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153586107|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586108|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586109|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
153586111|NCT01770106|Alendronate|alendronate|mesh-list
153586121|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586122|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
153586140|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153586141|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153586142|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586144|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153586145|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153586146|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
153586147|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586148|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153586149|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153586150|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586151|NCT01770223|Ribavirin|ribavirin|mesh-list
153586152|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153586153|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
153586154|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586155|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
153586156|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586157|NCT01770236|Acetaminophen|acetaminophen|mesh-list
153586158|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153586159|NCT01770236|Analgesics|analgesics|mesh-ancestor
153586160|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
153586161|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586162|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586163|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
153586165|NCT01770301|Bevacizumab|bevacizumab|mesh-list
153586166|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153586167|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586168|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
153586169|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
153586170|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
153586171|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586172|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153586173|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153586174|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153586175|NCT01770301|Growth Substances|growth substances|mesh-ancestor
153586203|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586204|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586205|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153586219|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586220|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586221|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586223|NCT01770795|genexol-PM|genexol-pm|mesh-list
153586224|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153586225|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
153586253|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586254|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153586255|NCT01771081|Ranibizumab|ranibizumab|mesh-list
153586256|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153586259|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586260|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
153586261|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586262|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
153586263|NCT01771146|Irinotecan|irinotecan|mesh-list
153586264|NCT01771146|Folfirinox|folfirinox|mesh-list
153586265|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586266|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153586267|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153586268|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586286|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
153586287|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586288|NCT01771302|Calcium|calcium|mesh-list
153586289|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153586290|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586291|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
153586292|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153586293|NCT01771328|Cortisone|cortisone|mesh-list
153586294|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586295|NCT01771406|Nebivolol|nebivolol|mesh-list
153586296|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153586297|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
153586298|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153586299|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153586300|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153586301|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
153687128|NCT00052754|Gefitinib|gefitinib|mesh-list
153586302|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586303|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586304|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586305|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153586306|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586307|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153586308|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586309|NCT01771458|Tamoxifen|tamoxifen|mesh-list
153586310|NCT01771458|Trastuzumab|trastuzumab|mesh-list
153586311|NCT01771458|Everolimus|everolimus|mesh-list
153586312|NCT01771458|Sorafenib|sorafenib|mesh-list
153586313|NCT01771458|Letrozole|letrozole|mesh-list
153586349|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
153586350|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586351|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586352|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586353|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586354|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153586355|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586356|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586357|NCT01771874|Bupropion|bupropion|mesh-list
153586358|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153586359|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153586360|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
153586361|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153586362|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153586363|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153586364|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153586365|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586366|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
153586367|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586368|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586369|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153586370|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153586371|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586372|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
153586373|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
153586374|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153586375|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
153586376|NCT01771978|Diltiazem|diltiazem|mesh-list
153586377|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153586378|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153586379|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153586406|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586459|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586460|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586503|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153586505|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586506|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586507|NCT01773005|Acetaminophen|acetaminophen|mesh-list
153586508|NCT01773005|Ibuprofen|ibuprofen|mesh-list
153586509|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153586510|NCT01773005|Analgesics|analgesics|mesh-ancestor
153586511|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
153586512|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586513|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586514|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
153586515|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153586516|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586517|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586518|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153586519|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586520|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586521|NCT01773044|Lidocaine|lidocaine|mesh-list
153586522|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
153586523|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
153586566|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586567|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153586568|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153586569|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153586571|NCT01773460|Everolimus|everolimus|mesh-list
153586572|NCT01773460|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153586573|NCT01773460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153586574|NCT01773460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586575|NCT01773460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586576|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586577|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
153586578|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586579|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586580|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153586581|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153586582|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153586583|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
153586584|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586585|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153586586|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153586587|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586589|NCT01773538|Lactulose|lactulose|mesh-list
153586590|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586591|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586592|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586593|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
153586594|NCT01773616|Prednisolone|prednisolone|mesh-list
153586645|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586647|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153586648|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586649|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153586650|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153586651|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153586652|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586668|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586670|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
153586671|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586689|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153586690|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153586691|NCT01774474|Growth Substances|growth substances|mesh-ancestor
153586692|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586693|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
153586694|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586695|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
153586696|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
153586697|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586698|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586699|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
153421381|NCT05973786|Valproic Acid|valproic acid|mesh-list
153586701|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586702|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153586703|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
153586704|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586705|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586706|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153586707|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586708|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
153586709|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153586710|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153586711|NCT01774474|Analgesics|analgesics|mesh-ancestor
153586712|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
153586713|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586726|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153586727|NCT01774838|Clopidogrel|clopidogrel|mesh-list
153586728|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153586729|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153586730|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153586731|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153586732|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153586733|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
153586734|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586735|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586736|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586737|NCT01774864|Udenafil|udenafil|mesh-list
153586738|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153586754|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153586756|NCT01775098|Protective Agents|protective agents|mesh-ancestor
153586757|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586758|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153586759|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
153586760|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586761|NCT01775397|Vancomycin|vancomycin|mesh-list
153586762|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
153586763|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586764|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586765|NCT01775540|Dexamethasone|dexamethasone|mesh-list
153586766|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
153586767|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586768|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
153586769|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
153586770|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586771|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586772|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586773|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
153586774|NCT01775540|Hormones|hormones|mesh-ancestor
153586775|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586776|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153586785|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153586786|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
153586787|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586788|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153586789|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153586790|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586791|NCT01775618|Factor VIII|factor viii|mesh-list
153586792|NCT01775618|Coagulants|coagulants|mesh-ancestor
153586793|NCT01775631|Rituximab|rituximab|mesh-list
153586794|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153586795|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586796|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
153586797|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586798|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586799|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
153586800|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586801|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586802|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153586821|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153586822|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153360080|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
153586824|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
153586825|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153586826|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153586827|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153586828|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
153586829|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586830|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153586831|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153586832|NCT01775839|Protective Agents|protective agents|mesh-ancestor
153586833|NCT01775891|Flecainide|flecainide|mesh-list
153586834|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153586835|NCT01775891|Propafenone|propafenone|mesh-list
153586836|NCT01775891|Pilsicainide|pilsicainide|mesh-list
153586837|NCT01775891|Lidocaine|lidocaine|mesh-list
153586838|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153586839|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153586840|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153586841|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586842|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
153586843|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
153586884|NCT01776567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153586885|NCT01776567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153586886|NCT01776567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586887|NCT01776567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586888|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586889|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
153586890|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586891|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586892|NCT01776671|Gabapentin|gabapentin|mesh-list
153586893|NCT01776671|Analgesics|analgesics|mesh-ancestor
153586894|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
153586895|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586896|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586897|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
153586924|NCT01776788|Hormones|hormones|mesh-ancestor
153586925|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586927|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586928|NCT01776970|Nabiximols|nabiximols|mesh-list
153586929|NCT01776970|Analgesics|analgesics|mesh-ancestor
153586930|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
153586931|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586932|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586933|NCT01777087|Capsaicin|capsaicin|mesh-list
153586934|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
153586935|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
153586936|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
153586937|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586945|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
153586946|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586947|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153586948|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153586949|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
153586950|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
153586951|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153586952|NCT01777464|Histamine|histamine|mesh-list
153586962|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586964|NCT01777477|Amebicides|amebicides|mesh-ancestor
153586965|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153586966|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153586967|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586968|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
153586969|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586970|NCT01777503|Clopidogrel|clopidogrel|mesh-list
153586971|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153586972|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153586973|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153586974|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153586975|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153586976|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
153586977|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586978|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586979|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586980|NCT01777685|Sulpiride|sulpiride|mesh-list
153586981|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153586982|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153586983|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586984|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586985|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153586986|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153586988|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586989|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586990|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153586991|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
153586992|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153586993|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153586994|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586995|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586996|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
153586997|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153586998|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153586999|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
153587000|NCT01777867|Miotics|miotics|mesh-ancestor
153587001|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
153587002|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587003|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587004|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153587005|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153587049|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153587050|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153587051|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
153587052|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
153587054|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
153587055|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
153587056|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153587057|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
153587058|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
153587059|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587060|NCT01778192|Cathartics|cathartics|mesh-ancestor
153587073|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153587074|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
153587075|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587076|NCT01778309|Expectorants|expectorants|mesh-ancestor
153587077|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
153587078|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153587079|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
153587080|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587081|NCT01778309|Protective Agents|protective agents|mesh-ancestor
153587082|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587083|NCT01778309|Antidotes|antidotes|mesh-ancestor
153587084|NCT01778400|Ethanol|ethanol|mesh-list
153587085|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153587086|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587087|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587088|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587089|NCT01778413|Tenofovir|tenofovir|mesh-list
153587090|NCT01778413|Emtricitabine|emtricitabine|mesh-list
153587091|NCT01778413|Efavirenz|efavirenz|mesh-list
153587092|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153587093|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
153587094|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587095|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153587096|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153587097|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587098|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587099|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153587100|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153587101|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153587102|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153587128|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587129|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
153587130|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
153587131|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
153587132|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587133|NCT01778842|Clopidogrel|clopidogrel|mesh-list
154263328|NCT05650879|Trastuzumab|trastuzumab|mesh-list
153747937|NCT02920801|Metformin|metformin|mesh-list
153587134|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153587135|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153587136|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153587137|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153587138|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153587139|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
153587140|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587141|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587142|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587143|NCT01779089|Minocycline|minocycline|mesh-list
153587144|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153587145|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587146|NCT01779232|Danazol|danazol|mesh-list
153587147|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153587148|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
153587199|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587200|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153587201|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153587202|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153587203|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153587239|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587240|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587241|NCT01779492|Analgesics|analgesics|mesh-ancestor
153587242|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
153587243|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587244|NCT01779518|Interferons|interferons|mesh-list
153587245|NCT01779518|Ribavirin|ribavirin|mesh-list
153587246|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
153587247|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587248|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
153587249|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587250|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
153587251|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587253|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153587254|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153587255|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587257|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153587258|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153587259|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587260|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
153587261|NCT01779687|Atorvastatin|atorvastatin|mesh-list
153587262|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153587263|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153587264|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
153587265|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587266|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153587267|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153587268|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587269|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153587270|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153587297|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587338|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153587341|NCT01780233|Citric Acid|citric acid|mesh-list
153587342|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
153587343|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153587344|NCT01780233|Narcotics|narcotics|mesh-ancestor
153587345|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587346|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587347|NCT01780233|Analgesics|analgesics|mesh-ancestor
153587348|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
153587349|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587350|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153587351|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153587352|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
153587353|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
153587354|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
153587355|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153587356|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
153587357|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
153587358|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263329|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154263330|NCT05650879|Maytansine|maytansine|mesh-list
154263331|NCT05650879|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154263332|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263333|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735924|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587359|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153587360|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153587361|NCT01780259|Triazolam|triazolam|mesh-list
153587362|NCT01780259|Esketamine|esketamine|mesh-list
153587363|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
153587364|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153587365|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153587366|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153587367|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153587368|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587369|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587394|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587395|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587396|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
153587397|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587398|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587399|NCT01780467|Protective Agents|protective agents|mesh-ancestor
153587400|NCT01780519|Lorazepam|lorazepam|mesh-list
153587401|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
153587402|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
153587403|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
153587404|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587405|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781632|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587406|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153587407|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153587408|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587409|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153587410|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153587411|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153587412|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
153587413|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
153587414|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587415|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587416|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153587417|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153587418|NCT01780558|Hormones|hormones|mesh-list
153587419|NCT01780558|Estradiol|estradiol|mesh-list
153587420|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153587421|NCT01780558|Progesterone|progesterone|mesh-list
153587422|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587423|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587424|NCT01780558|Estrogens|estrogens|mesh-ancestor
153587425|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153587426|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
153587427|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153587428|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153587429|NCT01780558|Progestins|progestins|mesh-ancestor
153587430|NCT01780610|Letrozole|letrozole|mesh-list
153587487|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
153587488|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587489|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153587490|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153587491|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587492|NCT01780948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153587525|NCT01781442|MTOR Inhibitors|mtor inhibitors|mesh-list
153587526|NCT01781442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587527|NCT01781442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587528|NCT01781442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587529|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153587530|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
153587531|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587532|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587533|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153587534|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587535|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153587546|NCT01781663|Petrolatum|petrolatum|mesh-list
153587547|NCT01781663|Emollients|emollients|mesh-ancestor
153587548|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
153587549|NCT01781702|Celecoxib|celecoxib|mesh-list
153587550|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153587575|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587576|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587578|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153587579|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
153587580|NCT01781936|Hormones|hormones|mesh-ancestor
153587581|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587582|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587583|NCT01781988|Carboplatin|carboplatin|mesh-list
153587584|NCT01781988|Gemcitabine|gemcitabine|mesh-list
153587585|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587586|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153587587|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
153587588|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587589|NCT01782001|Vitamins|vitamins|mesh-list
153587590|NCT01782001|Vitamin A|vitamin a|mesh-list
153587591|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
153587592|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
153587593|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587594|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
153587595|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587596|NCT01782001|Protective Agents|protective agents|mesh-ancestor
153587636|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153587637|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587638|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587640|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153587641|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153587642|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587643|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
153587644|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
153587646|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
153587647|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587648|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587649|NCT01782651|Capecitabine|capecitabine|mesh-list
153587650|NCT01782651|Lapatinib|lapatinib|mesh-list
153587651|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153587652|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
153587666|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153587668|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
153587669|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587670|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587671|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153587672|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153587673|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
153587674|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153587675|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
153587676|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
153587677|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
153587678|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153587679|NCT01782846|Codeine|codeine|mesh-list
153587680|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153587681|NCT01782846|Narcotics|narcotics|mesh-ancestor
153587682|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587683|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587684|NCT01782846|Analgesics|analgesics|mesh-ancestor
153587685|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
153587686|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587687|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
153587688|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
153587689|NCT01782911|Resveratrol|resveratrol|mesh-list
153587690|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
153587691|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587705|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
153587706|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153735930|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153587707|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587708|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
153587709|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153587710|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587711|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587712|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153587713|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153587725|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153587726|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153587727|NCT01782976|Growth Substances|growth substances|mesh-ancestor
153587728|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587729|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
153587730|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
153587731|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153587732|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587734|NCT01783106|Doxycycline|doxycycline|mesh-list
153587735|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
153587736|NCT01783106|Budesonide|budesonide|mesh-list
153587737|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153587738|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153587739|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
153587740|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587741|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587742|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153587743|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
153587744|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
153587745|NCT01783106|Hormones|hormones|mesh-ancestor
153587746|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587747|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
153587748|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153587749|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153587750|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587751|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587752|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587753|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153587754|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153587755|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153587756|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153587757|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587758|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153587759|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153587760|NCT01783340|Azithromycin|azithromycin|mesh-list
153587761|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153587762|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587763|NCT01783379|Micafungin|micafungin|mesh-list
153587764|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
153587765|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587766|NCT01783431|Poly ICLC|poly iclc|mesh-list
153587795|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687957|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587796|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587797|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153587798|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153587799|NCT01783834|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153587800|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587801|NCT01783951|Cisplatin|cisplatin|mesh-list
153587802|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587803|NCT01783964|Cytarabine|cytarabine|mesh-list
153587804|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153587805|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
153587806|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587807|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587808|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
153587809|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587810|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153587811|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
153587812|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587813|NCT01783977|Vaccines|vaccines|mesh-list
153587814|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
153587815|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587816|NCT01784107|Ifosfamide|ifosfamide|mesh-list
153587817|NCT01784107|Belotecan|belotecan|mesh-list
153421552|NCT05788393|Analgesics|analgesics|mesh-ancestor
153748480|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
153587818|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153587819|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
153587820|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587821|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587822|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153587823|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153587824|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587825|NCT01784120|Doxorubicin|doxorubicin|mesh-list
153587826|NCT01784120|genexol-PM|genexol-pm|mesh-list
153587827|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153587828|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587845|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153587846|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
153587870|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153587871|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153587872|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587873|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
153587874|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153587875|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153587876|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153587878|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
153587879|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587880|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688035|NCT00054236|Hormones|hormones|mesh-ancestor
153587881|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153587882|NCT01784315|Filaricides|filaricides|mesh-ancestor
153587883|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
153587884|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
153587885|NCT01784380|Metformin|metformin|mesh-list
153587886|NCT01784380|Clomiphene|clomiphene|mesh-list
153587887|NCT01784380|Enclomiphene|enclomiphene|mesh-list
153587888|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
153587889|NCT01784380|Menotropins|menotropins|mesh-list
153587890|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
153587891|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153587892|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587893|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153587894|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
153587895|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587896|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153587897|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
153587898|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153587899|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153587900|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153587901|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
153587902|NCT01784445|Ceftazidime|ceftazidime|mesh-list
153587933|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153587934|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153587935|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587937|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153587938|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153587969|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587970|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587971|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153587972|NCT01785030|Analgesics|analgesics|mesh-ancestor
153587973|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
153587974|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587975|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153587976|NCT01785043|Liraglutide|liraglutide|mesh-list
153587977|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153587978|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587979|NCT01785043|Incretins|incretins|mesh-ancestor
153587980|NCT01785043|Hormones|hormones|mesh-ancestor
153587981|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587982|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153587983|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
153587984|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587985|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587986|NCT01785043|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153735931|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153587987|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153587988|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
153688149|NCT00167518|Triamcinolone|triamcinolone|mesh-list
153587989|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587990|NCT01785108|Vitamin D|vitamin d|mesh-list
153587991|NCT01785108|Ibuprofen|ibuprofen|mesh-list
153587992|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
153587993|NCT01785108|Vitamins|vitamins|mesh-ancestor
153587994|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
153587995|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587996|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153587997|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153587998|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153587999|NCT01785108|Analgesics|analgesics|mesh-ancestor
153588000|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
153588001|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588002|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588003|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588004|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153588018|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588019|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153588020|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153588022|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588023|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588024|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153588026|NCT01785329|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153588027|NCT01785329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153588028|NCT01785329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153588064|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
153588065|NCT01785589|Adenosine|adenosine|mesh-list
153588066|NCT01785589|Analgesics|analgesics|mesh-ancestor
153588075|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588076|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588097|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
153588098|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588099|NCT01785836|Dapsone|dapsone|mesh-list
153588100|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153588101|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
153588102|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153588103|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153588104|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153588105|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588106|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588107|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
153588108|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153588109|NCT01785862|Ibuprofen|ibuprofen|mesh-list
153588110|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153588111|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588112|NCT01785862|Analgesics|analgesics|mesh-ancestor
153588113|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
153588114|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588115|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588116|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588117|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588118|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153588119|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588120|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588121|NCT01785979|Chloroquine|chloroquine|mesh-list
153588122|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153588123|NCT01785979|Prednisone|prednisone|mesh-list
153588124|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588125|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
153588126|NCT01785979|Hormones|hormones|mesh-ancestor
153588127|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588128|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588129|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153588130|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588131|NCT01785979|Amebicides|amebicides|mesh-ancestor
153588132|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153588167|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153588169|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153588170|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153588172|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588173|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154263334|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153588174|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
153588175|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588176|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588177|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153588178|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
153588179|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
153588180|NCT01786070|Hormones|hormones|mesh-ancestor
153588181|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588182|NCT01786200|Aspirin|aspirin|mesh-list
153588183|NCT01786200|Ibuprofen|ibuprofen|mesh-list
153588184|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153588185|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588186|NCT01786200|Analgesics|analgesics|mesh-ancestor
153588187|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
153588188|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588189|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588190|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588191|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588192|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153588193|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153588194|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588288|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153588289|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153588290|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153588291|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153588292|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153588335|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153588336|NCT01787396|Metformin|metformin|mesh-list
153588337|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153588338|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588339|NCT01787474|Cytarabine|cytarabine|mesh-list
153588340|NCT01787474|Fludarabine|fludarabine|mesh-list
153588341|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
153588342|NCT01787474|Lenograstim|lenograstim|mesh-list
153588343|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588344|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153588345|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
153588346|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588347|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153588348|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
153588349|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588350|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
153588351|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153588352|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153588353|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
153588354|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153588355|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
153588356|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588357|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
153588358|NCT01787630|Protective Agents|protective agents|mesh-ancestor
153588359|NCT01787669|Dexamethasone|dexamethasone|mesh-list
153588360|NCT01787669|Bevacizumab|bevacizumab|mesh-list
153588361|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153588362|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588363|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153588364|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153588365|NCT01787669|Growth Substances|growth substances|mesh-ancestor
153588366|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588367|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
153588409|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588411|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153588412|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153588413|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153588414|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
153588415|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
153588443|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153588444|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588445|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153588446|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153588447|NCT01788280|Growth Substances|growth substances|mesh-ancestor
153588448|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263335|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
153588449|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
153588450|NCT01788332|Olaparib|olaparib|mesh-list
153588451|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153588452|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588453|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588454|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588455|NCT01788371|Lamivudine|lamivudine|mesh-list
153588456|NCT01788371|Telbivudine|telbivudine|mesh-list
153588457|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153588458|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153588459|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588460|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588461|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
153588462|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153588479|NCT01788501|Methotrexate|methotrexate|mesh-list
153588481|NCT01788501|Cyclosporins|cyclosporins|mesh-list
153588482|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153588483|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
153588484|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588485|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588486|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153588487|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
153745643|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588488|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588489|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588490|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
153588491|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588492|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153588493|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153588494|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
153588495|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588496|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153588497|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153588498|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
153588544|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588546|NCT01789086|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153588547|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153588548|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588549|NCT01789086|Incretins|incretins|mesh-ancestor
153588550|NCT01789086|Hormones|hormones|mesh-ancestor
153588551|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588552|NCT01789099|Sargramostim|sargramostim|mesh-list
153588553|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
153588554|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588555|NCT01789125|Nicotine|nicotine|mesh-list
153588556|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153588557|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
153588558|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588559|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588560|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153588561|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153588562|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
153588563|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588564|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588565|NCT01789216|Ketorolac|ketorolac|mesh-list
153588566|NCT01789216|Meloxicam|meloxicam|mesh-list
153588567|NCT01789216|Pregabalin|pregabalin|mesh-list
153588604|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
153588605|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588606|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688400|NCT00169000|Docetaxel|docetaxel|mesh-list
153588607|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588608|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588609|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
153588610|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153588611|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588612|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588613|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588614|NCT01789385|Analgesics|analgesics|mesh-ancestor
153588615|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
153588616|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588617|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153588618|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153588620|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
153588621|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588622|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588623|NCT01789437|Dexamethasone|dexamethasone|mesh-list
153588624|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588625|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
153588626|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
153588627|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588628|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588629|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153588646|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588647|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588648|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153588679|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153588680|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153588681|NCT01789892|Prednisolone|prednisolone|mesh-list
153588682|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
153588683|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153588684|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
153588685|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153588686|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588687|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
153588688|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
153588689|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588725|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153588726|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153588747|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
153588748|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153588749|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153545900|NCT06297499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153588761|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588762|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588764|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
153588765|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588766|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153588767|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153588768|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153588769|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588770|NCT01794182|Glyburide|glyburide|mesh-list
153588771|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153588772|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588773|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153588774|NCT01794208|Hormones|hormones|mesh-ancestor
153688464|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
153588775|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588776|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588777|NCT01794247|Lidocaine|lidocaine|mesh-list
153588778|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
153588779|NCT01794247|Fentanyl|fentanyl|mesh-list
153588780|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
153588781|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
153588782|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588790|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588792|NCT01794247|Narcotics|narcotics|mesh-ancestor
153588793|NCT01794247|Analgesics|analgesics|mesh-ancestor
153588794|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153588795|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153588796|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
153588797|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
153588798|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153588799|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153588800|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
153588801|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588802|NCT01794429|Exenatide|exenatide|mesh-list
153588803|NCT01794429|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153588804|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153588805|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588806|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153588807|NCT01794429|Incretins|incretins|mesh-ancestor
153588808|NCT01794429|Hormones|hormones|mesh-ancestor
153588809|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588810|NCT01795248|Liraglutide|liraglutide|mesh-list
153588811|NCT01795248|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153588812|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153588815|NCT01795248|Hormones|hormones|mesh-ancestor
153588816|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588817|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153588818|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
153588819|NCT01796132|Citalopram|citalopram|mesh-list
153588820|NCT01796132|Fluoxetine|fluoxetine|mesh-list
153588821|NCT01796132|Paroxetine|paroxetine|mesh-list
153588846|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153588855|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
153588857|NCT01796522|Progesterone|progesterone|mesh-list
153588858|NCT01796522|Progestins|progestins|mesh-ancestor
153588859|NCT01796522|Hormones|hormones|mesh-ancestor
153588860|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588861|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588862|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153588863|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153588864|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588865|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153588866|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
153588867|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
153588868|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588869|NCT01796730|Bambuterol|bambuterol|mesh-list
153588870|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153588891|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
153588892|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588893|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153588894|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153588895|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
153588896|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153588897|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
153588898|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
153588899|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
153588900|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153588901|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
153588902|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153588903|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153588904|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588905|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
153588906|NCT01797289|Coagulants|coagulants|mesh-ancestor
153588907|NCT01797718|Letrozole|letrozole|mesh-list
153588908|NCT01797718|Testosterone|testosterone|mesh-list
153588909|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588910|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153588911|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153588933|NCT01798680|Vitamin D|vitamin d|mesh-list
153588934|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
153588935|NCT01798680|Vitamins|vitamins|mesh-ancestor
153588936|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
153588937|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588938|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153588939|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153588940|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153588941|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153588942|NCT01798836|Estradiol|estradiol|mesh-list
153588943|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153588944|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153588962|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153588963|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153588964|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
153588977|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153588978|NCT01799863|Laxatives|laxatives|mesh-ancestor
153588979|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153588980|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
153588981|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153588982|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
153588983|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153588984|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
153588985|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588986|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588987|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
153588989|NCT01800019|Varenicline|varenicline|mesh-list
153588990|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153588991|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
153588992|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263336|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
154263337|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
154263338|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263339|NCT05650879|Immunotoxins|immunotoxins|mesh-ancestor
154263340|NCT05650879|Immunoconjugates|immunoconjugates|mesh-ancestor
154263341|NCT05650879|Immunologic Factors|immunologic factors|mesh-ancestor
153749104|NCT00406874|Folic Acid|folic acid|mesh-list
153588993|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588994|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153588995|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153588996|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
153588997|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588998|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588999|NCT01800097|Modafinil|modafinil|mesh-list
153589000|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153589001|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589002|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153589003|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153688610|NCT00170404|Trace Elements|trace elements|mesh-list
153589004|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153589005|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589006|NCT01800227|Metformin|metformin|mesh-list
153589007|NCT01800227|Pioglitazone|pioglitazone|mesh-list
153589008|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153589009|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589010|NCT01800240|Metformin|metformin|mesh-list
153589011|NCT01800240|Pioglitazone|pioglitazone|mesh-list
153589012|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153589013|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589014|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
153810619|NCT00346827|Apomorphine|apomorphine|mesh-list
153589068|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
153589069|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589070|NCT01800526|Protective Agents|protective agents|mesh-ancestor
153589071|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589072|NCT01800526|Antidotes|antidotes|mesh-ancestor
153589073|NCT01800630|Gemcitabine|gemcitabine|mesh-list
153589074|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589075|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
153589076|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589089|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153589090|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
153589091|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589124|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153589125|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153589126|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589127|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589128|NCT01800825|Clindamycin|clindamycin|mesh-list
153589129|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
153589130|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
153589131|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589132|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589133|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153589172|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
153589173|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589174|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589175|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153589177|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
153589178|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153589179|NCT01801410|Misoprostol|misoprostol|mesh-list
153589180|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153589181|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
153589182|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153589183|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589184|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153589185|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153589186|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
153421701|NCT05556512|Hormones|hormones|mesh-ancestor
153589187|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
153589188|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589189|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
153589190|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589191|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589192|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153589193|NCT01801644|Cisplatin|cisplatin|mesh-list
153589194|NCT01801644|Gemcitabine|gemcitabine|mesh-list
153589195|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589220|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153589221|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153589222|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
153589223|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
153589224|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
153589225|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
153589226|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589227|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589228|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153589229|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153589230|NCT01802268|Sirolimus|sirolimus|mesh-list
153589231|NCT01802268|Tacrolimus|tacrolimus|mesh-list
153589256|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
153589257|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589258|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153589259|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153589260|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153589261|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589262|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153589263|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153589264|NCT01802502|Rifampin|rifampin|mesh-list
153589265|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153589266|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
153589267|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589268|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589269|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
153589270|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153589271|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589272|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589273|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153589284|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153589285|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589286|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589320|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153589321|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589322|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153589323|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153589324|NCT01802645|Growth Substances|growth substances|mesh-ancestor
153589325|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589326|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
153589327|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
153589328|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589329|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589330|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589331|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
153589363|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153589364|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153589365|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
153589366|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589367|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153589368|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153589369|NCT01802931|Ketoconazole|ketoconazole|mesh-list
153589370|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
153589371|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589372|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153589373|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153589374|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589375|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589376|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153589378|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589379|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589380|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153589382|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153589383|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589384|NCT01802970|Paclitaxel|paclitaxel|mesh-list
153589385|NCT01802970|Vinorelbine|vinorelbine|mesh-list
153589386|NCT01802970|Capecitabine|capecitabine|mesh-list
153910747|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
153589387|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153589388|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153589389|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589390|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
153589391|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
153589392|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
153589393|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589394|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589395|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
153589396|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589397|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
153589398|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153589399|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
153589427|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589428|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589482|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
153589499|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153589500|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153589501|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
153589502|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
153589503|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589505|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153589506|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153589507|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589508|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781638|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
153781639|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
153781640|NCT00266487|Pyridoxal|pyridoxal|mesh-list
153781641|NCT00266487|Pyridoxine|pyridoxine|mesh-list
153781642|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
153781643|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
153781644|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781645|NCT00266487|Hematinics|hematinics|mesh-ancestor
153781646|NCT00231452|Artesunate|artesunate|mesh-list
153781647|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
153781648|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
153781649|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153781650|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
153781651|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153781652|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153781653|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781654|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781655|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
153781656|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
153781657|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153781658|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
153781659|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153781660|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781661|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781662|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153781663|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
153781664|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153781665|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153781666|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153781667|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781668|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781689|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153781690|NCT00477334|Famciclovir|famciclovir|mesh-list
153781691|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
153781692|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781693|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153781694|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781695|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263342|NCT05650879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781696|NCT00231608|Topiramate|topiramate|mesh-list
153781697|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
153781698|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153781699|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781700|NCT00266604|Topiramate|topiramate|mesh-list
153589513|NCT01804335|Trifarotene|trifarotene|mesh-list
153781701|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
153781702|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153589532|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589533|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589534|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
153589535|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589536|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589537|NCT01804387|Lamivudine|lamivudine|mesh-list
153589538|NCT01804387|Adefovir|adefovir|mesh-list
153589539|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153589540|NCT01804387|Telbivudine|telbivudine|mesh-list
153589541|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153589542|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153589543|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589544|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589545|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
153589546|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589547|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153589548|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153589549|NCT01804400|Montelukast|montelukast|mesh-list
153589550|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153589551|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
153589552|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153688915|NCT00399867|Simvastatin|simvastatin|mesh-list
153589553|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
153589567|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
153589568|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153589583|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153589584|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153589585|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153589586|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589587|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153781704|NCT04561336|Cetuximab|cetuximab|mesh-list
153589588|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153589589|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153589590|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153589591|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
153589592|NCT01804985|Dasatinib|dasatinib|mesh-list
153589593|NCT01804985|Nilotinib|nilotinib|mesh-list
153589594|NCT01804985|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153589595|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589596|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589597|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589598|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589599|NCT01805115|Misoprostol|misoprostol|mesh-list
153589600|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153589601|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
153589602|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153589603|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589604|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153589605|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153589606|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
153589607|NCT01805232|Artesunate|artesunate|mesh-list
153589608|NCT01805232|Quinine|quinine|mesh-list
153589609|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
153589610|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153589611|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153589612|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589613|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589614|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
153589615|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
153589616|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153589617|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
153589618|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153589619|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589620|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153589621|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589622|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153589623|NCT01805232|Analgesics|analgesics|mesh-ancestor
153589624|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
153589627|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153589670|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
153589671|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
153589672|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
153589673|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589674|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589691|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153589692|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153589693|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153850251|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
153589694|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589696|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153589697|NCT01808014|Analgesics|analgesics|mesh-ancestor
153589698|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
153589699|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589700|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589701|NCT01808131|Lesinurad|lesinurad|mesh-list
153589702|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
153589703|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589704|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
153589705|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
153589706|NCT01808300|Pregabalin|pregabalin|mesh-list
153589707|NCT01808300|Analgesics|analgesics|mesh-ancestor
153589708|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
153589709|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589710|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589711|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
153589712|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153589713|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153589714|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589715|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153589716|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153589717|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153589718|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589719|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153589720|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
153589721|NCT01808300|Protective Agents|protective agents|mesh-ancestor
153589722|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
153589723|NCT01808300|Vitamins|vitamins|mesh-ancestor
153589724|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
153589725|NCT01808469|Antibodies|antibodies|mesh-list
153589726|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153589727|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
153589728|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589781|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
153589782|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
153589783|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589784|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589785|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589857|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153589858|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
153589859|NCT01809444|Hormones|hormones|mesh-ancestor
153589860|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589871|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153589872|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589873|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589874|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153589876|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
153589877|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589878|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589880|NCT01809743|Regadenoson|regadenoson|mesh-list
153589881|NCT01809743|Analgesics|analgesics|mesh-ancestor
153589882|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
153589883|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589884|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589885|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153589886|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
153589887|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153589888|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
153589889|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
153589914|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589915|NCT01809925|Psyllium|psyllium|mesh-list
153589916|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
154263343|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
153421797|NCT05468489|Carboplatin|carboplatin|mesh-list
153589917|NCT01809925|Cathartics|cathartics|mesh-ancestor
153589918|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153589919|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
153589920|NCT01810185|Naltrexone|naltrexone|mesh-list
153589921|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153589922|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153589923|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589924|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
153589925|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589926|NCT01810237|Dabigatran|dabigatran|mesh-list
153589939|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589940|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589941|NCT01810367|Cisplatin|cisplatin|mesh-list
153589942|NCT01810367|Gemcitabine|gemcitabine|mesh-list
153589943|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589944|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589945|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
153589946|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589947|NCT01810393|Trastuzumab|trastuzumab|mesh-list
153589948|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153589949|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589950|NCT01810458|Acetaminophen|acetaminophen|mesh-list
153589966|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153589968|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781705|NCT04561336|Avelumab|avelumab|mesh-list
153589969|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589970|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153589971|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153589972|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153589973|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153589974|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153589975|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153589976|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
153589977|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
153589978|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
153589979|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589980|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153589981|NCT01810458|Narcotics|narcotics|mesh-ancestor
153589982|NCT01810458|Analgesics|analgesics|mesh-ancestor
153589983|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153589984|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
153589985|NCT01810458|Hematinics|hematinics|mesh-ancestor
153589986|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
153589987|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
153589988|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153589989|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
153589990|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
153590006|NCT01810640|Hematinics|hematinics|mesh-ancestor
153590007|NCT01810731|Vaccines|vaccines|mesh-list
153590008|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
153590009|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590010|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153590011|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590012|NCT01810796|Ranolazine|ranolazine|mesh-list
153590013|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153590014|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153590015|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590017|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
153590018|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
153590019|NCT01810809|Protective Agents|protective agents|mesh-ancestor
153590020|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590021|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153590022|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
153590023|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
153590024|NCT01810848|Hylan|hylan|mesh-list
153590025|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153590026|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
153590027|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590040|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590041|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153590042|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153590045|NCT01810926|Methotrexate|methotrexate|mesh-list
153590046|NCT01810926|Fludarabine|fludarabine|mesh-list
153590047|NCT01810926|Thiotepa|thiotepa|mesh-list
153590048|NCT01810926|Treosulfan|treosulfan|mesh-list
153590049|NCT01810926|Antibodies|antibodies|mesh-list
153590051|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
153590052|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590053|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153590054|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590069|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153590070|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153590071|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
153590072|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153590073|NCT01811056|Mifepristone|mifepristone|mesh-list
153590074|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153590075|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
153590076|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153590077|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590078|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153590079|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153590080|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153590081|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
153590082|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153590083|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153590084|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
153590085|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590086|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
153590087|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153590088|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153590089|NCT01811160|Melatonin|melatonin|mesh-list
153590090|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
153590091|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590092|NCT01811160|Protective Agents|protective agents|mesh-ancestor
153590093|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590094|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590095|NCT01811251|Dexamethasone|dexamethasone|mesh-list
153590096|NCT01811251|Pregabalin|pregabalin|mesh-list
153590097|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590098|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
153590099|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
153590100|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590101|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590102|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590103|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
153590104|NCT01811251|Hormones|hormones|mesh-ancestor
153590105|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590132|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590134|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153590135|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
153590136|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
153590137|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153590138|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153590139|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153590140|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590141|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590142|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
153590143|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
153590144|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590145|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590146|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153590147|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
153590148|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689232|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
153590149|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590150|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153590151|NCT01811615|Ethanol|ethanol|mesh-list
153590152|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153590153|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590154|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590155|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590156|NCT01811667|Sirolimus|sirolimus|mesh-list
153590157|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153360120|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590158|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590159|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153590160|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421827|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
153590161|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
153590162|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153590163|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
153590164|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590166|NCT01811810|Hormones|hormones|mesh-ancestor
153590167|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590168|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590170|NCT01811836|Trace Elements|trace elements|mesh-ancestor
153590171|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
153590172|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590204|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
153590205|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590206|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590207|NCT01812135|Vaccines|vaccines|mesh-list
153590208|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
153590209|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590210|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
153590211|NCT01812200|Dabigatran|dabigatran|mesh-list
153590212|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
153590213|NCT01812200|Ticagrelor|ticagrelor|mesh-list
153590214|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153590215|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
153590216|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153590217|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
153590218|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590219|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590220|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
153590221|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153590222|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153590223|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153590224|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153689356|NCT00056654|Leuprolide|leuprolide|mesh-list
153590225|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
153590226|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590227|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590228|NCT01812239|Progesterone|progesterone|mesh-list
153590229|NCT01812239|Progestins|progestins|mesh-list
153590230|NCT01812239|Hormones|hormones|mesh-ancestor
153590231|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590232|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590233|NCT01812330|Clopidogrel|clopidogrel|mesh-list
153590234|NCT01812330|Ticagrelor|ticagrelor|mesh-list
153590235|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153590236|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153590237|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153590238|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153590252|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590254|NCT01812369|Doxorubicin|doxorubicin|mesh-list
153590255|NCT01812369|Vinblastine|vinblastine|mesh-list
153590256|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590257|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
153590258|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590259|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590260|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153590261|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153590262|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153590263|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590264|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153590266|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
153590267|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
153590284|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590285|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590286|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590287|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153590288|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590289|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590290|NCT01812551|Alendronate|alendronate|mesh-list
153590291|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153590292|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590293|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
153590294|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153590295|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153590297|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590307|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
153590308|NCT01812720|Hormones|hormones|mesh-ancestor
153590309|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590310|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153590311|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590312|NCT01812889|TOL-463|tol-463|mesh-list
153590313|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590314|NCT01812928|Diclofenac|diclofenac|mesh-list
153590315|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153590316|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153590317|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153590318|NCT01812928|Analgesics|analgesics|mesh-ancestor
153590319|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
153590320|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590321|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590322|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590323|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153590324|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590325|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590326|NCT01812954|Cyclosporine|cyclosporine|mesh-list
153590327|NCT01812954|Adalimumab|adalimumab|mesh-list
153590328|NCT01812954|Infliximab|infliximab|mesh-list
153590329|NCT01812954|Etanercept|etanercept|mesh-list
153590330|NCT01812954|Methotrexate|methotrexate|mesh-list
153590331|NCT01812954|Ustekinumab|ustekinumab|mesh-list
153590332|NCT01812954|Acitretin|acitretin|mesh-list
153590333|NCT01812954|Cyclosporins|cyclosporins|mesh-list
153590354|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590355|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153590356|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153590357|NCT01812954|Analgesics|analgesics|mesh-ancestor
153590358|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
153590359|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590360|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
153590361|NCT01812967|Caseins|caseins|mesh-list
153590362|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
153590363|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
153590389|NCT01813201|Hormones|hormones|mesh-ancestor
153590390|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590391|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590392|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153590393|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590394|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
153590395|NCT01813240|Minocycline|minocycline|mesh-list
153590396|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153590397|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590398|NCT01813253|Irinotecan|irinotecan|mesh-list
153590399|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
153590400|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153590401|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153590402|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590403|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590404|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590405|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153590406|NCT01813318|Acamprosate|acamprosate|mesh-list
153590407|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153590408|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
153590409|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153590410|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590411|NCT01813461|Isavuconazole|isavuconazole|mesh-list
153590412|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
153590562|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153590563|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590565|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
153590566|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590567|NCT01814098|Escitalopram|escitalopram|mesh-list
153590568|NCT01814098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153590569|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153590570|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153590571|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590805|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
153590806|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590810|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
153590811|NCT01815125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153590812|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153590813|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
153590814|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590815|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590816|NCT01815203|Caffeine|caffeine|mesh-list
153590817|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153590818|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590819|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153590820|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590821|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590822|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153590823|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153590824|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
153590825|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590826|NCT01815255|Tenofovir|tenofovir|mesh-list
153590827|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
153590828|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590829|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153590830|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153590831|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590832|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590833|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153590834|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153590835|NCT01815268|Vaccines|vaccines|mesh-list
153590836|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
153590837|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590838|NCT01815294|Doxorubicin|doxorubicin|mesh-list
153590839|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153590840|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153590841|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590842|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153590843|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153590844|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590845|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591120|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153591121|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153591122|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153591123|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591124|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153591125|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153591126|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591127|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
153591128|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153591129|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153591130|NCT01817439|Amiodarone|amiodarone|mesh-list
153591131|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153591132|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591133|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153591134|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591135|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591136|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153591137|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153591138|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153591139|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591140|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153591141|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153591295|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153591296|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
153591297|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591298|NCT01819012|Isoflurane|isoflurane|mesh-list
153591299|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153591300|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
153591301|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
153591388|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
153591389|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735941|NCT03974854|Capecitabine|capecitabine|mesh-list
153591391|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153591392|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153591393|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591395|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591396|NCT01819779|Amlodipine|amlodipine|mesh-list
153591397|NCT01819779|Valsartan|valsartan|mesh-list
153591398|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153591399|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591400|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153591688|NCT01821430|Pregabalin|pregabalin|mesh-list
153591689|NCT01821430|Analgesics|analgesics|mesh-ancestor
153591690|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
153591691|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591692|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591693|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
153591694|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153591695|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591696|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591697|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591698|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153591699|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153591744|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591746|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153591747|NCT01821703|Diuretics|diuretics|mesh-ancestor
153591748|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
153591749|NCT01821846|Liraglutide|liraglutide|mesh-list
153591781|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153591783|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153591784|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153591785|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
153591786|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591787|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153591788|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591789|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
153591790|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153591820|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591821|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153591822|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
153591823|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153591824|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591825|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153591826|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
153591827|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153591828|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591829|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591830|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591831|NCT01822600|Omeprazole|omeprazole|mesh-list
153591832|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153591833|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153591834|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153781709|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153591835|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592000|NCT01823809|Analgesics|analgesics|mesh-ancestor
153592001|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
153592002|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592003|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592004|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153592041|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592071|NCT01824420|Urological Agents|urological agents|mesh-ancestor
153592072|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
153592073|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
153592074|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592075|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153592076|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592077|NCT01824433|Fluoxetine|fluoxetine|mesh-list
154263344|NCT05640102|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153735942|NCT03974854|Irinotecan|irinotecan|mesh-list
153592078|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153592079|NCT01824433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153592285|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592286|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592288|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153592289|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153592290|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153592324|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153592325|NCT01825993|Narcotics|narcotics|mesh-ancestor
153592326|NCT01825993|Analgesics|analgesics|mesh-ancestor
153592327|NCT01826149|Propofol|propofol|mesh-list
153592328|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153592329|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592751|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592753|NCT01829685|Entecavir|entecavir|mesh-list
153592754|NCT01829685|Adefovir|adefovir|mesh-list
153592755|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
153592756|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592757|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153592758|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153592759|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592760|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592761|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153592762|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153592763|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592764|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
153592765|NCT01829711|Protective Agents|protective agents|mesh-list
153592766|NCT01829711|Immunotoxins|immunotoxins|mesh-ancestor
153592767|NCT01829711|Immunoconjugates|immunoconjugates|mesh-ancestor
153592768|NCT01829711|Immunologic Factors|immunologic factors|mesh-ancestor
153592769|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592770|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592771|NCT01829802|Ritonavir|ritonavir|mesh-list
153592772|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153592773|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
153592774|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153592775|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153592776|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
153592777|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592778|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592779|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153592780|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153592781|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
153592782|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592783|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153592784|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153592860|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153592861|NCT01832311|Ketorolac|ketorolac|mesh-list
153592862|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153592863|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153592864|NCT01832311|Analgesics|analgesics|mesh-ancestor
153592865|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
153592866|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592867|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592868|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153592869|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689707|NCT00179023|Trimethaphan|trimethaphan|mesh-list
153592870|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153592871|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592872|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592873|NCT01832350|Quinidine|quinidine|mesh-list
153592874|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
153592875|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
153592939|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593106|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153593107|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593109|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153593110|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153593113|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593114|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593115|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593116|NCT01840774|Ketamine|ketamine|mesh-list
153593117|NCT01840774|Analgesics|analgesics|mesh-list
153593118|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
153593119|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593237|NCT01841411|Protective Agents|protective agents|mesh-ancestor
153593238|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593239|NCT01841411|Antidotes|antidotes|mesh-ancestor
153593240|NCT01841424|Benzocaine|benzocaine|mesh-list
153593241|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
153593242|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
153593243|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593244|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593245|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
153593246|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593247|NCT01841463|Vemurafenib|vemurafenib|mesh-list
153593248|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593314|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593316|NCT01842113|Lactulose|lactulose|mesh-list
153593317|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593318|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593319|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593320|NCT01842139|Poly I-C|poly i-c|mesh-list
153593321|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153593916|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153593917|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153593918|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153593946|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153593947|NCT01845558|Wobenzym|wobenzym|mesh-list
153593948|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153593949|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
153593950|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593951|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
153593952|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153593953|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
153593954|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153593955|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
153593956|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593957|NCT01845610|Manganese|manganese|mesh-list
153593958|NCT01845610|Trace Elements|trace elements|mesh-ancestor
153593959|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
153593960|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593961|NCT01845675|Temozolomide|temozolomide|mesh-list
153593962|NCT01845675|Dacarbazine|dacarbazine|mesh-list
153593963|NCT01845675|Endostatins|endostatins|mesh-list
153593964|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153593965|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
153594048|NCT01846559|Clopidogrel|clopidogrel|mesh-list
153594049|NCT01846559|Ticagrelor|ticagrelor|mesh-list
153594050|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153594051|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153594052|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153594053|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153594054|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
153594055|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594056|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594057|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594058|NCT01846650|Capecitabine|capecitabine|mesh-list
153594059|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153594060|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
153594061|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594169|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153594170|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594171|NCT01847612|Methylene Blue|methylene blue|mesh-list
153594172|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594173|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594174|NCT01847664|Rifamycins|rifamycins|mesh-list
153594208|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153594209|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153594210|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
153594211|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750341|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
153594212|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153594213|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
153594214|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594215|NCT01847872|Vaccines|vaccines|mesh-list
153594216|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
153594411|NCT01849094|Milrinone|milrinone|mesh-list
153594412|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153594413|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153594414|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
153594415|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153594416|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153594417|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594418|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594419|NCT01849094|Protective Agents|protective agents|mesh-ancestor
153594420|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594421|NCT01849211|Rocuronium|rocuronium|mesh-list
153594422|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153594423|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153594424|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153594425|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594426|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594427|NCT01849406|Budesonide|budesonide|mesh-list
153594428|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153594429|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153594430|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
153594431|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594432|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594433|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153594434|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
153594435|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
153594436|NCT01849406|Hormones|hormones|mesh-ancestor
153594437|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594438|NCT01849640|Primaquine|primaquine|mesh-list
153594439|NCT01849640|Piperaquine|piperaquine|mesh-list
153594440|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
153594479|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
153594480|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594482|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153594483|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594484|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594485|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153594486|NCT01850017|Analgesics|analgesics|mesh-ancestor
153594487|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
153594488|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594489|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153594490|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153594491|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153594492|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
153594493|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594494|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594495|NCT01850095|Azelaic acid|azelaic acid|mesh-list
153594496|NCT01850095|Estradiol|estradiol|mesh-list
153594497|NCT01850095|Estrogens|estrogens|mesh-ancestor
153594498|NCT01850095|Hormones|hormones|mesh-ancestor
153594527|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594528|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
153594529|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594530|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153594531|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153594532|NCT01850251|Vitamin D|vitamin d|mesh-list
153594533|NCT01850251|Vitamins|vitamins|mesh-ancestor
153594534|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
153594535|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594536|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153594537|NCT01850277|Amiodarone|amiodarone|mesh-list
153594538|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594539|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153594540|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
153594541|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153594542|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153594543|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153594609|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594610|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594650|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594651|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594653|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153594655|NCT01851200|Immunotoxins|immunotoxins|mesh-ancestor
153594656|NCT01851200|Immunoconjugates|immunoconjugates|mesh-ancestor
153594657|NCT01851200|Immunologic Factors|immunologic factors|mesh-ancestor
153594658|NCT01851200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594659|NCT01851265|Olaparib|olaparib|mesh-list
153594763|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
153594764|NCT01851824|Vemurafenib|vemurafenib|mesh-list
153594765|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
153594766|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594767|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153594768|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594769|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594770|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
153594771|NCT01851850|Opicapone|opicapone|mesh-list
153594772|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153594773|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468594|NCT06271395|Botulinum Toxins|botulinum toxins|mesh-list
153594802|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153594803|NCT01851980|Furosemide|furosemide|mesh-list
153594804|NCT01851980|Diuretics|diuretics|mesh-ancestor
153594805|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
153594806|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594807|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153594808|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153594809|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594810|NCT01851993|Ondansetron|ondansetron|mesh-list
153594811|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
153594812|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
153594813|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594814|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594815|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153594816|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
153594817|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
153594818|NCT01851993|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153594819|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153594820|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
153594821|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594879|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594881|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
153594882|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
153594883|NCT01852565|Diltiazem|diltiazem|mesh-list
153594884|NCT01852565|Darapladib|darapladib|mesh-list
153594885|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153594886|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153594887|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153594888|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594889|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153594890|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594891|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
153594892|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153594893|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594894|NCT01852604|Interferons|interferons|mesh-list
153595558|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153595559|NCT01856998|Propofol|propofol|mesh-list
153595569|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
153595570|NCT01857011|Trace Elements|trace elements|mesh-ancestor
153595571|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
153595572|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595573|NCT01857011|Hematinics|hematinics|mesh-ancestor
153595574|NCT01857024|Sevelamer|sevelamer|mesh-list
153595575|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
153595576|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
153595577|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595763|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595765|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153595766|NCT01857856|Diuretics|diuretics|mesh-ancestor
154263345|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153595767|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
153595768|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153595769|NCT01857895|Exenatide|exenatide|mesh-list
153595770|NCT01857895|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153595771|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153595819|NCT01858077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595821|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
153595822|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595823|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595824|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
153595825|NCT01858090|Promethazine|promethazine|mesh-list
153595826|NCT01858090|Diclofenac|diclofenac|mesh-list
153595827|NCT01858090|Atropine|atropine|mesh-list
153595828|NCT01858090|Ephedrine|ephedrine|mesh-list
153595829|NCT01858090|Fentanyl|fentanyl|mesh-list
153595830|NCT01858090|Sufentanil|sufentanil|mesh-list
153595831|NCT01858090|Meperidine|meperidine|mesh-list
153595832|NCT01858090|Metoclopramide|metoclopramide|mesh-list
153595833|NCT01858090|Propofol|propofol|mesh-list
153595834|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
153595835|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153595836|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595837|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595838|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153595839|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
153595840|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
153595841|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153595842|NCT01858090|Narcotics|narcotics|mesh-ancestor
153595843|NCT01858090|Analgesics|analgesics|mesh-ancestor
153595844|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
153595845|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595846|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153595847|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153595848|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153595849|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595850|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690037|NCT00181870|Analgesics|analgesics|mesh-ancestor
153595851|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153595852|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595853|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595854|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153595855|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153595856|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
153595857|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153595858|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
153595859|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
153595860|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
153595861|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153595862|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153596773|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153596775|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
153596776|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596777|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153596778|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153596779|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596780|NCT01864057|Thiamine|thiamine|mesh-list
153596781|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
153596782|NCT01864057|Vitamins|vitamins|mesh-ancestor
153596783|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
153596784|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596785|NCT01864070|Everolimus|everolimus|mesh-list
153596786|NCT01864070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153596787|NCT01864070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153596788|NCT01864070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596789|NCT01864070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596790|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596791|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
153596792|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596793|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468788|NCT06053801|Omalizumab|omalizumab|mesh-list
153596794|NCT01864083|Fluorides|fluorides|mesh-list
153596795|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
153596796|NCT01864083|Protective Agents|protective agents|mesh-ancestor
153596797|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596798|NCT01864161|Iron|iron|mesh-list
153596799|NCT01864161|Trace Elements|trace elements|mesh-ancestor
153596800|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
153596810|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153596811|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153596812|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153596813|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
153596814|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596843|NCT01864551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153596844|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153596845|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596846|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596848|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
153596849|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
153596850|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153596851|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153596852|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153596854|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
153596856|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
153596857|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596858|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153596859|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153596860|NCT01864655|Saracatinib|saracatinib|mesh-list
153597075|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
153597076|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
153597077|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597078|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597079|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
153690118|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597080|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597081|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153597082|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153597083|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153597084|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153597085|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597086|NCT01866553|Interferons|interferons|mesh-list
153597087|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
153597088|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
153597089|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153597091|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597238|NCT01867866|Trifluridine|trifluridine|mesh-list
153597239|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
153597240|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597241|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
153597242|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597243|NCT01867892|Leucovorin|leucovorin|mesh-list
153597244|NCT01867892|Gemcitabine|gemcitabine|mesh-list
153597245|NCT01867892|Fluorouracil|fluorouracil|mesh-list
153597246|NCT01867892|Irinotecan|irinotecan|mesh-list
153597247|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
153597248|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153597249|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
153597250|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597251|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597252|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153597253|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
153597382|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153597383|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153598396|NCT05845489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153598397|NCT05845489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153598398|NCT05845489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153598490|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153598491|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153598492|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
153598493|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598494|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598495|NCT05634967|Ofatumumab|ofatumumab|mesh-list
153598496|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598497|NCT05563558|Carboplatin|carboplatin|mesh-list
153598498|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
153598499|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598500|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153598502|NCT05563558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598504|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598505|NCT05531994|Montelukast|montelukast|mesh-list
153598506|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153598507|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
153598508|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153598509|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
153598537|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153598538|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598540|NCT05385406|Retinol acetate|retinol acetate|mesh-list
153598541|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153598542|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598543|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153598544|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
153598545|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598546|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153598547|NCT05385406|Protective Agents|protective agents|mesh-ancestor
153598548|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598549|NCT05357547|Buspirone|buspirone|mesh-list
153598550|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153598551|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153598552|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598587|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153598588|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598589|NCT05242419|Huperzine A|huperzine a|mesh-list
153598590|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153690194|NCT00183040|Testosterone|testosterone|mesh-list
153598592|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598817|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598818|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598819|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599024|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599026|NCT02450773|Diuretics|diuretics|mesh-ancestor
153599027|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
153599028|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599029|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153599030|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153599031|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599032|NCT02445248|Tisagenlecleucel|tisagenlecleucel|mesh-list
153378895|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
153599033|NCT02445248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599034|NCT02445248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599035|NCT02412566|SMOFlipid|smoflipid|mesh-list
153599036|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153599037|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153599038|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153599039|NCT02397226|Anesthetics|anesthetics|mesh-list
153599040|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599041|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599042|NCT02296684|Cisplatin|cisplatin|mesh-list
153599043|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
153599044|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599045|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599046|NCT02296684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153599047|NCT02296684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599048|NCT01900574|Golimumab|golimumab|mesh-list
153599074|NCT00896493|Cyclosporins|cyclosporins|mesh-list
153599075|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153599076|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599077|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599078|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599079|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
153599080|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599081|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
153599082|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599083|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
153599084|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599085|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153599086|NCT00790010|Bevacizumab|bevacizumab|mesh-list
153599087|NCT00790010|Ipilimumab|ipilimumab|mesh-list
153599088|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599090|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153599091|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153599092|NCT00790010|Growth Substances|growth substances|mesh-ancestor
153599093|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599111|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599113|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
153599114|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599115|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599116|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153599117|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
153599118|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153599119|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153599120|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599121|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153599122|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599123|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153599124|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
153599125|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599126|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153599127|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153599129|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153599130|NCT01873144|Epinephrine|epinephrine|mesh-list
153599131|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153599132|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153599133|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153599134|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
153599135|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599136|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599137|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599138|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153599139|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153599140|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
153599141|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599142|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153599143|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
153599144|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
153599145|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
153599146|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153599147|NCT01873157|Bortezomib|bortezomib|mesh-list
153599148|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599149|NCT01873222|Sirolimus|sirolimus|mesh-list
153599150|NCT01873222|Umirolimus|umirolimus|mesh-list
153599151|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599152|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599153|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
153599154|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599155|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599156|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599157|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153599158|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599159|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
153599160|NCT01873313|Ropivacaine|ropivacaine|mesh-list
153599161|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
153599162|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
153599177|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
153599178|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
153599179|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
153599180|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
153599181|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599182|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781723|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599191|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153599192|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153599193|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599194|NCT01873430|Melatonin|melatonin|mesh-list
153599195|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
153599196|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599197|NCT01873430|Protective Agents|protective agents|mesh-ancestor
153599198|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599199|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599200|NCT01873443|Folic Acid|folic acid|mesh-list
153599201|NCT01873443|Rituximab|rituximab|mesh-list
153735944|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
153599202|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599203|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599204|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
153599205|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599206|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599207|NCT01873443|Hematinics|hematinics|mesh-ancestor
153599208|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
153599209|NCT01873443|Vitamins|vitamins|mesh-ancestor
153599210|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
153599211|NCT01873573|Triamcinolone|triamcinolone|mesh-list
153599212|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599213|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
153599214|NCT01873573|Hormones|hormones|mesh-ancestor
153360162|NCT02196857|Sorafenib|sorafenib|mesh-list
153599215|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599216|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599217|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
153599218|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599219|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599220|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599221|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153599222|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599235|NCT01873807|Etoposide|etoposide|mesh-list
153599236|NCT01873807|Idarubicin|idarubicin|mesh-list
153599237|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599238|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
153599239|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599240|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599241|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153599242|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
153599243|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599244|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599245|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153599246|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153599247|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599248|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153599249|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599250|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153599251|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
153599252|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
153599253|NCT01873820|Calcium|calcium|mesh-list
153599254|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153599255|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599256|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
153599257|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599258|NCT01873820|Protective Agents|protective agents|mesh-ancestor
153599259|NCT01873820|Vitamins|vitamins|mesh-ancestor
153599260|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
153599261|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
153599279|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
153599280|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599281|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
153599282|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599283|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
153599284|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
153599285|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
153599295|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599296|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599297|NCT01874171|Cetuximab|cetuximab|mesh-list
153599298|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599299|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599300|NCT01874236|Bupivacaine|bupivacaine|mesh-list
153599301|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
153599302|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
153599303|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599304|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599305|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
153599306|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599307|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
153599308|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599309|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731549|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731550|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
153731551|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153731553|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153731554|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
153731555|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153469202|NCT05421819|Vitamin D|vitamin d|mesh-list
153599310|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599311|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153599312|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599313|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599314|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599315|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
153599316|NCT01874470|Diuretics|diuretics|mesh-list
153599317|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
153599318|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599319|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
153599320|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599332|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599333|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
153599334|NCT01874574|Hormones|hormones|mesh-ancestor
153599335|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599336|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599337|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599338|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
153599339|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599340|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599341|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
153599342|NCT01874574|Protective Agents|protective agents|mesh-ancestor
153599343|NCT01874639|Hemostatics|hemostatics|mesh-list
153599344|NCT01874639|Coagulants|coagulants|mesh-ancestor
153599345|NCT01874678|Cisplatin|cisplatin|mesh-list
153599346|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599347|NCT01874717|Midazolam|midazolam|mesh-list
153599348|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153599349|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153599350|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599351|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599371|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153599373|NCT01874847|Melatonin|melatonin|mesh-list
153599374|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
153599375|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599376|NCT01874847|Protective Agents|protective agents|mesh-ancestor
153599377|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599378|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599379|NCT01874964|Methadone|methadone|mesh-list
153599380|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153599381|NCT01874964|Narcotics|narcotics|mesh-ancestor
153599382|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599383|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599384|NCT01874964|Analgesics|analgesics|mesh-ancestor
153599385|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
153599386|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599387|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
153360164|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
153599388|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
153599389|NCT01875107|Insulin|insulin|mesh-list
153599390|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153599391|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599392|NCT01875172|Bupropion|bupropion|mesh-list
153599393|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153599394|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
153599395|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153599396|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153599397|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153599398|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153599399|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599400|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
153599430|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153599431|NCT01875224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599432|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599434|NCT01875263|Levofloxacin|levofloxacin|mesh-list
153599435|NCT01875263|Cloxacillin|cloxacillin|mesh-list
153599436|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153690555|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
154263347|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263348|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599437|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599438|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599439|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599440|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153599441|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599442|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599443|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599444|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153599445|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153599446|NCT01875653|Molgramostim|molgramostim|mesh-list
153599447|NCT01875653|Sargramostim|sargramostim|mesh-list
153599448|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
153599449|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599450|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599451|NCT01875666|Trastuzumab|trastuzumab|mesh-list
153599452|NCT01875666|Pertuzumab|pertuzumab|mesh-list
153599453|NCT01875666|Lapatinib|lapatinib|mesh-list
153599454|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599455|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599456|NCT01875666|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153599457|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153599458|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599459|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599460|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
153599461|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599520|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153599522|NCT01876108|Bismuth|bismuth|mesh-list
153599523|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599524|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599525|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153599526|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153599527|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153599528|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599529|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599530|NCT01876108|Antacids|antacids|mesh-ancestor
153599531|NCT01876121|Celecoxib|celecoxib|mesh-list
153599532|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153599533|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153599534|NCT01876121|Analgesics|analgesics|mesh-ancestor
153599535|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
153599547|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
153599548|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599549|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599550|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599573|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599574|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599575|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599576|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153599577|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599578|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599579|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599580|NCT01876433|Mirabegron|mirabegron|mesh-list
153599581|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153599582|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153599583|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153599584|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
153599585|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599586|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599587|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599588|NCT01876433|Urological Agents|urological agents|mesh-ancestor
153599589|NCT01876550|Mupirocin|mupirocin|mesh-list
153599590|NCT01876550|Calcium|calcium|mesh-list
153599591|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153599592|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599593|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599594|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599595|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153599596|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263349|NCT05634369|Dexamethasone|dexamethasone|mesh-list
154263350|NCT05634369|Gemcitabine|gemcitabine|mesh-list
154263351|NCT05634369|Docetaxel|docetaxel|mesh-list
153599597|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599598|NCT01876563|Vitamin D|vitamin d|mesh-list
153599609|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599610|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599611|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599612|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153599613|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599614|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599615|NCT01876641|Decitabine|decitabine|mesh-list
153599616|NCT01876641|Vemurafenib|vemurafenib|mesh-list
153599631|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599632|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599634|NCT01876849|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153599635|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153599636|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599637|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153599638|NCT01876849|Incretins|incretins|mesh-ancestor
153599639|NCT01876849|Hormones|hormones|mesh-ancestor
153599640|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599641|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153599642|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
153599643|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599644|NCT01876966|Ritonavir|ritonavir|mesh-list
153599645|NCT01876966|Darunavir|darunavir|mesh-list
153599646|NCT01876966|Lumefantrine|lumefantrine|mesh-list
153599647|NCT01876966|Artemether|artemether|mesh-list
153599648|NCT01876966|Etravirine|etravirine|mesh-list
153599649|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153599650|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153599651|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153599652|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
153599653|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599654|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599655|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153599656|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153599657|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
153599658|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599659|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153599660|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153599661|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
153599662|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153599663|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153599664|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153599680|NCT01877226|Narcotics|narcotics|mesh-ancestor
153599681|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599682|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599683|NCT01877226|Analgesics|analgesics|mesh-ancestor
153599684|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
153599685|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599686|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153599687|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153599688|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153599689|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599690|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
153599711|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
153599712|NCT01877590|Vitamins|vitamins|mesh-ancestor
153599713|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
153599714|NCT01877746|Prednisone|prednisone|mesh-list
153599715|NCT01877746|Azathioprine|azathioprine|mesh-list
153599716|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599717|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
153599718|NCT01877746|Hormones|hormones|mesh-ancestor
153599719|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599720|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599721|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153599722|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599723|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
153599724|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599790|NCT01878357|Piperaquine|piperaquine|mesh-list
153599791|NCT01878357|Artenimol|artenimol|mesh-list
153599792|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
153599793|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153599794|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153599795|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599796|NCT01878422|Leucovorin|leucovorin|mesh-list
153599797|NCT01878422|Bevacizumab|bevacizumab|mesh-list
153599798|NCT01878422|Cetuximab|cetuximab|mesh-list
153599799|NCT01878422|Fluorouracil|fluorouracil|mesh-list
153599800|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
153599801|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599802|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599803|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153599804|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153599805|NCT01878422|Growth Substances|growth substances|mesh-ancestor
153599806|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599807|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
153599820|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
153599821|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599822|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599823|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599824|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153599825|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153599838|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153599839|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153599841|NCT01878643|Gentamicins|gentamicins|mesh-list
153599842|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599843|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599844|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153599845|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599846|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599847|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
153599848|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153599849|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
153599850|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599851|NCT01878695|Expectorants|expectorants|mesh-ancestor
153599852|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
153599853|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153599854|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
153599855|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599856|NCT01878695|Protective Agents|protective agents|mesh-ancestor
153599857|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599860|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
153599861|NCT01878708|Asparaginase|asparaginase|mesh-list
153599862|NCT01878708|Pegaspargase|pegaspargase|mesh-list
153599863|NCT01878708|BB 1101|bb 1101|mesh-list
153599864|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599865|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
153599866|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
153599867|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599868|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599869|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153599870|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
153599871|NCT01878708|Hormones|hormones|mesh-ancestor
153599872|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599873|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153599890|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153599891|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153599892|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153599893|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599894|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
153599895|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
153731556|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731557|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731558|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599896|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599897|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153599898|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153599899|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
153599900|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599901|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599902|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153599903|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
153599911|NCT01879033|Insulin|insulin|mesh-list
153599912|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153599913|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599914|NCT01879202|Methylphenidate|methylphenidate|mesh-list
153599915|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153599916|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599917|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153599918|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153599919|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153599920|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599921|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
153599922|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599923|NCT01879293|Metformin|metformin|mesh-list
153599924|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153599925|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599926|NCT01879358|Sirolimus|sirolimus|mesh-list
153599927|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599928|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599929|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153599930|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599931|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
153599959|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599960|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
153599962|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599963|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599964|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153599965|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599966|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153599967|NCT01879527|Amiloride|amiloride|mesh-list
153599968|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
153599969|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153599970|NCT01879527|Diuretics|diuretics|mesh-ancestor
153599971|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
153599972|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599973|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153599974|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153599975|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599976|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153600003|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153600004|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153600005|NCT01880112|Cefazolin|cefazolin|mesh-list
153600006|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153600007|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600008|NCT01880125|Acetaminophen|acetaminophen|mesh-list
153600009|NCT01880125|Tramadol|tramadol|mesh-list
153600010|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153600011|NCT01880125|Analgesics|analgesics|mesh-ancestor
153600012|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
153600013|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600014|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600015|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
153600016|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153600018|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600019|NCT01880138|Anesthetics|anesthetics|mesh-list
153600020|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600021|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600022|NCT01880216|Enoxaparin|enoxaparin|mesh-list
153600023|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
153600024|NCT01880216|Bemiparin|bemiparin|mesh-list
153600025|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
153600026|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153600067|NCT01880385|Fluorouracil|fluorouracil|mesh-list
153600068|NCT01880385|Trastuzumab|trastuzumab|mesh-list
153600069|NCT01880385|Epirubicin|epirubicin|mesh-list
153600070|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153600071|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
153600072|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600073|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600074|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153600082|NCT01880385|Growth Substances|growth substances|mesh-ancestor
153600083|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
153600084|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
153600085|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
153600086|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
153600087|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
153600088|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153600089|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153600090|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153600091|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153600092|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600093|NCT01880463|Vitamin D|vitamin d|mesh-list
153600094|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
153600095|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
153600096|NCT01880463|Vitamins|vitamins|mesh-list
153600097|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
153600098|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600099|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153600100|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153600101|NCT01880619|Tamsulosin|tamsulosin|mesh-list
153600102|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
153600103|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153600104|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153600105|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153600106|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600107|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600108|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600109|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600110|NCT01880619|Urological Agents|urological agents|mesh-ancestor
153600111|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153600112|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153600113|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
153600114|NCT01880658|Capecitabine|capecitabine|mesh-list
153600115|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153600116|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
153600117|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600118|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600119|NCT01880749|Everolimus|everolimus|mesh-list
153600120|NCT01880749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153600121|NCT01880749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153600122|NCT01880749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600123|NCT01880749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600124|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153600195|NCT01881568|Coagulants|coagulants|mesh-ancestor
153600196|NCT01881919|Quercetin|quercetin|mesh-list
153600197|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
153600198|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600199|NCT01881919|Protective Agents|protective agents|mesh-ancestor
153600200|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600201|NCT01881971|Calcium|calcium|mesh-list
153600202|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153600203|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600204|NCT01881997|Fentanyl|fentanyl|mesh-list
153600205|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153600206|NCT01881997|Narcotics|narcotics|mesh-ancestor
153600207|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600208|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600209|NCT01881997|Analgesics|analgesics|mesh-ancestor
153600210|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
153600211|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600212|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153600213|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153600214|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
153600215|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
153600216|NCT01882010|Sargramostim|sargramostim|mesh-list
153600217|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
153600218|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600219|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153600220|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
153600221|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
153600222|NCT01882127|Dexamethasone|dexamethasone|mesh-list
153600223|NCT01882127|Tretinoin|tretinoin|mesh-list
153600224|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600225|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
153600226|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
153600245|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
153600247|NCT01882296|Pantoprazole|pantoprazole|mesh-list
153600248|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153600249|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153600251|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600252|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600253|NCT01882322|Tacrolimus|tacrolimus|mesh-list
153600254|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153600255|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
153600256|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600257|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153600258|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600259|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600260|NCT01882361|Naltrexone|naltrexone|mesh-list
153731559|NCT00138554|Pioglitazone|pioglitazone|mesh-list
153600261|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153600262|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153600263|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600264|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
153600265|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600266|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153600267|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600268|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
153600269|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153600270|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600271|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
153600272|NCT01882400|Alendronate|alendronate|mesh-list
153600273|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
153600274|NCT01882400|Diphosphonates|diphosphonates|mesh-list
153600275|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153600276|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600277|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153600278|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153600279|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600280|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153600281|NCT01882530|Acetaminophen|acetaminophen|mesh-list
153600283|NCT01882530|Morphine|morphine|mesh-list
153600284|NCT01882530|Nefopam|nefopam|mesh-list
153600285|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153600286|NCT01882530|Narcotics|narcotics|mesh-ancestor
153600287|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600288|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600289|NCT01882530|Analgesics|analgesics|mesh-ancestor
153600290|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
153600299|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600300|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
153600301|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153600302|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153600303|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153600304|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153600305|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600306|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
153600307|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600325|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
153600326|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600327|NCT01883193|Micronutrients|micronutrients|mesh-list
153600328|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600329|NCT01883232|Lidocaine|lidocaine|mesh-list
153600330|NCT01883232|Epinephrine|epinephrine|mesh-list
153600331|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
153600332|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
153600333|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600334|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600335|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
153600336|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600337|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153600338|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153600339|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153600340|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153600341|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600342|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153600343|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153600344|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600345|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600346|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153600347|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153600348|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
153735948|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153600349|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153600350|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
153600351|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
153600352|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
153600353|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153600354|NCT01883323|Aldesleukin|aldesleukin|mesh-list
153600355|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
153600356|NCT01883323|Fludarabine|fludarabine|mesh-list
153600357|NCT01883323|Interleukin-2|interleukin-2|mesh-list
153600378|NCT01883531|Mannitol|mannitol|mesh-list
153600379|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153600380|NCT01883531|Diuretics|diuretics|mesh-ancestor
153600381|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
153600382|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600383|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
153600384|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153600385|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600386|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
153600405|NCT01883921|Antibodies|antibodies|mesh-list
153600406|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
153600407|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600408|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153600409|NCT01884116|Capsaicin|capsaicin|mesh-list
153600410|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
153600411|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
153600412|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
153600422|NCT01884272|Naproxen|naproxen|mesh-list
153600423|NCT01884272|Indomethacin|indomethacin|mesh-list
153600424|NCT01884272|Lesinurad|lesinurad|mesh-list
153600425|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153600426|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153600427|NCT01884272|Analgesics|analgesics|mesh-ancestor
153600428|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
153600429|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600430|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600431|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600432|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600433|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
153600434|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153600435|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600436|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600437|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
153600438|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153600439|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
153600440|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
153600441|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600442|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153600443|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600444|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600445|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
153600446|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600447|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600448|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153600450|NCT01884298|Remifentanil|remifentanil|mesh-list
153600451|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
153600489|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153600490|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
153600491|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
153600492|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
153600493|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153600494|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
153600495|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153600496|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600497|NCT01884441|Gemcitabine|gemcitabine|mesh-list
153600498|NCT01884441|Vinorelbine|vinorelbine|mesh-list
153600499|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153600500|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153600501|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
153600502|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600503|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600504|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153600505|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
153600542|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
153600569|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600570|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600571|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153600572|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153600573|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153600574|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600575|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600576|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600577|NCT01884909|Metoprolol|metoprolol|mesh-list
153600578|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153600579|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600580|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
153600581|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
153691250|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153600582|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600583|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600584|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153600585|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153600586|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153600587|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600588|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600589|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600590|NCT01884935|Natalizumab|natalizumab|mesh-list
153600591|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
153600592|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600593|NCT01885013|Metformin|metformin|mesh-list
153600594|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
153600595|NCT01885013|Doxorubicin|doxorubicin|mesh-list
153600596|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153600597|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
153600598|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600599|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600600|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153600601|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
153600602|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600603|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600604|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153600605|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153600606|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153600607|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153600608|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153600609|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600611|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153600612|NCT01885091|Growth Substances|growth substances|mesh-ancestor
153600613|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600614|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
153600615|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153600616|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
153600617|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600619|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
153600620|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153600621|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
153600645|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600647|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
153600648|NCT01885481|Betamethasone|betamethasone|mesh-list
153600649|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
153600650|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153600651|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
153600652|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153600653|NCT01885481|BB 1101|bb 1101|mesh-list
153600654|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600655|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
153600656|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
153600657|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600658|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600659|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153600660|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
153600661|NCT01885481|Hormones|hormones|mesh-ancestor
153600662|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600663|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153600664|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600665|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
153600666|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263352|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600667|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600668|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153600669|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
153600670|NCT01885585|Apixaban|apixaban|mesh-list
153600671|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153600672|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
153600673|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153600701|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153600702|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600703|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600704|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600705|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600706|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
153600707|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153600708|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
153600709|NCT01886001|Povidone|povidone|mesh-list
153600710|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153600711|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600712|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
153600713|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
153600714|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
153600715|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
153600716|NCT01886014|Oxytocin|oxytocin|mesh-list
153600717|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
153600718|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153600719|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600720|NCT01886053|Ertapenem|ertapenem|mesh-list
153600721|NCT01886053|beta-Lactams|beta-lactams|mesh-list
153600722|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153600723|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600724|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
153600725|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153600726|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600727|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600728|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153600729|NCT01886079|Analgesics|analgesics|mesh-ancestor
153600730|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
153600731|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600732|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153600733|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153600734|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153600735|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600736|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600737|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600738|NCT01886196|Ibuprofen|ibuprofen|mesh-list
153600747|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153600749|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600750|NCT01886209|Prednisone|prednisone|mesh-list
153600751|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
153600752|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153600753|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153600754|NCT01886209|Prednisolone|prednisolone|mesh-list
153600755|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
153600756|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153600757|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
153600758|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600787|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600788|NCT01886534|Diuretics|diuretics|mesh-list
153600789|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
153600790|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600791|NCT01886560|Doxycycline|doxycycline|mesh-list
153600792|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153600793|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600795|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153600796|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153600797|NCT01886573|Azacitidine|azacitidine|mesh-list
153600798|NCT01886573|Entinostat|entinostat|mesh-list
153600799|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153600800|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153600801|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
153600802|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600803|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600804|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263353|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
154263354|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
153600805|NCT01886599|Asunaprevir|asunaprevir|mesh-list
153600817|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153600818|NCT01886664|Sevoflurane|sevoflurane|mesh-list
153600819|NCT01886664|Desflurane|desflurane|mesh-list
153600832|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600833|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600834|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153600836|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
153600837|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600838|NCT01887158|Bisacodyl|bisacodyl|mesh-list
153600839|NCT01887158|Cathartics|cathartics|mesh-ancestor
153781725|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600840|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153600841|NCT01887158|Laxatives|laxatives|mesh-ancestor
153600842|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
153600843|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153600844|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600845|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600846|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153600847|NCT01887184|Analgesics|analgesics|mesh-ancestor
153600848|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
153600849|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600850|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153600851|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153600852|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153600853|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600854|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600855|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600856|NCT01887197|Mannitol|mannitol|mesh-list
153600857|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153600858|NCT01887197|Diuretics|diuretics|mesh-ancestor
153600859|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
153600860|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600861|NCT01887223|Timolol|timolol|mesh-list
153600862|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153600863|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600864|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153600865|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153600866|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153600887|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153600888|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153600889|NCT01887275|Interferons|interferons|mesh-list
153600890|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600891|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
153600892|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600893|NCT01887340|Carboplatin|carboplatin|mesh-list
153600894|NCT01887340|Etoposide|etoposide|mesh-list
153600895|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600896|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153600897|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153600898|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153600916|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600917|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153600918|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153600928|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600929|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153600930|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153600931|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600932|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600933|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153600934|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
153600935|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600936|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600937|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153600938|NCT01887561|Dasatinib|dasatinib|mesh-list
153600939|NCT01887561|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153600940|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153600941|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600942|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600943|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600945|NCT01887613|Analgesics|analgesics|mesh-ancestor
153600946|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
153600947|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600948|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600949|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
153600950|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153600951|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153600952|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600953|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153600954|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153600955|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153600956|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600957|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600958|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
153600959|NCT01887626|Ticagrelor|ticagrelor|mesh-list
153600970|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600971|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600972|NCT01887704|Aspirin|aspirin|mesh-list
153600973|NCT01887704|Sirolimus|sirolimus|mesh-list
153600974|NCT01887704|Paclitaxel|paclitaxel|mesh-list
153600975|NCT01887704|Everolimus|everolimus|mesh-list
153600976|NCT01887704|Clopidogrel|clopidogrel|mesh-list
153600977|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153600978|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600979|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
153600980|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
153600981|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
153600982|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600983|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153600984|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153600985|NCT01887704|Analgesics|analgesics|mesh-ancestor
153600991|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153600992|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153600993|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153600994|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153600995|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600997|NCT01887704|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153600998|NCT01887704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153600999|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601000|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
153601001|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153601002|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153601003|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153601004|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
153601005|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601006|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153601007|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601008|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153601009|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
153601010|NCT01887743|Pantoprazole|pantoprazole|mesh-list
153601011|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153601012|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601013|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153601014|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601015|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601016|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153601017|NCT01887795|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153601018|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153601019|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601020|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601021|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601022|NCT01887821|Chloroquine|chloroquine|mesh-list
153601023|NCT01887821|Piperaquine|piperaquine|mesh-list
153601024|NCT01887821|Artenimol|artenimol|mesh-list
153601025|NCT01887821|Amebicides|amebicides|mesh-ancestor
153601026|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153601027|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153601028|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601029|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
153601051|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601052|NCT01887951|Analgesics|analgesics|mesh-ancestor
153391416|NCT01641445|Topiramate|topiramate|mesh-list
153601053|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
153601054|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601055|NCT01888042|Everolimus|everolimus|mesh-list
153601069|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601070|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153601071|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601072|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470931|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
153601073|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601074|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153601075|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
153601076|NCT01888120|Ziconotide|ziconotide|mesh-list
153601077|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153601078|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601079|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601080|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153601081|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601082|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153601083|NCT01888120|Protective Agents|protective agents|mesh-ancestor
153601084|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153601085|NCT01888120|Analgesics|analgesics|mesh-ancestor
153601086|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
153601087|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601088|NCT01888224|Isotretinoin|isotretinoin|mesh-list
153601089|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
153601090|NCT01888250|Lamotrigine|lamotrigine|mesh-list
153601091|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
153601092|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153601093|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601094|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601109|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153601110|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601111|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601112|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601113|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153601114|NCT01888289|Isotretinoin|isotretinoin|mesh-list
153601115|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
153601140|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601141|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601142|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
153601143|NCT01888445|Hematinics|hematinics|mesh-ancestor
153601145|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
153601146|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601147|NCT01888536|Pregabalin|pregabalin|mesh-list
153601148|NCT01888536|Alprostadil|alprostadil|mesh-list
153601149|NCT01888536|Analgesics|analgesics|mesh-ancestor
153601150|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
153601151|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601152|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601153|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
153601154|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153601155|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601156|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601157|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153601158|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153601159|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601160|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601161|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601162|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153601163|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
153601164|NCT01888536|Urological Agents|urological agents|mesh-ancestor
153601165|NCT01888562|Ponatinib|ponatinib|mesh-list
153601166|NCT01888562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153601167|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153601168|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601188|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153601189|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153601190|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153601191|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
153601192|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
153601193|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601194|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601195|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601196|NCT01888731|Lamotrigine|lamotrigine|mesh-list
153601202|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601203|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153601204|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601206|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601207|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153601208|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153601211|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153601212|NCT01888744|Ganirelix|ganirelix|mesh-list
153601213|NCT01888744|Progestins|progestins|mesh-ancestor
153601214|NCT01888744|Hormones|hormones|mesh-ancestor
153601215|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601216|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601217|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153601218|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153601219|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
153601220|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
153601221|NCT01888757|Lamotrigine|lamotrigine|mesh-list
153601222|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
153601223|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153601233|NCT01888796|Linagliptin|linagliptin|mesh-list
153601234|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153601235|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601236|NCT01888796|Incretins|incretins|mesh-ancestor
153601237|NCT01888796|Hormones|hormones|mesh-ancestor
153601238|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601239|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153601240|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
153601241|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601242|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601243|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
153601244|NCT01888822|Ampicillin|ampicillin|mesh-list
153601245|NCT01888822|Sulbactam|sulbactam|mesh-list
153601246|NCT01888822|Sultamicillin|sultamicillin|mesh-list
153601247|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153601248|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601249|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153601250|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153601251|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601252|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601253|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601254|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153601255|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153601256|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153601257|NCT01888835|Mirtazapine|mirtazapine|mesh-list
153601258|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
153601259|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601260|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153601261|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
153601262|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
153601263|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601264|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601265|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601266|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153601267|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601268|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601269|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153601270|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153601271|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153601272|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
153601273|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153601284|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
153601285|NCT01888978|Leucovorin|leucovorin|mesh-list
153601286|NCT01888978|Gemcitabine|gemcitabine|mesh-list
153601287|NCT01888978|Fluorouracil|fluorouracil|mesh-list
153601288|NCT01888978|Docetaxel|docetaxel|mesh-list
153601301|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601302|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153601303|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153601304|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601305|NCT01888978|Antidotes|antidotes|mesh-ancestor
153601306|NCT01888978|Protective Agents|protective agents|mesh-ancestor
153601307|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
153601308|NCT01888978|Vitamins|vitamins|mesh-ancestor
153601309|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
153601310|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
153601312|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153601313|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601314|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601315|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153601316|NCT01889004|Analgesics|analgesics|mesh-ancestor
153601317|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
153601318|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601319|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153601320|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153601321|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153601322|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
153601323|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601324|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601325|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153601326|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
153601327|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
153601328|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
153601329|NCT01889056|Hematinics|hematinics|mesh-ancestor
153601330|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153601331|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153601332|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601333|NCT01889134|Alendronate|alendronate|mesh-list
153601334|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153601335|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601336|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
153601337|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153601338|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
153601339|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601340|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153601341|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601342|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153601343|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601344|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601345|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601346|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153601347|NCT01889212|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153601348|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153601349|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601350|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601351|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601361|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601376|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601377|NCT01889498|Acetazolamide|acetazolamide|mesh-list
153601378|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
153601379|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153601380|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601381|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601382|NCT01889498|Diuretics|diuretics|mesh-ancestor
153601383|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
153601384|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601385|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
153601386|NCT01889576|Antacids|antacids|mesh-ancestor
153601387|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601388|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601389|NCT01889680|Leucovorin|leucovorin|mesh-list
153601390|NCT01889680|Fluorouracil|fluorouracil|mesh-list
153601391|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
153601392|NCT01889680|Aflibercept|aflibercept|mesh-list
153601393|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
153601394|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
153601395|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601396|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153601397|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601398|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601399|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
153601400|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601401|NCT01889680|Antidotes|antidotes|mesh-ancestor
153601402|NCT01889680|Protective Agents|protective agents|mesh-ancestor
153601403|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
153601404|NCT01889680|Vitamins|vitamins|mesh-ancestor
153601405|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
153601406|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153601407|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153601409|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
153601410|NCT01889758|Tacrolimus|tacrolimus|mesh-list
153601411|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601412|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
153601413|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601414|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153601415|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601416|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601417|NCT01889771|Nicotine|nicotine|mesh-list
153601418|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153601432|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153601433|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153781727|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
153781728|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601434|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601446|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601447|NCT01889979|Analgesics|analgesics|mesh-ancestor
153601448|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
153601449|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601450|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
153601451|NCT01890538|Piracetam|piracetam|mesh-list
153601452|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
153601453|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
153601454|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601455|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601456|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601457|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153601458|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
153601459|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
153601460|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601461|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601462|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153601463|NCT01890538|Protective Agents|protective agents|mesh-ancestor
153601464|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
153601465|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
153601466|NCT01891292|Enalapril|enalapril|mesh-list
153601467|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153601468|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
153601469|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601470|NCT01891292|Expectorants|expectorants|mesh-ancestor
153601471|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
153601472|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153601473|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
153601474|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601475|NCT01891292|Protective Agents|protective agents|mesh-ancestor
153601476|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601477|NCT01891292|Antidotes|antidotes|mesh-ancestor
153601478|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153601479|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
153601493|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
153601494|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
153601495|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601496|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601497|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601498|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153601499|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601500|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601501|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601502|NCT01893229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153601503|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153601504|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601505|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601506|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601507|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
153601508|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
153601522|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153601523|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153601525|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601526|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
153601527|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601528|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153601529|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153601533|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153601534|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153601535|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153601536|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
153601537|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601538|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601539|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601540|NCT01894815|Dexetimide|dexetimide|mesh-list
153601541|NCT01894815|Citalopram|citalopram|mesh-list
153601542|NCT01894815|Escitalopram|escitalopram|mesh-list
153601543|NCT01894815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153601557|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
153601558|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153601559|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
153601560|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601561|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
153601562|NCT01895049|Prednisone|prednisone|mesh-list
153601563|NCT01895049|Everolimus|everolimus|mesh-list
153601564|NCT01895049|Tacrolimus|tacrolimus|mesh-list
153601565|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
153601566|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153601567|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153601568|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
153601569|NCT01895049|Hormones|hormones|mesh-ancestor
153601570|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601571|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601572|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153601573|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601574|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601575|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
153601576|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153601577|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601578|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601579|NCT01895049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153601580|NCT01895049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153601582|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153601583|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
153601584|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153601585|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601602|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153601603|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
153601604|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601609|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
153601610|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153601611|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601612|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601614|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
153601615|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153601616|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153601617|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601618|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601619|NCT01897740|Urological Agents|urological agents|mesh-ancestor
153601620|NCT01897753|Hormones|hormones|mesh-list
153601621|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601622|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601623|NCT01898065|Misonidazole|misonidazole|mesh-list
153601624|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601625|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153601626|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153601627|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601628|NCT01898221|Ethanol|ethanol|mesh-list
153601629|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153601630|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601631|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601632|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601633|NCT01898338|Daptomycin|daptomycin|mesh-list
153601634|NCT01898338|Fosfomycin|fosfomycin|mesh-list
153601635|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153601636|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601638|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154263356|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263357|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263358|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
154010288|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
154263359|NCT05634369|Hormones|hormones|mesh-ancestor
154263360|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263361|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154263362|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263363|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263364|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263365|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
154263366|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
154263367|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
154263368|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
153601639|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601640|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601641|NCT01900015|Efavirenz|efavirenz|mesh-list
153601642|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
153601643|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153601644|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153601645|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601646|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601647|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
153601648|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601663|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601665|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
153601666|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601667|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153601668|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153601669|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153601670|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
153601671|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601691|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601693|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153601694|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
153692173|NCT00084279|Interferons|interferons|mesh-list
153601695|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601696|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153601697|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153601698|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153601699|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153601700|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153601701|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153601702|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
153601703|NCT01900158|Cisplatin|cisplatin|mesh-list
153601704|NCT01900158|Gemcitabine|gemcitabine|mesh-list
153601705|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601706|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153601707|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
153601708|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601709|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153601710|NCT01900197|Hematinics|hematinics|mesh-ancestor
153601711|NCT01900301|Scopolamine|scopolamine|mesh-list
153601712|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154263369|NCT05630872|Lamivudine|lamivudine|mesh-list
154263370|NCT05630872|Dolutegravir|dolutegravir|mesh-list
154263371|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153601713|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153601714|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
153601715|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
153601716|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601717|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601718|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601719|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
153601720|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153601721|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
153601722|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601723|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601724|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153601725|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
153601759|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153601760|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
153601761|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
153601762|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601763|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601764|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601765|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
153601766|NCT01900509|Hormones|hormones|mesh-ancestor
153601767|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601768|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153601769|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601770|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153601771|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153601772|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153601773|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601774|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601775|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153601776|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
153601777|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153601778|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
153601779|NCT01900587|Tapentadol|tapentadol|mesh-list
153601780|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153601781|NCT01900587|Narcotics|narcotics|mesh-ancestor
153601782|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601783|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601784|NCT01900587|Analgesics|analgesics|mesh-ancestor
153601785|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
153601786|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601787|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153601788|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153601801|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692250|NCT00196690|Donepezil|donepezil|mesh-list
153601802|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153601803|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153601804|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601805|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153601819|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
153601820|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
153601821|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601822|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153601823|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601824|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
153601825|NCT01900717|Antidotes|antidotes|mesh-ancestor
153601826|NCT01900717|Protective Agents|protective agents|mesh-ancestor
153601827|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
153601828|NCT01900717|Vitamins|vitamins|mesh-ancestor
153601829|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
153601830|NCT01900795|Ibuprofen|ibuprofen|mesh-list
153601831|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153601832|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153601833|NCT01900795|Analgesics|analgesics|mesh-ancestor
153601834|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
153601835|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601836|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601837|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153601838|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263372|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153601839|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153601841|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601842|NCT01900860|Vitamin D|vitamin d|mesh-list
153601843|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
153601844|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
153601845|NCT01900860|Vitamins|vitamins|mesh-list
153601846|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
153601847|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601848|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153601849|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153601850|NCT01900886|Ribavirin|ribavirin|mesh-list
153601862|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
153601864|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153601865|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153601866|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601867|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601868|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
153601869|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
153601870|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601871|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601872|NCT01900951|Temozolomide|temozolomide|mesh-list
153601873|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153601874|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
153601875|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601876|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601877|NCT01901003|Lorazepam|lorazepam|mesh-list
153601878|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
153601879|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
153601880|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
153601893|NCT01901120|Mirabegron|mirabegron|mesh-list
153601894|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153601895|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153601896|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153601897|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
153601898|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601899|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601900|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601901|NCT01901120|Urological Agents|urological agents|mesh-ancestor
153601902|NCT01901172|Posaconazole|posaconazole|mesh-list
153601903|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
153601904|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601905|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153601906|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153601907|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153601908|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153601909|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153601910|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601911|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601912|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153601913|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
153601914|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601933|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601934|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
153601935|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153601937|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601938|NCT01901471|Cyclosporine|cyclosporine|mesh-list
153601939|NCT01901471|Cyclosporins|cyclosporins|mesh-list
153601940|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601941|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601942|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601943|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
153601944|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601945|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
153601946|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601947|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
153601948|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153601949|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153601950|NCT01901484|Praziquantel|praziquantel|mesh-list
153601951|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
153601952|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153601953|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263373|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263374|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601954|NCT01901549|Metoprolol|metoprolol|mesh-list
153601955|NCT01901549|Lisinopril|lisinopril|mesh-list
153601956|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153601957|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153601958|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
153601959|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
153601960|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601961|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601962|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153601971|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153601972|NCT01901549|Protective Agents|protective agents|mesh-ancestor
153601993|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
153601994|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
153601995|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601996|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601997|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601998|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153602000|NCT01902108|Bupivacaine|bupivacaine|mesh-list
153602001|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
153602002|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
153602003|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602004|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602005|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
153602006|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602007|NCT01902108|Analgesics|analgesics|mesh-ancestor
153602008|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153602009|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
153602010|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
153602011|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153602012|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153602013|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153602014|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
153602015|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602016|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602017|NCT01902121|Insulin|insulin|mesh-list
153602018|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153602019|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153602020|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602021|NCT01902160|Sirolimus|sirolimus|mesh-list
153602022|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153602023|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153602024|NCT01902160|Temsirolimus|temsirolimus|mesh-list
153602025|NCT01902160|MTOR Inhibitors|mtor inhibitors|mesh-list
153602026|NCT01902160|Antibodies|antibodies|mesh-list
153602034|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602035|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153602036|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
153602037|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602038|NCT01902160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153602039|NCT01902160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602040|NCT01902160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602043|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153602044|NCT01902186|Tenofovir|tenofovir|mesh-list
153602045|NCT01902186|Emtricitabine|emtricitabine|mesh-list
153602046|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
153602047|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153602048|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153602049|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
153602050|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602051|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602052|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153602053|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153602054|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
153602055|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602056|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153602085|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602086|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602087|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602088|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602089|NCT01902342|Oseltamivir|oseltamivir|mesh-list
153602091|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602092|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602093|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602105|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153602106|NCT01902498|Analgesics|analgesics|mesh-ancestor
153602107|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
153602108|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602109|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602110|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153602112|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153602128|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602129|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602130|NCT01902524|Analgesics|analgesics|mesh-ancestor
153602131|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
153602132|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602133|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153602134|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153602135|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
153602136|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
153602137|NCT01902537|Prucalopride|prucalopride|mesh-list
153602138|NCT01902537|Laxatives|laxatives|mesh-ancestor
153602139|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153602140|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153602141|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153602142|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
153602143|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602144|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602145|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602147|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153602148|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153602149|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
153602150|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
153602151|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602152|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602153|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153602154|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153602155|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153602156|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
153602157|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602179|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153602180|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153602181|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
153602182|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602183|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602184|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602185|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153602186|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153602187|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
153602188|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
153602189|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
153602190|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602191|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153602193|NCT01902862|Bortezomib|bortezomib|mesh-list
153602194|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153602222|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602223|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602224|NCT01903070|Linagliptin|linagliptin|mesh-list
153602225|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153602226|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602227|NCT01903070|Incretins|incretins|mesh-ancestor
153602228|NCT01903070|Hormones|hormones|mesh-ancestor
153602229|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153602230|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153602232|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602233|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602234|NCT01903083|Gemcitabine|gemcitabine|mesh-list
153602235|NCT01903083|Tadalafil|tadalafil|mesh-list
153602236|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153602237|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
153602238|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263375|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
153602239|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602240|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
153602241|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153602242|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153602243|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602244|NCT01903083|Urological Agents|urological agents|mesh-ancestor
153602245|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
153602246|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153602247|NCT01903109|Cevimeline|cevimeline|mesh-list
153602248|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153602249|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
153602250|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602251|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602252|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153602253|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153602254|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
153602255|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602256|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602257|NCT01903122|Cevimeline|cevimeline|mesh-list
153602258|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153602259|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
153602260|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602261|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602262|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153602263|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153602264|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
153602265|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602266|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602303|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602304|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153602305|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
153602307|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153602308|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153602309|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153602310|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153602311|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
153602312|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602313|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602314|NCT01903824|Modafinil|modafinil|mesh-list
153602315|NCT01903824|Donepezil|donepezil|mesh-list
153602316|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153602317|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692642|NCT00084825|Docetaxel|docetaxel|mesh-list
153602318|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602319|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
153602320|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602321|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602322|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
153602323|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153602324|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153602363|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602364|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
153602365|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602367|NCT01904253|Amrubicin|amrubicin|mesh-list
153602368|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153602369|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153602370|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602371|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602372|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602373|NCT01904357|Cefazolin|cefazolin|mesh-list
153602374|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153602375|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602376|NCT01904487|Tiagabine|tiagabine|mesh-list
153602377|NCT01904487|Flumazenil|flumazenil|mesh-list
153602378|NCT01904487|Antidotes|antidotes|mesh-ancestor
153602379|NCT01904487|Protective Agents|protective agents|mesh-ancestor
153602380|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602381|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
153602382|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
153602383|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602394|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153602395|NCT01904591|Vitamin E|vitamin e|mesh-list
153602396|NCT01904591|Selenium|selenium|mesh-list
153602397|NCT01904591|Vitamins|vitamins|mesh-ancestor
153602398|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
154263376|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602399|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602401|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602402|NCT01904591|Protective Agents|protective agents|mesh-ancestor
153602403|NCT01904591|Trace Elements|trace elements|mesh-ancestor
153602404|NCT01904643|Cytarabine|cytarabine|mesh-list
153602405|NCT01904643|Etoposide|etoposide|mesh-list
153602406|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
153602407|NCT01904643|Lenalidomide|lenalidomide|mesh-list
153602408|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
153602409|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153602410|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602411|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153602412|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153602413|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602414|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602415|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153602416|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
153602417|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
153602418|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602419|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602420|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
153602421|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602432|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602433|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602434|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
153602436|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153602437|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
153602438|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
153602439|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602440|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
153602441|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602442|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602443|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153602444|NCT01904734|Clomiphene|clomiphene|mesh-list
153602445|NCT01904734|Enclomiphene|enclomiphene|mesh-list
153602446|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
153602447|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153602448|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
153745646|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
153602449|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153602450|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602451|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153602452|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
153602453|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153602454|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153602455|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153602456|NCT01904747|Palbociclib|palbociclib|mesh-list
153602457|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602475|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
153602476|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602477|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602478|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153602479|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
153602480|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
153602481|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602482|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153602483|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153602490|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
153602491|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153602492|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153602493|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602494|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602495|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
153602496|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602497|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153602498|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153602499|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153602500|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153602502|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
153602503|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153602504|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153602505|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153602506|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153602507|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602508|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
153602509|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602510|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602511|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153602512|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602513|NCT01905150|Leucovorin|leucovorin|mesh-list
153602514|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
153602515|NCT01905150|Gemcitabine|gemcitabine|mesh-list
153602516|NCT01905150|Fluorouracil|fluorouracil|mesh-list
153602517|NCT01905150|Docetaxel|docetaxel|mesh-list
153602518|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
153602533|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602534|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
153602535|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153602536|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153602537|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602538|NCT01905150|Antidotes|antidotes|mesh-ancestor
153602539|NCT01905150|Protective Agents|protective agents|mesh-ancestor
153602540|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
153602541|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
153602542|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153602543|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
153602544|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153602545|NCT01905215|Vaccines|vaccines|mesh-list
153602546|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
153602547|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602548|NCT01905371|Amphetamine|amphetamine|mesh-list
153602549|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
153602550|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153602551|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602552|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
153602553|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
153602554|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602555|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
153602556|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602572|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
153602573|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602574|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602575|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602576|NCT01905618|Nicotine|nicotine|mesh-list
153602577|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153602578|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
153602579|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602580|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602581|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153602582|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153602583|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
153602584|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602585|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602586|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
153602587|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153602588|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
153602589|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602590|NCT01905696|Expectorants|expectorants|mesh-ancestor
153602591|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
153602592|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153602593|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
153602612|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153602613|NCT01906073|Narcotics|narcotics|mesh-ancestor
153602614|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602615|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602616|NCT01906073|Analgesics|analgesics|mesh-ancestor
153602621|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
153602622|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
153602623|NCT01906125|Palbociclib|palbociclib|mesh-list
153602624|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602625|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153602626|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602627|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263377|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154263378|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153735973|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153602629|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602630|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153602631|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602632|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602633|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
153602634|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153602636|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153602637|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602638|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
153602639|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153602640|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602641|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
153602642|NCT01906307|Giapreza|giapreza|mesh-list
153602643|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153602644|NCT01906411|Dopamine|dopamine|mesh-list
153602645|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153602646|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
153602647|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
153602648|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602649|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602650|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
153602651|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602652|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602653|NCT01906411|Protective Agents|protective agents|mesh-ancestor
153602654|NCT01906450|Azithromycin|azithromycin|mesh-list
153602655|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153602656|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602657|NCT01906528|Mivacurium|mivacurium|mesh-list
153602672|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602673|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153602674|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602675|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602676|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
153602677|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602678|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153602679|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602680|NCT01906749|Colchicine|colchicine|mesh-list
153602681|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
153602682|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153602683|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
153602684|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
153602685|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
153602686|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602687|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602688|NCT01906762|Acetaminophen|acetaminophen|mesh-list
153602699|NCT01906788|Lumefantrine|lumefantrine|mesh-list
153602700|NCT01906788|Artemether|artemether|mesh-list
153602701|NCT01906788|Primaquine|primaquine|mesh-list
153602702|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153602703|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
153602704|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153602705|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153602706|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602707|NCT01906801|Diacerein|diacerein|mesh-list
153602708|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153602710|NCT01906879|Antacids|antacids|mesh-ancestor
153602711|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602712|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153602713|NCT01906944|Triamcinolone|triamcinolone|mesh-list
153602714|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153602715|NCT01906944|Bupivacaine|bupivacaine|mesh-list
153602716|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
153602717|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
153602718|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602719|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602720|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
153602721|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602722|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153602723|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
153602724|NCT01906944|Hormones|hormones|mesh-ancestor
153602725|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263379|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153602726|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602727|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
153602728|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
153602729|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153602730|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
153602756|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
153602757|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602765|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
153602766|NCT01907204|Budesonide|budesonide|mesh-list
153602767|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153602768|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
153602769|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153602770|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
153602771|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
153602772|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602773|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602774|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153602775|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
153602776|NCT01907204|Hormones|hormones|mesh-ancestor
153602777|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153602778|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153602779|NCT01907204|Protective Agents|protective agents|mesh-ancestor
153602780|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153602781|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602782|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153602783|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153602785|NCT01907230|Entecavir|entecavir|mesh-list
153602786|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
153602787|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602800|NCT01907373|Probenecid|probenecid|mesh-list
153602801|NCT01907373|Olmesartan|olmesartan|mesh-list
153602802|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153602803|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153602804|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153602805|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153602806|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602807|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
153602808|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
153602809|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153602810|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
153602811|NCT01907529|Docetaxel|docetaxel|mesh-list
153602812|NCT01907529|Epirubicin|epirubicin|mesh-list
153602813|NCT01907529|Endostar protein|endostar protein|mesh-list
153602814|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602815|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
153602816|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602817|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153602818|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153602819|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
153602820|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602821|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602822|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153602823|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
153602824|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
153602825|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
153602826|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153602827|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153602828|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153602855|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602856|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153602857|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153602858|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
153602859|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602860|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602861|NCT01907685|Docetaxel|docetaxel|mesh-list
153602862|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602863|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
153602864|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
153781730|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153602865|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
153602866|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602867|NCT01907724|Simeprevir|simeprevir|mesh-list
153602868|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
153602869|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602871|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602872|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602874|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153602875|NCT01907776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153602925|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
153602926|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602927|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153602928|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153602947|NCT01908257|Ranitidine|ranitidine|mesh-list
153602948|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153602949|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153602950|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153602951|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153602952|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
153602953|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
153602954|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602955|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602956|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602957|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
153602958|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153602959|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
153602960|NCT01908283|Vaccines|vaccines|mesh-list
153602961|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
153602962|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602963|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153602964|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
153602965|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
153602966|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153602967|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153602976|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602978|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153602979|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153602980|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153602991|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602992|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
153602993|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602994|NCT01908348|Erythritol|erythritol|mesh-list
153602995|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
153602996|NCT01908387|Azacitidine|azacitidine|mesh-list
153602997|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153602998|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
153602999|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603000|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603001|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603002|NCT01908452|Pyridoxine|pyridoxine|mesh-list
153603003|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
153603004|NCT01908452|Vitamins|vitamins|mesh-ancestor
153603005|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
153603006|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603007|NCT01908478|Gemcitabine|gemcitabine|mesh-list
153603008|NCT01908478|Veliparib|veliparib|mesh-list
153603009|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153603010|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
153603011|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603012|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603013|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153603014|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603015|NCT01908556|Letrozole|letrozole|mesh-list
153603016|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603017|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153603018|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153603019|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603020|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603021|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153603022|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
153603023|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603024|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603025|NCT01908621|Cytarabine|cytarabine|mesh-list
153603026|NCT01908621|Lenograstim|lenograstim|mesh-list
153603027|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153603028|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
153603029|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263380|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153753715|NCT00177567|Olanzapine|olanzapine|mesh-list
153603030|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153603031|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
153603032|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603033|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603034|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
153603035|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603036|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153603037|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153603038|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
153603074|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153603075|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603076|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
153603077|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
153603078|NCT01909219|Cathartics|cathartics|mesh-ancestor
153603079|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603080|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
153603081|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
153603082|NCT01909557|Vitamins|vitamins|mesh-ancestor
153603083|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
153603084|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603085|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
153603086|NCT01909622|Vitamin D|vitamin d|mesh-list
153603087|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
153603088|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
153603089|NCT01909622|Vitamins|vitamins|mesh-list
153603090|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
153603091|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603092|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153603093|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603094|NCT01909661|Caseins|caseins|mesh-list
153603095|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
153603096|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
153603097|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603113|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
153603114|NCT01909830|Gemcitabine|gemcitabine|mesh-list
153603115|NCT01909830|Pemetrexed|pemetrexed|mesh-list
153603116|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153603117|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
153603118|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603119|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603120|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603121|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153603122|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153603123|NCT01909843|Gontivimab|gontivimab|mesh-list
153603124|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
153603125|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603126|NCT01909856|Dexamethasone|dexamethasone|mesh-list
153603127|NCT01909856|Palonosetron|palonosetron|mesh-list
153603128|NCT01909856|Granisetron|granisetron|mesh-list
153603129|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603130|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153603131|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
153603132|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
153603133|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603134|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603135|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603136|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
153603137|NCT01909856|Hormones|hormones|mesh-ancestor
153603138|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603139|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153603140|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153603141|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153603142|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
153603143|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603144|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603145|NCT01910077|Tacrolimus|tacrolimus|mesh-list
153603180|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
153603181|NCT01910142|Coagulants|coagulants|mesh-ancestor
153603182|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
153603183|NCT01910155|Dexamethasone|dexamethasone|mesh-list
153603184|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153603185|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
153603186|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
153603187|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603189|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603190|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
153603191|NCT01910155|Hormones|hormones|mesh-ancestor
153603192|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603193|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153603194|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603195|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153603196|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603197|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153603198|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153603199|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603200|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603212|NCT01910259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153603213|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153603214|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603215|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603216|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603217|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
153603218|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603219|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153603220|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
153603226|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153603227|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153603228|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153603229|NCT01910259|Protective Agents|protective agents|mesh-ancestor
153603230|NCT01910259|Diuretics|diuretics|mesh-ancestor
153603231|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
153603232|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153603233|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153603234|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153603235|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153603238|NCT01910285|Remifentanil|remifentanil|mesh-list
153781732|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
153781733|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603239|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153603240|NCT01910285|Narcotics|narcotics|mesh-ancestor
153603241|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603242|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603243|NCT01910285|Analgesics|analgesics|mesh-ancestor
153603244|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
153603245|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603246|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153603247|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153603248|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
153603249|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
153603250|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
153603251|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153603252|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153603253|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153603254|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603255|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603256|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
153603257|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603258|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603259|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153603260|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603261|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
153603262|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153603263|NCT01910415|Ivacaftor|ivacaftor|mesh-list
153603264|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153603265|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603266|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153603267|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153603268|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603303|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603304|NCT01910545|OTS167|ots167|mesh-list
153603305|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153603306|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603307|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603308|NCT01910766|Ubiquinone|ubiquinone|mesh-list
153603309|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
153603311|NCT01910766|Enclomiphene|enclomiphene|mesh-list
153603312|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
153603313|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153603314|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
153603315|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603316|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603317|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153603318|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
153603319|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153603349|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153603350|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153603351|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153603352|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603367|NCT01910987|Hormones|hormones|mesh-ancestor
153603368|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603369|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153603370|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603371|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
153603372|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603373|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603374|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
153603386|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603387|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603388|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153603390|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153603391|NCT01911299|Protective Agents|protective agents|mesh-ancestor
153603392|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603394|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603395|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
153603396|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
153603397|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
153603398|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603399|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
153603400|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153603401|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
153603402|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603403|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603404|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153603405|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
153603406|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
153603407|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153603408|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
153603409|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603410|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603411|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
153603412|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153603413|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153693636|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
153603414|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153603415|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603441|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153603442|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
153603443|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153603444|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603445|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603446|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603447|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
153603448|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153603449|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153603450|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
153603451|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
153603452|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153603453|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153603454|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153603455|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
153603456|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603457|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153603458|NCT01911507|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153603459|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153603460|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603461|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603462|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603511|NCT01911949|Bupivacaine|bupivacaine|mesh-list
153603512|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
153603513|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
153603514|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603515|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603516|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
153603517|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603527|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
153603529|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
153603530|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153603531|NCT01911975|Lacosamide|lacosamide|mesh-list
153603532|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
153603533|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153603539|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153603540|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
153603541|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603542|NCT01912066|Aceclofenac|aceclofenac|mesh-list
153603543|NCT01912066|Misoprostol|misoprostol|mesh-list
153603544|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153603545|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
153603546|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153603547|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603548|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153603549|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603550|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
153603551|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153603552|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153603553|NCT01912066|Analgesics|analgesics|mesh-ancestor
153603554|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
153603555|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603556|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153603557|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603558|NCT01912118|Remifentanil|remifentanil|mesh-list
153603559|NCT01912118|Propofol|propofol|mesh-list
153603560|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153603561|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603562|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603563|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153603564|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
153603565|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
153603566|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153603567|NCT01912118|Narcotics|narcotics|mesh-ancestor
153603568|NCT01912118|Analgesics|analgesics|mesh-ancestor
153603569|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
153603570|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603571|NCT01912261|Iron|iron|mesh-list
153603572|NCT01912261|Trace Elements|trace elements|mesh-ancestor
153603573|NCT01912261|Micronutrients|micronutrients|mesh-ancestor
153603574|NCT01912261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603575|NCT01912378|Oxytocin|oxytocin|mesh-list
153603576|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
153603577|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153603578|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603579|NCT01912391|Selegiline|selegiline|mesh-list
153603580|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
153603581|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153603582|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153603583|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153603584|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153603585|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603586|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603587|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153603588|NCT01912391|Protective Agents|protective agents|mesh-ancestor
153603627|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603628|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603629|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
153603631|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153603632|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153603633|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153603634|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
154263382|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154263383|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263384|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153603635|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603636|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153603637|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
153603638|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
153603639|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603640|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153603641|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153603642|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
153603643|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153603644|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153603645|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153603658|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153603659|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153603660|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603661|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603662|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153603663|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153603689|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
153603690|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153603691|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
153603692|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153603693|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603694|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153603695|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153603696|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603697|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603698|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603699|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603700|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153603701|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603702|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
153603703|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603704|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153603705|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603706|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603707|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
154191188|NCT05941585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603708|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603709|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603710|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153603711|NCT01913054|Fentanyl|fentanyl|mesh-list
153603712|NCT01913054|Propofol|propofol|mesh-list
153603713|NCT01913054|Etomidate|etomidate|mesh-list
153603714|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153603731|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603732|NCT01913119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153603733|NCT01913119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603734|NCT01913119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603735|NCT01913379|Itraconazole|itraconazole|mesh-list
153603736|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
153603737|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
153603738|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603739|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153603740|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153603741|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603742|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603743|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153603744|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
153603745|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603746|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603761|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
153603762|NCT01913691|Ipilimumab|ipilimumab|mesh-list
153603763|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153781734|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603764|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603765|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153603766|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603768|NCT01913808|Glycine|glycine|mesh-list
153603769|NCT01913808|Trace Elements|trace elements|mesh-ancestor
153603770|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
153603771|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603772|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
153603773|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603782|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153603784|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603785|NCT01913847|Urological Agents|urological agents|mesh-ancestor
153603786|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153603787|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603788|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
153603789|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
153603791|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
153603792|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603793|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
153603794|NCT01913990|Dexamethasone|dexamethasone|mesh-list
153603795|NCT01913990|Ondansetron|ondansetron|mesh-list
153603796|NCT01913990|Aprepitant|aprepitant|mesh-list
153603797|NCT01913990|Antiemetics|antiemetics|mesh-list
153603798|NCT01913990|Emetics|emetics|mesh-list
153603799|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153603800|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
153603801|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603802|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603803|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603804|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
153603805|NCT01913990|Hormones|hormones|mesh-ancestor
153603806|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603807|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153603808|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603809|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
153603810|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
153603811|NCT01913990|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153603812|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153603813|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
153603814|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191189|NCT05941585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603815|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603816|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153603817|NCT01914042|Morphine|morphine|mesh-list
153603818|NCT01914042|Milnacipran|milnacipran|mesh-list
153603837|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603838|NCT01914081|Protective Agents|protective agents|mesh-ancestor
153603863|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
153603864|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603865|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603866|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
153603868|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603869|NCT01914380|Aflibercept|aflibercept|mesh-list
153603870|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153603871|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153603872|NCT01914380|Growth Substances|growth substances|mesh-ancestor
153603873|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603874|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
153603875|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603876|NCT01914419|Oxytocin|oxytocin|mesh-list
153603877|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
153603878|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153603879|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603880|NCT01914432|Telmisartan|telmisartan|mesh-list
153603881|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153603882|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153603883|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153603884|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
153603885|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603886|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153603887|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153603888|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603889|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153603890|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153603891|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153603904|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
153603905|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
153603906|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153603907|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153603932|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603934|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603935|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153603936|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153603937|NCT01914770|Belimumab|belimumab|mesh-list
153603938|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153603939|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
153603940|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603941|NCT01914822|Methylphenidate|methylphenidate|mesh-list
153603942|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153603943|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603944|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153603945|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153603946|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603947|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603948|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
153603949|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603950|NCT01914939|Oxytocin|oxytocin|mesh-list
153603951|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
153603952|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153603953|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603954|NCT01914965|Bupropion|bupropion|mesh-list
153603955|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153603960|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603961|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603963|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603977|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603978|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153603979|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
153603980|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153603981|NCT01915069|Protective Agents|protective agents|mesh-ancestor
153603982|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153603983|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153603984|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603986|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153603987|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603988|NCT01915134|Cisplatin|cisplatin|mesh-list
153603989|NCT01915134|Gemcitabine|gemcitabine|mesh-list
153603990|NCT01915134|Endostatins|endostatins|mesh-list
153603991|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603992|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153603993|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
153603994|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603995|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153603996|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153603997|NCT01915134|Growth Substances|growth substances|mesh-ancestor
153603998|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603999|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
153604000|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153604001|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153604002|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
153604003|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604004|NCT01915264|Metformin|metformin|mesh-list
153604005|NCT01915264|Acarbose|acarbose|mesh-list
153604006|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153604007|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604008|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153604009|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604010|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604011|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
153604012|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153604013|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604014|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604015|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153604016|NCT01915277|Analgesics|analgesics|mesh-ancestor
153604017|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
153604018|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263385|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604019|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153604020|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153604021|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153604022|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
153604023|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604024|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604045|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604046|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604047|NCT01915537|Infliximab|infliximab|mesh-list
153604048|NCT01915537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153604049|NCT01915537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153604050|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
153604051|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153604052|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153604053|NCT01915550|Insulin|insulin|mesh-list
153604054|NCT01915550|Metformin|metformin|mesh-list
153604055|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153604056|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
153604057|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153604058|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604060|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604061|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153604062|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604063|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604064|NCT01915758|Clindamycin|clindamycin|mesh-list
153604065|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
153604066|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
153604067|NCT01915758|Tretinoin|tretinoin|mesh-list
153694182|NCT00227461|Levetiracetam|levetiracetam|mesh-list
153604068|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153604069|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604070|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153604071|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604072|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604073|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604074|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
153604075|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
153604076|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153604077|NCT01915901|Bismuth|bismuth|mesh-list
153604078|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153604079|NCT01915901|Antacids|antacids|mesh-ancestor
153604080|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604081|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153604082|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
153604083|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604084|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
153604085|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604086|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
153604087|NCT01915979|Betamethasone|betamethasone|mesh-list
153604088|NCT01915979|Mitogens|mitogens|mesh-list
153604089|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
153604090|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604091|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153604131|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
153604132|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153604133|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
153604134|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604135|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
153604136|NCT01916213|Protective Agents|protective agents|mesh-ancestor
153604137|NCT01916252|Dexamethasone|dexamethasone|mesh-list
153604138|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
153604139|NCT01916252|Lenalidomide|lenalidomide|mesh-list
153604141|NCT01916252|Melphalan|melphalan|mesh-list
153604142|NCT01916252|Busulfan|busulfan|mesh-list
153604143|NCT01916252|BB 1101|bb 1101|mesh-list
153604144|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153604145|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
153604146|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
153604147|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604148|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604162|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604164|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604165|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
153604166|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604167|NCT01916265|Glucagon|glucagon|mesh-list
153604168|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153604169|NCT01916265|Hormones|hormones|mesh-ancestor
153604170|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153604171|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604173|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604174|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604175|NCT01916395|Sumatriptan|sumatriptan|mesh-list
153604176|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153604177|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153604178|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153604179|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
153604180|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604203|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153604204|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153604205|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
153604206|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604207|NCT01916642|Lidocaine|lidocaine|mesh-list
153604208|NCT01916642|Etomidate|etomidate|mesh-list
153604218|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153604219|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604220|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153604221|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153604222|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
153604224|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
153604225|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153604226|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153604227|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604228|NCT01916720|Darapladib|darapladib|mesh-list
153604229|NCT01916720|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153604230|NCT01916720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604231|NCT01916720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604232|NCT01916733|Insulin|insulin|mesh-list
153604233|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153604234|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604235|NCT01916785|Dasatinib|dasatinib|mesh-list
153604236|NCT01916785|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153604237|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153604238|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604239|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604240|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604258|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153604259|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153604260|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153604261|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
153604262|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604263|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604264|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604265|NCT01916915|Tramadol|tramadol|mesh-list
153604266|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
153604267|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153604281|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153604282|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604283|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
153604284|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153604285|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153604286|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604287|NCT01917032|Folic Acid|folic acid|mesh-list
153604288|NCT01917032|Vitamin A|vitamin a|mesh-list
153604289|NCT01917032|Micronutrients|micronutrients|mesh-list
153604290|NCT01917032|Trace Elements|trace elements|mesh-list
153604291|NCT01917032|Tretinoin|tretinoin|mesh-list
153604292|NCT01917032|Vitamins|vitamins|mesh-ancestor
153604293|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604294|NCT01917032|Hematinics|hematinics|mesh-ancestor
153604295|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
153604296|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604297|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
153604298|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
153604299|NCT01917045|Sufentanil|sufentanil|mesh-list
153604300|NCT01917045|Morphine|morphine|mesh-list
153604301|NCT01917045|Dsuvia|dsuvia|mesh-list
153604302|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153604303|NCT01917045|Narcotics|narcotics|mesh-ancestor
153604318|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604319|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
154263386|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604320|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604321|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694381|NCT00228319|Vitamins|vitamins|mesh-list
153604322|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
153604323|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153604324|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604325|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604326|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153604327|NCT01917097|Analgesics|analgesics|mesh-ancestor
153604328|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
153604329|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604330|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153604331|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153604332|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153604345|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
153604346|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604347|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604348|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153604349|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153604350|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153604351|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
153604352|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604353|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153604354|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
153604355|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604356|NCT01917279|Docetaxel|docetaxel|mesh-list
153604357|NCT01917279|Capecitabine|capecitabine|mesh-list
153604358|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604359|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
153604360|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
153604361|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
153604362|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604363|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153604365|NCT01917318|Iloperidone|iloperidone|mesh-list
153604366|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153604367|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153604368|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604369|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604370|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153604371|NCT01917331|Beclomethasone|beclomethasone|mesh-list
153604372|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
153604373|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
153604374|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153604375|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
153604389|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
153604390|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153604391|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
153604392|NCT01917331|Hormones|hormones|mesh-ancestor
153604393|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153604394|NCT01917448|Morphine|morphine|mesh-list
153604427|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153604428|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604429|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
153604430|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153604431|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604432|NCT01917617|Cisplatin|cisplatin|mesh-list
153604433|NCT01917617|Gemcitabine|gemcitabine|mesh-list
153604434|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153604435|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604436|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153604437|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
153604438|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604448|NCT01917721|Doxycycline|doxycycline|mesh-list
153604449|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153604450|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604451|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
153604452|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153604453|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153604454|NCT01917799|Aspirin|aspirin|mesh-list
153604455|NCT01917799|Heparin|heparin|mesh-list
153604456|NCT01917799|Enoxaparin|enoxaparin|mesh-list
153604457|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153604459|NCT01917799|Analgesics|analgesics|mesh-ancestor
153604460|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
153604461|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604462|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604463|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153604464|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153604465|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153604466|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153604467|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604468|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153604469|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153604470|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604471|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
153604472|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
153604473|NCT01917890|Curcumin|curcumin|mesh-list
153604474|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153604475|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153604476|NCT01917890|Analgesics|analgesics|mesh-ancestor
153604493|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604495|NCT01918111|Adenosine|adenosine|mesh-list
153604496|NCT01918111|Analgesics|analgesics|mesh-ancestor
153604497|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
153604498|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604499|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604500|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153604501|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
153604502|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153604503|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
153604504|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
153604505|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604532|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
153604533|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604534|NCT01918176|Palbociclib|palbociclib|mesh-list
153604535|NCT01918176|Rabeprazole|rabeprazole|mesh-list
153604536|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604537|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153604538|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604539|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604540|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153604541|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153604542|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153604543|NCT01918241|Lenograstim|lenograstim|mesh-list
153604544|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153604545|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
153604546|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604547|NCT01918254|Paclitaxel|paclitaxel|mesh-list
153604548|NCT01918254|Pertuzumab|pertuzumab|mesh-list
153604549|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153604550|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604551|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
153604552|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
153604553|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
153604554|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604555|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604556|NCT01918358|Valsartan|valsartan|mesh-list
153604557|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153604564|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604565|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153604566|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153604587|NCT01918514|Analgesics|analgesics|mesh-ancestor
153604588|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
153781736|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
153604589|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604590|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604591|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
153604592|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604593|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153604594|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
153604595|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153604596|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153604597|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604598|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153604599|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
153604601|NCT01918631|Tenofovir|tenofovir|mesh-list
153604602|NCT01918631|Entecavir|entecavir|mesh-list
153604603|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
153604604|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604605|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153604606|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153604607|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604608|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604609|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153604610|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153604611|NCT01918709|Valsartan|valsartan|mesh-list
153604612|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153604613|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153604614|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153604615|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
153604616|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604617|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153604618|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153604644|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604645|NCT01918878|Aflibercept|aflibercept|mesh-list
153604646|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153604647|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153604648|NCT01918878|Growth Substances|growth substances|mesh-ancestor
153604649|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604650|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
153604651|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604652|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
153604653|NCT01918904|Antidotes|antidotes|mesh-ancestor
153604654|NCT01918904|Protective Agents|protective agents|mesh-ancestor
153604655|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604656|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
153604657|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604658|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
153604659|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153604660|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604661|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
153604662|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
153604663|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
153604664|NCT01918917|Morphine|morphine|mesh-list
153604665|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
153604666|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153604667|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604668|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604669|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153604670|NCT01918917|Analgesics|analgesics|mesh-ancestor
153604671|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
153604672|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604673|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153604674|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153604675|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153604676|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
153604677|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604678|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604690|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604691|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153604692|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
153604693|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153604694|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153604695|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153604696|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604697|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604698|NCT01919047|Mirabegron|mirabegron|mesh-list
153604699|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153604700|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153604701|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153604702|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
153604703|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604704|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604705|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604706|NCT01919047|Urological Agents|urological agents|mesh-ancestor
153604707|NCT01919203|Remifentanil|remifentanil|mesh-list
153604708|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153604709|NCT01919203|Narcotics|narcotics|mesh-ancestor
153604710|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604711|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604723|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
153604724|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604725|NCT01919255|Cathartics|cathartics|mesh-ancestor
153604726|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153604727|NCT01919255|Antacids|antacids|mesh-ancestor
153604728|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
153604729|NCT01919294|Testosterone|testosterone|mesh-list
153604730|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
153604731|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
153604732|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153604733|NCT01919294|Androgens|androgens|mesh-ancestor
153604735|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153604736|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604737|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153604738|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604739|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
153604741|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153604742|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604743|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
153604744|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604745|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
153604756|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604757|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604759|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153604760|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
153604761|NCT01919593|Povidone|povidone|mesh-list
153604762|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153604763|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604764|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
153604765|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
153604766|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
153604767|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
153604768|NCT01919788|Insulin|insulin|mesh-list
153604769|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153604770|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604771|NCT01919879|Cetuximab|cetuximab|mesh-list
153604772|NCT01919879|Afatinib|afatinib|mesh-list
153604773|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604774|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604775|NCT01919879|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153604776|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153604777|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604778|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604779|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
153604780|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
153604781|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153604782|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604783|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604784|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
153604785|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153604786|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604787|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604788|NCT01919905|Vitamin D|vitamin d|mesh-list
153604789|NCT01919905|Vitamins|vitamins|mesh-ancestor
153604790|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
153604791|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392335|NCT01621477|Plerixafor|plerixafor|mesh-list
153604820|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153604821|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153604823|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
153604825|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153604826|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
153604827|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604828|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604829|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153604830|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604831|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
153604832|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604833|NCT01920984|Bevacizumab|bevacizumab|mesh-list
153604834|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604835|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604836|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153735980|NCT03960008|Doxorubicin|doxorubicin|mesh-list
153684596|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
153604837|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153604838|NCT01920984|Growth Substances|growth substances|mesh-ancestor
153604839|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604840|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
153604841|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
153604842|NCT01921374|Interferons|interferons|mesh-list
153604843|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
153604844|NCT01921374|Interleukin-2|interleukin-2|mesh-list
153604845|NCT01921374|Interleukin-4|interleukin-4|mesh-list
153604846|NCT01921374|Dinoprostone|dinoprostone|mesh-list
153604847|NCT01921374|Hormones|hormones|mesh-list
153604848|NCT01921374|Estradiol|estradiol|mesh-list
153604849|NCT01921374|Testosterone|testosterone|mesh-list
153604850|NCT01921374|Progesterone|progesterone|mesh-list
153604851|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153604865|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604867|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
153604868|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604869|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153604870|NCT01921374|Estrogens|estrogens|mesh-ancestor
153604871|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153604872|NCT01921374|Androgens|androgens|mesh-ancestor
153604873|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
153604874|NCT01921374|Progestins|progestins|mesh-ancestor
153604875|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153604876|NCT01921374|Analgesics|analgesics|mesh-ancestor
153604877|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
153604878|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604879|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
153604891|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
153604892|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604893|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604894|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604895|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153604896|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153604897|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153604898|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604899|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
153604900|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153604901|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
153604902|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604903|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
153604905|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
153604906|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153604907|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604908|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604909|NCT01923454|Diuretics|diuretics|mesh-ancestor
153604910|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
153604911|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604912|NCT01923935|Melphalan|melphalan|mesh-list
153604913|NCT01923935|Busulfan|busulfan|mesh-list
153604914|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153604915|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
153604916|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604917|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604918|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153604919|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604920|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
153604921|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604922|NCT01923974|Melatonin|melatonin|mesh-list
153604923|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
153604924|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604925|NCT01923974|Protective Agents|protective agents|mesh-ancestor
153604926|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604937|NCT01924676|Narcotics|narcotics|mesh-ancestor
153604938|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604939|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604940|NCT01924676|Analgesics|analgesics|mesh-ancestor
153604941|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
153604962|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
153604963|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153604964|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153604965|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153781737|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153604967|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
153604969|NCT01927679|Antioxidants|antioxidants|mesh-list
153604971|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
153604972|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604973|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604974|NCT01927679|Protective Agents|protective agents|mesh-ancestor
153604975|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
153604976|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153604977|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
153604978|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604979|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604980|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153604982|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153604983|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153604984|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
153604985|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604986|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604987|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153604988|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153604989|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
153604990|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604991|NCT01928875|Anesthetics|anesthetics|mesh-list
153604992|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604993|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604994|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
153605020|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
153605021|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
153605022|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605024|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153605025|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153605026|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605027|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605028|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153605029|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153605030|NCT01930318|Analgesics|analgesics|mesh-ancestor
153605031|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
153605032|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605033|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605034|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605035|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605036|NCT01930331|Piperaquine|piperaquine|mesh-list
153605037|NCT01930331|Artenimol|artenimol|mesh-list
153605038|NCT01930331|Artemisinins|artemisinins|mesh-list
153605051|NCT01930396|Dalteparin|dalteparin|mesh-list
153605052|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
153605053|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153605054|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153605055|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605056|NCT01930461|Immunomodulating Agents|immunomodulating agents|mesh-list
153605057|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
153605058|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605060|NCT01930552|Fluorouracil|fluorouracil|mesh-list
153605061|NCT01930552|Irinotecan|irinotecan|mesh-list
153605062|NCT01930552|Aflibercept|aflibercept|mesh-list
153605063|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
153605064|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605065|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153605066|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605067|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153605068|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
153605069|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605070|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153605071|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153605072|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605073|NCT01930552|Antidotes|antidotes|mesh-ancestor
153605074|NCT01930552|Protective Agents|protective agents|mesh-ancestor
153605075|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
153605076|NCT01930552|Vitamins|vitamins|mesh-ancestor
153605077|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
153605098|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153605099|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154263388|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
153605100|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605101|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
153605102|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605103|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153605104|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153605105|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153605106|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153605107|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605108|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153605109|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
153605110|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153605111|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
153605112|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605113|NCT01930734|Dobutamine|dobutamine|mesh-list
153605114|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153605115|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
153605116|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
153605117|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605118|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605119|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153605120|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153605121|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153605122|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
153605123|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605158|NCT01930864|Irinotecan|irinotecan|mesh-list
153605159|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153605160|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605161|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153605162|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153605163|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605164|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605165|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605167|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
153605168|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
153605169|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605170|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605171|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
153605172|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605173|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153605174|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153605175|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153605176|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153605177|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605178|NCT01930916|Anticoagulants|anticoagulants|mesh-list
153605179|NCT01930916|Antibodies|antibodies|mesh-list
153605180|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
153605181|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
153605182|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
153605183|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605184|NCT01931085|Triclabendazole|triclabendazole|mesh-list
153605185|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153605186|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
153605187|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153605188|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605190|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153605202|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605203|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605205|NCT01931215|Morphine|morphine|mesh-list
153605206|NCT01931215|Ropivacaine|ropivacaine|mesh-list
153605217|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
153605218|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
153605219|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153605220|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153605221|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153605222|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
153605223|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605224|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605226|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
153605227|NCT01931293|Vitamins|vitamins|mesh-ancestor
153605228|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
153605229|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605230|NCT01931293|Hematinics|hematinics|mesh-ancestor
153605231|NCT01931306|Afatinib|afatinib|mesh-list
153423010|NCT03290378|Tramadol|tramadol|mesh-list
153605232|NCT01931306|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153605233|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605234|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605235|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605236|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605237|NCT01931319|Baclofen|baclofen|mesh-list
153605238|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153605239|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605240|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153605241|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605242|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153605243|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
153605244|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
153605245|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605246|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605247|NCT01931332|Heroin|heroin|mesh-list
153605248|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153605249|NCT01931332|Narcotics|narcotics|mesh-ancestor
153605250|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605251|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605253|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
153605254|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605255|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153605256|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153332969|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
153605261|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153605262|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605263|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153605264|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605265|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
153605266|NCT01931501|Montelukast|montelukast|mesh-list
153605267|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153781738|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605268|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
153605269|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153605270|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
153605271|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153605272|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605273|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153605274|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153605293|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605295|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
153605296|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153605297|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
153605298|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153605299|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605300|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153605301|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153605302|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153605303|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
153605304|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153605305|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153605306|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
153605307|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153605308|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
153605309|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153605310|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153605311|NCT01931683|Remifentanil|remifentanil|mesh-list
153605312|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153605313|NCT01931683|Narcotics|narcotics|mesh-ancestor
153605314|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605315|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605316|NCT01931683|Analgesics|analgesics|mesh-ancestor
153605317|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
153605318|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605319|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
153605320|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
153605321|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605322|NCT01931787|Protective Agents|protective agents|mesh-ancestor
153605359|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263389|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685057|NCT00150436|Pregabalin|pregabalin|mesh-list
153605360|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153605361|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153605362|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605363|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
153605383|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605392|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153605393|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153605395|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
153605396|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605397|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153605398|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153605399|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605400|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605401|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153605402|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
153605403|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153605404|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605405|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153605406|NCT01932372|Etanercept|etanercept|mesh-list
153605407|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
153333119|NCT01175395|Ranibizumab|ranibizumab|mesh-list
153605408|NCT01932372|Tofacitinib|tofacitinib|mesh-list
153605409|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153605410|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153605411|NCT01932372|Analgesics|analgesics|mesh-ancestor
153695472|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
153605412|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
153605413|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605414|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605415|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605452|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605490|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153605491|NCT01932580|Docetaxel|docetaxel|mesh-list
153605492|NCT01932580|Fluorouracil|fluorouracil|mesh-list
153605493|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
153605494|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605495|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
153605496|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
153605497|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
153605498|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605499|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
153605500|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153605501|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153605502|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
153605503|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605504|NCT01932918|Ketorolac|ketorolac|mesh-list
153605505|NCT01932918|Morphine|morphine|mesh-list
153605506|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153605507|NCT01932918|Narcotics|narcotics|mesh-ancestor
153605508|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605509|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605510|NCT01932918|Analgesics|analgesics|mesh-ancestor
153605511|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
153605512|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605513|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153605514|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153605515|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605516|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605517|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153605518|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605527|NCT01933022|Leuprolide|leuprolide|mesh-list
153605528|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153605529|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
153605530|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153605531|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605532|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153605533|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605534|NCT01933061|Paclitaxel|paclitaxel|mesh-list
153605535|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153605536|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153605544|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153605545|NCT01933152|Growth Substances|growth substances|mesh-ancestor
154263391|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263392|NCT05626322|Growth Substances|growth substances|mesh-ancestor
154263393|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263394|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263395|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
153735988|NCT03927989|Nicotine|nicotine|mesh-list
153605546|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605547|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
153605548|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605550|NCT01933347|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153605551|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605552|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605553|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605554|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605555|NCT01933360|Misoprostol|misoprostol|mesh-list
153605556|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153333271|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153605557|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
153605558|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153605559|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605560|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153605561|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605562|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
153605564|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
153605565|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605566|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
153605567|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153605568|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605569|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153605570|NCT01933503|Cathartics|cathartics|mesh-ancestor
153605571|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605572|NCT01933516|Rituximab|rituximab|mesh-list
153605573|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153605574|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605575|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
153605576|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605577|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605578|NCT01933542|Morphine|morphine|mesh-list
153605579|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
153605580|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153605581|NCT01933542|Narcotics|narcotics|mesh-ancestor
153605582|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605583|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605584|NCT01933542|Analgesics|analgesics|mesh-ancestor
153605585|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
153605586|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605587|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153605588|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153605589|NCT01933568|Cisplatin|cisplatin|mesh-list
153605590|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605591|NCT01933698|Amoxicillin|amoxicillin|mesh-list
153605592|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153605593|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605594|NCT01933711|Rituximab|rituximab|mesh-list
153605614|NCT01933971|Lenograstim|lenograstim|mesh-list
153605615|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153605616|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
153605617|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605618|NCT01933997|Pyridoxine|pyridoxine|mesh-list
153605619|NCT01933997|Metadoxine|metadoxine|mesh-list
153605620|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153605621|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
153605622|NCT01933997|Vitamins|vitamins|mesh-ancestor
153605623|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
153605624|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605625|NCT01934023|Varenicline|varenicline|mesh-list
153605626|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153605627|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153605628|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
153605629|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605630|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423036|NCT02076217|Progestins|progestins|mesh-ancestor
153685251|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153333346|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153605631|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605632|NCT01934049|Anesthetics|anesthetics|mesh-list
153605633|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605634|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605635|NCT01934088|Midazolam|midazolam|mesh-list
153605636|NCT01934088|Fentanyl|fentanyl|mesh-list
153605637|NCT01934088|Propofol|propofol|mesh-list
153605638|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153605639|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605640|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605641|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153605642|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
153605644|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153605645|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153605646|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153605647|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153605648|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
153605649|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
153605650|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605651|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605652|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153605653|NCT01934088|Narcotics|narcotics|mesh-ancestor
153605654|NCT01934088|Analgesics|analgesics|mesh-ancestor
153605655|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
153605656|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605657|NCT01934127|Vaccines|vaccines|mesh-list
153605658|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
153605659|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605660|NCT01934166|Nalmefene|nalmefene|mesh-list
153605661|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153605662|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605663|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
153605664|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605665|NCT01934205|Gepotidacin|gepotidacin|mesh-list
153605666|NCT01934205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153605667|NCT01934205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605698|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153605699|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153605700|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153605702|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153605703|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153605704|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
153605705|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153605706|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605707|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153605708|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153605709|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153605710|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
153605711|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153605712|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153605715|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153605716|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605717|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
153605718|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
153605719|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
153605720|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605721|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153605722|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
153605724|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153605725|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
153605726|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
153605727|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153605728|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153605729|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605730|NCT01934777|Vitamin E|vitamin e|mesh-list
153605731|NCT01934777|Choline|choline|mesh-list
153605732|NCT01934777|Vitamins|vitamins|mesh-ancestor
153605742|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153605743|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
153605744|NCT01934816|Liraglutide|liraglutide|mesh-list
154263396|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154263397|NCT05624554|Rituximab|rituximab|mesh-list
153605745|NCT01934816|Exenatide|exenatide|mesh-list
153605746|NCT01934816|Glucagon|glucagon|mesh-list
153605747|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153605748|NCT01934816|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153605749|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153605750|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605751|NCT01934816|Incretins|incretins|mesh-ancestor
153605752|NCT01934816|Hormones|hormones|mesh-ancestor
153605753|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153605754|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153605755|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605756|NCT01934829|Sorafenib|sorafenib|mesh-list
153605757|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605758|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605759|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605760|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605761|NCT01934933|Celecoxib|celecoxib|mesh-list
153605762|NCT01934933|Etanercept|etanercept|mesh-list
153605774|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605776|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153605777|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
153605778|NCT01935063|Lidocaine|lidocaine|mesh-list
153605779|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
153605780|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
153605781|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605782|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605783|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
153605784|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605785|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153605786|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153605787|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153605788|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153605789|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605790|NCT01935115|Ketamine|ketamine|mesh-list
153605791|NCT01935115|Propofol|propofol|mesh-list
153385657|NCT03847389|Clobetasol|clobetasol|mesh-list
153605792|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153605793|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605794|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605796|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
153605797|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
153605798|NCT01935115|Analgesics|analgesics|mesh-ancestor
153605812|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
153605813|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605814|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605815|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153605816|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153605817|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605818|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605819|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153605820|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153605821|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605822|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605823|NCT01935206|Naloxone|naloxone|mesh-list
153605824|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153605825|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605826|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
153605827|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605828|NCT01935310|Imiquimod|imiquimod|mesh-list
153605829|NCT01935310|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153605830|NCT01935310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605831|NCT01935310|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153605832|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
153605833|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605834|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153605835|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605846|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
153605847|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
153605848|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685468|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
154191190|NCT05941585|Antiviral Agents|antiviral agents|mesh-ancestor
153605849|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153605850|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153605851|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153605852|NCT01935492|Growth Substances|growth substances|mesh-ancestor
153605853|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605854|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
153605855|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153605856|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153605857|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153605867|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605868|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153605869|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153605870|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
153605871|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605872|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605873|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153605874|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
153605875|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153605876|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153605877|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153605878|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153605879|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
153605880|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153605881|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153605882|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605883|NCT01935518|Fasudil|fasudil|mesh-list
153605884|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153605885|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153605886|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605887|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153605888|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605890|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605891|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605892|NCT01935531|Diclofenac|diclofenac|mesh-list
153605893|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
153605894|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153605895|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153605896|NCT01935531|Analgesics|analgesics|mesh-ancestor
153605897|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
153605898|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605899|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605900|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605901|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605902|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153605903|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605904|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605905|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153605906|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
153605907|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
153605908|NCT01935531|Protective Agents|protective agents|mesh-ancestor
153605921|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605942|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605943|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605944|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153605945|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153605946|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
153605947|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605948|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153605949|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153605950|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153605951|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153605952|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
153605953|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153605954|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153605955|NCT01935804|Metformin|metformin|mesh-list
153605956|NCT01935804|Pioglitazone|pioglitazone|mesh-list
153605957|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153605958|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605959|NCT01935817|Vitamin E|vitamin e|mesh-list
153605960|NCT01935817|Silybin|silybin|mesh-list
154263398|NCT05624554|Fludarabine|fludarabine|mesh-list
153605961|NCT01935817|Vitamins|vitamins|mesh-ancestor
153605962|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
153605963|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605964|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
153605965|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605966|NCT01935817|Protective Agents|protective agents|mesh-ancestor
153605967|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153605968|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605969|NCT01935830|Ritonavir|ritonavir|mesh-list
153605970|NCT01935830|Efavirenz|efavirenz|mesh-list
153605971|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153605972|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153605973|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
153605974|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605975|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605976|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153605977|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153605978|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
153605984|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153605985|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153605986|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153605987|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153605988|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153605990|NCT01935869|Emollients|emollients|mesh-ancestor
153605991|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
153605992|NCT01935882|Lumefantrine|lumefantrine|mesh-list
153605993|NCT01935882|Artemether|artemether|mesh-list
153605994|NCT01935882|Primaquine|primaquine|mesh-list
153605995|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153606007|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606009|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153606010|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
153606011|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781739|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
153606012|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606013|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153606014|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153606015|NCT01936012|Protective Agents|protective agents|mesh-ancestor
153606016|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606017|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153606018|NCT01936025|Levomethorphan|levomethorphan|mesh-list
153606019|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
153606020|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153606021|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606022|NCT01936025|Incretins|incretins|mesh-ancestor
153606023|NCT01936025|Hormones|hormones|mesh-ancestor
153606024|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606025|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153606026|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
153606027|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606028|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606029|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
153606030|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
153606031|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153606032|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153606033|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606034|NCT01936025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153606035|NCT01936025|Narcotics|narcotics|mesh-ancestor
153606036|NCT01936025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606037|NCT01936025|Analgesics|analgesics|mesh-ancestor
153606038|NCT01936025|Sensory System Agents|sensory system agents|mesh-ancestor
153606039|NCT01936025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606040|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
153606041|NCT01936064|Epirubicin|epirubicin|mesh-list
153606042|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606043|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
153606044|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606045|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606046|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153606061|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153606062|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606063|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
153606064|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606065|NCT01936103|Atorvastatin|atorvastatin|mesh-list
153606066|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153606067|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153606068|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
153606069|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606070|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153606071|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153606072|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606082|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606083|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606084|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153606086|NCT01936233|Lamivudine|lamivudine|mesh-list
153606087|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153781740|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153606089|NCT01936233|Analgesics|analgesics|mesh-ancestor
153606090|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
153606091|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606092|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606093|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153606094|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606095|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153606096|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153606097|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606098|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153606099|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153606100|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606101|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
153606102|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153606103|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153606104|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
153606105|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606106|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153606121|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606122|NCT01936350|Urological Agents|urological agents|mesh-ancestor
153606123|NCT01936545|Propofol|propofol|mesh-list
153606124|NCT01936545|Desflurane|desflurane|mesh-list
153606125|NCT01936545|Liver Extracts|liver extracts|mesh-list
153606126|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153606127|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606128|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606129|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153606130|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
153606131|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
153606132|NCT01936545|Hematinics|hematinics|mesh-ancestor
153606133|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153606134|NCT06071585|Formaldehyde|formaldehyde|mesh-list
153606135|NCT06071585|Disinfectants|disinfectants|mesh-ancestor
153606136|NCT06071585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606137|NCT06071481|Vitamin D|vitamin d|mesh-list
153606138|NCT06071481|Ergocalciferols|ergocalciferols|mesh-list
153606139|NCT06071481|Cholecalciferol|cholecalciferol|mesh-list
153606140|NCT06071481|Vitamins|vitamins|mesh-list
153606141|NCT06071481|Micronutrients|micronutrients|mesh-ancestor
153606142|NCT06071481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606143|NCT06071481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153606144|NCT06071481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153606145|NCT06071013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153606146|NCT06071013|Gefitinib|gefitinib|mesh-list
153606147|NCT06071013|Afatinib|afatinib|mesh-list
153606148|NCT06071013|Nintedanib|nintedanib|mesh-list
153606149|NCT06071013|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153606150|NCT06071013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153606151|NCT06071013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606152|NCT06071013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606153|NCT06071013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606154|NCT06070948|Venetoclax|venetoclax|mesh-list
153606155|NCT06070948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606190|NCT06070480|Anesthetics|anesthetics|mesh-ancestor
153606191|NCT06070480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606192|NCT06070480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606193|NCT06070480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153606194|NCT06070480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153606195|NCT06070480|Anesthetics, General|anesthetics, general|mesh-ancestor
153606196|NCT06070480|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153606197|NCT06069830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153685809|NCT00153283|Gabapentin|gabapentin|mesh-list
153606198|NCT06069830|Pegaspargase|pegaspargase|mesh-list
153606199|NCT06069830|Asparaginase|asparaginase|mesh-list
153606200|NCT06069830|Antibodies|antibodies|mesh-list
153606201|NCT06069830|Immunoglobulins|immunoglobulins|mesh-list
153606202|NCT06069830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153606203|NCT06069830|Immunologic Factors|immunologic factors|mesh-ancestor
153606204|NCT06069830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606205|NCT06069830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606206|NCT06067594|Calcitonin|calcitonin|mesh-list
153606207|NCT06067594|Salmon calcitonin|salmon calcitonin|mesh-list
153606208|NCT06067594|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153606209|NCT06067594|Katacalcin|katacalcin|mesh-list
153606210|NCT06067594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153606211|NCT06067594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606212|NCT06067594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153606213|NCT06067594|Vasodilator Agents|vasodilator agents|mesh-ancestor
153606214|NCT06066918|Pregabalin|pregabalin|mesh-list
153606215|NCT06066918|Analgesics|analgesics|mesh-ancestor
153606216|NCT06066918|Sensory System Agents|sensory system agents|mesh-ancestor
153606217|NCT06066918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606218|NCT06066918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606219|NCT06066918|Anticonvulsants|anticonvulsants|mesh-ancestor
153606220|NCT06066918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153606221|NCT06066918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153606222|NCT06066918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606223|NCT06066918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153606224|NCT06066918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153606225|NCT06066918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153606236|NCT06066866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606237|NCT06066866|GABA Modulators|gaba modulators|mesh-ancestor
153606239|NCT06066866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153606240|NCT06066866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153606241|NCT06066866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153606242|NCT06065592|Palbociclib|palbociclib|mesh-list
153606243|NCT06065592|Rivaroxaban|rivaroxaban|mesh-list
153606244|NCT06065592|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153606260|NCT06062602|Antimitotic Agents|antimitotic agents|mesh-ancestor
153606261|NCT06062602|Mitosis Modulators|mitosis modulators|mesh-ancestor
153606262|NCT06062602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606263|NCT06062602|Antimetabolites|antimetabolites|mesh-ancestor
153606264|NCT06062602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153606265|NCT06062602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606266|NCT06062602|Immunologic Factors|immunologic factors|mesh-ancestor
153606267|NCT06062602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606268|NCT06061393|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153606269|NCT06061393|Hematinics|hematinics|mesh-ancestor
153606270|NCT06056869|Scopolamine|scopolamine|mesh-list
153606271|NCT06056869|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153606272|NCT06056869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153606273|NCT06056869|Antiemetics|antiemetics|mesh-ancestor
153606274|NCT06056869|Autonomic Agents|autonomic agents|mesh-ancestor
153606275|NCT06056869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606276|NCT06056869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606277|NCT06056869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153606278|NCT06056869|Mydriatics|mydriatics|mesh-ancestor
153606279|NCT06056869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153606280|NCT06056869|Cholinergic Agents|cholinergic agents|mesh-ancestor
153606281|NCT06056869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606282|NCT06056869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606283|NCT06056869|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153606284|NCT06056869|Parasympatholytics|parasympatholytics|mesh-ancestor
153606285|NCT06041282|Anesthetics|anesthetics|mesh-list
153606286|NCT06041282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606287|NCT06041282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606288|NCT06037135|Dexmedetomidine|dexmedetomidine|mesh-list
153606289|NCT06037135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153606290|NCT06037135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606324|NCT05900401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606325|NCT05900401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606326|NCT05900401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153606327|NCT05900401|Alkylating Agents|alkylating agents|mesh-ancestor
153606328|NCT05900401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606329|NCT05900401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606330|NCT05900401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153606331|NCT05900401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606332|NCT05883358|Clonidine|clonidine|mesh-list
153606333|NCT05883358|Buprenorphine|buprenorphine|mesh-list
153606334|NCT05883358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153606335|NCT05883358|Narcotics|narcotics|mesh-ancestor
153606336|NCT05883358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606337|NCT05883358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606350|NCT05883358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606352|NCT05866315|Desflurane|desflurane|mesh-list
153606353|NCT05866315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153606354|NCT05866315|Narcotics|narcotics|mesh-ancestor
153606355|NCT05866315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606356|NCT05866315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606357|NCT05866315|Analgesics|analgesics|mesh-ancestor
153606358|NCT05866315|Sensory System Agents|sensory system agents|mesh-ancestor
153606359|NCT05866315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606360|NCT05866315|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153606361|NCT05866315|Anesthetics, General|anesthetics, general|mesh-ancestor
153606362|NCT05866315|Anesthetics|anesthetics|mesh-ancestor
153606363|NCT05863052|Immunomodulating Agents|immunomodulating agents|mesh-list
153606364|NCT05863052|Immunologic Factors|immunologic factors|mesh-ancestor
153606365|NCT05863052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606366|NCT05839119|Gemcitabine|gemcitabine|mesh-list
153606378|NCT05824767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606380|NCT05824351|Pycnogenols|pycnogenols|mesh-list
153606381|NCT05824351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153606382|NCT05824351|Immunologic Factors|immunologic factors|mesh-ancestor
153606383|NCT05824351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606384|NCT05824351|Antioxidants|antioxidants|mesh-ancestor
153606385|NCT05824351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606386|NCT05824351|Protective Agents|protective agents|mesh-ancestor
153606387|NCT05824351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153606388|NCT05824351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606389|NCT05816655|Fulvestrant|fulvestrant|mesh-list
153606390|NCT05816655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153606391|NCT05816655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606392|NCT05816655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153606393|NCT05816655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153606394|NCT05816655|Hormone Antagonists|hormone antagonists|mesh-ancestor
153606395|NCT05816655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606396|NCT05816655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606398|NCT05741502|Risperidone|risperidone|mesh-list
153606399|NCT05741502|Aripiprazole|aripiprazole|mesh-list
153606400|NCT05741502|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153606401|NCT05741502|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153606402|NCT05741502|Ziprasidone|ziprasidone|mesh-list
153606403|NCT05741502|Antipsychotic Agents|antipsychotic agents|mesh-list
153606404|NCT05741502|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153606405|NCT05741502|Clozapine|clozapine|mesh-list
153606406|NCT05741502|Cariprazine|cariprazine|mesh-list
153606407|NCT05741502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153606408|NCT05741502|Serotonin Agents|serotonin agents|mesh-ancestor
153606409|NCT05741502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606410|NCT05741502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606411|NCT05741502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606412|NCT05741502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153606413|NCT05741502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606422|NCT05741502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153606423|NCT05741502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153606424|NCT05741502|Antidepressive Agents|antidepressive agents|mesh-ancestor
153606426|NCT05741502|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153606427|NCT05741502|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153606428|NCT05741502|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153606429|NCT05741502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153606442|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606443|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606444|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
153606445|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153606446|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
153606447|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
153606448|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153606449|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154263399|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606450|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153606451|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606452|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606453|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606454|NCT05706727|Protective Agents|protective agents|mesh-ancestor
153606456|NCT05679388|Itraconazole|itraconazole|mesh-list
153606457|NCT05679388|Relugolix|relugolix|mesh-list
153606458|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153606459|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153606460|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
153606461|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606462|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606463|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153606464|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153606465|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
153606466|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606467|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153606468|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153606469|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
153606470|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153606471|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153606472|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
153606473|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606474|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606475|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
153606477|NCT05628038|Folic Acid|folic acid|mesh-list
153606478|NCT05628038|Capecitabine|capecitabine|mesh-list
153606479|NCT05628038|Raltitrexed|raltitrexed|mesh-list
153606480|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
153606481|NCT05628038|Irinotecan|irinotecan|mesh-list
153606482|NCT05628038|Antibodies|antibodies|mesh-list
153606483|NCT05628038|Levoleucovorin|levoleucovorin|mesh-list
153606484|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
153606485|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606486|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153606487|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
153606488|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606489|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606490|NCT05628038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153606491|NCT05628038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153606492|NCT05628038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606527|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153606528|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
153606529|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153606530|NCT05540275|Bevacizumab|bevacizumab|mesh-list
153606531|NCT05540275|Tislelizumab|tislelizumab|mesh-list
153606532|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606533|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606534|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153606535|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153606536|NCT05540275|Growth Substances|growth substances|mesh-ancestor
153606537|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606538|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
153606539|NCT05539391|Rocuronium|rocuronium|mesh-list
153606540|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153606541|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153606542|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153606543|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606544|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606545|NCT05534750|Linezolid|linezolid|mesh-list
153606546|NCT05534750|Tedizolid|tedizolid|mesh-list
153606547|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
153606548|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153606549|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606550|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153606551|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606552|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606589|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606590|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153606591|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153606592|NCT05488522|Growth Substances|growth substances|mesh-ancestor
153606593|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606595|NCT05488522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153606596|NCT05488522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606597|NCT05392608|Fulvestrant|fulvestrant|mesh-list
153606598|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153606599|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606600|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153606601|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153606602|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
153606603|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606604|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606605|NCT05360160|Venetoclax|venetoclax|mesh-list
153606606|NCT05360160|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153606626|NCT05355051|Azacitidine|azacitidine|mesh-list
153606657|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153606658|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153606659|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606660|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
153606661|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606662|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
153606663|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153606664|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153606665|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606667|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153606668|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153606669|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153606670|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606671|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606683|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153606684|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153606685|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606686|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606687|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153606688|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
153334402|NCT01454180|Fluorouracil|fluorouracil|mesh-list
153606689|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153386548|NCT01904864|Iron|iron|mesh-list
153606690|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153606691|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606692|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
153606693|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
153606694|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606695|NCT04931225|Landiolol|landiolol|mesh-list
153606696|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153606697|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153606698|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606699|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606700|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606722|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
153606723|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153606724|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153606725|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153606726|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153606727|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606728|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
153606729|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606730|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606731|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153606732|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606748|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606749|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606750|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
153606751|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606752|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153606753|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153606754|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153606755|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153606756|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606758|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153606759|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334479|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606760|NCT04825678|Analgesics|analgesics|mesh-ancestor
153606761|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
153606762|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606785|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606786|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153606788|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153606789|NCT04788654|Analgesics|analgesics|mesh-ancestor
153606790|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
153606791|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
153606802|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
153606803|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606804|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
153606805|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606806|NCT04768569|Zonisamide|zonisamide|mesh-list
153606807|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
153606808|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153606809|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153606810|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606811|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153606812|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606814|NCT04759664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153606815|NCT04759664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606816|NCT04759664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606817|NCT04734210|Betamethasone|betamethasone|mesh-list
153606818|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
153606819|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153606820|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
153606821|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153606822|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153606823|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
153606824|NCT04734210|Hormones|hormones|mesh-ancestor
153606844|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606845|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731563|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153606846|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153606847|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153606850|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153606851|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
153606852|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153606853|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
153606854|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606855|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606856|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
153606886|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153606887|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606888|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153606889|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153606890|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153606891|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606892|NCT04560595|Caffeine|caffeine|mesh-list
153606893|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153696929|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153606894|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606895|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153606896|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606897|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606898|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153606899|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153606900|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
153606901|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606902|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153606903|NCT04489589|Midodrine|midodrine|mesh-list
153606904|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
153606905|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
153606906|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606916|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153606917|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
153606918|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606919|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153606962|NCT04419181|Immunotoxins|immunotoxins|mesh-ancestor
153606963|NCT04419181|Immunoconjugates|immunoconjugates|mesh-ancestor
153606964|NCT04419181|Immunologic Factors|immunologic factors|mesh-ancestor
153606967|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606968|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606969|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153606970|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606972|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153606973|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153606974|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153606975|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606976|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606977|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606978|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606979|NCT04386317|Urological Agents|urological agents|mesh-ancestor
153606980|NCT04380857|Dexamethasone|dexamethasone|mesh-list
153606981|NCT04380857|Prednisolone|prednisolone|mesh-list
153606982|NCT04380857|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153606983|NCT04380857|Methylprednisolone|methylprednisolone|mesh-list
153334705|NCT03767062|Topiramate|topiramate|mesh-list
153606984|NCT04380857|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153606985|NCT04380857|Prednisolone acetate|prednisolone acetate|mesh-list
153606986|NCT04380857|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153606987|NCT04380857|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153606988|NCT04380857|Prednisolone phosphate|prednisolone phosphate|mesh-list
153606989|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153606991|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
153606992|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606993|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606994|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153606995|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
153606996|NCT04380857|Hormones|hormones|mesh-ancestor
153606997|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606998|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153606999|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607000|NCT04380857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153607001|NCT04380857|Protective Agents|protective agents|mesh-ancestor
153607002|NCT04380857|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153607003|NCT04307485|Ticagrelor|ticagrelor|mesh-list
153607004|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153607005|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153607006|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153607007|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153607008|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
153607009|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607010|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607045|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607046|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
153607047|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607048|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607049|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607050|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607051|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
153607052|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607053|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607054|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153607055|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153607056|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153607057|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
153334782|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153607059|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
153607060|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607061|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
153607062|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
153607100|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153607101|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153607102|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607103|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
153607104|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153607105|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153607106|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153607107|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
153607108|NCT04162210|Dexamethasone|dexamethasone|mesh-list
153607109|NCT04162210|Pomalidomide|pomalidomide|mesh-list
153607110|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607111|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
153607112|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
153607113|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607114|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607115|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607116|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
153607117|NCT04162210|Hormones|hormones|mesh-ancestor
153607118|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607119|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153607120|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607121|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
153607122|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153607123|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153607124|NCT04162210|Growth Substances|growth substances|mesh-ancestor
153607125|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
153607141|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153607142|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
153607143|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607144|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607145|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607154|NCT04066114|Abatacept|abatacept|mesh-list
153607155|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
153607156|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153607157|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607158|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
153607159|NCT04066114|Hormones|hormones|mesh-ancestor
153607160|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607161|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607162|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153607163|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607164|NCT04066114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153607165|NCT04066114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153607166|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607167|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607168|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607169|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
153607170|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153697115|NCT00244426|Aspirin|aspirin|mesh-list
153607171|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153607172|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
153607173|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153607174|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607175|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
153607176|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
153607177|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607178|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607179|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153607180|NCT04066114|Protective Agents|protective agents|mesh-ancestor
153607181|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607182|NCT04066114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607183|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607184|NCT04060862|Fulvestrant|fulvestrant|mesh-list
153607185|NCT04060862|Palbociclib|palbociclib|mesh-list
153607186|NCT04060862|Ipatasertib|ipatasertib|mesh-list
153607187|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153607188|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607189|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153607190|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153607191|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
153607192|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607193|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607194|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153607224|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607225|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607226|NCT03829319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607227|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607228|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607229|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153607230|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153607231|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153607232|NCT03747159|Belimumab|belimumab|mesh-list
153607233|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607234|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
153607235|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607236|NCT03735628|Nivolumab|nivolumab|mesh-list
153607237|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607238|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607239|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607240|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607241|NCT03727100|Clonidine|clonidine|mesh-list
153607242|NCT03727100|Analgesics|analgesics|mesh-ancestor
153607243|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
153607244|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607245|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607246|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153607247|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
153607248|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
153607249|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153607250|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153607251|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153607252|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
153607253|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607254|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607255|NCT03685331|Fulvestrant|fulvestrant|mesh-list
153607256|NCT03685331|Olaparib|olaparib|mesh-list
153607257|NCT03685331|Palbociclib|palbociclib|mesh-list
153607258|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153607259|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607293|NCT03454646|Galantamine|galantamine|mesh-list
153607294|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
153607295|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607296|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607297|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
153607298|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607299|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607300|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
153607301|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153607302|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
153607303|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607304|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153607305|NCT03454646|Protective Agents|protective agents|mesh-ancestor
153607306|NCT03328026|Interferons|interferons|mesh-list
153607307|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
153607308|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607309|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
153607310|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607311|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607312|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153607313|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
153607314|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607315|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607316|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153607317|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
153607318|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607319|NCT03324932|Denosumab|denosumab|mesh-list
153607320|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153607321|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607322|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
153607323|NCT03266783|Apixaban|apixaban|mesh-list
153607324|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153607325|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
153607326|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153607327|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
153607328|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607329|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607330|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
153607331|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
153607332|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
153607333|NCT03219359|Vedolizumab|vedolizumab|mesh-list
153607334|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
153607335|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607336|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
153607337|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607338|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607339|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153423332|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
153607374|NCT03121352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607375|NCT02975882|Sirolimus|sirolimus|mesh-list
153607376|NCT02975882|Irinotecan|irinotecan|mesh-list
153607377|NCT02975882|Camptothecin|camptothecin|mesh-list
153607378|NCT02975882|Temozolomide|temozolomide|mesh-list
153607379|NCT02975882|Temsirolimus|temsirolimus|mesh-list
153607380|NCT02975882|MTOR Inhibitors|mtor inhibitors|mesh-list
153607381|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153607382|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153607383|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607384|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607385|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607386|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153607387|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
153607388|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153607389|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607390|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153607391|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
153607392|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607393|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
153607394|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607395|NCT02975882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153607396|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607397|NCT02811133|Inositol|inositol|mesh-list
153392686|NCT03668951|Analgesics|analgesics|mesh-ancestor
153607398|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
153607399|NCT02811133|Vitamins|vitamins|mesh-ancestor
153607400|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
153607401|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607402|NCT02775435|Paclitaxel|paclitaxel|mesh-list
153607403|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153607404|NCT02775435|Carboplatin|carboplatin|mesh-list
153607405|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
153607414|NCT02685826|Dexamethasone|dexamethasone|mesh-list
153607415|NCT02685826|Lenalidomide|lenalidomide|mesh-list
153607416|NCT02685826|Durvalumab|durvalumab|mesh-list
153607417|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607418|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
153607419|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
153607420|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607421|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607422|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607423|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
153607424|NCT02685826|Hormones|hormones|mesh-ancestor
153607425|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607426|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153810703|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
153781742|NCT04559425|Dexamethasone|dexamethasone|mesh-list
153607439|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607440|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607441|NCT02658981|Nivolumab|nivolumab|mesh-list
153607442|NCT02658981|Relatlimab|relatlimab|mesh-list
153607443|NCT02658981|Antibodies|antibodies|mesh-list
153607444|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153607445|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
153607446|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607447|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607448|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607449|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607450|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607451|NCT02575794|Masoprocol|masoprocol|mesh-list
153607452|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
153607453|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607454|NCT02575794|Protective Agents|protective agents|mesh-ancestor
153607455|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607456|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153607457|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607458|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153607459|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153607460|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153607461|NCT02575794|Analgesics|analgesics|mesh-ancestor
153607462|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
153607463|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607464|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607465|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686865|NCT00407017|Analgesics|analgesics|mesh-ancestor
153607466|NCT02403505|Vaccines|vaccines|mesh-list
153607467|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
153607468|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
153607469|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607470|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153607471|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153607495|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153607496|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153607497|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607499|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607500|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
153607501|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
153607502|NCT01962415|Fludarabine|fludarabine|mesh-list
153607503|NCT01962415|Melphalan|melphalan|mesh-list
153607504|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
153607505|NCT01962415|Thiotepa|thiotepa|mesh-list
153607506|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
153607507|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607508|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607509|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607510|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
153607511|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697335|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
153607512|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153607513|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
153607540|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
153607541|NCT01731236|Neomycin|neomycin|mesh-list
153607542|NCT01731236|Choline|choline|mesh-list
153607543|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153607544|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153607545|NCT01731236|Analgesics|analgesics|mesh-ancestor
153607546|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
153607547|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607548|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607549|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607550|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607551|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153607552|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153607553|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607554|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153607555|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153607556|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607557|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
153607558|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607559|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153607560|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153607561|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607562|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153607563|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153607564|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
153607565|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153607566|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
153607567|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607568|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153607569|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
153607570|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153607571|NCT01590069|Aldesleukin|aldesleukin|mesh-list
153607572|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607573|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153607574|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153607575|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
153607576|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607577|NCT01529593|Metformin|metformin|mesh-list
153607578|NCT01529593|Sirolimus|sirolimus|mesh-list
153607579|NCT01529593|Temsirolimus|temsirolimus|mesh-list
153607580|NCT01529593|MTOR Inhibitors|mtor inhibitors|mesh-list
153607581|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153607582|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607622|NCT01187199|Sirolimus|sirolimus|mesh-list
153607623|NCT01187199|Paclitaxel|paclitaxel|mesh-list
153607624|NCT01187199|Bevacizumab|bevacizumab|mesh-list
153607625|NCT01187199|Carboplatin|carboplatin|mesh-list
153607626|NCT01187199|Sorafenib|sorafenib|mesh-list
153607627|NCT01187199|Temsirolimus|temsirolimus|mesh-list
153607628|NCT01187199|MTOR Inhibitors|mtor inhibitors|mesh-list
153607629|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607630|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607631|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
154263401|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607632|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607633|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607634|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607635|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607636|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153607637|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153607638|NCT01187199|Growth Substances|growth substances|mesh-ancestor
153607639|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607640|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
153607641|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153607642|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607643|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607644|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
153607645|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153607653|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607654|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153607655|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153607656|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607657|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607658|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153607659|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
153607660|NCT01084252|Dexamethasone|dexamethasone|mesh-list
153335377|NCT01890902|Analgesics|analgesics|mesh-ancestor
153607661|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
153607662|NCT01084252|BB 1101|bb 1101|mesh-list
153607663|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607664|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
153607665|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
153607673|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607674|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
153607675|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607676|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607678|NCT00993044|Irinotecan|irinotecan|mesh-list
153607679|NCT00993044|Vincristine|vincristine|mesh-list
153607680|NCT00993044|Temozolomide|temozolomide|mesh-list
153607681|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607682|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607683|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153607684|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153607685|NCT00993044|Growth Substances|growth substances|mesh-ancestor
153607686|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607687|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
153607688|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153607689|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153607690|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607691|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607692|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607693|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
153607694|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607695|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607696|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153607697|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
153607698|NCT00955045|Istradefylline|istradefylline|mesh-list
153607699|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153607700|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153607701|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153607702|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
153607703|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607704|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607705|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607706|NCT00579644|Minocycline|minocycline|mesh-list
153607707|NCT00579644|Methotrexate|methotrexate|mesh-list
153607708|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153607709|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
153607710|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153607711|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607733|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607734|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607735|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607736|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
153607738|NCT00080886|Rituximab|rituximab|mesh-list
153607740|NCT00080886|Melphalan|melphalan|mesh-list
153607741|NCT00080886|Carmustine|carmustine|mesh-list
153607742|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607743|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607744|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
153607745|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607746|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607747|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607748|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153607749|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153607750|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607751|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607764|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607776|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607777|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153607778|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153607779|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607780|NCT01936961|Antibodies|antibodies|mesh-list
153607781|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
153607782|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607783|NCT01937013|Oxytocin|oxytocin|mesh-list
153607784|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
153607785|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153607786|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607787|NCT01937078|Famotidine|famotidine|mesh-list
153607788|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153607789|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607790|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153607791|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
153607792|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
153607793|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607794|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607795|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607796|NCT01937104|Remifentanil|remifentanil|mesh-list
153607797|NCT01937104|Desflurane|desflurane|mesh-list
153607798|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153607799|NCT01937104|Narcotics|narcotics|mesh-ancestor
153607800|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153607801|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607802|NCT01937104|Analgesics|analgesics|mesh-ancestor
153607803|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
153607804|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607805|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153607806|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
153607807|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
153607808|NCT01937169|Levodopa|levodopa|mesh-list
153607809|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153607810|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153607811|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
153607812|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335525|NCT02773576|Risperidone|risperidone|mesh-list
153607813|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607814|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607815|NCT01937182|Citalopram|citalopram|mesh-list
153607816|NCT01937182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153607817|NCT01937182|Serotonin|serotonin|mesh-list
153607818|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153607819|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153607820|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607821|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607822|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
153607823|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607824|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153607847|NCT01937442|Thalidomide|thalidomide|mesh-list
153607848|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607849|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
153607850|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607851|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
153607852|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153607853|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607854|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153607855|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153607856|NCT01937442|Growth Substances|growth substances|mesh-ancestor
154263402|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607857|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
153607858|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607859|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
153607860|NCT01937494|Histamine|histamine|mesh-list
153607861|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
153607862|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
153607863|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607864|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607865|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607866|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
153607867|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
153607868|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153607869|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
153607870|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607871|NCT01937611|Midazolam|midazolam|mesh-list
153607872|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
153607873|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153607874|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153607875|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607876|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153607877|NCT01937611|Analgesics|analgesics|mesh-ancestor
153607878|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
153607879|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607880|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153607881|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153607882|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153607883|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
153607884|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607885|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607886|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153335606|NCT01891916|Caseins|caseins|mesh-list
153607887|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153607888|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153607889|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153607899|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153607900|NCT01937728|Interferons|interferons|mesh-list
153607902|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
153607903|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
153607904|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153607905|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607906|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
153607907|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607908|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
153607909|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607910|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
153607921|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607922|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607923|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153607924|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
153607925|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
153607926|NCT01937754|Protective Agents|protective agents|mesh-ancestor
153607927|NCT01937767|Fentanyl|fentanyl|mesh-list
153607928|NCT01937767|Remifentanil|remifentanil|mesh-list
153607929|NCT01937767|Propofol|propofol|mesh-list
153607930|NCT01937767|Sevoflurane|sevoflurane|mesh-list
153607931|NCT01937767|Rocuronium|rocuronium|mesh-list
153607932|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153607933|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153607934|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607935|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153607936|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
153607937|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
153607938|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153607939|NCT01937767|Narcotics|narcotics|mesh-ancestor
153607940|NCT01937767|Analgesics|analgesics|mesh-ancestor
153607941|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
153607942|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607943|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153607944|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153607945|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153607946|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153607947|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153687398|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
153607948|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153607950|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
153607951|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607952|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153607953|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153607954|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607955|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607956|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153607957|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153607958|NCT01937832|Ertapenem|ertapenem|mesh-list
153607959|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153607960|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607973|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153607974|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153607975|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153607976|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153607977|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
153607978|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
153607979|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
153607980|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
153607981|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607982|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607983|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
153607984|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607985|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608008|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608009|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153608010|NCT01938235|Incretins|incretins|mesh-ancestor
153608011|NCT01938235|Hormones|hormones|mesh-ancestor
153608012|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153608013|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
153608014|NCT01938300|Analgesics|analgesics|mesh-ancestor
153608015|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
153608016|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608017|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608018|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
153608019|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608020|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153608021|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
153608022|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153608023|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608024|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608025|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608026|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
153608058|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697742|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
153608059|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608061|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
153608062|NCT01938729|Hormones|hormones|mesh-ancestor
153608063|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153608064|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153608065|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608066|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608067|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
153608068|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608069|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
153608070|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
153608107|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608108|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608109|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
153608110|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608111|NCT01939093|Thiamine|thiamine|mesh-list
153608112|NCT01939093|Cinnarizine|cinnarizine|mesh-list
153608113|NCT01939093|Diazepam|diazepam|mesh-list
153608114|NCT01939093|Vitamins|vitamins|mesh-ancestor
153608115|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
153608116|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608117|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
153608118|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153608119|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
153608120|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
153608121|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
153608122|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608123|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687474|NCT04731038|Paclitaxel|paclitaxel|mesh-list
153608124|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153608125|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608126|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153608127|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153608128|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153608129|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153608130|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153608131|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153608132|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
153608133|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
153608134|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
153608135|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
153608159|NCT01939379|Acetaminophen|acetaminophen|mesh-list
153608160|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153608161|NCT01939379|Morphine|morphine|mesh-list
153608162|NCT01939379|Oxycodone|oxycodone|mesh-list
153608163|NCT01939379|Analgesics|analgesics|mesh-list
153608164|NCT01939379|Ropivacaine|ropivacaine|mesh-list
153608165|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153608166|NCT01939379|Narcotics|narcotics|mesh-ancestor
153608167|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608168|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608169|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
153608170|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608202|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
153608203|NCT01939483|Irinotecan|irinotecan|mesh-list
153608204|NCT01939483|Camptothecin|camptothecin|mesh-list
153608205|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153608206|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153608207|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608208|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608209|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608210|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153608211|NCT01939509|Atenolol|atenolol|mesh-list
153608212|NCT01939509|Bisoprolol|bisoprolol|mesh-list
153608213|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153608214|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153608215|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
153608216|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
153608217|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608218|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608219|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153608220|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153608221|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153608222|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
153608223|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608224|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608225|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153608226|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
153608227|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608228|NCT01939561|Lamotrigine|lamotrigine|mesh-list
153608229|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
153608230|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153608231|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608232|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608233|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608281|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
153608282|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153608283|NCT01939730|Rituximab|rituximab|mesh-list
153608284|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608285|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608286|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
153608287|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608288|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153608289|NCT01939743|Diclofenac|diclofenac|mesh-list
153608290|NCT01939743|Lidocaine|lidocaine|mesh-list
153608291|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
153608292|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
153608293|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608294|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608295|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
153608296|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608306|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153608307|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153608308|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608309|NCT01939834|Insulin|insulin|mesh-list
153608310|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153608311|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608312|NCT01939886|Artesunate|artesunate|mesh-list
153608313|NCT01939886|Lumefantrine|lumefantrine|mesh-list
153608314|NCT01939886|Artemether|artemether|mesh-list
153608315|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153608316|NCT01939886|Mefloquine|mefloquine|mesh-list
153608317|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
153608318|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153608319|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153608320|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608321|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608322|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
153608323|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
153608324|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153608325|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
153608326|NCT01939912|Adenosine|adenosine|mesh-list
153608327|NCT01939912|Analgesics|analgesics|mesh-ancestor
153608328|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
153608329|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608330|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608331|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153608347|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608348|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153608349|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608350|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608351|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608352|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153608354|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608355|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608357|NCT01940224|Morphine|morphine|mesh-list
153608358|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153608359|NCT01940224|Narcotics|narcotics|mesh-ancestor
153608360|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608361|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608371|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153608372|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153608373|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
153608374|NCT01940250|Analgesics|analgesics|mesh-ancestor
153608375|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
153608376|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608377|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608378|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
153608379|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608380|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153608381|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
153608382|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153608383|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608384|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608385|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608386|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
153608387|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608388|NCT01940393|Cetirizine|cetirizine|mesh-list
153608389|NCT01940393|Fexofenadine|fexofenadine|mesh-list
153608390|NCT01940393|Desloratadine|desloratadine|mesh-list
153608391|NCT01940393|Ebastine|ebastine|mesh-list
153608392|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153608393|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153608394|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153608395|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
153608396|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
153608397|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608398|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608412|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
153608413|NCT01940536|Coagulants|coagulants|mesh-ancestor
153608414|NCT01940601|Lenograstim|lenograstim|mesh-list
153608415|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153608416|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
153608417|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608418|NCT01940627|Ubiquinone|ubiquinone|mesh-list
153608419|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
153608420|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
153608421|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608422|NCT01940627|Vitamins|vitamins|mesh-ancestor
153608423|NCT01940653|Estradiol|estradiol|mesh-list
153608424|NCT01940653|Progesterone|progesterone|mesh-list
153608425|NCT01940653|Estrogens|estrogens|mesh-ancestor
153608426|NCT01940653|Hormones|hormones|mesh-ancestor
153608449|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608450|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608451|NCT01940796|Immunotoxins|immunotoxins|mesh-ancestor
153608452|NCT01940796|Immunoconjugates|immunoconjugates|mesh-ancestor
153608453|NCT01940796|Immunologic Factors|immunologic factors|mesh-ancestor
153608454|NCT01940796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608456|NCT01940952|Udenafil|udenafil|mesh-list
153608457|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153608458|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608459|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608460|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
153608461|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608462|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608463|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
153608464|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153608465|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153608466|NCT01940965|Biguanides|biguanides|mesh-list
153608467|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153608468|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608469|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
153608470|NCT01940978|Methylphenidate|methylphenidate|mesh-list
153608471|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153608472|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608473|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153608474|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153608475|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608476|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608477|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
153608478|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608479|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
153608480|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153608508|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608509|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153608510|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153608511|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153608512|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153608513|NCT01941173|Leucovorin|leucovorin|mesh-list
153608514|NCT01941173|Fluorouracil|fluorouracil|mesh-list
153608515|NCT01941173|Irinotecan|irinotecan|mesh-list
153608516|NCT01941173|Aflibercept|aflibercept|mesh-list
153608517|NCT01941173|Calcium|calcium|mesh-list
153608518|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
153608519|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
153608520|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608521|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608522|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
153608523|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608524|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608525|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608526|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153608527|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
153608528|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153608529|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153608530|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608531|NCT01941173|Antidotes|antidotes|mesh-ancestor
153608532|NCT01941173|Protective Agents|protective agents|mesh-ancestor
153608533|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
153608534|NCT01941173|Vitamins|vitamins|mesh-ancestor
153608535|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
153608536|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153608537|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153608538|NCT01941173|Growth Substances|growth substances|mesh-ancestor
153608539|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
153608540|NCT01941199|Metformin|metformin|mesh-list
153608541|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153608542|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608543|NCT01941225|Iloprost|iloprost|mesh-list
153608544|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153608545|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
153608578|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153608612|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608613|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153608614|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
154263403|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153608615|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
153608616|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153608617|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153608618|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153608619|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153608620|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
153608621|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
153608622|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608623|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608624|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
153608625|NCT01941901|Bleomycin|bleomycin|mesh-list
153608626|NCT01941901|Calcium|calcium|mesh-list
153608627|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608628|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608629|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153608630|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153608631|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608632|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
153608633|NCT01941914|Calcium|calcium|mesh-list
153608634|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153698151|NCT00251524|Bevacizumab|bevacizumab|mesh-list
153608635|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608636|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153608637|NCT01941953|Metformin|metformin|mesh-list
153336348|NCT03626454|Norepinephrine|norepinephrine|mesh-list
153608648|NCT01941966|Mitomycins|mitomycins|mesh-list
153608649|NCT01941966|Mitomycin|mitomycin|mesh-list
153608650|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608651|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
153608652|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608653|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608654|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153608655|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
153608666|NCT01941979|Protective Agents|protective agents|mesh-ancestor
153608667|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608668|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
153608669|NCT01941979|Vitamins|vitamins|mesh-ancestor
153608670|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
153608671|NCT01942070|Everolimus|everolimus|mesh-list
153608672|NCT01942070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153608673|NCT01942070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153608674|NCT01942070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608675|NCT01942070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608676|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153608677|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
153608678|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608679|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608680|NCT01942109|Torsemide|torsemide|mesh-list
153608681|NCT01942109|Furosemide|furosemide|mesh-list
153608682|NCT01942109|Diuretics|diuretics|mesh-ancestor
153608683|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
153608684|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608685|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153608686|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608687|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608688|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153608689|NCT01942174|Methotrexate|methotrexate|mesh-list
153608690|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153608691|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153608692|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
153608693|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608694|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608695|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608696|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
153608697|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608698|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608699|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
153608700|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608701|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153608702|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153608703|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
153608704|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153608705|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153608706|NCT01942187|Aripiprazole|aripiprazole|mesh-list
154263404|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
153687887|NCT00165490|Irinotecan|irinotecan|mesh-list
153608707|NCT01942187|Bupropion|bupropion|mesh-list
153608708|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153608709|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
153608710|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153608711|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153608728|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153608729|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153608730|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153608731|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153608733|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
153608734|NCT01942291|Vitamins|vitamins|mesh-ancestor
153608735|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
153608736|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608737|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
153608738|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153608739|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
153608740|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608741|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153608742|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
153608743|NCT01942304|Calcium|calcium|mesh-list
153608744|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608745|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608746|NCT01942343|Droperidol|droperidol|mesh-list
153608747|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153608748|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
153608749|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
153731564|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
153608750|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608751|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608752|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153608753|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153608754|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153608755|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608756|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153608757|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153608758|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153608759|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
153608760|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608761|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608762|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153608763|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
153608764|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153608765|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
153608766|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608767|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608768|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153608769|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153608770|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608771|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153608772|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153608773|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153608774|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608775|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608776|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153608777|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153608778|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153608779|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
153608780|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608781|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608782|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153608801|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153608802|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
153608803|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153608804|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608805|NCT01942577|Protective Agents|protective agents|mesh-list
153608806|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608808|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
153608809|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
153608810|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608811|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687959|NCT00054197|Paclitaxel|paclitaxel|mesh-list
153608812|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153608813|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153608814|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
153608815|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608816|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608817|NCT01942681|Urological Agents|urological agents|mesh-ancestor
153608818|NCT01942889|Antioxidants|antioxidants|mesh-list
153608819|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608820|NCT01942889|Protective Agents|protective agents|mesh-ancestor
153608821|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608822|NCT01943019|Linagliptin|linagliptin|mesh-list
153608823|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153608824|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608825|NCT01943019|Incretins|incretins|mesh-ancestor
153608826|NCT01943019|Hormones|hormones|mesh-ancestor
153608827|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153608828|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153608829|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
153608830|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608831|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608832|NCT01943058|Megestrol|megestrol|mesh-list
153608833|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
153608834|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
153608835|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153608836|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
153608837|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608838|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608839|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153608840|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153608841|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153608842|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153608843|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153608844|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608845|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
153608846|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153608847|NCT01943136|Mupirocin|mupirocin|mesh-list
153608848|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153608849|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608850|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153608851|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608857|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153608858|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153608859|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
153336574|NCT01530880|Ibuprofen|ibuprofen|mesh-list
153608869|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608870|NCT01943305|Vaccines|vaccines|mesh-list
153608871|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
153608872|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608873|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153608874|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153608875|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153608876|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153608877|NCT01943422|Interferons|interferons|mesh-list
153608878|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
153608879|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
153608880|NCT01943422|Vemurafenib|vemurafenib|mesh-list
153608881|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608882|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
153608883|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608884|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
153608885|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608886|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153608887|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608888|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608889|NCT01943487|Verapamil|verapamil|mesh-list
153608890|NCT01943487|Tamsulosin|tamsulosin|mesh-list
153608891|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
153608892|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153608893|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153608894|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153608895|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
153608896|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423537|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
153608897|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608898|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608899|NCT01943487|Urological Agents|urological agents|mesh-ancestor
153608900|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153608901|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153608902|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
153608903|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153608904|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153608905|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608906|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608907|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
153608908|NCT01943526|Natalizumab|natalizumab|mesh-list
153608909|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
153608910|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608911|NCT01943617|Entecavir|entecavir|mesh-list
153608912|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
153608913|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608914|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
153608915|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153608916|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
153608917|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608918|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608919|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153608933|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
153608934|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608935|NCT01943786|Cetuximab|cetuximab|mesh-list
153608936|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608949|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608950|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153608951|NCT01943812|Progestins|progestins|mesh-ancestor
153608953|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608954|NCT01943942|Montelukast|montelukast|mesh-list
153608955|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153608956|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
153608957|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153608958|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
153608959|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153608960|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608961|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153608962|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153608963|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608964|NCT01944033|Terbutaline|terbutaline|mesh-list
153608965|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153608966|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
153608967|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608968|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608969|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153608970|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
153608971|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
153608972|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
153608973|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608974|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153608975|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153608976|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153608977|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
153608978|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608979|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608980|NCT01944085|Acetaminophen|acetaminophen|mesh-list
153608981|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
153608989|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608990|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
153608991|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153608992|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153608993|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153608994|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153608995|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608996|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608997|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
153608998|NCT01944085|Protective Agents|protective agents|mesh-ancestor
153608999|NCT01944176|Simvastatin|simvastatin|mesh-list
153609002|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
153609003|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609018|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153609020|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
153609021|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609022|NCT01944384|Spironolactone|spironolactone|mesh-list
153609023|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153609024|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
153609025|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609026|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609027|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153609028|NCT01944384|Diuretics|diuretics|mesh-ancestor
153609029|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
153609031|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
153609032|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609033|NCT01944436|Rivastigmine|rivastigmine|mesh-list
153609034|NCT01944436|Donepezil|donepezil|mesh-list
153609035|NCT01944436|Galantamine|galantamine|mesh-list
153609036|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
153609037|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609038|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609039|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609040|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609041|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609042|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
153609043|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153609044|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
153609045|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609046|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153609047|NCT01944436|Protective Agents|protective agents|mesh-ancestor
153609048|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
153609049|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153609068|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609069|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609071|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153609072|NCT01944735|Diuretics|diuretics|mesh-ancestor
153609073|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
153609074|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609075|NCT01944852|Icodextrin|icodextrin|mesh-list
153609076|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
153609077|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153609078|NCT01945021|Crizotinib|crizotinib|mesh-list
153609097|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609098|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609099|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153609100|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153609101|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153609102|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153609103|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153609106|NCT01945099|Insulin|insulin|mesh-list
153609107|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153609118|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609119|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153609120|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
153609121|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153609122|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609123|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609124|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153609125|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
153609126|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153609127|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153609128|NCT01945450|Clindamycin|clindamycin|mesh-list
153609129|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
153609130|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
153609131|NCT01945450|Gentamicins|gentamicins|mesh-list
153609132|NCT01945450|Ampicillin|ampicillin|mesh-list
153609133|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609134|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153609135|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609136|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609137|NCT01945476|Midazolam|midazolam|mesh-list
153609140|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609141|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609142|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153609143|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153609144|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153609157|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
153609158|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609159|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153609160|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153609161|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153609162|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609163|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609165|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
153609166|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
153609167|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609168|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609169|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
153609170|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609171|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
153609172|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153609203|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609204|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153609205|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
153731565|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609206|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609207|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153609208|NCT05410626|Methylphenidate|methylphenidate|mesh-list
153609209|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153609210|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609211|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153609212|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153609213|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609225|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609226|NCT05410314|Inositol|inositol|mesh-list
153609227|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
153609228|NCT05410314|Vitamins|vitamins|mesh-ancestor
153609229|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
153609230|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609231|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
153609232|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153609233|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
153609234|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153609235|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
153609236|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609237|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609238|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
153609239|NCT05410093|Vitamin E|vitamin e|mesh-list
153609240|NCT05410093|Tocopherols|tocopherols|mesh-list
153609241|NCT05410093|Resveratrol|resveratrol|mesh-list
153609242|NCT05410093|Vitamins|vitamins|mesh-ancestor
153609243|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
153609244|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609245|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
153609255|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153609256|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609258|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609259|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609260|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153609261|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153609262|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
153609263|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609264|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153609265|NCT05409339|Diuretics|diuretics|mesh-ancestor
153609266|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
153609267|NCT05155527|Ivermectin|ivermectin|mesh-list
153609268|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153609269|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609270|NCT05151146|Metformin|metformin|mesh-list
153609271|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153609272|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423586|NCT00376376|Levofloxacin|levofloxacin|mesh-list
153609273|NCT05068063|Bupivacaine|bupivacaine|mesh-list
153609274|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
153609275|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
153609276|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609277|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609278|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
153609292|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
153609293|NCT04887389|Protective Agents|protective agents|mesh-ancestor
153609294|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609295|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153609296|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609297|NCT04724655|Mineral Oil|mineral oil|mesh-list
153609298|NCT04724655|Emollients|emollients|mesh-ancestor
153609299|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
153609300|NCT04722835|Albuterol|albuterol|mesh-list
153609301|NCT04722835|Dimercaprol|dimercaprol|mesh-list
153609302|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153609303|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
153609304|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609305|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609306|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153609307|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
153609308|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
153609309|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153609310|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153609311|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153698722|NCT00070148|Megestrol|megestrol|mesh-list
153609312|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153609313|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
153609314|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609315|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609316|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
153609317|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
153609319|NCT04487990|Calcium heparin|calcium heparin|mesh-list
153609320|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
153609321|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153609322|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153609323|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609324|NCT04476979|Dexamethasone|dexamethasone|mesh-list
153609333|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609335|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609336|NCT04411953|Haloperidol|haloperidol|mesh-list
153609337|NCT04411953|Benztropine|benztropine|mesh-list
153609338|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
153609339|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
153609340|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
153609341|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609342|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609361|NCT04411940|Haloperidol|haloperidol|mesh-list
153609362|NCT04411940|Benztropine|benztropine|mesh-list
153609363|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
153609364|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
153609365|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
153609366|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609367|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609368|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153609369|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153609370|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153609371|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609372|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153609373|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153609374|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
153609375|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609376|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609377|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153609378|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153609379|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
153609380|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153609381|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153609382|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609383|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153609384|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153609385|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609386|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153688483|NCT00169195|Gemcitabine|gemcitabine|mesh-list
153609387|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153609388|NCT04030429|Crizotinib|crizotinib|mesh-list
153609389|NCT04030429|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153609390|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153609391|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609392|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609393|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609394|NCT03970694|Capecitabine|capecitabine|mesh-list
153609396|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153609397|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
153781748|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609407|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609409|NCT03714880|Mifepristone|mifepristone|mesh-list
153609410|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153609411|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
153609412|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153609413|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609414|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153609415|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153609416|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153698820|NCT00415285|Docetaxel|docetaxel|mesh-list
153609417|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
153609425|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153609426|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153609427|NCT03619850|Hematinics|hematinics|mesh-ancestor
153609428|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153609429|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153609430|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
153609431|NCT03559686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153609432|NCT03559686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153609433|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153609434|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
153609435|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609436|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153609437|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
153609438|NCT03559660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153609439|NCT03559660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153609440|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153609441|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
153609442|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609443|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153609444|NCT03532516|Brivaracetam|brivaracetam|mesh-list
153609445|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
153609446|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
153609447|NCT03333005|Clotrimazole|clotrimazole|mesh-list
153609449|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609450|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153609451|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153609452|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153609453|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609454|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609455|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153609456|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
153609457|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609458|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609459|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153609460|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153781749|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609471|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153609472|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153609473|NCT03148366|Antacids|antacids|mesh-ancestor
153609474|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153609475|NCT03122496|Durvalumab|durvalumab|mesh-list
153609476|NCT03122496|Tremelimumab|tremelimumab|mesh-list
153609477|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609478|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609479|NCT03073694|Melphalan|melphalan|mesh-list
153609480|NCT03073694|Mitomycins|mitomycins|mesh-list
153609481|NCT03073694|Mitomycin|mitomycin|mesh-list
153609482|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153609483|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
153609484|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688600|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
153609485|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609486|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153609487|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153609488|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
153609489|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609490|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153609504|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609505|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
153609506|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
153609507|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153609508|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609509|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153609510|NCT02335099|Ticagrelor|ticagrelor|mesh-list
153609511|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153609512|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153609513|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153609514|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153609515|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
153609516|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609517|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609518|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609519|NCT02330562|Bevacizumab|bevacizumab|mesh-list
153609520|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609521|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609522|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153609523|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153609524|NCT02330562|Growth Substances|growth substances|mesh-ancestor
153609530|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609532|NCT02053363|Coagulants|coagulants|mesh-ancestor
153609533|NCT01100775|Galantamine|galantamine|mesh-list
153609534|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153609535|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609536|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609537|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609538|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609539|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609540|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153609541|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
153337270|NCT03252600|Hormones|hormones|mesh-ancestor
153609542|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609543|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
153609544|NCT00504712|Testosterone|testosterone|mesh-list
153609545|NCT00504712|Androgens|androgens|mesh-ancestor
153609546|NCT00504712|Hormones|hormones|mesh-ancestor
153609547|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609548|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609549|NCT05413200|Isotretinoin|isotretinoin|mesh-list
153609550|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
153609551|NCT05412589|Apatinib|apatinib|mesh-list
153609552|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609553|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153609554|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609555|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609556|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
153609557|NCT05412472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153609578|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153609579|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153609580|NCT05411757|Growth Substances|growth substances|mesh-ancestor
153609581|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609582|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
153609583|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153609584|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609585|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609586|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153609587|NCT05411276|Maleic acid|maleic acid|mesh-list
153609588|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609589|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609590|NCT05396781|Proflavine|proflavine|mesh-list
153609591|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153609592|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609606|NCT04927585|Vaccines|vaccines|mesh-list
153609607|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
153423632|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153609608|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609609|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
153609610|NCT04898478|Narcotics|narcotics|mesh-ancestor
153609611|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609612|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609613|NCT04898478|Analgesics|analgesics|mesh-ancestor
153609614|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
153609615|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609616|NCT04725864|Progesterone|progesterone|mesh-list
153609617|NCT04725864|Progestins|progestins|mesh-ancestor
153609618|NCT04725864|Hormones|hormones|mesh-ancestor
153781750|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153609619|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609620|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609622|NCT04721821|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153609623|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153609641|NCT04609098|Tafenoquine|tafenoquine|mesh-list
153609642|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
153609643|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153609644|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153609645|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609647|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
153609648|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609649|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609650|NCT04605614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153609651|NCT04605614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609652|NCT04605614|Trace Elements|trace elements|mesh-ancestor
153609653|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
153609654|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609655|NCT04475016|Paclitaxel|paclitaxel|mesh-list
153609656|NCT04475016|Ifosfamide|ifosfamide|mesh-list
153609666|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
153609667|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609668|NCT04321551|Letrozole|letrozole|mesh-list
153609669|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
153609670|NCT04321551|Testosterone|testosterone|mesh-list
153609671|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
153609672|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
153609673|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153609674|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609675|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153609676|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153609677|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609678|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609679|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153609680|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
153609681|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609682|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609683|NCT04321551|Androgens|androgens|mesh-ancestor
153609684|NCT04321551|Hormones|hormones|mesh-ancestor
153609685|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153609686|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
153609687|NCT04174781|Immunomodulating Agents|immunomodulating agents|mesh-list
153609688|NCT04174781|Immunologic Factors|immunologic factors|mesh-ancestor
153609689|NCT04174781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609690|NCT04074460|Propofol|propofol|mesh-list
153609691|NCT04074460|Sevoflurane|sevoflurane|mesh-list
153609692|NCT04074460|Desflurane|desflurane|mesh-list
153609693|NCT04074460|Isoflurane|isoflurane|mesh-list
153609694|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153609708|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609709|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609710|NCT03703102|KHK4083|khk4083|mesh-list
153609711|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
153609712|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153609713|NCT03581370|Cephalosporins|cephalosporins|mesh-list
153609714|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
153609715|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153609716|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609717|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153609718|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153609719|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609720|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609721|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153609722|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153609739|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153609740|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153609742|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609743|NCT03246503|Bilirubin|bilirubin|mesh-list
153609744|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
153609745|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609746|NCT03246503|Protective Agents|protective agents|mesh-ancestor
153609747|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609748|NCT03091881|Granisetron|granisetron|mesh-list
153609749|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
153609750|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
153609751|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609752|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609753|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153609754|NCT03091881|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153609755|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153609756|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
153609757|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609758|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480208|NCT05925140|Remdesivir|remdesivir|mesh-list
153609759|NCT02864368|Temozolomide|temozolomide|mesh-list
153609760|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153609761|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
153609762|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609763|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609764|NCT02856698|Midazolam|midazolam|mesh-list
153609765|NCT02856698|Morphine|morphine|mesh-list
153609766|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153609767|NCT02856698|Narcotics|narcotics|mesh-ancestor
153609768|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609769|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609770|NCT02856698|Analgesics|analgesics|mesh-ancestor
153781751|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
153609771|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
153609781|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
153609790|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
153609791|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153609792|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
153609793|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609794|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609795|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153609796|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
153609797|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609798|NCT02625610|Antidotes|antidotes|mesh-ancestor
153609799|NCT02625610|Protective Agents|protective agents|mesh-ancestor
153609800|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
153609801|NCT02625610|Vitamins|vitamins|mesh-ancestor
153609802|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
153609803|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609804|NCT02515591|Dimercaprol|dimercaprol|mesh-list
153609805|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
153609806|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
153609807|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609808|NCT02514447|Topotecan|topotecan|mesh-list
153609809|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153609810|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153609811|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609812|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609813|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609814|NCT02257346|Lidocaine|lidocaine|mesh-list
153609815|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
153609816|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
153609817|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609818|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609819|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
153609820|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609821|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153609822|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153609823|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153609824|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609825|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609826|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
153609827|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
153423666|NCT03581084|Antidotes|antidotes|mesh-ancestor
153609828|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
153609829|NCT00712322|Darifenacin|darifenacin|mesh-list
153609830|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153609831|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153609832|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609833|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609834|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609835|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609836|NCT00712322|Urological Agents|urological agents|mesh-ancestor
153609837|NCT00323856|Factor VIII|factor viii|mesh-list
153609838|NCT00323856|Coagulants|coagulants|mesh-ancestor
153609839|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
153609840|NCT05415150|Eptifibatide|eptifibatide|mesh-list
153609841|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153609842|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153609843|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609844|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
153609845|NCT05414942|Narcotics|narcotics|mesh-ancestor
153609846|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609871|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609872|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
153609873|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609874|NCT05413902|Acetaminophen|acetaminophen|mesh-list
153609875|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
153609876|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153609877|NCT05413902|Lidocaine|lidocaine|mesh-list
153609878|NCT05413902|Epinephrine|epinephrine|mesh-list
153609879|NCT05413902|Morphine|morphine|mesh-list
153609880|NCT05413902|Narcotics|narcotics|mesh-list
153609881|NCT05413902|Gabapentin|gabapentin|mesh-list
153609882|NCT05413902|Orphenadrine|orphenadrine|mesh-list
153609883|NCT05413902|Bupivacaine|bupivacaine|mesh-list
153609884|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
153609885|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
153609886|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609887|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609888|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
153609889|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609890|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153609891|NCT05413902|Analgesics|analgesics|mesh-ancestor
153609892|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153609893|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
153609894|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153609895|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
153609896|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
153609897|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153609898|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
153609899|NCT05413902|Hormones|hormones|mesh-ancestor
153609900|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609901|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153609902|NCT05413902|Protective Agents|protective agents|mesh-ancestor
153609903|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153609904|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153609905|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
153609906|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609907|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609908|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153609909|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153609910|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153609911|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
153609912|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
153609913|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
153609914|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153609915|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
153609916|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153609917|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153609918|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153609919|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153609920|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153609939|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153609941|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
153609942|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153609943|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
153609944|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609945|NCT05397587|Vaccines|vaccines|mesh-list
153423681|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153688985|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
153609946|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
153852862|NCT05822076|Sensory System Agents|sensory system agents|mesh-ancestor
153609947|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609948|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
153609949|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
153609950|NCT05352178|Androgens|androgens|mesh-list
153609951|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153609952|NCT05352178|Hormones|hormones|mesh-ancestor
153609953|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609954|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609955|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
153609956|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609957|NCT05352178|Protective Agents|protective agents|mesh-ancestor
153609958|NCT05352178|Vitamins|vitamins|mesh-ancestor
153609959|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
153609960|NCT05352178|Estrogens|estrogens|mesh-ancestor
153609961|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153609962|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609963|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
153609964|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
153609965|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
153609966|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609967|NCT05328141|Protective Agents|protective agents|mesh-ancestor
153609968|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609969|NCT05328141|Vitamins|vitamins|mesh-ancestor
153609970|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
153609971|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
153609972|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153609973|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153609974|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609975|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609976|NCT05233709|Fesoterodine|fesoterodine|mesh-list
153609977|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153609978|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153609979|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609980|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609981|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609982|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609989|NCT05105282|Anesthetics|anesthetics|mesh-list
153610018|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610019|NCT04524663|Camostat|camostat|mesh-list
153610020|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
153610021|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610022|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610023|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153610024|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153610025|NCT04435795|Ciclesonide|ciclesonide|mesh-list
153610026|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
153610027|NCT04435795|Hormones|hormones|mesh-ancestor
153610028|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610029|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610030|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153610031|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
153610032|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153610062|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
153360202|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153610063|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610064|NCT03783013|Protective Agents|protective agents|mesh-ancestor
153610065|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610066|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153610067|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153610068|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610069|NCT03726229|Cholic Acids|cholic acids|mesh-list
153610070|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610071|NCT03712228|Antibodies|antibodies|mesh-list
153610072|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153610073|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
153610074|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610075|NCT03626922|Folic Acid|folic acid|mesh-list
153610076|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
153610077|NCT03626922|Dexamethasone|dexamethasone|mesh-list
153610101|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
153610102|NCT03600818|Prednisone|prednisone|mesh-list
153610103|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610104|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
153610105|NCT03600818|Hormones|hormones|mesh-ancestor
153610106|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610107|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610108|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153610109|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610110|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
153610111|NCT03578276|Prednisolone|prednisolone|mesh-list
153610112|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153610113|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
153610114|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153610115|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
153610116|NCT03578276|Bromfenac|bromfenac|mesh-list
153610117|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153610118|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
153610119|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610120|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
153610121|NCT03578276|Hormones|hormones|mesh-ancestor
153610122|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610123|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610124|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153610125|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610126|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
153610127|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
153337867|NCT02548650|Aspirin|aspirin|mesh-list
153610147|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
153610148|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
153610149|NCT03174184|Amoxicillin|amoxicillin|mesh-list
153610150|NCT03174184|Rifampin|rifampin|mesh-list
153610151|NCT03174184|Meropenem|meropenem|mesh-list
153610152|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
153610153|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
153610154|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153610155|NCT03174184|Rifamycins|rifamycins|mesh-list
153610156|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610157|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610158|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153610159|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
153610160|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
153610161|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153610162|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610163|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610164|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153610165|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153610166|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153610167|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153610168|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153610169|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153610170|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153610171|NCT03052933|Gemcitabine|gemcitabine|mesh-list
153610172|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153610173|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
153610174|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699433|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610175|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610176|NCT02959697|Lidocaine|lidocaine|mesh-list
153610177|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
153610178|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
153610179|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610180|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610181|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
153610182|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610183|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153610184|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153610185|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153610186|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153610187|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610191|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153610192|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610193|NCT02900560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153610209|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153610210|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610211|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610212|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610244|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153610245|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
153610246|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610247|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610248|NCT01427712|Pancrelipase|pancrelipase|mesh-list
153610249|NCT01427712|Pancreatin|pancreatin|mesh-list
153610250|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610251|NCT01369147|Clevidipine|clevidipine|mesh-list
153610252|NCT01369147|Propofol|propofol|mesh-list
153610253|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153610285|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
153610286|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610287|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610288|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610289|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
153610290|NCT01945892|Hormones|hormones|mesh-ancestor
153610291|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610317|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153610318|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153610319|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
153610320|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610321|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610322|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610323|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
153610324|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610325|NCT01946256|Amoxicillin|amoxicillin|mesh-list
153610326|NCT01946256|Erythromycin|erythromycin|mesh-list
153610327|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
153610328|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153610329|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
153610330|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610331|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610332|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610333|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153610334|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610335|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610336|NCT01946295|Famotidine|famotidine|mesh-list
153610337|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153610338|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610339|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153610340|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
153610341|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
153610342|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610343|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610344|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610345|NCT01946386|Betamethasone|betamethasone|mesh-list
153610346|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
153610347|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153610348|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
153610349|NCT01946386|Clobetasol|clobetasol|mesh-list
153610350|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153610351|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610352|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
153610353|NCT01946386|Hormones|hormones|mesh-ancestor
153610354|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610355|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610356|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153610357|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
153610358|NCT01946399|Dexamethasone|dexamethasone|mesh-list
153610359|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610360|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
153610375|NCT01946555|Hydromorphone|hydromorphone|mesh-list
153610376|NCT01946555|Tapentadol|tapentadol|mesh-list
153610394|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610395|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
153610396|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610397|NCT01946568|Dalbavancin|dalbavancin|mesh-list
153610398|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610399|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610400|NCT01946594|Acetaminophen|acetaminophen|mesh-list
153610401|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153610402|NCT01946594|Analgesics|analgesics|mesh-ancestor
153610403|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
153610404|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610405|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610406|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
153610408|NCT01946607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153610409|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153610410|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153610411|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610412|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610413|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
153610414|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610415|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153610416|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
153610417|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153610418|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
153610419|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153610420|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
153610421|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610422|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610423|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153610458|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
153610459|NCT01947062|Cisplatin|cisplatin|mesh-list
153610460|NCT01947062|Etoposide|etoposide|mesh-list
153610461|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
153610462|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153610496|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610498|NCT01947205|Acetaminophen|acetaminophen|mesh-list
153610499|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153610500|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153610501|NCT01947205|Analgesics|analgesics|mesh-ancestor
153610516|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610517|NCT01947465|Vaccines|vaccines|mesh-list
153610518|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
153610519|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610520|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
153610521|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153610522|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610524|NCT01947608|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153610525|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153610526|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745648|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153610527|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610528|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610530|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610531|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610532|NCT01947699|Glyburide|glyburide|mesh-list
153610533|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153610534|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610535|NCT01947777|Rifampin|rifampin|mesh-list
153610536|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153610537|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
153610538|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610539|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610555|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153610556|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153610557|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610558|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610559|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153610560|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153610561|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153610562|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
153610563|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610564|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610565|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153610566|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153610567|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
153610568|NCT01947920|Tramadol|tramadol|mesh-list
153610569|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153610570|NCT01947920|Narcotics|narcotics|mesh-ancestor
153610571|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610572|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610573|NCT01947920|Analgesics|analgesics|mesh-ancestor
153610574|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
153610575|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610576|NCT01947933|Mirikizumab|mirikizumab|mesh-list
153610577|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153610610|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
153610611|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610612|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610613|NCT01948011|Racecadotril|racecadotril|mesh-list
153610614|NCT01948011|Thiorphan|thiorphan|mesh-list
153610615|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
153610616|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610617|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
153610618|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610619|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610620|NCT01948024|Asenapine|asenapine|mesh-list
153610621|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153610622|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153610623|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610624|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610625|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153610626|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
153610627|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153610628|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
153610629|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
153610630|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610631|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610632|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153610633|NCT01948115|Analgesics|analgesics|mesh-ancestor
153610634|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
153610635|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610636|NCT01948128|Vitamin D|vitamin d|mesh-list
153610637|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
153610638|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
153610639|NCT01948128|Vitamins|vitamins|mesh-list
153610648|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610649|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153610651|NCT01948336|Ketamine|ketamine|mesh-list
153610652|NCT01948336|Propofol|propofol|mesh-list
153610653|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153610654|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610655|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610656|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153610657|NCT01948336|Analgesics|analgesics|mesh-ancestor
153610658|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
153610659|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610660|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153610661|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153610662|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153610663|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
153610664|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610675|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610676|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610677|NCT01948401|Prednisolone|prednisolone|mesh-list
153610678|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610679|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
153610680|NCT01948401|Hormones|hormones|mesh-ancestor
153610681|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610682|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610683|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153610684|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610685|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
153610686|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153610687|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
153610688|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610689|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
153610690|NCT01948583|Protective Agents|protective agents|mesh-ancestor
153610691|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153610692|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153610693|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153610694|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
153610695|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610696|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153610697|NCT01948765|Propofol|propofol|mesh-list
153610698|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153610699|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610700|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610701|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153610702|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
153610703|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
153610704|NCT01948804|Letrozole|letrozole|mesh-list
153610705|NCT01948804|Clomiphene|clomiphene|mesh-list
153610706|NCT01948804|Cetrorelix|cetrorelix|mesh-list
153610707|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153610708|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610709|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153610710|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153610711|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610712|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481137|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
153610713|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153610714|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
153610754|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610755|NCT01948999|Anesthetics|anesthetics|mesh-list
153610756|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610757|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610759|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153610760|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610761|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610762|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153610763|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153610764|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153610765|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
153610766|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
153610767|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610768|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610769|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
153610770|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610771|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
153610772|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
153610773|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
153610774|NCT01949168|Ribavirin|ribavirin|mesh-list
153610775|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153610776|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
153610777|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610778|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
153610779|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610780|NCT01949233|Doxycycline|doxycycline|mesh-list
153610788|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153610790|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610791|NCT01949363|Cefixime|cefixime|mesh-list
153610792|NCT01949363|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153610793|NCT01949363|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153610794|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610795|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610796|NCT01949454|Fluorometholone|fluorometholone|mesh-list
153610797|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153610798|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
153610808|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610809|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
153610810|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
153610811|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
153610812|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610813|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610814|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
153610815|NCT01949519|Protective Agents|protective agents|mesh-ancestor
153610816|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610817|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153610818|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153610820|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
153610821|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153610822|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153610823|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
153610824|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
153610825|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610826|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610827|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610829|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153610831|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153610832|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153610833|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153610834|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
153610835|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153610836|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153610837|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
153610838|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153610840|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
153610841|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610842|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153610844|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153610845|NCT01949766|Protective Agents|protective agents|mesh-ancestor
153610846|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610847|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610849|NCT01948245|Heparin|heparin|mesh-list
153610850|NCT01948245|Calcium heparin|calcium heparin|mesh-list
153610863|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610864|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610865|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153610866|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
153610867|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610868|NCT01949818|Prednisone|prednisone|mesh-list
153610869|NCT01949818|Prednisolone|prednisolone|mesh-list
153610870|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
153610871|NCT01949818|Doxorubicin|doxorubicin|mesh-list
153610872|NCT01949818|Vincristine|vincristine|mesh-list
153610873|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153610874|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
153610875|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610876|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153610877|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153610878|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
153610879|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610891|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153610892|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
153610893|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
153610894|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
153610895|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
153338610|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610896|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153610898|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610899|NCT01949935|Mupirocin|mupirocin|mesh-list
153610900|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610901|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610902|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153610904|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610905|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153610906|NCT01949948|Tenecteplase|tenecteplase|mesh-list
153610907|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153610908|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153610909|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610910|NCT01950000|Fentanyl|fentanyl|mesh-list
153610911|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153610912|NCT01950000|Narcotics|narcotics|mesh-ancestor
153610913|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610920|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
153610921|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
153610923|NCT01950182|Gemcitabine|gemcitabine|mesh-list
153610924|NCT01950182|Capecitabine|capecitabine|mesh-list
153610925|NCT01950182|Trastuzumab|trastuzumab|mesh-list
153610926|NCT01950182|Vinorelbine|vinorelbine|mesh-list
153610927|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153610928|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153610929|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
153610930|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610931|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610932|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153610933|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153610934|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
153610935|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
153610936|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
153610937|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153610938|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
153610939|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610940|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610941|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153610942|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153699944|NCT04709029|BB 1101|bb 1101|mesh-list
153610943|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153610944|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153610945|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153610946|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610947|NCT01950195|Ipilimumab|ipilimumab|mesh-list
153610948|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153610962|NCT01950481|Ceritinib|ceritinib|mesh-list
153610963|NCT01950481|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153610964|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153610965|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610966|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610967|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610968|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
153610969|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153610970|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610971|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
153610972|NCT01950507|Fluconazole|fluconazole|mesh-list
153610973|NCT01950507|Voriconazole|voriconazole|mesh-list
153610974|NCT01950507|Micafungin|micafungin|mesh-list
153610975|NCT01950507|Budesonide|budesonide|mesh-list
153610976|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610977|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153610978|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
153610979|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610980|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610981|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153610998|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
153610999|NCT01950546|Protective Agents|protective agents|mesh-ancestor
153481394|NCT03554473|Topotecan|topotecan|mesh-list
153611000|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611001|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
153611002|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611003|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
153611004|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611005|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611006|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153611007|NCT01950611|Bortezomib|bortezomib|mesh-list
153611008|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611009|NCT01950689|Nimorazole|nimorazole|mesh-list
153611010|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153611011|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153611012|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153611013|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611014|NCT01950793|Triamcinolone|triamcinolone|mesh-list
153611015|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153611016|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153611017|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
153611018|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153611019|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611020|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
153611021|NCT01950793|Hormones|hormones|mesh-ancestor
153611022|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611023|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611024|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153611068|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611069|NCT01951079|Protective Agents|protective agents|mesh-ancestor
153611070|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611071|NCT01951144|Lorazepam|lorazepam|mesh-list
153611072|NCT01951144|PF-06372865|pf-06372865|mesh-list
153611073|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
153611074|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
153611075|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
153611076|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611077|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611078|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153611079|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153700005|NCT00265018|Doxorubicin|doxorubicin|mesh-list
153611080|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611081|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153611082|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153611083|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154263405|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611084|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
153611085|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
153611086|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611087|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611088|NCT01951209|Rifaximin|rifaximin|mesh-list
153611089|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153611090|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611091|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153611092|NCT01951404|Allopurinol|allopurinol|mesh-list
153611106|NCT01951430|Fluconazole|fluconazole|mesh-list
153611107|NCT01951430|Posaconazole|posaconazole|mesh-list
153611133|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611134|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153611135|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153611136|NCT01951482|Growth Substances|growth substances|mesh-ancestor
153611137|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611138|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
153611139|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611140|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611141|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153611142|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153611143|NCT01951508|Methylphenidate|methylphenidate|mesh-list
153611144|NCT01951508|Modafinil|modafinil|mesh-list
153611145|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153611146|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611147|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153611148|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153611149|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153611150|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611151|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
153611152|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611184|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
153611185|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611207|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153611208|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153611209|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
153611210|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611211|NCT01951898|Montelukast|montelukast|mesh-list
153611212|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153611213|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
153611214|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153611215|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
153611216|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611217|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611218|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153611219|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153611220|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611221|NCT01951911|Ketamine|ketamine|mesh-list
153611222|NCT01951911|Analgesics|analgesics|mesh-ancestor
153611223|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
153611224|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611225|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611226|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153611227|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153611228|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
153611229|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
153611230|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611231|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153611232|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153611233|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611234|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611235|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
153611236|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153611237|NCT01951924|Antibodies|antibodies|mesh-list
153611238|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
153611239|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
153611240|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611241|NCT01952314|Naftopidil|naftopidil|mesh-list
153611242|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153689886|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153611243|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153611244|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
153611245|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611246|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611247|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611248|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153611249|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153611250|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153611251|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153611252|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153611274|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153611276|NCT01952652|Analgesics|analgesics|mesh-ancestor
153611277|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
153611278|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611279|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611280|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611281|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611282|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
153611283|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153611284|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611285|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611286|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153611287|NCT01952652|Narcotics|narcotics|mesh-ancestor
153611288|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611289|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
153611290|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
153611291|NCT01952756|Cilostazol|cilostazol|mesh-list
153611292|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153611293|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
153611294|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611295|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611296|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153611297|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
153611298|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153611299|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153611300|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611301|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153611302|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
153611303|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153611304|NCT01952756|Protective Agents|protective agents|mesh-ancestor
153611305|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153611306|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153611307|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611308|NCT01952769|Pidilizumab|pidilizumab|mesh-list
153611309|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153611310|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611311|NCT05876598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153611312|NCT05876598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611313|NCT05876585|Ondansetron|ondansetron|mesh-list
153611314|NCT05876585|Metoclopramide|metoclopramide|mesh-list
153611315|NCT05876585|Antiemetics|antiemetics|mesh-ancestor
153611316|NCT05876585|Autonomic Agents|autonomic agents|mesh-ancestor
153611317|NCT05876585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611318|NCT05876585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611319|NCT05876585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153611320|NCT05876585|Antipruritics|antipruritics|mesh-ancestor
153611321|NCT05876585|Dermatologic Agents|dermatologic agents|mesh-ancestor
153611322|NCT05876585|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153611323|NCT05876585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153611324|NCT05876585|Serotonin Agents|serotonin agents|mesh-ancestor
153611325|NCT05876585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611332|NCT05876481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611354|NCT05876039|Analgesics|analgesics|mesh-ancestor
153611355|NCT05876039|Sensory System Agents|sensory system agents|mesh-ancestor
153611356|NCT05876039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611357|NCT05875714|Apremilast|apremilast|mesh-list
153611358|NCT05875714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153611359|NCT05875714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153611360|NCT05875714|Analgesics|analgesics|mesh-ancestor
153611361|NCT05875714|Sensory System Agents|sensory system agents|mesh-ancestor
153611363|NCT05875714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611364|NCT05875714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611365|NCT05875714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611366|NCT05875714|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153611367|NCT05875714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153611368|NCT05875714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611369|NCT05875714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611371|NCT05875675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153611372|NCT05875675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611373|NCT05875610|Gabapentin|gabapentin|mesh-list
153611374|NCT05875610|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153611375|NCT05875610|Analgesics|analgesics|mesh-ancestor
153611376|NCT05875610|Sensory System Agents|sensory system agents|mesh-ancestor
153611377|NCT05875610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611378|NCT05875610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611379|NCT05875610|Anticonvulsants|anticonvulsants|mesh-ancestor
153611380|NCT05875610|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153611381|NCT05875610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153611382|NCT05875610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611383|NCT05875610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153611384|NCT05875610|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153611385|NCT05875610|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153611386|NCT05875610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611387|NCT05875610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611388|NCT05875610|Antimanic Agents|antimanic agents|mesh-ancestor
153611389|NCT05875610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153611428|NCT05874882|Antioxidants|antioxidants|mesh-ancestor
153611429|NCT05874882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611430|NCT05874882|Protective Agents|protective agents|mesh-ancestor
153611431|NCT05874882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611432|NCT05874882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611433|NCT05874882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153611434|NCT05874778|Prednisone|prednisone|mesh-list
153611435|NCT05874778|Cyclophosphamide|cyclophosphamide|mesh-list
153611436|NCT05874778|Vincristine|vincristine|mesh-list
153611437|NCT05874778|Rituximab|rituximab|mesh-list
153611438|NCT05874778|Doxorubicin|doxorubicin|mesh-list
153611439|NCT05874778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153611440|NCT05874778|Immunologic Factors|immunologic factors|mesh-ancestor
153611441|NCT05874778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611442|NCT05874778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611443|NCT05874778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153611444|NCT05874778|Alkylating Agents|alkylating agents|mesh-ancestor
153611445|NCT05874778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611446|NCT05874778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611447|NCT05874778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153611448|NCT05874778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611449|NCT05874778|Glucocorticoids|glucocorticoids|mesh-ancestor
153611450|NCT05874778|Hormones|hormones|mesh-ancestor
153611451|NCT05874778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611452|NCT05874778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153611470|NCT05874700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611471|NCT05874674|Nafamostat|nafamostat|mesh-list
153611472|NCT05874674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153611473|NCT05874674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153611474|NCT05874674|Analgesics|analgesics|mesh-ancestor
153611475|NCT05874674|Sensory System Agents|sensory system agents|mesh-ancestor
153611476|NCT05874674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611496|NCT05874518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611497|NCT05874518|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153611498|NCT05874518|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153611499|NCT05874518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611500|NCT05874518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611501|NCT05874518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153611502|NCT05874518|Hormone Antagonists|hormone antagonists|mesh-ancestor
153611503|NCT05874518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611504|NCT05874518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611507|NCT05874505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611508|NCT05874505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611509|NCT05872412|Paclitaxel|paclitaxel|mesh-list
153611510|NCT05872412|Cyclophosphamide|cyclophosphamide|mesh-list
153611524|NCT05872412|Alkylating Agents|alkylating agents|mesh-ancestor
153611525|NCT05872412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153611526|NCT05872412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153611527|NCT05872412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153611528|NCT05872412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153611529|NCT05872412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611530|NCT05871476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153611531|NCT05871476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700341|NCT00073580|Hirudins|hirudins|mesh-list
153611532|NCT05823675|Methylprednisolone|methylprednisolone|mesh-list
153611533|NCT05823675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153611534|NCT05823675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153611535|NCT05823675|Prednisolone|prednisolone|mesh-list
153611536|NCT05823675|Prednisolone acetate|prednisolone acetate|mesh-list
153611537|NCT05823675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153611538|NCT05823675|Prednisolone phosphate|prednisolone phosphate|mesh-list
153611539|NCT05823675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611540|NCT05823675|Antiemetics|antiemetics|mesh-ancestor
153611541|NCT05823675|Autonomic Agents|autonomic agents|mesh-ancestor
153611542|NCT05823675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611543|NCT05823675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611544|NCT05823675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153611545|NCT05823675|Glucocorticoids|glucocorticoids|mesh-ancestor
153611546|NCT05823675|Hormones|hormones|mesh-ancestor
153393347|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393348|NCT02372630|Incretins|incretins|mesh-ancestor
153393349|NCT02372630|Hormones|hormones|mesh-ancestor
153393350|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611565|NCT05799820|Growth Substances|growth substances|mesh-ancestor
153611566|NCT05799820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611567|NCT05799820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153611568|NCT05799820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153611570|NCT05799820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611571|NCT05790161|Caffeine|caffeine|mesh-list
153611572|NCT05790161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153611574|NCT05790161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153611592|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611593|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
153611594|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153611595|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153611596|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153611597|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153611598|NCT05510063|Adalimumab|adalimumab|mesh-list
153611599|NCT05510063|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153611600|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611601|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611602|NCT05508815|Methotrexate|methotrexate|mesh-list
153611603|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153611604|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
153611605|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153611606|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611607|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153611608|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
153611609|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611610|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611611|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
153611612|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611613|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153611614|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153611615|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
153611616|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611617|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153611618|NCT05463861|Lemborexant|lemborexant|mesh-list
153611619|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153611620|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357364|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
153611644|NCT05129722|Bumetanide|bumetanide|mesh-list
153611645|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153611646|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611647|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153611648|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611649|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153611651|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611652|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153611653|NCT05129722|Diuretics|diuretics|mesh-ancestor
153611654|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
153611655|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153611656|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153611657|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153611658|NCT05044962|Rilpivirine|rilpivirine|mesh-list
153611659|NCT05044962|Cabotegravir|cabotegravir|mesh-list
153611660|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153611661|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
153611662|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
153611663|NCT05044962|Etonogestrel|etonogestrel|mesh-list
153611664|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153611665|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
153611666|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153611667|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611668|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153611669|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153611670|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153611671|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153611672|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153611673|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153611674|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611675|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153611676|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153611677|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611678|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611679|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
153611680|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611681|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153611682|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153611683|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153611684|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153611685|NCT04994431|Tamsulosin|tamsulosin|mesh-list
153611686|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153611687|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153611722|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153611723|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153611724|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
153611725|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611726|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153611727|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153611728|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611729|NCT04705428|Fluorides|fluorides|mesh-list
153611730|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
153611731|NCT04705428|Protective Agents|protective agents|mesh-ancestor
153611732|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611733|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
153611734|NCT04664933|Protective Agents|protective agents|mesh-ancestor
153611735|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611736|NCT04660760|Trifluridine|trifluridine|mesh-list
153611737|NCT04660760|Paclitaxel|paclitaxel|mesh-list
153611738|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153611739|NCT04660760|Ramucirumab|ramucirumab|mesh-list
153611740|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153611741|NCT04660760|Antibodies|antibodies|mesh-list
153611742|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
153611743|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153611744|NCT04660760|Lexatumumab|lexatumumab|mesh-list
153611745|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153611746|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611747|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
153611748|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
153611749|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
153611782|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153611783|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
153611784|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
153611785|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611786|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611787|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611788|NCT04237103|Methotrexate|methotrexate|mesh-list
153611789|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153611791|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153611792|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611793|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153611795|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611796|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611797|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
153611798|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611799|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153611800|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153611801|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
153611819|NCT04179890|Gefitinib|gefitinib|mesh-list
153611820|NCT04179890|Osimertinib|osimertinib|mesh-list
153611821|NCT04179890|Afatinib|afatinib|mesh-list
153611822|NCT04179890|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153611823|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153611824|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611825|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611826|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611836|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611837|NCT04030026|Nalbuphine|nalbuphine|mesh-list
153611838|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153611839|NCT04030026|Narcotics|narcotics|mesh-ancestor
153611840|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611841|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611842|NCT04030026|Analgesics|analgesics|mesh-ancestor
153611843|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
153611844|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611845|NCT03927274|Topotecan|topotecan|mesh-list
153611846|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153611847|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153611848|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611849|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611850|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611851|NCT03923699|Anesthetics|anesthetics|mesh-list
153611852|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611853|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611854|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153611855|NCT03883880|Capsaicin|capsaicin|mesh-list
153611856|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
153611857|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
153611858|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
153611859|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611860|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611862|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339600|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
153611863|NCT03883880|Protective Agents|protective agents|mesh-ancestor
153611864|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153611865|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153611866|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611867|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153611869|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
153611870|NCT03649659|Protective Agents|protective agents|mesh-ancestor
153611871|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611872|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
153611892|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611906|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611907|NCT03348423|Analgesics|analgesics|mesh-ancestor
153611908|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
153611909|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611910|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153611911|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153611912|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
153611913|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
153611914|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
153611915|NCT03262142|Tazobactam|tazobactam|mesh-list
153611916|NCT03262142|Piperacillin|piperacillin|mesh-list
153611917|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153611918|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153611919|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611920|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153611921|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153611922|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611923|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611924|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611925|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153611926|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153611927|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153611929|NCT03150810|Pamiparib|pamiparib|mesh-list
153611930|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153611931|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
153611932|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611933|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611934|NCT03150810|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153611935|NCT03150810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611936|NCT03117998|Volagidemab|volagidemab|mesh-list
153611937|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153611938|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611939|NCT03114865|Dexamethasone|dexamethasone|mesh-list
153611940|NCT03114865|Blinatumomab|blinatumomab|mesh-list
153611969|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153611970|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
153611971|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611972|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
153611973|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153611974|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
153611975|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611976|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153611977|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611978|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
153611979|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611980|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
153611981|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153611982|NCT02739711|Protective Agents|protective agents|mesh-ancestor
153611983|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
153611984|NCT02607423|Cisplatin|cisplatin|mesh-list
153611985|NCT02607423|Gemcitabine|gemcitabine|mesh-list
153611986|NCT02607423|Docetaxel|docetaxel|mesh-list
153611987|NCT02607423|Pemetrexed|pemetrexed|mesh-list
153611988|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153611989|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611990|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153611991|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
153611992|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611993|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
153611994|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
153611995|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
153611996|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611997|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153611998|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153611999|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153612000|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
153612001|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612002|NCT02577523|Levodopa|levodopa|mesh-list
153612003|NCT02577523|Carbidopa|carbidopa|mesh-list
153612004|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153612005|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153612006|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153612007|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
153612008|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612009|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612010|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612011|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153612012|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612013|NCT02344810|Leucovorin|leucovorin|mesh-list
153612062|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153612063|NCT02177695|Gemcitabine|gemcitabine|mesh-list
153612064|NCT02177695|Doxorubicin|doxorubicin|mesh-list
153612065|NCT02177695|Methotrexate|methotrexate|mesh-list
153612066|NCT02177695|Vinblastine|vinblastine|mesh-list
153612067|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612068|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153612069|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
153612070|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612071|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153612072|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153612073|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153612074|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612096|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153612097|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612098|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612099|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153612100|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
153612101|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
153612102|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612113|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612114|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612115|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
153612116|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612117|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153612118|NCT01257594|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153612119|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153612120|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612121|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612122|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612123|NCT01004731|Carboplatin|carboplatin|mesh-list
153612124|NCT01004731|Gemcitabine|gemcitabine|mesh-list
153612125|NCT01004731|Cetuximab|cetuximab|mesh-list
153612126|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612127|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153612128|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
153612129|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612130|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153612131|NCT00771017|Leuprolide|leuprolide|mesh-list
153612132|NCT00771017|Goserelin|goserelin|mesh-list
153612133|NCT00771017|Bicalutamide|bicalutamide|mesh-list
153612134|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153612161|NCT00129090|Rituximab|rituximab|mesh-list
153612162|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153612163|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612164|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
153612165|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612166|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153612167|NCT01952886|Ondansetron|ondansetron|mesh-list
153612168|NCT01952886|Granisetron|granisetron|mesh-list
153612169|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
153612171|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612172|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612174|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
153612175|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
153612176|NCT01952886|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153612177|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153612178|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
153612179|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612180|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612181|NCT01952951|Capecitabine|capecitabine|mesh-list
153612182|NCT01952951|Fluorouracil|fluorouracil|mesh-list
153612183|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
153612184|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153612203|NCT01953367|Tobramycin|tobramycin|mesh-list
153612204|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153612205|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612206|NCT01953406|Fluorouracil|fluorouracil|mesh-list
153612207|NCT01953406|Mitomycins|mitomycins|mesh-list
153612208|NCT01953406|Mitomycin|mitomycin|mesh-list
153612209|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
153612210|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612211|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153612212|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612213|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612214|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
153612215|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612216|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153612267|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153612268|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153612269|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153612276|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153612278|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612279|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153612280|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
153612281|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612282|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612283|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153612284|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153612285|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153612286|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153612288|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
153612290|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
153612291|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
153612292|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612293|NCT01953757|Hematinics|hematinics|mesh-ancestor
153612294|NCT01953770|Cytarabine|cytarabine|mesh-list
153612295|NCT01953770|Prednisone|prednisone|mesh-list
153612296|NCT01953770|Methotrexate|methotrexate|mesh-list
153612297|NCT01953770|Daunorubicin|daunorubicin|mesh-list
153612298|NCT01953770|Asparaginase|asparaginase|mesh-list
153612299|NCT01953770|Pegaspargase|pegaspargase|mesh-list
153612300|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153612301|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
153612313|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
153612314|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612315|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153612316|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612317|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
153612318|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153612319|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153612321|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612322|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153612324|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153612325|NCT01953796|Clomiphene|clomiphene|mesh-list
153612326|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153612327|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
153612328|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612329|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612330|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153612331|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
153612332|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153612333|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153612334|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153612335|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153612336|NCT01953835|Simvastatin|simvastatin|mesh-list
153612337|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153612338|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153612339|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
153612340|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612341|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153612342|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153612343|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612344|NCT01953848|Tamsulosin|tamsulosin|mesh-list
153612345|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
153612346|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153612347|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153612348|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153612349|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
153612350|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612351|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612371|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612373|NCT01953978|Dexamethasone|dexamethasone|mesh-list
153612374|NCT01953978|Ibuprofen|ibuprofen|mesh-list
153612375|NCT01953978|Morphine|morphine|mesh-list
153612376|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153612377|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
153612378|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
153612379|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612380|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612381|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153612382|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
153612383|NCT01953978|Hormones|hormones|mesh-ancestor
153612384|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153424120|NCT03329911|Paclitaxel|paclitaxel|mesh-list
153690662|NCT00186745|Tinzaparin|tinzaparin|mesh-list
153612385|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153612386|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612387|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153612388|NCT01953978|Narcotics|narcotics|mesh-ancestor
153612389|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612390|NCT01953978|Analgesics|analgesics|mesh-ancestor
153612391|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
153612392|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153612393|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153612394|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153612395|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153612396|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612397|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612398|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
153612399|NCT01954030|Bevacizumab|bevacizumab|mesh-list
153612400|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
153612401|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153612402|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612403|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153612404|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153612405|NCT01954030|Growth Substances|growth substances|mesh-ancestor
153612406|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612407|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
153612408|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153612409|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153612410|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612411|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153612414|NCT01954043|Rabeprazole|rabeprazole|mesh-list
153612415|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153612416|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153612417|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153612418|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612419|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612420|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153612421|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
153612422|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153612423|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612424|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
153612425|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153612426|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153612455|NCT01954290|Diuretics|diuretics|mesh-ancestor
153612456|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
153612457|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612458|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153612459|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612460|NCT01954355|Paclitaxel|paclitaxel|mesh-list
153612461|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153612462|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612463|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
153612464|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612465|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612466|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612467|NCT01954368|Sufentanil|sufentanil|mesh-list
153612468|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153612469|NCT01954368|Narcotics|narcotics|mesh-ancestor
153612470|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612471|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612472|NCT01954368|Analgesics|analgesics|mesh-ancestor
153612473|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
153612474|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612475|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153700965|NCT00416377|Hormones|hormones|mesh-ancestor
153612476|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153612477|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
153612478|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
153612480|NCT01954693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153612481|NCT01954693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153612482|NCT01954693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612483|NCT01954693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612484|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612486|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612509|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153612510|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153612511|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153612512|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153612513|NCT01954784|Growth Substances|growth substances|mesh-ancestor
153612514|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
153612515|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153612516|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153612517|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
153612518|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153612519|NCT01954914|Plerixafor|plerixafor|mesh-list
153612520|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153612521|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153612522|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
153612523|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612524|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
153612525|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
153612560|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612562|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153612563|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
153612564|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153612565|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153612566|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612567|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
153612568|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612569|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612570|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
153612571|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153612572|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153612573|NCT01955187|Prednisolone|prednisolone|mesh-list
153612574|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
153612575|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
153612576|NCT01955187|Rituximab|rituximab|mesh-list
153612577|NCT01955187|Tacrolimus|tacrolimus|mesh-list
153612578|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153612579|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
153612580|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612581|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
153612582|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612583|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153612584|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153612585|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
153612586|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612587|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612588|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153612589|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153612590|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153612591|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612592|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153612593|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
153612594|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
153612595|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612596|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153612609|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153612611|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612612|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612613|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612623|NCT01955200|Protective Agents|protective agents|mesh-ancestor
153612624|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153612625|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153612626|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612627|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
153612628|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153612629|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612630|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
153612631|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612632|NCT01955252|Azithromycin|azithromycin|mesh-list
153612633|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153612634|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612635|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
154263408|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153612636|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153612637|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612638|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
153612639|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153612640|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
153612641|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612642|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612643|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612644|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153612645|NCT01955421|Gefitinib|gefitinib|mesh-list
153612646|NCT01955421|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153612647|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153612648|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612649|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612650|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612651|NCT01955577|Vitamin D|vitamin d|mesh-list
153612652|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
153612653|NCT01955577|Vitamins|vitamins|mesh-ancestor
153612654|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
153612655|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612656|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153612657|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153612658|NCT01955642|Clopidogrel|clopidogrel|mesh-list
153612679|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
153612680|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612681|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612682|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153612683|NCT01955694|Diuretics|diuretics|mesh-ancestor
153612684|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
153612685|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153612686|NCT01955759|Amiodarone|amiodarone|mesh-list
153612687|NCT01955759|Bisoprolol|bisoprolol|mesh-list
153612688|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153612689|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153612690|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153612691|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153612692|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
153340458|NCT05749900|Nivolumab|nivolumab|mesh-list
153612693|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612695|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153612696|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612697|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153612698|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
153612699|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612700|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612724|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153612725|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153612726|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153612727|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612729|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
153612730|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
153612731|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612732|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612733|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
153612734|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612735|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153612736|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153612737|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153612738|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153612739|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612740|NCT01956006|Milrinone|milrinone|mesh-list
153612741|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153612742|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153612743|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
153612744|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153612745|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153612746|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612747|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612748|NCT01956006|Protective Agents|protective agents|mesh-ancestor
153612749|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612751|NCT01956201|Fenofibrate|fenofibrate|mesh-list
153612752|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153612753|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153612754|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
153612755|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612756|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153612757|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153612758|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612759|NCT01956253|Neratinib|neratinib|mesh-list
153612760|NCT01956253|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153612761|NCT01956253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153612762|NCT01956253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612763|NCT01956253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612764|NCT01956305|Metformin|metformin|mesh-list
153612765|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153612766|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612775|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153612776|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153612777|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153612778|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153612779|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612781|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
153612790|NCT01956591|Urological Agents|urological agents|mesh-ancestor
153612791|NCT01956604|Clonidine|clonidine|mesh-list
153612792|NCT01956604|Analgesics|analgesics|mesh-ancestor
153612793|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
153612794|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612795|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612796|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153612797|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
153612798|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
153612799|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153612800|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153612801|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153612802|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
153612803|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612804|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612805|NCT01956695|Rituximab|rituximab|mesh-list
153612806|NCT01956695|Lenalidomide|lenalidomide|mesh-list
153612807|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153612808|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612809|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
153612810|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612811|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153612812|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153612813|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153612814|NCT01956695|Growth Substances|growth substances|mesh-ancestor
153612815|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
153612816|NCT01956734|Temozolomide|temozolomide|mesh-list
153612817|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153612818|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
153612819|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612820|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612821|NCT01956786|Amlodipine|amlodipine|mesh-list
153612822|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153612823|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153612824|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153612825|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612826|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153612827|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612828|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
153612829|NCT01956864|Vitamin D|vitamin d|mesh-list
153612830|NCT01956864|Vitamins|vitamins|mesh-ancestor
153612831|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
153612832|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612833|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153612842|NCT01956955|Calcium heparin|calcium heparin|mesh-list
153781987|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612843|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
153612844|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153612845|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153612846|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612847|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
153612848|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
153612849|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153612850|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612851|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612852|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153612869|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153612871|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612872|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
153612873|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612874|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612875|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612877|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153612878|NCT01957189|Tamsulosin|tamsulosin|mesh-list
153612879|NCT01957189|Dutasteride|dutasteride|mesh-list
153612880|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153612881|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153612882|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153612883|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
153612884|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612885|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612886|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612887|NCT01957189|Urological Agents|urological agents|mesh-ancestor
153612888|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153612889|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153612890|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612891|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
153612892|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612893|NCT01957293|Albuterol|albuterol|mesh-list
153612894|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153612895|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
153612896|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612897|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612906|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612907|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612908|NCT01957319|Vitamin E|vitamin e|mesh-list
153612909|NCT01957319|Silybin|silybin|mesh-list
153612910|NCT01957319|Vitamins|vitamins|mesh-ancestor
153612911|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
153612912|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612914|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612915|NCT01957319|Protective Agents|protective agents|mesh-ancestor
153612916|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153612917|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612918|NCT01957449|Propranolol|propranolol|mesh-list
153612919|NCT01957449|Metoprolol|metoprolol|mesh-list
153612934|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153612935|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153612936|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153612937|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153612938|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153612939|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
153612940|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612941|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612942|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612943|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
153612944|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153612945|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153612947|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
153612948|NCT01957631|Bupivacaine|bupivacaine|mesh-list
153612949|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153612950|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
153612951|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
153612952|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
153612953|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612954|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612955|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
153612956|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612957|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153612958|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
153612959|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
153612960|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153612961|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
153691160|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
153612963|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612964|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153612978|NCT01957852|Coagulants|coagulants|mesh-ancestor
153612980|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153612981|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153612982|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153612983|NCT01957995|Docetaxel|docetaxel|mesh-list
153612984|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612985|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
153612986|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612987|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612988|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612989|NCT01958138|Propofol|propofol|mesh-list
153612990|NCT01958138|Isoflurane|isoflurane|mesh-list
153612991|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153781988|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
153612999|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153613000|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153613002|NCT01958372|Etoposide|etoposide|mesh-list
153613003|NCT01958372|Pemetrexed|pemetrexed|mesh-list
153613004|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613005|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153613006|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153613007|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153613008|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613009|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613010|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153613011|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153613012|NCT01958580|Gemcitabine|gemcitabine|mesh-list
153613013|NCT01958580|Docetaxel|docetaxel|mesh-list
153613014|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153613015|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
153613016|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613017|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613018|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
153613019|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
153613020|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
153613022|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
153613023|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153613024|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
153613025|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153613026|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613036|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613038|NCT01958775|Incretins|incretins|mesh-ancestor
153613039|NCT01958814|Albuterol|albuterol|mesh-list
153613040|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153613041|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
153613042|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613043|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613044|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153613045|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
153613046|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
153613047|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153613048|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153613049|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153613050|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153613051|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613052|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613053|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613055|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153613056|NCT01958866|Analgesics|analgesics|mesh-ancestor
153613057|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
153613058|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613059|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613060|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
153613061|NCT01958905|Lumefantrine|lumefantrine|mesh-list
153613062|NCT01958905|Artemether|artemether|mesh-list
153613063|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153613064|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
153613065|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153613066|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153613067|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153613069|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153613080|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
153613081|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
153613082|NCT01958944|Protective Agents|protective agents|mesh-ancestor
153613083|NCT01958996|Idarubicin|idarubicin|mesh-list
153613084|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153613085|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613086|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153613087|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153613088|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613089|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613090|NCT01959022|Doxazosin|doxazosin|mesh-list
153613091|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153613092|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153613104|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
153613105|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613106|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153613107|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613108|NCT01959074|Aceclofenac|aceclofenac|mesh-list
153613109|NCT01959074|Naftopidil|naftopidil|mesh-list
153393540|NCT03083405|Opipramol|opipramol|mesh-list
153613110|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153613111|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153613112|NCT01959074|Analgesics|analgesics|mesh-ancestor
153613113|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
153613114|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613115|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613116|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153613117|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153613118|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153613119|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153613120|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613121|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613122|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613123|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153613124|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153613125|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613126|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153613127|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153613128|NCT01959100|Azithromycin|azithromycin|mesh-list
153613129|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153613130|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153613131|NCT01959152|Imidacloprid|imidacloprid|mesh-list
153613132|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
153613133|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613134|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613135|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340895|NCT01896440|Ondansetron|ondansetron|mesh-list
153613136|NCT01959191|Aspirin|aspirin|mesh-list
153613137|NCT01959191|Clopidogrel|clopidogrel|mesh-list
153613138|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153613139|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153613140|NCT01959191|Analgesics|analgesics|mesh-ancestor
153613141|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
153613142|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613173|NCT01959438|Selenious Acid|selenious acid|mesh-list
153613174|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
153613175|NCT01959438|Trace Elements|trace elements|mesh-ancestor
153613176|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
153613177|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613178|NCT01959451|Clopidogrel|clopidogrel|mesh-list
153613179|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153613180|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153613181|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153613182|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153613183|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153613184|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
153613185|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613186|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613187|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613188|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
153613189|NCT01959477|Busulfan|busulfan|mesh-list
153613190|NCT01959477|Etoposide|etoposide|mesh-list
153613191|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
154263409|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
153424254|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
153613192|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701494|NCT00277537|Diuretics|diuretics|mesh-ancestor
153613193|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
153613194|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613195|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153613196|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153613197|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
153613198|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613199|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613200|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153613214|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613217|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
153613218|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
153613219|NCT01959828|Protective Agents|protective agents|mesh-ancestor
153613220|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153613221|NCT01959854|Laxatives|laxatives|mesh-ancestor
153613222|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153613237|NCT01960023|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153613238|NCT01960023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153613239|NCT01960023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613240|NCT01960023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613241|NCT01960049|Ropivacaine|ropivacaine|mesh-list
153613242|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613243|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
153613244|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613245|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613246|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
153613247|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613249|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
153613250|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153613251|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153613252|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613253|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613254|NCT01960153|Urological Agents|urological agents|mesh-ancestor
153613255|NCT01960205|Metformin|metformin|mesh-list
153613256|NCT01960205|Saxagliptin|saxagliptin|mesh-list
153613257|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153613258|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613259|NCT01960205|Incretins|incretins|mesh-ancestor
153613260|NCT01960205|Hormones|hormones|mesh-ancestor
153613261|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613262|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153613263|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
153613264|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613265|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613266|NCT01960283|Methotrexate|methotrexate|mesh-list
153613267|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153613268|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
153613269|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153613270|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613271|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153613272|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
153613273|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613274|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613303|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
153613304|NCT01960569|Hirudins|hirudins|mesh-list
153613305|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
153613306|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153613307|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
153613308|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613309|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613310|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
153613311|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153613312|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153613313|NCT01960595|Fentanyl|fentanyl|mesh-list
153613314|NCT01960595|Bupivacaine|bupivacaine|mesh-list
153613315|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613316|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
153613317|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613318|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263410|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263411|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613319|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
153613320|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613321|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153613322|NCT01960595|Narcotics|narcotics|mesh-ancestor
153613323|NCT01960595|Analgesics|analgesics|mesh-ancestor
153613324|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153613325|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153613326|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
153613327|NCT01960647|Paclitaxel|paclitaxel|mesh-list
153613328|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153613329|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613330|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
153613331|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
153613332|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
153613333|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613334|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153613335|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153613336|NCT01960829|Everolimus|everolimus|mesh-list
153613337|NCT01960829|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153613338|NCT01960829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153613339|NCT01960829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613340|NCT01960829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613341|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153613342|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
153613343|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613344|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613345|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153613354|NCT01961154|Hormones|hormones|mesh-ancestor
153613355|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613356|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
153613357|NCT01961180|Escitalopram|escitalopram|mesh-list
153613358|NCT01961180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153613359|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153613360|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613376|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153613377|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613378|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153613379|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613380|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613382|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153613383|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153613384|NCT01961414|Growth Substances|growth substances|mesh-ancestor
153613385|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613386|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
153613387|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613388|NCT01961453|Isosorbide|isosorbide|mesh-list
153613389|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153613390|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153613391|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153613392|NCT01961453|Diuretics|diuretics|mesh-ancestor
153613393|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
153613394|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613395|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
153613396|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153613397|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613398|NCT01961635|Cimetidine|cimetidine|mesh-list
153613399|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153613400|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153613401|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153613402|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
153613403|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
153613404|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613405|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613406|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613407|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153613408|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153613409|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613410|NCT01961739|Lidocaine|lidocaine|mesh-list
153613411|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613421|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613423|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153613424|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153613425|NCT01961752|Bupivacaine|bupivacaine|mesh-list
153613426|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153701755|NCT00279565|Narcotics|narcotics|mesh-ancestor
153613427|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613428|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
153613429|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613440|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613442|NCT01961830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153613443|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153613444|NCT01961843|Prednisone|prednisone|mesh-list
153613445|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
153613446|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153613447|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
153613448|NCT01961843|Hormones|hormones|mesh-ancestor
153613449|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613450|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613451|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153613452|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613453|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153613454|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613455|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613456|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
153613457|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153613458|NCT01961856|Clopidogrel|clopidogrel|mesh-list
153613459|NCT01961856|Ticagrelor|ticagrelor|mesh-list
153613460|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153613461|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153613462|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153613463|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153613464|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
153613465|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613466|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613467|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613468|NCT01961947|Vaccines|vaccines|mesh-list
153613469|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
153613470|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613471|NCT01962116|Heparin|heparin|mesh-list
153613472|NCT01962116|Calcium heparin|calcium heparin|mesh-list
153613473|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
153613474|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613489|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613490|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153613491|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
153613492|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
153613493|NCT01962363|Tocotrienols|tocotrienols|mesh-list
153613494|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
153613495|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
153613496|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613497|NCT01962363|Protective Agents|protective agents|mesh-ancestor
153613498|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613499|NCT01962363|Vitamins|vitamins|mesh-ancestor
153613500|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
153613501|NCT01962376|Bevacizumab|bevacizumab|mesh-list
153613502|NCT01962376|Capecitabine|capecitabine|mesh-list
153613503|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
153613504|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153613505|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613506|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153613507|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153613521|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613522|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613523|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153613524|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613526|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
153613527|NCT01962571|Hematinics|hematinics|mesh-ancestor
153613528|NCT01962831|Dinoprostone|dinoprostone|mesh-list
153613529|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
153613530|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154263412|NCT05617313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153613531|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613532|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153613533|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
153613548|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613549|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
153613550|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613551|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613552|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
153613553|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613554|NCT01963299|Analgesics|analgesics|mesh-ancestor
153613555|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153613556|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
153613557|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
153613558|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153613559|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153613560|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153613561|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613562|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613563|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613565|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153613566|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153613567|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613568|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
153613569|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
153613570|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
153613571|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613572|NCT01963390|Testosterone|testosterone|mesh-list
153613573|NCT01963390|Androgens|androgens|mesh-ancestor
153613574|NCT01963390|Hormones|hormones|mesh-ancestor
153613575|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613576|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613577|NCT01963416|Micronutrients|micronutrients|mesh-list
153613578|NCT01963416|Trace Elements|trace elements|mesh-list
153613579|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613580|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153613615|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613616|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153613619|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153613620|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613621|NCT01963702|Capecitabine|capecitabine|mesh-list
153613622|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
153613623|NCT01963702|Docetaxel|docetaxel|mesh-list
153613624|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153613625|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
153613626|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613627|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613628|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
153613629|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153613630|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153613631|NCT01963741|Histamine|histamine|mesh-list
153613632|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
153613633|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
153613634|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613635|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613636|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613637|NCT01963754|Epinephrine|epinephrine|mesh-list
153613638|NCT01963754|Racepinephrine|racepinephrine|mesh-list
153613639|NCT01963754|Anesthetics|anesthetics|mesh-list
153613640|NCT01963754|Carticaine|carticaine|mesh-list
153613641|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
153613642|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613643|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613644|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153613645|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153613646|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613647|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613661|NCT01963832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153613663|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613664|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613665|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613666|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
153613667|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691724|NCT00193297|Topotecan|topotecan|mesh-list
153613668|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153613669|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
153613670|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153613689|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
153613691|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
153613692|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
153613693|NCT01964001|Pyridoxal|pyridoxal|mesh-list
153613694|NCT01964001|Pyridoxine|pyridoxine|mesh-list
153613695|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
153613696|NCT01964001|Ubiquinone|ubiquinone|mesh-list
153613697|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
153613698|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613699|NCT01964027|Irinotecan|irinotecan|mesh-list
153613700|NCT01964027|Epirubicin|epirubicin|mesh-list
153613701|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153613702|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153613703|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613704|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613705|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613706|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153613707|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153613708|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
153613709|NCT01964040|Bupivacaine|bupivacaine|mesh-list
153613721|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153613722|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613723|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613724|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613725|NCT01964079|Losartan|losartan|mesh-list
153613726|NCT01964079|Amlodipine|amlodipine|mesh-list
153613727|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153613728|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153613729|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613730|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613731|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153613732|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613733|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
153613734|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153613735|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153613736|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153613738|NCT01964157|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153613739|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153613740|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613755|NCT01964183|Urological Agents|urological agents|mesh-ancestor
153613756|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153613757|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153613758|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
153613759|NCT01964248|Lidocaine|lidocaine|mesh-list
153613760|NCT01964248|Prilocaine|prilocaine|mesh-list
153613761|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153613762|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613763|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
153613764|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613765|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613766|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
153613767|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613768|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153613769|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153613770|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153613771|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613786|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613788|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
153613789|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153613790|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153613791|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613792|NCT01964287|Antidotes|antidotes|mesh-ancestor
153613793|NCT01964287|Protective Agents|protective agents|mesh-ancestor
153613794|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613795|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
153613796|NCT01964287|Vitamins|vitamins|mesh-ancestor
153613797|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
153613798|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
153613799|NCT01964365|Fenofibrate|fenofibrate|mesh-list
153613800|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153613801|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153424363|NCT00422864|Leucovorin|leucovorin|mesh-list
153691868|NCT00060359|Carboplatin|carboplatin|mesh-list
153613802|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
153613803|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613804|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153613805|NCT01964391|Paclitaxel|paclitaxel|mesh-list
153613806|NCT01964391|Docetaxel|docetaxel|mesh-list
153613807|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
153613808|NCT01964391|Carboplatin|carboplatin|mesh-list
153341580|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
153613809|NCT01964391|Doxorubicin|doxorubicin|mesh-list
153613810|NCT01964391|Trastuzumab|trastuzumab|mesh-list
153613811|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153613812|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613813|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
153613814|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
153613815|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
153613831|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613833|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153613834|NCT01964404|Analgesics|analgesics|mesh-ancestor
153613836|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613837|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153613838|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153613839|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613840|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613841|NCT01964404|Hormones|hormones|mesh-ancestor
153613842|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613843|NCT01964534|Gemcitabine|gemcitabine|mesh-list
153613844|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153613845|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153613846|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
153613847|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613848|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613849|NCT01964573|Rotigotine|rotigotine|mesh-list
153613850|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
153613851|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
153613852|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613853|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613854|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613855|NCT01964586|Lidocaine|lidocaine|mesh-list
153613856|NCT01964586|Epinephrine|epinephrine|mesh-list
153613857|NCT01964586|Racepinephrine|racepinephrine|mesh-list
153613858|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
153613859|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
153613860|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613861|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
153613862|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613863|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613864|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
153613865|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613866|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153613867|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153613868|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153613869|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613870|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613871|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153613872|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153613889|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613890|NCT01964781|Epinephrine|epinephrine|mesh-list
153613891|NCT01964781|Racepinephrine|racepinephrine|mesh-list
153613892|NCT01964781|Bupivacaine|bupivacaine|mesh-list
153613893|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
153613894|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
153613895|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613896|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
153613897|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613898|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613899|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
153613900|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613901|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153613902|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153613903|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613905|NCT01964781|Coagulants|coagulants|mesh-ancestor
153613906|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153613907|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153613908|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613932|NCT01964846|Protective Agents|protective agents|mesh-ancestor
153613933|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153613934|NCT01964911|Ropivacaine|ropivacaine|mesh-list
153613935|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613936|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
153613937|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613938|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613939|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
153613940|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613941|NCT01965041|Aflibercept|aflibercept|mesh-list
153613942|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153613943|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153613944|NCT01965041|Growth Substances|growth substances|mesh-ancestor
153613945|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613946|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
153613947|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613948|NCT01965080|Exemestane|exemestane|mesh-list
153613949|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613950|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153613951|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153613952|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613953|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613954|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153613977|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153613978|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153613979|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
153613980|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
153613981|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613982|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613983|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153613984|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
153613987|NCT01965353|Lenalidomide|lenalidomide|mesh-list
153613989|NCT01965353|Panobinostat|panobinostat|mesh-list
153613990|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153613991|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
153613992|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
153613993|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613994|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613995|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153613996|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
153613997|NCT01965353|Hormones|hormones|mesh-ancestor
153613998|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613999|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153614000|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614001|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
153614002|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153614003|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153614004|NCT01965353|Growth Substances|growth substances|mesh-ancestor
153614005|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
153614006|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153614007|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614008|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614009|NCT01965522|Vitamin D|vitamin d|mesh-list
153614010|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
153614011|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
153614012|NCT01965522|Vitamins|vitamins|mesh-list
153614013|NCT01965522|Melatonin|melatonin|mesh-list
153614014|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
153853545|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153614015|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614016|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153614017|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153614018|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
153614019|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614020|NCT01965522|Protective Agents|protective agents|mesh-ancestor
153614021|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614022|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
153614023|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153614024|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
153614025|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153692029|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
153614035|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614036|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614037|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153614038|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
153614040|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614051|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
153614052|NCT01965730|Coagulants|coagulants|mesh-ancestor
153614054|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153614055|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
153614056|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153614057|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153614058|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153614059|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614060|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614061|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
153614062|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614063|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614064|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153614065|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153614066|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614067|NCT01965925|Modafinil|modafinil|mesh-list
153614068|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153614069|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614070|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153614071|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153614072|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153614073|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614075|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614076|NCT01966055|Solithromycin|solithromycin|mesh-list
153614077|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153614078|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614079|NCT01966133|Doxorubicin|doxorubicin|mesh-list
153614080|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153614081|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
153614082|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153614083|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614084|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153614085|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153614086|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614087|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614088|NCT01966172|Acetaminophen|acetaminophen|mesh-list
153614089|NCT01966172|Ibuprofen|ibuprofen|mesh-list
153614090|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153614091|NCT01966172|Morphine|morphine|mesh-list
153614108|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153614109|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153614110|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153614111|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153614112|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153614113|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614115|NCT01966276|Methylphenidate|methylphenidate|mesh-list
153614116|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153614117|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614118|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153614119|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153614133|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614134|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153614135|NCT01966302|Beraprost|beraprost|mesh-list
153614136|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153614137|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
153614138|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153614139|NCT01966341|Laxatives|laxatives|mesh-list
153614140|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
153614141|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614142|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153614143|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
153614144|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614145|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614146|NCT01966484|Succinylcholine|succinylcholine|mesh-list
153614147|NCT01966484|Mivacurium|mivacurium|mesh-list
153614148|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153736000|NCT03922542|Vitamins|vitamins|mesh-ancestor
153692163|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614149|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153614150|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153614165|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153614166|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153614167|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614168|NCT01966575|Hormones|hormones|mesh-ancestor
153614169|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614170|NCT01966627|Liver Extracts|liver extracts|mesh-list
153614171|NCT01966627|Hematinics|hematinics|mesh-ancestor
153614172|NCT01966653|Fosfomycin|fosfomycin|mesh-list
153614173|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
153614174|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153614175|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614176|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153614177|NCT01966692|Fluticasone|fluticasone|mesh-list
153614179|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614180|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153614181|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
153614182|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614183|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341953|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
153614184|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153614185|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
153614186|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
153614187|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153614188|NCT01966783|Budesonide|budesonide|mesh-list
153614190|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614191|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153614192|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
153614193|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614194|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614195|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153614209|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153614231|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614232|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614233|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
153614234|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614235|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153614236|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153614237|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153614238|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614239|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614240|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153614241|NCT01967095|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153614242|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153614243|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614244|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614245|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614247|NCT01967199|Everolimus|everolimus|mesh-list
153614248|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153614249|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614250|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
153614251|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
153614252|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
153614253|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614254|NCT01967199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153614255|NCT01967199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153614256|NCT01967199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614257|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342042|NCT01250977|Donepezil|donepezil|mesh-list
153614258|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
153614259|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614260|NCT01967251|Udenafil|udenafil|mesh-list
153394138|NCT01755169|Ketamine|ketamine|mesh-list
153614261|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153614278|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614279|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
153614280|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614281|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614282|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
153614283|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153614284|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153614285|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614286|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153614288|NCT01967459|Vitamin D|vitamin d|mesh-list
153614289|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153614298|NCT01967472|Amodiaquine|amodiaquine|mesh-list
153614299|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
153614300|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153614301|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153614302|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614303|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614304|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
153614305|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
153614306|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153614307|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
153614308|NCT01967498|Montelukast|montelukast|mesh-list
153614309|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153614310|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
153614311|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153614312|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
153614313|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614314|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614315|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153614316|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153614317|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614318|NCT01967524|Ropivacaine|ropivacaine|mesh-list
153614319|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153614320|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
153614321|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153614335|NCT01967758|Amoxicillin|amoxicillin|mesh-list
153614336|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153614337|NCT01967758|Trimethoprim|trimethoprim|mesh-list
153614338|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
153614339|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614340|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153614341|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
153614342|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153614343|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153614344|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153614345|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614346|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614347|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153614348|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153614349|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153614350|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153614351|NCT01967823|Aldesleukin|aldesleukin|mesh-list
153614352|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
153614353|NCT01967823|Fludarabine|fludarabine|mesh-list
153614354|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153614355|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
153614356|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614357|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614358|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153614359|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
153614360|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614361|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614362|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153614363|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153614364|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153614365|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
153614366|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614367|NCT01967875|Docetaxel|docetaxel|mesh-list
153614368|NCT01967875|Capecitabine|capecitabine|mesh-list
153614369|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614370|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
153614371|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
153614419|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153614420|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153614421|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614434|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153614435|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614438|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614439|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153614440|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
153614441|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614442|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614443|NCT01968083|Vaccines|vaccines|mesh-list
153614444|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
153614445|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614446|NCT01968161|Asenapine|asenapine|mesh-list
153614447|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153614448|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153614449|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614450|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614451|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153614452|NCT01968239|Ranibizumab|ranibizumab|mesh-list
153614453|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153614454|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153614455|NCT01968239|Growth Substances|growth substances|mesh-ancestor
153614456|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614457|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
153614458|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614459|NCT01968395|Caspofungin|caspofungin|mesh-list
153614460|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
153614461|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614462|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614463|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614464|NCT01968486|Ranibizumab|ranibizumab|mesh-list
153614478|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614479|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614480|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781753|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614481|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614482|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614483|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153614484|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153614494|NCT01968616|Growth Substances|growth substances|mesh-ancestor
153614495|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614496|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
153614497|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614498|NCT01968655|Factor VIII|factor viii|mesh-list
153614499|NCT01968655|Coagulants|coagulants|mesh-ancestor
153614501|NCT01968759|Irbesartan|irbesartan|mesh-list
153614502|NCT01968759|Sevelamer|sevelamer|mesh-list
153614503|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153614504|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
153614505|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614506|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614507|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153614508|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153614509|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153614510|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
153614511|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
153614512|NCT01968798|Aspirin|aspirin|mesh-list
153614513|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153614514|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153614515|NCT01968798|Analgesics|analgesics|mesh-ancestor
153614516|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
153614517|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614518|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614519|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614520|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614521|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153614522|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153614523|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614524|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153614525|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153614526|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614527|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
153614528|NCT01968850|Vitamin D|vitamin d|mesh-list
153614529|NCT01968850|Alendronate|alendronate|mesh-list
153614530|NCT01968850|Vitamins|vitamins|mesh-ancestor
153614531|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
153614532|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614544|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614545|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614547|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614548|NCT01969019|Prednisone|prednisone|mesh-list
153614549|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
153614550|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153614576|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
153614577|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
153614578|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
153614579|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614580|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153614581|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153614582|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153614583|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614584|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153614585|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
153614586|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153614587|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
153614588|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614589|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614590|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153614591|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
153614592|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153614593|NCT01969071|Simendan|simendan|mesh-list
153614594|NCT01969071|Dobutamine|dobutamine|mesh-list
153614595|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153614596|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
153614597|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153614598|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153614599|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614600|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614601|NCT01969071|Protective Agents|protective agents|mesh-ancestor
153614602|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614603|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
153614614|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
153614615|NCT01969149|Incretins|incretins|mesh-list
153614616|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153614617|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614618|NCT01969149|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153614619|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153614620|NCT01969149|Hormones|hormones|mesh-ancestor
153614621|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614622|NCT01969266|Ibrutinib|ibrutinib|mesh-list
153614623|NCT01969266|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153614624|NCT01969266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153614625|NCT01969266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614626|NCT01969266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342418|NCT04777838|Citalopram|citalopram|mesh-list
153614627|NCT01969318|Metformin|metformin|mesh-list
153614628|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153614629|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614630|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153614631|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153614644|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
153614645|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614646|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153614647|NCT01969656|Calcitriol|calcitriol|mesh-list
153614648|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153614649|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614650|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153614651|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614652|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614653|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153614654|NCT01969656|Vitamins|vitamins|mesh-ancestor
153614655|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
153614656|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153614657|NCT01969669|Ketoconazole|ketoconazole|mesh-list
153614658|NCT01969669|Venetoclax|venetoclax|mesh-list
153614659|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614660|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
153614661|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614662|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153614663|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154263413|NCT05617313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424497|NCT04045964|Nicotine|nicotine|mesh-list
153614664|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614665|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614666|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153614667|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
153614682|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153614683|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153614684|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153614685|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153614686|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153614687|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153614688|NCT01969695|Venetoclax|venetoclax|mesh-list
153614689|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614690|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
153614691|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153614692|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153614693|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153614694|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614695|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614696|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
153614697|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614698|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614699|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153614700|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614701|NCT01969877|Cetuximab|cetuximab|mesh-list
153614702|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614703|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153614704|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
153614705|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153614706|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614724|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153614725|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153614748|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153614749|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153614750|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
153614751|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614752|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614753|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
153614754|NCT01970059|Protective Agents|protective agents|mesh-ancestor
153614755|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153614756|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614757|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153614758|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
153614759|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153614760|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153614761|NCT01970072|Midazolam|midazolam|mesh-list
153614762|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153614763|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153614764|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614765|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614766|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153614767|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153614768|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153614769|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153614770|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
153614771|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
153614772|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
153614773|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
153614774|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614775|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614776|NCT01970202|Enoxaparin|enoxaparin|mesh-list
153614778|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
153614779|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153614797|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
153614798|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
153393920|NCT00003117|Carboplatin|carboplatin|mesh-list
153614799|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614800|NCT01970449|Vaccines|vaccines|mesh-list
153614801|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
153614802|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263414|NCT05608564|Amoxicillin|amoxicillin|mesh-list
153614803|NCT01970553|Gemcitabine|gemcitabine|mesh-list
153614804|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153614805|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
153614820|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614821|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614822|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153614823|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153614824|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
153614825|NCT01970800|Hormones|hormones|mesh-list
153614826|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614827|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614828|NCT01970904|Ribavirin|ribavirin|mesh-list
153614829|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153614830|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
153614831|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614832|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
153614833|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614834|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153614848|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153614849|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153614850|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614851|NCT01971190|Aflibercept|aflibercept|mesh-list
153614852|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153614853|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153614854|NCT01971190|Growth Substances|growth substances|mesh-ancestor
153614855|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614857|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614858|NCT01971242|Exenatide|exenatide|mesh-list
153614859|NCT01971242|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153614860|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153614861|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614862|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153614863|NCT01971242|Incretins|incretins|mesh-ancestor
153614864|NCT01971242|Hormones|hormones|mesh-ancestor
153614865|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614866|NCT01971268|Cimetidine|cimetidine|mesh-list
153614867|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153614868|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153614869|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153614870|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
153614871|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
153614872|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614873|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614874|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614875|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153614876|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153614877|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614878|NCT01971281|Paclitaxel|paclitaxel|mesh-list
153614894|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
153614895|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614896|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153614897|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153614898|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
153614899|NCT01971424|Antacids|antacids|mesh-ancestor
153614916|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153614917|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153614918|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153614919|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153614920|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
153614921|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614922|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153614923|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153614924|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614926|NCT01971632|Naloxone|naloxone|mesh-list
153614927|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153614929|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614930|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614931|NCT01971632|Analgesics|analgesics|mesh-ancestor
153614932|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
153614933|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614934|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153614935|NCT01971658|Thalidomide|thalidomide|mesh-list
154263416|NCT05608564|Tazobactam|tazobactam|mesh-list
153614936|NCT01971658|Dexamethasone|dexamethasone|mesh-list
153614937|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
153614938|NCT01971658|Bortezomib|bortezomib|mesh-list
153614939|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153614940|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
153614941|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614942|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614943|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153614944|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
153614945|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614946|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614947|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153614948|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614949|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
153614950|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
153614951|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614952|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153614953|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
153614954|NCT01971658|Hormones|hormones|mesh-ancestor
153614955|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614956|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153614975|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614976|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614977|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
153615004|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153615005|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153615006|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615008|NCT01972113|Coagulants|coagulants|mesh-ancestor
153615009|NCT01972230|Remifentanil|remifentanil|mesh-list
153615010|NCT01972230|Sevoflurane|sevoflurane|mesh-list
153615012|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153615013|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153615014|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
153615015|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
153615016|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615060|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
153615061|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
153615062|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615063|NCT01972620|Bupivacaine|bupivacaine|mesh-list
153615064|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
153615065|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
153615066|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615067|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615068|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
153615069|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615070|NCT01972711|Amisulpride|amisulpride|mesh-list
153615071|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153615072|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153615103|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615104|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615105|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153615106|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153615107|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615108|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615109|NCT01972984|Anastrozole|anastrozole|mesh-list
153615110|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615128|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153615129|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153615130|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615131|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615159|NCT01973400|Tocotrienols|tocotrienols|mesh-list
153615160|NCT01973400|Vitamin E|vitamin e|mesh-list
153615161|NCT01973400|Tocopherols|tocopherols|mesh-list
153615162|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
153615163|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615164|NCT01973400|Protective Agents|protective agents|mesh-ancestor
153615165|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615166|NCT01973400|Vitamins|vitamins|mesh-ancestor
153615167|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
153615194|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153615197|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
153615198|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615199|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615200|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615201|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153615202|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153615203|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153615204|NCT01973660|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153615256|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
153615257|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615258|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
153615259|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615261|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153615262|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615263|NCT01973920|Insulin|insulin|mesh-list
153615286|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
153615287|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615288|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615289|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153615290|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
153615291|NCT01974024|Hormones|hormones|mesh-ancestor
153615292|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615293|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153615294|NCT01974024|Protective Agents|protective agents|mesh-ancestor
153615295|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615296|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615297|NCT01974037|Capsaicin|capsaicin|mesh-list
153615298|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
153615299|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
153615300|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
153615301|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343087|NCT00002806|Vincristine|vincristine|mesh-list
153615302|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615349|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615350|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153615351|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153615352|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
153615353|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615354|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615355|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153615356|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153615357|NCT01974622|Verteporfin|verteporfin|mesh-list
153615358|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153615359|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
153615360|NCT01974648|Remifentanil|remifentanil|mesh-list
153615361|NCT01974648|Propofol|propofol|mesh-list
153615362|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153615363|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615364|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615365|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153615366|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
153615367|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
153615377|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615379|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
153615380|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615381|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153615382|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153615383|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153615384|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615406|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
153615407|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153615408|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615409|NCT01975142|Trastuzumab|trastuzumab|mesh-list
153615410|NCT01975142|Maytansine|maytansine|mesh-list
153615411|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153615412|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615413|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153615414|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
153615415|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
153615416|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
153615417|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615418|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153615419|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153615420|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153615422|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615423|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153615424|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153615425|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615426|NCT01975259|Glucagon|glucagon|mesh-list
153615427|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
153615428|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153615429|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153615430|NCT01975259|Hormones|hormones|mesh-ancestor
153615431|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615466|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153615467|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615468|NCT01975454|Capecitabine|capecitabine|mesh-list
153615469|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
153615470|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153615471|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
153615472|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615473|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615474|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153615475|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153615476|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153615477|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615478|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615479|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615480|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615481|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
153615482|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615483|NCT01975662|Vancomycin|vancomycin|mesh-list
153615484|NCT01975662|Daptomycin|daptomycin|mesh-list
153615485|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153615486|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615487|NCT01975688|Nabiximols|nabiximols|mesh-list
153615488|NCT01975688|Analgesics|analgesics|mesh-ancestor
153615489|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
153615490|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615491|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615492|NCT01975714|Bimatoprost|bimatoprost|mesh-list
153615493|NCT01975714|Latanoprost|latanoprost|mesh-list
153615494|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153615495|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153615496|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153615525|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
153615527|NCT01975779|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
153615528|NCT01975779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153615529|NCT01975779|Serotonin Agents|serotonin agents|mesh-ancestor
153615530|NCT01975779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615531|NCT01975779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615532|NCT01975779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615534|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153615535|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
153615536|NCT01975805|Povidone|povidone|mesh-list
153615537|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153615538|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615539|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
153615540|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
153615541|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
153615542|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
153615543|NCT01975961|Telmisartan|telmisartan|mesh-list
153615544|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153615545|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153615546|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153615547|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
153615548|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615549|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153615550|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153615551|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615552|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693208|NCT00222547|Vitamin A|vitamin a|mesh-list
153745650|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153615553|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153615554|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153615609|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153615610|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153615611|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
153615612|NCT01976520|Vaccines|vaccines|mesh-list
153615613|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
153615614|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615615|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
153615616|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153615617|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153615618|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153615726|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615727|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153615729|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615730|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153615731|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853763|NCT02939573|Dapsone|dapsone|mesh-list
153615732|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615733|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615734|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153615735|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153615736|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153615737|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
153615783|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615784|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
153615785|NCT01978405|Vitamins|vitamins|mesh-ancestor
153615786|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
153615787|NCT01978418|Albuterol|albuterol|mesh-list
153615788|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153615789|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
153615790|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615821|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153343610|NCT00003250|Fenretinide|fenretinide|mesh-list
153615823|NCT01978483|Denosumab|denosumab|mesh-list
153615847|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
153615848|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
153615849|NCT01978678|Hormones|hormones|mesh-ancestor
153615850|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615851|NCT01978704|Insulin|insulin|mesh-list
153615852|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153615853|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153615854|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615897|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153615898|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
153615899|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153615900|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153615901|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615902|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615903|NCT01979354|Morphine|morphine|mesh-list
153615904|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153615905|NCT01979354|Narcotics|narcotics|mesh-ancestor
153615906|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615907|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615908|NCT01979354|Analgesics|analgesics|mesh-ancestor
153615909|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
153615910|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615912|NCT01979510|Etoricoxib|etoricoxib|mesh-list
153615913|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153615914|NCT01979510|Analgesics|analgesics|mesh-ancestor
153615915|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
153615916|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615917|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615918|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
153615919|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153615920|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615921|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153615922|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153703528|NCT00078572|Lapatinib|lapatinib|mesh-list
153615930|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615931|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153615933|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
153615934|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615935|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153615936|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153615937|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153615938|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
153615939|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615940|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615961|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615962|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153615963|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153615964|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
153615965|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153615966|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153615967|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
153615969|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153615970|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153343755|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
153615971|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615973|NCT01980004|Diuretics|diuretics|mesh-ancestor
153615974|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
153615975|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615976|NCT01980004|Expectorants|expectorants|mesh-ancestor
153615977|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
153615978|NCT01980069|Neostigmine|neostigmine|mesh-list
153615979|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153615980|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615981|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615982|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
153615983|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781754|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615984|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615985|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153615986|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
153615987|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616008|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
153616009|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153616010|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
153616011|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616012|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153616013|NCT01980329|Maraviroc|maraviroc|mesh-list
153616072|NCT06329258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153616074|NCT06329258|Hormones|hormones|mesh-ancestor
153616075|NCT06329258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153616076|NCT06329258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616077|NCT06329258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153703582|NCT00078689|Daclizumab|daclizumab|mesh-list
153616078|NCT06329258|Respiratory System Agents|respiratory system agents|mesh-ancestor
153616079|NCT06329258|Dermatologic Agents|dermatologic agents|mesh-ancestor
153616080|NCT06329258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153616081|NCT06329258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616082|NCT06329258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616083|NCT06329076|Losartan|losartan|mesh-list
153616084|NCT06329076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153616085|NCT06329076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153616086|NCT06329076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153616087|NCT06329076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153616088|NCT06329076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616089|NCT06329063|Vasopressins|vasopressins|mesh-list
153616090|NCT06329063|Arginine Vasopressin|arginine vasopressin|mesh-list
153616091|NCT06329063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616092|NCT06329063|Hemostatics|hemostatics|mesh-ancestor
153616093|NCT06329063|Coagulants|coagulants|mesh-ancestor
153616165|NCT06328543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616166|NCT06328543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616167|NCT06328543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616168|NCT06328530|Histamine|histamine|mesh-list
153616169|NCT06328530|Histamine Agonists|histamine agonists|mesh-ancestor
153616170|NCT06328530|Histamine Agents|histamine agents|mesh-ancestor
153616171|NCT06328530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616172|NCT06328530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616215|NCT06328179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153616217|NCT06328179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153616219|NCT06328179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616220|NCT06328179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616221|NCT06328179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153616222|NCT06328179|Antimetabolites|antimetabolites|mesh-ancestor
153616223|NCT06328179|Antiviral Agents|antiviral agents|mesh-ancestor
153616224|NCT06328179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153616225|NCT06328179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153616226|NCT06328179|Immunologic Factors|immunologic factors|mesh-ancestor
153616227|NCT06328179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616228|NCT06328153|Celecoxib|celecoxib|mesh-list
153616229|NCT06328153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153616277|NCT06328036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616278|NCT06328036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616279|NCT06328036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616280|NCT06328036|Immunologic Factors|immunologic factors|mesh-ancestor
153703630|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
153616281|NCT06328036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616282|NCT06327932|Gemcitabine|gemcitabine|mesh-list
153616283|NCT06327932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153616284|NCT06327932|Antimetabolites|antimetabolites|mesh-ancestor
153616285|NCT06327932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616286|NCT06327932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616287|NCT06327815|Metformin|metformin|mesh-list
153616288|NCT06327815|Dapagliflozin|dapagliflozin|mesh-list
153616337|NCT06327399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616338|NCT06327399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153616339|NCT06327399|Analgesics|analgesics|mesh-ancestor
153616340|NCT06327399|Sensory System Agents|sensory system agents|mesh-ancestor
153616341|NCT06327399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616342|NCT06327399|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153616343|NCT06327399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153616344|NCT06327399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153616345|NCT06327399|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616346|NCT06327399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616347|NCT06327399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616348|NCT06327399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153616349|NCT06327399|Anesthetics, General|anesthetics, general|mesh-ancestor
153616350|NCT06327399|Anesthetics|anesthetics|mesh-ancestor
153616351|NCT06327399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153616352|NCT06327399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153616353|NCT06327399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153616354|NCT06327399|Autonomic Agents|autonomic agents|mesh-ancestor
153616355|NCT06327399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153616421|NCT06326983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616422|NCT06326983|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153616423|NCT06326983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153616424|NCT06326983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153616425|NCT06326983|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616426|NCT06326983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616427|NCT06326983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616428|NCT06326983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153616430|NCT06326983|Antipyretics|antipyretics|mesh-ancestor
153616431|NCT06326983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153616432|NCT06326983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153616433|NCT06326983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781755|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616434|NCT06326983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153616435|NCT06326983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616450|NCT06321562|Timolol|timolol|mesh-list
153616451|NCT06321562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153616452|NCT06321562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153616453|NCT06321562|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616454|NCT06321562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616455|NCT06321562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616456|NCT06321562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616457|NCT06321562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153616458|NCT06321562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153616491|NCT06309368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153616492|NCT06309368|Disinfectants|disinfectants|mesh-ancestor
153616493|NCT06309368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153616494|NCT06306300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153344278|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
153616495|NCT06306300|Sofosbuvir|sofosbuvir|mesh-list
153703741|NCT00119301|Vitamins|vitamins|mesh-ancestor
153616513|NCT06301737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153616514|NCT06301737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153616515|NCT06301737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616529|NCT06280196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153616530|NCT06280196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616531|NCT06280196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616532|NCT06280196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153616533|NCT06280196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153616534|NCT06274021|Tizanidine|tizanidine|mesh-list
153616535|NCT06274021|Baclofen|baclofen|mesh-list
153616536|NCT06274021|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153616537|NCT06274021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616538|NCT06274021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153616539|NCT06274021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616540|NCT06274021|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153616541|NCT06274021|GABA Agonists|gaba agonists|mesh-ancestor
153616542|NCT06274021|GABA Agents|gaba agents|mesh-ancestor
153616543|NCT06274021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616544|NCT06274021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616545|NCT06274021|Analgesics|analgesics|mesh-ancestor
153616546|NCT06274021|Sensory System Agents|sensory system agents|mesh-ancestor
153616547|NCT06274021|Anticonvulsants|anticonvulsants|mesh-ancestor
153616548|NCT06274021|Parasympatholytics|parasympatholytics|mesh-ancestor
153616549|NCT06274021|Autonomic Agents|autonomic agents|mesh-ancestor
153616550|NCT06274021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153616551|NCT06274021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153616552|NCT06274021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153616553|NCT06274021|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616554|NCT06269484|Dapagliflozin|dapagliflozin|mesh-list
153616555|NCT06269484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153616556|NCT06269484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616557|NCT06269484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153616558|NCT06269484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616559|NCT06265584|Methotrexate|methotrexate|mesh-list
153616560|NCT06265584|Tacrolimus|tacrolimus|mesh-list
153616561|NCT06265584|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153616562|NCT06265584|Abortifacient Agents|abortifacient agents|mesh-ancestor
153616563|NCT06265584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153616564|NCT06265584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616629|NCT06222593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153616630|NCT06222593|Growth Substances|growth substances|mesh-ancestor
153616631|NCT06222593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616632|NCT06222593|Growth Inhibitors|growth inhibitors|mesh-ancestor
153616633|NCT06222593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153616634|NCT06222593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745651|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616635|NCT06222593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616636|NCT06222593|Androgen Antagonists|androgen antagonists|mesh-ancestor
153616637|NCT06222593|Hormone Antagonists|hormone antagonists|mesh-ancestor
153616638|NCT06222593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153616639|NCT06212583|Abiraterone Acetate|abiraterone acetate|mesh-list
153616640|NCT06212583|Niraparib|niraparib|mesh-list
153616641|NCT06212583|Androgens|androgens|mesh-list
153616642|NCT06212583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616643|NCT06212583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153616644|NCT06212583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616645|NCT06212583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616646|NCT06212583|Hormone Antagonists|hormone antagonists|mesh-ancestor
153616647|NCT06212583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153616648|NCT06212583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616649|NCT06212583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153616650|NCT06212583|Hormones|hormones|mesh-ancestor
153616651|NCT06212583|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153616652|NCT06206733|Capecitabine|capecitabine|mesh-list
153616653|NCT06206733|Oxaliplatin|oxaliplatin|mesh-list
153616654|NCT06206733|Tislelizumab|tislelizumab|mesh-list
153616655|NCT06206733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153616656|NCT06206733|Antimetabolites|antimetabolites|mesh-ancestor
153616657|NCT06206733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616658|NCT06206733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616659|NCT06206733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616753|NCT06146972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616777|NCT06144177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616798|NCT06107205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153616799|NCT06107205|Antioxidants|antioxidants|mesh-ancestor
153616800|NCT06107205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616801|NCT06107205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153616802|NCT06107205|Protective Agents|protective agents|mesh-ancestor
153616803|NCT06107205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616804|NCT06106308|Bevacizumab|bevacizumab|mesh-list
153781757|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616805|NCT06106308|Onvansertib|onvansertib|mesh-list
153616806|NCT06106308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616807|NCT06106308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616808|NCT06106308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153616809|NCT06106308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153616810|NCT06106308|Growth Substances|growth substances|mesh-ancestor
153616811|NCT06106308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616812|NCT06106308|Growth Inhibitors|growth inhibitors|mesh-ancestor
153616813|NCT06106308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153616814|NCT06106308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616815|NCT06106308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616816|NCT06104280|Melatonin|melatonin|mesh-list
153616817|NCT06104280|Antioxidants|antioxidants|mesh-ancestor
153616818|NCT06104280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616916|NCT06044935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153616917|NCT06044935|Vasodilator Agents|vasodilator agents|mesh-ancestor
153616935|NCT06039826|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153616936|NCT06039826|Estradiol|estradiol|mesh-list
153616937|NCT06039826|Estrogens|estrogens|mesh-ancestor
153616938|NCT06039826|Hormones|hormones|mesh-ancestor
153616972|NCT06013241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153616973|NCT06013241|Dermatologic Agents|dermatologic agents|mesh-ancestor
153617106|NCT05789173|Efavirenz|efavirenz|mesh-list
153617107|NCT05789173|Clonidine|clonidine|mesh-list
153617108|NCT05789173|Methadone|methadone|mesh-list
153617109|NCT05789173|Tizanidine|tizanidine|mesh-list
153617110|NCT05789173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153617111|NCT05789173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153617112|NCT05789173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617113|NCT05789173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617115|NCT05789173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617116|NCT05789173|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153617117|NCT05789173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153617118|NCT05789173|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153617119|NCT05789173|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153617120|NCT05789173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153617121|NCT05789173|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153617122|NCT05789173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153617182|NCT05761327|Analgesics|analgesics|mesh-ancestor
153617183|NCT05761327|Sensory System Agents|sensory system agents|mesh-ancestor
153617184|NCT05761327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617185|NCT05761327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617186|NCT05761327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153617187|NCT05761327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153617188|NCT05761327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617247|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617249|NCT05673200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617250|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153617251|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
153617252|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617254|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617255|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617256|NCT05662527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617257|NCT05662527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617258|NCT05659537|Dulaglutide|dulaglutide|mesh-list
153617259|NCT05659537|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153617260|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153617261|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617274|NCT05649748|Treprostinil|treprostinil|mesh-list
153617275|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153617276|NCT05649137|Semaglutide|semaglutide|mesh-list
153617277|NCT05649137|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153617279|NCT05649137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617295|NCT05609630|Upadacitinib|upadacitinib|mesh-list
153617296|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153617297|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617298|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617299|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617300|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153617301|NCT05589181|Buprenorphine|buprenorphine|mesh-list
153617302|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153617303|NCT05589181|Narcotics|narcotics|mesh-ancestor
153617403|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153617404|NCT05471544|Amodiaquine|amodiaquine|mesh-list
153617405|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
153617406|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153617407|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153617408|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617409|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153617410|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617411|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617412|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153617413|NCT05455658|Vaccines|vaccines|mesh-list
153617414|NCT05455658|Sargramostim|sargramostim|mesh-list
153617535|NCT05171387|Hormones|hormones|mesh-ancestor
153617548|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617551|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617552|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153617553|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617554|NCT05139316|Prednisolone|prednisolone|mesh-list
153617555|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153617556|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
153617558|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153617559|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617560|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153617621|NCT05036278|Coagulants|coagulants|mesh-ancestor
153345436|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
153617622|NCT05031780|Mitapivat|mitapivat|mesh-list
153617644|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
153617684|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
153617709|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617710|NCT04879849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617711|NCT04879849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617712|NCT04853797|Cromakalim|cromakalim|mesh-list
153617713|NCT04853797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153617714|NCT04853797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153617715|NCT04853797|Autonomic Agents|autonomic agents|mesh-ancestor
153617716|NCT04853797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617717|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617718|NCT04853797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153617719|NCT04853797|Respiratory System Agents|respiratory system agents|mesh-ancestor
153617720|NCT04853797|Parasympatholytics|parasympatholytics|mesh-ancestor
153617721|NCT04853797|Vasodilator Agents|vasodilator agents|mesh-ancestor
153617722|NCT04762160|Rituximab|rituximab|mesh-list
153617723|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617752|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
153617753|NCT04716634|Tislelizumab|tislelizumab|mesh-list
153617754|NCT04716634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617755|NCT04716634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617756|NCT04707209|Sirolimus|sirolimus|mesh-list
153345583|NCT00005032|Paclitaxel|paclitaxel|mesh-list
153617778|NCT04702737|AMG 757|amg 757|mesh-list
153617779|NCT04702737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617780|NCT04645966|Acetaminophen|acetaminophen|mesh-list
153617781|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153617782|NCT04645966|Analgesics|analgesics|mesh-ancestor
153617783|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
153704137|NCT00299611|Sertraline|sertraline|mesh-list
153617784|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617785|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617786|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
153617787|NCT04626596|Etonogestrel|etonogestrel|mesh-list
153617788|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153617789|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
153617790|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153617835|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617836|NCT04547153|Docetaxel|docetaxel|mesh-list
153617837|NCT04547153|Fluorouracil|fluorouracil|mesh-list
153617844|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153617845|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153617868|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
153617869|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617870|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617871|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617872|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153617873|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
153617874|NCT04448886|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153617875|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617876|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617877|NCT04448886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617878|NCT04448886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617879|NCT04448886|Immunoconjugates|immunoconjugates|mesh-ancestor
153617880|NCT04448886|Immunologic Factors|immunologic factors|mesh-ancestor
153617881|NCT04448886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617882|NCT04396873|11C-PS13|11c-ps13|mesh-list
153617883|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153617884|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617899|NCT04351555|Carboplatin|carboplatin|mesh-list
153617900|NCT04351555|Pemetrexed|pemetrexed|mesh-list
153617901|NCT04351555|Osimertinib|osimertinib|mesh-list
153617902|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617903|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617904|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617905|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153617906|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153617907|NCT04351555|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153617908|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617914|NCT04313608|Gemcitabine|gemcitabine|mesh-list
153617915|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
153617916|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
153618020|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618041|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153618042|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618043|NCT04157348|Benralizumab|benralizumab|mesh-list
153618044|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153618045|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
153618046|NCT04150029|Azacitidine|azacitidine|mesh-list
153618047|NCT04150029|Venetoclax|venetoclax|mesh-list
153618048|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618049|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
153618050|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618051|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618052|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618053|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
153618054|NCT04106219|Topotecan|topotecan|mesh-list
153618055|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618056|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
153618057|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618058|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618059|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153618060|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
153704220|NCT00299923|Analgesics|analgesics|mesh-ancestor
153618061|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618062|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618063|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153618064|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153618065|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153618066|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618128|NCT03876769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618129|NCT03816332|Prednisone|prednisone|mesh-list
153618130|NCT03816332|Cortisone|cortisone|mesh-list
153618131|NCT03816332|Nivolumab|nivolumab|mesh-list
153618132|NCT03816332|Ipilimumab|ipilimumab|mesh-list
153618133|NCT03816332|Tacrolimus|tacrolimus|mesh-list
153618134|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153618135|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
153618146|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153618147|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618148|NCT03811002|Cisplatin|cisplatin|mesh-list
153618149|NCT03811002|Carboplatin|carboplatin|mesh-list
153618150|NCT03811002|Etoposide|etoposide|mesh-list
153694040|NCT00226447|Interferons|interferons|mesh-list
153618151|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
153618152|NCT03811002|Atezolizumab|atezolizumab|mesh-list
153618186|NCT03779854|Fludarabine|fludarabine|mesh-list
153618187|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
153618188|NCT03779854|Tacrolimus|tacrolimus|mesh-list
153618189|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618190|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
153618191|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618192|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618193|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153618194|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
153618195|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618196|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618197|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153618198|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153618199|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
153618200|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153618201|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618202|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
153618203|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
153618287|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
153618289|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153618290|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
153618291|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618298|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
153618299|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618300|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618301|NCT03602586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618302|NCT03602586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618303|NCT03580356|Omalizumab|omalizumab|mesh-list
153346096|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
153618304|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153618305|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153618306|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
153618352|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
153618353|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618354|NCT03401320|Letrozole|letrozole|mesh-list
153488185|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
153618355|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618356|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153853965|NCT01186328|Hormones|hormones|mesh-ancestor
153394211|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618377|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153618379|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153618380|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153618381|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153618382|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618384|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
153618385|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618386|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618387|NCT03304639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618388|NCT03304639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618389|NCT03283878|Cefazolin|cefazolin|mesh-list
153618390|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153618391|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618392|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
153618393|NCT03277729|Fludarabine|fludarabine|mesh-list
153618394|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
153618395|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618396|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
153618397|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618398|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618399|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153618400|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
153618401|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618402|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618403|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153618404|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618405|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
153618456|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153618457|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
153618458|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618459|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618526|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
153618527|NCT02891603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153618528|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
153618530|NCT02828358|Folic Acid|folic acid|mesh-list
153618532|NCT02828358|Dexamethasone|dexamethasone|mesh-list
153618533|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
153618534|NCT02828358|Prednisolone|prednisolone|mesh-list
153618535|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153618536|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
153618537|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153618538|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
153618539|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
153618551|NCT02828358|Pegaspargase|pegaspargase|mesh-list
153618552|NCT02828358|Thioguanine|thioguanine|mesh-list
153618553|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153618554|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
153618555|NCT02828358|BB 1101|bb 1101|mesh-list
153618556|NCT02828358|Calcium|calcium|mesh-list
153618586|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
153618587|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153618588|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153618590|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618591|NCT02828358|Antidotes|antidotes|mesh-ancestor
153618592|NCT02828358|Protective Agents|protective agents|mesh-ancestor
153618593|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
153618594|NCT02828358|Vitamins|vitamins|mesh-ancestor
153618595|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
153618596|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153618597|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618598|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
153618599|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
153618655|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153618656|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618657|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618658|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618706|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
153618707|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618708|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618709|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153618710|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153618711|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153618712|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153618752|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618753|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618805|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153618806|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153618807|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153618808|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618809|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618810|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618811|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
153618812|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
153618813|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618814|NCT01046825|Antidotes|antidotes|mesh-ancestor
153618815|NCT01046825|Protective Agents|protective agents|mesh-ancestor
153618816|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
153618817|NCT01046825|Vitamins|vitamins|mesh-ancestor
153618818|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
153618819|NCT01046825|Hematinics|hematinics|mesh-ancestor
153618820|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
153618821|NCT00501826|Cytarabine|cytarabine|mesh-list
153618822|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
153618823|NCT00501826|Dexamethasone|dexamethasone|mesh-list
153618824|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
153618825|NCT00501826|Prednisone|prednisone|mesh-list
153618826|NCT00501826|Cortisone|cortisone|mesh-list
153618827|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
153618828|NCT00501826|Doxorubicin|doxorubicin|mesh-list
153618829|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153618830|NCT00501826|Methotrexate|methotrexate|mesh-list
153618831|NCT00501826|Vincristine|vincristine|mesh-list
153618832|NCT00501826|Venetoclax|venetoclax|mesh-list
153618833|NCT00501826|Asparaginase|asparaginase|mesh-list
153618834|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
153618835|NCT00501826|Pegaspargase|pegaspargase|mesh-list
153618836|NCT00501826|BB 1101|bb 1101|mesh-list
153618837|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153489231|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
153489232|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489233|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489234|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489235|NCT05722548|Indomethacin|indomethacin|mesh-list
153489236|NCT05722548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153489237|NCT05722548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153427542|NCT00000452|Naltrexone|naltrexone|mesh-list
153489238|NCT05722548|Analgesics|analgesics|mesh-ancestor
153489239|NCT05722548|Sensory System Agents|sensory system agents|mesh-ancestor
153489240|NCT05722548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489241|NCT05722548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489242|NCT05722548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489243|NCT05722548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153489244|NCT05722548|Gout Suppressants|gout suppressants|mesh-ancestor
153489245|NCT05722548|Tocolytic Agents|tocolytic agents|mesh-ancestor
153489246|NCT05722548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153489247|NCT05722548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153489248|NCT05722548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489249|NCT05722548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489250|NCT05721456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153489277|NCT05719506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153489278|NCT05719506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489279|NCT05719506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489280|NCT05719506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153489281|NCT05719506|Analgesics|analgesics|mesh-ancestor
153489282|NCT05719506|Sensory System Agents|sensory system agents|mesh-ancestor
153489283|NCT05719506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489284|NCT05719506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153489285|NCT05719506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153489286|NCT05719506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153489287|NCT05719506|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489288|NCT05719506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489289|NCT05719506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489290|NCT05719506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153489291|NCT05719506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489292|NCT05719506|Anesthetics, General|anesthetics, general|mesh-ancestor
153489293|NCT05719506|Anesthetics|anesthetics|mesh-ancestor
153489294|NCT05719506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153489295|NCT05719506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153489296|NCT05716932|Ranibizumab|ranibizumab|mesh-list
153489297|NCT05716932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153489298|NCT05716932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153489299|NCT05716932|Growth Substances|growth substances|mesh-ancestor
153489300|NCT05716932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489301|NCT05716932|Growth Inhibitors|growth inhibitors|mesh-ancestor
153489331|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153489332|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489333|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489334|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489335|NCT05557812|Eugenol|eugenol|mesh-list
153489336|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
153489337|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
153489338|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
153489339|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
153489340|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153489341|NCT05557812|Protective Agents|protective agents|mesh-ancestor
153489342|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489343|NCT05557812|Hematinics|hematinics|mesh-ancestor
153489344|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489345|NCT05549466|Gemcitabine|gemcitabine|mesh-list
153489346|NCT05549466|Capecitabine|capecitabine|mesh-list
153489347|NCT05549466|Docetaxel|docetaxel|mesh-list
153489348|NCT05549466|Apatinib|apatinib|mesh-list
153489365|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489366|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489367|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153489368|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153489369|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153489370|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432257|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
153489371|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489372|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153489373|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489374|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153489375|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153489376|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489377|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153489378|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153489379|NCT05352282|Fentanyl|fentanyl|mesh-list
153489380|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153489382|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489383|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489384|NCT05352282|Analgesics|analgesics|mesh-ancestor
153489385|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
153489386|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489387|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153489388|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489389|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
153489390|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
153489392|NCT05322330|Fludarabine|fludarabine|mesh-list
153489393|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153489394|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
153489395|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489396|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153489397|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153489398|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
153489399|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489400|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489401|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153489402|NCT05251038|Leucovorin|leucovorin|mesh-list
153489403|NCT05251038|Paclitaxel|paclitaxel|mesh-list
153489404|NCT05251038|Gemcitabine|gemcitabine|mesh-list
153489405|NCT05251038|Fluorouracil|fluorouracil|mesh-list
153489406|NCT05251038|Irinotecan|irinotecan|mesh-list
153489407|NCT05251038|Sotorasib|sotorasib|mesh-list
153489408|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153489409|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489410|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
153489411|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489430|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
153489431|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
153489432|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489433|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489434|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489435|NCT05027646|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153489436|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153489437|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
153489438|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489439|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489440|NCT04988646|Acyclovir|acyclovir|mesh-list
153489441|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
153489442|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781829|NCT00231998|Analgesics|analgesics|mesh-ancestor
153489443|NCT04876638|Minocycline|minocycline|mesh-list
153489444|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153489445|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432336|NCT05039619|Prednisone|prednisone|mesh-list
153489446|NCT04754334|Insulin|insulin|mesh-list
153489447|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153489448|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489449|NCT04748796|Landiolol|landiolol|mesh-list
153489450|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153489451|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153489452|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489453|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489454|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489455|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489456|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153489457|NCT04599816|Simendan|simendan|mesh-list
153489458|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153489459|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
153489460|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153489461|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153489462|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489463|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489464|NCT04599816|Protective Agents|protective agents|mesh-ancestor
153489465|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489466|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153489467|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489468|NCT04509414|Midazolam|midazolam|mesh-list
153489469|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
153489470|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153489471|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489472|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489473|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153489474|NCT04509414|Analgesics|analgesics|mesh-ancestor
153708237|NCT05925023|Sirolimus|sirolimus|mesh-list
153489475|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
153489476|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489477|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153489516|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
153489517|NCT04307550|Ethanol|ethanol|mesh-list
153489518|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153489519|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781830|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
153489520|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489521|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489522|NCT04095858|Methotrexate|methotrexate|mesh-list
153489523|NCT04095858|Tacrolimus|tacrolimus|mesh-list
153489524|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153489525|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
153489526|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153489527|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489528|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153489529|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
153489530|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489531|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489532|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
153489550|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153489551|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153489552|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489558|NCT03813030|Lidocaine|lidocaine|mesh-list
153489559|NCT03813030|Prilocaine|prilocaine|mesh-list
153489560|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489562|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489563|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489564|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
153489565|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489566|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153489567|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153489568|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153489569|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153489570|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489571|NCT03653052|Durvalumab|durvalumab|mesh-list
153489572|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489573|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489574|NCT03640728|Tenofovir|tenofovir|mesh-list
153489575|NCT03640728|Entecavir|entecavir|mesh-list
153489576|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
153489577|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489578|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153489579|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153489580|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489581|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489582|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153489583|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153489584|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153489585|NCT03393780|Hormones|hormones|mesh-ancestor
153489586|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153489587|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489588|NCT03202758|Durvalumab|durvalumab|mesh-list
153489589|NCT03202758|Tremelimumab|tremelimumab|mesh-list
153489599|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153489601|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489602|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153489603|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153489604|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153489605|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153489606|NCT03042546|Calcium|calcium|mesh-list
153489607|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153489608|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489609|NCT02420652|Aspirin|aspirin|mesh-list
153489610|NCT02420652|Metformin|metformin|mesh-list
153489611|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153489612|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489613|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153489614|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153489615|NCT02420652|Analgesics|analgesics|mesh-ancestor
153489617|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489618|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489625|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489626|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
153489627|NCT02257242|Rituximab|rituximab|mesh-list
153489628|NCT02257242|Vincristine|vincristine|mesh-list
153489629|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153489630|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489631|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489632|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
153489633|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489634|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153489635|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153489636|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
153489637|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489638|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489639|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489640|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153489641|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
153489642|NCT02034630|Busulfan|busulfan|mesh-list
153489643|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
153489644|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489645|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153489646|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
153489647|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489648|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153489649|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489650|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153489651|NCT02025036|Capecitabine|capecitabine|mesh-list
153489652|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
153489670|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153489671|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153489672|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
153854033|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
153489673|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489674|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489675|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153489676|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489677|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153489678|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
153489679|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153489680|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153489681|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
153489682|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
153489683|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489684|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153489685|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153489692|NCT00281658|Lapatinib|lapatinib|mesh-list
153489693|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153489694|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489695|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
153489696|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489697|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489698|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489699|NCT00281658|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153489700|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153489701|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489702|NCT02417844|Tamsulosin|tamsulosin|mesh-list
153489703|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153489704|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153489705|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153489706|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489707|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489708|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489709|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489710|NCT02417844|Urological Agents|urological agents|mesh-ancestor
153489711|NCT02418312|Famotidine|famotidine|mesh-list
153489712|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
153489713|NCT02418312|Histamine|histamine|mesh-list
153489714|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153489715|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489724|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489725|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154255963|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153736023|NCT03865940|Lidocaine|lidocaine|mesh-list
153489726|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489727|NCT02422290|Ketamine|ketamine|mesh-list
153489728|NCT02422290|Analgesics|analgesics|mesh-ancestor
153489729|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
153489730|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489731|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489732|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153489733|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489734|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
153489735|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
153489736|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489737|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153489738|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153489739|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489740|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489742|NCT02430090|Sufentanil|sufentanil|mesh-list
153489743|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
153489744|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153489745|NCT02430090|Narcotics|narcotics|mesh-ancestor
153489746|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489747|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489748|NCT02430090|Analgesics|analgesics|mesh-ancestor
153489749|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
153489750|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489751|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153489752|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489753|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
153489754|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
153489755|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489766|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153489767|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489768|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
153489769|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489770|NCT02440308|Bombesin|bombesin|mesh-list
153489771|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489772|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489773|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489774|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
153489775|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153489776|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153489777|NCT02448654|Tolcapone|tolcapone|mesh-list
153489778|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153489779|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153489780|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153489781|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489782|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489783|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153489784|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153489785|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153489786|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489787|NCT02452866|Secnidazole|secnidazole|mesh-list
153489788|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153489789|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153489790|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489791|NCT02462148|Dexamethasone|dexamethasone|mesh-list
153489806|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153489808|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
153489809|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489810|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489811|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489812|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
153489813|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489814|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
153489815|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153489816|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153489817|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489818|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489819|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153489820|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153489821|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153427646|NCT00000512|L 647318|l 647318|mesh-list
153489838|NCT02464176|BB 1101|bb 1101|mesh-list
153489839|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489840|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
153489841|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
153489842|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489843|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489844|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489845|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
153489846|NCT02464176|Hormones|hormones|mesh-ancestor
153489847|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153489848|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153489849|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489850|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
153489851|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489852|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489853|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489854|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
153489855|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489856|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
153489857|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153489858|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153489859|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489860|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489861|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153489862|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153489863|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153489864|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
153489865|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
153489866|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
153489867|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153489868|NCT02468700|Dexamethasone|dexamethasone|mesh-list
153489869|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489891|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153489892|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489893|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489894|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489895|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489896|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
153489897|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153489898|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
153489899|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489900|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
153489901|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
153489902|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489903|NCT02484222|Fentanyl|fentanyl|mesh-list
153489904|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153489905|NCT02484222|Narcotics|narcotics|mesh-ancestor
153489906|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489907|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489908|NCT02484222|Analgesics|analgesics|mesh-ancestor
153489909|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
153489910|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489911|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153489912|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489913|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
153489914|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
153489915|NCT02486016|Fentanyl|fentanyl|mesh-list
153705188|NCT00303433|Memantine|memantine|mesh-list
153489916|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153489917|NCT02486016|Narcotics|narcotics|mesh-ancestor
153489918|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489919|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489920|NCT02486016|Analgesics|analgesics|mesh-ancestor
153489921|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
153489922|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489923|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153489924|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489925|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
153489935|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
153489936|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
153489937|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153489938|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153489940|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153489941|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
153489942|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
153489943|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489944|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489945|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153489946|NCT02486328|Narcotics|narcotics|mesh-ancestor
153489947|NCT02486328|Analgesics|analgesics|mesh-ancestor
153489948|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
153489949|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489950|NCT02491788|Suvorexant|suvorexant|mesh-list
153489951|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153489952|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153489953|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489954|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489955|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153489956|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489959|NCT02491944|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153489960|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153489961|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489962|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489963|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489964|NCT02492802|Posaconazole|posaconazole|mesh-list
153489965|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
153489966|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489967|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153489968|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153489969|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153489970|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153489971|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153489972|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489973|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489974|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153489975|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
153489976|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153489977|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489978|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
153489979|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489980|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489981|NCT02500602|Doxazosin|doxazosin|mesh-list
153489982|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153489983|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153489984|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153489985|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153489986|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489987|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489988|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489989|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489990|NCT02500836|Cocaine|cocaine|mesh-list
153489991|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153489992|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489993|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
153489994|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490002|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490003|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
153490004|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490005|NCT02508636|Leuprolide|leuprolide|mesh-list
153490006|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153490007|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
153490008|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153490009|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490010|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153490011|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490012|NCT02513940|Ibutilide|ibutilide|mesh-list
153490013|NCT02513940|Testosterone|testosterone|mesh-list
153490014|NCT02513940|Progesterone|progesterone|mesh-list
153490015|NCT02513940|Androgens|androgens|mesh-ancestor
153490016|NCT02513940|Hormones|hormones|mesh-ancestor
153490017|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490018|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490019|NCT02513940|Progestins|progestins|mesh-ancestor
153490020|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153490021|NCT02515890|Midazolam|midazolam|mesh-list
153490022|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
153490023|NCT02515890|Ketamine|ketamine|mesh-list
154255964|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153490024|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153490025|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490026|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490027|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153490033|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153490034|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
153490035|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490036|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490037|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153490038|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153490039|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
153490040|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
153490041|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153490042|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153490043|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153490044|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153490045|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153490046|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153490047|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
153490048|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
153490049|NCT02517996|Lidocaine|lidocaine|mesh-list
153705332|NCT00304135|Gemcitabine|gemcitabine|mesh-list
153490050|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
153490051|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
153490052|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490053|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490054|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
153490055|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490056|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153490057|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153490058|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153490059|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490060|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490061|NCT02525718|Dexamethasone|dexamethasone|mesh-list
153490062|NCT02525718|Epinephrine|epinephrine|mesh-list
153490063|NCT02525718|Bupivacaine|bupivacaine|mesh-list
153490064|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490065|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
153490066|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
153490067|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490083|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490085|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153490086|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153490087|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
153490088|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
153490089|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
153490090|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153490091|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
153490092|NCT02527512|Povidone|povidone|mesh-list
153490093|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
153490094|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
153490095|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153490096|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490097|NCT02529072|Nivolumab|nivolumab|mesh-list
153490101|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153490102|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490103|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153490104|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490105|NCT02530476|Sorafenib|sorafenib|mesh-list
153490106|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490107|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153490108|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490109|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490110|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
153490111|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153490112|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153490113|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490114|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
153490115|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
153490116|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153490118|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490119|NCT02536248|Incretins|incretins|mesh-ancestor
153490120|NCT02536248|Hormones|hormones|mesh-ancestor
153490121|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490122|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153490123|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
153490124|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490125|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490126|NCT02538042|Nicotine|nicotine|mesh-list
153490127|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153490128|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
153490129|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490152|NCT02541864|Tetracycline|tetracycline|mesh-list
153490153|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153490154|NCT02541864|Pantoprazole|pantoprazole|mesh-list
153490155|NCT02541864|Bismuth|bismuth|mesh-list
153490156|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153490157|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490158|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153490159|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153490160|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153490161|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490162|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490163|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153490164|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153490165|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153490166|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490167|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153490168|NCT02541864|Antacids|antacids|mesh-ancestor
153490169|NCT02542410|Cabergoline|cabergoline|mesh-list
153490170|NCT02542410|Norethindrone|norethindrone|mesh-list
153490171|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
153490172|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153490175|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
153490176|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153490177|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490178|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153490179|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153490180|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153490181|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153490182|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
153490183|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
153490184|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490185|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490222|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153490223|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490224|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
153490225|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
153490257|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
153490258|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490259|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153490260|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
153490261|NCT02563860|Lovastatin|lovastatin|mesh-list
153490262|NCT02563860|L 647318|l 647318|mesh-list
153490263|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
153490264|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153490265|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153490266|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
153490267|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490268|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153490269|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153490270|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490307|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490308|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153490309|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153490310|NCT02582970|Growth Substances|growth substances|mesh-ancestor
153539890|NCT01536158|Analgesics|analgesics|mesh-ancestor
153490327|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153490328|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490329|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490330|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
153490331|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490332|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490333|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153490334|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490335|NCT05248152|Acetaminophen|acetaminophen|mesh-list
153490336|NCT05248152|Ibuprofen|ibuprofen|mesh-list
153490337|NCT05248152|Pregabalin|pregabalin|mesh-list
154255965|NCT01157546|Lidocaine|lidocaine|mesh-list
154255966|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
154255967|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
153490338|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153490339|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153490340|NCT05248152|Analgesics|analgesics|mesh-ancestor
153490341|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
153490342|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490343|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490344|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490345|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153490346|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153490347|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490348|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490349|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
153490350|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153490351|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490352|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153490353|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153490354|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153490355|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490356|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153490357|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
153490358|NCT05247684|Paclitaxel|paclitaxel|mesh-list
153490359|NCT05247684|Carboplatin|carboplatin|mesh-list
153490360|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153490361|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490362|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
153490363|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
153490364|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
153490365|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490366|NCT04808466|Paclitaxel|paclitaxel|mesh-list
153490367|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153490368|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490369|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
153490370|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
153490383|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490384|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
153490385|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153490386|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490387|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153490388|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153490389|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490390|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490391|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
153490392|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153490393|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
153490395|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
153490396|NCT02108496|Protective Agents|protective agents|mesh-ancestor
153490398|NCT02056236|Levetiracetam|levetiracetam|mesh-list
153490399|NCT02056236|Valproic Acid|valproic acid|mesh-list
153490400|NCT02056236|Lorazepam|lorazepam|mesh-list
153490401|NCT02056236|Thiopental|thiopental|mesh-list
153490402|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
153490403|NCT02056236|Propofol|propofol|mesh-list
153490404|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153490405|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490406|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490407|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153490408|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
153490409|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
153490410|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153490411|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153490412|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153490413|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153490414|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
153490415|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
153490416|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490417|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490418|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
153490419|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490420|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
153490421|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
153490422|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
153490423|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490424|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490425|NCT01962246|Capecitabine|capecitabine|mesh-list
153490426|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
153490427|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153490428|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
153490429|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490430|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490431|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153490432|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
153490433|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490434|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153490435|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
153490436|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490437|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
153490455|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490456|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490457|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
153490458|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490459|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153490460|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153490461|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
153490462|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153490463|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153490464|NCT03560466|Prednisone|prednisone|mesh-list
153490465|NCT03560466|Prednisolone|prednisolone|mesh-list
153490466|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490467|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
153490468|NCT03560466|Hormones|hormones|mesh-ancestor
153490469|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490470|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490473|NCT03376698|Colchicine|colchicine|mesh-list
153490474|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
153490475|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153490476|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
153490477|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
153490478|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
153490479|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490480|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490481|NCT02595684|Tadalafil|tadalafil|mesh-list
153705880|NCT00308191|Bromides|bromides|mesh-list
153490482|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
153490483|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153490484|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153490485|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490486|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490487|NCT02595684|Urological Agents|urological agents|mesh-ancestor
153490488|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
153490489|NCT02604810|Antibodies|antibodies|mesh-list
153490490|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
153490491|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153490492|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153490493|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
153490494|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
153490495|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490496|NCT02607618|Vancomycin|vancomycin|mesh-list
153490498|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153490511|NCT05732064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490512|NCT05732064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153490513|NCT05732064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153490514|NCT05732064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153490515|NCT05732064|Adrenergic Agents|adrenergic agents|mesh-ancestor
153490516|NCT05732064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490517|NCT05732064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490518|NCT05732064|Antidepressive Agents|antidepressive agents|mesh-ancestor
153490519|NCT05732064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153490520|NCT05731752|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153490521|NCT05731752|Immunologic Factors|immunologic factors|mesh-ancestor
153490522|NCT05731752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490524|NCT05730738|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153490525|NCT05730738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490526|NCT05730738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490527|NCT05730660|Quercetin|quercetin|mesh-list
153490528|NCT05730660|Antioxidants|antioxidants|mesh-ancestor
153490529|NCT05730660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490530|NCT05730660|Protective Agents|protective agents|mesh-ancestor
153490531|NCT05730660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490533|NCT05419674|Clarithromycin|clarithromycin|mesh-list
153490534|NCT05419674|Rabeprazole|rabeprazole|mesh-list
153490536|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153490537|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490538|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153490539|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490540|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490541|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153490542|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153490543|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153490544|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490549|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153490550|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153490551|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490552|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153490553|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153490554|NCT05386524|Growth Substances|growth substances|mesh-ancestor
153490555|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490556|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
153490557|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153490558|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153490559|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153490560|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490561|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490562|NCT04965714|Nivolumab|nivolumab|mesh-list
153490563|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153490564|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490580|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
153490581|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490582|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
153490583|NCT04355130|Hematinics|hematinics|mesh-ancestor
153490584|NCT04107168|Bevacizumab|bevacizumab|mesh-list
153490585|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
153490586|NCT04107168|Nivolumab|nivolumab|mesh-list
153490587|NCT04107168|Ipilimumab|ipilimumab|mesh-list
153490588|NCT04107168|Atezolizumab|atezolizumab|mesh-list
153490589|NCT04107168|Durvalumab|durvalumab|mesh-list
153490590|NCT04107168|Tremelimumab|tremelimumab|mesh-list
153490591|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153490592|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490593|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153490594|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153490595|NCT04107168|Growth Substances|growth substances|mesh-ancestor
153490596|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490597|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
153490598|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153490599|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490600|NCT03958344|Prednisolone|prednisolone|mesh-list
153490601|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153490602|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
153490603|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153490604|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
153490605|NCT03958344|Triamcinolone|triamcinolone|mesh-list
153490606|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153490607|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
153490608|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490609|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
153490610|NCT03958344|Hormones|hormones|mesh-ancestor
153490611|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490612|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490613|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153490614|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490615|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
153490616|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
153490617|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490618|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490619|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153490620|NCT03958344|Protective Agents|protective agents|mesh-ancestor
153490622|NCT02960646|Melphalan|melphalan|mesh-list
153490623|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
153490624|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154255968|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490625|NCT02960646|Rituximab|rituximab|mesh-list
153490626|NCT02960646|Fludarabine|fludarabine|mesh-list
153490658|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153490659|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153490660|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490661|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490662|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
153490663|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490664|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153490665|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153490682|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490683|NCT02620878|Pancrelipase|pancrelipase|mesh-list
153490684|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490685|NCT02624700|Pemetrexed|pemetrexed|mesh-list
153490686|NCT02624700|Sorafenib|sorafenib|mesh-list
153490687|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490688|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490689|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490690|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153490692|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153490694|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
153490695|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490696|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153490697|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153490698|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490699|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490700|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153490701|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
153490702|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490703|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490704|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153490705|NCT02632812|Naproxen|naproxen|mesh-list
153490706|NCT02632812|Rebamipide|rebamipide|mesh-list
153490707|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153490708|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153490709|NCT02632812|Analgesics|analgesics|mesh-ancestor
153490710|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
153490711|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490712|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490713|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490714|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153490715|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
153490716|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153490717|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490718|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781833|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490719|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153490720|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490721|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
153490722|NCT02632812|Protective Agents|protective agents|mesh-ancestor
153490742|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490743|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490744|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153490745|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
153490746|NCT05585658|Hematinics|hematinics|mesh-ancestor
153490747|NCT05510856|Lacosamide|lacosamide|mesh-list
153490748|NCT05510856|Gabapentin|gabapentin|mesh-list
153490749|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153490750|NCT05510856|Analgesics|analgesics|mesh-ancestor
153490751|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
153490752|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490753|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490754|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
153490755|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153490756|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153490757|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490758|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153490759|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153490760|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154255969|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490761|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490762|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490764|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153490765|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153490766|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490767|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
153490768|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
153490769|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153490770|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153490772|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153490773|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490774|NCT05281770|Analgesics|analgesics|mesh-ancestor
153490775|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
153490790|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490791|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490793|NCT03693846|Ipilimumab|ipilimumab|mesh-list
153490794|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153490795|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490796|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153490797|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490798|NCT03529890|Nivolumab|nivolumab|mesh-list
153490799|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153490800|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490801|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153490802|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490803|NCT02649192|Vitamin D|vitamin d|mesh-list
153490804|NCT02649192|Vitamin A|vitamin a|mesh-list
153490805|NCT02649192|Vitamins|vitamins|mesh-ancestor
153490806|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
153490807|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490808|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153490809|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
153490810|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153490811|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153490812|NCT02652390|Prednisolone|prednisolone|mesh-list
153490813|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
153490814|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153490815|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
153490816|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490818|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
153490819|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394473|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490820|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490821|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490822|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
153490823|NCT02652390|Hormones|hormones|mesh-ancestor
153490824|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490825|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153490826|NCT02652390|Protective Agents|protective agents|mesh-ancestor
153490827|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153490828|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490829|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
153490830|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
153490831|NCT02653560|Citric Acid|citric acid|mesh-list
153490832|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
153490833|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
153490834|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153490836|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
153490861|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490862|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153490863|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
153490864|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153490866|NCT02655354|Promethazine|promethazine|mesh-list
153490867|NCT02655354|Prazosin|prazosin|mesh-list
153490868|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153490869|NCT02655354|Mirtazapine|mirtazapine|mesh-list
153490870|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
153490871|NCT02655354|Trazodone|trazodone|mesh-list
153490872|NCT02655354|Sertraline|sertraline|mesh-list
153490873|NCT02655354|Fluoxetine|fluoxetine|mesh-list
153490874|NCT02655354|Paroxetine|paroxetine|mesh-list
153490875|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153490876|NCT02655354|Citalopram|citalopram|mesh-list
153490877|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153490878|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153490879|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490880|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490881|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490882|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490884|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
153490903|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153490904|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
153490905|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
153490906|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153490907|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
153490908|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
153490909|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153490911|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153490913|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153490914|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
153490915|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153490916|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153490917|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153490918|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153490919|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153490920|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153490921|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153490923|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490924|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153490925|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153490926|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490927|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490928|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153490929|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
153490930|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490931|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490932|NCT02658240|Epinephrine|epinephrine|mesh-list
153490933|NCT02658240|Ropivacaine|ropivacaine|mesh-list
153490934|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
153490935|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
153490936|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490937|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490938|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
153490939|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490940|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153490960|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490962|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490964|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
153490965|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
153490966|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490967|NCT02673138|Canagliflozin|canagliflozin|mesh-list
153490968|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153490969|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490970|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153490971|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490972|NCT02673372|Ketamine|ketamine|mesh-list
153490973|NCT02673372|Morphine|morphine|mesh-list
153490974|NCT02673372|Analgesics|analgesics|mesh-ancestor
153490975|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
153490976|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490977|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490978|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153490979|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153490980|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
153490981|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
153490988|NCT02673372|Narcotics|narcotics|mesh-ancestor
153490989|NCT02682498|Bupivacaine|bupivacaine|mesh-list
153490990|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
153490991|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
153490992|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490993|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490994|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
153490995|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490997|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154255970|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
153427880|NCT00002156|Fomivirsen|fomivirsen|mesh-list
153490998|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153490999|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491000|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491001|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153491027|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153491028|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
153491029|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491030|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491031|NCT02704104|Hemostatics|hemostatics|mesh-list
153491032|NCT02704104|Coagulants|coagulants|mesh-ancestor
153491033|NCT02705352|Fluorouracil|fluorouracil|mesh-list
153491034|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
153491035|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491036|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153491037|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491038|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153491039|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
153491040|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491041|NCT02708238|Simethicone|simethicone|mesh-list
153491042|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
153491043|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491044|NCT02708238|Emollients|emollients|mesh-ancestor
153491045|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
153491046|NCT02709018|Losartan|losartan|mesh-list
153491047|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153491048|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153491049|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153491061|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491076|NCT02716818|Dexamethasone|dexamethasone|mesh-list
153491077|NCT02716818|Prednisone|prednisone|mesh-list
153491078|NCT02716818|Prednisolone|prednisolone|mesh-list
153491079|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
153491080|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153491081|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153491082|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153491083|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
153491084|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491085|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
153491086|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
153491087|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491088|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491089|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153491090|NCT02716818|Hormones|hormones|mesh-ancestor
153434002|NCT00002317|Leucovorin|leucovorin|mesh-list
153491091|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491092|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153491093|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491094|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
153491095|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153491096|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491097|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153491098|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153491099|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491100|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491101|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491102|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153491103|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153491104|NCT02726178|Ibuprofen|ibuprofen|mesh-list
153491105|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153491106|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153491107|NCT02726178|Analgesics|analgesics|mesh-ancestor
153491108|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
153491109|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491130|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491131|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153491132|NCT05444088|Bevacizumab|bevacizumab|mesh-list
153491133|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491134|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491135|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153491185|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491202|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491203|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491204|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491205|NCT05452434|Urological Agents|urological agents|mesh-ancestor
153491206|NCT05448924|Hormones|hormones|mesh-list
153491207|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491208|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491209|NCT05447364|Pregabalin|pregabalin|mesh-list
153491211|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
153491212|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491213|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491214|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
153491215|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153491216|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153491217|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491218|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153491220|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153491221|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491222|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153491223|NCT05418036|Sotalol|sotalol|mesh-list
153491224|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153491225|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153491226|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
153491227|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491228|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491229|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491230|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153491231|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
153491232|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
153491233|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491235|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153491236|NCT04522206|Narcotics|narcotics|mesh-ancestor
153491237|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491238|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491239|NCT04522206|Analgesics|analgesics|mesh-ancestor
153491240|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
153491241|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491242|NCT04505592|Tenecteplase|tenecteplase|mesh-list
153491243|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153491244|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153491245|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491282|NCT04104438|Basiliximab|basiliximab|mesh-list
153491283|NCT04104438|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153491284|NCT04104438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153491318|NCT00677586|Liver Extracts|liver extracts|mesh-list
153491319|NCT00677586|Hematinics|hematinics|mesh-ancestor
153491320|NCT05453448|Tenofovir|tenofovir|mesh-list
153491321|NCT05453448|Entecavir|entecavir|mesh-list
153491322|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
153491323|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491324|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153491325|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153491326|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491327|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491328|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153491329|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153491345|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491346|NCT04095624|Analgesics|analgesics|mesh-ancestor
153491347|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
153491348|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491349|NCT03341676|Dexamethasone|dexamethasone|mesh-list
153491350|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491351|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
153491352|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
153491353|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491354|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491355|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153491356|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
153491357|NCT03341676|Hormones|hormones|mesh-ancestor
153491358|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491359|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153491360|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491361|NCT03121716|Gemcitabine|gemcitabine|mesh-list
153491362|NCT03121716|Cisplatin|cisplatin|mesh-list
153491363|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153491381|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153491382|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153491383|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
153491384|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153491385|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153491386|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
153491387|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153491388|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153491389|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491390|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153491391|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153491392|NCT02714634|Analgesics|analgesics|mesh-ancestor
153491393|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
153491394|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491395|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491396|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153491397|NCT00553800|Bevacizumab|bevacizumab|mesh-list
153491398|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153491399|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491400|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491401|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153491402|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153491403|NCT00553800|Growth Substances|growth substances|mesh-ancestor
153491404|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491405|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
153491452|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
153491475|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491476|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491477|NCT02775240|Protective Agents|protective agents|mesh-ancestor
153491478|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491479|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
153491480|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
153491481|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153491482|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153491483|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491484|NCT02775240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153491485|NCT02775240|Narcotics|narcotics|mesh-ancestor
153491486|NCT02775240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491487|NCT02775240|Analgesics|analgesics|mesh-ancestor
153491502|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491505|NCT05348148|Phenylephrine|phenylephrine|mesh-list
153491506|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
153491507|NCT05348148|Levocetirizine|levocetirizine|mesh-list
153491508|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491509|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
153491510|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153491511|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153491512|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153491513|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
153491514|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
153491515|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491516|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491517|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491518|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153491519|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153491520|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
153491521|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
153491522|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
153491523|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811072|NCT00353340|Expectorants|expectorants|mesh-ancestor
153491569|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153491570|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491571|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
153491572|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491573|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491574|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153491599|NCT06085378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491600|NCT06085365|Fluorouracil|fluorouracil|mesh-list
153491601|NCT06085365|Antimetabolites|antimetabolites|mesh-ancestor
153491602|NCT06085365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491603|NCT06085365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153491604|NCT06085365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491606|NCT06085365|Immunologic Factors|immunologic factors|mesh-ancestor
153491607|NCT06085365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491608|NCT06085079|Ixekizumab|ixekizumab|mesh-list
153491623|NCT06084819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153491625|NCT06084819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491626|NCT06084819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491627|NCT06084819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153491628|NCT06084819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153491629|NCT06084780|Sirolimus|sirolimus|mesh-list
153491630|NCT06084780|Alemtuzumab|alemtuzumab|mesh-list
153491631|NCT06084780|Tacrolimus|tacrolimus|mesh-list
153491632|NCT06084780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153491633|NCT06084780|Immunologic Factors|immunologic factors|mesh-ancestor
153491634|NCT06084780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491635|NCT06084780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153491636|NCT06084780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491637|NCT06084780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491638|NCT06084780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153491650|NCT06084624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491652|NCT06084624|Hormones|hormones|mesh-ancestor
153491653|NCT06084624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491654|NCT06084624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491655|NCT06084624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153491656|NCT06084624|Respiratory System Agents|respiratory system agents|mesh-ancestor
153491657|NCT06084624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153491658|NCT06084624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153491659|NCT06084624|Antioxidants|antioxidants|mesh-ancestor
153491660|NCT06084624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491661|NCT06084624|Protective Agents|protective agents|mesh-ancestor
153491662|NCT06084624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491663|NCT06084507|Ritonavir|ritonavir|mesh-list
153491664|NCT06084507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153491665|NCT06084507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153491666|NCT06084507|Protease Inhibitors|protease inhibitors|mesh-ancestor
153491667|NCT06084507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491668|NCT06084507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491669|NCT06084507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153491670|NCT06084507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153491671|NCT06084507|Antiviral Agents|antiviral agents|mesh-ancestor
153491677|NCT06084156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491678|NCT06084130|Zolpidem|zolpidem|mesh-list
153491679|NCT06084130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153491680|NCT06084130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153491681|NCT06084130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491682|NCT06084130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491683|NCT06084130|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153491684|NCT06084130|GABA Agonists|gaba agonists|mesh-ancestor
153491685|NCT06084130|GABA Agents|gaba agents|mesh-ancestor
153491686|NCT06084130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491687|NCT06084130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491688|NCT06083961|Alirocumab|alirocumab|mesh-list
153491689|NCT06083961|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153491690|NCT06083961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153491691|NCT06083961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153491692|NCT06083961|Antimetabolites|antimetabolites|mesh-ancestor
153491693|NCT06083961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491694|NCT06083961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153491695|NCT06083961|Protease Inhibitors|protease inhibitors|mesh-ancestor
153491696|NCT06083961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491697|NCT06083961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153491698|NCT06083935|Metformin|metformin|mesh-list
153491699|NCT06083935|Contraceptive Agents|contraceptive agents|mesh-list
153491700|NCT06083935|Contraceptives, Oral|contraceptives, oral|mesh-list
153491701|NCT06083935|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153491702|NCT06083935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153491703|NCT06083935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491704|NCT06083935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153491705|NCT06083935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153491706|NCT06083688|Hydroxychloroquine|hydroxychloroquine|mesh-list
153706739|NCT00293839|Oxybutynin|oxybutynin|mesh-list
153491728|NCT06082817|Testosterone undecanoate|testosterone undecanoate|mesh-list
153491729|NCT06082817|Testosterone enanthate|testosterone enanthate|mesh-list
153491730|NCT06082817|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153491731|NCT06082817|Androgens|androgens|mesh-ancestor
153491733|NCT06082817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491734|NCT06082817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491735|NCT06082817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153491736|NCT06082817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491737|NCT06082817|Anabolic Agents|anabolic agents|mesh-ancestor
153491738|NCT06082232|Midazolam|midazolam|mesh-list
153491739|NCT06082232|Dexmedetomidine|dexmedetomidine|mesh-list
153491740|NCT06082232|Bupivacaine|bupivacaine|mesh-list
153491741|NCT06082232|Anesthetics, Local|anesthetics, local|mesh-ancestor
153491742|NCT06082232|Anesthetics|anesthetics|mesh-ancestor
153491743|NCT06082232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491746|NCT06082232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491747|NCT06082232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153491748|NCT06082232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153491749|NCT06082232|Analgesics|analgesics|mesh-ancestor
153491750|NCT06082232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153491751|NCT06082232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153491752|NCT06082232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153491753|NCT06082232|Adrenergic Agents|adrenergic agents|mesh-ancestor
153491754|NCT06082232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491755|NCT06082232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491756|NCT06082232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153491757|NCT06082232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153491758|NCT06082232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153491759|NCT06082232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153491760|NCT06082232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153491761|NCT06082232|Anesthetics, General|anesthetics, general|mesh-ancestor
153491762|NCT06082232|GABA Modulators|gaba modulators|mesh-ancestor
153491763|NCT06082232|GABA Agents|gaba agents|mesh-ancestor
153491764|NCT06077214|Bupivacaine|bupivacaine|mesh-list
153491791|NCT05936489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491792|NCT05936489|Miotics|miotics|mesh-ancestor
153491793|NCT05936489|Autonomic Agents|autonomic agents|mesh-ancestor
153491794|NCT05936489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491795|NCT05936489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153491796|NCT05806385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153491797|NCT05806385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491798|NCT05806385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491799|NCT05806385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491800|NCT05785065|Mycophenolic Acid|mycophenolic acid|mesh-list
153706829|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491801|NCT05785065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153491802|NCT05785065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491803|NCT05785065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153491804|NCT05785065|Antitubercular Agents|antitubercular agents|mesh-ancestor
153491805|NCT05785065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153491806|NCT05785065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491807|NCT05785065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491808|NCT05785065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491809|NCT05779020|Vaccines|vaccines|mesh-list
153491810|NCT05779020|Immunologic Factors|immunologic factors|mesh-ancestor
153491811|NCT05779020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491812|NCT05637216|Losartan|losartan|mesh-list
153491813|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153491814|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153491835|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153491836|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153491838|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
153491839|NCT05612984|Hematinics|hematinics|mesh-ancestor
153491840|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
153491841|NCT05612984|Vitamins|vitamins|mesh-ancestor
153491842|NCT05594017|Scopolamine|scopolamine|mesh-list
153491843|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153491844|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153491845|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
153491846|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
153491847|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491848|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491849|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153491850|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
153491851|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153491852|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
153491853|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491854|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491855|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153491856|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
153491857|NCT05576038|Tryptophan|tryptophan|mesh-list
153491858|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153491859|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
153491860|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153491861|NCT05529069|Venetoclax|venetoclax|mesh-list
153491862|NCT05529069|Pirtobrutinib|pirtobrutinib|mesh-list
153491863|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491864|NCT05529069|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153491865|NCT05529069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153491866|NCT05529069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491867|NCT05529069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491868|NCT05523596|Benzonidazole|benzonidazole|mesh-list
153491887|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153491888|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491889|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153491890|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491891|NCT05384821|Irinotecan|irinotecan|mesh-list
153491892|NCT05384821|Etoposide|etoposide|mesh-list
153491893|NCT05384821|Vincristine|vincristine|mesh-list
153491895|NCT05384821|Tretinoin|tretinoin|mesh-list
153491896|NCT05384821|Isotretinoin|isotretinoin|mesh-list
153491897|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153491898|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153491899|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491900|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491901|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491902|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153491903|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153491904|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
153491905|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
153491906|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
153491907|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153491908|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
153491909|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
153491910|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
153491911|NCT05199285|Nivolumab|nivolumab|mesh-list
153491912|NCT05199285|Ipilimumab|ipilimumab|mesh-list
153491913|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491914|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491915|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153491916|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491917|NCT05136976|Rituximab|rituximab|mesh-list
153491918|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491919|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491920|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
153491921|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491922|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153491926|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153491927|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491928|NCT05040282|Etonogestrel|etonogestrel|mesh-list
153491929|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153491930|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
153491943|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153491944|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491945|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
153491946|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
153491947|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
153491948|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491949|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153491950|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153491951|NCT05039801|Growth Substances|growth substances|mesh-ancestor
153491952|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491953|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
153491954|NCT05039801|Immunologic Factors|immunologic factors|mesh-ancestor
153491955|NCT05032183|Leucovorin|leucovorin|mesh-list
153491956|NCT05032183|Cytarabine|cytarabine|mesh-list
153491957|NCT05032183|Dexamethasone|dexamethasone|mesh-list
153491958|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
153491959|NCT05032183|Prednisone|prednisone|mesh-list
153491960|NCT05032183|Cortisone|cortisone|mesh-list
153491961|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
153491962|NCT05032183|Rituximab|rituximab|mesh-list
153491963|NCT05032183|Methotrexate|methotrexate|mesh-list
153491965|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
153491966|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153491967|NCT05032183|Antibodies|antibodies|mesh-list
153491968|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
153491969|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153491970|NCT05032183|Lenograstim|lenograstim|mesh-list
153491972|NCT05032183|Mesna|mesna|mesh-list
153491975|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491977|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153491978|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
153491979|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491980|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491981|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153491982|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491983|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
153491984|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
153491985|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491986|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153491987|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
153491988|NCT05032183|Hormones|hormones|mesh-ancestor
153491989|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491990|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153491991|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
153491992|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491993|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153491994|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
153491995|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153491996|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153491997|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
153491998|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
153491999|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153492000|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153492021|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492022|NCT05012943|Vaccines|vaccines|mesh-list
153492023|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
153492024|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492025|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153492026|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153492027|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153492028|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492029|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492030|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153492031|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153492032|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492033|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
153492034|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492035|NCT04992260|Vaccines|vaccines|mesh-list
153492036|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
153492037|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492038|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153492039|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153492040|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153492041|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492042|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492043|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153492050|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492052|NCT04947189|Docetaxel|docetaxel|mesh-list
153492053|NCT04947189|Seviteronel|seviteronel|mesh-list
153492054|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492055|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
153492056|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
153492057|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492058|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492059|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153492060|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
153492061|NCT04947189|Hormones|hormones|mesh-ancestor
153492062|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492063|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492064|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492096|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153492097|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
153492098|NCT04551170|Theophylline|theophylline|mesh-list
153492099|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153492100|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
154255972|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153492101|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492102|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492103|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153492104|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
153492105|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153492106|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492107|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492108|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
153492109|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153492110|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153492111|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
153492112|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492113|NCT04520503|Propofol|propofol|mesh-list
153492114|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153492115|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492116|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492117|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153492119|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
153492126|NCT04404088|Rituximab|rituximab|mesh-list
153492127|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153492128|NCT04404088|Lenalidomide|lenalidomide|mesh-list
153492129|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
153492130|NCT04404088|Antibodies|antibodies|mesh-list
153492131|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
153492132|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153492133|NCT04404088|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153492134|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
153492135|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492136|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492137|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492138|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153492139|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153492140|NCT04404088|Growth Substances|growth substances|mesh-ancestor
153492142|NCT04404088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492143|NCT04404088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781836|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492144|NCT04404088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492145|NCT04335292|Pemetrexed|pemetrexed|mesh-list
153492146|NCT04335292|Osimertinib|osimertinib|mesh-list
153492147|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492148|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492149|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492150|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153492151|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153492152|NCT04335292|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153492153|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492154|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
153492155|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492156|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492157|NCT04317534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153492158|NCT04317534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492159|NCT04260607|Ketamine|ketamine|mesh-list
153492160|NCT04260607|Analgesics|analgesics|mesh-ancestor
153492161|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
153492162|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492163|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492164|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153492165|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153492166|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
153492167|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
153492168|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492169|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153492170|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153492171|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492172|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492173|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153492174|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153492175|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153492176|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492190|NCT04172259|Paclitaxel|paclitaxel|mesh-list
153492193|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
153710299|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153492195|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153492196|NCT04172259|Trastuzumab|trastuzumab|mesh-list
153492197|NCT04172259|Epirubicin|epirubicin|mesh-list
153492198|NCT04172259|Pertuzumab|pertuzumab|mesh-list
153492199|NCT04172259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153492200|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492201|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
153492202|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
153492203|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
153492204|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492205|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492206|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
153492207|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492208|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492209|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153492210|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
153492211|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153492212|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153492213|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153492214|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153492215|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492216|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492217|NCT04155424|Eculizumab|eculizumab|mesh-list
153492218|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153435150|NCT00383474|Bortezomib|bortezomib|mesh-list
153492219|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492220|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
153492221|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492222|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
153492223|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153492224|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492225|NCT04075747|Venetoclax|venetoclax|mesh-list
153492226|NCT04075747|Midostaurin|midostaurin|mesh-list
153492227|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492255|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492256|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492257|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153492258|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492260|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153492261|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492262|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
153492263|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492264|NCT03751436|Venetoclax|venetoclax|mesh-list
153492270|NCT03735875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492271|NCT03735875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492272|NCT03735875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492274|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153492275|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153492276|NCT03629327|Analgesics|analgesics|mesh-ancestor
153492277|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
153492278|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492279|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492280|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492281|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492282|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153492297|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
153492298|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492299|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492300|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153492301|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153492302|NCT03450122|Analgesics|analgesics|mesh-ancestor
153492303|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
153492304|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492305|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153492306|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153492307|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
153492308|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492310|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153492311|NCT03382834|Vorinostat|vorinostat|mesh-list
153492312|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153492313|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
153492314|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492315|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492316|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492317|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492318|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153492319|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153492320|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153492321|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153492323|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492324|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
153492325|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492326|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
153492327|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
153492328|NCT03350516|Calcium|calcium|mesh-list
153492329|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153492330|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492339|NCT03348670|Glucocorticoids|glucocorticoids|mesh-ancestor
153492340|NCT03348670|Hormones|hormones|mesh-ancestor
153492341|NCT03348670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492342|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492343|NCT03348670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492344|NCT03348670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492345|NCT03348670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153492366|NCT03289949|Ketanserin|ketanserin|mesh-list
153492367|NCT03289949|Psilocybin|psilocybin|mesh-list
153492368|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
153492369|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492370|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153492371|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153492372|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153492373|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153492374|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
153492375|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492376|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492377|NCT03191461|Adenosine|adenosine|mesh-list
153492378|NCT03191461|Analgesics|analgesics|mesh-ancestor
153492379|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
153492380|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492381|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492382|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153492383|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
153492384|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153492385|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
153492386|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
153492387|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492388|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492389|NCT03166644|Sufentanil|sufentanil|mesh-list
153492390|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153492391|NCT03166644|Narcotics|narcotics|mesh-ancestor
153492392|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492393|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492394|NCT03166644|Analgesics|analgesics|mesh-ancestor
153492395|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
153492396|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492397|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153492412|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
153492413|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
153492427|NCT02726997|Paclitaxel|paclitaxel|mesh-list
153492428|NCT02726997|Carboplatin|carboplatin|mesh-list
153492429|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153492430|NCT02726997|Durvalumab|durvalumab|mesh-list
153492431|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
153492432|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153492433|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
153492434|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153492435|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492436|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
153492437|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
153492438|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
153492439|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492440|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492441|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
153781839|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492442|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492443|NCT02718911|Durvalumab|durvalumab|mesh-list
153492444|NCT02718911|Tremelimumab|tremelimumab|mesh-list
153492446|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492447|NCT02573896|Lenalidomide|lenalidomide|mesh-list
153492448|NCT02573896|Dinutuximab|dinutuximab|mesh-list
153492449|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
153492450|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492451|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153492452|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153492453|NCT02573896|Growth Substances|growth substances|mesh-ancestor
153492454|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
153492455|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492456|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
153492457|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153492458|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
153492459|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153492460|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492461|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153492462|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153492463|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153492464|NCT02416128|Prednisolone|prednisolone|mesh-list
153492465|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153492466|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
153492467|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153492468|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
153492469|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153492491|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492492|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492493|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153492494|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492495|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492497|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153492498|NCT02096055|Idarubicin|idarubicin|mesh-list
153492499|NCT02096055|Cladribine|cladribine|mesh-list
153492500|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
153492501|NCT02096055|Guadecitabine|guadecitabine|mesh-list
153492502|NCT02096055|Azacitidine|azacitidine|mesh-list
153492503|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153492504|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492505|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153492506|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153492507|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492508|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492509|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492510|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
153492511|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492512|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153492513|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
153492514|NCT02017717|Bevacizumab|bevacizumab|mesh-list
153492515|NCT02017717|Nivolumab|nivolumab|mesh-list
153492516|NCT02017717|Ipilimumab|ipilimumab|mesh-list
153492517|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492518|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492519|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153492520|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153492521|NCT02017717|Growth Substances|growth substances|mesh-ancestor
153492522|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492523|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
153492524|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153492551|NCT00828919|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153492552|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153492553|NCT00590902|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153492554|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492555|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492556|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492557|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492558|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
153492559|NCT00577122|Methotrexate|methotrexate|mesh-list
153492560|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153492561|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
153492562|NCT00577122|Progesterone|progesterone|mesh-list
153492563|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492564|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
153492565|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492566|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492567|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153492568|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
153492569|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492570|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492571|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153492572|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153492573|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
153492589|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153492590|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153492591|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492593|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153492594|NCT00419770|Deferasirox|deferasirox|mesh-list
153492595|NCT00419770|Amebicides|amebicides|mesh-ancestor
153492596|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153492597|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153492598|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492599|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153492600|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
153492601|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153492602|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
153492603|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
153492604|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492605|NCT00076310|Cisplatin|cisplatin|mesh-list
153492606|NCT00076310|Docetaxel|docetaxel|mesh-list
153492607|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153492608|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492609|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
153492610|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
153492612|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492613|NCT00076310|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153492614|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492615|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492616|NCT04340856|Bisacodyl|bisacodyl|mesh-list
153492617|NCT04340856|Laxatives|laxatives|mesh-list
153492618|NCT04340856|Cathartics|cathartics|mesh-ancestor
153492619|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153492620|NCT04040790|Phenylephrine|phenylephrine|mesh-list
153492621|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
153492622|NCT04040790|Tropicamide|tropicamide|mesh-list
153492623|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153492624|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
153492625|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
153492626|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492627|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492628|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
153492629|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153492630|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
153492631|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153492632|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153492633|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153492634|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153492635|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
153492649|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492650|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153492651|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
153492652|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153492653|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153492655|NCT04741620|Capsaicin|capsaicin|mesh-list
153492656|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
153492657|NCT04741620|Citric Acid|citric acid|mesh-list
153492658|NCT04741620|Piperine|piperine|mesh-list
153492659|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
153492660|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
153492661|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
153492662|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492663|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492664|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
153492665|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153492666|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
153492667|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
153492668|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492669|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153492670|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492671|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153707573|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
153492672|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492673|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153492674|NCT04741620|Protective Agents|protective agents|mesh-ancestor
153492675|NCT00800514|Amantadine|amantadine|mesh-list
153492676|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153492677|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153492678|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
153492679|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492680|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
153492681|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492682|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492683|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492684|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153492685|NCT00800514|Analgesics|analgesics|mesh-ancestor
153492686|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
153492688|NCT02780622|Oseltamivir|oseltamivir|mesh-list
153492689|NCT02780622|Warfarin|warfarin|mesh-list
153492690|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
153492691|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
153492692|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492693|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492694|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492695|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
153492696|NCT02791308|Tacrolimus|tacrolimus|mesh-list
153492697|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153492698|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153492707|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
153492708|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153492709|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492710|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492711|NCT02796144|Metformin|metformin|mesh-list
153492712|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153492713|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492714|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
153492715|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153492716|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492717|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153492718|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153492719|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492720|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492722|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153492723|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153492724|NCT02813070|Flutemetamol|flutemetamol|mesh-list
153492725|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153492726|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492727|NCT02815644|Empagliflozin|empagliflozin|mesh-list
153492728|NCT02815644|Linagliptin|linagliptin|mesh-list
153492729|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153492730|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492731|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153492732|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492733|NCT02815644|Incretins|incretins|mesh-ancestor
153492734|NCT02815644|Hormones|hormones|mesh-ancestor
153492735|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492736|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153492737|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
153492738|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492739|NCT02820324|Morphine|morphine|mesh-list
153854524|NCT01235728|Calcitriol|calcitriol|mesh-list
153492740|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153492741|NCT02820324|Narcotics|narcotics|mesh-ancestor
153492742|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492743|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492744|NCT02820324|Analgesics|analgesics|mesh-ancestor
153492745|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
153492746|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492747|NCT02821338|Lamotrigine|lamotrigine|mesh-list
153492748|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
153492749|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153492750|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153492751|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492752|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153492753|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492754|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153492755|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153492756|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492757|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153710813|NCT04716868|Levan|levan|mesh-list
153492758|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153492759|NCT02835846|Estrogens|estrogens|mesh-list
153492760|NCT02835846|Hormones|hormones|mesh-ancestor
153492766|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
153492767|NCT02844582|Hormones|hormones|mesh-ancestor
153492793|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492794|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492795|NCT02862912|Fentanyl|fentanyl|mesh-list
153492796|NCT02862912|Bupivacaine|bupivacaine|mesh-list
153492797|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
153492798|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
153492799|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
153492800|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492801|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492802|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
153492803|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492804|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153492805|NCT02862912|Narcotics|narcotics|mesh-ancestor
153492806|NCT02862912|Analgesics|analgesics|mesh-ancestor
153492807|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153492808|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153492809|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
153492810|NCT02864706|Cyclosporine|cyclosporine|mesh-list
153492811|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
153492812|NCT02864706|Everolimus|everolimus|mesh-list
153492813|NCT02864706|Cyclosporins|cyclosporins|mesh-list
153492814|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492815|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492816|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492838|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492839|NCT02873286|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153854538|NCT00559676|Leucovorin|leucovorin|mesh-list
153492840|NCT02873286|Antiviral Agents|antiviral agents|mesh-ancestor
153492841|NCT02873286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492842|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153492843|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153492844|NCT02880228|Dexamethasone|dexamethasone|mesh-list
153492845|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
153492846|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
153492847|NCT02880228|Lenalidomide|lenalidomide|mesh-list
153492848|NCT02880228|Ichthammol|ichthammol|mesh-list
153492849|NCT02880228|BB 1101|bb 1101|mesh-list
153492850|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492851|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
153492852|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
153492853|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492854|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492855|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153492856|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
153492857|NCT02880228|Hormones|hormones|mesh-ancestor
153492858|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492859|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492860|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492861|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492862|NCT02880228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153492863|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492864|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
153492865|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153492866|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153492867|NCT02880228|Growth Substances|growth substances|mesh-ancestor
153492868|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
153492869|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
153492870|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492871|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
153492872|NCT02880852|Belimumab|belimumab|mesh-list
153492914|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153492915|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153492916|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357648|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492928|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492929|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
153492930|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
153492931|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492932|NCT02911818|Liraglutide|liraglutide|mesh-list
153492933|NCT02911818|Phentermine|phentermine|mesh-list
153492934|NCT02911818|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153492935|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154263440|NCT05577702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153492936|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492938|NCT02911818|Hormones|hormones|mesh-ancestor
153492939|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492940|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153492941|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
153492942|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153492943|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
153492944|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
153492945|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492946|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
153492947|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492948|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492949|NCT02912364|Carbamazepine|carbamazepine|mesh-list
153492950|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153492951|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
153492952|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
153492953|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153492954|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492955|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492956|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153492957|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153492958|NCT02912364|Analgesics|analgesics|mesh-ancestor
153492959|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
153492960|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492961|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153492962|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153492963|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492964|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153492965|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153492966|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153492967|NCT02913924|Clonazepam|clonazepam|mesh-list
153492968|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
153492969|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
153492970|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
153492971|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492974|NCT02917122|Sertraline|sertraline|mesh-list
153492975|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
153492976|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153492977|NCT02917122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153492978|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153492979|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153492994|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492995|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153492996|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153492997|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
153492998|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
153492999|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493000|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153493001|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153493002|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493003|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493004|NCT02933034|Manganese|manganese|mesh-list
153493005|NCT02933034|Trace Elements|trace elements|mesh-ancestor
153493006|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
153493007|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493008|NCT02937168|Reslizumab|reslizumab|mesh-list
153493009|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153493010|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153493011|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493012|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153493013|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
153493014|NCT02937558|Glucagon|glucagon|mesh-list
153493015|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153493016|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493017|NCT02937558|Hormones|hormones|mesh-ancestor
153493018|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493019|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493020|NCT02937558|Incretins|incretins|mesh-ancestor
153493022|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493023|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
153493024|NCT02941692|Oxytocin|oxytocin|mesh-list
153493025|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
153493026|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153493027|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493028|NCT02953860|Fulvestrant|fulvestrant|mesh-list
153493029|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153493030|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493031|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153493032|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153493033|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
153493034|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493035|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493036|NCT02956044|Metformin|metformin|mesh-list
153493037|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153493038|NCT02956044|Glimepiride|glimepiride|mesh-list
153493039|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
153493040|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153493041|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493074|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493075|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493076|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153493077|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153493078|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
153493079|NCT02956746|Antibodies|antibodies|mesh-list
153493080|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
153493081|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153493082|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153493083|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
153493084|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493085|NCT02967354|Tryptophan|tryptophan|mesh-list
153493086|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
153493087|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153493088|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
153493089|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153493090|NCT02968134|Posaconazole|posaconazole|mesh-list
153493091|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
153493127|NCT02988882|Dexamethasone|dexamethasone|mesh-list
153493128|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153493129|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
153493130|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
153493131|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493132|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493133|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493134|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
153493135|NCT02988882|Hormones|hormones|mesh-ancestor
153493136|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493137|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153493138|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493139|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
153493140|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
153493141|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153493142|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493143|NCT03009162|Lasmiditan|lasmiditan|mesh-list
153493144|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153493145|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
153493146|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493147|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493148|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493149|NCT03009396|Clarithromycin|clarithromycin|mesh-list
153493150|NCT03009396|Rifabutin|rifabutin|mesh-list
153493151|NCT03009396|Clofazimine|clofazimine|mesh-list
153493152|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153493166|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
153493167|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153493168|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153493169|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493170|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493171|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493172|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153493173|NCT03017508|Protective Agents|protective agents|mesh-ancestor
153493174|NCT03020004|Ritonavir|ritonavir|mesh-list
153493178|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153493179|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
153493180|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493181|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493182|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153493183|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153493184|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
153493185|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493186|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153493187|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153493188|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
153493190|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153493191|NCT03020082|Ribavirin|ribavirin|mesh-list
153493192|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153493193|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153493194|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
153493195|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493196|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493197|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153493198|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153493199|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
153493200|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493201|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153493202|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153493203|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
153493204|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
153493205|NCT03026556|Apixaban|apixaban|mesh-list
153493206|NCT03026556|Dabigatran|dabigatran|mesh-list
153493207|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153493208|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
153493209|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153493210|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
153493211|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493212|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493213|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
153493214|NCT03035760|Oxfendazole|oxfendazole|mesh-list
153493215|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
153493216|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153493231|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
153493232|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
153493233|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
153493235|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153493236|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
153493237|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708138|NCT05984550|Niacinamide|niacinamide|mesh-list
153493238|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493239|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493240|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153493241|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
153493242|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
153493243|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493244|NCT03044418|Propofol|propofol|mesh-list
153493245|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
153493246|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493247|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493248|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153493259|NCT03051672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493260|NCT03057132|Protective Agents|protective agents|mesh-list
153493261|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493262|NCT03057366|Paclitaxel|paclitaxel|mesh-list
153493263|NCT03057366|Docetaxel|docetaxel|mesh-list
153493264|NCT03057366|Carboplatin|carboplatin|mesh-list
153493265|NCT03057366|Pevonedistat|pevonedistat|mesh-list
153493266|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153493267|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493268|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
153493269|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
153493270|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
153493271|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493272|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493273|NCT03060486|Hybenx|hybenx|mesh-list
153493274|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
153493275|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
153493276|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493277|NCT03061812|Dexamethasone|dexamethasone|mesh-list
153493278|NCT03061812|Topotecan|topotecan|mesh-list
153493279|NCT03061812|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
153493280|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153493281|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
153493282|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
153493283|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493284|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493285|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493286|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
153493287|NCT03061812|Hormones|hormones|mesh-ancestor
153493288|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493317|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153493318|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
153493319|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153493320|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493321|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153493322|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153493323|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493324|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153493325|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
153493326|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153493327|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153493328|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153493329|NCT03070548|Talazoparib|talazoparib|mesh-list
153493330|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153493331|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493332|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493333|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493334|NCT03080142|Bupivacaine|bupivacaine|mesh-list
153493335|NCT03080142|Ropivacaine|ropivacaine|mesh-list
153493336|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
153493337|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
153493338|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493339|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493340|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
153493368|NCT03096444|Analgesics|analgesics|mesh-ancestor
153493369|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153493370|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153493371|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
153493372|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153493373|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153493374|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493375|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153493376|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
153493377|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153493378|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153493379|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153493380|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153493381|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
153493382|NCT03107754|Lidocaine|lidocaine|mesh-list
153493383|NCT03107754|Anesthetics|anesthetics|mesh-list
153493384|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
153493385|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493411|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153493412|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493414|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153493415|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153493416|NCT03177798|Analgesics|analgesics|mesh-ancestor
153493417|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
153493418|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493419|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493420|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153493421|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153493422|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153493423|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153493424|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493425|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153493426|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153493428|NCT04933344|Daptomycin|daptomycin|mesh-list
153493429|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153493430|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493431|NCT05406180|Vaccines|vaccines|mesh-list
153493432|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
153493433|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493434|NCT05405478|Omalizumab|omalizumab|mesh-list
153493435|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153493436|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153493453|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493454|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
153493455|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493456|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708283|NCT05826964|Tamoxifen|tamoxifen|mesh-list
153493466|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493467|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493469|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153493470|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
153493471|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493472|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493473|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
153493474|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153493475|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493476|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
153493477|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
153493478|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153493479|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
153493480|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493481|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
153493482|NCT03883074|Protective Agents|protective agents|mesh-ancestor
153493484|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493485|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493486|NCT03670836|Misoprostol|misoprostol|mesh-list
153493487|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153493488|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
153493489|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153493490|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493491|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153493492|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493493|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
153493494|NCT03409614|Cemiplimab|cemiplimab|mesh-list
153493495|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153493496|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493497|NCT02651844|Mifepristone|mifepristone|mesh-list
153493498|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153493499|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
153493500|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153493501|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493502|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153493503|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153493543|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
153493544|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153493545|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153493546|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153493547|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493548|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493549|NCT03218592|Tenofovir|tenofovir|mesh-list
153493550|NCT03218592|Emtricitabine|emtricitabine|mesh-list
153493551|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153493552|NCT03218592|Dolutegravir|dolutegravir|mesh-list
153493553|NCT03218592|Maraviroc|maraviroc|mesh-list
153493554|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
153493555|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493563|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153493564|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153493565|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153708351|NCT05734053|Nilotinib|nilotinib|mesh-list
153493566|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153493567|NCT03219294|Bromides|bromides|mesh-list
153493568|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
153493569|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
153493570|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153493571|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153493572|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153493573|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493574|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493575|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153493576|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153493577|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
153493578|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493579|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493580|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
153493581|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153493582|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493583|NCT03223272|Reserpine|reserpine|mesh-list
153394889|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153394890|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153394891|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
153708402|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153708403|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153708404|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
153708405|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
153708406|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
153708407|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
153493584|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153493585|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153493586|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153493587|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493588|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493590|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153493591|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153493592|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493593|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493594|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
153493595|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493596|NCT03239106|Apremilast|apremilast|mesh-list
153493597|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153493598|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153493599|NCT03239106|Analgesics|analgesics|mesh-ancestor
153493600|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
153493601|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493602|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493603|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153493604|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153493605|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153545379|NCT06308887|Triamcinolone|triamcinolone|mesh-list
153736024|NCT03865940|Guanfacine|guanfacine|mesh-list
153708408|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708411|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
153493606|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153493607|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493608|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493609|NCT03257202|Clindamycin|clindamycin|mesh-list
153493610|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
153493611|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
153493612|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153493613|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153493614|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493615|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153493616|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493617|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493618|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493619|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153493620|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
153493621|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493635|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153493636|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493637|NCT03287310|Albuterol|albuterol|mesh-list
153493638|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153493639|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
153493640|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493641|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493642|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153493643|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
153493644|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
153493645|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153493646|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153493647|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153493648|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153493649|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
153493650|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493651|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493652|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153493653|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153493654|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153493655|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493656|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493657|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153493658|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626814|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493661|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493663|NCT03315780|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153493664|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153493665|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493666|NCT03334734|Isoniazid|isoniazid|mesh-list
153493667|NCT03334734|Macozinone|macozinone|mesh-list
153493668|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
153493669|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153493670|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493671|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153493672|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153493673|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
153493674|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493675|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153493676|NCT03336450|Midazolam|midazolam|mesh-list
153493677|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153493678|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153493679|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854638|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
153493680|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493681|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153493682|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153493683|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153493684|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153493685|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
153493686|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
153493687|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
153493718|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493719|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493720|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153493721|NCT03375294|Analgesics|analgesics|mesh-ancestor
153493722|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
153493723|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493724|NCT03395808|Tramadol|tramadol|mesh-list
153493725|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153493726|NCT03395808|Narcotics|narcotics|mesh-ancestor
153493727|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493728|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493729|NCT03395808|Analgesics|analgesics|mesh-ancestor
153493730|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
153493731|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493753|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493755|NCT03430050|Progesterone|progesterone|mesh-list
153493756|NCT03430050|Progestins|progestins|mesh-ancestor
153493757|NCT03430050|Hormones|hormones|mesh-ancestor
153493758|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493759|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493760|NCT03440424|Lemborexant|lemborexant|mesh-list
153493761|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153493762|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493763|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493764|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153493765|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153493766|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493767|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493768|NCT03448068|Ketamine|ketamine|mesh-list
153493769|NCT03448068|Analgesics|analgesics|mesh-ancestor
153493770|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
153493771|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493772|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493773|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153493774|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153493775|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
153493776|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
153493777|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493778|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153493779|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153493780|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493781|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493782|NCT03453060|Thrombin|thrombin|mesh-list
153493783|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
153493784|NCT03453060|Coagulants|coagulants|mesh-ancestor
153493785|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
153493786|NCT03459612|Promethazine|promethazine|mesh-list
153436744|NCT00003596|Fluorouracil|fluorouracil|mesh-list
153493787|NCT03459612|Lasmiditan|lasmiditan|mesh-list
153493788|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153493789|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153493801|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
153493802|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493803|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493804|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153493805|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
153493807|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153493808|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
153493809|NCT03463512|Racecadotril|racecadotril|mesh-list
153493810|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
153493811|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493812|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
153493813|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493814|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493815|NCT03473184|Diacerein|diacerein|mesh-list
153493816|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154263441|NCT05577702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153493817|NCT03485976|Ixekizumab|ixekizumab|mesh-list
153493818|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493819|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153493820|NCT03496974|Antibodies|antibodies|mesh-list
153493821|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
153493822|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153493823|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
153493824|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493825|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493826|NCT03503292|Ondansetron|ondansetron|mesh-list
153493827|NCT03503292|Granisetron|granisetron|mesh-list
153493828|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
153493829|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
153493830|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493831|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493832|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493833|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
153493834|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493835|NCT03503292|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153493836|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153493837|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
153493838|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708560|NCT05476354|Amlodipine|amlodipine|mesh-list
153493839|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493840|NCT03506724|Labetalol|labetalol|mesh-list
153493841|NCT03506724|Nifedipine|nifedipine|mesh-list
153493842|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153493843|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493844|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493845|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153493846|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493847|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
153493848|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
153493849|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153493850|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153493851|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153493852|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
153493853|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493854|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153493855|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
153493868|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493869|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
153493870|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493871|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
153493872|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
153493873|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
153493874|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493875|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153493876|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153493877|NCT03541356|Carbidopa|carbidopa|mesh-list
153493878|NCT03541356|Levodopa|levodopa|mesh-list
153493879|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
153493880|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153493881|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153493884|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493886|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153493887|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493888|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
153493889|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153493890|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493892|NCT03572478|Rucaparib|rucaparib|mesh-list
153493893|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153493894|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493895|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153493896|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493897|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153493898|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493899|NCT03574818|Gemcitabine|gemcitabine|mesh-list
153493900|NCT03574818|Necitumumab|necitumumab|mesh-list
153493901|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493902|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153493903|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
153493904|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493905|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153428582|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
153493906|NCT03593538|Metformin|metformin|mesh-list
153493907|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153493908|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493909|NCT03610464|Amphetamine|amphetamine|mesh-list
153493910|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153493911|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493912|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
153493913|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
153493914|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493915|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
153493916|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493917|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493918|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
153493919|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153493934|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493936|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153493937|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493938|NCT03655080|Paclitaxel|paclitaxel|mesh-list
153493939|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153493940|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153493941|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493942|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
153493943|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
153493944|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
153493945|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493946|NCT03674970|Nicotine|nicotine|mesh-list
153493947|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153493948|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
153493949|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493950|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493951|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153493953|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
153493954|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493955|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493956|NCT03704376|Clonidine|clonidine|mesh-list
153493957|NCT03704376|Ropivacaine|ropivacaine|mesh-list
153493958|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
153493959|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
153493960|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493961|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493962|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
153493963|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493964|NCT03704376|Analgesics|analgesics|mesh-ancestor
153493965|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153493966|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
153493967|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
153493968|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153394939|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153493969|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153493970|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153493971|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
153493972|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493973|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493974|NCT03716076|Carbetocin|carbetocin|mesh-list
153493975|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
153493976|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153493977|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493978|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
153494008|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494009|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153494011|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153494012|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
153494014|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494015|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494016|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153494017|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494018|NCT03541980|Acetaminophen|acetaminophen|mesh-list
153494019|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153494020|NCT03541980|Analgesics|analgesics|mesh-ancestor
153494021|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
153494022|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494023|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494024|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
153494025|NCT04511520|Trimetazidine|trimetazidine|mesh-list
153494053|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
153494054|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
153494055|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494056|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
153494057|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494058|NCT04204200|Protective Agents|protective agents|mesh-ancestor
153494059|NCT04179474|Erenumab|erenumab|mesh-list
153494060|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153494061|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494062|NCT04179474|Analgesics|analgesics|mesh-ancestor
153494063|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
153494064|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494065|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494066|NCT04150224|Macozinone|macozinone|mesh-list
153494067|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
153494068|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153494069|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494070|NCT04102956|Kallikreins|kallikreins|mesh-list
153494071|NCT04102956|Coagulants|coagulants|mesh-ancestor
153494072|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153708809|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708810|NCT05065424|Analgesics|analgesics|mesh-ancestor
153494073|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
153494074|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153494075|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494076|NCT04053270|Afamelanotide|afamelanotide|mesh-list
153494077|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
153494078|NCT03976752|Tenofovir|tenofovir|mesh-list
153494079|NCT03976752|Emtricitabine|emtricitabine|mesh-list
153494080|NCT03976752|Cobicistat|cobicistat|mesh-list
153494081|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153494110|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
153494111|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
153494112|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153494113|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494114|NCT03933774|Tretinoin|tretinoin|mesh-list
153494115|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494116|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
153494117|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
153494118|NCT03933618|Anastrozole|anastrozole|mesh-list
153494120|NCT03933618|Enclomiphene|enclomiphene|mesh-list
153494121|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
153494122|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494123|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153494124|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494125|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153494126|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153494127|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494128|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153494148|NCT03861000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153494149|NCT03861000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494150|NCT03861000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494151|NCT03865446|Dacomitinib|dacomitinib|mesh-list
153494152|NCT03865446|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153494153|NCT03865446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494154|NCT03865446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494155|NCT03865446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494156|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153494157|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153494158|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
153494159|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153494160|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153494161|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494162|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
153494163|NCT03856164|Coagulants|coagulants|mesh-ancestor
153494164|NCT03849690|Esomeprazole|esomeprazole|mesh-list
153494165|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153494166|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153494167|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153494168|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494169|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494170|NCT03822078|Denosumab|denosumab|mesh-list
153494171|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153494172|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494173|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
153494174|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153494175|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153494176|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494187|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494188|NCT03805386|Analgesics|analgesics|mesh-ancestor
153494189|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
153494190|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494191|NCT03796260|Entrectinib|entrectinib|mesh-list
153494192|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494208|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494209|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153494210|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153494211|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153494213|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494214|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494215|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153494216|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
153494217|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494218|NCT03370536|Ibutilide|ibutilide|mesh-list
153494219|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153494220|NCT03161964|Propranolol|propranolol|mesh-list
153494221|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153494222|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153494223|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494224|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494225|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494226|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494227|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153494228|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153494229|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
153494230|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
153494231|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153494232|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153708857|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494233|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153494234|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494235|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494236|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
153494237|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494238|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494239|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153494240|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494242|NCT03042780|Lenograstim|lenograstim|mesh-list
153494255|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
153494256|NCT02985840|Hormones|hormones|mesh-ancestor
153494257|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494258|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153494259|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494260|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
153494261|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
153494262|NCT02985840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153494263|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153494277|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153494278|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153494279|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
153494280|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153494281|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494282|NCT02966184|Albuterol|albuterol|mesh-list
153494283|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153494284|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
153494285|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494286|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494287|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153494288|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494289|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
153494290|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153494291|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153494292|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153494293|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153494294|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494295|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494296|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494297|NCT02744352|Ropivacaine|ropivacaine|mesh-list
153494298|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
153494299|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
153494300|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494301|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494302|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
153494303|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494304|NCT02587650|Ceritinib|ceritinib|mesh-list
153494305|NCT02587650|Entrectinib|entrectinib|mesh-list
153494308|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437268|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
153494309|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494310|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494311|NCT02514252|Fentanyl|fentanyl|mesh-list
153494312|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153494313|NCT02514252|Narcotics|narcotics|mesh-ancestor
153494314|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494315|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494316|NCT02514252|Analgesics|analgesics|mesh-ancestor
153494317|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
153494318|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494319|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153494320|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153494321|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
153494322|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
153494323|NCT02434146|Phenylephrine|phenylephrine|mesh-list
153494324|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
153494325|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153494326|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
153494347|NCT02345460|Irinotecan|irinotecan|mesh-list
153494348|NCT02345460|Calcium|calcium|mesh-list
153494349|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
153494350|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153494351|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494352|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
153494353|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494354|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153494355|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494356|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153494357|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
153494358|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153494359|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153494360|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494361|NCT02345460|Antidotes|antidotes|mesh-ancestor
153494362|NCT02345460|Protective Agents|protective agents|mesh-ancestor
153494363|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
153494364|NCT02345460|Vitamins|vitamins|mesh-ancestor
153494365|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
153494366|NCT02345772|Docetaxel|docetaxel|mesh-list
153494367|NCT02345772|Trastuzumab|trastuzumab|mesh-list
153494368|NCT02345772|Fulvestrant|fulvestrant|mesh-list
153494370|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494371|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
153494372|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
153494373|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
153494374|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494375|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153494376|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153494377|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153494378|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153494379|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
153626815|NCT02019186|Vitamins|vitamins|mesh-list
153494380|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494382|NCT02280252|Paclitaxel|paclitaxel|mesh-list
153494383|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153494401|NCT02015910|Hormones|hormones|mesh-ancestor
153494402|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494403|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153494404|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
153494405|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494406|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494407|NCT01980342|Efavirenz|efavirenz|mesh-list
153494408|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153494409|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153494410|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712032|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153494411|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494412|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
153494413|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494414|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153494415|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153494416|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153494417|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153494418|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153494419|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153494420|NCT01881984|Glycerol|glycerol|mesh-list
153494421|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153494422|NCT01881984|Protective Agents|protective agents|mesh-ancestor
153494423|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494424|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
153494425|NCT01878786|Everolimus|everolimus|mesh-list
153494426|NCT01878786|Tacrolimus|tacrolimus|mesh-list
153494427|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153494428|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
153494429|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494430|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153494431|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494432|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494433|NCT01878786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153494434|NCT01878786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494435|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494462|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153494463|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153494464|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494465|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153494466|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153494467|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153494468|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494469|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
153494471|NCT01800162|Methotrexate|methotrexate|mesh-list
153494472|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153494473|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
153494474|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153494475|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494476|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153494477|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
153494478|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494479|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494480|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
153494481|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494482|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153709110|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153494519|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153494520|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494521|NCT01602198|Rivastigmine|rivastigmine|mesh-list
153494531|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153494532|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494533|NCT01527942|Acetaminophen|acetaminophen|mesh-list
153494534|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153494535|NCT01527942|Analgesics|analgesics|mesh-ancestor
153494536|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
153494537|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494538|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494539|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
153494540|NCT01507584|Bimatoprost|bimatoprost|mesh-list
153494541|NCT01507584|Brinzolamide|brinzolamide|mesh-list
153494542|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153494543|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153494544|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494545|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494546|NCT01483872|Tigecycline|tigecycline|mesh-list
153494547|NCT01483872|Heparin|heparin|mesh-list
153494548|NCT01483872|Calcium heparin|calcium heparin|mesh-list
153494549|NCT01483872|Anticoagulants|anticoagulants|mesh-list
153494550|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494551|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153494552|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153494553|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154263442|NCT05577702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153494554|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494555|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153494556|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494557|NCT01385280|Exemestane|exemestane|mesh-list
153494558|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153494559|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153494560|NCT01385280|Estradiol|estradiol|mesh-list
153494561|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153494562|NCT01385280|Estrogens|estrogens|mesh-ancestor
153494563|NCT01385280|Hormones|hormones|mesh-ancestor
153709114|NCT04605393|Hormones|hormones|mesh-ancestor
153494564|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494565|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494566|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153494567|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
153494568|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153494569|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153494570|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494571|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153494572|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153494573|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494574|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494575|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153494576|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
153494577|NCT01350258|Fludarabine|fludarabine|mesh-list
153494578|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
153494579|NCT01350258|Melphalan|melphalan|mesh-list
153494580|NCT01350258|Thiotepa|thiotepa|mesh-list
153494581|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494582|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153494583|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
153494584|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494585|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153494586|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
153494587|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494588|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153494589|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
153494609|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494610|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494611|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153494613|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153494614|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153494615|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494616|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494617|NCT01183416|Tretinoin|tretinoin|mesh-list
153494618|NCT01183416|Isotretinoin|isotretinoin|mesh-list
153494619|NCT01183416|Antibodies|antibodies|mesh-list
153494620|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153494621|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
153494622|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494623|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494624|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
153494625|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
153494626|NCT01169610|Varenicline|varenicline|mesh-list
153494627|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153494628|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153494629|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
153494630|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494631|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494632|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494633|NCT01166724|Sirolimus|sirolimus|mesh-list
153494634|NCT01166724|Tacrolimus|tacrolimus|mesh-list
153494635|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709168|NCT04434664|Metoprolol|metoprolol|mesh-list
153494636|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
153494637|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494638|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153494639|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494640|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494641|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153494642|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494643|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153494644|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494645|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
153494646|NCT01151904|Timolol|timolol|mesh-list
153494647|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153494648|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153494649|NCT01151904|Latanoprost|latanoprost|mesh-list
153494650|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153494651|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153494652|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153494653|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494654|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539891|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
153494697|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153494698|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
153494699|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494700|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494701|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494702|NCT00903396|Palonosetron|palonosetron|mesh-list
153494703|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
153494704|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
153494705|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494723|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494725|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153494726|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494727|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494728|NCT00811590|Everolimus|everolimus|mesh-list
153494729|NCT00811590|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153494736|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494737|NCT00749658|Bupropion|bupropion|mesh-list
153494738|NCT00749658|Varenicline|varenicline|mesh-list
153494739|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153494740|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
153494741|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153494742|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153494743|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153494744|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494745|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494746|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
153494747|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494748|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494749|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153494750|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153494751|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494752|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153494753|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153437723|NCT00004922|Irinotecan|irinotecan|mesh-list
153494754|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
153494755|NCT00738972|Valsartan|valsartan|mesh-list
153494756|NCT00738972|Simvastatin|simvastatin|mesh-list
153494757|NCT00738972|Ezetimibe|ezetimibe|mesh-list
153494758|NCT00738972|Pravastatin|pravastatin|mesh-list
153494759|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153494760|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153494761|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
153494762|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494763|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154191191|NCT05941585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494764|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153494775|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
153494776|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494777|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494778|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153494779|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494780|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
153494781|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153494782|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153494783|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
153494784|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494785|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494786|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494788|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
153494789|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494790|NCT00692094|Protective Agents|protective agents|mesh-ancestor
153494791|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494792|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494793|NCT00676026|Zolpidem|zolpidem|mesh-list
153494794|NCT00676026|Fluoxetine|fluoxetine|mesh-list
153494795|NCT00676026|Progesterone|progesterone|mesh-list
153494796|NCT00676026|Progestins|progestins|mesh-ancestor
153494798|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494800|NCT00676026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153494801|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153494802|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494803|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494804|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494805|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
153494806|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153494807|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
153494808|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153494809|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153494810|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153494811|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494812|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153494813|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153494814|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494815|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153494816|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
153494817|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
153494818|NCT00656916|Fluticasone|fluticasone|mesh-list
153494820|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153494821|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153494822|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
153494823|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494824|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494825|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153781842|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153437798|NCT00003776|Vitamins|vitamins|mesh-ancestor
153494826|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494842|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153494843|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153494844|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
153494845|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494846|NCT00571194|Pravastatin|pravastatin|mesh-list
153494847|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153494848|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153494849|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
153494850|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494851|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153494852|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153494853|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494854|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153494855|NCT00570258|Fulvestrant|fulvestrant|mesh-list
153494856|NCT00570258|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153494857|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494858|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494859|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494860|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494861|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153494862|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153494863|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153494864|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
153494865|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494868|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494869|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
153494870|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494871|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494872|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153494873|NCT00577356|Docetaxel|docetaxel|mesh-list
153494874|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494875|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
153494876|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
153494877|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
153494878|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494879|NCT00569868|Bortezomib|bortezomib|mesh-list
153494880|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494881|NCT05599230|Ivacaftor|ivacaftor|mesh-list
153494882|NCT05599230|Elexacaftor|elexacaftor|mesh-list
153494883|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153494884|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494885|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494887|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494888|NCT05164614|Teriparatide|teriparatide|mesh-list
153494900|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
153494901|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153494902|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
153494903|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494904|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153494905|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153494906|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153494907|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494908|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494909|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494910|NCT05001048|Protective Agents|protective agents|mesh-ancestor
153494911|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153494912|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
153494914|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
153494915|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494916|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
153494917|NCT04575090|Simvastatin|simvastatin|mesh-list
153494918|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153494919|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153494920|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
153494921|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494922|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153494923|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153494924|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494925|NCT04100772|Vaccines|vaccines|mesh-list
153494926|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
153494927|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494928|NCT03472872|Acetaminophen|acetaminophen|mesh-list
153494929|NCT03472872|Ketorolac|ketorolac|mesh-list
153494930|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153494931|NCT03472872|Analgesics|analgesics|mesh-ancestor
153494932|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
153494933|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494934|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494935|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
153494936|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153494937|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153494938|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153494939|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153494941|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494942|NCT02411526|Risperidone|risperidone|mesh-list
153494943|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153494944|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
153494945|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494946|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494947|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494948|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153494949|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153494950|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494951|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153494952|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153494953|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
153494954|NCT00564876|Dasatinib|dasatinib|mesh-list
153494955|NCT00564876|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153494974|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494975|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494976|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494977|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494978|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153494979|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153494980|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
153494981|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494982|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153494983|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494984|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
153494985|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
153494986|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153494987|NCT00538980|Dasatinib|dasatinib|mesh-list
153494988|NCT00538980|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153494989|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494990|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494991|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494992|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494994|NCT00519090|Nilotinib|nilotinib|mesh-list
153494995|NCT00519090|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153494996|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494997|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494998|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494999|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495000|NCT00506064|Melatonin|melatonin|mesh-list
153495001|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
153495002|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495003|NCT00506064|Protective Agents|protective agents|mesh-ancestor
153495004|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495005|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495006|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
153495007|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495008|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153495009|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153495010|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
153495011|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495027|NCT00108342|Nicotine|nicotine|mesh-list
153495028|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153495029|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
153495030|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495031|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495032|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153495033|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153495034|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
153495035|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495036|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495037|NCT00090870|Interferons|interferons|mesh-list
153495038|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
153495039|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
153495040|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153495041|NCT00090870|Thalidomide|thalidomide|mesh-list
153495042|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495043|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
153495044|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495045|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
153495046|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495047|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495048|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
153495049|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495050|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153781844|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
153438023|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153495051|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153495052|NCT00090870|Growth Substances|growth substances|mesh-ancestor
153495053|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
153495054|NCT00074724|Dobutamine|dobutamine|mesh-list
153495055|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153495056|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
153495057|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
153495058|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495059|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495060|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153495061|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153495062|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153495063|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
153495064|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495065|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495066|NCT00074724|Protective Agents|protective agents|mesh-ancestor
153495067|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
153495068|NCT00058188|Vitamin D|vitamin d|mesh-list
153495069|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
153495070|NCT00058188|Calcium|calcium|mesh-list
153495071|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153495072|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495073|NCT00058188|Vitamins|vitamins|mesh-ancestor
153495074|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
153495075|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153495092|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153495093|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153495094|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
153495095|NCT04422210|Carboplatin|carboplatin|mesh-list
153495097|NCT04422210|Atezolizumab|atezolizumab|mesh-list
153495098|NCT04422210|Venetoclax|venetoclax|mesh-list
153495099|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495100|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153495101|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153495102|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153495103|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495104|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495105|NCT04422210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153495106|NCT04422210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153495107|NCT00000132|Betaxolol|betaxolol|mesh-list
153495108|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153495109|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
153495110|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
153495111|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495112|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495113|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153495114|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153495115|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153495116|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
153495117|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495118|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495119|NCT00000138|Acyclovir|acyclovir|mesh-list
153495120|NCT00000138|Prednisolone|prednisolone|mesh-list
153495121|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153495122|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
153495123|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153495124|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
153781845|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495125|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153495126|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
153495127|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153495128|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
153495129|NCT00000138|Hormones|hormones|mesh-ancestor
153495130|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153495131|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495132|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153495133|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495134|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
153495135|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
153495164|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153495165|NCT00000198|Protective Agents|protective agents|mesh-ancestor
153495166|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495167|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
153495168|NCT00000204|Buprenorphine|buprenorphine|mesh-list
153495169|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153495170|NCT00000204|Narcotics|narcotics|mesh-ancestor
153495171|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495172|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495173|NCT00000204|Analgesics|analgesics|mesh-ancestor
153495174|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
153495175|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495176|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495177|NCT00000210|Buprenorphine|buprenorphine|mesh-list
153495178|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153495179|NCT00000210|Narcotics|narcotics|mesh-ancestor
153495180|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495181|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495182|NCT00000210|Analgesics|analgesics|mesh-ancestor
153495183|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
153495214|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153495215|NCT00000240|Narcotics|narcotics|mesh-ancestor
153495216|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495217|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495218|NCT00000240|Analgesics|analgesics|mesh-ancestor
153495219|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
153495220|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495221|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495222|NCT00000246|Flumazenil|flumazenil|mesh-list
153495223|NCT00000246|Antidotes|antidotes|mesh-ancestor
153495224|NCT00000246|Protective Agents|protective agents|mesh-ancestor
153495225|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495226|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
153495227|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
153495228|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263444|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
153539892|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495263|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153495264|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495266|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495267|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495268|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153495269|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153495270|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495272|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153495273|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495274|NCT00000294|Carvedilol|carvedilol|mesh-list
153495275|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153495276|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153495277|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
153495278|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495279|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495280|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495281|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153495282|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
153495283|NCT00000294|Protective Agents|protective agents|mesh-ancestor
153495284|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153495285|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153495286|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153495287|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
153495288|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153495289|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153495290|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
153495291|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153495303|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495304|NCT00000318|Analgesics|analgesics|mesh-ancestor
153495327|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153495328|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
153495329|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495330|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495331|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495332|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153495333|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153495334|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495335|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153495336|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153495337|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
153495338|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
153495339|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
153709765|NCT02959619|Ensartinib|ensartinib|mesh-list
153495340|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
153495341|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495342|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495343|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495344|NCT00000354|Lofexidine|lofexidine|mesh-list
153495345|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153495346|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495347|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495348|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
153495349|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495350|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153495351|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153495352|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153495353|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
153495358|NCT00000372|Glycine|glycine|mesh-list
153495359|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153495372|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495373|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153495374|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
153495375|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
153495376|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
153495377|NCT00000384|Sertraline|sertraline|mesh-list
153495378|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
153495379|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153495380|NCT00000384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153495381|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153495382|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255973|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153495383|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495384|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495385|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
153495386|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495387|NCT00000390|Imipramine|imipramine|mesh-list
153495388|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153495389|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
153495390|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153495391|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153495392|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153495393|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153495394|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495395|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
153495396|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495397|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495398|NCT00000402|Calcium|calcium|mesh-list
153495399|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153495400|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495401|NCT00000438|Naltrexone|naltrexone|mesh-list
153495402|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153495403|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495404|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495405|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
153495406|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495408|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153495409|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
153495410|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495411|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495412|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153495413|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153495414|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
153495415|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191192|NCT05941585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495416|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495417|NCT00000450|Naltrexone|naltrexone|mesh-list
153495418|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153495419|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495420|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495421|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
153495451|NCT00000636|Pyridoxine|pyridoxine|mesh-list
153495452|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
153495453|NCT00000636|Rifampin|rifampin|mesh-list
153495454|NCT00000636|Isoniazid|isoniazid|mesh-list
153495455|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
153495456|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153495457|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
153495458|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495459|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495460|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
153495461|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495462|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495463|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495464|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153495465|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153495466|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153495467|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153495468|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153495469|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153495470|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153495471|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153495472|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
153495473|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153495512|NCT00000714|Calcium|calcium|mesh-list
153495513|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
153495514|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153495515|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495516|NCT00000714|Antidotes|antidotes|mesh-ancestor
153495517|NCT00000714|Protective Agents|protective agents|mesh-ancestor
153495518|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
153495519|NCT00000714|Vitamins|vitamins|mesh-ancestor
153495520|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
153495521|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
153495522|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429138|NCT00002552|Vitamins|vitamins|mesh-ancestor
153495523|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153495524|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
153495525|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495526|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495527|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153495555|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495556|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495558|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
153495559|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495560|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495561|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495592|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495594|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495595|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495596|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
153495597|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495598|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495599|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495600|NCT00000834|Lamivudine|lamivudine|mesh-list
153495601|NCT00000834|Zidovudine|zidovudine|mesh-list
153495602|NCT00000834|Methotrexate|methotrexate|mesh-list
153495603|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153495604|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
153495607|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153495608|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
153495626|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495627|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495628|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495630|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
153495631|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495632|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495633|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495634|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
153495635|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
153495636|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495637|NCT00000894|Ganciclovir|ganciclovir|mesh-list
153495638|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153495639|NCT00000894|Cidofovir|cidofovir|mesh-list
153495640|NCT00000894|Probenecid|probenecid|mesh-list
153495641|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
153495642|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495643|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495644|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495645|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495646|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
153495647|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
153495648|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153495649|NCT00000912|Efavirenz|efavirenz|mesh-list
153781847|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153495650|NCT00000912|Abacavir|abacavir|mesh-list
153495651|NCT00000912|Adefovir|adefovir|mesh-list
153495652|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153495653|NCT00000912|Nelfinavir|nelfinavir|mesh-list
153495654|NCT00000912|Indinavir|indinavir|mesh-list
153495655|NCT00000912|Saquinavir|saquinavir|mesh-list
153495656|NCT00000912|Amprenavir|amprenavir|mesh-list
153495657|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495658|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495659|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495660|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495661|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
153495662|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495663|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153495664|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153495665|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153495666|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153495688|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153495689|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153495690|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
153495691|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495692|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495693|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495694|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495695|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
153495696|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495697|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153495698|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153495699|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495700|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495701|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
153495702|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153495703|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153495704|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153495705|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153495706|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153495707|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153495708|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
153495709|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495712|NCT00000924|Nevirapine|nevirapine|mesh-list
153495713|NCT00000924|Stavudine|stavudine|mesh-list
153495714|NCT00000924|Didanosine|didanosine|mesh-list
153495715|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153495716|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153495717|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
153495718|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495719|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495720|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495721|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495722|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
153495723|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495724|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153495725|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153495747|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495749|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495750|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495763|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153495764|NCT00000954|Bleomycin|bleomycin|mesh-list
153495765|NCT00000954|Vincristine|vincristine|mesh-list
153495766|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153495767|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495768|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153495769|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153495770|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495771|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495772|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153495773|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
153495774|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
153495775|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
153495776|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
153495777|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495778|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495779|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
153495780|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495781|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495782|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495783|NCT00000960|Zidovudine|zidovudine|mesh-list
153495784|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
153495785|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191193|NCT05941585|Immunologic Factors|immunologic factors|mesh-ancestor
153495786|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495787|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495788|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495789|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
153495808|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153495810|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495812|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153495813|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
153495814|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495817|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153495818|NCT00001062|Ganciclovir|ganciclovir|mesh-list
153495819|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153495820|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
153495821|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495822|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495823|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495824|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495826|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495827|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495828|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495829|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495830|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
153495831|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495832|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495833|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495834|NCT00001080|Lamivudine|lamivudine|mesh-list
153495835|NCT00001080|Vaccines|vaccines|mesh-list
153495836|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153495837|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
153495838|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495839|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495840|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495841|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495842|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495843|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
153495844|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495845|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495846|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495847|NCT00001104|Zidovudine|zidovudine|mesh-list
153495848|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
153495884|NCT00001128|Paromomycin|paromomycin|mesh-list
153495908|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495909|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
153495910|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495911|NCT00001422|Fludarabine|fludarabine|mesh-list
153495912|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495913|NCT00001428|Fluorouracil|fluorouracil|mesh-list
153495914|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
153495915|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495916|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153495917|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495918|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495919|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
153495920|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495921|NCT00001440|Interleukin-2|interleukin-2|mesh-list
153495922|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495923|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153495924|NCT00001440|Analgesics|analgesics|mesh-ancestor
153495925|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
153495926|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495927|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495928|NCT00001446|Thalidomide|thalidomide|mesh-list
153495929|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495930|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
153495931|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495932|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
153495933|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495934|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495935|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153495936|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153495937|NCT00001446|Growth Substances|growth substances|mesh-ancestor
153495938|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
153495939|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495952|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153495953|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
153495954|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495955|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495956|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153495957|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495958|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
153495959|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495960|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
153495961|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153495964|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
153495965|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495966|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
153495967|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495968|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495969|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153495970|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153495971|NCT00001680|Growth Substances|growth substances|mesh-ancestor
153495972|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
153495975|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153495976|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153495977|NCT00001698|Analgesics|analgesics|mesh-ancestor
153495978|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
153495979|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495980|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495981|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153495982|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153495983|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153495984|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495985|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495986|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
153495987|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
153495988|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153495989|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
153495990|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495991|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495992|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153495993|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
153495994|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153495995|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
153495996|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495997|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495998|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153495999|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
153496000|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
153496001|NCT00001716|Protective Agents|protective agents|mesh-ancestor
153496002|NCT00001812|Nystatin|nystatin|mesh-list
153496022|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153496023|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
153496024|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153781848|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
153439001|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153496025|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153496026|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
153496027|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496028|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496029|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153496030|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153496031|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153496033|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
153496034|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496035|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
153496036|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496037|NCT00001860|Octreotide|octreotide|mesh-list
153496038|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153496039|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153496040|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496041|NCT00001890|Estrogens|estrogens|mesh-list
153496042|NCT00001890|Hormones|hormones|mesh-ancestor
153496043|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496044|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496045|NCT00001944|Vinorelbine|vinorelbine|mesh-list
153496046|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153496047|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496048|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
153496049|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
153496050|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
153496051|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496052|NCT00001968|Ritonavir|ritonavir|mesh-list
153496053|NCT00001968|Amprenavir|amprenavir|mesh-list
153496054|NCT00001968|Lamivudine|lamivudine|mesh-list
153496055|NCT00001968|Abacavir|abacavir|mesh-list
153496056|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496089|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496090|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153496091|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153496092|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
153496093|NCT00002022|Hematinics|hematinics|mesh-ancestor
153496094|NCT00002028|Didanosine|didanosine|mesh-list
153496108|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496109|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496111|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496112|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
153496113|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496114|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496115|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496117|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
153496118|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496119|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153496120|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496121|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496122|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496123|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153496124|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
153496125|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496126|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496127|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153496128|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153496130|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
153496131|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496132|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496133|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496134|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496135|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
153855099|NCT00446303|Azacitidine|azacitidine|mesh-list
153496136|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496137|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496138|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496139|NCT00002052|Amoxicillin|amoxicillin|mesh-list
153496140|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
153496141|NCT00002052|Ampicillin|ampicillin|mesh-list
153496142|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496143|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496144|NCT00002052|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153395363|NCT05742763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395364|NCT02504723|Carvedilol|carvedilol|mesh-list
153395365|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153395366|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153496145|NCT00002052|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153496146|NCT00002058|Clofazimine|clofazimine|mesh-list
153496147|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153496148|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
153496149|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496150|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496151|NCT00002064|Clindamycin|clindamycin|mesh-list
153496152|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
153496153|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
153496154|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
153496155|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496156|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496167|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
153496168|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496169|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
153496170|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496171|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496172|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496173|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496174|NCT00002076|Fluconazole|fluconazole|mesh-list
153496175|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
153496176|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496177|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153496178|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496179|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496180|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496181|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153496182|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
153496183|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496184|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496185|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153496186|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153496188|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496189|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496191|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496192|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496193|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496194|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496196|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496197|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
153496198|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
153496199|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153496200|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153496201|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496202|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
153496203|NCT00002106|Ranitidine|ranitidine|mesh-list
153496204|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153496205|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153496206|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153496207|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153496208|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
153496209|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
153496210|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153496211|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496212|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496213|NCT00002112|Fluconazole|fluconazole|mesh-list
153496214|NCT00002112|Nystatin|nystatin|mesh-list
153496215|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
153496216|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496217|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153496218|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496219|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496220|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496231|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
153496232|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496234|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496235|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496236|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
153496237|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496238|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496239|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496240|NCT00002124|Lamivudine|lamivudine|mesh-list
153496241|NCT00002124|Zidovudine|zidovudine|mesh-list
153496242|NCT00002124|Delavirdine|delavirdine|mesh-list
153496243|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153439226|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153496244|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496245|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496246|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496247|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
153496248|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496249|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496250|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496251|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
153496253|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153496254|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
153496255|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496256|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496258|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496259|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153496260|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153496261|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496262|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496263|NCT00002130|Protective Agents|protective agents|mesh-ancestor
153496264|NCT00002142|Cidofovir|cidofovir|mesh-list
153496265|NCT00002142|Probenecid|probenecid|mesh-list
153496266|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
153496267|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
153496268|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153496269|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
153496270|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496271|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496272|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496273|NCT00002148|OPC 14117|opc 14117|mesh-list
153496274|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153496275|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
153496276|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496277|NCT00002148|Protective Agents|protective agents|mesh-ancestor
153496278|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496279|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
153496280|NCT00002154|Selegiline|selegiline|mesh-list
153496281|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
153496283|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153496284|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153496285|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153496309|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496311|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496312|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
153496313|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496314|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496315|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496316|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153781850|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439305|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
153496317|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153496318|NCT00002178|Ritonavir|ritonavir|mesh-list
153496319|NCT00002178|Nelfinavir|nelfinavir|mesh-list
153496320|NCT00002178|Saquinavir|saquinavir|mesh-list
153496321|NCT00002178|Delavirdine|delavirdine|mesh-list
153496322|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496323|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496324|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496329|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
153496330|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496331|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496332|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496333|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496334|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496335|NCT00002184|Lamivudine|lamivudine|mesh-list
153496336|NCT00002184|Zidovudine|zidovudine|mesh-list
153496337|NCT00002184|Stavudine|stavudine|mesh-list
153496338|NCT00002184|Adefovir|adefovir|mesh-list
153496353|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496354|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496355|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496356|NCT00002190|Lamivudine|lamivudine|mesh-list
153496357|NCT00002190|Zidovudine|zidovudine|mesh-list
153496358|NCT00002190|Saquinavir|saquinavir|mesh-list
153496359|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496360|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496361|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496362|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496363|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
153496364|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496365|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496366|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496367|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
153496368|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496369|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496370|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496371|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496372|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496373|NCT00002202|Indinavir|indinavir|mesh-list
153496374|NCT00002202|Amprenavir|amprenavir|mesh-list
153496375|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496376|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496377|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496378|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496379|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496380|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496381|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496382|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
153496383|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496384|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153496385|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
153496386|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496387|NCT00002208|Lamivudine|lamivudine|mesh-list
153496388|NCT00002208|Zidovudine|zidovudine|mesh-list
153496389|NCT00002208|Stavudine|stavudine|mesh-list
153496390|NCT00002208|Indinavir|indinavir|mesh-list
153496391|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153781851|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153496392|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496393|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496394|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429371|NCT00002630|Cobalt|cobalt|mesh-list
153496399|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
153496400|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496401|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496419|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496421|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496422|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153496423|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496424|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153496425|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153496426|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153496427|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153496428|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496429|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496430|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496431|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496432|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153710577|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153496433|NCT00002226|Semaxinib|semaxinib|mesh-list
153496434|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153496435|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153496436|NCT00002226|Growth Substances|growth substances|mesh-ancestor
153496437|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496438|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
153496439|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496440|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153496441|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496442|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496443|NCT00002238|Interferons|interferons|mesh-list
153710578|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710579|NCT04729868|Analgesics|analgesics|mesh-ancestor
153710580|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153710582|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153710583|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
153710584|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710585|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710586|NCT00419887|Vildagliptin|vildagliptin|mesh-list
153710587|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153710590|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496444|NCT00002238|Zidovudine|zidovudine|mesh-list
153496445|NCT00002238|Interferon-beta|interferon-beta|mesh-list
153496446|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
153496447|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496448|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
153496449|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496450|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
153496451|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496452|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496453|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496454|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496455|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496502|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496503|NCT00002292|Pentamidine|pentamidine|mesh-list
153496504|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
153496505|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496506|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153496507|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153496508|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153496509|NCT00002298|Ribavirin|ribavirin|mesh-list
153496510|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
153496511|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496512|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
153496513|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496514|NCT00002304|Fluconazole|fluconazole|mesh-list
153496515|NCT00002304|Ketoconazole|ketoconazole|mesh-list
153496516|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
153496517|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496518|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153496519|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496520|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191194|NCT05941585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496521|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496522|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153496523|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
153496524|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496525|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496526|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153496527|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153496528|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496529|NCT00002316|Amphotericin B|amphotericin b|mesh-list
153496530|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153496531|NCT00002316|Amebicides|amebicides|mesh-ancestor
153496532|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153496533|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153496534|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496536|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
153496538|NCT00002322|Atevirdine|atevirdine|mesh-list
153496539|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
153496540|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496541|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496542|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496543|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496550|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496552|NCT00002334|Zalcitabine|zalcitabine|mesh-list
153496553|NCT00002334|Saquinavir|saquinavir|mesh-list
153496554|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
153496555|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496556|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496557|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496558|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496559|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
153496560|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496561|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496562|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496563|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496564|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496565|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496566|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496567|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496581|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496582|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496583|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496584|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496585|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496587|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496588|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496589|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496590|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496591|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
153496592|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496593|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496594|NCT00002358|Sorivudine|sorivudine|mesh-list
153496595|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
153496596|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496597|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496598|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496599|NCT00002364|Abacavir|abacavir|mesh-list
153496600|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496601|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496602|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496603|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496604|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
153496605|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496606|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496607|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496608|NCT00002370|Itraconazole|itraconazole|mesh-list
153496609|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
153496610|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496611|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153496612|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496613|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496623|NCT00002376|Didanosine|didanosine|mesh-list
153496624|NCT00002376|Indinavir|indinavir|mesh-list
153496625|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496626|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496627|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496628|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496629|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
153496630|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496631|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496632|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496633|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
153496634|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496635|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496636|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496637|NCT00002382|Saquinavir|saquinavir|mesh-list
153496638|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496639|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496640|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496641|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496651|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496652|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496653|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496654|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
153496655|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496656|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496657|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496658|NCT00002394|Terbinafine|terbinafine|mesh-list
153496659|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
153496660|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496661|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496662|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496663|NCT00002400|Lamivudine|lamivudine|mesh-list
153496664|NCT00002400|Zidovudine|zidovudine|mesh-list
153710688|NCT00123201|Dronabinol|dronabinol|mesh-list
153496665|NCT00002400|Delavirdine|delavirdine|mesh-list
153496666|NCT00002400|Indinavir|indinavir|mesh-list
153496667|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496668|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496669|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496670|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496671|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
153496672|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496673|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496674|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496675|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
153496676|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496677|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496678|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496679|NCT00002406|Indinavir|indinavir|mesh-list
153496680|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496683|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496684|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496685|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496686|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496687|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
153496688|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496689|NCT00002412|Stavudine|stavudine|mesh-list
153496690|NCT00002412|Didanosine|didanosine|mesh-list
153496691|NCT00002412|Emivirine|emivirine|mesh-list
153496692|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
153496693|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496695|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496696|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496697|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496698|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
153496699|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496700|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
153496701|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496702|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496703|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496704|NCT00002418|Nevirapine|nevirapine|mesh-list
153496705|NCT00002418|Stavudine|stavudine|mesh-list
153496706|NCT00002418|Didanosine|didanosine|mesh-list
153496707|NCT00002418|Emivirine|emivirine|mesh-list
153496708|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
153496709|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496710|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496711|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539910|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153496740|NCT00002430|Indinavir|indinavir|mesh-list
153496741|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496742|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496743|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496744|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496745|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
153496746|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496747|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496748|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496749|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496750|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496783|NCT00002448|Efavirenz|efavirenz|mesh-list
154191195|NCT05941585|Analgesics|analgesics|mesh-ancestor
153496784|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496785|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496786|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496787|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496788|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496789|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496790|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496791|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
153496792|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496793|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496794|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496795|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496796|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496821|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496822|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153496823|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153496824|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
153496825|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496826|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496827|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153496828|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153496831|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496832|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153496833|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
153496834|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
153496835|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
153496836|NCT00002472|Etoposide|etoposide|mesh-list
153496837|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496838|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153496839|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153496840|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153496841|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496842|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496843|NCT00002478|Etoposide|etoposide|mesh-list
153781852|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439845|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
153496844|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153496845|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496880|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153496881|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
153496882|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496883|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496884|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153496885|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153496900|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153496901|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496902|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153496903|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153496904|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496905|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496906|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153496907|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
153496908|NCT00002532|Leucovorin|leucovorin|mesh-list
153496909|NCT00002532|Cytarabine|cytarabine|mesh-list
153496910|NCT00002532|Dexamethasone|dexamethasone|mesh-list
153496911|NCT00002532|Prednisolone|prednisolone|mesh-list
153496912|NCT00002532|Methotrexate|methotrexate|mesh-list
153496913|NCT00002532|Etoposide|etoposide|mesh-list
153496914|NCT00002532|Daunorubicin|daunorubicin|mesh-list
153496915|NCT00002532|Asparaginase|asparaginase|mesh-list
153496916|NCT00002532|Ifosfamide|ifosfamide|mesh-list
153496917|NCT00002532|Idarubicin|idarubicin|mesh-list
153496918|NCT00002532|Vindesine|vindesine|mesh-list
153496919|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
153781853|NCT00232037|Tegaserod|tegaserod|mesh-list
153781854|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153496920|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153496921|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
153496922|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
153496923|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153496924|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496925|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153496926|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
153496927|NCT00002532|Hormones|hormones|mesh-ancestor
153496928|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496929|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153496930|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496931|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153496932|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
153496933|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153496934|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153496935|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
153496936|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496937|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
153496938|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496939|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153496940|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153496941|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
153496942|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153496943|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496944|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153496945|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153496946|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153496980|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496981|NCT00002556|Interferons|interferons|mesh-list
153496982|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
153496983|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
153496984|NCT00002556|Prednisone|prednisone|mesh-list
153496985|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
153496986|NCT00002556|Melphalan|melphalan|mesh-list
153496987|NCT00002556|Carmustine|carmustine|mesh-list
153496988|NCT00002556|Vincristine|vincristine|mesh-list
153496989|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153496990|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
153496991|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496992|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153496993|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153731653|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731654|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731655|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497019|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497020|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497021|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497022|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497023|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497024|NCT00002574|Interferons|interferons|mesh-list
153497025|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
153497035|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497036|NCT00002580|Tamoxifen|tamoxifen|mesh-list
153497037|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
153497038|NCT00002580|Fluorouracil|fluorouracil|mesh-list
153497039|NCT00002580|Methotrexate|methotrexate|mesh-list
153497040|NCT00002580|Leuprolide|leuprolide|mesh-list
153497041|NCT00002580|Goserelin|goserelin|mesh-list
153497042|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497043|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
153497044|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497045|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497046|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497047|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
153497048|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497049|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497050|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497051|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
153497052|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497054|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
153497055|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153497056|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497057|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497058|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153497059|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497060|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153497061|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
153497062|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497063|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497064|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153497065|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153497066|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153497067|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153497068|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
153497069|NCT00002586|Vitamin E|vitamin e|mesh-list
153497070|NCT00002586|Tocopherols|tocopherols|mesh-list
153497072|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
153497073|NCT00002586|Tretinoin|tretinoin|mesh-list
153497074|NCT00002586|Isotretinoin|isotretinoin|mesh-list
153497076|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
153497077|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497078|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
153497079|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497080|NCT00002586|Protective Agents|protective agents|mesh-ancestor
153497081|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497082|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
153497083|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497084|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
153497085|NCT00002592|Busulfan|busulfan|mesh-list
153497086|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497087|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
153497088|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497089|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497090|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497091|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
153497092|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497093|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497112|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153497113|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
153497114|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153497115|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497116|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
153497117|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497118|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497119|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153497120|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497121|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497122|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497123|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497124|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
153497125|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497126|NCT00002598|Analgesics|analgesics|mesh-ancestor
153497127|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
153497128|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497145|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
153711004|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497146|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497147|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497148|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497149|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
153497150|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497151|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497152|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497153|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497154|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497155|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497156|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497157|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497158|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153497159|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497160|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497161|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497162|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153497163|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497164|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153497165|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497167|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
153497168|NCT00002616|Thiotepa|thiotepa|mesh-list
153497199|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497200|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497201|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497202|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497204|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497205|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497206|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497207|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497208|NCT00002634|Trace Elements|trace elements|mesh-ancestor
153497209|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
153497210|NCT00002646|Tamoxifen|tamoxifen|mesh-list
153497211|NCT00002646|Fenretinide|fenretinide|mesh-list
153497212|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153497213|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
153497214|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497215|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497216|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497218|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153497249|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497250|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497251|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497252|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497253|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497254|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
153497255|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
153497256|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497257|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497259|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
153497260|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497261|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
153497262|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497263|NCT00002664|Sargramostim|sargramostim|mesh-list
153497264|NCT00002664|Edrecolomab|edrecolomab|mesh-list
153497266|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497297|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497298|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497300|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497301|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497302|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781855|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
153497303|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153497304|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
153497305|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153497306|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497307|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
153497308|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497309|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153497310|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497311|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
153497312|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497313|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497314|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497334|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497335|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153497336|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153497337|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153497338|NCT00002682|Antacids|antacids|mesh-ancestor
153497339|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
153497340|NCT00002688|Cyclosporine|cyclosporine|mesh-list
153497346|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497347|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497348|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497349|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497350|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497351|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
153497352|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497353|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
153497354|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497355|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497356|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497357|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153497359|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
153497360|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497361|NCT00002700|Leucovorin|leucovorin|mesh-list
153497362|NCT00002700|Cytarabine|cytarabine|mesh-list
153497363|NCT00002700|Dexamethasone|dexamethasone|mesh-list
153497364|NCT00002700|Prednisone|prednisone|mesh-list
153497365|NCT00002700|Prednisolone|prednisolone|mesh-list
153497366|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
153497367|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153497368|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153497369|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153497370|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
153497371|NCT00002700|Doxorubicin|doxorubicin|mesh-list
153497372|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153497373|NCT00002700|Methotrexate|methotrexate|mesh-list
153497374|NCT00002700|Vincristine|vincristine|mesh-list
153497375|NCT00002700|Daunorubicin|daunorubicin|mesh-list
153497376|NCT00002700|Asparaginase|asparaginase|mesh-list
153497377|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
153497378|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
153497379|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
153497380|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497381|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
153497382|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497383|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497404|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153497405|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497407|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497408|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153497409|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497410|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
153497411|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497412|NCT00002700|Antidotes|antidotes|mesh-ancestor
153497413|NCT00002700|Protective Agents|protective agents|mesh-ancestor
153497416|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
153497417|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497418|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497419|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497420|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497421|NCT00002700|Analgesics|analgesics|mesh-ancestor
153497422|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
153497423|NCT00002718|Cytarabine|cytarabine|mesh-list
153497424|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
153497425|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
153497426|NCT00002718|Thiotepa|thiotepa|mesh-list
153497427|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153497428|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497429|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
153497430|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497431|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497432|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497433|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
153497434|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497435|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497436|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497437|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497438|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
153497463|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497464|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153497465|NCT00002730|Protective Agents|protective agents|mesh-ancestor
153497466|NCT00002742|Amphotericin B|amphotericin b|mesh-list
153497467|NCT00002742|Nystatin|nystatin|mesh-list
153497468|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153497469|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
153497470|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
153497471|NCT00002742|Amebicides|amebicides|mesh-ancestor
153497472|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153497473|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153497474|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497475|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153497476|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
153497477|NCT00002742|Ionophores|ionophores|mesh-ancestor
153497478|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153497479|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497480|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153497481|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153497482|NCT00002748|Interleukin-2|interleukin-2|mesh-list
153497483|NCT00002748|Vaccines|vaccines|mesh-list
153497484|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497485|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153497486|NCT00002748|Analgesics|analgesics|mesh-ancestor
153497487|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
153497530|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497531|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497532|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
153497533|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497534|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497535|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497536|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497537|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497538|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153497539|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
153497540|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497541|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497542|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154255974|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154255975|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154255976|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736033|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153497543|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153497544|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153497545|NCT00002778|Sargramostim|sargramostim|mesh-list
153497546|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
153497547|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497548|NCT00002784|Tamoxifen|tamoxifen|mesh-list
153497579|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497580|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153497581|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153497582|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153497584|NCT00002790|Sirolimus|sirolimus|mesh-list
153497585|NCT00002790|Methotrexate|methotrexate|mesh-list
153497586|NCT00002790|Cyclosporins|cyclosporins|mesh-list
153497587|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153497588|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
153497589|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153497590|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497591|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497592|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
153497593|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497630|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497631|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497632|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497633|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497634|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
153497635|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497658|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
153497659|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
153497660|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497661|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497662|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153497663|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
153497664|NCT05497674|Rifampin|rifampin|mesh-list
153497665|NCT05497674|Probenecid|probenecid|mesh-list
153497666|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153497667|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
153497668|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153497669|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497670|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
153497671|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497672|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497673|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497674|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153497675|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153497676|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153497677|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153497678|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153497679|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153497680|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
153440680|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
153497681|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
153497682|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497684|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
153497699|NCT05312112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497701|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153497702|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153497703|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497704|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153497705|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497706|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
153497707|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153497708|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497709|NCT05048940|Vaccines|vaccines|mesh-list
154263446|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153497710|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
153497711|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497712|NCT04836780|Dexamethasone|dexamethasone|mesh-list
153497713|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153497714|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
153497715|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
153497716|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497717|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497718|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153497719|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
153497720|NCT04836780|Hormones|hormones|mesh-ancestor
153497721|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497722|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497723|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497724|NCT04705818|Durvalumab|durvalumab|mesh-list
153497725|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153497726|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497727|NCT04610736|Temozolomide|temozolomide|mesh-list
153497728|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497729|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
153497730|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497731|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497732|NCT04529538|Vaccines|vaccines|mesh-list
153497733|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
153497734|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497735|NCT04521114|Leronlimab|leronlimab|mesh-list
153497736|NCT04521114|HIV Antibodies|hiv antibodies|mesh-list
153497737|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153497738|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153497739|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497740|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153497741|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153497742|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
153497743|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497744|NCT04521114|Immunologic Factors|immunologic factors|mesh-ancestor
153497745|NCT04521114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497771|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153497772|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497773|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153497774|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
153497776|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497777|NCT03838848|Carboplatin|carboplatin|mesh-list
153497778|NCT03838848|Pemetrexed|pemetrexed|mesh-list
153497779|NCT03838848|Antibodies|antibodies|mesh-list
153497780|NCT03838848|Immunoglobulins|immunoglobulins|mesh-list
153497781|NCT03838848|Immunologic Factors|immunologic factors|mesh-ancestor
153497782|NCT03838848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497783|NCT03838848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497784|NCT03838848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497785|NCT03838848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497786|NCT03838848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153497787|NCT03838848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497788|NCT03787602|Avelumab|avelumab|mesh-list
153497789|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153497790|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497791|NCT03745170|Capecitabine|capecitabine|mesh-list
153497792|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
153497819|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497821|NCT00978822|Clevidipine|clevidipine|mesh-list
153497822|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153497823|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153497824|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781857|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497825|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153497826|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497827|NCT00002796|Interferons|interferons|mesh-list
153497829|NCT00002796|Indomethacin|indomethacin|mesh-list
153497830|NCT00002796|Fluorouracil|fluorouracil|mesh-list
153497831|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153497832|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
153714761|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153497833|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497834|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497835|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497836|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497837|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
153497838|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497864|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497865|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
153497866|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497867|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497868|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497869|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
153497870|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497871|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497872|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497873|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497874|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497875|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497876|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497877|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497878|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497879|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497880|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497881|NCT00002802|Trace Elements|trace elements|mesh-ancestor
153497882|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
153497884|NCT00002814|Topotecan|topotecan|mesh-list
153497885|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497886|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497887|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497888|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497889|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497890|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497891|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153497892|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497893|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497894|NCT00002832|Cyclosporine|cyclosporine|mesh-list
153497928|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497929|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497930|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
153497931|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497932|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497933|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497934|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
153497935|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497936|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497937|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497939|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
153497940|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497958|NCT00002898|Vincristine|vincristine|mesh-list
153497959|NCT00002898|Epirubicin|epirubicin|mesh-list
153497960|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497961|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
153497962|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497963|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497964|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497965|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
153497966|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497967|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497968|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497969|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497970|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497971|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497972|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497973|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497974|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497975|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497976|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497977|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153497978|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497979|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153440981|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
153714893|NCT01141309|Everolimus|everolimus|mesh-list
153497980|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497981|NCT00002904|Trabectedin|trabectedin|mesh-list
153497982|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497983|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
153497984|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497987|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497988|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497989|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497990|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497991|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497992|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497993|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
153497994|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497995|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
153497996|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497997|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711524|NCT00323830|Capecitabine|capecitabine|mesh-list
153497998|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497999|NCT00002946|Penclomedine|penclomedine|mesh-list
153498000|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498001|NCT00002952|Interleukin-12|interleukin-12|mesh-list
153498002|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153498021|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153498023|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153498024|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498025|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498026|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
153498027|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498028|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498029|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
153498030|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498031|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153498032|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498033|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
153498034|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498035|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153498036|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
153498037|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498038|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153498039|NCT00002976|Estrogens|estrogens|mesh-list
153498040|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153498041|NCT00002976|Hormones|hormones|mesh-ancestor
153498042|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153498043|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498044|NCT00002982|Cytarabine|cytarabine|mesh-list
153498045|NCT00002982|Carboplatin|carboplatin|mesh-list
153498046|NCT00002982|Etoposide|etoposide|mesh-list
153498047|NCT00002982|Melphalan|melphalan|mesh-list
153498048|NCT00002982|Ifosfamide|ifosfamide|mesh-list
153498049|NCT00002982|Carmustine|carmustine|mesh-list
153498050|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498051|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498052|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498053|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153781858|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498054|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498055|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498056|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498057|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
153498059|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498060|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498094|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
153498095|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
153498096|NCT00003012|Fluorouracil|fluorouracil|mesh-list
153498097|NCT00003012|Methotrexate|methotrexate|mesh-list
153498098|NCT00003012|Epirubicin|epirubicin|mesh-list
153498099|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498100|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
153498101|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498102|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498118|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498119|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498121|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153498122|NCT00003048|Protective Agents|protective agents|mesh-ancestor
153498123|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498124|NCT00003054|Paclitaxel|paclitaxel|mesh-list
153498125|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498126|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498127|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498128|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498129|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498130|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498131|NCT00003060|Cyclosporine|cyclosporine|mesh-list
153498132|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
153498133|NCT00003060|Busulfan|busulfan|mesh-list
153498137|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
153498138|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498139|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498140|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498141|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
153498142|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498143|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498144|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498145|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153498146|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
153498147|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153498148|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498149|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
153498150|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
153498151|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498152|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153498153|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153498154|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
153498155|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498156|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153498157|NCT00003066|Docetaxel|docetaxel|mesh-list
153498158|NCT00003066|Estramustine|estramustine|mesh-list
153498159|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498160|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498161|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498162|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498178|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498179|NCT00003078|Fluorouracil|fluorouracil|mesh-list
153498180|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498181|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
153498182|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498183|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498184|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498185|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
153498186|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498187|NCT00003084|Ketoconazole|ketoconazole|mesh-list
153498189|NCT00003084|Etoposide|etoposide|mesh-list
153498190|NCT00003084|Vinblastine|vinblastine|mesh-list
153498191|NCT00003084|Doxorubicin|doxorubicin|mesh-list
153498192|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153498193|NCT00003084|Estramustine|estramustine|mesh-list
153498194|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498195|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498196|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498197|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498198|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191196|NCT05941585|Sensory System Agents|sensory system agents|mesh-ancestor
153498199|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498200|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498201|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498202|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498203|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781859|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
153498204|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
153498205|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498206|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153498208|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153498209|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
153498210|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153498211|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498212|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153498213|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498214|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
153498215|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153498216|NCT00003090|Aldesleukin|aldesleukin|mesh-list
154255977|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153498236|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
153498237|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498238|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498239|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498240|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498241|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498242|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498243|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498245|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498246|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498247|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498248|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498249|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498250|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498251|NCT00003126|Aldesleukin|aldesleukin|mesh-list
153498252|NCT00003126|Interleukin-2|interleukin-2|mesh-list
153498253|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498254|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153498255|NCT00003126|Analgesics|analgesics|mesh-ancestor
153498256|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
153498257|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153498258|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498259|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153498260|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153498261|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
153498262|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498263|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
153498264|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498265|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153498266|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
153498267|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498268|NCT00003144|Gemcitabine|gemcitabine|mesh-list
153498269|NCT00003144|Amifostine|amifostine|mesh-list
153498270|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498271|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498272|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
153498273|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498274|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153498305|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498307|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153498308|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498309|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498310|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498311|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498312|NCT00003174|Cladribine|cladribine|mesh-list
153498313|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
153498314|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498315|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498316|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
153498317|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498318|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153498319|NCT00003018|Leucovorin|leucovorin|mesh-list
153498320|NCT00003018|Fluorouracil|fluorouracil|mesh-list
153498321|NCT00003018|Mitomycins|mitomycins|mesh-list
153498322|NCT00003018|Mitomycin|mitomycin|mesh-list
153498323|NCT00003018|Dipyridamole|dipyridamole|mesh-list
153498366|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
153498389|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
153498390|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498391|NCT00003216|Gemcitabine|gemcitabine|mesh-list
153498392|NCT00003216|Fluorouracil|fluorouracil|mesh-list
153498393|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498394|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
153498395|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498396|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498397|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498398|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
153498399|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498400|NCT00003234|Vinorelbine|vinorelbine|mesh-list
153498401|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498402|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498403|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498404|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498405|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498406|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498407|NCT00003240|Vinorelbine|vinorelbine|mesh-list
153498408|NCT00003240|Ifosfamide|ifosfamide|mesh-list
153498409|NCT00003240|Mitomycins|mitomycins|mesh-list
153498410|NCT00003240|Mitomycin|mitomycin|mesh-list
153498411|NCT00003240|Vinblastine|vinblastine|mesh-list
153498412|NCT00003240|Vindesine|vindesine|mesh-list
153498413|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498414|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498415|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498416|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498417|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
153539912|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498451|NCT00003294|Carboplatin|carboplatin|mesh-list
153498452|NCT00003294|Amifostine|amifostine|mesh-list
153498453|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498454|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498455|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498456|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498457|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498458|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498459|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498460|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153498461|NCT00003294|Protective Agents|protective agents|mesh-ancestor
153498462|NCT00003330|Interleukin-12|interleukin-12|mesh-list
153498463|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153498464|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
153498465|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498466|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153498467|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153498468|NCT00003330|Growth Substances|growth substances|mesh-ancestor
153498469|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
153498470|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498471|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
153498472|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
153498473|NCT00003336|Melphalan|melphalan|mesh-list
153498474|NCT00003336|Busulfan|busulfan|mesh-list
153498475|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153498476|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498477|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
153498478|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498479|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498480|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498481|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
153498482|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498492|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153498494|NCT00003336|Protective Agents|protective agents|mesh-ancestor
153498495|NCT00003342|Paclitaxel|paclitaxel|mesh-list
153498496|NCT00003342|Carboplatin|carboplatin|mesh-list
153498497|NCT00003342|Gemcitabine|gemcitabine|mesh-list
153498498|NCT00003342|Doxorubicin|doxorubicin|mesh-list
153498499|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153498500|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498501|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498502|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498503|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498521|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
153498522|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498524|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153498525|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498526|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498527|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498528|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498529|NCT00003378|Paclitaxel|paclitaxel|mesh-list
153498530|NCT00003378|Carboplatin|carboplatin|mesh-list
153498531|NCT00003378|Gemcitabine|gemcitabine|mesh-list
153498532|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498533|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498534|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498535|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498536|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
153711864|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498537|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498538|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498539|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
153498540|NCT00003390|Irofulven|irofulven|mesh-list
153498541|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498543|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498544|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498545|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
153498547|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153498548|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498567|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498568|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498569|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498570|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
153498571|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498599|NCT00003414|Interferons|interferons|mesh-list
153498600|NCT00003414|Aldesleukin|aldesleukin|mesh-list
153498601|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
153498602|NCT00003414|Cyclosporine|cyclosporine|mesh-list
153498603|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
153498604|NCT00003414|Busulfan|busulfan|mesh-list
153498605|NCT00003414|Cyclosporins|cyclosporins|mesh-list
153498606|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498607|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
153498608|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498610|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498611|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
153498612|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498613|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498614|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498615|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
153498616|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498617|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498618|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
153498619|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
153498620|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153498621|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153498622|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153498631|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498632|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
153498633|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498634|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498635|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498636|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498637|NCT00003528|Raltitrexed|raltitrexed|mesh-list
153498638|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498639|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
153498640|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498641|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498642|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153498643|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498644|NCT00003540|Gemcitabine|gemcitabine|mesh-list
153498645|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498646|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
153498647|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498648|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498649|NCT00003546|Gemcitabine|gemcitabine|mesh-list
153498650|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498651|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
153498652|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498653|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498654|NCT00003558|Leucovorin|leucovorin|mesh-list
153498655|NCT00003558|Paclitaxel|paclitaxel|mesh-list
153498656|NCT00003558|Etoposide|etoposide|mesh-list
153498657|NCT00003558|Carboplatin|carboplatin|mesh-list
153498658|NCT00003558|Fluorouracil|fluorouracil|mesh-list
153498659|NCT00003558|Calcium|calcium|mesh-list
153498660|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
153498661|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498662|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498663|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498664|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498665|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498666|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498667|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153498668|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498669|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
153498670|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153715421|NCT00127686|Narcotics|narcotics|mesh-ancestor
153498671|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498672|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
153498673|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498674|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498675|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498676|NCT00003558|Antidotes|antidotes|mesh-ancestor
153498677|NCT00003558|Protective Agents|protective agents|mesh-ancestor
153498678|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
153498679|NCT00003558|Vitamins|vitamins|mesh-ancestor
153498680|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
153498681|NCT00003564|Procarbazine|procarbazine|mesh-list
153498682|NCT00003564|Isotretinoin|isotretinoin|mesh-list
153498684|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
153498685|NCT00003576|Fluorouracil|fluorouracil|mesh-list
153498686|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498687|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
153498688|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498689|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153539913|NCT01536249|Pramipexole|pramipexole|mesh-list
153498710|NCT00003594|Fluorouracil|fluorouracil|mesh-list
153498711|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
153498712|NCT00003594|Irinotecan|irinotecan|mesh-list
153498713|NCT00003594|Calcium|calcium|mesh-list
153498714|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
153498715|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153498716|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498717|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
153498718|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498719|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498720|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498721|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498722|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
153498723|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153498724|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498725|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498726|NCT00003594|Antidotes|antidotes|mesh-ancestor
153498727|NCT00003594|Protective Agents|protective agents|mesh-ancestor
153498728|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
153498729|NCT00003594|Vitamins|vitamins|mesh-ancestor
153498730|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
153498731|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
153498732|NCT00003600|Hematinics|hematinics|mesh-ancestor
153498733|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
153498734|NCT00003606|Etoposide|etoposide|mesh-list
153441747|NCT00386269|Codeine|codeine|mesh-list
153498735|NCT00003606|Epirubicin|epirubicin|mesh-list
153498736|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498737|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
153498738|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498739|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498740|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498741|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
153498742|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498743|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498744|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498745|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498770|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498772|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498773|NCT00003636|Carboplatin|carboplatin|mesh-list
153498774|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498775|NCT00003642|Fluorouracil|fluorouracil|mesh-list
153498776|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498777|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
153498778|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498779|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498780|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498781|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
153498782|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498783|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153498784|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153498785|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498786|NCT00003666|Irofulven|irofulven|mesh-list
153498787|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498788|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
153498789|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498790|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498792|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153498793|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
153498794|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153498795|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498796|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153498797|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498808|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153498809|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498810|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498811|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
153498812|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153498813|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153498814|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
153498815|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153498816|NCT00003690|Carboplatin|carboplatin|mesh-list
153498817|NCT00003690|Alvocidib|alvocidib|mesh-list
153498818|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498819|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
153498820|NCT00003690|Growth Substances|growth substances|mesh-ancestor
153498821|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498822|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153498823|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498824|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498825|NCT00003696|Paclitaxel|paclitaxel|mesh-list
153498826|NCT00003696|Etoposide|etoposide|mesh-list
153498827|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
153498828|NCT00003696|Carboplatin|carboplatin|mesh-list
153498829|NCT00003696|Doxorubicin|doxorubicin|mesh-list
153731659|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153498831|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498832|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498833|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498834|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498835|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498836|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498837|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498838|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
153498839|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498840|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498841|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498842|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
153498843|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498844|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498845|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498846|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498847|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498848|NCT00003708|Temozolomide|temozolomide|mesh-list
153498849|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498850|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
153498851|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498852|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498853|NCT00003714|NSC 366140|nsc 366140|mesh-list
153498854|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498855|NCT00003720|Semaxinib|semaxinib|mesh-list
153498856|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153498857|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153498858|NCT00003720|Growth Substances|growth substances|mesh-ancestor
153539914|NCT01536249|Cimetidine|cimetidine|mesh-list
153498873|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498874|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153498875|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498876|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498878|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498879|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
153498880|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498881|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498882|NCT00003762|Gemcitabine|gemcitabine|mesh-list
153498883|NCT00003762|Docetaxel|docetaxel|mesh-list
153498884|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498885|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
153498886|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498887|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498888|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498889|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498890|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498891|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
153498892|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498893|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498894|NCT00003780|Gemcitabine|gemcitabine|mesh-list
153498895|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498896|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
153498897|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498898|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498899|NCT00003786|Irofulven|irofulven|mesh-list
153498900|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498901|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
153712158|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153498902|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731660|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153498905|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153498906|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
153498907|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498908|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
153498909|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498910|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153498911|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
153498912|NCT00003804|Dactinomycin|dactinomycin|mesh-list
153498913|NCT00003804|Vincristine|vincristine|mesh-list
153498914|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498915|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498916|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498917|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498918|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498919|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498942|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498943|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498944|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498945|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
153498946|NCT00003834|Antidotes|antidotes|mesh-ancestor
153498947|NCT00003834|Protective Agents|protective agents|mesh-ancestor
153498948|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
153498949|NCT00003834|Vitamins|vitamins|mesh-ancestor
153498950|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
153498951|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
153498952|NCT00003846|Thiotepa|thiotepa|mesh-list
153498953|NCT00003846|Carboplatin|carboplatin|mesh-list
153498954|NCT00003846|Vincristine|vincristine|mesh-list
153498955|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498956|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
153498957|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498958|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498959|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498960|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
153498961|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498962|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498963|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498964|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498965|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498966|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498967|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498968|NCT00003852|Paclitaxel|paclitaxel|mesh-list
153498969|NCT00003852|Etoposide|etoposide|mesh-list
153498970|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
153498971|NCT00003852|Carboplatin|carboplatin|mesh-list
153498972|NCT00003852|Epirubicin|epirubicin|mesh-list
153498973|NCT00003852|Ifosfamide|ifosfamide|mesh-list
153498974|NCT00003852|Thiotepa|thiotepa|mesh-list
153499005|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153499006|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499007|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
153712220|NCT00326404|Desogestrel|desogestrel|mesh-list
153499008|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499009|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499010|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499011|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
153499012|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499013|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499014|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499015|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153499016|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
153499035|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499036|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
154255978|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499037|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499038|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499039|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
153499040|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499041|NCT00003894|Thalidomide|thalidomide|mesh-list
153499042|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499043|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
153499044|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499045|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
153499046|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153499047|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499048|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153499049|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153499050|NCT00003894|Growth Substances|growth substances|mesh-ancestor
153499051|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
153499059|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499060|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153499061|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499062|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499064|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153499065|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153499066|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
153499067|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499068|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499069|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499070|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499071|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153499072|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153499073|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153499074|NCT00003912|Carboplatin|carboplatin|mesh-list
153499075|NCT00003912|Doxorubicin|doxorubicin|mesh-list
153499093|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499094|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499095|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499096|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499097|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499098|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499100|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
153499101|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153499102|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
153499103|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781861|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153499104|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499105|NCT00003954|Cyclosporine|cyclosporine|mesh-list
153499106|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
153499107|NCT00003954|Melphalan|melphalan|mesh-list
153499108|NCT00003954|Cyclosporins|cyclosporins|mesh-list
153499109|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499110|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499111|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499112|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
153499113|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499114|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
153499115|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499116|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
153499117|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499118|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153499119|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499121|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153499122|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
153499123|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153499124|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499125|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
153499126|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499127|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
153499128|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153499129|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153499130|NCT00003960|Prednisolone|prednisolone|mesh-list
153499131|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
153499132|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
153499151|NCT00003960|Hormones|hormones|mesh-ancestor
153499152|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499153|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153499154|NCT00003960|Protective Agents|protective agents|mesh-ancestor
153499155|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499156|NCT00003966|Defibrotide|defibrotide|mesh-list
153499157|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153499158|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153499159|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499160|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153499161|NCT00003972|Tamoxifen|tamoxifen|mesh-list
153499162|NCT00003972|Paclitaxel|paclitaxel|mesh-list
153499163|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
153499164|NCT00003972|Carboplatin|carboplatin|mesh-list
153499165|NCT00003972|Melphalan|melphalan|mesh-list
153499166|NCT00003972|Busulfan|busulfan|mesh-list
153499167|NCT00003972|Thiotepa|thiotepa|mesh-list
153499168|NCT00003972|Sargramostim|sargramostim|mesh-list
153499169|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499170|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712315|NCT00320047|Baclofen|baclofen|mesh-list
153499171|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499172|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499173|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499174|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499175|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499176|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
153499177|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499178|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499179|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499180|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
153499181|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499182|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153499183|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
153499184|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499185|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499186|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153499187|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153499188|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153499189|NCT00003984|Lintuzumab|lintuzumab|mesh-list
153499207|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499208|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499209|NCT00004014|Doxorubicin|doxorubicin|mesh-list
153499210|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153499211|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499212|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499213|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499214|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499215|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499216|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499217|NCT00004032|Interferons|interferons|mesh-list
153499218|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
153499219|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499220|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
153499221|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499222|NCT00004050|Interleukin-2|interleukin-2|mesh-list
153499223|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499224|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153499225|NCT00004050|Analgesics|analgesics|mesh-ancestor
153499226|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
153499227|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499228|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499229|NCT00004056|Cytarabine|cytarabine|mesh-list
153499230|NCT00004056|Thioguanine|thioguanine|mesh-list
153499231|NCT00004056|Melphalan|melphalan|mesh-list
153499232|NCT00004056|Daunorubicin|daunorubicin|mesh-list
153499233|NCT00004056|Asparaginase|asparaginase|mesh-list
153499234|NCT00004056|Lenograstim|lenograstim|mesh-list
153499235|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499236|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
153499237|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499238|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499239|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
153499240|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499241|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499242|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
153499243|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255980|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153499244|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153499245|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499246|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
153499247|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499248|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499265|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499266|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
153499267|NCT00004074|Carboplatin|carboplatin|mesh-list
153499268|NCT00004074|Trastuzumab|trastuzumab|mesh-list
153499269|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153499271|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499272|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153499274|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
153499275|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499276|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153499277|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153499278|NCT00004074|Growth Substances|growth substances|mesh-ancestor
153499279|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
153499280|NCT00004086|Cytarabine|cytarabine|mesh-list
153499281|NCT00004086|Etoposide|etoposide|mesh-list
153499282|NCT00004086|Ifosfamide|ifosfamide|mesh-list
153499283|NCT00004086|Epratuzumab|epratuzumab|mesh-list
153499284|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499285|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499286|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499287|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499288|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499289|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499290|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499291|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
153499292|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
153499293|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499294|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499295|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
153499296|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499297|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499298|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
153499299|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153499300|NCT00004104|Interferons|interferons|mesh-list
153499301|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
153499302|NCT00004104|Interleukin-2|interleukin-2|mesh-list
153499303|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499304|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
153499305|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499306|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
153499307|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499328|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781862|NCT02212210|Prednisolone|prednisolone|mesh-list
153499330|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499331|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
153781863|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
153499332|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499333|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153499334|NCT00004128|Cytarabine|cytarabine|mesh-list
153499335|NCT00004128|Aldesleukin|aldesleukin|mesh-list
153499336|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
153499337|NCT00004128|Busulfan|busulfan|mesh-list
153499338|NCT00004128|Etoposide|etoposide|mesh-list
153499339|NCT00004128|Daunorubicin|daunorubicin|mesh-list
153499340|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499341|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
153499342|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499343|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499344|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499345|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
153626818|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499347|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499348|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499349|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499350|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499351|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499352|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499353|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499354|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
154255981|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
153499355|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
153499356|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499357|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499358|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153499359|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153499360|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153499361|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153499362|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499371|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499372|NCT00004164|Leucovorin|leucovorin|mesh-list
153499373|NCT00004164|Docetaxel|docetaxel|mesh-list
153499374|NCT00004164|Fluorouracil|fluorouracil|mesh-list
153499375|NCT00004164|Calcium|calcium|mesh-list
153499376|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
153499377|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499378|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499379|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499380|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499381|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855936|NCT02900157|Durvalumab|durvalumab|mesh-list
153499382|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153499383|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499384|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
153499385|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499386|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499387|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
153499388|NCT00004164|Antidotes|antidotes|mesh-ancestor
153499389|NCT00004164|Protective Agents|protective agents|mesh-ancestor
153499390|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
153499391|NCT00004164|Vitamins|vitamins|mesh-ancestor
153499392|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
153499393|NCT00004176|Etoposide|etoposide|mesh-list
153499394|NCT00004176|Amifostine|amifostine|mesh-list
153499395|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499396|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499397|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499398|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499399|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499400|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499401|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153499402|NCT00004176|Protective Agents|protective agents|mesh-ancestor
153499403|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499404|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
153499405|NCT00004188|Melphalan|melphalan|mesh-list
153499406|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
153499407|NCT00004188|Cisplatin|cisplatin|mesh-list
153499408|NCT00004188|Carboplatin|carboplatin|mesh-list
153499409|NCT00004188|Doxorubicin|doxorubicin|mesh-list
153499410|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153499411|NCT00004188|Etoposide|etoposide|mesh-list
153499412|NCT00004188|Vincristine|vincristine|mesh-list
153499413|NCT00004188|Topotecan|topotecan|mesh-list
153499414|NCT00004188|Isotretinoin|isotretinoin|mesh-list
153499415|NCT00004188|Lenograstim|lenograstim|mesh-list
153499416|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499417|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
153499418|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499419|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499420|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499421|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
153499427|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499428|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499429|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499430|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153499431|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499432|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499433|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499434|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153499435|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
153499436|NCT00004194|Fludarabine|fludarabine|mesh-list
153499437|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
153499438|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499439|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499451|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
153499452|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
153499453|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499454|NCT00004206|Leucovorin|leucovorin|mesh-list
153499455|NCT00004206|Fluorouracil|fluorouracil|mesh-list
153499456|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
153499457|NCT00004206|Calcium|calcium|mesh-list
153499458|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
153499459|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153499460|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499461|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
153499462|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499463|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499464|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499465|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499466|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
153499467|NCT00004206|Antidotes|antidotes|mesh-ancestor
153499468|NCT00004206|Protective Agents|protective agents|mesh-ancestor
153499469|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
153499470|NCT00004206|Vitamins|vitamins|mesh-ancestor
153499471|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
153499472|NCT00004212|Exatecan|exatecan|mesh-list
153499473|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153499474|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499475|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499476|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499477|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499478|NCT00004218|Prednisolone|prednisolone|mesh-list
153499479|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
153499480|NCT00004218|Chlorambucil|chlorambucil|mesh-list
153499481|NCT00004218|Doxorubicin|doxorubicin|mesh-list
153499482|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153499483|NCT00004218|Fludarabine|fludarabine|mesh-list
153499484|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
153499485|NCT00004218|Vincristine|vincristine|mesh-list
153499486|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499487|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
153499488|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499489|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499490|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499491|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
153626819|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
153499510|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
153499511|NCT00004224|Etoposide|etoposide|mesh-list
153499512|NCT00004224|Vincristine|vincristine|mesh-list
153499513|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499514|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
153499515|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499516|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712680|NCT05457751|Rocuronium|rocuronium|mesh-list
153499517|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499518|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
153499519|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499520|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499583|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153499585|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499586|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153499587|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153499588|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499589|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153499590|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153499591|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153499592|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499601|NCT00004278|Ganciclovir|ganciclovir|mesh-list
153499602|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153499603|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
153499621|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499622|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499623|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499624|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499625|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153499626|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
153499627|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153499628|NCT00004368|Colchicine|colchicine|mesh-list
153499629|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
153499630|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499631|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499632|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499633|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499634|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499635|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255983|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154255984|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
153499636|NCT00004380|Methocarbamol|methocarbamol|mesh-list
153499637|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153499638|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499639|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153499640|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499641|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153499642|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499643|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499644|NCT00004404|Clotrimazole|clotrimazole|mesh-list
153499646|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
153499647|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499648|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
153499649|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499650|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499651|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153499652|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153499653|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499654|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
153499655|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153499656|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153499657|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153499658|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
153499659|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499683|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153499684|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
153539915|NCT01536249|Dexpramipexole|dexpramipexole|mesh-list
153499699|NCT00004446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153499700|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153499701|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153499702|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499703|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153499704|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
153499705|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499706|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153499707|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
153499708|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153499732|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499733|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499734|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499735|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499736|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499737|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
153499738|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
153499739|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499740|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
153499741|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499742|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153499743|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
153499744|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
153499745|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499746|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153499747|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153499748|NCT00004482|Protective Agents|protective agents|mesh-ancestor
153499749|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
153499750|NCT00004488|Vitamin D|vitamin d|mesh-list
153499751|NCT00004488|Alendronate|alendronate|mesh-list
153499752|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
153499753|NCT00004488|Calcium|calcium|mesh-list
153499754|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153499755|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499756|NCT00004488|Vitamins|vitamins|mesh-ancestor
153499757|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
153499758|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153499759|NCT00004488|Antacids|antacids|mesh-ancestor
153499760|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499792|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153499793|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153499794|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
153499797|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499798|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153499799|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
153499800|NCT00004650|Estrogens|estrogens|mesh-list
153499953|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153499954|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153499956|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153499957|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499958|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499959|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499960|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499961|NCT00004872|Endostatins|endostatins|mesh-list
153499962|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499963|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153499964|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153499965|NCT00004872|Growth Substances|growth substances|mesh-ancestor
153499966|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499967|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
153499968|NCT00004878|Cytarabine|cytarabine|mesh-list
153499969|NCT00004878|Methotrexate|methotrexate|mesh-list
153499997|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499998|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499999|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
153500000|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500001|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
153500002|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
153500003|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
153500004|NCT00004890|Aldesleukin|aldesleukin|mesh-list
153500005|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500006|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153500007|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500008|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
153500009|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500010|NCT00004920|Raltitrexed|raltitrexed|mesh-list
153500011|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500064|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
153500086|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500088|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
153500089|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153500090|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500091|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
153500092|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
153500093|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
153500094|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500095|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153500096|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
153500097|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500098|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
153500099|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500100|NCT00005046|Paclitaxel|paclitaxel|mesh-list
153500101|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153500102|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500103|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
153500104|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
153500105|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
153500106|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500107|NCT00005064|Bortezomib|bortezomib|mesh-list
153500202|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500203|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500243|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
153500244|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153500245|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153500246|NCT00005604|Growth Substances|growth substances|mesh-ancestor
153500247|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
153500248|NCT00005610|Sargramostim|sargramostim|mesh-list
153500249|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
153500250|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500251|NCT00005616|Antibodies|antibodies|mesh-list
153500252|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153500253|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
153500254|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500255|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
153500256|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716469|NCT04705402|Mannitol|mannitol|mesh-list
153500282|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500283|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
153500284|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500285|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500286|NCT00005658|Glycine|glycine|mesh-list
153500287|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
153500288|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500289|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500290|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500291|NCT00005796|Vincristine|vincristine|mesh-list
153500292|NCT00005796|Lomustine|lomustine|mesh-list
153500293|NCT00005796|Procarbazine|procarbazine|mesh-list
153500294|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153500295|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500296|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
153500297|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
153500298|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
153500299|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500300|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153500301|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
153500302|NCT00005802|Cytarabine|cytarabine|mesh-list
153500303|NCT00005802|Aldesleukin|aldesleukin|mesh-list
153500304|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
153500327|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153500328|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153500353|NCT00355290|Vitamin K|vitamin k|mesh-list
153500354|NCT00355290|Vitamins|vitamins|mesh-ancestor
153500355|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
153500356|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781865|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
153500388|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153500389|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153500390|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153500391|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153500392|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500393|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500394|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153500395|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153500396|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
153500397|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153500398|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153500399|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500400|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153500429|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153500430|NCT00356460|Mitogens|mitogens|mesh-list
153500431|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
153500432|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500433|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500434|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
153500594|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500595|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500596|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153500597|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153500598|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500599|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500600|NCT00358488|Albuterol|albuterol|mesh-list
153500601|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153500602|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153500603|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
153500604|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500605|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500606|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153500607|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
153500635|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500636|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
153500637|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500687|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500688|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500689|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500690|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
153500691|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
153500692|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500693|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154255985|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500694|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
153500695|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500696|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
153500697|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153500729|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500731|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
153500732|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500733|NCT00361920|Prednisone|prednisone|mesh-list
153500734|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500735|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
153500736|NCT00361920|Hormones|hormones|mesh-ancestor
153500737|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153500738|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500739|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153500740|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500741|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
153500742|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153500773|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153500774|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153500775|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500777|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
153500778|NCT00363090|Doxorubicin|doxorubicin|mesh-list
153500779|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153500780|NCT00363090|Vincristine|vincristine|mesh-list
153500781|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
153500782|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500783|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
153500784|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500785|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500786|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153500787|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
153500788|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500901|NCT00366834|Casopitant|casopitant|mesh-list
153500902|NCT00366834|BB 1101|bb 1101|mesh-list
153500903|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500904|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
153500905|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
153500906|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500907|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500908|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153500909|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
153500910|NCT00366834|Hormones|hormones|mesh-ancestor
153781867|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
153443901|NCT01936974|Carboplatin|carboplatin|mesh-list
153500933|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500936|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153500937|NCT00367302|Narcotics|narcotics|mesh-ancestor
153500938|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153500939|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500940|NCT00367302|Analgesics|analgesics|mesh-ancestor
153500941|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
153500942|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500943|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153500944|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
153500945|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
153500946|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
153500947|NCT00367536|Estrogens|estrogens|mesh-list
153500948|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153500949|NCT00367536|Hormones|hormones|mesh-ancestor
153500950|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153500951|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500952|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153500953|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153500954|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
153500955|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153500956|NCT00367614|Pantoprazole|pantoprazole|mesh-list
153500957|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153500958|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153500959|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153500960|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500990|NCT00368238|Hematinics|hematinics|mesh-ancestor
153500991|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
153500992|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153500993|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500994|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
153500995|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153501039|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153501040|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501041|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501043|NCT00369954|Gemcitabine|gemcitabine|mesh-list
153501044|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501045|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153501046|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
153501047|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501048|NCT00370188|Topiramate|topiramate|mesh-list
153501049|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
153501050|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153501051|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501052|NCT00370266|Triamcinolone|triamcinolone|mesh-list
153501053|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501054|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
153501055|NCT00370266|Hormones|hormones|mesh-ancestor
153501087|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501088|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501089|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153501090|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153501091|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153501092|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501093|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153501094|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153501095|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153501096|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501133|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
153501134|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501135|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501136|NCT00371592|Acyclovir|acyclovir|mesh-list
153501168|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501170|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
153501171|NCT00372294|Hormones|hormones|mesh-ancestor
153501251|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153501252|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501253|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
153501254|NCT00375258|Coagulants|coagulants|mesh-ancestor
153501255|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
153501256|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153501257|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501259|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153501260|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501261|NCT00376272|Valsartan|valsartan|mesh-list
153501262|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153501294|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153501295|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153501296|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
153501297|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501298|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153501299|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153501300|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501301|NCT00377910|Lidocaine|lidocaine|mesh-list
153501302|NCT00377910|Polidocanol|polidocanol|mesh-list
153501327|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153501328|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501329|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153501330|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153501331|NCT00378066|Growth Substances|growth substances|mesh-ancestor
153501332|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501333|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
153501334|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153501335|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
153501336|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501337|NCT00378144|Acetaminophen|acetaminophen|mesh-list
153731672|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153731673|NCT01243177|Lacosamide|lacosamide|mesh-list
154255987|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716791|NCT00428311|Metformin|metformin|mesh-list
153501338|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
153501339|NCT00378144|Ephedrine|ephedrine|mesh-list
153501340|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153501341|NCT00378144|Analgesics|analgesics|mesh-ancestor
153501342|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
153501343|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501344|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501345|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
153501346|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153501386|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153501387|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
153501388|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153501389|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501390|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153501391|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501392|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153501393|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
153501394|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501395|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153501396|NCT00379158|Micronutrients|micronutrients|mesh-list
153501397|NCT00379158|Trace Elements|trace elements|mesh-list
153501398|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501399|NCT00379626|Hormones|hormones|mesh-list
153501400|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856158|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153501401|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501402|NCT00380328|Neratinib|neratinib|mesh-list
153501432|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153501433|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501434|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
153444431|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
153501435|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153501436|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153501437|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153501438|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501439|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501440|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153501441|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153501442|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153501444|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153501475|NCT00381342|Hormones|hormones|mesh-ancestor
153501476|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501477|NCT00381654|MP 412|mp 412|mesh-list
153501478|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501479|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153501480|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501481|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501482|NCT00381732|Tadalafil|tadalafil|mesh-list
153501483|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
153501484|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153501485|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153501486|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501516|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153501517|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153501518|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501519|NCT00383214|Epratuzumab|epratuzumab|mesh-list
153501520|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153501521|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501522|NCT00383370|Aflibercept|aflibercept|mesh-list
153501523|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153501524|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153501525|NCT00383370|Growth Substances|growth substances|mesh-ancestor
153501526|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501572|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501573|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
153501575|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501576|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501577|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153501578|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501601|NCT00384618|Protective Agents|protective agents|mesh-ancestor
153501602|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153501603|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153501604|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
153501606|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153501607|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501608|NCT00384696|Nicotine|nicotine|mesh-list
153501609|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153501610|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
153501611|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501612|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501613|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153501614|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153501615|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
153501616|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501617|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501618|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
153501619|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501668|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
153501669|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501670|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501671|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501672|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501673|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153501674|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153501675|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
153501676|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153501677|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
153501678|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153501679|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153501680|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153501711|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153501712|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501713|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
153501714|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
153501715|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
153501716|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501717|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153501718|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
153501719|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153501720|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
153501721|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153501722|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153501723|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501724|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153501725|NCT00422994|Ropinirole|ropinirole|mesh-list
153501726|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153501727|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153501728|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
153501750|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153501752|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
153501753|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
153501754|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
153501755|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501756|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153501757|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
153501758|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153501759|NCT01790100|Ribavirin|ribavirin|mesh-list
153501760|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
153501813|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501814|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153501815|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153501816|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153501817|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
153501818|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501820|NCT02996916|Olmesartan|olmesartan|mesh-list
153501821|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153501822|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153501856|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501857|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
153501858|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
153501893|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501894|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
153501895|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501896|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501897|NCT02992938|Acetazolamide|acetazolamide|mesh-list
154255988|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
153430114|NCT01555489|Vitamins|vitamins|mesh-ancestor
153501898|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
153501934|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153501935|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
153501936|NCT02990286|Rituximab|rituximab|mesh-list
153501937|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153501974|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
153501976|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501977|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153502012|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
153502013|NCT01270932|Lenalidomide|lenalidomide|mesh-list
153502014|NCT01270932|BB 1101|bb 1101|mesh-list
153502058|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
153502059|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502119|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502120|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502121|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502123|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
153502124|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502125|NCT01274130|Metformin|metformin|mesh-list
153502126|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153502127|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502128|NCT01276080|Donepezil|donepezil|mesh-list
153502129|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153502130|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502131|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502132|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
153713430|NCT05831566|Budesonide|budesonide|mesh-list
153502133|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502134|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502135|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
153502136|NCT01276548|Carboplatin|carboplatin|mesh-list
153502137|NCT01276548|genexol-PM|genexol-pm|mesh-list
153502138|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502139|NCT01276548|Tubulin Modulators|tubulin modulators|mesh-ancestor
153502140|NCT01276548|Antimitotic Agents|antimitotic agents|mesh-ancestor
153502141|NCT01276548|Mitosis Modulators|mitosis modulators|mesh-ancestor
153502142|NCT01276548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502143|NCT01277172|Rituximab|rituximab|mesh-list
153502144|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153502145|NCT01277172|Antibodies|antibodies|mesh-list
153502146|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
153502147|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153502183|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502184|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502185|NCT01279668|Montelukast|montelukast|mesh-list
153502186|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153445187|NCT00000803|Zidovudine|zidovudine|mesh-list
153502187|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
153502220|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153502221|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153502222|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502224|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153502225|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
153502226|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502250|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153502251|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
153502252|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
153502253|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502254|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502255|NCT01272180|Vaccines|vaccines|mesh-list
153502256|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
153502257|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502258|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
153731674|NCT01243177|Carbamazepine|carbamazepine|mesh-list
153502259|NCT01271010|Rituximab|rituximab|mesh-list
153781872|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
153502261|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502262|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
153502263|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502264|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502265|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153502320|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502321|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502322|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502324|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502325|NCT01279980|Anesthetics|anesthetics|mesh-list
153502326|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
153502350|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153502351|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153502352|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
153502353|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153502354|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153502355|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
153502356|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153502357|NCT00249288|Folic Acid|folic acid|mesh-list
153502358|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
153502359|NCT00249288|Hematinics|hematinics|mesh-ancestor
153502360|NCT00249288|Vitamins|vitamins|mesh-ancestor
153502361|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
153502362|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502363|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
153502364|NCT00247962|Etanercept|etanercept|mesh-list
153502365|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153502366|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153502367|NCT00247962|Analgesics|analgesics|mesh-ancestor
153502368|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
153502406|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153502407|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153731675|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
153502408|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781873|NCT02212210|Hormones|hormones|mesh-ancestor
153502409|NCT00242580|Triamcinolone|triamcinolone|mesh-list
153502410|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153502411|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153502412|NCT00242580|Verteporfin|verteporfin|mesh-list
153502413|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153502414|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153502415|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
153502416|NCT00242580|Hormones|hormones|mesh-ancestor
153502417|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153502418|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502419|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502420|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
153502421|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502422|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502423|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153502442|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153502444|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
153502445|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502446|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153502447|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153502448|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502449|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502450|NCT03804840|Hormones|hormones|mesh-ancestor
153502451|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153502452|NCT03804372|Tenofovir|tenofovir|mesh-list
153502453|NCT03804372|Rituximab|rituximab|mesh-list
153502454|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502455|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502456|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
153502457|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502458|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502459|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
153502460|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502461|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153502462|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153502463|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502464|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502465|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153502466|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153502467|NCT03803124|Tolvaptan|tolvaptan|mesh-list
153502655|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502656|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502657|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
153502658|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502659|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502660|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153502661|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502663|NCT03216564|Calcitriol|calcitriol|mesh-list
153502664|NCT03216564|Vitamins|vitamins|mesh-ancestor
153502665|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
153502666|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502667|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153502668|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153502669|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153502670|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502671|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502672|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153502673|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153502674|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153502675|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
153539916|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153502757|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502758|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502759|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502760|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153502761|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153502776|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
153502777|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153502778|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502779|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153502780|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153502781|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153502782|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
153781877|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153781880|NCT00232076|Cyclosporins|cyclosporins|mesh-list
153781881|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781882|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502841|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502868|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502869|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153502871|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153502872|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502873|NCT01836822|Dimercaprol|dimercaprol|mesh-list
153502874|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
153502966|NCT01839864|Chrysarobin|chrysarobin|mesh-list
153502967|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153502968|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153502969|NCT01839864|Analgesics|analgesics|mesh-ancestor
153502970|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
153502980|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
153502981|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502982|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502983|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503011|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503012|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
153503013|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503014|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153503015|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153503016|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503017|NCT01836432|Antidotes|antidotes|mesh-ancestor
153503018|NCT01836432|Protective Agents|protective agents|mesh-ancestor
153503019|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
153503020|NCT01836432|Vitamins|vitamins|mesh-ancestor
153503021|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
153503022|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153503023|NCT01720056|Verapamil|verapamil|mesh-list
153503024|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503025|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
153503026|NCT01720056|Hormones|hormones|mesh-ancestor
153503027|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503028|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503029|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503030|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
153503031|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503032|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154255990|NCT01154348|Metformin|metformin|mesh-list
153503033|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153503034|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153503060|NCT01721616|Azithromycin|azithromycin|mesh-list
153503061|NCT01721616|Cefazolin|cefazolin|mesh-list
153503062|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153503063|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503064|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153503065|NCT01721694|Azithromycin|azithromycin|mesh-list
153503066|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153503067|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503068|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153503069|NCT01722396|Vitamin D|vitamin d|mesh-list
153503070|NCT01722396|Vitamins|vitamins|mesh-ancestor
153503071|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
153503072|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503073|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153503074|NCT01722630|Dopamine|dopamine|mesh-list
153503075|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153503076|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
153503077|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
153503078|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503079|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503080|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
153503081|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503082|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503083|NCT01722630|Protective Agents|protective agents|mesh-ancestor
153503084|NCT01722942|Amiodarone|amiodarone|mesh-list
153503111|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153503112|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
153503113|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503169|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153503170|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153503171|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153503195|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153503196|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153503197|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503198|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
153503200|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153503201|NCT01726530|Narcotics|narcotics|mesh-ancestor
153503202|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503203|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503204|NCT01726530|Analgesics|analgesics|mesh-ancestor
153503205|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
153503206|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503207|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153503208|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153503209|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
153503210|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
153503211|NCT01726686|Ropivacaine|ropivacaine|mesh-list
153503212|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
153503213|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
153503214|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503215|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503216|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
153503293|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
153503294|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
153503295|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153503296|NCT01724658|Androgens|androgens|mesh-ancestor
153503297|NCT01724658|Hormones|hormones|mesh-ancestor
153503298|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503299|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503300|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153503301|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503302|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
153503303|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
153503304|NCT01049334|Analgesics|analgesics|mesh-ancestor
153503305|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
153503306|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503307|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503308|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153503309|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503310|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503311|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503333|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153503334|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153503335|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503336|NCT01048866|Acetaminophen|acetaminophen|mesh-list
153503337|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
153503338|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503339|NCT01048866|Analgesics|analgesics|mesh-ancestor
153503340|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
153503341|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503342|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503343|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
153503344|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153503345|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503346|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503347|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153503348|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503349|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503350|NCT01048788|Tolvaptan|tolvaptan|mesh-list
153503351|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153503429|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
153503430|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731676|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153503431|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503433|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153503434|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153503435|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503436|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153503437|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153503438|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503439|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503440|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503441|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153503468|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503469|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
153503470|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503471|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503472|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153503474|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503475|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503476|NCT03402204|Ubenimex|ubenimex|mesh-list
153503477|NCT03402204|Simvastatin|simvastatin|mesh-list
153503478|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153503479|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153503480|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
153503481|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503482|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153503483|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153503484|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503485|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153503486|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
153503487|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503488|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153503523|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503524|NCT03401346|Analgesics|analgesics|mesh-ancestor
153503525|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
153503526|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503527|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
153503528|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153503566|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
153503567|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503568|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503608|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503609|NCT02241876|Expectorants|expectorants|mesh-ancestor
153503610|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
153503611|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153503612|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
153503613|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503614|NCT02241876|Protective Agents|protective agents|mesh-ancestor
153503615|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503616|NCT02241876|Antidotes|antidotes|mesh-ancestor
153503617|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153503618|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153503619|NCT02242344|Telmisartan|telmisartan|mesh-list
153503654|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
153503655|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
153503656|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503657|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713964|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
153503658|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153503659|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
153503660|NCT02243124|Hormones|hormones|mesh-ancestor
153503686|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
153503687|NCT02243436|Hormones|hormones|mesh-ancestor
153503688|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503689|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153503690|NCT02243436|Protective Agents|protective agents|mesh-ancestor
153503691|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153503692|NCT02243436|Immunotoxins|immunotoxins|mesh-ancestor
153503693|NCT02243436|Immunoconjugates|immunoconjugates|mesh-ancestor
153503694|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
153503695|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153503696|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
153503697|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
153503698|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503699|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503700|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503701|NCT02243826|Analgesics|analgesics|mesh-ancestor
153396612|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153396613|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396614|NCT01938079|Ketamine|ketamine|mesh-list
153396615|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153714008|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
153714009|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153714010|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153503702|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
153503703|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503704|NCT02244216|Fenoterol|fenoterol|mesh-list
153503705|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153503706|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
153503707|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503708|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503709|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153503734|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503735|NCT02244528|Urological Agents|urological agents|mesh-ancestor
153503736|NCT02245464|Telmisartan|telmisartan|mesh-list
153503737|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153503738|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153503739|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153503740|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503741|NCT02246244|Escitalopram|escitalopram|mesh-list
153503742|NCT02246244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153503755|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
153503756|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714011|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153714012|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153714013|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153503757|NCT02246868|Factor VIII|factor viii|mesh-list
153503758|NCT02246868|Coagulants|coagulants|mesh-ancestor
153503788|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503789|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
153503790|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
153503791|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153503792|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
153503793|NCT02247648|Tramadol|tramadol|mesh-list
153503794|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153503795|NCT02247648|Narcotics|narcotics|mesh-ancestor
153503796|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503797|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503798|NCT02247648|Analgesics|analgesics|mesh-ancestor
153503799|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
153503800|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503801|NCT02248428|Clarithromycin|clarithromycin|mesh-list
153503802|NCT02248428|Thalidomide|thalidomide|mesh-list
153503803|NCT02248428|Dexamethasone|dexamethasone|mesh-list
153503804|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
153503805|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503806|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
153503839|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153503840|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153503841|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503842|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503843|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153503844|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
153626820|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503880|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503902|NCT02244762|Analgesics|analgesics|mesh-ancestor
153430250|NCT00382538|Mifepristone|mifepristone|mesh-list
153503903|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
153503904|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503905|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
153503906|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
153503907|NCT02242734|Hydrocodone|hydrocodone|mesh-list
153503908|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153503909|NCT02242734|Narcotics|narcotics|mesh-ancestor
153503910|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503911|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503912|NCT02242734|Analgesics|analgesics|mesh-ancestor
153503913|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
153503914|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503915|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
153503916|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
153503917|NCT02244606|Fluconazole|fluconazole|mesh-list
153503918|NCT02244606|Micafungin|micafungin|mesh-list
153503919|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
153504007|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504008|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504009|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504010|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
153504011|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504012|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153504013|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
153504014|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153856364|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153504015|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153504052|NCT00553644|Growth Substances|growth substances|mesh-ancestor
153504081|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504082|NCT00550836|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153504083|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153504084|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504085|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504086|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
153504132|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504133|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153504134|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
153504135|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153504136|NCT03029676|Midazolam|midazolam|mesh-list
153504137|NCT03029676|Fentanyl|fentanyl|mesh-list
153504138|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
153504139|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504140|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504141|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153504142|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153504143|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153504144|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153504178|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153504179|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504180|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504182|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153504183|NCT03839160|Narcotics|narcotics|mesh-ancestor
153504184|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504185|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504186|NCT03839160|Analgesics|analgesics|mesh-ancestor
153504187|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
153504217|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504218|NCT03838068|Anesthetics|anesthetics|mesh-list
153504220|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
153504221|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504222|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504223|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
153504224|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504225|NCT05447208|Hormones|hormones|mesh-list
153504312|NCT05768542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504313|NCT05768464|Axitinib|axitinib|mesh-list
153504314|NCT05768464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504315|NCT05768464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153504345|NCT05768204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153504346|NCT05768204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504347|NCT05768204|Antiemetics|antiemetics|mesh-ancestor
153504348|NCT05768204|Autonomic Agents|autonomic agents|mesh-ancestor
153504349|NCT05768204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504350|NCT05768204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153504351|NCT05768204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153504352|NCT05768204|Protective Agents|protective agents|mesh-ancestor
153504353|NCT05768126|Rivastigmine|rivastigmine|mesh-list
153504354|NCT05768126|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153504355|NCT05768126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504356|NCT05768126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504357|NCT05768126|Cholinergic Agents|cholinergic agents|mesh-ancestor
153504358|NCT05768126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504359|NCT05768126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504389|NCT05767827|Autonomic Agents|autonomic agents|mesh-ancestor
153504390|NCT05767827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153504391|NCT05767827|Respiratory System Agents|respiratory system agents|mesh-ancestor
153504392|NCT05767827|Mydriatics|mydriatics|mesh-ancestor
153504393|NCT05767827|Sympathomimetics|sympathomimetics|mesh-ancestor
153504394|NCT05767827|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153504395|NCT05767723|Aspirin|aspirin|mesh-list
153504396|NCT05767723|Ticagrelor|ticagrelor|mesh-list
153504397|NCT05767723|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153504398|NCT05767723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153504399|NCT05767723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153504439|NCT05767255|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153504440|NCT05767255|Incretins|incretins|mesh-ancestor
153504441|NCT05767255|Hormones|hormones|mesh-ancestor
153504442|NCT05767255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153504443|NCT05767229|Carvedilol|carvedilol|mesh-list
153504444|NCT05767229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153504445|NCT05767229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153504446|NCT05767229|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504447|NCT05767229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153447497|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
153504448|NCT05767229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504449|NCT05767229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504450|NCT05767229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153504451|NCT05767229|Antioxidants|antioxidants|mesh-ancestor
153504452|NCT05767229|Protective Agents|protective agents|mesh-ancestor
153504453|NCT05767229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153504454|NCT05767229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504455|NCT05767229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153504456|NCT05767229|Vasodilator Agents|vasodilator agents|mesh-ancestor
153504457|NCT05767229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153504539|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
153504540|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153504541|NCT05604599|Narcotics|narcotics|mesh-ancestor
153504542|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153504543|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153504544|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153504545|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153504546|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153504547|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153504548|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153504549|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
153504550|NCT05543837|Capsaicin|capsaicin|mesh-list
153504551|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
153504552|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
153504587|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504608|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
153504609|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504610|NCT05078827|Fluorouracil|fluorouracil|mesh-list
153504611|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
153504612|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504613|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153504614|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504615|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153504616|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
153504617|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504618|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153504619|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153504620|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504621|NCT05065164|Denosumab|denosumab|mesh-list
153504622|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153504680|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153504681|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153504682|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
153731677|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153504704|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504705|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
153504706|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153504707|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504708|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153504709|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153504710|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504711|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504712|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153504713|NCT04612920|Narcotics|narcotics|mesh-ancestor
153504714|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504715|NCT04570293|Lidocaine|lidocaine|mesh-list
153504716|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
153504717|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
153504718|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504719|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504720|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
153504721|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504767|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
153504768|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504769|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153504770|NCT04263064|Clonidine|clonidine|mesh-list
153504771|NCT04263064|Analgesics|analgesics|mesh-ancestor
153504772|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
153504773|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504774|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504775|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153504776|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
153504777|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
153504778|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153504779|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153504780|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153504781|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504782|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504783|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504784|NCT04131309|Dexamethasone|dexamethasone|mesh-list
153504785|NCT04131309|Bortezomib|bortezomib|mesh-list
153504786|NCT04131309|Daratumumab|daratumumab|mesh-list
153504787|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504788|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
153504789|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
153504790|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504812|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504813|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504814|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504815|NCT03959423|Insulin|insulin|mesh-list
153504816|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504886|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
153504887|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
153504888|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504889|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153504890|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504891|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153504892|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
153504974|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153504975|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153504976|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504977|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153504978|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153504979|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504980|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504981|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504982|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
153504983|NCT02817360|Protective Agents|protective agents|mesh-ancestor
153504984|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153504985|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504986|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153504987|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
153504988|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153504989|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153504990|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153714242|NCT05794997|Propranolol|propranolol|mesh-list
153504991|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
153504992|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255992|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504993|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153504994|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153504995|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153504996|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153505009|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505023|NCT02659384|Bevacizumab|bevacizumab|mesh-list
153505024|NCT02659384|Atezolizumab|atezolizumab|mesh-list
153505025|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505026|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505027|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153505028|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153505029|NCT02659384|Growth Substances|growth substances|mesh-ancestor
153505030|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505031|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
153505032|NCT02659384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153505033|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505034|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153505035|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153505036|NCT02659384|Analgesics|analgesics|mesh-ancestor
153505037|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
153505038|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505039|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505040|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153505041|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153505042|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153505043|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153505044|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153505045|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505046|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
153505049|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505050|NCT02591147|Fluorides|fluorides|mesh-list
153505051|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
153505052|NCT02591147|Protective Agents|protective agents|mesh-ancestor
153505053|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505055|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153505056|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
153505057|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505058|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
153505059|NCT02588872|Protective Agents|protective agents|mesh-ancestor
153505060|NCT02387203|Amoxicillin|amoxicillin|mesh-list
153505082|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
153505083|NCT01992653|Rituximab|rituximab|mesh-list
153505084|NCT01992653|Doxorubicin|doxorubicin|mesh-list
153505085|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
153505086|NCT01992653|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153505087|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153505088|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
153505089|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505090|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153505091|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153505092|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
153505093|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505094|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505141|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153505142|NCT01681264|Narcotics|narcotics|mesh-ancestor
153505143|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153505144|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505145|NCT01681264|Analgesics|analgesics|mesh-ancestor
153505146|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
153505147|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505148|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153505149|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153505150|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153505151|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153505152|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
153505153|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505154|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505155|NCT01654276|Febuxostat|febuxostat|mesh-list
153505156|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
153505157|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539917|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153448259|NCT00003011|Marimastat|marimastat|mesh-list
153505203|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
154255993|NCT00075270|Paclitaxel|paclitaxel|mesh-list
154255994|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154255995|NCT00075270|Lapatinib|lapatinib|mesh-list
154255996|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154255997|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505204|NCT01685268|Hormones|hormones|mesh-ancestor
153505205|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505206|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505207|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153505208|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505209|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153505210|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191197|NCT05941585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505211|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505212|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
153505213|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153505214|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153505215|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
153505216|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505217|NCT01683084|Telmisartan|telmisartan|mesh-list
153505218|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153505219|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153505220|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153505242|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
153505243|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505244|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505245|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153505246|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153505247|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153505248|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
153505249|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505272|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505273|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153505274|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
153505300|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505301|NCT01384903|Antithrombins|antithrombins|mesh-list
153505302|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
153505303|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153505304|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
153505305|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505306|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505307|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
153505308|NCT01384994|Folic Acid|folic acid|mesh-list
153505309|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
153505310|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
153505311|NCT01384994|Fluorouracil|fluorouracil|mesh-list
153505312|NCT01384994|Panitumumab|panitumumab|mesh-list
153505313|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505314|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
153505315|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505316|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153505317|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153505318|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
153505319|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505320|NCT01384994|Hematinics|hematinics|mesh-ancestor
153505321|NCT01384994|Vitamins|vitamins|mesh-ancestor
153505322|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
153505323|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505324|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
153505325|NCT01385020|Red yeast rice|red yeast rice|mesh-list
153505362|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505379|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153505380|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
153505381|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
153505406|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
153505407|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505408|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505409|NCT01385956|Hormones|hormones|mesh-ancestor
154191198|NCT05941585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153505410|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505411|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505412|NCT01386086|Aripiprazole|aripiprazole|mesh-list
153505414|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153505415|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153505416|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153505417|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153505418|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505419|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
153505420|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
153505443|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505444|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153505445|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153505446|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153505447|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
153505448|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153505449|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153505450|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153505451|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153505452|NCT01386229|Ketamine|ketamine|mesh-list
153505453|NCT01386229|Etomidate|etomidate|mesh-list
153505454|NCT01386229|Analgesics|analgesics|mesh-ancestor
153505455|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
153505524|NCT01386567|Citric Acid|citric acid|mesh-list
153505525|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
153505526|NCT01386567|Enclomiphene|enclomiphene|mesh-list
153505527|NCT01386567|Clomiphene|clomiphene|mesh-list
153505528|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
153505529|NCT01386567|Testosterone|testosterone|mesh-list
153505530|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
153505531|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
153505532|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153505533|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
153505534|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153505535|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
153505536|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
153505537|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505538|NCT01386567|Androgens|androgens|mesh-ancestor
153505539|NCT01386567|Hormones|hormones|mesh-ancestor
153505540|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505541|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505542|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153505543|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505544|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
153505545|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153505546|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
153505547|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153505548|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
153505549|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153505550|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153505572|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505601|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153505603|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153505604|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153505605|NCT01386658|Analgesics|analgesics|mesh-ancestor
153505606|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
153505607|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505608|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505609|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505610|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153505611|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153505645|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153505646|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
153505647|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505648|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505649|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153505650|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
153505685|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153505687|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505688|NCT01387243|Orlistat|orlistat|mesh-list
153505689|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505690|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505691|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153505718|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153505719|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154255998|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
153505720|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153505721|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505722|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
153505781|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505782|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153505801|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505802|NCT01388270|Heparin|heparin|mesh-list
153505803|NCT01388270|Calcium heparin|calcium heparin|mesh-list
153505804|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
153505805|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153505806|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153505807|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505808|NCT01388322|Enoxaparin|enoxaparin|mesh-list
153505809|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
153505810|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153505840|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
153505841|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
153505863|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153505864|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
153505866|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153505867|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153505868|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153505869|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153505870|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
153448940|NCT00003953|Docetaxel|docetaxel|mesh-list
153505871|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505872|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505873|NCT01388621|Carboplatin|carboplatin|mesh-list
153505874|NCT01388621|Gemcitabine|gemcitabine|mesh-list
153505875|NCT01388621|Doxorubicin|doxorubicin|mesh-list
153505876|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153505877|NCT01388621|Panitumumab|panitumumab|mesh-list
153505878|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505888|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153505889|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153505890|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153505891|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153505892|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
153505893|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505905|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505906|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505907|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153505908|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
153505909|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153505910|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
153505911|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505912|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505913|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153505914|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
153505915|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
153505916|NCT01388842|Protective Agents|protective agents|mesh-ancestor
153505917|NCT01388855|Vitamin D|vitamin d|mesh-list
153505918|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
153505919|NCT01388855|Vitamins|vitamins|mesh-ancestor
153505920|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
153505921|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505922|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153505923|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153505924|NCT01388959|Rituximab|rituximab|mesh-list
153505925|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505926|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505927|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
153505928|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505929|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153505930|NCT01389063|Maraviroc|maraviroc|mesh-list
153505931|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153505932|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153505933|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505934|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153505935|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153505936|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
153505937|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154255999|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
154256000|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
154256001|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256002|NCT00075270|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154256003|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256004|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505938|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153505939|NCT01389167|Naltrexone|naltrexone|mesh-list
153505940|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153505941|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153505942|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505943|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
153781898|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505944|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505945|NCT01389193|Ibudilast|ibudilast|mesh-list
153505946|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153505947|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
153505948|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396813|NCT03081143|Growth Inhibitors|growth inhibitors|mesh-ancestor
153505949|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505950|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153505951|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506034|NCT01389440|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153506035|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153506036|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506037|NCT01389505|Bevacizumab|bevacizumab|mesh-list
153506038|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153506039|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506040|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153506091|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153506092|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
153506093|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153506094|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153506095|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153506096|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
153506097|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153506098|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
153506099|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153506100|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153506101|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506103|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153506156|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506157|NCT01390051|Tinzaparin|tinzaparin|mesh-list
153506158|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153506159|NCT01390051|Dalteparin|dalteparin|mesh-list
153506160|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
153506161|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153506196|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
153506197|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506198|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506199|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
153506273|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
153506274|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153506275|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153506276|NCT01390896|PENTA|penta|mesh-list
153506277|NCT01390896|Fondaparinux|fondaparinux|mesh-list
153506278|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153506279|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
153506280|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153506281|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506282|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191199|NCT05941585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153506283|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506284|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
153506285|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153506286|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153506287|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
153506288|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153506289|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153506290|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153506291|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256006|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
153506292|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506293|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
153506294|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506295|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506296|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153506297|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506385|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731679|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506434|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153506435|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506436|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153506438|NCT01392014|Piperaquine|piperaquine|mesh-list
153506439|NCT01392014|Artenimol|artenimol|mesh-list
153506440|NCT01392014|Artemisinins|artemisinins|mesh-list
153506441|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
153506442|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153506474|NCT01392209|Bevacizumab|bevacizumab|mesh-list
153506475|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153506476|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506477|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153506478|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153506479|NCT01392209|Growth Substances|growth substances|mesh-ancestor
153506480|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506481|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
153506482|NCT01392287|Memantine|memantine|mesh-list
153506483|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153506504|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
153506505|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506506|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506507|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153506508|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153506509|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153506510|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
153506511|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153506512|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153506513|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153506514|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
153506515|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153506516|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153506517|NCT01392534|Telmisartan|telmisartan|mesh-list
153506518|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
153506519|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153506520|NCT01392534|Diuretics|diuretics|mesh-ancestor
153506561|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153506562|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
153506564|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506565|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506566|NCT01392768|Levetiracetam|levetiracetam|mesh-list
153506567|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
153506568|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
153506569|NCT01392794|Ramosetron|ramosetron|mesh-list
153506570|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
153506571|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
153506572|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506573|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506574|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506575|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153506576|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
153506577|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506578|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506579|NCT01392807|Naloxegol|naloxegol|mesh-list
153506580|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153506581|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506582|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
153506583|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506584|NCT01392833|Prednisone|prednisone|mesh-list
153506585|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
153506586|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153506587|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153506625|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153506627|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506628|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153506629|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153506630|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153506631|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153506632|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153506633|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153506634|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
153506635|NCT01393080|Cisplatin|cisplatin|mesh-list
153506636|NCT01393080|Paclitaxel|paclitaxel|mesh-list
153506637|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153506638|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506639|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153506640|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
153506641|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
153506642|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
153506643|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506644|NCT01393145|Fluticasone|fluticasone|mesh-list
153506646|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
153506647|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153506680|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
153506681|NCT01393288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153506682|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153506683|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
153506684|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506685|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506686|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153506687|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
153506688|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153781900|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
153506707|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506727|NCT01393574|Melatonin|melatonin|mesh-list
153506728|NCT01393574|Methylphenidate|methylphenidate|mesh-list
153506729|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
153506730|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506731|NCT01393574|Protective Agents|protective agents|mesh-ancestor
153506732|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506733|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506734|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153506735|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153506736|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153506737|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153506738|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
153506739|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506740|NCT01393769|Melphalan|melphalan|mesh-list
153506741|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153506742|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
153506743|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506773|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153506774|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
153506775|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
153506776|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506777|NCT01394094|Calcium|calcium|mesh-list
153506778|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153506779|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506780|NCT01394133|Ritonavir|ritonavir|mesh-list
153506781|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153506782|NCT01394133|Tenofovir|tenofovir|mesh-list
153506783|NCT01394133|Emtricitabine|emtricitabine|mesh-list
153506784|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153506785|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153506786|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506809|NCT01394354|Doxorubicin|doxorubicin|mesh-list
153506810|NCT01394354|Bortezomib|bortezomib|mesh-list
153506811|NCT01394354|Vorinostat|vorinostat|mesh-list
153506812|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153506813|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
153506814|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
153506834|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153506835|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153781902|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
153506836|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
153506837|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
153506858|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506860|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506861|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718863|NCT00100685|Volociximab|volociximab|mesh-list
153506862|NCT01394445|Miotics|miotics|mesh-ancestor
153506863|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
153506864|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506865|NCT01394458|Ethanol|ethanol|mesh-list
153506866|NCT01394458|Heparin|heparin|mesh-list
153506867|NCT01394458|Citric Acid|citric acid|mesh-list
153506868|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
153506869|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
153506870|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153506871|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
153506872|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
153506873|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506874|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153506875|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153506876|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153506877|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506878|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506879|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506880|NCT01394471|Oxytocin|oxytocin|mesh-list
153506881|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
153506882|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153506883|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506884|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
153506885|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
153506886|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506887|NCT01394497|Expectorants|expectorants|mesh-ancestor
153506888|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506928|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153506929|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
153506930|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
153506931|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506932|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153731680|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
153506933|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153506934|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506935|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506936|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
153506937|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153506939|NCT01394770|Renin Inhibitors|renin inhibitors|mesh-ancestor
153506940|NCT01394770|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506941|NCT01394770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506942|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506943|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153506944|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
153506945|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506946|NCT01394796|Protective Agents|protective agents|mesh-ancestor
153506947|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506948|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153506949|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153506973|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506974|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506975|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153506976|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153506977|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153506978|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153507082|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153507083|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153507084|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507085|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507086|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
153507087|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507088|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153507089|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153507090|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
153507091|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
153507092|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507093|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153507094|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153507095|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
153507096|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153507122|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153507124|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507126|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153856660|NCT02092077|Hormones|hormones|mesh-list
153507127|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153507128|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153507129|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153507130|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153507131|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153507132|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153507133|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
153507134|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153507136|NCT01395667|Fluorouracil|fluorouracil|mesh-list
153507137|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
153507138|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507139|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507140|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
153507141|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507142|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153507143|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153507231|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153507289|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507290|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
153507291|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
153507292|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
153507293|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507294|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153507295|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153507296|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153507297|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507299|NCT01396668|Capecitabine|capecitabine|mesh-list
153507300|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507301|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153507302|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
153507303|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507304|NCT01396681|Gemcitabine|gemcitabine|mesh-list
153507305|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507350|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153507351|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507352|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153507353|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153507354|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153507355|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507356|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507357|NCT01397019|Leucovorin|leucovorin|mesh-list
153507358|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
153507359|NCT01397019|Irinotecan|irinotecan|mesh-list
153507360|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507361|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153507362|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153507363|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507364|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507397|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153507398|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153507399|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153507400|NCT01397305|Pemetrexed|pemetrexed|mesh-list
153507401|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507402|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507403|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507404|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153507405|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153507406|NCT01397331|Propofol|propofol|mesh-list
153507407|NCT01397331|Isoflurane|isoflurane|mesh-list
153507436|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507437|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153507438|NCT05268627|Liraglutide|liraglutide|mesh-list
153507439|NCT05268627|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153507440|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153507441|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507442|NCT05268627|Incretins|incretins|mesh-ancestor
153507443|NCT05268627|Hormones|hormones|mesh-ancestor
153507444|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507445|NCT05268601|Sotrovimab|sotrovimab|mesh-list
153507446|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
154256007|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507447|NCT05268601|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
153507498|NCT06105112|Viscosupplements|viscosupplements|mesh-ancestor
153507499|NCT06105112|Protective Agents|protective agents|mesh-ancestor
153507500|NCT06104644|Deucravacitinib|deucravacitinib|mesh-list
153507501|NCT06104644|Dermatologic Agents|dermatologic agents|mesh-ancestor
153507502|NCT06104644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153507513|NCT06104423|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153507514|NCT06104423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153507516|NCT06104423|Adrenergic Agents|adrenergic agents|mesh-ancestor
153507517|NCT06104423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507518|NCT06104423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507520|NCT06104111|Cholecalciferol|cholecalciferol|mesh-list
153507521|NCT06104111|Vitamins|vitamins|mesh-ancestor
153507522|NCT06104111|Micronutrients|micronutrients|mesh-ancestor
153507523|NCT06104111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507524|NCT06104111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153507525|NCT06104111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153507526|NCT06104059|Fentanyl|fentanyl|mesh-list
153507527|NCT06104059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153507528|NCT06104059|Narcotics|narcotics|mesh-ancestor
153507529|NCT06104059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507530|NCT06104059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507531|NCT06104059|Analgesics|analgesics|mesh-ancestor
153507532|NCT06104059|Sensory System Agents|sensory system agents|mesh-ancestor
153507564|NCT06103188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507565|NCT06103188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153507589|NCT06049576|Ipilimumab|ipilimumab|mesh-list
153715177|NCT00125463|Candesartan|candesartan|mesh-list
153507590|NCT06049576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507591|NCT06049576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507592|NCT06049576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153507593|NCT06049576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507594|NCT06044142|Curcumin|curcumin|mesh-list
153507595|NCT06044142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153507596|NCT06044142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153507597|NCT06044142|Analgesics|analgesics|mesh-ancestor
153507598|NCT06044142|Sensory System Agents|sensory system agents|mesh-ancestor
153507599|NCT06044142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507734|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
153507736|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507737|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153507738|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507777|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507778|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
153507780|NCT05286528|Ponatinib|ponatinib|mesh-list
153507781|NCT05286528|Nilotinib|nilotinib|mesh-list
153507782|NCT05286528|Bosutinib|bosutinib|mesh-list
153507783|NCT05286528|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153507784|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153507785|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715235|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153507786|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507787|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507788|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
153507824|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
153507825|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507826|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507848|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153507849|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153507850|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
153507851|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507852|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507853|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153507854|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507855|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507856|NCT04732065|Dopamine|dopamine|mesh-list
153507857|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153507858|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
153507859|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
153507860|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507861|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507862|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
153507863|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507864|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507865|NCT04732065|Protective Agents|protective agents|mesh-ancestor
153507866|NCT04723862|Spironolactone|spironolactone|mesh-list
153507867|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153507868|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
153507869|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507870|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507871|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153507872|NCT04723862|Diuretics|diuretics|mesh-ancestor
153507873|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
153507874|NCT04720105|Halobetasol|halobetasol|mesh-list
153507875|NCT04720105|Tazarotene|tazarotene|mesh-list
153507876|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
153507877|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
153507878|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153507879|NCT04693234|Tislelizumab|tislelizumab|mesh-list
153507880|NCT04693234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507903|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507904|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153507905|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153507907|NCT04410406|Albendazole|albendazole|mesh-list
153507908|NCT04410406|Moxidectin|moxidectin|mesh-list
153507909|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
153507921|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
153507922|NCT04410406|Filaricides|filaricides|mesh-ancestor
153507923|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153507924|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507925|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153396964|NCT02680457|Insulin|insulin|mesh-list
153507926|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153507927|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507928|NCT04323189|Incretins|incretins|mesh-ancestor
153507929|NCT04323189|Hormones|hormones|mesh-ancestor
153507930|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507931|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153507932|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
153507933|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507965|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507966|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153507967|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
153507968|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507970|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153507971|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153508017|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508019|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
153508020|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508048|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508049|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
153508050|NCT03766425|Aflibercept|aflibercept|mesh-list
153508051|NCT03766425|Mitomycins|mitomycins|mesh-list
153508052|NCT03766425|Mitomycin|mitomycin|mesh-list
153508053|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153508054|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153508055|NCT03766425|Growth Substances|growth substances|mesh-ancestor
153508056|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508057|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
153508058|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508059|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153508060|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
153508061|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508062|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153508092|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153508093|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
153508094|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508095|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508096|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508097|NCT03470675|Ketamine|ketamine|mesh-list
153508098|NCT03470675|Morphine|morphine|mesh-list
153508099|NCT03470675|Analgesics|analgesics|mesh-ancestor
153781904|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508100|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
153508101|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508102|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508103|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153508104|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153508154|NCT03281369|Atezolizumab|atezolizumab|mesh-list
153508155|NCT03281369|Ramucirumab|ramucirumab|mesh-list
153508156|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153508173|NCT03281369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508174|NCT03281369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508175|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153508176|NCT03281369|Incretins|incretins|mesh-ancestor
153508177|NCT03281369|Hormones|hormones|mesh-ancestor
153508178|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508179|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153508180|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
153508181|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508182|NCT03281369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153508183|NCT03281369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153508184|NCT03281369|Growth Substances|growth substances|mesh-ancestor
153856721|NCT01628094|Ritonavir|ritonavir|mesh-list
153508185|NCT03281369|Growth Inhibitors|growth inhibitors|mesh-ancestor
153508186|NCT03016871|Carboplatin|carboplatin|mesh-list
153508187|NCT03016871|Nivolumab|nivolumab|mesh-list
153508188|NCT03016871|Etoposide|etoposide|mesh-list
153508189|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
153508190|NCT03016871|Ifosfamide|ifosfamide|mesh-list
153508191|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
153508192|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
153508193|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508208|NCT03004443|Infliximab|infliximab|mesh-list
153508209|NCT03004443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153508210|NCT03004443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508211|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
153508212|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508213|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508214|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
153508215|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
153508216|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
153508230|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508231|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508232|NCT02402920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508233|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508234|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153508235|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153508236|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153508237|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508238|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
153508239|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
153508240|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
153508241|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
153508242|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
153508243|NCT02273375|Durvalumab|durvalumab|mesh-list
153508244|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508245|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508246|NCT02113202|Bevacizumab|bevacizumab|mesh-list
153508247|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508248|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508249|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153508250|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153508251|NCT02113202|Growth Substances|growth substances|mesh-ancestor
153508252|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508253|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
153508254|NCT01781468|Modafinil|modafinil|mesh-list
153508255|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153508256|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508257|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153508258|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153508259|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153508260|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508261|NCT01545141|Interferons|interferons|mesh-list
153508262|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
153508263|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
153508264|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153508265|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153508316|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508317|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
153508336|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153508337|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153508338|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153508339|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
153508341|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
153508342|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
153508343|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508344|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508345|NCT03524170|Atezolizumab|atezolizumab|mesh-list
153508346|NCT03524170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508347|NCT03524170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508348|NCT03524170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508349|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508350|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
153508351|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153508352|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508353|NCT03283813|Inositol|inositol|mesh-list
153508354|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
153508355|NCT03283813|Vitamins|vitamins|mesh-ancestor
153508356|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
153508357|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508358|NCT03245827|Clomiphene|clomiphene|mesh-list
153508359|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153508360|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
153508361|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508362|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508363|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153508364|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
153508365|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153508366|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153508367|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153508368|NCT03129321|Econazole|econazole|mesh-list
153508369|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
153508370|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508371|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153508372|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153508373|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508443|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
153508444|NCT05274438|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153508445|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153508446|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508447|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508448|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508449|NCT05274191|Maleic acid|maleic acid|mesh-list
153508450|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508451|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508453|NCT05274139|Dexamethasone|dexamethasone|mesh-list
153508454|NCT05274139|Temozolomide|temozolomide|mesh-list
153508455|NCT05274139|Fotemustine|fotemustine|mesh-list
153508456|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508457|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
153508458|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
153508459|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508460|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508461|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508462|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
153508463|NCT05274139|Hormones|hormones|mesh-ancestor
153508464|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508487|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153508488|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508489|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
153508490|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
153508491|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508492|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
153508493|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153508494|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
153508495|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508496|NCT05273944|Doxorubicin|doxorubicin|mesh-list
153508497|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153508498|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153508499|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508500|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153508501|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153508502|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508503|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508504|NCT05273528|Vaccines|vaccines|mesh-list
153508505|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
153508514|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508515|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153508516|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256009|NCT03884348|Metronidazole|metronidazole|mesh-list
154256010|NCT03884348|Clarithromycin|clarithromycin|mesh-list
153508517|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153508518|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153508534|NCT05271539|Ranibizumab|ranibizumab|mesh-list
153508535|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508536|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
153508537|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
153508538|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508539|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508540|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508541|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
153508542|NCT05271539|Hormones|hormones|mesh-ancestor
153508543|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508544|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153508545|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508546|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153508547|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153508548|NCT05271539|Growth Substances|growth substances|mesh-ancestor
153508549|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
153508550|NCT05271370|Leronlimab|leronlimab|mesh-list
153508551|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
153508552|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153508553|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153508554|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508555|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153508556|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153508557|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
153508558|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508559|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
153508560|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508561|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
153508562|NCT05271253|Bupivacaine|bupivacaine|mesh-list
153508563|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
153508564|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
153508565|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508566|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508567|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
153508568|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508569|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153508570|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153508571|NCT05271253|Analgesics|analgesics|mesh-ancestor
153508572|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153508573|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153508574|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153508575|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
153508576|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508577|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508578|NCT05271188|Anesthetics|anesthetics|mesh-list
153508579|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
153508580|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508609|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508610|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508612|NCT05271045|Vitamin D|vitamin d|mesh-list
153508613|NCT05271045|Vitamin A|vitamin a|mesh-list
153508614|NCT05271045|Vitamins|vitamins|mesh-ancestor
153508615|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
153508652|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
153508654|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153508655|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508656|NCT05270343|Vitamins|vitamins|mesh-ancestor
153508657|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
153508658|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153508659|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
153508660|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153508661|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
153508662|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508663|NCT05269654|Mannitol|mannitol|mesh-list
153508664|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153508665|NCT05269654|Diuretics|diuretics|mesh-ancestor
153508666|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
153508667|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508668|NCT05250141|Levodopa|levodopa|mesh-list
153508669|NCT05250141|Carbidopa|carbidopa|mesh-list
153508670|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153508671|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153508672|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
153508673|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508674|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508675|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508676|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153508698|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153508699|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781905|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451805|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153508700|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508701|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153508702|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153508703|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
153508704|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508705|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153508706|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153508707|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
153508708|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153508709|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
153508710|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
153508711|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
153508712|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153508713|NCT05232006|Niraparib|niraparib|mesh-list
153508714|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153508715|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508716|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508717|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508767|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153508768|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153508769|NCT05138029|Growth Substances|growth substances|mesh-ancestor
153508770|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
153508797|NCT05075122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508798|NCT05075122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508799|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
153508800|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508803|NCT05067439|Omeprazole|omeprazole|mesh-list
153508804|NCT05067439|Abrocitinib|abrocitinib|mesh-list
153508805|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153508806|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508807|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153508808|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508809|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508810|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153508811|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153508812|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
153508813|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508814|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153508815|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508816|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153508843|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
153508844|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153508845|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508846|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
153508847|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508848|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451953|NCT01907100|Cisplatin|cisplatin|mesh-list
153508849|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153508850|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
153508851|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508852|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508853|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153508854|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153508855|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
153508864|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508896|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153508897|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
153508898|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153508899|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508900|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153508901|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
153508902|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508903|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508904|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
153508905|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508906|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153508907|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508908|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
153508909|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508910|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153508947|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508948|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508972|NCT04690686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508973|NCT04690686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508974|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
153508975|NCT04682626|Vitamin D|vitamin d|mesh-list
153508976|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153508977|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508978|NCT04682626|Vitamins|vitamins|mesh-ancestor
153508979|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
153508980|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153508981|NCT04604691|Blinatumomab|blinatumomab|mesh-list
153508982|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508983|NCT04580381|Natalizumab|natalizumab|mesh-list
153508984|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
153508985|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508986|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
153508987|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153508988|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
153508989|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508990|NCT04476745|Vitamin D|vitamin d|mesh-list
153508991|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
153508992|NCT04476745|Vitamins|vitamins|mesh-ancestor
153508993|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
153508994|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508995|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153508996|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153508997|NCT04433390|Naloxegol|naloxegol|mesh-list
153508998|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153508999|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509026|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153509027|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509028|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153509029|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509030|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
153509031|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509032|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
153509033|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509034|NCT04368091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509035|NCT04368091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509036|NCT04368091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509070|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509072|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
153509073|NCT04008082|Lenvatinib|lenvatinib|mesh-list
153509074|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781908|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153509075|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509076|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509077|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509078|NCT03974243|Chiauranib|chiauranib|mesh-list
153509079|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509080|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509081|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509082|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509083|NCT03967925|Prednisone|prednisone|mesh-list
153509084|NCT03967925|Prednisolone|prednisolone|mesh-list
153509085|NCT03967925|Rituximab|rituximab|mesh-list
153509086|NCT03967925|Belimumab|belimumab|mesh-list
153509087|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153509088|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509089|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
153509090|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509091|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153509092|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153509093|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
153509094|NCT03967925|Hormones|hormones|mesh-ancestor
153509095|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430742|NCT00000223|Analgesics|analgesics|mesh-ancestor
153509096|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153509097|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509098|NCT03954743|Vaccines|vaccines|mesh-list
153509126|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509128|NCT03705338|Anesthetics|anesthetics|mesh-list
153509129|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
153509130|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153509131|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509132|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509133|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153509134|NCT03704285|Propofol|propofol|mesh-list
153509135|NCT03704285|Anesthetics|anesthetics|mesh-list
153509136|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
153856882|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153856883|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
153397125|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
153509137|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153509138|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509139|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509140|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153509141|NCT03696537|Fludarabine|fludarabine|mesh-list
153509142|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509143|NCT03661996|Lidocaine|lidocaine|mesh-list
153509144|NCT03661996|Epinephrine|epinephrine|mesh-list
153509145|NCT03661996|Capsaicin|capsaicin|mesh-list
153509146|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
153509147|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
153509171|NCT03410355|Cortisone|cortisone|mesh-list
153509172|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153509173|NCT03399617|Micronutrients|micronutrients|mesh-list
153509174|NCT03399617|Trace Elements|trace elements|mesh-list
153509191|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509192|NCT03359239|Atezolizumab|atezolizumab|mesh-list
153509194|NCT03359239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153781910|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153452324|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
153509226|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153509227|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153509228|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509229|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509230|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153509231|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153509232|NCT03276533|Analgesics|analgesics|mesh-ancestor
153509233|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153509234|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153509260|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153397126|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509261|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153509262|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
153509263|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509264|NCT03180294|Bupropion|bupropion|mesh-list
153509265|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153509266|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
153509267|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153509268|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153509269|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153509270|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509271|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509272|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
153509273|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509274|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509275|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153509276|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153509277|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509278|NCT03071601|Lidocaine|lidocaine|mesh-list
153509279|NCT03071601|Epinephrine|epinephrine|mesh-list
153509280|NCT03071601|Prilocaine|prilocaine|mesh-list
153509281|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153509282|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
153509283|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
153509284|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509303|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
153509335|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509336|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509337|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153509367|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153509369|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153509370|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153509371|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509372|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153509373|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153509374|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
153545906|NCT06294821|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153509427|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509429|NCT02889900|Cediranib|cediranib|mesh-list
153509430|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153509431|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509432|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509433|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509434|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509435|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
153509436|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
153509472|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153509474|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509475|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
153509512|NCT02619552|Budesonide|budesonide|mesh-list
153509513|NCT02619552|Adalimumab|adalimumab|mesh-list
153509514|NCT02619552|Infliximab|infliximab|mesh-list
153509515|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
153509516|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153509517|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
153509518|NCT02619552|Hormones|hormones|mesh-ancestor
153509571|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509572|NCT02423525|Afatinib|afatinib|mesh-list
153509609|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509610|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509611|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153509612|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153509613|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
153509614|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
153509663|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153509664|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153509665|NCT01951469|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153509666|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509667|NCT01940809|Nivolumab|nivolumab|mesh-list
153509668|NCT01940809|Ipilimumab|ipilimumab|mesh-list
153509669|NCT01940809|Trametinib|trametinib|mesh-list
153509670|NCT01940809|Dabrafenib|dabrafenib|mesh-list
153509671|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153509672|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509696|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509745|NCT01515306|Paclitaxel|paclitaxel|mesh-list
153509746|NCT01515306|Ramucirumab|ramucirumab|mesh-list
153509747|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153509748|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509749|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
153509750|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
153509751|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
153545907|NCT06294821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509752|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509753|NCT01515306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153509754|NCT01515306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153509755|NCT01515306|Growth Substances|growth substances|mesh-ancestor
153509756|NCT01515306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509757|NCT01515306|Growth Inhibitors|growth inhibitors|mesh-ancestor
153509759|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
153509760|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
153509761|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509762|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
153509763|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509764|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
153509765|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509766|NCT01433965|Lenalidomide|lenalidomide|mesh-list
153509767|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
153509768|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509769|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153509770|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153509771|NCT01433965|Growth Substances|growth substances|mesh-ancestor
153509802|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153509853|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509854|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153509882|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
153509883|NCT00430040|Protective Agents|protective agents|mesh-ancestor
153509884|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153509885|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256011|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153731683|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731684|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715944|NCT00344851|Metformin|metformin|mesh-list
153509886|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153509887|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
153509888|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153509889|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153509890|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153509891|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
153509892|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509893|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153509894|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
153509895|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153509896|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
153509897|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153509934|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509936|NCT01397994|Atenolol|atenolol|mesh-list
153509937|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153509975|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
153510011|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510013|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510014|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510015|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510040|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153510041|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153510061|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153510062|NCT01398371|Digoxin|digoxin|mesh-list
153510063|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153510064|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153510065|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626823|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153510097|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
153510098|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510099|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510100|NCT01398618|Rifampin|rifampin|mesh-list
153510101|NCT01398618|Isoniazid|isoniazid|mesh-list
153510102|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153510103|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
153510104|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510105|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510106|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
153510134|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510135|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510136|NCT01399086|Fulvestrant|fulvestrant|mesh-list
153510137|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153510138|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510139|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153510140|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153510141|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
153510142|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510143|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510145|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
153510146|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
153510147|NCT01399151|Vitamins|vitamins|mesh-list
153510148|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
153510149|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510265|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153510267|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
153510268|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153510269|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153510270|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
153510271|NCT01400191|Metformin|metformin|mesh-list
153618876|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
153510272|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510273|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510293|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
153510294|NCT01400464|Prednisone|prednisone|mesh-list
153510295|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510296|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
153510297|NCT01400464|Hormones|hormones|mesh-ancestor
153510298|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510299|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510300|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153720101|NCT00434824|Hormones|hormones|mesh-ancestor
153510301|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510302|NCT01400568|Fluticasone|fluticasone|mesh-list
153510304|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510305|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153510306|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
153510307|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510308|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510309|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153510310|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
153510311|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
153510312|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153510313|NCT01400633|Decitabine|decitabine|mesh-list
153510399|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
153510400|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
153510402|NCT01400867|Clindamycin|clindamycin|mesh-list
153510403|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
153510404|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
153510405|NCT01400867|Cefazolin|cefazolin|mesh-list
153510406|NCT01400867|Linezolid|linezolid|mesh-list
153510407|NCT01400867|Cephalexin|cephalexin|mesh-list
153510408|NCT01400867|Ceftaroline|ceftaroline|mesh-list
153510409|NCT01400867|Aztreonam|aztreonam|mesh-list
153510410|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510411|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510412|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153510413|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510447|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
153510448|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510449|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510450|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153510451|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510452|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510453|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153510454|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153510483|NCT01401491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153510484|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153510485|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153510486|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153510487|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
153510488|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153510571|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
153510572|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153510573|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510574|NCT01402193|Anastrozole|anastrozole|mesh-list
153510575|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153510576|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510577|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153510578|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153510579|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510605|NCT01402336|Hormones|hormones|mesh-ancestor
153510606|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510607|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510608|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
153510609|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153510610|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
153510611|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153510612|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153510613|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153510614|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510615|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153510616|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
153510617|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
153510618|NCT01402479|Ramipril|ramipril|mesh-list
153510619|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153510620|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
153510621|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510622|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510623|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153510624|NCT01402583|Ribavirin|ribavirin|mesh-list
153510625|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
153510642|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
153510668|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510669|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153430859|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
153510671|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153510672|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
153510673|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510674|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153510675|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
153510676|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153510677|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153510678|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510679|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
153510680|NCT01402882|Coagulants|coagulants|mesh-ancestor
153510681|NCT01403025|Liraglutide|liraglutide|mesh-list
153510682|NCT01403025|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153510683|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510711|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510712|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
153510713|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510714|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153510715|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153510805|NCT01403545|Analgesics|analgesics|mesh-ancestor
153510806|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
153510807|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510808|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510809|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510810|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153510811|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510812|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510813|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510814|NCT01403662|Minocycline|minocycline|mesh-list
153510815|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510862|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153510863|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
153510864|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153510865|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
153618880|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153453984|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153510866|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510867|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510868|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153510869|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153510870|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510871|NCT01404104|Sirolimus|sirolimus|mesh-list
153510872|NCT01404104|Temsirolimus|temsirolimus|mesh-list
153510873|NCT01404104|MTOR Inhibitors|mtor inhibitors|mesh-list
153510874|NCT01404104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153510875|NCT01404104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510876|NCT01404104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510877|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510878|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
153510879|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731685|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511007|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
153511089|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153511090|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511091|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511092|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511094|NCT01404767|Esmolol|esmolol|mesh-list
153511095|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153511096|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153511097|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
153511098|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
153511099|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511100|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511101|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153511102|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153511103|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153511104|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
153511105|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511106|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511107|NCT01404793|Rocuronium|rocuronium|mesh-list
153511135|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511137|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153511192|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153511194|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
153511195|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153511196|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
153511219|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
153511220|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511221|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511222|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511223|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
153511225|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511226|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153511227|NCT01405170|Protective Agents|protective agents|mesh-ancestor
153511228|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153511229|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511230|NCT01405235|Paclitaxel|paclitaxel|mesh-list
153511231|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153511232|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153511233|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511234|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
153511235|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
153511236|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
153511237|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511290|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511291|NCT01405612|Midazolam|midazolam|mesh-list
153511292|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153511324|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
153511325|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511326|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153511327|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153511328|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511329|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511330|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153511331|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
153626825|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511365|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511366|NCT01406080|Analgesics|analgesics|mesh-ancestor
153511367|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
153511368|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511369|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511370|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511371|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511397|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153511398|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153511399|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
153511400|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
153511401|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
153511402|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
153511403|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511404|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511405|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
153511406|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511407|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
153511454|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153511455|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153511456|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153511457|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
153511458|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511459|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153511488|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511489|NCT01406535|Urological Agents|urological agents|mesh-ancestor
153511490|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153511491|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153511492|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511494|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153511495|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153511496|NCT01406639|Growth Substances|growth substances|mesh-ancestor
153511497|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511498|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
153511499|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731687|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
153720342|NCT00436267|Fluorouracil|fluorouracil|mesh-list
153720343|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
153731688|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511500|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
153511501|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
153511502|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511503|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511504|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
153511505|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511506|NCT01406704|Protective Agents|protective agents|mesh-ancestor
153511507|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
153511526|NCT01407237|Giapreza|giapreza|mesh-list
153511527|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
153511528|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153511529|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153511530|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
153511531|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511532|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511533|NCT01407289|Insulin|insulin|mesh-list
153511534|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
153511535|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
153511536|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511537|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511538|NCT01407432|Folic Acid|folic acid|mesh-list
153511539|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
153511540|NCT01407432|Hematinics|hematinics|mesh-ancestor
153511541|NCT01407432|Vitamins|vitamins|mesh-ancestor
153511542|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
153511543|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511544|NCT01407471|Clobetasol|clobetasol|mesh-list
153511545|NCT01407471|Spironolactone|spironolactone|mesh-list
153511546|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153511561|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511562|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153511563|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511564|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153511566|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511567|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
153511568|NCT01407822|Cisplatin|cisplatin|mesh-list
153511569|NCT01407822|Gemcitabine|gemcitabine|mesh-list
153511605|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
153511606|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511607|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511608|NCT01408056|Mupirocin|mupirocin|mesh-list
153511630|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511631|NCT01408160|Cytarabine|cytarabine|mesh-list
153511632|NCT01408160|Immunotoxins|immunotoxins|mesh-list
153511633|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153511634|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
153511635|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511636|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511637|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
153511638|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511639|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153511640|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
153511641|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511642|NCT01408160|Immunoconjugates|immunoconjugates|mesh-ancestor
153511643|NCT01408173|Caffeine|caffeine|mesh-list
153511644|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
153511645|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511646|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153511647|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511648|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153511649|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511650|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153511651|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153511652|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
153511653|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511655|NCT01408186|Famotidine|famotidine|mesh-list
153511656|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153511657|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511658|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153511659|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626826|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397303|NCT01947907|Hormones|hormones|mesh-list
153511689|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720450|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511690|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511691|NCT01408446|Menthol|menthol|mesh-list
153511739|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153511740|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
153511741|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153511742|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
153511743|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153511744|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
153511745|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511746|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
153511747|NCT01408836|Hormones|hormones|mesh-ancestor
153511748|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511749|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511750|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153511751|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511752|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
153511753|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
153511754|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511755|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511777|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153511778|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511779|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
153511780|NCT01408953|Bevacizumab|bevacizumab|mesh-list
153511781|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153511782|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511783|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153511784|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153511785|NCT01408953|Growth Substances|growth substances|mesh-ancestor
153511786|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511787|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
153511788|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
153511789|NCT01408979|Analgesics|analgesics|mesh-ancestor
153511790|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
153511803|NCT01409005|Gemcitabine|gemcitabine|mesh-list
153511804|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153511805|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
153511830|NCT01409174|Cisplatin|cisplatin|mesh-list
153511831|NCT01409174|Temozolomide|temozolomide|mesh-list
153511832|NCT01409174|Ipilimumab|ipilimumab|mesh-list
153511833|NCT01409174|Interleukin-2|interleukin-2|mesh-list
153511834|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511835|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
153511836|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618884|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153454943|NCT01516008|Tapentadol|tapentadol|mesh-list
153511837|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153511838|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
153511839|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511840|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153511841|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153511842|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
153511843|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511844|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511845|NCT01409174|Analgesics|analgesics|mesh-ancestor
153511846|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
153511847|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511848|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153511849|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153511850|NCT01409187|Interferons|interferons|mesh-list
153511851|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
153511852|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
153511853|NCT01409187|Aldesleukin|aldesleukin|mesh-list
153511890|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511891|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511892|NCT01409408|Amlodipine|amlodipine|mesh-list
153511908|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153511909|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511910|NCT01409603|Analgesics|analgesics|mesh-ancestor
153618885|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153511911|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
153511912|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511913|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511914|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154256012|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154256013|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511915|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511916|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
153511917|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153511918|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511919|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511920|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153511921|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
153511922|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153511937|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511938|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153511939|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153511940|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511941|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153511942|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153511943|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511944|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
153511945|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153511946|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153511947|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153511948|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
153511949|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511950|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511951|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
153511979|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153511980|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511981|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511982|NCT01409499|Sorafenib|sorafenib|mesh-list
153511983|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511984|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153511985|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511986|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511987|NCT01410162|Tacrolimus|tacrolimus|mesh-list
154191200|NCT05941585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511988|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153511989|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
153511990|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511991|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153511992|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511993|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511994|NCT01410201|Dexamethasone|dexamethasone|mesh-list
153511995|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
153511996|NCT01410201|BB 1101|bb 1101|mesh-list
153511997|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511998|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
153511999|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
153512000|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512027|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512029|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512030|NCT01410630|Telbivudine|telbivudine|mesh-list
153397342|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397343|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153397344|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153397345|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
153716674|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716675|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716676|NCT00427102|Cisplatin|cisplatin|mesh-list
153716677|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716678|NCT00427414|Daunorubicin|daunorubicin|mesh-list
153716679|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512031|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
153512032|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512033|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153512034|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512035|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512036|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
153512037|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153512038|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512127|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153512128|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153512130|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
153512131|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153512132|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
153512133|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153512134|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512135|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
153512136|NCT01411254|Hormones|hormones|mesh-ancestor
153512137|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512183|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153512184|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
153512185|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720635|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512186|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512187|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153512188|NCT01411930|Olanzapine|olanzapine|mesh-list
153512189|NCT01411930|Aripiprazole|aripiprazole|mesh-list
153512190|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
153512191|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
153512192|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512217|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153512218|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
153512219|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512220|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512221|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512223|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
153512224|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512225|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
153512226|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153512227|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
153512228|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153512229|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
153512230|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153512231|NCT01411969|Protective Agents|protective agents|mesh-ancestor
153512232|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
153512233|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153512234|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512235|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512236|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
153512237|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512238|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512239|NCT01412073|Misoprostol|misoprostol|mesh-list
153512262|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153512263|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
153512264|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512266|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153512281|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153512282|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512283|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
153512285|NCT01412515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153512286|NCT01412515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512287|NCT01412515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512288|NCT01412515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512289|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512290|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
153512291|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512316|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512317|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153512318|NCT01412658|Caseins|caseins|mesh-list
153512319|NCT01412658|Glycerol|glycerol|mesh-list
153512320|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
153512321|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
153512322|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512323|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153512324|NCT01412658|Protective Agents|protective agents|mesh-ancestor
153512325|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512326|NCT01412671|Sorafenib|sorafenib|mesh-list
153512327|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512328|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512329|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512330|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512331|NCT01412840|Diclofenac|diclofenac|mesh-list
153512332|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153512333|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153512334|NCT01412840|Analgesics|analgesics|mesh-ancestor
153512335|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
153512336|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512337|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512338|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512339|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512340|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153512341|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512342|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512343|NCT01412892|Everolimus|everolimus|mesh-list
153512378|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153512379|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
153512380|NCT01413048|Protective Agents|protective agents|mesh-ancestor
153512419|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512420|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153512421|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512422|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512423|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
153512424|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512425|NCT01413620|Vitamins|vitamins|mesh-list
153512426|NCT01413620|Vitamin E|vitamin e|mesh-list
153512427|NCT01413620|Tocopherols|tocopherols|mesh-list
153512428|NCT01413620|Tocotrienols|tocotrienols|mesh-list
153512429|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
153512430|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
153731692|NCT00154440|Metronidazole|metronidazole|mesh-list
153512431|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512432|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
153626828|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153512448|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153512449|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512450|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
153512451|NCT01413854|Diclofenac|diclofenac|mesh-list
153512452|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153512453|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153512454|NCT01413854|Analgesics|analgesics|mesh-ancestor
153512455|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
153512456|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512457|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512458|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512459|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512460|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153512461|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512462|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512463|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
153512464|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153512465|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
153512466|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153512467|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512468|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153512469|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153512470|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153512471|NCT01414231|Cytarabine|cytarabine|mesh-list
153512472|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512473|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
153512474|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512475|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191201|NCT05940324|Naltrexone|naltrexone|mesh-list
153512477|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512478|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512479|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
153512480|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512481|NCT01414465|Orlistat|orlistat|mesh-list
153512482|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512483|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731695|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153512559|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153512560|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153512561|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
153512562|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512579|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512580|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153512581|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
153512582|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153512583|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153512584|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153512585|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512586|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
153512587|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512588|NCT01415141|Ribavirin|ribavirin|mesh-list
153455696|NCT05150938|Vitamin K|vitamin k|mesh-list
153512589|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153512590|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
153512591|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256014|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154256015|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153512593|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512594|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153512595|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
153512596|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
153512616|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153512617|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153512618|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153512619|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153512620|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512621|NCT01415505|Valsartan|valsartan|mesh-list
153512622|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153512623|NCT01415505|Nebivolol|nebivolol|mesh-list
153512624|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153512625|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153512626|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153512627|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512628|NCT01415505|Diuretics|diuretics|mesh-ancestor
153512629|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
153512630|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512631|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153512632|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512633|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
153512634|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153512635|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153512667|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512668|NCT01415687|Laxatives|laxatives|mesh-ancestor
153512669|NCT01415713|Leucovorin|leucovorin|mesh-list
153512670|NCT01415713|Gemcitabine|gemcitabine|mesh-list
153512671|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
153512672|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512673|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
153512674|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512675|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512676|NCT01415713|Antidotes|antidotes|mesh-ancestor
153512677|NCT01415713|Protective Agents|protective agents|mesh-ancestor
153512678|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512679|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
153512680|NCT01415713|Vitamins|vitamins|mesh-ancestor
153512681|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
153512682|NCT01415765|Prednisone|prednisone|mesh-list
153512683|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
153512684|NCT01415765|Rituximab|rituximab|mesh-list
153512685|NCT01415765|Doxorubicin|doxorubicin|mesh-list
153512686|NCT01415765|Etoposide|etoposide|mesh-list
153512687|NCT01415765|Vincristine|vincristine|mesh-list
153512688|NCT01415765|Pevonedistat|pevonedistat|mesh-list
153512689|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512690|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
153512691|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512692|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512693|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153512694|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
153512695|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512696|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512697|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153512698|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153512699|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153512700|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153512701|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153512702|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512703|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512704|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
153512706|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512707|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153512708|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153512731|NCT01415895|Analgesics|analgesics|mesh-ancestor
153512732|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153512733|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
153512734|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
153512756|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153512757|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512758|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
153512759|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512760|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153512794|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153512795|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153512796|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153512797|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
153512798|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153512799|NCT01416337|Trametinib|trametinib|mesh-list
153512800|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512801|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512802|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512803|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512836|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
153512837|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512838|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512839|NCT01416701|Vitamin D|vitamin d|mesh-list
153512840|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
153512841|NCT01416701|Vitamins|vitamins|mesh-list
153512842|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
153512843|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512844|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153512845|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153512846|NCT01416870|Bicalutamide|bicalutamide|mesh-list
153512847|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
153512872|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
153512873|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153512928|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
153512929|NCT01417364|Testosterone|testosterone|mesh-list
153512930|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
153512931|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
153512932|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153512933|NCT01417364|Androgens|androgens|mesh-ancestor
153512935|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512936|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512937|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153512938|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512939|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
153512940|NCT01417390|Cisplatin|cisplatin|mesh-list
153512941|NCT01417390|Gemcitabine|gemcitabine|mesh-list
153512942|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512943|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512944|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
153512973|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153512974|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512975|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153731697|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153731698|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153512976|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153512977|NCT01417494|Growth Substances|growth substances|mesh-ancestor
153512978|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512979|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
153513014|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153513015|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
153513016|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513017|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513018|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513019|NCT01417806|Topotecan|topotecan|mesh-list
153513020|NCT01417806|Pasireotide|pasireotide|mesh-list
153513021|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153513022|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153513023|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513024|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513025|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513026|NCT01417806|Hormones|hormones|mesh-ancestor
153513027|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513028|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513029|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153513030|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153513031|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154256016|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154256017|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256018|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513032|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153513033|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153513034|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
153513035|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513036|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513037|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513038|NCT01417897|Insulin|insulin|mesh-list
153513039|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153513040|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
153513041|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
153513042|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153513043|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513044|NCT01417923|Vitamin D|vitamin d|mesh-list
153513045|NCT01417923|Vitamins|vitamins|mesh-ancestor
153513046|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
153513067|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153513069|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
153513070|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153513071|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153513072|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153513073|NCT01418118|Protective Agents|protective agents|mesh-ancestor
153513074|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
153513075|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
153513095|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513097|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
153513098|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513099|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
153513100|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
153513101|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
153513122|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153513123|NCT01418274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153513124|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153513125|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513126|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513127|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
153513128|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513129|NCT01418417|Pantoprazole|pantoprazole|mesh-list
153513130|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153513131|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153513132|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153513133|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513134|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513135|NCT01418430|Daclizumab|daclizumab|mesh-list
153513136|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153513137|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
153513138|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513139|NCT01418443|Pantoprazole|pantoprazole|mesh-list
153513140|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153513141|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153513142|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153513143|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513144|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513145|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153513146|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513147|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153513148|NCT01418534|Isosorbide|isosorbide|mesh-list
153513149|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153513150|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153513151|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153513152|NCT01418534|Diuretics|diuretics|mesh-ancestor
153513153|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
153513187|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153513188|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153513189|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513190|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513191|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513192|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513193|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153513194|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
153513195|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513196|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153513197|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153513198|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153513199|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513200|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513201|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513202|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513228|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513229|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
153513230|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153513231|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153513232|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153513233|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513235|NCT01418794|Temsirolimus|temsirolimus|mesh-list
153513236|NCT01418794|MTOR Inhibitors|mtor inhibitors|mesh-list
153513237|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153513238|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513239|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153513240|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513241|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
153513242|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153513243|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
153513244|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513245|NCT01418794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153513246|NCT01418794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513247|NCT01418794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513248|NCT01419041|Crizotinib|crizotinib|mesh-list
153513265|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513266|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153513267|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513268|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513270|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
153513271|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
153513272|NCT01419262|Vitamins|vitamins|mesh-list
153513273|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
153513274|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513275|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153513285|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153513286|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153513288|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153513289|NCT01419353|Estrogens|estrogens|mesh-ancestor
153513290|NCT01419353|Hormones|hormones|mesh-ancestor
153513291|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513292|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513293|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153513294|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
153513295|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153513296|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153513297|NCT01419366|Donepezil|donepezil|mesh-list
153513298|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153513299|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513300|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513301|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
153513302|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513303|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513304|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
153513305|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
153626829|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513338|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
153513339|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
153513340|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513341|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153513342|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513343|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153513344|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513346|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513347|NCT01419730|Vitamin D|vitamin d|mesh-list
153513348|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
153513349|NCT01419730|Vitamins|vitamins|mesh-ancestor
153513350|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
153513382|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513383|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513385|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153513386|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154191202|NCT05940324|Ketamine|ketamine|mesh-list
153513387|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513388|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153513389|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153513390|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513391|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
153513392|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
153513420|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153513421|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153513422|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153513423|NCT01420406|Vitamin A|vitamin a|mesh-list
153513424|NCT01420406|Vitamins|vitamins|mesh-ancestor
153513425|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
153513426|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513427|NCT01420471|Triamcinolone|triamcinolone|mesh-list
153513428|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153513429|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153513430|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153513431|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513432|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
153513518|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153513537|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
153513538|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
153513539|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153513606|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
153513607|NCT01421693|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153513608|NCT01421693|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153513609|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153513610|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513611|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153513612|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153513613|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153513614|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153513615|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513616|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513617|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513618|NCT01421706|Clarithromycin|clarithromycin|mesh-list
153513619|NCT01421706|Sibutramine|sibutramine|mesh-list
153513620|NCT01421706|Clopidogrel|clopidogrel|mesh-list
153513621|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153513622|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153513623|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153513624|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153513650|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
153513651|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513652|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153513653|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153513654|NCT01421927|Growth Substances|growth substances|mesh-ancestor
153513655|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
153513656|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513657|NCT01421940|Udenafil|udenafil|mesh-list
153513658|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153513659|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153513660|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513661|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513662|NCT01421979|Caffeine|caffeine|mesh-list
153513663|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153513664|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513665|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153513666|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513667|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513710|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153513711|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513712|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
153513713|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153513714|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153513715|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153513716|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
153513717|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513718|NCT01422122|Vitamin D|vitamin d|mesh-list
153513719|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
153513720|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
153513721|NCT01422122|Vitamins|vitamins|mesh-list
154256020|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153736060|NCT03838042|Nivolumab|nivolumab|mesh-list
153513722|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
153513723|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513755|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513756|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
153513757|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513758|NCT01422460|Mitogens|mitogens|mesh-list
153513759|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
153513760|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513761|NCT01422499|Vorinostat|vorinostat|mesh-list
153513762|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513763|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153513764|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513765|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513766|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153513767|NCT01422590|Mitiglinide|mitiglinide|mesh-list
153513768|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153513805|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513806|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513807|NCT01422616|Analgesics|analgesics|mesh-ancestor
153513808|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
153513809|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153513846|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
153513925|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
153513926|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
153513927|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513928|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513929|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
153513930|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513931|NCT01423305|Budesonide|budesonide|mesh-list
153513932|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
153513933|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153513934|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513935|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153513936|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
153513971|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
153513972|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513973|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153513974|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153513975|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153514002|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
153514003|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
153514004|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514005|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153514006|NCT01423708|Everolimus|everolimus|mesh-list
153514007|NCT01423708|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153514008|NCT01423708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153514009|NCT01423708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514010|NCT01423708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514011|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514012|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
153514013|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514014|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514015|NCT01423747|Fludarabine|fludarabine|mesh-list
153514016|NCT01423747|Etoposide|etoposide|mesh-list
153514017|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
153514018|NCT01423747|Thiotepa|thiotepa|mesh-list
153514019|NCT01423747|Treosulfan|treosulfan|mesh-list
153514090|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
153514091|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514092|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514093|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153514094|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
153514095|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
153514096|NCT01424137|Hormones|hormones|mesh-ancestor
153514097|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514098|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
153514099|NCT01424176|Pramipexole|pramipexole|mesh-list
153514100|NCT01424176|Dexpramipexole|dexpramipexole|mesh-list
153514101|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
153514102|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514104|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514105|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
153514106|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514107|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153514108|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153514109|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
153514110|NCT01424241|Octreotide|octreotide|mesh-list
153514111|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153514112|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514149|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514150|NCT01424384|Citalopram|citalopram|mesh-list
153514151|NCT01424384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153514178|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153514180|NCT01424618|Ganirelix|ganirelix|mesh-list
153514181|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153514182|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
153514183|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153514184|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514185|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514186|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514187|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
153514188|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514189|NCT01424709|Cisplatin|cisplatin|mesh-list
153514190|NCT01424709|Gemcitabine|gemcitabine|mesh-list
153514191|NCT01424709|Docetaxel|docetaxel|mesh-list
153514192|NCT01424709|Irinotecan|irinotecan|mesh-list
153514193|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514194|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153514195|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
153514196|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514217|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514218|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153514219|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
153514220|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153514250|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514251|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
153514252|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153514253|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514273|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514274|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153514275|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153514276|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
153514277|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514278|NCT01425125|Tolvaptan|tolvaptan|mesh-list
153514279|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153514280|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514281|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
153514306|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153514307|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153514334|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
153514335|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153514336|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153514337|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153514338|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153514339|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
153514340|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514342|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153514343|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514345|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153514346|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153514347|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153514348|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514349|NCT01425424|Vitamin D|vitamin d|mesh-list
153514350|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
153514351|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
153514352|NCT01425424|Vitamins|vitamins|mesh-list
153514353|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
153514354|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514387|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857261|NCT06223854|Iodine|iodine|mesh-list
153514388|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153514438|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
153514439|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
154256021|NCT01154426|Gemcitabine|gemcitabine|mesh-list
154256022|NCT01154426|Veliparib|veliparib|mesh-list
153721564|NCT00452062|Hormones|hormones|mesh-ancestor
153514440|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514473|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514474|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514475|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153514476|NCT05386186|Glimepiride|glimepiride|mesh-list
153514477|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153514478|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153514479|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514480|NCT05386186|Incretins|incretins|mesh-ancestor
153514481|NCT05386186|Hormones|hormones|mesh-ancestor
153514482|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514483|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
153514484|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626830|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153514513|NCT05386056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514514|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
153514515|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514516|NCT05385861|Carboplatin|carboplatin|mesh-list
153514517|NCT05385861|Irinotecan|irinotecan|mesh-list
153514518|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514519|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153514520|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153514521|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514522|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514523|NCT05385744|Teriflunomide|teriflunomide|mesh-list
153514524|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153514525|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153514526|NCT05385744|Analgesics|analgesics|mesh-ancestor
153514527|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
153514528|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514529|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514530|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514531|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153514532|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514561|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514563|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514564|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514565|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153514566|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514567|NCT05379374|Morphine|morphine|mesh-list
153514646|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
153514647|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153514648|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153514649|NCT04673162|Prednisolone|prednisolone|mesh-list
153514650|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
153514651|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153514652|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
153514653|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514654|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
153514655|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
153514656|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514657|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514658|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153514659|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
153514660|NCT04673162|Hormones|hormones|mesh-ancestor
153514661|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514662|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153514663|NCT04673162|Protective Agents|protective agents|mesh-ancestor
153514664|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514665|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514666|NCT04560556|Antibodies|antibodies|mesh-list
153514667|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
153514668|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514669|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153514670|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514706|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514708|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514709|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
153514742|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514743|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153514745|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153514746|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153514747|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
153514748|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514780|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153618888|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514831|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153514832|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153514833|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514834|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514860|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514861|NCT01426022|Ethanol|ethanol|mesh-list
153514862|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153514863|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514864|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514865|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514866|NCT01426074|Bevacizumab|bevacizumab|mesh-list
153514867|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153514868|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514869|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153514870|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153514871|NCT01426074|Growth Substances|growth substances|mesh-ancestor
153514872|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514873|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
153514874|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153514875|NCT01426087|Somatostatin|somatostatin|mesh-list
153514876|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514877|NCT01426087|Hormones|hormones|mesh-ancestor
153514878|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514984|NCT01426880|Lapatinib|lapatinib|mesh-list
153514985|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153514986|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514987|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
153514988|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
153514989|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
153514990|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514991|NCT01426880|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153514992|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153514993|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514994|NCT01426906|Rifampin|rifampin|mesh-list
153514995|NCT01426906|Ketoconazole|ketoconazole|mesh-list
153514996|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153514997|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
153514998|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153514999|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515000|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
153515001|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153515002|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515003|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515004|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153515005|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153515006|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153515007|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153515008|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153515009|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153515010|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
153515011|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153515012|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153515013|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153515049|NCT01427114|Vincristine|vincristine|mesh-list
153515050|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515051|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
153515052|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515053|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515054|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153515055|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
153515056|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515057|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515058|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154256023|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736061|NCT03838042|Entinostat|entinostat|mesh-list
153515059|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515060|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153515061|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
153515062|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
153515063|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
153515064|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515065|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
153515066|NCT01427114|Hormones|hormones|mesh-ancestor
153515067|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515068|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153515069|NCT01427192|Acetazolamide|acetazolamide|mesh-list
153515070|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
153515071|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153515072|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515073|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515074|NCT01427192|Diuretics|diuretics|mesh-ancestor
153515105|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153515107|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515108|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515109|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
153515110|NCT01427335|Calcium|calcium|mesh-list
153515111|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153515112|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515113|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153515162|NCT01427842|Vancomycin|vancomycin|mesh-list
153515163|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153515164|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515165|NCT01427868|Maleic acid|maleic acid|mesh-list
153515166|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515167|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515168|NCT01427946|Everolimus|everolimus|mesh-list
153515169|NCT01427946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153515170|NCT01427946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153515171|NCT01427946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515172|NCT01427946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515220|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153515222|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515223|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626833|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
153515261|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515296|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
153515297|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
153515298|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515299|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515300|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153515301|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
153515302|NCT01428492|Hormones|hormones|mesh-ancestor
153515324|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515325|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515326|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
153515327|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153515328|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153515330|NCT01428544|Fondaparinux|fondaparinux|mesh-list
153515331|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153515332|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
153515333|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153515334|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
153515335|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515336|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515337|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
153515338|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153515339|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153515340|NCT01428622|Olodaterol|olodaterol|mesh-list
153515341|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153515342|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
153515383|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515384|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515385|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256025|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721837|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515387|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153515389|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515390|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515391|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153515392|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153515393|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
153515394|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515395|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515396|NCT01429181|Methadone|methadone|mesh-list
153515397|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153515398|NCT01429181|Narcotics|narcotics|mesh-ancestor
153515399|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515400|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515401|NCT01429181|Analgesics|analgesics|mesh-ancestor
153515402|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
153515403|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515404|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
153515405|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515406|NCT01429337|Midostaurin|midostaurin|mesh-list
153515407|NCT01429337|Staurosporine|staurosporine|mesh-list
153515408|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515432|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153515433|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153515434|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515435|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153515436|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
153515437|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153515439|NCT01429545|Vasotocin|vasotocin|mesh-list
153515440|NCT01429545|Atosiban|atosiban|mesh-list
153515441|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153515442|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153515443|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515534|NCT01429844|Cyclosporine|cyclosporine|mesh-list
153515566|NCT01430013|Endostatins|endostatins|mesh-list
153515567|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153515568|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153515569|NCT01430013|Growth Substances|growth substances|mesh-ancestor
153515570|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515571|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
153515572|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515573|NCT01430052|Gemcitabine|gemcitabine|mesh-list
153458690|NCT03891576|Niraparib|niraparib|mesh-list
153515574|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153515575|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
153515576|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515597|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
153515599|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153515600|NCT01430260|Ciclesonide|ciclesonide|mesh-list
153515601|NCT01430260|Cetirizine|cetirizine|mesh-list
153515602|NCT01430260|Levocetirizine|levocetirizine|mesh-list
153515603|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
153515604|NCT01430260|Hormones|hormones|mesh-ancestor
153515605|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515606|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515607|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153515608|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153515609|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153515610|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
153515611|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
153515612|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515613|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515614|NCT01430312|Azelaic acid|azelaic acid|mesh-list
153515615|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515711|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515712|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515713|NCT01431404|Etanercept|etanercept|mesh-list
153515714|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153515715|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515744|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
154256026|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721965|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
153515745|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153515746|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
153515760|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515761|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153515762|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
153626834|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
153515786|NCT01431690|Warfarin|warfarin|mesh-list
153515787|NCT01431690|Anticoagulants|anticoagulants|mesh-list
153515788|NCT01431729|Propolis|propolis|mesh-list
153515789|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515790|NCT01431742|Buprenorphine|buprenorphine|mesh-list
153515791|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153515792|NCT01431742|Narcotics|narcotics|mesh-ancestor
153515793|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515794|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515795|NCT01431742|Analgesics|analgesics|mesh-ancestor
153515796|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
153515797|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515798|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153515799|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153515800|NCT01431781|Somatostatin|somatostatin|mesh-list
153515801|NCT01431781|Hormones|hormones|mesh-ancestor
153515802|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515803|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515804|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
153515805|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153515806|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515807|NCT01431924|Fluticasone|fluticasone|mesh-list
153515808|NCT01431924|Xhance|xhance|mesh-list
153515809|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153515810|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515811|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153515812|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
153515813|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515814|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515815|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153515849|NCT01432080|Montelukast|montelukast|mesh-list
153515850|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153515851|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515852|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
153515854|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515855|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515856|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153515857|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515883|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515884|NCT01432119|Cetuximab|cetuximab|mesh-list
153515885|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153515886|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515887|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515888|NCT01432119|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153515896|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153515897|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515898|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
153515899|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
153515900|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
153515901|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515902|NCT01432249|Etanercept|etanercept|mesh-list
153515903|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153515904|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515978|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153515979|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153516010|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516011|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516013|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
153516014|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
153516015|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153516016|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
153516017|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
153516018|NCT01432977|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153516019|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153516020|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
153516021|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256027|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153516022|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516023|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153516024|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153516042|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
153516043|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191203|NCT05940324|Analgesics|analgesics|mesh-ancestor
153516044|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516045|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153516046|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
153516047|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153516048|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153516049|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153516050|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516051|NCT01433627|Hirudins|hirudins|mesh-list
153516052|NCT01433627|Bivalirudin|bivalirudin|mesh-list
153516053|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
153516054|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153516055|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
153516056|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516057|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516058|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
153516059|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153516060|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153516061|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
153516062|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153516063|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516064|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516065|NCT01433705|Regadenoson|regadenoson|mesh-list
153516066|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516067|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153516068|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153516070|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
153516071|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516072|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516073|NCT01433757|Ampicillin|ampicillin|mesh-list
153516074|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153516161|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
153516162|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516163|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516164|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153516165|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153516199|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153516200|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153516201|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516202|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516203|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516204|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153516205|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
153516231|NCT01434225|Bumetanide|bumetanide|mesh-list
153516232|NCT01434225|Diuretics|diuretics|mesh-ancestor
153516233|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
153516234|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516235|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153516236|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153516237|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516238|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
153516239|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153516240|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153516241|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153516242|NCT01434303|Trastuzumab|trastuzumab|mesh-list
153516243|NCT01434303|Lapatinib|lapatinib|mesh-list
153516244|NCT01434303|Entinostat|entinostat|mesh-list
153516245|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153516246|NCT01434303|Antibodies|antibodies|mesh-list
153516247|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
153516248|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153516249|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153516250|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
153618893|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516294|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
154256028|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516295|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516296|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516297|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516298|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153516299|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153516322|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153516323|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153731700|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516324|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516325|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153516326|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153516327|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153516328|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516329|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
153516331|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153516332|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153516333|NCT01435200|Hematinics|hematinics|mesh-ancestor
153516335|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153516336|NCT01435213|Ketamine|ketamine|mesh-list
153516337|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153516338|NCT01435213|Atipamezole|atipamezole|mesh-list
153516339|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516340|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516341|NCT01435213|Analgesics|analgesics|mesh-ancestor
153516342|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
153516343|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516344|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153516345|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153516346|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
153516347|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
153516348|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516349|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153516350|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153516351|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516470|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153516471|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153516472|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
153516473|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516474|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516475|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516476|NCT01435954|Urological Agents|urological agents|mesh-ancestor
153516477|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153516505|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516506|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516507|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153516508|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153516509|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153516510|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516511|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516512|NCT01436422|Vaccines|vaccines|mesh-list
153516513|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
153516514|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516562|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516563|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516565|NCT01436825|Coagulants|coagulants|mesh-ancestor
153516566|NCT01436838|Interferons|interferons|mesh-list
153516567|NCT01436838|Interferon-beta|interferon-beta|mesh-list
153516568|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
153516569|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516584|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516586|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516587|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
153516588|NCT01436994|Carbimazole|carbimazole|mesh-list
153516589|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
153516590|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516591|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
153516592|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
153516593|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516594|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256029|NCT01589744|Hemostatics|hemostatics|mesh-list
154256030|NCT01589744|Coagulants|coagulants|mesh-ancestor
153516596|NCT01437007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153516597|NCT01437007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516598|NCT01437007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516599|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153516600|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
153516601|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516602|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153516626|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516627|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153516628|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516629|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153516649|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
154191204|NCT05940324|Sensory System Agents|sensory system agents|mesh-ancestor
153516650|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516651|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153516652|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153516653|NCT01437371|Protective Agents|protective agents|mesh-ancestor
153516654|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516655|NCT01437462|Propofol|propofol|mesh-list
153516656|NCT01437462|Sevoflurane|sevoflurane|mesh-list
153516657|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153516658|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516659|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516660|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153516661|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
153516662|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
153516663|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153516664|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153516665|NCT01437566|Fulvestrant|fulvestrant|mesh-list
153516666|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153516667|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516668|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153516726|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516728|NCT01437800|Metformin|metformin|mesh-list
153516729|NCT01437800|Glimepiride|glimepiride|mesh-list
153516730|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516731|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516732|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153516770|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153516771|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516854|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153516855|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
153516856|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
153517029|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517030|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153517056|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153517057|NCT03232346|Narcotics|narcotics|mesh-ancestor
153517076|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517077|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517110|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517112|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517113|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517114|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517115|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153517116|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153517117|NCT02426502|Cyclosporine|cyclosporine|mesh-list
153517118|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
153517143|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
153517144|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153517146|NCT02275156|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153517147|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153517148|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153517149|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
153517150|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517151|NCT02275156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153517152|NCT02275156|Protease Inhibitors|protease inhibitors|mesh-ancestor
153517153|NCT02275156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517154|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153517155|NCT02124902|Carboplatin|carboplatin|mesh-list
153517156|NCT02124902|Docetaxel|docetaxel|mesh-list
154256031|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
153722402|NCT00144183|Nevirapine|nevirapine|mesh-list
153517157|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517158|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
153517159|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
153517160|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
153517161|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517162|NCT02067182|Dabigatran|dabigatran|mesh-list
153517163|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
153517164|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153517165|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
153517250|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
153517251|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
153517252|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153517253|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517254|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517255|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153517256|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153517257|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153517258|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153517259|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153517260|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153517290|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153517291|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153517292|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517293|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
153517294|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
153517354|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153517355|NCT01439100|Narcotics|narcotics|mesh-ancestor
153517356|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517357|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517358|NCT01439100|Analgesics|analgesics|mesh-ancestor
153517359|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
153517470|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517532|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517533|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517534|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
153517594|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
153517595|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517596|NCT01440790|Protective Agents|protective agents|mesh-ancestor
153517597|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
153517679|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718476|NCT00099008|Genistein|genistein|mesh-list
153517680|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517681|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153517682|NCT01441284|Pramipexole|pramipexole|mesh-list
153517683|NCT01441284|Dexpramipexole|dexpramipexole|mesh-list
153517684|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
153539918|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153517731|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517732|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517733|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153517734|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153517736|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153517737|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153517738|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
153517739|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
153517740|NCT01441531|Gabapentin|gabapentin|mesh-list
153517742|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
153517743|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517744|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517745|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
153517746|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153517747|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153517748|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517749|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153517750|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153517751|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153517752|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517753|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517754|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
153517777|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517779|NCT01441869|Hormones|hormones|mesh-ancestor
154256032|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153517780|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153517781|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153731704|NCT00139061|Atorvastatin|atorvastatin|mesh-list
153517840|NCT01442311|Interferons|interferons|mesh-list
153517842|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
153517843|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
153517844|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153517845|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517846|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
153517847|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517848|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
153517849|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517850|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
153517881|NCT01442519|Mitomycin|mitomycin|mesh-list
153517882|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
153517883|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153517884|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517885|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
153517886|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517887|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153517888|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517935|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153517936|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153517937|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
153517938|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517975|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517976|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153518006|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
153518008|NCT01442974|Gemcitabine|gemcitabine|mesh-list
153518009|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153518010|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518011|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
153518012|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
153518013|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
153518014|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518015|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153518016|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
153518017|NCT01442987|Irbesartan|irbesartan|mesh-list
153518018|NCT01442987|Atorvastatin|atorvastatin|mesh-list
153518019|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518020|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518021|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
153518022|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518023|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518024|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153518025|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518060|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153518061|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518062|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153518063|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
153518065|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
153518066|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518067|NCT01443169|Pregabalin|pregabalin|mesh-list
153731705|NCT00139061|Torcetrapib|torcetrapib|mesh-list
153731706|NCT00139061|Fenofibrate|fenofibrate|mesh-list
153518068|NCT01443169|Analgesics|analgesics|mesh-ancestor
153518069|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
153518119|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518120|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518156|NCT01443650|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518157|NCT01443650|Antimetabolites|antimetabolites|mesh-ancestor
153518158|NCT01443650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518188|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
153518189|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
153518190|NCT01443897|Vitamins|vitamins|mesh-list
153518191|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
153518192|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518193|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153518194|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153518195|NCT01443988|Travoprost|travoprost|mesh-list
153518196|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154256033|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154256034|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
153518198|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153518199|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
153518200|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518201|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
153518202|NCT01444118|Vaccines|vaccines|mesh-list
153518247|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153518248|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
153518249|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518250|NCT01444521|Irinotecan|irinotecan|mesh-list
153518251|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518252|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153518253|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153518254|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518255|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518256|NCT01444547|Paclitaxel|paclitaxel|mesh-list
153518306|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153518338|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153518339|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153518340|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153518341|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153618903|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518342|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153518343|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153518344|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
153518346|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
153518347|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518348|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518349|NCT01445106|Nelfinavir|nelfinavir|mesh-list
153518350|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153518351|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153518352|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518353|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518354|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518355|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153518356|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153518357|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
153518358|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518359|NCT01445119|Carboplatin|carboplatin|mesh-list
153518360|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518361|NCT01445210|Ropivacaine|ropivacaine|mesh-list
153518383|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153718703|NCT00099944|Vildagliptin|vildagliptin|mesh-list
153518384|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153518385|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153518386|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153518387|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153518399|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
153518400|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518401|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
153518402|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518404|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153518405|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153518406|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
153518407|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
153518408|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518409|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518410|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518411|NCT01445340|Romidepsin|romidepsin|mesh-list
153518412|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153518413|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731710|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731711|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518414|NCT01445340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153518415|NCT01445340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518416|NCT01445340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518417|NCT01445379|Ipilimumab|ipilimumab|mesh-list
153518418|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518419|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518420|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153518504|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518525|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153518526|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
153518527|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
153518528|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518529|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518530|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518531|NCT01446107|Fluorides|fluorides|mesh-list
153518532|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
153518533|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
153518534|NCT01446107|Protective Agents|protective agents|mesh-ancestor
153518535|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518536|NCT01446120|Insulin|insulin|mesh-list
153518558|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
153518559|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153518569|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153518570|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153518571|NCT01446211|Protective Agents|protective agents|mesh-ancestor
153518572|NCT01446276|Resveratrol|resveratrol|mesh-list
153518573|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
153518574|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518575|NCT01446276|Protective Agents|protective agents|mesh-ancestor
153518576|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518577|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518578|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153518580|NCT01446328|Aripiprazole|aripiprazole|mesh-list
153518581|NCT01446328|Amisulpride|amisulpride|mesh-list
153518582|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
153518583|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
153518584|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518585|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518586|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153518587|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153518588|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153518589|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518590|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153518591|NCT01446328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153518592|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153518593|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153518594|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518595|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518596|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
153518597|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
153518598|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
153518599|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
153518639|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
153518640|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153518641|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518643|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153518644|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153518645|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153518646|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
153518647|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518648|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518649|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518650|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153518651|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518652|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153518653|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153518654|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153518687|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
153518688|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518689|NCT01446952|Vitamin E|vitamin e|mesh-list
153518690|NCT01446952|Tocopherols|tocopherols|mesh-list
153518691|NCT01446952|Tocotrienols|tocotrienols|mesh-list
153518711|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518712|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518713|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153518714|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
153518740|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518741|NCT01447212|Analgesics|analgesics|mesh-ancestor
153518742|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
153518743|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518744|NCT01447355|Vitamin D|vitamin d|mesh-list
153518745|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
153518746|NCT01447355|Vitamins|vitamins|mesh-ancestor
154256035|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518747|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
153518748|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518749|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153518759|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
153518760|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
153518761|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153518762|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518763|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
153518764|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518765|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
153518766|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518767|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
153518768|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518769|NCT01447485|Valsartan|valsartan|mesh-list
153518770|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518771|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153518772|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153518773|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518803|NCT01447797|Irbesartan|irbesartan|mesh-list
153518804|NCT01447797|Atorvastatin|atorvastatin|mesh-list
153518805|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518806|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518807|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
153518808|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518809|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518810|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153518811|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518812|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518853|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518854|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518855|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
153518856|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518857|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518858|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153518859|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518860|NCT01448239|Alirocumab|alirocumab|mesh-list
153518861|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153518862|NCT01448239|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153518863|NCT01448239|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518864|NCT01448239|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518865|NCT01448239|Antimetabolites|antimetabolites|mesh-ancestor
153518866|NCT01448239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518867|NCT01448239|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153518868|NCT01448239|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518898|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153518899|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153518900|NCT01448317|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153518901|NCT01448317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518902|NCT01448317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518903|NCT01448317|Antimetabolites|antimetabolites|mesh-ancestor
153518904|NCT01448317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518905|NCT01448317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153518906|NCT01448317|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518907|NCT01448317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518908|NCT01448317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518909|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
153518910|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518911|NCT01448330|Aspirin|aspirin|mesh-list
153518912|NCT01448330|Clopidogrel|clopidogrel|mesh-list
153518913|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153518914|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153518915|NCT01448330|Analgesics|analgesics|mesh-ancestor
153718873|NCT00132756|Estramustine|estramustine|mesh-list
153518916|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
153518917|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518918|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518919|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153518920|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518921|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153518922|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153518923|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518924|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153518925|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153518926|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518928|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153518929|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153518971|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518972|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153518973|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153518974|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153518976|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518977|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518978|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153518979|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153518980|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
153518981|NCT01448733|Clindamycin|clindamycin|mesh-list
153518982|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
153518983|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
153518984|NCT01448733|Tretinoin|tretinoin|mesh-list
153518985|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153518986|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153518987|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518988|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153518989|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518990|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518991|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
153718938|NCT00132951|Azithromycin|azithromycin|mesh-list
153518992|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518993|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
153518994|NCT01448746|Heparin|heparin|mesh-list
153518995|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153518996|NCT01448746|Tinzaparin|tinzaparin|mesh-list
153518997|NCT01448746|Dalteparin|dalteparin|mesh-list
153518998|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
153518999|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153519000|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153519037|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153519038|NCT01448993|Azithromycin|azithromycin|mesh-list
153519039|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153519040|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519041|NCT01449045|Lumefantrine|lumefantrine|mesh-list
153519042|NCT01449045|Artemether|artemether|mesh-list
153519043|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153519044|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
153519045|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153519046|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153519047|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519048|NCT01449110|Resveratrol|resveratrol|mesh-list
153519049|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
153519050|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519051|NCT01449110|Protective Agents|protective agents|mesh-ancestor
153519052|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519053|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519054|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153519055|NCT01449123|Mannitol|mannitol|mesh-list
153519056|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153519057|NCT01449123|Diuretics|diuretics|mesh-ancestor
153519058|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
153519059|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519103|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519104|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
153519105|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
153519106|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519107|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519108|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519109|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
153519110|NCT01449344|Hormones|hormones|mesh-ancestor
153519111|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519134|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153519147|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519148|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519149|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731716|NCT04705584|Cyclosporine|cyclosporine|mesh-list
153519150|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153519151|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154256036|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256037|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153519152|NCT01449448|Analgesics|analgesics|mesh-ancestor
153519153|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
153519154|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519155|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519156|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153519157|NCT01447992|Pancrelipase|pancrelipase|mesh-list
153519158|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519159|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
153519160|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153519161|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153519162|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519163|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
153519164|NCT01449552|Coagulants|coagulants|mesh-ancestor
153519165|NCT01449565|Naltrexone|naltrexone|mesh-list
153519166|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153519167|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153519168|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519169|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
153519170|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519171|NCT01449578|Pramipexole|pramipexole|mesh-list
153519172|NCT01449578|Dexpramipexole|dexpramipexole|mesh-list
153519173|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
153539919|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
153519189|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519190|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519192|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153519193|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153519194|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519195|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153519196|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153519220|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153519221|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153519222|NCT01449825|Growth Substances|growth substances|mesh-ancestor
153519223|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519224|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
153519225|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153519226|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519227|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519228|NCT01449877|Trimethoprim|trimethoprim|mesh-list
153519229|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153519230|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
153519231|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153519232|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519233|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
153519234|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153519235|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153519236|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153519237|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519238|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519239|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153519240|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153519241|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153519242|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153519243|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
153519244|NCT01450163|Pregabalin|pregabalin|mesh-list
153519245|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519246|NCT01450163|Analgesics|analgesics|mesh-ancestor
153519247|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
153519248|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519249|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519252|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153519253|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519254|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153519255|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153519292|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519293|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519317|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
153519318|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
153519319|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154256038|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
153519340|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153519342|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519343|NCT01453283|Trabectedin|trabectedin|mesh-list
153519344|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153519345|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
153519346|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519347|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519348|NCT01454700|Insulin|insulin|mesh-list
153519349|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153519350|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519351|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519352|NCT01454869|Heparin|heparin|mesh-list
153519353|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
153519354|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153519355|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153519356|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519357|NCT05964387|Lidocaine|lidocaine|mesh-list
153519358|NCT05964387|Epinephrine|epinephrine|mesh-list
153519359|NCT05964387|Anesthetics, Local|anesthetics, local|mesh-ancestor
153519360|NCT05964387|Anesthetics|anesthetics|mesh-ancestor
153519361|NCT05964387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153519362|NCT05964387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519363|NCT05964387|Sensory System Agents|sensory system agents|mesh-ancestor
153519364|NCT05964387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519404|NCT05964101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519405|NCT05964101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519406|NCT05964101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153519407|NCT05963711|Chlorhexidine|chlorhexidine|mesh-list
153519408|NCT05963711|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153519409|NCT05963711|Clindamycin|clindamycin|mesh-list
153519410|NCT05963711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153519411|NCT05963711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519412|NCT05963711|Disinfectants|disinfectants|mesh-ancestor
153519413|NCT05963711|Dermatologic Agents|dermatologic agents|mesh-ancestor
153519414|NCT05963711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153519459|NCT05962619|Viscosupplements|viscosupplements|mesh-ancestor
153519460|NCT05962619|Protective Agents|protective agents|mesh-ancestor
153519461|NCT05962255|Furosemide|furosemide|mesh-list
153519462|NCT05962255|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153519463|NCT05962255|Diuretics|diuretics|mesh-ancestor
153519464|NCT05962255|Natriuretic Agents|natriuretic agents|mesh-ancestor
153519465|NCT05962255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519466|NCT05962255|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153519467|NCT05962255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153519468|NCT05962255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519469|NCT05962216|Brexpiprazole|brexpiprazole|mesh-list
153519470|NCT05962216|Serotonin Agents|serotonin agents|mesh-ancestor
153519471|NCT05962216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519472|NCT05962216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519473|NCT05962216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519474|NCT05962216|Dopamine Agonists|dopamine agonists|mesh-ancestor
153519523|NCT05960721|Sensory System Agents|sensory system agents|mesh-ancestor
153519524|NCT05960721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519525|NCT05960721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745653|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519601|NCT05887726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519602|NCT05887726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153519603|NCT05887726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153519604|NCT05887726|Tubulin Modulators|tubulin modulators|mesh-ancestor
153519605|NCT05887726|Antimitotic Agents|antimitotic agents|mesh-ancestor
153519606|NCT05887726|Mitosis Modulators|mitosis modulators|mesh-ancestor
153519652|NCT05841420|Tubulin Modulators|tubulin modulators|mesh-ancestor
153519653|NCT05841420|Antimitotic Agents|antimitotic agents|mesh-ancestor
153519654|NCT05841420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153519655|NCT05841420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519656|NCT05841420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153519657|NCT05841420|Antimetabolites|antimetabolites|mesh-ancestor
153519659|NCT05801315|Glycine Agents|glycine agents|mesh-ancestor
153519660|NCT05801315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519735|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519736|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
153519737|NCT05508100|Tislelizumab|tislelizumab|mesh-list
153519738|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519739|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519740|NCT05508100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153519741|NCT05508100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519742|NCT05498233|Pyridoxine|pyridoxine|mesh-list
153519743|NCT05498233|Doxylamine|doxylamine|mesh-list
153519744|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
153519745|NCT05498233|Vitamins|vitamins|mesh-ancestor
153519746|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
153519747|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519748|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
153519749|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
153519787|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519788|NCT05412173|Molnupiravir|molnupiravir|mesh-list
153519789|NCT05412173|Antiviral Agents|antiviral agents|mesh-ancestor
153519790|NCT05412173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519791|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153519792|NCT05390892|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153519793|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519794|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519795|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519796|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
153519797|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519839|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153519840|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519842|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
153519843|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519844|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
153519845|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857621|NCT04948749|Sirolimus|sirolimus|mesh-list
153519846|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519847|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
153519848|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153519849|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153519866|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153519867|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
153519868|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519869|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519870|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153519871|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153519872|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153519873|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
153519874|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
153519875|NCT05179512|Hormones|hormones|mesh-ancestor
153519876|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519877|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
153519878|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153519879|NCT05164081|Clindamycin|clindamycin|mesh-list
153519880|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
153519881|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
153519882|NCT05164081|Gentamicins|gentamicins|mesh-list
153519883|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153519889|NCT05162183|Liraglutide|liraglutide|mesh-list
153519890|NCT05162183|Glimepiride|glimepiride|mesh-list
153519891|NCT05162183|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153519892|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519893|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519894|NCT05162183|Incretins|incretins|mesh-ancestor
153519895|NCT05162183|Hormones|hormones|mesh-ancestor
153519896|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519897|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153519898|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153519899|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
153519900|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153519901|NCT05099198|Glimepiride|glimepiride|mesh-list
153519902|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519903|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519904|NCT05099198|Incretins|incretins|mesh-ancestor
153519905|NCT05099198|Hormones|hormones|mesh-ancestor
153463037|NCT03820518|Vitamins|vitamins|mesh-ancestor
153519906|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256039|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154256040|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
153519907|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153519908|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
153519909|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519942|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519943|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
153519944|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153519945|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153519946|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
153519988|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153519989|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
153519990|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153519991|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
153519992|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519993|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
153520044|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520045|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520047|NCT06257017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520048|NCT06257017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520065|NCT06256627|Analgesics|analgesics|mesh-ancestor
153520066|NCT06256627|Sensory System Agents|sensory system agents|mesh-ancestor
153520067|NCT06256627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520068|NCT06256627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520069|NCT06256627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153520070|NCT06256627|Immunologic Factors|immunologic factors|mesh-ancestor
153520071|NCT06256627|Leprostatic Agents|leprostatic agents|mesh-ancestor
153520072|NCT06256627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153520073|NCT06256627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520074|NCT06256627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153520095|NCT06256419|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153520096|NCT06256419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153520097|NCT06256419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520098|NCT06256328|Capecitabine|capecitabine|mesh-list
153520099|NCT06256328|Tegafur|tegafur|mesh-list
153520100|NCT06256328|Nivolumab|nivolumab|mesh-list
153520101|NCT06256328|Oxaliplatin|oxaliplatin|mesh-list
153520102|NCT06256328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520103|NCT06256328|Antimetabolites|antimetabolites|mesh-ancestor
153520104|NCT06256328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520105|NCT06256328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520106|NCT06256328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520107|NCT06256328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520108|NCT06256289|Metformin|metformin|mesh-list
153520109|NCT06256289|Canagliflozin|canagliflozin|mesh-list
153520110|NCT06256289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153520111|NCT06256289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520112|NCT06256289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153520113|NCT06256289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520114|NCT06256276|Psyllium|psyllium|mesh-list
153520115|NCT06256276|Calcium polycarbophil|calcium polycarbophil|mesh-list
153520116|NCT06256276|Cathartics|cathartics|mesh-ancestor
153520117|NCT06256276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153520118|NCT06256276|Antidiarrheals|antidiarrheals|mesh-ancestor
153520119|NCT06256237|Etoposide|etoposide|mesh-list
153520120|NCT06256237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153520121|NCT06256237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520122|NCT06256237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153520123|NCT06256237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153520124|NCT06256237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520125|NCT06256237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520126|NCT06256211|Acetaminophen|acetaminophen|mesh-list
153520226|NCT06254131|Autonomic Agents|autonomic agents|mesh-ancestor
153520227|NCT06254131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520228|NCT06254131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520239|NCT06253546|Autonomic Agents|autonomic agents|mesh-ancestor
153520240|NCT06253546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520241|NCT06253546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520242|NCT06253546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153520267|NCT06248593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153520268|NCT06248593|Nasal Decongestants|nasal decongestants|mesh-ancestor
153520269|NCT06248593|Respiratory System Agents|respiratory system agents|mesh-ancestor
153520271|NCT06248593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153520272|NCT06248593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153520273|NCT06248593|Adrenergic Agents|adrenergic agents|mesh-ancestor
153520274|NCT06248593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520275|NCT06248593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520276|NCT06248593|Protective Agents|protective agents|mesh-ancestor
153520278|NCT06245564|Amitriptyline|amitriptyline|mesh-list
153520279|NCT06245564|Histamine|histamine|mesh-list
153520280|NCT06245564|Analgesics|analgesics|mesh-ancestor
153520281|NCT06245564|Sensory System Agents|sensory system agents|mesh-ancestor
153520282|NCT06245564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520283|NCT06245564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520284|NCT06245564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153520285|NCT06245564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153520286|NCT06245564|Anesthetics, General|anesthetics, general|mesh-ancestor
153520338|NCT06223958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520339|NCT06223958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153520340|NCT06223958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520341|NCT06223958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520342|NCT06198686|Nalmefene|nalmefene|mesh-list
153520343|NCT06198686|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153520344|NCT06198686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520345|NCT06198686|Sensory System Agents|sensory system agents|mesh-ancestor
153520346|NCT06198686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520347|NCT06185933|Lidocaine|lidocaine|mesh-list
153520348|NCT06185933|Anesthetics, Local|anesthetics, local|mesh-ancestor
153520349|NCT06185933|Anesthetics|anesthetics|mesh-ancestor
153520350|NCT06185933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520351|NCT06185933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520352|NCT06185933|Sensory System Agents|sensory system agents|mesh-ancestor
153520385|NCT06079047|Autonomic Agents|autonomic agents|mesh-ancestor
153520386|NCT06079047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520387|NCT06079047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520388|NCT06079047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153520389|NCT06079047|Glucocorticoids|glucocorticoids|mesh-ancestor
153520390|NCT06079047|Hormones|hormones|mesh-ancestor
153520391|NCT06079047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520392|NCT06079047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153520393|NCT06079047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520394|NCT06064279|Poly ICLC|poly iclc|mesh-list
153520395|NCT06064279|Interferon Inducers|interferon inducers|mesh-ancestor
153520396|NCT06064279|Immunologic Factors|immunologic factors|mesh-ancestor
153520397|NCT06064279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520398|NCT06063486|Curcumin|curcumin|mesh-list
153520399|NCT06063486|Piperine|piperine|mesh-list
153520400|NCT06063486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153520401|NCT06063486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520402|NCT06063486|Analgesics|analgesics|mesh-ancestor
153520403|NCT06063486|Sensory System Agents|sensory system agents|mesh-ancestor
153520404|NCT06063486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857657|NCT04840823|Enoxacin|enoxacin|mesh-list
153520405|NCT06063486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520406|NCT06063486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153520407|NCT06063486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520408|NCT06063486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520409|NCT06063486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520438|NCT05989828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153520439|NCT05989828|Immunologic Factors|immunologic factors|mesh-ancestor
153520440|NCT05989828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520441|NCT05989828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520442|NCT05989828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153520443|NCT05989828|Alkylating Agents|alkylating agents|mesh-ancestor
153520444|NCT05989828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520445|NCT05989828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520446|NCT05989828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153520447|NCT05989828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520448|NCT05989828|Analgesics|analgesics|mesh-ancestor
153520449|NCT05989828|Sensory System Agents|sensory system agents|mesh-ancestor
153520450|NCT05989828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520451|NCT05989828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153520452|NCT05989828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153520453|NCT05989828|Antiviral Agents|antiviral agents|mesh-ancestor
153520454|NCT05989828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520455|NCT05982093|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154256041|NCT01154504|Protective Agents|protective agents|mesh-ancestor
153723581|NCT00426010|Caffeine|caffeine|mesh-list
153520456|NCT05982093|Luteolytic Agents|luteolytic agents|mesh-ancestor
153520457|NCT05982093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153520458|NCT05982093|Contraceptive Agents|contraceptive agents|mesh-ancestor
153520459|NCT05982093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153520460|NCT05982093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520461|NCT05982093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153520483|NCT05964868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153520485|NCT05964868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153520486|NCT05964868|Respiratory System Agents|respiratory system agents|mesh-ancestor
153520487|NCT05964868|Mydriatics|mydriatics|mesh-ancestor
153520488|NCT05964868|Sympathomimetics|sympathomimetics|mesh-ancestor
153520501|NCT05937854|Tadalafil|tadalafil|mesh-list
153520502|NCT05937854|Vasodilator Agents|vasodilator agents|mesh-ancestor
153618908|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520503|NCT05937854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153520504|NCT05937854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153520505|NCT05937854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520506|NCT05937854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520507|NCT05937854|Urological Agents|urological agents|mesh-ancestor
153520508|NCT05907213|Ketamine|ketamine|mesh-list
153520509|NCT05907213|Analgesics|analgesics|mesh-ancestor
153520510|NCT05907213|Sensory System Agents|sensory system agents|mesh-ancestor
153520511|NCT05907213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520512|NCT05907213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520513|NCT05907213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153857667|NCT04838743|Xultophy|xultophy|mesh-list
153520514|NCT05907213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153520515|NCT05907213|Anesthetics, General|anesthetics, general|mesh-ancestor
153520516|NCT05907213|Anesthetics|anesthetics|mesh-ancestor
153520517|NCT05907213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520518|NCT05907213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153520519|NCT05907213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153520520|NCT05907213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520521|NCT05907213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520522|NCT05904743|Insulin|insulin|mesh-list
153731725|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520549|NCT05862545|Budesonide|budesonide|mesh-list
153520550|NCT05862545|Glycopyrrolate|glycopyrrolate|mesh-list
153520551|NCT05862545|Formoterol Fumarate|formoterol fumarate|mesh-list
153520565|NCT05862545|Adrenergic Agents|adrenergic agents|mesh-ancestor
153520566|NCT05862545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520567|NCT05862545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520568|NCT05862545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153520569|NCT05862545|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153520570|NCT05862545|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153520571|NCT05862545|Cholinergic Agents|cholinergic agents|mesh-ancestor
153520572|NCT05853289|Analgesics, Opioid|analgesics, opioid|mesh-list
153520573|NCT05853289|Narcotics|narcotics|mesh-ancestor
153520574|NCT05853289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520575|NCT05853289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520576|NCT05853289|Analgesics|analgesics|mesh-ancestor
153463713|NCT02666742|Coagulants|coagulants|mesh-list
153520577|NCT05853289|Sensory System Agents|sensory system agents|mesh-ancestor
153520578|NCT05853289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520579|NCT05842174|Hydroxychloroquine|hydroxychloroquine|mesh-list
153520580|NCT05842174|Ethiodized Oil|ethiodized oil|mesh-list
153520581|NCT05842174|Antimalarials|antimalarials|mesh-ancestor
153520582|NCT05842174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153520611|NCT05813288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520623|NCT05775471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520624|NCT05775471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520625|NCT05775471|Immunologic Factors|immunologic factors|mesh-ancestor
153520626|NCT05775471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520627|NCT05765851|Trastuzumab|trastuzumab|mesh-list
153520628|NCT05765851|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153520629|NCT05765851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520630|NCT05765851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520631|NCT05765851|Immunoconjugates|immunoconjugates|mesh-ancestor
153520632|NCT05765851|Immunologic Factors|immunologic factors|mesh-ancestor
153520633|NCT05765851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520634|NCT05763329|Lemborexant|lemborexant|mesh-list
153520635|NCT05763329|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153520636|NCT05763329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723767|NCT00445042|Sorafenib|sorafenib|mesh-list
153520665|NCT05753436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520666|NCT05753436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520667|NCT05753436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520668|NCT05748600|Pramipexole|pramipexole|mesh-list
153520669|NCT05748600|Dexpramipexole|dexpramipexole|mesh-list
153520670|NCT05748600|Antioxidants|antioxidants|mesh-ancestor
153520671|NCT05748600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520672|NCT05748600|Protective Agents|protective agents|mesh-ancestor
153520673|NCT05748600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520674|NCT05748600|Dopamine Agents|dopamine agents|mesh-ancestor
153520675|NCT05748600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520699|NCT05723055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520700|NCT05723055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520701|NCT05697809|Dexamethasone|dexamethasone|mesh-list
153520858|NCT05504291|Vincristine|vincristine|mesh-list
153719615|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719616|NCT00134160|Amlodipine|amlodipine|mesh-list
153719617|NCT00134160|Olmesartan|olmesartan|mesh-list
153719618|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153719619|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
153719620|NCT00134160|Calcium|calcium|mesh-list
153520859|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
153520860|NCT05504291|Melphalan|melphalan|mesh-list
153520861|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
153520862|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
153520863|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153520887|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153520888|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520889|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153520890|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153520891|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153520892|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153520893|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153520894|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520895|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520896|NCT05485766|Paclitaxel|paclitaxel|mesh-list
153520897|NCT05485766|Carboplatin|carboplatin|mesh-list
153520898|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
153520899|NCT05485766|Olaparib|olaparib|mesh-list
153520900|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153520901|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520902|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
153520903|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
153520904|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
153520905|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520906|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520907|NCT05485766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153731728|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153731729|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731730|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
153731731|NCT04705584|Hormones|hormones|mesh-ancestor
153520908|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153520909|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520910|NCT05447520|Montelukast|montelukast|mesh-list
153520941|NCT05405309|Olaparib|olaparib|mesh-list
153719633|NCT00134199|Sibutramine|sibutramine|mesh-list
153520942|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153521023|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153521024|NCT05288348|Narcotics|narcotics|mesh-ancestor
153521025|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521026|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521028|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
153521029|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521080|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153521082|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153521083|NCT05174884|Progestins|progestins|mesh-ancestor
153521084|NCT05174884|Hormones|hormones|mesh-ancestor
153521085|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521086|NCT05160597|Edetic Acid|edetic acid|mesh-list
153521087|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153521088|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
153521089|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
153521090|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521091|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
153521092|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153521093|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153618912|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
153521094|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
153521117|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
153521120|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521141|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521143|NCT04863885|Immunologic Factors|immunologic factors|mesh-ancestor
153521144|NCT04863885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521179|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521180|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521182|NCT04673617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153521183|NCT04673617|Rituximab|rituximab|mesh-list
153521184|NCT04673617|Fludarabine|fludarabine|mesh-list
153521185|NCT04673617|Interleukin-2|interleukin-2|mesh-list
153521186|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521224|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
153521225|NCT04546009|Letrozole|letrozole|mesh-list
153521226|NCT04546009|Palbociclib|palbociclib|mesh-list
153521227|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521228|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153521229|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153521249|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521251|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
153521252|NCT04529265|Methylene Blue|methylene blue|mesh-list
153521253|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521254|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521255|NCT04513522|Nivolumab|nivolumab|mesh-list
153521256|NCT04513522|Ipilimumab|ipilimumab|mesh-list
153521257|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521258|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521259|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521260|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521261|NCT04486118|Lisinopril|lisinopril|mesh-list
153731732|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731733|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153521262|NCT04486118|Benazepril|benazepril|mesh-list
153521317|NCT04340882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521318|NCT04340882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153521319|NCT04340882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153521320|NCT04340882|Growth Substances|growth substances|mesh-ancestor
153521321|NCT04340882|Growth Inhibitors|growth inhibitors|mesh-ancestor
153521323|NCT04338204|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153521324|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521325|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521359|NCT04165096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521360|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521361|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153521362|NCT04165096|Analgesics|analgesics|mesh-ancestor
153521363|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
153521364|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521365|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521484|NCT03869437|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153521485|NCT03869437|Chelating Agents|chelating agents|mesh-ancestor
153521486|NCT03869437|Sequestering Agents|sequestering agents|mesh-ancestor
153521487|NCT03869437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521488|NCT03869437|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153521518|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153521519|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521520|NCT03709758|Cytarabine|cytarabine|mesh-list
153521521|NCT03709758|Daunorubicin|daunorubicin|mesh-list
153521522|NCT03709758|Venetoclax|venetoclax|mesh-list
153521523|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521608|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521609|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
153521611|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521612|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
153521613|NCT03475134|Nivolumab|nivolumab|mesh-list
153521614|NCT03475134|Fludarabine|fludarabine|mesh-list
153521615|NCT03475134|Interleukin-2|interleukin-2|mesh-list
153521616|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521617|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
153521618|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521619|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153724062|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724063|NCT00115635|Gemcitabine|gemcitabine|mesh-list
153521620|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521621|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
153521622|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521702|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
153521703|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
153521704|NCT02995330|Testosterone|testosterone|mesh-list
153521705|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
153521706|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
153521707|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153719701|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
153521708|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521709|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
153521710|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521711|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153521712|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521713|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
153521714|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521715|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521738|NCT02829918|Nivolumab|nivolumab|mesh-list
153521739|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521740|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521741|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521742|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521743|NCT02730923|Anastrozole|anastrozole|mesh-list
153521744|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153521797|NCT02456857|Doxorubicin|doxorubicin|mesh-list
153521798|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153521799|NCT02456857|Everolimus|everolimus|mesh-list
153521800|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
153521801|NCT02456857|Antibodies|antibodies|mesh-list
153521802|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
153521803|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153731738|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521804|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
153521805|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521806|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153521807|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153521808|NCT02456857|Growth Substances|growth substances|mesh-ancestor
153521809|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521810|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
153521811|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
153521812|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153521813|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153521814|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153521846|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
153521847|NCT02157051|Vaccines|vaccines|mesh-list
153521848|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
153521849|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521850|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153521939|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521940|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521941|NCT02029001|Everolimus|everolimus|mesh-list
153521942|NCT02029001|Sorafenib|sorafenib|mesh-list
153521943|NCT02029001|Durvalumab|durvalumab|mesh-list
153521944|NCT02029001|Olaparib|olaparib|mesh-list
153521945|NCT02029001|Lapatinib|lapatinib|mesh-list
153521946|NCT02029001|Tremelimumab|tremelimumab|mesh-list
153521947|NCT02029001|Nilotinib|nilotinib|mesh-list
153521980|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153521981|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
153521982|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521983|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
153465141|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153521984|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153521985|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153522018|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
153522019|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
153522020|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522021|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522022|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522099|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
153724174|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
153522100|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153522101|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153522102|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
153522103|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522104|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522105|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153522106|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
153522107|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
153522109|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522110|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153522111|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153522112|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153522113|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
153522114|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522137|NCT04848519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522138|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522139|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153522141|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
153522163|NCT06040489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522164|NCT06040489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153522165|NCT06040489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153522166|NCT06040489|Protective Agents|protective agents|mesh-ancestor
153522184|NCT06040112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522185|NCT06040112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153522186|NCT06040112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153522187|NCT06040112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153522188|NCT06040112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153522189|NCT06040112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522190|NCT06039891|Tislelizumab|tislelizumab|mesh-list
153522191|NCT06039891|Nimotuzumab|nimotuzumab|mesh-list
153522192|NCT06039891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522193|NCT06039891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522194|NCT06039592|Metoprolol|metoprolol|mesh-list
153522195|NCT06039592|Captopril|captopril|mesh-list
153522196|NCT06039592|Torsemide|torsemide|mesh-list
153522197|NCT06039592|Spironolactone|spironolactone|mesh-list
153522198|NCT06039592|Potassium Citrate|potassium citrate|mesh-list
153522199|NCT06039592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522200|NCT06039592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153522201|NCT06039592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153522202|NCT06039592|Sympatholytics|sympatholytics|mesh-ancestor
153522203|NCT06039592|Autonomic Agents|autonomic agents|mesh-ancestor
153522204|NCT06039592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522205|NCT06039592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522206|NCT06039592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153522207|NCT06039592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153857711|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
153522208|NCT06039592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153522209|NCT06039592|Adrenergic Agents|adrenergic agents|mesh-ancestor
153522210|NCT06039592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522211|NCT06039592|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153522212|NCT06039592|Hormone Antagonists|hormone antagonists|mesh-ancestor
153522213|NCT06039592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522272|NCT06039280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522352|NCT06037434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522353|NCT06037434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153522382|NCT06010927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522384|NCT06010927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153522385|NCT06010927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153522386|NCT06010927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153522387|NCT06010927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153522388|NCT06010927|GABA Modulators|gaba modulators|mesh-ancestor
153522389|NCT06010927|GABA Agents|gaba agents|mesh-ancestor
153522390|NCT05912946|Interferons|interferons|mesh-list
153522391|NCT05912946|Hyaluronic Acid|hyaluronic acid|mesh-list
153522392|NCT05912946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522393|NCT05912946|Antiviral Agents|antiviral agents|mesh-ancestor
153522394|NCT05912946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522395|NCT05912946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153522396|NCT05912946|Immunologic Factors|immunologic factors|mesh-ancestor
153522397|NCT05912946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256042|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154256043|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153522398|NCT05912946|Viscosupplements|viscosupplements|mesh-ancestor
153522399|NCT05912946|Protective Agents|protective agents|mesh-ancestor
153522432|NCT05548985|Metoclopramide|metoclopramide|mesh-list
153522433|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
153522434|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
153522435|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522436|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522437|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153522438|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153522439|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153522440|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
153522561|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
153522562|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522563|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731743|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
153522564|NCT05086627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522565|NCT05069597|Pancrelipase|pancrelipase|mesh-list
153522566|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153522567|NCT05011188|Antibodies|antibodies|mesh-list
153522692|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522693|NCT04294771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522694|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522696|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522934|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523089|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
153523090|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
153618923|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
153523091|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153523092|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
153523093|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523094|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523237|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523238|NCT04486391|Tislelizumab|tislelizumab|mesh-list
153523239|NCT04486391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523240|NCT04486391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523241|NCT04331002|Triamcinolone|triamcinolone|mesh-list
153523242|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153523243|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153523244|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153523245|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523246|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
153523247|NCT04331002|Hormones|hormones|mesh-ancestor
153523248|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523249|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523250|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153523251|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
153523252|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523253|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523254|NCT04291820|Anesthetics|anesthetics|mesh-list
153523255|NCT04291820|Sevoflurane|sevoflurane|mesh-list
153523256|NCT04291820|Desflurane|desflurane|mesh-list
153523257|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523258|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523259|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153523260|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153523261|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
153523263|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153523264|NCT04279054|Narcotics|narcotics|mesh-ancestor
153523265|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523266|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523267|NCT04279054|Analgesics|analgesics|mesh-ancestor
153523268|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
153523269|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523270|NCT04263051|Nivolumab|nivolumab|mesh-list
153523271|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523272|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523296|NCT04233021|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153523297|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153523298|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256044|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256046|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256047|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256048|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256049|NCT03880916|Analgesics|analgesics|mesh-ancestor
154256050|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
154256051|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256052|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
154256053|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153523393|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153523394|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523395|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523396|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523397|NCT03936049|Liraglutide|liraglutide|mesh-list
153523398|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153523399|NCT03936049|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153523432|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523433|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
153523434|NCT03900637|Letrozole|letrozole|mesh-list
153523435|NCT03900637|Leuprolide|leuprolide|mesh-list
153523436|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523437|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153811303|NCT00353808|Reboxetine|reboxetine|mesh-list
153523485|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523486|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523487|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
153523488|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153523489|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153523490|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153523491|NCT03769025|Narcotics|narcotics|mesh-ancestor
153523492|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523612|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523613|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153523614|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153781915|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523615|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
153523616|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
153523661|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523662|NCT02874742|Dexamethasone|dexamethasone|mesh-list
153523663|NCT02874742|Lenalidomide|lenalidomide|mesh-list
153523699|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153523700|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523701|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
153523702|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523703|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523755|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
153523756|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523783|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523784|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523785|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153523786|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153523787|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153523788|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523789|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523790|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153523791|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
153523792|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
153523793|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
153523794|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
153523795|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724460|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
153523844|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153523846|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153523847|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153523848|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
153523849|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
153523850|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523851|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153523852|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153523853|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153523854|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153523855|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153523856|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
153523857|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523858|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523859|NCT01614197|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153523945|NCT01042379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523946|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153523947|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
153523996|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
153523997|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523998|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153523999|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153524000|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
153524001|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524002|NCT01455350|Lidocaine|lidocaine|mesh-list
153524003|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
153524004|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
153524005|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524006|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524007|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
153524008|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524009|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153524010|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153524011|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153524012|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154191205|NCT05940324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524013|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524014|NCT01455636|Micronutrients|micronutrients|mesh-list
153524063|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
153524064|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
153524065|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524108|NCT01460212|Fluoxetine|fluoxetine|mesh-list
153524109|NCT01460212|Paroxetine|paroxetine|mesh-list
153524110|NCT01460212|Sertraline|sertraline|mesh-list
153524111|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
153524112|NCT01460212|Escitalopram|escitalopram|mesh-list
153524113|NCT01460212|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153524114|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153524115|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524116|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524117|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524118|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
153524119|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524120|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153524121|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153524122|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153524123|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153524124|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524125|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153524202|NCT01460706|Edotreotide|edotreotide|mesh-list
153524203|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153524204|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524205|NCT01460797|Metformin|metformin|mesh-list
153524206|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524207|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524208|NCT01460836|Tobramycin|tobramycin|mesh-list
153524209|NCT01460836|Aztreonam|aztreonam|mesh-list
153524210|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524211|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524212|NCT01460888|Olaparib|olaparib|mesh-list
153524213|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153524214|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256054|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
154256055|NCT01155908|Amlodipine|amlodipine|mesh-list
153524215|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524216|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524258|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153524259|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153524260|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153524261|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153524262|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153524264|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
153524266|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
153524267|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524268|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524269|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153524270|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153524271|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524272|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524273|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524274|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153524275|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
153524276|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524277|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524278|NCT01461616|Insulin|insulin|mesh-list
153524323|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524324|NCT01462422|Misoprostol|misoprostol|mesh-list
153524325|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153524326|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
153524327|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153524328|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524329|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153524330|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154191206|NCT05940324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524360|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524361|NCT01463046|Cytarabine|cytarabine|mesh-list
153524362|NCT01463046|Daunorubicin|daunorubicin|mesh-list
153524363|NCT01463046|Panobinostat|panobinostat|mesh-list
153524395|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524396|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524397|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524398|NCT01463215|Ambroxol|ambroxol|mesh-list
153524399|NCT01463215|Expectorants|expectorants|mesh-ancestor
153524400|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
153524401|NCT01463228|Metformin|metformin|mesh-list
153524402|NCT01463228|Canagliflozin|canagliflozin|mesh-list
153524403|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524439|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524440|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
153524454|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
153524455|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524456|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
153524489|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524490|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
153524491|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524492|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
153524493|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524494|NCT01464008|Interferons|interferons|mesh-list
153524534|NCT01464112|Hormones|hormones|mesh-ancestor
153524535|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524536|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153524537|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524539|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
153524540|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524541|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524542|NCT01464138|Clindamycin|clindamycin|mesh-list
153524543|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
153524544|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
153524545|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
153524546|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524547|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524548|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153524549|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539921|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524590|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524591|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154256056|NCT01155908|Benazepril|benazepril|mesh-list
154256057|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154256058|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153524592|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
153524594|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
153524595|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153524596|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153524597|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
153524598|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524599|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524600|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153524601|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153524602|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153524603|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
153524604|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524605|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153524606|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153524629|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524630|NCT01466829|Hormones|hormones|mesh-list
153524631|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
153524645|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
153524646|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153524647|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
153524648|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
153524649|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524650|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153524651|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524652|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524653|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153524654|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
153524655|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524656|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153524657|NCT01466959|Protective Agents|protective agents|mesh-ancestor
153524658|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524659|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
153524660|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153524661|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524662|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153524663|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
153524664|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524665|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524666|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524667|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524668|NCT01467115|Leucovorin|leucovorin|mesh-list
153524756|NCT01467518|Dolutegravir|dolutegravir|mesh-list
153524757|NCT01467518|Methadone|methadone|mesh-list
153524758|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153524759|NCT01467518|Narcotics|narcotics|mesh-ancestor
153524760|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524761|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524762|NCT01467518|Analgesics|analgesics|mesh-ancestor
153524763|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
153524764|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524765|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
153524814|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524815|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524818|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524819|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
153524820|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524821|NCT01467986|Sirolimus|sirolimus|mesh-list
153524822|NCT01467986|Irinotecan|irinotecan|mesh-list
153524823|NCT01467986|Temozolomide|temozolomide|mesh-list
153524824|NCT01467986|Dasatinib|dasatinib|mesh-list
153524825|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153524826|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153524827|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524871|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524872|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153524873|NCT01468051|Antacids|antacids|mesh-ancestor
153524874|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524875|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154256059|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256060|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524912|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153524913|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
153524964|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524974|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524975|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524976|NCT01468714|Ketoconazole|ketoconazole|mesh-list
153524977|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
153524978|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524979|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153524980|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153524981|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524982|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524983|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153524984|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
153525004|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525005|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153525006|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153525007|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153525008|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153525010|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525011|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
153525012|NCT01468740|Hormones|hormones|mesh-ancestor
153525013|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525014|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153525015|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153525016|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
153525017|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
153525018|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
153525019|NCT01469143|Insulin|insulin|mesh-list
153525020|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153525021|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
153525022|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
153525023|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153525024|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153525025|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525026|NCT01469169|Iloprost|iloprost|mesh-list
153525027|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153525038|NCT06078371|Analgesics, Opioid|analgesics, opioid|mesh-list
153525039|NCT06078371|Narcotics|narcotics|mesh-ancestor
153525040|NCT06078371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525041|NCT06078371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525042|NCT06078371|Analgesics|analgesics|mesh-ancestor
153525043|NCT06078371|Sensory System Agents|sensory system agents|mesh-ancestor
153525044|NCT06078371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525045|NCT06077708|Vitamin D|vitamin d|mesh-list
153525046|NCT06077708|Cholecalciferol|cholecalciferol|mesh-list
153525047|NCT06077708|Vitamins|vitamins|mesh-ancestor
153618926|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525048|NCT06077708|Micronutrients|micronutrients|mesh-ancestor
153525049|NCT06077708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525050|NCT06077708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153525078|NCT06077539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525079|NCT06077539|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153525080|NCT06077539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153525081|NCT06077539|Anesthetics, General|anesthetics, general|mesh-ancestor
153525082|NCT06077539|Anesthetics|anesthetics|mesh-ancestor
153525083|NCT06077539|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153525084|NCT06077539|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153525085|NCT06077292|Dronabinol|dronabinol|mesh-list
153525086|NCT06077292|Hallucinogens|hallucinogens|mesh-ancestor
153525087|NCT06077292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525088|NCT06077292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153525089|NCT06077292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525090|NCT06077292|Analgesics|analgesics|mesh-ancestor
153525091|NCT06077292|Sensory System Agents|sensory system agents|mesh-ancestor
153736079|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525092|NCT06077292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525112|NCT06077019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525113|NCT06077019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153525115|NCT06077019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525116|NCT06077019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525171|NCT06076772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525173|NCT06076759|Morphine|morphine|mesh-list
153525174|NCT06076759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153525175|NCT06076759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525176|NCT06076759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525238|NCT06072898|Micronutrients|micronutrients|mesh-ancestor
153525239|NCT06072898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525240|NCT06072898|Vitamin B Complex|vitamin b complex|mesh-ancestor
153525241|NCT06072898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153525316|NCT06071871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525317|NCT06071806|Fluorouracil|fluorouracil|mesh-list
153525318|NCT06071806|Antimetabolites|antimetabolites|mesh-ancestor
153525319|NCT06071806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525320|NCT06071806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525321|NCT06071806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525322|NCT06071806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153525323|NCT06071806|Immunologic Factors|immunologic factors|mesh-ancestor
153525324|NCT06071806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525355|NCT06060704|Bevacizumab|bevacizumab|mesh-list
153525356|NCT06060704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525357|NCT06060704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525358|NCT06060704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153525359|NCT06060704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153525370|NCT06058884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525371|NCT06048588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153525372|NCT06048588|Calcium|calcium|mesh-list
153525373|NCT06048588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153525374|NCT06048588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525375|NCT06048588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153525376|NCT06048588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153525377|NCT06048588|Antimetabolites|antimetabolites|mesh-ancestor
153525378|NCT06048588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525379|NCT06048588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153525404|NCT06017583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525406|NCT06017583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525407|NCT05998317|Dexamethasone|dexamethasone|mesh-list
153525408|NCT05998317|Dexamethasone acetate|dexamethasone acetate|mesh-list
153525409|NCT05998317|BB 1101|bb 1101|mesh-list
153525410|NCT05998317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525411|NCT05998317|Antiemetics|antiemetics|mesh-ancestor
153525412|NCT05998317|Autonomic Agents|autonomic agents|mesh-ancestor
153525413|NCT05998317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525414|NCT05998317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525415|NCT05998317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153525416|NCT05998317|Glucocorticoids|glucocorticoids|mesh-ancestor
153525417|NCT05998317|Hormones|hormones|mesh-ancestor
153525418|NCT05998317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525419|NCT05998317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153525420|NCT05998317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525421|NCT05998317|Protease Inhibitors|protease inhibitors|mesh-ancestor
153525422|NCT05998317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525448|NCT05965895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525451|NCT05939674|Protective Agents|protective agents|mesh-ancestor
153525452|NCT05939674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525453|NCT05939674|GABA Modulators|gaba modulators|mesh-ancestor
153525496|NCT05789303|Growth Inhibitors|growth inhibitors|mesh-ancestor
153525497|NCT05788328|Dabigatran|dabigatran|mesh-list
153525498|NCT05788328|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153525499|NCT05788328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153525500|NCT05788328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153525501|NCT05788328|Antimetabolites|antimetabolites|mesh-ancestor
153525502|NCT05788328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525503|NCT05788328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154256061|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154256062|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256063|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
154256064|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154256065|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
154256066|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256067|NCT03880448|Metronidazole|metronidazole|mesh-list
154256068|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256069|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153525504|NCT05788328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153525505|NCT05788328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525506|NCT05788328|Antithrombins|antithrombins|mesh-ancestor
153525507|NCT05788328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153525508|NCT05788328|Protease Inhibitors|protease inhibitors|mesh-ancestor
153525509|NCT05788328|Anticoagulants|anticoagulants|mesh-ancestor
153525510|NCT05784311|Metronidazole|metronidazole|mesh-list
153525511|NCT05784311|Cefuroxime|cefuroxime|mesh-list
153525512|NCT05784311|Cefuroxime axetil|cefuroxime axetil|mesh-list
153525513|NCT05784311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525514|NCT05784311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153525515|NCT05784311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153525516|NCT05784311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153525517|NCT05777824|Antibodies|antibodies|mesh-list
153525518|NCT05777824|Immunologic Factors|immunologic factors|mesh-ancestor
153525519|NCT05777824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525520|NCT05767086|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153525521|NCT05767086|Medroxyprogesterone|medroxyprogesterone|mesh-list
153525522|NCT05767086|Cetrorelix|cetrorelix|mesh-list
153525523|NCT05767086|Hormones|hormones|mesh-list
153525524|NCT05767086|Dydrogesterone|dydrogesterone|mesh-list
153525525|NCT05767086|Hormone Antagonists|hormone antagonists|mesh-list
153525556|NCT05746273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153525558|NCT05746273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525559|NCT05746273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525605|NCT05684692|Siltuximab|siltuximab|mesh-list
153525606|NCT05684692|Erenumab|erenumab|mesh-list
153525607|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153525608|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153525609|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525610|NCT05684692|Analgesics|analgesics|mesh-ancestor
153525671|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
153525672|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525673|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525674|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
153525757|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525758|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525759|NCT05287100|Midodrine|midodrine|mesh-list
153525760|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
153525785|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153525786|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153525787|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525788|NCT05211570|Azacitidine|azacitidine|mesh-list
153525789|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525790|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
153525791|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525792|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525793|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525794|NCT05206435|Nicotine|nicotine|mesh-list
153525795|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153525796|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
153525797|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525798|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525799|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153525800|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153525801|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
153525802|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256070|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154256071|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154256072|NCT03887858|Tamsulosin|tamsulosin|mesh-list
154256073|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153720593|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
154256074|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154256075|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154256076|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
154256077|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256078|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736092|NCT03801876|Paclitaxel|paclitaxel|mesh-list
153525803|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525804|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153525805|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153525806|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525807|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525808|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153525819|NCT05168618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525820|NCT05168618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525821|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525822|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
153525823|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525824|NCT05104866|Gemcitabine|gemcitabine|mesh-list
153525825|NCT05104866|Capecitabine|capecitabine|mesh-list
153525826|NCT05104866|Vinorelbine|vinorelbine|mesh-list
153525827|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525857|NCT05084248|Vitamins|vitamins|mesh-ancestor
153525858|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
153525859|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525860|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153525861|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153525862|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
153525863|NCT05081687|Irinotecan|irinotecan|mesh-list
153525864|NCT05081687|Folfirinox|folfirinox|mesh-list
153525865|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525866|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153525867|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153525868|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525869|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525870|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
153525906|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
153525907|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
153525908|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525909|NCT05067998|Vitamins|vitamins|mesh-list
153525910|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
153745655|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
153525911|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525912|NCT05062317|Leucovorin|leucovorin|mesh-list
153525913|NCT05062317|Bevacizumab|bevacizumab|mesh-list
153525914|NCT05062317|Capecitabine|capecitabine|mesh-list
153525915|NCT05062317|Fluorouracil|fluorouracil|mesh-list
153525916|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
153525917|NCT05062317|Irinotecan|irinotecan|mesh-list
153525918|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525919|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525920|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153525921|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153525922|NCT05062317|Growth Substances|growth substances|mesh-ancestor
153720684|NCT00439855|Heparin|heparin|mesh-list
153525963|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
153525964|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525965|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525966|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153525967|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153525968|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
153525969|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526001|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153526003|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
153736100|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
153526004|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526005|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526006|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526007|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153526008|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
153526009|NCT04939883|Protective Agents|protective agents|mesh-ancestor
153526010|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153526062|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153526063|NCT04892199|Semaglutide|semaglutide|mesh-list
153526064|NCT04892199|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153526065|NCT04892199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153526082|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153526083|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153526084|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526085|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526087|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526088|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153526089|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153526090|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153526091|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153526092|NCT04733183|Dacarbazine|dacarbazine|mesh-list
153526093|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153526094|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
153526095|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526114|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526115|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
153526116|NCT04650984|Doxorubicin|doxorubicin|mesh-list
153526117|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153526118|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526119|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153526120|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153526121|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526122|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526129|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526130|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526131|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153526132|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
153526133|NCT04601857|Futibatinib|futibatinib|mesh-list
153526134|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526135|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526136|NCT04601857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526137|NCT04601857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526138|NCT04591405|Vaccines|vaccines|mesh-list
153526139|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
153526140|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526141|NCT04557085|Cenobamate|cenobamate|mesh-list
153526142|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
153526143|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153526144|NCT04555694|Cyclosporine|cyclosporine|mesh-list
153526145|NCT04555694|Dexamethasone|dexamethasone|mesh-list
153526146|NCT04555694|Cyclosporins|cyclosporins|mesh-list
153526147|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526148|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
153526149|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
153526150|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526151|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526152|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526153|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
153526154|NCT04555694|Hormones|hormones|mesh-ancestor
153526155|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153526190|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526191|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526206|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526233|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
153526234|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526235|NCT04407247|Infliximab|infliximab|mesh-list
153526236|NCT04407247|Vedolizumab|vedolizumab|mesh-list
153526237|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
153526238|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
153526239|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
153526240|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256079|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526241|NCT04407247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153526242|NCT04407247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526243|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
153526244|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526245|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526246|NCT04364230|Poly ICLC|poly iclc|mesh-list
153526247|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
153618929|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526248|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526249|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
153526250|NCT04332341|Niacinamide|niacinamide|mesh-list
153526252|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
153526253|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
153526276|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153526277|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
153526338|NCT04033029|Ceftazidime|ceftazidime|mesh-list
153526339|NCT04033029|Cefepime|cefepime|mesh-list
153526340|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153526341|NCT04033029|Ceftolozane|ceftolozane|mesh-list
153526381|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526382|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153526383|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153526384|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526385|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526386|NCT03765918|Cisplatin|cisplatin|mesh-list
153526387|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
153526388|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526389|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526390|NCT03765918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526391|NCT03765918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526401|NCT03638999|Ketorolac|ketorolac|mesh-list
153526402|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153526403|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153526404|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153526405|NCT03638999|Analgesics|analgesics|mesh-ancestor
153526406|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
153526407|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526435|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526436|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153526438|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
153526439|NCT03567473|Epinephrine|epinephrine|mesh-list
153526440|NCT03567473|Racepinephrine|racepinephrine|mesh-list
153526441|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
153526442|NCT03567473|BB 1101|bb 1101|mesh-list
153526443|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526444|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
153526445|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
153526446|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526447|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526448|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526449|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
153526450|NCT03567473|Hormones|hormones|mesh-ancestor
153526451|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153526452|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153526453|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526454|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
153526455|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526456|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526457|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153526458|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153526459|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
153526460|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526461|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153526462|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153526463|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153526464|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
153526465|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
153526466|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
153526467|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153526468|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
153526469|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153526470|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526471|NCT03435250|Paclitaxel|paclitaxel|mesh-list
153526472|NCT03435250|Docetaxel|docetaxel|mesh-list
154256080|NCT03887858|Urological Agents|urological agents|mesh-ancestor
153526473|NCT03435250|Gemcitabine|gemcitabine|mesh-list
153526474|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153526530|NCT03190967|Trastuzumab|trastuzumab|mesh-list
153526572|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526591|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526592|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526593|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526595|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526596|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526597|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526598|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526599|NCT02966665|Vitamins|vitamins|mesh-list
153526600|NCT02966665|Vitamin E|vitamin e|mesh-list
153526601|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
153526602|NCT02966665|Fexofenadine|fexofenadine|mesh-list
153526603|NCT02966665|Valsartan|valsartan|mesh-list
153526604|NCT02966665|Nitroprusside|nitroprusside|mesh-list
153526605|NCT02966665|Phentolamine|phentolamine|mesh-list
153526606|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
153526607|NCT02966665|Norepinephrine|norepinephrine|mesh-list
153526608|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
153526609|NCT02966665|Giapreza|giapreza|mesh-list
153526610|NCT02966665|Acetylcholine|acetylcholine|mesh-list
153526611|NCT02966665|Ranitidine|ranitidine|mesh-list
153526612|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
153526613|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
153720951|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153526614|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526615|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153526621|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153526622|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153526623|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
153526624|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526625|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
153526626|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
153526627|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781917|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153526628|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153526629|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
153526630|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153526631|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153526632|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153526650|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153526651|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526652|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153526653|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
153526654|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526655|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526656|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
153526657|NCT02681211|Promethazine|promethazine|mesh-list
153526658|NCT02681211|Ketorolac|ketorolac|mesh-list
153526659|NCT02681211|Metoclopramide|metoclopramide|mesh-list
153526660|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153526661|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153526662|NCT02681211|Analgesics|analgesics|mesh-ancestor
153526663|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
153526664|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526665|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526666|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526667|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526668|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153526669|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526670|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526671|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153526672|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153526673|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153526674|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
153526675|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
153526676|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
153526677|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
153526678|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526679|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153526680|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
153526681|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
153526682|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526683|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153430948|NCT00000325|Hormones|hormones|mesh-ancestor
153526704|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526705|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526707|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
153526708|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526709|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153811326|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
153526754|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
153526781|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526782|NCT02352948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153730481|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526783|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526784|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526785|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526786|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
153526787|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526788|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153526789|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
153526790|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
153526791|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
153526793|NCT02315326|Methotrexate|methotrexate|mesh-list
153526794|NCT02315326|Procarbazine|procarbazine|mesh-list
153526795|NCT02315326|Ibrutinib|ibrutinib|mesh-list
153526796|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526797|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526798|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
153526844|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153526923|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153526924|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153526925|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526926|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153526927|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153526941|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153526942|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526943|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526944|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
153526946|NCT01068327|Protective Agents|protective agents|mesh-ancestor
153526947|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
153526948|NCT01068327|Vitamins|vitamins|mesh-ancestor
153526949|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
153526950|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153526951|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153526952|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
153526953|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526984|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526985|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526986|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153526987|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153526988|NCT01035463|Growth Substances|growth substances|mesh-ancestor
153526989|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
153526990|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153526991|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
153526992|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153526993|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
153527008|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153527009|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527010|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153527011|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527012|NCT00936390|Hormones|hormones|mesh-ancestor
153527013|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527014|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
153527015|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
153527016|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153527017|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
153527047|NCT00149149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527048|NCT00149149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527049|NCT00149149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153527050|NCT00149149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153527051|NCT00149149|Gout Suppressants|gout suppressants|mesh-ancestor
153527052|NCT00149149|Tocolytic Agents|tocolytic agents|mesh-ancestor
153527053|NCT00149149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153527054|NCT00149149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153527055|NCT00149149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256081|NCT02940574|Oxytocin|oxytocin|mesh-list
154256082|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
154256083|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153527056|NCT00149149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527070|NCT01469351|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153527072|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527073|NCT01469351|Incretins|incretins|mesh-ancestor
153527074|NCT01469351|Hormones|hormones|mesh-ancestor
153527075|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527100|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
153527102|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527104|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153527105|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
153527106|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527107|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
153527108|NCT01469507|Protective Agents|protective agents|mesh-ancestor
153527109|NCT01469520|Lamivudine|lamivudine|mesh-list
153527110|NCT01469520|Zidovudine|zidovudine|mesh-list
153527111|NCT01469520|Nevirapine|nevirapine|mesh-list
153527112|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153527113|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153527114|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527122|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153527124|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527125|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527159|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153527160|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527161|NCT01469884|Cyclosporine|cyclosporine|mesh-list
153527162|NCT01469884|Everolimus|everolimus|mesh-list
153527163|NCT01469884|Tacrolimus|tacrolimus|mesh-list
153527164|NCT01469884|Cyclosporins|cyclosporins|mesh-list
153527165|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153527166|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
153527212|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153527213|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
153527214|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153527215|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153527216|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
153527217|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527218|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527219|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153527220|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
153527221|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153527222|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527223|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527224|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153527225|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153527226|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
153527227|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
153618932|NCT01980979|Treprostinil|treprostinil|mesh-list
153527228|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527229|NCT01470092|Tibolone|tibolone|mesh-list
153527230|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
153527270|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153527271|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153527272|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153527273|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153527274|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527275|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527276|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527277|NCT01470339|Analgesics|analgesics|mesh-ancestor
153527278|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
153527321|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
153527322|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527323|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
153527324|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527325|NCT01470807|Pancrelipase|pancrelipase|mesh-list
153527326|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527327|NCT01470937|Acarbose|acarbose|mesh-list
153527328|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153527329|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527330|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527331|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527332|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527333|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
153527335|NCT01471067|Fludarabine|fludarabine|mesh-list
153527336|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
153527337|NCT01471067|Melphalan|melphalan|mesh-list
153527338|NCT01471067|Busulfan|busulfan|mesh-list
153527339|NCT01471067|Clofarabine|clofarabine|mesh-list
153527340|NCT01471067|Tacrolimus|tacrolimus|mesh-list
153527341|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
153527342|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153527343|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153527344|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527436|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153527437|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153527438|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153527439|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
153527440|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527441|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527442|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527471|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527472|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153527473|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
153527474|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527476|NCT01471847|Trastuzumab|trastuzumab|mesh-list
153527477|NCT01471847|Lapatinib|lapatinib|mesh-list
153527478|NCT01471847|Dactolisib|dactolisib|mesh-list
153527479|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527480|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
153527559|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527594|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527615|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527616|NCT01472640|Incretins|incretins|mesh-ancestor
153527617|NCT01472640|Hormones|hormones|mesh-ancestor
153527618|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527619|NCT01472653|Cetuximab|cetuximab|mesh-list
153527733|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527734|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
153527735|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527736|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527737|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527738|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153527739|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
153527740|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153527741|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153527812|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527813|NCT01474265|Varenicline|varenicline|mesh-list
153527814|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153527815|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153527816|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
153527817|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527818|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527819|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527820|NCT01474304|Acetaminophen|acetaminophen|mesh-list
153527821|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153527822|NCT01474304|Analgesics|analgesics|mesh-ancestor
153527823|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
153618933|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153618934|NCT01981005|Alectinib|alectinib|mesh-list
153527824|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527825|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527826|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
153527827|NCT01474330|Pomalidomide|pomalidomide|mesh-list
153527828|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
153527829|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527830|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153527831|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153527832|NCT01474330|Growth Substances|growth substances|mesh-ancestor
153527833|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
153527834|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527893|NCT01475032|Beclomethasone|beclomethasone|mesh-list
153527894|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
153527895|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153527896|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
153527919|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527920|NCT01475279|Warfarin|warfarin|mesh-list
153527921|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
153527922|NCT01475318|Letrozole|letrozole|mesh-list
153527923|NCT01475318|Misoprostol|misoprostol|mesh-list
153527924|NCT01475318|Mifepristone|mifepristone|mesh-list
153527925|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527926|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153527927|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153527928|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527929|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527930|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153527931|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
153527932|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527933|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527934|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153527935|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
153527995|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153527996|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
153527997|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527998|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153527999|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
153528016|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528017|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153528018|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528020|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
153528021|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
153528022|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
153528023|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
153528024|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528025|NCT01476007|Hematinics|hematinics|mesh-ancestor
153528027|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153528028|NCT01476124|Narcotics|narcotics|mesh-ancestor
153528029|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528030|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528031|NCT01476124|Analgesics|analgesics|mesh-ancestor
153528096|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153528097|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528098|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153528099|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153528100|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528224|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
153528225|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528226|NCT01477242|Ondansetron|ondansetron|mesh-list
153528227|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
153528228|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
153528229|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528230|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528265|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153528266|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528267|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528268|NCT01477411|Protective Agents|protective agents|mesh-ancestor
153528292|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528293|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
153528314|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
153528315|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153528316|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153528317|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153528318|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153528329|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528330|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153528331|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528332|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
153528333|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
153528334|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153528335|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153528336|NCT01477736|Urological Agents|urological agents|mesh-ancestor
153528337|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
153528338|NCT01477801|Vitamin D|vitamin d|mesh-list
154256084|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721348|NCT00443716|Estrogens|estrogens|mesh-list
153528339|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528340|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528341|NCT01477801|Vitamins|vitamins|mesh-ancestor
153528342|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
153528343|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153528344|NCT01477840|Misoprostol|misoprostol|mesh-list
153528345|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153528346|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
153528347|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153528348|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528349|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153528350|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528351|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
153528352|NCT01477931|Bupropion|bupropion|mesh-list
153528353|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153528354|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
153528355|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153528356|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153528372|NCT01478022|Ibuprofen|ibuprofen|mesh-list
153528373|NCT01478022|Isosorbide|isosorbide|mesh-list
153528374|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153528375|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153528376|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153528377|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528378|NCT01478022|Analgesics|analgesics|mesh-ancestor
153528379|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
153528380|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528381|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528386|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528387|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153528388|NCT01478022|Diuretics|diuretics|mesh-ancestor
153528389|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
153528390|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
153528391|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153528392|NCT01478074|Cytarabine|cytarabine|mesh-list
153528393|NCT01478074|Fludarabine|fludarabine|mesh-list
153528394|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528395|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153528396|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
153528397|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528398|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153528399|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
153528400|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528401|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
153528402|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528403|NCT01478165|Palonosetron|palonosetron|mesh-list
153528404|NCT01478165|Anesthetics|anesthetics|mesh-list
153528405|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528406|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528407|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
153528408|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
153528409|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528410|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528411|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153528412|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153528413|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
153528414|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528415|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528416|NCT01478230|Nicotine|nicotine|mesh-list
153528446|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
153528448|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153528449|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153528450|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
153528451|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153528452|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
153528453|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528470|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153528472|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153528473|NCT01478490|Urological Agents|urological agents|mesh-ancestor
153721441|NCT04698772|Ketamine|ketamine|mesh-list
153528475|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153528478|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
153528479|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528504|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153528505|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528506|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153528507|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153528508|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528509|NCT01478607|Capsaicin|capsaicin|mesh-list
153528514|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528515|NCT01478633|Galantamine|galantamine|mesh-list
153528516|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153528517|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528518|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528519|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
153528520|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528521|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528522|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153528523|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
153528524|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528525|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
153528527|NCT01478685|Carboplatin|carboplatin|mesh-list
153528528|NCT01478685|Azacitidine|azacitidine|mesh-list
153528529|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153528530|NCT01478685|Cc-486|cc-486|mesh-list
153528563|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153528564|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153528565|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528566|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153528567|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153528568|NCT01479036|Growth Substances|growth substances|mesh-ancestor
153528569|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528570|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
153528571|NCT01479088|Cinacalcet|cinacalcet|mesh-list
153528572|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528573|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528574|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153528575|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
153528640|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153528642|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528643|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
153528644|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528645|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153528646|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153528647|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153528648|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153528649|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153528650|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153528651|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
153528652|NCT01479751|Ketamine|ketamine|mesh-list
153528653|NCT01479751|Rocuronium|rocuronium|mesh-list
153528654|NCT01479751|Analgesics|analgesics|mesh-ancestor
153528655|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
153528656|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528657|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528658|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153528659|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153528660|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
153528661|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
153528662|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528663|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153528664|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153721563|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
153528665|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528666|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528667|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153528668|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
153528711|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
153528712|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528713|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153528714|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528715|NCT01480050|Temozolomide|temozolomide|mesh-list
154256086|NCT01264328|Panitumumab|panitumumab|mesh-list
153528717|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153528736|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153528737|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528738|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528739|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528740|NCT01480323|Aldesleukin|aldesleukin|mesh-list
153528741|NCT01480323|Ipilimumab|ipilimumab|mesh-list
153528742|NCT01480323|Interleukin-2|interleukin-2|mesh-list
153528743|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153528744|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528745|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153528746|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528747|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528748|NCT01480323|Analgesics|analgesics|mesh-ancestor
153528749|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
153528760|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153528761|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528762|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528763|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153528764|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153528765|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153528767|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153528768|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153528769|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153528770|NCT01480492|Telbivudine|telbivudine|mesh-list
153528772|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528773|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153528774|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528775|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528776|NCT01480531|Clevidipine|clevidipine|mesh-list
153528777|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153528778|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528809|NCT01480765|Pregabalin|pregabalin|mesh-list
153528810|NCT01480765|Ketamine|ketamine|mesh-list
153528811|NCT01480765|Analgesics|analgesics|mesh-ancestor
153528812|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
153528821|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153528822|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528823|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528824|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
153528825|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153528826|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528861|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
153528862|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
153528863|NCT01480869|Vitamin D|vitamin d|mesh-list
153528864|NCT01480869|Calcium|calcium|mesh-list
153528896|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528898|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
153528899|NCT01481194|Hormones|hormones|mesh-ancestor
153528900|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153528901|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153528902|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153528903|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153528904|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153528905|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528906|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153528907|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153528908|NCT01481194|Growth Substances|growth substances|mesh-ancestor
153528909|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
153528910|NCT01481233|Colchicine|colchicine|mesh-list
153528911|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
153528912|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528913|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
153528914|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
153528915|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
153528916|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528917|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528918|NCT01481259|Pemetrexed|pemetrexed|mesh-list
153528936|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528937|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726699|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153528938|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153528939|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
153528940|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
153528941|NCT01481454|Vaccines|vaccines|mesh-list
153528942|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
153528943|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528944|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
153528953|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528954|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528955|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528956|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
153528957|NCT01481519|Hormones|hormones|mesh-ancestor
153528958|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153528959|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153528960|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528961|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
153528962|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528963|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528964|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
153528965|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
153528966|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153528967|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528968|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153528969|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153528970|NCT01481610|Diclofenac|diclofenac|mesh-list
153528971|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
153528972|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153528973|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528974|NCT01481610|Analgesics|analgesics|mesh-ancestor
153528975|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
153528976|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528977|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528979|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528980|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153528981|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528982|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529003|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529004|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153529005|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153529006|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
153529007|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529008|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529009|NCT01481844|Amoxicillin|amoxicillin|mesh-list
153529010|NCT01481844|Metronidazole|metronidazole|mesh-list
153529011|NCT01481844|Clarithromycin|clarithromycin|mesh-list
153529012|NCT01481844|Tetracycline|tetracycline|mesh-list
153529013|NCT01481844|Tinidazole|tinidazole|mesh-list
153529014|NCT01481844|Lansoprazole|lansoprazole|mesh-list
153529015|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
153529016|NCT01481844|Bismuth|bismuth|mesh-list
153529020|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153529021|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153529022|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153529023|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529024|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529025|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153529026|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153529027|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153529028|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529029|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153529030|NCT01481844|Antacids|antacids|mesh-ancestor
153529031|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
153529032|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153529033|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
153529034|NCT01481870|Sorafenib|sorafenib|mesh-list
153529035|NCT01481870|Sunitinib|sunitinib|mesh-list
153529036|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529037|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529038|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529039|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529040|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154256087|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153529041|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153529042|NCT01481870|Growth Substances|growth substances|mesh-ancestor
153529043|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529065|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153529066|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
153529067|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153529068|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153529069|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
153529070|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153529071|NCT01482117|Protective Agents|protective agents|mesh-ancestor
153529072|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153529073|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153529074|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529077|NCT01482156|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153529078|NCT01482156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529079|NCT01482156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529080|NCT01482156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529081|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529082|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
153529083|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529084|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529085|NCT01482299|Everolimus|everolimus|mesh-list
153529086|NCT01482299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153529087|NCT01482299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529088|NCT01482299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529098|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153529099|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529100|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153529102|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
153529103|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153529104|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153529137|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153529139|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529140|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529141|NCT01482559|Dopamine|dopamine|mesh-list
153529142|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153529182|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529183|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
153529184|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
153529185|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529186|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529187|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153529188|NCT01482897|Protective Agents|protective agents|mesh-ancestor
153529189|NCT01482936|Oxycodone|oxycodone|mesh-list
153529190|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153529191|NCT01482936|Narcotics|narcotics|mesh-ancestor
153529192|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529193|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529194|NCT01482936|Analgesics|analgesics|mesh-ancestor
153529241|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529242|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529243|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529278|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
153529288|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153529289|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153529290|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529323|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153529324|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153529325|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153529326|NCT01484717|Nicotine|nicotine|mesh-list
153529327|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153529328|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
153529329|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529330|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529331|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153529332|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153529356|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529357|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745658|NCT03283150|Narcotics|narcotics|mesh-ancestor
153736103|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
154256088|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256089|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
154256090|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
154256091|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
154256092|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256093|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154256095|NCT01157858|Octreotide|octreotide|mesh-list
154256096|NCT01157858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154256097|NCT01157858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256098|NCT01157858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256099|NCT01157858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256100|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256101|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
154256102|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256103|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256104|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154256105|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154256106|NCT01157936|Allopurinol|allopurinol|mesh-list
154256107|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
154256108|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529358|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529359|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153529360|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529361|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153529362|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
153529363|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
153529364|NCT01485003|Natalizumab|natalizumab|mesh-list
153529365|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
153529366|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529367|NCT01485068|Paclitaxel|paclitaxel|mesh-list
153529368|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153529369|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529370|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
153529371|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
153529372|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
153529373|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529374|NCT01485081|Paclitaxel|paclitaxel|mesh-list
153529375|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153529376|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529377|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
153529378|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
153529379|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
153529380|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529381|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153529382|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153529383|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
153529384|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529385|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153529386|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256109|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256110|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
154256111|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154256112|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154256113|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
154256114|NCT01157936|Protective Agents|protective agents|mesh-ancestor
154256115|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256116|NCT01264484|Imidacloprid|imidacloprid|mesh-list
154256117|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
153529387|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529388|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529389|NCT01485185|Gabapentin|gabapentin|mesh-list
153529390|NCT01485185|Donepezil|donepezil|mesh-list
153529411|NCT01485198|Analgesics|analgesics|mesh-ancestor
153529412|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
153529434|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529435|NCT01485315|Mannitol|mannitol|mesh-list
153529436|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153529437|NCT01485315|Diuretics|diuretics|mesh-ancestor
153529438|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
153529439|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529440|NCT01485367|Adapalene|adapalene|mesh-list
153529441|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153529442|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153529443|NCT01485367|Analgesics|analgesics|mesh-ancestor
153529444|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
153529445|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529446|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529447|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153529448|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153529449|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
153529450|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153529451|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
153529452|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529453|NCT01485445|Fluticasone|fluticasone|mesh-list
153529455|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153529456|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153529457|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
153529458|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529459|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529460|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153529461|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
153529462|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
153529463|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153529464|NCT01485562|Misoprostol|misoprostol|mesh-list
153529465|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153529466|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
153529503|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529504|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529505|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
153529506|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
153529507|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529508|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529509|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153529510|NCT01485692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153529511|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153529512|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153529513|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
153529514|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153529515|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
153529516|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153529517|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153529518|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
153529519|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
153529520|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153529521|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
153529522|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
153529523|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154256118|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529524|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153529525|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
153529526|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
153529527|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
153529528|NCT01485718|Cathartics|cathartics|mesh-ancestor
153529529|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529530|NCT01485731|Nelfinavir|nelfinavir|mesh-list
153529531|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153618938|NCT01981005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472734|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153529546|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529561|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153529562|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153529563|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153529564|NCT01485835|Dexamethasone|dexamethasone|mesh-list
153529565|NCT01485835|Bortezomib|bortezomib|mesh-list
153529566|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153529567|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
153529568|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
153529569|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529570|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529571|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529572|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
153529573|NCT01485835|Hormones|hormones|mesh-ancestor
153529574|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153529575|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153529576|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529577|NCT01485848|Paclitaxel|paclitaxel|mesh-list
153529578|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153529579|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529580|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
153529581|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
153529582|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
153529583|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529584|NCT01485926|Carboplatin|carboplatin|mesh-list
153529585|NCT01485926|Docetaxel|docetaxel|mesh-list
153529586|NCT01485926|Trastuzumab|trastuzumab|mesh-list
153529587|NCT01485926|Lapatinib|lapatinib|mesh-list
153529588|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529589|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
153529590|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
153529591|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
153529592|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529593|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153529604|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153529605|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153529606|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153529607|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153529608|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529610|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153529611|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
153529612|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529613|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529614|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153529615|NCT01486004|Simeprevir|simeprevir|mesh-list
153529616|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
153618939|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
153529617|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529618|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
153618940|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529648|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529649|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529650|NCT01486433|Aspirin|aspirin|mesh-list
153529651|NCT01486433|Simvastatin|simvastatin|mesh-list
153529652|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153529653|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153529666|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
153529667|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153529668|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153529669|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
153529670|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153529671|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153529705|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
153529706|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
153529707|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153529708|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
153529709|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
153529710|NCT01486602|Paclitaxel|paclitaxel|mesh-list
153529711|NCT01486602|Carboplatin|carboplatin|mesh-list
153529712|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153529738|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153529739|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
153529740|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529741|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
153529742|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
153529743|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153529744|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529745|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529746|NCT01486888|Insulin|insulin|mesh-list
153529747|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153529748|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529749|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529750|NCT01486901|Insulin|insulin|mesh-list
153529751|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153529752|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
153529753|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
153529754|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
153529755|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529756|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529757|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
153529758|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529759|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529760|NCT01486940|Insulin|insulin|mesh-list
153529761|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153529762|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
153529763|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
153529764|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
153529765|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
153529766|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
153529767|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529768|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529770|NCT01486953|Desflurane|desflurane|mesh-list
153529803|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
153529804|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153529805|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529806|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153529807|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153529808|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529809|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529810|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529812|NCT01487226|Cisplatin|cisplatin|mesh-list
153529813|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153529814|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529815|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
153529816|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
153529817|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
153529818|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529819|NCT01487278|Misoprostol|misoprostol|mesh-list
153722219|NCT00456820|Bupropion|bupropion|mesh-list
153529820|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153529821|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
153529822|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153529823|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529824|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153529825|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529826|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
153529827|NCT01487304|Hormones|hormones|mesh-list
153539922|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529868|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
153529869|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529870|NCT01487564|Hydromorphone|hydromorphone|mesh-list
153529871|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153529872|NCT01487564|Narcotics|narcotics|mesh-ancestor
153529873|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529877|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529878|NCT01487629|Bevacizumab|bevacizumab|mesh-list
153529879|NCT01487629|Ranibizumab|ranibizumab|mesh-list
153529880|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153529881|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529882|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153529883|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153529884|NCT01487629|Growth Substances|growth substances|mesh-ancestor
153529885|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529886|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
153529887|NCT01487785|Gemcitabine|gemcitabine|mesh-list
153529888|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153529889|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
153529938|NCT01488266|Aripiprazole|aripiprazole|mesh-list
153529939|NCT01488266|Mirtazapine|mirtazapine|mesh-list
153529940|NCT01488266|Bupropion|bupropion|mesh-list
153529970|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153529971|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153529972|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153529973|NCT01488266|Analgesics|analgesics|mesh-ancestor
153529974|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
153529983|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153529984|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153529986|NCT01488305|Trace Elements|trace elements|mesh-list
153529987|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529988|NCT01488344|Nintedanib|nintedanib|mesh-list
153529989|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529990|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529991|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530013|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530014|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153530015|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153530016|NCT01488552|Metformin|metformin|mesh-list
153530017|NCT01488552|Paclitaxel|paclitaxel|mesh-list
153530018|NCT01488552|Gemcitabine|gemcitabine|mesh-list
153530019|NCT01488552|Folfirinox|folfirinox|mesh-list
153530020|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153530021|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530022|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
153530023|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
153530024|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
153530025|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530026|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153530027|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
153530028|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530029|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530030|NCT01488565|Azacitidine|azacitidine|mesh-list
153530031|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153530032|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
153530033|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530034|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530035|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530036|NCT01488656|Vitamin D|vitamin d|mesh-list
153530037|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153530038|NCT01488656|Antioxidants|antioxidants|mesh-list
153530039|NCT01488656|Vitamins|vitamins|mesh-ancestor
153530040|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
153530060|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
153530061|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153530062|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153530063|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153530064|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
153530076|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153530078|NCT01488955|Analgesics|analgesics|mesh-ancestor
153530079|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
153530080|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530081|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530082|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530083|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530084|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153530085|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256119|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736133|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
153530086|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530087|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153530088|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530089|NCT01489033|Immunomodulating Agents|immunomodulating agents|mesh-list
153530090|NCT01489033|Immunologic Factors|immunologic factors|mesh-ancestor
153530091|NCT01489033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530092|NCT01489059|Ipilimumab|ipilimumab|mesh-list
153530093|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153530094|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530095|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153530106|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153530107|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530108|NCT01489137|Remifentanil|remifentanil|mesh-list
153530109|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153530110|NCT01489137|Narcotics|narcotics|mesh-ancestor
153530111|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530112|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530113|NCT01489137|Analgesics|analgesics|mesh-ancestor
153530114|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
153530115|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530116|NCT01489202|Cobalt|cobalt|mesh-list
153530117|NCT01489202|Chromium|chromium|mesh-list
153530118|NCT01489202|Everolimus|everolimus|mesh-list
153530119|NCT01489202|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153530120|NCT01489202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153530121|NCT01489202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530122|NCT01489202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530123|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530124|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
153530125|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530126|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530127|NCT01489202|Trace Elements|trace elements|mesh-ancestor
153530128|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
153530129|NCT01489228|Benzonidazole|benzonidazole|mesh-list
153530130|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530131|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
153530132|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530133|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153530134|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153530135|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153530136|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530137|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153530154|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530155|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153530156|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153530157|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530158|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530159|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153530160|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
153530195|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153530196|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530197|NCT01489592|Turmeric extract|turmeric extract|mesh-list
153530198|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
153530199|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530200|NCT01489592|Protective Agents|protective agents|mesh-ancestor
153530201|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530216|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153530217|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153530218|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153530219|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530220|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530221|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
153530222|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153530224|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153530225|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153530226|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
153530227|NCT01489644|Metformin|metformin|mesh-list
153530228|NCT01489644|Repaglinide|repaglinide|mesh-list
153530229|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530230|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530231|NCT01489683|Lidocaine|lidocaine|mesh-list
153530232|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
153530233|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
153530234|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530235|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530236|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
153530237|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530238|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153530239|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153530240|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153530241|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153530242|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530243|NCT01489696|Tamsulosin|tamsulosin|mesh-list
153530261|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530262|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530281|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530282|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530283|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
153530284|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530285|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153530286|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530287|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
153530288|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153530289|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153530290|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153530291|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153530292|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530293|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
153530294|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530295|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530296|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153530297|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530298|NCT01489917|Heparin|heparin|mesh-list
153530299|NCT01489917|Hemostatics|hemostatics|mesh-list
153530300|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
153530301|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153530302|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153530303|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530304|NCT01489917|Coagulants|coagulants|mesh-ancestor
153530305|NCT01489943|Pioglitazone|pioglitazone|mesh-list
153530306|NCT01489943|Midazolam|midazolam|mesh-list
153530307|NCT01489943|Omeprazole|omeprazole|mesh-list
153530308|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153530309|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153530310|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153530311|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530312|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530313|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153530314|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153530315|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153530316|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153530317|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
153530353|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153530354|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153530355|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530356|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153530357|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153530358|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530359|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530360|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153530361|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153530362|NCT01490047|Analgesics|analgesics|mesh-ancestor
153530363|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
153530364|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530365|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530366|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530367|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530368|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153530369|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530370|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
153530372|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530373|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530374|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
153530375|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530376|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530377|NCT01490203|Edetic Acid|edetic acid|mesh-list
153530378|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
153530379|NCT01490203|Antidotes|antidotes|mesh-ancestor
153530380|NCT01490203|Protective Agents|protective agents|mesh-ancestor
153530391|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153530392|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153530393|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153530394|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530396|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530397|NCT01490229|Ezetimibe|ezetimibe|mesh-list
153530398|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153530399|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153530400|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
153539923|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530416|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153530417|NCT01490268|Narcotics|narcotics|mesh-ancestor
153530418|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530419|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530420|NCT01490268|Analgesics|analgesics|mesh-ancestor
153530421|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
153530422|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530423|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153530424|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153530425|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
153530426|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
153530427|NCT01490333|Vitamin D|vitamin d|mesh-list
153530428|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
153530429|NCT01490333|Vitamins|vitamins|mesh-ancestor
153530430|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
153530431|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530432|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153530433|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153530434|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153530435|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
153530436|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530437|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153530438|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153530439|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153530440|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
153530441|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530442|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153530443|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153530455|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530456|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153530457|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
153530458|NCT01490437|Hormones|hormones|mesh-ancestor
153530459|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153530460|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153530461|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530462|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530463|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153530464|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153530465|NCT01490476|Everolimus|everolimus|mesh-list
153530466|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530467|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530468|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
153530469|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530483|NCT01490658|Repaglinide|repaglinide|mesh-list
153530484|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530485|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530486|NCT01490671|Tenofovir|tenofovir|mesh-list
153530487|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
153530488|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530489|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153530490|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153530491|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530492|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530493|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153530494|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153530495|NCT01490749|Carboplatin|carboplatin|mesh-list
153530496|NCT01490749|Capecitabine|capecitabine|mesh-list
153530497|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
153530499|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530500|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153530501|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
153530502|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530503|NCT01490749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153530504|NCT01490749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153530505|NCT01490749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530506|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530507|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
153530508|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530525|NCT01490944|Iron|iron|mesh-list
153530526|NCT01490944|Folic Acid|folic acid|mesh-list
153530527|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
153530528|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
153530529|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
153530530|NCT01490944|Trace Elements|trace elements|mesh-ancestor
153530531|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
153530532|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530533|NCT01490944|Hematinics|hematinics|mesh-ancestor
153530534|NCT01490944|Vitamins|vitamins|mesh-ancestor
153530535|NCT01490996|Curcumin|curcumin|mesh-list
153530536|NCT01490996|Capecitabine|capecitabine|mesh-list
153530537|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153530538|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
153530539|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530540|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530541|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153530542|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153530543|NCT01490996|Analgesics|analgesics|mesh-ancestor
153530544|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
153530545|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530546|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530547|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530548|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530561|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
153530562|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
153530563|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
153530564|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530565|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530566|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153530581|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
153530582|NCT01491061|Ranolazine|ranolazine|mesh-list
153530583|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153530584|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153530585|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530586|NCT01491100|Interferons|interferons|mesh-list
153530587|NCT01491100|Interferon-beta|interferon-beta|mesh-list
153530588|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
153530589|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530590|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
153530591|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530592|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
153530593|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530594|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153530595|NCT01491139|Olaparib|olaparib|mesh-list
153530596|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530597|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153530598|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530599|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530600|NCT01491191|Palmidrol|palmidrol|mesh-list
153530601|NCT01491191|Analgesics|analgesics|mesh-ancestor
153530602|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
153530603|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530604|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530605|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153530606|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153530607|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530608|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530609|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
153530610|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530611|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154256120|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530612|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153530613|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530614|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530615|NCT01491191|Hormones|hormones|mesh-ancestor
153530616|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153530617|NCT01491204|Paclitaxel|paclitaxel|mesh-list
153530618|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153530619|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530620|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
153530621|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
153530622|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
153530623|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530624|NCT01491217|Paclitaxel|paclitaxel|mesh-list
153530643|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530644|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153530645|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153530646|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530647|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530648|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153530649|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153530650|NCT01491321|Loxoprofen|loxoprofen|mesh-list
153530651|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153530652|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153530653|NCT01491321|Analgesics|analgesics|mesh-ancestor
153530654|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
153530655|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530656|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530657|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530658|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530659|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153530660|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153530661|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530662|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
153530663|NCT01491503|Cetirizine|cetirizine|mesh-list
153530664|NCT01491503|Montelukast|montelukast|mesh-list
153530665|NCT01491503|Levocetirizine|levocetirizine|mesh-list
153530666|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153530667|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
153530668|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153530669|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
153530670|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153530671|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530672|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153530673|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153530674|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530675|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153530676|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153530677|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
153530678|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
153530679|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530680|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153530681|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153530682|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153530683|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153530684|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
153530685|NCT01491867|Travoprost|travoprost|mesh-list
153530686|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153530687|NCT01492062|Pancrelipase|pancrelipase|mesh-list
153530688|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153530689|NCT01492114|Resveratrol|resveratrol|mesh-list
153530690|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
153530691|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530692|NCT01492114|Protective Agents|protective agents|mesh-ancestor
153530693|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530717|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153530718|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530720|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153530721|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530722|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530723|NCT01492218|Insulin|insulin|mesh-list
153530724|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153530726|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530727|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153530728|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530729|NCT01492504|Asunaprevir|asunaprevir|mesh-list
153530730|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
153530731|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530732|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530733|NCT01492543|Tegafur|tegafur|mesh-list
153530734|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153530735|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
153530736|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530737|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530738|NCT01492556|Etoposide|etoposide|mesh-list
153530739|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153530740|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530741|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153530742|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153530743|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618944|NCT01981278|Narcotics|narcotics|mesh-ancestor
153530744|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530745|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
153530746|NCT01492608|Analgesics|analgesics|mesh-ancestor
153530747|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
153530748|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530749|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530750|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
153530751|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530752|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153530753|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
153530754|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153530755|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153530756|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530757|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153530758|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
153530774|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
153530776|NCT01492725|Plasminogen|plasminogen|mesh-list
153530777|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153530778|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153530779|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153530780|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530781|NCT01492881|Doxorubicin|doxorubicin|mesh-list
153530782|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153530783|NCT01492881|Bortezomib|bortezomib|mesh-list
153530785|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153530786|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530787|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153530788|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153530789|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530790|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530791|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153530792|NCT01492894|Cyclosporine|cyclosporine|mesh-list
153530793|NCT01492894|Sirolimus|sirolimus|mesh-list
153530794|NCT01492894|Tacrolimus|tacrolimus|mesh-list
153530795|NCT01492894|Cyclosporins|cyclosporins|mesh-list
153530796|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530797|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
153530798|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530799|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153530800|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530801|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530802|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
153530803|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530804|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
153530805|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530806|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153530807|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153530808|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530809|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
153530810|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
153530811|NCT01492920|Vitamins|vitamins|mesh-ancestor
153530812|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
153530813|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530814|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
153530815|NCT01492959|Insulin|insulin|mesh-list
153530817|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153474012|NCT00588900|Irinotecan|irinotecan|mesh-list
153530818|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530819|NCT01492985|Vaccines|vaccines|mesh-list
153530820|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
153530821|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530822|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
153530823|NCT01493050|Calcium|calcium|mesh-list
153530824|NCT01493050|Sevelamer|sevelamer|mesh-list
153530830|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
153530831|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
153530832|NCT01493102|Vasopressins|vasopressins|mesh-list
153530833|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
153530834|NCT01493102|Norepinephrine|norepinephrine|mesh-list
153530835|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153530836|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153530837|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
153530838|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530839|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530840|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530841|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
153530842|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
153530843|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530844|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153530861|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
153530862|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530863|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530864|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153530865|NCT01493310|Paclitaxel|paclitaxel|mesh-list
153530866|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153530867|NCT01493310|Mifepristone|mifepristone|mesh-list
153530868|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153530869|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530870|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
153530871|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
153530872|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
153530873|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530874|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153530875|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
153530876|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153530877|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530878|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153530879|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153530880|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153530881|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
153530882|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153530883|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153530884|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
153530885|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153530886|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
153530887|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153530888|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153530889|NCT01493336|Capecitabine|capecitabine|mesh-list
153530890|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618945|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530891|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
153530909|NCT01493622|Minocycline|minocycline|mesh-list
153530910|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153530911|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530912|NCT01493635|Analgesics|analgesics|mesh-list
153530913|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
153530914|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530915|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530916|NCT01493648|Vitamin D|vitamin d|mesh-list
153530917|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
153530918|NCT01493648|Vitamins|vitamins|mesh-ancestor
153530919|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
153812126|NCT01056276|Dexamethasone|dexamethasone|mesh-list
153530936|NCT01493843|Bevacizumab|bevacizumab|mesh-list
153530937|NCT01493843|Carboplatin|carboplatin|mesh-list
153530938|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153530939|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530940|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
153530941|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
153530942|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
154256121|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
153530943|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530944|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153530945|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153530946|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153530947|NCT01493843|Growth Substances|growth substances|mesh-ancestor
153530948|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530949|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
153530963|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530964|NCT01493999|Clopidogrel|clopidogrel|mesh-list
153530965|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153530966|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153530967|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153530968|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153530969|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153530970|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
153530971|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530972|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530973|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530974|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153530975|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153530976|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530977|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153530978|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153530979|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153530980|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
153530981|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530982|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153530983|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153530984|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530985|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
153530986|NCT01494155|Capecitabine|capecitabine|mesh-list
153530987|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153530988|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
153531003|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
153531004|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531005|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153531006|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153531007|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
153531008|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531016|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
153531017|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153531019|NCT01494311|Tetracaine|tetracaine|mesh-list
153531020|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
153531021|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
153531022|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531023|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531024|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
153531025|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531026|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153531027|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153531028|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153531029|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531030|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531031|NCT01494363|Leucovorin|leucovorin|mesh-list
153531032|NCT01494363|Fluorouracil|fluorouracil|mesh-list
153531033|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
153531034|NCT01494363|Irinotecan|irinotecan|mesh-list
153531035|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
153745660|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153531036|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531037|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153531038|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531039|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531040|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
153531041|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531042|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153531043|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153531044|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728137|NCT00496600|Everolimus|everolimus|mesh-list
153531046|NCT01494363|Protective Agents|protective agents|mesh-ancestor
153531047|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
153531049|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
153531050|NCT01494402|Aspirin|aspirin|mesh-list
153531051|NCT01494402|Esomeprazole|esomeprazole|mesh-list
153531052|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153531053|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153531054|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153531055|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531056|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812242|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531073|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531074|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
153531075|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
153531076|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
153531077|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531101|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153531102|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531103|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531105|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153531106|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531107|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
153531108|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
153531109|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723236|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153531110|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531111|NCT01494714|Petrolatum|petrolatum|mesh-list
153531112|NCT01494714|Emollients|emollients|mesh-ancestor
153531113|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
153531114|NCT01494727|Amlodipine|amlodipine|mesh-list
153531115|NCT01494727|Valsartan|valsartan|mesh-list
153531116|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153531117|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153531118|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153531119|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531120|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531121|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153531122|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531123|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
153531124|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153531125|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153531126|NCT01494740|Vaccines|vaccines|mesh-list
153531127|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
153531145|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
153531146|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531147|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531148|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531149|NCT01495026|Urological Agents|urological agents|mesh-ancestor
153531150|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153531151|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153531152|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531178|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153531179|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153531180|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531182|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
153531183|NCT01495117|Trace Elements|trace elements|mesh-ancestor
153531184|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
153531185|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531186|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
153531198|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153531199|NCT01495195|Selegiline|selegiline|mesh-list
153531200|NCT01495195|Donepezil|donepezil|mesh-list
153531201|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153531202|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531203|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531204|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
153531205|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531206|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531207|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
153531208|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
153531209|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153531210|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153531211|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153531214|NCT01495195|Protective Agents|protective agents|mesh-ancestor
153531215|NCT01495208|Aflibercept|aflibercept|mesh-list
153531216|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153531217|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153531242|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153531244|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
153531245|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531246|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531247|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531248|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531249|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153531281|NCT01495624|BB 1101|bb 1101|mesh-list
153531282|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531283|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
153531284|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
153531285|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531286|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531287|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153531288|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
153531289|NCT01495624|Hormones|hormones|mesh-ancestor
153531295|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531297|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531298|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
153531299|NCT01495715|Idebenone|idebenone|mesh-list
153531300|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
153531301|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531302|NCT01495715|Protective Agents|protective agents|mesh-ancestor
153531303|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531304|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
153531305|NCT01495806|Cathartics|cathartics|mesh-ancestor
153812411|NCT00328718|Xhance|xhance|mesh-list
153531315|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531316|NCT01495884|Lapatinib|lapatinib|mesh-list
153531317|NCT01495884|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153531318|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531319|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531320|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531321|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531322|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
153531323|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531324|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153531325|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531326|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531327|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
153531328|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153531329|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531330|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153531331|NCT01495949|Thiopental|thiopental|mesh-list
153531332|NCT01495949|Etomidate|etomidate|mesh-list
153531333|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153531334|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531335|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531336|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153531337|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
153531338|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
153531339|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
153531340|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
153531341|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
153531342|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531343|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531344|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
153531345|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153531346|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153531347|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153531348|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531349|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531350|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
153531351|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531352|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256122|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154256123|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153531353|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153531354|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531386|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153531387|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153531388|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531389|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
153531390|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153531391|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153531392|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153531393|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
153531394|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531408|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153531409|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531410|NCT01496417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153531442|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531443|NCT01496690|Pregabalin|pregabalin|mesh-list
153531444|NCT01496690|Analgesics|analgesics|mesh-ancestor
153531445|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
153531446|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531447|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531448|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
153531449|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153531450|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531451|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531452|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153531453|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153531494|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
153531495|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531497|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153531498|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
153531499|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531500|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531501|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
153531502|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531503|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531504|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
153531505|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531507|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
153531508|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531509|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
153531510|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
153531511|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
153531512|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531513|NCT01497093|Thalidomide|thalidomide|mesh-list
153531514|NCT01497093|Dexamethasone|dexamethasone|mesh-list
153531515|NCT01497093|Bortezomib|bortezomib|mesh-list
153531543|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153531545|NCT01497145|Hematinics|hematinics|mesh-ancestor
153531546|NCT01497288|Fentanyl|fentanyl|mesh-list
153531547|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153531548|NCT01497288|Narcotics|narcotics|mesh-ancestor
153531549|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531550|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531551|NCT01497288|Analgesics|analgesics|mesh-ancestor
153531552|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
153531553|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531554|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153531555|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153531556|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
153531557|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
153531558|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
153531559|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
153531560|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730484|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531561|NCT01497431|Selenium|selenium|mesh-list
153531562|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
153531563|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
153531564|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531565|NCT01497431|Protective Agents|protective agents|mesh-ancestor
153531566|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256124|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531567|NCT01497431|Trace Elements|trace elements|mesh-ancestor
153531568|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
153531569|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153531570|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531572|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531573|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531574|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812601|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153531608|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531610|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153531611|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
153531613|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531614|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531615|NCT01497548|Methylphenidate|methylphenidate|mesh-list
153531616|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153531617|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531618|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153531619|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153531620|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531621|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531622|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
153531623|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531624|NCT01497561|Insulin|insulin|mesh-list
153531625|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153531626|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
153531627|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
153531628|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
153531629|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
153531630|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531631|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531632|NCT01497574|Insulin|insulin|mesh-list
153531633|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153531634|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
153531635|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
153531636|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531637|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531638|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
153531639|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531640|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531641|NCT01497600|Insulin|insulin|mesh-list
153531642|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153531644|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
153531645|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
153531646|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
153531647|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531676|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153531677|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
153531678|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531679|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153531680|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153531681|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531682|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
153531683|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153531684|NCT01497977|Estrogens|estrogens|mesh-ancestor
153531685|NCT01497977|Hormones|hormones|mesh-ancestor
153531686|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153531687|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531688|NCT01497990|Ertapenem|ertapenem|mesh-list
153531689|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153531690|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531691|NCT01498003|Tirofiban|tirofiban|mesh-list
153531692|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153531693|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153531694|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531695|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153531696|NCT01498016|Busulfan|busulfan|mesh-list
153531697|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
153858466|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531698|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531699|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531700|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
153531701|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531702|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153531703|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531704|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153531705|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
153531706|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153531707|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
153531708|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531754|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153531755|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531756|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531757|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
153531758|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531759|NCT01498796|Ketorolac|ketorolac|mesh-list
153531760|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153531761|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153531763|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
153531764|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531765|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531766|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531767|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531768|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153531769|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531770|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531771|NCT01498809|Midodrine|midodrine|mesh-list
153531772|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
153531773|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
153812761|NCT00330317|Letrozole|letrozole|mesh-list
153531813|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153531814|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153531815|NCT01498900|Repaglinide|repaglinide|mesh-list
153531816|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531817|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531818|NCT01498913|Repaglinide|repaglinide|mesh-list
153531862|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531863|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531864|NCT01499225|Doxycycline|doxycycline|mesh-list
153531865|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153531866|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531867|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
153531868|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153531869|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153531870|NCT01499251|Temozolomide|temozolomide|mesh-list
153531871|NCT01499251|Macitentan|macitentan|mesh-list
153531872|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153531873|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
153531874|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531875|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812849|NCT00330824|Hormones|hormones|mesh-ancestor
153531916|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153531917|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153531918|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153531919|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
153531920|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153531921|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153531922|NCT01499641|Prednisolone|prednisolone|mesh-list
153531923|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
153531924|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153531925|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
153531926|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531927|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
153531928|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
153531929|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531930|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531931|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153531932|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
153531933|NCT01499641|Hormones|hormones|mesh-ancestor
153531934|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153531935|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153531936|NCT01499641|Protective Agents|protective agents|mesh-ancestor
153812893|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153531988|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
153531989|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
153531991|NCT01500070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153531992|NCT01500070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531993|NCT01500070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812939|NCT00331214|Testosterone|testosterone|mesh-list
153532018|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532019|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153532020|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
153532030|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153532032|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532033|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153532034|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532035|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532036|NCT01500577|Nimesulide|nimesulide|mesh-list
153532037|NCT01500577|Simvastatin|simvastatin|mesh-list
153532038|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153532039|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153532040|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
153532041|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532042|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153532043|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153532044|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532045|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153532046|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153532047|NCT01500577|Analgesics|analgesics|mesh-ancestor
153532048|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
153532049|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532050|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532051|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532052|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812985|NCT00431145|Vitamins|vitamins|mesh-ancestor
153532080|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153532082|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532083|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532084|NCT01500837|Levofloxacin|levofloxacin|mesh-list
153532085|NCT01500837|Ofloxacin|ofloxacin|mesh-list
153532086|NCT01500837|Rifampin|rifampin|mesh-list
153532087|NCT01500837|Clindamycin|clindamycin|mesh-list
153532102|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
153532103|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153532104|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153532105|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153532106|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153532107|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153532108|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153532109|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153532110|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153532111|NCT01500850|Insulin|insulin|mesh-list
153532112|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153532195|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532196|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153532197|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153532198|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
153532199|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153532200|NCT01501136|Dexamethasone|dexamethasone|mesh-list
153532201|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
153532243|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475440|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
153532244|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532245|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
153532246|NCT01501149|Hormones|hormones|mesh-ancestor
153532247|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532248|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153532249|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153532250|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
153532251|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532264|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153532265|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153532266|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532267|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153532268|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532269|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153532270|NCT01501344|Calcium|calcium|mesh-list
153532271|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153532272|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532274|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
153532275|NCT01501370|Lenalidomide|lenalidomide|mesh-list
153532276|NCT01501370|Vorinostat|vorinostat|mesh-list
153532277|NCT01501370|BB 1101|bb 1101|mesh-list
153532278|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532279|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
153532280|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
153532311|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532312|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153532313|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153532314|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153532315|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
153475525|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
153532316|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153532317|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153532318|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
153532319|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153532320|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153532321|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153532335|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
153532336|NCT01501435|Fenofibrate|fenofibrate|mesh-list
153532337|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153532338|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153532339|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
153532340|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532341|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153532342|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153532343|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153532344|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
153532345|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153532346|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153532347|NCT01501448|Estradiol|estradiol|mesh-list
153532348|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153532349|NCT01501448|Estrogens|estrogens|mesh-ancestor
153532350|NCT01501448|Hormones|hormones|mesh-ancestor
153532351|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532352|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532353|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153532354|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
153532355|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153532403|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532404|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532405|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153532406|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
153532407|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532437|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532438|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723937|NCT00401765|Docetaxel|docetaxel|mesh-list
153532439|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153532440|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532452|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153532453|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532454|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153532455|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153532456|NCT01501760|Growth Substances|growth substances|mesh-ancestor
153532457|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532458|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
153532459|NCT01501786|Ketamine|ketamine|mesh-list
153532460|NCT01501786|Propofol|propofol|mesh-list
153532461|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153532480|NCT01501799|Analgesics|analgesics|mesh-ancestor
153532481|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
153532482|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532483|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532484|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532485|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153532486|NCT01501890|Algestone|algestone|mesh-list
153532487|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153532488|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153532489|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153532490|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
153532491|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532492|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532494|NCT01501890|Hormones|hormones|mesh-ancestor
153532495|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153532496|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153532497|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153532498|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
153532499|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153532500|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153532501|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153532502|NCT01501916|Vitamin D|vitamin d|mesh-list
153532503|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
153532526|NCT01502020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532527|NCT01502020|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153532528|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
153532529|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532530|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153532531|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532532|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
153532533|NCT01502046|Dronabinol|dronabinol|mesh-list
153532534|NCT01502046|Cannabidiol|cannabidiol|mesh-list
153532535|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
153475746|NCT00830076|Metformin|metformin|mesh-list
153532536|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
153532537|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532538|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532567|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153532568|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
153532569|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532570|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153532572|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
153532573|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532574|NCT01502592|Ipilimumab|ipilimumab|mesh-list
153532575|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153532576|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532577|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153532578|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532579|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153532580|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153532581|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
153532582|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
153532583|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153532584|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
153532585|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532586|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532587|NCT01502774|Cyclosporine|cyclosporine|mesh-list
153532588|NCT01502774|Cyclosporins|cyclosporins|mesh-list
153532589|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532590|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532591|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153532592|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
153532593|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532594|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
153532595|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532596|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
153532597|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153532598|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153532599|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
153532600|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532649|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532650|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532651|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
153532652|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532653|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153532654|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153532655|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153532656|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153532657|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532658|NCT01503216|Vitamin D|vitamin d|mesh-list
153532659|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
153532660|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
153532662|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
153532663|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532664|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154256130|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532665|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153532679|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153532680|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532681|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
153532682|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532683|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
153532684|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475898|NCT00849810|Metoprolol|metoprolol|mesh-list
153532685|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153532686|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153532687|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153532688|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
153532689|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153532713|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153532714|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153532716|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532717|NCT01503398|Olanzapine|olanzapine|mesh-list
153532718|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
153532719|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
153532720|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532721|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532722|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532723|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153532724|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153532725|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532726|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532727|NCT01503398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153532728|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153532735|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
153532736|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532737|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532738|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532739|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153532740|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153532741|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532742|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532743|NCT01503424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153532744|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153532745|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153532746|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532771|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153532772|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153532773|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532774|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532775|NCT01503450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153532776|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153532777|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153532778|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532779|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532780|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
153532781|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
153532782|NCT01503502|Flumatinib|flumatinib|mesh-list
153532783|NCT01503502|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153532784|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153532785|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532786|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532787|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532788|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
153532789|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153532790|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153532791|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153532792|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
153532793|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532829|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532830|NCT01503736|Citric Acid|citric acid|mesh-list
153532831|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
153532832|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
153532833|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
153532834|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153532835|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
153532836|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
154256131|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256132|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153532837|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532838|NCT01503736|Hematinics|hematinics|mesh-ancestor
153532839|NCT01503788|Midazolam|midazolam|mesh-list
153532840|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153532841|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153532842|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532843|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532844|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153532845|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153532846|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532847|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153532848|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
153532849|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
153532850|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
153532851|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
153532852|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532888|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153532889|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153532891|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153532892|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
153532893|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532894|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153532895|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153532896|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153532897|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153532898|NCT01503918|Valacyclovir|valacyclovir|mesh-list
153532899|NCT01503918|Acyclovir|acyclovir|mesh-list
153532952|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153532953|NCT01504178|Levodopa|levodopa|mesh-list
153532954|NCT01504178|Apomorphine|apomorphine|mesh-list
153532955|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
153532956|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153532957|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153532958|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153532959|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532988|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153532989|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
153532990|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532991|NCT01504256|Antidotes|antidotes|mesh-ancestor
153532992|NCT01504256|Protective Agents|protective agents|mesh-ancestor
153532993|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
153532994|NCT01504256|Vitamins|vitamins|mesh-ancestor
153532995|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
153532996|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532997|NCT01504282|Mitomycins|mitomycins|mesh-list
153532998|NCT01504282|Mitomycin|mitomycin|mesh-list
153532999|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153533000|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533001|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
153533002|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533003|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153533004|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533005|NCT01504295|Metadoxine|metadoxine|mesh-list
153533006|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153533007|NCT01504321|Moxonidine|moxonidine|mesh-list
153533008|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153533009|NCT01504334|Pirfenidone|pirfenidone|mesh-list
153533010|NCT01504334|Analgesics|analgesics|mesh-ancestor
153533011|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
153533012|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533013|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533014|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153533015|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153533016|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153533017|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153533018|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533019|NCT01504347|Vaccines|vaccines|mesh-list
153533020|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
153533021|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533022|NCT01504386|Ropivacaine|ropivacaine|mesh-list
154256133|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
154256134|NCT01158014|Coagulants|coagulants|mesh-ancestor
153533023|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
153533024|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
153533025|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533026|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533027|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
153533072|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153533073|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153533074|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191207|NCT05940324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153533075|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533076|NCT01504724|Bevacizumab|bevacizumab|mesh-list
153533077|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153533078|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533079|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153533080|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153533081|NCT01504724|Growth Substances|growth substances|mesh-ancestor
153533127|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153533128|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
153533129|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153533130|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
153533131|NCT01505088|Citric Acid|citric acid|mesh-list
153533132|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
153533133|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153533134|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153533135|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153533136|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
153533137|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153533163|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533164|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153533165|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533166|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533167|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153533168|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153533169|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153533176|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153533177|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
153533178|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
153533179|NCT01505231|Vasopressins|vasopressins|mesh-list
153533180|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
153533181|NCT01505231|Norepinephrine|norepinephrine|mesh-list
153533182|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153533183|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153533184|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
153533185|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533186|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533187|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533188|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
153533189|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
153533190|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533191|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153533192|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
153533221|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533222|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533223|NCT01505413|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153533224|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533225|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533226|NCT01505426|Metformin|metformin|mesh-list
153533227|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
153533228|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533229|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533230|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153533231|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533232|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
153533233|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153533234|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153533235|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533236|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533237|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533272|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154256135|NCT03884036|Vitamin D|vitamin d|mesh-list
154256136|NCT03884036|Vitamins|vitamins|mesh-ancestor
154256137|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
153533273|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
153533274|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533275|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533276|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533277|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153533278|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
153533279|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533281|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
153533282|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
153533283|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533340|NCT01506050|Desloratadine|desloratadine|mesh-list
153533341|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153533342|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533343|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533344|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533345|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533346|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153533362|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
153533363|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533364|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533365|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533366|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153533367|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
153533369|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533370|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
153533406|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533413|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
153533414|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153533415|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533416|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153533417|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533418|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
153533419|NCT01506414|Rituximab|rituximab|mesh-list
153533501|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153533502|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
153533503|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533504|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533505|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533530|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533531|NCT01506765|Protective Agents|protective agents|mesh-ancestor
153533532|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533533|NCT01506765|Antidotes|antidotes|mesh-ancestor
153533534|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
153533535|NCT01506791|Ephedrine|ephedrine|mesh-list
153533536|NCT01506791|Desloratadine|desloratadine|mesh-list
153533537|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153533546|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153533547|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
153533548|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533549|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153533550|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
153533551|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
153533552|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153533553|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153533554|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
153533555|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
153533556|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
153533557|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153533558|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153533559|NCT01506804|Prednisolone|prednisolone|mesh-list
153533560|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
153533561|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153533562|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
153533563|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153533564|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
153533662|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533663|NCT01507389|Liraglutide|liraglutide|mesh-list
153784265|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153784266|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533664|NCT01507389|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153533665|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533666|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533667|NCT01507389|Incretins|incretins|mesh-ancestor
153533669|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533670|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
153533671|NCT01507428|Misonidazole|misonidazole|mesh-list
153533672|NCT01507428|Paclitaxel|paclitaxel|mesh-list
153533673|NCT01507428|Carboplatin|carboplatin|mesh-list
153533674|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153533675|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153533676|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153533677|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533678|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
153533679|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
153533680|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
153533681|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533682|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153533711|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153533712|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533713|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
153533714|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153533715|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
153533716|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533717|NCT01507519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533718|NCT01507519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533740|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533741|NCT01507597|Hormones|hormones|mesh-ancestor
153533742|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533743|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533744|NCT01507597|Incretins|incretins|mesh-ancestor
153533745|NCT01507701|Clonidine|clonidine|mesh-list
153533746|NCT01507701|Analgesics|analgesics|mesh-ancestor
153533747|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
153533748|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533749|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533763|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533765|NCT01507740|Sorafenib|sorafenib|mesh-list
153533766|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153533767|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533768|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153533769|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153533770|NCT01507740|Growth Substances|growth substances|mesh-ancestor
153533771|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533793|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
153533795|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
153533796|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533797|NCT01507922|Fenoverine|fenoverine|mesh-list
153533798|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
153533799|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
153533800|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533801|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533802|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153533803|NCT01507974|Amoxicillin|amoxicillin|mesh-list
153533804|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
153533805|NCT01507974|Cephalexin|cephalexin|mesh-list
153533806|NCT01507974|Cefuroxime|cefuroxime|mesh-list
153533807|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
153533808|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153533809|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153533810|NCT01507974|Trimethoprim|trimethoprim|mesh-list
153533811|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
153533812|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533813|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
153533814|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153533815|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
153533816|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153533817|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153533818|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153724675|NCT00460252|Insulin|insulin|mesh-list
153533819|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256138|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256139|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154256140|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153533820|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533821|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153533822|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153533823|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153533824|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153533826|NCT01508000|Panitumumab|panitumumab|mesh-list
153533827|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153533832|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533834|NCT01508104|Everolimus|everolimus|mesh-list
153533835|NCT01508104|Dactolisib|dactolisib|mesh-list
153533836|NCT01508104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153533837|NCT01508104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533932|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533933|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
153533934|NCT01508572|Bevacizumab|bevacizumab|mesh-list
153533935|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153533936|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533970|NCT01508806|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153533971|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533972|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533973|NCT01508806|Incretins|incretins|mesh-ancestor
153533975|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533976|NCT01508845|Vitamin D|vitamin d|mesh-list
153533977|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
153533978|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
153533979|NCT01508845|Vitamins|vitamins|mesh-list
153533980|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
153533981|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533982|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153533983|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153533984|NCT01508858|Liraglutide|liraglutide|mesh-list
153533985|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
153533986|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153533987|NCT01508858|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153533988|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533989|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533990|NCT01508858|Incretins|incretins|mesh-ancestor
153533991|NCT01508858|Hormones|hormones|mesh-ancestor
153533992|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533993|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153533994|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
153533995|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153533996|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153533997|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153533998|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153533999|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153534000|NCT01508858|Estrogens|estrogens|mesh-ancestor
153534001|NCT01508884|Imiquimod|imiquimod|mesh-list
153534002|NCT01508884|Vaccines|vaccines|mesh-list
153534003|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
153534004|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534013|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534014|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534015|NCT01508923|Incretins|incretins|mesh-ancestor
153534016|NCT01508923|Hormones|hormones|mesh-ancestor
153534017|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534018|NCT01509001|Metformin|metformin|mesh-list
153534019|NCT01509001|Glimepiride|glimepiride|mesh-list
153534042|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153534043|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
153534044|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534045|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153534046|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
153534047|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
153534048|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153534049|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154256141|NCT01158170|Gefitinib|gefitinib|mesh-list
154256142|NCT01158170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153534050|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
153534051|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534052|NCT01509261|Lansoprazole|lansoprazole|mesh-list
153534053|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
153534054|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153534055|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534056|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153534057|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534058|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534059|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
153534060|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
153534061|NCT01509300|Rituximab|rituximab|mesh-list
153534062|NCT01509300|Fludarabine|fludarabine|mesh-list
153534063|NCT01509300|Tacrolimus|tacrolimus|mesh-list
153534064|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153534065|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534066|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
153534067|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534068|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153534069|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153534070|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
153534071|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534072|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534073|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153534106|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534107|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534108|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
153534109|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153534110|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
153534111|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
153534112|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153534113|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153534114|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153534115|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534116|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534117|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534118|NCT01509521|Protective Agents|protective agents|mesh-ancestor
153534119|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153534120|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153534121|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153534122|NCT01509560|Everolimus|everolimus|mesh-list
153534123|NCT01509560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153534124|NCT01509560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153534125|NCT01509560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534126|NCT01509560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534127|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534128|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
153534129|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534130|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534131|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
153534132|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153534133|NCT01509755|Liraglutide|liraglutide|mesh-list
153534134|NCT01509755|Glimepiride|glimepiride|mesh-list
153534135|NCT01509755|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153730486|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153534136|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534168|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153534169|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
153534171|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534172|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534173|NCT01510132|Timolol|timolol|mesh-list
153534174|NCT01510132|Travoprost|travoprost|mesh-list
153534175|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153534176|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153534177|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534178|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858716|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
153534179|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534180|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534181|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153534182|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153534183|NCT01510171|Ticagrelor|ticagrelor|mesh-list
153534184|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153534187|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153534188|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153534189|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
153534190|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534191|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534192|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534193|NCT01510288|Ipilimumab|ipilimumab|mesh-list
153534194|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153534195|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534308|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
153534309|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534310|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153534311|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153534312|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
153534324|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534325|NCT01511159|Insulin|insulin|mesh-list
153534326|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153534327|NCT01511159|Liraglutide|liraglutide|mesh-list
153534328|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534352|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534355|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534356|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534357|NCT01511198|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153534358|NCT01511198|Incretins|incretins|mesh-ancestor
153534359|NCT01511198|Hormones|hormones|mesh-ancestor
153534360|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534361|NCT01511211|Dexamethasone|dexamethasone|mesh-list
153534362|NCT01511211|Ropivacaine|ropivacaine|mesh-list
153534363|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534364|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
153534365|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
153534366|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534367|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534368|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534369|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
153534370|NCT01511211|Hormones|hormones|mesh-ancestor
153534371|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534372|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153534373|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534374|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
153534375|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
153534376|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534391|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153534422|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
153534423|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
153534424|NCT01511302|Hormones|hormones|mesh-ancestor
153534425|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534426|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153534427|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153534428|NCT01511302|Analgesics|analgesics|mesh-ancestor
153534429|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
153534430|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153534431|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153534432|NCT01511367|Fluticasone|fluticasone|mesh-list
153534433|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153534460|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153534461|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534463|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153534464|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534465|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534466|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153534467|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
153534468|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
153534469|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534470|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534471|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
153534472|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534473|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153534474|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
154256143|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153534475|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153534476|NCT01511627|Anesthetics|anesthetics|mesh-list
153534477|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534478|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534479|NCT01511692|Liraglutide|liraglutide|mesh-list
153534480|NCT01511692|Glimepiride|glimepiride|mesh-list
153534481|NCT01511692|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153534482|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534483|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534484|NCT01511692|Incretins|incretins|mesh-ancestor
153534485|NCT01511692|Hormones|hormones|mesh-ancestor
153534486|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534487|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153534488|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534489|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
153534490|NCT01511705|Ondansetron|ondansetron|mesh-list
153534491|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
153534492|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
153534493|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534494|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534495|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534496|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
153534554|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153534555|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153534556|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153534557|NCT01511822|Estradiol|estradiol|mesh-list
153534558|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153534559|NCT01511822|Estrogens|estrogens|mesh-ancestor
153534560|NCT01511822|Hormones|hormones|mesh-ancestor
153534561|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534562|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534563|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153534564|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
153534565|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153534566|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153534567|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153534568|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153534569|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
153534570|NCT01511822|Vitamins|vitamins|mesh-ancestor
153534571|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
153534572|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153534573|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
153534574|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153534575|NCT01511822|Diuretics|diuretics|mesh-ancestor
153534576|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
153534577|NCT01511835|Folic Acid|folic acid|mesh-list
153534578|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
153534579|NCT01511835|Inositol|inositol|mesh-list
153534580|NCT01511835|Hematinics|hematinics|mesh-ancestor
153534581|NCT01511835|Vitamins|vitamins|mesh-ancestor
153534582|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
153534583|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534584|NCT01511848|Deferasirox|deferasirox|mesh-list
153534585|NCT01511848|Deferiprone|deferiprone|mesh-list
153534586|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153534587|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
153534588|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
153534589|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534590|NCT01511874|Leuprolide|leuprolide|mesh-list
153534591|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153534592|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
153534593|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153534594|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534595|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153534596|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534631|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
153534632|NCT01512147|Propofol|propofol|mesh-list
153534633|NCT01512147|Isoflurane|isoflurane|mesh-list
153534634|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153534635|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534636|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534637|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153534638|NCT01512147|Analgesics|analgesics|mesh-ancestor
153534639|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
153534640|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256144|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256145|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534641|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153534642|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153534643|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153534644|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534645|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534646|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534647|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153534648|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
153534650|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153534652|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153534653|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153534654|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534669|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
153534670|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534671|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153534672|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
153534673|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534683|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153534684|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153534685|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534686|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534687|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534688|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153534689|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153534690|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153534691|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153534692|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534693|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534694|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534695|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153534696|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
153534697|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153534699|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153534700|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153534701|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153534702|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153534703|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
153534704|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534705|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534706|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534707|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
153534708|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153534709|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
153534710|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
153534711|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534712|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534713|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153534714|NCT01512511|Analgesics|analgesics|mesh-ancestor
153534715|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
153534716|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534717|NCT01512537|Vitamin D|vitamin d|mesh-list
153534718|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
153534719|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
153534720|NCT01512537|Vitamins|vitamins|mesh-list
153534721|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
153534736|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534737|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153534753|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534754|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153534755|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
153534756|NCT01512914|Ropivacaine|ropivacaine|mesh-list
153534757|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
153534758|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
153534759|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534760|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256146|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256147|NCT01260974|Caspofungin|caspofungin|mesh-list
154256148|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
154256149|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534761|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
153534762|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534763|NCT01512953|Lansoprazole|lansoprazole|mesh-list
153534764|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
153534765|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153534766|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534767|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153534768|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477994|NCT01053078|Naltrexone|naltrexone|mesh-list
153534769|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534770|NCT01512966|Aflibercept|aflibercept|mesh-list
153534771|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153534772|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153534773|NCT01512966|Growth Substances|growth substances|mesh-ancestor
153534774|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534775|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
153534776|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534777|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
153534778|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153534779|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534780|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153534781|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
153534782|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153534783|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534784|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534785|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534786|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
153534787|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153534788|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534789|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153534790|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
153534791|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153534792|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534793|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534809|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478064|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
153534841|NCT01513200|Heparin|heparin|mesh-list
153534842|NCT01513200|Calcium heparin|calcium heparin|mesh-list
153534843|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
153534844|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153534845|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153534846|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534847|NCT01513499|Oxytocin|oxytocin|mesh-list
153534848|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
153534849|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153534850|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534851|NCT01513525|Liraglutide|liraglutide|mesh-list
153534877|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534879|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
153534880|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534881|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153534882|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153534883|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534884|NCT01513668|Acetaminophen|acetaminophen|mesh-list
153534885|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153534886|NCT01513668|Analgesics|analgesics|mesh-ancestor
153534887|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
153534888|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534889|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534890|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
153534891|NCT01513681|Lamotrigine|lamotrigine|mesh-list
153534892|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
153534893|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153534894|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153534895|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785577|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534896|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153534897|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534898|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153534899|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153534900|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534901|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153534902|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153534903|NCT01513720|Lamotrigine|lamotrigine|mesh-list
153534904|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
153534905|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153534906|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153534907|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534919|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153534920|NCT01513772|Analgesics|analgesics|mesh-ancestor
153534921|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
153534922|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534923|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153534924|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153534925|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153534926|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534927|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534928|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534929|NCT01513785|Amoxicillin|amoxicillin|mesh-list
153534930|NCT01513785|Rabeprazole|rabeprazole|mesh-list
153534931|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153534932|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534933|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153534934|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534935|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153534936|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191208|NCT05940324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153534937|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534938|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153534939|NCT01513863|Metronidazole|metronidazole|mesh-list
153534940|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534941|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153534942|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153534943|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153534944|NCT01513941|Interferons|interferons|mesh-list
153534945|NCT01513941|Ribavirin|ribavirin|mesh-list
153534969|NCT01514110|Paclitaxel|paclitaxel|mesh-list
153534970|NCT01514110|Carboplatin|carboplatin|mesh-list
153534976|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
153534977|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534978|NCT01514110|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153534979|NCT01514110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153534980|NCT01514110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534981|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534982|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
153534983|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534984|NCT01514123|Bevacizumab|bevacizumab|mesh-list
153534985|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153534986|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534987|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153534988|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153534989|NCT01514123|Growth Substances|growth substances|mesh-ancestor
153534990|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534991|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
153534992|NCT01514175|Ibuprofen|ibuprofen|mesh-list
153534993|NCT01514175|Ketorolac|ketorolac|mesh-list
153534994|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153534995|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153534996|NCT01514175|Analgesics|analgesics|mesh-ancestor
153534997|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
153534998|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534999|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535034|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535035|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153535036|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154256151|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256153|NCT01264640|Clopidogrel|clopidogrel|mesh-list
154256154|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153535037|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535038|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535066|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535067|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153535068|NCT01514695|Narcotics|narcotics|mesh-ancestor
153535069|NCT01514695|Analgesics|analgesics|mesh-ancestor
153535070|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
153535071|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535072|NCT01514721|Timolol|timolol|mesh-list
153535073|NCT01514721|Travoprost|travoprost|mesh-list
153535074|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535075|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153535076|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153535077|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
153535078|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535079|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535080|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153535081|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153535082|NCT01514812|Digoxin|digoxin|mesh-list
153535083|NCT01514812|Darexaban|darexaban|mesh-list
153535084|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153535085|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153535086|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535087|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535088|NCT01514812|Protective Agents|protective agents|mesh-ancestor
153535089|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535090|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153535091|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
153535092|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153535093|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535094|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
153535095|NCT01514825|Darexaban|darexaban|mesh-list
153535096|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153535097|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
153535098|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153535099|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535100|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535101|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535145|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
153535146|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535147|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
153535148|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153535149|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153535150|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153535151|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153535179|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153535180|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
153535181|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535182|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153535183|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
153535184|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153535185|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153535186|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153535187|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
153535188|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153535189|NCT01515228|Protective Agents|protective agents|mesh-ancestor
153535190|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153535191|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153535192|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153535193|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153535194|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535195|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535196|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153535197|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153535198|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535199|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
154256155|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153535200|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535227|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535228|NCT01515774|Pramipexole|pramipexole|mesh-list
153535229|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
153535230|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535231|NCT01515774|Protective Agents|protective agents|mesh-ancestor
153535232|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535233|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153535234|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153535235|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
153535236|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
153535237|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535238|NCT01515813|Tenofovir|tenofovir|mesh-list
153535239|NCT01515813|Emtricitabine|emtricitabine|mesh-list
153535240|NCT01515813|Efavirenz|efavirenz|mesh-list
153535241|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153535242|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153535243|NCT01515813|Pravastatin|pravastatin|mesh-list
153535244|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
153535245|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535246|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154191209|NCT05940324|Anesthetics, General|anesthetics, general|mesh-ancestor
153535247|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153535248|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535285|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535286|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535287|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153535288|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535289|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153535290|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
153535291|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153535292|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153535293|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153535294|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153535295|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
153535296|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
153535297|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
153535298|NCT01515839|Vinpocetine|vinpocetine|mesh-list
153535299|NCT01515839|Huperzine A|huperzine a|mesh-list
153535300|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
153535301|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535302|NCT01515839|Protective Agents|protective agents|mesh-ancestor
153535303|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535325|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153535326|NCT01515969|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153535327|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153535329|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535330|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535331|NCT01516060|Efavirenz|efavirenz|mesh-list
153535332|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153535333|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153535334|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535335|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535336|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
153535337|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535338|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153535339|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153535340|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153535367|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535368|NCT01514903|Urological Agents|urological agents|mesh-ancestor
153535369|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
153535370|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153535371|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535372|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535373|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153535374|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535375|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535376|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535377|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256156|NCT01264640|Analgesics|analgesics|mesh-ancestor
154256157|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
153535378|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153535379|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
153535380|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153535381|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535382|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153535383|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153535384|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153535385|NCT01516450|Belimumab|belimumab|mesh-list
153535386|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153535387|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
153535388|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535389|NCT01516463|Bacitracin|bacitracin|mesh-list
153535390|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153535391|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535392|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535393|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
153535394|NCT01516554|Testosterone|testosterone|mesh-list
153535395|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
153535396|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
153535397|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153535398|NCT01516554|Androgens|androgens|mesh-ancestor
153535399|NCT01516554|Hormones|hormones|mesh-ancestor
153535400|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535401|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535402|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153535403|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535404|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
153535405|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
153535406|NCT01516567|Rituximab|rituximab|mesh-list
153535447|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535448|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535449|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153535450|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
153535451|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153535452|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153535453|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
153535454|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
153535455|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153535456|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153535457|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
153535458|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535459|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153535460|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
153535461|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
153535462|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
153535463|NCT01516710|Liver Extracts|liver extracts|mesh-list
153535464|NCT01516710|Hematinics|hematinics|mesh-ancestor
153535465|NCT01516723|Sirolimus|sirolimus|mesh-list
153535466|NCT01516723|Everolimus|everolimus|mesh-list
153535467|NCT01516723|MTOR Inhibitors|mtor inhibitors|mesh-list
153535468|NCT01516723|Temsirolimus|temsirolimus|mesh-list
153535469|NCT01516723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153535470|NCT01516723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535471|NCT01516723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535472|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153535473|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
153535474|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535475|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535476|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535484|NCT01516814|Warfarin|warfarin|mesh-list
153535485|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
153359741|NCT04201457|Trametinib|trametinib|mesh-list
153535505|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153535507|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535508|NCT01516866|Listerine|listerine|mesh-list
153535509|NCT01516866|Fluorides|fluorides|mesh-list
153535510|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
153535511|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
153535512|NCT01516866|Protective Agents|protective agents|mesh-ancestor
153618953|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535513|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535514|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153535515|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535516|NCT01516996|Docetaxel|docetaxel|mesh-list
154256158|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256159|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786405|NCT02218762|Xhance|xhance|mesh-list
153535517|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
153535518|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535519|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
153535520|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
153535521|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
153535522|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535523|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153535524|NCT01517009|Docetaxel|docetaxel|mesh-list
153535525|NCT01517009|Capecitabine|capecitabine|mesh-list
153535526|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535527|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
153535528|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
153535529|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
153535530|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535531|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153535532|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
153535533|NCT01517022|Nicotine|nicotine|mesh-list
153535534|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153535535|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
153535536|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535537|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535538|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153535539|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153535540|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
153535541|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535584|NCT01517399|Midazolam|midazolam|mesh-list
153535585|NCT01517399|Caffeine|caffeine|mesh-list
153535586|NCT01517399|Omeprazole|omeprazole|mesh-list
153535587|NCT01517399|Warfarin|warfarin|mesh-list
153535588|NCT01517399|Vitamins|vitamins|mesh-ancestor
153535589|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
153618954|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
153535590|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535591|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153535592|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153535593|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153535594|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153535595|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153535596|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153535605|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153535606|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153535607|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535608|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153535609|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153535610|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
153535611|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153535612|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153535613|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153535614|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153535615|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153535616|NCT01517399|Protective Agents|protective agents|mesh-ancestor
153535617|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153535618|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153535619|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
153535620|NCT01517399|Coagulants|coagulants|mesh-ancestor
153535621|NCT01517490|Insulin|insulin|mesh-list
153535622|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153535623|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535624|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535625|NCT01517555|Acetaminophen|acetaminophen|mesh-list
153535626|NCT01517555|Liraglutide|liraglutide|mesh-list
153535627|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153535628|NCT01517555|Analgesics|analgesics|mesh-ancestor
153535629|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
153535630|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535631|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535632|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
153535633|NCT01517555|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535634|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535635|NCT01517555|Incretins|incretins|mesh-ancestor
153535636|NCT01517555|Hormones|hormones|mesh-ancestor
153535657|NCT01517815|Piperacillin|piperacillin|mesh-list
154256160|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154256161|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154256162|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153736162|NCT03651271|Ipilimumab|ipilimumab|mesh-list
153535658|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153535660|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535661|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535662|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153535663|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535664|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535684|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153535685|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
153535687|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
153535688|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
153726233|NCT00117702|Tacrolimus|tacrolimus|mesh-list
153535689|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153535690|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153535691|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535692|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535693|NCT01517854|Urological Agents|urological agents|mesh-ancestor
153535694|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
153535695|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153535696|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153535697|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535698|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153535699|NCT01517932|Analgesics|analgesics|mesh-ancestor
153535700|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
153535701|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535702|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153535703|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153535704|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153535705|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
153535706|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535707|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535766|NCT01518231|Edaravone|edaravone|mesh-list
153535767|NCT01518231|Warfarin|warfarin|mesh-list
153535768|NCT01518231|Atorvastatin|atorvastatin|mesh-list
153535769|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153535770|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153535771|NCT01518231|Analgesics|analgesics|mesh-ancestor
153535772|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
153535773|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535774|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535775|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153535776|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153535777|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153535778|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153535779|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535780|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153535781|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153535782|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535783|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
153535784|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153535785|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153535786|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
153535787|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153535796|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153535797|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535798|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535799|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535800|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535801|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153535802|NCT01518465|Dexamethasone|dexamethasone|mesh-list
153535803|NCT01518465|Lenalidomide|lenalidomide|mesh-list
153535804|NCT01518465|Dalteparin|dalteparin|mesh-list
153535805|NCT01518465|Tinzaparin|tinzaparin|mesh-list
153535806|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153535807|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153535808|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
153535809|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
153535810|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535811|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618955|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535812|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153535826|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535827|NCT01518569|Urinastatin|urinastatin|mesh-list
153535828|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153535829|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153535830|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535831|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535832|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535834|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153535835|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153726315|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
153535836|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535837|NCT01518608|Alfentanil|alfentanil|mesh-list
153535838|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153535839|NCT01518608|Narcotics|narcotics|mesh-ancestor
153535840|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153535841|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535842|NCT01518608|Analgesics|analgesics|mesh-ancestor
153535843|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
153535844|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535845|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153535846|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
153535847|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
153535848|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153535849|NCT01518621|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153535850|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153535851|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535852|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535853|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535875|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535876|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153535877|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153535878|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153535879|NCT01518790|Laxatives|laxatives|mesh-ancestor
153535880|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153535881|NCT01518855|Amlodipine|amlodipine|mesh-list
153535882|NCT01518855|Nifedipine|nifedipine|mesh-list
153535883|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153535884|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153535885|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153618957|NCT01981291|Mepivacaine|mepivacaine|mesh-list
153618958|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
153479108|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153535886|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535887|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153535888|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535889|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
153535964|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153535965|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153535966|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153535967|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536045|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
153536046|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
153536047|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
153536048|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536049|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536050|NCT01519752|Oxiconazole|oxiconazole|mesh-list
153536051|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
153536052|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536053|NCT01519856|Piribedil|piribedil|mesh-list
153536054|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153536055|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153536056|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
153536057|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
153536058|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536059|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536060|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536061|NCT01519986|Vitamin D|vitamin d|mesh-list
153536062|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
153536063|NCT01519986|Vitamins|vitamins|mesh-ancestor
153536064|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
153536065|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536066|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154256163|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154256164|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256165|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154003092|NCT06124118|Carboplatin|carboplatin|mesh-list
154256166|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153536103|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536104|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153536105|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153536107|NCT01520181|beta-Lactams|beta-lactams|mesh-list
153536108|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153536109|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536110|NCT01520285|Felodipine|felodipine|mesh-list
153536111|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153536112|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153536113|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153536114|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536115|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536116|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153536117|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536118|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
153536119|NCT01520298|Acetaminophen|acetaminophen|mesh-list
153536120|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536121|NCT01520298|Analgesics|analgesics|mesh-ancestor
153536122|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
153536123|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536124|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536168|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536169|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536170|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153536171|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536172|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536173|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
153536174|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536175|NCT01520467|Anastrozole|anastrozole|mesh-list
153536176|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153536177|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536178|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153536179|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153536180|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536181|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536182|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153536183|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
153536184|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536185|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536229|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
153536230|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153536231|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
153536232|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153536233|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536234|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536236|NCT01520896|Naloxegol|naloxegol|mesh-list
153536237|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
153536238|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536239|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153536240|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153536241|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536243|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153536244|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
153536245|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536246|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536247|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153536284|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153536329|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256167|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536330|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153536331|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153536332|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153536333|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153536334|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
153536335|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536446|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153536487|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153536488|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
153536489|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
153536490|NCT01522820|Sirolimus|sirolimus|mesh-list
153536491|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153536492|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536493|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153536494|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536495|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
153536496|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536497|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
153536498|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536499|NCT01522846|Heparin|heparin|mesh-list
153536500|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
153536501|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153536502|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153536503|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536504|NCT01522872|Dexamethasone|dexamethasone|mesh-list
153536505|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
153536506|NCT01522872|Bortezomib|bortezomib|mesh-list
153536507|NCT01522872|Pomalidomide|pomalidomide|mesh-list
153536508|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
153536509|NCT01522872|BB 1101|bb 1101|mesh-list
153536510|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536511|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
153536525|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153536526|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153536527|NCT01522872|Growth Substances|growth substances|mesh-ancestor
153536528|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
153536529|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153536530|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
153536531|NCT01522989|Fluorouracil|fluorouracil|mesh-list
153536532|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
153536533|NCT01522989|Palbociclib|palbociclib|mesh-list
153536534|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
153536535|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536536|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153536537|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536538|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536539|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
153536562|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536563|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536565|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153536566|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153536567|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
153536568|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
153536569|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536570|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536571|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153536572|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153536573|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153536584|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536585|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
153536586|NCT01523093|Ondansetron|ondansetron|mesh-list
153536587|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
153536588|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
153536589|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536590|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536591|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536592|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
153536593|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
153536594|NCT01523093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153536595|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153536596|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
153536597|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536598|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536599|NCT01523119|Ondansetron|ondansetron|mesh-list
154256169|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154256170|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154256171|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154256172|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
154256173|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536600|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
153536601|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
153536602|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536603|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536604|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536605|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
153536624|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536625|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
153536626|NCT01523314|Hormones|hormones|mesh-ancestor
153536627|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536628|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153479853|NCT06243536|Metformin|metformin|mesh-list
153536629|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536630|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153536631|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153536632|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153536633|NCT01523314|Growth Substances|growth substances|mesh-ancestor
153536634|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
153536635|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153536636|NCT01523327|Uric Acid|uric acid|mesh-list
153536637|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
153536657|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153536658|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
153536659|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536660|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536661|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
153536662|NCT01523431|Leucovorin|leucovorin|mesh-list
153536663|NCT01523431|Fluorouracil|fluorouracil|mesh-list
153536664|NCT01523431|Irinotecan|irinotecan|mesh-list
153536665|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
153536666|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536667|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153536668|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536669|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536670|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
153536671|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536672|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153536673|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153536674|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536675|NCT01523431|Antidotes|antidotes|mesh-ancestor
153536676|NCT01523431|Protective Agents|protective agents|mesh-ancestor
153536677|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
153536678|NCT01523431|Vitamins|vitamins|mesh-ancestor
153536679|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
153536680|NCT01523483|Progesterone|progesterone|mesh-list
153536681|NCT01523483|Progestins|progestins|mesh-ancestor
153536721|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153536722|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536723|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
153536724|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
153536725|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
153536726|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536728|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153536729|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536730|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153536758|NCT01524081|Metronidazole|metronidazole|mesh-list
153536759|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
153536760|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
153536761|NCT01524081|Cefuroxime|cefuroxime|mesh-list
153536772|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536773|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536774|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153536775|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
153536776|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256174|NCT01155986|Lidocaine|lidocaine|mesh-list
154256175|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
154256176|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
154256177|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536777|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536778|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153536779|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153536780|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153536781|NCT01524094|Leucovorin|leucovorin|mesh-list
153536782|NCT01524094|Fluorouracil|fluorouracil|mesh-list
153536783|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
153536784|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
153536785|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
153536878|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153536879|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153536880|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153536881|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
153536882|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536883|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153536884|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153536885|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536886|NCT01524731|Dexamethasone|dexamethasone|mesh-list
153536887|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
153536888|NCT01524731|BB 1101|bb 1101|mesh-list
153536889|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536890|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
153536891|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
153536892|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536893|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536894|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536895|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
153536896|NCT01524731|Hormones|hormones|mesh-ancestor
153536897|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536898|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153536899|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536900|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
153536901|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536902|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536903|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
153536904|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153536905|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536906|NCT01524744|Analgesics|analgesics|mesh-ancestor
153536907|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
153536908|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536909|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536910|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536911|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153536912|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153536913|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536914|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
153536915|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153536916|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536976|NCT06052995|Dermatologic Agents|dermatologic agents|mesh-ancestor
153536977|NCT06052995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536978|NCT06052995|Immunologic Factors|immunologic factors|mesh-ancestor
153536993|NCT06052111|Dexmedetomidine|dexmedetomidine|mesh-list
153536995|NCT06052111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536996|NCT06052111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536997|NCT06052111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536999|NCT06052111|Sensory System Agents|sensory system agents|mesh-ancestor
153537000|NCT06052111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537001|NCT06052111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153537002|NCT06052111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153537003|NCT06052111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153537004|NCT06052111|Adrenergic Agents|adrenergic agents|mesh-ancestor
153537005|NCT06052111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537006|NCT06052111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537007|NCT06052111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154256178|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537008|NCT06052111|Narcotics|narcotics|mesh-ancestor
153537009|NCT06052111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153537010|NCT06052111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153537011|NCT06052111|Anesthetics, General|anesthetics, general|mesh-ancestor
153537012|NCT06052111|Anesthetics|anesthetics|mesh-ancestor
153537014|NCT06051981|Calcium|calcium|mesh-list
153537015|NCT06051981|Fluorides|fluorides|mesh-list
153537016|NCT06051981|Sodium Fluoride|sodium fluoride|mesh-list
153537017|NCT06051981|Caseins|caseins|mesh-list
153537018|NCT06051981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153537019|NCT06051981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537020|NCT06051981|Cariostatic Agents|cariostatic agents|mesh-ancestor
153537021|NCT06051981|Protective Agents|protective agents|mesh-ancestor
153537022|NCT06051981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153537023|NCT06051981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153537024|NCT06051981|Chelating Agents|chelating agents|mesh-ancestor
153537025|NCT06051981|Sequestering Agents|sequestering agents|mesh-ancestor
153537026|NCT06051981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537027|NCT06051955|Sodium sulfate|sodium sulfate|mesh-list
153537028|NCT06051955|Cathartics|cathartics|mesh-ancestor
153537029|NCT06051955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153537030|NCT06051851|Paclitaxel|paclitaxel|mesh-list
153537031|NCT06051851|Gemcitabine|gemcitabine|mesh-list
153537032|NCT06051851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153537033|NCT06051851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537034|NCT06051851|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537035|NCT06051851|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537036|NCT06051851|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537037|NCT06051851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537038|NCT06051851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153537055|NCT06051786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153537056|NCT06051786|Histamine Antagonists|histamine antagonists|mesh-ancestor
153537057|NCT06051786|Histamine Agents|histamine agents|mesh-ancestor
153537058|NCT06051786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537059|NCT06051630|Lidocaine|lidocaine|mesh-list
153537060|NCT06051630|Anesthetics, Local|anesthetics, local|mesh-ancestor
153537061|NCT06051630|Anesthetics|anesthetics|mesh-ancestor
153537062|NCT06051630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537063|NCT06051630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537064|NCT06051630|Sensory System Agents|sensory system agents|mesh-ancestor
153537065|NCT06051630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537066|NCT06051630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153537067|NCT06051630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153537068|NCT06051630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153537069|NCT06051630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153537070|NCT06051630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537071|NCT06051370|Triamcinolone|triamcinolone|mesh-list
153537072|NCT06051370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153537073|NCT06051370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153537074|NCT06051370|Lidocaine|lidocaine|mesh-list
153537075|NCT06051370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153537076|NCT06051370|Anesthetics, Local|anesthetics, local|mesh-ancestor
153537077|NCT06051370|Anesthetics|anesthetics|mesh-ancestor
153537078|NCT06051370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537079|NCT06051370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537080|NCT06051370|Sensory System Agents|sensory system agents|mesh-ancestor
154191210|NCT05940324|Anesthetics|anesthetics|mesh-ancestor
153537081|NCT06051370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537082|NCT06051370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153537135|NCT05874570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153537136|NCT05874570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153537137|NCT05874570|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153537138|NCT05874570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153537139|NCT05874570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153537140|NCT05874570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153537141|NCT05874570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153537142|NCT05874570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537143|NCT05874570|Antimalarials|antimalarials|mesh-ancestor
153537144|NCT05874570|Antacids|antacids|mesh-ancestor
153537145|NCT05874570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153537146|NCT05874570|Diuretics|diuretics|mesh-ancestor
153537160|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153537161|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537163|NCT05494593|Methotrexate|methotrexate|mesh-list
153537164|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
154256179|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
153537165|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153537166|NCT05494593|Antibodies|antibodies|mesh-list
153537167|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
153537168|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153537169|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537170|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537171|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
153537172|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537173|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537174|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153537175|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
153537202|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153537203|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153537204|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618961|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
153537222|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153537223|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153537225|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537226|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153537227|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
153537228|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
153537229|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
153537230|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153537231|NCT05328440|Fulvestrant|fulvestrant|mesh-list
153537232|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153537233|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537234|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153537235|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153537236|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
153537237|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537238|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537239|NCT05296577|Vinorelbine|vinorelbine|mesh-list
153537240|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153537241|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537242|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537243|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537244|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537245|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537246|NCT05296564|Aldesleukin|aldesleukin|mesh-list
153537247|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
153537248|NCT05296564|Interleukin-2|interleukin-2|mesh-list
153537249|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537290|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153537291|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153537292|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
153537293|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
153537294|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537295|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153537296|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153537297|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537298|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537299|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153537300|NCT05176964|Capecitabine|capecitabine|mesh-list
153537301|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
153537302|NCT05176964|Tislelizumab|tislelizumab|mesh-list
153537303|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153537304|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
153537305|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537306|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537307|NCT05176964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537308|NCT05077098|Immunomodulating Agents|immunomodulating agents|mesh-list
153537309|NCT05077098|Immunologic Factors|immunologic factors|mesh-ancestor
153537310|NCT05077098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537311|NCT05017025|Osimertinib|osimertinib|mesh-list
153537312|NCT05017025|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153537313|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153537314|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537345|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537346|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153537347|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537348|NCT04681287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736181|NCT03647852|Hormones|hormones|mesh-ancestor
153537349|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537350|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153537351|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537352|NCT04681131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537353|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537354|NCT04626141|Abaloparatide|abaloparatide|mesh-list
153537355|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153537356|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537357|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
153537358|NCT04597619|Analgesics|analgesics|mesh-ancestor
153537359|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
153537360|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537361|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537362|NCT04593940|Remdesivir|remdesivir|mesh-list
153537363|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
153537364|NCT04593940|Infliximab|infliximab|mesh-list
153537365|NCT04593940|Abatacept|abatacept|mesh-list
153537366|NCT04593940|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153537367|NCT04593940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153537368|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
153537369|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153537370|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537371|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480601|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
153537372|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537373|NCT04593940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537374|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537375|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537376|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
153537377|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537378|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
153537385|NCT04562831|Niacin|niacin|mesh-list
153537386|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
153537387|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
153537388|NCT04562831|Vitamins|vitamins|mesh-ancestor
153537389|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
153537411|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537413|NCT04544111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537414|NCT04522739|Spironolactone|spironolactone|mesh-list
153537415|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153537416|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
153537417|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537418|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537419|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153537420|NCT04522739|Diuretics|diuretics|mesh-ancestor
153537421|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
153537422|NCT04402346|Pancrelipase|pancrelipase|mesh-list
153537423|NCT04402346|Pancreatin|pancreatin|mesh-list
153537424|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153537425|NCT04397484|Lidocaine|lidocaine|mesh-list
153537426|NCT04397484|Epinephrine|epinephrine|mesh-list
153537427|NCT04397484|Racepinephrine|racepinephrine|mesh-list
153537428|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
153537429|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
153537430|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
153537431|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
153537432|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537433|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537434|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
153537435|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537436|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153537437|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153537438|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153537439|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153537440|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537489|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537490|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153537491|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537493|NCT03884972|Trabectedin|trabectedin|mesh-list
153537494|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537495|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537496|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
154256180|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256181|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153537541|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537542|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
153537543|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537544|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537545|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537546|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
153537594|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153618963|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
153537595|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153539924|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153537624|NCT02876302|Paclitaxel|paclitaxel|mesh-list
153537625|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
153537626|NCT02876302|Doxorubicin|doxorubicin|mesh-list
153537627|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153537628|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537629|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537639|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153537640|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153537641|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153537642|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153537643|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537644|NCT02846623|Atezolizumab|atezolizumab|mesh-list
153537645|NCT02846623|Venetoclax|venetoclax|mesh-list
153537646|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
153537647|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153537648|NCT02846623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153537649|NCT02846623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537670|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537671|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153537672|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153537673|NCT02532257|Growth Substances|growth substances|mesh-ancestor
153537674|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
153537675|NCT02532257|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153537676|NCT02532257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153537677|NCT02532257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537678|NCT02532257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537679|NCT02113657|Ipilimumab|ipilimumab|mesh-list
153537680|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537681|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537682|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153537683|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537684|NCT01415882|Dexamethasone|dexamethasone|mesh-list
153537685|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
153537686|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
153537687|NCT01415882|Daratumumab|daratumumab|mesh-list
153537688|NCT01415882|Ixazomib|ixazomib|mesh-list
153537689|NCT01415882|Ichthammol|ichthammol|mesh-list
153537690|NCT01415882|BB 1101|bb 1101|mesh-list
153537691|NCT01415882|Glycine|glycine|mesh-list
153537692|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537693|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
153537694|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537695|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537696|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537712|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
153537713|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
153537714|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537715|NCT01092702|Varenicline|varenicline|mesh-list
153537716|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153537717|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153537718|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
153537719|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537720|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537734|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
153537735|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153537736|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153537737|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537738|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153537739|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154256182|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154256183|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153537740|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153537741|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537742|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
153537743|NCT00667121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153537744|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153537745|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153537746|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
153537747|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153537748|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153537750|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
153537751|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153537752|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153537753|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
153537754|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153537755|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
153537756|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153537767|NCT00591851|Doxorubicin|doxorubicin|mesh-list
153537768|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153537769|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153537770|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537771|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537772|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537773|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
153730490|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
153730491|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730492|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730493|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
153537774|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537775|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537776|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
153537777|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537778|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537779|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537780|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
153537781|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153537782|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153537783|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153537784|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153537785|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727171|NCT00488176|Cetirizine|cetirizine|mesh-list
153537786|NCT00336024|Calcium, Dietary|calcium, dietary|mesh-list
153537787|NCT00336024|Leucovorin|leucovorin|mesh-list
153537788|NCT00336024|Folic Acid|folic acid|mesh-list
153537789|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
153537790|NCT00336024|Thiotepa|thiotepa|mesh-list
153537805|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537806|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
153537807|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537808|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537809|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153537810|NCT00336024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153537811|NCT00336024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153537812|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153537813|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
153537814|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153537815|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153537816|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
153537817|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
153537818|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537819|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153537820|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153537838|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153537839|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537840|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153537841|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153537842|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153537843|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
153537844|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153537845|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153537846|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
154256184|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256185|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256186|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153736187|NCT03610061|Durvalumab|durvalumab|mesh-list
153537847|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537848|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
153537849|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153537850|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153537851|NCT01525043|Naproxen|naproxen|mesh-list
153537852|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153537853|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153537854|NCT01525043|Analgesics|analgesics|mesh-ancestor
153537855|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
153537856|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537857|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730494|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153537858|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153537859|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537860|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
153537861|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153537862|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537863|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537864|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153537865|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153537866|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153537867|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537868|NCT01525537|Sufentanil|sufentanil|mesh-list
153537900|NCT01525719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537901|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537902|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
153537903|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537904|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537906|NCT01525771|Docetaxel|docetaxel|mesh-list
153537907|NCT01525771|Capecitabine|capecitabine|mesh-list
153537908|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537909|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537910|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537911|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537912|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537913|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153537914|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
153537915|NCT01525823|Metformin|metformin|mesh-list
153537916|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153537917|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537918|NCT01525836|Rituximab|rituximab|mesh-list
153537919|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537920|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537921|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
153537922|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537923|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537924|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153537925|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153537926|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153537927|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537928|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
153537929|NCT01525914|Dutasteride|dutasteride|mesh-list
153537930|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153537931|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153537946|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537947|NCT01526070|Aflibercept|aflibercept|mesh-list
153537948|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153537949|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153537950|NCT01526070|Growth Substances|growth substances|mesh-ancestor
153537951|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537952|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
153537953|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537954|NCT01526083|Lacosamide|lacosamide|mesh-list
153537955|NCT01526083|Warfarin|warfarin|mesh-list
153537956|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
154256187|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154256188|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
154256189|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537958|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153537959|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153537960|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153537965|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153537966|NCT01526122|Analgesics|analgesics|mesh-ancestor
153537967|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
153618966|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537968|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537969|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537970|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153537971|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537972|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153537973|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153537974|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537975|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153537976|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153537977|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537979|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153537980|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153537981|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153537982|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
153537983|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537984|NCT01526161|Fluticasone|fluticasone|mesh-list
153537986|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153537987|NCT01526161|Montelukast|montelukast|mesh-list
153537988|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153537989|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153537990|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
153538000|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
153538001|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538002|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538003|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153538004|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
153538005|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538006|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153538007|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153538008|NCT01526174|Golimumab|golimumab|mesh-list
153538009|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153538010|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538011|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538012|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
153538013|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538014|NCT01526278|Alendronate|alendronate|mesh-list
153538015|NCT01526278|Calcitriol|calcitriol|mesh-list
153538016|NCT01526278|Maxmarvil|maxmarvil|mesh-list
153538017|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153538018|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538019|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153538020|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153538021|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538022|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538023|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153538024|NCT01526278|Vitamins|vitamins|mesh-ancestor
153538025|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
153538026|NCT01526317|Metformin|metformin|mesh-list
153538027|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153538028|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538029|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538030|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153538031|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153538032|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
153538033|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538034|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153538068|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538069|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
153538070|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538071|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153538072|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153538073|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
153538074|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538075|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538076|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153538077|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
153538078|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
153538079|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
153538080|NCT01526525|Acetaminophen|acetaminophen|mesh-list
153538081|NCT01526525|Parecoxib|parecoxib|mesh-list
153538082|NCT01526525|Ketamine|ketamine|mesh-list
153538083|NCT01526525|Morphine|morphine|mesh-list
153538084|NCT01526525|Tramadol|tramadol|mesh-list
153538085|NCT01526525|Analgesics|analgesics|mesh-ancestor
153538086|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
153538087|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538088|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538111|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
153538112|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538113|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
153538114|NCT01526616|Metformin|metformin|mesh-list
153538115|NCT01526616|Spironolactone|spironolactone|mesh-list
153538116|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538117|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481347|NCT03752307|Hormones|hormones|mesh-ancestor
153538118|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153538119|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
153538120|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538121|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153538135|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538137|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538138|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153538139|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
153538140|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538141|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538142|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
153538143|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
153538144|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153538145|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538146|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153538147|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153538148|NCT01526694|Growth Substances|growth substances|mesh-ancestor
153538149|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
153538150|NCT01526837|Bevacizumab|bevacizumab|mesh-list
153538151|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153538176|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538177|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153538178|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538180|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153538181|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
153538182|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
153538190|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
153538191|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
153538192|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153538193|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
153538194|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153538195|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538196|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538197|NCT01527019|Cephalosporins|cephalosporins|mesh-list
153538198|NCT01527019|Norfloxacin|norfloxacin|mesh-list
153538199|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153538200|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538201|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153538202|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153538203|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538204|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538205|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431004|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
153538225|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153538226|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538227|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
153538228|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
153538229|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153538230|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538231|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153538232|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153538233|NCT01527032|Growth Substances|growth substances|mesh-ancestor
153538234|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
153538236|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153538237|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153538238|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
153538239|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538240|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153538241|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153538242|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538243|NCT01527279|Antazoline|antazoline|mesh-list
153538244|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153538255|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538256|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538257|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153538258|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153538259|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
153538260|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153618968|NCT01981330|Protective Agents|protective agents|mesh-ancestor
153618969|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
153538261|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538262|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153538263|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153538264|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
153538265|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
153538266|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153538267|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153538281|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153538282|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
153538283|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538284|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538285|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153538286|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153538287|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153538288|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153538289|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538290|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538292|NCT01527422|Hormones|hormones|mesh-ancestor
153538293|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538294|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153538295|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153538296|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
153538297|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
153538298|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
153538299|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153538300|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
153538301|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538302|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153538303|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538304|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538305|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538306|NCT01527474|Escitalopram|escitalopram|mesh-list
153538317|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538318|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538319|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
153538320|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
153538321|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538322|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538323|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
153538324|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
153538325|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538326|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538327|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
153538328|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
153538329|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538332|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
153538333|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538334|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538335|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
153481578|NCT02817659|Glucagon|glucagon|mesh-list
153538336|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
153538337|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538338|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538385|NCT01527890|Narcotics|narcotics|mesh-ancestor
153538386|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538387|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538388|NCT01527890|Analgesics|analgesics|mesh-ancestor
153538389|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
153730497|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153538421|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538422|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538423|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153538424|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153538425|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538426|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538427|NCT01528007|Naltrexone|naltrexone|mesh-list
153538428|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153538441|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538442|NCT01528163|Methotrexate|methotrexate|mesh-list
153538443|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153538444|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
153538445|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153538479|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538481|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538482|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153538483|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538522|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
153538524|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538525|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538526|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
153538527|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538528|NCT01528800|Vitamin K|vitamin k|mesh-list
153538529|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
153538530|NCT01528800|Vitamins|vitamins|mesh-ancestor
153538531|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
153538532|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538533|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153538534|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153538535|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538536|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
153538537|NCT01528800|Coagulants|coagulants|mesh-ancestor
153538538|NCT01528813|Amorolfine|amorolfine|mesh-list
153538539|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
153538540|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538541|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
153538542|NCT01528826|Vinorelbine|vinorelbine|mesh-list
153538543|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538544|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153538545|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
153538546|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
153538547|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
153538548|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538581|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
153538582|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153538583|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153538584|NCT01529138|Sirolimus|sirolimus|mesh-list
153538585|NCT01529138|Temsirolimus|temsirolimus|mesh-list
153538586|NCT01529138|MTOR Inhibitors|mtor inhibitors|mesh-list
153538587|NCT01529138|Axitinib|axitinib|mesh-list
153538588|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153538589|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538590|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538591|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538592|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
153538593|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538594|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538595|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154256191|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788815|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
153538596|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538597|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153538598|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
153538599|NCT01529164|Leucovorin|leucovorin|mesh-list
153538600|NCT01529164|Fluorouracil|fluorouracil|mesh-list
153538601|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
153538602|NCT01529164|Endostar protein|endostar protein|mesh-list
153538603|NCT01529164|Endostatins|endostatins|mesh-list
153538604|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
153538605|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538606|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153538607|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538608|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538609|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
153538648|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538649|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538650|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153538652|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153730500|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730501|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538653|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538654|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538655|NCT01529229|Prednisolone|prednisolone|mesh-list
153538656|NCT01529229|Betamethasone|betamethasone|mesh-list
153538657|NCT01529229|Desloratadine|desloratadine|mesh-list
153538658|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
153538659|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538660|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
153538661|NCT01529229|Hormones|hormones|mesh-ancestor
153538662|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538683|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538685|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153538686|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538687|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153538688|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
153538689|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153538690|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
153538691|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538696|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
153538698|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
153538699|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538700|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153538701|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538702|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538703|NCT01529294|Iloperidone|iloperidone|mesh-list
153538704|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153538705|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538706|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538707|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538708|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538709|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
153538710|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153538711|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153538712|NCT01529320|Prednisolone|prednisolone|mesh-list
153538713|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
153538714|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
153538715|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153538716|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
153538717|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538718|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
153538719|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
153538720|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538749|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538750|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538751|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538752|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153538754|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538755|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538756|NCT01529541|Incretins|incretins|mesh-ancestor
153538757|NCT01529541|Hormones|hormones|mesh-ancestor
154256192|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154256194|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727949|NCT00494533|Treprostinil|treprostinil|mesh-list
154256195|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154256196|NCT01264874|Vitamin D|vitamin d|mesh-list
154256197|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
154256198|NCT01264874|Vitamins|vitamins|mesh-ancestor
153538758|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538759|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153538760|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
153538777|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538778|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538814|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
153538815|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153538816|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153538895|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153538896|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153538897|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538928|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153538929|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538931|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153538932|NCT01530542|Narcotics|narcotics|mesh-ancestor
153538933|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538934|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538935|NCT01530542|Analgesics|analgesics|mesh-ancestor
153538936|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
153538937|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538938|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
153538939|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
153538940|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538941|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538958|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
153538959|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538960|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538961|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153538962|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153538963|NCT01530620|Propiverine|propiverine|mesh-list
153538964|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
153538965|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
153538966|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538967|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538968|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153538969|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153538970|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
153538971|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538972|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538973|NCT01530620|Urological Agents|urological agents|mesh-ancestor
153538974|NCT01530698|Vaccines|vaccines|mesh-list
153538975|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
153538976|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538977|NCT01530711|Terlipressin|terlipressin|mesh-list
153538978|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153538979|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153538980|NCT01530737|Antithrombins|antithrombins|mesh-list
153538981|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
153538982|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153538983|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
153538984|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538985|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538986|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
153538987|NCT01530763|Amoxicillin|amoxicillin|mesh-list
153538988|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
153538989|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
153545840|NCT06299891|Topiramate|topiramate|mesh-list
153538990|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
153538991|NCT01530763|Ceftaroline|ceftaroline|mesh-list
153538992|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153538993|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153538994|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256199|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
154256200|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538995|NCT01530763|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153538996|NCT01530763|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153813342|NCT00333398|Vaccines|vaccines|mesh-list
153539027|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153539028|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153539029|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153539030|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153539031|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153539032|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
153539033|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539034|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539035|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539037|NCT01531140|Senna Extract|senna extract|mesh-list
153539039|NCT01531140|Cathartics|cathartics|mesh-ancestor
153539040|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153539041|NCT01531140|Laxatives|laxatives|mesh-ancestor
153539042|NCT01531166|Interferons|interferons|mesh-list
153539043|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
153539044|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
153539045|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153539046|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539047|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
153539048|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539049|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
153539050|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539051|NCT01531192|Nystatin|nystatin|mesh-list
153539052|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539053|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539054|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
153539055|NCT01531192|Ionophores|ionophores|mesh-ancestor
153539056|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153539057|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539058|NCT01531218|Azithromycin|azithromycin|mesh-list
153539059|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539075|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153539077|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153539078|NCT01531309|Agomelatine|agomelatine|mesh-list
153539079|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153539080|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539081|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539082|NCT01531322|Vaccines|vaccines|mesh-list
153539083|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153539084|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
153539098|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
153539100|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
153539101|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539102|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539103|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
153539104|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
153539105|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153539106|NCT01531569|Estrogens|estrogens|mesh-ancestor
153539107|NCT01531569|Hormones|hormones|mesh-ancestor
153730508|NCT00141492|Hormones|hormones|mesh-ancestor
153730509|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539108|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539109|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539110|NCT01531595|Bevacizumab|bevacizumab|mesh-list
153539111|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
153539112|NCT01531595|Irinotecan|irinotecan|mesh-list
153539113|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153539114|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539115|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153539116|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153539117|NCT01531595|Growth Substances|growth substances|mesh-ancestor
153539118|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539119|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
153539120|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153539156|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539157|NCT01531764|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153539158|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256201|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153539169|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539170|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539171|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153539172|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153539173|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153539174|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153539175|NCT01531790|Growth Substances|growth substances|mesh-ancestor
153539176|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539177|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
153539179|NCT01531829|Plasminogen|plasminogen|mesh-list
153539180|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153539181|NCT01531829|Tinzaparin|tinzaparin|mesh-list
153539182|NCT01531829|Dalteparin|dalteparin|mesh-list
153539183|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153539184|NCT01531829|Nadroparin|nadroparin|mesh-list
153539185|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
153539186|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153539187|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153539188|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539189|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153539190|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539191|NCT01531855|Insulin|insulin|mesh-list
153539200|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539202|NCT01532011|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153539203|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153539204|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539205|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539206|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539207|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153539208|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
153539209|NCT01532076|Coagulants|coagulants|mesh-ancestor
153539210|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
153539211|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539212|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
153539213|NCT01532115|Opicapone|opicapone|mesh-list
153539214|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539215|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539216|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153539217|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153539218|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539219|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539220|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539221|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153730510|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730511|NCT00141531|Apaziquone|apaziquone|mesh-list
153539222|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153539235|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
153539236|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153539237|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153539238|NCT01532466|Rocuronium|rocuronium|mesh-list
153539239|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153539240|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153539241|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153539242|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539243|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539244|NCT01532544|Heparin|heparin|mesh-list
153539245|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153539246|NCT01532544|Tinzaparin|tinzaparin|mesh-list
153539247|NCT01532544|Dalteparin|dalteparin|mesh-list
153539248|NCT01532544|Eptifibatide|eptifibatide|mesh-list
153539249|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
153539250|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153539251|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153728100|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153539252|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539253|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153539254|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
153539255|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153539256|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153539257|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
153539258|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153539259|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153539260|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256202|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154256203|NCT01262924|Vaccines|vaccines|mesh-list
154256204|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
154256205|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256206|NCT01158560|Vitamin D|vitamin d|mesh-list
153736200|NCT03520686|Cisplatin|cisplatin|mesh-list
153539261|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539262|NCT01532804|Bevacizumab|bevacizumab|mesh-list
153539263|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
153539264|NCT01532804|Raltitrexed|raltitrexed|mesh-list
153539265|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153539266|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539267|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153539268|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153539294|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539295|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153539296|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539297|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
153539298|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
153539299|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539300|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153539301|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
153539302|NCT01532856|Hormones|hormones|mesh-ancestor
153539303|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539304|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153539305|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
153539306|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539307|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
153539308|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539309|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539310|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153539311|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153539312|NCT01532856|Growth Substances|growth substances|mesh-ancestor
153539313|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
153730512|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539314|NCT01532895|Hydromorphone|hydromorphone|mesh-list
153539315|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153539316|NCT01532895|Narcotics|narcotics|mesh-ancestor
153539317|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539318|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539319|NCT01532895|Analgesics|analgesics|mesh-ancestor
153539320|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
153539321|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539322|NCT01532960|Poly ICLC|poly iclc|mesh-list
153539323|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
153539324|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
153539325|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539326|NCT01533090|Bisacodyl|bisacodyl|mesh-list
153539327|NCT01533090|Cathartics|cathartics|mesh-ancestor
153539328|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153539329|NCT01533090|Laxatives|laxatives|mesh-ancestor
153539330|NCT01533129|Testosterone|testosterone|mesh-list
153539331|NCT01533129|Androgens|androgens|mesh-ancestor
153539332|NCT01533129|Hormones|hormones|mesh-ancestor
154191211|NCT05940324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539333|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539352|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153539353|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153539354|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539375|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
153539376|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
153539377|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153539378|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
153539379|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
153539380|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153539381|NCT01533272|Tenofovir|tenofovir|mesh-list
153539382|NCT01533272|Emtricitabine|emtricitabine|mesh-list
153539383|NCT01533272|Lopinavir|lopinavir|mesh-list
153539384|NCT01533272|Maraviroc|maraviroc|mesh-list
153539385|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
153539386|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539387|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153539388|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154256207|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
154256208|NCT01158560|Vitamins|vitamins|mesh-ancestor
153539389|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539390|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539391|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153539392|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153539393|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153539394|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153539395|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
153539396|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153539397|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153539398|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153539399|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153539400|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153539401|NCT01533324|Leucovorin|leucovorin|mesh-list
153539402|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153539403|NCT01533324|Antidotes|antidotes|mesh-ancestor
153539404|NCT01533324|Protective Agents|protective agents|mesh-ancestor
153539405|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539406|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
153539407|NCT01533324|Vitamins|vitamins|mesh-ancestor
153730513|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153539436|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153539437|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153539486|NCT01533662|Protective Agents|protective agents|mesh-ancestor
153539487|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153539488|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153539489|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539490|NCT01533740|Leucovorin|leucovorin|mesh-list
153539491|NCT01533740|Folic Acid|folic acid|mesh-list
153539492|NCT01533740|Bevacizumab|bevacizumab|mesh-list
153539493|NCT01533740|Fluorouracil|fluorouracil|mesh-list
153539494|NCT01533740|Irinotecan|irinotecan|mesh-list
153539495|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
153539496|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153539497|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539498|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153539516|NCT01533740|Hematinics|hematinics|mesh-ancestor
153539517|NCT01533818|Amoxicillin|amoxicillin|mesh-list
153539518|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539546|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539547|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539548|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539549|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153539550|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153539551|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539552|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153539553|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153539554|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539555|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
153539556|NCT01534169|Dexamethasone|dexamethasone|mesh-list
153539557|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539558|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
153539559|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
153539560|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539561|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539573|NCT01534312|Mesalamine|mesalamine|mesh-list
153539574|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153539575|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153539576|NCT01534312|Analgesics|analgesics|mesh-ancestor
153539577|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
153539578|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539579|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539580|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539581|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539582|NCT01534442|Atropine|atropine|mesh-list
153539583|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153539584|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153539585|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153539586|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
153539587|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539588|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539589|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153539590|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
154256209|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
154256210|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539591|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
153539592|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
153539593|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153539594|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153539606|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153539608|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539609|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539611|NCT01534585|Mitogens|mitogens|mesh-list
153539612|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153539613|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539614|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618973|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539615|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
153539616|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
153539617|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539618|NCT01534702|Cytarabine|cytarabine|mesh-list
153539619|NCT01534702|Clofarabine|clofarabine|mesh-list
153539620|NCT01534702|Idarubicin|idarubicin|mesh-list
153539621|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153539622|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
153539623|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539624|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539625|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
153539626|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539652|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153539653|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539654|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539655|NCT01534845|Temozolomide|temozolomide|mesh-list
153539656|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153539657|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
153539658|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539659|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539660|NCT01534858|Polihexanide|polihexanide|mesh-list
153539661|NCT01534858|Betaine|betaine|mesh-list
153539662|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153730514|NCT00134069|Cetuximab|cetuximab|mesh-list
153539663|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
153539664|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153539665|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
153539666|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539667|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153539668|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
153539669|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539670|NCT01534884|Rituximab|rituximab|mesh-list
153539671|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153399757|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153539672|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539673|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
153539674|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539675|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539692|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153539693|NCT01535079|Ibuprofen|ibuprofen|mesh-list
153539694|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153539695|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153539696|NCT01535079|Analgesics|analgesics|mesh-ancestor
153539713|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
153539714|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539715|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153539716|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153539717|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539718|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539719|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153539720|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
153539721|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539722|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539723|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153539724|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539725|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153539726|NCT01535157|Protective Agents|protective agents|mesh-ancestor
153539728|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790014|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539729|NCT01535183|Irinotecan|irinotecan|mesh-list
153539730|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153539731|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153539732|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539750|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153539751|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539752|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539753|NCT01535469|Fluconazole|fluconazole|mesh-list
153539754|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
153539755|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539756|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153539757|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153539758|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539759|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539760|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153539761|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
153539762|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539763|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539764|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153539765|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153539766|NCT01535495|Propranolol|propranolol|mesh-list
153539767|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153730515|NCT00134069|Irinotecan|irinotecan|mesh-list
153730516|NCT00134069|Sorafenib|sorafenib|mesh-list
153730517|NCT00134069|Antibodies|antibodies|mesh-list
153539770|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539771|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539772|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539773|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153539774|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153539775|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
153539776|NCT01535547|Isavuconazole|isavuconazole|mesh-list
153539777|NCT01535547|Tacrolimus|tacrolimus|mesh-list
153539778|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153539779|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
153539780|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539781|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153539782|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539783|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539784|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
153539785|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539786|NCT01535612|Insulin|insulin|mesh-list
153539818|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
153539819|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153539820|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539821|NCT01535859|Cabergoline|cabergoline|mesh-list
153539822|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153539823|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153539824|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
153539825|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
153539826|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539827|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539841|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
153539842|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539843|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539844|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539845|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539846|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153539847|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
153539848|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153539850|NCT01535989|Immunoconjugates|immunoconjugates|mesh-ancestor
153539851|NCT01536002|Propofol|propofol|mesh-list
153539852|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153539853|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539854|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539855|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153539856|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
153539857|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
153539858|NCT01536028|Insulin|insulin|mesh-list
153539859|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153539860|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
154256211|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154256212|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153539862|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153539863|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
153539864|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153539865|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539866|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539867|NCT01536054|Sirolimus|sirolimus|mesh-list
153539868|NCT01536054|Sargramostim|sargramostim|mesh-list
153539869|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539870|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539871|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153539872|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539873|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
153539874|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153539875|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
153539876|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539877|NCT01536132|Simendan|simendan|mesh-list
153539878|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153539879|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
153539880|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153539881|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153539882|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730518|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
153730519|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153730520|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
154182256|NCT05713994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182268|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182269|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
154182270|NCT05656508|Vaccines|vaccines|mesh-list
154182271|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
154182272|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182273|NCT05651594|Leucovorin|leucovorin|mesh-list
154182274|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
154182275|NCT05651594|Fluorouracil|fluorouracil|mesh-list
154182276|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
154182277|NCT05651594|Propranolol|propranolol|mesh-list
154182278|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182279|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182280|NCT05651594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182281|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182282|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
154182283|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182284|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154182285|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
154182286|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182287|NCT05651594|Antidotes|antidotes|mesh-ancestor
154182288|NCT05651594|Protective Agents|protective agents|mesh-ancestor
154182289|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
154182290|NCT05651594|Vitamins|vitamins|mesh-ancestor
154182291|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
154182292|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154182293|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154182294|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
154182295|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182296|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154182297|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154182298|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
154182299|NCT05645432|Pregnanolone|pregnanolone|mesh-list
154182300|NCT05645432|Brexanolone|brexanolone|mesh-list
154182301|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
154182302|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154182303|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182304|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
154182305|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182306|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182307|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
154182308|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
154182309|NCT05631041|Silymarin|silymarin|mesh-list
154182310|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
154182311|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182312|NCT05631041|Protective Agents|protective agents|mesh-ancestor
154182313|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256213|NCT03879746|Paroxetine|paroxetine|mesh-list
154256214|NCT03879746|Tamsulosin|tamsulosin|mesh-list
154182315|NCT05612490|Diuretics|diuretics|mesh-ancestor
154182316|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
154182317|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182318|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154182319|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154182320|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182321|NCT05610735|Doxorubicin|doxorubicin|mesh-list
154182322|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154182337|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182338|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
154182339|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154182340|NCT05493566|Aldesleukin|aldesleukin|mesh-list
154182341|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
154182342|NCT05493566|Interleukin-2|interleukin-2|mesh-list
154182343|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182344|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182345|NCT05493566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182346|NCT05493566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182347|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154182348|NCT05493566|Analgesics|analgesics|mesh-ancestor
154182349|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
154182350|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182351|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182352|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154182353|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154182354|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
154182355|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182356|NCT05488678|Ceftibuten|ceftibuten|mesh-list
154182357|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154182358|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182359|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
154182360|NCT05468359|Bevacizumab|bevacizumab|mesh-list
154182361|NCT05468359|Sorafenib|sorafenib|mesh-list
154182362|NCT05468359|Atezolizumab|atezolizumab|mesh-list
154182363|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154182364|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
154182365|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182366|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154182367|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154182368|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
154182369|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182370|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182371|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154182372|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182373|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182374|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182375|NCT05468359|Growth Substances|growth substances|mesh-ancestor
154182376|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182377|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182378|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182379|NCT05468359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182380|NCT05462613|Aspirin|aspirin|mesh-list
154182381|NCT05462613|Bevacizumab|bevacizumab|mesh-list
153728760|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
154182382|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182383|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182394|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182395|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154182396|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154182397|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154182398|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182399|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154182400|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154182401|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182402|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
154182403|NCT05392946|Dexamethasone|dexamethasone|mesh-list
154182404|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
154182405|NCT05392946|Bortezomib|bortezomib|mesh-list
154182406|NCT05392946|Daratumumab|daratumumab|mesh-list
154182407|NCT05392946|Ichthammol|ichthammol|mesh-list
154182408|NCT05392946|BB 1101|bb 1101|mesh-list
154182409|NCT05392946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154182410|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182411|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
154182412|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
153736212|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182413|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182414|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182415|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182416|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
154182418|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182419|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154182420|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182421|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
154182422|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182423|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182424|NCT05392946|Immunologic Factors|immunologic factors|mesh-ancestor
154182425|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
154182426|NCT05378737|Exatecan|exatecan|mesh-list
154182427|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154182428|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154182429|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182430|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182431|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182432|NCT05314400|Liver Extracts|liver extracts|mesh-list
154182433|NCT05314400|Hematinics|hematinics|mesh-ancestor
154182434|NCT05309655|Adenosine|adenosine|mesh-list
154182435|NCT05309655|Analgesics|analgesics|mesh-ancestor
154182436|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
154182437|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182438|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182439|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154182440|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
154182441|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154182442|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
154182443|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
154182444|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182445|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182446|NCT05305794|Insulin|insulin|mesh-list
154182447|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154182448|NCT05305794|Semaglutide|semaglutide|mesh-list
154182449|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154182457|NCT05281601|Antiviral Agents|antiviral agents|mesh-ancestor
154182458|NCT05281601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182460|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182461|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182462|NCT05151731|Growth Substances|growth substances|mesh-ancestor
154182463|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182464|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182465|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182467|NCT05141721|Bevacizumab|bevacizumab|mesh-list
154182468|NCT05141721|Ipilimumab|ipilimumab|mesh-list
154182469|NCT05141721|Atezolizumab|atezolizumab|mesh-list
154182470|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182471|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182472|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182473|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182474|NCT05141721|Growth Substances|growth substances|mesh-ancestor
154182475|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182476|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182477|NCT05141721|Antidotes|antidotes|mesh-ancestor
154182478|NCT05141721|Protective Agents|protective agents|mesh-ancestor
154182479|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
154182480|NCT05141721|Vitamins|vitamins|mesh-ancestor
154182481|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
154182482|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182483|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182484|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154182485|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
154182486|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182487|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154182488|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
154182489|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182490|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182491|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154182492|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154182493|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154182494|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
154263447|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182495|NCT05126901|Ferric maltol|ferric maltol|mesh-list
154182496|NCT05126901|Hematinics|hematinics|mesh-ancestor
154182497|NCT05096728|Nifedipine|nifedipine|mesh-list
154182498|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154182499|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154182500|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182501|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154182502|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182503|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
154182504|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
154182505|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154182506|NCT05094154|Penicillins|penicillins|mesh-list
154182507|NCT05094154|Cephalosporins|cephalosporins|mesh-list
154182508|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154182509|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182510|NCT05076149|Ivacaftor|ivacaftor|mesh-list
154182511|NCT05076149|Elexacaftor|elexacaftor|mesh-list
154182512|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154182513|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154182514|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182515|NCT05030766|Nicotine|nicotine|mesh-list
154182516|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154182517|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
154182532|NCT04925479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929524|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
154182534|NCT04925479|Vitamins|vitamins|mesh-ancestor
154182535|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
154182536|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182537|NCT04915950|APD791|apd791|mesh-list
154182538|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154182539|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154182541|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182542|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182543|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182544|NCT04870034|Palbociclib|palbociclib|mesh-list
154182545|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182546|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182547|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182548|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182549|NCT04817241|Cytarabine|cytarabine|mesh-list
154182550|NCT04817241|Decitabine|decitabine|mesh-list
154182551|NCT04817241|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154182552|NCT04817241|Daunorubicin|daunorubicin|mesh-list
154182553|NCT04817241|Venetoclax|venetoclax|mesh-list
154182554|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182555|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
154182556|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182557|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182558|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
154182559|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182560|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154182561|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
154182562|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182563|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154182564|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154182565|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154182566|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182567|NCT04792385|Drospirenone|drospirenone|mesh-list
154182568|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
154182569|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
154182570|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154182571|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154182572|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182573|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154182574|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154182575|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
154182576|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182596|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154182597|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154182598|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154182599|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182600|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
154256215|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154256216|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154256217|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154256218|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
154256219|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256220|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256221|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256222|NCT03879746|Urological Agents|urological agents|mesh-ancestor
154256223|NCT03879746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154256224|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256225|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256226|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
154256227|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154256228|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
154256229|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154182601|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182602|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154182603|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
154182604|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182605|NCT04762953|Antidotes|antidotes|mesh-ancestor
154182606|NCT04762953|Protective Agents|protective agents|mesh-ancestor
154182607|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
154182608|NCT04762953|Vitamins|vitamins|mesh-ancestor
154182609|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
154182610|NCT04735978|Nivolumab|nivolumab|mesh-list
154182611|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182612|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182613|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182614|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182615|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
154182616|NCT04700072|Lenvatinib|lenvatinib|mesh-list
154182617|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182618|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182619|NCT04700072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182620|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182621|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182622|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182623|NCT04678154|Vancomycin|vancomycin|mesh-list
154182624|NCT04678154|Tobramycin|tobramycin|mesh-list
154182625|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154182626|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182627|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
154182628|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154182629|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
154182630|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182631|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182632|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182668|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182669|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182670|NCT04534218|Aspirin|aspirin|mesh-list
154182671|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
154182672|NCT04534218|Capecitabine|capecitabine|mesh-list
154182673|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154182674|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
154182700|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154182702|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256230|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154182703|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182704|NCT04495452|Analgesics|analgesics|mesh-ancestor
154182705|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
154182706|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182707|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154182708|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154182709|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
154182710|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
154182711|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154182712|NCT04476030|Citalopram|citalopram|mesh-list
154182713|NCT04476030|Sertraline|sertraline|mesh-list
154182714|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154182715|NCT04476030|Zuranolone|zuranolone|mesh-list
154182716|NCT04476030|Escitalopram|escitalopram|mesh-list
154182717|NCT04476030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154182718|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154182719|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154182720|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182752|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154182753|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182754|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
154182755|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182756|NCT04443062|Pluvicto|pluvicto|mesh-list
154182757|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154182758|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182759|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
154182760|NCT04438213|Metolazone|metolazone|mesh-list
154182761|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153929746|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154182762|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182792|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182793|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182794|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182795|NCT04303858|Atezolizumab|atezolizumab|mesh-list
154182796|NCT04303858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182797|NCT04303858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182798|NCT04303858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182799|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182800|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154182801|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182802|NCT04239794|Propofol|propofol|mesh-list
154182803|NCT04239794|Sevoflurane|sevoflurane|mesh-list
154182804|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154182805|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154182806|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182807|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154182808|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
154182864|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154182866|NCT03748953|Ixazomib|ixazomib|mesh-list
154182867|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182868|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
154182869|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182870|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182871|NCT03730194|Melatonin|melatonin|mesh-list
154182872|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
154182873|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182874|NCT03730194|Protective Agents|protective agents|mesh-ancestor
154182875|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182876|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154182877|NCT03723551|Afabicin|afabicin|mesh-list
154182878|NCT03723551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154182879|NCT03723551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182880|NCT03689699|Nivolumab|nivolumab|mesh-list
154182881|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182882|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182883|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182884|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182885|NCT03653507|Capecitabine|capecitabine|mesh-list
154182886|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
154182887|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182888|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
154256231|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154182889|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182890|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182891|NCT03568890|Aspirin|aspirin|mesh-list
154182892|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
154182893|NCT03568890|Apixaban|apixaban|mesh-list
154182894|NCT03568890|Edoxaban|edoxaban|mesh-list
154182895|NCT03568890|Dabigatran|dabigatran|mesh-list
154182896|NCT03568890|Clopidogrel|clopidogrel|mesh-list
154182897|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154182898|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154182899|NCT03568890|Analgesics|analgesics|mesh-ancestor
154182900|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
154182901|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182925|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154182926|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182927|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182928|NCT03530683|Dexamethasone|dexamethasone|mesh-list
154182929|NCT03530683|Azacitidine|azacitidine|mesh-list
154182930|NCT03530683|Venetoclax|venetoclax|mesh-list
154182931|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182932|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
154182933|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
154182934|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182935|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182936|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182937|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
154182938|NCT03530683|Hormones|hormones|mesh-ancestor
154182939|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182940|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154182941|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182942|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182943|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
154182944|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182945|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182946|NCT03513484|Azacitidine|azacitidine|mesh-list
154182947|NCT03513484|Nintedanib|nintedanib|mesh-list
154182948|NCT03513484|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154182949|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182950|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
154182951|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182952|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182978|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154182979|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
154182980|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182981|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182982|NCT03180502|Temozolomide|temozolomide|mesh-list
154182983|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154182984|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
154182985|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182986|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182987|NCT03117972|Leucovorin|leucovorin|mesh-list
154182988|NCT03117972|Bevacizumab|bevacizumab|mesh-list
154182989|NCT03117972|Capecitabine|capecitabine|mesh-list
154182990|NCT03117972|Fluorouracil|fluorouracil|mesh-list
154182991|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
154182992|NCT03117972|Irinotecan|irinotecan|mesh-list
154182993|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
154182994|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182995|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182996|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182997|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182998|NCT03117972|Growth Substances|growth substances|mesh-ancestor
154182999|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183000|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
154183016|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154183017|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
154183018|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183019|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183020|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154183021|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183022|NCT02937818|Carboplatin|carboplatin|mesh-list
154183023|NCT02937818|Durvalumab|durvalumab|mesh-list
154183024|NCT02937818|Olaparib|olaparib|mesh-list
154256232|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183026|NCT02937818|Adavosertib|adavosertib|mesh-list
154183027|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183028|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183029|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154183030|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183031|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183032|NCT02916511|Paclitaxel|paclitaxel|mesh-list
154183033|NCT02916511|Carboplatin|carboplatin|mesh-list
154183034|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154183035|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183036|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
154183037|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
154183038|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
154183039|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183040|NCT02864394|Docetaxel|docetaxel|mesh-list
154183041|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
154183042|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183043|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
154183044|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
154183045|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
154183046|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183047|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183048|NCT02864394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154183049|NCT02684006|Sunitinib|sunitinib|mesh-list
154183050|NCT02684006|Avelumab|avelumab|mesh-list
154183051|NCT02684006|Axitinib|axitinib|mesh-list
154183052|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183053|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154183054|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154183055|NCT02684006|Growth Substances|growth substances|mesh-ancestor
154183056|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183057|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
154183058|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154183059|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183060|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183061|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183077|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183078|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183079|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
154183080|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154183081|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
154183082|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183083|NCT02583672|Expectorants|expectorants|mesh-ancestor
154183084|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
154183085|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154183086|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
154183087|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183088|NCT02583672|Protective Agents|protective agents|mesh-ancestor
154183089|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183090|NCT02583672|Antidotes|antidotes|mesh-ancestor
154183091|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
154183092|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154183093|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154183094|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183095|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
154183096|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183097|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183107|NCT02491528|Insulin|insulin|mesh-list
154183108|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154183109|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
154183110|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
154183111|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154183112|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154183113|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183114|NCT02464878|Etanercept|etanercept|mesh-list
154183115|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
154183116|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154183117|NCT02464878|Basiliximab|basiliximab|mesh-list
154183118|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154183119|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
154183120|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154183121|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154183122|NCT02464878|Analgesics|analgesics|mesh-ancestor
154183123|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
154183124|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183125|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183126|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183127|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154183128|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153784138|NCT00414245|Metformin|metformin|mesh-list
154183129|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154183130|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
154183131|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154183154|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183155|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
154183156|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
154183157|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
154183158|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183159|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154183160|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
154183161|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183162|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154183163|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154183164|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
154183165|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154183166|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154183167|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154183168|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154183169|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183170|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
154183171|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154183172|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183173|NCT00670358|Prednisone|prednisone|mesh-list
154183174|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
154183175|NCT00670358|Rituximab|rituximab|mesh-list
154183176|NCT00670358|Doxorubicin|doxorubicin|mesh-list
154183177|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154183178|NCT00670358|Vincristine|vincristine|mesh-list
154183179|NCT00670358|Lenalidomide|lenalidomide|mesh-list
154183180|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154183181|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
154183182|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183183|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154183184|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154183185|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
154183186|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183187|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183188|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154183215|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
154183216|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
154183217|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183219|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
154183220|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
154183221|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154183222|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183223|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
154183224|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183225|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
154183226|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183227|NCT06050343|Insulin|insulin|mesh-list
154183228|NCT06050343|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154183229|NCT06050343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154183230|NCT06050343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183231|NCT06050200|Liver Extracts|liver extracts|mesh-list
154183232|NCT06050200|Hematinics|hematinics|mesh-ancestor
154183233|NCT06050044|Bupivacaine|bupivacaine|mesh-list
154183234|NCT06050044|Anesthetics, Local|anesthetics, local|mesh-ancestor
154183235|NCT06050044|Anesthetics|anesthetics|mesh-ancestor
154183236|NCT06050044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183237|NCT06050044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183238|NCT06050044|Sensory System Agents|sensory system agents|mesh-ancestor
154183247|NCT06049966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183248|NCT06049966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154183249|NCT06049966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154183250|NCT06049966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154183251|NCT06049966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183252|NCT06049966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183253|NCT06049966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154183254|NCT06049966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183255|NCT06049901|Nitazoxanide|nitazoxanide|mesh-list
154183256|NCT06049901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154183257|NCT06049901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183258|NCT06049758|Levofloxacin|levofloxacin|mesh-list
154183259|NCT06049758|Enoxaparin|enoxaparin|mesh-list
154183260|NCT06049758|Anticoagulants|anticoagulants|mesh-ancestor
154183261|NCT06049758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154183262|NCT06049758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154183263|NCT06049758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183264|NCT06049758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154183265|NCT06049758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183266|NCT06049758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154183267|NCT06049758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154183268|NCT06049758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154183269|NCT06049758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183270|NCT06049758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183271|NCT06049758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154183272|NCT06049758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154183273|NCT06049745|Misoprostol|misoprostol|mesh-list
154183274|NCT06049745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154183275|NCT06049745|Abortifacient Agents|abortifacient agents|mesh-ancestor
154183276|NCT06049745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154183277|NCT06049745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183278|NCT06049745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154183279|NCT06049745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154183280|NCT06049745|Oxytocics|oxytocics|mesh-ancestor
154183281|NCT06049186|Metformin|metformin|mesh-list
154183282|NCT06049186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154183283|NCT06049186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183284|NCT06048874|Ropivacaine|ropivacaine|mesh-list
154183285|NCT06048874|Anesthetics, Local|anesthetics, local|mesh-ancestor
154183286|NCT06048874|Anesthetics|anesthetics|mesh-ancestor
154183287|NCT06048874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183288|NCT06048874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183289|NCT06048874|Sensory System Agents|sensory system agents|mesh-ancestor
154183290|NCT06048874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183291|NCT06048848|Ropivacaine|ropivacaine|mesh-list
154183292|NCT06048848|Anesthetics, Local|anesthetics, local|mesh-ancestor
154183293|NCT06048848|Anesthetics|anesthetics|mesh-ancestor
154183294|NCT06048848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183295|NCT06048848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183296|NCT06048848|Sensory System Agents|sensory system agents|mesh-ancestor
154183297|NCT06048848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183298|NCT06048341|Ropivacaine|ropivacaine|mesh-list
154183299|NCT06048341|Anesthetics, Local|anesthetics, local|mesh-ancestor
154183300|NCT06048341|Anesthetics|anesthetics|mesh-ancestor
154183301|NCT06048341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183302|NCT06048341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183303|NCT06048341|Sensory System Agents|sensory system agents|mesh-ancestor
154183304|NCT06048341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183305|NCT06045884|Ropivacaine|ropivacaine|mesh-list
154183329|NCT06044805|Antinematodal Agents|antinematodal agents|mesh-ancestor
154183330|NCT06044805|Anthelmintics|anthelmintics|mesh-ancestor
154183331|NCT06044779|Bupivacaine|bupivacaine|mesh-list
154183332|NCT06044779|Anesthetics, Local|anesthetics, local|mesh-ancestor
154183333|NCT06044779|Anesthetics|anesthetics|mesh-ancestor
154183334|NCT06044779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183335|NCT06044779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183336|NCT06044779|Sensory System Agents|sensory system agents|mesh-ancestor
154183337|NCT06044779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183338|NCT06040060|Ketamine|ketamine|mesh-list
154183339|NCT06040060|Analgesics|analgesics|mesh-ancestor
154183340|NCT06040060|Sensory System Agents|sensory system agents|mesh-ancestor
154183341|NCT06040060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183342|NCT06040060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183343|NCT06040060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154183344|NCT06040060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154183345|NCT06040060|Anesthetics, General|anesthetics, general|mesh-ancestor
154183346|NCT06040060|Anesthetics|anesthetics|mesh-ancestor
154183347|NCT06040060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183348|NCT06040060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154183349|NCT06040060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154183350|NCT06040060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183351|NCT06040060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183352|NCT06040034|Lidocaine|lidocaine|mesh-list
154183354|NCT06040034|Anesthetics|anesthetics|mesh-ancestor
154183355|NCT06040034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183356|NCT06040034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183357|NCT06040034|Sensory System Agents|sensory system agents|mesh-ancestor
154183368|NCT06038981|Hemostatics|hemostatics|mesh-ancestor
154183369|NCT06038981|Coagulants|coagulants|mesh-ancestor
154183370|NCT05990400|Minoxidil|minoxidil|mesh-list
154183371|NCT05990400|Finasteride|finasteride|mesh-list
154183372|NCT05990400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154183373|NCT05990400|Vasodilator Agents|vasodilator agents|mesh-ancestor
154183374|NCT05990400|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154183375|NCT05990400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154183376|NCT05990400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183377|NCT05990400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183378|NCT05990400|Hormone Antagonists|hormone antagonists|mesh-ancestor
154183379|NCT05990400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183380|NCT05990400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183381|NCT05990400|Urological Agents|urological agents|mesh-ancestor
154183382|NCT05855577|Terazosin|terazosin|mesh-list
154183383|NCT05855577|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154183384|NCT05855577|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154183385|NCT05855577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154183386|NCT05855577|Adrenergic Agents|adrenergic agents|mesh-ancestor
154183387|NCT05855577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183388|NCT05855577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183389|NCT05855577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183390|NCT05855577|Urological Agents|urological agents|mesh-ancestor
154183391|NCT05809453|Lidocaine|lidocaine|mesh-list
154183392|NCT05809453|Cocaine|cocaine|mesh-list
154183393|NCT05809453|Anesthetics, Local|anesthetics, local|mesh-ancestor
154183394|NCT05809453|Anesthetics|anesthetics|mesh-ancestor
154183395|NCT05809453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183396|NCT05809453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183397|NCT05809453|Sensory System Agents|sensory system agents|mesh-ancestor
154183398|NCT05809453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183399|NCT05809453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154183400|NCT05809453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154183401|NCT05809453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154183402|NCT05809453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154183403|NCT05809453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183404|NCT05809453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154183405|NCT05809453|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154183406|NCT05809453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154183407|NCT05809453|Dopamine Agents|dopamine agents|mesh-ancestor
154183408|NCT05809453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183409|NCT05694819|Goserelin|goserelin|mesh-list
154183410|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154183411|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183412|NCT05668988|Carboplatin|carboplatin|mesh-list
154183413|NCT05668988|Pemetrexed|pemetrexed|mesh-list
154183414|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183415|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183416|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183417|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154183418|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154183435|NCT05590455|Adalimumab|adalimumab|mesh-list
154183436|NCT05590455|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154183437|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183438|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154183439|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154183440|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154183441|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183443|NCT05580003|Midazolam|midazolam|mesh-list
154183444|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153784789|NCT05876715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784826|NCT05815758|Dermatologic Agents|dermatologic agents|mesh-ancestor
154183445|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154183446|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183447|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183448|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154183449|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154183450|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154183451|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154183452|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
154256233|NCT03879590|Budesonide|budesonide|mesh-list
154183453|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
154183454|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
154183455|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
154183456|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183457|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183458|NCT05580003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154183459|NCT05580003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183460|NCT05580003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154183461|NCT05580003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154183462|NCT05580003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183463|NCT05580003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183464|NCT05572229|Lenalidomide|lenalidomide|mesh-list
154183465|NCT05572229|Daratumumab|daratumumab|mesh-list
154183466|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
154183467|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183468|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154183469|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154183470|NCT05572229|Growth Substances|growth substances|mesh-ancestor
154183471|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
154183472|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183473|NCT05569408|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154183474|NCT05569408|Antiviral Agents|antiviral agents|mesh-ancestor
154183475|NCT05569408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183476|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154183477|NCT05508152|Amoxicillin|amoxicillin|mesh-list
154183478|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
154183479|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
154183503|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
154183504|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154183505|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154183506|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
154183507|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
154183508|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183509|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183510|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183511|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154183512|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154183513|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183514|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154183515|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154183516|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154183517|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
154183518|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154183519|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154183520|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
154183521|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154183522|NCT05448547|Hormones|hormones|mesh-list
154183523|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183524|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183525|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
154183526|NCT05446779|Epinephrine|epinephrine|mesh-list
154183527|NCT05446779|Racepinephrine|racepinephrine|mesh-list
154183528|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
154183553|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183554|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154183555|NCT05323812|Edaravone|edaravone|mesh-list
154183556|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154183557|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
154183558|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183559|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154183560|NCT05323812|Protective Agents|protective agents|mesh-ancestor
154183561|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183562|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154183563|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183564|NCT05254236|Vaccines|vaccines|mesh-list
154183565|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
154183566|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183567|NCT05159245|Trastuzumab|trastuzumab|mesh-list
154183568|NCT05159245|Atezolizumab|atezolizumab|mesh-list
154183569|NCT05159245|Pertuzumab|pertuzumab|mesh-list
154183570|NCT05159245|Trametinib|trametinib|mesh-list
154183571|NCT05159245|Dabrafenib|dabrafenib|mesh-list
154183572|NCT05159245|Vemurafenib|vemurafenib|mesh-list
154183573|NCT05159245|Pralsetinib|pralsetinib|mesh-list
154183574|NCT05159245|Alectinib|alectinib|mesh-list
154183575|NCT05159245|Entrectinib|entrectinib|mesh-list
154183576|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183578|NCT05159245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154183579|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183580|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154183581|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183611|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154183612|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183613|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183614|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
154183615|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154183616|NCT05041842|Trastuzumab|trastuzumab|mesh-list
154183617|NCT05041842|Pertuzumab|pertuzumab|mesh-list
154183618|NCT05041842|Tucatinib|tucatinib|mesh-list
154183619|NCT05041842|Hormones|hormones|mesh-list
154183620|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183621|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183622|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183623|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183624|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154183625|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183634|NCT04995835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154183635|NCT04995835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183636|NCT04922034|Amoxicillin|amoxicillin|mesh-list
154183637|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154183638|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183639|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
154183640|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154183641|NCT04843917|Antibodies|antibodies|mesh-list
154183642|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
154183643|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
154183644|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183645|NCT04791514|Treprostinil|treprostinil|mesh-list
154183646|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154183647|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
154183648|NCT04789096|Trastuzumab|trastuzumab|mesh-list
154183649|NCT04789096|Capecitabine|capecitabine|mesh-list
154183650|NCT04789096|Tucatinib|tucatinib|mesh-list
154183651|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183652|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183653|NCT04789096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154183654|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183655|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154183656|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
154183657|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154183658|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183659|NCT04598451|Prednisone|prednisone|mesh-list
154183660|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785042|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
154183661|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
154183662|NCT04598451|Hormones|hormones|mesh-ancestor
154183663|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183664|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183665|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154183666|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183667|NCT04561466|Bezafibrate|bezafibrate|mesh-list
154183668|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154183669|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
154183670|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183671|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154183672|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
154183673|NCT04553263|Naltrexone|naltrexone|mesh-list
154183674|NCT04553263|Bupropion|bupropion|mesh-list
154183675|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154183676|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154183677|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183678|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
154183679|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183680|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154183681|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
154183682|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154183683|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154183684|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256235|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154256236|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154256237|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
154256238|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183685|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154183686|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183687|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
154183688|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183689|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154183690|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154183691|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183707|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183709|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154183710|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
154183711|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154183712|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
154183713|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183714|NCT04454476|Trametinib|trametinib|mesh-list
154183715|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785149|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154183716|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154183717|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183718|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183719|NCT04452461|Leucovorin|leucovorin|mesh-list
154183720|NCT04452461|Paclitaxel|paclitaxel|mesh-list
154183721|NCT04452461|Gemcitabine|gemcitabine|mesh-list
154183722|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
154183723|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154183724|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183725|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
154183726|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
154183727|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
154183728|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183729|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154183730|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
154183731|NCT04452461|Antidotes|antidotes|mesh-ancestor
154183732|NCT04452461|Protective Agents|protective agents|mesh-ancestor
154183733|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183734|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
154183735|NCT04452461|Vitamins|vitamins|mesh-ancestor
154183736|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
154183737|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154183738|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154183739|NCT04278404|Metformin|metformin|mesh-list
154183740|NCT04278404|Interferons|interferons|mesh-list
154183741|NCT04278404|Ritonavir|ritonavir|mesh-list
154183742|NCT04278404|Ribavirin|ribavirin|mesh-list
154183743|NCT04278404|Lopinavir|lopinavir|mesh-list
154183744|NCT04278404|Oseltamivir|oseltamivir|mesh-list
154183745|NCT04278404|Remdesivir|remdesivir|mesh-list
154183747|NCT04278404|Clindamycin|clindamycin|mesh-list
154183748|NCT04278404|Meropenem|meropenem|mesh-list
154183749|NCT04278404|Voriconazole|voriconazole|mesh-list
154183750|NCT04278404|Ceftazidime|ceftazidime|mesh-list
154183751|NCT04278404|Cefepime|cefepime|mesh-list
154183752|NCT04278404|Fosfomycin|fosfomycin|mesh-list
154183753|NCT04278404|Cefdinir|cefdinir|mesh-list
154183754|NCT04278404|Dexamethasone|dexamethasone|mesh-list
154183755|NCT04278404|Budesonide|budesonide|mesh-list
154183756|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
154183757|NCT04278404|Colchicine|colchicine|mesh-list
154183758|NCT04278404|Amiodarone|amiodarone|mesh-list
154183759|NCT04278404|Bosentan|bosentan|mesh-list
154183779|NCT04278404|Terbutaline|terbutaline|mesh-list
154183780|NCT04278404|Sevelamer|sevelamer|mesh-list
154183781|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183782|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
154183783|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
154183784|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183785|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183786|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154183787|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
154183788|NCT04278404|Hormones|hormones|mesh-ancestor
154183789|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183790|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154183791|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183792|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
154183793|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183794|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183795|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154183796|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154183797|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183798|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154183800|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
154183801|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154183802|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154183803|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154183804|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
154183805|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183806|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
154183807|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183808|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154183809|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154183810|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154183811|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154183812|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154183813|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154183814|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154183815|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154183816|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154183817|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
154183818|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154183819|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
154183820|NCT04278404|Coagulants|coagulants|mesh-ancestor
154183821|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154183822|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154183823|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
154183824|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154183825|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154183841|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154183842|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154183843|NCT04278404|Diuretics|diuretics|mesh-ancestor
154183844|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
154183845|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154183846|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
154183847|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
154183848|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
154183849|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
154183850|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154183851|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
154183852|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154183853|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154183854|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154183855|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154183856|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
154183857|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
154183858|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154183859|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
154183860|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154183861|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154183862|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154183863|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154183864|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
154183865|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
154183866|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154183867|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154183868|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154183869|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154183870|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154183871|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154183872|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154183873|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
154183874|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154183875|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154183876|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154183877|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154183878|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
154183879|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
154183880|NCT04278404|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154183881|NCT04278404|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154003167|NCT05860452|Ropivacaine|ropivacaine|mesh-list
154256239|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256240|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154183882|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154183883|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154183884|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154183895|NCT04166071|Naltrexone|naltrexone|mesh-list
154183896|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154183897|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154183898|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183899|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
154183900|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183901|NCT06083129|Thymoglobulin|thymoglobulin|mesh-list
154183902|NCT06083129|Immunologic Factors|immunologic factors|mesh-ancestor
154183903|NCT06083129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183904|NCT06083129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154183905|NCT06083116|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154183906|NCT06083116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154183907|NCT06083116|Diuretics|diuretics|mesh-ancestor
154183908|NCT06083116|Natriuretic Agents|natriuretic agents|mesh-ancestor
154183909|NCT06083116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183910|NCT06083116|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154183911|NCT06083116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154183912|NCT06083116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183913|NCT06082973|Insulin|insulin|mesh-list
154183914|NCT06082973|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154183915|NCT06082973|Glucagon|glucagon|mesh-list
154183916|NCT06082973|Hormones|hormones|mesh-list
154183917|NCT06082973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154183918|NCT06082973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183919|NCT06082973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183920|NCT06082973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154183921|NCT06082934|Dexamethasone|dexamethasone|mesh-list
154183922|NCT06082934|Venetoclax|venetoclax|mesh-list
154183923|NCT06082934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183924|NCT06082934|Antiemetics|antiemetics|mesh-ancestor
154183925|NCT06082934|Autonomic Agents|autonomic agents|mesh-ancestor
154183926|NCT06082934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183927|NCT06082934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183928|NCT06082934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154183929|NCT06082934|Glucocorticoids|glucocorticoids|mesh-ancestor
154183930|NCT06082934|Hormones|hormones|mesh-ancestor
154183931|NCT06082934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183932|NCT06082934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154183933|NCT06082934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183934|NCT06082635|Crizotinib|crizotinib|mesh-list
154183935|NCT06082635|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154183936|NCT06082635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154183937|NCT06082635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183938|NCT06082635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183939|NCT06082635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183940|NCT06082622|Laxatives|laxatives|mesh-list
154183941|NCT06082622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154183942|NCT06082531|Hyaluronic Acid|hyaluronic acid|mesh-list
154183943|NCT06082531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154183944|NCT06082531|Immunologic Factors|immunologic factors|mesh-ancestor
154183945|NCT06082531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183946|NCT06082531|Viscosupplements|viscosupplements|mesh-ancestor
154183947|NCT06082531|Protective Agents|protective agents|mesh-ancestor
154183948|NCT06082388|Atropine|atropine|mesh-list
154183949|NCT06082388|Isoproterenol|isoproterenol|mesh-list
154183959|NCT06082388|Parasympatholytics|parasympatholytics|mesh-ancestor
154183960|NCT06082388|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154183961|NCT06082388|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154183962|NCT06082388|Cholinergic Agents|cholinergic agents|mesh-ancestor
154183963|NCT06082388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183964|NCT06082388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183965|NCT06082388|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154183966|NCT06082388|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154183967|NCT06082388|Adrenergic Agents|adrenergic agents|mesh-ancestor
154183968|NCT06082388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154183969|NCT06082388|Sympathomimetics|sympathomimetics|mesh-ancestor
154183970|NCT06082388|Protective Agents|protective agents|mesh-ancestor
154183971|NCT06082375|Vitamin D|vitamin d|mesh-list
154183972|NCT06082375|Cholecalciferol|cholecalciferol|mesh-list
154183973|NCT06082375|Vitamins|vitamins|mesh-ancestor
154183974|NCT06082375|Micronutrients|micronutrients|mesh-ancestor
154183975|NCT06082375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183976|NCT06082375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154183977|NCT06082375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153930954|NCT02821468|Acetaminophen|acetaminophen|mesh-list
154183978|NCT06082245|Lidocaine|lidocaine|mesh-list
154183979|NCT06082245|Anesthetics, Local|anesthetics, local|mesh-ancestor
154183980|NCT06082245|Anesthetics|anesthetics|mesh-ancestor
154183981|NCT06082245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183982|NCT06082245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183983|NCT06082245|Sensory System Agents|sensory system agents|mesh-ancestor
154183984|NCT06082245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183985|NCT06082245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154183986|NCT06082245|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154183987|NCT06082245|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154183988|NCT06082245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154183989|NCT06082245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183990|NCT06082076|Meperidine|meperidine|mesh-list
154183991|NCT06082076|Dexmedetomidine|dexmedetomidine|mesh-list
154183992|NCT06082076|Ketamine|ketamine|mesh-list
154183993|NCT06082076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154183994|NCT06082076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183995|NCT06082076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183996|NCT06082076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154183997|NCT06082076|Analgesics|analgesics|mesh-ancestor
154183998|NCT06082076|Sensory System Agents|sensory system agents|mesh-ancestor
154183999|NCT06082076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184000|NCT06082076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154184001|NCT06082076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154184002|NCT06082076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154184003|NCT06082076|Adrenergic Agents|adrenergic agents|mesh-ancestor
154184004|NCT06082076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184005|NCT06082076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184006|NCT06082076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154184007|NCT06082076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154184008|NCT06082076|Anesthetics, General|anesthetics, general|mesh-ancestor
154184009|NCT06082076|Anesthetics|anesthetics|mesh-ancestor
154184010|NCT06082076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154184011|NCT06082076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154184012|NCT06082076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154184013|NCT06082076|Narcotics|narcotics|mesh-ancestor
154184014|NCT06082076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154184028|NCT06082063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184029|NCT06082063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154184030|NCT06082063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154184031|NCT06082063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184032|NCT06082063|Antipyretics|antipyretics|mesh-ancestor
154184033|NCT06082063|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154184034|NCT06082063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154184035|NCT06082063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154184036|NCT06081959|Gemcitabine|gemcitabine|mesh-list
154184037|NCT06081959|Capecitabine|capecitabine|mesh-list
154184038|NCT06081959|Vinorelbine|vinorelbine|mesh-list
154184039|NCT06081959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154184040|NCT06081959|Antimetabolites|antimetabolites|mesh-ancestor
154184041|NCT06081959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184042|NCT06081959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184043|NCT06081959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154184044|NCT06081959|Tubulin Modulators|tubulin modulators|mesh-ancestor
154184045|NCT06081959|Antimitotic Agents|antimitotic agents|mesh-ancestor
154184046|NCT06081959|Mitosis Modulators|mitosis modulators|mesh-ancestor
154184047|NCT06081933|Dexmedetomidine|dexmedetomidine|mesh-list
154184048|NCT06081933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154184049|NCT06081933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184050|NCT06081933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184051|NCT06081933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184052|NCT06081933|Analgesics|analgesics|mesh-ancestor
154184053|NCT06081933|Sensory System Agents|sensory system agents|mesh-ancestor
154184054|NCT06081933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184055|NCT06081933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154184056|NCT06081933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154184057|NCT06081933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154184058|NCT06081933|Adrenergic Agents|adrenergic agents|mesh-ancestor
154184059|NCT06081933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184060|NCT06081933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184061|NCT06081868|Fluorides|fluorides|mesh-list
154184062|NCT06081868|Fluorides, Topical|fluorides, topical|mesh-list
154184063|NCT06081868|Cariostatic Agents|cariostatic agents|mesh-ancestor
154184064|NCT06081868|Protective Agents|protective agents|mesh-ancestor
154184065|NCT06081868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184066|NCT06081842|Contraceptive Agents|contraceptive agents|mesh-list
154184067|NCT06081842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154184068|NCT06081842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184069|NCT06081803|Evolocumab|evolocumab|mesh-list
154184070|NCT06081803|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154184071|NCT06081803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154184072|NCT06081803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154184073|NCT06081803|Antimetabolites|antimetabolites|mesh-ancestor
154184080|NCT06081738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154184081|NCT06081738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184082|NCT06081738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184083|NCT06081738|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184084|NCT06081738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184085|NCT06081738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184086|NCT06081738|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154184087|NCT06081738|Autonomic Agents|autonomic agents|mesh-ancestor
154184088|NCT06081738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184090|NCT06081673|Cisplatin|cisplatin|mesh-list
154184091|NCT06081673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154184092|NCT06081673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184093|NCT06081673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154184094|NCT06081673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154184095|NCT06081673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154184096|NCT06081673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184097|NCT06081595|Apatinib|apatinib|mesh-list
154184098|NCT06081595|Fluzoparib|fluzoparib|mesh-list
154184099|NCT06081595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184100|NCT06081595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184101|NCT06081595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184102|NCT06081595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184103|NCT06081595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154184104|NCT06081582|Cisplatin|cisplatin|mesh-list
154184105|NCT06081582|Cetuximab|cetuximab|mesh-list
154184106|NCT06081582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184107|NCT06081582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184108|NCT06081387|Vitamin D|vitamin d|mesh-list
154184109|NCT06081387|Vitamins|vitamins|mesh-ancestor
154184110|NCT06081387|Micronutrients|micronutrients|mesh-ancestor
154184111|NCT06081387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184112|NCT06081387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154184113|NCT06078384|Paclitaxel|paclitaxel|mesh-list
154184114|NCT06078384|Pembrolizumab|pembrolizumab|mesh-list
154184115|NCT06078384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154184116|NCT06078384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184117|NCT06078384|Tubulin Modulators|tubulin modulators|mesh-ancestor
154184118|NCT06078384|Antimitotic Agents|antimitotic agents|mesh-ancestor
154184119|NCT06078384|Mitosis Modulators|mitosis modulators|mesh-ancestor
154184120|NCT06078384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184121|NCT06078384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184122|NCT06078384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154184123|NCT06078215|Cerebrolysin|cerebrolysin|mesh-list
154184124|NCT06078215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154184125|NCT06078215|Protective Agents|protective agents|mesh-ancestor
154184126|NCT06078215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184127|NCT06078215|Nootropic Agents|nootropic agents|mesh-ancestor
154184129|NCT06076551|Analgesics|analgesics|mesh-ancestor
154184130|NCT06076551|Sensory System Agents|sensory system agents|mesh-ancestor
154184131|NCT06076551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184132|NCT06076551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184133|NCT06076551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154184134|NCT06076551|Vasodilator Agents|vasodilator agents|mesh-ancestor
154184135|NCT06076551|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154184136|NCT06076551|Purinergic Agonists|purinergic agonists|mesh-ancestor
154184137|NCT06076551|Purinergic Agents|purinergic agents|mesh-ancestor
154184138|NCT06076551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184139|NCT06076551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184140|NCT06063941|Iodine|iodine|mesh-list
154184141|NCT06063941|Cadexomer iodine|cadexomer iodine|mesh-list
154184142|NCT06063941|Lugol's solution|lugol's solution|mesh-list
154184143|NCT06063941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154184158|NCT06034288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184159|NCT06034288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154184160|NCT06034288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154184161|NCT06034288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184162|NCT06034288|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184163|NCT06034288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184165|NCT06012175|Antioxidants|antioxidants|mesh-ancestor
154184166|NCT06012175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184167|NCT06012175|Protective Agents|protective agents|mesh-ancestor
154184168|NCT06012175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184169|NCT06012175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184170|NCT06003348|Potassium Citrate|potassium citrate|mesh-list
154184171|NCT06003348|Diuretics|diuretics|mesh-ancestor
154184172|NCT06003348|Natriuretic Agents|natriuretic agents|mesh-ancestor
154184173|NCT06003348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184174|NCT06003348|Expectorants|expectorants|mesh-ancestor
154184175|NCT06003348|Respiratory System Agents|respiratory system agents|mesh-ancestor
154184176|NCT05994638|Niacinamide|niacinamide|mesh-list
154184177|NCT05994638|Hyaluronic Acid|hyaluronic acid|mesh-list
154184179|NCT05994638|Micronutrients|micronutrients|mesh-ancestor
154184180|NCT05994638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184181|NCT05994638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154184182|NCT05994638|Immunologic Factors|immunologic factors|mesh-ancestor
154184183|NCT05994638|Viscosupplements|viscosupplements|mesh-ancestor
154184184|NCT05994638|Protective Agents|protective agents|mesh-ancestor
154184185|NCT05994638|Vitamin B Complex|vitamin b complex|mesh-ancestor
154184186|NCT05947162|Nicotine|nicotine|mesh-list
154184187|NCT05947162|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154184188|NCT05947162|Autonomic Agents|autonomic agents|mesh-ancestor
154184189|NCT05947162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184190|NCT05947162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184191|NCT05947162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154184192|NCT05947162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154184193|NCT05947162|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184194|NCT05947162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184195|NCT05947162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184196|NCT05945680|Tranexamic Acid|tranexamic acid|mesh-list
154184197|NCT05945680|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154184198|NCT05945680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154184199|NCT05945680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184200|NCT05945680|Hemostatics|hemostatics|mesh-ancestor
154184201|NCT05945680|Coagulants|coagulants|mesh-ancestor
154184202|NCT05943795|Docetaxel|docetaxel|mesh-list
154184203|NCT05943795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184204|NCT05943795|Tubulin Modulators|tubulin modulators|mesh-ancestor
154184205|NCT05943795|Antimitotic Agents|antimitotic agents|mesh-ancestor
154184206|NCT05943795|Mitosis Modulators|mitosis modulators|mesh-ancestor
154184220|NCT05880849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154184221|NCT05880849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154184222|NCT05880849|Nootropic Agents|nootropic agents|mesh-ancestor
154184223|NCT05878015|Acetaminophen|acetaminophen|mesh-list
154184224|NCT05878015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184225|NCT05878015|Analgesics|analgesics|mesh-ancestor
154184226|NCT05878015|Sensory System Agents|sensory system agents|mesh-ancestor
154184227|NCT05878015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184228|NCT05878015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184229|NCT05878015|Antipyretics|antipyretics|mesh-ancestor
154184230|NCT05844657|Ferrous fumarate|ferrous fumarate|mesh-list
154184231|NCT05844657|Trace Elements|trace elements|mesh-ancestor
154184232|NCT05844657|Micronutrients|micronutrients|mesh-ancestor
154184233|NCT05844657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184234|NCT05816226|Hydrocortisone|hydrocortisone|mesh-list
154184235|NCT05816226|Diclofenac|diclofenac|mesh-list
154184236|NCT05816226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184237|NCT05816226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154184238|NCT05816226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184239|NCT05816226|Analgesics|analgesics|mesh-ancestor
154184240|NCT05816226|Sensory System Agents|sensory system agents|mesh-ancestor
154184241|NCT05816226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184242|NCT05816226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184243|NCT05816226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184244|NCT05816226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154184245|NCT05816226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256241|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
154184246|NCT05816226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184247|NCT05771779|Vaccines|vaccines|mesh-list
154184248|NCT05771779|Immunologic Factors|immunologic factors|mesh-ancestor
154184249|NCT05771779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184250|NCT05753670|Tamsulosin|tamsulosin|mesh-list
154184251|NCT05753670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154184252|NCT05753670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154184253|NCT05753670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154184254|NCT05753670|Adrenergic Agents|adrenergic agents|mesh-ancestor
154184255|NCT05753670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184256|NCT05753670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184257|NCT05753670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184258|NCT05753670|Urological Agents|urological agents|mesh-ancestor
154184259|NCT05742698|Dronabinol|dronabinol|mesh-list
154184260|NCT05742698|Nabilone|nabilone|mesh-list
154184261|NCT05742698|Antiemetics|antiemetics|mesh-ancestor
154184262|NCT05742698|Autonomic Agents|autonomic agents|mesh-ancestor
154184263|NCT05742698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184264|NCT05742698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184265|NCT05742698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154184266|NCT05742698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154184267|NCT05742698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154184268|NCT05742698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184276|NCT05742698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184277|NCT05742698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184279|NCT05742698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154184280|NCT05731960|Dexamethasone|dexamethasone|mesh-list
154184281|NCT05731960|Metoclopramide|metoclopramide|mesh-list
154184282|NCT05731960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184283|NCT05731960|Antiemetics|antiemetics|mesh-ancestor
154184284|NCT05731960|Autonomic Agents|autonomic agents|mesh-ancestor
154184285|NCT05731960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184286|NCT05731960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184287|NCT05731960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154184288|NCT05731960|Glucocorticoids|glucocorticoids|mesh-ancestor
154184289|NCT05731960|Hormones|hormones|mesh-ancestor
154184290|NCT05731960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154184291|NCT05731960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154184292|NCT05731960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184293|NCT05731960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154184294|NCT05731960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154184295|NCT05731960|Dopamine Agents|dopamine agents|mesh-ancestor
154184296|NCT05731960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184297|NCT05731960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184298|NCT05688436|Interferons|interferons|mesh-list
154184299|NCT05688436|Interferon-beta|interferon-beta|mesh-list
154184300|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
154184301|NCT05688436|Ofatumumab|ofatumumab|mesh-list
154184302|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
154184303|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
154184304|NCT05688436|Natalizumab|natalizumab|mesh-list
154184305|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154184306|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
154184307|NCT05688436|Ozanimod|ozanimod|mesh-list
154184308|NCT05688436|Ponesimod|ponesimod|mesh-list
154184309|NCT05688436|Siponimod|siponimod|mesh-list
154184310|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184311|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
154184312|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786345|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
154184313|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184314|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
154184315|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184316|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154184317|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184318|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154184319|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154184320|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184321|NCT05637515|Adalimumab|adalimumab|mesh-list
154184322|NCT05637515|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154184323|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184324|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184325|NCT05635162|Rituximab|rituximab|mesh-list
154184326|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
154184327|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154256242|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
154256243|NCT03879590|Hormones|hormones|mesh-ancestor
154184328|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184329|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
154184330|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184331|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184332|NCT05635162|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154184333|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184334|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184335|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184336|NCT05614544|Propofol|propofol|mesh-list
154184337|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154184356|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
154184357|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184358|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154184360|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154184361|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
154184362|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184363|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184364|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154184365|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154184366|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184367|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184368|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184369|NCT05493657|Aspirin|aspirin|mesh-list
154184370|NCT05493657|Clopidogrel|clopidogrel|mesh-list
154184371|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154184372|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184373|NCT05493657|Analgesics|analgesics|mesh-ancestor
154184374|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
154184375|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184376|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184377|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184378|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184379|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154184380|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154184381|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184382|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154184383|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154184384|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184385|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
154184386|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154184387|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154184388|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154184389|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
154184453|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184454|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
154184455|NCT05287464|Nivolumab|nivolumab|mesh-list
154184456|NCT05287464|Ipilimumab|ipilimumab|mesh-list
154184457|NCT05287464|Atezolizumab|atezolizumab|mesh-list
154184458|NCT05287464|Avelumab|avelumab|mesh-list
154184459|NCT05287464|Lenvatinib|lenvatinib|mesh-list
154184460|NCT05287464|Axitinib|axitinib|mesh-list
153786451|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
154184461|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184462|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184463|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154184464|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184465|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184466|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184467|NCT05275907|Amlodipine|amlodipine|mesh-list
154184468|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
154184469|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154184470|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154184471|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154184472|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184473|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154184474|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184501|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184502|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184503|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154184504|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
153931470|NCT00680095|Tavaborole|tavaborole|mesh-list
154263448|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
154184505|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184506|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184507|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154184508|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184509|NCT05197842|Hormones|hormones|mesh-ancestor
154184510|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154184511|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154184512|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
154184513|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154184514|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184515|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154184516|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184517|NCT05107219|Linaclotide|linaclotide|mesh-list
154184518|NCT05107219|Plecanatide|plecanatide|mesh-list
154184519|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154184520|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
154184521|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184548|NCT05048797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154184549|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184550|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184551|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154184552|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154184553|NCT05048797|Immunoconjugates|immunoconjugates|mesh-ancestor
154184554|NCT05048797|Immunologic Factors|immunologic factors|mesh-ancestor
154184555|NCT05048797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184556|NCT04890236|Tisagenlecleucel|tisagenlecleucel|mesh-list
154184557|NCT04890236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184558|NCT04890236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184559|NCT04885998|AMG 757|amg 757|mesh-list
154184560|NCT04885998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184561|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
154184562|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184563|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184564|NCT04747054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154184565|NCT04747054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184566|NCT04682834|Probenecid|probenecid|mesh-list
154184567|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
154184568|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
154184569|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184570|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
154184571|NCT04643574|Fludarabine|fludarabine|mesh-list
154184579|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184580|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184581|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154184582|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184583|NCT04643574|Analgesics|analgesics|mesh-ancestor
154184584|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
154184585|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184586|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
154184587|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184588|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
154184589|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154184590|NCT04544475|Estrogens|estrogens|mesh-list
154184591|NCT04544475|Estradiol|estradiol|mesh-list
154184592|NCT04544475|Hormones|hormones|mesh-ancestor
154184593|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154184594|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184595|NCT04507438|Donepezil|donepezil|mesh-list
154184596|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154184597|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184598|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184599|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184600|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184601|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184602|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
154184603|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154184604|NCT04459273|FAPI-46|fapi-46|mesh-list
154184605|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154184606|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184607|NCT04457232|FAPI-46|fapi-46|mesh-list
154184608|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154263449|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263450|NCT05549037|Immunomodulating Agents|immunomodulating agents|mesh-list
154184609|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184610|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
154184611|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154184612|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
154184613|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154184614|NCT04381897|Expectorants|expectorants|mesh-ancestor
154184615|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
154184616|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154184617|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
154184618|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184619|NCT04381897|Protective Agents|protective agents|mesh-ancestor
154184620|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184621|NCT04381897|Antidotes|antidotes|mesh-ancestor
154184622|NCT04330690|Artesunate|artesunate|mesh-list
154184623|NCT04330690|Dexamethasone|dexamethasone|mesh-list
154184624|NCT04330690|Infliximab|infliximab|mesh-list
154184625|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
154184626|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184627|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
154184628|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
154184629|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184630|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184631|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154184632|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
154184633|NCT04330690|Hormones|hormones|mesh-ancestor
154184634|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154184635|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154184636|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184637|NCT04330690|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154184638|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184653|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184655|NCT04198116|Varenicline|varenicline|mesh-list
154184656|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154184657|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154184658|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184659|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184660|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184661|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184662|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154184663|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154184664|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154184665|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154184666|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
154184667|NCT04172844|Azacitidine|azacitidine|mesh-list
154184668|NCT04172844|Venetoclax|venetoclax|mesh-list
154184669|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154184670|NCT04172844|Pevonedistat|pevonedistat|mesh-list
154184671|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154184672|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
153786849|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184673|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184674|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184675|NCT04147494|Edetic Acid|edetic acid|mesh-list
154184676|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154184677|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154184678|NCT04147494|FAPI-46|fapi-46|mesh-list
154184679|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
154184680|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
154184681|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184682|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
154184683|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154184684|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154184685|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154184686|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154184687|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154184688|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184689|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184690|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154184691|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154184692|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184693|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184694|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256244|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256245|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
154184695|NCT04047251|Topotecan|topotecan|mesh-list
154184696|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154184697|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154184698|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184706|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184707|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
154184708|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184710|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154184711|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184712|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184713|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184714|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
154184715|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154184716|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
154184717|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184718|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184719|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154184720|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
154184721|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
154184722|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154184723|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184724|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184725|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184726|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154184727|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184728|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184729|NCT03947255|Immunotoxins|immunotoxins|mesh-ancestor
154184730|NCT03947255|Immunoconjugates|immunoconjugates|mesh-ancestor
154184731|NCT03947255|Immunologic Factors|immunologic factors|mesh-ancestor
154184732|NCT03947255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184733|NCT03929757|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154184734|NCT03929757|Antiviral Agents|antiviral agents|mesh-ancestor
154184735|NCT03929757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154184736|NCT03748823|Ravulizumab|ravulizumab|mesh-list
154184737|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154184738|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154184739|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
154184740|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184741|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
154184742|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
154184743|NCT03565913|Calcium|calcium|mesh-list
154184744|NCT03565913|Calcium acetate|calcium acetate|mesh-list
154184745|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154184746|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184747|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154184748|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
153786980|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
154184749|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
154184750|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184751|NCT03565913|Cathartics|cathartics|mesh-ancestor
154184752|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154184753|NCT03535883|Anticoagulants|anticoagulants|mesh-list
154184754|NCT03535883|Coagulants|coagulants|mesh-list
154184755|NCT03523156|Azithromycin|azithromycin|mesh-list
154184756|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154184757|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154184758|NCT03503058|Chloroquine|chloroquine|mesh-list
154184759|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154184760|NCT03503058|Amebicides|amebicides|mesh-ancestor
154184761|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154184762|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154184763|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154184764|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
154184774|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
154184775|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
154184776|NCT03428633|Morphine|morphine|mesh-list
154184777|NCT03428633|Ropivacaine|ropivacaine|mesh-list
154184778|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154184779|NCT03428633|Narcotics|narcotics|mesh-ancestor
154184780|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184781|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184782|NCT03428633|Analgesics|analgesics|mesh-ancestor
154256246|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154256247|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184783|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
154184784|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184785|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
154184786|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
154184787|NCT03330405|Avelumab|avelumab|mesh-list
154184788|NCT03330405|Talazoparib|talazoparib|mesh-list
154184789|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154184790|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184791|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184792|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
154184793|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184794|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154184795|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184796|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184797|NCT03164928|Denosumab|denosumab|mesh-list
154184798|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154184799|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184800|NCT03153280|Capecitabine|capecitabine|mesh-list
154184801|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
154184802|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154184803|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
154184804|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184805|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184806|NCT03150797|Melatonin|melatonin|mesh-list
154184807|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
154184808|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184809|NCT03150797|Protective Agents|protective agents|mesh-ancestor
154184810|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184811|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184812|NCT03096418|Paclitaxel|paclitaxel|mesh-list
154184813|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154184814|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184815|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
154184816|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
154184817|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787092|NCT00244517|Narcotics|narcotics|mesh-ancestor
154184818|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184819|NCT03074513|Bevacizumab|bevacizumab|mesh-list
154184820|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154184821|NCT03074513|Atezolizumab|atezolizumab|mesh-list
154184822|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
154184823|NCT03074513|Antibodies|antibodies|mesh-list
154184824|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
154184825|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154184826|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
154184827|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184828|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154184829|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154184830|NCT03074513|Growth Substances|growth substances|mesh-ancestor
154184863|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
154184864|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184866|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154184867|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
154184868|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154184869|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184870|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154184890|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184891|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
154184892|NCT01891981|Immunotoxins|immunotoxins|mesh-ancestor
154184893|NCT01891981|Immunoconjugates|immunoconjugates|mesh-ancestor
154184894|NCT01891981|Immunologic Factors|immunologic factors|mesh-ancestor
154184895|NCT01891981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184896|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184897|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154184898|NCT01174043|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154184899|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184900|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184901|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184902|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184903|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154184904|NCT00954226|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154256248|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256249|NCT01265108|Iron|iron|mesh-list
154184905|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184906|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184907|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184908|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184909|NCT00575549|Dobutamine|dobutamine|mesh-list
154184910|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154184911|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
154184912|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
154184913|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184914|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184915|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154184916|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154184917|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154184918|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
154184919|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184920|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184921|NCT00575549|Protective Agents|protective agents|mesh-ancestor
154184922|NCT00494728|Nicotine|nicotine|mesh-list
154184923|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154184924|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
154184935|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154184936|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
154184938|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184939|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184940|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184941|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154184942|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154184943|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184944|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154184945|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154184946|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154184947|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
154184948|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154184949|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154184950|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
154184951|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154184952|NCT00398034|Testosterone|testosterone|mesh-list
153931918|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153931919|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153931922|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
154184953|NCT00398034|Androgens|androgens|mesh-ancestor
154184954|NCT00398034|Hormones|hormones|mesh-ancestor
154184955|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154184956|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184957|NCT00329043|Sunitinib|sunitinib|mesh-list
154184958|NCT00329043|Leuprolide|leuprolide|mesh-list
154184959|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184960|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154184961|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154184962|NCT00329043|Growth Substances|growth substances|mesh-ancestor
154184963|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184964|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
154184965|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184966|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184967|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184968|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154184969|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
154184970|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154184971|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154184972|NCT00254384|Cisplatin|cisplatin|mesh-list
154184973|NCT00254384|Docetaxel|docetaxel|mesh-list
154184974|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154184975|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184976|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
154184977|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
154184978|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
154184979|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184980|NCT00254384|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154184981|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154263451|NCT05549037|Immunologic Factors|immunologic factors|mesh-ancestor
153794297|NCT00259805|Rituximab|rituximab|mesh-list
154184982|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184983|NCT00253318|Dexamethasone|dexamethasone|mesh-list
154184984|NCT00253318|Docetaxel|docetaxel|mesh-list
154184985|NCT00253318|Everolimus|everolimus|mesh-list
154184996|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184997|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
154184998|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
154184999|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
154185000|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185001|NCT00253318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154185002|NCT00253318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185003|NCT00253318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185004|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185005|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
154185006|NCT00081874|Everolimus|everolimus|mesh-list
154185007|NCT00081874|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154185008|NCT00081874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185009|NCT00081874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185010|NCT00081874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185011|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185012|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
154185013|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185014|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185015|NCT04119674|Temozolomide|temozolomide|mesh-list
154185016|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154185017|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
154185018|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185019|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185020|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
154185021|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154185022|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185023|NCT04032847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154185024|NCT04032847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185025|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
154185026|NCT03990571|Avelumab|avelumab|mesh-list
153931992|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
154185028|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154185029|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154185030|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185031|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185032|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185033|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185034|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
154185035|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185036|NCT03944434|Leuprolide|leuprolide|mesh-list
154185037|NCT03944434|Goserelin|goserelin|mesh-list
154185038|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154185039|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154185040|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154185041|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
154185042|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154185043|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185044|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185045|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185046|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
154185047|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154185048|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
154185049|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154185071|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
154185072|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185073|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154185074|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154185075|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154185076|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154185077|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185078|NCT03714815|Macitentan|macitentan|mesh-list
154185079|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154185080|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154185081|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185082|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154185083|NCT03712943|Nivolumab|nivolumab|mesh-list
154256250|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154256251|NCT01265108|Trace Elements|trace elements|mesh-ancestor
154256252|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
153736240|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
154185084|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154185085|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185086|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154185087|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185088|NCT03686488|Ramucirumab|ramucirumab|mesh-list
154185089|NCT03686488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154185090|NCT03686488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154185091|NCT03686488|Growth Substances|growth substances|mesh-ancestor
154185092|NCT03686488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185093|NCT03686488|Growth Inhibitors|growth inhibitors|mesh-ancestor
154185094|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185095|NCT03640312|Candesartan|candesartan|mesh-list
154185096|NCT03640312|Candesartan cilexetil|candesartan cilexetil|mesh-list
154185097|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154185098|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154185099|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154185110|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154185111|NCT03570827|Hormones|hormones|mesh-ancestor
154185112|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736180|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
154185113|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185114|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
154185115|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185116|NCT03570827|Protective Agents|protective agents|mesh-ancestor
154185117|NCT03570827|Vitamins|vitamins|mesh-ancestor
154185118|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
154185119|NCT03570827|Estrogens|estrogens|mesh-ancestor
154185120|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185121|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185122|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
154185123|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
154185124|NCT03404310|Astringents|astringents|mesh-ancestor
154185125|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185126|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
154185127|NCT03387553|Immunomodulating Agents|immunomodulating agents|mesh-list
154185128|NCT03387553|Immunologic Factors|immunologic factors|mesh-ancestor
154185129|NCT03387553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185130|NCT03367533|Ketamine|ketamine|mesh-list
154185131|NCT03367533|Analgesics|analgesics|mesh-ancestor
154185132|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
154185133|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185134|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185135|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154185136|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154185137|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
154185138|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
154185139|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154185140|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154185141|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154185142|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185143|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185144|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
154185145|NCT03299088|Trametinib|trametinib|mesh-list
154185146|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154185147|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185148|NCT03299088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154185149|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185150|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185151|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185152|NCT03272464|Trametinib|trametinib|mesh-list
154185153|NCT03272464|Dabrafenib|dabrafenib|mesh-list
154185154|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185155|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185156|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185157|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185158|NCT03263481|Secretin|secretin|mesh-list
154185159|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154185160|NCT03263481|Hormones|hormones|mesh-ancestor
154256253|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256254|NCT01265108|Hematinics|hematinics|mesh-ancestor
154256255|NCT01154738|Lidocaine|lidocaine|mesh-list
154256256|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
154256257|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
154256258|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256259|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256260|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
154256261|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256262|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154256263|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154256264|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154256265|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256266|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256267|NCT01263002|Adefovir|adefovir|mesh-list
154256268|NCT01263002|Clevudine|clevudine|mesh-list
154256269|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
154256270|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256271|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154256272|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154256273|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256274|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256275|NCT01261286|Verapamil|verapamil|mesh-list
154256276|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154256277|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154256278|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154185161|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185162|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185163|NCT03079011|Letrozole|letrozole|mesh-list
154185164|NCT03079011|Fulvestrant|fulvestrant|mesh-list
154185178|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154185179|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185180|NCT02866383|Nivolumab|nivolumab|mesh-list
154185181|NCT02866383|Ipilimumab|ipilimumab|mesh-list
154185182|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154185183|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185184|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154185185|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185186|NCT02841215|Ivermectin|ivermectin|mesh-list
154185187|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154185188|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185189|NCT02807571|Anesthetics|anesthetics|mesh-list
154185190|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154185191|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185192|NCT02793466|Durvalumab|durvalumab|mesh-list
154185193|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154185194|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154256279|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256280|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154256281|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256282|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
154256283|NCT01263080|Folic Acid|folic acid|mesh-list
154256284|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
154256285|NCT01263080|Mirtazapine|mirtazapine|mesh-list
154256286|NCT01263080|Vitamins|vitamins|mesh-ancestor
154256287|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
154256288|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256289|NCT01263080|Hematinics|hematinics|mesh-ancestor
154185195|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185196|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
154185197|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185198|NCT02767557|Paclitaxel|paclitaxel|mesh-list
154185199|NCT02767557|Gemcitabine|gemcitabine|mesh-list
154185200|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154185201|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185202|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
154185203|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
154185204|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
154185205|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185206|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154185207|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
154185208|NCT02461368|Triamcinolone|triamcinolone|mesh-list
154185209|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154185210|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154185211|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154185212|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185213|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
154185214|NCT02461368|Hormones|hormones|mesh-ancestor
154185215|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185216|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185217|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185218|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
154185219|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185220|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185221|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
154185222|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
154185223|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
154185224|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185225|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185239|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154185240|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185241|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185242|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
154185243|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787548|NCT00284505|Thalidomide|thalidomide|mesh-list
154185244|NCT02059499|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154185245|NCT02059499|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154185246|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154185247|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
154185248|NCT01607879|Androgens|androgens|mesh-list
153932221|NCT01153763|Dabrafenib|dabrafenib|mesh-list
154185249|NCT01607879|Hormones|hormones|mesh-ancestor
154185250|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185251|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185252|NCT01336933|Prednisone|prednisone|mesh-list
154185253|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
154185254|NCT01336933|Etoposide|etoposide|mesh-list
154185255|NCT01336933|Vincristine|vincristine|mesh-list
154185256|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
154185257|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185258|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
154185259|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185260|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154256290|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
154256291|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154256292|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154256293|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
154256294|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
154256295|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256296|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256297|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154185261|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154185262|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
154185263|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185264|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185265|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154185266|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185267|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
154185268|NCT01336933|Hormones|hormones|mesh-ancestor
154185269|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185270|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185271|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154185272|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154185273|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154185274|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185275|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
154185276|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
154185277|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
154185278|NCT01107522|Temozolomide|temozolomide|mesh-list
154185279|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154185280|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
154185281|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185282|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185283|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
154185284|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154185285|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185286|NCT00352027|Prednisone|prednisone|mesh-list
154185287|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
154185288|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
153359868|NCT03396601|Ketamine|ketamine|mesh-list
154185305|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154185306|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154185307|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154185308|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185309|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185310|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
154185312|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185313|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185314|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154185315|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
154185316|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
154185317|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
154185318|NCT00262470|Indomethacin|indomethacin|mesh-list
154185319|NCT00262470|Octreotide|octreotide|mesh-list
154185320|NCT00262470|Propranolol|propranolol|mesh-list
154185321|NCT00262470|Clonidine|clonidine|mesh-list
154185322|NCT00262470|Mecamylamine|mecamylamine|mesh-list
154185323|NCT00262470|Acetazolamide|acetazolamide|mesh-list
154185324|NCT00262470|Isosorbide|isosorbide|mesh-list
154185325|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154185326|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154185328|NCT00262470|Memantine|memantine|mesh-list
154185329|NCT00262470|Entacapone|entacapone|mesh-list
154185330|NCT00262470|Melatonin|melatonin|mesh-list
154185331|NCT00262470|Modafinil|modafinil|mesh-list
154185332|NCT00262470|Sertraline|sertraline|mesh-list
154185333|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154185334|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
154185335|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185336|NCT00262470|Protective Agents|protective agents|mesh-ancestor
154185337|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256298|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153794724|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154185338|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154185339|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154185340|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154185341|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
154185342|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185343|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154185344|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154185345|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
154185346|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
154185347|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154185348|NCT00262470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154185349|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154185350|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154185351|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
154185370|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154185371|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154185372|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154185373|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154185374|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154185375|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185376|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185377|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
154185378|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
154185379|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154185380|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154185381|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185382|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
154185383|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154185385|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
154185386|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
154185387|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154185388|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154185389|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154185390|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154185391|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154185392|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154185393|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154185394|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154185395|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
154185396|NCT00440271|Ritonavir|ritonavir|mesh-list
154185397|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
154185398|NCT00440271|Maraviroc|maraviroc|mesh-list
154185399|NCT00440271|Tipranavir|tipranavir|mesh-list
154185400|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
154185401|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154185402|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154185403|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154185404|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
154185405|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185406|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185407|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154185417|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153787847|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185418|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154185421|NCT00346216|Naproxen|naproxen|mesh-list
154185422|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154185423|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154185424|NCT00346216|Analgesics|analgesics|mesh-ancestor
154185425|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
154185426|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185427|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185428|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185429|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185430|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154185431|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185432|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185433|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154185434|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
154185435|NCT01051648|Triamcinolone|triamcinolone|mesh-list
154185436|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154185437|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154256299|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256300|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154256301|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154256302|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154256303|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
154185438|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154185439|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185440|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
154185442|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185443|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185444|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185445|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
154185446|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185447|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185448|NCT00429273|Guanfacine|guanfacine|mesh-list
154185449|NCT00429273|Methylphenidate|methylphenidate|mesh-list
154185450|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154185451|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154185452|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185453|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154185454|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154185455|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154185456|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185457|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
154185458|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185459|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154185460|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154185461|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154185462|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154185463|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
154185464|NCT00359632|Linezolid|linezolid|mesh-list
154185465|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154185466|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185467|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154185468|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185469|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185470|NCT01324960|Aldesleukin|aldesleukin|mesh-list
154185471|NCT01324960|Azacitidine|azacitidine|mesh-list
154185480|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154185481|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
154185482|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185483|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
154185484|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
154185485|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185487|NCT00417885|Exemestane|exemestane|mesh-list
154185488|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185489|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154185490|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154185491|NCT00417885|Growth Substances|growth substances|mesh-ancestor
154185492|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185493|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
154185494|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185495|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185496|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185497|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154185498|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154185499|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154185500|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
154185501|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185502|NCT01036893|Prucalopride|prucalopride|mesh-list
154185503|NCT01036893|Laxatives|laxatives|mesh-ancestor
154185504|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154185505|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154185506|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154185507|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
154185508|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256304|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154256305|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154256306|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
154256307|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154185509|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185510|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185511|NCT00525044|Ambroxol|ambroxol|mesh-list
154185512|NCT00525044|Expectorants|expectorants|mesh-ancestor
154185513|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
154185514|NCT00355342|Fluticasone|fluticasone|mesh-list
154185515|NCT00355342|Xhance|xhance|mesh-list
154185516|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154185517|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185518|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154185519|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
154185520|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185521|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185522|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154185523|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
154185524|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
154185525|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154185526|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154185527|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154185528|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154185529|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
154185530|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185531|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185532|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154185533|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
154185534|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154185535|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
154185536|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
154185537|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154185538|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154185552|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185553|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185554|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
154185555|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185556|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154185557|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
154185558|NCT02533648|Protective Agents|protective agents|mesh-ancestor
154185559|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185560|NCT02533492|Triclosan|triclosan|mesh-list
154185561|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154185562|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185563|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154185564|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154185565|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
154185566|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185567|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154185568|NCT01056874|Maraviroc|maraviroc|mesh-list
154185569|NCT01056874|Digoxin|digoxin|mesh-list
154185570|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154185571|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154185572|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185573|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185574|NCT01056874|Protective Agents|protective agents|mesh-ancestor
154185575|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185576|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154185577|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154185578|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154185579|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154185580|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
154185581|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185582|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154185583|NCT00355030|Leuprolide|leuprolide|mesh-list
154185584|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154185585|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
154185586|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154185587|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185588|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185590|NCT01057030|BMS 708163|bms 708163|mesh-list
154185591|NCT01057030|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154185592|NCT01057030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185593|NCT01057030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185594|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
154185595|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154185596|NCT01057186|Sevelamer|sevelamer|mesh-list
154185597|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
154185598|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
154185599|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185600|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154185620|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154185621|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
154185622|NCT03991312|Itraconazole|itraconazole|mesh-list
154185623|NCT03991312|Rifampin|rifampin|mesh-list
154185624|NCT03991312|Mitapivat|mitapivat|mesh-list
154185625|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
154185626|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185627|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154185628|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154185629|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185630|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185631|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154185632|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
154185633|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185634|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185635|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154185636|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154185637|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
154185638|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154185639|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
154185640|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154185641|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154185642|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154185643|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154185644|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154185645|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154185646|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154185647|NCT03991312|Enzyme Activators|enzyme activators|mesh-ancestor
154185648|NCT01057342|Paclitaxel|paclitaxel|mesh-list
154185649|NCT01057342|Carboplatin|carboplatin|mesh-list
154185650|NCT01057342|Vadimezan|vadimezan|mesh-list
154185651|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154185652|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185653|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
154185654|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
154185662|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185663|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185664|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185665|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185666|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154185667|NCT03742258|Prednisone|prednisone|mesh-list
154185668|NCT03742258|Cortisone|cortisone|mesh-list
154185669|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
154185670|NCT03742258|Rituximab|rituximab|mesh-list
154185671|NCT03742258|Doxorubicin|doxorubicin|mesh-list
154185672|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154185673|NCT03742258|Vincristine|vincristine|mesh-list
154185674|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154185675|NCT03742258|Antibodies|antibodies|mesh-list
154185676|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
154185677|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154185678|NCT03742258|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154185679|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185680|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
154185681|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185682|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185683|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154185684|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
154185685|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185686|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185687|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154185688|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154256308|NCT01263158|Oxytocin|oxytocin|mesh-list
154256309|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
154256310|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154185689|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154185690|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154185691|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185692|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185693|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
154185694|NCT03742258|Hormones|hormones|mesh-ancestor
154185695|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185696|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185697|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154185698|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
154185699|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
154185700|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
154185701|NCT03742258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185702|NCT00354172|Cyclosporine|cyclosporine|mesh-list
154185703|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
154185704|NCT00354172|Aldesleukin|aldesleukin|mesh-list
154185705|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
154185706|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154185707|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154185708|NCT00354172|Prednisolone|prednisolone|mesh-list
154185709|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
154185710|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
154185711|NCT00354172|Fludarabine|fludarabine|mesh-list
154185712|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
154185713|NCT00354172|Interleukin-2|interleukin-2|mesh-list
154185714|NCT00354172|Cyclosporins|cyclosporins|mesh-list
154185715|NCT00354172|Lenograstim|lenograstim|mesh-list
154185716|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154185717|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
154185718|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185719|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
154185720|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185721|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185722|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154185723|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
154185724|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185736|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154185737|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
154185738|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154185739|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185740|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
154185741|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
154185742|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185743|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154185744|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
154185745|NCT00354172|Hormones|hormones|mesh-ancestor
154185746|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185747|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154185748|NCT00354172|Protective Agents|protective agents|mesh-ancestor
154185749|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185750|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154185751|NCT00354172|Analgesics|analgesics|mesh-ancestor
154185752|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
154185753|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154185754|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154185755|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
154185756|NCT00353704|Pregabalin|pregabalin|mesh-list
154185757|NCT00353704|Morphine|morphine|mesh-list
154185758|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154185759|NCT00353704|Narcotics|narcotics|mesh-ancestor
154185760|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154185761|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185762|NCT00353704|Analgesics|analgesics|mesh-ancestor
154185763|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
154185764|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185765|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
154185766|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154185767|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154185768|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185769|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154185770|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154185771|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154256311|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256312|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
154256313|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154256314|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
154256315|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185772|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154185773|NCT03742180|Ketorolac|ketorolac|mesh-list
154185774|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
154185775|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154185776|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154185777|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185778|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154185779|NCT03742180|Analgesics|analgesics|mesh-ancestor
154185780|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
154185781|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185782|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154185783|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154185784|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154185785|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
154185786|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191212|NCT05940324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154185787|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185788|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154185800|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154185801|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185802|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185803|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154185804|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
154185805|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
154185806|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185807|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185808|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
154185809|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185810|NCT00512252|Analgesics|analgesics|mesh-ancestor
154185811|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
154185812|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185813|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154185814|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154185815|NCT00516386|Mecasermin|mecasermin|mesh-list
154185816|NCT00516386|Growth Substances|growth substances|mesh-ancestor
154185817|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185818|NCT00512096|Paclitaxel|paclitaxel|mesh-list
154185819|NCT00512096|Cisplatin|cisplatin|mesh-list
154185820|NCT00512096|Ifosfamide|ifosfamide|mesh-list
154185821|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154185822|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185823|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
154185824|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
154185825|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
154185826|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185827|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154185828|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
154185829|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
154185830|NCT04462796|Cathartics|cathartics|mesh-ancestor
154185831|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154185832|NCT00524030|Pregabalin|pregabalin|mesh-list
154185833|NCT00524030|Analgesics|analgesics|mesh-ancestor
154185834|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
154185835|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185836|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185837|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
154185838|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154185839|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154185840|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185841|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154185842|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154185843|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154185844|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154185845|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154185846|NCT00523718|Riluzole|riluzole|mesh-list
154185847|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
154256316|NCT03879356|Expectorants|expectorants|mesh-ancestor
154256317|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
154185848|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154185849|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154185850|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185851|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185852|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185853|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154185887|NCT00515294|Methamphetamine|methamphetamine|mesh-list
154185889|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154185890|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185891|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
154185892|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
154185905|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154185906|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
154185907|NCT00345046|Prednisolone|prednisolone|mesh-list
154185908|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154185909|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
154185910|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154185911|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
154185913|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154185914|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
154185915|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185916|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
154185917|NCT00345046|Hormones|hormones|mesh-ancestor
154185918|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185919|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185920|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185921|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185922|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
154185923|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
154185924|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185925|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154185926|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154185927|NCT00345046|Protective Agents|protective agents|mesh-ancestor
153932896|NCT01148537|Narcotics|narcotics|mesh-ancestor
154185928|NCT00515216|Leucovorin|leucovorin|mesh-list
154185929|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
154185930|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
154185931|NCT00515216|Fluorouracil|fluorouracil|mesh-list
154185932|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
154185933|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
154185934|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
154185935|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185936|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154185937|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185938|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185939|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
154185940|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185941|NCT00515216|Antidotes|antidotes|mesh-ancestor
154185942|NCT00515216|Protective Agents|protective agents|mesh-ancestor
154185943|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
154185944|NCT00515216|Vitamins|vitamins|mesh-ancestor
154185945|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
154185946|NCT00440193|Enoxaparin|enoxaparin|mesh-list
154185947|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
154185948|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154185949|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
154185950|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154185951|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
154185952|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185953|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185982|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154185983|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
154185984|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185985|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736198|NCT03520686|Paclitaxel|paclitaxel|mesh-list
154185986|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154185987|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
154185988|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154185989|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154185990|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154185991|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154185992|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
154256318|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154256319|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
154256320|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256321|NCT03879356|Protective Agents|protective agents|mesh-ancestor
154256322|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185993|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154185994|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154185995|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185996|NCT01033461|Calcium|calcium|mesh-list
154185997|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154185998|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860436|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153860437|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860438|NCT00543842|Bevacizumab|bevacizumab|mesh-list
153789139|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789140|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
153789141|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153789142|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153789143|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
153789163|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153789164|NCT01681537|Growth Substances|growth substances|mesh-ancestor
153789165|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
153789166|NCT01681537|Analgesics|analgesics|mesh-ancestor
153789169|NCT01681693|Metformin|metformin|mesh-list
154185999|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
154186000|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154186001|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154186016|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
154186017|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154186018|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
154186019|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
154186020|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186021|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186022|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154186023|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154186024|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186025|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154186026|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
154186027|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186028|NCT00416715|Antacids|antacids|mesh-ancestor
154186029|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186030|NCT01037517|Plerixafor|plerixafor|mesh-list
154186031|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154186032|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154186033|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
154186034|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186035|NCT00406029|Levodopa|levodopa|mesh-list
154186036|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154186037|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154186038|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
154186039|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186040|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186041|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186042|NCT00514514|Cyclosporine|cyclosporine|mesh-list
154186043|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
154186044|NCT00514514|Everolimus|everolimus|mesh-list
154186045|NCT00514514|Cyclosporins|cyclosporins|mesh-list
154186046|NCT00514514|Basiliximab|basiliximab|mesh-list
154186047|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186048|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186049|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186050|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
154186051|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186052|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
154186053|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186054|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
154186055|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186056|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154186057|NCT00514514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154186058|NCT00514514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154186059|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186060|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154186061|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154186062|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
154186063|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154186064|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154186065|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
154186079|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
154186080|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154186081|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
154186082|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186083|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186084|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154256324|NCT01159418|Paclitaxel|paclitaxel|mesh-list
154256325|NCT01159418|Carboplatin|carboplatin|mesh-list
154186085|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
154186086|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
154186087|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153789194|NCT02279914|Misoprostol|misoprostol|mesh-list
154186088|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
154186089|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186090|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186091|NCT01010646|Ribavirin|ribavirin|mesh-list
154186092|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
154186093|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
154186094|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154186095|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
154186096|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186097|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
154186098|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186099|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
154186100|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186101|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186102|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
154186103|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154186104|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186105|NCT00515112|Testosterone|testosterone|mesh-list
154186106|NCT00515112|Androgens|androgens|mesh-ancestor
154186107|NCT00515112|Hormones|hormones|mesh-ancestor
154186108|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186109|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186110|NCT03742557|Ketamine|ketamine|mesh-list
154186111|NCT03742557|Analgesics|analgesics|mesh-ancestor
154186112|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
154186113|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186114|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186115|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154186116|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154186117|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
154186118|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
154186119|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186120|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154186121|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154186122|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186123|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186124|NCT01324089|Resveratrol|resveratrol|mesh-list
154186125|NCT01324089|Piperine|piperine|mesh-list
154186126|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
154186127|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186135|NCT00404547|Hormones|hormones|mesh-ancestor
154186136|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186137|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186138|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154186139|NCT00515034|Imipenem|imipenem|mesh-list
154186140|NCT00515034|Doripenem|doripenem|mesh-list
154186141|NCT00515034|Cilastatin|cilastatin|mesh-list
154186142|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154186143|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186144|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
154186145|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186146|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186147|NCT00404235|Paclitaxel|paclitaxel|mesh-list
154186148|NCT00404235|Carboplatin|carboplatin|mesh-list
154186149|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154186150|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154186151|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186152|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
154186153|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
154186154|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
154186155|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186156|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154186157|NCT00509262|Glipizide|glipizide|mesh-list
154186158|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154186159|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186160|NCT00509262|Incretins|incretins|mesh-ancestor
154186161|NCT00509262|Hormones|hormones|mesh-ancestor
154186162|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256326|NCT01159418|Panobinostat|panobinostat|mesh-list
154256327|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154256328|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736311|NCT03106779|Bosutinib|bosutinib|mesh-list
154186163|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154186164|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
154186165|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186166|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186167|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
154186168|NCT00509106|Ceftaroline|ceftaroline|mesh-list
153592979|NCT01837290|Midazolam|midazolam|mesh-list
154186169|NCT00509106|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154186170|NCT00509106|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154186171|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154186172|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186173|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154186174|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154186175|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154186176|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154186177|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186178|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
154186179|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186180|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186181|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154186182|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186183|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
154186184|NCT00344968|Hormones|hormones|mesh-ancestor
154186185|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186186|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186187|NCT00509028|Budesonide|budesonide|mesh-list
154186188|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186189|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154186190|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
154186191|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186192|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186193|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154186214|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154186215|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186216|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154186217|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154186218|NCT00508872|Growth Substances|growth substances|mesh-ancestor
154186219|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186220|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
154186221|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
154186222|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186223|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154186224|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186225|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
154186226|NCT00508872|Antidotes|antidotes|mesh-ancestor
154186227|NCT00508872|Protective Agents|protective agents|mesh-ancestor
154186228|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
154186229|NCT00508872|Vitamins|vitamins|mesh-ancestor
154186230|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
154186231|NCT00508482|Lactulose|lactulose|mesh-list
154186232|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186233|NCT00344032|Vaccines|vaccines|mesh-list
154186234|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
154186235|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186236|NCT00607373|Mipomersen|mipomersen|mesh-list
154186237|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154186238|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154186239|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
154186240|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186241|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154186242|NCT00508404|Panitumumab|panitumumab|mesh-list
154186243|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154186244|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186245|NCT00352690|Paclitaxel|paclitaxel|mesh-list
154186246|NCT00352690|Carboplatin|carboplatin|mesh-list
154186247|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
154186248|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154256329|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736312|NCT03106779|Asciminib|asciminib|mesh-list
154186249|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186250|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
154186251|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
154186268|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154186269|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154186270|NCT03249012|Vitamins|vitamins|mesh-ancestor
154186271|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
154186272|NCT00893477|Rituximab|rituximab|mesh-list
154186273|NCT00893477|Sargramostim|sargramostim|mesh-list
154186274|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154186275|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186276|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
154186277|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186278|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186279|NCT00609245|Valproic Acid|valproic acid|mesh-list
154186280|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
154186281|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186282|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186283|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
154186284|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186285|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186286|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
154186287|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154186288|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186289|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186290|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
154186291|NCT01010802|Hematinics|hematinics|mesh-ancestor
154186292|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
154186293|NCT04036253|Hematinics|hematinics|mesh-ancestor
154186294|NCT00893555|Voriconazole|voriconazole|mesh-list
154186295|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
154186296|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186297|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154186298|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154186299|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186300|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186301|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154186302|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
154186303|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186304|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186305|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154186306|NCT02541071|Clonidine|clonidine|mesh-list
154186307|NCT02541071|Yohimbine|yohimbine|mesh-list
154186308|NCT02541071|Analgesics|analgesics|mesh-ancestor
153933269|NCT02786992|Oxytocin|oxytocin|mesh-list
154186309|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
154186310|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186319|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186320|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186322|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154186323|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154186324|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154186325|NCT02541071|Urological Agents|urological agents|mesh-ancestor
154186326|NCT01058824|Lincomycin|lincomycin|mesh-list
154186327|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154186328|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186329|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154186330|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186331|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186332|NCT00895739|Cyclosporine|cyclosporine|mesh-list
154186333|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
154186334|NCT00895739|Cyclosporins|cyclosporins|mesh-list
154186335|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186336|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186337|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186338|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
154186339|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186340|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
154186341|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186342|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
154186343|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186344|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154186345|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154186346|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186347|NCT01058902|Aspirin|aspirin|mesh-list
154186348|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154186349|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154186350|NCT01058902|Analgesics|analgesics|mesh-ancestor
154186351|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
154186352|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186353|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186354|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186355|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186356|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154186357|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154186358|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186359|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154186360|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154186361|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186362|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
154186363|NCT00609167|Dexamethasone|dexamethasone|mesh-list
154186364|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
154186365|NCT00609167|Bortezomib|bortezomib|mesh-list
154186366|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186367|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
154186368|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186369|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186370|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154186371|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
154186372|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186373|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186374|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154186375|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186376|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
154186387|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154186388|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
154186389|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
154186390|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186391|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186392|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186393|NCT00606281|Aripiprazole|aripiprazole|mesh-list
154186394|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
154186395|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186396|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154186397|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154186398|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186399|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186400|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
154186401|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
154186402|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186403|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186404|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154186405|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154186406|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
154186407|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154186408|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154186409|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154186410|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154186411|NCT00506142|Vincristine|vincristine|mesh-list
154186412|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154186413|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186414|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
154186415|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
154186416|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
154186417|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186418|NCT00891605|Paclitaxel|paclitaxel|mesh-list
154186419|NCT00891605|Navitoclax|navitoclax|mesh-list
154186420|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154186421|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186422|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
154186423|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
154186424|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
154186425|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186426|NCT00893711|Vitamin D|vitamin d|mesh-list
154186427|NCT00893711|Vitamins|vitamins|mesh-ancestor
154186428|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
154256330|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
154256331|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
154256332|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256333|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154186429|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186430|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154186432|NCT00514020|Fluorouracil|fluorouracil|mesh-list
154186433|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
154186434|NCT00514020|Calcium|calcium|mesh-list
154186435|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
154186436|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154186437|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186438|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
154186439|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186477|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
154186478|NCT00891761|Hormones|hormones|mesh-ancestor
154186479|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186480|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154186481|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186513|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
154186514|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186515|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186516|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154186517|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
154186518|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186519|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186520|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154186521|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154186522|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
154186523|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154186524|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154186525|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
154186526|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
154186527|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186544|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186545|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186546|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
154186547|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186548|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186549|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
154186550|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154186551|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186552|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186553|NCT00896519|Prednisone|prednisone|mesh-list
154186554|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
154186555|NCT00896519|Rituximab|rituximab|mesh-list
154186556|NCT00896519|Doxorubicin|doxorubicin|mesh-list
154186557|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154186558|NCT00896519|Vincristine|vincristine|mesh-list
154186559|NCT00896519|Sargramostim|sargramostim|mesh-list
154186560|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186561|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
154186562|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186563|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186564|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154186565|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
154186566|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186567|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186568|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154186569|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154186570|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154186571|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154186572|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154186573|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186574|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186575|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
154186576|NCT00896519|Hormones|hormones|mesh-ancestor
154186577|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256334|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186578|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154186579|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154186580|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
154186581|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
154186582|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
154186583|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154186584|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154186585|NCT00505752|Hormones|hormones|mesh-ancestor
154186618|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186619|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154186620|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
154186621|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
154186622|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154186623|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154186624|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186625|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186626|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186627|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
154186654|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186655|NCT00343252|Teriparatide|teriparatide|mesh-list
154186656|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
154186657|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
154186658|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154186659|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186660|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154186661|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154186662|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154186663|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186664|NCT00892229|Misoprostol|misoprostol|mesh-list
154186665|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154186666|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
154186667|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154186668|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186669|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154186670|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186671|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
154186672|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154186673|NCT00897221|Deferiprone|deferiprone|mesh-list
154186674|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154186675|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
154186696|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186698|NCT00894569|Paclitaxel|paclitaxel|mesh-list
154186699|NCT00894569|Carboplatin|carboplatin|mesh-list
154186700|NCT00894569|Cetuximab|cetuximab|mesh-list
154186701|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154186702|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186703|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
154186704|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
154186705|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
154186706|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186707|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154186708|NCT00337168|Cytarabine|cytarabine|mesh-list
154186709|NCT00337168|Clofarabine|clofarabine|mesh-list
154186710|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153400898|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400899|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400900|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153400901|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153400902|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186711|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
154186712|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186713|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186714|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
154186715|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186716|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186717|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
154186718|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186719|NCT00892385|Temozolomide|temozolomide|mesh-list
154186720|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154186721|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
154186722|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186723|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186724|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154186725|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
154186726|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186727|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154256335|NCT03886766|Efavirenz|efavirenz|mesh-list
154256336|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154186762|NCT03063762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186765|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154186789|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
154186790|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
154186791|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
154186792|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186793|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154186794|NCT04035707|Rocuronium|rocuronium|mesh-list
154186795|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186796|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154186797|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154186798|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153400903|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154186799|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186800|NCT02539745|Vitamin D|vitamin d|mesh-list
154186801|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154186802|NCT02539745|Vitamins|vitamins|mesh-ancestor
154186803|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
154186804|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186805|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154186806|NCT00894959|Heparin|heparin|mesh-list
154186807|NCT00894959|Calcium heparin|calcium heparin|mesh-list
154186808|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
154186809|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154186810|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154186811|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186812|NCT00895115|Vitamin E|vitamin e|mesh-list
154186813|NCT00895115|Vitamins|vitamins|mesh-ancestor
154186814|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
154186815|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186816|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
154186836|NCT02540837|Bupivacaine|bupivacaine|mesh-list
154186838|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
154186839|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186840|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186841|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
154186842|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186843|NCT00901823|Diazoxide|diazoxide|mesh-list
154186844|NCT00901823|Choline|choline|mesh-list
154186845|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
154186846|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154186847|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
154186848|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186849|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186850|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154186851|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
154186852|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154186853|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
154186854|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154186855|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
154186856|NCT00902057|Coagulants|coagulants|mesh-ancestor
154186857|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154186858|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
154186859|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186860|NCT00902135|Interferons|interferons|mesh-list
154186861|NCT00902135|Interferon-beta|interferon-beta|mesh-list
154186862|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
154186863|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186864|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
154186865|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186866|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
154186867|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186868|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154186869|NCT02540369|Aflibercept|aflibercept|mesh-list
154186870|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154186871|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154186872|NCT02540369|Growth Substances|growth substances|mesh-ancestor
154186891|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186893|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
154186894|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186895|NCT00902603|Iloprost|iloprost|mesh-list
154186896|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154256337|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154256338|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186897|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
154186898|NCT00902681|Fesoterodine|fesoterodine|mesh-list
154186899|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154186900|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154186901|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
154186902|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336733|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
154186903|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186904|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186905|NCT00902681|Urological Agents|urological agents|mesh-ancestor
154186906|NCT00906113|Melphalan|melphalan|mesh-list
154186907|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154186908|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
154186909|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186910|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933865|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154186911|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154186912|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153790268|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790269|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790270|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
153790271|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
153790272|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790296|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153790297|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736211|NCT03520686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153790298|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153790299|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
153790305|NCT00289419|Ketorolac|ketorolac|mesh-list
154186914|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186915|NCT00902837|Oxycodone|oxycodone|mesh-list
154186916|NCT00902837|Naloxone|naloxone|mesh-list
154186917|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154186918|NCT00902837|Narcotics|narcotics|mesh-ancestor
154186919|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186920|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186921|NCT00902837|Analgesics|analgesics|mesh-ancestor
154186922|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
154186923|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186924|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154186925|NCT00605813|Sertraline|sertraline|mesh-list
154186926|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
154186927|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186947|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186948|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186949|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186950|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
154186951|NCT00902915|Hormones|hormones|mesh-ancestor
154186952|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186953|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154186954|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186955|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
154186956|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154186957|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154186958|NCT00902915|Growth Substances|growth substances|mesh-ancestor
154186959|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
154186960|NCT04034771|Propofol|propofol|mesh-list
154186961|NCT04034771|Melatonin|melatonin|mesh-list
154186962|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154186963|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186964|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186965|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154186966|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
154186967|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
154186968|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
154186969|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186970|NCT04034771|Protective Agents|protective agents|mesh-ancestor
154186971|NCT00899483|Insulin|insulin|mesh-list
154186972|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154186973|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186974|NCT02539199|Misoprostol|misoprostol|mesh-list
154186975|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154186976|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
154186977|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154186978|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186979|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154186980|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186981|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
154186982|NCT00903227|Fluticasone|fluticasone|mesh-list
154187002|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187003|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154187004|NCT00899951|Fentanyl|fentanyl|mesh-list
154187005|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154187006|NCT00899951|Narcotics|narcotics|mesh-ancestor
154256339|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796313|NCT03892642|Avelumab|avelumab|mesh-list
154187007|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187008|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187009|NCT00899951|Analgesics|analgesics|mesh-ancestor
154187010|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
153790353|NCT00255593|Rituximab|rituximab|mesh-list
154187011|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187012|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154187013|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154187014|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
154187015|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
154187016|NCT02539979|Acetaminophen|acetaminophen|mesh-list
154187017|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154187018|NCT02539979|Analgesics|analgesics|mesh-ancestor
154187019|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
154187020|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187021|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187022|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
154187023|NCT05277701|Lazertinib|lazertinib|mesh-list
154187024|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154187025|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187026|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187027|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
154187028|NCT00605345|Hematinics|hematinics|mesh-ancestor
154187029|NCT00903851|Lidocaine|lidocaine|mesh-list
154187030|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
154187031|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
154187032|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187033|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187034|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
154187035|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187036|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154187037|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154187038|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154187039|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187071|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154187072|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187073|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187074|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154187075|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
154187076|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187077|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187079|NCT00904397|Lidocaine|lidocaine|mesh-list
154187080|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
154187081|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
154187099|NCT00904475|Lidocaine|lidocaine|mesh-list
154187100|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
154187101|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
154187102|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187103|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187104|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
154187105|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187106|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154187107|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154187108|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154187109|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187110|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187111|NCT00908921|Glimepiride|glimepiride|mesh-list
154187112|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154187113|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154187114|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187115|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187116|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
154187117|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
154187118|NCT00904631|Salicylates|salicylates|mesh-list
154187119|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187120|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
154187121|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
154187122|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
154187123|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154187124|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154187125|NCT00904631|Analgesics|analgesics|mesh-ancestor
153796380|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154187126|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
154187127|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187128|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187129|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154187130|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187131|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154187132|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187133|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187134|NCT00909077|Dexamethasone|dexamethasone|mesh-list
154187135|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
154187168|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154187169|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187171|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
154187172|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400944|NCT03170219|Furosemide|furosemide|mesh-list
154187173|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154187174|NCT01057966|Vitamins|vitamins|mesh-list
154187175|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
154187176|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187177|NCT00603941|Paclitaxel|paclitaxel|mesh-list
154187178|NCT00603941|Efatutazone|efatutazone|mesh-list
154187200|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187201|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154187202|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187203|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187204|NCT03986008|Liraglutide|liraglutide|mesh-list
154187205|NCT03986008|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154187206|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154187207|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187208|NCT03986008|Incretins|incretins|mesh-ancestor
154187209|NCT03986008|Hormones|hormones|mesh-ancestor
154187210|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187211|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154187212|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
154187213|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154187214|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154187215|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187216|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187217|NCT00909233|Urological Agents|urological agents|mesh-ancestor
154187218|NCT00909311|Ritonavir|ritonavir|mesh-list
154187219|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154187220|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154187221|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
154187222|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187223|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187224|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154187225|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154187226|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
154187227|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187228|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154187256|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154187257|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154187258|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154187259|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187260|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187262|NCT00336544|Cethromycin|cethromycin|mesh-list
154187263|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154187264|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187265|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154187266|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187267|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187268|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154187269|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154187270|NCT01059058|Fluorides|fluorides|mesh-list
154187271|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
154187272|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
154187282|NCT00605033|Analgesics|analgesics|mesh-ancestor
154187283|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
154187284|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187285|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154256340|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
154256341|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187286|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154187287|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154187288|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187289|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187290|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154187291|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
154187292|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187293|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187294|NCT00905723|Estradiol|estradiol|mesh-list
154187295|NCT00905723|Estrogens|estrogens|mesh-ancestor
154187296|NCT00905723|Hormones|hormones|mesh-ancestor
154187297|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860628|NCT05823870|Empagliflozin|empagliflozin|mesh-list
154187298|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187299|NCT00907985|Lamotrigine|lamotrigine|mesh-list
154187300|NCT00907985|Vofopitant|vofopitant|mesh-list
154187301|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
154187302|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154187303|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187304|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187305|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154187306|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187307|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154187308|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154187309|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187310|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154187311|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154187312|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
154187313|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
154187314|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187315|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154187316|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154187317|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187318|NCT01325194|Cytarabine|cytarabine|mesh-list
154187319|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154187320|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
153790802|NCT00271206|Progestins|progestins|mesh-ancestor
154187321|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187322|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187323|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
154187324|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187325|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187326|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
154187327|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187328|NCT00908219|Bevacizumab|bevacizumab|mesh-list
154187329|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187330|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187331|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154187332|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154187333|NCT00908219|Growth Substances|growth substances|mesh-ancestor
154187334|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187335|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
154187336|NCT00908297|Ubiquinone|ubiquinone|mesh-list
154187349|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
154187350|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154187351|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154187352|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790848|NCT00271245|Protective Agents|protective agents|mesh-ancestor
153790849|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790850|NCT00271245|Trace Elements|trace elements|mesh-ancestor
153790851|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
153790852|NCT02272855|Ipilimumab|ipilimumab|mesh-list
153790853|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187353|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
154187354|NCT00927797|Rituximab|rituximab|mesh-list
154187355|NCT00927797|Pentostatin|pentostatin|mesh-list
154187356|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187357|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
154187358|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187360|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154187361|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
154187362|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187363|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187364|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154187365|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187366|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154187367|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187368|NCT00338962|Naltrexone|naltrexone|mesh-list
154187369|NCT00338962|Paroxetine|paroxetine|mesh-list
154187371|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154187372|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154187373|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187374|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
153790854|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790857|NCT00257270|Gabapentin|gabapentin|mesh-list
154187375|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187376|NCT00338962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154187377|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154187378|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187379|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187380|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187381|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
154187382|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154187383|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
154187384|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154187385|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154187386|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154187387|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187388|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154187389|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154187390|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
154187391|NCT00931775|Pindolol|pindolol|mesh-list
154187392|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154187393|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154187394|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
154187395|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187396|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187397|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187398|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154187399|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154187400|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
154187412|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
154187413|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187414|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187415|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154187416|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
154187417|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154187418|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
154187419|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187420|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187421|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154187422|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
154187423|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
154187424|NCT00568061|Protective Agents|protective agents|mesh-ancestor
154187425|NCT03547427|Acetaminophen|acetaminophen|mesh-list
154187426|NCT03547427|Insulin|insulin|mesh-list
154187427|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154187428|NCT03547427|Pramlintide|pramlintide|mesh-list
154187429|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154187430|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187432|NCT03547427|Analgesics|analgesics|mesh-ancestor
154187433|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
154187434|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187435|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
154187436|NCT00338884|Sunitinib|sunitinib|mesh-list
154187437|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187438|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154187439|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154187440|NCT00338884|Growth Substances|growth substances|mesh-ancestor
154187441|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187442|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
154187443|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154187444|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187445|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187446|NCT03038100|Paclitaxel|paclitaxel|mesh-list
154187447|NCT03038100|Bevacizumab|bevacizumab|mesh-list
154187448|NCT03038100|Carboplatin|carboplatin|mesh-list
154187449|NCT03038100|Atezolizumab|atezolizumab|mesh-list
154187450|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154187451|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154187452|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187453|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
154187454|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
154187455|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
154187456|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187457|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187458|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154187459|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154187461|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187462|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
154187463|NCT03038100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154187464|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
154187465|NCT00338728|Letrozole|letrozole|mesh-list
154187466|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
154187477|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154187478|NCT01059136|Spironolactone|spironolactone|mesh-list
154187479|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153400981|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400982|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400983|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
153400984|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154187480|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
154187481|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187482|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187483|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154187484|NCT01059136|Diuretics|diuretics|mesh-ancestor
154187485|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
154187486|NCT00336856|Irinotecan|irinotecan|mesh-list
154187487|NCT00336856|Cetuximab|cetuximab|mesh-list
154187488|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154187489|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154187490|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187491|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187492|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187493|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187494|NCT00566501|Donepezil|donepezil|mesh-list
154187495|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154187496|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187497|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187498|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
154187499|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187500|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187501|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
154187502|NCT00504894|Thiopental|thiopental|mesh-list
154187503|NCT00504894|Propofol|propofol|mesh-list
154187504|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154187505|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187506|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187507|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154187508|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
154187509|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
153400988|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154187510|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
154187511|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
154187512|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
154187513|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191213|NCT05940324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154187514|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187515|NCT00924755|Caffeine|caffeine|mesh-list
154187516|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154187517|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187518|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154187519|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187520|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187521|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154187522|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154187523|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
154187524|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187525|NCT01011348|Ubiquinone|ubiquinone|mesh-list
154187526|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
154187527|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
154187528|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187529|NCT01011348|Vitamins|vitamins|mesh-ancestor
154187539|NCT01011426|Cathartics|cathartics|mesh-ancestor
154187540|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154187541|NCT01011426|Laxatives|laxatives|mesh-ancestor
154187542|NCT00932555|Factor VIII|factor viii|mesh-list
154187543|NCT00932555|Coagulants|coagulants|mesh-ancestor
154187544|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
154187545|NCT00513240|Hematinics|hematinics|mesh-ancestor
154187546|NCT00928811|Basiliximab|basiliximab|mesh-list
154187547|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187548|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
154187549|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187550|NCT00932867|Telmisartan|telmisartan|mesh-list
154256342|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154187551|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154187552|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154187553|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154187554|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187556|NCT00928967|Interferon-beta|interferon-beta|mesh-list
154187557|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
154187558|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187559|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
154187560|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187561|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
154187562|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187563|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154187564|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
154187565|NCT00933023|Betamethasone|betamethasone|mesh-list
154187566|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154187567|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
154187568|NCT00933023|Hormones|hormones|mesh-ancestor
154187569|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187570|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187571|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154187572|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
154187573|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
154187574|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154187575|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154187576|NCT00933179|Gestodene|gestodene|mesh-list
154187577|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154187578|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
153934533|NCT02777788|Paclitaxel|paclitaxel|mesh-list
154187579|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154187580|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187582|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154187583|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154187584|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154187585|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154187586|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154187587|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154187588|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154187589|NCT00933179|Progestins|progestins|mesh-ancestor
154187590|NCT00933179|Hormones|hormones|mesh-ancestor
154187591|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187592|NCT00504348|Tacrolimus|tacrolimus|mesh-list
154187593|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187594|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
154187595|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187596|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154187602|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187604|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
154187605|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187606|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187607|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154187608|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154187609|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
154187610|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187611|NCT00929279|Abciximab|abciximab|mesh-list
154187612|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
154187613|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154187614|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
154187615|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154187616|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187617|NCT00335764|Sirolimus|sirolimus|mesh-list
154187618|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154187619|NCT00335764|Sorafenib|sorafenib|mesh-list
154187620|NCT00335764|Temsirolimus|temsirolimus|mesh-list
154187621|NCT00335764|Tipifarnib|tipifarnib|mesh-list
154187622|NCT00335764|MTOR Inhibitors|mtor inhibitors|mesh-list
154187623|NCT00335764|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154187624|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154187625|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187626|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187627|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187628|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187630|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187631|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154187632|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187633|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154187635|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
154187636|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154187637|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187638|NCT03981484|Thrombin|thrombin|mesh-list
154187639|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
154187640|NCT03981484|Coagulants|coagulants|mesh-ancestor
154187641|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154187642|NCT00567359|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154187643|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154187644|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187645|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187646|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187647|NCT01063660|Treosulfan|treosulfan|mesh-list
154187648|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154187649|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
154187650|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187651|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187652|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
154187653|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
154187654|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154187655|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187656|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187657|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
154187658|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154187659|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187660|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187661|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
154187662|NCT00492726|Ertapenem|ertapenem|mesh-list
154187663|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154187664|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154187665|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860696|NCT05817474|Coagulants|coagulants|mesh-ancestor
154187692|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154187693|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
154187694|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187695|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187696|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154187697|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154187698|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154187699|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154187700|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187701|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
154187702|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154187703|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154187704|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
154187705|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187706|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154187707|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154187708|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154187709|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154187710|NCT03997500|Norepinephrine|norepinephrine|mesh-list
154187711|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154187732|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154187733|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154187734|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
154187735|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154187736|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154187737|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187738|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154187739|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154187740|NCT01011660|Diuretics|diuretics|mesh-ancestor
154187741|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
154187742|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154187743|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154187744|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154187745|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154256343|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154187747|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154187748|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187749|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187750|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
154187751|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187752|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187753|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154187754|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
154187755|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187756|NCT00506922|Methotrexate|methotrexate|mesh-list
154187757|NCT00506922|Pentostatin|pentostatin|mesh-list
154187758|NCT00506922|Tacrolimus|tacrolimus|mesh-list
154187759|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154187760|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
154187761|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153401018|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154187762|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187763|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154187764|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
154187765|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187784|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187785|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154187786|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154187787|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154187788|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187789|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187790|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
154187791|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
154187792|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154187793|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154187794|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187795|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154187796|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154187797|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187798|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187799|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934759|NCT01090050|Naproxen|naproxen|mesh-list
154187800|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154187801|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
154187802|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154187803|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187804|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154187805|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154187806|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154187807|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
154187808|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
154187809|NCT00926315|Calcitriol|calcitriol|mesh-list
154187810|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154187811|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187812|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153860710|NCT05780567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153860733|NCT05728294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187813|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187814|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187815|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154187816|NCT00926315|Vitamins|vitamins|mesh-ancestor
154187817|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
154187818|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154187819|NCT01013454|Varenicline|varenicline|mesh-list
154187820|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154187857|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187873|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187874|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187875|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154187876|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154187877|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154187878|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154187879|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
154187881|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
153401036|NCT03091673|Hormones|hormones|mesh-ancestor
153401037|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401038|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401039|NCT03091673|Incretins|incretins|mesh-ancestor
153401040|NCT02382848|Prazosin|prazosin|mesh-list
154187882|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
154187883|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187884|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256344|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154256345|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154256346|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153736322|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
154187885|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154187886|NCT01015482|Narcotics|narcotics|mesh-ancestor
154187887|NCT01015482|Analgesics|analgesics|mesh-ancestor
154187888|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
154187889|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187890|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
154187891|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154187892|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187893|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
154187894|NCT00934817|Metformin|metformin|mesh-list
154187895|NCT00934817|Glimepiride|glimepiride|mesh-list
154187896|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154187897|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187898|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154187899|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187900|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
154187901|NCT01013532|Aspirin|aspirin|mesh-list
154187902|NCT01013532|Cilostazol|cilostazol|mesh-list
154187903|NCT01013532|Probucol|probucol|mesh-list
154187904|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154187905|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154187906|NCT01013532|Analgesics|analgesics|mesh-ancestor
154187907|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
154187908|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187909|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187910|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154187911|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187912|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154187913|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154187914|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187915|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154187916|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154187917|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187918|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
154187919|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154187920|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
154187938|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154187940|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
154187941|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187942|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154187943|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154187944|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154187945|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
154187946|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187947|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187948|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154187949|NCT00926705|Narcotics|narcotics|mesh-ancestor
153791615|NCT06300203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153791616|NCT06300203|Immunologic Factors|immunologic factors|mesh-ancestor
153791617|NCT06300203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791618|NCT06300203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791619|NCT06300203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791620|NCT06300177|Docetaxel|docetaxel|mesh-list
153791621|NCT06300177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791622|NCT06300177|Tubulin Modulators|tubulin modulators|mesh-ancestor
153791623|NCT06300177|Antimitotic Agents|antimitotic agents|mesh-ancestor
153791624|NCT06300177|Mitosis Modulators|mitosis modulators|mesh-ancestor
153791625|NCT06300177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791626|NCT06300138|Itraconazole|itraconazole|mesh-list
153791627|NCT06300138|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153791628|NCT06300138|Antifungal Agents|antifungal agents|mesh-ancestor
154187950|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154187951|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154187952|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
153791629|NCT06300138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791652|NCT06299852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187954|NCT03415139|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154187955|NCT03415139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154187956|NCT03415139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187957|NCT01012284|Bedaquiline|bedaquiline|mesh-list
154187958|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
154187959|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154187960|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187961|NCT00934973|Mebeverine|mebeverine|mesh-list
154187962|NCT00934973|Alverine|alverine|mesh-list
154187963|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
154187964|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
154187965|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
154187966|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187967|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187968|NCT00485472|Lacosamide|lacosamide|mesh-list
154187969|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
154187970|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154187971|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154187972|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187973|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187974|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
154187975|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187976|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187978|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
154187979|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154188009|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154188010|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154188011|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
154188012|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188013|NCT00930839|Aspirin|aspirin|mesh-list
154188014|NCT00930839|Niacin|niacin|mesh-list
154188015|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
154188016|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154188017|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154188018|NCT00930839|Analgesics|analgesics|mesh-ancestor
154188019|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
154188020|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188021|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188022|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188023|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188024|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154188044|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188045|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154188046|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
154188047|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188048|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188049|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154188050|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154188051|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
154188052|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
154188054|NCT00935363|Rifampin|rifampin|mesh-list
154188055|NCT00935363|Fluconazole|fluconazole|mesh-list
154188056|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154188057|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
154188058|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188059|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188060|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
154188061|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154188062|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188063|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188064|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154188065|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154188066|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154188067|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154188068|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154188069|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154188070|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
153860736|NCT05704829|Trastuzumab|trastuzumab|mesh-list
154188071|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154188072|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154188073|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154188074|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
154188075|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188076|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188077|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154188078|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154188093|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
154188094|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188095|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154188096|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154188097|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154188098|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
154188099|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188100|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188101|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154188102|NCT00936689|Doxorubicin|doxorubicin|mesh-list
153401067|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
153401068|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401069|NCT05363501|Naloxone|naloxone|mesh-list
153401070|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153401071|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188103|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
154188104|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154188105|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188106|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154188107|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154188108|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188109|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188110|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154188111|NCT00936689|Estrogens|estrogens|mesh-ancestor
154188112|NCT00936689|Hormones|hormones|mesh-ancestor
154188113|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188114|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188115|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188116|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
154188117|NCT01018914|Tacrolimus|tacrolimus|mesh-list
154188118|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154188119|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
154188120|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188121|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154188122|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188123|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188124|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154188125|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401072|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
154188126|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154188127|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
154188128|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188129|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188130|NCT01019070|Asunaprevir|asunaprevir|mesh-list
154188131|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
154188132|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188133|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188134|NCT00936767|Artesunate|artesunate|mesh-list
154188135|NCT00936767|Mefloquine|mefloquine|mesh-list
154188136|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
154188137|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154188149|NCT00936923|Diuretics|diuretics|mesh-list
154188150|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
154188151|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188152|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154188153|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154188154|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188155|NCT01019382|Gemcitabine|gemcitabine|mesh-list
154188156|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154188157|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
154188158|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188159|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188160|NCT00935675|Escitalopram|escitalopram|mesh-list
154188161|NCT00935675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154188162|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154188163|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154188164|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188165|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188166|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
154188167|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188168|NCT01016184|Vitamin D|vitamin d|mesh-list
154188169|NCT01016184|Vitamins|vitamins|mesh-ancestor
154188170|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
154188171|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791772|NCT06285409|Ergonovine|ergonovine|mesh-list
154188172|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154188173|NCT02567825|Amoxicillin|amoxicillin|mesh-list
154188174|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
154188175|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
154188176|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
154188177|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154188178|NCT02567825|Ofloxacin|ofloxacin|mesh-list
154188179|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188180|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188181|NCT02567825|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154188182|NCT02567825|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154188183|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154188184|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188185|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188186|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154188187|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154188188|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154188190|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154188191|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154188192|NCT00490776|Panobinostat|panobinostat|mesh-list
154188193|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188194|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154188195|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188196|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188197|NCT00566735|Galantamine|galantamine|mesh-list
154188198|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154188199|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188200|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188201|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
154188206|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188207|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
154188208|NCT00936143|Infliximab|infliximab|mesh-list
154188209|NCT00936143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154188210|NCT00936143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188211|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
154188212|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154188213|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188214|NCT00937079|Exenatide|exenatide|mesh-list
154188215|NCT00937079|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154188216|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154188217|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188218|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154188219|NCT00937079|Incretins|incretins|mesh-ancestor
154188220|NCT00937079|Hormones|hormones|mesh-ancestor
154188221|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188222|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
154188223|NCT00566111|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154188224|NCT00566111|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154188225|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188226|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188227|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
154188228|NCT00937625|Fludarabine|fludarabine|mesh-list
154188229|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
154188230|NCT00937625|Interleukin-2|interleukin-2|mesh-list
154188231|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154188232|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
154188233|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188234|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188235|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154188236|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
154188237|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188238|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188239|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154188240|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154188241|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
154188242|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154188243|NCT00937625|Analgesics|analgesics|mesh-ancestor
154188244|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
154188245|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188246|NCT04014101|Apatinib|apatinib|mesh-list
153935209|NCT02617459|Betaxolol|betaxolol|mesh-list
154188247|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188248|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154188249|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188250|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188251|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154188252|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154188253|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
154188254|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154188255|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154188256|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188257|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
154188258|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188259|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188260|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154188261|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188262|NCT00564629|Acetaminophen|acetaminophen|mesh-list
154188263|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154188264|NCT00564629|Analgesics|analgesics|mesh-ancestor
154188265|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
153797605|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
154188266|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188267|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188268|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
154188269|NCT00564395|Insulin|insulin|mesh-list
154188270|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154188271|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
154188285|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188286|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154188287|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
154188288|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154188290|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188291|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188292|NCT00939497|Risperidone|risperidone|mesh-list
154188293|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154188294|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
154188295|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188296|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188297|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188298|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154188299|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154188300|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188301|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154188302|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154188303|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
154188304|NCT00502242|Ramipril|ramipril|mesh-list
154188305|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154188306|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
154188307|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188308|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188309|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154188310|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154188311|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154188312|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154188313|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
154188314|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188315|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154188316|NCT03045653|Tamoxifen|tamoxifen|mesh-list
154188317|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154188318|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
154188319|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188320|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188321|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188322|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188323|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154188324|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154188325|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154188327|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154188328|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
154188329|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188330|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188331|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154188345|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154188346|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188347|NCT04492254|Enoxaparin|enoxaparin|mesh-list
154188348|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
154188349|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154188350|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154188351|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188352|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
154188353|NCT03855228|Loratadine|loratadine|mesh-list
154188354|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188355|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
154188356|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154188357|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
154188358|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154188359|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154188360|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
154188361|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
154188362|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188363|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188364|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188366|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154188367|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188368|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188369|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
154188370|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188371|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188372|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
154188373|NCT00940667|Losartan|losartan|mesh-list
154188374|NCT00940667|Amlodipine|amlodipine|mesh-list
154188375|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154188376|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154188377|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154188378|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188379|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154188380|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188381|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
154188382|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154188383|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154188384|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154188385|NCT01019772|Vaccines|vaccines|mesh-list
154188386|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
154188387|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188388|NCT00513500|Amoxicillin|amoxicillin|mesh-list
154188389|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154188390|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188391|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188398|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154188399|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188400|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
154188401|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154188402|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154188403|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
154188404|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
154188405|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154188406|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188407|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188408|NCT00511004|Filaricides|filaricides|mesh-ancestor
154188409|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
154188410|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154188411|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188413|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
154188414|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188415|NCT00939965|Isotretinoin|isotretinoin|mesh-list
154188416|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
154188417|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154188418|NCT02877134|Ustekinumab|ustekinumab|mesh-list
154188419|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
154188420|NCT00563381|Bromides|bromides|mesh-list
154188421|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
154188422|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154188423|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154188424|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
154188425|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188426|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188427|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154188428|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
154188429|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
154188430|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154188431|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
154188432|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188433|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188434|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154188435|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154188436|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154188437|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
154188438|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
154188439|NCT00512798|Temozolomide|temozolomide|mesh-list
154188440|NCT00512798|Bortezomib|bortezomib|mesh-list
154188441|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154188442|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
154188443|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188444|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188445|NCT00940121|Mirabegron|mirabegron|mesh-list
153797809|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154188446|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154188447|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154188448|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154188449|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154188450|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188451|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188452|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188453|NCT00940121|Urological Agents|urological agents|mesh-ancestor
154188455|NCT04012619|Carboplatin|carboplatin|mesh-list
154188456|NCT04012619|Pemetrexed|pemetrexed|mesh-list
154188457|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188458|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860826|NCT04941105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188459|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188460|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154188468|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188469|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154188470|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154188472|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154188473|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154188474|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154188475|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154188476|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154188477|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
154188478|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188479|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188480|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188481|NCT00941057|Androgens|androgens|mesh-ancestor
154188482|NCT00941057|Hormones|hormones|mesh-ancestor
154188483|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
154188484|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
154188485|NCT00941057|Vitamins|vitamins|mesh-ancestor
154188486|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
154188487|NCT00561821|Mirtazapine|mirtazapine|mesh-list
154188488|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
154188489|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154188490|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154188491|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
154188492|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
154188493|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188494|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188495|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188496|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154188497|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154188498|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188499|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154188500|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154188501|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154188502|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
154188503|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154188504|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154188505|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
154188506|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154188507|NCT03684044|Baloxavir|baloxavir|mesh-list
154188508|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
154188509|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188510|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188511|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188512|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154188513|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154188514|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154188515|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188516|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
154188517|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154188518|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
154188519|NCT00335452|Clopidogrel|clopidogrel|mesh-list
154188520|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154188521|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154188522|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154188523|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153792642|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153792643|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154188524|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
153792645|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153792646|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153792647|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
153792648|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
154256347|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154188525|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188536|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188538|NCT00522392|Lenalidomide|lenalidomide|mesh-list
154188539|NCT00522392|Bortezomib|bortezomib|mesh-list
154188540|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188541|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
153935516|NCT02762344|Heparin|heparin|mesh-list
154188542|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
154188543|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188544|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188545|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154188546|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
154188547|NCT00522392|Hormones|hormones|mesh-ancestor
154188548|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188549|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188550|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188551|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
154188552|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154188553|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154188554|NCT00522392|Growth Substances|growth substances|mesh-ancestor
154188555|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
154188556|NCT01061320|Tocopherols|tocopherols|mesh-list
154188557|NCT01061320|Vitamin E|vitamin e|mesh-list
154188558|NCT01061320|Tocotrienols|tocotrienols|mesh-list
154188559|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
154188560|NCT01061320|Vitamins|vitamins|mesh-ancestor
154188561|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
154188562|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188563|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
154188564|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188565|NCT01061320|Protective Agents|protective agents|mesh-ancestor
154188566|NCT01012544|Clopidogrel|clopidogrel|mesh-list
154188567|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154188568|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154188569|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154188570|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154188571|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
154188572|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188573|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188574|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188575|NCT01012700|Poly ICLC|poly iclc|mesh-list
154188576|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
154188577|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
154188578|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188579|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
154188580|NCT01565720|Isavuconazole|isavuconazole|mesh-list
154188581|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188582|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188583|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154188584|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154188585|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188586|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188587|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188588|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
154188603|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154188604|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
154188605|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188606|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
154188607|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188608|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
154188609|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188610|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154188611|NCT00483756|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154188612|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154188613|NCT00309166|Vaccines|vaccines|mesh-list
154188614|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
154188615|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188616|NCT01063816|Carboplatin|carboplatin|mesh-list
154188617|NCT01063816|Gemcitabine|gemcitabine|mesh-list
154188618|NCT01063816|Veliparib|veliparib|mesh-list
154188619|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188620|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154188621|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
154256348|NCT01265342|Beclomethasone|beclomethasone|mesh-list
154188622|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188623|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154188624|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188625|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
154188626|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
154188627|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154188628|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
154188629|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188630|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188631|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154188632|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
154188633|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
154188634|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154188635|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
154188636|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188637|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188638|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154188639|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154188640|NCT00482274|Docetaxel|docetaxel|mesh-list
154188641|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188642|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
154188643|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
154188644|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
154188645|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188646|NCT00490542|Ziprasidone|ziprasidone|mesh-list
154188647|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154188648|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
154188649|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188650|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188675|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154188676|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
154188677|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188678|NCT02532634|Dexamethasone|dexamethasone|mesh-list
154188679|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
154188680|NCT02532634|Aprepitant|aprepitant|mesh-list
154188681|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
154188682|NCT02532634|Palonosetron|palonosetron|mesh-list
154188683|NCT02532634|Ramosetron|ramosetron|mesh-list
154188684|NCT02532634|BB 1101|bb 1101|mesh-list
154188685|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188686|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
154188687|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
153401184|NCT02393378|Hematinics|hematinics|mesh-ancestor
154188688|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188689|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188690|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154188691|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
154188692|NCT02532634|Hormones|hormones|mesh-ancestor
154188693|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188694|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188695|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188696|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
154188697|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188698|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188699|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154188700|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188701|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154188720|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188722|NCT01014234|Sirolimus|sirolimus|mesh-list
154188723|NCT01014234|Cyclosporins|cyclosporins|mesh-list
154188724|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188725|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188726|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154188727|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
154188728|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188729|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
154188730|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188731|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
154188732|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188733|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154188734|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188735|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154188736|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188737|NCT00501228|Lenograstim|lenograstim|mesh-list
154188739|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
154188740|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188741|NCT00308620|Chloroquine|chloroquine|mesh-list
154188742|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154188743|NCT00308620|Amebicides|amebicides|mesh-ancestor
154188744|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154188745|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154188746|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188747|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
154188748|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188749|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154188750|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154188751|NCT00308620|Analgesics|analgesics|mesh-ancestor
154188752|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
154188753|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188754|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188755|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188756|NCT00308620|Filaricides|filaricides|mesh-ancestor
154188757|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
154188758|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
154188759|NCT00492752|Sorafenib|sorafenib|mesh-list
154188767|NCT00505934|Levetiracetam|levetiracetam|mesh-list
154188768|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
154188769|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
154188770|NCT02532790|Prednisone|prednisone|mesh-list
154188771|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188772|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
154188773|NCT02532790|Hormones|hormones|mesh-ancestor
154188774|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188775|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188776|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188777|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188778|NCT00505778|Mesalamine|mesalamine|mesh-list
154188779|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154188780|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154188781|NCT00505778|Analgesics|analgesics|mesh-ancestor
154188782|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
154188783|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188784|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188785|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188786|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188787|NCT00308074|Aripiprazole|aripiprazole|mesh-list
154188788|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
154188789|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154188790|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154188791|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154188792|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188793|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188794|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
154188795|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
154188796|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188797|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188798|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154188799|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154188800|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
154188801|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154188802|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154188803|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154188804|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154188805|NCT03997058|Estazolam|estazolam|mesh-list
154188806|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
154188807|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154188808|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154188809|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188810|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188811|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154188812|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
154188813|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
154188814|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188815|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188816|NCT00500760|Panitumumab|panitumumab|mesh-list
154188817|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188818|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154188819|NCT01016730|Bortezomib|bortezomib|mesh-list
154188820|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188823|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188824|NCT04334330|Trastuzumab|trastuzumab|mesh-list
154188825|NCT04334330|Fulvestrant|fulvestrant|mesh-list
154188826|NCT04334330|Palbociclib|palbociclib|mesh-list
154188827|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154188840|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188841|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154188842|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154188843|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188844|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188845|NCT01009892|Codeine|codeine|mesh-list
154188846|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154188847|NCT01009892|Narcotics|narcotics|mesh-ancestor
154188848|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188849|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188850|NCT01009892|Analgesics|analgesics|mesh-ancestor
154188851|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
154188852|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188853|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
154188854|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
154188855|NCT00307684|Methylphenidate|methylphenidate|mesh-list
154188856|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154188857|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188858|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154188859|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154188860|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154188861|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188862|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
154188863|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188864|NCT00489918|Teriparatide|teriparatide|mesh-list
154188865|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154188866|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188867|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154188868|NCT01061788|Everolimus|everolimus|mesh-list
154188869|NCT01061788|Panitumumab|panitumumab|mesh-list
154188870|NCT01061788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154188871|NCT01061788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154188872|NCT01061788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188873|NCT01061788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188874|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154188875|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
154188876|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793246|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
153793247|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
153339745|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
153339814|NCT05751304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153793248|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793279|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793280|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793282|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153793283|NCT03612713|Narcotics|narcotics|mesh-ancestor
153793284|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153793286|NCT03612713|Analgesics|analgesics|mesh-ancestor
154188877|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188878|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154188879|NCT00307294|Thalidomide|thalidomide|mesh-list
154188880|NCT00307294|Doxorubicin|doxorubicin|mesh-list
154188881|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154188882|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188883|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154188884|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154188885|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188907|NCT03963401|PF-06700841|pf-06700841|mesh-list
154188908|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154188909|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188910|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188911|NCT04410965|Teriflunomide|teriflunomide|mesh-list
154188912|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154188913|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154188914|NCT04410965|Analgesics|analgesics|mesh-ancestor
154188915|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
154188916|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188917|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188918|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188919|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188920|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154188921|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
154188922|NCT04012775|Insulin|insulin|mesh-list
154188923|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154188924|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154188925|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188926|NCT00944723|Vitamins|vitamins|mesh-list
154188927|NCT00944723|Zinc|zinc|mesh-list
154188928|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
154188929|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
154188930|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
154188931|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188932|NCT00944723|Trace Elements|trace elements|mesh-ancestor
154188933|NCT00944723|Astringents|astringents|mesh-ancestor
154188934|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
154188935|NCT00944801|Doxorubicin|doxorubicin|mesh-list
154188936|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154188937|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154188938|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188939|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154188948|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188949|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154188950|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154188951|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154188952|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
154188953|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188954|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188955|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154188956|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154188957|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
154188958|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
154188959|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188960|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
154188961|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
154188962|NCT00306670|Prednisone|prednisone|mesh-list
154188963|NCT00306670|Rituximab|rituximab|mesh-list
154188964|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154188965|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188966|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
154188967|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188968|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188969|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188970|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
154188971|NCT00306670|Hormones|hormones|mesh-ancestor
154188972|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188973|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188974|NCT00306592|Natalizumab|natalizumab|mesh-list
154188975|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
154188976|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188977|NCT00321646|Bevacizumab|bevacizumab|mesh-list
154188978|NCT00321646|Docetaxel|docetaxel|mesh-list
154188979|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154188980|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188981|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154188982|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154188983|NCT00321646|Growth Substances|growth substances|mesh-ancestor
154188984|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188985|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
154188986|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
154188987|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
154188988|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
154188989|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188990|NCT00403767|Warfarin|warfarin|mesh-list
154188991|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
154188992|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
154188993|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154188994|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
153401266|NCT00355862|Prednisolone|prednisolone|mesh-list
154188995|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154188996|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
154188997|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188998|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188999|NCT00492284|Dexamethasone|dexamethasone|mesh-list
154189000|NCT00492284|Ranibizumab|ranibizumab|mesh-list
154189001|NCT00492284|Verteporfin|verteporfin|mesh-list
154189002|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189003|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
154189004|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
154189005|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189006|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189007|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154189024|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189025|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189026|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154189027|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
154189028|NCT01013012|Hormones|hormones|mesh-ancestor
154189029|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189030|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154189031|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189032|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154189033|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
154189034|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189035|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189036|NCT01009970|Prednisone|prednisone|mesh-list
154189037|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
154189038|NCT01009970|Rituximab|rituximab|mesh-list
154189039|NCT01009970|Doxorubicin|doxorubicin|mesh-list
154189040|NCT01009970|Vincristine|vincristine|mesh-list
154189041|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189042|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
154189043|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189044|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154189045|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154189046|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
154189047|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189048|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189049|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154189050|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189051|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154189052|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154189053|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154189054|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189055|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189056|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
154189057|NCT01009970|Hormones|hormones|mesh-ancestor
154189058|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189059|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154189060|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189061|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189062|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189063|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189064|NCT01015352|Azacitidine|azacitidine|mesh-list
154189065|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
154189066|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189067|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
154189085|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189087|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
154189088|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189089|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154189090|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154189091|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
154189092|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154189093|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189094|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
154189095|NCT03563157|Antidotes|antidotes|mesh-ancestor
154189096|NCT03563157|Protective Agents|protective agents|mesh-ancestor
154189097|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
154189098|NCT03563157|Vitamins|vitamins|mesh-ancestor
154189099|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
154189100|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189101|NCT01010048|Nifedipine|nifedipine|mesh-list
154189102|NCT01010048|Bromides|bromides|mesh-list
154189103|NCT01010048|Propantheline|propantheline|mesh-list
154189104|NCT01010048|Tamsulosin|tamsulosin|mesh-list
154189105|NCT01010048|Progesterone|progesterone|mesh-list
154189106|NCT01010048|Progestins|progestins|mesh-ancestor
154189107|NCT01010048|Hormones|hormones|mesh-ancestor
154189108|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189109|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189110|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
154189111|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154189112|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154189113|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154189114|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
154189115|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189116|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189117|NCT01010048|Urological Agents|urological agents|mesh-ancestor
154189118|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154256350|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
154189119|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154189120|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154189121|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
154189122|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
154189123|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154189124|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154189125|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154189126|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154189127|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154189128|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
153793534|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189141|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154189142|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189143|NCT01013480|Baclofen|baclofen|mesh-list
154189144|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154189145|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189146|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154189147|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189148|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154189149|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
154189150|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
154189151|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189152|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189153|NCT00500370|Exenatide|exenatide|mesh-list
154189154|NCT00500370|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154189155|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153793535|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793537|NCT02101775|Adavosertib|adavosertib|mesh-list
153793538|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153793539|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
153793540|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793541|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793542|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189156|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189157|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154189158|NCT00500370|Incretins|incretins|mesh-ancestor
154189159|NCT00500370|Hormones|hormones|mesh-ancestor
154189160|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189161|NCT00320788|Aflibercept|aflibercept|mesh-list
154189162|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189163|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189164|NCT00320788|Growth Substances|growth substances|mesh-ancestor
154189165|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189166|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189167|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189168|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
154189169|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
154189170|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
154189171|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154189172|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
154189173|NCT03996486|Paraproteins|paraproteins|mesh-list
154189174|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
154189175|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189176|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
154189177|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154189178|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154189179|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189180|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154189181|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
154189182|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189183|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154189184|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
154189185|NCT01014468|Bevacizumab|bevacizumab|mesh-list
154189186|NCT01014468|Ranibizumab|ranibizumab|mesh-list
154189187|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189188|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189189|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189190|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189191|NCT01014468|Growth Substances|growth substances|mesh-ancestor
154189192|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189209|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
154189210|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189211|NCT03996564|Acetaminophen|acetaminophen|mesh-list
154189212|NCT03996564|Diclofenac|diclofenac|mesh-list
154189213|NCT03996564|Ketorolac|ketorolac|mesh-list
154189214|NCT03996564|Diazepam|diazepam|mesh-list
154189215|NCT03996564|Hydrocodone|hydrocodone|mesh-list
154189216|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154189217|NCT03996564|Analgesics|analgesics|mesh-ancestor
154189218|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
154189219|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189220|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189221|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
154256351|NCT01265342|Hormones|hormones|mesh-ancestor
154256352|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256353|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256354|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154189222|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154189223|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189224|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154189225|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154189226|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189227|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189228|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153936190|NCT02758522|Insulin|insulin|mesh-list
154189229|NCT03996564|Narcotics|narcotics|mesh-ancestor
154189230|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189231|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
154189232|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
154189233|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154189234|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
154189235|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
154189236|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
154189237|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154189238|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153860963|NCT04424901|Dipyridamole|dipyridamole|mesh-list
154189239|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154189240|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154189241|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154189242|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154189243|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154189244|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154189245|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
154189246|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
154189247|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
154189248|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
154189249|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189250|NCT00565409|Etanercept|etanercept|mesh-list
154189251|NCT00565409|Methotrexate|methotrexate|mesh-list
154189252|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154189253|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
154189272|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189273|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154189275|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
154189276|NCT00394251|Bevacizumab|bevacizumab|mesh-list
154189277|NCT00394251|Doxorubicin|doxorubicin|mesh-list
154189278|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154189279|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154189280|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189281|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189282|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189283|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189284|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189285|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189286|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189287|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
154189288|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189289|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154189290|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154189291|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
154189292|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154189293|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189294|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189295|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189296|NCT00394251|Growth Substances|growth substances|mesh-ancestor
154189297|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189298|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154189299|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154189300|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154189301|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189302|NCT02532400|Goserelin|goserelin|mesh-list
154189303|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154189304|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189305|NCT00394095|Topiramate|topiramate|mesh-list
154189306|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
154189307|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154189333|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
154189334|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189335|NCT03984760|Sevelamer|sevelamer|mesh-list
154189336|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
154189337|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
154189338|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189339|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
154189340|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154189341|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154189342|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154189343|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
154189344|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189345|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189346|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189347|NCT01060618|Maraviroc|maraviroc|mesh-list
154189348|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154189349|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154189350|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189351|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154189352|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154189353|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
154189354|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154189355|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154189356|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
154189357|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189358|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
154189373|NCT00500292|Protective Agents|protective agents|mesh-ancestor
154189374|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
154189375|NCT00500292|Vitamins|vitamins|mesh-ancestor
154189376|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
154189377|NCT00500292|Hematinics|hematinics|mesh-ancestor
154189378|NCT01013558|Remifentanil|remifentanil|mesh-list
154189379|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154189380|NCT01013558|Narcotics|narcotics|mesh-ancestor
154189381|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189382|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189383|NCT01013558|Analgesics|analgesics|mesh-ancestor
154189384|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
154189385|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189386|NCT00499746|Tramadol|tramadol|mesh-list
154189387|NCT00499746|Hydromorphone|hydromorphone|mesh-list
154189388|NCT00499746|Methylphenidate|methylphenidate|mesh-list
154189389|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154189390|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189391|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154189392|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154189393|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154189394|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189395|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
154189396|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189397|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154189398|NCT00499746|Narcotics|narcotics|mesh-ancestor
154189399|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189400|NCT00499746|Analgesics|analgesics|mesh-ancestor
154189401|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
154189402|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189403|NCT01010516|Niacin|niacin|mesh-list
154189404|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154189405|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154189406|NCT01010516|Fenofibrate|fenofibrate|mesh-list
154189407|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154189408|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154189409|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
154189410|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189411|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154189412|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189413|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
154189414|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
154189415|NCT01010516|Vitamins|vitamins|mesh-ancestor
154189416|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
154189417|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189418|NCT01020162|Gabapentin|gabapentin|mesh-list
154189419|NCT01020162|Amitriptyline|amitriptyline|mesh-list
154189420|NCT01020162|Analgesics|analgesics|mesh-ancestor
154189421|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
154189422|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860986|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189423|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189437|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154189438|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154189439|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154189440|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
154189441|NCT01016886|Bisoprolol|bisoprolol|mesh-list
154189442|NCT01016886|Perindopril|perindopril|mesh-list
154189443|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154189444|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
154189445|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
154189446|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189447|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189448|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154189449|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154189450|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154189451|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
154189452|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189453|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189454|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154189455|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
154189456|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936403|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189457|NCT00499590|Ranibizumab|ranibizumab|mesh-list
154189458|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189459|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189460|NCT00499590|Growth Substances|growth substances|mesh-ancestor
154189461|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189462|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189463|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189465|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
154189466|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
154189467|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189468|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189469|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154189470|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154189471|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154189472|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189473|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154189474|NCT00510146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154189475|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154189476|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154189477|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189478|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189479|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
154189480|NCT00480636|Dalteparin|dalteparin|mesh-list
154189481|NCT00480636|Tinzaparin|tinzaparin|mesh-list
153793730|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793735|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
154189482|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154189483|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
154189498|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
154189499|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189500|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189501|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154189502|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189503|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189504|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189505|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154189506|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154189507|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154189508|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189509|NCT00393939|Docetaxel|docetaxel|mesh-list
154189510|NCT00393939|Sunitinib|sunitinib|mesh-list
154189511|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189512|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189513|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189514|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189515|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189516|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189517|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189518|NCT00393939|Growth Substances|growth substances|mesh-ancestor
154189519|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189520|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189521|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154189522|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189524|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189525|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189526|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189527|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189528|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189529|NCT00488826|Vaccines|vaccines|mesh-list
154189530|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154189531|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
153936478|NCT01127165|Zonisamide|zonisamide|mesh-list
154189532|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189534|NCT06314126|Vitamin B Complex|vitamin b complex|mesh-ancestor
154189535|NCT06314126|Vitamins|vitamins|mesh-ancestor
154189536|NCT06314126|Micronutrients|micronutrients|mesh-ancestor
154189537|NCT06314126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189538|NCT06314113|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154189539|NCT06314113|Antioxidants|antioxidants|mesh-ancestor
154189540|NCT06314113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189541|NCT06314113|Protective Agents|protective agents|mesh-ancestor
154189542|NCT06314113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189543|NCT06314113|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154189544|NCT06314113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154189558|NCT06313996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154189559|NCT06313996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154189560|NCT06313996|Alkylating Agents|alkylating agents|mesh-ancestor
154189561|NCT06313996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189562|NCT06313996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189563|NCT06313996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154189564|NCT06313996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189565|NCT06313996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154189566|NCT06313996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154189567|NCT06313996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154189568|NCT06313996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793797|NCT00271401|Heparin|heparin|mesh-list
153401354|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154189569|NCT06313996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189570|NCT06313996|Glucocorticoids|glucocorticoids|mesh-ancestor
154189571|NCT06313996|Hormones|hormones|mesh-ancestor
154189572|NCT06313996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189573|NCT06313996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154189574|NCT06313996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189575|NCT06313996|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189576|NCT06313996|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189577|NCT06313996|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189578|NCT06313996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189579|NCT06313996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189580|NCT06313996|Growth Substances|growth substances|mesh-ancestor
154189581|NCT06313996|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189582|NCT06313983|Capecitabine|capecitabine|mesh-list
154189583|NCT06313983|Lapatinib|lapatinib|mesh-list
154189584|NCT06313983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189585|NCT06313983|Antimetabolites|antimetabolites|mesh-ancestor
154189586|NCT06313983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189587|NCT06313983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189588|NCT06313983|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154189589|NCT06313983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154189590|NCT06313983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189591|NCT06313970|Paclitaxel|paclitaxel|mesh-list
154189592|NCT06313970|Bevacizumab|bevacizumab|mesh-list
154189593|NCT06313970|Gemcitabine|gemcitabine|mesh-list
154189594|NCT06313970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189595|NCT06313970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189596|NCT06313970|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189597|NCT06313970|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189598|NCT06313970|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189599|NCT06313970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189600|NCT06313970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189601|NCT06313970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189602|NCT06313970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189603|NCT06313970|Growth Substances|growth substances|mesh-ancestor
153936554|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
154189604|NCT06313970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189605|NCT06313970|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189606|NCT06313970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189607|NCT06313970|Antimetabolites|antimetabolites|mesh-ancestor
154189617|NCT06313801|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189618|NCT06313801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189619|NCT06313801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154189620|NCT06313801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189621|NCT06313801|Antimetabolites|antimetabolites|mesh-ancestor
154189622|NCT06313801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189623|NCT06313801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189624|NCT06313801|Immunologic Factors|immunologic factors|mesh-ancestor
154189626|NCT06313801|Protective Agents|protective agents|mesh-ancestor
154189627|NCT06313801|Vitamin B Complex|vitamin b complex|mesh-ancestor
154189628|NCT06313801|Vitamins|vitamins|mesh-ancestor
154189629|NCT06313801|Micronutrients|micronutrients|mesh-ancestor
154189630|NCT06313788|Analgesics|analgesics|mesh-list
154189631|NCT06313788|Sensory System Agents|sensory system agents|mesh-ancestor
154189632|NCT06313788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189633|NCT06313788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189634|NCT06313762|Vaccines|vaccines|mesh-list
154189635|NCT06313762|Immunologic Factors|immunologic factors|mesh-ancestor
154189636|NCT06313762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189637|NCT06313567|Capecitabine|capecitabine|mesh-list
154189638|NCT06313567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189639|NCT06313567|Antimetabolites|antimetabolites|mesh-ancestor
154189640|NCT06313567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189641|NCT06313567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189642|NCT06313554|Gemcitabine|gemcitabine|mesh-list
154189643|NCT06313554|Oxaliplatin|oxaliplatin|mesh-list
154189644|NCT06313554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189645|NCT06313554|Antimetabolites|antimetabolites|mesh-ancestor
154189646|NCT06313554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189647|NCT06313554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189648|NCT06313541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154189649|NCT06313541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189650|NCT06313541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793881|NCT01604629|Adalimumab|adalimumab|mesh-list
153401369|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
154189651|NCT06313541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189652|NCT06313463|Capecitabine|capecitabine|mesh-list
154189653|NCT06313463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189654|NCT06313463|Antimetabolites|antimetabolites|mesh-ancestor
154189655|NCT06313463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189656|NCT06313463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189657|NCT06313437|Cytarabine|cytarabine|mesh-list
154189658|NCT06313437|Daunorubicin|daunorubicin|mesh-list
154189659|NCT06313437|Midostaurin|midostaurin|mesh-list
154189660|NCT06313437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189661|NCT06313437|Antimetabolites|antimetabolites|mesh-ancestor
154189662|NCT06313437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189663|NCT06313437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189664|NCT06313437|Antiviral Agents|antiviral agents|mesh-ancestor
154189665|NCT06313437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154189666|NCT06313437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189667|NCT06313437|Immunologic Factors|immunologic factors|mesh-ancestor
154189668|NCT06313437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189669|NCT06313437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154189670|NCT06313437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154189671|NCT06313437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154189672|NCT06313437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189673|NCT06313437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154189674|NCT06313268|Bevacizumab|bevacizumab|mesh-list
154189675|NCT06313268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189676|NCT06313268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189688|NCT06313086|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154189689|NCT06313086|Maytansine|maytansine|mesh-list
154189690|NCT06313086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189691|NCT06313086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189692|NCT06313086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189693|NCT06313086|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189694|NCT06313086|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189695|NCT06313086|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189696|NCT06313086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189697|NCT06313086|Immunotoxins|immunotoxins|mesh-ancestor
154189698|NCT06313086|Immunoconjugates|immunoconjugates|mesh-ancestor
154189699|NCT06313086|Immunologic Factors|immunologic factors|mesh-ancestor
154189700|NCT06313086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189701|NCT06312982|Tislelizumab|tislelizumab|mesh-list
154189702|NCT06312982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189704|NCT06312904|Anesthetics|anesthetics|mesh-list
154189705|NCT06312904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189706|NCT06312904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189707|NCT06312813|Amitriptyline|amitriptyline|mesh-list
154189708|NCT06312813|Imipramine|imipramine|mesh-list
154189709|NCT06312813|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154189710|NCT06312813|Antidepressive Agents|antidepressive agents|mesh-ancestor
154189711|NCT06312813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154189712|NCT06312813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154189713|NCT06312813|Analgesics|analgesics|mesh-ancestor
154189714|NCT06312813|Sensory System Agents|sensory system agents|mesh-ancestor
154189715|NCT06312813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189716|NCT06312813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189717|NCT06312813|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154189718|NCT06312813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154189719|NCT06312813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154189720|NCT06312813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189721|NCT06312813|Adrenergic Agents|adrenergic agents|mesh-ancestor
154189722|NCT06312813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189723|NCT06312800|Methazolamide|methazolamide|mesh-list
154189724|NCT06312800|Acamprosate|acamprosate|mesh-list
154189725|NCT06312800|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154189726|NCT06312800|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154189727|NCT06312800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189728|NCT06312800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189729|NCT06312800|Diuretics|diuretics|mesh-ancestor
154189730|NCT06312800|Natriuretic Agents|natriuretic agents|mesh-ancestor
154189731|NCT06312800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189732|NCT06312761|Curcumin|curcumin|mesh-list
154189754|NCT06312761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189755|NCT06312761|Androgen Antagonists|androgen antagonists|mesh-ancestor
154189756|NCT06312761|Hormone Antagonists|hormone antagonists|mesh-ancestor
154189757|NCT06312748|Atorvastatin|atorvastatin|mesh-list
154189758|NCT06312748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154189759|NCT06312748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154189760|NCT06312748|Antimetabolites|antimetabolites|mesh-ancestor
154189761|NCT06312748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189762|NCT06312748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154189763|NCT06312748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154189764|NCT06312748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189765|NCT06312670|Androgens|androgens|mesh-list
154189766|NCT06312670|Hormones|hormones|mesh-ancestor
154189767|NCT06312670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189768|NCT06312670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189769|NCT06312644|Ravulizumab|ravulizumab|mesh-list
154189770|NCT06312644|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154189771|NCT06312644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189772|NCT06312644|Immunologic Factors|immunologic factors|mesh-ancestor
154189773|NCT06312644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189774|NCT06312618|Dexmedetomidine|dexmedetomidine|mesh-list
154189775|NCT06312618|Propofol|propofol|mesh-list
154189776|NCT06312618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154189777|NCT06312618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189778|NCT06312618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189779|NCT06312618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154189780|NCT06312618|Analgesics|analgesics|mesh-ancestor
154189781|NCT06312618|Sensory System Agents|sensory system agents|mesh-ancestor
154189782|NCT06312618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189783|NCT06312618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154189802|NCT06312254|Lidocaine|lidocaine|mesh-list
154189803|NCT06312254|Phenytoin|phenytoin|mesh-list
154189804|NCT06312254|Anesthetics, Local|anesthetics, local|mesh-ancestor
154189805|NCT06312254|Anesthetics|anesthetics|mesh-ancestor
154189806|NCT06312254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189807|NCT06312254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189808|NCT06312254|Sensory System Agents|sensory system agents|mesh-ancestor
154189809|NCT06312254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189810|NCT06312254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154189811|NCT06312254|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154189812|NCT06312254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154189813|NCT06312254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154189814|NCT06312254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189816|NCT06312254|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154189817|NCT06312254|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154189818|NCT06312254|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154189819|NCT06312254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154189820|NCT06312254|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154189821|NCT06312254|Histamine Antagonists|histamine antagonists|mesh-ancestor
154189822|NCT06312254|Histamine Agents|histamine agents|mesh-ancestor
154189823|NCT06312254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189824|NCT06312254|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154189825|NCT06312176|Paclitaxel|paclitaxel|mesh-list
154189826|NCT06312176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154189827|NCT06312176|Doxorubicin|doxorubicin|mesh-list
154189828|NCT06312176|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153936781|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
154189829|NCT06312176|Pembrolizumab|pembrolizumab|mesh-list
154189830|NCT06312176|Capecitabine|capecitabine|mesh-list
154189831|NCT06312176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189832|NCT06312176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189833|NCT06312176|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189834|NCT06312176|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189835|NCT06312176|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189836|NCT06312176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189837|NCT06312176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154189838|NCT06312176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154189839|NCT06312176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154189840|NCT06312176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189853|NCT06312137|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189854|NCT06312137|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189855|NCT06312137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189856|NCT06312137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189857|NCT06312137|Antimetabolites|antimetabolites|mesh-ancestor
154189858|NCT06312137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189859|NCT06312137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154189860|NCT06312137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189861|NCT06312137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154189862|NCT06312137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154189863|NCT06312033|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154189864|NCT06312033|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154189865|NCT06312033|Estradiol|estradiol|mesh-list
154189866|NCT06312033|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154189867|NCT06312033|Estrogens|estrogens|mesh-ancestor
154189868|NCT06312033|Hormones|hormones|mesh-ancestor
154189869|NCT06312033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189870|NCT06312033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189871|NCT06312033|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154189872|NCT06312033|Contraceptive Agents|contraceptive agents|mesh-ancestor
154189873|NCT06312033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154189874|NCT06312033|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154189875|NCT06311942|Lenvatinib|lenvatinib|mesh-list
154189876|NCT06311942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154189877|NCT06311942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189878|NCT06311942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154189879|NCT06311942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189880|NCT06311942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189881|NCT06311942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189882|NCT06311929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154189883|NCT06311929|Lenvatinib|lenvatinib|mesh-list
154189884|NCT06311929|Antibodies|antibodies|mesh-list
154189885|NCT06311929|Immunoglobulins|immunoglobulins|mesh-list
154189886|NCT06311929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154189887|NCT06311929|Immunologic Factors|immunologic factors|mesh-ancestor
154189888|NCT06311929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189889|NCT06311929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189890|NCT06311929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154189891|NCT06311929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189892|NCT06311929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189893|NCT06311916|Lenvatinib|lenvatinib|mesh-list
154189894|NCT06311916|Liver Extracts|liver extracts|mesh-list
154189895|NCT06311916|Hematinics|hematinics|mesh-ancestor
154189896|NCT06311916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189897|NCT06311916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154189898|NCT06311916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189899|NCT06311916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189900|NCT06311903|Norepinephrine|norepinephrine|mesh-list
154189901|NCT06311903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154189902|NCT06311903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154189903|NCT06311903|Adrenergic Agents|adrenergic agents|mesh-ancestor
153936854|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189913|NCT06311851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189914|NCT06311851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189915|NCT06311851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189916|NCT06311851|Growth Substances|growth substances|mesh-ancestor
154189917|NCT06311851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189918|NCT06311851|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189920|NCT06311721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189921|NCT06311721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189922|NCT06311721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154189923|NCT06311721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189925|NCT06311604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154189926|NCT06311604|Anesthetics, General|anesthetics, general|mesh-ancestor
154189927|NCT06311604|Anesthetics|anesthetics|mesh-ancestor
154189928|NCT06311604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189929|NCT06311604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189930|NCT06311227|Venetoclax|venetoclax|mesh-list
154189931|NCT06311227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189932|NCT06311214|Trastuzumab|trastuzumab|mesh-list
154189933|NCT06311214|Camptothecin|camptothecin|mesh-list
154189934|NCT06311214|Irinotecan|irinotecan|mesh-list
154189935|NCT06311214|Antibodies|antibodies|mesh-list
154189936|NCT06311214|Immunoglobulins|immunoglobulins|mesh-list
154189937|NCT06311214|Immunoconjugates|immunoconjugates|mesh-list
154189938|NCT06311214|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154189939|NCT06311214|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154189940|NCT06311214|Immunologic Factors|immunologic factors|mesh-ancestor
154189941|NCT06311214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189942|NCT06311214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189943|NCT06311214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189944|NCT06311214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189945|NCT06311214|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154189946|NCT06311214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154189947|NCT06311214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189948|NCT06311214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189949|NCT06311045|Acetylcysteine|acetylcysteine|mesh-list
154189950|NCT06311045|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154189951|NCT06311045|Antiviral Agents|antiviral agents|mesh-ancestor
154189952|NCT06311045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154189953|NCT06311045|Expectorants|expectorants|mesh-ancestor
154189954|NCT06311045|Respiratory System Agents|respiratory system agents|mesh-ancestor
154189955|NCT06311045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154189956|NCT06311045|Antioxidants|antioxidants|mesh-ancestor
154189957|NCT06311045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189958|NCT06311045|Protective Agents|protective agents|mesh-ancestor
154189959|NCT06311045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189960|NCT06311045|Antidotes|antidotes|mesh-ancestor
154189961|NCT06311019|Insulin|insulin|mesh-list
154189962|NCT06311019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154189963|NCT06311019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189964|NCT06310941|Hyaluronic Acid|hyaluronic acid|mesh-list
154189965|NCT06310941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154189966|NCT06310941|Immunologic Factors|immunologic factors|mesh-ancestor
154189967|NCT06310941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189968|NCT06310941|Viscosupplements|viscosupplements|mesh-ancestor
154189969|NCT06310941|Protective Agents|protective agents|mesh-ancestor
154189993|NCT06310863|Protective Agents|protective agents|mesh-ancestor
154189994|NCT06310850|Ketamine|ketamine|mesh-list
154189995|NCT06310850|Analgesics|analgesics|mesh-ancestor
154189996|NCT06310850|Sensory System Agents|sensory system agents|mesh-ancestor
154189997|NCT06310850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189998|NCT06310850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189999|NCT06310850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154190000|NCT06310850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154190001|NCT06310850|Anesthetics, General|anesthetics, general|mesh-ancestor
154190002|NCT06310850|Anesthetics|anesthetics|mesh-ancestor
154190003|NCT06310850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190004|NCT06310850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154190005|NCT06310850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154190006|NCT06310850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190007|NCT06310850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190009|NCT06310837|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154190010|NCT06310837|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154190011|NCT06310837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190012|NCT06310837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190013|NCT06310837|Immunologic Factors|immunologic factors|mesh-ancestor
154190014|NCT06310837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190015|NCT06310785|Sufentanil|sufentanil|mesh-list
154190016|NCT06310785|Esketamine|esketamine|mesh-list
154190017|NCT06310785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154190018|NCT06310785|Narcotics|narcotics|mesh-ancestor
154190019|NCT06310785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190020|NCT06310785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190021|NCT06310785|Analgesics|analgesics|mesh-ancestor
154190022|NCT06310785|Sensory System Agents|sensory system agents|mesh-ancestor
154190023|NCT06310785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190024|NCT06310785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154190025|NCT06310785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154190026|NCT06310785|Anesthetics, General|anesthetics, general|mesh-ancestor
154190027|NCT06310785|Anesthetics|anesthetics|mesh-ancestor
154190052|NCT06310642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190053|NCT06310642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154190054|NCT06310642|Antipruritics|antipruritics|mesh-ancestor
154190055|NCT06310642|Dermatologic Agents|dermatologic agents|mesh-ancestor
154190056|NCT06310642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154190057|NCT06310642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154190058|NCT06310642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154190059|NCT06310642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154190060|NCT06310642|Dopamine Agents|dopamine agents|mesh-ancestor
154190061|NCT06310616|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154190062|NCT06310616|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154190063|NCT06310616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154190064|NCT06310616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154190065|NCT06310616|Contraceptive Agents|contraceptive agents|mesh-ancestor
154190066|NCT06310616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154190067|NCT06310616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190068|NCT06310616|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154190069|NCT06310616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154190070|NCT06310616|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154190071|NCT06310616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154190073|NCT06310473|Oxaliplatin|oxaliplatin|mesh-list
154190074|NCT06310473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154190075|NCT06310473|Antimetabolites|antimetabolites|mesh-ancestor
154190076|NCT06310473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190077|NCT06310473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190078|NCT06310343|Alemtuzumab|alemtuzumab|mesh-list
154190096|NCT06308419|Antimetabolites|antimetabolites|mesh-ancestor
154190097|NCT06308419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190098|NCT06308419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190099|NCT06308419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154190100|NCT06308419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190101|NCT06308419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154190102|NCT06308419|Antifungal Agents|antifungal agents|mesh-ancestor
153401437|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
154190103|NCT06308419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154190104|NCT06308419|Immunologic Factors|immunologic factors|mesh-ancestor
154190105|NCT06308419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190106|NCT06306391|Naloxone|naloxone|mesh-list
154190107|NCT06306391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154190108|NCT06306391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190109|NCT06306391|Sensory System Agents|sensory system agents|mesh-ancestor
154190110|NCT06306391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190111|NCT06305520|Lidocaine|lidocaine|mesh-list
154190112|NCT06305520|Anesthetics, Local|anesthetics, local|mesh-ancestor
154190113|NCT06305520|Anesthetics|anesthetics|mesh-ancestor
154190114|NCT06305520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190115|NCT06305520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190116|NCT06305520|Sensory System Agents|sensory system agents|mesh-ancestor
154190117|NCT06305520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190118|NCT06305520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154190119|NCT06305520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154190120|NCT06305520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154190121|NCT06305520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190123|NCT06304909|Dexamethasone|dexamethasone|mesh-list
154190124|NCT06304909|Dexmedetomidine|dexmedetomidine|mesh-list
154190125|NCT06304909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190126|NCT06304909|Antiemetics|antiemetics|mesh-ancestor
154190127|NCT06304909|Autonomic Agents|autonomic agents|mesh-ancestor
154190128|NCT06304909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190129|NCT06304909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190130|NCT06304909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190131|NCT06304909|Glucocorticoids|glucocorticoids|mesh-ancestor
154190132|NCT06304909|Hormones|hormones|mesh-ancestor
154190133|NCT06304909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190160|NCT06304142|Anesthetics, Local|anesthetics, local|mesh-ancestor
154190161|NCT06304142|Anesthetics|anesthetics|mesh-ancestor
154190162|NCT06304142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190163|NCT06304142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190164|NCT06304142|Sensory System Agents|sensory system agents|mesh-ancestor
154190165|NCT06304142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190166|NCT06304142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154190167|NCT06304142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154190168|NCT06304142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154190169|NCT06304142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190170|NCT06304142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190171|NCT06304116|Lidocaine|lidocaine|mesh-list
154190172|NCT06304116|Anesthetics, Local|anesthetics, local|mesh-ancestor
154190173|NCT06304116|Anesthetics|anesthetics|mesh-ancestor
154190174|NCT06304116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190175|NCT06304116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190176|NCT06304116|Sensory System Agents|sensory system agents|mesh-ancestor
154190177|NCT06304116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190178|NCT06304116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153937159|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937160|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153861117|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
153937161|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190187|NCT06304090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190188|NCT06304090|Sensory System Agents|sensory system agents|mesh-ancestor
154190189|NCT06304090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190190|NCT06304090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154190191|NCT06304090|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154190192|NCT06304090|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154190193|NCT06304090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190194|NCT06304090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190195|NCT06303128|Amoxicillin|amoxicillin|mesh-list
154190196|NCT06303128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154190197|NCT06303128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190198|NCT06303115|Nicotine|nicotine|mesh-list
154190199|NCT06303115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154190200|NCT06303115|Autonomic Agents|autonomic agents|mesh-ancestor
154190201|NCT06303115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190202|NCT06303115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190203|NCT06303115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154190204|NCT06303115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154190205|NCT06303115|Cholinergic Agents|cholinergic agents|mesh-ancestor
154190206|NCT06303115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190207|NCT06303115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190208|NCT06294548|Bevacizumab|bevacizumab|mesh-list
154190209|NCT06294548|Atezolizumab|atezolizumab|mesh-list
154190210|NCT06294548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401449|NCT00376181|Pioglitazone|pioglitazone|mesh-list
154190211|NCT06294548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190212|NCT06294548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154190213|NCT06294548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154190214|NCT06294548|Growth Substances|growth substances|mesh-ancestor
154190215|NCT06294548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190216|NCT06294548|Growth Inhibitors|growth inhibitors|mesh-ancestor
154190217|NCT06294548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190218|NCT06294548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190236|NCT06289673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190238|NCT06289673|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154190239|NCT06289673|Abortifacient Agents|abortifacient agents|mesh-ancestor
154190240|NCT06289673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153799743|NCT00278408|Prednisone|prednisone|mesh-list
154190241|NCT06289673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154190242|NCT06289673|Antimetabolites|antimetabolites|mesh-ancestor
154190243|NCT06289673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190244|NCT06289673|Dermatologic Agents|dermatologic agents|mesh-ancestor
154190245|NCT06289673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190246|NCT06289673|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154190247|NCT06289673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154190248|NCT06289673|Immunologic Factors|immunologic factors|mesh-ancestor
154190249|NCT06289673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190250|NCT06289673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154190251|NCT06289673|Antiviral Agents|antiviral agents|mesh-ancestor
153794289|NCT00292110|Narcotics|narcotics|mesh-ancestor
154190252|NCT06289673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190253|NCT06289673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154190254|NCT06289673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154190255|NCT06289673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154190256|NCT06289673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154190257|NCT06289673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154190258|NCT06289673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154190259|NCT06289673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190260|NCT06289192|Nicotine|nicotine|mesh-list
154190261|NCT06289192|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154190262|NCT06289192|Autonomic Agents|autonomic agents|mesh-ancestor
154190263|NCT06289192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190264|NCT06289192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190265|NCT06289192|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154190266|NCT06289192|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154190267|NCT06289192|Cholinergic Agents|cholinergic agents|mesh-ancestor
154190268|NCT06289192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190269|NCT06289192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190270|NCT06288386|Z 350|z 350|mesh-list
154190271|NCT06288386|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154190272|NCT06288386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154190273|NCT06288386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190274|NCT06288386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190275|NCT06288386|Hormone Antagonists|hormone antagonists|mesh-ancestor
154190276|NCT06288386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190303|NCT06284122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190304|NCT06284122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154190305|NCT06284122|Alkylating Agents|alkylating agents|mesh-ancestor
154190306|NCT06284122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190307|NCT06284122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190308|NCT06284122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154190309|NCT06284122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190310|NCT06284122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154190311|NCT06284122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154190312|NCT06284122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190313|NCT06284122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190314|NCT06284122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190315|NCT06284122|Glucocorticoids|glucocorticoids|mesh-ancestor
154190316|NCT06284122|Hormones|hormones|mesh-ancestor
154190317|NCT06284122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190318|NCT06284122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190319|NCT06284122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154190320|NCT06284122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154190321|NCT06284122|Growth Substances|growth substances|mesh-ancestor
154190322|NCT06284122|Growth Inhibitors|growth inhibitors|mesh-ancestor
154190323|NCT06284122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154190324|NCT06284122|Tubulin Modulators|tubulin modulators|mesh-ancestor
154190345|NCT06274333|Narcotics|narcotics|mesh-ancestor
154190346|NCT06273891|Azithromycin|azithromycin|mesh-list
154190347|NCT06273891|Erythromycin|erythromycin|mesh-list
154190348|NCT06273891|Erythromycin Estolate|erythromycin estolate|mesh-list
154190349|NCT06273891|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154190350|NCT06273891|Erythromycin stearate|erythromycin stearate|mesh-list
154190351|NCT06273891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154190352|NCT06273891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190353|NCT06273891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190354|NCT06273891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154190355|NCT06273891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190356|NCT06273891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190357|NCT06273072|Metformin|metformin|mesh-list
153799825|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
153799839|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
154190358|NCT06273072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154190359|NCT06273072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190360|NCT06269185|Adalimumab|adalimumab|mesh-list
154190361|NCT06269185|Infliximab|infliximab|mesh-list
154190362|NCT06269185|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154190363|NCT06269185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190364|NCT06269185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190365|NCT06269185|Dermatologic Agents|dermatologic agents|mesh-ancestor
154190366|NCT06269185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190372|NCT06265285|Nivolumab|nivolumab|mesh-list
154190373|NCT06265285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190374|NCT06265285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190375|NCT06265285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190376|NCT06265285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190377|NCT06259058|Leucovorin|leucovorin|mesh-list
154190378|NCT06259058|Fluorouracil|fluorouracil|mesh-list
154190379|NCT06259058|Oxaliplatin|oxaliplatin|mesh-list
154190380|NCT06259058|Irinotecan|irinotecan|mesh-list
154190381|NCT06259058|Antimetabolites|antimetabolites|mesh-ancestor
154190382|NCT06259058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190383|NCT06259058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154190384|NCT06259058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190385|NCT06259058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154190386|NCT06259058|Immunologic Factors|immunologic factors|mesh-ancestor
154190387|NCT06259058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190388|NCT06259058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154190389|NCT06259058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190390|NCT06259058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190391|NCT06259058|Antidotes|antidotes|mesh-ancestor
154190392|NCT06259058|Protective Agents|protective agents|mesh-ancestor
154190393|NCT06259058|Vitamin B Complex|vitamin b complex|mesh-ancestor
154190394|NCT06259058|Vitamins|vitamins|mesh-ancestor
154190395|NCT06259058|Micronutrients|micronutrients|mesh-ancestor
154190396|NCT06255366|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154190397|NCT06255366|Hemostatics|hemostatics|mesh-ancestor
154190408|NCT06254053|Dopamine Agents|dopamine agents|mesh-ancestor
154190409|NCT06254053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190410|NCT06254053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937369|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
154190411|NCT06254053|Adrenergic Agents|adrenergic agents|mesh-ancestor
154190412|NCT06254053|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154190413|NCT06254053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154190414|NCT06254053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190415|NCT06254053|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154190417|NCT06252623|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154190418|NCT06252623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154190419|NCT06252623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190420|NCT06252623|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154190421|NCT06252623|Incretins|incretins|mesh-ancestor
154190422|NCT06252623|Hormones|hormones|mesh-ancestor
154190423|NCT06252623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190424|NCT06251973|Paclitaxel|paclitaxel|mesh-list
154190425|NCT06251973|Ramucirumab|ramucirumab|mesh-list
154190426|NCT06251973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154190427|NCT06251973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190428|NCT06251973|Tubulin Modulators|tubulin modulators|mesh-ancestor
154190429|NCT06251973|Antimitotic Agents|antimitotic agents|mesh-ancestor
154190430|NCT06251973|Mitosis Modulators|mitosis modulators|mesh-ancestor
154190431|NCT06251973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190432|NCT06251973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154190433|NCT06251973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154190434|NCT06251973|Growth Substances|growth substances|mesh-ancestor
154190435|NCT06251973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190436|NCT06251973|Growth Inhibitors|growth inhibitors|mesh-ancestor
154190437|NCT06249815|Misoprostol|misoprostol|mesh-list
154190438|NCT06249815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154190439|NCT06249815|Abortifacient Agents|abortifacient agents|mesh-ancestor
154190440|NCT06249815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154190441|NCT06249815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190442|NCT06249815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154190443|NCT06249815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190444|NCT06249815|Oxytocics|oxytocics|mesh-ancestor
154190445|NCT06246968|Pembrolizumab|pembrolizumab|mesh-list
154190446|NCT06246968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190448|NCT06246968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190449|NCT06246968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190450|NCT06243094|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154190451|NCT06243094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190452|NCT06234631|Cannabidiol|cannabidiol|mesh-list
154190453|NCT06234631|Anticonvulsants|anticonvulsants|mesh-ancestor
154190454|NCT06225466|Rocuronium|rocuronium|mesh-list
154190455|NCT06225466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154190456|NCT06225466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190457|NCT06225466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154190458|NCT06225466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154190459|NCT06225466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190460|NCT06224348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154190481|NCT06218797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154190482|NCT06218797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190483|NCT06218797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190484|NCT06218797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154190486|NCT06218797|Sensory System Agents|sensory system agents|mesh-ancestor
154190487|NCT06218797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190488|NCT06218797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154190489|NCT06218797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153736264|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154190490|NCT06218797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154190491|NCT06218797|Adrenergic Agents|adrenergic agents|mesh-ancestor
154190492|NCT06218797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190493|NCT06218797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190494|NCT06207877|Semaglutide|semaglutide|mesh-list
154190495|NCT06207877|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154190496|NCT06207877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154190497|NCT06207877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190498|NCT06207370|Tafenoquine|tafenoquine|mesh-list
154190499|NCT06207370|Antimalarials|antimalarials|mesh-ancestor
154190500|NCT06207370|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154190501|NCT06207370|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154190502|NCT06207370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190503|NCT06202066|Temozolomide|temozolomide|mesh-list
154190504|NCT06202066|Sargramostim|sargramostim|mesh-list
154190505|NCT06202066|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154190506|NCT06202066|Freund's Adjuvant|freund's adjuvant|mesh-list
154190507|NCT06202066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154190508|NCT06202066|Alkylating Agents|alkylating agents|mesh-ancestor
154190509|NCT06202066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190510|NCT06202066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190511|NCT06202066|Immunologic Factors|immunologic factors|mesh-ancestor
154190512|NCT06202066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190523|NCT06194448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154190524|NCT06194448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190525|NCT06194448|Tubulin Modulators|tubulin modulators|mesh-ancestor
154190526|NCT06194448|Antimitotic Agents|antimitotic agents|mesh-ancestor
154190527|NCT06194448|Mitosis Modulators|mitosis modulators|mesh-ancestor
154190528|NCT06194448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190529|NCT06194448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190530|NCT06194448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154190531|NCT06194448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154190532|NCT06194448|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154190533|NCT06194448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154190534|NCT06194032|Moxifloxacin|moxifloxacin|mesh-list
154190535|NCT06194032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154190536|NCT06194032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190537|NCT06194032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154190538|NCT06194032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190539|NCT06194032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190540|NCT06194032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190541|NCT06194032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190542|NCT06193616|Octreotide|octreotide|mesh-list
154190543|NCT06193616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190544|NCT06193616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190545|NCT06193616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190546|NCT06186700|Cyclophosphamide|cyclophosphamide|mesh-list
154190547|NCT06186700|Doxorubicin|doxorubicin|mesh-list
154190548|NCT06186700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154190549|NCT06186700|Pentoxifylline|pentoxifylline|mesh-list
153800078|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190550|NCT06186700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154190551|NCT06186700|Immunologic Factors|immunologic factors|mesh-ancestor
154190552|NCT06186700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190553|NCT06186700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190554|NCT06186700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154190555|NCT06186700|Alkylating Agents|alkylating agents|mesh-ancestor
154190556|NCT06186700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190557|NCT06186700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190558|NCT06186700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154190559|NCT06186700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154190560|NCT06186700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154190561|NCT06186700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190562|NCT06186700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190563|NCT06186700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154190564|NCT06186700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154190565|NCT06186700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154190566|NCT06186700|Protective Agents|protective agents|mesh-ancestor
154190567|NCT06186700|Vasodilator Agents|vasodilator agents|mesh-ancestor
154190568|NCT06186700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154190570|NCT06176339|Cyclophosphamide|cyclophosphamide|mesh-list
154190571|NCT06176339|Doxorubicin|doxorubicin|mesh-list
154190572|NCT06176339|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154190573|NCT06176339|Taxane|taxane|mesh-list
154190574|NCT06176339|Pentoxifylline|pentoxifylline|mesh-list
154190575|NCT06176339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154190576|NCT06176339|Immunologic Factors|immunologic factors|mesh-ancestor
154190577|NCT06176339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190578|NCT06176339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190579|NCT06176339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154190580|NCT06176339|Alkylating Agents|alkylating agents|mesh-ancestor
154190596|NCT06169215|Dexamethasone acetate|dexamethasone acetate|mesh-list
154190597|NCT06169215|Lenalidomide|lenalidomide|mesh-list
154190598|NCT06169215|Bortezomib|bortezomib|mesh-list
154190599|NCT06169215|Daratumumab|daratumumab|mesh-list
154190600|NCT06169215|Ichthammol|ichthammol|mesh-list
154190601|NCT06169215|BB 1101|bb 1101|mesh-list
154190602|NCT06169215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154190603|NCT06169215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190604|NCT06169215|Antiemetics|antiemetics|mesh-ancestor
154190605|NCT06169215|Autonomic Agents|autonomic agents|mesh-ancestor
154190606|NCT06169215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190607|NCT06169215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190608|NCT06169215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190609|NCT06169215|Glucocorticoids|glucocorticoids|mesh-ancestor
154190610|NCT06169215|Hormones|hormones|mesh-ancestor
154190611|NCT06169215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190612|NCT06169215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190613|NCT06169215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190614|NCT06169215|Protease Inhibitors|protease inhibitors|mesh-ancestor
154190615|NCT06169215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190616|NCT06169215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190617|NCT06169215|Immunologic Factors|immunologic factors|mesh-ancestor
154190618|NCT06169215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154190619|NCT06169215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154190620|NCT06169215|Growth Substances|growth substances|mesh-ancestor
154190621|NCT06169215|Growth Inhibitors|growth inhibitors|mesh-ancestor
154190622|NCT06169215|Dermatologic Agents|dermatologic agents|mesh-ancestor
154190623|NCT06163898|Dexamethasone|dexamethasone|mesh-list
154190624|NCT06163898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190625|NCT06163898|Antiemetics|antiemetics|mesh-ancestor
154190626|NCT06163898|Autonomic Agents|autonomic agents|mesh-ancestor
154190627|NCT06163898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190628|NCT06163898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190629|NCT06163898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190630|NCT06163898|Glucocorticoids|glucocorticoids|mesh-ancestor
154190631|NCT06163898|Hormones|hormones|mesh-ancestor
154190632|NCT06163898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190633|NCT06163898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153861222|NCT03456401|Sorafenib|sorafenib|mesh-list
154190634|NCT06163898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190635|NCT06159777|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154190637|NCT06159777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190638|NCT06157827|Cisplatin|cisplatin|mesh-list
154190639|NCT06157827|Carboplatin|carboplatin|mesh-list
154190640|NCT06157827|Etoposide|etoposide|mesh-list
154190641|NCT06157827|Etoposide phosphate|etoposide phosphate|mesh-list
154190642|NCT06157827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190665|NCT06143891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190666|NCT06143891|Glucocorticoids|glucocorticoids|mesh-ancestor
154190667|NCT06143891|Hormones|hormones|mesh-ancestor
154190668|NCT06143891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190669|NCT06143891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190670|NCT06143891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190671|NCT06143891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190672|NCT06143891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154190673|NCT06143891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190674|NCT06143891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190675|NCT06136650|Dexamethasone|dexamethasone|mesh-list
154190676|NCT06136650|Prednisone|prednisone|mesh-list
154190677|NCT06136650|Hydrocortisone|hydrocortisone|mesh-list
154190678|NCT06136650|Fludrocortisone|fludrocortisone|mesh-list
154190679|NCT06136650|Abiraterone Acetate|abiraterone acetate|mesh-list
154190680|NCT06136650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190681|NCT06136650|Antiemetics|antiemetics|mesh-ancestor
154190682|NCT06136650|Autonomic Agents|autonomic agents|mesh-ancestor
154190683|NCT06136650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794613|NCT00261170|Bupropion|bupropion|mesh-list
154190684|NCT06136650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190685|NCT06136650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190686|NCT06136650|Glucocorticoids|glucocorticoids|mesh-ancestor
154190687|NCT06136650|Hormones|hormones|mesh-ancestor
154190688|NCT06136650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190689|NCT06136650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190690|NCT06136650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190691|NCT06136650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154190692|NCT06136650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190701|NCT06136624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190702|NCT06136624|Antiemetics|antiemetics|mesh-ancestor
154190703|NCT06136624|Autonomic Agents|autonomic agents|mesh-ancestor
154190704|NCT06136624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190705|NCT06136624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190706|NCT06136624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190707|NCT06136624|Glucocorticoids|glucocorticoids|mesh-ancestor
154190708|NCT06136624|Hormones|hormones|mesh-ancestor
153937670|NCT03188068|Prednisolone|prednisolone|mesh-list
154190709|NCT06136624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190710|NCT06136624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190711|NCT06136624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190712|NCT06136624|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154190713|NCT06136624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190714|NCT06136624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190715|NCT06136624|Hormone Antagonists|hormone antagonists|mesh-ancestor
154190716|NCT06136624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154190717|NCT06133114|Buprenorphine|buprenorphine|mesh-list
154190718|NCT06133114|Clonazepam|clonazepam|mesh-list
154190719|NCT06133114|Olanzapine|olanzapine|mesh-list
154190720|NCT06133114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154190721|NCT06133114|Narcotics|narcotics|mesh-ancestor
154190722|NCT06133114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190723|NCT06133114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190724|NCT06133114|Analgesics|analgesics|mesh-ancestor
154190725|NCT06133114|Sensory System Agents|sensory system agents|mesh-ancestor
154190726|NCT06133114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190727|NCT06133114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154190728|NCT06133114|Antiemetics|antiemetics|mesh-ancestor
154190729|NCT06133114|Autonomic Agents|autonomic agents|mesh-ancestor
154190730|NCT06133114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190731|NCT06133114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154190732|NCT06133114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154190733|NCT06133114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154190734|NCT06133114|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154190735|NCT06133114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154190736|NCT06133114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190737|NCT06133114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190738|NCT06133114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190739|NCT06133114|Serotonin Agents|serotonin agents|mesh-ancestor
154190740|NCT06133114|Anticonvulsants|anticonvulsants|mesh-ancestor
154190741|NCT06133114|GABA Modulators|gaba modulators|mesh-ancestor
153794629|NCT00261287|Hormones|hormones|mesh-ancestor
154190742|NCT06133114|GABA Agents|gaba agents|mesh-ancestor
154190743|NCT06132126|Insulin|insulin|mesh-list
154190744|NCT06132126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154190745|NCT06132126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190746|NCT06128837|Irinotecan|irinotecan|mesh-list
154190747|NCT06128837|Topotecan|topotecan|mesh-list
154190748|NCT06128837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154190749|NCT06128837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190750|NCT06128837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190751|NCT06128837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190752|NCT06128837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190753|NCT06126276|Palbociclib|palbociclib|mesh-list
154190754|NCT06126276|Maleic acid|maleic acid|mesh-list
154190755|NCT06126276|Neratinib|neratinib|mesh-list
154190756|NCT06126276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190757|NCT06126276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190758|NCT06126276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190759|NCT06126276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154190760|NCT06126276|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154190779|NCT06119685|Immunologic Factors|immunologic factors|mesh-ancestor
154190780|NCT06119685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190781|NCT06119685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190782|NCT06119685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154190783|NCT06119685|Alkylating Agents|alkylating agents|mesh-ancestor
154190784|NCT06119685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190785|NCT06119685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190786|NCT06119685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154190787|NCT06119685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190788|NCT06119685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154190790|NCT06119685|Sensory System Agents|sensory system agents|mesh-ancestor
154190791|NCT06119685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190792|NCT06117891|Bevacizumab|bevacizumab|mesh-list
154190793|NCT06117891|Atezolizumab|atezolizumab|mesh-list
154190794|NCT06117891|Durvalumab|durvalumab|mesh-list
154190795|NCT06117891|Tremelimumab|tremelimumab|mesh-list
154190796|NCT06117891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190797|NCT06117891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190798|NCT06117891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154190799|NCT06117891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154190800|NCT06117891|Growth Substances|growth substances|mesh-ancestor
154190801|NCT06117891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190802|NCT06117891|Growth Inhibitors|growth inhibitors|mesh-ancestor
154190803|NCT06117891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190804|NCT06117891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190805|NCT06113341|Xultophy|xultophy|mesh-list
154190806|NCT06113341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154190807|NCT06113341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190808|NCT06113341|Incretins|incretins|mesh-ancestor
154190809|NCT06113341|Hormones|hormones|mesh-ancestor
154190810|NCT06113341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190811|NCT06111872|Midazolam|midazolam|mesh-list
154190812|NCT06111872|Meperidine|meperidine|mesh-list
154190813|NCT06111872|Ketamine|ketamine|mesh-list
154190814|NCT06111872|Analgesics|analgesics|mesh-ancestor
154190815|NCT06111872|Sensory System Agents|sensory system agents|mesh-ancestor
154190816|NCT06111872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190817|NCT06111872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190818|NCT06111872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154190819|NCT06111872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154190829|NCT06111872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154190830|NCT06111872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154190831|NCT06111872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154190832|NCT06111872|GABA Modulators|gaba modulators|mesh-ancestor
154190833|NCT06111872|GABA Agents|gaba agents|mesh-ancestor
154190834|NCT06111872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154190835|NCT06111872|Narcotics|narcotics|mesh-ancestor
154190836|NCT06102902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154190837|NCT06102902|Cetuximab|cetuximab|mesh-list
154190838|NCT06102902|Antibodies|antibodies|mesh-list
154190839|NCT06102902|Immunoglobulins|immunoglobulins|mesh-list
154190840|NCT06102902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154190841|NCT06102902|Immunologic Factors|immunologic factors|mesh-ancestor
154190842|NCT06102902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190843|NCT06102902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190844|NCT06100874|Trastuzumab|trastuzumab|mesh-list
154190845|NCT06100874|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154190846|NCT06100874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190847|NCT06100874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190848|NCT06100874|Immunoconjugates|immunoconjugates|mesh-ancestor
154190849|NCT06100874|Immunologic Factors|immunologic factors|mesh-ancestor
154190850|NCT06100874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190852|NCT06099782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190853|NCT06099782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190854|NCT06099782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190855|NCT06099782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190856|NCT06098144|Nicotine|nicotine|mesh-list
154190857|NCT06098144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154190858|NCT06098144|Autonomic Agents|autonomic agents|mesh-ancestor
154190859|NCT06098144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190860|NCT06098144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190861|NCT06098144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154190862|NCT06098144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154190863|NCT06098144|Cholinergic Agents|cholinergic agents|mesh-ancestor
154190864|NCT06098144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401582|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190865|NCT06098144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190867|NCT06094816|Diuretics|diuretics|mesh-list
154190868|NCT06094816|Natriuretic Agents|natriuretic agents|mesh-ancestor
154190869|NCT06094816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190870|NCT06094816|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154190871|NCT06094816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190872|NCT06094816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190873|NCT06090539|Rituximab|rituximab|mesh-list
154190874|NCT06090539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190875|NCT06090539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190876|NCT06090539|Immunologic Factors|immunologic factors|mesh-ancestor
154190877|NCT06090539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190878|NCT06090539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190879|NCT06088199|Apremilast|apremilast|mesh-list
154190880|NCT06088199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154190881|NCT06088199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154190882|NCT06088199|Analgesics|analgesics|mesh-ancestor
154190883|NCT06088199|Sensory System Agents|sensory system agents|mesh-ancestor
154190884|NCT06088199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190885|NCT06088199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190905|NCT06086340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154190906|NCT06086340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190907|NCT06084845|Cisplatin|cisplatin|mesh-list
154190908|NCT06084845|Carboplatin|carboplatin|mesh-list
154190909|NCT06084845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190910|NCT06081361|Moxifloxacin|moxifloxacin|mesh-list
154190911|NCT06081361|Levofloxacin|levofloxacin|mesh-list
154190912|NCT06081361|Linezolid|linezolid|mesh-list
154190913|NCT06081361|Cycloserine|cycloserine|mesh-list
154190914|NCT06081361|Pyrazinamide|pyrazinamide|mesh-list
154190915|NCT06081361|Ethambutol|ethambutol|mesh-list
154190916|NCT06081361|Bedaquiline|bedaquiline|mesh-list
154190917|NCT06081361|Clofazimine|clofazimine|mesh-list
154190918|NCT06081361|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154190919|NCT06081361|Prothionamide|prothionamide|mesh-list
154190920|NCT06081361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154190921|NCT06081361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190922|NCT06081361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154190923|NCT06081361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190924|NCT06081361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861261|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
154190925|NCT06081361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190926|NCT06081361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190927|NCT06081361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154190928|NCT06081361|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154190929|NCT06081361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154190930|NCT06081361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154190931|NCT06081361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154190932|NCT06081361|Antitubercular Agents|antitubercular agents|mesh-ancestor
154190933|NCT06081361|Antimetabolites|antimetabolites|mesh-ancestor
154190934|NCT06081361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190935|NCT06081361|Leprostatic Agents|leprostatic agents|mesh-ancestor
154190936|NCT06079918|Iron|iron|mesh-list
154190937|NCT06079918|Trace Elements|trace elements|mesh-list
154190938|NCT06079918|Micronutrients|micronutrients|mesh-list
153937915|NCT01121393|Afatinib|afatinib|mesh-list
154190939|NCT06079918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190941|NCT06077760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190957|NCT06066957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190959|NCT06066957|Antiviral Agents|antiviral agents|mesh-ancestor
154190960|NCT06066957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190965|NCT06058663|Durvalumab|durvalumab|mesh-list
154190966|NCT06058663|Ipilimumab|ipilimumab|mesh-list
153800528|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
153800530|NCT00311259|Protective Agents|protective agents|mesh-ancestor
154190967|NCT06058663|Tremelimumab|tremelimumab|mesh-list
154190968|NCT06058663|Immunoglobulins|immunoglobulins|mesh-list
154190969|NCT06058663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154190970|NCT06058663|Immunoglobulin G|immunoglobulin g|mesh-list
154190971|NCT06058663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190972|NCT06058663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190973|NCT06058663|Immunologic Factors|immunologic factors|mesh-ancestor
154190974|NCT06058663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190975|NCT06058663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190976|NCT06058663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190977|NCT06057675|Lidocaine|lidocaine|mesh-list
154190978|NCT06057675|Epinephrine|epinephrine|mesh-list
154190979|NCT06057675|Racepinephrine|racepinephrine|mesh-list
154190980|NCT06057675|Tranexamic Acid|tranexamic acid|mesh-list
154190981|NCT06057675|Epinephryl borate|epinephryl borate|mesh-list
154190982|NCT06057675|Anesthetics, Local|anesthetics, local|mesh-ancestor
154190983|NCT06057675|Anesthetics|anesthetics|mesh-ancestor
154190984|NCT06057675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190985|NCT06057675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190986|NCT06057675|Sensory System Agents|sensory system agents|mesh-ancestor
154190987|NCT06057675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190988|NCT06057675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154190989|NCT06057675|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154190990|NCT06057675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154190991|NCT06057675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190992|NCT06057675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190993|NCT06057675|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154190994|NCT06057675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154190995|NCT06057675|Hemostatics|hemostatics|mesh-ancestor
154190996|NCT06057675|Coagulants|coagulants|mesh-ancestor
154191019|NCT06046859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191020|NCT06046859|Serotonin Agents|serotonin agents|mesh-ancestor
154191021|NCT06046859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191022|NCT06046859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153401609|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191023|NCT06046859|Antidepressive Agents|antidepressive agents|mesh-ancestor
154191024|NCT06046859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154191025|NCT06046859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154191026|NCT06046859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154191027|NCT06046859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191029|NCT06041204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191030|NCT06041204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154191031|NCT06041204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154191032|NCT06041204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191033|NCT06041204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191034|NCT06041204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154191035|NCT06041204|Hormone Antagonists|hormone antagonists|mesh-ancestor
154191036|NCT06041204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154191037|NCT06041204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191038|NCT06039020|Immunoglobulins|immunoglobulins|mesh-list
154191039|NCT06039020|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154191040|NCT06039020|Antibodies|antibodies|mesh-list
154191041|NCT06039020|Immunologic Factors|immunologic factors|mesh-ancestor
154191042|NCT06039020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191043|NCT06034860|Nivolumab|nivolumab|mesh-list
154191044|NCT06034860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191045|NCT06034860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191058|NCT06033092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154191059|NCT06033092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154191060|NCT06033092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154191061|NCT06032052|Immunomodulating Agents|immunomodulating agents|mesh-list
154191062|NCT06032052|Immunologic Factors|immunologic factors|mesh-list
154191063|NCT06032052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191064|NCT06031363|Indomethacin|indomethacin|mesh-list
154191065|NCT06031363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154191066|NCT06031363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154191067|NCT06031363|Analgesics|analgesics|mesh-ancestor
154191068|NCT06031363|Sensory System Agents|sensory system agents|mesh-ancestor
154191069|NCT06031363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191070|NCT06031363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191071|NCT06031363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154191072|NCT06031363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191073|NCT06031363|Gout Suppressants|gout suppressants|mesh-ancestor
154191074|NCT06031363|Tocolytic Agents|tocolytic agents|mesh-ancestor
154191075|NCT06031363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154191076|NCT06031363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154191077|NCT06031363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191078|NCT06031363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191079|NCT06030037|Pembrolizumab|pembrolizumab|mesh-list
154191080|NCT06030037|Lenvatinib|lenvatinib|mesh-list
154191081|NCT06030037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191082|NCT06030037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191083|NCT06030037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191084|NCT06030037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191085|NCT06030037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154191086|NCT06030037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191087|NCT06028828|Fludarabine|fludarabine|mesh-list
154191088|NCT06028828|Melphalan|melphalan|mesh-list
153861287|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
154191089|NCT06028828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191090|NCT06028828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191091|NCT06028828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191092|NCT06028828|Immunologic Factors|immunologic factors|mesh-ancestor
154191093|NCT06028828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191094|NCT06028828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154191095|NCT06028828|Alkylating Agents|alkylating agents|mesh-ancestor
154191096|NCT06028828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154191097|NCT06022861|Fluorouracil|fluorouracil|mesh-list
154191098|NCT06022861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191099|NCT06022861|Antimetabolites|antimetabolites|mesh-ancestor
154191100|NCT06022861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191101|NCT06022861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191102|NCT06022861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191103|NCT06022861|Immunologic Factors|immunologic factors|mesh-ancestor
154191104|NCT06022861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191108|NCT06001372|Ketamine|ketamine|mesh-list
154191109|NCT06001372|Analgesics|analgesics|mesh-ancestor
154191110|NCT06001372|Sensory System Agents|sensory system agents|mesh-ancestor
154191111|NCT06001372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191135|NCT05956821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191137|NCT05956821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154191138|NCT05956821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154191139|NCT05956821|Growth Substances|growth substances|mesh-ancestor
154191140|NCT05956821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191141|NCT05956821|Growth Inhibitors|growth inhibitors|mesh-ancestor
154191142|NCT05947851|Rituximab|rituximab|mesh-list
154191143|NCT05947851|Venetoclax|venetoclax|mesh-list
154191144|NCT05947851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401626|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794951|NCT00299364|Hormones|hormones|mesh-ancestor
153973788|NCT06247787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973789|NCT06247787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973790|NCT06247787|Dermatologic Agents|dermatologic agents|mesh-ancestor
153973791|NCT06247787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973792|NCT06247787|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153760868|NCT00476593|Analgesics|analgesics|mesh-ancestor
153973811|NCT06247748|Calcium|calcium|mesh-list
153973812|NCT06247748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973813|NCT06247748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973814|NCT06247748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153973815|NCT06247748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153973816|NCT06247748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153973817|NCT06247748|Antimetabolites|antimetabolites|mesh-ancestor
153973818|NCT06247748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973819|NCT06247748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153973820|NCT06247748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153973821|NCT06247748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973822|NCT06247748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153973823|NCT06247748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153973824|NCT06247748|Protective Agents|protective agents|mesh-ancestor
153973825|NCT06247748|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153973826|NCT06247748|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153973827|NCT06247748|Incretins|incretins|mesh-ancestor
153973828|NCT06247748|Hormones|hormones|mesh-ancestor
154027523|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973829|NCT06247748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153973831|NCT06247488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153973832|NCT06247488|Narcotics|narcotics|mesh-ancestor
153973833|NCT06247488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973834|NCT06247488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973836|NCT06247488|Sensory System Agents|sensory system agents|mesh-ancestor
153973837|NCT06247488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860835|NCT02604537|Analgesics|analgesics|mesh-ancestor
154860836|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
154860837|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860838|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255030|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154255031|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154255032|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154255033|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154255034|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
154255035|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154255036|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154255037|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861307|NCT04645914|Nicotine|nicotine|mesh-list
154255038|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154255039|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154255040|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154255041|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135043|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
153973838|NCT06247462|Ibuprofen|ibuprofen|mesh-list
153973839|NCT06247462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973840|NCT06247462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973841|NCT06247462|Analgesics|analgesics|mesh-ancestor
153973842|NCT06247462|Sensory System Agents|sensory system agents|mesh-ancestor
153973843|NCT06247462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973844|NCT06247462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973845|NCT06247462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973846|NCT06247462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973847|NCT06247462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153973848|NCT06247462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973849|NCT06247462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973850|NCT06245980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153973851|NCT06245980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973867|NCT06193421|Respiratory System Agents|respiratory system agents|mesh-ancestor
153973868|NCT06162572|Cemiplimab|cemiplimab|mesh-list
153973869|NCT06162572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153973870|NCT06162572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973871|NCT06161493|Niraparib|niraparib|mesh-list
153973872|NCT06161493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153973873|NCT06161493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973874|NCT06161493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973875|NCT06161493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973876|NCT06141239|Calcitriol|calcitriol|mesh-list
153973877|NCT06141239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153973878|NCT06141239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973879|NCT06141239|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153973880|NCT06141239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973881|NCT06141239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973882|NCT06141239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153973883|NCT06141239|Vitamins|vitamins|mesh-ancestor
153973884|NCT06141239|Micronutrients|micronutrients|mesh-ancestor
153973885|NCT06141239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153973886|NCT06140407|Carboplatin|carboplatin|mesh-list
153973887|NCT06140407|Pembrolizumab|pembrolizumab|mesh-list
153973888|NCT06140407|Etoposide|etoposide|mesh-list
153973889|NCT06140407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973890|NCT06140407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153973891|NCT06140407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153973892|NCT06140407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973893|NCT06140407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153973894|NCT06140407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153973895|NCT06140407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153973896|NCT06140407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973897|NCT06108544|Apremilast|apremilast|mesh-list
153973898|NCT06108544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154860839|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154860840|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860841|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154860842|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154860843|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860844|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
154860845|NCT02604537|Hormones|hormones|mesh-ancestor
154860846|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154860847|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154860848|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
154860849|NCT01384773|Riboflavin|riboflavin|mesh-list
154860850|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154860851|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153795030|NCT06259760|Labetalol|labetalol|mesh-list
154255042|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154255043|NCT03610438|Immunotoxins|immunotoxins|mesh-ancestor
154255044|NCT03610438|Immunoconjugates|immunoconjugates|mesh-ancestor
154255045|NCT03610438|Immunologic Factors|immunologic factors|mesh-ancestor
154255046|NCT03610438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255047|NCT03908372|Docetaxel|docetaxel|mesh-list
154255048|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154255049|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
154135107|NCT00836654|Catumaxomab|catumaxomab|mesh-list
153973899|NCT06108544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973900|NCT06108544|Analgesics|analgesics|mesh-ancestor
153973901|NCT06108544|Sensory System Agents|sensory system agents|mesh-ancestor
153973902|NCT06108544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973903|NCT06108544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973904|NCT06108544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973905|NCT06108544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973906|NCT06108544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153973907|NCT06108544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153973908|NCT06108544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973909|NCT06108544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973910|NCT06090500|Dexamethasone|dexamethasone|mesh-list
153973911|NCT06090500|Diclofenac|diclofenac|mesh-list
153973928|NCT06090500|Analgesics|analgesics|mesh-ancestor
153973929|NCT06090500|Sensory System Agents|sensory system agents|mesh-ancestor
153973930|NCT06090500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973931|NCT06090500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153973932|NCT06090500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973933|NCT06090500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973934|NCT06090500|Protease Inhibitors|protease inhibitors|mesh-ancestor
153973935|NCT06088043|Apremilast|apremilast|mesh-list
153973936|NCT06088043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973937|NCT06088043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973938|NCT06088043|Analgesics|analgesics|mesh-ancestor
153973939|NCT06088043|Sensory System Agents|sensory system agents|mesh-ancestor
153973940|NCT06088043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973941|NCT06088043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973942|NCT06088043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973943|NCT06088043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973944|NCT06088043|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153401683|NCT05993767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973945|NCT06088043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153973946|NCT06088043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973947|NCT06088043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973948|NCT06074029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153973949|NCT06074029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973950|NCT06074029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153973951|NCT06074029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973952|NCT06070987|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153973953|NCT06070987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153973954|NCT06070987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153973955|NCT06070987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973956|NCT06070987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973957|NCT06070987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153973958|NCT06070987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973959|NCT06070987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973960|NCT06070987|Cholinergic Agents|cholinergic agents|mesh-ancestor
153973961|NCT06070987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973962|NCT06034418|Betamethasone|betamethasone|mesh-list
153973963|NCT06034418|Lidocaine|lidocaine|mesh-list
153973964|NCT06034418|Anesthetics, Local|anesthetics, local|mesh-ancestor
153973965|NCT06034418|Anesthetics|anesthetics|mesh-ancestor
153973966|NCT06034418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973967|NCT06034418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973968|NCT06034418|Sensory System Agents|sensory system agents|mesh-ancestor
153973981|NCT06029296|Diclofenac|diclofenac|mesh-list
153973982|NCT06029296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973983|NCT06029296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154860852|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
154860853|NCT01384773|Vitamins|vitamins|mesh-ancestor
154860854|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
154860855|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154860856|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154860857|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
154860858|NCT01063075|Carboplatin|carboplatin|mesh-list
154860859|NCT01063075|Cetuximab|cetuximab|mesh-list
154860860|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973985|NCT06029296|Sensory System Agents|sensory system agents|mesh-ancestor
153973986|NCT06029296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973987|NCT06029296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973988|NCT06029296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973989|NCT06029296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973990|NCT06029296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153973991|NCT06029296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973992|NCT06029296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973993|NCT06021600|Cladribine|cladribine|mesh-list
153973994|NCT06021600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973995|NCT06021600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973996|NCT06021600|Immunologic Factors|immunologic factors|mesh-ancestor
153973997|NCT06021600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973998|NCT06018337|Paclitaxel|paclitaxel|mesh-list
153973999|NCT06018337|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153974000|NCT06018337|Capecitabine|capecitabine|mesh-list
153974001|NCT06018337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974002|NCT06018337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974003|NCT06018337|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974004|NCT06018337|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974005|NCT06018337|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974006|NCT06018337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974007|NCT06018337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974008|NCT06018337|Antimetabolites|antimetabolites|mesh-ancestor
153974009|NCT06014658|Antibodies|antibodies|mesh-list
153974010|NCT06014658|Immunoconjugates|immunoconjugates|mesh-list
153974011|NCT06014658|Immunologic Factors|immunologic factors|mesh-ancestor
153974012|NCT06014658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974013|NCT06002217|Levobupivacaine|levobupivacaine|mesh-list
153974014|NCT06002217|Anesthetics, Local|anesthetics, local|mesh-ancestor
153974015|NCT06002217|Anesthetics|anesthetics|mesh-ancestor
153974016|NCT06002217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974017|NCT06002217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974018|NCT06002217|Sensory System Agents|sensory system agents|mesh-ancestor
153974019|NCT06002217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974020|NCT05994534|Acetylcysteine|acetylcysteine|mesh-list
153974021|NCT05994534|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153974022|NCT05994534|Cysteamine|cysteamine|mesh-list
153974023|NCT05994534|Antiviral Agents|antiviral agents|mesh-ancestor
153795160|NCT06258642|Irinotecan|irinotecan|mesh-list
153795194|NCT06258174|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153974024|NCT05994534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974025|NCT05994534|Expectorants|expectorants|mesh-ancestor
153974026|NCT05994534|Respiratory System Agents|respiratory system agents|mesh-ancestor
153974027|NCT05994534|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153974028|NCT05994534|Antioxidants|antioxidants|mesh-ancestor
153974029|NCT05994534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974046|NCT05983276|Antimitotic Agents|antimitotic agents|mesh-ancestor
154176473|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974047|NCT05983276|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974048|NCT05983276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974049|NCT05983276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974051|NCT05983276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974053|NCT05949541|Fulvestrant|fulvestrant|mesh-list
153974054|NCT05949541|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153974055|NCT05949541|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153974056|NCT05949541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974057|NCT05949541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974058|NCT05949541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974059|NCT05949541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153974060|NCT05949541|Immunologic Factors|immunologic factors|mesh-ancestor
153974061|NCT05949541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974062|NCT05949541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974063|NCT05949541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153974064|NCT05949541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153974065|NCT05949541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153974066|NCT05949541|Hormone Antagonists|hormone antagonists|mesh-ancestor
153974067|NCT05949541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974068|NCT05949541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153974070|NCT05941897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974071|NCT05941897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974072|NCT05933499|Vitamin D|vitamin d|mesh-list
153974073|NCT05933499|Semaglutide|semaglutide|mesh-list
153974074|NCT05933499|Calcium|calcium|mesh-list
153974075|NCT05933499|Vitamins|vitamins|mesh-ancestor
153974076|NCT05933499|Micronutrients|micronutrients|mesh-ancestor
153974077|NCT05933499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974078|NCT05933499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153974079|NCT05933499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153974080|NCT05933499|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153974081|NCT05933499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153974082|NCT05917522|Abatacept|abatacept|mesh-list
153974083|NCT05917522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974084|NCT05917522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974085|NCT05917522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974086|NCT05917522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974087|NCT05917522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153974088|NCT05917522|Immunologic Factors|immunologic factors|mesh-ancestor
153974103|NCT05916339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974104|NCT05916339|Adrenergic Agents|adrenergic agents|mesh-ancestor
153974105|NCT05916339|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153974106|NCT05912075|Capecitabine|capecitabine|mesh-list
153974107|NCT05912075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974108|NCT05912075|Antimetabolites|antimetabolites|mesh-ancestor
153974109|NCT05912075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974110|NCT05912075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974111|NCT05893810|Mupirocin|mupirocin|mesh-list
153974112|NCT05893810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153974113|NCT05893810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974114|NCT05893810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153974115|NCT05893810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974116|NCT05893810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974117|NCT05891093|Tamoxifen|tamoxifen|mesh-list
153974118|NCT05891093|Toremifene|toremifene|mesh-list
153974119|NCT05891093|Letrozole|letrozole|mesh-list
153974120|NCT05891093|Anastrozole|anastrozole|mesh-list
153974121|NCT05891093|Exemestane|exemestane|mesh-list
153974122|NCT05891093|Fluzoparib|fluzoparib|mesh-list
153974123|NCT05891093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974124|NCT05891093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153974125|NCT05891093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153974126|NCT05891093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974127|NCT05891093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974128|NCT05891093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153974129|NCT05891093|Hormone Antagonists|hormone antagonists|mesh-ancestor
153974130|NCT05891093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974131|NCT05891093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974132|NCT05891093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153974133|NCT05891093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153974134|NCT05891093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153974135|NCT05891093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153974136|NCT05891093|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153974137|NCT05877313|Nitric Oxide|nitric oxide|mesh-list
153974138|NCT05877313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153974139|NCT05877313|Autonomic Agents|autonomic agents|mesh-ancestor
153974140|NCT05877313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974141|NCT05877313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974142|NCT05877313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153974143|NCT05877313|Respiratory System Agents|respiratory system agents|mesh-ancestor
153974144|NCT05877313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153974145|NCT05877313|Antioxidants|antioxidants|mesh-ancestor
153974146|NCT05877313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974147|NCT05877313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974160|NCT05875428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974161|NCT05875428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974162|NCT05870579|Fulvestrant|fulvestrant|mesh-list
153974163|NCT05870579|Goserelin|goserelin|mesh-list
153974164|NCT05870579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153974165|NCT05870579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974166|NCT05870579|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153974167|NCT05870579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153974168|NCT05870579|Hormone Antagonists|hormone antagonists|mesh-ancestor
153974169|NCT05870579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974170|NCT05870579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974171|NCT05843838|Bupivacaine|bupivacaine|mesh-list
153974172|NCT05843838|Anesthetics|anesthetics|mesh-list
153974173|NCT05843838|Anesthetics, Local|anesthetics, local|mesh-ancestor
153974174|NCT05843838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974175|NCT05843838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974176|NCT05843838|Sensory System Agents|sensory system agents|mesh-ancestor
153974177|NCT05843838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974178|NCT05841121|Dexamethasone|dexamethasone|mesh-list
153974179|NCT05841121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153974180|NCT05841121|Antiemetics|antiemetics|mesh-ancestor
153974181|NCT05841121|Autonomic Agents|autonomic agents|mesh-ancestor
153974182|NCT05841121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974183|NCT05841121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974184|NCT05841121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153974185|NCT05841121|Glucocorticoids|glucocorticoids|mesh-ancestor
153974186|NCT05841121|Hormones|hormones|mesh-ancestor
153974187|NCT05841121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974188|NCT05841121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153974189|NCT05841121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974190|NCT05838521|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153974191|NCT05838521|Immunoconjugates|immunoconjugates|mesh-ancestor
153974192|NCT05838521|Immunologic Factors|immunologic factors|mesh-ancestor
153974193|NCT05838521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974194|NCT05827159|Naltrexone|naltrexone|mesh-list
153974195|NCT05827159|Gabapentin|gabapentin|mesh-list
153974196|NCT05827159|Analgesics|analgesics|mesh-ancestor
153974197|NCT05827159|Sensory System Agents|sensory system agents|mesh-ancestor
153974198|NCT05827159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974201|NCT05827159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153974202|NCT05827159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153974203|NCT05827159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974204|NCT05827159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153974205|NCT05827159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153974206|NCT05827159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153974207|NCT05827159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974208|NCT05827159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974209|NCT05827159|Antimanic Agents|antimanic agents|mesh-ancestor
153974210|NCT05827159|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153974211|NCT05827159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153974212|NCT05806060|Paclitaxel|paclitaxel|mesh-list
153974228|NCT05806060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974229|NCT05806060|Growth Inhibitors|growth inhibitors|mesh-ancestor
153861386|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153974230|NCT05806060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974231|NCT05806060|Antimetabolites|antimetabolites|mesh-ancestor
153974232|NCT05783817|Methamphetamine|methamphetamine|mesh-list
153974233|NCT05783817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153974234|NCT05783817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974235|NCT05783817|Sympathomimetics|sympathomimetics|mesh-ancestor
153974236|NCT05783817|Autonomic Agents|autonomic agents|mesh-ancestor
153974237|NCT05783817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974238|NCT05783817|Dopamine Agents|dopamine agents|mesh-ancestor
153974239|NCT05783817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974240|NCT05783817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974241|NCT05783817|Adrenergic Agents|adrenergic agents|mesh-ancestor
153974242|NCT05783817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153974243|NCT05783817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153974244|NCT05783817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974245|NCT05783817|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153974246|NCT05761405|Ceftriaxone|ceftriaxone|mesh-list
153974247|NCT05761405|Amikacin|amikacin|mesh-list
153974248|NCT05761405|Mannitol|mannitol|mesh-list
153974249|NCT05761405|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153974250|NCT05761405|Diuretics|diuretics|mesh-ancestor
153974251|NCT05761405|Natriuretic Agents|natriuretic agents|mesh-ancestor
153974252|NCT05761405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974253|NCT05761405|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153974254|NCT05761405|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153974255|NCT05761405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153974256|NCT05761405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974257|NCT05746559|Ravulizumab|ravulizumab|mesh-list
153974258|NCT05746559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153974259|NCT05746559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153974260|NCT05746559|Immunologic Factors|immunologic factors|mesh-ancestor
153974261|NCT05746559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974262|NCT05728892|Melatonin|melatonin|mesh-list
153974263|NCT05728892|Antioxidants|antioxidants|mesh-ancestor
153974264|NCT05728892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974265|NCT05728892|Protective Agents|protective agents|mesh-ancestor
153974266|NCT05728892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974267|NCT05728892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974268|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153974269|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154176474|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
153974277|NCT05681039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974278|NCT05681039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974312|NCT05633602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153974313|NCT05633602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153974314|NCT05633602|Growth Substances|growth substances|mesh-ancestor
153974315|NCT05633602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974316|NCT05633602|Growth Inhibitors|growth inhibitors|mesh-ancestor
153974317|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
153974318|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153761414|NCT00218049|Vanoxerine|vanoxerine|mesh-list
153974336|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
153974337|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153974338|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153974339|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153974340|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974341|NCT05572749|Metformin|metformin|mesh-list
153974342|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153974343|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974344|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
153974345|NCT05529173|Povidone|povidone|mesh-list
153974346|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
153974347|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
153974348|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153974349|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974350|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153974351|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
153974352|NCT05521828|Hormones|hormones|mesh-ancestor
153974353|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974354|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974355|NCT05521828|Progestins|progestins|mesh-ancestor
153974356|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153974357|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
153974358|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974359|NCT05471609|Levodopa|levodopa|mesh-list
153974360|NCT05471609|Carbidopa|carbidopa|mesh-list
153974361|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153974362|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153974363|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
153974364|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974365|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974366|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974367|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153974368|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974369|NCT05458479|Fluoxetine|fluoxetine|mesh-list
153974370|NCT05458479|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153974371|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153974372|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974373|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761449|NCT00218166|GABA Agonists|gaba agonists|mesh-list
153974406|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
153974407|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974408|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153974409|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153974410|NCT05429762|Maytansine|maytansine|mesh-list
153974411|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974412|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974413|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974414|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974415|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974416|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974417|NCT05417594|Trastuzumab|trastuzumab|mesh-list
153974418|NCT05417594|Temozolomide|temozolomide|mesh-list
153974419|NCT05417594|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153974420|NCT05417594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974421|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974422|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153974423|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
154255052|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974424|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974425|NCT05417594|Immunoconjugates|immunoconjugates|mesh-ancestor
153731998|NCT00140153|Hormones|hormones|mesh-ancestor
153974426|NCT05417594|Immunologic Factors|immunologic factors|mesh-ancestor
153974427|NCT05417594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974428|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
153974429|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153974430|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974431|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974432|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153974448|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974449|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
153974450|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974451|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974452|NCT05351151|Lidocaine|lidocaine|mesh-list
153974453|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
153974454|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
153974455|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974456|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974457|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
153974458|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974459|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153974460|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153974461|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153974462|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974463|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974464|NCT05264506|Estradiol|estradiol|mesh-list
153974465|NCT05264506|Estrogens|estrogens|mesh-ancestor
153974466|NCT05264506|Hormones|hormones|mesh-ancestor
153974467|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974468|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974469|NCT05223829|Brexanolone|brexanolone|mesh-list
153974470|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
153974471|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974472|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974473|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974474|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
153974475|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
153974476|NCT05205200|Paclitaxel|paclitaxel|mesh-list
153974477|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974478|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974479|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974480|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974481|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974482|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974483|NCT05192200|Interferons|interferons|mesh-list
153974484|NCT05192200|Interferon-beta|interferon-beta|mesh-list
153974485|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974486|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
153974487|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974488|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
153974489|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974490|NCT05170724|Remibrutinib|remibrutinib|mesh-list
153974491|NCT05170724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974503|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974504|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
153974505|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974506|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153974507|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153974508|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153974509|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974510|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974511|NCT05071053|Ramucirumab|ramucirumab|mesh-list
153974512|NCT05071053|Maytansine|maytansine|mesh-list
153974513|NCT05071053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153974514|NCT05071053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153974515|NCT05071053|Growth Substances|growth substances|mesh-ancestor
153974516|NCT05071053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974517|NCT05071053|Growth Inhibitors|growth inhibitors|mesh-ancestor
153974518|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860861|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154860862|NCT01341405|Celecoxib|celecoxib|mesh-list
154255053|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153974519|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974520|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974521|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974522|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974523|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974524|NCT05044611|Amiloride|amiloride|mesh-list
153974525|NCT05044611|Diuretics|diuretics|mesh-ancestor
153974526|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
153974527|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974528|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153974529|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153974530|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974531|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974532|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153974533|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153974534|NCT05016895|Azithromycin|azithromycin|mesh-list
153974535|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153974536|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974537|NCT04987463|Sirolimus|sirolimus|mesh-list
153974538|NCT04987463|Vigabatrin|vigabatrin|mesh-list
153974539|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153974540|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974541|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153974542|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974543|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
153974544|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153974545|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
153974546|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974547|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974548|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974549|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
153974550|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
153974551|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974552|NCT04964414|Budesonide|budesonide|mesh-list
153974562|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974563|NCT04953104|Nivolumab|nivolumab|mesh-list
153974564|NCT04953104|Relatlimab|relatlimab|mesh-list
153974565|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974566|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176475|NCT00841061|Trace Elements|trace elements|mesh-ancestor
153974567|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974568|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974570|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153974571|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974572|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153974574|NCT04934800|Cladribine|cladribine|mesh-list
153974575|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974576|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153974577|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
153974578|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974579|NCT04912596|Albuterol|albuterol|mesh-list
153974580|NCT04912596|Procaterol|procaterol|mesh-list
153974581|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
153974582|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153974583|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
153974584|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974585|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974586|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153974587|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
153974588|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
153974589|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153974590|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153974591|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153974592|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153974593|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
153974594|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974595|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974596|NCT04912596|Miotics|miotics|mesh-ancestor
153974597|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153974598|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153974599|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153974600|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154860863|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153974601|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
153974602|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
153974603|NCT04901975|Spironolactone|spironolactone|mesh-list
153974604|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153974605|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
153974606|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974607|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974608|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153974609|NCT04901975|Diuretics|diuretics|mesh-ancestor
153974610|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
153974611|NCT04878211|Interferons|interferons|mesh-list
153974612|NCT04878211|Ofatumumab|ofatumumab|mesh-list
153974613|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
153974614|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
153974615|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974616|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
153974617|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974618|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153974619|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
153761702|NCT00187031|Topotecan|topotecan|mesh-list
153974629|NCT04848974|Cladribine|cladribine|mesh-list
153974630|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974631|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
153974632|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974633|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974634|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
153974635|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974636|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153974637|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
153974638|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974639|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
153974640|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153974641|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974642|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974643|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
153974644|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732201|NCT00504946|Prednisone|prednisone|mesh-list
153974645|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974646|NCT04826432|Pasireotide|pasireotide|mesh-list
153974647|NCT04826432|Hormones|hormones|mesh-ancestor
153974648|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974649|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974651|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
153974652|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974653|NCT04800367|Denosumab|denosumab|mesh-list
153974654|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153974655|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974656|NCT04751175|Dexamethasone|dexamethasone|mesh-list
153974657|NCT04751175|Ketamine|ketamine|mesh-list
153974658|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153974659|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
153974660|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
153974661|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974662|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974663|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153974664|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
153974665|NCT04751175|Hormones|hormones|mesh-ancestor
153974666|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974667|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153974668|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974669|NCT04751175|Analgesics|analgesics|mesh-ancestor
153974670|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
153974671|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153974672|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153974673|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
153974674|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
153974675|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974676|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153974677|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153974678|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974679|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974680|NCT04732286|Bevacizumab|bevacizumab|mesh-list
153974681|NCT04732286|Atezolizumab|atezolizumab|mesh-list
153974682|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974683|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974684|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153761751|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
153974701|NCT04711824|Carboplatin|carboplatin|mesh-list
153974702|NCT04711824|Gemcitabine|gemcitabine|mesh-list
153974703|NCT04711824|Capecitabine|capecitabine|mesh-list
153974704|NCT04711824|Durvalumab|durvalumab|mesh-list
153974705|NCT04711824|Olaparib|olaparib|mesh-list
153974706|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974707|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974708|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974709|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974710|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974711|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974712|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974713|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
153974714|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974715|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153974716|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974717|NCT04699838|Carboplatin|carboplatin|mesh-list
153974718|NCT04699838|Etoposide|etoposide|mesh-list
153974719|NCT04699838|Durvalumab|durvalumab|mesh-list
153732276|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
153974720|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974721|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974722|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153974723|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153974724|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974725|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974726|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974727|NCT04685005|Caffeine|caffeine|mesh-list
153974728|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153974729|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974730|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153974731|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974732|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974733|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153974734|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153974735|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
153974736|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974737|NCT04661150|Capecitabine|capecitabine|mesh-list
153974738|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
153974739|NCT04661150|Trastuzumab|trastuzumab|mesh-list
153974740|NCT04661150|Atezolizumab|atezolizumab|mesh-list
153974741|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974742|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
153974753|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974755|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974756|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974757|NCT04634578|Bevacizumab|bevacizumab|mesh-list
153974758|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974759|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974760|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153974761|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153974762|NCT04634578|Growth Substances|growth substances|mesh-ancestor
153974763|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974764|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
153974765|NCT04586660|Denosumab|denosumab|mesh-list
153974766|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153974767|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974768|NCT04530630|Emtricitabine|emtricitabine|mesh-list
153974769|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
153974770|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974771|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153974772|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153974773|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974774|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974775|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153974776|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153974777|NCT04524689|Carboplatin|carboplatin|mesh-list
153974778|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
153974779|NCT04524689|Pemetrexed|pemetrexed|mesh-list
153974780|NCT04524689|Maytansine|maytansine|mesh-list
153974781|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974782|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974783|NCT04524689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974784|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974785|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974786|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153974787|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153974788|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974789|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974790|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974791|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974795|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153974797|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153974798|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
153974799|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974800|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974801|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153974802|NCT04507919|Dabrafenib|dabrafenib|mesh-list
153974803|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974804|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974805|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974806|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974807|NCT04494425|Paclitaxel|paclitaxel|mesh-list
153974808|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153974818|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974820|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974821|NCT04494425|Immunoconjugates|immunoconjugates|mesh-ancestor
153974822|NCT04494425|Immunologic Factors|immunologic factors|mesh-ancestor
153974823|NCT04494425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974824|NCT04489433|Trametinib|trametinib|mesh-list
153974825|NCT04489433|Dabrafenib|dabrafenib|mesh-list
153974826|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974827|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974828|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974829|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974830|NCT04477343|Nivolumab|nivolumab|mesh-list
153974831|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974832|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974833|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974834|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974835|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
153974836|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153974837|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974838|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153974839|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153974840|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974841|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974842|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974843|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153974844|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153974845|NCT04439318|Trametinib|trametinib|mesh-list
153974846|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153974847|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974848|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974849|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974850|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974851|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153974852|NCT04439318|Protective Agents|protective agents|mesh-ancestor
153974853|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974854|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153974855|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
153974856|NCT04435691|Azacitidine|azacitidine|mesh-list
153974857|NCT04435691|Venetoclax|venetoclax|mesh-list
153974858|NCT04435691|Magrolimab|magrolimab|mesh-list
153974859|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974860|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
153974861|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974862|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974863|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974864|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974884|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153974886|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
153974887|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153974888|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153974889|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974890|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974891|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153761945|NCT00188630|Antidotes|antidotes|mesh-ancestor
154135864|NCT00859118|Axitinib|axitinib|mesh-list
153974910|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974911|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153974912|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153974913|NCT04334070|Clofazimine|clofazimine|mesh-list
153974914|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153974915|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
153974916|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153974917|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974918|NCT04319198|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153974919|NCT04319198|Immunoconjugates|immunoconjugates|mesh-ancestor
153974920|NCT04319198|Immunologic Factors|immunologic factors|mesh-ancestor
153974921|NCT04319198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974922|NCT04316676|Regadenoson|regadenoson|mesh-list
153974923|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153974924|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153974925|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
153974926|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
153974927|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974928|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974929|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974931|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153974932|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
153974933|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974934|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974935|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153974936|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153974937|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
153974938|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974939|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974940|NCT04282044|Cyclophosphamide|cyclophosphamide|mesh-list
153974941|NCT04282044|Fludarabine|fludarabine|mesh-list
154176476|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
153974943|NCT04282044|Immunologic Factors|immunologic factors|mesh-ancestor
153974944|NCT04282044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974945|NCT04282044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153974946|NCT04282044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153974947|NCT04282044|Alkylating Agents|alkylating agents|mesh-ancestor
153974948|NCT04282044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974966|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153974967|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153974968|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153974969|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
153974970|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401817|NCT05988034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153974971|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974972|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974973|NCT04236414|Olaparib|olaparib|mesh-list
153974974|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153974975|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974976|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974977|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974978|NCT04205409|Nivolumab|nivolumab|mesh-list
153974979|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974980|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974981|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974982|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974983|NCT04191616|Dexamethasone|dexamethasone|mesh-list
153974984|NCT04191616|Pomalidomide|pomalidomide|mesh-list
153974985|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153974986|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
153974987|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
153974988|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974989|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974990|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153974991|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
153974992|NCT04191616|Hormones|hormones|mesh-ancestor
153974993|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153974994|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153974995|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974996|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
153974997|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153974998|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154860864|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153974999|NCT04191616|Growth Substances|growth substances|mesh-ancestor
153975000|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
153975001|NCT04175613|Apremilast|apremilast|mesh-list
153975002|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153975003|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975004|NCT04175613|Analgesics|analgesics|mesh-ancestor
153975005|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
153975023|NCT04139317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975024|NCT04139317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975025|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
153975026|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
153975027|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153975028|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153975029|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975030|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975031|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975032|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975033|NCT04111458|Trametinib|trametinib|mesh-list
153975034|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975035|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975036|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975037|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975038|NCT04081337|Tirzepatide|tirzepatide|mesh-list
153975039|NCT04081337|Incretins|incretins|mesh-ancestor
153975040|NCT04081337|Hormones|hormones|mesh-ancestor
153861492|NCT04635852|Fentanyl|fentanyl|mesh-list
153975041|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975042|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975043|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
153975044|NCT04049799|Narcotics|narcotics|mesh-ancestor
153975045|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975046|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975047|NCT04049799|Analgesics|analgesics|mesh-ancestor
153975048|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
153975049|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975056|NCT03909334|Osimertinib|osimertinib|mesh-list
153975057|NCT03909334|Ramucirumab|ramucirumab|mesh-list
153975058|NCT03909334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153975059|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975060|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975061|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975062|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975063|NCT03909334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153975064|NCT03909334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153975065|NCT03909334|Growth Substances|growth substances|mesh-ancestor
153975066|NCT03909334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975067|NCT03909334|Growth Inhibitors|growth inhibitors|mesh-ancestor
153975068|NCT03810287|Domperidone|domperidone|mesh-list
153975069|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
153975070|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
153975071|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975072|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975073|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153975074|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153975075|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
153975076|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975077|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975078|NCT03765619|Aspirin|aspirin|mesh-list
153762128|NCT00189371|Paclitaxel|paclitaxel|mesh-list
153975088|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153975089|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975090|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153975091|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153975092|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975094|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
153975095|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153975096|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153975097|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975098|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153975099|NCT03625141|Atezolizumab|atezolizumab|mesh-list
153975100|NCT03625141|Vemurafenib|vemurafenib|mesh-list
153975101|NCT03625141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975102|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975103|NCT03625141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975104|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135999|NCT00507442|Dexamethasone|dexamethasone|mesh-list
153975105|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975106|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975107|NCT03581487|Durvalumab|durvalumab|mesh-list
153975108|NCT03581487|Ipilimumab|ipilimumab|mesh-list
153975109|NCT03581487|Tremelimumab|tremelimumab|mesh-list
153975110|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
153975111|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153975112|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
153975113|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975114|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975115|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
153975116|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975117|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975118|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975119|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
153975120|NCT03570112|Velpatasvir|velpatasvir|mesh-list
153975121|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
153975122|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975123|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
153975124|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153975125|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153975126|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975127|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
153975128|NCT03553186|Coagulants|coagulants|mesh-ancestor
153975129|NCT03486457|Tofacitinib|tofacitinib|mesh-list
153975130|NCT03486457|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153975131|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975132|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975133|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975134|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
153975135|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975136|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975137|NCT03374332|Immunotoxins|immunotoxins|mesh-ancestor
153975138|NCT03374332|Immunoconjugates|immunoconjugates|mesh-ancestor
153975139|NCT03374332|Immunologic Factors|immunologic factors|mesh-ancestor
153975140|NCT03374332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975141|NCT03351296|Bevacizumab|bevacizumab|mesh-list
153975142|NCT03351296|Capecitabine|capecitabine|mesh-list
153975143|NCT03351296|Temozolomide|temozolomide|mesh-list
153975144|NCT03351296|Streptozocin|streptozocin|mesh-list
153975156|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
153975157|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153975158|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153975159|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975161|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153975162|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
153975163|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975164|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
153975165|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975166|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975167|NCT03108495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975168|NCT03108495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975170|NCT03107416|Diuretics|diuretics|mesh-ancestor
153975171|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
153975172|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975173|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153975174|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153975175|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975201|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153975202|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975203|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975204|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
153975205|NCT02775773|Oxytocin|oxytocin|mesh-list
153975206|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
153975207|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153975215|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975217|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975218|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975219|NCT02568423|Mirikizumab|mirikizumab|mesh-list
153975220|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153975221|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975222|NCT02568423|Analgesics|analgesics|mesh-ancestor
153975223|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
153975224|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860865|NCT01341405|Analgesics|analgesics|mesh-ancestor
153975225|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975226|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975227|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975228|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153975229|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153975231|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153975232|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975233|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
153975234|NCT02503319|Oxytocin|oxytocin|mesh-list
153975235|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
153975236|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153975237|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975238|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153975239|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154027524|NCT04210544|Caseins|caseins|mesh-list
154176477|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975240|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732802|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
153975241|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
153975242|NCT02503319|Coagulants|coagulants|mesh-ancestor
153975243|NCT02357797|Vortioxetine|vortioxetine|mesh-list
153975244|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
153975245|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153975246|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153975247|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153975248|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975249|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975250|NCT02357797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153975251|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153975252|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153975253|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975254|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975255|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
153975256|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153975257|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153975258|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153975259|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153975260|NCT02269280|Azacitidine|azacitidine|mesh-list
153975261|NCT02269280|Decitabine|decitabine|mesh-list
153975262|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975263|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
153975264|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975265|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975266|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975267|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
153975268|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
153975269|NCT02220985|Thiotepa|thiotepa|mesh-list
153975270|NCT02220985|Methotrexate|methotrexate|mesh-list
153975271|NCT02220985|Fludarabine|fludarabine|mesh-list
153975272|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
153975282|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153975283|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153975284|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
153975285|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153975286|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975287|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
153975288|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
153975289|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975290|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153975291|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153975292|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153975293|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153975294|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153861505|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
153975295|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
153975296|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153975297|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975298|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
153975299|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153975300|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975301|NCT01970345|Mecasermin|mecasermin|mesh-list
153975302|NCT01970345|Growth Substances|growth substances|mesh-ancestor
153975303|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975304|NCT01735955|Nilotinib|nilotinib|mesh-list
153975305|NCT01735955|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153975306|NCT01735955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154255054|NCT05617664|Mirabegron|mirabegron|mesh-list
153975307|NCT01735955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975308|NCT01735955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975309|NCT01653925|Dutasteride|dutasteride|mesh-list
153975310|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153975311|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153975312|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027525|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
153975313|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975314|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
153975315|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975316|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975317|NCT01344200|Celecoxib|celecoxib|mesh-list
153975318|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153975319|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975320|NCT01344200|Analgesics|analgesics|mesh-ancestor
153975321|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
153975322|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975323|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975324|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975325|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975326|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153975327|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153975328|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975329|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975330|NCT01305499|Azacitidine|azacitidine|mesh-list
153975331|NCT01305499|Entinostat|entinostat|mesh-list
153975332|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975333|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
153975334|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975335|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975345|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153975347|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153975348|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153975349|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
153975350|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975351|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975352|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975353|NCT00586391|Ipilimumab|ipilimumab|mesh-list
153975354|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975355|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975356|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975357|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975358|NCT00221429|Valproic Acid|valproic acid|mesh-list
153975359|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153975360|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975361|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975362|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
153975363|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153975364|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975365|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975366|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
153975367|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
153975368|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975369|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
153975370|NCT00085202|Vincristine|vincristine|mesh-list
153975371|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153975372|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
153975373|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975374|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975375|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153975376|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
153975377|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975378|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975379|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153975380|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153975381|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
153975382|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
153975383|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
153861525|NCT00548678|Diclofenac|diclofenac|mesh-list
153975384|NCT06183918|Tranexamic Acid|tranexamic acid|mesh-list
153975385|NCT06183918|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153975386|NCT06183918|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154860866|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
153975387|NCT06183918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975388|NCT06183918|Hemostatics|hemostatics|mesh-ancestor
153975389|NCT06183918|Coagulants|coagulants|mesh-ancestor
153975390|NCT06183892|Tacrolimus|tacrolimus|mesh-list
153975391|NCT06183892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153975392|NCT06183892|Immunologic Factors|immunologic factors|mesh-ancestor
153975393|NCT06183892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975394|NCT06183892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153975395|NCT06183892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975396|NCT06183892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975397|NCT06183749|Anesthetics|anesthetics|mesh-list
153975398|NCT06183749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975399|NCT06183749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975400|NCT06182592|Cytarabine|cytarabine|mesh-list
153975401|NCT06182592|Daunorubicin|daunorubicin|mesh-list
153975418|NCT06180083|Fluticasone|fluticasone|mesh-list
153975419|NCT06180083|Xhance|xhance|mesh-list
153975420|NCT06180083|Azelastine|azelastine|mesh-list
153975421|NCT06180083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975422|NCT06180083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153975423|NCT06180083|Autonomic Agents|autonomic agents|mesh-ancestor
153975424|NCT06180083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975425|NCT06180083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975426|NCT06180083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153975427|NCT06180083|Respiratory System Agents|respiratory system agents|mesh-ancestor
153975428|NCT06180083|Dermatologic Agents|dermatologic agents|mesh-ancestor
153975429|NCT06180083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153975430|NCT06180083|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153975431|NCT06180083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975432|NCT06180083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975433|NCT06180083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153975434|NCT06180083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153975435|NCT06180083|Histamine Antagonists|histamine antagonists|mesh-ancestor
153975436|NCT06180083|Histamine Agents|histamine agents|mesh-ancestor
153975437|NCT06180083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975438|NCT06180057|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153975439|NCT06180057|Cathartics|cathartics|mesh-ancestor
153975440|NCT06180057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153975441|NCT06173869|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153975442|NCT06173869|Hormones|hormones|mesh-ancestor
153975443|NCT06173869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975444|NCT06173869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975445|NCT06166628|Phenol|phenol|mesh-list
153975446|NCT06166628|Bupivacaine|bupivacaine|mesh-list
153975447|NCT06166628|Anesthetics, Local|anesthetics, local|mesh-ancestor
153975448|NCT06166628|Anesthetics|anesthetics|mesh-ancestor
153975449|NCT06166628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975450|NCT06166628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975451|NCT06166628|Sensory System Agents|sensory system agents|mesh-ancestor
153975452|NCT06166628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975453|NCT06166628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153975454|NCT06166628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975455|NCT06166628|Disinfectants|disinfectants|mesh-ancestor
153975456|NCT06166628|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153975457|NCT06166628|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153975458|NCT06154447|Itraconazole|itraconazole|mesh-list
153975459|NCT06154447|Midazolam|midazolam|mesh-list
153762508|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
153975472|NCT06154447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975473|NCT06154447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975474|NCT06154447|Antifungal Agents|antifungal agents|mesh-ancestor
153975475|NCT06154447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975476|NCT06154447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153975477|NCT06154447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153975478|NCT06154447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975479|NCT06154447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153975480|NCT06154447|Hormone Antagonists|hormone antagonists|mesh-ancestor
153975481|NCT06154447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975482|NCT06154447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153975483|NCT06149507|Acetaminophen|acetaminophen|mesh-list
153975484|NCT06149507|Ibuprofen|ibuprofen|mesh-list
153975485|NCT06149507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975486|NCT06149507|Analgesics|analgesics|mesh-ancestor
153975487|NCT06149507|Sensory System Agents|sensory system agents|mesh-ancestor
153975488|NCT06149507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975489|NCT06149507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255055|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154255056|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153975490|NCT06149507|Antipyretics|antipyretics|mesh-ancestor
153975491|NCT06149507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153975492|NCT06149507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975493|NCT06149507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975494|NCT06149507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153975495|NCT06149507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975496|NCT06149507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975497|NCT06070610|Pirfenidone|pirfenidone|mesh-list
153975498|NCT06070610|Nintedanib|nintedanib|mesh-list
153975499|NCT06070610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975500|NCT06070610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975501|NCT06070610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975502|NCT06070610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975503|NCT06070610|Analgesics|analgesics|mesh-ancestor
153975504|NCT06070610|Sensory System Agents|sensory system agents|mesh-ancestor
153975505|NCT06070610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975506|NCT06070610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975507|NCT06070610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153975508|NCT06070610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975509|NCT06070610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975510|NCT06070610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975511|NCT06068764|Propofol|propofol|mesh-list
153975512|NCT06068764|Etomidate|etomidate|mesh-list
153975513|NCT06068764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153975514|NCT06068764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975515|NCT06068764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975516|NCT06068764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153975517|NCT06068764|Anesthetics, General|anesthetics, general|mesh-ancestor
153975518|NCT06068764|Anesthetics|anesthetics|mesh-ancestor
153975519|NCT06067919|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153975520|NCT06067919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975521|NCT06043674|Atezolizumab|atezolizumab|mesh-list
153975522|NCT06043674|Obinutuzumab|obinutuzumab|mesh-list
153975533|NCT06007586|Autonomic Agents|autonomic agents|mesh-ancestor
153975534|NCT06007586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975535|NCT06007586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975536|NCT06007586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153975537|NCT06007586|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153975538|NCT06007586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975539|NCT06007586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733094|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975540|NCT06003283|Rituximab|rituximab|mesh-list
153975541|NCT06003283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975542|NCT06003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975543|NCT06003283|Immunologic Factors|immunologic factors|mesh-ancestor
153975544|NCT06003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975545|NCT06003283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975546|NCT05930171|Acetaminophen|acetaminophen|mesh-list
153975547|NCT05930171|Bupivacaine|bupivacaine|mesh-list
153975548|NCT05930171|Anesthetics, Local|anesthetics, local|mesh-ancestor
153975549|NCT05930171|Anesthetics|anesthetics|mesh-ancestor
153975550|NCT05930171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975551|NCT05930171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975552|NCT05930171|Sensory System Agents|sensory system agents|mesh-ancestor
153975553|NCT05930171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975554|NCT05930171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975555|NCT05930171|Analgesics|analgesics|mesh-ancestor
153975556|NCT05930171|Antipyretics|antipyretics|mesh-ancestor
153975557|NCT05871606|Nitrous Oxide|nitrous oxide|mesh-list
153975558|NCT05871606|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153975559|NCT05871606|Anesthetics, General|anesthetics, general|mesh-ancestor
153975560|NCT05871606|Anesthetics|anesthetics|mesh-ancestor
153975561|NCT05871606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975562|NCT05871606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975563|NCT05871606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975564|NCT05871606|Analgesics|analgesics|mesh-ancestor
153975565|NCT05871606|Sensory System Agents|sensory system agents|mesh-ancestor
153975566|NCT05871606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975567|NCT05772871|Levamisole|levamisole|mesh-list
153975568|NCT05772871|Prednisone|prednisone|mesh-list
153401907|NCT05985798|Estrogens|estrogens|mesh-ancestor
153975569|NCT05772871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975570|NCT05772871|Glucocorticoids|glucocorticoids|mesh-ancestor
154860867|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154860868|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154255057|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153975572|NCT05772871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975573|NCT05772871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975574|NCT05772871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153975575|NCT05772871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975576|NCT05772871|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153975577|NCT05772871|Immunologic Factors|immunologic factors|mesh-ancestor
153975578|NCT05772871|Antinematodal Agents|antinematodal agents|mesh-ancestor
153975579|NCT05772871|Anthelmintics|anthelmintics|mesh-ancestor
153975580|NCT05772871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153975581|NCT05772871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975582|NCT05772871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975583|NCT05718882|Lenvatinib|lenvatinib|mesh-list
153975584|NCT05718882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975585|NCT05718882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975586|NCT05718882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762621|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975602|NCT05714839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153975603|NCT05714839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153975605|NCT05714839|Growth Inhibitors|growth inhibitors|mesh-ancestor
153975606|NCT05707351|Factor VIII|factor viii|mesh-list
153975607|NCT05707351|BAX 855|bax 855|mesh-list
153975608|NCT05707351|Coagulants|coagulants|mesh-ancestor
153975609|NCT05659914|Durvalumab|durvalumab|mesh-list
153975610|NCT05659914|Olaparib|olaparib|mesh-list
153975611|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975612|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975628|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153975629|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153975630|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
153975631|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975632|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975633|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975635|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153975636|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975637|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
153975638|NCT05545280|Neostigmine|neostigmine|mesh-list
153975639|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153975640|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975641|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975642|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
153975643|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975644|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975645|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153975646|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
153975647|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975648|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153975649|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153975650|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153975651|NCT05498766|Capecitabine|capecitabine|mesh-list
153975652|NCT05498766|Tegafur|tegafur|mesh-list
153975653|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
153975654|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975655|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
153975656|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975657|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975658|NCT05393713|Antibodies|antibodies|mesh-list
153975659|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153975660|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
153975661|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975662|NCT05337540|Hylan|hylan|mesh-list
153975681|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
153975682|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975683|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975684|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153975685|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153975687|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
153975688|NCT05177484|Ferric maltol|ferric maltol|mesh-list
153975689|NCT05177484|Hematinics|hematinics|mesh-ancestor
153975690|NCT05149638|Cosyntropin|cosyntropin|mesh-list
153975691|NCT05149638|Hormones|hormones|mesh-ancestor
153975692|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975693|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975694|NCT05118724|Atezolizumab|atezolizumab|mesh-list
154860869|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136451|NCT05355597|Clonidine|clonidine|mesh-list
153975695|NCT05118724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975696|NCT05118724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975697|NCT05118724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975698|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975699|NCT04991480|Niraparib|niraparib|mesh-list
153975700|NCT04991480|Talazoparib|talazoparib|mesh-list
153975701|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153975702|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975703|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975704|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975705|NCT04972123|Phenylephrine|phenylephrine|mesh-list
153975706|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
153975707|NCT04972123|Caffeine|caffeine|mesh-list
153975708|NCT04972123|Capsaicin|capsaicin|mesh-list
153975709|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153975710|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975711|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153975712|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975713|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975714|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153975715|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153975716|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
153975717|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975718|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153975719|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
153762754|NCT06116214|Eusol|eusol|mesh-list
153975732|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
153975733|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
153975734|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153975735|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153975736|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153975737|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975738|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975739|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
153975740|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975741|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153975742|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153975744|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153975745|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
153975746|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
153975747|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975748|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975749|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153975750|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153975751|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153975752|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
153975753|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975754|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975755|NCT04827953|Paclitaxel|paclitaxel|mesh-list
153975756|NCT04827953|Gemcitabine|gemcitabine|mesh-list
153975757|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153975758|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975759|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
153975760|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
153975761|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
153975762|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975763|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975764|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
153975765|NCT04756232|Mecamylamine|mecamylamine|mesh-list
153975766|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153975768|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
153975769|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975770|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975771|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153975772|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153975773|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
153975774|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975775|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975776|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
153975777|NCT04676412|Lenvatinib|lenvatinib|mesh-list
153975778|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975779|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860870|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154255058|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
153975780|NCT04676412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975781|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975797|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975798|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975799|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975800|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975803|NCT04492033|Asciminib|asciminib|mesh-list
153975804|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153975805|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975806|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
153975807|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
153975808|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
153975809|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975810|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153975811|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153975812|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975813|NCT04492033|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153975814|NCT04492033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975815|NCT04483505|Fulvestrant|fulvestrant|mesh-list
153861581|NCT00549107|Protective Agents|protective agents|mesh-ancestor
153975816|NCT04483505|Palbociclib|palbociclib|mesh-list
153975817|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153975818|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975819|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153975820|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153975821|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
153975822|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975823|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975824|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975825|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975826|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975827|NCT04447768|Venetoclax|venetoclax|mesh-list
153975828|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
153975829|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975830|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975831|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
153975832|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153975833|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
153975834|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153975846|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975848|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153975849|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975850|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
153975851|NCT04234022|Pomalidomide|pomalidomide|mesh-list
153762871|NCT05894538|Ivermectin|ivermectin|mesh-list
153975874|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975876|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
153975877|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153975878|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975879|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153975880|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153975881|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
153975882|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153975883|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153975884|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975885|NCT04233866|Antidotes|antidotes|mesh-ancestor
153975886|NCT04233866|Protective Agents|protective agents|mesh-ancestor
153975887|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
153975888|NCT04233866|Vitamins|vitamins|mesh-ancestor
153975889|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
153975890|NCT04233866|Hematinics|hematinics|mesh-ancestor
153975891|NCT04228042|Infigratinib|infigratinib|mesh-list
153975892|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975904|NCT04207060|Indomethacin|indomethacin|mesh-list
153975905|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153975906|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975907|NCT04207060|Analgesics|analgesics|mesh-ancestor
153975908|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
153975909|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975910|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975911|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975912|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154860871|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153975913|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
153975914|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
153975915|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153975916|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153975917|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762918|NCT06319170|Olanzapine|olanzapine|mesh-list
153975927|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975928|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
153975929|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975930|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153975931|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
153975932|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975933|NCT04196010|Analgesics|analgesics|mesh-ancestor
153975934|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
153975935|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975936|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153975937|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153975938|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975939|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153975940|NCT04160546|Aspirin|aspirin|mesh-list
153975941|NCT04160546|Ponatinib|ponatinib|mesh-list
153975942|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153975943|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975944|NCT04160546|Analgesics|analgesics|mesh-ancestor
153975945|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
153975946|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975947|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975948|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975949|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975950|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153975951|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153975952|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975953|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153975954|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153975955|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975956|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
153975957|NCT04160546|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153975958|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975959|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975960|NCT04134000|Atezolizumab|atezolizumab|mesh-list
153975961|NCT04134000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975962|NCT04134000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975963|NCT04134000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975964|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975965|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
153975966|NCT04032704|SGN-LIV1A|sgn-liv1a|mesh-list
153975967|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975968|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975969|NCT04032704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975970|NCT04032704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975971|NCT04032704|Immunoconjugates|immunoconjugates|mesh-ancestor
153975972|NCT04032704|Immunologic Factors|immunologic factors|mesh-ancestor
153975973|NCT04032704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975974|NCT04019288|Durvalumab|durvalumab|mesh-list
153975975|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
153861604|NCT00549146|Hormones|hormones|mesh-ancestor
153975976|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153975977|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
153975978|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975979|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975980|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
153975981|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975982|NCT03984188|Theophylline|theophylline|mesh-list
153975983|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153976011|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
153976012|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976013|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976014|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153976015|NCT03731234|Ibrutinib|ibrutinib|mesh-list
153976016|NCT03731234|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153976017|NCT03731234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153976018|NCT03731234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976019|NCT03731234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976020|NCT03635021|Bevacizumab|bevacizumab|mesh-list
153976021|NCT03635021|Panitumumab|panitumumab|mesh-list
153976022|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976023|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976024|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153976025|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153976026|NCT03635021|Growth Substances|growth substances|mesh-ancestor
153976027|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976028|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
153976029|NCT03631199|Paclitaxel|paclitaxel|mesh-list
153763034|NCT06318104|Esomeprazole|esomeprazole|mesh-list
153976039|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
153976040|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976041|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976042|NCT03631199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976043|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976044|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153976045|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153976046|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
153976047|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976048|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
153976049|NCT03439137|Hematinics|hematinics|mesh-ancestor
153976050|NCT03425201|Niraparib|niraparib|mesh-list
153976051|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153976052|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976053|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976054|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976055|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
153976056|NCT03337087|Leucovorin|leucovorin|mesh-list
153976057|NCT03337087|Folic Acid|folic acid|mesh-list
153976058|NCT03337087|Fluorouracil|fluorouracil|mesh-list
153976059|NCT03337087|Irinotecan|irinotecan|mesh-list
153976060|NCT03337087|Rucaparib|rucaparib|mesh-list
153976061|NCT03337087|Calcium|calcium|mesh-list
153976062|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
154027526|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
153976063|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153401936|NCT05984511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153976064|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976065|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153976067|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976068|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976069|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976070|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976071|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
153976072|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153976073|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153976074|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976075|NCT03337087|Antidotes|antidotes|mesh-ancestor
153976076|NCT03337087|Protective Agents|protective agents|mesh-ancestor
153976077|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
153976078|NCT03337087|Vitamins|vitamins|mesh-ancestor
153976079|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
153976080|NCT03337087|Hematinics|hematinics|mesh-ancestor
153976081|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153976082|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
153976083|NCT03329196|Hematinics|hematinics|mesh-ancestor
153976084|NCT03318900|Aldesleukin|aldesleukin|mesh-list
153976085|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
153976086|NCT03318900|Interleukin-2|interleukin-2|mesh-list
153976087|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153976088|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
153976089|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976090|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
153976091|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976092|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976093|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153976094|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
153976095|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976096|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976097|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153976098|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153976124|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
153976125|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976126|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976127|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153976128|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
153976129|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976130|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153976131|NCT03101995|Gemcitabine|gemcitabine|mesh-list
153976132|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976133|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
153976134|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976135|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976136|NCT03093922|Gemcitabine|gemcitabine|mesh-list
153976137|NCT03093922|Atezolizumab|atezolizumab|mesh-list
153976138|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976139|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976141|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733699|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
153976142|NCT03093922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976143|NCT03093922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976144|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
153976145|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976146|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976147|NCT02949219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976148|NCT02949219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976168|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
153976169|NCT02873195|Antibodies|antibodies|mesh-list
153976170|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
153976171|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153976172|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
153976173|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976174|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153976175|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153976176|NCT02873195|Growth Substances|growth substances|mesh-ancestor
153976177|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976178|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
153976179|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
153976180|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976181|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
153976182|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976183|NCT02873195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976184|NCT02643667|Ibrutinib|ibrutinib|mesh-list
153976185|NCT02643667|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153976186|NCT02643667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153976187|NCT02643667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976188|NCT02643667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976189|NCT02252887|Gemcitabine|gemcitabine|mesh-list
153976190|NCT02252887|Trastuzumab|trastuzumab|mesh-list
153976191|NCT02252887|Pertuzumab|pertuzumab|mesh-list
153976192|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976193|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
153976194|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976195|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976196|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976197|NCT02205047|Capecitabine|capecitabine|mesh-list
153976198|NCT02205047|Fluorouracil|fluorouracil|mesh-list
153976199|NCT02205047|Trastuzumab|trastuzumab|mesh-list
153976200|NCT02205047|Pertuzumab|pertuzumab|mesh-list
153976201|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976202|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153763202|NCT06317064|Ibuprofen|ibuprofen|mesh-list
153976213|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976214|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976215|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976216|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976217|NCT02008656|Leucovorin|leucovorin|mesh-list
153976218|NCT02008656|Capecitabine|capecitabine|mesh-list
153976219|NCT02008656|Fluorouracil|fluorouracil|mesh-list
153976221|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976222|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
153401955|NCT05983237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976223|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976224|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976225|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976226|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
153976227|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976228|NCT02008656|Antidotes|antidotes|mesh-ancestor
153976229|NCT02008656|Protective Agents|protective agents|mesh-ancestor
153976230|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
153976231|NCT02008656|Vitamins|vitamins|mesh-ancestor
153976232|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
153976233|NCT01825603|Cisplatin|cisplatin|mesh-list
153976234|NCT01825603|Gemcitabine|gemcitabine|mesh-list
153976235|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976236|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976237|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
153976238|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976239|NCT00775463|Treprostinil|treprostinil|mesh-list
153976240|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153976241|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153976242|NCT00406640|Escitalopram|escitalopram|mesh-list
153976243|NCT00406640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153976244|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153976245|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153976246|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976247|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976248|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
153976249|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976250|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
153976251|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153976252|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153976253|NCT00229931|Triamcinolone|triamcinolone|mesh-list
153976254|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153976255|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153976256|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153976257|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976258|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
153976259|NCT00229931|Hormones|hormones|mesh-ancestor
153976260|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976261|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976262|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976263|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
153976264|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976265|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976266|NCT00150969|Vitamin K|vitamin k|mesh-list
153976267|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
153976268|NCT00150969|Vitamins|vitamins|mesh-ancestor
153976286|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976287|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976288|NCT00766636|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153976289|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153976290|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976292|NCT02581969|Coagulants|coagulants|mesh-ancestor
153976293|NCT00770692|Eszopiclone|eszopiclone|mesh-list
153976294|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153976295|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153976296|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976297|NCT02816203|Hemostatics|hemostatics|mesh-list
153976298|NCT02816203|Coagulants|coagulants|mesh-ancestor
153976300|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153976301|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153976302|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153976303|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
153976304|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976305|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153976306|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153976307|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976308|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
153976309|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153976310|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
153976311|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
153796933|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976312|NCT03183115|Lugol's solution|lugol's solution|mesh-list
153976313|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
153976314|NCT03183115|Coagulants|coagulants|mesh-ancestor
153976315|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153976316|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
153976317|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976318|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
153976319|NCT02743819|Ipilimumab|ipilimumab|mesh-list
153976320|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976321|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976322|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976323|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976324|NCT04074421|Rifaximin|rifaximin|mesh-list
153976325|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153976326|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976344|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153976345|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
153976346|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976348|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
153976349|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
153976350|NCT02705287|Vitamins|vitamins|mesh-list
153976351|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
153976352|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976353|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153976354|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153976355|NCT02578537|Clopidogrel|clopidogrel|mesh-list
153976356|NCT02578537|Ticagrelor|ticagrelor|mesh-list
153976357|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153976358|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153976359|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153976360|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153976361|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
153976362|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629968|NCT00005877|Rubitecan|rubitecan|mesh-list
153976363|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976364|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976365|NCT03011671|Temozolomide|temozolomide|mesh-list
153976366|NCT03011671|Acetazolamide|acetazolamide|mesh-list
153976367|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153976368|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
153976369|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976370|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976371|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
153976372|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153976373|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976374|NCT03011671|Diuretics|diuretics|mesh-ancestor
153976375|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
153976376|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976377|NCT00628706|Dronabinol|dronabinol|mesh-list
153976378|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
153861630|NCT04643691|Losartan|losartan|mesh-list
153976379|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976380|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153976381|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153976382|NCT00628706|Analgesics|analgesics|mesh-ancestor
153976383|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
153976384|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976401|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
153976402|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153976403|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153976404|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976405|NCT01004432|Golimumab|golimumab|mesh-list
153976406|NCT01004432|Methotrexate|methotrexate|mesh-list
153976407|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153976408|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153976409|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
153976410|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153976411|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976412|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976413|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
153976414|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976415|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976416|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
153976417|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976418|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153976419|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976420|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
153976421|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976422|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153976423|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153976424|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976425|NCT02576275|Rituximab|rituximab|mesh-list
153976426|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153976427|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976428|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976429|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
153976430|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976431|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976432|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153976433|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
153976434|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976435|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
153976436|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153976437|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153976438|NCT01000610|Prednisolone|prednisolone|mesh-list
153976439|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
153976441|NCT01000610|Methotrexate|methotrexate|mesh-list
153976467|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976469|NCT01000610|Protective Agents|protective agents|mesh-ancestor
153976470|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153976471|NCT02523469|Nivolumab|nivolumab|mesh-list
153976472|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976473|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976474|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976475|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976476|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
153976477|NCT00586924|Immunotoxins|immunotoxins|mesh-ancestor
153976478|NCT00586924|Immunoconjugates|immunoconjugates|mesh-ancestor
153976479|NCT00586924|Immunologic Factors|immunologic factors|mesh-ancestor
153976480|NCT00586924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976481|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976482|NCT01000376|Ketoconazole|ketoconazole|mesh-list
153976483|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
153976484|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976485|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153976486|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153976487|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976488|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976505|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976506|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976507|NCT00619203|Acetaminophen|acetaminophen|mesh-list
153976508|NCT00619203|Glycerol|glycerol|mesh-list
153976509|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153976510|NCT00619203|Analgesics|analgesics|mesh-ancestor
153976512|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976513|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976514|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
153976515|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153976516|NCT00619203|Protective Agents|protective agents|mesh-ancestor
153976517|NCT04072471|Lesinurad|lesinurad|mesh-list
153976518|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
153976519|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976520|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
153976521|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153976522|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153976523|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976524|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153976525|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153976526|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153976527|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976528|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
153976529|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976530|NCT01812603|Nabiximols|nabiximols|mesh-list
153976531|NCT01812603|Analgesics|analgesics|mesh-ancestor
153976532|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
153976533|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976534|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976535|NCT04211805|Tenofovir|tenofovir|mesh-list
153976536|NCT04211805|Vaccines|vaccines|mesh-list
153976537|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
153976538|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976539|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
153976540|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976541|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153976542|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153976543|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976544|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976545|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153976546|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153763542|NCT06179303|Exemestane|exemestane|mesh-list
153976569|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976570|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
153976571|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976572|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976573|NCT00628550|Vasopressins|vasopressins|mesh-list
153976574|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
153976575|NCT00628550|Epinephrine|epinephrine|mesh-list
153976576|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153976577|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153976578|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
153976579|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976580|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976581|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976582|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153976583|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153976584|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
153976585|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976586|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153976587|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
153976588|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
153976589|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
153976590|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153976591|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
153976592|NCT00628550|Coagulants|coagulants|mesh-ancestor
153976593|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153976594|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
153734156|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976596|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153976597|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153976598|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153976599|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976600|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153976601|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
153976620|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976621|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976622|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153976623|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153976624|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
153976625|NCT02871518|Cisplatin|cisplatin|mesh-list
153976626|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976627|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
153976628|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153976629|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153976630|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
153976631|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976632|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153976633|NCT00770224|Prednisone|prednisone|mesh-list
153976634|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
153976635|NCT00770224|Rituximab|rituximab|mesh-list
153976636|NCT00770224|Doxorubicin|doxorubicin|mesh-list
153976637|NCT00770224|Vincristine|vincristine|mesh-list
153976638|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
153976639|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976640|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
153976641|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976642|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976643|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153976644|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
153976645|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976646|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976647|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153976648|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976649|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153976650|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153976651|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153976652|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976653|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976654|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
153976655|NCT00770224|Hormones|hormones|mesh-ancestor
153976656|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976657|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153976658|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153976672|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976673|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976674|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153976675|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153976676|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976677|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976678|NCT02389465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153976679|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153976680|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153976681|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976682|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
153976683|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153976684|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153976685|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
153976686|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
153976687|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153976688|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153976689|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
153976690|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153976691|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
153976692|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153976693|NCT01057589|Folic Acid|folic acid|mesh-list
153976694|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
153976695|NCT01057589|Pemetrexed|pemetrexed|mesh-list
153976696|NCT01057589|Cetuximab|cetuximab|mesh-list
153976697|NCT01057589|Vitamins|vitamins|mesh-ancestor
153976698|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
153976699|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976700|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976701|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976702|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976703|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153976704|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153976705|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976706|NCT01057589|Hematinics|hematinics|mesh-ancestor
153976707|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
153976708|NCT02575885|Nicotine|nicotine|mesh-list
153976709|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153976710|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
153976711|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976712|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976713|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153976714|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153976715|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
153976716|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976717|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976718|NCT02575729|Betamethasone|betamethasone|mesh-list
153976719|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
153976720|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976721|NCT02575729|Hormones|hormones|mesh-ancestor
153976722|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976723|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976738|NCT00579553|Progestins|progestins|mesh-ancestor
153976739|NCT00579553|Hormones|hormones|mesh-ancestor
153976740|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976741|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976742|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153976743|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
153343802|NCT00003970|Irinotecan|irinotecan|mesh-list
153976744|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
153976745|NCT04209933|Bismuth|bismuth|mesh-list
153976746|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976747|NCT04209933|Antacids|antacids|mesh-ancestor
153976748|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976749|NCT04209933|Diuretics|diuretics|mesh-ancestor
153976750|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
153976751|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976752|NCT04209933|Expectorants|expectorants|mesh-ancestor
153976753|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
153976754|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153976755|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
153976756|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976757|NCT04209699|Deucravacitinib|deucravacitinib|mesh-list
153976758|NCT04209699|Famotidine|famotidine|mesh-list
153976759|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153976760|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976761|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153976762|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
153976763|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
153976764|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976765|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976766|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976767|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
153976768|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153976769|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976770|NCT00620295|Gemcitabine|gemcitabine|mesh-list
153976771|NCT00620295|Bortezomib|bortezomib|mesh-list
153976772|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154255059|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976773|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
153976774|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976775|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976776|NCT00581893|Phenytoin|phenytoin|mesh-list
153976777|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
153976778|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153976779|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153976780|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153976781|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976782|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153976796|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976797|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153797366|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153976798|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153976799|NCT02334865|Growth Substances|growth substances|mesh-ancestor
153976800|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
153976801|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976802|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153976803|NCT04073719|Acetic Acid|acetic acid|mesh-list
153976804|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153976805|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976806|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
153976807|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153976808|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153976809|NCT00379431|Prednisolone|prednisolone|mesh-list
153976810|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
153976811|NCT00379431|Rituximab|rituximab|mesh-list
153976812|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153976813|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
153976814|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976815|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976816|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
153976817|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976818|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976819|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976820|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
153976821|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
153976822|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976823|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976824|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
153976825|NCT00379431|Hormones|hormones|mesh-ancestor
153976826|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976827|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153976828|NCT00379431|Protective Agents|protective agents|mesh-ancestor
153976829|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153976830|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
153976831|NCT04954989|Hematinics|hematinics|mesh-ancestor
153976832|NCT00621699|Ezetimibe|ezetimibe|mesh-list
153976833|NCT00621699|Tacrolimus|tacrolimus|mesh-list
153976834|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976835|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
153976836|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976837|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153976838|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976839|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976840|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153976841|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153976842|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
153976843|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153976844|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153976845|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153976853|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976854|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153976855|NCT00915850|Cisplatin|cisplatin|mesh-list
153976856|NCT00915850|Docetaxel|docetaxel|mesh-list
153976857|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976858|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
153976859|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
153976860|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
153976861|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976862|NCT04208763|Imipenem|imipenem|mesh-list
153976863|NCT04208763|Colistin|colistin|mesh-list
153976864|NCT04208763|Tigecycline|tigecycline|mesh-list
153976865|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153976866|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154860872|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153976867|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153976868|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976869|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976871|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976872|NCT00620919|Hormones|hormones|mesh-ancestor
153976873|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976874|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976875|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
153976876|NCT00916552|Hematinics|hematinics|mesh-ancestor
153976877|NCT03950037|Albendazole|albendazole|mesh-list
153976878|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
153976879|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153976880|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976881|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
153976882|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153976883|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153976884|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
153976885|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
153976886|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
153976887|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976888|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976889|NCT04188171|Polidocanol|polidocanol|mesh-list
153976890|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153976891|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153976892|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
153976893|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
153976894|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
153976895|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153976896|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976897|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
153976898|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976900|NCT00622011|Zotepine|zotepine|mesh-list
153976901|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153976902|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
153976903|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976904|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976905|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976906|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153976907|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153976908|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153976909|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153976910|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153976911|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
153976912|NCT04208373|Itraconazole|itraconazole|mesh-list
153976913|NCT04208373|Etravirine|etravirine|mesh-list
153976914|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
153976915|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976916|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153976935|NCT01056341|Propranolol|propranolol|mesh-list
153976936|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153976937|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153976938|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
153976939|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976940|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976941|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976942|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153976943|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153976944|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
153976946|NCT00999518|Analgesics|analgesics|mesh-ancestor
153976947|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
153976948|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976949|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976950|NCT00621387|Ofloxacin|ofloxacin|mesh-list
153976951|NCT00621387|Roxithromycin|roxithromycin|mesh-list
153976952|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153976953|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976954|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153976955|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153976956|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153976957|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976958|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976959|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976960|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153976961|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154137355|NCT00994695|Vaccines|vaccines|mesh-list
153976962|NCT02873273|Dexamethasone|dexamethasone|mesh-list
153976963|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976964|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
153976966|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976967|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976968|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976969|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
153976978|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153976980|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976981|NCT00637143|Cyclosporine|cyclosporine|mesh-list
153976982|NCT00637143|Tacrolimus|tacrolimus|mesh-list
153976983|NCT00637143|Cyclosporins|cyclosporins|mesh-list
153976984|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976985|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
153976986|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976987|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153976988|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976989|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976990|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
153976991|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976992|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
153976993|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976994|NCT01056107|Glucagon|glucagon|mesh-list
153976995|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153976996|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976997|NCT01056107|Hormones|hormones|mesh-ancestor
153976998|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976999|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977000|NCT01056107|Incretins|incretins|mesh-ancestor
153977001|NCT03548805|Mitomycins|mitomycins|mesh-list
153977002|NCT03548805|Mitomycin|mitomycin|mesh-list
153977003|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153977004|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977005|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
153977006|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977007|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153977008|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977009|NCT01003886|Doxazosin|doxazosin|mesh-list
153977010|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153977011|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153977012|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153977013|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153977014|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
153977015|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977016|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977017|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977018|NCT04138641|Cangrelor|cangrelor|mesh-list
153977019|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153977020|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153977021|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153977022|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153977023|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
153977024|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977025|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977026|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977027|NCT01003184|Exenatide|exenatide|mesh-list
153977028|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
153977029|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153977030|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977031|NCT01003184|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153977032|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153977033|NCT01003184|Incretins|incretins|mesh-ancestor
153977034|NCT01003184|Hormones|hormones|mesh-ancestor
153977035|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977036|NCT01008410|Budesonide|budesonide|mesh-list
153601132|NCT01888341|Isotretinoin|isotretinoin|mesh-list
153977046|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977048|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153977049|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
153977050|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977051|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153977053|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154860873|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977054|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977055|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977056|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153977057|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153977058|NCT01972035|Valacyclovir|valacyclovir|mesh-list
153977059|NCT01972035|Valganciclovir|valganciclovir|mesh-list
153977060|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
153977061|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977062|NCT00622479|Sorafenib|sorafenib|mesh-list
153977063|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977064|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977065|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977066|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977067|NCT01207011|Docetaxel|docetaxel|mesh-list
153977068|NCT01207011|Amrubicin|amrubicin|mesh-list
153977069|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977070|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
153977071|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
153977072|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
153977073|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977074|NCT05264805|Bupivacaine|bupivacaine|mesh-list
153977075|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
153977076|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
153977077|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977078|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797631|NCT00295464|Hormones|hormones|mesh-ancestor
153977079|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
153977080|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977081|NCT05264493|Naloxone|naloxone|mesh-list
153977082|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153977083|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977084|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
153977085|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977086|NCT00612261|Triamcinolone|triamcinolone|mesh-list
153977087|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153977088|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153977089|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153977090|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153977091|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
153977092|NCT00612261|Hormones|hormones|mesh-ancestor
153977093|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977094|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977095|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977096|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
153977097|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977098|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977099|NCT00636909|Cyclosporine|cyclosporine|mesh-list
153977100|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
153977101|NCT00636909|Methotrexate|methotrexate|mesh-list
153977102|NCT00636909|Fludarabine|fludarabine|mesh-list
153977103|NCT00636909|Cyclosporins|cyclosporins|mesh-list
153977113|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153977114|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
153977115|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977117|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
153977118|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
153977119|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734679|NCT05986422|Antiemetics|antiemetics|mesh-ancestor
153977120|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153977121|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153977122|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
153977123|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977124|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153977125|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153977126|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153977127|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977128|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153977129|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153977130|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153977131|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153977132|NCT02697045|Aripiprazole|aripiprazole|mesh-list
153977133|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
153977134|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977135|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153977136|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153977137|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977138|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977139|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
153977140|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
153977141|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977142|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977143|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153977144|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153977145|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
153977146|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153977147|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153977148|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153977149|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153977150|NCT01007942|Trastuzumab|trastuzumab|mesh-list
153977151|NCT01007942|Everolimus|everolimus|mesh-list
153977152|NCT01007942|Vinorelbine|vinorelbine|mesh-list
153977153|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153977154|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977155|NCT01007942|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153977156|NCT01007942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977157|NCT01007942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977158|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977159|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977160|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
153977161|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977162|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153977163|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
153977164|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
153977165|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
153977166|NCT01023035|Ribavirin|ribavirin|mesh-list
153977167|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153977187|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977188|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153977189|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
153977191|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977192|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153977193|NCT00627731|Protective Agents|protective agents|mesh-ancestor
153977194|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153977195|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977196|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153977198|NCT01028027|Dexamethasone|dexamethasone|mesh-list
153977199|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153977200|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
153977201|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
153977202|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977203|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977204|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153977205|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
153977206|NCT01028027|Hormones|hormones|mesh-ancestor
153977207|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977208|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153977209|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977210|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977211|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977212|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153977213|NCT01007552|Bevacizumab|bevacizumab|mesh-list
153977214|NCT01007552|Gemcitabine|gemcitabine|mesh-list
153977215|NCT01007552|Capecitabine|capecitabine|mesh-list
153977216|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153977217|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977218|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153977219|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153977220|NCT01007552|Growth Substances|growth substances|mesh-ancestor
153977221|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977222|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
153977223|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153977224|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
153977225|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977244|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
153977245|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977246|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977247|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153977248|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153797752|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153977249|NCT02870036|Growth Substances|growth substances|mesh-ancestor
153977250|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
153977251|NCT04296422|Ibuprofen|ibuprofen|mesh-list
153977252|NCT04296422|Diclofenac|diclofenac|mesh-list
154255910|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153977253|NCT04296422|Naproxen|naproxen|mesh-list
153977254|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153977255|NCT04296422|Piroxicam|piroxicam|mesh-list
153977256|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
153977257|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
153977258|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153977259|NCT04296422|Analgesics|analgesics|mesh-ancestor
153977260|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
153977261|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977262|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977263|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153977264|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153977265|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153977266|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977267|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977268|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
153977269|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977270|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153977271|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
153977272|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
153977273|NCT00998738|Calcium|calcium|mesh-list
153977274|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153977275|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977276|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153977277|NCT00998738|Analgesics|analgesics|mesh-ancestor
153977278|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
153402144|NCT05752409|Ketamine|ketamine|mesh-list
153977279|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977280|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
153977281|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977282|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153977283|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
153977284|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153977285|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153977307|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977308|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977309|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
153977310|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153977311|NCT04296578|Trace Elements|trace elements|mesh-ancestor
153977312|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
153977313|NCT00996944|Ropinirole|ropinirole|mesh-list
153977314|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153977315|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153977316|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
153977317|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
153977318|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977319|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977320|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977321|NCT01027949|Treprostinil|treprostinil|mesh-list
153977322|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153977323|NCT01038323|Milnacipran|milnacipran|mesh-list
153977324|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
153977325|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153977326|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153977327|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153977328|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977329|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977330|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977331|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153977332|NCT01038323|Analgesics|analgesics|mesh-ancestor
153977333|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
153977334|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977335|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
153977336|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977351|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977352|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977353|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153977355|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
153977356|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977357|NCT01025843|Candesartan|candesartan|mesh-list
153977358|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
153977359|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154860874|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977360|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153977361|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153977362|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977364|NCT02873351|Carbidopa|carbidopa|mesh-list
153977365|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153977366|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153977367|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153977368|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
153977369|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977370|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977371|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977372|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153977373|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977374|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153977375|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
153977376|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
153977377|NCT04299971|Methotrexate|methotrexate|mesh-list
153977378|NCT04299971|Tofacitinib|tofacitinib|mesh-list
153977379|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153977380|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
153977381|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977382|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977383|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153977384|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
153977385|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402162|NCT05752409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977386|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977387|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
153977388|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977389|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153977390|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977391|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
153977392|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153977393|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153977394|NCT04299971|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153977395|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977396|NCT01020305|Sirolimus|sirolimus|mesh-list
153764392|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
153977412|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
153977413|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977414|NCT00627575|Lamotrigine|lamotrigine|mesh-list
153977416|NCT00627575|Atorvastatin|atorvastatin|mesh-list
153977417|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153977418|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153977419|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
153977420|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977421|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153977422|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153977423|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977424|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
153977425|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153977426|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153977427|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153977428|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977429|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153977430|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153977431|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977432|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977433|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153977434|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153977435|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153977436|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153977437|NCT00627809|Streptokinase|streptokinase|mesh-list
153977438|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153977439|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153977440|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977441|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153977442|NCT02872649|Warfarin|warfarin|mesh-list
153977443|NCT02872649|Dabigatran|dabigatran|mesh-list
153977444|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
153977445|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
153977446|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
153977447|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154137722|NCT05183139|Lenalidomide|lenalidomide|mesh-list
153977448|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
153977449|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977450|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977451|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153977452|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
153977453|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153977454|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153977455|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153764451|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
153977495|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977497|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153977498|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977499|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
153977500|NCT02575261|Immunomodulating Agents|immunomodulating agents|mesh-list
153977501|NCT02575261|Immunologic Factors|immunologic factors|mesh-ancestor
153977502|NCT02575261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977503|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
153977504|NCT01017731|Promethazine|promethazine|mesh-list
153977505|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
153977506|NCT01017731|Ramucirumab|ramucirumab|mesh-list
153977507|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977508|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977509|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153977510|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153977511|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977512|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977513|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977514|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977515|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153977516|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153977517|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977518|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
153977519|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
153977520|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
153977521|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977522|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
153977523|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
153977524|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153977525|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153977526|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
153977527|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
153977528|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977529|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153977530|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
153977531|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
153977532|NCT01017731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153977533|NCT01017731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153977534|NCT01017731|Growth Substances|growth substances|mesh-ancestor
153977535|NCT01017731|Growth Inhibitors|growth inhibitors|mesh-ancestor
153977536|NCT02575183|Varenicline|varenicline|mesh-list
153977537|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153977538|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153977539|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
153977540|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977541|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977542|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977568|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153977569|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
153977570|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
153977572|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
153977573|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977575|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977576|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977577|NCT04100434|Evolocumab|evolocumab|mesh-list
153977578|NCT04100434|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153977579|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153977580|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153977581|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
153977582|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977583|NCT04100434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153977584|NCT04100434|Protease Inhibitors|protease inhibitors|mesh-ancestor
153977585|NCT04100434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977586|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153977587|NCT00991952|Irinotecan|irinotecan|mesh-list
154860875|NCT05136157|Insulin|insulin|mesh-list
153977588|NCT00991952|Alvocidib|alvocidib|mesh-list
153977589|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153977590|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153977591|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182200|NCT05856695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153977620|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153977621|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
153977622|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
153977623|NCT02868632|Durvalumab|durvalumab|mesh-list
153977624|NCT02868632|Tremelimumab|tremelimumab|mesh-list
153977625|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153977626|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977627|NCT04021498|Simvastatin|simvastatin|mesh-list
153977628|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153977647|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977648|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977649|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153977650|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153977651|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977652|NCT04292444|Oxytocin|oxytocin|mesh-list
153977653|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
153977654|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977655|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977656|NCT01017575|Ribavirin|ribavirin|mesh-list
153977657|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153977658|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
153977659|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977660|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
153977661|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977662|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153977663|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
153977664|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153977665|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977666|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153977667|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153977668|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153977669|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977670|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
153977671|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977672|NCT00768664|Dacomitinib|dacomitinib|mesh-list
153977673|NCT00768664|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153977674|NCT00768664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977675|NCT00768664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977676|NCT00768664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977677|NCT01253161|Pasireotide|pasireotide|mesh-list
153977678|NCT01253161|Hormones|hormones|mesh-ancestor
153977679|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977680|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977681|NCT00709423|Moxaverine|moxaverine|mesh-list
153764683|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
153977699|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
153977700|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977701|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
153977702|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977703|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
153977704|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153977705|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153977706|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977707|NCT00627965|Urological Agents|urological agents|mesh-ancestor
153977708|NCT02576353|Fentanyl|fentanyl|mesh-list
153977709|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153977710|NCT02576353|Narcotics|narcotics|mesh-ancestor
153977711|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977712|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977714|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
153977715|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977716|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153977717|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153977718|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
153977720|NCT01016015|Sirolimus|sirolimus|mesh-list
153977721|NCT01016015|Temsirolimus|temsirolimus|mesh-list
153977722|NCT01016015|MTOR Inhibitors|mtor inhibitors|mesh-list
153977723|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153977724|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977725|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977726|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153977727|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977728|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
153977729|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977730|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
153977731|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977732|NCT01016015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977733|NCT01016015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977734|NCT01016015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977735|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
153977736|NCT00628043|Hematinics|hematinics|mesh-ancestor
153977737|NCT00709657|Bevacizumab|bevacizumab|mesh-list
153402201|NCT05646082|Dostarlimab|dostarlimab|mesh-list
153977738|NCT00709657|Ranibizumab|ranibizumab|mesh-list
153977768|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153977769|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977770|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153977771|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153977772|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977773|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977774|NCT02573701|Risperidone|risperidone|mesh-list
153977775|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
153977776|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153977777|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
153977778|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977779|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977780|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977781|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153977782|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977783|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977793|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
153977794|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977795|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977796|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153977797|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153977798|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
153977799|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977800|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977802|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153977803|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977804|NCT00710359|Vitamins|vitamins|mesh-list
153977805|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
153977806|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
153977807|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
153977808|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
153977809|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977810|NCT00710359|Hematinics|hematinics|mesh-ancestor
153977811|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153977812|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153977813|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
153977814|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977815|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153977816|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153977817|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
153977818|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
153977819|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977820|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977821|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
153977822|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153977823|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977824|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977825|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153977826|NCT00710437|Analgesics|analgesics|mesh-ancestor
153977827|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
153977828|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977829|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153977830|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153977831|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153977832|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
153977833|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977834|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977835|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
153977836|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153977837|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
153977838|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977839|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977840|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153977841|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153977842|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153977843|NCT00714883|Sirolimus|sirolimus|mesh-list
153977844|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977845|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977846|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153977847|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176480|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977862|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977863|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977865|NCT01014767|Dactinomycin|dactinomycin|mesh-list
153735437|NCT04835129|Elotuzumab|elotuzumab|mesh-list
153977866|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
153977867|NCT01014767|Temozolomide|temozolomide|mesh-list
153977868|NCT01014767|Cisplatin|cisplatin|mesh-list
153977869|NCT01014767|Carboplatin|carboplatin|mesh-list
153977870|NCT01014767|Doxorubicin|doxorubicin|mesh-list
153977871|NCT01014767|Methotrexate|methotrexate|mesh-list
153977872|NCT01014767|Irinotecan|irinotecan|mesh-list
153977873|NCT01014767|Etoposide|etoposide|mesh-list
153977874|NCT01014767|Vincristine|vincristine|mesh-list
153977875|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977876|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
153861866|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977877|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977878|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153977879|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153977880|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
153977881|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977882|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977883|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153977884|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153977885|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153977886|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153977887|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977888|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153977889|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
153977890|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977891|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153977892|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
153977893|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
153977894|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153977895|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153977896|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153977897|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153977898|NCT01014767|Antidotes|antidotes|mesh-ancestor
153977899|NCT01014767|Protective Agents|protective agents|mesh-ancestor
153977900|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
153977901|NCT01014767|Vitamins|vitamins|mesh-ancestor
153977902|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
153977903|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
153977904|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
153977905|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
153977906|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977907|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977908|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153977926|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977927|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
153977928|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153977929|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153977930|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977931|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977932|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153977933|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153977934|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977935|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977936|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
153977937|NCT02013427|Naproxen|naproxen|mesh-list
153977938|NCT02013427|Omeprazole|omeprazole|mesh-list
153977939|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153977940|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153977941|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153977942|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735513|NCT04700527|Butyric Acid|butyric acid|mesh-list
153977943|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860876|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153977944|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153977945|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153977946|NCT02013427|Analgesics|analgesics|mesh-ancestor
153977947|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
153977948|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977949|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977950|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153977951|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153977952|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
153977953|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153977954|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
153977955|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153977957|NCT01014143|Fluorides|fluorides|mesh-list
153977958|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
153977959|NCT01014143|Protective Agents|protective agents|mesh-ancestor
153977960|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977961|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153977962|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977963|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
153977964|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
153977965|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153977966|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153977967|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
153977979|NCT02574403|Eculizumab|eculizumab|mesh-list
153977980|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153402221|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
153977981|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977982|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
153977983|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977984|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
153977985|NCT01013753|Olodaterol|olodaterol|mesh-list
153977986|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153977987|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
153977988|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977989|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977990|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153977991|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
153977992|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153977993|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153977994|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153977995|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
153977996|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977997|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977998|NCT00715039|Lorazepam|lorazepam|mesh-list
153977999|NCT00715039|Paroxetine|paroxetine|mesh-list
153978000|NCT00715039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153978001|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153978002|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153978003|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978004|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978005|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
153978006|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978007|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153978008|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
153978009|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153978010|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154176481|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978011|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153978012|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978014|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
153978015|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
153978016|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735596|NCT04513717|Leuprolide|leuprolide|mesh-list
153978017|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153978018|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153978019|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153978020|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153978021|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153978022|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
153402250|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978023|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
153978024|NCT00711295|Vaccines|vaccines|mesh-list
153978025|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
153978026|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978027|NCT02871869|Buformin|buformin|mesh-list
153978042|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153978043|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978044|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
154138096|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978046|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978047|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153978048|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153978049|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153978050|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153978051|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978052|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153978053|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
153978054|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
153978055|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
153978056|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153978057|NCT01013597|Panobinostat|panobinostat|mesh-list
153978058|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978059|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153978060|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978061|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978062|NCT00715273|Niacin|niacin|mesh-list
153978063|NCT00715273|Niacinamide|niacinamide|mesh-list
153978064|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
153978065|NCT00715273|Atorvastatin|atorvastatin|mesh-list
153978066|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153978067|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153978068|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153978069|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
153978070|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978071|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153978072|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153978073|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978074|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
153978075|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
153978076|NCT00715273|Vitamins|vitamins|mesh-ancestor
153978077|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
153978078|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978079|NCT01013285|Bevacizumab|bevacizumab|mesh-list
153978080|NCT01013285|Temozolomide|temozolomide|mesh-list
153978081|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153978082|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978083|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153978084|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153978085|NCT01013285|Growth Substances|growth substances|mesh-ancestor
153978086|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978088|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153978089|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
153978090|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978108|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
153978109|NCT00711841|Hormones|hormones|mesh-ancestor
153978110|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978111|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153978112|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978113|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
153978114|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978115|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978116|NCT00711919|Pitavastatin|pitavastatin|mesh-list
153978117|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153978118|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153978119|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153978120|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
153978121|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978122|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978123|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153978124|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
153978125|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
153978126|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153978127|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153978128|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978129|NCT00712465|Digoxin|digoxin|mesh-list
153978130|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153978131|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153978132|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978133|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154860877|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
154089460|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154089461|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089462|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154089463|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154089464|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
153861907|NCT04639362|Venetoclax|venetoclax|mesh-list
154089465|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089466|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154089467|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154089468|NCT00782301|Maraviroc|maraviroc|mesh-list
154089469|NCT00782301|Etravirine|etravirine|mesh-list
154089470|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154089471|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154089472|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089473|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154089474|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154089475|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
154089476|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555883|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089507|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
154089508|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089509|NCT00790413|Rituximab|rituximab|mesh-list
154089510|NCT00790413|Fludarabine|fludarabine|mesh-list
154089511|NCT00790413|Thiotepa|thiotepa|mesh-list
154089512|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154089513|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154089514|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089515|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
154089516|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089517|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089518|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089519|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154089520|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154089521|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
154089522|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154089523|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089524|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154089538|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
154089539|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089540|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798362|NCT00269555|Hormones|hormones|mesh-ancestor
154089541|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154089542|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154089543|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
154089544|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089545|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154089546|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089547|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154089548|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154089549|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
154089550|NCT00790881|Lumefantrine|lumefantrine|mesh-list
154089551|NCT00790881|Artemether|artemether|mesh-list
154089552|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154089553|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
154089554|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154089555|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154089556|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089557|NCT01029769|Olanzapine|olanzapine|mesh-list
154089558|NCT01029769|Amisulpride|amisulpride|mesh-list
154089559|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
154089560|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
154089561|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089562|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089563|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089564|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154089565|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154089566|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089567|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154089568|NCT01029769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154089569|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154089570|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154089571|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089572|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089573|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
154089574|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154089575|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
154089576|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154089577|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
154089579|NCT02557945|Analgesics|analgesics|mesh-ancestor
154089580|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
153798366|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089581|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089582|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089583|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
154089584|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154089585|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154089586|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555984|NCT01610869|Nintedanib|nintedanib|mesh-list
154089601|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
154089602|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
154089603|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089604|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089605|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089606|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
154089607|NCT02581046|Hormones|hormones|mesh-ancestor
154089608|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089609|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154089610|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089611|NCT00664209|Amoxicillin|amoxicillin|mesh-list
154089612|NCT00664209|Omeprazole|omeprazole|mesh-list
154089613|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089614|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089615|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154089616|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089617|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154089618|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089619|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089620|NCT03192332|Plasminogen|plasminogen|mesh-list
154089621|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154089622|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154089623|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154089624|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089625|NCT02555943|Ritonavir|ritonavir|mesh-list
154089626|NCT02555943|Tenofovir|tenofovir|mesh-list
154089627|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
154089628|NCT02555943|Entecavir|entecavir|mesh-list
154089629|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154089630|NCT02555943|Ledipasvir|ledipasvir|mesh-list
154089631|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154089632|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154089633|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
154089634|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089635|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089636|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154089637|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154089638|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
154089639|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089640|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154089641|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089642|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153861928|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
154089643|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154089644|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
154089645|NCT00782847|Cyproterone|cyproterone|mesh-list
154089646|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
154089647|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
154089648|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089664|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154089665|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089666|NCT02452268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154089667|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089668|NCT02524249|Caffeine|caffeine|mesh-list
154089669|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154089670|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089671|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154089672|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089673|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089674|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154256637|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153658891|NCT02968342|Progesterone|progesterone|mesh-list
154089675|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154089677|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089678|NCT01033981|Sunitinib|sunitinib|mesh-list
154089679|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089680|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154089681|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154089682|NCT01033981|Growth Substances|growth substances|mesh-ancestor
154089683|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089684|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
154089685|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154089686|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089687|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089688|NCT02430194|Interferons|interferons|mesh-list
154089689|NCT02430194|Ritonavir|ritonavir|mesh-list
154089690|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
154089691|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
154089692|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154089693|NCT02430194|Lonafarnib|lonafarnib|mesh-list
154089694|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089695|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
154089696|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089697|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154089698|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154089699|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
154089700|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089701|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089702|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154089703|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154089704|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154089705|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089706|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
154089707|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089708|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
154089730|NCT04076228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089732|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
154089733|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089734|NCT02580734|Protective Agents|protective agents|mesh-ancestor
154089735|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089736|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089737|NCT00427999|Pioglitazone|pioglitazone|mesh-list
154089738|NCT00427999|Dexamethasone|dexamethasone|mesh-list
154089739|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
154089740|NCT00427999|Etoricoxib|etoricoxib|mesh-list
154089741|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
154089742|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154089743|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
154089744|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
154089745|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089746|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402285|NCT05493501|Paclitaxel|paclitaxel|mesh-list
154089747|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089748|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
154089750|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089751|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154089752|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089753|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154089754|NCT00427999|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154089755|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154089756|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089757|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089758|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154089784|NCT04038086|Insulin|insulin|mesh-list
154089785|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154089786|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089787|NCT04072640|Voriconazole|voriconazole|mesh-list
154089788|NCT04072640|Amphotericin B|amphotericin b|mesh-list
154089789|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154089790|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
154089791|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
154089792|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
154089793|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089794|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154089795|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089796|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089797|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089798|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154089799|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
154089800|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089801|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089802|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154089803|NCT04072640|Amebicides|amebicides|mesh-ancestor
154089804|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154089805|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154089823|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
154089824|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089825|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089826|NCT00427921|Adalimumab|adalimumab|mesh-list
154089827|NCT00427921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154089828|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154089829|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089830|NCT00432991|Ephedrine|ephedrine|mesh-list
154089831|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154089832|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861947|NCT00561327|Losartan|losartan|mesh-list
154089833|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
154089834|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
154089835|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089836|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154089837|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
154089838|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089839|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089840|NCT00580970|Lovastatin|lovastatin|mesh-list
154089841|NCT00580970|L 647318|l 647318|mesh-list
154089842|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
154089843|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154089844|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154089845|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
154089846|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089847|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154089848|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154089849|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089850|NCT01030081|Amlodipine|amlodipine|mesh-list
154089851|NCT01030081|Nifedipine|nifedipine|mesh-list
154089852|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154089853|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154089854|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154089855|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089856|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154089857|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089858|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
154089859|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
154089860|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154089861|NCT00426751|Abciximab|abciximab|mesh-list
154089862|NCT00426751|Eptifibatide|eptifibatide|mesh-list
154089863|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
153556266|NCT01612832|Pregabalin|pregabalin|mesh-list
154089891|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154089893|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154089894|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089895|NCT00786279|Ethanol|ethanol|mesh-list
154089896|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154089897|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089898|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089899|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089900|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154089901|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154089902|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154089903|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089904|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089905|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154089906|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154089922|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
154089923|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089924|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154089925|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
154089926|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089927|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089928|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154089929|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154089930|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154089931|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089932|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089933|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154089934|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154089935|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154089936|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
154089937|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089938|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089939|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154089940|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154089941|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
154089942|NCT00440401|Hemostatics|hemostatics|mesh-list
154089944|NCT00440401|Coagulants|coagulants|mesh-ancestor
154089945|NCT00791427|Ranibizumab|ranibizumab|mesh-list
154089946|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154089947|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154089948|NCT00791427|Growth Substances|growth substances|mesh-ancestor
154089949|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089950|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
154089951|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089952|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
154089953|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154089954|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
154089955|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154089956|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
154089957|NCT00791505|Trimethoprim|trimethoprim|mesh-list
154089958|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
154089959|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089960|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089961|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154089962|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154089963|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089964|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089965|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089966|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153556367|NCT01613105|Acarbose|acarbose|mesh-list
154089977|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154089978|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089979|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154089980|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089982|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
154089983|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089985|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154089986|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154089987|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089988|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089989|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
154089990|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089991|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154089992|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154089993|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089994|NCT00783081|Cilostazol|cilostazol|mesh-list
154089995|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154089996|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
154089997|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089998|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089999|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154090000|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
154090001|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154090002|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154090003|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090004|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154090005|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
154090006|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154090008|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154090009|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154090010|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090011|NCT00426127|Docetaxel|docetaxel|mesh-list
154090012|NCT00426127|Doxorubicin|doxorubicin|mesh-list
154090013|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154090014|NCT00426127|Enoxaparin|enoxaparin|mesh-list
154090015|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090016|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
154090017|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
154090018|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
154090019|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090020|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154090021|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154090022|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154090023|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090024|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
154090025|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154090026|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154090027|NCT00425503|Bortezomib|bortezomib|mesh-list
154090028|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090029|NCT00786669|Cefixime|cefixime|mesh-list
154090030|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
154090031|NCT00786669|Bevacizumab|bevacizumab|mesh-list
154090032|NCT00786669|Irinotecan|irinotecan|mesh-list
154090033|NCT00786669|Vincristine|vincristine|mesh-list
154090068|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154090069|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154090070|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090071|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154090101|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
154090102|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090103|NCT00783471|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154090104|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154090105|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090106|NCT02460900|Varenicline|varenicline|mesh-list
154090107|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154090108|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154090109|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
154090110|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090111|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090112|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090144|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090145|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090146|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154090147|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
154090148|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
154090149|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090150|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154090151|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
154090152|NCT03994783|Hormones|hormones|mesh-ancestor
154090153|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154090154|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154090155|NCT03994783|Protective Agents|protective agents|mesh-ancestor
154090156|NCT00440011|Bimatoprost|bimatoprost|mesh-list
154090157|NCT00440011|Travoprost|travoprost|mesh-list
154090158|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154090184|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090185|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090187|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
154090188|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090189|NCT00784017|Asparaginase|asparaginase|mesh-list
154090190|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090191|NCT04074122|Adenosine|adenosine|mesh-list
154090192|NCT04074122|Isoproterenol|isoproterenol|mesh-list
154090193|NCT04074122|Epinephrine|epinephrine|mesh-list
154090194|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154090195|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154090196|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
154090197|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090198|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090199|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090200|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154090201|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154090202|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
154090203|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090204|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154090205|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
154090206|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
154090207|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
154090208|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154090209|NCT04074122|Analgesics|analgesics|mesh-ancestor
154090210|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
154090211|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154090212|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
154090232|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154090233|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154090234|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154090235|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
154090236|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154090237|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154090238|NCT00788463|Beclomethasone|beclomethasone|mesh-list
153798834|NCT00272324|Aspirin|aspirin|mesh-list
154090239|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154090240|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
154090241|NCT00788463|Hormones|hormones|mesh-ancestor
154090242|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154090243|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090244|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154090245|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
154090246|NCT00579254|Amlodipine|amlodipine|mesh-list
154090247|NCT00579254|Atorvastatin|atorvastatin|mesh-list
154090248|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154090249|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154090250|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
154090251|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090252|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154090253|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154090254|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090255|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154090256|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154090257|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153413497|NCT04707950|Oxytocin|oxytocin|mesh-list
154090258|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154090259|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090260|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
154090261|NCT00793221|Sirolimus|sirolimus|mesh-list
154090262|NCT00793221|Everolimus|everolimus|mesh-list
154090263|NCT00793221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154090264|NCT00793221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154090265|NCT00793221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556672|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154090285|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090286|NCT01773278|Antioxidants|antioxidants|mesh-list
154090287|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090288|NCT01773278|Protective Agents|protective agents|mesh-ancestor
154090289|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090290|NCT00788931|Paclitaxel|paclitaxel|mesh-list
154090291|NCT00788931|Trastuzumab|trastuzumab|mesh-list
154090292|NCT00788931|Panobinostat|panobinostat|mesh-list
154090293|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154090294|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090295|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
154090296|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
154090297|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154090298|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090299|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090300|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154090301|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090302|NCT02577848|Liraglutide|liraglutide|mesh-list
154090303|NCT02577848|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154090304|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153402374|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
154090305|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090306|NCT02577848|Incretins|incretins|mesh-ancestor
154090307|NCT02577848|Hormones|hormones|mesh-ancestor
154090308|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154090309|NCT00582426|Octreotide|octreotide|mesh-list
154090310|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154090311|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154090312|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090313|NCT00709982|Folic Acid|folic acid|mesh-list
154090314|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154090315|NCT00709982|Norgestimate|norgestimate|mesh-list
154090317|NCT00709982|Estrogens|estrogens|mesh-ancestor
154090318|NCT00709982|Hormones|hormones|mesh-ancestor
154090319|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154090347|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154090348|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090349|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090351|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090352|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154090353|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154090354|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
154090355|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
154090356|NCT00773513|Hematinics|hematinics|mesh-ancestor
154090357|NCT00710528|Idelalisib|idelalisib|mesh-list
154090358|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090359|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090360|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090361|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
154090362|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154090363|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090364|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154090365|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154090366|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
154090397|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090398|NCT00711620|Thymalfasin|thymalfasin|mesh-list
154090399|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154090400|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
154090401|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090402|NCT02577614|Coagulants|coagulants|mesh-list
154090403|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
154090404|NCT02577458|Everolimus|everolimus|mesh-list
154090405|NCT02577458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154090406|NCT02577458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154090407|NCT02577458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090408|NCT02577458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090409|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154090410|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
154090411|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090412|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090414|NCT00767039|Beractant|beractant|mesh-list
154090415|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153556823|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
154090445|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090446|NCT02574338|Alprostadil|alprostadil|mesh-list
154090447|NCT02574338|Misoprostol|misoprostol|mesh-list
154090448|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154090449|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
154090450|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154090451|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090452|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154090453|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154090454|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
154090455|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154090456|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
154090457|NCT02574338|Urological Agents|urological agents|mesh-ancestor
154090458|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
154090483|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
154090484|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154090485|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
154090486|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154090487|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090488|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
154090489|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154090490|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090491|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090492|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154090493|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154090494|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154090495|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154090496|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154090497|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154090498|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154090499|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154090500|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
154090501|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154090502|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154090503|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154090504|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154090505|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154090506|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154090507|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
154090508|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154090535|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154090536|NCT03015792|Growth Substances|growth substances|mesh-ancestor
154090537|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
154090538|NCT03015792|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154090539|NCT03015792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154090540|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
154090541|NCT00789165|Quinidine|quinidine|mesh-list
154090542|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154090543|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154090544|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
154090545|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090546|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090547|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090548|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154090549|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
154090550|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154090551|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154090552|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090553|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090554|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154090555|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154090556|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
154090557|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154090558|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154090559|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153556962|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
154090588|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154090589|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
154090590|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090591|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090592|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154090593|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
154090594|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
154090595|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
154090596|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154090597|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154090598|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154090599|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090600|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154090601|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
154090602|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154090603|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154090604|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154090605|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154090622|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090624|NCT00660699|Docetaxel|docetaxel|mesh-list
154090625|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154090626|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
154090627|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090628|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090629|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
154090630|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
154090631|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
154090633|NCT02577068|Nefopam|nefopam|mesh-list
154090634|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154090635|NCT02577068|Analgesics|analgesics|mesh-ancestor
154090636|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
154090637|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090638|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090639|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154090640|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154090641|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090642|NCT00582114|Atenolol|atenolol|mesh-list
154090643|NCT00582114|Lisinopril|lisinopril|mesh-list
154090644|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154090645|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
154090646|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090647|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090648|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154090649|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154090650|NCT00582114|Protective Agents|protective agents|mesh-ancestor
154090651|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090652|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154090653|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
154090654|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
154090655|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090656|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154090657|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154090658|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154090659|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
154090660|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090661|NCT00582036|Insulin|insulin|mesh-list
154090662|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154090663|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154090664|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090684|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090685|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154090686|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154090687|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090689|NCT00660387|Levodopa|levodopa|mesh-list
154090690|NCT00660387|Carbidopa|carbidopa|mesh-list
154090691|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154090692|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154090693|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153799068|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090694|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
154090695|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090696|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090697|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090698|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154090699|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090700|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154090701|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
154090702|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
154090703|NCT00582738|Everolimus|everolimus|mesh-list
154090704|NCT00582738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154090705|NCT00582738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154090706|NCT00582738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090707|NCT00582738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090709|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
154090710|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090711|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090712|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
154090713|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154090714|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154090715|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090716|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154090717|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154090718|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090719|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090734|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154090735|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090737|NCT00713726|Tramadol|tramadol|mesh-list
154090738|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154090739|NCT00713726|Narcotics|narcotics|mesh-ancestor
154090740|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090741|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090742|NCT00713726|Analgesics|analgesics|mesh-ancestor
154090743|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
154090744|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090745|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154090746|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154090747|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
154090748|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
154090749|NCT00800553|Donepezil|donepezil|mesh-list
154090750|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154090751|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090752|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090753|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
154090754|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090755|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090756|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
154090757|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
154090758|NCT00793767|Hematinics|hematinics|mesh-ancestor
154090759|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154090760|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154090761|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154090762|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090763|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090764|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154090765|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154090766|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154090767|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
154090768|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090769|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090770|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154090771|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154090772|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
154090773|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
154090774|NCT00793845|Melphalan|melphalan|mesh-list
154090775|NCT00793845|Thiotepa|thiotepa|mesh-list
154090776|NCT00793845|Carboplatin|carboplatin|mesh-list
154090777|NCT00793845|Etoposide|etoposide|mesh-list
154090778|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154090779|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
154090780|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090781|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090782|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153557170|NCT01617811|Anesthetics|anesthetics|mesh-list
154090801|NCT00793923|Ranibizumab|ranibizumab|mesh-list
154090802|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154090803|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
154090804|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
154090805|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090806|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090807|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154090808|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
154090809|NCT00793923|Hormones|hormones|mesh-ancestor
154090810|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154090811|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154090812|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090813|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154090814|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154090815|NCT00793923|Growth Substances|growth substances|mesh-ancestor
154090816|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
154090817|NCT01247324|Interferons|interferons|mesh-list
154090818|NCT01247324|Interferon-beta|interferon-beta|mesh-list
154090819|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
154090820|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
154090821|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090822|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
154090823|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090824|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
154090825|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090826|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154090827|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154090828|NCT00772577|Ramipril|ramipril|mesh-list
154090829|NCT00772577|Aliskiren|aliskiren|mesh-list
154090830|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154090831|NCT00772577|Diuretics|diuretics|mesh-ancestor
154090832|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
154090833|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090834|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154090835|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154090836|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090837|NCT00772577|Renin Inhibitors|renin inhibitors|mesh-ancestor
154090838|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
154090839|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557223|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
154090861|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154090862|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154090864|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
154090865|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090866|NCT04073550|Topotecan|topotecan|mesh-list
154090867|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154090869|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090870|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090871|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090872|NCT02576600|Remifentanil|remifentanil|mesh-list
154090873|NCT02576600|Propofol|propofol|mesh-list
154090874|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154090875|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090876|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090877|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154090878|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
154090879|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
154090880|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154090881|NCT02576600|Narcotics|narcotics|mesh-ancestor
154090882|NCT02576600|Analgesics|analgesics|mesh-ancestor
154090883|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
154090884|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090885|NCT02863770|Pancrelipase|pancrelipase|mesh-list
154090886|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154090887|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154090888|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154090889|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154090890|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090891|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090892|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154090916|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090917|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090918|NCT04046133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154090919|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090920|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154090921|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
154090922|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154090923|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
154090924|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154090925|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090926|NCT02573714|Ketamine|ketamine|mesh-list
154090927|NCT02573714|Analgesics|analgesics|mesh-ancestor
154090928|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
154090929|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090930|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090931|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154090932|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154090933|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
154090934|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
154090935|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090936|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154090937|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154090938|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090939|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090941|NCT00794235|Dacarbazine|dacarbazine|mesh-list
154090942|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090943|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154090978|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090979|NCT00581100|Etanercept|etanercept|mesh-list
153799241|NCT00314379|Vitamins|vitamins|mesh-ancestor
154090980|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154090981|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154090982|NCT00581100|Analgesics|analgesics|mesh-ancestor
154091007|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
154091008|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154091009|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
154091010|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091011|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091012|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091013|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154091014|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154091015|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154091016|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154091017|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154091018|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
154091019|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
154091020|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091021|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
154091022|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
154091023|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154091025|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154091026|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154091027|NCT02577432|Fentanyl|fentanyl|mesh-list
154091028|NCT02577432|Bupivacaine|bupivacaine|mesh-list
154091029|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
154091030|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
154091031|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154091032|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091033|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
154091056|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154091057|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154091058|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
154091059|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091060|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091061|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091062|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154091063|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154091064|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
154091065|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
154091066|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154091067|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
154091068|NCT00801411|Docetaxel|docetaxel|mesh-list
154091069|NCT00801411|Doxorubicin|doxorubicin|mesh-list
154091070|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154091071|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091072|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
154091073|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091074|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154091075|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154091076|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
154091077|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091078|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091079|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154091080|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
154091081|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
154091082|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
154091083|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154091084|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154091085|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154091104|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154091105|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091106|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
154091107|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091108|NCT00621244|Panobinostat|panobinostat|mesh-list
154091109|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091110|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154091111|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091112|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091113|NCT00916409|Temozolomide|temozolomide|mesh-list
154091114|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154091115|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
154091116|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091117|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091118|NCT00714740|Acetazolamide|acetazolamide|mesh-list
154091119|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
154091120|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154091121|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091122|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091123|NCT00714740|Diuretics|diuretics|mesh-ancestor
154091124|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
153799313|NCT00308451|Chromium|chromium|mesh-list
154091125|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091126|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
154091127|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
154091128|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154091129|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154091130|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091131|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091132|NCT00659529|Urological Agents|urological agents|mesh-ancestor
154091133|NCT02575508|Fluorouracil|fluorouracil|mesh-list
154091134|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
154091135|NCT02575508|Irinotecan|irinotecan|mesh-list
154091136|NCT02575508|Camptothecin|camptothecin|mesh-list
154091137|NCT02575508|Infigratinib|infigratinib|mesh-list
154091138|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
154091139|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660097|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660098|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091140|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154091141|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091142|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091143|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
154091156|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154091157|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
154091158|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091159|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154091160|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
154091161|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
154091163|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
154091164|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091165|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
154091166|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154091167|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091168|NCT00843934|Epirubicin|epirubicin|mesh-list
154091169|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091170|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154091171|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154091172|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154091173|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091174|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091175|NCT00805701|Dutasteride|dutasteride|mesh-list
154091176|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154091177|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154091178|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091179|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091180|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
154091181|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091182|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091183|NCT04042948|Acetaminophen|acetaminophen|mesh-list
154091184|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154091185|NCT04042948|Analgesics|analgesics|mesh-ancestor
154091186|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
154091187|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091188|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091189|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
154091190|NCT00765245|Rituximab|rituximab|mesh-list
154091191|NCT00765245|Lenalidomide|lenalidomide|mesh-list
154091192|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154091193|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091194|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
154091195|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091196|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154091197|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154091198|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154091199|NCT00765245|Growth Substances|growth substances|mesh-ancestor
154091200|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
154091201|NCT00801879|Mupirocin|mupirocin|mesh-list
154091202|NCT00801879|Calcium|calcium|mesh-list
154091203|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154091204|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091205|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154091206|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557587|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
154091222|NCT00841126|Iron|iron|mesh-list
154091223|NCT00841126|Trace Elements|trace elements|mesh-ancestor
154091224|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
154091225|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091226|NCT00805857|Tipranavir|tipranavir|mesh-list
154091227|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154091228|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154091229|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
154091230|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091231|NCT00718562|Nilotinib|nilotinib|mesh-list
154091232|NCT00718562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154091233|NCT00718562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154091234|NCT00718562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091235|NCT00718562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091236|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
154091237|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154091238|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154091239|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154091240|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
154091241|NCT00801957|Tacrolimus|tacrolimus|mesh-list
154091242|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091243|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
154091244|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091245|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154091246|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091247|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091248|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091249|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
154091250|NCT00836134|Bupivacaine|bupivacaine|mesh-list
154091251|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
154091252|NCT00836134|Anesthetics|anesthetics|mesh-list
154091253|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154091254|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091255|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
154091256|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091257|NCT00782795|Pioglitazone|pioglitazone|mesh-list
154091258|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154091259|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091260|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
154091262|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154091263|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154091264|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091265|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154091266|NCT02573558|Analgesics|analgesics|mesh-ancestor
153557652|NCT01621022|Bupropion|bupropion|mesh-list
154091293|NCT00844012|Estrogens|estrogens|mesh-ancestor
154091295|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091296|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091297|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154091298|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
154091299|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154091300|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154091301|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154091302|NCT02574962|Hormones|hormones|mesh-ancestor
154091303|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091304|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091305|NCT00802035|Baclofen|baclofen|mesh-list
153414543|NCT02632045|Fulvestrant|fulvestrant|mesh-list
154091306|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154091307|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091308|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154091309|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091310|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154091312|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
154091313|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402522|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
153557707|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
154091334|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154091335|NCT00782717|Prednisolone|prednisolone|mesh-list
154091336|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154091337|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
154091338|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154091339|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
154091340|NCT00782717|Nepafenac|nepafenac|mesh-list
154091341|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154091342|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
154091343|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091344|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
154091345|NCT00782717|Hormones|hormones|mesh-ancestor
154091346|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091347|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091348|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154091349|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091350|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
154091351|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
154091352|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091353|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154091354|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154091355|NCT00782717|Protective Agents|protective agents|mesh-ancestor
154091356|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154091357|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154091358|NCT00782717|Analgesics|analgesics|mesh-ancestor
154091359|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
154091360|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154091361|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
154091362|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154091363|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154091364|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
154091385|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153799523|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
154091386|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154091387|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154091388|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091389|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091390|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091391|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154091392|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
154091395|NCT00656019|Calcipotriene|calcipotriene|mesh-list
154091396|NCT00656019|Vitamins|vitamins|mesh-ancestor
154091397|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
154091398|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091399|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154091400|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
154091401|NCT00841438|Abciximab|abciximab|mesh-list
154091402|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
154091403|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154091404|NCT00841516|Immunomodulating Agents|immunomodulating agents|mesh-list
154091405|NCT00841516|Immunologic Factors|immunologic factors|mesh-ancestor
154091406|NCT00841516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091407|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
154091408|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
154091409|NCT04068974|Apatinib|apatinib|mesh-list
154091410|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091411|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154091412|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091413|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091414|NCT00836368|Vitamin E|vitamin e|mesh-list
154091415|NCT00836368|Tocopherols|tocopherols|mesh-list
154091453|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154091454|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154091455|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
154091456|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091457|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091492|NCT00802581|Anesthetics|anesthetics|mesh-list
154091493|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
154091494|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557912|NCT01622439|Prednisone|prednisone|mesh-list
154091529|NCT00844324|Candesartan|candesartan|mesh-list
154091530|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
154091531|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154091532|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154091533|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154091554|NCT00836914|Idelalisib|idelalisib|mesh-list
154091555|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091556|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091557|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091558|NCT00844402|Atorvastatin|atorvastatin|mesh-list
154091559|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154091560|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154091561|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
154091562|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091563|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154091564|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154091565|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091566|NCT00806247|Tapentadol|tapentadol|mesh-list
154091567|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154091568|NCT00806247|Narcotics|narcotics|mesh-ancestor
154091569|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154091570|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091571|NCT00806247|Analgesics|analgesics|mesh-ancestor
154091572|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
154091573|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091574|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154091575|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154091576|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154091577|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091578|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
153660432|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
153660434|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091579|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091581|NCT00797745|Ribavirin|ribavirin|mesh-list
154091582|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154091583|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154091584|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154091585|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
154091586|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091587|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091607|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154091608|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154091609|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091610|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091611|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
154091612|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154091613|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
154091614|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154091615|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154091616|NCT00842452|Topotecan|topotecan|mesh-list
154091617|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154091618|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154091619|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091620|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091621|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091622|NCT02552745|Parecoxib|parecoxib|mesh-list
154091623|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154091624|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154091625|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091626|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091627|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154091628|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154091629|NCT02552745|Analgesics|analgesics|mesh-ancestor
154091630|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
154091631|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091632|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091633|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091634|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154091635|NCT02547844|Tenofovir|tenofovir|mesh-list
154091636|NCT02547844|Efavirenz|efavirenz|mesh-list
154091637|NCT02547844|Emtricitabine|emtricitabine|mesh-list
154091638|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
154091639|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091640|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154091641|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154091671|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
154091672|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154091673|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
154091674|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091675|NCT04045821|Plerixafor|plerixafor|mesh-list
154091676|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154091677|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154091679|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091680|NCT00803439|Clobetasol|clobetasol|mesh-list
154091681|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091682|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
154091683|NCT00803439|Hormones|hormones|mesh-ancestor
154091684|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558080|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
154091704|NCT00844792|Vitamin D|vitamin d|mesh-list
154091705|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
154091706|NCT00844792|Vitamins|vitamins|mesh-list
154091707|NCT00844792|Vitamin E|vitamin e|mesh-list
154091708|NCT00844792|Selenium|selenium|mesh-list
154091709|NCT00844792|Lycopene|lycopene|mesh-list
154091710|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
154091711|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091712|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154091713|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154091714|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
154091715|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091716|NCT00844792|Protective Agents|protective agents|mesh-ancestor
154091717|NCT00844792|Trace Elements|trace elements|mesh-ancestor
153660551|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
154091718|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091719|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154091720|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154091721|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091722|NCT00719420|Amoxicillin|amoxicillin|mesh-list
154091723|NCT00719420|Metronidazole|metronidazole|mesh-list
154091724|NCT00719420|Clarithromycin|clarithromycin|mesh-list
154091725|NCT00719420|Omeprazole|omeprazole|mesh-list
154091726|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154091727|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091728|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154091729|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154091730|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154091731|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154091732|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154091733|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091734|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091735|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154091736|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154091737|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154091738|NCT00803829|Sulfalene|sulfalene|mesh-list
154091739|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091740|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154091761|NCT00842998|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154091762|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154091763|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091764|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091765|NCT00716846|Atorvastatin|atorvastatin|mesh-list
154091766|NCT00716846|Simvastatin|simvastatin|mesh-list
154091767|NCT00716846|Pitavastatin|pitavastatin|mesh-list
154091768|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154091769|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154091770|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
154091771|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091772|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154091773|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154091774|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091776|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
154091777|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154091778|NCT00620854|Katacalcin|katacalcin|mesh-list
154091779|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154091780|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091781|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154091782|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
154091783|NCT00716924|Clopidogrel|clopidogrel|mesh-list
154091784|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154091785|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154091786|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154091787|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154091788|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
154091789|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091790|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091791|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091792|NCT00430027|Capecitabine|capecitabine|mesh-list
154091793|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
154091794|NCT00430027|Cetuximab|cetuximab|mesh-list
154091795|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154091796|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
153558178|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091820|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153799745|NCT00278408|Rituximab|rituximab|mesh-list
153402614|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154091821|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
154091823|NCT04068506|Analgesics|analgesics|mesh-ancestor
154091824|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
154091825|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091826|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091827|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
154091828|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154091829|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154091830|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154091831|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154091832|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154091833|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154091834|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091835|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091836|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
154091837|NCT00803907|Imiquimod|imiquimod|mesh-list
154091838|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
154091839|NCT00803907|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154091840|NCT00803907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091841|NCT00803907|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154091842|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091843|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154091844|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091868|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154091869|NCT00806871|Prednisolone|prednisolone|mesh-list
154091870|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
154091871|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154091872|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
154091873|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091874|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
154091875|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
154091876|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091877|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091878|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154091879|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
154091880|NCT00806871|Hormones|hormones|mesh-ancestor
154091881|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091882|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154091883|NCT00806871|Protective Agents|protective agents|mesh-ancestor
154091884|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154091885|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091886|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
154091887|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154091888|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091889|NCT00798213|Immunotoxins|immunotoxins|mesh-ancestor
154091890|NCT00798213|Immunoconjugates|immunoconjugates|mesh-ancestor
154091891|NCT00798213|Immunologic Factors|immunologic factors|mesh-ancestor
154091892|NCT00798213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091893|NCT04069208|Cytarabine|cytarabine|mesh-list
154091894|NCT04069208|Idarubicin|idarubicin|mesh-list
154091895|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154091896|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
154091921|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
154091922|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
154091923|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154091924|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154091925|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
154091926|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091927|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091928|NCT00763451|Metformin|metformin|mesh-list
154091929|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154091930|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091931|NCT00762762|Triclosan|triclosan|mesh-list
154091932|NCT00762762|Fluorides|fluorides|mesh-list
154091933|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
154091934|NCT00762762|Protective Agents|protective agents|mesh-ancestor
154091935|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091936|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154091937|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091938|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154091939|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154091940|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
154091941|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091942|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154091943|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
154091944|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154091945|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154091946|NCT00424489|Prednisolone|prednisolone|mesh-list
154091947|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
154091948|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
154091967|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091968|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154091970|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154091971|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
154091972|NCT00578864|Doxorubicin|doxorubicin|mesh-list
154091973|NCT00578864|Etoposide|etoposide|mesh-list
154091974|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
154091975|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091976|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
154091977|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091978|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154091979|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154091980|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
154091981|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091982|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091983|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154091984|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154091985|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154091986|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154091987|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091988|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154091991|NCT01034683|Protective Agents|protective agents|mesh-ancestor
154091992|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091993|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
154091994|NCT01034683|Vitamins|vitamins|mesh-ancestor
154091995|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
154091997|NCT00717470|Prednisone|prednisone|mesh-list
154091998|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
154091999|NCT00717470|Tacrolimus|tacrolimus|mesh-list
154092000|NCT00717470|Basiliximab|basiliximab|mesh-list
154092001|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154092002|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
154092003|NCT00717470|Hormones|hormones|mesh-ancestor
154092004|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092005|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092006|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154092029|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154092030|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092031|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092032|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154092033|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154092034|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154092035|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
154092036|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154092037|NCT00722852|Ketoprofen|ketoprofen|mesh-list
154092038|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154092039|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154092040|NCT00722852|Analgesics|analgesics|mesh-ancestor
154092041|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
154092042|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092043|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092044|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154092045|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154092046|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154092047|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092048|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092049|NCT05657444|Tenecteplase|tenecteplase|mesh-list
154092050|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154092051|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154092052|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092053|NCT04833426|Testosterone|testosterone|mesh-list
154092054|NCT04833426|Androgens|androgens|mesh-ancestor
154092055|NCT04833426|Hormones|hormones|mesh-ancestor
154092056|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092057|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092059|NCT02576964|Capecitabine|capecitabine|mesh-list
154092060|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154092083|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154092084|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092086|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154092087|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
154092088|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154092089|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092090|NCT02576808|Loratadine|loratadine|mesh-list
154092091|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
154092092|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
154092093|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154092094|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154092095|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154092096|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
153660884|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153660885|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154092097|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
154092098|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092099|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092100|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092101|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
154092102|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
154092103|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092104|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154092105|NCT04073160|Durvalumab|durvalumab|mesh-list
154092106|NCT04073160|Tremelimumab|tremelimumab|mesh-list
154092107|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092108|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092109|NCT00417079|Prednisone|prednisone|mesh-list
154092110|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
154092111|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154092127|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154092128|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
154092129|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154092130|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154092131|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154092132|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154092133|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092134|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
154092135|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092136|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092137|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154092138|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154092139|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092140|NCT00429169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154092141|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
154092143|NCT01037491|Rabeprazole|rabeprazole|mesh-list
154092144|NCT01037491|Clopidogrel|clopidogrel|mesh-list
154092145|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154092146|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154092147|NCT01037491|Analgesics|analgesics|mesh-ancestor
154092148|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
154092149|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092150|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092151|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154092152|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154092153|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154092154|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154092155|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092156|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154092157|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154092158|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092159|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
154092160|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154092161|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154092162|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154092163|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
154092164|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092165|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154092166|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154092167|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154092186|NCT02578602|Edetic Acid|edetic acid|mesh-list
154092187|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
154092188|NCT02578602|Antidotes|antidotes|mesh-ancestor
154092189|NCT02578602|Protective Agents|protective agents|mesh-ancestor
153402661|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
154092190|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092191|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
154092192|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
154092193|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092194|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154092195|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
154092196|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154092197|NCT00128856|Paclitaxel|paclitaxel|mesh-list
154092198|NCT00128856|Gemcitabine|gemcitabine|mesh-list
154092199|NCT00128856|Doxorubicin|doxorubicin|mesh-list
154092200|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154092201|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092202|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
154092203|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
154092204|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
154092205|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092206|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154092207|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
154092208|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154092209|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154092210|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092211|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092212|NCT00128778|Doxorubicin|doxorubicin|mesh-list
154092213|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154092214|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154092215|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092216|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154092217|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092218|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092219|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092220|NCT00709488|Talaporfin|talaporfin|mesh-list
154092221|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092222|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154092223|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
154092224|NCT00714246|Carboplatin|carboplatin|mesh-list
154092247|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092248|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092249|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154092251|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154092252|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154092253|NCT00709644|Hematinics|hematinics|mesh-ancestor
154092254|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
154092255|NCT00709644|Vitamins|vitamins|mesh-ancestor
154092256|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
154092257|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154092258|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154092259|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154092260|NCT00415597|Naltrexone|naltrexone|mesh-list
154092261|NCT00415597|Morphine|morphine|mesh-list
154092262|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154092263|NCT00415597|Narcotics|narcotics|mesh-ancestor
154092264|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092265|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092266|NCT00415597|Analgesics|analgesics|mesh-ancestor
154092267|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
154092268|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092269|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154092270|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154092271|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
154092272|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154092273|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
154092274|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092275|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154092276|NCT00714558|Fentanyl|fentanyl|mesh-list
154092277|NCT00714558|Naltrexone|naltrexone|mesh-list
153415522|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
154092278|NCT00714558|Naloxone|naloxone|mesh-list
154092279|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154092309|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154092310|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154092312|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
154092313|NCT02574468|BB 1101|bb 1101|mesh-list
154092314|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154092315|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
154092316|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
154092317|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092318|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092319|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154092320|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
154092321|NCT02574468|Hormones|hormones|mesh-ancestor
153800158|NCT00310323|Caffeine|caffeine|mesh-list
154092322|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092323|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154092324|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092325|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
154092338|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092339|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092340|NCT02575248|Dienogest|dienogest|mesh-list
154092341|NCT02575248|Clomiphene|clomiphene|mesh-list
154092342|NCT02575248|Enclomiphene|enclomiphene|mesh-list
154092343|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
154092344|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154092345|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
154092346|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092347|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092348|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154092349|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
154092350|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154092351|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154092352|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153415598|NCT02244164|Incretins|incretins|mesh-ancestor
154092353|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154092354|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
154092355|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154092356|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154092357|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154092358|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154092359|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154092360|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092361|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154092362|NCT00710736|Capecitabine|capecitabine|mesh-list
154092363|NCT00710736|Fluorouracil|fluorouracil|mesh-list
154092364|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154092365|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
154092366|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092367|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092368|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154092369|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
154092370|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092371|NCT00620542|Atorvastatin|atorvastatin|mesh-list
154092372|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154092373|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154092374|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154092375|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
154092376|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092377|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154092378|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154092379|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092380|NCT04070742|Minocycline|minocycline|mesh-list
154092381|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154092382|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092383|NCT00851344|Cetirizine|cetirizine|mesh-list
154092384|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154092385|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154092400|NCT05810571|Morphine|morphine|mesh-list
154092401|NCT05810571|Remifentanil|remifentanil|mesh-list
154092402|NCT05810571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154092403|NCT05810571|Narcotics|narcotics|mesh-ancestor
154092404|NCT05810571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092405|NCT05810571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092406|NCT05810571|Analgesics|analgesics|mesh-ancestor
154092407|NCT05810571|Sensory System Agents|sensory system agents|mesh-ancestor
154092408|NCT05810571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092409|NCT05810558|Glycine|glycine|mesh-list
154092410|NCT05810558|Glycine Agents|glycine agents|mesh-ancestor
154092411|NCT05810558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092412|NCT05810558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092413|NCT05810558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092414|NCT05810389|Fluorides|fluorides|mesh-list
154092415|NCT05810389|Cariostatic Agents|cariostatic agents|mesh-ancestor
154092416|NCT05810389|Protective Agents|protective agents|mesh-ancestor
154092417|NCT05810389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092418|NCT05809869|Durvalumab|durvalumab|mesh-list
154092419|NCT05809869|Tremelimumab|tremelimumab|mesh-list
154092420|NCT05809869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092421|NCT05809869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092422|NCT05809843|Pancrelipase|pancrelipase|mesh-list
154092423|NCT05809843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154092424|NCT05809804|Esketamine|esketamine|mesh-list
154092425|NCT05809804|Antidepressive Agents|antidepressive agents|mesh-ancestor
154092426|NCT05809804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154092427|NCT05809518|Dexmedetomidine|dexmedetomidine|mesh-list
154092428|NCT05809518|Propofol|propofol|mesh-list
154092429|NCT05809518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154092430|NCT05809518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092431|NCT05809518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092432|NCT05809518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154092433|NCT05809518|Analgesics|analgesics|mesh-ancestor
154092434|NCT05809518|Sensory System Agents|sensory system agents|mesh-ancestor
154092435|NCT05809518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092436|NCT05809518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154092437|NCT05809518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154092438|NCT05809518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154092439|NCT05809518|Adrenergic Agents|adrenergic agents|mesh-ancestor
154092440|NCT05809518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092441|NCT05809518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092442|NCT05809518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154092443|NCT05809518|Anesthetics, General|anesthetics, general|mesh-ancestor
154092444|NCT05809518|Anesthetics|anesthetics|mesh-ancestor
154092445|NCT05809336|Pembrolizumab|pembrolizumab|mesh-list
154092446|NCT05809336|Atezolizumab|atezolizumab|mesh-list
154092447|NCT05809336|Tislelizumab|tislelizumab|mesh-list
154092483|NCT05764876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154092484|NCT05764876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558874|NCT01629212|Tiropramide|tiropramide|mesh-list
154092501|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092502|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
154092503|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154092504|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092505|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092506|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154092507|NCT05642767|Cetrimonium|cetrimonium|mesh-list
154092508|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092509|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154092510|NCT05624138|Leucovorin|leucovorin|mesh-list
154092511|NCT05624138|Ketotifen|ketotifen|mesh-list
154092512|NCT05624138|Fluorouracil|fluorouracil|mesh-list
154092513|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
154092514|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092515|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
154092516|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092517|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154092518|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092520|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
154092521|NCT05624138|Antidotes|antidotes|mesh-ancestor
154092522|NCT05624138|Protective Agents|protective agents|mesh-ancestor
154092523|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
154092524|NCT05624138|Vitamins|vitamins|mesh-ancestor
154092525|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
154092526|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
154092527|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
154092528|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154092529|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
154092530|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
154092531|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092532|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154092533|NCT05610800|Exenatide|exenatide|mesh-list
154092534|NCT05610800|Nicotine|nicotine|mesh-list
154092535|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154092536|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
154092537|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092538|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092539|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154092540|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154092541|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
154092542|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092543|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092544|NCT05610800|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154092545|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154092546|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154092583|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
154092584|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
154092585|NCT05463601|Tamoxifen|tamoxifen|mesh-list
154092586|NCT05463601|Letrozole|letrozole|mesh-list
154092587|NCT05463601|Fulvestrant|fulvestrant|mesh-list
154092588|NCT05463601|Exemestane|exemestane|mesh-list
154092589|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092604|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092606|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
154092607|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092608|NCT05366764|Albuterol|albuterol|mesh-list
154092609|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154092610|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
154092611|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092612|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092613|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154092614|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
154092615|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
154092616|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154092617|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154092618|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154092619|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154092620|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
154092621|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092622|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092623|NCT05303844|Tislelizumab|tislelizumab|mesh-list
154092624|NCT05303844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092625|NCT05303844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092626|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154092627|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154092628|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092629|NCT05236946|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154092630|NCT05236946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154092631|NCT05236946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092632|NCT05236946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092633|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
154092634|NCT05216419|Vitamin D|vitamin d|mesh-list
154092635|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154092636|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092637|NCT05216419|Vitamins|vitamins|mesh-ancestor
154092638|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
154092639|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154092640|NCT05117034|Morphine|morphine|mesh-list
154092641|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154092642|NCT05117034|Narcotics|narcotics|mesh-ancestor
154092643|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092644|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092645|NCT05117034|Analgesics|analgesics|mesh-ancestor
154092646|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
154092667|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092668|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
154092669|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092670|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154092671|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
154092672|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154092673|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154092674|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092675|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154092676|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
154092677|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154092678|NCT05043805|Levomethorphan|levomethorphan|mesh-list
154092679|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
154092680|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
154092681|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
154092682|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154092683|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154092684|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092685|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092686|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092687|NCT05043805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154092688|NCT05043805|Narcotics|narcotics|mesh-ancestor
154092689|NCT05043805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092690|NCT05043805|Analgesics|analgesics|mesh-ancestor
154092691|NCT05043805|Sensory System Agents|sensory system agents|mesh-ancestor
154092692|NCT05043805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092693|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
154092694|NCT05033483|Trace Elements|trace elements|mesh-ancestor
154092695|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
154092696|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092697|NCT04982913|Oseltamivir|oseltamivir|mesh-list
154092698|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
154092699|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092711|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154092712|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092713|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256638|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256639|NCT03882008|Abatacept|abatacept|mesh-list
154092714|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154092715|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
154092716|NCT04929600|Amlodipine|amlodipine|mesh-list
154092717|NCT04929600|Valsartan|valsartan|mesh-list
154092718|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154092719|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154092720|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154092721|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154092722|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092723|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154092724|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092725|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
154092726|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154092727|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154092728|NCT04925648|Dasatinib|dasatinib|mesh-list
153800413|NCT00417053|Busulfan|busulfan|mesh-list
154092729|NCT04925648|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154092730|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154092731|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092732|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092733|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092734|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154092735|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092736|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154092737|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092738|NCT04852367|Doxorubicin|doxorubicin|mesh-list
154092739|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154092740|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092741|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154092742|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092743|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092744|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092745|NCT04727996|Tislelizumab|tislelizumab|mesh-list
154092746|NCT04727996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092747|NCT04727996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092748|NCT04692623|Insulin|insulin|mesh-list
154092749|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154092750|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
154092751|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
154092752|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154092753|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092754|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154092755|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092756|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154092757|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092758|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092759|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092760|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800431|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153402788|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
154092781|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092783|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
154092784|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092785|NCT04577001|Letrozole|letrozole|mesh-list
154092786|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092787|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154092788|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154092789|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092790|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092791|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154092792|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
154092793|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092794|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092795|NCT04576078|Nefopam|nefopam|mesh-list
154092796|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154092797|NCT04576078|Analgesics|analgesics|mesh-ancestor
154092798|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
154092799|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092800|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092801|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
154092802|NCT04561557|Fludarabine|fludarabine|mesh-list
153661606|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
154092803|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154092804|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
154092805|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092806|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154092807|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154092808|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
154092809|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092810|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092811|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154092813|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092814|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154092815|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559183|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154092836|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
154092837|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
154092838|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
154092839|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092840|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154092841|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
154092842|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092843|NCT04447092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154092844|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154092845|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092846|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092847|NCT04447092|Antidotes|antidotes|mesh-ancestor
153800474|NCT00317538|Infliximab|infliximab|mesh-list
154092848|NCT04447092|Protective Agents|protective agents|mesh-ancestor
154092849|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092850|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
154092851|NCT04447092|Vitamins|vitamins|mesh-ancestor
154092852|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
154092853|NCT04371224|Leucovorin|leucovorin|mesh-list
154092854|NCT04371224|Capecitabine|capecitabine|mesh-list
154092855|NCT04371224|Fluorouracil|fluorouracil|mesh-list
154092856|NCT04371224|Irinotecan|irinotecan|mesh-list
154092857|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154092858|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
154092859|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092860|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092861|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154092862|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
154092863|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092864|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154092865|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092866|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092867|NCT04371224|Antidotes|antidotes|mesh-ancestor
154092868|NCT04371224|Protective Agents|protective agents|mesh-ancestor
154092869|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
154092870|NCT04371224|Vitamins|vitamins|mesh-ancestor
154092871|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
154092872|NCT04306900|Paclitaxel|paclitaxel|mesh-list
154092873|NCT04306900|Docetaxel|docetaxel|mesh-list
154092874|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154092875|NCT04306900|Gemcitabine|gemcitabine|mesh-list
154092876|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
154092894|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154092895|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
154092896|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
154092897|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
154092898|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092899|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092900|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
154092902|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154092903|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
154092904|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092905|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
154092906|NCT04202692|Protective Agents|protective agents|mesh-ancestor
154092907|NCT04202692|Antacids|antacids|mesh-ancestor
154092908|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092909|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154092910|NCT04177758|Vitamin D|vitamin d|mesh-list
154092911|NCT04177758|Vitamins|vitamins|mesh-ancestor
154092912|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
154092913|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092914|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154092915|NCT04150458|Choline|choline|mesh-list
154092916|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
154256640|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154092917|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154092918|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
154092919|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092920|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154092921|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154092922|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
154092924|NCT04147208|Entecavir|entecavir|mesh-list
154092925|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154092926|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154092927|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
154092928|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092929|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092930|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154092931|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154092932|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
154092933|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092954|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
154092955|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092956|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154092957|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154092958|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092959|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092960|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154092961|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
154092962|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092963|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092964|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154092965|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154092966|NCT03945448|Amebicides|amebicides|mesh-ancestor
154092967|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154092968|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154092969|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154092971|NCT03941873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092972|NCT03941873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092973|NCT03941587|Aflibercept|aflibercept|mesh-list
154092974|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154092975|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154092976|NCT03941587|Growth Substances|growth substances|mesh-ancestor
154092977|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092978|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
154092979|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092980|NCT03917420|Tenofovir|tenofovir|mesh-list
154092981|NCT03917420|Emtricitabine|emtricitabine|mesh-list
154092982|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154092983|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
154092984|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093007|NCT03705845|Vitamin E|vitamin e|mesh-list
154093008|NCT03705845|Tocopherols|tocopherols|mesh-list
154093009|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
154093010|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093011|NCT03705845|Protective Agents|protective agents|mesh-ancestor
154093012|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093013|NCT03705845|Vitamins|vitamins|mesh-ancestor
154093014|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
154093015|NCT03669718|Cemiplimab|cemiplimab|mesh-list
154093016|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093017|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093018|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154093019|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093020|NCT03642990|Niacinamide|niacinamide|mesh-list
154093021|NCT03642990|Niacin|niacin|mesh-list
154093022|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
154093023|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
154093024|NCT03642990|Vitamins|vitamins|mesh-ancestor
154093025|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
154093026|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093027|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154093028|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
154093029|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093030|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154093031|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
154093032|NCT03582475|Cisplatin|cisplatin|mesh-list
154093033|NCT03582475|Carboplatin|carboplatin|mesh-list
154093034|NCT03582475|Docetaxel|docetaxel|mesh-list
154093035|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
154093036|NCT03582475|Etoposide|etoposide|mesh-list
154093037|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
154093060|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093061|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093062|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154093063|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093064|NCT03553563|Esomeprazole|esomeprazole|mesh-list
154093065|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154093066|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093067|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154093068|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093069|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093070|NCT06063473|Trifarotene|trifarotene|mesh-list
154093071|NCT06063473|Dermatologic Agents|dermatologic agents|mesh-ancestor
154093072|NCT06063369|Palmidrol|palmidrol|mesh-list
154093073|NCT06063369|Analgesics|analgesics|mesh-ancestor
154093074|NCT06063369|Sensory System Agents|sensory system agents|mesh-ancestor
154093075|NCT06063369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093076|NCT06063369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093077|NCT06063369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154093078|NCT06063369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154093079|NCT06063369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093080|NCT06063369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093081|NCT06063369|Antiviral Agents|antiviral agents|mesh-ancestor
154093082|NCT06063369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093083|NCT06063369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154093084|NCT06063369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154093085|NCT06063369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093086|NCT06063369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093087|NCT06063369|Hormones|hormones|mesh-ancestor
154093088|NCT06063369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093099|NCT06063070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154093101|NCT06063070|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154093102|NCT06063070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093103|NCT06063070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093104|NCT06063070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154093105|NCT06063070|Growth Substances|growth substances|mesh-ancestor
154093106|NCT06063070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416343|NCT05424523|Omalizumab|omalizumab|mesh-list
154093107|NCT06063070|Growth Inhibitors|growth inhibitors|mesh-ancestor
154093108|NCT06063070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093109|NCT06063070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093110|NCT06063057|Vaccines|vaccines|mesh-list
154093111|NCT06063057|Immunologic Factors|immunologic factors|mesh-ancestor
154093112|NCT06063057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093113|NCT06063018|Tislelizumab|tislelizumab|mesh-list
154093114|NCT06063018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093115|NCT06063018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093116|NCT06062953|Melatonin|melatonin|mesh-list
154093117|NCT06062953|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154093119|NCT06062953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093120|NCT06062953|Protective Agents|protective agents|mesh-ancestor
154093121|NCT06062953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093122|NCT06062953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154093123|NCT06062953|Antidepressive Agents|antidepressive agents|mesh-ancestor
154093124|NCT06062953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154093125|NCT06062953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154093126|NCT06062953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154093127|NCT06062875|Adalimumab|adalimumab|mesh-list
154093128|NCT06062875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154093129|NCT06062875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093130|NCT06062875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093131|NCT06062823|Afatinib|afatinib|mesh-list
154093132|NCT06062823|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154093133|NCT06062823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154093134|NCT06062823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093135|NCT06062823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093136|NCT06062823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093137|NCT06062719|Octreotide|octreotide|mesh-list
154093138|NCT06062719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093140|NCT06062719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093141|NCT06062498|Palbociclib|palbociclib|mesh-list
154093142|NCT06062498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093143|NCT06062498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154093144|NCT06062498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093145|NCT06062498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093146|NCT06062277|Colchicine|colchicine|mesh-list
154093147|NCT06062277|Gout Suppressants|gout suppressants|mesh-ancestor
154093148|NCT06062277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093149|NCT06062277|Tubulin Modulators|tubulin modulators|mesh-ancestor
154093150|NCT06062277|Antimitotic Agents|antimitotic agents|mesh-ancestor
154093151|NCT06062277|Mitosis Modulators|mitosis modulators|mesh-ancestor
154093179|NCT06018467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093180|NCT06018467|Vitamin B Complex|vitamin b complex|mesh-ancestor
154093181|NCT06018467|Vitamins|vitamins|mesh-ancestor
154093182|NCT06018467|Micronutrients|micronutrients|mesh-ancestor
154093183|NCT06018467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093184|NCT06018467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154093185|NCT06018467|Antimetabolites|antimetabolites|mesh-ancestor
154093186|NCT06018467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154093187|NCT06018467|Vasodilator Agents|vasodilator agents|mesh-ancestor
154093188|NCT06018467|Antioxidants|antioxidants|mesh-ancestor
154093189|NCT06018467|Protective Agents|protective agents|mesh-ancestor
154093190|NCT05992896|Bupivacaine|bupivacaine|mesh-list
154093191|NCT05992896|Anesthetics, Local|anesthetics, local|mesh-ancestor
154093192|NCT05992896|Anesthetics|anesthetics|mesh-ancestor
153339943|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093193|NCT05992896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154093194|NCT05992896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093195|NCT05992896|Sensory System Agents|sensory system agents|mesh-ancestor
154093196|NCT05992896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093197|NCT05920798|Pembrolizumab|pembrolizumab|mesh-list
154093198|NCT05920798|Vaccines|vaccines|mesh-list
154093199|NCT05920798|Immunologic Factors|immunologic factors|mesh-ancestor
154093209|NCT05907980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093210|NCT05906615|Lidocaine|lidocaine|mesh-list
154093211|NCT05906615|Anesthetics, Local|anesthetics, local|mesh-ancestor
154093212|NCT05906615|Anesthetics|anesthetics|mesh-ancestor
154093213|NCT05906615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154093214|NCT05906615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093215|NCT05906615|Sensory System Agents|sensory system agents|mesh-ancestor
154093216|NCT05906615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093217|NCT05906615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154093218|NCT05906615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154093219|NCT05906615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154093220|NCT05906615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154093221|NCT05906615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093222|NCT05889013|Nitric Oxide|nitric oxide|mesh-list
154093223|NCT05889013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154093224|NCT05889013|Autonomic Agents|autonomic agents|mesh-ancestor
154093225|NCT05889013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093226|NCT05889013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093227|NCT05889013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154093228|NCT05889013|Respiratory System Agents|respiratory system agents|mesh-ancestor
154093229|NCT05889013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154093230|NCT05889013|Antioxidants|antioxidants|mesh-ancestor
154093231|NCT05889013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093232|NCT05889013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093233|NCT05889013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154093234|NCT05889013|Vasodilator Agents|vasodilator agents|mesh-ancestor
154093235|NCT05889013|Gasotransmitters|gasotransmitters|mesh-ancestor
154093236|NCT05889013|Protective Agents|protective agents|mesh-ancestor
154093237|NCT05880355|Dapansutrile|dapansutrile|mesh-list
154093238|NCT05880355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093239|NCT05879367|Eflornithine|eflornithine|mesh-list
154093240|NCT05879367|Temozolomide|temozolomide|mesh-list
154093241|NCT05879367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153402894|NCT04676334|Rucaparib|rucaparib|mesh-list
154093242|NCT05879367|Alkylating Agents|alkylating agents|mesh-ancestor
154093243|NCT05879367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093244|NCT05879367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093245|NCT05879367|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154093246|NCT05879367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154093247|NCT05879367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154093248|NCT05879367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093249|NCT05879367|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154093251|NCT05853367|Pembrolizumab|pembrolizumab|mesh-list
154093252|NCT05853367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093253|NCT05853367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093254|NCT05853367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154093255|NCT05853367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093256|NCT05825092|Methyltestosterone|methyltestosterone|mesh-list
154093257|NCT05825092|Testosterone|testosterone|mesh-list
154093258|NCT05825092|Testosterone undecanoate|testosterone undecanoate|mesh-list
154093259|NCT05825092|Testosterone enanthate|testosterone enanthate|mesh-list
154093260|NCT05825092|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154093261|NCT05825092|Androgens|androgens|mesh-ancestor
154093286|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154093287|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093288|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093289|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154093290|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154093291|NCT05513560|Protective Agents|protective agents|mesh-ancestor
154093292|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093293|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
154093294|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154093295|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
154093296|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154093297|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
154093298|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093299|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154093300|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
154093301|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154093302|NCT05502913|Rifaximin|rifaximin|mesh-list
153800819|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
154093303|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093304|NCT05502913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093305|NCT05412082|Leucovorin|leucovorin|mesh-list
154093306|NCT05412082|Capecitabine|capecitabine|mesh-list
154093307|NCT05412082|Fluorouracil|fluorouracil|mesh-list
154093308|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
154093309|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093310|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
154093311|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093312|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093313|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093314|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
154093315|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093330|NCT05214573|Hormones|hormones|mesh-ancestor
154093331|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093332|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093333|NCT05214573|Incretins|incretins|mesh-ancestor
154093334|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093335|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154093336|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
154093337|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093338|NCT05204641|Rifaximin|rifaximin|mesh-list
154093339|NCT05204641|Levodopa|levodopa|mesh-list
154093340|NCT05204641|Benserazide|benserazide|mesh-list
154093341|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154093342|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154093343|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
154093344|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093345|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093346|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800871|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093347|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154093348|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093349|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093350|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093351|NCT05186974|Carboplatin|carboplatin|mesh-list
154093352|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
154093353|NCT05186974|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154093354|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093355|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093356|NCT05186974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154093357|NCT05186974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093358|NCT05186974|Immunoconjugates|immunoconjugates|mesh-ancestor
154093359|NCT05186974|Immunologic Factors|immunologic factors|mesh-ancestor
154093360|NCT05186974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093361|NCT05182840|Empagliflozin|empagliflozin|mesh-list
154256641|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093362|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154093363|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093364|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154093365|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093367|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
154093368|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093369|NCT05117489|Cortisone|cortisone|mesh-list
154093370|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093371|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154093372|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
154093373|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
154093374|NCT05064332|Estradiol|estradiol|mesh-list
154093375|NCT05064332|Estrogens|estrogens|mesh-ancestor
154093388|NCT04976088|Diclofenac|diclofenac|mesh-list
154093389|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154093390|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154093391|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154093392|NCT04976088|Analgesics|analgesics|mesh-ancestor
154093393|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
154093394|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093395|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093396|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093397|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093398|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154093399|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093400|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093401|NCT04771481|Metoclopramide|metoclopramide|mesh-list
154093402|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
154093403|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
154093404|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093405|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416643|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154093406|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093407|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154093408|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154093409|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
154093410|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093411|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093413|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093414|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093416|NCT04650893|Ketorolac|ketorolac|mesh-list
154093417|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093418|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
154093419|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
154093420|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093421|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093422|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093423|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
154093424|NCT04650893|Hormones|hormones|mesh-ancestor
154093425|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093426|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154093427|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093428|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154093429|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154093430|NCT04650893|Analgesics|analgesics|mesh-ancestor
154093431|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
154093432|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093433|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154093434|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093435|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093436|NCT04611152|Aflibercept|aflibercept|mesh-list
154093446|NCT04603937|Growth Substances|growth substances|mesh-ancestor
154093447|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093448|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
154093449|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093451|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
154093452|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093453|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154093454|NCT04602975|Vaccines|vaccines|mesh-list
154093455|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
154093456|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256642|NCT03882008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153862588|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093457|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154093458|NCT04602975|Antacids|antacids|mesh-ancestor
154093459|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093460|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093461|NCT04551547|Vaccines|vaccines|mesh-list
154093462|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
154093463|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093464|NCT04539236|Lenalidomide|lenalidomide|mesh-list
154093465|NCT04539236|Luspatercept|luspatercept|mesh-list
154093466|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
154093467|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093468|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154093469|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154093470|NCT04539236|Growth Substances|growth substances|mesh-ancestor
154093471|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
154093472|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093473|NCT04539236|Hematinics|hematinics|mesh-ancestor
154093474|NCT04509102|Adderall|adderall|mesh-list
154093475|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154093476|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093477|NCT04256317|Azacitidine|azacitidine|mesh-list
154093478|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093479|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
154093480|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093481|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093482|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093483|NCT04217447|Aspirin|aspirin|mesh-list
154093484|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154093485|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154093486|NCT04217447|Analgesics|analgesics|mesh-ancestor
154093487|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
154093488|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093489|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093490|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093491|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093492|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154093493|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154093494|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093495|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154093496|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154093497|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093498|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
154093499|NCT04210349|Vaccines|vaccines|mesh-list
154093500|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
154093501|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093502|NCT04203901|Nivolumab|nivolumab|mesh-list
154093517|NCT04198766|Antibodies|antibodies|mesh-list
154093518|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
154093519|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093520|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093521|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093522|NCT04198766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154093523|NCT04198766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093524|NCT04171700|Rucaparib|rucaparib|mesh-list
154093525|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154093526|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093527|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093528|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093529|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
154093530|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093531|NCT04096066|Dexamethasone|dexamethasone|mesh-list
154093532|NCT04096066|Lenalidomide|lenalidomide|mesh-list
154093533|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093534|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
154093535|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
154093536|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093537|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093538|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093539|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
154093540|NCT04096066|Hormones|hormones|mesh-ancestor
154093541|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093542|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154093543|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093544|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
154093545|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154093546|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154093547|NCT04096066|Growth Substances|growth substances|mesh-ancestor
154093548|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
154093549|NCT03976258|Naltrexone|naltrexone|mesh-list
154093550|NCT03976258|Buprenorphine|buprenorphine|mesh-list
154093551|NCT03976258|Methadone|methadone|mesh-list
154093552|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154093554|NCT03976258|Naloxone|naloxone|mesh-list
154093555|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154093556|NCT03976258|Narcotics|narcotics|mesh-ancestor
154093557|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154093558|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093559|NCT03976258|Analgesics|analgesics|mesh-ancestor
154093560|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
154093561|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093562|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154093563|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154093564|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
154093565|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
153402966|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801166|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
154093600|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154093601|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154093602|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154093603|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
154093604|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093605|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093606|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093627|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154093628|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093629|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
154093630|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153416861|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093631|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154093632|NCT03386500|Manganese|manganese|mesh-list
154093633|NCT03386500|Trace Elements|trace elements|mesh-ancestor
154093634|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
154093635|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093636|NCT03226418|Cytarabine|cytarabine|mesh-list
154093637|NCT03226418|Azacitidine|azacitidine|mesh-list
154093638|NCT03226418|Decitabine|decitabine|mesh-list
154093639|NCT03226418|Daunorubicin|daunorubicin|mesh-list
154093640|NCT03226418|Venetoclax|venetoclax|mesh-list
154093641|NCT03226418|Idarubicin|idarubicin|mesh-list
154093642|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093643|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
154093644|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093645|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093646|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
154093647|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093648|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093649|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
154093650|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093651|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093652|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154093653|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154093654|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154093655|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
154093656|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
154093657|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154093658|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154093659|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093660|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560026|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154093679|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093680|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
154093681|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093682|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093683|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093684|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154093685|NCT03066648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093686|NCT02766465|Sirolimus|sirolimus|mesh-list
154093687|NCT02766465|Methotrexate|methotrexate|mesh-list
154093688|NCT02766465|Fludarabine|fludarabine|mesh-list
154093689|NCT02766465|Melphalan|melphalan|mesh-list
154093690|NCT02766465|Busulfan|busulfan|mesh-list
154093691|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
153662426|NCT00140530|Sirolimus|sirolimus|mesh-list
154093692|NCT02766465|Tacrolimus|tacrolimus|mesh-list
154093693|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154093694|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
154093695|NCT02766465|Lenograstim|lenograstim|mesh-list
154093696|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154093697|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
154093698|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154093699|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093700|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093701|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
154093702|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093703|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093704|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154093705|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093706|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154093707|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093708|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
154093709|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093710|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154093711|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154093712|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154093713|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093714|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154093715|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
154093716|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154093717|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
154093718|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154093719|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154093730|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154093732|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154093733|NCT02020707|Bevacizumab|bevacizumab|mesh-list
154093734|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154093735|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
154093736|NCT02020707|Antibodies|antibodies|mesh-list
154093737|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
154093738|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154093739|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
154093740|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154093741|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093742|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
154093743|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
154093744|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
154093745|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093746|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154093747|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154093748|NCT02020707|Growth Substances|growth substances|mesh-ancestor
154093749|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093750|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
154093751|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
154093752|NCT01632436|Pixantrone|pixantrone|mesh-list
154093753|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154093754|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154093755|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093756|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093757|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093758|NCT01594047|Ketamine|ketamine|mesh-list
154093759|NCT01594047|Methadone|methadone|mesh-list
154093760|NCT01594047|Analgesics|analgesics|mesh-ancestor
154093761|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
154093762|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093763|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093764|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154093765|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154093766|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
154093767|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
154093768|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154093769|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154093770|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154093771|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093772|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093773|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154093774|NCT01594047|Narcotics|narcotics|mesh-ancestor
154093775|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
154256643|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093776|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154093777|NCT01268579|Ribavirin|ribavirin|mesh-list
154093778|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
154093779|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093780|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
154093781|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093782|NCT01165632|Fluorides|fluorides|mesh-list
154093783|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
154093784|NCT01165632|Protective Agents|protective agents|mesh-ancestor
153560141|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
154093810|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093811|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154093812|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093813|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
154093814|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093815|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154093816|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
154093817|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154093818|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154093819|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093820|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154093821|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154093822|NCT00579878|Analgesics|analgesics|mesh-ancestor
154093823|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
154093824|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093825|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093826|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093827|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
154093829|NCT00554788|Cisplatin|cisplatin|mesh-list
154093830|NCT00554788|Carboplatin|carboplatin|mesh-list
154093831|NCT00554788|Etoposide|etoposide|mesh-list
154093832|NCT00554788|Vincristine|vincristine|mesh-list
154093833|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
154093834|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
154093835|NCT00554788|Lenograstim|lenograstim|mesh-list
154093857|NCT00138216|Temozolomide|temozolomide|mesh-list
153402997|NCT04497142|Levetiracetam|levetiracetam|mesh-list
154093858|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154093859|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154093860|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093861|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093862|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093863|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154093864|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
154093865|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
154093866|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
154093867|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154093868|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
154093869|NCT03542760|Methylene Blue|methylene blue|mesh-list
154093870|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093871|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093872|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154093873|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093874|NCT03465540|Dexamethasone|dexamethasone|mesh-list
154093875|NCT03465540|Azacitidine|azacitidine|mesh-list
154093876|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093877|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
154093878|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
154093879|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093880|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093881|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093882|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
154093884|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093885|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154093886|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093887|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093888|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
154093909|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154093910|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093911|NCT03123029|Venetoclax|venetoclax|mesh-list
154093912|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093913|NCT03048877|Apatinib|apatinib|mesh-list
154093914|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093915|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154093916|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093917|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093918|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
154093919|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
154093920|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
154093921|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154093922|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093923|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
154093924|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093925|NCT02940925|Cisplatin|cisplatin|mesh-list
154093926|NCT02940925|Capecitabine|capecitabine|mesh-list
154093927|NCT02940925|Fluorouracil|fluorouracil|mesh-list
154093928|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093929|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093930|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
154093931|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093932|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093933|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
154093934|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093935|NCT02915705|Vitamin D|vitamin d|mesh-list
154093936|NCT02915705|Vitamins|vitamins|mesh-ancestor
154093937|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
154093938|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093939|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154093940|NCT02891278|Cytarabine|cytarabine|mesh-list
154093941|NCT02891278|Sertraline|sertraline|mesh-list
154093942|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093944|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093945|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093960|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093961|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093962|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
154093963|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093964|NCT02454543|Androgens|androgens|mesh-list
154093965|NCT02454543|Hormones|hormones|mesh-ancestor
154191145|NCT05947851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093966|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093967|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093968|NCT02384512|Rasagiline|rasagiline|mesh-list
154093969|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154093970|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093971|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093972|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154093973|NCT02384512|Protective Agents|protective agents|mesh-ancestor
154093974|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093975|NCT02366494|Docetaxel|docetaxel|mesh-list
154093976|NCT02366494|Leuprolide|leuprolide|mesh-list
154093977|NCT02366494|Goserelin|goserelin|mesh-list
154093978|NCT02366494|Bicalutamide|bicalutamide|mesh-list
154093979|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154093980|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093981|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
154093982|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
154093983|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
154093984|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093985|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154093986|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
154093987|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154093988|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093989|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154093990|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
154093991|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
154093992|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093993|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
154093994|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154093995|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
154093996|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154093997|NCT02157610|Nicotine|nicotine|mesh-list
154093998|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154093999|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
154094000|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094001|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094002|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154094003|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154094004|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
154094005|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560361|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154256645|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
154094023|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094024|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094025|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154094026|NCT01937156|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154094027|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154094028|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
154094029|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094030|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094032|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154094033|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154094034|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154094035|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094036|NCT01718873|Leucovorin|leucovorin|mesh-list
154094037|NCT01718873|Folic Acid|folic acid|mesh-list
154094038|NCT01718873|Bevacizumab|bevacizumab|mesh-list
154094039|NCT01718873|Capecitabine|capecitabine|mesh-list
154094040|NCT01718873|Fluorouracil|fluorouracil|mesh-list
154094041|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
154094042|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
154094043|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154094044|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094045|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154094046|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154094047|NCT01718873|Growth Substances|growth substances|mesh-ancestor
154094048|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094049|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
154094050|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154094051|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
154094052|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094053|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094054|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
154094055|NCT01718873|Antidotes|antidotes|mesh-ancestor
154094056|NCT01718873|Protective Agents|protective agents|mesh-ancestor
154094057|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
154094058|NCT01718873|Vitamins|vitamins|mesh-ancestor
154094059|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
154094060|NCT01718873|Hematinics|hematinics|mesh-ancestor
154094061|NCT01424566|Nabiximols|nabiximols|mesh-list
154094062|NCT01424566|Analgesics|analgesics|mesh-ancestor
154094074|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
154094075|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094076|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094077|NCT01337089|Nabiximols|nabiximols|mesh-list
154094078|NCT01337089|Analgesics|analgesics|mesh-ancestor
154094079|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
154094080|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094081|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094082|NCT01276587|Vitamin D|vitamin d|mesh-list
154094083|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
154094084|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
154094085|NCT01276587|Vitamins|vitamins|mesh-list
154094086|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
154094087|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094088|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154094089|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154094090|NCT01217580|Ropivacaine|ropivacaine|mesh-list
154094091|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
154094093|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094094|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094095|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
154094096|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094097|NCT00802646|Epinephrine|epinephrine|mesh-list
154094098|NCT00802646|Fentanyl|fentanyl|mesh-list
154094099|NCT00802646|Bupivacaine|bupivacaine|mesh-list
154094100|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
154094101|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
154094102|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094103|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094104|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
154094105|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094106|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154094107|NCT00802646|Narcotics|narcotics|mesh-ancestor
154094108|NCT00802646|Analgesics|analgesics|mesh-ancestor
154094109|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154094111|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
154094112|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154094113|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154094114|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
154094115|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094116|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094117|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154094118|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154094119|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
154094120|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154094121|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
154094122|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
154094123|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
154094124|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154094125|NCT00473707|Oxytocin|oxytocin|mesh-list
154094126|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
154094127|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153560480|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
153560482|NCT01638403|Modafinil|modafinil|mesh-list
154094155|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094157|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154094158|NCT00107744|Caseins|caseins|mesh-list
154094159|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
154094160|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
153403031|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
154094161|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094162|NCT00845338|Darifenacin|darifenacin|mesh-list
154094163|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154094164|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154094165|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
153417377|NCT02958800|Olanzapine|olanzapine|mesh-list
154094166|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094167|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094168|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094169|NCT00845338|Urological Agents|urological agents|mesh-ancestor
154094170|NCT00923962|Adenosine|adenosine|mesh-list
154094171|NCT00923962|Glucagon|glucagon|mesh-list
154094172|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154094183|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154094185|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
154094186|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094187|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094189|NCT02575092|Enalapril|enalapril|mesh-list
154094190|NCT02575092|Enalaprilat|enalaprilat|mesh-list
154094191|NCT02575092|Maleic acid|maleic acid|mesh-list
154094192|NCT02575092|Hematinics|hematinics|mesh-ancestor
154094193|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
154094194|NCT02575092|Vitamins|vitamins|mesh-ancestor
154094195|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
154094196|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094197|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094198|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094199|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154094200|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
154094201|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154094202|NCT04097470|Decitabine|decitabine|mesh-list
154094203|NCT04097470|Midostaurin|midostaurin|mesh-list
154094204|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154094205|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
154094206|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094207|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094208|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094209|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154094210|NCT04041934|Tryptophan|tryptophan|mesh-list
154094211|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154094212|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
154094213|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154094214|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154094215|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154094216|NCT00845572|Risperidone|risperidone|mesh-list
154094217|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154094218|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
154094219|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094220|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094221|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094222|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154094223|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154094224|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094225|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154094226|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154094227|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
154094228|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
154094229|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
154094230|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154094231|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154094232|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
154094233|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154094234|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154094235|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094236|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154094237|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094260|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
154094261|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094262|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154094263|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154094264|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154094265|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
154094266|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094267|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094269|NCT02573064|Colistin|colistin|mesh-list
154094270|NCT02573064|Tigecycline|tigecycline|mesh-list
154094271|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154094272|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094273|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154094274|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094275|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094276|NCT00845884|Bevacizumab|bevacizumab|mesh-list
154094277|NCT00845884|Cisplatin|cisplatin|mesh-list
154094278|NCT00845884|Docetaxel|docetaxel|mesh-list
154094279|NCT00845884|Capecitabine|capecitabine|mesh-list
154094280|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154094281|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094282|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154094283|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154094284|NCT00845884|Growth Substances|growth substances|mesh-ancestor
154094285|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094286|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
154094287|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
154094288|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
154094289|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
154094321|NCT02545738|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154094322|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154094323|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094324|NCT02545738|Incretins|incretins|mesh-ancestor
154094326|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154094327|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
154094328|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154094329|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
154094330|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094331|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094332|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154094333|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
154094346|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154094347|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154094348|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
154094349|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094350|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094351|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154094352|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
154094353|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
154094354|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154094355|NCT00712374|Amodiaquine|amodiaquine|mesh-list
154094356|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
154094357|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154094358|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154094359|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094360|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154094361|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094362|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094363|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154094364|NCT02573220|Leucovorin|leucovorin|mesh-list
154094365|NCT02573220|Fluorouracil|fluorouracil|mesh-list
154094366|NCT02573220|Irinotecan|irinotecan|mesh-list
154094367|NCT02573220|Cetuximab|cetuximab|mesh-list
154094368|NCT02573220|Camptothecin|camptothecin|mesh-list
154094369|NCT02573220|Calcium|calcium|mesh-list
154094370|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
154094371|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154094372|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094373|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
154094374|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094375|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154094376|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094377|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094378|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
154094379|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154094380|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154094381|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094382|NCT02573220|Antidotes|antidotes|mesh-ancestor
154094383|NCT02573220|Protective Agents|protective agents|mesh-ancestor
154094384|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
154094385|NCT02573220|Vitamins|vitamins|mesh-ancestor
154094386|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
154094387|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154094388|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154094389|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
153417609|NCT02766517|Capsaicin|capsaicin|mesh-list
154094390|NCT00712452|Vinblastine|vinblastine|mesh-list
154094391|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094392|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
154094393|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094394|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154094395|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154094396|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
154094414|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154094415|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154094416|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094417|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094418|NCT02544880|Urological Agents|urological agents|mesh-ancestor
154094419|NCT00856570|Warfarin|warfarin|mesh-list
154094420|NCT00856570|Mirabegron|mirabegron|mesh-list
154094421|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
154094422|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154094423|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154094424|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154094425|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
154094426|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094427|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094428|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094429|NCT00856570|Urological Agents|urological agents|mesh-ancestor
154094430|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
154094431|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154094432|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094433|NCT00856804|Ribavirin|ribavirin|mesh-list
154094434|NCT00856804|Thalidomide|thalidomide|mesh-list
154094435|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
154094436|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094437|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
154094438|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094439|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094440|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
154094441|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094442|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
154094443|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154094444|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154094445|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154094446|NCT00856804|Growth Substances|growth substances|mesh-ancestor
154094447|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
154094448|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094449|NCT00856882|Caseins|caseins|mesh-list
154094450|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
154094451|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
154094452|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094453|NCT00712686|Olanzapine|olanzapine|mesh-list
154094454|NCT00712686|Aripiprazole|aripiprazole|mesh-list
154094474|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154094475|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154094476|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154094477|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154094478|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154094479|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
154094480|NCT04041856|Povidone|povidone|mesh-list
154094481|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
154094482|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
154094483|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154094484|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094485|NCT00856960|Losartan|losartan|mesh-list
154094486|NCT00856960|Aliskiren|aliskiren|mesh-list
154094487|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154094488|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154094489|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154094490|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154094491|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094492|NCT00856960|Renin Inhibitors|renin inhibitors|mesh-ancestor
154094493|NCT00856960|Protease Inhibitors|protease inhibitors|mesh-ancestor
154094494|NCT00856960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094495|NCT00712764|Adenosine|adenosine|mesh-list
154094496|NCT00712764|Analgesics|analgesics|mesh-ancestor
154094497|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
154094498|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094499|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094500|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154094501|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
153801806|NCT00288470|Hylan|hylan|mesh-list
154094502|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154094503|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
154094504|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
154094505|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094506|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094507|NCT00848458|Azelaic acid|azelaic acid|mesh-list
153560872|NCT01645839|Cytarabine|cytarabine|mesh-list
154094535|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
154094536|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
154094537|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094538|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154094539|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154094540|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154094541|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154094542|NCT00717704|Dasatinib|dasatinib|mesh-list
154094543|NCT00717704|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154094544|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154094545|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094546|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094547|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094548|NCT00620074|Voriconazole|voriconazole|mesh-list
154094549|NCT00620074|Anidulafungin|anidulafungin|mesh-list
154094550|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
154094551|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094552|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154094553|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154094554|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560923|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094574|NCT00719316|Protease Inhibitors|protease inhibitors|mesh-ancestor
154094575|NCT00719316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094576|NCT00719316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094577|NCT00857116|Albendazole|albendazole|mesh-list
154094578|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
154094579|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154094580|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094581|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
154094582|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154094583|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154094584|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
154094585|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
154094586|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
154094587|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094588|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094589|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
154094590|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154094591|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154094592|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094593|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
154094594|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094595|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094596|NCT00717938|Carboplatin|carboplatin|mesh-list
154094597|NCT00717938|Etoposide|etoposide|mesh-list
154094598|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
154094599|NCT00717938|Cisplatin|cisplatin|mesh-list
154094600|NCT00717938|Enoxaparin|enoxaparin|mesh-list
154094601|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
154094602|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094603|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154094604|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154094605|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154094606|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094607|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094608|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
154094609|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154094622|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154094623|NCT04018768|Oxycodone|oxycodone|mesh-list
154094624|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154094625|NCT04018768|Analgesics|analgesics|mesh-ancestor
154094626|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
154094627|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094628|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094629|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
154094630|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154094631|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154094632|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154094633|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154094634|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094635|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094636|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154094637|NCT04018768|Narcotics|narcotics|mesh-ancestor
154094638|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094639|NCT00848848|Vaccines|vaccines|mesh-list
154094640|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
154094641|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094642|NCT02573922|Oxycodone|oxycodone|mesh-list
154094643|NCT02573922|Naloxone|naloxone|mesh-list
154094644|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154094645|NCT02573922|Narcotics|narcotics|mesh-ancestor
154094646|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094647|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094648|NCT02573922|Analgesics|analgesics|mesh-ancestor
154094649|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
154094650|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094651|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154094652|NCT00852436|Pregabalin|pregabalin|mesh-list
154094653|NCT00852436|Analgesics|analgesics|mesh-ancestor
154094654|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
154094655|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094656|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094657|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
154094658|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154094659|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154094660|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094661|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154094662|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154094663|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154094664|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094665|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154094666|NCT00720512|Leucovorin|leucovorin|mesh-list
154094667|NCT00720512|Bevacizumab|bevacizumab|mesh-list
154094668|NCT00720512|Fluorouracil|fluorouracil|mesh-list
154094669|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
154094670|NCT00720512|Irinotecan|irinotecan|mesh-list
154094671|NCT00720512|Calcium|calcium|mesh-list
154094672|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
154094673|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153561038|NCT01650441|Beclomethasone|beclomethasone|mesh-list
154094685|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
154094686|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154094687|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154094688|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094689|NCT00720512|Antidotes|antidotes|mesh-ancestor
154094690|NCT00720512|Protective Agents|protective agents|mesh-ancestor
154094691|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
154094692|NCT00720512|Vitamins|vitamins|mesh-ancestor
154094693|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
154094694|NCT04069286|Amoxicillin|amoxicillin|mesh-list
154094695|NCT04069286|Omeprazole|omeprazole|mesh-list
154094696|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154094697|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094698|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154094699|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154094700|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154094701|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094702|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094703|NCT00713622|Zonisamide|zonisamide|mesh-list
154094704|NCT00713622|Valproic Acid|valproic acid|mesh-list
154094705|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
154094706|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094707|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094708|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
154094709|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094710|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094711|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
154094712|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153730443|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730444|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
153730445|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730446|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730447|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
153730448|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153730449|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730450|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730451|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153730452|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
153730453|NCT00133757|Bupropion|bupropion|mesh-list
153730454|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153730455|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
153730456|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730457|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153730458|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153730459|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730460|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730461|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
153730462|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730463|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730464|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153730465|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154094721|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
154094722|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094723|NCT00720018|Sumatriptan|sumatriptan|mesh-list
154094724|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154094725|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154094726|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154094727|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
154094728|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094729|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094730|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094731|NCT00618826|Paclitaxel|paclitaxel|mesh-list
154094732|NCT00618826|Gemcitabine|gemcitabine|mesh-list
154094733|NCT00618826|Bevacizumab|bevacizumab|mesh-list
154094734|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154094735|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094736|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
154094737|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
154094738|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
154094739|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094740|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154094742|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154094743|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154094744|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154094745|NCT00618826|Growth Substances|growth substances|mesh-ancestor
154094746|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094747|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
154094748|NCT00720174|Doxorubicin|doxorubicin|mesh-list
154094749|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154094750|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154094751|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153802104|NCT06083480|Antidotes|antidotes|mesh-ancestor
153802141|NCT06002490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154094752|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094753|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154094754|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154094755|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094756|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094757|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
154094758|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094759|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154094760|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
154094761|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094762|NCT03834740|Everolimus|everolimus|mesh-list
154094763|NCT03834740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154094764|NCT03834740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154094765|NCT03834740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094766|NCT03834740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094767|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094801|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154094802|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154094803|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
154094804|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094805|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154094806|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154094807|NCT00718406|Metoprolol|metoprolol|mesh-list
154094808|NCT00718406|Morphine|morphine|mesh-list
154094809|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154094842|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094843|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154094844|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094845|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154094846|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
154094847|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154094848|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094850|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154094851|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094874|NCT00849550|Capecitabine|capecitabine|mesh-list
154094875|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
154094877|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154094878|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094879|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154094880|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154094881|NCT00849550|Growth Substances|growth substances|mesh-ancestor
154094882|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094883|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
154094884|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154094885|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
154094886|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094887|NCT00849550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154094888|NCT00849550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154094889|NCT00849550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094890|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094891|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
154094892|NCT03816488|Metformin|metformin|mesh-list
154094893|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154094894|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154094895|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094896|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154094897|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154094898|NCT03816488|Analgesics|analgesics|mesh-ancestor
154094899|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
154094900|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094901|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154094902|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154094903|NCT00858676|Acarbose|acarbose|mesh-list
154094923|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154094924|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
154094926|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
154094927|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
154094928|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094929|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094930|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154094931|NCT00723164|Narcotics|narcotics|mesh-ancestor
154094932|NCT00723164|Analgesics|analgesics|mesh-ancestor
154094933|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
154094934|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094935|NCT00723242|Ribavirin|ribavirin|mesh-list
154094936|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
154094937|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094938|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
154094939|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094940|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
154094941|NCT02545426|Calcium|calcium|mesh-list
154094942|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154094943|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094944|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154094945|NCT00720824|Anesthetics|anesthetics|mesh-list
154094946|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154094947|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
154094948|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094949|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094950|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
154094951|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094952|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
154094953|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154094954|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094955|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094956|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154094957|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153561354|NCT01652118|Clarithromycin|clarithromycin|mesh-list
154094977|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
154094978|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094979|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154094980|NCT00720564|Temozolomide|temozolomide|mesh-list
154094981|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
154094982|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154094983|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
154094984|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094985|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094986|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154094987|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154094988|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154094989|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154094990|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094991|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094992|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094993|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154094994|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
154094995|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154094996|NCT04067024|Anesthetics|anesthetics|mesh-list
154094997|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094998|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095000|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
154095001|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
154095002|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095003|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095004|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095005|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154095006|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154095007|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095008|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154095009|NCT00618748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154095010|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154095030|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154095031|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
154095032|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154095033|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154095034|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154095035|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154095036|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802283|NCT05645900|Vaccines|vaccines|mesh-list
154095038|NCT05659290|Capecitabine|capecitabine|mesh-list
154095039|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154095040|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095041|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154095042|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154095043|NCT05659290|Growth Substances|growth substances|mesh-ancestor
154095044|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095045|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
154095046|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154095047|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
154256646|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256647|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095048|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095049|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
154095051|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095052|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
154095053|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095054|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154095055|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095056|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095057|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154095058|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095059|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154095060|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
154095061|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154095062|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095063|NCT00859534|Afamelanotide|afamelanotide|mesh-list
154095064|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
154095065|NCT02571842|Prednisolone|prednisolone|mesh-list
154095066|NCT02571842|Rituximab|rituximab|mesh-list
154095090|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
154095091|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095092|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095093|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095094|NCT00853216|Oxycodone|oxycodone|mesh-list
154095095|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154095096|NCT00853216|Narcotics|narcotics|mesh-ancestor
154095097|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095098|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095099|NCT00853216|Analgesics|analgesics|mesh-ancestor
154095100|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
154095101|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095102|NCT04961528|Terlipressin|terlipressin|mesh-list
154095103|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
154095104|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154095105|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154095106|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095107|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
154095108|NCT04961528|Coagulants|coagulants|mesh-ancestor
154095109|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154095110|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154095111|NCT00721032|Amiodarone|amiodarone|mesh-list
154095112|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154095113|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
154095114|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154095115|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153561513|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095138|NCT00853294|Narcotics|narcotics|mesh-ancestor
154095139|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095140|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095141|NCT00853294|Analgesics|analgesics|mesh-ancestor
154095142|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
154095143|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095144|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
154095145|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
154095146|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
154095147|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
154095148|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154095149|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
154095150|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
154095151|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095152|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154095153|NCT00717834|Formaldehyde|formaldehyde|mesh-list
154095154|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
154095155|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095156|NCT00658359|Cyclosporine|cyclosporine|mesh-list
154095157|NCT00658359|Cyclosporins|cyclosporins|mesh-list
154095158|NCT00658359|Tofacitinib|tofacitinib|mesh-list
154095159|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095160|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095161|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095162|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
153862849|NCT02900417|Incretins|incretins|mesh-ancestor
154095163|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095164|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
154256648|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
154095165|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561566|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
154095187|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095188|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154095189|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154095190|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
154095193|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154095194|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
154095195|NCT00724022|Prednisolone|prednisolone|mesh-list
154095196|NCT00724022|Tacrolimus|tacrolimus|mesh-list
154095197|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
154095198|NCT00724022|Basiliximab|basiliximab|mesh-list
154095199|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095200|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
154095201|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095202|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154095203|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095204|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095205|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095206|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
154095207|NCT00724022|Hormones|hormones|mesh-ancestor
154095208|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095209|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095210|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095211|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154095212|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154095213|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
154095214|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154095215|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095216|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
154095217|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154095218|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095219|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154095246|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154095247|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
154095248|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095249|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095250|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154095251|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154095252|NCT00853684|Growth Substances|growth substances|mesh-ancestor
154095253|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095254|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
154095256|NCT00723060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154095257|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154095258|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154095259|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095260|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095261|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
154095262|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095263|NCT02571816|Gilteritinib|gilteritinib|mesh-list
154095264|NCT02571816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154095266|NCT02571816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561670|NCT01653457|Memantine|memantine|mesh-list
154095289|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095290|NCT02546050|Metformin|metformin|mesh-list
154095291|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154095292|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095293|NCT04800224|Propolis|propolis|mesh-list
154095294|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095295|NCT00718146|Vaccines|vaccines|mesh-list
154095296|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
154095297|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095298|NCT00860626|Interferons|interferons|mesh-list
154095299|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095300|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
154095301|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095302|NCT00724256|Ceftibuten|ceftibuten|mesh-list
154095303|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154095304|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095305|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154095306|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095307|NCT01005914|Cytarabine|cytarabine|mesh-list
154095308|NCT01005914|Dexamethasone|dexamethasone|mesh-list
154095309|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
154095310|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154095311|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154095312|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
154095313|NCT01005914|Doxorubicin|doxorubicin|mesh-list
154095314|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154095315|NCT01005914|Methotrexate|methotrexate|mesh-list
154095316|NCT01005914|Vincristine|vincristine|mesh-list
154095317|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
154095318|NCT01005914|Asparaginase|asparaginase|mesh-list
154095319|NCT01005914|Pegaspargase|pegaspargase|mesh-list
154095320|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095321|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
154095322|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095323|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095357|NCT01005914|Protective Agents|protective agents|mesh-ancestor
154095358|NCT01005914|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154095359|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154095360|NCT00854230|Naltrexone|naltrexone|mesh-list
153561775|NCT01654185|Exemestane|exemestane|mesh-list
154095375|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154095376|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154095377|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154095378|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095379|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095380|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154095381|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154095382|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154095383|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
154095384|NCT00721916|Leucovorin|leucovorin|mesh-list
154095385|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
154095386|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095387|NCT00721916|Antidotes|antidotes|mesh-ancestor
154095388|NCT00721916|Protective Agents|protective agents|mesh-ancestor
154095389|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095390|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
154095391|NCT00721916|Vitamins|vitamins|mesh-ancestor
154095392|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
154095393|NCT00861250|Dexamethasone|dexamethasone|mesh-list
154095394|NCT00861250|Bortezomib|bortezomib|mesh-list
154095395|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095396|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
154095397|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
154095398|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095399|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095400|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095401|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
154095402|NCT00861250|Hormones|hormones|mesh-ancestor
154095403|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095404|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095405|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095406|NCT00722150|Artesunate|artesunate|mesh-list
154095407|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
154095408|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154095409|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154095410|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095411|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095412|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
154095413|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
154095414|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154095415|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
154095416|NCT00861094|Leucovorin|leucovorin|mesh-list
154095417|NCT00861094|Folic Acid|folic acid|mesh-list
154095418|NCT00861094|Fluorouracil|fluorouracil|mesh-list
154095419|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
154095421|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095422|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
154191146|NCT05947851|Immunologic Factors|immunologic factors|mesh-ancestor
154095423|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095424|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154095446|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154095447|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
154095448|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095449|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095450|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154095451|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
154095452|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
154095453|NCT04019106|Hormones|hormones|mesh-ancestor
154095454|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095455|NCT02571608|Metformin|metformin|mesh-list
154095456|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154095457|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095458|NCT00865072|Metformin|metformin|mesh-list
154095459|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154095460|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095461|NCT00804297|Octreotide|octreotide|mesh-list
154095462|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095463|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095464|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095465|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
154095466|NCT00861328|Irinotecan|irinotecan|mesh-list
154095467|NCT00861328|Camptothecin|camptothecin|mesh-list
154095468|NCT00861328|ON 01910|on 01910|mesh-list
154095469|NCT00861328|Glycine|glycine|mesh-list
154095470|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095471|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154095472|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154095473|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095474|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095475|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154095476|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154095477|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
154095478|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095479|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095480|NCT00861406|Interferons|interferons|mesh-list
154095481|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
154095482|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
154095497|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095498|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095499|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154095500|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154095501|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095502|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154095503|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154095504|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154095505|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
154095506|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154095507|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154095508|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
154095509|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154095510|NCT00724724|Aspirin|aspirin|mesh-list
154095511|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154095512|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154095513|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154095514|NCT00724724|Analgesics|analgesics|mesh-ancestor
154095515|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
154095516|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095517|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095518|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095519|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095520|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154095521|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154095522|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095523|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154095524|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154095525|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095526|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
154095527|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154095528|NCT00724724|Protective Agents|protective agents|mesh-ancestor
154095529|NCT00865462|Bupropion|bupropion|mesh-list
154095530|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154095531|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
154095532|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154095533|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154095534|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154095535|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154095536|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095537|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
154095538|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095539|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095540|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154095541|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154095542|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664365|NCT00012506|Etanercept|etanercept|mesh-list
154095564|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154095566|NCT00865540|Ketorolac|ketorolac|mesh-list
154095567|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154095568|NCT00865540|Nepafenac|nepafenac|mesh-list
153802737|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
154095569|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154095570|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
154095571|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095572|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
154095573|NCT00865540|Hormones|hormones|mesh-ancestor
154095574|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095575|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095576|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095577|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095578|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
154095579|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
154095580|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095581|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095582|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154095583|NCT00865540|Protective Agents|protective agents|mesh-ancestor
154095584|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154095585|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154095586|NCT00865540|Analgesics|analgesics|mesh-ancestor
154095587|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
154095588|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095589|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154095590|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095591|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095592|NCT00865618|Eplerenone|eplerenone|mesh-list
154095593|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154095594|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
154095595|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095596|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561998|NCT01655316|Verapamil|verapamil|mesh-list
154095618|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154095619|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095620|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154095621|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154095622|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154095623|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
154095624|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154095625|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154095626|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
154095627|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154095628|NCT00724802|Triacetin|triacetin|mesh-list
154095629|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
154095630|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095631|NCT02545114|Tolvaptan|tolvaptan|mesh-list
154095632|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154095633|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095634|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
154095635|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095636|NCT00724880|Clopidogrel|clopidogrel|mesh-list
154095637|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154095638|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154095639|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154095640|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154095641|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
154095642|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095643|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095644|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095645|NCT00724074|Bupivacaine|bupivacaine|mesh-list
154095646|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
154095647|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
153562034|NCT01655641|Coagulants|coagulants|mesh-ancestor
154095684|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
154095685|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
154095686|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095687|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
153562089|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
154095719|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095721|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154256649|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154095722|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095723|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154095725|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095726|NCT00724620|Ribavirin|ribavirin|mesh-list
154095727|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154095728|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
154095729|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095761|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
154095762|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095763|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095764|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154095765|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
154095766|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095767|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095768|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154095769|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154095771|NCT00861874|Decitabine|decitabine|mesh-list
154095772|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154095773|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
154095790|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154095791|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154095792|NCT04067856|Growth Substances|growth substances|mesh-ancestor
154095793|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095794|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
154095796|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
154095797|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
154095798|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095799|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095800|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
154095801|NCT04067856|Hormones|hormones|mesh-ancestor
154095802|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095803|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095804|NCT04042714|Trifluridine|trifluridine|mesh-list
154095805|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
154095806|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095807|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
154095808|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095809|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154095810|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095811|NCT00725348|R 115866|r 115866|mesh-list
154095812|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154095813|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095814|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095815|NCT00577772|Rifaximin|rifaximin|mesh-list
154095816|NCT00577772|Lactulose|lactulose|mesh-list
154095817|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154095818|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095819|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095820|NCT00578136|Bupivacaine|bupivacaine|mesh-list
154095821|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
154095822|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
154095823|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095824|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095825|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
154095826|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095827|NCT00861952|Mineral Oil|mineral oil|mesh-list
154095828|NCT00861952|Emollients|emollients|mesh-ancestor
154095829|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
154095830|NCT00655551|Lacosamide|lacosamide|mesh-list
154095831|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
154095832|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154095833|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153562220|NCT01656122|Abacavir|abacavir|mesh-list
154095854|NCT00725426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154095855|NCT00725426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095856|NCT00725426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095857|NCT02553603|Hormones|hormones|mesh-list
154095858|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154095859|NCT02553603|Tesamorelin|tesamorelin|mesh-list
154191147|NCT05947851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095860|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095861|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095862|NCT02553603|Growth Substances|growth substances|mesh-ancestor
153419102|NCT05593939|Niacinamide|niacinamide|mesh-list
154095863|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154095864|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
154095865|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154095866|NCT00804531|Prednisolone|prednisolone|mesh-list
154095867|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
154095868|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154095870|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095871|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
154095872|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
154095873|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095874|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095875|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095876|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
154095877|NCT00804531|Hormones|hormones|mesh-ancestor
154095878|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095879|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154095880|NCT00804531|Protective Agents|protective agents|mesh-ancestor
154095881|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095882|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095883|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
154095884|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154095885|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
154095886|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095887|NCT00866866|Expectorants|expectorants|mesh-ancestor
154095902|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
154095903|NCT00804921|Bevacizumab|bevacizumab|mesh-list
154095904|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154095905|NCT00804921|Acetazolamide|acetazolamide|mesh-list
154095906|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154095907|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095908|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154095909|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154095910|NCT00804921|Growth Substances|growth substances|mesh-ancestor
154095911|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095912|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
154095913|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154095914|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154095915|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154095916|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154095917|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
154095918|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095919|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095920|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
154095921|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154095922|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095923|NCT00804921|Diuretics|diuretics|mesh-ancestor
154095924|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
154095925|NCT00866944|Leucovorin|leucovorin|mesh-list
154095926|NCT00866944|Fluorouracil|fluorouracil|mesh-list
154095927|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
154095928|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154095929|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
154095930|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095931|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154095932|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095933|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095934|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
154095935|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095936|NCT00866944|Antidotes|antidotes|mesh-ancestor
154095937|NCT00866944|Protective Agents|protective agents|mesh-ancestor
154095938|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
154095939|NCT00866944|Vitamins|vitamins|mesh-ancestor
154095940|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
154095941|NCT00577824|Exenatide|exenatide|mesh-list
154095942|NCT00577824|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154095943|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154095944|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095945|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154095946|NCT00577824|Incretins|incretins|mesh-ancestor
154095947|NCT00577824|Hormones|hormones|mesh-ancestor
153562325|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095979|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
154095980|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095981|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
154095982|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154095983|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
154095984|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154095985|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095986|NCT00730418|Doxazosin|doxazosin|mesh-list
154095987|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154095988|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154095989|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154095990|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154095991|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154096021|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154096022|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096024|NCT00798915|Hormones|hormones|mesh-ancestor
154096025|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154096026|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096027|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
154096028|NCT00798993|Vitamin D|vitamin d|mesh-list
154096029|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154096030|NCT00798993|Calcifediol|calcifediol|mesh-list
154096031|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154096032|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096033|NCT00798993|Vitamins|vitamins|mesh-ancestor
154096034|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
154096035|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154096036|NCT00862108|Methylphenidate|methylphenidate|mesh-list
153562427|NCT01657487|Fluticasone|fluticasone|mesh-list
154096059|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096061|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
154096062|NCT00862264|Hormones|hormones|mesh-ancestor
154096063|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154096064|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
154096065|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154096066|NCT00730574|Vitamins|vitamins|mesh-list
154096067|NCT00730574|Folic Acid|folic acid|mesh-list
154096068|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
154096069|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
154096070|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
154096071|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
154096072|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096073|NCT00730574|Hematinics|hematinics|mesh-ancestor
154096074|NCT00870532|Sorafenib|sorafenib|mesh-list
154096075|NCT00870532|Vinorelbine|vinorelbine|mesh-list
154096076|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096077|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096078|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096079|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096080|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154096081|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
154096082|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
154096083|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
154096084|NCT00725478|Piribedil|piribedil|mesh-list
154096085|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154096086|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154096087|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
154096119|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
154096120|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096121|NCT00617344|Vaccines|vaccines|mesh-list
154096122|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
154096123|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096124|NCT00862342|Bevacizumab|bevacizumab|mesh-list
154096125|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153562544|NCT01657929|Antacids|antacids|mesh-ancestor
154096161|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562556|NCT01657513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154096182|NCT00725790|Urological Agents|urological agents|mesh-ancestor
154096183|NCT00731276|Irinotecan|irinotecan|mesh-list
154096184|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154096185|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154096186|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096187|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096188|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096189|NCT00725946|Iodine|iodine|mesh-list
154096190|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
154096191|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154096192|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096193|NCT00725946|Trace Elements|trace elements|mesh-ancestor
154096194|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
154096195|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096196|NCT02569346|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
154096197|NCT02569346|Lamivudine|lamivudine|mesh-list
154096198|NCT02569346|Abacavir|abacavir|mesh-list
154096199|NCT02569346|Dolutegravir|dolutegravir|mesh-list
154096200|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154096201|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154096202|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
154096203|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096204|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154096205|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154096206|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096207|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096208|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154096209|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154096210|NCT00726804|Adalimumab|adalimumab|mesh-list
154096211|NCT00726804|Etanercept|etanercept|mesh-list
154096212|NCT00726804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154096248|NCT00726258|Analgesics|analgesics|mesh-ancestor
154096249|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
154096250|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096251|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096252|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153562650|NCT01658358|Doxorubicin|doxorubicin|mesh-list
154096285|NCT00726726|Vitamin K|vitamin k|mesh-list
154096286|NCT00726726|Midazolam|midazolam|mesh-list
154096287|NCT00726726|Levomethorphan|levomethorphan|mesh-list
154096288|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
154096289|NCT00726726|Caffeine|caffeine|mesh-list
154096290|NCT00726726|Omeprazole|omeprazole|mesh-list
154096291|NCT00726726|Warfarin|warfarin|mesh-list
154096292|NCT00726726|BMS 708163|bms 708163|mesh-list
154096293|NCT00726726|Vitamins|vitamins|mesh-ancestor
154096294|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
154096295|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096324|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
154096325|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154096326|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154096327|NCT00726726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154096328|NCT00726726|Narcotics|narcotics|mesh-ancestor
154096329|NCT00726726|Analgesics|analgesics|mesh-ancestor
154096330|NCT00726726|Sensory System Agents|sensory system agents|mesh-ancestor
154096331|NCT00726726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096332|NCT00726726|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154096333|NCT00654381|Inositol|inositol|mesh-list
154096334|NCT00654381|Linagliptin|linagliptin|mesh-list
154096335|NCT00654381|Voglibose|voglibose|mesh-list
154096336|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154096337|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096338|NCT00654381|Incretins|incretins|mesh-ancestor
154096339|NCT00654381|Hormones|hormones|mesh-ancestor
154096340|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154096341|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154096342|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
154096343|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096379|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154096380|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154096381|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154096382|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562772|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
154096415|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096416|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
154096417|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
154096418|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096419|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096451|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096453|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154096454|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
153803244|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
154096455|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096456|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096457|NCT00799071|Posaconazole|posaconazole|mesh-list
154096458|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
153562850|NCT01659437|Clarithromycin|clarithromycin|mesh-list
154096494|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154096529|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096530|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096532|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
154096533|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154096561|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256650|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
154096563|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154096564|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154096565|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154096566|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154096567|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
154096568|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096569|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096570|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096571|NCT00733148|Insulin|insulin|mesh-list
154096572|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154096573|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096574|NCT00730392|Etanercept|etanercept|mesh-list
154096575|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154096576|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154096577|NCT00730392|Analgesics|analgesics|mesh-ancestor
154096578|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
154096579|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096580|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096581|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096617|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096618|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154096619|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154096620|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
154096621|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
154096657|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096659|NCT02569554|Rabeprazole|rabeprazole|mesh-list
153563045|NCT01660620|Betaxolol|betaxolol|mesh-list
154096698|NCT00728832|Analgesics|analgesics|mesh-ancestor
154096731|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
154096732|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096733|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154096734|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154096735|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
154096736|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096737|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154096738|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154096774|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154096775|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
154096776|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
154096811|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
154096812|NCT00731016|Pravastatin|pravastatin|mesh-list
154096813|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154096814|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096815|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154096816|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154096817|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
154096818|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096819|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154096852|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096853|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096854|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
154096855|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154096856|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096857|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154096858|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154096859|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096860|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096861|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563236|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
154096896|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
154096897|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154096898|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154096899|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154096900|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154096901|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
154096933|NCT00653523|Simvastatin|simvastatin|mesh-list
154096935|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154096936|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154096937|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
154096938|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096939|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154096940|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154096942|NCT00808977|Mesalamine|mesalamine|mesh-list
154096943|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154096944|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154097010|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097011|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097012|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
154097013|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154097014|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154097015|NCT02569320|Growth Substances|growth substances|mesh-ancestor
154097016|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
154097017|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
154097019|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154097020|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097021|NCT00869908|Insulin|insulin|mesh-list
154097022|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154097023|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
154097024|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
154097045|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097046|NCT00870142|Amlodipine|amlodipine|mesh-list
154097047|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154097048|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154097049|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154097050|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097051|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154097052|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097053|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
154097054|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154097055|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154097056|NCT00870220|Estradiol|estradiol|mesh-list
154097057|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154097058|NCT00870220|Estrogens|estrogens|mesh-ancestor
154097060|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097061|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097062|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154097063|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
154097064|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154097065|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154097066|NCT00729768|Cyclosporine|cyclosporine|mesh-list
153803506|NCT00290030|Alfuzosin|alfuzosin|mesh-list
154097067|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
154097068|NCT00729768|Cyclosporins|cyclosporins|mesh-list
154097069|NCT00729768|Basiliximab|basiliximab|mesh-list
154097070|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097071|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097072|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097073|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
154097074|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097075|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
154097076|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097105|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
154097106|NCT00734448|Vitamins|vitamins|mesh-ancestor
154097107|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
154097108|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097109|NCT00734526|Temozolomide|temozolomide|mesh-list
154097110|NCT00734526|Sorafenib|sorafenib|mesh-list
154097111|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154097112|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
154097113|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097114|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097115|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154097116|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097117|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154097118|NCT00729404|Gestodene|gestodene|mesh-list
154097119|NCT00729404|Femovan|femovan|mesh-list
154097120|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154097121|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154097122|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154097123|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
154097124|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154097125|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097126|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154097193|NCT06146842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097195|NCT06146842|Sensory System Agents|sensory system agents|mesh-ancestor
154256651|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097196|NCT06146842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097197|NCT06146751|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154097198|NCT06146751|Hematinics|hematinics|mesh-ancestor
154097199|NCT06146751|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154097200|NCT06146751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154097201|NCT06146478|Thalidomide|thalidomide|mesh-list
154097202|NCT06146478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097203|NCT06146478|Immunologic Factors|immunologic factors|mesh-ancestor
154097204|NCT06146478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097205|NCT06146478|Leprostatic Agents|leprostatic agents|mesh-ancestor
154097235|NCT06145958|Hormones|hormones|mesh-list
154097236|NCT06145958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097237|NCT06145958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097238|NCT06145633|Deoxyglucose|deoxyglucose|mesh-list
154097239|NCT06145633|Vorinostat|vorinostat|mesh-list
154097240|NCT06145633|Edetic Acid|edetic acid|mesh-list
154097241|NCT06145633|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154097242|NCT06145633|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154097243|NCT06145633|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154097244|NCT06145633|Pluvicto|pluvicto|mesh-list
153803632|NCT00324129|Mocetinostat|mocetinostat|mesh-list
153803634|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097245|NCT06145633|Chelating Agents|chelating agents|mesh-ancestor
154097246|NCT06145633|Sequestering Agents|sequestering agents|mesh-ancestor
154097247|NCT06145633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097248|NCT06145633|Anticoagulants|anticoagulants|mesh-ancestor
154097249|NCT06145633|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154097284|NCT06145438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154097285|NCT06145438|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154097286|NCT06145438|Hormone Antagonists|hormone antagonists|mesh-ancestor
154097318|NCT06145269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097319|NCT06145217|Dasatinib|dasatinib|mesh-list
154097320|NCT06145217|Omeprazole|omeprazole|mesh-list
154097321|NCT06145217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154097322|NCT06145217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154097323|NCT06145217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154097324|NCT06145217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097325|NCT06145217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097326|NCT06145217|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154097327|NCT06145217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154097328|NCT06145217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097329|NCT06145165|Bupivacaine|bupivacaine|mesh-list
154097330|NCT06145165|Ropivacaine|ropivacaine|mesh-list
154097331|NCT06145165|Anesthetics, Local|anesthetics, local|mesh-ancestor
154097332|NCT06145165|Anesthetics|anesthetics|mesh-ancestor
154097333|NCT06145165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563708|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
154097362|NCT06116409|Anesthetics, Local|anesthetics, local|mesh-ancestor
154097363|NCT06116409|Anesthetics|anesthetics|mesh-ancestor
154097364|NCT06116409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097365|NCT06116409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097366|NCT06116409|Sensory System Agents|sensory system agents|mesh-ancestor
154097367|NCT06116409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097368|NCT06102057|Immunomodulating Agents|immunomodulating agents|mesh-list
154097369|NCT06102057|Immunologic Factors|immunologic factors|mesh-ancestor
154097370|NCT06102057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097372|NCT06091904|Remifentanil|remifentanil|mesh-list
154097373|NCT06091904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154097374|NCT06091904|Narcotics|narcotics|mesh-ancestor
154097375|NCT06091904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097376|NCT06091904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097377|NCT06091904|Analgesics|analgesics|mesh-ancestor
154097378|NCT06091904|Sensory System Agents|sensory system agents|mesh-ancestor
154097379|NCT06091904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097412|NCT06017284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097413|NCT06017284|Tubulin Modulators|tubulin modulators|mesh-ancestor
154097414|NCT06017284|Antimitotic Agents|antimitotic agents|mesh-ancestor
154097415|NCT06017284|Mitosis Modulators|mitosis modulators|mesh-ancestor
154097416|NCT06017284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191148|NCT05947851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097417|NCT06017284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154097418|NCT06017284|Antimetabolites|antimetabolites|mesh-ancestor
154097419|NCT06017284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097420|NCT06017284|Immunologic Factors|immunologic factors|mesh-ancestor
154097421|NCT06017284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097422|NCT06017284|Leprostatic Agents|leprostatic agents|mesh-ancestor
153666205|NCT05576324|Ivacaftor|ivacaftor|mesh-list
154097445|NCT05977673|Tislelizumab|tislelizumab|mesh-list
154097446|NCT05977673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097447|NCT05977673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097448|NCT05977465|Empagliflozin|empagliflozin|mesh-list
154097449|NCT05977465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154097450|NCT05977465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097451|NCT05977465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097452|NCT05977465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097453|NCT05975554|Interleukin-2|interleukin-2|mesh-list
154097454|NCT05975554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097455|NCT05975554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154097456|NCT05975554|Analgesics|analgesics|mesh-ancestor
154097457|NCT05975554|Sensory System Agents|sensory system agents|mesh-ancestor
154097458|NCT05975554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097459|NCT05975554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097463|NCT05965167|Teriparatide|teriparatide|mesh-list
154097464|NCT05965167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154097465|NCT05965167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097466|NCT05965167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154097467|NCT05950646|Dexmedetomidine|dexmedetomidine|mesh-list
154097468|NCT05950646|Esketamine|esketamine|mesh-list
154097469|NCT05950646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154097470|NCT05950646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097471|NCT05950646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097472|NCT05950646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154097473|NCT05950646|Analgesics|analgesics|mesh-ancestor
154097474|NCT05950646|Sensory System Agents|sensory system agents|mesh-ancestor
154097475|NCT05950646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097510|NCT05866354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097511|NCT05866354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097513|NCT05865457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154097514|NCT05865379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154097515|NCT05865379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154097516|NCT05863442|Eculizumab|eculizumab|mesh-list
154097517|NCT05863442|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154097518|NCT05863442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153563896|NCT01666600|Nintedanib|nintedanib|mesh-list
154097547|NCT05788458|Anesthetics|anesthetics|mesh-ancestor
154097548|NCT05788458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097549|NCT05788458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097550|NCT05788458|Sensory System Agents|sensory system agents|mesh-ancestor
154097551|NCT05788458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097552|NCT05756569|Pembrolizumab|pembrolizumab|mesh-list
154097553|NCT05756569|Immunoconjugates|immunoconjugates|mesh-list
154097554|NCT05756569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097555|NCT05756569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097556|NCT05756569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154097557|NCT05756569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097558|NCT05756569|Immunologic Factors|immunologic factors|mesh-ancestor
154097559|NCT05756569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097560|NCT05732883|Dexamethasone|dexamethasone|mesh-list
154097561|NCT05732883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154097562|NCT05732883|Antiemetics|antiemetics|mesh-ancestor
154097563|NCT05732883|Autonomic Agents|autonomic agents|mesh-ancestor
154097564|NCT05732883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097565|NCT05732883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097597|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154097598|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154097599|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
154097600|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097601|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097602|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154097603|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154097604|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154097605|NCT05700721|Niraparib|niraparib|mesh-list
154097606|NCT05700721|Dostarlimab|dostarlimab|mesh-list
154097607|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154097626|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097627|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
154097628|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097629|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097630|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154097632|NCT05683171|Growth Substances|growth substances|mesh-ancestor
154097633|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
154097634|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
154097635|NCT05675579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154097636|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097637|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097638|NCT05675579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154097639|NCT05675579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097640|NCT05675579|Immunoconjugates|immunoconjugates|mesh-ancestor
154097641|NCT05675579|Immunologic Factors|immunologic factors|mesh-ancestor
154097642|NCT05675579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097643|NCT05650008|Anesthetics|anesthetics|mesh-list
154097644|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097645|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097646|NCT05646719|Phentolamine|phentolamine|mesh-list
154097647|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154097648|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154097649|NCT05646719|Pilocarpine|pilocarpine|mesh-list
154097650|NCT05646719|Miotics|miotics|mesh-ancestor
154097651|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
154097652|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097653|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097654|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154097655|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154097656|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
154097657|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097658|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097659|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154097660|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154097661|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
154097662|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154097664|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097665|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097692|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097693|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154097695|NCT05538702|Menthol|menthol|mesh-list
154097696|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
154097697|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
154097698|NCT05498155|Durvalumab|durvalumab|mesh-list
154097699|NCT05498155|Olaparib|olaparib|mesh-list
154097700|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097701|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097702|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154097703|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097704|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097705|NCT05468372|Amphotericin B|amphotericin b|mesh-list
154097706|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154097707|NCT05468372|Posaconazole|posaconazole|mesh-list
154097708|NCT05468372|Amebicides|amebicides|mesh-ancestor
154097709|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154097710|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154097711|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097712|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153350426|NCT05901441|Ropivacaine|ropivacaine|mesh-list
154097713|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
154097714|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153564084|NCT01668043|UB-421|ub-421|mesh-list
154097749|NCT05400603|Dinutuximab|dinutuximab|mesh-list
154097750|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154097751|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154097752|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097753|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097772|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097774|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154097775|NCT05347199|Amisulpride|amisulpride|mesh-list
154097776|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154097777|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154097778|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097779|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097780|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154097781|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154097782|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
154097783|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097784|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256652|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
154097785|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154097786|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
154097787|NCT05346588|Propofol|propofol|mesh-list
154097788|NCT05346588|Anesthetics|anesthetics|mesh-list
154097789|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154097790|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097791|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097792|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154097793|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
154097794|NCT05340374|Pluvicto|pluvicto|mesh-list
154097795|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154097796|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097797|NCT05335356|Ustekinumab|ustekinumab|mesh-list
154097798|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
154097799|NCT05292404|Alirocumab|alirocumab|mesh-list
154097800|NCT05292404|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154097801|NCT05292404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154097802|NCT05292404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154097803|NCT05292404|Antimetabolites|antimetabolites|mesh-ancestor
154097804|NCT05292404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097805|NCT05292404|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154097806|NCT05292404|Protease Inhibitors|protease inhibitors|mesh-ancestor
154097807|NCT05292404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191149|NCT05945615|Phenylephrine|phenylephrine|mesh-list
154097832|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097834|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
154097835|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097836|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154097837|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154097838|NCT05222555|Growth Substances|growth substances|mesh-ancestor
154097839|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
154097840|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097841|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
154097842|NCT05202080|Narcotics|narcotics|mesh-ancestor
154097843|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097844|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097845|NCT05202080|Analgesics|analgesics|mesh-ancestor
154097846|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
154097847|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097848|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154097849|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
154097850|NCT05199324|Cefazolin|cefazolin|mesh-list
154097851|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
154097852|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154097853|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
154097854|NCT05199324|Trimethoprim|trimethoprim|mesh-list
154097855|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
154097856|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097857|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154097858|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154097859|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421131|NCT06286059|Phentolamine|phentolamine|mesh-list
154097883|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154097884|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097885|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154097886|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154097887|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154097889|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097890|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097891|NCT05131919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154097892|NCT05131919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097893|NCT05115838|Islatravir|islatravir|mesh-list
154097894|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
154097895|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097896|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097897|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097898|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154097899|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154097900|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154097901|NCT05083754|Temozolomide|temozolomide|mesh-list
154097902|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154097903|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
154097904|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256653|NCT01267214|Protective Agents|protective agents|mesh-ancestor
154256654|NCT01156922|Rituximab|rituximab|mesh-list
154097905|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097938|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097939|NCT05030441|Ivosidenib|ivosidenib|mesh-list
154097940|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097941|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097942|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097943|NCT05009992|TIC10 compound|tic10 compound|mesh-list
154097944|NCT05009992|Dopamine|dopamine|mesh-list
154097945|NCT05009992|GDC-0084|gdc-0084|mesh-list
154097946|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154097947|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
154097948|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
154097949|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097950|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097984|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154097985|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
154097986|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097987|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097988|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154097989|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154097990|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154097991|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154097992|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097993|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154097994|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
154097995|NCT04978584|Hormones|hormones|mesh-ancestor
154097996|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098030|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098032|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
154098033|NCT04941716|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154098034|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191150|NCT05945615|Oxymetazoline|oxymetazoline|mesh-list
154098035|NCT04941716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098036|NCT04941716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098037|NCT04941716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098040|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
154098062|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098063|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098064|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098065|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098066|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098067|NCT04852068|Vaccines|vaccines|mesh-list
154098068|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
154098069|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098070|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
154098071|NCT04822064|Ketamine|ketamine|mesh-list
154098072|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
154098073|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154098074|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098075|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098076|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154098077|NCT04822064|Analgesics|analgesics|mesh-ancestor
154098078|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
154098079|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098080|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154098081|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154098082|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154098083|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
154098084|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098085|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098086|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154098087|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154098088|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
154098089|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
154098090|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154098091|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154098092|NCT04821843|Paclitaxel|paclitaxel|mesh-list
154098093|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
154098120|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
154098121|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
154098122|NCT04738695|Antibodies|antibodies|mesh-list
154098123|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
154256655|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098124|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098126|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154098127|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
153403643|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
154098128|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154098129|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154098130|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098131|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098132|NCT04728932|Protective Agents|protective agents|mesh-ancestor
154098133|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098134|NCT04712643|Atezolizumab|atezolizumab|mesh-list
154098135|NCT04712643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154098136|NCT04712643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098137|NCT04712643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098138|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098139|NCT04710641|Sorafenib|sorafenib|mesh-list
154098140|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098141|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153564505|NCT01676987|Budesonide|budesonide|mesh-list
154098175|NCT04667663|Hormones|hormones|mesh-ancestor
154098176|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098177|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098178|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153804116|NCT00304785|Latanoprost|latanoprost|mesh-list
154098179|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153564548|NCT01677650|Methadone|methadone|mesh-list
154098210|NCT04564339|Ravulizumab|ravulizumab|mesh-list
154098211|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154098212|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154098213|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
154098214|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098215|NCT04552288|Benralizumab|benralizumab|mesh-list
154098216|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154098217|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154098218|NCT04551963|Clarithromycin|clarithromycin|mesh-list
154098219|NCT04551963|Fluconazole|fluconazole|mesh-list
154098220|NCT04551963|Voriconazole|voriconazole|mesh-list
154098221|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
154098222|NCT04551963|Diltiazem|diltiazem|mesh-list
154098223|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154098224|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098225|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154098243|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154098244|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154098245|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
154098246|NCT04527107|Aflibercept|aflibercept|mesh-list
154098247|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154098248|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154098249|NCT04527107|Growth Substances|growth substances|mesh-ancestor
154098250|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098251|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
154098252|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098253|NCT04502381|Amphotericin B|amphotericin b|mesh-list
154098254|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154098255|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
154098256|NCT04502381|Amebicides|amebicides|mesh-ancestor
154098257|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154098258|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153804128|NCT00293228|Isoniazid|isoniazid|mesh-list
154098259|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098260|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154098261|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
154098262|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154098263|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098264|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154098265|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098267|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098268|NCT04356638|Midazolam|midazolam|mesh-list
154098269|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
154098270|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154098271|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098272|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098273|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154098274|NCT04356638|Analgesics|analgesics|mesh-ancestor
154098275|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
154098276|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098277|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154098278|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154098279|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154098328|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154098329|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154098330|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154098331|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098332|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098334|NCT04307511|Ticagrelor|ticagrelor|mesh-list
154098335|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154098336|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154098337|NCT04307511|Analgesics|analgesics|mesh-ancestor
154098338|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
154098339|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098340|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098341|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098342|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098343|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154098344|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154098345|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098346|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154098347|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154098348|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098349|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
154098350|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154098351|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154098352|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154098353|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
154098354|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098355|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
154098356|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098357|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098358|NCT04301011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403661|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
154098359|NCT04301011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098360|NCT04227483|Prednisolone|prednisolone|mesh-list
154098361|NCT04227483|Deflazacort|deflazacort|mesh-list
154098362|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098363|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
154098364|NCT04227483|Hormones|hormones|mesh-ancestor
154098365|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098366|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098367|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098368|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098369|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154098370|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
154098371|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
154098372|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098373|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098374|NCT04219254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154098375|NCT04219254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098386|NCT04195633|Cyclosporine|cyclosporine|mesh-list
154098387|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
154098388|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
154098389|NCT04195633|Treosulfan|treosulfan|mesh-list
154098390|NCT04195633|Busulfan|busulfan|mesh-list
154098391|NCT04195633|Fludarabine|fludarabine|mesh-list
154098392|NCT04195633|Cyclosporins|cyclosporins|mesh-list
154098393|NCT04195633|Lenograstim|lenograstim|mesh-list
154098394|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154098429|NCT04120636|Celecoxib|celecoxib|mesh-list
154098430|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154098431|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154098432|NCT04120636|Analgesics|analgesics|mesh-ancestor
154098433|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
154098434|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098435|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098436|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098437|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098468|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
154098469|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098470|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154098471|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154098472|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098473|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098474|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154098475|NCT04116528|Narcotics|narcotics|mesh-ancestor
154098476|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154098477|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
154098478|NCT04103476|Estrogens|estrogens|mesh-list
154098479|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154098480|NCT04103476|Hormones|hormones|mesh-ancestor
154098481|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098519|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
154098520|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191151|NCT05945615|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154098521|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098522|NCT03958721|Capecitabine|capecitabine|mesh-list
154098556|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098558|NCT03900377|Rituximab|rituximab|mesh-list
154098559|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098560|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098561|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
154098562|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098563|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098564|NCT03824327|Papaverine|papaverine|mesh-list
154098594|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
154098595|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098596|NCT03693872|Dopamine|dopamine|mesh-list
154098597|NCT03693872|Apomorphine|apomorphine|mesh-list
154098598|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
154098599|NCT03693872|Emetics|emetics|mesh-ancestor
154098600|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098601|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
154098602|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098603|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098604|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
154098605|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098606|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098607|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154098608|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
153564918|NCT04797832|Hematinics|hematinics|mesh-ancestor
154098650|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154098651|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154098693|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
154098694|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154098695|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154098696|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
154098697|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098734|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
154098735|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098736|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782795|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
154098771|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098772|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
154098773|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098774|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098809|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098811|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154098812|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
154098813|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154098814|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
154098847|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098848|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098849|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154098850|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154098851|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098852|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154098853|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154098854|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098855|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
154098856|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154098857|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154098893|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154098894|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098895|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154098927|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345776|NCT00005596|Hormones|hormones|mesh-ancestor
154098928|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098931|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
154098932|NCT02903680|BB 1101|bb 1101|mesh-list
154098933|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098934|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
154098935|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
154098936|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098937|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098972|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098973|NCT02607722|Nintedanib|nintedanib|mesh-list
154098974|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098975|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098976|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098977|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098978|NCT02567253|Cisplatin|cisplatin|mesh-list
154098979|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098980|NCT02564068|Oxytocin|oxytocin|mesh-list
153565220|NCT02257970|Ketoprofen|ketoprofen|mesh-list
154099015|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
154099016|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
154099017|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
154099018|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
154099019|NCT02419495|Leucovorin|leucovorin|mesh-list
154099020|NCT02419495|Folic Acid|folic acid|mesh-list
154099021|NCT02419495|Paclitaxel|paclitaxel|mesh-list
154099022|NCT02419495|Camptothecin|camptothecin|mesh-list
154099023|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
154099024|NCT02419495|Carboplatin|carboplatin|mesh-list
154099025|NCT02419495|Doxorubicin|doxorubicin|mesh-list
154099026|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154191152|NCT05945615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154099061|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154099062|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154099063|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
154099064|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154099065|NCT02419495|Antidotes|antidotes|mesh-ancestor
154099066|NCT02419495|Protective Agents|protective agents|mesh-ancestor
154099067|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
154099069|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
154099070|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153565313|NCT05797558|Eplerenone|eplerenone|mesh-list
154099106|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
154099107|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099108|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154099109|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099110|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099111|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
154099112|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099113|NCT02193620|Nalbuphine|nalbuphine|mesh-list
153782847|NCT00235079|Colchicine|colchicine|mesh-list
154099149|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099150|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099151|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154099189|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154099190|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
154099191|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099192|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
154099224|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099225|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154099226|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
154099227|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154099228|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099229|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099230|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154099231|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154099232|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
154099233|NCT01349959|Azacitidine|azacitidine|mesh-list
154099234|NCT01349959|Entinostat|entinostat|mesh-list
154099235|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153804375|NCT00294593|Leucovorin|leucovorin|mesh-list
154099236|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153565377|NCT05597254|Vitamins|vitamins|mesh-ancestor
153565405|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
154099295|NCT00584532|Genistein|genistein|mesh-list
154099296|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154099297|NCT00584532|Protective Agents|protective agents|mesh-ancestor
154099298|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099299|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099300|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099301|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099302|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099303|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
154099304|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154099305|NCT00584532|Estrogens|estrogens|mesh-ancestor
154099306|NCT00584532|Hormones|hormones|mesh-ancestor
154099307|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099308|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
154099309|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
154099310|NCT00525759|Docetaxel|docetaxel|mesh-list
154099311|NCT00525759|Fluorouracil|fluorouracil|mesh-list
154099313|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099314|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
154099315|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099316|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099317|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154099318|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
154099319|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099320|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099321|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154099322|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
154099323|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
154099324|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
154099325|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
154099326|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154099327|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099344|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099346|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154099347|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
154099348|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099349|NCT00740090|Antacids|antacids|mesh-ancestor
154099350|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099351|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099352|NCT00738660|Telmisartan|telmisartan|mesh-list
154099353|NCT00738660|Ramipril|ramipril|mesh-list
154099354|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154099355|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154099356|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154099357|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099358|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154099359|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
154099360|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099361|NCT00740168|Bevacizumab|bevacizumab|mesh-list
154099362|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099363|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099364|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154099365|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154099366|NCT00740168|Growth Substances|growth substances|mesh-ancestor
154099367|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099368|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
154099369|NCT05225974|Liraglutide|liraglutide|mesh-list
154099370|NCT05225974|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154099371|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154099372|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099373|NCT05225974|Incretins|incretins|mesh-ancestor
154099374|NCT05225974|Hormones|hormones|mesh-ancestor
154099375|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099376|NCT00729638|Lenalidomide|lenalidomide|mesh-list
154099377|NCT00729638|Everolimus|everolimus|mesh-list
154099378|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
154099379|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099380|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154099381|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154099382|NCT00729638|Growth Substances|growth substances|mesh-ancestor
154099383|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
153565482|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
154099411|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099412|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099413|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154099414|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154099415|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099416|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099417|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154099418|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
154256656|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099419|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154099420|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099421|NCT05575440|Fluorides|fluorides|mesh-list
154099422|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
154099423|NCT05575440|Protective Agents|protective agents|mesh-ancestor
154099424|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099425|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
154099426|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
154099427|NCT00729794|Vasopressins|vasopressins|mesh-list
153804451|NCT00295178|Vancomycin|vancomycin|mesh-list
154099428|NCT00729794|Epinephrine|epinephrine|mesh-list
154099429|NCT00729794|Racepinephrine|racepinephrine|mesh-list
154099430|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
154099431|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154099432|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
154099433|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
154099456|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154099457|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
154099458|NCT00871546|Bortezomib|bortezomib|mesh-list
154099459|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
154099460|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099461|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099462|NCT00732186|Ipilimumab|ipilimumab|mesh-list
154099463|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099464|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099465|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154099466|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099468|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
154099469|NCT04039828|Trace Elements|trace elements|mesh-ancestor
154099470|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
154099471|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099472|NCT04039828|Astringents|astringents|mesh-ancestor
154099473|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
154099475|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099476|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099477|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154099478|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099479|NCT00616018|Acetaminophen|acetaminophen|mesh-list
154099480|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154099481|NCT00616018|Analgesics|analgesics|mesh-ancestor
154099482|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
154099483|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099484|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099485|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
154099486|NCT00740948|Rituximab|rituximab|mesh-list
154099487|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099500|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154099501|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154099503|NCT05157412|Prednisolone|prednisolone|mesh-list
154099504|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154099505|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
154099506|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154099507|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
154099508|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154099509|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
154099510|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154099511|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
154099512|NCT05157412|Hormones|hormones|mesh-ancestor
154099513|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099514|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099515|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154099516|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099517|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
154099518|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
154099519|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099520|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099521|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154099522|NCT05157412|Protective Agents|protective agents|mesh-ancestor
154099523|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154099524|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099525|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
154099526|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154099527|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154099528|NCT00732420|Topotecan|topotecan|mesh-list
154099529|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154099530|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154256657|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
153667827|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099531|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099532|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099533|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099534|NCT00735228|Pancrelipase|pancrelipase|mesh-list
154099535|NCT00735228|Pancreatin|pancreatin|mesh-list
154099536|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099537|NCT00739128|Vaccines|vaccines|mesh-list
154099538|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
154099539|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099541|NCT00863668|Emtricitabine|emtricitabine|mesh-list
154099542|NCT00863668|Efavirenz|efavirenz|mesh-list
154099543|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154099544|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
154099545|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154099546|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
154099547|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
154099548|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099549|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153565597|NCT03875755|Inositol|inositol|mesh-list
154099585|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154099586|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154099587|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
154099604|NCT00732966|Losartan|losartan|mesh-list
154099605|NCT00732966|Valsartan|valsartan|mesh-list
154099606|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154099607|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154099608|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154099609|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099610|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154099611|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154099612|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
154099613|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154099614|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
154099615|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154099616|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099617|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154099618|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154099619|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099620|NCT00424021|Ambrisentan|ambrisentan|mesh-list
154099621|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153422855|NCT04736719|Apixaban|apixaban|mesh-list
154099622|NCT00735930|Lenalidomide|lenalidomide|mesh-list
154099623|NCT00735930|Alvocidib|alvocidib|mesh-list
154099624|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
154099625|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099626|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154099627|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154099628|NCT00735930|Growth Substances|growth substances|mesh-ancestor
154099629|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
154099630|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099631|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099632|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099633|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099634|NCT00617734|Cetuximab|cetuximab|mesh-list
154099635|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154099636|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099637|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099638|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
154099639|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099640|NCT00577460|Pramipexole|pramipexole|mesh-list
154099641|NCT00577460|Dexpramipexole|dexpramipexole|mesh-list
154099642|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
154099643|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565697|NCT01299480|Vaccines|vaccines|mesh-list
154099661|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099662|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154099663|NCT00415519|Protective Agents|protective agents|mesh-ancestor
154099664|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099665|NCT02568176|Midazolam|midazolam|mesh-list
154099666|NCT02568176|Bupropion|bupropion|mesh-list
154099667|NCT02568176|Esketamine|esketamine|mesh-list
154099668|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154099669|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154099670|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099671|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099672|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154099673|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154099674|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154099675|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154099676|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
154099677|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
154099678|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
154099679|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
154099680|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099681|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863386|NCT04881929|Docetaxel|docetaxel|mesh-list
154099682|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154099683|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
154099684|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154099685|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154099687|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
154099688|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154099689|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154099690|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099691|NCT00741182|Teriparatide|teriparatide|mesh-list
154099692|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154099693|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099694|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154099695|NCT00423943|Modafinil|modafinil|mesh-list
154099696|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154099697|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099698|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154099699|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154099700|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154099701|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099726|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154099727|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154099728|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099729|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099731|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
154099732|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154099733|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
154099734|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154099735|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099736|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154099737|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154099738|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154099739|NCT00864214|Hormones|hormones|mesh-list
154099740|NCT00864214|Estradiol|estradiol|mesh-list
154099741|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099742|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099743|NCT00864214|Estrogens|estrogens|mesh-ancestor
154099744|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
154099745|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099746|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099747|NCT00428389|Rivastigmine|rivastigmine|mesh-list
154099748|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154099784|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154099785|NCT00406315|Ziprasidone|ziprasidone|mesh-list
154099786|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154099787|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
154099788|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099789|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099812|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154099814|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154099815|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099816|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099817|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154099818|NCT00864526|Narcotics|narcotics|mesh-ancestor
154099819|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099820|NCT00864604|Nabumetone|nabumetone|mesh-list
154099821|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154099822|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154099823|NCT00864604|Analgesics|analgesics|mesh-ancestor
154099824|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
154099825|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099826|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099827|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154099828|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099829|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154099830|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154099831|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099832|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099833|NCT04064138|Anesthetics|anesthetics|mesh-list
154099834|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099835|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099836|NCT01323751|Ricolinostat|ricolinostat|mesh-list
154099837|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099838|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154099839|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099840|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099861|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
154099862|NCT00710762|Nintedanib|nintedanib|mesh-list
154099863|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099864|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099865|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099866|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099867|NCT05137912|Immunomodulating Agents|immunomodulating agents|mesh-list
154099868|NCT05137912|Immunologic Factors|immunologic factors|mesh-ancestor
154099869|NCT05137912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099870|NCT00736814|Carboplatin|carboplatin|mesh-list
154099871|NCT00736814|Gemcitabine|gemcitabine|mesh-list
154099872|NCT00736814|Docetaxel|docetaxel|mesh-list
154099873|NCT00736814|Vinorelbine|vinorelbine|mesh-list
154099874|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099875|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154099876|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
154099877|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099878|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
154099879|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
153863415|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
154099880|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
154099881|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154099882|NCT04063904|Misoprostol|misoprostol|mesh-list
154099883|NCT04063904|Mifepristone|mifepristone|mesh-list
154099884|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154099885|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
154099886|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154099887|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099888|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154099889|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099890|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
154099891|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154099892|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153565943|NCT06212388|Interferons|interferons|mesh-list
154099925|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099927|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154099928|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099929|NCT00864838|Diuretics|diuretics|mesh-ancestor
154099930|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
154099957|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154099958|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154099959|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154099960|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154099961|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099962|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
154099963|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154099964|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154099965|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099966|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099967|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
154099968|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099969|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
154099970|NCT00577382|Sunitinib|sunitinib|mesh-list
154099971|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099972|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154100008|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154100009|NCT00873262|Estropipate|estropipate|mesh-list
154100010|NCT00873262|Estradiol|estradiol|mesh-list
154100032|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
153668458|NCT00031902|Hormones|hormones|mesh-ancestor
154100033|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100034|NCT00873340|Interferons|interferons|mesh-list
154100035|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
154100036|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100037|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
154100038|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100039|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154100040|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
154100041|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100042|NCT00740064|Lamivudine|lamivudine|mesh-list
154100043|NCT00740064|Abacavir|abacavir|mesh-list
154100044|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
154100045|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154100046|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154100047|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100048|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100049|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
154100050|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100051|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154100052|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154100053|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154100054|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154100055|NCT00614926|Modafinil|modafinil|mesh-list
154100056|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154100057|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100058|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154100059|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154100060|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154100061|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100062|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
154100063|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
154100064|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153566121|NCT05995535|Sympatholytics|sympatholytics|mesh-ancestor
154100100|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154100101|NCT05224492|Protective Agents|protective agents|mesh-ancestor
154100102|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100103|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100104|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154100105|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
154100106|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154100107|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154100108|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154100132|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154100133|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100134|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154100135|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100136|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154100137|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100138|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100139|NCT04064190|Durvalumab|durvalumab|mesh-list
154100140|NCT04064190|Vactosertib|vactosertib|mesh-list
154100141|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154100142|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100143|NCT04064190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154100144|NCT04064190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100145|NCT04064190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100146|NCT00873886|Oseltamivir|oseltamivir|mesh-list
154100147|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
154100148|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100149|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100150|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100151|NCT00880282|Sirolimus|sirolimus|mesh-list
154100152|NCT00880282|Temsirolimus|temsirolimus|mesh-list
154100153|NCT00880282|MTOR Inhibitors|mtor inhibitors|mesh-list
154100154|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154100155|NCT00880282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154100156|NCT00880282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100157|NCT00880282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100158|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100159|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
154100160|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100161|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566196|NCT05899127|Lidocaine|lidocaine|mesh-list
154100196|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256658|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256659|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154100197|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100199|NCT00710606|NuvaRing|nuvaring|mesh-list
154100200|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154100201|NCT00710606|Desogestrel|desogestrel|mesh-list
154100202|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154100234|NCT00737126|Hematinics|hematinics|mesh-ancestor
154100235|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
154100236|NCT00737126|Vitamins|vitamins|mesh-ancestor
154100237|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
154100238|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100239|NCT04063046|Anesthetics|anesthetics|mesh-list
154100240|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782988|NCT00268515|Prednisone|prednisone|mesh-list
154100302|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100303|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154100304|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
154100305|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
154100306|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154100307|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154100308|NCT00414973|Teriparatide|teriparatide|mesh-list
154100309|NCT00414973|Calcitonin|calcitonin|mesh-list
154100310|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
154100311|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154100312|NCT00414973|Katacalcin|katacalcin|mesh-list
154100313|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154100314|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100315|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154100316|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
154100317|NCT00423085|Rivastigmine|rivastigmine|mesh-list
154100318|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154100319|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100320|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100321|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
154100322|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100323|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100324|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154100325|NCT00423085|Protective Agents|protective agents|mesh-ancestor
154100363|NCT00404755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154100364|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154100389|NCT00737256|Aripiprazole|aripiprazole|mesh-list
154100390|NCT00737256|Perphenazine|perphenazine|mesh-list
153403809|NCT02511067|Ranibizumab|ranibizumab|mesh-list
154100391|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
154100392|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154100393|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154100394|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154100395|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100396|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100397|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
154100398|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
154100399|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100400|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100401|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154100402|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154100403|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
154100404|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154100405|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154100406|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154100407|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154100409|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
154100410|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100411|NCT00713310|Mesalamine|mesalamine|mesh-list
154100412|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154100439|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
154100440|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100441|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100442|NCT00880672|Dutasteride|dutasteride|mesh-list
154100443|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154100444|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154100445|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100446|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100447|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
154100448|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100449|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100450|NCT00737724|Efavirenz|efavirenz|mesh-list
154100451|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154100452|NCT00737724|Isoniazid|isoniazid|mesh-list
154100453|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154100454|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154100455|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100456|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100485|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154100486|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
154100487|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154100488|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100489|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100490|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154100491|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153863437|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
154100492|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154100493|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
154100494|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
154100495|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100496|NCT00874744|Triamcinolone|triamcinolone|mesh-list
154100497|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154100498|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154100499|NCT00874744|Bevacizumab|bevacizumab|mesh-list
154100500|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154100501|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566492|NCT06235099|Copper|copper|mesh-list
154100529|NCT05736744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154100530|NCT05736744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154100531|NCT05736744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100532|NCT05736744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154100533|NCT05736744|Tocolytic Agents|tocolytic agents|mesh-ancestor
154100534|NCT05736744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154100535|NCT05736744|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154100536|NCT05736744|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154100537|NCT05736744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154100538|NCT05736744|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154100539|NCT05736744|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154100540|NCT05736744|Cholinergic Agents|cholinergic agents|mesh-ancestor
154100541|NCT05736744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100543|NCT00920868|Capecitabine|capecitabine|mesh-list
154100544|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
154100545|NCT00920868|Dasatinib|dasatinib|mesh-list
154100546|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154100580|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100581|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100582|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
154100583|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154100584|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154100585|NCT00881140|Mifepristone|mifepristone|mesh-list
154100586|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154100587|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
154100588|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153566575|NCT06234579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100609|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
154100610|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100611|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154100612|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154100613|NCT00874978|Growth Substances|growth substances|mesh-ancestor
154100614|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
154100615|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100616|NCT00737880|Pancrelipase|pancrelipase|mesh-list
154100617|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154100618|NCT05728632|Nebivolol|nebivolol|mesh-list
154100619|NCT05728632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154100620|NCT05728632|Vasodilator Agents|vasodilator agents|mesh-ancestor
153863449|NCT00563394|Ofloxacin|ofloxacin|mesh-list
154100621|NCT05728632|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154100622|NCT05728632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154100623|NCT05728632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154100624|NCT05728632|Adrenergic Agents|adrenergic agents|mesh-ancestor
154100625|NCT05728632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100626|NCT05728632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100627|NCT05728632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100628|NCT00612586|Leucovorin|leucovorin|mesh-list
154100629|NCT00612586|Bevacizumab|bevacizumab|mesh-list
154100630|NCT00612586|Fluorouracil|fluorouracil|mesh-list
154100631|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154100632|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100633|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154100634|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154100635|NCT00612586|Growth Substances|growth substances|mesh-ancestor
154100636|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100637|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
154100638|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
154100639|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100640|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100641|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100654|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154100655|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154100656|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154100657|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100658|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154100659|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423908|NCT03538808|Varenicline|varenicline|mesh-list
154100660|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
154100661|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154100662|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154100663|NCT00738192|Fentanyl|fentanyl|mesh-list
154100664|NCT00738192|Sufentanil|sufentanil|mesh-list
154100666|NCT00738192|Butorphanol|butorphanol|mesh-list
154100667|NCT00738192|Citric Acid|citric acid|mesh-list
154100668|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
154100669|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154100670|NCT00738192|Narcotics|narcotics|mesh-ancestor
154100671|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100672|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100673|NCT00738192|Analgesics|analgesics|mesh-ancestor
154100674|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
154100675|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100676|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154100677|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154100678|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
154100679|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
154100680|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
154100681|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154100682|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
154100683|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
154100684|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100685|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
154100686|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
154100687|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153863460|NCT00563433|Ofloxacin|ofloxacin|mesh-list
154100688|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
154100689|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154100690|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154100691|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
154100692|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100693|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100694|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100695|NCT00884104|Urological Agents|urological agents|mesh-ancestor
154100696|NCT04140214|Carbocysteine|carbocysteine|mesh-list
154100697|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154100698|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100699|NCT04140214|Expectorants|expectorants|mesh-ancestor
154100700|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
154100701|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154100702|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154100703|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154100704|NCT00612508|Etonogestrel|etonogestrel|mesh-list
154100705|NCT00612508|Desogestrel|desogestrel|mesh-list
154100706|NCT00612508|NuvaRing|nuvaring|mesh-list
154100707|NCT00612508|Estradiol|estradiol|mesh-list
154100708|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154100743|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154100744|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100746|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154100777|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154100778|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100779|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154256660|NCT03877874|Terbutaline|terbutaline|mesh-list
153669077|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
154100780|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154100781|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
154100783|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100784|NCT00612352|Ethanol|ethanol|mesh-list
154100785|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154100786|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100787|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100788|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100789|NCT00884416|Sorafenib|sorafenib|mesh-list
154100790|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100791|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154100827|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
154100828|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154100829|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154100830|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100902|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
154100903|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100904|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154100905|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154100906|NCT00885820|Protective Agents|protective agents|mesh-ancestor
154100907|NCT02567838|Lidocaine|lidocaine|mesh-list
154100908|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
154100909|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
154100910|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100945|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100946|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
154100947|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100948|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154100949|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
154100950|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100976|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154100978|NCT00813735|Eszopiclone|eszopiclone|mesh-list
154100979|NCT00813735|Citalopram|citalopram|mesh-list
154100980|NCT00813735|Escitalopram|escitalopram|mesh-list
154100981|NCT00813735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154100982|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154100983|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154100984|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100985|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100986|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
154100987|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100988|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154100989|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154100990|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
154100991|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
154100992|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100993|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154100994|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154100995|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
154100996|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154100997|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
154100998|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154100999|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154101000|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101066|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101067|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154101068|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101069|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154101070|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154101071|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154101072|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154101073|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154101074|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101075|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101076|NCT00817713|Ivermectin|ivermectin|mesh-list
154101077|NCT00817713|Albendazole|albendazole|mesh-list
154101078|NCT00817713|Praziquantel|praziquantel|mesh-list
154101079|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154101080|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101081|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
154256662|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
154256663|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101082|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
154101120|NCT00422227|Etanercept|etanercept|mesh-list
154101146|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101147|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154101148|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154101149|NCT00811785|Copper|copper|mesh-list
154101150|NCT00811785|Trace Elements|trace elements|mesh-ancestor
154101151|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
154101152|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101153|NCT00814515|Cyclosporine|cyclosporine|mesh-list
154101154|NCT00814515|Cyclosporins|cyclosporins|mesh-list
154101155|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101156|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101157|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101158|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
154101159|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101160|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
154101161|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101162|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
154101163|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101164|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154101165|NCT00814593|Carmustine|carmustine|mesh-list
154101166|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154101167|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
154101168|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101169|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101170|NCT00421993|Adapalene|adapalene|mesh-list
154101199|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154101200|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154101201|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
154101202|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154101204|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101205|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154101206|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101207|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101209|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
154101210|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
154101211|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
154101212|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101213|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101214|NCT00812019|Vaccines|vaccines|mesh-list
154101215|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154101240|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154101241|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154101242|NCT00814905|Clindamycin|clindamycin|mesh-list
154101243|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
154101244|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
154101245|NCT00814905|Gentamicins|gentamicins|mesh-list
154101246|NCT00814905|Ampicillin|ampicillin|mesh-list
154101247|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154101248|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101249|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154101250|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101251|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101252|NCT00611884|Insulin|insulin|mesh-list
154101253|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154101254|NCT00611884|Metformin|metformin|mesh-list
154101255|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
154101256|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
154101257|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154101258|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101260|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
154101261|NCT00611806|Hematinics|hematinics|mesh-ancestor
154101262|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
154101263|NCT00611806|Vitamins|vitamins|mesh-ancestor
154101264|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
154101265|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101266|NCT00413413|Amlodipine|amlodipine|mesh-list
154101267|NCT00413413|Valsartan|valsartan|mesh-list
154101268|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154101269|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154101281|NCT00886132|Growth Substances|growth substances|mesh-ancestor
154101282|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101283|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
154101284|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154101285|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101286|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101287|NCT01040455|Lansoprazole|lansoprazole|mesh-list
154101288|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
154101289|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154101290|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154101291|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154101292|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101293|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101295|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101296|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
154101297|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
154101298|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
154101299|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101300|NCT01041313|Memantine|memantine|mesh-list
154101301|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154101302|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154101303|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
154101304|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101305|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101306|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101307|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154101308|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154101309|NCT00610714|Paclitaxel|paclitaxel|mesh-list
154101310|NCT00610714|Carboplatin|carboplatin|mesh-list
154101311|NCT00610714|Saracatinib|saracatinib|mesh-list
154101312|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154101313|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101314|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
154101315|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
154101316|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
154101317|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101318|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101319|NCT00403585|Adefovir|adefovir|mesh-list
154101320|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154101321|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
154101322|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101323|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154101324|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154101325|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101326|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101327|NCT00645411|Vaccines|vaccines|mesh-list
154101328|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
153348161|NCT01047527|Nicotine|nicotine|mesh-list
154101329|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101361|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154101362|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101363|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101364|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101365|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154101366|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
154101367|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154101368|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101369|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154101370|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154101371|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154101372|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154101403|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154101404|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154101405|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101406|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101407|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101408|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101409|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
154101410|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154101411|NCT00886990|Ritonavir|ritonavir|mesh-list
154101412|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154101413|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154101442|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101444|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154101445|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154101446|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
154101447|NCT00818103|Interferons|interferons|mesh-list
154101448|NCT00818103|Atorvastatin|atorvastatin|mesh-list
154101449|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101450|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
154101451|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101452|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154101453|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154101454|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
154101455|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101456|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154101457|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154101458|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101459|NCT00642369|Haloperidol|haloperidol|mesh-list
154101460|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154101461|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
154101485|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101486|NCT00889642|Lidocaine|lidocaine|mesh-list
154101487|NCT00889642|Epinephrine|epinephrine|mesh-list
154101488|NCT00889642|Racepinephrine|racepinephrine|mesh-list
154101489|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
154101490|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
154101491|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
154101492|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101493|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101494|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
154101495|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101496|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154101497|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154101498|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154101499|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101500|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101501|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154101502|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154101503|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
154101504|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101505|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154101506|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154101507|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
154101508|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154101509|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
154101510|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
154101530|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154101531|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
154101532|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154101533|NCT01037959|Norfloxacin|norfloxacin|mesh-list
154101534|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154101535|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101536|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154101537|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154101538|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101539|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101540|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101541|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154101542|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154101543|NCT01038037|Carboplatin|carboplatin|mesh-list
154101544|NCT01038037|Vinorelbine|vinorelbine|mesh-list
154101545|NCT01038037|Panitumumab|panitumumab|mesh-list
154101546|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101547|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154101548|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
154101549|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
154101550|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
154101551|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101552|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154101553|NCT00645099|Olanzapine|olanzapine|mesh-list
154101554|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154101555|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
154101556|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
154101557|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101558|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101559|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154101560|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154101561|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154101562|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101563|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154101564|NCT00645099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154101594|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
154101595|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154101596|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101597|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154101598|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154101599|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101600|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101601|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101602|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154101603|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154101604|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154101605|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
154101631|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154101632|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154101633|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101634|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154101635|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154101636|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101639|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154101640|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
154101641|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101642|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101643|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154101644|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
154101645|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154101646|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
154101647|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101648|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101649|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154101650|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
154101651|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
154101652|NCT02551107|Protective Agents|protective agents|mesh-ancestor
154101654|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101655|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
154101678|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101679|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154101681|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154101682|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101683|NCT00420199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154101684|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101685|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101686|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
154101687|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101688|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101689|NCT00649389|Amlodipine|amlodipine|mesh-list
154101690|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154101691|NCT00649389|Olmesartan|olmesartan|mesh-list
154101692|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154101693|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154101694|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154101695|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101696|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101697|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154101698|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101699|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
154101700|NCT00649389|Diuretics|diuretics|mesh-ancestor
154101701|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
154101702|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154101703|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153360935|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
154101704|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154101732|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154101733|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154101734|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
154101735|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101736|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101737|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154101738|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154101739|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154101740|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154101741|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154101742|NCT00641667|Fentanyl|fentanyl|mesh-list
154101743|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154101744|NCT00641667|Narcotics|narcotics|mesh-ancestor
154101745|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101746|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101747|NCT00641667|Analgesics|analgesics|mesh-ancestor
154101748|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
154101749|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101750|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154101811|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154101812|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101813|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101814|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
154101815|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101816|NCT03897192|Bevacizumab|bevacizumab|mesh-list
154101817|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154101818|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101819|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154101820|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154101821|NCT03897192|Growth Substances|growth substances|mesh-ancestor
154101822|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101823|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
154101824|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
154101825|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
154101826|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154101827|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
154101828|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101829|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101830|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154101831|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
154101832|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
154101833|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154101834|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
154101835|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101836|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101860|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101861|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
154101862|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101863|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
154101864|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
154101865|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101866|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
154101867|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154101868|NCT00890188|Thalidomide|thalidomide|mesh-list
154101869|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101870|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
154101871|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101872|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
154101873|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154101874|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101875|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154101876|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154101877|NCT00890188|Growth Substances|growth substances|mesh-ancestor
154101878|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
154101879|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101880|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
154101881|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154101882|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
154101883|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
154101884|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101885|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101886|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154101887|NCT05388942|Analgesics|analgesics|mesh-ancestor
154101913|NCT00627705|Protective Agents|protective agents|mesh-ancestor
154101914|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101916|NCT00610168|Vaccines|vaccines|mesh-list
154101917|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
154101918|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101919|NCT00921102|Atropine|atropine|mesh-list
154101920|NCT00921102|Morphine|morphine|mesh-list
154101921|NCT00921102|Bupivacaine|bupivacaine|mesh-list
154101922|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
154101923|NCT00921102|Anesthetics|anesthetics|mesh-list
154101924|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101925|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101926|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
154101927|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101928|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154101929|NCT00921102|Narcotics|narcotics|mesh-ancestor
154101930|NCT00921102|Analgesics|analgesics|mesh-ancestor
154101931|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154101932|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154101933|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154101934|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
154101935|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154101936|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
154101937|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
154101938|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
154101971|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101972|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154101973|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
154101974|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101975|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101976|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154101977|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154101978|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
154101979|NCT04061772|Hormones|hormones|mesh-ancestor
154101980|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154101981|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154101982|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154102013|NCT00643851|Metformin|metformin|mesh-list
154102014|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
154102015|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154102016|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102017|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154102018|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102019|NCT00821457|Mitogens|mitogens|mesh-list
154102020|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
154102021|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102022|NCT03667690|Fluconazole|fluconazole|mesh-list
154102023|NCT03667690|Caspofungin|caspofungin|mesh-list
154102024|NCT03667690|Rezafungin|rezafungin|mesh-list
154102025|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
154102026|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102027|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154102028|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154102029|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102055|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154102056|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
154102057|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102058|NCT04872582|Bevacizumab|bevacizumab|mesh-list
154102059|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154102060|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154102061|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102062|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154102063|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154102064|NCT04872582|Growth Substances|growth substances|mesh-ancestor
154102065|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102066|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
154102067|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102068|NCT04061538|Zinc|zinc|mesh-list
154102069|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
154102070|NCT04061538|Trace Elements|trace elements|mesh-ancestor
154102071|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
154102072|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102073|NCT04061538|Astringents|astringents|mesh-ancestor
154102074|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
154102075|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
154102076|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
154102077|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154102108|NCT00822081|Dorzolamide|dorzolamide|mesh-list
154102109|NCT00822081|Maleic acid|maleic acid|mesh-list
154102110|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
154102111|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863587|NCT02179151|CKD732|ckd732|mesh-list
154102112|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102113|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154102114|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154102115|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154102116|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102117|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102118|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154102119|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154102142|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154102143|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102145|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
154102146|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102147|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
154102148|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
154102149|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
154102150|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102151|NCT00698646|Valsartan|valsartan|mesh-list
154102152|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154102153|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154102154|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154102155|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154102156|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102157|NCT00698646|Diuretics|diuretics|mesh-ancestor
154102158|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
154102159|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102160|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154102161|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102162|NCT02565888|Ritonavir|ritonavir|mesh-list
154102163|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154102164|NCT02565888|Cobicistat|cobicistat|mesh-list
154102165|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154102166|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154102167|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154102168|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102205|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154102232|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154102233|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154102234|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102235|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154102236|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154102237|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102238|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102239|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102240|NCT02551185|Citarinostat|citarinostat|mesh-list
154102241|NCT02551185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154102242|NCT02551185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403991|NCT01687127|Hematinics|hematinics|mesh-ancestor
154102243|NCT02551185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102244|NCT00892996|Dexamethasone|dexamethasone|mesh-list
154102245|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
154102246|NCT00892996|BB 1101|bb 1101|mesh-list
154102247|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102248|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
154102249|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
154102250|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102251|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102252|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154102253|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
154102254|NCT00892996|Hormones|hormones|mesh-ancestor
154102280|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154102281|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154102283|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102284|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154102285|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
154102286|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154102287|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
154102288|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
154102289|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154102290|NCT00891670|Protective Agents|protective agents|mesh-ancestor
154102291|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154102292|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154102293|NCT00699192|Amlodipine|amlodipine|mesh-list
154102294|NCT00699192|Valsartan|valsartan|mesh-list
154102295|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154102296|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154102297|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102298|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102299|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154102300|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102301|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
154102327|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
154102328|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154102329|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
154102330|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
154102331|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154102332|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154102333|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154102334|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102335|NCT00696384|Diuretics|diuretics|mesh-ancestor
154102336|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
154102337|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102338|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154102339|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102341|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154102342|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102343|NCT01041625|Analgesics|analgesics|mesh-ancestor
154102344|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
154102345|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102346|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102347|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102382|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154102383|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
154102384|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102422|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102423|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102424|NCT00822549|Morphine|morphine|mesh-list
154102448|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102449|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154102451|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102452|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
154102453|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154102454|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154102455|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154102456|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
154102457|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102458|NCT00696072|Letrozole|letrozole|mesh-list
154102459|NCT00696072|Dasatinib|dasatinib|mesh-list
154102460|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102461|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154102462|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154102463|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102464|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102465|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154102466|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
154102467|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154102468|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102469|NCT00696072|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154102470|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154102471|NCT00816855|Docetaxel|docetaxel|mesh-list
154102472|NCT00816855|Fluorouracil|fluorouracil|mesh-list
154102473|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102474|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
154256664|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102509|NCT00817011|Mirtazapine|mirtazapine|mesh-list
154102511|NCT00817011|Bupropion|bupropion|mesh-list
154102512|NCT00817011|Fluoxetine|fluoxetine|mesh-list
154102513|NCT00817011|Paroxetine|paroxetine|mesh-list
154102514|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154102515|NCT00817011|Citalopram|citalopram|mesh-list
154102516|NCT00817011|Sertraline|sertraline|mesh-list
154102549|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154102550|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154102551|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154102552|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
154102553|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154102581|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
154102582|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102583|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102584|NCT00817245|Amoxicillin|amoxicillin|mesh-list
154102585|NCT00817245|Metronidazole|metronidazole|mesh-list
154102586|NCT00817245|Omeprazole|omeprazole|mesh-list
154102587|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154102588|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404007|NCT01476787|Lenalidomide|lenalidomide|mesh-list
154102589|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154102590|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154102591|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154102593|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154102594|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102595|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102596|NCT02550483|Beta Carotene|beta carotene|mesh-list
154102597|NCT02550483|Lycopene|lycopene|mesh-list
154102598|NCT02550483|Carotenoids|carotenoids|mesh-list
154102599|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
154102600|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102631|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154102632|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102634|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154102635|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
154102636|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102637|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102638|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
154102639|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102640|NCT00419263|Peramivir|peramivir|mesh-list
154102641|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
154102642|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102643|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102644|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102645|NCT01034995|Escitalopram|escitalopram|mesh-list
154102646|NCT01034995|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154102683|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102684|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154102685|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
154102702|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
154102703|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102704|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
154102705|NCT00399529|Trastuzumab|trastuzumab|mesh-list
154102706|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154102707|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
154102708|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102709|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102710|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154102711|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
154102712|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102713|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102714|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154102715|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154102716|NCT00712712|Acetaminophen|acetaminophen|mesh-list
154102717|NCT00712712|Morphine|morphine|mesh-list
154102718|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154102719|NCT00712712|Narcotics|narcotics|mesh-ancestor
154102720|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102721|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102722|NCT00712712|Analgesics|analgesics|mesh-ancestor
154102723|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
154102724|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102725|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102726|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
154102727|NCT00411151|Sunitinib|sunitinib|mesh-list
154102728|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102729|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154102730|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154102731|NCT00411151|Growth Substances|growth substances|mesh-ancestor
154102732|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102733|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
154102734|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154102735|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102736|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102738|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154102739|NCT00607048|Carboplatin|carboplatin|mesh-list
154102740|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153349557|NCT04346030|Lidocaine|lidocaine|mesh-list
154102741|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154102742|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102765|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154102767|NCT00893854|Diclofenac|diclofenac|mesh-list
154102768|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102769|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
154102770|NCT00893854|Hormones|hormones|mesh-ancestor
154102771|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154102772|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102773|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102774|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102775|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154102776|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102777|NCT00893854|Analgesics|analgesics|mesh-ancestor
154102778|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
154102779|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102780|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102781|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154102782|NCT00895804|Pindolol|pindolol|mesh-list
154102783|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154102784|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154102785|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
154102786|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102787|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102788|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102789|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154102790|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154102807|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154102809|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102810|NCT00894010|Carbamazepine|carbamazepine|mesh-list
154102811|NCT00894010|Levetiracetam|levetiracetam|mesh-list
154102812|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
154102813|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
154102814|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
154102815|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154102816|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102817|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102818|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154102819|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102820|NCT00894010|Analgesics|analgesics|mesh-ancestor
154102821|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
154102822|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102823|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154102824|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102825|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102826|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154102827|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154102828|NCT00895960|Temozolomide|temozolomide|mesh-list
154102829|NCT00895960|Dasatinib|dasatinib|mesh-list
154102830|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154102831|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
154102832|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102833|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102834|NCT00895960|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154102835|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154102836|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102837|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
154102838|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154102839|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102840|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154102841|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
154102842|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154102843|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102844|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102845|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102846|NCT00921128|Muscimol|muscimol|mesh-list
154102847|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154102848|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
154102849|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
154102869|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
154102870|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
154102871|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102872|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102873|NCT00410605|Dexamethasone|dexamethasone|mesh-list
154102874|NCT00410605|Bevacizumab|bevacizumab|mesh-list
154102875|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153806434|NCT00451880|Famotidine|famotidine|mesh-list
154102876|NCT00410605|Lenalidomide|lenalidomide|mesh-list
154102877|NCT00410605|Antibodies|antibodies|mesh-list
154102878|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
154102879|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154102880|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102881|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154102882|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154102883|NCT00410605|Growth Substances|growth substances|mesh-ancestor
154102884|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102885|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
154102886|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
154102887|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102888|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
154102889|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
154102890|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102891|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154102892|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
154102893|NCT00410605|Hormones|hormones|mesh-ancestor
154102894|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154102895|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154102896|NCT00742638|Valproic Acid|valproic acid|mesh-list
154102897|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154102898|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
154102899|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154102900|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154102901|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154102902|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332374|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
154102936|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102938|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
154102939|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102940|NCT00631371|Interferons|interferons|mesh-list
154102941|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
154102942|NCT00631371|Sirolimus|sirolimus|mesh-list
154102943|NCT00631371|Bevacizumab|bevacizumab|mesh-list
154102944|NCT00631371|Temsirolimus|temsirolimus|mesh-list
153332429|NCT04322968|Ketamine|ketamine|mesh-list
154102980|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154102981|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154102982|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154102983|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
153332471|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103011|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103013|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
154103014|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154103015|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103016|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103017|NCT00897520|Interferons|interferons|mesh-list
154103018|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
154103019|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103020|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
154103021|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404066|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103022|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
154103023|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103024|NCT00894634|Brompheniramine|brompheniramine|mesh-list
154103025|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103026|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154103027|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
154103028|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
154103029|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332510|NCT03655444|Nivolumab|nivolumab|mesh-list
154103050|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
154103051|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154103052|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154103053|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103054|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154103055|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
154103056|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154103057|NCT00823875|Protective Agents|protective agents|mesh-ancestor
154103058|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154103059|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154103060|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103061|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154103062|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154103063|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
154103064|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154103065|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
154103066|NCT00397189|Melatonin|melatonin|mesh-list
154103067|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
154103068|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103069|NCT00397189|Protective Agents|protective agents|mesh-ancestor
154103070|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103071|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103072|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
154103073|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154103074|NCT01035619|Moxidectin|moxidectin|mesh-list
154103075|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
154103076|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154103077|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103078|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
154103079|NCT04044651|Nivolumab|nivolumab|mesh-list
154103080|NCT04044651|Lenvatinib|lenvatinib|mesh-list
154103081|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154103082|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103083|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154103084|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103085|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154103086|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103087|NCT00606034|Insulin|insulin|mesh-list
153332567|NCT03018665|Metformin|metformin|mesh-list
154103116|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103117|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154103118|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154103119|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154103120|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
154103121|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103122|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103123|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154103124|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154103125|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
154103127|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
154103128|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154103129|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103130|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154103131|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154103132|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103165|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154103166|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
154103167|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103168|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103169|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154103170|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154103171|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
154103172|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103173|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103174|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
154103208|NCT00826527|Urological Agents|urological agents|mesh-ancestor
154103209|NCT02550717|Aspirin|aspirin|mesh-list
154103210|NCT02550717|Anticoagulants|anticoagulants|mesh-list
154103211|NCT02550717|Clopidogrel|clopidogrel|mesh-list
154103212|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154103213|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154103214|NCT02550717|Analgesics|analgesics|mesh-ancestor
154103215|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
154256665|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153332699|NCT04974151|Amlodipine|amlodipine|mesh-list
154103246|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103247|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
154103248|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103249|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154103250|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103251|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154103252|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154103253|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103254|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
154103256|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332744|NCT01126255|Clobetasol|clobetasol|mesh-list
154103293|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
154103294|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103295|NCT00606502|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154103296|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153332797|NCT01170247|Ketamine|ketamine|mesh-list
153863682|NCT02074007|Benzocaine|benzocaine|mesh-list
154103318|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154103319|NCT00826839|Ganirelix|ganirelix|mesh-list
154103320|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154103321|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103322|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154103323|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
154103324|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154103325|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103326|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154103327|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
154103328|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154103329|NCT04017988|Ethanol|ethanol|mesh-list
154103330|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154103331|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103332|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103333|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103334|NCT00825201|Paclitaxel|paclitaxel|mesh-list
154103335|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154103336|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154103337|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103338|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
154103339|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
154103340|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
154103341|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103343|NCT00820911|Everolimus|everolimus|mesh-list
154103344|NCT00820911|Cyclosporins|cyclosporins|mesh-list
154103345|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103346|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103347|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154103348|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
154103349|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103377|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154103378|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154103379|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103380|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103381|NCT00882076|Analgesics|analgesics|mesh-ancestor
154103382|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
154103383|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103384|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103385|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154103386|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
154103387|NCT00827151|Estrogens|estrogens|mesh-list
154103388|NCT00827151|Hormones|hormones|mesh-ancestor
154103389|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154103390|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103391|NCT00882154|Cefdinir|cefdinir|mesh-list
154103392|NCT00882154|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154103393|NCT00882154|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154103394|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103395|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103396|NCT00825591|Melatonin|melatonin|mesh-list
154103397|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
154103419|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154103421|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103422|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
154103423|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
154103424|NCT00605566|Sorafenib|sorafenib|mesh-list
154103425|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154103426|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
154103427|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103428|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103429|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154103430|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
154103431|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103432|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103433|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154103434|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154103435|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103436|NCT00882388|Aspirin|aspirin|mesh-list
154103437|NCT00882388|Celecoxib|celecoxib|mesh-list
154103438|NCT00882388|Clopidogrel|clopidogrel|mesh-list
154103439|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154103440|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154103441|NCT00882388|Analgesics|analgesics|mesh-ancestor
154103442|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
154103443|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103444|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103445|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103446|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103447|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154103448|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154103449|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103471|NCT00882466|Hematinics|hematinics|mesh-ancestor
154103472|NCT00901498|BMS 708163|bms 708163|mesh-list
154103473|NCT00901498|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154103474|NCT00901498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103475|NCT00901498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103476|NCT00628251|Doxorubicin|doxorubicin|mesh-list
154103477|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154103478|NCT00628251|Olaparib|olaparib|mesh-list
154103479|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154103480|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103481|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154103482|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154103483|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103484|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103485|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154103486|NCT01036399|Lenalidomide|lenalidomide|mesh-list
154103487|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
154103488|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103489|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154103490|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154103491|NCT01036399|Growth Substances|growth substances|mesh-ancestor
154103492|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
154103493|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103494|NCT00901654|Vaccines|vaccines|mesh-list
154103495|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
154103496|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103497|NCT00625131|Bupropion|bupropion|mesh-list
154103498|NCT00625131|Nicotine|nicotine|mesh-list
154103499|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154103500|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
154103501|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191153|NCT05945615|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103530|NCT00408499|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154103531|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154103532|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103533|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103535|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154103536|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154103537|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
154103538|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
154103539|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103540|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103541|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103542|NCT00900874|Albuterol|albuterol|mesh-list
154103570|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
154103571|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103572|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103573|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154103574|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
154103575|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
154103576|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154103577|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154103578|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154103579|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154103580|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103581|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103582|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103583|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
154103585|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154103586|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
154103587|NCT02549469|Naproxen|naproxen|mesh-list
154103588|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154103625|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
154103650|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
154103651|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
154103652|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154103653|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103654|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103655|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154103656|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
154103657|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154103659|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154103660|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154103661|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
154103662|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103663|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103664|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103665|NCT02538718|Ritodrine|ritodrine|mesh-list
154103666|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
154103667|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
154103668|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103669|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103670|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
154103671|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154103672|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154103673|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154103674|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154103675|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103676|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103709|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154103710|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
154103711|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103712|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154103713|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
154103714|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
154103715|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153333218|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
154103748|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154103750|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103751|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103752|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154103753|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103754|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103755|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
153807010|NCT00336921|Urological Agents|urological agents|mesh-ancestor
154103756|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154103757|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154103791|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154103792|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154103793|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103794|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103795|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103796|NCT00909688|BLI-489|bli-489|mesh-list
154103797|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154103798|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103835|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333333|NCT04395170|Antibodies|antibodies|mesh-list
154103858|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154103860|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
154103861|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103863|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154103864|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154103866|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103867|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154103868|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154103869|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103870|NCT00924586|Landiolol|landiolol|mesh-list
154103871|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154103872|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154103873|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103874|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103875|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103876|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103877|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154103878|NCT00903994|Ketoprofen|ketoprofen|mesh-list
154103879|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154103880|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154103881|NCT00903994|Analgesics|analgesics|mesh-ancestor
154103882|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
154103883|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333371|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
154103913|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154103914|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103916|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154103917|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103918|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154103919|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
154103920|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103921|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
154103922|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103923|NCT00904306|Chromium|chromium|mesh-list
154103924|NCT00904306|Picolinic acid|picolinic acid|mesh-list
154103925|NCT00904306|Trace Elements|trace elements|mesh-ancestor
154103926|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
154103927|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103965|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103982|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103983|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154103984|NCT00396565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154103985|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154103986|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154103987|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103988|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103989|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
154103990|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154103991|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154103992|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154103993|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154103994|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
154103995|NCT00906880|Eflornithine|eflornithine|mesh-list
154103996|NCT00906880|Nifurtimox|nifurtimox|mesh-list
154103997|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103998|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154103999|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154104000|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154104001|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104002|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154104003|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104004|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104005|NCT00904852|Bevacizumab|bevacizumab|mesh-list
154104006|NCT00904852|Temozolomide|temozolomide|mesh-list
154104007|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104008|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104009|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104010|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104011|NCT00904852|Growth Substances|growth substances|mesh-ancestor
154104012|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104013|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104014|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154104015|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
154104016|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104017|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154104018|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154104019|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
154104020|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154104021|NCT00394771|Estradiol|estradiol|mesh-list
154104056|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154104057|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104058|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104059|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
154104060|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104061|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104062|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
154104097|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
154104098|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
154104099|NCT00907036|Cyclosporine|cyclosporine|mesh-list
154104100|NCT00907036|Fludarabine|fludarabine|mesh-list
154104129|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154104131|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104132|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104133|NCT00907114|Ketorolac|ketorolac|mesh-list
154104134|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154104135|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154104136|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154104137|NCT00907114|Analgesics|analgesics|mesh-ancestor
154104138|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
154104139|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104140|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104141|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154104142|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104143|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154104144|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104145|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104146|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
154104182|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104184|NCT00396253|Tenecteplase|tenecteplase|mesh-list
154104185|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153333689|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807282|NCT00308321|Prednisolone|prednisolone|mesh-list
153807359|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154104214|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154104215|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
154104216|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154104217|NCT00928330|Trastuzumab|trastuzumab|mesh-list
154104218|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154104219|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104220|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104221|NCT00928330|Immunotoxins|immunotoxins|mesh-ancestor
154104222|NCT00928330|Immunoconjugates|immunoconjugates|mesh-ancestor
154104223|NCT00928330|Immunologic Factors|immunologic factors|mesh-ancestor
154104224|NCT00928330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104225|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
154104226|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
154104227|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
154104228|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104229|NCT00928798|Sirolimus|sirolimus|mesh-list
154104245|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104246|NCT04034368|Tenofovir|tenofovir|mesh-list
154104247|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
154104248|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104249|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154104250|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154104251|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104252|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104253|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154104254|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154104255|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
154104256|NCT00907270|Vitamin D|vitamin d|mesh-list
154104257|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154104258|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104259|NCT00907270|Vitamins|vitamins|mesh-ancestor
154104260|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
154104261|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154104262|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
154104263|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154104264|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104265|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154104266|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104267|NCT00907504|Cisplatin|cisplatin|mesh-list
154104268|NCT00907504|Gemcitabine|gemcitabine|mesh-list
153671664|NCT05209308|Rituximab|rituximab|mesh-list
154104269|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104270|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154104271|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
154104272|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104273|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
154104274|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154104275|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104276|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104277|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154104278|NCT00932386|Analgesics|analgesics|mesh-ancestor
154104279|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
154104280|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104281|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154104282|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154104283|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154104284|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
154104285|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104286|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104287|NCT00932464|Neratinib|neratinib|mesh-list
154104288|NCT00932464|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154104315|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154104316|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104317|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104318|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154104319|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154104320|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154104321|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154104322|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154104323|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154104324|NCT01045837|Prednisolone|prednisolone|mesh-list
154104325|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154104326|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
154104327|NCT01045837|Hormones|hormones|mesh-ancestor
154104328|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154104329|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104330|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154104331|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104332|NCT00567268|Gabapentin|gabapentin|mesh-list
154104333|NCT00567268|Analgesics|analgesics|mesh-ancestor
154104334|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
154104370|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104371|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154104372|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154104373|NCT03799744|Durvalumab|durvalumab|mesh-list
154104374|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104441|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154104442|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154104443|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154104444|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154104445|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
154104446|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104447|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104448|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154104449|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
154104451|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154104480|NCT00622869|Everolimus|everolimus|mesh-list
154104481|NCT00622869|Tacrolimus|tacrolimus|mesh-list
154104482|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154104483|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
154104484|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104485|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154104486|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104487|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104488|NCT00622869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154104489|NCT00622869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104490|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104491|NCT00366457|Bevacizumab|bevacizumab|mesh-list
154104492|NCT00366457|Gemcitabine|gemcitabine|mesh-list
154104493|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154104494|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104495|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104496|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104564|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
154104565|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154104566|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154104567|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154104568|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104569|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104570|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
154104571|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
154104572|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104573|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104574|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154104575|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154104576|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
154104600|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104602|NCT01046383|Caseins|caseins|mesh-list
154104603|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
154104604|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
154104605|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104606|NCT00831597|Rituximab|rituximab|mesh-list
153729666|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104608|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104609|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104610|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
154104611|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104612|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104613|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154104614|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
154104615|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104616|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154104617|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154104618|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
154104619|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104620|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104621|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154104622|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334127|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
153334136|NCT01222273|Vitamin D|vitamin d|mesh-list
154104653|NCT00828087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104654|NCT00828087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104655|NCT00828087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104656|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154104657|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
154104658|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104659|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104660|NCT00828087|Trace Elements|trace elements|mesh-ancestor
154104661|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
154104662|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
154104663|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
154104664|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
154104665|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104666|NCT00839085|Protective Agents|protective agents|mesh-ancestor
154104667|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104668|NCT00839085|Vitamins|vitamins|mesh-ancestor
154104742|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104743|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154104744|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
154104745|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104746|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104747|NCT00839397|Paroxetine|paroxetine|mesh-list
153334258|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104778|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
154104779|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154104780|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104781|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104782|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154104783|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154104784|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154104785|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154104786|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153334299|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
154104818|NCT00691938|Panobinostat|panobinostat|mesh-list
154104819|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154104821|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104822|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104823|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104824|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154104825|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
154104826|NCT00365365|Bevacizumab|bevacizumab|mesh-list
154104827|NCT00365365|Carboplatin|carboplatin|mesh-list
154104828|NCT00365365|Docetaxel|docetaxel|mesh-list
154104829|NCT00365365|Doxorubicin|doxorubicin|mesh-list
154104830|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154104831|NCT00365365|Trastuzumab|trastuzumab|mesh-list
154104832|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154104866|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104867|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154104868|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104869|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807657|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154104870|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154104871|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
154104908|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104909|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104910|NCT00372775|Growth Substances|growth substances|mesh-ancestor
154104911|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104939|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104941|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154104942|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154104943|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104944|NCT00934414|Insulin|insulin|mesh-list
154104945|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104946|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104947|NCT00930514|Rituximab|rituximab|mesh-list
154104948|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104949|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104950|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
154104951|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104952|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104953|NCT00936988|Cinacalcet|cinacalcet|mesh-list
154104954|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154104955|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104956|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154104957|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
154104991|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
154104992|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
154104993|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154104994|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154104995|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105028|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105029|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105031|NCT00931138|Daunorubicin|daunorubicin|mesh-list
154105032|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154105033|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105034|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154105035|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154105036|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105056|NCT00690378|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154105057|NCT00690378|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154105058|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
154105059|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105060|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105061|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154105063|NCT00574275|Aflibercept|aflibercept|mesh-list
154105064|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154105065|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
154105066|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105067|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105068|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154105069|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154105070|NCT00574275|Growth Substances|growth substances|mesh-ancestor
154105071|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105072|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
154105073|NCT01742832|Citalopram|citalopram|mesh-list
154105074|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154105075|NCT01742832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154105076|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256666|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
154105077|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154105078|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105079|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105080|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
154105081|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105082|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154105083|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
154105084|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154105085|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154105086|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154105087|NCT00833079|Tacrolimus|tacrolimus|mesh-list
154105088|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105089|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
154105090|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105091|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153334597|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
154105123|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105125|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154105126|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105127|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105128|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
154105129|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154105130|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154105165|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105167|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153334695|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105205|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105230|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105231|NCT00829647|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154105232|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154105233|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105234|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105235|NCT00939328|Rituximab|rituximab|mesh-list
154105236|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154105237|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154105238|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105239|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
154105240|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105241|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105242|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154105243|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
154105244|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807719|NCT00421122|Budesonide|budesonide|mesh-list
154105245|NCT00829881|Betahistine|betahistine|mesh-list
154105246|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
154105247|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
154105248|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
154105249|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105250|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105251|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105252|NCT04014244|Triamcinolone|triamcinolone|mesh-list
154105253|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153334777|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
154105277|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105279|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154105280|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
154105281|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105283|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
154105284|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154105285|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
154105286|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105287|NCT00830193|Protective Agents|protective agents|mesh-ancestor
154105288|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105289|NCT00830193|Antidotes|antidotes|mesh-ancestor
154105290|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
154105291|NCT00938158|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154105292|NCT00938158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154105293|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105294|NCT00840957|Infliximab|infliximab|mesh-list
154105295|NCT00840957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154105296|NCT00840957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154256668|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
154105297|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
154105298|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154105299|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105300|NCT00743964|Capecitabine|capecitabine|mesh-list
154105301|NCT00743964|Epirubicin|epirubicin|mesh-list
154105302|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105303|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154105340|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154105341|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
154105376|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154105377|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
154105378|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154105379|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105419|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154105420|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
154105526|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
154105527|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
154105528|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
154105529|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105530|NCT04249167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154105531|NCT04249167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154105532|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
154105533|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105534|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154105569|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105570|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105571|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
154105572|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
154105602|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153807808|NCT00339417|Ivermectin|ivermectin|mesh-list
154105603|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105604|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154105605|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154105606|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154105607|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105608|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
154105609|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105610|NCT00835965|Dexamethasone|dexamethasone|mesh-list
154105611|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
154105612|NCT00835965|Aprepitant|aprepitant|mesh-list
154105613|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
154105614|NCT00835965|BB 1101|bb 1101|mesh-list
154105615|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105616|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
154105642|NCT00738296|Ezetimibe|ezetimibe|mesh-list
154105643|NCT00738296|Pravastatin|pravastatin|mesh-list
154105644|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154105645|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154105646|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
154105647|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105648|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154105649|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154105651|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
154105652|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154105653|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105654|NCT02567396|Talazoparib|talazoparib|mesh-list
154105655|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154105656|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105657|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105658|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105659|NCT00738452|Antibodies|antibodies|mesh-list
154105660|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154105661|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
154105662|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105663|NCT05667428|Leuprolide|leuprolide|mesh-list
154105699|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154105700|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154105701|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105716|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154105717|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154105718|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
154105719|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
154105720|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
153807879|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
154105721|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105722|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154105723|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
154105724|NCT00842595|Analgesics|analgesics|mesh-ancestor
154105725|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
154105726|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105727|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154105728|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154105729|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105731|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154105732|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
154105733|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105734|NCT00836199|Vaccines|vaccines|mesh-list
154105735|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
154105736|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105737|NCT04013386|Dexamethasone|dexamethasone|mesh-list
154105738|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
154105739|NCT04013386|Aprepitant|aprepitant|mesh-list
154105740|NCT04013386|Mirtazapine|mirtazapine|mesh-list
154105741|NCT04013386|BB 1101|bb 1101|mesh-list
154105742|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105743|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
154105744|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
154105745|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105746|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105747|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154105748|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
154105749|NCT04013386|Hormones|hormones|mesh-ancestor
154105750|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105751|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154105752|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105753|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
154105754|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105755|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105756|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154105757|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105758|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
154105759|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154105760|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154105761|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
154105762|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
154105763|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154105764|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154105829|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105831|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
154105832|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
154105833|NCT00939718|Vitamins|vitamins|mesh-ancestor
154105834|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
154105835|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105836|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
154105837|NCT00939718|Hematinics|hematinics|mesh-ancestor
154105838|NCT00836667|Sertraline|sertraline|mesh-list
154105839|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
154105840|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154105841|NCT00836667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154105842|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154105843|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154105844|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105871|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105873|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
154105874|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105875|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105876|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
154105877|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105878|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154105879|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105880|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
154105881|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105882|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154105883|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
154105884|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105885|NCT00851175|Caffeine|caffeine|mesh-list
154256669|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154105886|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154105887|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154105888|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154105889|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
153808021|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
154105890|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105891|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154105892|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154105893|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105894|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153335440|NCT04758260|Antioxidants|antioxidants|mesh-list
154105920|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154105921|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
154105923|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
154105924|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154105925|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154105926|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105927|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154105928|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
154105929|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105930|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105931|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154105932|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
154105933|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
154105934|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154105935|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
154105936|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154105937|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
154105938|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105939|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105940|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154105941|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154105942|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154105943|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
154105944|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
154105960|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105961|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
154105962|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105964|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154105965|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
154105966|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808081|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153808082|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
153808083|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153808084|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153808085|NCT00347763|Permethrin|permethrin|mesh-list
153808086|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808087|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808088|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
153808089|NCT00313235|Vaccines|vaccines|mesh-list
154105967|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105968|NCT00563368|Topiramate|topiramate|mesh-list
154105969|NCT00563368|Phentermine|phentermine|mesh-list
154105970|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
154105971|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154105972|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105973|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154105974|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
154105975|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154105976|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
154105977|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
154105978|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105979|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
154105980|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105981|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105982|NCT00390013|Gabapentin|gabapentin|mesh-list
154105983|NCT00390013|Analgesics|analgesics|mesh-ancestor
154105984|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
154105985|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105986|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105987|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
154105988|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154105989|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154105990|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154105991|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154105992|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154105993|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154105994|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105995|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105996|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
154105997|NCT00562120|Fexofenadine|fexofenadine|mesh-list
154105998|NCT00562120|Terfenadine|terfenadine|mesh-list
154106000|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154106001|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154106002|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
154106003|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
154106004|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106005|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106043|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
154106044|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106045|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106076|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
154106077|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154106078|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
154106079|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154106080|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106081|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154106082|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106083|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106084|NCT02563704|Analgesics|analgesics|mesh-ancestor
154106085|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
154106086|NCT00848523|Panobinostat|panobinostat|mesh-list
154106087|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106088|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154106089|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106090|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106091|NCT00742404|Dexamethasone|dexamethasone|mesh-list
154106092|NCT00742404|Doxorubicin|doxorubicin|mesh-list
154106117|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106118|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154106120|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154106121|NCT04013620|Abatacept|abatacept|mesh-list
154106122|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154106123|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106124|NCT04013620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106125|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106126|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106127|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
154106128|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106129|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106130|NCT00749112|Rituximab|rituximab|mesh-list
154106131|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
154106132|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106133|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106134|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
154106135|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106136|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106137|NCT00848679|Lidocaine|lidocaine|mesh-list
154106138|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
154106139|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
154106140|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106141|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106155|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106156|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106157|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
154106158|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154106159|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154106160|NCT02545959|Prednisolone|prednisolone|mesh-list
154106161|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
154106162|NCT02545959|Rituximab|rituximab|mesh-list
154106163|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154106164|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
154106165|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106166|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106167|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
154106168|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106169|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106171|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
154106172|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
154106173|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106174|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154106175|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
154106176|NCT02545959|Hormones|hormones|mesh-ancestor
154106177|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106178|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154106179|NCT02545959|Protective Agents|protective agents|mesh-ancestor
154106180|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154106181|NCT00744900|Pemetrexed|pemetrexed|mesh-list
154106182|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106183|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106184|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106185|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154106186|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154106187|NCT00727090|Conivaptan|conivaptan|mesh-list
154106188|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154106189|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106190|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
154106191|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106192|NCT00689052|Pramipexole|pramipexole|mesh-list
154106193|NCT00689052|Dexpramipexole|dexpramipexole|mesh-list
154106194|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
154106195|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106196|NCT00689052|Protective Agents|protective agents|mesh-ancestor
154106197|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106198|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154106199|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154106200|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
154106201|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
154106202|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106203|NCT04012450|Anesthetics|anesthetics|mesh-list
154106225|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154106227|NCT05602064|Analgesics|analgesics|mesh-ancestor
154106228|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
154106229|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106230|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106231|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106232|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106233|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154106234|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106235|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106236|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
154106237|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154106238|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
154106239|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106240|NCT02562144|Lidocaine|lidocaine|mesh-list
154106241|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
154106242|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
154106243|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106244|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106245|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
154106246|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106247|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154106248|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154106249|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154106250|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154106251|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106252|NCT02562300|Misoprostol|misoprostol|mesh-list
154106253|NCT02562300|Oxytocin|oxytocin|mesh-list
154106254|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
154106275|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106276|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106277|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106278|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154106279|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154106280|NCT02562690|Thrombin|thrombin|mesh-list
154106281|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
154106282|NCT02562690|Coagulants|coagulants|mesh-ancestor
154106283|NCT00576758|Rituximab|rituximab|mesh-list
154106284|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
154106285|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106286|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106287|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
154106288|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106289|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106290|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154106291|NCT00923676|Fenofibrate|fenofibrate|mesh-list
154106292|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154106293|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153353141|NCT05622656|Analgesics|analgesics|mesh-ancestor
154106295|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106296|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154106297|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154106298|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106299|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
154106300|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154106301|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106302|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106303|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106304|NCT00921284|Analgesics|analgesics|mesh-ancestor
154106305|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
154106306|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106307|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153335854|NCT02518750|Hormones|hormones|mesh-ancestor
154106328|NCT00749736|Vitamins|vitamins|mesh-ancestor
154106329|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
154106330|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154106331|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
154106332|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
154106333|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154106334|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154106335|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106336|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106337|NCT00950404|Urological Agents|urological agents|mesh-ancestor
154106338|NCT00749814|Melatonin|melatonin|mesh-list
154106339|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
153808329|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154106340|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106341|NCT00749814|Protective Agents|protective agents|mesh-ancestor
154106342|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106343|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106344|NCT00748176|Anesthetics|anesthetics|mesh-list
154106345|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106346|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106347|NCT00619359|Dexamethasone|dexamethasone|mesh-list
154106348|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
154106349|NCT00619359|Ondansetron|ondansetron|mesh-list
154106350|NCT00619359|Aprepitant|aprepitant|mesh-list
154106351|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
154106352|NCT00619359|BB 1101|bb 1101|mesh-list
154106353|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106354|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
154106355|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
154106356|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106357|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106358|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154106359|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
154106360|NCT00619359|Hormones|hormones|mesh-ancestor
154106361|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106362|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154106389|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
154106390|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106391|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106392|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154106394|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154106395|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
154106396|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106397|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106398|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153808393|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154106399|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
154106400|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154106401|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154106402|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154106403|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
154106404|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106405|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106406|NCT00852189|Folic Acid|folic acid|mesh-list
154106407|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
154106408|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
154106409|NCT00852189|Hematinics|hematinics|mesh-ancestor
154106410|NCT00852189|Vitamins|vitamins|mesh-ancestor
154106411|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
154106448|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106449|NCT00855777|Analgesics|analgesics|mesh-ancestor
154106450|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
154106483|NCT00852423|Artesunate|artesunate|mesh-list
154106484|NCT00852423|Lumefantrine|lumefantrine|mesh-list
154106486|NCT00852423|Piperaquine|piperaquine|mesh-list
154106487|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154106488|NCT00852423|Amodiaquine|amodiaquine|mesh-list
154106490|NCT00852423|Mefloquine|mefloquine|mesh-list
154106491|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
154106492|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154106493|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154106494|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106519|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106520|NCT01049815|Antacids|antacids|mesh-ancestor
154106521|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404354|NCT01349192|Mupirocin|mupirocin|mesh-list
153808462|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153808463|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154106522|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154106523|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
153808464|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153808465|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
153808466|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808467|NCT00315185|Cetuximab|cetuximab|mesh-list
153808468|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153808469|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106524|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
154106525|NCT00849615|Leucovorin|leucovorin|mesh-list
154106526|NCT00849615|Folic Acid|folic acid|mesh-list
154106527|NCT00849615|Docetaxel|docetaxel|mesh-list
154106528|NCT00849615|Fluorouracil|fluorouracil|mesh-list
154106529|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
154106530|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
154106531|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106532|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
154106533|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
154106534|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
154106535|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106536|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
154106537|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154106538|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106539|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
154106540|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106541|NCT00849615|Antidotes|antidotes|mesh-ancestor
154106542|NCT00849615|Protective Agents|protective agents|mesh-ancestor
154106543|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
154106544|NCT00849615|Vitamins|vitamins|mesh-ancestor
154106545|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
154106546|NCT00849615|Hematinics|hematinics|mesh-ancestor
154106547|NCT00946036|Sertraline|sertraline|mesh-list
154106569|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154106570|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
154106571|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
154106572|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
154106573|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154106574|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154106575|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154106576|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106577|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
154106578|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154106579|NCT05323058|Benzydamine|benzydamine|mesh-list
154106580|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106581|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
154106582|NCT01046773|Vitamin D|vitamin d|mesh-list
154106583|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154106584|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106585|NCT01046773|Vitamins|vitamins|mesh-ancestor
154106586|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
154106587|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154106588|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
154106589|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154106590|NCT00850005|Antibodies|antibodies|mesh-list
154106591|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
154106592|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154106593|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
154106594|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106595|NCT00852579|Azithromycin|azithromycin|mesh-list
154106596|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106597|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106598|NCT00942136|Dolutegravir|dolutegravir|mesh-list
154106599|NCT00942136|Omeprazole|omeprazole|mesh-list
154106600|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153336141|NCT01006018|Hormones|hormones|mesh-ancestor
154106623|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106624|NCT00850161|Insulin|insulin|mesh-list
154106625|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154106626|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
154106627|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154106628|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106629|NCT00951574|Nadroparin|nadroparin|mesh-list
154106630|NCT00951574|Calcium|calcium|mesh-list
154106631|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154106632|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106634|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154106635|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154106636|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106637|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154106638|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
154106639|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
154106640|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106641|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
154106642|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106643|NCT00856089|Retapamulin|retapamulin|mesh-list
154106644|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106645|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106646|NCT00686712|Insulin|insulin|mesh-list
154106647|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154106648|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
154106649|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
154106650|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
154106651|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
154106652|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154106653|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106654|NCT00748644|Rituximab|rituximab|mesh-list
154106684|NCT00942526|Ionophores|ionophores|mesh-ancestor
154106685|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154106686|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106687|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
154106688|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154106689|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
154106690|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106691|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
154106692|NCT03967444|Protective Agents|protective agents|mesh-ancestor
154106693|NCT05300854|Anesthetics|anesthetics|mesh-list
154106694|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106695|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106696|NCT00946504|Glipizide|glipizide|mesh-list
154106697|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154106698|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106699|NCT00619983|Gabapentin|gabapentin|mesh-list
154106700|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154106716|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154106717|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154106718|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154106719|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
154106720|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
154106721|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154106722|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106723|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
154106724|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
154106725|NCT00942682|Sorafenib|sorafenib|mesh-list
154106726|NCT00942682|Everolimus|everolimus|mesh-list
154106727|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106728|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154106729|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106730|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106731|NCT00942682|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154106732|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106733|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
154106734|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106735|NCT00853983|Saracatinib|saracatinib|mesh-list
154106736|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106737|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106738|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106739|NCT00750048|Acetaminophen|acetaminophen|mesh-list
154106740|NCT00750048|Naloxone|naloxone|mesh-list
154106741|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106742|NCT00750048|Analgesics|analgesics|mesh-ancestor
154106743|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
154106744|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106745|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106746|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
154106747|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154106748|NCT00942838|Cisplatin|cisplatin|mesh-list
154106749|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106750|NCT04057014|Amoxicillin|amoxicillin|mesh-list
154106751|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106752|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106753|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154106754|NCT00364351|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154106755|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154106756|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106757|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106758|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106759|NCT00854139|Cyclosporine|cyclosporine|mesh-list
154106760|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
154106793|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106795|NCT00750126|Busulfan|busulfan|mesh-list
154106796|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
154106797|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106798|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808579|NCT00421434|Ribavirin|ribavirin|mesh-list
154106799|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106824|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154106825|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
154106826|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106827|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106828|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154106829|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154106830|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
154106831|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106833|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154106834|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
154106835|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106836|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106837|NCT02560974|Capecitabine|capecitabine|mesh-list
154106838|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
154106839|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154106840|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
154106841|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106842|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106843|NCT00854451|Amoxicillin|amoxicillin|mesh-list
154106844|NCT00854451|Omeprazole|omeprazole|mesh-list
154106845|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106846|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106847|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154106848|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153430164|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
153336385|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154106876|NCT00861315|Amikacin|amikacin|mesh-list
154106877|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106878|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106879|NCT00943540|Lamivudine|lamivudine|mesh-list
154106880|NCT00943540|Emtricitabine|emtricitabine|mesh-list
154106881|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
154106882|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154106883|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154106884|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154106885|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106886|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106887|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
154106888|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106889|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154106890|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154106891|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154106892|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154106893|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153808679|NCT06164535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154106894|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154106923|NCT00943930|Analgesics|analgesics|mesh-ancestor
154106924|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
154106925|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154106926|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154106927|NCT00943930|Hormones|hormones|mesh-ancestor
154106928|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106929|NCT00854763|Olmesartan|olmesartan|mesh-list
154106930|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154106931|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154106932|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154106933|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106934|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
154106935|NCT00854841|Dasatinib|dasatinib|mesh-list
154106936|NCT00854841|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154106937|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154106938|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106967|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
154106968|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
154106969|NCT00947128|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154106970|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154106971|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
154106972|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106973|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106974|NCT00861861|Atorvastatin|atorvastatin|mesh-list
154106975|NCT00861861|Pitavastatin|pitavastatin|mesh-list
154106976|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154106977|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154106978|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
154106979|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106980|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154106981|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154106982|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106983|NCT00686166|Capecitabine|capecitabine|mesh-list
154106984|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
154106985|NCT00686166|Cetuximab|cetuximab|mesh-list
154107016|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107017|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154107018|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
153808736|NCT06163755|Prednisolone|prednisolone|mesh-list
154107019|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107021|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107022|NCT00952978|Omeprazole|omeprazole|mesh-list
154107023|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154107024|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107025|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154107026|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107063|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154107064|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154107065|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
154107066|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107067|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107099|NCT00862095|Topiramate|topiramate|mesh-list
154107100|NCT00862095|Propranolol|propranolol|mesh-list
154107101|NCT00862095|Amitriptyline|amitriptyline|mesh-list
154107102|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154107103|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154107104|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
154107105|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107106|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107107|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336657|NCT02598778|Listerine|listerine|mesh-list
154107122|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107124|NCT04054128|Calcium heparin|calcium heparin|mesh-list
154107125|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
154107126|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154107127|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154107128|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107129|NCT00865215|Propranolol|propranolol|mesh-list
154107130|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154107131|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154107132|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
154107133|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107134|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107135|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107136|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154107137|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154107138|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
154107139|NCT00865371|Bupropion|bupropion|mesh-list
154107140|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154107141|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
154107142|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107143|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154107144|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154107145|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107146|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107147|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
154107148|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107149|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107150|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154107151|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154107152|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107153|NCT00865449|Spironolactone|spironolactone|mesh-list
154107154|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154107155|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
154107156|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154107157|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107158|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154107159|NCT00865449|Diuretics|diuretics|mesh-ancestor
154107160|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
154107161|NCT00858195|Indomethacin|indomethacin|mesh-list
154107162|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154107163|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154107164|NCT00858195|Analgesics|analgesics|mesh-ancestor
154107165|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
154107166|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336700|NCT00623974|Teriparatide|teriparatide|mesh-list
154107198|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
154107199|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
154107200|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
154107201|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153808941|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153808979|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153809005|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107202|NCT00685698|Nemonoxacin|nemonoxacin|mesh-list
153809007|NCT05401071|Rifapentine|rifapentine|mesh-list
153809008|NCT05401071|Rifampin|rifampin|mesh-list
153809009|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153809010|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
153809011|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153809012|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809013|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
153809014|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153809015|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809016|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594108|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154107203|NCT00685698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107204|NCT00685698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107205|NCT00858429|Capecitabine|capecitabine|mesh-list
154107206|NCT00858429|Doxifluridine|doxifluridine|mesh-list
154107207|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154107208|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
154107209|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336761|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154107237|NCT00956644|Irbesartan|irbesartan|mesh-list
154107238|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154107239|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154107240|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107241|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107242|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154107243|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107244|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
154107245|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154107246|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154107247|NCT00858663|Everolimus|everolimus|mesh-list
154107248|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107249|NCT00858663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154107250|NCT00858663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154107251|NCT00858663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107252|NCT00858663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107253|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154107254|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
154107255|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107256|NCT02544789|Clofarabine|clofarabine|mesh-list
154107257|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154107258|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
153336807|NCT00000772|Didanosine|didanosine|mesh-list
154107293|NCT00696410|Trace Elements|trace elements|mesh-ancestor
154107294|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
154107295|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107296|NCT00683904|Carboplatin|carboplatin|mesh-list
154107297|NCT00683904|Epothilones|epothilones|mesh-list
154107299|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154107300|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
154107301|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
154107302|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107333|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107334|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107335|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154107336|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154107337|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154107338|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107339|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154107341|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154107342|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154107343|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
154107344|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107345|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154256670|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153336896|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
154107375|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
154107376|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154107377|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154107378|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154107379|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154107380|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
154107381|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154107382|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154107383|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
154107384|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154107385|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
154107386|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154107387|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154107388|NCT00752544|Simeprevir|simeprevir|mesh-list
154107389|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
154107390|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809023|NCT05394337|Atezolizumab|atezolizumab|mesh-list
154107391|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
154107424|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107425|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154107426|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154107427|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
154107428|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154107429|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154107430|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107431|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154107432|NCT00752934|Baclofen|baclofen|mesh-list
153336989|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154107462|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154107463|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154107464|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107465|NCT00751764|Moxidectin|moxidectin|mesh-list
154107466|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
154107467|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154107468|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107469|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
154107470|NCT00757458|Propofol|propofol|mesh-list
154107471|NCT00757458|Edetic Acid|edetic acid|mesh-list
154107472|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
154107473|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154107474|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154107475|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107476|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154107498|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107500|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154107501|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
154107502|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107503|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107504|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154107505|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154107506|NCT02565602|Vitamin D|vitamin d|mesh-list
154107507|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
154107508|NCT02565602|Vitamins|vitamins|mesh-ancestor
154107509|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
154107510|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107511|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154107512|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154107513|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
154107514|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
154107515|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154107516|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154107517|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107518|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107519|NCT00866463|Urological Agents|urological agents|mesh-ancestor
154107520|NCT00695864|Ondansetron|ondansetron|mesh-list
154107521|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
153430842|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107522|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
154107523|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107524|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107525|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107526|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
154107527|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
154107528|NCT00695864|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154107529|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154107563|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
154107564|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154107565|NCT00684762|Protective Agents|protective agents|mesh-ancestor
154107566|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154107567|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154107568|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107569|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
154107570|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154107606|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107632|NCT00758004|Atorvastatin|atorvastatin|mesh-list
154107633|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154107634|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154107635|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
154107636|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107637|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154107638|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154107639|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107640|NCT02656706|Nivolumab|nivolumab|mesh-list
154107641|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154107642|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107643|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191154|NCT05945615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107644|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107646|NCT04049916|Primaquine|primaquine|mesh-list
154107647|NCT04049916|Piperaquine|piperaquine|mesh-list
154107648|NCT04049916|Artenimol|artenimol|mesh-list
154107649|NCT04049916|Pyronaridine|pyronaridine|mesh-list
154107650|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
154107651|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154107652|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154107653|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107654|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107655|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
154107656|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
154107657|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154107658|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
154107659|NCT00753558|Gentamicins|gentamicins|mesh-list
154107690|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154107692|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107693|NCT00553696|Sunitinib|sunitinib|mesh-list
154107694|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107695|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154107696|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154107697|NCT00553696|Growth Substances|growth substances|mesh-ancestor
154107698|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107699|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
154107700|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154107701|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107702|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107703|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
154107734|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154107735|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107736|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154107737|NCT00754104|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154107738|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154107739|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107740|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107741|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107742|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153809218|NCT04666636|Mirabegron|mirabegron|mesh-list
154107743|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107745|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
154107771|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154107772|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107773|NCT03992365|Bisacodyl|bisacodyl|mesh-list
154107774|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
154107775|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154107776|NCT03992365|Cathartics|cathartics|mesh-ancestor
154107777|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107778|NCT03992365|Laxatives|laxatives|mesh-ancestor
154107779|NCT00921804|Risperidone|risperidone|mesh-list
154107780|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154107781|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
154107782|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107783|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736436|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154107784|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107785|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154107786|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154107787|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154107788|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107789|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154107790|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
154107791|NCT00859911|Micronutrients|micronutrients|mesh-list
154107792|NCT00859911|Trace Elements|trace elements|mesh-list
154107793|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107794|NCT00698516|Bevacizumab|bevacizumab|mesh-list
154107795|NCT00698516|Topotecan|topotecan|mesh-list
153337346|NCT00001906|Interleukin-12|interleukin-12|mesh-list
154107829|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
154107830|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107831|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107832|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
154107833|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154107834|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337425|NCT00000964|Foscarnet|foscarnet|mesh-list
154107870|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154107907|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
154107908|NCT04019379|Calcium|calcium|mesh-list
154107909|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154107910|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337472|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107945|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154107946|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107947|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154107948|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107949|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107950|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153337514|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154107986|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154107987|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154107988|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
154107989|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337551|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154108024|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154108025|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154108026|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108027|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108028|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154108029|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154108030|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153337591|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154108064|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
154108065|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
154108066|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154108067|NCT00371761|Adefovir|adefovir|mesh-list
154108068|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154108069|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108070|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
154108071|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108085|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108087|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809319|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
153809353|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153809354|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
153809355|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809356|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809357|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
153809391|NCT03684564|Warfarin|warfarin|mesh-list
154108088|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108089|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
154108090|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154108091|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
154108092|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108093|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108095|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
154108096|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154108097|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153729667|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729668|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729669|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153729670|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729671|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729672|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
153729673|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
154108099|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108100|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108101|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108102|NCT05300386|Escitalopram|escitalopram|mesh-list
154108103|NCT05300386|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154108104|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154108105|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108106|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108107|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108108|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
154108109|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108110|NCT00863499|Methylphenidate|methylphenidate|mesh-list
154108111|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154108112|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108113|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154108114|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154108115|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108116|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108117|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
154108118|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108119|NCT00755118|Leucovorin|leucovorin|mesh-list
154108120|NCT00755118|Bevacizumab|bevacizumab|mesh-list
154108152|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154108153|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108154|NCT00549640|Methylphenidate|methylphenidate|mesh-list
154108155|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154108156|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108157|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153355009|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154108158|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154108159|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108160|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108162|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108163|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
154108164|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
153337737|NCT02548962|Ibrutinib|ibrutinib|mesh-list
154108232|NCT00863733|Acetic Acid|acetic acid|mesh-list
154108233|NCT00863733|Vadimezan|vadimezan|mesh-list
154108235|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108236|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108237|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154108238|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154108239|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154108240|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108241|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108242|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153864141|NCT01847573|Halofuginone|halofuginone|mesh-list
154108243|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154108244|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154108245|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
154108246|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108247|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108248|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154108249|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154108274|NCT04237012|Hormones|hormones|mesh-ancestor
154108275|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154108276|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154108277|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108278|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154108279|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154108280|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154108281|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
154108282|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154108283|NCT00863889|Prednisolone|prednisolone|mesh-list
154108284|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
154108285|NCT00863889|Lidocaine|lidocaine|mesh-list
154108286|NCT00863889|Bupivacaine|bupivacaine|mesh-list
154108287|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154108288|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
154108289|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
154108290|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
154256671|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154256672|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154108291|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108292|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108293|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
154108294|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108295|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154108296|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154108297|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154108298|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153809492|NCT03206671|Methotrexate|methotrexate|mesh-list
154108299|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337868|NCT02548650|Clopidogrel|clopidogrel|mesh-list
154108333|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154108334|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154108335|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108336|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108337|NCT00864045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154108338|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154108339|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108376|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337954|NCT00001996|Atovaquone|atovaquone|mesh-list
154108407|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154108408|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108409|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154108410|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
154108411|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154108412|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154108414|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
154108415|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
154108416|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108417|NCT00956098|Oltipraz|oltipraz|mesh-list
154108418|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
154108455|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108456|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154108490|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154108491|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
154108492|NCT02559102|Anesthetics|anesthetics|mesh-list
154108493|NCT02559102|Sevoflurane|sevoflurane|mesh-list
154108494|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108495|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783228|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
154108532|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108568|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108606|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108607|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
154108608|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108609|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338187|NCT02723162|Expectorants|expectorants|mesh-ancestor
154108642|NCT00877227|Protective Agents|protective agents|mesh-ancestor
154108643|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108644|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
154108645|NCT00877227|Vitamins|vitamins|mesh-ancestor
154108646|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
154108647|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
154108648|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154108649|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108650|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154108688|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154108689|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153338262|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809601|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153809687|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154108722|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153809688|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
153809707|NCT01387295|Trastuzumab|trastuzumab|mesh-list
153809708|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809709|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
153809710|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809711|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809712|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809713|NCT01288378|Caspofungin|caspofungin|mesh-list
153809714|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
153809715|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809716|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108723|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108724|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154108725|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
154108726|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108727|NCT00384085|Insulin|insulin|mesh-list
154108728|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154108729|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
154108730|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
154256673|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154256674|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108731|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154108732|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108733|NCT00361231|Bevacizumab|bevacizumab|mesh-list
154108734|NCT00361231|Gemcitabine|gemcitabine|mesh-list
154108735|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
154108761|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108763|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154108764|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154108765|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108766|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108767|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
154108768|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108769|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
154108770|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154108771|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
154108772|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108773|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108774|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154108775|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
154108776|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
154108777|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154108778|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
154108779|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108780|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108781|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154108816|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108817|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108818|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
154108819|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108820|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154108821|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154108822|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
154108852|NCT00873483|Hormones|hormones|mesh-ancestor
154108853|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154108854|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154108855|NCT00873483|Progestins|progestins|mesh-ancestor
154108856|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154108857|NCT01050517|Ivermectin|ivermectin|mesh-list
154108858|NCT01050517|Albendazole|albendazole|mesh-list
154108859|NCT01050517|Praziquantel|praziquantel|mesh-list
154108860|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154108861|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108862|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
154108863|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
154108864|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154108865|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154108866|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
154108867|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
154108868|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
154108869|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108898|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154108900|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
154108901|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154108902|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108903|NCT00879021|Pregabalin|pregabalin|mesh-list
154108904|NCT00879021|Analgesics|analgesics|mesh-ancestor
153809739|NCT00679029|Antibodies|antibodies|mesh-list
154108905|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
154108906|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108908|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
154108909|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154108910|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108911|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108912|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154108913|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154108914|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153338476|NCT00002074|Amebicides|amebicides|mesh-ancestor
154108951|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108990|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108991|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154108992|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154109019|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154109020|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154109021|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109022|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154109023|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154109024|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154109025|NCT00874107|Growth Substances|growth substances|mesh-ancestor
154109026|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109027|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
154109029|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154109030|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109031|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109032|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
154109033|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109034|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109035|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154109037|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
154109038|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109039|NCT00874419|Carboplatin|carboplatin|mesh-list
154109066|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154109067|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
154109068|NCT00614991|Ritonavir|ritonavir|mesh-list
154109069|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
154109070|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
154109071|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154109072|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154109073|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154109074|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109075|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109076|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154109077|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154109078|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
154109079|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109080|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154109081|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154109082|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154109083|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154109084|NCT00874575|Vitamin D|vitamin d|mesh-list
154109085|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
154109086|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
154109087|NCT00874575|Vitamins|vitamins|mesh-list
154109088|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
154109089|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109124|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109125|NCT00678288|Interferons|interferons|mesh-list
154109126|NCT00678288|Sorafenib|sorafenib|mesh-list
154109127|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109128|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
154109155|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154109156|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109157|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154109158|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154109159|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154109160|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154109161|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154109162|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154109163|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
154109164|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154109165|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154109166|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154109167|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154109168|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109169|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109170|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109171|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
154109172|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154109173|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
154109174|NCT00881049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154109175|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109176|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338727|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
154109207|NCT00875745|Sorafenib|sorafenib|mesh-list
154109208|NCT00875745|Vorinostat|vorinostat|mesh-list
154109209|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736438|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
154109210|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109211|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109212|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109213|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154109214|NCT00368875|Paclitaxel|paclitaxel|mesh-list
154109215|NCT00368875|Bevacizumab|bevacizumab|mesh-list
154109216|NCT00368875|Vorinostat|vorinostat|mesh-list
154109217|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154109218|NCT00368875|Antibodies|antibodies|mesh-list
154109219|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
154109220|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153338775|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109256|NCT00882765|Genistein|genistein|mesh-list
154109257|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153338824|NCT00002128|Adefovir|adefovir|mesh-list
154109279|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154109281|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109282|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154109283|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
154109285|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
154109286|NCT00613509|Vaccines|vaccines|mesh-list
154109287|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109288|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
154109289|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109290|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
154109291|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109292|NCT00881439|Aliskiren|aliskiren|mesh-list
154109293|NCT00881439|Renin Inhibitors|renin inhibitors|mesh-ancestor
154109294|NCT00881439|Protease Inhibitors|protease inhibitors|mesh-ancestor
154109295|NCT00881439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109296|NCT00881439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109297|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
154109298|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
154109299|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109300|NCT00881595|Temozolomide|temozolomide|mesh-list
154109301|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154109302|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
154109303|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109304|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109305|NCT00883155|Bupropion|bupropion|mesh-list
154109306|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153489741|NCT02430090|Fentanyl|fentanyl|mesh-list
154109307|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
154109308|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154109309|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153338861|NCT01661790|Bevacizumab|bevacizumab|mesh-list
154109331|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154109332|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109334|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154109335|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109336|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
154109337|NCT04487925|Hormones|hormones|mesh-list
154109338|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154109339|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154109340|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109341|NCT00547300|Metoprolol|metoprolol|mesh-list
154109342|NCT00547300|Nebivolol|nebivolol|mesh-list
154109343|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154109344|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154109345|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
154109346|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
154109347|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109348|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109349|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154109350|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154109351|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154109352|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
154109353|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109354|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109355|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
154109356|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154109357|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154109358|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153338903|NCT00000658|Doxorubicin|doxorubicin|mesh-list
153675481|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109381|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154109382|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154109383|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154109384|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
154109385|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154109386|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154109388|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154109389|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
154109390|NCT00958906|Infliximab|infliximab|mesh-list
154109391|NCT00958906|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154109392|NCT00958906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154109393|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
154109394|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154109395|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154109396|NCT00959062|Clonidine|clonidine|mesh-list
154109397|NCT00959062|Analgesics|analgesics|mesh-ancestor
154109398|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
154109399|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109400|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109401|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154109402|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
154109403|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
154109404|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154109405|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154109406|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154109407|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154109408|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109409|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109440|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109441|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
154109442|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109443|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154109445|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
154109446|NCT00963274|Bortezomib|bortezomib|mesh-list
154109447|NCT00963274|Romidepsin|romidepsin|mesh-list
154109448|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109449|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154109450|NCT00963274|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154109451|NCT00963274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109452|NCT00963274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109453|NCT00882609|Fluorides|fluorides|mesh-list
154109454|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
154109455|NCT00882609|Protective Agents|protective agents|mesh-ancestor
154109456|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109457|NCT00883623|Lenalidomide|lenalidomide|mesh-list
154109489|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109491|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154109492|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154109493|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154109494|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
154109495|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154109496|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109497|NCT04722718|Paclitaxel|paclitaxel|mesh-list
154109530|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109532|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109533|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
154109534|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109535|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154109536|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154109537|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
154109538|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109539|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154109540|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154109541|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109542|NCT00611559|PENTA|penta|mesh-list
154109543|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
154109544|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154109570|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154109571|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154109572|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
154109573|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109574|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109575|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
154109576|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
154109577|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109578|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154109579|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154109581|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
154109582|NCT02558868|Irinotecan|irinotecan|mesh-list
154109583|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109584|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153810201|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810202|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154109585|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154109586|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109587|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109588|NCT00611247|Temozolomide|temozolomide|mesh-list
154109589|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154109590|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
154109591|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339142|NCT00000724|Vitamins|vitamins|mesh-ancestor
154109624|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154109625|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109626|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109627|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109628|NCT02287818|Febuxostat|febuxostat|mesh-list
154109629|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
154109630|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154109631|NCT00762060|Anesthetics|anesthetics|mesh-list
154109632|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
154109633|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109634|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339192|NCT00002176|Nelfinavir|nelfinavir|mesh-list
154109666|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109667|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109668|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109669|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154109670|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154109671|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
154109672|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109673|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154109674|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
154109676|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
154109677|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154109678|NCT00886275|Midazolam|midazolam|mesh-list
153490117|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154109679|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
154109715|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109716|NCT02543385|Ketamine|ketamine|mesh-list
154109717|NCT02543385|Esketamine|esketamine|mesh-list
154109718|NCT02543385|Analgesics|analgesics|mesh-ancestor
154109719|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
154109744|NCT02543073|Hormones|hormones|mesh-ancestor
154109745|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154109746|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109747|NCT00546364|Docetaxel|docetaxel|mesh-list
154109748|NCT00546364|Capecitabine|capecitabine|mesh-list
154109749|NCT00546364|Epothilones|epothilones|mesh-list
154109750|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109751|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109752|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
154109753|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
154109754|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109755|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154109756|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
154109757|NCT00887211|Sirolimus|sirolimus|mesh-list
154109758|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154109759|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109760|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154109761|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109762|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
154109763|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154109764|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
154109765|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109766|NCT00887367|Ethanol|ethanol|mesh-list
154109767|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154109801|NCT05954078|Fluorouracil|fluorouracil|mesh-list
154109802|NCT05954078|Oxaliplatin|oxaliplatin|mesh-list
154109804|NCT05954078|Levoleucovorin|levoleucovorin|mesh-list
154109805|NCT05954078|Antimetabolites|antimetabolites|mesh-ancestor
154109806|NCT05954078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109807|NCT05954078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675779|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154109835|NCT05953675|Ethanol|ethanol|mesh-list
154109836|NCT05953675|Heparin|heparin|mesh-list
154109837|NCT05953675|Anticoagulants|anticoagulants|mesh-ancestor
154109838|NCT05953675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154109839|NCT05953675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154109840|NCT05953675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109841|NCT05953675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154109842|NCT05953675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109843|NCT05953675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109844|NCT05953675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109845|NCT05953376|Calcium, Dietary|calcium, dietary|mesh-list
154109846|NCT05953376|Calcium|calcium|mesh-list
154109847|NCT05953376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154109848|NCT05953376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109849|NCT05953376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154109850|NCT05953350|Hydroxychloroquine|hydroxychloroquine|mesh-list
154109851|NCT05953350|Palbociclib|palbociclib|mesh-list
154109852|NCT05953350|Antimalarials|antimalarials|mesh-ancestor
154109853|NCT05953350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154109854|NCT05953350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153339409|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
154109877|NCT05919030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191214|NCT05940324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109878|NCT05919030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109879|NCT05919030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154109881|NCT05917509|Cabotegravir|cabotegravir|mesh-list
154109882|NCT05917509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154109883|NCT05917509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154109884|NCT05917509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109885|NCT05917509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109886|NCT05917509|Antiviral Agents|antiviral agents|mesh-ancestor
154109887|NCT05917509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109888|NCT05917509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154109889|NCT05917509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154109890|NCT05917509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154109891|NCT05917509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154109892|NCT05895201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154109893|NCT05895201|Cyclophosphamide|cyclophosphamide|mesh-list
154109894|NCT05895201|Bortezomib|bortezomib|mesh-list
154109895|NCT05895201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154109896|NCT05895201|Immunologic Factors|immunologic factors|mesh-ancestor
154109897|NCT05895201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109898|NCT05895201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154109899|NCT05895201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154109900|NCT05895201|Alkylating Agents|alkylating agents|mesh-ancestor
154109901|NCT05895201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109902|NCT05895201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109903|NCT05895201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154109904|NCT05895201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154109905|NCT05895201|Incretins|incretins|mesh-ancestor
154109907|NCT05895201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154109908|NCT05895201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154109935|NCT05822063|Anesthetics, Local|anesthetics, local|mesh-ancestor
154109936|NCT05822063|Anesthetics|anesthetics|mesh-ancestor
154109937|NCT05822063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109938|NCT05822063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109939|NCT05822063|Sensory System Agents|sensory system agents|mesh-ancestor
154109940|NCT05822063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109941|NCT05822063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154109942|NCT05822063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154109943|NCT05822063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154109944|NCT05822063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154109945|NCT05822063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109946|NCT05820503|Anesthetics|anesthetics|mesh-list
154109947|NCT05820503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109948|NCT05820503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109949|NCT05817097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154109950|NCT05817097|Protease Inhibitors|protease inhibitors|mesh-ancestor
154109951|NCT05817097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109952|NCT05817097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109953|NCT05817097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154109954|NCT05817097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676033|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154109956|NCT05814354|Gemcitabine|gemcitabine|mesh-list
154109989|NCT05761041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109990|NCT05750966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154109991|NCT05750966|Ciprofloxacin|ciprofloxacin|mesh-list
154109992|NCT05750966|Gentamicins|gentamicins|mesh-list
154109993|NCT05750966|Ceftriaxone|ceftriaxone|mesh-list
154109994|NCT05750966|Cefuroxime|cefuroxime|mesh-list
154109995|NCT05750966|Cefuroxime axetil|cefuroxime axetil|mesh-list
154109996|NCT05750966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154109997|NCT05750966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109998|NCT05750966|Antitubercular Agents|antitubercular agents|mesh-ancestor
154109999|NCT05750966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154110000|NCT05750966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154110001|NCT05750966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110002|NCT05750966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110003|NCT05750966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110035|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110036|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154110037|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110038|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154110039|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154110041|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154110042|NCT05473273|Progesterone|progesterone|mesh-list
154110043|NCT05473273|Estrogens|estrogens|mesh-ancestor
154110044|NCT05473273|Hormones|hormones|mesh-ancestor
154110045|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110067|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154110068|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154110069|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110070|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154110071|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154110072|NCT05389813|Narcotics|narcotics|mesh-ancestor
154110073|NCT05341167|Phenylephrine|phenylephrine|mesh-list
154110074|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
154110075|NCT05341167|Norepinephrine|norepinephrine|mesh-list
154110076|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154110077|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
154110078|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
154110079|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110080|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110081|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
154110082|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154110083|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
154110084|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
154110085|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154110086|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154110087|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154110088|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
154110089|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110090|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110091|NCT05341167|Protective Agents|protective agents|mesh-ancestor
154110092|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
154110093|NCT05293132|Ubiquinone|ubiquinone|mesh-list
154110094|NCT05293132|Montelukast|montelukast|mesh-list
154110095|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154110096|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
154110097|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153339648|NCT00002236|Zidovudine|zidovudine|mesh-list
154110131|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154110132|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
154110133|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110134|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810496|NCT00319670|Laxatives|laxatives|mesh-ancestor
153404782|NCT01805271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110135|NCT05171062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154110136|NCT05171062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110137|NCT05148962|Vaccines|vaccines|mesh-list
154110165|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154110166|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154110167|NCT05050305|Growth Substances|growth substances|mesh-ancestor
154110168|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
154110169|NCT05020327|Amoxicillin|amoxicillin|mesh-list
154110170|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154110171|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110172|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
154110173|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154110174|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153676202|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153676206|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
154110175|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110176|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154110177|NCT04981951|Analgesics|analgesics|mesh-ancestor
154110178|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
154110180|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154110181|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154110182|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154110183|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
154110184|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110185|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110186|NCT04947527|Fluorides|fluorides|mesh-list
154110210|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154110211|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154110212|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
154110213|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
154110214|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110215|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154110216|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154110217|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110218|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110219|NCT04834375|Dexamethasone|dexamethasone|mesh-list
154110220|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
153810539|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810540|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153432232|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
154110221|NCT04834375|BB 1101|bb 1101|mesh-list
154110222|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110223|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
154110224|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
154110225|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110226|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110227|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154110228|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
154110229|NCT04834375|Hormones|hormones|mesh-ancestor
154110230|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110231|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154110232|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110233|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
154110234|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110235|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110236|NCT04788745|Trimetazidine|trimetazidine|mesh-list
154110247|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110249|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
154110250|NCT04710927|Protective Agents|protective agents|mesh-ancestor
154110251|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110253|NCT04694976|Vitamins|vitamins|mesh-ancestor
154110254|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
154110255|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110256|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154110257|NCT04683627|Diclofenac|diclofenac|mesh-list
154110258|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154110259|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154110260|NCT04683627|Analgesics|analgesics|mesh-ancestor
154110261|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
154110262|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110263|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110264|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110265|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154110266|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154110267|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110268|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110269|NCT04657666|Nabiximols|nabiximols|mesh-list
154110270|NCT04657666|Analgesics|analgesics|mesh-ancestor
154110271|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
154110272|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110273|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110274|NCT04646967|Acetaminophen|acetaminophen|mesh-list
154110275|NCT04646967|Ibuprofen|ibuprofen|mesh-list
154110276|NCT04646967|Ketorolac|ketorolac|mesh-list
154110277|NCT04646967|Bupivacaine|bupivacaine|mesh-list
154110278|NCT04646967|Sevoflurane|sevoflurane|mesh-list
154110279|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
154110280|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
153357178|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153357179|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
153357180|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
153357181|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
154110281|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110282|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110283|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
154110284|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110285|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154110286|NCT04646967|Analgesics|analgesics|mesh-ancestor
154110287|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
154110288|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154110289|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110290|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154110291|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154110292|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110293|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110294|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154110295|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154110296|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
154110297|NCT04563754|Proflavine|proflavine|mesh-list
154110298|NCT04563754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154110299|NCT04563754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110300|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
154110301|NCT04539249|Pentazocine|pentazocine|mesh-list
154110302|NCT04539249|Analgesics|analgesics|mesh-ancestor
154110303|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
154110338|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154110339|NCT04271189|Metformin|metformin|mesh-list
154110340|NCT04271189|Pioglitazone|pioglitazone|mesh-list
154110341|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154110342|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154110343|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110366|NCT04157725|Enclomiphene|enclomiphene|mesh-list
154110367|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
154110368|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154110369|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
154110370|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110371|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110372|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154110373|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
154110374|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154110375|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154110376|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153357214|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810541|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153810542|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153810543|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810544|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810545|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810546|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
153810547|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
153810569|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154110377|NCT04145518|Naproxen|naproxen|mesh-list
154110378|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154110379|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154110380|NCT04145518|Analgesics|analgesics|mesh-ancestor
154110381|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
154110382|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110383|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110384|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110385|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154110386|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
154110387|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154110388|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110389|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110390|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154110391|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154110392|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110393|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
154110394|NCT04101721|Aflibercept|aflibercept|mesh-list
154110395|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154110425|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
154110426|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110427|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110428|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110429|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110430|NCT03864926|Tacrolimus|tacrolimus|mesh-list
154110431|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154110432|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
154110433|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110434|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154110435|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110436|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110438|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154110439|NCT03809533|Velpatasvir|velpatasvir|mesh-list
154110440|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
154110441|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110442|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
154110443|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153676586|NCT00061815|Vitamins|vitamins|mesh-ancestor
154110444|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154110477|NCT03597568|Protective Agents|protective agents|mesh-ancestor
154110478|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110479|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110480|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154110481|NCT03593408|Midazolam|midazolam|mesh-list
154110482|NCT03593408|Fentanyl|fentanyl|mesh-list
154110483|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
154110484|NCT03593408|Morphine|morphine|mesh-list
154110520|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
154110521|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
154110522|NCT03432871|Vitamins|vitamins|mesh-ancestor
154110523|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
153340090|NCT01004705|Aspirin|aspirin|mesh-list
154110548|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
154110549|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
154110550|NCT03380468|Pemetrexed|pemetrexed|mesh-list
154110551|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110552|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110553|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110554|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154110555|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154110556|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
154110557|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110558|NCT03258853|Pancrelipase|pancrelipase|mesh-list
154110559|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154110560|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
154110561|NCT03236155|Narcotics|narcotics|mesh-ancestor
154110562|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110563|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110564|NCT03236155|Analgesics|analgesics|mesh-ancestor
154110565|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
154110566|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110567|NCT03177122|Inositol|inositol|mesh-list
154110568|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
154110569|NCT03177122|Vitamins|vitamins|mesh-ancestor
154110570|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
154110571|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110572|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154110594|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110596|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110597|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110598|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110599|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154110600|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154110602|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
154110603|NCT02923128|Dsuvia|dsuvia|mesh-list
154110604|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154110605|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110606|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110607|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154110608|NCT02923128|Analgesics|analgesics|mesh-ancestor
154110609|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
153357216|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
154110610|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110611|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154110612|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154110613|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154110614|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
154110615|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110616|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110617|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154110618|NCT02923128|Narcotics|narcotics|mesh-ancestor
154110619|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154110620|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154110621|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
154110622|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
154110623|NCT02839642|Rivastigmine|rivastigmine|mesh-list
154110658|NCT02575963|Furosemide|furosemide|mesh-list
154110659|NCT02575963|Spironolactone|spironolactone|mesh-list
154110660|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154110661|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
154110662|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110663|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110664|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
154110691|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154110692|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154110693|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
154110694|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110695|NCT02364089|Epinephrine|epinephrine|mesh-list
154110696|NCT02364089|Racepinephrine|racepinephrine|mesh-list
154110697|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
154110698|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154110699|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154110700|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
154110701|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110702|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110703|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110704|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154110705|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154110706|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
154110707|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110708|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153340270|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
154110733|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110734|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110735|NCT02115724|Protective Agents|protective agents|mesh-ancestor
153810582|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153810583|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110736|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
154110737|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
154110738|NCT02036372|Insulin|insulin|mesh-list
154110739|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154110740|NCT02036372|Liraglutide|liraglutide|mesh-list
154110741|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154110742|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110743|NCT02036372|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154110744|NCT02036372|Incretins|incretins|mesh-ancestor
154110745|NCT02036372|Hormones|hormones|mesh-ancestor
154110746|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110747|NCT01633541|Carboplatin|carboplatin|mesh-list
154110748|NCT01633541|Docetaxel|docetaxel|mesh-list
154110749|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110750|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
154110751|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
154110752|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
154110753|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110754|NCT01399372|Cytarabine|cytarabine|mesh-list
154110755|NCT01399372|Rituximab|rituximab|mesh-list
154110756|NCT01399372|Methotrexate|methotrexate|mesh-list
154110757|NCT01399372|Vincristine|vincristine|mesh-list
154110758|NCT01399372|Procarbazine|procarbazine|mesh-list
154110759|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110760|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110761|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
154110762|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110827|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154110828|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154110830|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
154110831|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154110832|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110833|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
154110834|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154110835|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154110836|NCT04017741|Prednisolone|prednisolone|mesh-list
154110837|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
154110838|NCT04017741|Lidocaine|lidocaine|mesh-list
154110839|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154110840|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
154110841|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
154110842|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
154110843|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110844|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110845|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
154110846|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110847|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154110873|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154110874|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154110876|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154110877|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110878|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110879|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
154110880|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110881|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110883|NCT00887757|Gemcitabine|gemcitabine|mesh-list
153676921|NCT00035984|Exenatide|exenatide|mesh-list
154110884|NCT00887757|Navitoclax|navitoclax|mesh-list
154110885|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154110886|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
154110887|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110888|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110889|NCT00965224|Immunomodulating Agents|immunomodulating agents|mesh-list
154110890|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
154110891|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110892|NCT04392921|Amiodarone|amiodarone|mesh-list
154110893|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154110894|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
154110895|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154110896|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154110968|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110969|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110970|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110971|NCT00610155|Pregabalin|pregabalin|mesh-list
154110972|NCT00610155|Tramadol|tramadol|mesh-list
154110973|NCT00610155|Analgesics|analgesics|mesh-ancestor
153340537|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
154111000|NCT00888303|Dexamethasone|dexamethasone|mesh-list
154111001|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111002|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
154111003|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
154111004|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111005|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111006|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111007|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
154111008|NCT00888303|Hormones|hormones|mesh-ancestor
154111009|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736361|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
153736362|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153736363|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
153736364|NCT02946996|Metformin|metformin|mesh-list
153736365|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153736366|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736367|NCT02931188|Anacetrapib|anacetrapib|mesh-list
153736368|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153736369|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153736370|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
153736371|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736372|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153864481|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864482|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864483|NCT01516346|Hydralazine|hydralazine|mesh-list
153864484|NCT01516346|Isosorbide|isosorbide|mesh-list
153864485|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154111010|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111011|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111012|NCT00967642|Insulin|insulin|mesh-list
154111013|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111014|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111015|NCT00674700|Immunomodulating Agents|immunomodulating agents|mesh-list
154111016|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
154111017|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111018|NCT00762918|Vitamin D|vitamin d|mesh-list
154111019|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
154111020|NCT00762918|Vitamins|vitamins|mesh-ancestor
154111021|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
154111056|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111057|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
154111090|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
154111091|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111092|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111094|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154111095|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
154111096|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154111097|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154111098|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154111129|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111130|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111131|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154111132|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154111133|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
154111134|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111135|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
154111136|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154111137|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111138|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154111139|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340704|NCT00002566|Ifosfamide|ifosfamide|mesh-list
154111173|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594201|NCT01847768|Miotics|miotics|mesh-ancestor
154111175|NCT00965926|Urological Agents|urological agents|mesh-ancestor
154111176|NCT00966004|Mirabegron|mirabegron|mesh-list
154111177|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154111178|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154111210|NCT00966160|Lamivudine|lamivudine|mesh-list
154111211|NCT00966160|Zidovudine|zidovudine|mesh-list
154111212|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154111213|NCT00966160|Efavirenz|efavirenz|mesh-list
154111214|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154111215|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154111216|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
154111217|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111218|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111219|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154111220|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154111221|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
154111222|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340790|NCT00199082|Vindesine|vindesine|mesh-list
154111250|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111251|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111252|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111253|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154111254|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154111255|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154111256|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111257|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154111258|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154111259|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111260|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
154111262|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154111263|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111264|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
154111265|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111266|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154111267|NCT00766896|Aspirin|aspirin|mesh-list
154111298|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111299|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
154111300|NCT04018131|Cimetidine|cimetidine|mesh-list
154111301|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154111302|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111303|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154111304|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
154111305|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
154111306|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111307|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111308|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111309|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153340879|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
154111340|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111341|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
154111342|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
154111343|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111344|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111345|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111346|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
154111347|NCT05279482|Hormones|hormones|mesh-ancestor
154111348|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111349|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154111350|NCT05279482|Protective Agents|protective agents|mesh-ancestor
154111351|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111352|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111385|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111386|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111387|NCT00890253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154111388|NCT00890253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154111389|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111390|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111391|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111392|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
154111393|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340977|NCT00002692|Leucovorin|leucovorin|mesh-list
154111416|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
154111417|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111418|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
154111419|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
154111420|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111421|NCT00968110|Omalizumab|omalizumab|mesh-list
154111422|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154111423|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154111424|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
154111425|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
154111426|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
154111427|NCT00608517|Fludarabine|fludarabine|mesh-list
154111428|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
154111429|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153677331|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111430|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111431|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
154111432|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111433|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154111434|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154111435|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
154111436|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111437|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111438|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154111439|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154111440|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
154111441|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111442|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
154111443|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
154111444|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111445|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111446|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
154111447|NCT00608517|Hormones|hormones|mesh-ancestor
153341008|NCT01895348|Propofol|propofol|mesh-list
154111477|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111478|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111479|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111480|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154111481|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154111482|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154111483|NCT00974272|Exenatide|exenatide|mesh-list
154111484|NCT00974272|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154111485|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111486|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111487|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154111488|NCT00974272|Incretins|incretins|mesh-ancestor
154111489|NCT00974272|Hormones|hormones|mesh-ancestor
154111490|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111491|NCT00974428|Wobenzym|wobenzym|mesh-list
154111492|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154111516|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
154111517|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111518|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154111519|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111520|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
154111521|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111522|NCT00974740|Atorvastatin|atorvastatin|mesh-list
154111523|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154111524|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154111525|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
154111526|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111527|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154111528|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154111529|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111531|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154111532|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111533|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111534|NCT05227300|Lidocaine|lidocaine|mesh-list
154111535|NCT05227300|Epinephrine|epinephrine|mesh-list
154111536|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
154111537|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
154111538|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154111539|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111540|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
154111541|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111542|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153810593|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153810595|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
153810596|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810597|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810598|NCT00351507|Vildagliptin|vildagliptin|mesh-list
153810599|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153810600|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111543|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154111544|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154111612|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111613|NCT00764166|Hormones|hormones|mesh-ancestor
154111614|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111615|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111616|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
154111617|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154111618|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154111619|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154111620|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111621|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111622|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
154111623|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111624|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111625|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154111626|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111627|NCT02557542|Polidocanol|polidocanol|mesh-list
154111657|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111659|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154111660|NCT00770640|Pioglitazone|pioglitazone|mesh-list
154111661|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111662|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111663|NCT00770718|Thrombin|thrombin|mesh-list
154111664|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
154111665|NCT00770718|Coagulants|coagulants|mesh-ancestor
154111666|NCT00770796|Atorvastatin|atorvastatin|mesh-list
154111667|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154111668|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154111669|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
153341251|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111695|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
154111696|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154111697|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154111698|NCT00609609|Prednisolone|prednisolone|mesh-list
154111699|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
154111700|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154111701|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
154111702|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111703|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
154111704|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
154111705|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111706|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810601|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154111707|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111708|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
154111709|NCT00609609|Hormones|hormones|mesh-ancestor
154111710|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111711|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154111712|NCT00609609|Protective Agents|protective agents|mesh-ancestor
154111713|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111714|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111715|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154111716|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154111717|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153341292|NCT05167175|Olaparib|olaparib|mesh-list
154111746|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
154111747|NCT00890955|Amrubicin|amrubicin|mesh-list
154111748|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111749|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
154111750|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111751|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154111752|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154111753|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
154111754|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111755|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111756|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154111757|NCT00975052|Metformin|metformin|mesh-list
154111758|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154111759|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111760|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111795|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111797|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
154111798|NCT00968578|Hormones|hormones|mesh-ancestor
154111799|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111800|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154111826|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111827|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154111828|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
154111829|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111830|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111831|NCT00378703|Sirolimus|sirolimus|mesh-list
154256675|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111832|NCT00378703|Bevacizumab|bevacizumab|mesh-list
154111833|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154111835|NCT00378703|Temsirolimus|temsirolimus|mesh-list
154111836|NCT00378703|MTOR Inhibitors|mtor inhibitors|mesh-list
154111837|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
154111838|NCT00378703|Antibodies|antibodies|mesh-list
154111839|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
154111840|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154111841|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
154111842|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111843|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153594206|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153594207|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
153594217|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594218|NCT01847976|Doxycycline|doxycycline|mesh-list
153594219|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594220|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594221|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
153594222|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153594223|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153594224|NCT01848106|Bivalirudin|bivalirudin|mesh-list
154111844|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154111845|NCT00378703|Growth Substances|growth substances|mesh-ancestor
154111846|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111847|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
154111848|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
153341430|NCT04330300|Trandolapril|trandolapril|mesh-list
154111870|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
154111871|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111872|NCT00891423|Meropenem|meropenem|mesh-list
154111873|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154111874|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111875|NCT04035382|Misoprostol|misoprostol|mesh-list
154111876|NCT04035382|Oxytocin|oxytocin|mesh-list
154111877|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
154111878|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154111879|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111880|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154111881|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
154111882|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154111883|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111884|NCT02541045|Metadoxine|metadoxine|mesh-list
154111885|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154111886|NCT00891579|Pemetrexed|pemetrexed|mesh-list
154111887|NCT00891579|Gefitinib|gefitinib|mesh-list
154111888|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111889|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111890|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111891|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154111892|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154111893|NCT00891579|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154111894|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154111896|NCT00968734|Vitamin D|vitamin d|mesh-list
154111897|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153810603|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357236|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154111898|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111899|NCT00968734|Vitamins|vitamins|mesh-ancestor
154111900|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
154111901|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154111902|NCT03620643|Fulvestrant|fulvestrant|mesh-list
154111936|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111937|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
154111938|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
154111939|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
154111940|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111941|NCT05008354|Pyridoxine|pyridoxine|mesh-list
154111974|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111975|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111976|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154111977|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
154111978|NCT00975910|Lidocaine|lidocaine|mesh-list
154111979|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
154111980|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
154111981|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154111982|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111983|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
154111984|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111985|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153341578|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112017|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112019|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112020|NCT00969592|Insulin|insulin|mesh-list
154112021|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154112022|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
154112023|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
153677746|NCT00066612|Irinotecan|irinotecan|mesh-list
154112024|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154112025|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
154112026|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154112027|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112028|NCT00368641|Icodextrin|icodextrin|mesh-list
154112029|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
154112058|NCT00979966|MTOR Inhibitors|mtor inhibitors|mesh-list
154112059|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112060|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154112061|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154112062|NCT00979966|Growth Substances|growth substances|mesh-ancestor
154112063|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112064|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
154112065|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154112066|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112067|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112068|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112069|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
154112070|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154112071|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112072|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154112073|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
154112074|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
154112075|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154112076|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
154112077|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112079|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
154112080|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154112109|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
154112110|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112111|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154112112|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112113|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112114|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
154112115|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112117|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154112118|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154112119|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359626|NCT04580771|Cisplatin|cisplatin|mesh-list
154112120|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112121|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154112122|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
154112123|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
154112124|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341708|NCT01059929|Analgesics|analgesics|mesh-ancestor
154112158|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154112159|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154112160|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154112161|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
154112184|NCT00368251|Brivaracetam|brivaracetam|mesh-list
154112185|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
154112186|NCT00893841|Pramipexole|pramipexole|mesh-list
154112187|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154112188|NCT00893841|Dexpramipexole|dexpramipexole|mesh-list
154112189|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
154112190|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154112191|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154112192|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154112194|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810605|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154112195|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
154112196|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112197|NCT00893841|Protective Agents|protective agents|mesh-ancestor
154112198|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154112199|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154112200|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
154112201|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
154112202|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112203|NCT00378079|Methadone|methadone|mesh-list
154112204|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154112205|NCT00378079|Narcotics|narcotics|mesh-ancestor
154112206|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112207|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112208|NCT00378079|Analgesics|analgesics|mesh-ancestor
154112209|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
154112210|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256676|NCT01160588|Sertraline|sertraline|mesh-list
154256677|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
154112211|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
154112212|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
154112213|NCT00970450|Acetaminophen|acetaminophen|mesh-list
154112214|NCT00970450|Tropisetron|tropisetron|mesh-list
154112246|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112247|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112249|NCT00978172|Mefloquine|mefloquine|mesh-list
154112250|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
154112251|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154112252|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154112253|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112254|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112255|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
154112256|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
154112257|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154112281|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112282|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154112283|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112284|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
154112285|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112286|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112287|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154112288|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
154112289|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154112290|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112291|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
154112292|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154112293|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154112294|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154112295|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154112296|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154112297|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154112298|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154112301|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
154112302|NCT00970996|Paclitaxel|paclitaxel|mesh-list
154112303|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154112304|NCT00970996|Cisplatin|cisplatin|mesh-list
154112305|NCT00970996|Temozolomide|temozolomide|mesh-list
154112306|NCT00970996|Interleukin-2|interleukin-2|mesh-list
154112307|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154112308|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112309|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
154112310|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
154112311|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
154112343|NCT00869271|Antidotes|antidotes|mesh-ancestor
154112344|NCT00869271|Protective Agents|protective agents|mesh-ancestor
154112345|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
154112347|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
154112348|NCT00971074|Hylan|hylan|mesh-list
154112349|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
154112350|NCT00971074|Protective Agents|protective agents|mesh-ancestor
154112351|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112352|NCT00971152|Menotropins|menotropins|mesh-list
154112353|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154112354|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
153341963|NCT00002896|Cobalt|cobalt|mesh-list
154112389|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154112390|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
154112391|NCT03992911|Carboplatin|carboplatin|mesh-list
154112392|NCT03992911|Etoposide|etoposide|mesh-list
154112393|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
154112424|NCT00869973|Dexamethasone|dexamethasone|mesh-list
154112425|NCT00869973|Aprepitant|aprepitant|mesh-list
154112426|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154112427|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
154112428|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
154112429|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112430|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112431|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154112432|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
154112433|NCT00869973|Hormones|hormones|mesh-ancestor
154112434|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112452|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112453|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
154112454|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154112455|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154112456|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154112457|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154112458|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112459|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
154112460|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112461|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112462|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154112463|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112464|NCT00978718|Selenium|selenium|mesh-list
154112465|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
154112466|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432550|NCT04560166|Irinotecan|irinotecan|mesh-list
154112467|NCT00978718|Protective Agents|protective agents|mesh-ancestor
154112468|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112469|NCT00978718|Trace Elements|trace elements|mesh-ancestor
154112470|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
154112471|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
154112472|NCT00895713|Antibodies|antibodies|mesh-list
154112473|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
154112474|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154112475|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154112476|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
154112477|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112478|NCT01051765|Irinotecan|irinotecan|mesh-list
154112479|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112480|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154112481|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154112482|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112483|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112484|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154112485|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154112486|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112487|NCT00978796|Incretins|incretins|mesh-ancestor
154112488|NCT00978796|Hormones|hormones|mesh-ancestor
153342060|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
154112508|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
154112509|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112510|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112511|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154112512|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112513|NCT00894621|Norepinephrine|norepinephrine|mesh-list
154112514|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154112515|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154112516|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
154112517|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112518|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112519|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112520|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
154112521|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
154112522|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112523|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154112524|NCT00376675|Methylphenidate|methylphenidate|mesh-list
154112525|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154112526|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112527|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154112528|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153810609|NCT00320567|Hormones|hormones|mesh-ancestor
154112529|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154112530|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112531|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
154112532|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112533|NCT00979186|Hemostatics|hemostatics|mesh-list
154112534|NCT00979186|Coagulants|coagulants|mesh-ancestor
154112536|NCT05178628|Gemcitabine|gemcitabine|mesh-list
154112537|NCT05178628|Tinzaparin|tinzaparin|mesh-list
154112538|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154112539|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112540|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
154112541|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
154112542|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342120|NCT01214161|Lidocaine|lidocaine|mesh-list
154112575|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112576|NCT00367237|Infliximab|infliximab|mesh-list
154112577|NCT00367237|Methotrexate|methotrexate|mesh-list
154112578|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154112579|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
154112580|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154112581|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112582|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154112600|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154112601|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112602|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112603|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
154112604|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112605|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154112606|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
154112607|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154112608|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154112609|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154112610|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112611|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
154112612|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154112613|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154112614|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154112615|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154112616|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112617|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154112619|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154112620|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
154112621|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112622|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112623|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154112624|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154112625|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
154112626|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112627|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112628|NCT00901719|Nitroprusside|nitroprusside|mesh-list
154112629|NCT00901719|Acetylcholine|acetylcholine|mesh-list
154112630|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154112631|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
154112632|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154112633|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112634|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154112635|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
154112636|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112637|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112638|NCT00972712|Bortezomib|bortezomib|mesh-list
154112639|NCT00972712|Tipifarnib|tipifarnib|mesh-list
153493118|NCT02970552|Hormones|hormones|mesh-ancestor
154112671|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112673|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154112674|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112675|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112676|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
154112677|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112678|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112679|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154112680|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
154112681|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112682|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
154112688|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
154112689|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112691|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154112692|NCT00901875|Naloxone|naloxone|mesh-list
154112693|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154112694|NCT00901875|Narcotics|narcotics|mesh-ancestor
154112695|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112696|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112697|NCT00901875|Analgesics|analgesics|mesh-ancestor
154112698|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
154112699|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112700|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154112701|NCT00972946|Dextrans|dextrans|mesh-list
154112702|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
154112703|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
154112704|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
154112705|NCT00606177|Aripiprazole|aripiprazole|mesh-list
154112706|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
154112707|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154112708|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154112709|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154112710|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112711|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112712|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
154112713|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
154112714|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112715|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112716|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154112717|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154112719|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154112720|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154112721|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154112722|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154112723|NCT00985270|Rifampin|rifampin|mesh-list
154112724|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154112725|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
154112726|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154112727|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112728|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
154112729|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154112730|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112731|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112732|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154112733|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154112734|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154112735|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154112736|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154112737|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154112739|NCT00359281|Levomethorphan|levomethorphan|mesh-list
154112740|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
154112741|NCT00359281|Atorvastatin|atorvastatin|mesh-list
154112742|NCT00359281|Simvastatin|simvastatin|mesh-list
154112743|NCT00359281|Ezetimibe|ezetimibe|mesh-list
154112744|NCT00359281|Fenofibrate|fenofibrate|mesh-list
154112745|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154112746|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154112747|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
154112748|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112749|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154112750|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154112751|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112752|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
153342323|NCT00003406|Carboplatin|carboplatin|mesh-list
154112787|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154112788|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
153810610|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112789|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112790|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112791|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112792|NCT00902187|Urological Agents|urological agents|mesh-ancestor
154112793|NCT01052311|Niacin|niacin|mesh-list
154112794|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154112795|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
154112796|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112797|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154112818|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154112819|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112820|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154112821|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154112822|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154112823|NCT00895089|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154112824|NCT00895089|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154112826|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
154112827|NCT00982540|Clotrimazole|clotrimazole|mesh-list
154112828|NCT00982540|Miconazole|miconazole|mesh-list
154112829|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112830|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112831|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112832|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154112833|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154112834|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154112835|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154112836|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
154112837|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112838|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112839|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154112840|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154112841|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154112842|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154112843|NCT00366535|Neurotropin|neurotropin|mesh-list
154112844|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154112845|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
154112846|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112847|NCT00366535|Analgesics|analgesics|mesh-ancestor
154112848|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
154112849|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112850|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
154112851|NCT00982618|Lidocaine|lidocaine|mesh-list
154112852|NCT00982618|Morphine|morphine|mesh-list
154112884|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112885|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112886|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
154112887|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112888|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154112889|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154112890|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
154112891|NCT00985660|Nisoldipine|nisoldipine|mesh-list
154112892|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154112893|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154112894|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154112922|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
154112923|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154112924|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112925|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112926|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154112927|NCT04006054|Analgesics|analgesics|mesh-ancestor
154112928|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
154112929|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112930|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154112931|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154112932|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154112933|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
154112934|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112935|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112936|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154112937|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154112938|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154112939|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154112964|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112965|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154112966|NCT01052389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154112967|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154112968|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154112969|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112970|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112971|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
154112972|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
154112973|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
154112974|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
154112975|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154112976|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154112977|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154112978|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154112979|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154112980|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154112981|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154112982|NCT00895323|Antibodies|antibodies|mesh-list
154112983|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154112984|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154112985|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
154112986|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112987|NCT00349921|Adenosine|adenosine|mesh-list
154112988|NCT00349921|Clonidine|clonidine|mesh-list
154112989|NCT00349921|Analgesics|analgesics|mesh-ancestor
154112990|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
154112991|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256678|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154256679|NCT01160588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154256680|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256681|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153678844|NCT00039962|Thymalfasin|thymalfasin|mesh-list
154112992|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112993|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154113021|NCT01052623|Estrogens|estrogens|mesh-ancestor
154113022|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154113023|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
154113024|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154113025|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154113026|NCT01052623|Analgesics|analgesics|mesh-ancestor
154113027|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
154113028|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113029|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154113030|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
154113031|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
154113032|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154113033|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154113034|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154113035|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
154113036|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113037|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113039|NCT00902811|Amodiaquine|amodiaquine|mesh-list
154113040|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
154113041|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154113073|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113074|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113075|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154113076|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154113077|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113078|NCT00902967|Atorvastatin|atorvastatin|mesh-list
154113079|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154113080|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154113081|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
154113082|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113083|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154113116|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113118|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154113119|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154113120|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113121|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153342714|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154113146|NCT00605865|Sertraline|sertraline|mesh-list
154113147|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
154113148|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154113149|NCT00605865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154113150|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154113151|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154113152|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113153|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113154|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
154113155|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113156|NCT00922467|Esmolol|esmolol|mesh-list
154113157|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154113158|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154113159|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154113160|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
154113161|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113162|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113163|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113164|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
154113165|NCT00903747|Prucalopride|prucalopride|mesh-list
154113166|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113167|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113168|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154113169|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154113170|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342757|NCT00003082|Antibodies|antibodies|mesh-list
154113188|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113189|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113190|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
154113191|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113192|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154113193|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154113194|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154113195|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154113196|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113197|NCT00904059|Asunaprevir|asunaprevir|mesh-list
154113198|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
154113199|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113200|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736374|NCT02903160|Carboplatin|carboplatin|mesh-list
153736375|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
153736376|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153736377|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736378|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153736379|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
154113201|NCT00337207|Bevacizumab|bevacizumab|mesh-list
154113202|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113203|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113204|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154113205|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154113206|NCT00337207|Growth Substances|growth substances|mesh-ancestor
154113207|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113208|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
154113209|NCT01055743|Fluorouracil|fluorouracil|mesh-list
154113210|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
154113211|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113212|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154113213|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113214|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113215|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
154113216|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113217|NCT00604695|Tenecteplase|tenecteplase|mesh-list
154113218|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154113219|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154113220|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113221|NCT01055821|Interferons|interferons|mesh-list
154113223|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113224|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
154113225|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113226|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
154113227|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113259|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154113260|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154113261|NCT00904605|Analgesics|analgesics|mesh-ancestor
154113262|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
154113263|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113264|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113265|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154113266|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436660|NCT00002701|Cytarabine|cytarabine|mesh-list
154113267|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154113268|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154113269|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113270|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113271|NCT00905073|Cyclosporine|cyclosporine|mesh-list
154113272|NCT00905073|Methotrexate|methotrexate|mesh-list
154113295|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
154113296|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113297|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153810626|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
154113298|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154113299|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113300|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
154113301|NCT00905229|Coagulants|coagulants|mesh-ancestor
154113302|NCT00905541|Simvastatin|simvastatin|mesh-list
154113303|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154113304|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154113305|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
154113306|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113307|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154113308|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154113309|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113311|NCT00348283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154113312|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154113313|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154113314|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
154113315|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154113316|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113317|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154113318|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
154113319|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113320|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113321|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113322|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113323|NCT00336583|Cytarabine|cytarabine|mesh-list
154113324|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
154113325|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
154113352|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113353|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113354|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154113355|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113356|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113357|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154113358|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154113359|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
154113360|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154113361|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154113362|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113363|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
154113364|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
154113365|NCT03987529|Propofol|propofol|mesh-list
154113366|NCT03987529|Sevoflurane|sevoflurane|mesh-list
154113367|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154113368|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113369|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113370|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154113371|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
154113372|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
154113373|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154113409|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154113410|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
154113411|NCT01059955|Hormones|hormones|mesh-ancestor
154113412|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113413|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154113414|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113415|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
154113443|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113444|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113445|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113446|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113447|NCT01060501|Leucovorin|leucovorin|mesh-list
154113448|NCT01060501|Folic Acid|folic acid|mesh-list
154113449|NCT01060501|Interferons|interferons|mesh-list
154113450|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
154113451|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
154113452|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113453|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
154113454|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113455|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
154113456|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113457|NCT01060501|Antidotes|antidotes|mesh-ancestor
154113458|NCT01060501|Protective Agents|protective agents|mesh-ancestor
154113459|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
154113460|NCT01060501|Vitamins|vitamins|mesh-ancestor
154113461|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
154113462|NCT01060501|Hematinics|hematinics|mesh-ancestor
154113463|NCT00671658|Cytarabine|cytarabine|mesh-list
154113464|NCT00671658|Dexamethasone|dexamethasone|mesh-list
154113465|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
154113466|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154113488|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154113490|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
154113491|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436880|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113492|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154113493|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
154113494|NCT00671658|Hormones|hormones|mesh-ancestor
154113495|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113496|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154113497|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113498|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154113499|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154113500|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154113501|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113502|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154113503|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
154113504|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154113505|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154113506|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
154113507|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
154113508|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154113509|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154113510|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
154113511|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113512|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154113513|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
154113514|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
154113515|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
154113516|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154113517|NCT00671658|Protective Agents|protective agents|mesh-ancestor
154113519|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154113520|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113521|NCT00768456|Ropivacaine|ropivacaine|mesh-list
154113542|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113543|NCT04048200|Fentanyl|fentanyl|mesh-list
154113544|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
154113545|NCT04048200|Ketamine|ketamine|mesh-list
154113546|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
154113547|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154113548|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113549|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113550|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154113551|NCT04048200|Analgesics|analgesics|mesh-ancestor
154113552|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
154113553|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113554|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154113555|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154113556|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154113557|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
154113558|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113559|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113560|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154113561|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154113562|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
154113563|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
154113564|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154113565|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154113566|NCT04048200|Narcotics|narcotics|mesh-ancestor
154113567|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153494010|NCT04420572|Betamethasone|betamethasone|mesh-list
154113569|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154113570|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113571|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154113572|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154113573|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
154113574|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153343152|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154113608|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113610|NCT00775086|Norelgestromin|norelgestromin|mesh-list
154113611|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
154113612|NCT00775086|Estradiol|estradiol|mesh-list
154113635|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
154113636|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113638|NCT00986050|Abciximab|abciximab|mesh-list
154113639|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113640|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113641|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154113643|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
154113644|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113645|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
154113646|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113647|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
154113648|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154113649|NCT00986128|Topiramate|topiramate|mesh-list
153679410|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
154113650|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
154113651|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154113652|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113653|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
154113654|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154113655|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
154113656|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113657|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113658|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154113659|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
154113660|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154113661|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
154113662|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113663|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343247|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
154113686|NCT04767256|Hormones|hormones|mesh-ancestor
154113687|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113688|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154113689|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113690|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154113691|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113692|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154113693|NCT04767256|Analgesics|analgesics|mesh-ancestor
154113694|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
154113695|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154113696|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154113697|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154113698|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154113699|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113700|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113701|NCT00771498|Lopinavir|lopinavir|mesh-list
154113702|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154113703|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154113704|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
154113705|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113706|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864858|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594225|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
153594226|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153594227|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
153594229|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113707|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154113708|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154113709|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
154113710|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113711|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154113712|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154113713|NCT00986284|Gefitinib|gefitinib|mesh-list
154113714|NCT00986284|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153729675|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113715|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154113716|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113717|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113750|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
154113751|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154113752|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154113753|NCT00986518|Immunomodulating Agents|immunomodulating agents|mesh-list
154113754|NCT00986518|Immunologic Factors|immunologic factors|mesh-ancestor
154113755|NCT00986518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113788|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113789|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113790|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
154113791|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154113792|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154113793|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154113794|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113795|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113796|NCT00771888|Lanreotide|lanreotide|mesh-list
154113797|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113798|NCT00605475|Metformin|metformin|mesh-list
154113834|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113835|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113836|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
154113837|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
154113838|NCT00908661|Coagulants|coagulants|mesh-ancestor
153432777|NCT03641755|Olaparib|olaparib|mesh-list
154113839|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
154113840|NCT00983398|Carboplatin|carboplatin|mesh-list
154113841|NCT00983398|Melphalan|melphalan|mesh-list
154113842|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
154113876|NCT05277675|Tislelizumab|tislelizumab|mesh-list
154113877|NCT05277675|Lenvatinib|lenvatinib|mesh-list
154113878|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113879|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113880|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154113881|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154113882|NCT05277675|Growth Substances|growth substances|mesh-ancestor
154113883|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113884|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
154113885|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153343481|NCT00384592|Esomeprazole|esomeprazole|mesh-list
154113918|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
154113919|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
154113920|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154113921|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
154113923|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113924|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113925|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113926|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
154113927|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113928|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113944|NCT00332839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154113945|NCT00332839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154113946|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113947|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154113948|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154113949|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
154113950|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113951|NCT00927147|Cetuximab|cetuximab|mesh-list
154113952|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113953|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113954|NCT05712616|Strontium ranelate|strontium ranelate|mesh-list
154113955|NCT05712616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154113956|NCT05712616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113957|NCT00927225|Ropivacaine|ropivacaine|mesh-list
154113958|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
154113959|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
154113960|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113961|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113962|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
154113963|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113964|NCT00357097|Ropinirole|ropinirole|mesh-list
154113965|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154113966|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154113967|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
154113968|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
154113969|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113970|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113971|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113972|NCT00983788|Bezafibrate|bezafibrate|mesh-list
154113973|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154113974|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
154113975|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113976|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154113977|NCT00983944|Prednisone|prednisone|mesh-list
154113978|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
154113979|NCT00983944|Rituximab|rituximab|mesh-list
154113980|NCT00983944|Doxorubicin|doxorubicin|mesh-list
154113981|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154113982|NCT00983944|Etoposide|etoposide|mesh-list
154113983|NCT00983944|Vincristine|vincristine|mesh-list
154113984|NCT00983944|Bleomycin|bleomycin|mesh-list
154113986|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
154113987|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113988|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154113989|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154113990|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
154113991|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113992|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114018|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154114021|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154114022|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114023|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154114024|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114025|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114026|NCT00909129|Interferons|interferons|mesh-list
154114027|NCT00909129|Ribavirin|ribavirin|mesh-list
154114028|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
154114029|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154114030|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114031|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
154114032|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114033|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
154114034|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114035|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
154114036|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114037|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154114038|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
154114039|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154114062|NCT03990103|Tegafur|tegafur|mesh-list
154114063|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114064|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114065|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114066|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114067|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114068|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114069|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154114070|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154114071|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154114072|NCT03990103|Growth Substances|growth substances|mesh-ancestor
154114073|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114074|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
154114075|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154114076|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
154114077|NCT00927693|Calcium|calcium|mesh-list
154114078|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154114079|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114080|NCT00987220|Donepezil|donepezil|mesh-list
154114081|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154114082|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114083|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114084|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
154114085|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114086|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114087|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
154114088|NCT01581151|Dexamethasone|dexamethasone|mesh-list
154114089|NCT01581151|Ranibizumab|ranibizumab|mesh-list
154114090|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114091|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
154114092|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
154114124|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114125|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114126|NCT01053637|Acetaminophen|acetaminophen|mesh-list
154114127|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154114128|NCT01053637|Hydrocodone|hydrocodone|mesh-list
154114129|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154114130|NCT01053637|Analgesics|analgesics|mesh-ancestor
154114131|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
154114132|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114133|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114134|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
154114135|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153810628|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114136|NCT01053637|Narcotics|narcotics|mesh-ancestor
154114166|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
154114167|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154114168|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154114169|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154114170|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154114171|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154114172|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154114173|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
154114174|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114175|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154114176|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154114177|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114178|NCT00907179|Pemetrexed|pemetrexed|mesh-list
154114179|NCT00907179|Panobinostat|panobinostat|mesh-list
154114180|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114204|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
154114205|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154114206|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154114207|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154114208|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154114209|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
154114210|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
154114211|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114212|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114213|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154114214|NCT01053871|Narcotics|narcotics|mesh-ancestor
154114215|NCT01053871|Analgesics|analgesics|mesh-ancestor
154114216|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
154114217|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114218|NCT01053949|Thalidomide|thalidomide|mesh-list
154114219|NCT01053949|Pomalidomide|pomalidomide|mesh-list
154114220|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
154114221|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114222|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154114223|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154114224|NCT01053949|Growth Substances|growth substances|mesh-ancestor
154114225|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
154114226|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114227|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114228|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
154114229|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154114230|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114231|NCT00987376|Choline|choline|mesh-list
154114232|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
154114233|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154114265|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154114266|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114267|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154114268|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114269|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
154114270|NCT01054027|Phenylephrine|phenylephrine|mesh-list
154114271|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
154114272|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
154114273|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154114274|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
154114275|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
154114276|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114277|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114278|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
154114279|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154114280|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
153343881|NCT00003292|Ifosfamide|ifosfamide|mesh-list
154114316|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154114317|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154114318|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114353|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
154114354|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114355|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154114356|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154114357|NCT00541450|Metformin|metformin|mesh-list
154114358|NCT00541450|Pioglitazone|pioglitazone|mesh-list
154114359|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154114360|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154114361|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114390|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114391|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114392|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154114393|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114394|NCT00540124|Tadalafil|tadalafil|mesh-list
154114395|NCT00540124|Tamsulosin|tamsulosin|mesh-list
154114396|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
154114397|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154114398|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154114399|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114400|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114401|NCT00540124|Urological Agents|urological agents|mesh-ancestor
154114402|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154114403|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154114404|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154114405|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
154114406|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114407|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114440|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114441|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
154114442|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114443|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114444|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
154114445|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154114446|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154114447|NCT00689936|Growth Substances|growth substances|mesh-ancestor
154114448|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
154114449|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154114450|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
154114451|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154114452|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114453|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
154114454|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154114481|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
154114482|NCT00671034|Pegaspargase|pegaspargase|mesh-list
154114483|NCT00671034|Thioguanine|thioguanine|mesh-list
154114484|NCT00671034|BB 1101|bb 1101|mesh-list
154114485|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
154114486|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114487|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
154114488|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114489|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114490|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154114491|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
154114492|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114493|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114494|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154114495|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114496|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
154114497|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
154114498|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114499|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114500|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
154114501|NCT00671034|Hormones|hormones|mesh-ancestor
154114502|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114503|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154114504|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
154114505|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114506|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153810631|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154114507|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154114508|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344085|NCT00003340|Topotecan|topotecan|mesh-list
154114535|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154114536|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114537|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154114538|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
154114539|NCT04425070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154114540|NCT00743678|Cetuximab|cetuximab|mesh-list
154114541|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154114542|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114543|NCT02679508|Lansoprazole|lansoprazole|mesh-list
154114544|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
154114545|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154114546|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114547|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154114548|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114549|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114550|NCT00775632|Cyclosporine|cyclosporine|mesh-list
154114551|NCT00775632|Methotrexate|methotrexate|mesh-list
154114552|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
154114553|NCT00775632|Cyclosporins|cyclosporins|mesh-list
154114554|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154114555|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
154114556|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154114557|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344151|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
154114576|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154114577|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256683|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680407|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
154114578|NCT04394182|Ritonavir|ritonavir|mesh-list
154114579|NCT04394182|Lopinavir|lopinavir|mesh-list
154114580|NCT04394182|Azithromycin|azithromycin|mesh-list
154114581|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
154114582|NCT04394182|Tazobactam|tazobactam|mesh-list
154114583|NCT04394182|Piperacillin|piperacillin|mesh-list
154114584|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154114585|NCT04394182|Heparin|heparin|mesh-list
154114586|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154114587|NCT04394182|Tinzaparin|tinzaparin|mesh-list
154114588|NCT04394182|Dalteparin|dalteparin|mesh-list
154114589|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154114590|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154114591|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
154114592|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114593|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114594|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154114595|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154114596|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
154114597|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114598|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154114599|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154114600|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
154114601|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154114602|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154114603|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154114604|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
154114605|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154114606|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154114607|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114608|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154114609|NCT00539734|Ranibizumab|ranibizumab|mesh-list
154114610|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154114611|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154114612|NCT00539734|Growth Substances|growth substances|mesh-ancestor
154114613|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114614|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
154114615|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114616|NCT04004572|Pegaspargase|pegaspargase|mesh-list
154114646|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
154114647|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114648|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
154114649|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114651|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154114652|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
154114653|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
154114654|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154114655|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114656|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154114657|NCT04008628|Analgesics|analgesics|mesh-ancestor
154114658|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
154114659|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114660|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
154114661|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154114679|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154114680|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114681|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114682|NCT04060472|Paclitaxel|paclitaxel|mesh-list
154114683|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
153357258|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153357259|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154114684|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154114685|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114686|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114687|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114688|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114689|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114690|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114691|NCT00329641|Paclitaxel|paclitaxel|mesh-list
154114692|NCT00329641|Carboplatin|carboplatin|mesh-list
154114693|NCT00329641|Sorafenib|sorafenib|mesh-list
154114694|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114695|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114696|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114697|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114698|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114699|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114700|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154114701|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114702|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154114703|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
154114704|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114705|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114706|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114707|NCT00743990|Camphor|camphor|mesh-list
154114708|NCT00743990|Menthol|menthol|mesh-list
154114709|NCT00743990|Petrolatum|petrolatum|mesh-list
154114710|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
154114711|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
154114712|NCT00743990|Emollients|emollients|mesh-ancestor
154114713|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154114714|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114715|NCT00329407|Topiramate|topiramate|mesh-list
154114716|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
154114717|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154114743|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
154114744|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
154114745|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154114746|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114747|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
154114748|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114749|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154114750|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154114751|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154114752|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154114753|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114755|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
154114756|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
154114757|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154114758|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154114759|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114760|NCT00770172|Lenograstim|lenograstim|mesh-list
154114761|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154114762|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
154114763|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114764|NCT02557620|Semaglutide|semaglutide|mesh-list
154114765|NCT02557620|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154114766|NCT02557620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154114767|NCT02557620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114768|NCT00776022|Cetirizine|cetirizine|mesh-list
154114786|NCT00779220|Methotrexate|methotrexate|mesh-list
154114787|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
154114788|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154114789|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
154114790|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154114791|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114792|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154114793|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
154114794|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114795|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114796|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
154114797|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114798|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154114799|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114800|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
154114801|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114802|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154114803|NCT00779376|Zidovudine|zidovudine|mesh-list
154114804|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
154114805|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114806|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154114807|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154114808|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114809|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
154114810|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114811|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154114812|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154114813|NCT00779454|Gemcitabine|gemcitabine|mesh-list
154114814|NCT00779454|Capecitabine|capecitabine|mesh-list
154114815|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
154114816|NCT00779454|Panitumumab|panitumumab|mesh-list
154114817|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154114818|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
153810634|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
153357260|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114819|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114820|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114821|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154114822|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
154114841|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114842|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114843|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154114844|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
154114845|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
154114846|NCT00667992|Hormones|hormones|mesh-ancestor
154114847|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114848|NCT00776490|Glimepiride|glimepiride|mesh-list
154114849|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154114850|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154114851|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114852|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114853|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
154114854|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
154114855|NCT00779922|Lenalidomide|lenalidomide|mesh-list
154114856|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
154114857|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114858|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154114859|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154114860|NCT00779922|Growth Substances|growth substances|mesh-ancestor
154114861|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
154114862|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114863|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154114864|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154114865|NCT00776646|Diuretics|diuretics|mesh-ancestor
154114866|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
154114867|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114868|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154114869|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154114870|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114872|NCT00776724|Epirubicin|epirubicin|mesh-list
154114873|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114874|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114875|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114876|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114877|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114878|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154114879|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154114880|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153865000|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153865001|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
154114913|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154114914|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154114916|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154114917|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114918|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
154114919|NCT00780780|Hormones|hormones|mesh-ancestor
154114920|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114921|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344501|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
154114984|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114985|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114986|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114987|NCT00669162|Docetaxel|docetaxel|mesh-list
154114988|NCT00669162|Leuprolide|leuprolide|mesh-list
154114989|NCT00669162|Goserelin|goserelin|mesh-list
154114990|NCT00669162|Bicalutamide|bicalutamide|mesh-list
154114991|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114992|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114993|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114994|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114995|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114996|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154114997|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
154114998|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154114999|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115000|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154115001|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
154115002|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
154115003|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115004|NCT00774696|Clarithromycin|clarithromycin|mesh-list
154115005|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154115006|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115007|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154115008|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115032|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115033|NCT00354770|Protective Agents|protective agents|mesh-ancestor
154115034|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115035|NCT00354770|Antidotes|antidotes|mesh-ancestor
154115037|NCT00744224|Prednisolone|prednisolone|mesh-list
153810635|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594230|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
153594231|NCT01848119|Gabapentin|gabapentin|mesh-list
154115038|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154115040|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154115041|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
154115042|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154115043|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
154115044|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115045|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
154115046|NCT00744224|Hormones|hormones|mesh-ancestor
154115047|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115048|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115049|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154115050|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115051|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
154115052|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
154115053|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115054|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154115055|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154115056|NCT00744224|Protective Agents|protective agents|mesh-ancestor
154115057|NCT00744224|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154115058|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154115059|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154115060|NCT00744224|Incretins|incretins|mesh-ancestor
154115093|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154115094|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115095|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154115096|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115097|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115098|NCT00781404|Adenosine|adenosine|mesh-list
154115099|NCT00781404|Analgesics|analgesics|mesh-ancestor
154115100|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
154115101|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115102|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115103|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154115104|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
154115105|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153344689|NCT05776212|Fluorides|fluorides|mesh-list
154115129|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154115130|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115131|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154115132|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
154115133|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115134|NCT00603915|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154115135|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154115136|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115137|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154115138|NCT00925977|Insulin|insulin|mesh-list
154115139|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154115140|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
154115141|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
154115142|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
154115143|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
154115144|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
154115145|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154115146|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115147|NCT00926055|Simvastatin|simvastatin|mesh-list
154115148|NCT00926055|Ezetimibe|ezetimibe|mesh-list
154115149|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154115150|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154115151|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154115152|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
154115153|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115154|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154115155|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154115178|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115179|NCT00690794|Travoprost|travoprost|mesh-list
154256685|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115181|NCT00690794|Latanoprost|latanoprost|mesh-list
154115182|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154115183|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154115184|NCT00666276|Linezolid|linezolid|mesh-list
154115185|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154115186|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115187|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154115188|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115189|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115190|NCT00567255|Naltrexone|naltrexone|mesh-list
154115191|NCT00567255|Bupropion|bupropion|mesh-list
154115192|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154115193|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154115194|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115195|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
154115196|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115197|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154115198|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
154115199|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154115200|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154115201|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154115202|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115203|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115204|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
154115205|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115206|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153344772|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
154115240|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115241|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154115242|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154115243|NCT00929799|Hormones|hormones|mesh-list
154115244|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115245|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115246|NCT00777738|Bortezomib|bortezomib|mesh-list
153344828|NCT05493475|Analgesics|analgesics|mesh-ancestor
154115299|NCT00931437|Vitamin K|vitamin k|mesh-list
154115300|NCT00931437|Vitamins|vitamins|mesh-ancestor
154115301|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
154115302|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115303|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154115304|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154115305|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115306|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
154115307|NCT00931437|Coagulants|coagulants|mesh-ancestor
154115308|NCT00742040|Captopril|captopril|mesh-list
154115309|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154115310|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
154115311|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115312|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115313|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154115314|NCT00926757|Entecavir|entecavir|mesh-list
154115315|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
154115316|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115317|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
154115318|NCT00782106|Antibodies|antibodies|mesh-list
154115319|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
154115320|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154115321|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154115322|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
154115323|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
154115324|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115325|NCT00929955|Ondansetron|ondansetron|mesh-list
154115326|NCT00929955|Simvastatin|simvastatin|mesh-list
154115327|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154115328|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154115329|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
154115330|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115331|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154115332|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154115333|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115334|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
154115335|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
154115336|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115337|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810637|NCT00320723|Nicotine|nicotine|mesh-list
154115364|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154115365|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
154115366|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
154115367|NCT00745004|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154115368|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154115369|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
154115370|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495815|NCT00001044|Antacids|antacids|mesh-ancestor
154115371|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115372|NCT04060550|Omalizumab|omalizumab|mesh-list
154115374|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154115375|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
154115376|NCT00921674|Ivermectin|ivermectin|mesh-list
154115377|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154115378|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115379|NCT00667446|Leuprolide|leuprolide|mesh-list
154115380|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154115381|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
154115382|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154115383|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115384|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154115385|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115386|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154115387|NCT00777972|Fosinopril|fosinopril|mesh-list
154115388|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154115406|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115407|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154115408|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
154115409|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
154115410|NCT00746486|Hormones|hormones|mesh-ancestor
154115411|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115412|NCT00778128|Gemcitabine|gemcitabine|mesh-list
154115413|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154115414|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
154115415|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115416|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115417|NCT00778284|Amoxicillin|amoxicillin|mesh-list
154115418|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154115419|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115420|NCT00749138|Tamoxifen|tamoxifen|mesh-list
154115421|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154115422|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
154115423|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115424|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115425|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154115426|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865051|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153810638|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153865052|NCT01157065|Ranibizumab|ranibizumab|mesh-list
153865059|NCT00566592|Ethanol|ethanol|mesh-list
153594232|NCT01848119|Analgesics|analgesics|mesh-ancestor
153594233|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
154115427|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154115428|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154115429|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154115430|NCT02563340|Rituximab|rituximab|mesh-list
154115431|NCT02563340|Bortezomib|bortezomib|mesh-list
154115432|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154115433|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115434|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
154115435|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115436|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115437|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
154115438|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154115439|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
154115440|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115441|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115442|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154115443|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
154115444|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154115475|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
154115476|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
154115477|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115478|NCT00567567|Vitamin A|vitamin a|mesh-list
154115479|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
154115480|NCT00567567|Melphalan|melphalan|mesh-list
154115481|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
154115482|NCT00567567|Thiotepa|thiotepa|mesh-list
154115483|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154115484|NCT00567567|Cisplatin|cisplatin|mesh-list
154115486|NCT00567567|Doxorubicin|doxorubicin|mesh-list
154115487|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154115488|NCT00567567|Etoposide|etoposide|mesh-list
154115489|NCT00567567|Vincristine|vincristine|mesh-list
154115490|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
154115524|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115525|NCT00666198|Urological Agents|urological agents|mesh-ancestor
154115526|NCT00778596|Prednisolone|prednisolone|mesh-list
154115527|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115528|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
153810639|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
153357261|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115529|NCT00778596|Hormones|hormones|mesh-ancestor
154115530|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115531|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115532|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154115533|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115548|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115549|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115550|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115551|NCT00778752|Growth Substances|growth substances|mesh-ancestor
154115552|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115553|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115554|NCT00926835|Lamotrigine|lamotrigine|mesh-list
154115555|NCT00926835|Dexetimide|dexetimide|mesh-list
154115556|NCT00926835|Aripiprazole|aripiprazole|mesh-list
154115557|NCT00926835|Mirtazapine|mirtazapine|mesh-list
154115558|NCT00926835|Citalopram|citalopram|mesh-list
154115559|NCT00926835|Bupropion|bupropion|mesh-list
154115560|NCT00926835|Paroxetine|paroxetine|mesh-list
154115561|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154115562|NCT00926835|Escitalopram|escitalopram|mesh-list
154115563|NCT00926835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154115564|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154115565|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115566|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115567|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115568|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
154115569|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115570|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154115571|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154115572|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
154115573|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
154115574|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115575|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154115576|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154115577|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
154115578|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154115579|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
154115580|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154115581|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154115582|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
154115583|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154115584|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154115585|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115586|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154115587|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154115588|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115589|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
154115590|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154115591|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154115592|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153345170|NCT00199095|Hormones|hormones|mesh-ancestor
154115617|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154115618|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115619|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115620|NCT00664560|Celecoxib|celecoxib|mesh-list
154115621|NCT00664560|Antacids|antacids|mesh-list
154115622|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154115623|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154115624|NCT00664560|Analgesics|analgesics|mesh-ancestor
154115625|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
154115626|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115627|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115628|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115629|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115630|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154115631|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154115632|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115633|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115634|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154115635|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154115636|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154115637|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154115638|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
154115657|NCT00930189|Ranibizumab|ranibizumab|mesh-list
154115658|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115659|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115660|NCT00930189|Growth Substances|growth substances|mesh-ancestor
154115661|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115662|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115663|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115664|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115665|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
154115666|NCT00930189|Hormones|hormones|mesh-ancestor
153810640|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357262|NCT01270802|Tenofovir|tenofovir|mesh-list
153405528|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594234|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594235|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594236|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
153594237|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154115667|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115668|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
154115669|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154115670|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154115671|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
153439079|NCT03234907|Vedolizumab|vedolizumab|mesh-list
154115672|NCT00931827|Etonogestrel|etonogestrel|mesh-list
154115673|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154115674|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
154115675|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154115676|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115677|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154115678|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154115679|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154115680|NCT00778908|Cisplatin|cisplatin|mesh-list
154115681|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115682|NCT02561468|Nefopam|nefopam|mesh-list
154115683|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154115684|NCT02561468|Analgesics|analgesics|mesh-ancestor
154115685|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
154115686|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115687|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115688|NCT02555748|Sunitinib|sunitinib|mesh-list
154115689|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115690|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115691|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115692|NCT02555748|Growth Substances|growth substances|mesh-ancestor
154115693|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115694|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
153345298|NCT00109395|Midazolam|midazolam|mesh-list
154115763|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115765|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115766|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
154115767|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
154115768|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115769|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
154115770|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154115771|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154115772|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154115773|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345387|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
154115796|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
154115797|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115798|NCT00786318|Ziprasidone|ziprasidone|mesh-list
154115799|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154115800|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
154115801|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115802|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115803|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115804|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154115805|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154115806|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115807|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154115808|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154115809|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
154115810|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154115811|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153681578|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
154115812|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154115813|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115814|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115815|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154115816|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154115817|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154115818|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
154115819|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115820|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115821|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154115822|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154115823|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
154115824|NCT00937911|Darexaban|darexaban|mesh-list
154115825|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154115826|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
154115858|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115859|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115860|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154115861|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154115862|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115863|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154115864|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154115865|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
154115866|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
154115867|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
154115868|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115869|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154115870|NCT00932529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154115905|NCT00931125|Ranibizumab|ranibizumab|mesh-list
154115906|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115907|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115908|NCT00931125|Growth Substances|growth substances|mesh-ancestor
154115909|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115910|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115911|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115912|NCT00932763|Amlodipine|amlodipine|mesh-list
153345525|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
153345569|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115971|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115972|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153496395|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
154115973|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154115974|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115975|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115977|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
154115978|NCT00565773|Abatacept|abatacept|mesh-list
154115979|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154115980|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115981|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154115982|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115983|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
154115984|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154115985|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
154115986|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115987|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115988|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154115989|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153594238|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153594239|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594240|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153594241|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153594242|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153594243|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115990|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115991|NCT00570492|Fluticasone|fluticasone|mesh-list
154115992|NCT00570492|Xhance|xhance|mesh-list
154115993|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115994|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154115995|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
154115996|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115997|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115998|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154116030|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154116031|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116032|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116033|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
154116034|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154116035|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116036|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116037|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
154116038|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
154116039|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116040|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154116041|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154116042|NCT00933231|Protective Agents|protective agents|mesh-ancestor
153345684|NCT00097448|Prednisone|prednisone|mesh-list
154116075|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154116076|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154116077|NCT00686894|Infliximab|infliximab|mesh-list
154116078|NCT00686894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154116079|NCT00686894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116080|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
154116081|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154116082|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116083|NCT00328627|Pioglitazone|pioglitazone|mesh-list
154116084|NCT00328627|Alogliptin|alogliptin|mesh-list
154116085|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154116118|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
154116120|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
154116121|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729678|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
154116122|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116123|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154116154|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154116155|NCT00752648|Simeprevir|simeprevir|mesh-list
154116156|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
154116157|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116158|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
154116159|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116160|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116161|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
154116162|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154116163|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154116164|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116165|NCT00752882|Ceftazidime|ceftazidime|mesh-list
154116166|NCT00752882|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154116167|NCT00752882|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154116189|NCT03989557|Analgesics|analgesics|mesh-ancestor
154116190|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
154116191|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116192|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116193|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116194|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116195|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154116196|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154116197|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116198|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154116199|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154116200|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116201|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
154116202|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154116203|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154116204|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154116205|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
154116206|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116207|NCT00790998|Ivermectin|ivermectin|mesh-list
154116208|NCT00790998|Moxidectin|moxidectin|mesh-list
154116209|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154116210|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594244|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594245|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
153594246|NCT01848132|Prednisone|prednisone|mesh-list
153594247|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
153594248|NCT01848132|Rituximab|rituximab|mesh-list
153594249|NCT01848132|Doxorubicin|doxorubicin|mesh-list
153594250|NCT01848132|Vincristine|vincristine|mesh-list
154116211|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
154116212|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
154116213|NCT02555046|Anesthetics|anesthetics|mesh-list
154116214|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116215|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116216|NCT00354679|Bevacizumab|bevacizumab|mesh-list
154116217|NCT00354679|Irinotecan|irinotecan|mesh-list
154116218|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154116219|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116220|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154116221|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154116222|NCT00354679|Growth Substances|growth substances|mesh-ancestor
154116223|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116243|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116244|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
154116245|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116246|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116247|NCT02022592|Midazolam|midazolam|mesh-list
154116248|NCT02022592|Lormetazepam|lormetazepam|mesh-list
154116249|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154116250|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154116251|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116252|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116253|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154116254|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154116255|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154116256|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154116257|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
154116258|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
154116259|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
154116260|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
154116261|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116262|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116263|NCT00683618|Atorvastatin|atorvastatin|mesh-list
154116264|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153810641|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116265|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154116266|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154116267|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
154116268|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116269|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154116270|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153496694|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
154116271|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116272|NCT00795678|Paclitaxel|paclitaxel|mesh-list
154116273|NCT00795678|Vinorelbine|vinorelbine|mesh-list
154116274|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154116275|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
154116276|NCT00795678|Gemcitabine|gemcitabine|mesh-list
154116277|NCT00795678|Doxorubicin|doxorubicin|mesh-list
154116278|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154116297|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154116298|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154116299|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154116300|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116301|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154116302|NCT00795678|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154116303|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154116305|NCT00753038|Carboplatin|carboplatin|mesh-list
154116306|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154116307|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116308|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116309|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116310|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116311|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116312|NCT00795756|Cytarabine|cytarabine|mesh-list
154116313|NCT00795756|Methotrexate|methotrexate|mesh-list
154116314|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154116315|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
154116316|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154116317|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116318|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154116319|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
154116320|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116321|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116322|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
154116323|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116324|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154116325|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116326|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
154116327|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116328|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154116329|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
154116330|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116331|NCT04058522|Triamcinolone|triamcinolone|mesh-list
154116332|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116333|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
154116334|NCT04058522|Hormones|hormones|mesh-ancestor
153345956|NCT00005110|Albuterol|albuterol|mesh-list
154116397|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
154116398|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154116399|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154116400|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154116401|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154116402|NCT00688064|Analgesics|analgesics|mesh-ancestor
154116403|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
154116404|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116405|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116406|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116407|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116408|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
154116409|NCT00788112|Vorinostat|vorinostat|mesh-list
154116410|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116411|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154116412|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116413|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116414|NCT00749918|Vitamin D|vitamin d|mesh-list
154116415|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
154116416|NCT00749918|Vitamins|vitamins|mesh-ancestor
154116417|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
154116440|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116441|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154116442|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154116443|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116444|NCT00683384|Etanercept|etanercept|mesh-list
154116445|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154116446|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154116447|NCT00683384|Analgesics|analgesics|mesh-ancestor
154116448|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
154116449|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116450|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116451|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116452|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116453|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154116454|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153594251|NCT01848132|Bortezomib|bortezomib|mesh-list
154116455|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
154116456|NCT00753740|Camptothecin|camptothecin|mesh-list
154116457|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153384909|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
154116458|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116459|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154116460|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154116461|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116462|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116463|NCT00326911|Bevacizumab|bevacizumab|mesh-list
154116464|NCT00326911|Cetuximab|cetuximab|mesh-list
154116465|NCT00326911|Gemcitabine|gemcitabine|mesh-list
154116466|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154116484|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
154116485|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116486|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116487|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154116488|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154116489|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
154116491|NCT00747110|Mesalamine|mesalamine|mesh-list
154116492|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116493|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154116494|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
154116496|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116497|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154116498|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
154116499|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
154116500|NCT00747110|Hormones|hormones|mesh-ancestor
154116501|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116502|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154116503|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154116504|NCT00747110|Analgesics|analgesics|mesh-ancestor
154116505|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
154116506|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116507|NCT00796458|Docetaxel|docetaxel|mesh-list
154116508|NCT00796458|Hormones|hormones|mesh-list
154116509|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116510|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116511|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116512|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116513|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116514|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116515|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116517|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154116518|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116519|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116520|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116521|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116522|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116541|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
154116542|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116543|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
154116544|NCT00791856|Testosterone|testosterone|mesh-list
154116545|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
154116546|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
154116547|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154116548|NCT00791856|Androgens|androgens|mesh-ancestor
154116549|NCT00791856|Hormones|hormones|mesh-ancestor
154116550|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116551|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116552|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154116553|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116554|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
154116555|NCT00796692|Heparin|heparin|mesh-list
154116556|NCT00796692|Calcium heparin|calcium heparin|mesh-list
154116557|NCT00796692|Nadroparin|nadroparin|mesh-list
154116558|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
154116559|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154116560|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154116561|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116562|NCT00540436|Ambrisentan|ambrisentan|mesh-list
154116563|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154116564|NCT00788580|Sirolimus|sirolimus|mesh-list
154116565|NCT00788580|Temsirolimus|temsirolimus|mesh-list
154116566|NCT00788580|MTOR Inhibitors|mtor inhibitors|mesh-list
153810644|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
153594252|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116567|NCT00788580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154116568|NCT00788580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116569|NCT00788580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116571|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
154116572|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116573|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116574|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116575|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116576|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154116577|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
154116578|NCT00792012|Temozolomide|temozolomide|mesh-list
154116579|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154116597|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154116598|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116599|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116600|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154116601|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154116602|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154116603|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154116604|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
154116605|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
154116606|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
154116607|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
154116608|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116609|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116610|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154116611|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154116612|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154116613|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154116614|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116615|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116616|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116617|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154116618|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
154116619|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154116621|NCT00687440|Doxorubicin|doxorubicin|mesh-list
154116622|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154116623|NCT00687440|Trastuzumab|trastuzumab|mesh-list
154116624|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116625|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116626|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116627|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116628|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116629|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154116630|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154116631|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154116632|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116633|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154116635|NCT02554734|Carbidopa|carbidopa|mesh-list
154116636|NCT02554734|Entacapone|entacapone|mesh-list
154116637|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154116638|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154116649|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
154116650|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116651|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116652|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154116653|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
154116654|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116655|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116656|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154116657|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154116659|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116660|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
154116661|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154116662|NCT00755066|Fluticasone|fluticasone|mesh-list
154116663|NCT00755066|Xhance|xhance|mesh-list
154116664|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116665|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154116666|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
154116667|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116668|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116669|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154116670|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
154116671|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
154116672|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154116673|NCT00990574|Anesthetics|anesthetics|mesh-list
154116674|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116675|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357265|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
153865337|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460106|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
153460108|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
153460109|NCT04597190|Norepinephrine|norepinephrine|mesh-list
153460110|NCT04597190|Serotonin|serotonin|mesh-list
153460111|NCT04597190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153460112|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153460113|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153460114|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
153594253|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
154116676|NCT00659490|Naproxen|naproxen|mesh-list
154116677|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154116678|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154116679|NCT00659490|Analgesics|analgesics|mesh-ancestor
154116680|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
154116681|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116682|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116683|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116684|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116685|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
154116686|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154116687|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116688|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116690|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
154116691|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116692|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154116693|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154116694|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116695|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116696|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154116697|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
154116698|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116699|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346307|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116734|NCT00990808|Anacetrapib|anacetrapib|mesh-list
154116735|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154116736|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154116737|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
154116738|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116739|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153346367|NCT00004582|Efavirenz|efavirenz|mesh-list
154116766|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153405777|NCT05920876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405778|NCT05920707|Vasopressins|vasopressins|mesh-list
153594254|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594255|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594256|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153594257|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
153594258|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594259|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594260|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153594261|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153594262|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153594263|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153594264|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153594265|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594266|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153594267|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
154116767|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154116769|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116770|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116771|NCT00990886|Urological Agents|urological agents|mesh-ancestor
154116772|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
154116773|NCT00797394|Urological Agents|urological agents|mesh-ancestor
154116774|NCT00681824|Thrombin|thrombin|mesh-list
154116775|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154116776|NCT00681824|Aprotinin|aprotinin|mesh-list
154116777|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
154116778|NCT00681824|Coagulants|coagulants|mesh-ancestor
154116779|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154116780|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154116781|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
154116782|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116783|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116784|NCT00797472|Bleomycin|bleomycin|mesh-list
154116785|NCT00797472|Dacarbazine|dacarbazine|mesh-list
154116786|NCT00797472|Vinblastine|vinblastine|mesh-list
154116787|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153865357|NCT00565383|Narcotics|narcotics|mesh-ancestor
153865358|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116788|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116789|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346416|NCT00004762|Cladribine|cladribine|mesh-list
154116811|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116813|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116814|NCT00539188|Antidotes|antidotes|mesh-ancestor
154116815|NCT00681590|Vitamin D|vitamin d|mesh-list
154116816|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
154116817|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
154116818|NCT00681590|Vitamins|vitamins|mesh-list
154116819|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
154116820|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116821|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154116822|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154116823|NCT05359432|Empagliflozin|empagliflozin|mesh-list
154116824|NCT05359432|Vildagliptin|vildagliptin|mesh-list
154116825|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154116826|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116827|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154116828|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116829|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154116830|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
154116831|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116832|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154116833|NCT00755534|Capecitabine|capecitabine|mesh-list
154116834|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
154116835|NCT00755534|Irinotecan|irinotecan|mesh-list
154116836|NCT00755534|Cetuximab|cetuximab|mesh-list
154116837|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154116838|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
154116839|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116840|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116841|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154116842|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154116843|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116868|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116869|NCT00685802|Cilostazol|cilostazol|mesh-list
154116870|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154116871|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
153810645|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357266|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
154116872|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116873|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116874|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154116875|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
154116876|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154116877|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154116878|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116879|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154116880|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
154116881|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154116882|NCT00685802|Protective Agents|protective agents|mesh-ancestor
154116883|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154116884|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154116885|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116886|NCT01054651|Artesunate|artesunate|mesh-list
154116887|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
154116888|NCT01054651|Sulfalene|sulfalene|mesh-list
154116889|NCT01054651|Praziquantel|praziquantel|mesh-list
154116890|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
154116891|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154116892|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154116893|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116894|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116895|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
153346512|NCT00101816|Dasatinib|dasatinib|mesh-list
154116913|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116914|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116915|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116916|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116917|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116918|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154116919|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
154116921|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116922|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116923|NCT00750620|Mirabegron|mirabegron|mesh-list
154116924|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154116925|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154116926|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154116927|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
154116928|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116929|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116930|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116931|NCT00750620|Urological Agents|urological agents|mesh-ancestor
154116932|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
154116933|NCT03827473|Prednisone|prednisone|mesh-list
154116934|NCT03827473|Cortisone|cortisone|mesh-list
154116935|NCT03827473|Docetaxel|docetaxel|mesh-list
154116936|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
154116937|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
154116938|NCT03827473|Hormones|hormones|mesh-list
154116939|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154116940|NCT03827473|Androgens|androgens|mesh-list
154116941|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
154116942|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116943|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116944|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116945|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116946|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116947|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116948|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
154116949|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116950|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116951|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154116952|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154116953|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116954|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
154116993|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154117011|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117012|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154117013|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
154117014|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154117015|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117016|NCT00326209|Mesalamine|mesalamine|mesh-list
154117017|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154117018|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154117019|NCT00326209|Analgesics|analgesics|mesh-ancestor
154117020|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
154117021|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117022|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117023|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117024|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117026|NCT00537940|Gabapentin|gabapentin|mesh-list
154117027|NCT00537940|Analgesics|analgesics|mesh-ancestor
154117028|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
154117029|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117030|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117031|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
154117032|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154117033|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154117034|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117035|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154117036|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154117037|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154117038|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117039|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154117040|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154117041|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154117042|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117043|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
154117044|NCT00661362|Metformin|metformin|mesh-list
154117045|NCT00661362|Saxagliptin|saxagliptin|mesh-list
154117046|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154117047|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117048|NCT00661362|Incretins|incretins|mesh-ancestor
154117049|NCT00661362|Hormones|hormones|mesh-ancestor
154117050|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117051|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154117052|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
154117076|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
154117077|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117078|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117079|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
154117080|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154117081|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117082|NCT03989089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154117083|NCT03989089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117084|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
154117085|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
154117086|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154117087|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154117088|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117089|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117090|NCT00793338|Urological Agents|urological agents|mesh-ancestor
154117091|NCT00344773|Gefitinib|gefitinib|mesh-list
154117092|NCT00344773|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153440526|NCT00004051|Irinotecan|irinotecan|mesh-list
154117093|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154117094|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117095|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117096|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117097|NCT02554344|Curcumin|curcumin|mesh-list
154117098|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154117099|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154117100|NCT02554344|Analgesics|analgesics|mesh-ancestor
154117133|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
154117134|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117135|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117136|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
154117138|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117139|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154117140|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154117141|NCT00748358|Growth Substances|growth substances|mesh-ancestor
154117174|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
154117175|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117176|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117177|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154117178|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154117179|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
154117180|NCT00751478|Naltrexone|naltrexone|mesh-list
154117181|NCT00751478|Morphine|morphine|mesh-list
154117182|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154117183|NCT00751478|Narcotics|narcotics|mesh-ancestor
154117209|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117210|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117211|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153405846|NCT05883852|Cyclophosphamide|cyclophosphamide|mesh-list
153460126|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
153460127|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460128|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460129|NCT04575961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460130|NCT04575961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460131|NCT04535271|Gemcitabine|gemcitabine|mesh-list
153460132|NCT04535271|Dacarbazine|dacarbazine|mesh-list
153460134|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460135|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
153594279|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
153594280|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
153594281|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594282|NCT01848236|Vitamin D|vitamin d|mesh-list
153594286|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
153594287|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594288|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153594289|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153594290|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153594291|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
153594292|NCT01848301|Acetylcholine|acetylcholine|mesh-list
153594293|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
153594294|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153594295|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
154117212|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154117213|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117214|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154117215|NCT00685334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154117216|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154117217|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154117218|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117219|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117220|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
154117221|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
154117222|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
154117223|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
154117224|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154117225|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154117226|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154117227|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154117228|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154117229|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154117231|NCT00801294|Afatinib|afatinib|mesh-list
154117232|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117267|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154117268|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154117269|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117270|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357268|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153405868|NCT05883852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594297|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594298|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594299|NCT01848340|Cabotegravir|cabotegravir|mesh-list
153594300|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153594301|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153594302|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594303|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594304|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153594305|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153594306|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
153594307|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594308|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153594309|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594310|NCT01848613|Vinorelbine|vinorelbine|mesh-list
153594312|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594320|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153594321|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153594322|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594323|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594324|NCT01848665|Indomethacin|indomethacin|mesh-list
154117271|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154117272|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154117273|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154117274|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154117275|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154117310|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154117311|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117312|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154117313|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117339|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117340|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117341|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117342|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
154117343|NCT00757874|Hormones|hormones|mesh-ancestor
154117344|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117345|NCT00344305|Vaccines|vaccines|mesh-list
154117346|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
154117347|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117348|NCT00933777|Everolimus|everolimus|mesh-list
154117349|NCT00933777|Sorafenib|sorafenib|mesh-list
154117350|NCT00933777|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154117351|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154117352|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865438|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153594331|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153594332|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594333|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
153594334|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
153594335|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153594336|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153594337|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594338|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594339|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
153594340|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
153594341|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594342|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
153594343|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594344|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594345|NCT01848743|Tenofovir|tenofovir|mesh-list
153594346|NCT01848743|Lamivudine|lamivudine|mesh-list
153594347|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
154117353|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594348|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117354|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117355|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
154117356|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117357|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117358|NCT00801450|Triamcinolone|triamcinolone|mesh-list
154117359|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154117360|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154117361|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154117362|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117363|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
153346982|NCT02973737|Capecitabine|capecitabine|mesh-list
154117395|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117397|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154117398|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117399|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117400|NCT01060891|Colistin|colistin|mesh-list
154117401|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154117402|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117403|NCT04003402|Ethanol|ethanol|mesh-list
153460137|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865458|NCT00562172|Metformin|metformin|mesh-list
153594352|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594353|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153594354|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153594356|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
153594357|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154117404|NCT04003402|ASP8062|asp8062|mesh-list
154117405|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154117406|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117407|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117408|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117438|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154117439|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
154117440|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117441|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117442|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
154117443|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117444|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117445|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
154117446|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117447|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117448|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
154117449|NCT00991744|Hormones|hormones|mesh-ancestor
154117450|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117451|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154117452|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
154117453|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
154117454|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117455|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117488|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
154117489|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117490|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117491|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117492|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154117493|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154117494|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154117495|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347121|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
154117517|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
153357269|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154117518|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154117519|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154117520|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117521|NCT00801606|Zinc|zinc|mesh-list
154117522|NCT00801606|Trace Elements|trace elements|mesh-list
154117523|NCT00801606|Micronutrients|micronutrients|mesh-list
154117524|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117525|NCT00934245|Vaccines|vaccines|mesh-list
154117526|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
154117527|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117528|NCT02560688|Clopidogrel|clopidogrel|mesh-list
154117529|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154117530|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154117531|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154117532|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154117533|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
154117534|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117535|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117536|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117537|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
154117538|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
154117539|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
154117540|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117541|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
154117542|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117543|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117544|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154117545|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
154117546|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117547|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117548|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154117549|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154117550|NCT00934323|Metformin|metformin|mesh-list
154117585|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117586|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117587|NCT00660348|Analgesics|analgesics|mesh-ancestor
154117588|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
154117589|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865492|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153594358|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
153594359|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594360|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594361|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153594362|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
153594363|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153594364|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153594365|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153594366|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
153594367|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594368|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594369|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153594370|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
153594371|NCT01848769|Hormones|hormones|mesh-ancestor
153594372|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594373|NCT01848808|Wobenzym|wobenzym|mesh-list
153594374|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153594375|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
153594376|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594377|NCT01848873|Amlodipine|amlodipine|mesh-list
153594390|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153594392|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154117590|NCT03734198|Daratumumab|daratumumab|mesh-list
153594393|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
154117591|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154117592|NCT03734198|Ibrutinib|ibrutinib|mesh-list
154117593|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117614|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117615|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117616|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154117617|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
154117618|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117619|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441075|NCT00003865|Toremifene|toremifene|mesh-list
154117620|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154117621|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154117622|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154117623|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154117624|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117625|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154117626|NCT00801918|Analgesics|analgesics|mesh-ancestor
154117627|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
154117628|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117629|NCT00799188|Everolimus|everolimus|mesh-list
154117630|NCT00799188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154117631|NCT00799188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154117632|NCT00799188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117633|NCT00799188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117634|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117635|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
154117636|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117637|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117638|NCT00571688|Risperidone|risperidone|mesh-list
154117639|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154117640|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
154117641|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117642|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117643|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117644|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154117645|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154117646|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117647|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154117680|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
154117681|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
154117682|NCT03988231|Enoxaparin|enoxaparin|mesh-list
154117683|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
154117684|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154117685|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154117686|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117714|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117715|NCT05407246|Hemay005|hemay005|mesh-list
154117716|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
154117717|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154117718|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154117719|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117720|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117721|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154117722|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
154117723|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117724|NCT00799890|Protective Agents|protective agents|mesh-ancestor
154117725|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117726|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154117727|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154117728|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117729|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154117730|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154117731|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153594396|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
153594397|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153347357|NCT01427881|Busulfan|busulfan|mesh-list
154117759|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117760|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
154117761|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
154117762|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117763|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117764|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
154117765|NCT00562965|Hormones|hormones|mesh-ancestor
154117766|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117767|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154117768|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154117769|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154117770|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
154117771|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
154117772|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
154117773|NCT00562965|Analgesics|analgesics|mesh-ancestor
154117774|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
154117775|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154117776|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154117777|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117778|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154117779|NCT00562965|Immunotoxins|immunotoxins|mesh-ancestor
154117780|NCT00562965|Immunoconjugates|immunoconjugates|mesh-ancestor
154117781|NCT05406934|Infliximab|infliximab|mesh-list
154117813|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
154117814|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154117816|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154117817|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
154117818|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154117819|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
154117820|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117821|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347444|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
154117834|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154117835|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117836|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153594398|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
153594399|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594400|NCT01849016|Protective Agents|protective agents|mesh-ancestor
153594401|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594402|NCT01849016|Antidotes|antidotes|mesh-ancestor
153594403|NCT01849042|Donepezil|donepezil|mesh-list
153594404|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153594405|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594406|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594407|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
153594408|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594409|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594410|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
153594444|NCT01849666|Vemurafenib|vemurafenib|mesh-list
153594445|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
153594446|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594447|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153594448|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594449|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594450|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
153594452|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153594453|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153594454|NCT01849835|Menthol|menthol|mesh-list
153594455|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
154117837|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154117838|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
154117840|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
154117841|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117842|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441290|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154117843|NCT01057849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154117844|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154117845|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154117846|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
154117847|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
154117848|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154117849|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154117850|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154117851|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154117852|NCT00794976|Dexamethasone|dexamethasone|mesh-list
154117853|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
154117854|NCT00794976|BB 1101|bb 1101|mesh-list
154117855|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117856|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
154117857|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
154117858|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117859|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117860|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117861|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
153357271|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117862|NCT00794976|Hormones|hormones|mesh-ancestor
154117863|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117864|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154117865|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117866|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
154117867|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117868|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117869|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154117870|NCT00939939|Glimepiride|glimepiride|mesh-list
154117871|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154117872|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117873|NCT00939939|Incretins|incretins|mesh-ancestor
154117874|NCT00939939|Hormones|hormones|mesh-ancestor
154117875|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117876|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154117877|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
154117878|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117879|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117880|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154117881|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117896|NCT04978012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117898|NCT00803166|Clobetasol|clobetasol|mesh-list
154117899|NCT00803166|Halobetasol|halobetasol|mesh-list
154117900|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154117901|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117902|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
154117903|NCT00803166|Hormones|hormones|mesh-ancestor
154117904|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117905|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117906|NCT00324961|Adefovir|adefovir|mesh-list
154117907|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154117908|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
154117909|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117910|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154117911|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154117912|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865519|NCT00562289|Dipyridamole|dipyridamole|mesh-list
153865520|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
153865521|NCT00562289|Apixaban|apixaban|mesh-list
153865522|NCT00562289|Dabigatran|dabigatran|mesh-list
153865523|NCT00562289|Antivitamins K|antivitamins k|mesh-list
153865524|NCT00562289|Clopidogrel|clopidogrel|mesh-list
153865525|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153405941|NCT05796791|Ketamine|ketamine|mesh-list
153405942|NCT05796791|Analgesics|analgesics|mesh-ancestor
153405943|NCT05796791|Sensory System Agents|sensory system agents|mesh-ancestor
153405944|NCT05796791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405945|NCT05796791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117913|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117914|NCT00935415|Montelukast|montelukast|mesh-list
153498355|NCT00003204|Prednisone|prednisone|mesh-list
154117915|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154117916|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
154117917|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154117918|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
154117919|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117920|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117921|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154117922|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154117923|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117924|NCT00935571|Remifentanil|remifentanil|mesh-list
154117925|NCT00935571|Propofol|propofol|mesh-list
154117926|NCT00935571|Sevoflurane|sevoflurane|mesh-list
154117927|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154117928|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117929|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117930|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154117931|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
154117932|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
154117933|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154117934|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154117935|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154117936|NCT00935571|Narcotics|narcotics|mesh-ancestor
154117937|NCT00935571|Analgesics|analgesics|mesh-ancestor
154117938|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
153347558|NCT01323595|Celecoxib|celecoxib|mesh-list
154117952|NCT03743259|Charcoal|charcoal|mesh-list
154117954|NCT03743259|Protective Agents|protective agents|mesh-ancestor
154117955|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117956|NCT03983239|Efavirenz|efavirenz|mesh-list
154117957|NCT03983239|Rifampin|rifampin|mesh-list
154117958|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154117959|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154117960|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117961|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117962|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
154117963|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117964|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154117965|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154117966|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154117967|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154117968|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154117969|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154117970|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154117971|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
154117972|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154117973|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
154117974|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154117975|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154117976|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154117977|NCT00935805|Insulin|insulin|mesh-list
154117978|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154117979|NCT00935805|Metformin|metformin|mesh-list
154117980|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
154117981|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
154117982|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
154117983|NCT00935805|Glyburide|glyburide|mesh-list
154117984|NCT00935805|Propranolol|propranolol|mesh-list
154117985|NCT00935805|Amlodipine|amlodipine|mesh-list
154117986|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154117987|NCT00935805|Captopril|captopril|mesh-list
154117988|NCT00935805|Diuretics|diuretics|mesh-list
154117989|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153441445|NCT00004903|Interferons|interferons|mesh-list
154117990|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117991|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154117992|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154117993|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154117994|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117995|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154117996|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
154117997|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
154117998|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153347605|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
154118016|NCT00935961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118017|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118018|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
154118019|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118021|NCT01055431|Trace Elements|trace elements|mesh-ancestor
154118022|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
154118023|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118024|NCT00803556|Paclitaxel|paclitaxel|mesh-list
154118025|NCT00803556|Trastuzumab|trastuzumab|mesh-list
154118026|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154118027|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118028|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154118029|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154118030|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154118031|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118032|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154118035|NCT00936195|Tenofovir|tenofovir|mesh-list
154118036|NCT00936195|Lamivudine|lamivudine|mesh-list
154118037|NCT00936195|Emtricitabine|emtricitabine|mesh-list
154118038|NCT00936195|Zidovudine|zidovudine|mesh-list
154118039|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154118040|NCT00936195|Efavirenz|efavirenz|mesh-list
154118041|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154118042|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154118043|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
154118044|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118045|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118046|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154118047|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154118048|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
154118049|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118050|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154118051|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154118052|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154118053|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154118054|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
154118055|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154118056|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154118057|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153347658|NCT03008317|Chromium|chromium|mesh-list
154118094|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118111|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118112|NCT00323557|Molgramostim|molgramostim|mesh-list
154118113|NCT00323557|Sargramostim|sargramostim|mesh-list
154118114|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154118115|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
154118116|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118117|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118118|NCT00558363|Dutasteride|dutasteride|mesh-list
154118119|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154118120|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154118121|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118122|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118123|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
154118124|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118125|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118126|NCT00323479|Anastrozole|anastrozole|mesh-list
154118127|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154118128|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118129|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154118130|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154118131|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118132|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118133|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154118134|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
154118135|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118136|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118137|NCT00352105|Fluorouracil|fluorouracil|mesh-list
154118138|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118139|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
154118140|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118141|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154118142|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118143|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
154118144|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118145|NCT03988075|Acetaminophen|acetaminophen|mesh-list
154118146|NCT03988075|Ibuprofen|ibuprofen|mesh-list
154118147|NCT03988075|Hydrocodone|hydrocodone|mesh-list
154118148|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154118149|NCT03988075|Analgesics|analgesics|mesh-ancestor
154118150|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
154118151|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361197|NCT00865202|Tryptophan|tryptophan|mesh-list
153347756|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154118169|NCT03985891|Antibodies|antibodies|mesh-list
154118170|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154118171|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
154118172|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118173|NCT00350779|Metformin|metformin|mesh-list
154118174|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154118175|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
154118176|NCT00350779|Glipizide|glipizide|mesh-list
154118177|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154118178|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118179|NCT00350779|Incretins|incretins|mesh-ancestor
154118181|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118182|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154118183|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
154118184|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118185|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118186|NCT00656136|Afatinib|afatinib|mesh-list
154118187|NCT00656136|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154118188|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118189|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118190|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118191|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118192|NCT00676520|Everolimus|everolimus|mesh-list
154118193|NCT00676520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154118194|NCT00676520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118195|NCT00676520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118196|NCT00676520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118197|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118198|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
154118199|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118200|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118201|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
154118202|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154118203|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
154118204|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118205|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
154118206|NCT02559908|Protective Agents|protective agents|mesh-ancestor
154118207|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154118208|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154118209|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154118232|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118233|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118234|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154118235|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
154118236|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154118237|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
154118238|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154118239|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154118240|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154118241|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153433860|NCT00000703|Vitamins|vitamins|mesh-ancestor
154118242|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154118243|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154118244|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154118245|NCT05427266|Bupivacaine|bupivacaine|mesh-list
154118246|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
154118247|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
154118248|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154118249|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118250|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
154118251|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118253|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154118254|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
154118255|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118256|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154118257|NCT00656058|Montelukast|montelukast|mesh-list
154118258|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154118259|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
154118260|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154118261|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
154118262|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118288|NCT00655980|Folic Acid|folic acid|mesh-list
154118289|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
154118290|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
154118291|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
154118292|NCT00655980|Vitamins|vitamins|mesh-ancestor
154118293|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
154118294|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118295|NCT00655980|Hematinics|hematinics|mesh-ancestor
154118296|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
154118297|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154118298|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
154118299|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
154118300|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154118301|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154118302|NCT00655980|Analgesics|analgesics|mesh-ancestor
154118303|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
154118304|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118305|NCT01063621|Apomorphine|apomorphine|mesh-list
154118306|NCT01063621|Emetics|emetics|mesh-ancestor
154118307|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118308|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
154118309|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118310|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154118311|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
154118344|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154118346|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
154118347|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118348|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118349|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118350|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118351|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154118352|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347974|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154118385|NCT02560376|Incretins|incretins|mesh-ancestor
154118386|NCT02560376|Hormones|hormones|mesh-ancestor
154118387|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118388|NCT00535288|Mirtazapine|mirtazapine|mesh-list
154118389|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118390|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
154118391|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154118417|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154118418|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118419|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118421|NCT02560220|Mitomycin|mitomycin|mesh-list
154118422|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154118423|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118424|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
154118425|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118426|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154118427|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118428|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
154118429|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154118430|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
154118431|NCT04836832|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154118432|NCT04836832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118433|NCT04836832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118434|NCT04836832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118435|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118436|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
153441901|NCT00005119|Calcium|calcium|mesh-list
154118437|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
153865621|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153865622|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865623|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865624|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
153865625|NCT04622891|Azithromycin|azithromycin|mesh-list
153865626|NCT04622891|Clarithromycin|clarithromycin|mesh-list
153865627|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153865628|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865629|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153865630|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594456|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
153594457|NCT01849861|Methimazole|methimazole|mesh-list
153594458|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
153594459|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
153594460|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594461|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594463|NCT01849926|Ibuprofen|ibuprofen|mesh-list
153594464|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154118438|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154118439|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118466|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118468|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
154118469|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154118470|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395870|NCT02592629|Hormones|hormones|mesh-ancestor
154118471|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
154118472|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154118473|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154118474|NCT00309907|Prednisolone|prednisolone|mesh-list
154118475|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
154118476|NCT00309907|Etanercept|etanercept|mesh-list
154118477|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154118478|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
154118479|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118480|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
154118481|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
154118482|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118483|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118484|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154118485|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
154118486|NCT00309907|Hormones|hormones|mesh-ancestor
153348104|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154118502|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154118503|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154118504|NCT03985969|Analgesics|analgesics|mesh-ancestor
154118505|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
154118506|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118507|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118508|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118509|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118510|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
154118511|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
154118512|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154118513|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154118514|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118515|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118516|NCT01061437|Lansoprazole|lansoprazole|mesh-list
154118517|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
154118518|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154118519|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154118520|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154118521|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118522|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118523|NCT00575588|Metformin|metformin|mesh-list
154118524|NCT00575588|Saxagliptin|saxagliptin|mesh-list
154118525|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154118526|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118527|NCT00575588|Incretins|incretins|mesh-ancestor
154118528|NCT00575588|Hormones|hormones|mesh-ancestor
154118529|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118530|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154118531|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
154118532|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118533|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118534|NCT01058317|Propranolol|propranolol|mesh-list
154118535|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154118536|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154118537|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
154118538|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118539|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118540|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118541|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154118542|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154118543|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
154118544|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154118545|NCT00810030|Hematinics|hematinics|mesh-ancestor
154118566|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
154118567|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
154118568|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
154118569|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118570|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154118571|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154118572|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154118573|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118574|NCT02559674|Paclitaxel|paclitaxel|mesh-list
154118575|NCT02559674|Gemcitabine|gemcitabine|mesh-list
154118576|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154118577|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118578|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
154118579|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
154118580|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
154118581|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118582|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154118583|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
154118584|NCT00761540|Liraglutide|liraglutide|mesh-list
154118585|NCT00761540|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154118586|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154118587|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118588|NCT00761540|Incretins|incretins|mesh-ancestor
154118589|NCT00761540|Hormones|hormones|mesh-ancestor
154118590|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118591|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154118592|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154118593|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154118594|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154118595|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118596|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118597|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118598|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154118599|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
154118600|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154118633|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154118634|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154118635|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154118636|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
154118637|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118638|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118639|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118640|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
154118641|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
154118642|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118643|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
154118644|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154118680|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
154118681|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118682|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118683|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154118684|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
154118685|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
154118718|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
154118719|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154118720|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154118721|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154118722|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154118723|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
154118724|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
154118725|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
154118727|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154118741|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118742|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118743|NCT04552886|Immunomodulating Agents|immunomodulating agents|mesh-list
154118744|NCT04552886|Immunologic Factors|immunologic factors|mesh-ancestor
154118745|NCT04552886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118746|NCT00762632|Everolimus|everolimus|mesh-list
154118747|NCT00762632|Nilotinib|nilotinib|mesh-list
154118748|NCT00762632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154118749|NCT00762632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118750|NCT00762632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118751|NCT00762632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118752|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118753|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
154118754|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118755|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118756|NCT00762632|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154118757|NCT00322387|Plerixafor|plerixafor|mesh-list
154118758|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154118759|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154118760|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
154118761|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118762|NCT00561015|Ribavirin|ribavirin|mesh-list
154118763|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
154118764|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154118765|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
154118766|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118767|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
153865671|NCT04622033|Brodalumab|brodalumab|mesh-list
153865672|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
153594465|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153594466|NCT01849926|Analgesics|analgesics|mesh-ancestor
153594499|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594500|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594501|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594503|NCT01850121|Infliximab|infliximab|mesh-list
153594504|NCT01850121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153594505|NCT01850121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118768|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118769|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118770|NCT04012047|Cromakalim|cromakalim|mesh-list
154118771|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154118772|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154118773|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
153402866|NCT04729725|Cemiplimab|cemiplimab|mesh-list
154118774|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118775|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118776|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154118777|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154118778|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
154118779|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
154118780|NCT00941265|Levodopa|levodopa|mesh-list
154118781|NCT00941265|Benserazide|benserazide|mesh-list
154118782|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154118783|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154118784|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
154118785|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118786|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118787|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118788|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118789|NCT00941343|Alfuzosin|alfuzosin|mesh-list
154118813|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154118814|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118815|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
154118816|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154118817|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154118818|NCT00308737|Insulin|insulin|mesh-list
154118819|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154118820|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118821|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154118822|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
154118823|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118824|NCT00941499|Leucovorin|leucovorin|mesh-list
154118825|NCT00941499|Bevacizumab|bevacizumab|mesh-list
154118826|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154118827|NCT00941499|Cetuximab|cetuximab|mesh-list
154118828|NCT00941499|Fluorouracil|fluorouracil|mesh-list
154118829|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
154118830|NCT00941499|Antibodies|antibodies|mesh-list
154118831|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
154118832|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154118833|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118834|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154118835|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154118836|NCT00941499|Growth Substances|growth substances|mesh-ancestor
154118837|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118838|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
154118839|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
154118840|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
153783356|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154118861|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154118862|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
154118863|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
154118864|NCT00945789|Protective Agents|protective agents|mesh-ancestor
154118865|NCT00945789|Hematinics|hematinics|mesh-ancestor
154118866|NCT00941811|Imiquimod|imiquimod|mesh-list
154118867|NCT00941811|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154118868|NCT00941811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118869|NCT00941811|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154118870|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
154118871|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118872|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154118873|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118874|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
154118875|NCT02553018|Methotrexate|methotrexate|mesh-list
154118876|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154118877|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
154118878|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154118879|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118880|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154118881|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
154118882|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118883|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118884|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
154118885|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118886|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154118887|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118888|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
154118889|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118890|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154118892|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
154118893|NCT00941967|Sorafenib|sorafenib|mesh-list
154118894|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154118895|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
153348497|NCT01474915|Aprepitant|aprepitant|mesh-list
154118910|NCT00338455|Dobutamine|dobutamine|mesh-list
154118911|NCT00338455|Milrinone|milrinone|mesh-list
154118912|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154118913|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154118914|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
154118915|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
154118916|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118917|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118918|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154118919|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154118920|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154118921|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
154118922|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118923|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118924|NCT00338455|Protective Agents|protective agents|mesh-ancestor
154118925|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154118926|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
154118927|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154118928|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154118929|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118930|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
154118931|NCT00678392|Sorafenib|sorafenib|mesh-list
154118932|NCT00678392|Axitinib|axitinib|mesh-list
154118933|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118934|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118935|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118936|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118937|NCT00950391|Tacrolimus|tacrolimus|mesh-list
154118938|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118939|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
154118940|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118941|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154118942|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118943|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118944|NCT00804336|Everolimus|everolimus|mesh-list
154118945|NCT00804336|Pasireotide|pasireotide|mesh-list
154118946|NCT00804336|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154118947|NCT00804336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118948|NCT00804336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118949|NCT00804336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118950|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118951|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
154118952|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118953|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118954|NCT00804336|Hormones|hormones|mesh-ancestor
153348550|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154118975|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
153865707|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153865708|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865709|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153865710|NCT01152190|Tadalafil|tadalafil|mesh-list
153865711|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
153865712|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153865713|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153865714|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865716|NCT01152190|Urological Agents|urological agents|mesh-ancestor
154118976|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154118977|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
154118978|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118979|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118980|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
154118981|NCT00946179|Vaccines|vaccines|mesh-list
154118982|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
154118983|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118984|NCT00950625|Lidocaine|lidocaine|mesh-list
154118985|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
154118986|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
154118987|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154118988|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118989|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
154118990|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118991|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154118992|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154118993|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154118994|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154118995|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118996|NCT00942591|Interferons|interferons|mesh-list
154118997|NCT00942591|Interferon-beta|interferon-beta|mesh-list
154118998|NCT00942591|Atorvastatin|atorvastatin|mesh-list
154118999|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
154119000|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119001|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
154119002|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119003|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154119004|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154119005|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
154119006|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119007|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154119008|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154119033|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154119034|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154119035|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119036|NCT00760448|Insulin|insulin|mesh-list
154119037|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154119038|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
154119039|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
153357275|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153865724|NCT01151410|Renin Inhibitors|renin inhibitors|mesh-ancestor
153865725|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
153865726|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865728|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153594506|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
153594507|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153594508|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594509|NCT01850147|Sunitinib|sunitinib|mesh-list
153594510|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594511|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154119040|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
154119041|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
154119042|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154119043|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119044|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154119045|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154119046|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154119047|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119048|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119049|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119050|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119051|NCT00763178|Analgesics|analgesics|mesh-ancestor
154119052|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
154119053|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119054|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
154119055|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154119056|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
154119057|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
154119123|NCT00322153|Memantine|memantine|mesh-list
154119124|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154119125|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154119126|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
154119127|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119128|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119129|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119130|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154119131|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154119132|NCT00806910|Conivaptan|conivaptan|mesh-list
154119133|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154119134|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119135|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
154119136|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119137|NCT00807066|Gefitinib|gefitinib|mesh-list
154119138|NCT00807066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154119139|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153348752|NCT00290810|Bevacizumab|bevacizumab|mesh-list
154119158|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119159|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119160|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154119161|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154119162|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119163|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154119164|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154119165|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119166|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119167|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
154119168|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119169|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154119170|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154119171|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154119172|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119173|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
154119174|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154119175|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
154119176|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153821390|NCT00474591|PENTA|penta|mesh-list
154119177|NCT00672620|Vortioxetine|vortioxetine|mesh-list
154119178|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154119179|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154119180|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119181|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119182|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119183|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119184|NCT00672620|Analgesics|analgesics|mesh-ancestor
154119185|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
154119186|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119187|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
154119188|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153810656|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357276|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154119189|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
154119190|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154119191|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154119192|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119220|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154119221|NCT00673790|Protective Agents|protective agents|mesh-ancestor
154119222|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119223|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
154119224|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154119225|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154119226|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154119227|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
154119228|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119229|NCT00763646|Docetaxel|docetaxel|mesh-list
154119230|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119231|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
154119232|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
154119233|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
154119234|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119235|NCT00763880|Lidocaine|lidocaine|mesh-list
154119236|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
154119237|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
154119238|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119273|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119275|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154119276|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
154119296|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
154119297|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119298|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154119299|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154119300|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119301|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154119302|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
154119303|NCT02558114|Ribavirin|ribavirin|mesh-list
154119304|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
154119305|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119306|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
154119307|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119308|NCT00770666|Bupropion|bupropion|mesh-list
154119309|NCT00770666|Nicotine|nicotine|mesh-list
154119310|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154119311|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
154119312|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119313|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119314|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154119315|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154119316|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
154119317|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119318|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119319|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154119320|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
154119321|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154119322|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154119323|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154119324|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119325|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
154119326|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154119327|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154119328|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119330|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
154119331|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154119332|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154119369|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154119381|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154119382|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154119383|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
154119384|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119385|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119386|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154119387|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154119388|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
154119389|NCT00770744|Olanzapine|olanzapine|mesh-list
154119390|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
154119391|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
154119392|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119393|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119394|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154119395|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154119396|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154119397|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119398|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154119399|NCT00770744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154119400|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154119401|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119402|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119403|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119404|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
154119405|NCT00655668|Lenalidomide|lenalidomide|mesh-list
154119406|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
154119407|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357277|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154119408|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153442879|NCT02079246|Serotonin Agents|serotonin agents|mesh-ancestor
154119409|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154119410|NCT00655668|Growth Substances|growth substances|mesh-ancestor
154119411|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
154119412|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119413|NCT00770900|Montelukast|montelukast|mesh-list
154119414|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154119415|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
154119416|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154119417|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
154119418|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154119419|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119420|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154119421|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154119422|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119423|NCT00766220|Irinotecan|irinotecan|mesh-list
154119424|NCT00766220|Cetuximab|cetuximab|mesh-list
154119425|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154119426|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154119427|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119428|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119429|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119465|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
154119466|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119467|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154119468|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154119493|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154119494|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154119495|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
154119496|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
154119497|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154119498|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154119499|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154119500|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154119501|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154119502|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119503|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119504|NCT00571064|Donepezil|donepezil|mesh-list
154119505|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154119506|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256689|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256690|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256691|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810658|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153357278|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154256692|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154256693|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154256694|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256695|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153736448|NCT02420847|Gemcitabine|gemcitabine|mesh-list
154119507|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119508|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
154119509|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119510|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119511|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
154119512|NCT00811980|Vancomycin|vancomycin|mesh-list
154119513|NCT00811980|Linezolid|linezolid|mesh-list
154119514|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119515|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119516|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154119517|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119542|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
154119543|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154119544|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154119545|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154119546|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154119547|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119548|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119549|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
154119550|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119551|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119552|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154119553|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119554|NCT00807534|Bromides|bromides|mesh-list
154119555|NCT00807534|Ipratropium|ipratropium|mesh-list
154119556|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
154119557|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154119559|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119560|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119561|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154119562|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
154119563|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154119564|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
154119565|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119566|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119567|NCT05589064|Vitamin D|vitamin d|mesh-list
153349169|NCT05414214|Anesthetics|anesthetics|mesh-list
154119601|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
154119602|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154119604|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154119605|NCT00654732|Doxorubicin|doxorubicin|mesh-list
154119606|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154119607|NCT00654732|Dacarbazine|dacarbazine|mesh-list
154119608|NCT00654732|Bleomycin|bleomycin|mesh-list
154119643|NCT00771368|Protective Agents|protective agents|mesh-ancestor
154119644|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
153406239|NCT05138614|Narcotics|narcotics|mesh-ancestor
153810659|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119645|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154119646|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119647|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119649|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154119650|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
154119685|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119686|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
153349295|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
154119713|NCT00560391|Lenalidomide|lenalidomide|mesh-list
154119715|NCT00560391|BB 1101|bb 1101|mesh-list
154119716|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154119717|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
154119718|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
154119719|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119720|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119721|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154119722|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
154119723|NCT00560391|Hormones|hormones|mesh-ancestor
154119724|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154119725|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154119726|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119727|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
154119728|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119729|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119730|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
154119731|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154119732|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154119733|NCT00560391|Growth Substances|growth substances|mesh-ancestor
154119734|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
154119735|NCT00560391|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153349336|NCT05266820|Thalidomide|thalidomide|mesh-list
154119763|NCT03982771|Bortezomib|bortezomib|mesh-list
154119764|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119765|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
154119766|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119767|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154119768|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154119769|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
153865812|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865813|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865814|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153865815|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
153865816|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154119770|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119771|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119772|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154119773|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154119774|NCT00775814|Candesartan|candesartan|mesh-list
154119775|NCT00775814|Candesartan cilexetil|candesartan cilexetil|mesh-list
154119776|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154119777|NCT00775814|Diuretics|diuretics|mesh-ancestor
154119778|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
154119779|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119780|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153349380|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119806|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154119807|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154119808|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119809|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154119810|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154119811|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
154119812|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119813|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119814|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154119815|NCT05355610|Gentamicins|gentamicins|mesh-list
154119816|NCT05355610|Dexamethasone|dexamethasone|mesh-list
154119817|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
154119818|NCT05355610|BB 1101|bb 1101|mesh-list
154119819|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154119820|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
154119821|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
154119822|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119823|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119824|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154119825|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
154119826|NCT05355610|Hormones|hormones|mesh-ancestor
154119827|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154119828|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154119829|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119852|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119853|NCT00552669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154119854|NCT00552669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119856|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154119857|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
154119858|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119859|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154119860|NCT00943137|Fluorouracil|fluorouracil|mesh-list
153594512|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153594513|NCT01850147|Growth Substances|growth substances|mesh-ancestor
153594514|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594515|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
153594516|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153594517|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594518|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594519|NCT01850160|Valsartan|valsartan|mesh-list
153594520|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
153594521|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
153594522|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
153594523|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153594524|NCT01850160|Diuretics|diuretics|mesh-list
153594525|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
153594526|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153594544|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154119861|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
154119862|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119863|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154119864|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119865|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119866|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
154119867|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119868|NCT00772616|Sufentanil|sufentanil|mesh-list
154119869|NCT00772616|Remifentanil|remifentanil|mesh-list
154119870|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154119871|NCT00772616|Narcotics|narcotics|mesh-ancestor
154119872|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119873|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119874|NCT00772616|Analgesics|analgesics|mesh-ancestor
154119875|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
154119876|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119877|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154119878|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154119879|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
154119880|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
154119881|NCT00768404|Phentermine|phentermine|mesh-list
154119882|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154119913|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154119914|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154119915|NCT00776360|Oxytocin|oxytocin|mesh-list
154119916|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
154119917|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154119918|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119919|NCT00946725|Atenolol|atenolol|mesh-list
154119920|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154119921|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154119922|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
154119923|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
154119924|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119925|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119947|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119948|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119949|NCT00952029|Leucovorin|leucovorin|mesh-list
154119950|NCT00952029|Bevacizumab|bevacizumab|mesh-list
154119951|NCT00952029|Fluorouracil|fluorouracil|mesh-list
154119952|NCT00952029|Irinotecan|irinotecan|mesh-list
154119953|NCT00952029|Calcium|calcium|mesh-list
154119954|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
154119955|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154119956|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119957|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154119958|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154119959|NCT00952029|Growth Substances|growth substances|mesh-ancestor
154119960|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119961|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
154119962|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154119963|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
154119964|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119965|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154119966|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119967|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
154119968|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154119969|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154119970|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119972|NCT00952029|Protective Agents|protective agents|mesh-ancestor
154119973|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
154119974|NCT00952029|Vitamins|vitamins|mesh-ancestor
154119975|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
154119976|NCT00667862|Panobinostat|panobinostat|mesh-list
154119977|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119978|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154119979|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119980|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119981|NCT00952185|Antibodies|antibodies|mesh-list
154120007|NCT00768638|Atorvastatin|atorvastatin|mesh-list
154120008|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154120009|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154120011|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120012|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154120013|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154120014|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120015|NCT02557958|Azithromycin|azithromycin|mesh-list
154120016|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154120017|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120018|NCT00776672|Fosinopril|fosinopril|mesh-list
154120019|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154120020|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
153406281|NCT04990037|Folfirinox|folfirinox|mesh-list
153594545|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153594546|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594547|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153594548|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154120021|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120022|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120023|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154120024|NCT00535132|Risperidone|risperidone|mesh-list
154120025|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154120026|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154120027|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
154120028|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349650|NCT01183481|Aprepitant|aprepitant|mesh-list
154120053|NCT00773084|Spironolactone|spironolactone|mesh-list
154120054|NCT00773084|Aliskiren|aliskiren|mesh-list
154120055|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154120056|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
154120057|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120058|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120059|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154120060|NCT00773084|Diuretics|diuretics|mesh-ancestor
154120061|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
154120062|NCT00773084|Renin Inhibitors|renin inhibitors|mesh-ancestor
154120063|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
154120064|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120065|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120066|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154120067|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154120068|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154120069|NCT00773084|Protective Agents|protective agents|mesh-ancestor
154120070|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
154120071|NCT00321919|Hematinics|hematinics|mesh-ancestor
154120072|NCT00781391|Warfarin|warfarin|mesh-list
154120073|NCT00781391|Edoxaban|edoxaban|mesh-list
154120074|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
154120075|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154120076|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
154120077|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154120078|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
154120106|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154120107|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120108|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154120109|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
154120110|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154120111|NCT00776828|Protective Agents|protective agents|mesh-ancestor
154120112|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154120113|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154120114|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120115|NCT01063933|Peramivir|peramivir|mesh-list
154120116|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
154120117|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120118|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120119|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120120|NCT02556866|Prednisone|prednisone|mesh-list
154120121|NCT02556866|Rituximab|rituximab|mesh-list
154120147|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120148|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154120149|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120150|NCT03982849|Silymarin|silymarin|mesh-list
154120151|NCT03982849|Hydroquinone|hydroquinone|mesh-list
154120152|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
154120153|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120154|NCT03982849|Protective Agents|protective agents|mesh-ancestor
154120155|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120156|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154120157|NCT05357872|Anesthetics|anesthetics|mesh-list
154120158|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120159|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120160|NCT00777218|Topiramate|topiramate|mesh-list
154120161|NCT00777218|Propranolol|propranolol|mesh-list
154120162|NCT00777218|Zonisamide|zonisamide|mesh-list
154120163|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154120164|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154120165|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
154120166|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120167|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120168|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120169|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154120170|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154120171|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
153361486|NCT01393457|Levodopa|levodopa|mesh-list
154120172|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
154120189|NCT00307801|Dienogest|dienogest|mesh-list
153810661|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
154120190|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154120191|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154120192|NCT00307801|Estradiol|estradiol|mesh-list
154120193|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154120194|NCT00307801|Estrogens|estrogens|mesh-ancestor
154120195|NCT00307801|Hormones|hormones|mesh-ancestor
154120196|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120197|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120198|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154120199|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
154120200|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154120201|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154120202|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154120203|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154120204|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154120205|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
154120206|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154120207|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120208|NCT00671060|Misoprostol|misoprostol|mesh-list
154120209|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154120210|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
154120211|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154120212|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120213|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154120214|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154120215|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
154120216|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
154120217|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154120218|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154120219|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
154120220|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120221|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120222|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120223|NCT00773552|Urological Agents|urological agents|mesh-ancestor
154120224|NCT04002700|Haloperidol|haloperidol|mesh-list
154120225|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
154120226|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
154120227|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
154120228|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
154120229|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120256|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
154120257|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120258|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
154120259|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
154120260|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154120261|NCT00654420|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154120262|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120263|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120264|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120265|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120266|NCT00773630|Cilostazol|cilostazol|mesh-list
154120267|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154120268|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
154120269|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120270|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120271|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154120272|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
154120273|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154120274|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154120275|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120276|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154120277|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
154120297|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154120298|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154120300|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120301|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154120302|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154120303|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154120304|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154120305|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153500763|NCT00362778|Insulin|insulin|mesh-list
154120307|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154120308|NCT00307489|Tenofovir|tenofovir|mesh-list
154120309|NCT00307489|Emtricitabine|emtricitabine|mesh-list
154120310|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
154120311|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120312|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154120313|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154120314|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120315|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120316|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154120317|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154120318|NCT00812292|Rilpivirine|rilpivirine|mesh-list
154120319|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154120320|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154120321|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120322|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120323|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
154120324|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120325|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153810663|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810664|NCT00351585|Vildagliptin|vildagliptin|mesh-list
153810665|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153810666|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810667|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153810668|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
153810669|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120326|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154120327|NCT00812370|Bivalirudin|bivalirudin|mesh-list
154120328|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
154120329|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154120330|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
154120331|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120332|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120333|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
154120334|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154120359|NCT00777530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120360|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154120361|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
154120362|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120363|NCT00770042|Ritonavir|ritonavir|mesh-list
154120364|NCT00770042|Ketoconazole|ketoconazole|mesh-list
154120365|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154120366|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154120367|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
154120368|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120369|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120370|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154120371|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154120372|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
154120373|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120374|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154120375|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154120376|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
154120377|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154120378|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154120379|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
154120380|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120381|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120382|NCT00654186|Lenalidomide|lenalidomide|mesh-list
154120383|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
154120384|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120385|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154120417|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120419|NCT04100447|Coagulants|coagulants|mesh-ancestor
154120420|NCT03274804|Maraviroc|maraviroc|mesh-list
153865908|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153865909|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154120421|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
154120422|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154120423|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120424|NCT03274804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154120425|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120426|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154120456|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
154120457|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
154120458|NCT00321685|Antibodies|antibodies|mesh-list
154120459|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
154120460|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154120461|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
154120462|NCT00321685|Calcium|calcium|mesh-list
154120463|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
154120464|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120465|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154120466|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154120467|NCT00321685|Growth Substances|growth substances|mesh-ancestor
154120468|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120469|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
154120470|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
154120471|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154120472|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154120473|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153350070|NCT00311246|Adalimumab|adalimumab|mesh-list
154120502|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154120503|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154120504|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120505|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154120506|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154120507|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154120508|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120509|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120510|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
154120511|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154120512|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154120513|NCT00774488|Incretins|incretins|mesh-ancestor
154120514|NCT00774488|Hormones|hormones|mesh-ancestor
154120515|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120516|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120517|NCT01066195|Pemetrexed|pemetrexed|mesh-list
154120518|NCT01066195|Gefitinib|gefitinib|mesh-list
154120519|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120520|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120552|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120554|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154120555|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120556|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154120557|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154120558|NCT00667394|Growth Substances|growth substances|mesh-ancestor
153350170|NCT00366626|Naltrexone|naltrexone|mesh-list
154120575|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154120576|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
154120577|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120578|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120580|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154120581|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120582|NCT00761735|Ribavirin|ribavirin|mesh-list
154120583|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154120584|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
154120585|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120586|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
154120587|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120588|NCT00569946|Axitinib|axitinib|mesh-list
154120589|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120590|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120591|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120592|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120593|NCT00778544|Amoxicillin|amoxicillin|mesh-list
154120594|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
154120595|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
154120596|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154120597|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154120598|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120599|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120600|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120601|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154120602|NCT04001374|Ticagrelor|ticagrelor|mesh-list
154120603|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154120604|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154120605|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154120606|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154120607|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
154120608|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120609|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120610|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120611|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
154120612|NCT05265910|Loratadine|loratadine|mesh-list
154120613|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154120614|NCT05265910|Dextrans|dextrans|mesh-list
154120615|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153865921|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153594549|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153594550|NCT01850511|Phenylephrine|phenylephrine|mesh-list
153594551|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
154120616|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154120617|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
154120618|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
154120619|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154120686|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120689|NCT00808314|Regadenoson|regadenoson|mesh-list
154120690|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154120691|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120692|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120693|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154120694|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
154120695|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154120696|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154120697|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
154120698|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
154120699|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120700|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120701|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154120767|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154120769|NCT00779792|Mineral Oil|mineral oil|mesh-list
154120770|NCT00779792|Tacrolimus|tacrolimus|mesh-list
154120771|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154120772|NCT00779792|Glycerol|glycerol|mesh-list
154120773|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154120774|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
154120775|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120776|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154120777|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120778|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120779|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120780|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
154120781|NCT00779792|Hormones|hormones|mesh-ancestor
154120782|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120783|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154120784|NCT00779792|Protective Agents|protective agents|mesh-ancestor
154120785|NCT00779792|Emollients|emollients|mesh-ancestor
154120786|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
154120787|NCT00992134|Cytarabine|cytarabine|mesh-list
154120822|NCT00815022|Morphine|morphine|mesh-list
154120823|NCT00815022|Bupivacaine|bupivacaine|mesh-list
154120824|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
154120825|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
154120826|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120827|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120857|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154120858|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120859|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120860|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154120861|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
154120862|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
154120863|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120864|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154120865|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
154120866|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120867|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154120868|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154120869|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
154120870|NCT00780104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120872|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
154120873|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120874|NCT04047680|Ritonavir|ritonavir|mesh-list
154120875|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
154120876|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154120877|NCT04047680|Grazoprevir|grazoprevir|mesh-list
154120902|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
154120903|NCT00815256|Vitamins|vitamins|mesh-ancestor
154120904|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
154120905|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120906|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154120907|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
153501358|NCT00378456|Leucovorin|leucovorin|mesh-list
154120908|NCT00778778|Cefprozil|cefprozil|mesh-list
154120910|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154120911|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120912|NCT00305773|Vorinostat|vorinostat|mesh-list
154120913|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120914|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154120915|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120916|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120917|NCT00780182|Brincidofovir|brincidofovir|mesh-list
154120918|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
154120919|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865948|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865949|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
153865950|NCT04587141|Hematinics|hematinics|mesh-ancestor
153406377|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
153406378|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
153406379|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406380|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406381|NCT04662086|Camostat|camostat|mesh-list
154120920|NCT00812994|Escitalopram|escitalopram|mesh-list
154120921|NCT00812994|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154120922|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154120923|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154120924|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120925|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120952|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154120953|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120954|NCT00647556|Adapalene|adapalene|mesh-list
154120955|NCT00647556|Tretinoin|tretinoin|mesh-list
154120956|NCT00647556|Emollients|emollients|mesh-list
154120957|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120958|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
154120959|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154120960|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154120961|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154120962|NCT00647556|Analgesics|analgesics|mesh-ancestor
154120963|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
154120964|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120965|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120966|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120967|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120968|NCT03978559|Trimethoprim|trimethoprim|mesh-list
154120969|NCT03978559|Caspofungin|caspofungin|mesh-list
154120970|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
154120971|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
154120972|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120973|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
154120974|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
154120975|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121003|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154121004|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121005|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154121006|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154121007|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121008|NCT00813228|Incretins|incretins|mesh-ancestor
154121009|NCT00813228|Hormones|hormones|mesh-ancestor
154121010|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406404|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
153406405|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406406|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406407|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406408|NCT04575597|Molnupiravir|molnupiravir|mesh-list
153406409|NCT04575597|Antiviral Agents|antiviral agents|mesh-ancestor
153406410|NCT04575597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406411|NCT04562792|Daunorubicin|daunorubicin|mesh-list
153406412|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153406413|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865951|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153865952|NCT04586790|Epinephrine|epinephrine|mesh-list
153865953|NCT04586790|Racepinephrine|racepinephrine|mesh-list
153865954|NCT04586790|Midodrine|midodrine|mesh-list
153594552|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153594553|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153594554|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
154121011|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154121012|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
154121013|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121014|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121015|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
154121016|NCT00808704|Hematinics|hematinics|mesh-ancestor
154121017|NCT00320515|Pemetrexed|pemetrexed|mesh-list
154121018|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121019|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121020|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121022|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154121059|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154121060|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154121061|NCT00661778|Growth Substances|growth substances|mesh-ancestor
154121084|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121085|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121086|NCT00653328|Doxorubicin|doxorubicin|mesh-list
154121087|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154121088|NCT00653328|Atrasentan|atrasentan|mesh-list
154121089|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154121090|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121091|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154121092|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154121093|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121094|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121095|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154121096|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154121098|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154121099|NCT01664182|Sunitinib|sunitinib|mesh-list
154121100|NCT01664182|Trebananib|trebananib|mesh-list
154121101|NCT01664182|Sorafenib|sorafenib|mesh-list
154121102|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
154121103|NCT01664182|Antibodies|antibodies|mesh-list
154121104|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
154121105|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154121106|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
154121107|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121108|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154121109|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154121110|NCT01664182|Growth Substances|growth substances|mesh-ancestor
154121111|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121112|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
154121113|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
153350685|NCT05299073|Denosumab|denosumab|mesh-list
154121180|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121181|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154121182|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154121184|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121185|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154121217|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121218|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121219|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121220|NCT02550444|Clonidine|clonidine|mesh-list
154121221|NCT02550444|Analgesics|analgesics|mesh-ancestor
154121222|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
154121223|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121224|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121225|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154121253|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121254|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
154121255|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
154121256|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
154121257|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154121258|NCT00775684|Exenatide|exenatide|mesh-list
154121259|NCT00775684|Glimepiride|glimepiride|mesh-list
154121260|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154121261|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121262|NCT00775684|Incretins|incretins|mesh-ancestor
154121263|NCT00775684|Hormones|hormones|mesh-ancestor
154121264|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121265|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154121266|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
154121267|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121268|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121269|NCT00775684|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154121270|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154121271|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154121304|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154121305|NCT00998920|Estrogens|estrogens|mesh-ancestor
154121306|NCT00998920|Hormones|hormones|mesh-ancestor
154121307|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594555|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121308|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121309|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
154121310|NCT00992758|Antibodies|antibodies|mesh-list
154121311|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
154121312|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121313|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121314|NCT00641706|Bortezomib|bortezomib|mesh-list
154121315|NCT00641706|Vorinostat|vorinostat|mesh-list
154121316|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121317|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154121352|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154121353|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121354|NCT00999232|Erythromycin|erythromycin|mesh-list
154121355|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
154121356|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154121357|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
154121358|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154121378|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
154121379|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154121380|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154121381|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121382|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154121383|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
154121385|NCT00644358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154121386|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154121387|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154121388|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121390|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
154121391|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121392|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154121393|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154121394|NCT00993694|Dapsone|dapsone|mesh-list
154121395|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121396|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
154121397|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154121398|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154121399|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154121400|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121401|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121402|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
154121403|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154121404|NCT00640926|Radezolid|radezolid|mesh-list
154121405|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
154121406|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154121407|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121408|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154121409|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121410|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121411|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154121412|NCT00821496|Norethindrone|norethindrone|mesh-list
154121413|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
154121440|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121442|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
154121443|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
154121444|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121445|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
154121446|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154121447|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154121448|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
154121449|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121450|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154121451|NCT00818298|Ziprasidone|ziprasidone|mesh-list
154121452|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154121453|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
154121454|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121455|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121456|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121457|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154121458|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154121459|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121460|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154121461|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154121462|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
154121463|NCT00821574|Valsartan|valsartan|mesh-list
154121464|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153351058|NCT03675893|Metformin|metformin|mesh-list
154121492|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154121494|NCT00821652|Resiquimod|resiquimod|mesh-list
154121495|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154121496|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
154121497|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121498|NCT00821652|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154121499|NCT00821652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121500|NCT00821652|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154121501|NCT00319501|Diazepam|diazepam|mesh-list
154121502|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154121503|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
154121504|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
154121505|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
154121506|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121507|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121508|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121509|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154121543|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154121544|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154121545|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154121546|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154121547|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154121548|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154121549|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121550|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121586|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121587|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154121588|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154121589|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121590|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121591|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121592|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154121619|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154121620|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154121621|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
154121622|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121623|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121624|NCT00996190|Protective Agents|protective agents|mesh-ancestor
154121627|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154121628|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154121629|NCT00640224|Estradiol|estradiol|mesh-list
154121630|NCT00640224|Estrogens|estrogens|mesh-ancestor
154121631|NCT00640224|Hormones|hormones|mesh-ancestor
154121632|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121633|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121634|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154121635|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
154121636|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154121637|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154121638|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154121639|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154121653|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121654|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121656|NCT02550756|Capsaicin|capsaicin|mesh-list
154121657|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
153357291|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121658|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121659|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
154121660|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121661|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121662|NCT01001260|Aspirin|aspirin|mesh-list
154121663|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154121664|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154121665|NCT01001260|Analgesics|analgesics|mesh-ancestor
154121666|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
154121667|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121668|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121669|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121670|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154121671|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154121672|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154121673|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121674|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154121675|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154121676|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121677|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
154121678|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
154121679|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154121680|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
154121681|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121682|NCT00996424|Expectorants|expectorants|mesh-ancestor
154121683|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
154121684|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154121685|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
154121686|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121687|NCT00996424|Protective Agents|protective agents|mesh-ancestor
154121688|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121689|NCT00996424|Antidotes|antidotes|mesh-ancestor
154121690|NCT05220280|Infliximab|infliximab|mesh-list
154121691|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
154121692|NCT05220280|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154121693|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154121694|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121695|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121696|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121697|NCT05220280|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154121698|NCT05220280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121699|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121700|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121701|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154121732|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121733|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121734|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121735|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
154121736|NCT01066429|Hormones|hormones|mesh-ancestor
153810674|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154121737|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121738|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154121739|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121740|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
154121741|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121742|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121743|NCT00994786|Pregabalin|pregabalin|mesh-list
154121744|NCT00994786|Analgesics|analgesics|mesh-ancestor
154121745|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
154121746|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351333|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154121778|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
154121779|NCT01003054|Busulfan|busulfan|mesh-list
154121780|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
154121781|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154121782|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
154121783|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121784|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154121785|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154121786|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
154121787|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121788|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121789|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154121790|NCT01003054|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154121827|NCT01003678|Clofarabine|clofarabine|mesh-list
154121828|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154121829|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
154121859|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154121861|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121862|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
154121863|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121864|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154121865|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154121866|NCT01005472|Temozolomide|temozolomide|mesh-list
154121867|NCT01005472|Sunitinib|sunitinib|mesh-list
154121868|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154121869|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
154121870|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121871|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121872|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154121873|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154121905|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154121906|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154121907|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121908|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154121909|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
154121910|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121911|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121912|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154121913|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
154121914|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121915|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154121916|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
154121917|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153351506|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
154121941|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121942|NCT01006720|Neostigmine|neostigmine|mesh-list
154121943|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154121944|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121945|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121946|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
154121947|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121948|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121949|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154121950|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
154121951|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121952|NCT01006876|Warfarin|warfarin|mesh-list
154121953|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
154121954|NCT03882424|Bevacizumab|bevacizumab|mesh-list
154121955|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153445399|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121956|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121957|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154121958|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154121959|NCT03882424|Growth Substances|growth substances|mesh-ancestor
154121960|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121961|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
154121962|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
154121963|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
154121965|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351561|NCT05299398|Trazodone|trazodone|mesh-list
154122000|NCT00642954|Dexamethasone|dexamethasone|mesh-list
154122001|NCT00642954|Lenalidomide|lenalidomide|mesh-list
154122002|NCT00642954|Vorinostat|vorinostat|mesh-list
154122003|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122004|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
154122005|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
153351602|NCT00379574|Prednisolone|prednisolone|mesh-list
154122065|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
154122066|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154122068|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122069|NCT01008046|Protective Agents|protective agents|mesh-ancestor
154122070|NCT01008046|Antidotes|antidotes|mesh-ancestor
154122072|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
154122073|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122074|NCT00530218|Ganciclovir|ganciclovir|mesh-list
154122075|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154122076|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
154122077|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122078|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153810675|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357293|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
153406553|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406554|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
153406555|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153406557|NCT04294459|Acetaminophen|acetaminophen|mesh-list
154122079|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122080|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122081|NCT00761267|Fluconazole|fluconazole|mesh-list
154122082|NCT00761267|Anidulafungin|anidulafungin|mesh-list
154122083|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
154122084|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122085|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154122086|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154122087|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122088|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122089|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154122090|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
154122091|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122092|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122093|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154122094|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154122123|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
154122124|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122126|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154122127|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154122128|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154122129|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154122130|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122131|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122132|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154122133|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154122134|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154122135|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
154122136|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122137|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122138|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154122139|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154122141|NCT01008358|Tremelimumab|tremelimumab|mesh-list
154122142|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122143|NCT01008592|Levocetirizine|levocetirizine|mesh-list
154122144|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154122179|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122181|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
154122182|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351791|NCT04270994|Misoprostol|misoprostol|mesh-list
153810676|NCT00347100|Metformin|metformin|mesh-list
154122214|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154122215|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154122216|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
154122217|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154122218|NCT02602301|Oxytocin|oxytocin|mesh-list
154122219|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
154122220|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154122221|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122222|NCT00316225|Pemetrexed|pemetrexed|mesh-list
154122223|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122224|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122246|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154122248|NCT00315445|Buprenorphine|buprenorphine|mesh-list
154122249|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154122250|NCT00315445|Analgesics|analgesics|mesh-ancestor
154122251|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
154122252|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122253|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122254|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
154122255|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154122256|NCT00315445|Narcotics|narcotics|mesh-ancestor
154122257|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122258|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154122259|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154122260|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122261|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122262|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154122263|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154122264|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154122265|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154122266|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122267|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
154122268|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122269|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122270|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154122271|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122272|NCT00779675|Infliximab|infliximab|mesh-list
154122273|NCT00779675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154122274|NCT00779675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122275|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
154122276|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154122312|NCT05774275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122313|NCT05774275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154122314|NCT05774275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154122315|NCT05774275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122316|NCT05774275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122317|NCT05774028|Dexamethasone|dexamethasone|mesh-list
154122349|NCT05773911|Sequestering Agents|sequestering agents|mesh-ancestor
154122351|NCT05773911|Coagulants|coagulants|mesh-ancestor
154122352|NCT05773859|Vaccines|vaccines|mesh-list
154122353|NCT05773859|Immunologic Factors|immunologic factors|mesh-ancestor
154122354|NCT05773859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122355|NCT05773807|Propofol|propofol|mesh-list
154122356|NCT05773807|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154122357|NCT05773807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122358|NCT05773807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122359|NCT05773807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154122360|NCT05773807|Anesthetics, General|anesthetics, general|mesh-ancestor
154122361|NCT05773807|Anesthetics|anesthetics|mesh-ancestor
154122362|NCT05773183|Testosterone|testosterone|mesh-list
154122363|NCT05773183|Androgens|androgens|mesh-ancestor
154122364|NCT05773183|Hormones|hormones|mesh-ancestor
153351951|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
154122396|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122397|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154122398|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122399|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122400|NCT05667896|Hormones|hormones|mesh-ancestor
154122401|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122402|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
154122403|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
154122404|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122405|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
154122406|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122407|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122408|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154122409|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
153445839|NCT00001115|Acyclovir|acyclovir|mesh-list
154122434|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
154122435|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154122436|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154122437|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122438|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122439|NCT05430074|Calpastatin|calpastatin|mesh-list
154122440|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154122441|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
154122442|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122443|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122444|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154122445|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154122446|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154122447|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122448|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122449|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154122450|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154122451|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154122452|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154122453|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
154122454|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122455|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122456|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154122457|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154122458|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
153352044|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122486|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122487|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122488|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154122489|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
154122490|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122491|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122492|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154122493|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154122494|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
154122495|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154122496|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
154122497|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154122498|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154122499|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154122500|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154122501|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154122502|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154122521|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154122522|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122523|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154122524|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
154122525|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154122526|NCT05195996|Propranolol|propranolol|mesh-list
154122527|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154122528|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154122529|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154122530|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122531|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122532|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122533|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154122534|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154122535|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
154122536|NCT05101564|Tamoxifen|tamoxifen|mesh-list
154122537|NCT05101564|Fulvestrant|fulvestrant|mesh-list
154122538|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154122539|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
154122540|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122541|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122542|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154122543|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122544|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154122545|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154122546|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154122547|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154122548|NCT05005741|Dulaglutide|dulaglutide|mesh-list
154122549|NCT05005741|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154122550|NCT05005741|Glucagon|glucagon|mesh-list
154122551|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154122552|NCT05005741|Incretins|incretins|mesh-ancestor
154122553|NCT05005741|Hormones|hormones|mesh-ancestor
154122554|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122555|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122556|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154122590|NCT04924699|Immunologic Factors|immunologic factors|mesh-ancestor
154122591|NCT04924699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122592|NCT04907539|Denosumab|denosumab|mesh-list
154122593|NCT04907539|Nivolumab|nivolumab|mesh-list
154122594|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122595|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122596|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154122597|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122598|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154122599|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122600|NCT04830397|Timolol|timolol|mesh-list
154122629|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154122631|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
154122632|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
154122633|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
154122634|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122635|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122636|NCT04393285|Letrozole|letrozole|mesh-list
154122637|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122638|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154122639|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154122640|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122641|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122642|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154122643|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
153406627|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
153810679|NCT00347100|Glipizide|glipizide|mesh-list
153810680|NCT00347100|Gliclazide|gliclazide|mesh-list
154122674|NCT04194359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154122675|NCT04194359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154122677|NCT04194359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122678|NCT04194359|Growth Inhibitors|growth inhibitors|mesh-ancestor
154122679|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154122680|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
154122681|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122682|NCT04053491|Anesthetics|anesthetics|mesh-list
154122683|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122684|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122712|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154122713|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154122714|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154122715|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154122716|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122717|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154122718|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
154122719|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122720|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
154122721|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122722|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122723|NCT03621982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154122724|NCT03621982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122725|NCT03608163|Diazoxide|diazoxide|mesh-list
154122726|NCT03608163|Naloxone|naloxone|mesh-list
154122727|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154122728|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122761|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122762|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122763|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154122764|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154122765|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
154122766|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122767|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122769|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154122796|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122797|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122798|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122799|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122800|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
154122801|NCT03011268|Adalimumab|adalimumab|mesh-list
154122802|NCT03011268|Infliximab|infliximab|mesh-list
154122803|NCT03011268|Golimumab|golimumab|mesh-list
154122804|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154122805|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154122806|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122807|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122808|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
154122809|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154122810|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122811|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
154122812|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122813|NCT02944578|Curcumin|curcumin|mesh-list
153352407|NCT00537290|Rituximab|rituximab|mesh-list
154122831|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
154122832|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122833|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122834|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154122835|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
154122836|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122837|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122838|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154122839|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122840|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154122841|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154122842|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154122843|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122844|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154122845|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
154122846|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
154122847|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
154122848|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122849|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
154122850|NCT02889523|Hormones|hormones|mesh-ancestor
154122851|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122852|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154122853|NCT02771626|Nivolumab|nivolumab|mesh-list
154122854|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122855|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122856|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154122857|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122858|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
154122859|NCT02616302|Lansoprazole|lansoprazole|mesh-list
153810681|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154122860|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154122861|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154122862|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154122863|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122864|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122865|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154122866|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154122867|NCT02469753|Analgesics|analgesics|mesh-ancestor
154122868|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
154122869|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352451|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154122891|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122892|NCT01582776|Lenalidomide|lenalidomide|mesh-list
154122893|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
154122894|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
154122895|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122896|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154122897|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154122898|NCT01582776|Growth Substances|growth substances|mesh-ancestor
154122899|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
154122900|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122901|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122902|NCT01464164|Prednisone|prednisone|mesh-list
154122903|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122904|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
154122905|NCT01464164|Hormones|hormones|mesh-ancestor
154122906|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122907|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122908|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154122909|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122910|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
154122911|NCT00602459|Rituximab|rituximab|mesh-list
154122912|NCT00602459|Fludarabine|fludarabine|mesh-list
154122913|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
154122914|NCT00602459|Lenalidomide|lenalidomide|mesh-list
154122915|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154122916|NCT00602459|Antibodies|antibodies|mesh-list
154122917|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
154122918|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154122919|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122920|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
154122921|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122922|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352508|NCT00473642|Ranibizumab|ranibizumab|mesh-list
154122945|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
154122946|NCT00199069|Thioguanine|thioguanine|mesh-list
154122947|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122948|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
154122949|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122950|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122951|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154122952|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
154122953|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122954|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122955|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154122956|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122957|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
154122958|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
154122959|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122960|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154122961|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
154122962|NCT00199069|Hormones|hormones|mesh-ancestor
154122963|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122964|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154122965|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154122966|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
154122967|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154122968|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154122969|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
154122970|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
154122971|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122972|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154122973|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154122974|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
154122975|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122976|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154122977|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
154122978|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
154123004|NCT01067053|Capecitabine|capecitabine|mesh-list
154123005|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
154123006|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154123007|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123008|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154123009|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154123010|NCT01067053|Growth Substances|growth substances|mesh-ancestor
154123011|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123012|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
154123013|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154123014|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
154123015|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123016|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
154123017|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154123018|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154123019|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154123020|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123021|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123022|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
154123023|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123024|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123025|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154123026|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123027|NCT01067365|Citric Acid|citric acid|mesh-list
154123057|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154123058|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123059|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154123060|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
154123061|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123062|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
154123063|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154123064|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
154123065|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154123066|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154123067|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123068|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123069|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123070|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
154123071|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123072|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123073|NCT00822666|Clopidogrel|clopidogrel|mesh-list
154123074|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154123075|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154123076|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154123077|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154123112|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154123115|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
154123116|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
154123137|NCT00819468|Teduglutide|teduglutide|mesh-list
154123138|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123139|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154123140|NCT00819468|Protective Agents|protective agents|mesh-ancestor
154123141|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123142|NCT01067599|Nicotine|nicotine|mesh-list
154123143|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154123144|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
154123145|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123146|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503559|NCT03400020|Protective Agents|protective agents|mesh-ancestor
154123147|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154123148|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154123149|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
154123150|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123151|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123152|NCT00778817|Mitotane|mitotane|mesh-list
154123153|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154123154|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123155|NCT00293059|Dienogest|dienogest|mesh-list
154123156|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154123157|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154123158|NCT00293059|Estradiol|estradiol|mesh-list
154123159|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154123160|NCT00293059|Estrogens|estrogens|mesh-ancestor
154123161|NCT00293059|Hormones|hormones|mesh-ancestor
154123162|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123163|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123164|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154123165|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
154123166|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153352752|NCT00546728|Hormones|hormones|mesh-ancestor
154123191|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123192|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
154123193|NCT00298831|Rocuronium|rocuronium|mesh-list
154123194|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154123195|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154123196|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154123197|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123198|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123199|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154123200|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154123201|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123202|NCT00758069|Incretins|incretins|mesh-ancestor
154123203|NCT00758069|Hormones|hormones|mesh-ancestor
154123204|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123205|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154123206|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
154123207|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123208|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123209|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
154123210|NCT01067677|Promethazine|promethazine|mesh-list
154123211|NCT01067677|Ondansetron|ondansetron|mesh-list
154123212|NCT01067677|Metoclopramide|metoclopramide|mesh-list
154123213|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
154123214|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
154123215|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123216|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123217|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123236|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154123237|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
154123238|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
154123240|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
154123241|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154123242|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154123243|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123244|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123245|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123246|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154123247|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123248|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154123249|NCT02600741|Droperidol|droperidol|mesh-list
154123250|NCT02600741|Haloperidol|haloperidol|mesh-list
154123251|NCT02600741|Pimozide|pimozide|mesh-list
154123252|NCT02600741|Olanzapine|olanzapine|mesh-list
154123253|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
154123255|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
154123256|NCT02600741|Risperidone|risperidone|mesh-list
154123257|NCT02600741|Aripiprazole|aripiprazole|mesh-list
154123258|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154123259|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154123260|NCT02600741|Ziprasidone|ziprasidone|mesh-list
154123261|NCT02600741|Clozapine|clozapine|mesh-list
154123262|NCT02600741|Asenapine|asenapine|mesh-list
154123263|NCT02600741|Loxapine|loxapine|mesh-list
154123264|NCT02600741|Iloperidone|iloperidone|mesh-list
154123265|NCT02600741|Perphenazine|perphenazine|mesh-list
154123266|NCT02600741|Fluphenazine|fluphenazine|mesh-list
154123267|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
154123268|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
154123269|NCT02600741|Thioridazine|thioridazine|mesh-list
154123270|NCT02600741|Thiothixene|thiothixene|mesh-list
154123271|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154123272|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
154123273|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123274|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123275|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123276|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154123277|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154123306|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123307|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
154123308|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123309|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123310|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
154123311|NCT01065727|Natalizumab|natalizumab|mesh-list
154123312|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
154123313|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154123314|NCT01065727|Immunomodulating Agents|immunomodulating agents|mesh-list
154123315|NCT01065727|Analgesics|analgesics|mesh-ancestor
154123316|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
154123317|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123318|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123319|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361775|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
153352917|NCT00496340|Rituximab|rituximab|mesh-list
154123350|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154123351|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154123352|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
154123353|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123354|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123355|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154123356|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154123357|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
154123358|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154123359|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
154123360|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154123361|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
154123362|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123363|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154123364|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154123365|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154123366|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154123402|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154123403|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
154123404|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
154123405|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154123406|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123435|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154123436|NCT00631410|Sunitinib|sunitinib|mesh-list
154123437|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123438|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154123439|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154123440|NCT00631410|Growth Substances|growth substances|mesh-ancestor
154123441|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123442|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
154123443|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154123444|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123445|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123446|NCT00817284|Bevacizumab|bevacizumab|mesh-list
154123447|NCT00817284|Irinotecan|irinotecan|mesh-list
154123448|NCT00817284|Temozolomide|temozolomide|mesh-list
154123449|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154123450|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123482|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154123483|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154123484|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123485|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123486|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
154123487|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
154123488|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154123489|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154123490|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154123491|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154123524|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123526|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154123527|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153357295|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866287|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866288|NCT00563147|Sirolimus|sirolimus|mesh-list
153406723|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
153406724|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406725|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406726|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406727|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406728|NCT03901482|Analgesics|analgesics|mesh-ancestor
153594556|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594557|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594558|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
153594559|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
153594560|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594561|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
154123529|NCT00527332|Morphine|morphine|mesh-list
154123530|NCT00527332|Bupivacaine|bupivacaine|mesh-list
154123531|NCT00527332|Propofol|propofol|mesh-list
154123532|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
154123533|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
153353132|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154123556|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154123557|NCT00820326|Dolasetron|dolasetron|mesh-list
154123558|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
154123559|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
154123560|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123561|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123562|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123563|NCT00820326|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154123564|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154123565|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
154123566|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123567|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123568|NCT00916097|Docetaxel|docetaxel|mesh-list
154123569|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123570|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
154123571|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
154123572|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
154123573|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123575|NCT00629772|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154123576|NCT00629772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154123577|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
154123578|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123579|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154123580|NCT00526630|Methylphenidate|methylphenidate|mesh-list
154123581|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154123582|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123583|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154123584|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153736380|NCT02903160|Hormones|hormones|mesh-ancestor
153406746|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153406747|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153406748|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
153406749|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406750|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
153406751|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
153406752|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406753|NCT03829371|Dexamethasone|dexamethasone|mesh-list
153406754|NCT03829371|Prednisone|prednisone|mesh-list
153406755|NCT03829371|Lenalidomide|lenalidomide|mesh-list
154123585|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353171|NCT01485055|Basiliximab|basiliximab|mesh-list
154123623|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
154123624|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153353233|NCT05139030|Bupivacaine|bupivacaine|mesh-list
154123647|NCT00826566|Caffeine|caffeine|mesh-list
154123648|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154123649|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123650|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154123651|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123652|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123653|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154123654|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154123655|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
154123656|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123657|NCT03999190|Raclopride|raclopride|mesh-list
154123658|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
154123659|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154123660|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123661|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154123662|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123663|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123664|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123665|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
154123666|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123667|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154123668|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154123669|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123670|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123671|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154123672|NCT05244694|Insulin|insulin|mesh-list
154123673|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154123674|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123675|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
154123697|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123698|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154123700|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
154123701|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
154123702|NCT04922944|Vaccines|vaccines|mesh-list
153810684|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153866303|NCT00570999|Mitogens|mitogens|mesh-list
153866304|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
153866305|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866306|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
153866307|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153866308|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
153866309|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866310|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866311|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866312|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866313|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153594562|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153594563|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
153594564|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153594565|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
153594566|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153594567|NCT01850511|Protective Agents|protective agents|mesh-ancestor
153594568|NCT01850628|Paclitaxel|paclitaxel|mesh-list
154123703|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
154123704|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123705|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
154123706|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
154123707|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123708|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123709|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123710|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
154123711|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154123712|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123713|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123714|NCT04044378|Ifosfamide|ifosfamide|mesh-list
154123715|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154123716|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
154123717|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123718|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123719|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154123720|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
154123721|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153361812|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
154123722|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154123723|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
154123724|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154123725|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
154123726|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123727|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123746|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
154123748|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
154123749|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123751|NCT00525148|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154123752|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866323|NCT00571116|Disulfiram|disulfiram|mesh-list
153866324|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866325|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153406762|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406763|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406764|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153406766|NCT03829371|Hormones|hormones|mesh-ancestor
153406767|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406768|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153406769|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406770|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
153406771|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153406772|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153406773|NCT03829371|Growth Substances|growth substances|mesh-ancestor
153406774|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
153406775|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153406776|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
154123753|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123754|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123755|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123756|NCT00754325|Dasatinib|dasatinib|mesh-list
154123757|NCT00754325|Fulvestrant|fulvestrant|mesh-list
154123758|NCT00754325|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154123759|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154123760|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123761|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123762|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123763|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154123764|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154123765|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154123766|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
154123767|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123768|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123769|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
154123770|NCT00524680|Vitamin D|vitamin d|mesh-list
154123771|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154123772|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123773|NCT00524680|Vitamins|vitamins|mesh-ancestor
154123774|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
154123775|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154123776|NCT00298363|Tenofovir|tenofovir|mesh-list
154123777|NCT00298363|Emtricitabine|emtricitabine|mesh-list
154123778|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154123779|NCT00298363|Entecavir|entecavir|mesh-list
153353367|NCT00442364|Polidocanol|polidocanol|mesh-list
154123801|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154123802|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
154123803|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123804|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123805|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154123806|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154123807|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
154123808|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406780|NCT03785964|Nirogacestat|nirogacestat|mesh-list
153818728|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123809|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154123810|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154123811|NCT00777101|Capecitabine|capecitabine|mesh-list
154123812|NCT00777101|Lapatinib|lapatinib|mesh-list
154123813|NCT00777101|Neratinib|neratinib|mesh-list
154123814|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154123815|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
154123816|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123817|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123818|NCT00777101|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154123819|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153447271|NCT00002531|Leucovorin|leucovorin|mesh-list
154123820|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123821|NCT00830856|Lamivudine|lamivudine|mesh-list
154123822|NCT00830856|Nevirapine|nevirapine|mesh-list
154123823|NCT00830856|Stavudine|stavudine|mesh-list
154123824|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
154123825|NCT00830856|Fluconazole|fluconazole|mesh-list
154123826|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154123827|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154123828|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123829|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123830|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
154123831|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123832|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154123833|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154123862|NCT00524134|Protective Agents|protective agents|mesh-ancestor
154123863|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154123864|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123865|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154123866|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
154123867|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154123868|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154123869|NCT00777023|Gabapentin|gabapentin|mesh-list
154123870|NCT00777023|Analgesics|analgesics|mesh-ancestor
154123871|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
153866343|NCT04613609|Nicotine|nicotine|mesh-list
153818729|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
153818730|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153818731|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153818732|NCT03934684|Growth Substances|growth substances|mesh-ancestor
154123872|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123873|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123874|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
154123875|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154123876|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153353477|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
154123893|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154123894|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154123895|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
154123896|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154123897|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
154123898|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154123899|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123900|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123901|NCT00292981|Complement C1s|complement c1s|mesh-list
154123902|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154123903|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154123904|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
154123905|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123906|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154123907|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154123908|NCT02598869|Triamcinolone|triamcinolone|mesh-list
154123909|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154123910|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154123911|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154123912|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154123913|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
154123914|NCT02598869|Hormones|hormones|mesh-ancestor
154123915|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123916|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123917|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154123918|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
154123919|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123920|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123922|NCT04095455|Analgesics|analgesics|mesh-ancestor
153406813|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406814|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153406815|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818733|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
153818734|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
153818735|NCT03899402|Semaglutide|semaglutide|mesh-list
153818736|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818737|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594576|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594577|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153594578|NCT01850680|Folic Acid|folic acid|mesh-list
153594579|NCT01850680|Methotrexate|methotrexate|mesh-list
153594580|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153594581|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
153594582|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153594583|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594585|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
153594586|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594587|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594588|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
153594589|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594590|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154123923|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
154123924|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123925|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123926|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154123927|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154123928|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
154123929|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
154123930|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123931|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153353524|NCT00519584|Bupivacaine|bupivacaine|mesh-list
154123957|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
154123958|NCT00523978|Sotalol|sotalol|mesh-list
154123959|NCT00523978|Flecainide|flecainide|mesh-list
154123960|NCT00523978|Propafenone|propafenone|mesh-list
154123961|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154123962|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154123963|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
154123964|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123965|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123966|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123967|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154123968|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
154123969|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
154123970|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123971|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154123972|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154123973|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123974|NCT00296647|Bupropion|bupropion|mesh-list
153810685|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
153594591|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153594592|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
153594593|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594594|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153594595|NCT01850680|Hematinics|hematinics|mesh-ancestor
153594596|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
153594597|NCT01850680|Vitamins|vitamins|mesh-ancestor
153594598|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
153594599|NCT01850940|Tolvaptan|tolvaptan|mesh-list
154123975|NCT00296647|Nicotine|nicotine|mesh-list
154123976|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154123977|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
154123994|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123996|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154123997|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123998|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123999|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
154124000|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124001|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124002|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
154124003|NCT00523744|Amlodipine|amlodipine|mesh-list
154124004|NCT00523744|Valsartan|valsartan|mesh-list
154124005|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154124006|NCT00523744|Olmesartan|olmesartan|mesh-list
154124007|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154124008|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154124009|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154124010|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124011|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124012|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154124013|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124014|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
154124015|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154124016|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154124017|NCT00523744|Diuretics|diuretics|mesh-ancestor
154124018|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
154124019|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154124020|NCT03979625|Heparin|heparin|mesh-list
154124021|NCT03979625|Antibodies|antibodies|mesh-list
154124022|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
154124023|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124024|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
153866370|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153866371|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866372|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
153866373|NCT00571740|Antidotes|antidotes|mesh-ancestor
153866374|NCT00571740|Protective Agents|protective agents|mesh-ancestor
153866375|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
153866376|NCT00571740|Vitamins|vitamins|mesh-ancestor
153866377|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
153594600|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153594601|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594603|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594604|NCT01850953|Varenicline|varenicline|mesh-list
153594605|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153594606|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153594619|NCT01851005|Remifentanil|remifentanil|mesh-list
153594620|NCT01851005|Anesthetics|anesthetics|mesh-list
153594621|NCT01851005|Propofol|propofol|mesh-list
153594622|NCT01851005|Sevoflurane|sevoflurane|mesh-list
153594623|NCT01851005|Rocuronium|rocuronium|mesh-list
153594624|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594625|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594626|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154124025|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154124026|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154124027|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124028|NCT02548494|Insulin|insulin|mesh-list
154124029|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
154124030|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154124031|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124032|NCT00752219|Metronidazole|metronidazole|mesh-list
154124033|NCT00752219|Meropenem|meropenem|mesh-list
154124069|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154124070|NCT00622908|Besifloxacin|besifloxacin|mesh-list
154124104|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
154124105|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
154124106|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124107|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154124108|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
154124109|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
154124110|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353716|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124144|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124147|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
154124148|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124149|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124150|NCT00296491|Fluticasone|fluticasone|mesh-list
154124151|NCT00296491|Xhance|xhance|mesh-list
154124152|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154124153|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154124154|NCT00296491|Montelukast|montelukast|mesh-list
154124182|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154124184|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594627|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406827|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406828|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153406829|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153406830|NCT03635489|Growth Substances|growth substances|mesh-ancestor
153406831|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406832|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
153406833|NCT03631784|Paclitaxel|paclitaxel|mesh-list
153406834|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153406835|NCT03631784|Carboplatin|carboplatin|mesh-list
153406836|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
153406837|NCT03631784|Pemetrexed|pemetrexed|mesh-list
153406838|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153406839|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406840|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
153594630|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594631|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154124185|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594632|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154124186|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
154124187|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154124188|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124189|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124190|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154124191|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154124192|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154124193|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154124194|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154124195|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154124197|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
154124198|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124199|NCT00296335|Mitomycins|mitomycins|mesh-list
154124227|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
154124228|NCT01065961|Hormones|hormones|mesh-ancestor
154124229|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154124230|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154124231|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124232|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
154124233|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124234|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124235|NCT01068223|Cetirizine|cetirizine|mesh-list
154124236|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154124237|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154124238|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154124239|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
154124240|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
154124241|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810686|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594642|NCT01851005|Narcotics|narcotics|mesh-ancestor
153594643|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153594644|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153594645|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153594646|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
154124242|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124243|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124244|NCT02600273|Nicotine|nicotine|mesh-list
154124245|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154124246|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
154124247|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124276|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124278|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154124279|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124280|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124281|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154124282|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154124283|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154124284|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124285|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154124286|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
154124287|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
154124288|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124289|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154124290|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
154124291|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
154124292|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353896|NCT00115700|Rituximab|rituximab|mesh-list
154124321|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154124322|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
154124323|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154124324|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124325|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
154124326|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154124327|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124328|NCT04093505|Immunotoxins|immunotoxins|mesh-ancestor
154124329|NCT04093505|Immunoconjugates|immunoconjugates|mesh-ancestor
154124330|NCT04093505|Immunologic Factors|immunologic factors|mesh-ancestor
154124331|NCT04093505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866385|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
153594647|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153594648|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
153594649|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594652|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153594660|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153594661|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594662|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594663|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594664|NCT01851278|Triamcinolone|triamcinolone|mesh-list
153594665|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153594666|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153594667|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153594668|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153594669|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
153594670|NCT01851278|Hormones|hormones|mesh-ancestor
153594671|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594672|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594673|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153594674|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
154124332|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
153594675|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124333|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154124334|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
154124335|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154124336|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
154124337|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447806|NCT00381953|Interferons|interferons|mesh-list
154124338|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124339|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
154124362|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154124364|NCT00998218|Ranolazine|ranolazine|mesh-list
154124365|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154124366|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124367|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124368|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154124369|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154124371|NCT00311311|Sirolimus|sirolimus|mesh-list
154124372|NCT00311311|Prednisone|prednisone|mesh-list
154124373|NCT00311311|Tacrolimus|tacrolimus|mesh-list
154124374|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154124375|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
154124376|NCT00311311|Hormones|hormones|mesh-ancestor
154124377|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866406|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
153406843|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406844|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406845|NCT03631784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406846|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406847|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153406848|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153406849|NCT03617705|Ethanol|ethanol|mesh-list
153406854|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
153818741|NCT03880019|Temozolomide|temozolomide|mesh-list
153818743|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153818744|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153818745|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
153818746|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818747|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818748|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818749|NCT03864419|Prednisone|prednisone|mesh-list
154124378|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124379|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154124381|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154124382|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
154124383|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154124384|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124385|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124386|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154124387|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154124388|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
154124389|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154124390|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124391|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
154124392|NCT04089605|Dexamethasone|dexamethasone|mesh-list
154124393|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
154124394|NCT04089605|Ranibizumab|ranibizumab|mesh-list
154124430|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154124431|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124432|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
154124461|NCT00827814|Dutasteride|dutasteride|mesh-list
154124462|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154124463|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154124464|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124465|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124466|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
154124467|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818750|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
153818751|NCT03864419|Rituximab|rituximab|mesh-list
153357296|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154124468|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124469|NCT01068847|Cycloserine|cycloserine|mesh-list
154124470|NCT01068847|Verapamil|verapamil|mesh-list
154124471|NCT01068847|Nifedipine|nifedipine|mesh-list
154124472|NCT01068847|Tizanidine|tizanidine|mesh-list
154124473|NCT01068847|Naloxone|naloxone|mesh-list
154124474|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154124475|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124476|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
154124477|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124478|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154124501|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
154124502|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124503|NCT00827892|Pioglitazone|pioglitazone|mesh-list
154124504|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154124505|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124506|NCT01070875|Heparin|heparin|mesh-list
154124507|NCT01070875|Calcium heparin|calcium heparin|mesh-list
154124508|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
154124509|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154124510|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154124511|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124512|NCT04043676|Ponatinib|ponatinib|mesh-list
154124513|NCT04043676|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154124514|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124515|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124516|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124517|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124518|NCT01325935|Clopidogrel|clopidogrel|mesh-list
154124519|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154124520|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154124521|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154124522|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154124523|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
154124524|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124525|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124526|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124527|NCT02549742|Bleomycin|bleomycin|mesh-list
154124528|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154124561|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154124562|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124563|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154124564|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154124565|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
154124566|NCT00291577|Docetaxel|docetaxel|mesh-list
154124567|NCT00291577|Sunitinib|sunitinib|mesh-list
154124568|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124569|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
154124570|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
154124571|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
154124590|NCT02549430|Exemestane|exemestane|mesh-list
154124591|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124592|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154124593|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154124594|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124595|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124596|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154124597|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
154124598|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154124599|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124600|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154124601|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154124602|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124603|NCT00943839|Sunitinib|sunitinib|mesh-list
154124604|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124605|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154124606|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154124607|NCT00943839|Growth Substances|growth substances|mesh-ancestor
154124608|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124609|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
154124610|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124611|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124612|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124613|NCT00832182|Insulin|insulin|mesh-list
154124614|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154124615|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
154124616|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
154124617|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
154124618|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
154124619|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154124620|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124621|NCT00952497|Capecitabine|capecitabine|mesh-list
154124622|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124623|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154124624|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
154124625|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124626|NCT00828282|Simvastatin|simvastatin|mesh-list
154124627|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154124628|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153810687|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124660|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154124661|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124662|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124663|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124665|NCT00944307|Protective Agents|protective agents|mesh-ancestor
154124666|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124667|NCT00944385|Urinastatin|urinastatin|mesh-list
154124668|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154124669|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154124670|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
154124671|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124684|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154124685|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154124686|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124687|NCT00956397|Rifaximin|rifaximin|mesh-list
154124688|NCT00956397|Lactulose|lactulose|mesh-list
154124689|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154124690|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124691|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124692|NCT05300373|Adenosine|adenosine|mesh-list
154124693|NCT05300373|Analgesics|analgesics|mesh-ancestor
154124694|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
154124695|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124696|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124697|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154124698|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
154124699|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154124700|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
154124701|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
154124702|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124703|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124704|NCT00953589|Ribavirin|ribavirin|mesh-list
154124705|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
154124706|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124707|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
154124708|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124709|NCT00947739|Camptothecin|camptothecin|mesh-list
154124710|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154124711|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124712|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154124713|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154124714|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124715|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124716|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
154124717|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154124718|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124719|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
154124720|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154124721|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154124722|NCT00947895|Prednisolone|prednisolone|mesh-list
154124723|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
154124724|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154124725|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
154124726|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154124727|NCT00947895|Hormones|hormones|mesh-ancestor
154124728|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154124729|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124730|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154124731|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
154124732|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
154124733|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124751|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
154124752|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124753|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124754|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124755|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
154124757|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154124758|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154124759|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124760|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154124761|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154124762|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124763|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154124764|NCT00623766|Protective Agents|protective agents|mesh-ancestor
154124765|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154124766|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
154124767|NCT00832494|Paclitaxel|paclitaxel|mesh-list
154124768|NCT00832494|Carboplatin|carboplatin|mesh-list
154124769|NCT00832494|Vadimezan|vadimezan|mesh-list
154124770|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153810688|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866424|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866425|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866426|NCT00563654|Alfuzosin|alfuzosin|mesh-list
153594686|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
153594687|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594688|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594689|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594690|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153594691|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
153594693|NCT01851473|Acetazolamide|acetazolamide|mesh-list
153594694|NCT01851473|Cocaine|cocaine|mesh-list
153594695|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
153594696|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153594697|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594698|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594699|NCT01851473|Diuretics|diuretics|mesh-ancestor
153594700|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
153594701|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594702|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
154124771|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124772|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
154124773|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
154124774|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
154124775|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124776|NCT00837564|Escitalopram|escitalopram|mesh-list
154124777|NCT00837564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154124778|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154124779|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124780|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124781|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124782|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
154124783|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124784|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
154124785|NCT00954135|Sorafenib|sorafenib|mesh-list
154124786|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154124787|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
154124788|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124789|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154124790|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154124791|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
154124792|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124793|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124829|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
154124830|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460151|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460152|NCT04439279|Trametinib|trametinib|mesh-list
153460153|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153460154|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460155|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460156|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460157|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460158|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154124831|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124832|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
154124833|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154124850|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124852|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
154124853|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154124854|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124855|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124856|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154124857|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124858|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154124859|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154124860|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124861|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153448340|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
154124862|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154124864|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124865|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154124866|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
154124867|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
154124868|NCT00837954|Coagulants|coagulants|mesh-ancestor
154124869|NCT00954525|Gemcitabine|gemcitabine|mesh-list
154124870|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154124871|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154124872|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
154124873|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124874|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124875|NCT00954525|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154124876|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124877|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124878|NCT00838032|Haloperidol|haloperidol|mesh-list
154124879|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154124880|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
154124881|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
154124882|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154124883|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154124884|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154124885|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124886|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124887|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
153450372|NCT00005627|Docetaxel|docetaxel|mesh-list
154124888|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
154124889|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124919|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124921|NCT02548806|Analgesics|analgesics|mesh-ancestor
154124922|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
154124923|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124924|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124925|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154124926|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
154124927|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
154124928|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154124929|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154124930|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154124931|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
154124932|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124933|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124934|NCT00549939|Alfuzosin|alfuzosin|mesh-list
154124952|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154124953|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154124954|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154124955|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
154124956|NCT00957879|Calcitriol|calcitriol|mesh-list
154124957|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
154124958|NCT00957879|Vitamin D|vitamin d|mesh-list
154124959|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154124960|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124961|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154124962|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124963|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124964|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154124965|NCT00957879|Vitamins|vitamins|mesh-ancestor
154124966|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
154124967|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154124968|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
154124969|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154124970|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124971|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
154124972|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124973|NCT00838266|Protective Agents|protective agents|mesh-ancestor
154124974|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124975|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
154124976|NCT04011033|Interleukin-2|interleukin-2|mesh-list
154124977|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154124978|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
154124979|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124980|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154124981|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154124982|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
154124983|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124984|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124985|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154124986|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154124987|NCT04011033|Analgesics|analgesics|mesh-ancestor
154124988|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
153435368|NCT00002551|Antidotes|antidotes|mesh-ancestor
154124989|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125023|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154125024|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
154125025|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125026|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125027|NCT02547402|CXA-10|cxa-10|mesh-list
154125028|NCT02547402|Simvastatin|simvastatin|mesh-list
154125029|NCT02547402|Ezetimibe|ezetimibe|mesh-list
154125134|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125135|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
154125136|NCT00744497|Prednisone|prednisone|mesh-list
154125137|NCT00744497|Docetaxel|docetaxel|mesh-list
154125231|NCT01069081|Cisplatin|cisplatin|mesh-list
154125232|NCT01069081|Docetaxel|docetaxel|mesh-list
154125233|NCT01069081|Esomeprazole|esomeprazole|mesh-list
154125234|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125235|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448718|NCT00002825|Docetaxel|docetaxel|mesh-list
154125236|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
154125237|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
154125238|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125239|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154125240|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154125241|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154125242|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125244|NCT00949455|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154125245|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154125246|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125247|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354855|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
154125339|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125340|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
154125341|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154125342|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125343|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
154125344|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125345|NCT00956163|Diphosphonates|diphosphonates|mesh-list
154125346|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
154125566|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154125567|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
153866471|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153460159|NCT04439279|Protective Agents|protective agents|mesh-ancestor
153460160|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460161|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153460162|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
153460163|NCT04294966|Dronabinol|dronabinol|mesh-list
153460164|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
153460165|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460166|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153460167|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153460168|NCT04294966|Analgesics|analgesics|mesh-ancestor
153460169|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
154125568|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125569|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
154125570|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125571|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125572|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154125573|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
154125574|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125575|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355177|NCT01589263|Tamsulosin|tamsulosin|mesh-list
154125612|NCT05299593|Timolol|timolol|mesh-list
154125613|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154125614|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154125615|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
154125803|NCT00267865|Vitamins|vitamins|mesh-ancestor
154125804|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
154125805|NCT00840918|Lidocaine|lidocaine|mesh-list
153355402|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
154125860|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154125861|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154125862|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154125863|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
154125864|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154125865|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154125866|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125869|NCT00845598|Azelastine|azelastine|mesh-list
154125870|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154125871|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154125872|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
154125873|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125874|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125875|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153355479|NCT02248129|Diuretics|diuretics|mesh-ancestor
153594728|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153594729|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
153594730|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
153594731|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153594732|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153594733|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153818758|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
153818759|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153818760|NCT03864419|Antibodies|antibodies|mesh-list
153818761|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
153818762|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153818763|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818764|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
153818765|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818766|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153818767|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153818768|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
153818769|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594734|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
153355513|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153355514|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355515|NCT00651560|Simvastatin|simvastatin|mesh-list
154126047|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154126048|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
154126049|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126050|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126051|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154126052|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126053|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154126054|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154126114|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126116|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154126117|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154126118|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355717|NCT05568979|Vaccines|vaccines|mesh-list
154126153|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154126155|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126156|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154126157|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
154126158|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
154126159|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
154126160|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154126216|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154126217|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153506645|NCT01393145|Xhance|xhance|mesh-list
154126218|NCT00266227|Rituximab|rituximab|mesh-list
153357297|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
153357298|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
153594735|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594736|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594737|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153594738|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153594739|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126219|NCT00266227|Methotrexate|methotrexate|mesh-list
154126220|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154126221|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126222|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
154126223|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126224|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126225|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154126226|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
154126227|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154126228|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154126229|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
154126230|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126231|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
154126232|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126233|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154126234|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126235|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154126236|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
154126237|NCT00968877|Vitamin D|vitamin d|mesh-list
154126238|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154126239|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126240|NCT00968877|Vitamins|vitamins|mesh-ancestor
154256696|NCT03877562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154256697|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256698|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154126242|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154126408|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154126410|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126501|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
154126502|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
154126503|NCT00970905|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154126504|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153594740|NCT01851551|Rituximab|rituximab|mesh-list
153594741|NCT01851551|Vincristine|vincristine|mesh-list
153594742|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153594743|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594744|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
153594745|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594746|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594747|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153594748|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
153594749|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
153594750|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
153594751|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594753|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594754|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594755|NCT01851733|Doxorubicin|doxorubicin|mesh-list
153594756|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153594757|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594758|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153594759|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153781713|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594760|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594761|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594762|NCT01851759|Cinepazide|cinepazide|mesh-list
154126505|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
154126506|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126507|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126508|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154126509|NCT00619476|Gabapentin|gabapentin|mesh-list
154126510|NCT00619476|Analgesics|analgesics|mesh-ancestor
154126511|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
154126512|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126513|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126514|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
154126515|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154126516|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154126517|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126518|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154126519|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154126520|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154126521|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126522|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126523|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
154126524|NCT00973713|Everolimus|everolimus|mesh-list
154126525|NCT00973713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154126556|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126557|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126558|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126560|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594774|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594775|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153594776|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154126561|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126562|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126563|NCT00959439|Naproxen|naproxen|mesh-list
154126564|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154126565|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154126566|NCT00959439|Analgesics|analgesics|mesh-ancestor
154126567|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
154126605|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126606|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
154126607|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
154126608|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154126686|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126687|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126688|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154126689|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
154126690|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126691|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126692|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154126693|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154126694|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154126695|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
154126696|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154126697|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
154126698|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
154126699|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
154126700|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126701|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
154126703|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126704|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154126705|NCT00781196|Folic Acid|folic acid|mesh-list
154126706|NCT00781196|Hematinics|hematinics|mesh-ancestor
154126707|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
154126708|NCT00781196|Vitamins|vitamins|mesh-ancestor
154256699|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126710|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126711|NCT00865644|Imiquimod|imiquimod|mesh-list
154126712|NCT00865644|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154126783|NCT00791024|Lidocaine|lidocaine|mesh-list
153356384|NCT01235897|Paclitaxel|paclitaxel|mesh-list
153810690|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153810691|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153866486|NCT00572208|Analgesics|analgesics|mesh-ancestor
153866487|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
153866488|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866490|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
154126794|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126796|NCT00781430|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154126797|NCT00781430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126798|NCT00781430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126799|NCT00781430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126800|NCT00666536|Amlodipine|amlodipine|mesh-list
154126801|NCT00666536|Valsartan|valsartan|mesh-list
154126802|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154126803|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154126804|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154126805|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154126806|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126807|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154126808|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126809|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
154126810|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154126811|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154126812|NCT00519532|Rotigotine|rotigotine|mesh-list
154126813|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
154126814|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
154126815|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126816|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126817|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126818|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154126819|NCT00666458|Saxagliptin|saxagliptin|mesh-list
154126820|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126821|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126822|NCT00666458|Incretins|incretins|mesh-ancestor
154126823|NCT00666458|Hormones|hormones|mesh-ancestor
154126824|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126825|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154126826|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
154126827|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126828|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126829|NCT00974961|Bupivacaine|bupivacaine|mesh-list
154126830|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
154126831|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
154126832|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
154126833|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126834|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126835|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
153866497|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357299|NCT01270256|Hormones|hormones|mesh-ancestor
153866498|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406938|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
153406939|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406940|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153406941|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153406942|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153406943|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406944|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406946|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
153406947|NCT03243552|Levodopa|levodopa|mesh-list
153406948|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153406949|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153406950|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
153406951|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126836|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406953|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126837|NCT00511108|Pioglitazone|pioglitazone|mesh-list
154126838|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154126839|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126840|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126841|NCT00511108|Incretins|incretins|mesh-ancestor
154126842|NCT00511108|Hormones|hormones|mesh-ancestor
154126843|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126844|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154126873|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126875|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126876|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126877|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154126878|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126879|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154126880|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
154126881|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154126882|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126883|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
154126884|NCT01012570|Adalimumab|adalimumab|mesh-list
154126885|NCT01012570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154126886|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126887|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154256700|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126888|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154126889|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154126890|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
154126891|NCT00661622|Molgramostim|molgramostim|mesh-list
154126923|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
154126924|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126925|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126926|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154126927|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154126928|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
154126929|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
154126930|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406955|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153406956|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
153406957|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153406958|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
153406959|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406960|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406961|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
153406962|NCT03198728|Testosterone|testosterone|mesh-list
153406963|NCT03198728|Androgens|androgens|mesh-ancestor
153406964|NCT03198728|Hormones|hormones|mesh-ancestor
153406965|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126931|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126933|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126934|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126935|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126936|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126937|NCT00792584|Efavirenz|efavirenz|mesh-list
154127061|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
154127062|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127063|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154127064|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154127065|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
154127066|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127067|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127068|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154127069|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154127070|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154127071|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154127072|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127073|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154127074|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
154127075|NCT00972387|Hormones|hormones|mesh-ancestor
154127076|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127077|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154127078|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154127079|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154127080|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154127081|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154127082|NCT00744263|Vaccines|vaccines|mesh-list
154127083|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154127084|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
154127085|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127086|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
154127087|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154127088|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154127089|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
154127090|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127091|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127092|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127093|NCT00866736|Dasatinib|dasatinib|mesh-list
154127094|NCT00866736|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154127095|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154127096|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866499|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
153866500|NCT00572364|Olaparib|olaparib|mesh-list
153866501|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153866502|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866503|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866504|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866505|NCT00563771|Rasburicase|rasburicase|mesh-list
153594777|NCT01851941|Leucovorin|leucovorin|mesh-list
153594778|NCT01851941|Folic Acid|folic acid|mesh-list
153594779|NCT01851941|Fluorouracil|fluorouracil|mesh-list
153594780|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
153594781|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
153594782|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
153594783|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594784|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153356656|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154127127|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
154127128|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127129|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127130|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127131|NCT00618774|Amlodipine|amlodipine|mesh-list
154127132|NCT00618774|Telmisartan|telmisartan|mesh-list
154127133|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154127134|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154127135|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154127136|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127137|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154127138|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127139|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
154127383|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
154127384|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127385|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127517|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127518|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127519|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
154127520|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154127566|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
154127567|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154127568|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
154127569|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154127570|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
154127665|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127666|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154127699|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
154127700|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127701|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127702|NCT00860340|Spironolactone|spironolactone|mesh-list
153866514|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866517|NCT00563849|Leflunomide|leflunomide|mesh-list
153594785|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594786|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153594787|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
153594788|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594789|NCT01851941|Antidotes|antidotes|mesh-ancestor
153594790|NCT01851941|Protective Agents|protective agents|mesh-ancestor
153594791|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
153594792|NCT01851941|Vitamins|vitamins|mesh-ancestor
153594793|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
153594794|NCT01851941|Hematinics|hematinics|mesh-ancestor
153594795|NCT01851954|Clarithromycin|clarithromycin|mesh-list
153594796|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594797|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594798|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154127703|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154127704|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
154127705|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127706|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127742|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154127743|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
154127744|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127745|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129273|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
154129274|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129275|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129276|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
154129277|NCT00797810|Cytarabine|cytarabine|mesh-list
154129278|NCT00797810|Dexamethasone|dexamethasone|mesh-list
154129279|NCT00797810|Prednisone|prednisone|mesh-list
154129370|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154129371|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129372|NCT00881166|Paclitaxel|paclitaxel|mesh-list
154129373|NCT00881166|Etoposide|etoposide|mesh-list
154129374|NCT00881166|Docetaxel|docetaxel|mesh-list
154129375|NCT00881166|Carboplatin|carboplatin|mesh-list
154129376|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154129377|NCT00881166|Topotecan|topotecan|mesh-list
154129378|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154129379|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129380|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
154129381|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
154129382|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
154129383|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129384|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154129385|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153406984|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406986|NCT03107923|Dobutamine|dobutamine|mesh-list
153594799|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594800|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594801|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153594822|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594823|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
153594824|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153594825|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153594826|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594827|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
153594828|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
153594829|NCT01852266|Vaccines|vaccines|mesh-list
153594830|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
153594831|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594832|NCT01852318|Fexofenadine|fexofenadine|mesh-list
153594833|NCT01852318|Pregabalin|pregabalin|mesh-list
153594834|NCT01852318|Analgesics|analgesics|mesh-ancestor
153594835|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
153594836|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594837|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594838|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
154129386|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129387|NCT00881166|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154129388|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154129389|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154129441|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154129442|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154129443|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129444|NCT00805064|Triamcinolone|triamcinolone|mesh-list
154129445|NCT00805064|Bevacizumab|bevacizumab|mesh-list
154129446|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129447|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129448|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154129449|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154129577|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129578|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
154129579|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129580|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
154129582|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154129583|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129584|NCT00809744|Vitamins|vitamins|mesh-ancestor
154129585|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
154129586|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154129587|NCT00246337|Rizatriptan|rizatriptan|mesh-list
154129588|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154129624|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256703|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153594839|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153866532|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154256704|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
154256705|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256706|NCT03876548|Iodine|iodine|mesh-list
154256707|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
154256708|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154256709|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256710|NCT03876548|Trace Elements|trace elements|mesh-ancestor
154256711|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
153731764|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154130214|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154130216|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154130217|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130218|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154130219|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154130220|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154130221|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154130222|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130223|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130224|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154130225|NCT04589676|Naloxone|naloxone|mesh-list
154130226|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154130227|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130228|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
154130229|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130230|NCT00724451|Ribavirin|ribavirin|mesh-list
154130231|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154130232|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154130233|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
154130255|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
154130256|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130257|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154130258|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154130259|NCT00724061|Interferons|interferons|mesh-list
154130260|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
154130261|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
154130262|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154130263|NCT00724061|Furocoumarins|furocoumarins|mesh-list
154130264|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130265|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
154130266|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130267|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
154130268|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130269|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
154130270|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154130271|NCT02594423|Bevacizumab|bevacizumab|mesh-list
154130272|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866537|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866538|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
153866539|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866540|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153866541|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866542|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
153866543|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866544|NCT01150123|Vaccines|vaccines|mesh-list
153866545|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
153866546|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866547|NCT00572559|Vancomycin|vancomycin|mesh-list
153866548|NCT00572559|Linezolid|linezolid|mesh-list
153866549|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153866550|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866551|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153866552|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594842|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154130273|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130274|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154130275|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154130276|NCT02594423|Growth Substances|growth substances|mesh-ancestor
154130277|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130278|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
154130279|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
154130280|NCT00882414|Hematinics|hematinics|mesh-ancestor
154130281|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154130282|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154130283|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154130284|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
154130285|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130649|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130650|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362071|NCT05827484|Losartan|losartan|mesh-list
154130651|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
154130652|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130781|NCT00891072|Carboplatin|carboplatin|mesh-list
154130782|NCT00891072|Retinol acetate|retinol acetate|mesh-list
154130783|NCT00891072|Gossypol|gossypol|mesh-list
154130899|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154130900|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
154130901|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130902|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
154130903|NCT00812396|Testosterone|testosterone|mesh-list
154130904|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
154130905|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
154130906|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154130907|NCT00812396|Androgens|androgens|mesh-ancestor
154130908|NCT00812396|Hormones|hormones|mesh-ancestor
154132667|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
154132668|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
154132669|NCT00905190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154132670|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153866555|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153866556|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
153406998|NCT03107923|Protective Agents|protective agents|mesh-ancestor
154132671|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
154132672|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132673|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132674|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154132675|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
154132676|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
154132947|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132948|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
154132949|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154132950|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154132951|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132952|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
154132953|NCT03970213|Coagulants|coagulants|mesh-ancestor
154132954|NCT00821834|Ticlopidine|ticlopidine|mesh-list
154132955|NCT00821834|Clopidogrel|clopidogrel|mesh-list
154132956|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153513334|NCT01419548|Veliparib|veliparib|mesh-list
154132957|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154132958|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154132959|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154132960|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
154132961|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132962|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132963|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132964|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154132965|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154132966|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154132967|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154132968|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132970|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
154132971|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
154132972|NCT04005417|Protective Agents|protective agents|mesh-ancestor
154132973|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132974|NCT01073839|Gemcitabine|gemcitabine|mesh-list
154132975|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132976|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154133008|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
154133009|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133010|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154133012|NCT00987441|Analgesics|analgesics|mesh-ancestor
154133013|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154133014|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154133015|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
154133016|NCT00584987|Fluticasone|fluticasone|mesh-list
153594849|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153818770|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133017|NCT00584987|Xhance|xhance|mesh-list
154133018|NCT00584987|Phenylephrine|phenylephrine|mesh-list
154133052|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133053|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
154133054|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133055|NCT00821912|Docetaxel|docetaxel|mesh-list
154133056|NCT00821912|Capecitabine|capecitabine|mesh-list
154133057|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133058|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
154133059|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
154133060|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133255|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133256|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133257|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
154133313|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154133314|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
154133315|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133316|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154133317|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154133318|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133319|NCT00987909|Immunomodulating Agents|immunomodulating agents|mesh-list
154133320|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
154133321|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133322|NCT00822380|Iron|iron|mesh-list
154133323|NCT00822380|Trace Elements|trace elements|mesh-list
154133324|NCT00822380|Folic Acid|folic acid|mesh-list
154133325|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
154133326|NCT00822380|Micronutrients|micronutrients|mesh-list
154133522|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154133523|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
154133524|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133525|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154133526|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
154133527|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
154133528|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
154133529|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154134087|NCT00622466|Paclitaxel|paclitaxel|mesh-list
154134088|NCT00622466|Sorafenib|sorafenib|mesh-list
153818771|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153818772|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153818773|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153818774|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153818778|NCT03864419|Hormones|hormones|mesh-ancestor
153818779|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818780|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153818781|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153460170|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460171|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153460172|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153460173|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594850|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
154134089|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154134090|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134091|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
154134092|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
154134093|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
154134094|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134095|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154134096|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134097|NCT04043858|Midodrine|midodrine|mesh-list
154134252|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
154134253|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154134254|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154134306|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
154134307|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154134309|NCT02547350|Epirubicin|epirubicin|mesh-list
154134310|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134311|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154134312|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154134313|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154134314|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134315|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134316|NCT00838214|Prednisone|prednisone|mesh-list
154134317|NCT00838214|Budesonide|budesonide|mesh-list
154134318|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134319|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
154134385|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154134386|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154134387|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
154134388|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134389|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153407029|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134390|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153387019|NCT01203371|Tamsulosin|tamsulosin|mesh-list
154134485|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134486|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
154134487|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
154134488|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134489|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
154134490|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
154134492|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
154134493|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134494|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
154134495|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154134496|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134497|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134498|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134499|NCT00622388|Ofatumumab|ofatumumab|mesh-list
154134500|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134501|NCT01156389|Ritonavir|ritonavir|mesh-list
154134502|NCT01156389|Artesunate|artesunate|mesh-list
154134650|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
154134651|NCT02549846|Atorvastatin|atorvastatin|mesh-list
154134652|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154134653|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154134654|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154134655|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
154134656|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134657|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154134658|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154134659|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134660|NCT05407155|Paclitaxel|paclitaxel|mesh-list
154134691|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
154134692|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134693|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134694|NCT00537303|Insulin|insulin|mesh-list
154134695|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154134696|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
154134697|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
154134698|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154134699|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
154134899|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134900|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154134902|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
154134903|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134904|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153469560|NCT04847557|Hormones|hormones|mesh-ancestor
154134934|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134935|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594851|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
153594852|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594853|NCT01852409|Bevacizumab|bevacizumab|mesh-list
153594854|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153594855|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594856|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153594857|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153594858|NCT01852409|Growth Substances|growth substances|mesh-ancestor
153594859|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594860|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
153594861|NCT01852461|Poractant alfa|poractant alfa|mesh-list
153594862|NCT01852461|Beractant|beractant|mesh-list
153594863|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153594864|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
154134936|NCT00621140|Incretins|incretins|mesh-ancestor
154134937|NCT00621140|Hormones|hormones|mesh-ancestor
154134938|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134939|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154134940|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
154134941|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134942|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134943|NCT00207727|Ustekinumab|ustekinumab|mesh-list
154134944|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
154134945|NCT00841880|Felodipine|felodipine|mesh-list
154134946|NCT00841880|Ramipril|ramipril|mesh-list
154134947|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154134948|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
154134949|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135051|NCT02546648|Coagulants|coagulants|mesh-ancestor
154135053|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
154135054|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135055|NCT00842582|Azacitidine|azacitidine|mesh-list
154135056|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135057|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
154135058|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135059|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135333|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135335|NCT00855530|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
154135336|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154135337|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154135338|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
154135339|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135340|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810695|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866589|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153594865|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
153594866|NCT01852539|Propofol|propofol|mesh-list
153594867|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153594868|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594869|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594870|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153594871|NCT01852539|Analgesics|analgesics|mesh-ancestor
153594872|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
153594873|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594874|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153594875|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153594876|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153470137|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
154135375|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154135376|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154135377|NCT00619112|Temozolomide|temozolomide|mesh-list
154135378|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154135379|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
154135380|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135450|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135452|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135453|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
154135454|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135455|NCT00856310|Fasinumab|fasinumab|mesh-list
154135456|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154135457|NCT00856310|Analgesics|analgesics|mesh-ancestor
154135458|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
154135459|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135460|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135528|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470409|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154135658|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154135694|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135695|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154135718|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135719|NCT00715559|Cysteamine|cysteamine|mesh-list
154135720|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154135721|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135722|NCT00620282|Liraglutide|liraglutide|mesh-list
154135723|NCT00620282|Glimepiride|glimepiride|mesh-list
154135724|NCT00620282|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154135725|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154135726|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135727|NCT00620282|Incretins|incretins|mesh-ancestor
154135728|NCT00620282|Hormones|hormones|mesh-ancestor
154135760|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135761|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135762|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154135763|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154135764|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
154135765|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135766|NCT00857870|Metformin|metformin|mesh-list
154135767|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
154135768|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154135769|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135770|NCT00848432|Risperidone|risperidone|mesh-list
154135771|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154135772|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
154135773|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135874|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
154135875|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135876|NCT00859274|Budesonide|budesonide|mesh-list
154135877|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135878|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154135879|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
154135880|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135881|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135882|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154135883|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
154135884|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
154135885|NCT00859274|Hormones|hormones|mesh-ancestor
154135886|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135887|NCT00859352|Midazolam|midazolam|mesh-list
154135888|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154135889|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154135890|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135891|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135892|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154135893|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154135930|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470932|NCT00612222|Fludarabine|fludarabine|mesh-list
154136037|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136038|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136039|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
153357313|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153357314|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153357315|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
153357316|NCT01273532|Tapentadol|tapentadol|mesh-list
153357317|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153357318|NCT01273532|Narcotics|narcotics|mesh-ancestor
153357319|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357320|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357321|NCT01273532|Analgesics|analgesics|mesh-ancestor
153866601|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154136040|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136041|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136043|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
154136044|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136045|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154136046|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
154136308|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
154136310|NCT00713609|Tazarotene|tazarotene|mesh-list
154136311|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136312|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136313|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154136314|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136315|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136533|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
154136534|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136535|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154136536|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136537|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136538|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
154136539|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136540|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
154136541|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136670|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136671|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154136672|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136674|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154136675|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154136676|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
154136708|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154136709|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136710|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154136711|NCT00872378|Incretins|incretins|mesh-ancestor
154136713|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136714|NCT00994071|Temozolomide|temozolomide|mesh-list
154136715|NCT00994071|Veliparib|veliparib|mesh-list
154136716|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154136717|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
153810696|NCT00321074|Tacrolimus|tacrolimus|mesh-list
153810697|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810698|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
153810699|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810700|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153810701|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810702|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136718|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136719|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471919|NCT01250496|Aminophylline|aminophylline|mesh-list
154136921|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136922|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
154136923|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154136924|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154136925|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154136926|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136927|NCT01015300|Bevacizumab|bevacizumab|mesh-list
154136928|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154136929|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136930|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154136931|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154136932|NCT01015300|Growth Substances|growth substances|mesh-ancestor
154136933|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136934|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
154136935|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
154136936|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
154136937|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136938|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
154136939|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136940|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136941|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154136942|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
154136976|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136977|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
154136978|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136979|NCT00919919|Progesterone|progesterone|mesh-list
154136980|NCT00919919|Progestins|progestins|mesh-ancestor
154136981|NCT00919919|Hormones|hormones|mesh-ancestor
154136982|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472266|NCT04364022|Ritonavir|ritonavir|mesh-list
154137019|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
154137042|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137043|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137044|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154137045|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153866622|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137046|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137047|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154137048|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154137049|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154137050|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
154137051|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154137052|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154137053|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
154137054|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154137056|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154137057|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
154137058|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
154137059|NCT04018274|Estradiol|estradiol|mesh-list
154137060|NCT04018274|Estrogens|estrogens|mesh-ancestor
154137061|NCT04018274|Hormones|hormones|mesh-ancestor
154137062|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137063|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137064|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154137065|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154137066|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154137067|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154137068|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154137104|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137105|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154137106|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154137107|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137108|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137109|NCT02587169|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154137136|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
154137137|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154137138|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154137139|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137140|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137141|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153517518|NCT01440439|Insulin|insulin|mesh-list
154137142|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137143|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
153810717|NCT00347256|Cisplatin|cisplatin|mesh-list
153357323|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407099|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407100|NCT02519439|Ganaxolone|ganaxolone|mesh-list
153407101|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
153407102|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407103|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407104|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407105|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
153407106|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
153407107|NCT02359175|Acetaminophen|acetaminophen|mesh-list
153407108|NCT02359175|Fentanyl|fentanyl|mesh-list
153407109|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
153407110|NCT02359175|Bupivacaine|bupivacaine|mesh-list
153594877|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
154137144|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154137145|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
154137146|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137147|NCT05683301|Diuretics|diuretics|mesh-ancestor
154137148|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
154137149|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154137151|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154137152|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
154137153|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137154|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137155|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154137156|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154137157|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
154137158|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137159|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137179|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137180|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137181|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
154137182|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137183|NCT04731155|Alirocumab|alirocumab|mesh-list
154137184|NCT04731155|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154137185|NCT04731155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154137186|NCT04731155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154137187|NCT04731155|Antimetabolites|antimetabolites|mesh-ancestor
154137188|NCT04731155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137189|NCT04731155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154137190|NCT04731155|Protease Inhibitors|protease inhibitors|mesh-ancestor
154137191|NCT04731155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137192|NCT04731155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154137193|NCT04729049|Morphine|morphine|mesh-list
154137194|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154137195|NCT04729049|Narcotics|narcotics|mesh-ancestor
154137196|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137197|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137198|NCT04729049|Analgesics|analgesics|mesh-ancestor
154137199|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
153866638|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153866643|NCT00575523|Atropine|atropine|mesh-list
153594878|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594880|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153594896|NCT01852604|Ribavirin|ribavirin|mesh-list
153594897|NCT01852604|Simeprevir|simeprevir|mesh-list
153594898|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594899|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
153594900|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594901|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153594902|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153594904|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594905|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594906|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154137200|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137201|NCT02585765|Pioglitazone|pioglitazone|mesh-list
154137202|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154137203|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137204|NCT04634669|Levomethorphan|levomethorphan|mesh-list
154137205|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
154137206|NCT04634669|Bupropion|bupropion|mesh-list
154137207|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154137208|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
154137209|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154137210|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154137211|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154137212|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153472483|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
154137242|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137243|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154137244|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154137245|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
154137246|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137247|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137248|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154137249|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154137250|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154137251|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
154137252|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
154137253|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
154137254|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154137255|NCT00920153|Cytarabine|cytarabine|mesh-list
154137256|NCT00920153|Dexamethasone|dexamethasone|mesh-list
154137289|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154137291|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137292|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866652|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
153866659|NCT01149421|Dulaglutide|dulaglutide|mesh-list
153594907|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153594908|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153594909|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153594910|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
153594911|NCT01852630|Imipenem|imipenem|mesh-list
153594912|NCT01852630|Cefepime|cefepime|mesh-list
153594913|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594914|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594915|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
153594916|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
153594917|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153594918|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153594919|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594920|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154137293|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
154137294|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
154137295|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
154137296|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
154137297|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154137298|NCT00920153|Protective Agents|protective agents|mesh-ancestor
154137299|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154137300|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
154137301|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154137302|NCT04080713|Budesonide|budesonide|mesh-list
154137303|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137329|NCT00533949|Cetuximab|cetuximab|mesh-list
154137330|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154137331|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137332|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
154137333|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
154137334|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
154137335|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594921|NCT01852903|Vitamins|vitamins|mesh-list
153594922|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
153810718|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894725|NCT01192191|Xhance|xhance|mesh-list
154137336|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154137337|NCT00485134|Vaccines|vaccines|mesh-list
154137338|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
154137339|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137340|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154137341|NCT02585141|Clindamycin|clindamycin|mesh-list
154137342|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
154137343|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
154137344|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137345|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154137346|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137347|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137348|NCT04079231|Aflibercept|aflibercept|mesh-list
154137349|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154137350|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154137351|NCT04079231|Growth Substances|growth substances|mesh-ancestor
154137352|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137353|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
153472673|NCT04341402|Clotrimazole|clotrimazole|mesh-list
154137381|NCT00994773|Simvastatin|simvastatin|mesh-list
154137382|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
154137383|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137384|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154256712|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137385|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154137386|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137387|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137388|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154137389|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154137390|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154137391|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154137392|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
154137393|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154137394|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154137395|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
154137396|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154137397|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
154137398|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154137399|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
154137400|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137419|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137421|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154137422|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
154137423|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154137424|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137425|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154137426|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154137427|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154137428|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154137429|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154137430|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154137431|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154137432|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
154137433|NCT00996099|Insulin|insulin|mesh-list
154137434|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154137435|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154137436|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137437|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
154137438|NCT02584751|Omeprazole|omeprazole|mesh-list
154137439|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154137440|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137441|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154137442|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137443|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137444|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154137445|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
154137446|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137447|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137448|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154137449|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
154137450|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154137451|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
154137452|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137453|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154137454|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
154137455|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
153407143|NCT02101021|Gemcitabine|gemcitabine|mesh-list
153407144|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
153407145|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407146|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407147|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
153407148|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407149|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407150|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137480|NCT04079933|Nicotine|nicotine|mesh-list
154137481|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154137482|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
154137483|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137484|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137485|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154137486|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154137487|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
154137488|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137489|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137490|NCT00999297|Capsaicin|capsaicin|mesh-list
154137491|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
154137492|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
154137493|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
154137494|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137495|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137496|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
154137497|NCT00583115|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154137498|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154137499|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137500|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137501|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137503|NCT00532779|Bupropion|bupropion|mesh-list
154137504|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154137505|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154137506|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137507|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
154137530|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137531|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
154137532|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154137533|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137534|NCT02852655|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154137535|NCT02852655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137536|NCT00500110|Docetaxel|docetaxel|mesh-list
154137537|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
154137538|NCT00500110|Leuprolide|leuprolide|mesh-list
154137539|NCT00500110|Goserelin|goserelin|mesh-list
154137540|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137541|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810719|NCT00347295|Estazolam|estazolam|mesh-list
153810720|NCT00347295|Brotizolam|brotizolam|mesh-list
153357324|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153594941|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594942|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
153594943|NCT01853111|Aldesleukin|aldesleukin|mesh-list
153594944|NCT01853111|Interleukin-2|interleukin-2|mesh-list
153594945|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594946|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153594947|NCT01853111|Analgesics|analgesics|mesh-ancestor
153594948|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
153594949|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137542|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154137543|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154137544|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137545|NCT00500110|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154137546|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154137547|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137548|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154137549|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
154137550|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154137551|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137552|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154137553|NCT05304533|Itraconazole|itraconazole|mesh-list
154137554|NCT05304533|Verapamil|verapamil|mesh-list
154137555|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
154137556|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137557|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154137571|NCT00534495|Rilonacept|rilonacept|mesh-list
154137572|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137573|NCT04077827|Propofol|propofol|mesh-list
154137574|NCT04077827|Desflurane|desflurane|mesh-list
154137575|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154137576|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137577|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137578|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154137579|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
154137580|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
154137581|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154137582|NCT00996723|Dasatinib|dasatinib|mesh-list
154137583|NCT00996723|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154137584|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154137585|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137586|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137587|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435975|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
154137588|NCT05332587|Rituximab|rituximab|mesh-list
154137589|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154137590|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137591|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
154137592|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137593|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154137594|NCT00996879|Midazolam|midazolam|mesh-list
154137595|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154137596|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154137597|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137598|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137599|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154137600|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154137601|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154137602|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154137603|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
154137605|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
154137606|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
154137607|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137608|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137609|NCT02582177|Ketoconazole|ketoconazole|mesh-list
154137610|NCT02582177|Clotrimazole|clotrimazole|mesh-list
154137611|NCT02582177|Miconazole|miconazole|mesh-list
154137614|NCT02582177|Betamethasone|betamethasone|mesh-list
154137615|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
154137616|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154137617|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
153472986|NCT03033732|Naloxone|naloxone|mesh-list
154137639|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154137640|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154137642|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154137643|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154137644|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154137645|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
154137646|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
154137647|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154137648|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154137649|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153810721|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
153810722|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153594950|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594951|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153594952|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153594953|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
153594956|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153594957|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137650|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137651|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137652|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
154137653|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137654|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137655|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154137656|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137657|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154137658|NCT00997191|Triamcinolone|triamcinolone|mesh-list
154137659|NCT00997191|Bevacizumab|bevacizumab|mesh-list
154137660|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154137661|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137662|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154137663|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154137664|NCT00997191|Growth Substances|growth substances|mesh-ancestor
154137665|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137666|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
154137667|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137694|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154137695|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
154137696|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154137697|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154137698|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
154137699|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137700|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
154137701|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154137702|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154137703|NCT00997581|Apremilast|apremilast|mesh-list
154137704|NCT00997581|Indomethacin|indomethacin|mesh-list
154137705|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154137706|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154137707|NCT00997581|Analgesics|analgesics|mesh-ancestor
154137708|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
153866730|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153866731|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154137709|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137710|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137711|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137712|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154137713|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154137714|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154137715|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473147|NCT03016806|Busulfan|busulfan|mesh-list
154137739|NCT05183139|Growth Substances|growth substances|mesh-ancestor
154137740|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
154137741|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
154137742|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137743|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137744|NCT00999843|Sorafenib|sorafenib|mesh-list
154137745|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137746|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154137747|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137748|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137749|NCT00997659|Chromium|chromium|mesh-list
154137750|NCT00997659|Picolinic acid|picolinic acid|mesh-list
154137751|NCT00997659|Trace Elements|trace elements|mesh-ancestor
154137752|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
154137753|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137754|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154137755|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
154137756|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
154137757|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137758|NCT03827213|Bupivacaine|bupivacaine|mesh-list
154137759|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
154137760|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
154137761|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137762|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137763|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
154137764|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137765|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
154137766|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154137767|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154137768|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154137769|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137790|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137791|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
153810723|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153594958|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594959|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594960|NCT01853423|Sirolimus|sirolimus|mesh-list
153594961|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594962|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594963|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153594964|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594965|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
153594966|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153594967|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
154137792|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153594968|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594969|NCT01853449|Fentanyl|fentanyl|mesh-list
153594970|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154137793|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154137794|NCT01000233|Inositol|inositol|mesh-list
154137795|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
154137796|NCT01000233|Vitamins|vitamins|mesh-ancestor
154137797|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
154137798|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137799|NCT04075955|Olanzapine|olanzapine|mesh-list
154137800|NCT04075955|Aprepitant|aprepitant|mesh-list
154137801|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
154137802|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
154137803|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137804|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137805|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137806|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154137807|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154137808|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137809|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154137810|NCT04075955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154137811|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154137812|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137813|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137814|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137815|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
154137816|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154137817|NCT00484198|Pioglitazone|pioglitazone|mesh-list
154137818|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154137819|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518197|NCT01444001|Vaccines|vaccines|mesh-list
154137820|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
154137821|NCT04077905|Doxorubicin|doxorubicin|mesh-list
154137822|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153810724|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137823|NCT04077905|Etoposide|etoposide|mesh-list
154137824|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154137852|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
154137853|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137855|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137856|NCT01014520|Gabapentin|gabapentin|mesh-list
154137857|NCT01014520|Amitriptyline|amitriptyline|mesh-list
154137858|NCT01014520|Analgesics|analgesics|mesh-ancestor
154137859|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
154137860|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137861|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137862|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
154137863|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154137864|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154137865|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137866|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154137867|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154137868|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154137869|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137870|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137871|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
154137901|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154137902|NCT00499252|Paclitaxel|paclitaxel|mesh-list
154137903|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154137904|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154256714|NCT03760250|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154256715|NCT03760250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137905|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137906|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
154137907|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
154137908|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
154137909|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137910|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154137911|NCT01019590|Olmesartan|olmesartan|mesh-list
154137912|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154137913|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154137914|NCT01019590|Diuretics|diuretics|mesh-ancestor
154137915|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
154137916|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137917|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154137926|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154137928|NCT00532155|Docetaxel|docetaxel|mesh-list
154137929|NCT00532155|Aflibercept|aflibercept|mesh-list
154137930|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137931|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
154137932|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
154137933|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137934|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137935|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137936|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
154137937|NCT00532155|Hormones|hormones|mesh-ancestor
154137938|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137939|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154137940|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137941|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
154137942|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
154137943|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
154137944|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137945|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154137946|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154137947|NCT00532155|Growth Substances|growth substances|mesh-ancestor
154137948|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
154137949|NCT01019668|Verteporfin|verteporfin|mesh-list
154137950|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154137951|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
154137953|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154137954|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137955|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137956|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154137957|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
154137958|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
154137959|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
154137960|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154137961|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154137962|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
154137963|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137964|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137965|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154137966|NCT03762395|CXA-10|cxa-10|mesh-list
154137967|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137968|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
154137969|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154137970|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
154137971|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154137972|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137973|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137974|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154137975|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
154137976|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137977|NCT01014832|Insulin|insulin|mesh-list
154137978|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154137979|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154137980|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137981|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
154138008|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138009|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138010|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154138012|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154138013|NCT00998439|Paclitaxel|paclitaxel|mesh-list
154138014|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138015|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138016|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138017|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138018|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138019|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138020|NCT01000779|Propranolol|propranolol|mesh-list
154138021|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154138022|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154138023|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
153473537|NCT02980926|Bupivacaine|bupivacaine|mesh-list
154138035|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138036|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
154138037|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138038|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154138039|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
154138040|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154138041|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154138042|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154138043|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138045|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138046|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138047|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
154138048|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154138049|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
154138050|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138051|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
154138052|NCT02580695|Protective Agents|protective agents|mesh-ancestor
154138053|NCT02581553|Allopurinol|allopurinol|mesh-list
154138054|NCT02581553|Lesinurad|lesinurad|mesh-list
153810726|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153407217|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594971|NCT01853449|Narcotics|narcotics|mesh-ancestor
153594972|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594973|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594974|NCT01853449|Analgesics|analgesics|mesh-ancestor
153594975|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
153594976|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594978|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153594979|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
153818782|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
153818783|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153818784|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818785|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
153818786|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
153818787|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153818788|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153818789|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153818790|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818791|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
153818792|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
153594980|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
154138055|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
154138056|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138057|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138058|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
154138059|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138060|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154138061|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
154138062|NCT02581553|Protective Agents|protective agents|mesh-ancestor
154138063|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138064|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
154138065|NCT03944915|Paclitaxel|paclitaxel|mesh-list
154138066|NCT03944915|Carboplatin|carboplatin|mesh-list
154138067|NCT03944915|Fluorouracil|fluorouracil|mesh-list
154138068|NCT03944915|Nivolumab|nivolumab|mesh-list
154138069|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
154138070|NCT03944915|Lenograstim|lenograstim|mesh-list
154138071|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138072|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138073|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138074|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138075|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138076|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138077|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
154138078|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138079|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138080|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
154138081|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138082|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153594981|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
153594982|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
153594983|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153594984|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153594985|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594986|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594987|NCT01853540|Urological Agents|urological agents|mesh-ancestor
153545903|NCT06297499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594989|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594990|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594991|NCT01853709|Bisacodyl|bisacodyl|mesh-list
153594992|NCT01853709|Cathartics|cathartics|mesh-ancestor
153594993|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154138083|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154138084|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154138085|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
154138107|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154138108|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154138109|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138110|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138111|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154138112|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154138113|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138114|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461608|NCT04433988|Protective Agents|protective agents|mesh-ancestor
154138115|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138116|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
154138117|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
154138118|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138119|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138120|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
154138121|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138122|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154138123|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
154138124|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154138125|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
154138126|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
154138127|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138128|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138129|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138130|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138131|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
154138132|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153866772|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866773|NCT00575913|Urological Agents|urological agents|mesh-ancestor
153866774|NCT04579302|Bupivacaine|bupivacaine|mesh-list
153866775|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
153866776|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
153866777|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866778|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866779|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
153866780|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594994|NCT01853709|Laxatives|laxatives|mesh-ancestor
153594995|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
153594996|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153594997|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154138133|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154138134|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138136|NCT02580227|Coagulants|coagulants|mesh-ancestor
154138137|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
154138138|NCT04218695|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154138139|NCT04218695|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154138140|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138141|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138142|NCT01001013|Pioglitazone|pioglitazone|mesh-list
153658667|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
153658668|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473771|NCT04743180|Paclitaxel|paclitaxel|mesh-list
153658697|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
153658698|NCT02539537|Vitamins|vitamins|mesh-ancestor
153658699|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
153658700|NCT02539537|Hematinics|hematinics|mesh-ancestor
153658701|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658702|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
153658703|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
153658704|NCT02537613|Ibrutinib|ibrutinib|mesh-list
153658705|NCT02537613|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153658706|NCT02537613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153658707|NCT02537613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658708|NCT02537613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658709|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658710|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658711|NCT02479451|Theophylline|theophylline|mesh-list
153658712|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153658713|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
153658714|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658715|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658716|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153658717|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
153658718|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153658719|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658720|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357325|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153436170|NCT00003242|Paclitaxel|paclitaxel|mesh-list
153594998|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
153594999|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818793|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
153818794|NCT03829111|Nivolumab|nivolumab|mesh-list
153818795|NCT03829111|Ipilimumab|ipilimumab|mesh-list
153818796|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818797|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818798|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818799|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658721|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
153658722|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153658723|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153658724|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
153658725|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658731|NCT02437110|Ritonavir|ritonavir|mesh-list
153658732|NCT02437110|Darunavir|darunavir|mesh-list
153658733|NCT02437110|Tenofovir|tenofovir|mesh-list
153658734|NCT02437110|Dolutegravir|dolutegravir|mesh-list
153658735|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153658736|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153658737|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
153658738|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658739|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658740|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153473817|NCT05314140|Calcium|calcium|mesh-list
153658780|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153658781|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153658782|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
153658783|NCT01846663|Rifaximin|rifaximin|mesh-list
153658784|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153658785|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658786|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153658787|NCT01659151|Aldesleukin|aldesleukin|mesh-list
153658788|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
153658789|NCT01659151|Fludarabine|fludarabine|mesh-list
153658790|NCT01659151|Interleukin-2|interleukin-2|mesh-list
153658791|NCT01659151|Vemurafenib|vemurafenib|mesh-list
153658792|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153658793|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658794|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
153658795|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658796|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658797|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407274|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153460186|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460187|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153460188|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153460189|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
153460190|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
153460191|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153460192|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153460193|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153460194|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595008|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595009|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
153595010|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153595011|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
153595012|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153595013|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
153595014|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595015|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658798|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
153595016|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
153595017|NCT01853813|Bevacizumab|bevacizumab|mesh-list
153658799|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658800|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658801|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153658802|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153658803|NCT01659151|Analgesics|analgesics|mesh-ancestor
153658804|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
153658805|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658806|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153658807|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153658808|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
153658809|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658810|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153658811|NCT01597388|Fulvestrant|fulvestrant|mesh-list
153658896|NCT02968303|Vemurafenib|vemurafenib|mesh-list
153658897|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658915|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658916|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153658917|NCT00061711|Estrogens|estrogens|mesh-ancestor
153658918|NCT00061750|Deferasirox|deferasirox|mesh-list
153658919|NCT00061750|Deferoxamine|deferoxamine|mesh-list
153658937|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153658938|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595025|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
153595029|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595030|NCT01853956|Alprazolam|alprazolam|mesh-list
153595031|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153595032|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595033|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818800|NCT03828227|Bevacizumab|bevacizumab|mesh-list
153818801|NCT03828227|Capecitabine|capecitabine|mesh-list
153818802|NCT03828227|Fluorouracil|fluorouracil|mesh-list
153818803|NCT03828227|Oxaliplatin|oxaliplatin|mesh-list
153818804|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818805|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818806|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153818807|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153818808|NCT03828227|Growth Substances|growth substances|mesh-ancestor
153818809|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818810|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
153818811|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818812|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
153818813|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818814|NCT03828227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818815|NCT03828227|Immunologic Factors|immunologic factors|mesh-ancestor
153460202|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153460203|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153460204|NCT04214990|Analgesics|analgesics|mesh-ancestor
153658939|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658941|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153658942|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153658943|NCT00061906|Analgesics|analgesics|mesh-ancestor
153658944|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
153658945|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658946|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658947|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658948|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658949|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153658950|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153658951|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658952|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658953|NCT00398554|Prednisone|prednisone|mesh-list
153658954|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
153658955|NCT00398554|Doxorubicin|doxorubicin|mesh-list
153658956|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153658957|NCT00398554|Etoposide|etoposide|mesh-list
153658958|NCT00398554|Vincristine|vincristine|mesh-list
153658959|NCT00398554|Vinblastine|vinblastine|mesh-list
153658960|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658961|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
153658962|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658963|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460205|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
153460206|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460207|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460208|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153460209|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460210|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153460211|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153460212|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460213|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153460214|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153658964|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153658965|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
153658966|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658967|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658968|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153658969|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153658970|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153659017|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153659018|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153659019|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659020|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
153659021|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153659022|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153659023|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659024|NCT00062062|Paclitaxel|paclitaxel|mesh-list
153659025|NCT00062062|Carboplatin|carboplatin|mesh-list
153659026|NCT00062062|Gefitinib|gefitinib|mesh-list
153659027|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153659028|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256716|NCT03760250|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154256717|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
154256718|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659029|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
153659030|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
153659031|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
153659050|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153659051|NCT00062101|Celecoxib|celecoxib|mesh-list
153659052|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153659053|NCT00062101|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153659071|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659072|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659073|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153595042|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595043|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595045|NCT01854073|Bromides|bromides|mesh-list
153595046|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153595047|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
153595048|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153659074|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
153659075|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659076|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659077|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153659078|NCT00062179|Celecoxib|celecoxib|mesh-list
153659079|NCT00062179|Paclitaxel|paclitaxel|mesh-list
153659080|NCT00062179|Carboplatin|carboplatin|mesh-list
153659081|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153659082|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659083|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
153659084|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
153659085|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
153659086|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659087|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153659108|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659109|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659110|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153659111|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153659112|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153659113|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659114|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659116|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153659117|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
153659118|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659119|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
153659120|NCT02967874|Protective Agents|protective agents|mesh-ancestor
153659121|NCT04733625|Vitamin D|vitamin d|mesh-list
153659122|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
153659123|NCT04733625|Vitamins|vitamins|mesh-ancestor
153659124|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
153659125|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659126|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153659127|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153659128|NCT00062686|Lapatinib|lapatinib|mesh-list
153866848|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866849|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153866852|NCT00576225|Paclitaxel|paclitaxel|mesh-list
153659129|NCT00062686|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153659130|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659172|NCT00063583|Analgesics|analgesics|mesh-ancestor
153659173|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
153659174|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659175|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659176|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153659177|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659178|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659179|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659180|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659181|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153659182|NCT00063895|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153659183|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659184|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659185|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659186|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659188|NCT00064012|Bortezomib|bortezomib|mesh-list
153659189|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659190|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
153659191|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
153659192|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
153659193|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659194|NCT00064051|Gemcitabine|gemcitabine|mesh-list
153659226|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
153659227|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659228|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659229|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
153659230|NCT00064285|Alvocidib|alvocidib|mesh-list
153659231|NCT00064285|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153659232|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659233|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659234|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659235|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659268|NCT00064636|Bortezomib|bortezomib|mesh-list
153659269|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659270|NCT05113394|Immunomodulating Agents|immunomodulating agents|mesh-list
153659271|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
153659272|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659273|NCT00065143|Clofarabine|clofarabine|mesh-list
153659304|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
153659305|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595049|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
153595050|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
153595051|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595052|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595053|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153595054|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
153595055|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153595056|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
153595057|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595058|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595059|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153595060|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
153595077|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
153595078|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595079|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595080|NCT01854424|Dimercaprol|dimercaprol|mesh-list
153595081|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
153595082|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
153595083|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595084|NCT01854463|Vitamin D|vitamin d|mesh-list
153595085|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
153595086|NCT01854463|Vitamins|vitamins|mesh-ancestor
153595087|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
153659306|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153659307|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153659308|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
153659309|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659310|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659311|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153659312|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153659313|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153659314|NCT00065884|Valproic Acid|valproic acid|mesh-list
153659315|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
153659316|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659317|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659318|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
153659319|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659320|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659321|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
153659322|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153659323|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153659324|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153659326|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
153659327|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153659328|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659329|NCT00065962|Secretin|secretin|mesh-list
153659330|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153659331|NCT00065962|Hormones|hormones|mesh-ancestor
153866871|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
153866872|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153866873|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153866874|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866875|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595088|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595089|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153595090|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153659332|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659333|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659334|NCT00066001|Metronidazole|metronidazole|mesh-list
153659335|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153659348|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659350|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153659351|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
153659352|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153659353|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153659354|NCT00066157|Progestins|progestins|mesh-ancestor
153659355|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153659356|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153659357|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153659358|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153659359|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153659381|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153659382|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659383|NCT00066274|Antidotes|antidotes|mesh-ancestor
153659384|NCT00066274|Protective Agents|protective agents|mesh-ancestor
153659385|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
153659386|NCT00066274|Vitamins|vitamins|mesh-ancestor
153659387|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
153659388|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
153659389|NCT04401150|Vitamins|vitamins|mesh-ancestor
153659390|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
153659391|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659392|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
153659393|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659394|NCT04401150|Protective Agents|protective agents|mesh-ancestor
153659395|NCT05077280|Immunomodulating Agents|immunomodulating agents|mesh-list
153659396|NCT05077280|Immunologic Factors|immunologic factors|mesh-ancestor
153659397|NCT05077280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659401|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659416|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153659418|NCT00066508|Bortezomib|bortezomib|mesh-list
153595091|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
153595092|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153595093|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153595094|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595095|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
153595096|NCT01854476|Coagulants|coagulants|mesh-ancestor
153659419|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659420|NCT00066547|Antibodies|antibodies|mesh-list
153659421|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153659422|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
153659423|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659424|NCT00066586|Exemestane|exemestane|mesh-list
153659425|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659426|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153659427|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153659428|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659429|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659430|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153659431|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
153474357|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153659449|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659450|NCT04235673|Protective Agents|protective agents|mesh-ancestor
153659451|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659452|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153659453|NCT00067015|Goserelin|goserelin|mesh-list
153659454|NCT00067015|Bicalutamide|bicalutamide|mesh-list
153659455|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153659456|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659457|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
153659458|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
153659459|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659490|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153659491|NCT00067405|Micronutrients|micronutrients|mesh-list
153659492|NCT00067405|Trace Elements|trace elements|mesh-list
153659493|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659494|NCT00067444|Paroxetine|paroxetine|mesh-list
153659495|NCT00067444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153659496|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153659497|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357327|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595097|NCT01854489|Rifampin|rifampin|mesh-list
153595098|NCT01854489|Buprenorphine|buprenorphine|mesh-list
153595099|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153595100|NCT01854489|Narcotics|narcotics|mesh-ancestor
153595101|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595102|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595104|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
153595105|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659498|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659499|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659500|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
153659501|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659502|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153659503|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
153659504|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153659505|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153659506|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153659507|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659516|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
153659517|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659518|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
153659519|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153659520|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
153659521|NCT00065533|Pemetrexed|pemetrexed|mesh-list
153659522|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659523|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659524|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659543|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153659544|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
153659545|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153659546|NCT05010707|Diuretics|diuretics|mesh-ancestor
153659547|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
153659548|NCT00067756|Butyric Acid|butyric acid|mesh-list
153659549|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
153659550|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
153659551|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659552|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659553|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659554|NCT04091880|Vaccines|vaccines|mesh-list
153659555|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
153407370|NCT01063179|Hormones|hormones|mesh-ancestor
153659556|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659557|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153659558|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153659559|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153659560|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153659561|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153659562|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659563|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659564|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659566|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
153659567|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659568|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
153659569|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153659570|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
153659592|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659594|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659595|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153659596|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
153659597|NCT00068302|Sirolimus|sirolimus|mesh-list
153659598|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153659599|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153659600|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153474519|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153659652|NCT00399061|Cyclosporins|cyclosporins|mesh-list
153659653|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659654|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659655|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659656|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
153659657|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659658|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
153659659|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496620|NCT00002376|Lamivudine|lamivudine|mesh-list
153659710|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153659711|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659712|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
153659713|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
153659714|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
153659715|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659716|NCT00069940|Sargramostim|sargramostim|mesh-list
153659717|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
153659718|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659719|NCT00070057|Celecoxib|celecoxib|mesh-list
153659720|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153659721|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659722|NCT00070057|Analgesics|analgesics|mesh-ancestor
153659723|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
153659724|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659725|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659726|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659727|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659738|NCT00070174|Daunorubicin|daunorubicin|mesh-list
153659739|NCT00070174|Asparaginase|asparaginase|mesh-list
153659740|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
153659741|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
153659742|NCT00070174|Cyclosporins|cyclosporins|mesh-list
153659743|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659744|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
153659745|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659746|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659747|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153659781|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153659782|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659783|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659784|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
153659785|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659786|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659787|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659788|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
153659789|NCT00070213|Antidotes|antidotes|mesh-ancestor
153659876|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
153659877|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659879|NCT00071188|Carboplatin|carboplatin|mesh-list
153474844|NCT00733278|Copper|copper|mesh-list
153659916|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
153659917|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153436434|NCT00004010|Hormones|hormones|mesh-ancestor
153659918|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153659919|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659920|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659921|NCT02966743|Analgesics|analgesics|mesh-ancestor
153659922|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
153659923|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659924|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153659925|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153659926|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153659927|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
153659928|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659929|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659930|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153659931|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153659932|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153659933|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153659934|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153659935|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
153659936|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
153659937|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
153659938|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
153659939|NCT00071539|Immunotoxins|immunotoxins|mesh-list
153659940|NCT00071539|Immunoconjugates|immunoconjugates|mesh-ancestor
153659941|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
153659942|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659943|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153659944|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153659945|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153659962|NCT00071968|MTOR Inhibitors|mtor inhibitors|mesh-list
153659963|NCT00071968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659964|NCT00071968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659965|NCT00071968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659966|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659967|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
153659968|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659969|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659970|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153659971|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153659972|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153659973|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
153659975|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153659976|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
153659977|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659978|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659979|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153659980|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
153659981|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153659982|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
153659983|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659984|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659985|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153659986|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
153659987|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
153659988|NCT00390065|Protective Agents|protective agents|mesh-ancestor
153659989|NCT00072007|Prednisone|prednisone|mesh-list
153659990|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
153659991|NCT00072007|Rituximab|rituximab|mesh-list
153659992|NCT00072007|Doxorubicin|doxorubicin|mesh-list
153659993|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153659994|NCT00072007|Vincristine|vincristine|mesh-list
153659995|NCT00072007|Cladribine|cladribine|mesh-list
153659996|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659997|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
153659998|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659999|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660000|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660001|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
153660002|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660003|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660004|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153660005|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660006|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660007|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660008|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660026|NCT00072046|Growth Substances|growth substances|mesh-ancestor
153357330|NCT00744380|Midazolam|midazolam|mesh-list
153357331|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
153866955|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153595106|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153660027|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660028|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
153660030|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660031|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
153660038|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153660039|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660040|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153660041|NCT04730596|Analgesics|analgesics|mesh-ancestor
153660042|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
153660043|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660044|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153660045|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153660046|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153660047|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
153660048|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660049|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660050|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153660051|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153660052|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
153660053|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
153660054|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153660055|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153660056|NCT00072085|Aldesleukin|aldesleukin|mesh-list
153660057|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
153660058|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660059|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153660060|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153660061|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
153660062|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660063|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153660064|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
153660065|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660066|NCT04730674|Tetracycline|tetracycline|mesh-list
153660067|NCT04730674|Lidocaine|lidocaine|mesh-list
153660068|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
153660069|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
153407446|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407447|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407448|NCT00330564|Sunitinib|sunitinib|mesh-list
153866963|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153866964|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866965|NCT04596488|Efavirenz|efavirenz|mesh-list
153866966|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153866967|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153866968|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866969|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407449|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407450|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153866970|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
153866971|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866972|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153866973|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153660070|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595107|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153595116|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153660071|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660072|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
153660116|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660117|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660118|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
153660119|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660120|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660121|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660122|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
153660123|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153660124|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660125|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660126|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660127|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660129|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153660130|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153660131|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660132|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
153660133|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660153|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153660154|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660156|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660157|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660158|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660159|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660160|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
153660161|NCT00072553|Antidotes|antidotes|mesh-ancestor
153660162|NCT00072553|Protective Agents|protective agents|mesh-ancestor
153660163|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
153660164|NCT00072553|Vitamins|vitamins|mesh-ancestor
153660172|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660173|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153595119|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153595120|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153595121|NCT01854502|Fluorides|fluorides|mesh-list
153595122|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
153595123|NCT01854502|Protective Agents|protective agents|mesh-ancestor
153660174|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153660175|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660176|NCT00072592|Rituximab|rituximab|mesh-list
153660177|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660178|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660179|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
153660180|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660181|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660182|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153660183|NCT00072631|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153660184|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153660185|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660186|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660187|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660188|NCT00072670|Trabectedin|trabectedin|mesh-list
153660189|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660190|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
153660191|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660192|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660193|NCT02966704|Caseins|caseins|mesh-list
153660194|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
153660195|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
153660196|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660197|NCT00072748|EKB 569|ekb 569|mesh-list
153660232|NCT00072982|Borage oil|borage oil|mesh-list
153660233|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660264|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153660265|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153660266|NCT00073411|Escitalopram|escitalopram|mesh-list
153660267|NCT00073411|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153660268|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153475481|NCT00803400|Alprazolam|alprazolam|mesh-list
153660413|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153660415|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
153407466|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
153407467|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407468|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407469|NCT00309478|Tamoxifen|tamoxifen|mesh-list
153407470|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
153407471|NCT00309478|Fluorouracil|fluorouracil|mesh-list
153660416|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153660417|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
153660418|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660419|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660420|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
153660497|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660498|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
153660518|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660519|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660520|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660831|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660832|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661268|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661269|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661315|NCT00080626|Docetaxel|docetaxel|mesh-list
153661316|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661317|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661318|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661319|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
153476794|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153661699|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153661700|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153661701|NCT04733508|Exenatide|exenatide|mesh-list
153661702|NCT04733508|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153661703|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153661704|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661705|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153661706|NCT04733508|Incretins|incretins|mesh-ancestor
153661707|NCT04733508|Hormones|hormones|mesh-ancestor
153661718|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153661719|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
153661720|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661722|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
153661723|NCT00135499|Rituximab|rituximab|mesh-list
153661724|NCT00135499|Doxorubicin|doxorubicin|mesh-list
153661725|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153661726|NCT00135499|Vincristine|vincristine|mesh-list
153662090|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153662091|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
153357332|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153357333|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595124|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595125|NCT01854515|Dexamethasone|dexamethasone|mesh-list
153595126|NCT01854515|Budesonide|budesonide|mesh-list
153595127|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
153595128|NCT01854515|BB 1101|bb 1101|mesh-list
153818817|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153818818|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
153818819|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818820|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153818821|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
153662092|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153662093|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153662094|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
153662095|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662096|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153662097|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153662098|NCT00138541|Vildagliptin|vildagliptin|mesh-list
153662099|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153662100|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662101|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153662111|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662113|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
153477446|NCT05557877|Aspirin|aspirin|mesh-list
153662144|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153662145|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662147|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153662148|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
153662149|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
153662150|NCT00138970|Cyclosporine|cyclosporine|mesh-list
153662151|NCT00138970|Prednisolone|prednisolone|mesh-list
153662152|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153662153|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
153662154|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153662155|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
153662297|NCT03837977|Leucovorin|leucovorin|mesh-list
153662298|NCT03837977|Folic Acid|folic acid|mesh-list
153662299|NCT03837977|Docetaxel|docetaxel|mesh-list
153662300|NCT03837977|Fluorouracil|fluorouracil|mesh-list
153662301|NCT03837977|Irinotecan|irinotecan|mesh-list
153662302|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
153662303|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662304|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
153662305|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662306|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662307|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818822|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153818823|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
153818824|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153818825|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
153595129|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595130|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
153595131|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
153595132|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595133|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595134|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153662308|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
153662309|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153662310|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662311|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
153662312|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662313|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153662314|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153662315|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662316|NCT03837977|Antidotes|antidotes|mesh-ancestor
153662317|NCT03837977|Protective Agents|protective agents|mesh-ancestor
153662318|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
153662319|NCT03837977|Vitamins|vitamins|mesh-ancestor
153662320|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
153662321|NCT03837977|Hematinics|hematinics|mesh-ancestor
153662322|NCT00404326|Hydralazine|hydralazine|mesh-list
153662323|NCT00404326|Valproic Acid|valproic acid|mesh-list
153662441|NCT00140569|Interferons|interferons|mesh-list
153662442|NCT00140569|Fludarabine|fludarabine|mesh-list
153662443|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662444|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
153662445|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662446|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
153662447|NCT00140647|Ramipril|ramipril|mesh-list
153662448|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153662449|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662450|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153662451|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
153662452|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662453|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662454|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153662467|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662468|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153662469|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153662470|NCT00140764|Metronidazole|metronidazole|mesh-list
153810731|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153810732|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
153357334|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595135|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
153595136|NCT01854515|Hormones|hormones|mesh-ancestor
153595137|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781714|NCT04560751|Lenvatinib|lenvatinib|mesh-list
153595138|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153595139|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595140|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153595141|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153595142|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
153595143|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
153662471|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662472|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662473|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153662502|NCT03136497|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153662503|NCT03136497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153662505|NCT03136497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662506|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153662507|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153662508|NCT00140998|Estradiol|estradiol|mesh-list
153662509|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153662510|NCT00140998|Estrogens|estrogens|mesh-ancestor
153662511|NCT00140998|Hormones|hormones|mesh-ancestor
153662512|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360894|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662513|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662514|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153662515|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
153662516|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153662517|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153662518|NCT00141154|Celecoxib|celecoxib|mesh-list
153662519|NCT00141154|Loxoprofen|loxoprofen|mesh-list
153662530|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662793|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153662794|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662795|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153662797|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153662798|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153662799|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
153662800|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662801|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153867042|NCT01147744|Montelukast|montelukast|mesh-list
153595144|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595145|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595146|NCT01854606|Everolimus|everolimus|mesh-list
153595147|NCT01854606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153595148|NCT01854606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153595149|NCT01854606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595150|NCT01854606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595151|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818826|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818827|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818828|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
153818829|NCT03744104|Vaccines|vaccines|mesh-list
153818830|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
153818831|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460215|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460216|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
153595157|NCT01854723|Insulin|insulin|mesh-list
153595158|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153595159|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
153595160|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
153662802|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153662837|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153662838|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662839|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662840|NCT00143221|Urological Agents|urological agents|mesh-ancestor
153662841|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
153662854|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662856|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153662857|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662858|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153662859|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153662860|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153662861|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
153662862|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662863|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662864|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662865|NCT00143377|Urological Agents|urological agents|mesh-ancestor
153662866|NCT02972216|Docetaxel|docetaxel|mesh-list
153662867|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662868|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
153662869|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662870|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662871|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662872|NCT04726345|Fexofenadine|fexofenadine|mesh-list
153662943|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662944|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
153662945|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153810733|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153595161|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
153595162|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
153595163|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153595164|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595165|NCT01854749|Cisplatin|cisplatin|mesh-list
153595166|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595167|NCT01854762|Ritonavir|ritonavir|mesh-list
153595168|NCT01854762|Lopinavir|lopinavir|mesh-list
153595169|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
153595170|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153662946|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
153662947|NCT00143806|Cyclosporine|cyclosporine|mesh-list
153662948|NCT00143806|Alefacept|alefacept|mesh-list
153662949|NCT00143806|Cyclosporins|cyclosporins|mesh-list
153662950|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662951|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662952|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662953|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
153662954|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662955|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
153662956|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662957|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
153662958|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663184|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153663185|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
153663186|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478510|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663655|NCT01466478|Calcipotriene|calcipotriene|mesh-list
153663656|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
153663657|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153663658|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362711|NCT05310344|Paclitaxel|paclitaxel|mesh-list
153663659|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153663660|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153663661|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663662|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153663663|NCT01466478|Vitamins|vitamins|mesh-ancestor
153663664|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
153663665|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153663666|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663667|NCT00063830|Alicaforsen|alicaforsen|mesh-list
153663668|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478848|NCT01198158|Everolimus|everolimus|mesh-list
153357335|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153357337|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
153357338|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436675|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
153357339|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153357340|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153867059|NCT04313374|Morphine|morphine|mesh-list
153595171|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153595172|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
153663831|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663832|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153663833|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153663834|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479026|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664035|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664036|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
153664037|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664039|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
153664040|NCT01464606|Ifosfamide|ifosfamide|mesh-list
153665283|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
153665284|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153665285|NCT00016172|Doxorubicin|doxorubicin|mesh-list
153665286|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153665287|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153665288|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665289|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665290|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665291|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665317|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665318|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665319|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
153665320|NCT00394368|Hormones|hormones|mesh-ancestor
153665321|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665322|NCT01441349|Simvastatin|simvastatin|mesh-list
153665323|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153665324|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153665325|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
153665326|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665327|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153665328|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153665329|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665330|NCT00394407|Insulin|insulin|mesh-list
153665331|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153665332|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153665333|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357341|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153357342|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
153407544|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665334|NCT00130143|Amifostine|amifostine|mesh-list
153665335|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153665336|NCT00130143|Protective Agents|protective agents|mesh-ancestor
153665337|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665371|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
153665372|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666623|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153666624|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153666625|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
153736430|NCT02690558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153666626|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666627|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153666691|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666692|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666693|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666694|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
153666695|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153666696|NCT00022737|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153666697|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153666698|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666699|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
153666701|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
153666702|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666703|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666704|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153360203|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153480773|NCT05096481|Temozolomide|temozolomide|mesh-list
153667400|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667401|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667402|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153667403|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153667404|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
153667405|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667406|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153667407|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153667408|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153667409|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153667442|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667443|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667444|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
153480882|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153480883|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153810734|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
153810735|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
153810736|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153810737|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810738|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153810739|NCT00321191|Analgesics|analgesics|mesh-ancestor
153810740|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
153810741|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810742|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
153810743|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153810744|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
153810745|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480884|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
153480885|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480886|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153480907|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480909|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480910|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667590|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
153480924|NCT04764188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480925|NCT04738422|Glycine|glycine|mesh-list
153480926|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
153480927|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480928|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480929|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480930|NCT04725032|Propofol|propofol|mesh-list
153480931|NCT04725032|Sevoflurane|sevoflurane|mesh-list
153480932|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153480933|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480934|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480935|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153480979|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
153480980|NCT04625283|Ketamine|ketamine|mesh-list
153480981|NCT04625283|Analgesics|analgesics|mesh-ancestor
153480982|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
153480983|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668354|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153668355|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668356|NCT00031707|Megestrol|megestrol|mesh-list
153668357|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
153668358|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153668359|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153668360|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153668361|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
153668575|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668576|NCT00032292|Visilizumab|visilizumab|mesh-list
153668577|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
153668578|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668579|NCT00032799|Natalizumab|natalizumab|mesh-list
153668580|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
153668581|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668585|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668586|NCT00032838|Yohimbine|yohimbine|mesh-list
153668587|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
153668588|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
153668589|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668590|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407599|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
153668591|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153668592|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153668634|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153481458|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481459|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
153481460|NCT03448393|Fludarabine|fludarabine|mesh-list
153481461|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481462|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
153481463|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481464|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481465|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153481466|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
153481468|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481523|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481539|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481541|NCT03065062|Gedatolisib|gedatolisib|mesh-list
153481542|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668723|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153668724|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153668725|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668727|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
153668739|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153668740|NCT00033462|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153668741|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153668743|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668744|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668745|NCT00393263|Clobetasol|clobetasol|mesh-list
153668746|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
153668747|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668748|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
153668749|NCT00393263|Hormones|hormones|mesh-ancestor
153668750|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668751|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668752|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153668753|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153668754|NCT00393263|Analgesics|analgesics|mesh-ancestor
153595173|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595174|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595175|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153595176|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153595185|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481546|NCT03036098|Carboplatin|carboplatin|mesh-list
153668869|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
153668870|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668871|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668872|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153668873|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153668874|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
153668875|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668876|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153668877|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153668904|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668905|NCT01807325|Pancrelipase|pancrelipase|mesh-list
153668906|NCT01807325|Pancreatin|pancreatin|mesh-list
153668907|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153668908|NCT01807286|Dexamethasone|dexamethasone|mesh-list
153668909|NCT01807286|Melphalan|melphalan|mesh-list
153668910|NCT01807286|Pomalidomide|pomalidomide|mesh-list
153668911|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668912|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
153668913|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
153668914|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668915|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668916|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481632|NCT02500407|Atezolizumab|atezolizumab|mesh-list
153669593|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669594|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669595|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669596|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153669597|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153669615|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
153669616|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669617|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669618|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669619|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153669620|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153810755|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153357358|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867151|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153867152|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153407612|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407613|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
153595186|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153595187|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595188|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595190|NCT01855009|Vitamin D|vitamin d|mesh-list
153595191|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
153595192|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
153595193|NCT01855009|Calcium|calcium|mesh-list
153595194|NCT01855009|Vitamins|vitamins|mesh-ancestor
153595195|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
153595196|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818832|NCT03674112|Trastuzumab|trastuzumab|mesh-list
153818833|NCT03674112|Pertuzumab|pertuzumab|mesh-list
153669621|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153669622|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669623|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153669624|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153669625|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669627|NCT00037596|Cytarabine|cytarabine|mesh-list
153669628|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
153669629|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153669630|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
153669631|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669632|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669633|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
153669634|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669635|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153669636|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
153669637|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669638|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153482126|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
153482127|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482128|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482129|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153482130|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153482131|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153482132|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
153482133|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153482134|NCT01404936|Interferons|interferons|mesh-list
153482135|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
153482136|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
153482137|NCT01404936|Doxorubicin|doxorubicin|mesh-list
153482138|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153482139|NCT01404936|Bleomycin|bleomycin|mesh-list
153482140|NCT01404936|Dacarbazine|dacarbazine|mesh-list
153482141|NCT01404936|Vinblastine|vinblastine|mesh-list
153407637|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153482142|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153482143|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482144|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153482145|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153482146|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482147|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482148|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
153482149|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482155|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
153482156|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
153482157|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
153482213|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153482279|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482281|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153482283|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153669853|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
153669854|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
153482304|NCT01457430|Analgesics|analgesics|mesh-ancestor
153670025|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670043|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670044|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153482511|NCT01513122|Lopinavir|lopinavir|mesh-list
153670124|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670126|NCT00041340|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153670127|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670128|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670129|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670130|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670347|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153670348|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153670349|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
153670350|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
153670351|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670352|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153670353|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153670390|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
153670391|NCT00275015|Etoposide|etoposide|mesh-list
153670392|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670393|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
153670394|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670512|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
153670513|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
153670514|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670515|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810756|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357359|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867167|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867168|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867169|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153867170|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153867171|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867172|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153867173|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153867174|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867175|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
153867176|NCT04592822|Dabigatran|dabigatran|mesh-list
153867177|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
153867178|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153867182|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
153818834|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818835|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670516|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153670542|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670544|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
153670545|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670546|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153670547|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670548|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
153670549|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670550|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153670551|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153670552|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153670553|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
153670554|NCT00129233|Amlodipine|amlodipine|mesh-list
153670555|NCT00129233|Valsartan|valsartan|mesh-list
153670556|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153670557|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153670558|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670559|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670560|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153670561|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670562|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
153670589|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670590|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153670591|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153670592|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670593|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
153670594|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153482975|NCT05724316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153482976|NCT05724316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153482977|NCT05723588|Nicotine|nicotine|mesh-list
153482978|NCT05723588|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153482979|NCT05723588|Autonomic Agents|autonomic agents|mesh-ancestor
153482980|NCT05723588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482981|NCT05723588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818836|NCT03673501|Sunitinib|sunitinib|mesh-list
153482982|NCT05723588|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153482983|NCT05723588|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153482987|NCT05705492|Olanzapine|olanzapine|mesh-list
153483154|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670872|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153670873|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153670895|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153670896|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
153670897|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
153670898|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153670900|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
153670901|NCT05258721|Protective Agents|protective agents|mesh-ancestor
153670902|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670903|NCT05192850|Metformin|metformin|mesh-list
153670904|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153670905|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670906|NCT05111717|Desflurane|desflurane|mesh-list
153671009|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153671010|NCT04846348|Analgesics|analgesics|mesh-ancestor
153671011|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671012|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671013|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153671014|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671015|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
153671016|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
153671017|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153671018|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
153671019|NCT04771520|Piperazine|piperazine|mesh-list
153671020|NCT04771520|Mebendazole|mebendazole|mesh-list
153671021|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
153671022|NCT04771520|DMP 777|dmp 777|mesh-list
153671023|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
153671024|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
153671025|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153671026|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671027|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
153671028|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
153671046|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671047|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
153671049|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153483332|NCT03834766|Amphetamine|amphetamine|mesh-list
153483570|NCT01508949|Liraglutide|liraglutide|mesh-list
153671428|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
153483587|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483588|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483590|NCT01428089|Progestins|progestins|mesh-ancestor
153483591|NCT01428089|Hormones|hormones|mesh-ancestor
153810758|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
153810759|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
153867190|NCT04592666|Carboplatin|carboplatin|mesh-list
153483592|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483594|NCT01425541|Progesterone|progesterone|mesh-list
153671510|NCT05771181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671511|NCT05771181|Antioxidants|antioxidants|mesh-ancestor
153671512|NCT05771181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671513|NCT05771181|Protective Agents|protective agents|mesh-ancestor
153671514|NCT05771038|Alendronate|alendronate|mesh-list
153671515|NCT05771038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153671516|NCT05771038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671517|NCT05771012|Cyclosporine|cyclosporine|mesh-list
153671518|NCT05771012|Cyclosporins|cyclosporins|mesh-list
153671519|NCT05771012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671520|NCT05771012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671521|NCT05771012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671522|NCT05771012|Immunologic Factors|immunologic factors|mesh-ancestor
153671523|NCT05771012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483782|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483783|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483784|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483785|NCT01542684|Azacitidine|azacitidine|mesh-list
153483786|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153483787|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
153483788|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483789|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483790|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483791|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
153483792|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
153483793|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483794|NCT01543074|Protective Agents|protective agents|mesh-ancestor
153483795|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483796|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153483797|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813883|NCT00420836|Tobramycin|tobramycin|mesh-list
153813884|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153483813|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
153483814|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483830|NCT01553058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153483832|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153483833|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153407676|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
153407677|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153483834|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
153483835|NCT01556724|Ropivacaine|ropivacaine|mesh-list
153483836|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
153483837|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
153483838|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483839|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483840|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
153483841|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483842|NCT01558128|Amiodarone|amiodarone|mesh-list
153483843|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153483844|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
153671987|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153508944|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
153671988|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153671989|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
153671990|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671991|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671992|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153671993|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
153671994|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
153671995|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
153671996|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153671997|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153671998|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
153671999|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672150|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672151|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672152|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153672153|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153672154|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672155|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153672156|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153484188|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153484190|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
153484191|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484192|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484193|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153484194|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
153484195|NCT01605942|Hormones|hormones|mesh-ancestor
153484196|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484197|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153484198|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484199|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
153484200|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153484201|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153484213|NCT01610154|Incretins|incretins|mesh-ancestor
153484214|NCT01610154|Hormones|hormones|mesh-ancestor
153484215|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484216|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153484217|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
153484218|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484239|NCT01614210|Tamoxifen|tamoxifen|mesh-list
153484264|NCT01619982|Vancomycin|vancomycin|mesh-list
153672618|NCT00040014|Exemestane|exemestane|mesh-list
153672619|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672620|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153672621|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153672622|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672623|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672624|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153672625|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
153672626|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153672627|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672721|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153672722|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
153672723|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672724|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672847|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672848|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672849|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672850|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672852|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153672853|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672854|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
153672855|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672856|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153672857|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153484567|NCT01689324|Vaccines|vaccines|mesh-list
153484746|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
153484747|NCT01309074|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153484748|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153484893|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153810760|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484900|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
153484901|NCT02996760|Mitogens|mitogens|mesh-list
153673606|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485000|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153485001|NCT01746420|Growth Substances|growth substances|mesh-ancestor
153485082|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
153673920|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
153485261|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153485308|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153485309|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153485311|NCT01818414|Hematinics|hematinics|mesh-ancestor
153485312|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
153485313|NCT06020560|Dalteparin|dalteparin|mesh-list
153485314|NCT06020560|Tinzaparin|tinzaparin|mesh-list
153485315|NCT06020560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153485316|NCT06020560|Anticoagulants|anticoagulants|mesh-ancestor
153485317|NCT06020560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153485318|NCT06020560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153674367|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674369|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153674370|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153674371|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
153674372|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153485476|NCT05997134|Anesthetics|anesthetics|mesh-ancestor
153674427|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674429|NCT00026078|Ifosfamide|ifosfamide|mesh-list
153674430|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674431|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674432|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674433|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674434|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674435|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674436|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
153674437|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153674438|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153674439|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674440|NCT00026156|Docetaxel|docetaxel|mesh-list
153674441|NCT00026156|Vinorelbine|vinorelbine|mesh-list
153674442|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674443|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674444|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674445|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
153485521|NCT05971719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674534|NCT00026351|Rituximab|rituximab|mesh-list
153674535|NCT00026351|Pentostatin|pentostatin|mesh-list
153674536|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153674537|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674538|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
153674539|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674540|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674979|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153674980|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153674981|NCT00028496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153674983|NCT00028535|Trastuzumab|trastuzumab|mesh-list
153674984|NCT00028535|Interleukin-12|interleukin-12|mesh-list
153674985|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674986|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674987|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674988|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674989|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674990|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674991|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153674992|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153674993|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
153674994|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674995|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674996|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674997|NCT00028535|Growth Substances|growth substances|mesh-ancestor
153674998|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674999|NCT00056277|Lamotrigine|lamotrigine|mesh-list
153675000|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
153675001|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153675002|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675003|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675004|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153675005|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675006|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153675007|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153675008|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675009|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675010|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153675011|NCT00028574|Gabapentin|gabapentin|mesh-list
153675042|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675043|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
153675044|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675045|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153675046|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153675047|NCT00028652|Growth Substances|growth substances|mesh-ancestor
153675048|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
153675049|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675050|NCT00028691|Chlorambucil|chlorambucil|mesh-list
153675051|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153675052|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
153407784|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818839|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153818840|NCT03673501|Growth Substances|growth substances|mesh-ancestor
153818841|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460226|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153460227|NCT04095364|Letrozole|letrozole|mesh-list
153460228|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153675071|NCT00028847|Cytarabine|cytarabine|mesh-list
153675072|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
153675073|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675074|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
153675075|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675076|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675077|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
153675078|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675079|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675080|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
153675081|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675082|NCT00028847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153675083|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153675084|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675085|NCT00028886|Interferons|interferons|mesh-list
153675089|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
153675090|NCT00028886|Melphalan|melphalan|mesh-list
153675091|NCT00028886|Doxorubicin|doxorubicin|mesh-list
153675092|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153675093|NCT00028886|Vincristine|vincristine|mesh-list
153675094|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675095|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
153675096|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512028|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
153675097|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675098|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153675099|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
153675100|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675101|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675102|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153675103|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153675104|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
153675105|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
153675106|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675107|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153675108|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
153675109|NCT00028886|Hormones|hormones|mesh-ancestor
153675144|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153675145|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675146|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
153675147|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675148|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
153675179|NCT00029042|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153675180|NCT00029042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153675181|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
153675182|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153675183|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675185|NCT00423540|Analgesics|analgesics|mesh-ancestor
153675186|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
153675187|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675188|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675189|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
153675190|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675191|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153675218|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153675219|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675220|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
153675221|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675222|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675223|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
153675224|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153675225|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675226|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675227|NCT00423696|Antidotes|antidotes|mesh-ancestor
153675228|NCT00423696|Protective Agents|protective agents|mesh-ancestor
153675229|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
153675230|NCT00423696|Vitamins|vitamins|mesh-ancestor
153675231|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
153675232|NCT00029315|Plasminogen|plasminogen|mesh-list
153675233|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153675234|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153675235|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153675236|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675237|NCT00056823|Ranibizumab|ranibizumab|mesh-list
153675238|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153675239|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153675240|NCT00056823|Growth Substances|growth substances|mesh-ancestor
153675241|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675269|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153675271|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153675272|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153675273|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153675274|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
153675275|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675276|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675280|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153675281|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675282|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675283|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153675284|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
153675285|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
153675286|NCT00395720|Vaccines|vaccines|mesh-list
153675287|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
153675288|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675289|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
153675290|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153675304|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153675305|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
153675306|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153675307|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153675308|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153675309|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153675310|NCT00029861|Rimonabant|rimonabant|mesh-list
153675311|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153675312|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153675313|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153675314|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675315|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675316|NCT00029861|Hormones|hormones|mesh-ancestor
153675317|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675318|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675319|NCT00057369|Dalbavancin|dalbavancin|mesh-list
153675320|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153675321|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675322|NCT00057408|Olanzapine|olanzapine|mesh-list
153810762|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
153810763|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810764|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153675323|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
153675324|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
153675325|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
153512251|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
153675326|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675327|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675328|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153675329|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153675330|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675331|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675332|NCT00057408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153675333|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153675334|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675335|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675336|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675337|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
153675338|NCT00030056|Molgramostim|molgramostim|mesh-list
153675339|NCT00030056|Sargramostim|sargramostim|mesh-list
153675340|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
153675341|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675342|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675343|NCT00057447|Interferons|interferons|mesh-list
153675344|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
153675345|NCT00057447|Rituximab|rituximab|mesh-list
153675346|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153675347|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675348|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
153675349|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675378|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675380|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675381|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
153675382|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675383|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675384|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675385|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
153675386|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
153675387|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153675388|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675389|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153675392|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
153675394|NCT00030368|Bortezomib|bortezomib|mesh-list
153407841|NCT04332809|Gentamicins|gentamicins|mesh-list
153460229|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675395|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153675396|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675397|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675430|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153675431|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153675432|NCT00030446|Carboplatin|carboplatin|mesh-list
153675433|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153675434|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675435|NCT00030446|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153675436|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153675456|NCT00030524|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153675457|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153675459|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675460|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675461|NCT00030563|Irinotecan|irinotecan|mesh-list
153675462|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153675463|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675464|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675465|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675466|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675467|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
153675468|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675469|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
153675470|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675471|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
153675472|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512402|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
153675473|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
153675474|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153675475|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153675476|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675477|NCT00057759|Urological Agents|urological agents|mesh-ancestor
153675478|NCT00030641|Docetaxel|docetaxel|mesh-list
153675479|NCT00030641|Oblimersen|oblimersen|mesh-list
153675480|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867355|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867356|NCT00567710|Risperidone|risperidone|mesh-list
153867357|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153867358|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
153675482|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675483|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675484|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675485|NCT00057798|Gemcitabine|gemcitabine|mesh-list
153675486|NCT00057798|Vinorelbine|vinorelbine|mesh-list
153675487|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675488|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
153675505|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675506|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153675507|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153675508|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675509|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675511|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153675512|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153675513|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153675514|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675515|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
153675516|NCT00030719|Melphalan|melphalan|mesh-list
153675517|NCT00030719|Busulfan|busulfan|mesh-list
153675518|NCT00030719|Carboplatin|carboplatin|mesh-list
153675519|NCT00030719|Etoposide|etoposide|mesh-list
153675520|NCT00030719|Vincristine|vincristine|mesh-list
153675521|NCT00030719|Dinutuximab|dinutuximab|mesh-list
153675522|NCT00030719|Isotretinoin|isotretinoin|mesh-list
153675523|NCT00030719|Antibodies|antibodies|mesh-list
153675524|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153675525|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675526|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
153675527|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675528|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675529|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153675530|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
153486046|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675533|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153675534|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153675535|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153675536|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675537|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675538|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675539|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407858|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460230|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460231|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460232|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460233|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460234|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153460235|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153460236|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460237|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153460238|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
153460239|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595197|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153595198|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153595200|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595201|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153595202|NCT01855061|Midazolam|midazolam|mesh-list
153595203|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153595204|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153675540|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675541|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
153675543|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675544|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
153675545|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675546|NCT04730895|Tretinoin|tretinoin|mesh-list
153512476|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
153675547|NCT04730895|Isotretinoin|isotretinoin|mesh-list
153675569|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153675570|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153675571|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675572|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675573|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675574|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675575|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153675576|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
153675577|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675578|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153675579|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153675580|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153675581|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
153675582|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153675583|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153675584|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153675585|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153675586|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153595205|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675587|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675589|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
153675590|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675591|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
153675592|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675593|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675594|NCT00058227|Rituximab|rituximab|mesh-list
153675595|NCT00058227|Fludarabine|fludarabine|mesh-list
153675596|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
153675597|NCT00058227|Alvocidib|alvocidib|mesh-list
153675598|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153675599|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675600|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
153675617|NCT00031070|Cyclosporins|cyclosporins|mesh-list
153675618|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153675619|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
153675620|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675621|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675622|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675623|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675624|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
153675625|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675626|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
153675627|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675628|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153675629|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153675630|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153675631|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
153675632|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153675633|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153675634|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
153675635|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153675636|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153675637|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153675640|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153675642|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
153407885|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153407886|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153595206|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595207|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153595208|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153595209|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153595210|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153595211|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
153675643|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153675644|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675645|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675646|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675647|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675648|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675649|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675650|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
153675651|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675652|NCT00058461|Cytarabine|cytarabine|mesh-list
153675653|NCT00058461|Rituximab|rituximab|mesh-list
153675654|NCT00058461|Carboplatin|carboplatin|mesh-list
153675655|NCT00058461|Methotrexate|methotrexate|mesh-list
153675656|NCT00058461|Etoposide|etoposide|mesh-list
153675657|NCT00058461|Ifosfamide|ifosfamide|mesh-list
153675658|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153675659|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675660|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
153675661|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675662|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675693|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
153675694|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675695|NCT00031109|Antacids|antacids|mesh-ancestor
153675696|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675697|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153675698|NCT00031148|Mitogens|mitogens|mesh-list
153675699|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675700|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675701|NCT00031187|Docetaxel|docetaxel|mesh-list
153675702|NCT00031187|Doxorubicin|doxorubicin|mesh-list
153675703|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
153675738|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153675739|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
153675740|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675741|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675742|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153675775|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
153675776|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153675777|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675778|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
153675780|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153675781|NCT00059358|Interferons|interferons|mesh-list
153675782|NCT00059358|Ribavirin|ribavirin|mesh-list
153675783|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
153675784|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
153675785|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153675786|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675822|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675823|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675824|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
153675825|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675826|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
153675862|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153675863|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153675924|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675925|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675926|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
153675927|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675928|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
153675929|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675930|NCT00032045|Ipilimumab|ipilimumab|mesh-list
153675931|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
153675932|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153675933|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675934|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153675935|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675936|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675937|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
153675938|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675939|NCT00059865|Gemcitabine|gemcitabine|mesh-list
153675976|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153675977|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153675978|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
153675979|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675980|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153675981|NCT00032123|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153675982|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153675983|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675984|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675985|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675987|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675988|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
153407902|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407903|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
153407904|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153407905|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407906|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407907|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153675989|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675990|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675991|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676013|NCT00032396|Hormones|hormones|mesh-ancestor
153676014|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676015|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676016|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
153676017|NCT00060255|Melphalan|melphalan|mesh-list
153676018|NCT00060255|Busulfan|busulfan|mesh-list
153676019|NCT00060255|Thiotepa|thiotepa|mesh-list
153676020|NCT00060255|Carmustine|carmustine|mesh-list
153676021|NCT00060255|Carboplatin|carboplatin|mesh-list
153676022|NCT00060255|Etoposide|etoposide|mesh-list
153676023|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676024|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
153676025|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676026|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153676027|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153676028|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
153676029|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676030|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676031|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153676032|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153676034|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676035|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676036|NCT00060294|Rituximab|rituximab|mesh-list
153676037|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153676038|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676039|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
153676040|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676041|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153676042|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153676043|NCT00060372|Ipilimumab|ipilimumab|mesh-list
153676044|NCT00060372|Antibodies|antibodies|mesh-list
153676045|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
153676046|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153676060|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153676061|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
153676062|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676063|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153676064|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153676065|NCT00060411|Growth Substances|growth substances|mesh-ancestor
153676066|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676067|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
153676073|NCT00060411|Antidotes|antidotes|mesh-ancestor
153676074|NCT00060411|Protective Agents|protective agents|mesh-ancestor
153676075|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
153676076|NCT00060411|Vitamins|vitamins|mesh-ancestor
153676077|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
153676078|NCT00060411|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153676079|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153676080|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676081|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
153676082|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153676083|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
153676084|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676085|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676086|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153676087|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
153676088|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153676089|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
153676090|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676091|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676092|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153676093|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
153676094|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
153676095|NCT00060450|Protective Agents|protective agents|mesh-ancestor
153676096|NCT00032747|Vasopressins|vasopressins|mesh-list
153676097|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
153676098|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
153676099|NCT00032747|Coagulants|coagulants|mesh-ancestor
153676100|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153676101|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153676102|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
153676103|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676104|NCT00032786|Natalizumab|natalizumab|mesh-list
153676105|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
153676106|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676107|NCT02968719|Donepezil|donepezil|mesh-list
153676108|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153676109|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676180|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153676181|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153676182|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153867429|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153867430|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153867431|NCT00581607|Bosentan|bosentan|mesh-list
153867432|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153676183|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
153676184|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676185|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676199|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676200|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153676201|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153676203|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
153676204|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676205|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676207|NCT00060918|Protective Agents|protective agents|mesh-ancestor
153676208|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153676209|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676210|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153676211|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
153676212|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153676213|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153676215|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
153676216|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676217|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676218|NCT02968641|Ritonavir|ritonavir|mesh-list
153676219|NCT02968641|Lonafarnib|lonafarnib|mesh-list
153676220|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153676221|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153676222|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
153676228|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676229|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153676230|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153676231|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
153676232|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
153676233|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676234|NCT00033176|Protective Agents|protective agents|mesh-ancestor
153676235|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676236|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
153676237|NCT00033176|Vitamins|vitamins|mesh-ancestor
153676238|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
153676239|NCT00033215|S 3304|s 3304|mesh-list
153676240|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
153357363|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407935|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595212|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
153595213|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
153595214|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
153595215|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595228|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153595229|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
153595230|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676241|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
153676242|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676243|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676244|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
153676245|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153676246|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153676281|NCT00033332|Thalidomide|thalidomide|mesh-list
153676282|NCT00033332|Dexamethasone|dexamethasone|mesh-list
153676283|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153676284|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
153676285|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
153676286|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676347|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676348|NCT00033644|Doxorubicin|doxorubicin|mesh-list
153676349|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153676350|NCT00033644|Mitomycins|mitomycins|mesh-list
153676351|NCT00033644|Mitomycin|mitomycin|mesh-list
153676352|NCT00033644|Dacarbazine|dacarbazine|mesh-list
153676353|NCT00033644|Sargramostim|sargramostim|mesh-list
153676354|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676355|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153676356|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153676357|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676358|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676359|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676360|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
153676361|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676362|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
153676363|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153676364|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153676365|NCT00033683|Tamoxifen|tamoxifen|mesh-list
153676366|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
153676367|NCT00033683|Docetaxel|docetaxel|mesh-list
153676368|NCT00033683|Fluorouracil|fluorouracil|mesh-list
153676369|NCT00033683|Methotrexate|methotrexate|mesh-list
153810765|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153676400|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153676401|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153676402|NCT00061308|Gemcitabine|gemcitabine|mesh-list
153676403|NCT00061308|Topotecan|topotecan|mesh-list
153676404|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153676405|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
153676406|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676407|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676408|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153676409|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676410|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676442|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
153676443|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676444|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676445|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676446|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153676447|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153676448|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
153676449|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
153676484|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676485|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676487|NCT00034346|Carboplatin|carboplatin|mesh-list
153676488|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153676489|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676490|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676491|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676492|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676493|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676495|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
153676496|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676498|NCT00034463|Vitamins|vitamins|mesh-ancestor
153676499|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
153676500|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676501|NCT00034463|Hematinics|hematinics|mesh-ancestor
153676534|NCT00034502|Irinotecan|irinotecan|mesh-list
153676535|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153676536|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676537|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676538|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676539|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676540|NCT00034541|Paclitaxel|paclitaxel|mesh-list
153676541|NCT00034541|Carboplatin|carboplatin|mesh-list
153676542|NCT00034541|Cetuximab|cetuximab|mesh-list
153676543|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153676544|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676545|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676563|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
153676564|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
153676565|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676566|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676567|NCT00034580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153676568|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153676569|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676570|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
153676571|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676572|NCT00061815|Leucovorin|leucovorin|mesh-list
153676573|NCT00061815|Fluorouracil|fluorouracil|mesh-list
153676574|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
153676575|NCT00061815|Cetuximab|cetuximab|mesh-list
153676576|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
153676577|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676578|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153676579|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676580|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676581|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
153676582|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676583|NCT00061815|Antidotes|antidotes|mesh-ancestor
153676584|NCT00061815|Protective Agents|protective agents|mesh-ancestor
153676585|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
153676587|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
153676588|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153676589|NCT00061854|Soblidotin|soblidotin|mesh-list
153676590|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676591|NCT00034658|Posaconazole|posaconazole|mesh-list
153676592|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
153676593|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676594|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153676595|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153676598|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153676599|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676600|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676601|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153513519|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153676602|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
153676630|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676631|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153676632|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153676633|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676634|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676635|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676636|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676637|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153676638|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153676639|NCT02967939|Tenofovir|tenofovir|mesh-list
153676640|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
153676641|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676642|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153676643|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153676644|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676645|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676646|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153676667|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676668|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
153676669|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676670|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
153676671|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153676672|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676673|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153676674|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153676676|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
153676678|NCT00034853|Meloxicam|meloxicam|mesh-list
153407956|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810766|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153407957|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
153407958|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595231|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595232|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
153595233|NCT01855256|Oxybutynin|oxybutynin|mesh-list
153595234|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
153595235|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
153595236|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595237|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595238|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153595239|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153595240|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
153595241|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595242|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595243|NCT01855256|Urological Agents|urological agents|mesh-ancestor
153595244|NCT01855321|Vitamin D|vitamin d|mesh-list
153595245|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
153595246|NCT01855321|Vitamins|vitamins|mesh-ancestor
153595247|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
153676679|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153676680|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153676681|NCT00034853|Analgesics|analgesics|mesh-ancestor
153676682|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
153676683|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676684|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676685|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153676686|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153676687|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
153676688|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153676689|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676690|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676691|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153676692|NCT00034892|Olanzapine|olanzapine|mesh-list
153676693|NCT00034892|Risperidone|risperidone|mesh-list
153676694|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153676695|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
153676696|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676697|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676698|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676699|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153676700|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153676701|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595256|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153595257|NCT01855334|Diuretics|diuretics|mesh-ancestor
153595258|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
153676733|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153676734|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676735|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
153676736|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
153676737|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676738|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676739|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153676740|NCT00062283|Alanosine|alanosine|mesh-list
153676741|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153676742|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676760|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676762|NCT00062322|Irinotecan|irinotecan|mesh-list
153676763|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676767|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676768|NCT00035126|Epothilones|epothilones|mesh-list
153676769|NCT00035126|Epothilone B|epothilone b|mesh-list
153676770|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676771|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676772|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676773|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676774|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676775|NCT00035165|Epothilones|epothilones|mesh-list
153676776|NCT00035165|Epothilone B|epothilone b|mesh-list
153676777|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676778|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676779|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676780|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676781|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676782|NCT00035204|Galantamine|galantamine|mesh-list
153676783|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153676784|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676785|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676786|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
153676787|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676788|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810767|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153867480|NCT04586543|Protective Agents|protective agents|mesh-ancestor
153676789|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153676790|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
153676791|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676792|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
153676794|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153676795|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676796|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153676797|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676798|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676835|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
153676836|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676837|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676838|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676868|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153676869|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153676870|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676871|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676872|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676873|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676874|NCT00062673|Analgesics|analgesics|mesh-ancestor
153676875|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
153676876|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676877|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
153676878|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676879|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
153676880|NCT00035477|Azimilide|azimilide|mesh-list
153676881|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153676908|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676909|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676910|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676911|NCT00062946|Fallypride|fallypride|mesh-list
153676912|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153676913|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153676914|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
153676915|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407991|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
153407992|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
153407993|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153595259|NCT01855386|Liver Extracts|liver extracts|mesh-list
153595260|NCT01855386|Hematinics|hematinics|mesh-ancestor
153595261|NCT01855490|Exenatide|exenatide|mesh-list
153676916|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676917|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676918|NCT00063024|Calcium|calcium|mesh-list
153676919|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153676920|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676922|NCT00035984|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153676923|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153676924|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676925|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153676962|NCT00036179|Micafungin|micafungin|mesh-list
153676963|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
153676964|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676965|NCT00036218|Ropinirole|ropinirole|mesh-list
153676966|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153676967|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153677006|NCT00036452|Tenofovir|tenofovir|mesh-list
153677007|NCT00036452|Emtricitabine|emtricitabine|mesh-list
153677044|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153677081|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
153677082|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677109|NCT00037037|Sargramostim|sargramostim|mesh-list
153677110|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
153677111|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677112|NCT00064194|Vitamin E|vitamin e|mesh-list
153677113|NCT00064194|Selenium|selenium|mesh-list
153677114|NCT00064194|Vitamins|vitamins|mesh-ancestor
153677115|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
153677116|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677117|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
153677118|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677119|NCT00064194|Protective Agents|protective agents|mesh-ancestor
153514045|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153677120|NCT00064194|Trace Elements|trace elements|mesh-ancestor
153677121|NCT00064233|Dasatinib|dasatinib|mesh-list
153677122|NCT00064233|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153677123|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153677124|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810768|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810769|NCT00351702|Isoniazid|isoniazid|mesh-list
153357369|NCT00744848|Epinephrine|epinephrine|mesh-list
153595262|NCT01855490|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153595272|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153595273|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595274|NCT01855529|Ropivacaine|ropivacaine|mesh-list
153595275|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
153595276|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
153595277|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595278|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677125|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677126|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677127|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
153677128|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153677129|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677130|NCT00037115|Interferons|interferons|mesh-list
153677131|NCT00037115|Interferon-beta|interferon-beta|mesh-list
153677152|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677153|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
153677154|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
153677155|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677156|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153677157|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
153677158|NCT00037115|Hormones|hormones|mesh-ancestor
153677159|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677160|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153677161|NCT00037115|Protective Agents|protective agents|mesh-ancestor
153677162|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153677163|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
153677164|NCT00037154|Urological Agents|urological agents|mesh-ancestor
153677165|NCT00064389|Albuterol|albuterol|mesh-list
153677166|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153677167|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
153677168|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677169|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677170|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153677171|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
153677172|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
153677173|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153677174|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153677175|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153677176|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153677177|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
153407998|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407999|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153818842|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
153818843|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153818844|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818845|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818846|NCT03668340|Adavosertib|adavosertib|mesh-list
153818847|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818848|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818849|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
153818850|NCT03650764|Ramucirumab|ramucirumab|mesh-list
153677178|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153677179|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677180|NCT00064428|PENTA|penta|mesh-list
153677181|NCT00064428|Fondaparinux|fondaparinux|mesh-list
153677182|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153677183|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
153677184|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153677185|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
153677186|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486985|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
153677316|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153677317|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153677319|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
153677320|NCT00065325|Fulvestrant|fulvestrant|mesh-list
153677321|NCT00065325|Exemestane|exemestane|mesh-list
153677322|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153677323|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677324|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153677325|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153677326|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
153677327|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677328|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677330|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153677332|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677333|NCT00038168|Paclitaxel|paclitaxel|mesh-list
153677334|NCT00038168|Estramustine|estramustine|mesh-list
153677335|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153677336|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677337|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677468|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153677470|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677471|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810770|NCT00351702|Ethambutol|ethambutol|mesh-list
153867523|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
153818851|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818852|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818853|NCT03650764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818854|NCT03650764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818855|NCT03650764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153460242|NCT03969420|Alvocidib|alvocidib|mesh-list
153460243|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460244|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
153460245|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460246|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460247|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
153460248|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460249|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460250|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
153595280|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595281|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
153595282|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153677472|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677473|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
153677474|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677475|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
153677476|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677477|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677478|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677479|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
153677480|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
153677481|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677482|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153677483|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
153677505|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677506|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153677507|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
153677508|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153677630|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153677631|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677633|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
153677634|NCT00070278|Gemcitabine|gemcitabine|mesh-list
153677636|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153677637|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677638|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677639|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677640|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677666|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
153677667|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677668|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677669|NCT00066417|Cyclosporine|cyclosporine|mesh-list
153677717|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677719|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677720|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677721|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677722|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
153677723|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153677724|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153677725|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677726|NCT00070434|Antidotes|antidotes|mesh-ancestor
153677727|NCT00070434|Protective Agents|protective agents|mesh-ancestor
153677728|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
153677729|NCT00070434|Vitamins|vitamins|mesh-ancestor
153677730|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
153677731|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
153677732|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
153487519|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487520|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487521|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153487522|NCT05242692|Analgesics|analgesics|mesh-ancestor
153487523|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
153487524|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487525|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153487526|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153487527|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153487528|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487529|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487530|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487531|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153487532|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153487539|NCT05087940|Diuretics|diuretics|mesh-list
153678140|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
153487620|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153678377|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678378|NCT00071994|Gefitinib|gefitinib|mesh-list
153678379|NCT00071994|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153678380|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678381|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408048|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153408049|NCT05646264|Agomelatine|agomelatine|mesh-list
153408050|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153408051|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678382|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678383|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678384|NCT00203788|Risperidone|risperidone|mesh-list
153678385|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153678519|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678520|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153678521|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153678522|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678523|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678524|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678525|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
153678526|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678527|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153678528|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
153678530|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678531|NCT00204646|Carboplatin|carboplatin|mesh-list
153678532|NCT00204646|Etoposide|etoposide|mesh-list
153678533|NCT00204646|Doxorubicin|doxorubicin|mesh-list
153487786|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487787|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153487788|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153487789|NCT02002650|Indomethacin|indomethacin|mesh-list
153487790|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153487791|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153487792|NCT02002650|Analgesics|analgesics|mesh-ancestor
153487793|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
153487794|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487795|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487796|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487797|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487798|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
153487799|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
153487800|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153487801|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153487812|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487814|NCT02004366|Hormones|hormones|mesh-ancestor
153678815|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678816|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153678825|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153678826|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678827|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678828|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153678829|NCT00411229|Capecitabine|capecitabine|mesh-list
153678830|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
153867549|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
153867551|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
153678831|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153678832|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
153678833|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678834|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678835|NCT00411268|Hydromorphone|hydromorphone|mesh-list
153678836|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153678837|NCT00411268|Narcotics|narcotics|mesh-ancestor
153678838|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678839|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678840|NCT00411268|Analgesics|analgesics|mesh-ancestor
153678841|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
153678842|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487913|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488046|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488048|NCT02061384|Vitamins|vitamins|mesh-ancestor
153488049|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
153488050|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153488051|NCT02061774|Acetaminophen|acetaminophen|mesh-list
153488052|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488142|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488143|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
153488144|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153488145|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
153488146|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
153488147|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153488148|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
153488149|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
153488150|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488151|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488152|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488153|NCT02139540|Analgesics|analgesics|mesh-ancestor
153488154|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
153488155|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488156|NCT02148588|Lidocaine|lidocaine|mesh-list
153488157|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488158|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
153488159|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488160|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488161|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
153488162|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488163|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153488168|NCT02149524|Trastuzumab|trastuzumab|mesh-list
153488169|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153488170|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488171|NCT02154048|Dexamethasone|dexamethasone|mesh-list
153488172|NCT02154048|Ropivacaine|ropivacaine|mesh-list
153488173|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153488174|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
153488175|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
153488176|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488177|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488178|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153488179|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
153488180|NCT02154048|Hormones|hormones|mesh-ancestor
153813925|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153488181|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488182|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153679359|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679360|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679361|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679362|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
153679363|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679364|NCT00209014|Thalidomide|thalidomide|mesh-list
153679365|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679366|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
153679367|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679368|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
153679386|NCT00041054|Protective Agents|protective agents|mesh-ancestor
153679387|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488233|NCT02160990|Incretins|incretins|mesh-ancestor
153679415|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153679416|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153679417|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679418|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679419|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679420|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
153679421|NCT00209209|Hormones|hormones|mesh-ancestor
153679422|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679423|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153679424|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
153679425|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679426|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153679427|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679446|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357371|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
153595283|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153595284|NCT01855555|Propofol|propofol|mesh-list
153679447|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679448|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153679449|NCT00209482|Metformin|metformin|mesh-list
153679450|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679451|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679452|NCT00041171|Docetaxel|docetaxel|mesh-list
153679453|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679454|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679455|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679456|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
153488292|NCT02192814|Lacosamide|lacosamide|mesh-list
153679483|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679484|NCT00209716|Cisplatin|cisplatin|mesh-list
153679485|NCT00209716|Docetaxel|docetaxel|mesh-list
153679486|NCT00209716|Fluorouracil|fluorouracil|mesh-list
153679511|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256720|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679512|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153679513|NCT00209833|Cytarabine|cytarabine|mesh-list
153679514|NCT00209833|Fludarabine|fludarabine|mesh-list
153679515|NCT00209833|Etoposide|etoposide|mesh-list
153679516|NCT00209833|Idarubicin|idarubicin|mesh-list
153679517|NCT00209833|Daunorubicin|daunorubicin|mesh-list
153679518|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679519|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679520|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
153679521|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679522|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679523|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
153679524|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679525|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153736444|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679526|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153679527|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679528|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488404|NCT02223702|Amoxicillin|amoxicillin|mesh-list
153488405|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
153488406|NCT02223702|Metronidazole|metronidazole|mesh-list
153867583|NCT00566904|Analgesics|analgesics|mesh-ancestor
153488407|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153488408|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488409|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153488410|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153488411|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488412|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488432|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
153488433|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153488434|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488435|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
153488436|NCT02233998|Protective Agents|protective agents|mesh-ancestor
153488437|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488438|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
153488439|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
153679876|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153679877|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153679879|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679994|NCT02966730|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153679995|NCT02966730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153679996|NCT02966730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679997|NCT02966730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679999|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153680000|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153680001|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680002|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680003|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680058|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680059|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680060|NCT00213694|Celecoxib|celecoxib|mesh-list
153680061|NCT00213694|Docetaxel|docetaxel|mesh-list
153680207|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153680208|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680209|NCT00214981|Modafinil|modafinil|mesh-list
153680210|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153680211|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680212|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153680213|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153680214|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153680215|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680216|NCT00397241|Timolol|timolol|mesh-list
153680217|NCT00397241|Dorzolamide|dorzolamide|mesh-list
153680218|NCT00397241|Latanoprost|latanoprost|mesh-list
153680219|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
153680220|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153680221|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153680222|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680223|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680224|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680225|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680226|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153680227|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153680228|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153680229|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153680230|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153680231|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680232|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153680233|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153680234|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153680235|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680236|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680237|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153680238|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153680239|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153680240|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
153680270|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680271|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680272|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153680273|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
153488642|NCT02284386|Bupivacaine|bupivacaine|mesh-list
153680362|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680364|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153680365|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680366|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
153680367|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153680383|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680385|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153680386|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153680387|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153680388|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153680389|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
153680390|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
153810771|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
153357372|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
153680391|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
153680392|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
153680393|NCT00216268|Ribavirin|ribavirin|mesh-list
153680394|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
153680395|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680396|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
153680397|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680398|NCT00216346|Amphotericin B|amphotericin b|mesh-list
153680449|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680450|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153680451|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153680453|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
153680454|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153680455|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
153488793|NCT02303184|Aflibercept|aflibercept|mesh-list
153488796|NCT02303184|Growth Substances|growth substances|mesh-ancestor
153680534|NCT00412204|Bromides|bromides|mesh-list
153680535|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
153680536|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153680537|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
153680538|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680539|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680540|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153680541|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
153680542|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
153680543|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153680544|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
153680573|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153680574|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153680575|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153680576|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153680577|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680578|NCT00217282|Bevacizumab|bevacizumab|mesh-list
153680579|NCT00217282|Gemcitabine|gemcitabine|mesh-list
153680580|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
153680581|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153680582|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680583|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153680584|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153680585|NCT00217282|Growth Substances|growth substances|mesh-ancestor
153680586|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680587|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
153680588|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153595285|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153595286|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595287|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595288|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153595289|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
153595290|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
153595292|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153595293|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
153595294|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153595295|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680619|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153680620|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153680622|NCT00217789|Dimercaprol|dimercaprol|mesh-list
153680623|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
153680624|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
153488834|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
153680661|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813935|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488897|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153488898|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
153488899|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488900|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488901|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153488902|NCT02354352|Diuretics|diuretics|mesh-ancestor
153488903|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
153488904|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153488905|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
153488906|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488907|NCT02357706|Acetaminophen|acetaminophen|mesh-list
153488908|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488909|NCT02357706|Analgesics|analgesics|mesh-ancestor
153488910|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
153488911|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680688|NCT00218374|Analgesics|analgesics|mesh-ancestor
153680689|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
153680690|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680691|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680692|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
153680693|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153680694|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153680695|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680696|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153595296|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680697|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153680726|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153680727|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680728|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680729|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680731|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153680732|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153680733|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680734|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
153680735|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680736|NCT00218608|Disulfiram|disulfiram|mesh-list
153680773|NCT00219193|Aliskiren|aliskiren|mesh-list
153680774|NCT00219193|Renin Inhibitors|renin inhibitors|mesh-ancestor
153680775|NCT00219193|Protease Inhibitors|protease inhibitors|mesh-ancestor
153680776|NCT00219193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680777|NCT00219193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680778|NCT00219232|Rivastigmine|rivastigmine|mesh-list
153680779|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153680780|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680781|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680782|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
153680783|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680784|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680785|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153680786|NCT00219232|Protective Agents|protective agents|mesh-ancestor
153680787|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
153680788|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153680789|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680790|NCT00219310|Famciclovir|famciclovir|mesh-list
153680791|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
153680792|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680793|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153680794|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680795|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680796|NCT00219388|Simendan|simendan|mesh-list
153680797|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153810773|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595297|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
153595298|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595299|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595300|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
153595301|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595302|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153680829|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680830|NCT00219700|Ibuprofen|ibuprofen|mesh-list
153680831|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153680832|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153680833|NCT00219700|Analgesics|analgesics|mesh-ancestor
153680834|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
153680835|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680836|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680837|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153680838|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680839|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153680840|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680841|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680875|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153680876|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489004|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
153680919|NCT00042536|Naltrexone|naltrexone|mesh-list
153680920|NCT00042536|Yohimbine|yohimbine|mesh-list
153680921|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153680922|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153680923|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680924|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
153680925|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680926|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
153680927|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
153680928|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153680929|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153680930|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153680931|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680932|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680933|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680934|NCT00042536|Urological Agents|urological agents|mesh-ancestor
153595303|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153595304|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
153595305|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680958|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361036|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153680959|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680960|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680961|NCT00042575|Analgesics|analgesics|mesh-ancestor
153680962|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
153680963|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680964|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
153680965|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153680966|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
153680967|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153680968|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
153680969|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680970|NCT00077454|Temozolomide|temozolomide|mesh-list
153680971|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153680972|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153680973|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
153489079|NCT05718492|Micronutrients|micronutrients|mesh-ancestor
153681020|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681021|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681022|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681023|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681024|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
153681025|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681026|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
153681060|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153681061|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681062|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681064|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153681065|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153681066|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681067|NCT02966067|Anesthetics|anesthetics|mesh-list
153681068|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153681069|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681102|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153408164|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153408165|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153595306|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153595307|NCT01855581|Ketamine|ketamine|mesh-list
153595314|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
153595315|NCT01855581|Analgesics|analgesics|mesh-ancestor
153595316|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
153595317|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681103|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681104|NCT00221260|Anesthetics|anesthetics|mesh-list
153681105|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681106|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681107|NCT00402259|Esomeprazole|esomeprazole|mesh-list
153681108|NCT00402259|Omeprazole|omeprazole|mesh-list
153681109|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153681137|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153681138|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153681139|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153681140|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153681142|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153681143|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153681144|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681145|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153681146|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
153681194|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681195|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681197|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681218|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153681219|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681220|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
153681221|NCT02965443|Saxagliptin|saxagliptin|mesh-list
153681222|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153681223|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681224|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153681225|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681226|NCT02965443|Incretins|incretins|mesh-ancestor
153681227|NCT02965443|Hormones|hormones|mesh-ancestor
153681228|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153681229|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153867677|NCT04583111|Domperidone|domperidone|mesh-list
153681230|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153681231|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681232|NCT00042965|Gemcitabine|gemcitabine|mesh-list
153681233|NCT00042965|Capecitabine|capecitabine|mesh-list
153681234|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681235|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
153681236|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681237|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681238|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153681239|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
153681240|NCT00123175|Progestins|progestins|mesh-list
153681241|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153681242|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153681243|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153681380|NCT02970539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153681382|NCT02970539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681383|NCT02970539|Growth Inhibitors|growth inhibitors|mesh-ancestor
153681384|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
153681385|NCT00124111|Fluorouracil|fluorouracil|mesh-list
153681386|NCT00124111|Methotrexate|methotrexate|mesh-list
153681387|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681388|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
153681389|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681390|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153681391|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153681392|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
153681393|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681394|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681395|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153681396|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
153681397|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681421|NCT02958046|Lansoprazole|lansoprazole|mesh-list
153681422|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
153681473|NCT00043121|Antidotes|antidotes|mesh-ancestor
153681474|NCT00043121|Protective Agents|protective agents|mesh-ancestor
153681475|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
153681476|NCT00043121|Vitamins|vitamins|mesh-ancestor
153681477|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
153681478|NCT00402415|Sirolimus|sirolimus|mesh-list
153681479|NCT00402415|Sunitinib|sunitinib|mesh-list
153681480|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153681481|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681482|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153681483|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681484|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
153681540|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681541|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357373|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681542|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681544|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681545|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681546|NCT00043277|Bivalirudin|bivalirudin|mesh-list
153681563|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681564|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
153681565|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153681566|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681567|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153681568|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153681569|NCT00124813|Growth Substances|growth substances|mesh-ancestor
153681570|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
153681571|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681572|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153681600|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
153681601|NCT00043316|Interferons|interferons|mesh-list
153681602|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
153681603|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681604|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
153681633|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681634|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681635|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153681636|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681637|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153681639|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
153681640|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681641|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
153681642|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681643|NCT00125398|Fospropofol|fospropofol|mesh-list
153681644|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153681645|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681646|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681647|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
153681648|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153681649|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
153681717|NCT00078117|Analgesics|analgesics|mesh-ancestor
153681718|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
153681719|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681720|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153681721|NCT00125983|Ritonavir|ritonavir|mesh-list
153681722|NCT00125983|Lopinavir|lopinavir|mesh-list
153681723|NCT00125983|Norinyl|norinyl|mesh-list
153681724|NCT00125983|Ortho Evra|ortho evra|mesh-list
153681725|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153681726|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153681727|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
153681728|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681729|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681730|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153681731|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153681732|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
153681733|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681734|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153681735|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153681736|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153681737|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153681738|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153681739|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
153681740|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153681741|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681742|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153681743|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153681744|NCT00126022|Tedisamil|tedisamil|mesh-list
153681745|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153681830|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681832|NCT00123253|Growth Substances|growth substances|mesh-ancestor
153681833|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681834|NCT00126139|Abciximab|abciximab|mesh-list
153681835|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
153681836|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153681837|NCT00074100|Amonafide|amonafide|mesh-list
153681838|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681839|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
153681840|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681841|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681842|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681875|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
153681876|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681877|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681878|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437700|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
153810774|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153810775|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153357374|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867708|NCT01145755|Analgesics|analgesics|mesh-ancestor
153595318|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153595319|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153681880|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
153681881|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
153681918|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153681919|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681921|NCT00074178|Dexamethasone|dexamethasone|mesh-list
153681922|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
153681923|NCT00074178|Methotrexate|methotrexate|mesh-list
153681924|NCT00074178|Etoposide|etoposide|mesh-list
153681925|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
153681926|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681927|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
153681928|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681929|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153681930|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153681931|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
153681932|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681933|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681934|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153681935|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153681936|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
153681937|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
153681938|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681969|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
153681970|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681971|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153681972|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153681973|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
153681974|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
153681975|NCT00402571|Acetaminophen|acetaminophen|mesh-list
153681976|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153681977|NCT00402571|Analgesics|analgesics|mesh-ancestor
153681978|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
153681979|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681980|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681981|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
153681983|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153682004|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
153408216|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408217|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153408218|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153408219|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
153408220|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408221|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408223|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
153408224|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
153408225|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408226|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408227|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
153408228|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408229|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153408230|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153408231|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153408232|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153595323|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
153682005|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682006|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
153682007|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682008|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682009|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682010|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153682011|NCT00127114|Analgesics|analgesics|mesh-ancestor
153682012|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
153682013|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682015|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
153682016|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153682017|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153682018|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682019|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153682076|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153682077|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682109|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153682110|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153682111|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
153682112|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682113|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
153682114|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682115|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682116|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682117|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153682143|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
153682144|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153682145|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682146|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682147|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153682148|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153682149|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153810776|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
153595325|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153595326|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682150|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153682151|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153682153|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153682154|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153682155|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
153682156|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153682157|NCT00402766|Dexamethasone|dexamethasone|mesh-list
153682158|NCT00402766|Cisplatin|cisplatin|mesh-list
153682193|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153682194|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153682195|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153682196|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
153682197|NCT00043940|Bivalirudin|bivalirudin|mesh-list
153682198|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
153682199|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153682200|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
153682201|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682202|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682203|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
153682204|NCT04711434|Antibodies|antibodies|mesh-list
153682205|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
153682206|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682207|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
153682208|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153682209|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153682210|NCT00128245|Analgesics|analgesics|mesh-ancestor
153682211|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
153682212|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682213|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682214|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153682215|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682216|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
153682217|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682218|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
153682219|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153682220|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867741|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595327|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595328|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
153595329|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153595330|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595331|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595332|NCT01855711|Alosetron|alosetron|mesh-list
153595333|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153682221|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682269|NCT00078351|Protective Agents|protective agents|mesh-ancestor
153682270|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682272|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153682273|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153682274|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682275|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682276|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
153682277|NCT00397358|Icodextrin|icodextrin|mesh-list
153682278|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
153682279|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153682280|NCT05519917|Afatinib|afatinib|mesh-list
153682281|NCT05519917|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153682300|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682301|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153682302|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
153781920|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682303|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682304|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682306|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153682307|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682309|NCT00044525|IDN 5109|idn 5109|mesh-list
153682310|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682311|NCT00074607|Gemcitabine|gemcitabine|mesh-list
153682312|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682313|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
153682314|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682315|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682316|NCT05305885|Pemetrexed|pemetrexed|mesh-list
153682317|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682378|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153682379|NCT00403039|Growth Substances|growth substances|mesh-ancestor
153357375|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
153408260|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
153408261|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408262|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595334|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153595335|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
153682380|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682381|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
153682382|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682413|NCT00044798|Citalopram|citalopram|mesh-list
153682414|NCT00044798|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153682466|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682467|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682468|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153682469|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
153682470|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153682471|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153682472|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153682473|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153682474|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153682475|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153682476|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153682477|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682478|NCT04457557|Ropivacaine|ropivacaine|mesh-list
153682501|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153682502|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682523|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682524|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682526|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
153682527|NCT00044954|Fludarabine|fludarabine|mesh-list
153682528|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
153682529|NCT00044954|Cyclosporins|cyclosporins|mesh-list
153682530|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682562|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153682563|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682564|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
153682565|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
153682566|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
153682567|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357376|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867757|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153867758|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867760|NCT00568295|Rofecoxib|rofecoxib|mesh-list
153595336|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595337|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595338|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595339|NCT01855724|Gemcitabine|gemcitabine|mesh-list
153595340|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153595341|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
153595350|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682568|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153682569|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153682570|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153682571|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682572|NCT00079131|Oblimersen|oblimersen|mesh-list
153682573|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682574|NCT00045149|Aldesleukin|aldesleukin|mesh-list
153682575|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682602|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682603|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682604|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
153682605|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
153682606|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
153682607|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682608|NCT00075075|Infliximab|infliximab|mesh-list
153682609|NCT00075075|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153682610|NCT00075075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153682611|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
153682612|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153682613|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682614|NCT04065451|Epinephrine|epinephrine|mesh-list
153682706|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682707|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682708|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153682709|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153682710|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
153682711|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682712|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153682713|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153682714|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153682715|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153682716|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
153682717|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153595351|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153595352|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
153595353|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595354|NCT01855971|Protective Agents|protective agents|mesh-ancestor
153595355|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595356|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153595357|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153818856|NCT03650764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153818857|NCT03650764|Growth Substances|growth substances|mesh-ancestor
153682718|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153682719|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153682720|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153682721|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153682722|NCT00403312|Nicotine|nicotine|mesh-list
153682723|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153682724|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
153682725|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682726|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682751|NCT00045539|Methotrexate|methotrexate|mesh-list
153682752|NCT00045539|Thiotepa|thiotepa|mesh-list
153682753|NCT00045539|Calcium|calcium|mesh-list
153682754|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
153682755|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154256722|NCT01157000|Canagliflozin|canagliflozin|mesh-list
153682756|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682809|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682810|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153682811|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153682812|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153682869|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153682870|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682871|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
153682872|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682873|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682874|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682876|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682877|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682878|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153682879|NCT00079443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153357377|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153818858|NCT03650764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818859|NCT03650764|Growth Inhibitors|growth inhibitors|mesh-ancestor
153818860|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
153818861|NCT03644485|Tacrolimus|tacrolimus|mesh-list
153818862|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818863|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
153818864|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818865|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153818866|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682880|NCT00079443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682881|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153682917|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153682918|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153682919|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153682920|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153682921|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
153682922|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682923|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682925|NCT00079638|Atorvastatin|atorvastatin|mesh-list
153682926|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153682927|NCT00079638|Simvastatin|simvastatin|mesh-list
153682928|NCT00079638|Ezetimibe|ezetimibe|mesh-list
153682929|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153682930|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153682931|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
153682932|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682933|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153682934|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153682935|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682936|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
153682937|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
153682938|NCT00079638|Vitamins|vitamins|mesh-ancestor
153682939|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
153682940|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682941|NCT00046241|Bupropion|bupropion|mesh-list
153682942|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153682990|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683011|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153683012|NCT00130819|Narcotics|narcotics|mesh-ancestor
153683013|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153683014|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683015|NCT00130819|Analgesics|analgesics|mesh-ancestor
153683016|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
153683017|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683018|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153683019|NCT00130858|Carboplatin|carboplatin|mesh-list
153683020|NCT00130858|Topotecan|topotecan|mesh-list
153683021|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683022|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153683023|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683024|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683025|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683026|NCT00130897|Sunitinib|sunitinib|mesh-list
153683027|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683028|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153683029|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153683030|NCT00130897|Growth Substances|growth substances|mesh-ancestor
153683031|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683032|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
153683033|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153683034|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683035|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683037|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153683038|NCT00079833|Esomeprazole|esomeprazole|mesh-list
153683039|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153683040|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683224|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
153683225|NCT00403780|Pregabalin|pregabalin|mesh-list
153683226|NCT00403780|Analgesics|analgesics|mesh-ancestor
153683227|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
153683228|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814300|NCT00451386|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153814301|NCT00451386|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153731814|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731815|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731816|NCT00139646|Analgesics|analgesics|mesh-ancestor
153731817|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
153731818|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731819|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818867|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818868|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153818869|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818870|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153818871|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
153460258|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153460259|NCT03921242|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153595358|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595359|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153595360|NCT01855984|Tocotrienols|tocotrienols|mesh-list
153595361|NCT01855984|Vitamin E|vitamin e|mesh-list
153731820|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731821|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731822|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153731823|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731824|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731825|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154256737|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154256739|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
154256740|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256741|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154256742|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154256743|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256744|NCT01161134|Meloxicam|meloxicam|mesh-list
154256745|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154256746|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154256747|NCT01161134|Analgesics|analgesics|mesh-ancestor
154256748|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
154256749|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256750|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256751|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154256752|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154256753|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154256754|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154256755|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256756|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256757|NCT01268384|Gemcitabine|gemcitabine|mesh-list
154256758|NCT01268384|Capecitabine|capecitabine|mesh-list
154256759|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154256760|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
153867844|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
153867845|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867846|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408335|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408336|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
153408337|NCT05430048|Coagulants|coagulants|mesh-ancestor
153408338|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153408339|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
153408340|NCT02975570|Levofloxacin|levofloxacin|mesh-list
153408342|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
153408343|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153408344|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408345|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153408346|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153408347|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153408348|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408350|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256761|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256762|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256763|NCT01269476|Fluorides|fluorides|mesh-list
154256764|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
154256765|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
154256766|NCT01269476|Protective Agents|protective agents|mesh-ancestor
154256767|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256768|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154256769|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731789|NCT00161421|Leuprolide|leuprolide|mesh-list
153361350|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361351|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361353|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
153821924|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153821927|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821928|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153821929|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
153821930|NCT00440921|Coagulants|coagulants|mesh-ancestor
153821931|NCT00440960|Lidocaine|lidocaine|mesh-list
153821932|NCT00440960|Midazolam|midazolam|mesh-list
153821933|NCT00440960|Alfentanil|alfentanil|mesh-list
153821934|NCT00440960|Propofol|propofol|mesh-list
153371021|NCT01242644|Morphine|morphine|mesh-list
153821973|NCT00441155|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153821974|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153821975|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821976|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361933|NCT05946486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361934|NCT05946486|Immunologic Factors|immunologic factors|mesh-ancestor
153361935|NCT05946486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361969|NCT05946005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153361970|NCT05946005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153361971|NCT05946005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153361972|NCT05946005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153361973|NCT05946005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362387|NCT03356483|Niacin|niacin|mesh-list
153362388|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
153362389|NCT03356483|Psilocybin|psilocybin|mesh-list
153362390|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153362391|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
153357378|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153408351|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153822589|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
153822590|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153822591|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153822592|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822593|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
153822594|NCT00444470|Coagulants|coagulants|mesh-ancestor
153822595|NCT00444548|Reboxetine|reboxetine|mesh-list
153822596|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
153822597|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153822598|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153822599|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153822600|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362578|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
153362579|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362580|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153831171|NCT05809011|Hormones|hormones|mesh-ancestor
153822667|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822669|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153822670|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
153822671|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
153822676|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153822677|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822678|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153822679|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153822680|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153822681|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
153822682|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363213|NCT01554683|Levetiracetam|levetiracetam|mesh-list
153363214|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
153823308|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823309|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
153823310|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823311|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823312|NCT00458042|Treprostinil|treprostinil|mesh-list
153823313|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153823314|NCT00458081|Rimonabant|rimonabant|mesh-list
153823315|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153823316|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153823317|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153823318|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363296|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363297|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
153363298|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363326|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153363327|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
153363328|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
153867847|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595362|NCT01855984|Tocopherols|tocopherols|mesh-list
153595363|NCT01855984|Tocovid|tocovid|mesh-list
153595364|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
153595365|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595366|NCT01855984|Protective Agents|protective agents|mesh-ancestor
153363329|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
153363330|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
153363331|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153363332|NCT03217292|Tramadol|tramadol|mesh-list
153363333|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153363336|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363337|NCT03217292|Analgesics|analgesics|mesh-ancestor
153363359|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153363360|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
153363362|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153363363|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363364|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153363365|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363366|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363367|NCT01836224|Terlipressin|terlipressin|mesh-list
153363368|NCT01836224|Norepinephrine|norepinephrine|mesh-list
153363369|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153363370|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153363371|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153363372|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153363373|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
153363374|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363375|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371628|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823503|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153823504|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153823505|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
153823506|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823507|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153823508|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153823509|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
153823510|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
153823511|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823512|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153823513|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153867870|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153810778|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153357379|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
153823514|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
153823515|NCT00488670|Escitalopram|escitalopram|mesh-list
153823516|NCT00488670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153823527|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823528|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823530|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
153823531|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
153823532|NCT00488709|Cytarabine|cytarabine|mesh-list
153823533|NCT00488709|Fludarabine|fludarabine|mesh-list
153823534|NCT00488709|Topotecan|topotecan|mesh-list
153363488|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
153363489|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363490|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153363491|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
153363492|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
153363493|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
153363494|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153363495|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
153363496|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
153363497|NCT01837394|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153363498|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153363499|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
153363500|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823552|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823553|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823555|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153823556|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831603|NCT04177095|Abatacept|abatacept|mesh-list
153363606|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153363607|NCT01464359|Analgesics|analgesics|mesh-ancestor
153363608|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
153363609|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363610|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
153363611|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
153363612|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363613|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
153363614|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153363615|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
153364519|NCT03005483|Gabapentin|gabapentin|mesh-list
153363616|NCT01464359|Protective Agents|protective agents|mesh-ancestor
153823643|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153823644|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153823645|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
153371677|NCT01731041|Ticagrelor|ticagrelor|mesh-list
153823851|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
153595367|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595368|NCT01855984|Vitamins|vitamins|mesh-ancestor
153595369|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
153595370|NCT01856062|Dexamethasone|dexamethasone|mesh-list
153595371|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595372|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
153595373|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
153595374|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595375|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595376|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153595377|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
153595378|NCT01856062|Hormones|hormones|mesh-ancestor
153595379|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595380|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153595381|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595382|NCT01856101|Dactolisib|dactolisib|mesh-list
153595383|NCT01856101|MTOR Inhibitors|mtor inhibitors|mesh-list
153595384|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595385|NCT01856101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823852|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823853|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363813|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363814|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153363815|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363816|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153363817|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363818|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363820|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153363821|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363822|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153363947|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
153363955|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363956|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363958|NCT01728740|Acarbose|acarbose|mesh-list
153363959|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153363960|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363961|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153363962|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363963|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363964|NCT01728818|Gemcitabine|gemcitabine|mesh-list
153363965|NCT01728818|Afatinib|afatinib|mesh-list
153363966|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153363967|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
153824013|NCT00463268|Vitamins|vitamins|mesh-ancestor
153824014|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
153810779|NCT00351975|Azacitidine|azacitidine|mesh-list
153357380|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824015|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824016|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153824017|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153364025|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153364027|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153364028|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
153824065|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
153824066|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824067|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824068|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824070|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153364038|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364039|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364043|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153364044|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153364045|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364046|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364047|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
153364048|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364049|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153364050|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153824074|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
153824075|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153824077|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824078|NCT00497328|Protective Agents|protective agents|mesh-ancestor
153824079|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824080|NCT00497328|Antidotes|antidotes|mesh-ancestor
153824081|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
153824082|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
153824083|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153824084|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
153824085|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824086|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824087|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153824088|NCT00466154|Aspirin|aspirin|mesh-list
153824089|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153824090|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153824091|NCT00466154|Analgesics|analgesics|mesh-ancestor
153408390|NCT04662242|Protective Agents|protective agents|mesh-ancestor
153814864|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814865|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153824092|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
153824093|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824094|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824095|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824096|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153824097|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153824098|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153364056|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364057|NCT01578317|Vaccines|vaccines|mesh-list
153364058|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
153364059|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364060|NCT03830216|Insulin|insulin|mesh-list
153824145|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153824146|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
153824147|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
153824148|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153824149|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153824150|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153824151|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153824152|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
153824153|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364147|NCT03405584|Expectorants|expectorants|mesh-ancestor
153364148|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
153364149|NCT03007121|Sufentanil|sufentanil|mesh-list
153364150|NCT03007121|Morphine|morphine|mesh-list
153364151|NCT03007121|Dsuvia|dsuvia|mesh-list
153364152|NCT03007121|Bupivacaine|bupivacaine|mesh-list
153364153|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
153364154|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
153364155|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364156|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364157|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
153824194|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153824195|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824196|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824197|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824198|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
153824199|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153824214|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153824215|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824216|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824217|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
153824218|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153824219|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153867890|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153867891|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824220|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153364185|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364186|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364187|NCT02981459|Urological Agents|urological agents|mesh-ancestor
153364189|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153364190|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
153364191|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
153364192|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364193|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153364194|NCT03006809|Metronidazole|metronidazole|mesh-list
153364195|NCT03006809|Vancomycin|vancomycin|mesh-list
153364196|NCT03006809|Neomycin|neomycin|mesh-list
153364197|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364198|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153824301|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
153824302|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824303|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364359|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153364360|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153364361|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
153364362|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
153364363|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364364|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364365|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
153364366|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364385|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153364555|NCT03005171|Lidocaine|lidocaine|mesh-list
153364386|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153364387|NCT01586975|Analgesics|analgesics|mesh-ancestor
153824427|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153824428|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824429|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824430|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824431|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153824432|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153364402|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153364424|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
153595386|NCT01856101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364425|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153364426|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153364427|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364428|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364429|NCT01588457|Lamotrigine|lamotrigine|mesh-list
153364430|NCT01588457|Valproic Acid|valproic acid|mesh-list
153364431|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153364432|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
153824456|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
153824457|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824458|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153824459|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824460|NCT00466895|Growth Substances|growth substances|mesh-ancestor
153824461|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
153824462|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824464|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153824465|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
153824466|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824467|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364482|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153364484|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364485|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364486|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153364487|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153364488|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364489|NCT03005405|Methamphetamine|methamphetamine|mesh-list
153364490|NCT03005405|Fluorides|fluorides|mesh-list
153364500|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364509|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364510|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364511|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153364512|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
153364513|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153364514|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153364515|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153810782|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
153595387|NCT01856101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595388|NCT01856101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364516|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
153824552|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153824553|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364545|NCT01593215|Urological Agents|urological agents|mesh-ancestor
153364546|NCT03005015|Doxorubicin|doxorubicin|mesh-list
153364547|NCT03005015|Lenvatinib|lenvatinib|mesh-list
153364548|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153364549|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364550|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153364551|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153364552|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364564|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153364565|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153364566|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364567|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364568|NCT01041638|Vitamin A|vitamin a|mesh-list
153364569|NCT01041638|Aldesleukin|aldesleukin|mesh-list
153364570|NCT01041638|Interleukin-2|interleukin-2|mesh-list
153364571|NCT01041638|Tretinoin|tretinoin|mesh-list
153364572|NCT01041638|Dinutuximab|dinutuximab|mesh-list
153364573|NCT01041638|Isotretinoin|isotretinoin|mesh-list
153364574|NCT01041638|Sargramostim|sargramostim|mesh-list
153364575|NCT01041638|Vitamins|vitamins|mesh-ancestor
153364669|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364671|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153364673|NCT02218463|Estrogens|estrogens|mesh-ancestor
153364674|NCT02218463|Hormones|hormones|mesh-ancestor
153824705|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824706|NCT00499005|Carbetocin|carbetocin|mesh-list
153824707|NCT00499005|Oxytocin|oxytocin|mesh-list
153824708|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
153824709|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153824710|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824711|NCT00491946|Dactinomycin|dactinomycin|mesh-list
153364675|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364676|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824718|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408419|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153408420|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824719|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824720|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824721|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153824722|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153824723|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831787|NCT03241732|Expectorants|expectorants|mesh-ancestor
153824786|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824787|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824803|NCT04130776|Kallikreins|kallikreins|mesh-list
153364814|NCT03401606|Remifentanil|remifentanil|mesh-list
153364815|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153364816|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824850|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153824851|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153364877|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364878|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364888|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153364889|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153364890|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153364891|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364892|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824961|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
153824962|NCT00593164|Analgesics|analgesics|mesh-ancestor
153824963|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
153824964|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824975|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153824977|NCT01316107|Nateglinide|nateglinide|mesh-list
153824978|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153824979|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824980|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824981|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824982|NCT05654194|Azacitidine|azacitidine|mesh-list
153824983|NCT05654194|Venetoclax|venetoclax|mesh-list
153824984|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153824985|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
153824986|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824987|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824988|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364956|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
153825190|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810783|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825191|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825192|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825193|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153825195|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153365190|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153365191|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
153365192|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
153825253|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153825254|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153825255|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
153825256|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
153825257|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831822|NCT03151005|Metformin|metformin|mesh-list
153825261|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825262|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153365262|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365263|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153814871|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365264|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153365265|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153825286|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153825287|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153825288|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365311|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153825322|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825323|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825324|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153825325|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
153825326|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825327|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
153825328|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825367|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153825391|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825392|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825393|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153825394|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
153825395|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153825397|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408454|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
153825398|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825399|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153825400|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153825401|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
153825402|NCT00500253|Protective Agents|protective agents|mesh-ancestor
153825404|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153825405|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153825718|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153825720|NCT04697732|Anesthetics|anesthetics|mesh-list
153825721|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825722|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409668|NCT02976727|Lidocaine|lidocaine|mesh-list
153825723|NCT00501267|Oxybutynin|oxybutynin|mesh-list
153825724|NCT00501267|Solabegron|solabegron|mesh-list
153825725|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
153825770|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153825771|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825772|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
153825773|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153825774|NCT00599287|Protective Agents|protective agents|mesh-ancestor
153825775|NCT04326166|Metformin|metformin|mesh-list
153825776|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153825777|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825778|NCT00501384|Satavaptan|satavaptan|mesh-list
153825779|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153825780|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825781|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
153825782|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825783|NCT00599560|Vasopressins|vasopressins|mesh-list
153825907|NCT00501579|Prednisolone|prednisolone|mesh-list
153825908|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153825909|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
153825910|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153825911|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
153365884|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153365885|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365886|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
153365887|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365889|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365890|NCT00942578|Prednisone|prednisone|mesh-list
153365891|NCT00942578|Bevacizumab|bevacizumab|mesh-list
153365892|NCT00942578|Lenalidomide|lenalidomide|mesh-list
153365893|NCT00942578|Docetaxel|docetaxel|mesh-list
153365894|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365895|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365896|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153365897|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153365898|NCT00942578|Growth Substances|growth substances|mesh-ancestor
153366005|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366006|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826092|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153826093|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
154256885|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154256886|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256887|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256888|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256889|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256890|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256891|NCT01269866|Analgesics|analgesics|mesh-ancestor
154256892|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
154256893|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364603|NCT01725542|Asunaprevir|asunaprevir|mesh-list
153826094|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153366098|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366099|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
153366100|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153366101|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153366102|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153366103|NCT01703039|Protective Agents|protective agents|mesh-ancestor
153366109|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
153366110|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366111|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153366112|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153366113|NCT02158520|Paclitaxel|paclitaxel|mesh-list
153366114|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153366115|NCT02158520|Bevacizumab|bevacizumab|mesh-list
153366116|NCT02158520|Ipilimumab|ipilimumab|mesh-list
153366117|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153371945|NCT01355588|Ketorolac|ketorolac|mesh-list
153826168|NCT01246362|Analgesics|analgesics|mesh-ancestor
153826169|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
153826170|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826171|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826172|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826173|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153826174|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153826175|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153826176|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826177|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826178|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
153826179|NCT00470405|Pemetrexed|pemetrexed|mesh-list
153366192|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153366193|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
153366194|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366196|NCT01620047|Ropivacaine|ropivacaine|mesh-list
153366197|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
153366198|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
153366199|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831891|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366201|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
153366202|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366227|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366228|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366229|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153366230|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153366231|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
153366232|NCT01661621|Urological Agents|urological agents|mesh-ancestor
153366233|NCT01620593|Metformin|metformin|mesh-list
153366234|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153366235|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366236|NCT00939536|Zolpidem|zolpidem|mesh-list
153366237|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153366238|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153366239|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366240|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366272|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
153826287|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
153366284|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153366285|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366286|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
153366287|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366288|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366289|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153867993|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867994|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867995|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153867996|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153460260|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153595393|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
153595394|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153595395|NCT01856127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153595396|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153595397|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153595398|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595399|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595400|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
153595401|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595402|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153595403|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153595404|NCT01856166|Sufentanil|sufentanil|mesh-list
153366290|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153366291|NCT02777372|Sertraline|sertraline|mesh-list
153366373|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366374|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
153366375|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826384|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826385|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153826386|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153826387|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826388|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153826389|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153826390|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153826391|NCT00470990|Acyline|acyline|mesh-list
153366403|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153366404|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
153366405|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153366406|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153366407|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153366408|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366409|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366410|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
153366411|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366412|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826534|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153826541|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153826542|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826543|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
153826544|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826545|NCT01244217|Fexofenadine|fexofenadine|mesh-list
153810784|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868017|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153868018|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153826546|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153826558|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826559|NCT00494559|Pioglitazone|pioglitazone|mesh-list
153826560|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153826561|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826625|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153826626|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826656|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153826657|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153826658|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153366674|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153366675|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153366676|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366677|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366679|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153366680|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366681|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153366682|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153366683|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153832023|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366687|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366688|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366703|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
153366705|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153366706|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153366707|NCT01015586|Lamotrigine|lamotrigine|mesh-list
153366708|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
153366709|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153366710|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366711|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366712|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153366713|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366714|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153366715|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153366716|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366717|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153366718|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153366719|NCT01676831|Resiquimod|resiquimod|mesh-list
153826712|NCT00477035|Vinorelbine|vinorelbine|mesh-list
153826713|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153826714|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
153826715|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826716|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153826717|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153826718|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
153826719|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826720|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826721|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153826722|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826723|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
153826724|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153826725|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153826726|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153826727|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826728|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
153826729|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
153826730|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
153826731|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
153826732|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153826782|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826783|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826784|NCT05645302|Lidocaine|lidocaine|mesh-list
153826785|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
153826786|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
153826787|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153826788|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826867|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826868|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153826869|NCT00503607|Laxatives|laxatives|mesh-ancestor
153826871|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
153826872|NCT00477503|Gallium citrate|gallium citrate|mesh-list
153826873|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
153826874|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
153826875|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826876|NCT00477503|Antidotes|antidotes|mesh-ancestor
153826877|NCT00477503|Protective Agents|protective agents|mesh-ancestor
153826878|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826879|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153826880|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153366868|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153366869|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
153366870|NCT01685411|Protective Agents|protective agents|mesh-ancestor
153366871|NCT02243813|Psilocybin|psilocybin|mesh-list
153372170|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
153372171|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153868031|NCT00584493|Tremelimumab|tremelimumab|mesh-list
153868032|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868033|NCT04580342|Propranolol|propranolol|mesh-list
153868034|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153868035|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153366939|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
153366940|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366941|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366942|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366943|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153366944|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153826971|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366962|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153366964|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
153366965|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366966|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366967|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
153826973|NCT00477893|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153826979|NCT01247337|Cetuximab|cetuximab|mesh-list
153827019|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153827020|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
153827021|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827022|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827023|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
153827024|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153827025|NCT01247493|Cytarabine|cytarabine|mesh-list
153367015|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367016|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153367017|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
153367018|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
153367019|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
153367020|NCT01689779|Vitamin D|vitamin d|mesh-list
153367021|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
153367022|NCT01689779|Vitamins|vitamins|mesh-ancestor
153367023|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
153367024|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367025|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153367026|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153367027|NCT05388500|Paclitaxel|paclitaxel|mesh-list
153367028|NCT05388500|Trastuzumab|trastuzumab|mesh-list
153367029|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153367030|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408557|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408558|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408559|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153367031|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
153367032|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
153367033|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
153367034|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367035|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153367036|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153827037|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153827038|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153827039|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153827040|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827041|NCT04325425|Carboplatin|carboplatin|mesh-list
153827042|NCT04325425|Etoposide|etoposide|mesh-list
153827043|NCT04325425|Folfirinox|folfirinox|mesh-list
153827044|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827045|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153827046|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153827047|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153827107|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827108|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
153827109|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
153827110|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
153827111|NCT00478946|Leucovorin|leucovorin|mesh-list
153367128|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153367129|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367131|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
153367132|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367133|NCT02161484|Bupivacaine|bupivacaine|mesh-list
153367134|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
153367135|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
153367136|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367137|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367138|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
153827244|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827246|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
153827247|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827248|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
153827249|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827250|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153827251|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153827252|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153827253|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153827254|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827255|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827256|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357381|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868070|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868071|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153868072|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153827257|NCT00479726|Analgesics|analgesics|mesh-ancestor
153827258|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
153827260|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
153827261|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153367251|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367252|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367253|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153827330|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153827331|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153827332|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827333|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
153827334|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827335|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827336|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153827337|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367360|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153367361|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153367362|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367363|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367427|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367429|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
153367430|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367431|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367432|NCT01005290|Ramipril|ramipril|mesh-list
153367433|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153367434|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
153827441|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
153827443|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153827444|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153827445|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
153827446|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153827447|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827448|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153827449|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153367553|NCT03014882|Protective Agents|protective agents|mesh-ancestor
153367554|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367555|NCT03014882|Antidotes|antidotes|mesh-ancestor
153868098|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153868099|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
153868100|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153868101|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868102|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153868103|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153868104|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153868105|NCT00584610|Trace Elements|trace elements|mesh-ancestor
153595405|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
153595406|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153367556|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153367557|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
153367558|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153827543|NCT00480272|Hormones|hormones|mesh-ancestor
153827544|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827545|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827546|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153827547|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827579|NCT00482222|Leucovorin|leucovorin|mesh-list
153827580|NCT00482222|Capecitabine|capecitabine|mesh-list
153827581|NCT00482222|Fluorouracil|fluorouracil|mesh-list
153827582|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
153827583|NCT00482222|Cetuximab|cetuximab|mesh-list
153827798|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153827799|NCT00482573|Anesthetics|anesthetics|mesh-list
153827800|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827801|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367793|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367794|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367795|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153367796|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153367797|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
153367798|NCT03015818|Calcium|calcium|mesh-list
153367799|NCT03015818|Fluorides|fluorides|mesh-list
153827814|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
153832234|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827880|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827881|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
153827908|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827909|NCT01308736|Varenicline|varenicline|mesh-list
153827910|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153827911|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153827912|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
153827913|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827921|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827923|NCT00483054|Nevirapine|nevirapine|mesh-list
153827959|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827960|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827968|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827969|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153827970|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153827971|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827972|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827995|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827996|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153832260|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
153898592|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
153898593|NCT01263704|Rituximab|rituximab|mesh-list
153439920|NCT00003595|Hormones|hormones|mesh-ancestor
153439933|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439934|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439936|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439937|NCT00003079|Cytarabine|cytarabine|mesh-list
153814891|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
153439938|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
153439939|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439940|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
153898650|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898651|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898652|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153898653|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
153898654|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
153898656|NCT00932893|Pemetrexed|pemetrexed|mesh-list
153898657|NCT00932893|Crizotinib|crizotinib|mesh-list
153898658|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898659|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
153898660|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
153898661|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439986|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439988|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439990|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
153439991|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153439992|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153439993|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153439994|NCT00002881|Leuprolide|leuprolide|mesh-list
153439995|NCT00002881|Goserelin|goserelin|mesh-list
153439996|NCT00002881|Flutamide|flutamide|mesh-list
153439997|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439998|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153439999|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
153440000|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153440001|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440002|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153440003|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440004|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
153440005|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
153810786|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153868107|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
153868108|NCT00571298|Gemcitabine|gemcitabine|mesh-list
153868109|NCT00571298|Amifostine|amifostine|mesh-list
153868110|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868111|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153868112|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
153868113|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595407|NCT01856166|Narcotics|narcotics|mesh-ancestor
153595408|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595409|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440006|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153440007|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
153440022|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153440024|NCT00003619|Cytarabine|cytarabine|mesh-list
153440025|NCT00003619|Fludarabine|fludarabine|mesh-list
153832310|NCT00507975|Nicotine|nicotine|mesh-list
153898742|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
153898743|NCT00608335|Micafungin|micafungin|mesh-list
153898744|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
153898745|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898746|NCT00927589|Carboplatin|carboplatin|mesh-list
153898747|NCT00927589|Docetaxel|docetaxel|mesh-list
153898748|NCT00927589|Trastuzumab|trastuzumab|mesh-list
153898749|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898750|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
153898751|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
153898752|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
153898753|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898754|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153440085|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153440086|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440087|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440088|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
153440089|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440090|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153440091|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440092|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
153440114|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
153898811|NCT05937490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153440148|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440149|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440150|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440152|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
153440153|NCT00003955|Irinotecan|irinotecan|mesh-list
153440154|NCT00003955|Vincristine|vincristine|mesh-list
153814894|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153814895|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153868129|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814897|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
153440155|NCT00003955|Sargramostim|sargramostim|mesh-list
153440156|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440157|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
153440158|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440159|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440160|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440161|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
153440162|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898824|NCT05937191|Immunologic Factors|immunologic factors|mesh-ancestor
153440231|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
153440233|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153440234|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153440235|NCT00003661|Protective Agents|protective agents|mesh-ancestor
153440236|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440237|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440238|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
153440239|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440240|NCT00003967|Etoposide|etoposide|mesh-list
153440241|NCT00003967|Topotecan|topotecan|mesh-list
153440242|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153898935|NCT05793632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153898936|NCT05793632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153898937|NCT05793632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153898938|NCT05793632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898939|NCT05793632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899056|NCT04268498|Lenalidomide|lenalidomide|mesh-list
153899057|NCT04268498|Bortezomib|bortezomib|mesh-list
153899058|NCT04268498|Daratumumab|daratumumab|mesh-list
153899059|NCT04268498|Montelukast|montelukast|mesh-list
153899060|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153899061|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
153899062|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
153899063|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899064|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832367|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
153440455|NCT00004039|Doxorubicin|doxorubicin|mesh-list
153440456|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153440457|NCT00004039|Vincristine|vincristine|mesh-list
153440458|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440459|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
153440460|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440461|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153899110|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899111|NCT04098432|Nivolumab|nivolumab|mesh-list
153440471|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440472|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153440473|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
153440475|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153440476|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153814898|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440477|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
153440478|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440479|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440480|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440481|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440482|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440483|NCT00003151|Amoxicillin|amoxicillin|mesh-list
153440484|NCT00003151|Metronidazole|metronidazole|mesh-list
153440485|NCT00003151|Clarithromycin|clarithromycin|mesh-list
153899143|NCT03637764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153899144|NCT03637764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899145|NCT03637764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899146|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899147|NCT06268912|Mepivacaine|mepivacaine|mesh-list
153899148|NCT06268912|Anesthetics, Local|anesthetics, local|mesh-ancestor
153899149|NCT06268912|Anesthetics|anesthetics|mesh-ancestor
153899150|NCT06268912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899151|NCT06268912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899152|NCT06268912|Sensory System Agents|sensory system agents|mesh-ancestor
153899153|NCT06268912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899154|NCT06268873|Dapagliflozin|dapagliflozin|mesh-list
153899155|NCT06268873|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153440497|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440498|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440499|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153440500|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153440501|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153440503|NCT00004045|Exatecan|exatecan|mesh-list
153440504|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440505|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440506|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440507|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440508|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595410|NCT01856166|Analgesics|analgesics|mesh-ancestor
153595411|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
153595412|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595413|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153595414|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153595415|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
153595416|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
153595417|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
153595418|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
153595419|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153595420|NCT01856205|Antibodies|antibodies|mesh-list
153595421|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
153595422|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153595423|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
153595424|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595425|NCT01856283|Nilotinib|nilotinib|mesh-list
153595426|NCT01856283|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153595427|NCT01856283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153595428|NCT01856283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595429|NCT01856283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595430|NCT01856348|Vitamin D|vitamin d|mesh-list
153595431|NCT01856348|Vitamins|vitamins|mesh-ancestor
153595432|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
153440509|NCT00003715|Interferons|interferons|mesh-list
153440510|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
153440511|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
153440512|NCT00003715|Vaccines|vaccines|mesh-list
153440513|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
153440514|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
153440515|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440516|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440517|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440518|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153899163|NCT06268769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153899164|NCT06268769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899165|NCT06268769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440548|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440549|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440550|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
153440551|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440552|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440553|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440554|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440555|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
153440556|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899229|NCT06268457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153899230|NCT06268457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153595433|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595434|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153408656|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408657|NCT05369364|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153408658|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408659|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408660|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408661|NCT00361244|Irinotecan|irinotecan|mesh-list
153408662|NCT00361244|Cetuximab|cetuximab|mesh-list
153408663|NCT00361244|Sunitinib|sunitinib|mesh-list
153408664|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153408665|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153408667|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408668|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899231|NCT06268457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899232|NCT06268457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899233|NCT06268431|Oxytocin|oxytocin|mesh-list
153440563|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440564|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440565|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440566|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440567|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440568|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440569|NCT00004063|Interferons|interferons|mesh-list
153440570|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
153440571|NCT00004063|Gemcitabine|gemcitabine|mesh-list
153814899|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440572|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440573|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440575|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440576|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
153440577|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440578|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
153440579|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440580|NCT00003733|Paclitaxel|paclitaxel|mesh-list
153899253|NCT06268301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153440585|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440586|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440587|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440588|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440589|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440590|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440591|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440592|NCT00003739|Lenograstim|lenograstim|mesh-list
153899271|NCT06268210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899272|NCT06268210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914656|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440605|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440606|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
153440607|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440608|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440609|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440610|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
153440611|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440612|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357384|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
153440613|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440614|NCT00004081|Docetaxel|docetaxel|mesh-list
153440615|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440616|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440617|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440618|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440619|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440620|NCT00003751|Penicillamine|penicillamine|mesh-list
153440621|NCT00003751|Antidotes|antidotes|mesh-ancestor
153440622|NCT00003751|Protective Agents|protective agents|mesh-ancestor
153440623|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440624|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
153440625|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
153440626|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440627|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440663|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
153899313|NCT06267820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153899314|NCT06267820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899315|NCT06267820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899316|NCT06267794|Pirfenidone|pirfenidone|mesh-list
153899317|NCT06267794|Analgesics|analgesics|mesh-ancestor
153440668|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
153440669|NCT00003763|Vitamins|vitamins|mesh-ancestor
153440670|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
153440671|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440672|NCT00003181|Aldesleukin|aldesleukin|mesh-list
153440673|NCT00003181|Vinblastine|vinblastine|mesh-list
153440674|NCT00003181|Sargramostim|sargramostim|mesh-list
153440675|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
153440676|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440677|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440678|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153440679|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153440681|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440682|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440683|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440684|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440685|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440686|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440687|NCT00004105|Paclitaxel|paclitaxel|mesh-list
153440688|NCT00004105|Vinorelbine|vinorelbine|mesh-list
153440689|NCT00004105|Estramustine|estramustine|mesh-list
153832532|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899368|NCT06267053|Vitamins|vitamins|mesh-list
153899369|NCT06267053|Folic Acid|folic acid|mesh-list
153899370|NCT06267053|Vitamin B 12|vitamin b 12|mesh-list
154256903|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256904|NCT03871322|Vitamin D|vitamin d|mesh-list
154256905|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
154256906|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
153868155|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
154256907|NCT03871322|Vitamins|vitamins|mesh-list
154256908|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
154256909|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256910|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153364864|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153899371|NCT06267053|Micronutrients|micronutrients|mesh-ancestor
153440709|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440710|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
153440711|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440712|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440713|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440714|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153440715|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
153440716|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153899392|NCT06266962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899393|NCT06266962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899394|NCT06266962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153899395|NCT06266962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153899397|NCT06266962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899398|NCT06266962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153899399|NCT06266962|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899400|NCT06266962|Mydriatics|mydriatics|mesh-ancestor
153440740|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440741|NCT00003775|Leflunomide|leflunomide|mesh-list
153440742|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832583|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
153899402|NCT06266962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153899403|NCT06266962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153899404|NCT06266962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153899405|NCT06266962|Parasympatholytics|parasympatholytics|mesh-ancestor
153899406|NCT06266962|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153899407|NCT06266962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153899408|NCT06266962|Cholinergic Agents|cholinergic agents|mesh-ancestor
153899409|NCT06266871|Tislelizumab|tislelizumab|mesh-list
153899413|NCT06266832|Oxaliplatin|oxaliplatin|mesh-list
153899414|NCT06266832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153899415|NCT06266832|Antimetabolites|antimetabolites|mesh-ancestor
153372686|NCT01372202|Paclitaxel|paclitaxel|mesh-list
153899438|NCT06265870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899439|NCT06265870|Anthelmintics|anthelmintics|mesh-ancestor
153899440|NCT06265870|Anticestodal Agents|anticestodal agents|mesh-ancestor
153832638|NCT01248611|Fentanyl|fentanyl|mesh-list
153899465|NCT06263816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153899466|NCT06263816|Adrenergic Agents|adrenergic agents|mesh-ancestor
153899467|NCT06263816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868166|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
153868167|NCT02883595|Thymalfasin|thymalfasin|mesh-list
153868168|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153868169|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
153868170|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868171|NCT01143259|Alvimopan|alvimopan|mesh-list
153899468|NCT06263816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899498|NCT06238245|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153899499|NCT06238245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153899500|NCT06238245|Immunologic Factors|immunologic factors|mesh-ancestor
153899501|NCT06238245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899502|NCT06238245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153899511|NCT06233864|Antimetabolites|antimetabolites|mesh-ancestor
153899512|NCT06233864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899513|NCT06233864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899514|NCT06233864|Immunoconjugates|immunoconjugates|mesh-ancestor
153899515|NCT06233864|Immunologic Factors|immunologic factors|mesh-ancestor
153899516|NCT06233864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899517|NCT06221735|Interferon-beta|interferon-beta|mesh-list
153899518|NCT06221735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899519|NCT06221735|Antiviral Agents|antiviral agents|mesh-ancestor
153899520|NCT06221735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899521|NCT06221735|Immunologic Factors|immunologic factors|mesh-ancestor
153899522|NCT06221735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899523|NCT06210334|Lenvatinib|lenvatinib|mesh-list
153899524|NCT06210334|Tislelizumab|tislelizumab|mesh-list
153899525|NCT06210334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899526|NCT06210334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153899527|NCT06210334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899528|NCT06210334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899529|NCT06210334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899530|NCT06202495|Fluorides|fluorides|mesh-list
153899531|NCT06202495|Cariostatic Agents|cariostatic agents|mesh-ancestor
153899532|NCT06202495|Protective Agents|protective agents|mesh-ancestor
153899533|NCT06202495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899534|NCT06192082|Anesthetics|anesthetics|mesh-list
153899552|NCT06191692|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153899553|NCT06191692|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153899554|NCT06191692|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153899555|NCT06191692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153899556|NCT06191692|Antimetabolites|antimetabolites|mesh-ancestor
153899557|NCT06191692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153899558|NCT06185218|Botulinum Toxins|botulinum toxins|mesh-list
153899559|NCT06185218|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153440928|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
153440929|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899560|NCT06185218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153899561|NCT06185218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899562|NCT06185218|Cholinergic Agents|cholinergic agents|mesh-ancestor
153899563|NCT06185218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899564|NCT06185218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899587|NCT06155981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408682|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408683|NCT04968522|Methylphenidate|methylphenidate|mesh-list
153899588|NCT06155981|Sensory System Agents|sensory system agents|mesh-ancestor
153372820|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
153440967|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440968|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440969|NCT00003223|Fenretinide|fenretinide|mesh-list
153440971|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440972|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153899654|NCT06112353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441038|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
153441039|NCT00385021|Antidotes|antidotes|mesh-ancestor
153441053|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899695|NCT06039137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814902|NCT00344006|Artesunate|artesunate|mesh-list
153899696|NCT06039137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899697|NCT06019507|Mycophenolic Acid|mycophenolic acid|mesh-list
153899698|NCT06019507|Cyclophosphamide|cyclophosphamide|mesh-list
153899699|NCT06019507|Tacrolimus|tacrolimus|mesh-list
153899700|NCT06019507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153899701|NCT06019507|Immunologic Factors|immunologic factors|mesh-ancestor
153899702|NCT06019507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899703|NCT06019507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153899704|NCT06019507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153899705|NCT06019507|Alkylating Agents|alkylating agents|mesh-ancestor
153899706|NCT06019507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899707|NCT06019507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899708|NCT06019507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153899709|NCT06019507|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153899710|NCT06019507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441107|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441108|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
153899743|NCT05949099|Nirogacestat|nirogacestat|mesh-list
153899744|NCT05949099|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153899745|NCT05949099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899746|NCT05949099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899747|NCT05944016|Dapagliflozin|dapagliflozin|mesh-list
153899748|NCT05944016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153899749|NCT05944016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899750|NCT05944016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153899751|NCT05944016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441109|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441110|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441129|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153810788|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441130|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441131|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153441132|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153441133|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153441135|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
153441136|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441137|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441138|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441139|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441154|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441155|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441156|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153899807|NCT05870917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899808|NCT05870917|Immunologic Factors|immunologic factors|mesh-ancestor
153441167|NCT00003259|Vinorelbine|vinorelbine|mesh-list
153441168|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441169|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441170|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441171|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441172|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441267|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153441268|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153441269|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
153441270|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
153441271|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373069|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
153441307|NCT00004861|Tacedinaline|tacedinaline|mesh-list
153441308|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441309|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
153441310|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441311|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441312|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153441353|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733418|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733419|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733420|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153733421|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153595450|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595451|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595452|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153595453|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595454|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153595455|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
153595456|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
153595457|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
153595458|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595459|NCT01856517|Clonidine|clonidine|mesh-list
153595460|NCT01856517|Analgesics|analgesics|mesh-ancestor
153595461|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
153595462|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595463|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595464|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153595465|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
153410629|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153899982|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899983|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153899987|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899988|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153899989|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833117|NCT01243658|Oxytocin|oxytocin|mesh-list
153900003|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900004|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153900005|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153733422|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733423|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153733424|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153733426|NCT05148403|Glyburide|glyburide|mesh-list
153733427|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153900006|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900007|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153595466|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
153595469|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153868177|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868178|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868179|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868180|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
153868181|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868182|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868187|NCT00572078|Sorafenib|sorafenib|mesh-list
153595488|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595489|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
153595490|NCT01856621|Antidotes|antidotes|mesh-ancestor
153460269|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460270|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460271|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460272|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460273|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595491|NCT01856621|Protective Agents|protective agents|mesh-ancestor
153595493|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153900008|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153900009|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
153900010|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
153900011|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900012|NCT05637086|Phenytoin|phenytoin|mesh-list
153900013|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
153900014|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153441386|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441387|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441388|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441389|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441390|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
153441391|NCT00003331|Antidotes|antidotes|mesh-ancestor
153441392|NCT00003331|Protective Agents|protective agents|mesh-ancestor
153441393|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
153441394|NCT00003331|Vitamins|vitamins|mesh-ancestor
153441395|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
153441396|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153900015|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900016|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900017|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153900018|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153900019|NCT05637086|Protective Agents|protective agents|mesh-ancestor
153900020|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900021|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
153900022|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153900024|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
153900025|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153814911|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153814912|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900026|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153408696|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
153810789|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408697|NCT00361322|Salicylates|salicylates|mesh-list
153408698|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153408699|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408700|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153595494|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595495|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595496|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
153595497|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595498|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595499|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153595500|NCT01856738|Protective Agents|protective agents|mesh-ancestor
153595501|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
153595502|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153595503|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
153595504|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595505|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153595506|NCT01856946|Vitamin D|vitamin d|mesh-list
153595507|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
153595509|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
153900027|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153900028|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153900029|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153900030|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153900031|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153833142|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833143|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153900043|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900051|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900053|NCT05610163|Protective Agents|protective agents|mesh-ancestor
153900066|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900067|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
153441442|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441443|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
153441444|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
153441447|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
153441448|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
153441449|NCT00004903|Melphalan|melphalan|mesh-list
153441450|NCT00004903|Etoposide|etoposide|mesh-list
153441451|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441452|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
153441453|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441454|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441455|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153441456|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
153441457|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441458|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441459|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153868192|NCT00572312|Atorvastatin|atorvastatin|mesh-list
153595510|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595516|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
153595517|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595518|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595519|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
153595520|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595521|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153595522|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
153441460|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441461|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441462|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153373204|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373205|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
153900072|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900073|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
153900074|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900075|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
153900076|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
153900085|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900086|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153441465|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441466|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441467|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
153441468|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
153441469|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153441470|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153441471|NCT00004357|Prednisolone|prednisolone|mesh-list
153441472|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
153441473|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153441474|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
153441475|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153441476|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
153441477|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
153441478|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441479|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441480|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441481|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
153441482|NCT00004357|Hormones|hormones|mesh-ancestor
153441483|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441484|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153441485|NCT00004357|Protective Agents|protective agents|mesh-ancestor
153868215|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153595523|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153595524|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153595525|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595526|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153595527|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
153595528|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153441486|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153441487|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441488|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
153441489|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153441490|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
153441491|NCT00004363|Coagulants|coagulants|mesh-ancestor
153441492|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153441493|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
153441494|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441495|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153441496|NCT04069117|Letrozole|letrozole|mesh-list
153441499|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153441500|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900106|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
153900107|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
153900108|NCT05424003|Semaglutide|semaglutide|mesh-list
153900109|NCT05424003|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153900110|NCT05424003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153900111|NCT05424003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900112|NCT05397964|Calcium|calcium|mesh-list
153900113|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153900114|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900115|NCT05393804|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
153900116|NCT05393804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900117|NCT05393804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900118|NCT05384015|Carboplatin|carboplatin|mesh-list
153900119|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
153900120|NCT05384015|Etoposide|etoposide|mesh-list
153900121|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
153900122|NCT05384015|Lenvatinib|lenvatinib|mesh-list
153900123|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900124|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900125|NCT05384015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153441501|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810790|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357388|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
153595529|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153595530|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
153460274|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460275|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460276|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
153460277|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460278|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460279|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
153460280|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460281|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153460282|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
153460283|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460284|NCT03861767|Metformin|metformin|mesh-list
153460285|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153460286|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460287|NCT03756298|Capecitabine|capecitabine|mesh-list
153460288|NCT03756298|Atezolizumab|atezolizumab|mesh-list
153460289|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460290|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
153441503|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
153441504|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441505|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441506|NCT00004921|Paclitaxel|paclitaxel|mesh-list
153441507|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
153900146|NCT05303792|Doxorubicin|doxorubicin|mesh-list
153900147|NCT05303792|Methotrexate|methotrexate|mesh-list
153900148|NCT05303792|Vincristine|vincristine|mesh-list
153900149|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
153900150|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153900151|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441557|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153441558|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900153|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900154|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900155|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153900156|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
153900157|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900158|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900159|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153900160|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153900161|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
153900162|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
153833202|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900191|NCT05303792|Immunoconjugates|immunoconjugates|mesh-ancestor
153733428|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373258|NCT01794143|Incretins|incretins|mesh-ancestor
153441586|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441587|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
153810793|NCT00352092|Sirolimus|sirolimus|mesh-list
153810794|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153868220|NCT00572390|Hormones|hormones|mesh-ancestor
153868221|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441588|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441590|NCT00003385|Carboplatin|carboplatin|mesh-list
153441591|NCT00003385|Doxorubicin|doxorubicin|mesh-list
153441592|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153441593|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441600|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441601|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441602|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441603|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153900211|NCT05205109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900212|NCT05205109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153900213|NCT05205109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900214|NCT05174507|Empagliflozin|empagliflozin|mesh-list
153900215|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153900216|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153900217|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833222|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
153900254|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900255|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153900256|NCT05100264|Protective Agents|protective agents|mesh-ancestor
153900257|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900258|NCT05089734|Docetaxel|docetaxel|mesh-list
153900259|NCT05089734|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153900260|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900261|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900262|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
153900263|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
153900264|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441640|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
153441641|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153441642|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441643|NCT00005017|Ritonavir|ritonavir|mesh-list
153441644|NCT00005017|Amprenavir|amprenavir|mesh-list
153441645|NCT00005017|Lamivudine|lamivudine|mesh-list
153441646|NCT00005017|Abacavir|abacavir|mesh-list
153441647|NCT00005017|Stavudine|stavudine|mesh-list
153441648|NCT00005017|Efavirenz|efavirenz|mesh-list
153441649|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153441650|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153900275|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153900276|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900277|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900278|NCT04998903|Dimercaprol|dimercaprol|mesh-list
153900279|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
153900280|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
153900281|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408742|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153408746|NCT04818450|Gabapentin|gabapentin|mesh-list
153460291|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460292|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460293|NCT03756298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460294|NCT03756298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153595537|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595539|NCT01856985|Mifepristone|mifepristone|mesh-list
153595540|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153595541|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
153595542|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153595543|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595544|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153900301|NCT04939090|Megestrol|megestrol|mesh-list
153900302|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
153900303|NCT04939090|Olanzapine|olanzapine|mesh-list
153900304|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
153900305|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
153900306|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441680|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
153441681|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441682|NCT00004429|Hormones|hormones|mesh-list
153900324|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153900325|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153900326|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900327|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900328|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
153900331|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900332|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900333|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
153900334|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900340|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
153900341|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900342|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153900343|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900344|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900345|NCT04914676|Cytarabine|cytarabine|mesh-list
153900346|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900347|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
153900348|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900349|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441772|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
153441773|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441774|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
153357391|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441775|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441776|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153441777|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153373348|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
153441799|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441800|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441801|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
153441802|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441803|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900406|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900407|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153900409|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153900410|NCT04736199|Androgens|androgens|mesh-list
153900411|NCT04736199|Hormones|hormones|mesh-ancestor
153900412|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900413|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900497|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153900498|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
153900499|NCT04569032|Hormones|hormones|mesh-ancestor
153441883|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441884|NCT00004573|Ganciclovir|ganciclovir|mesh-list
153441885|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153441886|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
153441887|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441888|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153441889|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441890|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441891|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
153441892|NCT00005623|Cyproterone|cyproterone|mesh-list
153441893|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
153441894|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
153441895|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441896|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441897|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441898|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153441899|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
153441900|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153441902|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153441903|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441904|NCT00004585|Lamivudine|lamivudine|mesh-list
153441905|NCT00004585|Zidovudine|zidovudine|mesh-list
153441906|NCT00004585|Efavirenz|efavirenz|mesh-list
153441907|NCT00004585|Abacavir|abacavir|mesh-list
153441908|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
153441909|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153441910|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153441911|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153441912|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441913|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441914|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
153441915|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441916|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153441917|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153441918|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
153441920|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153441921|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153900520|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
153900521|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900522|NCT04457596|Immunotoxins|immunotoxins|mesh-ancestor
153900523|NCT04457596|Immunoconjugates|immunoconjugates|mesh-ancestor
153900524|NCT04457596|Immunologic Factors|immunologic factors|mesh-ancestor
153900525|NCT04457596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900526|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900527|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900529|NCT04428307|Artemisinin|artemisinin|mesh-list
153900530|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
153900531|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153900532|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153900533|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900535|NCT04424225|Psilocybin|psilocybin|mesh-list
153900536|NCT04424225|Vitamins|vitamins|mesh-ancestor
153900537|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
153900538|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900539|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
153900549|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900550|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900551|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
153810796|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900552|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810797|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153900554|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153900555|NCT04404283|Lenalidomide|lenalidomide|mesh-list
153900556|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900557|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833411|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
153441983|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441984|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
153373481|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373482|NCT01833845|Ribavirin|ribavirin|mesh-list
153900572|NCT04340141|Leucovorin|leucovorin|mesh-list
153900573|NCT04340141|Fluorouracil|fluorouracil|mesh-list
153900574|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
153900575|NCT04340141|Irinotecan|irinotecan|mesh-list
153900576|NCT04340141|Calcium|calcium|mesh-list
153900577|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
153900578|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153900579|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900580|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
153900581|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900582|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900583|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900584|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900585|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
153900586|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153900587|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153900588|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900589|NCT04340141|Antidotes|antidotes|mesh-ancestor
153900590|NCT04340141|Protective Agents|protective agents|mesh-ancestor
153900591|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
153900592|NCT04340141|Vitamins|vitamins|mesh-ancestor
153900593|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
153900594|NCT04224545|Colchicine|colchicine|mesh-list
153900595|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
153900596|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900597|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900598|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
153900599|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
153833450|NCT02955641|Analgesics|analgesics|mesh-ancestor
153442023|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442024|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153442025|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153442027|NCT00004747|Antibodies|antibodies|mesh-list
153442028|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
153442029|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153442030|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153900626|NCT04165590|Immunomodulating Agents|immunomodulating agents|mesh-list
153900627|NCT04165590|Immunologic Factors|immunologic factors|mesh-ancestor
153900628|NCT04165590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900629|NCT04098874|Bupropion|bupropion|mesh-list
153900630|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153411022|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
154256924|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154256925|NCT03871478|Lidocaine|lidocaine|mesh-list
154256926|NCT03871478|Bupivacaine|bupivacaine|mesh-list
154256927|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
154256928|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
154256929|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256930|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256931|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
154256932|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256933|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154256934|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154256935|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154256936|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365057|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
153900631|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
153900632|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153900633|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153900634|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153900635|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153900636|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900637|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
153900638|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900639|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900640|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153900641|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153900642|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900643|NCT04061798|Heparin|heparin|mesh-list
153900644|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
153900645|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153408788|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408789|NCT05330754|Caffeine|caffeine|mesh-list
153408790|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153595545|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153442031|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
153442032|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442034|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153442044|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442045|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442047|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
153442048|NCT00004759|Hormones|hormones|mesh-ancestor
153442049|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153442050|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153442051|NCT00004759|Protective Agents|protective agents|mesh-ancestor
153442052|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153442053|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442054|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
153442055|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442056|NCT00004771|Leuprolide|leuprolide|mesh-list
153442057|NCT00004771|Testosterone|testosterone|mesh-list
153442058|NCT00004771|Androgens|androgens|mesh-ancestor
153442059|NCT00004771|Hormones|hormones|mesh-ancestor
153900682|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900683|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900684|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153900685|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
153914659|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153442077|NCT00004807|Donepezil|donepezil|mesh-list
153442078|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153442079|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442080|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442081|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
153442082|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442083|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442088|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442089|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153442090|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153442091|NCT00004807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153442093|NCT00004807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442094|NCT00004807|Analgesics|analgesics|mesh-ancestor
153595546|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
153595547|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153595548|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153595549|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153595550|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153595551|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
153595552|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153595553|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153595554|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
153595555|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733430|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153442095|NCT00004807|Sensory System Agents|sensory system agents|mesh-ancestor
153442096|NCT00004807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833507|NCT00514527|Oritavancin|oritavancin|mesh-list
153900711|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
153900712|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900713|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900714|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
153900715|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900716|NCT03801369|Durvalumab|durvalumab|mesh-list
153900717|NCT03801369|Olaparib|olaparib|mesh-list
153900718|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153900719|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
153900720|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153900721|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
153900722|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153373604|NCT04740021|Etoposide|etoposide|mesh-list
153442153|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153442154|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153442155|NCT00005779|Growth Substances|growth substances|mesh-ancestor
153442156|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
153442157|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442158|NCT00005791|Fluorouracil|fluorouracil|mesh-list
153900739|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153900740|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153900741|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
153900742|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900743|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900744|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153900745|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
153900746|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153900747|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153810799|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153357396|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810800|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810801|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408801|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153595556|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
153595557|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153595578|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
153595579|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153900748|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
153900749|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
153900751|NCT03728179|Celecoxib|celecoxib|mesh-list
153900752|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
153900753|NCT03728179|Nivolumab|nivolumab|mesh-list
153900754|NCT03728179|Ipilimumab|ipilimumab|mesh-list
153900755|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900756|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
153900757|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900758|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900759|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153900760|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
153900761|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900762|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900763|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153900764|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900765|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153900766|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153900767|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153900768|NCT03728179|Analgesics|analgesics|mesh-ancestor
153900769|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
153900770|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900771|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153900772|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153900773|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153900777|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
153900778|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153900779|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153900780|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153900782|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153442174|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
153442175|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442176|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153442177|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153442178|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
153442179|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442180|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442181|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153442182|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153442183|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153442184|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153442185|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442186|NCT00005815|Thalidomide|thalidomide|mesh-list
153442187|NCT00005815|Temozolomide|temozolomide|mesh-list
153442188|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153442189|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
153442190|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442191|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442192|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900795|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900796|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
153900797|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900798|NCT03500380|Capecitabine|capecitabine|mesh-list
153900799|NCT03500380|Lapatinib|lapatinib|mesh-list
153900808|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900809|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900810|NCT03406091|Plerixafor|plerixafor|mesh-list
153442201|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
153442202|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
153442203|NCT02132754|MK-4166|mk-4166|mesh-list
153442204|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153442205|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442206|NCT02132754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153442207|NCT02132754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442208|NCT02151786|Lansoprazole|lansoprazole|mesh-list
153442209|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
153442210|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153442211|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153442212|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153411140|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900811|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153900812|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153900813|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
153833613|NCT01243073|Imetelstat|imetelstat|mesh-list
153833614|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
153900816|NCT03401788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900817|NCT03376646|Paclitaxel|paclitaxel|mesh-list
153900827|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153900828|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868316|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900829|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
153900830|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153900831|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153900832|NCT03355482|Prednisolone|prednisolone|mesh-list
153900833|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
153900834|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153900835|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
153442227|NCT02131272|Insulin|insulin|mesh-list
153442228|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153442229|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
153442230|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
153442231|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
153442232|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
153442233|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153442234|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442235|NCT02130882|Benralizumab|benralizumab|mesh-list
153442236|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153442237|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442238|NCT02149836|Ezogabine|ezogabine|mesh-list
153442239|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
153442240|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442241|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442242|NCT02130024|Ranibizumab|ranibizumab|mesh-list
153442243|NCT02130024|Aflibercept|aflibercept|mesh-list
153900857|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
153900858|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153442252|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442254|NCT02105454|Grazoprevir|grazoprevir|mesh-list
153442255|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
153442256|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442257|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
153442258|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442259|NCT02104752|Curcumin|curcumin|mesh-list
153442260|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153442261|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153442262|NCT02104752|Analgesics|analgesics|mesh-ancestor
153442263|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
153442264|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442266|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442267|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153442268|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442269|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373695|NCT02714283|Azithromycin|azithromycin|mesh-list
153900859|NCT03345576|Androgens|androgens|mesh-ancestor
154191155|NCT05945615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810802|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357398|NCT01278134|Ribavirin|ribavirin|mesh-list
153595580|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595581|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595583|NCT01857141|Analgesics|analgesics|mesh-ancestor
153595584|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
153900861|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900862|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900863|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900864|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900865|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
153900866|NCT03327805|Choline|choline|mesh-list
153900867|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
153900868|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153900869|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
153442283|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
153442284|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
153442285|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
153442286|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442287|NCT02127372|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153442288|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153442289|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442290|NCT02125734|Bromides|bromides|mesh-list
153442291|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
153442292|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153442293|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
153900876|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900877|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900878|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
153900879|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
153442307|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442308|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153442310|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
153442311|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
153442316|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153442317|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153442318|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153442319|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153442320|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900917|NCT03150693|Cytarabine|cytarabine|mesh-list
153900918|NCT03150693|Dexamethasone|dexamethasone|mesh-list
153868325|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595585|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595586|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153595587|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153595588|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153595589|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
153595590|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900919|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
153900920|NCT03150693|Rituximab|rituximab|mesh-list
153900921|NCT03150693|Doxorubicin|doxorubicin|mesh-list
153900922|NCT03150693|Methotrexate|methotrexate|mesh-list
153900923|NCT03150693|Vincristine|vincristine|mesh-list
153900924|NCT03150693|Daunorubicin|daunorubicin|mesh-list
153900925|NCT03150693|Asparaginase|asparaginase|mesh-list
153900926|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
153900927|NCT03150693|Thioguanine|thioguanine|mesh-list
153900928|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153900929|NCT03150693|Pegaspargase|pegaspargase|mesh-list
153900930|NCT03150693|Allopurinol|allopurinol|mesh-list
153900931|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900932|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
153900933|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900934|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900935|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153900936|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
153900937|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900938|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900939|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153900940|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153900941|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
153900942|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
153900943|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900944|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153900945|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
153900946|NCT03150693|Hormones|hormones|mesh-ancestor
153900947|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900948|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900949|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900950|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153900951|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153900952|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153900953|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810804|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153357400|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153914660|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
153442350|NCT02100228|Apixaban|apixaban|mesh-list
153442351|NCT02100228|Vitamins|vitamins|mesh-ancestor
153442375|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442376|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442377|NCT02098746|Pioglitazone|pioglitazone|mesh-list
153442378|NCT02098746|Glimepiride|glimepiride|mesh-list
153442379|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153442380|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442381|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153442382|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153442383|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
153900954|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153900955|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
153900956|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153900957|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900958|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
153900959|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
153900960|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153900961|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153442384|NCT02122770|Itraconazole|itraconazole|mesh-list
153442385|NCT02122770|Fluconazole|fluconazole|mesh-list
153442386|NCT02122770|Paclitaxel|paclitaxel|mesh-list
153900962|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
153900963|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900964|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153900965|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900966|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
153900967|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
153900968|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
153900969|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153900970|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
153900971|NCT03150693|Protective Agents|protective agents|mesh-ancestor
153900972|NCT03150693|Immunotoxins|immunotoxins|mesh-ancestor
153900973|NCT03150693|Immunoconjugates|immunoconjugates|mesh-ancestor
153900974|NCT03052608|Crizotinib|crizotinib|mesh-list
153900975|NCT03052608|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153900976|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900977|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900978|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868335|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900979|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900980|NCT03008369|Lenvatinib|lenvatinib|mesh-list
153900997|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900999|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153901000|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901001|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
153901002|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901003|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
153901004|NCT02901899|Guadecitabine|guadecitabine|mesh-list
153901005|NCT02901899|Azacitidine|azacitidine|mesh-list
153901006|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901007|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901008|NCT02901899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153901009|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442454|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
153442455|NCT02120664|Corticosterone|corticosterone|mesh-list
153442456|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901024|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901025|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901026|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
153901027|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901028|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733434|NCT05148169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442457|NCT01627860|Topiramate|topiramate|mesh-list
153901034|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901035|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901036|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
153901037|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901038|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153901039|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153901040|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153901041|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
153901042|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901048|NCT02363335|Incretins|incretins|mesh-ancestor
153901049|NCT02363335|Hormones|hormones|mesh-ancestor
153901050|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901051|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153901052|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
153901055|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
153901056|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901057|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901058|NCT02325557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153901059|NCT02325557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442463|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
153442464|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357401|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153408862|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408863|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
153408864|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408865|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153408867|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153442465|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442466|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153442467|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153442468|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
153442469|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
153901075|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901076|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153901077|NCT02226276|Trace Elements|trace elements|mesh-ancestor
153901078|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
153901079|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901080|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153833771|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153442513|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153442514|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442515|NCT02095158|Phenylephrine|phenylephrine|mesh-list
153442516|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
153442517|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153442518|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153442519|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153442520|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442521|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442522|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442523|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
153442524|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
153442525|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442526|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
153442527|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153442528|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442529|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153442530|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
153442531|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153442532|NCT02095158|Protective Agents|protective agents|mesh-ancestor
153442533|NCT02118714|Atrasentan|atrasentan|mesh-list
153442534|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442535|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153442536|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153901111|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153901112|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153901113|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
153901114|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733435|NCT05148169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810807|NCT00322127|Plerixafor|plerixafor|mesh-list
153357402|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
153868353|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733436|NCT05148169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733438|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733439|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153901115|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901116|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153901137|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901138|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
153901139|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
153901140|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901141|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153442544|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
153442545|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442546|NCT02138838|Cinacalcet|cinacalcet|mesh-list
153442547|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153442548|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442549|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153442565|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442566|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
153442567|NCT02092116|Romidepsin|romidepsin|mesh-list
153442568|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153442569|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901155|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
153901157|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901158|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153901159|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733440|NCT05148169|Protective Agents|protective agents|mesh-ancestor
153733441|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733442|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
153733443|NCT00144482|Hematinics|hematinics|mesh-ancestor
153901160|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153901161|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
153901162|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901163|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
153901164|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153901165|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153901166|NCT01754402|Growth Substances|growth substances|mesh-ancestor
153442570|NCT02092116|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153442571|NCT02092116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810808|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153868373|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
153442572|NCT02092116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442573|NCT02091414|Cyclosporine|cyclosporine|mesh-list
153442574|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
153442575|NCT02091414|Cyclosporins|cyclosporins|mesh-list
153442576|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442577|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442578|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153442579|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
153442580|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442581|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
153442582|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442583|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
153901167|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
153901168|NCT01740297|Ipilimumab|ipilimumab|mesh-list
153901169|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153901170|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901171|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901172|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153901173|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901174|NCT01572506|Biotin|biotin|mesh-list
153901175|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
153901176|NCT01572506|Vitamins|vitamins|mesh-ancestor
153901177|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
153901178|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901179|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
153901180|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
153901181|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153901182|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
153901183|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153442606|NCT02116530|Palonosetron|palonosetron|mesh-list
153442607|NCT02116530|Granisetron|granisetron|mesh-list
153442608|NCT02116530|Antiemetics|antiemetics|mesh-list
153442609|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153442610|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
153442611|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442612|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153442613|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153442614|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
153357403|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408910|NCT05722795|Imatinib Mesylate|imatinib mesylate|mesh-list
153408911|NCT05722795|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153408912|NCT05722795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408913|NCT05722795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408914|NCT05722795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408915|NCT05722795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442615|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442616|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442617|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153442618|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442619|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
153901188|NCT01236560|Bevacizumab|bevacizumab|mesh-list
153901189|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153901190|NCT01236560|Temozolomide|temozolomide|mesh-list
153901191|NCT01236560|Vorinostat|vorinostat|mesh-list
153901192|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
153901193|NCT01236560|Antibodies|antibodies|mesh-list
153901194|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
153901195|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153901196|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
153901197|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901198|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153901199|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153901200|NCT01236560|Growth Substances|growth substances|mesh-ancestor
153901201|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442620|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901227|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901228|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153901229|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153901230|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153901231|NCT02936843|Analgesics|analgesics|mesh-ancestor
153733445|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153733446|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153442638|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442639|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153442640|NCT02116530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153442654|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153442655|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153442656|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442657|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153833856|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
153901237|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
153901238|NCT02811861|Everolimus|everolimus|mesh-list
153595591|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595592|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
153595593|NCT01857154|Vitamin D|vitamin d|mesh-list
153901239|NCT02811861|Sunitinib|sunitinib|mesh-list
153901240|NCT02811861|Lenvatinib|lenvatinib|mesh-list
153901241|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901242|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901243|NCT02811861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153901244|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901245|NCT02811861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153901246|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153901247|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901248|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901249|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
153901250|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901251|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153901252|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153901253|NCT02811861|Growth Substances|growth substances|mesh-ancestor
153901254|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
153901255|NCT02700451|Acetaminophen|acetaminophen|mesh-list
153901256|NCT02700451|Ketorolac|ketorolac|mesh-list
153901257|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153901258|NCT02700451|Analgesics|analgesics|mesh-ancestor
153901259|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
153901260|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901261|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901262|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
153901263|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154256939|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153901264|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901265|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901266|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153901267|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901268|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901276|NCT02697344|BB 1101|bb 1101|mesh-list
153901277|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901278|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
153901279|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
153914661|NCT00606268|Micafungin|micafungin|mesh-list
153442683|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595594|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
153595596|NCT01857154|Calcium|calcium|mesh-list
153595597|NCT01857154|Vitamins|vitamins|mesh-ancestor
153595598|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
153595599|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595600|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153442684|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442721|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442722|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442723|NCT02084082|Metformin|metformin|mesh-list
153833911|NCT01243944|Pipobroman|pipobroman|mesh-list
153442726|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442727|NCT02084082|Incretins|incretins|mesh-ancestor
153442728|NCT02084082|Hormones|hormones|mesh-ancestor
153442729|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153442730|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153442731|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
153442732|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442733|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442734|NCT02083926|Ketamine|ketamine|mesh-list
153442735|NCT02083926|Analgesics|analgesics|mesh-ancestor
153442736|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
153442737|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442738|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442739|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153442740|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153442741|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
153442742|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
153442743|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901307|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153901308|NCT02667418|Vancomycin|vancomycin|mesh-list
153901309|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
153901310|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153901311|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901312|NCT02623426|Dexamethasone|dexamethasone|mesh-list
153901313|NCT02623426|Methotrexate|methotrexate|mesh-list
153901314|NCT02623426|Ranibizumab|ranibizumab|mesh-list
153442744|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153901315|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901316|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
153901317|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
153868433|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868434|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
153868451|NCT01137955|Rifaximin|rifaximin|mesh-list
153901318|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901319|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901320|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901321|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
153901322|NCT02623426|Hormones|hormones|mesh-ancestor
153901323|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901325|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901326|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153901327|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
153901328|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153901337|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901338|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153901339|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153901340|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153901341|NCT02623426|Growth Substances|growth substances|mesh-ancestor
153901342|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
153901343|NCT02580058|Doxorubicin|doxorubicin|mesh-list
153901344|NCT02580058|Avelumab|avelumab|mesh-list
153901345|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153901346|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901347|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153442753|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442755|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153442756|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
153442765|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442766|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153442767|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442768|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
153442769|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153442770|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
153442771|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733453|NCT05146687|Aflibercept|aflibercept|mesh-list
153733454|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411467|NCT00003723|Gemcitabine|gemcitabine|mesh-list
153901348|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153901349|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901350|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901370|NCT02539394|Protective Agents|protective agents|mesh-ancestor
153901371|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153901372|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408964|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408966|NCT05263986|Adagrasib|adagrasib|mesh-list
153901373|NCT02539394|Coagulants|coagulants|mesh-ancestor
153901374|NCT02530437|Paclitaxel|paclitaxel|mesh-list
153901375|NCT02530437|Carboplatin|carboplatin|mesh-list
153901376|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153442782|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
153442783|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442785|NCT02082522|Gemcitabine|gemcitabine|mesh-list
153442786|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153442787|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
153442788|NCT02082522|Trioxsalen|trioxsalen|mesh-list
153442789|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442790|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153442791|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
153374031|NCT01400906|Xhance|xhance|mesh-list
153901391|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153901393|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901394|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153901395|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153901396|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153901397|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901398|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153901399|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
153901400|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153901407|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153901408|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153901409|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
153901410|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
153901411|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
153901412|NCT01889199|Flutamide|flutamide|mesh-list
153442818|NCT01624662|Fluticasone|fluticasone|mesh-list
153442819|NCT01624662|Xhance|xhance|mesh-list
153442820|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442821|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153442822|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
153442823|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442824|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442825|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153442826|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442827|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
153810809|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153810810|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
153868459|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868460|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153868461|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
153868472|NCT00586131|Citric Acid|citric acid|mesh-list
153595601|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153595602|NCT01857154|Antacids|antacids|mesh-ancestor
153442828|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153442829|NCT02106390|Vaccines|vaccines|mesh-list
153442830|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
153442831|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442832|NCT02064894|Ibuprofen|ibuprofen|mesh-list
153901453|NCT05940441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153442862|NCT02079636|Ramucirumab|ramucirumab|mesh-list
153442863|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153442864|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
153442865|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442866|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442867|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153442868|NCT02079636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153442869|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442870|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153442871|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153442872|NCT02079636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153442873|NCT02079636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153442874|NCT02079636|Growth Substances|growth substances|mesh-ancestor
153442875|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442876|NCT02079636|Growth Inhibitors|growth inhibitors|mesh-ancestor
153442877|NCT02079246|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
153442878|NCT02079246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153901455|NCT05940441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901456|NCT05940441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901457|NCT05940376|Insulin, Short-Acting|insulin, short-acting|mesh-list
153374102|NCT05437029|Coagulants|coagulants|mesh-ancestor
153901481|NCT05940064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901482|NCT05940064|Immunoconjugates|immunoconjugates|mesh-ancestor
153442891|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442892|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442893|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442894|NCT02045862|Urological Agents|urological agents|mesh-ancestor
153442895|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153442896|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153442903|NCT04182984|Tacrolimus|tacrolimus|mesh-list
153442904|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153442905|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153442906|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442907|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
153442908|NCT04182984|Hormones|hormones|mesh-ancestor
153442909|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153442910|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442911|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153442912|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442913|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
153442914|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153442915|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442916|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442917|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153442918|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153442924|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153442925|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901483|NCT05940051|Rituximab|rituximab|mesh-list
153901484|NCT05940051|Zanubrutinib|zanubrutinib|mesh-list
153901485|NCT05940051|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153901486|NCT05940051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901487|NCT05940051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901488|NCT05940051|Immunologic Factors|immunologic factors|mesh-ancestor
153901489|NCT05940051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901490|NCT05940051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901491|NCT05940051|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153901492|NCT05940051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153901493|NCT05940051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901494|NCT05940051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901495|NCT05940051|Immunoconjugates|immunoconjugates|mesh-ancestor
153901496|NCT05939882|Atropine|atropine|mesh-list
153901497|NCT05939882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153901498|NCT05939882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153901499|NCT05939882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153901500|NCT05939882|Autonomic Agents|autonomic agents|mesh-ancestor
153901501|NCT05939882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733458|NCT05146687|Growth Substances|growth substances|mesh-ancestor
153733459|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733460|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
153733461|NCT05141422|Efavirenz|efavirenz|mesh-list
153733462|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153901502|NCT05939882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810811|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810812|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
153901503|NCT05939882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153901504|NCT05939882|Respiratory System Agents|respiratory system agents|mesh-ancestor
153901505|NCT05939882|Mydriatics|mydriatics|mesh-ancestor
153901506|NCT05939882|Parasympatholytics|parasympatholytics|mesh-ancestor
153901507|NCT05939882|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153901508|NCT05939882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153901509|NCT05939882|Cholinergic Agents|cholinergic agents|mesh-ancestor
153901510|NCT05939882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901511|NCT05939882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901512|NCT05939817|Triamcinolone|triamcinolone|mesh-list
153901513|NCT05939817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153901514|NCT05939817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153901515|NCT05939817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153901516|NCT05939817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442926|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153442927|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
153442928|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442943|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442945|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442947|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153442948|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153442949|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442950|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153442951|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442952|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
153442953|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
153442954|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442955|NCT02062632|Doxepin|doxepin|mesh-list
153442956|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153442957|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153442958|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442959|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442960|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153901517|NCT05939817|Glucocorticoids|glucocorticoids|mesh-ancestor
153901518|NCT05939817|Hormones|hormones|mesh-ancestor
153901519|NCT05939817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901520|NCT05939817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901521|NCT05939817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901522|NCT05939817|Immunologic Factors|immunologic factors|mesh-ancestor
153901523|NCT05939817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901524|NCT05939817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901525|NCT05939284|Cetrorelix|cetrorelix|mesh-list
153901526|NCT05939284|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153901527|NCT05939284|Fertility Agents|fertility agents|mesh-ancestor
153901528|NCT05939284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153901529|NCT05939284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901530|NCT05939284|Hormone Antagonists|hormone antagonists|mesh-ancestor
153901531|NCT05939284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901532|NCT05939180|Cytarabine|cytarabine|mesh-list
153901533|NCT05939180|Azacitidine|azacitidine|mesh-list
153901534|NCT05939180|Daunorubicin|daunorubicin|mesh-list
153901535|NCT05939180|Venetoclax|venetoclax|mesh-list
153901536|NCT05939180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153901537|NCT05939180|Antimetabolites|antimetabolites|mesh-ancestor
153901538|NCT05939180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901539|NCT05939180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901540|NCT05939180|Antiviral Agents|antiviral agents|mesh-ancestor
153901541|NCT05939180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901542|NCT05939180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901543|NCT05939180|Immunologic Factors|immunologic factors|mesh-ancestor
153901544|NCT05939180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901545|NCT05939180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901546|NCT05939180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153733463|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153442974|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442975|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442976|NCT02043366|Analgesics|analgesics|mesh-ancestor
153442977|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
153442978|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442979|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153442980|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153442981|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
153442982|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
153442983|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153442984|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153442985|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442986|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153442987|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153442988|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442989|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442990|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
153901558|NCT05939076|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153901559|NCT05939076|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153901560|NCT05939076|Adrenergic Agents|adrenergic agents|mesh-ancestor
153357408|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901561|NCT05939076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901562|NCT05939076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901563|NCT05939076|Sympatholytics|sympatholytics|mesh-ancestor
153901564|NCT05939076|Autonomic Agents|autonomic agents|mesh-ancestor
153901565|NCT05939076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901566|NCT05939037|Zanubrutinib|zanubrutinib|mesh-list
153901567|NCT05939037|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153901568|NCT05939037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153901569|NCT05939037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901570|NCT05939037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901571|NCT05939037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901573|NCT05938972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153901574|NCT05938972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153901575|NCT05938972|Respiratory System Agents|respiratory system agents|mesh-ancestor
153901576|NCT05937282|Lidocaine|lidocaine|mesh-list
153901577|NCT05937282|Dexmedetomidine|dexmedetomidine|mesh-list
153901578|NCT05937282|Propofol|propofol|mesh-list
153901579|NCT05937282|Anesthetics, Local|anesthetics, local|mesh-ancestor
153901580|NCT05937282|Anesthetics|anesthetics|mesh-ancestor
153901581|NCT05937282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901582|NCT05937282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442993|NCT02060370|Sunitinib|sunitinib|mesh-list
153901586|NCT05937282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153901587|NCT05937282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154256940|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901588|NCT05937282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153901589|NCT05937282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901590|NCT05937282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153901591|NCT05937282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153901593|NCT05937282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153901594|NCT05937282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153901595|NCT05937282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153901596|NCT05937282|Adrenergic Agents|adrenergic agents|mesh-ancestor
153901597|NCT05937282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901598|NCT05937282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153901599|NCT05937282|Anesthetics, General|anesthetics, general|mesh-ancestor
153901601|NCT05936268|Gout Suppressants|gout suppressants|mesh-ancestor
153901602|NCT05936268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901603|NCT05936268|Tubulin Modulators|tubulin modulators|mesh-ancestor
153901604|NCT05936268|Antimitotic Agents|antimitotic agents|mesh-ancestor
153901605|NCT05936268|Mitosis Modulators|mitosis modulators|mesh-ancestor
153901606|NCT05936268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443018|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153443019|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
153443020|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
153409058|NCT05721079|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153409059|NCT05721079|Dermatologic Agents|dermatologic agents|mesh-ancestor
153409060|NCT00362570|Temozolomide|temozolomide|mesh-list
153409061|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153409062|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
153409063|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409064|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409065|NCT00357253|Capecitabine|capecitabine|mesh-list
153409066|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153409067|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
153409068|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443021|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153443022|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443023|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
153443024|NCT02043132|Coagulants|coagulants|mesh-ancestor
153443025|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
153443026|NCT02059434|LAS190792|las190792|mesh-list
153443027|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153443028|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
153443029|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443030|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443031|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153443032|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
153443033|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
153443034|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153443035|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
153443036|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443037|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443038|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153443039|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153443040|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153443041|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153443042|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
153443043|NCT02059278|Latanoprost|latanoprost|mesh-list
153443044|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153443045|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153443046|NCT02020512|Bimatoprost|bimatoprost|mesh-list
153443047|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153443048|NCT02019420|Linezolid|linezolid|mesh-list
153443049|NCT02019420|Tedizolid|tedizolid|mesh-list
153443050|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
153443051|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153443052|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443053|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153901607|NCT05936268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901608|NCT05935787|Niacinamide|niacinamide|mesh-list
153901609|NCT05935787|Niacin|niacin|mesh-list
153901610|NCT05935787|Nicotinic Acids|nicotinic acids|mesh-list
153901611|NCT05935787|Riboflavin|riboflavin|mesh-list
153901612|NCT05935787|Vitamin B Complex|vitamin b complex|mesh-ancestor
153868537|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810817|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
153868538|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153868539|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868540|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901613|NCT05935787|Vitamins|vitamins|mesh-ancestor
153901614|NCT05935787|Micronutrients|micronutrients|mesh-ancestor
153901615|NCT05935787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901616|NCT05935787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153901617|NCT05935787|Antimetabolites|antimetabolites|mesh-ancestor
153901625|NCT05933642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153901626|NCT05933642|Autonomic Agents|autonomic agents|mesh-ancestor
153901627|NCT05933642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901628|NCT05933642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901629|NCT05933642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153901630|NCT05933642|Respiratory System Agents|respiratory system agents|mesh-ancestor
153901631|NCT05933642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153901632|NCT05933642|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154256941|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153901633|NCT05933642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901634|NCT05933642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901635|NCT05933642|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153901636|NCT05933642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153901637|NCT05933642|Purinergic Agents|purinergic agents|mesh-ancestor
153901638|NCT05933642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901639|NCT05933642|Protective Agents|protective agents|mesh-ancestor
153901641|NCT05933642|Natriuretic Agents|natriuretic agents|mesh-ancestor
153901642|NCT05933642|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153901643|NCT05933642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153901645|NCT05932251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153901646|NCT05932251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443059|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153443060|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153443061|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443062|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443063|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153443064|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443065|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
153443066|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
153443067|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443068|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
153443069|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595603|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818894|NCT03598270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818895|NCT03598270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818896|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
153818897|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818898|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153818899|NCT03593317|Spironolactone|spironolactone|mesh-list
153443070|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
153443071|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153443072|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153443073|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153443074|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153443075|NCT02017860|Everolimus|everolimus|mesh-list
153443076|NCT02017860|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153443077|NCT02017860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443078|NCT02017860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443079|NCT02017860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443080|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443081|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
153443082|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443083|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443084|NCT02040870|Ceritinib|ceritinib|mesh-list
153443087|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901647|NCT05928520|Lidocaine|lidocaine|mesh-list
153901648|NCT05928520|Tramadol|tramadol|mesh-list
153901649|NCT05928520|Anesthetics, Local|anesthetics, local|mesh-ancestor
153901650|NCT05928520|Anesthetics|anesthetics|mesh-ancestor
153901651|NCT05928520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901652|NCT05928520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901653|NCT05928520|Sensory System Agents|sensory system agents|mesh-ancestor
153901654|NCT05928520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901655|NCT05928520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153901656|NCT05928520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153901657|NCT05928520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153901661|NCT05928520|Narcotics|narcotics|mesh-ancestor
153901662|NCT05928520|Analgesics|analgesics|mesh-ancestor
153901663|NCT05923411|Rabeprazole|rabeprazole|mesh-list
153901664|NCT05923411|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153901665|NCT05923411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901666|NCT05923411|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153901667|NCT05923411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901668|NCT05923411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901669|NCT05923190|Pembrolizumab|pembrolizumab|mesh-list
153901670|NCT05923190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901671|NCT05923190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901672|NCT05923190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153901673|NCT05923190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901674|NCT05919173|Dexmedetomidine|dexmedetomidine|mesh-list
153901675|NCT05919173|Bupivacaine|bupivacaine|mesh-list
153901676|NCT05919173|Anesthetics, Local|anesthetics, local|mesh-ancestor
153901677|NCT05919173|Anesthetics|anesthetics|mesh-ancestor
153901678|NCT05919173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901679|NCT05919173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901680|NCT05919173|Sensory System Agents|sensory system agents|mesh-ancestor
153901681|NCT05919173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901682|NCT05919173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153901683|NCT05919173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153901684|NCT05919173|Analgesics|analgesics|mesh-ancestor
153901685|NCT05919173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153901686|NCT05919173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153901687|NCT05919173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153901688|NCT05919173|Adrenergic Agents|adrenergic agents|mesh-ancestor
153901689|NCT05919173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901690|NCT05919173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901691|NCT05908747|Paclitaxel|paclitaxel|mesh-list
153901692|NCT05908747|Gemcitabine|gemcitabine|mesh-list
153443105|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
153443106|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
153443107|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443108|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443110|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
153443111|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443112|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153443113|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443114|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443115|NCT04678362|Avelumab|avelumab|mesh-list
153443116|NCT04678362|Talazoparib|talazoparib|mesh-list
153443117|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443118|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443119|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153443120|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443121|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443122|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
153443123|NCT04678050|Ketamine|ketamine|mesh-list
153443124|NCT04678050|Propofol|propofol|mesh-list
153409098|NCT02444234|Tedizolid|tedizolid|mesh-list
153409099|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
153409100|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409101|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818900|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153818901|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
153818902|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818903|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595604|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153595605|NCT01857193|Everolimus|everolimus|mesh-list
153595606|NCT01857193|Exemestane|exemestane|mesh-list
153595607|NCT01857193|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153595608|NCT01857193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153595609|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595610|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595611|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153595612|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
153595613|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595614|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595615|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153595616|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153443125|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153901693|NCT05908747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153901694|NCT05908747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901695|NCT05908747|Tubulin Modulators|tubulin modulators|mesh-ancestor
153901696|NCT05908747|Antimitotic Agents|antimitotic agents|mesh-ancestor
153901697|NCT05908747|Mitosis Modulators|mitosis modulators|mesh-ancestor
153901698|NCT05908747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901699|NCT05908747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153901700|NCT05908747|Antimetabolites|antimetabolites|mesh-ancestor
153901701|NCT05904808|Metolazone|metolazone|mesh-list
153901702|NCT05904808|Furosemide|furosemide|mesh-list
153901703|NCT05904808|Acetazolamide|acetazolamide|mesh-list
153901704|NCT05904808|Magnesium citrate|magnesium citrate|mesh-list
153901705|NCT05904808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901706|NCT05904808|Diuretics|diuretics|mesh-ancestor
153901707|NCT05904808|Natriuretic Agents|natriuretic agents|mesh-ancestor
153901708|NCT05904808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901709|NCT05904808|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153901710|NCT05904808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153901711|NCT05904808|Anticonvulsants|anticonvulsants|mesh-ancestor
153901712|NCT05904808|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153443126|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153443127|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443128|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153443130|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
153443143|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153443144|NCT02038920|Vedolizumab|vedolizumab|mesh-list
153443145|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153443146|NCT02014740|Metformin|metformin|mesh-list
153901713|NCT05904808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901714|NCT05904808|Cathartics|cathartics|mesh-ancestor
153901715|NCT05904808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901716|NCT05904808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153901717|NCT05904808|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153901719|NCT05888350|Formoterol Fumarate|formoterol fumarate|mesh-list
153901720|NCT05888350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153901721|NCT05888350|Autonomic Agents|autonomic agents|mesh-ancestor
153901722|NCT05888350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901723|NCT05888350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901724|NCT05888350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153901725|NCT05888350|Respiratory System Agents|respiratory system agents|mesh-ancestor
153901726|NCT05888350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153901727|NCT05888350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153901728|NCT05888350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153901729|NCT05888350|Adrenergic Agents|adrenergic agents|mesh-ancestor
153901730|NCT05888350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901731|NCT05888350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901732|NCT05888350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901733|NCT05888350|Glucocorticoids|glucocorticoids|mesh-ancestor
153901734|NCT05888350|Hormones|hormones|mesh-ancestor
153901735|NCT05888350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901736|NCT05881083|Nicotine|nicotine|mesh-list
153443150|NCT02014740|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153443151|NCT02014740|Incretins|incretins|mesh-ancestor
153443152|NCT02014740|Hormones|hormones|mesh-ancestor
153443153|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443154|NCT02014584|Dutasteride|dutasteride|mesh-list
153443155|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153901773|NCT05833776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153901774|NCT05833776|Anesthetics, General|anesthetics, general|mesh-ancestor
153443187|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
153443188|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153443189|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153443190|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443191|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153810824|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
153439349|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
153868617|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868618|NCT00587145|Docetaxel|docetaxel|mesh-list
153868619|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868620|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
153868621|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
153868622|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
153409128|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409129|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409130|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153409131|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153409132|NCT04344457|Analgesics|analgesics|mesh-ancestor
153409133|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
153409137|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
153443192|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153443193|NCT02057250|Analgesics|analgesics|mesh-ancestor
153443194|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
153443195|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443196|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153443197|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153443198|NCT02036502|Dexamethasone|dexamethasone|mesh-list
153443199|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
153443201|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153443202|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
153443203|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
153443204|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443205|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443206|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153443207|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
153443209|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901777|NCT05816616|Anesthetics, General|anesthetics, general|mesh-ancestor
153901778|NCT05816616|Anesthetics|anesthetics|mesh-ancestor
153901779|NCT05816616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901780|NCT05816616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901781|NCT05760261|Midazolam|midazolam|mesh-list
153901792|NCT05760261|GABA Modulators|gaba modulators|mesh-ancestor
153901793|NCT05760261|GABA Agents|gaba agents|mesh-ancestor
153901794|NCT05760261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901795|NCT05760261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901796|NCT05746377|Metoclopramide|metoclopramide|mesh-list
153901797|NCT05746377|Antiemetics|antiemetics|mesh-ancestor
153901798|NCT05746377|Autonomic Agents|autonomic agents|mesh-ancestor
153443210|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153443211|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443212|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443213|NCT02036502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153443214|NCT02036502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901799|NCT05746377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901800|NCT05746377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901801|NCT05746377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901802|NCT05746377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153409146|NCT02446496|Cefadroxil|cefadroxil|mesh-list
153901803|NCT05746377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153901804|NCT05746377|Dopamine Agents|dopamine agents|mesh-ancestor
153901805|NCT05746377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901806|NCT05746377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443220|NCT02056626|Carvedilol|carvedilol|mesh-list
153443221|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153443222|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153443223|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
153443224|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443225|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443226|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443227|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153443228|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
153443229|NCT02056626|Protective Agents|protective agents|mesh-ancestor
153443230|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153443231|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153443232|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153443233|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
153443234|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153443235|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153443236|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
153733468|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153901808|NCT05725798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153901809|NCT05725798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901810|NCT05725798|Incretins|incretins|mesh-ancestor
153901811|NCT05725798|Hormones|hormones|mesh-ancestor
153901812|NCT05725798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901813|NCT05725798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153901814|NCT05725798|Protease Inhibitors|protease inhibitors|mesh-ancestor
153901815|NCT05725798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901816|NCT05725798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901817|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153901818|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901819|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901820|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
153810825|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
153901821|NCT05625594|Fludarabine|fludarabine|mesh-list
153901822|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901823|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
153901824|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901825|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901826|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153901827|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
153901828|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901829|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901830|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153901831|NCT05549778|Polaprezinc|polaprezinc|mesh-list
153901832|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153914662|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
153443245|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
153443246|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153443247|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153443248|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
153443249|NCT02034552|Hormones|hormones|mesh-ancestor
153443251|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443252|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153443253|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443254|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153443255|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443256|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443257|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
153443258|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153443259|NCT02011386|Golimumab|golimumab|mesh-list
153443260|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153443261|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901860|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153901861|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901862|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901864|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153901865|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
153901866|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
153901867|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901868|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901869|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153409178|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153409179|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
153409180|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
153409181|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
153409182|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
153409183|NCT01638546|Temozolomide|temozolomide|mesh-list
153409184|NCT01638546|Veliparib|veliparib|mesh-list
153409186|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
153901870|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
153901871|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
153901872|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901873|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
153901874|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443307|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153443308|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153443309|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153443310|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153443311|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153443312|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443313|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443314|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
153443315|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153443316|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
153443317|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443319|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153443320|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153901878|NCT05340868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153901879|NCT05340868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901880|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153901881|NCT05330130|Hormones|hormones|mesh-ancestor
153901882|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901883|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901884|NCT05323981|Pertuzumab|pertuzumab|mesh-list
153901893|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
153443324|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443325|NCT02007096|Bupivacaine|bupivacaine|mesh-list
153443326|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
153443327|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
153443328|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153443329|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443330|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
153443331|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443332|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
153443333|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153443334|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153443335|NCT02006706|Prednisolone|prednisolone|mesh-list
153443336|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
153443337|NCT02006706|Rituximab|rituximab|mesh-list
153443339|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153443340|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
153443341|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443342|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443343|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
153443346|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153443348|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153443349|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153443350|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
153443351|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443352|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
153443353|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443354|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153443355|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443356|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153443357|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153443358|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
153443359|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
153443360|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443361|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153443362|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
153443363|NCT02006706|Hormones|hormones|mesh-ancestor
153443364|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443365|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153443366|NCT02006706|Protective Agents|protective agents|mesh-ancestor
153443367|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153733469|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153443368|NCT02049138|Upadacitinib|upadacitinib|mesh-list
153443369|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153443370|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443371|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443372|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443373|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443374|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153443375|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153443376|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901929|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
153901946|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153901947|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
153901948|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901949|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901950|NCT05111145|Ivacaftor|ivacaftor|mesh-list
153409194|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153409195|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153595617|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153595618|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
153595619|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595620|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153595621|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153595622|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153595623|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153595624|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
153595625|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901951|NCT05111145|Elexacaftor|elexacaftor|mesh-list
153901952|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153901953|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153901954|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901955|NCT05023980|Rituximab|rituximab|mesh-list
153901956|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153901957|NCT05023980|Pirtobrutinib|pirtobrutinib|mesh-list
153901958|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443377|NCT02048904|Incretins|incretins|mesh-ancestor
153443378|NCT02048904|Hormones|hormones|mesh-ancestor
153443379|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443380|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153443381|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
153443382|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443383|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443385|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
153443386|NCT02029638|Acetaminophen|acetaminophen|mesh-list
153443389|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
153443390|NCT02029638|Prednisone|prednisone|mesh-list
153443391|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
153443392|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
153443393|NCT02029638|Fludarabine|fludarabine|mesh-list
153443394|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
153443395|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153443396|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443397|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
153443398|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443399|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443400|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153443401|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
153443402|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443403|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443404|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153810827|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
153595626|NCT01857349|Ethanol|ethanol|mesh-list
153595627|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
153443405|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153443406|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
153443407|NCT02029638|Hormones|hormones|mesh-ancestor
153901959|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901960|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
153901963|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153901964|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
153901965|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901966|NCT05023980|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153901967|NCT05023980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153901968|NCT05023980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901969|NCT05007522|Ketotifen|ketotifen|mesh-list
153901970|NCT05007522|Indomethacin|indomethacin|mesh-list
153901971|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153901972|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153901973|NCT05007522|Analgesics|analgesics|mesh-ancestor
153901974|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
153901975|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901976|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901977|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901978|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901979|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
153901980|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
153901981|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153901982|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153901983|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443424|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153443425|NCT02029638|Protective Agents|protective agents|mesh-ancestor
153901987|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153901988|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
153901989|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
153901990|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901991|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153901992|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
153901993|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901994|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
153901995|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
153901996|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
153901997|NCT04952779|Insulin|insulin|mesh-list
153901998|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153901999|NCT04952779|Liraglutide|liraglutide|mesh-list
153902000|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
153902001|NCT04952779|Xultophy|xultophy|mesh-list
153902002|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153902003|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902004|NCT04952779|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153902005|NCT04952779|Incretins|incretins|mesh-ancestor
153902006|NCT04952779|Hormones|hormones|mesh-ancestor
153902007|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902009|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153902010|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
153443431|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153443432|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
153443433|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
153443459|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443460|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443461|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
153443462|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443463|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443464|NCT02003898|Insulin|insulin|mesh-list
153443465|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153443466|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902011|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
153902012|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902013|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902014|NCT04900623|Paclitaxel|paclitaxel|mesh-list
153902015|NCT04900623|Cisplatin|cisplatin|mesh-list
153902016|NCT04900623|Carboplatin|carboplatin|mesh-list
153902017|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153902018|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902019|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
153902020|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
153902021|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
153902022|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902023|NCT04899050|Cannabidiol|cannabidiol|mesh-list
153902024|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
153902025|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
153902026|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
153902027|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409239|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153409240|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409241|NCT03172494|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153409242|NCT03172494|Incretins|incretins|mesh-ancestor
153409243|NCT03172494|Hormones|hormones|mesh-ancestor
153409244|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409245|NCT02452346|Tosedostat|tosedostat|mesh-list
153409246|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868706|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
153868707|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153868708|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868709|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153868710|NCT02883478|Riboflavin|riboflavin|mesh-list
153868711|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
153595628|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153595629|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153595630|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902028|NCT04808622|Protective Agents|protective agents|mesh-ancestor
153902029|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902030|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153902031|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902032|NCT04783675|Rituximab|rituximab|mesh-list
153902033|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153902034|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902035|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
153902036|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902037|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902039|NCT04781374|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153902040|NCT04781374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153902041|NCT04781374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902042|NCT04781374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902043|NCT04695080|Cladribine|cladribine|mesh-list
153902044|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902045|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443468|NCT01994226|Colchicine|colchicine|mesh-list
153443469|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153443470|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153443478|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153443479|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443480|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443481|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
153443482|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
153443483|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
153443508|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153443509|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
153443510|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443511|NCT01990560|Mifepristone|mifepristone|mesh-list
153443512|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153902062|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153902063|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902064|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902065|NCT04402385|Aspirin|aspirin|mesh-list
153902066|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153902067|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153902068|NCT04402385|Analgesics|analgesics|mesh-ancestor
153902069|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
153902070|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902071|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902072|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902073|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902074|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153902075|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153902076|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902084|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153902085|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
153902086|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153902087|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902090|NCT04378868|Metronidazole|metronidazole|mesh-list
153902091|NCT04378868|Cefuroxime|cefuroxime|mesh-list
153443513|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
153443514|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153443515|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443516|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153443517|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153443518|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153443519|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
153443520|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153443521|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153443522|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
153443523|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443524|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
153443525|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153443526|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153443528|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
153443529|NCT01967628|Vitamins|vitamins|mesh-ancestor
153443530|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
153443531|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443532|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153443533|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153443535|NCT01998906|Doxorubicin|doxorubicin|mesh-list
153443536|NCT01998906|Trastuzumab|trastuzumab|mesh-list
153409267|NCT05716945|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153409268|NCT05716867|Cystatins|cystatins|mesh-list
153409269|NCT05716867|Salivary Cystatins|salivary cystatins|mesh-list
153409270|NCT05716867|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153409271|NCT05716867|Protease Inhibitors|protease inhibitors|mesh-ancestor
153409272|NCT05716867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409273|NCT05716867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409275|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443537|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153443538|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443539|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
153443540|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
153443541|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
153443542|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443543|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153443544|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153902092|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
153902093|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153902094|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902095|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
153365888|NCT04942470|Propolis|propolis|mesh-list
153902096|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153902097|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153902098|NCT04218357|Probenecid|probenecid|mesh-list
153902099|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
153902100|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
153902101|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902102|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
153902103|NCT04166877|Analgesics|analgesics|mesh-ancestor
153902112|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902113|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902114|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153902116|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153902117|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
153902118|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153902119|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902120|NCT04164979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153902121|NCT04164979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902122|NCT04135846|Doxazosin|doxazosin|mesh-list
153443545|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153443546|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443547|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443548|NCT01967550|Diclofenac|diclofenac|mesh-list
153443549|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153443553|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443554|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443555|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153443556|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443557|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153443558|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595631|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595632|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443559|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443560|NCT01989546|Talazoparib|talazoparib|mesh-list
153443561|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153443562|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902123|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153902124|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153733471|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153733472|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153733473|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153902125|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153902126|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153902127|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
153902128|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902129|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902130|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902131|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153902132|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
153902133|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153902134|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
153902135|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902136|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
153902137|NCT04117893|Protective Agents|protective agents|mesh-ancestor
153902138|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153902139|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153902140|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902141|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902142|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902143|NCT04117893|Analgesics|analgesics|mesh-ancestor
153902144|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
153902145|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902146|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
153902147|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153902148|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
153595633|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
153595634|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
153595635|NCT01857375|Insulin|insulin|mesh-list
153595636|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818904|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153902159|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153902160|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902161|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
153902162|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
153902163|NCT03810105|Durvalumab|durvalumab|mesh-list
153902164|NCT03810105|Olaparib|olaparib|mesh-list
153902165|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153902166|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256950|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154256951|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902167|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153902168|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902169|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902170|NCT03785210|Vancomycin|vancomycin|mesh-list
153902171|NCT03785210|Nivolumab|nivolumab|mesh-list
153902172|NCT03785210|Tadalafil|tadalafil|mesh-list
153902173|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153902174|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902175|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153902176|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902177|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153443601|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
153443602|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443603|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443604|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153443605|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
153443606|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
153443607|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153443608|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
153443609|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443610|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443613|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153443614|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443615|NCT01945866|Dexamethasone|dexamethasone|mesh-list
153443616|NCT01945866|Ranibizumab|ranibizumab|mesh-list
153443617|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153443618|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
153443619|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
153443620|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443621|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443622|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153733476|NCT05148637|Anesthetics|anesthetics|mesh-list
153733477|NCT05148637|Sevoflurane|sevoflurane|mesh-list
153733478|NCT05148637|Desflurane|desflurane|mesh-list
153733479|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
153733480|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733481|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733482|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
153733483|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733484|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153733485|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153733486|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153733487|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153733488|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733489|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153733490|NCT05148637|Narcotics|narcotics|mesh-ancestor
153733491|NCT05148637|Analgesics|analgesics|mesh-ancestor
153733492|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153733493|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153733494|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
153733495|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153733496|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153733497|NCT00148278|Dobutamine|dobutamine|mesh-list
153733498|NCT00148278|Epinephrine|epinephrine|mesh-list
153733499|NCT00148278|Norepinephrine|norepinephrine|mesh-list
153733500|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153733501|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153733502|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
153733503|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733504|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733505|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733506|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153733507|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153868813|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868814|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153868815|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153868816|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409326|NCT03836833|Lamivudine|lamivudine|mesh-list
153733508|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
153733509|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733510|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153733511|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
153733512|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
153733513|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
153733514|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153733525|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
153733526|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
153733527|NCT05594849|Hormones|hormones|mesh-ancestor
153733528|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733529|NCT00507247|Daptomycin|daptomycin|mesh-list
153733530|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153733531|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733532|NCT00507286|Alprostadil|alprostadil|mesh-list
153733533|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153733534|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
153733535|NCT00507286|Urological Agents|urological agents|mesh-ancestor
153733536|NCT05143762|Acetaminophen|acetaminophen|mesh-list
153733537|NCT05143762|Dexamethasone|dexamethasone|mesh-list
153733538|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153733541|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733542|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733543|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153733544|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
153570581|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153733546|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733547|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153733548|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733549|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153733550|NCT05143762|Analgesics|analgesics|mesh-ancestor
153733551|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
153733552|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
153733553|NCT00148356|Paclitaxel|paclitaxel|mesh-list
153733554|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153733555|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733556|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
153733557|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
153733558|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
153733559|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733561|NCT00424281|Fondaparinux|fondaparinux|mesh-list
153733562|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153818905|NCT03593317|Diuretics|diuretics|mesh-ancestor
153818906|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
153818907|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
153818908|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818909|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818910|NCT03568058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153595637|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595639|NCT01857453|Carboplatin|carboplatin|mesh-list
153595640|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153595641|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595642|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153595643|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153595644|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595645|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595646|NCT01857479|Amphotericin B|amphotericin b|mesh-list
153733563|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
153733564|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153733565|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
153733566|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733567|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733568|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
153733569|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153733570|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153733571|NCT00148395|Carboplatin|carboplatin|mesh-list
153733572|NCT00148395|Gemcitabine|gemcitabine|mesh-list
153733573|NCT00148395|Ifosfamide|ifosfamide|mesh-list
153733574|NCT00148395|Mitomycins|mitomycins|mesh-list
153733575|NCT00148395|Mitomycin|mitomycin|mesh-list
153733576|NCT00148395|Vinorelbine|vinorelbine|mesh-list
153733577|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733578|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153902180|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153902181|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153902182|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902183|NCT03785210|Urological Agents|urological agents|mesh-ancestor
153902185|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
153902186|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902187|NCT03750968|Protective Agents|protective agents|mesh-ancestor
153733580|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733581|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153733582|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
153733583|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153733584|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153733585|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595647|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153595648|NCT01857479|Budesonide|budesonide|mesh-list
153595649|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595650|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153595651|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
153595652|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595654|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153733586|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153733587|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
153733588|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
153733589|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
153733591|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
153733592|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153733593|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733594|NCT05141344|Melatonin|melatonin|mesh-list
153733595|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
153733596|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733598|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733599|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733600|NCT00156858|Busulfan|busulfan|mesh-list
153733601|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
153733602|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733603|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733604|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
153733605|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733606|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153733607|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733608|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153733609|NCT03451825|Avelumab|avelumab|mesh-list
153733610|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153733611|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153733612|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902188|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902189|NCT03722498|Leucovorin|leucovorin|mesh-list
153902190|NCT03722498|Fluorouracil|fluorouracil|mesh-list
153902191|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
153902192|NCT03722498|Sorafenib|sorafenib|mesh-list
153902193|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
153733613|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
153733614|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733616|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409347|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
153409348|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595655|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
153595656|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
153595657|NCT01857479|Hormones|hormones|mesh-ancestor
153733617|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733618|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153902194|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902195|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153902196|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902197|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153902198|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
153902199|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902200|NCT03722498|Antidotes|antidotes|mesh-ancestor
153902201|NCT03722498|Protective Agents|protective agents|mesh-ancestor
153443623|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
153443624|NCT01945866|Hormones|hormones|mesh-ancestor
153443625|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443626|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153443627|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443628|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153443629|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153443630|NCT01945866|Growth Substances|growth substances|mesh-ancestor
153443631|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
153443632|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153443633|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153443634|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153443635|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153443636|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443637|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153443638|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153443639|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154256952|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153443640|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153443641|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
153443642|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902202|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
153902204|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
153902205|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153902206|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810830|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357421|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595658|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595659|NCT01857479|Amebicides|amebicides|mesh-ancestor
153595660|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153902207|NCT03710824|Nintedanib|nintedanib|mesh-list
153902208|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902209|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153902210|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902211|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902212|NCT03648892|Raclopride|raclopride|mesh-list
153902213|NCT03648892|Fallypride|fallypride|mesh-list
153902214|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153902215|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153902216|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902217|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902218|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153902219|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153902220|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
153902221|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902222|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902223|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153902224|NCT03626831|Evolocumab|evolocumab|mesh-list
153902225|NCT03626831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153733619|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153570656|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733620|NCT03459859|Cytarabine|cytarabine|mesh-list
153733621|NCT03459859|Pevonedistat|pevonedistat|mesh-list
153733622|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153733623|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
153733624|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733625|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733626|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
153733627|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733628|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733629|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
153733630|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733631|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733632|NCT05594459|Analgesics|analgesics|mesh-list
153733633|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733634|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
153733635|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733636|NCT00507403|Infliximab|infliximab|mesh-list
153733637|NCT00507403|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153733638|NCT00507403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153733639|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
153733640|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153733641|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153733642|NCT00156975|Capecitabine|capecitabine|mesh-list
153733643|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
153733644|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153733645|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
153733646|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733647|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733648|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
153733649|NCT05594381|Tegafur|tegafur|mesh-list
153733650|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733651|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153733652|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
153733653|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733654|NCT00148473|Misoprostol|misoprostol|mesh-list
153902226|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153902227|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153733655|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153733656|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
153733657|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153733658|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733659|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153733660|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153733661|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
153733662|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
153733663|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153733664|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153733665|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153733666|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153733667|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153733668|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733669|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
153733670|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733671|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733672|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153733673|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733674|NCT05594342|Dobutamine|dobutamine|mesh-list
153733675|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153733676|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
153733678|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733679|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733680|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153733681|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153733682|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153733683|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
153733684|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733685|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733686|NCT05594342|Protective Agents|protective agents|mesh-ancestor
153868866|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868867|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153868868|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868869|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
153868870|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868871|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153868872|NCT02883439|Fluticasone|fluticasone|mesh-list
153868873|NCT02883439|Xhance|xhance|mesh-list
153868874|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868875|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153868876|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
153902228|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
153902229|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902230|NCT03626831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153902231|NCT03626831|Protease Inhibitors|protease inhibitors|mesh-ancestor
153902232|NCT03626831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902233|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153443655|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443656|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153443657|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
153733689|NCT00507793|Cyclosporine|cyclosporine|mesh-list
153733691|NCT00507793|Cyclosporins|cyclosporins|mesh-list
153733692|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733693|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733694|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733695|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
153733696|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733697|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
153733698|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733700|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153733701|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153733702|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153733703|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153733704|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733705|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
153733706|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153733707|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153733708|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153733709|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
153733710|NCT00507832|Tacrolimus|tacrolimus|mesh-list
153733711|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153733712|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153733713|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153733714|NCT00507832|Analgesics|analgesics|mesh-ancestor
153733715|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
153733716|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733717|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443658|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409401|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
153409402|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409403|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409407|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
153443659|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443660|NCT01945086|Ustekinumab|ustekinumab|mesh-list
153443661|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
153443662|NCT01963728|Insulin|insulin|mesh-list
153443663|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153443678|NCT01985334|Bromides|bromides|mesh-list
153443682|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153443683|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153443684|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
153443685|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443686|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733718|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153733719|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
153733720|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733721|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
153733722|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153733723|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733724|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733726|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
153733727|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153733728|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153733729|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153733730|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
153733731|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153733732|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733733|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153733734|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153733735|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153733736|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733737|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
153733738|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153733740|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153733741|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153733742|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153733743|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153733744|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
153733746|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412207|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
153902234|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
153902235|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153902236|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810833|NCT00352443|Everolimus|everolimus|mesh-list
153810834|NCT00352443|Lapatinib|lapatinib|mesh-list
153810835|NCT00352443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153902237|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153902238|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733747|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733748|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733749|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
153733750|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733751|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733752|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
153733753|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
153733754|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
153733755|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
153733756|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153733757|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153733758|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153733759|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733760|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
153733761|NCT05594186|Coagulants|coagulants|mesh-ancestor
153902239|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153902240|NCT03342690|Eplerenone|eplerenone|mesh-list
153902241|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153902242|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
153902243|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902244|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902245|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153902246|NCT03342690|Diuretics|diuretics|mesh-ancestor
153902247|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
153902248|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153902249|NCT03262662|Varenicline|varenicline|mesh-list
153902250|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153902251|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153902252|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
153902253|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902254|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902255|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902256|NCT03257267|Cemiplimab|cemiplimab|mesh-list
153902257|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153902258|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902259|NCT03190668|Cefazolin|cefazolin|mesh-list
153902260|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
153902261|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153902262|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902263|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153902264|NCT03162653|Allopurinol|allopurinol|mesh-list
153902265|NCT03162653|Mannitol|mannitol|mesh-list
153443688|NCT01944774|Nemonoxacin|nemonoxacin|mesh-list
153443689|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153443690|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443691|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153443692|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153443693|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443694|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443695|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443696|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153443697|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
153443710|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
153443712|NCT01984242|Bevacizumab|bevacizumab|mesh-list
153443713|NCT01984242|Atezolizumab|atezolizumab|mesh-list
153443715|NCT01984242|Antibodies|antibodies|mesh-list
153443716|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153443717|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153733762|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153733763|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733764|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153733765|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153733766|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153733767|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153733768|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
153733769|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153733770|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153733771|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
153733772|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733773|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733774|NCT00148590|Memantine|memantine|mesh-list
153733775|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153733776|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153733777|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
153733778|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733779|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733780|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733781|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153733782|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153733783|NCT02954068|Oxytocin|oxytocin|mesh-list
153733784|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
153733785|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153733786|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733787|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153733788|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
153733789|NCT00157131|Coagulants|coagulants|mesh-ancestor
153733790|NCT02954029|Hemostatics|hemostatics|mesh-list
153733791|NCT02954029|Coagulants|coagulants|mesh-ancestor
153733792|NCT00508456|Temozolomide|temozolomide|mesh-list
153733793|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153733794|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
153733795|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366144|NCT04359524|Vitamin D|vitamin d|mesh-list
153733796|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733797|NCT00508495|Acetaminophen|acetaminophen|mesh-list
153733800|NCT00508495|Analgesics|analgesics|mesh-ancestor
153443718|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443719|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153443720|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153443722|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902266|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
153902267|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902268|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902269|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
153902270|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902271|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153902272|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
153902273|NCT03162653|Protective Agents|protective agents|mesh-ancestor
153902274|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902275|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153902276|NCT03162653|Diuretics|diuretics|mesh-ancestor
153902277|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
153902278|NCT02991456|Ondansetron|ondansetron|mesh-list
153902279|NCT02991456|Rolapitant|rolapitant|mesh-list
153902280|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
153902281|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
153902282|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902283|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902284|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153902285|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
153902286|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
153902287|NCT02991456|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153868941|NCT00564200|Dexamethasone|dexamethasone|mesh-list
153595661|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153595662|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595663|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153595664|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
153595665|NCT01857544|Aflibercept|aflibercept|mesh-list
153902288|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153902289|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
153902290|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902291|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902292|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153902293|NCT02842827|Tretinoin|tretinoin|mesh-list
153902294|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902295|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
153902296|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
153902297|NCT02503774|Durvalumab|durvalumab|mesh-list
153902298|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153902299|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902300|NCT02432274|Etoposide|etoposide|mesh-list
153443733|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153443734|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
153443735|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443736|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443737|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443738|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153443739|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443740|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153443741|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
153443742|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
153443744|NCT01984164|Candesartan cilexetil|candesartan cilexetil|mesh-list
153443745|NCT01984164|Lisinopril|lisinopril|mesh-list
153443746|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153443747|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153443748|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153443749|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443750|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153443751|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
153443752|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443753|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153443754|NCT01984164|Protective Agents|protective agents|mesh-ancestor
153409472|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409473|NCT02465450|Lenabasum|lenabasum|mesh-list
153409474|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153409475|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153443755|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443756|NCT01983774|Esomeprazole|esomeprazole|mesh-list
153443757|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153902302|NCT02432274|Lenvatinib|lenvatinib|mesh-list
153902303|NCT02432274|Ifosfamide|ifosfamide|mesh-list
153902304|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
153902305|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153902306|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902307|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153733801|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
153733802|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733803|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733805|NCT00508690|Metronidazole|metronidazole|mesh-list
153733806|NCT00508690|Kanamycin|kanamycin|mesh-list
153733807|NCT00508690|Cefmetazole|cefmetazole|mesh-list
153733808|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733809|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153733810|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153733811|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153733812|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153733813|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733814|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733815|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153733816|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733817|NCT02953522|Folic Acid|folic acid|mesh-list
153733818|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
153733819|NCT02953522|Hematinics|hematinics|mesh-ancestor
153733820|NCT02953522|Vitamins|vitamins|mesh-ancestor
153733821|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
153733822|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733823|NCT00148746|Cyclosporine|cyclosporine|mesh-list
153733824|NCT00148746|Prednisolone|prednisolone|mesh-list
153733825|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
153733826|NCT00148746|Prednicarbate|prednicarbate|mesh-list
153733827|NCT00148746|Tacrolimus|tacrolimus|mesh-list
153733828|NCT00148746|Cyclosporins|cyclosporins|mesh-list
153733829|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733830|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
153733831|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733832|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153733833|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733834|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733846|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153733847|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153733848|NCT00148746|Analgesics|analgesics|mesh-ancestor
153733849|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
153733850|NCT00148785|Ritonavir|ritonavir|mesh-list
153868959|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153868960|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
153868961|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153868962|NCT00193479|Prednisone|prednisone|mesh-list
153733851|NCT00148785|Indinavir|indinavir|mesh-list
153733852|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
153733853|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153733854|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153733855|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
153733856|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733857|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733858|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153733859|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153733860|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
153733861|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733862|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153733863|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153733864|NCT00148824|Vaccines|vaccines|mesh-list
153733865|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153733866|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
153733867|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733868|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
153733869|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
153733870|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153733871|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733872|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153733873|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153733874|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733875|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733876|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733877|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153733890|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153733891|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733892|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733893|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
153733894|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153733895|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154256953|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366195|NCT01620047|Fentanyl|fentanyl|mesh-list
153733896|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153733897|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733898|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153733900|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
153733901|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153733902|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153733903|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733904|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733905|NCT00157326|Urological Agents|urological agents|mesh-ancestor
153733906|NCT00466843|Prednisone|prednisone|mesh-list
153733907|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153733908|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153733909|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
153733910|NCT00466843|Hormones|hormones|mesh-ancestor
153733911|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733912|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733913|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153733914|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733915|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
153902309|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902310|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902311|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153902312|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153902313|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
153902314|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
153902315|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
153902318|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153902319|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
153902320|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153902322|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
153902323|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902324|NCT01359592|Prednisone|prednisone|mesh-list
153902325|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
153902326|NCT01359592|Rituximab|rituximab|mesh-list
153902327|NCT01359592|Doxorubicin|doxorubicin|mesh-list
153902336|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
153902337|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443758|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153443759|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153443760|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443761|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443762|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
153443763|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
153443764|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443765|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
153443766|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443767|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443768|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153443769|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
153443770|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443771|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443772|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153357424|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153357425|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357426|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357427|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
153409523|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409524|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
153409525|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
153409526|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
153409527|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409528|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
153409529|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
153443773|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153443774|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153443775|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
153443776|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153443777|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733953|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733954|NCT00467194|Sirolimus|sirolimus|mesh-list
153733955|NCT00467194|Bevacizumab|bevacizumab|mesh-list
153733956|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153733957|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733958|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153733959|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153733960|NCT00467194|Growth Substances|growth substances|mesh-ancestor
153733961|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733962|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
153733963|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153733964|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733965|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153733966|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
153902338|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902339|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153902340|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153902350|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153902352|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
153902353|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
153902354|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153902355|NCT01331018|Plerixafor|plerixafor|mesh-list
153902356|NCT01331018|Prednisone|prednisone|mesh-list
153902357|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
153902358|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153443778|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443779|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
153443780|NCT01940484|Hematinics|hematinics|mesh-ancestor
153443781|NCT01960296|Clopidogrel|clopidogrel|mesh-list
153443782|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153443783|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153443784|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153443785|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153443786|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
153443787|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191156|NCT05945615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869009|NCT00193050|Docetaxel|docetaxel|mesh-list
153869010|NCT00193050|Epirubicin|epirubicin|mesh-list
153869012|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
153443788|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443789|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443790|NCT01939314|Bupivacaine|bupivacaine|mesh-list
153443791|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
153443792|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
153443793|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153443794|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443795|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
153443796|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443797|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153443798|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
153443799|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443800|NCT01939002|Interferons|interferons|mesh-list
153443801|NCT01939002|Interferon-beta|interferon-beta|mesh-list
153443802|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
153443803|NCT01939002|Naproxen|naproxen|mesh-list
153443804|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153443805|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153443806|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443807|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
153443808|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443809|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153443810|NCT01939002|Analgesics|analgesics|mesh-ancestor
153443811|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
153443812|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902359|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153902360|NCT01331018|Prednisolone|prednisolone|mesh-list
153902361|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
153902362|NCT01331018|Cortisone|cortisone|mesh-list
153902363|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153902364|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
153902365|NCT01331018|Lenograstim|lenograstim|mesh-list
153902366|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902367|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
153902368|NCT01331018|Hormones|hormones|mesh-ancestor
153902369|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902370|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902389|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
153902390|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902391|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902393|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153902394|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153902395|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902396|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
153902397|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
153902398|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
153443817|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443818|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443819|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
153443820|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153733984|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153733985|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733986|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153733987|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153733988|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153733989|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153733990|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
153733991|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733992|NCT03271918|Cabergoline|cabergoline|mesh-list
153733993|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153733994|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153733995|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
153733996|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
153733997|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733998|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733999|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734000|NCT00467467|Alfuzosin|alfuzosin|mesh-list
153734001|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153734002|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153734003|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153734004|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
153734005|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734006|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734007|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734008|NCT00467467|Urological Agents|urological agents|mesh-ancestor
153734009|NCT00406887|Difluprednate|difluprednate|mesh-list
153734010|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
153734012|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734013|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734014|NCT00467506|Antibodies|antibodies|mesh-list
153595666|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153734015|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153734016|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
153734017|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734022|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734023|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734024|NCT00467662|Acyclovir|acyclovir|mesh-list
153734025|NCT00467662|Docosanol|docosanol|mesh-list
153734026|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
153734027|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734028|NCT05497310|Tretinoin|tretinoin|mesh-list
153734029|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
153734030|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734031|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
153734032|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
153734033|NCT00467935|Ranibizumab|ranibizumab|mesh-list
153734034|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153734035|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153734036|NCT00467935|Growth Substances|growth substances|mesh-ancestor
153734037|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734038|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
153734039|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734040|NCT00149019|Antibodies|antibodies|mesh-list
153734041|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153734042|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
153734043|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734044|NCT00468091|Atropine|atropine|mesh-list
153734045|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153734046|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153734047|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153734048|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
153734075|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
153571110|NCT04989049|Hematinics|hematinics|mesh-ancestor
153734077|NCT03271450|Apixaban|apixaban|mesh-list
153734078|NCT03271450|Edoxaban|edoxaban|mesh-list
153734079|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
153734080|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153734081|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
153734082|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153734083|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
153734084|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409572|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
153409573|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
153409574|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
153409575|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409576|NCT02977897|Octreotide|octreotide|mesh-list
153409580|NCT00359905|Tamsulosin|tamsulosin|mesh-list
153734085|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734086|NCT00468754|Insulin|insulin|mesh-list
153734087|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734088|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734089|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153734090|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153734091|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734092|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
153734093|NCT00468871|Hormones|hormones|mesh-ancestor
153734094|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734095|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734096|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
153734097|NCT00468988|Travoprost|travoprost|mesh-list
153734098|NCT00468988|Latanoprost|latanoprost|mesh-list
153734099|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153734100|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153734101|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153734102|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
153734103|NCT00149136|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153734104|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153734105|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734106|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734108|NCT00469261|Doxycycline|doxycycline|mesh-list
153734121|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153734122|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734123|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153734124|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734125|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734126|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153734127|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153734128|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153734129|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153734130|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153734131|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153734132|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
153734133|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734134|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734135|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153734136|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153734137|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153734138|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
153810843|NCT00352443|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153810844|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
153734139|NCT00469495|Anthelmintics|anthelmintics|mesh-list
153734140|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153734141|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734142|NCT00469651|Vaccines|vaccines|mesh-list
153734143|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
153734144|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734145|NCT00149253|Etoricoxib|etoricoxib|mesh-list
153734146|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734147|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153734148|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153734149|NCT00149253|Analgesics|analgesics|mesh-ancestor
153734150|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
153734151|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734152|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734153|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734154|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153734155|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153734158|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153734159|NCT00469690|Bromfenac|bromfenac|mesh-list
153734160|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153734162|NCT00469690|Analgesics|analgesics|mesh-ancestor
153734163|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
153734164|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734165|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734166|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734167|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734168|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153734169|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734170|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734171|NCT00469768|Dapivirine|dapivirine|mesh-list
153734172|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153734173|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153734174|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
153734175|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734176|NCT06183567|Anesthetics|anesthetics|mesh-list
153734177|NCT06183567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734178|NCT06183567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734179|NCT06183242|Niacinamide|niacinamide|mesh-list
153734180|NCT06183242|Niacin|niacin|mesh-list
153734181|NCT06183242|Nicotinic Acids|nicotinic acids|mesh-list
153734182|NCT06183242|Vitamin B Complex|vitamin b complex|mesh-ancestor
153734183|NCT06183242|Vitamins|vitamins|mesh-ancestor
153734184|NCT06183242|Micronutrients|micronutrients|mesh-ancestor
153734185|NCT06183242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869081|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869082|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
153409589|NCT00359905|Urological Agents|urological agents|mesh-ancestor
153409590|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
153409591|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153409592|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
153409593|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409594|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
153409595|NCT05086939|Protective Agents|protective agents|mesh-ancestor
153409596|NCT00358813|Casopitant|casopitant|mesh-list
153409597|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
153409598|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
153409599|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409600|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734186|NCT06183242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153734187|NCT06183242|Antimetabolites|antimetabolites|mesh-ancestor
153734188|NCT06183242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734189|NCT06183242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153734190|NCT06183242|Vasodilator Agents|vasodilator agents|mesh-ancestor
153734191|NCT06183216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153734192|NCT06183216|Immunologic Factors|immunologic factors|mesh-ancestor
153734193|NCT06183216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734200|NCT06183073|Sensory System Agents|sensory system agents|mesh-ancestor
153734201|NCT06183073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734202|NCT06183073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153734203|NCT06183073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153734204|NCT06183073|Analgesics|analgesics|mesh-ancestor
153734205|NCT06183073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153734206|NCT06183073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153734207|NCT06183073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153734208|NCT06183073|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366316|NCT01623323|Xhance|xhance|mesh-list
153734209|NCT06183073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734210|NCT06183073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734211|NCT06183008|Immunoglobulins|immunoglobulins|mesh-list
153734212|NCT06183008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153734213|NCT06183008|Antibodies|antibodies|mesh-list
153734214|NCT06183008|gamma-Globulins|gamma-globulins|mesh-list
153734215|NCT06183008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153734216|NCT06183008|Immunologic Factors|immunologic factors|mesh-ancestor
153734217|NCT06183008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734218|NCT06247410|Rotigotine|rotigotine|mesh-list
153734219|NCT06247410|Dopamine Agonists|dopamine agonists|mesh-ancestor
153734220|NCT06247410|Dopamine Agents|dopamine agents|mesh-ancestor
153734221|NCT06247410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734222|NCT06247410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734223|NCT06247410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734224|NCT06247267|Methyltestosterone|methyltestosterone|mesh-list
153734225|NCT06247267|Estradiol|estradiol|mesh-list
153734226|NCT06247267|Testosterone|testosterone|mesh-list
153734227|NCT06247267|Testosterone undecanoate|testosterone undecanoate|mesh-list
153734228|NCT06247267|Testosterone enanthate|testosterone enanthate|mesh-list
153409610|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409611|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810846|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153810847|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153734229|NCT06247267|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153734230|NCT06247267|Estrogens|estrogens|mesh-ancestor
153734231|NCT06247267|Hormones|hormones|mesh-ancestor
153443821|NCT01938846|Paclitaxel|paclitaxel|mesh-list
153443822|NCT01938846|Exemestane|exemestane|mesh-list
153443823|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153443824|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443825|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
153443826|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
153443827|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
153443828|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443829|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153443830|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153443831|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443832|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153734232|NCT06247267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734233|NCT06247267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734234|NCT06247267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153734235|NCT06247267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734236|NCT06247267|Anabolic Agents|anabolic agents|mesh-ancestor
153734237|NCT06247267|Androgens|androgens|mesh-ancestor
153734238|NCT06246916|Nivolumab|nivolumab|mesh-list
153734239|NCT06246916|Cemiplimab|cemiplimab|mesh-list
153734240|NCT06246916|Relatlimab|relatlimab|mesh-list
153734241|NCT06246916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734242|NCT06246916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734243|NCT06246916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153734244|NCT06246916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734245|NCT06246799|Metformin|metformin|mesh-list
153734246|NCT06246799|Pioglitazone|pioglitazone|mesh-list
153734247|NCT06246799|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153734248|NCT06246799|Tirzepatide|tirzepatide|mesh-list
153734249|NCT06246799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734250|NCT06246799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734251|NCT06246799|Incretins|incretins|mesh-ancestor
153734252|NCT06246799|Hormones|hormones|mesh-ancestor
153734253|NCT06246799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734254|NCT06246799|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153734255|NCT06246799|Protease Inhibitors|protease inhibitors|mesh-ancestor
153734256|NCT06246799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734257|NCT06246799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734258|NCT06246786|Cyclosporine|cyclosporine|mesh-list
153734259|NCT06246786|Cyclosporins|cyclosporins|mesh-list
153734260|NCT06246786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734261|NCT06246786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734262|NCT06246786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153734263|NCT06246786|Immunologic Factors|immunologic factors|mesh-ancestor
153734264|NCT06246786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734265|NCT06246786|Antifungal Agents|antifungal agents|mesh-ancestor
153734266|NCT06246786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734273|NCT06246695|Antifungal Agents|antifungal agents|mesh-ancestor
153734274|NCT06246695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734275|NCT06246695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153734276|NCT06246695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153734277|NCT06246695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734278|NCT06246695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734279|NCT06246695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153734280|NCT06246695|Hormone Antagonists|hormone antagonists|mesh-ancestor
153734281|NCT06246695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734282|NCT06246695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734283|NCT06246695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153734284|NCT06246695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153734285|NCT06246695|Antitubercular Agents|antitubercular agents|mesh-ancestor
153734286|NCT06246695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153734287|NCT06246695|Leprostatic Agents|leprostatic agents|mesh-ancestor
153734288|NCT06246695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153734289|NCT06246695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153734290|NCT06246695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153734291|NCT06246695|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153734292|NCT06246695|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153734293|NCT06246695|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153734294|NCT06246695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153734295|NCT06246513|Prednisone|prednisone|mesh-list
153734296|NCT06246513|Glucocorticoids|glucocorticoids|mesh-list
153734297|NCT06246513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734298|NCT06246513|Hormones|hormones|mesh-ancestor
153734299|NCT06246513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734300|NCT06246513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734303|NCT06246461|Capecitabine|capecitabine|mesh-list
153734312|NCT06246422|Hemostatics|hemostatics|mesh-ancestor
153734313|NCT06246422|Coagulants|coagulants|mesh-ancestor
153734314|NCT06246188|Regadenoson|regadenoson|mesh-list
153734315|NCT06246188|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153734316|NCT06246188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153734317|NCT06246188|Purinergic Agonists|purinergic agonists|mesh-ancestor
153595667|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153595668|NCT01857544|Growth Substances|growth substances|mesh-ancestor
153595669|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818911|NCT03568058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818912|NCT03517969|Carboplatin|carboplatin|mesh-list
153818913|NCT03517969|Docetaxel|docetaxel|mesh-list
153818914|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818915|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818916|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460302|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153460303|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595670|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
153595671|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595673|NCT01857596|Bupropion|bupropion|mesh-list
153595674|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153595675|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
153595676|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153734318|NCT06246188|Purinergic Agents|purinergic agents|mesh-ancestor
153734319|NCT06246188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734320|NCT06246188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734321|NCT06246188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734323|NCT06245902|Naltrexone|naltrexone|mesh-list
153734324|NCT06245902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153734325|NCT06245902|Analgesics|analgesics|mesh-ancestor
153734326|NCT06245902|Sensory System Agents|sensory system agents|mesh-ancestor
153734327|NCT06245902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734328|NCT06245902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734329|NCT06245902|Antipyretics|antipyretics|mesh-ancestor
153734330|NCT06245902|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153734331|NCT06245902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153734332|NCT06245824|Trastuzumab|trastuzumab|mesh-list
153734333|NCT06245824|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153734334|NCT06245824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734335|NCT06245824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734336|NCT06245824|Immunoconjugates|immunoconjugates|mesh-ancestor
153734337|NCT06245824|Immunologic Factors|immunologic factors|mesh-ancestor
153734338|NCT06245824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734339|NCT06245707|Prednisone|prednisone|mesh-list
153734340|NCT06245707|Cyclophosphamide|cyclophosphamide|mesh-list
153734341|NCT06245707|Rituximab|rituximab|mesh-list
153734342|NCT06245707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153734343|NCT06245707|Immunologic Factors|immunologic factors|mesh-ancestor
153734353|NCT06245707|Glucocorticoids|glucocorticoids|mesh-ancestor
153734357|NCT06245681|Hormones|hormones|mesh-list
153734358|NCT06245681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734359|NCT06245681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734360|NCT06245629|Bortezomib|bortezomib|mesh-list
153440069|NCT00003937|Cisplatin|cisplatin|mesh-list
153595677|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153595678|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153595679|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153595680|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595681|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
153595682|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595683|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734361|NCT06245629|Melphalan|melphalan|mesh-list
153734362|NCT06245629|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153734363|NCT06245629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734364|NCT06245629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153734365|NCT06245629|Alkylating Agents|alkylating agents|mesh-ancestor
153734366|NCT06245629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734367|NCT06245629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153734368|NCT06245629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153734369|NCT06245629|Immunologic Factors|immunologic factors|mesh-ancestor
153734370|NCT06245629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734371|NCT06245590|Midodrine|midodrine|mesh-list
153734372|NCT06245590|Sympathomimetics|sympathomimetics|mesh-ancestor
153734373|NCT06245590|Autonomic Agents|autonomic agents|mesh-ancestor
153734374|NCT06245590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734375|NCT06245590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734376|NCT06245590|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153734377|NCT06245590|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153734378|NCT06245590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153571415|NCT04169451|Letrozole|letrozole|mesh-list
153734379|NCT06245590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153734380|NCT06245590|Adrenergic Agents|adrenergic agents|mesh-ancestor
153734381|NCT06245590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734382|NCT06245590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734383|NCT06245551|Budesonide|budesonide|mesh-list
153734384|NCT06245551|Albuterol|albuterol|mesh-list
153734385|NCT06245551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734386|NCT06245551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153734399|NCT06245551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153734400|NCT06245551|Adrenergic Agents|adrenergic agents|mesh-ancestor
153734401|NCT06245551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734402|NCT06245551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734403|NCT06245291|Durvalumab|durvalumab|mesh-list
153734404|NCT06245291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734405|NCT06245291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734406|NCT06245161|Anesthetics|anesthetics|mesh-list
153734407|NCT06245161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734408|NCT06245161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443833|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
153443834|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443835|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443836|NCT01960140|Simvastatin|simvastatin|mesh-list
153443837|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153443838|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153443839|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
153443840|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443841|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153443842|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153443844|NCT01980888|Rituximab|rituximab|mesh-list
153443845|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153902401|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153902402|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
153902404|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902405|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902406|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153902407|NCT00697073|Idebenone|idebenone|mesh-list
153902408|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
153902409|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902410|NCT00697073|Protective Agents|protective agents|mesh-ancestor
153902411|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902412|NCT00656331|Amlodipine|amlodipine|mesh-list
153902413|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153902414|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153902415|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902416|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902417|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153902418|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902419|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
153902420|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
153902421|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153902422|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
153810852|NCT00322400|Docetaxel|docetaxel|mesh-list
153810853|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
153810854|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153357436|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153357437|NCT04385264|Diuretics|diuretics|mesh-ancestor
153357438|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
153357439|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902423|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902424|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
153902425|NCT00653432|Protective Agents|protective agents|mesh-ancestor
153902426|NCT00537680|Ubiquinone|ubiquinone|mesh-list
153902427|NCT00537680|Idebenone|idebenone|mesh-list
153902428|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
153902429|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902430|NCT00537680|Protective Agents|protective agents|mesh-ancestor
153902431|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902432|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
153902433|NCT00446043|Adapalene|adapalene|mesh-list
153902434|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
153902435|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153902436|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
153902437|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153902438|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153902439|NCT00446043|Analgesics|analgesics|mesh-ancestor
153443857|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
153443859|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734409|NCT06245109|Celecoxib|celecoxib|mesh-list
153443860|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443861|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
153443862|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443863|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153443864|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153443865|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153443866|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153443867|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443868|NCT01937364|Baclofen|baclofen|mesh-list
153443869|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153443870|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443871|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153443872|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443873|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153443874|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
153443875|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
153443876|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191157|NCT05945615|Sympathomimetics|sympathomimetics|mesh-ancestor
153869123|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869124|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153869125|NCT00190983|Pemetrexed|pemetrexed|mesh-list
153869126|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869127|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869128|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869129|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153595684|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153595685|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153443877|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443878|NCT01979952|Nintedanib|nintedanib|mesh-list
153443879|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902440|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
153902441|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902442|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902443|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902444|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902446|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902447|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
153902448|NCT00400725|Hormones|hormones|mesh-ancestor
153902449|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902450|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902451|NCT00932113|Folic Acid|folic acid|mesh-list
153902452|NCT00932113|Adalimumab|adalimumab|mesh-list
153902453|NCT00932113|Methotrexate|methotrexate|mesh-list
153902454|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153902455|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
153902456|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153902457|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902458|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153902459|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
153902460|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902461|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902462|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
153443880|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443881|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443882|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443884|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153443885|NCT01999218|Glimepiride|glimepiride|mesh-list
153443886|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
153443887|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153443906|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153443907|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153443908|NCT01936974|Growth Substances|growth substances|mesh-ancestor
153409661|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153810882|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153810883|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153810884|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810885|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153810886|NCT00322595|Paroxetine|paroxetine|mesh-list
153443909|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357470|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
153443910|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
153443911|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153734411|NCT06245109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153734413|NCT06245109|Analgesics|analgesics|mesh-ancestor
153734414|NCT06245109|Sensory System Agents|sensory system agents|mesh-ancestor
153734415|NCT06245109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734416|NCT06245109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734417|NCT06245109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734418|NCT06245109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734419|NCT06245109|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153734420|NCT06245109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153734421|NCT06245109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734422|NCT06245109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734423|NCT06245109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153734424|NCT06245109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153734425|NCT06245109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153734426|NCT06245109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734427|NCT06245109|Antidepressive Agents|antidepressive agents|mesh-ancestor
153734428|NCT06245109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153734429|NCT06245109|Dopamine Agents|dopamine agents|mesh-ancestor
153734430|NCT06244407|Metformin|metformin|mesh-list
153734431|NCT06244407|Vildagliptin|vildagliptin|mesh-list
153734432|NCT06244407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734433|NCT06244407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734434|NCT06244407|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153734435|NCT06244407|Protease Inhibitors|protease inhibitors|mesh-ancestor
153734436|NCT06244407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734437|NCT06244407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734438|NCT06243809|Linagliptin|linagliptin|mesh-list
153734439|NCT06243809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734440|NCT06243809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734441|NCT06243809|Incretins|incretins|mesh-ancestor
153734451|NCT06241781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734452|NCT06241781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734453|NCT06241456|Cyclophosphamide|cyclophosphamide|mesh-list
153734454|NCT06241456|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153734455|NCT06241456|Docetaxel|docetaxel|mesh-list
153734456|NCT06241456|Fludarabine|fludarabine|mesh-list
153734457|NCT06241456|Cetuximab|cetuximab|mesh-list
153734458|NCT06241456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153734459|NCT06241456|Immunologic Factors|immunologic factors|mesh-ancestor
153734460|NCT06241456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734461|NCT06241456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734462|NCT06241456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153734463|NCT06241456|Alkylating Agents|alkylating agents|mesh-ancestor
153734464|NCT06241456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734465|NCT06241456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734466|NCT06241456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153734467|NCT06241456|Tubulin Modulators|tubulin modulators|mesh-ancestor
153734468|NCT06241456|Antimitotic Agents|antimitotic agents|mesh-ancestor
153734469|NCT06241456|Mitosis Modulators|mitosis modulators|mesh-ancestor
153734470|NCT06241456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734471|NCT06241261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153734472|NCT06241261|Fluorides|fluorides|mesh-list
153734473|NCT06241261|Cariostatic Agents|cariostatic agents|mesh-ancestor
153734474|NCT06241261|Protective Agents|protective agents|mesh-ancestor
153734475|NCT06241261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734476|NCT06231212|Ibuprofen|ibuprofen|mesh-list
153734477|NCT06231212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153734478|NCT06231212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153734479|NCT06231212|Analgesics|analgesics|mesh-ancestor
153734480|NCT06231212|Sensory System Agents|sensory system agents|mesh-ancestor
153734488|NCT06227429|Nitisinone|nitisinone|mesh-list
153734495|NCT06217562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153734498|NCT06217562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734499|NCT06209112|Sevoflurane|sevoflurane|mesh-list
153734500|NCT06209112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153734501|NCT06209112|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153734502|NCT06209112|Anesthetics, General|anesthetics, general|mesh-ancestor
153734503|NCT06209112|Anesthetics|anesthetics|mesh-ancestor
153734504|NCT06209112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734505|NCT06209112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734506|NCT06204016|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153734507|NCT06204016|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153734508|NCT06204016|Estradiol|estradiol|mesh-list
153734509|NCT06204016|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153734510|NCT06204016|Estrogens|estrogens|mesh-ancestor
153734511|NCT06204016|Hormones|hormones|mesh-ancestor
153734512|NCT06204016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734513|NCT06204016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734514|NCT06204016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153734515|NCT06204016|Contraceptive Agents|contraceptive agents|mesh-ancestor
153734516|NCT06204016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153734517|NCT06204016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153734518|NCT06201000|Dapagliflozin|dapagliflozin|mesh-list
153734519|NCT06201000|Empagliflozin|empagliflozin|mesh-list
153734520|NCT06201000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153734521|NCT06201000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734522|NCT06201000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734523|NCT06201000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902463|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902464|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153902465|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153902466|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
153902467|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902468|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153902469|NCT00932113|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153902470|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902471|NCT00932113|Hematinics|hematinics|mesh-ancestor
153902472|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
153902473|NCT00932113|Vitamins|vitamins|mesh-ancestor
153902474|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
153902475|NCT00931801|Tenofovir|tenofovir|mesh-list
153734541|NCT06181591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734542|NCT06181591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734543|NCT06181591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734544|NCT06181591|Urological Agents|urological agents|mesh-ancestor
153734545|NCT06181591|Parasympatholytics|parasympatholytics|mesh-ancestor
153734546|NCT06181591|Autonomic Agents|autonomic agents|mesh-ancestor
153734547|NCT06181591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734548|NCT06181591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153734549|NCT06181591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153734550|NCT06181591|Cholinergic Agents|cholinergic agents|mesh-ancestor
153734576|NCT06120972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734577|NCT06120972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734578|NCT06120972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734580|NCT06120075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734581|NCT06120075|Tubulin Modulators|tubulin modulators|mesh-ancestor
153734582|NCT06120075|Antimitotic Agents|antimitotic agents|mesh-ancestor
153734583|NCT06120075|Mitosis Modulators|mitosis modulators|mesh-ancestor
153734584|NCT06120075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734585|NCT06097390|Semaglutide|semaglutide|mesh-list
154191158|NCT05945615|Autonomic Agents|autonomic agents|mesh-ancestor
153734586|NCT06097390|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153734587|NCT06097390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734588|NCT06097390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734589|NCT06086457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153734590|NCT06086457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734591|NCT06086457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734592|NCT06086457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902479|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
153902480|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902481|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153902482|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153902483|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782034|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153782035|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153902484|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902490|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153902491|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
153902492|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153375158|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
153902493|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
153443913|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443914|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
153443915|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
153443916|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153443917|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
153443918|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443919|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443920|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153443921|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
153443922|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
153443923|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153443924|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
153443925|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443926|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443927|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153443928|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153443929|NCT01979016|Emollients|emollients|mesh-list
153443930|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
153443931|NCT01935336|Ponatinib|ponatinib|mesh-list
153443932|NCT01935336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153409719|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810888|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153443933|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443934|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734593|NCT06072131|Prednisone|prednisone|mesh-list
153734594|NCT06072131|Cyclophosphamide|cyclophosphamide|mesh-list
153734595|NCT06072131|Doxorubicin|doxorubicin|mesh-list
153734596|NCT06072131|Vincristine|vincristine|mesh-list
153734597|NCT06072131|Belinostat|belinostat|mesh-list
153734598|NCT06072131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153734599|NCT06072131|Immunologic Factors|immunologic factors|mesh-ancestor
153734600|NCT06072131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734601|NCT06072131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734602|NCT06072131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153734603|NCT06072131|Alkylating Agents|alkylating agents|mesh-ancestor
153734604|NCT06072131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734605|NCT06072131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734606|NCT06072131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153734607|NCT06072131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153734608|NCT06072131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153734609|NCT06072131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153734610|NCT06072131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734611|NCT06072131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734612|NCT06072131|Glucocorticoids|glucocorticoids|mesh-ancestor
153734613|NCT06072131|Hormones|hormones|mesh-ancestor
153734614|NCT06072131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734615|NCT06072131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153734616|NCT06072131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153734617|NCT06072131|Tubulin Modulators|tubulin modulators|mesh-ancestor
153734618|NCT06072131|Antimitotic Agents|antimitotic agents|mesh-ancestor
153734619|NCT06072131|Mitosis Modulators|mitosis modulators|mesh-ancestor
153734620|NCT06072131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153734621|NCT06059846|Imipenem|imipenem|mesh-list
153734622|NCT06059846|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
153734623|NCT06059846|Cilastatin|cilastatin|mesh-list
153734632|NCT06052839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153734633|NCT06052839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734634|NCT06052839|Tubulin Modulators|tubulin modulators|mesh-ancestor
153734635|NCT06052839|Antimitotic Agents|antimitotic agents|mesh-ancestor
153734636|NCT06052839|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869199|NCT00198276|Bleomycin|bleomycin|mesh-list
153734637|NCT06052839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734638|NCT06052839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734639|NCT06052839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153734641|NCT06042920|Dermatologic Agents|dermatologic agents|mesh-ancestor
153734642|NCT06042920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153734643|NCT06042920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734644|NCT06042920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734645|NCT06040905|Ubiquinone|ubiquinone|mesh-list
153734646|NCT06040905|Coenzyme Q10|coenzyme q10|mesh-list
153734647|NCT06040905|Micronutrients|micronutrients|mesh-ancestor
153734648|NCT06040905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734649|NCT06040905|Vitamins|vitamins|mesh-ancestor
153734650|NCT06030843|Empagliflozin|empagliflozin|mesh-list
153734651|NCT06030843|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153734652|NCT06030843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734653|NCT06030843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734654|NCT06030843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734655|NCT06012266|Dapagliflozin|dapagliflozin|mesh-list
153734656|NCT06012266|Empagliflozin|empagliflozin|mesh-list
153734657|NCT06012266|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153734659|NCT06012266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734664|NCT06002789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153734665|NCT06002789|Immunologic Factors|immunologic factors|mesh-ancestor
153734666|NCT06002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734667|NCT06002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734668|NCT05988684|Metformin|metformin|mesh-list
153734669|NCT05988684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734670|NCT05988684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734671|NCT05986422|Methylprednisolone|methylprednisolone|mesh-list
153734672|NCT05986422|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153734673|NCT05986422|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153734674|NCT05986422|Prednisolone|prednisolone|mesh-list
153734675|NCT05986422|Prednisolone acetate|prednisolone acetate|mesh-list
153734676|NCT05986422|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153734677|NCT05986422|Prednisolone phosphate|prednisolone phosphate|mesh-list
153734678|NCT05986422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153440271|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810890|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153409749|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734680|NCT05986422|Autonomic Agents|autonomic agents|mesh-ancestor
153734681|NCT05986422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734682|NCT05986422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734683|NCT05986422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153734684|NCT05986422|Glucocorticoids|glucocorticoids|mesh-ancestor
153734685|NCT05986422|Hormones|hormones|mesh-ancestor
153734686|NCT05986422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734687|NCT05986422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153734688|NCT05986422|Protective Agents|protective agents|mesh-ancestor
153734689|NCT05986422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153734716|NCT05915169|Analgesics|analgesics|mesh-ancestor
153734721|NCT05915169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734723|NCT05913284|Methadone|methadone|mesh-list
153734724|NCT05913284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153734725|NCT05913284|Narcotics|narcotics|mesh-ancestor
153734726|NCT05913284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734727|NCT05913284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734728|NCT05913284|Analgesics|analgesics|mesh-ancestor
153734729|NCT05913284|Sensory System Agents|sensory system agents|mesh-ancestor
153734730|NCT05913284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734731|NCT05913284|Antitussive Agents|antitussive agents|mesh-ancestor
153734732|NCT05913284|Respiratory System Agents|respiratory system agents|mesh-ancestor
153734733|NCT05903339|MEDI9197|medi9197|mesh-list
153734734|NCT05903339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153734735|NCT05903339|Immunologic Factors|immunologic factors|mesh-ancestor
153734736|NCT05903339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734737|NCT05891171|Leucovorin|leucovorin|mesh-list
153734739|NCT05891171|Fluorouracil|fluorouracil|mesh-list
153734740|NCT05891171|Oxaliplatin|oxaliplatin|mesh-list
153734741|NCT05891171|Pemetrexed|pemetrexed|mesh-list
153734769|NCT05878522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153734770|NCT05878522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734771|NCT05878522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153734772|NCT05878522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153734773|NCT05878522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734774|NCT05878522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734775|NCT05878522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734776|NCT05876572|Naloxone|naloxone|mesh-list
153869219|NCT00564590|Melatonin|melatonin|mesh-list
153810891|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595686|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595687|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153595688|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153595689|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595690|NCT01857596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153595691|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
153595692|NCT01857609|Metformin|metformin|mesh-list
153595693|NCT01857609|Rabeprazole|rabeprazole|mesh-list
153595694|NCT01857609|Pantoprazole|pantoprazole|mesh-list
153595695|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153595696|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595697|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153734777|NCT05876572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153734778|NCT05876572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734779|NCT05876572|Sensory System Agents|sensory system agents|mesh-ancestor
153734780|NCT05876572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902494|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153902495|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153902496|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153902497|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902498|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902499|NCT05025397|Propofol|propofol|mesh-list
153902500|NCT05025397|Sevoflurane|sevoflurane|mesh-list
153902501|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153902502|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902503|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443936|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443937|NCT01978236|Trametinib|trametinib|mesh-list
153443938|NCT01978236|Dabrafenib|dabrafenib|mesh-list
153443939|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443940|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443941|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443942|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443943|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153443944|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443945|NCT01934556|Ranibizumab|ranibizumab|mesh-list
153443946|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153734796|NCT05867251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153734797|NCT05867251|Hormone Antagonists|hormone antagonists|mesh-ancestor
153902521|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153734805|NCT05828147|Rituximab|rituximab|mesh-list
153734806|NCT05828147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734807|NCT05828147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734808|NCT05828147|Immunologic Factors|immunologic factors|mesh-ancestor
153734809|NCT05828147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734810|NCT05828147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734811|NCT05822362|Cannabidiol|cannabidiol|mesh-list
153734812|NCT05822362|Anticonvulsants|anticonvulsants|mesh-ancestor
153734813|NCT05770544|Entrectinib|entrectinib|mesh-list
153734814|NCT05770544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153734815|NCT05770544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734816|NCT05770544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734817|NCT05747469|Lidocaine|lidocaine|mesh-list
153734818|NCT05747469|Anesthetics, Local|anesthetics, local|mesh-list
153734819|NCT05747469|Anesthetics|anesthetics|mesh-list
153734820|NCT05747469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734821|NCT05747469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734822|NCT05747469|Sensory System Agents|sensory system agents|mesh-ancestor
153734823|NCT05747469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734824|NCT05747469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153902522|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902523|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902524|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153902525|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902526|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153902527|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902528|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
153443960|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443961|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153443962|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153443963|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
153443964|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
153443965|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443966|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443967|NCT01932996|Nicotine|nicotine|mesh-list
153443968|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153443969|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
153443970|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443971|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443972|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153443973|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153734825|NCT05747469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153869242|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357471|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357472|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
153357473|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
153357474|NCT01279616|Busulfan|busulfan|mesh-list
153357475|NCT01279616|Rituximab|rituximab|mesh-list
153357476|NCT01279616|Fludarabine|fludarabine|mesh-list
153357477|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
153357478|NCT01279616|Tacrolimus|tacrolimus|mesh-list
153357479|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
153357480|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153357481|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
153357482|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734826|NCT05747469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153734827|NCT05747469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153734828|NCT05747469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734829|NCT05737576|Insulin Aspart|insulin aspart|mesh-list
153571861|NCT05161468|Hormones|hormones|mesh-ancestor
153734830|NCT05737576|Insulin, Long-Acting|insulin, long-acting|mesh-list
153734831|NCT05737576|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153734832|NCT05737576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734833|NCT05737576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734834|NCT05736562|Vitamins|vitamins|mesh-list
153734835|NCT05736562|Micronutrients|micronutrients|mesh-ancestor
153734836|NCT05736562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734837|NCT05726318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153734838|NCT05726318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734839|NCT05713877|Melatonin|melatonin|mesh-list
153734840|NCT05713877|Antioxidants|antioxidants|mesh-ancestor
153734841|NCT05713877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734881|NCT05624996|Carboplatin|carboplatin|mesh-list
153734882|NCT05624996|Pemetrexed|pemetrexed|mesh-list
153734883|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153734884|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
153734885|NCT05624996|Durvalumab|durvalumab|mesh-list
153734886|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
153734887|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153734888|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
153734889|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153734890|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734891|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
153734892|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
153734893|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
153734894|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734895|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153734896|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153734897|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734898|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153734899|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153734900|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734901|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
153810894|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153810895|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153810896|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810897|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810898|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
153810899|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153810900|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153810901|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153357483|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734902|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734903|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
153734904|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
153734905|NCT05624840|Ritonavir|ritonavir|mesh-list
153734906|NCT05624840|Nirmatrelvir|nirmatrelvir|mesh-list
153734907|NCT05624840|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153734908|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153734909|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153734910|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
153734911|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734912|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734913|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153734914|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153734915|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
153734916|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734917|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153734919|NCT05613153|Peppermint oil|peppermint oil|mesh-list
153734920|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
153734921|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
153734922|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734923|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734924|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153734925|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
153734926|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
153734927|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
153734928|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734929|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
153734930|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734931|NCT05593042|Vaccines|vaccines|mesh-list
153734932|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
153734933|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734934|NCT05591001|Ketamine|ketamine|mesh-list
153734935|NCT05591001|Propofol|propofol|mesh-list
153734936|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153734937|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734938|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734939|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153734940|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
153869283|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869284|NCT00589485|Cobalt|cobalt|mesh-list
153869285|NCT00589485|Trace Elements|trace elements|mesh-ancestor
153869286|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
153869287|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869288|NCT00564941|Deferasirox|deferasirox|mesh-list
153869289|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153869290|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
153869291|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
153869292|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869293|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153869294|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153869295|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869296|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
153869297|NCT00589953|Hematinics|hematinics|mesh-ancestor
153869298|NCT00589992|Ibutilide|ibutilide|mesh-list
153595698|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153734941|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
153734942|NCT05591001|Analgesics|analgesics|mesh-ancestor
153734943|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
153734944|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734945|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153734946|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153734947|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153734948|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734949|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734950|NCT05584683|Amoxicillin|amoxicillin|mesh-list
153734951|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
153734965|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
153734966|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734967|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734968|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153734969|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
153734970|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734971|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734972|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153734973|NCT05568095|Antidotes|antidotes|mesh-ancestor
153734974|NCT05568095|Protective Agents|protective agents|mesh-ancestor
153734975|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
153734977|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
153734978|NCT05559099|Tecovirimat|tecovirimat|mesh-list
153734979|NCT05559099|Antiviral Agents|antiviral agents|mesh-ancestor
153734980|NCT05559099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734981|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153734982|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734983|NCT05522660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734984|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734985|NCT05522361|Risdiplam|risdiplam|mesh-list
153734986|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153734987|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734988|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734989|NCT05515315|Paclitaxel|paclitaxel|mesh-list
153734990|NCT05515315|Tislelizumab|tislelizumab|mesh-list
153409827|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153409828|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153409829|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
153409830|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409831|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409832|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153409833|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
153409834|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
153409835|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153409836|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153409837|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153409838|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153409839|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
153409840|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409841|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734991|NCT05515315|Nedaplatin|nedaplatin|mesh-list
153413022|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
153902531|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153902532|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153902533|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153902534|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902535|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902536|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
153902537|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734993|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734994|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153734995|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153734996|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153734997|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734998|NCT05515315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734999|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
153735000|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735001|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735002|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
153735003|NCT05466799|Irinotecan|irinotecan|mesh-list
153735004|NCT05466799|Folfirinox|folfirinox|mesh-list
153735005|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735006|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153735007|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153735008|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413044|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
153902545|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902547|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
153902548|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902549|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902550|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153902551|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
153902552|NCT00609817|Hormones|hormones|mesh-ancestor
153902553|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902554|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153902555|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902556|NCT00929695|Prednisone|prednisone|mesh-list
153902557|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
153902558|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153357484|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153409846|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
153409847|NCT03822637|Protective Agents|protective agents|mesh-ancestor
153409848|NCT03822637|Antidotes|antidotes|mesh-ancestor
153595699|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153443976|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443977|NCT01932762|Ribavirin|ribavirin|mesh-list
153443978|NCT01932762|Grazoprevir|grazoprevir|mesh-list
153443979|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
153443980|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443981|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
153443982|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443983|NCT01977456|Eptifibatide|eptifibatide|mesh-list
153443984|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153443985|NCT01957644|Azacitidine|azacitidine|mesh-list
153735009|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735011|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
153735012|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
153735013|NCT05458024|Vitamins|vitamins|mesh-list
153735014|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
153735015|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735016|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153735017|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153735018|NCT05431270|Tislelizumab|tislelizumab|mesh-list
153735019|NCT05431270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735020|NCT05431270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735021|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153735022|NCT05408845|Trastuzumab|trastuzumab|mesh-list
153735023|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153735024|NCT05408845|Docetaxel|docetaxel|mesh-list
153735025|NCT05408845|Maytansine|maytansine|mesh-list
153735026|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153735027|NCT05408845|Antibodies|antibodies|mesh-list
153735028|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
153735029|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153735030|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
153735031|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
153735032|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735033|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735034|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
153735035|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
153735036|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735039|NCT05408845|Immunotoxins|immunotoxins|mesh-ancestor
153810903|NCT00352677|Bafetinib|bafetinib|mesh-list
153357485|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
153357486|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357487|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357488|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153357489|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153357490|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153357491|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
153357492|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153357493|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735058|NCT05355441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735059|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735061|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
153735062|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735063|NCT05355441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153735064|NCT05355441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153735065|NCT05355441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735066|NCT05355441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735067|NCT05355441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153735068|NCT05355441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735079|NCT05339256|Buprenorphine|buprenorphine|mesh-list
153735080|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153735081|NCT05339256|Narcotics|narcotics|mesh-ancestor
153735082|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735083|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735084|NCT05339256|Analgesics|analgesics|mesh-ancestor
153735085|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
153735086|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735087|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153735088|NCT05338541|Etoposide|etoposide|mesh-list
153735089|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153735090|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735092|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153735093|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735094|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735095|NCT05327647|Bicalutamide|bicalutamide|mesh-list
153735096|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
153735097|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
153735098|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
153735099|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735100|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735101|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735102|NCT05314569|Midazolam|midazolam|mesh-list
153735103|NCT05314569|Fentanyl|fentanyl|mesh-list
153735104|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
153735105|NCT05314569|Ketamine|ketamine|mesh-list
153735106|NCT05314569|Isoflurane|isoflurane|mesh-list
153735107|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153735108|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735109|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735110|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153735111|NCT05314569|Analgesics|analgesics|mesh-ancestor
153735112|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
153735113|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735114|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153735115|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153735118|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735119|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735120|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153735121|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153735123|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
153735134|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153735137|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153735138|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735139|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735140|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735141|NCT05288374|Celecoxib|celecoxib|mesh-list
153735142|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153735143|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153735144|NCT05288374|Analgesics|analgesics|mesh-ancestor
153735145|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
153735146|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735147|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735148|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735149|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735150|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153735151|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153735152|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735153|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735154|NCT05234684|Prednisone|prednisone|mesh-list
153735155|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
153735156|NCT05234684|Vincristine|vincristine|mesh-list
153735157|NCT05234684|Rituximab|rituximab|mesh-list
153735158|NCT05234684|Doxorubicin|doxorubicin|mesh-list
153735159|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153735160|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
153735161|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735162|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735163|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153735164|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
153735165|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810904|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153810905|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810906|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810907|NCT00331149|Ropinirole|ropinirole|mesh-list
153810908|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153810909|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153810910|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
153810911|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
153810912|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735166|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735167|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153735168|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735169|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
153735170|NCT05234684|Hormones|hormones|mesh-ancestor
153736455|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735171|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735172|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735173|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153735174|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
153735175|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
153735176|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735177|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735178|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153735179|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153735180|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153735181|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735183|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153735184|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
153735185|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
153735186|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735187|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735188|NCT05189483|Paclitaxel|paclitaxel|mesh-list
153735189|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153735190|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153735191|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735192|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
153735193|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
153735194|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735196|NCT05188820|Cortisone|cortisone|mesh-list
153735221|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153735222|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153735223|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735224|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735225|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153735226|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153735227|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153735228|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153735229|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
153735231|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
153735232|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
153735233|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409890|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
153409896|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595700|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595701|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595702|NCT01857726|Doxorubicin|doxorubicin|mesh-list
153595703|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595704|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153595705|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153460304|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
153460305|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595706|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153735234|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735235|NCT05100654|Doxycycline|doxycycline|mesh-list
153735236|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
153735237|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153735238|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153735239|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153735240|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153735241|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
153735242|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153735276|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153366742|NCT01680887|Varenicline|varenicline|mesh-list
153735277|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735278|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
153735279|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
153735280|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735281|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735282|NCT05092373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153735283|NCT05092373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735284|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
153735285|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735286|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153735287|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153735288|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153735289|NCT05069740|Analgesics|analgesics|mesh-ancestor
153735290|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
153735291|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735292|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735293|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735294|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735295|NCT05066308|Cannabidiol|cannabidiol|mesh-list
153735296|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
153735297|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
153409919|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595707|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595708|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735298|NCT05059626|Simvastatin|simvastatin|mesh-list
153735299|NCT05059626|Estrogens|estrogens|mesh-list
153444018|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444019|NCT01930188|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153444020|NCT01976364|Methotrexate|methotrexate|mesh-list
153444021|NCT01976364|Tofacitinib|tofacitinib|mesh-list
153444022|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153444023|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
153444024|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153444025|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444026|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153444027|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
153444028|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444029|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444030|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
153444031|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444032|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153444033|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153444034|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
153444035|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444036|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153444037|NCT01976364|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153444038|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153444039|NCT01929876|Itraconazole|itraconazole|mesh-list
153444040|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
153444041|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444042|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153444043|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153444044|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444045|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444046|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153444047|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
153902631|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444048|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444049|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444061|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
153444062|NCT01975272|Trace Elements|trace elements|mesh-ancestor
153444063|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
153444064|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444066|NCT03965039|Fluorides|fluorides|mesh-list
153444067|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
153444068|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
153444069|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
153444070|NCT03965039|Protective Agents|protective agents|mesh-ancestor
153444071|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444072|NCT03961295|Vedolizumab|vedolizumab|mesh-list
153444073|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153444074|NCT03935399|Oxytocin|oxytocin|mesh-list
153902633|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902635|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153902636|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153902637|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902638|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902639|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153902640|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153902641|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153902642|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
153902643|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902644|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
153902645|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153902646|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
153902647|NCT05013463|Indapamide|indapamide|mesh-list
153902648|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
153902649|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153902650|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153902651|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902652|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902653|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902654|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735301|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153735302|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
153735303|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735304|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153440488|NCT00003151|Omeprazole|omeprazole|mesh-list
153735305|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153735306|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735307|NCT05059626|Hormones|hormones|mesh-ancestor
153735308|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735309|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735310|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153735311|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153735312|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
153735313|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153735314|NCT05053152|Relugolix|relugolix|mesh-list
153735315|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
153735316|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
153735317|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735318|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735319|NCT05050162|Cisplatin|cisplatin|mesh-list
153735320|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
153413276|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
153444087|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444088|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444089|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
153444090|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444091|NCT03115853|Aliskiren|aliskiren|mesh-list
153444092|NCT03115853|Renin Inhibitors|renin inhibitors|mesh-ancestor
153444093|NCT03115853|Protease Inhibitors|protease inhibitors|mesh-ancestor
153444094|NCT03115853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444095|NCT03115853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444097|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153444098|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153444099|NCT03888755|Analgesics|analgesics|mesh-ancestor
153444100|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
153444101|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444102|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902660|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902661|NCT00922987|Pregabalin|pregabalin|mesh-list
153902662|NCT00922987|Analgesics|analgesics|mesh-ancestor
153902663|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
153902664|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902665|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902666|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
153902667|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153902668|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902669|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902670|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153902671|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153902672|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153735321|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735322|NCT05050084|Leuprolide|leuprolide|mesh-list
153735323|NCT05050084|Goserelin|goserelin|mesh-list
153735324|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153735325|NCT05050084|Flutamide|flutamide|mesh-list
153735326|NCT05050084|Bicalutamide|bicalutamide|mesh-list
153735327|NCT05050084|Tryptophan|tryptophan|mesh-list
153735328|NCT05050084|Buserelin|buserelin|mesh-list
153735329|NCT05050084|Hormones|hormones|mesh-list
153735330|NCT05050084|Relugolix|relugolix|mesh-list
153735331|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357494|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153409972|NCT00589316|Iodine|iodine|mesh-list
153595709|NCT01857752|Temozolomide|temozolomide|mesh-list
153735332|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735333|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153735334|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
153735335|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153735336|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735337|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735338|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
153735339|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
153735340|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
153735341|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153735342|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
153735343|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153735344|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153735345|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
153735346|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153735347|NCT05048342|Remibrutinib|remibrutinib|mesh-list
153735348|NCT05048342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153735349|NCT05048342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735350|NCT05048342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735351|NCT05036109|Aspirin|aspirin|mesh-list
153735352|NCT05036109|Vitamin D|vitamin d|mesh-list
153735353|NCT05036109|Vitamins|vitamins|mesh-ancestor
153735354|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
153735355|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735356|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153735359|NCT05036109|Analgesics|analgesics|mesh-ancestor
153735362|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735363|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735364|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153735365|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153735366|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735367|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153735368|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153735369|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735371|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
153735372|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153735373|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153735374|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735375|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
153735376|NCT05024253|Coagulants|coagulants|mesh-ancestor
153735377|NCT04954287|Vaccines|vaccines|mesh-list
153735378|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
153735379|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735380|NCT04929028|Capecitabine|capecitabine|mesh-list
153735381|NCT04929028|Fluorouracil|fluorouracil|mesh-list
153735382|NCT04929028|Nivolumab|nivolumab|mesh-list
153735383|NCT04929028|Mitomycins|mitomycins|mesh-list
153735384|NCT04929028|Mitomycin|mitomycin|mesh-list
153735385|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153735386|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
153735387|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735388|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735389|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153735390|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
153735391|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735392|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735393|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153735394|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153735395|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
153735404|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
153735405|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735406|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153735407|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153735408|NCT04902443|Growth Substances|growth substances|mesh-ancestor
153735409|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
153735411|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153735412|NCT04882202|Analgesics|analgesics|mesh-ancestor
153735413|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
153735414|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735415|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735416|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
153735417|NCT04871321|Paclitaxel|paclitaxel|mesh-list
153735418|NCT04871321|Gemcitabine|gemcitabine|mesh-list
153735419|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153735420|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735421|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
153735422|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
153595710|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153595711|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
153595712|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595713|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902673|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902674|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153902675|NCT00610909|Paroxetine|paroxetine|mesh-list
153902676|NCT00610909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153902677|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153902678|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902679|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902680|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902681|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
153902682|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902683|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153902684|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
153444103|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902685|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153902686|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153444111|NCT00378755|Bortezomib|bortezomib|mesh-list
153902687|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153902688|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902689|NCT00927901|Maleic acid|maleic acid|mesh-list
153902690|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444132|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444133|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375493|NCT04336917|Bupivacaine|bupivacaine|mesh-list
153444134|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153444135|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444136|NCT03888365|Treprostinil|treprostinil|mesh-list
153444137|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153444138|NCT00377975|Pioglitazone|pioglitazone|mesh-list
153444140|NCT00377975|Caffeine|caffeine|mesh-list
153444141|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153444142|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444143|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153444144|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153595714|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153595715|NCT01857804|Amoxicillin|amoxicillin|mesh-list
153595716|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
153595726|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
153595727|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595728|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595729|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460307|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153460308|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460309|NCT03691935|Ropivacaine|ropivacaine|mesh-list
153460310|NCT03691935|Anesthetics|anesthetics|mesh-list
153460311|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
153460312|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153460313|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460314|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
153460315|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460317|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460318|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460319|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460320|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595730|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153444145|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444146|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444147|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153735423|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735424|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735434|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153735435|NCT04835129|Dexamethasone|dexamethasone|mesh-list
153572475|NCT03569475|Analgesics|analgesics|mesh-ancestor
153735436|NCT04835129|Pomalidomide|pomalidomide|mesh-list
153735438|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153735439|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735440|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
153735441|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
153735442|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735443|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735444|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153735445|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
153735447|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735448|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153444148|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153444149|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
153444150|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902712|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902714|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
153735449|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735450|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
153735451|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153735452|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153735453|NCT04835129|Growth Substances|growth substances|mesh-ancestor
153735454|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
153735455|NCT04808843|Dienogest|dienogest|mesh-list
153735456|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153735457|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
153735458|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153735459|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735460|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153735461|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153735463|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153735464|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
153735465|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735466|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735467|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735468|NCT04787471|Riboflavin|riboflavin|mesh-list
153735469|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
153735470|NCT04787471|Vitamins|vitamins|mesh-ancestor
153735471|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
153902715|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153902716|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153902717|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902718|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902719|NCT01217892|Metformin|metformin|mesh-list
153902720|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
153902721|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153902722|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444163|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444164|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153444165|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153444167|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444168|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
153444169|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153444170|NCT02936999|Vitamin D|vitamin d|mesh-list
153902727|NCT01217814|Golimumab|golimumab|mesh-list
153902728|NCT01217814|Methotrexate|methotrexate|mesh-list
153902729|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
153902730|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153902731|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
153595731|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153902732|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153902733|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902734|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153902735|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
153902736|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902737|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902738|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
153902739|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902740|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153902741|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153902742|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
153902743|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902751|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153902752|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902753|NCT01217190|Ondansetron|ondansetron|mesh-list
153444180|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444181|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444182|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
153444183|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444184|NCT00378443|Prednisone|prednisone|mesh-list
153444185|NCT00378443|Losartan|losartan|mesh-list
153444186|NCT00378443|Cilazapril|cilazapril|mesh-list
153902775|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902776|NCT05178693|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153902777|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153902778|NCT05178693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153902779|NCT05178693|Antimetabolites|antimetabolites|mesh-ancestor
153902780|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902781|NCT05178693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902782|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153902783|NCT01136655|Budesonide|budesonide|mesh-list
153902785|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153902786|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902787|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153902788|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
153357496|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
153869576|NCT00473694|Neostigmine|neostigmine|mesh-list
153595733|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153595734|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153595735|NCT01857817|Analgesics|analgesics|mesh-ancestor
153595736|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
153595737|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595738|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595739|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153595740|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153595741|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153595742|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595743|NCT01857843|Everolimus|everolimus|mesh-list
153595744|NCT01857843|Simvastatin|simvastatin|mesh-list
153595745|NCT01857843|Ezetimibe|ezetimibe|mesh-list
153595746|NCT01857843|Pravastatin|pravastatin|mesh-list
153595747|NCT01857843|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153595748|NCT01857843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153595749|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595750|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595751|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153595752|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
153595753|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902789|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902790|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902791|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153902792|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
153902793|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
153902794|NCT01136655|Hormones|hormones|mesh-ancestor
153902795|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902796|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153444225|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153444226|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444227|NCT03855059|Dexamethasone|dexamethasone|mesh-list
153444228|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
153735472|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735474|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
153735475|NCT04762979|Fulvestrant|fulvestrant|mesh-list
153735476|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153735477|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735478|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735479|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153735480|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153735481|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
153735482|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735483|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735484|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153595754|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810920|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595757|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
153595758|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153595759|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153595760|NCT01857856|Eplerenone|eplerenone|mesh-list
153595761|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153595762|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
153595764|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595772|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595773|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153595774|NCT01857895|Incretins|incretins|mesh-ancestor
153595775|NCT01857895|Hormones|hormones|mesh-ancestor
153595787|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
153595789|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153595790|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153735485|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735486|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735487|NCT04731974|Melatonin|melatonin|mesh-list
153735488|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
153735489|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735490|NCT04731974|Protective Agents|protective agents|mesh-ancestor
153735491|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735492|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735493|NCT04726332|Prednisone|prednisone|mesh-list
153735494|NCT04726332|Fulvestrant|fulvestrant|mesh-list
153735495|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735496|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
153735497|NCT04726332|Hormones|hormones|mesh-ancestor
153735498|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444229|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153444230|NCT03855059|BB 1101|bb 1101|mesh-list
153444231|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444232|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
153444233|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
153444234|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444235|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444236|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153444237|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
153444238|NCT03855059|Hormones|hormones|mesh-ancestor
153444239|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444241|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444242|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
153444243|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444244|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444245|NCT01301963|Plerixafor|plerixafor|mesh-list
153810921|NCT00352833|Catumaxomab|catumaxomab|mesh-list
153595791|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153595792|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153595793|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595794|NCT01858025|Fluorouracil|fluorouracil|mesh-list
153595795|NCT01858025|Mitomycins|mitomycins|mesh-list
153595796|NCT01858025|Mitomycin|mitomycin|mesh-list
153595797|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
153595798|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595799|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153595800|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595801|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153595802|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
153595803|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595804|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153595805|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
153595806|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153595807|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595808|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
153595809|NCT01858051|Vitamin D|vitamin d|mesh-list
153444246|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153444247|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153735499|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735500|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735501|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735502|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153735503|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153735504|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
153735505|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
153735506|NCT04722848|Blinatumomab|blinatumomab|mesh-list
153735507|NCT04722848|Ponatinib|ponatinib|mesh-list
153735508|NCT04722848|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153735509|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153735511|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902797|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153902798|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153902799|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
153902800|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902801|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902802|NCT01135017|Dronedarone|dronedarone|mesh-list
153902803|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153902804|NCT01134705|Beclomethasone|beclomethasone|mesh-list
153595812|NCT01858051|Vitamins|vitamins|mesh-ancestor
153410127|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410139|NCT00383487|Vitamins|vitamins|mesh-ancestor
153595866|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
153595867|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
153595868|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153595869|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153595870|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
153595871|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
153595872|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153595873|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
153595874|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
153595875|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153595876|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153595877|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
153595878|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153902805|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595879|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
153595880|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153595881|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
153595882|NCT01858155|Melatonin|melatonin|mesh-list
153595883|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
153818921|NCT03507491|Paclitaxel|paclitaxel|mesh-list
153818922|NCT03507491|Gemcitabine|gemcitabine|mesh-list
153902806|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
153902807|NCT01134705|Hormones|hormones|mesh-ancestor
153902808|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902809|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902810|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153902811|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
153902812|NCT01134627|Minocycline|minocycline|mesh-list
153902813|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153902814|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902815|NCT01134393|Amlodipine|amlodipine|mesh-list
153902816|NCT01134393|Telmisartan|telmisartan|mesh-list
153902817|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153902818|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153444248|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
153444249|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444250|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
153444251|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153444252|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153444253|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444254|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444255|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
153444256|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444257|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818923|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153818924|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357497|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153818930|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
153818931|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
153595889|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153444258|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153444259|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444260|NCT02708849|Lamotrigine|lamotrigine|mesh-list
153444261|NCT02708849|Ketamine|ketamine|mesh-list
153735512|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735514|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
153735515|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
153735516|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735517|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735518|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735519|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
153735520|NCT04697940|Fludarabine|fludarabine|mesh-list
153735521|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
153735522|NCT04697940|Decitabine|decitabine|mesh-list
153735523|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153735524|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
153735525|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735526|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735527|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153735528|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
153735529|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735530|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735531|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153735532|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153735533|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
153735534|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256954|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256955|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154256956|NCT01165580|Valganciclovir|valganciclovir|mesh-list
153735535|NCT04694183|Paclitaxel|paclitaxel|mesh-list
153735536|NCT04694183|Oxaliplatin|oxaliplatin|mesh-list
153735537|NCT04694183|Tegafur|tegafur|mesh-list
153735538|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153735539|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735540|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
153735541|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
153595890|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595891|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153595892|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153595893|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595894|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595895|NCT01858311|Tocotrienols|tocotrienols|mesh-list
153595896|NCT01858311|Vitamin E|vitamin e|mesh-list
153595897|NCT01858311|Tocopherols|tocopherols|mesh-list
153595898|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
153595899|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595900|NCT01858311|Protective Agents|protective agents|mesh-ancestor
153781715|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595901|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595902|NCT01858311|Vitamins|vitamins|mesh-ancestor
153595903|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
153595904|NCT01858402|Acetaminophen|acetaminophen|mesh-list
153595905|NCT01858402|Dipyrone|dipyrone|mesh-list
153595906|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153595907|NCT01858402|Analgesics|analgesics|mesh-ancestor
153595908|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
153595909|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595910|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818932|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153735542|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735543|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735544|NCT04694183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153444262|NCT02708849|Analgesics|analgesics|mesh-ancestor
153444263|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
153444264|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902819|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153735546|NCT04693715|RNS60|rns60|mesh-list
153735547|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153735548|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153735549|NCT04693715|Analgesics|analgesics|mesh-ancestor
153735550|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
153735551|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735552|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735553|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735554|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735555|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153735556|NCT04590326|Cemiplimab|cemiplimab|mesh-list
153735557|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735558|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735559|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
153735560|NCT04581824|Dostarlimab|dostarlimab|mesh-list
153735561|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735562|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735563|NCT04581824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153413635|NCT00366002|Urological Agents|urological agents|mesh-ancestor
153410152|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810922|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810923|NCT00331305|Sertraline|sertraline|mesh-list
153357498|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357499|NCT01275638|Prednisolone|prednisolone|mesh-list
153818933|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818934|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
153818935|NCT03441282|Fentanyl|fentanyl|mesh-list
153818936|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153460321|NCT03677141|Prednisone|prednisone|mesh-list
153460322|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
153460323|NCT03677141|Doxorubicin|doxorubicin|mesh-list
153460324|NCT03677141|Vincristine|vincristine|mesh-list
153460325|NCT03677141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153460326|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153902820|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153460327|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
153902821|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902822|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153902823|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902824|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
153902825|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153902826|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153902827|NCT05331469|Insulin|insulin|mesh-list
153902828|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153902829|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902830|NCT00922441|Valsartan|valsartan|mesh-list
153902831|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153902832|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153902833|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153902834|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902835|NCT01217112|Cannabidiol|cannabidiol|mesh-list
153902836|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
153902837|NCT01216332|Vaccines|vaccines|mesh-list
153902838|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
153460328|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460329|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153595924|NCT01858571|Thalidomide|thalidomide|mesh-list
153595932|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153818937|NCT03441282|Narcotics|narcotics|mesh-ancestor
153818938|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153818939|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818940|NCT03441282|Analgesics|analgesics|mesh-ancestor
153595933|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
153595934|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595935|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595936|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153595937|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153595938|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153902839|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902840|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153902841|NCT00922207|Entecavir|entecavir|mesh-list
153902842|NCT00922207|Adefovir|adefovir|mesh-list
153902843|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
153902844|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444279|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153444280|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153444281|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153444282|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153444283|NCT01222871|Triamcinolone|triamcinolone|mesh-list
153444292|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153444293|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
153444294|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153444295|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153444296|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153444297|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444298|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444299|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
153902848|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902849|NCT01134315|Calcitriol|calcitriol|mesh-list
153902850|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153902851|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902852|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153902853|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902854|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902855|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153902856|NCT01134315|Vitamins|vitamins|mesh-ancestor
153902857|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
153902858|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153902859|NCT01216176|Anastrozole|anastrozole|mesh-list
153902860|NCT01216176|Saracatinib|saracatinib|mesh-list
153902861|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153444306|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444307|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153444308|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153444309|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153444310|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153444312|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153444313|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153444314|NCT01216631|Prednisolone|prednisolone|mesh-list
153444315|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
153444316|NCT01216631|Infliximab|infliximab|mesh-list
153444317|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153444318|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
153444325|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
153735564|NCT04581824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735565|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
153735566|NCT04579523|Fludarabine|fludarabine|mesh-list
153735567|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
153735568|NCT04579523|Daratumumab|daratumumab|mesh-list
153735569|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153735570|NCT04579523|Antibodies|antibodies|mesh-list
153735571|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
153735572|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153735573|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153735574|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
153735575|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735576|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735577|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153735578|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
153444326|NCT01216631|Hormones|hormones|mesh-ancestor
153444327|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444328|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153902869|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902870|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902871|NCT01133847|Guanfacine|guanfacine|mesh-list
153902872|NCT01133847|Methylphenidate|methylphenidate|mesh-list
153902873|NCT01133847|Amphetamine|amphetamine|mesh-list
153902874|NCT01133847|Adderall|adderall|mesh-list
153902875|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153902876|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153902892|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153902893|NCT01133379|Fluorides|fluorides|mesh-list
153902894|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
153902895|NCT01133379|Protective Agents|protective agents|mesh-ancestor
153902896|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444329|NCT01216631|Protective Agents|protective agents|mesh-ancestor
153444330|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153444331|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444332|NCT01216631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153444333|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
153444334|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444336|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444337|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444338|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444339|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153444340|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153444341|NCT03860753|Pioglitazone|pioglitazone|mesh-list
153444342|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153444343|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444344|NCT02687165|Cycloserine|cycloserine|mesh-list
153444345|NCT02687165|Milnacipran|milnacipran|mesh-list
153444346|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
153444347|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153444348|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444349|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153444350|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
153444351|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153444352|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
153444353|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444354|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153444355|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153444356|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444357|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902897|NCT00637455|Fexofenadine|fexofenadine|mesh-list
153902898|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153902899|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153902900|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153902901|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
153902902|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
153902903|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902915|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153902916|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153902917|NCT01131585|Growth Substances|growth substances|mesh-ancestor
153902918|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902919|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
153902920|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902921|NCT01131507|Pancrelipase|pancrelipase|mesh-list
153410199|NCT00003297|Topotecan|topotecan|mesh-list
153595939|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153595940|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595941|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153595942|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153595943|NCT01858571|Analgesics|analgesics|mesh-ancestor
153595944|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
153595945|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595946|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595948|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153595949|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
153595950|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153595951|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595952|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153595953|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153595954|NCT01858571|Growth Substances|growth substances|mesh-ancestor
153595955|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
153595956|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153902922|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153902923|NCT00919633|Interferons|interferons|mesh-list
153902924|NCT00919633|Ribavirin|ribavirin|mesh-list
153902925|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
153902926|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
153902927|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153902928|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902929|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902930|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
153902931|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902932|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
153902933|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902934|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
153902935|NCT00926029|Listerine|listerine|mesh-list
153902936|NCT00926029|Triclosan|triclosan|mesh-list
153902937|NCT00926029|Fluorides|fluorides|mesh-list
153902938|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
153902939|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
153902940|NCT00926029|Protective Agents|protective agents|mesh-ancestor
153444372|NCT02654639|Bevacizumab|bevacizumab|mesh-list
153444373|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153444374|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444375|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153444376|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153444377|NCT02654639|Growth Substances|growth substances|mesh-ancestor
153444378|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444379|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
153444381|NCT02634827|Midostaurin|midostaurin|mesh-list
153444382|NCT02634827|Staurosporine|staurosporine|mesh-list
153444383|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153444384|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
153810927|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153357503|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
153595957|NCT01858610|Irbesartan|irbesartan|mesh-list
153595958|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153595959|NCT01858610|Diuretics|diuretics|mesh-ancestor
153595960|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
153595961|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595962|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153595963|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153595964|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818941|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
153818942|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818943|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153818944|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153595966|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153595967|NCT01858623|Losartan|losartan|mesh-list
153595968|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153595969|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153595970|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153595971|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153595972|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153595973|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444385|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444386|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444387|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444388|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153444389|NCT02506985|Warfarin|warfarin|mesh-list
153444390|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
153444391|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
153444392|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153444393|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
153444394|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153444395|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
153444396|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902941|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902942|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153735579|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735580|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735581|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153735582|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153735583|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
153735584|NCT04577638|Nivolumab|nivolumab|mesh-list
153735585|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735586|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595974|NCT01858623|Diuretics|diuretics|mesh-ancestor
153818947|NCT03439462|Sirolimus|sirolimus|mesh-list
153818948|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818949|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818950|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153818951|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818952|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153818953|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
153818954|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818955|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
153818956|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
153818957|NCT03414502|Minocycline|minocycline|mesh-list
153818958|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
153818959|NCT03414502|Adalimumab|adalimumab|mesh-list
153818960|NCT03414502|Infliximab|infliximab|mesh-list
153818961|NCT03414502|Golimumab|golimumab|mesh-list
153818962|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
153460344|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460345|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460346|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
153735587|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153735588|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735589|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
153735591|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735592|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735593|NCT04543227|Analgesics|analgesics|mesh-ancestor
153735594|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
153735595|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735597|NCT04513717|Goserelin|goserelin|mesh-list
153735598|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153735599|NCT04513717|Flutamide|flutamide|mesh-list
153735600|NCT04513717|Bicalutamide|bicalutamide|mesh-list
153735601|NCT04513717|Tryptophan|tryptophan|mesh-list
153735602|NCT04513717|Buserelin|buserelin|mesh-list
153735603|NCT04513717|Hormones|hormones|mesh-list
153735604|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735605|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735606|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153735607|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
153735608|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153735609|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735610|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413787|NCT05272202|Propofol|propofol|mesh-list
153902949|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
153902950|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153902951|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902952|NCT01130493|Levodopa|levodopa|mesh-list
153902953|NCT01130493|Carbidopa|carbidopa|mesh-list
153902954|NCT01130493|Entacapone|entacapone|mesh-list
153810928|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153410220|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
153460347|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460348|NCT03677141|Immunoconjugates|immunoconjugates|mesh-ancestor
153460349|NCT03617679|Rucaparib|rucaparib|mesh-list
153460350|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153460351|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460352|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460353|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460354|NCT03593915|Azacitidine|azacitidine|mesh-list
153460355|NCT03593915|Decitabine|decitabine|mesh-list
153902955|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153902956|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153902957|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153902958|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
153902959|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444397|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902960|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902961|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444399|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902962|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153902963|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902964|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153902965|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153902966|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
153902967|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
153902968|NCT01130337|Capecitabine|capecitabine|mesh-list
153902969|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
153902970|NCT01130337|Trastuzumab|trastuzumab|mesh-list
153902971|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153902972|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
153902973|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902974|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902975|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153902976|NCT04901689|Leronlimab|leronlimab|mesh-list
153902977|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153902978|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153902979|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902980|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153902981|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153902982|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
153902983|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902984|NCT04252963|Streptokinase|streptokinase|mesh-list
153460356|NCT03593915|Alvocidib|alvocidib|mesh-list
153460357|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460358|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
153460359|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460360|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460362|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
153460363|NCT03593915|Growth Substances|growth substances|mesh-ancestor
153460364|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460365|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460366|NCT03572634|Ibrutinib|ibrutinib|mesh-list
153595986|NCT01858649|Growth Substances|growth substances|mesh-ancestor
153595987|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595988|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
153595989|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153595990|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153595991|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595992|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595993|NCT01858662|Leucovorin|leucovorin|mesh-list
153595994|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
153595995|NCT01858662|Irinotecan|irinotecan|mesh-list
153595996|NCT01858662|Cetuximab|cetuximab|mesh-list
153595997|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595998|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153595999|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153902985|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153902986|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153444421|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444423|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153444424|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153444425|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153444426|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153444427|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
153444428|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444429|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444432|NCT02501759|Antidotes|antidotes|mesh-ancestor
153444433|NCT02501759|Protective Agents|protective agents|mesh-ancestor
153444434|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444435|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
153444436|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
153444437|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444438|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153444439|NCT02499887|Prednisone|prednisone|mesh-list
153444440|NCT02499887|Albuterol|albuterol|mesh-list
153444441|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444442|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
153444443|NCT02499887|Hormones|hormones|mesh-ancestor
153444444|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153596000|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596002|NCT01858662|Antidotes|antidotes|mesh-ancestor
153596003|NCT01858662|Protective Agents|protective agents|mesh-ancestor
153818963|NCT03414502|Etanercept|etanercept|mesh-list
153818964|NCT03414502|Rituximab|rituximab|mesh-list
153818965|NCT03414502|Abatacept|abatacept|mesh-list
153818966|NCT03414502|Methotrexate|methotrexate|mesh-list
153818967|NCT03414502|Azathioprine|azathioprine|mesh-list
153596004|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596005|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
153596007|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
153596008|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153596009|NCT01858792|Belimumab|belimumab|mesh-list
153596010|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596011|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
153596012|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596013|NCT01858831|Atovaquone|atovaquone|mesh-list
153902995|NCT01130103|Paroxetine|paroxetine|mesh-list
153902996|NCT01130103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153902997|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153902998|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902999|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903000|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903001|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
153903002|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903003|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153903004|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
153903005|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153903006|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153903007|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153903008|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903009|NCT04254523|Morphine|morphine|mesh-list
153903010|NCT04254523|Bupivacaine|bupivacaine|mesh-list
153903011|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
153903012|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
153903013|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153903014|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903015|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
153903017|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153903018|NCT04254523|Narcotics|narcotics|mesh-ancestor
153903019|NCT04254523|Analgesics|analgesics|mesh-ancestor
153903020|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153903021|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
153903022|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153903023|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153903024|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153903025|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
153596014|NCT01858831|Proguanil|proguanil|mesh-list
153596015|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153596016|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596017|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
153596018|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153596019|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153596020|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596021|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596022|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
153818975|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153818976|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
153818977|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153818978|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818979|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
153903026|NCT00625209|Protein C|protein c|mesh-list
153903027|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903028|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
153903029|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153903030|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153903031|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903032|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903033|NCT04254601|Erythromycin|erythromycin|mesh-list
153444469|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153444470|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
153444471|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444472|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153444473|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153444474|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
153444475|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153444476|NCT02450591|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153444477|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153444478|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444479|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444480|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444482|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153444494|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444495|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153444496|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153444497|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
153444498|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903042|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903043|NCT01129557|Valsartan|valsartan|mesh-list
153903044|NCT01129557|Aliskiren|aliskiren|mesh-list
153903045|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153903046|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153903047|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153903048|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903049|NCT01129557|Renin Inhibitors|renin inhibitors|mesh-ancestor
153903050|NCT01129557|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903051|NCT01129557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903052|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
153903053|NCT04254679|Analgesics|analgesics|mesh-list
153903054|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
153903055|NCT04254679|Narcotics|narcotics|mesh-ancestor
153903056|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153903057|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903058|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
153903059|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735612|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
153735613|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
153735614|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153735615|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
153735616|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153735617|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153735618|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
153903060|NCT01129011|Naproxen|naproxen|mesh-list
153903061|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153903062|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153903063|NCT01129011|Analgesics|analgesics|mesh-ancestor
153444499|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444500|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153444501|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153444508|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444509|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153444510|NCT03796013|Entrectinib|entrectinib|mesh-list
153444511|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153444512|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444513|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444514|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
153810930|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810931|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
153357506|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444515|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153444516|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444517|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444518|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153444519|NCT03793751|Analgesics|analgesics|mesh-ancestor
153444520|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
153444521|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444522|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153444523|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153444524|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153903069|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
153903070|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153903071|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903072|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903074|NCT04252885|Lopinavir|lopinavir|mesh-list
153735620|NCT04475731|Ponatinib|ponatinib|mesh-list
153735621|NCT04475731|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153735622|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153735623|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735624|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735625|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735626|NCT04474483|Melatonin|melatonin|mesh-list
153735627|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
153735628|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735629|NCT04474483|Protective Agents|protective agents|mesh-ancestor
153735630|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735631|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735632|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
153735633|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153735634|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153735635|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153735636|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735637|NCT04458922|Atezolizumab|atezolizumab|mesh-list
153735638|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153735639|NCT04458922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153735640|NCT04458922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735641|NCT04458922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735642|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735643|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
153735644|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869716|NCT01133626|Prednisone|prednisone|mesh-list
153818980|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818981|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
153818982|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818983|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153818984|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818985|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153818986|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153460367|NCT03572634|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153460368|NCT03572634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460369|NCT03572634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460370|NCT03572634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460371|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
153460372|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
153460373|NCT03541850|Hormones|hormones|mesh-list
153460374|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153903075|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153903076|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153903077|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903078|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903079|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903080|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153903081|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153903082|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
153903083|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903084|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153903085|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153903086|NCT04962841|Metformin|metformin|mesh-list
153903087|NCT04962841|Amlodipine|amlodipine|mesh-list
153903088|NCT04962841|Ramipril|ramipril|mesh-list
153903089|NCT04962841|Nebivolol|nebivolol|mesh-list
153903090|NCT04962841|Rivastigmine|rivastigmine|mesh-list
153444550|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
153444551|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153444553|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153444554|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
153444555|NCT01009931|Analgesics|analgesics|mesh-ancestor
153375932|NCT01469234|Loratadine|loratadine|mesh-list
153903123|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903124|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903125|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
153903126|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903127|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153903128|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153903129|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153903130|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153440895|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
153810932|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357507|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
153460375|NCT03541850|Androgens|androgens|mesh-list
153596028|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596029|NCT01858909|Melatonin|melatonin|mesh-list
153596030|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
153903131|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
153903132|NCT04252261|Sulforaphane|sulforaphane|mesh-list
153903133|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153903134|NCT04252261|Protective Agents|protective agents|mesh-ancestor
153903135|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903136|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903137|NCT04251871|Interferons|interferons|mesh-list
153903138|NCT04251871|Ritonavir|ritonavir|mesh-list
153903139|NCT04251871|Lopinavir|lopinavir|mesh-list
153903140|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
153903141|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153903142|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903143|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
153903144|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903145|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153903146|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153903147|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903148|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903149|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903150|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153903151|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153444590|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444604|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153444605|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444606|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
153444607|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
153444608|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444609|NCT00962429|Protective Agents|protective agents|mesh-ancestor
153444610|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735645|NCT04457089|Simvastatin|simvastatin|mesh-list
153735646|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153735647|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153735648|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
153735649|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735650|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153596031|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596032|NCT01858909|Protective Agents|protective agents|mesh-ancestor
153596033|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596034|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596035|NCT01858961|Interferons|interferons|mesh-list
153596036|NCT01858961|Ribavirin|ribavirin|mesh-list
153596037|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596038|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
153596039|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596040|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
153596041|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596042|NCT01859234|Bevacizumab|bevacizumab|mesh-list
153596043|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
153596044|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153596045|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735651|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153735652|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414005|NCT02471521|Rocuronium|rocuronium|mesh-list
153444611|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
153444612|NCT00962429|Vitamins|vitamins|mesh-ancestor
153444613|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
153444614|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153444615|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444616|NCT00920309|Sirolimus|sirolimus|mesh-list
153444617|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153903152|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153903153|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153903154|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
153903155|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903156|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153903157|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153903158|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153903159|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
153903160|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903161|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153903162|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153903163|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903164|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153903165|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153903166|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903167|NCT01128621|Incretins|incretins|mesh-ancestor
153903168|NCT01128621|Hormones|hormones|mesh-ancestor
153903169|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869731|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810933|NCT00322751|Topotecan|topotecan|mesh-list
153596046|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153596047|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153596048|NCT01859234|Growth Substances|growth substances|mesh-ancestor
153596049|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444618|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903170|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153903171|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903172|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903173|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903174|NCT00918463|Dasatinib|dasatinib|mesh-list
153903175|NCT00918463|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153903176|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153903177|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903178|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903179|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903180|NCT05330065|Bevacizumab|bevacizumab|mesh-list
153903181|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153903182|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903183|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153903184|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153903185|NCT05330065|Growth Substances|growth substances|mesh-ancestor
153903190|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153903191|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903193|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
153903194|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
153903195|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444637|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153444638|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444639|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
153444640|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
153444641|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
153444643|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
153444644|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444645|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153444646|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153444647|NCT02075021|Growth Substances|growth substances|mesh-ancestor
153444648|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
153444649|NCT02057237|Mitotane|mitotane|mesh-list
153357508|NCT01275638|Hormones|hormones|mesh-ancestor
153596050|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
153596051|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153460376|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
153460377|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153460378|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596065|NCT01859455|Atorvastatin|atorvastatin|mesh-list
153596066|NCT01859455|Simvastatin|simvastatin|mesh-list
153596067|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153596068|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153596069|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
153596070|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596071|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153596072|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153596073|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444650|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153444651|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256958|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256959|NCT01048619|ON 01910|on 01910|mesh-list
153367485|NCT04171466|Metronidazole|metronidazole|mesh-list
153903196|NCT01128543|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153903198|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903199|NCT01128387|Panitumumab|panitumumab|mesh-list
153903200|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153903201|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903202|NCT01214850|Vaccines|vaccines|mesh-list
153903203|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
153903204|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903205|NCT01128153|Saxagliptin|saxagliptin|mesh-list
153903206|NCT01128153|Incretins|incretins|mesh-ancestor
153903207|NCT01128153|Hormones|hormones|mesh-ancestor
153903208|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153903209|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903210|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153903211|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903212|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903213|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903214|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153903215|NCT00925015|Irinotecan|irinotecan|mesh-list
153903216|NCT00925015|Cetuximab|cetuximab|mesh-list
153903217|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153903218|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153903219|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153903220|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903221|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596074|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
153596075|NCT01859468|Calcium|calcium|mesh-list
153596076|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153596077|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596078|NCT01859468|Antacids|antacids|mesh-ancestor
153596079|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596080|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596081|NCT01859481|Eletriptan|eletriptan|mesh-list
153596082|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153596083|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
153596084|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596085|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596086|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596087|NCT01859585|Ketorolac|ketorolac|mesh-list
153596088|NCT01859585|Parecoxib|parecoxib|mesh-list
153596089|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153596090|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153596091|NCT01859585|Analgesics|analgesics|mesh-ancestor
153596092|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
153596093|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460380|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460381|NCT03541850|Protective Agents|protective agents|mesh-ancestor
153460382|NCT03541850|Vitamins|vitamins|mesh-ancestor
153460383|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
153460384|NCT03541850|Estrogens|estrogens|mesh-ancestor
153903222|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903223|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153903224|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
153903225|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903226|NCT01127763|Carboplatin|carboplatin|mesh-list
153903227|NCT01127763|Everolimus|everolimus|mesh-list
153903228|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903229|NCT01127763|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153903230|NCT01127763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153903231|NCT01127763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903232|NCT01127763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903233|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153903234|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
153903235|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903236|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153903237|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153903238|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903239|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153444703|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444704|NCT01978535|Hematinics|hematinics|mesh-ancestor
153444705|NCT00808769|Omeprazole|omeprazole|mesh-list
153444706|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
153444707|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153444708|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153357509|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410308|NCT00002829|Etoposide|etoposide|mesh-list
153460385|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153460386|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460387|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
153460388|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
153460389|NCT03535272|Bismuth|bismuth|mesh-list
153460390|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153460391|NCT03535272|Antacids|antacids|mesh-ancestor
153460392|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460393|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153460394|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
153460395|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
153460396|NCT03517137|Dacarbazine|dacarbazine|mesh-list
153444709|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153444710|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444711|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444712|NCT00379067|Tamsulosin|tamsulosin|mesh-list
153444713|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153444714|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153444715|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153444716|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
153444717|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735654|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153735655|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153735656|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153735657|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153735658|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735676|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735677|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
153735678|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
153735679|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
153903253|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
153903254|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
153903255|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735680|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735681|NCT04381832|Docetaxel|docetaxel|mesh-list
153735682|NCT04381832|Quemliclustat|quemliclustat|mesh-list
153735683|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735684|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
153735685|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
153735686|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
153735687|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596094|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596095|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596096|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596097|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153596098|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596099|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596100|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153596101|NCT01859624|Albuterol|albuterol|mesh-list
153596102|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153596103|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
153596104|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596105|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596106|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153596107|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
153596108|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
153596109|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153596110|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153596111|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153596112|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153596113|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
153596114|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735688|NCT04381832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153735689|NCT04381832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735690|NCT04367688|Tenofovir|tenofovir|mesh-list
153735691|NCT04367688|Emtricitabine|emtricitabine|mesh-list
153735692|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
153735693|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153735694|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153735695|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153735696|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903256|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903257|NCT01214616|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153903258|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153903259|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903260|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153903261|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
153903262|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153903263|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153903264|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153903265|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153903266|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903267|NCT01213524|Nicotine|nicotine|mesh-list
153903268|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153903269|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
153903272|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153903273|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153903274|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
153869765|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
153810935|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153869767|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
153596115|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596116|NCT01859728|Cisplatin|cisplatin|mesh-list
153596117|NCT01859728|Gemcitabine|gemcitabine|mesh-list
153596118|NCT01859728|Irinotecan|irinotecan|mesh-list
153903275|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444719|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444721|NCT00378287|Rabeprazole|rabeprazole|mesh-list
153444722|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153444723|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153444724|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153444725|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444726|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444727|NCT01938833|Paclitaxel|paclitaxel|mesh-list
153444728|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153444729|NCT01938833|Romidepsin|romidepsin|mesh-list
153444730|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153444731|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444732|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
153444733|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
153444734|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
153444735|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444736|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153444737|NCT01938833|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153444738|NCT01938833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444739|NCT01893359|Riboflavin|riboflavin|mesh-list
153444740|NCT01893359|Dextrans|dextrans|mesh-list
153444741|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153444742|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153444743|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
153444744|NCT01893359|Vitamins|vitamins|mesh-ancestor
153444745|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
153444746|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444747|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153444748|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
153444749|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
153903286|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153903288|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
153903289|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153903290|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
153903291|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153596119|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596120|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153596121|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
153596141|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596142|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596143|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153596144|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
153596145|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
153596146|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153596147|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153818999|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153819000|NCT03414502|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153819001|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153819002|NCT03410615|Durvalumab|durvalumab|mesh-list
153819003|NCT03410615|Tremelimumab|tremelimumab|mesh-list
153903292|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153903293|NCT00918385|Dasatinib|dasatinib|mesh-list
153903294|NCT00918385|Nilutamide|nilutamide|mesh-list
153903295|NCT00918385|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153903296|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153903297|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903298|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903299|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903300|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
153903301|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
153903302|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153903303|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444750|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
153444751|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
153444753|NCT00795665|Carmustine|carmustine|mesh-list
153444754|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153444755|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444756|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153444757|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153444758|NCT00795665|Growth Substances|growth substances|mesh-ancestor
153444759|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444760|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
153444761|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153444762|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
153444766|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444767|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444768|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153444769|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
153596148|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153444770|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444771|NCT00780455|Interferons|interferons|mesh-list
153444772|NCT00780455|Interferon-beta|interferon-beta|mesh-list
153903304|NCT00637819|Leflunomide|leflunomide|mesh-list
153903305|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903306|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903308|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
153903309|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903310|NCT00631501|Doxycycline|doxycycline|mesh-list
153903311|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153903312|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903313|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
153903314|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153903315|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153903316|NCT04782037|Calcium|calcium|mesh-list
153903317|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153903318|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903319|NCT00924469|Prednisone|prednisone|mesh-list
153903320|NCT00924469|Leuprolide|leuprolide|mesh-list
153903321|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903322|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
153903323|NCT00924469|Hormones|hormones|mesh-ancestor
153903324|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153903325|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903326|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153903327|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903328|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153903329|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
153903330|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153903331|NCT00631579|Rasburicase|rasburicase|mesh-list
153444778|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444780|NCT00755261|Bevacizumab|bevacizumab|mesh-list
153444781|NCT00755261|Doxorubicin|doxorubicin|mesh-list
153444782|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153444783|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444784|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153444785|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153810937|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810938|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596149|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153596150|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
153596151|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596152|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596153|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
153596154|NCT01860066|Hormones|hormones|mesh-ancestor
153596155|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153596156|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
153596157|NCT01860105|Clopidogrel|clopidogrel|mesh-list
153596160|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153596161|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153596162|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
153596163|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596164|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596165|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596167|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153596168|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819004|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819006|NCT03384914|Vaccines|vaccines|mesh-list
153444786|NCT00755261|Growth Substances|growth substances|mesh-ancestor
153444787|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444788|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
153444789|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153444790|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153444791|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153444792|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444793|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444794|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
153444795|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
153444796|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444797|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444798|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444800|NCT00746603|Simvastatin|simvastatin|mesh-list
153903341|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903342|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
153903343|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
153903344|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
153903345|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903346|NCT01209078|Linezolid|linezolid|mesh-list
153903347|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153903348|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903349|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153903350|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903351|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903352|NCT04318158|Fentanyl|fentanyl|mesh-list
153903353|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
153903354|NCT04318158|Bupivacaine|bupivacaine|mesh-list
153903355|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
153903356|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
153903357|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444804|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444805|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153444806|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153444807|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444808|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153444809|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444811|NCT00716807|Naloxone|naloxone|mesh-list
153444812|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153444813|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444814|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
153444815|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444816|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153444817|NCT00716807|Narcotics|narcotics|mesh-ancestor
153444818|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444819|NCT00716807|Analgesics|analgesics|mesh-ancestor
153444820|NCT03426137|Ketorolac|ketorolac|mesh-list
153444821|NCT03426137|Oxycodone|oxycodone|mesh-list
153444822|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153444823|NCT03426137|Narcotics|narcotics|mesh-ancestor
153444824|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444825|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444827|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
153444828|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903363|NCT04318158|Analgesics|analgesics|mesh-ancestor
153903364|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153903365|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153903366|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153903367|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153903368|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357512|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819012|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153819013|NCT03371498|Prednisolone|prednisolone|mesh-list
153819014|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
153460397|NCT03517137|Etoposide|etoposide|mesh-list
153460398|NCT03517137|Doxorubicin|doxorubicin|mesh-list
153460399|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153460400|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153460401|NCT03517137|Vinblastine|vinblastine|mesh-list
153460402|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460403|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
153460404|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460405|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460406|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460407|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
153460408|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460409|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460410|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153460411|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460412|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153460413|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460414|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460415|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153596169|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153903369|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903370|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153903371|NCT04318158|Narcotics|narcotics|mesh-ancestor
153735697|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735698|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153735699|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153735700|NCT04361214|Leflunomide|leflunomide|mesh-list
153735701|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735702|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735703|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153735704|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
153735705|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735706|NCT04328727|Cyclosporine|cyclosporine|mesh-list
153735707|NCT04328727|Cyclosporins|cyclosporins|mesh-list
153735708|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153735709|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
153735710|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735711|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735712|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153735713|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
153735714|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735715|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
153735716|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153735717|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
153735718|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596170|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153596171|NCT01860144|Growth Substances|growth substances|mesh-ancestor
153596172|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596173|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
153596174|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
153596175|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153596176|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596177|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153596178|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
153596179|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153596180|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596181|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596182|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596183|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153596184|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153596185|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596186|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596187|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153596188|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596189|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596190|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
153735719|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153735720|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153735721|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153735722|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153735723|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153735724|NCT04326257|Nivolumab|nivolumab|mesh-list
153735725|NCT04326257|Ipilimumab|ipilimumab|mesh-list
153735726|NCT04326257|Relatlimab|relatlimab|mesh-list
153735727|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735728|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735729|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153735730|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903372|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153903373|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153903374|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
153903375|NCT01207596|Hydromorphone|hydromorphone|mesh-list
153903376|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153903377|NCT01207596|Narcotics|narcotics|mesh-ancestor
153903378|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735731|NCT04313244|Vaccines|vaccines|mesh-list
153735732|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
153735733|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735734|NCT04304040|Antibodies|antibodies|mesh-list
153735735|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153735736|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
153735737|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460416|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460417|NCT03517137|Immunotoxins|immunotoxins|mesh-ancestor
153460418|NCT03517137|Immunoconjugates|immunoconjugates|mesh-ancestor
153460419|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460420|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460421|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460422|NCT03442309|Fluorides|fluorides|mesh-list
153460423|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
153596200|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
153596201|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
153596202|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153735738|NCT04301765|Testosterone|testosterone|mesh-list
153735748|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735749|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
153735750|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735751|NCT04276259|Naltrexone|naltrexone|mesh-list
153735752|NCT04276259|Buprenorphine|buprenorphine|mesh-list
153735753|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153903379|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903380|NCT01207596|Analgesics|analgesics|mesh-ancestor
153903381|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
153444829|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153444830|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153444831|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444832|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444833|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153444834|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444835|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444836|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153444837|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153444838|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444839|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153444840|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153444841|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444842|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444843|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
153444844|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444845|NCT00669461|Lubiprostone|lubiprostone|mesh-list
153444846|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153444847|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444848|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444849|NCT00673595|Varenicline|varenicline|mesh-list
153410384|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153596203|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153596204|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596205|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153596206|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596207|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596208|NCT01860391|Fluorides|fluorides|mesh-list
153596209|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
153444850|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153444851|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153444852|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
153444853|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735754|NCT04276259|Narcotics|narcotics|mesh-ancestor
153735755|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735756|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735757|NCT04276259|Analgesics|analgesics|mesh-ancestor
153735758|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
153735759|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735760|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153903382|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903392|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
153903394|NCT04203043|Protective Agents|protective agents|mesh-ancestor
153903395|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153903396|NCT04435015|Camostat|camostat|mesh-list
153903397|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903398|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903399|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903400|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153903401|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153903402|NCT00631813|Prucalopride|prucalopride|mesh-list
153903403|NCT00631813|Laxatives|laxatives|mesh-ancestor
153903404|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153903405|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153903406|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153903407|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
153444854|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444855|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444856|NCT03248141|Factor VIII|factor viii|mesh-list
153444857|NCT03248141|Coagulants|coagulants|mesh-ancestor
153444858|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
153444859|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444860|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153444861|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153596210|NCT01860391|Protective Agents|protective agents|mesh-ancestor
153596211|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596212|NCT01860417|Mepivacaine|mepivacaine|mesh-list
153596213|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
153596214|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
153596215|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596216|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596217|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
153596218|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596219|NCT01860469|Vancomycin|vancomycin|mesh-list
153596220|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153596221|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596222|NCT01860482|Rabeprazole|rabeprazole|mesh-list
153596223|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153596224|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596225|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153596226|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596227|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596231|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596232|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596233|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153444862|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
153444863|NCT01754987|Sorafenib|sorafenib|mesh-list
153444864|NCT01754987|Vitamins|vitamins|mesh-ancestor
153444865|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
153444866|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444867|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444868|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153444869|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444870|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444871|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
153444872|NCT01754987|Protective Agents|protective agents|mesh-ancestor
153444873|NCT00652457|Memantine|memantine|mesh-list
153444874|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153444875|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153444876|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
153444877|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444878|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903408|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903425|NCT00637897|Docetaxel|docetaxel|mesh-list
153903426|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153903427|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153903428|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903429|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
153903430|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
153903431|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
153914663|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444879|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444880|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153444881|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153444883|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153444884|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444885|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153444886|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444887|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444888|NCT00616577|Ropivacaine|ropivacaine|mesh-list
153444889|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
153444890|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
153444891|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444892|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444893|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
153444894|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444895|NCT00616343|Zonisamide|zonisamide|mesh-list
153444896|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
153444897|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153903442|NCT04203511|Pemetrexed|pemetrexed|mesh-list
153903443|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153903444|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903445|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
153903446|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
153903447|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
153903448|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903449|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153903450|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153444898|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444899|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444900|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153444901|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444902|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
153444903|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153444904|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
153444905|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444906|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444907|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153444908|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
153596234|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153596235|NCT01860625|Donepezil|donepezil|mesh-list
153596236|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153596237|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596238|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596239|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
153596240|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596241|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596247|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596248|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153596249|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153596250|NCT01860638|Growth Substances|growth substances|mesh-ancestor
153596251|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596252|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
153819015|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153819016|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
153819017|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153819018|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
153819019|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
153819020|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819021|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819022|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153819023|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
153444909|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153444910|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
153444911|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444912|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444913|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153414446|NCT00367250|Trastuzumab|trastuzumab|mesh-list
153444914|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
153444915|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
153444916|NCT05599919|Protective Agents|protective agents|mesh-ancestor
153444918|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153444919|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153444920|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444921|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903451|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903452|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153903453|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153903454|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
153903463|NCT00910273|Analgesics|analgesics|mesh-ancestor
153903464|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
153836209|NCT00515736|Zinc|zinc|mesh-list
153903465|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903466|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903467|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903468|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153869851|NCT04570254|Antioxidants|antioxidants|mesh-list
153819024|NCT03371498|Hormones|hormones|mesh-ancestor
153819025|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819026|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153819027|NCT03371498|Protective Agents|protective agents|mesh-ancestor
153819028|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819029|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819030|NCT03368729|Trastuzumab|trastuzumab|mesh-list
153819031|NCT03368729|Niraparib|niraparib|mesh-list
153819032|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819033|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819034|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153819035|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819036|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819037|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
153819038|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153596253|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153596255|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596256|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
153596257|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596258|NCT01860690|Methotrexate|methotrexate|mesh-list
153596260|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
153903469|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153903470|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153903471|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
153903473|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903474|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153903475|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153903476|NCT00910039|Growth Substances|growth substances|mesh-ancestor
153444922|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153444923|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444924|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
153444925|NCT00608465|Ramipril|ramipril|mesh-list
153444926|NCT00608465|Eplerenone|eplerenone|mesh-list
153444927|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153444928|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
153444929|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444930|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444931|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153444932|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153444933|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
153444934|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444935|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810945|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153810946|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153357516|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596266|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596267|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
153596268|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596269|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153596270|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596271|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
153596272|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819039|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460424|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
153460425|NCT03442309|Protective Agents|protective agents|mesh-ancestor
153460426|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460427|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
153460428|NCT03384836|Propranolol|propranolol|mesh-list
153460429|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153444936|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153444937|NCT00608465|Diuretics|diuretics|mesh-ancestor
153735761|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153444938|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
153444939|NCT00608777|Betamethasone|betamethasone|mesh-list
153444940|NCT00608777|Calcipotriene|calcipotriene|mesh-list
153444941|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444942|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
153444943|NCT00608777|Hormones|hormones|mesh-ancestor
153444944|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444945|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903477|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903478|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
153367839|NCT01083368|Sirolimus|sirolimus|mesh-list
153903479|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153903480|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903481|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903482|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
153903483|NCT00909181|Oxybutynin|oxybutynin|mesh-list
153903484|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
153903485|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
153460430|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596275|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
153596276|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903486|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903487|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903488|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153903489|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153903491|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903492|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903493|NCT00909181|Urological Agents|urological agents|mesh-ancestor
153903494|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153903495|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903496|NCT01286987|Talazoparib|talazoparib|mesh-list
153903497|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153903498|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903499|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903500|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444946|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153444947|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
153444948|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
153444949|NCT00379457|Dactinomycin|dactinomycin|mesh-list
153444950|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
153444951|NCT00379457|Ifosfamide|ifosfamide|mesh-list
153444952|NCT00379457|Carboplatin|carboplatin|mesh-list
153444953|NCT00379457|Doxorubicin|doxorubicin|mesh-list
153444954|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153444955|NCT00379457|Etoposide|etoposide|mesh-list
153444956|NCT00379457|Vincristine|vincristine|mesh-list
153444957|NCT00379457|Topotecan|topotecan|mesh-list
153444958|NCT00379457|Vinorelbine|vinorelbine|mesh-list
153444959|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153444960|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
153444961|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444962|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444963|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153735762|NCT04276155|Anticoagulants|anticoagulants|mesh-list
153735763|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
153735764|NCT04239092|Temozolomide|temozolomide|mesh-list
153735765|NCT04239092|Irinotecan|irinotecan|mesh-list
153735766|NCT04239092|Topotecan|topotecan|mesh-list
153869871|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153596277|NCT01860716|Protective Agents|protective agents|mesh-ancestor
153596278|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596279|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596280|NCT01860729|Anacetrapib|anacetrapib|mesh-list
153596281|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153596282|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153596283|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
153596284|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596285|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153596286|NCT01860742|Interferons|interferons|mesh-list
153596287|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
153596288|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
153596289|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153596290|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596291|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
153596292|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596293|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
153596294|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596295|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153735767|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153735768|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
153735769|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735770|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735771|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153735772|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
153735773|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735774|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735775|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153735776|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153735777|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153735778|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735779|NCT04186598|Nifedipine|nifedipine|mesh-list
153735780|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153735781|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153735782|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735783|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153735784|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735785|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
153735786|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
153735787|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153444964|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
153444965|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444971|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444972|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153444973|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410456|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153596296|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460455|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460456|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153460457|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
153460458|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
153819040|NCT03325101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153819041|NCT03325101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444974|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
153444975|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
153444976|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153444977|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153444978|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444979|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153444990|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444991|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444992|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444993|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153444994|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153414583|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
153444995|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444996|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153444997|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153903518|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
153903519|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153903520|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153903521|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
153903522|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153903523|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153903524|NCT01283009|Prednisolone|prednisolone|mesh-list
153903525|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
153903526|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153903527|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
153903528|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903529|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
153903530|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
153903531|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903532|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903533|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153903534|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
153903535|NCT01283009|Hormones|hormones|mesh-ancestor
153810948|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153357519|NCT00724568|Dexamethasone|dexamethasone|mesh-list
153819042|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
153819043|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153819044|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
153819045|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819046|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819047|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153819048|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
153819049|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153819050|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
153903536|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153903537|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153903538|NCT01283009|Protective Agents|protective agents|mesh-ancestor
153903539|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153903540|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903541|NCT01282463|Docetaxel|docetaxel|mesh-list
153903542|NCT01282463|Ramucirumab|ramucirumab|mesh-list
153903543|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903544|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
153903545|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
153903546|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
153903547|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903548|NCT01282463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153903549|NCT01282463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153444998|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444999|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
153445000|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153445001|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153445002|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153445003|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153445004|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
153445005|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445006|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
153445007|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
153445008|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153445009|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153445010|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153445011|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445012|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445026|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153903550|NCT01282463|Growth Substances|growth substances|mesh-ancestor
153903551|NCT01282463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410464|NCT00002865|Etoposide|etoposide|mesh-list
153810949|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357520|NCT00724568|Lenalidomide|lenalidomide|mesh-list
153819051|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819052|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819053|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153819054|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
153596297|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153596298|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153596299|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153596300|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596301|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596302|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153596304|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153596305|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
153596306|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596307|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596308|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153596309|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153596310|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
153596311|NCT01860833|Ibuprofen|ibuprofen|mesh-list
153903552|NCT01282463|Growth Inhibitors|growth inhibitors|mesh-ancestor
153903553|NCT01281917|Sirolimus|sirolimus|mesh-list
153903554|NCT01281917|Bortezomib|bortezomib|mesh-list
153903555|NCT01281917|Temsirolimus|temsirolimus|mesh-list
153903556|NCT01281917|MTOR Inhibitors|mtor inhibitors|mesh-list
153903557|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903558|NCT01281917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153903559|NCT01281917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903560|NCT01281917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903561|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153903562|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
153903563|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903564|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153903565|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903566|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153903567|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
153903568|NCT01281839|Ribavirin|ribavirin|mesh-list
153903569|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153903570|NCT01281839|Simeprevir|simeprevir|mesh-list
153903571|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
153903572|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903573|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
153903574|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903575|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
153596312|NCT01860833|Celecoxib|celecoxib|mesh-list
153596313|NCT01860833|Diclofenac|diclofenac|mesh-list
153596320|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596321|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596322|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153596323|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596324|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596325|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153596326|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153596327|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903576|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903577|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
153903578|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153445027|NCT00423059|Growth Substances|growth substances|mesh-ancestor
153445028|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445029|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
153445030|NCT00585611|Atorvastatin|atorvastatin|mesh-list
153445031|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153445032|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153445033|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
153445034|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445035|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153445036|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153445037|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445038|NCT00379691|Phenylephrine|phenylephrine|mesh-list
153445039|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
153445040|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153445041|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
153445042|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
153445043|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445044|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445045|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
153445046|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153445047|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
153445048|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
153445049|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153445050|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153445051|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153445052|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
153445053|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445054|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735792|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869904|NCT04575194|Bupropion|bupropion|mesh-list
153596328|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596329|NCT01861015|Vasopressins|vasopressins|mesh-list
153596335|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596336|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596337|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596338|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153596339|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153596340|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
153735793|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445056|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
153445057|NCT01685333|Hematinics|hematinics|mesh-ancestor
153445058|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153445059|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153903581|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
153903582|NCT01280981|Coagulants|coagulants|mesh-ancestor
153903584|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153903585|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445060|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
153445061|NCT00546455|Fenretinide|fenretinide|mesh-list
153903586|NCT01280591|Analgesics|analgesics|mesh-ancestor
153903587|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
153903588|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903589|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903590|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903591|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903592|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
153903593|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153903594|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903595|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903596|NCT04323761|Remdesivir|remdesivir|mesh-list
153903597|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
153903598|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903599|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
153903600|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903601|NCT05566223|Aldesleukin|aldesleukin|mesh-list
153903602|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
153903603|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
153903604|NCT05566223|Fludarabine|fludarabine|mesh-list
153903605|NCT05566223|Interleukin-2|interleukin-2|mesh-list
153903606|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153903607|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
153903608|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357522|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903609|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903610|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153903611|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
153903612|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903613|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903614|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153903615|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153903616|NCT05566223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153903617|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153903618|NCT05566223|Analgesics|analgesics|mesh-ancestor
153445069|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
153445070|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445071|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445072|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445073|NCT00000737|Analgesics|analgesics|mesh-ancestor
153445074|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
153445075|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445076|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153445077|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153445078|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445079|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445080|NCT00000737|Hormones|hormones|mesh-ancestor
153445081|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153445082|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153445083|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153445084|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153445085|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
153445086|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153445087|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153445088|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153445089|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153445090|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445091|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
153735794|NCT04161885|Azacitidine|azacitidine|mesh-list
153735795|NCT04161885|Venetoclax|venetoclax|mesh-list
153445092|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153596341|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596342|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153596343|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
153596344|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
153596345|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
153596346|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153596347|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
153596348|NCT01861015|Coagulants|coagulants|mesh-ancestor
153596349|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153596350|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
153596351|NCT01861041|Bupivacaine|bupivacaine|mesh-list
153596352|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
153596353|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
153596354|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445093|NCT00528437|Carboplatin|carboplatin|mesh-list
153445094|NCT00528437|Temozolomide|temozolomide|mesh-list
153445095|NCT00528437|Thiotepa|thiotepa|mesh-list
153445096|NCT00528437|Tretinoin|tretinoin|mesh-list
153445097|NCT00528437|Isotretinoin|isotretinoin|mesh-list
153445099|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153445100|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
153445101|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445102|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153445103|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153903619|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
153903622|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153903623|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
153903624|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903625|NCT01274351|Nilotinib|nilotinib|mesh-list
153903626|NCT01274351|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153903627|NCT01274351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153903628|NCT01274351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903629|NCT01274351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903630|NCT01271933|Pregabalin|pregabalin|mesh-list
153903631|NCT01271933|Analgesics|analgesics|mesh-ancestor
153903632|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
153903633|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903634|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903635|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
153903636|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153903637|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903638|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903639|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153903640|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153903641|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153596355|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596356|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
153596357|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596358|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
153596359|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596360|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
153596361|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153819055|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
153903642|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153903643|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153903644|NCT01269125|Leuprolide|leuprolide|mesh-list
153903645|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153903646|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
153903647|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153903648|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903649|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153903650|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903651|NCT01268891|Rasagiline|rasagiline|mesh-list
153903652|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153903653|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445104|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
153445105|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445106|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
153445107|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
153445108|NCT00000743|Zidovudine|zidovudine|mesh-list
153445109|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
153445110|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445111|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445112|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445113|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445114|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
153445115|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445116|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445117|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445118|NCT00506909|Oxytocin|oxytocin|mesh-list
153445119|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
153445120|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153445121|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445130|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
153445131|NCT00500045|Vitamins|vitamins|mesh-ancestor
153445132|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
153445133|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810952|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153357524|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
153819056|NCT03260569|Protective Agents|protective agents|mesh-ancestor
153819057|NCT03258593|Acetaminophen|acetaminophen|mesh-list
153819058|NCT03258593|Diphenhydramine|diphenhydramine|mesh-list
153819059|NCT03258593|Durvalumab|durvalumab|mesh-list
153819060|NCT03258593|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153819061|NCT03258593|Histamine Antagonists|histamine antagonists|mesh-list
153819062|NCT03258593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153819063|NCT03258593|Analgesics|analgesics|mesh-ancestor
153819064|NCT03258593|Sensory System Agents|sensory system agents|mesh-ancestor
153819065|NCT03258593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819066|NCT03258593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819067|NCT03258593|Antipyretics|antipyretics|mesh-ancestor
153819068|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819069|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819070|NCT03258593|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153819071|NCT03258593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153819072|NCT03258593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819073|NCT03258593|Anesthetics, Local|anesthetics, local|mesh-ancestor
153445134|NCT00000767|Vaccines|vaccines|mesh-list
153445135|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
153445136|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445137|NCT05383547|Bortezomib|bortezomib|mesh-list
153445138|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445139|NCT00456989|Docetaxel|docetaxel|mesh-list
153445140|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445141|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
153903672|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903674|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
153903675|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
153903676|NCT02889497|Vaccines|vaccines|mesh-list
153903677|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
153903678|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903679|NCT01266317|Rituximab|rituximab|mesh-list
153903680|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153903681|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903682|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
153903683|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903684|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903685|NCT01266161|Ibuprofen|ibuprofen|mesh-list
153903686|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153903687|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153903688|NCT01266161|Analgesics|analgesics|mesh-ancestor
153903689|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
153903690|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903691|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903692|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903693|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153445148|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153869953|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460459|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153596373|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
153596374|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
153596375|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596376|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596377|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596378|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
153596379|NCT01861340|Hormones|hormones|mesh-ancestor
153596380|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153596381|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153596382|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596383|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
153445149|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153445150|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445151|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445152|NCT00428207|Insulin|insulin|mesh-list
153445153|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153445154|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
153445155|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
153445156|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153445157|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
153445158|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153445159|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445160|NCT00000791|Zidovudine|zidovudine|mesh-list
153445161|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
153445162|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445163|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445164|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445165|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903696|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903697|NCT01265849|Indomethacin|indomethacin|mesh-list
153903698|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
153903699|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153903700|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
153903701|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903702|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903703|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153903704|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
153903705|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903706|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903707|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154191159|NCT05945615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410543|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
153810953|NCT00322907|Analgesics|analgesics|mesh-ancestor
153810954|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
153903708|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153903709|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153903710|NCT01265849|Analgesics|analgesics|mesh-ancestor
153903711|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
153903712|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903713|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903714|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
153903715|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
153903716|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153903717|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153903718|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445174|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445175|NCT00374543|Ziprasidone|ziprasidone|mesh-list
153445176|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153445177|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
153445178|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445179|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445180|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445181|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153445182|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153445183|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445184|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445185|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153445186|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
153445188|NCT00000803|Didanosine|didanosine|mesh-list
153445189|NCT00000803|Delavirdine|delavirdine|mesh-list
153445190|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
153445191|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445192|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445193|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445194|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903732|NCT01264679|Hematinics|hematinics|mesh-ancestor
153903733|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153903734|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153903735|NCT01263509|Inositol|inositol|mesh-list
153903736|NCT01263509|Alogliptin|alogliptin|mesh-list
153903737|NCT01263509|Voglibose|voglibose|mesh-list
153903738|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153903739|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903740|NCT01263509|Incretins|incretins|mesh-ancestor
153869966|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153596384|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153596385|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153596386|NCT01861340|Growth Substances|growth substances|mesh-ancestor
153596387|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
153596388|NCT01861535|Imiquimod|imiquimod|mesh-list
153596389|NCT01861535|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153596390|NCT01861535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596391|NCT01861535|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153460462|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153903741|NCT01263509|Hormones|hormones|mesh-ancestor
153903742|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153445199|NCT00299195|Sulindac|sulindac|mesh-list
153445200|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153445201|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445202|NCT00299195|Analgesics|analgesics|mesh-ancestor
153445203|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
153445204|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445205|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445206|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153445207|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153445208|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445209|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153445210|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903756|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
153903757|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903758|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903759|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445217|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445218|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153445219|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153445220|NCT01351415|Growth Substances|growth substances|mesh-ancestor
153445221|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445222|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
153445223|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
153445224|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
153445225|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
153445226|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445227|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445228|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153445243|NCT00281879|Etoposide|etoposide|mesh-list
153445244|NCT00281879|Tacrolimus|tacrolimus|mesh-list
153460463|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
153460464|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460465|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460466|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
153460467|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153460468|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153460469|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460471|NCT03136445|Coagulants|coagulants|mesh-ancestor
153460472|NCT03083665|Brivaracetam|brivaracetam|mesh-list
153460473|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
153596392|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
153596393|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596394|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153596395|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596396|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
153596398|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596399|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
153596400|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596401|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596402|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153596403|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
153596404|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596405|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445245|NCT00281879|Cyclosporins|cyclosporins|mesh-list
153445246|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153445247|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153445248|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
153445249|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445250|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903760|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153903761|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153903762|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
153903763|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153903764|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
153903765|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903766|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153903767|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
153903768|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
153903769|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153903770|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153903771|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153903772|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153903773|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153903774|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903775|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
153903776|NCT01263119|Warfarin|warfarin|mesh-list
153903777|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
153903778|NCT01262651|Nabiximols|nabiximols|mesh-list
153903779|NCT01262651|Analgesics|analgesics|mesh-ancestor
153441418|NCT00004885|Vitamins|vitamins|mesh-ancestor
153596406|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153903780|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
153903781|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903782|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903783|NCT01261793|Epratuzumab|epratuzumab|mesh-list
153903784|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153903785|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903786|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
153903787|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
153903788|NCT04321655|Ibuprofen|ibuprofen|mesh-list
153903789|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153903790|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153903791|NCT04321655|Analgesics|analgesics|mesh-ancestor
153903792|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
153445251|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153445253|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445254|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445255|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153445256|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153445257|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
153445258|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153445259|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153445260|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
153445261|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
153445262|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445263|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153445264|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445265|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153445266|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153445267|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153445268|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
153445269|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445270|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153445271|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
153445272|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153445273|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153410556|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
153596407|NCT01861626|Isotretinoin|isotretinoin|mesh-list
153596408|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
153596409|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
153596410|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
153596411|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596412|NCT01861951|Doxorubicin|doxorubicin|mesh-list
153596413|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153819077|NCT03258593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153445274|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
153445275|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153445276|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153445277|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
153903793|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903794|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903795|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153903796|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153903797|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153903798|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903799|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903800|NCT01261325|Brivaracetam|brivaracetam|mesh-list
153903812|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153903813|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153903814|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
153903815|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903816|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903817|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903818|NCT01260311|Urological Agents|urological agents|mesh-ancestor
153903819|NCT00623987|Warfarin|warfarin|mesh-list
153903820|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
153903821|NCT01259375|Amrubicin|amrubicin|mesh-list
153903822|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903823|NCT00624143|Voriconazole|voriconazole|mesh-list
153903824|NCT00624143|Amphotericin B|amphotericin b|mesh-list
153903825|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153903826|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
153903827|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903828|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153903829|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153903830|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903831|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191160|NCT05945615|Nasal Decongestants|nasal decongestants|mesh-ancestor
153819078|NCT03258593|Histamine Agents|histamine agents|mesh-ancestor
153819079|NCT03258593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819080|NCT03258593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819081|NCT03258593|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153819082|NCT03212742|Temozolomide|temozolomide|mesh-list
153819083|NCT03212742|Olaparib|olaparib|mesh-list
153819084|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153819085|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
153819086|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819087|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819088|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153819089|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596414|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596415|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153596416|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153903832|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153903833|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
153903834|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153903835|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903836|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153445296|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153445297|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153445298|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
153445299|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445300|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445301|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445302|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
153445303|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153445304|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445305|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445306|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153445307|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153445308|NCT00205049|Protective Agents|protective agents|mesh-ancestor
153445309|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445310|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
153414866|NCT02600767|Artemether|artemether|mesh-list
153445311|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153445312|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
153445313|NCT00000833|Ribavirin|ribavirin|mesh-list
153445314|NCT00000833|Didanosine|didanosine|mesh-list
153445315|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
153445316|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445317|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
153596417|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781716|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153445318|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445319|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153376688|NCT05699473|Calcium|calcium|mesh-list
153445327|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153903837|NCT00624143|Amebicides|amebicides|mesh-ancestor
153903849|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903850|NCT04320173|Lidocaine|lidocaine|mesh-list
153903851|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
153903852|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
153903853|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153903854|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903855|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
153903856|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903857|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153903858|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153903859|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153903860|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903861|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903862|NCT04321733|Amoxicillin|amoxicillin|mesh-list
153903863|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
153903864|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
153903865|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153903866|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153903867|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153903868|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153903869|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903870|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903871|NCT01613495|Octreotide|octreotide|mesh-list
153903872|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153903873|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153903874|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903875|NCT00694733|Anastrozole|anastrozole|mesh-list
153903876|NCT00694733|Leuprolide|leuprolide|mesh-list
153903877|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
153903878|NCT00694733|Estradiol|estradiol|mesh-list
153445339|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445340|NCT00133679|Urological Agents|urological agents|mesh-ancestor
153445341|NCT00000875|Acetaminophen|acetaminophen|mesh-list
153445342|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
153445343|NCT00000875|Promethazine|promethazine|mesh-list
153445344|NCT00000875|Lamivudine|lamivudine|mesh-list
153445345|NCT00000875|Zidovudine|zidovudine|mesh-list
153445346|NCT00000875|Aldesleukin|aldesleukin|mesh-list
153445347|NCT00000875|Indinavir|indinavir|mesh-list
153445348|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445349|NCT00000875|Analgesics|analgesics|mesh-ancestor
153445350|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
153445351|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445352|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445353|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
153445354|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445355|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445356|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445357|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445358|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
153445359|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445360|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153903889|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153903890|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903891|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153903892|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903893|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903894|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153903895|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
153903896|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153903897|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
153903899|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
153445361|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445362|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
153445363|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445364|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153553831|NCT01594918|Analgesics|analgesics|mesh-ancestor
153445365|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153445366|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445367|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
153445368|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
153445369|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
153445370|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
153445371|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153445372|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153445373|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
153445374|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
153445375|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445376|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153445377|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
153445378|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
153735802|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414933|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
153445379|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153445385|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153445386|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
153445387|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153445388|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445389|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153445390|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153445392|NCT04941833|Hormones|hormones|mesh-ancestor
153445393|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153445394|NCT04841369|Vaccines|vaccines|mesh-list
153836656|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445396|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445397|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153445398|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153445401|NCT00521885|Fondaparinux|fondaparinux|mesh-list
153445402|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
153445403|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153445404|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153445405|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445406|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153445407|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
153445408|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153445409|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
153445410|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445411|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
153903918|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
153903919|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903920|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903921|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153903922|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
153903923|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
153903924|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153903925|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
153903926|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903927|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903929|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
153903930|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903931|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153445412|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
153903932|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903933|NCT01126359|Lidocaine|lidocaine|mesh-list
153903934|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
153903935|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
153903936|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153903937|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903938|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
153903939|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903940|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153903941|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153903942|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153554015|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903943|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903944|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903946|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153903947|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153903948|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153903949|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903950|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903951|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
153903952|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903953|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903954|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153903955|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153903956|NCT01125813|Factor VIII|factor viii|mesh-list
153903957|NCT01125813|Coagulants|coagulants|mesh-ancestor
153903958|NCT04311645|Charcoal|charcoal|mesh-list
153903959|NCT04311645|Antidotes|antidotes|mesh-ancestor
153445427|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445428|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445429|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
153445430|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445431|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445432|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445433|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
153445434|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153445435|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153445436|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
153445437|NCT00000119|Heparin|heparin|mesh-list
153445438|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
153445439|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153445440|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153836668|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445443|NCT00000923|Zidovudine|zidovudine|mesh-list
153445444|NCT00000923|Didanosine|didanosine|mesh-list
153445445|NCT00000923|Stavudine|stavudine|mesh-list
153445446|NCT00000923|Aldesleukin|aldesleukin|mesh-list
153445447|NCT00000923|Indinavir|indinavir|mesh-list
153445448|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445449|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445450|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445451|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445452|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
153445453|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445454|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445455|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445457|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445458|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153445459|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153445460|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903960|NCT04311645|Protective Agents|protective agents|mesh-ancestor
153903961|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903962|NCT01257581|Tamoxifen|tamoxifen|mesh-list
153903963|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153903964|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
153903965|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153903966|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903967|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153903968|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903969|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153903970|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153903971|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153903972|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
153903973|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153903974|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903975|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153903976|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
153903977|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153903978|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
153903979|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153903980|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903981|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153903982|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153903983|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554087|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554088|NCT01596387|Propofol|propofol|mesh-list
153554089|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153903984|NCT00995488|Paclitaxel|paclitaxel|mesh-list
153903985|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153903986|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153903987|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903988|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
153903989|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
153445462|NCT00000161|Vitamins|vitamins|mesh-list
153445463|NCT00000161|Vitamin E|vitamin e|mesh-list
153445464|NCT00000161|Beta Carotene|beta carotene|mesh-list
153445465|NCT00000161|Carotenoids|carotenoids|mesh-list
153445466|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
153445467|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445468|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153445469|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445470|NCT00000161|Analgesics|analgesics|mesh-ancestor
153445471|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
153445472|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445473|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153445474|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153445475|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153445477|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445478|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153415019|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445479|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153445480|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445481|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
153445482|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
153445483|NCT00000161|Protective Agents|protective agents|mesh-ancestor
153445484|NCT00000161|Provitamins|provitamins|mesh-ancestor
153368276|NCT02437383|Propranolol|propranolol|mesh-list
153445486|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153445487|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153445488|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445489|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153445490|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
153445491|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153445492|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153445493|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
153445494|NCT00000935|Antibodies|antibodies|mesh-list
153445495|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
153554092|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153445496|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153445497|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153445498|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
153903990|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
153903991|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903992|NCT04293172|Ticagrelor|ticagrelor|mesh-list
153903993|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153903994|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153903995|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153903996|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153903997|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
153903998|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903999|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904001|NCT01256879|Cimetidine|cimetidine|mesh-list
153904002|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153904003|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153904004|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153904005|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
153904006|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
153904007|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904008|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904009|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904010|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153904011|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153904012|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554156|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554186|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
153904013|NCT02869672|Vaccines|vaccines|mesh-list
153904014|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
153904015|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904016|NCT01125189|Interferons|interferons|mesh-list
153904017|NCT01125189|Ribavirin|ribavirin|mesh-list
153904018|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
153904019|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
153904020|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153904021|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904022|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
153445499|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445500|NCT00000197|Propranolol|propranolol|mesh-list
153445501|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153445502|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153445503|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
153445504|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445505|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445506|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445507|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153445508|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153445509|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
153445510|NCT00000947|Azithromycin|azithromycin|mesh-list
153445511|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153445513|NCT00000203|Buprenorphine|buprenorphine|mesh-list
153445514|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445515|NCT00000203|Narcotics|narcotics|mesh-ancestor
153445516|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445517|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445518|NCT00000203|Analgesics|analgesics|mesh-ancestor
153445519|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
153904039|NCT01256567|Growth Inhibitors|growth inhibitors|mesh-ancestor
153904040|NCT00996736|Voriconazole|voriconazole|mesh-list
153904041|NCT00996736|Natamycin|natamycin|mesh-list
153904042|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
153904043|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445520|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445521|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153445522|NCT00000209|Buprenorphine|buprenorphine|mesh-list
153445523|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445524|NCT00000209|Narcotics|narcotics|mesh-ancestor
153445525|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445526|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445527|NCT00000209|Analgesics|analgesics|mesh-ancestor
153445528|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
153445529|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445530|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153445531|NCT00000215|Pergolide|pergolide|mesh-list
153445532|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
153445533|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
153445534|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445535|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445536|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445538|NCT00000953|Sorivudine|sorivudine|mesh-list
153445539|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
153445540|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445541|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904054|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904056|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153904057|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904059|NCT00996658|Hormones|hormones|mesh-ancestor
153904060|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904061|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153904062|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
153904063|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445542|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445543|NCT00000983|Zidovudine|zidovudine|mesh-list
153445544|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
153445545|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445546|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445547|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445548|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445549|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
153445550|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445551|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445552|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445553|NCT00000227|Buprenorphine|buprenorphine|mesh-list
153445554|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445555|NCT00000227|Narcotics|narcotics|mesh-ancestor
153445556|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445557|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445558|NCT00000227|Analgesics|analgesics|mesh-ancestor
153445565|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445566|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445567|NCT00000233|Analgesics|analgesics|mesh-ancestor
153445568|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
153445569|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445570|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153445571|NCT00000239|Buprenorphine|buprenorphine|mesh-list
153445572|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153410690|NCT00003555|Paclitaxel|paclitaxel|mesh-list
153554295|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
153445573|NCT00000239|Narcotics|narcotics|mesh-ancestor
153554296|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153368335|NCT02518191|Goserelin|goserelin|mesh-list
153445574|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445575|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445576|NCT00000239|Analgesics|analgesics|mesh-ancestor
153904064|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904065|NCT04310631|Ranibizumab|ranibizumab|mesh-list
153445577|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
153445578|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904066|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153904067|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153904068|NCT04310631|Growth Substances|growth substances|mesh-ancestor
153904069|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904070|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
153904071|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904072|NCT01256411|Amlodipine|amlodipine|mesh-list
153904073|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153904074|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153904075|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153904076|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153904077|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904078|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904079|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153904080|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904081|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
153904082|NCT01256411|Diuretics|diuretics|mesh-ancestor
153904083|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
153904084|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153904085|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153904086|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
153904087|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153904088|NCT00996580|Estradiol|estradiol|mesh-list
153904089|NCT00996580|Estrogens|estrogens|mesh-ancestor
153904090|NCT00996580|Hormones|hormones|mesh-ancestor
153904091|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904092|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904093|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153904094|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
153904095|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153904096|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153904097|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153904098|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153904099|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153445581|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153445582|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
153445583|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445584|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445585|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445586|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153445587|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153445588|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153445589|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
153445590|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445591|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445592|NCT00000263|Ethanol|ethanol|mesh-list
153445593|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
153445594|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153445606|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
153445608|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445610|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445611|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
153445612|NCT03967223|Fludarabine|fludarabine|mesh-list
153735805|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153445613|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153445614|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
153445615|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445616|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904126|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
153904127|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153904128|NCT00999544|Narcotics|narcotics|mesh-ancestor
153904129|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904130|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904131|NCT00999544|Analgesics|analgesics|mesh-ancestor
153904132|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
153904133|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904134|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
153904135|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
153904136|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153445617|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153445618|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
153445619|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445620|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445621|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153445622|NCT00000989|Zidovudine|zidovudine|mesh-list
153445623|NCT00000989|Ganciclovir|ganciclovir|mesh-list
153445624|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153445625|NCT00000989|Sargramostim|sargramostim|mesh-list
153445626|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
153445627|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445628|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445630|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445631|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
153735806|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415189|NCT02633371|Oxybutynin|oxybutynin|mesh-list
153445632|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445633|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445634|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445635|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
153445636|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445637|NCT00000995|Zidovudine|zidovudine|mesh-list
153445638|NCT00000995|Ganciclovir|ganciclovir|mesh-list
153445639|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153445640|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
153445641|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445642|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445643|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153904148|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904149|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904150|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153904151|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
153904152|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153904153|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153904154|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904155|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904156|NCT01123395|Colchicine|colchicine|mesh-list
153904157|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
153904158|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904159|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
153904160|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
153904161|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
153904162|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904163|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904164|NCT01255787|Vortioxetine|vortioxetine|mesh-list
153445648|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445649|NCT00001025|Zidovudine|zidovudine|mesh-list
153445650|NCT00001025|Didanosine|didanosine|mesh-list
153445651|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
153445652|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445653|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445654|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445655|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445656|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
153445657|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445658|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445659|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445665|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445666|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554488|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445667|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904172|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153904173|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904174|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904175|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904177|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153904178|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153904179|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153904180|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153904182|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153904183|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445668|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153445669|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153445670|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376971|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153376972|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
153376973|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
153376974|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
153445679|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
153736457|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153445680|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445681|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445682|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445683|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
153445684|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153445685|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
153445686|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445687|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153445688|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445689|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
153445690|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445691|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
153445692|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153445693|NCT00001055|Protective Agents|protective agents|mesh-ancestor
153445694|NCT00000275|Flupenthixol|flupenthixol|mesh-list
153445695|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
153445696|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153445697|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153445698|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445699|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445700|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904184|NCT01255163|Exenatide|exenatide|mesh-list
153904185|NCT01255163|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153445701|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153445702|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
153445703|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445704|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904186|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153904187|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904188|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153904189|NCT01255163|Incretins|incretins|mesh-ancestor
153904190|NCT01255163|Hormones|hormones|mesh-ancestor
153904191|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904192|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
153904193|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
153904194|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904195|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153904196|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
153904197|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153904198|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904199|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
153904200|NCT01254305|Milnacipran|milnacipran|mesh-list
153904201|NCT01254305|Sertraline|sertraline|mesh-list
153904202|NCT01254305|Fluoxetine|fluoxetine|mesh-list
153904203|NCT01254305|Paroxetine|paroxetine|mesh-list
153904204|NCT01254305|Citalopram|citalopram|mesh-list
153904205|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
153904206|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
153904207|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904208|NCT01254305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153904209|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153904210|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904211|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904212|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904213|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
153904214|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904215|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153904216|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153904217|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153904219|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445706|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153445707|NCT00001061|Foscarnet|foscarnet|mesh-list
153445708|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153445709|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
153445710|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445711|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445712|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445713|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445714|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445715|NCT00000281|Amantadine|amantadine|mesh-list
153445716|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153735808|NCT04128696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735810|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
153445717|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153445718|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
153445719|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445720|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
153445721|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445722|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554638|NCT01598649|Mannitol|mannitol|mesh-list
153445723|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445724|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445725|NCT00000281|Analgesics|analgesics|mesh-ancestor
153445726|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
153445727|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445728|NCT00001067|Lamivudine|lamivudine|mesh-list
153445729|NCT00001067|Zidovudine|zidovudine|mesh-list
153445730|NCT00001067|Stavudine|stavudine|mesh-list
153445731|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445732|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445733|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445734|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445735|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
153904226|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904227|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153904228|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153904229|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904230|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904231|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
153904232|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
153904233|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904234|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904235|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153904236|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153904237|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
153904238|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153904239|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153904240|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153904241|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153904243|NCT01254227|Deferoxamine|deferoxamine|mesh-list
153904244|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153904245|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
153904246|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
153904247|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445736|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445737|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445738|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445739|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
153445740|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
153445741|NCT00001079|Megestrol|megestrol|mesh-list
153445742|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
153445743|NCT00001079|Testosterone|testosterone|mesh-list
153445744|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
153445745|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
153445746|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153445747|NCT00001079|Androgens|androgens|mesh-ancestor
153445748|NCT00001079|Hormones|hormones|mesh-ancestor
153445749|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153445750|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445751|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153445752|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445753|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
153445754|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153445755|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153445756|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153445757|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
153445758|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153445759|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153445760|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153445761|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
153445762|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153445763|NCT00000293|Nefazodone|nefazodone|mesh-list
153445764|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153445765|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153445766|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153445767|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445768|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445769|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904248|NCT01254227|Siderophores|siderophores|mesh-ancestor
153904249|NCT04311255|Anesthetics|anesthetics|mesh-list
153904250|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904251|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904252|NCT01122381|Ethosuximide|ethosuximide|mesh-list
153904253|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
153904254|NCT00996034|Nicotine|nicotine|mesh-list
153904255|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904256|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153904257|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
153904258|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904259|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153904260|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153904261|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
153904262|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904263|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904264|NCT01121991|Hormones|hormones|mesh-list
153904265|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904266|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904267|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153904268|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
153904269|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153904270|NCT04292236|Protective Agents|protective agents|mesh-ancestor
153904271|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904272|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904273|NCT01121913|Trazodone|trazodone|mesh-list
153904274|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153904275|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153904276|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904277|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904278|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904279|NCT01121913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153904280|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153904282|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904283|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904284|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
153904285|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153445776|NCT00001091|Ritonavir|ritonavir|mesh-list
153445777|NCT00001091|Nelfinavir|nelfinavir|mesh-list
153445778|NCT00001091|Lamivudine|lamivudine|mesh-list
153445779|NCT00001091|Nevirapine|nevirapine|mesh-list
153445780|NCT00001091|Stavudine|stavudine|mesh-list
153445781|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153445782|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153445783|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
153445784|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452464|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445785|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445786|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445787|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445788|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
153445789|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445790|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153445791|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153445792|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445793|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445794|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153445795|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153445796|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
153445797|NCT00000299|Buprenorphine|buprenorphine|mesh-list
153445798|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445799|NCT00000299|Narcotics|narcotics|mesh-ancestor
153445800|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445801|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445802|NCT00000299|Analgesics|analgesics|mesh-ancestor
153904291|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904292|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
153904293|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153904294|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904295|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904296|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153904297|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153904298|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153904299|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904300|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904301|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
153904302|NCT04292314|Deferoxamine|deferoxamine|mesh-list
153904303|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904304|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
153904305|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904306|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904307|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153904308|NCT04292314|Siderophores|siderophores|mesh-ancestor
153904309|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153904310|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
153904311|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
153904312|NCT01121757|Lenalidomide|lenalidomide|mesh-list
153904313|NCT01121757|Azacitidine|azacitidine|mesh-list
153445804|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445805|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153445806|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
153445807|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153445808|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445809|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153445810|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153735811|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
153735812|NCT04118010|Vitamins|vitamins|mesh-list
153735813|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
153735814|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735815|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153735816|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153735817|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153735818|NCT04117945|Cetuximab|cetuximab|mesh-list
153735819|NCT04117945|Panitumumab|panitumumab|mesh-list
153735820|NCT04117945|Irinotecan|irinotecan|mesh-list
153735821|NCT04117945|Antibodies|antibodies|mesh-list
153735822|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
153735823|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153735824|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
153735825|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735826|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735827|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153870225|NCT00587873|Leucovorin|leucovorin|mesh-list
153445811|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153445819|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445820|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445822|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
153445823|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445824|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153445825|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
153445826|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
153445827|NCT00000317|Risperidone|risperidone|mesh-list
153735828|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153904314|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
153904315|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904316|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153904317|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153904318|NCT01121757|Growth Substances|growth substances|mesh-ancestor
153904319|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
153904320|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904321|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153904322|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
153904323|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904324|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904325|NCT04319471|Capecitabine|capecitabine|mesh-list
153904326|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153904327|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
153904328|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904330|NCT02882217|Histamine|histamine|mesh-list
153904331|NCT02882217|Glutarimide|glutarimide|mesh-list
153904332|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
153904333|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
153904334|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904335|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904336|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445828|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153555127|NCT05705388|Incretins|incretins|mesh-ancestor
153445829|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
153445830|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445831|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904344|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904346|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904347|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904348|NCT01120899|Minocycline|minocycline|mesh-list
153904349|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904350|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445843|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
153445844|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445845|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153445846|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153445847|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445848|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445849|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153445850|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
153445851|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153445852|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445853|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153445854|NCT00001133|Ritonavir|ritonavir|mesh-list
153445855|NCT00001133|Indinavir|indinavir|mesh-list
153445856|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153904352|NCT01120275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153415424|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
153377151|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
153904354|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904355|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
153904356|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153904357|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904358|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153904359|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
153904360|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904361|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904362|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904363|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904364|NCT01119963|Castor Oil|castor oil|mesh-list
153904365|NCT01119963|Progesterone|progesterone|mesh-list
153904366|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153904367|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153904368|NCT01119963|Progestins|progestins|mesh-ancestor
153904369|NCT01119963|Hormones|hormones|mesh-ancestor
153904370|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904371|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904372|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153904373|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
153904374|NCT01119963|Cathartics|cathartics|mesh-ancestor
153445867|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
153445868|NCT00000329|Narcotics|narcotics|mesh-ancestor
153445869|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445870|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445871|NCT00000329|Analgesics|analgesics|mesh-ancestor
153445872|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
153445873|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445874|NCT00000335|Morphine|morphine|mesh-list
153445875|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445876|NCT00000335|Narcotics|narcotics|mesh-ancestor
153445877|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904394|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904395|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153904396|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
153904398|NCT02868580|Abacavir|abacavir|mesh-list
153904399|NCT02868580|Dolutegravir|dolutegravir|mesh-list
153904400|NCT02868580|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
153904401|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153904410|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153904411|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
153904412|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
153904413|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445908|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445909|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445910|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153445911|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153445912|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
153445913|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445914|NCT00000353|Buprenorphine|buprenorphine|mesh-list
153445915|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153445917|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445918|NCT00000353|Narcotics|narcotics|mesh-ancestor
153445919|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153445920|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445921|NCT00000353|Analgesics|analgesics|mesh-ancestor
153445922|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
153445923|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445924|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153445925|NCT00000377|Nortriptyline|nortriptyline|mesh-list
153445926|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153445927|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
153445928|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445929|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153445930|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153445931|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153445932|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445933|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
153904414|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153904415|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904416|NCT01119105|Vancomycin|vancomycin|mesh-list
153904417|NCT01119105|Lefamulin|lefamulin|mesh-list
153904418|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904419|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904420|NCT01118949|Lacosamide|lacosamide|mesh-list
153904421|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
153904422|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153904423|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153904424|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904425|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904426|NCT01252355|Interferons|interferons|mesh-list
153904427|NCT01252355|Interferon-beta|interferon-beta|mesh-list
153904428|NCT01252355|Teriflunomide|teriflunomide|mesh-list
153904429|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904430|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
153445946|NCT00000389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153445947|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153445948|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153445949|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445950|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445951|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
153415503|NCT02018263|Cocaine|cocaine|mesh-list
153904443|NCT01118325|Ticagrelor|ticagrelor|mesh-list
153904444|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153904445|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153904446|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153904447|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153904448|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
153904449|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904450|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904452|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153445964|NCT00001877|Protective Agents|protective agents|mesh-ancestor
153555335|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153445965|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555336|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445966|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
153445967|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153445968|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
153445969|NCT00380939|Atorvastatin|atorvastatin|mesh-list
153445970|NCT00380939|Pravastatin|pravastatin|mesh-list
153445971|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153452465|NCT01846104|Vaccines|vaccines|mesh-list
153904461|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904462|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
153904463|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904464|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
153904465|NCT00991276|Pregabalin|pregabalin|mesh-list
153904466|NCT00991276|Pramipexole|pramipexole|mesh-list
153904467|NCT00991276|Dexpramipexole|dexpramipexole|mesh-list
153904468|NCT00991276|Analgesics|analgesics|mesh-ancestor
153904469|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
153904470|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904472|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
153904473|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153904474|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904475|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445979|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153445980|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
153445981|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
153445982|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445983|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445984|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153445985|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153445986|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153445987|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
153445988|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153445989|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445990|NCT00001889|Protective Agents|protective agents|mesh-ancestor
153445991|NCT00001901|Etanercept|etanercept|mesh-list
153445992|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153904482|NCT00991276|Protective Agents|protective agents|mesh-ancestor
153904483|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153904485|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
153904487|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904488|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153904489|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153904490|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904491|NCT00990652|Temozolomide|temozolomide|mesh-list
153904492|NCT00990652|Bortezomib|bortezomib|mesh-list
153904493|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153904494|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
153904495|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904496|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904497|NCT02867878|Adenosine|adenosine|mesh-list
153904499|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
153904500|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904501|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904502|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153904503|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
153904504|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153445993|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445997|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445998|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153445999|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153446000|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153446001|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153446002|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
153446004|NCT00000437|Nicotine|nicotine|mesh-list
153446005|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153446006|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
153446007|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446008|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555385|NCT02990806|Infliximab|infliximab|mesh-list
153446009|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153446010|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153446011|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
153446012|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153446013|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446014|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153446015|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153446016|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
153446017|NCT00000443|Ondansetron|ondansetron|mesh-list
153446018|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
153446019|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
153446020|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446021|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446022|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153446023|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
153446024|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
153446025|NCT00000443|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153446026|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153446027|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
153446028|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904505|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
153904506|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
153904507|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904508|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904509|NCT01207440|Ponatinib|ponatinib|mesh-list
153904510|NCT01207440|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153904511|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153904512|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904513|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904514|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904515|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153904516|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153904517|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153904518|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
153904519|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904520|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153904521|NCT00990106|Prazosin|prazosin|mesh-list
153904522|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153904523|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153904524|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153904525|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153904526|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
153904527|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904528|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904529|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904530|NCT02867566|Rituximab|rituximab|mesh-list
153904531|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153904532|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904533|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
153904534|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904535|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904536|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153904537|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153904538|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
153446029|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446031|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153446032|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153446033|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446034|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
154256979|NCT01167530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446036|NCT00000455|Naltrexone|naltrexone|mesh-list
153446037|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153446038|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153446039|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446040|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
153446041|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446042|NCT00001307|Capsaicin|capsaicin|mesh-list
153446043|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
153446044|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
153446045|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
153446046|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446047|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446048|NCT04713761|Carboplatin|carboplatin|mesh-list
153446049|NCT04713761|Pemetrexed|pemetrexed|mesh-list
153446050|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446051|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446052|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446053|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153446054|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446055|NCT00001937|Fluconazole|fluconazole|mesh-list
153904539|NCT02867800|Acetaminophen|acetaminophen|mesh-list
153904540|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
153904541|NCT02867800|Promethazine|promethazine|mesh-list
153904542|NCT02867800|Cyclosporine|cyclosporine|mesh-list
153904543|NCT02867800|Sirolimus|sirolimus|mesh-list
153904544|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
153735833|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
153735834|NCT04114136|Nivolumab|nivolumab|mesh-list
153735835|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153415605|NCT02152670|Raclopride|raclopride|mesh-list
153904545|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
153904546|NCT02867800|Methotrexate|methotrexate|mesh-list
153904547|NCT02867800|Fludarabine|fludarabine|mesh-list
153904548|NCT02867800|Melphalan|melphalan|mesh-list
153904549|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
153904550|NCT02867800|Abatacept|abatacept|mesh-list
153904551|NCT02867800|Thiotepa|thiotepa|mesh-list
153904552|NCT02867800|Meperidine|meperidine|mesh-list
153904553|NCT02867800|Tacrolimus|tacrolimus|mesh-list
153904554|NCT02867800|Cyclosporins|cyclosporins|mesh-list
153904555|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
153904556|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153904557|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
153904558|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153904559|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904560|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153904561|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
153904562|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904563|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904564|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
153904565|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904566|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153904567|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153446056|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
153446057|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446075|NCT00001955|Etanercept|etanercept|mesh-list
153555561|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446076|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153446078|NCT00001955|Analgesics|analgesics|mesh-ancestor
153446079|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
153446080|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446081|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446082|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153446083|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153446084|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153446085|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153446086|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446087|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446088|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153446089|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153446090|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
153446091|NCT04943783|Atorvastatin|atorvastatin|mesh-list
153446092|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153446093|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153446094|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
153446095|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446096|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153446097|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153446098|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446099|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153446100|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
153446101|NCT00000605|Hormones|hormones|mesh-list
153446102|NCT00000605|Estrogens|estrogens|mesh-list
153446103|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153446104|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446105|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153446106|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153446107|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153446108|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
153904586|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153904587|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
153904588|NCT02867800|Hormones|hormones|mesh-ancestor
153904589|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904590|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153904591|NCT02867800|Protective Agents|protective agents|mesh-ancestor
153904592|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153904593|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
153904594|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153904595|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153904596|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153904597|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153904598|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153904599|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904600|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
153904602|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153904603|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
153904604|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
153904605|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904606|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153904607|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
153904608|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153904609|NCT02867800|Narcotics|narcotics|mesh-ancestor
153904610|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153904611|NCT00629200|Interferons|interferons|mesh-list
153904612|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
153904613|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
153904614|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153904615|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904616|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
153904617|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904618|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
153904619|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904620|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153904621|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153904622|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
153446109|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153446110|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153369007|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446111|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153446112|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153446113|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153446114|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446115|NCT00000617|Azithromycin|azithromycin|mesh-list
153446116|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446117|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446119|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
153555672|NCT01599572|Zinc|zinc|mesh-list
153555727|NCT01599936|Antivenins|antivenins|mesh-list
153446120|NCT00000623|Deferiprone|deferiprone|mesh-list
153904623|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153904624|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
153904625|NCT02867176|Ketorolac|ketorolac|mesh-list
153904626|NCT02867176|Gabapentin|gabapentin|mesh-list
153904627|NCT02867176|Analgesics|analgesics|mesh-ancestor
153904628|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
153904629|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904630|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904631|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
153904632|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153904633|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153904634|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904635|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153904636|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153904637|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153904638|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904639|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904640|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
153904641|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153904642|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153904643|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904644|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904645|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153904646|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904647|NCT00982228|Insulin|insulin|mesh-list
153904648|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153904649|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
153904650|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
153904651|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153904652|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904653|NCT02867956|Etoposide|etoposide|mesh-list
153904654|NCT02867956|Apatinib|apatinib|mesh-list
153904655|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153904656|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904657|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153904658|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153904659|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735836|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904660|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904661|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153904662|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
153904663|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153904664|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904665|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
153904666|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904667|NCT04291066|Expectorants|expectorants|mesh-ancestor
153904668|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
153904669|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153904670|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
153904671|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904672|NCT04291066|Protective Agents|protective agents|mesh-ancestor
153446121|NCT00000623|Deferoxamine|deferoxamine|mesh-list
153446123|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
153904673|NCT04291066|Antidotes|antidotes|mesh-ancestor
153904674|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
153904675|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
153904676|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904677|NCT01260194|Trastuzumab|trastuzumab|mesh-list
153904678|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153904679|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904680|NCT00629278|Tamoxifen|tamoxifen|mesh-list
153904681|NCT00629278|Docetaxel|docetaxel|mesh-list
153904682|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
153555826|NCT01604213|Metformin|metformin|mesh-list
153555861|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153904683|NCT00629278|Doxorubicin|doxorubicin|mesh-list
153904684|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153904685|NCT00629278|Fluorouracil|fluorouracil|mesh-list
153904686|NCT00629278|Trastuzumab|trastuzumab|mesh-list
153904687|NCT00629278|Epirubicin|epirubicin|mesh-list
153446173|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
153446174|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446175|NCT00000629|Zidovudine|zidovudine|mesh-list
153446176|NCT00000629|Valproic Acid|valproic acid|mesh-list
153446177|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
153446178|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446179|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446180|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446181|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446182|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
153446183|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446184|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446185|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446186|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
153446187|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
153446188|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153446189|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446190|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
153446191|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153446192|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153446193|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153446194|NCT00000647|Interferons|interferons|mesh-list
153446195|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
153446196|NCT00000647|Zidovudine|zidovudine|mesh-list
153904688|NCT00629278|Hormones|hormones|mesh-list
153904689|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153904690|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904691|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
153904692|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
153904693|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
153904694|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904695|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153555862|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153904696|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
153904697|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904698|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904699|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153904700|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
153904701|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153904702|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153904703|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153904704|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153904705|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904706|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
153904707|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153904708|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153904709|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904710|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153904711|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
153446197|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
153446198|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904712|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153904713|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153904714|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153904715|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153904716|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153904717|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
153904718|NCT04207112|Linezolid|linezolid|mesh-list
153904719|NCT04207112|Bedaquiline|bedaquiline|mesh-list
153904720|NCT04207112|Clofazimine|clofazimine|mesh-list
153904721|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904722|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904723|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153904724|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153904725|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904726|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904727|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904728|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153904729|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
153904730|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904731|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
153904732|NCT01259492|Methylphenidate|methylphenidate|mesh-list
153904733|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153446224|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
153446236|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446237|NCT00381017|Interferons|interferons|mesh-list
153446238|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
153446239|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
153446240|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153837468|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
153446241|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446242|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
153446243|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446244|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
153446245|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446246|NCT00002015|Ganciclovir|ganciclovir|mesh-list
153446247|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153446248|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
153446249|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446250|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446251|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446252|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446253|NCT00002021|Foscarnet|foscarnet|mesh-list
153904735|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153904736|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153904737|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904738|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904739|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
153904740|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904742|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153904743|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153904744|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
153904745|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904746|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904747|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904748|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153904749|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153556035|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
153904750|NCT05512910|Minocycline|minocycline|mesh-list
153904751|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904752|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904753|NCT02888990|Dasatinib|dasatinib|mesh-list
153904754|NCT02888990|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153904755|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153904756|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904757|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904758|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904759|NCT05101928|Prednisone|prednisone|mesh-list
153904760|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904761|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
153904762|NCT05101928|Hormones|hormones|mesh-ancestor
153904763|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153446255|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
153446256|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446257|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446258|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153904769|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153904770|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153904771|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153904772|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
153904773|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153904774|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904775|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904777|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
153904778|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153904779|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
153446272|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446273|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
153446274|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446276|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446277|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446278|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446279|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446280|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
153446281|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446291|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446292|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446293|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153446294|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
153446295|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446296|NCT00000725|Interferons|interferons|mesh-list
153446297|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
153446307|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446308|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446309|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446310|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446311|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446312|NCT00002033|Zidovudine|zidovudine|mesh-list
153446313|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
153904794|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153904795|NCT04291664|Prednisone|prednisone|mesh-list
153904796|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
153904797|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153904798|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
153415821|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904799|NCT04291664|Hormones|hormones|mesh-ancestor
153904800|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904801|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904802|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153904803|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904804|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153904805|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904806|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904807|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
153904808|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153904809|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
153904810|NCT04187469|Rifampin|rifampin|mesh-list
153904811|NCT04187469|Isoniazid|isoniazid|mesh-list
153904812|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
153904813|NCT04187469|Ethambutol|ethambutol|mesh-list
153904814|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904815|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556082|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
153556134|NCT01611909|Terpin|terpin|mesh-list
153904816|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153904817|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153904818|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837550|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153904820|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904821|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153446314|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446315|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446316|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446317|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446318|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
153446319|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446320|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446321|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446322|NCT00002039|Foscarnet|foscarnet|mesh-list
153446323|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153446324|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
153446325|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446326|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446327|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446328|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446343|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
153446344|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446345|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446346|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446347|NCT00002045|Zidovudine|zidovudine|mesh-list
153446348|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
153446349|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446350|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446359|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
153446360|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446361|NCT00001499|Paclitaxel|paclitaxel|mesh-list
153446362|NCT00001499|Cisplatin|cisplatin|mesh-list
153446363|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153446364|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446365|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
153446366|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
153904861|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153904863|NCT04319978|Hormones|hormones|mesh-ancestor
153904864|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904865|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153904866|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904867|NCT01114737|Verapamil|verapamil|mesh-list
153904868|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153904869|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153446367|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
153446368|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446370|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446371|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446372|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
153446373|NCT00002057|Ionophores|ionophores|mesh-ancestor
153446374|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153446375|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446376|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
153446377|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153446378|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
153446379|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446380|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
153556217|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153446381|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446382|NCT00001535|Interleukin-2|interleukin-2|mesh-list
153446383|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446384|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153446385|NCT00001535|Analgesics|analgesics|mesh-ancestor
153446386|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
153446387|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446388|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446389|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
153446390|NCT00002303|Hematinics|hematinics|mesh-ancestor
153446391|NCT00002063|Zidovudine|zidovudine|mesh-list
153446392|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
153446393|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446394|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153904892|NCT02867332|Interleukin-2|interleukin-2|mesh-list
153904893|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153904894|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
153904895|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904896|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153904897|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153904898|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
153446399|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446400|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446401|NCT00002069|Ditiocarb|ditiocarb|mesh-list
153446402|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153446403|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
153446404|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446405|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
153446406|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446410|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153446411|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446412|NCT00002309|Azithromycin|azithromycin|mesh-list
153446413|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446414|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446415|NCT00002315|Acyclovir|acyclovir|mesh-list
153446416|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
153446417|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
153446418|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446419|NCT00002075|Fluconazole|fluconazole|mesh-list
153446420|NCT00002075|Amphotericin B|amphotericin b|mesh-list
153446424|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446425|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153446426|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446427|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446428|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446429|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153446430|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
153446431|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153446432|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446433|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153446434|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153446435|NCT00002075|Amebicides|amebicides|mesh-ancestor
153446436|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153446437|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153446438|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446439|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
153446440|NCT00001577|Melphalan|melphalan|mesh-list
153904936|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904937|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904938|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
153904939|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556316|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446441|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153446443|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446444|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446445|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153446446|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153446447|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
153446448|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446449|NCT00002081|Zidovudine|zidovudine|mesh-list
153446450|NCT00002081|Zalcitabine|zalcitabine|mesh-list
153446451|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
153446452|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446453|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446454|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446455|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446456|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
153446457|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446458|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446459|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446460|NCT00002093|Doxorubicin|doxorubicin|mesh-list
153446461|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153446462|NCT00002093|Daunorubicin|daunorubicin|mesh-list
153446463|NCT00002093|Bleomycin|bleomycin|mesh-list
153446465|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153446466|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446467|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153446468|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153446469|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446470|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904941|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
153904942|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153904943|NCT02866786|Estradiol|estradiol|mesh-list
153904944|NCT02866786|Cyproterone|cyproterone|mesh-list
153904945|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153904946|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904947|NCT02866786|Estrogens|estrogens|mesh-ancestor
153904948|NCT02866786|Hormones|hormones|mesh-ancestor
153904949|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904950|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153904951|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
153904952|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153904953|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153904954|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153904955|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153446472|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
153904956|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
153904957|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
153904958|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904959|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153904960|NCT00979654|Sifalimumab|sifalimumab|mesh-list
153904961|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
153904962|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904963|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153904964|NCT00978562|Hematinics|hematinics|mesh-ancestor
153904965|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153904966|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153904967|NCT04289974|Fulvestrant|fulvestrant|mesh-list
153904968|NCT04289974|Palbociclib|palbociclib|mesh-list
153904969|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153904970|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904971|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153904972|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153904973|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
153904974|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153904975|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904976|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153904977|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904979|NCT02865616|Vancomycin|vancomycin|mesh-list
153904980|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904981|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904982|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
153904983|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
153446486|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153446487|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
153446488|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446489|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446490|NCT00002321|Aldesleukin|aldesleukin|mesh-list
153446491|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446492|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446493|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446494|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
153446495|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446496|NCT00002327|Cidofovir|cidofovir|mesh-list
153446497|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
153446498|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446499|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446500|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446501|NCT00002333|Saquinavir|saquinavir|mesh-list
153446502|NCT00002333|Zalcitabine|zalcitabine|mesh-list
153446503|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446504|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446505|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446506|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446507|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446508|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446509|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446510|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
153446511|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446512|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153446513|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446514|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
153446520|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153904984|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904985|NCT02865460|Vitamins|vitamins|mesh-ancestor
153904986|NCT01206816|Afatinib|afatinib|mesh-list
153904987|NCT01206816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153904988|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153904989|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904990|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904991|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904992|NCT01259102|Buprenorphine|buprenorphine|mesh-list
153904993|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153904994|NCT01259102|Narcotics|narcotics|mesh-ancestor
153904995|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153904996|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904997|NCT01259102|Analgesics|analgesics|mesh-ancestor
153904999|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905000|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153905001|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
153905002|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
153905003|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905004|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
153905005|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153556477|NCT01613846|Sorafenib|sorafenib|mesh-list
153905006|NCT01259024|Estrogens|estrogens|mesh-ancestor
153905007|NCT01259024|Hormones|hormones|mesh-ancestor
153905008|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905009|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905010|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153905011|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905013|NCT04319900|Favipiravir|favipiravir|mesh-list
153905014|NCT04319900|Amebicides|amebicides|mesh-ancestor
153905015|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153905016|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153905017|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446521|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446522|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446523|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446524|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153446525|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
153446526|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153446527|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446528|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153446529|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153446530|NCT00002105|Doxorubicin|doxorubicin|mesh-list
153446531|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153446532|NCT00002105|Bleomycin|bleomycin|mesh-list
153446533|NCT00002105|Vincristine|vincristine|mesh-list
153446534|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153446535|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446536|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153446537|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153446538|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446539|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446540|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153446541|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
153446542|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
153905033|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153905034|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905036|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
153905037|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
153905038|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
153905039|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153905041|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153446543|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
153446545|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
153446546|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153446547|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153446548|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153446549|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
153446550|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153446551|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446552|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153446553|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153446554|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153446555|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446556|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
153446557|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153446558|NCT00002111|Saquinavir|saquinavir|mesh-list
153446559|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446560|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446561|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446562|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446563|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446564|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446565|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446566|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
153446567|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905049|NCT01257542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905051|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153905052|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
153905053|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905054|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905055|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153905056|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
153905057|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
153905058|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153905059|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
153905060|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905061|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905062|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153905063|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153905064|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
153905065|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905066|NCT01204710|Prednisone|prednisone|mesh-list
153446568|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153446569|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446571|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446572|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446573|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446574|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446575|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446576|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446577|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446578|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
153446579|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446580|NCT00002357|Zidovudine|zidovudine|mesh-list
153446581|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
153446582|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446583|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446584|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446585|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446586|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
153446587|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446588|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446589|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446590|NCT00002117|Zidovudine|zidovudine|mesh-list
153446591|NCT00002117|Zalcitabine|zalcitabine|mesh-list
153446592|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
153446593|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446594|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446595|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446596|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446597|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
154191161|NCT05945615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153556769|NCT01615601|Etravirine|etravirine|mesh-list
153905082|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905083|NCT01256450|Buprenorphine|buprenorphine|mesh-list
153905084|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153905085|NCT01256450|Narcotics|narcotics|mesh-ancestor
153905086|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905087|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905088|NCT01256450|Analgesics|analgesics|mesh-ancestor
153905089|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
153905090|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905091|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153905092|NCT01204398|Amlodipine|amlodipine|mesh-list
153905093|NCT01204398|Telmisartan|telmisartan|mesh-list
153905094|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153905095|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153446598|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446599|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153837861|NCT02947880|Bumetanide|bumetanide|mesh-list
153446600|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446601|NCT00002123|Didanosine|didanosine|mesh-list
153446602|NCT00002123|Delavirdine|delavirdine|mesh-list
153446603|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
153446604|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446605|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446606|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446607|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446608|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
153446609|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446610|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446611|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446612|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
153446613|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153446614|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
153446615|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446616|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153446617|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153446618|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
153446619|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446620|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446621|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153446622|NCT00002129|Vesnarinone|vesnarinone|mesh-list
153446623|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153446624|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
153446625|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446626|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446627|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
153446628|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446629|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153446630|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153905102|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153905103|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153905104|NCT01111851|Dexamethasone|dexamethasone|mesh-list
153905105|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
153905106|NCT01111851|Ondansetron|ondansetron|mesh-list
153905107|NCT01111851|Aprepitant|aprepitant|mesh-list
153905108|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
153905109|NCT01111851|BB 1101|bb 1101|mesh-list
153905110|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153905111|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
153905112|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
153905113|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905114|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905115|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153905116|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
153905117|NCT01111851|Hormones|hormones|mesh-ancestor
153905118|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556854|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
153905119|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153905120|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905121|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
153905122|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905123|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905124|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
153905125|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
153905126|NCT01111851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153446631|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446632|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446633|NCT00002129|Protective Agents|protective agents|mesh-ancestor
153446634|NCT00002135|Ganciclovir|ganciclovir|mesh-list
153446640|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446641|NCT00002141|Abacavir|abacavir|mesh-list
153446642|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446643|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446644|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446645|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446646|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
153446647|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446648|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446649|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446650|NCT00002369|Lamivudine|lamivudine|mesh-list
153446651|NCT00002369|Zidovudine|zidovudine|mesh-list
153446652|NCT00002369|Stavudine|stavudine|mesh-list
153446653|NCT00002369|Indinavir|indinavir|mesh-list
153446654|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446655|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446656|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446657|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446658|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
153446659|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446660|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446661|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446662|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
153446663|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446664|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446665|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
153905127|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153905128|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
153905129|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905130|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153905131|NCT01256294|Tacrolimus|tacrolimus|mesh-list
153905132|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153905133|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
153905141|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905143|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
153905144|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153905145|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905146|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905147|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153905148|NCT01255904|Analgesics|analgesics|mesh-ancestor
153905149|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
153905150|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905151|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153905152|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153905153|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153905154|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
153905155|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905156|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905157|NCT01255670|Metronidazole|metronidazole|mesh-list
153905158|NCT01255670|Penicillins|penicillins|mesh-list
153557006|NCT01617135|Levodopa|levodopa|mesh-list
153905159|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905160|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446666|NCT00002375|Nelfinavir|nelfinavir|mesh-list
153446667|NCT00002375|Indinavir|indinavir|mesh-list
153446669|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446671|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446672|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446673|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446674|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446675|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
153446676|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446677|NCT00002381|Nevirapine|nevirapine|mesh-list
153446678|NCT00002381|Stavudine|stavudine|mesh-list
153446679|NCT00002381|Nelfinavir|nelfinavir|mesh-list
153446680|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446681|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446682|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446683|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446684|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
153446685|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446686|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446687|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446688|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153446689|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153446690|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446691|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446692|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446693|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
153446694|NCT00002387|Efavirenz|efavirenz|mesh-list
153446695|NCT00002387|Indinavir|indinavir|mesh-list
153446696|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153870584|NCT01088802|Carboplatin|carboplatin|mesh-list
153557098|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153446697|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446698|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446699|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905161|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153905162|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153905163|NCT01203930|Rituximab|rituximab|mesh-list
153905164|NCT01203930|Idelalisib|idelalisib|mesh-list
153905165|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153905166|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905167|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
153905168|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905169|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153905170|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905171|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905173|NCT01254890|Sorafenib|sorafenib|mesh-list
153905174|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153905175|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
153905176|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905177|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905178|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905179|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153905181|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
153905182|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153557138|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153905183|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153905184|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
153905185|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
153905186|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905187|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905188|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153905189|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153905190|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153905191|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
153905192|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914665|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153446700|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
153446701|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446703|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446704|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153446705|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153446706|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153446707|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153446708|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446709|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446710|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446711|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446712|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446713|NCT00002393|Efavirenz|efavirenz|mesh-list
153446714|NCT00002393|Indinavir|indinavir|mesh-list
153446715|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446716|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446717|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557144|NCT01617733|Hormones|hormones|mesh-ancestor
153446718|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446719|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
153446720|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446721|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153446722|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446723|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153446724|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153446725|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153446726|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153446727|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446728|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153905193|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905194|NCT01203852|Diuretics|diuretics|mesh-ancestor
153905195|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
153905196|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153905197|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905198|NCT01203072|Edoxaban|edoxaban|mesh-list
153905199|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153905200|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
153905201|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153905202|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
153905203|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446746|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153905223|NCT01111539|Aripiprazole|aripiprazole|mesh-list
153905224|NCT01111539|Escitalopram|escitalopram|mesh-list
153905225|NCT01111539|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153905226|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153905227|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905228|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905229|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905230|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
153905231|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905232|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
153905234|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153905235|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153905236|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153446751|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
153446752|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446753|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446754|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446755|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446756|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446757|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446758|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446760|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446761|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
153446762|NCT00002417|Amprenavir|amprenavir|mesh-list
153446763|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153446764|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
153446765|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446766|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446767|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446768|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446769|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446770|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446771|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446772|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446773|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446774|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
153446775|NCT00002423|Lamivudine|lamivudine|mesh-list
153905241|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153905242|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153905243|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153905244|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153905245|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
153905246|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153905247|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905248|NCT02880345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153905249|NCT02880345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905250|NCT02879955|Acarbose|acarbose|mesh-list
153905251|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153905252|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905253|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905254|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153905255|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905256|NCT02880033|Deferiprone|deferiprone|mesh-list
153905257|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153905259|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
153378116|NCT03087136|Antibodies|antibodies|mesh-list
153905262|NCT00625911|Morphine|morphine|mesh-list
153905263|NCT00625911|Analgesics|analgesics|mesh-ancestor
153446783|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446784|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
153446785|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446786|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446787|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446788|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446789|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446790|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446791|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153446792|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
153446793|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446794|NCT02973581|Acetaminophen|acetaminophen|mesh-list
153446795|NCT02973581|Dipyrone|dipyrone|mesh-list
153446796|NCT02973581|Lidocaine|lidocaine|mesh-list
153446797|NCT02973581|Bupivacaine|bupivacaine|mesh-list
153446798|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
153446799|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
153446800|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
153446801|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905268|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153905269|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
153905270|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
153557273|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153557303|NCT01618773|Adapalene|adapalene|mesh-list
153905271|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905272|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153905273|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153905274|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905275|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905276|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153905277|NCT00625911|Narcotics|narcotics|mesh-ancestor
153905278|NCT01111149|Bupropion|bupropion|mesh-list
153905279|NCT01111149|Varenicline|varenicline|mesh-list
153905280|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153905281|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
153905282|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153416360|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153905284|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153905285|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905286|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905287|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
153905288|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905289|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905290|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153446802|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446803|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
153446804|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446805|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153446806|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153446807|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153446808|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153446809|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446810|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153446812|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
153446813|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153446814|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153446815|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153446816|NCT00002435|Zidovudine|zidovudine|mesh-list
153446817|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
153446818|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446819|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446820|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153905291|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153905292|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905293|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153905294|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153905295|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
153905296|NCT01254656|Efavirenz|efavirenz|mesh-list
153905297|NCT01254656|Etravirine|etravirine|mesh-list
153905298|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153905299|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153905300|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905301|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905302|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
153905303|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905304|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153905305|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153905306|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153905307|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153905308|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153905309|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153905310|NCT01254344|Metronidazole|metronidazole|mesh-list
153905311|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
153905312|NCT01254344|Ertapenem|ertapenem|mesh-list
153905313|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905314|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153905315|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153905316|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153905317|NCT01254344|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153905318|NCT01254344|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153905319|NCT05051007|Lidocaine|lidocaine|mesh-list
153905320|NCT05051007|Fentanyl|fentanyl|mesh-list
153905321|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
153905322|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
153905323|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905324|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905325|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
153905326|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905327|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153905328|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153905329|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153905330|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905331|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736458|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153905332|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153905333|NCT05051007|Narcotics|narcotics|mesh-ancestor
153905337|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
153905338|NCT01102803|Cycloserine|cycloserine|mesh-list
153905339|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153905340|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905341|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153905342|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
153905343|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153446853|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446854|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446855|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446856|NCT00002465|Megestrol|megestrol|mesh-list
153446857|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
153446858|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153446859|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153446860|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153446861|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
153446862|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153446863|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446864|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153446865|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153446866|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153446867|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446868|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
153446869|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153446870|NCT00002471|Leucovorin|leucovorin|mesh-list
153446871|NCT00002471|Cytarabine|cytarabine|mesh-list
153446872|NCT00002471|Dexamethasone|dexamethasone|mesh-list
153446873|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
153446874|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
153446875|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153446876|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153446877|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153446878|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
153446879|NCT00002471|Thiotepa|thiotepa|mesh-list
153446880|NCT00002471|Methotrexate|methotrexate|mesh-list
153446881|NCT00002471|Etoposide|etoposide|mesh-list
153446882|NCT00002471|Vincristine|vincristine|mesh-list
153446883|NCT00002471|Daunorubicin|daunorubicin|mesh-list
153446884|NCT00002471|Asparaginase|asparaginase|mesh-list
153446885|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
153446886|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153446887|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
153446888|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446889|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153446890|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153446891|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
153905344|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
153905345|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905346|NCT01254188|Nilotinib|nilotinib|mesh-list
153905347|NCT01254188|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153905348|NCT01254188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153905349|NCT01254188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905350|NCT01254188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905351|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153905352|NCT01109979|Drospirenone|drospirenone|mesh-list
153905353|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153905354|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153905355|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
153905356|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153905357|NCT01109979|Estradiol|estradiol|mesh-list
153905358|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153905359|NCT01109979|Estrogens|estrogens|mesh-ancestor
153905360|NCT01109979|Hormones|hormones|mesh-ancestor
153905361|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905362|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905363|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153905364|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
153905365|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153905366|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153736459|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153905367|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153905368|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153446892|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446893|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446894|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153446895|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153446896|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
153446897|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
153446898|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446899|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153446900|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
153446901|NCT00002471|Hormones|hormones|mesh-ancestor
153446902|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153446903|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153557584|NCT01620320|Protective Agents|protective agents|mesh-ancestor
153557624|NCT01620684|Metyrapone|metyrapone|mesh-list
153446904|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153446905|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
153446906|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153446907|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153446908|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
153446909|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
153905379|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
153905380|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
153905381|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905382|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905383|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153905384|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153905385|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
153905386|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905387|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905389|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153905390|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153446933|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
153905397|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153905398|NCT01253408|Analgesics|analgesics|mesh-ancestor
153905399|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
153905400|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905401|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153905402|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153905403|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905404|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905405|NCT01253408|Hormones|hormones|mesh-ancestor
153905406|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905407|NCT02879643|Vincristine|vincristine|mesh-list
153905408|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153905409|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905410|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
153905411|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
153905412|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
153446942|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153446945|NCT00002489|Leucovorin|leucovorin|mesh-list
153446946|NCT00002489|Dactinomycin|dactinomycin|mesh-list
153446947|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
153446948|NCT00002489|Carboplatin|carboplatin|mesh-list
153446949|NCT00002489|Doxorubicin|doxorubicin|mesh-list
153446950|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153446951|NCT00002489|Methotrexate|methotrexate|mesh-list
153446952|NCT00002489|Etoposide|etoposide|mesh-list
153446953|NCT00002489|Vincristine|vincristine|mesh-list
153446954|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
153446955|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153446956|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
153905440|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905441|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905443|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905444|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153905445|NCT01108731|Analgesics|analgesics|mesh-ancestor
153905446|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
153905447|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905448|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
153905449|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153905450|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
153905451|NCT04308525|Narcotics|narcotics|mesh-ancestor
153905454|NCT04308525|Analgesics|analgesics|mesh-ancestor
153905455|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
153905456|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905457|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153905459|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153905460|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
153905461|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905462|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905463|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
153446981|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
153446982|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
153446983|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
153446984|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
153557678|NCT01621100|Analgesics|analgesics|mesh-ancestor
153446985|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153870730|NCT03452579|Growth Substances|growth substances|mesh-ancestor
153446986|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446987|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153446988|NCT00002495|Doxorubicin|doxorubicin|mesh-list
153446989|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153446990|NCT00002495|Vinblastine|vinblastine|mesh-list
153446991|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153446992|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446993|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153446994|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153446995|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446996|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446997|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153446998|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
153446999|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447000|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447001|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
153905464|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
153905466|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153905467|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153905468|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905469|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905470|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153905471|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153905472|NCT01252238|Amlodipine|amlodipine|mesh-list
153905473|NCT01252238|Valsartan|valsartan|mesh-list
153905474|NCT01252238|Aliskiren|aliskiren|mesh-list
153905475|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153905476|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153557739|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
153905477|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905478|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905479|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153905480|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905482|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153905483|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153905484|NCT01252238|Renin Inhibitors|renin inhibitors|mesh-ancestor
153905485|NCT01252238|Protease Inhibitors|protease inhibitors|mesh-ancestor
153905486|NCT01252238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905487|NCT01101321|Oxycodone|oxycodone|mesh-list
153905488|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153905489|NCT01101321|Narcotics|narcotics|mesh-ancestor
153905490|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905491|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905492|NCT01101321|Analgesics|analgesics|mesh-ancestor
153905493|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
153447002|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447011|NCT00002147|Doxorubicin|doxorubicin|mesh-list
153905494|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905495|NCT04309929|Analgesics|analgesics|mesh-list
153905496|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
153905497|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905498|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905499|NCT01101165|Oxycodone|oxycodone|mesh-list
153557784|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153905500|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153905501|NCT01101165|Narcotics|narcotics|mesh-ancestor
153905502|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905506|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905507|NCT01100853|Naltrexone|naltrexone|mesh-list
153905508|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153905509|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153905511|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
153905512|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905514|NCT02879097|Carboplatin|carboplatin|mesh-list
153447032|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153447034|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153447035|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153447036|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153447037|NCT00002165|Nelfinavir|nelfinavir|mesh-list
153447038|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447039|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447040|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447041|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905531|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905533|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447053|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447054|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447055|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
153447056|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447058|NCT00002177|Didanosine|didanosine|mesh-list
153447059|NCT00002177|Stavudine|stavudine|mesh-list
153447060|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
153447061|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447062|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
153447063|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447064|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447065|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447066|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447067|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447068|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447069|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447070|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447071|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
153447072|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447073|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
153447074|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153447075|NCT00002183|Lamivudine|lamivudine|mesh-list
153447076|NCT00002183|Zidovudine|zidovudine|mesh-list
153447077|NCT00002183|Abacavir|abacavir|mesh-list
153447078|NCT00002183|Amprenavir|amprenavir|mesh-list
153905544|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153905545|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905546|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
153905547|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
153905548|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
153905549|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905550|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153905551|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
153905552|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153905553|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153905554|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153905555|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905556|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
153447079|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153447080|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447081|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447082|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447083|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
153447084|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447085|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447086|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447087|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
153447088|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153447089|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
153447090|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153447091|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447092|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447093|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447094|NCT00002189|Paclitaxel|paclitaxel|mesh-list
153447095|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447096|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447097|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447098|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447099|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447100|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447101|NCT00002195|Lamivudine|lamivudine|mesh-list
153447102|NCT00002195|Zidovudine|zidovudine|mesh-list
153905570|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153905571|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153905572|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153905573|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905574|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153905576|NCT01097421|Dexpramipexole|dexpramipexole|mesh-list
153905577|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
153905578|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905579|NCT01097421|Protective Agents|protective agents|mesh-ancestor
153447103|NCT00002195|Amprenavir|amprenavir|mesh-list
153447104|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153447105|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447107|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447108|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
153447109|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447110|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447111|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447112|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
153447113|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153447114|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
153447115|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153447116|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447117|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447118|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447119|NCT00002201|Ritonavir|ritonavir|mesh-list
153447120|NCT00002201|Nelfinavir|nelfinavir|mesh-list
153905589|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
153905590|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153905591|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905592|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153905593|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
153905594|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905595|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905596|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
153447121|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447122|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447123|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447124|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447125|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447127|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447128|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
153447129|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447130|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153447131|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153447132|NCT00002213|Efavirenz|efavirenz|mesh-list
153447133|NCT00002213|Abacavir|abacavir|mesh-list
153447134|NCT00002213|Amprenavir|amprenavir|mesh-list
153447135|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153447148|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447149|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153447150|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
153447151|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153447152|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447153|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447154|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
154256989|NCT01167764|Coagulants|coagulants|mesh-ancestor
154256990|NCT01164176|Everolimus|everolimus|mesh-list
154256991|NCT01164176|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153905612|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153905613|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153905614|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153905615|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905616|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905617|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
153905618|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905619|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905620|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153905621|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905622|NCT01251146|Atenolol|atenolol|mesh-list
153905623|NCT01251146|Bisoprolol|bisoprolol|mesh-list
153905624|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153905625|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153905626|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
153905627|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
153905628|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905629|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905630|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153447155|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153447156|NCT00381251|Estrogens|estrogens|mesh-ancestor
153447157|NCT00381251|Hormones|hormones|mesh-ancestor
153447158|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153447159|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447160|NCT00002219|Nelfinavir|nelfinavir|mesh-list
153447161|NCT00002219|Adefovir|adefovir|mesh-list
153447162|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153447163|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447164|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447165|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447166|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447167|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447168|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447169|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447170|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
153447171|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447172|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153447173|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447174|NCT00002225|Efavirenz|efavirenz|mesh-list
153447175|NCT00002225|Didanosine|didanosine|mesh-list
153447176|NCT00002225|Stavudine|stavudine|mesh-list
153447177|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153558158|NCT01624051|Cisplatin|cisplatin|mesh-list
153447178|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447179|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447180|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447181|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
153447182|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447183|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153447184|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153905632|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153905633|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
153905634|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905635|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905636|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
153905637|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153905638|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905639|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905640|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154256992|NCT01164176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256993|NCT01164176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256994|NCT01164176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905641|NCT02878707|Analgesics|analgesics|mesh-ancestor
153905642|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
153905643|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905644|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153905645|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153905646|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153905647|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
153905648|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905649|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905650|NCT01096017|Albuterol|albuterol|mesh-list
153905651|NCT01096017|Terbutaline|terbutaline|mesh-list
153905652|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153905653|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
153905654|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905655|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905656|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153905657|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
153905658|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
153905659|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153905660|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153905661|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153905662|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153905663|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
153905664|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905665|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905666|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
153905667|NCT00626223|Folic Acid|folic acid|mesh-list
153905668|NCT00626223|Hematinics|hematinics|mesh-ancestor
153905669|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
153905670|NCT00626223|Vitamins|vitamins|mesh-ancestor
153905671|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
153905672|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905673|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
153905674|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
153905675|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447200|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153447201|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447202|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447203|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447204|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447205|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447206|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153447207|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153447209|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
153447210|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
153447211|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447212|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153447213|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447214|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447215|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
153447216|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447217|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447218|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447219|NCT00002255|Hematinics|hematinics|mesh-ancestor
153447221|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
153447222|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447223|NCT00002507|Mitomycins|mitomycins|mesh-list
153447224|NCT00002507|Mitomycin|mitomycin|mesh-list
153447225|NCT00002507|Porfiromycin|porfiromycin|mesh-list
153447226|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447227|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447228|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
153447229|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447230|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447231|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447232|NCT00002519|Paclitaxel|paclitaxel|mesh-list
153447233|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447234|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905694|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905695|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905696|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153905697|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905698|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153905699|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
153905700|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153905701|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153905702|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
153905703|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905704|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
153905705|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905706|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153905707|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153905708|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
153905709|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153905710|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153416844|NCT02618720|Ornidazole|ornidazole|mesh-list
153447237|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447238|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447239|NCT00002267|Rifabutin|rifabutin|mesh-list
153447240|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153447241|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447242|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153447243|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
153447244|NCT00002273|Ganciclovir|ganciclovir|mesh-list
153447245|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153905720|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
153447249|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447250|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447251|NCT00002279|Zalcitabine|zalcitabine|mesh-list
153447252|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
153447253|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447254|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153447255|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447256|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447257|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
153447258|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447259|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447260|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447261|NCT00002285|Zidovudine|zidovudine|mesh-list
153447262|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
153905733|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905734|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153905735|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153905736|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153447263|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447264|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153447265|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447266|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447267|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
153447268|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447269|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447270|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447273|NCT00002531|Dexamethasone|dexamethasone|mesh-list
153447274|NCT00002531|Prednisolone|prednisolone|mesh-list
153447275|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
153447276|NCT00002531|Ifosfamide|ifosfamide|mesh-list
153447277|NCT00002531|Doxorubicin|doxorubicin|mesh-list
153447278|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153447279|NCT00002531|Methotrexate|methotrexate|mesh-list
153447280|NCT00002531|Etoposide|etoposide|mesh-list
153447281|NCT00002531|Vincristine|vincristine|mesh-list
153447282|NCT00002531|Daunorubicin|daunorubicin|mesh-list
153447283|NCT00002531|Asparaginase|asparaginase|mesh-list
153447284|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
153447285|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
153905754|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153905755|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
153905756|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153447286|NCT00002531|Thioguanine|thioguanine|mesh-list
153447287|NCT00002531|Vindesine|vindesine|mesh-list
153558529|NCT01627132|Dasatinib|dasatinib|mesh-list
153447288|NCT00002531|Teniposide|teniposide|mesh-list
153447289|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
153447290|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447291|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
153447292|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447293|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447294|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447295|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
153447296|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447297|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447298|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153447299|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153447300|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
153447301|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
153447302|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447303|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153447304|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
153447312|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153447314|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153447315|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447316|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
153447317|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
153447318|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153447319|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447320|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447321|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
153447322|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447323|NCT00002531|Antidotes|antidotes|mesh-ancestor
153447324|NCT00002531|Protective Agents|protective agents|mesh-ancestor
153447336|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447337|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447338|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447339|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
153447340|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153447341|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447342|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447343|NCT00002291|Pentamidine|pentamidine|mesh-list
153447344|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
153447345|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447346|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153447347|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153447348|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153447349|NCT00002549|Cytarabine|cytarabine|mesh-list
153447350|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
153447351|NCT00002549|Busulfan|busulfan|mesh-list
153447352|NCT00002549|Etoposide|etoposide|mesh-list
153447353|NCT00002549|Daunorubicin|daunorubicin|mesh-list
153447354|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
153905806|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905807|NCT00637611|Fexofenadine|fexofenadine|mesh-list
153905808|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153905809|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153905810|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153905811|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
153905812|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
153905813|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905814|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905815|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905816|NCT00626535|Esomeprazole|esomeprazole|mesh-list
153905817|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153905819|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153447355|NCT00002549|Idarubicin|idarubicin|mesh-list
153447356|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447357|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
153447358|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447359|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447360|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447361|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
153447362|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447363|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447364|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153447365|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447366|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447367|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447376|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447377|NCT00002555|Cobalt|cobalt|mesh-list
153447378|NCT00002555|Trace Elements|trace elements|mesh-ancestor
153447379|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
153447380|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447381|NCT00002561|Doxorubicin|doxorubicin|mesh-list
153447382|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153447383|NCT00002561|Bleomycin|bleomycin|mesh-list
153447384|NCT00002561|Dacarbazine|dacarbazine|mesh-list
153447385|NCT00002561|Vinblastine|vinblastine|mesh-list
153447386|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447387|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447401|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447402|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447403|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447404|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905856|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905857|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
153905858|NCT01198548|Vitamins|vitamins|mesh-ancestor
153905859|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
153905860|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
153905861|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153905862|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153905863|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
153905864|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905865|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153905866|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153905867|NCT01198548|Antidotes|antidotes|mesh-ancestor
153447405|NCT00002579|Tamoxifen|tamoxifen|mesh-list
153447406|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
153447407|NCT00002579|Fluorouracil|fluorouracil|mesh-list
153447408|NCT00002579|Methotrexate|methotrexate|mesh-list
153447409|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447410|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
153447411|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447412|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447413|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447414|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
153447415|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447416|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447417|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153447418|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
153447419|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447420|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153447421|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
153447422|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153447423|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
153447424|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447425|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153447426|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447427|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153447428|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
153447429|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153447430|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153447431|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153447432|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153447433|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153447434|NCT00002585|NSC 366140|nsc 366140|mesh-list
153447435|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447436|NCT00002609|Cytarabine|cytarabine|mesh-list
153905882|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153905883|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905884|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153905885|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153905886|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905887|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
153905888|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153905889|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153905890|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153905891|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
153905892|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153905893|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153905897|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447438|NCT00002609|Lintuzumab|lintuzumab|mesh-list
153447439|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447440|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
153447441|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447442|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447443|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
153447444|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447445|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447446|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
153447447|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447448|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447449|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447450|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447451|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447452|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153447453|NCT00002615|Fluorouracil|fluorouracil|mesh-list
153447454|NCT00002615|Epirubicin|epirubicin|mesh-list
153447455|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447456|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
153447457|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447458|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447461|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447462|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447463|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447464|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153736462|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
153447465|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447466|NCT00002621|Interferons|interferons|mesh-list
153447467|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
153447468|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
153870876|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
153447469|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447470|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
153447471|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447472|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
153447473|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447474|NCT00002627|Paclitaxel|paclitaxel|mesh-list
153447475|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
153447476|NCT00002627|Carboplatin|carboplatin|mesh-list
153447477|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447478|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447479|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447480|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447481|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447482|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447483|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447484|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
153447485|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447486|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153905921|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905922|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905923|NCT02437279|Nivolumab|nivolumab|mesh-list
153905924|NCT02437279|Ipilimumab|ipilimumab|mesh-list
153905925|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153838695|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
153905926|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905927|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153838697|NCT02924454|Metoprolol|metoprolol|mesh-list
153905933|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
153905934|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905935|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905936|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
153905937|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
153905938|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
153905939|NCT01251653|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153905940|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153905941|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905942|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
153905943|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153905944|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905945|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153905946|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
153447487|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447488|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
153447489|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153447491|NCT00002633|Goserelin|goserelin|mesh-list
153447492|NCT00002633|Flutamide|flutamide|mesh-list
153447493|NCT00002633|Bicalutamide|bicalutamide|mesh-list
153447494|NCT00002633|Nilutamide|nilutamide|mesh-list
153447495|NCT00002633|Buserelin|buserelin|mesh-list
153447496|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153447498|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153447499|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447500|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153447501|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447502|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
153447503|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
153447504|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153447505|NCT00002639|Suramin|suramin|mesh-list
153447506|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
153447507|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
153447508|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153447509|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447510|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447511|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153447512|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153447513|NCT00002657|Interferons|interferons|mesh-list
153447514|NCT00002657|Cytarabine|cytarabine|mesh-list
153447515|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
153447516|NCT00002657|Prednisone|prednisone|mesh-list
153447517|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
153447518|NCT00002657|Doxorubicin|doxorubicin|mesh-list
153447519|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153905947|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153905948|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905949|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905950|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905951|NCT01077375|Milnacipran|milnacipran|mesh-list
153905952|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
153905953|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153905954|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153905955|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905956|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905957|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153447520|NCT00002657|Methotrexate|methotrexate|mesh-list
153447521|NCT00002657|Etoposide|etoposide|mesh-list
153447522|NCT00002657|Vincristine|vincristine|mesh-list
153905958|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905960|NCT01077375|Analgesics|analgesics|mesh-ancestor
153905961|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
153905962|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153905963|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
153905964|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153905965|NCT02877771|Insulin|insulin|mesh-list
153905967|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905968|NCT04306653|Betamethasone|betamethasone|mesh-list
153905969|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153905970|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
153905971|NCT04306653|Hormones|hormones|mesh-ancestor
153905972|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153905973|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905974|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153905975|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
153905976|NCT04306731|Trimethoprim|trimethoprim|mesh-list
153905977|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153905978|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153905979|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
153905980|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153905981|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153905982|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153905983|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905984|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905985|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153905986|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153447534|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447535|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447536|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447537|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153447538|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
153447539|NCT00002657|Hormones|hormones|mesh-ancestor
153447540|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417278|NCT02751385|Nintedanib|nintedanib|mesh-list
153447541|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153447542|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153411537|NCT00003735|Topotecan|topotecan|mesh-list
153447543|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
153447544|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153447545|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447546|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
153447547|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
153447548|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153447549|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447550|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447551|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
153447552|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447553|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447554|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447555|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447556|NCT00381875|Sargramostim|sargramostim|mesh-list
153447557|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
153447558|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
153447559|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447560|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153447561|NCT00002669|Interferons|interferons|mesh-list
153447562|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
153447563|NCT00002669|Aldesleukin|aldesleukin|mesh-list
153447564|NCT00002669|Dacarbazine|dacarbazine|mesh-list
153447565|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447566|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
153447567|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447568|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
153447569|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447570|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447571|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153905987|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153905988|NCT02877537|Albuterol|albuterol|mesh-list
153905989|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153905990|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
153905991|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559002|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153905992|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905993|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153905994|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
153905995|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
153905996|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153905997|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153905998|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153905999|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153906000|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
153906001|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906002|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906003|NCT01250873|Sertraline|sertraline|mesh-list
153906004|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
153906005|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153906006|NCT01250873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153906007|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153906008|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906009|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906010|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906011|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
153906012|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906013|NCT02888327|Oseltamivir|oseltamivir|mesh-list
153906014|NCT02888327|Digoxin|digoxin|mesh-list
153906015|NCT02888327|Midazolam|midazolam|mesh-list
153906016|NCT02888327|Pitavastatin|pitavastatin|mesh-list
153906017|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153906018|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153906019|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906020|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906021|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153906022|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153447572|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447573|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
153447574|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447575|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
153447576|NCT00002675|Carboplatin|carboplatin|mesh-list
153447577|NCT00002675|Etoposide|etoposide|mesh-list
153447578|NCT00002675|Vincristine|vincristine|mesh-list
153447580|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
153447581|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447582|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447583|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447584|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
153447585|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447586|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447587|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153447588|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447589|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447590|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447591|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447592|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447593|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447594|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447595|NCT00002681|Aldesleukin|aldesleukin|mesh-list
153447596|NCT00002681|Daclizumab|daclizumab|mesh-list
153447597|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447598|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447599|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447600|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
153447601|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447602|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447603|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
153447604|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447605|NCT02973113|Nivolumab|nivolumab|mesh-list
153906023|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153447606|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153447607|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447608|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153906024|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153906025|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
153906026|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
153906027|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
153906028|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
153906029|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906030|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906031|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153906047|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906048|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153906049|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153906050|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
153906051|NCT01248065|Hormones|hormones|mesh-ancestor
153906052|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906053|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153906054|NCT01250756|Vaccines|vaccines|mesh-list
153906055|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153906056|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
153906057|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906058|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
153906059|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153447609|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447610|NCT00002687|Aldesleukin|aldesleukin|mesh-list
153447611|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447612|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447613|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447614|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
153447615|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447616|NCT00002693|Carboplatin|carboplatin|mesh-list
153447617|NCT00002693|Topotecan|topotecan|mesh-list
153447618|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447619|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153447620|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447621|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447622|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447623|NCT00002705|Topotecan|topotecan|mesh-list
153447624|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153447625|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447626|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447627|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447628|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447629|NCT00002711|Paclitaxel|paclitaxel|mesh-list
153447630|NCT00002711|Cisplatin|cisplatin|mesh-list
153447631|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447632|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447633|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447634|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447635|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
154257009|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257010|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257011|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
154257012|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
154257013|NCT01167920|Diuretics|diuretics|mesh-list
154257014|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154257015|NCT01167920|Renin Inhibitors|renin inhibitors|mesh-list
154257016|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154257017|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731861|NCT00161577|Ketorolac|ketorolac|mesh-list
153906060|NCT00977470|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153906061|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906062|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906063|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906064|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906065|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
153906066|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153906067|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153906069|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906070|NCT02865304|Endostar protein|endostar protein|mesh-list
153906071|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153906072|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153906073|NCT02865304|Growth Substances|growth substances|mesh-ancestor
153906074|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906075|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
153906076|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906077|NCT04075474|Listerine|listerine|mesh-list
153906078|NCT04075474|Fluorides|fluorides|mesh-list
153906079|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
153906080|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
153906081|NCT04075474|Protective Agents|protective agents|mesh-ancestor
153906082|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906083|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153906084|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906085|NCT02866396|Pregabalin|pregabalin|mesh-list
153447636|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447637|NCT00002717|Paclitaxel|paclitaxel|mesh-list
153447638|NCT00002717|Cisplatin|cisplatin|mesh-list
153447639|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153447640|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447641|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447642|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447643|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447644|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447647|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
153447648|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153447649|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447650|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447651|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153447652|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153447654|NCT00002735|Cisplatin|cisplatin|mesh-list
153447655|NCT00002735|Fluorouracil|fluorouracil|mesh-list
153447656|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447657|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
153906090|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
153906091|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153906092|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906093|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906094|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153906095|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153906097|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906099|NCT01087203|Tanezumab|tanezumab|mesh-list
153906100|NCT01087203|Analgesics|analgesics|mesh-ancestor
153906101|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
153906102|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906103|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906104|NCT01246583|Tofacitinib|tofacitinib|mesh-list
153906105|NCT01246583|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153559259|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
153906106|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153559324|NCT01631838|Tocotrienols|tocotrienols|mesh-list
153906107|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906108|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906109|NCT00626613|Risperidone|risperidone|mesh-list
153447662|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447663|NCT00002735|Trace Elements|trace elements|mesh-ancestor
153447664|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
153447665|NCT00002747|Cobalt|cobalt|mesh-list
153447666|NCT00002747|Fluorouracil|fluorouracil|mesh-list
153447667|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447668|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
153447669|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447670|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447671|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447672|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
153447673|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447675|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
153447676|NCT02973035|Amlodipine|amlodipine|mesh-list
153447677|NCT02973035|Valsartan|valsartan|mesh-list
153447678|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153447679|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153447680|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153447681|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906112|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
153906113|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906114|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906115|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906116|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153906117|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153906118|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906119|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153906120|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153906121|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
153906122|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153906123|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906124|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
153906125|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153906126|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
153906128|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
153906130|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153906131|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906132|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153906133|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153906134|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153906135|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906136|NCT01079949|Cetrorelix|cetrorelix|mesh-list
153447690|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447691|NCT00002759|Cyclosporine|cyclosporine|mesh-list
153447692|NCT00002759|Irinotecan|irinotecan|mesh-list
153447693|NCT00002759|Phenobarbital|phenobarbital|mesh-list
153447694|NCT00002759|Cyclosporins|cyclosporins|mesh-list
153447695|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153447696|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447697|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447698|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447699|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447700|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447701|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
153447718|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153447720|NCT00002765|Immunoconjugates|immunoconjugates|mesh-ancestor
153447722|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447723|NCT00002771|Interferons|interferons|mesh-list
153447724|NCT00002771|Cytarabine|cytarabine|mesh-list
153447725|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
153447726|NCT00002771|Busulfan|busulfan|mesh-list
153447727|NCT00002771|Idarubicin|idarubicin|mesh-list
153447728|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
153447729|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447730|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
153447731|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447732|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447733|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
153447734|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906152|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906153|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153906154|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906155|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906156|NCT04083157|Imiquimod|imiquimod|mesh-list
153906157|NCT04083157|Vaccines|vaccines|mesh-list
153906158|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
153906159|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906160|NCT04083157|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153906161|NCT04083157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906162|NCT04083157|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153906163|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153906175|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153906177|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153447735|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447736|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
153447737|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447738|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
153447739|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447740|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153447741|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447742|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447743|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447744|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447745|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
153447746|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447747|NCT00002777|Tamoxifen|tamoxifen|mesh-list
153447748|NCT00002777|Exemestane|exemestane|mesh-list
153447749|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447750|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153447751|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
153447752|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153447753|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447754|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153447755|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447756|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153447757|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153447758|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153447759|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153447760|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153447761|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257048|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257049|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
154257050|NCT01281878|Pyridoxal|pyridoxal|mesh-list
154257051|NCT01281878|Pyridoxine|pyridoxine|mesh-list
154257052|NCT01281878|Vitamins|vitamins|mesh-ancestor
154257053|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
154257054|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257055|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
154257056|NCT01164488|Ritonavir|ritonavir|mesh-list
154257057|NCT01164488|Ketoconazole|ketoconazole|mesh-list
154257058|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154257059|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153906178|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906179|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153906180|NCT00908011|Ezetimibe|ezetimibe|mesh-list
153906181|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153906182|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153906183|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
153906184|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906185|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153906186|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153906187|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906188|NCT00976456|Bevacizumab|bevacizumab|mesh-list
153906189|NCT00976456|Carboplatin|carboplatin|mesh-list
153906190|NCT00976456|Pemetrexed|pemetrexed|mesh-list
153906191|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153906192|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906193|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153906194|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153906195|NCT00976456|Growth Substances|growth substances|mesh-ancestor
153906196|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906198|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906199|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906200|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153906201|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153906202|NCT01243151|Bococizumab|bococizumab|mesh-list
153906203|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153906204|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153447762|NCT00002783|Leucovorin|leucovorin|mesh-list
153447763|NCT00002783|Fluorouracil|fluorouracil|mesh-list
153447764|NCT00002783|Floxuridine|floxuridine|mesh-list
153447765|NCT00002783|Calcium|calcium|mesh-list
153447766|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
153447767|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447768|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153447769|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447770|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
153447771|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447772|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447773|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447774|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
153447775|NCT00002783|Antidotes|antidotes|mesh-ancestor
153447776|NCT00002783|Protective Agents|protective agents|mesh-ancestor
153447777|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
153447778|NCT00002783|Vitamins|vitamins|mesh-ancestor
153447779|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
153447780|NCT00002789|Cyclosporine|cyclosporine|mesh-list
153447781|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
153447782|NCT00002789|Busulfan|busulfan|mesh-list
153447783|NCT00002789|Methotrexate|methotrexate|mesh-list
153447784|NCT00002789|Cyclosporins|cyclosporins|mesh-list
153447785|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447786|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
153447787|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447788|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447789|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447790|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
153906206|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906207|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153906208|NCT00629512|Esomeprazole|esomeprazole|mesh-list
153906209|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153906210|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153906211|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153906212|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906213|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906214|NCT01711021|Amphetamine|amphetamine|mesh-list
153906215|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
153906216|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153906217|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906218|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
153906219|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
153906220|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906221|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
153906222|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906223|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906224|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
153906225|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153906226|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153906227|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906228|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153906230|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
153906232|NCT02864602|BB 1101|bb 1101|mesh-list
153906233|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906234|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
153447794|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153447795|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
153447796|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153447797|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153447798|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
153447799|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
153447800|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447801|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153447802|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153447803|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
153447804|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447805|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153447807|NCT00381953|Ribavirin|ribavirin|mesh-list
153447808|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
153447810|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153447811|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447812|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
154257074|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257076|NCT00312845|Bortezomib|bortezomib|mesh-list
154257077|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154257078|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447813|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447814|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
153447815|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447816|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
153447817|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447818|NCT00382343|Trimethoprim|trimethoprim|mesh-list
153447819|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153447820|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
153447821|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153447822|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447823|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
153447824|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153447825|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153447826|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153906235|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
153906236|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906237|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906238|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153906239|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
153906240|NCT02864602|Hormones|hormones|mesh-ancestor
153906241|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906242|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153906243|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906244|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
153906245|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906246|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906247|NCT00993148|Ritonavir|ritonavir|mesh-list
153906248|NCT00993148|Darunavir|darunavir|mesh-list
153906249|NCT00993148|Maraviroc|maraviroc|mesh-list
153906250|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153906251|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153906252|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
153906253|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906254|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906255|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153906256|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153906257|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
153906258|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906259|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153906274|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447850|NCT05749367|Anesthetics|anesthetics|mesh-ancestor
153447851|NCT05749367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153447852|NCT05749367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447853|NCT05749367|Sensory System Agents|sensory system agents|mesh-ancestor
153447854|NCT05749367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447859|NCT02972957|Azithromycin|azithromycin|mesh-list
153447860|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153447861|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447862|NCT05545319|Ritonavir|ritonavir|mesh-list
153447863|NCT05545319|Nirmatrelvir|nirmatrelvir|mesh-list
153447864|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153447865|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153447866|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
153447867|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447868|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447869|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447870|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447871|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
153447872|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447873|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153447874|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153447875|NCT05523869|Topotecan|topotecan|mesh-list
153906283|NCT01241591|Etanercept|etanercept|mesh-list
153906284|NCT01241591|Tofacitinib|tofacitinib|mesh-list
153906285|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153906286|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153906287|NCT01241591|Analgesics|analgesics|mesh-ancestor
153906288|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
153906289|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906290|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906291|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906292|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906293|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153906294|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906295|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
153906296|NCT01241591|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153906297|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906298|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906299|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906300|NCT04319705|Azithromycin|azithromycin|mesh-list
153906301|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153906302|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906303|NCT00906373|Sorafenib|sorafenib|mesh-list
153906304|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153906305|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906306|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906307|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906308|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906310|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906312|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
153906313|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
153906314|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447876|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153447877|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447879|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447880|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447882|NCT05522465|Prednisone|prednisone|mesh-list
153906323|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906324|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906325|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906326|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
153906327|NCT04220203|Capecitabine|capecitabine|mesh-list
153906328|NCT04220203|Trastuzumab|trastuzumab|mesh-list
153906329|NCT04220203|Tucatinib|tucatinib|mesh-list
153906331|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
153906332|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906333|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447897|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153447898|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447899|NCT05215691|Analgesics|analgesics|mesh-ancestor
153447900|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
153447901|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447902|NCT04824053|Selenium|selenium|mesh-list
153447910|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
153447911|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
153447912|NCT04811339|Bismuth|bismuth|mesh-list
153447913|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153447914|NCT04811339|Antacids|antacids|mesh-ancestor
153906344|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906345|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906346|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906347|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906348|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153906349|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906350|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906352|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153906353|NCT02850211|Narcotics|narcotics|mesh-ancestor
153559767|NCT01635387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906354|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906355|NCT02850289|Interferons|interferons|mesh-list
153447921|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447922|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447924|NCT00382421|Amlodipine|amlodipine|mesh-list
153447925|NCT00382421|Bisoprolol|bisoprolol|mesh-list
153447926|NCT00382421|Molsidomine|molsidomine|mesh-list
153447927|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153447928|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153447929|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153447930|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447931|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153447932|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447933|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
153447934|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154257084|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
153447935|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153447936|NCT00382421|Analgesics|analgesics|mesh-ancestor
153447937|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
153447938|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447939|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153447940|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447941|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153447942|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153447943|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153447944|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153447945|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447946|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
153447947|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
153447948|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
153447949|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153447950|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153447951|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153447952|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
153447953|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906356|NCT02850289|Ribavirin|ribavirin|mesh-list
153906357|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906358|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
153906359|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906360|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
153906361|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447954|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153447955|NCT05007509|Vaccines|vaccines|mesh-list
153906362|NCT05331781|Morphine|morphine|mesh-list
153906363|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153906364|NCT05331781|Narcotics|narcotics|mesh-ancestor
153906365|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906366|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906367|NCT05331781|Analgesics|analgesics|mesh-ancestor
153906368|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
153906369|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906370|NCT04202887|Fentanyl|fentanyl|mesh-list
153906371|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153906372|NCT04202887|Narcotics|narcotics|mesh-ancestor
153906373|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906374|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906375|NCT04202887|Analgesics|analgesics|mesh-ancestor
153906376|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
153906377|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906378|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153906379|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153906380|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
153906381|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
153906382|NCT05324215|Fentanyl|fentanyl|mesh-list
153906383|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153906384|NCT05324215|Narcotics|narcotics|mesh-ancestor
153906385|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906386|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906387|NCT05324215|Analgesics|analgesics|mesh-ancestor
153906388|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
153906389|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906390|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153906391|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153906394|NCT00905437|Pregabalin|pregabalin|mesh-list
153906395|NCT00905437|Analgesics|analgesics|mesh-ancestor
153906396|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
153447962|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447963|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
153447964|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447967|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153447968|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153447969|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447971|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
153447972|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447973|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447974|NCT00382889|Beclomethasone|beclomethasone|mesh-list
153447975|NCT00382889|Albuterol|albuterol|mesh-list
153447976|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153447977|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
153447978|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153447979|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906411|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
153906412|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
153906413|NCT01238861|Benralizumab|benralizumab|mesh-list
153906414|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153906415|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
153906416|NCT02888561|Dobutamine|dobutamine|mesh-list
153447982|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
153447983|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153447984|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153447985|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153447986|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153447987|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
153447988|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153447989|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447990|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153447991|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
153447992|NCT00382889|Hormones|hormones|mesh-ancestor
153447993|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153447994|NCT04482959|Carbetocin|carbetocin|mesh-list
153447995|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
153447996|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153447997|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447998|NCT04571879|Lidocaine|lidocaine|mesh-list
153447999|NCT04571879|Midazolam|midazolam|mesh-list
153906431|NCT04319549|Ketorolac|ketorolac|mesh-list
153906432|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153906433|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153448000|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
153448001|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
153448002|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153448003|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448005|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153448006|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153448007|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153448008|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153448009|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153448010|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448011|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153906457|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153906458|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906459|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906460|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153906461|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906462|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
153906463|NCT01237223|Renin Inhibitors|renin inhibitors|mesh-ancestor
153906464|NCT01237223|Protease Inhibitors|protease inhibitors|mesh-ancestor
153448034|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448036|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153448037|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
153448038|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448039|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153448040|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153448041|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
153448042|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153448043|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153448044|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448045|NCT03575195|Rifaximin|rifaximin|mesh-list
153448046|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153448047|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448048|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153448049|NCT00002897|Fluorouracil|fluorouracil|mesh-list
153448050|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448051|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
153417971|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
153448052|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448055|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
153448056|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448058|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448059|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448060|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448061|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448062|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448063|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153448064|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448065|NCT00002915|Penclomedine|penclomedine|mesh-list
153448066|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448067|NCT00002921|Suramin|suramin|mesh-list
153448068|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
153448069|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153448070|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153448071|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153448072|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153448073|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
153448074|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
153448075|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153448076|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906500|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153906501|NCT01235351|Clopidogrel|clopidogrel|mesh-list
153906502|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153906503|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153906504|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153448077|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448078|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153448079|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153448081|NCT00383045|Buprenorphine|buprenorphine|mesh-list
153448082|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153448084|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153448085|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448086|NCT00383045|Analgesics|analgesics|mesh-ancestor
153448087|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
153448088|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153448089|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153448090|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153448091|NCT00383591|Vaccines|vaccines|mesh-list
153448092|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
153736464|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448107|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448108|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153448109|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448110|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448111|NCT03085823|Sirolimus|sirolimus|mesh-list
153448112|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153448113|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448114|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448115|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448116|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
153448117|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448118|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
153736465|NCT02397720|Nivolumab|nivolumab|mesh-list
153906541|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153906542|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
153906543|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153448119|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448121|NCT00002945|Aldesleukin|aldesleukin|mesh-list
153448122|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
153448123|NCT00002945|Melphalan|melphalan|mesh-list
153448124|NCT00002945|Etoposide|etoposide|mesh-list
153448125|NCT00002945|Idarubicin|idarubicin|mesh-list
153448127|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
153448164|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153448166|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153448167|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906566|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906567|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906568|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153906581|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
153906582|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906583|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906584|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153906585|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
153906586|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906587|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906588|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153906589|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153906590|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448168|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153448169|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153448170|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
153448171|NCT00002969|Paclitaxel|paclitaxel|mesh-list
153448172|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448173|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448174|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448175|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448176|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448178|NCT00002987|Prednisolone|prednisolone|mesh-list
153448179|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
153448180|NCT00002987|Doxorubicin|doxorubicin|mesh-list
153448181|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153448182|NCT00002987|Etoposide|etoposide|mesh-list
153448183|NCT00002987|Vincristine|vincristine|mesh-list
153448185|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448186|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
153448187|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448188|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448189|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448190|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
153448191|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448192|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448193|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448194|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448195|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153906591|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
153906592|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153906593|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
153906594|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
153906595|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
153906596|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906597|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
153906609|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153906610|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153906611|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906612|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906613|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906614|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153906615|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153906616|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560183|NCT01637233|Emtricitabine|emtricitabine|mesh-list
153448196|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448197|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448198|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448199|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448200|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448201|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448202|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153448203|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
153448204|NCT00002987|Hormones|hormones|mesh-ancestor
153418083|NCT04333550|Deferoxamine|deferoxamine|mesh-list
153906617|NCT04778787|Protective Agents|protective agents|mesh-ancestor
153906618|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
153906619|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906620|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
153906621|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153448231|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153735840|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839615|NCT06025825|Epinephrine|epinephrine|mesh-list
153906631|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
153906632|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906633|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906634|NCT02875587|Cabergoline|cabergoline|mesh-list
153906635|NCT02875587|Calcium|calcium|mesh-list
153906636|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153906637|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906638|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153906639|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153906640|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
153906641|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
153906642|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906643|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906644|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153906645|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153906646|NCT01070979|Estradiol|estradiol|mesh-list
153906647|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153906648|NCT01070979|Estrogens|estrogens|mesh-list
153906649|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153906650|NCT01070979|Hormones|hormones|mesh-ancestor
153914666|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153448232|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153448233|NCT01928082|Estradiol|estradiol|mesh-list
153448234|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153448235|NCT01928082|Estrogens|estrogens|mesh-ancestor
153448236|NCT01928082|Hormones|hormones|mesh-ancestor
153448237|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448238|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448239|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153448240|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
153448241|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153448242|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153448243|NCT00002999|Fluorouracil|fluorouracil|mesh-list
153906661|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906662|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906663|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906664|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906665|NCT02848963|Ketamine|ketamine|mesh-list
153906666|NCT02848963|Propofol|propofol|mesh-list
153906667|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153906668|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906669|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906670|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153448253|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448254|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153448255|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448256|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448257|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
153448258|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448260|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448261|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448262|NCT00003017|Interleukin-12|interleukin-12|mesh-list
153448263|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153448264|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
153448265|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448266|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153906694|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
153906695|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914667|NCT05342857|Growth Substances|growth substances|mesh-ancestor
153448282|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448283|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153448284|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153448285|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448286|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448287|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448288|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448289|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448291|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448292|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
153448293|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448294|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448295|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448296|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
153448297|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448299|NCT00003035|Paclitaxel|paclitaxel|mesh-list
153448300|NCT00003035|Doxorubicin|doxorubicin|mesh-list
153448301|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153448302|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448303|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448304|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
153906697|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153906698|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153906699|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906700|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906701|NCT01073943|Bisacodyl|bisacodyl|mesh-list
153906702|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
153906703|NCT01073943|Cathartics|cathartics|mesh-ancestor
153906704|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153906705|NCT01073943|Laxatives|laxatives|mesh-ancestor
153906706|NCT01073865|Goserelin|goserelin|mesh-list
153906707|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153906708|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906709|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
153906710|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
153906711|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906727|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906728|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153906729|NCT04697485|Diuretics|diuretics|mesh-ancestor
153906730|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
153906731|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153906732|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153906733|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906734|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906735|NCT01073631|Voriconazole|voriconazole|mesh-list
153906736|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
153906737|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906738|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153448326|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448327|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448328|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448330|NCT00003065|Topotecan|topotecan|mesh-list
153448331|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448332|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448333|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448334|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448335|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448336|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448337|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153448338|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448339|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448341|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
153448342|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153448343|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153448344|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448345|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448346|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448347|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906754|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906755|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
153906756|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153906757|NCT00626769|Estrogens|estrogens|mesh-ancestor
153448348|NCT00383357|Zolpidem|zolpidem|mesh-list
153448349|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153448350|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153448351|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153448352|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448353|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153448354|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
153448355|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
153448356|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153448357|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448358|NCT00003089|Paclitaxel|paclitaxel|mesh-list
153448359|NCT00003089|Carboplatin|carboplatin|mesh-list
153448360|NCT00003089|Amifostine|amifostine|mesh-list
153448361|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448362|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448363|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448364|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448365|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448366|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448367|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153448368|NCT00003089|Protective Agents|protective agents|mesh-ancestor
153379941|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906759|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906760|NCT02875743|Posaconazole|posaconazole|mesh-list
153906761|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
153906762|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906770|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153906771|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
153906772|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906773|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906775|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153379942|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153906776|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153906777|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379943|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153906778|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
153906779|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448373|NCT00003101|Lomustine|lomustine|mesh-list
153448374|NCT00003101|Procarbazine|procarbazine|mesh-list
153448375|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
153448376|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448377|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448378|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448379|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448380|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448381|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448387|NCT00003107|Interleukin-12|interleukin-12|mesh-list
153448388|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153448389|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
153448390|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448391|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153448392|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153448393|NCT00003107|Growth Substances|growth substances|mesh-ancestor
153448394|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
153448395|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448396|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
153448398|NCT00003113|Etoposide|etoposide|mesh-list
153448399|NCT00003113|Procarbazine|procarbazine|mesh-list
153448400|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906781|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153906782|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
153906783|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906784|NCT02875821|Metformin|metformin|mesh-list
153906785|NCT02875821|Pioglitazone|pioglitazone|mesh-list
153906786|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
153906787|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906788|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906789|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153906790|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906791|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
153906792|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906793|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
153448404|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448406|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448407|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448408|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448409|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448410|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448411|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448412|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448414|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
153448415|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
153448416|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
153448417|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906807|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906808|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906809|NCT04305015|Analgesics|analgesics|mesh-ancestor
153906810|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
153906811|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906812|NCT01231607|Finasteride|finasteride|mesh-list
153906813|NCT01231607|Dutasteride|dutasteride|mesh-list
153448418|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448419|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
153448420|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153448421|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153448422|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153448423|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153448424|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153448425|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448435|NCT00003119|Sargramostim|sargramostim|mesh-list
153448436|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448437|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
153418250|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
153906825|NCT00975130|Golimumab|golimumab|mesh-list
153906826|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153906827|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153906828|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906829|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906830|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
153906831|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906832|NCT01230827|Golimumab|golimumab|mesh-list
153906833|NCT01230827|Methotrexate|methotrexate|mesh-list
153906834|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153906835|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
153906836|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153906837|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906838|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153906839|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
153906844|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153906845|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906847|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906848|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153906849|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153906850|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906851|NCT01230749|Pioglitazone|pioglitazone|mesh-list
153906852|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153448447|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448448|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448449|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448462|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448463|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448464|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448465|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448466|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
153906853|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906855|NCT00903175|Sunitinib|sunitinib|mesh-list
153906856|NCT00903175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153906857|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906858|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906859|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906860|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906861|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
153906862|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906863|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906864|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153906865|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153906866|NCT00903175|Growth Substances|growth substances|mesh-ancestor
153448483|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448484|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448485|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448486|NCT00003125|Aldesleukin|aldesleukin|mesh-list
153448487|NCT00003125|Vaccines|vaccines|mesh-list
153448488|NCT00003125|Sargramostim|sargramostim|mesh-list
153448489|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
153448490|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448491|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448492|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153448493|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153448494|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
153448495|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448496|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
153448497|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153448498|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448499|NCT00003131|Immunotoxins|immunotoxins|mesh-ancestor
153448500|NCT00003131|Immunoconjugates|immunoconjugates|mesh-ancestor
153448501|NCT00003131|Immunologic Factors|immunologic factors|mesh-ancestor
153448502|NCT00003131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448503|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
154257098|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257099|NCT01165814|Analgesics|analgesics|mesh-ancestor
153448504|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153448505|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153448506|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153448507|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153448508|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448509|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
153448510|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906883|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
153906884|NCT02848183|Idarubicin|idarubicin|mesh-list
153906885|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153906886|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906887|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153906888|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153906889|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840102|NCT05891132|Lidocaine|lidocaine|mesh-list
153906910|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906911|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153906912|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906913|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153906914|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
153906915|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
153448511|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448512|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153448513|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153448514|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
153448515|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153448516|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448517|NCT00003413|Paclitaxel|paclitaxel|mesh-list
153448518|NCT00003413|Melphalan|melphalan|mesh-list
153448519|NCT00003413|Carmustine|carmustine|mesh-list
153448520|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448521|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448522|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448523|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448524|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448525|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448526|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
153448527|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448528|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448529|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
153906926|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906927|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906929|NCT02847403|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153906930|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906931|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906932|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153906933|NCT02847403|Incretins|incretins|mesh-ancestor
153906934|NCT02847403|Hormones|hormones|mesh-ancestor
153448530|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448531|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448532|NCT00003137|Irinotecan|irinotecan|mesh-list
153448533|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153448534|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448535|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448536|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448537|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448538|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
153448539|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448540|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
153448541|NCT00003425|Melphalan|melphalan|mesh-list
153448542|NCT00003425|Amifostine|amifostine|mesh-list
153448543|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448544|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
153448545|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448546|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448547|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448548|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
153448549|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448550|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448551|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448553|NCT00003425|Protective Agents|protective agents|mesh-ancestor
153371830|NCT05317325|Vaccines|vaccines|mesh-list
153448554|NCT00330551|Risperidone|risperidone|mesh-list
153448555|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153448556|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
153560841|NCT01643434|Spironolactone|spironolactone|mesh-list
153448557|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153448558|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448559|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448560|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153448561|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153448562|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153448563|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153840150|NCT05839899|Misoprostol|misoprostol|mesh-list
153906943|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906944|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906945|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153906946|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153906947|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906948|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153906949|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153906950|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906951|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
153906952|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153906953|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153906954|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906955|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
153906956|NCT04216303|Chrysarobin|chrysarobin|mesh-list
153906957|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153906958|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153906959|NCT04216303|Analgesics|analgesics|mesh-ancestor
153906960|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
153906961|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906962|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906963|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906964|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906965|NCT02847013|Bupivacaine|bupivacaine|mesh-list
153906966|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
153906967|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
153448564|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153448565|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
153448566|NCT00001259|Leuprolide|leuprolide|mesh-list
153448567|NCT00001259|Estradiol|estradiol|mesh-list
153448568|NCT00001259|Progesterone|progesterone|mesh-list
153448569|NCT00001259|Estrogens|estrogens|mesh-ancestor
153448570|NCT00001259|Hormones|hormones|mesh-ancestor
153448571|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448572|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448573|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153448574|NCT00001259|Progestins|progestins|mesh-ancestor
153448575|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153448576|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
153448577|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448578|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448579|NCT00003143|Amifostine|amifostine|mesh-list
153840181|NCT05835011|Decitabine|decitabine|mesh-list
153448584|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153448585|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
153448586|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448587|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153448588|NCT00003431|Protective Agents|protective agents|mesh-ancestor
153448590|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153448591|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
153448592|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448593|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153448594|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153448595|NCT00003149|Growth Substances|growth substances|mesh-ancestor
153448596|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
153448597|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448598|NCT00003437|Cytarabine|cytarabine|mesh-list
153448599|NCT00003437|Dexamethasone|dexamethasone|mesh-list
153448600|NCT00003437|Prednisolone|prednisolone|mesh-list
153906994|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153906995|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
153906996|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906997|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
153906998|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153906999|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153907000|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448601|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
153448602|NCT00003437|Doxorubicin|doxorubicin|mesh-list
153448603|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153448604|NCT00003437|Methotrexate|methotrexate|mesh-list
153448605|NCT00003437|Vincristine|vincristine|mesh-list
153448606|NCT00003437|Daunorubicin|daunorubicin|mesh-list
153448607|NCT00003437|Asparaginase|asparaginase|mesh-list
153448608|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
153448609|NCT00003437|Pegaspargase|pegaspargase|mesh-list
153448610|NCT00003437|Thioguanine|thioguanine|mesh-list
153448611|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448612|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
153448613|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448614|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448615|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448616|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
153448617|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448618|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448619|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153907010|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153907011|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153907012|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
153907013|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907014|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907015|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907016|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
153907017|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
153448620|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153448621|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
153448622|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
153448623|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153448624|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153448625|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
153448627|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448628|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448629|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448630|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448631|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448632|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448633|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153448634|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
153448635|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153448636|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448637|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
153907035|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153907036|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448638|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
153448639|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153448640|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153448641|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
153448642|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448643|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448644|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448645|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
153561075|NCT01650649|Lofexidine|lofexidine|mesh-list
153448646|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448647|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
153448648|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153448649|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
153448650|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448651|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448652|NCT00003449|Dexamethasone|dexamethasone|mesh-list
153448653|NCT00003449|Paclitaxel|paclitaxel|mesh-list
153448654|NCT00003449|Gemcitabine|gemcitabine|mesh-list
153448655|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448656|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448657|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
153907049|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153907050|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153907051|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153907052|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153907053|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153907054|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154257100|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
154257101|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548609|NCT04671875|Antibodies|antibodies|mesh-list
153448658|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448659|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448660|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448661|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153448663|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
153448664|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153448665|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448666|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153448667|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
153448668|NCT00003449|Hormones|hormones|mesh-ancestor
153448669|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448670|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448671|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448672|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
153448673|NCT00002801|Leucovorin|leucovorin|mesh-list
153448674|NCT00002801|Tegafur|tegafur|mesh-list
153448675|NCT00002801|Calcium|calcium|mesh-list
153448676|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
153448677|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153840398|NCT05296772|Antibodies|antibodies|mesh-list
153448687|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448688|NCT00002813|Vinorelbine|vinorelbine|mesh-list
153448689|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448690|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448691|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448692|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448693|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448694|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448695|NCT00002819|Paclitaxel|paclitaxel|mesh-list
153448696|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
153448697|NCT00002819|Carboplatin|carboplatin|mesh-list
153448700|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448701|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448702|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448703|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448704|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448705|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448706|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
153448707|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448708|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448709|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448710|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
153448711|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448712|NCT00002819|Analgesics|analgesics|mesh-ancestor
153448713|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
153448714|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153448715|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448716|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448717|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448719|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448720|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448730|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
153448731|NCT00002831|Busulfan|busulfan|mesh-list
153448732|NCT00002831|Methotrexate|methotrexate|mesh-list
153907095|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
153907096|NCT04452565|BB 1101|bb 1101|mesh-list
153907097|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907098|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
153907099|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
153907100|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907101|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907102|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907103|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
153907104|NCT04452565|Hormones|hormones|mesh-ancestor
153907105|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153907106|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153907107|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907108|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
153907109|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907110|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257102|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154257104|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907111|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153907112|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153907113|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153907114|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153907115|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
153907116|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907117|NCT02863120|Bupivacaine|bupivacaine|mesh-list
153907118|NCT02863120|Ropivacaine|ropivacaine|mesh-list
153907119|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
153907120|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
153907121|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153907122|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907123|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
153907124|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907125|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153907126|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153448734|NCT00002831|Tacrolimus|tacrolimus|mesh-list
153448735|NCT00002831|Cyclosporins|cyclosporins|mesh-list
153448736|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153448737|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
153448738|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448739|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
153448740|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448741|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448742|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448743|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
153448744|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448745|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448746|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448747|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153448748|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
153448749|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153448750|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448751|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
153448752|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
153448753|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380653|NCT01924169|Vaccines|vaccines|mesh-list
153907137|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
153907138|NCT04292704|Clotrimazole|clotrimazole|mesh-list
153907139|NCT04292704|Miconazole|miconazole|mesh-list
153907140|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153907141|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907142|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
153907143|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153907144|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153907145|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448754|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153448755|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153448756|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153448757|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
153448758|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448759|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153448760|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
153448761|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
153448762|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153448763|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153448764|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
153448765|NCT00002831|Hormones|hormones|mesh-ancestor
153448766|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448767|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153448768|NCT00002831|Protective Agents|protective agents|mesh-ancestor
153448771|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
153448772|NCT00002837|Doxorubicin|doxorubicin|mesh-list
153448773|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153448774|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448775|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448776|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448777|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448778|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448779|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448784|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448785|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
153448786|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448787|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448788|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448789|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448790|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448792|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153907179|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907180|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
153448793|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
153448794|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448795|NCT00003467|Carmustine|carmustine|mesh-list
153448796|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448797|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
153448798|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448799|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448800|NCT00002849|Interferons|interferons|mesh-list
153448801|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
153448802|NCT00002849|Dexamethasone|dexamethasone|mesh-list
153448803|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153448804|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
153448805|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
153448806|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907192|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153907193|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153907194|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
153448807|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448808|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153448810|NCT00002849|Hormones|hormones|mesh-ancestor
153448811|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448812|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448813|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448814|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
153448815|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448816|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
153448817|NCT00002855|Ketoconazole|ketoconazole|mesh-list
153448818|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
153448819|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153448820|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153448821|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153448822|NCT00002855|Doxorubicin|doxorubicin|mesh-list
153448823|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153448824|NCT00002855|Bicalutamide|bicalutamide|mesh-list
153448825|NCT00002855|Vinblastine|vinblastine|mesh-list
153448826|NCT00002855|Flutamide|flutamide|mesh-list
153448827|NCT00002855|Estramustine|estramustine|mesh-list
153448829|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448830|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448831|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448832|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448833|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448834|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448835|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153448836|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
153448837|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448838|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153448839|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153448840|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153448841|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
153448842|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448843|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448844|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153448845|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
153448846|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448847|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448848|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448849|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448850|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448851|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448852|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
153448854|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
153548879|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
153548880|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
153448855|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448856|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448857|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
153448858|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448859|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448860|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153907215|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
153907216|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907217|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907218|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153907219|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153907220|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153907221|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153907222|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
153907223|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907224|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153907225|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
153907226|NCT02845999|Fludarabine|fludarabine|mesh-list
153907227|NCT02845999|Cetuximab|cetuximab|mesh-list
153907228|NCT02845999|Interleukin-2|interleukin-2|mesh-list
153907229|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907230|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
153907231|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907232|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907233|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153907234|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
153907235|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907236|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907237|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153907238|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907239|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153907240|NCT02845999|Analgesics|analgesics|mesh-ancestor
153907241|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
153907242|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907243|NCT05337085|Midazolam|midazolam|mesh-list
153907244|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
153907245|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153448867|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
153448868|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153448869|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448870|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153448871|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153448872|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153448873|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448874|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448875|NCT00002879|Cladribine|cladribine|mesh-list
153448876|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907260|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153907261|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153907262|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153907263|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
153907264|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
153907265|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
153448877|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448878|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
153448879|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448881|NCT00003185|Sargramostim|sargramostim|mesh-list
153448882|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448883|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
153448884|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448885|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448886|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448887|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
153448888|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448889|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561602|NCT01653067|Cytarabine|cytarabine|mesh-list
153448890|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448891|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
153448892|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448893|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448894|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
154257105|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448896|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448897|NCT00003935|Etoposide|etoposide|mesh-list
153448898|NCT00003935|Vincristine|vincristine|mesh-list
153448899|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448900|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448901|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448902|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448903|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448904|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448905|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448906|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448907|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448908|NCT00003191|Fenretinide|fenretinide|mesh-list
153448909|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448910|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153448911|NCT00003191|Protective Agents|protective agents|mesh-ancestor
153448912|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840848|NCT04530409|Dexamethasone|dexamethasone|mesh-list
153907295|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907296|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
153907297|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907298|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
153907299|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153448913|NCT00003941|Etoposide|etoposide|mesh-list
153448914|NCT00003941|Ifosfamide|ifosfamide|mesh-list
153448915|NCT00003941|Bleomycin|bleomycin|mesh-list
153448916|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448917|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448918|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448919|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448920|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448930|NCT00003569|Paclitaxel|paclitaxel|mesh-list
153448931|NCT00003569|Cisplatin|cisplatin|mesh-list
153448932|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448933|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448934|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448935|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448936|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448937|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448938|NCT00003953|Tamoxifen|tamoxifen|mesh-list
153448939|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
153448941|NCT00003953|Doxorubicin|doxorubicin|mesh-list
153448942|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153448943|NCT00003953|Fluorouracil|fluorouracil|mesh-list
153448944|NCT00003953|Methotrexate|methotrexate|mesh-list
153448945|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448946|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
153448947|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448948|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907300|NCT02845219|Semaglutide|semaglutide|mesh-list
153907301|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153907302|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153907303|NCT02845219|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153907305|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907306|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153907307|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
153907308|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153907309|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153907310|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153907311|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153907312|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153907313|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153735852|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735853|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907314|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153907315|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153907316|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153907317|NCT00968968|Trastuzumab|trastuzumab|mesh-list
153907318|NCT00968968|Lapatinib|lapatinib|mesh-list
153907319|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907320|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907321|NCT00968968|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153907322|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154257106|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
153907323|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907324|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907326|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153907327|NCT00973102|Hormones|hormones|mesh-ancestor
153907328|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448949|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448950|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
153448951|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448952|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448953|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448954|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448955|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
153907345|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153907346|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153448967|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153448968|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153448969|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153448970|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
153448971|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448972|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448973|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153381075|NCT04707027|Growth Substances|growth substances|mesh-ancestor
153907347|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
153561823|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153907348|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
153907349|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153907350|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
153907351|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907352|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
153907353|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153907355|NCT02842567|Tocopherols|tocopherols|mesh-list
153907356|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
153907357|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
153907358|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
153907359|NCT02842567|Vitamins|vitamins|mesh-ancestor
153907360|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
153907361|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907362|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
153907363|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907364|NCT02842567|Protective Agents|protective agents|mesh-ancestor
153448984|NCT00003203|Carboplatin|carboplatin|mesh-list
153448985|NCT00003203|Vincristine|vincristine|mesh-list
153448986|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448987|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
153448988|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448989|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448990|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448991|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
153448992|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448993|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448994|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448995|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449006|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449007|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449008|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153449009|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
153907365|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907366|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153907367|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153907368|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
153907369|NCT00705211|Ezetimibe|ezetimibe|mesh-list
153907370|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153907371|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153907372|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
153907373|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907374|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153907375|NCT02839213|Scopolamine|scopolamine|mesh-list
153907376|NCT02839213|Bromides|bromides|mesh-list
153907377|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153907379|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153907380|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
153907381|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
153549146|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
153907382|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907383|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907384|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907385|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
153907386|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153907387|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
153907388|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907389|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449010|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449011|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449012|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
153449013|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153449014|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153449015|NCT00003575|Growth Substances|growth substances|mesh-ancestor
153449016|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
153449017|NCT00003539|Paclitaxel|paclitaxel|mesh-list
153449018|NCT00003539|Trastuzumab|trastuzumab|mesh-list
153449019|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449020|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449021|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449022|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449023|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449024|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907397|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907398|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907399|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907401|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907402|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907403|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907404|NCT02838823|Antibodies|antibodies|mesh-list
153907405|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153907406|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
153907407|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907408|NCT00156091|Olanzapine|olanzapine|mesh-list
153907409|NCT00156091|Asenapine|asenapine|mesh-list
153449030|NCT00003209|Mitomycin|mitomycin|mesh-list
153449031|NCT00003209|Bleomycin|bleomycin|mesh-list
153449032|NCT00003209|Vinblastine|vinblastine|mesh-list
153449033|NCT00003209|Vindesine|vindesine|mesh-list
153449034|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449035|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
153449036|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449037|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449038|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449039|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
153449040|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449041|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153449042|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
153449043|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153449044|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
153449045|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381203|NCT01603940|Losartan|losartan|mesh-list
153907414|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907415|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153907416|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153907417|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153907418|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153907419|NCT00156091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153907420|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153907421|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153907422|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907423|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907424|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
153907425|NCT00140959|Losartan|losartan|mesh-list
153907426|NCT00140959|Atenolol|atenolol|mesh-list
153907427|NCT00140959|Amlodipine|amlodipine|mesh-list
153907428|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153907429|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153449051|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153449052|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449053|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
153372072|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153549228|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153449054|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449055|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449056|NCT00003587|Paclitaxel|paclitaxel|mesh-list
153449057|NCT00003587|Vinorelbine|vinorelbine|mesh-list
153449058|NCT00003587|Docetaxel|docetaxel|mesh-list
153449059|NCT00003587|Carboplatin|carboplatin|mesh-list
153449060|NCT00003587|Gemcitabine|gemcitabine|mesh-list
153449061|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449062|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449063|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449064|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449065|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449066|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449067|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449068|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
153449069|NCT00003215|Leucovorin|leucovorin|mesh-list
153907442|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
153907443|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153907444|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153907445|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153907447|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153907448|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153907449|NCT00095017|Analgesics|analgesics|mesh-ancestor
153449075|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153449076|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153449077|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
153449078|NCT00003215|Melphalan|melphalan|mesh-list
153449079|NCT00003215|Doxorubicin|doxorubicin|mesh-list
153449080|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153449081|NCT00003215|Methotrexate|methotrexate|mesh-list
153449082|NCT00003215|Etoposide|etoposide|mesh-list
153449083|NCT00003215|Vincristine|vincristine|mesh-list
153449084|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
153449085|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
153449086|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449087|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
153449088|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449089|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449090|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449091|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
153449092|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449093|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907458|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907459|NCT00092755|Ibuprofen|ibuprofen|mesh-list
153907460|NCT00092755|Etoricoxib|etoricoxib|mesh-list
153418844|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907461|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153907462|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153907463|NCT00092755|Analgesics|analgesics|mesh-ancestor
153907464|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
153907465|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907466|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449094|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153449095|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153449096|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449097|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449098|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449099|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153449100|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
153449102|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153449103|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153449104|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153449105|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
153449106|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153449107|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449108|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
153449109|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
153449110|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153449111|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153449112|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449113|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
153449114|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549307|NCT04199026|Everolimus|everolimus|mesh-list
153449115|NCT00003215|Antidotes|antidotes|mesh-ancestor
153449116|NCT00003215|Protective Agents|protective agents|mesh-ancestor
153449117|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
153449118|NCT00003215|Vitamins|vitamins|mesh-ancestor
153449120|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449121|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449122|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449123|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
153449124|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
153449125|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153449126|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153449127|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153449128|NCT00003215|Analgesics|analgesics|mesh-ancestor
153449129|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
153449130|NCT00003995|Trastuzumab|trastuzumab|mesh-list
153449131|NCT00003995|Irinotecan|irinotecan|mesh-list
153907467|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907468|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907469|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153907470|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907471|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907472|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153907473|NCT00899431|Rituximab|rituximab|mesh-list
153907474|NCT00899431|Fludarabine|fludarabine|mesh-list
153907475|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
153907476|NCT00899431|Lenalidomide|lenalidomide|mesh-list
153907477|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153907478|NCT00899431|Allopurinol|allopurinol|mesh-list
153907479|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
153907480|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153907481|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907482|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907484|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907485|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907486|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153907487|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
153907488|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907489|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907490|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153907491|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153907492|NCT00899431|Growth Substances|growth substances|mesh-ancestor
153907493|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
153907494|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153907495|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
153907496|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907497|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
153907498|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153907499|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
153907500|NCT00899431|Protective Agents|protective agents|mesh-ancestor
153907501|NCT00898807|Citalopram|citalopram|mesh-list
153907502|NCT00898807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153907503|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153449133|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449134|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153449135|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449136|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449137|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449138|NCT00003593|Cytarabine|cytarabine|mesh-list
153449139|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
153449140|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153449141|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153449142|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153449143|NCT00003593|Methotrexate|methotrexate|mesh-list
153449144|NCT00003593|Thioguanine|thioguanine|mesh-list
153449145|NCT00003593|Daunorubicin|daunorubicin|mesh-list
153449146|NCT00003593|Asparaginase|asparaginase|mesh-list
153449147|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153449148|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
153449149|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153449150|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449151|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449152|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
153449153|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449154|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449155|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
153449156|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449157|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153449158|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449159|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
153907512|NCT01229267|Vaccines|vaccines|mesh-list
153907513|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
153907514|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907515|NCT00897715|Rilonacept|rilonacept|mesh-list
153907516|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907517|NCT00633295|Nilotinib|nilotinib|mesh-list
153907518|NCT00633295|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153907519|NCT00633295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153907520|NCT00633295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907521|NCT00633295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907522|NCT01229111|Leucovorin|leucovorin|mesh-list
153907523|NCT01229111|Fluorouracil|fluorouracil|mesh-list
153907524|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
153907525|NCT01229111|Cediranib|cediranib|mesh-list
153907526|NCT01229111|Calcium|calcium|mesh-list
153907527|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
153907528|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153907529|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907530|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
153449160|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449161|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153449162|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
153449163|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449164|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153449165|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153449166|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449167|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449169|NCT00003599|Tocopherols|tocopherols|mesh-list
153449170|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
153449171|NCT00003599|Isotretinoin|isotretinoin|mesh-list
153449172|NCT00003599|Vitamins|vitamins|mesh-ancestor
153449173|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
153449174|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449175|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
153449176|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449177|NCT00003599|Protective Agents|protective agents|mesh-ancestor
153449178|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
153449179|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
153449180|NCT00003605|Rituximab|rituximab|mesh-list
153449181|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449182|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
153449183|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907536|NCT01229111|Antidotes|antidotes|mesh-ancestor
153907537|NCT01229111|Protective Agents|protective agents|mesh-ancestor
153907538|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
153907539|NCT01229111|Vitamins|vitamins|mesh-ancestor
153907540|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
153907541|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907542|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153907543|NCT02843815|Immunomodulating Agents|immunomodulating agents|mesh-list
153907544|NCT02843815|Immunologic Factors|immunologic factors|mesh-ancestor
153907545|NCT02843815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907546|NCT01228175|Riboflavin|riboflavin|mesh-list
153907547|NCT01228175|Varenicline|varenicline|mesh-list
153907548|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153907549|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153735857|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907550|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
153907551|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907552|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907553|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449185|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449186|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
153449187|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449188|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449189|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153449190|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449191|NCT00003611|Acitretin|acitretin|mesh-list
153449192|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
153449193|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
153449194|NCT00003617|Clarithromycin|clarithromycin|mesh-list
153449195|NCT00003617|Tinidazole|tinidazole|mesh-list
153449196|NCT00003617|Chlorambucil|chlorambucil|mesh-list
153907561|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
153907562|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907563|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154257107|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153372185|NCT01364558|Diazepam|diazepam|mesh-list
153907564|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
153907565|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
153907566|NCT01228019|Vitamins|vitamins|mesh-ancestor
153418953|NCT05827497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907568|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907569|NCT01227707|Leucovorin|leucovorin|mesh-list
153907570|NCT01227707|Bevacizumab|bevacizumab|mesh-list
153907571|NCT01227707|Capecitabine|capecitabine|mesh-list
153907572|NCT01227707|Fluorouracil|fluorouracil|mesh-list
153562341|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907573|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449204|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449205|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153449206|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153449207|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153449208|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449209|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
153449210|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449211|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153449212|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153449213|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153449215|NCT00004001|Docetaxel|docetaxel|mesh-list
153449216|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
153449217|NCT00004001|Estramustine|estramustine|mesh-list
153449228|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153449230|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
153449231|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153449232|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153907574|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907575|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153907576|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153907577|NCT01227707|Growth Substances|growth substances|mesh-ancestor
153907578|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907579|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
153907580|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153907581|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
153907582|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907583|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907584|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
153907585|NCT01227707|Antidotes|antidotes|mesh-ancestor
153907586|NCT01227707|Protective Agents|protective agents|mesh-ancestor
153907587|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
153907588|NCT01227707|Vitamins|vitamins|mesh-ancestor
153907589|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
153907590|NCT00633373|Cyclosporine|cyclosporine|mesh-list
153907591|NCT00633373|Cyclosporins|cyclosporins|mesh-list
153907592|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907593|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907594|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907595|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
153907596|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907598|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907599|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
153907600|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907601|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153907602|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
153449233|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449234|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449235|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449236|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
153449237|NCT00004013|Paclitaxel|paclitaxel|mesh-list
153449238|NCT00004013|Trastuzumab|trastuzumab|mesh-list
153449239|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449240|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449241|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449242|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449243|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449244|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907604|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
153907605|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907607|NCT05334745|Protective Agents|protective agents|mesh-ancestor
153907608|NCT02838589|Exenatide|exenatide|mesh-list
153907609|NCT02838589|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153907610|NCT02838589|Glucagon|glucagon|mesh-list
153907612|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153907613|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907615|NCT02838589|Incretins|incretins|mesh-ancestor
153907616|NCT02838589|Hormones|hormones|mesh-ancestor
153907617|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153907618|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907619|NCT02839135|Scopolamine|scopolamine|mesh-list
153907620|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153907621|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153907622|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
153907623|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
153907624|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907625|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907627|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
153907628|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153907629|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
153381531|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
153449282|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449283|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
153449284|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449285|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449286|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153562682|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
153449287|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
153907645|NCT00895843|Analgesics|analgesics|mesh-ancestor
153907646|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907647|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907648|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153907649|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907650|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907651|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153907652|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153907653|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
153907654|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907655|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153907656|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153907657|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
153907658|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153907659|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
153449288|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449290|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153449291|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449292|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449293|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449294|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449308|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449309|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907660|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
153907661|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
153907662|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153907663|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
153907664|NCT05333809|Disitamab vedotin|disitamab vedotin|mesh-list
153907665|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907666|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907667|NCT05333809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153907668|NCT05333809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907670|NCT05333809|Immunologic Factors|immunologic factors|mesh-ancestor
153907671|NCT05333809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907672|NCT05333731|Oxytocin|oxytocin|mesh-list
153907673|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
153907674|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153907675|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907676|NCT02843581|Immunomodulating Agents|immunomodulating agents|mesh-list
153907677|NCT02843581|Immunologic Factors|immunologic factors|mesh-ancestor
153907678|NCT02843581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907679|NCT00895453|Iron|iron|mesh-list
153907680|NCT00895453|Itraconazole|itraconazole|mesh-list
153907681|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
153449310|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449311|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
153449312|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153449313|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153449315|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449317|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449318|NCT00004073|Suramin|suramin|mesh-list
153449319|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
153449320|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
153449321|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153841516|NCT03109795|Analgesics|analgesics|mesh-ancestor
153907682|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907683|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153907684|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153907685|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907686|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907687|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153907688|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
153907690|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907691|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153907692|NCT00895453|Trace Elements|trace elements|mesh-ancestor
153907693|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
153907694|NCT00893737|Naproxen|naproxen|mesh-list
153907695|NCT00893737|Sumatriptan|sumatriptan|mesh-list
153907696|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153907697|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153907698|NCT00893737|Analgesics|analgesics|mesh-ancestor
153907699|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
153907700|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907701|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907702|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907703|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907704|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
153449336|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449337|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449338|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449339|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449340|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449341|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449343|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
153449344|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449345|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
153449346|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449347|NCT00004103|Irinotecan|irinotecan|mesh-list
153449348|NCT00004103|Floxuridine|floxuridine|mesh-list
153449349|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449350|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153449351|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153907712|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907713|NCT00893113|Alfuzosin|alfuzosin|mesh-list
153907714|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153907715|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153907716|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153907717|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
153907718|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907719|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907720|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907721|NCT00893113|Urological Agents|urological agents|mesh-ancestor
153449353|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449354|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449356|NCT00004109|Doxorubicin|doxorubicin|mesh-list
153449357|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153449358|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153449359|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563039|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449360|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449361|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449363|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449364|NCT00003239|Interferons|interferons|mesh-list
153449365|NCT00003239|Cytarabine|cytarabine|mesh-list
153449366|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
153449367|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
153449368|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
153449369|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449370|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
153449371|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449372|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153907738|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
153907739|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907740|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907741|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
154257108|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257109|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257110|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
154257111|NCT00367991|Hematinics|hematinics|mesh-ancestor
153907742|NCT05322733|Fludarabine|fludarabine|mesh-list
153907743|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
153907744|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907745|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
153449376|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
153449377|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449378|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449379|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153449380|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449382|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153449383|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
153449384|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449385|NCT00003245|Irinotecan|irinotecan|mesh-list
153449386|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153449387|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449388|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449389|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449390|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449394|NCT00004127|Calcium|calcium|mesh-list
153449395|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
153449396|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153449397|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449398|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
153449399|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449400|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449401|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449402|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449403|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
153449404|NCT00004127|Antidotes|antidotes|mesh-ancestor
153449405|NCT00004127|Protective Agents|protective agents|mesh-ancestor
153449406|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
153449407|NCT00004127|Vitamins|vitamins|mesh-ancestor
153449408|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
153449409|NCT00003251|Paclitaxel|paclitaxel|mesh-list
153907772|NCT00992056|Metoprolol|metoprolol|mesh-list
153907773|NCT00992056|Nebivolol|nebivolol|mesh-list
153907774|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153907775|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153907776|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
153907777|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
153449410|NCT00003251|Amifostine|amifostine|mesh-list
153449411|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449412|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449413|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449414|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449415|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449416|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449417|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153449418|NCT00003251|Protective Agents|protective agents|mesh-ancestor
153449419|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449420|NCT00004139|Gemcitabine|gemcitabine|mesh-list
153449421|NCT00004139|Docetaxel|docetaxel|mesh-list
153449422|NCT00004139|Irinotecan|irinotecan|mesh-list
153449423|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449424|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
153449425|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449426|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381765|NCT04316871|Morphine|morphine|mesh-list
153907793|NCT00967798|Incretins|incretins|mesh-ancestor
153449427|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449428|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449429|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449430|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153449440|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449441|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449442|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
153449443|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563484|NCT01663961|Digoxin|digoxin|mesh-list
153735858|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449444|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257113|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153449445|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153449446|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153907794|NCT00967798|Hormones|hormones|mesh-ancestor
153907795|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153907796|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153907797|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
153907798|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907799|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907800|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
153907801|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153907802|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907803|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153907804|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153907805|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907806|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907807|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907809|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
153907810|NCT02833987|Dabigatran|dabigatran|mesh-list
153907811|NCT02833987|Apixaban|apixaban|mesh-list
153907812|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
153907813|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153449448|NCT00003263|Interferons|interferons|mesh-list
153449449|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
153449450|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449452|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449453|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
153449454|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449455|NCT00004157|Oprelvekin|oprelvekin|mesh-list
153449456|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449457|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
153449458|NCT00003269|Etoposide|etoposide|mesh-list
153449459|NCT00003269|Sargramostim|sargramostim|mesh-list
153449460|NCT00003269|Amifostine|amifostine|mesh-list
153449461|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449462|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
153449463|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449464|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449465|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449466|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
153449467|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449468|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449469|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153449470|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449471|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449472|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449473|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449474|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153449476|NCT00004163|Trastuzumab|trastuzumab|mesh-list
153449477|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449478|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449479|NCT00003281|Paclitaxel|paclitaxel|mesh-list
153449480|NCT00003281|Topotecan|topotecan|mesh-list
153449481|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449482|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449483|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449484|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449485|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
153907814|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
153907815|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153907816|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
153907817|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907818|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907819|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
153907820|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153907821|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153907822|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907823|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
153907824|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907825|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907826|NCT00965458|Alefacept|alefacept|mesh-list
153907827|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
153907828|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
154257114|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153550008|NCT03660930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907829|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907830|NCT04249531|Amikacin|amikacin|mesh-list
153907831|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153907832|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907833|NCT02836639|Etoposide|etoposide|mesh-list
153907834|NCT02836639|Busulfan|busulfan|mesh-list
153907835|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153907836|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153907837|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907838|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153907839|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153907840|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907841|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907843|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907844|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
153907845|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907846|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153907847|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153907848|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
153449487|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153449488|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449489|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449490|NCT00003287|Leucovorin|leucovorin|mesh-list
153449491|NCT00003287|Fluorouracil|fluorouracil|mesh-list
153449492|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
153449493|NCT00003287|Calcium|calcium|mesh-list
153449494|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
153907851|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153907852|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907853|NCT05333419|Latanoprost|latanoprost|mesh-list
153907854|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153907855|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153907856|NCT02836795|Antibodies|antibodies|mesh-list
153907857|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153907858|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
153907859|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907860|NCT02836483|Linezolid|linezolid|mesh-list
153449500|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449501|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449502|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
153449503|NCT00003287|Antidotes|antidotes|mesh-ancestor
153449504|NCT00003287|Protective Agents|protective agents|mesh-ancestor
153449505|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
153449506|NCT00003287|Vitamins|vitamins|mesh-ancestor
153449507|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
153907861|NCT02836483|Delpazolid|delpazolid|mesh-list
153907862|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
153907863|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153907864|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907865|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153907866|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907867|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907868|NCT02836171|Itraconazole|itraconazole|mesh-list
153907869|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153907870|NCT02836171|Apatinib|apatinib|mesh-list
153907871|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907872|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153907873|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907874|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907875|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
153907876|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449517|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449518|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153449519|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449520|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449521|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
153449522|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153449523|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449534|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449535|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449536|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
153449537|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449538|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
153449539|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
153449540|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449541|NCT00003299|Paclitaxel|paclitaxel|mesh-list
153449542|NCT00003299|Etoposide|etoposide|mesh-list
153449543|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449544|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449545|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449546|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449547|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449548|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907877|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153907878|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153907879|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153907880|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
153907881|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153907882|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907883|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153907884|NCT00971932|Carboplatin|carboplatin|mesh-list
153907885|NCT00971932|Fluorouracil|fluorouracil|mesh-list
153907886|NCT00971932|Cetuximab|cetuximab|mesh-list
153907887|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907888|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
153907889|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907890|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153907891|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907892|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
153907893|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907894|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907895|NCT04400929|Molgramostim|molgramostim|mesh-list
153907896|NCT04400929|Sargramostim|sargramostim|mesh-list
153907897|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
153907898|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907899|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907900|NCT05170672|Abatacept|abatacept|mesh-list
153907901|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153907902|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907903|NCT05170672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907904|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907905|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449549|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449550|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449551|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449552|NCT00004205|Tamoxifen|tamoxifen|mesh-list
153449553|NCT00004205|Letrozole|letrozole|mesh-list
153449554|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449555|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449556|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153449557|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153907913|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907914|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153907915|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153907916|NCT00970684|Growth Substances|growth substances|mesh-ancestor
153907917|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907918|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
153907919|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153907920|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
153907921|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907923|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
153564072|NCT01667718|Antacids|antacids|mesh-ancestor
153564123|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
153907924|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
153907925|NCT00967330|Bevacizumab|bevacizumab|mesh-list
153907926|NCT00967330|Irinotecan|irinotecan|mesh-list
153907927|NCT00967330|Temozolomide|temozolomide|mesh-list
153449570|NCT00003305|Aminopterin|aminopterin|mesh-list
153449571|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153449572|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449573|NCT00003305|Antidotes|antidotes|mesh-ancestor
153449574|NCT00003305|Protective Agents|protective agents|mesh-ancestor
153449575|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
153449576|NCT00003305|Vitamins|vitamins|mesh-ancestor
153449577|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
153449578|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153449579|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841882|NCT01431326|Protective Agents|protective agents|mesh-ancestor
153449591|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449592|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449593|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
153907928|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907929|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907930|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153907931|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153907932|NCT00967330|Growth Substances|growth substances|mesh-ancestor
153907933|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907934|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
153907935|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153907936|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153907937|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907938|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907939|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153907940|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
153907941|NCT02863276|Insulin|insulin|mesh-list
153907942|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153907943|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153907944|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907945|NCT04286152|Mirabegron|mirabegron|mesh-list
153907946|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153907947|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153907948|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153907949|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
153449594|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449595|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449596|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153449597|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153449598|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
153449599|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
153449600|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153449601|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153449602|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
153449603|NCT00003311|Hormones|hormones|mesh-ancestor
153449604|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153449613|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449614|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
153449615|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
153449616|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153449617|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153449618|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
153449619|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449620|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449621|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449622|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
153907950|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907951|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907952|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907953|NCT04286152|Urological Agents|urological agents|mesh-ancestor
153907955|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153907956|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153907957|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153907958|NCT00965848|Doripenem|doripenem|mesh-list
153907959|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153907960|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907961|NCT03447574|Ethanol|ethanol|mesh-list
153907962|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153907963|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907964|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153907965|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907966|NCT04284826|Mitomycins|mitomycins|mesh-list
153907967|NCT04284826|Mitomycin|mitomycin|mesh-list
153907968|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153907969|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907970|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
153907971|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907972|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153907973|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907974|NCT04285528|Lidocaine|lidocaine|mesh-list
153907975|NCT04285528|Fentanyl|fentanyl|mesh-list
153907977|NCT04285528|Propofol|propofol|mesh-list
153907978|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
154257115|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153907979|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
153564247|NCT01669044|Analgesics|analgesics|mesh-ancestor
153907980|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153449623|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449624|NCT00003317|Paclitaxel|paclitaxel|mesh-list
153449625|NCT00003317|Carboplatin|carboplatin|mesh-list
153449626|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449627|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449628|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449629|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449630|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449631|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449632|NCT00004217|Cytarabine|cytarabine|mesh-list
153449633|NCT00004217|Daunorubicin|daunorubicin|mesh-list
153449634|NCT00004217|Sargramostim|sargramostim|mesh-list
153449635|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449636|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
153449637|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907989|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153907990|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153907991|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
153907993|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153907994|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153907995|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153907996|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907997|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153907998|NCT04285528|Narcotics|narcotics|mesh-ancestor
153907999|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153908000|NCT00629824|Interferons|interferons|mesh-list
153908001|NCT00629824|Ribavirin|ribavirin|mesh-list
153908003|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153449647|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449648|NCT00003323|Flutamide|flutamide|mesh-list
153449649|NCT00003323|Finasteride|finasteride|mesh-list
153449650|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153449651|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153449652|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449653|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449654|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
153449655|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153449656|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449657|NCT00003323|Urological Agents|urological agents|mesh-ancestor
153449658|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
153449659|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153449660|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449661|NCT00004229|Endostatins|endostatins|mesh-list
153449662|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449663|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153449664|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153908022|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908023|NCT00964678|Carvedilol|carvedilol|mesh-list
153908024|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153449668|NCT00004235|Docetaxel|docetaxel|mesh-list
153449669|NCT00004235|Irinotecan|irinotecan|mesh-list
153449670|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449671|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449672|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449673|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449674|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449675|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153449676|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449677|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449678|NCT00003335|Cyclosporine|cyclosporine|mesh-list
153449679|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
153449680|NCT00003335|Melphalan|melphalan|mesh-list
153449681|NCT00003335|Busulfan|busulfan|mesh-list
153449682|NCT00003335|Cyclosporins|cyclosporins|mesh-list
153449683|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153449684|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449685|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449686|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449687|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
153842031|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153564475|NCT01675115|Aspirin|aspirin|mesh-list
153908035|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153908036|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
154257116|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153908037|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153908038|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153908039|NCT00964366|Clindamycin|clindamycin|mesh-list
153908040|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
153908041|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
153908043|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153908044|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153908045|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908046|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153908047|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908048|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449698|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153449699|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
153449700|NCT00003335|Hormones|hormones|mesh-ancestor
153449701|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153449702|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153449704|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449705|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449706|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
153449707|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153449708|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
153449709|NCT00003341|Hematinics|hematinics|mesh-ancestor
153449710|NCT00004253|Paclitaxel|paclitaxel|mesh-list
153449711|NCT00004253|Carboplatin|carboplatin|mesh-list
153449712|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449713|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449714|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449715|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449716|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449717|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449718|NCT00004265|Paclitaxel|paclitaxel|mesh-list
153908061|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908063|NCT00630214|Vitamin D|vitamin d|mesh-list
153908064|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
153908065|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
153908066|NCT00630214|Vitamins|vitamins|mesh-list
153908067|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
153908068|NCT00630214|Calcium|calcium|mesh-list
153908069|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
153908070|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908071|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153908072|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153908073|NCT00630214|Antacids|antacids|mesh-ancestor
153908074|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449721|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449722|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
153564528|NCT01677065|Oxycodone|oxycodone|mesh-list
153449723|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449724|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449725|NCT00003365|Curcumin|curcumin|mesh-list
153449726|NCT00003365|Sulindac|sulindac|mesh-list
153449727|NCT00003365|Quercetin|quercetin|mesh-list
153449728|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153449729|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153449730|NCT00003365|Analgesics|analgesics|mesh-ancestor
153449731|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
153449732|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153449733|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449742|NCT00004829|Tobramycin|tobramycin|mesh-list
153449743|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153449744|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908075|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908076|NCT02860858|Aflibercept|aflibercept|mesh-list
153908077|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153908078|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153908079|NCT02860858|Growth Substances|growth substances|mesh-ancestor
153908080|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908081|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
153908082|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908083|NCT00960076|Metformin|metformin|mesh-list
153908084|NCT00960076|Saxagliptin|saxagliptin|mesh-list
153908085|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153908086|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908087|NCT00960076|Incretins|incretins|mesh-ancestor
153908088|NCT00960076|Hormones|hormones|mesh-ancestor
153908089|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153908090|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153908091|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908092|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908093|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908094|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153908095|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153908096|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908097|NCT04284202|Dasatinib|dasatinib|mesh-list
153449745|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153449746|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153449747|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
153449748|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449749|NCT00004853|Lenograstim|lenograstim|mesh-list
153449750|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153449751|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
153449752|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449754|NCT00004865|Fluorouracil|fluorouracil|mesh-list
153449755|NCT00004865|Cetuximab|cetuximab|mesh-list
153449756|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449757|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449758|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449759|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449760|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
153908105|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
153908106|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
153908107|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153908108|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908109|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908110|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908111|NCT00963820|Ixazomib|ixazomib|mesh-list
153908112|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908113|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908114|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908115|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908116|NCT03241186|Nivolumab|nivolumab|mesh-list
153908117|NCT03241186|Ipilimumab|ipilimumab|mesh-list
153908118|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153908119|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908120|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153908121|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908122|NCT01227395|Azithromycin|azithromycin|mesh-list
153449771|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153449772|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449775|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
153449776|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
153449777|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449779|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153449780|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153449781|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449782|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153449783|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153449784|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153449785|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
153908123|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153908124|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908125|NCT01226459|Minoxidil|minoxidil|mesh-list
153908126|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153564745|NCT05596149|Listerine|listerine|mesh-list
153908127|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
153908128|NCT01225991|Milnacipran|milnacipran|mesh-list
153908129|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
153908130|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153908131|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153908132|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153908133|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908134|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908135|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908136|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153908137|NCT01225991|Analgesics|analgesics|mesh-ancestor
153908138|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
153908139|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908140|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
153908141|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153908142|NCT04283110|Midazolam|midazolam|mesh-list
153908143|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153908144|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153550587|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
153550588|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550589|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550590|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550591|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550592|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153550635|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153550636|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153550637|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550638|NCT02653300|Insulin|insulin|mesh-list
153550639|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153550640|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550641|NCT02645266|Aflibercept|aflibercept|mesh-list
153550655|NCT02636322|Vincristine|vincristine|mesh-list
153550656|NCT02636322|Lenalidomide|lenalidomide|mesh-list
153550657|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
153550658|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
153550660|NCT02636322|Antibodies|antibodies|mesh-list
153908145|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908146|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449796|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153449797|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449798|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449799|NCT00004883|Trastuzumab|trastuzumab|mesh-list
153449800|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449801|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449802|NCT00004403|Albendazole|albendazole|mesh-list
153449803|NCT00004403|Dexamethasone|dexamethasone|mesh-list
153449804|NCT00004403|Phenytoin|phenytoin|mesh-list
153449805|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153449806|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
153449807|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
153449808|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153449809|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449810|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153449811|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
153449812|NCT00004403|Hormones|hormones|mesh-ancestor
153449820|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153449821|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153449822|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449823|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449824|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449825|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449826|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
153449827|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153449828|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153449829|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153908147|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153908148|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153908149|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153908150|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153908151|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
153908152|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
153908153|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
153908154|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
153908155|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908156|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908157|NCT02860780|Prexasertib|prexasertib|mesh-list
153908158|NCT02860780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153908159|NCT02860780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908160|NCT02860780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908161|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153908162|NCT01225835|Cetrorelix|cetrorelix|mesh-list
153908163|NCT01225835|Menotropins|menotropins|mesh-list
153908164|NCT01225835|Progesterone|progesterone|mesh-list
153908165|NCT01225835|Progestins|progestins|mesh-ancestor
153908166|NCT01225835|Hormones|hormones|mesh-ancestor
153908167|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153908168|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908169|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153908170|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153908171|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
153908172|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
153908173|NCT04282096|Caseins|caseins|mesh-list
153908174|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
153908175|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
153908176|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908177|NCT02899000|Doxycycline|doxycycline|mesh-list
153908178|NCT02899000|Adapalene|adapalene|mesh-list
153908179|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153908180|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153908181|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449830|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153449831|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153449832|NCT00004889|Rituximab|rituximab|mesh-list
153449833|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449835|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
153449836|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449837|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449838|NCT00385307|Amibegron|amibegron|mesh-list
153449839|NCT00385307|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153449840|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153449841|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153449842|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
153449843|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153449844|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449845|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842261|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449854|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153908182|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
153908183|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153908184|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153908185|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
153908186|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153908187|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153908188|NCT02899000|Analgesics|analgesics|mesh-ancestor
153908189|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
153908190|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908191|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908192|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153908193|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153908194|NCT04281862|Prednisolone|prednisolone|mesh-list
153908195|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153908196|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
153908197|NCT04281862|Hormones|hormones|mesh-ancestor
153908198|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153908199|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908200|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153908201|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908202|NCT03122002|Clopidogrel|clopidogrel|mesh-list
153908203|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908204|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908205|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153449855|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
153449856|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449857|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
153449858|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449859|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153449861|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
153782832|NCT00424944|Vaccines|vaccines|mesh-list
153449863|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153449864|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449865|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257117|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
153550849|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
153449867|NCT00004913|Docetaxel|docetaxel|mesh-list
153449868|NCT00004913|Fluorouracil|fluorouracil|mesh-list
153449869|NCT00004913|Calcium|calcium|mesh-list
153449870|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
153449871|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449872|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449873|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449874|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449875|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449876|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153908214|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153908215|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908216|NCT02861716|Fentanyl|fentanyl|mesh-list
153908217|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
153908218|NCT02861716|Bupivacaine|bupivacaine|mesh-list
153908219|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
153908220|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
153908221|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908222|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908223|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
153908224|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908225|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153908226|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153908227|NCT02861716|Analgesics|analgesics|mesh-ancestor
153908228|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153908229|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153908230|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153908231|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
153449883|NCT00004913|Protective Agents|protective agents|mesh-ancestor
153449884|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
153449885|NCT00004913|Vitamins|vitamins|mesh-ancestor
153449886|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
153449887|NCT00004919|Irinotecan|irinotecan|mesh-list
153449888|NCT00004919|Amifostine|amifostine|mesh-list
153449889|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449891|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449892|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449893|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449894|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153449895|NCT00004919|Protective Agents|protective agents|mesh-ancestor
153449896|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449897|NCT00004925|Doxorubicin|doxorubicin|mesh-list
153449898|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153449899|NCT00004925|Trastuzumab|trastuzumab|mesh-list
153449900|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153449901|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449902|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449903|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449904|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449905|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449906|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449907|NCT00004931|Leucovorin|leucovorin|mesh-list
153449908|NCT00004931|Fluorouracil|fluorouracil|mesh-list
153908245|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908246|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153908247|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153908248|NCT00960934|Antacids|antacids|mesh-ancestor
153908249|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908250|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908251|NCT00892177|Bevacizumab|bevacizumab|mesh-list
153908252|NCT00892177|Dasatinib|dasatinib|mesh-list
153908253|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153908254|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908255|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153908256|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153908257|NCT00892177|Growth Substances|growth substances|mesh-ancestor
153908258|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908259|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
153449912|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153449913|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449914|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
153449915|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449916|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449917|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449918|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449919|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
153449920|NCT00004931|Antidotes|antidotes|mesh-ancestor
153449921|NCT00004931|Protective Agents|protective agents|mesh-ancestor
153449922|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
153449923|NCT00004931|Vitamins|vitamins|mesh-ancestor
153449924|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
153449925|NCT00004979|Paclitaxel|paclitaxel|mesh-list
153449926|NCT00004979|Topotecan|topotecan|mesh-list
153449927|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449928|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449929|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449930|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449931|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449932|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449933|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153449934|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449935|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449936|NCT00004985|Nelfinavir|nelfinavir|mesh-list
153449937|NCT00004985|Capravirine|capravirine|mesh-list
153449938|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153449947|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153449948|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153449949|NCT00004997|Leucovorin|leucovorin|mesh-list
153908260|NCT00892177|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153908261|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153908262|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191162|NCT05945615|Respiratory System Agents|respiratory system agents|mesh-ancestor
153908263|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908265|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153908266|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153908267|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153908268|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908269|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
153908270|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908271|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908272|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
153908273|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153908274|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908275|NCT02821000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153908276|NCT02821000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908277|NCT02860624|Esomeprazole|esomeprazole|mesh-list
153908278|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153908279|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908280|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153908281|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908282|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908283|NCT00892099|Vitamin D|vitamin d|mesh-list
153908284|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
153908285|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
153908286|NCT00892099|Vitamins|vitamins|mesh-list
153908287|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
153908288|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908289|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153908290|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153908291|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
153908292|NCT00960856|Fenofibrate|fenofibrate|mesh-list
153908293|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153908294|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153449951|NCT00004997|Protective Agents|protective agents|mesh-ancestor
153449952|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449953|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
153449954|NCT00004997|Vitamins|vitamins|mesh-ancestor
153449955|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
153449956|NCT00005009|Vaccines|vaccines|mesh-list
153449957|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
153449958|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449959|NCT00004583|Ritonavir|ritonavir|mesh-list
153449960|NCT00004583|Lopinavir|lopinavir|mesh-list
153449962|NCT00004583|Lamivudine|lamivudine|mesh-list
153449963|NCT00004583|Stavudine|stavudine|mesh-list
153449964|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153449965|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153449966|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
153449967|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449968|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449969|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153449970|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153449971|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
153449972|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449973|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153908316|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449975|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153449976|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153449977|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
153449978|NCT00005015|Fluoxetine|fluoxetine|mesh-list
153449979|NCT00005015|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153449980|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153449981|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153449982|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449983|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153449984|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
153449985|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449986|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153449987|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
153449988|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153449989|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153449990|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153449991|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449992|NCT00004637|Vitamin E|vitamin e|mesh-list
153449993|NCT00004637|Vitamins|vitamins|mesh-ancestor
153449994|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
153449995|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449996|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
153449997|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449998|NCT00004637|Protective Agents|protective agents|mesh-ancestor
153449999|NCT00005021|Paclitaxel|paclitaxel|mesh-list
153450000|NCT00005021|Carboplatin|carboplatin|mesh-list
153450001|NCT00005021|Topotecan|topotecan|mesh-list
153450002|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153450003|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450004|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
153908328|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153908329|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153908330|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
153908331|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908332|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153908333|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153908334|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153908335|NCT02831491|Docetaxel|docetaxel|mesh-list
153908336|NCT02831491|Ramucirumab|ramucirumab|mesh-list
153908337|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908338|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
153908339|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
153908340|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
153908341|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908342|NCT02831491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153908343|NCT02831491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153908344|NCT02831491|Growth Substances|growth substances|mesh-ancestor
153908345|NCT02831491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908346|NCT02831491|Growth Inhibitors|growth inhibitors|mesh-ancestor
153450005|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450006|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450007|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450008|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153450009|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153450010|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450011|NCT00004643|Cytarabine|cytarabine|mesh-list
153450012|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153450013|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
153450014|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450017|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450018|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153450019|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
153450020|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450021|NCT00005033|Trastuzumab|trastuzumab|mesh-list
153450022|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153450023|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450024|NCT00005039|Vaccines|vaccines|mesh-list
153450025|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
153450026|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450027|NCT00004685|Albuterol|albuterol|mesh-list
153450028|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153450029|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
153450030|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450031|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450032|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153450033|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
153450034|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
153908356|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
153908357|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908358|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908359|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908360|NCT02835391|Surgiflo|surgiflo|mesh-list
153908361|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
153908362|NCT02835391|Coagulants|coagulants|mesh-ancestor
153908363|NCT02831101|Sufentanil|sufentanil|mesh-list
153908364|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153908365|NCT02831101|Narcotics|narcotics|mesh-ancestor
154191176|NCT05941741|Gemcitabine|gemcitabine|mesh-list
153908366|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908367|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908368|NCT02831101|Analgesics|analgesics|mesh-ancestor
153908369|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
153908370|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908371|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153908372|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153908373|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
153908374|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
153908375|NCT04245787|Fluorides|fluorides|mesh-list
153908376|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
153908377|NCT04245787|Protective Agents|protective agents|mesh-ancestor
153908378|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450035|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153450036|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153450037|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153450038|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153450039|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
153450040|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450041|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450042|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
153450043|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450044|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153450045|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450046|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450047|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153450048|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450049|NCT00005051|Paclitaxel|paclitaxel|mesh-list
153450050|NCT00005051|Carboplatin|carboplatin|mesh-list
153450051|NCT00005051|Topotecan|topotecan|mesh-list
153450052|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153450053|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450054|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450055|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450056|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450057|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450058|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153450059|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153450060|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450061|NCT00004697|Choline|choline|mesh-list
153450062|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
153450063|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153450064|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
153450065|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565924|NCT06220344|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153450066|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153450067|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153450068|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
153908384|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908385|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908386|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153908387|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
153908388|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153908389|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908390|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
153908391|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
153908392|NCT02830789|Calcium|calcium|mesh-list
153908393|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153908394|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908395|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153908396|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908397|NCT02830789|Antacids|antacids|mesh-ancestor
153908398|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908399|NCT04243993|Calcium|calcium|mesh-list
153908400|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153908401|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908402|NCT04245319|Acitretin|acitretin|mesh-list
153908403|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
153908404|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
153908405|NCT02828059|Ropivacaine|ropivacaine|mesh-list
153908406|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
153908407|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
153908408|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908409|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908410|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
153908411|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908412|NCT02827903|Metformin|metformin|mesh-list
153450069|NCT00004727|Aspirin|aspirin|mesh-list
153450070|NCT00004727|Ticlopidine|ticlopidine|mesh-list
153450071|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153450072|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153450073|NCT00004727|Analgesics|analgesics|mesh-ancestor
153450074|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
153450075|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450076|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450077|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153450078|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450079|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153450080|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153450081|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450082|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153450083|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153450084|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450085|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
153450086|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153450087|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153450088|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153450089|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
153450090|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450091|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153450092|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153450093|NCT00004733|Levodopa|levodopa|mesh-list
153450094|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153450095|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153450096|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
153908413|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153908414|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153908415|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908416|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153908417|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153908418|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
153908419|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908420|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153842663|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
153908432|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153908434|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908435|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908436|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908437|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
153908438|NCT02831023|Primaquine|primaquine|mesh-list
153908439|NCT02831023|Piperaquine|piperaquine|mesh-list
153908440|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
153908441|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153908442|NCT02831023|Amodiaquine|amodiaquine|mesh-list
153908443|NCT02831023|Artenimol|artenimol|mesh-list
153551620|NCT01572350|Growth Substances|growth substances|mesh-ancestor
153908444|NCT02831023|Methylene Blue|methylene blue|mesh-list
153908445|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
153908446|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153908447|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153908448|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908449|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153908450|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908451|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908452|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153908453|NCT04244695|Dexamethasone|dexamethasone|mesh-list
153908454|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153908455|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
153908456|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
153908457|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908458|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450115|NCT00004763|Leuprolide|leuprolide|mesh-list
153450116|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153450117|NCT00004763|Norethindrone|norethindrone|mesh-list
153450118|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
153450119|NCT00004763|Norinyl|norinyl|mesh-list
153450120|NCT00004763|Estradiol|estradiol|mesh-list
153450121|NCT00004763|Estrogens|estrogens|mesh-ancestor
153450122|NCT00004763|Hormones|hormones|mesh-ancestor
153450123|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450124|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450125|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153450126|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
153450127|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153450128|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153450129|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153450131|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153450132|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450133|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153450134|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153450135|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153450136|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153450137|NCT00004787|Lenograstim|lenograstim|mesh-list
153450138|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153450139|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
153450140|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450259|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153383041|NCT02406443|Hormones|hormones|mesh-ancestor
153450268|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153450269|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153450270|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
153450271|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153450272|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153450273|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
153450274|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
153450275|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450276|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153450277|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153450278|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
153450279|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450280|NCT00005585|Antidotes|antidotes|mesh-ancestor
153450281|NCT00005585|Protective Agents|protective agents|mesh-ancestor
153450282|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
153450283|NCT00005585|Vitamins|vitamins|mesh-ancestor
153450284|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
153450285|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153450286|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450287|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450288|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450289|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153450290|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153450291|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153450292|NCT00005591|Gemcitabine|gemcitabine|mesh-list
153450293|NCT00005591|Cetuximab|cetuximab|mesh-list
153450294|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153450295|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
153450296|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450297|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450298|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153908633|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551727|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908634|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908635|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153908636|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450300|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153450301|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
153450318|NCT00005603|Daunorubicin|daunorubicin|mesh-list
153450319|NCT00005603|Asparaginase|asparaginase|mesh-list
153450320|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
153450321|NCT00005603|Thioguanine|thioguanine|mesh-list
153450322|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153450323|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
153450324|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450325|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450326|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450327|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
153450328|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450329|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450330|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153450331|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153450333|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
153450334|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908637|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153908638|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153908639|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908640|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153908641|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153908642|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908643|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
153842981|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450338|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450339|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153450341|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153450342|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153450343|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450344|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153450345|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
153450346|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153450347|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153450348|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
153450349|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
153450350|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153450351|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153450352|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
153450353|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450354|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153450355|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450357|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
153908700|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908701|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908702|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908703|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
153908704|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908705|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
153450410|NCT00005777|Dexamethasone|dexamethasone|mesh-list
153450411|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153450455|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450456|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450458|NCT05895526|Fluorides, Topical|fluorides, topical|mesh-list
153450459|NCT05895526|Cariostatic Agents|cariostatic agents|mesh-ancestor
153450484|NCT05895240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450485|NCT05895240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450486|NCT05895123|Atorvastatin|atorvastatin|mesh-list
153450487|NCT05895123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153450488|NCT05895123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153450489|NCT05895123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153450490|NCT05895123|Antimetabolites|antimetabolites|mesh-ancestor
153450491|NCT05895123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450492|NCT05895123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153450493|NCT05895123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153450494|NCT05895123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450496|NCT05894954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450497|NCT05894954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450499|NCT05894889|Carboplatin|carboplatin|mesh-list
153450500|NCT05894889|Pembrolizumab|pembrolizumab|mesh-list
153450501|NCT05894889|Pemetrexed|pemetrexed|mesh-list
153450502|NCT05894889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153908804|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153908805|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153908806|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153843192|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
153450507|NCT05894889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450508|NCT05894889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153450509|NCT05894889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153450510|NCT05894889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450511|NCT05894889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153450512|NCT05894889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153450513|NCT05894824|Ramucirumab|ramucirumab|mesh-list
153450514|NCT05894824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153450515|NCT05894824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153450516|NCT05894824|Growth Substances|growth substances|mesh-ancestor
153450517|NCT05894824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450518|NCT05894824|Growth Inhibitors|growth inhibitors|mesh-ancestor
153450519|NCT05894824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450520|NCT05894486|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153450521|NCT05894486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153450522|NCT05894486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450523|NCT05894447|Pembrolizumab|pembrolizumab|mesh-list
153450524|NCT05894447|Obinutuzumab|obinutuzumab|mesh-list
153450525|NCT05894447|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
153450526|NCT05894447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153843218|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908834|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908835|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419922|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
153908836|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153908837|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153566631|NCT06234345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153908838|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
153908839|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908840|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908841|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
153908842|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153908843|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908844|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908845|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153908846|NCT02818621|Analgesics|analgesics|mesh-ancestor
153908847|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
153908848|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843228|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
153908888|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153908889|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153908890|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153908891|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
153908892|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153908893|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153908894|NCT04472143|Granisetron|granisetron|mesh-list
153908895|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
153908896|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
153908897|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908898|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908899|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908900|NCT04472143|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153908901|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153908902|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
153450582|NCT05885230|Sensory System Agents|sensory system agents|mesh-ancestor
153450583|NCT05885230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450584|NCT05885230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153908936|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908937|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908938|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153908939|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
153908940|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257118|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908941|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153908942|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
153908943|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153450626|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450627|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450628|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153450629|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450630|NCT05590468|Niacinamide|niacinamide|mesh-list
153450632|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
153450633|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
153450634|NCT05590468|Vitamins|vitamins|mesh-ancestor
153450635|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
153450636|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450637|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153450638|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
153450639|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450640|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153450641|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
153450642|NCT05565560|Apremilast|apremilast|mesh-list
153450643|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153450644|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153450645|NCT05565560|Analgesics|analgesics|mesh-ancestor
153450646|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
153450647|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450648|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450649|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153450650|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450651|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153450652|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153450653|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450654|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450655|NCT05527808|Carboplatin|carboplatin|mesh-list
153450656|NCT05527808|Pemetrexed|pemetrexed|mesh-list
153450657|NCT05527808|Tislelizumab|tislelizumab|mesh-list
153450658|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908959|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908960|NCT02816905|Fluorometholone|fluorometholone|mesh-list
153908961|NCT02816905|Dexamethasone|dexamethasone|mesh-list
153908962|NCT02816905|Rimexolone|rimexolone|mesh-list
153908963|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153908964|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
153908965|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
153908966|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908967|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908968|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908969|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
153908970|NCT02816905|Hormones|hormones|mesh-ancestor
153908971|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153908972|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153908973|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908975|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
153450659|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450660|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450661|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153450662|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153450663|NCT05527808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153450676|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153450677|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153450678|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566690|NCT06233617|Dexamethasone|dexamethasone|mesh-list
153450679|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450680|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450681|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450683|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
153450684|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450685|NCT05426031|Coagulants|coagulants|mesh-ancestor
153450686|NCT05423106|Tenofovir|tenofovir|mesh-list
153450687|NCT05423106|Entecavir|entecavir|mesh-list
153450688|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
153450689|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450690|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153908976|NCT05654077|Fludarabine|fludarabine|mesh-list
153908977|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153908978|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
153908979|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908980|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153908984|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908985|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153908986|NCT04303767|Calcium|calcium|mesh-list
153908987|NCT04303767|Caseins|caseins|mesh-list
153908988|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153908989|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908990|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
153908991|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
153908992|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908993|NCT02874963|Ethanol|ethanol|mesh-list
153908994|NCT02874963|Listerine|listerine|mesh-list
153908996|NCT02874963|Eucalyptol|eucalyptol|mesh-list
153908997|NCT02874963|Salicylates|salicylates|mesh-list
153908998|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
153908999|NCT02874963|Menthol|menthol|mesh-list
153909000|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153909001|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909002|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909003|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909004|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
153909005|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
153909006|NCT02874963|Protective Agents|protective agents|mesh-ancestor
153909007|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153909008|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909009|NCT02874963|Analgesics|analgesics|mesh-ancestor
153909010|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
153450691|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153450692|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450693|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450694|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153450695|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153450696|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
153450697|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153450698|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
153450699|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153450700|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
153450701|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450702|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450703|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
153450704|NCT05319873|Carboplatin|carboplatin|mesh-list
153450705|NCT05319873|Docetaxel|docetaxel|mesh-list
153450706|NCT05319873|Trastuzumab|trastuzumab|mesh-list
153450707|NCT05319873|Fulvestrant|fulvestrant|mesh-list
153450708|NCT05319873|Pertuzumab|pertuzumab|mesh-list
153450709|NCT05319873|Tucatinib|tucatinib|mesh-list
153450710|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153909021|NCT02818309|Lesogaberan|lesogaberan|mesh-list
153909022|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153909023|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153909024|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
153909025|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
153909026|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909027|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909028|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909029|NCT01238822|Methylphenidate|methylphenidate|mesh-list
153909030|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153909031|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909032|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153909033|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153909034|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909035|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909036|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
153909037|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909038|NCT02818387|Midazolam|midazolam|mesh-list
153909039|NCT02818387|Remifentanil|remifentanil|mesh-list
153909040|NCT02818387|Propofol|propofol|mesh-list
153909041|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153909042|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909043|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909044|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153909045|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
153909046|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
153909047|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153783096|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
153783097|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153783098|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153783099|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783100|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
153783101|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
153552312|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450770|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153450771|NCT05160896|Growth Substances|growth substances|mesh-ancestor
153450772|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909052|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
153909053|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909054|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909055|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153909056|NCT02818387|Narcotics|narcotics|mesh-ancestor
153909057|NCT02818387|Analgesics|analgesics|mesh-ancestor
153909058|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
153909059|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909060|NCT05296629|Doxycycline|doxycycline|mesh-list
153909061|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153909062|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909063|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
153909064|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153909065|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153909066|NCT01238588|Sevelamer|sevelamer|mesh-list
153450779|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
153450780|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153450781|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
153450783|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450784|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153450785|NCT05128617|Paclitaxel|paclitaxel|mesh-list
153450786|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
153450787|NCT05128617|Epirubicin|epirubicin|mesh-list
153450788|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153450789|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843444|NCT02921204|Vitamin D|vitamin d|mesh-list
153450815|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450816|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153450817|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153450818|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153450819|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
153450820|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450821|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450822|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
153450823|NCT04989829|Omeprazole|omeprazole|mesh-list
153450824|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153450825|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153450826|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153450851|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
153450852|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153450853|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153450854|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
153450855|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
153450856|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153450857|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153783110|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783111|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783112|NCT00268671|Docetaxel|docetaxel|mesh-list
153450858|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909150|NCT02813863|Metformin|metformin|mesh-list
153909151|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909152|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909153|NCT02874729|Dimercaprol|dimercaprol|mesh-list
153450863|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153450865|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153735868|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735869|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735870|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735871|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153735872|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153735873|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450866|NCT04723134|Leucovorin|leucovorin|mesh-list
153450867|NCT04723134|Folic Acid|folic acid|mesh-list
153450868|NCT04723134|Calcium|calcium|mesh-list
153450869|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
153450870|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153450871|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909197|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909198|NCT01053429|Ziprasidone|ziprasidone|mesh-list
153909199|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153909200|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
153909201|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909202|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909203|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909204|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153909205|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153909206|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909207|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153909208|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153909209|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
153450881|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153909210|NCT01233284|Bromides|bromides|mesh-list
153909211|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
153909212|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153909213|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
153909214|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909215|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909216|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153383706|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909251|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909252|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450941|NCT04581447|Metformin|metformin|mesh-list
153450942|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153450943|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450944|NCT04520685|Cannabidiol|cannabidiol|mesh-list
153450945|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
153783135|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783136|NCT02212639|Digoxin|digoxin|mesh-list
153450946|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
153450947|NCT04519151|Lenvatinib|lenvatinib|mesh-list
153450948|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153450949|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450950|NCT04519151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153450951|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450952|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153450953|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450954|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153450955|NCT04497012|Iron|iron|mesh-list
153909266|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909267|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909268|NCT00957268|Incretins|incretins|mesh-ancestor
153909269|NCT00957268|Hormones|hormones|mesh-ancestor
153909270|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153909271|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153450994|NCT04299113|Mocetinostat|mocetinostat|mesh-list
153450995|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153450996|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450997|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450998|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
153909288|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153909289|NCT01230710|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153909290|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153909291|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909292|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909293|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909294|NCT00627081|Remifentanil|remifentanil|mesh-list
153909295|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153909296|NCT00627081|Narcotics|narcotics|mesh-ancestor
153909297|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909298|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909299|NCT00627081|Analgesics|analgesics|mesh-ancestor
153909300|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
153909301|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909302|NCT02888054|Allopurinol|allopurinol|mesh-list
153909304|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
153909305|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909306|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909307|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
153909308|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909309|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153909310|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
153909311|NCT02888054|Protective Agents|protective agents|mesh-ancestor
153909312|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909313|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
153451003|NCT04285580|Bimatoprost|bimatoprost|mesh-list
153451004|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153451005|NCT04245371|Lidocaine|lidocaine|mesh-list
153451006|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
153735875|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153735876|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552607|NCT01579110|Levamisole|levamisole|mesh-list
153735877|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
153735878|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153735879|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
153735880|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153735881|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
153735882|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
153451007|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
153451008|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451009|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451010|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
153451011|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451012|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153451013|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153451014|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153451015|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153451028|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153451029|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153451030|NCT04200248|Growth Substances|growth substances|mesh-ancestor
153451031|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451032|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
153451033|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451034|NCT04137887|Vaccines|vaccines|mesh-list
153451035|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
153451036|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909314|NCT01040793|Olodaterol|olodaterol|mesh-list
153909315|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153909316|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
153909317|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909318|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909319|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153909320|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
153909322|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
153909323|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
153909324|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909325|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909326|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153909327|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153909328|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909329|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909330|NCT04192903|Cisplatin|cisplatin|mesh-list
153909331|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909332|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
153909333|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153909334|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909335|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909336|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909337|NCT02810899|Analgesics|analgesics|mesh-ancestor
153909338|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
153451050|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153451051|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153460608|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451052|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451053|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153451054|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451055|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153451056|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153451057|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451059|NCT03912220|Niacin|niacin|mesh-list
153451060|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
153451061|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
153451062|NCT03912220|Vitamins|vitamins|mesh-ancestor
153451063|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
153451064|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451065|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153451066|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
153909368|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153909369|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153909370|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153909371|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
153909372|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153909373|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
153909374|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153909376|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153909377|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153909378|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909380|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
153909381|NCT02858206|Nedaplatin|nedaplatin|mesh-list
153909382|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153909383|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909384|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153451074|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451075|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
153451076|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451077|NCT03864042|Losartan|losartan|mesh-list
153451078|NCT03864042|Midazolam|midazolam|mesh-list
153451079|NCT03864042|Levomethorphan|levomethorphan|mesh-list
153451080|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
153783148|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153451108|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153451109|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153451110|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153451111|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153451112|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153451113|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153451114|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
153451115|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153451116|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153909425|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909426|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909427|NCT02815111|Analgesics|analgesics|mesh-ancestor
153909428|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153909429|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153909430|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
153909431|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153909432|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153909433|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909434|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909435|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
153909436|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
153909437|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153909438|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153909439|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153909440|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
153909441|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
153909442|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909443|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909444|NCT02809729|Cefazolin|cefazolin|mesh-list
153909445|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153909446|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451168|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451169|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153451170|NCT03563690|Celecoxib|celecoxib|mesh-list
153451171|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153451172|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153451173|NCT03563690|Analgesics|analgesics|mesh-ancestor
153451174|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
153451175|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451176|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451177|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451178|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451179|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153451180|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153451181|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451184|NCT03557008|Vancomycin|vancomycin|mesh-list
153451211|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451212|NCT02366728|Temozolomide|temozolomide|mesh-list
153451213|NCT02366728|Basiliximab|basiliximab|mesh-list
153451214|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
153451215|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451216|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153909524|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909525|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
153909526|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153909527|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
153384014|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
153909546|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
153909575|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
153909577|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153909578|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153909579|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384066|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
153552831|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153384067|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384068|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384069|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153384070|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153384071|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
153384072|NCT01878656|Sevoflurane|sevoflurane|mesh-list
153384073|NCT01878656|Desflurane|desflurane|mesh-list
153384074|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153384075|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153384076|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
153384077|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
153451306|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153451307|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
153451308|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451309|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451310|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451311|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
153451312|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451329|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
153451330|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451331|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153451332|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153451333|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
153451334|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451335|NCT00003671|Antidotes|antidotes|mesh-ancestor
153909606|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153909607|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
153909608|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909609|NCT02856724|Dinoprostone|dinoprostone|mesh-list
153909610|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
153909611|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153909612|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909613|NCT02808325|Polygeline|polygeline|mesh-list
153909614|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
153909615|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
153909616|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153909617|NCT00955474|Citalopram|citalopram|mesh-list
153909618|NCT00955474|Sertraline|sertraline|mesh-list
153909619|NCT00955474|Escitalopram|escitalopram|mesh-list
153909620|NCT00955474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153909621|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153909622|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909623|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909624|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909625|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
153909626|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909627|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153909628|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
153909629|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153909630|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153909631|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153909632|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909634|NCT02808247|Nintedanib|nintedanib|mesh-list
153909635|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153909636|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
153909637|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909642|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909643|NCT02811991|Acetaminophen|acetaminophen|mesh-list
153909674|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909676|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153909677|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153909678|NCT00946192|Desogestrel|desogestrel|mesh-list
153909679|NCT00946192|Estradiol|estradiol|mesh-list
153909680|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153909681|NCT00946192|Progesterone|progesterone|mesh-list
153451375|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
153451376|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451377|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451378|NCT00003719|Irinotecan|irinotecan|mesh-list
153451379|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153552930|NCT01588171|Enoxaparin|enoxaparin|mesh-list
153451380|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153451381|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451410|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451411|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451412|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153451413|NCT05444153|Semaglutide|semaglutide|mesh-list
153451414|NCT05444153|Empagliflozin|empagliflozin|mesh-list
153451415|NCT05444153|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153451416|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153451417|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451418|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153384231|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451438|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153451440|NCT00003815|Vincristine|vincristine|mesh-list
153451441|NCT00003815|Bleomycin|bleomycin|mesh-list
153451442|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153451443|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
153451444|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451445|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451446|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451447|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
153451448|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909752|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153909753|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909754|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153909755|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153909756|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909757|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
153909758|NCT01081912|Hydrocodone|hydrocodone|mesh-list
153909759|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153909760|NCT01081912|Narcotics|narcotics|mesh-ancestor
153909761|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909762|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909763|NCT01081912|Analgesics|analgesics|mesh-ancestor
153909764|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
153909765|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909766|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
153909767|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
153909768|NCT01038609|Acetaminophen|acetaminophen|mesh-list
153909769|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153451495|NCT00003881|Carboplatin|carboplatin|mesh-list
153451496|NCT00003881|Trastuzumab|trastuzumab|mesh-list
153451497|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153451498|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451499|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
153451500|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451501|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844213|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909809|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153909810|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153909811|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
153909812|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
153909813|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153909814|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909815|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153909824|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909825|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909826|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
153909827|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909828|NCT04236115|Felypressin|felypressin|mesh-list
153909829|NCT04236115|Carticaine|carticaine|mesh-list
153909830|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
153909831|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
153909832|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909833|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909834|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
153909835|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909836|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153909837|NCT02853370|Rituximab|rituximab|mesh-list
153909838|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153553003|NCT01590199|Pasireotide|pasireotide|mesh-list
153909839|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153844255|NCT00532857|Paclitaxel|paclitaxel|mesh-list
153451564|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153451566|NCT00003929|Procarbazine|procarbazine|mesh-list
153451567|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451568|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
153451569|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451570|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451571|NCT02210663|Veliparib|veliparib|mesh-list
153451572|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153451826|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153451827|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
153451828|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451829|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451830|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153451831|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
153451850|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451851|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451852|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153451853|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153451854|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153451855|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153451856|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
153451857|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451858|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910196|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
153910197|NCT02792491|Hormones|hormones|mesh-ancestor
153910198|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910199|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153910200|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153910201|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
153910202|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
153910203|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
153910204|NCT02792803|Latanoprost|latanoprost|mesh-list
153910205|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153910206|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153910207|NCT02797249|Aspirin|aspirin|mesh-list
153910208|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
153910209|NCT02797249|Salicylates|salicylates|mesh-list
153910210|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153910211|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910212|NCT02797249|Analgesics|analgesics|mesh-ancestor
153910213|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
153910214|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910215|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910216|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844925|NCT00596479|Lenograstim|lenograstim|mesh-list
153451945|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153451946|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153451947|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153451948|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153451949|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153451950|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153451951|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
153451952|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153451954|NCT01907100|Pemetrexed|pemetrexed|mesh-list
153451955|NCT01907100|Nintedanib|nintedanib|mesh-list
153451956|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451957|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451958|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910253|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153910254|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
153910255|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910256|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910257|NCT02791243|Finasteride|finasteride|mesh-list
153910258|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153910259|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153910260|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910261|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910262|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
153783157|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153910263|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257119|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553106|NCT01590901|Probucol|probucol|mesh-list
153910264|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910265|NCT02791243|Urological Agents|urological agents|mesh-ancestor
153910266|NCT02797015|Ozanimod|ozanimod|mesh-list
153910267|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153451995|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153451996|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451997|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
153451998|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153451999|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452000|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452001|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153452002|NCT01904760|Analgesics|analgesics|mesh-ancestor
153452003|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
153452004|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452005|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153452006|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153452007|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153452008|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
153452009|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452010|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452011|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153452012|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153452013|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153452014|NCT01881126|Timolol|timolol|mesh-list
153910277|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
153910278|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910279|NCT01196988|Vaccines|vaccines|mesh-list
153452017|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452018|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153452020|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
153452021|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452022|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845048|NCT00597415|Celecoxib|celecoxib|mesh-list
153910315|NCT01196052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910316|NCT02689921|Trastuzumab|trastuzumab|mesh-list
153910318|NCT02689921|Letrozole|letrozole|mesh-list
153910319|NCT02689921|Anastrozole|anastrozole|mesh-list
153910320|NCT02689921|Leuprolide|leuprolide|mesh-list
153910321|NCT02689921|Exemestane|exemestane|mesh-list
153910322|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153910323|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910324|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153910325|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153910326|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452056|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452057|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452058|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452059|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
153452060|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
153452061|NCT01902966|Propranolol|propranolol|mesh-list
153452062|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153452063|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153452064|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
153452065|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452066|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452067|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452068|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153452069|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153452070|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
153452071|NCT01862328|Paclitaxel|paclitaxel|mesh-list
153452072|NCT01862328|Docetaxel|docetaxel|mesh-list
153452073|NCT01862328|Carboplatin|carboplatin|mesh-list
153452074|NCT01862328|Gemcitabine|gemcitabine|mesh-list
153910375|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910376|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910377|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153910378|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
153910379|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153910380|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153910381|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153452117|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154257120|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257121|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
153452118|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452119|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452120|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153452121|NCT04414800|Narcotics|narcotics|mesh-ancestor
153385237|NCT04149405|Diphosphonates|diphosphonates|mesh-list
153910416|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153736468|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153452122|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153452124|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153452125|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153452126|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153452127|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153452128|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
153452129|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452130|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845149|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910426|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910427|NCT02821507|Sirolimus|sirolimus|mesh-list
153910428|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
153910429|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910430|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
153910431|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910432|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910433|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153910434|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
153452171|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153332251|NCT00953849|Vitamins|vitamins|mesh-ancestor
153452172|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153452173|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452174|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452175|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153452176|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153452177|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
153452178|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153452179|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153452180|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153452181|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153452182|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153452183|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153385297|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910477|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910479|NCT02782273|Morphine|morphine|mesh-list
153910480|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153910481|NCT02782273|Narcotics|narcotics|mesh-ancestor
153845225|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153452203|NCT01856322|Sulindac|sulindac|mesh-list
153452204|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153452205|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153452206|NCT01856322|Analgesics|analgesics|mesh-ancestor
153452207|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
153452208|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452209|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452210|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452211|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452212|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452213|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153452214|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452215|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452216|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153452217|NCT01871532|Hormones|hormones|mesh-ancestor
153910490|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910491|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153452225|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452227|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153452228|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452229|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153452230|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153452231|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
153452232|NCT01895322|Tolvaptan|tolvaptan|mesh-list
153452233|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154257122|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153553330|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
153452234|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452235|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
153452236|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452237|NCT01894776|Maraviroc|maraviroc|mesh-list
153452238|NCT01894776|Rifabutin|rifabutin|mesh-list
153452239|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153452240|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153385395|NCT02354508|Pasireotide|pasireotide|mesh-list
153910539|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452282|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452283|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153452284|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452285|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452319|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910639|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153910640|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153910641|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910642|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
153910643|NCT02780245|Coagulants|coagulants|mesh-ancestor
153910644|NCT05340985|Vitamin D|vitamin d|mesh-list
153910645|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
153910646|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
153910647|NCT05340985|Calcifediol|calcifediol|mesh-list
153910648|NCT05340985|Vitamins|vitamins|mesh-list
153910649|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
153910650|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
153910651|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
153910652|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910653|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153452389|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452390|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153452391|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
153452392|NCT01867710|Hormones|hormones|mesh-ancestor
153452393|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452394|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153452395|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452396|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153452397|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452398|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910683|NCT04231435|Metformin|metformin|mesh-list
153910684|NCT04231435|Digoxin|digoxin|mesh-list
153910685|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153910686|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910687|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910688|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153910689|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153910690|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
153452399|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
153452400|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153452402|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
153452403|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452404|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153452405|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153452406|NCT01832766|Analgesics|analgesics|mesh-ancestor
153452407|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
153452408|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452409|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153452410|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153332403|NCT00957359|Niacin|niacin|mesh-list
153452411|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452412|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452413|NCT01832766|Hormones|hormones|mesh-ancestor
153452414|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452415|NCT01832532|Liraglutide|liraglutide|mesh-list
153452416|NCT01832532|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153910704|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910706|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910707|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
153910708|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153910709|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153910710|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154257124|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
153910711|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910712|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910713|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153910714|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153910715|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910716|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
153910717|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910718|NCT05322031|Aripiprazole|aripiprazole|mesh-list
153910719|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
153910720|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153910721|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153910722|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153910723|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910724|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910725|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
153910726|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
153910727|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845518|NCT01258738|Etanercept|etanercept|mesh-list
153745725|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153745726|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
153745741|NCT02295722|Melphalan|melphalan|mesh-list
153745742|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153745743|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
153332421|NCT00957593|Oxytocin|oxytocin|mesh-list
153745744|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745745|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745746|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153745747|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
153745748|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153745749|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745750|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
153745751|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745752|NCT02282059|Sunitinib|sunitinib|mesh-list
153745753|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745754|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153745755|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153745756|NCT02282059|Growth Substances|growth substances|mesh-ancestor
153745757|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745758|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
153845583|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153745824|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
153745825|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745826|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745827|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745861|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745862|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153745863|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153745864|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
153745865|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
153745866|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
153745867|NCT00405977|Analgesics|analgesics|mesh-ancestor
153745868|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
153745869|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745870|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745871|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
153745872|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745873|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153745874|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
153745875|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153745876|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745877|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745878|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153745879|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
153745880|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153745881|NCT02914327|Ibrutinib|ibrutinib|mesh-list
153745882|NCT02914327|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153745883|NCT02914327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745884|NCT02914327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845631|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153745988|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746039|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
153746040|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
153746041|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153746042|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153746043|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746044|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746045|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746046|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746047|NCT00150293|Pregabalin|pregabalin|mesh-list
153746048|NCT00150293|Analgesics|analgesics|mesh-ancestor
153746049|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
153746050|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746051|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746052|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
153845701|NCT01255423|Diclofenac|diclofenac|mesh-list
153746154|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153746156|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746157|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
153746158|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153746159|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
153746160|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746161|NCT02712814|Estrogens|estrogens|mesh-list
153746162|NCT02712814|Hormones|hormones|mesh-ancestor
153746163|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746164|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746165|NCT00150527|Dexamethasone|dexamethasone|mesh-list
153746166|NCT00150527|Citalopram|citalopram|mesh-list
153746167|NCT00150527|Escitalopram|escitalopram|mesh-list
153746387|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746388|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153746389|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
153746390|NCT00151034|Paclitaxel|paclitaxel|mesh-list
153746391|NCT00151034|Carboplatin|carboplatin|mesh-list
153746392|NCT00151034|Gemcitabine|gemcitabine|mesh-list
153746393|NCT00151034|Trastuzumab|trastuzumab|mesh-list
153746394|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153746395|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746396|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
153746397|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
153746398|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
153746399|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746493|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
153746494|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153845837|NCT04320589|Anesthetics|anesthetics|mesh-list
153746553|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153746562|NCT00171678|Diclofenac|diclofenac|mesh-list
153746563|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153746564|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153746565|NCT00171678|Analgesics|analgesics|mesh-ancestor
153746566|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
153385985|NCT02717949|Ribavirin|ribavirin|mesh-list
153746593|NCT00151502|Atorvastatin|atorvastatin|mesh-list
153746594|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153746595|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153746596|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
153746597|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746598|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153746599|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153746600|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746601|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
153746602|NCT00164463|Isoniazid|isoniazid|mesh-list
153746603|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153746604|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746605|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153746606|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153746607|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746608|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746609|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746610|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
153746611|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153746612|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153845889|NCT04356430|Prednisone|prednisone|mesh-list
153746681|NCT00532675|Panobinostat|panobinostat|mesh-list
153746682|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
153746683|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746684|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153746685|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153746686|NCT00532675|Growth Substances|growth substances|mesh-ancestor
154257125|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257126|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746687|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
153746688|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746689|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153746690|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746691|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746692|NCT05308030|Aspirin|aspirin|mesh-list
153746693|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
153746694|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153746695|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153746696|NCT05308030|Analgesics|analgesics|mesh-ancestor
153746697|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
153746698|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332854|NCT01170949|Miltefosine|miltefosine|mesh-list
153746699|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746700|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153746701|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746702|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153386043|NCT01882868|Vitamins|vitamins|mesh-ancestor
153746791|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153746792|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
153746793|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746794|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746795|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153746796|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153746797|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
153746798|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153735895|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735896|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735897|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735898|NCT04064359|Antibodies|antibodies|mesh-list
153735899|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
153735900|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
153735901|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746799|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153746800|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153746801|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153386072|NCT01379469|Carbamazepine|carbamazepine|mesh-list
153746846|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153746847|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153746848|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153746849|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153746850|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746851|NCT00164775|Imipramine|imipramine|mesh-list
153746852|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153746853|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
153746854|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153746866|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153746867|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746868|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746869|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746870|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746871|NCT00533026|Analgesics|analgesics|mesh-ancestor
153746872|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
153746873|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746874|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
153746875|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153746876|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
153746877|NCT00152126|Melphalan|melphalan|mesh-list
153746878|NCT00152126|Busulfan|busulfan|mesh-list
153746879|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153746880|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
153845963|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746896|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
153746897|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
153583957|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
153746898|NCT00425451|Analgesics|analgesics|mesh-ancestor
153746899|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
153746900|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553776|NCT01594697|Metformin|metformin|mesh-list
153746901|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746902|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153746903|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153746904|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153746905|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746906|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153746907|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746908|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746909|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
153746958|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746959|NCT00152399|Somatostatin|somatostatin|mesh-list
153746961|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746962|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746963|NCT00164931|Omeprazole|omeprazole|mesh-list
153746994|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746995|NCT02937415|Protective Agents|protective agents|mesh-ancestor
153746996|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746997|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
153746998|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
153746999|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747000|NCT00152594|Voriconazole|voriconazole|mesh-list
153747001|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
153747035|NCT02937181|Ceftaroline|ceftaroline|mesh-list
153747036|NCT02937181|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153747037|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153747038|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747039|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153747040|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153747041|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747042|NCT00425490|Incretins|incretins|mesh-ancestor
153747043|NCT00425490|Hormones|hormones|mesh-ancestor
153747044|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153747045|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153747046|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
153747047|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747048|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747099|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747101|NCT00165087|Protective Agents|protective agents|mesh-ancestor
153747102|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747103|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
153747104|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
153747105|NCT00152750|Clonidine|clonidine|mesh-list
153747106|NCT00152750|Analgesics|analgesics|mesh-ancestor
153747107|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
153747108|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747109|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747110|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747173|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
153747174|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747175|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153747195|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747197|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
153747199|NCT02935855|Apixaban|apixaban|mesh-list
153747200|NCT02935855|Edoxaban|edoxaban|mesh-list
153747201|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
153333190|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153747202|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153747203|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
153747204|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153747205|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
153747232|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153483203|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153747262|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747263|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153747264|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
153747265|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
153747266|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153747267|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
153747268|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747269|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747270|NCT02935075|Tenofovir|tenofovir|mesh-list
153747271|NCT02935075|Lamivudine|lamivudine|mesh-list
153747272|NCT02935075|Efavirenz|efavirenz|mesh-list
153747273|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
153747274|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747275|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153747276|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153747277|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483261|NCT04437485|Bupropion|bupropion|mesh-list
153747284|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153747285|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153386237|NCT02298192|Incretins|incretins|mesh-ancestor
153747316|NCT00165204|Hormones|hormones|mesh-ancestor
153747317|NCT02934763|Propranolol|propranolol|mesh-list
153747318|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153747319|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153747320|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747321|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747322|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747323|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747324|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153747388|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747398|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747399|NCT02933905|Ranibizumab|ranibizumab|mesh-list
153747400|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153846142|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747430|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153747431|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153747434|NCT00165399|Bicalutamide|bicalutamide|mesh-list
153747435|NCT00165399|Estramustine|estramustine|mesh-list
153747436|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747437|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
153747438|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
153747439|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
153747440|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747441|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153747442|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
153747443|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
153747444|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153747445|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747468|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153747469|NCT00153491|Lumefantrine|lumefantrine|mesh-list
153747470|NCT00153491|Artemether|artemether|mesh-list
153747471|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153747472|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
153747473|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153747474|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153747475|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747476|NCT02933437|Ajmaline|ajmaline|mesh-list
153747477|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153747478|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153747479|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153747480|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153747481|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747482|NCT00153530|Methotrexate|methotrexate|mesh-list
153747483|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153747484|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
153747485|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153747486|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747487|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153747488|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
153747489|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747490|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747491|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
153747492|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747493|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153747494|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153747495|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
153747496|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747497|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153747498|NCT00165477|Lenalidomide|lenalidomide|mesh-list
153747499|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
153747500|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747501|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153747502|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153333397|NCT04558502|Amoxicillin|amoxicillin|mesh-list
153747503|NCT00165477|Growth Substances|growth substances|mesh-ancestor
153747504|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
153747505|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747506|NCT02932930|Ropivacaine|ropivacaine|mesh-list
153747507|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
153747508|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
153747509|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747510|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747511|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
153747512|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747513|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
153747514|NCT00165516|Antidotes|antidotes|mesh-ancestor
153747548|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
153747549|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153747550|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747551|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747552|NCT00153725|Aspirin|aspirin|mesh-list
153747553|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747554|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747555|NCT00153725|Analgesics|analgesics|mesh-ancestor
153747556|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
153747557|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747558|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747559|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747560|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747561|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153747562|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153747563|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747564|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153747565|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153747566|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747567|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
153747569|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
153747570|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747571|NCT00180102|Cytarabine|cytarabine|mesh-list
153747572|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
153747610|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747612|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
153747613|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153747614|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
153747615|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153747616|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747617|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747618|NCT02931877|Propofol|propofol|mesh-list
153747619|NCT02931877|Sevoflurane|sevoflurane|mesh-list
153747620|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153747621|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747622|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747623|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153747624|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
153747625|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
153747626|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153747676|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153747677|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153747678|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153747679|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747681|NCT02924974|Narcotics|narcotics|mesh-ancestor
153747682|NCT02924974|Analgesics|analgesics|mesh-ancestor
153747683|NCT00154037|Pioglitazone|pioglitazone|mesh-list
153747684|NCT00154037|Candesartan|candesartan|mesh-list
153747685|NCT00154037|Candesartan cilexetil|candesartan cilexetil|mesh-list
153747686|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153747687|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747688|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747689|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153747690|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153747691|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747692|NCT00154076|Topiramate|topiramate|mesh-list
153747736|NCT00154193|Cyclosporins|cyclosporins|mesh-list
153747737|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846327|NCT01266148|Everolimus|everolimus|mesh-list
153747768|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153747769|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747770|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154257128|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747771|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
153747772|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153747773|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747774|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747775|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747776|NCT02923687|Ketorolac|ketorolac|mesh-list
153747781|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
153846356|NCT00538317|Tirofiban|tirofiban|mesh-list
153747809|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747810|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
153747811|NCT02922946|Entinostat|entinostat|mesh-list
153747812|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747813|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153747814|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747815|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747816|NCT02922712|Nimesulide|nimesulide|mesh-list
153747817|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747818|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747819|NCT02922712|Analgesics|analgesics|mesh-ancestor
153747820|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
153747821|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747822|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747823|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747824|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747825|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153747867|NCT02921659|Niacinamide|niacinamide|mesh-list
153747868|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
153747869|NCT02921659|Vitamins|vitamins|mesh-ancestor
153747870|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
153747871|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747872|NCT04689100|Leucovorin|leucovorin|mesh-list
153747873|NCT04689100|Fluorouracil|fluorouracil|mesh-list
153747874|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
153747875|NCT04689100|Irinotecan|irinotecan|mesh-list
153747876|NCT04689100|Calcium|calcium|mesh-list
153747877|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
153747878|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153747879|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747880|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
153747881|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747882|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153747883|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747884|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153747885|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
153747886|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153747887|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153747888|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747951|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
153747952|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153747953|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
153747954|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747955|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747956|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153747957|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
153747958|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
153747959|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153747960|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153747961|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153747962|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153747963|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747964|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748020|NCT00154700|Paclitaxel|paclitaxel|mesh-list
153748021|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153748022|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748023|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
153748024|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
153748025|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153748120|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748133|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748134|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748135|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153748136|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153748137|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153748165|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
154257129|NCT03874832|Analgesics|analgesics|mesh-ancestor
153748166|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748167|NCT02908945|Ketamine|ketamine|mesh-list
153748168|NCT02908945|Analgesics|analgesics|mesh-ancestor
153748169|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
153748170|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748171|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748172|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153748173|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153748174|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
153748175|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
153748176|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748177|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153748178|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153748179|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748180|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748181|NCT02939833|Ropivacaine|ropivacaine|mesh-list
153748182|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
153748183|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
153748196|NCT00188643|Lamotrigine|lamotrigine|mesh-list
153748224|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748225|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748226|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153748227|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
153748228|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
153748229|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153748230|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748231|NCT00181662|Curcumin|curcumin|mesh-list
153748232|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153748233|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748234|NCT00181662|Analgesics|analgesics|mesh-ancestor
153748235|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
153748236|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748237|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748238|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153748239|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846549|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
153748350|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748351|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
153748352|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153748353|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153748354|NCT00409227|Alfuzosin|alfuzosin|mesh-list
153748355|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
153748356|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153748357|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153748358|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
153748359|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748360|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748361|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748362|NCT00409227|Urological Agents|urological agents|mesh-ancestor
153748363|NCT00533962|Anecortave|anecortave|mesh-list
153748364|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153748365|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153748366|NCT00533962|Growth Substances|growth substances|mesh-ancestor
153748367|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748368|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
153748369|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748370|NCT00181818|Bupropion|bupropion|mesh-list
153748371|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153748372|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
153748373|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748374|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153748375|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153748376|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484363|NCT01640340|Aprepitant|aprepitant|mesh-list
153748404|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748405|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748407|NCT00181896|Bupropion|bupropion|mesh-list
153386698|NCT03723447|Hormones|hormones|mesh-ancestor
153748470|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748472|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
153748473|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
153748474|NCT04893148|Dulaglutide|dulaglutide|mesh-list
153748475|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154257130|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
153731939|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748476|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748477|NCT04893148|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153748478|NCT04883632|Lidocaine|lidocaine|mesh-list
153748479|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
153748481|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748482|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748483|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
153748484|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748485|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153748486|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153748487|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153748488|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748489|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748490|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153748491|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
153748492|NCT00181974|Coagulants|coagulants|mesh-ancestor
153748493|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153748494|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153748495|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153748496|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
153748497|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748498|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153748499|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153748500|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748522|NCT00182013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153484508|NCT01667796|Vitamins|vitamins|mesh-ancestor
153748529|NCT01715974|Molgramostim|molgramostim|mesh-list
153748530|NCT01715974|Sargramostim|sargramostim|mesh-list
153748531|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
153748532|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748533|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748534|NCT05471479|Charcoal|charcoal|mesh-list
153748535|NCT05471479|Antidotes|antidotes|mesh-ancestor
153748536|NCT05471479|Protective Agents|protective agents|mesh-ancestor
153748537|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748538|NCT00188877|Fluorouracil|fluorouracil|mesh-list
153748539|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
153748540|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748541|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153748542|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748543|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153748544|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
153748545|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748546|NCT00182169|Hormones|hormones|mesh-list
153748547|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748548|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748549|NCT05471050|Danazol|danazol|mesh-list
153748550|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153748551|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
153748552|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748553|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748554|NCT05470972|Ethanol|ethanol|mesh-list
153748555|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153748556|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748557|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748558|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748559|NCT04686058|Midazolam|midazolam|mesh-list
153748560|NCT04686058|Meperidine|meperidine|mesh-list
153748561|NCT04686058|Propofol|propofol|mesh-list
153748581|NCT00156299|Dexamethasone|dexamethasone|mesh-list
153748582|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
153748583|NCT00156299|Choline|choline|mesh-list
153748584|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153748585|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
153748586|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
153748587|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748588|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748589|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153748590|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
153748591|NCT00156299|Hormones|hormones|mesh-ancestor
153554461|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748592|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748602|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
153748603|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153748604|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748605|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153748607|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748608|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153748609|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748610|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748612|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153748613|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748614|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153748615|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748616|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
153748617|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153748618|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
153748619|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748621|NCT00536068|Aspirin|aspirin|mesh-list
153748622|NCT00536068|Diclofenac|diclofenac|mesh-list
153748623|NCT00536068|Naproxen|naproxen|mesh-list
153748624|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748625|NCT00536068|Analgesics|analgesics|mesh-ancestor
153748626|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
153748627|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748628|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748629|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
153748646|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153748647|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748648|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748649|NCT00188994|Insulin|insulin|mesh-list
153748650|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153748651|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748652|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153748653|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
153748654|NCT00408525|Donepezil|donepezil|mesh-list
153748655|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153748656|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748657|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748658|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
153748659|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748669|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748670|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153748672|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153748673|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
153748674|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748675|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748676|NCT00189033|Psyllium|psyllium|mesh-list
153748677|NCT00189033|Cathartics|cathartics|mesh-ancestor
153748678|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153748679|NCT05469061|Cisplatin|cisplatin|mesh-list
153748680|NCT05469061|Tislelizumab|tislelizumab|mesh-list
153748681|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748682|NCT05469061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153748683|NCT05469022|Lazertinib|lazertinib|mesh-list
153748684|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153748685|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748686|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748687|NCT00189072|Gabapentin|gabapentin|mesh-list
153748688|NCT00189072|Analgesics|analgesics|mesh-ancestor
153748689|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
153748690|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748691|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748692|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
153748693|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153748694|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748695|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748696|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748753|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153735932|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
153748754|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748755|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748756|NCT05468047|Ketamine|ketamine|mesh-list
154257131|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748757|NCT05468047|Analgesics|analgesics|mesh-ancestor
153748758|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
153748759|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748760|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748761|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153748762|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153748763|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
153748764|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
153748765|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748766|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153748767|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153748768|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748811|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
153748812|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748813|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748814|NCT00189345|Catumaxomab|catumaxomab|mesh-list
153748815|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
153748816|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
153748817|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748818|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153748819|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153748863|NCT04685512|Emtricitabine|emtricitabine|mesh-list
153386871|NCT00379509|Lapatinib|lapatinib|mesh-list
153748889|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153748891|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153748892|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153748893|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
153748894|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
153748895|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748896|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748897|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
153748898|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748899|NCT00536848|Metronidazole|metronidazole|mesh-list
153748900|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748901|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153748902|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153748903|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153748904|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
153748905|NCT00157079|Antibodies|antibodies|mesh-list
153748906|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
153748907|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153748908|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153748909|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
153748910|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748935|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
153748936|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386887|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749000|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153749001|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153749002|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749016|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749017|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
153749018|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749020|NCT00534391|Neomycin|neomycin|mesh-list
153749021|NCT00534391|Polymyxin B|polymyxin b|mesh-list
153749052|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153749054|NCT00182715|Antidotes|antidotes|mesh-ancestor
153749055|NCT00182715|Protective Agents|protective agents|mesh-ancestor
153749056|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
153749057|NCT00182715|Vitamins|vitamins|mesh-ancestor
153749058|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
153749059|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153749060|NCT00534586|Ketamine|ketamine|mesh-list
153749061|NCT00534586|Remifentanil|remifentanil|mesh-list
153749062|NCT00534586|Propofol|propofol|mesh-list
153749063|NCT00534586|Sevoflurane|sevoflurane|mesh-list
153749064|NCT00534586|Esketamine|esketamine|mesh-list
153735933|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735934|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735935|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
153846806|NCT01263028|Vitamin D|vitamin d|mesh-list
153749098|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153749099|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
153373503|NCT01416584|Methadone|methadone|mesh-list
153554772|NCT05690321|Analgesics|analgesics|mesh-ancestor
153749100|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153749101|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749102|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
153749103|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153749105|NCT00406874|Hematinics|hematinics|mesh-ancestor
153749106|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
153749107|NCT00406874|Vitamins|vitamins|mesh-ancestor
153749108|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
153749109|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749110|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
153749111|NCT04106830|Azathioprine|azathioprine|mesh-list
153749112|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749113|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
153334975|NCT00378118|Antibodies|antibodies|mesh-list
153749114|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749115|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153749116|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153485113|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749138|NCT00406913|Mupirocin|mupirocin|mesh-list
153749139|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749140|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749141|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153749142|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749143|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749144|NCT00406952|Sertraline|sertraline|mesh-list
153749145|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
153749146|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153749147|NCT00406952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153749148|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153749149|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749150|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749151|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749152|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
153749153|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749154|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
153749156|NCT00157547|Fluoxetine|fluoxetine|mesh-list
153749157|NCT00157547|Paroxetine|paroxetine|mesh-list
153749158|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153749159|NCT00157547|Sertraline|sertraline|mesh-list
153749160|NCT00157547|Escitalopram|escitalopram|mesh-list
153749161|NCT00157547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153749162|NCT00157547|Serotonin|serotonin|mesh-list
153749163|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153749164|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749165|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749166|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749231|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153749232|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
153749233|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153749234|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
153749235|NCT04686643|Vitamins|vitamins|mesh-ancestor
153749236|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
153749237|NCT00534898|Fenretinide|fenretinide|mesh-list
153749238|NCT00534898|Bexarotene|bexarotene|mesh-list
153749239|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749240|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153749241|NCT00534898|Protective Agents|protective agents|mesh-ancestor
153749242|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749243|NCT03748810|Metformin|metformin|mesh-list
153749244|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
153749245|NCT03748810|Empagliflozin|empagliflozin|mesh-list
153749246|NCT03748810|Glimepiride|glimepiride|mesh-list
153749247|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153749248|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153749249|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386967|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
153749265|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
153749266|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153749267|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153749268|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749269|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749270|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153749282|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153749283|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749284|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153749285|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749286|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153749287|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749288|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
153749289|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153749290|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
153749291|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
153749292|NCT00158093|Atenolol|atenolol|mesh-list
153749293|NCT00158093|Nebivolol|nebivolol|mesh-list
153749294|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749295|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749296|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153749297|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749298|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749299|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749300|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749301|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749302|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153749303|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153749304|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
153749305|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
153749306|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749307|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153749308|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153749309|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153749310|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
153749311|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749312|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
153749313|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153749314|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153749315|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153749316|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153749317|NCT03429946|Spironolactone|spironolactone|mesh-list
153749318|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153749319|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
153749370|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749371|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749372|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
153749373|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749374|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749375|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153749376|NCT00158210|Protective Agents|protective agents|mesh-ancestor
153749378|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153749379|NCT00190008|Protective Agents|protective agents|mesh-ancestor
153749380|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749381|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
153749382|NCT00183222|Naltrexone|naltrexone|mesh-list
153749391|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153749392|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
153749393|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
153749394|NCT00183222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153749395|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153749396|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
153749397|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749398|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749400|NCT00158405|Indinavir|indinavir|mesh-list
153749401|NCT00158405|Lamivudine|lamivudine|mesh-list
153749402|NCT00158405|Zidovudine|zidovudine|mesh-list
153749403|NCT00158405|Efavirenz|efavirenz|mesh-list
153749404|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153749405|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153749406|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
153749407|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735939|NCT04009967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749408|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749409|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153749410|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153749411|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
153749412|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749413|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153749445|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749446|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586504|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
153749447|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153749448|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
153749449|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749457|NCT00538096|Blinatumomab|blinatumomab|mesh-list
153749458|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749459|NCT00158678|Cisplatin|cisplatin|mesh-list
153749460|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749461|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
153749462|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153387049|NCT01548651|Saxagliptin|saxagliptin|mesh-list
153749472|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749473|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153749474|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153749475|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153749476|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153749477|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
153749478|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749479|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153749480|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153749481|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749482|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749483|NCT00538486|Metformin|metformin|mesh-list
153749484|NCT00538486|Amlodipine|amlodipine|mesh-list
153749485|NCT00538486|Telmisartan|telmisartan|mesh-list
153749486|NCT00538486|Candesartan|candesartan|mesh-list
153749487|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
153749488|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153749489|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749490|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153749491|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153749492|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749493|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749494|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153749495|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
153749496|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153749497|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153749498|NCT00538525|Docetaxel|docetaxel|mesh-list
153749499|NCT00538525|Doxorubicin|doxorubicin|mesh-list
153749500|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749501|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
153749502|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
153749503|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
153749504|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749505|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153749506|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153749507|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749508|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749509|NCT00538564|Tadalafil|tadalafil|mesh-list
153749510|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
153749511|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153749512|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153749513|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749514|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749515|NCT00538564|Urological Agents|urological agents|mesh-ancestor
153749516|NCT00538603|Paclitaxel|paclitaxel|mesh-list
153749517|NCT00538603|Carboplatin|carboplatin|mesh-list
153749518|NCT00538603|Doxorubicin|doxorubicin|mesh-list
153749519|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153749525|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749527|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153749528|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749529|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749530|NCT00158834|Fluticasone|fluticasone|mesh-list
153749532|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153846952|NCT02907749|Diuretics|diuretics|mesh-ancestor
153749546|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749547|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749549|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
153749550|NCT00538720|Vitamins|vitamins|mesh-ancestor
153749551|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
153749552|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749553|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153749554|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153749555|NCT00536887|Atorvastatin|atorvastatin|mesh-list
153749556|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153749557|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153749558|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
153749559|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749560|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153749561|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153749562|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749563|NCT00158873|Midazolam|midazolam|mesh-list
153749564|NCT00158873|Fentanyl|fentanyl|mesh-list
153749565|NCT00158873|Morphine|morphine|mesh-list
153749566|NCT00158873|Remifentanil|remifentanil|mesh-list
153749567|NCT00158873|Lorazepam|lorazepam|mesh-list
153749568|NCT00158873|Propofol|propofol|mesh-list
153749569|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153749570|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153749571|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749572|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153749573|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
153749574|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
153749575|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153749576|NCT00158873|Narcotics|narcotics|mesh-ancestor
153749577|NCT00158873|Analgesics|analgesics|mesh-ancestor
153749578|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
153749579|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335730|NCT01231750|Capsaicin|capsaicin|mesh-list
153749580|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153749581|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153749582|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153749583|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153749584|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
153749585|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
153749586|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749587|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749588|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
153749589|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
153749590|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
153749591|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153749602|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749603|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749604|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153749605|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
153749628|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153749629|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153749630|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749631|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
153749632|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153749633|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153749634|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153749635|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
153749636|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749637|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153749638|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153749639|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749640|NCT00158990|Sertraline|sertraline|mesh-list
153749641|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
153749642|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153749643|NCT00158990|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153749644|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153749645|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749646|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749647|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749648|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
153749649|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749650|NCT00537355|Histamine|histamine|mesh-list
153749651|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
153749652|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
153749653|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335731|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
153335786|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153749654|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749655|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749656|NCT00183612|Olanzapine|olanzapine|mesh-list
153749657|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
153847031|NCT04682132|Antibodies|antibodies|mesh-list
153749695|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153749696|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153749698|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153749699|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154257133|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154257134|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
154257135|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749700|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153749701|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
153749702|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
153749703|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
153749704|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153749705|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153749706|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749707|NCT00159146|Pindolol|pindolol|mesh-list
153749708|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153749709|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153749710|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
153749711|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749712|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749713|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749714|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153749715|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153749716|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
153749721|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749722|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
153749723|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749724|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749725|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749726|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
153749727|NCT00538954|Antacids|antacids|mesh-ancestor
153749728|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749729|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153749730|NCT00539071|Risperidone|risperidone|mesh-list
153749748|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153335787|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
153749749|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749750|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749751|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749752|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153749753|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153749755|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
153749756|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749757|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749758|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153749759|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153749760|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153749761|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153749762|NCT00539773|Interferons|interferons|mesh-list
153749763|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749764|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
153749765|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749766|NCT00409461|Sirolimus|sirolimus|mesh-list
153749767|NCT00409461|Tacrolimus|tacrolimus|mesh-list
153749768|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153749769|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
153749770|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749771|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153749772|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749773|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749774|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749775|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749776|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153749777|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749778|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
153749779|NCT00539890|Insulin|insulin|mesh-list
153749780|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153749781|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749782|NCT00539968|Docetaxel|docetaxel|mesh-list
153749783|NCT00539968|Lonafarnib|lonafarnib|mesh-list
153749784|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749785|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
153749786|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
153749787|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
153749788|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485766|NCT05348200|Clobetasol|clobetasol|mesh-list
153749804|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153749829|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749830|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153749831|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153749832|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
153749833|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749834|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153749835|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153749837|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749838|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749839|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
153749840|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749841|NCT00183924|Carboplatin|carboplatin|mesh-list
153749842|NCT00183924|Docetaxel|docetaxel|mesh-list
153749843|NCT00183924|Estramustine|estramustine|mesh-list
153749844|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749845|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
153749846|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
153749847|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
153485831|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749857|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153749858|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
153749859|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153749860|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
153749861|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847125|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
153749886|NCT00540787|Amiodarone|amiodarone|mesh-list
153749887|NCT00540787|Flecainide|flecainide|mesh-list
153749888|NCT00540787|Sotalol|sotalol|mesh-list
153749889|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153749890|NCT00540787|Propafenone|propafenone|mesh-list
153749891|NCT00540787|Dofetilide|dofetilide|mesh-list
153749892|NCT00540787|Cifenline|cifenline|mesh-list
153749893|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
153749894|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153749895|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749896|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
153749897|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153749898|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749899|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749900|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153749901|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153749902|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153749903|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749904|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153749905|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153749906|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153749907|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153749908|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153749909|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153749910|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
153749911|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749918|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153749942|NCT00159458|Gemcitabine|gemcitabine|mesh-list
153749943|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
153749944|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749945|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
154191177|NCT05941741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153749946|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749947|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749948|NCT00541021|Gemcitabine|gemcitabine|mesh-list
153749949|NCT00541021|Sorafenib|sorafenib|mesh-list
153749950|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749951|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
153749952|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749953|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749954|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153749955|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749956|NCT00541138|Tamoxifen|tamoxifen|mesh-list
153749957|NCT00541138|Carboplatin|carboplatin|mesh-list
153749958|NCT00541138|Topotecan|topotecan|mesh-list
153749959|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749960|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749961|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153555508|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153749962|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749963|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749964|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153749965|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
153749966|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153749967|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749980|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153749995|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153749996|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
153749997|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749998|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749999|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
153750000|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153750001|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
153750002|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750003|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750004|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750006|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153750007|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750008|NCT00159536|Metformin|metformin|mesh-list
153750009|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153750010|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750011|NCT00541411|Dactinomycin|dactinomycin|mesh-list
153750012|NCT00541411|Vincristine|vincristine|mesh-list
153750013|NCT00541411|Ifosfamide|ifosfamide|mesh-list
153750014|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153750015|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750016|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
153750017|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
153750018|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
153750019|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750020|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153750021|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
153750022|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153750023|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750024|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153750025|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153750026|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750027|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153750028|NCT00541489|Naproxen|naproxen|mesh-list
153750029|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
153750030|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153750031|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153750032|NCT00541489|Analgesics|analgesics|mesh-ancestor
153750033|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
153750034|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750035|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750036|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750037|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750038|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
153750039|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153750040|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486022|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
153750076|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750078|NCT00159614|Diuretics|diuretics|mesh-ancestor
153750079|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
153847228|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750097|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750098|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336163|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
153750099|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750100|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153750101|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153750102|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153750103|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153750104|NCT00541918|Propofol|propofol|mesh-list
153750105|NCT00541918|Sevoflurane|sevoflurane|mesh-list
153750106|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153750107|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750108|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750109|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153750110|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
153750111|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
153750112|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154257136|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257137|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154257138|NCT01169012|Clofarabine|clofarabine|mesh-list
153750113|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153750114|NCT00190515|Leucovorin|leucovorin|mesh-list
153750115|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
153750116|NCT00190515|Antidotes|antidotes|mesh-ancestor
153750117|NCT00190515|Protective Agents|protective agents|mesh-ancestor
153750118|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750119|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
153750120|NCT00190515|Vitamins|vitamins|mesh-ancestor
153750135|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750136|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750137|NCT00542152|Cyclosporine|cyclosporine|mesh-list
153750138|NCT00542152|Infliximab|infliximab|mesh-list
153750139|NCT00542152|Cyclosporins|cyclosporins|mesh-list
153750140|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750141|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750142|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750143|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
153750144|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750145|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
153750146|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750147|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
153750148|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750149|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153750150|NCT00542152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153750151|NCT00542152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750205|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153387433|NCT00000189|Gepirone|gepirone|mesh-list
153750226|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153750228|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750229|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750230|NCT00184041|Cytarabine|cytarabine|mesh-list
153750231|NCT00184041|Prednisone|prednisone|mesh-list
153750232|NCT00184041|Methotrexate|methotrexate|mesh-list
153750233|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
153750234|NCT00184041|Vincristine|vincristine|mesh-list
153750235|NCT00184041|Daunorubicin|daunorubicin|mesh-list
153750236|NCT00184041|Asparaginase|asparaginase|mesh-list
153750237|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
153750238|NCT00184041|Thioguanine|thioguanine|mesh-list
153750264|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
153750265|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
153750266|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
153750267|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
153750268|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750269|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153750270|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153750271|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153750273|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587332|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
153750274|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153750275|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153750276|NCT00543049|Growth Substances|growth substances|mesh-ancestor
153750277|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336317|NCT03428958|Leucovorin|leucovorin|mesh-list
153750278|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
153750279|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153750280|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750281|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750282|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153750283|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153750307|NCT00159809|Urological Agents|urological agents|mesh-ancestor
153750308|NCT00543244|Interferons|interferons|mesh-list
153750310|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
153750311|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153750312|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750313|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
153750314|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750315|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
153750316|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750317|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
153750318|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750319|NCT00190710|Carboplatin|carboplatin|mesh-list
153750320|NCT00190710|Gemcitabine|gemcitabine|mesh-list
153555733|NCT01599949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555755|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
153750321|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750322|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750323|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
153750324|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750325|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
153750326|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
153750327|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153750328|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750329|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336426|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750330|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153750332|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
153750333|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750334|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153750335|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153750336|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153750337|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
153750338|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750339|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750340|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
153750342|NCT03456544|Vancomycin|vancomycin|mesh-list
153750343|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153750344|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750345|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
153750346|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750347|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
153750348|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153750349|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153750363|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153750364|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153750400|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750447|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153750448|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750449|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750450|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
153750451|NCT00544219|Hormones|hormones|mesh-ancestor
153750452|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750453|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153750454|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153750455|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
153750456|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
153750457|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
153750458|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153750459|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153750460|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750461|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750462|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750463|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750538|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750540|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153750541|NCT02963181|Melatonin|melatonin|mesh-list
153750542|NCT02963181|Yohimbine|yohimbine|mesh-list
153750543|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
153750544|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750545|NCT02963181|Protective Agents|protective agents|mesh-ancestor
153750546|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750547|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750548|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
153750549|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
153750550|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750551|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153750552|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153750553|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153750564|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
153750565|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750566|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750567|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
153750568|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750569|NCT00544999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154257139|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750570|NCT00544999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153750571|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735943|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750572|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153750573|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153750574|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153750576|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
153750577|NCT00160316|Estrogens|estrogens|mesh-ancestor
153750578|NCT00160316|Hormones|hormones|mesh-ancestor
153750579|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750600|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750602|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
153750603|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750604|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153336563|NCT00691444|Melatonin|melatonin|mesh-list
153750605|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
153750606|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153750607|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
153750608|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153750609|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153750610|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153750611|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
153750612|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750613|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750614|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750615|NCT00160394|Adapalene|adapalene|mesh-list
153750616|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153750617|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153750618|NCT00160394|Analgesics|analgesics|mesh-ancestor
153750619|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
153750620|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750641|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153750643|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
153750644|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750645|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750646|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750648|NCT00545467|Aripiprazole|aripiprazole|mesh-list
153750649|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750650|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750651|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153750652|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153750706|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750709|NCT00546130|Irinotecan|irinotecan|mesh-list
153750710|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750711|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153750712|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153750713|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750714|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750732|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750733|NCT00191178|Coagulants|coagulants|mesh-ancestor
153750734|NCT00546169|Thrombin|thrombin|mesh-list
153750735|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
153750736|NCT00546169|Coagulants|coagulants|mesh-ancestor
153750737|NCT00160628|Levetiracetam|levetiracetam|mesh-list
153750738|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
153750739|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
153750740|NCT00546286|Timolol|timolol|mesh-list
153750741|NCT00546286|Dorzolamide|dorzolamide|mesh-list
153750742|NCT00546286|Maleic acid|maleic acid|mesh-list
153750743|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750744|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750745|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153750746|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153750747|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
153750748|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750749|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750750|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153750751|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153750752|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153750753|NCT00546325|Rimonabant|rimonabant|mesh-list
153750754|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153750755|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153750789|NCT00546559|Simvastatin|simvastatin|mesh-list
153750790|NCT00546559|Pravastatin|pravastatin|mesh-list
153587864|NCT01784315|Chloroquine|chloroquine|mesh-list
153750791|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153750793|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
153750794|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750795|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153750796|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153750797|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750798|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153750799|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153750800|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153750801|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
153750802|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750803|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153750804|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153750805|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750806|NCT00546676|Telithromycin|telithromycin|mesh-list
153750807|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153750808|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750809|NCT00546832|Celecoxib|celecoxib|mesh-list
153750810|NCT00546832|Diclofenac|diclofenac|mesh-list
153847532|NCT00551889|Analgesics|analgesics|mesh-ancestor
153750865|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750867|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
153750868|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153750869|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153750870|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336740|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750871|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750872|NCT00547495|Urological Agents|urological agents|mesh-ancestor
153750873|NCT02277223|Curcumin|curcumin|mesh-list
153750874|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153750875|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153750876|NCT02277223|Analgesics|analgesics|mesh-ancestor
153750877|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
153750878|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750912|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750913|NCT00184665|Insulin|insulin|mesh-list
153750914|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153750915|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
153750916|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
153750917|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
153750918|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
153750919|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
153750920|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153750921|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750922|NCT04974385|Bupivacaine|bupivacaine|mesh-list
153750923|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
153750924|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
153750925|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750926|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750927|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
153750928|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750929|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
153750930|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153750971|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153750973|NCT00191490|Docetaxel|docetaxel|mesh-list
153750974|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750975|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750976|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
153750977|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750978|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
153750979|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
153750980|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
153750981|NCT00548080|Caspofungin|caspofungin|mesh-list
153750982|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
153750983|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750984|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750985|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750986|NCT00161096|Pantoprazole|pantoprazole|mesh-list
153750987|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153750988|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153750989|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153750990|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750991|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750992|NCT00184821|Glyburide|glyburide|mesh-list
153750993|NCT00184821|Adenosine|adenosine|mesh-list
153750994|NCT00184821|Diazoxide|diazoxide|mesh-list
153751032|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
153751034|NCT00184899|Calcium heparin|calcium heparin|mesh-list
153751035|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153751036|NCT00184899|Glycerol|glycerol|mesh-list
153751037|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
153751038|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153751039|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153751040|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751041|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153751042|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153751043|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153751044|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153751045|NCT00184899|Protective Agents|protective agents|mesh-ancestor
153751046|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751047|NCT00548821|Cisplatin|cisplatin|mesh-list
153751048|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751049|NCT00161291|Bevacizumab|bevacizumab|mesh-list
153751050|NCT00161291|Letrozole|letrozole|mesh-list
153751051|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153751052|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751053|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153751054|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153751069|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751070|NCT00191568|Gemcitabine|gemcitabine|mesh-list
153751071|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
153751072|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153751073|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
153751074|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751075|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751076|NCT00548938|Temozolomide|temozolomide|mesh-list
153751077|NCT00548938|Carmustine|carmustine|mesh-list
153751078|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153751079|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
153588171|NCT01786070|Budesonide|budesonide|mesh-list
153751090|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910742|NCT02780011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751091|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751092|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153751093|NCT00184938|Morphine|morphine|mesh-list
153751094|NCT00184938|Naloxone|naloxone|mesh-list
153751095|NCT00184938|Annexin A5|annexin a5|mesh-list
153751096|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153751097|NCT00184938|Narcotics|narcotics|mesh-ancestor
153751098|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153751099|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751100|NCT00184938|Analgesics|analgesics|mesh-ancestor
153751101|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
153751102|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751103|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153751104|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751105|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751106|NCT00549133|Irbesartan|irbesartan|mesh-list
153751107|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153751108|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153751109|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153751110|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751111|NCT00191607|Gemcitabine|gemcitabine|mesh-list
153751112|NCT00191607|Doxorubicin|doxorubicin|mesh-list
153751113|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153751114|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153751115|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
153751116|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751117|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751118|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153751119|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153751120|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153751142|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487133|NCT01906866|Melatonin|melatonin|mesh-list
153751150|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153751151|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
153751152|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751153|NCT00184977|Protective Agents|protective agents|mesh-ancestor
153751154|NCT00184977|Antidotes|antidotes|mesh-ancestor
153751155|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
154004074|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
153751156|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751157|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
153751158|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
153751159|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
153751160|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153751161|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
153751162|NCT00161447|Testosterone|testosterone|mesh-list
153751163|NCT00161447|Acyline|acyline|mesh-list
153751164|NCT00161447|Androgens|androgens|mesh-ancestor
153751165|NCT00161447|Hormones|hormones|mesh-ancestor
153751166|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751167|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751168|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153751169|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735945|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735946|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751170|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153751171|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153751172|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153751173|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
153751174|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153751175|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153751176|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153751177|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153751178|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
153751197|NCT00161486|Acyline|acyline|mesh-list
153751198|NCT00161486|Androgens|androgens|mesh-ancestor
153751199|NCT00161486|Hormones|hormones|mesh-ancestor
153751200|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751201|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751202|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153751203|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751204|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
153751205|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
153751206|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
153751207|NCT00549874|Glyburide|glyburide|mesh-list
153751208|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153751209|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751210|NCT00191763|Gemcitabine|gemcitabine|mesh-list
153751211|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751212|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153751213|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
153751225|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153751226|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153751227|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153751228|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751229|NCT00550108|Ethanol|ethanol|mesh-list
153751230|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153751231|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751232|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153751233|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751234|NCT00185094|Losartan|losartan|mesh-list
153751235|NCT00185094|Atenolol|atenolol|mesh-list
153751236|NCT00185094|Olmesartan|olmesartan|mesh-list
153751237|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153751238|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153751239|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153751240|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153588315|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153751241|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153751242|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751243|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
153751270|NCT00161681|Estradiol|estradiol|mesh-list
153751271|NCT00161681|Estrogens|estrogens|mesh-ancestor
153751272|NCT00161681|Hormones|hormones|mesh-ancestor
154191178|NCT05941741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751273|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751274|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751275|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153751276|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
153751296|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153751297|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153751298|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
153751299|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556350|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556351|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153751300|NCT00191802|Teriparatide|teriparatide|mesh-list
153751301|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153751302|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751303|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153751304|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
153387895|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
153751327|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153751328|NCT00550927|Growth Substances|growth substances|mesh-ancestor
153751329|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751330|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
153751350|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153751351|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751352|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153751353|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153751354|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751355|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751356|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153751357|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153751358|NCT00551005|Analgesics|analgesics|mesh-ancestor
153751359|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
153751360|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751361|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751362|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153751363|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414636|NCT05345210|Clarithromycin|clarithromycin|mesh-list
153751364|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153751365|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153751366|NCT00551044|Bicalutamide|bicalutamide|mesh-list
153751367|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
153751368|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
153751369|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751370|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751371|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751372|NCT00161759|Thrombin|thrombin|mesh-list
153751399|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
153751400|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751401|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751402|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153751403|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
153751404|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751405|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153751406|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153751407|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153751408|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751409|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153751410|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153751411|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153751412|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751413|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751414|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
153751415|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751416|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751417|NCT00551317|Darapladib|darapladib|mesh-list
153751418|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153751419|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751420|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751421|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
153751422|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153751423|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751424|NCT02963337|Remifentanil|remifentanil|mesh-list
153751425|NCT02963337|Bupivacaine|bupivacaine|mesh-list
153751426|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
153751427|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
153751428|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153751429|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751430|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
153751431|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751432|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153751433|NCT02963337|Narcotics|narcotics|mesh-ancestor
153751434|NCT02963337|Analgesics|analgesics|mesh-ancestor
154257141|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257142|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751435|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153751436|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153751437|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153751438|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751439|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751440|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751441|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751442|NCT00191919|Analgesics|analgesics|mesh-ancestor
153387960|NCT00359879|Exenatide|exenatide|mesh-list
153751486|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153751488|NCT00191997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153751489|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153873953|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153751528|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751529|NCT00162149|Ritonavir|ritonavir|mesh-list
153751530|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153751531|NCT00162149|Nevirapine|nevirapine|mesh-list
153751532|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153751533|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153751534|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
153751535|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751536|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751537|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153751538|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153751539|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
153751540|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751541|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153751542|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153751543|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153751544|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153847864|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
153751564|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751565|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751566|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
153751567|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751568|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153751569|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153751570|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153751571|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153751572|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153751573|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153751574|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153751575|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153751576|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751577|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153751578|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153751579|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153751600|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751601|NCT04684498|Oseltamivir|oseltamivir|mesh-list
153751602|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
153751603|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751604|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751605|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751606|NCT00552799|Penicillins|penicillins|mesh-list
153751607|NCT00552799|Penicillin V|penicillin v|mesh-list
153751608|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153751609|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751611|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751612|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
153751613|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153751614|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751615|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153751616|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751693|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487700|NCT01984398|Citric Acid|citric acid|mesh-list
153751705|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154257143|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153751706|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
153751707|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751708|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751709|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153751712|NCT00162695|Epirubicin|epirubicin|mesh-list
153751713|NCT00162695|Ifosfamide|ifosfamide|mesh-list
153751714|NCT00162695|Carboplatin|carboplatin|mesh-list
153751715|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153751716|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751717|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153751739|NCT00162812|Epirubicin|epirubicin|mesh-list
153751740|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153751741|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751742|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153751743|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153751744|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751745|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751746|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
153751747|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153751748|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751749|NCT04015414|Varenicline|varenicline|mesh-list
153751750|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153751751|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153751752|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
153751753|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751754|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751755|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751756|NCT00185835|Gefitinib|gefitinib|mesh-list
153487762|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
153751785|NCT00185874|Immunomodulating Agents|immunomodulating agents|mesh-list
153751786|NCT00185874|Immunologic Factors|immunologic factors|mesh-ancestor
153751787|NCT00185874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751788|NCT00163046|Gabapentin|gabapentin|mesh-list
153751789|NCT00163046|Analgesics|analgesics|mesh-ancestor
153751790|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
153751791|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751792|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751793|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
153751794|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153751795|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153751796|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153751797|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153751798|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153751823|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153751824|NCT00192621|Lopinavir|lopinavir|mesh-list
153751825|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153751826|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153751827|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751828|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751829|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
153751830|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751831|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153751832|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153751833|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
153751834|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153751835|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153751836|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
153751837|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153751838|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153751839|NCT03516604|Citalopram|citalopram|mesh-list
153751840|NCT03516604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153751841|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153751842|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751843|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751844|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751845|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
153751846|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751847|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153751848|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
153751849|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153751850|NCT00185991|Gentamicins|gentamicins|mesh-list
153556757|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556758|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
153751851|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153751852|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751853|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153751854|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751855|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751856|NCT03434158|Olaparib|olaparib|mesh-list
153751857|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153751858|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751859|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751860|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751861|NCT00163202|Atorvastatin|atorvastatin|mesh-list
153751862|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153388129|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
153751905|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751906|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153751907|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153751908|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153751909|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153751910|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
153751911|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153751912|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153751913|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153751914|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153751915|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153751916|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153751917|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
153735949|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751918|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153751919|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153751920|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153751921|NCT00163241|Celecoxib|celecoxib|mesh-list
153751922|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153751923|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153751924|NCT00163241|Analgesics|analgesics|mesh-ancestor
153751987|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751988|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751990|NCT00163397|Ciclesonide|ciclesonide|mesh-list
153751991|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
153751992|NCT00163397|Hormones|hormones|mesh-ancestor
153626772|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752001|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153735950|NCT03974152|Nicotine|nicotine|mesh-list
153735951|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153752002|NCT00186420|Docetaxel|docetaxel|mesh-list
153752003|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752004|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752005|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752006|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752007|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752008|NCT00163514|Ciclesonide|ciclesonide|mesh-list
153752009|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
153752010|NCT00163514|Hormones|hormones|mesh-ancestor
153752011|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752012|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752013|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153752014|NCT00717652|Triamcinolone|triamcinolone|mesh-list
153752015|NCT00717652|Tretinoin|tretinoin|mesh-list
153752016|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153752017|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
153752018|NCT00717652|Hormones|hormones|mesh-ancestor
153752019|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752020|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752021|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752022|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
153752023|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
153752024|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
153752025|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
153752026|NCT00066040|Fluorides|fluorides|mesh-list
153752027|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
153848092|NCT05255367|Phenol|phenol|mesh-list
153752047|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
153752048|NCT04683445|Trastuzumab|trastuzumab|mesh-list
153752049|NCT04683445|Pertuzumab|pertuzumab|mesh-list
153752050|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752051|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589134|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752052|NCT04683445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153752053|NCT04683445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752054|NCT00192777|Capecitabine|capecitabine|mesh-list
153752055|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752056|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
153752057|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752058|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752066|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153752067|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
153752068|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153752069|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153752070|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752071|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153752072|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
153752073|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153752074|NCT05808387|Resveratrol|resveratrol|mesh-list
153752075|NCT05808387|Antioxidants|antioxidants|mesh-ancestor
153752076|NCT05808387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752077|NCT05808387|Protective Agents|protective agents|mesh-ancestor
153752078|NCT05808387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752079|NCT05808387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910743|NCT02780479|Dexamethasone|dexamethasone|mesh-list
153752080|NCT05808387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153752081|NCT05808231|Quinine|quinine|mesh-list
153752082|NCT05808231|Antimalarials|antimalarials|mesh-ancestor
153752083|NCT05808231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153752084|NCT05808231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153752085|NCT05808231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752086|NCT05808231|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153752087|NCT05808231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752088|NCT05808231|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153848114|NCT03639389|Narcotics|narcotics|mesh-ancestor
153752110|NCT05807893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752111|NCT05807893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153752112|NCT05807893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153752113|NCT05807893|Growth Substances|growth substances|mesh-ancestor
153752114|NCT05807893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752115|NCT05807893|Growth Inhibitors|growth inhibitors|mesh-ancestor
153752116|NCT05807880|Capecitabine|capecitabine|mesh-list
153752117|NCT05807880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752118|NCT05807880|Antimetabolites|antimetabolites|mesh-ancestor
153752119|NCT05807880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752120|NCT05807880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752121|NCT05807776|Lenvatinib|lenvatinib|mesh-list
153752122|NCT05807776|Tislelizumab|tislelizumab|mesh-list
153752123|NCT05807776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752124|NCT05807776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153752125|NCT05807776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626773|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153752143|NCT05807542|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752144|NCT05807542|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752145|NCT05807542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752146|NCT05807542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752147|NCT05807503|Cerebrolysin|cerebrolysin|mesh-list
153752148|NCT05807503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153752149|NCT05807503|Protective Agents|protective agents|mesh-ancestor
153752150|NCT05807503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752151|NCT05807503|Nootropic Agents|nootropic agents|mesh-ancestor
153752152|NCT05807425|Polidocanol|polidocanol|mesh-list
153752153|NCT05807425|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153752154|NCT05807425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153752155|NCT05807347|Cytarabine|cytarabine|mesh-list
153752211|NCT05709509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153752212|NCT05709509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752213|NCT05709509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153752214|NCT05709509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153752234|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752235|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752236|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
153752237|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752238|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752239|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153752240|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
153752241|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153752242|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
153752243|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153752254|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
153752255|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752256|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752257|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
153752258|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153752259|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153752260|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153752261|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153752263|NCT05627947|Mitomycins|mitomycins|mesh-list
153752264|NCT05627947|Mitomycin|mitomycin|mesh-list
153752265|NCT05627947|Cyclosporins|cyclosporins|mesh-list
153752266|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752267|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752268|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752269|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
153752270|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752271|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
153752272|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752273|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
153752274|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752275|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153752276|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153752277|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752278|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
153752279|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153752280|NCT05617118|Baclofen|baclofen|mesh-list
153752281|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
153752306|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752314|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153752315|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153752316|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153752317|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752319|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752320|NCT05267873|Analgesics|analgesics|mesh-ancestor
153752321|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
153752322|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752323|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
153752324|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153752325|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
153752326|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153752327|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153752328|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752329|NCT05267873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153752330|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
153752331|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153752332|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153752333|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153752334|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153752335|NCT04962503|Afamelanotide|afamelanotide|mesh-list
153848217|NCT05093205|Estrogens|estrogens|mesh-ancestor
153752357|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153752358|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
153752359|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752360|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752361|NCT04767841|Metformin|metformin|mesh-list
153752362|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153752363|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752364|NCT04761861|Vildagliptin|vildagliptin|mesh-list
153752365|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153752366|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752367|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153752368|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
153752369|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257144|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154257145|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752370|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752371|NCT04716699|Lidocaine|lidocaine|mesh-list
153752372|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
153752373|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
153752383|NCT04685980|Morphine|morphine|mesh-list
153752384|NCT04685980|Anesthetics|anesthetics|mesh-list
153752385|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
153752386|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752387|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752388|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153752389|NCT04685980|Narcotics|narcotics|mesh-ancestor
153752390|NCT04685980|Analgesics|analgesics|mesh-ancestor
153752391|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
153752392|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752393|NCT04657692|Anesthetics|anesthetics|mesh-list
153752394|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752395|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752396|NCT04577690|Epinephrine|epinephrine|mesh-list
153752397|NCT04577690|Racepinephrine|racepinephrine|mesh-list
153752398|NCT04577690|Bupivacaine|bupivacaine|mesh-list
153752426|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153752427|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752428|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
153752429|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752430|NCT04531176|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153752431|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153752433|NCT04531176|Hormones|hormones|mesh-ancestor
153752434|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752435|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153752436|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
153752437|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153752438|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153752447|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
153752448|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153752449|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153752450|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153752451|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
153752452|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
153752453|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
153752454|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
153752455|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
153752456|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752475|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752476|NCT04075110|Montelukast|montelukast|mesh-list
153752477|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153752478|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
153752479|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153752480|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
153752481|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752482|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752483|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153752484|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153752485|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752486|NCT04055909|Nangibotide|nangibotide|mesh-list
153752487|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153752488|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
153752489|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752490|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752491|NCT03978689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153752492|NCT03978689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752493|NCT03816553|Apatinib|apatinib|mesh-list
153752494|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752495|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153752496|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752497|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752498|NCT03729245|Nivolumab|nivolumab|mesh-list
153752499|NCT03729245|Sunitinib|sunitinib|mesh-list
153752500|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752501|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752502|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154257146|NCT01169090|Incretins|incretins|mesh-ancestor
153626774|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
153752526|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153338987|NCT01029587|Eculizumab|eculizumab|mesh-list
153752527|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752528|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153752529|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752530|NCT03501381|Aldesleukin|aldesleukin|mesh-list
153752531|NCT03501381|Interleukin-2|interleukin-2|mesh-list
153752532|NCT03501381|Entinostat|entinostat|mesh-list
153752533|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752534|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153752535|NCT03501381|Analgesics|analgesics|mesh-ancestor
153752536|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
153752537|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752578|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
153752579|NCT03330028|Promethazine|promethazine|mesh-list
153752580|NCT03330028|Dexamethasone|dexamethasone|mesh-list
153752581|NCT03330028|Paclitaxel|paclitaxel|mesh-list
153752582|NCT03330028|Cisplatin|cisplatin|mesh-list
153752583|NCT03330028|Mitomycins|mitomycins|mesh-list
153752584|NCT03330028|Mitomycin|mitomycin|mesh-list
153752585|NCT03330028|Famotidine|famotidine|mesh-list
153752586|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153752587|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752588|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752589|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752590|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752591|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752592|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153752593|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
153752594|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
153752595|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752596|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752597|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153752598|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
153752599|NCT03330028|Hormones|hormones|mesh-ancestor
153752600|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752601|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153752602|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153752603|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
153752604|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153752605|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752606|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153752607|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153752652|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153752653|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
153752654|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735952|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
153735953|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735954|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735955|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153735956|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153735957|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
153848374|NCT02342249|Oseltamivir|oseltamivir|mesh-list
153752673|NCT02401035|Pantoprazole|pantoprazole|mesh-list
153752674|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153752675|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153752676|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153752686|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752687|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
153752688|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752689|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153752690|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153752691|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
153752692|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153752693|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153752694|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
153752695|NCT02060721|Macitentan|macitentan|mesh-list
153752696|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153752710|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153752711|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
153752712|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752713|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153752714|NCT01306045|Sunitinib|sunitinib|mesh-list
153752715|NCT01306045|Lapatinib|lapatinib|mesh-list
153752716|NCT01306045|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154257147|NCT01169090|Hormones|hormones|mesh-ancestor
153557455|NCT01619566|Analgesics|analgesics|mesh-ancestor
153752717|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153752718|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752719|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752720|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752721|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153752722|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153752723|NCT01306045|Growth Substances|growth substances|mesh-ancestor
153752724|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752725|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
153752726|NCT01196936|Tamoxifen|tamoxifen|mesh-list
153752727|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153752728|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
153752729|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752730|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752731|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153752732|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752733|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153752734|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153752735|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153752737|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153752738|NCT01075971|Narcotics|narcotics|mesh-ancestor
153874081|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153752739|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752740|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752749|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752751|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153752752|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
153752753|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752754|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752755|NCT00324922|Vancomycin|vancomycin|mesh-list
153752756|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153752757|NCT00324922|Trimethoprim|trimethoprim|mesh-list
153752758|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
153752759|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153752760|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752761|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153752762|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
153752780|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752781|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752782|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
153752783|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752784|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153752785|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153752786|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153752787|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752788|NCT00163748|Gemcitabine|gemcitabine|mesh-list
153752789|NCT00163748|Vinorelbine|vinorelbine|mesh-list
153752790|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752791|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
153752792|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752793|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752794|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153752795|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752796|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752797|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752798|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
153752799|NCT00193011|Docetaxel|docetaxel|mesh-list
153752800|NCT00193011|Fluorouracil|fluorouracil|mesh-list
153752801|NCT00193011|Methotrexate|methotrexate|mesh-list
153752802|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752803|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
153752804|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752805|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752806|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153752807|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
153752820|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752821|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153752822|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153752823|NCT00193089|Docetaxel|docetaxel|mesh-list
153752824|NCT00193089|Trastuzumab|trastuzumab|mesh-list
153752825|NCT00193089|Vinorelbine|vinorelbine|mesh-list
153752826|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834027|NCT04510220|Ofatumumab|ofatumumab|mesh-list
153752827|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752828|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752829|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752830|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848443|NCT04678076|Ketoprofen|ketoprofen|mesh-list
153752863|NCT00193284|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153752864|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153752865|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752866|NCT00163982|Norfloxacin|norfloxacin|mesh-list
153752867|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153752868|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752869|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153752870|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153735970|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735971|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752945|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752966|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752967|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153752969|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752970|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
153752971|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752972|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
153752973|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153752974|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
153752975|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752976|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752977|NCT04977232|Escitalopram|escitalopram|mesh-list
153874097|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
153752978|NCT04977232|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153752979|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153752980|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153752981|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752982|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752983|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
153488983|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
153752999|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153753000|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753001|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153753002|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
153753003|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753004|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753005|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753006|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753007|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
153753008|NCT00193674|Progestins|progestins|mesh-ancestor
153753009|NCT00193674|Hormones|hormones|mesh-ancestor
153753010|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753011|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753012|NCT00164450|Isoniazid|isoniazid|mesh-list
153753013|NCT00164450|Rifapentine|rifapentine|mesh-list
153753014|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
153753015|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753016|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753017|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153753041|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
153753042|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
153753069|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753070|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
153753071|NCT00176280|Hormones|hormones|mesh-ancestor
153753072|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753073|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153753074|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753075|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
153753076|NCT04723940|Doxycycline|doxycycline|mesh-list
153753077|NCT04723940|Clindamycin|clindamycin|mesh-list
153753078|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
153753079|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
153753080|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153753081|NCT04723940|Cefadroxil|cefadroxil|mesh-list
153753082|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753083|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753084|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
153753085|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153557641|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153753086|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153753087|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153753088|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753089|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626775|NCT02018991|Everolimus|everolimus|mesh-list
153753106|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753108|NCT04635007|Coagulants|coagulants|mesh-ancestor
153753109|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153753110|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
153848523|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
153753130|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753131|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
153753132|NCT00164996|Anesthetics|anesthetics|mesh-list
153753133|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753134|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753135|NCT04418557|Antibodies|antibodies|mesh-list
153753136|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
153753137|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753138|NCT04682782|Esketamine|esketamine|mesh-list
153753139|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
153753140|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753141|NCT00165035|Paclitaxel|paclitaxel|mesh-list
153753142|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153753143|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153753160|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753162|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153753163|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753164|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
153753165|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753166|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153753167|NCT00165191|Doxorubicin|doxorubicin|mesh-list
153753168|NCT00165191|Fluorouracil|fluorouracil|mesh-list
153753169|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753170|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153753171|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153753172|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153753173|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753174|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753175|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
153753176|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590265|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
153753192|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
153753193|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753194|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153753195|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
153753196|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753198|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
153753199|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
153735972|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153753200|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
153753223|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153753224|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753225|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753226|NCT00176670|Midazolam|midazolam|mesh-list
153753227|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153753228|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153753229|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753230|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753231|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153753232|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153753233|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753234|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153753235|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
153753236|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
153753237|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
153753238|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
153753239|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753240|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753241|NCT00165464|Irinotecan|irinotecan|mesh-list
153753242|NCT00165464|Docetaxel|docetaxel|mesh-list
153557775|NCT01621451|Analgesics|analgesics|mesh-ancestor
153557776|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
153753243|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753244|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153753245|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153753246|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753247|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753248|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
153753249|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
153753250|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
153753266|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753267|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153753268|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753270|NCT03978208|Naproxen|naproxen|mesh-list
153753271|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153753272|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153753273|NCT03978208|Analgesics|analgesics|mesh-ancestor
153753298|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153753299|NCT00165737|Donepezil|donepezil|mesh-list
153753300|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153753301|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753302|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753303|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
153753304|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753305|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753306|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
153753307|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153753308|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153626776|NCT02018991|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153753318|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753319|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753320|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753321|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153753322|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153753323|NCT03789916|Analgesics|analgesics|mesh-ancestor
153753324|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
153753325|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753326|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753327|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153753328|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153753329|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153848607|NCT01230892|Atenolol|atenolol|mesh-list
153753350|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
153753351|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
153753352|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753353|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753354|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753355|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
153753356|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
153753357|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153753358|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753359|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153753360|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753361|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753362|NCT00177060|Hydromorphone|hydromorphone|mesh-list
153753363|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153753364|NCT00177060|Narcotics|narcotics|mesh-ancestor
153753365|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753366|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753367|NCT00177060|Analgesics|analgesics|mesh-ancestor
153753368|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
153753369|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753370|NCT00177099|Tacrolimus|tacrolimus|mesh-list
153753371|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753372|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
153753389|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753390|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
153753391|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153753392|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153753393|NCT03413800|Growth Substances|growth substances|mesh-ancestor
153753394|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
153753395|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153753396|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
153753397|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753399|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153753422|NCT00166127|Protective Agents|protective agents|mesh-ancestor
153753423|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753424|NCT00194649|Miglustat|miglustat|mesh-list
153753425|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753426|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753427|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153753428|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153753429|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
153753450|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753451|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153753452|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753453|NCT05311774|Tramadol|tramadol|mesh-list
153753454|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153753455|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153753456|NCT05311774|Narcotics|narcotics|mesh-ancestor
153753457|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753458|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753459|NCT05311774|Analgesics|analgesics|mesh-ancestor
153753460|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
153753461|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753462|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153753463|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153753464|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153753465|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753466|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753538|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735975|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
153753539|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153753540|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753541|NCT00166595|Risperidone|risperidone|mesh-list
153753542|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153753543|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
153753544|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753545|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753546|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753547|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153753548|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153753549|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753550|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753575|NCT05124067|BB 1101|bb 1101|mesh-list
153753576|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753577|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
153753578|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
153753579|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753580|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753581|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753582|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
153753583|NCT05124067|Hormones|hormones|mesh-ancestor
153753584|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753585|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153753586|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753587|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
153753588|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753600|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
153753601|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
153414874|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
153753602|NCT05124067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153753603|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153753604|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
153753606|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753607|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753608|NCT02277184|Cisplatin|cisplatin|mesh-list
153753609|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753610|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
153753611|NCT00166829|Sirolimus|sirolimus|mesh-list
153753612|NCT00166829|Tacrolimus|tacrolimus|mesh-list
153753613|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753614|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
153753615|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848687|NCT01209520|Pemetrexed|pemetrexed|mesh-list
153374206|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
153753631|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153753633|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753634|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753635|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153753636|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753637|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753638|NCT00194961|Hormones|hormones|mesh-list
153753639|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753640|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753641|NCT00177372|Misoprostol|misoprostol|mesh-list
153753642|NCT00177372|Mifepristone|mifepristone|mesh-list
153753643|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153753644|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
153753645|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153753646|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753647|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153753648|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753649|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
153753650|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153753651|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153753657|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
153753658|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753659|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
153753660|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153753661|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153753662|NCT04819399|Catumaxomab|catumaxomab|mesh-list
153753663|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753664|NCT00177411|Hormones|hormones|mesh-list
153753665|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
153753666|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
153753667|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753668|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753669|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153753670|NCT00195078|Gefitinib|gefitinib|mesh-list
153753671|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753672|NCT00195078|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153753673|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153753674|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874170|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153753675|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753676|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
153753677|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
153753678|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153388894|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
153753706|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153753707|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153753708|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153753709|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753711|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753712|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753713|NCT00177567|Lamotrigine|lamotrigine|mesh-list
153753714|NCT00177567|Valproic Acid|valproic acid|mesh-list
153753716|NCT00177567|Risperidone|risperidone|mesh-list
153753717|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
153683243|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683267|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683268|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683270|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683271|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153683272|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683273|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683274|NCT00132106|Phentolamine|phentolamine|mesh-list
153683275|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153683276|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153414906|NCT02608177|Linagliptin|linagliptin|mesh-list
153683277|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
153683278|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683279|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683280|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683281|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153683282|NCT00080340|Gefitinib|gefitinib|mesh-list
153683283|NCT00080340|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153558225|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153683284|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153683285|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683286|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683299|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683300|NCT00132379|Immunoconjugates|immunoconjugates|mesh-ancestor
153683301|NCT00132379|Immunologic Factors|immunologic factors|mesh-ancestor
153683302|NCT00132379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683303|NCT00132418|Etanercept|etanercept|mesh-list
153848811|NCT04664894|Ribavirin|ribavirin|mesh-list
153683325|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153683326|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683327|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683328|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153683329|NCT00132613|Bleomycin|bleomycin|mesh-list
153683330|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153683331|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683332|NCT00132652|Lamivudine|lamivudine|mesh-list
153683333|NCT00132652|Telbivudine|telbivudine|mesh-list
153683334|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153683335|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153683336|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683337|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683338|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
153683339|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683340|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153683341|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153683342|NCT00046748|Omalizumab|omalizumab|mesh-list
153683343|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153683344|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153683345|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
153683346|NCT00132886|Tolvaptan|tolvaptan|mesh-list
153683347|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153683348|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520287|NCT06245564|Anesthetics|anesthetics|mesh-ancestor
153683349|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
153683350|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683362|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683364|NCT00133003|Abciximab|abciximab|mesh-list
153683365|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
153683366|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153683367|NCT00046787|Lurtotecan|lurtotecan|mesh-list
153683368|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683369|NCT00133042|Omalizumab|omalizumab|mesh-list
153683403|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153683404|NCT00046826|Growth Substances|growth substances|mesh-ancestor
153683405|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
153683406|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153683407|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
153683408|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153683409|NCT00133237|Sirolimus|sirolimus|mesh-list
153683410|NCT00133237|Paclitaxel|paclitaxel|mesh-list
153683411|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153683412|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683452|NCT00133315|Analgesics|analgesics|mesh-ancestor
153683453|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
153683454|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683455|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683456|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683457|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
153683458|NCT00080496|Imipenem|imipenem|mesh-list
153683459|NCT00080496|Tigecycline|tigecycline|mesh-list
153683460|NCT00080496|Cilastatin|cilastatin|mesh-list
153683461|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153683462|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683475|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683476|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683477|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153683478|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
153683479|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
153683480|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153683481|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683482|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683483|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154263467|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153683485|NCT00133393|Protective Agents|protective agents|mesh-ancestor
153683486|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683487|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
153683488|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153683489|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
153683490|NCT00046904|Etanercept|etanercept|mesh-list
153683491|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153683492|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153683493|NCT00046904|Analgesics|analgesics|mesh-ancestor
153683494|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
153683495|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683496|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683497|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683498|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683499|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683500|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683501|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
153683502|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153683503|NCT00403897|Laxatives|laxatives|mesh-ancestor
153683504|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683505|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153683506|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153683507|NCT00046943|Atrasentan|atrasentan|mesh-list
153683508|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683509|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153683510|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153683511|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735977|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153683512|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153683537|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683539|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
153683540|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683541|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153683542|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683543|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683544|NCT00133627|Ketotifen|ketotifen|mesh-list
153683545|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
153683546|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
153683547|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153683548|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
153874252|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153683549|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
153683550|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683551|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683552|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683553|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153683554|NCT00133744|Folic Acid|folic acid|mesh-list
153683555|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
153683556|NCT00133744|Vitamins|vitamins|mesh-ancestor
153683557|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
153683558|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683559|NCT00133744|Hematinics|hematinics|mesh-ancestor
153683560|NCT00080808|Phentolamine|phentolamine|mesh-list
153683561|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
153683562|NCT00080808|Alprostadil|alprostadil|mesh-list
153683563|NCT00080808|Papaverine|papaverine|mesh-list
153683564|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683565|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
153683566|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153683567|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153683568|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683569|NCT00080808|Urological Agents|urological agents|mesh-ancestor
153683570|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153683571|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153683572|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
153683573|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683574|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683575|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153683576|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153683577|NCT00047099|Tamoxifen|tamoxifen|mesh-list
153683578|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
153683579|NCT00047099|Docetaxel|docetaxel|mesh-list
153683581|NCT00047099|Epirubicin|epirubicin|mesh-list
153683582|NCT00047099|Goserelin|goserelin|mesh-list
153558516|NCT01627106|Amiodarone|amiodarone|mesh-list
153683583|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683584|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
153683617|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735978|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
153735979|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153683618|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153683619|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153683620|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
153683621|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
153683622|NCT00133822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153683623|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153683624|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153683625|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
153683626|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153683627|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153683628|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683629|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
153683630|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683631|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683633|NCT00134095|Tegafur|tegafur|mesh-list
153683634|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153683635|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683636|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683637|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683638|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683639|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153683640|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
153683641|NCT00047138|Dactinomycin|dactinomycin|mesh-list
153683642|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
153683666|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683667|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153683668|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153683670|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
153683671|NCT00080847|Rituximab|rituximab|mesh-list
153683672|NCT00080847|Doxorubicin|doxorubicin|mesh-list
153683673|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153683674|NCT00080847|Vincristine|vincristine|mesh-list
153683675|NCT00080847|Oblimersen|oblimersen|mesh-list
153683676|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683677|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
153683678|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683679|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683680|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153683681|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
153683682|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683683|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683684|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153683685|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153683686|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153683772|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683773|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683774|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683775|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
153683776|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
153683777|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153683778|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153683779|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153683780|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683781|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
153683782|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683783|NCT00047255|Carboplatin|carboplatin|mesh-list
153683784|NCT00047255|Docetaxel|docetaxel|mesh-list
153683785|NCT00047255|Trastuzumab|trastuzumab|mesh-list
153683786|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683787|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683788|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683789|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683809|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683810|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153683811|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153683812|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683813|NCT00047294|Thalidomide|thalidomide|mesh-list
153683814|NCT00047294|Celecoxib|celecoxib|mesh-list
153374366|NCT01871441|Tacrolimus|tacrolimus|mesh-list
153683834|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153683835|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683836|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153683837|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153683838|NCT00047294|Growth Substances|growth substances|mesh-ancestor
153683839|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
153683840|NCT00042822|Romidepsin|romidepsin|mesh-list
153683841|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153683842|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683843|NCT00042822|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153683844|NCT00042822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683845|NCT00042822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683865|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
153683866|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683867|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683868|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153683869|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153683870|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683871|NCT00081042|Paclitaxel|paclitaxel|mesh-list
153683872|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153683873|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153683874|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683875|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683876|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683877|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683878|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683879|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153683880|NCT00047333|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153683881|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153683883|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683884|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683886|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153683887|NCT00134875|Naloxone|naloxone|mesh-list
153683888|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153683926|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
153683928|NCT00042861|Protective Agents|protective agents|mesh-ancestor
153683929|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
153683930|NCT00042861|Vitamins|vitamins|mesh-ancestor
153683931|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
153683932|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153683933|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683934|NCT00134992|Prednisolone|prednisolone|mesh-list
153683935|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153683936|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
153683937|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153683938|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
153683939|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153683940|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
153683941|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683942|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
153683943|NCT00134992|Hormones|hormones|mesh-ancestor
153683944|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683945|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683946|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153683996|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683997|NCT00145210|Atenolol|atenolol|mesh-list
153683998|NCT00145210|Nebivolol|nebivolol|mesh-list
153683999|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153684000|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
153684001|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153684002|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153684003|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153684004|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
153684005|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684006|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684007|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684008|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153684009|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
153684010|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
154263469|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263470|NCT05461794|Docetaxel|docetaxel|mesh-list
154263471|NCT05461794|Irinotecan|irinotecan|mesh-list
153684011|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684012|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153684013|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153684014|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153684015|NCT00081276|Cisplatin|cisplatin|mesh-list
153684016|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684017|NCT00145405|Octreotide|octreotide|mesh-list
153684018|NCT00145405|Lanreotide|lanreotide|mesh-list
153684019|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153684068|NCT00145561|Ritonavir|ritonavir|mesh-list
153684069|NCT00145561|Saquinavir|saquinavir|mesh-list
153684070|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153684071|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153684072|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
153684073|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684113|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684114|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684115|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
153684116|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153684117|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
153684118|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684119|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684120|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
153684121|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684122|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
153684123|NCT00081471|Hematinics|hematinics|mesh-ancestor
153684124|NCT00047645|Interferons|interferons|mesh-list
153684125|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
153684126|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684127|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
153684128|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684129|NCT00146146|Letrozole|letrozole|mesh-list
153684130|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
153684131|NCT00146146|Dutasteride|dutasteride|mesh-list
153684132|NCT00146146|Testosterone|testosterone|mesh-list
153684133|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
153684134|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
153684135|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153684136|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684137|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153684138|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153389194|NCT00002397|Lamivudine|lamivudine|mesh-list
153422866|NCT02221284|Incretins|incretins|mesh-ancestor
153684182|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684184|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153684185|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
153684186|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684187|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153684188|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153684189|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684190|NCT00047723|Minocycline|minocycline|mesh-list
153684191|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153849044|NCT06086106|Analgesics|analgesics|mesh-list
153684229|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684230|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684231|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
153684232|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684233|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684234|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
153684235|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415038|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153684236|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153684237|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684238|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
153684239|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153684240|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153684241|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153684242|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684243|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684244|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684245|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
153684246|NCT00047762|Bevacizumab|bevacizumab|mesh-list
153684247|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153684248|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263472|NCT05461794|Tislelizumab|tislelizumab|mesh-list
153684249|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684250|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153684251|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153684305|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153684306|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684344|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153684346|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
153684347|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153684348|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
153684349|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
153684350|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153684351|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153684352|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153684353|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153684354|NCT00147121|Rituximab|rituximab|mesh-list
153684355|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153684356|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684357|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
153684358|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684412|NCT00147355|Narcotics|narcotics|mesh-ancestor
153684413|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341100|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
153684414|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
153684415|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
153684416|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
153684417|NCT00048152|Cyclosporine|cyclosporine|mesh-list
153684501|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684536|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153684597|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684598|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684599|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153684600|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
153684601|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684602|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684603|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684604|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684605|NCT00148291|Docetaxel|docetaxel|mesh-list
153684606|NCT00148291|Vinorelbine|vinorelbine|mesh-list
153684607|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684608|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
153684609|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
153684610|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
153684611|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684639|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153684640|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153684641|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153684642|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
153684643|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684644|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684645|NCT00148408|Montelukast|montelukast|mesh-list
153684646|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153684647|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
153684648|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153684649|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
153684650|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684651|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684652|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153684653|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153684676|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684677|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153684678|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153684679|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153684680|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415070|NCT04741165|Bevacizumab|bevacizumab|mesh-list
153684681|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153684682|NCT00148564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153684683|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153684684|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153684685|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684686|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684687|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
153684688|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153684689|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153558950|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558952|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
153684690|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
153389317|NCT00002223|Ritonavir|ritonavir|mesh-list
153684790|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
153684791|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153684792|NCT00048776|Protective Agents|protective agents|mesh-ancestor
153684793|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153684794|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153684795|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684796|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
153684797|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153684798|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684799|NCT00048854|Sertraline|sertraline|mesh-list
153684816|NCT00149539|Buprenorphine|buprenorphine|mesh-list
153684817|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153684818|NCT00149539|Naloxone|naloxone|mesh-list
153684819|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153684820|NCT00149539|Narcotics|narcotics|mesh-ancestor
153684821|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684822|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684823|NCT00149539|Analgesics|analgesics|mesh-ancestor
153684824|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
153684825|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684826|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153684827|NCT00149578|Leucovorin|leucovorin|mesh-list
153684828|NCT00149578|Gemcitabine|gemcitabine|mesh-list
153684829|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
153684830|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684831|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
153684832|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684833|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684834|NCT00149578|Antidotes|antidotes|mesh-ancestor
153684835|NCT00149578|Protective Agents|protective agents|mesh-ancestor
153684836|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684837|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
153684838|NCT00149578|Vitamins|vitamins|mesh-ancestor
153684839|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
153684840|NCT00149617|Buspirone|buspirone|mesh-list
153684841|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153684842|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153684843|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684844|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684845|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153684846|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153684847|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
153684848|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684863|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684864|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684865|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153684866|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153684867|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684868|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684869|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684871|NCT00149851|Tegaserod|tegaserod|mesh-list
153684904|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684905|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684906|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153684907|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
153684908|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684909|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684920|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
153849210|NCT06047834|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153684947|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153684948|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684950|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684951|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684952|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153684953|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
153684954|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684955|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684956|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684957|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684958|NCT00150046|Everolimus|everolimus|mesh-list
153684959|NCT00150046|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153684960|NCT00150046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153684961|NCT00150046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684962|NCT00150046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684963|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684964|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
153684965|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684966|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684967|NCT00150085|Cyclosporine|cyclosporine|mesh-list
153684968|NCT00150085|Cyclosporins|cyclosporins|mesh-list
153685018|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685019|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685089|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153685090|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153685091|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153685092|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685093|NCT00082446|Vaccines|vaccines|mesh-list
153685094|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
153685095|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685108|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153685109|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153685110|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153685111|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153685112|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685113|NCT00150670|Cisplatin|cisplatin|mesh-list
153685114|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685115|NCT00150748|Levetiracetam|levetiracetam|mesh-list
153685116|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
153685117|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
153685118|NCT00150787|Levetiracetam|levetiracetam|mesh-list
153685119|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
153685120|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
153685121|NCT00150826|Quinapril|quinapril|mesh-list
153685122|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153685123|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
153685124|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685125|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685126|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153685127|NCT00150865|Ropivacaine|ropivacaine|mesh-list
153685128|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
153685129|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
153685130|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685131|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685132|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
153685158|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153685159|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
153685160|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153685194|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685195|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153685196|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
153685197|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
153685198|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685199|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153685200|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153685201|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153685202|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
153685203|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685296|NCT00049790|Carboplatin|carboplatin|mesh-list
153685297|NCT00049790|Angiostatins|angiostatins|mesh-list
153685298|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153685299|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685300|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
153685301|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
153685302|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
153685303|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685348|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153685349|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153685350|NCT00406042|Protective Agents|protective agents|mesh-ancestor
153685351|NCT00082563|Azithromycin|azithromycin|mesh-list
153685352|NCT00082563|Chloroquine|chloroquine|mesh-list
153685467|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685469|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685470|NCT00049946|Risperidone|risperidone|mesh-list
153685471|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153685472|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
153685473|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685474|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685475|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685476|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153685477|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685478|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685491|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341572|NCT03852797|Analgesics|analgesics|mesh-ancestor
153685492|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685493|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
153685494|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153849319|NCT05756673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685526|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685528|NCT00152308|Ethanol|ethanol|mesh-list
153685529|NCT00152308|Temsirolimus|temsirolimus|mesh-list
153685530|NCT00152308|MTOR Inhibitors|mtor inhibitors|mesh-list
153685531|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153685532|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685533|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153685534|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685535|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
153685536|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685537|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
153685538|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685539|NCT00152308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849338|NCT05647889|Lidocaine|lidocaine|mesh-list
153685658|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153685691|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685692|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153685693|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
153685694|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685695|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153685696|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
153685697|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
153685698|NCT00152893|Vitamins|vitamins|mesh-ancestor
153685699|NCT00152932|Dorzolamide|dorzolamide|mesh-list
153685700|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153685701|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153685702|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685713|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685715|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153685716|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153685717|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153685718|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153685719|NCT00083031|Growth Substances|growth substances|mesh-ancestor
153685720|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
153685721|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153415117|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
153685722|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
153685723|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153685724|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685725|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
153685726|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
153685727|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685728|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153685729|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153685730|NCT00050336|Lonafarnib|lonafarnib|mesh-list
153685756|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153685757|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685758|NCT00083070|Temozolomide|temozolomide|mesh-list
153685759|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685760|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
153685761|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685762|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685788|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685789|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
153685790|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685791|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
153685793|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153685794|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685795|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153685796|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153685797|NCT00153244|Lamotrigine|lamotrigine|mesh-list
153685798|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
153685799|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153685800|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685851|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685852|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153685853|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153685854|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153685856|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
153685857|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685858|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
153685859|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685860|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
153685861|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685862|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685892|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389587|NCT00002517|Etoposide|etoposide|mesh-list
153389590|NCT00002517|Idarubicin|idarubicin|mesh-list
153685987|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685988|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685989|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685990|NCT00043875|Lamotrigine|lamotrigine|mesh-list
153685991|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
153685992|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153685993|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685994|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191179|NCT05941741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685995|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153685996|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685997|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153685998|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685999|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686000|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686001|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153686003|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153686004|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
153686046|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686047|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686048|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153686049|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686050|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153686051|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153874407|NCT04551248|Vaccines|vaccines|mesh-list
153341750|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153686052|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735992|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686053|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686054|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153686055|NCT04705987|Colchicine|colchicine|mesh-list
153686056|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
153686057|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686058|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686059|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686060|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686061|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686062|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686063|NCT04705909|Pitavastatin|pitavastatin|mesh-list
153686064|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153686065|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153686066|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153686067|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
153686068|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686069|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686070|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153686071|NCT00083304|Efaproxiral|efaproxiral|mesh-list
153686072|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
153686090|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686092|NCT00406432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153686093|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153686094|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686128|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686145|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153686146|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686147|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686148|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
153686149|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
153686150|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686151|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686259|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686260|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153686261|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153686262|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153686263|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153686265|NCT00083538|Dexamethasone|dexamethasone|mesh-list
153686266|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
153686267|NCT00083538|Etoposide|etoposide|mesh-list
153686268|NCT00083538|Doxorubicin|doxorubicin|mesh-list
153686269|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153686270|NCT00083538|Cisplatin|cisplatin|mesh-list
153686271|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686272|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
153415142|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
153686273|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686274|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686275|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153686276|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
153686277|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686278|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686279|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153686352|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
153686353|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686355|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153686356|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153686357|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686358|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686392|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686393|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686394|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686395|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686396|NCT00083694|Growth Substances|growth substances|mesh-ancestor
153686397|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686422|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153686423|NCT00157105|Factor VIII|factor viii|mesh-list
153686424|NCT00157105|Coagulants|coagulants|mesh-ancestor
153783281|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153686425|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153686426|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
153686427|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686467|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686468|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153686469|NCT00398099|Ertapenem|ertapenem|mesh-list
153686470|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686471|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686472|NCT00406978|Thalidomide|thalidomide|mesh-list
153686473|NCT00406978|Prednisone|prednisone|mesh-list
153686474|NCT00406978|Melphalan|melphalan|mesh-list
153686475|NCT00406978|Defibrotide|defibrotide|mesh-list
153686476|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341978|NCT00002896|Vitamins|vitamins|mesh-ancestor
153686477|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
153686478|NCT00406978|Hormones|hormones|mesh-ancestor
153686479|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153686480|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686481|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153686482|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686483|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153686484|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
153686509|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686510|NCT00051506|Carboplatin|carboplatin|mesh-list
153686511|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686512|NCT00157729|Pyridoxal|pyridoxal|mesh-list
153686513|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
153686545|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686547|NCT00051584|Doxorubicin|doxorubicin|mesh-list
153686548|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
153686549|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153686550|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
153686551|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686552|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686553|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153342049|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
153686554|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153686555|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153686556|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686557|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
153686558|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263474|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
154263475|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686567|NCT00158158|Nicotine|nicotine|mesh-list
153686568|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153523498|NCT03762473|Tacrolimus|tacrolimus|mesh-list
153686569|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
153686570|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686571|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389716|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
153686627|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
153686628|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153686655|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686656|NCT00158821|Tenofovir|tenofovir|mesh-list
153686657|NCT00158821|Lamivudine|lamivudine|mesh-list
153686658|NCT00158821|Efavirenz|efavirenz|mesh-list
153686659|NCT00158821|Stavudine|stavudine|mesh-list
153686660|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
153686661|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686662|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153686663|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153686664|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686665|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686666|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153686667|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153686668|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153686669|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153686670|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153686671|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153389745|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
153389746|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389747|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
153389748|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686732|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686733|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
153686734|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
153686735|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686736|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686737|NCT00051974|Bortezomib|bortezomib|mesh-list
153686738|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686739|NCT00159211|Pioglitazone|pioglitazone|mesh-list
153686740|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153686741|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686742|NCT05567718|Anesthetics|anesthetics|mesh-list
153686743|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686780|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686781|NCT00159679|Pregabalin|pregabalin|mesh-list
153686830|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686832|NCT00052169|Gefitinib|gefitinib|mesh-list
153686833|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686834|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686847|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686848|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686849|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686850|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
153686851|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
153686852|NCT00407017|Ketorolac|ketorolac|mesh-list
153686853|NCT00407017|Nepafenac|nepafenac|mesh-list
153686854|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
153686855|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686856|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686857|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153849599|NCT04621526|Ketamine|ketamine|mesh-list
153686877|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686878|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686879|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686880|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686881|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686882|NCT00052286|Modafinil|modafinil|mesh-list
153686883|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153686884|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686885|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153686886|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153686887|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153686888|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686889|NCT00160186|Pancreatin|pancreatin|mesh-list
153686890|NCT00160186|Pancrelipase|pancrelipase|mesh-list
153686891|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153686892|NCT05567484|Itraconazole|itraconazole|mesh-list
153686893|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
153686894|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686895|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153686896|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153686897|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686933|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153686934|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
153686935|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
153686936|NCT00052403|Mitogens|mitogens|mesh-list
153686937|NCT00052403|Immunomodulating Agents|immunomodulating agents|mesh-list
153686946|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686947|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153686948|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686950|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153686951|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153686952|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
153686953|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
153686954|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686955|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686979|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342243|NCT04781270|Bevacizumab|bevacizumab|mesh-list
153686980|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153686981|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
153686982|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735994|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153686983|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686984|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153686985|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
153686986|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686987|NCT00160927|Nitroprusside|nitroprusside|mesh-list
153686988|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153686989|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
153686990|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153686991|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686992|NCT00160966|Cyclosporine|cyclosporine|mesh-list
153686993|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
153686994|NCT00160966|Everolimus|everolimus|mesh-list
153686995|NCT00160966|Tacrolimus|tacrolimus|mesh-list
153686996|NCT00160966|Cyclosporins|cyclosporins|mesh-list
153686997|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686998|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
153686999|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687000|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153687001|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687002|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687025|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
153687026|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
153687027|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
153687028|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687029|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153389789|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
153687051|NCT00161200|Pantoprazole|pantoprazole|mesh-list
153687052|NCT00161200|Ranitidine|ranitidine|mesh-list
153687053|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153687054|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154191180|NCT05941741|Antimetabolites|antimetabolites|mesh-ancestor
153342307|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687055|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687056|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153687057|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687091|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
153687092|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
153687093|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
153687094|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687095|NCT00044616|Fluoxetine|fluoxetine|mesh-list
153687096|NCT00044616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153687104|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
153687105|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153687106|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153687107|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153687108|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559756|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
153687109|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153687110|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
153687111|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342308|NCT00002950|Topotecan|topotecan|mesh-list
153687112|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153687113|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153687114|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153687115|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153687116|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687118|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
153687119|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687120|NCT00044694|Exenatide|exenatide|mesh-list
153687121|NCT00044694|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153687122|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153687123|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687124|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153687125|NCT00044694|Incretins|incretins|mesh-ancestor
153687126|NCT00044694|Hormones|hormones|mesh-ancestor
153687159|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
153687160|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687161|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687162|NCT00044733|Immunotoxins|immunotoxins|mesh-ancestor
153687163|NCT00044733|Immunoconjugates|immunoconjugates|mesh-ancestor
153687197|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153687198|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153687199|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153687200|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
153687201|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687251|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153687252|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153687253|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687254|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687255|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153687256|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153687257|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687258|NCT00162409|Folic Acid|folic acid|mesh-list
153687259|NCT00162409|Hematinics|hematinics|mesh-ancestor
153687260|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
153687261|NCT00162409|Vitamins|vitamins|mesh-ancestor
153687262|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
153687263|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687264|NCT00053144|Cytarabine|cytarabine|mesh-list
153687265|NCT00053144|Irinotecan|irinotecan|mesh-list
153389827|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
153687334|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153687335|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153687336|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153687337|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153687338|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
153687339|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687340|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153687341|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153687342|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153687343|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153687344|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687345|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687346|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819316|NCT02351063|Diuretics|diuretics|mesh-list
153687347|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153687348|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
153687349|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153687350|NCT00162721|Doxorubicin|doxorubicin|mesh-list
153687351|NCT00162721|Ifosfamide|ifosfamide|mesh-list
153687352|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687353|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153687354|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153687355|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687356|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687357|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687358|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153687359|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
153687360|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
153687361|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687433|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153559845|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687434|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153687435|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687436|NCT00163267|Clopidogrel|clopidogrel|mesh-list
153687437|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153389869|NCT00002565|Analgesics|analgesics|mesh-ancestor
153687467|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153687469|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
153687470|NCT00163423|Hormones|hormones|mesh-ancestor
153687471|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687472|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687473|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153687475|NCT04731038|Carboplatin|carboplatin|mesh-list
153687493|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687494|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687495|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153687496|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153874512|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153687497|NCT00053300|Growth Substances|growth substances|mesh-ancestor
153687498|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
153687524|NCT00053378|Calcium|calcium|mesh-list
153687525|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153687526|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687527|NCT02970383|Narcotics|narcotics|mesh-list
153687528|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153687529|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687530|NCT02970383|Analgesics|analgesics|mesh-ancestor
153687531|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
153687555|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153687556|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687557|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153687558|NCT00164047|Analgesics|analgesics|mesh-ancestor
153687559|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
153687560|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687561|NCT00164086|Atorvastatin|atorvastatin|mesh-list
153687562|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153687563|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153687564|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
153687565|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687566|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153687567|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153687568|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687608|NCT00164359|Artesunate|artesunate|mesh-list
153687609|NCT00164359|Amodiaquine|amodiaquine|mesh-list
153687610|NCT00164359|Dapsone|dapsone|mesh-list
153687611|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
153687612|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
153687613|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153687614|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153687615|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687616|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524538|NCT01464125|Azithromycin|azithromycin|mesh-list
153687617|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
153687618|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
153687619|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153687620|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
153687621|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153687622|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687623|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687624|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
153687625|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687627|NCT00053612|Vitamins|vitamins|mesh-ancestor
153687669|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153687671|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687672|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342465|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
153342466|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
153342471|NCT04776590|Tislelizumab|tislelizumab|mesh-list
153687673|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687674|NCT00164788|Esomeprazole|esomeprazole|mesh-list
153687675|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153687676|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687677|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153687678|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687679|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687680|NCT00053768|Prednisone|prednisone|mesh-list
153687681|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
153687682|NCT00053768|Doxorubicin|doxorubicin|mesh-list
153374606|NCT04766463|Morphine|morphine|mesh-list
153559942|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
153687683|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153687684|NCT00053768|Etoposide|etoposide|mesh-list
153687685|NCT00053768|Vincristine|vincristine|mesh-list
153687686|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687687|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
153687688|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687689|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687690|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153687691|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
153910745|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153687692|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687693|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687694|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153687695|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153687696|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153687743|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
153687744|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
153687745|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
153687746|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153687747|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153687748|NCT00053807|Interferons|interferons|mesh-list
153687749|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
153687750|NCT00053807|Aldesleukin|aldesleukin|mesh-list
153687751|NCT00053807|Fluorouracil|fluorouracil|mesh-list
153687752|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
153687753|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687754|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153687755|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687756|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687757|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
153687758|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687759|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
153687760|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687761|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388077|NCT00000921|Prednisone|prednisone|mesh-list
153687762|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153687763|NCT00165178|Leucovorin|leucovorin|mesh-list
153687772|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
153687773|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153687775|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
153687776|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687777|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423487|NCT03468920|Acetaminophen|acetaminophen|mesh-list
153687797|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
153687798|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687799|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153687800|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
153687801|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342604|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
153687802|NCT00165178|Antidotes|antidotes|mesh-ancestor
153687803|NCT00165178|Protective Agents|protective agents|mesh-ancestor
153687804|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
153687806|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
153687807|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153687808|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
153687809|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
153687810|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
153687811|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153687812|NCT00165217|Thalidomide|thalidomide|mesh-list
153687813|NCT00165217|Capecitabine|capecitabine|mesh-list
153687814|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153687815|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
153687816|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687817|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687818|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687819|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
153687820|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687821|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
153687822|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687823|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687824|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153687825|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153687826|NCT00165217|Growth Substances|growth substances|mesh-ancestor
153687827|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
153687828|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
153389989|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560067|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
153560068|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
153687858|NCT00165451|Etoposide|etoposide|mesh-list
153687859|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687860|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
153687861|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687862|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687863|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153687864|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
153687865|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687866|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687867|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153687868|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153687869|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153687870|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687871|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687872|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153687873|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153687874|NCT00165451|Analgesics|analgesics|mesh-ancestor
153423505|NCT03256136|Carboplatin|carboplatin|mesh-list
153687875|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
153687876|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687877|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153687878|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153687879|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153687880|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
153687881|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687882|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687883|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153388221|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
153342712|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849817|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
153687993|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153687994|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687995|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687996|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
153687997|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687998|NCT00166465|Antidotes|antidotes|mesh-ancestor
153687999|NCT00166465|Protective Agents|protective agents|mesh-ancestor
153688000|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
153688001|NCT00166465|Vitamins|vitamins|mesh-ancestor
153688002|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
153688003|NCT00166621|Buspirone|buspirone|mesh-list
153688004|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153688005|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153688006|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153688007|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688008|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153688009|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153688010|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
153688011|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688012|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688041|NCT00054392|Gemcitabine|gemcitabine|mesh-list
153688042|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153688079|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688080|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688081|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688115|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
153688116|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688117|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688118|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688119|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153688120|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153688121|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153688122|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153688123|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153688138|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153688139|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688140|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688141|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688142|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
153688169|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
153688170|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688171|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153688172|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153560169|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688173|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153688174|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153688175|NCT00054626|Gemcitabine|gemcitabine|mesh-list
153688176|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388361|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
153688177|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688178|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
153688179|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688180|NCT00167713|Ibuprofen|ibuprofen|mesh-list
153688181|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153688182|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153688183|NCT00167713|Analgesics|analgesics|mesh-ancestor
153688184|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
153688185|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688201|NCT00045591|Analgesics|analgesics|mesh-ancestor
153688202|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
153688203|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688204|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688205|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688206|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342855|NCT00058370|Lomustine|lomustine|mesh-list
153688230|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688231|NCT00167986|Vancomycin|vancomycin|mesh-list
153688232|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153688233|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688234|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
153688235|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153688236|NCT00168025|Antibodies|antibodies|mesh-list
153688237|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
153688238|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688239|NCT00168181|Pilocarpine|pilocarpine|mesh-list
153688240|NCT00168181|Miotics|miotics|mesh-ancestor
153688241|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
153688242|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688243|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688244|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153688245|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153688260|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342894|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153342932|NCT00067028|Idarubicin|idarubicin|mesh-list
153688262|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153688263|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688264|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688265|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
153688266|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688267|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688268|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153688269|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
153688270|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688271|NCT00407407|Carboplatin|carboplatin|mesh-list
153688272|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153688273|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849934|NCT03061474|Vitamins|vitamins|mesh-ancestor
153910746|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
153688296|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153688297|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
153688298|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688299|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688300|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688301|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153688302|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153688314|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153688315|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153688316|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153688317|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153688319|NCT00168610|Vitamins|vitamins|mesh-ancestor
153688320|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
153688321|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688322|NCT04731948|Vitamins|vitamins|mesh-list
153688323|NCT04731948|Folic Acid|folic acid|mesh-list
153688324|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
153688325|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
153688326|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
153688327|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
153688328|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688329|NCT04731948|Hematinics|hematinics|mesh-ancestor
153688330|NCT00168649|Vitamin A|vitamin a|mesh-list
153688331|NCT00168649|Vitamins|vitamins|mesh-ancestor
153688332|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
153342934|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
153688353|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153688354|NCT00168766|Protective Agents|protective agents|mesh-ancestor
153688355|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
153688356|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153688358|NCT00168883|Vinorelbine|vinorelbine|mesh-list
153688359|NCT00168883|Carboplatin|carboplatin|mesh-list
153688360|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153688361|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688362|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688363|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688364|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688365|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688366|NCT04731909|Cisplatin|cisplatin|mesh-list
153688367|NCT04731909|Carboplatin|carboplatin|mesh-list
153688368|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688379|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153688380|NCT00054938|Analgesics|analgesics|mesh-ancestor
153688381|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
153819438|NCT01508897|Hormones|hormones|mesh-ancestor
153388862|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
153688382|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688383|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688384|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688385|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153688386|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153688387|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688388|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153688389|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153688390|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688391|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
153343074|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343079|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
153688392|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153688393|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
153688394|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153688395|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153688396|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153688397|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
153688398|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153688424|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688425|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688426|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688427|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153688428|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153688429|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153688430|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153688431|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
153688433|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
153688448|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688449|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688450|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688451|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688452|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
153688453|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688454|NCT00169156|Prednisone|prednisone|mesh-list
153688455|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
153688456|NCT00169156|Rituximab|rituximab|mesh-list
153688457|NCT00169156|Doxorubicin|doxorubicin|mesh-list
153688458|NCT00169156|Vincristine|vincristine|mesh-list
153688459|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688460|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
153688461|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688462|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688480|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688481|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688482|NCT00169195|Rituximab|rituximab|mesh-list
153688484|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
153688485|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688486|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343134|NCT00002812|Hormones|hormones|mesh-ancestor
153688487|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
153688488|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688489|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688490|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688491|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
153688492|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688493|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153688494|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
153688495|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263477|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688496|NCT00169468|Rituximab|rituximab|mesh-list
153688513|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
153688514|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153688515|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153688516|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153688517|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153688518|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
153343145|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
153688519|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688520|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688522|NCT00398372|Epratuzumab|epratuzumab|mesh-list
153688523|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688524|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688525|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
153688526|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688527|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153525449|NCT05939674|Flumazenil|flumazenil|mesh-list
153688528|NCT00169585|Levofloxacin|levofloxacin|mesh-list
153688529|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153688530|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688531|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153688532|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153688533|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153688534|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388961|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688551|NCT00407680|Valsartan|valsartan|mesh-list
153688552|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153688553|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153688554|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153688568|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688569|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153688570|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688571|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
153343197|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153688572|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688573|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
153688574|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688576|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688577|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
153688578|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688579|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688580|NCT00170209|Rifampin|rifampin|mesh-list
153688581|NCT00170209|Isoniazid|isoniazid|mesh-list
153688582|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153688583|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
153343206|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688584|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153688585|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688586|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
153688587|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153688588|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688589|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688590|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153688591|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153688592|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153688593|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153688594|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153688595|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153688596|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153688597|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153688598|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
153688599|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153688601|NCT02964091|Ledipasvir|ledipasvir|mesh-list
153688602|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
153688604|NCT00170404|Vitamins|vitamins|mesh-list
153688605|NCT00170404|Folic Acid|folic acid|mesh-list
153688606|NCT00170404|Vitamin A|vitamin a|mesh-list
153688607|NCT00170404|Thiamine|thiamine|mesh-list
153688608|NCT00170404|Selenium|selenium|mesh-list
153688609|NCT00170404|Micronutrients|micronutrients|mesh-list
153688640|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
153688641|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688642|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688643|NCT00170833|Everolimus|everolimus|mesh-list
153688644|NCT00170833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153688645|NCT00170833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153688646|NCT00170833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560498|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153688647|NCT00170833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688648|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688649|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
153688650|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688651|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688652|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
153688653|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153688654|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153688655|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688656|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688657|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153688658|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153688659|NCT00170872|Analgesics|analgesics|mesh-ancestor
153688660|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
153688661|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688662|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688663|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688664|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688665|NCT00170989|Valsartan|valsartan|mesh-list
153688666|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153688667|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153688668|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153688669|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153688670|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688671|NCT00170989|Diuretics|diuretics|mesh-ancestor
153688672|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
153688673|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688674|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153688685|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688686|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153688687|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688689|NCT00171067|Lisinopril|lisinopril|mesh-list
153688690|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153688691|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153688692|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153343348|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153688693|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688694|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153688695|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
153688696|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688699|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688700|NCT00171106|Valsartan|valsartan|mesh-list
153688701|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153688702|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153688703|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153688704|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688705|NCT00171145|Darifenacin|darifenacin|mesh-list
153688706|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153688707|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153688708|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
153688709|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688710|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688711|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688712|NCT00171145|Urological Agents|urological agents|mesh-ancestor
153688713|NCT00171184|Darifenacin|darifenacin|mesh-list
153688714|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153688715|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153688716|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
153688717|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688718|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688719|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688720|NCT00171184|Urological Agents|urological agents|mesh-ancestor
153688721|NCT00055523|Adalimumab|adalimumab|mesh-list
153688722|NCT00055523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153688723|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688724|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688725|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
153343513|NCT00003232|Analgesics|analgesics|mesh-ancestor
153688726|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153688727|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560620|NCT01639027|Drotaverin|drotaverin|mesh-list
153688728|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153688729|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
153688730|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153688731|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688732|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688733|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688734|NCT00171418|Tegaserod|tegaserod|mesh-list
153688735|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153688748|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688749|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153688750|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153688751|NCT00055562|Growth Substances|growth substances|mesh-ancestor
153688752|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
153688753|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688754|NCT00171496|Cyclosporine|cyclosporine|mesh-list
153688755|NCT00171496|Tacrolimus|tacrolimus|mesh-list
153688756|NCT00171496|Cyclosporins|cyclosporins|mesh-list
153688757|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688758|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
153688759|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688760|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153688761|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688762|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688763|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
153688764|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688765|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
153688766|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688767|NCT00171535|Amlodipine|amlodipine|mesh-list
153688768|NCT00171535|Valsartan|valsartan|mesh-list
153688769|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153688770|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153850148|NCT01207453|Milnacipran|milnacipran|mesh-list
153688783|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343588|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688784|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153688785|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
153688786|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688787|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153688788|NCT00171574|Protective Agents|protective agents|mesh-ancestor
153688789|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688790|NCT00171613|Octreotide|octreotide|mesh-list
153688791|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153688792|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153688793|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688794|NCT04920981|Atezolizumab|atezolizumab|mesh-list
153688795|NCT04920981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153688796|NCT04920981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688829|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153688830|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153688831|NCT00171652|Analgesics|analgesics|mesh-ancestor
153688832|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
153688833|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688834|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688835|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688836|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688837|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153688838|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688851|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688852|NCT00171769|Certoparin|certoparin|mesh-list
153688853|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
153688854|NCT00171808|Letrozole|letrozole|mesh-list
153688855|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688856|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153688857|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153688858|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688859|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343655|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688860|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153688861|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
153688862|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153688863|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688864|NCT00171847|Trastuzumab|trastuzumab|mesh-list
153688865|NCT00171847|Letrozole|letrozole|mesh-list
153688866|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688867|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688868|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153688869|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153688870|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850175|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153688898|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
153688899|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153688909|NCT00055757|Gemcitabine|gemcitabine|mesh-list
153688911|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688912|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688913|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
153688914|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688939|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
153688940|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
153688941|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688942|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
153688943|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688944|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688945|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
153343674|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
153688946|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688947|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688948|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
153688949|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688950|NCT00055874|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153688951|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153688952|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688953|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
153688954|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153688955|NCT00407719|Bevacizumab|bevacizumab|mesh-list
153688956|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688957|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688958|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153688959|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153688960|NCT00407719|Growth Substances|growth substances|mesh-ancestor
153688961|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688962|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
153688963|NCT00055913|Bevacizumab|bevacizumab|mesh-list
153688964|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153343808|NCT00085436|Interferons|interferons|mesh-list
153688965|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153850230|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153688990|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
153688991|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688992|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153688993|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153688994|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
153688995|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688996|NCT00055952|Exatecan|exatecan|mesh-list
153688997|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153688998|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153688999|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689000|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689001|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689002|NCT00055991|Bexarotene|bexarotene|mesh-list
153689003|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689004|NCT00056030|Leucovorin|leucovorin|mesh-list
153689005|NCT00056030|Fluorouracil|fluorouracil|mesh-list
153689006|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
153689007|NCT00056030|Cetuximab|cetuximab|mesh-list
153689008|NCT00056030|Calcium|calcium|mesh-list
153689009|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
153689010|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153689011|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689012|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
153689013|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689014|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153689015|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689016|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689017|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
153689018|NCT00056030|Antidotes|antidotes|mesh-ancestor
153689019|NCT00056030|Protective Agents|protective agents|mesh-ancestor
153689020|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
153689021|NCT00056030|Vitamins|vitamins|mesh-ancestor
153689022|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
153689023|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153343850|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
153343865|NCT00003730|Fluorouracil|fluorouracil|mesh-list
153689024|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153689025|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153560848|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
153560851|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153689026|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689027|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689065|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153689066|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153689067|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689068|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153689069|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689087|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153689088|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
153689089|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689090|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689092|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153689093|NCT00174538|Narcotics|narcotics|mesh-ancestor
153689094|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689095|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689096|NCT00174538|Analgesics|analgesics|mesh-ancestor
153689097|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
153689098|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689099|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
153689100|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
153689101|NCT00174577|Risperidone|risperidone|mesh-list
153689102|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153689103|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
153689104|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689105|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343952|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
153689106|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689107|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153689108|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153689109|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689110|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689111|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153689112|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
153689113|NCT00046137|Teriparatide|teriparatide|mesh-list
153689114|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153689115|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153689116|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343992|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153689117|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153689118|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153689119|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
153689120|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689121|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153689122|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153689123|NCT00056225|Vitamins|vitamins|mesh-list
153689124|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
153689125|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
153689145|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153689146|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
153689147|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344031|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689148|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689149|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153689150|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
153689151|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
153689152|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
153689153|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153689154|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153689155|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153689169|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
153689170|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153689171|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689173|NCT00174772|Docetaxel|docetaxel|mesh-list
153689174|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689175|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
153689176|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
153689177|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
153689178|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598861|NCT03973203|Niacin|niacin|mesh-list
153689179|NCT00174811|Telithromycin|telithromycin|mesh-list
153689180|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153689181|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689182|NCT02963779|Apremilast|apremilast|mesh-list
153689183|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153689184|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153689197|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
153689198|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153689199|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153689200|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689201|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689202|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
153689203|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689204|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153689205|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153689206|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
153689207|NCT00174928|Lansoprazole|lansoprazole|mesh-list
153689208|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
153689209|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153689210|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153689211|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153689212|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689213|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689214|NCT00175045|Lansoprazole|lansoprazole|mesh-list
153689215|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
153689216|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153689217|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153689218|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153689219|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689220|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689221|NCT00056381|Anidulafungin|anidulafungin|mesh-list
153689222|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
153689223|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689224|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153689225|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153689226|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153689227|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689228|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689229|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153689230|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153344114|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
153689231|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689240|NCT00175357|Analgesics|analgesics|mesh-ancestor
153689241|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
153689242|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689243|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
153689244|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
153689245|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
153689246|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153689247|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689261|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153689262|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689263|NCT00175396|Hormones|hormones|mesh-ancestor
153689264|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689265|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
153689266|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689267|NCT00175396|Protective Agents|protective agents|mesh-ancestor
153689268|NCT00175396|Vitamins|vitamins|mesh-ancestor
153689269|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
153689270|NCT00175396|Estrogens|estrogens|mesh-ancestor
153689271|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
153689272|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
153689273|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
153689274|NCT00056459|Vatalanib|vatalanib|mesh-list
153689275|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153689276|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689277|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689279|NCT00175435|Resiquimod|resiquimod|mesh-list
153689280|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
153689281|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689282|NCT00175435|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153689283|NCT00175435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689284|NCT00175435|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153689285|NCT00175513|Valacyclovir|valacyclovir|mesh-list
153689286|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
153689287|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689288|NCT00175591|Bupivacaine|bupivacaine|mesh-list
153689289|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
153689290|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
153689291|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689292|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689293|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
153689294|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689295|NCT00175630|Bupivacaine|bupivacaine|mesh-list
153689296|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
153689297|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
153689298|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689299|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689300|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
153689301|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689302|NCT00056537|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
153344231|NCT00004060|Exatecan|exatecan|mesh-list
153689303|NCT00056537|Immunoconjugates|immunoconjugates|mesh-ancestor
153689304|NCT00056537|Immunologic Factors|immunologic factors|mesh-ancestor
153689305|NCT00056537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689306|NCT00408031|Cycloserine|cycloserine|mesh-list
153689307|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153689308|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689309|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153689310|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
153689311|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153689312|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
153689313|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689314|NCT00175747|Budesonide|budesonide|mesh-list
153689377|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689378|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689379|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689381|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153689382|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
153689383|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153689384|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153689385|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153689386|NCT04420533|Mirabegron|mirabegron|mesh-list
153689387|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153689388|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153689389|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153689390|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
153689391|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689392|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689396|NCT00176020|Niacin|niacin|mesh-list
153689397|NCT00176020|Niacinamide|niacinamide|mesh-list
153689398|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
153689399|NCT00176020|Vitamins|vitamins|mesh-ancestor
153689400|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
153689401|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689402|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153689403|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
153344281|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153689404|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689405|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153689406|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
153689407|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
153689408|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153689409|NCT00176059|Antibodies|antibodies|mesh-list
153689410|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
153689411|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153689412|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
153689413|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689414|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153689415|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689416|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689417|NCT00176293|Dexamethasone|dexamethasone|mesh-list
153689418|NCT00176293|Doxorubicin|doxorubicin|mesh-list
153689419|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153689420|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
153689421|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
153689422|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689423|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689424|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153344335|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689439|NCT00056693|Growth Substances|growth substances|mesh-ancestor
153689440|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689441|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
153689442|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153689443|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689444|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689445|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153689446|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153689447|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153689448|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
153689449|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689450|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153689451|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153689452|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689453|NCT00176449|Bupropion|bupropion|mesh-list
153689454|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153689455|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
153689456|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689457|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153391859|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689458|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689459|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689460|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689461|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
153689462|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689463|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689464|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153689465|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153689466|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689467|NCT00398450|Interferons|interferons|mesh-list
153689468|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
153689469|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
153689470|NCT00398450|Azacitidine|azacitidine|mesh-list
153344409|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392171|NCT01676311|Huperzine A|huperzine a|mesh-list
153689471|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689472|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
153689473|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689474|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153689475|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
153689476|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689477|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689478|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
153689524|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153689525|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689526|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153689527|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
153344423|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344425|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689528|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689529|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153689530|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153689531|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153689532|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153689533|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153689534|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153689535|NCT00176761|Interleukin-2|interleukin-2|mesh-list
153689536|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689537|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153689538|NCT00176761|Analgesics|analgesics|mesh-ancestor
153689539|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
153689554|NCT00408148|Rimonabant|rimonabant|mesh-list
153689555|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153689556|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153393163|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153689557|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153689558|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689559|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689560|NCT00408148|Hormones|hormones|mesh-ancestor
153689561|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689562|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390609|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
153689582|NCT00177580|Pravastatin|pravastatin|mesh-list
153689583|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153689584|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153689585|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
153689586|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689587|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153689588|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153689589|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689590|NCT04723342|Blinatumomab|blinatumomab|mesh-list
153689591|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689592|NCT00177619|Alendronate|alendronate|mesh-list
153689593|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153689594|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374947|NCT02688309|Hormones|hormones|mesh-ancestor
153689595|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
153689596|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153689597|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689607|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153689608|NCT00177853|Analgesics|analgesics|mesh-ancestor
153689609|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
153689610|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689611|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689612|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153689613|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689614|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153689615|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153689616|NCT00178048|Paroxetine|paroxetine|mesh-list
153689617|NCT00178048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153689618|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689619|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689620|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689621|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689622|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
153689624|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153689625|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
153689626|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153344496|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344531|NCT00004102|Antidotes|antidotes|mesh-ancestor
153344609|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
153689627|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153689628|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153689629|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689630|NCT00056966|Fludarabine|fludarabine|mesh-list
153689631|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
153689632|NCT00056966|Tacrolimus|tacrolimus|mesh-list
153689633|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689634|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689635|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689636|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
153689637|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689638|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153689639|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689640|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153689641|NCT00178828|Bupropion|bupropion|mesh-list
153689642|NCT00178828|Sertraline|sertraline|mesh-list
153689643|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153689644|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
153689645|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689646|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153689647|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689648|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689649|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689650|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
153689651|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689652|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689653|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153689654|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153689655|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689656|NCT00178828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153689657|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
153689658|NCT00408187|Cyclosporine|cyclosporine|mesh-list
153689659|NCT00408187|Cyclosporins|cyclosporins|mesh-list
153689660|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689670|NCT00408226|Pemetrexed|pemetrexed|mesh-list
153689671|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689672|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689673|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689674|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153689675|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153689676|NCT02963896|Gentamicins|gentamicins|mesh-list
153689677|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153689678|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689679|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153689680|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344669|NCT05776940|Protease Inhibitors|protease inhibitors|mesh-ancestor
153689681|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689682|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
153689683|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153689684|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153374980|NCT00552617|Rocuronium|rocuronium|mesh-list
153561450|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
153689685|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153689686|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689687|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689688|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
153689689|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689690|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689691|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153689692|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689693|NCT00397722|Paroxetine|paroxetine|mesh-list
153689694|NCT00397722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153344710|NCT05775965|Analgesics|analgesics|mesh-ancestor
153689695|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689696|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689697|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689698|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689699|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
153689700|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689701|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153689702|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
153689718|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153689719|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153689720|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
153689721|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
153689722|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689723|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344748|NCT05775692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689740|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689741|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153689742|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153689744|NCT00179062|Risperidone|risperidone|mesh-list
153689745|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153689746|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
153689747|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689748|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689749|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689750|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153689751|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153689752|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689753|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689754|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153689755|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
153689756|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
153689757|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
153689758|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344762|NCT05775536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153344805|NCT05638594|Docetaxel|docetaxel|mesh-list
153689759|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153689760|NCT00179062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153689761|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689762|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689763|NCT04723459|Ivermectin|ivermectin|mesh-list
153689764|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153689765|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689766|NCT00179257|Sertraline|sertraline|mesh-list
153689767|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
153689768|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689769|NCT00179257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153689770|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153344809|NCT05638594|Hormones|hormones|mesh-list
153461033|NCT03438318|Atezolizumab|atezolizumab|mesh-list
153689771|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689772|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689773|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689774|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
153689775|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689776|NCT00408382|Atorvastatin|atorvastatin|mesh-list
153689777|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153689809|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153689811|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
153689812|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689813|NCT00179686|Lenalidomide|lenalidomide|mesh-list
153689814|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
153689815|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689816|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153561593|NCT01653041|Everolimus|everolimus|mesh-list
153344821|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153344822|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
153689817|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153689818|NCT00179686|Growth Substances|growth substances|mesh-ancestor
153689819|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
153689820|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689821|NCT00179725|Doxorubicin|doxorubicin|mesh-list
153689822|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153689823|NCT00179725|Lenalidomide|lenalidomide|mesh-list
153689824|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153689825|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689826|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153689827|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153689828|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689829|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689830|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
153689831|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689832|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153689833|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153689834|NCT00179725|Growth Substances|growth substances|mesh-ancestor
153689835|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
153689836|NCT00179764|Busulfan|busulfan|mesh-list
153689850|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689851|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
153344935|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689852|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153689853|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689854|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153689855|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153689856|NCT00179881|Growth Substances|growth substances|mesh-ancestor
153689857|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
153689858|NCT00179920|Carboplatin|carboplatin|mesh-list
153689859|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689861|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
153689862|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
153689863|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689864|NCT00180037|Vitamins|vitamins|mesh-ancestor
153689865|NCT00180076|Budesonide|budesonide|mesh-list
153689866|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153689867|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153689868|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
153689869|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850548|NCT01205581|Vaccines|vaccines|mesh-list
153689879|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689881|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
153689882|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689883|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689884|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
153689885|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689887|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689888|NCT00180310|Paclitaxel|paclitaxel|mesh-list
153689889|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153689890|NCT00180310|Everolimus|everolimus|mesh-list
153689891|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153689892|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689893|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
153689894|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
153689895|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
153689896|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689897|NCT00180310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153689898|NCT00180310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153689914|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153689915|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689916|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689917|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
153689918|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
153689919|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
153689920|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153689921|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
153689922|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689923|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689924|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153689925|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
153689926|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153689927|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
153689928|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689929|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561716|NCT01653639|Coagulants|coagulants|mesh-ancestor
153689930|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153689931|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
153689932|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
153689933|NCT00180622|Protective Agents|protective agents|mesh-ancestor
153689934|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
153689935|NCT00180895|Rituximab|rituximab|mesh-list
153689936|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153689937|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345063|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689938|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
153689939|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689940|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689941|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
153689942|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526883|NCT01848639|Diuretics|diuretics|mesh-ancestor
153689943|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
153689944|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689945|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689946|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153689948|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
153689949|NCT04729491|Dutasteride|dutasteride|mesh-list
153689950|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153689966|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
153689967|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
153689968|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689969|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689970|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
153689971|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689972|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153689973|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153689974|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153689975|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689976|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689977|NCT00181246|Fentanyl|fentanyl|mesh-list
153345117|NCT00723697|Buprenorphine|buprenorphine|mesh-list
153689978|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153689979|NCT00181246|Narcotics|narcotics|mesh-ancestor
153689980|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423940|NCT02171130|Glucagon|glucagon|mesh-list
153689981|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689982|NCT00181246|Analgesics|analgesics|mesh-ancestor
153689983|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
153689984|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689985|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153689986|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153689987|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
153689988|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
153689989|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
153689990|NCT00181558|Atrasentan|atrasentan|mesh-list
153689991|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153689992|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689993|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689994|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153689995|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153689996|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689997|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
153689998|NCT00181597|Trilostane|trilostane|mesh-list
153689999|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153690000|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153690001|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
153690002|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690003|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690004|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690005|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690006|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690007|NCT00181636|Galantamine|galantamine|mesh-list
153690008|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153690009|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690010|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690011|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
153690012|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690013|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690014|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153690015|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
153345191|NCT00199056|Cytarabine|cytarabine|mesh-list
153690016|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690017|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
153690018|NCT00181675|Galantamine|galantamine|mesh-list
153690019|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153690020|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690035|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153690036|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153690038|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
153690039|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690040|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153690041|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690042|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690043|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153690044|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153690045|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153690046|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153690047|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153690048|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690049|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690050|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
153690051|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690052|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690053|NCT00181987|Methylphenidate|methylphenidate|mesh-list
153690054|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153690055|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690056|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153690057|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153690058|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690059|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690060|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
153690061|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690063|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
153690064|NCT00182143|Heparin|heparin|mesh-list
153690065|NCT00182143|Calcium heparin|calcium heparin|mesh-list
153690066|NCT00182143|Dalteparin|dalteparin|mesh-list
153690067|NCT00182143|Tinzaparin|tinzaparin|mesh-list
153690068|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153690069|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
153690070|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153690071|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153690072|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690073|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
153690074|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153690075|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153690076|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690077|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
153690078|NCT00182221|Coagulants|coagulants|mesh-ancestor
153690079|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153690080|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345272|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690081|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690082|NCT00408538|UC-781|uc-781|mesh-list
153690083|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
153690084|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153690097|NCT00408655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153690098|NCT00408655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690099|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690100|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
153690101|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690102|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153690103|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690104|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153690105|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
153690106|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153690107|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
153690108|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
153690110|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
153690111|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153690112|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690113|NCT00182494|Metformin|metformin|mesh-list
153690114|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153690115|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690116|NCT00182533|Sertraline|sertraline|mesh-list
153345314|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
153345315|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
153345316|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
153690117|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
153690126|NCT00182572|Naltrexone|naltrexone|mesh-list
153690127|NCT00182572|Buprenorphine|buprenorphine|mesh-list
153690128|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153690129|NCT00182572|Narcotics|narcotics|mesh-ancestor
153690130|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153690131|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690132|NCT00182572|Analgesics|analgesics|mesh-ancestor
153690133|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
153690134|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690135|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153690136|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153690137|NCT00182611|Tegafur|tegafur|mesh-list
153690138|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690139|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345339|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
153690140|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
153690141|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690142|NCT00182650|Aldesleukin|aldesleukin|mesh-list
153690143|NCT00182650|Rituximab|rituximab|mesh-list
153690144|NCT00182650|Fludarabine|fludarabine|mesh-list
153690145|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
153690146|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153690147|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690158|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690159|NCT00182806|Gemcitabine|gemcitabine|mesh-list
153690160|NCT00182806|Irinotecan|irinotecan|mesh-list
153690161|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690162|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
153690163|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690164|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690165|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153690166|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153690167|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345422|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153690168|NCT00182845|Donepezil|donepezil|mesh-list
153690169|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153690170|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690171|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690172|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
153690173|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690174|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690175|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
153690176|NCT00182884|Donepezil|donepezil|mesh-list
153690177|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153690178|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690179|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690180|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
153690181|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690182|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690183|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
153690184|NCT00183001|Vitamin K|vitamin k|mesh-list
153690185|NCT00183001|Vitamins|vitamins|mesh-ancestor
153690186|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
153690187|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690188|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153690189|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153690190|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690191|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
153690192|NCT00183001|Coagulants|coagulants|mesh-ancestor
153690193|NCT00183040|Hormones|hormones|mesh-list
153690198|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
153690199|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690200|NCT00183235|Aripiprazole|aripiprazole|mesh-list
153690201|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
153690202|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153690203|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153690204|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153690205|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153690206|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690207|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
153690208|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
153690209|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690210|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690211|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153690225|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153690226|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153690227|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153690228|NCT00057512|Analgesics|analgesics|mesh-ancestor
153690229|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
153562075|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153562076|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690230|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690231|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153690232|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690234|NCT00183742|Doxorubicin|doxorubicin|mesh-list
153690235|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153690236|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690237|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690238|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690239|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690240|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690242|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153690243|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153690244|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690245|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
153690246|NCT02965248|Leucovorin|leucovorin|mesh-list
153690247|NCT02965248|Capecitabine|capecitabine|mesh-list
153690248|NCT02965248|Raltitrexed|raltitrexed|mesh-list
153690249|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
153690250|NCT02965248|Calcium|calcium|mesh-list
153690251|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
153690252|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153690253|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690254|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153690255|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690256|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
153690257|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690258|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690259|NCT02965248|Antidotes|antidotes|mesh-ancestor
153690260|NCT02965248|Protective Agents|protective agents|mesh-ancestor
153690261|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
153690262|NCT02965248|Vitamins|vitamins|mesh-ancestor
153690263|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
153690264|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153690265|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690266|NCT00183820|Paclitaxel|paclitaxel|mesh-list
153690267|NCT00183820|Gemcitabine|gemcitabine|mesh-list
153690268|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
153690269|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153690270|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690271|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690272|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690273|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690274|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690275|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690286|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345789|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690287|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850741|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690289|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690291|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
153690292|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690293|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
153690294|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690295|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690296|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153690297|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690299|NCT00183937|Bortezomib|bortezomib|mesh-list
153690300|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690301|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690302|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690303|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690304|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690305|NCT00408772|Bevacizumab|bevacizumab|mesh-list
153690306|NCT00408772|Capecitabine|capecitabine|mesh-list
153690307|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
153690308|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153690309|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345790|NCT00005596|Antidotes|antidotes|mesh-ancestor
153345791|NCT00005596|Protective Agents|protective agents|mesh-ancestor
153345864|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690310|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153690311|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153527254|NCT01470209|Everolimus|everolimus|mesh-list
153690312|NCT00408772|Growth Substances|growth substances|mesh-ancestor
153690313|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690314|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
153690315|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153562264|NCT01656642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153690316|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
153690317|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690318|NCT00408850|Pioglitazone|pioglitazone|mesh-list
153690319|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153690320|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690321|NCT00183976|Rituximab|rituximab|mesh-list
153690322|NCT00183976|Doxorubicin|doxorubicin|mesh-list
153690323|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153690324|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153690325|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690326|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
153690327|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690328|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690329|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153690330|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153690331|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153690332|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690333|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690334|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
153690335|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153690336|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690337|NCT00184015|Bevacizumab|bevacizumab|mesh-list
153690338|NCT00184015|Bortezomib|bortezomib|mesh-list
153690339|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153690340|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690354|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
153690355|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
153690356|NCT00184171|Hormones|hormones|mesh-ancestor
153690357|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153690358|NCT00184171|Antacids|antacids|mesh-ancestor
153690359|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690360|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153690361|NCT00057707|Modafinil|modafinil|mesh-list
153690362|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153690363|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690364|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153690365|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153690366|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153690367|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690368|NCT00184522|Esomeprazole|esomeprazole|mesh-list
153690369|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153690370|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153690371|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153690372|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850757|NCT03456648|Apixaban|apixaban|mesh-list
153690392|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690393|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153690394|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
153690395|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690396|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153690397|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153690398|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153690399|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153690400|NCT00058253|Docetaxel|docetaxel|mesh-list
153690401|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690402|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690433|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153690434|NCT03816774|Simethicone|simethicone|mesh-list
153690435|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
153690436|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690437|NCT03816774|Emollients|emollients|mesh-ancestor
153690438|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
153690439|NCT00184912|Caffeine|caffeine|mesh-list
153690440|NCT00184912|Annexin A5|annexin a5|mesh-list
153690441|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153690442|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690443|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153690444|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690445|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690446|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153690447|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153690448|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
154257148|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257149|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154257150|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
153690463|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153690465|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153690466|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153690467|NCT00185068|Diuretics|diuretics|mesh-ancestor
153690468|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
153690469|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690470|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153690471|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690472|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850786|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
153690477|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153690478|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153690479|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153690480|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
153690481|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690482|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153345935|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
153690483|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153690484|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690485|NCT00058448|Docetaxel|docetaxel|mesh-list
153690486|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690487|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690488|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690489|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690490|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690491|NCT00185185|Atenolol|atenolol|mesh-list
153690492|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153690493|NCT00185185|Olmesartan|olmesartan|mesh-list
153690494|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153690495|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153690496|NCT00185185|Diuretics|diuretics|mesh-ancestor
153690497|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
153690498|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690499|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153690500|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690501|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690502|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153690503|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153690504|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153690505|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
153690506|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
153690507|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690519|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690520|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153690521|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153690522|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153690523|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153690524|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153690525|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153690527|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153690528|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690529|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690530|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690531|NCT00058487|Thalidomide|thalidomide|mesh-list
153690532|NCT00058487|Epirubicin|epirubicin|mesh-list
153690533|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153690534|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690535|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153690536|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153690537|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346003|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
153346138|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153690538|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690539|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690540|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
153690541|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690542|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
153690543|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153562551|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562552|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690544|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690545|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153690546|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153690547|NCT00058487|Growth Substances|growth substances|mesh-ancestor
153690548|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
153690550|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690551|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690552|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153690553|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153690565|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690584|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690585|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690586|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153690587|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153690588|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
153690589|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
153690590|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690591|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153690592|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
153690593|NCT03731832|Hormones|hormones|mesh-ancestor
153690594|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153690595|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153690596|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153690597|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153690598|NCT03731832|Growth Substances|growth substances|mesh-ancestor
153690599|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
153690600|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
153690601|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690602|NCT00185887|Terbutaline|terbutaline|mesh-list
153690603|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153690604|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
153690605|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690606|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690607|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153690608|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
153690609|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
153690610|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
153690611|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690612|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153690613|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153690614|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153690615|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
153690616|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690617|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690618|NCT00186082|Cefoxitin|cefoxitin|mesh-list
153690619|NCT00186082|Cefotetan|cefotetan|mesh-list
153346227|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153690620|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153690621|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690622|NCT00186277|Docetaxel|docetaxel|mesh-list
153690623|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
153690624|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690640|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690641|NCT00186706|Protective Agents|protective agents|mesh-ancestor
153690642|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690643|NCT00186706|Trace Elements|trace elements|mesh-ancestor
153690644|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
153690645|NCT00409201|Reboxetine|reboxetine|mesh-list
153690646|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
153690647|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153690648|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153850816|NCT00558077|Metformin|metformin|mesh-list
153690653|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690654|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690655|NCT00046878|Carmustine|carmustine|mesh-list
153690656|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153690657|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153690658|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
153690659|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690660|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562842|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690661|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690663|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153690664|NCT00186745|Dalteparin|dalteparin|mesh-list
153690665|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
153690666|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153690667|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153690668|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690669|NCT00186823|Antibodies|antibodies|mesh-list
153690670|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
153690671|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690672|NCT00186862|Interleukin-2|interleukin-2|mesh-list
153690673|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690674|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690675|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153690676|NCT00186862|Analgesics|analgesics|mesh-ancestor
153690677|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
153690678|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690679|NCT00186940|Rasburicase|rasburicase|mesh-list
153690680|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
153690681|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690682|NCT00186979|Cefixime|cefixime|mesh-list
153690683|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
153690684|NCT00186979|Cefpodoxime Proxetil|cefpodoxime proxetil|mesh-list
153690685|NCT00186979|Irinotecan|irinotecan|mesh-list
153690686|NCT00186979|Vincristine|vincristine|mesh-list
153690716|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690717|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
153690718|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690719|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690720|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153690721|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
153690722|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690723|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690724|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153690725|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153690726|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
153690727|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
153690728|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690729|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153690730|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
153690731|NCT00187057|Hormones|hormones|mesh-ancestor
153690732|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153690733|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153690734|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153690735|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153690753|NCT00046917|Alvocidib|alvocidib|mesh-list
153690754|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690755|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153690756|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153690757|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690758|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690759|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
153690760|NCT00046917|Growth Substances|growth substances|mesh-ancestor
153690761|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690762|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153690763|NCT00187174|Everolimus|everolimus|mesh-list
153690764|NCT00187174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153690765|NCT00187174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153690766|NCT00187174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424149|NCT03336853|Hybenx|hybenx|mesh-list
153690779|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
153690780|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690781|NCT00187330|Protective Agents|protective agents|mesh-ancestor
153690782|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690783|NCT00187330|Antidotes|antidotes|mesh-ancestor
153690784|NCT00187408|Heparin|heparin|mesh-list
153690785|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153690786|NCT00187408|Tinzaparin|tinzaparin|mesh-list
153690787|NCT00187408|Dalteparin|dalteparin|mesh-list
153690788|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
153690789|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153690790|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153690791|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690792|NCT00187447|Indomethacin|indomethacin|mesh-list
153690793|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153782703|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153782704|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
153690794|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153690807|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
153690808|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153690809|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690811|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153690812|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153690813|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
153690814|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690815|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690816|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690817|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153690818|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153690819|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
153783322|NCT00236054|Tiagabine|tiagabine|mesh-list
153690820|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
153690821|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690822|NCT00187564|Protective Agents|protective agents|mesh-ancestor
153690823|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690824|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
153690826|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
153690827|NCT00046995|Leucovorin|leucovorin|mesh-list
153690828|NCT00046995|Carboplatin|carboplatin|mesh-list
153690829|NCT00046995|Fluorouracil|fluorouracil|mesh-list
153690830|NCT00046995|Calcium|calcium|mesh-list
153690831|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
153690832|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690833|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153690834|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690835|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
153690836|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690837|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690838|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690839|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
153690840|NCT00046995|Antidotes|antidotes|mesh-ancestor
153690841|NCT00046995|Protective Agents|protective agents|mesh-ancestor
153690842|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
153690846|NCT00058955|Triazolam|triazolam|mesh-list
153690847|NCT00058955|Pentobarbital|pentobarbital|mesh-list
153690848|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153690849|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153690850|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
153690851|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
153690852|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153690853|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690854|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153690855|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153690856|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153690857|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
153690858|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
153690871|NCT00058994|Growth Substances|growth substances|mesh-ancestor
153690872|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690873|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
153690874|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690875|NCT00187915|Cyclosporine|cyclosporine|mesh-list
153690876|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
153690877|NCT00187915|Tacrolimus|tacrolimus|mesh-list
153690878|NCT00187915|Cyclosporins|cyclosporins|mesh-list
153690879|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153424161|NCT03949244|Latanoprost|latanoprost|mesh-list
153690880|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
153690881|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690882|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153690883|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690884|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690885|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
153690886|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690887|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
153690888|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690889|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153690890|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690891|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153690892|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
153690893|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153690894|NCT00187993|Hormones|hormones|mesh-list
154257151|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375244|NCT01502306|Nicotine|nicotine|mesh-list
153690895|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153690896|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690897|NCT00188071|Acetaminophen|acetaminophen|mesh-list
153690898|NCT00188071|Ketoprofen|ketoprofen|mesh-list
153690899|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153690900|NCT00188071|Analgesics|analgesics|mesh-ancestor
153690901|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
153690902|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690903|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690904|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
153690905|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153690906|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153690907|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690908|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153346485|NCT01342549|Naltrexone|naltrexone|mesh-list
153346535|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153690909|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690910|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690911|NCT00188227|Midazolam|midazolam|mesh-list
153690912|NCT00188227|Pirinitramide|pirinitramide|mesh-list
153690913|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153690914|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153690915|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153690916|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690917|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153690918|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153690919|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153690920|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153690921|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
153527853|NCT01474473|Calpastatin|calpastatin|mesh-list
153690938|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690939|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
153690940|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690941|NCT00047073|Sirolimus|sirolimus|mesh-list
153690942|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153690943|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690944|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153690954|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690955|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
153690956|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690957|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690958|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690959|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153690960|NCT00188383|Analgesics|analgesics|mesh-ancestor
153690961|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
153690962|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690963|NCT02969447|Oxytocin|oxytocin|mesh-list
153690964|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
153690965|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690966|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690967|NCT00188617|Gefitinib|gefitinib|mesh-list
153690968|NCT00188617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153690969|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153690970|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690971|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690972|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690973|NCT00047112|Fluorouracil|fluorouracil|mesh-list
153690974|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690975|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
153690976|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690977|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690978|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690979|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
153690980|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346602|NCT01351753|Metformin|metformin|mesh-list
153690981|NCT00409318|Etanercept|etanercept|mesh-list
153690993|NCT00409357|Alfuzosin|alfuzosin|mesh-list
153690994|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153690995|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153690996|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153527950|NCT01475552|Abciximab|abciximab|mesh-list
153690997|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
153690998|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257152|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257153|NCT01282502|Midostaurin|midostaurin|mesh-list
153690999|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691000|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691001|NCT00409357|Urological Agents|urological agents|mesh-ancestor
153691002|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153691003|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153691004|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691005|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691006|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691007|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
153691008|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691009|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
153691010|NCT00188773|Heparin|heparin|mesh-list
153691011|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153691012|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153691013|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
153691014|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153691015|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153691016|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691017|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
153691018|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691019|NCT00188773|Expectorants|expectorants|mesh-ancestor
153691023|NCT00188773|Protective Agents|protective agents|mesh-ancestor
153691024|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691025|NCT00188773|Antidotes|antidotes|mesh-ancestor
153691026|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153691027|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153691028|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153691029|NCT00188812|Donepezil|donepezil|mesh-list
153691030|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153691031|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691032|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691033|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
153691034|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691035|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691036|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
153691037|NCT02963194|Oxytocin|oxytocin|mesh-list
153691038|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
153691039|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153691040|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691041|NCT00059306|Aspirin|aspirin|mesh-list
153691042|NCT00059306|Clopidogrel|clopidogrel|mesh-list
153691043|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153691058|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153691059|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153691060|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153691061|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
153691062|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691063|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
153691064|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
153691065|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691066|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
153691067|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691068|NCT00189007|Allopurinol|allopurinol|mesh-list
153691069|NCT00189007|Mannitol|mannitol|mesh-list
153691070|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
153691071|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691072|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691073|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
153691074|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153691075|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153691076|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
153691077|NCT00189007|Protective Agents|protective agents|mesh-ancestor
153691078|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691079|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153691080|NCT00189007|Diuretics|diuretics|mesh-ancestor
153691081|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
153691082|NCT00399945|Tobramycin|tobramycin|mesh-list
153691083|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153691084|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691085|NCT00189085|Simvastatin|simvastatin|mesh-list
153691086|NCT00189085|Ezetimibe|ezetimibe|mesh-list
153691087|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153375281|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153563973|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691088|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153691089|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153391173|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153691130|NCT00189553|Carboplatin|carboplatin|mesh-list
153691131|NCT00189553|Doxorubicin|doxorubicin|mesh-list
153346808|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691132|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153691133|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691134|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691135|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691136|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691137|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691138|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691139|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153691140|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153691141|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153691142|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691143|NCT00189709|Fluconazole|fluconazole|mesh-list
153691145|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
153528084|NCT01476410|Doxorubicin|doxorubicin|mesh-list
153691146|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691147|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153691148|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153691149|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691150|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691151|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153691155|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153691156|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153691157|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153691159|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691166|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691167|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
153691168|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691169|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153691170|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691171|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691172|NCT00059462|Interleukin-2|interleukin-2|mesh-list
153691173|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691174|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153691175|NCT00059462|Analgesics|analgesics|mesh-ancestor
153691176|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
153691177|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691178|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691180|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691181|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
153691182|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691183|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153691184|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691185|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691186|NCT00047190|Tipifarnib|tipifarnib|mesh-list
153691187|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691188|NCT00189904|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153691189|NCT00189904|Antiviral Agents|antiviral agents|mesh-ancestor
153691190|NCT00189904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691191|NCT00189943|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153691192|NCT00189943|Antiviral Agents|antiviral agents|mesh-ancestor
153691193|NCT00189943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691194|NCT00189982|Factor VIII|factor viii|mesh-list
153691195|NCT00189982|Coagulants|coagulants|mesh-ancestor
153691196|NCT00190021|Donepezil|donepezil|mesh-list
153691197|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153691198|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691199|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691200|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
153691201|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691202|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691203|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
153691204|NCT00190060|Testosterone|testosterone|mesh-list
153691205|NCT00190060|Androgens|androgens|mesh-ancestor
153691207|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153691208|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691209|NCT00047229|Doxorubicin|doxorubicin|mesh-list
153691210|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153691211|NCT00047229|Oblimersen|oblimersen|mesh-list
153691212|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153691213|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691214|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153691215|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153691216|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691217|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691218|NCT00190099|Dexamethasone|dexamethasone|mesh-list
153691219|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153691220|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
153691221|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
153691222|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691223|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346941|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
153347069|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153691224|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153691225|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
153691226|NCT00190099|Hormones|hormones|mesh-ancestor
153691227|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153691228|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153691259|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
153691260|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153691261|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
153691262|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153691263|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153691265|NCT03238365|Tadalafil|tadalafil|mesh-list
153691266|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153691267|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691268|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153691269|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691270|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
153691271|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153691272|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153691273|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691274|NCT03238365|Urological Agents|urological agents|mesh-ancestor
153691275|NCT00059618|Carboplatin|carboplatin|mesh-list
153691276|NCT00059618|Bortezomib|bortezomib|mesh-list
153691277|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691278|NCT00190333|Escitalopram|escitalopram|mesh-list
153691279|NCT00190333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153691280|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691292|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
153691293|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
153691294|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691295|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691296|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
153691297|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153691298|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153691299|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153691300|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691301|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691302|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691303|NCT00047307|Gemcitabine|gemcitabine|mesh-list
153691304|NCT00047307|Alvocidib|alvocidib|mesh-list
153691305|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691306|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
153691307|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691308|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691309|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
153691310|NCT00047307|Growth Substances|growth substances|mesh-ancestor
153691311|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691312|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153691313|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691314|NCT00190489|Docetaxel|docetaxel|mesh-list
153691315|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691316|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691317|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691318|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691319|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691320|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153564301|NCT01669304|Verapamil|verapamil|mesh-list
153691321|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153691322|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691331|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153691332|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
153691333|NCT02969252|Rifamycins|rifamycins|mesh-list
153691334|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
153691335|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153691336|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691337|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153691338|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153691339|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153691340|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691341|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691360|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691361|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
153691362|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153691363|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
153691364|NCT00190762|Pemetrexed|pemetrexed|mesh-list
153691366|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691367|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691368|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153691369|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691370|NCT00190801|Pemetrexed|pemetrexed|mesh-list
153691371|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691372|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691373|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691374|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153691375|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691376|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153691377|NCT00047346|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153691378|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153691379|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691380|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691381|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691382|NCT00190840|Pemetrexed|pemetrexed|mesh-list
153691383|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691384|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691385|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691386|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153691387|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691388|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153691389|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153691390|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691391|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691392|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691393|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691414|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691416|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691417|NCT00190996|Analgesics|analgesics|mesh-ancestor
153691418|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
153691419|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691420|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
153691421|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153691422|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
153691423|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153691429|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691430|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691431|NCT02922894|Trazodone|trazodone|mesh-list
153691432|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153691433|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153691434|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153691435|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691436|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153691437|NCT02922894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153691438|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691439|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691440|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691456|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691457|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691458|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153691459|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691460|NCT00191425|Teriparatide|teriparatide|mesh-list
153691461|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153691462|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153735997|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691463|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691464|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153691465|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153691466|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
153691467|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153691468|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153691469|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153691470|NCT00191464|Insulin|insulin|mesh-list
153691471|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153691472|NCT00191464|Metformin|metformin|mesh-list
153691473|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
153691474|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
153691475|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153691476|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691477|NCT04723030|Paclitaxel|paclitaxel|mesh-list
153691478|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691479|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691480|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691481|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691482|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691483|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691484|NCT00191503|Gemcitabine|gemcitabine|mesh-list
153691485|NCT00191503|Pemetrexed|pemetrexed|mesh-list
153691486|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691487|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
153691488|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691489|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691490|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691491|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153691492|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691493|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153691494|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153691495|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691496|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691497|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691498|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691513|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691514|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691515|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
153691516|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691521|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691522|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691523|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691524|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691525|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153691526|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153691527|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691528|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691529|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691530|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691531|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691532|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691533|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153691534|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153691535|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691536|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691537|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691538|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691539|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691540|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691541|NCT00191893|Teriparatide|teriparatide|mesh-list
153691542|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153691543|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691544|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153691545|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153691546|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153691547|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691548|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691549|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691550|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691560|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
153691562|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691563|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
153691564|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691565|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
153691566|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691567|NCT00191971|Gemcitabine|gemcitabine|mesh-list
153691568|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691569|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
153691570|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691571|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691572|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
153691573|NCT00047502|Lonafarnib|lonafarnib|mesh-list
153691574|NCT00047502|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153528532|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691575|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153691576|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691577|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691578|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691579|NCT00192049|Gemcitabine|gemcitabine|mesh-list
153691580|NCT00192049|Mitomycins|mitomycins|mesh-list
153691581|NCT00192049|Mitomycin|mitomycin|mesh-list
153691582|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691583|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
153691584|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691585|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691586|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153691587|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
153691588|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153347540|NCT01323517|Ipilimumab|ipilimumab|mesh-list
153691589|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691590|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
153691591|NCT00192088|Pemetrexed|pemetrexed|mesh-list
153691592|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691594|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691596|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691597|NCT00059852|Gemcitabine|gemcitabine|mesh-list
153691598|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153691599|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691600|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
153691601|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691602|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691603|NCT00059852|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153691604|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153691605|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691606|NCT00047580|Tizanidine|tizanidine|mesh-list
153691607|NCT00047580|Analgesics|analgesics|mesh-ancestor
153691608|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
153691609|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691610|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691611|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
153691612|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153691613|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153691614|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
153691615|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
153691616|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153691625|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153691627|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691628|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691629|NCT02968901|Urological Agents|urological agents|mesh-ancestor
153691630|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153691631|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153347583|NCT03009097|Atorvastatin|atorvastatin|mesh-list
153691632|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153691633|NCT00192595|Tenofovir|tenofovir|mesh-list
153735999|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
153691634|NCT00192595|Lamivudine|lamivudine|mesh-list
153691635|NCT00192595|Zidovudine|zidovudine|mesh-list
153691636|NCT00192595|Efavirenz|efavirenz|mesh-list
153375389|NCT05244993|Paclitaxel|paclitaxel|mesh-list
153564800|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564801|NCT05539924|Analgesics|analgesics|mesh-ancestor
153691637|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
153691638|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691639|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153691640|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691641|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691642|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691643|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153691644|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153691645|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
153691646|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153691647|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153691648|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153528609|NCT01479361|Atovaquone|atovaquone|mesh-list
153691649|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153691650|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153691651|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153691652|NCT00192634|Tenofovir|tenofovir|mesh-list
153691653|NCT00192634|Lamivudine|lamivudine|mesh-list
153691654|NCT00192634|Emtricitabine|emtricitabine|mesh-list
153691655|NCT00192634|Abacavir|abacavir|mesh-list
153691656|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
153691657|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691658|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153691659|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691660|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691661|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691662|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153691663|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153691664|NCT00192673|Asparaginase|asparaginase|mesh-list
153691665|NCT00192673|Pegaspargase|pegaspargase|mesh-list
153691666|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691667|NCT00192712|Gemcitabine|gemcitabine|mesh-list
153691683|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691699|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
153691700|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691701|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
153691702|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153691703|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691704|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153691705|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153783343|NCT00236093|Fentanyl|fentanyl|mesh-list
153691706|NCT00193102|Growth Substances|growth substances|mesh-ancestor
153691707|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
153691709|NCT00193141|Carboplatin|carboplatin|mesh-list
153691710|NCT00193141|Fluorouracil|fluorouracil|mesh-list
153691711|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691712|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691713|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691714|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691715|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691716|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691717|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
153691718|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691719|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691720|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
153691721|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691722|NCT00193297|Paclitaxel|paclitaxel|mesh-list
153691723|NCT00193297|Carboplatin|carboplatin|mesh-list
153691725|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691726|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691727|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691728|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691729|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691730|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691731|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153691732|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153691733|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691734|NCT00193336|Gefitinib|gefitinib|mesh-list
153691735|NCT00193336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153691736|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153691737|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375403|NCT01558700|Analgesics|analgesics|mesh-ancestor
153565146|NCT02975037|Urological Agents|urological agents|mesh-ancestor
153565147|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153565148|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691738|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691739|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691740|NCT00193531|Paclitaxel|paclitaxel|mesh-list
153691741|NCT00193531|Etoposide|etoposide|mesh-list
153691742|NCT00193531|Carboplatin|carboplatin|mesh-list
153691756|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691757|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691758|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691760|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153691761|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691762|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153691763|NCT00047736|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153691764|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153691765|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691766|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691767|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691768|NCT00409591|Ritonavir|ritonavir|mesh-list
153691769|NCT00409591|Lopinavir|lopinavir|mesh-list
153691770|NCT00409591|Zidovudine|zidovudine|mesh-list
153691771|NCT00409591|Nevirapine|nevirapine|mesh-list
153691772|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153691773|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153691774|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
153691775|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691776|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691777|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153691778|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153691779|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
153691780|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691781|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153691782|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153691783|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
153691784|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153691785|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691786|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153691787|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153691788|NCT00409630|Fluticasone|fluticasone|mesh-list
153691789|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153691790|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153691791|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
153691792|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691793|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691794|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153691795|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
153691796|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
153691797|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153691798|NCT00060125|Tipifarnib|tipifarnib|mesh-list
153691799|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691800|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
153691801|NCT00193648|Adalimumab|adalimumab|mesh-list
153691802|NCT00193648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153691803|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153691804|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153691838|NCT00193921|Gemcitabine|gemcitabine|mesh-list
153691839|NCT00193921|Vinorelbine|vinorelbine|mesh-list
153691840|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691841|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691842|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
153691843|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691844|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691845|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691861|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
153691862|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153691863|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153691864|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153691865|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153691867|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154257154|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375429|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691869|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153691870|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691871|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691872|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691873|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691874|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691875|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691876|NCT00194272|Methotrexate|methotrexate|mesh-list
153528828|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153691877|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153691878|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
153691879|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153691880|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851263|NCT05797623|Cyclosporins|cyclosporins|mesh-list
153691896|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691897|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347848|NCT00265850|Leucovorin|leucovorin|mesh-list
153691898|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153691899|NCT00194467|Valganciclovir|valganciclovir|mesh-list
153691900|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
153691901|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691902|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
153691903|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153691904|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153691922|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153691923|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153691924|NCT00194818|Analgesics|analgesics|mesh-ancestor
153691925|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
153691926|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691927|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691928|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153691929|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153691930|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
153691931|NCT00194857|Hematinics|hematinics|mesh-ancestor
153691933|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153691934|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153691935|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691936|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691937|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691938|NCT00194974|Clonidine|clonidine|mesh-list
153691939|NCT00194974|Labetalol|labetalol|mesh-list
153691940|NCT00194974|Methyldopa|methyldopa|mesh-list
153691941|NCT00194974|Nifedipine|nifedipine|mesh-list
153691942|NCT00194974|Analgesics|analgesics|mesh-ancestor
153691943|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
153691944|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691945|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691946|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153691947|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
153691948|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
153691949|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153691950|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153691951|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153691952|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691953|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691954|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691955|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153691956|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691957|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153691958|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
153691959|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
153691960|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153691968|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153691969|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153691970|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691971|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691972|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153691973|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153691974|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153691975|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
153347912|NCT01042145|Hormones|hormones|mesh-ancestor
153348049|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
153691976|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691977|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153691978|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153691979|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691980|NCT00195286|Tazobactam|tazobactam|mesh-list
153691981|NCT00195286|Piperacillin|piperacillin|mesh-list
153691982|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153691983|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153691984|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691985|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153691986|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691987|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691988|NCT00084201|Amoxicillin|amoxicillin|mesh-list
153691989|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153691990|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691991|NCT00195364|Etanercept|etanercept|mesh-list
153691992|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153691993|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153691994|NCT00195364|Analgesics|analgesics|mesh-ancestor
153691995|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
153691996|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691997|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691998|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153691999|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692000|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692001|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692002|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
153692003|NCT00195481|Sirolimus|sirolimus|mesh-list
153692004|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153692005|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692006|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153692007|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692008|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
153692009|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692010|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
153692011|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692012|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
153692013|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153692014|NCT00195559|Estradiol|estradiol|mesh-list
153692015|NCT00195559|Estrogens|estrogens|mesh-ancestor
153692016|NCT00195559|Hormones|hormones|mesh-ancestor
153692017|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153692018|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692019|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153692020|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
153692021|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153692022|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153692023|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153692024|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153692025|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153528978|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692026|NCT00084240|Azithromycin|azithromycin|mesh-list
153692027|NCT00084240|Chloroquine|chloroquine|mesh-list
153692028|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153692059|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692061|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692062|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153692063|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
153692064|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692065|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153692066|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153692067|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851314|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692071|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
153692086|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692087|NCT00195793|Atorvastatin|atorvastatin|mesh-list
153692088|NCT00195793|Ezetimibe|ezetimibe|mesh-list
153692089|NCT00195793|Fenofibrate|fenofibrate|mesh-list
153692090|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153692091|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153692092|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
153692093|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692094|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153692095|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153692096|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692097|NCT00195871|Cytarabine|cytarabine|mesh-list
153692098|NCT00195871|Prednisone|prednisone|mesh-list
153692099|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
154257155|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154257156|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565630|NCT03015740|Nivolumab|nivolumab|mesh-list
153692100|NCT00195871|Methotrexate|methotrexate|mesh-list
153692101|NCT00195871|Etoposide|etoposide|mesh-list
153692102|NCT00195871|Vincristine|vincristine|mesh-list
153692103|NCT00195871|Daunorubicin|daunorubicin|mesh-list
153692104|NCT00195871|Asparaginase|asparaginase|mesh-list
153692105|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692106|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
153692107|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692108|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692109|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153692110|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
153692111|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692112|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692113|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153692114|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692115|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
153692116|NCT00195871|Hormones|hormones|mesh-ancestor
153692117|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153692118|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153692119|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153692120|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
153692121|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153692122|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153692123|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
153692124|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
153692125|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692126|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153692127|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153692128|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153692129|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153692130|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153692131|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
153692132|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
153692149|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
153692150|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692151|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153692152|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692153|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692154|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153692155|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692156|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153692157|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
153692158|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153692159|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692160|NCT00060476|Rofecoxib|rofecoxib|mesh-list
153692161|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153692162|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153692164|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692165|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153692166|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153692167|NCT00060476|Analgesics|analgesics|mesh-ancestor
153692168|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
153692169|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692170|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692183|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
153692184|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692185|NCT00196378|Estrogens|estrogens|mesh-list
153692186|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153692187|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
153692188|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
153692189|NCT00196378|Hormones|hormones|mesh-ancestor
153692190|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153692200|NCT00060554|Fondaparinux|fondaparinux|mesh-list
153692201|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
153692202|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153692203|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153692204|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692205|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153565739|NCT06225271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565740|NCT06225258|Xanthohumol|xanthohumol|mesh-list
153565765|NCT06224946|Mitogens|mitogens|mesh-list
153692206|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
153692207|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153692208|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
153692209|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692210|NCT00048087|Docetaxel|docetaxel|mesh-list
153692211|NCT00048087|Gefitinib|gefitinib|mesh-list
153692212|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692213|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
153692214|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
153692215|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
153692216|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692217|NCT00048087|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692218|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692219|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692220|NCT00196534|Thrombin|thrombin|mesh-list
153692221|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
153692222|NCT00196534|Coagulants|coagulants|mesh-ancestor
153692223|NCT00048126|Capecitabine|capecitabine|mesh-list
153692224|NCT00048126|Irinotecan|irinotecan|mesh-list
153692225|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153692226|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
153692227|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692228|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692229|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153692230|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153692231|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692232|NCT00196612|Emtricitabine|emtricitabine|mesh-list
153692233|NCT00196612|Efavirenz|efavirenz|mesh-list
153692234|NCT00196612|Didanosine|didanosine|mesh-list
153692235|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
153692236|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692237|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153692238|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153692239|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692240|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692241|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153692242|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153851374|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
153692252|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692253|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692254|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
153692255|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692256|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692257|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
153692258|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
153692280|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
153692281|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692282|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
153692283|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153692284|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
153692285|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692286|NCT00196885|Expectorants|expectorants|mesh-ancestor
153692287|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
153692288|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153692289|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
153692290|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692291|NCT00196885|Protective Agents|protective agents|mesh-ancestor
153692292|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692293|NCT00196885|Antidotes|antidotes|mesh-ancestor
153692294|NCT00048204|Paroxetine|paroxetine|mesh-list
153692295|NCT00048204|Vestipitant|vestipitant|mesh-list
153692296|NCT00048204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153692297|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153692298|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692299|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692300|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692301|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
153692302|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692303|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153692304|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
153692305|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565913|NCT06222723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692306|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153692307|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153692308|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692309|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153692310|NCT00197080|Ropinirole|ropinirole|mesh-list
153692327|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692328|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692329|NCT00197197|Aplaviroc|aplaviroc|mesh-list
153692330|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153692331|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153692332|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692333|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153692334|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153692335|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
153692336|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692337|NCT00409903|Eprosartan|eprosartan|mesh-list
153692338|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153692339|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
153692340|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153692341|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692342|NCT00084435|Docetaxel|docetaxel|mesh-list
153692343|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692348|NCT00197353|Bupivacaine|bupivacaine|mesh-list
153692349|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
153692350|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
153692351|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692352|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692353|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
153692354|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692356|NCT02962999|Analgesics|analgesics|mesh-ancestor
153692357|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
153692358|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692359|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692360|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153692361|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153692362|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
153692363|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
153692364|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692365|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153692366|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153692367|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692385|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
153692386|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692387|NCT00197548|Hematinics|hematinics|mesh-ancestor
153692388|NCT00197587|Nevirapine|nevirapine|mesh-list
153692389|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153692390|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153692391|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692392|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692393|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
153692394|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692395|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153692396|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153692397|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153692398|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153692399|NCT00197743|Vitamin A|vitamin a|mesh-list
153692400|NCT00197743|Beta Carotene|beta carotene|mesh-list
153692401|NCT00197743|Carotenoids|carotenoids|mesh-list
153692402|NCT00197743|Vitamins|vitamins|mesh-ancestor
153692403|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
153692404|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692405|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
153692406|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692407|NCT00197743|Protective Agents|protective agents|mesh-ancestor
153692408|NCT00197743|Provitamins|provitamins|mesh-ancestor
153692409|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
153692410|NCT00084630|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692411|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692412|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692413|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692414|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692415|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154263479|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154263480|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263481|NCT05461794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263482|NCT05401097|Azacitidine|azacitidine|mesh-list
154263483|NCT05401097|Venetoclax|venetoclax|mesh-list
154263484|NCT05401097|Ivosidenib|ivosidenib|mesh-list
154263485|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263486|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
153692416|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
153692417|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692418|NCT00084669|Zolpidem|zolpidem|mesh-list
153692419|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153692420|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153692421|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153692422|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692423|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692432|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153692433|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
153692434|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
153692435|NCT00060866|Propranolol|propranolol|mesh-list
153692436|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153692437|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153692438|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
153692439|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692440|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692441|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692442|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153692443|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153692444|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
153692445|NCT00048360|Bupropion|bupropion|mesh-list
153692446|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153692447|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
153692448|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692449|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153692450|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153692451|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692452|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692453|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
153692454|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692455|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692456|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153692457|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153692458|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692459|NCT00198055|Aripiprazole|aripiprazole|mesh-list
153692460|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
153692461|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692462|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153692463|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153692464|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692465|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692466|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
153692467|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
153692468|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692469|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692470|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153692471|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153692472|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
153692473|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153692474|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153692475|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153692476|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153692478|NCT00198094|Sertraline|sertraline|mesh-list
153692479|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
153692480|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692481|NCT00198094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153692482|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153692483|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692484|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692485|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692486|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
153692505|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692506|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692507|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692508|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153692509|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
153692510|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692512|NCT00084708|Dexamethasone|dexamethasone|mesh-list
153692513|NCT00084708|Gefitinib|gefitinib|mesh-list
153692514|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692515|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
153692516|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
153692517|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692518|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692519|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692520|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
153692521|NCT00084708|Hormones|hormones|mesh-ancestor
153692526|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692527|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692528|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692529|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153692530|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153692531|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692532|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153692534|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
153692535|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153692536|NCT00198367|Cisplatin|cisplatin|mesh-list
153692537|NCT00198367|Carboplatin|carboplatin|mesh-list
153692538|NCT00198367|Vinorelbine|vinorelbine|mesh-list
153692539|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692564|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692566|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153692567|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736001|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
153692568|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692569|NCT00198523|Tobramycin|tobramycin|mesh-list
153692570|NCT00198523|Prednisolone|prednisolone|mesh-list
153692571|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153692572|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
153692573|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153692574|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
153692575|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153692576|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
153692577|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692578|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
153692579|NCT00198523|Hormones|hormones|mesh-ancestor
153692580|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153692581|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692582|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153692583|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692584|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
153692585|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
153692586|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692587|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692588|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153692589|NCT00198523|Protective Agents|protective agents|mesh-ancestor
153692609|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153692610|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692611|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692612|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153692613|NCT00084786|Docetaxel|docetaxel|mesh-list
153692614|NCT00084786|Gefitinib|gefitinib|mesh-list
153692615|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692616|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
153692617|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
153692618|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
153692619|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566480|NCT06235177|Vitamins|vitamins|mesh-list
153692620|NCT00084786|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692621|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692623|NCT00409981|Paclitaxel|paclitaxel|mesh-list
153692624|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153692625|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692626|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
153692627|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
153692628|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
153692629|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692630|NCT00198601|Gentamicins|gentamicins|mesh-list
153692631|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153692632|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692633|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153692634|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692636|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153692637|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692638|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
153692639|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153692640|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692641|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
153692643|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
153692644|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692670|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
153692671|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692672|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153692673|NCT00199186|Cytarabine|cytarabine|mesh-list
153692674|NCT00199186|Dexamethasone|dexamethasone|mesh-list
153692675|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
153692676|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
153692677|NCT00199186|Methotrexate|methotrexate|mesh-list
153692678|NCT00199186|Vincristine|vincristine|mesh-list
153692679|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
153692680|NCT00199186|Idarubicin|idarubicin|mesh-list
153692681|NCT00199186|BB 1101|bb 1101|mesh-list
153692682|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692683|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
153692684|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692685|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153424513|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692686|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153692687|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
153692688|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692689|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692690|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153692691|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692692|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
153692693|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
153692694|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692713|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
153692714|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
153692715|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692716|NCT00199186|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692717|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692718|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153692719|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153692720|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153692722|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153692723|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692724|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153692725|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153692726|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692727|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692728|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692729|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
153692730|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
153692731|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692732|NCT00061022|Protective Agents|protective agents|mesh-ancestor
153692733|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692734|NCT00199264|Albaconazole|albaconazole|mesh-list
153348952|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
153692735|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
153692736|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692737|NCT00199342|Ecromeximab|ecromeximab|mesh-list
153692738|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153692739|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692740|NCT00199420|Istradefylline|istradefylline|mesh-list
153692741|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153375687|NCT05437965|Hormones|hormones|mesh-ancestor
153566643|NCT06234046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692742|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153692743|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153692744|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
153692745|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692746|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692747|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692748|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
153692779|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
153692780|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
153692781|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
153692783|NCT00084981|Azacitidine|azacitidine|mesh-list
153692790|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
153692791|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
153692792|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692793|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692794|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
153692805|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
153692806|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153692807|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692808|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692809|NCT00085020|Trastuzumab|trastuzumab|mesh-list
153692810|NCT00085020|Lapatinib|lapatinib|mesh-list
153692811|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153692812|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692813|NCT00085020|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692814|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692815|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692816|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692817|NCT00410215|Bisacodyl|bisacodyl|mesh-list
153736002|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736003|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153692818|NCT00410215|Cathartics|cathartics|mesh-ancestor
153692819|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692820|NCT00410215|Laxatives|laxatives|mesh-ancestor
153692821|NCT00410254|Midazolam|midazolam|mesh-list
153692822|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153692823|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153692824|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692825|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692826|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153692827|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153692828|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692829|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153692830|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
153692831|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
153692832|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
153692833|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
153692834|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692835|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692836|NCT00061178|Bevacizumab|bevacizumab|mesh-list
153692837|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153692838|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692839|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153692840|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153692841|NCT00061178|Growth Substances|growth substances|mesh-ancestor
153692842|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692843|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
153692844|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153692845|NCT00200395|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692846|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692847|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692848|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692849|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692851|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153692852|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
153692853|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153692854|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153692855|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153692856|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
153692857|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692858|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692859|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692860|NCT00200473|Nebivolol|nebivolol|mesh-list
153692894|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692898|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692899|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
153692900|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692932|NCT00200629|Analgesics|analgesics|mesh-ancestor
153692933|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
153692934|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692935|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692936|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153692937|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
153692938|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153692939|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
153692940|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
153692941|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692942|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692943|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153692944|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153692945|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692946|NCT00048594|Aprepitant|aprepitant|mesh-list
153692947|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
153692963|NCT00201331|Leucovorin|leucovorin|mesh-list
153692964|NCT00201331|Antidotes|antidotes|mesh-ancestor
153692965|NCT00201331|Protective Agents|protective agents|mesh-ancestor
153692966|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692967|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
153692968|NCT00201331|Vitamins|vitamins|mesh-ancestor
153692969|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
153692970|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
153692971|NCT00048672|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692972|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692973|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692974|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692975|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692976|NCT00201682|Etanercept|etanercept|mesh-list
153692977|NCT00201682|Rituximab|rituximab|mesh-list
153692978|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153692979|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692980|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
153692981|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692982|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692983|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153692984|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153692985|NCT00201682|Analgesics|analgesics|mesh-ancestor
153692986|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
153692987|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692988|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692989|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692990|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692991|NCT00410371|Lamotrigine|lamotrigine|mesh-list
153692992|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
153692993|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153692994|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692995|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692996|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153692997|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692998|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153692999|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693000|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693001|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693002|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153693003|NCT00410449|Tocopherols|tocopherols|mesh-list
153693004|NCT00410449|Vitamin E|vitamin e|mesh-list
153693005|NCT00410449|Tocotrienols|tocotrienols|mesh-list
153693006|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
153693007|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
153693039|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153693040|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153693042|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153693043|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153693044|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153693047|NCT00221494|Citalopram|citalopram|mesh-list
153693048|NCT00221494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153693049|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153693050|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693082|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693083|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153693084|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693085|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153693086|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
153693087|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
153693088|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693089|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693090|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
153693091|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
153693092|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693093|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693094|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693108|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693109|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153693110|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153693111|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693112|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693113|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693114|NCT00048828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153693115|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153693116|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693117|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693118|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693119|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
153349375|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
153693120|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153693121|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
153693122|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
153693123|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153693124|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153693125|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153693126|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693127|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153693128|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153693129|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153693130|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
153693131|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693132|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693133|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693134|NCT00221845|Telmisartan|telmisartan|mesh-list
153693135|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693136|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153693137|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153693138|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693139|NCT00085761|Capsaicin|capsaicin|mesh-list
153693140|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
153693141|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
153693142|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
153693143|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693144|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693145|NCT00221962|Aripiprazole|aripiprazole|mesh-list
153693146|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693147|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693148|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153693149|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693150|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693151|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693152|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
153693154|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693155|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693156|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153693193|NCT00061646|Carboplatin|carboplatin|mesh-list
153693194|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693195|NCT00222469|Bevacizumab|bevacizumab|mesh-list
153693196|NCT00222469|Gemcitabine|gemcitabine|mesh-list
153693197|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
153693198|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153693199|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693200|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153693201|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153693202|NCT00222469|Growth Substances|growth substances|mesh-ancestor
153693203|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736004|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
153693204|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
153693205|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153693206|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
153693207|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693209|NCT00222547|Albendazole|albendazole|mesh-list
153693211|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
153693212|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391842|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693220|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153693236|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
153693237|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153693238|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
153693239|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693240|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693241|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153693242|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
153693243|NCT00222820|Escitalopram|escitalopram|mesh-list
153693244|NCT00222820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153693245|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153693246|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693247|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693248|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693249|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
153693250|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693251|NCT00085332|Docetaxel|docetaxel|mesh-list
153693252|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693253|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
153693254|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
153693255|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
153693256|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693257|NCT00222976|Naproxen|naproxen|mesh-list
153693258|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153693259|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153693260|NCT00222976|Analgesics|analgesics|mesh-ancestor
153693261|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
153693262|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693263|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693264|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153693265|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153693266|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
153693267|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153693268|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693269|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693270|NCT00223015|Tacrolimus|tacrolimus|mesh-list
153693271|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153693272|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
153693273|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693274|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153693275|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693276|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693277|NCT00061763|Deferasirox|deferasirox|mesh-list
153693278|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153693279|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
153693280|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
153693296|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153693297|NCT00223054|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153693298|NCT00223054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153693299|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693300|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153693301|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153693302|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153693303|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693304|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693305|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153693306|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693307|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693308|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693309|NCT00061802|Risperidone|risperidone|mesh-list
153693327|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693328|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693329|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693330|NCT00223288|Escitalopram|escitalopram|mesh-list
153693331|NCT00223288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153693332|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153693333|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693334|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693335|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693336|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
153693337|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693338|NCT00085449|Cyclosporine|cyclosporine|mesh-list
153693339|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
153693340|NCT00085449|Fludarabine|fludarabine|mesh-list
153693365|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153693366|NCT00223561|Methylphenidate|methylphenidate|mesh-list
153693367|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153693368|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693369|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153530336|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693370|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153693371|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693372|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693373|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
153693374|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693376|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
153693377|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153693378|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693381|NCT00223717|Metoprolol|metoprolol|mesh-list
153693382|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153693383|NCT00223717|Clonidine|clonidine|mesh-list
153693384|NCT00223717|Eplerenone|eplerenone|mesh-list
153693385|NCT00223717|Nebivolol|nebivolol|mesh-list
153693386|NCT00223717|Bosentan|bosentan|mesh-list
153693387|NCT00223717|Diltiazem|diltiazem|mesh-list
153693388|NCT00223717|Guanfacine|guanfacine|mesh-list
153693389|NCT00223717|Prazosin|prazosin|mesh-list
153693390|NCT00223717|Captopril|captopril|mesh-list
153693391|NCT00223717|Hydralazine|hydralazine|mesh-list
153693392|NCT00223717|Nifedipine|nifedipine|mesh-list
153391912|NCT00000345|Lofexidine|lofexidine|mesh-list
153693424|NCT00223717|Diuretics|diuretics|mesh-ancestor
153693425|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
153693426|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153693427|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693428|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
153693429|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
153693430|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153693431|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153693432|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153693433|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
153693434|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693435|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153693436|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153693437|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153693453|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153693454|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153693455|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153693456|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153693457|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
153693458|NCT00223717|Coagulants|coagulants|mesh-ancestor
153693459|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153693460|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153693461|NCT00061919|Thalidomide|thalidomide|mesh-list
153693462|NCT00061919|Carboplatin|carboplatin|mesh-list
153693463|NCT00061919|Etoposide|etoposide|mesh-list
153693464|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
153693465|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693466|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153693467|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153693468|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153693469|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693470|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693471|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153693472|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
153693473|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693474|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
153693475|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153693476|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693477|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153693478|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153693479|NCT00061919|Growth Substances|growth substances|mesh-ancestor
153693480|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
153693482|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153693483|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693484|NCT00085527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153693485|NCT00085527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693486|NCT00085527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693487|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
153693488|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693489|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
153693490|NCT00224068|Hematinics|hematinics|mesh-ancestor
153693491|NCT00224146|Oxybutynin|oxybutynin|mesh-list
153693492|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
153693493|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
153693494|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693495|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693496|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153693527|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
153693528|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153693529|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153693530|NCT00062036|Analgesics|analgesics|mesh-ancestor
153693531|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
153693532|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693533|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153693534|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153693535|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
153693536|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693537|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153693538|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153851722|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153693560|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693561|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153693562|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153693563|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
153693564|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693565|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693567|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153693568|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153693569|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153693570|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693571|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693572|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
153693573|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693574|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153693575|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153693576|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153693577|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153693578|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153693579|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153693580|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428037|NCT03764449|Balovaptan|balovaptan|mesh-list
153693581|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153693582|NCT00062114|Rituximab|rituximab|mesh-list
153693583|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153693584|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693585|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
153693586|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693587|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153693588|NCT00095043|Gaboxadol|gaboxadol|mesh-list
153693589|NCT00095043|Analgesics|analgesics|mesh-ancestor
153693590|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
153693591|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693592|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693593|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
153693594|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
153693595|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
153693596|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693597|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693598|NCT00095082|Insulin|insulin|mesh-list
153693599|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153693617|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693619|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153693620|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
153693621|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153693622|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693623|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153693624|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153693625|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153693626|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153693627|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153693628|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153693629|NCT00224692|Ketamine|ketamine|mesh-list
153693630|NCT00224692|Analgesics|analgesics|mesh-ancestor
153693631|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
153693632|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693633|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693634|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153693635|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153349961|NCT01793636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693649|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153693650|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153693651|NCT00224809|Analgesics|analgesics|mesh-ancestor
153693652|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
153693653|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693654|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693655|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153693679|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153693680|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
153693681|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693682|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
153693683|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
153693684|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
153693685|NCT00062270|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153693686|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153693687|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693688|NCT00413023|Casopitant|casopitant|mesh-list
153693689|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
153693690|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
153693691|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693692|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693693|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153693694|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153693695|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693696|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693697|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
153693698|NCT00095277|Hematinics|hematinics|mesh-ancestor
153693699|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
153693700|NCT00413101|Hematinics|hematinics|mesh-ancestor
153693701|NCT00413179|Metformin|metformin|mesh-list
153693702|NCT00413179|Clomiphene|clomiphene|mesh-list
153693703|NCT00413179|Enclomiphene|enclomiphene|mesh-list
153693704|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
153693705|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153693706|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693707|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153693740|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
153693742|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
153693743|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153693744|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153693745|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
153693746|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153693747|NCT00225043|Protective Agents|protective agents|mesh-ancestor
153693748|NCT00225121|Dacomitinib|dacomitinib|mesh-list
153693771|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153693772|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153693773|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153693774|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693775|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693781|NCT00062426|Calcium|calcium|mesh-list
153693782|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
153693783|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153693784|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693785|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153693786|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153693787|NCT00062426|Growth Substances|growth substances|mesh-ancestor
153693788|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693789|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
153693790|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153693791|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153693792|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
153693793|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693794|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153350147|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
153693795|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
153693796|NCT00062426|Antidotes|antidotes|mesh-ancestor
153693797|NCT00062426|Protective Agents|protective agents|mesh-ancestor
153693798|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
153693799|NCT00062426|Vitamins|vitamins|mesh-ancestor
153693800|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
153693801|NCT00095433|Ranibizumab|ranibizumab|mesh-list
153693802|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153693821|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153693822|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693823|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153530784|NCT01492881|Vorinostat|vorinostat|mesh-list
153693824|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693825|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693826|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153693827|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693828|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
153693829|NCT02962258|Diuretics|diuretics|mesh-ancestor
153693830|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
153693831|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153693832|NCT00225511|Milnacipran|milnacipran|mesh-list
153693833|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153693834|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
153693835|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153693836|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153693837|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693838|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693839|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693840|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350224|NCT00369590|Growth Substances|growth substances|mesh-ancestor
153693841|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153693842|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693843|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693844|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153693845|NCT00225511|Analgesics|analgesics|mesh-ancestor
153693846|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
153693847|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693848|NCT00095511|Aripiprazole|aripiprazole|mesh-list
153693849|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693850|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693851|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153693852|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693853|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693854|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693855|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
153693856|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
153693873|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693875|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153693876|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693877|NCT02967887|Fluorouracil|fluorouracil|mesh-list
153693878|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693879|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
153693880|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693889|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693890|NCT00225706|Ibuprofen|ibuprofen|mesh-list
153693891|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153693892|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153693893|NCT00225706|Analgesics|analgesics|mesh-ancestor
153693894|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
153693895|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693896|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693897|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153693898|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153693899|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153693900|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693901|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693903|NCT00095667|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153693904|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153693905|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693906|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693907|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693908|NCT00225862|Ropinirole|ropinirole|mesh-list
153693909|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153693910|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153693911|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
153693929|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153693930|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153693931|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693932|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
153693933|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153693934|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
153693935|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153693936|NCT00095745|Aripiprazole|aripiprazole|mesh-list
153693937|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
153693938|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693939|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153693940|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693941|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693942|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693943|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
153693944|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
153693945|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693946|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693947|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153693948|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153693949|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
153693950|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153693951|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153693952|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153693953|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153693954|NCT00226096|Metoprolol|metoprolol|mesh-list
153693955|NCT00226096|Clonidine|clonidine|mesh-list
153693956|NCT00226096|Nitroprusside|nitroprusside|mesh-list
153693957|NCT00226096|Labetalol|labetalol|mesh-list
153693958|NCT00226096|Hydralazine|hydralazine|mesh-list
153350400|NCT05901571|Dexetimide|dexetimide|mesh-list
153693959|NCT00226096|Nicardipine|nicardipine|mesh-list
153693960|NCT00226096|Phentolamine|phentolamine|mesh-list
153693961|NCT00226096|Urapidil|urapidil|mesh-list
153693962|NCT00226096|Enalaprilat|enalaprilat|mesh-list
153693963|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
153693964|NCT00226096|Esmolol|esmolol|mesh-list
153693965|NCT00226096|Glycerol|glycerol|mesh-list
153693966|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153694000|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694001|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153694002|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694003|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694004|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
153694005|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153694006|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694007|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153694008|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153694009|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153694010|NCT00400374|Celecoxib|celecoxib|mesh-list
153694011|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153694012|NCT00400374|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153694013|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153375936|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
153694014|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694015|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694016|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694017|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153694018|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153694019|NCT00400374|Analgesics|analgesics|mesh-ancestor
153694020|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
153694021|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694022|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694023|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694024|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694025|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153694026|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153694027|NCT00226330|Pioglitazone|pioglitazone|mesh-list
153694028|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694029|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694030|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
153694031|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694032|NCT00226408|Interferons|interferons|mesh-list
153694033|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
153694034|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
153350582|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153694035|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694036|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
153694037|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694038|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
153694039|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694041|NCT00226447|Lamivudine|lamivudine|mesh-list
153694042|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694043|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
153694044|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694045|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153694046|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153694047|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694048|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694050|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153694051|NCT00062660|Tipranavir|tipranavir|mesh-list
153694052|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153694053|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153694054|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
153694055|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694056|NCT00413296|Levetiracetam|levetiracetam|mesh-list
153694057|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
153694058|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
153694059|NCT00413452|Etanercept|etanercept|mesh-list
153694060|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153694061|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153694062|NCT00413452|Analgesics|analgesics|mesh-ancestor
153694063|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
153694067|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694068|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153694069|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694070|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
153694071|NCT00095823|Aripiprazole|aripiprazole|mesh-list
153694072|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
153694073|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694074|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153694075|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153694076|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694077|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694078|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
153694079|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
153694080|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694081|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694082|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153694083|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153694084|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
153694085|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153694086|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153694087|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153694088|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153694089|NCT00226564|Alfentanil|alfentanil|mesh-list
153694090|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154257157|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257158|NCT01269242|Bindarit|bindarit|mesh-list
153694091|NCT00226564|Narcotics|narcotics|mesh-ancestor
153694092|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694093|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694094|NCT00226564|Analgesics|analgesics|mesh-ancestor
153694121|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694122|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694124|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153694125|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
153694126|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
153350640|NCT05519111|Hormones|hormones|mesh-ancestor
153694127|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694128|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694129|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153694130|NCT00226837|Analgesics|analgesics|mesh-ancestor
153694131|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
153694132|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694133|NCT00226915|Paclitaxel|paclitaxel|mesh-list
153694134|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153694135|NCT00226915|Carboplatin|carboplatin|mesh-list
153694136|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153694137|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694138|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
153694139|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
153694140|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
153694170|NCT00227110|Pioglitazone|pioglitazone|mesh-list
153694171|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694172|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694173|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
153694174|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694175|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153694176|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
153694177|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694178|NCT00096057|Antibodies|antibodies|mesh-list
153694179|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153694180|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
153694215|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694218|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694219|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
153694220|NCT00227656|Interferons|interferons|mesh-list
153694221|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
153694222|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
153694223|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153694224|NCT00227656|Capecitabine|capecitabine|mesh-list
153694243|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
153694244|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694245|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694246|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153694247|NCT00063011|Calcium|calcium|mesh-list
153694248|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153694249|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694250|NCT00227773|Octreotide|octreotide|mesh-list
153694251|NCT00227773|Hormones|hormones|mesh-list
153694252|NCT00227773|Somatostatin|somatostatin|mesh-list
153694253|NCT00227773|Mitogens|mitogens|mesh-list
153694254|NCT00227773|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153694255|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153694256|NCT00227773|Vatalanib|vatalanib|mesh-list
153694257|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694258|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694259|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
153694260|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694261|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153694262|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153694263|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694264|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153694265|NCT00227812|Bupropion|bupropion|mesh-list
153350891|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153350892|NCT04535687|Fluzoparib|fluzoparib|mesh-list
153350988|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
153694266|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153694267|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
153694268|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153531240|NCT01495338|Cetirizine|cetirizine|mesh-list
153694269|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153694270|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153694271|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694272|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694273|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
153694274|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694275|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694276|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153694277|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153694278|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694279|NCT00096291|Paclitaxel|paclitaxel|mesh-list
153694290|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153694291|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153694292|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694293|NCT02967302|Triamcinolone|triamcinolone|mesh-list
153694294|NCT02967302|Morphine|morphine|mesh-list
153694295|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153694296|NCT02967302|Narcotics|narcotics|mesh-ancestor
153694297|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694298|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694299|NCT02967302|Analgesics|analgesics|mesh-ancestor
153694300|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
153694301|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694302|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694303|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
153694304|NCT02967302|Hormones|hormones|mesh-ancestor
153425046|NCT03565328|Niacin|niacin|mesh-list
153350989|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694305|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694306|NCT00096330|Folic Acid|folic acid|mesh-list
153694307|NCT00096330|Hematinics|hematinics|mesh-ancestor
153694308|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
153694309|NCT00096330|Vitamins|vitamins|mesh-ancestor
153694310|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
153392143|NCT00000483|Clofibrate|clofibrate|mesh-list
153694330|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153694331|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153694332|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694333|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694334|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
153694335|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694336|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
153694337|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
153694338|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694339|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
153694340|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153694341|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
153694342|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694343|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
153694344|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
153694358|NCT00228163|Analgesics|analgesics|mesh-ancestor
153694359|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
153694360|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694361|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694362|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694363|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694364|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694365|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
153694366|NCT00063128|Insulin|insulin|mesh-list
153694367|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153694368|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153351039|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153694369|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694370|NCT00075465|Docetaxel|docetaxel|mesh-list
153694371|NCT00075465|Epirubicin|epirubicin|mesh-list
153694372|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694373|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
153694374|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
153694375|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
153694376|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694377|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153694388|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694389|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
153694390|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694391|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
153694392|NCT00228319|Protective Agents|protective agents|mesh-ancestor
153694393|NCT00096525|Lenalidomide|lenalidomide|mesh-list
153694394|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
153694395|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257159|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694396|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153694397|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153694398|NCT00096525|Growth Substances|growth substances|mesh-ancestor
153694399|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
153694400|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694401|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
153694402|NCT00228358|Interleukin-2|interleukin-2|mesh-list
153694403|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
153694404|NCT00228358|Immunotoxins|immunotoxins|mesh-list
153694405|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694406|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
153694407|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694408|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694409|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153694410|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
153694429|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
153694430|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694431|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
153694432|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
153351174|NCT01366612|Busulfan|busulfan|mesh-list
153694433|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
153694434|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694435|NCT00228475|Budesonide|budesonide|mesh-list
153694436|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694437|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153694438|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
153694439|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694440|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694441|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153694442|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
153694443|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
153694444|NCT00228475|Hormones|hormones|mesh-ancestor
153694445|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694446|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153694447|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153694448|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153694449|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
153694450|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694451|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153694452|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153694453|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694454|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
153694455|NCT00228592|Antibodies|antibodies|mesh-list
153694456|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
153694457|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153694458|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153694459|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
153694460|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694461|NCT00075621|Melphalan|melphalan|mesh-list
153694462|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
153851994|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153694503|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694505|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694506|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694507|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153694508|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153694509|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694511|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
153694512|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694534|NCT00229450|Estrogens|estrogens|mesh-list
153694535|NCT00229450|Hormones|hormones|mesh-ancestor
153694536|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694537|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694538|NCT00229528|Paroxetine|paroxetine|mesh-list
153694539|NCT00229528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153694540|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153694541|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694542|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694543|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694544|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
153694545|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694546|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154257160|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153694548|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694549|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153694550|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153694551|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694552|NCT00075699|Vincristine|vincristine|mesh-list
153694553|NCT00075699|Vinorelbine|vinorelbine|mesh-list
153694554|NCT00075699|Mitomycins|mitomycins|mesh-list
153694555|NCT00075699|Mitomycin|mitomycin|mesh-list
153694556|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694557|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153694558|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
153694559|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
153694560|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
153694561|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694562|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153694581|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153694582|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
153694583|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153694584|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153694585|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694586|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153694587|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
153694588|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694589|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153351298|NCT00396032|Tenecteplase|tenecteplase|mesh-list
153694590|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153694591|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694592|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694594|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153694595|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694596|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153852013|NCT01239394|Ofatumumab|ofatumumab|mesh-list
153694599|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694600|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694601|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153694602|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153694604|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694605|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694606|NCT00096720|Levodopa|levodopa|mesh-list
153694607|NCT00096720|Pramipexole|pramipexole|mesh-list
153694608|NCT00096720|Dexpramipexole|dexpramipexole|mesh-list
153694609|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153694610|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153694611|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
153694612|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694613|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694614|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694615|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
153694616|NCT00096720|Protective Agents|protective agents|mesh-ancestor
153694617|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
153694618|NCT00413608|Clopidogrel|clopidogrel|mesh-list
153694634|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694635|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694636|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694637|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
153694638|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694639|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694640|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153694641|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153531612|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
153425111|NCT01155518|Androgens|androgens|mesh-ancestor
153694642|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153694644|NCT00229996|Norethindrone|norethindrone|mesh-list
153694645|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
153694646|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
153694647|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
153694648|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153694649|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
153694650|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153694651|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694652|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153694653|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257161|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257162|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694654|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153694655|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153694656|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153694657|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153694658|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
153694659|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
153694660|NCT00230035|Rituximab|rituximab|mesh-list
153694661|NCT00230035|Methotrexate|methotrexate|mesh-list
153694662|NCT00230035|Azathioprine|azathioprine|mesh-list
153694663|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
153694664|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153694665|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153694666|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
153694667|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153694668|NCT00230035|Leflunomide|leflunomide|mesh-list
153694669|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
153694670|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153694671|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351504|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351585|NCT05258292|Insulin|insulin|mesh-list
153694672|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694673|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
153694674|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694675|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694676|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153694677|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
153694689|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153694690|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694691|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694692|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
153694693|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
153694695|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153694696|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
153694697|NCT00230035|Hormones|hormones|mesh-ancestor
153694698|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694699|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153694700|NCT00230035|Protective Agents|protective agents|mesh-ancestor
153694701|NCT00063401|Paclitaxel|paclitaxel|mesh-list
153694702|NCT00063401|Carboplatin|carboplatin|mesh-list
153694703|NCT00063401|Cetuximab|cetuximab|mesh-list
153694704|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153694705|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694706|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
153694707|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
153694708|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
153694709|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694710|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153694711|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
153694712|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694713|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153694714|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
153694715|NCT00230464|Vildagliptin|vildagliptin|mesh-list
153694716|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694717|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694718|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153694719|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
153694720|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694721|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694722|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
153694723|NCT00096915|Hematinics|hematinics|mesh-ancestor
153694724|NCT00230503|Adefovir|adefovir|mesh-list
153694725|NCT00230503|Pradefovir|pradefovir|mesh-list
153694726|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
153694727|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694728|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153425130|NCT03333746|Nivolumab|nivolumab|mesh-list
153694729|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153694730|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694731|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694732|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153694733|NCT00424723|Pemetrexed|pemetrexed|mesh-list
153694734|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694735|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694736|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332957|NCT02186665|Vitamins|vitamins|mesh-ancestor
153332968|NCT04141930|Baloxavir|baloxavir|mesh-list
153694737|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153694738|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153694739|NCT00230542|Carboplatin|carboplatin|mesh-list
153694740|NCT00230542|Pemetrexed|pemetrexed|mesh-list
153694760|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153694761|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
153694762|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
153694763|NCT02962336|Amlodipine|amlodipine|mesh-list
153694764|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153694765|NCT02962336|Olmesartan|olmesartan|mesh-list
153694766|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153694767|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153694768|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153694769|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694770|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694771|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153694772|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694773|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
153694774|NCT02962336|Diuretics|diuretics|mesh-ancestor
153694775|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
153694776|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153694777|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153694778|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153694779|NCT00075738|Leucovorin|leucovorin|mesh-list
153694780|NCT00075738|Fluorouracil|fluorouracil|mesh-list
153694781|NCT00075738|Irinotecan|irinotecan|mesh-list
153694782|NCT00075738|Calcium|calcium|mesh-list
153694783|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
153694784|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694785|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153694810|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153694811|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694812|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694813|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153694814|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153694815|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153694816|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694817|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694818|NCT00075777|Valproic Acid|valproic acid|mesh-list
153694819|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
153694820|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694821|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694822|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
153694823|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694824|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694825|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
153694826|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153694827|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694828|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694829|NCT02967614|Timolol|timolol|mesh-list
153694830|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153694831|NCT02967614|Dorzolamide|dorzolamide|mesh-list
153694832|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153736006|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153694833|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153694834|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
153694835|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694836|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694837|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694838|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153694839|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153694840|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153694841|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153694842|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153351854|NCT00409292|Everolimus|everolimus|mesh-list
153694843|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153694844|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694845|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153694846|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153694847|NCT00230815|Hormones|hormones|mesh-ancestor
153694848|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694849|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257163|NCT01169792|Tamoxifen|tamoxifen|mesh-list
154257164|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153694850|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153694851|NCT00097071|Insulin|insulin|mesh-list
153694852|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153694853|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
153694854|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
153852080|NCT04647773|Analgesics|analgesics|mesh-ancestor
153694856|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694857|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
153694883|NCT00231322|Praziquantel|praziquantel|mesh-list
153694884|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
153694885|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153694886|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694888|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153694889|NCT00231517|Narcotics|narcotics|mesh-ancestor
153694890|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694891|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694892|NCT00231517|Analgesics|analgesics|mesh-ancestor
153694893|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
153694894|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694895|NCT00075894|Alanosine|alanosine|mesh-list
153694896|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153694897|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694898|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
153694899|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
153694900|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694901|NCT00231556|Topiramate|topiramate|mesh-list
153694902|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
153694903|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694904|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694913|NCT00231673|Topiramate|topiramate|mesh-list
153694914|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
153694915|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694916|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694917|NCT00097188|Rituximab|rituximab|mesh-list
153351985|NCT05236530|Dolutegravir|dolutegravir|mesh-list
153694918|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153694919|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694920|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
153694921|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694922|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694923|NCT00231829|Celecoxib|celecoxib|mesh-list
153694924|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153694925|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153694926|NCT00231829|Analgesics|analgesics|mesh-ancestor
153694927|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
153694928|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694929|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694930|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694931|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694932|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153694933|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153694934|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694935|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694936|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
153694937|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694938|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153694939|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153736007|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694940|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694941|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694942|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
153694943|NCT00063713|Bortezomib|bortezomib|mesh-list
153694944|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694945|NCT00232024|Tegaserod|tegaserod|mesh-list
153694946|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153694947|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
153694948|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694949|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694950|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694951|NCT00232063|Cyclosporine|cyclosporine|mesh-list
153694952|NCT00232063|Cyclosporins|cyclosporins|mesh-list
153694953|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694954|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694955|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694956|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
153694957|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694958|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
153694959|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694965|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
153694966|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694967|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694968|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694969|NCT00097227|Paclitaxel|paclitaxel|mesh-list
153694970|NCT00097227|Carboplatin|carboplatin|mesh-list
153694971|NCT00097227|Cetuximab|cetuximab|mesh-list
153694972|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153694973|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694987|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694988|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694989|NCT00063791|Bortezomib|bortezomib|mesh-list
153694990|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694991|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153694992|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
153694993|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694994|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153694995|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153694996|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694997|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694998|NCT00232492|Ketamine|ketamine|mesh-list
153694999|NCT00232492|Analgesics|analgesics|mesh-ancestor
153695000|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
153695001|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695002|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695003|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153695004|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153695005|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
153695006|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
153695007|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695008|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153695009|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153695010|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695011|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695012|NCT00075972|Nicotine|nicotine|mesh-list
153695013|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153695014|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
153695015|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695016|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695017|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153695018|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153695019|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
153695020|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695021|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695023|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153695024|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153695025|NCT00063869|Analgesics|analgesics|mesh-ancestor
153695026|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
153695027|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695028|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695029|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695030|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153695031|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695032|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695033|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
153695034|NCT00232531|Niacin|niacin|mesh-list
153695059|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695060|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695061|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
153695062|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
153695063|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695064|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695065|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153695066|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153695067|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
153695080|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
153695081|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695082|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695083|NCT00063947|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153695084|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695085|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352234|NCT01795664|Fluticasone|fluticasone|mesh-list
153434075|NCT00001891|Protective Agents|protective agents|mesh-ancestor
153352359|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257165|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
153695107|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695108|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153695109|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153695111|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153695112|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153695113|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153695114|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153695115|NCT00232765|Sirolimus|sirolimus|mesh-list
153695116|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695117|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695118|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153695119|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695120|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
153695121|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695122|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
153695123|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695124|NCT02958566|Acetaminophen|acetaminophen|mesh-list
153695125|NCT02958566|Ketorolac|ketorolac|mesh-list
153695126|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153695127|NCT02958566|Lidocaine|lidocaine|mesh-list
153695128|NCT02958566|Fentanyl|fentanyl|mesh-list
153695129|NCT02958566|Ketamine|ketamine|mesh-list
153695130|NCT02958566|Morphine|morphine|mesh-list
153695131|NCT02958566|Gabapentin|gabapentin|mesh-list
153695132|NCT02958566|Tramadol|tramadol|mesh-list
153695133|NCT02958566|Methadone|methadone|mesh-list
153695134|NCT02958566|Hydrocodone|hydrocodone|mesh-list
153695135|NCT02958566|Hydromorphone|hydromorphone|mesh-list
153695136|NCT02958566|Orphenadrine|orphenadrine|mesh-list
153695137|NCT02958566|Bupivacaine|bupivacaine|mesh-list
153695138|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
153695139|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
153695140|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695141|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695142|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
153695169|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153695170|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695171|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
153695172|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
153695173|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153695174|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153695175|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153695176|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153695177|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
153695178|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
153695179|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153695180|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153695186|NCT00097344|Hormones|hormones|mesh-list
153695187|NCT00097344|Atamestane|atamestane|mesh-list
153695188|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
153695189|NCT00097344|Estrogens|estrogens|mesh-list
153695190|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
153695221|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153695222|NCT00232882|Diuretics|diuretics|mesh-ancestor
153695223|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
153695224|NCT00064064|Gemcitabine|gemcitabine|mesh-list
153695225|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153695226|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
153695227|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695228|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695229|NCT00413686|Gemcitabine|gemcitabine|mesh-list
153695263|NCT00064142|Growth Substances|growth substances|mesh-ancestor
153695264|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695265|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
153695266|NCT00064181|Leucovorin|leucovorin|mesh-list
153695267|NCT00064181|Celecoxib|celecoxib|mesh-list
153695268|NCT00064181|Capecitabine|capecitabine|mesh-list
153695269|NCT00064181|Fluorouracil|fluorouracil|mesh-list
153695270|NCT00064181|Irinotecan|irinotecan|mesh-list
153695337|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695339|NCT00233779|Heparin|heparin|mesh-list
153695340|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695341|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695342|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153695343|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695344|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
153695345|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695346|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
153731949|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695347|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695348|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695349|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
153695350|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153695351|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153695352|NCT00233818|Sirolimus|sirolimus|mesh-list
153695353|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695354|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695355|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153695356|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695393|NCT00234091|Abacavir|abacavir|mesh-list
153695394|NCT00234091|Efavirenz|efavirenz|mesh-list
153695395|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153695396|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153695397|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
153695420|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153695421|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153695422|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153695423|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695424|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153695425|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695426|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695427|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153695428|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153695429|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153695430|NCT00076284|Aplaviroc|aplaviroc|mesh-list
153695431|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153695432|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153695433|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695434|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153695435|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153695436|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
153695437|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695438|NCT00234403|Fulvestrant|fulvestrant|mesh-list
153695439|NCT00234403|Gefitinib|gefitinib|mesh-list
153695440|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153695441|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695442|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153695443|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153695484|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153695485|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153695486|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
153695487|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695488|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695489|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695490|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153695491|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153695492|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153695493|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695494|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
153695528|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695529|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153695530|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153695531|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
153695532|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695533|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153695534|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153695535|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153695536|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153695569|NCT00400530|Alendronate|alendronate|mesh-list
153695570|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695571|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153695572|NCT00064610|Bortezomib|bortezomib|mesh-list
153695573|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695574|NCT00235222|Stavudine|stavudine|mesh-list
153695575|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
153695576|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695577|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153695578|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153695579|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695580|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
153731950|NCT04724187|Misoprostol|misoprostol|mesh-list
153334120|NCT01222117|Plasminogen|plasminogen|mesh-list
153695581|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695582|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153695619|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695620|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
153695631|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695633|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695634|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695635|NCT00235651|Amphotericin B|amphotericin b|mesh-list
153695636|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153352651|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
153695637|NCT00235651|Amebicides|amebicides|mesh-ancestor
153695638|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153695642|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
153695643|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
153695644|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153695645|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695646|NCT00064766|Doxycycline|doxycycline|mesh-list
153695647|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695648|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695649|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
153695650|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153695651|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153695652|NCT00235729|Lofexidine|lofexidine|mesh-list
153695653|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153695654|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153695655|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695656|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
153695657|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695658|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153695659|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153695660|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153695661|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
153695662|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695663|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695664|NCT00235885|Adalimumab|adalimumab|mesh-list
153695665|NCT00235885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153695666|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695667|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153695668|NCT04728750|Pancrelipase|pancrelipase|mesh-list
153695669|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695670|NCT00235963|Simvastatin|simvastatin|mesh-list
153695671|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153695672|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153695673|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
153695674|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695675|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153695676|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153695677|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695678|NCT00236002|Alendronate|alendronate|mesh-list
153695679|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153695680|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695681|NCT00414037|Eszopiclone|eszopiclone|mesh-list
153695682|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153695683|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695693|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
153695694|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695695|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695696|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695697|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153695698|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695699|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695700|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695701|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153695702|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
153695704|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153695705|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695706|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153695707|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695708|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695709|NCT00236431|Galantamine|galantamine|mesh-list
153695710|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153695711|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695712|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695713|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
153695714|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695715|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695716|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153695717|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
153695718|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695719|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
153695720|NCT00097929|Vorinostat|vorinostat|mesh-list
153695723|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695724|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695725|NCT00236470|Risperidone|risperidone|mesh-list
153695726|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153695727|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
153695728|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695729|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695730|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695731|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153695732|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695733|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695734|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695735|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153695736|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
153695737|NCT00236509|Topiramate|topiramate|mesh-list
153695738|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
153695739|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695740|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695741|NCT02962141|Paclitaxel|paclitaxel|mesh-list
153695742|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153695743|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695744|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
153695745|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
153695746|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
153695747|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695748|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
153695768|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695769|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695770|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153695771|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695772|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695773|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695774|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153695775|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
153695776|NCT00236626|Topiramate|topiramate|mesh-list
153695777|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
153695778|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695779|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695780|NCT00236665|Topiramate|topiramate|mesh-list
153695781|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
153695782|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695783|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695784|NCT00399282|Vitamin E|vitamin e|mesh-list
153695785|NCT00399282|Vitamins|vitamins|mesh-ancestor
153695786|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
153695787|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695788|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
153695789|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695790|NCT00399282|Protective Agents|protective agents|mesh-ancestor
153695791|NCT00236704|Topiramate|topiramate|mesh-list
153695792|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
153695793|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695794|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695795|NCT00236743|Topiramate|topiramate|mesh-list
153695796|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
153695797|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695798|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695799|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153695800|NCT00236782|Norelgestromin|norelgestromin|mesh-list
153695801|NCT00236782|Estradiol|estradiol|mesh-list
153695802|NCT00236782|Estrogens|estrogens|mesh-ancestor
153695803|NCT00236782|Hormones|hormones|mesh-ancestor
153695804|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695805|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392459|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153695879|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153695880|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
154257166|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257167|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257168|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154257169|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257170|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154257171|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154257172|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154257173|NCT01169402|Fluconazole|fluconazole|mesh-list
154257174|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
153695881|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695882|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695884|NCT00098007|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153695885|NCT00098007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695886|NCT00098007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695887|NCT00098007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695888|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695889|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
153425284|NCT03582553|Naringenin|naringenin|mesh-list
153695890|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695891|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695907|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695908|NCT00237367|Rabeprazole|rabeprazole|mesh-list
153695909|NCT00237367|Pantoprazole|pantoprazole|mesh-list
153695910|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153695911|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695912|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153695913|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695914|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695915|NCT00098046|Famciclovir|famciclovir|mesh-list
153695916|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
153695917|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695918|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153695919|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695920|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695921|NCT00065273|Olanzapine|olanzapine|mesh-list
153695922|NCT00065273|Risperidone|risperidone|mesh-list
153695923|NCT00065273|Clozapine|clozapine|mesh-list
153695924|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153695925|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
153695926|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781924|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
153695927|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695928|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695929|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153695930|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695931|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695932|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695933|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153695934|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
153695935|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
153392471|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
153392472|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153695988|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153695989|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696024|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696025|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153696026|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696027|NCT00237874|Aripiprazole|aripiprazole|mesh-list
153696028|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
153696029|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153696030|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153696031|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154257175|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257176|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153696095|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696096|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153696097|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
153696098|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
153696099|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
153696100|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153696101|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153696102|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696103|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153696104|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696105|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696106|NCT00238225|Calcitriol|calcitriol|mesh-list
153696107|NCT00238225|Ketoconazole|ketoconazole|mesh-list
153696108|NCT00238225|Dexamethasone|dexamethasone|mesh-list
153696109|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153696110|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
153696111|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
153696112|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696113|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696138|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
153696139|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696140|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153696141|NCT00065546|Choline|choline|mesh-list
153696142|NCT00065546|Estrogens|estrogens|mesh-list
153696143|NCT00065546|Hormones|hormones|mesh-ancestor
153696144|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696145|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696146|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
153696147|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153696148|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
153852274|NCT06237569|Midazolam|midazolam|mesh-list
153696151|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153696153|NCT00098280|Eculizumab|eculizumab|mesh-list
153696154|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153696155|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696156|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
153696157|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696158|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153696159|NCT00238459|Vaccines|vaccines|mesh-list
153696160|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
153696161|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696189|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
153696190|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153696191|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
153696192|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696193|NCT00238927|Fluticasone|fluticasone|mesh-list
153696194|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153696195|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153696196|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
153696197|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696198|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696199|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153696200|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
153696201|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
153696202|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153696203|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
153696204|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
153696205|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696206|NCT00065624|Protective Agents|protective agents|mesh-ancestor
153696207|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696208|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
153696242|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
153696243|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696244|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
153696245|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696246|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696247|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153696279|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153696280|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696281|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696282|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153696283|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154257177|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154257178|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696284|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
153696285|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696286|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153696287|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153696288|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153696289|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
153696290|NCT02961829|Vitamins|vitamins|mesh-ancestor
153353225|NCT00508118|Nicardipine|nicardipine|mesh-list
153696301|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696302|NCT00065741|Protective Agents|protective agents|mesh-ancestor
153696303|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696305|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696306|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696307|NCT00098397|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153696308|NCT00098397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910748|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696309|NCT00098397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696310|NCT00239278|Prednisolone|prednisolone|mesh-list
153696312|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
153696313|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153696314|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
153696315|NCT00239278|Hormones|hormones|mesh-ancestor
153696316|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696317|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696318|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153696319|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696346|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696347|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
153696348|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696349|NCT00239434|Bromides|bromides|mesh-list
153696350|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
153696351|NCT00239434|Ipratropium|ipratropium|mesh-list
153696352|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153696353|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
153696354|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696355|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696364|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153696365|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
153696366|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153696367|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
153696368|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696369|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696370|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153696371|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
153696372|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
153696381|NCT00239512|Analgesics|analgesics|mesh-ancestor
153696382|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
153696383|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696384|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696385|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153696386|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696387|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153696388|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696389|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696390|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
153696391|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
153696392|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153696393|NCT00076674|Levodopa|levodopa|mesh-list
153696394|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153696395|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153696396|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
153696397|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696398|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696399|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696400|NCT00239551|Lansoprazole|lansoprazole|mesh-list
153696401|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153696402|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153696403|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153696404|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696405|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696406|NCT00239629|Teriparatide|teriparatide|mesh-list
153696407|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
153696408|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153696409|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696410|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153696411|NCT00098436|Temozolomide|temozolomide|mesh-list
153696412|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153696413|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
153696414|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696415|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696416|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
153696417|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153696418|NCT00239707|Incretins|incretins|mesh-ancestor
153696419|NCT00239707|Hormones|hormones|mesh-ancestor
153696420|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696430|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696431|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153696432|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696433|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696434|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153696435|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153696436|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696437|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696438|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
153696439|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392526|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
153696444|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
153781926|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
153696445|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696446|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153696447|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153696448|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696449|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696450|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
153696451|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696452|NCT00239980|Dalteparin|dalteparin|mesh-list
153696453|NCT00239980|Tinzaparin|tinzaparin|mesh-list
153696454|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153696455|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
153696456|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153696457|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153696458|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696459|NCT00240019|Furosemide|furosemide|mesh-list
153696460|NCT00240019|Diuretics|diuretics|mesh-ancestor
153696461|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
153696462|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696463|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153696464|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153696465|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696466|NCT00240058|Phenylephrine|phenylephrine|mesh-list
153696467|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
153696468|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
153696469|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153696470|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
153696471|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
153696472|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696473|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696474|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
153696475|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153696476|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
153696477|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
153696478|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153696479|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153353556|NCT01395043|Bupivacaine|bupivacaine|mesh-list
153696480|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153696481|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
153696499|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696500|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696501|NCT00240214|Sirolimus|sirolimus|mesh-list
153696502|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153696503|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696504|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696505|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696506|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
153696507|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696508|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
153696509|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696510|NCT00240253|Pramlintide|pramlintide|mesh-list
153696511|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153696512|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696513|NCT00065936|Naltrexone|naltrexone|mesh-list
153696514|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153696515|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153696516|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696517|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
153696518|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696519|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153696520|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153696521|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153696522|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
153696523|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696535|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153696536|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
153696537|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
153696538|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696539|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
153696571|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153696572|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153696573|NCT00240682|Cetuximab|cetuximab|mesh-list
153696574|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153696575|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696576|NCT00240721|Topiramate|topiramate|mesh-list
153696577|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
153696578|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153696579|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696590|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153696591|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
153696592|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696593|NCT04720807|Letrozole|letrozole|mesh-list
153696594|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696595|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153696596|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153696597|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696598|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696599|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153696600|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
153696601|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696602|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696603|NCT00240799|Acetaminophen|acetaminophen|mesh-list
153696604|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153696605|NCT00240799|Analgesics|analgesics|mesh-ancestor
153696606|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
153696607|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696608|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696609|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
153696610|NCT00240838|Acetaminophen|acetaminophen|mesh-list
153696611|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153696612|NCT00240838|Analgesics|analgesics|mesh-ancestor
153696613|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
153696614|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696615|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696616|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
153696617|NCT02965404|Vaccines|vaccines|mesh-list
153696618|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
153696619|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696620|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
153696621|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696628|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696629|NCT00241072|Valsartan|valsartan|mesh-list
153696630|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153696631|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153696632|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153696633|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696634|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
153696635|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153696636|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696637|NCT00241150|Valsartan|valsartan|mesh-list
153696638|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153696639|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153696640|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153696641|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696668|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
153696669|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
153696670|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153696671|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153696672|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
153696673|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
153696674|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696675|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696676|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153696677|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
153696678|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153696679|NCT00241189|Sirolimus|sirolimus|mesh-list
153696680|NCT00241189|Methotrexate|methotrexate|mesh-list
153696681|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153696682|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
153696683|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153696684|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696685|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153696686|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
153696687|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696688|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696689|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
153696690|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696691|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153696710|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696711|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153696712|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696713|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696714|NCT00241423|Exenatide|exenatide|mesh-list
153696715|NCT00241423|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153696716|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153696717|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696718|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153696720|NCT00241423|Hormones|hormones|mesh-ancestor
153696721|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696722|NCT00241501|Esomeprazole|esomeprazole|mesh-list
153696723|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153696724|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153696725|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153696726|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696727|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696728|NCT00076986|Carmustine|carmustine|mesh-list
153696729|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153696730|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
153696731|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696747|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
153696779|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153696781|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696782|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696783|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153696784|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153696785|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153696786|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153696787|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696788|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153696789|NCT00066482|Protective Agents|protective agents|mesh-ancestor
153696790|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696792|NCT00099060|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153353970|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696793|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696794|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696815|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
153696816|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153696817|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
153533794|NCT01507857|Vaccines|vaccines|mesh-list
153696818|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
153696819|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153696820|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696821|NCT02962024|Morphine|morphine|mesh-list
153696822|NCT02962024|Bupivacaine|bupivacaine|mesh-list
153731963|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
153696823|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
153696824|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
153696825|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153696826|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696827|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
153696828|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696829|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153696830|NCT02962024|Narcotics|narcotics|mesh-ancestor
153696831|NCT02962024|Analgesics|analgesics|mesh-ancestor
153696832|NCT00066638|Romidepsin|romidepsin|mesh-list
153696833|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696834|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696835|NCT00066638|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153696836|NCT00066638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696837|NCT00066638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696838|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
153696839|NCT00242203|Docetaxel|docetaxel|mesh-list
153696840|NCT00242203|Trastuzumab|trastuzumab|mesh-list
153696841|NCT00242203|Epirubicin|epirubicin|mesh-list
153353971|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354022|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696842|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696843|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
153696844|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
153696860|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696861|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153696862|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153696863|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153696864|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153696865|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
153696866|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696867|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696868|NCT00242359|Omalizumab|omalizumab|mesh-list
153696869|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153696870|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153696871|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
153696872|NCT00066716|Celecoxib|celecoxib|mesh-list
153696873|NCT00066716|Paclitaxel|paclitaxel|mesh-list
153696874|NCT00066716|Carboplatin|carboplatin|mesh-list
153696875|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153696876|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696877|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
153696878|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
153696879|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
153696880|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696881|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153696882|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153696883|NCT00066716|Analgesics|analgesics|mesh-ancestor
153696884|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
153696885|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696886|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696887|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153696888|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696889|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153696890|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153696891|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696892|NCT00077103|Doxorubicin|doxorubicin|mesh-list
153696893|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153696895|NCT00077103|Combretastatin|combretastatin|mesh-list
153696896|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696897|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696898|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153696899|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153696900|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696901|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696902|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153696903|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
153696904|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
153696905|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
153696906|NCT00242437|Hemostatics|hemostatics|mesh-list
153696907|NCT00242437|Thrombin|thrombin|mesh-list
153696908|NCT00242437|Coagulants|coagulants|mesh-ancestor
153696909|NCT00066794|Cytarabine|cytarabine|mesh-list
153696910|NCT00066794|Cyclosporine|cyclosporine|mesh-list
153696911|NCT00066794|Daunorubicin|daunorubicin|mesh-list
153696919|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696920|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153335991|NCT02297230|Trastuzumab|trastuzumab|mesh-list
153335992|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153696921|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
153696922|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696923|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696924|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
153696925|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
153696926|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696927|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153696928|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696939|NCT00242749|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153696940|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696942|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696943|NCT00242788|Capecitabine|capecitabine|mesh-list
153696944|NCT00242788|Gefitinib|gefitinib|mesh-list
153696945|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153696946|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
153696947|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696948|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696949|NCT00242788|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153696950|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696951|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696952|NCT00066872|Imiquimod|imiquimod|mesh-list
153696953|NCT00066872|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153696954|NCT00066872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696955|NCT00066872|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153696956|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
153696957|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696958|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153696959|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696960|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
153696961|NCT00243100|Gemcitabine|gemcitabine|mesh-list
153696962|NCT00243100|Vorinostat|vorinostat|mesh-list
153696963|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153696964|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
153696965|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696966|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696967|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153696968|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696969|NCT00099216|Rivastigmine|rivastigmine|mesh-list
153696970|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153696971|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696972|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696973|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
153696974|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696975|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696976|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153696977|NCT00099216|Protective Agents|protective agents|mesh-ancestor
153696978|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
153696979|NCT00066989|Antibodies|antibodies|mesh-list
153696991|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696992|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696993|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696994|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
153696995|NCT00243256|Vitamin D|vitamin d|mesh-list
153696996|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153696997|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696998|NCT00243256|Vitamins|vitamins|mesh-ancestor
153696999|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
153697000|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153697001|NCT00243646|Bicalutamide|bicalutamide|mesh-list
153697002|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697003|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697006|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697008|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153697009|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697010|NCT00099333|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153697011|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153697012|NCT00099333|Incretins|incretins|mesh-ancestor
153697013|NCT00099333|Hormones|hormones|mesh-ancestor
153697014|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697015|NCT00243724|Esomeprazole|esomeprazole|mesh-list
153731964|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697016|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153697017|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697018|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153697019|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697020|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697022|NCT00243880|L 647318|l 647318|mesh-list
153697023|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
153697024|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153697025|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153697026|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
153697027|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697028|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153354309|NCT01568905|Nicotine|nicotine|mesh-list
153697029|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153697030|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697031|NCT00244075|Hormones|hormones|mesh-list
153697032|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697033|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697034|NCT00244153|Dexamethasone|dexamethasone|mesh-list
153697035|NCT00244153|Morphine|morphine|mesh-list
153697036|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697037|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
153697038|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
153697039|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697040|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697041|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697042|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
153697063|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153697064|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
153697065|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697066|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697067|NCT00244192|Infliximab|infliximab|mesh-list
153697068|NCT00244192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153697069|NCT00244192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697070|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
153697071|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697072|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697073|NCT00077181|Cytarabine|cytarabine|mesh-list
153697074|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153697075|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
153697076|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697077|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697078|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
153697079|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697080|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153697081|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
153697082|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697083|NCT00244309|Tamsulosin|tamsulosin|mesh-list
153697084|NCT00244309|Dutasteride|dutasteride|mesh-list
153697085|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153697086|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153697087|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153697088|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
153697089|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697090|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697091|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697092|NCT00244309|Urological Agents|urological agents|mesh-ancestor
153697093|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153697094|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153697095|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697096|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
153697123|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697124|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697125|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153697126|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153697127|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697128|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153697129|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153697130|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697131|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
153697132|NCT00398957|Naltrexone|naltrexone|mesh-list
153697133|NCT00398957|Hydromorphone|hydromorphone|mesh-list
153697134|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
153697135|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153376538|NCT05833763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697136|NCT00398957|Narcotics|narcotics|mesh-ancestor
153697137|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697138|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697139|NCT00398957|Analgesics|analgesics|mesh-ancestor
153697140|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
153697141|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697142|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153697143|NCT00099450|INS 50589|ins 50589|mesh-list
153697144|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153697145|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153697146|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
153697147|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697148|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697149|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697150|NCT00244504|Moxonidine|moxonidine|mesh-list
153697151|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153697152|NCT00099489|Interferons|interferons|mesh-list
153697153|NCT00099489|Interferon-beta|interferon-beta|mesh-list
153697154|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
153697155|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697156|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
153697157|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697158|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
153697159|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697173|NCT00244738|Cathartics|cathartics|mesh-ancestor
153697174|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697175|NCT00077259|Epothilones|epothilones|mesh-list
153697176|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
153697177|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
153697178|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
153697183|NCT00067301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153697184|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153697185|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697186|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697187|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697188|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
153697189|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697190|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153697191|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
153697192|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697194|NCT00244972|Tipifarnib|tipifarnib|mesh-list
153697195|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697196|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153697197|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697198|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697199|NCT00245089|Dactinomycin|dactinomycin|mesh-list
153697200|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
153697201|NCT00245089|Vincristine|vincristine|mesh-list
153697202|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153697203|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
153697204|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697205|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697206|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153697207|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
153697208|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697209|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697210|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153697211|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153697212|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
153697213|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
153697214|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
153697215|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153697216|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697217|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153697218|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153697219|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697220|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153697221|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
153697235|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697237|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153697238|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
153697239|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
153697240|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
153697241|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697242|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697243|NCT00245206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153697244|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153697245|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697246|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
153697247|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
153697248|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153697249|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153354511|NCT01532089|Antibodies|antibodies|mesh-list
153697250|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153697251|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153697252|NCT00245245|Factor VIII|factor viii|mesh-list
153697253|NCT00245245|Coagulants|coagulants|mesh-ancestor
153697254|NCT00077298|Bevacizumab|bevacizumab|mesh-list
153697255|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153697256|NCT00077298|Cetuximab|cetuximab|mesh-list
153697257|NCT00077298|Irinotecan|irinotecan|mesh-list
153697258|NCT00077298|Antibodies|antibodies|mesh-list
153697259|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
153697260|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153697261|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697262|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153392665|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697269|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153697270|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697271|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697272|NCT00245401|Sirolimus|sirolimus|mesh-list
153697273|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153697274|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697275|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153697276|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697277|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
153697278|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153697279|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
153697280|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697281|NCT00245440|Azithromycin|azithromycin|mesh-list
153697282|NCT00245440|Telithromycin|telithromycin|mesh-list
153697283|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153697303|NCT00245674|Amisulpride|amisulpride|mesh-list
153697304|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153697305|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153697306|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697307|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697308|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697309|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153697310|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
153697311|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697312|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697313|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153697314|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
153697315|NCT00245713|Levetiracetam|levetiracetam|mesh-list
153697316|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
153697317|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
153697318|NCT00067457|Alosetron|alosetron|mesh-list
153697319|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697320|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153697321|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
153697322|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697323|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697324|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697325|NCT00102843|Folic Acid|folic acid|mesh-list
153697326|NCT00102843|Betaine|betaine|mesh-list
153697327|NCT00102843|Hematinics|hematinics|mesh-ancestor
153697328|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
153697329|NCT00102843|Vitamins|vitamins|mesh-ancestor
153697330|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
153697331|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697332|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697333|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
153697334|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153697352|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153697353|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
153697354|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153697355|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697356|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697357|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697358|NCT00245908|Azithromycin|azithromycin|mesh-list
153376606|NCT05766267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153697359|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153697360|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697361|NCT00067496|Modafinil|modafinil|mesh-list
153697362|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153697363|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697364|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153697365|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153697366|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153697367|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697368|NCT00246064|Infliximab|infliximab|mesh-list
153697369|NCT00246064|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153697370|NCT00246064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697371|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
153697372|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697373|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697374|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
153697375|NCT00246103|Fluorouracil|fluorouracil|mesh-list
153697376|NCT00246103|Epirubicin|epirubicin|mesh-list
153697377|NCT00246103|Valproic Acid|valproic acid|mesh-list
153697378|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153697379|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
153697380|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697381|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697382|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153697383|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
153697384|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697385|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697386|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153697387|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
153697388|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153697389|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153697390|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153697391|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153697392|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697393|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
153697394|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
153697395|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697396|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
153697397|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153697405|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697406|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
153697407|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697408|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697409|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153697410|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697412|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
153697413|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
153697414|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697415|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697416|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
153697417|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697419|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153697420|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153697421|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697422|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697423|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
153697424|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697425|NCT00102882|Fluticasone|fluticasone|mesh-list
153697426|NCT00102882|Xhance|xhance|mesh-list
153697431|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
153697432|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697433|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697434|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153697435|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
153697436|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
153697437|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153697438|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153697439|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153697440|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153697441|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
153697442|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376639|NCT05735431|Autonomic Agents|autonomic agents|mesh-ancestor
153336889|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336890|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
153697443|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697444|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
153697445|NCT00102882|Hormones|hormones|mesh-ancestor
153697446|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697447|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
153697448|NCT00246220|Methylphenidate|methylphenidate|mesh-list
153697449|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153697450|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697451|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153697452|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153697453|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697454|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697455|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
153697456|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697457|NCT00424801|Nicorandil|nicorandil|mesh-list
153697458|NCT00424801|Valsartan|valsartan|mesh-list
153697459|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153697460|NCT00424801|Doxazosin|doxazosin|mesh-list
153697461|NCT00424801|Lercanidipine|lercanidipine|mesh-list
153697462|NCT00424801|Pindolol|pindolol|mesh-list
153697463|NCT00424801|Moxonidine|moxonidine|mesh-list
153697464|NCT00424801|Amiloride|amiloride|mesh-list
153697465|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153697479|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153697480|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153697481|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153697482|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153697483|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153392724|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392725|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
153392726|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
153697495|NCT00246415|Memantine|memantine|mesh-list
153697496|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153697497|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153697498|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
153697499|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697500|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697501|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697502|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153697503|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153697504|NCT00246532|Morphine|morphine|mesh-list
153697505|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153697506|NCT00246532|Narcotics|narcotics|mesh-ancestor
153697507|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697508|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697509|NCT00246532|Analgesics|analgesics|mesh-ancestor
153697510|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
153697511|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697512|NCT00246610|Nelfinavir|nelfinavir|mesh-list
153697513|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153697514|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153697515|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
153697516|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697517|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697518|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153697519|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153697520|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
153697521|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697522|NCT00246688|Sagopilone|sagopilone|mesh-list
153697523|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697524|NCT04728516|Amoxicillin|amoxicillin|mesh-list
153697556|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
153697557|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153697558|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
153697559|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697560|NCT00247507|Expectorants|expectorants|mesh-ancestor
153356126|NCT00654836|Growth Substances|growth substances|mesh-ancestor
153356325|NCT01288781|Diuretics|diuretics|mesh-ancestor
153697561|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
153697562|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153697563|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
153534538|NCT01511770|Fluconazole|fluconazole|mesh-list
153697564|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337104|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153697565|NCT00247507|Protective Agents|protective agents|mesh-ancestor
153697566|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697567|NCT00247507|Antidotes|antidotes|mesh-ancestor
153697569|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153697585|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697587|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153697588|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153697589|NCT00247663|Letrozole|letrozole|mesh-list
153697590|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697591|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153697592|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153697593|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697594|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697598|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697600|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
153697601|NCT01349660|Bevacizumab|bevacizumab|mesh-list
153697602|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153697603|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697604|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153697605|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153697606|NCT01349660|Growth Substances|growth substances|mesh-ancestor
153697607|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697608|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
153697609|NCT00247741|Lidocaine|lidocaine|mesh-list
153697610|NCT00247741|Carticaine|carticaine|mesh-list
153697611|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
153697612|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
153697613|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697614|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697615|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
153697616|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697617|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153697618|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153697619|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153697620|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697621|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697622|NCT00099684|Ezetimibe|ezetimibe|mesh-list
153697623|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153697624|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153697625|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
153697635|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697636|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697637|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697638|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697639|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697640|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697641|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697642|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153697643|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153697644|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697645|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153697646|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153697647|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697648|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697649|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
153697650|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697652|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697653|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153697654|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697655|NCT00248209|Bupropion|bupropion|mesh-list
153697656|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153697657|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
153697658|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697659|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153697660|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153697661|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697662|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697663|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
153697664|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337336|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337337|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153697665|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356459|NCT00664430|Calcitriol|calcitriol|mesh-list
153356539|NCT01287377|Nicotine|nicotine|mesh-list
153697666|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153697667|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153697668|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697669|NCT00248248|Doxorubicin|doxorubicin|mesh-list
153697670|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153697671|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153697672|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697706|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697708|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697709|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153697710|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153697711|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
153697712|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697713|NCT00249106|Vaccines|vaccines|mesh-list
153697714|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
153697715|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697716|NCT00068042|Octreotide|octreotide|mesh-list
153697717|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697718|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153697719|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697720|NCT00249145|Risperidone|risperidone|mesh-list
153697721|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153697722|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
153697723|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697724|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697725|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697726|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153697727|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153697728|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697729|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697730|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153697731|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
153697732|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153697733|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153697734|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697735|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153697736|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
153697737|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697738|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
153697745|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697746|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697748|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153697749|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
153697750|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697781|NCT00249574|Narcotics|narcotics|mesh-ancestor
153697782|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697783|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697784|NCT00249574|Analgesics|analgesics|mesh-ancestor
153697785|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
153697786|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697787|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153697788|NCT00249691|Topiramate|topiramate|mesh-list
153697789|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
153697790|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153697791|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697792|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
153697793|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
153697794|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153697795|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153697816|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697818|NCT00249886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153697819|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153697820|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697821|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697822|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697823|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
153697824|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697825|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153697826|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
153697827|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697828|NCT00249964|Paclitaxel|paclitaxel|mesh-list
153697829|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153697830|NCT00249964|Carboplatin|carboplatin|mesh-list
153697831|NCT00249964|Temozolomide|temozolomide|mesh-list
153697832|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153697833|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697834|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
153697835|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
153697836|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
153697837|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697838|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153697839|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
153697840|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
153697841|NCT00068276|Vitamin D|vitamin d|mesh-list
153697842|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153697843|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697844|NCT00068276|Vitamins|vitamins|mesh-ancestor
153697845|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
153697846|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153356753|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
153697863|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153697864|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
153697865|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697866|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153697867|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
153697868|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153697869|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697870|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697871|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
153697872|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697873|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697874|NCT00250120|Camptothecin|camptothecin|mesh-list
153697875|NCT00250120|Rubitecan|rubitecan|mesh-list
153697881|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697883|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153697884|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697885|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697886|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
153697887|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697888|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697889|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153697890|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
153697891|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697892|NCT00103545|Abagovomab|abagovomab|mesh-list
153697893|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153697894|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697895|NCT00068432|Celecoxib|celecoxib|mesh-list
153697896|NCT00068432|Gemcitabine|gemcitabine|mesh-list
153697897|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153697898|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
153697899|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697900|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697901|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153697902|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153697903|NCT00068432|Analgesics|analgesics|mesh-ancestor
153697904|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
153697923|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153697924|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
153697925|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697926|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697927|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153697928|NCT00099957|Vildagliptin|vildagliptin|mesh-list
153697929|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153697930|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697931|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153697932|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
153697933|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697934|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697935|NCT00250315|Dobutamine|dobutamine|mesh-list
153697936|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153697937|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
153376732|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153337888|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
153337890|NCT00000310|Risperidone|risperidone|mesh-list
153697938|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
153379366|NCT03008889|Protective Agents|protective agents|mesh-ancestor
153697939|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697940|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697941|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153697942|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153697943|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153697944|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
153697945|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697946|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697947|NCT00250315|Protective Agents|protective agents|mesh-ancestor
153697948|NCT00068471|Anidulafungin|anidulafungin|mesh-list
153697949|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
153697950|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697951|NCT00250354|Risperidone|risperidone|mesh-list
153697952|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153697953|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
153697954|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697955|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697956|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697957|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153697958|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153697959|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697960|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697988|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
153697989|NCT00250744|Analgesics|analgesics|mesh-ancestor
153697990|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
153697991|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697992|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697993|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
153697994|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153697995|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153697996|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697997|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697998|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153697999|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153698000|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698001|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698002|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
153698003|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
153698004|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
153698005|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153698006|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153698007|NCT00103623|Abarelix|abarelix|mesh-list
153698008|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
153698009|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698010|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698011|NCT00250861|Aldesleukin|aldesleukin|mesh-list
153698012|NCT00250861|Rituximab|rituximab|mesh-list
153698013|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153698014|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698015|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
153698016|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698017|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153698018|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153698019|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153698020|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
153698021|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698022|NCT00068549|Gemcitabine|gemcitabine|mesh-list
153698037|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153698039|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153698040|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698041|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153698042|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153698043|NCT00250978|Growth Substances|growth substances|mesh-ancestor
153698044|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698045|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
153698046|NCT00068666|Temozolomide|temozolomide|mesh-list
153698047|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154257179|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338328|NCT00000412|Vitamins|vitamins|mesh-ancestor
153698048|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
153698049|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698050|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698051|NCT00103701|Dasatinib|dasatinib|mesh-list
153392797|NCT05738564|Mydriatics|mydriatics|mesh-ancestor
153698062|NCT00251056|Diuretics|diuretics|mesh-ancestor
153698063|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
153698064|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698065|NCT00251095|Paclitaxel|paclitaxel|mesh-list
153698066|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153698067|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698068|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
153698069|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
153698070|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
153698071|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698072|NCT00100074|Lobeline|lobeline|mesh-list
153698073|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153698074|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
153698075|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698076|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698077|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153698078|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153698079|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
153698080|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698081|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698101|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698102|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
153698103|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698104|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698105|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
153698106|NCT00068783|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153698107|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153698108|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365468|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
153698109|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698110|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698111|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
153698112|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698113|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
153698114|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153698115|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698116|NCT00251407|Docetaxel|docetaxel|mesh-list
153698117|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698118|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
153698119|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
153698120|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
153698121|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698122|NCT02966522|Thalidomide|thalidomide|mesh-list
153698123|NCT02966522|Dexamethasone|dexamethasone|mesh-list
153698124|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153698125|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
153698126|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
153698127|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698128|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698129|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153698130|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
153698131|NCT02966522|Hormones|hormones|mesh-ancestor
153698132|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698133|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153698134|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698135|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153698136|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
153698147|NCT00100152|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
153698150|NCT00100152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698152|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
153698153|NCT00251524|Pemetrexed|pemetrexed|mesh-list
153698154|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153698155|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698156|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153698157|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153338514|NCT00000484|Diuretics|diuretics|mesh-ancestor
153698158|NCT00251524|Growth Substances|growth substances|mesh-ancestor
153698159|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736009|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698160|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
153698161|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387028|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153698162|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698163|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153698164|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153698166|NCT00068861|Clomiphene|clomiphene|mesh-list
153698167|NCT00068861|Enclomiphene|enclomiphene|mesh-list
153698168|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
153698169|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153698170|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698171|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153698172|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
153698173|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698174|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153698175|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
153698176|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153698177|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153698178|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153698179|NCT00251602|Propranolol|propranolol|mesh-list
153698180|NCT00251602|Atropine|atropine|mesh-list
153698181|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153698182|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153698183|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
153698184|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698185|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698186|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698187|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153698188|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153698189|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
153698190|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153698191|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153698192|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
153698193|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698194|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153698195|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
153698196|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
153698197|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
153698198|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153698214|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698215|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698216|NCT00251680|Atorvastatin|atorvastatin|mesh-list
153698217|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153698218|NCT00251680|Simvastatin|simvastatin|mesh-list
153698219|NCT00251680|Fenofibrate|fenofibrate|mesh-list
153698220|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153698221|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153698222|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
153698223|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698224|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153698225|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153698226|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698227|NCT00251797|Thalidomide|thalidomide|mesh-list
153698228|NCT00251797|Irinotecan|irinotecan|mesh-list
153698229|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153698230|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535207|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698231|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698232|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698251|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698252|NCT00100269|Protective Agents|protective agents|mesh-ancestor
153698253|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698254|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
153698255|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
153698256|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153698257|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
153698258|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153698259|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153698273|NCT00251992|Esomeprazole|esomeprazole|mesh-list
153698274|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154257180|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154257181|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
153698275|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153698276|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153698277|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698278|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698279|NCT00103935|Exenatide|exenatide|mesh-list
153698280|NCT00103935|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153698281|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153470779|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698282|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698283|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153698284|NCT00103935|Incretins|incretins|mesh-ancestor
153698285|NCT00103935|Hormones|hormones|mesh-ancestor
153698286|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698287|NCT00399152|Sunitinib|sunitinib|mesh-list
153698288|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698289|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153698290|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153698291|NCT00399152|Growth Substances|growth substances|mesh-ancestor
153698292|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698293|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
153698294|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153698295|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698296|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698297|NCT00104013|Xaliproden|xaliproden|mesh-list
153698298|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153698299|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153698300|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
153698301|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698305|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
153698306|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698307|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153698308|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
153698309|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153698310|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153698311|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153698312|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153698313|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698314|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
153698315|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698316|NCT00252304|Astringents|astringents|mesh-ancestor
153698317|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
153698318|NCT00252343|Amibegron|amibegron|mesh-list
153698319|NCT00252343|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153698320|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153698331|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153698332|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
153698333|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698334|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153698335|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470781|NCT00605904|Yohimbine|yohimbine|mesh-list
153698336|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698337|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153698338|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698339|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153698340|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698341|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
153698342|NCT00252811|Gefitinib|gefitinib|mesh-list
153698343|NCT00252811|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153698344|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153698345|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698346|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698347|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698348|NCT00069251|Bupropion|bupropion|mesh-list
153698349|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153698350|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
153698351|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153698352|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153698353|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153698354|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153698355|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698356|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
153698357|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698358|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698359|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153698360|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153698362|NCT00252889|Doxorubicin|doxorubicin|mesh-list
153698363|NCT00252889|Topotecan|topotecan|mesh-list
153698364|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
153698370|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698371|NCT00252928|Troclosene|troclosene|mesh-list
153698372|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
153698373|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698374|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
153698375|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
153698376|NCT00253123|Risperidone|risperidone|mesh-list
153698377|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153698378|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
153698379|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698380|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698381|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698382|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153698383|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153698402|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698403|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698404|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
153698405|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471422|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
153698406|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698407|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153698408|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
153698409|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698410|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
153698411|NCT00100464|Paroxetine|paroxetine|mesh-list
153698412|NCT00100464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153698413|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153698414|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153698415|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698416|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698417|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
153698418|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698419|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153698420|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
153698421|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153698422|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153698423|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153698424|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698425|NCT00253396|Heparin|heparin|mesh-list
153698426|NCT00253396|Enoxaparin|enoxaparin|mesh-list
153698427|NCT00253396|Calcium heparin|calcium heparin|mesh-list
153698428|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
153698429|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153698430|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153698431|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698432|NCT00253474|Interferons|interferons|mesh-list
153698433|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
153698434|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
153698435|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153698437|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
153698438|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698439|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
153698440|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698441|NCT00253552|Cyclosporine|cyclosporine|mesh-list
153698442|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
153698462|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698463|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153698464|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153698465|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153472223|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
153698466|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153698467|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153698468|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
153698469|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698470|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153698471|NCT00253591|Vinorelbine|vinorelbine|mesh-list
153698472|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698482|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698483|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153339171|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
153339173|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698484|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153698485|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698487|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153698488|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153698489|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698490|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153698491|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153698492|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
153698493|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698494|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698495|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
153698496|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
153698497|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
153698510|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
153698511|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153698512|NCT00254137|Capecitabine|capecitabine|mesh-list
153698513|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
153698514|NCT00254137|Irinotecan|irinotecan|mesh-list
153698515|NCT00254137|Cetuximab|cetuximab|mesh-list
153698516|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698517|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
153698518|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698519|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698520|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153698521|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153698522|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698523|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153698524|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
153698525|NCT00104169|Hematinics|hematinics|mesh-ancestor
153698526|NCT00415090|Nevirapine|nevirapine|mesh-list
153698527|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153698528|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153698529|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698530|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535506|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
153698531|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
153698532|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698533|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153698534|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153698535|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153698536|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153698537|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
153698538|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153698539|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153698540|NCT00254254|Exenatide|exenatide|mesh-list
153698542|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153698543|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698544|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153698545|NCT00254254|Incretins|incretins|mesh-ancestor
153698546|NCT00254254|Hormones|hormones|mesh-ancestor
153698547|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698548|NCT00254371|Androgens|androgens|mesh-list
153698549|NCT00254371|Hormones|hormones|mesh-ancestor
153698550|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698555|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
153698556|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698573|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698574|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698575|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153698576|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
153698577|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153698578|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153698579|NCT00254800|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153698580|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153698581|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153698582|NCT00254800|Incretins|incretins|mesh-ancestor
153698583|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153698584|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154257182|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257183|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257184|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154257185|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154257187|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154257188|NCT01274780|Darunavir|darunavir|mesh-list
153698585|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153698586|NCT00104403|Dexamethasone|dexamethasone|mesh-list
153698587|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
153698588|NCT00104403|Ondansetron|ondansetron|mesh-list
153698590|NCT00104403|BB 1101|bb 1101|mesh-list
153698591|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153698592|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
153698593|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
153698594|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698595|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698596|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153698597|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
153698598|NCT00104403|Hormones|hormones|mesh-ancestor
153698599|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698600|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153698601|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698602|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
153698603|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698604|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698605|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
153698606|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
153698607|NCT00104403|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153698608|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153698609|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
153698610|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698611|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153698612|NCT00069836|Metformin|metformin|mesh-list
153698613|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
153698614|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153698615|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698616|NCT00254878|Methylphenidate|methylphenidate|mesh-list
153698617|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153698630|NCT00254956|Hormones|hormones|mesh-ancestor
153698631|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698632|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698633|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153698634|NCT00255073|Baclofen|baclofen|mesh-list
153698635|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153698636|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698637|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153698638|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698639|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153698640|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
153698641|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
153698642|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698665|NCT00104442|Protective Agents|protective agents|mesh-ancestor
153698667|NCT00255385|Trace Elements|trace elements|mesh-list
153698668|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698669|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153698670|NCT00255424|Hematinics|hematinics|mesh-ancestor
153698671|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153698672|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153698673|NCT00069992|Fludarabine|fludarabine|mesh-list
153698674|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
153698675|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698676|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153698677|NCT00255463|Gefitinib|gefitinib|mesh-list
153698678|NCT00255463|Anastrozole|anastrozole|mesh-list
153698679|NCT00255463|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153698701|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
153698702|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698703|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698705|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153698706|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698707|NCT00255658|Sirolimus|sirolimus|mesh-list
153698708|NCT00255658|Sorafenib|sorafenib|mesh-list
153698709|NCT00255658|Temsirolimus|temsirolimus|mesh-list
153698710|NCT00255658|MTOR Inhibitors|mtor inhibitors|mesh-list
153698711|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698712|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153698713|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698714|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698723|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
153698724|NCT00070148|Oxandrolone|oxandrolone|mesh-list
153698725|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153698726|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153698727|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153698728|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
153698729|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153698730|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698731|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153698732|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153698751|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698752|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
153698753|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698754|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153698755|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153698756|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
153698757|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698758|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698759|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153698760|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153698761|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153698762|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153698763|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153698764|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153698765|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
153698766|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
153698767|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698768|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153698769|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153698770|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153698771|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153698772|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153698774|NCT00070187|Cytarabine|cytarabine|mesh-list
153698775|NCT00070187|Aldesleukin|aldesleukin|mesh-list
153698776|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
153698777|NCT00070187|Cyclosporine|cyclosporine|mesh-list
153698778|NCT00070187|Etoposide|etoposide|mesh-list
153698779|NCT00070187|Melphalan|melphalan|mesh-list
153698780|NCT00070187|Interleukin-2|interleukin-2|mesh-list
153698781|NCT00070187|Carmustine|carmustine|mesh-list
153698782|NCT00070187|Cyclosporins|cyclosporins|mesh-list
153698783|NCT00070187|Lenograstim|lenograstim|mesh-list
153698784|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153698785|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698786|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153698787|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153698788|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698789|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698790|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
153698791|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698792|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698793|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
153698813|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153698814|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
153698815|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153698816|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698817|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153698818|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153698819|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698826|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698827|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698829|NCT00256009|Misoprostol|misoprostol|mesh-list
153698830|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153698831|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
153535813|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
153698832|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153698833|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698834|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153698835|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153698836|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
153698837|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
153698838|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153698839|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698840|NCT00070265|Capecitabine|capecitabine|mesh-list
153698841|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
153698842|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698843|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
153698844|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698845|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698846|NCT00104598|Bupropion|bupropion|mesh-list
153698847|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153698872|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698873|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153698874|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153698875|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153698876|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153698877|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698878|NCT00070304|Gemcitabine|gemcitabine|mesh-list
153698879|NCT00070304|Vinorelbine|vinorelbine|mesh-list
153698880|NCT00070304|Lenograstim|lenograstim|mesh-list
153698881|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698882|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
153698883|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698884|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698885|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153698886|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
153698887|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698888|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153698889|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
153698890|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
153698891|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
153698893|NCT00100737|Interleukin-2|interleukin-2|mesh-list
153698894|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153698895|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698907|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698908|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698909|NCT00104715|Docetaxel|docetaxel|mesh-list
153698910|NCT00104715|Goserelin|goserelin|mesh-list
153698911|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
153698912|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698913|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
153698914|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
153698915|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
153698916|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698917|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153698918|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
153698919|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698920|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698921|NCT00256711|Vinorelbine|vinorelbine|mesh-list
153698922|NCT00256711|Gefitinib|gefitinib|mesh-list
153698923|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153698953|NCT00100776|Olanzapine|olanzapine|mesh-list
153698954|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
153698955|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
153698956|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698957|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698977|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
153698978|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698979|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153535963|NCT01519297|Irbesartan|irbesartan|mesh-list
153698980|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153698981|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153698982|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153698983|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698984|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153698985|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153698986|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154257190|NCT01274780|Emtricitabine|emtricitabine|mesh-list
154257191|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153731974|NCT00140075|Taxane|taxane|mesh-list
153698995|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698996|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153698997|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153698998|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153698999|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699000|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699001|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699002|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153699003|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153699004|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153699005|NCT00100854|Fulvestrant|fulvestrant|mesh-list
153699006|NCT00100854|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153699007|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153699008|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699018|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153699019|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699020|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699021|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153699022|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153699023|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699024|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699025|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699026|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153699027|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153699028|NCT00257257|Rimonabant|rimonabant|mesh-list
153699029|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153699030|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153699031|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153699032|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699033|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699034|NCT00257257|Hormones|hormones|mesh-ancestor
153699035|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699036|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699037|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
153699038|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
153699039|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699051|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
153699052|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
153699053|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153699054|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
153699055|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699057|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153699058|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153736011|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153699059|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153699060|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699061|NCT00104793|Carboplatin|carboplatin|mesh-list
153699062|NCT00104793|Irinotecan|irinotecan|mesh-list
153699063|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699064|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153699065|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153699066|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699067|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699068|NCT00070655|Vitamin K|vitamin k|mesh-list
153699069|NCT00070655|Warfarin|warfarin|mesh-list
153699070|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
153699071|NCT00070655|Idraparinux|idraparinux|mesh-list
153699082|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
153699083|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153699084|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
153699085|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699087|NCT00257530|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153699088|NCT00257530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699089|NCT00257530|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153699090|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
153699091|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257192|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153699092|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153699093|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699094|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
153699095|NCT00257569|Cetirizine|cetirizine|mesh-list
153699096|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153699097|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153699098|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153699099|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
153699100|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
153699101|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699102|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699103|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699104|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
153699105|NCT00100893|Procyanidin|procyanidin|mesh-list
153699106|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
153699107|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699108|NCT00100893|Protective Agents|protective agents|mesh-ancestor
153699109|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699110|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153699111|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153699112|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699113|NCT00257803|Oxytocin|oxytocin|mesh-list
153699128|NCT00401115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153699129|NCT00401115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699130|NCT00401115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699131|NCT00257959|Amiodarone|amiodarone|mesh-list
153699132|NCT00257959|Sotalol|sotalol|mesh-list
153699133|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153699134|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153699135|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
153699136|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699155|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
153699156|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
153699157|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153699158|NCT00070733|Androgens|androgens|mesh-ancestor
153699159|NCT00070733|Hormones|hormones|mesh-ancestor
153910749|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699160|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699161|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699162|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153699163|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699164|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
153699165|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
153699166|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153699167|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699168|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153699169|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153699170|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153699171|NCT00258115|Analgesics|analgesics|mesh-ancestor
153699172|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
153699173|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699174|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699175|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699176|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699177|NCT00258193|Linaclotide|linaclotide|mesh-list
153699178|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153699179|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
153699180|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699181|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699182|NCT00100971|Vaccines|vaccines|mesh-list
153699183|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
153699184|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699185|NCT00258232|Celecoxib|celecoxib|mesh-list
153699186|NCT00258232|Capecitabine|capecitabine|mesh-list
153699187|NCT00258232|Irinotecan|irinotecan|mesh-list
153699188|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699189|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
153852846|NCT05854537|Sensory System Agents|sensory system agents|mesh-ancestor
153699210|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699211|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699212|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
153699213|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257193|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
154257194|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699214|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699215|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
153699216|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699217|NCT00258271|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153699218|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153699219|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699220|NCT00101088|Sirolimus|sirolimus|mesh-list
153699221|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
153699222|NCT00101088|Temsirolimus|temsirolimus|mesh-list
153699223|NCT00101088|MTOR Inhibitors|mtor inhibitors|mesh-list
153699224|NCT00101088|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153699225|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153699226|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699227|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699228|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699229|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699230|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
153699231|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699232|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699233|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699234|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153699235|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
153699236|NCT00258622|Lidocaine|lidocaine|mesh-list
153699237|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
153699238|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
153699239|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153699240|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699241|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
153699242|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699243|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153699244|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153699260|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
153699261|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699262|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699263|NCT00104910|Cetuximab|cetuximab|mesh-list
153699264|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699265|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153699266|NCT00415324|Cisplatin|cisplatin|mesh-list
153699267|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699268|NCT00258739|Carboplatin|carboplatin|mesh-list
153699269|NCT00258739|Gemcitabine|gemcitabine|mesh-list
153699270|NCT00258739|Docetaxel|docetaxel|mesh-list
153699271|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699272|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699273|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
153699274|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699275|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
153699276|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
153699277|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
153699278|NCT00104949|Trastuzumab|trastuzumab|mesh-list
153699279|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153699280|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699281|NCT00101127|Gemcitabine|gemcitabine|mesh-list
153852857|NCT05822076|Ropivacaine|ropivacaine|mesh-list
153699294|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699295|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699296|NCT00259129|Sorafenib|sorafenib|mesh-list
153699297|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699298|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153699299|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699300|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699301|NCT00259168|Nateglinide|nateglinide|mesh-list
153699302|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153699303|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699304|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
153699305|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699328|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153699330|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
153699331|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699332|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
153699333|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699334|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154257195|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257196|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154257197|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154257198|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
153699335|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699336|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
153699337|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699338|NCT00259441|Simvastatin|simvastatin|mesh-list
153699339|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153699340|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153699341|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
153699342|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699343|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153699344|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153473577|NCT02976246|Vitamins|vitamins|mesh-ancestor
153813801|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
153473653|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153699345|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699346|NCT00071201|Adefovir|adefovir|mesh-list
153699347|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153536325|NCT01521689|Rituximab|rituximab|mesh-list
153699348|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
153699349|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699350|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153699351|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153699352|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699387|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699389|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
153699390|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699391|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153699392|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
153699393|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699394|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699395|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153699396|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
153699397|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
153699398|NCT00259792|Hormones|hormones|mesh-ancestor
153699399|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699400|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153699401|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153699402|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153699403|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
153699404|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699413|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
153473696|NCT02641314|Celecoxib|celecoxib|mesh-list
153699414|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
153699415|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699416|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699417|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699418|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153699419|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153699420|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153699421|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153699422|NCT00259870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153699423|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153699424|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153699425|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699426|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699427|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
153699428|NCT00071279|Idraparinux|idraparinux|mesh-list
153699429|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153699430|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
153699431|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153699432|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
153699440|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699442|NCT00260026|Docetaxel|docetaxel|mesh-list
153699443|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699444|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
153699445|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
153699446|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
153699447|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699448|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
153699449|NCT00260143|Testosterone|testosterone|mesh-list
153699450|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
153731978|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699451|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
153699452|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153699453|NCT00260143|Androgens|androgens|mesh-ancestor
153699454|NCT00260143|Hormones|hormones|mesh-ancestor
153699455|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699456|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699457|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153699458|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699459|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
153699460|NCT00260260|Oxycodone|oxycodone|mesh-list
153699461|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153699462|NCT00260260|Narcotics|narcotics|mesh-ancestor
153699463|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910751|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
153699464|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699465|NCT00260260|Analgesics|analgesics|mesh-ancestor
153813803|NCT00335270|Abacavir|abacavir|mesh-list
153699466|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
153699467|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699468|NCT00105300|Adalimumab|adalimumab|mesh-list
153699469|NCT00105300|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153699470|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699483|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
153699484|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699485|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
153699487|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
153699488|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699489|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153699490|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153699491|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153699492|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699493|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699494|NCT00260923|Aliskiren|aliskiren|mesh-list
153699495|NCT00260923|Renin Inhibitors|renin inhibitors|mesh-ancestor
153699496|NCT00260923|Protease Inhibitors|protease inhibitors|mesh-ancestor
153699497|NCT00260923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699498|NCT00260923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699499|NCT00261079|Fexofenadine|fexofenadine|mesh-list
153699500|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153699501|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153699502|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153699503|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
153699504|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
153699505|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699506|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699507|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699508|NCT00261118|Rituximab|rituximab|mesh-list
153699509|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153699510|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699511|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
153699518|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699519|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153699520|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699521|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153699522|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153699523|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153699524|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153699525|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153699526|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
153699527|NCT00261313|Hematinics|hematinics|mesh-ancestor
153699528|NCT00261352|Metformin|metformin|mesh-list
153699529|NCT00261352|Fenofibrate|fenofibrate|mesh-list
153699530|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153699531|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699532|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153699533|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
153699534|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699547|NCT00261469|Topiramate|topiramate|mesh-list
153699548|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
153699549|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153699550|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257200|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153699551|NCT00261508|Risperidone|risperidone|mesh-list
153699552|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153699553|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
153699554|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699555|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699556|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699557|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153699558|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153699559|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153699560|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153699561|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153699562|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
153699564|NCT00261586|Acetaminophen|acetaminophen|mesh-list
153699565|NCT00261586|Ibuprofen|ibuprofen|mesh-list
153699566|NCT00261586|Celecoxib|celecoxib|mesh-list
153699567|NCT00261586|Naproxen|naproxen|mesh-list
153699568|NCT00261586|Rofecoxib|rofecoxib|mesh-list
153699569|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153699570|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153699571|NCT00261586|Analgesics|analgesics|mesh-ancestor
153699572|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
153699573|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536552|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699574|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699575|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699576|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699577|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153699578|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153699579|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699580|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153699581|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153699582|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699583|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
153699584|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153699585|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
153699586|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
153699587|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153699588|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699589|NCT00261625|Alendronate|alendronate|mesh-list
153699590|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153473974|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699591|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699592|NCT00261703|Cisplatin|cisplatin|mesh-list
153699593|NCT00261703|Docetaxel|docetaxel|mesh-list
153699594|NCT00261703|Fluorouracil|fluorouracil|mesh-list
153699619|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699620|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699621|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153699622|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699623|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153699624|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
153699625|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699626|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699627|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
153699628|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699629|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
153699630|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
153699631|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699632|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699633|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
153699634|NCT00261820|Hormones|hormones|mesh-ancestor
153699635|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699636|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153699637|NCT00261820|Protective Agents|protective agents|mesh-ancestor
153699638|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153699639|NCT00072098|Interleukin-12|interleukin-12|mesh-list
153699640|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153699641|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
153699642|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699643|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153699644|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153699645|NCT00072098|Growth Substances|growth substances|mesh-ancestor
153699646|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
153699647|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699648|NCT00261937|Furosemide|furosemide|mesh-list
153699649|NCT00261937|Diuretics|diuretics|mesh-ancestor
153425959|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699650|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
153474136|NCT00603720|Phenylephrine|phenylephrine|mesh-list
153699651|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699652|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153699653|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153699654|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699655|NCT00105495|Deferiprone|deferiprone|mesh-list
153699656|NCT00105495|Deferoxamine|deferoxamine|mesh-list
153699657|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153699658|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
153699659|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
153699660|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699661|NCT00105495|Siderophores|siderophores|mesh-ancestor
153699662|NCT00261976|Infliximab|infliximab|mesh-list
153699663|NCT00261976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153699693|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
153699694|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699695|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
153852953|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
153852958|NCT05624918|Paclitaxel|paclitaxel|mesh-list
153699699|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
153699700|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699701|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699702|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699703|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699704|NCT00262210|Prednisolone|prednisolone|mesh-list
153699705|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
153699706|NCT00262210|Etoposide|etoposide|mesh-list
153699707|NCT00262210|Epirubicin|epirubicin|mesh-list
153699708|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699709|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
153699710|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699711|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699712|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153699713|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
153699727|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153699728|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153699729|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699730|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
153699731|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699732|NCT00262327|Endostatins|endostatins|mesh-list
153699733|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699734|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153699735|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153699736|NCT00262327|Growth Substances|growth substances|mesh-ancestor
153699737|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699738|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
153699739|NCT02966288|Ibuprofen|ibuprofen|mesh-list
153699740|NCT02966288|Ketorolac|ketorolac|mesh-list
153699741|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153699742|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153699743|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153699744|NCT02966288|Analgesics|analgesics|mesh-ancestor
153699745|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
153699746|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699747|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699748|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699749|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699750|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153699751|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699752|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699753|NCT00262405|Prednisone|prednisone|mesh-list
153699754|NCT00262405|Zileuton|zileuton|mesh-list
153699755|NCT00262405|Azathioprine|azathioprine|mesh-list
153699756|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699757|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
153699758|NCT00262405|Hormones|hormones|mesh-ancestor
153699759|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699760|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699761|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153699762|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699763|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
153341380|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153910752|NCT02780479|Hormones|hormones|mesh-ancestor
153425971|NCT04429880|Oxytocin|oxytocin|mesh-list
153699764|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699765|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699766|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699767|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
153699768|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699769|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153699770|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153699771|NCT00262405|Analgesics|analgesics|mesh-ancestor
153699772|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
153852970|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
153699797|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153699798|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699800|NCT00072215|Paclitaxel|paclitaxel|mesh-list
153699801|NCT00072215|Vinblastine|vinblastine|mesh-list
153699802|NCT00072215|Ifosfamide|ifosfamide|mesh-list
153781929|NCT04557943|Protective Agents|protective agents|mesh-ancestor
153699803|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153699804|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699805|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
153699806|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
153699807|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
153699808|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699809|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153699810|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
153699811|NCT00262795|Fludarabine|fludarabine|mesh-list
153699812|NCT00262795|Chlorambucil|chlorambucil|mesh-list
153699813|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699814|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699815|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153699816|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
153699817|NCT00072332|Cisplatin|cisplatin|mesh-list
153699818|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699819|NCT00263029|Capecitabine|capecitabine|mesh-list
153699820|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
153699821|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699822|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
153699823|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699824|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699825|NCT00263068|Rotigotine|rotigotine|mesh-list
153699841|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699843|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153699844|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
153699845|NCT00263185|Vitamin D|vitamin d|mesh-list
153699846|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
153699847|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
153699848|NCT00263185|Vitamins|vitamins|mesh-list
153699849|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
153699850|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
153699851|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699852|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153699853|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153699854|NCT00263185|Antacids|antacids|mesh-ancestor
153699855|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699856|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699857|NCT00263263|Sirolimus|sirolimus|mesh-list
153699858|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699859|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699860|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153699861|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699862|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
153699863|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699864|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
153699865|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699866|NCT00101673|Vildagliptin|vildagliptin|mesh-list
153699867|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153699868|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699869|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153699870|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
153699871|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699872|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699873|NCT00263302|Dexamethasone|dexamethasone|mesh-list
153699874|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257201|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154257202|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153699875|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
153699876|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
153699877|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699878|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699879|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699880|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
153699897|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153699898|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
153699899|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699900|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699901|NCT00072527|Carboplatin|carboplatin|mesh-list
153699902|NCT00072527|Irinotecan|irinotecan|mesh-list
153699903|NCT00072527|Etoposide|etoposide|mesh-list
153699904|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699905|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153699906|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153699907|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699908|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699909|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153699910|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153699911|NCT00263965|Metformin|metformin|mesh-list
153699912|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153699913|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699914|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
153699915|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153699916|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699917|NCT00072683|Tolvaptan|tolvaptan|mesh-list
153699918|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153699919|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699920|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
153699921|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699922|NCT00264160|Nilotinib|nilotinib|mesh-list
153699923|NCT00264160|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153699924|NCT00264160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153699925|NCT00264160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699926|NCT00264160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699927|NCT00101790|Pamidronate|pamidronate|mesh-list
153699928|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153699929|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699930|NCT00264277|Vitamin K|vitamin k|mesh-list
153699931|NCT00264277|Anticoagulants|anticoagulants|mesh-list
153699932|NCT00264277|Vitamins|vitamins|mesh-ancestor
153699933|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
153699934|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699935|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153699936|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153699937|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699938|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
153699939|NCT00264277|Coagulants|coagulants|mesh-ancestor
153699940|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153853015|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699966|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699967|NCT00264355|Cyclosporine|cyclosporine|mesh-list
153699968|NCT00264355|Cyclosporins|cyclosporins|mesh-list
153699969|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699970|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699971|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699972|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
153699973|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699974|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
153699975|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699976|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
153699977|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699978|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153699979|NCT00264472|Eniluracil|eniluracil|mesh-list
153699980|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699981|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699982|NCT00101829|Rituximab|rituximab|mesh-list
153699983|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153699984|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699985|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
154257203|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154257205|NCT01169870|genexol-PM|genexol-pm|mesh-list
153699986|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699987|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699988|NCT00072839|Teduglutide|teduglutide|mesh-list
153699989|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153474567|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
153699990|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153699991|NCT00072839|Protective Agents|protective agents|mesh-ancestor
153699992|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699993|NCT00264628|Casopitant|casopitant|mesh-list
153699994|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
153699995|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
153699996|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699997|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699998|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699999|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153700000|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700001|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700002|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
153700003|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153700023|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
153700024|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153700025|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153700026|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153700027|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700028|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700030|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700031|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700032|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153700033|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153700034|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700035|NCT00265252|Alendronate|alendronate|mesh-list
153700036|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153700037|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700038|NCT00265291|Fluoxetine|fluoxetine|mesh-list
153700039|NCT00265291|Desipramine|desipramine|mesh-list
153700040|NCT00265291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153700041|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153700042|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700043|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700044|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700045|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
153700046|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700047|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153700048|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
153700049|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153700050|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153700051|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153700052|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700053|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153700054|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153700055|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
153700056|NCT00265408|Aspirin|aspirin|mesh-list
153700057|NCT00265408|Warfarin|warfarin|mesh-list
153700058|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153700059|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153700060|NCT00265408|Analgesics|analgesics|mesh-ancestor
153700061|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
153474702|NCT00717054|Scopolamine|scopolamine|mesh-list
153700062|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700063|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700064|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700065|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153700066|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153700067|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153700068|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700069|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153700070|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153700071|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700072|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
154257206|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153700073|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
153700074|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
153700075|NCT00265486|Hematinics|hematinics|mesh-ancestor
153700076|NCT00265642|Irbesartan|irbesartan|mesh-list
153700100|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153700101|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153700102|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700103|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153700104|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153700105|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153700106|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153700107|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
153700108|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700109|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153700110|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700111|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700113|NCT00415831|Carbidopa|carbidopa|mesh-list
153700114|NCT00415831|Entacapone|entacapone|mesh-list
153700115|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153700116|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153700117|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153700118|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
153700119|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700120|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700121|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700122|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153700123|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700124|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153700125|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153700126|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
153700127|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
153700128|NCT00102141|Drospirenone|drospirenone|mesh-list
153700129|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153700130|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153700131|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153700132|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153700133|NCT00102141|Estradiol|estradiol|mesh-list
153700134|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153700135|NCT00102141|Estrogens|estrogens|mesh-ancestor
153700136|NCT00102141|Hormones|hormones|mesh-ancestor
153700137|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153700162|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153700163|NCT00266539|Narcotics|narcotics|mesh-ancestor
153700164|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700165|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700166|NCT00266539|Analgesics|analgesics|mesh-ancestor
153700167|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
153700168|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700169|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153700170|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153700171|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
153700172|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
153700173|NCT00266578|Fluticasone|fluticasone|mesh-list
153700174|NCT00266578|Xhance|xhance|mesh-list
153700181|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
153700182|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700183|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153700184|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
153700185|NCT00266617|Hematinics|hematinics|mesh-ancestor
153700186|NCT00102219|Doxorubicin|doxorubicin|mesh-list
153700187|NCT00102219|Pemetrexed|pemetrexed|mesh-list
153700188|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153700189|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700204|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700206|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153700207|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700208|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700209|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
153700210|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700211|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700212|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
153700213|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
153700214|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
153700215|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153700216|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
154257207|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700217|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700218|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700220|NCT00073385|Docetaxel|docetaxel|mesh-list
153700221|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700222|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
153700223|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
153700224|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
153700225|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700226|NCT00102258|Hormones|hormones|mesh-list
153700227|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153700228|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700229|NCT00267514|Sevelamer|sevelamer|mesh-list
153700230|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
153700231|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
153700232|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700233|NCT00267553|Toremifene|toremifene|mesh-list
153700234|NCT00267553|Letrozole|letrozole|mesh-list
153700235|NCT00267553|Atamestane|atamestane|mesh-list
153700236|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700237|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153700238|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153700239|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700240|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700241|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153700242|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
153700243|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153700244|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700245|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153700246|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153700247|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153700248|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153700261|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700262|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
153700263|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153700264|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153700265|NCT00267709|Visilizumab|visilizumab|mesh-list
153700266|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
153700267|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700268|NCT00267826|Rituximab|rituximab|mesh-list
153700269|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153700270|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700295|NCT00268138|Fluorides|fluorides|mesh-list
153700296|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
153700297|NCT00268138|Protective Agents|protective agents|mesh-ancestor
153700298|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700299|NCT00102375|Topotecan|topotecan|mesh-list
153700300|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153700301|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700302|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700303|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700304|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700305|NCT00268177|Fluticasone|fluticasone|mesh-list
153700306|NCT00268177|Xhance|xhance|mesh-list
153700307|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153700308|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700309|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153700323|NCT00268216|Fluticasone|fluticasone|mesh-list
153700324|NCT00268216|Xhance|xhance|mesh-list
153700325|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153700326|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700327|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153700328|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
153853104|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153700353|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153700354|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
153700355|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700356|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700357|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700358|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153700359|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153700360|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700361|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153700362|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153700363|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
153700364|NCT00073658|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153700365|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153700366|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700367|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153700368|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
153700369|NCT00268255|Gefitinib|gefitinib|mesh-list
153700370|NCT00268255|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153700393|NCT00268333|Antidotes|antidotes|mesh-ancestor
153700394|NCT00268333|Protective Agents|protective agents|mesh-ancestor
153700395|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
153700397|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
153700398|NCT00073697|Dexetimide|dexetimide|mesh-list
153700399|NCT00073697|Citalopram|citalopram|mesh-list
153700400|NCT00073697|Escitalopram|escitalopram|mesh-list
153700401|NCT00073697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153700402|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153700411|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
153700412|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700413|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153700414|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153700415|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
153700416|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153700417|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
153700418|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153700419|NCT00268372|Docetaxel|docetaxel|mesh-list
153700420|NCT00268372|Fluorouracil|fluorouracil|mesh-list
153700421|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446207|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700422|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
153700423|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
153700441|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700442|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
153700443|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700444|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700445|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
153700446|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700447|NCT00268489|Bevacizumab|bevacizumab|mesh-list
153700448|NCT00268489|Pemetrexed|pemetrexed|mesh-list
153700449|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153700450|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700451|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153700452|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153700453|NCT00268489|Growth Substances|growth substances|mesh-ancestor
153700454|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700474|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
153700475|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153700476|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153700478|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153700480|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700508|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153700509|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700510|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153700511|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700512|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700513|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700514|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700515|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
153700516|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
153700517|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153700518|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700519|NCT00268684|Temozolomide|temozolomide|mesh-list
153700520|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153700521|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153700522|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
153477602|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700523|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700524|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700525|NCT00268684|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153700526|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153700541|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
153700542|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
153700543|NCT00073931|Sargramostim|sargramostim|mesh-list
153700544|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
153700545|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700546|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700547|NCT00268723|Albuterol|albuterol|mesh-list
154257208|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
154257209|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342449|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
153700559|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
153700560|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700561|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700562|NCT00268840|Gemcitabine|gemcitabine|mesh-list
153700563|NCT00268840|Docetaxel|docetaxel|mesh-list
153700564|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700565|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
153700566|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700567|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700568|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
153700569|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
153700570|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
153700571|NCT00268879|Renzapride|renzapride|mesh-list
153700572|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153700573|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
153700574|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700575|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700576|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700577|NCT00268918|Docetaxel|docetaxel|mesh-list
153700578|NCT00268918|Vatalanib|vatalanib|mesh-list
153700579|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700580|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
153700581|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
153700582|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
153700583|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700584|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153700585|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700586|NCT00268957|Sevelamer|sevelamer|mesh-list
153700587|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
153447018|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477891|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700588|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
153700604|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
153700605|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
153700606|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700630|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153700631|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700632|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700633|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153700634|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153700635|NCT00074087|Doxorubicin|doxorubicin|mesh-list
153700636|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153700637|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153700638|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700639|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153700640|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700641|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700642|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700643|NCT00269542|Iron|iron|mesh-list
153700644|NCT00269542|Folic Acid|folic acid|mesh-list
153700645|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
153700646|NCT00269542|Trace Elements|trace elements|mesh-ancestor
153700668|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153700669|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153700671|NCT00074204|Gemcitabine|gemcitabine|mesh-list
153700672|NCT00074204|Docetaxel|docetaxel|mesh-list
153700673|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700674|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700675|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
153700676|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700677|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
153700678|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447198|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153853165|NCT05141682|Azacitidine|azacitidine|mesh-list
153700685|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700686|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153700687|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700688|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
153700689|NCT00416221|Escitalopram|escitalopram|mesh-list
153700690|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153700691|NCT00416221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153426167|NCT03663283|Bupivacaine|bupivacaine|mesh-list
153700692|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153342608|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153700693|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700694|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700695|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700696|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
153700697|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700698|NCT00269737|Fentanyl|fentanyl|mesh-list
153700699|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153700700|NCT00269737|Narcotics|narcotics|mesh-ancestor
153700701|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700702|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700720|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153700721|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700723|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153700724|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153478199|NCT01100112|Budesonide|budesonide|mesh-list
153700725|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700726|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
153700727|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700728|NCT00269854|Infliximab|infliximab|mesh-list
153700729|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153700730|NCT00269854|Antibodies|antibodies|mesh-list
153700731|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
153700732|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153700733|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
153700734|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700735|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700736|NCT00269854|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153700737|NCT00269854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700738|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700739|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153700784|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153700785|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153700786|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
153700787|NCT00269971|Hematinics|hematinics|mesh-ancestor
153700788|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
153700789|NCT00270010|Hematinics|hematinics|mesh-ancestor
153700790|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
153700791|NCT00270049|Hematinics|hematinics|mesh-ancestor
153700792|NCT00107016|Letrozole|letrozole|mesh-list
153700793|NCT00107016|Everolimus|everolimus|mesh-list
153700794|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700795|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153700796|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153700797|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700798|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700799|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153700800|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
153700801|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153700802|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700803|NCT00107016|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153478884|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
153700804|NCT00107016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153426183|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700805|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700806|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
153700809|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
153700820|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153700821|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153700822|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153700823|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153700824|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
153700825|NCT00270283|Hematinics|hematinics|mesh-ancestor
153700826|NCT00270322|Fentanyl|fentanyl|mesh-list
153700827|NCT00270322|Morphine|morphine|mesh-list
153700828|NCT00270322|Bupivacaine|bupivacaine|mesh-list
153700829|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153700830|NCT00270322|Narcotics|narcotics|mesh-ancestor
153700831|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700832|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700833|NCT00270322|Analgesics|analgesics|mesh-ancestor
153700834|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
153700835|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700836|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153700837|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154257210|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
153700838|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
153700839|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
153700840|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
153478885|NCT01208922|Rifamycins|rifamycins|mesh-list
153479062|NCT01232946|Insulin|insulin|mesh-list
153700841|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153700842|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
153700843|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700844|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
153700845|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
153700846|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
153700847|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700848|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700849|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
153700850|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700851|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153700852|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
153700853|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700854|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153700856|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
153700857|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
153700858|NCT00270478|Hematinics|hematinics|mesh-ancestor
153700859|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700860|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
153700861|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700862|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700863|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153700864|NCT00270517|Telithromycin|telithromycin|mesh-list
153700865|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153700866|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700867|NCT00270556|Tenofovir|tenofovir|mesh-list
153700868|NCT00270556|Abacavir|abacavir|mesh-list
153479705|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479707|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153700869|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
153480426|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
153700870|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700871|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153700872|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153700873|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700874|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700875|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153700876|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153700877|NCT00074438|Rituximab|rituximab|mesh-list
153700878|NCT00074438|Methotrexate|methotrexate|mesh-list
153700894|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153700895|NCT00270751|Minocycline|minocycline|mesh-list
153700896|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153700897|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700898|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153700899|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
153700900|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700908|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700909|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153700910|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153700911|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153700912|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
153700913|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700914|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700916|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153700917|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700918|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
153700919|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700920|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700921|NCT00271063|Annamycin|annamycin|mesh-list
153700922|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153700923|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700924|NCT00107523|Cytarabine|cytarabine|mesh-list
153700925|NCT00107523|Idarubicin|idarubicin|mesh-list
153700926|NCT00107523|Pravastatin|pravastatin|mesh-list
153700927|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153537905|NCT01525771|Cisplatin|cisplatin|mesh-list
153700928|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
153700929|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700930|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700931|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
153700932|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700933|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700934|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
153481366|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700935|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700948|NCT00416377|Vincristine|vincristine|mesh-list
153700949|NCT00416377|Dacarbazine|dacarbazine|mesh-list
153700950|NCT00416377|Vinblastine|vinblastine|mesh-list
153700951|NCT00416377|Procarbazine|procarbazine|mesh-list
153700952|NCT00416377|Chlorambucil|chlorambucil|mesh-list
153700953|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153700954|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700955|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153700956|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700957|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700958|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700959|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153700960|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
153700961|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
153700962|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
153700963|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700964|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
153700990|NCT00271414|Fentanyl|fentanyl|mesh-list
153700991|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153700992|NCT00271414|Narcotics|narcotics|mesh-ancestor
153700993|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700994|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700995|NCT00271414|Analgesics|analgesics|mesh-ancestor
153700996|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
153700997|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700998|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153701014|NCT00271492|Atrasentan|atrasentan|mesh-list
153701015|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701016|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153701017|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153701035|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153701036|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701037|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
153701038|NCT00272428|Vitamin E|vitamin e|mesh-list
153701039|NCT00272428|Beta Carotene|beta carotene|mesh-list
153701040|NCT00272428|Selenium|selenium|mesh-list
153701041|NCT00272428|Carotenoids|carotenoids|mesh-list
153701042|NCT00272428|Vitamins|vitamins|mesh-ancestor
153701043|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
153701044|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701045|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
153701046|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701047|NCT00272428|Protective Agents|protective agents|mesh-ancestor
153701048|NCT00272428|Trace Elements|trace elements|mesh-ancestor
153701049|NCT00272428|Provitamins|provitamins|mesh-ancestor
153701050|NCT00272467|Omeprazole|omeprazole|mesh-list
153701051|NCT00272467|Rebamipide|rebamipide|mesh-list
153481661|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
153481662|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
153701052|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153701053|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701054|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153701055|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701056|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701057|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
153701058|NCT00272467|Protective Agents|protective agents|mesh-ancestor
153701059|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701060|NCT00272584|Risperidone|risperidone|mesh-list
153701061|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153701072|NCT00272701|Esomeprazole|esomeprazole|mesh-list
153701073|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153701074|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701075|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153701076|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701077|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701078|NCT00272740|Fulvestrant|fulvestrant|mesh-list
153701079|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153701080|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701081|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153701082|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153701083|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
153701084|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481676|NCT01772472|Trastuzumab|trastuzumab|mesh-list
153701085|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701086|NCT00074750|Molgramostim|molgramostim|mesh-list
153701087|NCT00074750|Sargramostim|sargramostim|mesh-list
153701088|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
153853237|NCT04908579|Analgesics|analgesics|mesh-ancestor
153701094|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153343091|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343092|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
153701095|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701096|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
153701097|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
153701098|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
153701099|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701100|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153701101|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153701102|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153701103|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701104|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153701105|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
153701106|NCT00416533|Hormones|hormones|mesh-ancestor
153701107|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701108|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701109|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153701110|NCT00107796|Modafinil|modafinil|mesh-list
153701111|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153701112|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701113|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153701114|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153701115|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153701116|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701117|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
153701118|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701119|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
153701120|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153701121|NCT00272896|Protective Agents|protective agents|mesh-ancestor
153482891|NCT05997732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701122|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701123|NCT00272935|Estrogens|estrogens|mesh-list
153701124|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153701140|NCT00107835|Tetracaine|tetracaine|mesh-list
153701141|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
153701142|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
153701143|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701144|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701145|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
153701171|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
153701172|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701173|NCT00273442|Timolol|timolol|mesh-list
153701174|NCT00273442|Dorzolamide|dorzolamide|mesh-list
153701175|NCT00273442|Maleic acid|maleic acid|mesh-list
153701176|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701177|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701178|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153701179|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153701180|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
153701181|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736013|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153701200|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701201|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153701202|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153701203|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
153701204|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701205|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701226|NCT00273871|Cyclosporine|cyclosporine|mesh-list
153701227|NCT00273871|Tacrolimus|tacrolimus|mesh-list
153701228|NCT00273871|Cyclosporins|cyclosporins|mesh-list
153701229|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701230|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
153482973|NCT05724316|Micronutrients|micronutrients|mesh-ancestor
153701231|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701232|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153701233|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701234|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701235|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
153701236|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701237|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
153701238|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153701239|NCT00273949|Lactulose|lactulose|mesh-list
153701254|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153701255|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
153701256|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701257|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701258|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153701259|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701260|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
153701261|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153701262|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
153701263|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701264|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701265|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
153701266|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153701267|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153701268|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701269|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701270|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
153701271|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701272|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701273|NCT00274066|Fenoterol|fenoterol|mesh-list
153701274|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
153701291|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153701292|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153701293|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
153701295|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701296|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153701297|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153701298|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701299|NCT00274144|Telmisartan|telmisartan|mesh-list
153701310|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701311|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153701312|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153701313|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153701314|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153701315|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701316|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701317|NCT00274339|Lansoprazole|lansoprazole|mesh-list
153701318|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153701319|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701320|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153701321|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701322|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701323|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153701324|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
153701325|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701326|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153701327|NCT00416650|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153701328|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153701329|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701330|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701331|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452251|NCT01854918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153483988|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153701332|NCT00274417|Dutasteride|dutasteride|mesh-list
153701333|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153701334|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153701335|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701336|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701337|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
153701338|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701355|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153701356|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701357|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
153701358|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153701359|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
153701360|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701370|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701371|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701372|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153701373|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701374|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
153701375|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153701376|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
153701377|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343429|NCT00002854|Ifosfamide|ifosfamide|mesh-list
153701378|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701379|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
153701380|NCT00274612|Telmisartan|telmisartan|mesh-list
153701381|NCT00274612|Ramipril|ramipril|mesh-list
153484506|NCT01667796|Vitamin D|vitamin d|mesh-list
153484562|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
153484563|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701382|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701383|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153701384|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153701385|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701386|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153701387|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
153701388|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701389|NCT00075374|Docetaxel|docetaxel|mesh-list
153701390|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701391|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
153701392|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
153701393|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
153701394|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701395|NCT00274690|Casopitant|casopitant|mesh-list
153701396|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
153701397|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
153701398|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701399|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701400|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701401|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153701402|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701403|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701404|NCT00274807|Cytarabine|cytarabine|mesh-list
153701405|NCT00274807|Etoposide|etoposide|mesh-list
153701406|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
153701407|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153701411|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701412|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701413|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153701414|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
153701415|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
153701416|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701417|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701418|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
153701419|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701420|NCT00274807|Analgesics|analgesics|mesh-ancestor
153701421|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
153701422|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701423|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
153701424|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701425|NCT00277225|Abatacept|abatacept|mesh-list
153701444|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701445|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701447|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701448|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153452538|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153701449|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153701450|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153701451|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
153701452|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701453|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701454|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701455|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
153701456|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701457|NCT00277342|Insulin|insulin|mesh-list
153701458|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153701459|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701460|NCT00277498|Timolol|timolol|mesh-list
153701461|NCT00277498|Latanoprost|latanoprost|mesh-list
153701462|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153701463|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153701464|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
153701465|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701466|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701467|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701468|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153701469|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701470|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153701471|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153701472|NCT00108498|Mirtazapine|mirtazapine|mesh-list
153377510|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153343617|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
153701473|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
153393549|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393551|NCT00383799|Amiodarone|amiodarone|mesh-list
153701504|NCT00108537|Nicotine|nicotine|mesh-list
153701505|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153701506|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
153485612|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701507|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701508|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701509|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153701510|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153701511|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
153701512|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701513|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701514|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153701515|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
153701516|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701517|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153701518|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153701519|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153701520|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
153701521|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153701522|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153701523|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701524|NCT00277654|Risperidone|risperidone|mesh-list
153701525|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153701527|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701528|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701529|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701530|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153701531|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153701532|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701533|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701534|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153701535|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
153701536|NCT00277693|Spironolactone|spironolactone|mesh-list
153701537|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153701538|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
153701539|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701540|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853320|NCT04761848|Protective Agents|protective agents|mesh-ancestor
153701635|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153701636|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701638|NCT00075686|Cetuximab|cetuximab|mesh-list
153701639|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153701640|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
153701641|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701642|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701643|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153701644|NCT00278824|Fentanyl|fentanyl|mesh-list
153701645|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153701646|NCT00278824|Narcotics|narcotics|mesh-ancestor
153701647|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701648|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701649|NCT00278824|Analgesics|analgesics|mesh-ancestor
153701650|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
153701671|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153701672|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
153701673|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701674|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701677|NCT00108849|Hormones|hormones|mesh-ancestor
153701678|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701679|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701680|NCT00279058|Immunomodulating Agents|immunomodulating agents|mesh-list
153701681|NCT00279058|Immunologic Factors|immunologic factors|mesh-ancestor
153701682|NCT00279058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701683|NCT00279253|Clonidine|clonidine|mesh-list
153701684|NCT00279253|Analgesics|analgesics|mesh-ancestor
153701685|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
153701686|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343805|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701687|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701688|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701689|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
153701690|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
153701691|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153701692|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153701693|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153701694|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
153426369|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701695|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701696|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701697|NCT00109044|Escitalopram|escitalopram|mesh-list
153701698|NCT00109044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153393589|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
153701767|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701769|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153701770|NCT00109161|Daclizumab|daclizumab|mesh-list
153701771|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
153701772|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701773|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701774|NCT00279760|Abatacept|abatacept|mesh-list
153701775|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153701776|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701777|NCT00279760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153701778|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701779|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701780|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
153701781|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701782|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153701783|NCT00109200|Omalizumab|omalizumab|mesh-list
153701784|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153701785|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153701786|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701787|NCT00416728|Valsartan|valsartan|mesh-list
153701788|NCT00416728|Aliskiren|aliskiren|mesh-list
153701789|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153485924|NCT04753437|Antacids|antacids|mesh-ancestor
153485961|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
153701790|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153701791|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153701792|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701793|NCT00416728|Renin Inhibitors|renin inhibitors|mesh-ancestor
153701794|NCT00416728|Protease Inhibitors|protease inhibitors|mesh-ancestor
153701795|NCT00416728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701796|NCT00416767|Leucovorin|leucovorin|mesh-list
153701797|NCT00416767|Fluorouracil|fluorouracil|mesh-list
153701798|NCT00416767|Irinotecan|irinotecan|mesh-list
153701799|NCT00416767|Calcium|calcium|mesh-list
153701800|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
153701893|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701895|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
153701896|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701897|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153701898|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153701899|NCT00076349|Rituximab|rituximab|mesh-list
153538873|NCT01530308|Dopamine|dopamine|mesh-list
153701900|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153701901|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153701902|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701903|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
153701904|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701905|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153701906|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153701907|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
153701908|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701942|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
153701943|NCT00109551|Vitamins|vitamins|mesh-ancestor
153701944|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
153701945|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701946|NCT00109551|Astringents|astringents|mesh-ancestor
153701947|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
153701948|NCT00280930|Letrozole|letrozole|mesh-list
153701949|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701950|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153701951|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153701969|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153701971|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153701972|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153538951|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
153701973|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153701974|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
153701975|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153701976|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153701977|NCT00281008|Mipomersen|mipomersen|mesh-list
153701978|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153701979|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153426418|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701980|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
153701981|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701982|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153701983|NCT00281125|Pemetrexed|pemetrexed|mesh-list
153701984|NCT00281125|Vatalanib|vatalanib|mesh-list
153701985|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701986|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701987|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702080|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702081|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
153702082|NCT00109941|Mitogens|mitogens|mesh-list
153702101|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485989|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
153486018|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153702102|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
153702103|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153702104|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153702105|NCT00281710|Prednisolone|prednisolone|mesh-list
153702106|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
153702107|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153702108|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
153702109|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153702110|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
153702111|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
153702112|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702113|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702114|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153702115|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
153702116|NCT00281710|Hormones|hormones|mesh-ancestor
153702117|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702118|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153702119|NCT00281710|Protective Agents|protective agents|mesh-ancestor
153702120|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153702121|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702122|NCT00076544|Ziconotide|ziconotide|mesh-list
153702123|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153702124|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153539099|NCT01531517|Vitamins|vitamins|mesh-ancestor
153702125|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702126|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153702127|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702128|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153702129|NCT00076544|Protective Agents|protective agents|mesh-ancestor
153702130|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153702132|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
153702181|NCT00110058|Fludarabine|fludarabine|mesh-list
153702182|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
153702229|NCT00281983|Fludarabine|fludarabine|mesh-list
153702230|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
153702231|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
153702232|NCT00281983|Cyclosporins|cyclosporins|mesh-list
153702233|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153702234|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702235|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
153702236|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702237|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702238|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153702239|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
153393742|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
153702255|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153702256|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153702257|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153702258|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
153702259|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153702260|NCT00282061|Melatonin|melatonin|mesh-list
153702261|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
153344183|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153702262|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702263|NCT00282061|Protective Agents|protective agents|mesh-ancestor
153702264|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702265|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702266|NCT00282100|Gefitinib|gefitinib|mesh-list
153702286|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153702287|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153702288|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153702290|NCT00110253|Lidocaine|lidocaine|mesh-list
153702291|NCT00110253|Tetracaine|tetracaine|mesh-list
153702292|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
153702293|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
153702294|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702295|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702296|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
153702297|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702298|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153702299|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153702300|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153702301|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702302|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702303|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153702304|NCT00282178|Candesartan|candesartan|mesh-list
153702305|NCT00282178|Candesartan cilexetil|candesartan cilexetil|mesh-list
153702306|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153702307|NCT00282178|Diuretics|diuretics|mesh-ancestor
153702308|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
153702309|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702310|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153702311|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702312|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702313|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153702341|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702343|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702344|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453188|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153702345|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153702346|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702347|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
153702348|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153702349|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153702350|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153702351|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702352|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702353|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
153736015|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
153702354|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702355|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702356|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153702357|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702358|NCT00282997|Pregabalin|pregabalin|mesh-list
153702359|NCT00282997|Analgesics|analgesics|mesh-ancestor
153702360|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
153702361|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702362|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702363|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
153702364|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153702365|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702366|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702367|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153702368|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153702369|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153486179|NCT03694262|Rucaparib|rucaparib|mesh-list
153702370|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702394|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702396|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
153702415|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702416|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153702417|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
153702450|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702451|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
153702452|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153702453|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153702454|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
153702455|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
153702456|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
153702457|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702458|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702459|NCT00283777|Chromium|chromium|mesh-list
153702460|NCT00283777|Picolinic acid|picolinic acid|mesh-list
153702461|NCT00283777|Trace Elements|trace elements|mesh-ancestor
153702462|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
153702481|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153702482|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702483|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
153702484|NCT00284206|Risperidone|risperidone|mesh-list
153702485|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153702486|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
153702487|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486206|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702488|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702489|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702490|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153702491|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153702492|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702493|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153702494|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153702495|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
153702496|NCT00284323|Adenosine|adenosine|mesh-list
153702497|NCT00284323|Analgesics|analgesics|mesh-ancestor
153702517|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702539|NCT00284791|Sertraline|sertraline|mesh-list
153702540|NCT00284791|Fluoxetine|fluoxetine|mesh-list
153702541|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
153702542|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153702543|NCT00284791|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153702544|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153702545|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702546|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702547|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702548|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
153702549|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702550|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153702551|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153702552|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153702553|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702554|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
153702555|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153702556|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153702557|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153702558|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153702559|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702560|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153702561|NCT00284947|Prednisone|prednisone|mesh-list
153702562|NCT00284947|Prednisolone|prednisolone|mesh-list
153702563|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
153702564|NCT00284947|Basiliximab|basiliximab|mesh-list
153702565|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153702566|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
153702567|NCT00284947|Hormones|hormones|mesh-ancestor
153702568|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702590|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153702591|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153702592|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702593|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
153702594|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
153702595|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
153702596|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702597|NCT00110721|Fluorouracil|fluorouracil|mesh-list
153702598|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
153702599|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702600|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702601|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702602|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702603|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
153702604|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702605|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
153702606|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153702607|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702608|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
153702609|NCT00425035|Panitumumab|panitumumab|mesh-list
153702610|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153702611|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702612|NCT00110760|Lidocaine|lidocaine|mesh-list
153702613|NCT00110760|Tetracaine|tetracaine|mesh-list
153702614|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
153702615|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
153702616|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702617|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702618|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
153702619|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702620|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153702621|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153702622|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153702623|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702624|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702625|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
153702626|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153702627|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702628|NCT00285181|Simvastatin|simvastatin|mesh-list
153702637|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153702638|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702639|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702640|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153702641|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153702642|NCT00285298|Protective Agents|protective agents|mesh-ancestor
153702643|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702644|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
153702645|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153702647|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153702648|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
153702649|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153702650|NCT00285376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153702651|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153702652|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702653|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702654|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702655|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
153702656|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702657|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153702673|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702675|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153702676|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153702677|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
153702678|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
153702679|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380711|NCT01938989|Hormones|hormones|mesh-ancestor
153453961|NCT01695954|Darunavir|darunavir|mesh-list
153702680|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702681|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702682|NCT00077402|Fenretinide|fenretinide|mesh-list
153702683|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702684|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153702685|NCT00077402|Protective Agents|protective agents|mesh-ancestor
153702686|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736017|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
153736018|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153702687|NCT00285766|Selegiline|selegiline|mesh-list
153702688|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
153702689|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153702690|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153702691|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153702692|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153702693|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702710|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153702711|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153702712|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153702713|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153702714|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702715|NCT00077441|Bortezomib|bortezomib|mesh-list
153702716|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539705|NCT01535092|Silybin|silybin|mesh-list
153702717|NCT00285883|Saquinavir|saquinavir|mesh-list
153344619|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153702718|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153702719|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153702720|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
153702721|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702722|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702723|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153702724|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153486413|NCT01231906|Etoposide|etoposide|mesh-list
153486449|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153702725|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
153702726|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702727|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153702728|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153702730|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153702772|NCT00286273|Citric Acid|citric acid|mesh-list
153702773|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
153702774|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
153702775|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153702776|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
153702777|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
153702778|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702779|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153702780|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153702781|NCT00286312|Atorvastatin|atorvastatin|mesh-list
153702782|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153702783|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153702784|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
153702785|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702786|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153702787|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153702788|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702789|NCT00286351|Goserelin|goserelin|mesh-list
153702790|NCT00286351|Anastrozole|anastrozole|mesh-list
153702791|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153702792|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702793|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153702794|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153702796|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702797|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153702798|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
153702846|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153702847|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702848|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153702859|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702860|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153702861|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702862|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
153702863|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153702864|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153702865|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153702866|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702867|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702868|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153840623|NCT04988945|Durvalumab|durvalumab|mesh-list
153486509|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153702869|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153702870|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153702871|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
153702872|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702873|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702874|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153702875|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153702876|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
153702877|NCT00111150|Tenofovir|tenofovir|mesh-list
153702878|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
153702879|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702880|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153702881|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153702882|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702883|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702884|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153702885|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153702886|NCT00417430|Fulvestrant|fulvestrant|mesh-list
153702887|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153702888|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702889|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153344770|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153702890|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153702891|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
153702892|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702893|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702894|NCT00077753|Enoxaparin|enoxaparin|mesh-list
153702895|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
153702896|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
153702897|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153702898|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153702899|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702940|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702941|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
153702942|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
153702943|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702944|NCT00287170|Calcitriol|calcitriol|mesh-list
153702945|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
153486547|NCT01827462|Vaccines|vaccines|mesh-list
153702946|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153702947|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702948|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153702949|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702950|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702951|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153702952|NCT00287170|Vitamins|vitamins|mesh-ancestor
153702953|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
153702954|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153702955|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
153702956|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702957|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702958|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702959|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
153702960|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153702961|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702962|NCT00287209|Amiodarone|amiodarone|mesh-list
153703000|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153703001|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703002|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703003|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703004|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703005|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
153703006|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703007|NCT00287326|Clonidine|clonidine|mesh-list
153703008|NCT00287326|Morphine|morphine|mesh-list
153703009|NCT00287326|Bupivacaine|bupivacaine|mesh-list
153703010|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
153703011|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
153703012|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153703013|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703014|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
153703015|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703016|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153703017|NCT00287326|Narcotics|narcotics|mesh-ancestor
153539997|NCT01536665|Incretins|incretins|mesh-ancestor
153703018|NCT00287326|Analgesics|analgesics|mesh-ancestor
153703019|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153703020|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
153703021|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
153703022|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153703038|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703039|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703040|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703042|NCT00287521|Latanoprost|latanoprost|mesh-list
153703043|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703044|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153703045|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153703075|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
153703076|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703077|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153703078|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153703079|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153703106|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703108|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153703109|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153703111|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703112|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393923|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486642|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153486706|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153703113|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
153703114|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
153703115|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
153703116|NCT00288028|Bortezomib|bortezomib|mesh-list
153703117|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703118|NCT00111540|Exenatide|exenatide|mesh-list
153703119|NCT00111540|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153703120|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153703121|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703122|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153703123|NCT00111540|Incretins|incretins|mesh-ancestor
153703124|NCT00111540|Hormones|hormones|mesh-ancestor
153703125|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703126|NCT00288184|Allopurinol|allopurinol|mesh-list
153703127|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
153703151|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703152|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153703153|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
153703154|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
153703156|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703157|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153703158|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153703159|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153703160|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703161|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703162|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703164|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
153703165|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703166|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153703167|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153703168|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703169|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703170|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153703171|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153703172|NCT00111618|Vadimezan|vadimezan|mesh-list
153703173|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703174|NCT00399425|Heparin|heparin|mesh-list
153703175|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153703176|NCT00399425|Tinzaparin|tinzaparin|mesh-list
153703177|NCT00399425|Dalteparin|dalteparin|mesh-list
153703178|NCT00399425|Bemiparin|bemiparin|mesh-list
153703179|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
153703192|NCT00399464|Alfuzosin|alfuzosin|mesh-list
153703193|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153703194|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153703195|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153703196|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703197|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703198|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703199|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703200|NCT00399464|Urological Agents|urological agents|mesh-ancestor
153703201|NCT00288652|Reboxetine|reboxetine|mesh-list
153703227|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153703228|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153703229|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703230|NCT00111891|Niacin|niacin|mesh-list
153703231|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153703232|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
153703233|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703234|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153703235|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
153703236|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
153703237|NCT00111891|Vitamins|vitamins|mesh-ancestor
153703238|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
153703239|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703240|NCT00289354|Chromium|chromium|mesh-list
153540224|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153703241|NCT00289354|Biotin|biotin|mesh-list
153703264|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153703265|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703266|NCT00401661|Alfuzosin|alfuzosin|mesh-list
153426641|NCT00001790|Micafungin|micafungin|mesh-list
153703267|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153486824|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703268|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153703270|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703288|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703289|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703290|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703291|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153703292|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153703293|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
153703294|NCT00112008|Hematinics|hematinics|mesh-ancestor
153703295|NCT00112086|Paclitaxel|paclitaxel|mesh-list
153703296|NCT00112086|Carboplatin|carboplatin|mesh-list
153703311|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153703312|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153703313|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703314|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703315|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703316|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
153703317|NCT00290485|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153703318|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703319|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703320|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703321|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703322|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153703323|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703324|NCT00078260|Pemetrexed|pemetrexed|mesh-list
153703325|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703326|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703327|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703328|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153703329|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153703330|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
153703331|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153703332|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153703333|NCT00290602|Prednisolone|prednisolone|mesh-list
153703334|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
153703335|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153703336|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
153703337|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703338|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
153703339|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
153703340|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703341|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703423|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153703425|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703426|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153703427|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
153703428|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
153703429|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
153703430|NCT04729556|Coagulants|coagulants|mesh-ancestor
153703431|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153703432|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
153703433|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703434|NCT00290914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153703435|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153703436|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153486836|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
153486889|NCT05327088|Analgesics|analgesics|mesh-ancestor
153703437|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703438|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703439|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
153703440|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703441|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153703442|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153703443|NCT00290992|Rasburicase|rasburicase|mesh-list
153703444|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
153703445|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703446|NCT00291109|Letrozole|letrozole|mesh-list
153703464|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153703465|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703485|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
153703486|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703487|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703488|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153345274|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
153703489|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
153703490|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
153703491|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153703492|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153703493|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153703494|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153703495|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703496|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703497|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703498|NCT00112476|Sirolimus|sirolimus|mesh-list
153703499|NCT00112476|Temsirolimus|temsirolimus|mesh-list
153703500|NCT00112476|MTOR Inhibitors|mtor inhibitors|mesh-list
153703501|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
153703502|NCT00112476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703518|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
153703519|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153703520|NCT00291616|Thymalfasin|thymalfasin|mesh-list
153703521|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703522|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
153703523|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703524|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
153703525|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703551|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703552|NCT00291811|Plerixafor|plerixafor|mesh-list
153703553|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153703554|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153703555|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
153703556|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703557|NCT00291850|Paclitaxel|paclitaxel|mesh-list
153703558|NCT00291850|Cisplatin|cisplatin|mesh-list
153703559|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153703560|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703561|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
153703562|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
153703563|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
153703569|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703570|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
153703571|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703572|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703573|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
153703574|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703575|NCT04718311|Tacrolimus|tacrolimus|mesh-list
153703576|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703577|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
153703578|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703579|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153703580|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703605|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153703606|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153703607|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
153703608|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
153703609|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703610|NCT00112710|Carboplatin|carboplatin|mesh-list
153703611|NCT00112710|Gemcitabine|gemcitabine|mesh-list
153703612|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703613|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703614|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
153703615|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703616|NCT00275236|Rotigotine|rotigotine|mesh-list
153703617|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
153703618|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
153703619|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703620|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703621|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703622|NCT00275197|Sertraline|sertraline|mesh-list
153703623|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
153703624|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703625|NCT00275197|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153703626|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153703627|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153703628|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703629|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487025|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
153703682|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153703683|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
153345475|NCT00005002|Lamivudine|lamivudine|mesh-list
153703684|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703685|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703717|NCT00119301|Leucovorin|leucovorin|mesh-list
153703718|NCT00119301|Trimetrexate|trimetrexate|mesh-list
153703719|NCT00119301|Methotrexate|methotrexate|mesh-list
153703720|NCT00119301|Calcium|calcium|mesh-list
153703721|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
153703722|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153703723|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703724|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153703725|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
153703758|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
153703759|NCT00130195|Methotrexate|methotrexate|mesh-list
153703760|NCT00130195|Vincristine|vincristine|mesh-list
153703761|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
153703762|NCT00130195|Daunorubicin|daunorubicin|mesh-list
153703763|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703764|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
153703765|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703766|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703767|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153703768|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
153703769|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703770|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703771|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153703772|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703774|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
153703775|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703776|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153703777|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
153703778|NCT00130195|Hormones|hormones|mesh-ancestor
153703779|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703780|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153703781|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153703782|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
153703783|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153703784|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703785|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
153703786|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
153703787|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703788|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153703811|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
153703812|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703813|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703814|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
153703815|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703816|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703817|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
153703818|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703819|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
153703820|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703821|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153853828|NCT02519348|Bevacizumab|bevacizumab|mesh-list
153703839|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153703840|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703841|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153703865|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
153703866|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
153703867|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703868|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153703869|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
153703870|NCT00129805|Aspirin|aspirin|mesh-list
153703871|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
153703872|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153487219|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153487222|NCT01920282|Nebivolol|nebivolol|mesh-list
153703873|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153703874|NCT00129805|Analgesics|analgesics|mesh-ancestor
153703875|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
153703876|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703877|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703878|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703879|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703880|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153703881|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153703882|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377863|NCT03671811|Megestrol|megestrol|mesh-list
153345706|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
153703883|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153703884|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153703885|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703886|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
153703887|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153703888|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
153703889|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703890|NCT00129727|Paclitaxel|paclitaxel|mesh-list
153703891|NCT00129727|Bevacizumab|bevacizumab|mesh-list
153703892|NCT00129727|Carboplatin|carboplatin|mesh-list
153703893|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153703894|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703895|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
153703896|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
153703912|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703913|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
153703914|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703915|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853838|NCT02492464|Red yeast rice|red yeast rice|mesh-list
153703941|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153703942|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153703943|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
153703944|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703946|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
153703947|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153703948|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153703949|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703950|NCT00298324|Cyclosporine|cyclosporine|mesh-list
153703951|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
153703952|NCT00298324|Prednisone|prednisone|mesh-list
153703953|NCT00298324|Cyclosporins|cyclosporins|mesh-list
153703954|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703955|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
153703956|NCT00298324|Hormones|hormones|mesh-ancestor
153853860|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153704031|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153704033|NCT00298675|Irinotecan|irinotecan|mesh-list
153704034|NCT00298675|Iniparib|iniparib|mesh-list
153704035|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153704036|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153704037|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704038|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704039|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704040|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153704041|NCT00298714|Losartan|losartan|mesh-list
153704042|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153704043|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153704044|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153704045|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153704075|NCT00299026|Paclitaxel|paclitaxel|mesh-list
153704076|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153704077|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704078|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
153704079|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
153704080|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
153704081|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704082|NCT00299065|Zileuton|zileuton|mesh-list
153704083|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153704084|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153704085|NCT00299065|Analgesics|analgesics|mesh-ancestor
153704086|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
153487349|NCT01955382|Charcoal|charcoal|mesh-list
153456515|NCT01499160|Lapatinib|lapatinib|mesh-list
153704087|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704088|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704089|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704090|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704091|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153704120|NCT00119613|Hematinics|hematinics|mesh-ancestor
153704121|NCT00299377|Abciximab|abciximab|mesh-list
153704122|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
153704123|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153394124|NCT01754623|Gemcitabine|gemcitabine|mesh-list
153704176|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153704177|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704178|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704179|NCT00299884|Atorvastatin|atorvastatin|mesh-list
153704180|NCT00299884|Ezetimibe|ezetimibe|mesh-list
153704181|NCT00299884|Fenofibrate|fenofibrate|mesh-list
153704193|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153704194|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153704195|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153704196|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704197|NCT00119652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153704198|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153704199|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153704200|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704201|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704202|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
153704203|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153704204|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153704205|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153704206|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704207|NCT00299923|Ribavirin|ribavirin|mesh-list
153704208|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153704209|NCT00299923|Amantadine|amantadine|mesh-list
153488276|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704210|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
153704211|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704212|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
153704213|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704214|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153704215|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153704216|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
153704217|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541198|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
153853902|NCT01829568|Rituximab|rituximab|mesh-list
153704229|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704231|NCT00418171|Ziprasidone|ziprasidone|mesh-list
153704232|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
153704233|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
153704234|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704235|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704236|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153704237|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153704238|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153704239|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153704240|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153704241|NCT00418171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153704242|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153704276|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704277|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704278|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153704279|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153704280|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
153704281|NCT00300118|Hormones|hormones|mesh-ancestor
153704282|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704283|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153704314|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153704315|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704316|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704318|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704319|NCT00399659|Tegaserod|tegaserod|mesh-list
153704320|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153704321|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
153704322|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704323|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704324|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704332|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153704334|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153704335|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153704336|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704337|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704338|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153704339|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
153704340|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704341|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704342|NCT00086463|Iloprost|iloprost|mesh-list
153377896|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153704343|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153704344|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
153704345|NCT00079976|Tigecycline|tigecycline|mesh-list
153704346|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704347|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704348|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153704349|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704366|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704367|NCT00300586|Gemcitabine|gemcitabine|mesh-list
153704368|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153704369|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153704370|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
153704371|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704372|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704373|NCT00300586|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153704374|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153704375|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704376|NCT00086541|Interferons|interferons|mesh-list
153704377|NCT00086541|Ribavirin|ribavirin|mesh-list
153704378|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
153704379|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704380|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
153704381|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704382|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
153704383|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704384|NCT00300664|Hormones|hormones|mesh-list
153704385|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704386|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704387|NCT04718038|Cetuximab|cetuximab|mesh-list
153704388|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704389|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704390|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
153704391|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704392|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153488519|NCT02251938|Sirolimus|sirolimus|mesh-list
153704419|NCT00418249|Protective Agents|protective agents|mesh-ancestor
153704420|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153704421|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153704422|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704423|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704424|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
153704425|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704426|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
153704427|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
153704428|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153704429|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
153704430|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153704431|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153704437|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
153704438|NCT00301093|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153704471|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704472|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153704473|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153704474|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
153704475|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153704476|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153704477|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153704478|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153704479|NCT00301405|Thalidomide|thalidomide|mesh-list
153704480|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704481|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
153704482|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704496|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
153704497|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704498|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704499|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704500|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704501|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
153704503|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153704504|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704505|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
153704506|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
153704507|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
153704508|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704509|NCT00080405|Bortezomib|bortezomib|mesh-list
153704510|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704511|NCT00292123|Methadone|methadone|mesh-list
153704512|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153704513|NCT00292123|Narcotics|narcotics|mesh-ancestor
153704514|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541493|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704515|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488750|NCT02289222|Growth Substances|growth substances|mesh-ancestor
153704517|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
153704518|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704519|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
153704520|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
153704521|NCT00080444|Dexamethasone|dexamethasone|mesh-list
153704522|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
153704523|NCT00080444|Ondansetron|ondansetron|mesh-list
153704524|NCT00080444|Aprepitant|aprepitant|mesh-list
153704525|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
153704526|NCT00080444|BB 1101|bb 1101|mesh-list
153704527|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704545|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
153704557|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153704558|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704559|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153704560|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704561|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704562|NCT00292201|Atorvastatin|atorvastatin|mesh-list
153704563|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153704564|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153704565|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
153704566|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704567|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153704568|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153704569|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704570|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153704571|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153704572|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153704573|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153704574|NCT00080522|Ritonavir|ritonavir|mesh-list
153704575|NCT00080522|Lopinavir|lopinavir|mesh-list
153704576|NCT00080522|Lamivudine|lamivudine|mesh-list
153704577|NCT00080522|Zidovudine|zidovudine|mesh-list
153704578|NCT00080522|Stavudine|stavudine|mesh-list
153704579|NCT00080522|Didanosine|didanosine|mesh-list
153704580|NCT00080522|Efavirenz|efavirenz|mesh-list
153704581|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153704582|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153704583|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
153704584|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704585|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704586|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153704587|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153704588|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
153704589|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541571|NCT01545804|Growth Substances|growth substances|mesh-ancestor
153704590|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153704591|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153704592|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153704593|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153704594|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
153853999|NCT01054196|Lenalidomide|lenalidomide|mesh-list
153854000|NCT01054196|Melphalan|melphalan|mesh-list
153704596|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153704597|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153704598|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153704599|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153704600|NCT00086775|Rituximab|rituximab|mesh-list
153704601|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
153704602|NCT00086775|Fludarabine|fludarabine|mesh-list
153704603|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
153704604|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704605|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704606|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
153704607|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704629|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153704630|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153704631|NCT00292747|Analgesics|analgesics|mesh-ancestor
153704632|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
153704633|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704634|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704635|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704636|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704637|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153704638|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704639|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704640|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
153704641|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
153704642|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
153704643|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153704644|NCT00292747|Urological Agents|urological agents|mesh-ancestor
153704645|NCT00120003|Candesartan|candesartan|mesh-list
153704646|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
153704647|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153704648|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153704649|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153704650|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704651|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
153704652|NCT00201721|Rituximab|rituximab|mesh-list
153704653|NCT00201721|Pentostatin|pentostatin|mesh-list
153704654|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704655|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
153704656|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704657|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704658|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153704659|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
153704660|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704661|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704662|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153704676|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
153704677|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
153704679|NCT00080678|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153704680|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153704681|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704683|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153704684|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153704685|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
153704686|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704687|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704688|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704689|NCT00201955|Rebamipide|rebamipide|mesh-list
153489002|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
153458582|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153605806|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
153605807|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153605808|NCT01935141|Growth Substances|growth substances|mesh-ancestor
153605809|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605810|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
153605811|NCT01935193|Analgesics|analgesics|mesh-ancestor
153605858|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605859|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153605860|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
153605861|NCT01935505|Bupropion|bupropion|mesh-list
153704690|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153704691|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153704692|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
153704693|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704694|NCT00201955|Protective Agents|protective agents|mesh-ancestor
153704695|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704696|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704697|NCT00080795|Gemcitabine|gemcitabine|mesh-list
153704698|NCT00080795|Doxorubicin|doxorubicin|mesh-list
153704699|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153704700|NCT00080795|Ifosfamide|ifosfamide|mesh-list
153704701|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704702|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153704703|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
153704704|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704705|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153704706|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153704707|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153704708|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704709|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153704710|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
153704711|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153704712|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153704713|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
153704714|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704715|NCT00120081|Antacids|antacids|mesh-ancestor
153704716|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704717|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153704718|NCT00201994|Tolvaptan|tolvaptan|mesh-list
153704719|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153704720|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257211|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257213|NCT01165970|Laxatives|laxatives|mesh-ancestor
153704721|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
153704722|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704723|NCT00120120|Lenalidomide|lenalidomide|mesh-list
153704724|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
153704725|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704761|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704762|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704763|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704764|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
153704765|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
153704767|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
153704768|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704781|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
153704782|NCT00418600|Vitamins|vitamins|mesh-ancestor
153704783|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
153704784|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704785|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153704790|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704791|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704792|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704793|NCT00080951|Leucovorin|leucovorin|mesh-list
153704794|NCT00080951|Fluorouracil|fluorouracil|mesh-list
153704795|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
153704796|NCT00080951|Irinotecan|irinotecan|mesh-list
153704797|NCT00080951|Calcium|calcium|mesh-list
153704798|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
153704799|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153704800|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704801|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
153704802|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704803|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153704804|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704805|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704806|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
153704807|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153704808|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153704809|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704810|NCT00080951|Antidotes|antidotes|mesh-ancestor
153704811|NCT00080951|Protective Agents|protective agents|mesh-ancestor
153704812|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
153704813|NCT00080951|Vitamins|vitamins|mesh-ancestor
153704814|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
153704815|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
153704816|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153704817|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704818|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153704819|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
153704820|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704821|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704822|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704823|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704824|NCT00301639|Methylphenidate|methylphenidate|mesh-list
153704825|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153704826|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704827|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153704829|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153704830|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704832|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704858|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704859|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
153704860|NCT00080990|Antidotes|antidotes|mesh-ancestor
153704861|NCT00080990|Protective Agents|protective agents|mesh-ancestor
153704862|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
153704864|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
153333575|NCT04394390|Vitamin D|vitamin d|mesh-list
153605862|NCT01935505|Nicotine|nicotine|mesh-list
153605863|NCT01935505|Varenicline|varenicline|mesh-list
153605864|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153605865|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
153605866|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605922|NCT01935596|Ropivacaine|ropivacaine|mesh-list
153605923|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
153605924|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
153704865|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
153704866|NCT00080990|Growth Substances|growth substances|mesh-ancestor
153704867|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153704868|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704869|NCT00301912|Methotrexate|methotrexate|mesh-list
153704870|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
153704871|NCT00301912|Fludarabine|fludarabine|mesh-list
153704872|NCT00301912|Busulfan|busulfan|mesh-list
153704873|NCT00301912|Tacrolimus|tacrolimus|mesh-list
153704874|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153704875|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
153704876|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153704877|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704878|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153426988|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
153704879|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
153704880|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704881|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704882|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
153704883|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704884|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153704903|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704905|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
153704906|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704907|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153704908|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704909|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153704910|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153704911|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
153704912|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704913|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704914|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
153704915|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460767|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704916|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153704917|NCT00301990|Aldesleukin|aldesleukin|mesh-list
153704918|NCT00301990|Bevacizumab|bevacizumab|mesh-list
153704919|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704920|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704921|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153704922|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153704923|NCT00301990|Growth Substances|growth substances|mesh-ancestor
153704924|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704925|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
153854041|NCT00408005|Leucovorin|leucovorin|mesh-list
153854042|NCT00408005|Folic Acid|folic acid|mesh-list
153704939|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153704940|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153704941|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704971|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704972|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
153704973|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153704974|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153704975|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153704976|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153704977|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153704978|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153704979|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704980|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153704981|NCT00302419|Streptokinase|streptokinase|mesh-list
153705004|NCT00081224|Capecitabine|capecitabine|mesh-list
153705005|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705006|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
153705007|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705008|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705009|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153705010|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153705011|NCT00081224|Analgesics|analgesics|mesh-ancestor
153705012|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
153705013|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705014|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605925|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
153605926|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605927|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605928|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
153705015|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153705016|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153705017|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153705018|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153705019|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705020|NCT00120237|Misoprostol|misoprostol|mesh-list
153705021|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153705022|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
153705023|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153705024|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705025|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153378008|NCT03299049|Cabotegravir|cabotegravir|mesh-list
153346704|NCT01411501|Mosapride|mosapride|mesh-list
153346705|NCT01411501|Citric Acid|citric acid|mesh-list
153705026|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705027|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
153705029|NCT00081302|Carboplatin|carboplatin|mesh-list
153705030|NCT00081302|Cetuximab|cetuximab|mesh-list
153705031|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153705032|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705033|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
153705067|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705069|NCT00418366|Hormones|hormones|mesh-ancestor
153705070|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705071|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153705089|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705112|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705113|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153705114|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
153542103|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
153705115|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705116|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153705117|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705118|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705119|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705120|NCT00081536|Capecitabine|capecitabine|mesh-list
153705121|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705122|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
153705123|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705124|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705126|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
153705127|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
153705159|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153705161|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705162|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705163|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
153705164|NCT00081614|Bevacizumab|bevacizumab|mesh-list
153705165|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153705166|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153705182|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705183|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153705184|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153705185|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705203|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705205|NCT00120354|Lamivudine|lamivudine|mesh-list
153705206|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153705207|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153705208|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705209|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705210|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
153705211|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705212|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153705213|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153705214|NCT00399698|Risperidone|risperidone|mesh-list
153705215|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153705216|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
153705217|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705218|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705219|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705220|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153705221|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705222|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705223|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705224|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153705239|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153705240|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153705241|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153705242|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705243|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705244|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705245|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153705246|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153705247|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153705249|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
153705250|NCT00120432|Tropicamide|tropicamide|mesh-list
153705251|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153705252|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
153705253|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
153705254|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705255|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705256|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
153705257|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153705264|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705265|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705266|NCT00120432|Protective Agents|protective agents|mesh-ancestor
153705267|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153705268|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153705269|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
153705270|NCT00303745|Capecitabine|capecitabine|mesh-list
153705272|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705273|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
153705274|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705275|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705276|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153705277|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153705278|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705279|NCT00303784|Goserelin|goserelin|mesh-list
153705280|NCT00303784|Estradiol|estradiol|mesh-list
153705281|NCT00303784|Estrogens|estrogens|mesh-ancestor
153705282|NCT00303784|Hormones|hormones|mesh-ancestor
153705283|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705284|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705285|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153705286|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705287|NCT00081887|Clofarabine|clofarabine|mesh-list
153705288|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705310|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705311|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153705312|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815069|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153705313|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705314|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
153705315|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705316|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153705317|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
153705318|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153705319|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153705320|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153705321|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705322|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153705323|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
153705324|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153705325|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153705326|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
153705327|NCT00081926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153705382|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153705383|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153705412|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153705413|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153705414|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153705415|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705417|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705419|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153705420|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
153705421|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705422|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153705423|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705424|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705426|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
153606376|NCT05824767|Protease Inhibitors|protease inhibitors|mesh-ancestor
153705427|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705428|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153705429|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705430|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705458|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153705459|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153705460|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153705461|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153705462|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153705463|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
153705464|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705465|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153705466|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705467|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705508|NCT00305383|Taribavirin|taribavirin|mesh-list
153705509|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
153705510|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705511|NCT00305422|Risperidone|risperidone|mesh-list
153705512|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153705513|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153705514|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
153705515|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705516|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705517|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705549|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705550|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
153705551|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705553|NCT00305539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153705554|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153705555|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153705556|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
153705557|NCT00305734|Gemcitabine|gemcitabine|mesh-list
153705570|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705572|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153705573|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153705574|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705576|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705577|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153705578|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153705579|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
153705580|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705581|NCT00306046|Diphosphonates|diphosphonates|mesh-list
153705582|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153705583|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705584|NCT00306124|Levodopa|levodopa|mesh-list
153705585|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153705586|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153705587|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
153705588|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705589|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705590|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705591|NCT00082589|Eplerenone|eplerenone|mesh-list
153705592|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153705593|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
153705594|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705595|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705596|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153705597|NCT00082589|Diuretics|diuretics|mesh-ancestor
153705598|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
153705599|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153705600|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153705601|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153705602|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153705603|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
153705604|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705605|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705606|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705607|NCT00313924|Urological Agents|urological agents|mesh-ancestor
153705608|NCT00306475|Valproic Acid|valproic acid|mesh-list
153705609|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
153705610|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705611|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394342|NCT03499483|Tenofovir|tenofovir|mesh-list
153705649|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705651|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153705652|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153705653|NCT00082823|Growth Substances|growth substances|mesh-ancestor
153705654|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705655|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
154257214|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257215|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153705656|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705657|NCT00087945|Lamivudine|lamivudine|mesh-list
153705658|NCT00087945|Zidovudine|zidovudine|mesh-list
153705659|NCT00087945|Abacavir|abacavir|mesh-list
153705660|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
153705672|NCT00082862|Gemcitabine|gemcitabine|mesh-list
153705673|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705674|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705675|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
153606634|NCT05243641|Neratinib|neratinib|mesh-list
153705676|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705677|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
153705678|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705679|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
153705680|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705681|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153705683|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705684|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
153705685|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705686|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153705687|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
153705688|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
153705689|NCT00307177|Vaccines|vaccines|mesh-list
153705690|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
153705691|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705692|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
153705693|NCT00120705|Hematinics|hematinics|mesh-ancestor
153705694|NCT00307255|Paclitaxel|paclitaxel|mesh-list
153705695|NCT00307255|Gemcitabine|gemcitabine|mesh-list
153705696|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153705697|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153705698|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705699|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
153705700|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705701|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
153705702|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705703|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705704|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
153705705|NCT00307411|Hormones|hormones|mesh-list
153705706|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705707|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705708|NCT00307450|Levetiracetam|levetiracetam|mesh-list
153705709|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
153542696|NCT01553786|Lenalidomide|lenalidomide|mesh-list
153705710|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
153606679|NCT05071703|Etoposide|etoposide|mesh-list
153606931|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
153705711|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153705712|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
153705713|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705714|NCT00120744|Ondansetron|ondansetron|mesh-list
153705715|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
153705716|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
153705800|NCT00120783|Lamivudine|lamivudine|mesh-list
153705801|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153705802|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153705803|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
153705804|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705805|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705806|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153705807|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153705808|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
153705809|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705810|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153705811|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153705812|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153705845|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705846|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
153705847|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705848|NCT00307996|Ubiquinone|ubiquinone|mesh-list
153705849|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
153705850|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
153705851|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705852|NCT00307996|Vitamins|vitamins|mesh-ancestor
153705853|NCT00083252|Cisplatin|cisplatin|mesh-list
153705854|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705855|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
153378128|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153705856|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153606952|NCT04419181|Pertuzumab|pertuzumab|mesh-list
153387499|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607278|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
153705857|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705874|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705876|NCT00418756|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153705896|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153705897|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
153705899|NCT00308269|Folic Acid|folic acid|mesh-list
153705900|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
153705901|NCT00308269|Hematinics|hematinics|mesh-ancestor
153705902|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
153705903|NCT00308269|Vitamins|vitamins|mesh-ancestor
153705904|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
153705905|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705906|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705907|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
153705908|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705909|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
153705910|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705911|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
153427114|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153705912|NCT00308425|Valsartan|valsartan|mesh-list
153705913|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153705914|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705915|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153705916|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
153705917|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153705927|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705928|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153705929|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153705930|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
153705931|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705932|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705933|NCT00308542|Dexamethasone|dexamethasone|mesh-list
153705934|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153705935|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
153705936|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
153705937|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705938|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705945|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
153607475|NCT01993810|Etoposide|etoposide|mesh-list
153705946|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153705947|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705948|NCT00083408|Pamidronate|pamidronate|mesh-list
153705949|NCT00083408|Thalidomide|thalidomide|mesh-list
153705950|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153705951|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
153705952|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705953|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
153705954|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153705955|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705956|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153705957|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153705958|NCT00083408|Growth Substances|growth substances|mesh-ancestor
153705959|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
153705960|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705961|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153705962|NCT00308971|Vitamin E|vitamin e|mesh-list
153705963|NCT00308971|Tocopherols|tocopherols|mesh-list
153705964|NCT00308971|Tocotrienols|tocotrienols|mesh-list
153705965|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
153705966|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
153705967|NCT00308971|Vitamins|vitamins|mesh-ancestor
153705968|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
153705969|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705970|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
153705971|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705972|NCT00308971|Protective Agents|protective agents|mesh-ancestor
153705973|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
153705974|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
153705975|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705976|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153705977|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
153705978|NCT00309049|Epothilones|epothilones|mesh-list
153705979|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
153854179|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153706022|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706023|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706024|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706025|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153706026|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153706027|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153706028|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153706029|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706030|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706031|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706069|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
153706070|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153706071|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
153706087|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153706088|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153543069|NCT05847660|Fertility Agents|fertility agents|mesh-ancestor
153706089|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153706090|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153706091|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153706092|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153706093|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153706094|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153706095|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153706096|NCT00309556|Docetaxel|docetaxel|mesh-list
153706097|NCT00309556|Capecitabine|capecitabine|mesh-list
153706098|NCT00309556|Trastuzumab|trastuzumab|mesh-list
153706099|NCT00309556|Epirubicin|epirubicin|mesh-list
153706100|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706101|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
153706102|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
153706103|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
153854192|NCT04645745|Folic Acid|folic acid|mesh-list
153706114|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706115|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153706116|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
153706117|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706118|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706119|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153706120|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
153706121|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
153706122|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153706123|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
153706124|NCT00402207|Hormones|hormones|mesh-ancestor
153706125|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706126|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153706127|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
153706128|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607648|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
153607775|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
153706129|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706130|NCT00309634|Vaccines|vaccines|mesh-list
153706156|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706157|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706158|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153706159|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153706160|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153706161|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153706162|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153706163|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
153706164|NCT00088608|Pasireotide|pasireotide|mesh-list
153706165|NCT00088608|Hormones|hormones|mesh-ancestor
153706166|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706167|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706168|NCT00310024|Bortezomib|bortezomib|mesh-list
153706169|NCT00310024|Vorinostat|vorinostat|mesh-list
153706170|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706171|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153706172|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706173|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706174|NCT00310141|Nicotine|nicotine|mesh-list
153706175|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153706213|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153706214|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
153706215|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153706216|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
153706217|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153706218|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706219|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153706220|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153706222|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
153706223|NCT00121095|Docetaxel|docetaxel|mesh-list
153706224|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
153706225|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706226|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
153706237|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706238|NCT00310336|Interferons|interferons|mesh-list
153706240|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
153706241|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
153706242|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153706243|NCT00310336|Betaine|betaine|mesh-list
153706244|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706245|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
153706246|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706247|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
153706248|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706249|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
153706250|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706251|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706252|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
153706253|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153706254|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153706255|NCT05568602|Dexamethasone|dexamethasone|mesh-list
153706256|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706257|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
153706258|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
153706259|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706260|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706261|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706262|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
153706263|NCT05568602|Hormones|hormones|mesh-ancestor
153706264|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706265|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153706279|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153706280|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153706282|NCT00309673|Prilocaine|prilocaine|mesh-list
153706283|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153706284|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
153706285|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
153706286|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153706287|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706288|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
153706289|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706290|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153706291|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153706292|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153706303|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153706304|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153706305|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153706306|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153706307|NCT00310921|Misoprostol|misoprostol|mesh-list
153706308|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153706309|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
153706310|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153706311|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706312|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153706313|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706314|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
153706315|NCT05568212|Durvalumab|durvalumab|mesh-list
153706316|NCT05568212|Olaparib|olaparib|mesh-list
153706317|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153706318|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706319|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153706320|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706321|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608157|NCT01939327|Growth Substances|growth substances|mesh-ancestor
153732017|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153706322|NCT00121329|Lidocaine|lidocaine|mesh-list
153706323|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
153706324|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
153706325|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153706326|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706327|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
153347812|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347813|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706328|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706329|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153706330|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153706331|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153706332|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153706333|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706348|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706349|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
153706350|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706351|NCT00311116|Protective Agents|protective agents|mesh-ancestor
153706352|NCT00088959|Celecoxib|celecoxib|mesh-list
153706353|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153706354|NCT00088959|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153706376|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153706377|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706378|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153706379|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153706380|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
153706381|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706382|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706383|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153706384|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706385|NCT00088998|Bevacizumab|bevacizumab|mesh-list
153706386|NCT00088998|Docetaxel|docetaxel|mesh-list
153706387|NCT00088998|Capecitabine|capecitabine|mesh-list
153706388|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387500|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608576|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153706390|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153706391|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153706392|NCT00088998|Growth Substances|growth substances|mesh-ancestor
153706393|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706394|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
153706395|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
153706396|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
153706397|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
153706398|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706399|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153706400|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
153706401|NCT00311467|Interferons|interferons|mesh-list
153706402|NCT00311467|Capecitabine|capecitabine|mesh-list
153706403|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153706404|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
153706405|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706406|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706407|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
153706423|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706424|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153706425|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153706426|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
153706427|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706428|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153706429|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153706430|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153706431|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706447|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706449|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153706450|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
153706451|NCT00311857|Cetuximab|cetuximab|mesh-list
153706452|NCT00311857|Temozolomide|temozolomide|mesh-list
153706453|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153706454|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706455|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153706456|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
153706457|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706458|NCT00311896|Bemiparin|bemiparin|mesh-list
153706459|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
153706460|NCT00121446|Enoxaparin|enoxaparin|mesh-list
153706461|NCT00121446|Tenecteplase|tenecteplase|mesh-list
153706462|NCT00121446|Clopidogrel|clopidogrel|mesh-list
153706463|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153706464|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153706465|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153706466|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153706467|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
153706482|NCT00121524|Amiodarone|amiodarone|mesh-list
153706483|NCT00121524|Epinephrine|epinephrine|mesh-list
153706484|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153706485|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153706486|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
153706487|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706488|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381517|NCT01619774|Trametinib|trametinib|mesh-list
153706489|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706490|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153706491|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153706492|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
153706493|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706494|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153706495|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
153706497|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
153706498|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153706499|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153706500|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153706501|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
153706502|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153706503|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153706504|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
153706505|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
153706506|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153706508|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153706509|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153706510|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153706511|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706512|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153706513|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153706514|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153706515|NCT00312130|Vildagliptin|vildagliptin|mesh-list
153706516|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153706517|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706518|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153706519|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
153706520|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706521|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706522|NCT00089115|Rituximab|rituximab|mesh-list
153706523|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
153706524|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153706525|NCT00089115|Antibodies|antibodies|mesh-list
153706526|NCT00089115|Sargramostim|sargramostim|mesh-list
153609053|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
153609054|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153706527|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153706528|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153706529|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706553|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
153706554|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153706555|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706556|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
153706557|NCT00312481|Protective Agents|protective agents|mesh-ancestor
153706558|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706559|NCT00312481|Vitamins|vitamins|mesh-ancestor
153706560|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
153706561|NCT00312481|Cathartics|cathartics|mesh-ancestor
153706562|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706563|NCT00312481|Laxatives|laxatives|mesh-ancestor
153706564|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
153706565|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153706566|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153706567|NCT00312520|Prednisolone|prednisolone|mesh-list
153706568|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
153706569|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153706570|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
153706600|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706601|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
153706603|NCT00121563|Ibuprofen|ibuprofen|mesh-list
153706604|NCT00121563|Diazepam|diazepam|mesh-list
153706605|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153706606|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153706607|NCT00121563|Analgesics|analgesics|mesh-ancestor
153706608|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
153348150|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153543598|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153706609|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706610|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706611|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706612|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706613|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153706614|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706615|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706616|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153706617|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
153706618|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
153706619|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153706620|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706621|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153706622|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153706623|NCT00121563|Growth Substances|growth substances|mesh-ancestor
153706624|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
153706625|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706626|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153706627|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
153706628|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
153706629|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
153706630|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706631|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153706632|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153706633|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153706634|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153706635|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153706636|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153706637|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153706638|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153706639|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
153706640|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
153706641|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
153706642|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
153706659|NCT00293371|Docetaxel|docetaxel|mesh-list
153706660|NCT00293371|Vatalanib|vatalanib|mesh-list
153394558|NCT01808755|Trimethoprim|trimethoprim|mesh-list
153706685|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153706687|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
153706688|NCT00121602|Hematinics|hematinics|mesh-ancestor
153706689|NCT00293527|Interferons|interferons|mesh-list
153706691|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
153706692|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706693|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
153706694|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706695|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
153706696|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706697|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
153706698|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
153706699|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
153706700|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706742|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706743|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706744|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153706745|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153706746|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
153706747|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706748|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706749|NCT00293839|Urological Agents|urological agents|mesh-ancestor
153706750|NCT00293917|Tacrolimus|tacrolimus|mesh-list
153706751|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153706752|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
153706753|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706754|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153706755|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706756|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706757|NCT05567081|Triamcinolone|triamcinolone|mesh-list
153706758|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153706817|NCT00294463|Hormones|hormones|mesh-ancestor
153706818|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706819|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706820|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153706821|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
153731982|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706822|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153706823|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153706824|NCT00294463|Progestins|progestins|mesh-ancestor
153706825|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
153706826|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
153706827|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706872|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706874|NCT00294775|Candesartan|candesartan|mesh-list
153706875|NCT00294775|Candesartan cilexetil|candesartan cilexetil|mesh-list
153706876|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706877|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153706878|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153706879|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706880|NCT00121680|Lenvatinib|lenvatinib|mesh-list
153706881|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706882|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153706883|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706884|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706885|NCT00294853|Calcium|calcium|mesh-list
153706930|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736020|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153706932|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153706933|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
153706934|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706935|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706936|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706937|NCT00295165|Sargramostim|sargramostim|mesh-list
153706938|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
153706939|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706940|NCT00295243|Topotecan|topotecan|mesh-list
153706941|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153706942|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153706943|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706944|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706945|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706946|NCT00295282|Antibodies|antibodies|mesh-list
153706947|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153389802|NCT00002553|Cobalt|cobalt|mesh-list
153610001|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610002|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
153706948|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
153706949|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706950|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153706951|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706952|NCT00089622|Levodopa|levodopa|mesh-list
153706953|NCT00089622|Lisuride|lisuride|mesh-list
153706954|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153706955|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153706956|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
153706957|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706958|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706959|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706960|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153706961|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
153706962|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
153706963|NCT00295555|Doxazosin|doxazosin|mesh-list
153706964|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706965|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153706966|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153706988|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706989|NCT00295789|Paclitaxel|paclitaxel|mesh-list
153706990|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153706991|NCT00295789|Carboplatin|carboplatin|mesh-list
153706992|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153706993|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706994|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
153706995|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
153706996|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
153706997|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706998|NCT00089700|Ibalizumab|ibalizumab|mesh-list
153706999|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153707000|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153707001|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
153707002|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707003|NCT04718584|Antibodies|antibodies|mesh-list
153707004|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153707006|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707007|NCT00417937|Azelaic acid|azelaic acid|mesh-list
153707008|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707009|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
153707010|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153610059|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610060|NCT03783013|Lycopene|lycopene|mesh-list
153610061|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153707011|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
153707012|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
153707013|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
153394660|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153707050|NCT00296023|Fludarabine|fludarabine|mesh-list
153707051|NCT00296023|Busulfan|busulfan|mesh-list
153707052|NCT00296023|Tacrolimus|tacrolimus|mesh-list
153707053|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153707054|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153707055|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
153707056|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153707057|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707058|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153544045|NCT02823574|Nivolumab|nivolumab|mesh-list
153707059|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
153707060|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707061|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707063|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707064|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153707065|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707066|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
153707067|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394661|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
153707071|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153707072|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153707073|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
153707074|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153707075|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707076|NCT00296062|Bevacizumab|bevacizumab|mesh-list
153707077|NCT00296062|Capecitabine|capecitabine|mesh-list
153707078|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
153707079|NCT00296062|Irinotecan|irinotecan|mesh-list
153707080|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153707081|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707082|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153707083|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153813949|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
153610256|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153610270|NCT01945840|Hormones|hormones|mesh-list
153707084|NCT00296062|Growth Substances|growth substances|mesh-ancestor
153707085|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707104|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153707105|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153707106|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153707107|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707108|NCT00089856|Prednisone|prednisone|mesh-list
153707109|NCT00089856|Docetaxel|docetaxel|mesh-list
153707110|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153707111|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
153707112|NCT00089856|Hormones|hormones|mesh-ancestor
153707113|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153707114|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707115|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153707116|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707117|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
153707118|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
153707119|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
153707120|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707121|NCT00296257|Rimacalib|rimacalib|mesh-list
153707122|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153707123|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707124|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707125|NCT00296530|Fluticasone|fluticasone|mesh-list
153707126|NCT00296530|Xhance|xhance|mesh-list
153707127|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153707128|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153707129|NCT00296530|Montelukast|montelukast|mesh-list
153707130|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153707131|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153707132|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
153707133|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707134|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707135|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153378345|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153348547|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
153707167|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707169|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
153707170|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
153707171|NCT00296608|Leucovorin|leucovorin|mesh-list
153707172|NCT00296608|Fluorouracil|fluorouracil|mesh-list
153707173|NCT00296608|Calcium|calcium|mesh-list
153707174|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
153707175|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153707176|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707177|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
153707178|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707179|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153707180|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707181|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707182|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
153707183|NCT00296608|Antidotes|antidotes|mesh-ancestor
153707184|NCT00296608|Protective Agents|protective agents|mesh-ancestor
153707185|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
153707186|NCT00296608|Vitamins|vitamins|mesh-ancestor
153707187|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
153707188|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
153707189|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
153707190|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153707191|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707192|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153381662|NCT02988843|Bevacizumab|bevacizumab|mesh-list
153813950|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610475|NCT01947114|Ketamine|ketamine|mesh-list
153707193|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153610476|NCT01947114|Remifentanil|remifentanil|mesh-list
153707194|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153707195|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707196|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
153707197|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707198|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
153707234|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
153707235|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707236|NCT00297349|Topiramate|topiramate|mesh-list
153707237|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
153707238|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153707239|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707240|NCT00297388|Risperidone|risperidone|mesh-list
153707241|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153707242|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
153707243|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707244|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707245|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707246|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153707247|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153707248|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707249|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707250|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153707251|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
153707252|NCT00297466|Nicotine|nicotine|mesh-list
153707253|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153707254|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
153707255|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707256|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707257|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153707258|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153707259|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
153707260|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707333|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
153707334|NCT00090246|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153707335|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153707336|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
153707337|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707338|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610477|NCT01947114|Propofol|propofol|mesh-list
153732018|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153707339|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153707340|NCT00297817|Vaccines|vaccines|mesh-list
153707341|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
153707342|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707343|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153707344|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
153707345|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348659|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
153707346|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153707347|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153707348|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707349|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707350|NCT00122226|Ritonavir|ritonavir|mesh-list
153707351|NCT00122226|Lopinavir|lopinavir|mesh-list
153707352|NCT00122226|Lamivudine|lamivudine|mesh-list
153707353|NCT00122226|Zidovudine|zidovudine|mesh-list
153544338|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
153707354|NCT00122226|Nevirapine|nevirapine|mesh-list
153707371|NCT00298012|Methotrexate|methotrexate|mesh-list
153707372|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153707373|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
153707374|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153707375|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707376|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153707377|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
153707378|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707379|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707380|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
153707381|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707382|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153707383|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707384|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
153707385|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153707386|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153707387|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
153707388|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153707438|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
153707439|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707440|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
153707441|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707442|NCT00314080|Antitoxins|antitoxins|mesh-list
153707443|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
153707444|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
153707445|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707446|NCT00314158|Timolol|timolol|mesh-list
153707447|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153707448|NCT00314158|Brinzolamide|brinzolamide|mesh-list
153707449|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153707450|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153707451|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153707452|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707453|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610487|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153610493|NCT01947114|Narcotics|narcotics|mesh-ancestor
153815073|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610601|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610603|NCT01947998|Warfarin|warfarin|mesh-list
153610604|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
153707454|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707455|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707456|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153707457|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153707458|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153707495|NCT00323011|Fluorouracil|fluorouracil|mesh-list
153707496|NCT00323011|Irinotecan|irinotecan|mesh-list
153707497|NCT00323011|Dalteparin|dalteparin|mesh-list
153707498|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
153707499|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153707500|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707501|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153707502|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153707503|NCT00323011|Growth Substances|growth substances|mesh-ancestor
153707504|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707505|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
153544488|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153707506|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
153707507|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707508|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153707509|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707510|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
153707511|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153707512|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153707513|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707514|NCT00323011|Antidotes|antidotes|mesh-ancestor
153707515|NCT00323011|Protective Agents|protective agents|mesh-ancestor
153707516|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
153707527|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153707528|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153707529|NCT00323206|Growth Substances|growth substances|mesh-ancestor
153348831|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153348833|NCT01141049|Gabapentin|gabapentin|mesh-list
153381718|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
153707530|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
153707531|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707532|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
153707533|NCT04717531|Docetaxel|docetaxel|mesh-list
153707534|NCT04717531|Trastuzumab|trastuzumab|mesh-list
153707535|NCT04717531|Epirubicin|epirubicin|mesh-list
153707536|NCT04717531|Pertuzumab|pertuzumab|mesh-list
153707537|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707538|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
153707539|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707540|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153707541|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153707542|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
153707543|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707544|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707545|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153707546|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
153707547|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
153707548|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
153707549|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153707550|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153707551|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153707552|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153707553|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707554|NCT00323323|Prednisone|prednisone|mesh-list
153707555|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
153707556|NCT00323323|Doxorubicin|doxorubicin|mesh-list
153707557|NCT00323323|Vincristine|vincristine|mesh-list
153707558|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
153707559|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707560|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
153707575|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153707576|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153707577|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153707579|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
153544563|NCT01558960|Melphalan|melphalan|mesh-list
153707580|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
153707581|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153707582|NCT00122499|Tadalafil|tadalafil|mesh-list
153707583|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
153611044|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153707621|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153707657|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153707658|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153707659|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
153707675|NCT06002659|Cyclophosphamide|cyclophosphamide|mesh-list
153707676|NCT06002659|Fludarabine|fludarabine|mesh-list
153707677|NCT06002659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707678|NCT06002659|Immunologic Factors|immunologic factors|mesh-ancestor
153707679|NCT06002659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707680|NCT06002659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153707681|NCT06002659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153707682|NCT06002659|Alkylating Agents|alkylating agents|mesh-ancestor
153707683|NCT06002659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707684|NCT06002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707685|NCT06002659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153707687|NCT06002646|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153707688|NCT06002646|Eusol|eusol|mesh-list
153707689|NCT06002646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153707690|NCT06002646|Trace Elements|trace elements|mesh-ancestor
153707691|NCT06002646|Micronutrients|micronutrients|mesh-ancestor
153707692|NCT06002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707693|NCT06002646|Disinfectants|disinfectants|mesh-ancestor
153707694|NCT06002646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707695|NCT06002035|Vitamin D|vitamin d|mesh-list
153707696|NCT06002035|Vitamins|vitamins|mesh-ancestor
153707697|NCT06002035|Micronutrients|micronutrients|mesh-ancestor
153707698|NCT06002035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707699|NCT06002035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153707700|NCT06001749|Psilocybin|psilocybin|mesh-list
153707701|NCT06001749|Hallucinogens|hallucinogens|mesh-ancestor
153707702|NCT06001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707703|NCT06001749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153611183|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153707704|NCT06001619|Tamsulosin|tamsulosin|mesh-list
153707705|NCT06001619|Finasteride|finasteride|mesh-list
153707706|NCT06001619|Dutasteride|dutasteride|mesh-list
153707707|NCT06001619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153707708|NCT06001619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153707714|NCT06001619|Urological Agents|urological agents|mesh-ancestor
153707715|NCT06001619|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153707716|NCT06001619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153707717|NCT06001619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707718|NCT06001619|Hormone Antagonists|hormone antagonists|mesh-ancestor
153707719|NCT06001619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153707720|NCT06001593|Betahistine|betahistine|mesh-list
153707739|NCT06000917|Tubulin Modulators|tubulin modulators|mesh-ancestor
153707740|NCT06000917|Antimitotic Agents|antimitotic agents|mesh-ancestor
153707741|NCT06000917|Mitosis Modulators|mitosis modulators|mesh-ancestor
153707742|NCT06000917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707743|NCT06000917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153707744|NCT06000358|Pembrolizumab|pembrolizumab|mesh-list
153707745|NCT06000358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153707746|NCT06000358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707747|NCT06000358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153707748|NCT06000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707749|NCT06000137|Flurbiprofen|flurbiprofen|mesh-list
153707752|NCT06000137|Dezocine|dezocine|mesh-list
153707753|NCT06000137|Granisetron|granisetron|mesh-list
153707754|NCT06000137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153707755|NCT06000137|Narcotics|narcotics|mesh-ancestor
153707756|NCT06000137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707757|NCT06000137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707758|NCT06000137|Analgesics|analgesics|mesh-ancestor
153707759|NCT06000137|Sensory System Agents|sensory system agents|mesh-ancestor
153611197|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611468|NCT05874700|Glycine Agents|glycine agents|mesh-ancestor
153707760|NCT06000137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707761|NCT06000137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153707762|NCT06000137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153707763|NCT06000137|Anesthetics, General|anesthetics, general|mesh-ancestor
153707764|NCT06000137|Anesthetics|anesthetics|mesh-ancestor
153707765|NCT06000137|Antiemetics|antiemetics|mesh-ancestor
153707767|NCT06000137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153707768|NCT06000137|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153707769|NCT06000137|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153707770|NCT06000137|Serotonin Agents|serotonin agents|mesh-ancestor
153707771|NCT06000137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707772|NCT06000137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707773|NCT06000137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153707774|NCT06000137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153707775|NCT06000137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153707821|NCT05999474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707822|NCT05999474|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153707823|NCT05999474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153707824|NCT05999474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707825|NCT05999474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707826|NCT05999474|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153707827|NCT05999474|Hormone Antagonists|hormone antagonists|mesh-ancestor
153707828|NCT05999474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153707845|NCT05999331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707846|NCT05999227|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153707847|NCT05999227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153707848|NCT05999227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707849|NCT05998876|Methadone|methadone|mesh-list
153707850|NCT05998876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153707851|NCT05998876|Narcotics|narcotics|mesh-ancestor
153707852|NCT05998876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707853|NCT05998876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707854|NCT05998876|Analgesics|analgesics|mesh-ancestor
153707855|NCT05998876|Sensory System Agents|sensory system agents|mesh-ancestor
153707856|NCT05998876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707857|NCT05998876|Antitussive Agents|antitussive agents|mesh-ancestor
153707858|NCT05998876|Respiratory System Agents|respiratory system agents|mesh-ancestor
153707859|NCT05998551|Fentanyl|fentanyl|mesh-list
153707860|NCT05998551|Dexmedetomidine|dexmedetomidine|mesh-list
153707875|NCT05998551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707879|NCT05998551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153707880|NCT05998551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153707881|NCT05998551|Anesthetics, General|anesthetics, general|mesh-ancestor
153707882|NCT05998525|Dapagliflozin|dapagliflozin|mesh-list
153707883|NCT05998525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153349160|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
153381759|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153349161|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707884|NCT05998525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707885|NCT05998525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153707894|NCT05998421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707895|NCT05998421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153707896|NCT05998421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153707897|NCT05998421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153707898|NCT05998421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153707899|NCT05998421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707900|NCT05998421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153707901|NCT05998421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153707902|NCT05998421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707903|NCT05998421|Antipyretics|antipyretics|mesh-ancestor
153707904|NCT05998421|Anticoagulants|anticoagulants|mesh-ancestor
153707905|NCT05998356|Anesthetics|anesthetics|mesh-list
153707906|NCT05998356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707907|NCT05998356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707908|NCT05998226|Anti-Infective Agents|anti-infective agents|mesh-list
153707909|NCT05998226|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153707910|NCT05998200|Glycolic acid|glycolic acid|mesh-list
153707911|NCT05998200|Keratolytic Agents|keratolytic agents|mesh-ancestor
153707912|NCT05998200|Dermatologic Agents|dermatologic agents|mesh-ancestor
153707913|NCT05998187|Botulinum Toxins|botulinum toxins|mesh-list
153707914|NCT05998187|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153707915|NCT05998187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153707916|NCT05998187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707917|NCT05998187|Cholinergic Agents|cholinergic agents|mesh-ancestor
153707918|NCT05998187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707919|NCT05998187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707920|NCT05998096|Caffeine|caffeine|mesh-list
153707921|NCT05998096|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153707922|NCT05998096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707923|NCT05998096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153707924|NCT05998096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707925|NCT05998096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707926|NCT05998096|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153707927|NCT05998096|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153707928|NCT05998096|Purinergic Agents|purinergic agents|mesh-ancestor
153611584|NCT05641467|Methamphetamine|methamphetamine|mesh-list
153813954|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153611894|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153707929|NCT05998096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707946|NCT05997524|Oxaliplatin|oxaliplatin|mesh-list
153707947|NCT05997524|Trastuzumab|trastuzumab|mesh-list
153707948|NCT05997524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153707949|NCT05997524|Antimetabolites|antimetabolites|mesh-ancestor
153707950|NCT05997524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707951|NCT05997524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707968|NCT05997355|Analgesics|analgesics|mesh-ancestor
153707969|NCT05997355|Sensory System Agents|sensory system agents|mesh-ancestor
153707970|NCT05997355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707971|NCT05997355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707972|NCT05997355|Anticonvulsants|anticonvulsants|mesh-ancestor
153707973|NCT05997355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153707974|NCT05997355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153707975|NCT05997355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707976|NCT05997355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707977|NCT05997355|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153707978|NCT05997355|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153707979|NCT05997355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707980|NCT05997355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707981|NCT05997355|Antimanic Agents|antimanic agents|mesh-ancestor
153707982|NCT05997303|Norepinephrine|norepinephrine|mesh-list
153707983|NCT05997303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153707984|NCT05997303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153707985|NCT05997303|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707986|NCT05997303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707987|NCT05997303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707988|NCT05997303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707989|NCT05997303|Sympathomimetics|sympathomimetics|mesh-ancestor
153707990|NCT05997303|Autonomic Agents|autonomic agents|mesh-ancestor
153707991|NCT05997303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707992|NCT05997303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153708006|NCT05997043|Antiparkinson Agents|antiparkinson agents|mesh-list
153708007|NCT05997043|Botulinum Toxins|botulinum toxins|mesh-list
153708008|NCT05997043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153708009|NCT05997043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708057|NCT05996406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708058|NCT05996393|Cyclosporine|cyclosporine|mesh-list
153708059|NCT05996393|Cyclosporins|cyclosporins|mesh-list
153708060|NCT05996393|Thymoglobulin|thymoglobulin|mesh-list
153708061|NCT05996393|Immunoglobulins|immunoglobulins|mesh-list
153611899|NCT03354013|Calcium|calcium|mesh-list
153612029|NCT02344810|Vitamins|vitamins|mesh-ancestor
153612030|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
153708062|NCT05996393|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153708063|NCT05996393|Antibodies|antibodies|mesh-list
153708064|NCT05996393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708065|NCT05996393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708066|NCT05996393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153708067|NCT05996393|Immunologic Factors|immunologic factors|mesh-ancestor
153708068|NCT05996393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708069|NCT05996393|Antifungal Agents|antifungal agents|mesh-ancestor
153708099|NCT05995314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708100|NCT05995119|Apixaban|apixaban|mesh-list
153708101|NCT05995119|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153708102|NCT05995119|Antithrombins|antithrombins|mesh-ancestor
153708103|NCT05995119|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153708104|NCT05995119|Protease Inhibitors|protease inhibitors|mesh-ancestor
153708105|NCT05995119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708106|NCT05995119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708107|NCT05995119|Anticoagulants|anticoagulants|mesh-ancestor
153708109|NCT05990985|Cyclophosphamide|cyclophosphamide|mesh-list
153708110|NCT05990985|Rituximab|rituximab|mesh-list
153708111|NCT05990985|Vincristine|vincristine|mesh-list
153708112|NCT05990985|Mitoxantrone|mitoxantrone|mesh-list
153708113|NCT05990985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153708114|NCT05990985|Immunologic Factors|immunologic factors|mesh-ancestor
153708115|NCT05990985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708124|NCT05990985|Tubulin Modulators|tubulin modulators|mesh-ancestor
153708125|NCT05990985|Antimitotic Agents|antimitotic agents|mesh-ancestor
153708126|NCT05990985|Mitosis Modulators|mitosis modulators|mesh-ancestor
153708127|NCT05990985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708128|NCT05990985|Glucocorticoids|glucocorticoids|mesh-ancestor
153708129|NCT05990985|Hormones|hormones|mesh-ancestor
153708130|NCT05990985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708131|NCT05990985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153708132|NCT05990985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708133|NCT05990985|Analgesics|analgesics|mesh-ancestor
153708150|NCT05980546|Autonomic Agents|autonomic agents|mesh-ancestor
153708151|NCT05980546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708152|NCT05980546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708153|NCT05980546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153708154|NCT05980546|Glucocorticoids|glucocorticoids|mesh-ancestor
153612031|NCT02333565|Everolimus|everolimus|mesh-list
153813957|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153708155|NCT05980546|Hormones|hormones|mesh-ancestor
153708156|NCT05980546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708157|NCT05980546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153708158|NCT05980546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708159|NCT05980546|Anesthetics, Local|anesthetics, local|mesh-ancestor
153708160|NCT05980546|Anesthetics|anesthetics|mesh-ancestor
153708161|NCT05980546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708162|NCT05980546|Sensory System Agents|sensory system agents|mesh-ancestor
153708163|NCT05980546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153708164|NCT05980546|Narcotics|narcotics|mesh-ancestor
153708165|NCT05980546|Analgesics|analgesics|mesh-ancestor
153708166|NCT05980546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153708167|NCT05980546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153708168|NCT05980546|Anesthetics, General|anesthetics, general|mesh-ancestor
153708169|NCT05975463|Bevacizumab|bevacizumab|mesh-list
153708170|NCT05975463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708171|NCT05975463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708172|NCT05975463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153708173|NCT05975463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153708174|NCT05975463|Growth Substances|growth substances|mesh-ancestor
153708175|NCT05975463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708176|NCT05975463|Growth Inhibitors|growth inhibitors|mesh-ancestor
153708177|NCT05966246|Prucalopride|prucalopride|mesh-list
153708178|NCT05966246|Mosapride|mosapride|mesh-list
153708179|NCT05966246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708180|NCT05966246|Laxatives|laxatives|mesh-ancestor
153708181|NCT05966246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153708199|NCT05952713|Imipramine|imipramine|mesh-list
153708200|NCT05952713|Escitalopram|escitalopram|mesh-list
153349563|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
153708201|NCT05952713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153708202|NCT05952713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153708203|NCT05952713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708204|NCT05952713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708205|NCT05952713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708206|NCT05952713|Serotonin Agents|serotonin agents|mesh-ancestor
153708207|NCT05952713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708216|NCT05952713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153708217|NCT05952713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708218|NCT05952713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153708219|NCT05952713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153708220|NCT05952713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708221|NCT05952713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153708222|NCT05952713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153708223|NCT05952713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153708224|NCT05952713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153708225|NCT05952713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153708226|NCT05952713|Histamine Antagonists|histamine antagonists|mesh-ancestor
153708227|NCT05952713|Histamine Agents|histamine agents|mesh-ancestor
153708228|NCT05952713|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153708229|NCT05952713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153708230|NCT05952713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153708231|NCT05952713|Adrenergic Agents|adrenergic agents|mesh-ancestor
153708232|NCT05952713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153708233|NCT05952713|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153708234|NCT05952713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153708235|NCT05952713|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153708236|NCT05952713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153708238|NCT05925023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153708239|NCT05925023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708240|NCT05925023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153708241|NCT05925023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708257|NCT05894928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708259|NCT05831358|Myeloma Proteins|myeloma proteins|mesh-list
153708260|NCT05831358|Paraproteins|paraproteins|mesh-list
153708261|NCT05831358|Immunologic Factors|immunologic factors|mesh-ancestor
153708262|NCT05831358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708263|NCT05828966|Magnesium Sulfate|magnesium sulfate|mesh-list
153708264|NCT05828966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153708265|NCT05828966|Analgesics|analgesics|mesh-ancestor
153708266|NCT05828966|Sensory System Agents|sensory system agents|mesh-ancestor
153708267|NCT05828966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708268|NCT05828966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708269|NCT05828966|Anesthetics|anesthetics|mesh-ancestor
153708270|NCT05828966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708271|NCT05828966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153708272|NCT05828966|Anticonvulsants|anticonvulsants|mesh-ancestor
153708289|NCT05826964|Fulvestrant|fulvestrant|mesh-list
153708290|NCT05826964|Palbociclib|palbociclib|mesh-list
153708291|NCT05826964|Anastrozole|anastrozole|mesh-list
153708293|NCT05826964|Temsirolimus|temsirolimus|mesh-list
153708294|NCT05826964|MTOR Inhibitors|mtor inhibitors|mesh-list
153708295|NCT05826964|Elafin|elafin|mesh-list
153612199|NCT01953172|Protective Agents|protective agents|mesh-ancestor
153612436|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
153708296|NCT05826964|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153708297|NCT05826964|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
153708298|NCT05826964|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
153708299|NCT05826964|Estrogens|estrogens|mesh-list
153708300|NCT05826964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153708301|NCT05826964|Antimetabolites|antimetabolites|mesh-ancestor
153708302|NCT05826964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708303|NCT05826964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708316|NCT05826964|Antifungal Agents|antifungal agents|mesh-ancestor
153708317|NCT05826964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153708318|NCT05826964|Tubulin Modulators|tubulin modulators|mesh-ancestor
153708319|NCT05826964|Antimitotic Agents|antimitotic agents|mesh-ancestor
153708320|NCT05826964|Mitosis Modulators|mitosis modulators|mesh-ancestor
153708321|NCT05826964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153708322|NCT05826964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153708323|NCT05826964|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153708324|NCT05826964|Hormones|hormones|mesh-ancestor
153708325|NCT05826964|Protease Inhibitors|protease inhibitors|mesh-ancestor
153378536|NCT00373581|Cocaine|cocaine|mesh-list
153708326|NCT05826574|Rifampin|rifampin|mesh-list
153708327|NCT05826574|Esomeprazole|esomeprazole|mesh-list
153708328|NCT05826574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153708329|NCT05826574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153708330|NCT05826574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153708331|NCT05826574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708332|NCT05826574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545322|NCT06309589|Vitamin D|vitamin d|mesh-list
153708333|NCT05826574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153708334|NCT05826574|Antitubercular Agents|antitubercular agents|mesh-ancestor
153708335|NCT05826574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153708336|NCT05826574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708337|NCT05826574|Leprostatic Agents|leprostatic agents|mesh-ancestor
153708360|NCT05733351|Immunologic Factors|immunologic factors|mesh-ancestor
153708361|NCT05733351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708362|NCT05733351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708363|NCT05733351|Tubulin Modulators|tubulin modulators|mesh-ancestor
153708364|NCT05733351|Antimitotic Agents|antimitotic agents|mesh-ancestor
153708365|NCT05733351|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612438|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
153708376|NCT05721027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708377|NCT05721027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153708379|NCT05721027|Hormones|hormones|mesh-ancestor
153708380|NCT05721027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708381|NCT05721027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153708382|NCT05721027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708383|NCT05721027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153708384|NCT05721027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153708385|NCT05721027|Analgesics|analgesics|mesh-ancestor
153708386|NCT05721027|Sensory System Agents|sensory system agents|mesh-ancestor
153708387|NCT05721027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708388|NCT05721027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153708389|NCT05721027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708390|NCT05721027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708391|NCT05714865|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153708392|NCT05714865|Respiratory System Agents|respiratory system agents|mesh-ancestor
153708393|NCT05706753|Drospirenone|drospirenone|mesh-list
153708394|NCT05706753|Midazolam|midazolam|mesh-list
153708395|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153708396|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153708397|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153708398|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708399|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708400|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153708401|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153708409|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708410|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153708412|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708413|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153708414|NCT05706753|Diuretics|diuretics|mesh-ancestor
153708415|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
153708416|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153708417|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153708418|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153708419|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
153708420|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153708421|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153708422|NCT05706753|Estrogens|estrogens|mesh-ancestor
153708423|NCT05706753|Hormones|hormones|mesh-ancestor
153813964|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153612770|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
153612771|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708424|NCT05688098|Amlodipine|amlodipine|mesh-list
153708425|NCT05688098|Irbesartan|irbesartan|mesh-list
153708426|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153708427|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153708428|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708458|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
153708459|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708460|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
153708461|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153708462|NCT05677373|Trametinib|trametinib|mesh-list
153708463|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708464|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153708465|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708466|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708467|NCT05663073|Amlodipine|amlodipine|mesh-list
153349851|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153708468|NCT05663073|Irbesartan|irbesartan|mesh-list
153708469|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153708470|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153708471|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708472|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708473|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153708474|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708475|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
153708476|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153708477|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153708478|NCT05654506|Daratumumab|daratumumab|mesh-list
153708479|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708480|NCT05620862|Irinotecan|irinotecan|mesh-list
153612772|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153613094|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153708481|NCT05620862|Vincristine|vincristine|mesh-list
153708482|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
153545446|NCT06308068|Diacerein|diacerein|mesh-list
153708483|NCT05620862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153708484|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153708485|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708486|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708487|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708502|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
153708504|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153708530|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708531|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708532|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708533|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153708534|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153708535|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
153708536|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
153708537|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708538|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708539|NCT05558982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153708573|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153708574|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153708575|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708576|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708577|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153708578|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708580|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153708581|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153708582|NCT05467670|Doxorubicin|doxorubicin|mesh-list
153708583|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153708584|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
153708585|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153708587|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153708588|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153708589|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708590|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613295|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708591|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708592|NCT05467670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153708593|NCT05424445|Misoprostol|misoprostol|mesh-list
153708594|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153708595|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
153708596|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153708597|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708616|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708617|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
153708618|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
153708619|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708620|NCT05401916|Acetaminophen|acetaminophen|mesh-list
153708621|NCT05401916|Ibuprofen|ibuprofen|mesh-list
153708622|NCT05401916|Tramadol|tramadol|mesh-list
153854656|NCT01228747|Levetiracetam|levetiracetam|mesh-list
153708647|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153708648|NCT05375903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153708649|NCT05375903|Antimetabolites|antimetabolites|mesh-ancestor
153708650|NCT05375903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708651|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708652|NCT05375903|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153708653|NCT05375903|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153708654|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
153708671|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153708672|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
153708673|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708674|NCT05342519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153708675|NCT05342519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708676|NCT05342519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708677|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
153708679|NCT05331664|Trimethoprim|trimethoprim|mesh-list
153708680|NCT05331664|Prednisolone|prednisolone|mesh-list
153708681|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
153708682|NCT05331664|Triamcinolone|triamcinolone|mesh-list
153708683|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153708684|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153708685|NCT05331664|Atropine|atropine|mesh-list
153708686|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153708687|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153708688|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708704|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
153708705|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153708706|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153708707|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153708708|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153708709|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153613480|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153708710|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
153708711|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153708712|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153708713|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153708728|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153708729|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153708731|NCT05321940|Vaccines|vaccines|mesh-list
153708732|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
153708733|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708734|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708735|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
153708736|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708737|NCT05307874|Aldesleukin|aldesleukin|mesh-list
153708738|NCT05307874|Pembrolizumab|pembrolizumab|mesh-list
153708739|NCT05307874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708740|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708741|NCT05307874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153708742|NCT05307874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708743|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153708744|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153708745|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
153708746|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708773|NCT05221749|Protective Agents|protective agents|mesh-ancestor
153708774|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708776|NCT05190471|Oblimersen|oblimersen|mesh-list
153708797|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153708798|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153708799|NCT05065918|Ethanol|ethanol|mesh-list
153708800|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153708801|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708802|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708803|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708805|NCT05065424|Fentanyl|fentanyl|mesh-list
153708806|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153708807|NCT05065424|Narcotics|narcotics|mesh-ancestor
153708808|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854695|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
153708855|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
153708878|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
153708879|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708880|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613652|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613653|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153708881|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153708883|NCT04938765|Analgesics|analgesics|mesh-ancestor
153708884|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
153708885|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708886|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736026|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
153736027|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708887|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
153708888|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708889|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153708890|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
153708891|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153708892|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708893|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708894|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153708895|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
153708909|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
153708910|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
153708911|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708912|NCT04921189|Protective Agents|protective agents|mesh-ancestor
153708913|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708914|NCT04921189|Vitamins|vitamins|mesh-ancestor
153708915|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
153708932|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
153708933|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153708934|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708935|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708936|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153708937|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
153708938|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708939|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153708940|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153708941|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153708942|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708943|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153708944|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153708945|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708946|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153708947|NCT04885530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153613654|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
153613915|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
153613916|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
153708948|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153708949|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708950|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708951|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
153708952|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153708953|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
153708994|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708996|NCT04802837|Ridinilazole|ridinilazole|mesh-list
153708997|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153708998|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708999|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153709000|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
153709001|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545977|NCT06275087|Propofol|propofol|mesh-list
153709002|NCT04757883|Antibodies|antibodies|mesh-list
153709003|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
153709004|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709005|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
153709006|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
153709007|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709008|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709009|NCT04722172|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153709021|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153709022|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709023|NCT04708145|Growth Substances|growth substances|mesh-ancestor
153709024|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709025|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709026|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709027|NCT04694846|Bupropion|bupropion|mesh-list
153709028|NCT04694846|Nicotine|nicotine|mesh-list
153709029|NCT04694846|Varenicline|varenicline|mesh-list
153394978|NCT05324995|Epinephrine|epinephrine|mesh-list
153709034|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153709035|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153709036|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
153709037|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709038|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709039|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153709040|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
153709041|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153709042|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153614030|NCT01965626|Oseltamivir|oseltamivir|mesh-list
153614031|NCT01965626|Dexamethasone|dexamethasone|mesh-list
153709043|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153709044|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153709046|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153709047|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154257216|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154257217|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154257218|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154257219|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257220|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257221|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257222|NCT01166048|Analgesics|analgesics|mesh-ancestor
154257223|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
154257224|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257225|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
154257226|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154257227|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
154257228|NCT03869762|Denosumab|denosumab|mesh-list
154257229|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154257230|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257231|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154257232|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732002|NCT00140309|Rifampin|rifampin|mesh-list
153709048|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614092|NCT01966172|Gabapentin|gabapentin|mesh-list
153732020|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153709049|NCT04659382|Bevacizumab|bevacizumab|mesh-list
153709050|NCT04659382|Atezolizumab|atezolizumab|mesh-list
153709051|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709052|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709053|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153709054|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709055|NCT04659382|Growth Substances|growth substances|mesh-ancestor
153709056|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709057|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709058|NCT04659382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709059|NCT04659382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709060|NCT04652700|Tenofovir|tenofovir|mesh-list
153709061|NCT04652700|Emtricitabine|emtricitabine|mesh-list
153709062|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153709063|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153709064|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
153709065|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709066|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153709067|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153709068|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709069|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709070|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153709071|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153709099|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153709101|NCT04605393|Cannabidiol|cannabidiol|mesh-list
153709102|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
153709103|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
153709104|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709105|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153709106|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153709107|NCT04605393|Analgesics|analgesics|mesh-ancestor
153709108|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
153709109|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709154|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257233|NCT01283048|Bevacizumab|bevacizumab|mesh-list
154257234|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154257235|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813969|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153813970|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153614402|NCT01968005|Lidocaine|lidocaine|mesh-list
153709177|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153709178|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
153709179|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
153709180|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709181|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153709182|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153709195|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709197|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709198|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153709199|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153736028|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709200|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709201|NCT04400175|Silicon|silicon|mesh-list
153709202|NCT04400175|Trace Elements|trace elements|mesh-ancestor
153709203|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
153709204|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709205|NCT04360551|Telmisartan|telmisartan|mesh-list
153709206|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153709207|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153709208|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153709209|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709210|NCT04288778|Metformin|metformin|mesh-list
153709211|NCT04288778|Canagliflozin|canagliflozin|mesh-list
153709212|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153709213|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709214|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153709215|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709216|NCT04278781|Ivosidenib|ivosidenib|mesh-list
153709217|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709228|NCT04262687|Growth Substances|growth substances|mesh-ancestor
153709229|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709230|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709231|NCT04262687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709232|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709233|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153709234|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
153709235|NCT04246697|Acetaminophen|acetaminophen|mesh-list
153709236|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153709237|NCT04246697|Morphine|morphine|mesh-list
153709238|NCT04246697|Oxycodone|oxycodone|mesh-list
153709239|NCT04246697|Gabapentin|gabapentin|mesh-list
153709240|NCT04246697|Bupivacaine|bupivacaine|mesh-list
153709241|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
153709242|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
153709243|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153709253|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153709254|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153709255|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153709256|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709257|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709258|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
153709259|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153709260|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
153709261|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153709262|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153709263|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709264|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153709265|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709266|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
153709267|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153709268|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153709269|NCT04233164|Prednisolone|prednisolone|mesh-list
153709270|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
153709271|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153709272|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
153709273|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153709274|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
153709275|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
153709276|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709277|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709278|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709279|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
153614785|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153709280|NCT04233164|Hormones|hormones|mesh-ancestor
153427806|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
153709281|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709282|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153709283|NCT04233164|Protective Agents|protective agents|mesh-ancestor
153709284|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153709285|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709286|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
153709287|NCT04230265|Fludarabine|fludarabine|mesh-list
153709288|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709289|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
153709290|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709291|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709305|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
153709306|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709307|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709308|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153709309|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
153709322|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614786|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
153709323|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709324|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153709325|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153709326|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
153709327|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
153709328|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153709329|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153709330|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153709331|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709332|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709333|NCT04126473|Ivacaftor|ivacaftor|mesh-list
153709334|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153709335|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153709336|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709337|NCT04119336|Dexamethasone|dexamethasone|mesh-list
153709338|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
153709339|NCT04119336|Nivolumab|nivolumab|mesh-list
153709340|NCT04119336|Ixazomib|ixazomib|mesh-list
153709341|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709342|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
153813973|NCT00335933|Analgesics|analgesics|mesh-ancestor
153615025|NCT01972269|Lidocaine|lidocaine|mesh-list
153382081|NCT04960215|Ubiquinone|ubiquinone|mesh-list
153615172|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
153709343|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709344|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709345|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153709346|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
153709347|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709348|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709349|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153709350|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153709351|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
153709352|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
153709353|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709354|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709355|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
153709356|NCT04119336|Hormones|hormones|mesh-ancestor
153709357|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709358|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153709359|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709360|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709361|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
153709362|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709407|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
153709408|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709409|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709410|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
153709411|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
153709412|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153709413|NCT03908593|Pantoprazole|pantoprazole|mesh-list
153615178|NCT01973517|Hematinics|hematinics|mesh-ancestor
153615241|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
153615242|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709414|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153709415|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709416|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153709417|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709418|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257236|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154257237|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709419|NCT03901612|Ropivacaine|ropivacaine|mesh-list
153709420|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
153709421|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
153709422|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153709423|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709424|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
153709425|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709426|NCT03874884|Olaparib|olaparib|mesh-list
153709427|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153709428|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709429|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854820|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709457|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709458|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153709459|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709460|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709461|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
153709462|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153709463|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
153709464|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153709465|NCT03774394|Clopidogrel|clopidogrel|mesh-list
153709466|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153709467|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153709468|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153813976|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813977|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
153709469|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153709470|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
153709471|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709472|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709473|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736030|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709474|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
153709475|NCT03766126|Fludarabine|fludarabine|mesh-list
153709476|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709477|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
153709478|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709479|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709480|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153709481|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
153709482|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709483|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709484|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153709485|NCT03765788|Prednisolone|prednisolone|mesh-list
153709486|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153709487|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
153709488|NCT03765788|Hormones|hormones|mesh-ancestor
153709489|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709512|NCT03731923|Hematinics|hematinics|mesh-ancestor
153709513|NCT03713801|Metformin|metformin|mesh-list
153709514|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153709515|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709516|NCT03699995|Lidocaine|lidocaine|mesh-list
153709517|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
153709518|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
153709519|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615625|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709520|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709521|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
153709522|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709523|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153709524|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153709525|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153709526|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153709527|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709528|NCT03692403|Quinagolide|quinagolide|mesh-list
153709561|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
153709562|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709563|NCT03548064|Vaccines|vaccines|mesh-list
153709564|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
153709565|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709566|NCT03527108|Nivolumab|nivolumab|mesh-list
153709567|NCT03527108|Ramucirumab|ramucirumab|mesh-list
153709568|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709569|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709570|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709571|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709572|NCT03527108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153709573|NCT03527108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709574|NCT03527108|Growth Substances|growth substances|mesh-ancestor
153709575|NCT03527108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709576|NCT03527108|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709577|NCT03514069|Temozolomide|temozolomide|mesh-list
153709578|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153709579|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
153709580|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615626|NCT01976676|Folic Acid|folic acid|mesh-list
153615670|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
153615673|NCT01977300|Valproic Acid|valproic acid|mesh-list
153709581|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709582|NCT03512197|Midostaurin|midostaurin|mesh-list
153709583|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709584|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153709585|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709586|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709587|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
153709627|NCT03425838|Anastrozole|anastrozole|mesh-list
153709628|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153709629|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709630|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153709631|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709632|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709633|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153709634|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
153709635|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709636|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709637|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153709638|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153709639|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153615832|NCT01978665|Prednisone|prednisone|mesh-list
153709640|NCT03367013|Lactoferrin|lactoferrin|mesh-list
153709641|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709642|NCT03336398|Ketamine|ketamine|mesh-list
153709643|NCT03336398|Analgesics|analgesics|mesh-ancestor
153709644|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
153709645|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709646|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709647|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153709648|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153709649|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
153709650|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
153709651|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854863|NCT04635293|Protective Agents|protective agents|mesh-ancestor
153709686|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
153709687|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709688|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709689|NCT03260504|Aldesleukin|aldesleukin|mesh-list
153709690|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
153709691|NCT03260504|Interleukin-2|interleukin-2|mesh-list
153709692|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
153709693|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
153709694|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709695|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709696|NCT03260504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709697|NCT03260504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709698|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
153709699|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709700|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153709701|NCT03260504|Analgesics|analgesics|mesh-ancestor
153709702|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
153709703|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709704|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153709705|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153709706|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
153709707|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709708|NCT03259074|Adalimumab|adalimumab|mesh-list
153709725|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
153709726|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257239|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257240|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709727|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709728|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
153709729|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709730|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709731|NCT03210662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709732|NCT03210662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709733|NCT03190330|Ibrutinib|ibrutinib|mesh-list
153709734|NCT03190330|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153709735|NCT03190330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153709736|NCT03190330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709737|NCT03190330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709738|NCT03132467|Durvalumab|durvalumab|mesh-list
153709739|NCT03132467|Ipilimumab|ipilimumab|mesh-list
153709740|NCT03132467|Tremelimumab|tremelimumab|mesh-list
153709741|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
153709742|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153709743|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
153709744|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709745|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709746|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
153709747|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709748|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153854891|NCT00624676|Analgesics|analgesics|mesh-ancestor
153709801|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153709802|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153709804|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709805|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
153709806|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153709807|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709808|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
153709809|NCT02885753|Antidotes|antidotes|mesh-ancestor
153709810|NCT02885753|Protective Agents|protective agents|mesh-ancestor
153709811|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
153709812|NCT02885753|Vitamins|vitamins|mesh-ancestor
153709813|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
153709814|NCT02885753|Hematinics|hematinics|mesh-ancestor
153709815|NCT02754583|Azithromycin|azithromycin|mesh-list
153709816|NCT02754583|Tetracycline|tetracycline|mesh-list
153709817|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153709818|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709819|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153709820|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709821|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709822|NCT02741323|Maraviroc|maraviroc|mesh-list
153546794|NCT05925504|Luspatercept|luspatercept|mesh-list
153709823|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153709824|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153709825|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709826|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153709827|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153709828|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
153709829|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709830|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153709831|NCT02703220|Acetazolamide|acetazolamide|mesh-list
153709842|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
153709843|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709844|NCT02703220|Urological Agents|urological agents|mesh-ancestor
153709845|NCT02677051|Sulforaphane|sulforaphane|mesh-list
153709846|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153709847|NCT02677051|Protective Agents|protective agents|mesh-ancestor
153709848|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709849|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709850|NCT02638701|Infliximab|infliximab|mesh-list
153709851|NCT02638701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153709852|NCT02638701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153709853|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
153709854|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709855|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709856|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
153709857|NCT02615184|Lansoprazole|lansoprazole|mesh-list
153709858|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153709859|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709860|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154257241|NCT03873740|Vaccines|vaccines|mesh-list
153378740|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
153709861|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709862|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709881|NCT02426125|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709882|NCT02395497|Antibodies|antibodies|mesh-list
153709883|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153709884|NCT02395497|Tacrolimus|tacrolimus|mesh-list
153709885|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
153709886|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709887|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709888|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153709889|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709890|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709891|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
153709892|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709893|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709894|NCT02362594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709895|NCT02362594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709896|NCT02355379|Capecitabine|capecitabine|mesh-list
153709918|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153709919|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153709920|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
153709921|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709922|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709923|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153709924|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153709925|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
153616485|NCT06309368|Betaine|betaine|mesh-list
153616486|NCT06309368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709926|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709927|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153709928|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153709929|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153709930|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153709931|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153709932|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153709933|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153709934|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
153709935|NCT02046395|Amlodipine|amlodipine|mesh-list
153709936|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153709937|NCT02046395|Hydralazine|hydralazine|mesh-list
153709938|NCT02046395|Terazosin|terazosin|mesh-list
153709939|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153854986|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
153709947|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
153709960|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153709961|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709962|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
153709963|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
153709964|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
153616489|NCT06309368|Antimetabolites|antimetabolites|mesh-ancestor
153813984|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709965|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709966|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
153709967|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
153709968|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709969|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153709970|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
153709971|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
153709972|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709973|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709974|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153709975|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
153709976|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
153709977|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
153709978|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153709979|NCT01851642|Albuterol|albuterol|mesh-list
153709980|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153709981|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
153428051|NCT00002186|Acyclovir|acyclovir|mesh-list
153709982|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709983|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709984|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153709985|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
153709986|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
153709987|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153709988|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153709989|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153709990|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153709991|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
153709992|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709993|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709994|NCT01838187|Vorinostat|vorinostat|mesh-list
153709995|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153709996|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709997|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153709998|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709999|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710036|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710038|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153710039|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710040|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
153710041|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
153616949|NCT06039826|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153710042|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710043|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710044|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
153710045|NCT00871013|Hormones|hormones|mesh-ancestor
153710046|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710047|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547018|NCT05803382|Capecitabine|capecitabine|mesh-list
153710048|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153710049|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153710050|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153710051|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710052|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153710053|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
153710054|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153710055|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710056|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153710057|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153710058|NCT00871013|Growth Substances|growth substances|mesh-ancestor
153710059|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
153710060|NCT00585650|Etanercept|etanercept|mesh-list
153710061|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153710062|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710063|NCT00585650|Analgesics|analgesics|mesh-ancestor
153710064|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
153855022|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
153855025|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
153710100|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
153710101|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710102|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710103|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
153710104|NCT00039130|Hormones|hormones|mesh-ancestor
153710105|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710106|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153710107|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153382260|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
153396915|NCT02669615|Melphalan|melphalan|mesh-list
153710108|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153710109|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153710110|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153710111|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710112|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153710113|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
153710114|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153710115|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710116|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
153710117|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
153710118|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153710119|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153710120|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153710162|NCT00313261|Clevudine|clevudine|mesh-list
153710163|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
153710164|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710165|NCT00425074|Aspirin|aspirin|mesh-list
153710166|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
153710167|NCT00425074|Salicylates|salicylates|mesh-list
153710168|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710169|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
153710170|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
153710171|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
153710172|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154257243|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710173|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710174|NCT00425074|Analgesics|analgesics|mesh-ancestor
153710175|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
153710192|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153710193|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710194|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
153710195|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617369|NCT05544929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617370|NCT05544929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617391|NCT05505825|Chiauranib|chiauranib|mesh-list
153710196|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710197|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710198|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710199|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
153710200|NCT00425152|Antidotes|antidotes|mesh-ancestor
153710201|NCT00425152|Protective Agents|protective agents|mesh-ancestor
153710202|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
153710204|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
153710205|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153710206|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
153710207|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
153710208|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153710209|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710210|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710212|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153710213|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428098|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153710214|NCT00122616|Ribavirin|ribavirin|mesh-list
153710215|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153710216|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153710217|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
153710218|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710219|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
153710220|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710221|NCT04984070|Metformin|metformin|mesh-list
153710222|NCT04984070|Drospirenone|drospirenone|mesh-list
153710223|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
153710224|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153710225|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
153710226|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153710227|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153710228|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153710229|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710230|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153710231|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153710232|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153855066|NCT01225549|Budesonide|budesonide|mesh-list
153710277|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153710278|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153710279|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153710280|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153710281|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153710282|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153710283|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153710285|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710286|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
153710287|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710356|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710357|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153710358|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710359|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
153710360|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
153710361|NCT00314743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153710362|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153710363|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
153710364|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710375|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
153710376|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153710377|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710399|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710401|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
153710402|NCT00091104|Fludarabine|fludarabine|mesh-list
153710403|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
153710404|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
153710405|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154257244|NCT01172756|Riociguat|riociguat|mesh-list
154257245|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
153710406|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
153710407|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710408|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710409|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153710410|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
153710411|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617687|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153710412|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710413|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153710414|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710415|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
153710416|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153710417|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153710418|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153710419|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
153710420|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710421|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
153710449|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710450|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710452|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153710453|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153710454|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710455|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153710456|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153710457|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
153710458|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710459|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710460|NCT00091143|Fludarabine|fludarabine|mesh-list
153710461|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
153710462|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
153710463|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153710464|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710465|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710466|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
153710467|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710468|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710469|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
153710470|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710471|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153710472|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
153710473|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710475|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710477|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153710478|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153710479|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153710480|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710481|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153710482|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153710483|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
153710484|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710485|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710486|NCT00091299|Warfarin|warfarin|mesh-list
153617688|NCT04903197|Growth Substances|growth substances|mesh-ancestor
153710487|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
153710488|NCT04607603|Cannabidiol|cannabidiol|mesh-list
153710489|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
153710490|NCT00122772|Cisplatin|cisplatin|mesh-list
153710517|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
153710518|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710519|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
153710520|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153710521|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
153710522|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153710523|NCT03975439|Chrysarobin|chrysarobin|mesh-list
153710524|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153710525|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710526|NCT03975439|Analgesics|analgesics|mesh-ancestor
153710527|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
153710528|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710529|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710530|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710531|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710533|NCT00091377|Cisplatin|cisplatin|mesh-list
153352314|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153710534|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153710535|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710547|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710548|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
153710549|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153710550|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153710551|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153710553|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
153710554|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
153710555|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710556|NCT00122889|Protective Agents|protective agents|mesh-ancestor
153710557|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710558|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153710559|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710560|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153710561|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710562|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710563|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153710564|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
153710565|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153710566|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153710567|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153710568|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
153710569|NCT04729868|Bupivacaine|bupivacaine|mesh-list
153710570|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
153710571|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
153710572|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
153710573|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153710574|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710575|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
153710576|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395406|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153710598|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710621|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710622|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153710623|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153710624|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153710625|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710626|NCT00315016|Eplerenone|eplerenone|mesh-list
153710627|NCT00315016|Fosinopril|fosinopril|mesh-list
153710628|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153710629|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
153710643|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710645|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
153710646|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153710647|NCT00419146|Vitamins|vitamins|mesh-list
153710648|NCT00419146|Vitamin E|vitamin e|mesh-list
153710649|NCT00419146|Tocopherols|tocopherols|mesh-list
153710650|NCT00419146|Tocotrienols|tocotrienols|mesh-list
153710651|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
153710661|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710662|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
153710663|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
153710664|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710665|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710666|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710667|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
153710668|NCT02965196|Hormones|hormones|mesh-ancestor
153710669|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814000|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
153814001|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
153710670|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153710671|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710672|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
153710673|NCT00091611|Fludarabine|fludarabine|mesh-list
153710674|NCT00091611|Interleukin-2|interleukin-2|mesh-list
153710675|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710676|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
153710677|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710678|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710679|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153710680|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
153710681|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710682|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710683|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153710684|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710685|NCT00091611|Analgesics|analgesics|mesh-ancestor
153710686|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
153710710|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710711|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153710712|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710713|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153710714|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710715|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710726|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153710727|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153710728|NCT00091650|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153710729|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153710730|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153710731|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710732|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710733|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
153710735|NCT01691833|Vitamins|vitamins|mesh-ancestor
153710736|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
153710737|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710738|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153710739|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153710740|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
153710741|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
153710742|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
153710743|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153710744|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153710745|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710755|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153710756|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710757|NCT00091806|Panitumumab|panitumumab|mesh-list
153710758|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153710759|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710760|NCT00123318|Cisplatin|cisplatin|mesh-list
153710761|NCT00123318|Fluorouracil|fluorouracil|mesh-list
153710762|NCT00123318|Epirubicin|epirubicin|mesh-list
153710763|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710764|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
153710765|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710766|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710767|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710768|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
153710769|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710770|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153710771|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153710772|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153710773|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710774|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
153710775|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
153710776|NCT00327535|Hematinics|hematinics|mesh-ancestor
153710777|NCT00327691|Atorvastatin|atorvastatin|mesh-list
153710778|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153710779|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153710795|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153710796|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
153710797|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710798|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
153710799|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710800|NCT00327730|Eperisone|eperisone|mesh-list
153710801|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
153547775|NCT05286814|Irinotecan|irinotecan|mesh-list
153710802|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153710803|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153710804|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710848|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153710850|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710851|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710852|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710878|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
153710879|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153710880|NCT00327847|Vitamin D|vitamin d|mesh-list
153428358|NCT00002252|Octreotide|octreotide|mesh-list
153710881|NCT00327847|Vitamins|vitamins|mesh-ancestor
153710882|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
153710883|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257246|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814003|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
153618362|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618363|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710884|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153710885|NCT00327925|Antibodies|antibodies|mesh-list
153710886|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
153710887|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710888|NCT03709550|Decitabine|decitabine|mesh-list
153710889|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710890|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
153710891|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710892|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710893|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710894|NCT00315211|Docetaxel|docetaxel|mesh-list
153710895|NCT00315211|Topotecan|topotecan|mesh-list
153710896|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710897|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710898|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
153710899|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710900|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710901|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153710902|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153710935|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153710936|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710937|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
153710938|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
153710939|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710940|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
153710941|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153710942|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710943|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710944|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153710945|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153710946|NCT00315679|Protective Agents|protective agents|mesh-ancestor
153710947|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710948|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
153710949|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153710950|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
153710951|NCT00092274|Ofatumumab|ofatumumab|mesh-list
153710952|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710953|NCT00315835|Buprenorphine|buprenorphine|mesh-list
153710954|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153710956|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153618364|NCT03361800|Entinostat|entinostat|mesh-list
153814006|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153710957|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710958|NCT00315835|Analgesics|analgesics|mesh-ancestor
153710959|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
153710960|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710961|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153710962|NCT00315874|Buprenorphine|buprenorphine|mesh-list
153710963|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153710964|NCT00315874|Narcotics|narcotics|mesh-ancestor
153710965|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153710966|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710967|NCT00315874|Analgesics|analgesics|mesh-ancestor
153710968|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
153710969|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711001|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
153711002|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711003|NCT00316030|Bexarotene|bexarotene|mesh-list
153711055|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711056|NCT00316498|Miglustat|miglustat|mesh-list
153711057|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711058|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711059|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153711060|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153711061|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
153711062|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711063|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153711064|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153711065|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711066|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
153711067|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
153711068|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153711082|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711083|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352783|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153711084|NCT00316849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153711109|NCT00316927|Hormones|hormones|mesh-ancestor
153711110|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153711111|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153711112|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711113|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153711114|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711115|NCT00316927|Analgesics|analgesics|mesh-ancestor
153711116|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
153711117|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711118|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153711119|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153711120|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618617|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618619|NCT02649790|Dexamethasone|dexamethasone|mesh-list
153711121|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153711122|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153711123|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711124|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
153711125|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153711126|NCT00316927|Estrogens|estrogens|mesh-ancestor
153711127|NCT00123669|Progesterone|progesterone|mesh-list
153711128|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153711129|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153711130|NCT00123669|Progestins|progestins|mesh-ancestor
153711131|NCT00123669|Hormones|hormones|mesh-ancestor
153711132|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153711146|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153711147|NCT00317200|Growth Substances|growth substances|mesh-ancestor
153711148|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711149|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
153855320|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
153711179|NCT00328432|Celecoxib|celecoxib|mesh-list
153711180|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153548153|NCT05010122|Venetoclax|venetoclax|mesh-list
153711181|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711182|NCT00328432|Analgesics|analgesics|mesh-ancestor
153711183|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
153711184|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711185|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711186|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711187|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711188|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153711189|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153711190|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711191|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711203|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
153711204|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711230|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711231|NCT01821833|Paclitaxel|paclitaxel|mesh-list
153711232|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153711233|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711234|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
153711235|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
153711236|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
153711237|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711238|NCT00328900|Atropine|atropine|mesh-list
153711239|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153711240|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153711241|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153711242|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
153711243|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711244|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711245|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153711246|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
153711247|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
153711248|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
153711249|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153711250|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153711251|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
153618731|NCT01737502|Sirolimus|sirolimus|mesh-list
153711252|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395630|NCT02576249|Hormones|hormones|mesh-ancestor
153711296|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711297|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153711298|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153711299|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711301|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711302|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711303|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
153711304|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711308|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
153711309|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711310|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711311|NCT00329368|Folic Acid|folic acid|mesh-list
153711312|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
153711313|NCT00329368|Interferons|interferons|mesh-list
153711314|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
153711315|NCT00329368|Interleukin-2|interleukin-2|mesh-list
153711316|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153711317|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711318|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
153711319|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711334|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153711335|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711336|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711337|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
153711338|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711339|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
153711340|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711341|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153711342|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153711343|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711344|NCT00092937|Busulfan|busulfan|mesh-list
153711345|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
153711346|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711347|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618784|NCT01046825|Doxorubicin|doxorubicin|mesh-list
153711348|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
153711349|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711350|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153711351|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711352|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153711353|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153711354|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153711355|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
153711356|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
153711357|NCT04716751|Paclitaxel|paclitaxel|mesh-list
153711358|NCT04716751|Carboplatin|carboplatin|mesh-list
153711359|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153711360|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711361|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
153711362|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
153711363|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
153711364|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711365|NCT00123903|Metoprolol|metoprolol|mesh-list
153711366|NCT00123903|Carvedilol|carvedilol|mesh-list
153711367|NCT00123903|Lisinopril|lisinopril|mesh-list
153711368|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153711369|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153711370|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
153711371|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
153711372|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711373|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711374|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153711375|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153711410|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153711411|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
153711412|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711413|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153711414|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153618785|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153618786|NCT01046825|Rituximab|rituximab|mesh-list
153618787|NCT01046825|Rasburicase|rasburicase|mesh-list
153618788|NCT01046825|Lenograstim|lenograstim|mesh-list
153618789|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
153618790|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153618791|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
153359392|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
153359842|NCT03742349|Spartalizumab|spartalizumab|mesh-list
153711415|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711416|NCT00329914|Progesterone|progesterone|mesh-list
153711417|NCT00329914|Progestins|progestins|mesh-ancestor
153711419|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153711420|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711421|NCT00092976|Factor VIII|factor viii|mesh-list
153711422|NCT00092976|Coagulants|coagulants|mesh-ancestor
153711423|NCT00083876|Thalidomide|thalidomide|mesh-list
153711424|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711425|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
154257247|NCT02525822|Tazarotene|tazarotene|mesh-list
154257248|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
153711426|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711427|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
153711428|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711429|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711430|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153711431|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153711432|NCT00083876|Growth Substances|growth substances|mesh-ancestor
153711433|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
153711434|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711435|NCT00330148|Eflornithine|eflornithine|mesh-list
153711436|NCT00330148|Nifurtimox|nifurtimox|mesh-list
153711437|NCT00330148|Melarsoprol|melarsoprol|mesh-list
153711438|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711439|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153711440|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153711449|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
153711450|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153711451|NCT00093093|Taribavirin|taribavirin|mesh-list
153711452|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711453|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
153711474|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711475|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153711476|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
153711477|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711478|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153711479|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153711480|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711481|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360071|NCT01321151|Resveratrol|resveratrol|mesh-list
153360292|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
153360816|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153361946|NCT05946135|Fexuprazan|fexuprazan|mesh-list
153362482|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
153362620|NCT02966912|Antacids|antacids|mesh-ancestor
153362770|NCT00891878|Capecitabine|capecitabine|mesh-list
153363440|NCT01561703|Amoxicillin|amoxicillin|mesh-list
153363828|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153367786|NCT02485184|Propranolol|propranolol|mesh-list
153367930|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153368996|NCT02494713|Docetaxel|docetaxel|mesh-list
153819671|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153819672|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819673|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819674|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819675|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153819676|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153814011|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370485|NCT04297605|Paclitaxel|paclitaxel|mesh-list
153711482|NCT00330577|Timolol|timolol|mesh-list
153711483|NCT00330577|Latanoprost|latanoprost|mesh-list
153711484|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
153711485|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711486|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153711487|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153711488|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
153711489|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711490|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711491|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153711492|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153711493|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153711494|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153711495|NCT00083993|Sirolimus|sirolimus|mesh-list
153711496|NCT00083993|Letrozole|letrozole|mesh-list
153711497|NCT00083993|Temsirolimus|temsirolimus|mesh-list
153711498|NCT00083993|MTOR Inhibitors|mtor inhibitors|mesh-list
153711499|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711500|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153711501|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153711502|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711503|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711504|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153711505|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
153711506|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153711507|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711523|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711538|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711539|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
153711540|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153711541|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
153711542|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711543|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153711544|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153711545|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711546|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711547|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153371315|NCT01307462|Xhance|xhance|mesh-list
153371624|NCT01250210|Estradiol|estradiol|mesh-list
153371711|NCT01732445|Danazol|danazol|mesh-list
153371767|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
153372135|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153372298|NCT01324700|Dexetimide|dexetimide|mesh-list
153374321|NCT01868633|Dexamethasone|dexamethasone|mesh-list
153374693|NCT05448885|Tislelizumab|tislelizumab|mesh-list
153375805|NCT00373503|Dronabinol|dronabinol|mesh-list
153376106|NCT06190600|Paclitaxel|paclitaxel|mesh-list
153376334|NCT06113913|Infliximab|infliximab|mesh-list
153376631|NCT05765266|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153376929|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377231|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377686|NCT04083950|Analgesics|analgesics|mesh-ancestor
153377758|NCT03936218|Goserelin|goserelin|mesh-list
153814012|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153377984|NCT03341078|Ibudilast|ibudilast|mesh-list
153711548|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
153711549|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711550|NCT00323947|Methylphenidate|methylphenidate|mesh-list
153711551|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153711552|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711553|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153711554|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153711555|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153711556|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711557|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
153548534|NCT04733118|Pertuzumab|pertuzumab|mesh-list
153711559|NCT00323986|Azithromycin|azithromycin|mesh-list
153711560|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711561|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711562|NCT00324025|Efungumab|efungumab|mesh-list
153711563|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
153711564|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711565|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153711566|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
153711567|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153711575|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711576|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711577|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153711578|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
153711579|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
153711580|NCT00317629|Protective Agents|protective agents|mesh-ancestor
153711581|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153711582|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153711583|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711584|NCT00093249|Clevidipine|clevidipine|mesh-list
153711585|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153736031|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153711586|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153711587|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711588|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153855501|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711611|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711612|NCT00324376|Sevelamer|sevelamer|mesh-list
153711613|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
153711614|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
153711615|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711616|NCT00084227|Azithromycin|azithromycin|mesh-list
153711617|NCT00084227|Chloroquine|chloroquine|mesh-list
153711618|NCT00084227|Atovaquone|atovaquone|mesh-list
153711619|NCT00084227|Proguanil|proguanil|mesh-list
153711620|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153711621|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711622|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711623|NCT00084227|Amebicides|amebicides|mesh-ancestor
153711624|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153711625|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153378287|NCT02069730|Androgens|androgens|mesh-list
153378519|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
153393162|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
153393919|NCT00003117|Paclitaxel|paclitaxel|mesh-list
153394214|NCT04005079|Miotics|miotics|mesh-ancestor
153394365|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153394977|NCT05324995|Celecoxib|celecoxib|mesh-list
153395498|NCT04341077|Fluzoparib|fluzoparib|mesh-list
153395652|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
153711626|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
153711627|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711628|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711629|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711630|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
153711631|NCT00317746|Citalopram|citalopram|mesh-list
153711632|NCT00317746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153548610|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153711633|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153711634|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153711658|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153711659|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
153711660|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153711661|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711662|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
153711663|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
153711664|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711679|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153711680|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153711681|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711682|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
153711683|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711684|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711685|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153711696|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711699|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153711700|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814017|NCT00336518|Ribavirin|ribavirin|mesh-list
153814018|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153814019|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
153711701|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
153711702|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
153711703|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711705|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153711706|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711707|NCT00084461|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153711708|NCT00084461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711709|NCT00084461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711710|NCT00324610|Capecitabine|capecitabine|mesh-list
153711711|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711712|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
153711713|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711714|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711715|NCT00093366|Etanercept|etanercept|mesh-list
153711716|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
153711717|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153711718|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711719|NCT00093366|Analgesics|analgesics|mesh-ancestor
153711720|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
153711721|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711722|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711723|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711724|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711725|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153711726|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711727|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
153711728|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711729|NCT00324688|Tenofovir|tenofovir|mesh-list
153711730|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
153711731|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711732|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153711733|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153781999|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
153711763|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711764|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711765|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711766|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153711767|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153711768|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711769|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711770|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153711772|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153711773|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153711774|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711775|NCT00093444|Doxorubicin|doxorubicin|mesh-list
153711776|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153711777|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153711778|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711779|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153711780|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153711781|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711782|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711784|NCT00325000|Sertraline|sertraline|mesh-list
153711785|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
153711786|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711787|NCT00325000|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153711788|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153711789|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153711790|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711791|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711792|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
153711810|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711812|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153711813|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711814|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153711815|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
153711816|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711817|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711832|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711833|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153711834|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711835|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
153711836|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711837|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
153711838|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
154257249|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
154257250|NCT01172912|Dexamethasone|dexamethasone|mesh-list
153711839|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711840|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153711841|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
153711842|NCT00084695|Hormones|hormones|mesh-ancestor
153711843|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153711844|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153711845|NCT00084695|Protective Agents|protective agents|mesh-ancestor
153711846|NCT00325351|Carboplatin|carboplatin|mesh-list
153711847|NCT00325351|Sagopilone|sagopilone|mesh-list
153711848|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711849|NCT00093483|Cytarabine|cytarabine|mesh-list
153711850|NCT00093483|Idarubicin|idarubicin|mesh-list
153711851|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
153711852|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711853|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
153711854|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711855|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711856|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
153711857|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711858|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711859|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
153711860|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711861|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153711862|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153711863|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153711891|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153711893|NCT00084773|Cetuximab|cetuximab|mesh-list
153399622|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
153819679|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153819680|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711894|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
153711895|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711896|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711897|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711898|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711899|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
153711900|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711901|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153711902|NCT00325546|Rimonabant|rimonabant|mesh-list
153711903|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153711904|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153711905|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153711906|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711907|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711908|NCT00325546|Hormones|hormones|mesh-ancestor
153711909|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153711910|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711911|NCT00084812|Safingol|safingol|mesh-list
153711912|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711913|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711914|NCT02959879|Folfirinox|folfirinox|mesh-list
153711915|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711916|NCT04717609|Ropivacaine|ropivacaine|mesh-list
153711917|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
153711918|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
153819681|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
153819682|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153819683|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
153819684|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153711919|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711920|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711921|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
153711922|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711923|NCT00318760|Clonidine|clonidine|mesh-list
153711924|NCT00318760|Analgesics|analgesics|mesh-ancestor
153711971|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711972|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153855689|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
153711998|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
153711999|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712000|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153712001|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153712002|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153712003|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
153712004|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712005|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712013|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153712014|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712016|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153712017|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712018|NCT00093600|Cytarabine|cytarabine|mesh-list
153712019|NCT00093600|Daunorubicin|daunorubicin|mesh-list
153712020|NCT00093600|Midostaurin|midostaurin|mesh-list
153712021|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153712022|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
153712023|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712024|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712025|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
153712026|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712027|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712028|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
153712057|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153712059|NCT00085163|Analgesics|analgesics|mesh-ancestor
153712060|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
153819685|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153400222|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
153712061|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712062|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712063|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712064|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153712065|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153712066|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712067|NCT00319072|Hormones|hormones|mesh-list
153712068|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712069|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712070|NCT00093639|Everolimus|everolimus|mesh-list
153712071|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
153712072|NCT00093639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153712073|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712074|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712085|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712086|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153712097|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153712098|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
153712099|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712100|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712101|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
153712102|NCT00400088|Paroxetine|paroxetine|mesh-list
153712103|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
153712104|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712105|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712106|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712107|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
153712108|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153712109|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153712110|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712111|NCT00400088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153712112|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153428841|NCT01525927|Cisplatin|cisplatin|mesh-list
153712113|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712114|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712115|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
153712116|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153712117|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153814026|NCT00347490|Enoxaparin|enoxaparin|mesh-list
153712118|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153712119|NCT00326092|Timolol|timolol|mesh-list
153712120|NCT00326092|Brinzolamide|brinzolamide|mesh-list
153712121|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153712122|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153712123|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
153712124|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712125|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712126|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712127|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153712128|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153712129|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153712130|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712131|NCT00326131|Taxane|taxane|mesh-list
153712132|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712133|NCT00319189|Nateglinide|nateglinide|mesh-list
153712134|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153712135|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712136|NCT00319267|Bosentan|bosentan|mesh-list
153712137|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153712138|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153712149|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712150|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814029|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153712151|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153712152|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153712153|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712154|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712156|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
153396022|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712188|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153712189|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153712190|NCT00085358|Growth Substances|growth substances|mesh-ancestor
153712191|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712192|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
153712193|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
153712195|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153712196|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153712197|NCT00093678|Analgesics|analgesics|mesh-ancestor
153712198|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
153712240|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712242|NCT00319618|Gefitinib|gefitinib|mesh-list
153712243|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712244|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
153712245|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
153712246|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
153712247|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712248|NCT00319618|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712249|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712250|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712251|NCT00124332|Rimonabant|rimonabant|mesh-list
153712252|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153712253|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153712254|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153712255|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712261|NCT00085553|Tipifarnib|tipifarnib|mesh-list
153712262|NCT00085553|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712263|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712264|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712265|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712266|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712267|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
153712268|NCT00400335|Testosterone|testosterone|mesh-list
153712269|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
153712270|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
153712271|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153712272|NCT00400335|Dutasteride|dutasteride|mesh-list
153712273|NCT00400335|Androgens|androgens|mesh-ancestor
153712305|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712306|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153712308|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
153712309|NCT04717102|Desflurane|desflurane|mesh-list
153712310|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153712311|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
153712312|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
153712313|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153712314|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712323|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712348|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
153712349|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712350|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712351|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712352|NCT00320320|Irinotecan|irinotecan|mesh-list
153712353|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153712354|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712355|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712356|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712357|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712358|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
153712359|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153712360|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153712361|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712362|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
153712363|NCT00327106|Coagulants|coagulants|mesh-ancestor
153712364|NCT00320359|Cisplatin|cisplatin|mesh-list
153712365|NCT00320359|Etoposide|etoposide|mesh-list
153712366|NCT00320359|Topotecan|topotecan|mesh-list
153712367|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814032|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153712368|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153712369|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153712370|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712371|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712390|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712391|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153712392|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712394|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153712395|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153712396|NCT00327145|Diuretics|diuretics|mesh-ancestor
153712397|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
153712398|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153712399|NCT00085943|Ritonavir|ritonavir|mesh-list
153712400|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
153712401|NCT00085943|Lamivudine|lamivudine|mesh-list
153712402|NCT00085943|Abacavir|abacavir|mesh-list
153712403|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153712404|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153712405|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
153712406|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712407|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712408|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153712409|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153712410|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
153712411|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712412|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153712423|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712424|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
153712425|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153712432|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
153712433|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
153712434|NCT00320476|Bortezomib|bortezomib|mesh-list
153712435|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712436|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
153712437|NCT00327262|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712438|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712439|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712440|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712441|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712442|NCT00093990|Tipifarnib|tipifarnib|mesh-list
153712443|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712444|NCT00327379|Aprotinin|aprotinin|mesh-list
153712445|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
153712446|NCT00327379|Coagulants|coagulants|mesh-ancestor
153712447|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153712448|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153712449|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
153712450|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712451|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712452|NCT00327418|Atorvastatin|atorvastatin|mesh-list
153712453|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153712454|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153712455|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
153712456|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712457|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153712458|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153712459|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712460|NCT00094029|Sunitinib|sunitinib|mesh-list
153712461|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712462|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153712463|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153712464|NCT00094029|Growth Substances|growth substances|mesh-ancestor
153712465|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712466|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
153712467|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712468|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712469|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712470|NCT00086099|Amifostine|amifostine|mesh-list
153712471|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153712472|NCT00086099|Protective Agents|protective agents|mesh-ancestor
153712473|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712474|NCT00320632|Desipramine|desipramine|mesh-list
153712475|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153712476|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
153712477|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712478|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712479|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712480|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153712481|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153712482|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712549|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
153712550|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712551|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
153712552|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712553|NCT00086333|Docetaxel|docetaxel|mesh-list
153712554|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712555|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
153712556|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
153712557|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
153712558|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712559|NCT05458180|Prednisone|prednisone|mesh-list
153712560|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
153712585|NCT05458180|Analgesics|analgesics|mesh-ancestor
153712586|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
153712587|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712588|NCT00419653|Haloperidol|haloperidol|mesh-list
153712589|NCT00419653|Olanzapine|olanzapine|mesh-list
153712590|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
153712591|NCT00419653|Amisulpride|amisulpride|mesh-list
153712592|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
153855944|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153712640|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153814039|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153814040|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712641|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153712642|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
153712643|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712644|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153712645|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153712658|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712659|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712660|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712661|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712662|NCT05457829|Doxorubicin|doxorubicin|mesh-list
153712663|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153712664|NCT05457829|Irinotecan|irinotecan|mesh-list
153712665|NCT05457829|Vincristine|vincristine|mesh-list
153712666|NCT05457829|Temozolomide|temozolomide|mesh-list
153712687|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153712688|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153712689|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
153712691|NCT00124566|Capecitabine|capecitabine|mesh-list
153712692|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
153712693|NCT00124566|Irofulven|irofulven|mesh-list
153712694|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153712695|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
153712696|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712697|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712698|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712699|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
153712700|NCT00124566|Hormones|hormones|mesh-ancestor
153712701|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712702|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712703|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153712704|NCT00124566|Analgesics|analgesics|mesh-ancestor
153712705|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
153712706|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712707|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153712726|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712727|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153712728|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
153712729|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712730|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153712731|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153712732|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
153712733|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
153712734|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855966|NCT02931071|Plerixafor|plerixafor|mesh-list
153712758|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153712759|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153819686|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153712760|NCT00086801|Gemcitabine|gemcitabine|mesh-list
153712761|NCT00086801|Doxorubicin|doxorubicin|mesh-list
153712762|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153712774|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153712775|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
153712776|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
153712777|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
153712780|NCT00124644|Daunorubicin|daunorubicin|mesh-list
153712781|NCT00124644|Tipifarnib|tipifarnib|mesh-list
153712782|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153712783|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153712784|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712785|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153712786|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712787|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712788|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153712789|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
153712790|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
153712791|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712792|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712793|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
153712794|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712795|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153712796|NCT00086840|Sirolimus|sirolimus|mesh-list
153712797|NCT00086840|Temsirolimus|temsirolimus|mesh-list
153712798|NCT00086840|MTOR Inhibitors|mtor inhibitors|mesh-list
153712799|NCT00086840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712800|NCT00086840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712807|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819687|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
153819688|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153819689|NCT00469560|Deferasirox|deferasirox|mesh-list
153461090|NCT03087864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461092|NCT01678716|Trace Elements|trace elements|mesh-list
153461093|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461094|NCT00081510|Anastrozole|anastrozole|mesh-list
153461095|NCT00081510|Lonafarnib|lonafarnib|mesh-list
153461096|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153461097|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461098|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153461099|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153461100|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461101|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461102|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153461103|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
153712808|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153712809|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
153712810|NCT00124683|Bupropion|bupropion|mesh-list
153712811|NCT00124683|Nicotine|nicotine|mesh-list
153712812|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153712813|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
153712814|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712815|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712816|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153712817|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153712818|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
153712819|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712820|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712821|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153712822|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
153712823|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712824|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153712825|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153429099|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712826|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712839|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712841|NCT00086879|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712842|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712843|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712844|NCT00124722|Bromides|bromides|mesh-list
153712845|NCT00124722|Rocuronium|rocuronium|mesh-list
153712846|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
153712847|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153712848|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153712849|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153712850|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712851|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712852|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
153396280|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712879|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
153712880|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712881|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712882|NCT00087035|Docetaxel|docetaxel|mesh-list
153712883|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153712884|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712885|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
153712886|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
153712887|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
153712907|NCT00087074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712908|NCT00087074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712909|NCT00087074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712910|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712911|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
153712912|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712913|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712914|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856031|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153712919|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153712920|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
153712921|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712922|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
153712923|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712925|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712926|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712927|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712928|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153712929|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153712930|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153712931|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712932|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
153712933|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153712934|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153712935|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153712936|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153712937|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712938|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153712939|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712940|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712941|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712942|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712943|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153712987|NCT00087269|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712988|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712989|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712990|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712991|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712992|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153712993|NCT00087347|Hematinics|hematinics|mesh-ancestor
153712994|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153712995|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153712996|NCT00419692|Ropinirole|ropinirole|mesh-list
153712997|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153712998|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153712999|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
153713000|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
153713001|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713002|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713003|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713004|NCT00419731|Naltrexone|naltrexone|mesh-list
153713005|NCT00419731|Bupropion|bupropion|mesh-list
153713006|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153713007|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153713008|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713037|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713038|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153713039|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153713040|NCT00330655|Memantine|memantine|mesh-list
153713041|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153713042|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153713043|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
153713044|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732021|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153461104|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461105|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461106|NCT00088452|Lamotrigine|lamotrigine|mesh-list
153461107|NCT00088452|Valproic Acid|valproic acid|mesh-list
153461108|NCT00088452|Ethosuximide|ethosuximide|mesh-list
153461109|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
153461110|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153461111|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153713045|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713046|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713047|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153713067|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153713068|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153713069|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
153713070|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713071|NCT00094926|Risperidone|risperidone|mesh-list
153713072|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153856072|NCT05184192|Gabapentin|gabapentin|mesh-list
153713099|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
153713100|NCT00331084|Dexamethasone|dexamethasone|mesh-list
153713101|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
153713102|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153713122|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
153713123|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153713124|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153713125|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153713126|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153713127|NCT00420355|Ritonavir|ritonavir|mesh-list
153713128|NCT00420355|Lopinavir|lopinavir|mesh-list
153713129|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153713130|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153713131|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153713132|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
153713133|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713134|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713135|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153713136|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153713137|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
153713138|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713139|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153713140|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153713178|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713179|NCT00087581|Cyclosporine|cyclosporine|mesh-list
153713180|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
153713181|NCT00087581|Tacrolimus|tacrolimus|mesh-list
153713182|NCT00087581|Cyclosporins|cyclosporins|mesh-list
153713183|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814045|NCT00336791|Paclitaxel|paclitaxel|mesh-list
153713184|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
153713185|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713186|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153713187|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713188|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713189|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
153713190|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713191|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
153713192|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153713193|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153713194|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713195|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153713196|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
153713197|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153713198|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
153713199|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713200|NCT00331435|Verteporfin|verteporfin|mesh-list
153713201|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153713202|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
153713209|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153713210|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153713211|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153713212|NCT00087620|Capecitabine|capecitabine|mesh-list
153713213|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153713214|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
153713215|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713216|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713217|NCT00124995|Terbutaline|terbutaline|mesh-list
153713218|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153713219|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
153713242|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
153713243|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
153713244|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153713245|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
153713246|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153713247|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713248|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713249|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153713250|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
153713251|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
153713252|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153713253|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
153713254|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713255|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153713256|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153713257|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
153713258|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153713259|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713261|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
153814046|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
153713262|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
153713263|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153713264|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153713265|NCT00331786|Analgesics|analgesics|mesh-ancestor
153713266|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
153713267|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713268|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713269|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713270|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153713271|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153713272|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153713281|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
153713282|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153713283|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
153713284|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713285|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153713286|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
153713320|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153713321|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153713322|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153713323|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153713324|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713325|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713333|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713334|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713336|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153713337|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
153713353|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713355|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
153713356|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153713357|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
153713358|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153713359|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
153713360|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713361|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713362|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
153713363|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153713364|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153814049|NCT00336791|Fluorouracil|fluorouracil|mesh-list
153626796|NCT02019056|Metadoxine|metadoxine|mesh-list
153819690|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153819691|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
153819692|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
153819693|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819694|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
153819695|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153819696|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153713366|NCT02965274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153713367|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153713368|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153713369|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713370|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713371|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
153713372|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713373|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153713374|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
153713375|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713376|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153713377|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153713378|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713379|NCT00332059|Timolol|timolol|mesh-list
153713380|NCT00332059|Bimatoprost|bimatoprost|mesh-list
153713381|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153713382|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153713383|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
153713384|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713385|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713386|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713387|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153713388|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153713389|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153713390|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153713391|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153713392|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
153713393|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713394|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713425|NCT05831761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153713463|NCT05831345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713465|NCT05831345|Sensory System Agents|sensory system agents|mesh-ancestor
153713466|NCT05831345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713467|NCT05831345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153713468|NCT05831345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153713469|NCT05831345|Anesthetics, General|anesthetics, general|mesh-ancestor
153713470|NCT05831345|Anesthetics|anesthetics|mesh-ancestor
153819697|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819698|NCT00469599|Vitamins|vitamins|mesh-ancestor
153819699|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
153819700|NCT00429377|Tacrolimus|tacrolimus|mesh-list
153819701|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819702|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
153819703|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819704|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153819705|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819706|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819707|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153819708|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
153819709|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
153713471|NCT05831345|Antitussive Agents|antitussive agents|mesh-ancestor
153713472|NCT05831345|Respiratory System Agents|respiratory system agents|mesh-ancestor
153713473|NCT05831267|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153713474|NCT05831267|Hemostatics|hemostatics|mesh-ancestor
153713475|NCT05831267|Coagulants|coagulants|mesh-ancestor
153713476|NCT05830916|Antibodies|antibodies|mesh-list
153713477|NCT05830916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
153713478|NCT05830916|Immunologic Factors|immunologic factors|mesh-ancestor
153713479|NCT05830916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713480|NCT05830747|Prednisone|prednisone|mesh-list
153713481|NCT05830747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713482|NCT05830747|Glucocorticoids|glucocorticoids|mesh-ancestor
153713483|NCT05830747|Hormones|hormones|mesh-ancestor
153713484|NCT05830747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713485|NCT05830747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713486|NCT05830747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153713487|NCT05830747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713488|NCT05830604|Salicylic Acid|salicylic acid|mesh-list
153713526|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713527|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153713528|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153713529|NCT05665270|Protective Agents|protective agents|mesh-ancestor
153713530|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153713531|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
153713533|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153713534|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153713535|NCT05660447|Protective Agents|protective agents|mesh-ancestor
153713536|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713537|NCT05653973|Acetylcholine|acetylcholine|mesh-list
153713538|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
153713539|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153713540|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
153713541|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713542|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713543|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713544|NCT05546359|Dexamethasone|dexamethasone|mesh-list
153713545|NCT05546359|Amisulpride|amisulpride|mesh-list
153713546|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713547|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
153713548|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
153713549|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713550|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713551|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153713552|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
153713553|NCT05546359|Hormones|hormones|mesh-ancestor
153713554|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713555|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153713556|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814050|NCT00336791|Epirubicin|epirubicin|mesh-list
153819710|NCT00429533|Dapsone|dapsone|mesh-list
153461112|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461113|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153461114|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461116|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153461117|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461118|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153461119|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153461120|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461121|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
153461122|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461123|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
153814051|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153713557|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153713558|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153713559|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713577|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
153713578|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713579|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713580|NCT05303857|Semaglutide|semaglutide|mesh-list
153713581|NCT05303857|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153713582|NCT05303857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153713599|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713601|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713602|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153713603|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153713604|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153713605|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153379276|NCT01596842|Vitamins|vitamins|mesh-ancestor
153356544|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153713606|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713607|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153713608|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153713609|NCT05243940|Analgesics|analgesics|mesh-ancestor
153713610|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153713611|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153713612|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153713613|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
153713614|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713615|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153713640|NCT05141474|Fludarabine|fludarabine|mesh-list
153713641|NCT05141474|Interleukin-2|interleukin-2|mesh-list
153713642|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153713643|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
153713644|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713645|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153713646|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153713647|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
153713648|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713649|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713650|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153713651|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153713652|NCT05141474|Analgesics|analgesics|mesh-ancestor
153713653|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
153713654|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713655|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153713656|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153713657|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
153713658|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713659|NCT05126719|Docetaxel|docetaxel|mesh-list
153713660|NCT05126719|Capecitabine|capecitabine|mesh-list
153814052|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713661|NCT05126719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713662|NCT05126719|Tubulin Modulators|tubulin modulators|mesh-ancestor
153713663|NCT05126719|Antimitotic Agents|antimitotic agents|mesh-ancestor
153713697|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713699|NCT04800393|Sevoflurane|sevoflurane|mesh-list
153713700|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153713701|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713702|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713703|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153713704|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
153713705|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
153713706|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153713707|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153713708|NCT04521868|Sulforaphane|sulforaphane|mesh-list
153713709|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153713710|NCT04521868|Protective Agents|protective agents|mesh-ancestor
153713711|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713712|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713713|NCT04419493|Heparin|heparin|mesh-list
153713739|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713741|NCT04334876|Antibodies|antibodies|mesh-list
153713742|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
153713743|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
153713763|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153713764|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713765|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713766|NCT04088604|Fluorouracil|fluorouracil|mesh-list
153713767|NCT04088604|Irinotecan|irinotecan|mesh-list
153713768|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
153713769|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713770|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153713771|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819711|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819712|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
153819713|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153819714|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153819715|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153819716|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819717|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819718|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
153819719|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153819720|NCT00461136|Aliskiren|aliskiren|mesh-list
153819721|NCT00461136|Renin Inhibitors|renin inhibitors|mesh-ancestor
153819722|NCT00461136|Protease Inhibitors|protease inhibitors|mesh-ancestor
153819723|NCT00461136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461125|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153461126|NCT01679106|Narcotics|narcotics|mesh-ancestor
153461127|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461133|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153713772|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153713773|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
153713774|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713775|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153713776|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153713777|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713778|NCT04006288|Aspirin|aspirin|mesh-list
153713779|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
153713780|NCT04006288|Clopidogrel|clopidogrel|mesh-list
153357842|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153713781|NCT04006288|Ticagrelor|ticagrelor|mesh-list
153713793|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713794|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153713795|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153713796|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713830|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153713831|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153713833|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713834|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153713835|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153713836|NCT03643822|Dexamethasone|dexamethasone|mesh-list
153713837|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
153713838|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
153713839|NCT03643822|BB 1101|bb 1101|mesh-list
153713840|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713841|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
153713863|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713865|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713866|NCT03575000|Bromocriptine|bromocriptine|mesh-list
153713867|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153713868|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153713922|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713923|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
153713924|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
153713925|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713926|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
153713927|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713928|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713929|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
153713930|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153713931|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153713932|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153713933|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153713934|NCT03002103|Paclitaxel|paclitaxel|mesh-list
153713935|NCT03002103|Gemcitabine|gemcitabine|mesh-list
153461135|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
153461136|NCT04403100|Ritonavir|ritonavir|mesh-list
153461137|NCT04403100|Lopinavir|lopinavir|mesh-list
153461138|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
153461139|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153461140|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153461141|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
153713936|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153713937|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713938|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
153713939|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
153713940|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
153713963|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153714002|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714003|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153714004|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153714005|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153714006|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714007|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714014|NCT02187224|Progesterone|progesterone|mesh-list
153714015|NCT02187224|Progestins|progestins|mesh-ancestor
153714016|NCT02187224|Hormones|hormones|mesh-ancestor
153551045|NCT01375829|Epothilones|epothilones|mesh-list
153714017|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714018|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714019|NCT02099825|Cycloserine|cycloserine|mesh-list
153714020|NCT02099825|Mifepristone|mifepristone|mesh-list
153714021|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153714022|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
153714023|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153714024|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714025|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153714026|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153714027|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153714028|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
153714029|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153714030|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153714031|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
153714032|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714033|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
153714034|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153714054|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714055|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154257252|NCT01172912|Etoposide|etoposide|mesh-list
153714070|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714071|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153714072|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714073|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
153714074|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153714075|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153714076|NCT01946477|Growth Substances|growth substances|mesh-ancestor
153714077|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
153714078|NCT05953168|Trastuzumab|trastuzumab|mesh-list
153714079|NCT05953168|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153714080|NCT05953168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714081|NCT05953168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714082|NCT05953168|Immunoconjugates|immunoconjugates|mesh-ancestor
153714083|NCT05953168|Immunologic Factors|immunologic factors|mesh-ancestor
153856372|NCT02153502|Sensory System Agents|sensory system agents|mesh-ancestor
153714113|NCT05952128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714115|NCT05952050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153714116|NCT05952050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714117|NCT05952050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714127|NCT05952050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714128|NCT05951842|Anesthetics|anesthetics|mesh-list
153714129|NCT05951842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402013|NCT05900882|Hormones|hormones|mesh-ancestor
153819724|NCT00461136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819725|NCT04704245|Petrolatum|petrolatum|mesh-list
153714130|NCT05951842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714131|NCT05951816|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
153714132|NCT05951816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153714133|NCT05951816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714137|NCT05951686|Remifentanil|remifentanil|mesh-list
153714138|NCT05951686|Propofol|propofol|mesh-list
153714139|NCT05951686|Desflurane|desflurane|mesh-list
153714140|NCT05951686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153714173|NCT05951361|Glucocorticoids|glucocorticoids|mesh-ancestor
153714174|NCT05951361|Hormones|hormones|mesh-ancestor
153714175|NCT05951361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714176|NCT05951361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714177|NCT05951361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153714178|NCT05951361|Immunologic Factors|immunologic factors|mesh-ancestor
153714179|NCT05951361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714180|NCT05951361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714181|NCT05951361|Anesthetics, Local|anesthetics, local|mesh-ancestor
153714182|NCT05951361|Anesthetics|anesthetics|mesh-ancestor
153714183|NCT05951361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714184|NCT05951361|Sensory System Agents|sensory system agents|mesh-ancestor
153396629|NCT02641691|Leucovorin|leucovorin|mesh-list
153714222|NCT05901974|Venetoclax|venetoclax|mesh-list
153714223|NCT05901974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714224|NCT05871333|Losartan|losartan|mesh-list
153714225|NCT05871333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153714226|NCT05871333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153714227|NCT05871333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153714228|NCT05871333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153714229|NCT05871333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714230|NCT05846750|Lenalidomide|lenalidomide|mesh-list
153714231|NCT05846750|Obinutuzumab|obinutuzumab|mesh-list
153714232|NCT05846750|Immunologic Factors|immunologic factors|mesh-ancestor
153714233|NCT05846750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714234|NCT05846750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153714235|NCT05846750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153714236|NCT05846750|Growth Substances|growth substances|mesh-ancestor
153714237|NCT05846750|Growth Inhibitors|growth inhibitors|mesh-ancestor
153714238|NCT05846750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714239|NCT05846750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714240|NCT05811390|Erythritol|erythritol|mesh-list
153819726|NCT04704245|Mitogens|mitogens|mesh-list
153819727|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
153819728|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819729|NCT04704245|Emollients|emollients|mesh-ancestor
153819730|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
153819731|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153819732|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153819733|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
153714269|NCT05742399|Immunologic Factors|immunologic factors|mesh-ancestor
153714270|NCT05742399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714271|NCT05742399|Viscosupplements|viscosupplements|mesh-ancestor
153714272|NCT05742399|Protective Agents|protective agents|mesh-ancestor
153714273|NCT05734560|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
153714274|NCT05734560|Immunoconjugates|immunoconjugates|mesh-ancestor
153714275|NCT05734560|Immunologic Factors|immunologic factors|mesh-ancestor
153714276|NCT05734560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714277|NCT05726110|Cytarabine|cytarabine|mesh-list
153714278|NCT05726110|Daunorubicin|daunorubicin|mesh-list
153714279|NCT05726110|Homoharringtonine|homoharringtonine|mesh-list
153714280|NCT05726110|Aclacinomycins|aclacinomycins|mesh-list
153714281|NCT05726110|Lenograstim|lenograstim|mesh-list
153714282|NCT05726110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153714283|NCT05726110|Antimetabolites|antimetabolites|mesh-ancestor
153714284|NCT05726110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714285|NCT05726110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714286|NCT05726110|Antiviral Agents|antiviral agents|mesh-ancestor
153714287|NCT05726110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714288|NCT05726110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153714289|NCT05726110|Immunologic Factors|immunologic factors|mesh-ancestor
153714290|NCT05726110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714291|NCT05726110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153714292|NCT05726110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153714293|NCT05726110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153714294|NCT05726110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714295|NCT05726110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153714296|NCT05726110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153714297|NCT05726110|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153714298|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
153714299|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714300|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781762|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714301|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153714302|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714303|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714304|NCT05635370|Cilostazol|cilostazol|mesh-list
153714305|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
153714306|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153714307|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714308|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714309|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153714310|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153714311|NCT05635370|Protective Agents|protective agents|mesh-ancestor
153714312|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714313|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
153714331|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714332|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714333|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153714334|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
153714358|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153714359|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153714360|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
153714361|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714362|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714363|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153714364|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
153714365|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
153714366|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153714367|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153714368|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
153714369|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714370|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153714398|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714399|NCT05170893|Vitamins|vitamins|mesh-ancestor
153714400|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153714401|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153714402|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153714403|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153714404|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714405|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714406|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153714407|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153714408|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714455|NCT05059600|Brexanolone|brexanolone|mesh-list
153714456|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
153856479|NCT02916602|Losartan|losartan|mesh-list
153714461|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714463|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
153551494|NCT01572012|Ondansetron|ondansetron|mesh-list
153714464|NCT05049902|Amoxicillin|amoxicillin|mesh-list
153714465|NCT05049902|Metronidazole|metronidazole|mesh-list
153714466|NCT05049902|Clarithromycin|clarithromycin|mesh-list
153714467|NCT05049902|Tetracycline|tetracycline|mesh-list
153714468|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
153714469|NCT05049902|Bismuth|bismuth|mesh-list
153387291|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153387292|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714470|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714471|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714472|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714473|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153714474|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153714475|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153714476|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714477|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153714478|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153714479|NCT05049902|Antacids|antacids|mesh-ancestor
153714480|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153714481|NCT05049902|Diuretics|diuretics|mesh-ancestor
153714498|NCT04957485|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153714500|NCT04957485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714502|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714503|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714504|NCT04793906|Iron|iron|mesh-list
153714505|NCT04793906|Trace Elements|trace elements|mesh-ancestor
153814062|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
153714506|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
153714507|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714508|NCT04716413|Dsuvia|dsuvia|mesh-list
153714509|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153714510|NCT04716413|Narcotics|narcotics|mesh-ancestor
153714511|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714512|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714513|NCT04716413|Analgesics|analgesics|mesh-ancestor
153714514|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
153856495|NCT02916251|Glucagon|glucagon|mesh-list
153714527|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
153714529|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714530|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153714531|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714532|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
153714533|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153714534|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153714535|NCT04635189|Growth Substances|growth substances|mesh-ancestor
153714536|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
153714537|NCT04608448|Sirolimus|sirolimus|mesh-list
153714538|NCT04608448|Petrolatum|petrolatum|mesh-list
153714539|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714540|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714560|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
153714561|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714562|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153714563|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
153714564|NCT04500899|Phenylephrine|phenylephrine|mesh-list
153714565|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153714566|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
153714567|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
153714568|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736032|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153736034|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153429618|NCT01821859|Growth Substances|growth substances|mesh-ancestor
153714569|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714570|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
153714571|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153714572|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
153714573|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
153714574|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153714575|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153714576|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153814063|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153814064|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153819740|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
153819741|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819742|NCT00430001|Docetaxel|docetaxel|mesh-list
153819743|NCT00430001|Trastuzumab|trastuzumab|mesh-list
153714577|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
153714578|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714579|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714580|NCT04500899|Protective Agents|protective agents|mesh-ancestor
153714581|NCT04485039|Tecovirimat|tecovirimat|mesh-list
153714583|NCT04485039|Calcium acetate|calcium acetate|mesh-list
153714584|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
153714585|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
153714586|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714587|NCT04485039|Antiviral Agents|antiviral agents|mesh-ancestor
153470777|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153470780|NCT00605904|Acamprosate|acamprosate|mesh-list
153714588|NCT04485039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714589|NCT04428671|Cemiplimab|cemiplimab|mesh-list
153714590|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714591|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714592|NCT04413890|Dinoprostone|dinoprostone|mesh-list
153714593|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
153714594|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153856507|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
153714659|NCT04153487|Protective Agents|protective agents|mesh-ancestor
153714661|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153714662|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153714663|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153714664|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714665|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153714666|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714667|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
153714668|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
153714669|NCT04116437|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153461164|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429642|NCT00002738|Leucovorin|leucovorin|mesh-list
153714670|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153714671|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714675|NCT03895567|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153714676|NCT03895567|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153714677|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714678|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714680|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153714681|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153714682|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714683|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714684|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153714685|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
153714686|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
153714687|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714688|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714689|NCT03688178|Temozolomide|temozolomide|mesh-list
153714690|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153714691|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
153714692|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714693|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714694|NCT03671109|Piperaquine|piperaquine|mesh-list
153714695|NCT03671109|Artenimol|artenimol|mesh-list
153714696|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
153714697|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153714698|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153714699|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714700|NCT03532399|Bivalirudin|bivalirudin|mesh-list
153714701|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
153714702|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153714703|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
153714704|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714705|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714706|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
153714707|NCT03464942|Atezolizumab|atezolizumab|mesh-list
153714708|NCT03464942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153714709|NCT03464942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714710|NCT03464942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714711|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461165|NCT03081858|Paclitaxel|paclitaxel|mesh-list
153461166|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153714712|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
153714713|NCT03431831|Naltrexone|naltrexone|mesh-list
153714714|NCT03431831|Bupropion|bupropion|mesh-list
153714715|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153714716|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153714717|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153714718|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856551|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
153856552|NCT01699464|Timolol|timolol|mesh-list
153856553|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153714770|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714771|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714772|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
153714773|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
153839428|NCT02942888|Niacin|niacin|mesh-list
153471954|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714801|NCT02953834|Insulin|insulin|mesh-list
153714819|NCT02633397|Riociguat|riociguat|mesh-list
153714820|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
153856578|NCT01669980|Ceftaroline|ceftaroline|mesh-list
153396821|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714835|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153714837|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714838|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714839|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153714840|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
153714841|NCT02592707|Hormones|hormones|mesh-ancestor
153714842|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714843|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153714844|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714845|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551865|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153714846|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
153714847|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
153781763|NCT04559308|Metformin|metformin|mesh-list
153819754|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819755|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714848|NCT02592707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153714849|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153714850|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
153714851|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714852|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
153714853|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
153714854|NCT02326805|Metronidazole|metronidazole|mesh-list
153714855|NCT02326805|Vaccines|vaccines|mesh-list
153714856|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
153714857|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714872|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714873|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714874|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153714875|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153714876|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
153714877|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856586|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714909|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
153714961|NCT00087854|Amonafide|amonafide|mesh-list
153714983|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153714984|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714985|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714986|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153714987|NCT00088049|Olanzapine|olanzapine|mesh-list
153714988|NCT00088049|Aripiprazole|aripiprazole|mesh-list
153714989|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
153714990|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
153714991|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714992|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714993|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153714994|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153714995|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153714996|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714997|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153714998|NCT00088049|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153714999|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153819756|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819757|NCT00430118|Cytarabine|cytarabine|mesh-list
153819758|NCT00430118|Dexamethasone|dexamethasone|mesh-list
153819759|NCT00430118|Prednisone|prednisone|mesh-list
153819760|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
153819761|NCT00430118|Ifosfamide|ifosfamide|mesh-list
153819762|NCT00430118|Doxorubicin|doxorubicin|mesh-list
153819763|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153819764|NCT00430118|Methotrexate|methotrexate|mesh-list
153819765|NCT00430118|Etoposide|etoposide|mesh-list
153819766|NCT00430118|Vincristine|vincristine|mesh-list
153819767|NCT00430118|Daunorubicin|daunorubicin|mesh-list
153461167|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461168|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
153461169|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
153461170|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
153715000|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153715001|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715002|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715003|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
153715004|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
153715048|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715049|NCT00333034|Etanercept|etanercept|mesh-list
153715050|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153715051|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153715052|NCT00333034|Analgesics|analgesics|mesh-ancestor
153715053|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
153715054|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715055|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715056|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715057|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715065|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257253|NCT01172912|Ifosfamide|ifosfamide|mesh-list
154257254|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472469|NCT04354662|Antidotes|antidotes|mesh-ancestor
153715066|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715067|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153715068|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153715069|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715070|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715071|NCT00088478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153715072|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153715073|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153715074|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715075|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715076|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
153715078|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153715079|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715080|NCT00333112|Tamsulosin|tamsulosin|mesh-list
153715106|NCT00088556|Carboplatin|carboplatin|mesh-list
153461171|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461172|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
153461173|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461175|NCT01679574|Letrozole|letrozole|mesh-list
153461176|NCT01679574|Clomiphene|clomiphene|mesh-list
153461177|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153461178|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461179|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461180|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153461181|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153461182|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461183|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461184|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153461185|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
153715107|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715108|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715109|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
153715110|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
153715111|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
153715112|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715113|NCT00127140|Vorinostat|vorinostat|mesh-list
153715114|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715115|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153715116|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715117|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715118|NCT00333307|Methocarbamol|methocarbamol|mesh-list
153715148|NCT00333385|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153715150|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153715151|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715152|NCT00127257|Diazepam|diazepam|mesh-list
153715153|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153715154|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
153715155|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
153715156|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
153715157|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715158|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715159|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715160|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153715161|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819768|NCT00430118|Asparaginase|asparaginase|mesh-list
153715162|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153814066|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153814067|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814068|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
153814069|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153819769|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
153819770|NCT00430118|Thioguanine|thioguanine|mesh-list
153819771|NCT00430118|Vindesine|vindesine|mesh-list
153715163|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153715164|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153715165|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153715166|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715167|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153715168|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
153715169|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
153715170|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
153715171|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
153715172|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715173|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715174|NCT00333424|Vaccines|vaccines|mesh-list
153715175|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
153715176|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715214|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153715215|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715216|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153715217|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153715218|NCT00334048|Ropinirole|ropinirole|mesh-list
153715219|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153715220|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153715221|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
153715222|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
153715223|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715224|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715225|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715226|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153715227|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153715228|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
153715229|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715230|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153715231|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153715232|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715233|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715234|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153715305|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819772|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819773|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
153819774|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819775|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819776|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153819777|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
153819778|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819779|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819780|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153819781|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153814077|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153814078|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814079|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153814080|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819782|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
153461197|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153461198|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
153461199|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715306|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715307|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153715308|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153715309|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715310|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
153715311|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715312|NCT00089258|Isotretinoin|isotretinoin|mesh-list
153715314|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153715315|NCT00089258|Sargramostim|sargramostim|mesh-list
153715316|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
153715317|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715318|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
153715319|NCT00127569|Rituximab|rituximab|mesh-list
153715320|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715321|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715322|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
153715323|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715324|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715325|NCT00334594|Pemetrexed|pemetrexed|mesh-list
153715326|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715327|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715328|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715329|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153715330|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153715331|NCT00334672|Cyclosporine|cyclosporine|mesh-list
153715332|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
153715340|NCT00334672|Methotrexate|methotrexate|mesh-list
153715341|NCT00334672|Etoposide|etoposide|mesh-list
153715342|NCT00334672|Cyclosporins|cyclosporins|mesh-list
153715343|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153819787|NCT00430118|Hormones|hormones|mesh-ancestor
153715344|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715345|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
153715346|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715347|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715348|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153715349|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
153715350|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715351|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715352|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153715353|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715354|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
153715355|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
153715356|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715357|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715358|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
153715359|NCT00334672|Hormones|hormones|mesh-ancestor
153715360|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715361|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153715362|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153715363|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
153715364|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153715376|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153715377|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153715378|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153715379|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
153715380|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153715382|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
153715383|NCT00089453|Melphalan|melphalan|mesh-list
153715384|NCT00089453|Fludarabine|fludarabine|mesh-list
153461207|NCT03089658|Avelumab|avelumab|mesh-list
153715385|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715386|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
153715387|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715388|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715389|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153715390|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
153715391|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715393|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153715394|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715395|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
153715396|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
153715397|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715398|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715399|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
153715400|NCT00089453|Hormones|hormones|mesh-ancestor
153715414|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
153715415|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153715416|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153715417|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715418|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715419|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715420|NCT00127686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153715422|NCT00127686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715423|NCT00127686|Analgesics|analgesics|mesh-ancestor
153715424|NCT00127686|Sensory System Agents|sensory system agents|mesh-ancestor
153715425|NCT00127686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715427|NCT00334789|Tretinoin|tretinoin|mesh-list
153715440|NCT00334867|Ifosfamide|ifosfamide|mesh-list
153715441|NCT00334867|Doxorubicin|doxorubicin|mesh-list
153715442|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153715443|NCT00334867|Etoposide|etoposide|mesh-list
153715444|NCT00334867|Vincristine|vincristine|mesh-list
153715445|NCT00334867|Topotecan|topotecan|mesh-list
153715446|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
153715447|NCT00334867|Razoxane|razoxane|mesh-list
153715448|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715449|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
153715450|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715451|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715452|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153715453|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
153715454|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461208|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461209|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461210|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
153461211|NCT03417492|Citric Acid|citric acid|mesh-list
153461212|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
153461213|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
153814088|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153715455|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715456|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153715457|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153856746|NCT02914145|Piperaquine|piperaquine|mesh-list
153715482|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715483|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
153715484|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715485|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715486|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
153715487|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
153715488|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715489|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
153715491|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153715492|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153715493|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
153715514|NCT00127764|Dexamethasone|dexamethasone|mesh-list
153715515|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715516|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
153715517|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
153715518|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397016|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715581|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715582|NCT00343369|Cytarabine|cytarabine|mesh-list
153715583|NCT00343369|Dexamethasone|dexamethasone|mesh-list
153715584|NCT00343369|Prednisolone|prednisolone|mesh-list
153715585|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
153715586|NCT00343369|Doxorubicin|doxorubicin|mesh-list
153715587|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153715588|NCT00343369|Methotrexate|methotrexate|mesh-list
153715589|NCT00343369|Vincristine|vincristine|mesh-list
153715590|NCT00343369|Daunorubicin|daunorubicin|mesh-list
153715591|NCT00343369|Asparaginase|asparaginase|mesh-list
153715592|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
153715593|NCT00343369|Pegaspargase|pegaspargase|mesh-list
153715594|NCT00343369|Thioguanine|thioguanine|mesh-list
153552623|NCT01579149|Plerixafor|plerixafor|mesh-list
153715595|NCT00343369|Teniposide|teniposide|mesh-list
153715596|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715597|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
153715598|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715599|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814089|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153626797|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153819800|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153819801|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153715600|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153715602|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715603|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715604|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153715605|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715606|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
153715607|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
153715608|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397050|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
153715647|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153715648|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715649|NCT00343486|Solabegron|solabegron|mesh-list
153715650|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153715651|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153715652|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153715653|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
153715654|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715655|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715656|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715657|NCT00089804|Abetimus|abetimus|mesh-list
153715658|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715659|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
153715660|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715661|NCT00343525|Bavituximab|bavituximab|mesh-list
153715662|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715663|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715664|NCT00127881|Zanolimumab|zanolimumab|mesh-list
153715665|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715666|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715667|NCT00343720|Bortezomib|bortezomib|mesh-list
153715668|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715682|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
153715683|NCT00343798|Cyclosporine|cyclosporine|mesh-list
153715684|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
153715685|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
153715686|NCT00343798|Fludarabine|fludarabine|mesh-list
153715687|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
153715706|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153715707|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
153715708|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153715709|NCT00343876|Aspirin|aspirin|mesh-list
153715710|NCT00343876|Clopidogrel|clopidogrel|mesh-list
153715711|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153715712|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153715713|NCT00343876|Analgesics|analgesics|mesh-ancestor
153715714|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
153715715|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429871|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
153715716|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715717|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153819802|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153819803|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
153819804|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819805|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
153819806|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
153819807|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
153819808|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
153819809|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153814106|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153819810|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153819811|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461214|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153715718|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715719|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153715720|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153715721|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715722|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153715723|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153715724|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715725|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
153715726|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153715727|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153715728|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153715729|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
153715730|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715731|NCT00402636|Sirolimus|sirolimus|mesh-list
153715748|NCT00344110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715749|NCT00344110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715750|NCT00344149|Rituximab|rituximab|mesh-list
153715751|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715752|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715753|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
153715754|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715755|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715756|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
153715757|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153715758|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715774|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153715775|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
153715776|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153715777|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153715778|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153715779|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153715780|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153715781|NCT00344422|Dexamethasone|dexamethasone|mesh-list
153715782|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
153715783|NCT00344422|Doxorubicin|doxorubicin|mesh-list
153715784|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153715785|NCT00344422|Vincristine|vincristine|mesh-list
153715786|NCT00344422|BB 1101|bb 1101|mesh-list
153715787|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715788|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
153715789|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
153715790|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715791|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715792|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715793|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
153715800|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461215|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
153461216|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
153461217|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461218|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
153461219|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153715802|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153715803|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153715804|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715805|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
153715806|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
153715807|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
153715808|NCT00090038|Rituximab|rituximab|mesh-list
153715809|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715810|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715811|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
153429886|NCT00002774|Cisplatin|cisplatin|mesh-list
153715812|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715813|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715814|NCT00402792|Acetaminophen|acetaminophen|mesh-list
153715815|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153715816|NCT00402792|Hydrocodone|hydrocodone|mesh-list
153715817|NCT00402792|Oxycodone|oxycodone|mesh-list
153715818|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153715819|NCT00402792|Analgesics|analgesics|mesh-ancestor
153715820|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
153715821|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715822|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715823|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
153397110|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715828|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
153715829|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153715830|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715831|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715833|NCT00127959|Emtricitabine|emtricitabine|mesh-list
153715834|NCT00127959|Zidovudine|zidovudine|mesh-list
153715835|NCT00127959|Efavirenz|efavirenz|mesh-list
153715836|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
153715837|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715838|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153715839|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153715840|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715841|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715842|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153715843|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153715844|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
153715845|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153715846|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153715847|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153715848|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153715849|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153715850|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153715851|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153715852|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153715853|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
153715854|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715855|NCT00344539|Antacids|antacids|mesh-ancestor
153715856|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715857|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715893|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153715894|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
153715895|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153715896|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153715897|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715898|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736036|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153781767|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715900|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715901|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715902|NCT00344695|Bupropion|bupropion|mesh-list
153715903|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153715904|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
153715905|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715906|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153715907|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153715908|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153715909|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715910|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
153715911|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715912|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715924|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715925|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715926|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
153715927|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
153715928|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
153715929|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153715930|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715931|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715932|NCT00344812|Buprenorphine|buprenorphine|mesh-list
153715933|NCT00344812|Methadone|methadone|mesh-list
153715934|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153715935|NCT00344812|Narcotics|narcotics|mesh-ancestor
153715959|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715960|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
153715961|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
153715962|NCT00090155|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153715963|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153715964|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
153715965|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715966|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715967|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153715968|NCT00335413|Spironolactone|spironolactone|mesh-list
153715969|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153715970|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
153814120|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814121|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819824|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715971|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715972|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715973|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153715974|NCT00335413|Diuretics|diuretics|mesh-ancestor
153715975|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
153715976|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
153716008|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153716009|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716010|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716095|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716096|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716097|NCT00346099|Capecitabine|capecitabine|mesh-list
153716098|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
153716124|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153716147|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153716148|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716150|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
153716151|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
153716152|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716153|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
153716154|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716155|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
153429967|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153716156|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716157|NCT00346567|Tenofovir|tenofovir|mesh-list
153716158|NCT00346567|Lamivudine|lamivudine|mesh-list
153473485|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153473486|NCT02987556|Insulin|insulin|mesh-list
153716159|NCT00346567|Emtricitabine|emtricitabine|mesh-list
153716160|NCT00346567|Zidovudine|zidovudine|mesh-list
153716161|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153716162|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153716163|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
153716164|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819825|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819826|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
153716165|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153716166|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153716167|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716195|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716196|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153716197|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153716198|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153716199|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153716200|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716201|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716202|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716203|NCT00125892|Analgesics|analgesics|mesh-ancestor
153716204|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
153716205|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716206|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
153716207|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716208|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
153716210|NCT00346801|Cisplatin|cisplatin|mesh-list
153716211|NCT00346801|Irinotecan|irinotecan|mesh-list
153716212|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716282|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153716283|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716284|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
153716285|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716286|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
153716287|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716288|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716289|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153716290|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153716291|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153716292|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153716293|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153716294|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153461230|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153461231|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461232|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
153461233|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153461234|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461235|NCT03088254|Amlodipine|amlodipine|mesh-list
153403044|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153716295|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
153716296|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716297|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716298|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716310|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716312|NCT00347152|Valproic Acid|valproic acid|mesh-list
153716313|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
153716314|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716341|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153716342|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
153716343|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553363|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
153716344|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716345|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153716346|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
153716347|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716348|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716349|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
153716350|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716351|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153716352|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716353|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
153716354|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716355|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153716356|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
153716357|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716358|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153716359|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
153716360|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153716361|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153716362|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856990|NCT01999764|Protective Agents|protective agents|mesh-ancestor
153716403|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153781768|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820709|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153819836|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819837|NCT00430235|Sorafenib|sorafenib|mesh-list
153819838|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819839|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153819840|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819841|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819842|NCT00470340|Gemcitabine|gemcitabine|mesh-list
153819843|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
153819844|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
153819845|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819846|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153819847|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
153814138|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153814139|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153814140|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716404|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
153716405|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716406|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153716407|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153716408|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716409|NCT00126087|Dopamine|dopamine|mesh-list
153716410|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153716411|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
153716412|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
153716413|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716414|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716415|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
153716416|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716417|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716418|NCT00126087|Protective Agents|protective agents|mesh-ancestor
153716419|NCT00347503|Ketorolac|ketorolac|mesh-list
153716420|NCT00347503|Bromfenac|bromfenac|mesh-list
153716421|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153716423|NCT00347503|Analgesics|analgesics|mesh-ancestor
153716424|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
153716447|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716448|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716449|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
153716450|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153716457|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153716458|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153716459|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
153716460|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716461|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716462|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716463|NCT00126204|Doxycycline|doxycycline|mesh-list
153716464|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716465|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716466|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
153716467|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153716468|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153716470|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153716471|NCT04705402|Diuretics|diuretics|mesh-ancestor
153716472|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
153716473|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716474|NCT00091130|Vaccines|vaccines|mesh-list
153716475|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
153716476|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716497|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153716498|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153716499|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716500|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153461250|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716501|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461251|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153716502|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
153716503|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153716504|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153716506|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
153716507|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153716508|NCT04705519|Paclitaxel|paclitaxel|mesh-list
153716509|NCT04705519|Bevacizumab|bevacizumab|mesh-list
153716510|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153716511|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716512|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
153716513|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
153716514|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
153716554|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716555|NCT00091247|Tetracycline|tetracycline|mesh-list
153716556|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716557|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716558|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153716559|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716560|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716561|NCT00126360|Anastrozole|anastrozole|mesh-list
153716562|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153716563|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716564|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153473877|NCT00577590|Metformin|metformin|mesh-list
153473878|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
153473881|NCT00578214|Midazolam|midazolam|mesh-list
153716565|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153716566|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716567|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716568|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153716569|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
153716570|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153716571|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716572|NCT01058863|Albuterol|albuterol|mesh-list
153716573|NCT01058863|Procaterol|procaterol|mesh-list
153716574|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153716575|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
153716576|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716577|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716578|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153461252|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153461253|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
153461254|NCT05684484|Salicylates|salicylates|mesh-list
153461255|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781769|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
153716579|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
153716580|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
153716581|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153716587|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716608|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153716609|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716610|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153716611|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
153716612|NCT00126516|Giapreza|giapreza|mesh-list
153716613|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153716614|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
153716615|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153716616|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153716617|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716618|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153716619|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153716620|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
153716621|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153716622|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
153716623|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716624|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153716625|NCT01058005|Interferons|interferons|mesh-list
153716626|NCT01058005|Interferon-beta|interferon-beta|mesh-list
153716627|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
153716628|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
153716629|NCT01058005|Natalizumab|natalizumab|mesh-list
153716630|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
153716631|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716632|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
153716633|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716634|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
153716635|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716636|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153716637|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716638|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716639|NCT00091559|Vorinostat|vorinostat|mesh-list
153716640|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716641|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153716642|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403289|NCT04023019|Thrombin|thrombin|mesh-list
153819848|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814163|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732022|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153819849|NCT00430469|Lactoferrin|lactoferrin|mesh-list
153819850|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819851|NCT00461643|Metformin|metformin|mesh-list
153819852|NCT00461643|Citric Acid|citric acid|mesh-list
153819853|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
153716643|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716644|NCT00426829|Bevacizumab|bevacizumab|mesh-list
153716645|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153553669|NCT01594177|Paclitaxel|paclitaxel|mesh-list
153716672|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716673|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153716687|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153716688|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716690|NCT00427492|Antacids|antacids|mesh-ancestor
153716691|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716703|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716704|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153716705|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
153716706|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
153716707|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
153716708|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153716709|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153474083|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474085|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
153716710|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
153716711|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153716712|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716713|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716714|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
153716731|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153716732|NCT04704622|Analgesics|analgesics|mesh-ancestor
153716733|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
153716734|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716735|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153716736|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153716737|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153716738|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
153716739|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716740|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716741|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153716742|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153716743|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
153716744|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
153819854|NCT00461643|Clomiphene|clomiphene|mesh-list
153819855|NCT00461643|Enclomiphene|enclomiphene|mesh-list
153819856|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
153819857|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153819858|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819859|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
153819860|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153819861|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
153716745|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153716746|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153716747|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153716748|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153716749|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153716750|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716751|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
153716752|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
153716753|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153716754|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716761|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716762|NCT03769467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153716763|NCT03769467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716764|NCT00092183|Ondansetron|ondansetron|mesh-list
153716765|NCT00092183|Aprepitant|aprepitant|mesh-list
153716766|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
153716767|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
153716768|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736040|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
153716769|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716770|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716771|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
153716772|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
153716773|NCT00092183|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153716774|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153716775|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
153716776|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716779|NCT00428272|Interferons|interferons|mesh-list
153716780|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
153716781|NCT00428272|Lexatumumab|lexatumumab|mesh-list
153716782|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153716783|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716784|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
153716785|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716786|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
153716787|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716788|NCT01580254|Latanoprost|latanoprost|mesh-list
153716789|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153716790|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153716792|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
153716793|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153716794|NCT00428311|Estradiol|estradiol|mesh-list
153716795|NCT00428311|Cyproterone|cyproterone|mesh-list
153716796|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153814174|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814175|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814176|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
153814177|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814178|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153814179|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153814180|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153716797|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716798|NCT00428311|Estrogens|estrogens|mesh-ancestor
153716799|NCT00428311|Hormones|hormones|mesh-ancestor
153716800|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153716801|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153716802|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
153716803|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153716804|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153716805|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153716806|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153716807|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
153716808|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
153716809|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716810|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153716811|NCT00092300|Valdecoxib|valdecoxib|mesh-list
153716812|NCT00092300|Rofecoxib|rofecoxib|mesh-list
153716813|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153716814|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153716815|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716816|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716850|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153716851|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716852|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716853|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153716854|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153716855|NCT00092339|Analgesics|analgesics|mesh-ancestor
153716856|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
153716857|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716858|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716859|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153716860|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716861|NCT00428545|Bevacizumab|bevacizumab|mesh-list
153716862|NCT00428545|Bortezomib|bortezomib|mesh-list
153716863|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716864|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716865|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153716866|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153716867|NCT00428545|Growth Substances|growth substances|mesh-ancestor
153716868|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716869|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
153716870|NCT00092378|Diclofenac|diclofenac|mesh-list
153716871|NCT00092378|Rofecoxib|rofecoxib|mesh-list
153814181|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814182|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814207|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153814208|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
153814209|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
153814210|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153814211|NCT00337883|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153814212|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153814213|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716872|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153716907|NCT00093158|Bivalirudin|bivalirudin|mesh-list
153716908|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
153716909|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153716910|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
153716911|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716933|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
153716934|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716935|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716936|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153716937|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153716938|NCT05561049|Growth Substances|growth substances|mesh-ancestor
153716939|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
153716942|NCT05561010|Bupivacaine|bupivacaine|mesh-list
153716943|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
153716944|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
153716945|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716946|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716947|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
153716948|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716950|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
153716951|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
153716952|NCT03448107|Protective Agents|protective agents|mesh-ancestor
153716953|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716954|NCT00093314|Ofatumumab|ofatumumab|mesh-list
153716955|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716956|NCT00093353|Cefixime|cefixime|mesh-list
153716957|NCT00093353|Irinotecan|irinotecan|mesh-list
153716958|NCT00093353|Temozolomide|temozolomide|mesh-list
153716959|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153716960|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153716961|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716962|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716963|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716964|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153716965|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
153716966|NCT00093353|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153716967|NCT00093353|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153716990|NCT00093548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153716991|NCT05549895|Dexamethasone|dexamethasone|mesh-list
153716992|NCT05549895|Bupivacaine|bupivacaine|mesh-list
153716993|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153716994|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
153716995|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
153461281|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461282|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461283|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153461284|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
153461285|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814214|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814215|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819878|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153819879|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
153716996|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257255|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257256|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
154257257|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
153716997|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716998|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716999|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
153717000|NCT05549895|Hormones|hormones|mesh-ancestor
153717001|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717002|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153717003|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717004|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
153717005|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
153717006|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153717007|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
153717008|NCT00093587|Cyclosporine|cyclosporine|mesh-list
153717009|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
153717010|NCT00093587|Busulfan|busulfan|mesh-list
153717011|NCT00093587|Cyclosporins|cyclosporins|mesh-list
153717012|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153717013|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717014|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
153717015|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717016|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717017|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153717018|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
153717019|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717020|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717021|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153717041|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153717042|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153717043|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717044|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
153717045|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
153717046|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717047|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153857121|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153717073|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
153717074|NCT01055314|Temozolomide|temozolomide|mesh-list
153819880|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153819881|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153819882|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819883|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819884|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153819885|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153819886|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819887|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
153819889|NCT01053962|Plecanatide|plecanatide|mesh-list
153717075|NCT01055314|Ifosfamide|ifosfamide|mesh-list
153717076|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
153717077|NCT01055314|Doxorubicin|doxorubicin|mesh-list
153717078|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153717079|NCT01055314|Irinotecan|irinotecan|mesh-list
153717080|NCT01055314|Etoposide|etoposide|mesh-list
153717096|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153717097|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153717098|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717099|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153717100|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153717101|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
153857142|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153717109|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153717110|NCT00093743|Cyclosporine|cyclosporine|mesh-list
153717111|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
153717112|NCT00093743|Fludarabine|fludarabine|mesh-list
153717113|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
153717114|NCT00093743|Cyclosporins|cyclosporins|mesh-list
153717115|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717116|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717117|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
153717118|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717119|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717120|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
153717121|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717122|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717123|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
153717124|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717125|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
153717126|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717127|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153717128|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153717129|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153717130|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
153430143|NCT05296759|Gabapentin|gabapentin|mesh-list
154257258|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732011|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717131|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153717132|NCT00400322|Valganciclovir|valganciclovir|mesh-list
153717133|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
153717134|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717135|NCT00093860|Propranolol|propranolol|mesh-list
153717136|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153717137|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153717138|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
153717139|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717140|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717164|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717165|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717166|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
153461297|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153461298|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153461299|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153461300|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461301|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461302|NCT05688306|Oprelvekin|oprelvekin|mesh-list
153461303|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461304|NCT03086148|Ketamine|ketamine|mesh-list
153461305|NCT03086148|Analgesics|analgesics|mesh-ancestor
153461306|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
153819900|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153717167|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717168|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153717169|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153717170|NCT00094406|Dimercaprol|dimercaprol|mesh-list
153717171|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
153717220|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717221|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717222|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717223|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153717224|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153717225|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153717226|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153717227|NCT00094640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153717228|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153717229|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153717230|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717273|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717275|NCT00095225|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153717276|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717277|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717278|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717279|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
153717280|NCT00095264|Hematinics|hematinics|mesh-ancestor
153717282|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
153717283|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717284|NCT00403611|Praziquantel|praziquantel|mesh-list
153717285|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
153717286|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153717287|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717288|NCT00428896|Gefitinib|gefitinib|mesh-list
153717289|NCT00428896|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153717290|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717291|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717292|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717293|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717294|NCT01990911|Diuretics|diuretics|mesh-list
153717295|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
153717296|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717297|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153717298|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153717299|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153717300|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153717333|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717334|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153717335|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
153819901|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819902|NCT00470379|Resiquimod|resiquimod|mesh-list
153819903|NCT00470379|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153819904|NCT00470379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819905|NCT00470379|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153814222|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814223|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
153814224|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814225|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717336|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717337|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717338|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153717339|NCT00095693|Sorafenib|sorafenib|mesh-list
153717340|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153717341|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717342|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717343|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717344|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717345|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153717346|NCT01054573|Interferons|interferons|mesh-list
153474716|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
153474718|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
153717347|NCT01054573|Ribavirin|ribavirin|mesh-list
153430171|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717348|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717349|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
153717350|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717351|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
153717352|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717353|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
153717354|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717355|NCT00429442|Simvastatin|simvastatin|mesh-list
153717356|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153717357|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153717358|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
153814226|NCT00337922|Lamivudine|lamivudine|mesh-list
153814227|NCT00337922|Abacavir|abacavir|mesh-list
153814228|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153814229|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153461307|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461308|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461309|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153461310|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153461311|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
153461312|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
153461313|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814234|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153814235|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153819910|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153819911|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819912|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819913|NCT00430742|Hormones|hormones|mesh-ancestor
153397464|NCT02661971|Antidotes|antidotes|mesh-ancestor
153717400|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717401|NCT00095888|Gemcitabine|gemcitabine|mesh-list
153717402|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717403|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
153717404|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717405|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717406|NCT00429676|Haloperidol|haloperidol|mesh-list
153717407|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
153717408|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
153717409|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
153717410|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717411|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717412|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717413|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153717414|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153717415|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153717416|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153717417|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153717418|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
153717419|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717420|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717436|NCT00095927|Protective Agents|protective agents|mesh-ancestor
153717437|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717438|NCT00429754|Aprepitant|aprepitant|mesh-list
153717439|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
153717440|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
153717441|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717442|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857245|NCT06225440|Hormones|hormones|mesh-ancestor
153717444|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153717445|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819914|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819915|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781772|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819918|NCT00470457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819919|NCT03271164|Vitamin E|vitamin e|mesh-list
153819920|NCT03271164|Vitamins|vitamins|mesh-ancestor
153819921|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
153461325|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
153461326|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461327|NCT05345808|Triamcinolone|triamcinolone|mesh-list
153461328|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153461329|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153461330|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153814253|NCT00338000|Hematinics|hematinics|mesh-ancestor
153814254|NCT00338117|Galantamine|galantamine|mesh-list
153461331|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153717446|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717447|NCT00429832|Promethazine|promethazine|mesh-list
153717448|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
153717449|NCT00429832|Ondansetron|ondansetron|mesh-list
153717450|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
153717451|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
153717452|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717453|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717454|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717455|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
153717456|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
153717457|NCT00429832|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153717458|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153717459|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
153717460|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717461|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717462|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153717463|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
153717464|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
153717465|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153717466|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153717467|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153717468|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153717469|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
153717470|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
153717471|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
153717473|NCT00429871|Capecitabine|capecitabine|mesh-list
153717474|NCT00429871|Epirubicin|epirubicin|mesh-list
153717475|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717476|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
153717477|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
153554493|NCT01597934|Tenofovir|tenofovir|mesh-list
153717478|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
153717479|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717480|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717481|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
153717497|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
153717498|NCT01803594|Vitamins|vitamins|mesh-ancestor
153717499|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
153717500|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717501|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153717502|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
153717503|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717504|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153717505|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
153717506|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
153717507|NCT00430066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153717508|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717509|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717510|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717511|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717537|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717539|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717540|NCT00096083|Melphalan|melphalan|mesh-list
153461332|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
153461333|NCT05345808|Hormones|hormones|mesh-ancestor
153814265|NCT00338195|Caffeine|caffeine|mesh-list
153461349|NCT03085368|Lapatinib|lapatinib|mesh-list
153717541|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153717542|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
153430209|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717561|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
153717562|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717563|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717564|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
153717565|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717566|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
153717567|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717568|NCT01726452|Antidotes|antidotes|mesh-ancestor
153717569|NCT01726452|Protective Agents|protective agents|mesh-ancestor
153717570|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
153717571|NCT01726452|Vitamins|vitamins|mesh-ancestor
153717572|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
153717573|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153717574|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153717587|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717588|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153717589|NCT00096395|Gemcitabine|gemcitabine|mesh-list
153717590|NCT00096395|Sorafenib|sorafenib|mesh-list
153717591|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717592|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
153717593|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717594|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717595|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717596|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717597|NCT00096473|Donepezil|donepezil|mesh-list
153717598|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153717599|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717600|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717621|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153717622|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153717623|NCT00130572|Analgesics|analgesics|mesh-ancestor
153717624|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
153814266|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153814267|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814268|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153717625|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717626|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717627|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153717628|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717629|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
153717630|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717631|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
153717632|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153717633|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717634|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717635|NCT00096629|Vaccines|vaccines|mesh-list
153717636|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
153717637|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717638|NCT00430651|Carboplatin|carboplatin|mesh-list
153717639|NCT00430651|Docetaxel|docetaxel|mesh-list
153717640|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717641|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
153717642|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
153717643|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
153717644|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717645|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
153397522|NCT04449965|Povidone|povidone|mesh-list
153717684|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717686|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717687|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153717688|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153717689|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717690|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717691|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153717692|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153717693|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717694|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
153717695|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814269|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814270|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819929|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814271|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153717696|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153717722|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153717747|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717749|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717750|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717751|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153717752|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
153717753|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153717754|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153717755|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153717756|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153717757|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717758|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
153717759|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717760|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153717761|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
153717762|NCT00431119|Azathioprine|azathioprine|mesh-list
153717763|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153717764|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717765|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153717766|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
153717767|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153717768|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717769|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717770|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717859|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717860|NCT00431392|Protective Agents|protective agents|mesh-ancestor
153717861|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153717862|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153717863|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153717864|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153717865|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
153717866|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153717867|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153717868|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
153717869|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153717870|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153717871|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153717872|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
153814272|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153814273|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
153814274|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814275|NCT00338273|Aripiprazole|aripiprazole|mesh-list
153814276|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
153626799|NCT02019056|Vitamins|vitamins|mesh-ancestor
153819930|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153819931|NCT00461916|Buserelin|buserelin|mesh-list
153819941|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
153461354|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717873|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717874|NCT00130884|Simendan|simendan|mesh-list
153717875|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153717876|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
153717877|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153717878|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153717879|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717880|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717881|NCT00130884|Protective Agents|protective agents|mesh-ancestor
153717882|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717883|NCT01052662|Memantine|memantine|mesh-list
153717884|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153717885|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153717886|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
153717887|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717888|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717889|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717890|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153717891|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153717892|NCT00097214|Carboplatin|carboplatin|mesh-list
153717894|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717895|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153717896|NCT00431665|Heparin|heparin|mesh-list
153717897|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153717898|NCT00431665|Somatostatin|somatostatin|mesh-list
153717899|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153717900|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717901|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
153717902|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153717903|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153717904|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717905|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153717906|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153397583|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153717996|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718019|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718020|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718021|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718022|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
153718023|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
153461355|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461356|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153461357|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153461358|NCT05687760|Calcium|calcium|mesh-list
153461359|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153461360|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461361|NCT03084978|Anesthetics|anesthetics|mesh-list
153461362|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461363|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461364|NCT03084588|Methadone|methadone|mesh-list
153387526|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153718024|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153718025|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718026|NCT02957656|Vaccines|vaccines|mesh-list
153718027|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
153718028|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718029|NCT00097799|Ritonavir|ritonavir|mesh-list
153718030|NCT00097799|Tipranavir|tipranavir|mesh-list
153718031|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153718032|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153718033|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718034|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718035|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718036|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153718037|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153718038|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
153718039|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718040|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153718041|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153718042|NCT01051921|Interferons|interferons|mesh-list
153718043|NCT01051921|Ribavirin|ribavirin|mesh-list
153718067|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153718068|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153718069|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718070|NCT00097877|Insulin|insulin|mesh-list
153718071|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153718072|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
153718073|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
153718074|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
153718075|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153718076|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718077|NCT00097916|Memantine|memantine|mesh-list
153718079|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153718080|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
153718081|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718082|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718083|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718084|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153718085|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153718086|NCT00433069|Pioglitazone|pioglitazone|mesh-list
153718087|NCT00433069|Interferons|interferons|mesh-list
153430334|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153718088|NCT00433069|Ribavirin|ribavirin|mesh-list
153718089|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
153718090|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
153718091|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718092|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
153403644|NCT03121677|Laxatives|laxatives|mesh-ancestor
153384053|NCT01877642|Loxapine|loxapine|mesh-list
153718093|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718094|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
153718095|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718096|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
153718097|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718098|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153718099|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153718100|NCT01580371|CKD-581|ckd-581|mesh-list
153718101|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718102|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718103|NCT00097955|Aliskiren|aliskiren|mesh-list
153718104|NCT00097955|Renin Inhibitors|renin inhibitors|mesh-ancestor
153718105|NCT00097955|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718106|NCT00097955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718107|NCT00097955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718108|NCT00403026|Bevacizumab|bevacizumab|mesh-list
153718109|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153718110|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718111|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153718185|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153718187|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
153718188|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
153718189|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718190|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153718191|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153718192|NCT00433225|Protective Agents|protective agents|mesh-ancestor
153718193|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153718194|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718195|NCT00433225|Analgesics|analgesics|mesh-ancestor
153718196|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
153718197|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718198|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153718199|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718200|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718201|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718202|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718203|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153718204|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153718205|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153718206|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153718207|NCT00433342|Floxacillin|floxacillin|mesh-list
153718208|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718209|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718248|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718249|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153718250|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153718251|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153718252|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718253|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718254|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153718280|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718281|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718282|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
153718283|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153718284|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718285|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718286|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153718287|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153718288|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153718289|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
153718290|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718292|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153718293|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
153718294|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718295|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718296|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
153718297|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718298|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718299|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
153718300|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718301|NCT01050790|Lenalidomide|lenalidomide|mesh-list
153718302|NCT01050790|Azacitidine|azacitidine|mesh-list
153718303|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
153718304|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718324|NCT00433927|Growth Substances|growth substances|mesh-ancestor
153718325|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718326|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
153718327|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153718328|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153819951|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153819952|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
153819953|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153819954|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819955|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819956|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819957|NCT00431054|Docetaxel|docetaxel|mesh-list
153819958|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819959|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
153819960|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
153819961|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
153819962|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819963|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
153819964|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
153819965|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153718349|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153718350|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718352|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718353|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
153718354|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718355|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718356|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718357|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718358|NCT00098462|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153718359|NCT00098501|Sirolimus|sirolimus|mesh-list
153718378|NCT00434005|Expectorants|expectorants|mesh-ancestor
153718379|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
153718380|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153718381|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
153718382|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718383|NCT00434005|Protective Agents|protective agents|mesh-ancestor
153718384|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718385|NCT00434005|Antidotes|antidotes|mesh-ancestor
153718386|NCT00434044|Etanercept|etanercept|mesh-list
153718387|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153718388|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718394|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718395|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153718396|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718397|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
153718398|NCT00434083|Naproxen|naproxen|mesh-list
153718399|NCT00434083|Sumatriptan|sumatriptan|mesh-list
153718400|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153718401|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718402|NCT00434083|Analgesics|analgesics|mesh-ancestor
153718403|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
153718404|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718405|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718406|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718407|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819966|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718408|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
153718409|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153718410|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718411|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718412|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153718413|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153718414|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153718415|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
153718416|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718417|NCT00098540|Sorafenib|sorafenib|mesh-list
153718428|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153718429|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718430|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718431|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
153718432|NCT00098579|Growth Substances|growth substances|mesh-ancestor
153718463|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718464|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718465|NCT00098969|Resveratrol|resveratrol|mesh-list
153718466|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
153718467|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718468|NCT00098969|Protective Agents|protective agents|mesh-ancestor
153718469|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718470|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718471|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153718472|NCT04702516|Semaglutide|semaglutide|mesh-list
153718473|NCT04702516|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153718474|NCT04702516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153857422|NCT05746897|Pembrolizumab|pembrolizumab|mesh-list
153397669|NCT00370253|Terlipressin|terlipressin|mesh-list
153718518|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
154257262|NCT01172912|Hormones|hormones|mesh-ancestor
153718519|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153718520|NCT00131703|Amodiaquine|amodiaquine|mesh-list
153718521|NCT00131703|Amebicides|amebicides|mesh-ancestor
153718522|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153718523|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153718524|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718525|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
153718526|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718527|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153461384|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153461385|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153461386|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
153461387|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461388|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461389|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153828119|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
153368181|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
153368182|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368183|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718528|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718529|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718530|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153718531|NCT01051414|Asunaprevir|asunaprevir|mesh-list
153718532|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718533|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718538|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153718539|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153718540|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153718541|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
153718542|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718543|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718544|NCT00099164|Progestins|progestins|mesh-ancestor
153718545|NCT00099164|Hormones|hormones|mesh-ancestor
153718546|NCT00131742|Lamivudine|lamivudine|mesh-list
153718547|NCT00131742|Telbivudine|telbivudine|mesh-list
153736046|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736047|NCT03859687|Vitamins|vitamins|mesh-list
153736048|NCT03859687|Vitamin A|vitamin a|mesh-list
153736049|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
153736050|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
153736051|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736052|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
153718548|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153718549|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153718550|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718551|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718552|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
153718564|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718565|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718566|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718567|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718568|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
153718569|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
153718570|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
153718571|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
153718572|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153718573|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718574|NCT00099242|Rivastigmine|rivastigmine|mesh-list
153718575|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153718576|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718577|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718578|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
153718579|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718580|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718581|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153718582|NCT00099242|Protective Agents|protective agents|mesh-ancestor
153718583|NCT00099320|Exenatide|exenatide|mesh-list
153718584|NCT00099320|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153718585|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153718586|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718587|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153718588|NCT00099320|Incretins|incretins|mesh-ancestor
153718589|NCT00099320|Hormones|hormones|mesh-ancestor
153718590|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718591|NCT00403650|Iloprost|iloprost|mesh-list
153718592|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153718593|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
153718594|NCT00403728|Cyclosporine|cyclosporine|mesh-list
153718595|NCT00403728|Cyclosporins|cyclosporins|mesh-list
153718596|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718597|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718598|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718599|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
153718600|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718601|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
153718617|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718618|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153368184|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153368185|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153368186|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
153368187|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368188|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368189|NCT01098500|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153828182|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153828183|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828185|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153828186|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
153828187|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828188|NCT01307020|Ibuprofen|ibuprofen|mesh-list
153718620|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718621|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718622|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718623|NCT00400556|Lenograstim|lenograstim|mesh-list
153718624|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153718625|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
153718626|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718627|NCT00400595|Mupirocin|mupirocin|mesh-list
153718628|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718629|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718630|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153718631|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718632|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718633|NCT00099554|Etanercept|etanercept|mesh-list
153718634|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153718635|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718636|NCT00099554|Analgesics|analgesics|mesh-ancestor
153718637|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
153718638|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718639|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718640|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718641|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718642|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153718643|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718644|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
153718645|NCT00132054|Irinotecan|irinotecan|mesh-list
153718646|NCT00132054|Amrubicin|amrubicin|mesh-list
153718647|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153718648|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153718649|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718650|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718651|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718652|NCT00099710|Curcumin|curcumin|mesh-list
153718653|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153718654|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718655|NCT00099710|Analgesics|analgesics|mesh-ancestor
153718656|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
153718657|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857479|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
153857480|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718768|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
153718769|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718770|NCT00100568|Lamivudine|lamivudine|mesh-list
153718771|NCT00100568|Zidovudine|zidovudine|mesh-list
153718772|NCT00100568|Efavirenz|efavirenz|mesh-list
153718773|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153368357|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153718774|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153718775|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153718776|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718777|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718778|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
153718779|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718780|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153718781|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153718782|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
153718783|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153718784|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153718785|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153718786|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153718787|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153718788|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153718789|NCT00132561|Artesunate|artesunate|mesh-list
153718790|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
153718791|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
153718792|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
153718793|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153718794|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153718795|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718796|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718797|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
153718798|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
153482638|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153482681|NCT06114979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153482933|NCT05891548|Axitinib|axitinib|mesh-list
153718799|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153718800|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
153718801|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153718802|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718803|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718804|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153368358|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153368359|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153368360|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153368362|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368385|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153368386|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153718812|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718813|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153718814|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153718815|NCT04728659|Progestins|progestins|mesh-ancestor
153718816|NCT04728659|Hormones|hormones|mesh-ancestor
153718817|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718828|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718829|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153718832|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153718833|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718834|NCT04728386|Analgesics|analgesics|mesh-ancestor
153718835|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
153718836|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718837|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718838|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718839|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718840|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718841|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718842|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718843|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
153718844|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718845|NCT00100646|Ritonavir|ritonavir|mesh-list
153718846|NCT00100646|Lopinavir|lopinavir|mesh-list
153718847|NCT00100646|Lamivudine|lamivudine|mesh-list
153718848|NCT00100646|Stavudine|stavudine|mesh-list
153718849|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153452457|NCT01846416|Atezolizumab|atezolizumab|mesh-list
153718850|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153718851|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718852|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718853|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718854|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153718855|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153718856|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
153718857|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718858|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153718859|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153718860|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153718861|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153718862|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
153828422|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828423|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828424|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828425|NCT01242449|Trastuzumab|trastuzumab|mesh-list
153828426|NCT01242449|Vinorelbine|vinorelbine|mesh-list
153718864|NCT00100685|Antibodies|antibodies|mesh-list
153718883|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153718896|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718897|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718898|NCT00132912|Vorapaxar|vorapaxar|mesh-list
153718899|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153718900|NCT00403182|Letrozole|letrozole|mesh-list
153718901|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718902|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153718903|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153718904|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718905|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718906|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153718907|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
153718908|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718909|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718910|NCT00101114|Interferons|interferons|mesh-list
153718911|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
153718912|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
153718913|NCT00101114|Sorafenib|sorafenib|mesh-list
153718914|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718915|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
153718916|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718917|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718918|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718919|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718920|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
153718921|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718922|NCT00101153|Cytarabine|cytarabine|mesh-list
153718923|NCT00101153|Daunorubicin|daunorubicin|mesh-list
153718924|NCT00101153|Tipifarnib|tipifarnib|mesh-list
153718925|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153718926|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
153718927|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718928|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718929|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
153718930|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718983|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718985|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718986|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153718987|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153718988|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
153718989|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718990|NCT00101348|Bevacizumab|bevacizumab|mesh-list
153718991|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153718992|NCT00101348|Cetuximab|cetuximab|mesh-list
153718993|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153718994|NCT00101348|Antibodies|antibodies|mesh-list
153718995|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
153718996|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153718997|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718998|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153718999|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153719000|NCT00101348|Growth Substances|growth substances|mesh-ancestor
153719001|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368534|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
153719002|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
153719003|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
153719004|NCT00101348|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153719005|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153719006|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719007|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719008|NCT00101426|Ranirestat|ranirestat|mesh-list
153719009|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719010|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719011|NCT00133185|Losartan|losartan|mesh-list
153719012|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153719013|NCT00133185|Telmisartan|telmisartan|mesh-list
153719014|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153719015|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153719027|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153719029|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719030|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153719031|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719032|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719033|NCT00133224|Prednisone|prednisone|mesh-list
153719034|NCT00133224|Docetaxel|docetaxel|mesh-list
153430569|NCT00402883|Folic Acid|folic acid|mesh-list
153719035|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719036|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
153719037|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
153719038|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
153719039|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719040|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153719041|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
153719042|NCT00133224|Hormones|hormones|mesh-ancestor
153719043|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153719044|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719045|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153719046|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
153719047|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153719048|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719049|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153719066|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153719067|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
153719068|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
153719069|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153719070|NCT00135720|Etanercept|etanercept|mesh-list
153719071|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153719072|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153719073|NCT00135720|Analgesics|analgesics|mesh-ancestor
153719074|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
153719075|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719076|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719102|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
153719103|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719104|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719105|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153719106|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719107|NCT00135837|Verteporfin|verteporfin|mesh-list
153719108|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153719109|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
153719110|NCT00133380|Atorvastatin|atorvastatin|mesh-list
153719111|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153719112|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153719113|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
153719114|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719115|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153719116|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153719117|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719118|NCT00102167|Gaboxadol|gaboxadol|mesh-list
153719119|NCT00102167|Analgesics|analgesics|mesh-ancestor
153719120|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
153719121|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719122|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719123|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
153719124|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
153719125|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
153719145|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
153719146|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719147|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719149|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153719150|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
153719151|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719152|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153719153|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153719155|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153719156|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
153719158|NCT00102284|Modafinil|modafinil|mesh-list
153719159|NCT00102284|Rivastigmine|rivastigmine|mesh-list
153719160|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153719161|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153719162|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
153719163|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828547|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719164|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719165|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719166|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153719167|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153719168|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153719169|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153719170|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153719171|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719172|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
153719173|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153719174|NCT00102284|Protective Agents|protective agents|mesh-ancestor
153719175|NCT00135525|Paroxetine|paroxetine|mesh-list
153719176|NCT00135525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153719177|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153719178|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719179|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719180|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719181|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
153719182|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719183|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153719184|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
153719198|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153719199|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
153485853|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719200|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719201|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153719202|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153719203|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719204|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153719206|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
153719207|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719208|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153719209|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153719210|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719236|NCT00135954|Hormones|hormones|mesh-ancestor
153452458|NCT01846416|Antibodies|antibodies|mesh-list
153719237|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153719238|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153719239|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
153719240|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
153719241|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153719242|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153397890|NCT03029533|Leuprolide|leuprolide|mesh-list
153719311|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153719312|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153719313|NCT00102830|Growth Substances|growth substances|mesh-ancestor
153719314|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719315|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
153719316|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719317|NCT00136110|Valproic Acid|valproic acid|mesh-list
153719318|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
153719319|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719320|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719321|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
153719322|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719323|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719324|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
153719325|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153719326|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719327|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719328|NCT00136188|Folic Acid|folic acid|mesh-list
153719329|NCT00136188|Hematinics|hematinics|mesh-ancestor
153719330|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
153719331|NCT00136188|Vitamins|vitamins|mesh-ancestor
153719332|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
153719333|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719334|NCT00102869|Levodopa|levodopa|mesh-list
153719335|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153719336|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153719337|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
153719338|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719339|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719340|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719341|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
153719342|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153719355|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719357|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153719358|NCT00102947|Daptomycin|daptomycin|mesh-list
153719359|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153719360|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719361|NCT00136344|Levofloxacin|levofloxacin|mesh-list
153719362|NCT00136344|Cefuroxime|cefuroxime|mesh-list
153719370|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719371|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719372|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153719373|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153430676|NCT02973451|Bupivacaine|bupivacaine|mesh-list
153719375|NCT00102986|Lopinavir|lopinavir|mesh-list
153719376|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153719377|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153719378|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
153719379|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719380|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719381|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153719382|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153719383|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
153719384|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719385|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153719386|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153719387|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153719388|NCT00136383|Paroxetine|paroxetine|mesh-list
153719389|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153719390|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153719391|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719392|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719393|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719394|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719395|NCT00136383|Analgesics|analgesics|mesh-ancestor
153719396|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
153719397|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719398|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
153719430|NCT00133692|Diuretics|diuretics|mesh-ancestor
153719431|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
153719432|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719433|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153719434|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719435|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719436|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153719437|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
153719438|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
153719439|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719440|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153719441|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153719442|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153719443|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
153719444|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719445|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153719446|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153719447|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
153719448|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153719449|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
153719450|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719452|NCT00133731|Calcium heparin|calcium heparin|mesh-list
153719453|NCT00133731|Otamixaban|otamixaban|mesh-list
153719454|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
153719455|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153719456|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153719457|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719458|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153719459|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
153719460|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153719461|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
153719462|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719463|NCT00103298|Leucovorin|leucovorin|mesh-list
153719464|NCT00103298|Fluorouracil|fluorouracil|mesh-list
153719484|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153397915|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153719505|NCT00133887|Cyclosporins|cyclosporins|mesh-list
153719506|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719507|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
153719508|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719509|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153719510|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719511|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719512|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153719513|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719514|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153719515|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719516|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
153719517|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
153719518|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719519|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
153719520|NCT00136539|Doxorubicin|doxorubicin|mesh-list
153719521|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153719522|NCT00136539|Trastuzumab|trastuzumab|mesh-list
153719523|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719531|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153719532|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153719533|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153719534|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153719535|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719536|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153719538|NCT00103571|Aripiprazole|aripiprazole|mesh-list
153857668|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153719555|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
153719556|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
153719557|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153719558|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153719559|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153719560|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153719561|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153719562|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153719563|NCT00136578|Carboplatin|carboplatin|mesh-list
153719564|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719566|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153719567|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153719568|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
153719569|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719570|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719571|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719572|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
153719573|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153719574|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153719575|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719576|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719577|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153719578|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153719579|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719580|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
153719581|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
153719582|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719583|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719584|NCT00103727|Risperidone|risperidone|mesh-list
153719585|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153719586|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
153719587|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719588|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719609|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153719610|NCT00404040|Laxatives|laxatives|mesh-ancestor
153719611|NCT00103922|Cilomilast|cilomilast|mesh-list
153719612|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153719613|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153719614|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719646|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153719647|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719648|NCT00136734|Methylphenidate|methylphenidate|mesh-list
153719649|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153719650|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719658|NCT00136773|Benazepril|benazepril|mesh-list
153719659|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153719660|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153719661|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719662|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830717|NCT00498953|Docetaxel|docetaxel|mesh-list
153830718|NCT00498953|Fluorouracil|fluorouracil|mesh-list
153830719|NCT00498953|Lapatinib|lapatinib|mesh-list
153830739|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830740|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830741|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
153830742|NCT05145543|Dexamethasone|dexamethasone|mesh-list
153830743|NCT05145543|Fentanyl|fentanyl|mesh-list
153370825|NCT01716221|Citalopram|citalopram|mesh-list
153452459|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
153719663|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153719664|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719665|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
153719666|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153719667|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
153719668|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719669|NCT00136851|Amlodipine|amlodipine|mesh-list
153719670|NCT00136851|Benazepril|benazepril|mesh-list
153719671|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153719672|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153719673|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719674|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719675|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153719676|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719677|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
153719678|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153719679|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
153719680|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719681|NCT00104273|Rasagiline|rasagiline|mesh-list
153719683|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719684|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719685|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153719686|NCT00104273|Protective Agents|protective agents|mesh-ancestor
153719687|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719688|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
153719689|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153719690|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719691|NCT00134355|Vatalanib|vatalanib|mesh-list
153719692|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153719693|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719694|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719695|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153719696|NCT00104429|Aplaviroc|aplaviroc|mesh-list
153719697|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153719736|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
153719737|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719738|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719739|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153719740|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153719741|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
153719742|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
153719743|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830933|NCT01246817|Temsirolimus|temsirolimus|mesh-list
153719744|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153719745|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153719746|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719747|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719748|NCT00104546|Vitamin K|vitamin k|mesh-list
153719749|NCT00104546|Vitamins|vitamins|mesh-ancestor
153719776|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
153719777|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
153719778|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719779|NCT00104663|Quinacrine|quinacrine|mesh-list
153719797|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719798|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153719799|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153719800|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719801|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
153556814|NCT01615913|Ketoconazole|ketoconazole|mesh-list
153719802|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
153719803|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153719804|NCT00134511|Atorvastatin|atorvastatin|mesh-list
153719805|NCT00134511|Torcetrapib|torcetrapib|mesh-list
153719806|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153719807|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153719808|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
153719809|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719814|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153719815|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
153719816|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719817|NCT00134550|Atorvastatin|atorvastatin|mesh-list
153719818|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153719819|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153719820|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
153719821|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719822|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153719823|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153719824|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719825|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
153719826|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153719828|NCT00104819|Sargramostim|sargramostim|mesh-list
153719829|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153719830|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
153719831|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719832|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
153719833|NCT00137202|Promethazine|promethazine|mesh-list
153719834|NCT00137202|Ondansetron|ondansetron|mesh-list
153719835|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
153719836|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
153719867|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719868|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
153719869|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263487|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719870|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153719871|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719872|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153719873|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
153719874|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153719875|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153719876|NCT00137358|Amifostine|amifostine|mesh-list
153719877|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153719878|NCT00137358|Protective Agents|protective agents|mesh-ancestor
153719879|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719881|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153719882|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
153719891|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153719892|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153719893|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
153719894|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830972|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
153830973|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719895|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719896|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719897|NCT00137397|Urological Agents|urological agents|mesh-ancestor
153719899|NCT00134745|Estrogens|estrogens|mesh-ancestor
153719900|NCT00134745|Hormones|hormones|mesh-ancestor
153719901|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153719902|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719903|NCT00105209|Aspirin|aspirin|mesh-list
153719904|NCT00105209|Clopidogrel|clopidogrel|mesh-list
153719905|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153719906|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153719915|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719916|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153719917|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153719918|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719919|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
153719920|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153719921|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153719922|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153719923|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
153719924|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719925|NCT00105287|Fentanyl|fentanyl|mesh-list
153719926|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153719927|NCT00105287|Narcotics|narcotics|mesh-ancestor
153719928|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719929|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719930|NCT00105287|Analgesics|analgesics|mesh-ancestor
153719931|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
153719932|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719933|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153719934|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153719935|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
153719936|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
153831031|NCT06154590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831032|NCT06154590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153831033|NCT06154590|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153831034|NCT06154590|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153371178|NCT02613117|Fluorides|fluorides|mesh-list
153719937|NCT00137514|Chloroquine|chloroquine|mesh-list
153719938|NCT00137514|Amodiaquine|amodiaquine|mesh-list
153719939|NCT00137514|Amebicides|amebicides|mesh-ancestor
153719940|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153719941|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153719942|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719943|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
153719944|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719945|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153719946|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153719947|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153719948|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719949|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719950|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719977|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153719978|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719979|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719980|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
153719981|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719982|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719983|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
153719984|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153719985|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
153719986|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831144|NCT05851508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831145|NCT05851508|Antiemetics|antiemetics|mesh-ancestor
153831146|NCT05851508|Autonomic Agents|autonomic agents|mesh-ancestor
153831147|NCT05851508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831148|NCT05851508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831149|NCT05851508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153831150|NCT05851508|Glucocorticoids|glucocorticoids|mesh-ancestor
153831151|NCT05851508|Hormones|hormones|mesh-ancestor
153371234|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
153371248|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371249|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153371250|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153371251|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
153371252|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153371253|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
153371254|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
153371255|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
153371256|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153371257|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
153371258|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
153371259|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153719987|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719988|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153719989|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
153719990|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153719991|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153719992|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153719993|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
153719994|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719995|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469168|NCT05452772|Psilocybin|psilocybin|mesh-list
153720010|NCT00137709|Valproic Acid|valproic acid|mesh-list
153720011|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
153720012|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153720028|NCT01054144|Lenalidomide|lenalidomide|mesh-list
153720030|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
153720031|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
153720032|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720033|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720034|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153720035|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
153720036|NCT01054144|Hormones|hormones|mesh-ancestor
153720037|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153720038|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153720039|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720040|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
153720041|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153720042|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153720043|NCT01054144|Growth Substances|growth substances|mesh-ancestor
153720044|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
153720045|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
153720046|NCT00137787|Cefepime|cefepime|mesh-list
153720047|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153720048|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720049|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153720050|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720051|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720052|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720053|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720054|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153720055|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153720056|NCT04702048|Aflibercept|aflibercept|mesh-list
153720057|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153371342|NCT01307618|Interleukin-12|interleukin-12|mesh-list
153831436|NCT04942626|Capecitabine|capecitabine|mesh-list
153720058|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153720076|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
153720077|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
153720078|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720079|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153720080|NCT00434746|Fezakinumab|fezakinumab|mesh-list
153720081|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
153720082|NCT00137826|Bevacizumab|bevacizumab|mesh-list
153720083|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153720084|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720085|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720086|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153720087|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153720088|NCT00137826|Growth Substances|growth substances|mesh-ancestor
153720094|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720096|NCT00434824|Testosterone|testosterone|mesh-list
153720097|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
153720098|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
153720099|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153720100|NCT00434824|Androgens|androgens|mesh-ancestor
153720102|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153720103|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720104|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153720105|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720106|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
153720107|NCT00105950|Lapatinib|lapatinib|mesh-list
153720108|NCT00105950|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153720109|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720110|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263489|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720111|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720112|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720113|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
153720114|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153720115|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153720116|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153720117|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153469169|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153720126|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
153720127|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720128|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720129|NCT00135096|Insulin|insulin|mesh-list
153720130|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153720131|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
153720132|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
153720133|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153720134|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720135|NCT00435058|Timolol|timolol|mesh-list
153720136|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153720137|NCT00435058|Travoprost|travoprost|mesh-list
153720138|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720139|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153720140|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153720141|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
153720142|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720143|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720144|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153720145|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153720146|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153720147|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153720148|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153720149|NCT00435175|Estradiol|estradiol|mesh-list
153720150|NCT00435175|Estrogens|estrogens|mesh-ancestor
153720151|NCT00435175|Hormones|hormones|mesh-ancestor
153831561|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153831562|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371615|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831613|NCT04177095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831614|NCT04177095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371665|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153371666|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371668|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
153371669|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371695|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153371696|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831615|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831616|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
153831617|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153831618|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153831619|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831620|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
153831621|NCT04177095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153371734|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720152|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153720153|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720154|NCT00135135|Carboplatin|carboplatin|mesh-list
153720155|NCT00135135|Doxorubicin|doxorubicin|mesh-list
153720156|NCT00135135|Irinotecan|irinotecan|mesh-list
153720157|NCT00135135|Etoposide|etoposide|mesh-list
153720158|NCT00135135|Melphalan|melphalan|mesh-list
153720159|NCT00135135|Topotecan|topotecan|mesh-list
153720160|NCT00135135|Gefitinib|gefitinib|mesh-list
153720161|NCT00135135|Tretinoin|tretinoin|mesh-list
153720162|NCT00135135|Isotretinoin|isotretinoin|mesh-list
153720163|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720164|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153720165|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153720166|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720167|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720173|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153720174|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720175|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
153720176|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720177|NCT00135135|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153720178|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720179|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
153720180|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
153720182|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153720183|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153720184|NCT00435292|Analgesics|analgesics|mesh-ancestor
153720201|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
153720203|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720204|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153720205|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720206|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153720207|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
153720208|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153720209|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153720210|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153720211|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153720212|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720213|NCT00435760|Bromides|bromides|mesh-list
153720214|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
153720215|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153831762|NCT03467867|Rituximab|rituximab|mesh-list
153720216|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
154263490|NCT05353257|Carboplatin|carboplatin|mesh-list
153720217|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720218|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720219|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153720220|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
153720221|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
153720222|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153720223|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
153720224|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720225|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720226|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
153720227|NCT00435799|Riboflavin|riboflavin|mesh-list
153720228|NCT00435799|Dextrans|dextrans|mesh-list
153720229|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153720230|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
153720231|NCT00435799|Vitamins|vitamins|mesh-ancestor
153720232|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
153720233|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720234|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153720235|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
153720236|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153720237|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
153720238|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
153720239|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
153720240|NCT00142467|Bevacizumab|bevacizumab|mesh-list
153720241|NCT00142467|Gemcitabine|gemcitabine|mesh-list
153720242|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
153720254|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720255|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720256|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
153720257|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720258|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153720259|NCT00436033|Milnacipran|milnacipran|mesh-list
153720260|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
153720261|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153720262|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153720263|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720264|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720272|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153720273|NCT00436072|Irinotecan|irinotecan|mesh-list
153720274|NCT00436072|Cetuximab|cetuximab|mesh-list
153720275|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153720276|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720277|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720278|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720279|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720280|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720281|NCT03276052|Bromides|bromides|mesh-list
153720282|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
153720283|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
153720284|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153720285|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
153720286|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153720287|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
153720288|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720289|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720290|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
153720291|NCT04702360|Ivacaftor|ivacaftor|mesh-list
153720292|NCT04702360|Elexacaftor|elexacaftor|mesh-list
153720293|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153720294|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720295|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720296|NCT04702204|Denosumab|denosumab|mesh-list
153720297|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153720298|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720299|NCT00138060|Fluorouracil|fluorouracil|mesh-list
153720300|NCT00138060|Irinotecan|irinotecan|mesh-list
153720301|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
153720302|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720303|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720304|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720310|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720311|NCT04702009|Antibodies|antibodies|mesh-list
153720312|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153720313|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
153720314|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720315|NCT00106145|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
153720316|NCT00106145|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153720317|NCT00106145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720318|NCT00106145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720319|NCT00142545|Apomorphine|apomorphine|mesh-list
153720320|NCT00142545|Emetics|emetics|mesh-ancestor
153831873|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
153371980|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
153720321|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720322|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
153720323|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720324|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153720325|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
153720326|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
153720327|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557338|NCT01618877|Levetiracetam|levetiracetam|mesh-list
153720328|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720329|NCT00106262|Irinotecan|irinotecan|mesh-list
153720330|NCT00106262|Bortezomib|bortezomib|mesh-list
153720331|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153720332|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720333|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720334|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720335|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720336|NCT00106301|Romidepsin|romidepsin|mesh-list
153720352|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720353|NCT00138099|Dalteparin|dalteparin|mesh-list
153720354|NCT00138099|Tinzaparin|tinzaparin|mesh-list
153720355|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153720356|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
153720357|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153720358|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153720359|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720360|NCT00106379|Tenofovir|tenofovir|mesh-list
153720361|NCT00106379|Emtricitabine|emtricitabine|mesh-list
153720362|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153831927|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831928|NCT02314481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831929|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720363|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
153720364|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720365|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153720366|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153720367|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720368|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720369|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153720370|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153720387|NCT00106418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720388|NCT00106418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720389|NCT00436930|Sargramostim|sargramostim|mesh-list
153720390|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
153720391|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720392|NCT00437008|Benphothiamine|benphothiamine|mesh-list
153720393|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153720394|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
153720395|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720396|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
153720397|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
153720398|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720399|NCT00437086|Bortezomib|bortezomib|mesh-list
153720400|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557418|NCT01619436|Clonidine|clonidine|mesh-list
153720401|NCT00437164|Insulin|insulin|mesh-list
153720402|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153720403|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153720404|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720405|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153720406|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153720407|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
153720408|NCT00106496|Tacrolimus|tacrolimus|mesh-list
153720409|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720410|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
153832137|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153832138|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153372183|NCT03684785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153372186|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153720411|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720412|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153720422|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720423|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153720424|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
153720425|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153720426|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720427|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153720449|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720451|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153720452|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153720453|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
153720454|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720455|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
153720457|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
153720458|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153720459|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153720460|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
153720461|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720462|NCT00106613|Romidepsin|romidepsin|mesh-list
153720463|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153720464|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720465|NCT00106613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153720466|NCT00106613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720467|NCT00106613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720468|NCT00401180|Docetaxel|docetaxel|mesh-list
153720469|NCT00401180|Temozolomide|temozolomide|mesh-list
153720470|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720471|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
153720472|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
153720473|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
153557484|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
153720474|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372257|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372258|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
153372259|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153372260|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153372261|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372262|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
153720475|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153720476|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
153720477|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
153720478|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720479|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720496|NCT00438139|Analgesics|analgesics|mesh-ancestor
153720497|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
153720498|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720499|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153720500|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153720501|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720502|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720503|NCT00438139|Hormones|hormones|mesh-ancestor
153720504|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153720505|NCT00438178|Obatoclax|obatoclax|mesh-list
153720506|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720507|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720508|NCT00438217|Leuprolide|leuprolide|mesh-list
153720509|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153720510|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153720511|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153720512|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
153720513|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153720530|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
153720531|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153720532|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720533|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
153720534|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720535|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153720536|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153720537|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153736053|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720548|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
153720550|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
153372273|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372287|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153372442|NCT01779167|Rituximab|rituximab|mesh-list
153720551|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153720552|NCT00438568|Insulin|insulin|mesh-list
153720553|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153720554|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153720555|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720556|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
153720557|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153720558|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153720559|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153720560|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
153720561|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720562|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720563|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720564|NCT00106847|Infliximab|infliximab|mesh-list
153720565|NCT00106847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153720566|NCT00106847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153720567|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
153720568|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153720569|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153720570|NCT00106886|Folic Acid|folic acid|mesh-list
153720571|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
153720572|NCT00106886|Pyridoxal|pyridoxal|mesh-list
153720573|NCT00106886|Pyridoxine|pyridoxine|mesh-list
153720574|NCT00106886|Vitamins|vitamins|mesh-ancestor
153720575|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
153720576|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720577|NCT00106886|Hematinics|hematinics|mesh-ancestor
153720578|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
153720579|NCT00438841|Thalidomide|thalidomide|mesh-list
153720580|NCT00438841|Dexamethasone|dexamethasone|mesh-list
153720581|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
153720582|NCT00438841|Bortezomib|bortezomib|mesh-list
153372443|NCT01779167|Lenalidomide|lenalidomide|mesh-list
153372444|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153372445|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372446|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
153372479|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372480|NCT02865473|Pilocarpine|pilocarpine|mesh-list
153372481|NCT02865473|Miotics|miotics|mesh-ancestor
153372482|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
153372484|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832456|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153832458|NCT02274974|Epinephrine|epinephrine|mesh-list
153720583|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720584|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
153720592|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153720594|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
153720595|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720596|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153720597|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
153720598|NCT00438841|Hormones|hormones|mesh-ancestor
153720599|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153720600|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153720601|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
153720602|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153720603|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720618|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153720619|NCT00107081|Amoxicillin|amoxicillin|mesh-list
153720620|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
153720621|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720622|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153720623|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720624|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720625|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720626|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720627|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153720628|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153720629|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153720630|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153720631|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153720632|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
153720633|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720634|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720636|NCT00439192|Urological Agents|urological agents|mesh-ancestor
153720638|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
153720639|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720640|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
153832471|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153832472|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832473|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832474|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153832564|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720641|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720642|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720643|NCT00138138|Methylphenidate|methylphenidate|mesh-list
153720644|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153720645|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720646|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153720647|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153720648|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720649|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720650|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
153720651|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720652|NCT00439504|Lobeline|lobeline|mesh-list
153720653|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153720654|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
153720655|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720656|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720657|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153720658|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153720659|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
153720660|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720661|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720662|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
153720680|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720704|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720705|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720706|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
153720707|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720708|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153720709|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153832565|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153832566|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153832567|NCT00501527|Immunomodulating Agents|immunomodulating agents|mesh-list
153832568|NCT00501527|Immunologic Factors|immunologic factors|mesh-ancestor
153832569|NCT00501527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832570|NCT02955524|Lidocaine|lidocaine|mesh-list
153832571|NCT02955524|Tetracaine|tetracaine|mesh-list
153372620|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372621|NCT01267136|Analgesics|analgesics|mesh-ancestor
153372622|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
153372623|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720710|NCT00107354|Analgesics|analgesics|mesh-ancestor
153720711|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
153720712|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720713|NCT00138177|Leucovorin|leucovorin|mesh-list
153720714|NCT00138177|Fluorouracil|fluorouracil|mesh-list
153720715|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
153720716|NCT00138177|Vorinostat|vorinostat|mesh-list
153720717|NCT00138177|Calcium|calcium|mesh-list
153720718|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
153720719|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153720720|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720721|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
153720722|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720742|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
153720743|NCT00107393|Capecitabine|capecitabine|mesh-list
153720744|NCT00107393|Trastuzumab|trastuzumab|mesh-list
153720745|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720746|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
153720747|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720748|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720749|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720750|NCT00105586|Escitalopram|escitalopram|mesh-list
153720751|NCT00105586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153720752|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153720753|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720757|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720759|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720760|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720761|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372670|NCT01791491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153372671|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372672|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372673|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
153372674|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832614|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832615|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832616|NCT02952573|Dexamethasone|dexamethasone|mesh-list
153832617|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
153832618|NCT02952573|BB 1101|bb 1101|mesh-list
153832619|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832620|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
153832626|NCT02952573|Hormones|hormones|mesh-ancestor
153832674|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
153720762|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720763|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
153720764|NCT00439972|Ortho Evra|ortho evra|mesh-list
153720765|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153720766|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153720767|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
153720768|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153720769|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720770|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153720771|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720772|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153720773|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720774|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720775|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720776|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720777|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153720790|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720792|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153720793|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832675|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153832676|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153832677|NCT00510003|Analgesics|analgesics|mesh-ancestor
153832678|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
153832679|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832680|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832681|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832682|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372733|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832700|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153832701|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153832702|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153832703|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832704|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832705|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832706|NCT00501878|Protective Agents|protective agents|mesh-ancestor
153832707|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
153832708|NCT00501917|Hematinics|hematinics|mesh-ancestor
153832709|NCT00510588|Metformin|metformin|mesh-list
153819994|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153819995|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153819996|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819997|NCT00431522|Valproic Acid|valproic acid|mesh-list
153819998|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
153720794|NCT00440167|Gemcitabine|gemcitabine|mesh-list
153832710|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153720795|NCT00440167|Capecitabine|capecitabine|mesh-list
153720796|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153720797|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720798|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
153720799|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720800|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720801|NCT00440167|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153720802|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720803|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720804|NCT00107471|Topotecan|topotecan|mesh-list
153720805|NCT00107471|Lenograstim|lenograstim|mesh-list
153720806|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153720807|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
153720808|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720809|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153720810|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720811|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720812|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720813|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720814|NCT00404157|Rituximab|rituximab|mesh-list
153720815|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720816|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720817|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
153720818|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720819|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153720820|NCT02957266|Gemcitabine|gemcitabine|mesh-list
153720821|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720822|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720823|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
153720824|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720825|NCT03279562|Nalmefene|nalmefene|mesh-list
153398168|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832711|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832712|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
153832713|NCT00510627|Irinotecan|irinotecan|mesh-list
153832714|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832715|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153832716|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153832717|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832718|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372864|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720838|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720840|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153720841|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
153720842|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720896|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153720897|NCT00440479|Bortezomib|bortezomib|mesh-list
153720898|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720899|NCT00440635|Bortezomib|bortezomib|mesh-list
153720900|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720901|NCT00440674|Paclitaxel|paclitaxel|mesh-list
153720902|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153720903|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720904|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
153720905|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
153720906|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
153720907|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720908|NCT00440713|Aripiprazole|aripiprazole|mesh-list
153720909|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
153720910|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153720911|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153720912|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153720913|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153720914|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720915|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
153720916|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
153720917|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720918|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720919|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153720920|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153720921|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
153720922|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153720923|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153720924|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153720925|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153720926|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
153720927|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153720928|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
153372962|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720929|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720930|NCT00440869|Expectorants|expectorants|mesh-ancestor
153720931|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
153720932|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153720945|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720946|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153720947|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153720948|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720949|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720950|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153720971|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153720972|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720974|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
153720975|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
153720976|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153720977|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720978|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
153720979|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720980|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153720981|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153720982|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153720983|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720984|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720985|NCT00441649|Methylphenidate|methylphenidate|mesh-list
153720986|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153720987|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372963|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372964|NCT01273766|Deferasirox|deferasirox|mesh-list
153372965|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153372966|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
153832931|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153832932|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373008|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373009|NCT02235909|Losartan|losartan|mesh-list
153373010|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153373011|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153373012|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153373013|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153373014|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153833026|NCT00511446|Capecitabine|capecitabine|mesh-list
153833027|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
153833028|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833029|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
153373176|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720988|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153720989|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153720990|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720991|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720992|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
153720993|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720994|NCT00107822|Lidocaine|lidocaine|mesh-list
153721014|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721016|NCT00441844|Simvastatin|simvastatin|mesh-list
153721017|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153721018|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153721019|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
153721020|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721021|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153721022|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153721023|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721024|NCT03279133|Ledipasvir|ledipasvir|mesh-list
153721025|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
153721026|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721027|NCT00108017|Timolol|timolol|mesh-list
153721028|NCT00108017|Dorzolamide|dorzolamide|mesh-list
153721029|NCT00108017|Maleic acid|maleic acid|mesh-list
153721030|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721031|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721032|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153721033|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153721034|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
153721035|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721036|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721037|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153721038|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153721039|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153373177|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373178|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373179|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
153373180|NCT00368121|Hormones|hormones|mesh-ancestor
153833125|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833126|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
153833127|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833129|NCT00513162|Valproic Acid|valproic acid|mesh-list
153833130|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153373317|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153721040|NCT00441922|Docetaxel|docetaxel|mesh-list
153721041|NCT00441922|Vinorelbine|vinorelbine|mesh-list
153721042|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721043|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
153721044|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
153721045|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
153721046|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721047|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153721048|NCT00441961|Methotrexate|methotrexate|mesh-list
153469170|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
153721058|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721059|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153721060|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153721061|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
153721062|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721063|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153721064|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
153721065|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153721066|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721067|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153736056|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736057|NCT03848065|Vaccines|vaccines|mesh-list
153736058|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
153721068|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153721069|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721070|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721071|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721072|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153721073|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153721074|NCT00442234|Monteplase|monteplase|mesh-list
153721075|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153721076|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153721077|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721078|NCT00108095|Ondansetron|ondansetron|mesh-list
153721079|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
153721080|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
153721081|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721082|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721083|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721084|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
153721085|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
153721086|NCT00108095|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153721087|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153721088|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
153721089|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721090|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721091|NCT03278938|Bupropion|bupropion|mesh-list
153721092|NCT03278938|Citalopram|citalopram|mesh-list
153721093|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153721100|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
153721101|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721102|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721103|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153721104|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153721105|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721106|NCT03278938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153721107|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
153721108|NCT03278860|Oxytocin|oxytocin|mesh-list
153721109|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
153721110|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153721111|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721124|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
153721125|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721126|NCT00442585|Ibuprofen|ibuprofen|mesh-list
153721127|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153721128|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153721129|NCT00442585|Analgesics|analgesics|mesh-ancestor
153721130|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
153721131|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721132|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721133|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721134|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721135|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153373519|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721136|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721137|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721138|NCT00442741|Epothilone B|epothilone b|mesh-list
153721139|NCT00442741|Epothilones|epothilones|mesh-list
153721140|NCT00442741|Omeprazole|omeprazole|mesh-list
153721141|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153721142|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721143|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153721144|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721145|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721146|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721147|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
153721148|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
153721149|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
153721150|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
153721151|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153721152|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153721153|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153721154|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
153721155|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721156|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721157|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721158|NCT00404586|Fluticasone|fluticasone|mesh-list
153721160|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721161|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153721162|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
153721163|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721164|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721165|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153721166|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373591|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373592|NCT01836185|Evacetrapib|evacetrapib|mesh-list
153373593|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153373594|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153373595|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
153833555|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
153833556|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153373632|NCT03349281|Pegaspargase|pegaspargase|mesh-list
153373633|NCT03349281|Pevonedistat|pevonedistat|mesh-list
153373634|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373635|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
153373636|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
153721167|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
153721168|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153721169|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153721170|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
153721171|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153721189|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153721200|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721201|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721202|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153721203|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153721204|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721205|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153721206|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153721207|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
153721208|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153721209|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721210|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153721211|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153721212|NCT00443170|Analgesics|analgesics|mesh-ancestor
153721213|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
153721214|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721215|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153721216|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153721217|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721218|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721219|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153721220|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153721221|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
153721222|NCT00138567|Vildagliptin|vildagliptin|mesh-list
153721223|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153721224|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721225|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153721226|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
153721227|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721228|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721229|NCT00108368|Olanzapine|olanzapine|mesh-list
153721230|NCT00108368|Risperidone|risperidone|mesh-list
153721245|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721246|NCT00108368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153721247|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153721248|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721250|NCT00108446|Fentanyl|fentanyl|mesh-list
153721251|NCT00108446|Levomethorphan|levomethorphan|mesh-list
153721252|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
153721253|NCT00108446|Naloxone|naloxone|mesh-list
153721254|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
153833643|NCT01249521|Trebananib|trebananib|mesh-list
153721255|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
153721256|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153721257|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721258|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
153721259|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721260|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153721261|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153721262|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153721263|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721264|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721265|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153721266|NCT00108446|Narcotics|narcotics|mesh-ancestor
153721267|NCT00108446|Analgesics|analgesics|mesh-ancestor
153721268|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153721269|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153721273|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
153721274|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153721275|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153721276|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721278|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153721279|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721280|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153721281|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
153721282|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721283|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721284|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
153721285|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153721286|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
153721287|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558306|NCT01625351|Melphalan|melphalan|mesh-list
153721288|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721289|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153721301|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489038|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153489039|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489040|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153721302|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
153721303|NCT00443521|Hormones|hormones|mesh-ancestor
153721304|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721305|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721306|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153721307|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
153721308|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721309|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721310|NCT03278431|Albendazole|albendazole|mesh-list
153721311|NCT03278431|Mebendazole|mebendazole|mesh-list
153373879|NCT01852955|Analgesics|analgesics|mesh-ancestor
153721312|NCT03278431|Piperazine|piperazine|mesh-list
153721313|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
153721314|NCT03278431|Pyrantel|pyrantel|mesh-list
153721315|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
153721316|NCT03278431|Oxantel|oxantel|mesh-list
153721317|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
153721318|NCT03278431|DMP 777|dmp 777|mesh-list
153721319|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
153721320|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153721321|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721322|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
153721323|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153721324|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153721325|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
153721326|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
153721327|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
153721328|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721329|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721330|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
153721331|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721332|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153721333|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153721334|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153721335|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721336|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721337|NCT00108563|Citalopram|citalopram|mesh-list
153721338|NCT00108563|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153721339|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153736059|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721340|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721341|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721342|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721343|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
153721344|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721345|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153373880|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
153833853|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153373901|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153721361|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721362|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721363|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721364|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721365|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153721366|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153721367|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721368|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153721369|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153721370|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721372|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153721373|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153721374|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
153721375|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153721376|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153721377|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153721378|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
153721379|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153721380|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153721381|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
153721382|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
153721383|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153721384|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153721385|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153721386|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
153721387|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721388|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721389|NCT00443794|Diuretics|diuretics|mesh-ancestor
153721390|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
153721391|NCT00108602|Acetazolamide|acetazolamide|mesh-list
153721392|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
153721393|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153721394|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721395|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721396|NCT00108602|Diuretics|diuretics|mesh-ancestor
153721397|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
153721398|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721400|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153721401|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721402|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721404|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153721405|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153721406|NCT00443950|Analgesics|analgesics|mesh-ancestor
153721407|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
153721408|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721409|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721410|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721411|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721412|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721413|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153721414|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
153721415|NCT00444184|Timolol|timolol|mesh-list
153721416|NCT00444184|Travoprost|travoprost|mesh-list
153721417|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153721418|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153721419|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
153721420|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721446|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721447|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153721448|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153721449|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
153721450|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
153721451|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153721452|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153721453|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153721454|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721455|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721456|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153721457|NCT04698772|Narcotics|narcotics|mesh-ancestor
153721458|NCT00451594|Dexamethasone|dexamethasone|mesh-list
153721459|NCT00451594|Prednisolone|prednisolone|mesh-list
153721460|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721461|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
153721462|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
153721463|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721464|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721465|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721466|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
153721467|NCT00451594|Hormones|hormones|mesh-ancestor
153721468|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721469|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153721470|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834074|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153721471|NCT00139035|Cyclosporine|cyclosporine|mesh-list
153721472|NCT00139035|Cyclosporins|cyclosporins|mesh-list
153721473|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721474|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721475|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153721505|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
153721506|NCT00139074|Valproic Acid|valproic acid|mesh-list
153721507|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153721508|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
153721509|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153721510|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153721511|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153721512|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153721513|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721514|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
153721515|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721516|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721517|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
153721518|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721519|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
153721520|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
153721543|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153721544|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721545|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721546|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721547|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
153721548|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721549|NCT00451984|Interleukin-2|interleukin-2|mesh-list
153721550|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721551|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153721552|NCT00451984|Analgesics|analgesics|mesh-ancestor
153721553|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
153721554|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721555|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721556|NCT00452062|Dexamethasone|dexamethasone|mesh-list
153721557|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721558|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
153834075|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153834076|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153834077|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834078|NCT02275598|Immunotoxins|immunotoxins|mesh-ancestor
153834082|NCT00517062|Hormones|hormones|mesh-list
153721559|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
153721560|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721585|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
153721586|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153721587|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721588|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721589|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153721590|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153721591|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153721592|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153721593|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153721594|NCT00109070|Bevacizumab|bevacizumab|mesh-list
153721595|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153721596|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721597|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153721598|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153721599|NCT00109070|Growth Substances|growth substances|mesh-ancestor
153721600|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721601|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
153721602|NCT00452218|Sorafenib|sorafenib|mesh-list
153721603|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721604|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153721605|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721606|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721607|NCT00143169|Parecoxib|parecoxib|mesh-list
153721608|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153721609|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153721610|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721611|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721612|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153721613|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153721614|NCT00143169|Analgesics|analgesics|mesh-ancestor
153721615|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
153721616|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721617|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721618|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721619|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721620|NCT00109109|Vorinostat|vorinostat|mesh-list
153721621|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721622|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153721623|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721624|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721625|NCT03275116|Bromides|bromides|mesh-list
153721626|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
153721627|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
153721628|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153721629|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
153721644|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
153721645|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153721646|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153721651|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721653|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153721654|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721655|NCT00452569|Thalidomide|thalidomide|mesh-list
153721656|NCT00452569|Dexamethasone|dexamethasone|mesh-list
153721657|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721658|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
153721659|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
153721660|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721661|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721662|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721663|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
153721664|NCT00452569|Hormones|hormones|mesh-ancestor
153721665|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721666|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153374174|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374175|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374176|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
153374177|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374178|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153374179|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153374180|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374181|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374182|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153374183|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153374185|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374186|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153374187|NCT02651415|Perindopril|perindopril|mesh-list
153374188|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153721667|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721668|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153721669|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
153721670|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
153721671|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153721672|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721673|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153721674|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153721675|NCT00452569|Growth Substances|growth substances|mesh-ancestor
153721676|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
153721677|NCT00143286|Varenicline|varenicline|mesh-list
153721678|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153721679|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153721680|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
153721681|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721682|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721683|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721684|NCT00109187|Omalizumab|omalizumab|mesh-list
153721685|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153721686|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153721695|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721696|NCT00109226|Bevacizumab|bevacizumab|mesh-list
153721697|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153721698|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721699|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153721700|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153721701|NCT00109226|Growth Substances|growth substances|mesh-ancestor
153721702|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721703|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
153721704|NCT00452725|Hormones|hormones|mesh-list
153721705|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721706|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721707|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153721708|NCT00109265|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153834118|NCT00517491|Lanreotide|lanreotide|mesh-list
153834119|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834120|NCT04517201|Insulin|insulin|mesh-list
153834121|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153834122|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153721709|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153721710|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721711|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721712|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721713|NCT00143364|Varenicline|varenicline|mesh-list
153721714|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153721715|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153721716|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
153721717|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721718|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721719|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721720|NCT00452881|Gemcitabine|gemcitabine|mesh-list
153721721|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
153721722|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858071|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
153721731|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721732|NCT00143442|Reboxetine|reboxetine|mesh-list
153721733|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
153721734|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153721735|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154263492|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721736|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153721737|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721738|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721739|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
153721740|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721741|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721742|NCT00109382|Aspirin|aspirin|mesh-list
153721743|NCT00109382|Clopidogrel|clopidogrel|mesh-list
153721744|NCT00109382|Simvastatin|simvastatin|mesh-list
153721745|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153721746|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153721747|NCT00109382|Analgesics|analgesics|mesh-ancestor
153721748|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
153721749|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721750|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721757|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153721758|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721759|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
153721760|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153374209|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721761|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153721762|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153721763|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
153721764|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721765|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153721766|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153721767|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
153721768|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153721769|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153721770|NCT00453076|Paclitaxel|paclitaxel|mesh-list
153721771|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153721772|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721773|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
153721774|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
153721775|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
153721776|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721777|NCT00453115|Gemcitabine|gemcitabine|mesh-list
153721778|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
153721779|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153721780|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
153721781|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721782|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721783|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153721784|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153721785|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153721786|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
153721787|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721788|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721789|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721790|NCT00143481|Urological Agents|urological agents|mesh-ancestor
153721791|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153858086|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
153721800|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721801|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153721802|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
153721803|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153721804|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721805|NCT00143520|Pioglitazone|pioglitazone|mesh-list
153721806|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153721807|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721808|NCT00143559|Antibodies|antibodies|mesh-list
153721809|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
153721810|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721811|NCT00453778|Fluticasone|fluticasone|mesh-list
153721812|NCT00453778|Xhance|xhance|mesh-list
153721813|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721814|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153721815|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
153721816|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721838|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721839|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153721841|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
153721842|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721843|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
153721844|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153721845|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
153721846|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721848|NCT03274765|Estrogens|estrogens|mesh-ancestor
153721849|NCT03274765|Hormones|hormones|mesh-ancestor
153721850|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721851|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721852|NCT00454402|Alfuzosin|alfuzosin|mesh-list
153721853|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153721854|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153721855|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153721856|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
153721857|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721858|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721859|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721860|NCT00454402|Urological Agents|urological agents|mesh-ancestor
153721861|NCT00143676|Atorvastatin|atorvastatin|mesh-list
153721862|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153721863|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153721864|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
153721865|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721866|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153374252|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374253|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374254|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153374255|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153374256|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
153374269|NCT05439993|Paclitaxel|paclitaxel|mesh-list
153721867|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153721868|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721869|NCT00454480|Cytarabine|cytarabine|mesh-list
153721870|NCT00454480|Fludarabine|fludarabine|mesh-list
153721871|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
153721901|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
153721902|NCT00110006|Rituximab|rituximab|mesh-list
153721903|NCT00110006|Doxorubicin|doxorubicin|mesh-list
153721904|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153721905|NCT00110006|Vincristine|vincristine|mesh-list
153721906|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153721907|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153721908|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
153721909|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721913|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721915|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153721916|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153721917|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153721918|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153721919|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153721920|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721921|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721922|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
153721923|NCT00110006|Hormones|hormones|mesh-ancestor
153721948|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721949|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721951|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
153721952|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153721953|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153721954|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558977|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
153721955|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721956|NCT00454714|Urological Agents|urological agents|mesh-ancestor
153721957|NCT00143715|Vitamin K|vitamin k|mesh-list
153721958|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
153721959|NCT00143715|Vitamins|vitamins|mesh-ancestor
153721960|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
153721961|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721962|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153721963|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153721964|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721966|NCT00143715|Coagulants|coagulants|mesh-ancestor
153721967|NCT00454831|Chitosan|chitosan|mesh-list
153721968|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153721969|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153721970|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
153721971|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721972|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153721995|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153834221|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721996|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153721997|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
153721998|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721999|NCT00110162|Hormones|hormones|mesh-list
153722000|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
153722001|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722002|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722003|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
153722004|NCT02273713|Paclitaxel|paclitaxel|mesh-list
153722005|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153722006|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722007|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
153722008|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
153722009|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
153722010|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722011|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153722012|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
153722013|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722014|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153722015|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153722016|NCT02273791|Clomiphene|clomiphene|mesh-list
153722017|NCT02273791|Enclomiphene|enclomiphene|mesh-list
153722018|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
153722019|NCT02273791|Estradiol|estradiol|mesh-list
153722020|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153722021|NCT02273791|Estrogens|estrogens|mesh-ancestor
153722022|NCT02273791|Hormones|hormones|mesh-ancestor
153722023|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722053|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
153722054|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722055|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153722056|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
153722057|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153722058|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153722059|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153722060|NCT00143871|Rituximab|rituximab|mesh-list
153722061|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153834222|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153834223|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
153834224|NCT01242930|Vitamins|vitamins|mesh-ancestor
153834225|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
153834226|NCT01241214|Cetirizine|cetirizine|mesh-list
153834227|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153834228|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153722062|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834229|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153722063|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
153722064|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722065|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722066|NCT00455572|Vinorelbine|vinorelbine|mesh-list
153722067|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722068|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153722069|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
153722070|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
153722071|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
153722072|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722073|NCT00401492|Gemcitabine|gemcitabine|mesh-list
153722074|NCT00401492|Vinorelbine|vinorelbine|mesh-list
153722075|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722076|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153722077|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
153722078|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722079|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153722080|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
153722104|NCT00110474|Acetaminophen|acetaminophen|mesh-list
153722105|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153722106|NCT00110474|Analgesics|analgesics|mesh-ancestor
153834230|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
153834231|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
153834232|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834233|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834234|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834235|NCT01240512|Vitamin D|vitamin d|mesh-list
153834236|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
153834237|NCT01240512|Vitamins|vitamins|mesh-ancestor
153834238|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
153834239|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834240|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153834241|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153374297|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
153374298|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374299|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153374300|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153374301|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374302|NCT00553319|Amphetamine|amphetamine|mesh-list
153820001|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
153820002|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736062|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153722107|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
153722108|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722109|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722110|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
153722111|NCT00113100|Ethanol|ethanol|mesh-list
153722112|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153722113|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153722114|NCT00113100|Estradiol|estradiol|mesh-list
153722115|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153722116|NCT00113100|Estrogens|estrogens|mesh-ancestor
153722117|NCT00113100|Hormones|hormones|mesh-ancestor
153722118|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722119|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722120|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153722121|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
153381398|NCT02288819|Diuretics|diuretics|mesh-list
153722122|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153722123|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153722124|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153722125|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722126|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153722127|NCT00143949|Losartan|losartan|mesh-list
153722128|NCT00143949|Enalapril|enalapril|mesh-list
153722129|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153722130|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153722131|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153722132|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153722143|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722144|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153722145|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722146|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834265|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153722159|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
153722160|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722161|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722162|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153722163|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
153722164|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
153722165|NCT00456313|Hormones|hormones|mesh-ancestor
153722166|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722167|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
153722168|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722169|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
153722170|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153722171|NCT00110630|Nicotine|nicotine|mesh-list
153722172|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153722173|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
153722174|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722175|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722176|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153722177|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153722178|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
153722179|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722180|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722181|NCT00456430|Escitalopram|escitalopram|mesh-list
153722182|NCT00456430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153834266|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
153834267|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834268|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153834269|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834270|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834271|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153834272|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834273|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153834274|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834275|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
153834276|NCT00518193|Cetuximab|cetuximab|mesh-list
153834277|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153834278|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834279|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
153834280|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834281|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834282|NCT00518466|Topiramate|topiramate|mesh-list
153834283|NCT00518466|Phentermine|phentermine|mesh-list
153834284|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
153834285|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834286|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834289|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153722183|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153722184|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722185|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722187|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
153722188|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722189|NCT00456586|Istradefylline|istradefylline|mesh-list
153736063|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722190|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153722191|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153722192|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153722193|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
153722194|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722195|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722196|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722205|NCT00454558|Riociguat|riociguat|mesh-list
153722206|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
153722207|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722208|NCT00113256|Rubitecan|rubitecan|mesh-list
153722209|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722210|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153722211|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153722212|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722213|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722214|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
153722215|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153722216|NCT00110708|Antibodies|antibodies|mesh-list
153722217|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
153722226|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722228|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263493|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153722229|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722230|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153722231|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153722232|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722233|NCT00456898|Codeine|codeine|mesh-list
153722234|NCT00456898|Paroxetine|paroxetine|mesh-list
153722235|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153722236|NCT00456898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153722237|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153834296|NCT00518583|Paclitaxel|paclitaxel|mesh-list
153722238|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722239|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722240|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722241|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
153722242|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722243|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153722244|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
153722245|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153722246|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153722247|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153722248|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722249|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153722250|NCT00456898|Narcotics|narcotics|mesh-ancestor
153722251|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153722252|NCT00456898|Analgesics|analgesics|mesh-ancestor
153722253|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
153722254|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722255|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
153722256|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
153722257|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153722258|NCT03274102|Vaccines|vaccines|mesh-list
153722259|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
153722260|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722272|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722273|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722274|NCT00456937|Escitalopram|escitalopram|mesh-list
153722275|NCT00456937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153722276|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153722277|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430923|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722278|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374383|NCT04338711|Tofacitinib|tofacitinib|mesh-list
153834300|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834301|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
153834302|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
153834303|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
153834304|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834305|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153834306|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153834307|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834308|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834322|NCT00519870|Nifedipine|nifedipine|mesh-list
153722279|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722280|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
153722281|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722282|NCT00456976|Selegiline|selegiline|mesh-list
153722283|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
153722284|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153722285|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153722286|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153722287|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153722288|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858180|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
153722292|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722294|NCT00144066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153722295|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153722296|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722297|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722298|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722299|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
153722300|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
153722301|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153722302|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722303|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722304|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
153722305|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153722306|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153722307|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722308|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
153722309|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153722310|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257263|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722311|NCT00457405|Dipyridamole|dipyridamole|mesh-list
153834323|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153834324|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153834325|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153834326|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153834327|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834328|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153374384|NCT04338711|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153374388|NCT01874951|Naltrexone|naltrexone|mesh-list
153834329|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722312|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153722313|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722314|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722315|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153722316|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
153722317|NCT00457483|Valsartan|valsartan|mesh-list
153722318|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153722319|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153722320|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153722321|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153722346|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153722347|NCT00457678|Growth Substances|growth substances|mesh-ancestor
153722348|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
153722349|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153722350|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
153722351|NCT00457717|Atropine|atropine|mesh-list
153722352|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153722353|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153722354|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153722355|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
153722356|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722357|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722358|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153722359|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
153722360|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
153722361|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
153722362|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153722363|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153722364|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
153722365|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722366|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722367|NCT00110903|Etanercept|etanercept|mesh-list
153722368|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153722369|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153722370|NCT00110903|Analgesics|analgesics|mesh-ancestor
153834330|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153374407|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
153374408|NCT03024437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153374409|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374410|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153820040|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153461452|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461453|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461454|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
153461455|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461456|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153461457|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
153461458|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153461459|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722371|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
153430925|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153722403|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
153722404|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722405|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153722406|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153722407|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722408|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
153722409|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722410|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153722411|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153722412|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153722431|NCT00465907|Irinotecan|irinotecan|mesh-list
153722432|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153722433|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722434|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
153722435|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
153722436|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
153722437|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722438|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153722439|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153722440|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722441|NCT00113685|Dextrans|dextrans|mesh-list
153722442|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153722443|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
153722444|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
153722445|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
153722446|NCT00111020|Sorafenib|sorafenib|mesh-list
153722447|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722448|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153722449|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722450|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722451|NCT00466063|Deferasirox|deferasirox|mesh-list
153722452|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153722453|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
154257264|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153722454|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
153722455|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722456|NCT00466102|Everolimus|everolimus|mesh-list
153722457|NCT00466102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153722458|NCT00466102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153461460|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461461|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153461462|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
153461463|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153461464|NCT03082482|Nicotine|nicotine|mesh-list
153820041|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820042|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153820043|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153820044|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820045|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722459|NCT00466102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722460|NCT00466102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722461|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153722462|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
153722463|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722464|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722465|NCT00144222|Telmisartan|telmisartan|mesh-list
153722466|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153722467|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153722468|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153722469|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722470|NCT00466180|Nevirapine|nevirapine|mesh-list
153722471|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153722472|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153722473|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722474|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722475|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
153559500|NCT01633762|Gentamicins|gentamicins|mesh-list
153722476|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722477|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153722478|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153722479|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153722493|NCT00144261|Nevirapine|nevirapine|mesh-list
153722494|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153722495|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153722496|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430926|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153834342|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
153834343|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834344|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834345|NCT04514588|Caffeine|caffeine|mesh-list
153834346|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153834347|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374412|NCT01489826|HU 211|hu 211|mesh-list
153374424|NCT01489826|Protective Agents|protective agents|mesh-ancestor
153722497|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722498|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
153722499|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722500|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153722501|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153722512|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722513|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
153722514|NCT00111098|Hematinics|hematinics|mesh-ancestor
153722515|NCT00347698|Bevacizumab|bevacizumab|mesh-list
153722516|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153722517|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722518|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153722519|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153722520|NCT00347698|Growth Substances|growth substances|mesh-ancestor
153722521|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722522|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
153722523|NCT00347737|Teriparatide|teriparatide|mesh-list
153722524|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153722525|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722526|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153722527|NCT00347815|Buprenorphine|buprenorphine|mesh-list
153374425|NCT02677623|Mannitol|mannitol|mesh-list
153374426|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153374427|NCT02677623|Diuretics|diuretics|mesh-ancestor
153374428|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
153461472|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461473|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461475|NCT03308916|Hematinics|hematinics|mesh-ancestor
153461476|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
153461477|NCT03081702|Itraconazole|itraconazole|mesh-list
153461478|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
153461479|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153461480|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153461481|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461482|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461483|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461484|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461485|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
153461486|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153461487|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153461488|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153461489|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
153461490|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461491|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781773|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153820057|NCT00431678|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153834355|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
153722528|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153722529|NCT00347815|Narcotics|narcotics|mesh-ancestor
153722530|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153722531|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722532|NCT00347815|Analgesics|analgesics|mesh-ancestor
153722533|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
153722534|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722535|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153722536|NCT00113802|Epratuzumab|epratuzumab|mesh-list
153722538|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
153722539|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722540|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153722541|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722542|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
153722578|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153722579|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722580|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722581|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722601|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
154257265|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153722602|NCT00111215|Coagulants|coagulants|mesh-ancestor
153722603|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153722604|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
153722605|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722606|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
153722607|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
153722608|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
153722609|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722610|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722611|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
153722612|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153722613|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153722614|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
153722615|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834356|NCT02276300|Imiquimod|imiquimod|mesh-list
153834357|NCT02276300|Sargramostim|sargramostim|mesh-list
153834358|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153834359|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
153834360|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834361|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153834362|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153834363|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
153834364|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820058|NCT00431678|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153820059|NCT00471003|Telmisartan|telmisartan|mesh-list
153820060|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153820061|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153820062|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153820063|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820064|NCT00471042|Buprenorphine|buprenorphine|mesh-list
153722616|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722617|NCT00348244|Prednisolone|prednisolone|mesh-list
153722618|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153722619|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
153722624|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
153736064|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153722625|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722626|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
153722627|NCT00348244|Hormones|hormones|mesh-ancestor
153722628|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722629|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722630|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153722631|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722632|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
153722633|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
153722634|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722669|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
153722670|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722671|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722672|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722673|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153722674|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722675|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
153722697|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722699|NCT00348712|Metformin|metformin|mesh-list
153722700|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
153722701|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153722702|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834365|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834366|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153834367|NCT02276300|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153834368|NCT02276300|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153834369|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153834370|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
153834371|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
153834372|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
153374429|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374430|NCT02677701|Azithromycin|azithromycin|mesh-list
153374431|NCT02677701|Tobramycin|tobramycin|mesh-list
153722703|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461500|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461501|NCT03237390|Gemcitabine|gemcitabine|mesh-list
153722705|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722706|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722707|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722708|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153722709|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153722710|NCT00348985|Bortezomib|bortezomib|mesh-list
153722711|NCT00348985|Belinostat|belinostat|mesh-list
153722712|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722713|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153722714|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722715|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722716|NCT00349024|Povidone|povidone|mesh-list
153722717|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
153722718|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153722719|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
153722720|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722721|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
153722722|NCT00349024|Protective Agents|protective agents|mesh-ancestor
153722723|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
153722724|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
153722725|NCT00111371|Levodopa|levodopa|mesh-list
153722726|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153722727|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153461502|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153461503|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
153461504|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461505|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722728|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
153722729|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722730|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722741|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153722742|NCT00421369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153722743|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153722744|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722745|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722746|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722747|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
153722748|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722749|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153722750|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
153722751|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153722752|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722753|NCT00421447|Anastrozole|anastrozole|mesh-list
153722754|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153722755|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722756|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153722757|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153430927|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722762|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722763|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722766|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153722767|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722768|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
153722769|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153722770|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153722771|NCT00349219|Cisplatin|cisplatin|mesh-list
153722772|NCT00349219|Gemcitabine|gemcitabine|mesh-list
153722773|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153722774|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722775|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153722776|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
153834379|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834380|NCT02955251|Nivolumab|nivolumab|mesh-list
153834381|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153834382|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834383|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153834384|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834385|NCT00518895|Dacarbazine|dacarbazine|mesh-list
153834386|NCT00518895|Oblimersen|oblimersen|mesh-list
153834387|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153374464|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153559802|NCT01635686|Etanercept|etanercept|mesh-list
153722777|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722778|NCT00349219|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153722779|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153722780|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722782|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153722783|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153722784|NCT00111449|Analgesics|analgesics|mesh-ancestor
153722785|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
153722786|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722787|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722788|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722789|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722790|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722791|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153722792|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
153722793|NCT00349258|Leuprolide|leuprolide|mesh-list
153722794|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153722795|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
153722814|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722816|NCT00349492|Cisplatin|cisplatin|mesh-list
153722817|NCT00349492|Irinotecan|irinotecan|mesh-list
153722818|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722819|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153722820|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153722821|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722822|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722823|NCT00349531|Pramipexole|pramipexole|mesh-list
153834401|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153834402|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153834403|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
153834405|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834406|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153374465|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
153374466|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374467|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374468|NCT02425098|Vaccines|vaccines|mesh-list
153374469|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
153374470|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374471|NCT02424630|Ropivacaine|ropivacaine|mesh-list
153374472|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
153374473|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
153374474|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374475|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374476|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
153722824|NCT00349531|Dexpramipexole|dexpramipexole|mesh-list
153722825|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
153722826|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722827|NCT00349531|Protective Agents|protective agents|mesh-ancestor
153722828|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722829|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153722830|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153722831|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
153722832|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
153722833|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722834|NCT00111566|Eptifibatide|eptifibatide|mesh-list
153722835|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153722836|NCT00404703|Bevacizumab|bevacizumab|mesh-list
153722837|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153722838|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722839|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153722840|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153722841|NCT00404703|Growth Substances|growth substances|mesh-ancestor
153722842|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722843|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
153722844|NCT00349726|Inositol|inositol|mesh-list
153722845|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
153722846|NCT00349726|Vitamins|vitamins|mesh-ancestor
153722847|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
153722848|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722873|NCT00114153|Capecitabine|capecitabine|mesh-list
153722874|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722875|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430928|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
153722876|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
153722877|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722878|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
153722879|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
153722880|NCT00350116|Vitamins|vitamins|mesh-ancestor
153722881|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
153722882|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722883|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
153722884|NCT00350116|Hematinics|hematinics|mesh-ancestor
153722885|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
153722886|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153722887|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153722888|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722889|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722890|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153722891|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153722892|NCT00350155|Analgesics|analgesics|mesh-ancestor
153722893|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
153722894|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722895|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722896|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722897|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722898|NCT00404781|Aspirin|aspirin|mesh-list
153722899|NCT00404781|Cilostazol|cilostazol|mesh-list
153722900|NCT00404781|Clopidogrel|clopidogrel|mesh-list
153722901|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153722902|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153722903|NCT00404781|Analgesics|analgesics|mesh-ancestor
153722904|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
153722905|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722906|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722907|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722908|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722909|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153722910|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153722916|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153722917|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153722918|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153722919|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
153722920|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722921|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153722923|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153722924|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
153722925|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
153722926|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153722927|NCT00404781|Protective Agents|protective agents|mesh-ancestor
153722928|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153722929|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153559949|NCT01636271|Darapladib|darapladib|mesh-list
153722931|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153722932|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
153722933|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722934|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722935|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153722936|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153722937|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
153722938|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722939|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722940|NCT00114192|Thalidomide|thalidomide|mesh-list
153722941|NCT00114192|Docetaxel|docetaxel|mesh-list
153722942|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722943|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
153722944|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
153374555|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
153374556|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
153834460|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153834461|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153722951|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153722952|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722954|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153722955|NCT00114192|Growth Substances|growth substances|mesh-ancestor
153722956|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
153722958|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153722959|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
153722960|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
153722961|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722962|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722963|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722964|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153722965|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153722966|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153722967|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153722968|NCT00350467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153722969|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153722970|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722971|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722972|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722973|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
153722974|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153722975|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153722976|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153722977|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153722978|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
153722991|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722992|NCT00350857|Carbamazepine|carbamazepine|mesh-list
153722993|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
153722994|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
153722995|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153722996|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153722997|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722998|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153722999|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153723000|NCT00350857|Analgesics|analgesics|mesh-ancestor
153723001|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
153723002|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723003|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153723004|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723005|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723006|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153723007|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153723009|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153834464|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723010|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153723011|NCT00111956|Analgesics|analgesics|mesh-ancestor
153723012|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
153723013|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723014|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723015|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723016|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723017|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153723018|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723019|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
153723020|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
153723021|NCT00114270|Letrozole|letrozole|mesh-list
153723022|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723023|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153723024|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153723032|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
153723033|NCT00111995|Hematinics|hematinics|mesh-ancestor
153723034|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
153723035|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153723036|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153723037|NCT00351052|Analgesics|analgesics|mesh-ancestor
153723038|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
153723039|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723040|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723041|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723076|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560121|NCT01636908|Everolimus|everolimus|mesh-list
153723077|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723078|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723087|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723089|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
153374573|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
153374574|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153374575|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153374576|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153834492|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153834493|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834494|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153834495|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153834497|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
153834498|NCT02949258|Etoposide|etoposide|mesh-list
153834499|NCT02949258|Epirubicin|epirubicin|mesh-list
153834500|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834509|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
153723090|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723091|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
153723092|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153723093|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153723094|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153723095|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723096|NCT00401648|Brivaracetam|brivaracetam|mesh-list
153723097|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
153723098|NCT00351286|Simvastatin|simvastatin|mesh-list
153723099|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153723100|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153723101|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
153723102|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723103|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153723104|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153723105|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723106|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
153723107|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153723108|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153723109|NCT00112034|Prednisolone|prednisolone|mesh-list
153723110|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
153723111|NCT00112034|Methotrexate|methotrexate|mesh-list
153723112|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153723113|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
153723114|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153723115|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
153723116|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153723117|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723118|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723119|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
153723120|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723121|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723122|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
153723123|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723124|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153723125|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723126|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
153723127|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723128|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153723129|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723130|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
153723135|NCT00112034|Hormones|hormones|mesh-ancestor
153723136|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153723137|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153723138|NCT00112034|Protective Agents|protective agents|mesh-ancestor
153723139|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153723140|NCT00114387|Tocopherols|tocopherols|mesh-list
153723141|NCT00114387|Vitamin E|vitamin e|mesh-list
153723142|NCT00114387|Tocotrienols|tocotrienols|mesh-list
153723143|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
153723165|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723166|NCT05595096|Anesthetics|anesthetics|mesh-list
153723167|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723168|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723169|NCT00351637|Methadone|methadone|mesh-list
153723170|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153723171|NCT00351637|Narcotics|narcotics|mesh-ancestor
153723172|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723173|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723174|NCT00351637|Analgesics|analgesics|mesh-ancestor
153723175|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
153723176|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723177|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
153723178|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
153723179|NCT00351715|Methadone|methadone|mesh-list
153723180|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153723181|NCT00351715|Narcotics|narcotics|mesh-ancestor
153723182|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723183|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723184|NCT00351715|Analgesics|analgesics|mesh-ancestor
153723185|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
153723186|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257267|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153723187|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
153723188|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
153723189|NCT00351832|Vildagliptin|vildagliptin|mesh-list
153723190|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153723191|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723192|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153374621|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153374622|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374623|NCT04553367|Meropenem|meropenem|mesh-list
153374624|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153374625|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374626|NCT00369837|Clevidipine|clevidipine|mesh-list
153374648|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723193|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
153723194|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723195|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723196|NCT00351871|Ribavirin|ribavirin|mesh-list
153723210|NCT00351910|Sertraline|sertraline|mesh-list
153723211|NCT00351910|Escitalopram|escitalopram|mesh-list
153723212|NCT00351910|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153723213|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153723214|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723215|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723216|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723217|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
153723218|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723219|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723220|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153723221|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
153723222|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153723223|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153723224|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
153723225|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153723226|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153723227|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723228|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153723229|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153723230|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723231|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153723232|NCT00351910|Analgesics|analgesics|mesh-ancestor
153723233|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
153723234|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153374649|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153374650|NCT05441631|Insulin|insulin|mesh-list
153374651|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153374652|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153374653|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374654|NCT01546454|Leuprolide|leuprolide|mesh-list
153834560|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
153834561|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153834562|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153834563|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153834564|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153834580|NCT02954939|Prednisone|prednisone|mesh-list
153374655|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153723235|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153723243|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723244|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153723245|NCT00352144|Eszopiclone|eszopiclone|mesh-list
153723246|NCT00352144|Zopiclone|zopiclone|mesh-list
153723247|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153723248|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723249|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723250|NCT00352183|Simvastatin|simvastatin|mesh-list
153723251|NCT00352183|Fenofibrate|fenofibrate|mesh-list
153723252|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153723253|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153723254|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
153723255|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723256|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153723257|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153723258|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723259|NCT00112619|Topotecan|topotecan|mesh-list
153723270|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153723271|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723272|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723273|NCT00352300|Paclitaxel|paclitaxel|mesh-list
153723274|NCT00352300|Carboplatin|carboplatin|mesh-list
153723275|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153723276|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723277|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723278|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
153723279|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723280|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723281|NCT00112658|Leucovorin|leucovorin|mesh-list
153723282|NCT00112658|Gemcitabine|gemcitabine|mesh-list
153374656|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153374657|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
153374658|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153374659|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153374660|NCT01546454|Estradiol|estradiol|mesh-list
153374661|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153374662|NCT01546454|Progesterone|progesterone|mesh-list
153374663|NCT01546454|Estrogens|estrogens|mesh-ancestor
153374664|NCT01546454|Hormones|hormones|mesh-ancestor
153374665|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153374666|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374667|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153374686|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723283|NCT00112658|Fluorouracil|fluorouracil|mesh-list
153723284|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
153723285|NCT00112658|Irinotecan|irinotecan|mesh-list
153723286|NCT00112658|Calcium|calcium|mesh-list
153723287|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
153723288|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723289|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
154257269|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723290|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723291|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723292|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723293|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723294|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723295|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
153723296|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153723297|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153723298|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723299|NCT00112658|Antidotes|antidotes|mesh-ancestor
153723300|NCT00112658|Protective Agents|protective agents|mesh-ancestor
153723301|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
153723303|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
153723304|NCT00352339|Aripiprazole|aripiprazole|mesh-list
153723305|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
153723306|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153723307|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153723308|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153723309|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723310|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723311|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
153723312|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
153723313|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723314|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723315|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153723320|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153723321|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153723322|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
153723323|NCT00352378|Docetaxel|docetaxel|mesh-list
153723324|NCT00352378|Doxorubicin|doxorubicin|mesh-list
153723325|NCT00352378|Capecitabine|capecitabine|mesh-list
153723326|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723347|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153723348|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723349|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
153723350|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723351|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723352|NCT00112697|Docetaxel|docetaxel|mesh-list
153723353|NCT00112697|Fluorouracil|fluorouracil|mesh-list
153723354|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723355|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723356|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
153723357|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723358|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723359|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
153723360|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723361|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723362|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
153723363|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723364|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
153723365|NCT02959606|Clopidogrel|clopidogrel|mesh-list
153723366|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153723367|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153723368|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153723369|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153723370|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
153723371|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723372|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723373|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723374|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153723375|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153560408|NCT01638182|Vitamin K|vitamin k|mesh-list
153723376|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153723377|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
153723378|NCT00352651|Pregabalin|pregabalin|mesh-list
153723379|NCT00352651|Analgesics|analgesics|mesh-ancestor
153723380|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
153723400|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723401|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723402|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153723403|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153723404|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723405|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723406|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153723407|NCT00352768|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153723408|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153723409|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153858417|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723416|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153723417|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153723418|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153723419|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153723420|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153723421|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153723422|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
153723423|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723424|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723425|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723426|NCT00112853|Etoposide|etoposide|mesh-list
153723427|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
153723428|NCT00112853|Tipifarnib|tipifarnib|mesh-list
153723429|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153723430|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723431|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153723455|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153834632|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
153374742|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374743|NCT01431014|Dexamethasone|dexamethasone|mesh-list
153723456|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153374744|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
153723457|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153723458|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723459|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723461|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153723462|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723463|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723464|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723465|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723466|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153723467|NCT00112892|Selenium|selenium|mesh-list
153723468|NCT00112892|Irinotecan|irinotecan|mesh-list
153723469|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153723470|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153723471|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723472|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723473|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723474|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
153723475|NCT00112892|Protective Agents|protective agents|mesh-ancestor
153723476|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723477|NCT00112892|Trace Elements|trace elements|mesh-ancestor
153723478|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
153723479|NCT00353665|Riluzole|riluzole|mesh-list
153723491|NCT00353665|Protective Agents|protective agents|mesh-ancestor
153723492|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
153723493|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153723494|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723495|NCT00353743|Metronidazole|metronidazole|mesh-list
153723496|NCT00353743|Doxycycline|doxycycline|mesh-list
153723497|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723498|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153723499|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153374745|NCT01431014|BB 1101|bb 1101|mesh-list
153374746|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374747|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
153374748|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
153374749|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374750|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374751|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374752|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
153723500|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153723501|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
153723502|NCT00113165|Lamotrigine|lamotrigine|mesh-list
153723503|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
153858429|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
153723513|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153723514|NCT00354094|Reboxetine|reboxetine|mesh-list
153723515|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
153723516|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153723517|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153723518|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153723519|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723520|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723521|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
153723522|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723523|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257270|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153723524|NCT00114816|Docetaxel|docetaxel|mesh-list
153723525|NCT00114816|Capecitabine|capecitabine|mesh-list
153723526|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723527|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723528|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
153723529|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723530|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723531|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723532|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
153723533|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
153723534|NCT00354367|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153723535|NCT00354367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723536|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723537|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
153723538|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723539|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723540|NCT00354406|Abciximab|abciximab|mesh-list
153723541|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
153723542|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153723543|NCT00354523|Capecitabine|capecitabine|mesh-list
153723556|NCT00114933|Lopinavir|lopinavir|mesh-list
153723557|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153834672|NCT00521430|Busulfan|busulfan|mesh-list
153723558|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153723559|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
153723560|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723561|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723562|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153723563|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153723564|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
153723565|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723566|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153723567|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153723568|NCT00113282|Interleukin-2|interleukin-2|mesh-list
153723569|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723570|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153723571|NCT00113282|Analgesics|analgesics|mesh-ancestor
153723572|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
153723573|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723574|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723575|NCT00425932|Rituximab|rituximab|mesh-list
153858448|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
153723578|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
153723579|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723580|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723582|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153723583|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723584|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153723585|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723586|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723587|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153723588|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153723589|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
153723590|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723591|NCT00115011|Escitalopram|escitalopram|mesh-list
153723592|NCT00115011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153723593|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153723594|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723595|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723596|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723597|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
153723598|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723599|NCT00113594|Olanzapine|olanzapine|mesh-list
153723600|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
153723601|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
153723602|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723603|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723640|NCT00115245|Telbivudine|telbivudine|mesh-list
153723641|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
153723663|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723664|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723665|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153723666|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723667|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
153723668|NCT00444379|Ritonavir|ritonavir|mesh-list
153560716|NCT01639807|Latanoprost|latanoprost|mesh-list
153723669|NCT00444379|Lopinavir|lopinavir|mesh-list
153723670|NCT00444379|Tenofovir|tenofovir|mesh-list
153723671|NCT00444379|Emtricitabine|emtricitabine|mesh-list
153723672|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153723673|NCT00444379|Efavirenz|efavirenz|mesh-list
153723674|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153723675|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153723676|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
153723677|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723678|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723679|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153723680|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153723681|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
153723682|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723683|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153723684|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153723685|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153723686|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153723687|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153723688|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153723724|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
153723725|NCT00113828|Cyclosporine|cyclosporine|mesh-list
153723726|NCT00113828|Cyclosporins|cyclosporins|mesh-list
153723727|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723728|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723729|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723730|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
153723731|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723732|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
153723733|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834728|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153834729|NCT05146778|Analgesics|analgesics|mesh-ancestor
153834730|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153374816|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153374817|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153374819|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374820|NCT02371746|Travoprost|travoprost|mesh-list
153374821|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153374822|NCT01431794|Paclitaxel|paclitaxel|mesh-list
153374823|NCT01431794|Gemcitabine|gemcitabine|mesh-list
153374824|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153834732|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153834735|NCT05146778|Narcotics|narcotics|mesh-ancestor
153723734|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
153723735|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723736|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153723759|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153723760|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723761|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723762|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723763|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723764|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153723765|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
153723766|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153723768|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723769|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153723770|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723771|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723772|NCT00445081|Cyclosporine|cyclosporine|mesh-list
153723773|NCT00445081|Prednisolone|prednisolone|mesh-list
153723774|NCT00445081|Cyclosporins|cyclosporins|mesh-list
153723775|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723776|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
153723777|NCT00445081|Hormones|hormones|mesh-ancestor
153723778|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153723779|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723780|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153723781|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723782|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723783|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723784|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723785|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
153723786|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
153723787|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723802|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153723804|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153723805|NCT00445276|Diacerein|diacerein|mesh-list
153723806|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723807|NCT00113984|Metronidazole|metronidazole|mesh-list
153723808|NCT00113984|Ipilimumab|ipilimumab|mesh-list
153723809|NCT00113984|Sargramostim|sargramostim|mesh-list
153723810|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
153723811|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723812|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723813|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153723814|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153723815|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723816|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723817|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153723818|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153723823|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723824|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723826|NCT00114023|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153723827|NCT00114023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783829|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834782|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834783|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153834784|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153723828|NCT00114023|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153723829|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
153723830|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723831|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153723832|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723833|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
153723834|NCT00445861|Docetaxel|docetaxel|mesh-list
153723835|NCT00445861|Cetuximab|cetuximab|mesh-list
153723836|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723837|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723838|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
153723839|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723840|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723841|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153723842|NCT00445900|Thalidomide|thalidomide|mesh-list
153723844|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
153723845|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723871|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
153723872|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723873|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
153723874|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723876|NCT00446017|Epinephrine|epinephrine|mesh-list
153723877|NCT00446017|Racepinephrine|racepinephrine|mesh-list
153723878|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
153723879|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153723880|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153723881|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
153723882|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723883|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723884|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723885|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153723886|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153723887|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
153723888|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723889|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153723890|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
153723891|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
153723892|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
153723893|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153723894|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153723923|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723924|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723925|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153723926|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
153723927|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153723929|NCT00446368|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153723930|NCT00446368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153723931|NCT00446368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723932|NCT00446368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723933|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723934|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
153724012|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724013|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
153724014|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724015|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724016|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724017|NCT00114374|Escitalopram|escitalopram|mesh-list
153724018|NCT00114374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153724019|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153724020|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153724049|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153724050|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
153724051|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724052|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724053|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153724054|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153724055|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153724056|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
153724057|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724058|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724059|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153724060|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153724061|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
153724064|NCT00115635|Docetaxel|docetaxel|mesh-list
153724078|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724079|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724080|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153724081|NCT00447577|Tobramycin|tobramycin|mesh-list
153724082|NCT00447577|Dexamethasone|dexamethasone|mesh-list
153724083|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724084|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
153724085|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
153724086|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724087|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724088|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724089|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
153724090|NCT00447577|Hormones|hormones|mesh-ancestor
153724091|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724092|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153724093|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724094|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153724095|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724096|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153724097|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153724098|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153724099|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153724100|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
153724101|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724102|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153724103|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153724104|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724105|NCT00114569|Lorazepam|lorazepam|mesh-list
153724106|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
153724107|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
153724117|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
153724118|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
153834845|NCT00521859|Fludarabine|fludarabine|mesh-list
153834846|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
153834847|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834848|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153834851|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153834852|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
153834853|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724119|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724120|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724121|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
153724122|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
153724123|NCT00447967|Leucovorin|leucovorin|mesh-list
153724124|NCT00447967|Fluorouracil|fluorouracil|mesh-list
153724125|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
153724126|NCT00447967|Irinotecan|irinotecan|mesh-list
153724127|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
153724152|NCT00448240|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153724153|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724154|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724155|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724156|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724158|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724159|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
153724160|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724161|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724162|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724163|NCT00114686|Valproic Acid|valproic acid|mesh-list
153724164|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153724165|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
153724166|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153724167|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153724168|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153724169|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724170|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724171|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724172|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724173|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
153724175|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
153724176|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724190|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724191|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724192|NCT00448552|Capecitabine|capecitabine|mesh-list
153724193|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
153724194|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153724195|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
153724196|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724197|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724199|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153724200|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724201|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724202|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724203|NCT00114764|Lenograstim|lenograstim|mesh-list
153724204|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153724205|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
153724206|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724207|NCT00448786|Niacinamide|niacinamide|mesh-list
153724215|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
153724216|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724218|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
153724219|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153724220|NCT00114803|Katacalcin|katacalcin|mesh-list
153724221|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153724222|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724223|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153724224|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
153724225|NCT00448825|Topiramate|topiramate|mesh-list
153724226|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
153724227|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724228|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724229|NCT00448903|Bemiparin|bemiparin|mesh-list
153724230|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
153724231|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
153724232|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153724233|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724234|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
153724235|NCT00402012|Pioglitazone|pioglitazone|mesh-list
153724236|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724237|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724238|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
153724239|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153724253|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153724254|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724255|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153724256|NCT03276325|Narcotics|narcotics|mesh-ancestor
153724257|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724258|NCT03276325|Analgesics|analgesics|mesh-ancestor
153724259|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
153724260|NCT00449020|Carboplatin|carboplatin|mesh-list
153724261|NCT00449020|Docetaxel|docetaxel|mesh-list
153724262|NCT00449020|Irinotecan|irinotecan|mesh-list
153724263|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724264|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
153724265|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724266|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724267|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724269|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153724273|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153724275|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724276|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153724277|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153724278|NCT00115752|Analgesics|analgesics|mesh-ancestor
153724279|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
153724280|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724281|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724282|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724283|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153724284|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
153724285|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
153724286|NCT00114920|Resiquimod|resiquimod|mesh-list
153834903|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
153724287|NCT00114920|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153724288|NCT00114920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724289|NCT00114920|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153724290|NCT00114920|Immunologic Factors|immunologic factors|mesh-ancestor
153724291|NCT00114920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724292|NCT00449137|Leucovorin|leucovorin|mesh-list
153724293|NCT00449137|Fluorouracil|fluorouracil|mesh-list
153724294|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
153724295|NCT00449137|Calcium|calcium|mesh-list
153724296|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
153724297|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153724298|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724299|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
153724300|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724301|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153724302|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724303|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153724304|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
153724317|NCT00449410|Atorvastatin|atorvastatin|mesh-list
153724318|NCT00449410|Ezetimibe|ezetimibe|mesh-list
153724319|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153724320|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153724321|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
153724322|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724323|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153724324|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153724325|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724326|NCT00449449|Lidocaine|lidocaine|mesh-list
153724327|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
153724328|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
153724329|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724330|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724331|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
153724332|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724333|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153724334|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153724335|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153724336|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153724337|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724338|NCT00115115|Dopamine|dopamine|mesh-list
153724339|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153724340|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
153724341|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
153724342|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724343|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834932|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724344|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
153724345|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724346|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724347|NCT00115115|Protective Agents|protective agents|mesh-ancestor
153724348|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
153724349|NCT00449488|Hematinics|hematinics|mesh-ancestor
153724350|NCT00115830|Atorvastatin|atorvastatin|mesh-list
153724351|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153724352|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153724353|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153736068|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
153736069|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153736070|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153736071|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736072|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
153736073|NCT03822793|Coagulants|coagulants|mesh-ancestor
153736074|NCT03816358|Gemcitabine|gemcitabine|mesh-list
153736075|NCT03816358|Nivolumab|nivolumab|mesh-list
153736076|NCT03816358|Ipilimumab|ipilimumab|mesh-list
153724362|NCT00115154|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153724363|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
153724364|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724365|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153724366|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724367|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
153724368|NCT00449527|Budesonide|budesonide|mesh-list
153724369|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
153724390|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
153724391|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724392|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724393|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724394|NCT00449683|Urological Agents|urological agents|mesh-ancestor
153724396|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153724397|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153724398|NCT00449722|Analgesics|analgesics|mesh-ancestor
153724399|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
153724400|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724401|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834965|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724402|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724403|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153724404|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
153724405|NCT00449800|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153724406|NCT00449800|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153724407|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153724408|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724409|NCT00449839|Insulin|insulin|mesh-list
153724410|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153724411|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
153724412|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
153724413|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153724414|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724415|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724416|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153724417|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153724418|NCT00450229|Protective Agents|protective agents|mesh-ancestor
153724419|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724420|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724421|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153724445|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724446|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724447|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153724451|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724453|NCT05536362|Ketamine|ketamine|mesh-list
153724454|NCT05536362|Propofol|propofol|mesh-list
153724455|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153724456|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724457|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724458|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153724459|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
153724461|NCT05536362|Analgesics|analgesics|mesh-ancestor
153724462|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
153724463|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834966|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153375032|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375033|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153834984|NCT00523692|Protective Agents|protective agents|mesh-ancestor
153724464|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153724465|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153724466|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153724467|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724468|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724469|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153724470|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
153724471|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
153724484|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
153724485|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724486|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724488|NCT00450892|Trastuzumab|trastuzumab|mesh-list
153724489|NCT00450892|Lapatinib|lapatinib|mesh-list
153545822|NCT06300099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724490|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724491|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
153724492|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724493|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724494|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724495|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153724496|NCT00450892|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153724497|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724498|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724499|NCT00115310|Capsaicin|capsaicin|mesh-list
153724500|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
153724501|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
153724502|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
153724503|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724504|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724505|NCT00115908|Ribavirin|ribavirin|mesh-list
153724506|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153724507|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
153724508|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724509|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
153724510|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724511|NCT00458185|Etanercept|etanercept|mesh-list
153834985|NCT00523692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153375090|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724512|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153724513|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153724514|NCT00458185|Analgesics|analgesics|mesh-ancestor
153724515|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
153724516|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724517|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724518|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724519|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153724520|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724521|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153724522|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
153724523|NCT00458263|Hormones|hormones|mesh-list
153724524|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724525|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724526|NCT00458419|Naloxone|naloxone|mesh-list
153724527|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153724528|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724529|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
153724530|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724531|NCT00458458|Leuprolide|leuprolide|mesh-list
153724558|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153724559|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724560|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153724561|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153375091|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153834991|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834992|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834993|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834994|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
153834995|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
153834996|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834997|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
153834998|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153834999|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
153835000|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153835001|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
153835002|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153835003|NCT05148689|Protective Agents|protective agents|mesh-ancestor
153835004|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
153835005|NCT00522444|Analgesics|analgesics|mesh-ancestor
153835006|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
153835007|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835008|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835009|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
153835010|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724562|NCT00458731|Growth Substances|growth substances|mesh-ancestor
153724563|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736077|NCT03816358|Maytansine|maytansine|mesh-list
153724564|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
153724565|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
153724566|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724567|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724568|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724569|NCT03274024|Mitomycins|mitomycins|mesh-list
153724570|NCT03274024|Mitomycin|mitomycin|mesh-list
153724571|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153724572|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724573|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
153724574|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724575|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153724576|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724577|NCT00115947|Terlipressin|terlipressin|mesh-list
153724578|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153724579|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153724580|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
153724581|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724582|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153724583|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724584|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724585|NCT00459004|Rimonabant|rimonabant|mesh-list
153724586|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153724587|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153724612|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
153724613|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724614|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724615|NCT04728321|Lenvatinib|lenvatinib|mesh-list
153724616|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724617|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724618|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724619|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724620|NCT00459901|Capecitabine|capecitabine|mesh-list
153724621|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153724622|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153724623|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
153724624|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724625|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724626|NCT00459901|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153724627|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724628|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724629|NCT00401804|Dexamethasone|dexamethasone|mesh-list
153724630|NCT00401804|Doxorubicin|doxorubicin|mesh-list
153724631|NCT00401804|Bortezomib|bortezomib|mesh-list
153724632|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724633|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
153724634|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
153724635|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724636|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724662|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153724663|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153724665|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724666|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
153724667|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153724668|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
153724669|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724670|NCT00460213|Valsartan|valsartan|mesh-list
153724718|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724719|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
153736078|NCT03816358|Anetumab ravtansine|anetumab ravtansine|mesh-list
153724720|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724721|NCT00460681|Thymopentin|thymopentin|mesh-list
153724722|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153724723|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
153724724|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724739|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724740|NCT00460876|Topotecan|topotecan|mesh-list
153724741|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153724742|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153724743|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724744|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724745|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724746|NCT00460915|Amlodipine|amlodipine|mesh-list
153724747|NCT00460915|Lacidipine|lacidipine|mesh-list
153724748|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153724749|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153724750|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153724751|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724752|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153724753|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724754|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
153724755|NCT00460954|Levodopa|levodopa|mesh-list
153835038|NCT05145218|Paclitaxel|paclitaxel|mesh-list
153835071|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153724756|NCT00460954|Carbidopa|carbidopa|mesh-list
153724757|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153724758|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153724759|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153724760|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
153724761|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724762|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724763|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724764|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153724765|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724766|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153724767|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
153724768|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
153724769|NCT00461149|Octreotide|octreotide|mesh-list
153724770|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724771|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153724772|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724773|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
153724774|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724775|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398967|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
153724782|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724784|NCT00461344|Docetaxel|docetaxel|mesh-list
153724785|NCT00461344|Doxorubicin|doxorubicin|mesh-list
153724786|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724810|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724811|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724812|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724813|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153375137|NCT04849377|Cisplatin|cisplatin|mesh-list
153375138|NCT04849377|Carboplatin|carboplatin|mesh-list
153375140|NCT05511779|Brincidofovir|brincidofovir|mesh-list
153724814|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
153724815|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724816|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153724817|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153724818|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
153724819|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153724820|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153724821|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153724822|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153724823|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153724824|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724825|NCT03273595|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153724826|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724827|NCT03273556|Lidocaine|lidocaine|mesh-list
153724828|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
154257272|NCT01283204|Leucovorin|leucovorin|mesh-list
154257273|NCT01283204|Paclitaxel|paclitaxel|mesh-list
153724829|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
153724830|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724831|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724832|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
153724833|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724834|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153724835|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153724836|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153724837|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153724852|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
153724853|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
153724854|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724855|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153724856|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153835099|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835100|NCT05141240|Palbociclib|palbociclib|mesh-list
153835101|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835102|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153835103|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835104|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835105|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
153835106|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
153835107|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724857|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724858|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
153724859|NCT04697992|Coagulants|coagulants|mesh-ancestor
153724860|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
153724861|NCT04697992|Protective Agents|protective agents|mesh-ancestor
153724862|NCT05483634|Estrogens|estrogens|mesh-list
153724863|NCT05483634|Hormones|hormones|mesh-ancestor
153724864|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724865|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724866|NCT00461578|Artesunate|artesunate|mesh-list
153724867|NCT00461578|Dapsone|dapsone|mesh-list
153724868|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
153724869|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
153724870|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153724871|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153724872|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724873|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724874|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
153724875|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
153724876|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153724877|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
153724878|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153724879|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724880|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724881|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
153724885|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724887|NCT00116064|Paraldehyde|paraldehyde|mesh-list
153724888|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
153724889|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
153724890|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
153724891|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724892|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724893|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724894|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153724895|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724896|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153724897|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153724898|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153724899|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
153724900|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
153724928|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153724929|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724930|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724932|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724933|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724934|NCT00462358|Filanesib|filanesib|mesh-list
153724935|NCT00462358|Lenograstim|lenograstim|mesh-list
153724936|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153724937|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
153724938|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724939|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724940|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724941|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724942|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724943|NCT00116181|Etanercept|etanercept|mesh-list
153724944|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153724945|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153724946|NCT00116181|Analgesics|analgesics|mesh-ancestor
153724982|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153724983|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
153724984|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724985|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725020|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375241|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
153725022|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725023|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
153725024|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153725025|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153725131|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725132|NCT00463957|Urological Agents|urological agents|mesh-ancestor
153725133|NCT00464035|Calcium|calcium|mesh-list
153725134|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153725147|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153725148|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153725149|NCT00464347|Bevacizumab|bevacizumab|mesh-list
153725150|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153725151|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153725152|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725153|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153725154|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153725155|NCT00464347|Growth Substances|growth substances|mesh-ancestor
153725156|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725157|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
153725158|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725159|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
153725160|NCT00464347|Hormones|hormones|mesh-ancestor
153725161|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725162|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725163|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
153725187|NCT00464503|Pravastatin|pravastatin|mesh-list
153725188|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153725189|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153725190|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
153725191|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725192|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153725193|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153725194|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725195|NCT00116675|Resiquimod|resiquimod|mesh-list
153725196|NCT00116675|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153725197|NCT00116675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725228|NCT00464971|Estradiol|estradiol|mesh-list
153725229|NCT00464971|Estrogens|estrogens|mesh-ancestor
153725230|NCT00464971|Hormones|hormones|mesh-ancestor
153725231|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725232|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736080|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
153736081|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736082|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736083|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736084|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153375242|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153375273|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736085|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153736086|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736087|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
153725237|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153725238|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
153725239|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725240|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153725271|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
153725272|NCT03272425|Allopurinol|allopurinol|mesh-list
153725273|NCT03272425|Lesinurad|lesinurad|mesh-list
153725274|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
153725275|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725276|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725277|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
153725278|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725279|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153725280|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
153725281|NCT03272425|Protective Agents|protective agents|mesh-ancestor
153725282|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725283|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
153725284|NCT00116948|Cimetidine|cimetidine|mesh-list
153725285|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153725286|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725287|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153725288|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
153725309|NCT00465439|Racepinephrine|racepinephrine|mesh-list
153725310|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
153725311|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
153725312|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
153562363|NCT01657201|Voriconazole|voriconazole|mesh-list
153725313|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153725314|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725315|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
153725316|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725317|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153725318|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153375274|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725319|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153725320|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153725321|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725322|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153725323|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153725324|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
153725325|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725326|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153725327|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153725328|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
153725329|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153725330|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
153725331|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
153725332|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
153725333|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153725334|NCT00116727|Etanercept|etanercept|mesh-list
153725335|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153725336|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153725337|NCT00116727|Analgesics|analgesics|mesh-ancestor
153725338|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
153736089|NCT03816358|Immunoconjugates|immunoconjugates|mesh-ancestor
153736090|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
153736091|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736093|NCT03801876|Docetaxel|docetaxel|mesh-list
153736094|NCT03801876|Carboplatin|carboplatin|mesh-list
153736095|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153736096|NCT03801876|Fluorouracil|fluorouracil|mesh-list
153375299|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375300|NCT02215070|Pasireotide|pasireotide|mesh-list
153375301|NCT02215070|Hormones|hormones|mesh-ancestor
153835215|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153835216|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153835217|NCT00525993|Analgesics|analgesics|mesh-ancestor
153835233|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153835234|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
153835235|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
153835236|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153736097|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153736098|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736099|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
153725339|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725340|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725352|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
153725353|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399049|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725357|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725359|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153725360|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153725361|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153725362|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
153725363|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725364|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153725365|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153725366|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
153725367|NCT00117026|Benphothiamine|benphothiamine|mesh-list
153725368|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153725369|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
153725370|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725371|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
153725372|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
153725373|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725374|NCT00473980|Celecoxib|celecoxib|mesh-list
153725375|NCT00473980|Indomethacin|indomethacin|mesh-list
153725376|NCT00473980|Esomeprazole|esomeprazole|mesh-list
153725377|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153725378|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153725379|NCT00473980|Analgesics|analgesics|mesh-ancestor
153725380|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
153725381|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725382|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725383|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725384|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725385|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154257274|NCT01283204|Docetaxel|docetaxel|mesh-list
154257275|NCT01283204|Cisplatin|cisplatin|mesh-list
153725386|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153725387|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725388|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375317|NCT03708237|Gabapentin|gabapentin|mesh-list
153375346|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725389|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153375347|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
153725390|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725391|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153725392|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
153725393|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
153725394|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153725395|NCT00474019|Esomeprazole|esomeprazole|mesh-list
153725396|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153725397|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725398|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153725399|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725400|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725401|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
153725402|NCT00117065|Hematinics|hematinics|mesh-ancestor
153725403|NCT00474136|Diclofenac|diclofenac|mesh-list
153725404|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153725405|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153725406|NCT00474136|Analgesics|analgesics|mesh-ancestor
153725439|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
153725441|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725442|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
153725443|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
153725444|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153725445|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153725446|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153725447|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153725448|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
153725449|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375348|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375349|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153375350|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375351|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375352|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153375353|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375354|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153375355|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
153375356|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375357|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835274|NCT05143073|Ethanol|ethanol|mesh-list
153835295|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153375359|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153375360|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375361|NCT01440764|Furosemide|furosemide|mesh-list
153375362|NCT01440764|Diuretics|diuretics|mesh-ancestor
153375363|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
153725450|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725483|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725484|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725485|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153725486|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725487|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725488|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153725517|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725518|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153725519|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725520|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725521|NCT00475072|Ribavirin|ribavirin|mesh-list
153725522|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153725523|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
153725524|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725525|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
153725526|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725527|NCT00117299|Vatalanib|vatalanib|mesh-list
153725528|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153725529|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725530|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725531|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
153725532|NCT00117000|Testosterone|testosterone|mesh-list
153725533|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
153725534|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
153725535|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153725536|NCT00117000|Androgens|androgens|mesh-ancestor
153725537|NCT00117000|Hormones|hormones|mesh-ancestor
153725538|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725539|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725540|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153725541|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725542|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
153725543|NCT02956408|Vitamin D|vitamin d|mesh-list
153725544|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
153725545|NCT02956408|Vitamins|vitamins|mesh-ancestor
153725546|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
153725547|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725548|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153725549|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153725550|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
153725551|NCT00475189|Norinyl|norinyl|mesh-list
153725552|NCT00475189|Mestranol|mestranol|mesh-list
153725553|NCT00475189|Norethindrone|norethindrone|mesh-list
153725554|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153725574|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725576|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
153736101|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
153725577|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725578|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
153725579|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153725580|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725585|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725587|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153725588|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153725589|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
153725590|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
153725591|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725592|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725593|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153725594|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153725595|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153725596|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
153725597|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725598|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725599|NCT00475618|Fluorides|fluorides|mesh-list
153725600|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
153725601|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
153725602|NCT00475618|Protective Agents|protective agents|mesh-ancestor
153725603|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725604|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
153725605|NCT00117039|Hematinics|hematinics|mesh-ancestor
153725606|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153725607|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153725624|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153725625|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725626|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
153725627|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
153725628|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
153725629|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725630|NCT00475813|Fluticasone|fluticasone|mesh-list
153725631|NCT00475813|Xhance|xhance|mesh-list
153725632|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
153725633|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725634|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153725635|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
153725636|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725637|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835347|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153725638|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153725639|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
153725640|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
153725641|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153725642|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153725643|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153725644|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153725645|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
153725646|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725647|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725648|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
153725649|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153725650|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725651|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
153725652|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725653|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
153725654|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153725655|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153725656|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725657|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
153725658|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
153725659|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153725660|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153725661|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153725662|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154257276|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
154257277|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
153813986|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
153725663|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725664|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430946|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153725707|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
153725708|NCT00117117|Hematinics|hematinics|mesh-ancestor
153835348|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153835349|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
153835358|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
153835359|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
153835360|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
153835361|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153835362|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835363|NCT00525252|Baclofen|baclofen|mesh-list
153375454|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
153725709|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153725710|NCT00117494|Pravastatin|pravastatin|mesh-list
153725741|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725742|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725743|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725744|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
153725745|NCT02273947|BMS-955176|bms-955176|mesh-list
153725746|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153725747|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153725748|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
153725749|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725750|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
153725751|NCT00117689|Tacrolimus|tacrolimus|mesh-list
153725752|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
153725753|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153725754|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725755|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
153725756|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725786|NCT00117728|Nevirapine|nevirapine|mesh-list
153725787|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153725788|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153725789|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725790|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725791|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
153725792|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725793|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153725794|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153375455|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375456|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153835367|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835368|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153835369|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
153835370|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
153835371|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835372|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835373|NCT02947113|Etoposide|etoposide|mesh-list
153835374|NCT02947113|Pemetrexed|pemetrexed|mesh-list
153835375|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835376|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153835377|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153835378|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153835379|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835392|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
153835393|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375457|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153375458|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375461|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
153725795|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153725796|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153725797|NCT00117767|Terbinafine|terbinafine|mesh-list
153725798|NCT00117767|Griseofulvin|griseofulvin|mesh-list
153725799|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
153725800|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725837|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153725857|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153725858|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
153725859|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153725860|NCT00118313|Protective Agents|protective agents|mesh-ancestor
153725861|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153725862|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
153725863|NCT03271021|Minocycline|minocycline|mesh-list
153725864|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153725865|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725866|NCT02273986|Digoxin|digoxin|mesh-list
153725867|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153725868|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153725869|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725870|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725871|NCT02273986|Protective Agents|protective agents|mesh-ancestor
153725872|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725873|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
153725881|NCT00476983|Saquinavir|saquinavir|mesh-list
153725882|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153725883|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153725884|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153725885|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
153725886|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725887|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725888|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153725889|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153725890|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
153725920|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725921|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725922|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725923|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
153725924|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725925|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
154257278|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154257279|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257280|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
154257281|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
154257282|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
154257283|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257284|NCT01283204|Antidotes|antidotes|mesh-ancestor
153375468|NCT02762331|Vitamins|vitamins|mesh-ancestor
154257285|NCT01283204|Protective Agents|protective agents|mesh-ancestor
154257286|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257287|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
154257289|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
154257290|NCT03869528|Lidocaine|lidocaine|mesh-list
154257291|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
154257292|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
154257293|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257294|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257295|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
154257296|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257297|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153725926|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725927|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
153725928|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725929|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153725930|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
153725931|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153725932|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153725965|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153725966|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725968|NCT00478504|Clomiphene|clomiphene|mesh-list
153725969|NCT00478504|Enclomiphene|enclomiphene|mesh-list
153725970|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
153725971|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725972|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725991|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153725992|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725994|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725995|NCT00478543|Furosemide|furosemide|mesh-list
153725996|NCT00478543|Diuretics|diuretics|mesh-ancestor
153725997|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
153725998|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725999|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153726000|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153726001|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726002|NCT00118937|Metformin|metformin|mesh-list
153726003|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726004|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726005|NCT00478621|Vaccines|vaccines|mesh-list
153726006|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
153726007|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726008|NCT00478660|Adalimumab|adalimumab|mesh-list
153726009|NCT00478660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153726010|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726011|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726012|NCT00478699|Cisplatin|cisplatin|mesh-list
153726013|NCT00478699|Gemcitabine|gemcitabine|mesh-list
153726014|NCT00478699|Docetaxel|docetaxel|mesh-list
153726015|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726016|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153726017|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
153726018|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726023|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153726025|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726026|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726052|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726054|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
153726055|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153726056|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153726057|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726058|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726059|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
153726060|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
153726061|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153726062|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
153726063|NCT00119132|Artesunate|artesunate|mesh-list
153726064|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
153726065|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
153726066|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153726067|NCT00119132|Amodiaquine|amodiaquine|mesh-list
153835435|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835436|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153835437|NCT00526305|Analgesics|analgesics|mesh-ancestor
153835438|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
153835439|NCT02276768|Trimebutine|trimebutine|mesh-list
153835440|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835448|NCT05147753|Moxonidine|moxonidine|mesh-list
153835478|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545823|NCT06300099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726068|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
153726069|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153726070|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153726071|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726072|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726073|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
153726074|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
153726075|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153726092|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726093|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726094|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153726095|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153726096|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726097|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153726098|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153726099|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726100|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
153726101|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
153726102|NCT00119171|Capecitabine|capecitabine|mesh-list
153726103|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153726104|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
153726105|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726106|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726107|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
153726108|NCT00117624|Hematinics|hematinics|mesh-ancestor
153726109|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
153726110|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
153726111|NCT00479479|Vitamins|vitamins|mesh-ancestor
153726112|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
153726113|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726114|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
153726115|NCT00479479|Hematinics|hematinics|mesh-ancestor
153726116|NCT00119210|Bupropion|bupropion|mesh-list
153726117|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153726118|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
153726119|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726120|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153726121|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153375549|NCT02346240|Etanercept|etanercept|mesh-list
153726122|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153726123|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726124|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
153726125|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726129|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726130|NCT00117663|Hormones|hormones|mesh-list
153726131|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726132|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726146|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153726147|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153726148|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726149|NCT00479908|Urological Agents|urological agents|mesh-ancestor
153382390|NCT03440229|Laxatives|laxatives|mesh-ancestor
153726150|NCT00479986|Pioglitazone|pioglitazone|mesh-list
153726151|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726152|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726153|NCT00480064|Cytarabine|cytarabine|mesh-list
153726154|NCT00480064|Lomustine|lomustine|mesh-list
153726155|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153726156|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
153726157|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726158|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726159|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
153726160|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726161|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726162|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
153726163|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835486|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
153835487|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835488|NCT02946060|TEMPO|tempo|mesh-list
153835489|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
153835490|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835491|NCT02946060|Protective Agents|protective agents|mesh-ancestor
153835492|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835493|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153835494|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153835495|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
153835496|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835497|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835498|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153835499|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
153835500|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153835501|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153835502|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153835503|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
153726164|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153726165|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
153726166|NCT00480103|Mineral Oil|mineral oil|mesh-list
153726167|NCT00480103|Emollients|emollients|mesh-ancestor
153726168|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
153726169|NCT00480142|Oxycodone|oxycodone|mesh-list
153726170|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153726171|NCT00480142|Narcotics|narcotics|mesh-ancestor
153726172|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726173|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726174|NCT00480142|Analgesics|analgesics|mesh-ancestor
153726175|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
153726176|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726177|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
153726178|NCT00119483|Testosterone|testosterone|mesh-list
153726179|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
153726180|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
153726181|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153726182|NCT00119483|Androgens|androgens|mesh-ancestor
153726183|NCT00119483|Hormones|hormones|mesh-ancestor
153726184|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726185|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726186|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153726187|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726188|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
153726189|NCT00480181|Nabilone|nabilone|mesh-list
153726190|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
153726191|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
153726192|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726193|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726194|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375574|NCT02774343|Pioglitazone|pioglitazone|mesh-list
153375575|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153375576|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375577|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
153375579|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
153375580|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375581|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153726195|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153726210|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835521|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
153726211|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726212|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
153726213|NCT00480298|Hormones|hormones|mesh-ancestor
153726214|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726215|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153726216|NCT00480298|Protective Agents|protective agents|mesh-ancestor
153726217|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153726218|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726219|NCT00480376|Gentamicins|gentamicins|mesh-list
153726220|NCT00480376|Ofloxacin|ofloxacin|mesh-list
153726221|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153726222|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726223|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153726224|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726230|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153726231|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153726234|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726235|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
153726236|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726237|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153726238|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726239|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726240|NCT00117702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153726241|NCT00117702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153726242|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726243|NCT00480454|Vaccines|vaccines|mesh-list
153726244|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
153726245|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726247|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
153726248|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
153726249|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726250|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726251|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726252|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153726253|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153726254|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726255|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726256|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153726274|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
153726275|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
153726276|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153726277|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153726278|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153726279|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153726280|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
153726281|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726282|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726283|NCT00119639|Sorafenib|sorafenib|mesh-list
153726284|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726285|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153726286|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726287|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726288|NCT00480844|Risperidone|risperidone|mesh-list
153726289|NCT00480844|Sertindole|sertindole|mesh-list
153726290|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153726291|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
153726292|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726293|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726294|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726295|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153726296|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153726297|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726298|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726299|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153726300|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
153726301|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153726302|NCT00480883|Allopurinol|allopurinol|mesh-list
153726303|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
153726304|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726305|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726306|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
153726307|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726308|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153726309|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
153726310|NCT00480883|Protective Agents|protective agents|mesh-ancestor
153726343|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153726346|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153726347|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153726348|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153726349|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153375637|NCT04334967|Vitamins|vitamins|mesh-ancestor
153835577|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726350|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726351|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726352|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726353|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153726354|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153726355|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
153726356|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726357|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726392|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726393|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153726394|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153726396|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
153726397|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726398|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726418|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153726419|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
153726420|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726421|NCT00481663|Metformin|metformin|mesh-list
153726422|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153726423|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726424|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726426|NCT00481663|Hormones|hormones|mesh-ancestor
153726427|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726428|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153726429|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
153726430|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726431|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726432|NCT00481702|Metronidazole|metronidazole|mesh-list
153726433|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
153726434|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726435|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153726436|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153726437|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153726438|NCT00481702|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153726439|NCT00481702|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153726440|NCT00481741|Hemostatics|hemostatics|mesh-list
153726441|NCT00481741|Coagulants|coagulants|mesh-ancestor
153726442|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
153726443|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
153726444|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153726445|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153726446|NCT00481819|Prednisolone|prednisolone|mesh-list
153726447|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
153835578|NCT00526617|Temozolomide|temozolomide|mesh-list
153726449|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153726450|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
153726451|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726452|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
153726453|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726454|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153726455|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726456|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726457|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153726458|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726459|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153726460|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
153726489|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
153858919|NCT04669392|Ethanol|ethanol|mesh-list
153726498|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153726499|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
153726500|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153726501|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153726502|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
153726503|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726504|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
153726505|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153726515|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726516|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726517|NCT00120185|Analgesics|analgesics|mesh-ancestor
153726518|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
153726519|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726520|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726521|NCT01240642|Vadimezan|vadimezan|mesh-list
153726522|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726523|NCT00117975|Galiximab|galiximab|mesh-list
153726524|NCT00117975|Rituximab|rituximab|mesh-list
153726525|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153726526|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726527|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
153726528|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726529|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726530|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726531|NCT00482521|Pomalidomide|pomalidomide|mesh-list
153726532|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
153726533|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726534|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153726535|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153726536|NCT00482521|Growth Substances|growth substances|mesh-ancestor
153726537|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
153726538|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726539|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
153726540|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153726541|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726543|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
153726544|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726545|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726546|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726547|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726548|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
153726549|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726550|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
153726551|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153726552|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726553|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726554|NCT00482716|Iron|iron|mesh-list
153726555|NCT00482716|Dextrans|dextrans|mesh-list
153726556|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
153726557|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153726558|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
153726559|NCT00482716|Trace Elements|trace elements|mesh-ancestor
153726560|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
153726561|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726562|NCT00482716|Hematinics|hematinics|mesh-ancestor
153726563|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
153726564|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
153726565|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
153726566|NCT00120341|Analgesics|analgesics|mesh-list
153726585|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
153726586|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726587|NCT00118014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153726588|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153726589|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153726590|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726591|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726592|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
153726593|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726594|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
153726595|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153726596|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726597|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153545824|NCT06300099|Glucocorticoids|glucocorticoids|mesh-ancestor
153726598|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
153726599|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153726600|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726601|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726602|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726603|NCT01241032|Udenafil|udenafil|mesh-list
153726604|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153726605|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153726606|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726607|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726608|NCT00483067|Cytarabine|cytarabine|mesh-list
153726609|NCT00483067|Cladribine|cladribine|mesh-list
153726610|NCT00483067|Lenograstim|lenograstim|mesh-list
153375692|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
153726611|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153726612|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
153726613|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726614|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726615|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
153726616|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726617|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726618|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
153726619|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726620|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153726621|NCT00483106|Methylphenidate|methylphenidate|mesh-list
153430952|NCT04181203|Goserelin|goserelin|mesh-list
153726622|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153726623|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726624|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153726625|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153726626|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153726627|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726628|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
153726629|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726630|NCT00118170|Sorafenib|sorafenib|mesh-list
153726631|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726632|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153726633|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726634|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726636|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726644|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726645|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153726646|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726649|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726650|NCT00120536|Vildagliptin|vildagliptin|mesh-list
153726651|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726652|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726653|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153726654|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
153726655|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726656|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726657|NCT00483730|Actovegin|actovegin|mesh-list
153726658|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153726659|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726660|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153726661|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726662|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
153726663|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726664|NCT00483730|Protective Agents|protective agents|mesh-ancestor
153726665|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153726666|NCT00118326|Lenograstim|lenograstim|mesh-list
153726667|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153726668|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
153726669|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726670|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
153726671|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726672|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726673|NCT00405171|Nevirapine|nevirapine|mesh-list
153726674|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153726675|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153726676|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726677|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726678|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
153726679|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726680|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153726681|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153726682|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153726683|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153726684|NCT00483886|Prucalopride|prucalopride|mesh-list
153726685|NCT00483886|Laxatives|laxatives|mesh-ancestor
153726686|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726687|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153726688|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153726689|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
153726690|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726691|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726692|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726693|NCT00483964|Olanzapine|olanzapine|mesh-list
153726694|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
153726695|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
153726696|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726697|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726698|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726700|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153726701|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726702|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726703|NCT00483964|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153726714|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726715|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726716|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726717|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726718|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
153726719|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726720|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
153726721|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153726722|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726723|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726725|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153726727|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153726728|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153726734|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153726736|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
153726737|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
153726738|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726739|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726740|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726741|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153726742|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153545825|NCT06300099|Hormones|hormones|mesh-ancestor
153726744|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726745|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726746|NCT00484120|Diclofenac|diclofenac|mesh-list
153726747|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153726748|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726749|NCT00484120|Analgesics|analgesics|mesh-ancestor
153726750|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
153726751|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726752|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726753|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726754|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726755|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153726756|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726757|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726758|NCT00484237|Etanercept|etanercept|mesh-list
153726759|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153726760|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726761|NCT00484237|Analgesics|analgesics|mesh-ancestor
153726762|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
153726763|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726764|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726765|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726775|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726776|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153726777|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153726778|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726779|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726780|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
153726781|NCT00484510|Vitamins|vitamins|mesh-ancestor
153726782|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
153726783|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726784|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
153726785|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726786|NCT00484510|Protective Agents|protective agents|mesh-ancestor
153726787|NCT00120731|Acetazolamide|acetazolamide|mesh-list
153726788|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
153452460|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736102|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726789|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726790|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
153726791|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153726792|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726793|NCT00120731|Diuretics|diuretics|mesh-ancestor
153726794|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
153726795|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726796|NCT00120731|Expectorants|expectorants|mesh-ancestor
153726797|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
153726798|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
153726799|NCT00484744|Acetaminophen|acetaminophen|mesh-list
153726800|NCT00484744|Ibuprofen|ibuprofen|mesh-list
153726801|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726802|NCT00484744|Analgesics|analgesics|mesh-ancestor
153726803|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
153726811|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726812|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726813|NCT00484822|Heparin|heparin|mesh-list
153726814|NCT00484822|Calcium heparin|calcium heparin|mesh-list
153726815|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
153726816|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153726817|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153563858|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
153726818|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726819|NCT00405210|Docetaxel|docetaxel|mesh-list
153726820|NCT00405210|Sorafenib|sorafenib|mesh-list
153726821|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726822|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
153726823|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
153726824|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
153726825|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726826|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153726827|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726828|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
153726829|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
153726830|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153726831|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
153726832|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153726833|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153726855|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726856|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153835750|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153726857|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153726858|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726859|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
153726860|NCT00118638|Hematinics|hematinics|mesh-ancestor
153726861|NCT00485368|Perindopril|perindopril|mesh-list
153726862|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153726863|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
153726864|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726865|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726866|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153726867|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153726868|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153726869|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153726870|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153726871|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726872|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
153726873|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726874|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726875|NCT01241500|ON 01910|on 01910|mesh-list
153726876|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726880|NCT02274181|Enclomiphene|enclomiphene|mesh-list
153736104|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736105|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736106|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
153736107|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736108|NCT03777657|Capecitabine|capecitabine|mesh-list
153736109|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
153736110|NCT03777657|Tislelizumab|tislelizumab|mesh-list
153736111|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736112|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736113|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
153736114|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736115|NCT03777657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736116|NCT03775265|Cisplatin|cisplatin|mesh-list
153736117|NCT03775265|Gemcitabine|gemcitabine|mesh-list
153736118|NCT03775265|Fluorouracil|fluorouracil|mesh-list
153736119|NCT03775265|Atezolizumab|atezolizumab|mesh-list
153736120|NCT03775265|Mitomycins|mitomycins|mesh-list
153736121|NCT03775265|Mitomycin|mitomycin|mesh-list
153736122|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153736123|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736124|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736125|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
153726881|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153726882|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
153726883|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726884|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726897|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153375897|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726898|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153726899|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726901|NCT02274337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153726902|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153726903|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726904|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726905|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153726906|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726907|NCT00485680|Olanzapine|olanzapine|mesh-list
153726908|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
153726909|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
153726910|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
153726911|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726912|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726913|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726914|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153726915|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153726916|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726917|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153375898|NCT02785185|Clobetasol|clobetasol|mesh-list
153375899|NCT02785185|Halobetasol|halobetasol|mesh-list
153375900|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153375901|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375902|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
153375903|NCT02785185|Hormones|hormones|mesh-ancestor
153375904|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375905|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375906|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
153375907|NCT02787057|Vancomycin|vancomycin|mesh-list
153375908|NCT02787057|Ceftazidime|ceftazidime|mesh-list
153375909|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375910|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835814|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153835815|NCT00527085|Cinacalcet|cinacalcet|mesh-list
153835816|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835817|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835818|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153461539|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461540|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153461541|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153726921|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736126|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736127|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736128|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
153736129|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736130|NCT03775265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153736131|NCT03775265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430962|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
153726922|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726923|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
153726924|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
153726925|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726926|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
153726927|NCT00118794|Lumefantrine|lumefantrine|mesh-list
153726928|NCT00118794|Artemether|artemether|mesh-list
153726929|NCT00118794|Dapsone|dapsone|mesh-list
153726930|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
153726931|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153726932|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
153726933|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153726934|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153726935|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726936|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153726937|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726938|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726939|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
153726940|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153726941|NCT01241773|Efavirenz|efavirenz|mesh-list
153726942|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
153726943|NCT01241773|Simeprevir|simeprevir|mesh-list
153726944|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153726945|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153726959|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153726960|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
153726961|NCT00121277|Capecitabine|capecitabine|mesh-list
153726962|NCT00121277|Vorinostat|vorinostat|mesh-list
153726963|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153726964|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
153726965|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726966|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835855|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
153726967|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153726968|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726969|NCT00485797|Methylphenidate|methylphenidate|mesh-list
153726970|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153726971|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726972|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153726973|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153726974|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153726975|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726976|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
153726977|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726978|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153726979|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153726980|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153726981|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153726982|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726983|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
153726984|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726985|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726986|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
153726987|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153726988|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726990|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
153726991|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726992|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727000|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727001|NCT00118950|Metformin|metformin|mesh-list
153727002|NCT00118950|Repaglinide|repaglinide|mesh-list
153727003|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727015|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153727016|NCT00486343|Analgesics|analgesics|mesh-ancestor
153835856|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835857|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835858|NCT00528216|Capsaicin|capsaicin|mesh-list
153835859|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
153835860|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
153835861|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
153835862|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835864|NCT00528255|Misoprostol|misoprostol|mesh-list
153727017|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
153727018|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727019|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727020|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153727021|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153727022|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153727023|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727024|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727025|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153727026|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
153727027|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727028|NCT00486421|Prednisone|prednisone|mesh-list
153727029|NCT00486421|Rituximab|rituximab|mesh-list
153727030|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153727031|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727032|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
153727033|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727034|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153727035|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153727036|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
153564085|NCT01668043|Antibodies|antibodies|mesh-list
153727038|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727039|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153727040|NCT00486460|Curcumin|curcumin|mesh-list
153727041|NCT00486460|Celecoxib|celecoxib|mesh-list
153727042|NCT00486460|Gemcitabine|gemcitabine|mesh-list
153727043|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727044|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
153727045|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727046|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727047|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153727048|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153727049|NCT00486460|Analgesics|analgesics|mesh-ancestor
153727050|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
153835878|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835879|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153835880|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
153727051|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727052|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727053|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153727054|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153727055|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727056|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153727057|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153727058|NCT00121511|Fluorouracil|fluorouracil|mesh-list
153727059|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
153727060|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727061|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727062|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727063|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727064|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
153727065|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727066|NCT00486694|Artesunate|artesunate|mesh-list
153727067|NCT00486694|Chloroquine|chloroquine|mesh-list
153727068|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
153727078|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153727084|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727087|NCT00486772|Sevelamer|sevelamer|mesh-list
153727088|NCT00486772|Calcium acetate|calcium acetate|mesh-list
153727089|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153727090|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727091|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
153727092|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
153727093|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727094|NCT00121550|Clarithromycin|clarithromycin|mesh-list
153727095|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153727096|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727097|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153727099|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727100|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153727101|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153727102|NCT01242046|Caffeine|caffeine|mesh-list
153727103|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153727104|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727105|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153727106|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727107|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727108|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153727109|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153727110|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
153727111|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727112|NCT01242202|Acarbose|acarbose|mesh-list
153727113|NCT01242202|Voglibose|voglibose|mesh-list
153727114|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
153727115|NCT01242202|Miglitol|miglitol|mesh-list
153727116|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
153727117|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727118|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727119|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727120|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727121|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153727122|NCT00119145|Artesunate|artesunate|mesh-list
153727123|NCT00119145|Amodiaquine|amodiaquine|mesh-list
153727124|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153727125|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
153727126|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153727127|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153727128|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727129|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727130|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
153727131|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
153727132|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153727133|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
153727134|NCT00119184|Anesthetics|anesthetics|mesh-list
153727152|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727153|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153727154|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153727155|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727156|NCT00487786|Docetaxel|docetaxel|mesh-list
153727157|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727158|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
153727159|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
153727160|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
153727161|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727162|NCT00488137|Prucalopride|prucalopride|mesh-list
153727163|NCT00488137|Laxatives|laxatives|mesh-ancestor
153727164|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153727165|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153727172|NCT00488176|Montelukast|montelukast|mesh-list
153727173|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153727174|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
153727175|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153727176|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
153452461|NCT01846416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153835936|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153727177|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727178|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727179|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153727180|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153727181|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727182|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153727183|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153564279|NCT01669226|Taxane|taxane|mesh-list
153727184|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153727185|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
153727186|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
153727187|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727188|NCT00488215|Prucalopride|prucalopride|mesh-list
153727196|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727197|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
153727198|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153727199|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727200|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727201|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153727202|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
153727203|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727204|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
153727205|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727206|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727207|NCT00488566|Lamotrigine|lamotrigine|mesh-list
153727208|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
153727209|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153727210|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153727211|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727212|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153727213|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727214|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153727215|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153727216|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153727217|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153727218|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153727219|NCT00488722|Goserelin|goserelin|mesh-list
153727220|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153727221|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727222|NCT00488761|Tigecycline|tigecycline|mesh-list
153727223|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153727224|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727225|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153727226|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727227|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727228|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
153727229|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153727230|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727231|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153727232|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
153727233|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153727234|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727235|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859168|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153727239|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
153727240|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153727241|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153727242|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153727243|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
153727244|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727245|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727246|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727247|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
153727248|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153727249|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727250|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153727251|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
153727252|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727253|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
153736134|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153727273|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153727274|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153727275|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153727276|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727277|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727278|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
153727279|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727280|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153727281|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153727282|NCT00145314|Leucovorin|leucovorin|mesh-list
153727283|NCT00145314|Folic Acid|folic acid|mesh-list
153727284|NCT00145314|Fluorouracil|fluorouracil|mesh-list
153727285|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
153727286|NCT00145314|Cetuximab|cetuximab|mesh-list
153727287|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
153727288|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
153727289|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727290|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727291|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727292|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727293|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
153727294|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727295|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153727296|NCT00145314|Antidotes|antidotes|mesh-ancestor
153727297|NCT00145314|Protective Agents|protective agents|mesh-ancestor
153727298|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
153727299|NCT00145314|Vitamins|vitamins|mesh-ancestor
153727300|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
153727301|NCT00145314|Hematinics|hematinics|mesh-ancestor
153727302|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
153727303|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727304|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727305|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
153727306|NCT00489229|Ramipril|ramipril|mesh-list
153727307|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727308|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727309|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153727330|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727331|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564387|NCT01670149|Rifaximin|rifaximin|mesh-list
153727333|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
153727334|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153727335|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
153727336|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727337|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727338|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153727339|NCT00121979|Racivir|racivir|mesh-list
153727340|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153727341|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727342|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727343|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
153727344|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727345|NCT00489658|Eflornithine|eflornithine|mesh-list
153727354|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727355|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
153727356|NCT00122018|Fenoldopam|fenoldopam|mesh-list
153727357|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153727358|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
153727359|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727360|NCT00122018|Expectorants|expectorants|mesh-ancestor
153727361|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
153727362|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153727363|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
153727389|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153727390|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153727391|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153727392|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727393|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153727394|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727395|NCT00489892|Modafinil|modafinil|mesh-list
153727396|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153727397|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727398|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153727399|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153727400|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153727401|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727402|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
153727403|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153727404|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
153727405|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153727406|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727407|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153727408|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153382954|NCT02068157|Trioxsalen|trioxsalen|mesh-list
153727444|NCT00490243|Montelukast|montelukast|mesh-list
153727445|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153727467|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727468|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
153727469|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727470|NCT00490399|Gemcitabine|gemcitabine|mesh-list
153727471|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727472|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727473|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
153727474|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727475|NCT00490633|Ethanol|ethanol|mesh-list
153727476|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
153727477|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153727478|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727479|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153727480|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727481|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
153727482|NCT00490711|Paclitaxel|paclitaxel|mesh-list
153836081|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727483|NCT00490711|Carboplatin|carboplatin|mesh-list
153727484|NCT00490711|Gemcitabine|gemcitabine|mesh-list
153727485|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153727486|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727487|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
153727488|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
153727489|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
153727490|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727491|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727492|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
153727525|NCT00490906|Interferons|interferons|mesh-list
153727526|NCT00490906|Interferon-beta|interferon-beta|mesh-list
153727527|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
153727528|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
153727529|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
153727530|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
153727531|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727532|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
153727533|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727534|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
153727535|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727536|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153727537|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727538|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153727539|NCT00122486|Tenofovir|tenofovir|mesh-list
153727540|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
153727541|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727542|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153727543|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153727544|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727545|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727546|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153727547|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153727548|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
153727549|NCT00491413|Hematinics|hematinics|mesh-ancestor
153727550|NCT00145665|Telbivudine|telbivudine|mesh-list
153727551|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
153727552|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727553|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153564620|NCT01679093|Hormones|hormones|mesh-ancestor
153727554|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727573|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727575|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153727576|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
153727577|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727578|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153727579|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153727580|NCT00491920|Vitamin D|vitamin d|mesh-list
153727581|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
153727582|NCT00491920|Vitamins|vitamins|mesh-ancestor
153727583|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
153727584|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727585|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153836086|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727586|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153727587|NCT00491998|Entacapone|entacapone|mesh-list
153727588|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153727589|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153727590|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153727591|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727592|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727602|NCT00402272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727604|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
153727605|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727606|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727607|NCT00492388|Ketamine|ketamine|mesh-list
153727608|NCT00492388|Analgesics|analgesics|mesh-ancestor
153727609|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
153727644|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153727645|NCT00492466|Protective Agents|protective agents|mesh-ancestor
153727646|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
153727647|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153727648|NCT00492505|Tamoxifen|tamoxifen|mesh-list
153727649|NCT00492505|Sorafenib|sorafenib|mesh-list
153727659|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153727660|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153727661|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153727662|NCT00492661|Tacrolimus|tacrolimus|mesh-list
153727663|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727664|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
153727665|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727666|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153727667|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727668|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727669|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
153727670|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727671|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727672|NCT00402350|Fentanyl|fentanyl|mesh-list
153727673|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153727674|NCT00402350|Narcotics|narcotics|mesh-ancestor
153727675|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153727676|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727677|NCT00402350|Analgesics|analgesics|mesh-ancestor
153727678|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
153727679|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727680|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153836126|NCT00510263|Protective Agents|protective agents|mesh-ancestor
153727681|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153727682|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
153727683|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
153727684|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
153727685|NCT00122720|Hematinics|hematinics|mesh-ancestor
153727686|NCT00492934|Menotropins|menotropins|mesh-list
153727687|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153727688|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
153727689|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153727690|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727692|NCT02274454|Calcium|calcium|mesh-list
153727693|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153727694|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727695|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
153727696|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153727697|NCT04760730|Vaccines|vaccines|mesh-list
153727698|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
153727699|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727700|NCT00122759|Ketamine|ketamine|mesh-list
153727701|NCT00122759|Analgesics|analgesics|mesh-ancestor
153727702|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
153727714|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
153727737|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727738|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727740|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153727741|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
153727742|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727743|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
153727744|NCT01243801|Ketamine|ketamine|mesh-list
153727745|NCT01243801|Analgesics|analgesics|mesh-ancestor
153727746|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
153727747|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727748|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727749|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153727750|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153727751|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
153727752|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
153727753|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257298|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153836127|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
153727754|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153727755|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153727756|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727757|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727758|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153727759|NCT00126620|Sorafenib|sorafenib|mesh-list
153727760|NCT00126620|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153727761|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153727762|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727763|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727764|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727765|NCT00493363|Artesunate|artesunate|mesh-list
153727766|NCT00493363|Mefloquine|mefloquine|mesh-list
153727788|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153727789|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153727791|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153727792|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153727793|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153727794|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153727795|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153727796|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
153727797|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153727798|NCT00493402|Estrogens|estrogens|mesh-ancestor
153727799|NCT00493402|Hormones|hormones|mesh-ancestor
153727800|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727801|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727802|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153727803|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727804|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
153727805|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
153727806|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153727807|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153727816|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727817|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727818|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727819|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153727820|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153727852|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727853|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
153727854|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727856|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153727857|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
153727858|NCT00493987|Testosterone|testosterone|mesh-list
153727859|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
153727860|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
153727861|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153727862|NCT00493987|Dutasteride|dutasteride|mesh-list
153727863|NCT00493987|Androgens|androgens|mesh-ancestor
153727879|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153727880|NCT00405366|Sorafenib|sorafenib|mesh-list
153727881|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727882|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153727883|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727884|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727885|NCT00494338|Docetaxel|docetaxel|mesh-list
153727886|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727887|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
153727888|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
153727889|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
153727890|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727891|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153727892|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153727893|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153727894|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153727895|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727896|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727897|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727898|NCT00494377|Analgesics|analgesics|mesh-ancestor
153727899|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
153727900|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727902|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153727903|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
153727904|NCT00146016|Amantadine|amantadine|mesh-list
153727905|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153727906|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153727907|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
153727908|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727909|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
153727910|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727911|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727912|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727913|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153727914|NCT00146016|Analgesics|analgesics|mesh-ancestor
153727915|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
153727916|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727917|NCT00126971|Dapsone|dapsone|mesh-list
153727918|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
153727919|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727920|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
153859306|NCT01215097|Incretins|incretins|mesh-ancestor
153727956|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727957|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727958|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153727959|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153727960|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727962|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153727963|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727964|NCT00127049|Gemcitabine|gemcitabine|mesh-list
153727965|NCT00127049|Ifosfamide|ifosfamide|mesh-list
153727966|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727967|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727975|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153727977|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727978|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727979|NCT00127088|Docetaxel|docetaxel|mesh-list
153727980|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727981|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
153727982|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
153727983|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
153727984|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727985|NCT02957877|Heparin|heparin|mesh-list
153727986|NCT02957877|Calcium heparin|calcium heparin|mesh-list
153727987|NCT02957877|Nadroparin|nadroparin|mesh-list
153727988|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
153727989|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153727990|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153727991|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727992|NCT01244581|Amoxicillin|amoxicillin|mesh-list
153727993|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
153727994|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
153727995|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153727996|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153727997|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727998|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153836207|NCT00515736|Vitamin E|vitamin e|mesh-list
153727999|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565068|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153728000|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728002|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728003|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
153728004|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728005|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153728006|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728007|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728008|NCT01244698|Clindamycin|clindamycin|mesh-list
153728009|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
153728010|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
153728011|NCT01244698|Cefazolin|cefazolin|mesh-list
153728012|NCT01244698|Cefadroxil|cefadroxil|mesh-list
153545826|NCT06300099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153545827|NCT06300099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153545828|NCT06300099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545829|NCT06300099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153545830|NCT06300099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545831|NCT06300099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153545832|NCT06300099|Analgesics|analgesics|mesh-ancestor
153545846|NCT06299891|Appetite Depressants|appetite depressants|mesh-ancestor
153545851|NCT06299891|Adrenergic Agents|adrenergic agents|mesh-ancestor
153545852|NCT06299891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545853|NCT06299891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545855|NCT06299137|Anesthetics, Local|anesthetics, local|mesh-ancestor
153545856|NCT06299137|Anesthetics|anesthetics|mesh-ancestor
153545857|NCT06299137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836248|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376319|NCT06132685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376320|NCT06132685|Antiemetics|antiemetics|mesh-ancestor
153376321|NCT06132685|Autonomic Agents|autonomic agents|mesh-ancestor
153376322|NCT06132685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376323|NCT06132685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376324|NCT06132685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153376325|NCT06132685|Glucocorticoids|glucocorticoids|mesh-ancestor
153376326|NCT06132685|Hormones|hormones|mesh-ancestor
153376328|NCT06132685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153545858|NCT06299137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545859|NCT06299137|Sensory System Agents|sensory system agents|mesh-ancestor
153545860|NCT06299137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545861|NCT06297967|Acetic Acid|acetic acid|mesh-list
153545862|NCT06297967|Retinol acetate|retinol acetate|mesh-list
153545863|NCT06297967|Betaine|betaine|mesh-list
153545864|NCT06297967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153545865|NCT06297967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545866|NCT06297967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153545867|NCT06297967|Immunologic Factors|immunologic factors|mesh-ancestor
153545868|NCT06297967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545869|NCT06297967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153545870|NCT06297967|Protective Agents|protective agents|mesh-ancestor
153545871|NCT06297967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545872|NCT06297967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153545873|NCT06297967|Lipotropic Agents|lipotropic agents|mesh-ancestor
153545874|NCT06297967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153545875|NCT06297967|Antimetabolites|antimetabolites|mesh-ancestor
153545876|NCT06297967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545877|NCT06297967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153545878|NCT06297772|Fludarabine|fludarabine|mesh-list
153545879|NCT06297772|Busulfan|busulfan|mesh-list
153545880|NCT06297772|Decitabine|decitabine|mesh-list
153545881|NCT06297772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545882|NCT06297772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153545883|NCT06297772|Antimetabolites|antimetabolites|mesh-ancestor
153545884|NCT06297772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545885|NCT06297772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728013|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728014|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728015|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153376347|NCT06104449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376348|NCT06104449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153376349|NCT06104449|Glucocorticoids|glucocorticoids|mesh-ancestor
153376350|NCT06104449|Hormones|hormones|mesh-ancestor
153376351|NCT06104449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376352|NCT06104449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153376353|NCT06104449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376354|NCT06061575|Acetaminophen|acetaminophen|mesh-list
153376355|NCT06061575|Ibuprofen|ibuprofen|mesh-list
153836265|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
153836266|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153836267|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836290|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
153728016|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728017|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728018|NCT00495118|Risperidone|risperidone|mesh-list
153728019|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153728020|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
153728021|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728022|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728023|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728024|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153728026|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728028|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153728029|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
153728030|NCT00495313|Metronidazole|metronidazole|mesh-list
153728031|NCT00495313|Doxycycline|doxycycline|mesh-list
153728032|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728033|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728034|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153728035|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153728036|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
153728037|NCT00495352|Bupropion|bupropion|mesh-list
153728038|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153728039|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
153728040|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153736136|NCT03757858|Antibodies|antibodies|mesh-list
153728041|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153728042|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153728043|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153728044|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728045|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
153728054|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
153728055|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728056|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728057|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728058|NCT00495547|Hematinics|hematinics|mesh-ancestor
153728059|NCT00495781|Iron|iron|mesh-list
153728060|NCT00495781|Trace Elements|trace elements|mesh-ancestor
153728061|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
153728062|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728063|NCT00405405|Bevacizumab|bevacizumab|mesh-list
153728064|NCT00405405|Cisplatin|cisplatin|mesh-list
153728065|NCT00405405|Docetaxel|docetaxel|mesh-list
153728066|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153728067|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728068|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728069|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153728070|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153728071|NCT00405405|Growth Substances|growth substances|mesh-ancestor
153376392|NCT06023329|Anesthetics, Local|anesthetics, local|mesh-ancestor
153728072|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728073|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
153728074|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
153728075|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
153728076|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
153728077|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728078|NCT00405405|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728079|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728080|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728081|NCT00495898|Sirolimus|sirolimus|mesh-list
153728082|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728083|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728084|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153728085|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728086|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
153728087|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728088|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
153728089|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728090|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153728091|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
153728092|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728094|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728095|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153728096|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153728097|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859366|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
153728102|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728103|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728104|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153728105|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153728106|NCT00496405|Growth Substances|growth substances|mesh-ancestor
153728107|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728108|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
153728109|NCT00496444|Azacitidine|azacitidine|mesh-list
153728110|NCT00496444|Valproic Acid|valproic acid|mesh-list
153376393|NCT06023329|Anesthetics|anesthetics|mesh-ancestor
153376395|NCT06023329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836335|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728111|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836336|NCT00515892|Immunoconjugates|immunoconjugates|mesh-ancestor
153728112|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
153728116|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
153728117|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
153728118|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728119|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728120|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
153728121|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153728122|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728123|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153728124|NCT00496561|Immunomodulating Agents|immunomodulating agents|mesh-list
153728125|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
153728126|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728127|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
153728128|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153728129|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
153728130|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
153728131|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728132|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728133|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153728134|NCT00146250|Analgesics|analgesics|mesh-ancestor
153728135|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
153728136|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728138|NCT00496600|Epothilone B|epothilone b|mesh-list
153728139|NCT00496600|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153728140|NCT00496600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728141|NCT00496600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728142|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728143|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728144|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
153728145|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836337|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836338|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153836339|NCT00513539|Trioxsalen|trioxsalen|mesh-list
153836340|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836341|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
153836342|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153836343|NCT00511979|Insulin|insulin|mesh-list
153836344|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153836345|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153836346|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836347|NCT00513578|Sargramostim|sargramostim|mesh-list
153836348|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
153376434|NCT06001658|Antimetabolites|antimetabolites|mesh-ancestor
153728146|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728147|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
153728148|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
153728149|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
153728150|NCT00127595|Gemcitabine|gemcitabine|mesh-list
153728151|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
153728152|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153728153|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
153728154|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728155|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728156|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
153728157|NCT00497107|Leucovorin|leucovorin|mesh-list
153728158|NCT00497107|Calcium|calcium|mesh-list
153728159|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
153728160|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153728161|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728162|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153728163|NCT00497107|Antidotes|antidotes|mesh-ancestor
153728164|NCT00497107|Protective Agents|protective agents|mesh-ancestor
153728165|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
153728167|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
153728168|NCT00146289|Telmisartan|telmisartan|mesh-list
153728169|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153728170|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153728171|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153728172|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728173|NCT01244932|Bupivacaine|bupivacaine|mesh-list
153728174|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
153728192|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153728193|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153728194|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728195|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153728196|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153728197|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153728198|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728199|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153728200|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153728201|NCT00497224|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728202|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728203|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728204|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728205|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728207|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
153728208|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153728209|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728210|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728211|NCT04726982|Diuretics|diuretics|mesh-ancestor
153728212|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
153728213|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728214|NCT00497341|Cefuroxime|cefuroxime|mesh-list
153728215|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
153728216|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728217|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728218|NCT00127829|Gefitinib|gefitinib|mesh-list
153728219|NCT00127829|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728220|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728221|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728222|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728223|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728224|NCT00497458|Testosterone|testosterone|mesh-list
153728225|NCT00497458|Androgens|androgens|mesh-ancestor
153728226|NCT00497458|Hormones|hormones|mesh-ancestor
153728227|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728228|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728229|NCT00497497|Bevacizumab|bevacizumab|mesh-list
153728230|NCT00497497|Cetuximab|cetuximab|mesh-list
153728231|NCT00497497|Irinotecan|irinotecan|mesh-list
153728232|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728233|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728234|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153728235|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153728236|NCT00497497|Growth Substances|growth substances|mesh-ancestor
153728237|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728238|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
153728239|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153728240|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153728241|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728250|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153728251|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153728252|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728253|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728254|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153728255|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
153728257|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728258|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153728259|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
153728260|NCT00127868|Protective Agents|protective agents|mesh-ancestor
153728261|NCT00127868|Trace Elements|trace elements|mesh-ancestor
153728262|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
153728263|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
153728264|NCT00497536|Insulin|insulin|mesh-list
153728265|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153728266|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
153728267|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
153728268|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153728269|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153728270|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728271|NCT00497614|Adalimumab|adalimumab|mesh-list
153728272|NCT00497614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153728273|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153728274|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728275|NCT00127907|Vasopressins|vasopressins|mesh-list
153728276|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
153728277|NCT00127907|Epinephrine|epinephrine|mesh-list
153728278|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153728279|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153728280|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
153728281|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728282|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728283|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728284|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153728285|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153728286|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
153728287|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728288|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153728289|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
153728290|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
153728291|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
153728292|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153728293|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
153728294|NCT00127907|Coagulants|coagulants|mesh-ancestor
153728295|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153728296|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
153728297|NCT00497809|Lenograstim|lenograstim|mesh-list
153728298|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153728299|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
153728300|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728301|NCT00146484|Insulin|insulin|mesh-list
153728302|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153728303|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728304|NCT00402584|Sibutramine|sibutramine|mesh-list
153728305|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
153728306|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153728307|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
153728308|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153728309|NCT00498004|Risperidone|risperidone|mesh-list
153728310|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153728311|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153728312|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
153728313|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728318|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728319|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153728320|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153728321|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
153728322|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
153728323|NCT00146523|Mifepristone|mifepristone|mesh-list
153728324|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153728325|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
153728326|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153728327|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728328|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153728329|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153728330|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153728351|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
153728352|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728353|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728354|NCT00402662|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728355|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
153728356|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
153728357|NCT00498316|Melphalan|melphalan|mesh-list
153728358|NCT00498316|Busulfan|busulfan|mesh-list
153728359|NCT00498316|Rituximab|rituximab|mesh-list
153728360|NCT00498316|Fludarabine|fludarabine|mesh-list
153728361|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
153728362|NCT00498316|Clofarabine|clofarabine|mesh-list
153728363|NCT00498316|Tacrolimus|tacrolimus|mesh-list
153728364|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
153728365|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153728366|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728367|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
153728368|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728369|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728370|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153728371|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
153728372|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728373|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728374|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153728375|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376527|NCT05861336|Antimetabolites|antimetabolites|mesh-ancestor
153728376|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153728377|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
153728378|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736137|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
153736138|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728379|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153728380|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728381|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153728382|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153728383|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
153728384|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728407|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728408|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728409|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
153728410|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728411|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153728412|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728413|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
153728414|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728415|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153728416|NCT00498745|Neratinib|neratinib|mesh-list
153728417|NCT00498745|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728418|NCT00498745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728419|NCT00498745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728420|NCT00498745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728471|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728472|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728473|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728474|NCT01245244|Morphine|morphine|mesh-list
153728475|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153728476|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153728477|NCT01245244|Narcotics|narcotics|mesh-ancestor
153728478|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728479|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728480|NCT01245244|Analgesics|analgesics|mesh-ancestor
153728481|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
153728485|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153728487|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
153728488|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728489|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153728490|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153728491|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728493|NCT00499018|Prednisone|prednisone|mesh-list
153728494|NCT00499018|Rituximab|rituximab|mesh-list
153728518|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
153728519|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728520|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153728521|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153728522|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728523|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153728524|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
153728525|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153728526|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153728527|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153728528|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
153728529|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
153728530|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
153728531|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153728532|NCT00127985|Prednisolone|prednisolone|mesh-list
153728533|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153728534|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
153728535|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153728536|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
153728537|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153728538|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
153728539|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153728540|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
153728541|NCT00127985|Hormones|hormones|mesh-ancestor
153565571|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
153728542|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728543|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728544|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153728545|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728615|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728616|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728617|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
153728618|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728619|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728620|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153728621|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153728622|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728623|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728652|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728653|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
153728654|NCT00500188|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728655|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728656|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728657|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728658|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728659|NCT04710914|Midazolam|midazolam|mesh-list
153728660|NCT04710914|Isoflurane|isoflurane|mesh-list
153728661|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153728662|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153376588|NCT05766267|Rifampin|rifampin|mesh-list
153728663|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728664|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728665|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153728666|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153728667|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153728668|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153728669|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
153728670|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
153728671|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
153728672|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
153859498|NCT04678830|Leronlimab|leronlimab|mesh-list
153728717|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153728718|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153728719|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153728721|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
153728722|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728723|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728724|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153728755|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728756|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153728757|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728758|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728759|NCT01246180|Diuretics|diuretics|mesh-ancestor
153728767|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153728802|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728803|NCT00501787|Metformin|metformin|mesh-list
153728804|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153728829|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728830|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728831|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728832|NCT00502060|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728833|NCT00502099|Interferons|interferons|mesh-list
153728834|NCT00502099|Ribavirin|ribavirin|mesh-list
153728835|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
153728836|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
153728837|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153728838|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153728839|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728840|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
153565862|NCT06223477|Vitamin D|vitamin d|mesh-list
153728841|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728842|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
153728843|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728844|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
153728845|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728846|NCT00502138|Pramlintide|pramlintide|mesh-list
153728847|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
153728848|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153728849|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728850|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
153728851|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153728852|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
153728853|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728854|NCT00502294|Visilizumab|visilizumab|mesh-list
153728885|NCT00502567|Cetuximab|cetuximab|mesh-list
153728886|NCT00502567|Cediranib|cediranib|mesh-list
153728887|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728888|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
153728889|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
153728890|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
153728891|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728892|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
153728893|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153728894|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728895|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
153736140|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728896|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728897|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153728898|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153728899|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728900|NCT00502567|Antidotes|antidotes|mesh-ancestor
153728934|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153728936|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728937|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728938|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728939|NCT00502879|Etanercept|etanercept|mesh-list
153728940|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153728973|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728974|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728975|NCT00503503|Etanercept|etanercept|mesh-list
153728976|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153728977|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153728978|NCT00503503|Analgesics|analgesics|mesh-ancestor
153728979|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
153729015|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
153729016|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153729018|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153729019|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729020|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153729021|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153729022|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729023|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729024|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
153729041|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729043|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153729044|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153729045|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
153729046|NCT01246921|Fluticasone|fluticasone|mesh-list
153729047|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729048|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153729049|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
153729050|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729051|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729052|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153729053|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
153729054|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
153729055|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153729056|NCT04696939|Carboplatin|carboplatin|mesh-list
153729057|NCT04696939|Etoposide|etoposide|mesh-list
153729058|NCT04696939|Atezolizumab|atezolizumab|mesh-list
153729059|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729060|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153729061|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153729062|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153729063|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729064|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729065|NCT04696939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153729066|NCT04696939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153729067|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153729068|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153729069|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153729070|NCT05560919|Protective Agents|protective agents|mesh-ancestor
153729071|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729072|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153729074|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729075|NCT05560919|Vitamins|vitamins|mesh-ancestor
153729076|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
153729077|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153729078|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
153736141|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729079|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153729080|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153729081|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153729082|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153729118|NCT01247077|Trace Elements|trace elements|mesh-ancestor
153729119|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
153729120|NCT03990467|Tazobactam|tazobactam|mesh-list
153729155|NCT01247857|Ropivacaine|ropivacaine|mesh-list
153729156|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
153729157|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
153729158|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376665|NCT05726916|Eculizumab|eculizumab|mesh-list
153729159|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729160|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
153729195|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729227|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
153729228|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729229|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729230|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153729231|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153729232|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
153729233|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729234|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729235|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
153729236|NCT03809429|Cetrorelix|cetrorelix|mesh-list
153729237|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153729238|NCT03809429|Hormones|hormones|mesh-ancestor
153729239|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729240|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729241|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153729242|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
153729243|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153729244|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
153729245|NCT00504127|Naproxen|naproxen|mesh-list
153729246|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
153729247|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153729248|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153729249|NCT00504127|Analgesics|analgesics|mesh-ancestor
153729251|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729252|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729253|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729287|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
153729288|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153729289|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729290|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153729291|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729292|NCT01249690|Growth Substances|growth substances|mesh-ancestor
153729293|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729294|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153729308|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729310|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729311|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153729312|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
153729313|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729314|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729315|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153729316|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153729317|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
153729318|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153729319|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736142|NCT03734809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153729320|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729321|NCT00405444|Fentanyl|fentanyl|mesh-list
153729322|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153729323|NCT00405444|Narcotics|narcotics|mesh-ancestor
153729324|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729325|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729326|NCT00405444|Analgesics|analgesics|mesh-ancestor
153729327|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
153729328|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729348|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729349|NCT00504400|Ranibizumab|ranibizumab|mesh-list
153729350|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153729351|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729352|NCT00504400|Growth Substances|growth substances|mesh-ancestor
153729353|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729354|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729355|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729356|NCT00504439|Simvastatin|simvastatin|mesh-list
153729357|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153729373|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153729374|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729375|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729376|NCT01249651|Esomeprazole|esomeprazole|mesh-list
153729377|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153729378|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729379|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153729380|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729381|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729382|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
153729384|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
153729385|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729386|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
153729387|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729388|NCT03999723|Protective Agents|protective agents|mesh-ancestor
153729389|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
153729390|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153729391|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153729392|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153729393|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153729394|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729395|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
153729396|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729397|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729398|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153729399|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729485|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153729486|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729487|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153729488|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153729490|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
153729491|NCT02736422|Xenon|xenon|mesh-list
153836679|NCT00514982|Adalimumab|adalimumab|mesh-list
153729492|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153729493|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
153729494|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
153729495|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729528|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153729529|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153729531|NCT00139269|Fluorouracil|fluorouracil|mesh-list
153729532|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729533|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
153729534|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
153729535|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
153729536|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729537|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
153729538|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153729539|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153729540|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
153729571|NCT00403442|Verteporfin|verteporfin|mesh-list
153729572|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153729573|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729574|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153729575|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729576|NCT00403442|Growth Substances|growth substances|mesh-ancestor
153729577|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729621|NCT00139620|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153729622|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153729623|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783880|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153783881|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
153783882|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
153783883|NCT04539301|Anticoagulants|anticoagulants|mesh-list
153783884|NCT00237419|Infliximab|infliximab|mesh-list
153783885|NCT00237419|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153783886|NCT00237419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783887|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
153783888|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783889|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783890|NCT04539106|Ranibizumab|ranibizumab|mesh-list
153783891|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153783892|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153783893|NCT04539106|Growth Substances|growth substances|mesh-ancestor
153783894|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783895|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
153376826|NCT05586802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153783896|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783897|NCT00237497|Zopiclone|zopiclone|mesh-list
153736143|NCT03734809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783898|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153783899|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783900|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783901|NCT00416130|Vorinostat|vorinostat|mesh-list
153783902|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783903|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153783904|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783905|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783906|NCT00416169|Galantamine|galantamine|mesh-list
153783907|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153783908|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783909|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783910|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
153783936|NCT02215720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783937|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783938|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
153783939|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783940|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153783941|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783942|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153783943|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
153783944|NCT00416208|Bortezomib|bortezomib|mesh-list
153783945|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783946|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153783947|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153383490|NCT02368457|Tocotrienols|tocotrienols|mesh-list
153783948|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153783949|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783950|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783951|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783952|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783953|NCT02215798|Analgesics|analgesics|mesh-ancestor
153783954|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
153783955|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783982|NCT04543123|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153783984|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783985|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783986|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783987|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
153783988|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783989|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153783990|NCT04539418|Vitamin K|vitamin k|mesh-list
153783991|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
153783992|NCT04539418|Vitamins|vitamins|mesh-ancestor
153783993|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
153783994|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783995|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153783996|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153783997|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783998|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
153783999|NCT04539418|Coagulants|coagulants|mesh-ancestor
153784000|NCT00269724|Oxybutynin|oxybutynin|mesh-list
153784001|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
153784002|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
153784003|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784004|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784005|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153784006|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153784038|NCT04538521|Vitamins|vitamins|mesh-ancestor
153784039|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
153784040|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784041|NCT00269763|Fentanyl|fentanyl|mesh-list
153784042|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153784043|NCT00269763|Narcotics|narcotics|mesh-ancestor
153784044|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784045|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736144|NCT03704610|Infliximab|infliximab|mesh-list
153784046|NCT00269763|Analgesics|analgesics|mesh-ancestor
153784047|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
153836772|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153836773|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
153836774|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836775|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153836776|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153836777|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836778|NCT00516152|Methotrexate|methotrexate|mesh-list
153836779|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
153836780|NCT00516152|Fludarabine|fludarabine|mesh-list
153836781|NCT00516152|Busulfan|busulfan|mesh-list
153836782|NCT00516152|Tacrolimus|tacrolimus|mesh-list
153836783|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153836784|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
153784082|NCT00237614|Expectorants|expectorants|mesh-ancestor
153784083|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
153784105|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153784106|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
153784107|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784108|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784109|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153784110|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
153784111|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784112|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784113|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153784114|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153784115|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153784116|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
153784117|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784118|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784119|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784120|NCT04538365|Triclosan|triclosan|mesh-list
153784121|NCT04538365|Propranolol|propranolol|mesh-list
153784122|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153784123|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153784124|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784125|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153784126|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153784127|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
153784128|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784129|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153784130|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153784131|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153784132|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
153784134|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784135|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153784175|NCT00237731|Analgesics|analgesics|mesh-ancestor
153784176|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
153784177|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784179|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
153784180|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
153784181|NCT00270036|Hematinics|hematinics|mesh-ancestor
153784182|NCT00262392|Pamidronate|pamidronate|mesh-list
153784210|NCT02216149|Tegafur|tegafur|mesh-list
153784211|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
153784212|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153784213|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
153784214|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784215|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784216|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
153784217|NCT00238004|Niacin|niacin|mesh-list
153784218|NCT00238004|Niacinamide|niacinamide|mesh-list
153784219|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
153784220|NCT00238004|Vitamins|vitamins|mesh-ancestor
153784221|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
153784222|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784223|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153784224|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
153784225|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784226|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153784256|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153784257|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153784258|NCT04536922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153784259|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153784260|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153784261|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
153784262|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784263|NCT04536961|Deucravacitinib|deucravacitinib|mesh-list
153784264|NCT04536961|Famotidine|famotidine|mesh-list
153784267|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153784268|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
153784269|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
153784270|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784271|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784308|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784309|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784343|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153784344|NCT04536493|Lidocaine|lidocaine|mesh-list
153784345|NCT04536493|Epinephrine|epinephrine|mesh-list
153784346|NCT04536493|Racepinephrine|racepinephrine|mesh-list
153784347|NCT04536493|Tetracaine|tetracaine|mesh-list
153784348|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
153784349|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
153784375|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
153784376|NCT04536181|Hormones|hormones|mesh-ancestor
153784377|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784378|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784379|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153784380|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784381|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
153784382|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
153784383|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784384|NCT02216227|Iodine|iodine|mesh-list
153784385|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
153784386|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153784387|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
153784388|NCT02216227|Vancomycin|vancomycin|mesh-list
153784389|NCT02216227|Cefazolin|cefazolin|mesh-list
153784390|NCT02216227|Mupirocin|mupirocin|mesh-list
153784391|NCT02216227|Povidone|povidone|mesh-list
153784392|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153784393|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784394|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
153784398|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784399|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784427|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153784428|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
153784429|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784430|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784431|NCT04535518|Aspirin|aspirin|mesh-list
153784432|NCT04535518|Infliximab|infliximab|mesh-list
153784433|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
153784436|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153784437|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153784438|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153784439|NCT04535518|Analgesics|analgesics|mesh-ancestor
153784440|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
153784441|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784442|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784443|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784444|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784459|NCT02216383|Ergonovine|ergonovine|mesh-list
153784460|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
153784461|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153784462|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784463|NCT00262782|Fludarabine|fludarabine|mesh-list
153784464|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784465|NCT00238394|Cediranib|cediranib|mesh-list
153784466|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784467|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784468|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784469|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153784470|NCT00238472|Nateglinide|nateglinide|mesh-list
153784471|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153784472|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784473|NCT00238628|Bexarotene|bexarotene|mesh-list
153736145|NCT03704610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153784474|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784475|NCT02216617|Docetaxel|docetaxel|mesh-list
153784476|NCT02216617|Afatinib|afatinib|mesh-list
153784477|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784478|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
153784479|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
153784480|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
153784481|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784482|NCT02216617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153784483|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153784484|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784485|NCT00262977|Aspirin|aspirin|mesh-list
153784486|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153784487|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153784488|NCT00262977|Analgesics|analgesics|mesh-ancestor
153784489|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
153836856|NCT02951039|Edoxaban|edoxaban|mesh-list
153784490|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784491|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784492|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784493|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784494|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153784495|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153784496|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784497|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153784498|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153784499|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784500|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
153784501|NCT00238667|Aspirin|aspirin|mesh-list
153784502|NCT00238667|Heparin|heparin|mesh-list
153784503|NCT00238667|Calcium heparin|calcium heparin|mesh-list
153784504|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153784505|NCT00238667|Dalteparin|dalteparin|mesh-list
153784525|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153784526|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153784527|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153784528|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
153784529|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784530|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153784531|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
153784532|NCT00263016|Docetaxel|docetaxel|mesh-list
153784533|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784534|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
153784535|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
153784536|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
153784537|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784538|NCT04534465|Mannitol|mannitol|mesh-list
153784539|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153784540|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153784542|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
153784543|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784544|NCT04534465|Laxatives|laxatives|mesh-ancestor
153784545|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153784546|NCT02216656|Cinacalcet|cinacalcet|mesh-list
153784547|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153784548|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784549|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153784550|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
153784551|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784552|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
153784553|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784554|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
153784555|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153784556|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153784557|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
153376964|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153784558|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784559|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784560|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153784561|NCT04534231|Nicotine|nicotine|mesh-list
153784562|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153784563|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
153784564|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784565|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784566|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153784567|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153784568|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
153784569|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784570|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784571|NCT00263094|Rofecoxib|rofecoxib|mesh-list
153784605|NCT00263133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153784606|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153784607|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153784608|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784609|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784636|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784637|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
153784638|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153784643|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784644|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784645|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784646|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
153784647|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153784648|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784649|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153784650|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
153784651|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784652|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784653|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784683|NCT02217007|Calcium|calcium|mesh-list
153784684|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153784685|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784686|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153784687|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153784688|NCT05897372|Semaglutide|semaglutide|mesh-list
153784689|NCT05897372|Pentoxifylline|pentoxifylline|mesh-list
153784690|NCT05897372|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153784691|NCT05897372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153784692|NCT05897372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784693|NCT05897372|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153784694|NCT05897372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784695|NCT05897372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784696|NCT05897372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153784714|NCT05896930|Amoxicillin|amoxicillin|mesh-list
153784715|NCT05896930|Rifampin|rifampin|mesh-list
153784716|NCT05896930|Meropenem|meropenem|mesh-list
153784717|NCT05896930|Ertapenem|ertapenem|mesh-list
153784718|NCT05896930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784719|NCT05896930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784720|NCT05896930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153784721|NCT05896930|Antitubercular Agents|antitubercular agents|mesh-ancestor
153784723|NCT05896930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153784724|NCT05896930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784725|NCT05896930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784726|NCT05896930|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153784727|NCT05896930|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153836943|NCT02942706|Cetuximab|cetuximab|mesh-list
153836974|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
153784728|NCT05896930|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153784729|NCT05896930|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153784730|NCT05896930|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153784731|NCT05896930|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153784732|NCT05896787|Paclitaxel|paclitaxel|mesh-list
153784733|NCT05896787|Carboplatin|carboplatin|mesh-list
153784734|NCT05896787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153784735|NCT05896787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784736|NCT05896787|Tubulin Modulators|tubulin modulators|mesh-ancestor
153784737|NCT05896787|Antimitotic Agents|antimitotic agents|mesh-ancestor
153784738|NCT05896787|Mitosis Modulators|mitosis modulators|mesh-ancestor
153784739|NCT05896787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784740|NCT05896631|Bupivacaine|bupivacaine|mesh-list
153784741|NCT05896631|Anesthetics, Local|anesthetics, local|mesh-ancestor
153784742|NCT05896631|Anesthetics|anesthetics|mesh-ancestor
153784743|NCT05896631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784744|NCT05896631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784745|NCT05896631|Sensory System Agents|sensory system agents|mesh-ancestor
153784746|NCT05896631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784747|NCT05896605|Azathioprine|azathioprine|mesh-list
153784748|NCT05896605|Antimetabolites|antimetabolites|mesh-ancestor
153784749|NCT05896605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784750|NCT05896605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153784751|NCT05896605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784788|NCT05876715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153784864|NCT05611905|Probenecid|probenecid|mesh-list
153784865|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
153784866|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
153784867|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784868|NCT05586373|Dipyrone|dipyrone|mesh-list
153784869|NCT05586373|Ibuprofen|ibuprofen|mesh-list
153784891|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
153784892|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784893|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153784894|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153784895|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153784896|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153784897|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784898|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
153784899|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153784900|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784901|NCT05197322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153784902|NCT05197322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784903|NCT05145764|Suvorexant|suvorexant|mesh-list
153784904|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153784905|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153784906|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784907|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784908|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153784909|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784910|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784911|NCT05087342|Semaglutide|semaglutide|mesh-list
153784912|NCT05087342|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153784913|NCT05087342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153784914|NCT05087342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784915|NCT04983836|Anesthetics|anesthetics|mesh-list
153784916|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784917|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784918|NCT04933383|Budesonide|budesonide|mesh-list
153784955|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153784956|NCT04521920|Narcotics|narcotics|mesh-ancestor
153784986|NCT04101877|Bevacizumab|bevacizumab|mesh-list
153784987|NCT04101877|Aflibercept|aflibercept|mesh-list
153784988|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430986|NCT00380263|Growth Substances|growth substances|mesh-ancestor
153784989|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784991|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153784992|NCT04101877|Growth Substances|growth substances|mesh-ancestor
153784993|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784994|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
153784996|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
153784997|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784998|NCT04026958|Clarithromycin|clarithromycin|mesh-list
153784999|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153785000|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785001|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153785002|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785034|NCT03730649|Protective Agents|protective agents|mesh-ancestor
153785035|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785049|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785050|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153785077|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153785078|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785079|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785080|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785081|NCT03373760|Durvalumab|durvalumab|mesh-list
153785082|NCT03373760|Ipilimumab|ipilimumab|mesh-list
153785083|NCT03373760|Tremelimumab|tremelimumab|mesh-list
153785084|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
153785085|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153785086|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
153785087|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153785088|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785089|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
153785090|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785091|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153785092|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785093|NCT03290794|Aflibercept|aflibercept|mesh-list
153785094|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153785095|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153785096|NCT03290794|Growth Substances|growth substances|mesh-ancestor
153785097|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785098|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
153785099|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785100|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
153785127|NCT02935634|Linrodostat|linrodostat|mesh-list
153785128|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153785129|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785130|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153785131|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785132|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153785133|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785134|NCT02864992|Tepotinib|tepotinib|mesh-list
153785135|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785136|NCT02740712|Vitamin K|vitamin k|mesh-list
153785137|NCT02740712|Rucaparib|rucaparib|mesh-list
153785138|NCT02740712|Digoxin|digoxin|mesh-list
153785139|NCT02740712|Midazolam|midazolam|mesh-list
153785140|NCT02740712|Caffeine|caffeine|mesh-list
153785141|NCT02740712|Omeprazole|omeprazole|mesh-list
153785142|NCT02740712|Warfarin|warfarin|mesh-list
153785143|NCT02740712|Vitamins|vitamins|mesh-ancestor
153736146|NCT03704610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153736147|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
153785144|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
153785145|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785146|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153785147|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153400093|NCT01983878|Growth Substances|growth substances|mesh-ancestor
153785303|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153785304|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785305|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785306|NCT00239174|Hormones|hormones|mesh-ancestor
153785307|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785308|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785309|NCT04531423|Golimumab|golimumab|mesh-list
153785310|NCT04531423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153785331|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153785332|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785334|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785335|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153785336|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785351|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785352|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153785353|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153785354|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
153785355|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153785356|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153785357|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153785358|NCT00414323|Escitalopram|escitalopram|mesh-list
153785359|NCT00414323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153736148|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153736149|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736150|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153736151|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
153785360|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153785361|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785362|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785398|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153785400|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
153785401|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153785427|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
153785429|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153785430|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785431|NCT02217553|Vitamins|vitamins|mesh-ancestor
153785432|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
153785433|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153785434|NCT02217631|Prednisolone|prednisolone|mesh-list
153785435|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153785436|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
153785437|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153785438|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
153785439|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153785440|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
153785441|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785442|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
153785443|NCT02217631|Hormones|hormones|mesh-ancestor
153785444|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785445|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785446|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153785447|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785448|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
153785449|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
153785450|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785472|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153785473|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153785474|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
153785475|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785476|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153785491|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153837068|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153837069|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785492|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785494|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
153785495|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785496|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153785497|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785498|NCT04529668|Vitamin D|vitamin d|mesh-list
153785499|NCT04529668|Vitamins|vitamins|mesh-ancestor
153785500|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
153785501|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785502|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153785503|NCT00239408|Bromides|bromides|mesh-list
153785541|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785574|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153785575|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785576|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153736152|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785578|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785579|NCT01642108|Incretins|incretins|mesh-ancestor
153785580|NCT01642108|Hormones|hormones|mesh-ancestor
154257299|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153469171|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785615|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153785616|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785617|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785651|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
153785652|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785653|NCT01644253|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153785654|NCT01644253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153785655|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785673|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785674|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785675|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785676|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
153785677|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153785678|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
153785679|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785680|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785681|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153785682|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
153785683|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
153785684|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153785685|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
153785686|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
153785687|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153785709|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
153785710|NCT04528888|Hormones|hormones|mesh-ancestor
153785711|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785712|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153785713|NCT04528888|Protective Agents|protective agents|mesh-ancestor
153785714|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153332153|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785715|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785716|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
153785717|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153785730|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785731|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153785732|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153785733|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785734|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785735|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
153785736|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785737|NCT01645423|Atorvastatin|atorvastatin|mesh-list
153785738|NCT01645423|Calcium|calcium|mesh-list
153785739|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153785740|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785741|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153785742|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153736153|NCT03675672|Misoprostol|misoprostol|mesh-list
153736154|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153736155|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
153736156|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153785743|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
153785744|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785745|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153785746|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153785747|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785748|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
153785749|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153785755|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
153785756|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
153785757|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785758|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
153785759|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153785760|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
153785761|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153785762|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153785763|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785764|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785765|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
153383826|NCT04419948|Ibuprofen|ibuprofen|mesh-list
153785766|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785767|NCT02961075|Anesthetics|anesthetics|mesh-list
153785768|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377202|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
153785769|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785771|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153785772|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153785773|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153785774|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785806|NCT00239954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153785807|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153785808|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785809|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785810|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785811|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
153785812|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785813|NCT04528927|Azithromycin|azithromycin|mesh-list
153785814|NCT04528927|Doxycycline|doxycycline|mesh-list
153785815|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153785816|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785852|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
153785853|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785854|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785855|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153785856|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785857|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785876|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785877|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153785878|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
153785879|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785880|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153785881|NCT00240149|Insulin|insulin|mesh-list
153785882|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153785883|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153785884|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837148|NCT02940756|Amodiaquine|amodiaquine|mesh-list
153837149|NCT02940756|Artenimol|artenimol|mesh-list
153837150|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
153837151|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153837152|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153837153|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837154|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837155|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
153837156|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
153785885|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153785886|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153785887|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
153785888|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153785889|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
153736157|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785890|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785891|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785892|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
153785893|NCT01647646|Hormones|hormones|mesh-ancestor
153785894|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785895|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
153785896|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
153785897|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153785898|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153785899|NCT01647685|Prednisolone|prednisolone|mesh-list
153785909|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
153785911|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785912|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153785913|NCT01647685|Protective Agents|protective agents|mesh-ancestor
153785947|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153785948|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785949|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
153785950|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153785951|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153785952|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153785987|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
153785988|NCT02279563|Fluticasone|fluticasone|mesh-list
153785989|NCT02279563|Xhance|xhance|mesh-list
153785990|NCT02279563|Azelastine|azelastine|mesh-list
153785991|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785992|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153785993|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
153785994|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786019|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786021|NCT00415740|Levodopa|levodopa|mesh-list
153786022|NCT00415740|Carbidopa|carbidopa|mesh-list
153786023|NCT00415740|Entacapone|entacapone|mesh-list
153786024|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153786025|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153786026|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153786027|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
153786028|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786029|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786030|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786031|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153786032|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786033|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153786034|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153786035|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
153786036|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
153786037|NCT01649479|Antibodies|antibodies|mesh-list
153786038|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
153786039|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
153786040|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786041|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
153786042|NCT01649635|Prednisone|prednisone|mesh-list
153786043|NCT01649635|Lenograstim|lenograstim|mesh-list
153786077|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786078|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786079|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786080|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
153786081|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153786082|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786105|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153786106|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786107|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786108|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786109|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153736158|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153786111|NCT00240656|Protective Agents|protective agents|mesh-ancestor
153786112|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153786120|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786121|NCT00250575|Clozapine|clozapine|mesh-list
153786122|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153786123|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
153786124|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786125|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786126|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786127|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153786128|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153786129|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786148|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153786149|NCT04720248|Analgesics|analgesics|mesh-ancestor
153786150|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
153786151|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786152|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786153|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786154|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786155|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
153786156|NCT01646515|Udenafil|udenafil|mesh-list
153786157|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153786158|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153786159|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786160|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332598|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786161|NCT00240773|Acetaminophen|acetaminophen|mesh-list
153786163|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153786164|NCT00240773|Analgesics|analgesics|mesh-ancestor
153786165|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
153786166|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786167|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786168|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
153786169|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153786170|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786171|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786172|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
153786173|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153786174|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786175|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786176|NCT01688401|Melphalan|melphalan|mesh-list
153786177|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153786178|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
153786179|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786180|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786181|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153786182|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153786183|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
153786184|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786185|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153786186|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153786187|NCT04708821|Dexamethasone|dexamethasone|mesh-list
153786221|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786222|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786223|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786224|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153786225|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786226|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786262|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
153786289|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153786348|NCT00241124|Protective Agents|protective agents|mesh-ancestor
153786349|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786350|NCT00241163|Thrombin|thrombin|mesh-list
153786366|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786368|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786369|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
153786370|NCT02279602|Combretastatin|combretastatin|mesh-list
153786371|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153786372|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786373|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786374|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786375|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786376|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786377|NCT00241436|Anastrozole|anastrozole|mesh-list
153786378|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153377319|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377320|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377321|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
153377322|NCT04894864|Anesthetics|anesthetics|mesh-list
153377323|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377324|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377325|NCT04894864|Narcotics|narcotics|mesh-ancestor
153786379|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786380|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153786381|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153786382|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786383|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786385|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
153786386|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786387|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786388|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
153786389|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153786390|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786391|NCT00241475|Gefitinib|gefitinib|mesh-list
153786392|NCT00241475|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153786393|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153786394|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786395|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786396|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786397|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
153786398|NCT01685359|Hematinics|hematinics|mesh-ancestor
153786399|NCT02278978|Nintedanib|nintedanib|mesh-list
153786400|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786401|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153786402|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786403|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786404|NCT02218762|Fluticasone|fluticasone|mesh-list
153786406|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153786407|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153736163|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736164|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786408|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786409|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153786410|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
153786411|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786412|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786436|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153786437|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
153786438|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153786439|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
153786440|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786441|NCT00241553|Esomeprazole|esomeprazole|mesh-list
153786442|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153786443|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153786444|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153786445|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786446|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786447|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
153786448|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153786449|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153786456|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786457|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786458|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153786459|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786460|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153786495|NCT02219737|Ifosfamide|ifosfamide|mesh-list
153786496|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
153786497|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
153786498|NCT02219737|Antibodies|antibodies|mesh-list
153786499|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
153786500|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153786501|NCT02219737|Ibrutinib|ibrutinib|mesh-list
153786502|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
153786533|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153786534|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
153786535|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
153786536|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153786537|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153786538|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153786539|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153786540|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786541|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377358|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377359|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153377360|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377361|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377362|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
153377363|NCT04678401|Thiotepa|thiotepa|mesh-list
153377368|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786542|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786544|NCT00264654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153786545|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153786579|NCT00241982|Prednisolone|prednisolone|mesh-list
153786580|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786581|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
153786582|NCT00241982|Hormones|hormones|mesh-ancestor
153786583|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786584|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786585|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153786586|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786624|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786660|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
153786687|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153786688|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153786689|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153786691|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786692|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786693|NCT00273039|Paroxetine|paroxetine|mesh-list
153786694|NCT00273039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153786695|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153786696|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786697|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786698|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786699|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
153786700|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786727|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786728|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786729|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786730|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377369|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153377370|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
153377371|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377372|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377373|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153377375|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153377376|NCT04659044|Venetoclax|venetoclax|mesh-list
153786731|NCT00242762|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153786732|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153786733|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786734|NCT00242801|Gefitinib|gefitinib|mesh-list
153786735|NCT00242801|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153786736|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153786737|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400302|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
153786741|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153786742|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153786743|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
153786744|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786745|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786746|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153786747|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153786779|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786780|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153786781|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
153786782|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786783|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786784|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153786785|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153786786|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153786787|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153786788|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153786789|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786790|NCT00273390|Infliximab|infliximab|mesh-list
153786791|NCT00273390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153786792|NCT00273390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786805|NCT00273429|Timolol|timolol|mesh-list
153786806|NCT00273429|Dorzolamide|dorzolamide|mesh-list
153786807|NCT00273429|Latanoprost|latanoprost|mesh-list
153786808|NCT00273429|Maleic acid|maleic acid|mesh-list
153786809|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786810|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786811|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153786812|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153786813|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786814|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786815|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786816|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153786817|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153786818|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153786819|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153786820|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153786821|NCT00273468|Granisetron|granisetron|mesh-list
153786822|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
153786823|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
153786824|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786825|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786826|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837302|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
153786827|NCT00273468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153786828|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153786829|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
153786830|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786831|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786833|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
153786834|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153786835|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
153786836|NCT00243464|Calcipotriene|calcipotriene|mesh-list
153736165|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153736166|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736167|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
153736168|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153736169|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153786837|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153786838|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786839|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
153786840|NCT00243464|Hormones|hormones|mesh-ancestor
153786841|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786842|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786843|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153786844|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
153786845|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
153786846|NCT00273507|Paclitaxel|paclitaxel|mesh-list
153786847|NCT00273507|Carboplatin|carboplatin|mesh-list
153786851|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786852|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786853|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786854|NCT00282945|Metformin|metformin|mesh-list
153786855|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
153786856|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153786857|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786858|NCT00273546|Docetaxel|docetaxel|mesh-list
153786883|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
153786884|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153786885|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
153786886|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786887|NCT00273702|Protective Agents|protective agents|mesh-ancestor
153786888|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786889|NCT00273702|Antidotes|antidotes|mesh-ancestor
153786890|NCT00243815|Ibuprofen|ibuprofen|mesh-list
153786891|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153786892|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153786893|NCT00243815|Analgesics|analgesics|mesh-ancestor
153786894|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
153786895|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786896|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786897|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786898|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786899|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153786900|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333348|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786901|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786902|NCT00283179|Risperidone|risperidone|mesh-list
153786903|NCT00283179|Aripiprazole|aripiprazole|mesh-list
153786904|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153786906|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786907|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786908|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786909|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153786910|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153786911|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786940|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786941|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786942|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786943|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786944|NCT00243893|Doxycycline|doxycycline|mesh-list
153786945|NCT00243893|Minocycline|minocycline|mesh-list
153786946|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153786947|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786948|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
153786949|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153786950|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153786951|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
153786952|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153736170|NCT03647852|Prednisolone|prednisolone|mesh-list
153786953|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153786954|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786966|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786967|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153786968|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153786969|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786970|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
153786971|NCT00244127|Hormones|hormones|mesh-ancestor
153786972|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786973|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153786974|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153333422|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153786975|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786976|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786977|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786978|NCT00244166|Prednisolone|prednisolone|mesh-list
153786979|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786982|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786984|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153786985|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786986|NCT00273975|Lamivudine|lamivudine|mesh-list
153786987|NCT00273975|Zidovudine|zidovudine|mesh-list
153786988|NCT00273975|Nevirapine|nevirapine|mesh-list
153786989|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153786990|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153786991|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786992|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786993|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
153837391|NCT04974684|Apixaban|apixaban|mesh-list
153786994|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786995|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153786996|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153786997|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
153786998|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153786999|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153787000|NCT00244283|Sevoflurane|sevoflurane|mesh-list
153787001|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153787002|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153787003|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
153787004|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
153787005|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787006|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787007|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
153787008|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153787009|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
153787010|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787011|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153787012|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153787013|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153787014|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787015|NCT00244322|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
153787038|NCT00244439|Malathion|malathion|mesh-list
153787039|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787040|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787041|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153787042|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
153787043|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787044|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787045|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153787046|NCT00417144|Ganirelix|ganirelix|mesh-list
153787047|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
153787048|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153787049|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
153787050|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153787051|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787052|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153787053|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153787054|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736171|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
153736172|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153736173|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
153736174|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153736175|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
153736176|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
153787055|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
153787056|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787057|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
153787058|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153787059|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
153787060|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787061|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787062|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153787063|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
153787064|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
153787065|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153787105|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153787106|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
153787107|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787108|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787109|NCT00244556|Etanercept|etanercept|mesh-list
153787110|NCT00244556|Methotrexate|methotrexate|mesh-list
153787111|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153787112|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
153787113|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153787114|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787115|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153787126|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153787128|NCT00244556|Analgesics|analgesics|mesh-ancestor
153787129|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
153787130|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787131|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787132|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153787133|NCT00274131|Pramipexole|pramipexole|mesh-list
153787134|NCT00274131|Dexpramipexole|dexpramipexole|mesh-list
153787135|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
153787136|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787137|NCT00274131|Protective Agents|protective agents|mesh-ancestor
153787138|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257300|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787139|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153787140|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153787141|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
153787142|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
153787143|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787144|NCT00274170|Octreotide|octreotide|mesh-list
153787145|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153787146|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153787147|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787148|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
153787149|NCT00244829|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153787150|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787151|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787152|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787153|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736177|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736178|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787154|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
153787155|NCT00244907|Genistein|genistein|mesh-list
153787156|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153787157|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787158|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787164|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787165|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787166|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787167|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
153787168|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153787169|NCT00244907|Estrogens|estrogens|mesh-ancestor
153787170|NCT00244907|Hormones|hormones|mesh-ancestor
153787171|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787172|NCT00244946|Cytarabine|cytarabine|mesh-list
153787173|NCT00244946|Etoposide|etoposide|mesh-list
153787174|NCT00244946|Melphalan|melphalan|mesh-list
153787175|NCT00244946|Carmustine|carmustine|mesh-list
153787176|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153787177|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787178|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153787197|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787198|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787199|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787200|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787201|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787202|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153787203|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787204|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787205|NCT00274326|Satavaptan|satavaptan|mesh-list
153787206|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153787207|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787208|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
153787209|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787210|NCT00245141|Dactinomycin|dactinomycin|mesh-list
153787211|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
153787212|NCT00245141|Vincristine|vincristine|mesh-list
153787213|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787214|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
153787215|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787216|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787217|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153787218|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
153377560|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377561|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377562|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377563|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837465|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837466|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
153837473|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837474|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153837475|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837477|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153787219|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787220|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787221|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153787222|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153787223|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787224|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787225|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787226|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153787227|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787228|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153787229|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153787267|NCT00245375|Ibuprofen|ibuprofen|mesh-list
153787268|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153787269|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153787270|NCT00245375|Analgesics|analgesics|mesh-ancestor
153787271|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
153787280|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153787281|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
153787282|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
153787283|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787284|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
153736179|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153787285|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787286|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
153787287|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153787288|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
153787289|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787297|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787298|NCT00245453|Azithromycin|azithromycin|mesh-list
153787299|NCT00245453|Clarithromycin|clarithromycin|mesh-list
153787300|NCT00245453|Telithromycin|telithromycin|mesh-list
153787301|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153787302|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787303|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153787304|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787305|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787306|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153787307|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153837507|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787308|NCT00245609|Pregabalin|pregabalin|mesh-list
153787309|NCT00245609|Alprazolam|alprazolam|mesh-list
153787310|NCT00245609|Analgesics|analgesics|mesh-ancestor
153787311|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
153787312|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787313|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787314|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
153787315|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153787316|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787317|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787318|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153787319|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153787320|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787321|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787322|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787323|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153787324|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
153787325|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
153787326|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787327|NCT00274638|Losartan|losartan|mesh-list
153787328|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153787329|NCT00274638|Telmisartan|telmisartan|mesh-list
153787330|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153787331|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153787332|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153787333|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153787334|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787335|NCT00274638|Diuretics|diuretics|mesh-ancestor
153787336|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
153787337|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787353|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153787355|NCT00245921|Estrogens|estrogens|mesh-ancestor
153787356|NCT00245921|Hormones|hormones|mesh-ancestor
153787357|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787358|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787359|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153787360|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
153787361|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153787362|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153787363|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153787364|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153787365|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153787366|NCT00274794|Rituximab|rituximab|mesh-list
153787367|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153787368|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787369|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
153787370|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787371|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787372|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
153787377|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787380|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787381|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153787382|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787383|NCT00284193|Thrombin|thrombin|mesh-list
153787384|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
153787385|NCT00284193|Factor VIII|factor viii|mesh-list
153787386|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
153787387|NCT00284193|Coagulants|coagulants|mesh-ancestor
153787388|NCT00246194|Risperidone|risperidone|mesh-list
153787389|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153787390|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
153787391|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787392|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787393|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787405|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787406|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153787407|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153787408|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787409|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787411|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787412|NCT00274833|Temozolomide|temozolomide|mesh-list
153787413|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153787414|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153787415|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
153787416|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787417|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787418|NCT00274833|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153333946|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153787419|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787421|NCT00274872|Leucovorin|leucovorin|mesh-list
153787422|NCT00274872|Fluorouracil|fluorouracil|mesh-list
153787423|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
153787424|NCT00274872|Calcium|calcium|mesh-list
153787425|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
153787426|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153787427|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787428|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
153837537|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153787429|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837583|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787430|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153787431|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787432|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787433|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
153787434|NCT00274872|Antidotes|antidotes|mesh-ancestor
153787435|NCT00274872|Protective Agents|protective agents|mesh-ancestor
153787436|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
153787437|NCT00274872|Vitamins|vitamins|mesh-ancestor
153787438|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
153787439|NCT00246272|Risperidone|risperidone|mesh-list
153787440|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153787441|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
153787442|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787443|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787444|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787445|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153787446|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787447|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787448|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787449|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153787450|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
153787451|NCT00284271|Prednisone|prednisone|mesh-list
153787457|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
153787458|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787468|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787470|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153787471|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787472|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787473|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787474|NCT00284271|Hematinics|hematinics|mesh-ancestor
153787475|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153837584|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
153837585|NCT02931357|Lidocaine|lidocaine|mesh-list
153837586|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
153837587|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
153377666|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377667|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
153377668|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
153377669|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
153377670|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377671|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377672|NCT04094298|FX006|fx006|mesh-list
153377674|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
153787476|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
153787477|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153787478|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
153787479|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787480|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153787481|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787482|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153787483|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787484|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787485|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787486|NCT00274911|Vincristine|vincristine|mesh-list
153787487|NCT00274911|Lomustine|lomustine|mesh-list
153787488|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787489|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153787490|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787491|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787492|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787493|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334022|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787494|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153787495|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
153787496|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153787497|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153787498|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
153787499|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787500|NCT00246467|Antacids|antacids|mesh-ancestor
153787501|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787502|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153787503|NCT00277251|Alendronate|alendronate|mesh-list
153787504|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153787505|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787506|NCT00246584|Aliskiren|aliskiren|mesh-list
153787507|NCT00246584|Renin Inhibitors|renin inhibitors|mesh-ancestor
153787508|NCT00246584|Protease Inhibitors|protease inhibitors|mesh-ancestor
153787509|NCT00246584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837589|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837590|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377694|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153377697|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
153787510|NCT00246584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787511|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
153787512|NCT00416676|Carboplatin|carboplatin|mesh-list
153787513|NCT00416676|Etoposide|etoposide|mesh-list
153787514|NCT00416676|Vincristine|vincristine|mesh-list
153787515|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787516|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
153787517|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787518|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787519|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153787520|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
153787521|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787535|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
153787536|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787537|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
153787538|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787539|NCT00284427|Protective Agents|protective agents|mesh-ancestor
153787540|NCT00246701|Simvastatin|simvastatin|mesh-list
153787541|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153787542|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153787543|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
153787544|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787547|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787549|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787550|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
153787551|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787552|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
153787553|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153736182|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736183|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153787554|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787555|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153368438|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368439|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153368440|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787556|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153787558|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
153787559|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787560|NCT00246974|Gemcitabine|gemcitabine|mesh-list
153787561|NCT00246974|Gefitinib|gefitinib|mesh-list
153787562|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787563|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153787564|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
153787565|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787566|NCT00246974|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153787567|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787568|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787569|NCT00284583|Lidocaine|lidocaine|mesh-list
153787570|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
153787571|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
153787572|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787573|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787574|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
153787575|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787576|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153787577|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153787578|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153787579|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787580|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787581|NCT00247052|Diclofenac|diclofenac|mesh-list
153787582|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153787591|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787592|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787594|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
153787595|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153787596|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153787597|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787598|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787599|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787600|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153787601|NCT00277602|Protective Agents|protective agents|mesh-ancestor
153787602|NCT00277641|Lamotrigine|lamotrigine|mesh-list
153787603|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
153787604|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153787605|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787606|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787607|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153787608|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787609|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153787610|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787611|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787612|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787613|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153787614|NCT00247130|Omeprazole|omeprazole|mesh-list
153787615|NCT00247130|Ranitidine|ranitidine|mesh-list
153787616|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153787617|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153787618|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153787619|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153787620|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787624|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
153787625|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787626|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787627|NCT00247169|Progesterone|progesterone|mesh-list
153787628|NCT00247169|Progestins|progestins|mesh-ancestor
153787629|NCT00247169|Hormones|hormones|mesh-ancestor
153828453|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153828454|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
153828455|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828456|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828457|NCT00484133|Protective Agents|protective agents|mesh-ancestor
153828458|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
153828459|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153828460|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153736184|NCT03647852|Protective Agents|protective agents|mesh-ancestor
153430996|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787630|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787631|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787632|NCT00247208|Paclitaxel|paclitaxel|mesh-list
153787633|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153837689|NCT00522665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153837698|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153837699|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837700|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153837701|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
153837702|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377780|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153377781|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
153377786|NCT03850366|Bortezomib|bortezomib|mesh-list
153787634|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787635|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787636|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787637|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787638|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787639|NCT00284778|Docetaxel|docetaxel|mesh-list
153334097|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
153787640|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787641|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787642|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787643|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787644|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787645|NCT00247247|Entacapone|entacapone|mesh-list
153787646|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153787676|NCT00424814|Lopinavir|lopinavir|mesh-list
153787677|NCT00424814|Lamivudine|lamivudine|mesh-list
153787678|NCT00424814|Zidovudine|zidovudine|mesh-list
153787679|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153787680|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153787681|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153787682|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
153787683|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787684|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787685|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153787686|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153787687|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
153787688|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787689|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153787690|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153787691|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153787692|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153787693|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
153787728|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153787729|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
153787730|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787731|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787762|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153787763|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153787764|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153787765|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787766|NCT00278070|Vinorelbine|vinorelbine|mesh-list
153787767|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153787768|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787769|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787770|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787771|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787772|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787773|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
153787774|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153787775|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787776|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154257301|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787777|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153787778|NCT00247910|Diuretics|diuretics|mesh-ancestor
153787779|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
153787812|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153787850|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153787851|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153736185|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153736186|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787852|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787853|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787854|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153787856|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
153787857|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153787882|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787883|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153787884|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
153787885|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787886|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787887|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153787888|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153787889|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153787890|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153787891|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153377829|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837733|NCT02936895|Vitamin D|vitamin d|mesh-list
153787892|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787893|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787894|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
153787896|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787897|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153787898|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153787899|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787900|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787901|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787902|NCT00248456|Betamethasone|betamethasone|mesh-list
153787903|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
153787904|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153787905|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
153787906|NCT00248456|Calcipotriene|calcipotriene|mesh-list
153787942|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787943|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
153787944|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153787945|NCT00248963|Estradiol|estradiol|mesh-list
153787978|NCT00278772|Valproic Acid|valproic acid|mesh-list
153787979|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
153787980|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787981|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787982|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
153787983|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787984|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787985|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
153788014|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153788015|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
153788016|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153788017|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153788018|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153788019|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153788020|NCT00249197|Levofloxacin|levofloxacin|mesh-list
153788021|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153788022|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788023|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153788024|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153788025|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153788068|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153736188|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736189|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788069|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788070|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153788071|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153788089|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
153788090|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788091|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153788092|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829045|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
153829046|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829047|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829048|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829049|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153829050|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153829051|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829185|NCT00486317|Calcitonin|calcitonin|mesh-list
153788093|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788094|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788095|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
153788096|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788097|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788098|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153788099|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153788100|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788101|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153788102|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153788103|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153788104|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
153788105|NCT00279084|Chrysarobin|chrysarobin|mesh-list
153788106|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
153788107|NCT00279084|Hematinics|hematinics|mesh-ancestor
153788108|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153788109|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153788110|NCT00279084|Analgesics|analgesics|mesh-ancestor
153788111|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
153788112|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788113|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788114|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153788115|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153788116|NCT00249587|Methadone|methadone|mesh-list
153788117|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153788118|NCT00249587|Narcotics|narcotics|mesh-ancestor
153788119|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788120|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788121|NCT00249587|Analgesics|analgesics|mesh-ancestor
153377883|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
153788122|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
153788123|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788124|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
153788157|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153788158|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788159|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788160|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
153788162|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153788194|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788195|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788196|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
153788205|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788206|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788232|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788233|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788234|NCT00286143|Analgesics|analgesics|mesh-ancestor
153788235|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
153788236|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788237|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153788238|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153788239|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
153788240|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
153788241|NCT00286260|Levetiracetam|levetiracetam|mesh-list
153788242|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
153788243|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
153788244|NCT00250367|Risperidone|risperidone|mesh-list
153788245|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153788246|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
153788247|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369778|NCT05624151|Bupivacaine|bupivacaine|mesh-list
153369779|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
153370091|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153370092|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153370093|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153370175|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
153830117|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830118|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153788248|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788249|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788250|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153788251|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153788252|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788253|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788254|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153788255|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
153788257|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153788273|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788274|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788275|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
153788276|NCT00279747|Naproxen|naproxen|mesh-list
153788277|NCT00279747|Meloxicam|meloxicam|mesh-list
153788278|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153788279|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153788280|NCT00279747|Analgesics|analgesics|mesh-ancestor
153788281|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
153788282|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788283|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788284|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153788285|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153788286|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
153788287|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153788288|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788289|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788290|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153788291|NCT00250640|Iloprost|iloprost|mesh-list
153788292|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153788293|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
153788294|NCT00250796|Interferons|interferons|mesh-list
153788295|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
153788296|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153788297|NCT00250796|Thalidomide|thalidomide|mesh-list
153788298|NCT00250796|Octreotide|octreotide|mesh-list
153788299|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788300|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
153788301|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788302|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788303|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
153334773|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153788304|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788348|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788349|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788350|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153788351|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788352|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788354|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837862|NCT02947880|Diuretics|diuretics|mesh-ancestor
153788355|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153788357|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153788358|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153788359|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334933|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334934|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153334936|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334937|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334938|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153830600|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830601|NCT00495092|Biperiden|biperiden|mesh-list
153830602|NCT00495092|Caffeine|caffeine|mesh-list
153830603|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153830604|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370669|NCT02243579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153370670|NCT02243579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370672|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
153370674|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370675|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
153830614|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
153830642|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334939|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153334940|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153334941|NCT01143181|Brincidofovir|brincidofovir|mesh-list
153334942|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
153788387|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
153788388|NCT00416832|Hormones|hormones|mesh-ancestor
153788389|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153788390|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153788391|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153788392|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788428|NCT00279903|Cortisone|cortisone|mesh-list
153788429|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
153788430|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153788431|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153788432|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153788433|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788458|NCT01640665|Sorafenib|sorafenib|mesh-list
153788459|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788460|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
153788461|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788462|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788463|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153788464|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788465|NCT01640782|Leucovorin|leucovorin|mesh-list
153788466|NCT01640782|Docetaxel|docetaxel|mesh-list
153788467|NCT01640782|Fluorouracil|fluorouracil|mesh-list
153788475|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
153334947|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153334948|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
153334965|NCT01187017|Fludarabine|fludarabine|mesh-list
153788476|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788477|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788478|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
153788479|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788480|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153788481|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153788482|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788483|NCT01640782|Antidotes|antidotes|mesh-ancestor
153788517|NCT01641406|Epirubicin|epirubicin|mesh-list
153788518|NCT01641406|Vinorelbine|vinorelbine|mesh-list
153788519|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788520|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
153788521|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788522|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153788523|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153788524|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
153788525|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788526|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788527|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153788558|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788559|NCT00251381|Cetuximab|cetuximab|mesh-list
153788560|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153788562|NCT01685827|Eflornithine|eflornithine|mesh-list
153788563|NCT01685827|Nifurtimox|nifurtimox|mesh-list
153788564|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788565|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153788566|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153788567|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153788568|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788569|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153788570|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788594|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788595|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
153788596|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788597|NCT04823065|Scopolamine|scopolamine|mesh-list
153788598|NCT04823065|Loperamide|loperamide|mesh-list
153788599|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
153788600|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153788601|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788602|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153788603|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
153788604|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
153788605|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788606|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788607|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
153788608|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153788609|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
153788610|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788611|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788612|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153788613|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
153788614|NCT00280176|Fluorouracil|fluorouracil|mesh-list
153788615|NCT00280176|Bortezomib|bortezomib|mesh-list
153788616|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
153788617|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788618|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788619|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788645|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
153788647|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153788648|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153788649|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153788650|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153788651|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
153788652|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788653|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788654|NCT02276755|Vitamin D|vitamin d|mesh-list
153788655|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
153788656|NCT02276755|Vitamins|vitamins|mesh-ancestor
153788657|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
153788658|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788659|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153788660|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153788661|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
153788662|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153788663|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
153788664|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788665|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788666|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153788694|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
153788695|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788696|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788697|NCT00286962|Insulin|insulin|mesh-list
153788698|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153788699|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153788700|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788701|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
153335171|NCT03995680|Mebendazole|mebendazole|mesh-list
153788702|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153788703|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788704|NCT00251849|KRM 1648|krm 1648|mesh-list
153788705|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153788706|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
153788707|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153788708|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788709|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
153788710|NCT00251888|Irinotecan|irinotecan|mesh-list
153788711|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788809|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378045|NCT03188796|Vitamin D|vitamin d|mesh-list
153788810|NCT00252356|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153788812|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153788813|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788814|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788816|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
153788817|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788818|NCT02754154|Warfarin|warfarin|mesh-list
153788819|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
153788820|NCT02754154|Dabigatran|dabigatran|mesh-list
153788821|NCT02754154|Apixaban|apixaban|mesh-list
153788822|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
153788823|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153788824|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
153788825|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153788826|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
153789086|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789087|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789088|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153789089|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
153789090|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
153789091|NCT00252824|Hormones|hormones|mesh-ancestor
153789092|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789093|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153789094|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153789095|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153789096|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
153789097|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789126|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153789128|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153789129|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
153789130|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789131|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789132|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
153789133|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153789134|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153789135|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
153789136|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153789137|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153789138|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153789167|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
153789168|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789170|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153789171|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789172|NCT01681966|Ropivacaine|ropivacaine|mesh-list
153789173|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153789174|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
153789175|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
153789176|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789177|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789178|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
153789179|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789180|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153789181|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153789182|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789183|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789184|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789185|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789186|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153789514|NCT00281502|Rifaximin|rifaximin|mesh-list
153789515|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153789542|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153789543|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789545|NCT00253526|Gemcitabine|gemcitabine|mesh-list
153736201|NCT03520686|Carboplatin|carboplatin|mesh-list
153736202|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
153736203|NCT03520686|Pemetrexed|pemetrexed|mesh-list
153736204|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153789546|NCT00253526|Antibodies|antibodies|mesh-list
153789547|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
153789548|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153789549|NCT00253526|Mitogens|mitogens|mesh-list
153789550|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153789551|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789552|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154257302|NCT01283360|Tenofovir|tenofovir|mesh-list
153789553|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153789554|NCT00253526|Growth Substances|growth substances|mesh-ancestor
153789555|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789556|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
153789557|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
153789558|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153789628|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153789629|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153789630|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789631|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789632|NCT00253721|Melphalan|melphalan|mesh-list
153789633|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153789634|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
153789635|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789636|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789637|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153789638|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789639|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
153789640|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789641|NCT00281892|Vidarabine|vidarabine|mesh-list
153789642|NCT00281892|Fludarabine|fludarabine|mesh-list
153789643|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
153789644|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860513|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
153860516|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
153789739|NCT01687894|Coagulants|coagulants|mesh-ancestor
153789740|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153789741|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153789764|NCT01688206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153789765|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789766|NCT00288171|Allopurinol|allopurinol|mesh-list
153789767|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
153789768|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789769|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789770|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
153789771|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153789772|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153789773|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
153789774|NCT00288171|Protective Agents|protective agents|mesh-ancestor
153789775|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789776|NCT00253955|Levofloxacin|levofloxacin|mesh-list
153789777|NCT00253955|Tazobactam|tazobactam|mesh-list
153789778|NCT00253955|Piperacillin|piperacillin|mesh-list
153789779|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153789780|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153789833|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
153789834|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
153789835|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789867|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153789868|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789869|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789870|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153789871|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153789872|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
153789873|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
153789874|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
153789875|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153789876|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789877|NCT00417729|Acarbose|acarbose|mesh-list
153400839|NCT02054156|Azithromycin|azithromycin|mesh-list
153790153|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790154|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153790155|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153790156|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790157|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790158|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153790159|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
153790173|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
153790174|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790175|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
153790176|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153790177|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153790178|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153790179|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
153790180|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831215|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
153831216|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831217|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831218|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
153831225|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790181|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790182|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790183|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
153790184|NCT00270075|Hematinics|hematinics|mesh-ancestor
153790185|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
153790187|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
153790194|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153378145|NCT02757859|Pancrelipase|pancrelipase|mesh-list
153790195|NCT01588756|Protective Agents|protective agents|mesh-ancestor
153790196|NCT04719104|Bilirubin|bilirubin|mesh-list
153790197|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
153790198|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790199|NCT04719104|Protective Agents|protective agents|mesh-ancestor
153790200|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790201|NCT01588795|Vitamin D|vitamin d|mesh-list
153790202|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
153790203|NCT01588795|Diuretics|diuretics|mesh-list
153790204|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153790205|NCT01588795|Vitamins|vitamins|mesh-ancestor
153790206|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
153790207|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790208|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153790209|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153790210|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
153790211|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790212|NCT00107614|Rituximab|rituximab|mesh-list
153790213|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153790214|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790215|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
153790216|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790217|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790218|NCT00255242|Simvastatin|simvastatin|mesh-list
153790240|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
153790241|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790242|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790243|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153790244|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153790245|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153790246|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153790247|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153790248|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790249|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790250|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
153790251|NCT00107380|Hormones|hormones|mesh-ancestor
153790252|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153790253|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153790254|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153790255|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790256|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
153790257|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
153790258|NCT00270153|Enalapril|enalapril|mesh-list
153790259|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153790260|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
153790261|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790262|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336810|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
153790263|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153790264|NCT04054531|Paclitaxel|paclitaxel|mesh-list
153790265|NCT04054531|Carboplatin|carboplatin|mesh-list
153790266|NCT04054531|Pemetrexed|pemetrexed|mesh-list
153790267|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153790313|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790314|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790315|NCT00289419|Analgesics|analgesics|mesh-ancestor
153790316|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
153790317|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371606|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153371607|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
153371608|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153371609|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
153371610|NCT01749293|Busulfan|busulfan|mesh-list
153371611|NCT01749293|Fludarabine|fludarabine|mesh-list
153371612|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153371613|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
153831549|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790318|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
153790319|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
153790320|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153790321|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153790463|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790464|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
153790499|NCT00270777|Racepinephrine|racepinephrine|mesh-list
153790532|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153790533|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153790534|NCT00256256|Hormones|hormones|mesh-ancestor
153790535|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153790536|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790537|NCT00256256|Incretins|incretins|mesh-ancestor
153790538|NCT00256334|Resveratrol|resveratrol|mesh-list
153790539|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
153790540|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790541|NCT00256334|Protective Agents|protective agents|mesh-ancestor
153790628|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
153790629|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
153790630|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153790631|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
153790632|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
153790716|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
153790717|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153790718|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153790855|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153790856|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790858|NCT00257270|Analgesics|analgesics|mesh-ancestor
153790859|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
153337334|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790860|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790861|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790862|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
153790863|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153790891|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790892|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736213|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153736214|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153736215|NCT03472092|Amitriptyline|amitriptyline|mesh-list
153736216|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153736217|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
153736218|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153736219|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153736222|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736223|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736224|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153736225|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153736226|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153736227|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736228|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
153431022|NCT00000781|Didanosine|didanosine|mesh-list
153790893|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
153790894|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790895|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
153790896|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790897|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
153790898|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790899|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154257303|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
154257304|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257305|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154257306|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154257307|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257308|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790900|NCT00257426|Octreotide|octreotide|mesh-list
153790901|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153790902|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153790903|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790904|NCT01601509|Tramazoline|tramazoline|mesh-list
153790905|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
153790906|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
153790907|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790908|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790909|NCT00416325|Lycopene|lycopene|mesh-list
153790910|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790911|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
153790946|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
153790947|NCT01602055|Azithromycin|azithromycin|mesh-list
153790948|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153790949|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790964|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153790965|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153790966|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
153790967|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
153790968|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790969|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790970|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790971|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153790972|NCT01602289|Gefitinib|gefitinib|mesh-list
153790975|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790976|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790977|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790978|NCT00257621|Ritonavir|ritonavir|mesh-list
153790979|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153790980|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153790981|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
153431024|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
153790982|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790983|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790984|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153790985|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153790986|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
153790987|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790988|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153790989|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153790990|NCT01602406|Trastuzumab|trastuzumab|mesh-list
153790991|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153790992|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790993|NCT00290628|Cyclosporine|cyclosporine|mesh-list
153790994|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
153790995|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
153790996|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
153790997|NCT00290628|Melphalan|melphalan|mesh-list
153790998|NCT00290628|Busulfan|busulfan|mesh-list
153790999|NCT00290628|Cyclosporins|cyclosporins|mesh-list
153791000|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153791001|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153791002|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
153791003|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791004|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791005|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153791099|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
153791100|NCT01602757|Lidocaine|lidocaine|mesh-list
153791101|NCT01602757|Tetracaine|tetracaine|mesh-list
153791129|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
153791130|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791131|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153371894|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153371895|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153371896|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153371897|NCT01759277|Anesthetics|anesthetics|mesh-list
153371898|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
153371899|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371900|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371901|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
153791132|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
153791133|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153791134|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153791135|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153791136|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791137|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153791138|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153791139|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
153791140|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153791141|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153791142|NCT00257699|Metronidazole|metronidazole|mesh-list
153791143|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
153791144|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791145|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153791181|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791215|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153791216|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153791217|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
153791218|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
153791219|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
153791220|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153791221|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
153791222|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153791223|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153791252|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791253|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791254|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791255|NCT00257855|Lamotrigine|lamotrigine|mesh-list
153791256|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
153791257|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153791258|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153791301|NCT06302569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791302|NCT06302569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153791303|NCT06302569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337796|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
153791348|NCT06302218|Anesthetics, Local|anesthetics, local|mesh-ancestor
153791349|NCT06302218|Anesthetics|anesthetics|mesh-ancestor
153791350|NCT06302218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791351|NCT06302218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791358|NCT06302062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791391|NCT06301828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791392|NCT06301828|Growth Inhibitors|growth inhibitors|mesh-ancestor
153791393|NCT06301828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791394|NCT06301802|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153791395|NCT06301802|Cholinergic Agents|cholinergic agents|mesh-ancestor
153791396|NCT06301802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791397|NCT06301802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791426|NCT06301399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791427|NCT06301399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791428|NCT06301386|Everolimus|everolimus|mesh-list
153791429|NCT06301386|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153736229|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791430|NCT06301386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153791431|NCT06301386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791432|NCT06301386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791433|NCT06301386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372050|NCT01318694|Ribavirin|ribavirin|mesh-list
153372051|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153372052|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
153372053|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372054|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
153372055|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832021|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153832022|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
153372094|NCT01322048|Propranolol|propranolol|mesh-list
153372095|NCT01322048|Clonidine|clonidine|mesh-list
153372096|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153372097|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153372098|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832049|NCT00732212|Hemostatics|hemostatics|mesh-list
153791434|NCT06301386|Immunologic Factors|immunologic factors|mesh-ancestor
153791435|NCT06301386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791436|NCT06301386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791437|NCT06301373|Methotrexate|methotrexate|mesh-list
153791438|NCT06301373|Tofacitinib|tofacitinib|mesh-list
153791439|NCT06301373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153791440|NCT06301373|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153791473|NCT06301308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153791474|NCT06301308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791476|NCT06301282|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153791477|NCT06301282|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153791478|NCT06301282|Dopamine Agents|dopamine agents|mesh-ancestor
153791479|NCT06301282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401030|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791592|NCT06300333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791593|NCT06300333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791595|NCT06300333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791596|NCT06300333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153791597|NCT06300333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153791598|NCT06300333|Immunologic Factors|immunologic factors|mesh-ancestor
153791599|NCT06300333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791600|NCT06300333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153791601|NCT06300268|Sirolimus|sirolimus|mesh-list
153791602|NCT06300268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153791603|NCT06300268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791604|NCT06300268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153791605|NCT06300268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791606|NCT06300268|Antifungal Agents|antifungal agents|mesh-ancestor
153791607|NCT06300268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153791608|NCT06300268|Immunologic Factors|immunologic factors|mesh-ancestor
153791609|NCT06300268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736230|NCT03449251|Verapamil|verapamil|mesh-list
153791611|NCT06300216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791612|NCT06300216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791613|NCT06300216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791614|NCT06300203|Interleukin-4|interleukin-4|mesh-list
153791653|NCT06299670|Thalidomide|thalidomide|mesh-list
153791654|NCT06299670|Hydroxyurea|hydroxyurea|mesh-list
153791655|NCT06299670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153791656|NCT06299670|Immunologic Factors|immunologic factors|mesh-ancestor
153791657|NCT06299670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791667|NCT06299670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832140|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832141|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832142|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832145|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
153791668|NCT06299670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791669|NCT06299670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153791670|NCT06299605|Amoxicillin|amoxicillin|mesh-list
153791671|NCT06299605|Tetracycline|tetracycline|mesh-list
153791673|NCT06299605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153791674|NCT06299605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791675|NCT06299605|Antacids|antacids|mesh-ancestor
153791676|NCT06299605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791677|NCT06299605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791678|NCT06299605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153791679|NCT06299605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791703|NCT06294561|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153791704|NCT06294561|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153791705|NCT06294561|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153791717|NCT06293807|Lidocaine|lidocaine|mesh-list
153791718|NCT06293807|Epinephrine|epinephrine|mesh-list
153791719|NCT06293807|Racepinephrine|racepinephrine|mesh-list
153791720|NCT06293807|Bupivacaine|bupivacaine|mesh-list
153791721|NCT06293807|Epinephryl borate|epinephryl borate|mesh-list
153791722|NCT06293807|Anesthetics, Local|anesthetics, local|mesh-ancestor
153791723|NCT06293807|Anesthetics|anesthetics|mesh-ancestor
153791724|NCT06293807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791754|NCT06290050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153791755|NCT06290050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791756|NCT06290050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791757|NCT06290050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153791758|NCT06290050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153791759|NCT06290050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153791760|NCT06290050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153791761|NCT06290050|Anesthetics, General|anesthetics, general|mesh-ancestor
153791762|NCT06290050|Anesthetics|anesthetics|mesh-ancestor
153791763|NCT06290050|GABA Modulators|gaba modulators|mesh-ancestor
153791764|NCT06290050|GABA Agents|gaba agents|mesh-ancestor
153791765|NCT06290050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791766|NCT06290050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791767|NCT06290050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153791769|NCT06285409|Carbetocin|carbetocin|mesh-list
153791770|NCT06285409|Carboprost|carboprost|mesh-list
153791877|NCT06184373|Sensory System Agents|sensory system agents|mesh-ancestor
153791878|NCT06184373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791908|NCT06163807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
153838342|NCT02929095|Narcotics|narcotics|mesh-ancestor
153791909|NCT06163807|Respiratory System Agents|respiratory system agents|mesh-ancestor
153791910|NCT06162663|Suvorexant|suvorexant|mesh-list
153791911|NCT06162663|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153791912|NCT06162663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153401094|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
153401095|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401096|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
153401097|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401098|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401099|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
153401100|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153401101|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153401102|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153401104|NCT02389088|Letrozole|letrozole|mesh-list
153791964|NCT06136598|Fludrocortisone|fludrocortisone|mesh-list
153791965|NCT06136598|BB 1101|bb 1101|mesh-list
153791966|NCT06136598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153791967|NCT06136598|Antiemetics|antiemetics|mesh-ancestor
153791968|NCT06136598|Autonomic Agents|autonomic agents|mesh-ancestor
153791969|NCT06136598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338457|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
153736231|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153792104|NCT05955170|Tucatinib|tucatinib|mesh-list
153792105|NCT05955170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792106|NCT05955170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792136|NCT05900206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153372360|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153372361|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372362|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153372363|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153372364|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792137|NCT05900206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792138|NCT05900206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153792139|NCT05900206|Immunologic Factors|immunologic factors|mesh-ancestor
153792140|NCT05900206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792141|NCT05900206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153792142|NCT05900206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153792143|NCT05900206|Alkylating Agents|alkylating agents|mesh-ancestor
153792144|NCT05900206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153792145|NCT05900206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792146|NCT05900206|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153792147|NCT05900206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153792148|NCT05900206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792149|NCT05900206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153792150|NCT05900206|Hormone Antagonists|hormone antagonists|mesh-ancestor
153792151|NCT05900206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792152|NCT05900206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153792183|NCT05796167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153792184|NCT05796167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153792435|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153792436|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
153792437|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
153792438|NCT05508074|Riluzole|riluzole|mesh-list
153792439|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
153469174|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
153792471|NCT05462756|Insulin|insulin|mesh-list
153792472|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153792473|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
153792474|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
153792475|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153792476|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792477|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153792478|NCT05433584|Tirzepatide|tirzepatide|mesh-list
153792479|NCT05433584|Incretins|incretins|mesh-ancestor
153792480|NCT05433584|Hormones|hormones|mesh-ancestor
153792481|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792482|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792649|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792650|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153792651|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153792652|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153792687|NCT05064878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153736232|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153736233|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153792688|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153792689|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153792690|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792691|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792692|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
153792706|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153792707|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792717|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
153792718|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792719|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792720|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257309|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154257310|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154257311|NCT01173068|Ertapenem|ertapenem|mesh-list
154257312|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154257313|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257314|NCT03267940|Atezolizumab|atezolizumab|mesh-list
154257315|NCT03267940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154257316|NCT03267940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792721|NCT04978272|Piperaquine|piperaquine|mesh-list
153792722|NCT04978272|Artenimol|artenimol|mesh-list
153792723|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
153792724|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153792725|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153339213|NCT00002182|Megestrol|megestrol|mesh-list
153792726|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792727|NCT04969887|Nivolumab|nivolumab|mesh-list
153792728|NCT04969887|Ipilimumab|ipilimumab|mesh-list
153792729|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792730|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792731|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792732|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792733|NCT04966299|Erythritol|erythritol|mesh-list
153792734|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
153792735|NCT04949113|Nivolumab|nivolumab|mesh-list
153792736|NCT04949113|Ipilimumab|ipilimumab|mesh-list
153792737|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792738|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792739|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792740|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792741|NCT04907851|Denosumab|denosumab|mesh-list
153792742|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
153792743|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792744|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792745|NCT04907851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792746|NCT04907851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792747|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153792748|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792749|NCT04906395|Tamoxifen|tamoxifen|mesh-list
153792750|NCT04906395|Letrozole|letrozole|mesh-list
153792751|NCT04906395|Anastrozole|anastrozole|mesh-list
153792752|NCT04906395|Exemestane|exemestane|mesh-list
153793150|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860903|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153793285|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793287|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
153793288|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793289|NCT03564821|Ivosidenib|ivosidenib|mesh-list
153793290|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793291|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793309|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793310|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153793312|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793313|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793314|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153793315|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153793316|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153793317|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793318|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793319|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793320|NCT03456076|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153793339|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793340|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793341|NCT03335072|Azithromycin|azithromycin|mesh-list
153793342|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153793343|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793344|NCT03322215|Capecitabine|capecitabine|mesh-list
153793345|NCT03322215|Fulvestrant|fulvestrant|mesh-list
153793346|NCT03322215|Palbociclib|palbociclib|mesh-list
153793347|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153793348|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
153793349|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793350|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793365|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793366|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793367|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793368|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793369|NCT03093064|Natalizumab|natalizumab|mesh-list
153793370|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
153793371|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793372|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
153793374|NCT03070392|Dacarbazine|dacarbazine|mesh-list
153793375|NCT03070392|Imidazole|imidazole|mesh-list
153793376|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793377|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793378|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153793379|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793380|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153793381|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
153793382|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793383|NCT03036930|Vaccines|vaccines|mesh-list
153793384|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
153793409|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793434|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793436|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
153793437|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793438|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793439|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793440|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153793441|NCT02639273|Nalmefene|nalmefene|mesh-list
153793442|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153793443|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793553|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793555|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153793556|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793557|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793558|NCT01412333|Interferons|interferons|mesh-list
153793559|NCT01412333|Interferon-beta|interferon-beta|mesh-list
153793602|NCT00602641|Thalidomide|thalidomide|mesh-list
153793603|NCT00602641|Prednisone|prednisone|mesh-list
153793604|NCT00602641|Cortisone|cortisone|mesh-list
153793605|NCT00602641|Lenalidomide|lenalidomide|mesh-list
153793606|NCT00602641|Melphalan|melphalan|mesh-list
153793607|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
153793608|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153793609|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793610|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
153793611|NCT00602641|Hormones|hormones|mesh-ancestor
153793612|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860967|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153860968|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
153860969|NCT04415060|Sevoflurane|sevoflurane|mesh-list
153860970|NCT04415060|Isoflurane|isoflurane|mesh-list
153860971|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153860972|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153793669|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793670|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793671|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793672|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793673|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
153793674|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793675|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793676|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153793677|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
153793678|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153793679|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153793680|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153793681|NCT00433511|Growth Substances|growth substances|mesh-ancestor
153793682|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
153793683|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153793853|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
153793854|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793855|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793856|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153793857|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153793858|NCT00258245|Analgesics|analgesics|mesh-ancestor
153793859|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
153793860|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793861|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153793862|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153793863|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153793864|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153793865|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
153793874|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153793875|NCT00258245|Growth Substances|growth substances|mesh-ancestor
153793876|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
153793878|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153793879|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793955|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793956|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793958|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153793959|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153793960|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793961|NCT00258557|Darunavir|darunavir|mesh-list
153793962|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153793963|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153793964|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
153793965|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793966|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793967|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153793968|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153793969|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
153793970|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793971|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153793972|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
153793973|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793974|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
153793975|NCT00271635|Vitamins|vitamins|mesh-ancestor
153793976|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
153793977|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793978|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
153793979|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793980|NCT00271635|Protective Agents|protective agents|mesh-ancestor
153793981|NCT00258596|Sirolimus|sirolimus|mesh-list
153793982|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153793983|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793984|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153793985|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793986|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
153793987|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793988|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
153794025|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794026|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153794027|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153794028|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
153794029|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
153401386|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794112|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794113|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794115|NCT01332292|Xhance|xhance|mesh-list
153794116|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794180|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153794181|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794182|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794183|NCT00272025|Escitalopram|escitalopram|mesh-list
153794184|NCT00272025|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153794185|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153794186|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153736238|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
153736239|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794187|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794188|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794189|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
153794212|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794213|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153794214|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
153794215|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153833031|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
153373104|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
153373105|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373107|NCT02023593|Fluorouracil|fluorouracil|mesh-list
153373108|NCT02023593|Irinotecan|irinotecan|mesh-list
153373109|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
153373110|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373174|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
153794216|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153794217|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153794218|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153794219|NCT04709081|Protective Agents|protective agents|mesh-ancestor
153794221|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153794222|NCT00272064|Metformin|metformin|mesh-list
153340719|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153794223|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
153794224|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
153794225|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153794226|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794228|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153794229|NCT01332019|Interferons|interferons|mesh-list
153794230|NCT01332019|Interferon-beta|interferon-beta|mesh-list
153794231|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
153794232|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794233|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
153794234|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794235|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
153794236|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794237|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153794238|NCT00415376|Levetiracetam|levetiracetam|mesh-list
153794239|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
153794240|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
153794241|NCT00291915|Adalimumab|adalimumab|mesh-list
153794242|NCT00291915|Methotrexate|methotrexate|mesh-list
153794243|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153794244|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
153794245|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153794246|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794394|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794395|NCT00260624|Escitalopram|escitalopram|mesh-list
153794396|NCT00260624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153794397|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153794398|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153794399|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794400|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794412|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794413|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153794414|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
153794415|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
153794416|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794417|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794418|NCT00260702|Omalizumab|omalizumab|mesh-list
153794419|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153794452|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
153794453|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794454|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
153794455|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
153794456|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
153794457|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
153794458|NCT00298506|Tacrolimus|tacrolimus|mesh-list
153736253|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153736254|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153736255|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153736256|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153833240|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833241|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153833242|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153373284|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153373285|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153373286|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153373287|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736257|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736258|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736259|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153736260|NCT03393858|Antibodies|antibodies|mesh-list
153736261|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
153736262|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794559|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794560|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
153794561|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
153794562|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
153401542|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
153794578|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794579|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153794580|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794581|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794582|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153794583|NCT01330381|Prucalopride|prucalopride|mesh-list
153794584|NCT01330381|Laxatives|laxatives|mesh-ancestor
153794585|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153794586|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153794604|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153794605|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153794606|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153794607|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794635|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153794637|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794638|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153794639|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153794670|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153794671|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
153794672|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153794673|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153794674|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153794675|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153794676|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
153794677|NCT00261521|Hematinics|hematinics|mesh-ancestor
153794678|NCT00298857|Valproic Acid|valproic acid|mesh-list
153794679|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
153794680|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794681|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794682|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
153794683|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794706|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
153736289|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153794723|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153794725|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794726|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794727|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153794728|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
153794730|NCT00261677|Hematinics|hematinics|mesh-ancestor
153794731|NCT00298974|Acetaminophen|acetaminophen|mesh-list
153794732|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153794733|NCT00298974|Hydrocodone|hydrocodone|mesh-list
153794734|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794735|NCT00298974|Analgesics|analgesics|mesh-ancestor
153794736|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
153794737|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385159|NCT00377325|Cyclosporine|cyclosporine|mesh-list
153833397|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153833399|NCT01244126|Fentanyl|fentanyl|mesh-list
153833400|NCT01244126|Morphine|morphine|mesh-list
153833401|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153833402|NCT01244126|Narcotics|narcotics|mesh-ancestor
153833403|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833404|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373445|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833451|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
153833452|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794747|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794749|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153794750|NCT00293436|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153794751|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153794752|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794753|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794754|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794773|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794774|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
153794775|NCT00293475|Rituximab|rituximab|mesh-list
153794776|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153794777|NCT00293475|Carboplatin|carboplatin|mesh-list
153794778|NCT00293475|Methotrexate|methotrexate|mesh-list
153794779|NCT00293475|Mannitol|mannitol|mesh-list
153794780|NCT00293475|Antibodies|antibodies|mesh-list
153794781|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
153794782|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153794783|NCT00293475|Antidotes|antidotes|mesh-list
153794784|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
153794785|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794786|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794787|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401593|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
153401595|NCT03319277|Narcotics|narcotics|mesh-ancestor
153794824|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794825|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794826|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794827|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794830|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794831|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153794832|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153794833|NCT00299013|Protective Agents|protective agents|mesh-ancestor
153794835|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
153794836|NCT00293514|Coagulants|coagulants|mesh-ancestor
153794837|NCT00299091|Efavirenz|efavirenz|mesh-list
153794838|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153794839|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153794840|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794841|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794842|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
153794843|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794844|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153794845|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153794846|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153794847|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153794848|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153794849|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153794850|NCT00299208|Azithromycin|azithromycin|mesh-list
153794851|NCT00299208|Artesunate|artesunate|mesh-list
153794852|NCT00299208|Quinine|quinine|mesh-list
153794853|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153794854|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794855|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
153794856|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153833557|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833558|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153373622|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373624|NCT00559637|Hematinics|hematinics|mesh-ancestor
153373625|NCT03349281|Cytarabine|cytarabine|mesh-list
153373626|NCT03349281|Dexamethasone|dexamethasone|mesh-list
153373627|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
153373628|NCT03349281|Doxorubicin|doxorubicin|mesh-list
153833587|NCT01240382|Protective Agents|protective agents|mesh-ancestor
153833588|NCT01244828|Asenapine|asenapine|mesh-list
153833589|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153833590|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153833591|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373630|NCT03349281|Vincristine|vincristine|mesh-list
153373631|NCT03349281|Asparaginase|asparaginase|mesh-list
153794857|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153794858|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794859|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
153794860|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
153794861|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153794862|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
153794863|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153794881|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794882|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794883|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794884|NCT00293631|Ketorolac|ketorolac|mesh-list
153794885|NCT00293631|Lornoxicam|lornoxicam|mesh-list
153794886|NCT00293631|Piroxicam|piroxicam|mesh-list
153794887|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153794888|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794894|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794895|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153794896|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794897|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794898|NCT00262262|Levetiracetam|levetiracetam|mesh-list
153794899|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
153736295|NCT03181789|Interleukin-12|interleukin-12|mesh-list
153736296|NCT03181789|Vaccines|vaccines|mesh-list
153736297|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
153794900|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
153794901|NCT00293670|Goserelin|goserelin|mesh-list
153794902|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794903|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794904|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
153794905|NCT00262379|Hematinics|hematinics|mesh-ancestor
153794906|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
153794907|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
153794908|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
153794909|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153794910|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153794911|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794912|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153794913|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794914|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794915|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153794916|NCT00262418|Ivermectin|ivermectin|mesh-list
153794917|NCT00262418|Permethrin|permethrin|mesh-list
153794918|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153794919|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794920|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794921|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378947|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153378948|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
153378949|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378950|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
153378951|NCT01586312|Protective Agents|protective agents|mesh-ancestor
153378952|NCT00373893|Lidocaine|lidocaine|mesh-list
153378953|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
153378954|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
153378955|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153794922|NCT00299286|Lapatinib|lapatinib|mesh-list
153794923|NCT00299286|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153794924|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153833611|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153833633|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153833634|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
153833635|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833636|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153833637|NCT00516282|Temozolomide|temozolomide|mesh-list
153833638|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153833639|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
153861300|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153401618|NCT03323801|Isotretinoin|isotretinoin|mesh-list
153401622|NCT04450355|Nefopam|nefopam|mesh-list
153794982|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153794984|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
153794985|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794991|NCT00262808|Protective Agents|protective agents|mesh-ancestor
153794992|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
153794993|NCT00262808|Vitamins|vitamins|mesh-ancestor
153794994|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
153794995|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
153794996|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
153794997|NCT00262886|Fludarabine|fludarabine|mesh-list
153794998|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
153794999|NCT00262886|Tacrolimus|tacrolimus|mesh-list
153795000|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153795001|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153795002|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
153795003|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795004|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153795005|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153795006|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
153795078|NCT06259526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861333|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401672|NCT03203681|Hormones|hormones|mesh-ancestor
153795190|NCT06258226|GABA Agents|gaba agents|mesh-ancestor
153795191|NCT06258226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795192|NCT06258226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795193|NCT06258174|Pirtobrutinib|pirtobrutinib|mesh-list
153795202|NCT06258070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795203|NCT06258070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795204|NCT06258070|Cholinergic Agents|cholinergic agents|mesh-ancestor
153795205|NCT06258070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795206|NCT06258070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795207|NCT06258070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153795208|NCT06258070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795209|NCT06258031|Psilocybin|psilocybin|mesh-list
153795210|NCT06258031|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153795211|NCT06258031|Hallucinogens|hallucinogens|mesh-ancestor
153795212|NCT06258031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795213|NCT06258031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795214|NCT06258031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153795215|NCT06258031|Serotonin Agents|serotonin agents|mesh-ancestor
153795216|NCT06258031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795217|NCT06258031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795218|NCT06258031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153795219|NCT06258018|Temozolomide|temozolomide|mesh-list
153795220|NCT06258018|Niraparib|niraparib|mesh-list
153795221|NCT06258018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153795222|NCT06258018|Alkylating Agents|alkylating agents|mesh-ancestor
153795223|NCT06258018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795224|NCT06258018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795225|NCT06258018|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153795226|NCT06258018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795227|NCT06257966|Metformin|metformin|mesh-list
153795228|NCT06257966|Dulaglutide|dulaglutide|mesh-list
153795229|NCT06257966|Exenatide|exenatide|mesh-list
153795230|NCT06257966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153795231|NCT06257966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257317|NCT03267940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154257318|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257319|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
154257320|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257321|NCT01170104|Sorafenib|sorafenib|mesh-list
154257322|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257323|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154257324|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257325|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257326|NCT01284764|Mosapride|mosapride|mesh-list
154257327|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257328|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154257329|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
154257330|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385261|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
153833703|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833704|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833705|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833706|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
153833707|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153833708|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153833709|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838889|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153838890|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838891|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153838893|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379017|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833710|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833711|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833712|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
153833713|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153833714|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153833739|NCT04519385|Hormones|hormones|mesh-ancestor
153795243|NCT06257537|Sensory System Agents|sensory system agents|mesh-ancestor
153795244|NCT06257537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795245|NCT06257537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861372|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795286|NCT06250413|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153795288|NCT06250413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795289|NCT06243263|Bupivacaine|bupivacaine|mesh-list
153795301|NCT06225349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795303|NCT06225349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153795304|NCT06225349|Antacids|antacids|mesh-ancestor
153795305|NCT06125054|Ketamine|ketamine|mesh-list
153795306|NCT06125054|Analgesics|analgesics|mesh-ancestor
153795307|NCT06125054|Sensory System Agents|sensory system agents|mesh-ancestor
153795308|NCT06125054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795309|NCT06125054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795310|NCT06125054|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153795311|NCT06125054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154263495|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154263496|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263497|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263498|NCT05347238|Dopamine|dopamine|mesh-list
154263499|NCT05347238|Norepinephrine|norepinephrine|mesh-list
154263500|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154263501|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154263502|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
153385290|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
153833786|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
153833787|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
153833788|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153833789|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833790|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833791|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153795312|NCT06125054|Anesthetics, General|anesthetics, general|mesh-ancestor
153795313|NCT06125054|Anesthetics|anesthetics|mesh-ancestor
153795314|NCT06125054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795315|NCT06125054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153795316|NCT06125054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153795317|NCT06125054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795318|NCT06125054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795319|NCT06123338|Pembrolizumab|pembrolizumab|mesh-list
153795320|NCT06123338|Trastuzumab|trastuzumab|mesh-list
153795321|NCT06123338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153795322|NCT06123338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795323|NCT06123338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153795324|NCT06123338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795325|NCT06093126|Lemborexant|lemborexant|mesh-list
153795326|NCT06093126|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153795327|NCT06093126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736303|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
153401727|NCT05992883|Ketorolac|ketorolac|mesh-list
153795365|NCT06059118|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153795366|NCT06059118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795367|NCT06059118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795368|NCT06053281|Vitamin D|vitamin d|mesh-list
153795369|NCT06053281|Cholecalciferol|cholecalciferol|mesh-list
153795370|NCT06053281|Vitamins|vitamins|mesh-ancestor
153795371|NCT06053281|Micronutrients|micronutrients|mesh-ancestor
153795372|NCT06053281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795373|NCT06053281|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153795374|NCT06053281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153795375|NCT06047379|Paclitaxel|paclitaxel|mesh-list
153795376|NCT06047379|Bevacizumab|bevacizumab|mesh-list
153795377|NCT06047379|Carboplatin|carboplatin|mesh-list
153795378|NCT06047379|Pembrolizumab|pembrolizumab|mesh-list
153795379|NCT06047379|Nivolumab|nivolumab|mesh-list
153795380|NCT06047379|Ipilimumab|ipilimumab|mesh-list
153795381|NCT06047379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153795382|NCT06047379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795383|NCT06047379|Tubulin Modulators|tubulin modulators|mesh-ancestor
153795384|NCT06047379|Antimitotic Agents|antimitotic agents|mesh-ancestor
153795385|NCT06047379|Mitosis Modulators|mitosis modulators|mesh-ancestor
153795386|NCT06047379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795387|NCT06047379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153795388|NCT06047379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153795389|NCT06047379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153833881|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833882|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
153833883|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833884|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833885|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833886|NCT01246011|Warfarin|warfarin|mesh-list
153833887|NCT01246011|Argatroban|argatroban|mesh-list
153833888|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
153833889|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
153833890|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153795390|NCT06047379|Growth Substances|growth substances|mesh-ancestor
153795391|NCT06047379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795392|NCT06047379|Growth Inhibitors|growth inhibitors|mesh-ancestor
153795393|NCT06047379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153795394|NCT06042855|Metformin|metformin|mesh-list
153795395|NCT06042855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153795396|NCT06042855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795397|NCT06041711|Anesthetics|anesthetics|mesh-list
153795398|NCT06041711|Propofol|propofol|mesh-list
153795399|NCT06041711|Sevoflurane|sevoflurane|mesh-list
153838950|NCT00531089|Rituximab|rituximab|mesh-list
153795400|NCT06041711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795401|NCT06041711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736307|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736308|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153795402|NCT06041711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153795420|NCT05974267|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153795439|NCT05964647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795440|NCT05964647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795441|NCT05964647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153795443|NCT05964647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153795444|NCT05964647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795445|NCT05964647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795446|NCT05964647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153795464|NCT05894577|Respiratory System Agents|respiratory system agents|mesh-ancestor
153795465|NCT05894577|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153795466|NCT05894577|Hormone Antagonists|hormone antagonists|mesh-ancestor
153795467|NCT05894577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795468|NCT05894577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795469|NCT05894577|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153795470|NCT05894577|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153795471|NCT05894577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795472|NCT05873881|Thiamine|thiamine|mesh-list
153795473|NCT05873881|Colchicine|colchicine|mesh-list
153795474|NCT05873881|Gout Suppressants|gout suppressants|mesh-ancestor
153795475|NCT05873881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153795476|NCT05873881|Tubulin Modulators|tubulin modulators|mesh-ancestor
153795477|NCT05873881|Antimitotic Agents|antimitotic agents|mesh-ancestor
153795478|NCT05873881|Mitosis Modulators|mitosis modulators|mesh-ancestor
153795479|NCT05873881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795508|NCT05867914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153795509|NCT05867914|Autonomic Agents|autonomic agents|mesh-ancestor
153795510|NCT05867914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795511|NCT05867914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795512|NCT05867914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153795513|NCT05867914|Respiratory System Agents|respiratory system agents|mesh-ancestor
153795514|NCT05867914|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153795516|NCT05867914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736309|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401742|NCT05992610|Paclitaxel|paclitaxel|mesh-list
153401743|NCT05992610|Carboplatin|carboplatin|mesh-list
153795554|NCT05766683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795555|NCT05766683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153795556|NCT05766683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834038|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834040|NCT04510337|Rocuronium|rocuronium|mesh-list
153834041|NCT04510337|Analgesics|analgesics|mesh-ancestor
153834042|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
153834043|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834044|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834045|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
153834048|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
153795557|NCT05766683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795558|NCT05766683|Cholinergic Agents|cholinergic agents|mesh-ancestor
153795559|NCT05766683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795560|NCT05765500|Leuprolide|leuprolide|mesh-list
153342151|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795561|NCT05765500|Relugolix|relugolix|mesh-list
153795562|NCT05765500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153795563|NCT05765500|Fertility Agents|fertility agents|mesh-ancestor
153795564|NCT05765500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153795565|NCT05765500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795566|NCT05765500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153795567|NCT05765500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795568|NCT05765500|Androgen Antagonists|androgen antagonists|mesh-ancestor
153795569|NCT05765500|Hormone Antagonists|hormone antagonists|mesh-ancestor
153795570|NCT05765500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861425|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153795574|NCT05741372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153795575|NCT05741372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153795576|NCT05741372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795608|NCT05739682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153795609|NCT05739682|Respiratory System Agents|respiratory system agents|mesh-ancestor
153795610|NCT05739682|Mydriatics|mydriatics|mesh-ancestor
153795611|NCT05739682|Sympathomimetics|sympathomimetics|mesh-ancestor
153795612|NCT05739682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153795613|NCT05739682|Sensory System Agents|sensory system agents|mesh-ancestor
153795614|NCT05722002|Acetaminophen|acetaminophen|mesh-list
153795615|NCT05722002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153795616|NCT05722002|Analgesics|analgesics|mesh-ancestor
153795617|NCT05722002|Sensory System Agents|sensory system agents|mesh-ancestor
153795618|NCT05722002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795636|NCT05681481|Hormones|hormones|mesh-ancestor
153795637|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795638|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795639|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153795640|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795641|NCT05672524|Trastuzumab|trastuzumab|mesh-list
153795642|NCT05672524|Tucatinib|tucatinib|mesh-list
153795643|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153795644|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795645|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153795646|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795647|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795648|NCT05665465|Nicotine|nicotine|mesh-list
153795649|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153795650|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
153795651|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795652|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795653|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153795654|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153795655|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
153795656|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795657|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795658|NCT05657678|Vitamin D|vitamin d|mesh-list
153795659|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
153795660|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
153795661|NCT05657678|Vitamins|vitamins|mesh-list
153795662|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
153374146|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
153374147|NCT02651259|Isoniazid|isoniazid|mesh-list
153374148|NCT02651259|Rifapentine|rifapentine|mesh-list
153374149|NCT02651259|Rifamycins|rifamycins|mesh-list
153374150|NCT02651259|Hydrazine|hydrazine|mesh-list
153374151|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
153374157|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153795663|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795664|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153795665|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153795666|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
153401777|NCT05990894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153795728|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153795729|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
153795730|NCT05444946|Hormones|hormones|mesh-ancestor
153795731|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795732|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795733|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153795734|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795735|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
153795736|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795737|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153795738|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153795739|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795756|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795757|NCT05403580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153795758|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153795759|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795784|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795785|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153795786|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795787|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795788|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153795789|NCT05379179|Fentanyl|fentanyl|mesh-list
153795790|NCT05379179|Ketamine|ketamine|mesh-list
153795791|NCT05379179|Analgesics|analgesics|mesh-ancestor
153795792|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
153795793|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795794|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795795|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153795811|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153795813|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795814|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153795815|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795816|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153795817|NCT05363462|Vancomycin|vancomycin|mesh-list
153795818|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795819|NCT05355272|Hormones|hormones|mesh-list
153795820|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795821|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795822|NCT05283304|Buprenorphine|buprenorphine|mesh-list
153861471|NCT04644354|Nifedipine|nifedipine|mesh-list
153795841|NCT05271630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795842|NCT05270733|Ustekinumab|ustekinumab|mesh-list
153795843|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
153795844|NCT05270057|Prednisone|prednisone|mesh-list
153795845|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
153795846|NCT05270057|Rituximab|rituximab|mesh-list
153795847|NCT05270057|Doxorubicin|doxorubicin|mesh-list
153795848|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153795849|NCT05270057|Etoposide|etoposide|mesh-list
153795850|NCT05270057|Vincristine|vincristine|mesh-list
153795851|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153342380|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795852|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153795853|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
153795854|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795864|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153795865|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795866|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153795867|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
153795868|NCT05270057|Hormones|hormones|mesh-ancestor
153795869|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795879|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
153795880|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153795881|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153795882|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
153795883|NCT05253833|Protective Agents|protective agents|mesh-ancestor
153795884|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795885|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
153795886|NCT05219604|Promethazine|promethazine|mesh-list
153795887|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153795888|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153795889|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795890|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795891|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
153795892|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
153795893|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
153795894|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795895|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
153795896|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
153795897|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153795898|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153795899|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
153795900|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
153795901|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795902|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795903|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153795904|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
153795905|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
153736317|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153795913|NCT05201352|Trifluridine|trifluridine|mesh-list
153795914|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
153795919|NCT05189457|Tislelizumab|tislelizumab|mesh-list
153795942|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
153795944|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153795945|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153795946|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795947|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795948|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795949|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
153795950|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795951|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795952|NCT05160051|FAPI-46|fapi-46|mesh-list
153795953|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153795954|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795955|NCT05159830|Cannabidiol|cannabidiol|mesh-list
153795956|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
153795957|NCT05143489|Lidocaine|lidocaine|mesh-list
153795958|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
153795959|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
153795960|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795961|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795962|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
153795963|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795964|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153795965|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153795966|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153795967|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795968|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795969|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
153795984|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
153795985|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795986|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153795987|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153795988|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153795990|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796014|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
153796102|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153796103|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796104|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796105|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153374227|NCT03021083|Fentanyl|fentanyl|mesh-list
153796106|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
153796107|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796108|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796109|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153796110|NCT04814875|Carboplatin|carboplatin|mesh-list
153796111|NCT04814875|Doxorubicin|doxorubicin|mesh-list
153796133|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796135|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796147|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
153796148|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796149|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796150|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153796151|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153796152|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153796153|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153796154|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796155|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153796156|NCT04648696|Vancomycin|vancomycin|mesh-list
153796157|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153796158|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153796159|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
153796160|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153796161|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153796162|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
153796163|NCT04599634|Venetoclax|venetoclax|mesh-list
153796164|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
153796165|NCT04599634|Magrolimab|magrolimab|mesh-list
153796185|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796186|NCT04352777|Fulvestrant|fulvestrant|mesh-list
153796201|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
153796202|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
153796203|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796204|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796205|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796206|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
153796207|NCT04329728|Hormones|hormones|mesh-ancestor
153796208|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796209|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796210|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796211|NCT04300647|Atezolizumab|atezolizumab|mesh-list
153796212|NCT04300647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796213|NCT04300647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796214|NCT04300647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796279|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796281|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
153796282|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153379225|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
153796283|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153796284|NCT04045795|Growth Substances|growth substances|mesh-ancestor
153796285|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
153796286|NCT04035486|Carboplatin|carboplatin|mesh-list
153796287|NCT04035486|Pemetrexed|pemetrexed|mesh-list
153796288|NCT04035486|Osimertinib|osimertinib|mesh-list
153796289|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796290|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796291|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796292|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153796293|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153796294|NCT04035486|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153796295|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153796296|NCT04004442|Avelumab|avelumab|mesh-list
153796297|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796298|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736320|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153796349|NCT03740334|Dexamethasone|dexamethasone|mesh-list
153796350|NCT03740334|Everolimus|everolimus|mesh-list
153796351|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153796352|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
153796353|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
153796354|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796355|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796356|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796357|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
153796358|NCT03740334|Hormones|hormones|mesh-ancestor
153374262|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153796359|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796360|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796361|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796362|NCT03740334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153796363|NCT03740334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153796364|NCT03740334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796365|NCT03740334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796366|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153796367|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
153796368|NCT03708341|Melatonin|melatonin|mesh-list
153796369|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
153796370|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796371|NCT03708341|Protective Agents|protective agents|mesh-ancestor
153342898|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153342972|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153796372|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796373|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796388|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
153796390|NCT03670056|Ipilimumab|ipilimumab|mesh-list
153796391|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796392|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796393|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796401|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153796402|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153796403|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
153796404|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796405|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796406|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153796407|NCT03620578|Nivolumab|nivolumab|mesh-list
153796408|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153379251|NCT01595516|Bradykinin|bradykinin|mesh-list
153796409|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796410|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796411|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796412|NCT03604406|Vaccines|vaccines|mesh-list
153796413|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
153796414|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796415|NCT03574597|Semaglutide|semaglutide|mesh-list
153796416|NCT03574597|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153796417|NCT03574597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153796418|NCT03574597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796419|NCT03567642|Etoposide|etoposide|mesh-list
153796420|NCT03567642|Osimertinib|osimertinib|mesh-list
153796421|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153796422|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796423|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153796424|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153796425|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796448|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153796449|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
153796450|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796451|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796452|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796453|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153796454|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153796455|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796456|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153796457|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153796458|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
153796459|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
153796460|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
153796505|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153796506|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
153796507|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796508|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796509|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153796529|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
153796530|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153796531|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153796532|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153796534|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153796535|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154257331|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796536|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
153796537|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796538|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796539|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796540|NCT03283917|Dexamethasone|dexamethasone|mesh-list
153796541|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
153796542|NCT03283917|Daratumumab|daratumumab|mesh-list
153796543|NCT03283917|Ixazomib|ixazomib|mesh-list
153796544|NCT03283917|Ichthammol|ichthammol|mesh-list
153796545|NCT03283917|BB 1101|bb 1101|mesh-list
153796546|NCT03283917|Glycine|glycine|mesh-list
153796547|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153796548|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
153796549|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
153796550|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796551|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796552|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796553|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
153796554|NCT03283917|Hormones|hormones|mesh-ancestor
153796555|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796556|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796557|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796558|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
153796559|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796622|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153796623|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153796624|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153796625|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796626|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153796627|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153796628|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
153796629|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796630|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796631|NCT02959463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796632|NCT02959463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796633|NCT02951052|Rilpivirine|rilpivirine|mesh-list
153796634|NCT02951052|Cabotegravir|cabotegravir|mesh-list
153796635|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153796647|NCT02724878|Bevacizumab|bevacizumab|mesh-list
153796648|NCT02724878|Atezolizumab|atezolizumab|mesh-list
153796649|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796650|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796651|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153796652|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153796653|NCT02724878|Growth Substances|growth substances|mesh-ancestor
153796654|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796655|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
153796656|NCT02724878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796657|NCT02724878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796658|NCT02723331|Paclitaxel|paclitaxel|mesh-list
153796659|NCT02723331|Gemcitabine|gemcitabine|mesh-list
153796660|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153796661|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796662|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
153796663|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
153796664|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
153796665|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796666|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153401932|NCT05985070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153401934|NCT05984511|Bevacizumab|bevacizumab|mesh-list
153796672|NCT02717624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796674|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
153796675|NCT02638090|Vorinostat|vorinostat|mesh-list
153796676|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796677|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796678|NCT02638090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796679|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796680|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153796681|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796682|NCT02606305|Bevacizumab|bevacizumab|mesh-list
153796683|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
153796684|NCT02606305|Carboplatin|carboplatin|mesh-list
153796685|NCT02606305|Doxorubicin|doxorubicin|mesh-list
153796686|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153796687|NCT02606305|Maytansine|maytansine|mesh-list
153796688|NCT02606305|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
153796689|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796690|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796691|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153796692|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153796693|NCT02606305|Growth Substances|growth substances|mesh-ancestor
153796694|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796695|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
153796696|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153796710|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
153796711|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796712|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796713|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796716|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796717|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796719|NCT02560805|Atenolol|atenolol|mesh-list
153796720|NCT02560805|Nitroprusside|nitroprusside|mesh-list
153796721|NCT02560805|Phenylephrine|phenylephrine|mesh-list
153796722|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
153796723|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153796724|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153796725|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153796726|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153796727|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796728|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153796729|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
153796730|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
153796731|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796732|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796733|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
153839219|NCT00531674|Vitamins|vitamins|mesh-ancestor
153796734|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153796735|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
153796736|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
153796737|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153796738|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153796739|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153796740|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
153343274|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343278|NCT01260649|Ketamine|ketamine|mesh-list
153796741|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796743|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
153796744|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153796745|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153796746|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153796747|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
153796748|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153796757|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796759|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
153796781|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
153796782|NCT02522715|Hormones|hormones|mesh-ancestor
153796783|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796784|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796785|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796786|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796787|NCT02447029|Lidocaine|lidocaine|mesh-list
153796788|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
153796789|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
153796790|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796791|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796792|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
153796793|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796794|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153796795|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153796796|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153796797|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153796798|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796799|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
153796800|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796801|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796802|NCT02312557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796803|NCT02312557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796804|NCT02206984|Tamoxifen|tamoxifen|mesh-list
153796805|NCT02206984|Fulvestrant|fulvestrant|mesh-list
153796806|NCT02206984|Anastrozole|anastrozole|mesh-list
153796807|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153796847|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796848|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796850|NCT01862991|Misoprostol|misoprostol|mesh-list
153796851|NCT01862991|Mifepristone|mifepristone|mesh-list
153796852|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153796853|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
153796854|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153796875|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153796876|NCT01821690|Buspirone|buspirone|mesh-list
153796877|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153796878|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153796879|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796880|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796881|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153796882|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153796883|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
153796884|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796885|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796886|NCT01701674|Aldesleukin|aldesleukin|mesh-list
153796988|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153796989|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
153796990|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736321|NCT03043053|Oxytocin|oxytocin|mesh-list
153796991|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796992|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153796993|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796994|NCT00577200|Midazolam|midazolam|mesh-list
153796995|NCT00577200|Sufentanil|sufentanil|mesh-list
153796996|NCT00577200|Propofol|propofol|mesh-list
153796997|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153796998|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796999|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797000|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153797001|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
153797002|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
153797003|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153797004|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153797005|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153797006|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153797007|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
153797008|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
153797009|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797103|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153797104|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153797105|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153797106|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
153797118|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153797119|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797120|NCT00263627|Immunomodulating Agents|immunomodulating agents|mesh-list
153797121|NCT00263627|Immunologic Factors|immunologic factors|mesh-ancestor
153797122|NCT00263627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797123|NCT00425594|Bisacodyl|bisacodyl|mesh-list
153797124|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153797125|NCT00425594|Cathartics|cathartics|mesh-ancestor
153797126|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153797127|NCT00425594|Laxatives|laxatives|mesh-ancestor
153797128|NCT00294255|Risperidone|risperidone|mesh-list
153797129|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153797130|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
153797149|NCT00263744|Antacids|antacids|mesh-ancestor
153797150|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797151|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153797152|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153797153|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
153797300|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
153797301|NCT00294918|Hormones|hormones|mesh-list
153797302|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797303|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797304|NCT00264680|Lamotrigine|lamotrigine|mesh-list
153797305|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
153797404|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153797406|NCT00265031|Procarbazine|procarbazine|mesh-list
153797407|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153797408|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
153797409|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797410|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797411|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153797423|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153797424|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797425|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
153797426|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
153797427|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
153797428|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153797429|NCT00300924|Acetaminophen|acetaminophen|mesh-list
153797430|NCT00300924|Rizatriptan|rizatriptan|mesh-list
153797431|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797432|NCT00300924|Analgesics|analgesics|mesh-ancestor
153797433|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
153797434|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797435|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797436|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
153797437|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153797438|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
153797439|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797440|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797441|NCT00265070|Gefitinib|gefitinib|mesh-list
153797442|NCT00265070|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153797443|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153797444|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797445|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797446|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797447|NCT00295035|Celecoxib|celecoxib|mesh-list
153797448|NCT00295035|Curcumin|curcumin|mesh-list
153797449|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153797450|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797451|NCT00295035|Analgesics|analgesics|mesh-ancestor
153861698|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153861699|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153797499|NCT00301002|Alefacept|alefacept|mesh-list
153797500|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
153797501|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
153797502|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797503|NCT00265694|Carboplatin|carboplatin|mesh-list
153797504|NCT00265694|Gemcitabine|gemcitabine|mesh-list
153797551|NCT00265928|Bortezomib|bortezomib|mesh-list
153797552|NCT00265928|Antibodies|antibodies|mesh-list
153797553|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
153797554|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153797555|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153797556|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
153797719|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797721|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797722|NCT00266357|Gaboxadol|gaboxadol|mesh-list
153797723|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797724|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797725|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797726|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797727|NCT00266357|Analgesics|analgesics|mesh-ancestor
153797728|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
153797729|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
153797730|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
153797731|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
153797765|NCT00301587|Hormones|hormones|mesh-ancestor
153797788|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
153797789|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153797790|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797791|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
153797792|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153797793|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153797794|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153797795|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797796|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797797|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
153797798|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797799|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797800|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153797801|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797802|NCT00295776|Lamotrigine|lamotrigine|mesh-list
153797803|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
153797804|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153797834|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797835|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153797836|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797837|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797839|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153797840|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
153797841|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344394|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797842|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797843|NCT00295971|Fludarabine|fludarabine|mesh-list
153797844|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
153797845|NCT00295971|Thiotepa|thiotepa|mesh-list
153797846|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153797847|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797848|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153797849|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
153797921|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797922|NCT00301782|Carboplatin|carboplatin|mesh-list
153797923|NCT00301782|Etoposide|etoposide|mesh-list
153797924|NCT00301782|Vincristine|vincristine|mesh-list
153797925|NCT00301782|Bleomycin|bleomycin|mesh-list
153797926|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
153797927|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797928|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153797929|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153797930|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153797931|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797980|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797981|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153797982|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153797983|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
153797984|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153797985|NCT00301899|Trastuzumab|trastuzumab|mesh-list
153797986|NCT00301899|Pertuzumab|pertuzumab|mesh-list
153797987|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153797988|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797989|NCT00296127|Celecoxib|celecoxib|mesh-list
153797990|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153344623|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153797991|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797993|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
153798005|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798006|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153798007|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153798008|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
153798009|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861838|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861846|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861847|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
153861848|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861851|NCT00553124|Vitamin E|vitamin e|mesh-list
153798075|NCT00268151|Capecitabine|capecitabine|mesh-list
153798076|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
153798077|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153798078|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
153798079|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798080|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798081|NCT00418080|Bicalutamide|bicalutamide|mesh-list
153798082|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
153798083|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
153798084|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798085|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798194|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798195|NCT00302406|Methylphenidate|methylphenidate|mesh-list
153798196|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153798197|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798198|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153798199|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153798200|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153798201|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798202|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
153798203|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798205|NCT00268814|Heroin|heroin|mesh-list
153798206|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153798207|NCT00268814|Narcotics|narcotics|mesh-ancestor
153798208|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402232|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402233|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402234|NCT05576207|Micronutrients|micronutrients|mesh-list
153798253|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798254|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153798255|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798256|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798257|NCT02960412|Furosemide|furosemide|mesh-list
153798258|NCT02960412|Diuretics|diuretics|mesh-ancestor
153798259|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
153798260|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798261|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153798262|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153798263|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798264|NCT00269126|Fluticasone|fluticasone|mesh-list
153798293|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153798294|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
153798295|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
153798296|NCT00269204|Vitamins|vitamins|mesh-ancestor
153798297|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
153798298|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798299|NCT00297141|Capecitabine|capecitabine|mesh-list
153798300|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
153798426|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153798427|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153798428|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344999|NCT03947671|Analgesics|analgesics|mesh-ancestor
153798430|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798519|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798520|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
153798521|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798522|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153798541|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798543|NCT00270647|Provitamins|provitamins|mesh-ancestor
153798544|NCT00297960|Olanzapine|olanzapine|mesh-list
153798545|NCT00297960|Ziprasidone|ziprasidone|mesh-list
153798546|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
153798547|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
153798548|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798549|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798550|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798551|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153798632|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153798633|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153798634|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798635|NCT00416429|Interferons|interferons|mesh-list
153798636|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
153798637|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
153736328|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153402315|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402316|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153402317|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
153402318|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153402319|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402320|NCT05461755|Tretinoin|tretinoin|mesh-list
153402321|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861960|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153861961|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798779|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153798780|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153798781|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
153798782|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798783|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798784|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798785|NCT00307203|Bupropion|bupropion|mesh-list
153834373|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153834374|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379558|NCT02921061|Analgesics|analgesics|mesh-ancestor
153834375|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834376|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
153834377|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153834378|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798786|NCT00307203|Nicotine|nicotine|mesh-list
153798787|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153798788|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
153402346|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402347|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402348|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153402349|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
153798887|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153798888|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153798890|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
153798891|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
153798892|NCT00307671|Methotrexate|methotrexate|mesh-list
153798893|NCT00307671|Azathioprine|azathioprine|mesh-list
153798894|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153798895|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
153798896|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798897|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
153798898|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798899|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153798914|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
153798915|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
153798982|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153798983|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
153798984|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798985|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798986|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153798987|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
153798988|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
153798990|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798991|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153799060|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153799061|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
153799062|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799063|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799064|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799065|NCT00272948|Defibrotide|defibrotide|mesh-list
153799066|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153799067|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153799170|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
153799171|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153799172|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153799173|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799174|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799175|NCT00273416|Urological Agents|urological agents|mesh-ancestor
153799176|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153799177|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
153799178|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153799179|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153799180|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153799181|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799182|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799183|NCT00273455|Timolol|timolol|mesh-list
153799184|NCT00273455|Bimatoprost|bimatoprost|mesh-list
153799185|NCT00273455|Dorzolamide|dorzolamide|mesh-list
153799186|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799187|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799188|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153799189|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153799190|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
153799191|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799192|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834393|NCT02954978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153834394|NCT02954978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834395|NCT02954978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834396|NCT00520104|Ketamine|ketamine|mesh-list
153834397|NCT00520104|Analgesics|analgesics|mesh-ancestor
153834398|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
153834399|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834400|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834404|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
153799193|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153799194|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153799195|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153799196|NCT00273533|Ramipril|ramipril|mesh-list
153799197|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153799237|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799238|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
153799239|NCT00273767|Hematinics|hematinics|mesh-ancestor
153345819|NCT00005068|Antidotes|antidotes|mesh-ancestor
153345822|NCT00005068|Vitamins|vitamins|mesh-ancestor
153799240|NCT00314379|Vitamin E|vitamin e|mesh-list
153799255|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153799256|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
153799257|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799258|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799260|NCT00308373|Pioglitazone|pioglitazone|mesh-list
153799261|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153799262|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153799263|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799265|NCT00273962|Ipratropium|ipratropium|mesh-list
153799266|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153799267|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
153799268|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799269|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799296|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
153799297|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799298|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799299|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153799300|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
153799301|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
153862117|NCT00561756|Vaccines|vaccines|mesh-list
153379601|NCT02860845|Miconazole|miconazole|mesh-list
153862118|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
153862119|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862120|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
153862121|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153862122|NCT04683146|Propranolol|propranolol|mesh-list
153862123|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153862124|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862134|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153862135|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
153862136|NCT04800302|Morphine|morphine|mesh-list
153862137|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153862138|NCT04800302|Narcotics|narcotics|mesh-ancestor
153862139|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862140|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862141|NCT04800302|Analgesics|analgesics|mesh-ancestor
153799378|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
153799379|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
153799380|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153799381|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799382|NCT00308607|Interferons|interferons|mesh-list
153799383|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
153799384|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
153799385|NCT00308607|Bevacizumab|bevacizumab|mesh-list
153799386|NCT00308607|Dacarbazine|dacarbazine|mesh-list
153799387|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153799388|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345966|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153345972|NCT00004330|Hormones|hormones|mesh-list
153799389|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153834407|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153834408|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834409|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834410|NCT00519012|Sertraline|sertraline|mesh-list
153834411|NCT00519012|Paroxetine|paroxetine|mesh-list
153834412|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
153834413|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153834415|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153839538|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
153839539|NCT02940821|Protective Agents|protective agents|mesh-ancestor
153839540|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839541|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153799390|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153799392|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799393|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
153799394|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
153799395|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799396|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
153799397|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153799398|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
153799399|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799400|NCT00314613|Risperidone|risperidone|mesh-list
153799401|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
153799402|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153799403|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
153799404|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799405|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799406|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799407|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153799408|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799409|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153799410|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153799411|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
153799412|NCT00274352|Adalimumab|adalimumab|mesh-list
153799413|NCT00274352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153799494|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
153799495|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799496|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799497|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
153799498|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
153799499|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799500|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153799501|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
153799503|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153799504|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153799505|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799506|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
153799507|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799508|NCT00274820|Protective Agents|protective agents|mesh-ancestor
153799509|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153799510|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
153799511|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
153799512|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153799513|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799514|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153799515|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153799516|NCT00274820|Growth Substances|growth substances|mesh-ancestor
153799517|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153799518|NCT00308841|Lidocaine|lidocaine|mesh-list
153799519|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
153799520|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
153862196|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
153862197|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
153862198|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402530|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153402531|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153402532|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402534|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153402535|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402545|NCT05105841|Venetoclax|venetoclax|mesh-list
154257333|NCT01170182|Omeprazole|omeprazole|mesh-list
154257334|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154257335|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257336|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154257337|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257338|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257339|NCT01170260|Ethanol|ethanol|mesh-list
154257340|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154257341|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257342|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386014|NCT01377441|Ibuprofen|ibuprofen|mesh-list
153834426|NCT00520260|Bromfenac|bromfenac|mesh-list
153834427|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153834428|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153834429|NCT00520260|Analgesics|analgesics|mesh-ancestor
153834430|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
153834431|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834432|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834433|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153834434|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153834435|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153834436|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374498|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153374499|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
153374500|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374504|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153799588|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799589|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153799590|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153799591|NCT00315003|Azithromycin|azithromycin|mesh-list
153799592|NCT00315003|Telithromycin|telithromycin|mesh-list
153799593|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153799616|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799617|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799619|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153799620|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153799621|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
153799622|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153799623|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799624|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
153799625|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
153799626|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799627|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799628|NCT00277706|Vitamin D|vitamin d|mesh-list
153799629|NCT00277706|Calcium|calcium|mesh-list
153799630|NCT00277706|Vitamins|vitamins|mesh-ancestor
153799631|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
153799632|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386062|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
153834449|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834450|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834451|NCT00519051|Fluoxetine|fluoxetine|mesh-list
153834452|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
153834453|NCT00519051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153834454|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153834455|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153799633|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153799634|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153799635|NCT00277862|Ribavirin|ribavirin|mesh-list
153799636|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
153799637|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
153799638|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153799639|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153799640|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
153799690|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153799691|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153799692|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862249|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862250|NCT04626414|Ferric maltol|ferric maltol|mesh-list
153862251|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
153862252|NCT04626414|Hematinics|hematinics|mesh-ancestor
153799799|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799800|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
153799801|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153799802|NCT00309543|Leucovorin|leucovorin|mesh-list
153799803|NCT00309543|Fluorouracil|fluorouracil|mesh-list
153799804|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
153799805|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799806|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153799807|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799808|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153799809|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
153799810|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799811|NCT00309543|Antidotes|antidotes|mesh-ancestor
153799812|NCT00309543|Protective Agents|protective agents|mesh-ancestor
153799973|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153799974|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153799975|NCT00316329|Artesunate|artesunate|mesh-list
153799976|NCT00316329|Amodiaquine|amodiaquine|mesh-list
153799977|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
153799978|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153799979|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153799980|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799981|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799982|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
153799983|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
153799984|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153799985|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
153799986|NCT00279539|Mitogens|mitogens|mesh-list
153379741|NCT02863263|Povidone|povidone|mesh-list
153799987|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
153799988|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
153799989|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799990|NCT00279539|Growth Substances|growth substances|mesh-ancestor
153799991|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799992|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
153799993|NCT00279578|Factor VIII|factor viii|mesh-list
153799994|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153800073|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153800075|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
153800076|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800077|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800079|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
153800080|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
153800081|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800082|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153834479|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834480|NCT02590094|Bevacizumab|bevacizumab|mesh-list
153834481|NCT02590094|Aflibercept|aflibercept|mesh-list
153834482|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153834483|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834484|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153834485|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153834486|NCT02590094|Growth Substances|growth substances|mesh-ancestor
153834489|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
153800083|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
153800085|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800169|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
153800170|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153800171|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153800172|NCT00310323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153800173|NCT00310323|Narcotics|narcotics|mesh-ancestor
153800174|NCT00310323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800175|NCT00310323|Analgesics|analgesics|mesh-ancestor
153800176|NCT00310323|Sensory System Agents|sensory system agents|mesh-ancestor
153800177|NCT00310323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800179|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153800180|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800181|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153800182|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800183|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153800275|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
153800276|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
153800277|NCT00280787|Paclitaxel|paclitaxel|mesh-list
153800278|NCT00280787|Carboplatin|carboplatin|mesh-list
153800279|NCT00280787|Irinotecan|irinotecan|mesh-list
153800280|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153800281|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800282|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
153800283|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
153800284|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
153800285|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800322|NCT00281255|Allopurinol|allopurinol|mesh-list
153800323|NCT00281255|Dobutamine|dobutamine|mesh-list
153800324|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
153402737|NCT04927780|Fluorouracil|fluorouracil|mesh-list
153402738|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
153402739|NCT04927780|Irinotecan|irinotecan|mesh-list
153402740|NCT04927780|Calcium|calcium|mesh-list
153402741|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
153402742|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153402743|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402744|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
153402745|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402746|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153402747|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402748|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153402749|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
153402750|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153402751|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153402759|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
153862388|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
153862389|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862390|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862391|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
153862392|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153862393|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153800487|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800488|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
153800489|NCT00281645|Analgesics|analgesics|mesh-list
153800490|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
153800514|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800515|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154257343|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257344|NCT00312377|Docetaxel|docetaxel|mesh-list
154257345|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257346|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
154257347|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
154257348|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
154257349|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257350|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
154257351|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153386125|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
153834502|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153834503|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834504|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834505|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834506|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153834507|NCT04514081|Decitabine|decitabine|mesh-list
153800516|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800517|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800518|NCT00281996|Gemcitabine|gemcitabine|mesh-list
153800519|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
153800520|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153800521|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
153800522|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800523|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800524|NCT00281996|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153800525|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153800526|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800527|NCT00311259|Melatonin|melatonin|mesh-list
153800529|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800531|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800532|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800533|NCT00317733|Ketoprofen|ketoprofen|mesh-list
153862434|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153862435|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153862436|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153862437|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
153862438|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
153862439|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153862440|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153862441|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862442|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862445|NCT04652739|Prednisolone|prednisolone|mesh-list
153402813|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153402814|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153402815|NCT04791228|Doxorubicin|doxorubicin|mesh-list
153402816|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153402817|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153402818|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402819|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153402820|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153402821|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402822|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402824|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153402825|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153862450|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800649|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153800650|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153834531|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
153834532|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
153834533|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834534|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153834535|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153834536|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834537|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834538|NCT00519324|Everolimus|everolimus|mesh-list
153834539|NCT00519324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153374607|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153374608|NCT04766463|Narcotics|narcotics|mesh-ancestor
153374609|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374611|NCT04766463|Analgesics|analgesics|mesh-ancestor
153800651|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800652|NCT00318201|Erythromycin|erythromycin|mesh-list
153800653|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
153379830|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153800654|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153800655|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
153800656|NCT00318201|Diltiazem|diltiazem|mesh-list
153800934|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153800935|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800936|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153800937|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
153800938|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153800939|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800941|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800942|NCT00319059|Annexin A5|annexin a5|mesh-list
153800943|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402944|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862571|NCT02902523|Tenofovir|tenofovir|mesh-list
153801026|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801027|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801028|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801050|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
153801051|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801052|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801053|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153801054|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
153801055|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
153801056|NCT00319488|Hormones|hormones|mesh-ancestor
153862590|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862591|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862592|NCT02902133|Acetazolamide|acetazolamide|mesh-list
153862593|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
153862594|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153862623|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862624|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153801278|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801280|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153801281|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801411|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153801412|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801413|NCT00287300|Azithromycin|azithromycin|mesh-list
153801414|NCT00287300|Artesunate|artesunate|mesh-list
153801415|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
153801416|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
153801417|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153801418|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153834553|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834554|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
153834555|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
153834556|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834557|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834558|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153834559|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153374629|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374630|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153374631|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374632|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
153801419|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801420|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
153801421|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153801422|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153801423|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801424|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
153801425|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
153801458|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801459|NCT00313833|Buprenorphine|buprenorphine|mesh-list
153801497|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153801498|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
153801499|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801500|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801501|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153801502|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153801503|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
153801556|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348138|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801557|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862681|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153862682|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862683|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
153862684|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862685|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
153801791|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801792|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801793|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
153801794|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153801795|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801796|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153801797|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
153801798|NCT00417716|Bevacizumab|bevacizumab|mesh-list
153801799|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403092|NCT04230304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403093|NCT04230304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403094|NCT04205552|Nivolumab|nivolumab|mesh-list
153403095|NCT04205552|Relatlimab|relatlimab|mesh-list
153403096|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153403097|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403098|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403099|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153801931|NCT06139666|Anesthetics, Local|anesthetics, local|mesh-ancestor
153801932|NCT06139666|Anesthetics|anesthetics|mesh-ancestor
153801933|NCT06139666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801934|NCT06139666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801935|NCT06139666|Sensory System Agents|sensory system agents|mesh-ancestor
153403113|NCT04181996|Colchicine|colchicine|mesh-list
153403114|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
153403115|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153403116|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403117|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403118|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403119|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403120|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403122|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
153403123|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403124|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403125|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403126|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
153403127|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
153403128|NCT04173780|Atropine|atropine|mesh-list
153403129|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153801988|NCT06138834|Cilostazol|cilostazol|mesh-list
153801989|NCT06138834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153801990|NCT06138834|Autonomic Agents|autonomic agents|mesh-ancestor
153801991|NCT06138834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801992|NCT06138834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801993|NCT06138834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153801994|NCT06138834|Respiratory System Agents|respiratory system agents|mesh-ancestor
153801995|NCT06138834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153736334|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801996|NCT06138834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153801997|NCT06138834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801998|NCT06138834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153802062|NCT06136754|Protective Agents|protective agents|mesh-ancestor
153802063|NCT06136754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802064|NCT06135831|Calcium, Dietary|calcium, dietary|mesh-list
153802065|NCT06135831|Vitamin D|vitamin d|mesh-list
153802066|NCT06135831|Diphosphonates|diphosphonates|mesh-list
153802067|NCT06135831|Vitamins|vitamins|mesh-list
153802068|NCT06135831|Calcium|calcium|mesh-list
153802069|NCT06135831|Micronutrients|micronutrients|mesh-ancestor
153802070|NCT06135831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802071|NCT06135831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153802072|NCT06135831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153802174|NCT05884866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153802217|NCT05826912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153802218|NCT05826912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802219|NCT05826912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153802220|NCT05826912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802221|NCT05826912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153802222|NCT05826912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153802223|NCT05826912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153802225|NCT05799144|Vaccines|vaccines|mesh-list
153802226|NCT05799144|Immunologic Factors|immunologic factors|mesh-ancestor
153348798|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153802227|NCT05799144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802239|NCT05781217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802241|NCT05781217|Luteolytic Agents|luteolytic agents|mesh-ancestor
153802242|NCT05781217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153802243|NCT05781217|Contraceptive Agents|contraceptive agents|mesh-ancestor
153802244|NCT05781217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153802245|NCT05781217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802246|NCT05781217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153802247|NCT05781217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153802248|NCT05781217|Fertility Agents|fertility agents|mesh-ancestor
153802249|NCT05767736|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153802250|NCT05767736|Dermatologic Agents|dermatologic agents|mesh-ancestor
153802251|NCT05767736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153802252|NCT05767736|Immunologic Factors|immunologic factors|mesh-ancestor
153802253|NCT05767736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802254|NCT05745467|Povidone-Iodine|povidone-iodine|mesh-list
153802255|NCT05745467|Povidone|povidone|mesh-list
153802256|NCT05745467|Plasma Substitutes|plasma substitutes|mesh-ancestor
153802257|NCT05745467|Blood Substitutes|blood substitutes|mesh-ancestor
153802258|NCT05745467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153802259|NCT05745467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802260|NCT05718843|BI 425809|bi 425809|mesh-list
153839849|NCT06022939|Hormones|hormones|mesh-ancestor
153802261|NCT05718843|Nootropic Agents|nootropic agents|mesh-ancestor
153839896|NCT06019741|Antipyretics|antipyretics|mesh-ancestor
153802262|NCT05712707|Lofexidine|lofexidine|mesh-list
153802263|NCT05712707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153802264|NCT05712707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153802265|NCT05712707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802266|NCT05712707|Sensory System Agents|sensory system agents|mesh-ancestor
153802267|NCT05712707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834619|NCT04513457|Hematinics|hematinics|mesh-ancestor
153834620|NCT00521040|Levocetirizine|levocetirizine|mesh-list
153834621|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153374694|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374695|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153374696|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
153374697|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374698|NCT05448885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153374700|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153374701|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153374702|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153374703|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153374704|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
153374705|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374706|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374707|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374708|NCT02980016|Isoniazid|isoniazid|mesh-list
153802268|NCT05712707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153802269|NCT05712707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153802270|NCT05712707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153802271|NCT05712707|Adrenergic Agents|adrenergic agents|mesh-ancestor
153802272|NCT05712707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802273|NCT05712707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802274|NCT05692154|Fexofenadine|fexofenadine|mesh-list
153802275|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153862800|NCT04621110|Midazolam|midazolam|mesh-list
153802338|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153802339|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
153862820|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
153802380|NCT05278494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403204|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153403205|NCT04109924|Irinotecan|irinotecan|mesh-list
153403206|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
153403207|NCT04109924|Antibodies|antibodies|mesh-list
153403208|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
153403209|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153403221|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
153862857|NCT04620837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153862859|NCT04620018|Amoxicillin|amoxicillin|mesh-list
153862860|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153862861|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862862|NCT02900105|Letrozole|letrozole|mesh-list
153862863|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802479|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
153802480|NCT04684212|Dabigatran|dabigatran|mesh-list
153802481|NCT04684212|Edoxaban|edoxaban|mesh-list
153802482|NCT04684212|Apixaban|apixaban|mesh-list
153802483|NCT04684212|Betrixaban|betrixaban|mesh-list
153802484|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
153802485|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153802486|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
153802487|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153802488|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
153802489|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802490|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802491|NCT04679012|Prednisone|prednisone|mesh-list
153802492|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
154257353|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154257354|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154257355|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257356|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257357|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257358|NCT01580891|Naftifine|naftifine|mesh-list
154257359|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
154257360|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257361|NCT01059383|Esomeprazole|esomeprazole|mesh-list
154257362|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154257363|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257364|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154257365|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386343|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834641|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374714|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153374715|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153374716|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
153374717|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374718|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153374719|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153374720|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
153374721|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153374722|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374723|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153374724|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153374725|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153374726|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153374727|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153374728|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153374730|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153374731|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
153802493|NCT04679012|Rituximab|rituximab|mesh-list
153802494|NCT04679012|Doxorubicin|doxorubicin|mesh-list
153802495|NCT04679012|Etoposide|etoposide|mesh-list
153802496|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153802497|NCT04679012|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153802498|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153802499|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
153802500|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802501|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802502|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153802503|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
153802504|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802505|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802506|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153802548|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802549|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802550|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153802551|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153802552|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802553|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862880|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802639|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802641|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153802642|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153802643|NCT04405167|Growth Substances|growth substances|mesh-ancestor
153802644|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
153802645|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153802646|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153802647|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802648|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153802649|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
153802650|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153802651|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153802668|NCT04251741|Adalimumab|adalimumab|mesh-list
153802669|NCT04251741|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153802670|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802671|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802672|NCT04239339|Escitalopram|escitalopram|mesh-list
153403281|NCT04024163|Benzonidazole|benzonidazole|mesh-list
153802698|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802699|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802700|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153802701|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153802702|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
153802703|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802704|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802729|NCT04030143|Aripiprazole|aripiprazole|mesh-list
153802730|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
153802731|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153802732|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153802733|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153802734|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403308|NCT04005053|Expectorants|expectorants|mesh-ancestor
153403309|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
153403310|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153403311|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
153403312|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403313|NCT04005053|Protective Agents|protective agents|mesh-ancestor
153403314|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403315|NCT04005053|Antidotes|antidotes|mesh-ancestor
153403316|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
153403317|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153403318|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
153403319|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403320|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153403321|NCT03981796|Paclitaxel|paclitaxel|mesh-list
153403322|NCT03981796|Carboplatin|carboplatin|mesh-list
153403323|NCT03981796|Niraparib|niraparib|mesh-list
153403324|NCT03981796|Dostarlimab|dostarlimab|mesh-list
153403325|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153403326|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403327|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403328|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
153862968|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153862969|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862970|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862971|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153862972|NCT01189435|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153862973|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153349459|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386441|NCT02379585|Paclitaxel|paclitaxel|mesh-list
153834698|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
153374772|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374773|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153374774|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153374775|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153374776|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153403362|NCT03908736|Picolinic acid|picolinic acid|mesh-list
153802992|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
153802993|NCT03441048|Cladribine|cladribine|mesh-list
153802994|NCT03441048|Lintuzumab|lintuzumab|mesh-list
153802995|NCT03441048|Lenograstim|lenograstim|mesh-list
153803075|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803076|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
153803077|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803078|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803079|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803080|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
153803081|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803082|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803109|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803111|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803112|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803113|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153803114|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803115|NCT03080974|Nivolumab|nivolumab|mesh-list
153803116|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803146|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
153803147|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
153803148|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803149|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153803150|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
153803151|NCT03004287|Hormones|hormones|mesh-ancestor
153380073|NCT04350671|Interferons|interferons|mesh-list
153803152|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153803153|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153803154|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153803155|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153803156|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153803230|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153803231|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
153803232|NCT02615119|Protective Agents|protective agents|mesh-ancestor
153803234|NCT02558010|Methadone|methadone|mesh-list
153803235|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153803236|NCT02558010|Narcotics|narcotics|mesh-ancestor
153803237|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803238|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803239|NCT02558010|Analgesics|analgesics|mesh-ancestor
153803240|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
153803241|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803242|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
153803243|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
153803299|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153803300|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
153803301|NCT01863550|Hormones|hormones|mesh-ancestor
153803302|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153803303|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153803304|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803305|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
153803306|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153803307|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153803308|NCT01863550|Growth Substances|growth substances|mesh-ancestor
153803366|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
153803367|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803397|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
153803398|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
153803399|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153803400|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
153834731|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153374802|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374803|NCT04732455|Analgesics|analgesics|mesh-ancestor
153374804|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
153374805|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153374806|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
153374808|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153374809|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153374810|NCT04306965|Analgesics|analgesics|mesh-ancestor
153374811|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
153374812|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374813|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374814|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374815|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153374818|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803401|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153803452|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803455|NCT00323583|Fluorouracil|fluorouracil|mesh-list
153803456|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
153803457|NCT00323583|Calcium|calcium|mesh-list
153803458|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153803459|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803460|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803461|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
153839997|NCT05971810|Chlorhexidine|chlorhexidine|mesh-list
153803516|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153803517|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153803518|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153803542|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153803543|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153803544|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153803545|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153803546|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153803547|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153803548|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
153803549|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
153803550|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
153803551|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803788|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803789|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803790|NCT00291707|Pemetrexed|pemetrexed|mesh-list
153803791|NCT00291707|Cetuximab|cetuximab|mesh-list
153803792|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803793|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803794|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803795|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153803796|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153803797|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803798|NCT00324519|Misoprostol|misoprostol|mesh-list
153863198|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803835|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
153803837|NCT00324558|Bemiparin|bemiparin|mesh-list
153803838|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
153803839|NCT00291863|Simvastatin|simvastatin|mesh-list
153803840|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153803841|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153803842|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
153803843|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803844|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153803845|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153803846|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803847|NCT00304200|Temozolomide|temozolomide|mesh-list
153803849|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153803913|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153803914|NCT00324831|Immunomodulating Agents|immunomodulating agents|mesh-list
153803915|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
153803916|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803917|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803918|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803919|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153803920|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
153840039|NCT05924321|Oxytocics|oxytocics|mesh-ancestor
153803921|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803922|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803923|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153803924|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803925|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153803953|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153804009|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153804010|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153863243|NCT04650555|Genistein|genistein|mesh-list
153863245|NCT04650555|Protective Agents|protective agents|mesh-ancestor
153863246|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863247|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863248|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153863249|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863250|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804101|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804103|NCT00293111|Etodolac|etodolac|mesh-list
153804104|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153804105|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153804106|NCT00293111|Analgesics|analgesics|mesh-ancestor
153804107|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
153403648|NCT03110926|Leucovorin|leucovorin|mesh-list
153804175|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804176|NCT00293735|Labetalol|labetalol|mesh-list
153804177|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153804178|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153804179|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804180|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804181|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804182|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804200|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804201|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804202|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153804203|NCT00293891|Tacrolimus|tacrolimus|mesh-list
153804204|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804205|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
153804206|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403673|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403674|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403675|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
153403676|NCT03035331|Vaccines|vaccines|mesh-list
153403677|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
153804222|NCT00293969|Narcotics|narcotics|mesh-ancestor
153804223|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804224|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804225|NCT00293969|Analgesics|analgesics|mesh-ancestor
153804226|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
153804227|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804228|NCT00294008|Risperidone|risperidone|mesh-list
153804229|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153804230|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
153804231|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804232|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804233|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804234|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153804235|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153804236|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804237|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804238|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153804239|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
153804240|NCT00294086|Valsartan|valsartan|mesh-list
153804241|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153804252|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804253|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154263504|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263505|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263506|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
154263507|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
154263508|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263509|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154263510|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154263511|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
154263512|NCT05347238|Protective Agents|protective agents|mesh-ancestor
154263513|NCT05335252|Dronabinol|dronabinol|mesh-list
154263514|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
154263515|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263516|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154263517|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154263518|NCT05335252|Analgesics|analgesics|mesh-ancestor
154263519|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
153386562|NCT00989937|Oxytocin|oxytocin|mesh-list
153374875|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374876|NCT03160911|Hemostatics|hemostatics|mesh-list
153374877|NCT03160911|Coagulants|coagulants|mesh-ancestor
153374878|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
153374879|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153374880|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374881|NCT04685499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153374882|NCT04685499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374883|NCT00369603|Donepezil|donepezil|mesh-list
153374884|NCT00369603|Galantamine|galantamine|mesh-list
153374885|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153374886|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374887|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374888|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
153374889|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804254|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153804255|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804256|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804257|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153804258|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
153804259|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
153804287|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153403687|NCT02944500|Incretins|incretins|mesh-ancestor
153403688|NCT02944500|Hormones|hormones|mesh-ancestor
153403689|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263520|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263521|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154263522|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154263523|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263524|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263525|NCT05335252|Hormones|hormones|mesh-ancestor
154263526|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263527|NCT05327270|Nivolumab|nivolumab|mesh-list
154263528|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153386607|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153374895|NCT01551056|Cetirizine|cetirizine|mesh-list
153403690|NCT02923934|Nivolumab|nivolumab|mesh-list
153403691|NCT02923934|Ipilimumab|ipilimumab|mesh-list
153403692|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403693|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403694|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403695|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403696|NCT02913313|Nivolumab|nivolumab|mesh-list
153403697|NCT02913313|Ipilimumab|ipilimumab|mesh-list
153403698|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403699|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863316|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153380249|NCT00555971|Omalizumab|omalizumab|mesh-list
153863318|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
153863319|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863320|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863321|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863322|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
153863323|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863327|NCT00563160|Carboplatin|carboplatin|mesh-list
153863328|NCT00563160|Gemcitabine|gemcitabine|mesh-list
153804403|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153804405|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153804406|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153804407|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153804408|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804409|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153804410|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804411|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
153804412|NCT00305487|Ciclesonide|ciclesonide|mesh-list
153804413|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
153804414|NCT00305487|Hormones|hormones|mesh-ancestor
153804415|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804416|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804417|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153804442|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153804443|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153804444|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863343|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804498|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863347|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153863348|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840163|NCT05839899|Contraceptive Agents|contraceptive agents|mesh-ancestor
153380271|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153380272|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153380273|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380274|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
153380276|NCT01338740|Adalimumab|adalimumab|mesh-list
153863350|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153863351|NCT04934228|Clonidine|clonidine|mesh-list
153863352|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153804555|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804556|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
153804557|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
153804558|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
153804596|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153804597|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
153804598|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374926|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153374927|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374928|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153374929|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153374930|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374931|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374932|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153374933|NCT02768727|Xenon|xenon|mesh-list
153374934|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153374935|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
153804599|NCT00295958|Immunoconjugates|immunoconjugates|mesh-ancestor
153804600|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
153804601|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
153804603|NCT00295997|Methotrexate|methotrexate|mesh-list
153804604|NCT00295997|Fludarabine|fludarabine|mesh-list
153804605|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
153804606|NCT00295997|Tacrolimus|tacrolimus|mesh-list
153804607|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153804608|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804609|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
153804610|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804611|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153804612|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153804613|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
153804614|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804615|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804616|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153804617|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153804618|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
153804619|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153804623|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804624|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153804625|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153804626|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153804627|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153804628|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153840171|NCT05838560|Dasatinib|dasatinib|mesh-list
153804629|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
153804630|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153804631|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804660|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153804661|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804662|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804663|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153804664|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804665|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153804666|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
153804667|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153804668|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804669|NCT00296387|Atorvastatin|atorvastatin|mesh-list
153804670|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153804671|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153804672|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153804673|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
153804674|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804675|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153804676|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153804677|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804678|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
153804679|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
153431149|NCT06316076|Cyclophosphamide|cyclophosphamide|mesh-list
153804701|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153804702|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153804703|NCT00326859|Remifentanil|remifentanil|mesh-list
153804704|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153386686|NCT00832299|Vitamins|vitamins|mesh-ancestor
153374950|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374951|NCT00370851|Bevacizumab|bevacizumab|mesh-list
153374952|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153374953|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374954|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153374955|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153374956|NCT00370851|Growth Substances|growth substances|mesh-ancestor
153374957|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804705|NCT00326859|Narcotics|narcotics|mesh-ancestor
153804706|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804764|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153804765|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804766|NCT00296972|Interferons|interferons|mesh-list
153804767|NCT00296972|Ribavirin|ribavirin|mesh-list
153804768|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804769|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
153804770|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804771|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
153804772|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804773|NCT00297011|Valacyclovir|valacyclovir|mesh-list
153804774|NCT00297011|Clobetasol|clobetasol|mesh-list
153804775|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
153380321|NCT02946489|Ketamine|ketamine|mesh-list
153804776|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804786|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153804798|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153804799|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
153804800|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804801|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804802|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153804804|NCT00327132|Clarithromycin|clarithromycin|mesh-list
153804805|NCT00327132|Omeprazole|omeprazole|mesh-list
153804806|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153804807|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804808|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153804809|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153804810|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153804811|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804812|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804813|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153804814|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153804815|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153804816|NCT00297206|Valacyclovir|valacyclovir|mesh-list
153804817|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
153804818|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804819|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
153804820|NCT04478019|Povidone|povidone|mesh-list
153804821|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
153804822|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
153804823|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153863418|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804836|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804837|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
153804838|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804839|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
153804840|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804841|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
153804855|NCT04333134|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153804857|NCT04333134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804858|NCT04333134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804859|NCT00327327|Gemcitabine|gemcitabine|mesh-list
153804860|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153804861|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
153804862|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804863|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840236|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
153374975|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153374976|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153374977|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374979|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374981|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
153374982|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153374983|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153374984|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153374985|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804864|NCT00297362|Galantamine|galantamine|mesh-list
153804865|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153804866|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804867|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804868|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
153804869|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804870|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804871|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153403800|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
153403801|NCT02514382|Hormones|hormones|mesh-ancestor
153804886|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153804887|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
153804888|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
153804889|NCT04231773|Protective Agents|protective agents|mesh-ancestor
153804890|NCT00297674|Clarithromycin|clarithromycin|mesh-list
153804891|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153804892|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804893|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153804894|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804895|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804896|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153736339|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
153804897|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153804898|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153804899|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153804900|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804901|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153804932|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
153804933|NCT00298025|Cetrorelix|cetrorelix|mesh-list
153804934|NCT00298025|Menotropins|menotropins|mesh-list
153804940|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804942|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153804968|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804969|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
153804970|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
153804971|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
153380387|NCT01915823|Xhance|xhance|mesh-list
153804972|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804973|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153804974|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
153804975|NCT00298415|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153804976|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351542|NCT00405938|Bevacizumab|bevacizumab|mesh-list
153351543|NCT00405938|Fulvestrant|fulvestrant|mesh-list
153351544|NCT00405938|Anastrozole|anastrozole|mesh-list
153804977|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804979|NCT00298454|Diuretics|diuretics|mesh-ancestor
153804980|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
153804981|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374997|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153374999|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375000|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153375001|NCT03022877|Simendan|simendan|mesh-list
153375002|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153375003|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
153375004|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153375005|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153375006|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375007|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375008|NCT03022877|Protective Agents|protective agents|mesh-ancestor
153804982|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153804983|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153804984|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804986|NCT00298571|Bupivacaine|bupivacaine|mesh-list
153804987|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
153804988|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
153804989|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804990|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804991|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
153403814|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
153403815|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403816|NCT02458274|Dimercaprol|dimercaprol|mesh-list
153403817|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
153403818|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
153805026|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805027|NCT00299039|Acetaminophen|acetaminophen|mesh-list
153805028|NCT00299039|Ibuprofen|ibuprofen|mesh-list
153805029|NCT00299039|Codeine|codeine|mesh-list
153805030|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153805031|NCT00299039|Analgesics|analgesics|mesh-ancestor
153805032|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
153805033|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805034|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805035|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
153805036|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153805037|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153805038|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805039|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153805040|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805041|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805042|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153805043|NCT00299039|Narcotics|narcotics|mesh-ancestor
153805044|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805045|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
153805046|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
153805047|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153805076|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153805077|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805078|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805079|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
153805080|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153805081|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153805082|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
153805083|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805085|NCT05455944|Analgesics|analgesics|mesh-ancestor
153805086|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
153805087|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805088|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375018|NCT02420262|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153375020|NCT02420262|Hormones|hormones|mesh-ancestor
153375021|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375022|NCT00369993|Fluticasone|fluticasone|mesh-list
153375023|NCT00369993|Xhance|xhance|mesh-list
153375024|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153375025|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375026|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153375027|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
153375028|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375029|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375030|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153375031|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
153834950|NCT00523692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153805089|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
153805090|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153805091|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805092|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403825|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
153403826|NCT02409147|Hormones|hormones|mesh-ancestor
153403827|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153403828|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403829|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153403830|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805102|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
153805103|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805104|NCT00300014|Triamcinolone|triamcinolone|mesh-list
153805105|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153805106|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
153805107|NCT00300014|Hormones|hormones|mesh-ancestor
153805108|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805133|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153805134|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
153805135|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805136|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805137|NCT00300287|Vildagliptin|vildagliptin|mesh-list
153805138|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153805139|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805140|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153805141|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
153805142|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805143|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805144|NCT00300404|Leucovorin|leucovorin|mesh-list
153805145|NCT00300404|Folic Acid|folic acid|mesh-list
153805146|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
153805147|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
153805148|NCT00300404|Antidotes|antidotes|mesh-ancestor
153805149|NCT00300404|Protective Agents|protective agents|mesh-ancestor
153805150|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805151|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
153805152|NCT00300404|Vitamins|vitamins|mesh-ancestor
153805153|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
153805154|NCT00300404|Hematinics|hematinics|mesh-ancestor
153805155|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
153805156|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153805157|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153805158|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805208|NCT00300833|Tirofiban|tirofiban|mesh-list
153805209|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153805210|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153375036|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153375037|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
153375038|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375039|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375040|NCT00552305|Lacosamide|lacosamide|mesh-list
153375041|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
153375042|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153375043|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153375044|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375046|NCT01854255|Cisplatin|cisplatin|mesh-list
153805239|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
153805240|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805241|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153805242|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153805243|NCT00301106|Growth Substances|growth substances|mesh-ancestor
153805244|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
153805245|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805247|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153805248|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153805249|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
153805250|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805251|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403842|NCT02392026|Metronidazole|metronidazole|mesh-list
153805276|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
153805277|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805278|NCT00301535|Chrysarobin|chrysarobin|mesh-list
153351840|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153805280|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153805281|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153805282|NCT00301535|Analgesics|analgesics|mesh-ancestor
153805283|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
153805284|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805285|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805286|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153805287|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805288|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
153805289|NCT00301574|Galantamine|galantamine|mesh-list
153805290|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153805291|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805292|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805293|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
153840357|NCT05304273|Misoprostol|misoprostol|mesh-list
153805294|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805295|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805296|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153805297|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
153805298|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805299|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
153805300|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153805301|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153805302|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153805303|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805304|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805305|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
153805306|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805307|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805308|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
153805309|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153805310|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805311|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153805348|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805383|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
153805384|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805385|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153386859|NCT01841931|Analgesics|analgesics|mesh-ancestor
153375063|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375064|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
153375065|NCT01555281|Hormones|hormones|mesh-ancestor
153805386|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805407|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
153805408|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
153805409|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805410|NCT00328107|Coagulants|coagulants|mesh-ancestor
153805411|NCT00302432|Menthol|menthol|mesh-list
153805412|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
153805413|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
153805414|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153805415|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153805416|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
153805417|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805418|NCT00302549|Tacrolimus|tacrolimus|mesh-list
153805455|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153805456|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
153805457|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805458|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153805459|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805461|NCT00302666|Hormones|hormones|mesh-ancestor
153805462|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
153805463|NCT00328302|Candesartan|candesartan|mesh-list
153805464|NCT00328302|Candesartan cilexetil|candesartan cilexetil|mesh-list
153805465|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153805466|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153805467|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153805468|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805469|NCT00328380|Rifaximin|rifaximin|mesh-list
153805470|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153805472|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153805474|NCT00418496|Sorafenib|sorafenib|mesh-list
153805475|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805476|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153805477|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805478|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805479|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153805480|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153805481|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
153840384|NCT05303805|Sevoflurane|sevoflurane|mesh-list
153805482|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805483|NCT00302705|Valsartan|valsartan|mesh-list
153805484|NCT00302705|Enalapril|enalapril|mesh-list
153805485|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153805486|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153805487|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153805488|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805489|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153805490|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
153805491|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805492|NCT00302822|Tenofovir|tenofovir|mesh-list
153805493|NCT00302822|Emtricitabine|emtricitabine|mesh-list
153805494|NCT00302822|Efavirenz|efavirenz|mesh-list
153805495|NCT00302822|Lopinavir|lopinavir|mesh-list
153805496|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
153805497|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
153805498|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352065|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
153805499|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153805500|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153805501|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805502|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805504|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153805505|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153805527|NCT00303017|Analgesics|analgesics|mesh-ancestor
153805528|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
153805529|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805530|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403915|NCT02043457|Hormones|hormones|mesh-list
153805555|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805575|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375099|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375100|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153375101|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
153375102|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375103|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375104|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153375105|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375106|NCT03996057|Methenamine|methenamine|mesh-list
153375107|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
153375108|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
153805577|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
153863523|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153863524|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
153863525|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153863526|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
153863527|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153863528|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
153863529|NCT00563589|Cyclosporine|cyclosporine|mesh-list
153863530|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
153863531|NCT00563589|Methotrexate|methotrexate|mesh-list
153863532|NCT00563589|Cyclosporins|cyclosporins|mesh-list
153805641|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
153805642|NCT00303758|Antidotes|antidotes|mesh-ancestor
153805643|NCT00303758|Protective Agents|protective agents|mesh-ancestor
153805698|NCT00332319|Casopitant|casopitant|mesh-list
153805699|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
153805700|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
153805724|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352361|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
153805725|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
153805726|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805727|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
153805728|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805729|NCT00332397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153805730|NCT00332397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805731|NCT00332397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805732|NCT00304460|Aldesleukin|aldesleukin|mesh-list
153805733|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805735|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153863561|NCT02204345|Paclitaxel|paclitaxel|mesh-list
153403947|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153403948|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
153403949|NCT01758081|Vitamin D|vitamin d|mesh-list
153403950|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
153805814|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153805815|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805816|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805817|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
153805818|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
153805819|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805820|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805821|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153805822|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153805823|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
153805824|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153805825|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153805826|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153805827|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153805828|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153805829|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153805830|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153805831|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153805832|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
153805833|NCT00332553|Estradiol|estradiol|mesh-list
153805834|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153805835|NCT00332553|Estrogens|estrogens|mesh-list
153805836|NCT00332553|Hormones|hormones|mesh-ancestor
154257366|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257367|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154257368|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154257369|NCT01170338|Varenicline|varenicline|mesh-list
154257370|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154257371|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154257372|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
154257373|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257374|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257375|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257376|NCT00312221|Oxycodone|oxycodone|mesh-list
154257377|NCT00312221|Buprenorphine|buprenorphine|mesh-list
154257378|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154257379|NCT00312221|Narcotics|narcotics|mesh-ancestor
154257380|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257381|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732028|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732029|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153375119|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
153375120|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
153375121|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375122|NCT00552071|Octreotide|octreotide|mesh-list
153375123|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375124|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153375125|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805837|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805875|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
153805876|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805877|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805878|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153805879|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153805881|NCT00304811|Rifampin|rifampin|mesh-list
153805882|NCT00304811|Gentamicins|gentamicins|mesh-list
153805883|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153805884|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805885|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153805886|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
153805887|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
153805888|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153805889|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805890|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805891|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153805892|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153805893|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153805894|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153375141|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
153375142|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375143|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
153375144|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153375145|NCT00551525|Analgesics|analgesics|mesh-ancestor
153375146|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
153375147|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375148|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375149|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153835073|NCT05142098|Analgesics|analgesics|mesh-ancestor
153805895|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153805896|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153805897|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153805898|NCT00332787|Fluoxetine|fluoxetine|mesh-list
153805899|NCT00332787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153805900|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153805901|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805902|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863569|NCT02187302|Bevacizumab|bevacizumab|mesh-list
153805940|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153805941|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805943|NCT00329355|Sumatriptan|sumatriptan|mesh-list
153805944|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153805945|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153805946|NCT00329355|Analgesics|analgesics|mesh-ancestor
153805947|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
153805948|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805949|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805968|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805969|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153805970|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153805971|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
153805972|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153805973|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
153380647|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805974|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805998|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805999|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
153806000|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806001|NCT00329472|Gemcitabine|gemcitabine|mesh-list
153806002|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806003|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806004|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
153806005|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352585|NCT00420992|Naltrexone|naltrexone|mesh-list
153806012|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153806013|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153806014|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806015|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153806016|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153806017|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
153806018|NCT00329511|Clonidine|clonidine|mesh-list
153806019|NCT00329511|Methyldopa|methyldopa|mesh-list
153806020|NCT00329511|Analgesics|analgesics|mesh-ancestor
153806021|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
153806022|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806023|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806024|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153806025|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
153806061|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153806062|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153806063|NCT00305552|Growth Substances|growth substances|mesh-ancestor
153806101|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
153806128|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806129|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153386997|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
153375177|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153375178|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
153375179|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153835088|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835089|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153835090|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
153835091|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835092|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153835093|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835094|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153835095|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153835096|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835097|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806130|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806131|NCT00305786|Gemcitabine|gemcitabine|mesh-list
153806132|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
153806133|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806134|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
153806135|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806136|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806137|NCT00305825|Bevacizumab|bevacizumab|mesh-list
153806138|NCT00305825|Letrozole|letrozole|mesh-list
153806139|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153806140|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806141|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153806142|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153806143|NCT00305825|Growth Substances|growth substances|mesh-ancestor
153806144|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806145|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
153806228|NCT00330018|Acyclovir|acyclovir|mesh-list
153806229|NCT00330018|Valganciclovir|valganciclovir|mesh-list
153806230|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
153806231|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806232|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153352809|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806247|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153806248|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153806249|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153806250|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806251|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
153806252|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153806253|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
153806254|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806255|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
153806256|NCT00330135|Protective Agents|protective agents|mesh-ancestor
153806258|NCT03275558|Axitinib|axitinib|mesh-list
153806259|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806260|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153806261|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153806262|NCT03275558|Growth Substances|growth substances|mesh-ancestor
153806282|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806283|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806284|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806285|NCT00330252|Rituximab|rituximab|mesh-list
153806286|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
153806287|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153806288|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806289|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
153375205|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
153840579|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380699|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380700|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
153380701|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
153380702|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380703|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
153380704|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380705|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380706|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
153380707|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153380708|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153380709|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375206|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153375207|NCT02370498|Paclitaxel|paclitaxel|mesh-list
153375208|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
153375209|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153835115|NCT00524160|Narcotics|narcotics|mesh-ancestor
153835116|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835117|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835118|NCT00524160|Analgesics|analgesics|mesh-ancestor
153835119|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
153835120|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835121|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153835122|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153835123|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
153835124|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
153835126|NCT00524199|Protective Agents|protective agents|mesh-ancestor
153806290|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806291|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806307|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806309|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153806310|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153806311|NCT00420537|Cyclosporine|cyclosporine|mesh-list
153806312|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
153806314|NCT00420537|Cyclosporins|cyclosporins|mesh-list
153806315|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806316|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806317|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806318|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
153806319|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806320|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
153806321|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806322|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
153806323|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806324|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153806325|NCT00420537|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153806326|NCT00420537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153806327|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806328|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153806329|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153806330|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
153806331|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153806393|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153806394|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806395|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153840581|NCT05027048|Calcium|calcium|mesh-list
153806396|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153806412|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806414|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153806415|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806416|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153806417|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153806418|NCT00451763|Growth Substances|growth substances|mesh-ancestor
153806419|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806420|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
153806421|NCT00330798|Ketorolac|ketorolac|mesh-list
153806422|NCT00330798|Nepafenac|nepafenac|mesh-list
153806423|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153806445|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806446|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
153835144|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835145|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153835146|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153835148|NCT04696250|Immunomodulating Agents|immunomodulating agents|mesh-list
153835149|NCT04696250|Immunologic Factors|immunologic factors|mesh-ancestor
153835150|NCT04696250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835151|NCT00524433|Tezosentan|tezosentan|mesh-list
153835152|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
153835153|NCT02947932|Indomethacin|indomethacin|mesh-list
153806447|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806448|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806449|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
153806450|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806451|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806452|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
153806453|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806454|NCT00451997|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153806482|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806483|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380736|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
153380737|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153380738|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153380739|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153806484|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
153806486|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
153806487|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153806488|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806489|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153806537|NCT00334347|Valproic Acid|valproic acid|mesh-list
153806538|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
153806539|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806540|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806541|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
153806542|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806543|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806545|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153806581|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806611|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153806612|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153806613|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806614|NCT00452270|Xylometazoline|xylometazoline|mesh-list
153806615|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
153806616|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153806617|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
153806618|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
153806619|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
153806620|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153806621|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153806622|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806623|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806624|NCT00452582|Urological Agents|urological agents|mesh-ancestor
153806657|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153806658|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806659|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806660|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153806661|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
153806662|NCT00334932|Doxorubicin|doxorubicin|mesh-list
153806663|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153806664|NCT00334932|Bortezomib|bortezomib|mesh-list
153806665|NCT00334932|Melphalan|melphalan|mesh-list
153806666|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153806667|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806668|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153806669|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153806670|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375257|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375258|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375259|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375260|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375261|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153835162|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153835163|NCT02947932|Analgesics|analgesics|mesh-ancestor
153835164|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
153806671|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806672|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153806673|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
153806674|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153806675|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353257|NCT05021094|Hormones|hormones|mesh-ancestor
153353259|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806676|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
153806677|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806678|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
153806679|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
153806680|NCT00452855|Remifentanil|remifentanil|mesh-list
153806681|NCT00452855|Sevoflurane|sevoflurane|mesh-list
153806682|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
153806719|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
153806720|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806721|NCT00335166|Protective Agents|protective agents|mesh-ancestor
153806722|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806723|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153806724|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153806725|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
153806726|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
153806727|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806728|NCT00452972|Anesthetics|anesthetics|mesh-list
153806729|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806730|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806731|NCT00335205|Ropinirole|ropinirole|mesh-list
153806732|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153806733|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153806734|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
153806735|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
153806736|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806737|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863688|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806786|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806787|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
153806788|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
153806789|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
153806790|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806791|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806792|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
153806793|NCT00335439|Ketorolac|ketorolac|mesh-list
153806824|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153806825|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153806826|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153806827|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
153353478|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
153806828|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153806829|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
153806830|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153806831|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
153806832|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806850|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806851|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806853|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153806854|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153806855|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153806856|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
153835197|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835198|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153835199|NCT00524706|Leucovorin|leucovorin|mesh-list
153835200|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
153835201|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835202|NCT00524706|Antidotes|antidotes|mesh-ancestor
153835203|NCT00524706|Protective Agents|protective agents|mesh-ancestor
153835204|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835205|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
153806857|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806858|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153806859|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153806860|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840677|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153806861|NCT00336375|Lumefantrine|lumefantrine|mesh-list
153806862|NCT00336375|Artemether|artemether|mesh-list
153806871|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806872|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
153806873|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806874|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806875|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153806876|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
153806877|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806878|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806879|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153806880|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806881|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
153806883|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806884|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153806885|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
153806886|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806887|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
153806888|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
153806914|NCT00336648|Bevacizumab|bevacizumab|mesh-list
153806915|NCT00336648|Gemcitabine|gemcitabine|mesh-list
153806916|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153806917|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806918|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153806919|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153806920|NCT00336648|Growth Substances|growth substances|mesh-ancestor
153806921|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806922|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
153806923|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806924|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
153806925|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806926|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153806927|NCT03274817|Escitalopram|escitalopram|mesh-list
153806928|NCT03274817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153806929|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153806930|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153806931|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806932|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806933|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
153806948|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
153806949|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806950|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806951|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153806952|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153806953|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806954|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153806955|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806956|NCT00230399|Analgesics|analgesics|mesh-ancestor
153806992|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
153806993|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
153806994|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153807046|NCT00418535|Cisplatin|cisplatin|mesh-list
153835218|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
153835219|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835220|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835221|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153835222|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835223|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153835224|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153835225|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835226|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835227|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
153835228|NCT02947854|Poly ICLC|poly iclc|mesh-list
153835229|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153835230|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
153835231|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
153835232|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807076|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
153807078|NCT00337389|Protective Agents|protective agents|mesh-ancestor
153807079|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
153807081|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
153807082|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153807083|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153807084|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153807085|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
153807086|NCT00306878|Abatacept|abatacept|mesh-list
153807087|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153807088|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807089|NCT00306878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153807090|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807091|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807092|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
153807093|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807094|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153807095|NCT00337506|Dexamethasone|dexamethasone|mesh-list
153807096|NCT00337506|Bortezomib|bortezomib|mesh-list
153807097|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807098|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
153807099|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
153807100|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807101|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807102|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807103|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
153807104|NCT00337506|Hormones|hormones|mesh-ancestor
153807105|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807106|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807107|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807108|NCT00307307|Niacin|niacin|mesh-list
153807109|NCT00307307|Simvastatin|simvastatin|mesh-list
153807110|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153807237|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807238|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153807240|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807241|NCT00308048|Interferons|interferons|mesh-list
153807242|NCT00308048|Ribavirin|ribavirin|mesh-list
153807243|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
153807386|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807407|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
153807408|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807409|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153807410|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153835240|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835241|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
153835242|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380884|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153380885|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153380886|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
153380887|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380888|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380889|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153380890|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380891|NCT03093207|Aspirin|aspirin|mesh-list
153835243|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835244|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153835245|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835246|NCT00507221|Albendazole|albendazole|mesh-list
153835247|NCT00507221|Praziquantel|praziquantel|mesh-list
153835248|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
153835249|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153835250|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835251|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
153835252|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153807411|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807412|NCT00309413|Cannabidiol|cannabidiol|mesh-list
153807413|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
153807414|NCT00309491|Tamoxifen|tamoxifen|mesh-list
153807415|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
153807416|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153807417|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
153807418|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807419|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807420|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807421|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807459|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807460|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153807461|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
153807462|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153807463|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
153840770|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153840771|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
153840772|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840773|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153840774|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153840775|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
153840776|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840777|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840778|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153840779|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153840780|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
153840781|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
153840782|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840783|NCT04623944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840784|NCT04590937|Metformin|metformin|mesh-list
153840785|NCT04590937|Digoxin|digoxin|mesh-list
153807464|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807465|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153807466|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153807467|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153807468|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153807469|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153807470|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153807471|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153807472|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153807473|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153807474|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807475|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153807476|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153807477|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153807478|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
153807479|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807480|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807481|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153807482|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153807483|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
153807484|NCT00309725|Galantamine|galantamine|mesh-list
153807539|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153807540|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807541|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807542|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
153807543|NCT00309881|Hormones|hormones|mesh-ancestor
153807544|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807545|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807546|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153807547|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807548|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
153807549|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835262|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153835263|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835264|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835265|NCT05146895|Imiquimod|imiquimod|mesh-list
153835266|NCT05146895|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153835267|NCT05146895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835268|NCT05146895|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153807550|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
153807551|NCT00309920|Docetaxel|docetaxel|mesh-list
153807574|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807575|NCT00309920|Hematinics|hematinics|mesh-ancestor
153807576|NCT00309998|Bevacizumab|bevacizumab|mesh-list
153807577|NCT00309998|Vinorelbine|vinorelbine|mesh-list
153807578|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153807590|NCT00310154|Docetaxel|docetaxel|mesh-list
153807591|NCT00310154|Gefitinib|gefitinib|mesh-list
153807592|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807593|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807594|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
153807595|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
153807596|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807597|NCT00310154|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153807598|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153807599|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807600|NCT00338910|Metronidazole|metronidazole|mesh-list
153807601|NCT00338910|Budesonide|budesonide|mesh-list
153807602|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807618|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
153807619|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
153807620|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807621|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807622|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153807623|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
153807624|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807625|NCT00310505|Amphotericin B|amphotericin b|mesh-list
153807626|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153807627|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
153807628|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
153807629|NCT00310505|Amebicides|amebicides|mesh-ancestor
153807630|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153807631|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153807632|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807633|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153807634|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
153807635|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153807636|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807638|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
153807639|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153807640|NCT00339066|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153807641|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153380969|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380970|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380971|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153380972|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
153380973|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
153380974|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
153380975|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153380976|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153380977|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
153380978|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380989|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380990|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153380991|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153380993|NCT02366130|Denosumab|denosumab|mesh-list
153807642|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153807643|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807644|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807645|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
153807646|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807647|NCT00310583|Pregabalin|pregabalin|mesh-list
153354215|NCT03094286|Durvalumab|durvalumab|mesh-list
153354219|NCT03071666|Vitamins|vitamins|mesh-ancestor
153354291|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807648|NCT00310583|Analgesics|analgesics|mesh-ancestor
153807649|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
153807650|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807651|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807652|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
153807653|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154257382|NCT00312221|Analgesics|analgesics|mesh-ancestor
154257383|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
154257384|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257385|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154257386|NCT03872570|Phenylephrine|phenylephrine|mesh-list
154257387|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
154257388|NCT03872570|Norepinephrine|norepinephrine|mesh-list
154257389|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154257390|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
154257391|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
154257392|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387364|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835275|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153835276|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835277|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835278|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835279|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
153835280|NCT00524901|Hematinics|hematinics|mesh-ancestor
153835281|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
153835282|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
153835283|NCT02954588|Vitamins|vitamins|mesh-ancestor
153835284|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
153835285|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835286|NCT02954549|Vitamin D|vitamin d|mesh-list
153835287|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
153835288|NCT02954549|Vitamins|vitamins|mesh-ancestor
153835289|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
153835290|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835291|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153835294|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
153375358|NCT01439672|Insulin|insulin|mesh-list
153807692|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153807693|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
153807694|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807695|NCT00421083|Tadalafil|tadalafil|mesh-list
153807696|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
153807697|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153807698|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153807699|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807700|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807701|NCT00421083|Urological Agents|urological agents|mesh-ancestor
153807702|NCT00310895|Imetelstat|imetelstat|mesh-list
153807703|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
153807704|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807705|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807706|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153807707|NCT00310934|Buprenorphine|buprenorphine|mesh-list
153807708|NCT00310934|Methadone|methadone|mesh-list
153807709|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153835302|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835303|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153835304|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153835305|NCT02946294|Epinephrine|epinephrine|mesh-list
153835306|NCT02946294|Racepinephrine|racepinephrine|mesh-list
153835307|NCT02946294|Bupivacaine|bupivacaine|mesh-list
153835308|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
153835309|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
153835310|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
153835311|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835312|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835313|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
153835315|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153807711|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153807712|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807744|NCT00311012|Protease Inhibitors|protease inhibitors|mesh-ancestor
153807745|NCT00311012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807746|NCT00311012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807748|NCT00311051|Montelukast|montelukast|mesh-list
153807749|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153807750|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
153807751|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153807752|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
153807753|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807754|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807755|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153807756|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153840895|NCT04495608|Fluconazole|fluconazole|mesh-list
153807757|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807758|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153807759|NCT00311129|Rituximab|rituximab|mesh-list
153807760|NCT00311129|Fludarabine|fludarabine|mesh-list
153807761|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
153807762|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153807763|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807764|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
153807765|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807766|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153807767|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807768|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
153807769|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807770|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807771|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
153807772|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807773|NCT00342381|Amifampridine|amifampridine|mesh-list
153807774|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153807775|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807776|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807777|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153807778|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153807804|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807805|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807806|NCT00418925|Hormones|hormones|mesh-ancestor
153840901|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840902|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153840903|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
153840904|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153840905|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840906|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153840907|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153840908|NCT04478838|Olanzapine|olanzapine|mesh-list
153840909|NCT04478838|Risperidone|risperidone|mesh-list
153840910|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153840911|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
153840912|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840913|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840914|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431575|NCT06081829|Ivosidenib|ivosidenib|mesh-list
153807820|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807821|NCT00311636|Paclitaxel|paclitaxel|mesh-list
153807822|NCT00311636|Docetaxel|docetaxel|mesh-list
153807823|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
154257393|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257394|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
154257395|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154257396|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
154257397|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
154257398|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154257399|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154257400|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154257401|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
153387454|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153835322|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
153835323|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153835324|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
153835325|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
153835326|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
153835327|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153807824|NCT00311636|Doxorubicin|doxorubicin|mesh-list
153807825|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153807826|NCT00311636|Fluorouracil|fluorouracil|mesh-list
153807827|NCT00311636|Methotrexate|methotrexate|mesh-list
153807828|NCT00311636|Epirubicin|epirubicin|mesh-list
153807829|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153807830|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153807847|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
153807848|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807849|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153807850|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
153807851|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153807852|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
153807853|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153807854|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153807855|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
153807856|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153807857|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
153807858|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153807859|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807860|NCT00311753|Heparin|heparin|mesh-list
153807861|NCT00311753|Certoparin|certoparin|mesh-list
153807862|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
153807863|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153807864|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153807865|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807866|NCT00311870|Lisinopril|lisinopril|mesh-list
153807867|NCT00311870|Nisoldipine|nisoldipine|mesh-list
153807868|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153354437|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153807869|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
153807870|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807871|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807872|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153807873|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153807874|NCT00311870|Protective Agents|protective agents|mesh-ancestor
153807875|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807876|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153807877|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153863837|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807934|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153807935|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153807950|NCT00312299|Protective Agents|protective agents|mesh-ancestor
153807951|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257402|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257403|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257404|NCT03872570|Protective Agents|protective agents|mesh-ancestor
154257405|NCT01173926|Insulin|insulin|mesh-list
154257406|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154257407|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
154257408|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
154257409|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154257410|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154257411|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257412|NCT03349268|Xenon|xenon|mesh-list
153387504|NCT02294682|Gepotidacin|gepotidacin|mesh-list
153835350|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835351|NCT04693026|Remdesivir|remdesivir|mesh-list
153835352|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
153835353|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835354|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
153835355|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835356|NCT02276859|Insulin|insulin|mesh-list
153835357|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153807952|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153807953|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153807954|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153807955|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153807956|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153807957|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
153807958|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807959|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807989|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807990|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
153807991|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808005|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153808006|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153840957|NCT04322305|Pregabalin|pregabalin|mesh-list
153808007|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153808008|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808009|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808010|NCT00347685|Tramadol|tramadol|mesh-list
153808011|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153808012|NCT00347685|Narcotics|narcotics|mesh-ancestor
153808013|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808014|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808015|NCT00347685|Analgesics|analgesics|mesh-ancestor
153808016|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
153808017|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808018|NCT00343239|Docetaxel|docetaxel|mesh-list
153808020|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404273|NCT02358889|Growth Substances|growth substances|mesh-ancestor
153404301|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153863904|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153863905|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863906|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863907|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153863908|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153863910|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
153835389|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835390|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153835391|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153404330|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153404331|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153808299|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808300|NCT00344253|Interferons|interferons|mesh-list
153808301|NCT00344253|Interferon-beta|interferon-beta|mesh-list
153808302|NCT00344253|Methotrexate|methotrexate|mesh-list
153808303|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153808304|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
153808376|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808378|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153808379|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808380|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153808381|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153808382|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153808383|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808384|NCT00314678|Paclitaxel|paclitaxel|mesh-list
153808385|NCT00314678|Topotecan|topotecan|mesh-list
153840978|NCT04305158|Analgesics|analgesics|mesh-ancestor
153808386|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153354960|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808387|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808388|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
153808389|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
153808390|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
153355032|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808391|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808392|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153736351|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153736352|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153736353|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
153736354|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808513|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808514|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808515|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
153808516|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808517|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808518|NCT00349089|Pemetrexed|pemetrexed|mesh-list
153808519|NCT00349089|Vinorelbine|vinorelbine|mesh-list
153808520|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808521|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808522|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808524|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153808525|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153808526|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
153808527|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
153808528|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
153808529|NCT00349128|Metformin|metformin|mesh-list
153808530|NCT00349128|Fenofibrate|fenofibrate|mesh-list
153808531|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808532|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808533|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153808534|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
153469179|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153808564|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808565|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808566|NCT00315887|Analgesics|analgesics|mesh-ancestor
153808567|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
153808568|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808569|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153808570|NCT00421395|Epratuzumab|epratuzumab|mesh-list
153808571|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153808572|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808573|NCT00315926|Melatonin|melatonin|mesh-list
153808574|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
153808575|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808576|NCT00315926|Protective Agents|protective agents|mesh-ancestor
153808577|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808607|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
153808608|NCT00349245|Remifentanil|remifentanil|mesh-list
153808609|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153808610|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808611|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808612|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153808613|NCT00349245|Analgesics|analgesics|mesh-ancestor
153808614|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
153808615|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808616|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153808617|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153808618|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153808619|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
153736355|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736356|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736357|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
153736358|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
153431803|NCT05818150|Methylprednisolone|methylprednisolone|mesh-list
153808620|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808621|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808622|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153808623|NCT00349245|Narcotics|narcotics|mesh-ancestor
153808624|NCT06165432|Benzocaine|benzocaine|mesh-list
153808625|NCT06165432|Anesthetics, Local|anesthetics, local|mesh-ancestor
153808626|NCT06165432|Anesthetics|anesthetics|mesh-ancestor
153808627|NCT06165432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808628|NCT06165432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808629|NCT06165432|Sensory System Agents|sensory system agents|mesh-ancestor
153808630|NCT06165432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808631|NCT06165276|Vaccines|vaccines|mesh-list
153808632|NCT06165276|Immunologic Factors|immunologic factors|mesh-ancestor
153808633|NCT06165276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808634|NCT06165146|Repaglinide|repaglinide|mesh-list
153808635|NCT06165146|Pirtobrutinib|pirtobrutinib|mesh-list
153808636|NCT06165146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808637|NCT06165146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808638|NCT06165146|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153808639|NCT06165146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153808669|NCT06164834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808670|NCT06164834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153808671|NCT06164834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153808672|NCT06164834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153808673|NCT06164834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808674|NCT06164665|Pioglitazone|pioglitazone|mesh-list
153808675|NCT06164665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808676|NCT06164665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835471|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153835472|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153835473|NCT00525447|Growth Substances|growth substances|mesh-ancestor
153835474|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
153835475|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153835476|NCT00525486|Nifedipine|nifedipine|mesh-list
153808677|NCT06164535|Metformin|metformin|mesh-list
153808719|NCT06164080|Respiratory System Agents|respiratory system agents|mesh-ancestor
153808720|NCT06164067|Misoprostol|misoprostol|mesh-list
153808721|NCT06164067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153808722|NCT06164067|Abortifacient Agents|abortifacient agents|mesh-ancestor
153808723|NCT06164067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153808724|NCT06164067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808725|NCT06164067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153808726|NCT06164067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153808727|NCT06164067|Oxytocics|oxytocics|mesh-ancestor
153808728|NCT06163989|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153808729|NCT06163989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153808730|NCT06163768|Insulin|insulin|mesh-list
153808731|NCT06163768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808732|NCT06163768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808733|NCT06163755|Methylprednisolone|methylprednisolone|mesh-list
153404405|NCT02112578|Meclizine|meclizine|mesh-list
153808843|NCT05809414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808844|NCT05809414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808845|NCT05809414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808846|NCT05809414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153808847|NCT05809414|Analgesics|analgesics|mesh-ancestor
153808848|NCT05809414|Sensory System Agents|sensory system agents|mesh-ancestor
153808938|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
153808939|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808940|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809097|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809099|NCT05211336|Lenalidomide|lenalidomide|mesh-list
153809100|NCT05211336|Venetoclax|venetoclax|mesh-list
153809101|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
153809130|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153809131|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
153809145|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809146|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153809147|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153809148|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
153809149|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809150|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809151|NCT05050942|Octreotide|octreotide|mesh-list
153809152|NCT05050942|Lanreotide|lanreotide|mesh-list
153809153|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153809154|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153809155|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809156|NCT04959331|Fosfomycin|fosfomycin|mesh-list
153809157|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
153809158|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
153809159|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153809160|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404504|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404505|NCT05718037|Vaccines|vaccines|mesh-list
153809317|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153809318|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153809491|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153809930|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153809931|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
153809963|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
153809964|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809965|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153809966|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809967|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
153809968|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809969|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153809994|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
153809995|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809996|NCT00344994|Protective Agents|protective agents|mesh-ancestor
153809997|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809998|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153809999|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153810000|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
153810001|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
153810002|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810003|NCT00349791|Testosterone|testosterone|mesh-list
153810004|NCT00349791|Androgens|androgens|mesh-ancestor
153810006|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153810007|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810008|NCT00317096|Rituximab|rituximab|mesh-list
153810009|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810010|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810011|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
153810012|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810013|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810014|NCT00317135|Vaccines|vaccines|mesh-list
153810015|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
153810016|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810017|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
153810018|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153810019|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810020|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153810021|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810022|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810023|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153810024|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
153810025|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810026|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810028|NCT00317330|Isoniazid|isoniazid|mesh-list
153810029|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
153810030|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153810031|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
153810032|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153810033|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810034|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
153810035|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153810036|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810037|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810038|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153810051|NCT00317408|Dexamethasone|dexamethasone|mesh-list
153810052|NCT00317408|Prednisolone|prednisolone|mesh-list
153810053|NCT00317408|Carboplatin|carboplatin|mesh-list
153810054|NCT00317408|Methotrexate|methotrexate|mesh-list
153810055|NCT00317408|Etoposide|etoposide|mesh-list
153810056|NCT00317408|Melphalan|melphalan|mesh-list
153810057|NCT00317408|Busulfan|busulfan|mesh-list
153810090|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841111|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153841112|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153841113|NCT04021862|Antibodies|antibodies|mesh-list
153841114|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153841115|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
153841116|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841117|NCT03998813|Ropivacaine|ropivacaine|mesh-list
153810091|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
153810092|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810093|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153810094|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153810095|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153810096|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153810097|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
153810098|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356666|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153810099|NCT00317408|Antidotes|antidotes|mesh-ancestor
153810100|NCT00317408|Protective Agents|protective agents|mesh-ancestor
153810101|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
153810102|NCT00317408|Vitamins|vitamins|mesh-ancestor
153810103|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
153810133|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
153810134|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153810135|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810136|NCT00345306|Progesterone|progesterone|mesh-list
153810137|NCT00345306|Progestins|progestins|mesh-ancestor
153810138|NCT00345306|Hormones|hormones|mesh-ancestor
153810139|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153810140|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835548|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
153835549|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835550|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835551|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835552|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153835553|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
153835554|NCT02945982|Protective Agents|protective agents|mesh-ancestor
153835555|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153810142|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810143|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
153810144|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810145|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153810146|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810147|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810148|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
153810149|NCT00350181|Sirolimus|sirolimus|mesh-list
153810150|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
153810151|NCT00350181|Busulfan|busulfan|mesh-list
153810152|NCT00350181|Carmustine|carmustine|mesh-list
153810153|NCT00350181|Etoposide|etoposide|mesh-list
153810154|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810155|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
153810156|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810157|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810158|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153810159|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
153810160|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810161|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810162|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153810177|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
153810178|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810179|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810180|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
153810181|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810183|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153810184|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153810185|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810186|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153810187|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810188|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
153810189|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810190|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
153810191|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810192|NCT00345501|Iloprost|iloprost|mesh-list
153810193|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153810194|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
153810195|NCT00345657|Niacin|niacin|mesh-list
153810196|NCT00345657|Lovastatin|lovastatin|mesh-list
153810197|NCT00345657|L 647318|l 647318|mesh-list
153810198|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
153810199|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153810200|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
153810292|NCT00350454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810293|NCT00350454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810295|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153810297|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153810298|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810299|NCT00345735|Analgesics|analgesics|mesh-ancestor
153810300|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
153810301|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810302|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153810303|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153810304|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
153810305|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
153810306|NCT02959749|Bevacizumab|bevacizumab|mesh-list
153810307|NCT02959749|Docetaxel|docetaxel|mesh-list
153810308|NCT02959749|Osimertinib|osimertinib|mesh-list
153810309|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153835579|NCT00526617|Veliparib|veliparib|mesh-list
153835580|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153835581|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
153835582|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835583|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375645|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375646|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153375647|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
153375648|NCT04334967|Protective Agents|protective agents|mesh-ancestor
153375649|NCT04335123|Losartan|losartan|mesh-list
153375650|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153810310|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810311|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810312|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153810313|NCT02959749|Growth Substances|growth substances|mesh-ancestor
153810314|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810315|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
153810316|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810317|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
153810318|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
153810319|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810320|NCT02959749|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153810321|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153810322|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810323|NCT00318383|Vaccines|vaccines|mesh-list
153810324|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
153810325|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356889|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810326|NCT00318422|Liraglutide|liraglutide|mesh-list
153810368|NCT00318890|Docetaxel|docetaxel|mesh-list
153810369|NCT00318890|Amifostine|amifostine|mesh-list
153810370|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810371|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810372|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153810388|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
153810389|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810390|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810391|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153810392|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810393|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810394|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153810395|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810396|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810397|NCT00350961|Gemcitabine|gemcitabine|mesh-list
153810398|NCT00350961|Capecitabine|capecitabine|mesh-list
153356964|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810399|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
153810400|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153810401|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
153357036|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153810402|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810403|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810404|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
153810405|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153810406|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810408|NCT00421473|Proguanil|proguanil|mesh-list
153810409|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153810410|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810411|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
153810412|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153810413|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153810414|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810415|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257434|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154004375|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
154257435|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154257436|NCT03294538|Estradiol|estradiol|mesh-list
154257437|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153388035|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
153835766|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153835767|NCT00508976|Lidocaine|lidocaine|mesh-list
153835768|NCT00508976|Bupivacaine|bupivacaine|mesh-list
153375829|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375830|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153375831|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153375832|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
153375833|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375834|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153375835|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153375836|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
153375837|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
153375838|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375839|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375840|NCT01515566|Fentanyl|fentanyl|mesh-list
153375842|NCT01515566|Narcotics|narcotics|mesh-ancestor
153375855|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375856|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375857|NCT01516268|Analgesics|analgesics|mesh-ancestor
153375858|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
153375859|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375860|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153375861|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153375862|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
153375863|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
153375864|NCT05440968|Chrysarobin|chrysarobin|mesh-list
153357246|NCT00741104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153357247|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
153357248|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375996|NCT06194968|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153375997|NCT06194968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153375998|NCT06194968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153375999|NCT06194968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376124|NCT06190600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153376125|NCT06190600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153376126|NCT06190600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153376128|NCT06190600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376129|NCT06190535|Ethamsylate|ethamsylate|mesh-list
153865002|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
153381356|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153865003|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865004|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257481|NCT03865550|Analgesics|analgesics|mesh-ancestor
154257482|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
154257483|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257484|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257485|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154257486|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154257487|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
154257488|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
154257489|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257490|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154257491|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154257492|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388735|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153376330|NCT06132685|Protease Inhibitors|protease inhibitors|mesh-ancestor
153376331|NCT06132685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376332|NCT06132685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376333|NCT06132685|Dermatologic Agents|dermatologic agents|mesh-ancestor
153376335|NCT06113913|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153376336|NCT06113913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153836249|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153836250|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153836251|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
153836252|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836253|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836254|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153836260|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
153810654|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153357274|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153866010|NCT04618952|Calcium|calcium|mesh-list
153406479|NCT04383262|Antiviral Agents|antiviral agents|mesh-ancestor
153836574|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153836575|NCT00531024|Growth Substances|growth substances|mesh-ancestor
153836576|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836577|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
153836578|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
153836579|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
153836580|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
153836581|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153836582|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836603|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153836604|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836606|NCT02943369|Cangrelor|cangrelor|mesh-list
153836607|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153841250|NCT03756961|Narcotics|narcotics|mesh-ancestor
153836608|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153836609|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153376695|NCT05689671|Paclitaxel|paclitaxel|mesh-list
154257549|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257550|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154257551|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257552|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154257553|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
154257554|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
154257555|NCT01170806|Orlistat|orlistat|mesh-list
154257556|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257557|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257558|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154257559|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154257560|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
154257561|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154257562|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
153389221|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153836643|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836644|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
153836645|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836646|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153836647|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153836648|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153836649|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153836650|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836651|NCT02951234|Aspirin|aspirin|mesh-list
153836652|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153836653|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
153836654|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153376739|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153376740|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376744|NCT05681299|Liraglutide|liraglutide|mesh-list
154257563|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
154257564|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153841270|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
153841271|NCT03723590|Protective Agents|protective agents|mesh-ancestor
154257565|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257566|NCT01280006|Celecoxib|celecoxib|mesh-list
154257567|NCT01280006|Indomethacin|indomethacin|mesh-list
154257568|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154257569|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154257570|NCT01280006|Analgesics|analgesics|mesh-ancestor
154257571|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
154257572|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257573|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257574|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257575|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154257576|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153732040|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836687|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153836688|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836690|NCT00514982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153836691|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153836692|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153836693|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
153836694|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836695|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
153376769|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153376770|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376771|NCT05639647|Aztreonam|aztreonam|mesh-list
153376772|NCT05639647|Avibactam|avibactam|mesh-list
153376773|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153376774|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376775|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153376776|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376777|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376778|NCT05613608|Cannabidiol|cannabidiol|mesh-list
153376794|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153866408|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866409|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153866410|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866411|NCT04613804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866412|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866413|NCT04613102|Cannabidiol|cannabidiol|mesh-list
153866414|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
153866415|NCT04613219|Tofacitinib|tofacitinib|mesh-list
153866416|NCT04613219|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153866417|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866418|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866419|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810689|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866534|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153866535|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866536|NCT00563927|Fluorouracil|fluorouracil|mesh-list
153406999|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
153407000|NCT03043664|Lanreotide|lanreotide|mesh-list
153407001|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407002|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407003|NCT03043664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153841318|NCT03586999|Nivolumab|nivolumab|mesh-list
153407004|NCT03043664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407005|NCT02992522|Lenalidomide|lenalidomide|mesh-list
153407006|NCT02992522|Venetoclax|venetoclax|mesh-list
153407007|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
153407008|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
153407009|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407010|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153407030|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153407031|NCT02949700|Metformin|metformin|mesh-list
153407032|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153407033|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407034|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153407035|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153407036|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153407037|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
153407038|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866605|NCT00575406|Rituximab|rituximab|mesh-list
153407080|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153407081|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153866621|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153866623|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866624|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
153866625|NCT00575406|Hormones|hormones|mesh-ancestor
153407151|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407152|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
153407153|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866732|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153407312|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
153407551|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
153407600|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407638|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
153407639|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407640|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153407641|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
153407642|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407643|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153407644|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153407645|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153407646|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
154257581|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
154257582|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153381483|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
154257583|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154257584|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154257585|NCT03865160|Atropine|atropine|mesh-list
154257586|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154257587|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154257588|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154257589|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153732042|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153732043|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153836889|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153836890|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153836891|NCT00515684|Growth Substances|growth substances|mesh-ancestor
153836892|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836893|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
153836894|NCT05317767|Vaccines|vaccines|mesh-list
153836895|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
153836896|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836897|NCT00515801|Glyburide|glyburide|mesh-list
153836898|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153836899|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836900|NCT05317611|Ondansetron|ondansetron|mesh-list
153836901|NCT05317611|Bupivacaine|bupivacaine|mesh-list
153836902|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
153836903|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
153376975|NCT05455697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153376977|NCT05444543|Xhance|xhance|mesh-list
153376978|NCT05444543|Budesonide|budesonide|mesh-list
153376979|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376980|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153376981|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
153376982|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376983|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841369|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153841370|NCT03390296|Avelumab|avelumab|mesh-list
153841371|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
153841372|NCT03390296|Azacitidine|azacitidine|mesh-list
153841373|NCT03390296|Venetoclax|venetoclax|mesh-list
153841374|NCT03390296|Calicheamicins|calicheamicins|mesh-list
153841375|NCT03390296|Antibodies|antibodies|mesh-list
153841376|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
153841377|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153841378|NCT03390296|Maleic acid|maleic acid|mesh-list
153841379|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
153841383|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
153381523|NCT01651442|Zolpidem|zolpidem|mesh-list
153376984|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153376985|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
153376986|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
153867555|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153867556|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153867557|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153867558|NCT00582582|Docetaxel|docetaxel|mesh-list
153867559|NCT00582582|Vitamins|vitamins|mesh-ancestor
153867560|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
153867561|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867562|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408059|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
153408060|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
153408061|NCT04904978|Protective Agents|protective agents|mesh-ancestor
153408062|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408063|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153408064|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408065|NCT03631433|Acetaminophen|acetaminophen|mesh-list
153408066|NCT03631433|Ibuprofen|ibuprofen|mesh-list
153836935|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
153408067|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153408068|NCT03631433|Analgesics|analgesics|mesh-ancestor
153867584|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867585|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867586|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153867587|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153867588|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153867589|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153867590|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867591|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
153867592|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153867593|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153408075|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153408076|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153408090|NCT04439396|Ketorolac|ketorolac|mesh-list
153867673|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867674|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867675|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153867676|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153867678|NCT04583111|Sulpiride|sulpiride|mesh-list
153867679|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
154257605|NCT01059461|Protective Agents|protective agents|mesh-ancestor
154257606|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257607|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
153389538|NCT00002499|Hormones|hormones|mesh-ancestor
153836945|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836946|NCT00516464|Ranibizumab|ranibizumab|mesh-list
153836947|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153836948|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153867680|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
153867681|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867682|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867683|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867684|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153867685|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
153867686|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867687|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867688|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153867689|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153867692|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153867693|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
153867694|NCT01146613|Varenicline|varenicline|mesh-list
153867695|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153867696|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153867697|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
153867698|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867699|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867700|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408322|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153408349|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408352|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153408353|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153408354|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
153408355|NCT03524339|Tamsulosin|tamsulosin|mesh-list
153408356|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153408357|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153408358|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153408359|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
153408360|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867871|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408361|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408362|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408363|NCT03524339|Urological Agents|urological agents|mesh-ancestor
153408364|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
153408365|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153867954|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
153867955|NCT00569816|Sevoflurane|sevoflurane|mesh-list
153867956|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153867957|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153867958|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
153867959|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
153867962|NCT00570050|Insulin|insulin|mesh-list
153408475|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
153868019|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868020|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153868021|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153868022|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153868023|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868024|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153408517|NCT00361790|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153408522|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
153408539|NCT00361868|Fenofibrate|fenofibrate|mesh-list
153408540|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408541|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408542|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153408543|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
153408544|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408545|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153868028|NCT00570830|Hormones|hormones|mesh-ancestor
153868036|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
153408560|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408561|NCT04075409|Padsevonil|padsevonil|mesh-list
153408562|NCT04075409|Anticonvulsants|anticonvulsants|mesh-ancestor
153408563|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
153408564|NCT03743246|Fludarabine|fludarabine|mesh-list
153868053|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868054|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153868055|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153868056|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153868057|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
153868058|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
153868059|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868060|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868061|NCT00584571|Dexetimide|dexetimide|mesh-list
153868062|NCT00584571|Citalopram|citalopram|mesh-list
153868073|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
153868074|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
153868075|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868076|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153868077|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154257612|NCT01286246|Progestins|progestins|mesh-ancestor
154257613|NCT01286246|Hormones|hormones|mesh-ancestor
154257614|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257615|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257616|NCT03981887|Nafithromycin|nafithromycin|mesh-list
154257617|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154257618|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732045|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153732046|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
153837035|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
153837036|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837037|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153837038|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
153837039|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153837040|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153837041|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837042|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153837043|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153837044|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
153837045|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153837046|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153837047|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153837048|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
153837049|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837050|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153868078|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
153868079|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153408620|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153408621|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153408622|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408623|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153408624|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408625|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408626|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153408627|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153408671|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153408672|NCT00361244|Growth Substances|growth substances|mesh-ancestor
153408673|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408674|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
153408675|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408676|NCT03381482|Anesthetics|anesthetics|mesh-list
153408677|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408678|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408679|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153408680|NCT03545165|Pluvicto|pluvicto|mesh-list
153408681|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153868296|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868297|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153868299|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
153868336|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
153868337|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868338|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153868339|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153868340|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153868341|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153868342|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868344|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
153868345|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868346|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153868347|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153868348|NCT00573404|Growth Substances|growth substances|mesh-ancestor
153868349|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868350|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
153868351|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408866|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153408868|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153408869|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408870|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153408871|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153408872|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
153408873|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408876|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
153868354|NCT00573404|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153868355|NCT01139125|Cysteamine|cysteamine|mesh-list
153868356|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153868374|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
153868435|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153868436|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868437|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868438|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153841495|NCT03210688|Prednisone|prednisone|mesh-list
153868439|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153868440|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153868441|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
153408965|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153868664|NCT03454919|Palbociclib|palbociclib|mesh-list
153868665|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868666|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868667|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868668|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868669|NCT00198822|Vitamin A|vitamin a|mesh-list
153837238|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153837240|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153868670|NCT00198822|Beta Carotene|beta carotene|mesh-list
153868671|NCT00198822|Carotenoids|carotenoids|mesh-list
153868672|NCT00198822|Vitamins|vitamins|mesh-ancestor
153868673|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
153868674|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868697|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868698|NCT01137292|Voriconazole|voriconazole|mesh-list
153868699|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
153868700|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868701|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153868702|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153409215|NCT04341818|Vitamin D|vitamin d|mesh-list
153409274|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153409276|NCT04341428|Lansoprazole|lansoprazole|mesh-list
153409277|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
153409278|NCT04341428|Fexuprazan|fexuprazan|mesh-list
153409279|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153409280|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409281|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153409282|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409283|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409284|NCT02453360|Bupivacaine|bupivacaine|mesh-list
153409285|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
153868782|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409327|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153409328|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153409329|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409330|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409331|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
153409332|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409333|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153409334|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154257673|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154257674|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257675|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
153837301|NCT02949206|Thrombin|thrombin|mesh-list
153409411|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409412|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153409413|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
153409414|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409415|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
153868916|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868917|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868918|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153868919|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868920|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868921|NCT00195273|Cyclosporine|cyclosporine|mesh-list
153409430|NCT02977741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153409431|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153409432|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153409476|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409477|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409478|NCT02465450|Hormones|hormones|mesh-ancestor
153409479|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409480|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409481|NCT00608972|Bevacizumab|bevacizumab|mesh-list
153409482|NCT00608972|Carboplatin|carboplatin|mesh-list
153409483|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868947|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
153868948|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868949|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868950|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868951|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
153868963|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
153868964|NCT00193479|Rituximab|rituximab|mesh-list
153868965|NCT00193479|Vincristine|vincristine|mesh-list
153868966|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
153868967|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868968|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
153868969|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868970|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868971|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153868972|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
153868973|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868974|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868975|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153868976|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868977|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868978|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
153868979|NCT00193479|Hormones|hormones|mesh-ancestor
153868980|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153868981|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153868982|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153868983|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
153868984|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
153868987|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
153868988|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868989|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153868990|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153868991|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868992|NCT00193206|Paclitaxel|paclitaxel|mesh-list
153868993|NCT00193206|Gemcitabine|gemcitabine|mesh-list
153868994|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153868995|NCT00193206|Epirubicin|epirubicin|mesh-list
153869011|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869013|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869014|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869015|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
153869016|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869017|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869018|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153869019|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153869020|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153869021|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869022|NCT04608734|Midazolam|midazolam|mesh-list
153869023|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153409577|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409578|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153409579|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409581|NCT00359905|Silodosin|silodosin|mesh-list
153409582|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153409583|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153409584|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153409585|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
153409601|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257699|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
154257700|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154257701|NCT05275270|Oxytocin|oxytocin|mesh-list
154257702|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
154257703|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154257704|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257705|NCT03868202|Estradiol|estradiol|mesh-list
153732062|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153837467|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
153837469|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153837470|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837471|NCT02939898|Letrozole|letrozole|mesh-list
153837472|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153553964|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553965|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153553966|NCT01595867|Naltrexone|naltrexone|mesh-list
153553967|NCT01595867|Morphine|morphine|mesh-list
153553968|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153553969|NCT01595867|Narcotics|narcotics|mesh-ancestor
153553970|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553971|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553972|NCT01595867|Analgesics|analgesics|mesh-ancestor
153553973|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
153553974|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553975|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153553976|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153553977|NCT01595880|Metformin|metformin|mesh-list
153553978|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153553979|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553995|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553996|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
153782609|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
153782610|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782611|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782612|NCT00234416|Gemcitabine|gemcitabine|mesh-list
153841597|NCT02789020|Rasagiline|rasagiline|mesh-list
153553997|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553998|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153553999|NCT01595984|Cyclosporine|cyclosporine|mesh-list
153554000|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
153554001|NCT01595984|Everolimus|everolimus|mesh-list
153554002|NCT01595984|Cyclosporins|cyclosporins|mesh-list
153554003|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554004|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554005|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153554006|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
153554007|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554008|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
153554009|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554010|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
153554011|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554012|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153554013|NCT01595984|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153554014|NCT01595984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153410636|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410637|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153410638|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153410639|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
153410640|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153410641|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410643|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410644|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153837497|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153837498|NCT00520949|Furazolidone|furazolidone|mesh-list
153837499|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153837500|NCT00520949|Esomeprazole|esomeprazole|mesh-list
153837501|NCT00520949|Bismuth|bismuth|mesh-list
153837502|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153837503|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837509|NCT00520949|Antacids|antacids|mesh-ancestor
153410645|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410646|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410647|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410648|NCT00003951|Exatecan|exatecan|mesh-list
153410649|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153870064|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870065|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153870066|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
153554482|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
153554483|NCT01597817|Coagulants|coagulants|mesh-ancestor
153554484|NCT01597895|Maraviroc|maraviroc|mesh-list
153554485|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153870149|NCT00586976|Ropivacaine|ropivacaine|mesh-list
153554983|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
153554984|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554985|NCT04563494|Dexamethasone|dexamethasone|mesh-list
153554986|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554987|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
153554988|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
153554989|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555018|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841631|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153841661|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153555020|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153555021|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555022|NCT04265755|Analgesics|analgesics|mesh-ancestor
153555023|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
153555024|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555025|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555183|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555184|NCT05701124|Growth Substances|growth substances|mesh-ancestor
153555185|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555254|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153555255|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555256|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
153555257|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153555258|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
153555259|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555260|NCT04077515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555261|NCT04077515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555262|NCT04077515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555263|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
153555265|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
153555266|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
153555267|NCT03841110|Nivolumab|nivolumab|mesh-list
153555268|NCT03841110|Fludarabine|fludarabine|mesh-list
153555269|NCT03841110|Atezolizumab|atezolizumab|mesh-list
153555270|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153555271|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
153555295|NCT03802630|Growth Substances|growth substances|mesh-ancestor
153555314|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153555315|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153555316|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
153555317|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
153555318|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153555319|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153555320|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555321|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153555322|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153555323|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154257707|NCT03868202|Estrogens|estrogens|mesh-ancestor
154257708|NCT03868202|Hormones|hormones|mesh-ancestor
154257709|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257710|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257711|NCT03868202|Progestins|progestins|mesh-ancestor
154257712|NCT00311363|Gabapentin|gabapentin|mesh-list
154257713|NCT00311363|Analgesics|analgesics|mesh-ancestor
154257714|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
154257715|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257716|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257717|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
154257718|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154257719|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153732063|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
153837527|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153837528|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
153837534|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
153555324|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
153555325|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153555327|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153555328|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555329|NCT03710564|Growth Substances|growth substances|mesh-ancestor
153555330|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555331|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
153555332|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555334|NCT03624127|Deucravacitinib|deucravacitinib|mesh-list
153555429|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153555431|NCT01970410|Analgesics|analgesics|mesh-ancestor
153555432|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
153555433|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555434|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555465|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
153555483|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555485|NCT01545843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153555486|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153555487|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153555488|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555489|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555491|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555492|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153555493|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
153555494|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153555495|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153555496|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153555497|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555498|NCT00843791|Pioglitazone|pioglitazone|mesh-list
153555499|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153555500|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153410884|NCT00004005|Vitamins|vitamins|mesh-ancestor
153555555|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
153555556|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555557|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153555558|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153555559|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555627|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837563|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837564|NCT00521300|Octreotide|octreotide|mesh-list
153837565|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837566|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153837567|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837568|NCT00523133|Naltrexone|naltrexone|mesh-list
153837569|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153837570|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153837571|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837572|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
153837573|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837574|NCT02937792|Bupivacaine|bupivacaine|mesh-list
153837575|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
153837576|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
153837577|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837578|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837579|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
153837581|NCT02931474|Tesamorelin|tesamorelin|mesh-list
153555628|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555629|NCT02466243|Lenabasum|lenabasum|mesh-list
153555630|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153555631|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153555632|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555633|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555634|NCT02466243|Hormones|hormones|mesh-ancestor
153555635|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153555657|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381859|NCT01668836|Resveratrol|resveratrol|mesh-list
153555658|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555659|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555660|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
153555661|NCT01657591|Vemurafenib|vemurafenib|mesh-list
153555662|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555663|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555980|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555981|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153556033|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
153556034|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556130|NCT01611896|Protective Agents|protective agents|mesh-ancestor
153556131|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556132|NCT01611896|Trace Elements|trace elements|mesh-ancestor
153556133|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
153556409|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153556410|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153556411|NCT01613547|Amoxicillin|amoxicillin|mesh-list
153556412|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153556413|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556414|NCT01613573|Hormones|hormones|mesh-list
153556415|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556416|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556417|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153556418|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
153556419|NCT01613664|Coagulants|coagulants|mesh-ancestor
153556420|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
153556421|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153556422|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153556423|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154257720|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257721|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154257722|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154257723|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154257724|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841745|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841746|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841747|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841748|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841749|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381888|NCT00375375|Lactulose|lactulose|mesh-list
154257725|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257726|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
154257727|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154257728|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153390078|NCT05806723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837591|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
153837592|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837593|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153837594|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153837595|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153837596|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153837597|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837598|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153837599|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
153837600|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
153837601|NCT02931357|Protective Agents|protective agents|mesh-ancestor
153837602|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153837603|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837605|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837606|NCT00521963|Infliximab|infliximab|mesh-list
153837607|NCT00521963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153837608|NCT00521963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837609|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
153837610|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837611|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837612|NCT02937402|Dimercaprol|dimercaprol|mesh-list
153837613|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
153377692|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153377693|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837615|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837616|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
153837617|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
153837618|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837619|NCT02937363|Protective Agents|protective agents|mesh-ancestor
153837620|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837621|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
153837622|NCT02937363|Vitamins|vitamins|mesh-ancestor
153837623|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
153837624|NCT02948348|Capecitabine|capecitabine|mesh-list
153837625|NCT02948348|Nivolumab|nivolumab|mesh-list
153837626|NCT02948348|Ipilimumab|ipilimumab|mesh-list
153837627|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153377705|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153556424|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
153556425|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556426|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556436|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
153556437|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153556438|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153556439|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153556441|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381897|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153556442|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153556443|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153556444|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556445|NCT01613807|Insulin|insulin|mesh-list
153556446|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153556447|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
153556448|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
153556449|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
153556450|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153731946|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
153556451|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556452|NCT01613820|Scopolamine|scopolamine|mesh-list
153556453|NCT01613820|Ketamine|ketamine|mesh-list
153556455|NCT01613820|Analgesics|analgesics|mesh-ancestor
153556456|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
153556457|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556458|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556459|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153556460|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153556705|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556753|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153556754|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153556759|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556760|NCT01615445|Resveratrol|resveratrol|mesh-list
153556761|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
153556762|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556763|NCT01615445|Protective Agents|protective agents|mesh-ancestor
153556764|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556765|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556766|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153556767|NCT01615601|Ritonavir|ritonavir|mesh-list
153556768|NCT01615601|Darunavir|darunavir|mesh-list
153557001|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
153557002|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870574|NCT01080222|Ribavirin|ribavirin|mesh-list
153557209|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
153557211|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257729|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153837640|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
153557212|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153557213|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557214|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557215|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153557216|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557217|NCT01618396|Midazolam|midazolam|mesh-list
153557366|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
153557367|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153557368|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
153557369|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557370|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557371|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
153557372|NCT01619046|Factor VIII|factor viii|mesh-list
153557373|NCT01619046|Coagulants|coagulants|mesh-ancestor
153557374|NCT01619072|Misoprostol|misoprostol|mesh-list
153557375|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153557376|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
153557377|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153557378|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557379|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153557380|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153557381|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
153557382|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
153557383|NCT01619137|Povidone|povidone|mesh-list
153557384|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
153557417|NCT01619345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557420|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
153374045|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557421|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557422|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557423|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153557447|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153557449|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153557450|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153557451|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153870671|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153557669|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
153557670|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153557671|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153557672|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557673|NCT01621100|Hydromorphone|hydromorphone|mesh-list
153557674|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153557675|NCT01621100|Narcotics|narcotics|mesh-ancestor
153557676|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557677|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870702|NCT03450161|Analgesics|analgesics|mesh-ancestor
153557888|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153557889|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557890|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
153557891|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557892|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153557927|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153557928|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153557964|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153557965|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153557966|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153557967|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
153557988|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153557989|NCT01622881|Analgesics|analgesics|mesh-ancestor
153557990|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
153557991|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557992|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557993|NCT01622933|Interferons|interferons|mesh-list
153557994|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
153557995|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381952|NCT02594111|Colchicine|colchicine|mesh-list
153557996|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
153557997|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557998|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
153557999|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782648|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153837690|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153837691|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
153837692|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837693|NCT00522743|Hormones|hormones|mesh-list
153837694|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837695|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837696|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153837697|NCT02937012|Bezafibrate|bezafibrate|mesh-list
153558000|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
153558001|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153558053|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153558054|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
153558055|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153558056|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558057|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
153558058|NCT01623401|Tedizolid|tedizolid|mesh-list
153558059|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153558060|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558061|NCT01623440|Naltrexone|naltrexone|mesh-list
153558062|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153558063|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153558064|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558065|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
153558066|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558067|NCT01623505|Varenicline|varenicline|mesh-list
153558068|NCT01623505|Nicotine|nicotine|mesh-list
153558069|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153558156|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870768|NCT04564638|Cyclosporine|cyclosporine|mesh-list
153558200|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
153558201|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558202|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558203|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153558204|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
153558205|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
153558206|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153558208|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153558209|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153558210|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
153558211|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558212|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153558213|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153558214|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558215|NCT01624246|Ceftaroline|ceftaroline|mesh-list
153558216|NCT01624246|Avibactam|avibactam|mesh-list
153558217|NCT01624246|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153558218|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153558219|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558220|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153558221|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558222|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558223|NCT01624337|Piperaquine|piperaquine|mesh-list
153558270|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153558271|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
153558272|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
153558273|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153558274|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558276|NCT01624766|Everolimus|everolimus|mesh-list
153558277|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153558278|NCT01624766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153558279|NCT01624766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153558302|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558303|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558305|NCT01625351|Fludarabine|fludarabine|mesh-list
153558307|NCT01625351|Busulfan|busulfan|mesh-list
153558308|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
153558309|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
153558310|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837720|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153837721|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
153837722|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
153837723|NCT00522782|Protective Agents|protective agents|mesh-ancestor
153837724|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153837725|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
153837727|NCT00522821|Antibodies|antibodies|mesh-list
153558311|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558312|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558313|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
153558314|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558315|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153558316|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558317|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153558318|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
153558319|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153558320|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
153870799|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
153558428|NCT01626222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153558429|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558430|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558431|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558432|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
153558433|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558434|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382039|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
153558435|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153558436|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153558437|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153558438|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
153558461|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153558462|NCT01626534|Clopidogrel|clopidogrel|mesh-list
153558463|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153411439|NCT00004233|Leucovorin|leucovorin|mesh-list
153558565|NCT01627171|Bisacodyl|bisacodyl|mesh-list
153558566|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
153558567|NCT01627171|Cathartics|cathartics|mesh-ancestor
153558568|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153558569|NCT01627171|Laxatives|laxatives|mesh-ancestor
153558570|NCT01627223|Lamivudine|lamivudine|mesh-list
153558571|NCT01627223|Entecavir|entecavir|mesh-list
153558572|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153411455|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
153558648|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558649|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558650|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153558651|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153558652|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153558653|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558654|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153558655|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153558656|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558657|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
153558658|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153558659|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153558674|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153558675|NCT01627626|Pilocarpine|pilocarpine|mesh-list
153558677|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
153558678|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558679|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558680|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153558681|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153558682|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
153558683|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558684|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558685|NCT01627639|Acetazolamide|acetazolamide|mesh-list
153558686|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
153837745|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837746|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837748|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
153837749|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837750|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
153837751|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
153837752|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377830|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558687|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153558688|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558689|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558690|NCT01627639|Diuretics|diuretics|mesh-ancestor
153558691|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
153558692|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558693|NCT01627678|Molgramostim|molgramostim|mesh-list
153558748|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
153558749|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558764|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153558765|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
153558766|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
153558767|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558768|NCT01628341|Insulin|insulin|mesh-list
153558769|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153558770|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558771|NCT01628354|Ranibizumab|ranibizumab|mesh-list
153558772|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153558773|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153558774|NCT01628354|Growth Substances|growth substances|mesh-ancestor
153558775|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558776|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
153558777|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558778|NCT01628445|Liraglutide|liraglutide|mesh-list
153558779|NCT01628445|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153558780|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153558781|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558782|NCT01628445|Incretins|incretins|mesh-ancestor
153558783|NCT01628445|Hormones|hormones|mesh-ancestor
153558812|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153374397|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558828|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153558829|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558830|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558831|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558832|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153558834|NCT01628783|Escitalopram|escitalopram|mesh-list
153558835|NCT01628783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153558836|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153558837|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558838|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558839|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558840|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
153558910|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
153558926|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558927|NCT01629446|Lofexidine|lofexidine|mesh-list
153558928|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153558929|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153559102|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154257730|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154257731|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154257732|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154257733|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
154257734|NCT01286090|Cisapride|cisapride|mesh-list
154257735|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154257736|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257737|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154257738|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
154257739|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257740|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257741|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257742|NCT00310817|Vaccines|vaccines|mesh-list
153732065|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837765|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153837766|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153837767|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153837768|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
153837769|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837770|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837771|NCT02930733|Bupivacaine|bupivacaine|mesh-list
153837772|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
153377851|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377852|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153837778|NCT00523055|Lidocaine|lidocaine|mesh-list
153559104|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
153559105|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559106|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559107|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559109|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153559110|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559111|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153559112|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559113|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559114|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559115|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559116|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
153559117|NCT01630720|Vitamin D|vitamin d|mesh-list
153559153|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
153559154|NCT01631058|Hormones|hormones|mesh-ancestor
153841957|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153559155|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153559156|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559157|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153559158|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559159|NCT01631058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154257743|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
154257744|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257745|NCT03783286|Ivacaftor|ivacaftor|mesh-list
154257746|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154257747|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154257748|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257749|NCT03863366|Prucalopride|prucalopride|mesh-list
154257750|NCT03863366|Laxatives|laxatives|mesh-ancestor
154257751|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257752|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154257753|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154257754|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
153837788|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153837789|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837790|NCT00523289|Bupivacaine|bupivacaine|mesh-list
153837791|NCT00523289|Ropivacaine|ropivacaine|mesh-list
153837792|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
153837793|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
153837794|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837795|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377874|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377875|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
153377876|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153377877|NCT03652961|Abatacept|abatacept|mesh-list
153377878|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153559160|NCT01631058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153559161|NCT01631058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559162|NCT01631058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559163|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153559164|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
153559165|NCT01631058|Cathartics|cathartics|mesh-ancestor
153559166|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153559167|NCT01631097|Tivozanib|tivozanib|mesh-list
153559168|NCT01631097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153559169|NCT01631097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559170|NCT01631097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559171|NCT01631136|Cisplatin|cisplatin|mesh-list
153559172|NCT01631136|Gemcitabine|gemcitabine|mesh-list
153559173|NCT01631136|Pemetrexed|pemetrexed|mesh-list
153559174|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559175|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153870948|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559224|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559225|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
153559226|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559227|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559228|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153559229|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
153837815|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153837816|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153837817|NCT00524498|Cisplatin|cisplatin|mesh-list
153837818|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837819|NCT00523406|Triamcinolone|triamcinolone|mesh-list
153377897|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153377898|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377899|NCT03592576|Venetoclax|venetoclax|mesh-list
153377900|NCT03592576|Navitoclax|navitoclax|mesh-list
153377901|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377902|NCT03590821|Aspirin|aspirin|mesh-list
153377903|NCT03590821|Celecoxib|celecoxib|mesh-list
153377906|NCT03590821|Analgesics|analgesics|mesh-ancestor
153559230|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559231|NCT01631409|Aspirin|aspirin|mesh-list
153559232|NCT01631409|Atenolol|atenolol|mesh-list
153559233|NCT01631409|Enalapril|enalapril|mesh-list
153559234|NCT01631409|Enalaprilat|enalaprilat|mesh-list
153559235|NCT01631409|Amlodipine|amlodipine|mesh-list
153559236|NCT01631409|Isosorbide|isosorbide|mesh-list
153559237|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153559238|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153559256|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
153782661|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153559257|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559258|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153559291|NCT01631526|Vitamin D|vitamin d|mesh-list
153559292|NCT01631526|Vitamins|vitamins|mesh-ancestor
153559293|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
153559311|NCT01631669|Celecoxib|celecoxib|mesh-list
153559312|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153559313|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559314|NCT01631669|Analgesics|analgesics|mesh-ancestor
153559315|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
153559316|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559317|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559318|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559319|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870960|NCT00194012|Aripiprazole|aripiprazole|mesh-list
153382152|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
153559373|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559374|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559375|NCT01632514|Vitamins|vitamins|mesh-ancestor
153559376|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
153559377|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153559378|NCT01632540|Beclomethasone|beclomethasone|mesh-list
153559379|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559380|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
153559381|NCT01632540|Hormones|hormones|mesh-ancestor
153559382|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153559383|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559384|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153559385|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
153559440|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559442|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559443|NCT01633203|Capecitabine|capecitabine|mesh-list
153559444|NCT01633203|Epirubicin|epirubicin|mesh-list
153559445|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559446|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559447|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
153559482|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
153559483|NCT01633645|Gemcitabine|gemcitabine|mesh-list
153559484|NCT01633645|Bortezomib|bortezomib|mesh-list
153559485|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559486|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559487|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
153559488|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559489|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
154257755|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257756|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257757|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257759|NCT01175486|Acarbose|acarbose|mesh-list
154257760|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154257761|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390438|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
153837833|NCT00523445|Varenicline|varenicline|mesh-list
153837834|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153837835|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153377912|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153377913|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153377914|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377915|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153377916|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153377917|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377918|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
153377919|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153377920|NCT03535727|Paclitaxel|paclitaxel|mesh-list
153377921|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153377922|NCT03535727|Cisplatin|cisplatin|mesh-list
153377923|NCT03535727|Gemcitabine|gemcitabine|mesh-list
153377924|NCT03535727|Capecitabine|capecitabine|mesh-list
153377925|NCT03535727|Irinotecan|irinotecan|mesh-list
153837836|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
153837837|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837838|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837839|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837840|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
153837841|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153837842|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153837843|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837844|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
153837845|NCT02936661|Coagulants|coagulants|mesh-ancestor
153837846|NCT02948075|Paclitaxel|paclitaxel|mesh-list
153559490|NCT01633658|Vitamin D|vitamin d|mesh-list
153559491|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559492|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559493|NCT01633658|Vitamins|vitamins|mesh-ancestor
153559494|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
154257762|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153559495|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153559497|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
153559498|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559499|NCT01633762|Vancomycin|vancomycin|mesh-list
153559501|NCT01633762|Meropenem|meropenem|mesh-list
153559502|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153559503|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559504|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153559505|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559506|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559507|NCT01633957|Warfarin|warfarin|mesh-list
153559521|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
153559522|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559523|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153559524|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153559525|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153559526|NCT01633970|Growth Substances|growth substances|mesh-ancestor
153559527|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559528|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
153559529|NCT01633970|Antidotes|antidotes|mesh-ancestor
153559530|NCT01633970|Protective Agents|protective agents|mesh-ancestor
153559531|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
153559532|NCT01633970|Vitamins|vitamins|mesh-ancestor
153559533|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
153559534|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559535|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153559536|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153559537|NCT01633970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153559538|NCT01633983|Methotrexate|methotrexate|mesh-list
153382200|NCT04501523|Capecitabine|capecitabine|mesh-list
153559539|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153559540|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
153559541|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153411625|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
153559601|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
153559602|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153559603|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153559604|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153559605|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559606|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559607|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153559608|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
153559609|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153559610|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153559611|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153559652|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153559653|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153559654|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
153559655|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559656|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559657|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153559658|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153559659|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
153559660|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
153559661|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153559662|NCT01634594|Narcotics|narcotics|mesh-ancestor
153559663|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559664|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153871041|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153559675|NCT01634698|Vitamin A|vitamin a|mesh-list
153559676|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
153559677|NCT01634698|Vitamins|vitamins|mesh-ancestor
153559678|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
153559679|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559680|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
153559681|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559682|NCT01634698|Protective Agents|protective agents|mesh-ancestor
153559683|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153559684|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559707|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153559708|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559709|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559710|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
153559711|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153837892|NCT02936427|BB 1101|bb 1101|mesh-list
153837893|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377973|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377974|NCT03471663|Palbociclib|palbociclib|mesh-list
153377975|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377976|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153377977|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377978|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842137|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377979|NCT03399513|Ibrutinib|ibrutinib|mesh-list
153377980|NCT03399513|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153377981|NCT03399513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153377982|NCT03399513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377983|NCT03399513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377985|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153377986|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
153377987|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837900|NCT02936427|Hormones|hormones|mesh-ancestor
153559712|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153559713|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559714|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153559715|NCT01634906|Atorvastatin|atorvastatin|mesh-list
153559716|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153559717|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153559718|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153559719|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
153559720|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559721|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153559722|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153559723|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559724|NCT01634932|Iron|iron|mesh-list
153559725|NCT01634932|Trace Elements|trace elements|mesh-ancestor
153559726|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
153559727|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559728|NCT01634945|Amodiaquine|amodiaquine|mesh-list
153559729|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
153559730|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153559731|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153559732|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559733|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153559734|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153559735|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
153559736|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559752|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559753|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559754|NCT01635296|Cytarabine|cytarabine|mesh-list
153559755|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559757|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559758|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559759|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
153559760|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559761|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153559762|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
153559763|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559764|NCT01635387|Aliskiren|aliskiren|mesh-list
153559765|NCT01635387|Renin Inhibitors|renin inhibitors|mesh-ancestor
153837911|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
153377990|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
153377991|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153377992|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377993|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377994|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153377995|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
153377996|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
153377997|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377998|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378003|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559766|NCT01635387|Protease Inhibitors|protease inhibitors|mesh-ancestor
153559781|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153559782|NCT01635530|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153559783|NCT01635530|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153559784|NCT01635608|Acetaminophen|acetaminophen|mesh-list
153559785|NCT01635608|Amoxicillin|amoxicillin|mesh-list
153559787|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559788|NCT01635608|Analgesics|analgesics|mesh-ancestor
153559789|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
153559790|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559791|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559792|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
153559793|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153559794|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559795|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153559796|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153559797|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
153559798|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559812|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153559813|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
153559814|NCT01635751|Pregabalin|pregabalin|mesh-list
153559815|NCT01635751|Analgesics|analgesics|mesh-ancestor
153559816|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
153559817|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559818|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559819|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
153559820|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153559821|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559822|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559823|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559824|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153559825|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153559826|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559827|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153559828|NCT01635777|Miltefosine|miltefosine|mesh-list
153559829|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
153559830|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559831|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559832|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153559833|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153559834|NCT01635790|Bevacizumab|bevacizumab|mesh-list
153559835|NCT01635790|Ranibizumab|ranibizumab|mesh-list
153559836|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153559837|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559838|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153559839|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153559840|NCT01635790|Growth Substances|growth substances|mesh-ancestor
153559841|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411713|NCT00003783|Etoposide|etoposide|mesh-list
153559861|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559862|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153559871|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153378015|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153378016|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153378017|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153378018|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153378019|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153378020|NCT03298945|Laxatives|laxatives|mesh-ancestor
153378021|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153559872|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153559873|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153559875|NCT01635946|Atorvastatin|atorvastatin|mesh-list
153559876|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153559877|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153559878|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
153559879|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559880|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153559881|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153559882|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559883|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
153559884|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559885|NCT01635972|Isavuconazole|isavuconazole|mesh-list
153559886|NCT01635972|Bupropion|bupropion|mesh-list
153559887|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153559888|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
153559889|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153559890|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153559891|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153559892|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559893|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559894|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
153559895|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559896|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559897|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153559898|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153559899|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559900|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
153559901|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559902|NCT01636037|Levodopa|levodopa|mesh-list
153559903|NCT01636037|Carbidopa|carbidopa|mesh-list
153559904|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153559905|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153559906|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153559907|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
153559908|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559909|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559910|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411730|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
153559924|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559936|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559937|NCT01636180|Clopidogrel|clopidogrel|mesh-list
153842185|NCT01294579|Ofatumumab|ofatumumab|mesh-list
153559938|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153559939|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153559940|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153559941|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153559943|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559944|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559945|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559946|NCT01636245|Vaccines|vaccines|mesh-list
153559947|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
153559948|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559950|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153559951|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559952|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559953|NCT01636310|Nicotine|nicotine|mesh-list
153378051|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153378052|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153378053|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153378054|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378056|NCT03167905|Meperidine|meperidine|mesh-list
153378057|NCT03167905|Remifentanil|remifentanil|mesh-list
153378058|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
153378059|NCT03167905|Ropivacaine|ropivacaine|mesh-list
153559954|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153559955|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
153559956|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559957|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559958|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153559959|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153559960|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
153559961|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559962|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559963|NCT01636323|Nicotine|nicotine|mesh-list
153559964|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153559965|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
153559966|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559967|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559968|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153559969|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153559970|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
153559971|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559972|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559973|NCT01636336|Nicotine|nicotine|mesh-list
153559974|NCT01636336|Progesterone|progesterone|mesh-list
153559975|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153559976|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
153559977|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559978|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559979|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153559980|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153559981|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
153559982|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559983|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560019|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
153560065|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153560066|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560069|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
153560070|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560071|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153560072|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560073|NCT01636700|Tramadol|tramadol|mesh-list
153560074|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153560075|NCT01636700|Narcotics|narcotics|mesh-ancestor
153560076|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560077|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560078|NCT01636700|Analgesics|analgesics|mesh-ancestor
153560079|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
153560080|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560082|NCT01635426|Clopidogrel|clopidogrel|mesh-list
153560099|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153560100|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153560101|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
153560102|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560103|NCT01636869|Bupivacaine|bupivacaine|mesh-list
153560104|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
153560105|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
153560106|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560107|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560108|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
154257763|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257764|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257765|NCT01177904|Progesterone|progesterone|mesh-list
154257766|NCT01177904|Progestins|progestins|mesh-ancestor
154257767|NCT01177904|Hormones|hormones|mesh-ancestor
154257768|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257769|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257770|NCT02940886|Iron|iron|mesh-list
153390630|NCT02624518|Hormones|hormones|mesh-ancestor
153378076|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
153378077|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
153378078|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378079|NCT03161028|Protective Agents|protective agents|mesh-ancestor
153378080|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378081|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
153378082|NCT03161028|Vitamins|vitamins|mesh-ancestor
153378083|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
153378084|NCT03132129|Manganese|manganese|mesh-list
153378085|NCT03132129|Calcium|calcium|mesh-list
153378086|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153837986|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837988|NCT02935764|Leucovorin|leucovorin|mesh-list
153560109|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560110|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
153560111|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153560112|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
153560134|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560135|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560136|NCT01636908|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153560137|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153560138|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153560139|NCT01636908|Growth Substances|growth substances|mesh-ancestor
153560151|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
153560152|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
153560153|NCT01637025|Coagulants|coagulants|mesh-ancestor
153560155|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
153560156|NCT01637155|Vitamins|vitamins|mesh-ancestor
153382392|NCT01963091|Oxytocin|oxytocin|mesh-list
153782668|NCT04562311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153560157|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
153560158|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560159|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153560160|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153560161|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153560162|NCT01637194|Cetuximab|cetuximab|mesh-list
153560163|NCT01637194|Everolimus|everolimus|mesh-list
153560164|NCT01637194|Antibodies|antibodies|mesh-list
153560165|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
153560166|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153560167|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
153560168|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560170|NCT01637194|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153560171|NCT01637194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153560172|NCT01637194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560173|NCT01637194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560174|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560175|NCT01637233|Ritonavir|ritonavir|mesh-list
153378110|NCT03110107|Ipilimumab|ipilimumab|mesh-list
153378111|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378112|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378113|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153378114|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378115|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
153560176|NCT01637233|Lopinavir|lopinavir|mesh-list
153560177|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153560178|NCT01637233|Darunavir|darunavir|mesh-list
153560179|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
153560180|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153560181|NCT01637233|Tenofovir|tenofovir|mesh-list
153560182|NCT01637233|Lamivudine|lamivudine|mesh-list
153782669|NCT04562311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560236|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
153560237|NCT01637454|Terlipressin|terlipressin|mesh-list
153560238|NCT01637454|Norepinephrine|norepinephrine|mesh-list
153560239|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153560240|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153560241|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153560242|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153560243|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
153560244|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560245|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560246|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560247|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
153560248|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
153560249|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560250|NCT01637532|Interferons|interferons|mesh-list
153560251|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
153560252|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
153560253|NCT01637532|Carboplatin|carboplatin|mesh-list
153560254|NCT01637532|Doxorubicin|doxorubicin|mesh-list
153560255|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560256|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153560278|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153560279|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153560280|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
153411828|NCT00004467|Expectorants|expectorants|mesh-ancestor
153560293|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
153560294|NCT01637571|Lansoprazole|lansoprazole|mesh-list
153560295|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153560296|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153560297|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153560298|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560299|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560300|NCT01637636|Rifampin|rifampin|mesh-list
153560301|NCT01637636|Ketoconazole|ketoconazole|mesh-list
153560302|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153560303|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
153560304|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153560305|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560306|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
153560307|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560308|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560309|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560326|NCT01637675|Citric Acid|citric acid|mesh-list
153560327|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
153560328|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
153560329|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153560330|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
153560331|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
153560332|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560333|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
153560334|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153560335|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153560336|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560337|NCT01637675|Urological Agents|urological agents|mesh-ancestor
153560338|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560339|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153838049|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
153838050|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153838051|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153838052|NCT00524186|Growth Substances|growth substances|mesh-ancestor
153838053|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
153838054|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153838055|NCT00525005|Docetaxel|docetaxel|mesh-list
153838056|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
153838057|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838058|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153838059|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153842327|NCT02937662|Cytarabine|cytarabine|mesh-list
153838060|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153838061|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382491|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838062|NCT00525200|Docetaxel|docetaxel|mesh-list
153838063|NCT00525200|Cisplatin|cisplatin|mesh-list
153838064|NCT00525200|Fluorouracil|fluorouracil|mesh-list
153838065|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560340|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153560341|NCT01637675|Analgesics|analgesics|mesh-ancestor
153560342|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
153560343|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560344|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560345|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153560346|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560347|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153560348|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560349|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560350|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
153560351|NCT01637753|Carmustine|carmustine|mesh-list
153560352|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153560353|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
153560354|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560355|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560356|NCT01637766|Melphalan|melphalan|mesh-list
153560357|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153560358|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
153560386|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153560387|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
153560388|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153560389|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
153560390|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153560391|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560392|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153560393|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153560394|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560395|NCT01638078|Thalidomide|thalidomide|mesh-list
153374729|NCT01493180|Rebamipide|rebamipide|mesh-list
153560396|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560397|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
153560398|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560399|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
153560400|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153560401|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560402|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153560403|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153560404|NCT01638078|Growth Substances|growth substances|mesh-ancestor
153560405|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
153560406|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560407|NCT01638182|Vitamins|vitamins|mesh-list
153560409|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
153838074|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560410|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
153560411|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
153560412|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560413|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153560414|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153560415|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560416|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
153560417|NCT01638182|Coagulants|coagulants|mesh-ancestor
153560418|NCT01638234|Melatonin|melatonin|mesh-list
153560419|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
153560420|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560421|NCT01638234|Protective Agents|protective agents|mesh-ancestor
153560422|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560423|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560441|NCT01638247|Hormones|hormones|mesh-ancestor
153560442|NCT01638260|Liraglutide|liraglutide|mesh-list
153560443|NCT01638260|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153560444|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560445|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560446|NCT01638260|Incretins|incretins|mesh-ancestor
153560447|NCT01638260|Hormones|hormones|mesh-ancestor
153560448|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153560449|NCT01638273|Pregabalin|pregabalin|mesh-list
153560450|NCT01638273|Analgesics|analgesics|mesh-ancestor
153560451|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
153560461|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560462|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153560464|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560465|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560466|NCT01638325|Insulin|insulin|mesh-list
153560467|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153560468|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
153560469|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560470|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560471|NCT01638364|Ethanol|ethanol|mesh-list
153560472|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153560473|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560474|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560475|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560476|NCT01638377|Naltrexone|naltrexone|mesh-list
153560477|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153560478|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153560479|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560490|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153842388|NCT02937779|Tenofovir|tenofovir|mesh-list
153560491|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560492|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560493|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153560494|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
153560495|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
153560496|NCT01638650|Ritonavir|ritonavir|mesh-list
153560497|NCT01638650|Saquinavir|saquinavir|mesh-list
153560499|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153560500|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153560501|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
153560502|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560503|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560504|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153560505|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153560506|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
153560507|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560508|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153560509|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153560510|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560511|NCT01638663|Tolvaptan|tolvaptan|mesh-list
153560512|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153560513|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560514|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
153560515|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560516|NCT01638676|Metformin|metformin|mesh-list
153560517|NCT01638676|Vemurafenib|vemurafenib|mesh-list
153560518|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560519|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560520|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378231|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378232|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153378233|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378234|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153838117|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153838118|NCT02947334|Bococizumab|bococizumab|mesh-list
153838119|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153838124|NCT00525278|Levocetirizine|levocetirizine|mesh-list
153560521|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153560522|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560523|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560524|NCT01638689|Escitalopram|escitalopram|mesh-list
153560525|NCT01638689|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153560526|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153560541|NCT01638715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842429|NCT02909751|Vitamin E|vitamin e|mesh-list
153560569|NCT01638936|Immunoconjugates|immunoconjugates|mesh-ancestor
153560570|NCT01638936|Immunologic Factors|immunologic factors|mesh-ancestor
153560571|NCT01638936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560572|NCT01638962|Acetaminophen|acetaminophen|mesh-list
153560574|NCT01638962|Ibuprofen|ibuprofen|mesh-list
153560575|NCT01638962|Celecoxib|celecoxib|mesh-list
153560576|NCT01638962|Diclofenac|diclofenac|mesh-list
153560577|NCT01638962|Naproxen|naproxen|mesh-list
153560578|NCT01638962|Indomethacin|indomethacin|mesh-list
153560579|NCT01638962|Etoricoxib|etoricoxib|mesh-list
153560580|NCT01638962|Meloxicam|meloxicam|mesh-list
153560581|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153560582|NCT01638962|Etodolac|etodolac|mesh-list
153560583|NCT01638962|Lornoxicam|lornoxicam|mesh-list
153560584|NCT01638962|Nabumetone|nabumetone|mesh-list
153560585|NCT01638962|Tenoxicam|tenoxicam|mesh-list
153560586|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
153560587|NCT01638962|Analgesics|analgesics|mesh-list
153560588|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153560589|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
153560599|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153560601|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153560602|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153560603|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153560604|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
153782673|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560605|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153560606|NCT01638988|Metformin|metformin|mesh-list
153560607|NCT01638988|Clomiphene|clomiphene|mesh-list
153560608|NCT01638988|Enclomiphene|enclomiphene|mesh-list
153842472|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
153842473|NCT02913885|Protective Agents|protective agents|mesh-ancestor
153842474|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842475|NCT01290601|Chloroquine|chloroquine|mesh-list
153842476|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153842477|NCT01290601|Primaquine|primaquine|mesh-list
153842478|NCT01290601|Tafenoquine|tafenoquine|mesh-list
153842479|NCT01290601|Amebicides|amebicides|mesh-ancestor
153842480|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153842481|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153382594|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
153382595|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153382596|NCT02986451|Clarithromycin|clarithromycin|mesh-list
153382597|NCT02986451|Dexamethasone|dexamethasone|mesh-list
153382598|NCT02986451|Lenalidomide|lenalidomide|mesh-list
153382599|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382600|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
153382601|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
153382602|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382603|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382604|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153382605|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
153382606|NCT02986451|Hormones|hormones|mesh-ancestor
153382608|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153560609|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
153560610|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560611|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560612|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153560613|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
153560614|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153560615|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153560616|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
153560617|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153560618|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153560619|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153560621|NCT01639027|Analgesics|analgesics|mesh-ancestor
153560622|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
153560623|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560624|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560625|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
153560626|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
153560627|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
153560628|NCT01639066|Tenofovir|tenofovir|mesh-list
153560629|NCT01639066|Entecavir|entecavir|mesh-list
153560630|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
153560654|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153560678|NCT01639521|Methotrexate|methotrexate|mesh-list
153560679|NCT01639521|Vinblastine|vinblastine|mesh-list
153560680|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560681|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154257771|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154257772|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154257773|NCT02940886|Trace Elements|trace elements|mesh-ancestor
154257774|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
154257775|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257776|NCT02940886|Hematinics|hematinics|mesh-ancestor
154257777|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
154257778|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154257779|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154257780|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257781|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257782|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154257783|NCT05216614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154257784|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154257785|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153382629|NCT01974245|Vitamin D|vitamin d|mesh-list
153842511|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154257786|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732067|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
153838152|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153838153|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153838154|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838155|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838156|NCT00525473|Azathioprine|azathioprine|mesh-list
153838157|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
153838158|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838159|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838160|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838161|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838162|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
153838163|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838164|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153838165|NCT00526175|Cytarabine|cytarabine|mesh-list
153838166|NCT00526175|Prednisone|prednisone|mesh-list
153838167|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
153838168|NCT00526175|Methotrexate|methotrexate|mesh-list
153560683|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560684|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153560685|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153560686|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154257787|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257788|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
154257789|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154257790|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
154257791|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154257792|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154257793|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838180|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838181|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153838182|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838183|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
153838184|NCT00526175|Hormones|hormones|mesh-ancestor
153838185|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153838186|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153838187|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153838188|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
153838189|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153838191|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
153560687|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560688|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153560689|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
153560690|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153560691|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560692|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
153560693|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153560694|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560695|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
153560696|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560697|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560698|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153560699|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
153560700|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
153560701|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
153560702|NCT01639547|Ribavirin|ribavirin|mesh-list
153560703|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153560704|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
153560705|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560706|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
153560751|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153560752|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153560767|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560768|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153560769|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
153560770|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
153560771|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560772|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153560773|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
153560774|NCT01640743|Hormones|hormones|mesh-ancestor
153560775|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153560776|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153560777|NCT01640743|Protective Agents|protective agents|mesh-ancestor
153560778|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153560779|NCT01641016|Efavirenz|efavirenz|mesh-list
153838209|NCT02930031|Expectorants|expectorants|mesh-ancestor
153838210|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
153838211|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153838212|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
153838213|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838214|NCT02930031|Protective Agents|protective agents|mesh-ancestor
153838215|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838216|NCT02930031|Antidotes|antidotes|mesh-ancestor
153838217|NCT02929563|Pantoprazole|pantoprazole|mesh-list
153382671|NCT02305277|Opicapone|opicapone|mesh-list
153838218|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153560780|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153560781|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560782|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560783|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560784|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
153560785|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560786|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153560787|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153560788|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153560789|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153560790|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153560791|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153560792|NCT01642771|Docetaxel|docetaxel|mesh-list
153560793|NCT01642771|Capecitabine|capecitabine|mesh-list
153560794|NCT01642771|Fluorouracil|fluorouracil|mesh-list
153560795|NCT01642771|Epirubicin|epirubicin|mesh-list
153560796|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560797|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
153560798|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
153560799|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
153560800|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560801|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153560802|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
153560803|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560804|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
153560805|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560806|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153560807|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153560808|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153560809|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560810|NCT01642979|Cyclosporine|cyclosporine|mesh-list
153560811|NCT01642979|Levamisole|levamisole|mesh-list
153560812|NCT01642979|Cyclosporins|cyclosporins|mesh-list
153560813|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
153560814|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560999|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153561000|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
153561002|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153561003|NCT01650376|Carboplatin|carboplatin|mesh-list
153561004|NCT01650376|Olaparib|olaparib|mesh-list
153561005|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153561006|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561007|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
153561008|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
153561009|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
153561010|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561011|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153561012|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561055|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561056|NCT01650493|Listerine|listerine|mesh-list
153561058|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
153561059|NCT01650493|Protective Agents|protective agents|mesh-ancestor
153838239|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838240|NCT04288323|Antidotes|antidotes|mesh-ancestor
153838241|NCT04288323|Protective Agents|protective agents|mesh-ancestor
153838242|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838243|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
153838244|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
153838245|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153838246|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
153838247|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153838248|NCT02946359|Bevacizumab|bevacizumab|mesh-list
153838250|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153838251|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378336|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
153378337|NCT01780844|Prednisone|prednisone|mesh-list
153378338|NCT01780844|Tacrolimus|tacrolimus|mesh-list
153378339|NCT01780844|Basiliximab|basiliximab|mesh-list
153378340|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153561060|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561061|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153561062|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561063|NCT01650506|Metformin|metformin|mesh-list
153561064|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153561065|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153561066|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561067|NCT01650506|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153561068|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153561069|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561070|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561071|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561072|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
153561073|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561136|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561137|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561138|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153561139|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153561141|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561142|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561143|NCT01651130|Carbetocin|carbetocin|mesh-list
153561144|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
153842585|NCT01289353|Carboplatin|carboplatin|mesh-list
153561145|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153561146|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561147|NCT01651156|Tolvaptan|tolvaptan|mesh-list
153561148|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153561149|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561150|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
153561151|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561152|NCT01651169|Methylphenidate|methylphenidate|mesh-list
153561165|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
153561166|NCT01651182|Coagulants|coagulants|mesh-ancestor
153561168|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153561169|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153561170|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153561171|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
153561172|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561173|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561174|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561176|NCT01651325|Isavuconazole|isavuconazole|mesh-list
154257794|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154257795|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154257796|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154257798|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154257799|NCT03860636|Progesterone|progesterone|mesh-list
154257800|NCT03860636|Estrogens|estrogens|mesh-ancestor
154257801|NCT03860636|Hormones|hormones|mesh-ancestor
154257802|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257803|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257804|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154257805|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
154004752|NCT04649203|Riboflavin|riboflavin|mesh-list
154257806|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154257807|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154257808|NCT03860636|Progestins|progestins|mesh-ancestor
154257809|NCT03285646|Fasinumab|fasinumab|mesh-list
154257810|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154257811|NCT03285646|Analgesics|analgesics|mesh-ancestor
154257812|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
153732068|NCT00140543|Sirolimus|sirolimus|mesh-list
153390982|NCT00002715|Prednisone|prednisone|mesh-list
153838252|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153838253|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153838254|NCT02946359|Growth Substances|growth substances|mesh-ancestor
153838255|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838256|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
153838257|NCT02946359|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153838258|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153838259|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378346|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838267|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153838268|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
153838269|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
153838270|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153838271|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153838272|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153838273|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153838274|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
153838275|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
153378359|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153378360|NCT01606878|Vincristine|vincristine|mesh-list
153378361|NCT01606878|Topotecan|topotecan|mesh-list
153378362|NCT01606878|Crizotinib|crizotinib|mesh-list
153378363|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
153561177|NCT01651325|Levomethorphan|levomethorphan|mesh-list
153561178|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
153561179|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
153561180|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
153561181|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153561182|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153561183|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561184|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561185|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561186|NCT01651325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153561187|NCT01651325|Narcotics|narcotics|mesh-ancestor
153561188|NCT01651325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153561189|NCT01651325|Analgesics|analgesics|mesh-ancestor
153561251|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561252|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561253|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153561254|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153561288|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561290|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153561291|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561293|NCT01651923|Calcium heparin|calcium heparin|mesh-list
153561294|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
153561295|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153561296|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153561297|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561321|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
153561322|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561323|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561325|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153561326|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153561327|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561328|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153561329|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
153561330|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
153561331|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
153561343|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561344|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153561345|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561347|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153561348|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561349|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153561350|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153561370|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561371|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
153561372|NCT01652196|Leucovorin|leucovorin|mesh-list
153561373|NCT01652196|Fluorouracil|fluorouracil|mesh-list
153561374|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
153561375|NCT01652196|Aflibercept|aflibercept|mesh-list
153561376|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
154257813|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257814|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257816|NCT03860012|Hematinics|hematinics|mesh-ancestor
154257817|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
154257818|NCT03860012|Vitamins|vitamins|mesh-ancestor
154257819|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
154257820|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257821|NCT03859934|Melatonin|melatonin|mesh-list
154257822|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
154257823|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391041|NCT01625455|Aprepitant|aprepitant|mesh-list
153838284|NCT02946632|Saxagliptin|saxagliptin|mesh-list
153838285|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153838286|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838287|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153838288|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378372|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378373|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561377|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153561378|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
153561379|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561380|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561381|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561382|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561383|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
153561384|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561385|NCT01652196|Antidotes|antidotes|mesh-ancestor
153561386|NCT01652196|Protective Agents|protective agents|mesh-ancestor
153561387|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
153561388|NCT01652196|Vitamins|vitamins|mesh-ancestor
153561389|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
153561390|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153561391|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153561392|NCT01652196|Growth Substances|growth substances|mesh-ancestor
153561393|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
153561394|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153561395|NCT01652313|Rasagiline|rasagiline|mesh-list
153561396|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153561397|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561398|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561399|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153561400|NCT01652313|Protective Agents|protective agents|mesh-ancestor
153561401|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561402|NCT01652326|Diazepam|diazepam|mesh-list
153561403|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153561404|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
153561405|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
153561406|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
153561427|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153561428|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153782680|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
153561429|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153561430|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782681|NCT04561921|Nordefrin|nordefrin|mesh-list
154257824|NCT03859934|Protective Agents|protective agents|mesh-ancestor
154257825|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257826|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257827|NCT01178372|Lactulose|lactulose|mesh-list
154257828|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257829|NCT01178450|Cinacalcet|cinacalcet|mesh-list
154257830|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154257831|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257832|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153838313|NCT02929251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153838314|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838315|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378400|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
153378401|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153378402|NCT01175356|Isotretinoin|isotretinoin|mesh-list
153378403|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378404|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
153378405|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378406|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378407|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153378408|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
153378409|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378410|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378411|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153378412|NCT01175356|Vitamins|vitamins|mesh-ancestor
153838316|NCT02929095|Midazolam|midazolam|mesh-list
153838317|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
153838318|NCT02929095|Remifentanil|remifentanil|mesh-list
153838319|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153838320|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838321|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838322|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153838323|NCT02929095|Analgesics|analgesics|mesh-ancestor
153838324|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
153838325|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561431|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153561432|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561433|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
153561485|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838326|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153378413|NCT01175356|Micronutrients|micronutrients|mesh-ancestor
153561486|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561487|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153561489|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
153561490|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561491|NCT01652547|Pasireotide|pasireotide|mesh-list
153561492|NCT01652547|Somatostatin|somatostatin|mesh-list
153561493|NCT01652547|Hormones|hormones|mesh-ancestor
153561494|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561495|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561496|NCT01652560|Bevacizumab|bevacizumab|mesh-list
153561541|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153561542|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561543|NCT01652638|Heparin|heparin|mesh-list
153561544|NCT01652638|Calcium heparin|calcium heparin|mesh-list
153561545|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
153561546|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153561547|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153561548|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561549|NCT01652781|Azacitidine|azacitidine|mesh-list
153561550|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561551|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
153561552|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561553|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561554|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561555|NCT01652794|Carboplatin|carboplatin|mesh-list
153561556|NCT01652794|Gemcitabine|gemcitabine|mesh-list
153561557|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561558|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561559|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
153561560|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561561|NCT01652820|Carboplatin|carboplatin|mesh-list
153561562|NCT01652820|Gemcitabine|gemcitabine|mesh-list
153561563|NCT01652820|Docetaxel|docetaxel|mesh-list
153561564|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561588|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153561589|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561591|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
153561592|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561594|NCT01653041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153561595|NCT01653041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153561596|NCT01653041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561597|NCT01653041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561598|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561599|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
153561642|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
153561643|NCT01653171|Simethicone|simethicone|mesh-list
153561644|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153561645|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
153561646|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561647|NCT01653171|Expectorants|expectorants|mesh-ancestor
153561648|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
153561649|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153561650|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
153561651|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561652|NCT01653171|Protective Agents|protective agents|mesh-ancestor
153561653|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561654|NCT01653171|Antidotes|antidotes|mesh-ancestor
153561655|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
153561657|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
153561658|NCT01653236|Ribavirin|ribavirin|mesh-list
153561659|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153561660|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
153842961|NCT02933099|Dexamethasone|dexamethasone|mesh-list
153842962|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
153842963|NCT02933099|Aprepitant|aprepitant|mesh-list
153561661|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561662|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
153561663|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561664|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
153561665|NCT01653314|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153561666|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153561667|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561668|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561669|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561697|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154257833|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
154257834|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257835|NCT00074490|Prednisone|prednisone|mesh-list
154257836|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
154257837|NCT00074490|Rituximab|rituximab|mesh-list
154257838|NCT00074490|Doxorubicin|doxorubicin|mesh-list
154257839|NCT00074490|Fludarabine|fludarabine|mesh-list
154257840|NCT00074490|Etoposide|etoposide|mesh-list
154257841|NCT00074490|Vincristine|vincristine|mesh-list
154257842|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154257843|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
154257844|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257845|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154257846|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154257847|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
153391133|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
153838363|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378451|NCT00335816|Fluorouracil|fluorouracil|mesh-list
153378452|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
153378453|NCT00335816|Calcium|calcium|mesh-list
153378454|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
153378455|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153378456|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378457|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
153378458|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378459|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153378460|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378461|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378462|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
153378463|NCT00335816|Antidotes|antidotes|mesh-ancestor
153378464|NCT00335816|Protective Agents|protective agents|mesh-ancestor
153378465|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
153378466|NCT00335816|Vitamins|vitamins|mesh-ancestor
153378467|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
153378468|NCT00295893|Paclitaxel|paclitaxel|mesh-list
153378469|NCT00295893|Docetaxel|docetaxel|mesh-list
153378470|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
153378471|NCT00295893|Carboplatin|carboplatin|mesh-list
153838364|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838365|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263529|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561698|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561699|NCT01653470|Antidotes|antidotes|mesh-ancestor
153561700|NCT01653470|Protective Agents|protective agents|mesh-ancestor
153561701|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
153561748|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153561749|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153561750|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153561751|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153561752|NCT01654081|Irinotecan|irinotecan|mesh-list
153561753|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153561754|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153561755|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561756|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561757|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561758|NCT01654120|Liraglutide|liraglutide|mesh-list
153561759|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153561760|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561761|NCT01654120|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153561762|NCT01654120|Incretins|incretins|mesh-ancestor
153561763|NCT01654120|Hormones|hormones|mesh-ancestor
153561764|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561765|NCT01654146|Paclitaxel|paclitaxel|mesh-list
153561766|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153561767|NCT01654146|Carboplatin|carboplatin|mesh-list
153561768|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153561769|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561770|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
153561771|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
153561772|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
153561805|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561807|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
153561808|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871506|NCT00470366|Paclitaxel|paclitaxel|mesh-list
153561856|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153561857|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561858|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153561859|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561906|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153561907|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
153561908|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561909|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561910|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
153561911|NCT01655082|Nicotine|nicotine|mesh-list
153561912|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153561913|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
153561914|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561915|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561916|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153561917|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153561918|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
153561919|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843205|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561920|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561935|NCT01655147|Rifampin|rifampin|mesh-list
153561936|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
153561937|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153561953|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
153561954|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561955|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561956|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153561957|NCT01655199|Albuterol|albuterol|mesh-list
153561958|NCT01655199|Ipratropium|ipratropium|mesh-list
153561959|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153561960|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
153561961|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561962|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561963|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153561964|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
153561965|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
153561966|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153561967|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153561968|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153838433|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838434|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153838435|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153838436|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153838437|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
153378527|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153378528|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153378529|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153378530|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
153378531|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378532|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153378533|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378534|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
153378535|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
153378537|NCT00373581|Vigabatrin|vigabatrin|mesh-list
153378538|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
153378539|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
153561969|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153561970|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
153561971|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561972|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561973|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153561974|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
153561975|NCT01655212|Valganciclovir|valganciclovir|mesh-list
153561976|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
153561977|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561978|NCT01655303|Propranolol|propranolol|mesh-list
153561979|NCT01655303|Metoprolol|metoprolol|mesh-list
153561980|NCT01655303|Verapamil|verapamil|mesh-list
153561981|NCT01655303|Diltiazem|diltiazem|mesh-list
153562001|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562002|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562003|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562004|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562006|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
153562007|NCT01655524|Aminophylline|aminophylline|mesh-list
153562008|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153562009|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
153562010|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562011|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562012|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562013|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562123|NCT01655966|Ribavirin|ribavirin|mesh-list
153562124|NCT01655966|Vitamins|vitamins|mesh-ancestor
153562125|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
153562126|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562157|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153562159|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153562160|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153562161|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153562162|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
153562163|NCT01656005|Protective Agents|protective agents|mesh-ancestor
153562164|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153562165|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562166|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562167|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
153562168|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153562200|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153562201|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153391217|NCT00002793|Vitamins|vitamins|mesh-ancestor
153838447|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153838448|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153378540|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378541|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378542|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
153378543|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378544|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153378545|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153378546|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153378547|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153378548|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378549|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
153378550|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378551|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
153843404|NCT02932761|Goserelin|goserelin|mesh-list
153378552|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378553|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
153562202|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562203|NCT01656070|Vitamin D|vitamin d|mesh-list
153562204|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
153562205|NCT01656070|Vitamins|vitamins|mesh-ancestor
153562206|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
153562207|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562208|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153562209|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562210|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153562211|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153562212|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153562229|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
153562230|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153562231|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562232|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562233|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
153562234|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153562235|NCT01656226|Protective Agents|protective agents|mesh-ancestor
153562236|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562237|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
153562238|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
153562239|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153562240|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
153562241|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153562242|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
153562256|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562257|NCT01656616|Antidotes|antidotes|mesh-list
153562258|NCT01656616|Protective Agents|protective agents|mesh-ancestor
153562259|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562260|NCT01656642|Atezolizumab|atezolizumab|mesh-list
153562261|NCT01656642|Vemurafenib|vemurafenib|mesh-list
153562262|NCT01656642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153562263|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562265|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562266|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153562267|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562268|NCT01656668|Theobromine|theobromine|mesh-list
153562269|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153562270|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
153562291|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
154257848|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257849|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257850|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154257851|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154257852|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154257853|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154257854|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154257855|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391271|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838467|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838468|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838469|NCT00526643|Gemcitabine|gemcitabine|mesh-list
153378561|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
153378562|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153378563|NCT01470170|Narcotics|narcotics|mesh-ancestor
153378564|NCT01470170|Analgesics|analgesics|mesh-ancestor
153378565|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
153378566|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378567|NCT04311567|Methotrexate|methotrexate|mesh-list
153378568|NCT04311567|Tofacitinib|tofacitinib|mesh-list
153378569|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153378570|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
153378571|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153378572|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378573|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153378574|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
153562292|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153562293|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
153562294|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
153562295|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562296|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
153562297|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153562298|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153562299|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562300|NCT01656798|Urological Agents|urological agents|mesh-ancestor
153562301|NCT01656811|Albuterol|albuterol|mesh-list
153562302|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153562303|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
153562304|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562305|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562306|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562307|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562308|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
153562309|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153562310|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153562311|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153562312|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153562313|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
153838488|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153838489|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153838490|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153838491|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
153838492|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153378587|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153378588|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378589|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153378590|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562314|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562315|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562316|NCT01656980|Carmustine|carmustine|mesh-list
153562317|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153562318|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
153562319|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562320|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562321|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
153562322|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
153562323|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
153562324|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562339|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562340|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562361|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562362|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562364|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
153562365|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562366|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153562367|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153562368|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562369|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562370|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153375136|NCT03833427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562371|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
153562372|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562373|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562374|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153562375|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153562376|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153562377|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153562378|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153562379|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153562380|NCT01657240|Analgesics|analgesics|mesh-ancestor
153562381|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
153562382|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562413|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
153562414|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562415|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562416|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153562417|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562418|NCT01657448|Methenamine|methenamine|mesh-list
153562419|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
153562420|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
153562421|NCT01657448|Methylene Blue|methylene blue|mesh-list
153562507|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562508|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562509|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153562511|NCT01657851|Dutasteride|dutasteride|mesh-list
153562633|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153562634|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
153562635|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838506|NCT02927379|Ketamine|ketamine|mesh-list
153838507|NCT02927379|Bupivacaine|bupivacaine|mesh-list
153838508|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
153838509|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
153838510|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378605|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153378606|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378607|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378608|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
153378609|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153378610|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153378611|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
153378612|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
153378613|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
153562636|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562637|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
153562638|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153562639|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562640|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
153562641|NCT01658319|Fludarabine|fludarabine|mesh-list
153562642|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
153562643|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562644|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153562645|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
153562680|NCT01658527|Bicalutamide|bicalutamide|mesh-list
153562681|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
153412369|NCT00005811|Topotecan|topotecan|mesh-list
153563000|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153563001|NCT01660386|Glimepiride|glimepiride|mesh-list
153563002|NCT01660386|Saxagliptin|saxagliptin|mesh-list
153563003|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153871800|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
153563268|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563270|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153563271|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153563436|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153563437|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
153563438|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
153563439|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153563440|NCT01663090|Hematinics|hematinics|mesh-ancestor
153563441|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153563464|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153563465|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563466|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
153563467|NCT01663662|Tolvaptan|tolvaptan|mesh-list
153563468|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153563469|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563470|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
153563471|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563472|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153563473|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153563474|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563475|NCT01663805|Everolimus|everolimus|mesh-list
153563476|NCT01663805|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153563477|NCT01663805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153563539|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153563540|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153563661|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153563662|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563663|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153563664|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153563702|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153563703|NCT01665404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154257856|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257857|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
154257859|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257860|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154257861|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154257862|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
154257863|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
154257864|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
154257865|NCT03859856|Hormones|hormones|mesh-list
154257866|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391401|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153838526|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153838527|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153838529|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153838530|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
153838531|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838532|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838533|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838534|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153838535|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153378630|NCT01524302|Ceftaroline|ceftaroline|mesh-list
153378631|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153378632|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378633|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153844003|NCT00532662|Ketamine|ketamine|mesh-list
153378634|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153378635|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153378636|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378637|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378638|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563732|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
153563733|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153563734|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153563735|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
153563736|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563737|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563738|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563739|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153563740|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153563741|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
153563742|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563743|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153563744|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
153563745|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
153563746|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
153563747|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153563775|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
153563776|NCT01665742|Lycopene|lycopene|mesh-list
153563867|NCT01666431|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153871907|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
153563962|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
153563963|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153563964|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563965|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153563966|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563967|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563968|NCT01667094|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153384149|NCT04351100|Diacerein|diacerein|mesh-list
153384150|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384151|NCT05328674|Mitogens|mitogens|mesh-list
153384152|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
153384153|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384154|NCT01798316|Acetaminophen|acetaminophen|mesh-list
153384155|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153384156|NCT01798316|Analgesics|analgesics|mesh-ancestor
153564053|NCT01667718|Amoxicillin|amoxicillin|mesh-list
153564054|NCT01667718|Levofloxacin|levofloxacin|mesh-list
153564055|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
153564056|NCT01667718|Lansoprazole|lansoprazole|mesh-list
153564057|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
153564058|NCT01667718|Bismuth|bismuth|mesh-list
153564059|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153564060|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564120|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153564121|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153564122|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153564210|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153564211|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564212|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
153564213|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
153564214|NCT01668927|Amoxicillin|amoxicillin|mesh-list
153564215|NCT01668927|Metronidazole|metronidazole|mesh-list
153564216|NCT01668927|Tetracycline|tetracycline|mesh-list
153564217|NCT01668927|Furazolidone|furazolidone|mesh-list
153564270|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564297|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153564298|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564299|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
153564300|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153564302|NCT01669304|Sertraline|sertraline|mesh-list
153564303|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
153564304|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153564305|NCT01669304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153564306|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153564307|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153564308|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564309|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564310|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
153844084|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153844085|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153844086|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153844087|NCT01275625|Maraviroc|maraviroc|mesh-list
153844088|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153844089|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153844091|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153564311|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564312|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153564313|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153564314|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153564315|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
153564316|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
153564317|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
153564451|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153564452|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
153564584|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153564585|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564586|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782730|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153782731|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
153782732|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153378692|NCT02802501|Artenimol|artenimol|mesh-list
153378693|NCT02802501|Tafenoquine|tafenoquine|mesh-list
153378694|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
153378695|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153378696|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153378697|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378698|NCT01528592|Levodopa|levodopa|mesh-list
153838579|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153838580|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838581|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
153782733|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564613|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564614|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
153564615|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
153564616|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564617|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564618|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564619|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
153564621|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153564622|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153564641|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564643|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564644|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153564645|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564646|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564647|NCT01680120|Anesthetics|anesthetics|mesh-list
153564730|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153564731|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564732|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564733|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153564734|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
153564735|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153564736|NCT05596227|Analgesics|analgesics|mesh-ancestor
153782750|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782751|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782753|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
153564751|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564752|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153564753|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564754|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
153564755|NCT05596097|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153564756|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153564757|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564758|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564759|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564760|NCT05596071|Sufentanil|sufentanil|mesh-list
153564762|NCT05596071|Ropivacaine|ropivacaine|mesh-list
153564763|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
153564764|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
153564902|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153564903|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564904|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564905|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153564906|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153564907|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153564938|NCT04231838|Nicotine|nicotine|mesh-list
153564939|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153564940|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
153782774|NCT02213887|Pantoprazole|pantoprazole|mesh-list
153782775|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153782776|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782777|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153782778|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782779|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782780|NCT00234962|Ritonavir|ritonavir|mesh-list
153782781|NCT00234962|Lopinavir|lopinavir|mesh-list
153838619|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153838620|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564941|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564942|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564943|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153564981|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782791|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153565210|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153565211|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153565212|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565214|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153565215|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153565216|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153565217|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565218|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565249|NCT05838001|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153565250|NCT05838001|beta-Endorphin|beta-endorphin|mesh-list
153565251|NCT05838001|Hormones|hormones|mesh-ancestor
153565252|NCT05838001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565253|NCT05838001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565254|NCT05838001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565255|NCT05838001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565256|NCT05837689|Blinatumomab|blinatumomab|mesh-list
153412790|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
153782840|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153782841|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782842|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565346|NCT05781308|Growth Inhibitors|growth inhibitors|mesh-ancestor
153565347|NCT05781308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153565348|NCT05772156|Methylergonovine|methylergonovine|mesh-list
153565349|NCT05772156|Oxytocics|oxytocics|mesh-ancestor
153565372|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
153565373|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565374|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153782879|NCT04550611|Antibodies|antibodies|mesh-list
153782880|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
153782881|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153782882|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
153782883|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565395|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565396|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565397|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153565398|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153565399|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154257867|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257868|NCT01094028|Oxytocin|oxytocin|mesh-list
154257869|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
154257870|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154257871|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257872|NCT01288508|Psyllium|psyllium|mesh-list
154257873|NCT01288508|Cathartics|cathartics|mesh-ancestor
154257874|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154257875|NCT01175954|Lacosamide|lacosamide|mesh-list
154257876|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
153391527|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153838621|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153838622|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838623|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153838624|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838625|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838626|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
153838628|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153838629|NCT00528281|Pemetrexed|pemetrexed|mesh-list
153838630|NCT00528281|Lapatinib|lapatinib|mesh-list
153838631|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838632|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838633|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838634|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153838635|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153838636|NCT00528281|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153838637|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153838638|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
153838639|NCT01580501|Tadalafil|tadalafil|mesh-list
153838640|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
153838641|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153838642|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153838643|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378741|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378742|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
153378743|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565400|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565401|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153838648|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153838649|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838650|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153838651|NCT00528359|Olanzapine|olanzapine|mesh-list
153838652|NCT00528359|Risperidone|risperidone|mesh-list
153838653|NCT00528359|Aripiprazole|aripiprazole|mesh-list
153838654|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153782890|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565466|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565467|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153565468|NCT05109650|Antibodies|antibodies|mesh-list
153565469|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
153565470|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
153565471|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565472|NCT05108259|Adalimumab|adalimumab|mesh-list
153565473|NCT05108259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153565474|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153565475|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153565476|NCT05032118|Ketamine|ketamine|mesh-list
153565477|NCT05032118|Propofol|propofol|mesh-list
153565494|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565495|NCT04862234|Dulaglutide|dulaglutide|mesh-list
153565496|NCT04862234|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153565497|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153565498|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565499|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
153565500|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
153565501|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565502|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
153565503|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565504|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
153565506|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
153565507|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565508|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
153565509|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565510|NCT04505878|Protective Agents|protective agents|mesh-ancestor
153565511|NCT04505189|Psilocybin|psilocybin|mesh-list
153565512|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
153782901|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782902|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
153565513|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565514|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565516|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565517|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782910|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153782912|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153782913|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153782914|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153782915|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782916|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153782917|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
153782918|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
153782919|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
153782920|NCT00268359|Bevacizumab|bevacizumab|mesh-list
153782921|NCT00268359|Irinotecan|irinotecan|mesh-list
153782922|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782923|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782924|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153782925|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153565566|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153565567|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153565568|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565569|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153565570|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
153565572|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
153565573|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
153565574|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385067|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153565575|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565576|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153838659|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838660|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153838661|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153838662|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838663|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153838664|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153838665|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
153838666|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
153838667|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
153838668|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838669|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153838670|NCT00528359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153565577|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565578|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153565621|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565623|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565624|NCT03250624|Ivermectin|ivermectin|mesh-list
153565625|NCT03250624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153375487|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
153565626|NCT03250624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565627|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
153782944|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
153565628|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153565629|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153565631|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565632|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565633|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153565634|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565635|NCT02881242|Trametinib|trametinib|mesh-list
153565636|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565637|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153565703|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
153565704|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565705|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
153565706|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565707|NCT01681875|Nicotine|nicotine|mesh-list
153565708|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153565709|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
153565710|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565711|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565712|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153565713|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153565714|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
153565715|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565716|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565717|NCT06225310|Methylprednisolone|methylprednisolone|mesh-list
153565718|NCT06225310|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153565719|NCT06225310|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153565720|NCT06225310|Prednisolone|prednisolone|mesh-list
153565721|NCT06225310|Prednisolone acetate|prednisolone acetate|mesh-list
153565722|NCT06225310|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153565723|NCT06225310|Prednisolone phosphate|prednisolone phosphate|mesh-list
153565724|NCT06225310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153565725|NCT06225310|Antiemetics|antiemetics|mesh-ancestor
153565726|NCT06225310|Autonomic Agents|autonomic agents|mesh-ancestor
153565727|NCT06225310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565728|NCT06225310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565729|NCT06225310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153565730|NCT06225310|Glucocorticoids|glucocorticoids|mesh-ancestor
153565731|NCT06225310|Hormones|hormones|mesh-ancestor
153565779|NCT06224881|Micronutrients|micronutrients|mesh-ancestor
153565780|NCT06224842|Azacitidine|azacitidine|mesh-list
153565781|NCT06224842|Mitoxantrone|mitoxantrone|mesh-list
154257877|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154257878|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154257879|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154257880|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257882|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154257883|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
154257884|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257885|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154257886|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732069|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153391633|NCT05735756|Citalopram|citalopram|mesh-list
153838671|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153838672|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153838673|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
153838674|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
153838675|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153838676|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153838677|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153838678|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153838679|NCT00527150|Varenicline|varenicline|mesh-list
153838680|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153838681|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153838682|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
153838683|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378781|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378782|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378783|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378784|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
153378785|NCT00373659|Ranibizumab|ranibizumab|mesh-list
153378786|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153378787|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153378788|NCT00373659|Growth Substances|growth substances|mesh-ancestor
153378789|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378790|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
153378791|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154257887|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257888|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
154257889|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257890|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257891|NCT02525276|Hormones|hormones|mesh-list
154257892|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257893|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257894|NCT01172444|Mesalamine|mesalamine|mesh-list
154257895|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154257896|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154257897|NCT01172444|Analgesics|analgesics|mesh-ancestor
154257898|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
154257899|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257900|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257901|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257902|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154257903|NCT01288742|Simeprevir|simeprevir|mesh-list
153391663|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
153838685|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838687|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838688|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838689|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
153838690|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838691|NCT00527267|Cinacalcet|cinacalcet|mesh-list
153838692|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153838693|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838694|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153378792|NCT02885025|Fluticasone|fluticasone|mesh-list
153378793|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378794|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154257904|NCT01288742|Digoxin|digoxin|mesh-list
154257905|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154257906|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154257907|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154257908|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
154257909|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257910|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154257911|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154257912|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154257913|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154257914|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154257915|NCT01288742|Protective Agents|protective agents|mesh-ancestor
154257916|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257917|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
154257918|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257919|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
154257920|NCT01178996|Ribavirin|ribavirin|mesh-list
154257921|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154257922|NCT01178996|Thymalfasin|thymalfasin|mesh-list
154257923|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
154257924|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257925|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
154257926|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257927|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154257928|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
154257929|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257930|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
154257931|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154257932|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
153391696|NCT01662115|Nicotine|nicotine|mesh-list
153838702|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153838703|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
153838704|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
153838705|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838706|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378807|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154257933|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154257934|NCT03862586|Expectorants|expectorants|mesh-ancestor
154257935|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
154257936|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154257937|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
154257938|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257939|NCT03862586|Protective Agents|protective agents|mesh-ancestor
154257940|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257941|NCT03862586|Antidotes|antidotes|mesh-ancestor
154257943|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
154257944|NCT01180946|Vitamins|vitamins|mesh-ancestor
153391733|NCT00000315|Cocaine|cocaine|mesh-list
153838723|NCT00528515|Desflurane|desflurane|mesh-list
153838724|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153378822|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378823|NCT01582880|Riboflavin|riboflavin|mesh-list
153378824|NCT01582880|Vitamins|vitamins|mesh-ancestor
153378825|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
153378826|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378827|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
153378828|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153378829|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
153378830|NCT02889393|Teduglutide|teduglutide|mesh-list
153378831|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153378832|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153378833|NCT02889393|Protective Agents|protective agents|mesh-ancestor
153378834|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378835|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
153378836|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153378837|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378838|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378839|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378840|NCT02818569|Analgesics|analgesics|mesh-ancestor
153565782|NCT06224842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153565783|NCT06224842|Antimetabolites|antimetabolites|mesh-ancestor
153565784|NCT06224842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565785|NCT06224842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845359|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
153565786|NCT06224842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565787|NCT06224842|Analgesics|analgesics|mesh-ancestor
153565788|NCT06224842|Sensory System Agents|sensory system agents|mesh-ancestor
153565789|NCT06224842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565790|NCT06224842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565791|NCT06224842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154257946|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257947|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154257948|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154257949|NCT01179152|Budesonide|budesonide|mesh-list
154257950|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
154257951|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154257952|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154257953|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
154257954|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391750|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153378843|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153378844|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153378845|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153378846|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
153378847|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378848|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378849|NCT03581409|Aspirin|aspirin|mesh-list
153378850|NCT03581409|Cilostazol|cilostazol|mesh-list
153378851|NCT03581409|Clopidogrel|clopidogrel|mesh-list
153378852|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153378853|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153378854|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378855|NCT03581409|Analgesics|analgesics|mesh-ancestor
153378856|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
153838745|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
153565792|NCT06224842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153565793|NCT06224790|Pirfenidone|pirfenidone|mesh-list
153565794|NCT06224790|Analgesics|analgesics|mesh-ancestor
153565795|NCT06224790|Sensory System Agents|sensory system agents|mesh-ancestor
153565885|NCT06223074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153565886|NCT06223074|Glucocorticoids|glucocorticoids|mesh-ancestor
153565887|NCT06223074|Hormones|hormones|mesh-ancestor
153565911|NCT06222723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565912|NCT06222723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565914|NCT06222723|Glucocorticoids|glucocorticoids|mesh-ancestor
153565915|NCT06222723|Hormones|hormones|mesh-ancestor
153565916|NCT06222723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565917|NCT06222723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153565918|NCT06222723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565919|NCT06222723|Antimetabolites|antimetabolites|mesh-ancestor
153565920|NCT06222723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565921|NCT06222723|Antiviral Agents|antiviral agents|mesh-ancestor
153565922|NCT06222723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565923|NCT06220344|Iodine|iodine|mesh-list
153565965|NCT06207734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565966|NCT06207734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565967|NCT06199232|Cetuximab|cetuximab|mesh-list
153565968|NCT06199232|Tislelizumab|tislelizumab|mesh-list
153565969|NCT06199232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153391771|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
153838769|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378866|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378867|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
153378868|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153378869|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153378870|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153378871|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
153378872|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378873|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153378874|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
153378875|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153378876|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
153378877|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
153378878|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153378879|NCT03581409|Protective Agents|protective agents|mesh-ancestor
153378880|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153838770|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838771|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
153838772|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153838773|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153838775|NCT04691687|Diuretics|diuretics|mesh-ancestor
153838776|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
153565970|NCT06199232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565971|NCT06199232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565972|NCT06199232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565984|NCT06192160|Rifampin|rifampin|mesh-list
153565985|NCT06192160|Isoniazid|isoniazid|mesh-list
153565986|NCT06192160|Linezolid|linezolid|mesh-list
153565987|NCT06192160|Pyrazinamide|pyrazinamide|mesh-list
153565988|NCT06192160|Ethambutol|ethambutol|mesh-list
153565989|NCT06192160|Bedaquiline|bedaquiline|mesh-list
153782955|NCT00268398|Protective Agents|protective agents|mesh-ancestor
153565990|NCT06192160|Oxazolidinones|oxazolidinones|mesh-list
153566023|NCT06144944|Immunologic Factors|immunologic factors|mesh-ancestor
153566024|NCT06144944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566025|NCT06144944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153566026|NCT06144944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153566027|NCT06144944|Alkylating Agents|alkylating agents|mesh-ancestor
153782963|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566140|NCT05994287|Antipyretics|antipyretics|mesh-ancestor
153385732|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
153566141|NCT05994287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153566142|NCT05992428|Paroxetine|paroxetine|mesh-list
153566143|NCT05992428|Mirabegron|mirabegron|mesh-list
153566144|NCT05992428|DA-8010|da-8010|mesh-list
153566145|NCT05992428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153566146|NCT05992428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153566147|NCT05992428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153566148|NCT05992428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566149|NCT05992428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566150|NCT05992428|Serotonin Agents|serotonin agents|mesh-ancestor
153566151|NCT05992428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257956|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154257957|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
154004899|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154257958|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
154257959|NCT01179152|Hormones|hormones|mesh-ancestor
154257960|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154257961|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154257962|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154257963|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154257964|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
154257965|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154257966|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257967|NCT01179230|Dipyridamole|dipyridamole|mesh-list
154257968|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153391787|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
153838783|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
153378881|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153378883|NCT01533116|Carbidopa|carbidopa|mesh-list
153378884|NCT01533116|Opicapone|opicapone|mesh-list
153378885|NCT01533116|Benserazide|benserazide|mesh-list
153378886|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153378887|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153378888|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
153378889|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378890|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378891|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378892|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153378893|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378894|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153378896|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
153378897|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153378898|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
153378899|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566152|NCT05992428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153566153|NCT05992428|Antidepressive Agents|antidepressive agents|mesh-ancestor
153566154|NCT05992428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154257970|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154257971|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154257972|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
154257973|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
154257974|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154257975|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
154257976|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154257977|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257978|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154257979|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154257980|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154257981|NCT01179308|Anesthetics|anesthetics|mesh-list
154257982|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257983|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154257984|NCT03088826|Acetaminophen|acetaminophen|mesh-list
154257985|NCT03088826|Morphine|morphine|mesh-list
154257986|NCT03088826|Oxycodone|oxycodone|mesh-list
154257987|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154257988|NCT03088826|Narcotics|narcotics|mesh-ancestor
154257989|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154257990|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566155|NCT05992428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153566156|NCT05992428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153566188|NCT05991401|Cholinergic Agents|cholinergic agents|mesh-ancestor
153566189|NCT05991401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566223|NCT05899127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153566225|NCT05870800|Capecitabine|capecitabine|mesh-list
153566226|NCT05870800|Fluorouracil|fluorouracil|mesh-list
153566227|NCT05870800|Oxaliplatin|oxaliplatin|mesh-list
153566228|NCT05870800|Atezolizumab|atezolizumab|mesh-list
153566229|NCT05870800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153566230|NCT05870800|Antimetabolites|antimetabolites|mesh-ancestor
153566231|NCT05870800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566232|NCT05870800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566233|NCT05870800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153566234|NCT05870800|Immunologic Factors|immunologic factors|mesh-ancestor
153566236|NCT05870800|Antidotes|antidotes|mesh-ancestor
153566237|NCT05870800|Protective Agents|protective agents|mesh-ancestor
153566238|NCT05870800|Vitamin B Complex|vitamin b complex|mesh-ancestor
153566239|NCT05870800|Vitamins|vitamins|mesh-ancestor
153782983|NCT00235508|Eszopiclone|eszopiclone|mesh-list
153782984|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153782985|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782986|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782987|NCT00268515|Cyclosporine|cyclosporine|mesh-list
153566298|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386040|NCT01882868|Antidotes|antidotes|mesh-ancestor
153566299|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566300|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566301|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153566302|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
153566303|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153378928|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378929|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
153378930|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153378931|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378932|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153378933|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153378934|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
153378935|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153378936|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153378937|NCT00373815|Everolimus|everolimus|mesh-list
153378938|NCT00373815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153566304|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153566357|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566358|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
153566359|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566360|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566361|NCT05533697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153566362|NCT05533697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566363|NCT05529251|Carboplatin|carboplatin|mesh-list
153566364|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566365|NCT05473520|Doxycycline|doxycycline|mesh-list
153566366|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153566367|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566368|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
153566369|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153566370|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153566432|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153566433|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566434|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
153566435|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
153566436|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566437|NCT05414474|Protective Agents|protective agents|mesh-ancestor
153566438|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566439|NCT05414474|Vitamins|vitamins|mesh-ancestor
153566440|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
153566441|NCT05363111|Daratumumab|daratumumab|mesh-list
153566442|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153566443|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153566444|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566473|NCT06235216|Immunologic Factors|immunologic factors|mesh-ancestor
153566474|NCT06235216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566475|NCT06235203|Gemcitabine|gemcitabine|mesh-list
153566476|NCT06235203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153566477|NCT06235203|Antimetabolites|antimetabolites|mesh-ancestor
153566478|NCT06235203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566479|NCT06235203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566481|NCT06235177|Micronutrients|micronutrients|mesh-ancestor
153566482|NCT06235177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566483|NCT06235164|Nivolumab|nivolumab|mesh-list
153566484|NCT06235164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153566485|NCT06235164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566486|NCT06235164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566487|NCT06235164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566489|NCT06235151|Trace Elements|trace elements|mesh-ancestor
153566526|NCT06234813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566558|NCT06234592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566559|NCT06234592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566560|NCT06234592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566561|NCT06234592|Sympathomimetics|sympathomimetics|mesh-ancestor
153566562|NCT06234592|Autonomic Agents|autonomic agents|mesh-ancestor
154257992|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
154257993|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154257994|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154257995|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
154257996|NCT00367133|Triamcinolone|triamcinolone|mesh-list
154257997|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154257998|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154257999|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154258000|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154258001|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
154258002|NCT00367133|Hormones|hormones|mesh-ancestor
154258003|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732070|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378960|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153378961|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153378962|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153378963|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378964|NCT02977299|Aripiprazole|aripiprazole|mesh-list
153378965|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153378966|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
153378967|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153378968|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153378969|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153378970|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378971|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378972|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
153838862|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838863|NCT02925975|Carvedilol|carvedilol|mesh-list
153838864|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153838865|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153838866|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
153838867|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566566|NCT06234592|Coagulants|coagulants|mesh-ancestor
153566567|NCT06234592|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153566568|NCT06234592|Natriuretic Agents|natriuretic agents|mesh-ancestor
153566569|NCT06234592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153566570|NCT06234592|Protease Inhibitors|protease inhibitors|mesh-ancestor
153566571|NCT06234592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566572|NCT06234579|Alectinib|alectinib|mesh-list
153566592|NCT06234462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153566593|NCT06234462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153566594|NCT06234462|Antiviral Agents|antiviral agents|mesh-ancestor
153566595|NCT06234462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566596|NCT06234462|Dopamine Agents|dopamine agents|mesh-ancestor
153566597|NCT06234462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566598|NCT06234462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566599|NCT06234462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566600|NCT06234462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153566622|NCT06234345|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566623|NCT06234345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566624|NCT06234345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566625|NCT06234345|Anticonvulsants|anticonvulsants|mesh-ancestor
153566626|NCT06234345|Glucocorticoids|glucocorticoids|mesh-ancestor
153566627|NCT06234345|Hormones|hormones|mesh-ancestor
153566628|NCT06234345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566629|NCT06234345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153566630|NCT06234345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153413099|NCT02432456|Ketamine|ketamine|mesh-list
153566670|NCT06233799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153566672|NCT06233799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153566673|NCT06233799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153566674|NCT06233799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153566675|NCT06233799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153566676|NCT06233799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566677|NCT06233799|Dopamine Agents|dopamine agents|mesh-ancestor
153566678|NCT06233799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566679|NCT06233799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153566680|NCT06233799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153566681|NCT06233799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566682|NCT06233630|Anesthetics|anesthetics|mesh-list
153566683|NCT06233630|Ropivacaine|ropivacaine|mesh-list
153566684|NCT06233630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153566685|NCT06233630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566686|NCT06233630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566687|NCT06233630|Anesthetics, Local|anesthetics, local|mesh-ancestor
153566711|NCT06233617|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566712|NCT06233617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566713|NCT06233617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566714|NCT06233604|Dexamethasone|dexamethasone|mesh-list
153566715|NCT06233604|Dexmedetomidine|dexmedetomidine|mesh-list
153566716|NCT06233604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566717|NCT06233604|Antiemetics|antiemetics|mesh-ancestor
153566718|NCT06233604|Autonomic Agents|autonomic agents|mesh-ancestor
153566752|NCT06233565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153566753|NCT06233565|Glucocorticoids|glucocorticoids|mesh-ancestor
153566754|NCT06233565|Hormones|hormones|mesh-ancestor
153566755|NCT06233565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783056|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
153783057|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
153783058|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
153783059|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783060|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783107|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153783108|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
153783109|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332037|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
153332038|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332039|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
153332041|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153332077|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153332078|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153332080|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375964|NCT06195306|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153332083|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332110|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
153332111|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872837|NCT01126879|Estrogens|estrogens|mesh-ancestor
153332160|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332161|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153332162|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332163|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332164|NCT03016793|Puerarin|puerarin|mesh-list
153332165|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
153332166|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153332167|NCT03928522|Vancomycin|vancomycin|mesh-list
153332168|NCT03928522|Tobramycin|tobramycin|mesh-list
153332169|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332170|NCT01010399|Ritonavir|ritonavir|mesh-list
153332171|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
153332172|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153332173|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153332207|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153332208|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153332226|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332227|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332228|NCT03921190|Anesthetics|anesthetics|mesh-list
153332229|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332230|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332231|NCT00953849|Calcitriol|calcitriol|mesh-list
153332232|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153332233|NCT00953849|Vitamin D|vitamin d|mesh-list
153332234|NCT00953849|Celecoxib|celecoxib|mesh-list
153332235|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153332236|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332237|NCT00953849|Analgesics|analgesics|mesh-ancestor
153332238|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
153332239|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332240|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332241|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332242|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332243|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153332244|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153379175|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
153379176|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379177|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379178|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
153379179|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
153379180|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153379181|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153379182|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153379183|NCT01592006|Ribavirin|ribavirin|mesh-list
153332245|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332246|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332247|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153332248|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153332249|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332250|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153332297|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153332298|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153332299|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153332300|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153332301|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153332302|NCT03889444|Dexamethasone|dexamethasone|mesh-list
153332303|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332304|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
153332305|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
153332306|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332307|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332308|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332309|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
153332311|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332312|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153332313|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332331|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
153332332|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153332333|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153332334|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
153332335|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332336|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
153332337|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332338|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153332339|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153332340|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
153332341|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332342|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153332365|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
153332366|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153846301|NCT01266460|Vaccines|vaccines|mesh-list
153332367|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332368|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153332369|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153332370|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
153332371|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
153332372|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332373|NCT03885154|Analgesics|analgesics|mesh-ancestor
153332395|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376012|NCT06194734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153332396|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332397|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153332398|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
153332399|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153332400|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153332401|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332402|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332404|NCT00957359|Psilocybin|psilocybin|mesh-list
153332405|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153332406|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153332407|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
153332408|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332409|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153332410|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
153332411|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
153332412|NCT00957359|Vitamins|vitamins|mesh-ancestor
153332413|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
153332414|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332415|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
153332416|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153332546|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153332588|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153332589|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332590|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153332591|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153332592|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153332593|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
153332594|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
153332595|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332596|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332597|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153332599|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332600|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332601|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153332602|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153846417|NCT02942498|Vitamins|vitamins|mesh-list
153332603|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153332604|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332605|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332606|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
153332607|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332608|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153332638|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
153332639|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332640|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332641|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153332642|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
153332735|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153332736|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153332737|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153332739|NCT01168687|Levetiracetam|levetiracetam|mesh-list
153332740|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
153332741|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
153332742|NCT03685396|Hemostatics|hemostatics|mesh-list
153332776|NCT04822363|Clopidogrel|clopidogrel|mesh-list
153332777|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153332778|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332779|NCT04822363|Analgesics|analgesics|mesh-ancestor
153332780|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
153783166|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153332782|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332783|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376092|NCT06190782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153332784|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332785|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153332786|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153332820|NCT01170715|Etanercept|etanercept|mesh-list
153332821|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153332822|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332823|NCT01170715|Analgesics|analgesics|mesh-ancestor
153332846|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332847|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332848|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153332849|NCT03809182|Narcotics|narcotics|mesh-ancestor
153332850|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153332851|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153332852|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
153332853|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
153332960|NCT01172197|Ropivacaine|ropivacaine|mesh-list
153332961|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
153332962|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
153332963|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
153332964|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332965|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258026|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154258027|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258028|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258029|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
154258030|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
154258031|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154004976|NCT05338476|Midazolam|midazolam|mesh-list
154258032|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
154258033|NCT00367055|Metformin|metformin|mesh-list
154258034|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
153732073|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153379260|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153332966|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
153332967|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332970|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332971|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332972|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332973|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153332974|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153332997|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332998|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332999|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153333000|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
153333001|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153783167|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153333002|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
153333003|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333004|NCT03783130|Antacids|antacids|mesh-ancestor
153333005|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333006|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153333007|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153333008|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153333023|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153333024|NCT01926236|Leucovorin|leucovorin|mesh-list
153333025|NCT01926236|Folic Acid|folic acid|mesh-list
153333057|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333058|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153333059|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153333060|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333061|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153333062|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333063|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
153333064|NCT01173211|Vaccines|vaccines|mesh-list
153333065|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
153333066|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333067|NCT00983294|Azithromycin|azithromycin|mesh-list
153333068|NCT00983294|Colchicine|colchicine|mesh-list
153333069|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333070|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333096|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333097|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153333098|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333100|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
153333101|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333102|NCT00982280|Tapentadol|tapentadol|mesh-list
153333103|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153333104|NCT00982280|Narcotics|narcotics|mesh-ancestor
153333105|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153333106|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333107|NCT00982280|Analgesics|analgesics|mesh-ancestor
153333108|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
153333109|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333110|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153376139|NCT06190483|Micronutrients|micronutrients|mesh-ancestor
153333111|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153333112|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333113|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333114|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
153333115|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333116|NCT01175395|Triamcinolone|triamcinolone|mesh-list
153333156|NCT03011905|Analgesics|analgesics|mesh-ancestor
153333181|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333182|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
153333183|NCT01177189|Vitamins|vitamins|mesh-ancestor
153333184|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
153333185|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333186|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
153333187|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333188|NCT01177189|Protective Agents|protective agents|mesh-ancestor
153333189|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
153413752|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
153333288|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333289|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333290|NCT01139515|Eletriptan|eletriptan|mesh-list
153333321|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153333323|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
153333324|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333325|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333326|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333327|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333328|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153333329|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333330|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333452|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153333453|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153333454|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
153333455|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
153333457|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333458|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333460|NCT04556084|Blinatumomab|blinatumomab|mesh-list
153333461|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333462|NCT04394234|Warfarin|warfarin|mesh-list
153333463|NCT04394234|Anticoagulants|anticoagulants|mesh-list
153333464|NCT02569710|Simeprevir|simeprevir|mesh-list
153333465|NCT02569710|Odalasvir|odalasvir|mesh-list
153333466|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
153333467|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333503|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333519|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333520|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153333522|NCT01927874|Bupivacaine|bupivacaine|mesh-list
153333523|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
153333524|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
153333525|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153333560|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333561|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333595|NCT04120454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153333756|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333758|NCT00974051|Insulin|insulin|mesh-list
153413870|NCT00300768|Moxidectin|moxidectin|mesh-list
153333800|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333801|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333802|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153333803|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
153333804|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153333806|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333807|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333808|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153333809|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
153333810|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
153333811|NCT00955487|Protective Agents|protective agents|mesh-ancestor
153333812|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
153333813|NCT04120922|Calcium|calcium|mesh-list
153333814|NCT04120922|Sevelamer|sevelamer|mesh-list
153333815|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153333816|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333817|NCT04120922|Antacids|antacids|mesh-ancestor
153333818|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333819|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154258035|NCT00367055|Gliclazide|gliclazide|mesh-list
154258036|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153379341|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
153333820|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
153333821|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
153333822|NCT01663740|Valganciclovir|valganciclovir|mesh-list
153333823|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
153333824|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333825|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
153333872|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333873|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333874|NCT04129112|Propofol|propofol|mesh-list
153333875|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
153333876|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153333877|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333878|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153333879|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153333914|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333915|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153333916|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333917|NCT00979745|Afamelanotide|afamelanotide|mesh-list
153333918|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
153333919|NCT00042341|Clofarabine|clofarabine|mesh-list
153333989|NCT04127396|Estrogens|estrogens|mesh-ancestor
153333990|NCT04127396|Hormones|hormones|mesh-ancestor
153333991|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153333992|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333993|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153333994|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
153333995|NCT04120064|Vitamin D|vitamin d|mesh-list
153333996|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153333997|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333998|NCT04120064|Vitamins|vitamins|mesh-ancestor
153334032|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334033|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334034|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
153334035|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
153334036|NCT02979548|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153334037|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153334038|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
153334039|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334040|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334041|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153334042|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153334043|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153334044|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
153334161|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334162|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153334163|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334164|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
153334165|NCT01142323|Fenofibrate|fenofibrate|mesh-list
153334166|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153334167|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
153334168|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334169|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153334170|NCT01142947|Beclomethasone|beclomethasone|mesh-list
153334171|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334174|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334175|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334176|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153334207|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153334208|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
153783178|NCT00268710|Docetaxel|docetaxel|mesh-list
153334209|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153783179|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783180|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
153334210|NCT02983214|Protective Agents|protective agents|mesh-ancestor
153334211|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153334212|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153334213|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334214|NCT03825068|Anesthetics|anesthetics|mesh-list
153334215|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
153334216|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334424|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153334425|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153334426|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334427|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334586|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334587|NCT05562882|Daratumumab|daratumumab|mesh-list
153334588|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334589|NCT05560542|Dexamethasone|dexamethasone|mesh-list
153334590|NCT05560542|Atropine|atropine|mesh-list
153334591|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334593|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
153387597|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
153334611|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
153334612|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334613|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334615|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153334616|NCT05560308|Trastuzumab|trastuzumab|mesh-list
153334617|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153334618|NCT05560308|Maytansine|maytansine|mesh-list
153334619|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153334620|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334621|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334624|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
153334625|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
153334626|NCT05560308|Immunotoxins|immunotoxins|mesh-ancestor
153334627|NCT05560308|Immunoconjugates|immunoconjugates|mesh-ancestor
153334647|NCT05436522|Propofol|propofol|mesh-list
153334648|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153334649|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334650|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334651|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153334652|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
153334653|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
153334688|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334689|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153334690|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
153334691|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
153334692|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
153334693|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153334694|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153334733|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334797|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
153334798|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334799|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153334800|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153334801|NCT04391660|Ethanol|ethanol|mesh-list
153414050|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335132|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153335134|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
153335135|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335169|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153335170|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153335172|NCT03995680|Piperazine|piperazine|mesh-list
153335173|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
153335174|NCT03995680|DMP 777|dmp 777|mesh-list
153335206|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335207|NCT05495100|Analgesics|analgesics|mesh-ancestor
153335208|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
153335209|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335210|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335211|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153335212|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153335213|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
153335214|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153335215|NCT03325114|Diuretics|diuretics|mesh-ancestor
153335216|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
153335217|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873399|NCT04557137|Somatostatin|somatostatin|mesh-list
153335358|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153335359|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153335361|NCT03984838|Dolutegravir|dolutegravir|mesh-list
153335362|NCT03984838|Rilpivirine|rilpivirine|mesh-list
153335538|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
153335539|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
153335554|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379432|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153379433|NCT02999126|Remifentanil|remifentanil|mesh-list
153379434|NCT02999126|Propofol|propofol|mesh-list
153379435|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153379436|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379437|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335556|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
153335557|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
153335558|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335685|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153335686|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
153335712|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
153335713|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335714|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153335715|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335716|NCT01893788|Eplerenone|eplerenone|mesh-list
153335717|NCT01893788|Aliskiren|aliskiren|mesh-list
153335718|NCT01893788|Renin Inhibitors|renin inhibitors|mesh-ancestor
153335719|NCT01893788|Protease Inhibitors|protease inhibitors|mesh-ancestor
153846921|NCT00534846|Toremifene|toremifene|mesh-list
153335720|NCT01893788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335721|NCT01893788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335722|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153335723|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
153335724|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335725|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335726|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153335727|NCT01893788|Diuretics|diuretics|mesh-ancestor
153335728|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
153335729|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153335774|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335775|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335776|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153335778|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
153335779|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153335780|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
153335781|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153335782|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153335783|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335784|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335785|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153335841|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335842|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335843|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153335844|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
153335845|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335846|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335847|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153335848|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335895|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153335896|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153335897|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153335900|NCT01182610|Fluorouracil|fluorouracil|mesh-list
153335901|NCT01182610|Panitumumab|panitumumab|mesh-list
153335902|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153387599|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153335923|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153335924|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335925|NCT05507398|Metformin|metformin|mesh-list
153335926|NCT05507398|Atorvastatin|atorvastatin|mesh-list
153335927|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153335928|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335929|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153335930|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153335931|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
153335932|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335933|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153335956|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335957|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335981|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
153335982|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335983|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335984|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153335986|NCT00378976|Valacyclovir|valacyclovir|mesh-list
153335987|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
153335988|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335990|NCT02297230|Capecitabine|capecitabine|mesh-list
153335993|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335994|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
153335995|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
153335996|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
153335997|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335998|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335999|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
153336000|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336001|NCT02282332|Ticagrelor|ticagrelor|mesh-list
153336002|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153336003|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153336037|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336038|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153336039|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
153336073|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
153336074|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336075|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336076|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336077|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153336078|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153336178|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
153336179|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336180|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336181|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783207|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
153336205|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
153336206|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336207|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
153336208|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153336209|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153336210|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336211|NCT01996852|Urological Agents|urological agents|mesh-ancestor
153336213|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
153336214|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
153336215|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336216|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336217|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153336218|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336219|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153336220|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153336221|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336300|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
153336301|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336302|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
153336303|NCT05474898|Analgesics|analgesics|mesh-ancestor
153336304|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
153336305|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336306|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336307|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
153873671|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336575|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153336576|NCT01530880|Analgesics|analgesics|mesh-ancestor
153336608|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153336609|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
153336610|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336611|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336612|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153336613|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153336614|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
153336615|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336616|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336617|NCT00542542|Midazolam|midazolam|mesh-list
153336650|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336652|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153379519|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
153379520|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
153336653|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153336654|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
153336794|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153336795|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153336796|NCT00000766|Ganciclovir|ganciclovir|mesh-list
153336797|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153336799|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153336800|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
153336801|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336828|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153336829|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336830|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336831|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387178|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387179|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153394792|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153387180|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153387181|NCT00523809|Growth Substances|growth substances|mesh-ancestor
153387182|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387183|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
153847071|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336832|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153336833|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153336834|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
153336835|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153336836|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153336838|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153336839|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
153336840|NCT00000778|Vitamins|vitamins|mesh-ancestor
153336841|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
153336842|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336843|NCT00000796|Pyridoxine|pyridoxine|mesh-list
153783215|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336968|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336969|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336971|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153336972|NCT00177970|Antibodies|antibodies|mesh-list
153336973|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
153336974|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
153336975|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153336976|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
153336977|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336978|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153336979|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
153336980|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336981|NCT00088972|Celecoxib|celecoxib|mesh-list
153336982|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153336983|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153336984|NCT00088972|Analgesics|analgesics|mesh-ancestor
153336985|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
153337019|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
153337103|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337106|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
153337107|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337109|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153337110|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337111|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337112|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153337113|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
153337114|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337115|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337231|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337232|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153337233|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
153337234|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
153337235|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
153337236|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153337237|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153337238|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
153337239|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783218|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
153337240|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337241|NCT00001870|Acetylcholine|acetylcholine|mesh-list
153337242|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
153337243|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153337244|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
153337245|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379559|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
153379560|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839424|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
153839425|NCT02941562|Vitamins|vitamins|mesh-ancestor
153337246|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337247|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337248|NCT03252600|Dexamethasone|dexamethasone|mesh-list
153337249|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
153337250|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
153337251|NCT03252600|Lenalidomide|lenalidomide|mesh-list
153337252|NCT03252600|Elotuzumab|elotuzumab|mesh-list
153337253|NCT03252600|Ichthammol|ichthammol|mesh-list
153337285|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337286|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153337287|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153337288|NCT02749526|Growth Substances|growth substances|mesh-ancestor
153337289|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337290|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
153337291|NCT00000916|Lamivudine|lamivudine|mesh-list
153337292|NCT00000916|Zidovudine|zidovudine|mesh-list
153337293|NCT00000916|Didanosine|didanosine|mesh-list
153337294|NCT00000916|Stavudine|stavudine|mesh-list
153337295|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153337384|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337386|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
153337387|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153337388|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
153847153|NCT04043494|Vindesine|vindesine|mesh-list
153337389|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337390|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
153337391|NCT04390100|Protective Agents|protective agents|mesh-ancestor
153337392|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
153337393|NCT04390100|Coagulants|coagulants|mesh-ancestor
153337394|NCT00000202|Buprenorphine|buprenorphine|mesh-list
153337431|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153337432|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
153337433|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
153337434|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414598|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
153337694|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
153337695|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337696|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337697|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153337698|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
153337699|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
153337700|NCT04331470|Hormones|hormones|mesh-ancestor
153337701|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337702|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153337703|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153337704|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153337705|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
153337706|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337707|NCT04331470|Amebicides|amebicides|mesh-ancestor
153337708|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153337709|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153337711|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153337712|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
153337713|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
153337715|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
153337716|NCT00001090|Sargramostim|sargramostim|mesh-list
153337717|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
153337718|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337719|NCT01147627|Insulin|insulin|mesh-list
153337720|NCT01147627|Pioglitazone|pioglitazone|mesh-list
153337721|NCT01147627|Exenatide|exenatide|mesh-list
153337722|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
153337723|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153337724|NCT01147627|Protamines|protamines|mesh-list
153337725|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153337726|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337727|NCT01147627|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153847190|NCT02899286|BCT-100|bct-100|mesh-list
153337728|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153337729|NCT01147627|Incretins|incretins|mesh-ancestor
153337730|NCT01147627|Hormones|hormones|mesh-ancestor
153337731|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337732|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
154258037|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258039|NCT00057330|Vaccines|vaccines|mesh-list
154258040|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
154258041|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
154258042|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258043|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154258044|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154258045|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258046|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
154258047|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258048|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
154258049|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153392426|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153839467|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153839468|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839469|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
153839470|NCT03458468|Coagulants|coagulants|mesh-ancestor
153839471|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153839475|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
153337733|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337734|NCT01147627|Coagulants|coagulants|mesh-ancestor
153337735|NCT02548962|Dexamethasone|dexamethasone|mesh-list
153337736|NCT02548962|Pomalidomide|pomalidomide|mesh-list
153337766|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
153337767|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337768|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337770|NCT02743598|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153337771|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153847241|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153847243|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847244|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847245|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847246|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153847247|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153847248|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
153337772|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337773|NCT02743598|Incretins|incretins|mesh-ancestor
153783222|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783223|NCT02213029|Oxytocin|oxytocin|mesh-list
153337891|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153337892|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
153337893|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337894|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337895|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337896|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153337897|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153337898|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337899|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153337900|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153337901|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
153337902|NCT01227655|Levodopa|levodopa|mesh-list
153337903|NCT01227655|Carbidopa|carbidopa|mesh-list
153337904|NCT01227655|Opicapone|opicapone|mesh-list
153337905|NCT01227655|Benserazide|benserazide|mesh-list
153337906|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153873955|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153337908|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
153337909|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337910|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337911|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337947|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
153337948|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258050|NCT00057330|Protective Agents|protective agents|mesh-ancestor
154258051|NCT03283696|Doxorubicin|doxorubicin|mesh-list
154258052|NCT03283696|Ifosfamide|ifosfamide|mesh-list
154258053|NCT03283696|Olaratumab|olaratumab|mesh-list
154258054|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154258055|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258056|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154258057|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154258058|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258059|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258060|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154258061|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
153392436|NCT04942899|Capecitabine|capecitabine|mesh-list
153839502|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153839503|NCT02941445|Metformin|metformin|mesh-list
153839504|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153839505|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153839506|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839507|NCT02941445|Incretins|incretins|mesh-ancestor
153839508|NCT02941445|Hormones|hormones|mesh-ancestor
153839509|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839510|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153839511|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
153839512|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839513|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839514|NCT02919501|Vortioxetine|vortioxetine|mesh-list
153839515|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
153839516|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153839517|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153839518|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153839519|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379639|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337949|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
153337950|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337951|NCT01026623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153337952|NCT01026623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337953|NCT01026623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337992|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153337993|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338023|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
153338025|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
154258062|NCT01176344|Vitamin D|vitamin d|mesh-list
154258063|NCT01176344|Vitamins|vitamins|mesh-ancestor
154258064|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
154258065|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258066|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154258067|NCT02530788|Selenium|selenium|mesh-list
154258068|NCT02530788|Selenious Acid|selenious acid|mesh-list
153732081|NCT00154791|Gemcitabine|gemcitabine|mesh-list
153338026|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153338027|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338028|NCT00002002|Antidotes|antidotes|mesh-ancestor
153338029|NCT00002002|Protective Agents|protective agents|mesh-ancestor
153338030|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
153338031|NCT00002002|Vitamins|vitamins|mesh-ancestor
153338032|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
153338033|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153338034|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338035|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
153338070|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153338071|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
153338102|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153338103|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153338105|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
153338106|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338107|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783230|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153387424|NCT02959229|Lactoferrin|lactoferrin|mesh-list
153338145|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338217|NCT02143388|Cisplatin|cisplatin|mesh-list
153338218|NCT02143388|Capecitabine|capecitabine|mesh-list
153783231|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338219|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338253|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153338254|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153338255|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
153338256|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338257|NCT00002044|Zidovudine|zidovudine|mesh-list
153338258|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
153338259|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338260|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338261|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338363|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338364|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153338365|NCT00380770|Lamivudine|lamivudine|mesh-list
153338366|NCT00380770|Stavudine|stavudine|mesh-list
153338367|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
153338368|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338369|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338370|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338371|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338372|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
153338373|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338374|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338375|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338376|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
153338377|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
153338378|NCT01231399|Leucovorin|leucovorin|mesh-list
153338379|NCT01231399|Fluorouracil|fluorouracil|mesh-list
153338380|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
153338418|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
153338419|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338420|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153338421|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
153338423|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338506|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338508|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153338509|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338510|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153338511|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
153338512|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
154258069|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
154258070|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
153839571|NCT03153150|Dabigatran|dabigatran|mesh-list
153783246|NCT00235898|Antidotes|antidotes|mesh-ancestor
153338513|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153338515|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
153338551|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338588|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338589|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338617|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338618|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338620|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153338621|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
153338622|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338623|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338624|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153338625|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
153338626|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
153338627|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153338632|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338633|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338635|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
153338636|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153338637|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338663|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338664|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
153338665|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
153338666|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
153338667|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338668|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153338669|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338670|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153338671|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338672|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338673|NCT00000574|Ibuprofen|ibuprofen|mesh-list
153338674|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153338675|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153338676|NCT00000574|Analgesics|analgesics|mesh-ancestor
153338677|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
153338678|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338679|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338680|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153338681|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338682|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153338683|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338684|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338722|NCT00001498|Methotrexate|methotrexate|mesh-list
153387623|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338723|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153338724|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338725|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
153338726|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
153338746|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153338747|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338749|NCT00001498|Protective Agents|protective agents|mesh-ancestor
153338750|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
153338751|NCT00001498|Vitamins|vitamins|mesh-ancestor
153338752|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
153338753|NCT00001504|Tretinoin|tretinoin|mesh-list
153338754|NCT00001504|Alitretinoin|alitretinoin|mesh-list
153338755|NCT00001504|Isotretinoin|isotretinoin|mesh-list
153338761|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
153338762|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
153338763|NCT02688140|Idarubicin|idarubicin|mesh-list
153338764|NCT02688140|Tretinoin|tretinoin|mesh-list
153338765|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
153338766|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153338767|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
153338768|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153338769|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376791|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
153338770|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153338771|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
153338772|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392484|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
153839610|NCT06025851|Antibodies|antibodies|mesh-list
153338773|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338774|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
153338804|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153338805|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153783254|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153338806|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153338807|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
153338809|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153387624|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847502|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338810|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153338811|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153338812|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153338813|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338814|NCT01027559|Sertraline|sertraline|mesh-list
153338815|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
153338850|NCT00000634|Nevirapine|nevirapine|mesh-list
153387601|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338872|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338873|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338874|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338875|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338877|NCT00985907|Melphalan|melphalan|mesh-list
153783255|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153338882|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338884|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338885|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
153338886|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338887|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153338888|NCT00002140|Azithromycin|azithromycin|mesh-list
153338889|NCT00002140|Clarithromycin|clarithromycin|mesh-list
153338890|NCT00002140|Ethambutol|ethambutol|mesh-list
153338891|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153338892|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338893|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153338894|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338895|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338896|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153338897|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153387671|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
153387672|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153387673|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153847519|NCT00551889|Celecoxib|celecoxib|mesh-list
153847520|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
153847521|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847522|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
153847523|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847524|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847525|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153847526|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
153847527|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847528|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847554|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153338898|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
153338899|NCT00000658|Leucovorin|leucovorin|mesh-list
153338900|NCT00000658|Cytarabine|cytarabine|mesh-list
153338901|NCT00000658|Dexamethasone|dexamethasone|mesh-list
153338927|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338928|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153338929|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153338930|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153338931|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153338932|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338933|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153338934|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
153338935|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153338936|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153338937|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
153338938|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
153338939|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153338940|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338941|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
153338942|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338943|NCT00000658|Antidotes|antidotes|mesh-ancestor
153338944|NCT00000658|Protective Agents|protective agents|mesh-ancestor
153338945|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
153338946|NCT00000658|Vitamins|vitamins|mesh-ancestor
153338947|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
153338948|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153338949|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
153338950|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
153783256|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338951|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
153874037|NCT04561947|Mitogens|mitogens|mesh-list
153339002|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339003|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339004|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263530|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153339037|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339038|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339039|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153387695|NCT00000237|Narcotics|narcotics|mesh-ancestor
153339040|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339041|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339042|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339043|NCT01894412|Etanercept|etanercept|mesh-list
153339044|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153339045|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153339046|NCT01894412|Analgesics|analgesics|mesh-ancestor
153339047|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
153339048|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339049|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414762|NCT02513095|Dantrolene|dantrolene|mesh-list
153339132|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339133|NCT00000724|Leucovorin|leucovorin|mesh-list
153339134|NCT00000724|Trimetrexate|trimetrexate|mesh-list
153339135|NCT00000724|Calcium|calcium|mesh-list
153339136|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
153339137|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153339138|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339139|NCT00000724|Antidotes|antidotes|mesh-ancestor
153339168|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
153339169|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339170|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339174|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153339175|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339176|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153339177|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339178|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
153339179|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153339180|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153339181|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153339182|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339183|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339271|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339272|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339273|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339274|NCT01152697|Haloperidol|haloperidol|mesh-list
153339275|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
153339276|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
153339313|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153339314|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339315|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339343|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
153339344|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339345|NCT00002200|Abacavir|abacavir|mesh-list
153339346|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339347|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339348|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339349|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339350|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
153339351|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339352|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339353|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339354|NCT00002356|Fomivirsen|fomivirsen|mesh-list
153339355|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
153339356|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339357|NCT00994175|Pioglitazone|pioglitazone|mesh-list
153339434|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153339436|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
153339437|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339438|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339439|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339440|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153339442|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
153339443|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339444|NCT00995501|Insulin|insulin|mesh-list
153339445|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153339447|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
153339448|NCT00995501|Anesthetics|anesthetics|mesh-list
153339449|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
153387603|NCT03465735|Enoxaparin|enoxaparin|mesh-list
153339473|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153339474|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
153339475|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339476|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339478|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339479|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
153339480|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339481|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153339482|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339483|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
153339484|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339485|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339486|NCT00002380|Nelfinavir|nelfinavir|mesh-list
153339487|NCT00002380|Saquinavir|saquinavir|mesh-list
153339488|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153339489|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153339491|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339492|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339493|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339494|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339549|NCT05751850|Fluorouracil|fluorouracil|mesh-list
153339550|NCT05751850|Oxaliplatin|oxaliplatin|mesh-list
153339551|NCT05751850|Calcium|calcium|mesh-list
153339552|NCT05751850|Levoleucovorin|levoleucovorin|mesh-list
153339553|NCT05751850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153339554|NCT05751850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339555|NCT05751850|Tubulin Modulators|tubulin modulators|mesh-ancestor
153339556|NCT05751850|Antimitotic Agents|antimitotic agents|mesh-ancestor
153339557|NCT05751850|Mitosis Modulators|mitosis modulators|mesh-ancestor
153339585|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153339586|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339588|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
153339589|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339590|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339591|NCT03009877|Midazolam|midazolam|mesh-list
153339592|NCT03009877|Fentanyl|fentanyl|mesh-list
153339593|NCT03009877|Propofol|propofol|mesh-list
153339594|NCT03009877|Rocuronium|rocuronium|mesh-list
153339595|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153339596|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153339597|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414821|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
153339642|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153339643|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339644|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153339668|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339669|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
153339670|NCT00002404|Valacyclovir|valacyclovir|mesh-list
153339671|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
153339672|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339673|NCT01242241|Propofol|propofol|mesh-list
153339674|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153339675|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153339676|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339677|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153339678|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
153339679|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
153339680|NCT02393690|Iodine|iodine|mesh-list
153339681|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
153339682|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153339683|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339684|NCT02393690|Trace Elements|trace elements|mesh-ancestor
153339685|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
153339686|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339687|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
153339688|NCT01200433|Propofol|propofol|mesh-list
153339689|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153874138|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
153339772|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
153339773|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
153339774|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339775|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339776|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339777|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153379887|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379888|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153379889|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153379890|NCT02247518|Tadalafil|tadalafil|mesh-list
153847760|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
153379891|NCT02247518|Tamsulosin|tamsulosin|mesh-list
153839756|NCT06024915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839757|NCT06024915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153839758|NCT06024915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153339778|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153339779|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153339780|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153339781|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
153339782|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153339783|NCT01001975|Protective Agents|protective agents|mesh-ancestor
153339784|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339785|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
153339786|NCT00002260|Alovudine|alovudine|mesh-list
153339808|NCT05751304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339818|NCT05751304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339819|NCT05751304|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153339820|NCT05751304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153339821|NCT05751304|Anesthetics, General|anesthetics, general|mesh-ancestor
153339822|NCT05751304|Anesthetics|anesthetics|mesh-ancestor
153339823|NCT05751304|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153339824|NCT05751304|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153339825|NCT01202071|Rabeprazole|rabeprazole|mesh-list
153339826|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153339827|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339828|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153339829|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339830|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339831|NCT00002428|Vaccines|vaccines|mesh-list
153339832|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
153339833|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339834|NCT01422746|Metformin|metformin|mesh-list
153339835|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153387604|NCT03465735|Dalteparin|dalteparin|mesh-list
153339847|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153339848|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
153339849|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339850|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153339851|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153339852|NCT01002755|Growth Substances|growth substances|mesh-ancestor
153339853|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
153339854|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339855|NCT00002434|Leucovorin|leucovorin|mesh-list
153339856|NCT00002434|Trimetrexate|trimetrexate|mesh-list
153339857|NCT00002434|Calcium|calcium|mesh-list
153339858|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
153339859|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153339860|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387942|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387943|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153387944|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153387945|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
153387946|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387947|NCT00000297|Labetalol|labetalol|mesh-list
153387948|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153387949|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153387950|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
153387951|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387952|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387953|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387954|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153339861|NCT00002434|Antidotes|antidotes|mesh-ancestor
153339862|NCT00002434|Protective Agents|protective agents|mesh-ancestor
153339863|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
153339864|NCT00002434|Vitamins|vitamins|mesh-ancestor
153339865|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
153339875|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
153339876|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153339877|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153339878|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339879|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
153339880|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
153339881|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
153339882|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339883|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339884|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339885|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153339886|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
154258072|NCT02530788|Protective Agents|protective agents|mesh-ancestor
154258073|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258074|NCT02530788|Trace Elements|trace elements|mesh-ancestor
154258075|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
154258076|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
154258077|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154258078|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258079|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154258080|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732085|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379920|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153379921|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
153379922|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379923|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839786|NCT06024252|Atezolizumab|atezolizumab|mesh-list
153839787|NCT06024252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153339887|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
153339888|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339889|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339891|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153339892|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153387955|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
153339893|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
153339895|NCT00002440|Nelfinavir|nelfinavir|mesh-list
153339896|NCT00002440|Indinavir|indinavir|mesh-list
153339897|NCT00002440|Saquinavir|saquinavir|mesh-list
153339898|NCT00002440|Amprenavir|amprenavir|mesh-list
153339899|NCT00002440|Abacavir|abacavir|mesh-list
153339900|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153339901|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153339902|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
153339903|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387605|NCT03465735|Warfarin|warfarin|mesh-list
153339937|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339968|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153339969|NCT01884740|Bevacizumab|bevacizumab|mesh-list
153339970|NCT01884740|Cetuximab|cetuximab|mesh-list
153339971|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153339972|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339973|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153339974|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153339975|NCT01884740|Growth Substances|growth substances|mesh-ancestor
153339976|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339977|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
153339978|NCT00002290|Zidovudine|zidovudine|mesh-list
153339979|NCT00002290|Acyclovir|acyclovir|mesh-list
153339980|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
153339981|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339982|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339983|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339984|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339985|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
153339986|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339987|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339988|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339989|NCT01003769|Acetic Acid|acetic acid|mesh-list
153839828|NCT06022939|Mechlorethamine|mechlorethamine|mesh-list
153839829|NCT06022939|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153839830|NCT06022939|Bortezomib|bortezomib|mesh-list
153839831|NCT06022939|Daratumumab|daratumumab|mesh-list
153839832|NCT06022939|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153839833|NCT06022939|BB 1101|bb 1101|mesh-list
153839834|NCT06022939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153839835|NCT06022939|Immunologic Factors|immunologic factors|mesh-ancestor
153839836|NCT06022939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839837|NCT06022939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153339990|NCT01003769|Lenalidomide|lenalidomide|mesh-list
153339991|NCT01003769|Retinol acetate|retinol acetate|mesh-list
153339992|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
153339993|NCT01003769|Gossypol|gossypol|mesh-list
153340021|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
153340022|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340023|NCT01004393|Bromides|bromides|mesh-list
153340024|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
153340025|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
153340026|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153731976|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
153340027|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340028|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
153340029|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340031|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153340212|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153340213|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
153340214|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153340215|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340216|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
153340217|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340218|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153340219|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153340220|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340221|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
153340222|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376976|NCT05444543|Fluticasone|fluticasone|mesh-list
153340223|NCT00002494|Antidotes|antidotes|mesh-ancestor
153340314|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
153340315|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340316|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340317|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340318|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
153387607|NCT03465735|Dabigatran|dabigatran|mesh-list
153340338|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153340339|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340341|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340343|NCT00002524|Protective Agents|protective agents|mesh-ancestor
153340344|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
153340345|NCT00002524|Vitamins|vitamins|mesh-ancestor
153340346|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
153340347|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340348|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340349|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
153340350|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
153340351|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
153340352|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340353|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153340354|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153340355|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153340356|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153340357|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153340358|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153340359|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
153340360|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153340361|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153340362|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153839874|NCT06020755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153839875|NCT06020755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839876|NCT06020755|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153839877|NCT06020755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839878|NCT06020755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839879|NCT06020755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153839880|NCT06019741|Aspirin|aspirin|mesh-list
153839881|NCT06019741|Rivaroxaban|rivaroxaban|mesh-list
153839882|NCT06019741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153839884|NCT06019741|Analgesics|analgesics|mesh-ancestor
153340363|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153340364|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153340365|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153340366|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
153340367|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153340368|NCT00002536|Vincristine|vincristine|mesh-list
153340451|NCT03011125|Lansoprazole|lansoprazole|mesh-list
153340452|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153340453|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153340454|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153340455|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340480|NCT05749666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340481|NCT05749666|Antiemetics|antiemetics|mesh-ancestor
153340482|NCT05749666|Autonomic Agents|autonomic agents|mesh-ancestor
153340483|NCT05749666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340484|NCT05749666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153340485|NCT05749666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153340486|NCT05749666|Protective Agents|protective agents|mesh-ancestor
153340487|NCT05749666|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153340488|NCT05749666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153340489|NCT05749666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340490|NCT05749666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340491|NCT05449535|Omalizumab|omalizumab|mesh-list
153340492|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153340493|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153340494|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
153340495|NCT05749276|Daratumumab|daratumumab|mesh-list
153340496|NCT05749276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340497|NCT05749042|Cisplatin|cisplatin|mesh-list
153340498|NCT05749042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414959|NCT05732155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153340614|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340616|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340783|NCT00199082|Prednisolone|prednisolone|mesh-list
153340784|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
153340785|NCT00199082|Ifosfamide|ifosfamide|mesh-list
153340786|NCT00199082|Rituximab|rituximab|mesh-list
153340787|NCT00199082|Methotrexate|methotrexate|mesh-list
153340788|NCT00199082|Vincristine|vincristine|mesh-list
153340789|NCT00199082|Doxorubicin|doxorubicin|mesh-list
153340820|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340821|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340822|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340823|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340824|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
153340825|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340826|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340827|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340829|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153340830|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153340831|NCT00194090|Analgesics|analgesics|mesh-ancestor
153340832|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
153387608|NCT03465735|Apixaban|apixaban|mesh-list
153340860|NCT00002620|Mitolactol|mitolactol|mesh-list
153340861|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154258082|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154258083|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258084|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
154258085|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154258086|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258087|NCT02564380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154258088|NCT02564380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258089|NCT01093092|Calcitriol|calcitriol|mesh-list
153340862|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
153340863|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340864|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341245|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153341246|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341247|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
153341248|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
153341281|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153341282|NCT00002764|Ifosfamide|ifosfamide|mesh-list
153341283|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153341284|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341324|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341325|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341327|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341328|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341329|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153848007|NCT04090775|Nivolumab|nivolumab|mesh-list
153341330|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153341331|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153341332|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153341333|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341334|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341335|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
153341337|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341338|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341339|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153341340|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
153341690|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341691|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341693|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153783278|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153341694|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
153341695|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153342164|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342166|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
153342270|NCT00003400|Vinorelbine|vinorelbine|mesh-list
153342271|NCT00003400|Carmustine|carmustine|mesh-list
153342272|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342273|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
153874482|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153342996|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342997|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388442|NCT00359333|Gemcitabine|gemcitabine|mesh-list
153344176|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344177|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344178|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344179|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344181|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344182|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344184|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
153345638|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345639|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345640|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
153388239|NCT00001017|Fluconazole|fluconazole|mesh-list
153345641|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345642|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345643|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154258090|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154258091|NCT01093092|Gemcitabine|gemcitabine|mesh-list
154258092|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258093|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153839956|NCT05990790|Propofol|propofol|mesh-list
153345644|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153345645|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345646|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345647|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345648|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345649|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
153345650|NCT00005578|Hormones|hormones|mesh-ancestor
153345651|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345652|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345653|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345654|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153345655|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345656|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345885|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345886|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345888|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345889|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
153345890|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345891|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345892|NCT00101036|Lapatinib|lapatinib|mesh-list
153345893|NCT00101036|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153345894|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153345895|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345914|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
153345916|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153345917|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345918|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345919|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345920|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345921|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
153345922|NCT00005092|Thiotepa|thiotepa|mesh-list
153345923|NCT00005092|Methoxsalen|methoxsalen|mesh-list
153345924|NCT00005092|Furocoumarins|furocoumarins|mesh-list
153345925|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345926|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
153345928|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345929|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345930|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
153345931|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345932|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345933|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153345934|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153403510|NCT03493412|Verapamil|verapamil|mesh-list
153345978|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153345979|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153345980|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345981|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345982|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153345983|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
153345984|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345985|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345986|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153345987|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
153345988|NCT00030992|Promethazine|promethazine|mesh-list
153345989|NCT00030992|Ranitidine|ranitidine|mesh-list
153345990|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153345991|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153345992|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153345993|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153345994|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345995|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
153345996|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
153345997|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
153345998|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345999|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
153346000|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
153346001|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153346002|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153404746|NCT00003165|Doxorubicin|doxorubicin|mesh-list
153346121|NCT02197273|Narcotics|narcotics|mesh-ancestor
153346122|NCT02197273|Analgesics|analgesics|mesh-ancestor
153346123|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153346124|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153346125|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
153346126|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153346127|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153346128|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
153346129|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346130|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346131|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153346132|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153346133|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
153346134|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153346135|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
153346136|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
153346137|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
153346173|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346174|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153346175|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346176|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346177|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153346179|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
153346180|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153346181|NCT01288807|Milnacipran|milnacipran|mesh-list
153346182|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153346183|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153346184|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346185|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346186|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346187|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346188|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153346189|NCT01288807|Analgesics|analgesics|mesh-ancestor
153346190|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
153346191|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346193|NCT00005764|Zidovudine|zidovudine|mesh-list
153346194|NCT00005764|Abacavir|abacavir|mesh-list
153346195|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153346196|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153346197|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153732194|NCT00141011|Ancrod|ancrod|mesh-list
153732195|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
153848197|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153848198|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153848199|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848200|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848201|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153848202|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153848203|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153388331|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346198|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346217|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153346218|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
153346219|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346220|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153346221|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153346222|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
153783319|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346223|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346224|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346225|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153346249|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153346250|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346267|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346268|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153346269|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153346270|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
153346271|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153346272|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
153346273|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346274|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346275|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153346276|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
153346277|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153346278|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
153346279|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346280|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258094|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
153346281|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153346282|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
153346283|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
153346284|NCT00005776|Protective Agents|protective agents|mesh-ancestor
153346285|NCT00005782|Lenograstim|lenograstim|mesh-list
153346286|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153346287|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
153406057|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153346299|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346301|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
153346302|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153346303|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346304|NCT00005800|Docetaxel|docetaxel|mesh-list
153346305|NCT00005800|Doxorubicin|doxorubicin|mesh-list
153346306|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153346318|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153346320|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
153346321|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346322|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153346323|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153346324|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346325|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153346326|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153346327|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153346328|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153346329|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
153346330|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346331|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346332|NCT01268527|Calcipotriene|calcipotriene|mesh-list
153346333|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
153346334|NCT00005806|Paclitaxel|paclitaxel|mesh-list
153346336|NCT00005806|Gefitinib|gefitinib|mesh-list
153346337|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153346338|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346339|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
153346340|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
153346341|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
153346342|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346343|NCT00005806|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153346344|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153346345|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346346|NCT00005812|Temozolomide|temozolomide|mesh-list
153346347|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153346348|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
153346349|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346350|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346351|NCT01270555|Bupropion|bupropion|mesh-list
153346352|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153346353|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
153346354|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153346355|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153346356|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153346357|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346358|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346359|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
153346360|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346534|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153346578|NCT00103844|Dasatinib|dasatinib|mesh-list
153346579|NCT00103844|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153346580|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153346581|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346582|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346583|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346584|NCT01402375|Acetaminophen|acetaminophen|mesh-list
153346585|NCT01402375|Oxycodone|oxycodone|mesh-list
153346586|NCT01402375|Hydrocodone|hydrocodone|mesh-list
153346588|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153346589|NCT01402375|Analgesics|analgesics|mesh-ancestor
153346590|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
153346591|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346592|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346593|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
154258095|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258096|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154258097|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258098|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154258099|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154258100|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154258102|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
154258103|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154258104|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
154258105|NCT01289054|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154258106|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154005047|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153346594|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153346595|NCT01402375|Narcotics|narcotics|mesh-ancestor
153346596|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346597|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
153346598|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
153346599|NCT01302379|Metformin|metformin|mesh-list
153346600|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153346601|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346693|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153346694|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346695|NCT01357135|Incretins|incretins|mesh-ancestor
153346697|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346750|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153346752|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346753|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
153346754|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
153346755|NCT01311895|Hydromorphone|hydromorphone|mesh-list
153346756|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153346757|NCT01311895|Narcotics|narcotics|mesh-ancestor
153346758|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732222|NCT00504946|Vitamins|vitamins|mesh-ancestor
153346759|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346760|NCT01311895|Analgesics|analgesics|mesh-ancestor
153346761|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
153346762|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346763|NCT01362127|Cisplatin|cisplatin|mesh-list
153346764|NCT01362127|Carboplatin|carboplatin|mesh-list
153346765|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
153346766|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346767|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
153346768|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153346769|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346770|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346806|NCT01363843|Antidotes|antidotes|mesh-ancestor
153346807|NCT01363843|Protective Agents|protective agents|mesh-ancestor
153346900|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153346901|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153346903|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346904|NCT01316263|Olaratumab|olaratumab|mesh-list
153346905|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346940|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347025|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153347026|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153347027|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153347028|NCT01109069|Ibrutinib|ibrutinib|mesh-list
153347029|NCT01109069|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153347030|NCT01109069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153347031|NCT01109069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258107|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258108|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258111|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154258112|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
153732226|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153732227|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732229|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153732230|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732232|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
154258113|NCT01181414|Amiodarone|amiodarone|mesh-list
154258114|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154258115|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154258116|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
154258117|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258118|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258119|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258120|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154258121|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
153732100|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153732101|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732102|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
153732103|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732104|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732105|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
153732106|NCT00162006|Antibodies|antibodies|mesh-list
153732107|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
153732108|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153732109|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153732110|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
153732111|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347062|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347064|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
153347065|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347066|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412300|NCT02974933|Apatinib|apatinib|mesh-list
153347116|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347117|NCT01859819|Cytarabine|cytarabine|mesh-list
153347118|NCT01859819|Rituximab|rituximab|mesh-list
153347119|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153347153|NCT03013361|Ropivacaine|ropivacaine|mesh-list
153347154|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
153347155|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
153347156|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347157|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347158|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
153347159|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347160|NCT01077401|Ranibizumab|ranibizumab|mesh-list
153848351|NCT00554528|Meloxicam|meloxicam|mesh-list
153347181|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347183|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347184|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347185|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153783336|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153347186|NCT01034111|Metformin|metformin|mesh-list
153347187|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153347188|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153347189|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347190|NCT01034111|Incretins|incretins|mesh-ancestor
153347191|NCT01034111|Hormones|hormones|mesh-ancestor
153347192|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347193|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153347194|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
153347195|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347196|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347197|NCT01114997|Lidocaine|lidocaine|mesh-list
153412439|NCT02483000|Biotin|biotin|mesh-list
153347248|NCT01317901|Rituximab|rituximab|mesh-list
153347249|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153347250|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153347251|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347252|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
153347253|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347272|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153347273|NCT01899170|Narcotics|narcotics|mesh-ancestor
153347274|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347275|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347276|NCT01899170|Analgesics|analgesics|mesh-ancestor
153347277|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
153347278|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347279|NCT01425229|Bosentan|bosentan|mesh-list
153347280|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153347281|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153347282|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347283|NCT00258362|Carboplatin|carboplatin|mesh-list
153347284|NCT00258362|Docetaxel|docetaxel|mesh-list
153347285|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347286|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
153347287|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
153347288|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
153347289|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347290|NCT00258830|Vaccines|vaccines|mesh-list
153347291|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
153378090|NCT03128021|Milnacipran|milnacipran|mesh-list
153732257|NCT00141167|Varenicline|varenicline|mesh-list
153347292|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347293|NCT02539368|Infliximab|infliximab|mesh-list
153347294|NCT02539368|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153347295|NCT02539368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347296|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347297|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153347298|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347299|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
153347300|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347302|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347303|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413261|NCT02546570|Oxytocin|oxytocin|mesh-list
153347428|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
153347429|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347430|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153347507|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153347508|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
153347509|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
153347510|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
153347511|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
153347512|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
153347513|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347514|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347515|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153347516|NCT00176852|Vidarabine|vidarabine|mesh-list
153347517|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
153347518|NCT00176852|Busulfan|busulfan|mesh-list
153347519|NCT00176852|Fludarabine|fludarabine|mesh-list
153347520|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
153347545|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347546|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347547|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
153347548|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153347549|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347550|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
153380312|NCT03111381|Analgesics|analgesics|mesh-ancestor
153347563|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347564|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347565|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347566|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732264|NCT00141206|Varenicline|varenicline|mesh-list
153347567|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153347568|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153347569|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347570|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347571|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153347572|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153347573|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347574|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153347575|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347576|NCT01431391|Leuprolide|leuprolide|mesh-list
153347577|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153347578|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
153347579|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153347580|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347581|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153347582|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347650|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347652|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153347653|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
153347654|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153347655|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347656|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153347657|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347676|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347677|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
153347678|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347679|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347680|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153347681|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153347682|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347683|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
153347684|NCT01381471|Fluticasone|fluticasone|mesh-list
153347686|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153347687|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347688|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153347689|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
153414362|NCT02577991|Triamcinolone|triamcinolone|mesh-list
153347809|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
153347810|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347811|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347830|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153347832|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347833|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
153347834|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347836|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
153347837|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153347839|NCT01384591|Protective Agents|protective agents|mesh-ancestor
153347840|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347841|NCT01384591|Antidotes|antidotes|mesh-ancestor
153347842|NCT01086605|Pixantrone|pixantrone|mesh-list
153347843|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153347844|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153347905|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347906|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
153347952|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347953|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153347955|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153347956|NCT01473745|Growth Substances|growth substances|mesh-ancestor
153347957|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347959|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
153347960|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
153347961|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347962|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347963|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
153347964|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347966|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
153347967|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
153347968|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
153347969|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347970|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388629|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
153388630|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153388631|NCT00380835|Amrubicin|amrubicin|mesh-list
153388632|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388633|NCT00001311|Heparin|heparin|mesh-list
153388634|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
153388635|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153848498|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153848516|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
153848517|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153848518|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153848519|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848520|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153388673|NCT00002085|Azithromycin|azithromycin|mesh-list
153347971|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153347972|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153347973|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348007|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
153348008|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153348009|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
153348010|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
153348011|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348012|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348013|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348014|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
153348015|NCT00128180|Hormones|hormones|mesh-ancestor
153387675|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153348048|NCT01445821|Fludarabine|fludarabine|mesh-list
153348094|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153348095|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
153348097|NCT01093469|Decanoic acid|decanoic acid|mesh-list
153348098|NCT01093469|Petrolatum|petrolatum|mesh-list
153348099|NCT01093469|Emollients|emollients|mesh-ancestor
153348100|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
153348101|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
153348102|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348103|NCT02543658|Neostigmine|neostigmine|mesh-list
153348131|NCT00183794|Docetaxel|docetaxel|mesh-list
153348132|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153348133|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
153348134|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348135|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348136|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
153348137|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
153348139|NCT00270296|Ritonavir|ritonavir|mesh-list
153348140|NCT00270296|Lopinavir|lopinavir|mesh-list
153348141|NCT00270296|Lamivudine|lamivudine|mesh-list
153348142|NCT00270296|Zidovudine|zidovudine|mesh-list
153348143|NCT00270296|Nevirapine|nevirapine|mesh-list
153348144|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153348145|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153348146|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153348147|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
153348148|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348149|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348151|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153348152|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
153348153|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348154|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153348169|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348191|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153348192|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153348194|NCT03013205|Hormones|hormones|mesh-ancestor
153348195|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348196|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348197|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153348198|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
153348199|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348200|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348201|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
153348202|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
153348203|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348204|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
153348205|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348206|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153348207|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153348208|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153348209|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348210|NCT01094717|Tazarotene|tazarotene|mesh-list
153348211|NCT01094717|Acitretin|acitretin|mesh-list
153348230|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348231|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348236|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348237|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348238|NCT05307341|Analgesics|analgesics|mesh-ancestor
153348239|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
153417111|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348304|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348305|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348307|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153348308|NCT02246855|Antibodies|antibodies|mesh-list
153348309|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
153417180|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
153348406|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348407|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348408|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348409|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348410|NCT04751318|Analgesics|analgesics|mesh-ancestor
153348411|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
153348412|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348413|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
153348414|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348415|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
153348416|NCT01105247|Ibrutinib|ibrutinib|mesh-list
153348417|NCT01105247|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153348418|NCT01105247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153348419|NCT01105247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348420|NCT01105247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348421|NCT01107665|Paclitaxel|paclitaxel|mesh-list
153348422|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153348423|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348424|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
153348425|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
153348426|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
153348428|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
153348429|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153348430|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348431|NCT01447225|Carboplatin|carboplatin|mesh-list
153348432|NCT01447225|Gemcitabine|gemcitabine|mesh-list
153348433|NCT01447225|Pemetrexed|pemetrexed|mesh-list
153348434|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348435|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153348436|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
153348437|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348438|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348439|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153417316|NCT05057689|Analgesics|analgesics|mesh-ancestor
153348474|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348475|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348477|NCT01474213|Analgesics|analgesics|mesh-ancestor
153348478|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
153348479|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348480|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153348481|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153348482|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153348483|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
153348484|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348485|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348486|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153348487|NCT01474213|Narcotics|narcotics|mesh-ancestor
153348488|NCT00147212|Trabectedin|trabectedin|mesh-list
153348489|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153348491|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348492|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348493|NCT01474915|Promethazine|promethazine|mesh-list
153348494|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
153348495|NCT01474915|Dexamethasone|dexamethasone|mesh-list
153348496|NCT01474915|Ondansetron|ondansetron|mesh-list
153348517|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153348518|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
153348519|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
153348520|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154258123|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348521|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153348522|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153783358|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
153783359|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
153348523|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348524|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
153348526|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
153348527|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
153348528|NCT01899794|Oxybutynin|oxybutynin|mesh-list
153348529|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
153348530|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
153348531|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348532|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348533|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153348534|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153348535|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
153348536|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348537|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348538|NCT01899794|Urological Agents|urological agents|mesh-ancestor
153348539|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153348540|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348541|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
153348594|NCT00210470|Omeprazole|omeprazole|mesh-list
153348595|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153348596|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
153348597|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348598|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417521|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153348609|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348610|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153348611|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153348632|NCT01108445|Growth Substances|growth substances|mesh-ancestor
153348633|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
153348634|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153348635|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153348636|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348637|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153348638|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
153348639|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153348640|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153348642|NCT04352153|Citric Acid|citric acid|mesh-list
153348643|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
153348644|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153348645|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
153348646|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
153348647|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348648|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
153348649|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153348651|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348652|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
153348653|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
153348654|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
153348655|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348656|NCT01162733|Vancomycin|vancomycin|mesh-list
153348657|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153348658|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348660|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
153348661|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348662|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
153348663|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348664|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348665|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
153348666|NCT01131065|Antibodies|antibodies|mesh-list
153348667|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
153348668|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153848684|NCT01209520|Docetaxel|docetaxel|mesh-list
153348686|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153417746|NCT04507022|Estradiol|estradiol|mesh-list
153348711|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153348774|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
153348775|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153348776|NCT00293540|Tamoxifen|tamoxifen|mesh-list
153348777|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153348778|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
153380491|NCT01691690|Acetaminophen|acetaminophen|mesh-list
153348779|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348780|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348781|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153348782|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348783|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153348784|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153348785|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153348786|NCT03012113|Mirabegron|mirabegron|mesh-list
153348787|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153348788|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153348789|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153348790|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
153348811|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153348812|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153348813|NCT00294632|Growth Substances|growth substances|mesh-ancestor
153348814|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
153348815|NCT01898624|Mirabegron|mirabegron|mesh-list
153348816|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153348817|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153348818|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153348845|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348846|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348875|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153348877|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348879|NCT00297596|Trastuzumab|trastuzumab|mesh-list
153348880|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348881|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153348882|NCT01144637|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153348883|NCT01144637|Antiviral Agents|antiviral agents|mesh-ancestor
153348884|NCT01144637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348885|NCT00298610|Artesunate|artesunate|mesh-list
153348886|NCT00298610|Atovaquone|atovaquone|mesh-list
153348887|NCT00298610|Proguanil|proguanil|mesh-list
153348888|NCT00298610|Quinidine|quinidine|mesh-list
153348889|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153348890|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
153348891|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153348892|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153348893|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783367|NCT02213653|Iron|iron|mesh-list
153348928|NCT00215930|Vinorelbine|vinorelbine|mesh-list
153348929|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348930|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153418906|NCT05828199|Ketamine|ketamine|mesh-list
153348976|NCT01147601|Timolol|timolol|mesh-list
153348977|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153348978|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153348979|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
153348980|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348981|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348982|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348983|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153348984|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153349030|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349031|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153349032|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
153349033|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153349034|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153349035|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153349036|NCT03886649|Venetoclax|venetoclax|mesh-list
153783369|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
153423734|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153349046|NCT03835949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153349047|NCT03835949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349048|NCT03835949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153349049|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349050|NCT01177709|Metformin|metformin|mesh-list
153349051|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153349052|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349053|NCT01179113|Esmolol|esmolol|mesh-list
153349054|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153349055|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154258124|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154258125|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154258126|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153392815|NCT05738408|Nicotine|nicotine|mesh-list
153349056|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153349057|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
153349058|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349059|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349060|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349061|NCT01152515|Remifentanil|remifentanil|mesh-list
153349062|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153349063|NCT01152515|Narcotics|narcotics|mesh-ancestor
153349064|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349065|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349066|NCT01152515|Analgesics|analgesics|mesh-ancestor
153349067|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
153349068|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349069|NCT03011177|Linagliptin|linagliptin|mesh-list
153349070|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153349071|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349072|NCT03011177|Incretins|incretins|mesh-ancestor
153349073|NCT03011177|Hormones|hormones|mesh-ancestor
153349074|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349075|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153349076|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
153349077|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349078|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349113|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848768|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153848769|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
153848771|NCT04665830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153349114|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153349115|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
153349116|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153349142|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153349143|NCT00300482|Calcium|calcium|mesh-list
153349144|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153349145|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349146|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153349147|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153349148|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
153349149|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349150|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153349151|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153349152|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349153|NCT00301028|Paclitaxel|paclitaxel|mesh-list
153349154|NCT00301028|Carboplatin|carboplatin|mesh-list
153349155|NCT00301028|Cetuximab|cetuximab|mesh-list
153349156|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153424385|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
153349192|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
153349193|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
153349194|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349195|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349196|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153349197|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
153349198|NCT01478581|Hormones|hormones|mesh-ancestor
153349199|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349200|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153349201|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349202|NCT01478581|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153349203|NCT01478581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153349204|NCT01478581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349205|NCT01478581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349206|NCT00239642|Iron|iron|mesh-list
153349207|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153349208|NCT00239642|Trace Elements|trace elements|mesh-ancestor
153349209|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
153349210|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349211|NCT00239642|Hematinics|hematinics|mesh-ancestor
153349212|NCT00241904|Propranolol|propranolol|mesh-list
153349213|NCT00241904|Metoprolol|metoprolol|mesh-list
153349214|NCT00241904|Atenolol|atenolol|mesh-list
153349215|NCT00241904|Lisinopril|lisinopril|mesh-list
153840468|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153380586|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380587|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
153380588|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
153380589|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
153380591|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153349248|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349250|NCT01479127|Levodopa|levodopa|mesh-list
153349251|NCT01479127|Carbidopa|carbidopa|mesh-list
153349252|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153349253|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153349254|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
153349289|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153349290|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349291|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
153349292|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349293|NCT03783416|Ixazomib|ixazomib|mesh-list
153349294|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349329|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153349330|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783374|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349355|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349356|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349358|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349359|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153349360|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349361|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349362|NCT02099006|Ketoprofen|ketoprofen|mesh-list
153349363|NCT02099006|Ketamine|ketamine|mesh-list
153349364|NCT02099006|Gabapentin|gabapentin|mesh-list
153349365|NCT02099006|Amitriptyline|amitriptyline|mesh-list
153349366|NCT02099006|Baclofen|baclofen|mesh-list
153349367|NCT02099006|Loperamide|loperamide|mesh-list
153349368|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
153349369|NCT02099006|Analgesics|analgesics|mesh-ancestor
153349370|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
153349371|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349372|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349373|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153349422|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153349423|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349448|NCT01480297|Analgesics|analgesics|mesh-ancestor
153349449|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
153349450|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349451|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349452|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349453|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349454|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153349455|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349456|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349457|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
153349458|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153349460|NCT01392703|Dasatinib|dasatinib|mesh-list
153349461|NCT01392703|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153349462|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153349463|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349464|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349465|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349466|NCT01392859|Levocetirizine|levocetirizine|mesh-list
153349467|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153349468|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153349469|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
153349470|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
153349471|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349493|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
153349494|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349495|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153349496|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349498|NCT01460875|Interferons|interferons|mesh-list
153349499|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
153349522|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349523|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
153349524|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153349525|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349558|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153349559|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
153349560|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
153349561|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349562|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349564|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349565|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153349566|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153349567|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153349568|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732350|NCT04511728|Propofol|propofol|mesh-list
153349569|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349591|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349592|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349593|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349594|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153349595|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153349596|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
153349597|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
153349598|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349599|NCT02106494|Dexamethasone|dexamethasone|mesh-list
153349600|NCT02106494|Ondansetron|ondansetron|mesh-list
153349601|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
153349602|NCT02106494|Aprepitant|aprepitant|mesh-list
153349603|NCT02106494|Granisetron|granisetron|mesh-list
153349604|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349605|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
153349606|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
153349659|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349660|NCT01183481|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153349661|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153349662|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
153349663|NCT01183559|Paclitaxel|paclitaxel|mesh-list
153349664|NCT01183559|Carboplatin|carboplatin|mesh-list
153349665|NCT01183559|Fluorouracil|fluorouracil|mesh-list
153349666|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153349667|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349668|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
153349669|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
153349670|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
153349671|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349672|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
153349698|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153349699|NCT01222091|Narcotics|narcotics|mesh-ancestor
153349700|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349701|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349702|NCT01222091|Analgesics|analgesics|mesh-ancestor
153349703|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
153349704|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349705|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153349706|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153783380|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153349707|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
153349761|NCT01161563|Leuprolide|leuprolide|mesh-list
153389102|NCT00002367|Lamivudine|lamivudine|mesh-list
153349762|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153349763|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153349764|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
153349765|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153349790|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
153349791|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153349792|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153349793|NCT02191865|Nintedanib|nintedanib|mesh-list
153349794|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349795|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153349796|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349797|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349798|NCT04352465|Methotrexate|methotrexate|mesh-list
153349799|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153349800|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
153349801|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154258128|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154258129|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154258130|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154258131|NCT01094340|Thalidomide|thalidomide|mesh-list
154258132|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258133|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
153732119|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153349802|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349803|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153349804|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
153349805|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349806|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349807|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
153349808|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349809|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153425579|NCT01804166|Infliximab|infliximab|mesh-list
153349858|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153349859|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
153349860|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349861|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349862|NCT01650350|Naltrexone|naltrexone|mesh-list
153349863|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153349864|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153426964|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
153349910|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
153349911|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349912|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349913|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389125|NCT00002379|Lamivudine|lamivudine|mesh-list
153349915|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153361332|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153349916|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
153349917|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349936|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349937|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
153349938|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349939|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349940|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153349941|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
153349942|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349943|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349944|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153349945|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153349946|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153349947|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
153349948|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153349949|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349950|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349951|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
153349952|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153349953|NCT00306488|Antioxidants|antioxidants|mesh-list
153349954|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153349955|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349956|NCT00306488|Protective Agents|protective agents|mesh-ancestor
153349957|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349959|NCT01793636|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153349960|NCT01793636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350020|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350021|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153350022|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
153731993|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153731994|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731995|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
153731996|NCT00140153|Testosterone|testosterone|mesh-list
153731997|NCT00140153|Androgens|androgens|mesh-ancestor
153731999|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732000|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732001|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
153350398|NCT05901701|Keratolytic Agents|keratolytic agents|mesh-ancestor
153428774|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
153732390|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153350545|NCT05837000|Tocolytic Agents|tocolytic agents|mesh-ancestor
153350546|NCT05837000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153350547|NCT05833139|Itraconazole|itraconazole|mesh-list
153350548|NCT05833139|Antifungal Agents|antifungal agents|mesh-ancestor
153350549|NCT05833139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350550|NCT05833139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153350577|NCT05707273|Fludarabine|fludarabine|mesh-list
153350578|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153350579|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
153350580|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350581|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429042|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
153351318|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
153351319|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
153351320|NCT02271230|Vitamins|vitamins|mesh-list
153351321|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
153351322|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351323|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153351324|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153351325|NCT00396266|Plerixafor|plerixafor|mesh-list
153351326|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153351327|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153351328|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
153351329|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351330|NCT05610384|Ibuprofen|ibuprofen|mesh-list
153351331|NCT05610384|Ketorolac|ketorolac|mesh-list
153351361|NCT00401414|Warfarin|warfarin|mesh-list
153351362|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
153351363|NCT00370838|Clonidine|clonidine|mesh-list
153351364|NCT00370838|Levetiracetam|levetiracetam|mesh-list
153351365|NCT00370838|Analgesics|analgesics|mesh-ancestor
153351366|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
153351367|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351368|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351369|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153351370|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
153351371|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
153351372|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153351720|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351721|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153351722|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153351724|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153351725|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153351726|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378755|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351727|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153351728|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153351729|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153351903|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153351904|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
153351905|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351907|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153351943|NCT00411086|Molgramostim|molgramostim|mesh-list
153351944|NCT00411086|Sargramostim|sargramostim|mesh-list
153351945|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351946|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351947|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
153378767|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153351948|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351949|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351980|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351981|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351982|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351984|NCT05236530|Repaglinide|repaglinide|mesh-list
153352072|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352073|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352074|NCT00457730|Analgesics|analgesics|mesh-ancestor
153352075|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
153352076|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352077|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
153352078|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153352186|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153352187|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153352189|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
153352190|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352191|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352192|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352225|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352226|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153352227|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153352319|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153352320|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153352349|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352350|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153352351|NCT05168280|Analgesics|analgesics|mesh-ancestor
153352352|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
153352353|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352354|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153352355|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153352356|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153352357|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352358|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352466|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352467|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352468|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352539|NCT00540722|Acetic Acid|acetic acid|mesh-list
153352540|NCT00540722|Retinol acetate|retinol acetate|mesh-list
153352541|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
153352542|NCT00540722|Gossypol|gossypol|mesh-list
153352543|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153352544|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352545|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153352546|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
153352547|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352548|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153352549|NCT00540722|Protective Agents|protective agents|mesh-ancestor
153352550|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352551|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153352552|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
153352553|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153352554|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153352555|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153352556|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153352557|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153352558|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
153352559|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153352560|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
153352581|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153352582|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352583|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352584|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
153352586|NCT00420992|Morphine|morphine|mesh-list
153352587|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153352588|NCT00420992|Narcotics|narcotics|mesh-ancestor
153352589|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352590|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352591|NCT00420992|Analgesics|analgesics|mesh-ancestor
153352592|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
153352593|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352594|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153352595|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153352596|NCT00423878|Olanzapine|olanzapine|mesh-list
153352597|NCT00423878|Risperidone|risperidone|mesh-list
153434300|NCT00002047|Zidovudine|zidovudine|mesh-list
153352694|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
153352695|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
153352696|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
153352697|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352698|NCT00486824|Indomethacin|indomethacin|mesh-list
153352699|NCT00486824|Nifedipine|nifedipine|mesh-list
153352700|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153352701|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153352702|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352703|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154258136|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154258137|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258138|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154258139|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154258140|NCT01094340|Growth Substances|growth substances|mesh-ancestor
154258141|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
154258142|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258143|NCT00056862|Ribavirin|ribavirin|mesh-list
154258144|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154258145|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
154258146|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
153352704|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352705|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
153352706|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
153352707|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153352744|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352745|NCT00546728|Metformin|metformin|mesh-list
153352746|NCT00546728|Exenatide|exenatide|mesh-list
153352747|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153352771|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352773|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153352774|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
153352775|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153352776|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153352777|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153352778|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352779|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352780|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
153352781|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153352782|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153352784|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153352785|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
153352786|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153352787|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352788|NCT00492206|Cetuximab|cetuximab|mesh-list
153352789|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153352790|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352791|NCT00431132|Estradiol|estradiol|mesh-list
153352857|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352907|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153352909|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352910|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
153352911|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
153352912|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352913|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
153352914|NCT05150496|Vaccines|vaccines|mesh-list
153352915|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
153352945|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153352946|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352947|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352948|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153352949|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
153352950|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153352951|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352952|NCT00555152|Lapatinib|lapatinib|mesh-list
153352953|NCT00555152|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153353169|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353194|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
153353195|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153353196|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153353197|NCT05028348|Growth Substances|growth substances|mesh-ancestor
153353198|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
153353199|NCT01486615|Melatonin|melatonin|mesh-list
153353200|NCT01486615|Alprazolam|alprazolam|mesh-list
153353201|NCT01486615|Azaperone|azaperone|mesh-list
153353202|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
153380841|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380842|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380843|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153380844|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153380845|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153840694|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
153840695|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
153840696|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
153840699|NCT04803474|Hormones|hormones|mesh-list
153353203|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353204|NCT01486615|Protective Agents|protective agents|mesh-ancestor
153353205|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353206|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353207|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153353208|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153353209|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153353210|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353211|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
153353212|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
153353213|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353214|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153353215|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153353216|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
153353217|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153353219|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353220|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153353221|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
153353222|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153353223|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
153353224|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353303|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153353304|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
153353305|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353306|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353307|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153353308|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
153353309|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153353310|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153353311|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153353312|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
153353313|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353314|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353315|NCT01488409|Acipimox|acipimox|mesh-list
153353316|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153353338|NCT01364922|Narcotics|narcotics|mesh-ancestor
153353339|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353340|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
153353341|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
153353342|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153849619|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153353343|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353344|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353346|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
153353347|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353348|NCT01489969|Protective Agents|protective agents|mesh-ancestor
153353349|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353350|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353351|NCT00509288|Aldesleukin|aldesleukin|mesh-list
153353352|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
153353353|NCT00509288|Fludarabine|fludarabine|mesh-list
153353354|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353355|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
153353356|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258147|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258148|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
154258149|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258150|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
154258151|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353411|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353412|NCT00446264|Sirolimus|sirolimus|mesh-list
153353413|NCT00446264|Tacrolimus|tacrolimus|mesh-list
153353414|NCT00446264|Daclizumab|daclizumab|mesh-list
153353415|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353416|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
153353417|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353418|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153353419|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353420|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353471|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
153353472|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153353473|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
153353474|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153353475|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153353476|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
153353507|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153353508|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153353509|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153353510|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849620|NCT04592809|Midazolam|midazolam|mesh-list
153353511|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353512|NCT00517010|Ranibizumab|ranibizumab|mesh-list
153353513|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153353561|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
153353562|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353563|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153353564|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153353565|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
153353566|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353567|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353568|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153353569|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153353570|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
153353571|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153353572|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
153353640|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353642|NCT00524342|Oprelvekin|oprelvekin|mesh-list
153353643|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353644|NCT00524576|Vaccines|vaccines|mesh-list
153353645|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
153353646|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353647|NCT02516202|Estradiol|estradiol|mesh-list
153353648|NCT02516202|Estrogens|estrogens|mesh-ancestor
153353649|NCT02516202|Hormones|hormones|mesh-ancestor
153353650|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353651|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353652|NCT00526058|Clotrimazole|clotrimazole|mesh-list
153353653|NCT00526058|Miconazole|miconazole|mesh-list
153353654|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153353655|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353656|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
153353657|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153353658|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153353659|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353660|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353661|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153353662|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
153389855|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153849744|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153849745|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153849746|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849747|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153849748|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
153353663|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353788|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840789|NCT04590937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353790|NCT01508455|Fentanyl|fentanyl|mesh-list
153353791|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
153353792|NCT01508455|Morphine|morphine|mesh-list
153353793|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153353794|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353822|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
153353823|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353824|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353826|NCT02482428|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153353827|NCT02482428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353828|NCT02482428|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153353829|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
153353830|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353831|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153353832|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353833|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
153353834|NCT01510327|Aspirin|aspirin|mesh-list
153353835|NCT01510327|Everolimus|everolimus|mesh-list
153353836|NCT01510327|Ticlopidine|ticlopidine|mesh-list
153353837|NCT01510327|Clopidogrel|clopidogrel|mesh-list
153353838|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153353839|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153353924|NCT03243890|Vitamins|vitamins|mesh-ancestor
153353925|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
153353926|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353927|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153353928|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153353929|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153353930|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353931|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
153353932|NCT03243890|Coagulants|coagulants|mesh-ancestor
153353933|NCT00560612|Paroxetine|paroxetine|mesh-list
153353934|NCT00560612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153353960|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353962|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
153353963|NCT03236792|Ixazomib|ixazomib|mesh-list
153353964|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353965|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
153353966|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353967|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353968|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153353969|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
153435924|NCT00002882|Analgesics|analgesics|mesh-ancestor
153354107|NCT03303950|Fludarabine|fludarabine|mesh-list
153354108|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354109|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
153354110|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354111|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354112|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153354113|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
153354114|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354139|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
153354140|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354142|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153354143|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153354144|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354146|NCT01797926|Amlodipine|amlodipine|mesh-list
153354147|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153354148|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153354149|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153354150|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354151|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153354152|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354153|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
153354154|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153354155|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153354156|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153354157|NCT03008083|Clopidogrel|clopidogrel|mesh-list
153354158|NCT03008083|Ticagrelor|ticagrelor|mesh-list
153354159|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153436134|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380979|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380980|NCT02389764|Nintedanib|nintedanib|mesh-list
153380981|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380982|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153380983|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380984|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380985|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153380986|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153380987|NCT01647932|Diuretics|diuretics|mesh-ancestor
153380988|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
153354243|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153354244|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153354245|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
153354246|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354247|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354248|NCT05473286|Semaglutide|semaglutide|mesh-list
153354249|NCT05473286|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153354250|NCT05473286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153354251|NCT05473286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354253|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
153354254|NCT02129426|Ketamine|ketamine|mesh-list
153354255|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153436261|NCT00002653|Prednisone|prednisone|mesh-list
153354331|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
153354332|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153354333|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354334|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783426|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354335|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153354336|NCT01528891|Analgesics|analgesics|mesh-ancestor
153354337|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
153354338|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354339|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153354340|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153354341|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153354342|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
153354343|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354344|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354345|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
153436294|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354367|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
153354368|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354369|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354370|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
153354371|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354372|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153354373|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354374|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
153354375|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354376|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153354377|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153354378|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153354379|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153354395|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354396|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153354397|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354398|NCT00569660|Azacitidine|azacitidine|mesh-list
153354399|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153354400|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
153354401|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354402|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354403|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354404|NCT01573273|Oxytocin|oxytocin|mesh-list
154258153|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
153381020|NCT02389452|Hylan|hylan|mesh-list
153354405|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
153354406|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153354407|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354408|NCT00572468|Simvastatin|simvastatin|mesh-list
153783427|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354409|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153354410|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153354411|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
153354412|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354413|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153436381|NCT00002665|Vitamins|vitamins|mesh-ancestor
153354496|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354497|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
153354498|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153354499|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153354500|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354501|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153354502|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153354503|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153354504|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354505|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354506|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
153354507|NCT01532089|Bevacizumab|bevacizumab|mesh-list
153354508|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153354509|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153354510|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
153354568|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
153354569|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354570|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153354571|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153354572|NCT05245448|Tetrandrine|tetrandrine|mesh-list
153849890|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849906|NCT03267121|Tegafur|tegafur|mesh-list
153354573|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
153354574|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153354575|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153354576|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354596|NCT01798472|Cimetidine|cimetidine|mesh-list
153354597|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153354598|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153354599|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153354600|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
153354601|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
153354602|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354603|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436588|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354628|NCT01534897|Dabrafenib|dabrafenib|mesh-list
153354629|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354630|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153354631|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354632|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354633|NCT05121350|Epirubicin|epirubicin|mesh-list
153354670|NCT00583700|Protective Agents|protective agents|mesh-ancestor
153354671|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153354672|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354673|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153354674|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153354675|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
153354676|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153354874|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153354875|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
153354876|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
153354877|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354878|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354879|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
153354880|NCT00668564|Busulfan|busulfan|mesh-list
153354881|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
153354882|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354883|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
153354884|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354885|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436648|NCT00003584|Hormones|hormones|mesh-ancestor
153355210|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153355211|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
153355212|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
153355213|NCT00675584|Hormones|hormones|mesh-ancestor
153387709|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355247|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355248|NCT02513472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153355249|NCT02513472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355250|NCT00621686|Bevacizumab|bevacizumab|mesh-list
153355436|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355437|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
153355438|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
153355439|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153355497|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355498|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
153355499|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153355500|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355501|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153355502|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
153355503|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153355504|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355505|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355506|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355508|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
153355509|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355510|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153355511|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153355512|NCT00684242|Growth Substances|growth substances|mesh-ancestor
153355672|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355673|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
153355674|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153355675|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153355676|NCT00687674|Growth Substances|growth substances|mesh-ancestor
153355677|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
153355851|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355852|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355853|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153355854|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153355855|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153355856|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
153355857|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153355858|NCT02137538|Letrozole|letrozole|mesh-list
153355859|NCT02137538|Anastrozole|anastrozole|mesh-list
153355860|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355861|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153355862|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153355863|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355864|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355865|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153355866|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
153355867|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355868|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356035|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356036|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356037|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153356122|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153356123|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356124|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153356125|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153437129|NCT00002767|Interferons|interferons|mesh-list
153356181|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153356182|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153356183|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
153356186|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
153356187|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356188|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153356189|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
153356190|NCT02997332|Docetaxel|docetaxel|mesh-list
153356191|NCT02997332|Fluorouracil|fluorouracil|mesh-list
153356192|NCT02997332|Durvalumab|durvalumab|mesh-list
153356193|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356230|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356231|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
153356232|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
153356308|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356310|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153356311|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153356312|NCT04270370|Atorvastatin|atorvastatin|mesh-list
153356313|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153356322|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153356323|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356439|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356440|NCT02979392|Paclitaxel|paclitaxel|mesh-list
153356441|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153356498|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153356499|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153356500|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
153356501|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153783451|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356502|NCT02195921|Antiemetics|antiemetics|mesh-list
153356503|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
153356504|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356505|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356506|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153356507|NCT02189213|Sertraline|sertraline|mesh-list
153356508|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
153356509|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356693|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
153356694|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356695|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356696|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153356697|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
153356699|NCT01294319|Diuretics|diuretics|mesh-ancestor
153356700|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
153356994|NCT00711464|Modafinil|modafinil|mesh-list
153356995|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153850058|NCT01711658|Lapatinib|lapatinib|mesh-list
153357133|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357134|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153357135|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
153357136|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153357839|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357840|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357841|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153357935|NCT01214759|Emtricitabine|emtricitabine|mesh-list
153357936|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153357970|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153357971|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357972|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357973|NCT00781508|Urological Agents|urological agents|mesh-ancestor
153357974|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
153357976|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153357977|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357978|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358013|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153358014|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437683|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
153359637|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
153359638|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
153359639|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359640|NCT04527991|Immunoconjugates|immunoconjugates|mesh-ancestor
153359641|NCT04527991|Immunologic Factors|immunologic factors|mesh-ancestor
153359642|NCT04527991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359643|NCT04496063|Ustekinumab|ustekinumab|mesh-list
153359644|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
153359645|NCT04493060|Niraparib|niraparib|mesh-list
153382569|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382570|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382571|NCT01968317|Metformin|metformin|mesh-list
153382572|NCT01968317|Megestrol|megestrol|mesh-list
153382573|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
153382574|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153382575|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382576|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153382577|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153382578|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153382579|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
153382580|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153382581|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153382582|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153382583|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153382585|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
153382586|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153382587|NCT01971593|Eplerenone|eplerenone|mesh-list
153382588|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153382738|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382739|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153382740|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153382741|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
153382742|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382743|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382744|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
153382745|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153382800|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153382801|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153382802|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
153382803|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
153382804|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382805|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382806|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382808|NCT03496545|Bromocriptine|bromocriptine|mesh-list
153382809|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153382810|NCT03496545|Analgesics|analgesics|mesh-ancestor
153383389|NCT02363621|Aflibercept|aflibercept|mesh-list
153383651|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
153383652|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438210|NCT00003902|Capecitabine|capecitabine|mesh-list
153386627|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153386629|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153386630|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386631|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153386632|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
153386633|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
153387025|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387026|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387027|NCT01203371|Urological Agents|urological agents|mesh-ancestor
153469647|NCT04659811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470775|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
153470776|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470778|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153471105|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
153850116|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850117|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
153850118|NCT01208038|Testosterone|testosterone|mesh-list
153850119|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
153850120|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
153850121|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153850122|NCT01208038|Androgens|androgens|mesh-ancestor
153850123|NCT01208038|Hormones|hormones|mesh-ancestor
153850136|NCT01207687|Bevacizumab|bevacizumab|mesh-list
153850137|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153850138|NCT01207687|Antibodies|antibodies|mesh-list
153471106|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471107|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471108|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153471417|NCT05171660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471418|NCT05171660|Growth Inhibitors|growth inhibitors|mesh-ancestor
153471419|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471420|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
153471953|NCT00651456|Growth Substances|growth substances|mesh-ancestor
153472203|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153472204|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472205|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
153472206|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
153472207|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
153472208|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472209|NCT04366128|Immunomodulating Agents|immunomodulating agents|mesh-list
153472210|NCT04366128|Immunologic Factors|immunologic factors|mesh-ancestor
153472211|NCT04366128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472212|NCT04365582|Ritonavir|ritonavir|mesh-list
153472213|NCT04365582|Lopinavir|lopinavir|mesh-list
153472214|NCT04365582|Azithromycin|azithromycin|mesh-list
153472215|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472216|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153472217|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153472218|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472219|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472220|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472221|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153472222|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153472383|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153472384|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472385|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
153472420|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
153472421|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
153472422|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472423|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472515|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472518|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472519|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153472520|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472521|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472522|NCT04351152|Lenzilumab|lenzilumab|mesh-list
153472523|NCT04351152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472524|NCT04350528|Pentobarbital|pentobarbital|mesh-list
153472718|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472719|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
153472720|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153472721|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153472722|NCT04340388|Tenofovir|tenofovir|mesh-list
153472723|NCT04340388|Lamivudine|lamivudine|mesh-list
153472724|NCT04340388|Zidovudine|zidovudine|mesh-list
153472725|NCT04340388|Dolutegravir|dolutegravir|mesh-list
153472726|NCT04340388|Darunavir|darunavir|mesh-list
153472727|NCT04340388|Abacavir|abacavir|mesh-list
153472728|NCT04340388|Cobicistat|cobicistat|mesh-list
154258154|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154258155|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154258156|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154258157|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153393186|NCT01715233|Vitamins|vitamins|mesh-ancestor
153472729|NCT04340388|Rilpivirine|rilpivirine|mesh-list
153472730|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153472731|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
153472732|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472766|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472767|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
153472768|NCT04338126|Coagulants|coagulants|mesh-ancestor
153472769|NCT04337658|Capecitabine|capecitabine|mesh-list
153472770|NCT04337658|Trastuzumab|trastuzumab|mesh-list
153472771|NCT04337658|Fulvestrant|fulvestrant|mesh-list
153472811|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153472813|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472814|NCT04334928|Tenofovir|tenofovir|mesh-list
153472815|NCT04334928|Emtricitabine|emtricitabine|mesh-list
153472816|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153472829|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472830|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153472831|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472832|NCT04334382|Azithromycin|azithromycin|mesh-list
153472833|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472834|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153472835|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472836|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
153472837|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472838|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472839|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472840|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472841|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472842|NCT04333992|Remifentanil|remifentanil|mesh-list
153472843|NCT04333992|Propofol|propofol|mesh-list
153472844|NCT04333992|Sevoflurane|sevoflurane|mesh-list
153472845|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153472846|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472847|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472848|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153472960|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
153472961|NCT03035214|BB 1101|bb 1101|mesh-list
153472962|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472963|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
153472964|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
153472965|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472966|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472967|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472968|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
153472969|NCT03035214|Hormones|hormones|mesh-ancestor
153472970|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472971|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153472972|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472973|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472974|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473027|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153473028|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473029|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
153473030|NCT03023514|Progesterone|progesterone|mesh-list
153473031|NCT03023514|Progestins|progestins|mesh-ancestor
153473032|NCT03023514|Hormones|hormones|mesh-ancestor
153473033|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473034|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473035|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
153473036|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473037|NCT03023514|Protective Agents|protective agents|mesh-ancestor
153473038|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
153473039|NCT03023514|Vitamins|vitamins|mesh-ancestor
153473102|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
153473103|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153473104|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154258158|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473105|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473106|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153473107|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153473108|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153473109|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473110|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153473111|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473112|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473113|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473114|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473153|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473154|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153473155|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
153439744|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
153473208|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473209|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
153473210|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153473211|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
153473212|NCT03014778|Povidone|povidone|mesh-list
153473213|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153473214|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473215|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
153390407|NCT04389177|Paclitaxel|paclitaxel|mesh-list
153473216|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
153473217|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
153473218|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
153473219|NCT03014076|Trastuzumab|trastuzumab|mesh-list
153473220|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153473221|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473222|NCT03013140|Anesthetics|anesthetics|mesh-list
153473223|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473224|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473225|NCT03011970|Oxytocin|oxytocin|mesh-list
153473226|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
153473227|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153473228|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473229|NCT03010098|Remifentanil|remifentanil|mesh-list
153473230|NCT03010098|Propofol|propofol|mesh-list
153473231|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153473232|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473233|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473234|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153473235|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
153360189|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153473292|NCT03006042|Bupivacaine|bupivacaine|mesh-list
153473293|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
153473294|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
153473295|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473296|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473297|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
153473298|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473301|NCT03005496|Beta Carotene|beta carotene|mesh-list
153473303|NCT03005496|Dexamethasone|dexamethasone|mesh-list
153473304|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
153473305|NCT03005496|Nifedipine|nifedipine|mesh-list
153473354|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153473355|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153473356|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
153473357|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473358|NCT03005184|Icatibant|icatibant|mesh-list
153473359|NCT03005184|Valsartan|valsartan|mesh-list
153473360|NCT03005184|Enalapril|enalapril|mesh-list
153473361|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153473362|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153473363|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153473364|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153473365|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473366|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153473367|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
153439983|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153473495|NCT02987244|Etoposide|etoposide|mesh-list
153473496|NCT02987244|Epirubicin|epirubicin|mesh-list
153473497|NCT02987244|Vindesine|vindesine|mesh-list
154258160|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154258161|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154258162|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258163|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154258164|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258165|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
154258166|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
153473498|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153473522|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473523|NCT02987166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153473524|NCT02987166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473525|NCT02982486|Nivolumab|nivolumab|mesh-list
153473526|NCT02982486|Ipilimumab|ipilimumab|mesh-list
153473527|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153473528|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473529|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153473530|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473531|NCT02981784|Ponatinib|ponatinib|mesh-list
153473532|NCT02981784|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153473568|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473570|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153473571|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153473572|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
153473573|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473574|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473575|NCT02976246|Vitamin K|vitamin k|mesh-list
153473651|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
153473652|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
153813800|NCT00335270|Amprenavir|amprenavir|mesh-list
153473760|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813802|NCT00335270|Lamivudine|lamivudine|mesh-list
153360192|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153473812|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
153473813|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473833|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
153473834|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473835|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
153473836|NCT05313828|Hormones|hormones|mesh-ancestor
153473863|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153473864|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153473865|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473866|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
153821660|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
153473867|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153473868|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153473869|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153473870|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153473871|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473959|NCT03297684|Growth Substances|growth substances|mesh-ancestor
153473960|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473961|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
153473962|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473963|NCT01685424|Etoricoxib|etoricoxib|mesh-list
153473964|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473965|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473966|NCT01685424|Analgesics|analgesics|mesh-ancestor
153473967|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
153473968|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473969|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473970|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473971|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473972|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153473973|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153474059|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474060|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153841192|NCT03759093|Bortezomib|bortezomib|mesh-list
153474061|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474062|NCT00592176|Growth Substances|growth substances|mesh-ancestor
153474063|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474077|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153474078|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
153474079|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
153474080|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474081|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153474082|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153474084|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474086|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
153474087|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153474088|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474089|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474090|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
153474091|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153474092|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474093|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474094|NCT00597402|Bevacizumab|bevacizumab|mesh-list
153474095|NCT00597402|Irinotecan|irinotecan|mesh-list
153474096|NCT00597402|Temozolomide|temozolomide|mesh-list
153474097|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474098|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474125|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474247|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474248|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153474264|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474265|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474266|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153474267|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
153474268|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153474269|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153474270|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153474271|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
153474272|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474273|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474274|NCT00644592|Fenofibrate|fenofibrate|mesh-list
153474275|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153474276|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
153474277|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474330|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474332|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153474333|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474334|NCT00666666|Acetic Acid|acetic acid|mesh-list
153474335|NCT00666666|Bicalutamide|bicalutamide|mesh-list
153474336|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
153474337|NCT00666666|Gossypol|gossypol|mesh-list
153474338|NCT00666666|Hormones|hormones|mesh-list
153474339|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474340|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474341|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
153360194|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474342|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
153474395|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153474396|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153474397|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474398|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153474399|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474400|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
153474401|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153474402|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
153474403|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474404|NCT00672438|Alfentanil|alfentanil|mesh-list
153474405|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153474406|NCT00672438|Narcotics|narcotics|mesh-ancestor
153474407|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474408|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474409|NCT00672438|Analgesics|analgesics|mesh-ancestor
153474410|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
153474411|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474412|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153474413|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
153474414|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
153474415|NCT00672594|Sunitinib|sunitinib|mesh-list
153474416|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474417|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474434|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153474501|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
153474502|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153474503|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153474506|NCT00683046|Melphalan|melphalan|mesh-list
153474507|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
153474508|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474509|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474510|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153474511|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
153474512|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474513|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153474514|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
153474515|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153474516|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474517|NCT00687102|Tamoxifen|tamoxifen|mesh-list
153474534|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153474536|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
153474537|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153474538|NCT00691002|Calcitriol|calcitriol|mesh-list
153474539|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
153360195|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153474540|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153474541|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153474542|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153474543|NCT00691002|Calcipotriene|calcipotriene|mesh-list
153474544|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474545|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
153474546|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153474547|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474548|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153443100|NCT02015676|Paclitaxel|paclitaxel|mesh-list
153474773|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474774|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153474775|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474807|NCT00728910|Vitamins|vitamins|mesh-ancestor
153474808|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
153474809|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474810|NCT00729846|Bevacizumab|bevacizumab|mesh-list
153474811|NCT00729846|Verteporfin|verteporfin|mesh-list
153474812|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474813|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474814|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474815|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474923|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474924|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153474944|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474945|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474946|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153474948|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153474949|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153474950|NCT00742872|Mosapride|mosapride|mesh-list
153474951|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474952|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153474953|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153474954|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
153474955|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474956|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474957|NCT00743574|Vitamin D|vitamin d|mesh-list
153474958|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
153474959|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
153474960|NCT00743574|Vitamins|vitamins|mesh-list
153474961|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153474962|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
153474963|NCT00743574|Calcium|calcium|mesh-list
153474964|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
153474965|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475059|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475062|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153841294|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153841295|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
153841296|NCT03602157|Fludarabine|fludarabine|mesh-list
153841297|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153841298|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841299|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841300|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153841301|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
153841302|NCT03601442|Tisagenlecleucel|tisagenlecleucel|mesh-list
153841303|NCT03601442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841304|NCT03601442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841305|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153841306|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841307|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841308|NCT03587740|Immunotoxins|immunotoxins|mesh-ancestor
153841309|NCT03587740|Immunoconjugates|immunoconjugates|mesh-ancestor
153841310|NCT03587740|Immunologic Factors|immunologic factors|mesh-ancestor
153841311|NCT03587740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841312|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841313|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
153475063|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475089|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153813810|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360196|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153475091|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475092|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
153475152|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
153475153|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153475154|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
153475155|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475156|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475157|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475158|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153475159|NCT00766116|Immunotoxins|immunotoxins|mesh-ancestor
153475160|NCT00766116|Immunoconjugates|immunoconjugates|mesh-ancestor
153475161|NCT00766116|Immunologic Factors|immunologic factors|mesh-ancestor
153475162|NCT00766116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475163|NCT00767364|Vaccines|vaccines|mesh-list
153475164|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
153475165|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475166|NCT00769314|Acyclovir|acyclovir|mesh-list
153475167|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
153475168|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475169|NCT00769392|Lidocaine|lidocaine|mesh-list
153475193|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475195|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153475196|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
153475197|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475198|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475199|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153475200|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153475201|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
153475202|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475203|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258167|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154258169|NCT01181570|Mannitol|mannitol|mesh-list
154258170|NCT01181570|Citric Acid|citric acid|mesh-list
154258171|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
154258172|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
154258173|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154258174|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
154258175|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
154258176|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258177|NCT01181570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154258178|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154258179|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154258180|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154258181|NCT01181570|Diuretics|diuretics|mesh-ancestor
154258182|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
153732132|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393326|NCT02296346|Hormones|hormones|mesh-ancestor
153841328|NCT03586999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153841329|NCT03586999|Alkylating Agents|alkylating agents|mesh-ancestor
153841330|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841331|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841332|NCT03586999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153841333|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841334|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153381457|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381458|NCT02290613|Ambrisentan|ambrisentan|mesh-list
153381459|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153381460|NCT02986685|Rabeprazole|rabeprazole|mesh-list
153381461|NCT02986685|Trimebutine|trimebutine|mesh-list
153381462|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381463|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381464|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153381465|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381466|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153381467|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
153475204|NCT00780234|Pioglitazone|pioglitazone|mesh-list
153475205|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153475206|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475425|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258183|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258184|NCT05200312|Prednisone|prednisone|mesh-list
153475443|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153475444|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
153850500|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153475445|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153475446|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153475447|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153475448|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813812|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153813813|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153813814|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
153360200|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475449|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475450|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475451|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
153475452|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153475453|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
153475454|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153475455|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153475456|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153475457|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475459|NCT00803010|Methotrexate|methotrexate|mesh-list
153475461|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153475462|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
153475463|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153475464|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475465|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153475466|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
153475467|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475468|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475469|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
153475470|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475471|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153475472|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153477599|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153477600|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
153477601|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153477881|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477882|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477884|NCT03636451|Vasopressins|vasopressins|mesh-list
153477885|NCT03636451|Arginine Vasopressin|arginine vasopressin|mesh-list
153477886|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
153477887|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
153477888|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477889|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477890|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
153480862|NCT04893109|Immunologic Factors|immunologic factors|mesh-ancestor
153480863|NCT04893109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480864|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
153480865|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153480866|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480867|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480868|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480869|NCT04871308|Analgesics|analgesics|mesh-ancestor
153480870|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
153480871|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481362|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481363|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
153481364|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
153481365|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
153481586|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481587|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481588|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153481589|NCT02765256|Promethazine|promethazine|mesh-list
153481590|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
153481591|NCT02765256|Vancomycin|vancomycin|mesh-list
153481592|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
153481593|NCT02765256|Neomycin|neomycin|mesh-list
153481594|NCT02765256|Fluconazole|fluconazole|mesh-list
153481595|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153481596|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153481656|NCT01796197|Trastuzumab|trastuzumab|mesh-list
154258185|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
154258186|NCT05200312|Rituximab|rituximab|mesh-list
153481657|NCT01796197|Pertuzumab|pertuzumab|mesh-list
153481658|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153481659|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481660|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
153485552|NCT05877820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485553|NCT05877820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485554|NCT05877820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485555|NCT05877820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153485556|NCT05875077|Dexmedetomidine|dexmedetomidine|mesh-list
153485557|NCT05875077|Propofol|propofol|mesh-list
153485558|NCT05875077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153485559|NCT05875077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485560|NCT05875077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485561|NCT05875077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153485562|NCT05875077|Analgesics|analgesics|mesh-ancestor
153485563|NCT05875077|Sensory System Agents|sensory system agents|mesh-ancestor
153485564|NCT05875077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485565|NCT05875077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153485566|NCT05875077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153485567|NCT05875077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153485609|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485610|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153486122|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153486123|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486124|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486125|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486126|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153486127|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
153486131|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
153486132|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153486133|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486134|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486135|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486136|NCT03974932|Acetaminophen|acetaminophen|mesh-list
153486137|NCT03974932|Ibuprofen|ibuprofen|mesh-list
153486138|NCT03974932|Celecoxib|celecoxib|mesh-list
153486139|NCT03974932|Bupivacaine|bupivacaine|mesh-list
153486140|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
153486141|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
153486142|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153486143|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486144|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
153486145|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486146|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153486147|NCT03974932|Analgesics|analgesics|mesh-ancestor
153486148|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
153486149|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153486150|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153486151|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486152|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153486153|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486154|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486155|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153486157|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
153486158|NCT03777813|Durvalumab|durvalumab|mesh-list
153486160|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486162|NCT03777813|Protective Agents|protective agents|mesh-ancestor
153486176|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486178|NCT03694262|Atezolizumab|atezolizumab|mesh-list
153486393|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486394|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486395|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
153486396|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153486409|NCT01231906|Ifosfamide|ifosfamide|mesh-list
153486410|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
153486411|NCT01231906|Doxorubicin|doxorubicin|mesh-list
153486412|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153486494|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153486496|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486497|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
153486498|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
154258188|NCT05200312|Vincristine|vincristine|mesh-list
153486499|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486500|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486501|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153486502|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153486503|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153486504|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153486505|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153486506|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486507|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153486508|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153486601|NCT01835262|Narcotics|narcotics|mesh-ancestor
153390825|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
153390826|NCT00002649|Aldesleukin|aldesleukin|mesh-list
153390827|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
153390828|NCT00002649|Etoposide|etoposide|mesh-list
153390829|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
153486602|NCT01835496|Deferiprone|deferiprone|mesh-list
153486603|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153486604|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
153486605|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
153486821|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486823|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486851|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
153486852|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486853|NCT01876212|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153486854|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153486855|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486856|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486857|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486858|NCT01876992|Metformin|metformin|mesh-list
153486859|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486860|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486861|NCT01877538|Donepezil|donepezil|mesh-list
153486862|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153486863|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486864|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486865|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
153486866|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486867|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486868|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
153486869|NCT01878006|Morphine|morphine|mesh-list
153486870|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153486871|NCT01878006|Narcotics|narcotics|mesh-ancestor
153486872|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153486873|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486874|NCT01878006|Analgesics|analgesics|mesh-ancestor
153486875|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
153486876|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486877|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153486878|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
153486879|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153486880|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153486881|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153486884|NCT05327088|Nalbuphine|nalbuphine|mesh-list
153486885|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153486886|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153486887|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486888|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153486939|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486940|NCT05746728|Tislelizumab|tislelizumab|mesh-list
153486948|NCT05714670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486949|NCT05714670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486950|NCT05714670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153486951|NCT05714670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486952|NCT05714670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486953|NCT05714670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486954|NCT05714670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486955|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
153486956|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153486957|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486958|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486959|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486960|NCT05472948|Capecitabine|capecitabine|mesh-list
154258189|NCT05200312|Lenalidomide|lenalidomide|mesh-list
154258190|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
154258191|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486961|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486962|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
153486963|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487001|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153487002|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153487003|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487004|NCT04470804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153487005|NCT04418466|Risperidone|risperidone|mesh-list
153487006|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153487007|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
153487008|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487323|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487324|NCT01951950|Nicardipine|nicardipine|mesh-list
153487326|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153487327|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153487328|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153487348|NCT01955382|Amodiaquine|amodiaquine|mesh-list
153488340|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488341|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488342|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153488343|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153488344|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
153488345|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
153488346|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488370|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488372|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
153488373|NCT02214420|Simeprevir|simeprevir|mesh-list
153488374|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
153456725|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153488555|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488556|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488557|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488558|NCT02267772|Acetaminophen|acetaminophen|mesh-list
153488559|NCT02267772|Morphine|morphine|mesh-list
153488560|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153488618|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153488620|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
153488621|NCT02282904|Busulfan|busulfan|mesh-list
153488622|NCT02282904|Fludarabine|fludarabine|mesh-list
153488652|NCT02284464|Hormones|hormones|mesh-ancestor
153488653|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488654|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488655|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153488656|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488657|NCT02284854|Carbamazepine|carbamazepine|mesh-list
153488658|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153488659|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
153488660|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
153488696|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
153488697|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153488698|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
153488699|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
153488700|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
153488701|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153488728|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488729|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488730|NCT02289222|Dexamethasone|dexamethasone|mesh-list
153813932|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153488731|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
153850722|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850723|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488732|NCT02289222|Pomalidomide|pomalidomide|mesh-list
153488733|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153488734|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
153488735|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
153488736|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488737|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488738|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153488739|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
153488740|NCT02289222|Hormones|hormones|mesh-ancestor
153488741|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488855|NCT02331108|Anesthetics|anesthetics|mesh-list
154258192|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
154258193|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258194|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154258195|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154258196|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
154258197|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258198|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258199|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154258200|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154258201|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154258202|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154258203|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154258204|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258205|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154258206|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
154258207|NCT05200312|Hormones|hormones|mesh-ancestor
154258208|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258209|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154258210|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154258211|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
153850761|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
153850762|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850763|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850764|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
153850765|NCT00557921|Aspirin|aspirin|mesh-list
153850766|NCT00557921|Omeprazole|omeprazole|mesh-list
153390947|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390948|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153390949|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153732528|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258212|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
153732136|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153381651|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153381652|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153381653|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488856|NCT02331108|Sevoflurane|sevoflurane|mesh-list
153488857|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153488858|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488859|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488860|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153488861|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
153488862|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153488863|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153488864|NCT02340156|Temozolomide|temozolomide|mesh-list
153488865|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153488866|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
153488867|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488868|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488881|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488882|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153488883|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153488884|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153488885|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488886|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488887|NCT02353806|Amlodipine|amlodipine|mesh-list
153488890|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488891|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488892|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153488893|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488895|NCT02354352|Eplerenone|eplerenone|mesh-list
153488896|NCT02354352|Spironolactone|spironolactone|mesh-list
153813934|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488975|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390963|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153390964|NCT04054115|Alprostadil|alprostadil|mesh-list
153390965|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153390966|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
153488976|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153488977|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153488978|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153488988|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488990|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153488991|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
153488992|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
153488993|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153488994|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153488995|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153488996|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153488997|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153488998|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488999|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489000|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489001|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489061|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153489062|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153489063|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153489064|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489066|NCT05718492|Fluorouracil|fluorouracil|mesh-list
153489067|NCT05718492|Oxaliplatin|oxaliplatin|mesh-list
153489068|NCT05718492|Antimetabolites|antimetabolites|mesh-ancestor
153489069|NCT05718492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489070|NCT05718492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153489071|NCT05718492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489072|NCT05718492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153489073|NCT05718492|Immunologic Factors|immunologic factors|mesh-ancestor
153489074|NCT05718492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489075|NCT05718492|Antidotes|antidotes|mesh-ancestor
153489076|NCT05718492|Protective Agents|protective agents|mesh-ancestor
153489077|NCT05718492|Vitamin B Complex|vitamin b complex|mesh-ancestor
153489078|NCT05718492|Vitamins|vitamins|mesh-ancestor
153457940|NCT03596970|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153381711|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381712|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381713|NCT01662908|Heparin|heparin|mesh-list
153381714|NCT01662908|Enoxaparin|enoxaparin|mesh-list
153381715|NCT01662908|Calcium heparin|calcium heparin|mesh-list
153381716|NCT01662908|Warfarin|warfarin|mesh-list
153381717|NCT01662908|Edoxaban|edoxaban|mesh-list
153814141|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
153814142|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
154258230|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
154258231|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154258232|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154258233|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
154258234|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
154258235|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258236|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258237|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154258238|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154258239|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
154258240|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850807|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
154258241|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258242|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
154258243|NCT01587638|Protective Agents|protective agents|mesh-ancestor
154258244|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154258245|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154258246|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154258247|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
154258248|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154258249|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154258250|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153732138|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381734|NCT02234570|Oxfendazole|oxfendazole|mesh-list
153381735|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
153381736|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153381737|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841598|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153841599|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841600|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841601|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153841602|NCT02789020|Protective Agents|protective agents|mesh-ancestor
153841603|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841612|NCT02719314|Hormones|hormones|mesh-ancestor
153814143|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
153814144|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814145|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153814146|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814147|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154258251|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154258252|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154258254|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
154258255|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258256|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258257|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154258258|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154258259|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153732139|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381753|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381754|NCT01664858|Calcium|calcium|mesh-list
153381755|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153381756|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381757|NCT04348695|Simvastatin|simvastatin|mesh-list
153381758|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153841617|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153841618|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841619|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153841620|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153841621|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841622|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841623|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841624|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153841625|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153841626|NCT02585388|Letrozole|letrozole|mesh-list
153841627|NCT02585388|Vinorelbine|vinorelbine|mesh-list
153841628|NCT02585388|Anastrozole|anastrozole|mesh-list
153841629|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841630|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153814148|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
153814149|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814150|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
153814151|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814152|NCT00337493|Cyclosporine|cyclosporine|mesh-list
153828469|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828470|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828471|NCT01242566|Temozolomide|temozolomide|mesh-list
153828472|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153828473|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
153368480|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368481|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
153368484|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
153368485|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368486|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153368487|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153368502|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
153368504|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
153368505|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153368506|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368507|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368508|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153368509|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153368510|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368511|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368512|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828497|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368531|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368532|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153368533|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153828539|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153368546|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
153828829|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153828830|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828831|NCT01241487|Amlodipine|amlodipine|mesh-list
153828832|NCT01241487|Valsartan|valsartan|mesh-list
153828833|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153368847|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828848|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828849|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828850|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
153828851|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828852|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828853|NCT04697511|Midazolam|midazolam|mesh-list
153828854|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153828855|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153828856|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829189|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153829190|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369244|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153369245|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369246|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153369247|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153369248|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369249|NCT01186562|Incretins|incretins|mesh-ancestor
153369250|NCT01186562|Hormones|hormones|mesh-ancestor
153369251|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369252|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153829360|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829361|NCT00491348|Analgesics|analgesics|mesh-ancestor
153829362|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
153829363|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829364|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
153829416|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829417|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
153829418|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
153829419|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829420|NCT02275962|Rifampin|rifampin|mesh-list
153829421|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153829422|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
153830422|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830466|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
153830467|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153830468|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153830469|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830470|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830471|NCT05146674|Urological Agents|urological agents|mesh-ancestor
153830472|NCT00507195|Midazolam|midazolam|mesh-list
153830473|NCT00507195|Propofol|propofol|mesh-list
153841689|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
153841690|NCT02498912|Fludarabine|fludarabine|mesh-list
153391065|NCT00002733|Interferons|interferons|mesh-list
153841691|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841692|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
153841693|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841694|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153841695|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153841696|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
153841697|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830474|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153830475|NCT00507195|Sevoflurane|sevoflurane|mesh-list
153830476|NCT00507195|Desflurane|desflurane|mesh-list
153830477|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830478|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830479|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153830480|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
153830644|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830645|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
153830646|NCT00497939|Urological Agents|urological agents|mesh-ancestor
153830647|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
153830648|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153830649|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830650|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830651|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153830652|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153830653|NCT00498134|Analgesics|analgesics|mesh-ancestor
153830654|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
153830655|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830656|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370689|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153370690|NCT00003407|Protective Agents|protective agents|mesh-ancestor
153370691|NCT04838717|Doxycycline|doxycycline|mesh-list
153370692|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153370693|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370694|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
153830657|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850906|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153850907|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
153850908|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850910|NCT04649645|Nicotine|nicotine|mesh-list
153830658|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830710|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
153830711|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153830712|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153830713|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830714|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830715|NCT00498680|Urological Agents|urological agents|mesh-ancestor
153830716|NCT00498953|Carboplatin|carboplatin|mesh-list
153830890|NCT00499265|Gemcitabine|gemcitabine|mesh-list
153830891|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
153830892|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
153830893|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830894|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
153830932|NCT01246817|Sirolimus|sirolimus|mesh-list
153831343|NCT05037812|Epinephrine|epinephrine|mesh-list
153831344|NCT05037812|Morphine|morphine|mesh-list
153831345|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153831346|NCT05037812|Narcotics|narcotics|mesh-ancestor
153831347|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831348|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831405|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831406|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153831407|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371519|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831435|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831731|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
153831732|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831753|NCT03559413|Imiquimod|imiquimod|mesh-list
154258260|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154258261|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154258262|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
154258263|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
154258264|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258265|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258266|NCT01180322|Cytarabine|cytarabine|mesh-list
154258267|NCT01180322|Etoposide|etoposide|mesh-list
154258268|NCT01180322|Idarubicin|idarubicin|mesh-list
154258269|NCT01180322|Azacitidine|azacitidine|mesh-list
153831754|NCT03559413|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153831755|NCT03559413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831814|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371891|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153371892|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153371893|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153371902|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831863|NCT02872116|Capecitabine|capecitabine|mesh-list
153831864|NCT02872116|Fluorouracil|fluorouracil|mesh-list
153831865|NCT02872116|Nivolumab|nivolumab|mesh-list
153831866|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
153831867|NCT02872116|Ipilimumab|ipilimumab|mesh-list
153831868|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831869|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
153831870|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371974|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153371975|NCT02621619|Narcotics|narcotics|mesh-ancestor
153371976|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371977|NCT01253642|Docetaxel|docetaxel|mesh-list
153371978|NCT01253642|Phenelzine|phenelzine|mesh-list
153371979|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832918|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153373729|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833679|NCT01244256|Miconazole|miconazole|mesh-list
153833680|NCT01244256|Beclomethasone|beclomethasone|mesh-list
153833681|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153373753|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373754|NCT01848041|Phenylephrine|phenylephrine|mesh-list
153373755|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
153373756|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153373757|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153373758|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153833697|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153833698|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
153833699|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153833700|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153833701|NCT01249833|Oseltamivir|oseltamivir|mesh-list
153833702|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
153833715|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153833716|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153833783|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833784|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
153833785|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153833792|NCT02275182|Analgesics|analgesics|mesh-ancestor
153833793|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
153833794|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833795|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153833796|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153833797|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153833798|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
153833799|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833800|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833801|NCT01248780|Golimumab|golimumab|mesh-list
153833802|NCT01248780|Methotrexate|methotrexate|mesh-list
153833803|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153373850|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154258270|NCT01180322|Lenograstim|lenograstim|mesh-list
154258271|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841754|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
153833828|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373875|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373877|NCT01852955|Acetaminophen|acetaminophen|mesh-list
153373878|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153833973|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833974|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374059|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153374060|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153374062|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
153374063|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374064|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374066|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153374067|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
153374068|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153834068|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153834069|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834070|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834071|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
153834072|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834073|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153374169|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153374170|NCT05442411|Parecoxib|parecoxib|mesh-list
153374171|NCT05442411|Ropivacaine|ropivacaine|mesh-list
153374172|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
153374173|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
153374242|NCT03000257|Immunoconjugates|immunoconjugates|mesh-ancestor
153834154|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834155|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834156|NCT01240863|Analgesics|analgesics|mesh-ancestor
153834157|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
153834158|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374248|NCT05442801|Tropicamide|tropicamide|mesh-list
153374249|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
153374250|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
153374251|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
153374278|NCT00554099|Mesalamine|mesalamine|mesh-list
153374279|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374280|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153374281|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153374282|NCT00554099|Analgesics|analgesics|mesh-ancestor
153374283|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
153374284|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374285|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374286|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374287|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153374288|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
153374289|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153374290|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153374291|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374292|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
153374293|NCT02664909|Coagulants|coagulants|mesh-ancestor
153374294|NCT00368589|Atorvastatin|atorvastatin|mesh-list
153374295|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153732025|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153732026|NCT00161811|Vaccines|vaccines|mesh-list
153374296|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153374374|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374375|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153374376|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153374377|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374378|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153374379|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153374380|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
153374381|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153374382|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834425|NCT00520260|Ketorolac|ketorolac|mesh-list
153841790|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841792|NCT01906814|Etoposide|etoposide|mesh-list
153841793|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
153841794|NCT01906814|Vincristine|vincristine|mesh-list
153841795|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841796|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841797|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153841804|NCT01894308|Testosterone|testosterone|mesh-list
153374501|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153374502|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153374503|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153374505|NCT02396316|Aflibercept|aflibercept|mesh-list
153374506|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153374507|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153374508|NCT02396316|Growth Substances|growth substances|mesh-ancestor
153374509|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374510|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
153374511|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374512|NCT02682381|Teduglutide|teduglutide|mesh-list
153374513|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374514|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153374515|NCT02682381|Protective Agents|protective agents|mesh-ancestor
153374516|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374517|NCT04976595|Testosterone|testosterone|mesh-list
153374518|NCT04976595|Androgens|androgens|mesh-ancestor
153374519|NCT04976595|Hormones|hormones|mesh-ancestor
153374520|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153374521|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374522|NCT00367965|Eszopiclone|eszopiclone|mesh-list
153834437|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834439|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153834440|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153834441|NCT00520338|Analgesics|analgesics|mesh-ancestor
153834442|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
153834443|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834444|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834445|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374552|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153374553|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153374554|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
153834490|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153374557|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374558|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153374560|NCT02683707|Analgesics|analgesics|mesh-ancestor
153374561|NCT02371980|Vortioxetine|vortioxetine|mesh-list
153374562|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
153374563|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153374564|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153374565|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153374566|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374567|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374568|NCT02371980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153374569|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153374570|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374571|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374572|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834527|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834528|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834529|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153851062|NCT06022419|Calpastatin|calpastatin|mesh-list
153834530|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153374610|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374612|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
153374613|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374614|NCT05447169|Antibodies|antibodies|mesh-list
153841821|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841822|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841824|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153841825|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153841826|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
153841827|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153841828|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153374615|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
153374616|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374617|NCT04652193|Anesthetics|anesthetics|mesh-list
153374618|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374619|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374620|NCT05451147|Metformin|metformin|mesh-list
153374687|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374688|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374689|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153834585|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834586|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153834587|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834588|NCT00519519|Omeprazole|omeprazole|mesh-list
153834589|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153834590|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153834591|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153834592|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834593|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834594|NCT00520806|Methocarbamol|methocarbamol|mesh-list
153834595|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153834596|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834597|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153834598|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834599|NCT00505739|Mifepristone|mifepristone|mesh-list
153834600|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153834601|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
153834602|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153834603|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834605|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153834606|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153834607|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
153851084|NCT06021951|Ezetimibe|ezetimibe|mesh-list
153834608|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153834609|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153834610|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
153834611|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834612|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
153834613|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153834614|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153834615|NCT02948985|Cetuximab|cetuximab|mesh-list
153834616|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153834617|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374709|NCT02980016|Rifapentine|rifapentine|mesh-list
153374710|NCT02980016|Rifampin|rifampin|mesh-list
153374711|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
153374712|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153374713|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834622|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153834623|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
153834624|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
153834625|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834626|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834627|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834628|NCT04513340|Levodopa|levodopa|mesh-list
153834629|NCT04513340|Carbidopa|carbidopa|mesh-list
153834659|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153374734|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
153374735|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841853|NCT01431326|Bosentan|bosentan|mesh-list
153841854|NCT01431326|Labetalol|labetalol|mesh-list
153841855|NCT01431326|Nifedipine|nifedipine|mesh-list
153841856|NCT01431326|Spironolactone|spironolactone|mesh-list
153841857|NCT01431326|Pentobarbital|pentobarbital|mesh-list
153841858|NCT01431326|Oxycodone|oxycodone|mesh-list
153841859|NCT01431326|Alfentanil|alfentanil|mesh-list
153841860|NCT01431326|Haloperidol|haloperidol|mesh-list
153841861|NCT01431326|Zolpidem|zolpidem|mesh-list
153841862|NCT01431326|Ziprasidone|ziprasidone|mesh-list
153841863|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153841864|NCT01431326|Clozapine|clozapine|mesh-list
153841865|NCT01431326|Molindone|molindone|mesh-list
153841866|NCT01431326|Warfarin|warfarin|mesh-list
153841867|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
153841868|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
153841869|NCT01431326|Rocuronium|rocuronium|mesh-list
153841870|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
153841871|NCT01431326|Sevelamer|sevelamer|mesh-list
153841872|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841873|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
153841874|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
153841875|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374736|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
153374737|NCT01493180|Protective Agents|protective agents|mesh-ancestor
153374738|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153374739|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374740|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
153374741|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374778|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153374779|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374800|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153834699|NCT00521430|Hormones|hormones|mesh-ancestor
153834700|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834701|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153834702|NCT00521430|Protective Agents|protective agents|mesh-ancestor
153834703|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
153834704|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153834705|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153834706|NCT00521274|Docetaxel|docetaxel|mesh-list
153834707|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834708|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
153834709|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
153834710|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
153834711|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834712|NCT05146778|Lidocaine|lidocaine|mesh-list
153834713|NCT05146778|Fentanyl|fentanyl|mesh-list
153834714|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
153834715|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
153834716|NCT05146778|Anesthetics|anesthetics|mesh-list
153834717|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
153834718|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834719|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834720|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
153834721|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834722|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153834723|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153834724|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154258273|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154258274|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154258275|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258276|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258277|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154258279|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
154258280|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258281|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258282|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
153732628|NCT00141830|Methotrexate|methotrexate|mesh-list
153732629|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153732630|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
153732631|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153732632|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732633|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153396587|NCT01936519|Everolimus|everolimus|mesh-list
153851160|NCT06021119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851161|NCT06021119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153851162|NCT06021119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851163|NCT06021015|Irinotecan|irinotecan|mesh-list
153851164|NCT06021015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153851165|NCT06021015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153851166|NCT06021015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851167|NCT06021015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258283|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258284|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154258285|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154258286|NCT01287494|Sertraline|sertraline|mesh-list
153732145|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153834725|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834726|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834727|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153374843|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374844|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374846|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153374847|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153374848|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374849|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153834755|NCT02948283|Metformin|metformin|mesh-list
153834756|NCT02948283|Ritonavir|ritonavir|mesh-list
153834757|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834758|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834759|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153834760|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153834761|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
153834762|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834763|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834764|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153834765|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153834766|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
153834767|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834768|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153834769|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153834770|NCT04512872|Denosumab|denosumab|mesh-list
153834771|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153834772|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834773|NCT00523185|Diazepam|diazepam|mesh-list
153834774|NCT00523185|Lorazepam|lorazepam|mesh-list
153834775|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
153834776|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
153834777|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
153834778|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834779|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834780|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153834781|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153834797|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153834798|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153834799|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
153834800|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834802|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153834804|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
153374873|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153374874|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
153374890|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374891|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
153374892|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153374893|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
153374894|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834805|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834807|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
153834808|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
153834809|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834810|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834811|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
153834812|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834813|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153834814|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153834815|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153834816|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834817|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834818|NCT00521742|Pioglitazone|pioglitazone|mesh-list
153834819|NCT00521742|Glyburide|glyburide|mesh-list
153834820|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153374912|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374913|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
153374914|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
153374915|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153374916|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153374917|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374918|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374919|NCT01499498|Urological Agents|urological agents|mesh-ancestor
153374920|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153374921|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153374922|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374923|NCT02421588|Doxorubicin|doxorubicin|mesh-list
153374924|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153834826|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
153834827|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834828|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153834829|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
153834830|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153834831|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834832|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153834833|NCT00521781|Hormones|hormones|mesh-ancestor
153834834|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834835|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
153834836|NCT00521820|Pioglitazone|pioglitazone|mesh-list
153834837|NCT00521820|Glyburide|glyburide|mesh-list
153834838|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834839|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834840|NCT00523263|Heparin|heparin|mesh-list
153834841|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
153834842|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153834843|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153834844|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834854|NCT02954822|Glimepiride|glimepiride|mesh-list
153834855|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153834856|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834857|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374925|NCT02421588|Topotecan|topotecan|mesh-list
153374936|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
153374937|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374938|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374939|NCT02688309|Dexamethasone|dexamethasone|mesh-list
153374940|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374941|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
153374942|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
153374943|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374944|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374945|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374946|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
153393771|NCT00003021|Bizelesin|bizelesin|mesh-list
153841963|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841964|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153841965|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153841966|NCT01303679|Growth Substances|growth substances|mesh-ancestor
153834858|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153834859|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
153834860|NCT00522015|Rivastigmine|rivastigmine|mesh-list
153834861|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153834862|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834863|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834864|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
153834865|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834866|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834867|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153834868|NCT00522015|Protective Agents|protective agents|mesh-ancestor
153834869|NCT00523380|Doxorubicin|doxorubicin|mesh-list
153834870|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153834871|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153834872|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834873|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153834874|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834875|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834876|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834877|NCT00523458|Efavirenz|efavirenz|mesh-list
153834878|NCT00523458|Nevirapine|nevirapine|mesh-list
153834889|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153834890|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153834891|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153834892|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153834893|NCT00507065|Amphetamine|amphetamine|mesh-list
153834894|NCT00507065|Adderall|adderall|mesh-list
153834895|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153834896|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834897|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
153834898|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
153834899|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834900|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
153834901|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834902|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834921|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834923|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153834924|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
153834925|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153834926|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153834927|NCT00522249|Sunitinib|sunitinib|mesh-list
153834928|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834929|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
153374994|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153374995|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153374996|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375009|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375010|NCT02420262|Insulin|insulin|mesh-list
153375011|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153375012|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
153375013|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
153834930|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834931|NCT00522249|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153375135|NCT03833427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153835046|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
153835047|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153835048|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835049|NCT05146271|Anesthetics|anesthetics|mesh-list
153835050|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835051|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835052|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
153835053|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
153835054|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732146|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841998|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153841999|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153842000|NCT01191697|Growth Substances|growth substances|mesh-ancestor
153842001|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842002|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
153842003|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153835055|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
153835056|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835057|NCT05142098|Dexamethasone|dexamethasone|mesh-list
153835058|NCT05142098|Etoricoxib|etoricoxib|mesh-list
153835059|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
153835060|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
153835061|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153835062|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
153835063|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
153835064|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835065|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835066|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835067|NCT05142098|Hormones|hormones|mesh-ancestor
153835068|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835069|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153835070|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835133|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835135|NCT00523068|Urological Agents|urological agents|mesh-ancestor
153835136|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153835137|NCT02276378|Telmisartan|telmisartan|mesh-list
153835138|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153835139|NCT02276378|Diuretics|diuretics|mesh-ancestor
153835140|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
153835141|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835142|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153835143|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375210|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375211|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
153375212|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
153375213|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
153375214|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375215|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153375216|NCT02370498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153375217|NCT01554488|Fluticasone|fluticasone|mesh-list
153375218|NCT01554488|Xhance|xhance|mesh-list
153375219|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375220|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153375221|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
153375222|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375223|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375224|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153375225|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
153375226|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375227|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153375228|NCT02347332|Methotrexate|methotrexate|mesh-list
153835154|NCT02947932|Resveratrol|resveratrol|mesh-list
153835155|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
153835156|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835157|NCT02947932|Protective Agents|protective agents|mesh-ancestor
153835158|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835159|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835160|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153835161|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153375229|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153375230|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
153375231|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153375232|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375233|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153375234|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
154258287|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
154258288|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153842050|NCT00990275|Ethanol|ethanol|mesh-list
153375235|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375236|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375237|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375238|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375239|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153375240|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153835175|NCT02947893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835176|NCT02947893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835177|NCT05146154|Imipenem|imipenem|mesh-list
153835178|NCT05146154|Relebactam|relebactam|mesh-list
153835179|NCT05146154|Cilastatin|cilastatin|mesh-list
153835180|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153835181|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835182|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
153835183|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835184|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835185|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153835186|NCT00524667|Fludarabine|fludarabine|mesh-list
153375262|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153375263|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153375264|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375265|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
153375266|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
153375267|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153375268|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
153375269|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375270|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
153375272|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153835270|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835271|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153835272|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835273|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
153375338|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153375339|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375340|NCT01556594|Hormones|hormones|mesh-ancestor
153375341|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375342|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375343|NCT01556594|Incretins|incretins|mesh-ancestor
153375344|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
153375345|NCT00371319|Tacrolimus|tacrolimus|mesh-list
153375386|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
153375387|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153375388|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153375390|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153375391|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375392|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
153375393|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
153375394|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
153375395|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375396|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153375397|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153375398|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153835318|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835319|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835320|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153835321|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153835328|NCT05146232|Anesthetics|anesthetics|mesh-list
153835329|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835330|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835331|NCT00525096|Celecoxib|celecoxib|mesh-list
153835332|NCT00525096|Exemestane|exemestane|mesh-list
153835333|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153835334|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153835335|NCT00525096|Analgesics|analgesics|mesh-ancestor
153391569|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
153835336|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
153835337|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375399|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153835346|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153835398|NCT00526305|Prednisone|prednisone|mesh-list
153835399|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
153835400|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
153835401|NCT00526305|Vincristine|vincristine|mesh-list
153835402|NCT00526305|Daunorubicin|daunorubicin|mesh-list
153835403|NCT00526305|Asparaginase|asparaginase|mesh-list
153835404|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
153835405|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
153835406|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153835407|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
153835408|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835409|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835410|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153835411|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
153835412|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732030|NCT00140348|Immunomodulating Agents|immunomodulating agents|mesh-list
153835413|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835414|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153835415|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153835484|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153835485|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153375619|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153375620|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375622|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
153835570|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153835571|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
153835572|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835573|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835574|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835575|NCT00507494|Pioglitazone|pioglitazone|mesh-list
153835576|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153835596|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835597|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835598|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
153835599|NCT00507962|Cisplatin|cisplatin|mesh-list
153835600|NCT00507962|Doxorubicin|doxorubicin|mesh-list
153375667|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
153375668|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
153375669|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375670|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375671|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
153375672|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375673|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153375674|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153375688|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375689|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375690|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
153375691|NCT00372099|Calcitonin|calcitonin|mesh-list
153375706|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153375707|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375709|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
153375710|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153375711|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375712|NCT05013255|Pioglitazone|pioglitazone|mesh-list
153375713|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153835630|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
153835631|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153835632|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153835633|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
153835634|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835635|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153835636|NCT02946684|Letrozole|letrozole|mesh-list
153835637|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153835638|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835639|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153835640|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835641|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835642|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153835643|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
153842126|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153842127|NCT02915055|Narcotics|narcotics|mesh-ancestor
153842128|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842129|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
153842134|NCT02918760|Gabapentin|gabapentin|mesh-list
153835644|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835645|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835646|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
153835647|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153835648|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
153835649|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153835650|NCT02946801|Listerine|listerine|mesh-list
153835651|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
153835652|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153835653|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835654|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
153835655|NCT02946801|Protective Agents|protective agents|mesh-ancestor
153835656|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835657|NCT02953847|Rifampin|rifampin|mesh-list
153835658|NCT02953847|Isoniazid|isoniazid|mesh-list
153835659|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153835660|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
153835661|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153835662|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835663|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
153835664|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153835665|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835666|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835667|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153835668|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153835669|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153835679|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153835680|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
153835681|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
153835682|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835683|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835684|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
153835685|NCT00526929|Hematinics|hematinics|mesh-ancestor
153835686|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
153835687|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
153835688|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835689|NCT00526734|Melphalan|melphalan|mesh-list
153835690|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
153835691|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835692|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153835693|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
153835694|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835695|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835696|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153835697|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153835698|NCT00508859|Sertraline|sertraline|mesh-list
153835699|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
153375767|NCT00372645|Hematinics|hematinics|mesh-ancestor
153375768|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
153375769|NCT00372645|Vitamins|vitamins|mesh-ancestor
153835711|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153835712|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153835713|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835714|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153835715|NCT00508898|Vitamins|vitamins|mesh-ancestor
153835716|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
153835717|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153835718|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
153375778|NCT00372801|Ibuprofen|ibuprofen|mesh-list
153375788|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375789|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375790|NCT05455359|Famotidine|famotidine|mesh-list
153375791|NCT05455359|Prucalopride|prucalopride|mesh-list
153375792|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153375793|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375794|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153375795|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
154258289|NCT01287494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153375797|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375798|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835719|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153835720|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
153835721|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835722|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
153835723|NCT04692558|Protective Agents|protective agents|mesh-ancestor
153835724|NCT02952599|Edoxaban|edoxaban|mesh-list
153835725|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153835726|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
153391654|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391655|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153391656|NCT02987348|Incretins|incretins|mesh-ancestor
153391657|NCT02987348|Hormones|hormones|mesh-ancestor
153391658|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391659|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391660|NCT01656031|Cytarabine|cytarabine|mesh-list
153391661|NCT01656031|Clofarabine|clofarabine|mesh-list
153851439|NCT05320380|Hormones|hormones|mesh-ancestor
153835727|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153835728|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
153835729|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835730|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835731|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
153835732|NCT00510419|Sumatriptan|sumatriptan|mesh-list
153835733|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153835744|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835745|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835746|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
153835747|NCT03458715|Empagliflozin|empagliflozin|mesh-list
153835748|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153835749|NCT03458715|Linagliptin|linagliptin|mesh-list
153835772|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835773|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
153835774|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835775|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153835776|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153835777|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153835778|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153835779|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835781|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
153835782|NCT00509015|Primaquine|primaquine|mesh-list
153835783|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
153835784|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153835785|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
153375865|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153375866|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153835812|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153375877|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375878|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375879|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153375880|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153375881|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375882|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153375883|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153375884|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
153375885|NCT02368314|Enoxaparin|enoxaparin|mesh-list
153375886|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
153375887|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
153375888|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153375889|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153375890|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375891|NCT01463384|Minocycline|minocycline|mesh-list
153375892|NCT01463384|Tetracycline|tetracycline|mesh-list
153375893|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375894|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375895|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153375896|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851480|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835851|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835852|NCT00509678|Rituximab|rituximab|mesh-list
153835853|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153835854|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835922|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
153835923|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835924|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835925|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153835926|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835927|NCT00510965|Ranibizumab|ranibizumab|mesh-list
153835929|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153835930|NCT00510965|Growth Substances|growth substances|mesh-ancestor
153835931|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835932|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
153835933|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835934|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
153835945|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
153835946|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153835947|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835948|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835949|NCT03459911|Losartan|losartan|mesh-list
153835950|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153835951|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153835952|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153835953|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153835954|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835955|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
153851481|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851482|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851483|NCT04902261|Paclitaxel|paclitaxel|mesh-list
153851484|NCT04902261|Gemcitabine|gemcitabine|mesh-list
153851485|NCT04902261|Tislelizumab|tislelizumab|mesh-list
153851486|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153851487|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851488|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
153851489|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
153851490|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
153851491|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851492|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851493|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
153391694|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391695|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153391697|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153391698|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
153391705|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835956|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153835957|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
153835958|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835996|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
153836011|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836013|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836014|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153836015|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
153836016|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836017|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153836018|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153836019|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836020|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836021|NCT02953184|Vitamins|vitamins|mesh-list
153836022|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
153836045|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153836046|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376113|NCT06190600|Tubulin Modulators|tubulin modulators|mesh-ancestor
153376114|NCT06190600|Antimitotic Agents|antimitotic agents|mesh-ancestor
153376115|NCT06190600|Mitosis Modulators|mitosis modulators|mesh-ancestor
153376116|NCT06190600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376117|NCT06190600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376118|NCT06190600|Immunologic Factors|immunologic factors|mesh-ancestor
153376130|NCT06190535|Hemostatics|hemostatics|mesh-ancestor
153376131|NCT06190535|Coagulants|coagulants|mesh-ancestor
153376132|NCT06190483|Ascorbic Acid|ascorbic acid|mesh-list
153376133|NCT06190483|Diazepam|diazepam|mesh-list
153376134|NCT06190483|Antioxidants|antioxidants|mesh-ancestor
153376135|NCT06190483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376136|NCT06190483|Protective Agents|protective agents|mesh-ancestor
153391706|NCT01598545|Hydromorphone|hydromorphone|mesh-list
153391707|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153391708|NCT01598545|Narcotics|narcotics|mesh-ancestor
153391709|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391710|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391711|NCT01598545|Analgesics|analgesics|mesh-ancestor
153391712|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
153391713|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391714|NCT01598701|Acetaminophen|acetaminophen|mesh-list
153391715|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153391716|NCT01598701|Analgesics|analgesics|mesh-ancestor
153391717|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
153391718|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391719|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391720|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
153851502|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376137|NCT06190483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376138|NCT06190483|Vitamins|vitamins|mesh-ancestor
153836047|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153836048|NCT02953184|Protective Agents|protective agents|mesh-ancestor
153836049|NCT00515229|Amitriptyline|amitriptyline|mesh-list
153836050|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153836051|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
153836052|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836053|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153836054|NCT00515229|Analgesics|analgesics|mesh-ancestor
153836055|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
153836056|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836057|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376166|NCT06190405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153836071|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153836072|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153836073|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836074|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
153836075|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153836076|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836077|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153836078|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
153836079|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153836080|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376172|NCT06190405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376183|NCT06190301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376185|NCT06190301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376186|NCT06190301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376189|NCT06190158|Cosyntropin|cosyntropin|mesh-list
153376190|NCT06190158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376191|NCT06190158|Antiemetics|antiemetics|mesh-ancestor
153376192|NCT06190158|Autonomic Agents|autonomic agents|mesh-ancestor
153376193|NCT06190158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376194|NCT06190158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376195|NCT06190158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851503|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851504|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
153376196|NCT06190158|Glucocorticoids|glucocorticoids|mesh-ancestor
153376197|NCT06190158|Hormones|hormones|mesh-ancestor
153836096|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
153836097|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153836098|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153836099|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153836100|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836101|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153836102|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836103|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
153836104|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153836105|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153836106|NCT00510263|Valacyclovir|valacyclovir|mesh-list
153836107|NCT00510263|Prednisolone|prednisolone|mesh-list
153836108|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153836109|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
153836110|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153376221|NCT06190132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376222|NCT06190132|Anticonvulsants|anticonvulsants|mesh-ancestor
153376223|NCT06190132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153376224|NCT06190132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153376225|NCT06190132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376226|NCT06190132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153376227|NCT06190132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153836124|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836125|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153376233|NCT06189898|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153376234|NCT06189898|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153376245|NCT06188026|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153376246|NCT06188026|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153836173|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836175|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153836176|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836177|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153836178|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836179|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836180|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153836181|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153376255|NCT06188026|Estrogens|estrogens|mesh-ancestor
153376256|NCT06188026|Hormones|hormones|mesh-ancestor
153376257|NCT06188026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376258|NCT06188026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153376259|NCT06187311|Rivaroxaban|rivaroxaban|mesh-list
153376260|NCT06187311|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153376261|NCT06187311|Antithrombins|antithrombins|mesh-ancestor
153376262|NCT06187311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153376263|NCT06187311|Protease Inhibitors|protease inhibitors|mesh-ancestor
153376264|NCT06187311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836195|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836196|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
153836197|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
153376304|NCT06178640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153376305|NCT06178640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376306|NCT06145373|Antithrombins|antithrombins|mesh-list
153376307|NCT06145373|Antithrombin III|antithrombin iii|mesh-list
153376308|NCT06145373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153836204|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836205|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153836206|NCT00515736|Vitamins|vitamins|mesh-list
153836247|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
153836301|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836302|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153836303|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
154258290|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153836304|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153836305|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153836306|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836307|NCT00513266|Antidotes|antidotes|mesh-ancestor
153836308|NCT00513266|Protective Agents|protective agents|mesh-ancestor
153836309|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
153836310|NCT00513266|Vitamins|vitamins|mesh-ancestor
153836311|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
153836312|NCT00513383|Paclitaxel|paclitaxel|mesh-list
153836313|NCT00513383|Docetaxel|docetaxel|mesh-list
153836314|NCT00513383|Carboplatin|carboplatin|mesh-list
153376386|NCT06026852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376387|NCT06026852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153376388|NCT06026852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376389|NCT06026852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391792|NCT01940510|Rifampin|rifampin|mesh-list
153391793|NCT01940510|Alectinib|alectinib|mesh-list
153376390|NCT06023576|Antihypertensive Agents|antihypertensive agents|mesh-list
153376391|NCT06023329|Ropivacaine|ropivacaine|mesh-list
153836384|NCT00513968|Adefovir|adefovir|mesh-list
153836385|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
153836386|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836387|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153836388|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153836389|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836390|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836391|NCT03459248|Anesthetics|anesthetics|mesh-list
153836392|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376469|NCT05947448|Nifedipine|nifedipine|mesh-list
153376470|NCT05947448|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153376471|NCT05947448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376472|NCT05947448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153376485|NCT05938608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376486|NCT05934448|Cyclophosphamide|cyclophosphamide|mesh-list
153376487|NCT05934448|Pembrolizumab|pembrolizumab|mesh-list
153376488|NCT05934448|Fludarabine|fludarabine|mesh-list
153376489|NCT05934448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376490|NCT05934448|Immunologic Factors|immunologic factors|mesh-ancestor
153376491|NCT05934448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376492|NCT05934448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376493|NCT05934448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153376494|NCT05934448|Alkylating Agents|alkylating agents|mesh-ancestor
153376495|NCT05934448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376496|NCT05934448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376497|NCT05934448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153376525|NCT05861336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836466|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376539|NCT05833763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376540|NCT05819619|Ibuprofen|ibuprofen|mesh-list
153376541|NCT05819619|Ondansetron|ondansetron|mesh-list
153391794|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153391795|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
153391796|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153391797|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391798|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
153391799|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153391800|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391808|NCT01940510|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153376542|NCT05819619|Misoprostol|misoprostol|mesh-list
153376543|NCT05819619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153376544|NCT05819619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153376545|NCT05819619|Analgesics|analgesics|mesh-ancestor
153376546|NCT05819619|Sensory System Agents|sensory system agents|mesh-ancestor
153376547|NCT05819619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376548|NCT05819619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376549|NCT05819619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376550|NCT05819619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376551|NCT05819619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153376552|NCT05819619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376553|NCT05819619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376554|NCT05819619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153376555|NCT05819619|Abortifacient Agents|abortifacient agents|mesh-ancestor
153376556|NCT05819619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153376557|NCT05819619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153376558|NCT05819619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153376559|NCT05819619|Oxytocics|oxytocics|mesh-ancestor
153376560|NCT05819619|Antiemetics|antiemetics|mesh-ancestor
153376561|NCT05819619|Autonomic Agents|autonomic agents|mesh-ancestor
153836492|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153836494|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
153836495|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258291|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153836496|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376568|NCT05817851|Vitamins|vitamins|mesh-list
153376569|NCT05817851|Thiamine|thiamine|mesh-list
153376570|NCT05817851|Micronutrients|micronutrients|mesh-ancestor
153376571|NCT05817851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376572|NCT05817851|Vitamin B Complex|vitamin b complex|mesh-ancestor
153376573|NCT05799105|Omeprazole|omeprazole|mesh-list
153376574|NCT05799105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153376575|NCT05799105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851595|NCT04431635|Nivolumab|nivolumab|mesh-list
153851596|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851597|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851598|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
153851599|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851600|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851601|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153376576|NCT05799105|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153376577|NCT05799105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376578|NCT05799105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376579|NCT05766501|Islatravir|islatravir|mesh-list
153376580|NCT05766501|Antiviral Agents|antiviral agents|mesh-ancestor
153376581|NCT05766501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376582|NCT05766501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376583|NCT05766501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376584|NCT05766501|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153376585|NCT05766501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153376586|NCT05766501|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153376587|NCT05766267|Moxifloxacin|moxifloxacin|mesh-list
153836508|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836509|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153836510|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
153836512|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836513|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836514|NCT02943603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153836515|NCT02943603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836516|NCT00531687|Paclitaxel|paclitaxel|mesh-list
153836517|NCT00531687|Gemcitabine|gemcitabine|mesh-list
153836518|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153836519|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836520|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
153836521|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
153836522|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
153836523|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376618|NCT05765266|Prednisolone|prednisolone|mesh-list
153376619|NCT05765266|Prednisolone acetate|prednisolone acetate|mesh-list
153376620|NCT05765266|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153376621|NCT05765266|Prednisolone phosphate|prednisolone phosphate|mesh-list
153376622|NCT05765266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376623|NCT05765266|Antiemetics|antiemetics|mesh-ancestor
153376624|NCT05765266|Autonomic Agents|autonomic agents|mesh-ancestor
153376625|NCT05765266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391826|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
153391827|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
153391828|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376626|NCT05765266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376627|NCT05765266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153376628|NCT05765266|Glucocorticoids|glucocorticoids|mesh-ancestor
153376630|NCT05765266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376632|NCT05765266|Protective Agents|protective agents|mesh-ancestor
153376633|NCT05765266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153732038|NCT00140387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376634|NCT05765266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376635|NCT05735431|Fluticasone|fluticasone|mesh-list
153376636|NCT05735431|Formoterol Fumarate|formoterol fumarate|mesh-list
153376637|NCT05735431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376638|NCT05735431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153836534|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836535|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836536|NCT00530868|Bevacizumab|bevacizumab|mesh-list
153836537|NCT00530868|Letrozole|letrozole|mesh-list
153836538|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836539|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836540|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153836541|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153836542|NCT00530868|Growth Substances|growth substances|mesh-ancestor
153836543|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836544|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
153376649|NCT05735431|Adrenergic Agents|adrenergic agents|mesh-ancestor
153376650|NCT05735431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376651|NCT05735431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376652|NCT05730920|Methadone|methadone|mesh-list
153376653|NCT05730920|Bupivacaine|bupivacaine|mesh-list
154258292|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376654|NCT05730920|Anesthetics, Local|anesthetics, local|mesh-ancestor
153376656|NCT05730920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376657|NCT05730920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376658|NCT05730920|Sensory System Agents|sensory system agents|mesh-ancestor
153376659|NCT05730920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376660|NCT05730920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153376661|NCT05730920|Narcotics|narcotics|mesh-ancestor
153376662|NCT05730920|Analgesics|analgesics|mesh-ancestor
153376663|NCT05730920|Antitussive Agents|antitussive agents|mesh-ancestor
153732692|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153732693|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153732694|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153732695|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
153732696|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851673|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851674|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376664|NCT05730920|Respiratory System Agents|respiratory system agents|mesh-ancestor
153836613|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836614|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836615|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
153376696|NCT05689671|Carboplatin|carboplatin|mesh-list
153376697|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
153376698|NCT05689671|Pemetrexed|pemetrexed|mesh-list
153376699|NCT05689671|Atezolizumab|atezolizumab|mesh-list
153376700|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153376701|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376702|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
153376703|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
153376704|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
153836642|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376719|NCT05688475|Hormones|hormones|mesh-ancestor
153376720|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376721|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153376722|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376723|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153376724|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153376725|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376726|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153376727|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153376728|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153376729|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376730|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
153376731|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836659|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836660|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376756|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376757|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376758|NCT05675813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376759|NCT05651711|KHK4083|khk4083|mesh-list
153376760|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
153376761|NCT05644665|Ozanimod|ozanimod|mesh-list
153376762|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153376763|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376764|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376765|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
153376766|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376767|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153836711|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836712|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153836713|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153836714|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
153836715|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836716|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153836717|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153836718|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153836719|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153836720|NCT05319912|Molybdenum|molybdenum|mesh-list
153836721|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153836722|NCT05319912|Choline|choline|mesh-list
153836723|NCT05319912|Omeprazole|omeprazole|mesh-list
153836724|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153851682|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851683|NCT03936517|Prednisolone|prednisolone|mesh-list
153851684|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
153851685|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851686|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
153851687|NCT03936517|Hormones|hormones|mesh-ancestor
153851688|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851689|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851690|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153851691|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851692|NCT03889795|Metformin|metformin|mesh-list
153851693|NCT03889795|Digoxin|digoxin|mesh-list
153851694|NCT03889795|Simvastatin|simvastatin|mesh-list
153851695|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153851696|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851697|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153851698|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153851699|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
153851701|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153836725|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153362078|NCT05820841|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153836726|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153836727|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376815|NCT05586802|Semaglutide|semaglutide|mesh-list
153376816|NCT05586802|Anastrozole|anastrozole|mesh-list
153376817|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153376818|NCT05586802|Testosterone|testosterone|mesh-list
153376819|NCT05586802|Androgens|androgens|mesh-ancestor
153376820|NCT05586802|Hormones|hormones|mesh-ancestor
153376821|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836757|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836758|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836759|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153836760|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
153836761|NCT00515255|Minocycline|minocycline|mesh-list
153376833|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153376834|NCT05583474|Carteolol|carteolol|mesh-list
153376835|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153376836|NCT05583474|Latanoprost|latanoprost|mesh-list
153376837|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153376838|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153836764|NCT00516113|Paroxetine|paroxetine|mesh-list
153836765|NCT00516113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153836766|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153836767|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153836768|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836769|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836770|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
153836771|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836815|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153836816|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
153836817|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836819|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153836820|NCT00515450|Antibodies|antibodies|mesh-list
153836821|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
153391918|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153391919|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153391920|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153391921|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
153391922|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391936|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
153836822|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153836823|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
153836824|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836825|NCT00515489|Risperidone|risperidone|mesh-list
153836826|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153836827|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
153836828|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836829|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376922|NCT05494762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376923|NCT05494762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376924|NCT05492123|Cisplatin|cisplatin|mesh-list
153376925|NCT05492123|Nivolumab|nivolumab|mesh-list
153376926|NCT05492123|Ipilimumab|ipilimumab|mesh-list
153376927|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376928|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376930|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376931|NCT05461053|Lidocaine|lidocaine|mesh-list
153376932|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
153376933|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
153376934|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376935|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376936|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
153376937|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376938|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153376939|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153376940|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153376941|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153376942|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376943|NCT05455697|Prednisone|prednisone|mesh-list
153376944|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
153376945|NCT05455697|Rituximab|rituximab|mesh-list
153376946|NCT05455697|Doxorubicin|doxorubicin|mesh-list
153376947|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153376948|NCT05455697|Vincristine|vincristine|mesh-list
153376949|NCT05455697|Daunorubicin|daunorubicin|mesh-list
153836840|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
153836841|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
153836842|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836843|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
153836844|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836845|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836846|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
153836847|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153836848|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153376954|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376955|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376956|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153376958|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376959|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376960|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153836884|NCT02950220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153836885|NCT02950220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836886|NCT00515684|Bevacizumab|bevacizumab|mesh-list
153836887|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836888|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376962|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153376963|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153377003|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377005|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153377006|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
153377007|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377008|NCT05413018|Azacitidine|azacitidine|mesh-list
153377009|NCT05413018|Cc-486|cc-486|mesh-list
153377010|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153377011|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
153377012|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377013|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377014|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377015|NCT05406583|Dolutegravir|dolutegravir|mesh-list
153377016|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153377017|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153836934|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153836936|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836937|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836938|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153836939|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153836940|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153836941|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153377028|NCT05377242|Resveratrol|resveratrol|mesh-list
153377029|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153391971|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153377030|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153732697|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732698|NCT00141908|Progestins|progestins|mesh-ancestor
153732699|NCT00141908|Hormones|hormones|mesh-ancestor
153732700|NCT00141908|Cathartics|cathartics|mesh-ancestor
153732701|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732702|NCT00162669|Bevacizumab|bevacizumab|mesh-list
153851742|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851743|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153377031|NCT05377242|Analgesics|analgesics|mesh-ancestor
153851744|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153377032|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
153377033|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377034|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377035|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377036|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377037|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377038|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377039|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377040|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
153377041|NCT05377242|Protective Agents|protective agents|mesh-ancestor
153377042|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153377043|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
153377044|NCT05359211|Fludarabine|fludarabine|mesh-list
153377045|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153377046|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
153377047|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377048|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377049|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153377050|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
153377051|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377052|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836944|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836949|NCT00516464|Growth Substances|growth substances|mesh-ancestor
153836950|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836951|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
153836952|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836953|NCT00516542|Letrozole|letrozole|mesh-list
153836954|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836955|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153836956|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153842559|NCT01289782|Simeprevir|simeprevir|mesh-list
153836957|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836958|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836959|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153836960|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
153836961|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836962|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836963|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
153836964|NCT03458481|Yimitasvir|yimitasvir|mesh-list
153836965|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
153851745|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153851746|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
153836966|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836967|NCT02949752|Aripiprazole|aripiprazole|mesh-list
153836968|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
153836969|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836970|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153836971|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153836972|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836973|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377078|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
153377079|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836987|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
153836988|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153836989|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836990|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
153836991|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836992|NCT04694612|Remdesivir|remdesivir|mesh-list
153836993|NCT04694612|Favipiravir|favipiravir|mesh-list
153836994|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
153836995|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836996|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
153836997|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836998|NCT02941224|Sirolimus|sirolimus|mesh-list
153836999|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153837000|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837001|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153377093|NCT05298592|Pemetrexed|pemetrexed|mesh-list
153377094|NCT05298592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153377095|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377096|NCT05298592|Tubulin Modulators|tubulin modulators|mesh-ancestor
153377097|NCT05298592|Antimitotic Agents|antimitotic agents|mesh-ancestor
153377098|NCT05298592|Mitosis Modulators|mitosis modulators|mesh-ancestor
153377099|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377100|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377101|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377102|NCT05298592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377103|NCT05298592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153377104|NCT05298592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153377105|NCT05259566|Menthol|menthol|mesh-list
153377106|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
153377107|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
153837013|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153837014|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153837015|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153837016|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
153837017|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
153837018|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837019|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837020|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
153837021|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
153837022|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837023|NCT02940990|Paclitaxel|paclitaxel|mesh-list
153837024|NCT02940990|Etoposide|etoposide|mesh-list
153837025|NCT02940990|Vinorelbine|vinorelbine|mesh-list
153837026|NCT02940990|Docetaxel|docetaxel|mesh-list
153837027|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153837028|NCT02940990|Carboplatin|carboplatin|mesh-list
153837029|NCT02940990|Gemcitabine|gemcitabine|mesh-list
153837030|NCT02940990|Pemetrexed|pemetrexed|mesh-list
153837031|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153837032|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837033|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
153837034|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
153377108|NCT05257824|Aspirin|aspirin|mesh-list
153377109|NCT05257824|Clopidogrel|clopidogrel|mesh-list
153377110|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153377111|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377112|NCT05257824|Analgesics|analgesics|mesh-ancestor
154258293|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377113|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
153377114|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377115|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837054|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153837055|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153837058|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153837059|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837060|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153837061|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153377135|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377137|NCT05251948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377138|NCT05251948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377139|NCT05248984|Ketorolac|ketorolac|mesh-list
153377140|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153377141|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377142|NCT05248984|Analgesics|analgesics|mesh-ancestor
153377143|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
153377144|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377145|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377146|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392022|NCT01673191|Hormones|hormones|mesh-ancestor
153377155|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
153837062|NCT02942043|Growth Substances|growth substances|mesh-ancestor
153837063|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837064|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
153732047|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153389652|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
153837065|NCT00516971|Esomeprazole|esomeprazole|mesh-list
153837066|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153837067|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153360845|NCT01370369|Hormones|hormones|mesh-ancestor
153837103|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153837104|NCT02939430|Atropine|atropine|mesh-list
153837105|NCT02939430|Neostigmine|neostigmine|mesh-list
153837106|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153837107|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153837108|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153837116|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153837117|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153837118|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
153837119|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837120|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837121|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153837122|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837123|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153837124|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
153837125|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
153837126|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153837127|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377228|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
153377229|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377230|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377232|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837128|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837129|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
153837130|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153837131|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837132|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837134|NCT00518765|Renin Inhibitors|renin inhibitors|mesh-ancestor
153837135|NCT00518765|Protease Inhibitors|protease inhibitors|mesh-ancestor
153837136|NCT00518765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837137|NCT00518765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837138|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
153837139|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
153732048|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389699|NCT00002283|Trimethoprim|trimethoprim|mesh-list
153837140|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
153837141|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837142|NCT00517517|Coagulants|coagulants|mesh-ancestor
153837143|NCT02940756|Artesunate|artesunate|mesh-list
153837144|NCT02940756|Lumefantrine|lumefantrine|mesh-list
153837145|NCT02940756|Artemether|artemether|mesh-list
153837146|NCT02940756|Piperaquine|piperaquine|mesh-list
153837147|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153837170|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153837171|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
153837172|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837173|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837174|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153837175|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153837176|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
153837177|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837178|NCT02939274|Verteporfin|verteporfin|mesh-list
153837179|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153837180|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
153837182|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
153837183|NCT00517946|Ephedrine|ephedrine|mesh-list
153837185|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153837186|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153837187|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
153837188|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
153837189|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837190|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837191|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837192|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153837193|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
153851831|NCT03261830|Cefazolin|cefazolin|mesh-list
153837194|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837195|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153837196|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
153837197|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
153837198|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153837199|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153837200|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
153837201|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
153377278|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153377279|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
153377280|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377281|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153377282|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153377283|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
153377284|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377285|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377286|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153377287|NCT04931017|Metformin|metformin|mesh-list
153377301|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
153377302|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837202|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153837203|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153837204|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153837205|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153837206|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732052|NCT02955628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153732053|NCT02955628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837207|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837208|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837210|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
153837211|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837212|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
153837213|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153837214|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
153837215|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153837217|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392053|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
153392054|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153837218|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837219|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
153837220|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
153837221|NCT00518102|Becaplermin|becaplermin|mesh-list
153837222|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
153837223|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
153837224|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153837225|NCT00518102|Growth Substances|growth substances|mesh-ancestor
153837226|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837227|NCT02939235|Morphine|morphine|mesh-list
153837228|NCT02939235|Metoclopramide|metoclopramide|mesh-list
153377303|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154258294|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
153377304|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153377305|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377306|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377307|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153377308|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
153377309|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377310|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377311|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153377313|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
153377314|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
153377315|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377316|NCT04902703|Molgramostim|molgramostim|mesh-list
153377317|NCT04902703|Sargramostim|sargramostim|mesh-list
153377318|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
153377355|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
153377356|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377357|NCT04720768|Palbociclib|palbociclib|mesh-list
153377398|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
153377399|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
153377400|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377401|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377402|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153377403|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
153377404|NCT04653246|Hormones|hormones|mesh-ancestor
153377405|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377406|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153377407|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377408|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
153377409|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153377410|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153377411|NCT04653246|Growth Substances|growth substances|mesh-ancestor
153377412|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
153377413|NCT04640545|Axitinib|axitinib|mesh-list
153837321|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837322|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153837323|NCT02940366|Atorvastatin|atorvastatin|mesh-list
153837324|NCT02940366|Pitavastatin|pitavastatin|mesh-list
153837325|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153837326|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153837327|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
153837328|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837329|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153837330|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153837331|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837332|NCT02940405|Ketorolac|ketorolac|mesh-list
153837333|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153837344|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837347|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153837348|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153837349|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837350|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
153837351|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153837352|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837353|NCT04690647|Dexamethasone|dexamethasone|mesh-list
153837354|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
153837355|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837356|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
153837357|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
153837358|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837359|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837360|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837361|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
153837362|NCT04690647|Hormones|hormones|mesh-ancestor
153837363|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837364|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153837365|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837366|NCT04690647|Analgesics|analgesics|mesh-ancestor
153837367|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
153837368|NCT00519467|Artesunate|artesunate|mesh-list
153837369|NCT00519467|Dapsone|dapsone|mesh-list
153837370|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
153837371|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
154258295|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258296|NCT02524964|Tanshinone|tanshinone|mesh-list
153851907|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153851919|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153392133|NCT00000477|L 647318|l 647318|mesh-list
154258297|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258298|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154258299|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153837372|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153837373|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153837374|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837375|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377449|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
153377450|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153377451|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377452|NCT04439201|Palbociclib|palbociclib|mesh-list
153377453|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377454|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153377455|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377456|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377457|NCT04429321|Nivolumab|nivolumab|mesh-list
153377458|NCT04429321|Ipilimumab|ipilimumab|mesh-list
153377459|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377460|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377461|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377462|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377463|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
153377464|NCT04425902|Metoprolol|metoprolol|mesh-list
153377465|NCT04425902|Digoxin|digoxin|mesh-list
153377466|NCT04425902|Midazolam|midazolam|mesh-list
153377467|NCT04425902|Caffeine|caffeine|mesh-list
153377468|NCT04425902|Omeprazole|omeprazole|mesh-list
153377469|NCT04425902|Pravastatin|pravastatin|mesh-list
153377470|NCT04425902|Montelukast|montelukast|mesh-list
153377471|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153377472|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153377489|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153377490|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
153377491|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153377492|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153377493|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153837412|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837413|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837414|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153837415|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153837416|NCT00520169|Ketamine|ketamine|mesh-list
153837417|NCT00520169|Analgesics|analgesics|mesh-ancestor
153837430|NCT00520247|Folic Acid|folic acid|mesh-list
153837431|NCT00520247|Enalapril|enalapril|mesh-list
153837432|NCT00520247|Hematinics|hematinics|mesh-ancestor
153837433|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
153837434|NCT00520247|Vitamins|vitamins|mesh-ancestor
153837435|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
153837436|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837437|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153377511|NCT04425902|Protective Agents|protective agents|mesh-ancestor
153377512|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153377513|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153377514|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
153377515|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153377516|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153377517|NCT04425902|Analgesics|analgesics|mesh-ancestor
153377518|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
153377519|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153377520|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377521|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377522|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377523|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153377524|NCT04413799|Lidocaine|lidocaine|mesh-list
153377525|NCT04413799|Ketamine|ketamine|mesh-list
153377526|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
153377527|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
153377528|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377529|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377530|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
153377531|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258300|NCT02524964|Analgesics|analgesics|mesh-ancestor
154258301|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
154258302|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258303|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258304|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154258305|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154258306|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
154258307|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154258308|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258309|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258310|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
153732152|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843021|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153851955|NCT01042561|Vitamin D|vitamin d|mesh-list
153851956|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
153843022|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153843023|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377532|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153851957|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
153851958|NCT01042561|Vitamins|vitamins|mesh-list
153851959|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
153851960|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851961|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153851962|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153851963|NCT00848328|Rituximab|rituximab|mesh-list
153377533|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153837452|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153837453|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153837455|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
153837456|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837457|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837458|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837459|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837460|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153837461|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837462|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837463|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153837464|NCT00520442|Narcotics|narcotics|mesh-ancestor
153377538|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153377539|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153377540|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
153377541|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153377542|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153377543|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377544|NCT04407234|Acetaminophen|acetaminophen|mesh-list
153377545|NCT04407234|Tirzepatide|tirzepatide|mesh-list
153377546|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377547|NCT04407234|Analgesics|analgesics|mesh-ancestor
153377548|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
153377549|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377550|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377551|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
153377552|NCT04407234|Incretins|incretins|mesh-ancestor
153377553|NCT04407234|Hormones|hormones|mesh-ancestor
153377554|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377555|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
153377556|NCT04322643|Nivolumab|nivolumab|mesh-list
153377557|NCT04322643|Atezolizumab|atezolizumab|mesh-list
153377558|NCT04322643|Durvalumab|durvalumab|mesh-list
153377559|NCT04322643|Avelumab|avelumab|mesh-list
153837506|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153837529|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837530|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837531|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153837532|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153851964|NCT00848328|Lenalidomide|lenalidomide|mesh-list
153851965|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153837533|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153837535|NCT02938182|Clopidogrel|clopidogrel|mesh-list
153837536|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153377641|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383346|NCT02314403|Abatacept|abatacept|mesh-list
153383347|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153383348|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383349|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
153843288|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843289|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843290|NCT02665143|Nintedanib|nintedanib|mesh-list
153843291|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843292|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153377642|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153377649|NCT04126278|Dexamethasone|dexamethasone|mesh-list
153837539|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153837540|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
153837541|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837542|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837543|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837544|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
153837545|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
153837546|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837547|NCT00521612|Sevoflurane|sevoflurane|mesh-list
153837548|NCT00521612|Isoflurane|isoflurane|mesh-list
153837549|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153837556|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153837557|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
153837558|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837559|NCT02931591|Metformin|metformin|mesh-list
153837560|NCT02931591|Hormones|hormones|mesh-list
153837561|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153837562|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837580|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837582|NCT02931474|Growth Substances|growth substances|mesh-ancestor
153377740|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377741|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377742|NCT04007289|Apixaban|apixaban|mesh-list
153377743|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153377744|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
153377745|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153377746|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
153377747|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837649|NCT02936934|Morphine|morphine|mesh-list
153837685|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837686|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837687|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153837688|NCT00522665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153377820|NCT03747939|Analgesics|analgesics|mesh-ancestor
153377821|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
153377822|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377823|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377824|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377825|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377826|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153377827|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153377828|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837775|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837776|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
153837777|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837779|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
153837780|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
153837781|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837782|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837801|NCT00524381|Analgesics|analgesics|mesh-ancestor
153837802|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
153837803|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837804|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837805|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837806|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154258311|NCT01289756|Clarithromycin|clarithromycin|mesh-list
154258312|NCT01289756|Paroxetine|paroxetine|mesh-list
154258313|NCT01289756|Clomiphene|clomiphene|mesh-list
154258314|NCT01289756|Enclomiphene|enclomiphene|mesh-list
154258315|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
154258316|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153837807|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837808|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153837809|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
153837810|NCT04502667|Vitamin D|vitamin d|mesh-list
153837811|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
153837812|NCT04502667|Vitamins|vitamins|mesh-ancestor
153837813|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
153837814|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852029|NCT02908698|Prednisone|prednisone|mesh-list
153377904|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153377905|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377907|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
153377908|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377939|NCT03514368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377940|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377941|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
153377942|NCT03502577|Fludarabine|fludarabine|mesh-list
153377943|NCT03502577|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
153837870|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
153837871|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837872|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837873|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153837874|NCT00523757|Diuretics|diuretics|mesh-ancestor
153837875|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
153837876|NCT00524693|Montelukast|montelukast|mesh-list
153837877|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153837878|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
153837879|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153837880|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
153837881|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837882|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837883|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153378034|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
153837979|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153837980|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153837981|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
153837982|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
153837983|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837984|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153837985|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153378065|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
153392243|NCT00000549|Estrogens|estrogens|mesh-list
153852033|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852035|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153852036|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852038|NCT00544596|Etoposide|etoposide|mesh-list
153378066|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378067|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153838002|NCT02935764|Protective Agents|protective agents|mesh-ancestor
153838003|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
153838004|NCT02935764|Vitamins|vitamins|mesh-ancestor
153838005|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
153838006|NCT02935998|Ziprasidone|ziprasidone|mesh-list
153838007|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153378087|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378088|NCT03132129|Trace Elements|trace elements|mesh-ancestor
153378089|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
153378091|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
153378092|NCT03128021|Escitalopram|escitalopram|mesh-list
153378093|NCT03128021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153378094|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153378095|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153378096|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378097|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378098|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
153378099|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378100|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378101|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
153378102|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153378103|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153843424|NCT01283971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153378104|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378106|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
153378107|NCT03126214|Warfarin|warfarin|mesh-list
153378108|NCT03126214|Anticoagulants|anticoagulants|mesh-list
153378117|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
153378118|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378119|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153378122|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
153838031|NCT00524186|Sunitinib|sunitinib|mesh-list
153838032|NCT00524186|Calcium|calcium|mesh-list
153838033|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
153362255|NCT04452214|Pemetrexed|pemetrexed|mesh-list
153392276|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
153392277|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153852064|NCT02908191|Entecavir|entecavir|mesh-list
153838034|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153838035|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838036|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
153838037|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838038|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838039|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838040|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838041|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
153838042|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153838043|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153838044|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838045|NCT00524186|Antidotes|antidotes|mesh-ancestor
153838046|NCT00524186|Protective Agents|protective agents|mesh-ancestor
153838047|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
153838048|NCT00524186|Vitamins|vitamins|mesh-ancestor
153378129|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
153378130|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
153378131|NCT02915198|Metformin|metformin|mesh-list
153378132|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153378133|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378134|NCT02913482|Risdiplam|risdiplam|mesh-list
153378135|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153378136|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378137|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378138|NCT02838420|Crizotinib|crizotinib|mesh-list
153378139|NCT02838420|Alectinib|alectinib|mesh-list
153378140|NCT02838420|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153378162|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
153378163|NCT02719613|Hormones|hormones|mesh-ancestor
153378164|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153378165|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153378166|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378167|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
153378168|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838066|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
153838067|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
153838068|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153838069|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838070|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
153838071|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838072|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838073|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
153838075|NCT02930265|Liraglutide|liraglutide|mesh-list
153838076|NCT02930265|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153838077|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153838078|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838079|NCT02930265|Incretins|incretins|mesh-ancestor
153838080|NCT02930265|Hormones|hormones|mesh-ancestor
153838081|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153838082|NCT02947178|Bupivacaine|bupivacaine|mesh-list
153838083|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
153838084|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
153838085|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838086|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838087|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
153838088|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838089|NCT02929797|Gemcitabine|gemcitabine|mesh-list
153838090|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838091|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
153838092|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838093|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838094|NCT00525239|Ritonavir|ritonavir|mesh-list
153838095|NCT00525239|Lopinavir|lopinavir|mesh-list
153843595|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153843596|NCT01282216|Vaccines|vaccines|mesh-list
153843597|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153838116|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
153378199|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378200|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153378201|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
153378202|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378203|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378204|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153378205|NCT02625480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378206|NCT02620046|Vedolizumab|vedolizumab|mesh-list
153378207|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153378208|NCT02500849|Busulfan|busulfan|mesh-list
153378209|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
153378210|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378211|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378212|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
153378213|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378214|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153378215|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378216|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153378217|NCT02477826|Paclitaxel|paclitaxel|mesh-list
153378218|NCT02477826|Carboplatin|carboplatin|mesh-list
153378219|NCT02477826|Gemcitabine|gemcitabine|mesh-list
153378220|NCT02477826|Nivolumab|nivolumab|mesh-list
153378221|NCT02477826|Pemetrexed|pemetrexed|mesh-list
153378222|NCT02477826|Ipilimumab|ipilimumab|mesh-list
153378223|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153392322|NCT00000621|Tretinoin|tretinoin|mesh-list
153378224|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378225|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
153378226|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
153378227|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
153378229|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838120|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153838150|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
153838151|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378235|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153378236|NCT02386774|Benoxinate|benoxinate|mesh-list
153378237|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153378238|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153378239|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
153378240|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
153378241|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378242|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378243|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
153378244|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838169|NCT00526175|Vincristine|vincristine|mesh-list
153838170|NCT00526175|Daunorubicin|daunorubicin|mesh-list
153838171|NCT00526175|Asparaginase|asparaginase|mesh-list
153838172|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
153838173|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838174|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
153838197|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
153838198|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
153838199|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
153838200|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
153838201|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838202|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153838203|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153838204|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153838205|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
153838206|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153378290|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153378291|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378292|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
153378293|NCT02037048|Leucovorin|leucovorin|mesh-list
153378294|NCT02037048|Paclitaxel|paclitaxel|mesh-list
153378295|NCT02037048|Carboplatin|carboplatin|mesh-list
153378296|NCT02037048|Fluorouracil|fluorouracil|mesh-list
153378297|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
153378298|NCT02037048|Calcium|calcium|mesh-list
153378299|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
154258318|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154258319|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258320|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258321|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154258322|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153392341|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
154258323|NCT01289756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154258324|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154258325|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154258326|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732154|NCT00155064|Captopril|captopril|mesh-list
153394299|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
153383813|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
153383814|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383815|NCT00355667|Furosemide|furosemide|mesh-list
153383816|NCT00355667|Azosemide|azosemide|mesh-list
153383817|NCT00355667|Diuretics|diuretics|mesh-ancestor
153383818|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
153383822|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383823|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153383824|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
153383825|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383837|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383839|NCT01312922|Pipamperone|pipamperone|mesh-list
153383840|NCT01312922|Citalopram|citalopram|mesh-list
153383841|NCT01312922|Escitalopram|escitalopram|mesh-list
153843716|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153843717|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843718|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
153843719|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153843720|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153843721|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843722|NCT01279447|Bupivacaine|bupivacaine|mesh-list
153843723|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
153843724|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
153378300|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154258327|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
154258328|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258329|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154258330|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
154258331|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154258332|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154258333|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154258334|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
154258335|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258336|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154258337|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
154258338|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154258339|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154258340|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154258341|NCT01181882|Aspirin|aspirin|mesh-list
154258342|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153732155|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153732156|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383869|NCT01783574|Androgens|androgens|mesh-ancestor
153843766|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
153843767|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843768|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153843769|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153843770|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153843771|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843772|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843773|NCT02919605|Pentamidine|pentamidine|mesh-list
153378301|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378302|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
153378303|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
153378304|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
153378305|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378306|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153378307|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378319|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378320|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838234|NCT00525551|Antidotes|antidotes|mesh-ancestor
153838235|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
153838236|NCT04288323|Edetic Acid|edetic acid|mesh-list
153838237|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
153838238|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153378341|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
153378342|NCT01780844|Hormones|hormones|mesh-ancestor
154258343|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154258344|NCT01181882|Analgesics|analgesics|mesh-ancestor
154258345|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
153384044|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
153378343|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153378344|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838262|NCT02946437|Propofol|propofol|mesh-list
153838263|NCT02946437|Sevoflurane|sevoflurane|mesh-list
153838264|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153838265|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838266|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378364|NCT01606878|Razoxane|razoxane|mesh-list
153392393|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
153392394|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392395|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153392396|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153392397|NCT01701505|Phenylephrine|phenylephrine|mesh-list
153392398|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
153392399|NCT01701505|Tetracaine|tetracaine|mesh-list
153392400|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
153392401|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
153392404|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
153392405|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392406|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153378365|NCT01606878|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153378366|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378367|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
153378368|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378369|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378370|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153378371|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
153838276|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378394|NCT01175356|Doxorubicin|doxorubicin|mesh-list
153378395|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153378396|NCT01175356|Etoposide|etoposide|mesh-list
153378397|NCT01175356|Vincristine|vincristine|mesh-list
153378398|NCT01175356|Topotecan|topotecan|mesh-list
153378399|NCT01175356|Tretinoin|tretinoin|mesh-list
153838289|NCT02946632|Incretins|incretins|mesh-ancestor
153838290|NCT02946632|Hormones|hormones|mesh-ancestor
153838291|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153838292|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153838293|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
153838294|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838295|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153838296|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838297|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
153838298|NCT02929134|Doxycycline|doxycycline|mesh-list
153838299|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153838300|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838301|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
153838302|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153838303|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153838304|NCT02929212|Acetaminophen|acetaminophen|mesh-list
153838305|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153838306|NCT02929212|Analgesics|analgesics|mesh-ancestor
153838307|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
153838308|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378430|NCT01064466|Etoposide|etoposide|mesh-list
153378431|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
153378432|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153378433|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378434|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153378435|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153378436|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378437|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378438|NCT01005745|Aldesleukin|aldesleukin|mesh-list
153378439|NCT01005745|Interleukin-2|interleukin-2|mesh-list
153378440|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378441|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378442|NCT01005745|Analgesics|analgesics|mesh-ancestor
153378443|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
153378444|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378445|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378446|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153378447|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153378448|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
153378449|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378450|NCT00335816|Leucovorin|leucovorin|mesh-list
153838328|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153838329|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
153838330|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838331|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838332|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153838333|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153838334|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154258346|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258347|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838335|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153838336|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153838337|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
153838339|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
153838340|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
153838341|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153838362|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838366|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153852238|NCT04646135|Lorazepam|lorazepam|mesh-list
153852239|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
153852240|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
153838367|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153838368|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838369|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838370|NCT02928510|Idelalisib|idelalisib|mesh-list
153838371|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838372|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838373|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838374|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
153838375|NCT02946944|Apixaban|apixaban|mesh-list
153838376|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
153838377|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153838378|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153838379|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391151|NCT00002763|Interferons|interferons|mesh-list
153838380|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838381|NCT02946944|Urological Agents|urological agents|mesh-ancestor
153838382|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153378472|NCT00295893|Doxorubicin|doxorubicin|mesh-list
153378473|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153378474|NCT00295893|Trastuzumab|trastuzumab|mesh-list
153378475|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153378476|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378477|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
153378478|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
153378479|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
153378480|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378481|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378482|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
153378483|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378484|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378485|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153378486|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
153378487|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153838394|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838395|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
153838396|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
153838397|NCT02928315|Analgesics|analgesics|mesh-ancestor
153838398|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
153838399|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838400|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838401|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
153838402|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838403|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153838404|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
153838405|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153838406|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153838407|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838408|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153838409|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
153838410|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153838411|NCT00526409|Cytarabine|cytarabine|mesh-list
153838412|NCT00526409|Prednisolone|prednisolone|mesh-list
153838413|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
153838414|NCT00526409|Methotrexate|methotrexate|mesh-list
153838415|NCT00526409|Vincristine|vincristine|mesh-list
153838416|NCT00526409|Daunorubicin|daunorubicin|mesh-list
153838417|NCT00526409|Asparaginase|asparaginase|mesh-list
153838418|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838419|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
153838420|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838421|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153838422|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153838423|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
154258348|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154258349|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154258350|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154258351|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154258352|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838424|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838425|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838426|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153838427|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153838428|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
153838429|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153838430|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838431|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
153838432|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
153838438|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
153838439|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
153838440|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838441|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
153838442|NCT00526409|Hormones|hormones|mesh-ancestor
153838443|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153838458|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153838459|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838460|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153838461|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838462|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
153838463|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153838464|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153838465|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838466|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
153378575|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378576|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378577|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
153378578|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378579|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153378580|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378581|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
153378582|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378583|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153378584|NCT04311567|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153378585|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153378586|NCT04259775|Insulin|insulin|mesh-list
153838470|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838471|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838472|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
153838473|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838474|NCT02945163|Tenofovir|tenofovir|mesh-list
153838475|NCT02945163|Lamivudine|lamivudine|mesh-list
153838476|NCT02945163|Efavirenz|efavirenz|mesh-list
153838477|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
153838478|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838479|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153838480|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153838481|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838482|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838483|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153838484|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153838485|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153838493|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838494|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838495|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153838496|NCT00526760|Analgesics|analgesics|mesh-ancestor
153838497|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
153838498|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838499|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153838500|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153838501|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153838502|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
153844519|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
153838503|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838504|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838505|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
153378614|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153378615|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378616|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
153378617|NCT01523834|Panobinostat|panobinostat|mesh-list
153378618|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378619|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153378620|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838511|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392642|NCT05681702|Aspirin|aspirin|mesh-list
153838512|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
153838513|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838514|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153838515|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153838516|NCT02927379|Analgesics|analgesics|mesh-ancestor
153838517|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153838518|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153838519|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153838520|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
153838521|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838522|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838523|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153838524|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153838525|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
153378621|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378622|NCT01472432|Vildagliptin|vildagliptin|mesh-list
153378623|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153378624|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378625|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153378626|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
153378627|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838549|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153838550|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153838551|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153838552|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
153838553|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838554|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838555|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838556|NCT00527033|Urological Agents|urological agents|mesh-ancestor
153838557|NCT02945072|Sevoflurane|sevoflurane|mesh-list
153838558|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153838559|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153838560|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
153838561|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
153838562|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838563|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838565|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153838566|NCT02924922|Diuretics|diuretics|mesh-ancestor
153838567|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
153838568|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838569|NCT04692896|Lidocaine|lidocaine|mesh-list
153378687|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378688|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153378689|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153378690|NCT02802501|Primaquine|primaquine|mesh-list
153378691|NCT02802501|Piperaquine|piperaquine|mesh-list
153838582|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153838583|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
153838584|NCT00528008|Povidone|povidone|mesh-list
153838585|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153838586|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838587|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
153838588|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
153838589|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
153838590|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
153838593|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
153838594|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838595|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838596|NCT02925000|Vinorelbine|vinorelbine|mesh-list
153838597|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153838598|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385047|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153844949|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838599|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
153838600|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
153838601|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
153378718|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378719|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378720|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153378721|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
153378722|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
153378723|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153378724|NCT02803749|Buspirone|buspirone|mesh-list
153378725|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153378726|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153378727|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378728|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378729|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153378730|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153378731|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
153378732|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378733|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378734|NCT01578980|Pancrelipase|pancrelipase|mesh-list
153378735|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153378736|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153378737|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378738|NCT00372879|Vitamin E|vitamin e|mesh-list
153378739|NCT00372879|Vitamins|vitamins|mesh-ancestor
153378744|NCT00372879|Protective Agents|protective agents|mesh-ancestor
153378745|NCT02806869|Ibuprofen|ibuprofen|mesh-list
153378746|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153378747|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378748|NCT02806869|Analgesics|analgesics|mesh-ancestor
153378749|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
153378750|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378751|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378769|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
153378770|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378771|NCT02814279|Dipyrone|dipyrone|mesh-list
153392776|NCT05738564|Oxymetazoline|oxymetazoline|mesh-list
153392777|NCT05738564|Anesthetics, Local|anesthetics, local|mesh-ancestor
153392778|NCT05738564|Anesthetics|anesthetics|mesh-ancestor
153852556|NCT06224569|Purinergic Agents|purinergic agents|mesh-ancestor
153392786|NCT05738564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392792|NCT05738564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153392793|NCT05738564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153392812|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
153732945|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153732946|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461656|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
153461657|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
153461658|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
153461659|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461660|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378772|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
153378773|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153378774|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378775|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
153378776|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153378777|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378778|NCT02814279|Analgesics|analgesics|mesh-ancestor
153378779|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
153378780|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378810|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
153378811|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153378812|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378813|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153378814|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153378815|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378816|NCT01582490|Bupivacaine|bupivacaine|mesh-list
153378817|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
153378818|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
153378819|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378820|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378821|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
153838709|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153838714|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
153838715|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153838716|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838717|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153838718|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153838719|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838720|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838721|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838722|NCT00528515|Propofol|propofol|mesh-list
153378858|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394433|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
153845041|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
153845042|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153845043|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
153845044|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378859|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378860|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378861|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153378862|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153378863|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378864|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153378865|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153838744|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838746|NCT00528593|Hematinics|hematinics|mesh-ancestor
153838747|NCT02926326|Azithromycin|azithromycin|mesh-list
153838748|NCT02926326|Acumapimod|acumapimod|mesh-list
153838749|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153838750|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838751|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153838752|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838753|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838754|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
153838755|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
153838756|NCT00528827|Nicardipine|nicardipine|mesh-list
153838757|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153838758|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153838759|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153838760|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838761|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153838762|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838763|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
153838764|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
153838765|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153838798|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838799|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
153838800|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838801|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
153838802|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838803|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
153378901|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
153391816|NCT05364645|Carboplatin|carboplatin|mesh-list
153378902|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153378903|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
153378904|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378905|NCT03510741|Protective Agents|protective agents|mesh-ancestor
153378906|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378907|NCT03510741|Antidotes|antidotes|mesh-ancestor
153378908|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
153378909|NCT01584518|Furosemide|furosemide|mesh-list
153378910|NCT01584518|Diuretics|diuretics|mesh-ancestor
153378911|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
153378912|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378913|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153378914|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153378915|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378916|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
153378917|NCT02901249|Sertraline|sertraline|mesh-list
153378918|NCT02901249|Nortriptyline|nortriptyline|mesh-list
153378919|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
153378920|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153392826|NCT01352117|Emtricitabine|emtricitabine|mesh-list
153378921|NCT02901249|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153378922|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153378944|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378945|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378946|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
153378977|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153378979|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153378980|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153378981|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153845213|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153845214|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
153378982|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153378983|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153378984|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153378985|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153378986|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153378987|NCT02212106|Vaccines|vaccines|mesh-list
153378988|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
153378989|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378990|NCT02903121|Tamoxifen|tamoxifen|mesh-list
153378991|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153378992|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
153378993|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153378994|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378995|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153378996|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378997|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153378998|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153378999|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153379000|NCT02904915|Lidocaine|lidocaine|mesh-list
153379001|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
153379002|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
153379003|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838877|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153838878|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153838879|NCT02945033|Aspirin|aspirin|mesh-list
153838880|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153838881|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153838882|NCT02945033|Analgesics|analgesics|mesh-ancestor
153838883|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
153838884|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838885|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838886|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838887|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153838888|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153379036|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153379037|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
153379039|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153379040|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153379041|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
153379042|NCT01536938|Hormones|hormones|mesh-ancestor
153379043|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379044|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838918|NCT02945267|Tegafur|tegafur|mesh-list
153838919|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
153838920|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838921|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
153838922|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838923|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838924|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153838925|NCT00529646|APD791|apd791|mesh-list
153838926|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153838927|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153838928|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
153838929|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838930|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838931|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838932|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
153838933|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838934|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
153838935|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153838936|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838937|NCT00529880|Cytarabine|cytarabine|mesh-list
153838938|NCT00529880|Fludarabine|fludarabine|mesh-list
153838939|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838940|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838941|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
153838942|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379066|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
153379067|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258353|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153394480|NCT02115997|Rituximab|rituximab|mesh-list
153379069|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
153379070|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
153379071|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
153379072|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153379073|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153379074|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153379075|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153838957|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153838958|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153838959|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153838960|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838961|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838962|NCT02922660|Remifentanil|remifentanil|mesh-list
153838963|NCT02922660|Anesthetics|anesthetics|mesh-list
153838964|NCT02922660|Propofol|propofol|mesh-list
153838965|NCT02922660|Desflurane|desflurane|mesh-list
153838966|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838967|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838968|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153379081|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379082|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153379083|NCT02914119|Rocuronium|rocuronium|mesh-list
153379084|NCT02914119|Mivacurium|mivacurium|mesh-list
153379085|NCT02914119|Cisatracurium|cisatracurium|mesh-list
153379086|NCT02914119|Succinylcholine|succinylcholine|mesh-list
153379087|NCT02914119|Neostigmine|neostigmine|mesh-list
153379088|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153379089|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153379090|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153379091|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379092|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379093|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153379094|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379095|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379096|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
153379097|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379098|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153379099|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
153379100|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153379101|NCT01589510|Bimatoprost|bimatoprost|mesh-list
153379102|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153379103|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153379104|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153379105|NCT02914509|Travoprost|travoprost|mesh-list
153852713|NCT06126952|Analgesics|analgesics|mesh-ancestor
153838985|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838986|NCT02944292|Propofol|propofol|mesh-list
153838987|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153838988|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838989|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838990|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153839016|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
153839034|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
153379132|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153379133|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153379134|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153379135|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153379136|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153379137|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732072|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
153379138|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153379140|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153379141|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153379142|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153379143|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153379144|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
153379145|NCT02430233|Progesterone|progesterone|mesh-list
153379146|NCT02430233|Progestins|progestins|mesh-ancestor
153379147|NCT02430233|Hormones|hormones|mesh-ancestor
153379148|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379149|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379150|NCT01589978|Aspirin|aspirin|mesh-list
153845548|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153845549|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153385660|NCT03847389|Hormones|hormones|mesh-ancestor
153379151|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
153379152|NCT01589978|Salicylates|salicylates|mesh-list
153379153|NCT01589978|Ticlopidine|ticlopidine|mesh-list
153379154|NCT01589978|Clopidogrel|clopidogrel|mesh-list
153379155|NCT01589978|Ticagrelor|ticagrelor|mesh-list
153379156|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153379157|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153379158|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153379159|NCT01589978|Analgesics|analgesics|mesh-ancestor
153379160|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
153379161|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379162|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379163|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153379164|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153379165|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153379166|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153839037|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153839038|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839039|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153839040|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
153839041|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
153839042|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379167|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379169|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153379170|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379172|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153379173|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153379174|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153379184|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153379185|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
153379186|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379188|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379189|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
153379190|NCT00551291|Prednisone|prednisone|mesh-list
153379191|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
153379192|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153379193|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
153379194|NCT00551291|Hormones|hormones|mesh-ancestor
153379195|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839091|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839092|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153839093|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153839094|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839095|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153839096|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153839097|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839098|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
153839099|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
153379198|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379199|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153379206|NCT00551291|Hematinics|hematinics|mesh-ancestor
153379207|NCT02981264|Lidocaine|lidocaine|mesh-list
153379208|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
153379209|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
153379210|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379211|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379212|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
153379213|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379214|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153852830|NCT05872425|Diuretics|diuretics|mesh-ancestor
153379215|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153379216|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153379217|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153379218|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379219|NCT01593722|Ivermectin|ivermectin|mesh-list
153379220|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
153379221|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153379222|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379223|NCT01593722|Filaricides|filaricides|mesh-ancestor
153379224|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
153839118|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258354|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154258355|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839119|NCT04000854|Calcium|calcium|mesh-list
153839120|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153839121|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839122|NCT00530387|Ibuprofen|ibuprofen|mesh-list
153839123|NCT00530387|Diclofenac|diclofenac|mesh-list
153839124|NCT00530387|Ketoprofen|ketoprofen|mesh-list
153839125|NCT00530387|Piroxicam|piroxicam|mesh-list
153839126|NCT00530387|Salicylates|salicylates|mesh-list
153839127|NCT00530387|Etofenamate|etofenamate|mesh-list
153839128|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
153839129|NCT00530387|Homosalate|homosalate|mesh-list
153839130|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
153839131|NCT00530387|Benzophenone|benzophenone|mesh-list
153839132|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153839133|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153839134|NCT00530387|Analgesics|analgesics|mesh-ancestor
153839135|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
153839136|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839137|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839138|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153839139|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839140|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153839141|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839142|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839143|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153839144|NCT00530387|Protective Agents|protective agents|mesh-ancestor
153839145|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
153379243|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379244|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153379245|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153379246|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153379247|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379248|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379250|NCT01595516|Nebivolol|nebivolol|mesh-list
153379267|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153379268|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153379269|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153379270|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
153379271|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379272|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
153379274|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153839146|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153839147|NCT04689165|Vaccines|vaccines|mesh-list
153839148|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
153839149|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839150|NCT00530582|Progesterone|progesterone|mesh-list
153839151|NCT00530582|Progestins|progestins|mesh-ancestor
153839152|NCT00530582|Hormones|hormones|mesh-ancestor
153839153|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839154|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839155|NCT02944175|Neostigmine|neostigmine|mesh-list
153839156|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153839157|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839158|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839159|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
153839160|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839161|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839162|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153839163|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
153839164|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839165|NCT02917746|Imiquimod|imiquimod|mesh-list
153839166|NCT02917746|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153839167|NCT02917746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839168|NCT02917746|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153839169|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
153839170|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839171|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153839172|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839173|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
153839174|NCT00531557|Ritonavir|ritonavir|mesh-list
153379275|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379278|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154258356|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
154258357|NCT01181960|Risperidone|risperidone|mesh-list
154258358|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154258359|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
153845937|NCT04283513|Ribavirin|ribavirin|mesh-list
153379279|NCT02217800|Octreotide|octreotide|mesh-list
153379280|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153379281|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153379282|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379283|NCT02218190|Alvimopan|alvimopan|mesh-list
153839180|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839182|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153839183|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
153839184|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852929|NCT05670509|Midazolam|midazolam|mesh-list
153839185|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153839186|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153839187|NCT00531596|Selegiline|selegiline|mesh-list
153839188|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
153839189|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153839190|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153839191|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153839192|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153839193|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839194|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839195|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153839196|NCT00531596|Protective Agents|protective agents|mesh-ancestor
153839197|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839198|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153379334|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
153379335|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379336|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379337|NCT00551213|Capecitabine|capecitabine|mesh-list
153379338|NCT00551213|Irinotecan|irinotecan|mesh-list
153379339|NCT00551213|Cetuximab|cetuximab|mesh-list
153839224|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839225|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
153839226|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839227|NCT02943317|Avelumab|avelumab|mesh-list
153839228|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153839229|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839230|NCT02943356|Tadalafil|tadalafil|mesh-list
153839231|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
153839232|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153839233|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153839234|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839235|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839236|NCT02943356|Urological Agents|urological agents|mesh-ancestor
153839237|NCT02917512|Cyclosporine|cyclosporine|mesh-list
153839238|NCT02917512|Cyclosporins|cyclosporins|mesh-list
153839239|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839240|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839241|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153839242|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
153839243|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839244|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
153839245|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839246|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
153839247|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839248|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153839249|NCT02943902|Vaccines|vaccines|mesh-list
153393195|NCT04826588|Prednisolone|prednisolone|mesh-list
153839250|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153839251|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
153839252|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839253|NCT00531908|Furosemide|furosemide|mesh-list
153839254|NCT00531908|Diuretics|diuretics|mesh-ancestor
153839255|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
153839256|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839257|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153839258|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153839259|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839260|NCT03403569|Triptolide|triptolide|mesh-list
153839261|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153732162|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386171|NCT02325414|Diphosphonates|diphosphonates|mesh-list
153839262|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839263|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153839264|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
153379367|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379369|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153379370|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
153379371|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379372|NCT03000218|Metformin|metformin|mesh-list
153379373|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153379374|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153379375|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379398|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153379399|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379400|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153839265|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153839266|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153839267|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
153839268|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153839269|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
153839270|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839271|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839272|NCT00531791|Prednisone|prednisone|mesh-list
153839273|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153839274|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
153839275|NCT00531791|Hormones|hormones|mesh-ancestor
153839276|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839277|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839278|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153839279|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839280|NCT02921178|Omalizumab|omalizumab|mesh-list
153839281|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153839282|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153839283|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
153839284|NCT00531986|Lopinavir|lopinavir|mesh-list
153839285|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153839286|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153839287|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
153839288|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839289|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839290|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153839291|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153839292|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
153379431|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153379438|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153839305|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839306|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839307|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
153839308|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839309|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153839310|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153839329|NCT02920515|Leuprolide|leuprolide|mesh-list
153839330|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153839331|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
153839332|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153839333|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839334|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153839335|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839336|NCT02917005|Palbociclib|palbociclib|mesh-list
153379439|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
153379440|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
153379441|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153379442|NCT02999126|Narcotics|narcotics|mesh-ancestor
153379443|NCT02999126|Analgesics|analgesics|mesh-ancestor
153379444|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
153379445|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379446|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
153379447|NCT03019887|Haloperidol|haloperidol|mesh-list
153379448|NCT03019887|Olanzapine|olanzapine|mesh-list
153379449|NCT03019887|Risperidone|risperidone|mesh-list
153379450|NCT03019887|Aripiprazole|aripiprazole|mesh-list
153379451|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153853039|NCT05354102|Nivolumab|nivolumab|mesh-list
153379452|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153379453|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
154258360|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154258361|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
153732163|NCT02483260|Ribavirin|ribavirin|mesh-list
153379454|NCT03019887|Perphenazine|perphenazine|mesh-list
153379455|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153379456|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
153379457|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379458|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379459|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379460|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153379461|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153379462|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379463|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153379464|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153379465|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
153839338|NCT02917005|Goserelin|goserelin|mesh-list
153839339|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839340|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153839341|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839362|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839363|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153839364|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153839365|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153839366|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
153839367|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839368|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839369|NCT02942693|Apatinib|apatinib|mesh-list
153839370|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839371|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153839372|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839373|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839374|NCT02920593|Vitamin D|vitamin d|mesh-list
153839375|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
153839376|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
153839377|NCT02920593|Vitamins|vitamins|mesh-list
153839378|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
153839379|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839380|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153839381|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153839382|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
153839383|NCT02942732|Vitamin D|vitamin d|mesh-list
153839384|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153839385|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379489|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153379490|NCT05406752|Analgesics|analgesics|mesh-ancestor
153379491|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
153379492|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379493|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379494|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
153379495|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
153379496|NCT02247362|Vaccines|vaccines|mesh-list
153733090|NCT00163488|Ciclesonide|ciclesonide|mesh-list
153839387|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
153839388|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153839389|NCT02942420|Bucillamine|bucillamine|mesh-list
153839390|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153839391|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153839392|NCT02942420|Analgesics|analgesics|mesh-ancestor
153839393|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
153839394|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839395|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839396|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153839397|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839398|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
153839399|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839400|NCT02942420|Protective Agents|protective agents|mesh-ancestor
153839401|NCT02920359|Leuprolide|leuprolide|mesh-list
153839402|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153839403|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
153839404|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153839405|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839406|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153379549|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258362|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379550|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839449|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839450|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153839451|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839452|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
153839453|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153839454|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153839455|NCT02916420|Growth Substances|growth substances|mesh-ancestor
153839456|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
153839457|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
153839458|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
153839459|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153839460|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153839461|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839462|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839463|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839464|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839465|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
153461718|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153393373|NCT01727089|Antibodies|antibodies|mesh-list
153379591|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153379592|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
153379593|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
153379594|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379595|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379596|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153379597|NCT02860845|Clindamycin|clindamycin|mesh-list
153379598|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
153379599|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
153379600|NCT02860845|Clotrimazole|clotrimazole|mesh-list
153839472|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153839473|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153839474|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839476|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839477|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839478|NCT02916381|Anesthetics|anesthetics|mesh-list
153839479|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839480|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839481|NCT02920047|Amlodipine|amlodipine|mesh-list
153839482|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153839483|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153839484|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153839485|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839486|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153839487|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839488|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
153839489|NCT02941016|Evolocumab|evolocumab|mesh-list
153839490|NCT02941016|Alirocumab|alirocumab|mesh-list
153839491|NCT02941016|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153839492|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153839493|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153839494|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
153839495|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839500|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
153839501|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379640|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153379641|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379642|NCT05140694|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153379643|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
153379645|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
153379646|NCT02987699|Fluorouracil|fluorouracil|mesh-list
153379647|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
153379648|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379649|NCT02987699|Antidotes|antidotes|mesh-ancestor
153379650|NCT02987699|Protective Agents|protective agents|mesh-ancestor
153379651|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839527|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153839528|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153839529|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153839530|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153839531|NCT02919579|Esketamine|esketamine|mesh-list
153839532|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
153839533|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153839534|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153846413|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153839535|NCT02940821|Fluorides|fluorides|mesh-list
153839536|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
153839537|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
153732076|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732077|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
153732078|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732079|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
153732080|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732082|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
153839560|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153839561|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153839562|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153839563|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
153839564|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
153839565|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
153839566|NCT02941367|Metformin|metformin|mesh-list
153839567|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153839568|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839569|NCT03153150|Warfarin|warfarin|mesh-list
153732083|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153732084|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
153839570|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
153839572|NCT03153150|Apixaban|apixaban|mesh-list
153839573|NCT03153150|Edoxaban|edoxaban|mesh-list
153839574|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
153839575|NCT03153150|Phenindione|phenindione|mesh-list
153839576|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
153839577|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153839578|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
153839579|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153839580|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
153839581|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839582|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839583|NCT02916147|Propofol|propofol|mesh-list
153839584|NCT02916147|Sevoflurane|sevoflurane|mesh-list
153839585|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153839586|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839587|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839588|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153839589|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
153839590|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
153839591|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153839592|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153839593|NCT06026163|Caffeine|caffeine|mesh-list
153379696|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379697|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379698|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153379699|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
153379700|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153379701|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153379702|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153379703|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
153839597|NCT06026163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839598|NCT06026163|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153839599|NCT06026163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839600|NCT06026163|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153839601|NCT06026163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153839602|NCT06026163|Purinergic Agents|purinergic agents|mesh-ancestor
153839603|NCT06026163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839604|NCT06025916|Tranexamic Acid|tranexamic acid|mesh-list
153839605|NCT06025916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153839606|NCT06025916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153839607|NCT06025916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839609|NCT06025916|Coagulants|coagulants|mesh-ancestor
153839611|NCT06025851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153839612|NCT06025851|Immunologic Factors|immunologic factors|mesh-ancestor
153839613|NCT06025851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839614|NCT06025825|Lidocaine|lidocaine|mesh-list
153379738|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379762|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
153379763|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379764|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379765|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153379766|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
153379767|NCT01887587|Hormones|hormones|mesh-ancestor
153846588|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846592|NCT01540253|Docetaxel|docetaxel|mesh-list
153379768|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839635|NCT06025825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153839636|NCT06025825|Autonomic Agents|autonomic agents|mesh-ancestor
153839637|NCT06025825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153839638|NCT06025825|Respiratory System Agents|respiratory system agents|mesh-ancestor
153839639|NCT06025825|Mydriatics|mydriatics|mesh-ancestor
153839640|NCT06025825|Sympathomimetics|sympathomimetics|mesh-ancestor
153839641|NCT06025825|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153839642|NCT06025812|Vaccines|vaccines|mesh-list
153839643|NCT06025812|Immunologic Factors|immunologic factors|mesh-ancestor
153839644|NCT06025812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839645|NCT06025773|Lansoprazole|lansoprazole|mesh-list
153839646|NCT06025773|Dexlansoprazole|dexlansoprazole|mesh-list
153839647|NCT06025773|Calcium Carbonate|calcium carbonate|mesh-list
153839648|NCT06025773|Calcium|calcium|mesh-list
153839649|NCT06025773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153839650|NCT06025773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839651|NCT06025773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153839652|NCT06025773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153393563|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153839653|NCT06025773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153839654|NCT06025773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839655|NCT06025773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839656|NCT06025773|Antacids|antacids|mesh-ancestor
153839657|NCT06025474|Pregabalin|pregabalin|mesh-list
153379790|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
153379791|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
153379792|NCT00374205|Artesunate|artesunate|mesh-list
153379793|NCT00374205|Lumefantrine|lumefantrine|mesh-list
153379794|NCT00374205|Artemether|artemether|mesh-list
153379795|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153379796|NCT00374205|Amodiaquine|amodiaquine|mesh-list
153379797|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
153379798|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153379799|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153379800|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379801|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379802|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
153379803|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
153839683|NCT06025474|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153839685|NCT06025474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153839686|NCT06025474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153839687|NCT06025474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839688|NCT06025474|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153839689|NCT06025474|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153839690|NCT06025474|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153839691|NCT06025474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153839693|NCT06025409|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153839694|NCT06025409|Fertility Agents|fertility agents|mesh-ancestor
153839695|NCT06025409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153839696|NCT06025409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839697|NCT06025409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153839698|NCT06025409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839699|NCT06025240|Antibodies|antibodies|mesh-list
153839700|NCT06025240|Immunologic Factors|immunologic factors|mesh-ancestor
153839701|NCT06025240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839702|NCT06025214|Fluticasone|fluticasone|mesh-list
153839703|NCT06025214|Xhance|xhance|mesh-list
153839704|NCT06025214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153839705|NCT06025214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153839706|NCT06025214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153839707|NCT06025214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153839708|NCT06025214|Autonomic Agents|autonomic agents|mesh-ancestor
153839709|NCT06025214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839710|NCT06025214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839711|NCT06025214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153839712|NCT06025214|Respiratory System Agents|respiratory system agents|mesh-ancestor
153839713|NCT06025214|Dermatologic Agents|dermatologic agents|mesh-ancestor
153839714|NCT06025214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153839715|NCT06025214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153379819|NCT03029715|Propofol|propofol|mesh-list
153379820|NCT03029715|Desflurane|desflurane|mesh-list
153379821|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153379822|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379823|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379824|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153379825|NCT03029715|Analgesics|analgesics|mesh-ancestor
153379826|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
153379827|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379847|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
153379848|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379849|NCT03035955|Azelaic acid|azelaic acid|mesh-list
153839716|NCT06025214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153839717|NCT06025214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153379850|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379851|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
153379852|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
153839740|NCT06025071|Tubulin Modulators|tubulin modulators|mesh-ancestor
153839741|NCT06025071|Antimitotic Agents|antimitotic agents|mesh-ancestor
153839742|NCT06025071|Mitosis Modulators|mitosis modulators|mesh-ancestor
153839743|NCT06025071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839744|NCT06025071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839747|NCT06024915|Antifungal Agents|antifungal agents|mesh-ancestor
153839748|NCT06024915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839749|NCT06024915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153839750|NCT06024915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153839751|NCT06024915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839752|NCT06024915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839753|NCT06024915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153839754|NCT06024915|Hormone Antagonists|hormone antagonists|mesh-ancestor
153839755|NCT06024915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379861|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153379862|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
153379863|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
153379864|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
153379865|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153379866|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153379867|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
153379868|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379869|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379870|NCT03002792|Anesthetics|anesthetics|mesh-list
153379871|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379872|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379873|NCT02927457|GSK2646264|gsk2646264|mesh-list
153839765|NCT06024915|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153839766|NCT06024915|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153839767|NCT06024915|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153839768|NCT06024915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153839770|NCT06024746|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153839771|NCT06024746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839772|NCT06024746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153839773|NCT06024746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839774|NCT06024525|Paclitaxel|paclitaxel|mesh-list
153839775|NCT06024525|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153839776|NCT06024525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153839777|NCT06024525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839778|NCT06024525|Tubulin Modulators|tubulin modulators|mesh-ancestor
153839779|NCT06024525|Antimitotic Agents|antimitotic agents|mesh-ancestor
153839780|NCT06024525|Mitosis Modulators|mitosis modulators|mesh-ancestor
153839781|NCT06024525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839782|NCT06024356|Thymalfasin|thymalfasin|mesh-list
153839783|NCT06024356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153839784|NCT06024356|Immunologic Factors|immunologic factors|mesh-ancestor
153839785|NCT06024356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379892|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
153379893|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153379894|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153379895|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379896|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379897|NCT02247518|Urological Agents|urological agents|mesh-ancestor
153379898|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153379899|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153379900|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154258363|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258364|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258365|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154258366|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258367|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154258368|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153379901|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
153379902|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379903|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379904|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
153379905|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153379906|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153379907|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379908|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
153379909|NCT02867163|Coagulants|coagulants|mesh-ancestor
153379910|NCT03022097|Bromides|bromides|mesh-list
153379911|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
153379912|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153379913|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
153839796|NCT06023459|Naloxone|naloxone|mesh-list
153839797|NCT06023459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153839798|NCT06023459|Narcotics|narcotics|mesh-ancestor
153839799|NCT06023459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839800|NCT06023459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839801|NCT06023459|Analgesics|analgesics|mesh-ancestor
153839802|NCT06023459|Sensory System Agents|sensory system agents|mesh-ancestor
153839803|NCT06023459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839804|NCT06023459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153839805|NCT06023225|Analgesics, Opioid|analgesics, opioid|mesh-list
153839806|NCT06023225|Narcotics|narcotics|mesh-ancestor
153839807|NCT06023225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839808|NCT06023225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839809|NCT06023225|Analgesics|analgesics|mesh-ancestor
153839810|NCT06023225|Sensory System Agents|sensory system agents|mesh-ancestor
153839811|NCT06023225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839812|NCT06023043|Dexamethasone|dexamethasone|mesh-list
153839813|NCT06023043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153839814|NCT06023043|Antiemetics|antiemetics|mesh-ancestor
153839815|NCT06023043|Autonomic Agents|autonomic agents|mesh-ancestor
153839816|NCT06023043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839817|NCT06023043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839818|NCT06023043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153839819|NCT06023043|Glucocorticoids|glucocorticoids|mesh-ancestor
153839820|NCT06023043|Hormones|hormones|mesh-ancestor
153839821|NCT06023043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839822|NCT06023043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153839823|NCT06023043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839824|NCT06022939|Dexamethasone|dexamethasone|mesh-list
153839825|NCT06022939|Dexamethasone acetate|dexamethasone acetate|mesh-list
153839826|NCT06022939|Cyclophosphamide|cyclophosphamide|mesh-list
153379932|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379933|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379934|NCT04047875|Norethindrone|norethindrone|mesh-list
153379935|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
153379936|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153379937|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153379938|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153379939|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
153379940|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153839838|NCT06022939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153839839|NCT06022939|Alkylating Agents|alkylating agents|mesh-ancestor
153839840|NCT06022939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839841|NCT06022939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379970|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379972|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153379973|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379974|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394744|NCT02519387|Buprenorphine|buprenorphine|mesh-list
153846873|NCT03809442|Analgesics|analgesics|mesh-ancestor
153839850|NCT06022939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839851|NCT06022939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153839852|NCT06022939|Protease Inhibitors|protease inhibitors|mesh-ancestor
153839853|NCT06022939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839854|NCT06022835|Chlorhexidine|chlorhexidine|mesh-list
153839855|NCT06022835|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153839856|NCT06022835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153839857|NCT06022835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839858|NCT06022835|Disinfectants|disinfectants|mesh-ancestor
153839859|NCT06022835|Dermatologic Agents|dermatologic agents|mesh-ancestor
153839860|NCT06022692|Tislelizumab|tislelizumab|mesh-list
153839861|NCT06022692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153839862|NCT06022692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153839863|NCT06022692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839864|NCT06022692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839865|NCT06022588|Butyric Acid|butyric acid|mesh-list
153839866|NCT06022588|Histamine Antagonists|histamine antagonists|mesh-ancestor
153839867|NCT06022588|Histamine Agents|histamine agents|mesh-ancestor
153839868|NCT06022588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839869|NCT06022588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839870|NCT06022588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839871|NCT06020755|Dactinomycin|dactinomycin|mesh-list
153839872|NCT06020755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153839883|NCT06019741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153839885|NCT06019741|Sensory System Agents|sensory system agents|mesh-ancestor
153839886|NCT06019741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839887|NCT06019741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839888|NCT06019741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380018|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153380020|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153380021|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
153380022|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380023|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380024|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380025|NCT02872857|Galantamine|galantamine|mesh-list
153380026|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153380027|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380028|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380029|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
153380030|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380031|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380032|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153839900|NCT06019741|Protease Inhibitors|protease inhibitors|mesh-ancestor
153839901|NCT06019741|Anticoagulants|anticoagulants|mesh-ancestor
153839902|NCT06017362|Lubricant Eye Drops|lubricant eye drops|mesh-list
153839903|NCT06017362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153853621|NCT03798626|Protective Agents|protective agents|mesh-ancestor
153853622|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
153853623|NCT03798626|Vitamins|vitamins|mesh-ancestor
153853624|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
153393847|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393848|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393849|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
153839904|NCT06017362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153839915|NCT06013618|Temozolomide|temozolomide|mesh-list
153839916|NCT06013618|Molgramostim|molgramostim|mesh-list
153839917|NCT06013618|Sargramostim|sargramostim|mesh-list
153839918|NCT06013618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153839919|NCT06013618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839920|NCT06013618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839921|NCT06013618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839922|NCT06013618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153839923|NCT06013618|Alkylating Agents|alkylating agents|mesh-ancestor
153839924|NCT06013618|Immunologic Factors|immunologic factors|mesh-ancestor
153839925|NCT06013618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839926|NCT06012734|Atezolizumab|atezolizumab|mesh-list
153380037|NCT02996318|Paclitaxel|paclitaxel|mesh-list
153380038|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153380039|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380040|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
153380041|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
153380042|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
153380043|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380044|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153380045|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380046|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153380047|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
154258369|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
154258370|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154258371|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153380048|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153380049|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
153380050|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380051|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153380052|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153380053|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
153380054|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380056|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380057|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380058|NCT02994602|ST 1435|st 1435|mesh-list
153380059|NCT02994602|Testosterone|testosterone|mesh-list
153380060|NCT02994602|Androgens|androgens|mesh-ancestor
153380061|NCT02994602|Hormones|hormones|mesh-ancestor
153839945|NCT06008405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839946|NCT05993390|Neostigmine|neostigmine|mesh-list
153839947|NCT05993390|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153839948|NCT05993390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839949|NCT05993390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839950|NCT05993390|Cholinergic Agents|cholinergic agents|mesh-ancestor
153839951|NCT05993390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839952|NCT05993390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839953|NCT05993390|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153839954|NCT05993390|Autonomic Agents|autonomic agents|mesh-ancestor
153839955|NCT05993390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393874|NCT00003099|Tamoxifen|tamoxifen|mesh-list
153839957|NCT05990790|Sevoflurane|sevoflurane|mesh-list
153839958|NCT05990790|Desflurane|desflurane|mesh-list
153839959|NCT05990790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153839960|NCT05990790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839961|NCT05990790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839962|NCT05990790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153839963|NCT05990790|Anesthetics, General|anesthetics, general|mesh-ancestor
153839964|NCT05990790|Anesthetics|anesthetics|mesh-ancestor
153839965|NCT05990790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153839966|NCT05990790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153839967|NCT05986136|Dapagliflozin|dapagliflozin|mesh-list
153839968|NCT05986136|Mesalamine|mesalamine|mesh-list
153839969|NCT05986136|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153839970|NCT05986136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380093|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153380094|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380095|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
153380096|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380097|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153380098|NCT04850846|Metformin|metformin|mesh-list
153380099|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153380100|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380101|NCT02759588|Bevacizumab|bevacizumab|mesh-list
153380102|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153380103|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380104|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153380105|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153380106|NCT02759588|Growth Substances|growth substances|mesh-ancestor
153380107|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380108|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
153839971|NCT05986136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153839972|NCT05986136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839973|NCT05986136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153839974|NCT05986136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153839975|NCT05986136|Analgesics|analgesics|mesh-ancestor
153839976|NCT05986136|Sensory System Agents|sensory system agents|mesh-ancestor
153839977|NCT05986136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839978|NCT05986136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153839979|NCT05986136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839980|NCT05982392|Naproxen|naproxen|mesh-list
153839981|NCT05982392|Tramadol|tramadol|mesh-list
153839982|NCT05982392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153839983|NCT05982392|Narcotics|narcotics|mesh-ancestor
153839984|NCT05982392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839985|NCT05982392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258372|NCT03858062|Insulin|insulin|mesh-list
153847006|NCT04682249|Apatinib|apatinib|mesh-list
153839986|NCT05982392|Analgesics|analgesics|mesh-ancestor
153839987|NCT05982392|Sensory System Agents|sensory system agents|mesh-ancestor
153839988|NCT05982392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839989|NCT05982392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153839990|NCT05982392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153839991|NCT05982392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380123|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
153380124|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153380125|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153380126|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380127|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153380128|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380129|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153380130|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380132|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
153380133|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380134|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
153380137|NCT02219516|Verinurad|verinurad|mesh-list
153840011|NCT05942313|Antitussive Agents|antitussive agents|mesh-ancestor
153840012|NCT05942313|Respiratory System Agents|respiratory system agents|mesh-ancestor
153840013|NCT05933044|Durvalumab|durvalumab|mesh-list
153840014|NCT05933044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840015|NCT05933044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840016|NCT05930119|Rabeprazole|rabeprazole|mesh-list
153840017|NCT05930119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153840018|NCT05930119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153840019|NCT05930119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153840020|NCT05930119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840021|NCT05930119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840022|NCT05926427|Rituximab|rituximab|mesh-list
153840023|NCT05926427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840024|NCT05926427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840025|NCT05926427|Immunologic Factors|immunologic factors|mesh-ancestor
153840026|NCT05926427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840027|NCT05926427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153840028|NCT05924321|Moxifloxacin|moxifloxacin|mesh-list
153840029|NCT05924321|Carbetocin|carbetocin|mesh-list
153840030|NCT05924321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153840031|NCT05924321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840032|NCT05924321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153840033|NCT05924321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153392658|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153840034|NCT05924321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840035|NCT05924321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840036|NCT05924321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840037|NCT05924321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153380196|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153840074|NCT05903417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153840075|NCT05903417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153840076|NCT05903417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153840077|NCT05903417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840078|NCT05896007|Rituximab|rituximab|mesh-list
153840079|NCT05896007|Methotrexate|methotrexate|mesh-list
153840080|NCT05896007|Temozolomide|temozolomide|mesh-list
153840081|NCT05896007|Zanubrutinib|zanubrutinib|mesh-list
153840082|NCT05896007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840083|NCT05896007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840084|NCT05896007|Immunologic Factors|immunologic factors|mesh-ancestor
153840085|NCT05896007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840086|NCT05896007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153840087|NCT05896007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153840088|NCT05896007|Abortifacient Agents|abortifacient agents|mesh-ancestor
153840089|NCT05896007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153840090|NCT05896007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153380225|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380227|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153380228|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153380229|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
153380230|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380231|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153380232|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154258373|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153380233|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153380234|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153380235|NCT02227316|Acetaminophen|acetaminophen|mesh-list
153840132|NCT05890638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153840133|NCT05890638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153380239|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
153380240|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380241|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380242|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
153380243|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153380244|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380245|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732112|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153732113|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153392699|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
153840141|NCT05885503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840143|NCT05876949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153840144|NCT05876949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840145|NCT05869812|Calcium, Dietary|calcium, dietary|mesh-list
153840157|NCT05839899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153840158|NCT05839899|Oxytocics|oxytocics|mesh-ancestor
153840159|NCT05839899|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153840160|NCT05839899|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153840161|NCT05839899|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153840162|NCT05839899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153840197|NCT05834569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153840198|NCT05834569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840200|NCT05834569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153840201|NCT05834569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840202|NCT05834569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840203|NCT05831683|Anesthetics|anesthetics|mesh-list
153380311|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153732114|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380313|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
153380314|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380315|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380316|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380317|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380318|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153380319|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840209|NCT05820347|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153840210|NCT05820347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153840211|NCT05820347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840212|NCT05820347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840213|NCT05820347|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153840214|NCT05819710|Zopiclone|zopiclone|mesh-list
153840215|NCT05819710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153840216|NCT05819710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840217|NCT05819710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840218|NCT05789043|Apatinib|apatinib|mesh-list
153840219|NCT05789043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840220|NCT05789043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153840221|NCT05789043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840222|NCT05789043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840223|NCT05701215|Venetoclax|venetoclax|mesh-list
153840224|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840225|NCT05700422|Varenicline|varenicline|mesh-list
153840226|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153840227|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153840228|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
153840229|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840230|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840231|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840232|NCT05681377|Flumazenil|flumazenil|mesh-list
153853890|NCT01955499|Ibrutinib|ibrutinib|mesh-list
153840233|NCT05681377|Antidotes|antidotes|mesh-ancestor
153840234|NCT05681377|Protective Agents|protective agents|mesh-ancestor
153840235|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380373|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153380374|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153380375|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258374|NCT03858062|Pancrelipase|pancrelipase|mesh-list
154258375|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154258376|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380377|NCT03115827|Droxidopa|droxidopa|mesh-list
153380378|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153380379|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153380380|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
153380381|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380382|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380383|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380384|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153380385|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380386|NCT01915823|Fluticasone|fluticasone|mesh-list
153840273|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153840274|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153840275|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153840276|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
153840277|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840278|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840279|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
153840280|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840281|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840282|NCT05594043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153840283|NCT05594043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840284|NCT05563155|Dexamethasone|dexamethasone|mesh-list
153840285|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840286|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
153840287|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
153840288|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840289|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380398|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153380399|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394167|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
153380424|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153380425|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380426|NCT01934231|Amoxicillin|amoxicillin|mesh-list
153380427|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
153380428|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
153380429|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153380430|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153380431|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380432|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153840290|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153840291|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
153840292|NCT05563155|Hormones|hormones|mesh-ancestor
153840293|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153840294|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153840295|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840296|NCT05552859|Insulin|insulin|mesh-list
153840297|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153840298|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
153840299|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153840300|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840301|NCT05526586|Ethanol|ethanol|mesh-list
153840302|NCT05526586|Listerine|listerine|mesh-list
153840304|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840305|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840306|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840308|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840309|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153840310|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840311|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840312|NCT05488626|Immunomodulating Agents|immunomodulating agents|mesh-list
153840313|NCT05488626|Immunologic Factors|immunologic factors|mesh-ancestor
153840314|NCT05488626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840343|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153840344|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840345|NCT05376579|Siponimod|siponimod|mesh-list
153840346|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153840347|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840348|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153840349|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
153847221|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
153840350|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840351|NCT05304351|Vaccines|vaccines|mesh-list
153840352|NCT05304351|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
153840353|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
153840354|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840355|NCT05304351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153840356|NCT05304273|Letrozole|letrozole|mesh-list
153380495|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
153380496|NCT01691690|Ondansetron|ondansetron|mesh-list
153380497|NCT01691690|Propofol|propofol|mesh-list
153380498|NCT01691690|Sevoflurane|sevoflurane|mesh-list
153380499|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380500|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
153380501|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
153380502|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380503|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380504|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380505|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
153380506|NCT01691690|Hormones|hormones|mesh-ancestor
153380507|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380508|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153380509|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380510|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153380511|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380512|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153380513|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
153380514|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
153840376|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153840377|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153840378|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
153840390|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840391|NCT05302921|Nivolumab|nivolumab|mesh-list
153840392|NCT05302921|Ipilimumab|ipilimumab|mesh-list
153840393|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840394|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840395|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153840396|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840397|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
153840401|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840402|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840404|NCT05296772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153840405|NCT05296772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840406|NCT05245916|Rituximab|rituximab|mesh-list
153362887|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
153840407|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394355|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
153840408|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840409|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
153840410|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840411|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153840412|NCT05230368|Decitabine|decitabine|mesh-list
153840413|NCT05230368|Romidepsin|romidepsin|mesh-list
153840414|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153840415|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
153840416|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840417|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840418|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840419|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153840420|NCT05230368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153840421|NCT05223478|Phentolamine|phentolamine|mesh-list
153840422|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153840423|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153840424|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153380540|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153380541|NCT02283827|Phenytoin|phenytoin|mesh-list
153380542|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
153380543|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153380544|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153732117|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153732118|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380545|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153380546|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847293|NCT03244176|Avelumab|avelumab|mesh-list
153847296|NCT00535665|Vaccines|vaccines|mesh-list
153380547|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153840436|NCT05206084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840438|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
153840439|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840440|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840441|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153840442|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840443|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153840444|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
153840445|NCT05205499|Sirolimus|sirolimus|mesh-list
153840446|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153840447|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840448|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153380606|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153380607|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380608|NCT01921751|Paclitaxel|paclitaxel|mesh-list
153380609|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153380610|NCT01921751|Gemcitabine|gemcitabine|mesh-list
153380626|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380627|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
153380628|NCT01629134|Protective Agents|protective agents|mesh-ancestor
153380629|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
153380630|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
153380631|NCT01629290|Protective Agents|protective agents|mesh-ancestor
153380632|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380633|NCT01696760|Aspirin|aspirin|mesh-list
153380634|NCT01696760|Enoxaparin|enoxaparin|mesh-list
153380635|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
153380636|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
153380637|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153380638|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153380639|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380640|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153380641|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153380642|NCT01696760|Analgesics|analgesics|mesh-ancestor
153380643|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
153380644|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380645|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840525|NCT05110781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840526|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840527|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
153840528|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840529|NCT05100134|Ceritinib|ceritinib|mesh-list
153840530|NCT05100134|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153840531|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153840532|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840533|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840534|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840535|NCT05084222|Budesonide|budesonide|mesh-list
153840536|NCT05084222|Albuterol|albuterol|mesh-list
153840537|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
153854188|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854189|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153854190|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
153854191|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394445|NCT02454179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153394446|NCT02454179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394447|NCT02041533|Paclitaxel|paclitaxel|mesh-list
153394448|NCT02041533|Carboplatin|carboplatin|mesh-list
153394449|NCT02041533|Gemcitabine|gemcitabine|mesh-list
153840538|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840539|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153840540|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
153840541|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840542|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840543|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153840544|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
153840545|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
153840546|NCT05084222|Hormones|hormones|mesh-ancestor
153380667|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380668|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
153380669|NCT01924871|Remifentanil|remifentanil|mesh-list
153380670|NCT01924871|Desflurane|desflurane|mesh-list
153380686|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
153380687|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
153380688|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380689|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
153380690|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153380691|NCT01924949|Ledipasvir|ledipasvir|mesh-list
153380692|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
153380693|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380694|NCT01938989|Methamphetamine|methamphetamine|mesh-list
154258377|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154258378|NCT03307174|Fentanyl|fentanyl|mesh-list
154258379|NCT03307174|Bupivacaine|bupivacaine|mesh-list
154258380|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
153380695|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
153380696|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153380697|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153380698|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153840547|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153840548|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153840549|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153840550|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153840551|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
153840552|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840553|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840554|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
153840555|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153840556|NCT05080322|Fluticasone|fluticasone|mesh-list
153840558|NCT05080322|Azelastine|azelastine|mesh-list
153840559|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840560|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153840561|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
153840562|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840563|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840564|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153840565|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
153840566|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
153840567|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153840568|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153840569|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840570|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840571|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153840572|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153840573|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
153840574|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
153840575|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840576|NCT05065190|Nintedanib|nintedanib|mesh-list
153840577|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840578|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153840607|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153840608|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153840609|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
153840610|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840611|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153840612|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153840613|NCT05001984|Alirocumab|alirocumab|mesh-list
153840614|NCT05001984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153840615|NCT05001984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153840616|NCT05001984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153840617|NCT05001984|Antimetabolites|antimetabolites|mesh-ancestor
153840618|NCT05001984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840656|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153840657|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153840658|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840659|NCT04870645|Chelating Agents|chelating agents|mesh-list
153840660|NCT04870645|Sequestering Agents|sequestering agents|mesh-ancestor
153840661|NCT04870645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840662|NCT04824911|Aspirin|aspirin|mesh-list
153380780|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380781|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380782|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
153840663|NCT04824911|Clopidogrel|clopidogrel|mesh-list
153840664|NCT04824911|Atorvastatin|atorvastatin|mesh-list
153840665|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153840666|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153840667|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153840668|NCT04824911|Analgesics|analgesics|mesh-ancestor
153840669|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
153840670|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840671|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840672|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387614|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153840673|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153840674|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153840675|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153840676|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840725|NCT04753879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153380846|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153380847|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
153380848|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
153380875|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
153380876|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380877|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840749|NCT04707469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153840750|NCT04707469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840751|NCT04675827|Trastuzumab|trastuzumab|mesh-list
153840752|NCT04675827|Pertuzumab|pertuzumab|mesh-list
153840753|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153840754|NCT04675827|Maytansine|maytansine|mesh-list
153840755|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840756|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840757|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153380878|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380879|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
153380880|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153380881|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380882|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153380883|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
153840811|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840812|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153840813|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
153840814|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153840815|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153840816|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
153840822|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153840823|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
153840824|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153840825|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153840826|NCT04562558|Antidotes|antidotes|mesh-ancestor
153840827|NCT04562558|Protective Agents|protective agents|mesh-ancestor
153840828|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
153840829|NCT04562558|Vitamins|vitamins|mesh-ancestor
153840830|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
153840831|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153840832|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840833|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153840834|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153840835|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153840836|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153840837|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153840838|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153380960|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380961|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
153380962|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380963|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153380964|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
153380965|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153380966|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153380967|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153380968|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
153840879|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840882|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153840883|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
153840884|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840885|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840886|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
153840887|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840888|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153840889|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
153840890|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381039|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381040|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381042|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854340|NCT02904564|Fluorouracil|fluorouracil|mesh-list
153381043|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381044|NCT01639352|Pasireotide|pasireotide|mesh-list
153381045|NCT01639352|Hormones|hormones|mesh-ancestor
153381046|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381047|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381048|NCT01705496|Fialuridine|fialuridine|mesh-list
153381049|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
153381050|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381051|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153840897|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840898|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153840899|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153840900|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381072|NCT04707027|Aflibercept|aflibercept|mesh-list
153381076|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381077|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
153381078|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381079|NCT01602068|Dexamethasone|dexamethasone|mesh-list
153381080|NCT01602068|Citric Acid|citric acid|mesh-list
153381081|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
153381082|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153381083|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153381084|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
153840933|NCT04446416|Growth Substances|growth substances|mesh-ancestor
153840934|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840935|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
153840936|NCT04421378|Bevacizumab|bevacizumab|mesh-list
153840937|NCT04421378|Temozolomide|temozolomide|mesh-list
153840938|NCT04421378|Carmustine|carmustine|mesh-list
153840939|NCT04421378|Lomustine|lomustine|mesh-list
153840940|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840941|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840942|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153840943|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153840944|NCT04421378|Growth Substances|growth substances|mesh-ancestor
153840945|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394695|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153394696|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153394697|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153394698|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840946|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
153840971|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
153840972|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153840973|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
153840974|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
153840975|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381098|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381099|NCT02978157|Amoxicillin|amoxicillin|mesh-list
153381100|NCT02978157|Levofloxacin|levofloxacin|mesh-list
153381101|NCT02978157|Ofloxacin|ofloxacin|mesh-list
153381102|NCT02978157|Tetracycline|tetracycline|mesh-list
153381103|NCT02978157|Esomeprazole|esomeprazole|mesh-list
153381104|NCT02978157|Bismuth|bismuth|mesh-list
153381105|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153381106|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381107|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153381108|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381109|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153381110|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381111|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381112|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153381113|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153381114|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153381115|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841005|NCT04256213|Ipilimumab|ipilimumab|mesh-list
153841006|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841007|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841008|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153841009|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841010|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
153841011|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
153841012|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153841023|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
153841024|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841025|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153841026|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153381171|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381172|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153381173|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381174|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258382|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381176|NCT01602692|Epinephrine|epinephrine|mesh-list
153381177|NCT01602692|Racepinephrine|racepinephrine|mesh-list
153381178|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153381179|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
153381180|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
153381181|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
153381182|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153841030|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153841031|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841032|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153841033|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153841034|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153841035|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841036|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841037|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
153841038|NCT04231448|Hormones|hormones|mesh-ancestor
153841039|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841040|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841041|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841042|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841043|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841044|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841045|NCT04224051|Metformin|metformin|mesh-list
153841046|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153381194|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381195|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153381196|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153381197|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
153381198|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153381199|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
153381204|NCT01603940|Benazepril|benazepril|mesh-list
153381205|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153381206|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153381207|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153381208|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153381209|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381210|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153841059|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153841060|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841061|NCT04166435|Temozolomide|temozolomide|mesh-list
153841062|NCT04166435|Olaparib|olaparib|mesh-list
153841063|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153841064|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
153841065|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841066|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841067|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153841068|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841103|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153381227|NCT01706666|Bortezomib|bortezomib|mesh-list
153381228|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153381229|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
153381230|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381231|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381232|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153381233|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
153841139|NCT03927079|Dimercaprol|dimercaprol|mesh-list
153841140|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841141|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
153841142|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
153841143|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
153841144|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841145|NCT03866499|Gefitinib|gefitinib|mesh-list
153841146|NCT03866499|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153841147|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153841148|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841149|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841150|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841151|NCT03822962|Acetaminophen|acetaminophen|mesh-list
153841152|NCT03822962|Ibuprofen|ibuprofen|mesh-list
153841153|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154258383|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854565|NCT04681053|Ivermectin|ivermectin|mesh-list
153854566|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153854567|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854568|NCT04639193|Acetazolamide|acetazolamide|mesh-list
153394840|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153394843|NCT02531321|Hormones|hormones|mesh-ancestor
153394844|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394845|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394846|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153394847|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
153394848|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153394849|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153854598|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153841154|NCT03822962|Analgesics|analgesics|mesh-ancestor
153841155|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
153841156|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841167|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841168|NCT03770260|Ixazomib|ixazomib|mesh-list
153841169|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153841170|NCT03770260|Pevonedistat|pevonedistat|mesh-list
153841171|NCT03770260|Glycine|glycine|mesh-list
153841172|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841173|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841174|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
153841175|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
153841176|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381300|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153381301|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153381302|NCT02288273|Exenatide|exenatide|mesh-list
153381303|NCT02288273|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153381304|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153381305|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381306|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153381307|NCT02288273|Incretins|incretins|mesh-ancestor
153381308|NCT02288273|Hormones|hormones|mesh-ancestor
153381309|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381310|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153381311|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
153381312|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381313|NCT01606124|Protective Agents|protective agents|mesh-ancestor
153381314|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381315|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153381316|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153381317|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381318|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153394855|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
153394856|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394857|NCT01805089|Protective Agents|protective agents|mesh-ancestor
153394858|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394870|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153394872|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
153394873|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394874|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394875|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394881|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153854651|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
153394892|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
153394893|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394894|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394895|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153394896|NCT02419547|Narcotics|narcotics|mesh-ancestor
153394897|NCT02419547|Analgesics|analgesics|mesh-ancestor
153394898|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
153394899|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394900|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153363011|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153363012|NCT02476422|Analgesics|analgesics|mesh-ancestor
153363013|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
153363014|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363015|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363016|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153363017|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381319|NCT01607450|Glucagon|glucagon|mesh-list
153381320|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153381321|NCT01607450|Incretins|incretins|mesh-ancestor
153381322|NCT01607450|Hormones|hormones|mesh-ancestor
153381323|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381324|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381325|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153841198|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153841199|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
153841200|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841201|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841202|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153841203|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841204|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
153841205|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
153841206|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841207|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153841208|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
153841209|NCT03759093|Hormones|hormones|mesh-ancestor
153841210|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841211|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841212|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
153841213|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841214|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153841215|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153841216|NCT03759093|Growth Substances|growth substances|mesh-ancestor
153841217|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
153841218|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
153841219|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153841220|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841221|NCT03756961|Lidocaine|lidocaine|mesh-list
153841222|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
153841223|NCT03756961|Remifentanil|remifentanil|mesh-list
153841224|NCT03756961|Oxycodone|oxycodone|mesh-list
153381347|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153381348|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381350|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
153363018|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153363019|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381351|NCT02331095|Atorvastatin|atorvastatin|mesh-list
153381352|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153381353|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153381354|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
153387936|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153387937|NCT00000861|Indinavir|indinavir|mesh-list
153841236|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153841237|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153841238|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841239|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153841240|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153841241|NCT03756961|Analgesics|analgesics|mesh-ancestor
153841242|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153841243|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153841244|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153381394|NCT05738681|Antidotes|antidotes|mesh-ancestor
153381395|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
153381396|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
153381397|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381399|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153381400|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
153381401|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381402|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381403|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381404|NCT01642238|Aspirin|aspirin|mesh-list
153381405|NCT01642238|Hirudins|hirudins|mesh-list
153381406|NCT01642238|Bivalirudin|bivalirudin|mesh-list
153381407|NCT01642238|Clopidogrel|clopidogrel|mesh-list
153381408|NCT01642238|Ticagrelor|ticagrelor|mesh-list
153381409|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153381410|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153381411|NCT01642238|Analgesics|analgesics|mesh-ancestor
153381412|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
153381413|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381470|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381471|NCT01610570|Plicamycin|plicamycin|mesh-list
153381472|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153381473|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381474|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153381475|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841335|NCT03586999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841336|NCT03586999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153841337|NCT03586999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153841338|NCT03586999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841339|NCT03586999|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841340|NCT03586999|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841341|NCT03586999|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841342|NCT03586999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153841343|NCT03586999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841344|NCT03586999|Glucocorticoids|glucocorticoids|mesh-ancestor
153393330|NCT02296346|Protective Agents|protective agents|mesh-ancestor
153841345|NCT03586999|Hormones|hormones|mesh-ancestor
153841346|NCT03586999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841347|NCT03586999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841348|NCT03537495|Linezolid|linezolid|mesh-list
153841349|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153841350|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841351|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153841352|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381476|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153381477|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381478|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381479|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153381480|NCT01611662|Gemcitabine|gemcitabine|mesh-list
153381481|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841364|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
153841365|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841366|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841367|NCT03480672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153841368|NCT03480672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841414|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153841415|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153841416|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
153841417|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841418|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258385|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258386|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154258387|NCT03307174|Narcotics|narcotics|mesh-ancestor
153841419|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153841420|NCT03306264|Decitabine|decitabine|mesh-list
153841421|NCT03306264|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153841422|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153841423|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
153841424|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841425|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841426|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381580|NCT01659866|Imipenem|imipenem|mesh-list
153381581|NCT01659866|Amikacin|amikacin|mesh-list
153381582|NCT01659866|Cefuroxime|cefuroxime|mesh-list
153381583|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153381584|NCT01659866|Aztreonam|aztreonam|mesh-list
153381585|NCT01659866|Trimethoprim|trimethoprim|mesh-list
153381586|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
153381587|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153381588|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381589|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153841436|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841437|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153841438|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153841439|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153841440|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
153841441|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841442|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381601|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153381602|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153381603|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153381604|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153381605|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153381606|NCT02249702|Gemcitabine|gemcitabine|mesh-list
153841481|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841482|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841483|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153841484|NCT03249870|Immunotoxins|immunotoxins|mesh-ancestor
153841485|NCT03249870|Immunoconjugates|immunoconjugates|mesh-ancestor
153841486|NCT03249870|Immunologic Factors|immunologic factors|mesh-ancestor
153841487|NCT03249870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841488|NCT03235739|Naloxegol|naloxegol|mesh-list
153841489|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153381647|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381648|NCT02683265|Methylphenidate|methylphenidate|mesh-list
153381649|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153381650|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381654|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381655|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
153381656|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841528|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
153841529|NCT02980510|Irinotecan|irinotecan|mesh-list
153841530|NCT02980510|Panitumumab|panitumumab|mesh-list
153841531|NCT02980510|Fluorouracil|fluorouracil|mesh-list
153841532|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
153841533|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841534|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153841535|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153841536|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841537|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841538|NCT02980510|Antidotes|antidotes|mesh-ancestor
153841539|NCT02980510|Protective Agents|protective agents|mesh-ancestor
153841540|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841541|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
153381663|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153381664|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153381665|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381666|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153381667|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153381668|NCT02988843|Growth Substances|growth substances|mesh-ancestor
153381669|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388145|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388146|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
153381670|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
153381671|NCT02988843|Immunotoxins|immunotoxins|mesh-ancestor
153381672|NCT02988843|Immunoconjugates|immunoconjugates|mesh-ancestor
153381673|NCT02988843|Immunologic Factors|immunologic factors|mesh-ancestor
153381681|NCT03000309|Apremilast|apremilast|mesh-list
153381682|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153381683|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153381684|NCT03000309|Analgesics|analgesics|mesh-ancestor
153381685|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
153381686|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381687|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381688|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153381689|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381690|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153381691|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153381692|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381693|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381694|NCT02992028|Vitamins|vitamins|mesh-list
153841543|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
153841544|NCT02980510|Hematinics|hematinics|mesh-ancestor
153841545|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841546|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
153841562|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841563|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
153841564|NCT02939742|Hormones|hormones|mesh-ancestor
153841565|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841566|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841567|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153841568|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
153841569|NCT02902484|Nintedanib|nintedanib|mesh-list
153841570|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841571|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153841572|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841573|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381695|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
153381697|NCT03165981|Vaccines|vaccines|mesh-list
153381698|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153381699|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
153381700|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381701|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
153381702|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153381703|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381704|NCT03170661|Rocuronium|rocuronium|mesh-list
153381705|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153381706|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153381707|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153381708|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381741|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381742|NCT02240030|Levodopa|levodopa|mesh-list
153381743|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153381744|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153381745|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
153381746|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381747|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381748|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381749|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
153381750|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153854881|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
153381751|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381752|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153381779|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153381780|NCT00375765|Dutasteride|dutasteride|mesh-list
153381781|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153381782|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153381783|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381784|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381785|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
153381786|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381787|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381788|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
154258389|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153394991|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
153841638|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841639|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841640|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841641|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841642|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841643|NCT02584465|Tamoxifen|tamoxifen|mesh-list
153841644|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153841645|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
153841646|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841647|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841648|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841649|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841650|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153841651|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153841652|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153841653|NCT02579161|Ciprofloxacin|ciprofloxacin|mesh-list
153841654|NCT02579161|Clindamycin|clindamycin|mesh-list
153841655|NCT02579161|Gentamicins|gentamicins|mesh-list
153841656|NCT02579161|Penicillins|penicillins|mesh-list
153841657|NCT02579161|Ampicillin|ampicillin|mesh-list
153841658|NCT02579161|Cephalosporins|cephalosporins|mesh-list
153841659|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
153841660|NCT02579161|Lincosamides|lincosamides|mesh-list
153841719|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841720|NCT02425566|Trimethaphan|trimethaphan|mesh-list
153841721|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
153841722|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
153841723|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
153381842|NCT00375843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153381843|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153381844|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381845|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381846|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381847|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
153381848|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381849|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
153381850|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153381851|NCT03247569|Edoxaban|edoxaban|mesh-list
153381852|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153381853|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
153381854|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153381855|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
153381856|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381857|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381858|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
153841767|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841769|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841770|NCT02037529|Paclitaxel|paclitaxel|mesh-list
153841771|NCT02037529|Halichondrin B|halichondrin b|mesh-list
153841772|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153841773|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841774|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841775|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841776|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841777|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841778|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841779|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153841780|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153841781|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
153841782|NCT02030028|Hormones|hormones|mesh-ancestor
153841783|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841784|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841785|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841786|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841787|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153841788|NCT01956123|Hormones|hormones|mesh-ancestor
153841789|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381909|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258390|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154258391|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
154258392|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
154258393|NCT03448978|Fludarabine|fludarabine|mesh-list
154258394|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258395|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
154258396|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258397|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154258398|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154258399|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
154258400|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258401|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258402|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154258403|NCT01290926|Sorafenib|sorafenib|mesh-list
154258404|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258405|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258406|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258407|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258408|NCT01185236|Atorvastatin|atorvastatin|mesh-list
154258409|NCT01185236|Simvastatin|simvastatin|mesh-list
154258410|NCT01185236|Ezetimibe|ezetimibe|mesh-list
154258411|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153732183|NCT04515628|Branebrutinib|branebrutinib|mesh-list
153381910|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381911|NCT01455051|Ofatumumab|ofatumumab|mesh-list
153381912|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381913|NCT01673828|Pregnanolone|pregnanolone|mesh-list
153381914|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153381915|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
153381916|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153841799|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841800|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841801|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841802|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841803|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841805|NCT01894308|Androgens|androgens|mesh-ancestor
153841806|NCT01894308|Hormones|hormones|mesh-ancestor
153841807|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841808|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841809|NCT01705158|Carboplatin|carboplatin|mesh-list
153841810|NCT01705158|Doxorubicin|doxorubicin|mesh-list
153841811|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153841812|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841813|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153841814|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153841815|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153841816|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841817|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841818|NCT01583322|Nintedanib|nintedanib|mesh-list
153841819|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841820|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153381941|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154258412|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154258413|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
154258414|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258415|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154258416|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154258417|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258418|NCT02524652|Ropivacaine|ropivacaine|mesh-list
153732196|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153381942|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381943|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
153381944|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153381966|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381967|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153381968|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381969|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
153381970|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
153381971|NCT02589353|Acarbose|acarbose|mesh-list
153841829|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841830|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841831|NCT01571037|Protective Agents|protective agents|mesh-ancestor
153841832|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841833|NCT01469650|Vitamin D|vitamin d|mesh-list
153841834|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
153841835|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
153841836|NCT01469650|Vitamins|vitamins|mesh-list
153841837|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
153841838|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841839|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153841840|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153841841|NCT01431326|Vancomycin|vancomycin|mesh-list
153841842|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
153841843|NCT01431326|Tazobactam|tazobactam|mesh-list
153841844|NCT01431326|Piperacillin|piperacillin|mesh-list
153841845|NCT01431326|Tobramycin|tobramycin|mesh-list
153841846|NCT01431326|Amikacin|amikacin|mesh-list
153841847|NCT01431326|Cefepime|cefepime|mesh-list
153841848|NCT01431326|Fosfomycin|fosfomycin|mesh-list
153841849|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153841850|NCT01431326|Nafcillin|nafcillin|mesh-list
153841851|NCT01431326|Cidofovir|cidofovir|mesh-list
153381972|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153381973|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381974|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381975|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153395311|NCT02434523|Analgesics|analgesics|mesh-ancestor
153381976|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381998|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153381999|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153382000|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
153382001|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382002|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382003|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841876|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841877|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153841878|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
153841879|NCT01431326|Hormones|hormones|mesh-ancestor
153841880|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841881|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153841883|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841884|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153841885|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153841886|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841887|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
153841888|NCT01431326|Coagulants|coagulants|mesh-ancestor
153841889|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153841890|NCT01431326|Narcotics|narcotics|mesh-ancestor
153382005|NCT01461915|Gemcitabine|gemcitabine|mesh-list
153382006|NCT01461915|Heparin|heparin|mesh-list
153382007|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154258419|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
154258420|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
154258421|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258422|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258423|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
154258424|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258425|NCT01182272|Sorafenib|sorafenib|mesh-list
154258426|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258427|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258428|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258429|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258430|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154258431|NCT01185470|Morphine|morphine|mesh-list
154258432|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154258433|NCT01185470|Narcotics|narcotics|mesh-ancestor
154258434|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258435|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258436|NCT01185470|Analgesics|analgesics|mesh-ancestor
154258437|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
153363132|NCT03219788|Analgesics|analgesics|mesh-ancestor
154258438|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258439|NCT00056160|Dexamethasone|dexamethasone|mesh-list
153382008|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382009|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
153382010|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
153382011|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
153382012|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841905|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153841906|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
153841907|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153841908|NCT01431326|Diuretics|diuretics|mesh-ancestor
153841909|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
153382026|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382027|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382028|NCT01683422|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153382029|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153382030|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382031|NCT03194373|Carboplatin|carboplatin|mesh-list
153382032|NCT03194373|Palbociclib|palbociclib|mesh-list
153382033|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382034|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153382035|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382036|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382038|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
153841922|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841923|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153841924|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153841945|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153841946|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
153382063|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153382064|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382065|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382066|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153732228|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154258440|NCT00056160|Lenalidomide|lenalidomide|mesh-list
154258441|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154258442|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
154258443|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
154258444|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258445|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258446|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154258447|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
154258448|NCT00056160|Hormones|hormones|mesh-ancestor
154258449|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258450|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154258451|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258452|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
154258453|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154258454|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154258455|NCT00056160|Growth Substances|growth substances|mesh-ancestor
154258456|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
154258457|NCT01290146|Simendan|simendan|mesh-list
154258458|NCT01290146|Diuretics|diuretics|mesh-list
154258459|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
154258460|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382067|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153382069|NCT02249546|Expectorants|expectorants|mesh-ancestor
153382070|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
153382071|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153382072|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
153382073|NCT02249546|Protective Agents|protective agents|mesh-ancestor
153382074|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382075|NCT02249546|Antidotes|antidotes|mesh-ancestor
153382076|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
153382077|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153382078|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153382079|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
153382080|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382082|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
153382083|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
153382084|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841947|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
153841948|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
153841949|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153382085|NCT04960215|Vitamins|vitamins|mesh-ancestor
153382087|NCT02333045|Maraviroc|maraviroc|mesh-list
153841950|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153841951|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
153841952|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153841953|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
153841954|NCT01303679|Paclitaxel|paclitaxel|mesh-list
153841955|NCT01303679|Bevacizumab|bevacizumab|mesh-list
153841956|NCT01303679|Exemestane|exemestane|mesh-list
153841985|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153841986|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
153841987|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841988|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841989|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154258462|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
154258463|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154258464|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154258465|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258466|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258467|NCT01290146|Protective Agents|protective agents|mesh-ancestor
154258468|NCT00061932|Irinotecan|irinotecan|mesh-list
154258469|NCT00061932|Bortezomib|bortezomib|mesh-list
154258470|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154258471|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154258472|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258473|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258474|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258475|NCT03856970|Glyburide|glyburide|mesh-list
154258476|NCT03856970|Digoxin|digoxin|mesh-list
154258477|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154258478|NCT03856970|Norethindrone|norethindrone|mesh-list
154258479|NCT03856970|Estradiol|estradiol|mesh-list
153732244|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153732245|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
153841990|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153841991|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153841992|NCT01191697|Bevacizumab|bevacizumab|mesh-list
153841993|NCT01191697|Trastuzumab|trastuzumab|mesh-list
153841994|NCT01191697|Capecitabine|capecitabine|mesh-list
153841996|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841997|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382114|NCT03978767|Ibuprofen|ibuprofen|mesh-list
153382115|NCT03978767|Ketorolac|ketorolac|mesh-list
153382116|NCT03978767|Oxycodone|oxycodone|mesh-list
153382117|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153382118|NCT03978767|Analgesics|analgesics|mesh-ancestor
153382119|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
153382120|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382121|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382122|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
153382123|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153382124|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842007|NCT01189643|Irinotecan|irinotecan|mesh-list
153842008|NCT01189643|Temozolomide|temozolomide|mesh-list
153842009|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153842010|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842011|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153842012|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153842013|NCT01189643|Growth Substances|growth substances|mesh-ancestor
153842014|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842015|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
153842016|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153842017|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153842018|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842019|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842020|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153842021|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
153842022|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
154258480|NCT03856970|Estrogens|estrogens|mesh-ancestor
154258481|NCT03856970|Hormones|hormones|mesh-ancestor
154258482|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258483|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258484|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154258485|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
154258486|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154258487|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154258488|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154258489|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154258490|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154258491|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154258492|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258493|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258494|NCT03856970|Protective Agents|protective agents|mesh-ancestor
154258495|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154258496|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154258497|NCT06193837|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154258498|NCT06193837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154258499|NCT06193837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258500|NCT06193837|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154258501|NCT06193837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258502|NCT06193837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258503|NCT06193525|Talazoparib|talazoparib|mesh-list
154258504|NCT06193525|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154258505|NCT06193525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732261|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842023|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
153842024|NCT01044745|Busulfan|busulfan|mesh-list
153842025|NCT01044745|Rituximab|rituximab|mesh-list
153842026|NCT01044745|Fludarabine|fludarabine|mesh-list
153842027|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
153842028|NCT01044745|Tacrolimus|tacrolimus|mesh-list
153842029|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
153842030|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153382148|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153842034|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842035|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153842036|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
153842037|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842038|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842039|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153382188|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
153382189|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382190|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848429|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153848430|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153848435|NCT01210495|Axitinib|axitinib|mesh-list
153382191|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153382192|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153382193|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
153382194|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
153382195|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382216|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153842065|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842066|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
153842067|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153842068|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842069|NCT02277041|Misoprostol|misoprostol|mesh-list
153842070|NCT02277041|Carbetocin|carbetocin|mesh-list
153842071|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153842072|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
153842073|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153842074|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842075|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153842076|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153842077|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
153842078|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
153842079|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153842080|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
153842081|NCT02915289|Povidone|povidone|mesh-list
153842082|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153842083|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842084|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
153842085|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
153842086|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
153842087|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
153842088|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
153842089|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153842090|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842091|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
153842092|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842093|NCT02939417|Protective Agents|protective agents|mesh-ancestor
153842094|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842095|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153842096|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842097|NCT02915172|Capecitabine|capecitabine|mesh-list
153842098|NCT02915172|Lenvatinib|lenvatinib|mesh-list
153842104|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842105|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
153842106|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153842107|NCT02938988|Methylene Blue|methylene blue|mesh-list
153842108|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842109|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842110|NCT02915055|Acetaminophen|acetaminophen|mesh-list
153842111|NCT02915055|Ibuprofen|ibuprofen|mesh-list
153855385|NCT05425368|Fluorides|fluorides|mesh-list
153842112|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153842113|NCT02915055|Oxycodone|oxycodone|mesh-list
153842114|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153842115|NCT02915055|Analgesics|analgesics|mesh-ancestor
153842116|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
153842117|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842118|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842119|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
153842120|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153842121|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842122|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842123|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153842124|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842125|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842130|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153842131|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842132|NCT01295827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153842133|NCT01295827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842135|NCT02918760|Analgesics|analgesics|mesh-ancestor
153842136|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
153382272|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382273|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154258506|NCT06193525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258507|NCT06193525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258508|NCT06193330|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154258509|NCT06193330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258510|NCT06193304|Eliglustat|eliglustat|mesh-list
154258511|NCT06193304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258512|NCT06193304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258513|NCT06193187|Valsartan|valsartan|mesh-list
153382274|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382275|NCT04706949|Carboplatin|carboplatin|mesh-list
153382276|NCT04706949|Pemetrexed|pemetrexed|mesh-list
153382277|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382278|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382279|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382280|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153382281|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153382282|NCT02299349|Epinephrine|epinephrine|mesh-list
153382283|NCT02299349|Racepinephrine|racepinephrine|mesh-list
153382284|NCT02299349|Morphine|morphine|mesh-list
153382285|NCT02299349|Bupivacaine|bupivacaine|mesh-list
153382286|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
153382287|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
153382288|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
153382289|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382290|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382291|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
153382292|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382293|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153382294|NCT02299349|Narcotics|narcotics|mesh-ancestor
153842145|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153842146|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842147|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842148|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
153842149|NCT04690751|Cenobamate|cenobamate|mesh-list
153842150|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
153842151|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
153842152|NCT03458078|Midazolam|midazolam|mesh-list
153842153|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153842154|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153842155|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842156|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382298|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
153382299|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382300|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382301|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153382302|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153382303|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
153382304|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153382305|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
153382306|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
153382307|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
153382308|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153382310|NCT03296163|Bevacizumab|bevacizumab|mesh-list
153382311|NCT03296163|Carboplatin|carboplatin|mesh-list
153382312|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153382313|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382314|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
153382315|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
153382316|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
153382317|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382318|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153382319|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153382320|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153382321|NCT03296163|Growth Substances|growth substances|mesh-ancestor
153382322|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382323|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
153382324|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
153382325|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
153848576|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842179|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153842180|NCT04690556|Growth Substances|growth substances|mesh-ancestor
153842181|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842182|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
153842183|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842208|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842209|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153842210|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842211|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
153842212|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153842213|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153842214|NCT02918331|Growth Substances|growth substances|mesh-ancestor
153842215|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
153842216|NCT02918136|Cortisone|cortisone|mesh-list
153842217|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842218|NCT01294462|Aspirin|aspirin|mesh-list
153842219|NCT01294462|Clopidogrel|clopidogrel|mesh-list
153842220|NCT01294462|Ticagrelor|ticagrelor|mesh-list
153842221|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153842222|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153382340|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153382341|NCT01989221|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153382342|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153382343|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
153382344|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382345|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382347|NCT03226899|Allopurinol|allopurinol|mesh-list
153382348|NCT03226899|Febuxostat|febuxostat|mesh-list
153382349|NCT03226899|Lesinurad|lesinurad|mesh-list
153382350|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
153382351|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153382352|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
153382353|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
153842227|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842228|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842229|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153842230|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153842231|NCT01294462|Analgesics|analgesics|mesh-ancestor
153842232|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
153842233|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842234|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842235|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842236|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153842237|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153842238|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153842239|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842240|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
153842241|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
153842242|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153842243|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842244|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153842245|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842246|NCT02910570|Liraglutide|liraglutide|mesh-list
153842247|NCT02910570|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153842248|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153842249|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842250|NCT02910570|Incretins|incretins|mesh-ancestor
153842251|NCT02910570|Hormones|hormones|mesh-ancestor
153842252|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842253|NCT02910141|Insulin|insulin|mesh-list
153842254|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153842255|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153842256|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842257|NCT04817033|Midazolam|midazolam|mesh-list
153842258|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
153842259|NCT04817033|Anesthetics|anesthetics|mesh-list
153842260|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842262|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153842263|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153842264|NCT04817033|Analgesics|analgesics|mesh-ancestor
153842265|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
153388800|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
153842266|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842267|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153842268|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153842269|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153382409|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382410|NCT03298113|Protective Agents|protective agents|mesh-list
153382411|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382412|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
153382413|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153382414|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382415|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
153382416|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
153382417|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842271|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842272|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842273|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153842274|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153842275|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153842276|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153842277|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153842278|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
153842279|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
153842280|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
153842281|NCT01292473|Omalizumab|omalizumab|mesh-list
153842282|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153842283|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153842284|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
153842285|NCT02938286|Epinephrine|epinephrine|mesh-list
153842286|NCT02938286|Carticaine|carticaine|mesh-list
153842287|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153842288|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153842289|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
153842290|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842291|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842292|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842293|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153842294|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153842295|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
153842296|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842297|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153842298|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
153842299|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
153382441|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
153382442|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
153382443|NCT01994993|Gentamicins|gentamicins|mesh-list
153382444|NCT01994993|Tazobactam|tazobactam|mesh-list
153382445|NCT01994993|Piperacillin|piperacillin|mesh-list
153382446|NCT01994993|Ampicillin|ampicillin|mesh-list
153382447|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153382448|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382449|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153382450|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153382451|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153382452|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382453|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382454|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153382455|NCT01688336|Leucovorin|leucovorin|mesh-list
153382456|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
153382457|NCT01688336|Irinotecan|irinotecan|mesh-list
153382458|NCT01688336|Folfirinox|folfirinox|mesh-list
153382459|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382460|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153382461|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153382462|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382463|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382464|NCT01688336|Antidotes|antidotes|mesh-ancestor
153842319|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842320|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842321|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153842322|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
153842323|NCT05600179|Hormones|hormones|mesh-ancestor
153842324|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842354|NCT02937857|Antipyretics|antipyretics|mesh-list
153842355|NCT02937857|Expectorants|expectorants|mesh-list
153842356|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
154258514|NCT06193187|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154258515|NCT06193187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154258516|NCT06193187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154258517|NCT06193187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154258518|NCT06193187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258519|NCT06193031|Treprostinil|treprostinil|mesh-list
154258520|NCT06193031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154258521|NCT06192849|Aflutinib|aflutinib|mesh-list
154258522|NCT06192849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258523|NCT06192849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258524|NCT06192849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258525|NCT06192797|Lenvatinib|lenvatinib|mesh-list
154258526|NCT06192797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258527|NCT06192797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258528|NCT06192797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258529|NCT06192797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258530|NCT06192693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154258531|NCT06192641|Melatonin|melatonin|mesh-list
154258532|NCT06192641|Antioxidants|antioxidants|mesh-ancestor
154258533|NCT06192641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258534|NCT06192641|Protective Agents|protective agents|mesh-ancestor
154258535|NCT06192641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258536|NCT06192641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258537|NCT06192615|Dexmedetomidine|dexmedetomidine|mesh-list
154258538|NCT06192615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154258539|NCT06192615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258540|NCT06192615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258541|NCT06192615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855628|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153842357|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842358|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
153732148|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153842359|NCT04324060|Danazol|danazol|mesh-list
153842360|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153842361|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
153842362|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842363|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842364|NCT01290718|Capecitabine|capecitabine|mesh-list
153842365|NCT01290718|Trastuzumab|trastuzumab|mesh-list
153842366|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382486|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382487|NCT04436744|Palbociclib|palbociclib|mesh-list
153382488|NCT04436744|Anastrozole|anastrozole|mesh-list
154258543|NCT06192615|Sensory System Agents|sensory system agents|mesh-ancestor
154258544|NCT06192615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258545|NCT06192615|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154258546|NCT06192615|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154258547|NCT06192615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154258548|NCT06192615|Adrenergic Agents|adrenergic agents|mesh-ancestor
153855653|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855654|NCT00449618|Analgesics|analgesics|mesh-ancestor
153855655|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
153855656|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855657|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855658|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855659|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855660|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153855661|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153855662|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855663|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153855664|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153855665|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855666|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
153855667|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
153395923|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395924|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823320|NCT00458081|Hormones|hormones|mesh-ancestor
153823323|NCT00481182|Ritonavir|ritonavir|mesh-list
153820228|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820229|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820230|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
153820231|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820232|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154258549|NCT06192615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382518|NCT03241485|Morphine|morphine|mesh-list
153842368|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842369|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842370|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153842371|NCT02937896|Ketorolac|ketorolac|mesh-list
153842372|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153842373|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153842374|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153842375|NCT02937896|Analgesics|analgesics|mesh-ancestor
153842376|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
153842377|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842378|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842379|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842380|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842381|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153842382|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842383|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842384|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
153842385|NCT02937896|Coagulants|coagulants|mesh-ancestor
153842386|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153842387|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
153382535|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153382536|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
153382537|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382538|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382539|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842413|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842414|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842415|NCT02890186|Remifentanil|remifentanil|mesh-list
153842416|NCT02890186|Propofol|propofol|mesh-list
153842417|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153842418|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842419|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842420|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153842421|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
153842422|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
153842453|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
153842454|NCT02909751|Protective Agents|protective agents|mesh-ancestor
153395927|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
153842456|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
153842457|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
153842458|NCT02909712|Piperaquine|piperaquine|mesh-list
153842459|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
153842460|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153842461|NCT02909712|Artenimol|artenimol|mesh-list
153842462|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
153842463|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153842464|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153842465|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842466|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153842467|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842468|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842469|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153842470|NCT02913885|Fluorides|fluorides|mesh-list
153842471|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
153842504|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153842505|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
153842506|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842507|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153842508|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
154258550|NCT06192615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258551|NCT06192472|Polidocanol|polidocanol|mesh-list
154258552|NCT06192472|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
154258553|NCT06192472|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154258554|NCT06192472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154258555|NCT06192407|Palmitic Acid|palmitic acid|mesh-list
154258556|NCT06192407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258557|NCT06192407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258558|NCT06192303|Dimercaprol|dimercaprol|mesh-list
154258559|NCT06192303|Chelating Agents|chelating agents|mesh-ancestor
154258560|NCT06192303|Sequestering Agents|sequestering agents|mesh-ancestor
153842509|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
153842510|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
153382651|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382653|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
153382654|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382655|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
153382656|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153382657|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
153382658|NCT02007863|Fludarabine|fludarabine|mesh-list
153382660|NCT02007863|Busulfan|busulfan|mesh-list
153382661|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382662|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382663|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153842550|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
153842551|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
153842552|NCT02913768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153842553|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153842554|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
153855726|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
153842555|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842556|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842557|NCT01289782|Ribavirin|ribavirin|mesh-list
153842558|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153842560|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
153842561|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842562|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
153842563|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842564|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
153382697|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
153382698|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382699|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382700|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
153382701|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382702|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382703|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
153382704|NCT03468075|Protective Agents|protective agents|mesh-ancestor
153382705|NCT03468933|Plasminogen|plasminogen|mesh-list
153382706|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153382707|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153382708|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153842570|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153842571|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842572|NCT02936492|Clobetasol|clobetasol|mesh-list
153842573|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842574|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
153842575|NCT02936492|Hormones|hormones|mesh-ancestor
153842576|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842577|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842578|NCT02913573|Bupivacaine|bupivacaine|mesh-list
153842579|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
153842580|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
153382717|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153382719|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
153382720|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
154258561|NCT06192303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258562|NCT06192277|Penicillins|penicillins|mesh-list
154258563|NCT06192277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154258564|NCT06192277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258565|NCT06192147|Vitamin D|vitamin d|mesh-list
154258566|NCT06192147|Vitamins|vitamins|mesh-ancestor
154258567|NCT06192147|Micronutrients|micronutrients|mesh-ancestor
154258568|NCT06192147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258569|NCT06192147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154258570|NCT06191991|Atorvastatin|atorvastatin|mesh-list
154258571|NCT06191991|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154258572|NCT06191991|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154258573|NCT06191991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154258574|NCT06191991|Antimetabolites|antimetabolites|mesh-ancestor
154258575|NCT06191991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258576|NCT06191991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154258577|NCT06191991|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154258578|NCT06191991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258579|NCT06191770|Morphine|morphine|mesh-list
154258580|NCT06191770|Nalbuphine|nalbuphine|mesh-list
153732345|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
153382721|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
153382722|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382723|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153382724|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153382725|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153382726|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382728|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
153382729|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153842624|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842625|NCT01289119|Incretins|incretins|mesh-ancestor
153842626|NCT01289119|Hormones|hormones|mesh-ancestor
153842627|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842628|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153842629|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
153842630|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842631|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842632|NCT01287832|Vancomycin|vancomycin|mesh-list
153842633|NCT01287832|Daptomycin|daptomycin|mesh-list
153842634|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153842635|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842636|NCT02913066|Cisplatin|cisplatin|mesh-list
153842637|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842638|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153842639|NCT01287754|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153842640|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153842641|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842642|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842643|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842644|NCT02912793|Betadex|betadex|mesh-list
153842645|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
153842646|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842647|NCT02935751|Apixaban|apixaban|mesh-list
153842648|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154258581|NCT06191770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154258583|NCT06191770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258584|NCT06191770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258585|NCT06191770|Analgesics|analgesics|mesh-ancestor
154258586|NCT06191770|Sensory System Agents|sensory system agents|mesh-ancestor
154258587|NCT06191770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258588|NCT06188728|Psyllium|psyllium|mesh-list
153732365|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
153732366|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153848938|NCT00557180|Hormones|hormones|mesh-ancestor
153842649|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
153842650|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153842651|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
153842652|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842653|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842654|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
153382792|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153382793|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842665|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842666|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842667|NCT02912910|Labetalol|labetalol|mesh-list
153842668|NCT02912910|Nifedipine|nifedipine|mesh-list
153842669|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153842670|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153842671|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842672|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153842673|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842674|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
153842675|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
153842676|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153842677|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153842678|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153842679|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
153842700|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153842701|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842702|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153842703|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
153842704|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842705|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842706|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
153855904|NCT00451061|Tamsulosin|tamsulosin|mesh-list
153842707|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842708|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153842709|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153842710|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
153842711|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842712|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153842713|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
153382834|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382835|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
153382836|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
153382837|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
153382838|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382839|NCT02013245|Vaccines|vaccines|mesh-list
153382840|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
153382841|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382842|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
153382843|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
153382844|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382845|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
153382846|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382847|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382848|NCT01981967|Vaccines|vaccines|mesh-list
153382849|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
154258589|NCT06188728|Calcium polycarbophil|calcium polycarbophil|mesh-list
154258590|NCT06188728|Cathartics|cathartics|mesh-ancestor
154258591|NCT06188728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154258592|NCT06188728|Antidiarrheals|antidiarrheals|mesh-ancestor
154258593|NCT06188585|Epinephrine|epinephrine|mesh-list
154258594|NCT06188585|Racepinephrine|racepinephrine|mesh-list
154258595|NCT06188585|Hemostatics|hemostatics|mesh-list
154258596|NCT06188585|Epinephryl borate|epinephryl borate|mesh-list
154258597|NCT06188585|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154258598|NCT06188585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154258599|NCT06188585|Adrenergic Agents|adrenergic agents|mesh-ancestor
154258600|NCT06188585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258601|NCT06188585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258602|NCT06188585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258603|NCT06188585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154258604|NCT06188585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154258605|NCT06188585|Autonomic Agents|autonomic agents|mesh-ancestor
154258606|NCT06188585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258607|NCT06188585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154258608|NCT06188585|Respiratory System Agents|respiratory system agents|mesh-ancestor
154258609|NCT06188585|Mydriatics|mydriatics|mesh-ancestor
154258610|NCT06188585|Sympathomimetics|sympathomimetics|mesh-ancestor
154258611|NCT06188585|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154258612|NCT06188585|Coagulants|coagulants|mesh-ancestor
154258613|NCT06187285|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153732373|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382850|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382851|NCT01982123|Edetic Acid|edetic acid|mesh-list
153382852|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
153382853|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
153842893|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383032|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153383033|NCT02029703|Hylan|hylan|mesh-list
153383058|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153383059|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153383060|NCT02342015|Atorvastatin|atorvastatin|mesh-list
153383061|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153383062|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153383063|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
153842953|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842954|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153842955|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
153842956|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
153842957|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153842958|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153842959|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842960|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153843167|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843168|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
153843170|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258614|NCT06187285|Empagliflozin|empagliflozin|mesh-list
154258615|NCT06187285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154258616|NCT06187285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258617|NCT06187285|Incretins|incretins|mesh-ancestor
154258618|NCT06187285|Hormones|hormones|mesh-ancestor
154258619|NCT06187285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258620|NCT06187285|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154258621|NCT06187285|Protease Inhibitors|protease inhibitors|mesh-ancestor
154258622|NCT06187285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258623|NCT06187285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258624|NCT06187285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154258625|NCT06182839|Canagliflozin|canagliflozin|mesh-list
154258626|NCT06182839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154258627|NCT06182839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258628|NCT06182839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154258629|NCT06182839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843171|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153843172|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153383310|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383312|NCT05718011|Dexmedetomidine|dexmedetomidine|mesh-list
153843193|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843194|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843195|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
153843196|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843197|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153843198|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843199|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
153843200|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843201|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153843202|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153843203|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
153843204|NCT01286077|Bortezomib|bortezomib|mesh-list
153383404|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153383405|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
153383406|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843327|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
153843328|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843329|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
153843330|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153843331|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153843333|NCT02922686|Penicillin V|penicillin v|mesh-list
153843334|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153843335|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843337|NCT02922491|Vitamins|vitamins|mesh-ancestor
153843338|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
153843339|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383440|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
153383441|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383442|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383443|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153383444|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
153383445|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
153383446|NCT03809234|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153383447|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153383448|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
153383449|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005585|NCT00611455|Ofatumumab|ofatumumab|mesh-list
154258630|NCT06179290|Menthol|menthol|mesh-list
154258631|NCT06179290|Antipruritics|antipruritics|mesh-ancestor
154258632|NCT06179290|Dermatologic Agents|dermatologic agents|mesh-ancestor
154258633|NCT06090669|Imatinib Mesylate|imatinib mesylate|mesh-list
154258634|NCT06090669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154258635|NCT06090669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258636|NCT06090669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732415|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153383450|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383451|NCT03711188|Nivolumab|nivolumab|mesh-list
153383452|NCT03711188|Ipilimumab|ipilimumab|mesh-list
153383453|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153396307|NCT00550537|Carboplatin|carboplatin|mesh-list
153383454|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383455|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153843360|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153843362|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
153383464|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
153843377|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
153843378|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153843379|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
153843380|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843381|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843382|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153843383|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
153843384|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
153843385|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153843386|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
153383491|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
153383492|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
153383493|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153383494|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383495|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383496|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153383497|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153383498|NCT02368457|Protective Agents|protective agents|mesh-ancestor
153383499|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383500|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
153383501|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153383527|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
153843387|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843388|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843389|NCT04615143|Tislelizumab|tislelizumab|mesh-list
153843390|NCT04615143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153843391|NCT04615143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843392|NCT01284634|Cannabidiol|cannabidiol|mesh-list
153843393|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
153843394|NCT02932722|Anesthetics|anesthetics|mesh-list
153843395|NCT02932722|Propofol|propofol|mesh-list
153856120|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153843396|NCT02932722|Sevoflurane|sevoflurane|mesh-list
153843428|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153843462|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153843463|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153843464|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153843465|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
153843466|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383571|NCT00354809|Casopitant|casopitant|mesh-list
153383572|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
153383573|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
153383665|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383666|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
153383667|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
153383668|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383669|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
153383670|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383671|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383672|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
153383673|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153389552|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
153389564|NCT00002505|Interferons|interferons|mesh-list
153383674|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153383675|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383676|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153383677|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
153383678|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
153383679|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383680|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
153383681|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153383683|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153383684|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383685|NCT01768520|Analgesics|analgesics|mesh-ancestor
153843605|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843606|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843607|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
153843608|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843609|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843610|NCT01281865|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153843611|NCT02920658|Betamethasone|betamethasone|mesh-list
153383752|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
153383753|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153843639|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843640|NCT00623857|Trace Elements|trace elements|mesh-ancestor
153843641|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153843643|NCT01280968|Nicotine|nicotine|mesh-list
153843644|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
153843645|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360992|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843669|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
153843670|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
153843671|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843672|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843673|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
153843674|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843675|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843676|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
153843677|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
153383806|NCT01780454|Rituximab|rituximab|mesh-list
153383807|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153383808|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383809|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
153383810|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383811|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383812|NCT00355901|Visilizumab|visilizumab|mesh-list
153843725|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843726|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843727|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
153843728|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843729|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
153843730|NCT02932254|Analgesics|analgesics|mesh-ancestor
153843731|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
153843732|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843733|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843734|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
153843735|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843736|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153843737|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
153843834|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
153843835|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153843836|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
153843913|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843914|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153843915|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384012|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
153384013|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153856257|NCT04798287|Infliximab|infliximab|mesh-list
153384043|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
153732157|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153394319|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153843916|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
153843917|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
153843918|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843919|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153843920|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
154258637|NCT06090669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258638|NCT06090669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258639|NCT06023862|Paclitaxel|paclitaxel|mesh-list
154258640|NCT06023862|Bevacizumab|bevacizumab|mesh-list
154258641|NCT06023862|Gemcitabine|gemcitabine|mesh-list
154258642|NCT06023862|Doxorubicin|doxorubicin|mesh-list
154258643|NCT06023862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154258644|NCT06023862|Dostarlimab|dostarlimab|mesh-list
154258645|NCT06023862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154258646|NCT06023862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258647|NCT06023862|Tubulin Modulators|tubulin modulators|mesh-ancestor
154258648|NCT06023862|Antimitotic Agents|antimitotic agents|mesh-ancestor
154258649|NCT06023862|Mitosis Modulators|mitosis modulators|mesh-ancestor
154258650|NCT06023862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258651|NCT06023862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154258652|NCT06023862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154258653|NCT06023862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154258654|NCT06023862|Growth Substances|growth substances|mesh-ancestor
154258655|NCT06023862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258656|NCT06023862|Growth Inhibitors|growth inhibitors|mesh-ancestor
154258657|NCT06023862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154258658|NCT06023862|Antimetabolites|antimetabolites|mesh-ancestor
154258659|NCT06023862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154258660|NCT06023862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154258661|NCT06023862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154258662|NCT06023862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258663|NCT05981703|Tislelizumab|tislelizumab|mesh-list
153732419|NCT00162435|Warfarin|warfarin|mesh-list
153732420|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
153843921|NCT02918747|Hormones|hormones|mesh-ancestor
153843922|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843923|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153843924|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153843925|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
153843926|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153843927|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153844013|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153396518|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
153844015|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844016|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844017|NCT05467436|Analgesics|analgesics|mesh-list
153844018|NCT05467436|Anesthetics|anesthetics|mesh-list
153384134|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
153384135|NCT03974789|Hormones|hormones|mesh-ancestor
153384136|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153384137|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154258664|NCT05981703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154258665|NCT05981703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258666|NCT05935098|Tislelizumab|tislelizumab|mesh-list
154258667|NCT05935098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153384138|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384139|NCT01812668|Fluorides|fluorides|mesh-list
153384140|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
153384141|NCT01812668|Protective Agents|protective agents|mesh-ancestor
153384142|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384143|NCT02570477|Vancomycin|vancomycin|mesh-list
153384144|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384145|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384146|NCT04344821|Calcium|calcium|mesh-list
153384147|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153384148|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844281|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153384382|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
153384383|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384384|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384385|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153384386|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384387|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384485|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384486|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
153384487|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384488|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
153384489|NCT00376467|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153384490|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153384491|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396599|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396600|NCT01936519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153396601|NCT01936519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153396602|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384492|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384493|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384494|NCT03556761|Furosemide|furosemide|mesh-list
153384495|NCT03556761|Diuretics|diuretics|mesh-ancestor
153384496|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
153384497|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384498|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153384499|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844476|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153844477|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844478|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844520|NCT00535808|Sevoflurane|sevoflurane|mesh-list
153844521|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153844522|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153844523|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
153844524|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
153384715|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384716|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384717|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
153384718|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384719|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153384720|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
153844912|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153844951|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153844952|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844953|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153844954|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844955|NCT05312866|Acetaminophen|acetaminophen|mesh-list
153844956|NCT05312866|Dexamethasone|dexamethasone|mesh-list
153844957|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
153844958|NCT05312866|Fentanyl|fentanyl|mesh-list
153844959|NCT05312866|Bupivacaine|bupivacaine|mesh-list
153844960|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844961|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
153844962|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
153844963|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844964|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844965|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153844966|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
153844967|NCT05312866|Hormones|hormones|mesh-ancestor
153844968|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258668|NCT05935098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258670|NCT05906836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154258671|NCT05906836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154258672|NCT05906836|Antimetabolites|antimetabolites|mesh-ancestor
154258673|NCT05906836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258674|NCT05906836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154258675|NCT05906836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154258676|NCT05906836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258677|NCT05904496|Tislelizumab|tislelizumab|mesh-list
154258678|NCT05904496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154258679|NCT05904496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258680|NCT05878717|Belimumab|belimumab|mesh-list
154258681|NCT05878717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258682|NCT05878717|Immunologic Factors|immunologic factors|mesh-ancestor
154258683|NCT05878717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258684|NCT05859412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154258685|NCT05859412|Methylprednisolone|methylprednisolone|mesh-list
154258686|NCT05859412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154258687|NCT05859412|Prednisolone|prednisolone|mesh-list
154258688|NCT05859412|Prednisolone acetate|prednisolone acetate|mesh-list
154258689|NCT05859412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153844969|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385119|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385121|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153385122|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153385123|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153385124|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385125|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153385126|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153385127|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
153385128|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845022|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153845023|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845024|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
153845025|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845026|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153845027|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845028|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153845029|NCT00597259|Entecavir|entecavir|mesh-list
153845030|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
153845031|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845032|NCT05470764|Amlodipine|amlodipine|mesh-list
153845033|NCT05470764|Perindopril|perindopril|mesh-list
153845034|NCT05470764|Indapamide|indapamide|mesh-list
153845035|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153845036|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153845037|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153385234|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
153385235|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153845134|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
153845135|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845136|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845137|NCT02891785|Antipain|antipain|mesh-list
153845138|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
153385282|NCT04137627|Melatonin|melatonin|mesh-list
153385283|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
153385284|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385285|NCT04137627|Protective Agents|protective agents|mesh-ancestor
153385286|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385287|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385288|NCT04136145|Belimumab|belimumab|mesh-list
153845210|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
153845211|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845212|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845215|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
153845216|NCT00624208|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153845217|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153845218|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
153845219|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845220|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845221|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153845222|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153845223|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153385360|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385361|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385362|NCT03958071|Analgesics|analgesics|mesh-ancestor
153385363|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
153385364|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385365|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385366|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153385367|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845253|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153845254|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153845255|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
153845256|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153845257|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153845258|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
153845259|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
153845260|NCT05312346|Hematinics|hematinics|mesh-ancestor
153845261|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
153845262|NCT05312346|Vitamins|vitamins|mesh-ancestor
153845289|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845290|NCT00537173|Paclitaxel|paclitaxel|mesh-list
153845291|NCT00537173|Bevacizumab|bevacizumab|mesh-list
153845305|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153845307|NCT02503839|Analgesics|analgesics|mesh-ancestor
153845308|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
153845309|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845310|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845311|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845312|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845313|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153845314|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153845315|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845316|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845317|NCT05469750|Capecitabine|capecitabine|mesh-list
153845318|NCT05469750|Letrozole|letrozole|mesh-list
153845319|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153845320|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
153385462|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153385463|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
153385582|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153385583|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
153385584|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
153385585|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385586|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153845486|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845487|NCT00552266|Methylphenidate|methylphenidate|mesh-list
153845488|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153845489|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845490|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153845491|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153845492|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153845493|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845496|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
153845497|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153845498|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153845499|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
153845500|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845501|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845502|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153385634|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153385635|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
153385636|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153385637|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
153385638|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153385639|NCT00552110|Protective Agents|protective agents|mesh-ancestor
153385640|NCT02301624|Eculizumab|eculizumab|mesh-list
153385641|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153385642|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385643|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
153385644|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385645|NCT02007122|Ceftaroline|ceftaroline|mesh-list
153385646|NCT02007122|Cephalosporins|cephalosporins|mesh-list
153385647|NCT02007122|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153385648|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153385649|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385650|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
153385721|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153385722|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385723|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
153385724|NCT03825939|Coagulants|coagulants|mesh-ancestor
153385725|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
153385726|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153385727|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385728|NCT03988647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153385729|NCT03988647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385730|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
153385731|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153845642|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845643|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153845644|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153845645|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
153845646|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
153845647|NCT04687566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153845648|NCT04687566|Narcotics|narcotics|mesh-ancestor
153845649|NCT04687566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845650|NCT04687566|Analgesics|analgesics|mesh-ancestor
153845651|NCT04687566|Sensory System Agents|sensory system agents|mesh-ancestor
153845652|NCT04687566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845653|NCT01256476|Pravastatin|pravastatin|mesh-list
153845694|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845695|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845725|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153845726|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153845727|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845728|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732160|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153845730|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385844|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153385845|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153385846|NCT00550550|Analgesics|analgesics|mesh-ancestor
153385847|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
153385848|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385849|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153385850|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845875|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153845876|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153845878|NCT01252186|Hormones|hormones|mesh-ancestor
153845879|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845880|NCT01731782|Bupivacaine|bupivacaine|mesh-list
153386020|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386021|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386023|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153386025|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386027|NCT01882868|Irinotecan|irinotecan|mesh-list
153386028|NCT01882868|Aflibercept|aflibercept|mesh-list
153386029|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
153386030|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153386031|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153386032|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845939|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845940|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
153386055|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386056|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
153386057|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
153386058|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
153845943|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153845944|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153845945|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153845946|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153845947|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845948|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
153845949|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845950|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845951|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153845952|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845954|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153845955|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153845956|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153845957|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386108|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386109|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153386110|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153386112|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
153386113|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386114|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153386115|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153386116|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386117|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386118|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
153386119|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153386120|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
153386149|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153386150|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153386151|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386152|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153846008|NCT04320277|Lopinavir|lopinavir|mesh-list
153846009|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153846010|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153846011|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
153846012|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846013|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846014|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153363501|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363502|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153363503|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153363504|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
153363505|NCT01462565|Epoprostenol|epoprostenol|mesh-list
153856842|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846015|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153846016|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
153856843|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856844|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856845|NCT02044341|Benzocaine|benzocaine|mesh-list
153856846|NCT02044341|Glycerol|glycerol|mesh-list
153856847|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153856848|NCT02044341|Protective Agents|protective agents|mesh-ancestor
153846046|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846047|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
153386163|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
153386164|NCT02326272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153386165|NCT02326272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153386166|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386167|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
153386168|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386169|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153386170|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
153386172|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153386173|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386174|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
153846064|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846065|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153846066|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153846067|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846068|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846069|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153846070|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
154258690|NCT05859412|Prednisolone phosphate|prednisolone phosphate|mesh-list
154258691|NCT05859412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154258692|NCT05859412|Antiemetics|antiemetics|mesh-ancestor
154258693|NCT05859412|Autonomic Agents|autonomic agents|mesh-ancestor
153856850|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
154258694|NCT05859412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258695|NCT05859412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258696|NCT05859412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846071|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846072|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846114|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
153846115|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846117|NCT01246960|Protective Agents|protective agents|mesh-ancestor
153846118|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
153846119|NCT01246960|Vitamins|vitamins|mesh-ancestor
153846120|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
153846121|NCT01246960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153846122|NCT01246960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153846123|NCT01246960|Growth Substances|growth substances|mesh-ancestor
153846124|NCT01246960|Growth Inhibitors|growth inhibitors|mesh-ancestor
153846125|NCT00544986|Anastrozole|anastrozole|mesh-list
153846126|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153846133|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
153846134|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846135|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846136|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
153846137|NCT01244620|Tadalafil|tadalafil|mesh-list
153846138|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
153846139|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846140|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153846141|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153386295|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153386296|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386297|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
153386298|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153386299|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846187|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846188|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153846189|NCT01267201|Protective Agents|protective agents|mesh-ancestor
153846190|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153846191|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846192|NCT03736616|Cytarabine|cytarabine|mesh-list
153386353|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153386355|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153386356|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386357|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
153386360|NCT00378027|PENTA|penta|mesh-list
153846227|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153846228|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397100|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397101|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397102|NCT01643772|Analgesics|analgesics|mesh-ancestor
153397103|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
153397104|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846229|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846230|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846231|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153846232|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153846233|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
153846234|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846235|NCT00537966|Ritonavir|ritonavir|mesh-list
153846236|NCT00537966|Darunavir|darunavir|mesh-list
153386408|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386410|NCT02411643|Calcipotriene|calcipotriene|mesh-list
153386411|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
153386412|NCT01085643|Lubiprostone|lubiprostone|mesh-list
153386413|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153846290|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846292|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
153846293|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153846294|NCT00545493|Antibodies|antibodies|mesh-list
153846295|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846296|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
153846297|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846298|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153846299|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386464|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153386465|NCT01048125|Nitroprusside|nitroprusside|mesh-list
153386466|NCT01048125|Phenylephrine|phenylephrine|mesh-list
153386467|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
153386468|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153386469|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
153386470|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
153386499|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386500|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386502|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386503|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153386504|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153386505|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386506|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386507|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153386508|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
153846389|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153846390|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
153846391|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846393|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
153846394|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153846395|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
153846396|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386509|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386510|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386511|NCT01025271|Daptomycin|daptomycin|mesh-list
153386512|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153386513|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386514|NCT01902758|Ambrisentan|ambrisentan|mesh-list
153846406|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846407|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
153846408|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153846409|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153846410|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846411|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153386620|NCT00924807|Sorafenib|sorafenib|mesh-list
153386621|NCT00924807|Leuprolide|leuprolide|mesh-list
153386622|NCT00924807|Bicalutamide|bicalutamide|mesh-list
153386623|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386624|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153386625|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846526|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
153846527|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846528|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846529|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153846530|NCT00539331|Paclitaxel|paclitaxel|mesh-list
153386670|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
153386671|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
153386672|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
153386674|NCT00832299|Fluorouracil|fluorouracil|mesh-list
153386675|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
153386676|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
153386677|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386678|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153846582|NCT01715714|Atorvastatin|atorvastatin|mesh-list
153846583|NCT01715714|Simvastatin|simvastatin|mesh-list
153846584|NCT01715714|Pravastatin|pravastatin|mesh-list
153846585|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153846586|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153846587|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
153846589|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153846590|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153846591|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846593|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856947|NCT03455049|Analgesics|analgesics|mesh-ancestor
153386727|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153386728|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153386729|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386730|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386731|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386732|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
153386733|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153386734|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
153386735|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386736|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850198|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153850199|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153850201|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850202|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153850203|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153850204|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153386737|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153386738|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386739|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153386740|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
153386741|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386760|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153386761|NCT00760461|Domperidone|domperidone|mesh-list
153386762|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
153846648|NCT00546546|Methotrexate|methotrexate|mesh-list
153846649|NCT00546546|Azathioprine|azathioprine|mesh-list
153846650|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153846651|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153846652|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
153846653|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153846654|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823559|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153397267|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397268|NCT00368303|Paroxetine|paroxetine|mesh-list
153397269|NCT00368303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153397270|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153397271|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153397272|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397273|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397274|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
153397275|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397277|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
153846655|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153846656|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
153846657|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846658|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846659|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
153846660|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846661|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153846662|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
153846663|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846664|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153846665|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153846666|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153846667|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846668|NCT00659711|Incretins|incretins|mesh-ancestor
153846669|NCT00659711|Hormones|hormones|mesh-ancestor
153846670|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386821|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153386822|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153386823|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
153386824|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153386825|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153386826|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153386827|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386828|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386829|NCT01856361|Ramipril|ramipril|mesh-list
153386830|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153846687|NCT00546741|Metformin|metformin|mesh-list
153846688|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
153846689|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153846690|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846691|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153846692|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846693|NCT00546936|Ranibizumab|ranibizumab|mesh-list
153846694|NCT00546936|Verteporfin|verteporfin|mesh-list
153857038|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857039|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
153857040|NCT01975818|Hematinics|hematinics|mesh-ancestor
153857041|NCT01973049|Ribavirin|ribavirin|mesh-list
153857042|NCT01973049|Asunaprevir|asunaprevir|mesh-list
153857043|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
153857050|NCT01185964|Olaratumab|olaratumab|mesh-list
153846695|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153846696|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153846697|NCT00546936|Growth Substances|growth substances|mesh-ancestor
153846698|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846699|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
153846700|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386840|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386841|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153386842|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153386891|NCT00588471|Simvastatin|simvastatin|mesh-list
153732165|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850268|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153850269|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153850270|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153850271|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153850272|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153390453|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153390454|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153390455|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
153390456|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390457|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153390467|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
153732166|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
153386892|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153386893|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153386894|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
153846781|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846782|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
153846783|NCT00547287|Tadalafil|tadalafil|mesh-list
153846784|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
153386927|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386928|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386929|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
153386930|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386931|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153386932|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
153386933|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153386934|NCT01691079|Bromides|bromides|mesh-list
153386935|NCT01691079|Ipratropium|ipratropium|mesh-list
153386936|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
153386937|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153386938|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
153386939|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846816|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846817|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
153846818|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
153846819|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
153846844|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846845|NCT02908295|Misoprostol|misoprostol|mesh-list
153846846|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153846847|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
153846848|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153846866|NCT03809442|Hormones|hormones|mesh-ancestor
153846867|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846868|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153846869|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846870|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153846871|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387006|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387008|NCT05550519|Tenofovir|tenofovir|mesh-list
153387009|NCT05550519|Entecavir|entecavir|mesh-list
153387010|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
153387011|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387012|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153387013|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153387018|NCT01203371|Naftopidil|naftopidil|mesh-list
153846877|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153846878|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
153846879|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846880|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846881|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153846882|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153846904|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
153846905|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258699|NCT05859412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258700|NCT05859412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154258701|NCT05859412|Protective Agents|protective agents|mesh-ancestor
154258702|NCT05859412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154258703|NCT05859412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258704|NCT05851547|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154258705|NCT05851547|Androgens|androgens|mesh-list
154258706|NCT05851547|Hormones|hormones|mesh-ancestor
154258707|NCT05851547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258708|NCT05851547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258709|NCT05851547|Luteolytic Agents|luteolytic agents|mesh-ancestor
154258710|NCT05851547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154258711|NCT05851547|Contraceptive Agents|contraceptive agents|mesh-ancestor
154258712|NCT05851547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154258713|NCT05851547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154258714|NCT05851547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154258715|NCT05851547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258716|NCT05824871|Bedaquiline|bedaquiline|mesh-list
154258717|NCT05824871|Antitubercular Agents|antitubercular agents|mesh-ancestor
154258718|NCT05824871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154258719|NCT05824871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258720|NCT05770102|Atezolizumab|atezolizumab|mesh-list
154258721|NCT05770102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154258722|NCT05770102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258723|NCT05770102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153846907|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153846908|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
153846909|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153846910|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846911|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
153846912|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153846913|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846914|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846915|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153846916|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153846917|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153846918|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153732167|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732168|NCT00140933|Diclofenac|diclofenac|mesh-list
153732169|NCT00140933|Rofecoxib|rofecoxib|mesh-list
153394761|NCT02524769|Estrogens|estrogens|mesh-list
153846940|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153846941|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153846943|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
153397492|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397494|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153397495|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153397496|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153397497|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153857246|NCT06225440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857247|NCT06224855|Immunoconjugates|immunoconjugates|mesh-list
153857248|NCT06224855|Immunologic Factors|immunologic factors|mesh-ancestor
153857250|NCT06224725|Chrysarobin|chrysarobin|mesh-list
153850317|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850318|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
153850319|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153850320|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850321|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850322|NCT00541086|Tamoxifen|tamoxifen|mesh-list
153850323|NCT00541086|Letrozole|letrozole|mesh-list
153850324|NCT00541086|Anastrozole|anastrozole|mesh-list
153850325|NCT00541086|Exemestane|exemestane|mesh-list
153850326|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850327|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846944|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153846945|NCT02907749|Carvedilol|carvedilol|mesh-list
153846946|NCT02907749|Spironolactone|spironolactone|mesh-list
153846947|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153846948|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
153846949|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846950|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846961|NCT02907749|Protective Agents|protective agents|mesh-ancestor
153846962|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153846963|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153846964|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153846965|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846966|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153846967|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153387080|NCT05722301|Methyltestosterone|methyltestosterone|mesh-list
153387081|NCT05722301|Testosterone|testosterone|mesh-list
153387082|NCT05722301|Testosterone undecanoate|testosterone undecanoate|mesh-list
153387083|NCT05722301|Testosterone enanthate|testosterone enanthate|mesh-list
153387084|NCT05722301|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153387085|NCT05722301|Androgens|androgens|mesh-ancestor
153387086|NCT05722301|Hormones|hormones|mesh-ancestor
153387087|NCT05722301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387088|NCT05722301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387089|NCT05722301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153397509|NCT02588027|Ibuprofen|ibuprofen|mesh-list
153387090|NCT05722301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387091|NCT05722301|Anabolic Agents|anabolic agents|mesh-ancestor
153387092|NCT01534143|Sirolimus|sirolimus|mesh-list
153846971|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153846972|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
153846973|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846974|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846975|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153846976|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
153846977|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
153846978|NCT02907593|Hormones|hormones|mesh-ancestor
153846979|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846980|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153846995|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153846996|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153394776|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846997|NCT02907710|Growth Substances|growth substances|mesh-ancestor
153846998|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846999|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
153847000|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847001|NCT03781362|Capecitabine|capecitabine|mesh-list
153847002|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153847003|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
153847004|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847005|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847007|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387122|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153387123|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154258724|NCT05770102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258726|NCT05770037|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154258727|NCT05770037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258728|NCT05770037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258729|NCT05770037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258730|NCT05750056|Lidocaine|lidocaine|mesh-list
154258731|NCT05750056|Sufentanil|sufentanil|mesh-list
154258732|NCT05750056|Dsuvia|dsuvia|mesh-list
154258733|NCT05750056|Propofol|propofol|mesh-list
153732503|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395874|NCT02596451|Diclofenac|diclofenac|mesh-list
153390564|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
153390565|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390566|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390567|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390568|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153390569|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
153390570|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153390571|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153390572|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
153387138|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153387139|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153387141|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387142|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
153387143|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
153387145|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847008|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153847009|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847010|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847011|NCT00548379|Vitamin D|vitamin d|mesh-list
153847012|NCT00548379|Vitamins|vitamins|mesh-ancestor
153847013|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
153847014|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847015|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153847016|NCT04972617|Furosemide|furosemide|mesh-list
153847017|NCT04972617|Diuretics|diuretics|mesh-ancestor
153847018|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
153847039|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
153847040|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847041|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
153847042|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847043|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
153847044|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847045|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153847047|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
153847048|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
153847049|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847050|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847051|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153847052|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153847053|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153847054|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
153847055|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258734|NCT05750056|Anesthetics, Local|anesthetics, local|mesh-ancestor
154258735|NCT05750056|Anesthetics|anesthetics|mesh-ancestor
154258736|NCT05750056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258737|NCT05750056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258738|NCT05750056|Sensory System Agents|sensory system agents|mesh-ancestor
153847056|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847057|NCT02907437|Minocycline|minocycline|mesh-list
153387170|NCT05721443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387171|NCT00523809|Bevacizumab|bevacizumab|mesh-list
153387172|NCT00523809|Fludarabine|fludarabine|mesh-list
153387173|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
153387174|NCT00523809|Melphalan|melphalan|mesh-list
153387175|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
153387176|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153387177|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387254|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
153387255|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387256|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387257|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153847111|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
153847112|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847113|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153847114|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847115|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153847116|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847118|NCT00535119|Carboplatin|carboplatin|mesh-list
153847119|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153847120|NCT00535119|Veliparib|veliparib|mesh-list
153847121|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153394816|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
153847122|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847183|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153847184|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
153847222|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847223|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153847224|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153847225|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847226|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847227|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
153847294|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847295|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847297|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
153387410|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387411|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153387412|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
153387413|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153387414|NCT00000123|Protective Agents|protective agents|mesh-ancestor
153387415|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387416|NCT00380133|Prednisolone|prednisolone|mesh-list
153387417|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387418|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
153387472|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387474|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
153387475|NCT01807611|Melphalan|melphalan|mesh-list
153857520|NCT05230758|Metformin|metformin|mesh-list
153387476|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
153387477|NCT01807611|Thiotepa|thiotepa|mesh-list
153387478|NCT01807611|Fludarabine|fludarabine|mesh-list
153387479|NCT01807611|Lenograstim|lenograstim|mesh-list
153847342|NCT03088410|Nevirapine|nevirapine|mesh-list
153847343|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
153387480|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847344|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847345|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153847346|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153847347|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847348|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
153847349|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847350|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153847351|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153847352|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153850465|NCT04655807|Adalimumab|adalimumab|mesh-list
153847353|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153847354|NCT02897765|Nivolumab|nivolumab|mesh-list
153847355|NCT02897765|Poly ICLC|poly iclc|mesh-list
153847371|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
153847372|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847373|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847374|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153387516|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153387517|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153387518|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387519|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153387520|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153387521|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153387523|NCT01692717|Diuretics|diuretics|mesh-ancestor
153847388|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153847389|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847390|NCT04321837|Vitamin D|vitamin d|mesh-list
153847391|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
153847392|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
153847426|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153847489|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
153847490|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153847491|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397779|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
153847492|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153847493|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
153847494|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153847495|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847496|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387611|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153387612|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153387613|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387615|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
153387616|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153387617|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
153387618|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387619|NCT05637671|Paroxetine|paroxetine|mesh-list
153387620|NCT05637671|Oxybutynin|oxybutynin|mesh-list
153387621|NCT05637671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153387622|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153821109|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
153387759|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
153847627|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153847628|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153847629|NCT02895113|Analgesics|analgesics|mesh-ancestor
153847650|NCT02894957|Varenicline|varenicline|mesh-list
153847651|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153847652|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153847653|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
153847654|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847655|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847656|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847657|NCT00550992|Leucovorin|leucovorin|mesh-list
153847658|NCT00550992|Cytarabine|cytarabine|mesh-list
153847659|NCT00550992|Cyclosporine|cyclosporine|mesh-list
153847660|NCT00550992|Prednisone|prednisone|mesh-list
153847661|NCT00550992|Prednisolone|prednisolone|mesh-list
153847662|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
153847663|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153847664|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153847665|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153847684|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847685|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153387803|NCT00001677|Methotrexate|methotrexate|mesh-list
153387804|NCT00001677|Fludarabine|fludarabine|mesh-list
153387828|NCT00001713|Plasminogen|plasminogen|mesh-list
153387829|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153387830|NCT00001713|Warfarin|warfarin|mesh-list
153387831|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
153387832|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153847686|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
153387833|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153847687|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847688|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847689|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153847690|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153847691|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
154258739|NCT05750056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847692|NCT00550992|Hormones|hormones|mesh-ancestor
153847693|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847694|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153847695|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153847696|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
153847697|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153847698|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153847720|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153847722|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
153847723|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
153847724|NCT02895074|Tropicamide|tropicamide|mesh-list
153847725|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
153847726|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
153847727|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847728|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847729|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153847745|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153847747|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
153847748|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153847749|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847750|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
153847751|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847752|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847753|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153847754|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
153847755|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847756|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847757|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153847758|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
153847759|NCT02894606|Basiliximab|basiliximab|mesh-list
153847785|NCT02894645|Dexamethasone|dexamethasone|mesh-list
153847786|NCT02894645|Prednisolone|prednisolone|mesh-list
153847787|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
153847788|NCT02894645|Doxorubicin|doxorubicin|mesh-list
153847813|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153857602|NCT04989699|Aflibercept|aflibercept|mesh-list
153387930|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387931|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153387932|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
153387933|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
153387934|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387935|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153387938|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153387939|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153387940|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
153387941|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387967|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387968|NCT00000303|Baclofen|baclofen|mesh-list
153387969|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153387970|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387971|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153387972|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847860|NCT05427305|Growth Substances|growth substances|mesh-ancestor
153847861|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847862|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
153847863|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
153388010|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
153388011|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388012|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
153388013|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388014|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
153388015|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153388016|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153388019|NCT00000885|Efavirenz|efavirenz|mesh-list
153388080|NCT00000921|Hormones|hormones|mesh-ancestor
153388081|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153388082|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388083|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153388084|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388085|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
153388086|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153388087|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153388088|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153388089|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153388090|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388091|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
153847967|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847968|NCT04335305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153847969|NCT04335305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847970|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
153847971|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153388144|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388147|NCT02319642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153857725|NCT04681677|Bevacizumab|bevacizumab|mesh-list
153388148|NCT02319642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153388149|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388150|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
153388151|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388152|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848023|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848024|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388179|NCT00000987|Doxorubicin|doxorubicin|mesh-list
153388180|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153388181|NCT00000987|Bleomycin|bleomycin|mesh-list
153388182|NCT00000987|Vincristine|vincristine|mesh-list
153388183|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153388184|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388185|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153388186|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153388187|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388188|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388189|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153388190|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388191|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
153388192|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
153388193|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
153388194|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388196|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
153848044|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848045|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153848046|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153361082|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388285|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153388286|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
153388287|NCT00001035|Interferons|interferons|mesh-list
153388288|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
153388289|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
153388290|NCT00001035|Zidovudine|zidovudine|mesh-list
153388291|NCT00001035|Didanosine|didanosine|mesh-list
153388292|NCT00001035|Zalcitabine|zalcitabine|mesh-list
153388293|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388294|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
153388295|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388296|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
153388297|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388298|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
153848168|NCT03182231|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153848169|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153848170|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857757|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
153361106|NCT00862784|Growth Inhibitors|growth inhibitors|mesh-ancestor
153361108|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361109|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153361110|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361111|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361112|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153361113|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153361114|NCT00820664|Estradiol|estradiol|mesh-list
153361115|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153361116|NCT00820664|Estrogens|estrogens|mesh-ancestor
153848254|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
153821158|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821159|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
153821160|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821161|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821162|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
153821163|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
153821164|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821165|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821166|NCT00437333|Metformin|metformin|mesh-list
153821167|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153361117|NCT00820664|Hormones|hormones|mesh-ancestor
153848286|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153848287|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153848288|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
153848289|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153848290|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848291|NCT03425565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153848292|NCT03425565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388452|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
153732205|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
153732206|NCT00504946|Hormones|hormones|mesh-ancestor
153732207|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732208|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732209|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153398040|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732210|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732211|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153388466|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388467|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388468|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153388469|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
153388470|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153388471|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388472|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153848328|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153848329|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
153848330|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153848331|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848332|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153848333|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153848334|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153848335|NCT04684017|Carboplatin|carboplatin|mesh-list
153848336|NCT04684017|Etoposide|etoposide|mesh-list
153848337|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848338|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153732225|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153821199|NCT00482313|Methylphenidate|methylphenidate|mesh-list
153821200|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153821201|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388551|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153388569|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
153388570|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
153388571|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153388572|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153388573|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153388574|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
153388575|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388576|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388577|NCT05043077|Protective Agents|protective agents|mesh-ancestor
153388578|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153388579|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153388580|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
153388581|NCT00002055|Pentamidine|pentamidine|mesh-list
153388582|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
153388583|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848418|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
153848419|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
153848420|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848421|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153848422|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
153388606|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153388607|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153388608|NCT05029973|Growth Substances|growth substances|mesh-ancestor
153388609|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388610|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
153388611|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
153388612|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153388613|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
153388614|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388615|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
153388616|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388617|NCT00002067|Megestrol|megestrol|mesh-list
153388618|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
154258740|NCT05750056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154258741|NCT05750056|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154258742|NCT05750056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154258743|NCT05750056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154258744|NCT05750056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258745|NCT05750056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153732504|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153732505|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153732506|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153732507|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732508|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732509|NCT00141596|Amiloride|amiloride|mesh-list
153732510|NCT00141596|Furosemide|furosemide|mesh-list
153396130|NCT01642212|Hormones|hormones|mesh-ancestor
153390890|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390891|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
153390892|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
153390893|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
153857833|NCT04206787|Afatinib|afatinib|mesh-list
153461738|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850691|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
153850692|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850693|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850694|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153850695|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850696|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153850697|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
153850698|NCT01014546|Vitamins|vitamins|mesh-list
153850699|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
153850700|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
153850701|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
153850702|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850703|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
153850704|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850705|NCT01014546|Protective Agents|protective agents|mesh-ancestor
153850706|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850707|NCT00543231|Oblimersen|oblimersen|mesh-list
154258746|NCT05750056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154258747|NCT05750056|Anesthetics, General|anesthetics, general|mesh-ancestor
154258748|NCT05750056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154258749|NCT05750056|Narcotics|narcotics|mesh-ancestor
154258750|NCT05750056|Analgesics|analgesics|mesh-ancestor
154258751|NCT05750056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154258752|NCT05731973|Sufentanil|sufentanil|mesh-list
154258753|NCT05731973|Oxycodone|oxycodone|mesh-list
154258754|NCT05731973|Analgesics, Opioid|analgesics, opioid|mesh-list
153732511|NCT00141596|Diuretics|diuretics|mesh-ancestor
153732512|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
153732513|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732514|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153732515|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732516|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390904|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153388619|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153388620|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153388621|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153388622|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
153848453|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153848454|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388625|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153388626|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153388627|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153388628|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848549|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848550|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153848551|NCT01210144|Hormones|hormones|mesh-list
153848552|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153848553|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848554|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848555|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153848556|NCT01209949|Adapalene|adapalene|mesh-list
153848557|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153848558|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
153848559|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153848560|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153848561|NCT01209949|Analgesics|analgesics|mesh-ancestor
153388746|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153388747|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153388748|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
153388749|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388776|NCT00002109|Stavudine|stavudine|mesh-list
153388777|NCT00002109|Zalcitabine|zalcitabine|mesh-list
153388778|NCT00002109|Thymopentin|thymopentin|mesh-list
153388779|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
153388780|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388781|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388782|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388783|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388784|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
153388785|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848678|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153848679|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153848680|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153848681|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153848682|NCT01209520|Paclitaxel|paclitaxel|mesh-list
153848683|NCT01209520|Vinorelbine|vinorelbine|mesh-list
153390929|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390930|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390931|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390932|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390934|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
153390935|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390936|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153390937|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
153390938|NCT00002691|Hormones|hormones|mesh-ancestor
153390939|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390940|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390941|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153390942|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
153390943|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153390944|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153388902|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848731|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153732320|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732321|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732322|NCT00505102|Everolimus|everolimus|mesh-list
153732323|NCT00505102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153732324|NCT00505102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153732325|NCT00505102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732326|NCT00505102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848744|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
153821297|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153821298|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153821300|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848845|NCT04663763|Antibodies|antibodies|mesh-list
153848846|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
153848847|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848848|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153848849|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
153848850|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848851|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848852|NCT04351737|Dexamethasone|dexamethasone|mesh-list
153848853|NCT04351737|Prednisolone|prednisolone|mesh-list
153848854|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153848855|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
153848856|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153848857|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
153389053|NCT00002343|Ethambutol|ethambutol|mesh-list
153389054|NCT00002343|Rifabutin|rifabutin|mesh-list
153389055|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
153389056|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153848906|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153848907|NCT03986424|Memantine|memantine|mesh-list
153848908|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153732346|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732347|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153389066|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389067|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389092|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389094|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389095|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154258755|NCT05731973|Bupivacaine|bupivacaine|mesh-list
154258756|NCT05731973|Anesthetics, Local|anesthetics, local|mesh-ancestor
154258757|NCT05731973|Anesthetics|anesthetics|mesh-ancestor
154258758|NCT05731973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398227|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258759|NCT05731973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258760|NCT05731973|Sensory System Agents|sensory system agents|mesh-ancestor
154258761|NCT05731973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258762|NCT05731973|Narcotics|narcotics|mesh-ancestor
154258763|NCT05731973|Analgesics|analgesics|mesh-ancestor
154258764|NCT05731973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154258765|NCT05731973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154258766|NCT05731973|Anesthetics, General|anesthetics, general|mesh-ancestor
154258767|NCT05718583|Butyric Acid|butyric acid|mesh-list
154258768|NCT05718583|Histamine Antagonists|histamine antagonists|mesh-ancestor
154258769|NCT05718583|Histamine Agents|histamine agents|mesh-ancestor
154258770|NCT05718583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258771|NCT05718583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258772|NCT05718583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258773|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
154258774|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154258775|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153732518|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153732519|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153732520|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153732521|NCT02275663|Cytarabine|cytarabine|mesh-list
153732522|NCT02275663|Fludarabine|fludarabine|mesh-list
153732523|NCT02275663|Azacitidine|azacitidine|mesh-list
153732524|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732525|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153732526|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
153389096|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389097|NCT00002181|Cidofovir|cidofovir|mesh-list
153389098|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
153389099|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848971|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389115|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389116|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389117|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153857993|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857994|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
153857995|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857996|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153857997|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153857998|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153398250|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
153389118|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389119|NCT00002187|Fomivirsen|fomivirsen|mesh-list
153389120|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
153389121|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389122|NCT00002373|Maribavir|maribavir|mesh-list
153389123|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
153389124|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389181|NCT00002199|Indinavir|indinavir|mesh-list
153850767|NCT00557921|Clopidogrel|clopidogrel|mesh-list
153850768|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153850769|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850770|NCT00557921|Analgesics|analgesics|mesh-ancestor
153850771|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
153850772|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850773|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850774|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850775|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850776|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153850777|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153850778|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850779|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153850780|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153732374|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153732375|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732376|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153732377|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732378|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153732379|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153732380|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732381|NCT00404456|Melatonin|melatonin|mesh-list
153732382|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
153732383|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732384|NCT00404456|Protective Agents|protective agents|mesh-ancestor
153732385|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732386|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732387|NCT00404534|Amoxicillin|amoxicillin|mesh-list
153732388|NCT00404534|Clarithromycin|clarithromycin|mesh-list
153732389|NCT00404534|Omeprazole|omeprazole|mesh-list
153821355|NCT00438152|Ritonavir|ritonavir|mesh-list
153732411|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
153398323|NCT04337099|Tempol|tempol|mesh-list
153732412|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389322|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389324|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153849146|NCT06078228|Autonomic Agents|autonomic agents|mesh-ancestor
153849147|NCT06078228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153849148|NCT06078228|Respiratory System Agents|respiratory system agents|mesh-ancestor
153849149|NCT06078228|Mydriatics|mydriatics|mesh-ancestor
153849150|NCT06078228|Parasympatholytics|parasympatholytics|mesh-ancestor
153849151|NCT06078228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153849152|NCT06078228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153849153|NCT06078228|Cholinergic Agents|cholinergic agents|mesh-ancestor
153849154|NCT06078228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849155|NCT06078228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849156|NCT06078228|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153849157|NCT06078228|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153849158|NCT06078228|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153849159|NCT06078228|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153849160|NCT06077981|Hyaluronic Acid|hyaluronic acid|mesh-list
153821369|NCT00438230|Warfarin|warfarin|mesh-list
153732417|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732418|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849184|NCT06072521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849185|NCT06053983|Atorvastatin|atorvastatin|mesh-list
153849186|NCT06053983|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153849187|NCT06053983|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153849188|NCT06053983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153849189|NCT06053983|Antimetabolites|antimetabolites|mesh-ancestor
153849190|NCT06053983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258776|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258778|NCT05688111|Coagulants|coagulants|mesh-ancestor
154258779|NCT05687344|Nifedipine|nifedipine|mesh-list
154258780|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154005726|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
154258781|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732538|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732539|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732540|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732541|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
153732542|NCT02275702|Hormones|hormones|mesh-ancestor
153732543|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732544|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153850801|NCT00557960|Adderall|adderall|mesh-list
153858053|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
153850802|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153849209|NCT06047834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153389360|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389361|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
153389362|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389363|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153389364|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389365|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389366|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389367|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
153389368|NCT00002235|Efavirenz|efavirenz|mesh-list
153389369|NCT00002235|Nelfinavir|nelfinavir|mesh-list
153389370|NCT00002235|Indinavir|indinavir|mesh-list
153389501|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389502|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389503|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153389504|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153389547|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389548|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
153389549|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389550|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153389551|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389553|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389582|NCT00002271|Alovudine|alovudine|mesh-list
153389583|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
153361375|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153361377|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153361378|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361379|NCT00876200|Minoxidil|minoxidil|mesh-list
153389706|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153389707|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153389708|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389709|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389710|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153389781|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
153389782|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821453|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361403|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153361404|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153361406|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
153398398|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398399|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153398400|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153398401|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
153398402|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398414|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398415|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153361407|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849742|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258791|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154258792|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258793|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258794|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154258795|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
154258796|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
154258797|NCT05643066|Analgesics|analgesics|mesh-ancestor
154258798|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
154258799|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258800|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154258801|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154258802|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154258803|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258804|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258805|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
154258806|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153849743|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
153821469|NCT00475293|Panitumumab|panitumumab|mesh-list
153389957|NCT00002595|Toremifene|toremifene|mesh-list
153389958|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389959|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389960|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153389961|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153389962|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
153389963|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389964|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389978|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
153389979|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
153389980|NCT00002619|Carboplatin|carboplatin|mesh-list
153389982|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391034|NCT04739345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153389983|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
153389984|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389985|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389986|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
153389987|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389988|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390011|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390014|NCT04343729|Hormones|hormones|mesh-ancestor
153390015|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390016|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153390017|NCT04343729|Protective Agents|protective agents|mesh-ancestor
153390018|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390019|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390020|NCT00002631|Fluorouracil|fluorouracil|mesh-list
153390021|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390022|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
153390023|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390024|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153390025|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390026|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
153390027|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390028|NCT00002637|Interferons|interferons|mesh-list
153390029|NCT00002637|Aldesleukin|aldesleukin|mesh-list
153849825|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849889|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153849960|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153849961|NCT02899728|Maleic acid|maleic acid|mesh-list
153849962|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849963|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153849964|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153849965|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153849966|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849967|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849968|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
153849969|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
153849970|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
153849971|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
153849972|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
153398454|NCT04757675|Analgesics|analgesics|mesh-ancestor
153849973|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849974|NCT02780804|Entinostat|entinostat|mesh-list
153849975|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858213|NCT00352534|Cactinomycin|cactinomycin|mesh-list
153390150|NCT05805930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390151|NCT05805930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390152|NCT05805930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390153|NCT05805930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390154|NCT05805930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390155|NCT05805631|Pemetrexed|pemetrexed|mesh-list
153390156|NCT05805631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390157|NCT05805631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390158|NCT05805631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390159|NCT05805631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153390176|NCT05805553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390178|NCT05805553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153390179|NCT05804747|Edoxaban|edoxaban|mesh-list
153390180|NCT05804747|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153390204|NCT05775237|Protective Agents|protective agents|mesh-ancestor
153850000|NCT02500797|Ipilimumab|ipilimumab|mesh-list
153850001|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850002|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850003|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153850004|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850030|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
153850031|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850032|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850033|NCT02017704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850034|NCT02017704|Immunologic Factors|immunologic factors|mesh-ancestor
153850035|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850036|NCT02017704|Antidotes|antidotes|mesh-ancestor
153391076|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153391077|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391078|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153391079|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
153850037|NCT02017704|Protective Agents|protective agents|mesh-ancestor
153390212|NCT05775237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390213|NCT05775237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390215|NCT05751044|Dexamethasone|dexamethasone|mesh-list
153398469|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
153398470|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153398471|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
153398473|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153398474|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153398475|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153390216|NCT05751044|Cyclophosphamide|cyclophosphamide|mesh-list
153390217|NCT05751044|Venetoclax|venetoclax|mesh-list
153390218|NCT05751044|Dasatinib|dasatinib|mesh-list
153390219|NCT05751044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390220|NCT05751044|Immunologic Factors|immunologic factors|mesh-ancestor
153390221|NCT05751044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390222|NCT05751044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390223|NCT05751044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390224|NCT05751044|Alkylating Agents|alkylating agents|mesh-ancestor
153850093|NCT04660916|Isotretinoin|isotretinoin|mesh-list
153850094|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
153850095|NCT00540150|Immunomodulating Agents|immunomodulating agents|mesh-list
153850096|NCT00540150|Immunologic Factors|immunologic factors|mesh-ancestor
153850097|NCT00540150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850098|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
153850099|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153850100|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153850101|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850102|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850103|NCT04660565|Prednisone|prednisone|mesh-list
153850104|NCT04660565|Belimumab|belimumab|mesh-list
153850105|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850106|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
153850107|NCT04660565|Hormones|hormones|mesh-ancestor
153850108|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850109|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850110|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153850111|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850112|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850113|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
153850114|NCT04319341|Autoantibodies|autoantibodies|mesh-list
153850115|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
153823905|NCT00591916|Thrombin|thrombin|mesh-list
153398491|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
153398492|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
153398493|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
153398494|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398495|NCT03763175|Lovastatin|lovastatin|mesh-list
153398496|NCT03763175|L 647318|l 647318|mesh-list
153398534|NCT00372515|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153390344|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
153390345|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153390346|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153390347|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390348|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
153390349|NCT04947514|Coagulants|coagulants|mesh-ancestor
153390350|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
153390351|NCT04860011|Metolazone|metolazone|mesh-list
153390352|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153390353|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390354|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153390355|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390356|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153390357|NCT04860011|Diuretics|diuretics|mesh-ancestor
153390358|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
153390359|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153390360|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153390361|NCT04704050|Dronedarone|dronedarone|mesh-list
153821587|NCT00475800|Analgesics|analgesics|mesh-ancestor
153850208|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153850210|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153850211|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153850212|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153850213|NCT01206517|Asenapine|asenapine|mesh-list
153850214|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153850215|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153850216|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153390395|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
153390396|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390397|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154258807|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
154258808|NCT05627232|Promethazine|promethazine|mesh-list
153398535|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153398536|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398537|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398538|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398539|NCT04448119|Favipiravir|favipiravir|mesh-list
153398540|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
153398541|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398542|NCT03047473|Avelumab|avelumab|mesh-list
153398543|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153398551|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398553|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153398554|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398555|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153398556|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
153398557|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398558|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858296|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
154258809|NCT05627232|Cytarabine|cytarabine|mesh-list
154258810|NCT05627232|Daunorubicin|daunorubicin|mesh-list
154258811|NCT05627232|Palbociclib|palbociclib|mesh-list
154258812|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154258813|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
154258814|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258815|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258816|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
154258817|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258818|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154258819|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
154258820|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258821|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154258822|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154258823|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154258824|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258825|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154258826|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153732574|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732575|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
153732576|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
153732577|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
153732578|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153732579|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732580|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732581|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153732582|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153732583|NCT00162552|Protective Agents|protective agents|mesh-ancestor
153732584|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258827|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154258828|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258829|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
154258830|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
154258831|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
154258832|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258833|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
154258834|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
153823914|NCT00462215|Vaccines|vaccines|mesh-list
154258835|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154258836|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154258837|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
154258838|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
154258839|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258840|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154258841|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
154258842|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
154258843|NCT05592223|Rifampin|rifampin|mesh-list
154258844|NCT05592223|Isoniazid|isoniazid|mesh-list
154258845|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
154258846|NCT05592223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154258847|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
153732593|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732594|NCT04516681|Protective Agents|protective agents|mesh-ancestor
153732595|NCT00141791|Etanercept|etanercept|mesh-list
153390398|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153390399|NCT04578600|Growth Substances|growth substances|mesh-ancestor
153390400|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
153390401|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390402|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153390403|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
153390404|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390405|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390449|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
153390450|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390451|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390452|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850259|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
153850260|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850261|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153850262|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153850263|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153850264|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
153850265|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850266|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850267|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
153390468|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
153390469|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153390470|NCT03927222|Temozolomide|temozolomide|mesh-list
153398605|NCT04332497|Fentanyl|fentanyl|mesh-list
153390471|NCT03927222|Molgramostim|molgramostim|mesh-list
153390472|NCT03927222|Sargramostim|sargramostim|mesh-list
153390473|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
153390474|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258848|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154258849|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154258850|NCT05592223|Leprostatic Agents|leprostatic agents|mesh-ancestor
154258851|NCT05592223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154258852|NCT05592223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258853|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258854|NCT05592223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153732613|NCT00162591|Narcotics|narcotics|mesh-ancestor
153732614|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732615|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732616|NCT00162591|Analgesics|analgesics|mesh-ancestor
153732617|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
153732618|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732619|NCT00505492|Paclitaxel|paclitaxel|mesh-list
153732620|NCT00505492|Cisplatin|cisplatin|mesh-list
153396449|NCT00367445|Insulin|insulin|mesh-list
153850944|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153850945|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850946|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850947|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
153850948|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850949|NCT05476432|Antidotes|antidotes|mesh-ancestor
153850950|NCT05476432|Protective Agents|protective agents|mesh-ancestor
153850951|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
153850952|NCT05476432|Vitamins|vitamins|mesh-ancestor
153850953|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
153850954|NCT01239745|Exemestane|exemestane|mesh-list
153850955|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850956|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153850957|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153850958|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850959|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850964|NCT01239472|Everolimus|everolimus|mesh-list
153390475|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390476|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
153390477|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390478|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390479|NCT03822663|Caffeine|caffeine|mesh-list
153390480|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153390481|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390482|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153390494|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850966|NCT01239472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153850967|NCT01239472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850968|NCT01239472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850969|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850970|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
153850971|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850972|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850973|NCT00544284|Temozolomide|temozolomide|mesh-list
153850974|NCT00544284|Bortezomib|bortezomib|mesh-list
153850975|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153391202|NCT00002793|Leucovorin|leucovorin|mesh-list
153390495|NCT03767933|Analgesics|analgesics|mesh-ancestor
153390496|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
153390497|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390498|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390499|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
153732476|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732477|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153732478|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
153732479|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732480|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732481|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153732482|NCT00505336|Diuretics|diuretics|mesh-ancestor
153732483|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
153732484|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153732485|NCT04518202|Lidocaine|lidocaine|mesh-list
153850309|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850310|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
153850311|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850312|NCT00541008|Sunitinib|sunitinib|mesh-list
153850313|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850314|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153850315|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153850316|NCT00541008|Growth Substances|growth substances|mesh-ancestor
153850328|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153850329|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153850330|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850331|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153850332|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
153850333|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850334|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850335|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390551|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390552|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390573|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390574|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390579|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
153390580|NCT02975492|Vitamins|vitamins|mesh-list
153390581|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
153390582|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390583|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153850398|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850400|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
153850401|NCT00541281|Hormones|hormones|mesh-ancestor
153850402|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850403|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850404|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153850405|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153850406|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
153395911|NCT00553501|Rituximab|rituximab|mesh-list
153850407|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
153390588|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390589|NCT02821832|Rifampin|rifampin|mesh-list
153390590|NCT02821832|Isoniazid|isoniazid|mesh-list
153390591|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
153390592|NCT02821832|Ethambutol|ethambutol|mesh-list
153390593|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153390594|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
153390595|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390596|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390597|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
153390598|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153850441|NCT04656665|Analgesics|analgesics|mesh-ancestor
153850442|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
153850443|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850444|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850445|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850446|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390646|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153390647|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
153390649|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390650|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390651|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390652|NCT01370811|Mandelic Acids|mandelic acids|mesh-list
153390653|NCT01370811|Clonidine|clonidine|mesh-list
153390654|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153390674|NCT01370811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153390675|NCT01370811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390677|NCT01323569|Dronabinol|dronabinol|mesh-list
153390678|NCT01323569|Analgesics|analgesics|mesh-ancestor
153390679|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
153390680|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390681|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390682|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
153390683|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153398663|NCT00373451|Heparin|heparin|mesh-list
153390684|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153390685|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153390686|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153390687|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390688|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390689|NCT01323569|Hormones|hormones|mesh-ancestor
153390691|NCT01323465|Rifampin|rifampin|mesh-list
153390692|NCT01323465|Ketoconazole|ketoconazole|mesh-list
153850486|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153850487|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153850488|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850489|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850490|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
153850491|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
153850492|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850493|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850494|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153850495|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153850496|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
153850497|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153850498|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153821700|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821701|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821702|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
153821703|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821704|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153821705|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153821706|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153821707|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153821708|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153821709|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153361664|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153361665|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
153361666|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153361667|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361668|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153361669|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153850560|NCT00542295|Alverine|alverine|mesh-list
153850561|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
153850562|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
153391279|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
153391280|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391281|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391282|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
153850563|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850564|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850565|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
153850566|NCT03454841|Ticagrelor|ticagrelor|mesh-list
153850567|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153850568|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153850569|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153361678|NCT01395329|Nitroprusside|nitroprusside|mesh-list
153390777|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850582|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850583|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850584|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850585|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850586|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153850587|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850597|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153850598|NCT00542412|Protective Agents|protective agents|mesh-ancestor
153850599|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
153850600|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153850601|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153850602|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850604|NCT04653623|Coagulants|coagulants|mesh-ancestor
153850605|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
153850606|NCT00542568|Hematinics|hematinics|mesh-ancestor
153850607|NCT04653779|Metformin|metformin|mesh-list
153850608|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153821727|NCT00439751|Goserelin|goserelin|mesh-list
153390872|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390873|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390874|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153390875|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
153390878|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390879|NCT02249299|Nabiximols|nabiximols|mesh-list
153390880|NCT02249299|Analgesics|analgesics|mesh-ancestor
153390922|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
153390923|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390924|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
153390925|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390926|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461739|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
153850713|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850714|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
153850715|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850716|NCT04651556|Acetaminophen|acetaminophen|mesh-list
153850718|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
153850719|NCT04651556|Bupivacaine|bupivacaine|mesh-list
153850720|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
153850721|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
153821757|NCT00440024|Tazarotene|tazarotene|mesh-list
153391010|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391012|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391013|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
153391014|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391015|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391016|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
153391017|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391018|NCT00002721|Doxorubicin|doxorubicin|mesh-list
153391019|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153391020|NCT00002721|Estramustine|estramustine|mesh-list
153391021|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153391022|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391023|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153391024|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153391025|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391026|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850811|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
153850812|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
153850813|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850814|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
154258855|NCT05592223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153850827|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153850828|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153850829|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153732545|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732546|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
153732547|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153732548|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153732549|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732550|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
153732551|NCT04518163|Coagulants|coagulants|mesh-ancestor
153732552|NCT04517227|Durvalumab|durvalumab|mesh-list
153732553|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850839|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153850840|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153850841|NCT00543504|Growth Substances|growth substances|mesh-ancestor
153850842|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850843|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
153850844|NCT00543504|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153391027|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153391028|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
153391029|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153391030|NCT04739345|Pentoxifylline|pentoxifylline|mesh-list
153391031|NCT04739345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153391032|NCT04739345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391033|NCT04739345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391035|NCT04739345|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153391036|NCT04739345|Protective Agents|protective agents|mesh-ancestor
153391037|NCT04739345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391038|NCT04739345|Vasodilator Agents|vasodilator agents|mesh-ancestor
153391039|NCT04739345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153391040|NCT04739345|Antioxidants|antioxidants|mesh-ancestor
153391042|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
153391043|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
153398795|NCT00372827|Travoprost|travoprost|mesh-list
153391044|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850853|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153850854|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
153850855|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153850857|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850858|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850859|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153850860|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
153850861|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
153850862|NCT00543933|Protective Agents|protective agents|mesh-ancestor
153850863|NCT00544011|Bevacizumab|bevacizumab|mesh-list
153850864|NCT00544011|Capecitabine|capecitabine|mesh-list
153850865|NCT00544011|Fluorouracil|fluorouracil|mesh-list
153850866|NCT00544011|Irinotecan|irinotecan|mesh-list
153850867|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850868|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850869|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153850870|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153850871|NCT00544011|Growth Substances|growth substances|mesh-ancestor
153850872|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850873|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
153850874|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153850875|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
153850876|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850879|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153850880|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153850893|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850894|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153850895|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153850896|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153850897|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153850898|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153850899|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153850901|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153850902|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153850903|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850904|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258856|NCT05592223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154005798|NCT04038073|Antibodies|antibodies|mesh-list
154258857|NCT05592223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154258858|NCT05592223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154258859|NCT05592223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154258860|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154258861|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154258862|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
154258863|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154258864|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154258865|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
154258866|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258867|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153850905|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732610|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732611|NCT00162591|Remifentanil|remifentanil|mesh-list
153732612|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153850934|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850935|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153850936|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153850937|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153850938|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153850939|NCT05476432|Leucovorin|leucovorin|mesh-list
153850940|NCT05476432|Fluorouracil|fluorouracil|mesh-list
153850941|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
153850942|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
153850943|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391128|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153391129|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153391130|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153391131|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391132|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153391134|NCT00002757|Hormones|hormones|mesh-ancestor
153391135|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391136|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153391137|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153391138|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
153391139|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153850977|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850978|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850979|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
153850980|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153850981|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850982|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391197|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153391198|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153391199|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
153391200|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391201|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153391203|NCT00002793|Fluorouracil|fluorouracil|mesh-list
153391204|NCT00002793|Calcium|calcium|mesh-list
153391205|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
153391206|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153391207|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391208|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
153391209|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361816|NCT00886262|Vasopressins|vasopressins|mesh-list
153361817|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
153851040|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258868|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154258869|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
154258870|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
154258871|NCT05588102|Citalopram|citalopram|mesh-list
154258872|NCT05588102|Fluoxetine|fluoxetine|mesh-list
154258873|NCT05588102|Paroxetine|paroxetine|mesh-list
154258874|NCT05588102|Sertraline|sertraline|mesh-list
154258875|NCT05588102|Escitalopram|escitalopram|mesh-list
154258876|NCT05588102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154258877|NCT05588102|Serotonin|serotonin|mesh-list
154258878|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154258879|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154258880|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258881|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258882|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
154258883|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258884|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153364062|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154258885|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
154258886|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154258887|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154258888|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154258889|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154258890|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153732634|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
153732635|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732636|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732637|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
153732638|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732639|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153732640|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732641|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
153732642|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732643|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153732644|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
153732645|NCT04516174|Ropivacaine|ropivacaine|mesh-list
153732646|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153851076|NCT06022237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851077|NCT06022237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153732656|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
154258891|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154258892|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258893|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154258894|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154258895|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154258896|NCT05582811|Riociguat|riociguat|mesh-list
154258897|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
154258898|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258899|NCT05554627|Aripiprazole|aripiprazole|mesh-list
154258900|NCT05554627|Esketamine|esketamine|mesh-list
154258901|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
154258902|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154258903|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154258904|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154258905|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258906|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732657|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851208|NCT05975580|Anticonvulsants|anticonvulsants|mesh-ancestor
153851209|NCT05975580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153851210|NCT05975580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851211|NCT05975580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153851212|NCT05975580|Appetite Depressants|appetite depressants|mesh-ancestor
153851078|NCT06022237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153851080|NCT06022198|Chelating Agents|chelating agents|mesh-ancestor
153391272|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391273|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
153391274|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391275|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391276|NCT04248179|Sufentanil|sufentanil|mesh-list
153391277|NCT04248179|Ropivacaine|ropivacaine|mesh-list
153391278|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391283|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391284|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153391285|NCT04248179|Narcotics|narcotics|mesh-ancestor
153391286|NCT04248179|Analgesics|analgesics|mesh-ancestor
153391287|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153391288|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153391289|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
153391290|NCT00361517|Amphotericin B|amphotericin b|mesh-list
153391291|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153391292|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
153391293|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
153391294|NCT00361517|Amebicides|amebicides|mesh-ancestor
153391295|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153361839|NCT01397591|Bortezomib|bortezomib|mesh-list
153851104|NCT06021756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851105|NCT06021756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153851106|NCT06021756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153851107|NCT06021756|Anesthetics, General|anesthetics, general|mesh-ancestor
153851108|NCT06021756|Anesthetics|anesthetics|mesh-ancestor
154258907|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
153851109|NCT06021756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391303|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153391304|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391305|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391306|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153391308|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
153391309|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391310|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153391311|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153391312|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153851127|NCT06021717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851128|NCT06021717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851129|NCT06021717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153851131|NCT06021587|Simendan|simendan|mesh-list
153851132|NCT06021587|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153851133|NCT06021587|Vasodilator Agents|vasodilator agents|mesh-ancestor
153851134|NCT06021587|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153851135|NCT06021587|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153851136|NCT06021587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851137|NCT06021587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851138|NCT06021587|Protective Agents|protective agents|mesh-ancestor
153851139|NCT06021587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851140|NCT06021522|Ecopipam|ecopipam|mesh-list
153851141|NCT06021522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153851142|NCT06021522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153851143|NCT06021522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851144|NCT06021522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391369|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153391375|NCT04004845|Misoprostol|misoprostol|mesh-list
153391376|NCT04004845|Oxytocin|oxytocin|mesh-list
153851158|NCT06021119|Protease Inhibitors|protease inhibitors|mesh-ancestor
153851159|NCT06021119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732622|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153732623|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732624|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
153732625|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
153732626|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
153732627|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851202|NCT05989217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821903|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153821904|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153391406|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391407|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153391408|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391409|NCT01640197|Resveratrol|resveratrol|mesh-list
153391410|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
153391411|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391412|NCT01640197|Protective Agents|protective agents|mesh-ancestor
153391413|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391414|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391415|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153851213|NCT05975580|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153851214|NCT05975580|Sympathomimetics|sympathomimetics|mesh-ancestor
153851215|NCT05975580|Autonomic Agents|autonomic agents|mesh-ancestor
153851216|NCT05975580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851217|NCT05975580|Adrenergic Agents|adrenergic agents|mesh-ancestor
153851218|NCT05975580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851219|NCT05975580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851220|NCT05963347|Prednisone|prednisone|mesh-list
153851221|NCT05963347|Cyclophosphamide|cyclophosphamide|mesh-list
153851222|NCT05963347|Doxorubicin|doxorubicin|mesh-list
153851223|NCT05963347|Vincristine|vincristine|mesh-list
153851224|NCT05963347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858714|NCT01782729|Tacrolimus|tacrolimus|mesh-list
153851225|NCT05963347|Immunologic Factors|immunologic factors|mesh-ancestor
153391419|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258908|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
154258909|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154258910|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258911|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154258912|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154258913|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
154258914|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153732658|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732659|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
153732660|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
153732661|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
153732662|NCT04515979|Vactosertib|vactosertib|mesh-list
153732663|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153732664|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851280|NCT05746065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851281|NCT05746065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153851282|NCT05746065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153851283|NCT05708989|Dexmedetomidine|dexmedetomidine|mesh-list
153851284|NCT05708989|Ropivacaine|ropivacaine|mesh-list
153851285|NCT05708989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153851286|NCT05708989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851287|NCT05708989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851288|NCT05708989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153851289|NCT05708989|Analgesics|analgesics|mesh-ancestor
153851290|NCT05708989|Sensory System Agents|sensory system agents|mesh-ancestor
153851291|NCT05708989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851292|NCT05708989|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153851293|NCT05708989|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153851294|NCT05708989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153851295|NCT05708989|Adrenergic Agents|adrenergic agents|mesh-ancestor
153851296|NCT05708989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391420|NCT04185311|Nivolumab|nivolumab|mesh-list
153391421|NCT04185311|Ipilimumab|ipilimumab|mesh-list
153391422|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153391423|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153391424|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391425|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153391426|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391427|NCT05513937|Amlodipine|amlodipine|mesh-list
153391428|NCT05513937|Nebivolol|nebivolol|mesh-list
153391429|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153851249|NCT05847517|Metoprolol|metoprolol|mesh-list
153851250|NCT05847517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153851307|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153851308|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153851309|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153851310|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851312|NCT05657496|Hormones|hormones|mesh-ancestor
153851313|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851315|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851316|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
153851317|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851251|NCT05847517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153851252|NCT05847517|Sympatholytics|sympatholytics|mesh-ancestor
153851253|NCT05847517|Autonomic Agents|autonomic agents|mesh-ancestor
153851254|NCT05847517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851255|NCT05847517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851256|NCT05847517|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153851257|NCT05847517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153391474|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391476|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153391477|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391478|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153391479|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391480|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391481|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153391482|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
153391483|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
153391484|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391485|NCT03002935|Vitamins|vitamins|mesh-ancestor
153391486|NCT03788291|Rituximab|rituximab|mesh-list
153391487|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
153391500|NCT03251924|Nivolumab|nivolumab|mesh-list
153851265|NCT05797623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851266|NCT05797623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851267|NCT05797623|Immunologic Factors|immunologic factors|mesh-ancestor
153851268|NCT05797623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851269|NCT05797623|Antifungal Agents|antifungal agents|mesh-ancestor
153851270|NCT05797623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851271|NCT05797623|Dermatologic Agents|dermatologic agents|mesh-ancestor
153851272|NCT05797623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851273|NCT05797623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153851274|NCT05746065|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153391522|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153391524|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
153851318|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851319|NCT05609929|Omeprazole|omeprazole|mesh-list
153851320|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153851321|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851322|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153851323|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851324|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851325|NCT05607407|Methimazole|methimazole|mesh-list
153851326|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
153851327|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
153851328|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851329|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391525|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153391526|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153391528|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
153391529|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364161|NCT03007121|Analgesics|analgesics|mesh-ancestor
153391530|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391531|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
153391532|NCT02975921|Povidone|povidone|mesh-list
153851338|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
153851339|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851340|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851341|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851342|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
153851343|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
153851344|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153851347|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153851348|NCT05585229|Psilocybin|psilocybin|mesh-list
153851349|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
153851350|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851352|NCT05579730|Ketotifen|ketotifen|mesh-list
153391533|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
153391534|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
153391535|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153391536|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391537|NCT05452785|Minocycline|minocycline|mesh-list
153391538|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153391539|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391540|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
153851359|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153851360|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
153391557|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391558|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391559|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
153391560|NCT02219581|Hormones|hormones|mesh-ancestor
153391561|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391562|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153391563|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391564|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
153391565|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391566|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391567|NCT01912274|Azacitidine|azacitidine|mesh-list
153391568|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153732665|NCT04515979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153732666|NCT04515979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732667|NCT04515979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153732669|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
153732670|NCT00505531|Tramadol|tramadol|mesh-list
153851369|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153851370|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
153851371|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153851372|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153851386|NCT05473715|Aflibercept|aflibercept|mesh-list
153851387|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153851388|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153851389|NCT05473715|Growth Substances|growth substances|mesh-ancestor
153391588|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391589|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391590|NCT05184777|Progestins|progestins|mesh-ancestor
153391591|NCT01912352|Methylphenidate|methylphenidate|mesh-list
153391592|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153391593|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391594|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153851403|NCT05320380|Cytarabine|cytarabine|mesh-list
153361945|NCT05946135|Dexlansoprazole|dexlansoprazole|mesh-list
153361947|NCT05946135|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153391645|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391647|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153391648|NCT02987348|Exenatide|exenatide|mesh-list
153391649|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
153391681|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153391682|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153391683|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153391684|NCT01658995|Doxycycline|doxycycline|mesh-list
153391685|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153391686|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391687|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
153391688|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153391689|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153391690|NCT01350141|Bococizumab|bococizumab|mesh-list
153391691|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153391692|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153391693|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
153851470|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851471|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
153851472|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851473|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851474|NCT05005442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153851475|NCT05005442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851476|NCT04953910|Decitabine|decitabine|mesh-list
153851477|NCT04953910|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153851478|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851479|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
153391766|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153391767|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391768|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153391770|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851549|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851550|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391788|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391789|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153391790|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
153391791|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153851672|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732689|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732691|NCT00141908|Castor Oil|castor oil|mesh-list
153851737|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391969|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
153391970|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399185|NCT01960387|Cytarabine|cytarabine|mesh-list
153822125|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851425|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
153851426|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851427|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851428|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
153391986|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153391987|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153391989|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
153391990|NCT01610011|Glycine|glycine|mesh-list
153391991|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
153391992|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391993|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391994|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391995|NCT00000399|Hormones|hormones|mesh-list
153364199|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153364200|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153391996|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391997|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391998|NCT02237989|Acetaminophen|acetaminophen|mesh-list
153391999|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153392000|NCT02237989|Analgesics|analgesics|mesh-ancestor
153392001|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
153392002|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392003|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392004|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
153392005|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
153392006|NCT00000429|Calcium|calcium|mesh-list
153392007|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392018|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392019|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362134|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153362135|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822170|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153822171|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
153851856|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
153851873|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822199|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822200|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392093|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
153392094|NCT01675297|Vitamin D|vitamin d|mesh-list
153392095|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
153392096|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
153392097|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392098|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392099|NCT01675297|Vitamins|vitamins|mesh-ancestor
153392100|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
153392101|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153392102|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153392103|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392104|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392105|NCT05295537|Liver Extracts|liver extracts|mesh-list
153851893|NCT02201108|Teriflunomide|teriflunomide|mesh-list
153851894|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153851895|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153851896|NCT02201108|Analgesics|analgesics|mesh-ancestor
153851897|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
153851898|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851899|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851900|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851901|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851902|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851903|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
153851904|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153851905|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392205|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392206|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153392207|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153392208|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392220|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392221|NCT00000513|Atenolol|atenolol|mesh-list
153392222|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
153392223|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153392224|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153392225|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
153392226|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
153362242|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153362243|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362244|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392317|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153392318|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
153392319|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392330|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
153392331|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824222|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153858922|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858923|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858925|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153858930|NCT00533312|Niacin|niacin|mesh-list
153392332|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153392333|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392334|NCT01621477|Cytarabine|cytarabine|mesh-list
153852103|NCT01237678|Immunotoxins|immunotoxins|mesh-ancestor
153852104|NCT01237678|Immunoconjugates|immunoconjugates|mesh-ancestor
153852105|NCT01237678|Immunologic Factors|immunologic factors|mesh-ancestor
153852106|NCT01237678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852107|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154258932|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154258933|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258934|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154258935|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154258937|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154258938|NCT05417100|Narcotics|narcotics|mesh-ancestor
154258939|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364220|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153364221|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
153364222|NCT03001349|Octreotide|octreotide|mesh-list
153364223|NCT03001349|Edotreotide|edotreotide|mesh-list
153364224|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364225|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364226|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154258940|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258941|NCT05417100|Analgesics|analgesics|mesh-ancestor
153852108|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153852109|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153852110|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153852111|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153852122|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153852123|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153852124|NCT02908152|Analgesics|analgesics|mesh-ancestor
153852125|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
153852126|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852127|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852128|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852129|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153852130|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852131|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852132|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852133|NCT01237327|Exemestane|exemestane|mesh-list
153392337|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
153392338|NCT01621477|Busulfan|busulfan|mesh-list
153392339|NCT01621477|Clofarabine|clofarabine|mesh-list
153392340|NCT01621477|Tacrolimus|tacrolimus|mesh-list
153852139|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852140|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852141|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153852142|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
153852153|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
153852154|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153852155|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153852156|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153852157|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
153852158|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399245|NCT00374621|Isosorbide|isosorbide|mesh-list
153392363|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153392364|NCT00000627|Fluconazole|fluconazole|mesh-list
153392365|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
153392366|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392367|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153392368|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153392369|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392370|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822322|NCT00443339|Hematinics|hematinics|mesh-ancestor
153852163|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852164|NCT04647695|Interferons|interferons|mesh-list
153852165|NCT04647695|Interferon-beta|interferon-beta|mesh-list
153852166|NCT04647695|Remdesivir|remdesivir|mesh-list
153852167|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
153852168|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852169|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
153852170|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852171|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
153852172|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852173|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
153852174|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852175|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153852176|NCT04647344|Paclitaxel|paclitaxel|mesh-list
153732759|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154258942|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
154258943|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258944|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
154258945|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
154258950|NCT05369819|Midazolam|midazolam|mesh-list
154258951|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154258952|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154258953|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154258954|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258955|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153732675|NCT00505531|Analgesics|analgesics|mesh-ancestor
153732676|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
153732677|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391729|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391730|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153391731|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153391732|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
153391734|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391735|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
153391736|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391738|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
153732760|NCT02275897|Methamphetamine|methamphetamine|mesh-list
153732761|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153732762|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732763|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
153732764|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
153732765|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732766|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
153397408|NCT04537793|Ivacaftor|ivacaftor|mesh-list
153852177|NCT04647344|Carboplatin|carboplatin|mesh-list
153852178|NCT04647344|Pemetrexed|pemetrexed|mesh-list
153852179|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153399285|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852180|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852181|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
153392384|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153392385|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392386|NCT00000657|Zidovudine|zidovudine|mesh-list
153392387|NCT00000657|Didanosine|didanosine|mesh-list
153392388|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
153392389|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392390|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153392391|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153392392|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392589|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
153392592|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
153392593|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392594|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
153392595|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392596|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392597|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154258956|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154258957|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154258958|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154258959|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
154258960|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
154258961|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
154258962|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
154258963|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732678|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153732679|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153732680|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
153732681|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
153732682|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
153732683|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
153732684|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732685|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153391751|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391752|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391753|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153391754|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153391755|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391756|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
153391757|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391758|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391760|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
153391761|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153391762|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
153391763|NCT01940276|Hormones|hormones|mesh-ancestor
153391769|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392598|NCT04699383|Allopurinol|allopurinol|mesh-list
153392599|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
153392600|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392601|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392602|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
153392603|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392604|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153392605|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
153392606|NCT04699383|Protective Agents|protective agents|mesh-ancestor
153392607|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392608|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153852389|NCT06236230|Levodopa|levodopa|mesh-list
153852390|NCT06236230|Carbidopa|carbidopa|mesh-list
153852391|NCT06236230|Entacapone|entacapone|mesh-list
153852392|NCT06236230|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153852393|NCT06236230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153852394|NCT06236230|Dopamine Agents|dopamine agents|mesh-ancestor
153852395|NCT06236230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852396|NCT06236230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851568|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153851569|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851570|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153851571|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
153391772|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153391774|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153391775|NCT00000327|Narcotics|narcotics|mesh-ancestor
153391776|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391777|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391778|NCT00000327|Analgesics|analgesics|mesh-ancestor
153391779|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
153391780|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391781|NCT01919216|Citalopram|citalopram|mesh-list
153391782|NCT01919216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153852397|NCT06236230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852398|NCT06236230|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153852399|NCT06236230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852400|NCT06236230|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153852401|NCT06236191|Melatonin|melatonin|mesh-list
153852402|NCT06236191|Antioxidants|antioxidants|mesh-ancestor
153852403|NCT06236191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852404|NCT06236191|Protective Agents|protective agents|mesh-ancestor
153392610|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392611|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
153392612|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153362379|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362380|NCT03401450|Bupivacaine|bupivacaine|mesh-list
153362381|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
153362382|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
153362383|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362384|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362385|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
153852439|NCT06236126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153852440|NCT06236126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153852441|NCT06236126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153852442|NCT06236126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852443|NCT06236126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852444|NCT06236074|Anesthetics|anesthetics|mesh-list
153852445|NCT06236074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852446|NCT06236074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852447|NCT06236061|Amlodipine|amlodipine|mesh-list
153852448|NCT06236061|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153392675|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
153392676|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392677|NCT04675983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153392678|NCT04675983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153392679|NCT04675983|Growth Substances|growth substances|mesh-ancestor
153392680|NCT04675983|Growth Inhibitors|growth inhibitors|mesh-ancestor
153392681|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
153852450|NCT06236061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153852507|NCT06235567|Antiemetics|antiemetics|mesh-ancestor
153852508|NCT06235567|Autonomic Agents|autonomic agents|mesh-ancestor
153852509|NCT06235567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852510|NCT06235567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153852511|NCT06235567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153852512|NCT06235567|Protective Agents|protective agents|mesh-ancestor
154258964|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258965|NCT05358587|Anesthetics|anesthetics|mesh-list
154258966|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
154258967|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154258968|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852513|NCT06235567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153852514|NCT06235320|Acetaminophen|acetaminophen|mesh-list
153852515|NCT06235320|Ibuprofen|ibuprofen|mesh-list
153852516|NCT06235320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153852517|NCT06235320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153392728|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153392729|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153392730|NCT01706263|Analgesics|analgesics|mesh-ancestor
153392731|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
153392732|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392751|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392752|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392753|NCT04342247|Androgens|androgens|mesh-ancestor
153392754|NCT05738642|Thrombin|thrombin|mesh-list
153392755|NCT05738642|Hemostatics|hemostatics|mesh-ancestor
153392756|NCT05738642|Coagulants|coagulants|mesh-ancestor
153392757|NCT01690663|Dexamethasone|dexamethasone|mesh-list
153392758|NCT01690663|Bupivacaine|bupivacaine|mesh-list
153914613|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392759|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392760|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
153392761|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
153392762|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392763|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392764|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153392765|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
153392766|NCT01690663|Hormones|hormones|mesh-ancestor
153392767|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392772|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392773|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
153392775|NCT05738564|Epinephrine|epinephrine|mesh-list
153392830|NCT01352117|Etoposide|etoposide|mesh-list
153392831|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153392832|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392833|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153392834|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153392835|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392836|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392837|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
153392838|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392839|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153392840|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153392841|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153852598|NCT06189833|Lenalidomide|lenalidomide|mesh-list
153852599|NCT06189833|Bortezomib|bortezomib|mesh-list
153852600|NCT06189833|Daratumumab|daratumumab|mesh-list
153852601|NCT06189833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852602|NCT06189833|Antiemetics|antiemetics|mesh-ancestor
153852603|NCT06189833|Autonomic Agents|autonomic agents|mesh-ancestor
153852604|NCT06189833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852605|NCT06189833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399341|NCT01965002|Enoxaparin|enoxaparin|mesh-list
153852606|NCT06189833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153852607|NCT06189833|Glucocorticoids|glucocorticoids|mesh-ancestor
153852608|NCT06189833|Hormones|hormones|mesh-ancestor
153852609|NCT06189833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852610|NCT06189833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153852611|NCT06189833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852612|NCT06189833|Immunologic Factors|immunologic factors|mesh-ancestor
153852613|NCT06189833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153852614|NCT06189833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153852617|NCT06164743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153852618|NCT06164743|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153852619|NCT06158152|Immunoferon|immunoferon|mesh-list
153852620|NCT06158152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153852621|NCT06158152|Immunologic Factors|immunologic factors|mesh-ancestor
154258969|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396988|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
153852622|NCT06158152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852623|NCT06151652|Thioctic Acid|thioctic acid|mesh-list
153852624|NCT06151652|Antioxidants|antioxidants|mesh-ancestor
153392866|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153392867|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852630|NCT06151652|Micronutrients|micronutrients|mesh-ancestor
153392926|NCT04595565|Immunologic Factors|immunologic factors|mesh-ancestor
153392927|NCT04595565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392928|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153392929|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
153392930|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153392931|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153362483|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
153822492|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
153822493|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822494|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822495|NCT00441246|Expectorants|expectorants|mesh-ancestor
153822496|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153822497|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153822498|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
153822499|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153822500|NCT00478959|Lenalidomide|lenalidomide|mesh-list
153822501|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
153822502|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822503|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153393037|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393038|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153393051|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393053|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393054|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
153393055|NCT04965116|Progestins|progestins|mesh-list
153393056|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153393057|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393058|NCT04965116|Hormones|hormones|mesh-ancestor
153393059|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393060|NCT02259517|Guanfacine|guanfacine|mesh-list
153852821|NCT05888922|Vasodilator Agents|vasodilator agents|mesh-ancestor
153852822|NCT05872425|Drospirenone|drospirenone|mesh-list
153852823|NCT05872425|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153852824|NCT05872425|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153393078|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393079|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393080|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153393081|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
153393082|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153393083|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
153393084|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393085|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393086|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153393087|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
153393088|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
153393089|NCT04358588|Protective Agents|protective agents|mesh-ancestor
153822560|NCT00479193|Bacitracin|bacitracin|mesh-list
153852889|NCT05689372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153852890|NCT05689372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852891|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
153852892|NCT05688215|Leucovorin|leucovorin|mesh-list
153852893|NCT05688215|Folic Acid|folic acid|mesh-list
153852894|NCT05688215|Fluorouracil|fluorouracil|mesh-list
153852895|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
153852896|NCT05688215|Irinotecan|irinotecan|mesh-list
153852897|NCT05688215|Quemliclustat|quemliclustat|mesh-list
153852898|NCT05688215|Calcium|calcium|mesh-list
153393133|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393134|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393135|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393136|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393137|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
153393138|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153393139|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
153393140|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393141|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393142|NCT01710787|Phenylephrine|phenylephrine|mesh-list
154258970|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
154258971|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154258973|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154258974|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
154258975|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258976|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154258977|NCT05342597|Protective Agents|protective agents|mesh-ancestor
154258978|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258979|NCT05315947|Brivaracetam|brivaracetam|mesh-list
153732687|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
153732688|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393143|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
153393144|NCT01710787|Tetracaine|tetracaine|mesh-list
153393145|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
153393146|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
153393147|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153393148|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852948|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
153852949|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852950|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
153852951|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824314|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153852952|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852965|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852966|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393178|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
153393179|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393180|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393181|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
153393182|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393183|NCT01715233|Antidotes|antidotes|mesh-ancestor
153393184|NCT01715233|Protective Agents|protective agents|mesh-ancestor
153393185|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
153393187|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
153393188|NCT04865744|Semaglutide|semaglutide|mesh-list
153393189|NCT04865744|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153393190|NCT04865744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153393191|NCT04865744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393192|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
153393193|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153393232|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
153393233|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393234|NCT02250703|Midazolam|midazolam|mesh-list
153393235|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
153393236|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153393237|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153853020|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153853022|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
153853023|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153733047|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153733048|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853024|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153853026|NCT05468892|Panitumumab|panitumumab|mesh-list
153393238|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393239|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153393240|NCT02250703|Analgesics|analgesics|mesh-ancestor
153393241|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
153362624|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
153362625|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
153362626|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362627|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
153393288|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154258981|NCT05273827|Paclitaxel|paclitaxel|mesh-list
154258982|NCT05273827|Pemetrexed|pemetrexed|mesh-list
154258983|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154258984|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154258985|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
154258986|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
154258987|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393294|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153393295|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393297|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
153393299|NCT01722487|Ibrutinib|ibrutinib|mesh-list
153393300|NCT01722487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153393301|NCT01722487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153393302|NCT01722487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393303|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393304|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153393305|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
153393306|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393307|NCT02730962|Vancomycin|vancomycin|mesh-list
153393308|NCT02730962|Clindamycin|clindamycin|mesh-list
153393310|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
153393312|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153853092|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853093|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153853094|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853095|NCT05333289|Vaccines|vaccines|mesh-list
153853096|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
153853097|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853098|NCT05323396|Metronidazole|metronidazole|mesh-list
153853099|NCT05323396|Albendazole|albendazole|mesh-list
153853100|NCT05323396|Praziquantel|praziquantel|mesh-list
153393313|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153393314|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153393315|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393316|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393317|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153393318|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153393319|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
153393320|NCT02296346|Prednisolone|prednisolone|mesh-list
153393321|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
153393322|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153393323|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
153393324|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153393325|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
153393327|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393328|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393329|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153853129|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853131|NCT05266937|Carboplatin|carboplatin|mesh-list
153393344|NCT02501330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393345|NCT02372630|Linagliptin|linagliptin|mesh-list
153393346|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153853148|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853149|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
153853150|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853151|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853152|NCT05174065|Apremilast|apremilast|mesh-list
153853153|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153853154|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153853155|NCT05174065|Analgesics|analgesics|mesh-ancestor
153853156|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
153853157|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393416|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853198|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
153853199|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853200|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258991|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154258992|NCT05223647|Carboplatin|carboplatin|mesh-list
154258993|NCT05223647|Etoposide|etoposide|mesh-list
153853201|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153853202|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
153853203|NCT05000658|Hormones|hormones|mesh-ancestor
153853204|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153853205|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153393421|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153393422|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153393423|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
153393424|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393425|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153393426|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153393427|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393428|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
153393429|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153393430|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393431|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393432|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153393442|NCT02975141|Afatinib|afatinib|mesh-list
153393443|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393444|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393445|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393446|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393447|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393448|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393449|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393450|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
153393451|NCT02975141|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153393452|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153393453|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393454|NCT04341935|Linagliptin|linagliptin|mesh-list
153393455|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153393490|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
153393491|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853287|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853288|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153853289|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
153393511|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153393524|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153393525|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
153393526|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153393527|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393528|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393529|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
153853290|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153853291|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153853292|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853293|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153853294|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
153853295|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153853296|NCT04789837|Protective Agents|protective agents|mesh-ancestor
153853297|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153853298|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153853299|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853300|NCT04772196|Vitamin D|vitamin d|mesh-list
153822773|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853377|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
153853378|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393622|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
153393623|NCT05315557|Coagulants|coagulants|mesh-ancestor
153393624|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153393625|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153393626|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
153393627|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853404|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
153853405|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153393668|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
153393683|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
153393684|NCT00002967|Doxorubicin|doxorubicin|mesh-list
153393692|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
153393693|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393694|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393695|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153393696|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153853438|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
153853439|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853440|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
153853441|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853442|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853443|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853444|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853445|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
153853446|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153853447|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853448|NCT04433741|Oxytocin|oxytocin|mesh-list
153853449|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
153853450|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153853451|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853452|NCT04410341|Vildagliptin|vildagliptin|mesh-list
153853470|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393715|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
153393716|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393717|NCT00002985|Doxorubicin|doxorubicin|mesh-list
153393718|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153393719|NCT00002985|Daunorubicin|daunorubicin|mesh-list
153393720|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153393721|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393722|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393723|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393724|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393725|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393726|NCT00363389|Misoprostol|misoprostol|mesh-list
153393727|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153853515|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
153853516|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153853517|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853518|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
153853519|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
153853521|NCT04196530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853522|NCT04196530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853523|NCT04196530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853542|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153393767|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153393768|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393769|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153393770|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393772|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153393773|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393774|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153393775|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
154258996|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154258997|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154258998|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153859302|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154258999|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259000|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259001|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259002|NCT05198843|Dasatinib|dasatinib|mesh-list
154259003|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154259004|NCT05198843|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154259005|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153732703|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153393776|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393778|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393779|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
153393780|NCT00003039|Growth Substances|growth substances|mesh-ancestor
153853569|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153853570|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153853571|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
153853572|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853573|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853574|NCT03959176|Protective Agents|protective agents|mesh-ancestor
153853575|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153853576|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153853577|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153853578|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153853579|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
153853580|NCT03891953|Spartalizumab|spartalizumab|mesh-list
153853581|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153393828|NCT02348385|Amphetamine|amphetamine|mesh-list
153393829|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
153393830|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153393831|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393832|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
153393833|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
153393834|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393835|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
153393836|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393837|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393838|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
153393839|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153393840|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153393841|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153393842|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153393843|NCT00003087|Paclitaxel|paclitaxel|mesh-list
153393844|NCT00003087|Cisplatin|cisplatin|mesh-list
153393845|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393846|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853599|NCT03798626|Ramucirumab|ramucirumab|mesh-list
153853616|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
153853617|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153853618|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853619|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853620|NCT03798626|Antidotes|antidotes|mesh-ancestor
153853643|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853644|NCT03486301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153393883|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154259006|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259007|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259008|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259009|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154259010|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154259012|NCT05180318|Esketamine|esketamine|mesh-list
154259013|NCT05180318|Analgesics|analgesics|mesh-ancestor
154259014|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
153732716|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732717|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153851857|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851858|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851859|NCT02542657|Clarithromycin|clarithromycin|mesh-list
153851860|NCT02542657|Dexamethasone|dexamethasone|mesh-list
153851861|NCT02542657|Pomalidomide|pomalidomide|mesh-list
153851862|NCT02542657|Ixazomib|ixazomib|mesh-list
153851863|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851864|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
153851865|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
153851866|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851867|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393885|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153393886|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153393887|NCT00003099|Protective Agents|protective agents|mesh-ancestor
153393888|NCT00003105|Paclitaxel|paclitaxel|mesh-list
153393889|NCT00003105|Gemcitabine|gemcitabine|mesh-list
153393890|NCT00003105|Doxorubicin|doxorubicin|mesh-list
153393891|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153393892|NCT00003105|Ifosfamide|ifosfamide|mesh-list
153393893|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393894|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393895|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393896|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393897|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853679|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
153853680|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853681|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853682|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853683|NCT03361748|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
153853684|NCT03361748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853685|NCT03361748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853686|NCT03312699|Vaccines|vaccines|mesh-list
153853687|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
153853688|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853689|NCT03238196|Fulvestrant|fulvestrant|mesh-list
153733182|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153733184|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733185|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
153853780|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153394034|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394035|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
153394036|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
153394037|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394038|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394039|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851885|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
153851886|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
153851887|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
153851888|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153851889|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153851890|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851891|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
153851892|NCT02229968|Coagulants|coagulants|mesh-ancestor
153394041|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153394042|NCT04581343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853781|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153394054|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394055|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394056|NCT01746043|Minocycline|minocycline|mesh-list
153394058|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394059|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394060|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153853815|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853816|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853817|NCT02603276|Red yeast rice|red yeast rice|mesh-list
153853818|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153853819|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153853820|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153853821|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
153853822|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853854|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394084|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
153394085|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
153394086|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394087|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394089|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153394090|NCT01746511|Protective Agents|protective agents|mesh-ancestor
153394091|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394092|NCT01746979|Gemcitabine|gemcitabine|mesh-list
153394093|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394094|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
153394095|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394096|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394097|NCT05614453|Tislelizumab|tislelizumab|mesh-list
153394098|NCT05614453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394099|NCT05614453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394100|NCT01754389|Sirolimus|sirolimus|mesh-list
153394101|NCT01754389|Methotrexate|methotrexate|mesh-list
153394102|NCT01754389|Bortezomib|bortezomib|mesh-list
153394103|NCT01754389|Tacrolimus|tacrolimus|mesh-list
153822861|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153394143|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153394144|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153394145|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
153394147|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364403|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
153394148|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153394149|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153394150|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394151|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394152|NCT01755949|Colchicine|colchicine|mesh-list
153394153|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
153394154|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394155|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
153394156|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
153394157|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394158|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394159|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394160|NCT01756885|Varenicline|varenicline|mesh-list
153394161|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153394162|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153394163|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
154259015|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259016|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259017|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153732720|NCT00141986|Vitamin D|vitamin d|mesh-list
153394164|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394165|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394166|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394197|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
153394198|NCT04062097|Coagulants|coagulants|mesh-ancestor
153394199|NCT02241655|Anesthetics|anesthetics|mesh-list
153394200|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394201|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394243|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394244|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
153394245|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153394295|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153394336|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
153394337|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394345|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
153394346|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394347|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153394348|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153394349|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394350|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394351|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153394352|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153394353|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
153394354|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153854169|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
153394404|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153394405|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824433|NCT00591994|Piribedil|piribedil|mesh-list
153364433|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
153394406|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
153394407|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394408|NCT01783561|Caffeine|caffeine|mesh-list
153394409|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
153394410|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394411|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153394412|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394413|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153394422|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153394423|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394424|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153394426|NCT04744727|Acetaminophen|acetaminophen|mesh-list
153394427|NCT04744727|Meperidine|meperidine|mesh-list
153394428|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153854186|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854187|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854256|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
153854294|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854295|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153854296|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153854297|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854298|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854299|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
153854300|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153854301|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153854302|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394534|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153394535|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
153394536|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153394537|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394584|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394585|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394586|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
153394587|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394588|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153854326|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153854327|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
154259023|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154259024|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259025|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259026|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
154259028|NCT05169437|Niraparib|niraparib|mesh-list
153732722|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
153854328|NCT02904759|Coagulants|coagulants|mesh-ancestor
153854329|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153854330|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
153854331|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854332|NCT02898792|Remifentanil|remifentanil|mesh-list
153854333|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153859440|NCT04679064|Doxorubicin|doxorubicin|mesh-list
153859441|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153859442|NCT04679064|Topotecan|topotecan|mesh-list
153859443|NCT04679064|Niraparib|niraparib|mesh-list
153854334|NCT02898792|Narcotics|narcotics|mesh-ancestor
153854335|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854336|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854337|NCT02898792|Analgesics|analgesics|mesh-ancestor
153854338|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
153854339|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394692|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394693|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394694|NCT00363701|Esomeprazole|esomeprazole|mesh-list
153394786|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153394788|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153394789|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394790|NCT01804075|Morphine|morphine|mesh-list
153394791|NCT01804075|Methadone|methadone|mesh-list
153854550|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854551|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854552|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
153854553|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153394793|NCT01804075|Narcotics|narcotics|mesh-ancestor
153822989|NCT00455585|Lamivudine|lamivudine|mesh-list
153362985|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153362986|NCT01654302|Lidocaine|lidocaine|mesh-list
153854747|NCT01227967|Amantadine|amantadine|mesh-list
153854748|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
153854749|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363021|NCT01450319|Cetuximab|cetuximab|mesh-list
153363022|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153363023|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363024|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153363025|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
153363026|NCT01552343|Coagulants|coagulants|mesh-ancestor
153363027|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153395018|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395019|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
153395020|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
153395021|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
153395022|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395023|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153395024|NCT02420873|Immunotoxins|immunotoxins|mesh-ancestor
153395025|NCT02420873|Immunoconjugates|immunoconjugates|mesh-ancestor
153392209|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392210|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392211|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153859444|NCT04679064|Dostarlimab|dostarlimab|mesh-list
153392212|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153392213|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
153392214|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153392215|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153392216|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
153392217|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
153392218|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392219|NCT00382629|Protective Agents|protective agents|mesh-ancestor
153395026|NCT02420873|Immunologic Factors|immunologic factors|mesh-ancestor
153395027|NCT02420873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395028|NCT02534129|Petrolatum|petrolatum|mesh-list
153395029|NCT02534129|Emollients|emollients|mesh-ancestor
153395030|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
153395031|NCT02420951|Bupivacaine|bupivacaine|mesh-list
153395032|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
153395033|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
153395034|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854769|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854770|NCT04637360|Calcitriol|calcitriol|mesh-list
153854771|NCT04637360|Cinacalcet|cinacalcet|mesh-list
153854772|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153854773|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854774|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153854775|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153854786|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854787|NCT00560222|Lactoferrin|lactoferrin|mesh-list
153854788|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854789|NCT04317508|Benzocaine|benzocaine|mesh-list
153854790|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
153854791|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
153854792|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395035|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395036|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
153395037|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395038|NCT02267083|Doxorubicin|doxorubicin|mesh-list
153395056|NCT01823497|Narcotics|narcotics|mesh-ancestor
153395057|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395058|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395059|NCT01823497|Analgesics|analgesics|mesh-ancestor
153854793|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854794|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
153854795|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854797|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
153395063|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153395064|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395065|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395066|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395067|NCT00363935|Analgesics|analgesics|mesh-ancestor
153395068|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
153395069|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395070|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153395095|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395096|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
153854846|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854847|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854848|NCT02894892|Antacids|antacids|mesh-ancestor
153854849|NCT04635566|Mebeverine|mebeverine|mesh-list
153395131|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153395132|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259029|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154259030|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259031|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259032|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259034|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154259035|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
154259036|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259037|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154259038|NCT05096442|Paclitaxel|paclitaxel|mesh-list
154259039|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153732726|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153732727|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153732728|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
153732729|NCT04514731|Analgesics|analgesics|mesh-ancestor
153732730|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
153732731|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732732|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732733|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
153732734|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732735|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153732736|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
153732737|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153392244|NCT00000549|Progestins|progestins|mesh-list
153392245|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392246|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392247|NCT01617577|Lenograstim|lenograstim|mesh-list
153392248|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153392249|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
153392250|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392251|NCT01701037|Trametinib|trametinib|mesh-list
153852030|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852032|NCT02908698|Hormones|hormones|mesh-ancestor
153852034|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395133|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153395134|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395136|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153395137|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
153395138|NCT02487563|Decitabine|decitabine|mesh-list
153852050|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852051|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153852052|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
153852053|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392252|NCT01701037|Dabrafenib|dabrafenib|mesh-list
153392253|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392254|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153392255|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392256|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395139|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153854873|NCT02888392|Psyllium|psyllium|mesh-list
153854874|NCT02888392|Cathartics|cathartics|mesh-ancestor
153854875|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854876|NCT01227577|Nilotinib|nilotinib|mesh-list
153854910|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854911|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
153854912|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854914|NCT00560690|Interferons|interferons|mesh-list
153854915|NCT00560690|Ribavirin|ribavirin|mesh-list
153854916|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153854917|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395152|NCT02490293|Cephalosporins|cephalosporins|mesh-list
153395153|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153395154|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395155|NCT02539511|Ketamine|ketamine|mesh-list
153395156|NCT02539511|Analgesics|analgesics|mesh-ancestor
153395157|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
153395158|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395159|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395160|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153395161|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153395162|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
153395163|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
153395164|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395165|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153395166|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153395167|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395168|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395169|NCT02493257|Ethanol|ethanol|mesh-list
153395170|NCT02493257|Capsaicin|capsaicin|mesh-list
153395171|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153395172|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395173|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395174|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395175|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
153395176|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
153395177|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
153395178|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395186|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854952|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153854954|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
153854955|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
153854956|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854957|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
153854958|NCT04633733|Tacrolimus|tacrolimus|mesh-list
153854959|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854960|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
153854961|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854962|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153854963|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364470|NCT01725230|Simvastatin|simvastatin|mesh-list
153854964|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854965|NCT05427942|Adalimumab|adalimumab|mesh-list
153855004|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
153855005|NCT00445523|Vaccines|vaccines|mesh-list
153855006|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855007|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
153855008|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392279|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153392281|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153392282|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
153392283|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153392284|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153392285|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153392294|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
153855009|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
153855010|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855011|NCT02903004|Paclitaxel|paclitaxel|mesh-list
153855012|NCT02903004|Carboplatin|carboplatin|mesh-list
153855013|NCT02903004|Gemcitabine|gemcitabine|mesh-list
153855014|NCT02903004|Doxorubicin|doxorubicin|mesh-list
153855015|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153855016|NCT02903004|Topotecan|topotecan|mesh-list
153855017|NCT02903004|Trabectedin|trabectedin|mesh-list
153855018|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153855019|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855020|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
153855021|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
153395253|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395254|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153395255|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
153395256|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395257|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855069|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
153395301|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395302|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395303|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153395304|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395305|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395307|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153395308|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
153395309|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153363100|NCT01534013|Insulin|insulin|mesh-list
153855078|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153855079|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855080|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
153855081|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855082|NCT00446069|Morphine|morphine|mesh-list
153855083|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153855084|NCT00446069|Narcotics|narcotics|mesh-ancestor
153855085|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395348|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395349|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395350|NCT05742763|Acetaminophen|acetaminophen|mesh-list
153395352|NCT05742763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395353|NCT05742763|Analgesics|analgesics|mesh-ancestor
153395378|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153395379|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153395380|NCT02439281|Clonidine|clonidine|mesh-list
153395381|NCT02439281|Ropivacaine|ropivacaine|mesh-list
153399921|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153395382|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
153395414|NCT02505269|Immunologic Factors|immunologic factors|mesh-ancestor
153395415|NCT02505269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395416|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153395417|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
153395427|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153395428|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395429|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395430|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153395431|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153395432|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153395433|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153395435|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
153395436|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
153395460|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153395512|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
153395513|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259040|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154259041|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259042|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
154259043|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
154259044|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
154259045|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259046|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
154259047|NCT05073237|Estrogens|estrogens|mesh-list
154259048|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154259049|NCT05073237|Hormones|hormones|mesh-ancestor
154259050|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259051|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259052|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154259053|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154259054|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
154259055|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154259056|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154259057|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154259058|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154259059|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732738|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732739|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732740|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153732741|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
153732742|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153732743|NCT04514419|Docetaxel|docetaxel|mesh-list
153732744|NCT04514419|Trastuzumab|trastuzumab|mesh-list
153732745|NCT04514419|Pertuzumab|pertuzumab|mesh-list
153395514|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
153395535|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153395536|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395537|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395538|NCT05446883|Paclitaxel|paclitaxel|mesh-list
153395539|NCT05446883|Carboplatin|carboplatin|mesh-list
153395540|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153395541|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395542|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
153395543|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
153395544|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
153395545|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395546|NCT00363857|Ropinirole|ropinirole|mesh-list
153855301|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397359|NCT04739111|Antibodies|antibodies|mesh-list
153852112|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153852113|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153852114|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
153852115|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852116|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852117|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852118|NCT01229371|Vaccines|vaccines|mesh-list
153852119|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
153852120|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852121|NCT02908152|Curcumin|curcumin|mesh-list
153855303|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153855304|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153855305|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153855306|NCT00446810|Benphothiamine|benphothiamine|mesh-list
153855307|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153855308|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
153855309|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855310|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
153855311|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
153855312|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855313|NCT01220167|Ondansetron|ondansetron|mesh-list
153855314|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
153855315|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
153855316|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855317|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855344|NCT00447473|Ketoconazole|ketoconazole|mesh-list
153395609|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
153395610|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395611|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
153395612|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153395613|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153395614|NCT02576249|Prednisolone|prednisolone|mesh-list
153395615|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
153395616|NCT02576249|Ropivacaine|ropivacaine|mesh-list
153395617|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153859692|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395618|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
153395619|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
153395620|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
153395621|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395622|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395623|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
153395624|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855383|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363163|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153855423|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153855424|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855425|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153855426|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855427|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
153733314|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153733315|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855429|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
153855430|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855431|NCT02901366|Dotinurad|dotinurad|mesh-list
153855432|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
153855433|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
153855434|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855435|NCT03276689|Pregabalin|pregabalin|mesh-list
153855436|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153855437|NCT03276689|Analgesics|analgesics|mesh-ancestor
153855438|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
153855439|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395674|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153395676|NCT04743011|Calcium heparin|calcium heparin|mesh-list
153859693|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153859694|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859695|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859696|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153859697|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859698|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153399998|NCT02024204|Xhance|xhance|mesh-list
153852143|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852144|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852145|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153852146|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153852147|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153852148|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
153852149|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153852150|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153852151|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153852152|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153395677|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153395678|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
153395679|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153395680|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153855459|NCT01220128|Doxorubicin|doxorubicin|mesh-list
153855460|NCT01220128|Fluorouracil|fluorouracil|mesh-list
153855461|NCT01220128|Trastuzumab|trastuzumab|mesh-list
153855463|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153855464|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153855465|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855466|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
153855467|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
153855468|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
153855469|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855470|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153855471|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
153855472|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855473|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855474|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153855475|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
153855476|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153855477|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153855478|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153855479|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153855480|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855481|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
153395734|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395735|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153363196|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363197|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
153363198|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363199|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363200|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153363201|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
153363202|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855520|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153855521|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153855522|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153855523|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153855524|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153855525|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153855526|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153855527|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153855528|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153855529|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
153855530|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153855580|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153855581|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153855582|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
153855583|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
154259060|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259061|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
154259062|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259063|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154259064|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154259065|NCT05055050|Imiquimod|imiquimod|mesh-list
154259066|NCT05055050|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154259067|NCT05055050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855584|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
153395847|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395848|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395849|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395850|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153400040|NCT02349152|Analgesics|analgesics|mesh-ancestor
153400041|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
153400042|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400043|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153400044|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153859750|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153859751|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153859752|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
153859753|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153855592|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153855593|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153855594|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
153855595|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855596|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153855619|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855620|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855622|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
153855623|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
153823275|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153395900|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
153395901|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395902|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395904|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153395905|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153395906|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
153395907|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
153395908|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855640|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855641|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855642|NCT01188655|Analgesics|analgesics|mesh-ancestor
153855643|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
153855644|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855645|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855646|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855647|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855648|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855649|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153855650|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
153855651|NCT00449618|Aspirin|aspirin|mesh-list
153855652|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855719|NCT02900742|Gemcitabine|gemcitabine|mesh-list
153855720|NCT02900742|Docetaxel|docetaxel|mesh-list
153855721|NCT02900742|Pemetrexed|pemetrexed|mesh-list
153855722|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855723|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
153824532|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153855724|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396011|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
153855776|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855777|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153855778|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
153855779|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855780|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855781|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153855782|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
153855783|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
153855784|NCT00450086|Hormones|hormones|mesh-ancestor
153855785|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855786|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855787|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855788|NCT00450086|Analgesics|analgesics|mesh-ancestor
153855789|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
153397428|NCT05446805|Corticosterone|corticosterone|mesh-list
153852202|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
153852203|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153852204|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852205|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852206|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153852207|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
153824533|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824534|NCT00467012|Growth Substances|growth substances|mesh-ancestor
153824535|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824536|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
153824537|NCT03272867|Mannitol|mannitol|mesh-list
153824538|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153824539|NCT03272867|Diuretics|diuretics|mesh-ancestor
153824540|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
153852208|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153852209|NCT02908035|Sirolimus|sirolimus|mesh-list
153852210|NCT02908035|Temsirolimus|temsirolimus|mesh-list
153852211|NCT02908035|MTOR Inhibitors|mtor inhibitors|mesh-list
153852212|NCT02908035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153855790|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855791|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
153396026|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153396027|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153396028|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
153396029|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153396030|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153396031|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153396032|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153396033|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153396034|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153396035|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153396036|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
153396037|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
153396038|NCT02815033|Choline|choline|mesh-list
153363281|NCT01557959|Docetaxel|docetaxel|mesh-list
153855835|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855836|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153855837|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153855846|NCT00450203|Growth Substances|growth substances|mesh-ancestor
153855847|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855848|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
153855849|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855850|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
153396229|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396230|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396231|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
153396232|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153396233|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
153396234|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153396235|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153396236|NCT05068349|Protective Agents|protective agents|mesh-ancestor
153396237|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396238|NCT00364871|Naltrexone|naltrexone|mesh-list
153396239|NCT00364871|Bupropion|bupropion|mesh-list
153396293|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396294|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153396295|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396296|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396297|NCT04741295|Heparin|heparin|mesh-list
153396298|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153396299|NCT04741295|Tinzaparin|tinzaparin|mesh-list
153396300|NCT04741295|Dalteparin|dalteparin|mesh-list
153396301|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
153396302|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153824547|NCT01327495|Acyline|acyline|mesh-list
153856063|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856064|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
153856065|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396303|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153396304|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259068|NCT05055050|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154259069|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
154259070|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259071|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154259072|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259073|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
154259074|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
154259075|NCT05047055|Rifampin|rifampin|mesh-list
154259076|NCT05047055|Isoniazid|isoniazid|mesh-list
154259077|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
154259078|NCT05047055|Ethambutol|ethambutol|mesh-list
154259079|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259080|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259081|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153732767|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732768|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852227|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852228|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852229|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153852230|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153852231|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153392437|NCT04942899|Letrozole|letrozole|mesh-list
153392438|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153392439|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
153392442|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153392443|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153392444|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392445|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153392446|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
153392447|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392448|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392449|NCT00000693|Zidovudine|zidovudine|mesh-list
153392450|NCT00000693|Acyclovir|acyclovir|mesh-list
153392451|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
154259082|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154259083|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259084|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259085|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259086|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154259087|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
154259088|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
154259089|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153732769|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
153732770|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153732771|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153732772|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732773|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153732774|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
153732775|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
153732776|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
153732777|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153852243|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852244|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153852245|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153852246|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852247|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153852248|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153392453|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153392454|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153852249|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153852250|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
153852251|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
153852252|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852253|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852254|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
153852255|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
153852256|NCT06237751|Sildenafil Citrate|sildenafil citrate|mesh-list
153852257|NCT06237751|Nitroglycerin|nitroglycerin|mesh-list
153396305|NCT00550537|Paclitaxel|paclitaxel|mesh-list
153396306|NCT00550537|Bevacizumab|bevacizumab|mesh-list
153856067|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856096|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733317|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
154259090|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154259091|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154259092|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154259093|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154259094|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154259095|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154259096|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154259097|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154259098|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
154259099|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154259100|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
154259101|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
154259103|NCT05031897|Fludarabine|fludarabine|mesh-list
154259104|NCT05031897|Tacrolimus|tacrolimus|mesh-list
154259105|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732778|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
153732779|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
153732780|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397498|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
153852258|NCT06237751|Vasodilator Agents|vasodilator agents|mesh-ancestor
153852259|NCT06237751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153852260|NCT06237751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153852261|NCT06237751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852262|NCT06237751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392485|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153392486|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392487|NCT04931979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153392488|NCT04931979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392489|NCT00000723|Leucovorin|leucovorin|mesh-list
154259106|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
154259107|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259108|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259109|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154259110|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
154259111|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259112|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259113|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154259114|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153732781|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732782|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732783|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
153732784|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153732785|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732786|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
153732787|NCT00505804|Haloperidol|haloperidol|mesh-list
153732788|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
153732789|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153732790|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852281|NCT06237569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852282|NCT06237569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153852283|NCT06237569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153852284|NCT06237569|Anesthetics, General|anesthetics, general|mesh-ancestor
153852285|NCT06237569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153852286|NCT06237569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153852287|NCT06237569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852288|NCT06237569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852289|NCT06237569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153852290|NCT06237569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153852291|NCT06237569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153852294|NCT06237569|GABA Modulators|gaba modulators|mesh-ancestor
153856097|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856098|NCT02929316|Vedolizumab|vedolizumab|mesh-list
153856099|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153856100|NCT02928965|Minocycline|minocycline|mesh-list
153856101|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856102|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856103|NCT02928692|Minocycline|minocycline|mesh-list
153856104|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856105|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856106|NCT04679142|Baclofen|baclofen|mesh-list
153852304|NCT06237465|Botulinum Toxins|botulinum toxins|mesh-list
153852305|NCT06237465|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153364553|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364554|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153364556|NCT03005171|Bupivacaine|bupivacaine|mesh-list
153364557|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
153852306|NCT06237465|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153852307|NCT06237465|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153852308|NCT06237465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852309|NCT06237465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852310|NCT06237465|Cholinergic Agents|cholinergic agents|mesh-ancestor
153392514|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392515|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153392516|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153392517|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
153392518|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392519|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153392520|NCT00000723|Antidotes|antidotes|mesh-ancestor
153392521|NCT00000723|Protective Agents|protective agents|mesh-ancestor
153856107|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153856108|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856109|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153856110|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856111|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153856112|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
153396376|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153396377|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396378|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
153396379|NCT00557401|Baclofen|baclofen|mesh-list
153396380|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153396381|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396382|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153396383|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396385|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
153856116|NCT02928419|Lenalidomide|lenalidomide|mesh-list
153856117|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
153856118|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856119|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153856215|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
153856216|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
153396483|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396484|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
153396485|NCT00550459|Tolvaptan|tolvaptan|mesh-list
153396486|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153396487|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396488|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
153396489|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396490|NCT01871077|Ketorolac|ketorolac|mesh-list
153396491|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153396492|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856255|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856256|NCT04798287|Adalimumab|adalimumab|mesh-list
153396564|NCT01936363|Niacinamide|niacinamide|mesh-list
153396565|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
153396566|NCT01936363|Vitamins|vitamins|mesh-ancestor
153396567|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
153396568|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396569|NCT04893629|Digoxin|digoxin|mesh-list
153396570|NCT04893629|Captopril|captopril|mesh-list
153396588|NCT01936519|Tacrolimus|tacrolimus|mesh-list
153859925|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
153859926|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
153859927|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
153859928|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859929|NCT00554424|Lidocaine|lidocaine|mesh-list
153859930|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
153859931|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
153859932|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859933|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859934|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
153400230|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400231|NCT02034578|Apixaban|apixaban|mesh-list
153400232|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153400233|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
153400234|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153396589|NCT01936519|Cyclosporins|cyclosporins|mesh-list
153396590|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153396591|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153400235|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
153396592|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
153396593|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259115|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259116|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154259117|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154259118|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
154259119|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259120|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259122|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
154259123|NCT04984889|Protein C|protein c|mesh-list
153397573|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
153852311|NCT06237465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852312|NCT06237465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852313|NCT06237465|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153852314|NCT06237465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852315|NCT06237257|Carboplatin|carboplatin|mesh-list
153852316|NCT06237257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852317|NCT06237205|Niraparib|niraparib|mesh-list
153852318|NCT06237205|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153852319|NCT06237205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852320|NCT06237205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852321|NCT06237205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824588|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852322|NCT06237192|Venetoclax|venetoclax|mesh-list
153852323|NCT06237192|Blinatumomab|blinatumomab|mesh-list
153852324|NCT06237192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852325|NCT06237153|Triamcinolone|triamcinolone|mesh-list
153392534|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392535|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
153392536|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392537|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392538|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153392539|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
153392540|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392541|NCT04750395|Haloperidol|haloperidol|mesh-list
153392542|NCT04750395|Olanzapine|olanzapine|mesh-list
153392543|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
153392544|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
153392545|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
154259124|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
154259125|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154259126|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154259127|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259128|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
154259129|NCT04983238|Trastuzumab|trastuzumab|mesh-list
154259130|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259131|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732791|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852332|NCT06237153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852333|NCT06237153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852345|NCT06236997|Carboplatin|carboplatin|mesh-list
153852346|NCT06236997|Etoposide|etoposide|mesh-list
153852347|NCT06236997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852348|NCT06236997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153852349|NCT06236997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153852350|NCT06236997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153852351|NCT06236997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852352|NCT06236997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852353|NCT06236932|Melatonin|melatonin|mesh-list
153852354|NCT06236932|Antioxidants|antioxidants|mesh-ancestor
153392556|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392557|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392558|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
153392559|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153392560|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
153392561|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153392562|NCT00000729|Foscarnet|foscarnet|mesh-list
153392563|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153392564|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
153392565|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392566|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153392567|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153392568|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392569|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392570|NCT03438773|Tacrolimus|tacrolimus|mesh-list
153396594|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259132|NCT04983238|Antidotes|antidotes|mesh-ancestor
154259133|NCT04983238|Protective Agents|protective agents|mesh-ancestor
154259134|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259135|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
154259136|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259137|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
154259138|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259139|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259140|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
154259141|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
154259142|NCT04887792|Acetazolamide|acetazolamide|mesh-list
154259143|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
154259144|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154259145|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259146|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259147|NCT04887792|Diuretics|diuretics|mesh-ancestor
154259148|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
154259149|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259150|NCT04760288|Pralsetinib|pralsetinib|mesh-list
154259151|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259152|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
154259153|NCT04746924|Tislelizumab|tislelizumab|mesh-list
154259154|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259155|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259156|NCT04746924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153397618|NCT02377271|Bosentan|bosentan|mesh-list
153392571|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153392572|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
153392573|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852355|NCT06236932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852356|NCT06236932|Protective Agents|protective agents|mesh-ancestor
153852357|NCT06236932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852358|NCT06236932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852359|NCT06236789|Ifosfamide|ifosfamide|mesh-list
153852360|NCT06236789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153852361|NCT06236789|Alkylating Agents|alkylating agents|mesh-ancestor
153396595|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396596|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
154259157|NCT04746924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259158|NCT04716686|Niraparib|niraparib|mesh-list
154259159|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154259160|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364581|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
154259161|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259162|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259163|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
154259164|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154259165|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
153732792|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153732793|NCT00505804|Analgesics|analgesics|mesh-ancestor
153732794|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
153732795|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732796|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153732797|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153852372|NCT06236555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852373|NCT06236555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852374|NCT06236555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153852375|NCT06236555|Vasodilator Agents|vasodilator agents|mesh-ancestor
153852376|NCT06236555|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153852377|NCT06236555|Purinergic Agonists|purinergic agonists|mesh-ancestor
153852378|NCT06236555|Purinergic Agents|purinergic agents|mesh-ancestor
153852379|NCT06236555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852380|NCT06236555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852381|NCT06236555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153852382|NCT06236555|Abortifacient Agents|abortifacient agents|mesh-ancestor
153852383|NCT06236555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153852384|NCT06236555|Oxytocics|oxytocics|mesh-ancestor
153852385|NCT06236269|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153852386|NCT06236269|Immunoconjugates|immunoconjugates|mesh-ancestor
153852387|NCT06236269|Immunologic Factors|immunologic factors|mesh-ancestor
153392590|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396597|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396598|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
153856468|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153856469|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
153860027|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153860028|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860029|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400319|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400320|NCT02359058|Capecitabine|capecitabine|mesh-list
153400321|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
153400322|NCT02359058|Ramucirumab|ramucirumab|mesh-list
153400326|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856470|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856471|NCT01709214|Oxycodone|oxycodone|mesh-list
153363427|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
153396785|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
154259166|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259167|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
154259168|NCT04702776|Protective Agents|protective agents|mesh-ancestor
153364596|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
154259169|NCT04696822|Epinephrine|epinephrine|mesh-list
154259170|NCT04696822|Racepinephrine|racepinephrine|mesh-list
154259171|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
154259172|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154259173|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154259174|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
154259175|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259176|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259177|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259178|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154259179|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154259180|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
153732798|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153732799|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
153732800|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732801|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732803|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
153732804|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732805|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153732806|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153732807|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732808|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153732809|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
153732810|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153732811|NCT00505843|Levodopa|levodopa|mesh-list
153732812|NCT00505843|Carbidopa|carbidopa|mesh-list
153732813|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153732814|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153732815|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
153852388|NCT06236269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396786|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153396787|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153396788|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153396789|NCT02654483|Serlopitant|serlopitant|mesh-list
153856521|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856522|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856523|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153856524|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153856525|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856526|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259181|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259182|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153364598|NCT03404024|Mitogens|mitogens|mesh-list
154259183|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
154259185|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
154259186|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154259187|NCT04694586|Rifampin|rifampin|mesh-list
154259188|NCT04694586|Isoniazid|isoniazid|mesh-list
154259189|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
154259190|NCT04694586|Ethambutol|ethambutol|mesh-list
154259191|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154259192|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
154259193|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259194|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732816|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732817|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732818|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732819|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153397667|NCT01897285|Laxatives|laxatives|mesh-ancestor
153392620|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392621|NCT02975219|Bevacizumab|bevacizumab|mesh-list
153852405|NCT06236191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852406|NCT06236191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852407|NCT06236178|Anesthetics|anesthetics|mesh-list
153852408|NCT06236178|Anesthetics, Local|anesthetics, local|mesh-list
153852409|NCT06236178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852410|NCT06236178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852411|NCT06236178|Sensory System Agents|sensory system agents|mesh-ancestor
153852412|NCT06236178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852413|NCT06236152|Prednisone|prednisone|mesh-list
153852414|NCT06236152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852415|NCT06236152|Glucocorticoids|glucocorticoids|mesh-ancestor
153852416|NCT06236152|Hormones|hormones|mesh-ancestor
153392622|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153392623|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392624|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153392625|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154259195|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
154259196|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154259197|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259198|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259199|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154259200|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154259201|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154259202|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154259203|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154259204|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153732820|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732821|NCT00505882|Pramlintide|pramlintide|mesh-list
153856527|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396799|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
153396800|NCT02655653|Coagulants|coagulants|mesh-ancestor
153856571|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856572|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
153856573|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153856574|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856575|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399991|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153856601|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396886|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
153396887|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
153396888|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
153396889|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396890|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153396891|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153396892|NCT02350517|Growth Substances|growth substances|mesh-ancestor
153396893|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396894|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823491|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
153823492|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823493|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153856674|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
153856675|NCT02914652|Albuterol|albuterol|mesh-list
153856676|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153856677|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
153856678|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856679|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856680|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153856681|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
153856682|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
153856683|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153856684|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153856685|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153856686|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153856687|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
153396927|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396928|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396929|NCT02672111|Analgesics|analgesics|mesh-ancestor
153396930|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
153396931|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856693|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856694|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153856695|NCT02081118|Incretins|incretins|mesh-ancestor
153856696|NCT02081118|Hormones|hormones|mesh-ancestor
153856697|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856698|NCT02077881|Paclitaxel|paclitaxel|mesh-list
153856699|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154259205|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154259206|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154259207|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
154259208|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154259209|NCT04661137|Dexamethasone|dexamethasone|mesh-list
154259210|NCT04661137|Daratumumab|daratumumab|mesh-list
154259211|NCT04661137|Pomalidomide|pomalidomide|mesh-list
154259212|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154259213|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
154259214|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
154259215|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259216|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259217|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732832|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732833|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153732834|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153732835|NCT00162864|Montelukast|montelukast|mesh-list
153732836|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153732837|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
153732838|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153732839|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
153732840|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732841|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732842|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153732843|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153852449|NCT06236061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153392659|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392660|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
153392661|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153392662|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153392663|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153392664|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
153392669|NCT04675983|Ramucirumab|ramucirumab|mesh-list
153392670|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392671|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153392672|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
154259219|NCT04661137|Hormones|hormones|mesh-ancestor
154259220|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259221|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154259222|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259223|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
154259224|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154259225|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154259226|NCT04661137|Growth Substances|growth substances|mesh-ancestor
153732844|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732845|NCT04512313|Rocuronium|rocuronium|mesh-list
153732846|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153732847|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153732848|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153732849|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732850|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732851|NCT00142493|Midazolam|midazolam|mesh-list
153732852|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
153852452|NCT06236061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852453|NCT06236061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153852454|NCT06236061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852455|NCT06236061|Vasodilator Agents|vasodilator agents|mesh-ancestor
153852456|NCT06236061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153852457|NCT06236022|Sirolimus|sirolimus|mesh-list
153852458|NCT06236022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153852459|NCT06236022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852460|NCT06236022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153852461|NCT06236022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852462|NCT06236022|Antifungal Agents|antifungal agents|mesh-ancestor
153852463|NCT06236022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153852464|NCT06236022|Immunologic Factors|immunologic factors|mesh-ancestor
153852465|NCT06236022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852466|NCT06235931|Letrozole|letrozole|mesh-list
153852467|NCT06235931|Anastrozole|anastrozole|mesh-list
153852468|NCT06235931|Exemestane|exemestane|mesh-list
153852469|NCT06235931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259228|NCT04649385|Tislelizumab|tislelizumab|mesh-list
154006174|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154259229|NCT04649385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259230|NCT04649385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259231|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
154259232|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
154259233|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259234|NCT04603898|Protective Agents|protective agents|mesh-ancestor
154259235|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259236|NCT04603898|Vitamins|vitamins|mesh-ancestor
154259237|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
154259238|NCT04597437|Zanamivir|zanamivir|mesh-list
153732853|NCT00142493|Thiopental|thiopental|mesh-list
153732854|NCT00142493|Propofol|propofol|mesh-list
153732855|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153732856|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732857|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732858|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153732859|NCT00142493|Analgesics|analgesics|mesh-ancestor
153824655|NCT02893111|Bortezomib|bortezomib|mesh-list
153400467|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153732860|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
153732861|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732862|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153732863|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153732864|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153732865|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
153852475|NCT06235931|Hormone Antagonists|hormone antagonists|mesh-ancestor
153852478|NCT06235931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153852479|NCT06235918|Paclitaxel|paclitaxel|mesh-list
153852480|NCT06235918|Carboplatin|carboplatin|mesh-list
153852481|NCT06235918|Tislelizumab|tislelizumab|mesh-list
153852482|NCT06235918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153852483|NCT06235918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852484|NCT06235918|Tubulin Modulators|tubulin modulators|mesh-ancestor
153852485|NCT06235918|Antimitotic Agents|antimitotic agents|mesh-ancestor
153856700|NCT02077881|Gemcitabine|gemcitabine|mesh-list
153856701|NCT02077881|Tryptophan|tryptophan|mesh-list
153856702|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153856733|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153856735|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
153856736|NCT02073123|Nivolumab|nivolumab|mesh-list
153856737|NCT02073123|Ipilimumab|ipilimumab|mesh-list
153856738|NCT02073123|Tryptophan|tryptophan|mesh-list
154259239|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
154259240|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259241|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259242|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259243|NCT04542733|Everolimus|everolimus|mesh-list
154259244|NCT04542733|Tacrolimus|tacrolimus|mesh-list
154259245|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259246|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
154259247|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259248|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154259249|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259250|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732866|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732867|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569912|NCT01690325|Epirubicin|epirubicin|mesh-list
153732868|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153732869|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
153852490|NCT06235749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153852491|NCT06235749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852492|NCT06235567|Prednisolone|prednisolone|mesh-list
153852493|NCT06235567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153852494|NCT06235567|Methylprednisolone|methylprednisolone|mesh-list
153400478|NCT03124121|Golimumab|golimumab|mesh-list
153852495|NCT06235567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153852496|NCT06235567|Prednisolone acetate|prednisolone acetate|mesh-list
153852497|NCT06235567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153852498|NCT06235567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153852499|NCT06235567|Prednisolone phosphate|prednisolone phosphate|mesh-list
153852500|NCT06235567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852501|NCT06235567|Glucocorticoids|glucocorticoids|mesh-ancestor
153852502|NCT06235567|Hormones|hormones|mesh-ancestor
153852504|NCT06235567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852505|NCT06235567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153852506|NCT06235567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856739|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153856740|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856741|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153856742|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856743|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153856744|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
153856745|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153392737|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392738|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392739|NCT05738798|Immunomodulating Agents|immunomodulating agents|mesh-list
153392740|NCT05738798|Immunologic Factors|immunologic factors|mesh-ancestor
153392741|NCT05738798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392742|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
153392743|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153396984|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153396985|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363469|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
153856759|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
153856760|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153856761|NCT02914028|Narcotics|narcotics|mesh-ancestor
153856762|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856763|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
153856764|NCT02064426|Hematinics|hematinics|mesh-ancestor
153856766|NCT02063997|Allopurinol|allopurinol|mesh-list
153856767|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
153856768|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856769|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
153856770|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
153856771|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
153856772|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856773|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856774|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
153397085|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
153397087|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397088|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153397089|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153397090|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397091|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397092|NCT02705807|Epoprostenol|epoprostenol|mesh-list
153397093|NCT02705807|Tezosentan|tezosentan|mesh-list
153856840|NCT01186744|Tofacitinib|tofacitinib|mesh-list
153856841|NCT01186744|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153856908|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
153856909|NCT02912702|Hormones|hormones|mesh-ancestor
153914633|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153914634|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153397252|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
153397253|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397255|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153397256|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397257|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153397258|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
153397259|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153397260|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153397261|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153856981|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153397262|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397263|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
153397264|NCT02731469|Hematinics|hematinics|mesh-ancestor
153397265|NCT01944319|Meropenem|meropenem|mesh-list
153397266|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153397356|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397357|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857129|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857130|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
153857131|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
153857132|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153857133|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153857134|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857135|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857136|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397377|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154259252|NCT04542733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154259253|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259254|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154259255|NCT04520126|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
154259256|NCT04520126|Oleuropein|oleuropein|mesh-list
154259257|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259258|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
154259259|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259260|NCT04520126|Protective Agents|protective agents|mesh-ancestor
154259261|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732870|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
153732871|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153732872|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153732873|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153732874|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732875|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
153732876|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
153732877|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
153732878|NCT04511923|Heparin|heparin|mesh-list
153732879|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
153732880|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153732881|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153857609|NCT04965493|Rituximab|rituximab|mesh-list
153852534|NCT06228482|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153852535|NCT06228482|Chelating Agents|chelating agents|mesh-ancestor
153852536|NCT06228482|Sequestering Agents|sequestering agents|mesh-ancestor
153852537|NCT06228482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397378|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153397379|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153397380|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
153397381|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397382|NCT01889797|Rituximab|rituximab|mesh-list
153397383|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
153397384|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153397385|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397386|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
153857218|NCT06225895|Sensory System Agents|sensory system agents|mesh-ancestor
153397485|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153397486|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153397487|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259262|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154259263|NCT04520126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154259264|NCT04520126|Disinfectants|disinfectants|mesh-ancestor
154259265|NCT04520126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154259266|NCT04520126|Vasodilator Agents|vasodilator agents|mesh-ancestor
154259267|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
154259268|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259269|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154259270|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400552|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259271|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259272|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
154259273|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259274|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732882|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732884|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153732885|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
153732886|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153732887|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
153732888|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732889|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732890|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
153732891|NCT04511299|SMOFlipid|smoflipid|mesh-list
153732892|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153732893|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153732894|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153732895|NCT00142571|Gemcitabine|gemcitabine|mesh-list
153732896|NCT00142571|Docetaxel|docetaxel|mesh-list
153392779|NCT05738564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852548|NCT06224569|Caffeine|caffeine|mesh-list
154259275|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154259276|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154259277|NCT04428866|Glucagon|glucagon|mesh-list
154259278|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154259279|NCT04428866|Hormones|hormones|mesh-ancestor
154259280|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259281|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259282|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
154259283|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154259284|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259285|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154259286|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259287|NCT04381936|Aspirin|aspirin|mesh-list
154259288|NCT04381936|Empagliflozin|empagliflozin|mesh-list
153732897|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153732898|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
153732899|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732900|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732901|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
153732902|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
153732903|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
153732904|NCT00142610|Vitamins|vitamins|mesh-list
153732905|NCT00142610|Vitamin E|vitamin e|mesh-list
153732906|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
153732907|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732908|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
153732909|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732910|NCT00142610|Protective Agents|protective agents|mesh-ancestor
153732911|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
153400609|NCT00374855|Diuretics|diuretics|mesh-ancestor
153852557|NCT06224569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852558|NCT06222489|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154259289|NCT04381936|Ritonavir|ritonavir|mesh-list
154259290|NCT04381936|Lopinavir|lopinavir|mesh-list
154259291|NCT04381936|Azithromycin|azithromycin|mesh-list
154259292|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
154259293|NCT04381936|Oseltamivir|oseltamivir|mesh-list
154259294|NCT04381936|Nirmatrelvir|nirmatrelvir|mesh-list
154259295|NCT04381936|Sotrovimab|sotrovimab|mesh-list
154259296|NCT04381936|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154259297|NCT04381936|Molnupiravir|molnupiravir|mesh-list
154259298|NCT04381936|Baloxavir|baloxavir|mesh-list
154259299|NCT04381936|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154259300|NCT04381936|Dexamethasone|dexamethasone|mesh-list
154259301|NCT04381936|Dexamethasone acetate|dexamethasone acetate|mesh-list
154259302|NCT04381936|Colchicine|colchicine|mesh-list
154259303|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153732912|NCT04510870|Hematinics|hematinics|mesh-ancestor
153732913|NCT00406575|Methocarbamol|methocarbamol|mesh-list
153732914|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153732915|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732916|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153732917|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732918|NCT02275975|Fluconazole|fluconazole|mesh-list
153732919|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
153732920|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732921|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153732922|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153732923|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397897|NCT04921007|Bupivacaine|bupivacaine|mesh-list
153852567|NCT06207305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852568|NCT06207305|Tubulin Modulators|tubulin modulators|mesh-ancestor
153852569|NCT06207305|Antimitotic Agents|antimitotic agents|mesh-ancestor
153852570|NCT06207305|Mitosis Modulators|mitosis modulators|mesh-ancestor
153852571|NCT06207305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259305|NCT04381936|Antibodies|antibodies|mesh-list
154259306|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
154259307|NCT04381936|BB 1101|bb 1101|mesh-list
154259308|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
154259309|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259310|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154259311|NCT04381936|Antiemetics|antiemetics|mesh-ancestor
154259312|NCT04381936|Autonomic Agents|autonomic agents|mesh-ancestor
154259313|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259314|NCT04381936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154259315|NCT04381936|Glucocorticoids|glucocorticoids|mesh-ancestor
153400632|NCT04737473|Anesthetics|anesthetics|mesh-list
154259316|NCT04381936|Hormones|hormones|mesh-ancestor
154259317|NCT04381936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259318|NCT04381936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154259319|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259320|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
154259321|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259322|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259323|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154259324|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154259325|NCT04381936|Analgesics|analgesics|mesh-ancestor
154259326|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
154259327|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732924|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732925|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153732926|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
153732928|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852583|NCT06207305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153852584|NCT06207305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852585|NCT06207305|Anesthetics, Local|anesthetics, local|mesh-ancestor
153852586|NCT06207305|Anesthetics|anesthetics|mesh-ancestor
153852596|NCT06207305|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153852597|NCT06189833|Dexamethasone|dexamethasone|mesh-list
153392813|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392814|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397488|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153397489|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153397490|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
153397491|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857362|NCT05919472|Micronutrients|micronutrients|mesh-ancestor
153857375|NCT05900245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857376|NCT05900245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857377|NCT05900245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153857378|NCT05900245|Anesthetics, General|anesthetics, general|mesh-ancestor
153857379|NCT05900245|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153857380|NCT05900245|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153397643|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397644|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153397645|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153397646|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153397648|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153397649|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397706|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397707|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
153397708|NCT05364515|Hormones|hormones|mesh-ancestor
153397709|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397710|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397711|NCT01438073|Hormones|hormones|mesh-list
153397712|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397713|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397714|NCT00371033|Pregabalin|pregabalin|mesh-list
153397715|NCT00371033|Analgesics|analgesics|mesh-ancestor
153397716|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
153397717|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397718|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397719|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
153397720|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153400362|NCT00374465|Verapamil|verapamil|mesh-list
153397721|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153857469|NCT05489926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857471|NCT05446870|Docetaxel|docetaxel|mesh-list
153857472|NCT05446870|Bevacizumab|bevacizumab|mesh-list
153857473|NCT05446870|Carboplatin|carboplatin|mesh-list
153857474|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
153857475|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153397722|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397723|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153397724|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153397725|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153397726|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397727|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153397728|NCT00371111|Triamcinolone|triamcinolone|mesh-list
153397729|NCT00371111|Bevacizumab|bevacizumab|mesh-list
153397730|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153397731|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397732|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153363617|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
153857552|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153823681|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153823682|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153823683|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363675|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259328|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154259329|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154259330|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154259331|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154259333|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154259334|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154259335|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154259336|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154259337|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
154259338|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259339|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154259340|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154259341|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259342|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
154259343|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154259344|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154259345|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154259346|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154259347|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
154259348|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
154259349|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
154259350|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
153732947|NCT00506194|Gliclazide|gliclazide|mesh-list
153363676|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363678|NCT01720238|Adefovir|adefovir|mesh-list
153363679|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153397895|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153397896|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397899|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
153397900|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397901|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397902|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
153397903|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397904|NCT01904071|Morphine|morphine|mesh-list
153397905|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153397906|NCT01904071|Narcotics|narcotics|mesh-ancestor
153397907|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857652|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857654|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
153857655|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397958|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153397959|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397960|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397961|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397962|NCT01909141|Estrogens|estrogens|mesh-ancestor
153397963|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153857721|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
153397998|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153397999|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154259351|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
154259352|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259353|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
154259354|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
154259355|NCT04370301|Melphalan|melphalan|mesh-list
154259356|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
154259357|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154259358|NCT04370301|Fludarabine|fludarabine|mesh-list
154259359|NCT04370301|Tacrolimus|tacrolimus|mesh-list
153392882|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392883|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392884|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153392885|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
153392886|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392887|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392888|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153392889|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392890|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392891|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153852674|NCT06126991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153852675|NCT06126991|Anesthetics, General|anesthetics, general|mesh-ancestor
153852676|NCT06126991|Anesthetics|anesthetics|mesh-ancestor
153852677|NCT06126991|GABA Modulators|gaba modulators|mesh-ancestor
153852678|NCT06126991|GABA Agents|gaba agents|mesh-ancestor
153852679|NCT06126991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914614|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
153392892|NCT01707043|Vitamins|vitamins|mesh-ancestor
153392893|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
153392894|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153392895|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
153392896|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
153392897|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392898|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392899|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392900|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
153852680|NCT06126991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852681|NCT06126991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153852682|NCT06126991|Narcotics|narcotics|mesh-ancestor
153852683|NCT06126991|Analgesics|analgesics|mesh-ancestor
153852684|NCT06126991|Sensory System Agents|sensory system agents|mesh-ancestor
153852685|NCT06126991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852686|NCT06126991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153852687|NCT06126991|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153852688|NCT06126991|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153852689|NCT06126991|Histamine Antagonists|histamine antagonists|mesh-ancestor
153852690|NCT06126991|Histamine Agents|histamine agents|mesh-ancestor
153852691|NCT06126952|Mometasone Furoate|mometasone furoate|mesh-list
153364799|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153364800|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364801|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153861057|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861058|NCT03416179|Cytarabine|cytarabine|mesh-list
153861059|NCT03416179|Azacitidine|azacitidine|mesh-list
153852692|NCT06126952|Azelastine|azelastine|mesh-list
153392905|NCT01708525|Protective Agents|protective agents|mesh-ancestor
153392906|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398000|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153398001|NCT04404959|Ropivacaine|ropivacaine|mesh-list
153398002|NCT04404959|Anesthetics|anesthetics|mesh-list
153398003|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
153398004|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398005|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398006|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
153857736|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857738|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857739|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857740|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153857741|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
153857742|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857743|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857744|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153857746|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
153857747|NCT04662515|Dabigatran|dabigatran|mesh-list
153857748|NCT04662515|Apixaban|apixaban|mesh-list
153857749|NCT04662515|Edoxaban|edoxaban|mesh-list
153857750|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
153857751|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153857752|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
153398033|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
153398034|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
153857776|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857777|NCT04454528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857778|NCT04454528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857779|NCT04421963|Olaparib|olaparib|mesh-list
153857780|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153857781|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857782|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861060|NCT03416179|Daunorubicin|daunorubicin|mesh-list
153398035|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398036|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398038|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153398039|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
153823754|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857824|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857825|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153857826|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
153857827|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153857828|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
153857829|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823789|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
153857853|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153398135|NCT01929889|Iloperidone|iloperidone|mesh-list
153398136|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153852693|NCT06126952|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153852694|NCT06126952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852695|NCT06126952|Dermatologic Agents|dermatologic agents|mesh-ancestor
153852696|NCT06126952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153852697|NCT06126952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153852698|NCT06126952|Autonomic Agents|autonomic agents|mesh-ancestor
153852699|NCT06126952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852700|NCT06126952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852701|NCT06126952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153852702|NCT06126952|Respiratory System Agents|respiratory system agents|mesh-ancestor
153852703|NCT06126952|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153852704|NCT06126952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852705|NCT06126952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852706|NCT06126952|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153852707|NCT06126952|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153398137|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153398138|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398139|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398140|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153398141|NCT05738473|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153398142|NCT05738473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857902|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
153857903|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857904|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857905|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
153857906|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398158|NCT05738317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153398159|NCT05738317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153398209|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398211|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153398212|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153398213|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398214|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153398215|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153398216|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
153398217|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398218|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398219|NCT02327195|Methylphenidate|methylphenidate|mesh-list
153398220|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153364817|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364818|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153402468|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153402469|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402471|NCT05177146|Analgesics|analgesics|mesh-ancestor
153402472|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
153402473|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862152|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153862153|NCT04710719|Fluorouracil|fluorouracil|mesh-list
153862154|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153862155|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
153862156|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862214|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153398221|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398222|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153862215|NCT04655040|Caffeine|caffeine|mesh-list
153402584|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
153398223|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153398224|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153398225|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398226|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
153398244|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
153398245|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153398246|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
153398247|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398248|NCT01614665|Tacrolimus|tacrolimus|mesh-list
153398249|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857985|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857986|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153857987|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
153857988|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259360|NCT04370301|Lenograstim|lenograstim|mesh-list
154259361|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154259362|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259363|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
153402585|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259364|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259365|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259366|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154259367|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
154259368|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259369|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259370|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154259371|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154259372|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732950|NCT00404573|Cariprazine|cariprazine|mesh-list
153732951|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153732952|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153732953|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732954|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732955|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732956|NCT00506272|Insulin|insulin|mesh-list
153732957|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153732958|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732959|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153732960|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
153732961|NCT00506311|Coagulants|coagulants|mesh-ancestor
153857989|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153857990|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857991|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
153857992|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363823|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153858046|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153858047|NCT02659930|Growth Substances|growth substances|mesh-ancestor
153858048|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
153858049|NCT02611037|Gemcitabine|gemcitabine|mesh-list
153858050|NCT02611037|Methotrexate|methotrexate|mesh-list
153398349|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153398350|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398351|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
153398352|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398360|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398361|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153398362|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398363|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
153398395|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398396|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398397|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
153858210|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
153858211|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153858212|NCT00352534|Dactinomycin|dactinomycin|mesh-list
153858309|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259373|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154259374|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154259375|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
154259376|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259377|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259378|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154259379|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154259380|NCT04348045|Fluorouracil|fluorouracil|mesh-list
154259381|NCT04348045|Irinotecan|irinotecan|mesh-list
153732964|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732965|NCT00142844|Naltrexone|naltrexone|mesh-list
153732966|NCT00142844|Disulfiram|disulfiram|mesh-list
153732967|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153732968|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153732969|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732970|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
153732971|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398037|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
153852764|NCT06040255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153852765|NCT06040255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852766|NCT06040255|Antiemetics|antiemetics|mesh-ancestor
153852767|NCT06040255|Autonomic Agents|autonomic agents|mesh-ancestor
153852768|NCT06040255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852769|NCT06040255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153852775|NCT06029023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153852777|NCT06029023|Sensory System Agents|sensory system agents|mesh-ancestor
153392992|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
153392993|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392994|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153392995|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153392996|NCT00421967|Analgesics|analgesics|mesh-ancestor
153392997|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392998|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392999|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153393000|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363886|NCT04205994|Tolcapone|tolcapone|mesh-list
153363891|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363892|NCT02218307|Mupirocin|mupirocin|mesh-list
153363893|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259384|NCT04348045|Antimetabolites|antimetabolites|mesh-ancestor
154259385|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259386|NCT04348045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154259387|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259388|NCT04348045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259389|NCT04348045|Immunologic Factors|immunologic factors|mesh-ancestor
153732972|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153398048|NCT01916941|Prazosin|prazosin|mesh-list
153393001|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393002|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153393003|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153393004|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
153393005|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393006|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153393007|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153393008|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
153393009|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153393010|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
153852778|NCT06029023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852779|NCT06029023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852780|NCT06029023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852781|NCT06029023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153852782|NCT06029023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852783|NCT06029023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852784|NCT06029023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852785|NCT06029023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852786|NCT05970263|Budesonide|budesonide|mesh-list
153852787|NCT05970263|Glycopyrrolate|glycopyrrolate|mesh-list
153824855|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
153403186|NCT04135690|Sorafenib|sorafenib|mesh-list
153403187|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403188|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153403189|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403190|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403191|NCT04126317|Aflibercept|aflibercept|mesh-list
153403192|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153403193|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153403194|NCT04126317|Growth Substances|growth substances|mesh-ancestor
153403195|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403196|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
153852788|NCT05970263|Formoterol Fumarate|formoterol fumarate|mesh-list
153393030|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393031|NCT00362531|Prednisone|prednisone|mesh-list
153393032|NCT00362531|Tacrolimus|tacrolimus|mesh-list
153852808|NCT05970263|Cholinergic Agents|cholinergic agents|mesh-ancestor
154259391|NCT04348045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154259392|NCT04348045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154259393|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259394|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259395|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154259396|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154259397|NCT04270019|Laxatives|laxatives|mesh-ancestor
153732973|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732974|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732975|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153732976|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153732977|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
153732978|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732979|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398063|NCT04210037|Paclitaxel|paclitaxel|mesh-list
153852811|NCT05963984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852812|NCT05963984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153852813|NCT05963984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153852814|NCT05963984|Hormone Antagonists|hormone antagonists|mesh-ancestor
153852815|NCT05963984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852816|NCT05963984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852817|NCT05909683|Anti-Infective Agents|anti-infective agents|mesh-list
153363894|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363895|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153363913|NCT01573949|Metformin|metformin|mesh-list
153823934|NCT00497172|Sirolimus|sirolimus|mesh-list
153823935|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823936|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823937|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153823938|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823939|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
153823940|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823941|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
153823942|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823943|NCT03273296|Amoxicillin|amoxicillin|mesh-list
153858374|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153858375|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858376|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
153858377|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858378|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153398643|NCT01989793|Losartan|losartan|mesh-list
153398644|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153398645|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153398646|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153398647|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153398648|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259398|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154259400|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
154259401|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259402|NCT04224987|Azithromycin|azithromycin|mesh-list
154259403|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259404|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259405|NCT04205630|Trastuzumab|trastuzumab|mesh-list
154259406|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259407|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259408|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
154259409|NCT04199104|Lenvatinib|lenvatinib|mesh-list
154259410|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259411|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259412|NCT04199104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153732980|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153732981|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153732982|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153732983|NCT00142883|Pregabalin|pregabalin|mesh-list
153732984|NCT00142883|Analgesics|analgesics|mesh-ancestor
153732985|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
153732986|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732987|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732988|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
153732989|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153732990|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732991|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732992|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153852834|NCT05872425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153852835|NCT05872425|Contraceptive Agents|contraceptive agents|mesh-ancestor
153852836|NCT05872425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153852837|NCT05872425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153852838|NCT05872425|Estrogens|estrogens|mesh-ancestor
154259413|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259414|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154259415|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259416|NCT04165772|Capecitabine|capecitabine|mesh-list
154259417|NCT04165772|Dostarlimab|dostarlimab|mesh-list
154259418|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154259419|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
154259420|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259421|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259422|NCT04007055|Ticagrelor|ticagrelor|mesh-list
154259423|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154259424|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154259425|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154259426|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154259427|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
154259428|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259429|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259430|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259431|NCT03915769|Ozanimod|ozanimod|mesh-list
153732993|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153732994|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153732995|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732996|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732997|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153732998|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153732999|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153733000|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153733001|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733005|NCT00163254|Abciximab|abciximab|mesh-list
153398649|NCT01992523|Ticagrelor|ticagrelor|mesh-list
153398650|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153398651|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153398652|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153398653|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153398654|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
153398655|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398656|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398657|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398658|NCT00373373|Sorafenib|sorafenib|mesh-list
153858384|NCT04675008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858385|NCT04675008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733014|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
153393090|NCT03166761|Dexamethasone|dexamethasone|mesh-list
153393091|NCT03166761|Triamcinolone|triamcinolone|mesh-list
153393092|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153393093|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153393094|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153393095|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153393096|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
153393097|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
153858386|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153858387|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
153858388|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153858389|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858390|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858421|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858422|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153858423|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858424|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153398689|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398690|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153398692|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153398693|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153398694|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
153398695|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
153398696|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
153858437|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153858439|NCT04312555|Urological Agents|urological agents|mesh-ancestor
153858440|NCT01184989|Dabigatran|dabigatran|mesh-list
153858441|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
153858442|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153858443|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
153858444|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858445|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403620|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153863307|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863308|NCT04616586|Siltuximab|siltuximab|mesh-list
153863309|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403678|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398709|NCT01993849|Protective Agents|protective agents|mesh-ancestor
153398737|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153398738|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
153398739|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
153398740|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398741|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398742|NCT02303977|Gemcitabine|gemcitabine|mesh-list
153398743|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153398744|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153398745|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
153398746|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398747|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398748|NCT01997515|Ketamine|ketamine|mesh-list
153398749|NCT01997515|Analgesics|analgesics|mesh-ancestor
153398750|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
153398751|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398752|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398753|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153398754|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153398755|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
153398756|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
153398757|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398758|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153398759|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153858473|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858474|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363969|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398781|NCT02789033|Diuretics|diuretics|mesh-ancestor
153858494|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
153858495|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858496|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153858497|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153403679|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403683|NCT02944500|Liraglutide|liraglutide|mesh-list
154259432|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154259433|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259434|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259435|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
154259436|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259437|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154259438|NCT03910972|Vaccines|vaccines|mesh-list
154259439|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
154259440|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259441|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154259442|NCT03910972|Antacids|antacids|mesh-ancestor
153733015|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153733016|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
153733017|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733018|NCT00506506|Expectorants|expectorants|mesh-ancestor
153733019|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
153733020|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153733021|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
153733022|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733023|NCT00506506|Protective Agents|protective agents|mesh-ancestor
153733024|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733025|NCT00506506|Antidotes|antidotes|mesh-ancestor
153398129|NCT05349071|Hormones|hormones|mesh-ancestor
153852899|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
153852900|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153852901|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852902|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153852903|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
153393118|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393119|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153393120|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153393121|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153393122|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154259443|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259444|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154259445|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
154259446|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
154259447|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259448|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
154259449|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259450|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259451|NCT03875911|Mitomycins|mitomycins|mesh-list
154259452|NCT03875911|Mitomycin|mitomycin|mesh-list
153733026|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
153733027|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153733028|NCT00163332|Ciclesonide|ciclesonide|mesh-list
153733029|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
153733030|NCT00163332|Hormones|hormones|mesh-ancestor
153733031|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733032|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852908|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
153852909|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153852910|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153852911|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852912|NCT05688215|Antidotes|antidotes|mesh-ancestor
153852913|NCT05688215|Protective Agents|protective agents|mesh-ancestor
153393131|NCT00002901|Docetaxel|docetaxel|mesh-list
153393132|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858498|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153858499|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153858500|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858501|NCT04673955|Cetuximab|cetuximab|mesh-list
153858502|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858503|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858504|NCT01904409|Rifaximin|rifaximin|mesh-list
153858505|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153858506|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858507|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153858508|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
153398800|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858520|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
153858521|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
153858522|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858523|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
153858524|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153858525|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858526|NCT01871415|Metformin|metformin|mesh-list
153858527|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153858528|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858529|NCT05189717|Everolimus|everolimus|mesh-list
153858530|NCT05189717|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153858531|NCT05189717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153858532|NCT05189717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858533|NCT05189717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259453|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154259454|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259455|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
154259456|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259457|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154259458|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259459|NCT03854019|Quinidine|quinidine|mesh-list
154259460|NCT03854019|Levomethorphan|levomethorphan|mesh-list
154259461|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
153733033|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153733034|NCT00163371|Ciclesonide|ciclesonide|mesh-list
153733035|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
153733036|NCT00163371|Hormones|hormones|mesh-ancestor
153733037|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733038|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733039|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153733040|NCT00143156|Pregabalin|pregabalin|mesh-list
153733041|NCT00143156|Analgesics|analgesics|mesh-ancestor
153398161|NCT05738317|Growth Substances|growth substances|mesh-ancestor
153852936|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153852937|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153852938|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
153852939|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
153852940|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
153852941|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
153852944|NCT05631236|Methamphetamine|methamphetamine|mesh-list
153858534|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858535|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
153858536|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858537|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858538|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153858539|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
153858540|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398809|NCT02278315|Hormones|hormones|mesh-ancestor
153398810|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398811|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153398812|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398813|NCT02795117|Ivermectin|ivermectin|mesh-list
153398814|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153398815|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398816|NCT02882633|Bupivacaine|bupivacaine|mesh-list
153858542|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858543|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858544|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
153858545|NCT00555087|Testosterone|testosterone|mesh-list
153858546|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
153733360|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858547|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
153858548|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153858550|NCT00555087|Hormones|hormones|mesh-ancestor
153858551|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259462|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
154259463|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
154259464|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154259465|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154259466|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259467|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259468|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733042|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
153733043|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364901|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
153364902|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364903|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153364904|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153364905|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403977|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403978|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153403980|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403981|NCT01726582|Antidotes|antidotes|mesh-ancestor
153403982|NCT01726582|Protective Agents|protective agents|mesh-ancestor
153733044|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733045|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
153733046|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153398171|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153852973|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852974|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
153852975|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
153852976|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153852977|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852978|NCT05567588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153852979|NCT05567588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852980|NCT05551858|Proglumide|proglumide|mesh-list
153852981|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153852982|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153852983|NCT05516628|Bevacizumab|bevacizumab|mesh-list
153852984|NCT05516628|Atezolizumab|atezolizumab|mesh-list
153852985|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153852986|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852987|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153852988|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153393201|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
153393202|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
153393203|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393204|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393207|NCT04826588|Hormones|hormones|mesh-ancestor
153858552|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858553|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153858554|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858555|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
153858556|NCT04673214|Acetaminophen|acetaminophen|mesh-list
154259470|NCT03854019|Narcotics|narcotics|mesh-ancestor
154259471|NCT03854019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154259472|NCT03854019|Analgesics|analgesics|mesh-ancestor
154259473|NCT03854019|Sensory System Agents|sensory system agents|mesh-ancestor
154259474|NCT03854019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259475|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154259476|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154259477|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
154259478|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154259479|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
153398200|NCT02833805|Tacrolimus|tacrolimus|mesh-list
153852989|NCT05516628|Growth Substances|growth substances|mesh-ancestor
153852990|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824931|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824932|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824933|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153824934|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852991|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
153852992|NCT05516628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153852993|NCT05516628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852995|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153852996|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153852997|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
153852998|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852999|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
153853000|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853001|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853002|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853003|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153853004|NCT05479032|Analgesics|analgesics|mesh-ancestor
153853005|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
153393219|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393220|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393221|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153393222|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153393227|NCT02276040|Bupivacaine|bupivacaine|mesh-list
153858557|NCT04673214|Azithromycin|azithromycin|mesh-list
153858558|NCT04673214|Ivermectin|ivermectin|mesh-list
153398828|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153398829|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398830|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398832|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
153398833|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153398834|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
154259481|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154259482|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259483|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853025|NCT05468892|Trifluridine|trifluridine|mesh-list
153398835|NCT02882711|Ketamine|ketamine|mesh-list
153398836|NCT02882711|Analgesics|analgesics|mesh-ancestor
153398837|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
153398838|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398839|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398840|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153398841|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153398842|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
153398843|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
153398844|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398845|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153398846|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153398847|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398848|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398849|NCT02794337|Sorafenib|sorafenib|mesh-list
153398850|NCT02794337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153398851|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858562|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858563|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858564|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
153858565|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153858566|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858579|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858580|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858581|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153858582|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153398852|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153398853|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398854|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398855|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
153398857|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398858|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398859|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153398860|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153398861|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398862|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398863|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398864|NCT02895035|Ketorolac|ketorolac|mesh-list
153858596|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858597|NCT04676763|Histamine|histamine|mesh-list
153858598|NCT04676763|Substance P|substance p|mesh-list
153858599|NCT04676763|Neurokinin A|neurokinin a|mesh-list
153858600|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
153858601|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
153858602|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858603|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858604|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398873|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398874|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153398875|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153398876|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
153398877|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398878|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153398883|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153398884|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398885|NCT02895035|Analgesics|analgesics|mesh-ancestor
153398886|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
153398887|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398888|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364068|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364073|NCT01723748|Hormones|hormones|mesh-list
153858634|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153858635|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
153858636|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259485|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154259486|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
154259487|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154259488|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154259489|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824943|NCT00593008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153824944|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824945|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824946|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
153824947|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824948|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824949|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824950|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153404059|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
154259490|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153733049|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153733050|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153733051|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153733052|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733053|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153733054|NCT00163410|Ciclesonide|ciclesonide|mesh-list
153733055|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
153733056|NCT00163410|Hormones|hormones|mesh-ancestor
153398234|NCT04768465|Hormones|hormones|mesh-ancestor
153853054|NCT05351489|Analgesics|analgesics|mesh-ancestor
153853055|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153853056|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153853057|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153853058|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
153853059|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853060|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853061|NCT05342974|Misoprostol|misoprostol|mesh-list
153853062|NCT05342974|Atorvastatin|atorvastatin|mesh-list
153853063|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153853064|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153853065|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
153853066|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404060|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853067|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153853068|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153853069|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853070|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153858637|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858638|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153858639|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153858640|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
153824951|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
153824952|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153824953|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153824954|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824955|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153863701|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
153863702|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863703|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863704|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
153863705|NCT00554918|Hormones|hormones|mesh-ancestor
153824958|NCT00593125|Levetiracetam|levetiracetam|mesh-list
153858641|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858642|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154259491|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154259492|NCT03728673|Dexetimide|dexetimide|mesh-list
154259493|NCT03728673|Citalopram|citalopram|mesh-list
154259494|NCT03728673|Escitalopram|escitalopram|mesh-list
154259495|NCT03728673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154259496|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154259497|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154259498|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259499|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259500|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
154259501|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259502|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154259503|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154259504|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
154259505|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
154259506|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259507|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154259508|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154259509|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
154259510|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154259511|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
154259512|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153733057|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733058|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733059|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153733079|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
153733080|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733081|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153733082|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153858643|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153858644|NCT04672317|Immunomodulating Agents|immunomodulating agents|mesh-list
153858645|NCT04672317|Immunologic Factors|immunologic factors|mesh-ancestor
153858646|NCT04672317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398922|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153398924|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
153858653|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858654|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858655|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858656|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153858657|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153858658|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153858659|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153858660|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
153858661|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
153858662|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
153858663|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
153858664|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858665|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858666|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858667|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153858668|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153858669|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153858670|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153858671|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153858672|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
153398996|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
153398997|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398998|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153398999|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153399000|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
153399001|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399002|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153399003|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399004|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858733|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399005|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
153399006|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153399007|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153824140|NCT00497523|Albuterol|albuterol|mesh-list
153858758|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153858759|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858760|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858761|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153858762|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858763|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154259534|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259535|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154259536|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259537|NCT03704480|Durvalumab|durvalumab|mesh-list
154259538|NCT03704480|Tremelimumab|tremelimumab|mesh-list
154259539|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259540|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259541|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
154259542|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154259543|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
154259544|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259545|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
154259546|NCT03697876|Protective Agents|protective agents|mesh-ancestor
154259547|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154259548|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
154259549|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259550|NCT03656549|Pemetrexed|pemetrexed|mesh-list
154259551|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824970|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153824971|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824972|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364938|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153364939|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364940|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153364941|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
153364942|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259552|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259553|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259554|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154259555|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154259556|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
154259557|NCT03615326|Capecitabine|capecitabine|mesh-list
153733096|NCT00143351|Ziprasidone|ziprasidone|mesh-list
153733097|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153733098|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
153733099|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733100|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364944|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153364946|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733101|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733102|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153393342|NCT02501330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853123|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853124|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853126|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153853127|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853128|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853130|NCT05266937|Paclitaxel|paclitaxel|mesh-list
153858764|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858765|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
153858766|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153858767|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
153858768|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858769|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
153858770|NCT04671108|Protective Agents|protective agents|mesh-ancestor
153858771|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153858772|NCT01779453|Atorvastatin|atorvastatin|mesh-list
153858773|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153858774|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153399061|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153399062|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153399063|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399064|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153399065|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399066|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399067|NCT01959685|Enclomiphene|enclomiphene|mesh-list
153399068|NCT01959685|Clomiphene|clomiphene|mesh-list
153399069|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
153399070|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153399071|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
153399072|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863781|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863782|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153863783|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863784|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
153863785|NCT04611165|Nivolumab|nivolumab|mesh-list
153863786|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863787|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863788|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153863789|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863790|NCT02014649|Laninamivir|laninamivir|mesh-list
153863791|NCT02014649|Zanamivir|zanamivir|mesh-list
153863793|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399073|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399074|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153399079|NCT04333589|Favipiravir|favipiravir|mesh-list
153399080|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
153858783|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153858784|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153858785|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153858786|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153858787|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858788|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
153858789|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858790|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858791|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153858792|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858793|NCT01774578|Gemcitabine|gemcitabine|mesh-list
153858794|NCT01774578|Docetaxel|docetaxel|mesh-list
153858795|NCT01774578|Pemetrexed|pemetrexed|mesh-list
153858796|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858797|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
153858798|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858799|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858800|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
153858801|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
153858802|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858803|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858804|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153858805|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153858806|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
153858809|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858810|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
153858811|NCT04670601|Analgesics|analgesics|mesh-ancestor
153858812|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
153399110|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399111|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399112|NCT02301416|Topiramate|topiramate|mesh-list
153399113|NCT02301416|Phentermine|phentermine|mesh-list
153399114|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
153399115|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154259558|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
154259559|NCT03615326|Trastuzumab|trastuzumab|mesh-list
154259560|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259561|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259562|NCT03615326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154259563|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259564|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154259565|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
154259566|NCT03599635|Bupivacaine|bupivacaine|mesh-list
154259567|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
154259568|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
154259569|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733103|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153733104|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733105|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153733106|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153733107|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
153733108|NCT00163605|Thrombin|thrombin|mesh-list
153733109|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153733110|NCT00163605|Calcium|calcium|mesh-list
153853187|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153853188|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
153853189|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853190|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853191|NCT05062083|11C-PS13|11c-ps13|mesh-list
153853192|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153393408|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393409|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
153393410|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153393411|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153853197|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
153399116|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399117|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153399157|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
153399158|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399159|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399160|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
153399161|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153399162|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399163|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153399164|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153399165|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399166|NCT01988246|Aflibercept|aflibercept|mesh-list
153399167|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153399168|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154259570|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259571|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
154259572|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259573|NCT03540420|Atezolizumab|atezolizumab|mesh-list
154259574|NCT03540420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154259575|NCT03540420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259576|NCT03540420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259577|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259578|NCT03500731|Rituximab|rituximab|mesh-list
154259579|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
153733111|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153733112|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733113|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
153733114|NCT00163605|Coagulants|coagulants|mesh-ancestor
153733115|NCT02598583|Ravulizumab|ravulizumab|mesh-list
153733116|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153733117|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733118|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
153733119|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733120|NCT00143429|Latanoprost|latanoprost|mesh-list
153733121|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153393433|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153393434|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153393435|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153393436|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393437|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
153393438|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393439|NCT02975141|Paclitaxel|paclitaxel|mesh-list
153393440|NCT02975141|Gemcitabine|gemcitabine|mesh-list
153853219|NCT04961632|Tamoxifen|tamoxifen|mesh-list
153853220|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153853221|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
153853222|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153853223|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393441|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153858887|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153858888|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
153858889|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259580|NCT03500731|Fludarabine|fludarabine|mesh-list
154259581|NCT03500731|Thiotepa|thiotepa|mesh-list
153824989|NCT05653453|Paclitaxel|paclitaxel|mesh-list
153824990|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153824991|NCT05653453|Gemcitabine|gemcitabine|mesh-list
153824992|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153824993|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863828|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
153863829|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259582|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
154259583|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259584|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259585|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
154259586|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259587|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259588|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733122|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153733123|NCT02598895|Carboplatin|carboplatin|mesh-list
153733124|NCT02598895|Docetaxel|docetaxel|mesh-list
153733125|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733126|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
153733127|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
153733128|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
153733129|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733130|NCT00143546|Defibrotide|defibrotide|mesh-list
153733131|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153393456|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393457|NCT04341935|Incretins|incretins|mesh-ancestor
153393459|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393460|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153393461|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
153393462|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853228|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153853229|NCT04908579|Ketamine|ketamine|mesh-list
153853230|NCT04908579|Bupivacaine|bupivacaine|mesh-list
153853231|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
153853232|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
153393467|NCT05316883|Clozapine|clozapine|mesh-list
153393468|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153393469|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
153393470|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393473|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153393481|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153393482|NCT05316649|Analgesics|analgesics|mesh-ancestor
153863830|NCT04677335|Lovastatin|lovastatin|mesh-list
153404233|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153825005|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364971|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364972|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
153364973|NCT02241200|Hematinics|hematinics|mesh-ancestor
153364974|NCT02241278|Ketamine|ketamine|mesh-list
153364975|NCT02241278|Analgesics|analgesics|mesh-ancestor
153364976|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
153364977|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364978|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393483|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
153393484|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393485|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393486|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153393487|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393488|NCT03990363|Allopurinol|allopurinol|mesh-list
153393489|NCT03990363|Verinurad|verinurad|mesh-list
153858890|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858891|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153858892|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
153858893|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
153858894|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153399169|NCT01988246|Growth Substances|growth substances|mesh-ancestor
153364179|NCT02981459|Mirabegron|mirabegron|mesh-list
153399189|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399190|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399192|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399193|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858895|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153858896|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153858897|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153401604|NCT04624295|Analgesics|analgesics|mesh-ancestor
153858898|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
153858899|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858900|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858901|NCT01712217|Crizotinib|crizotinib|mesh-list
153858902|NCT01712217|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153858903|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153858904|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858905|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858906|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858907|NCT04669821|Propofol|propofol|mesh-list
153858908|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858909|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858910|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858911|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153858912|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
153858913|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
153858914|NCT00532025|Sorafenib|sorafenib|mesh-list
153858915|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858916|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153858917|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399206|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399207|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399208|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153399210|NCT03008213|Palonosetron|palonosetron|mesh-list
153399211|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
153399212|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
153399213|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399214|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399215|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364979|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153364980|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153364981|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
153399216|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153399217|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153399218|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
153399219|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399220|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399221|NCT02059070|Bupivacaine|bupivacaine|mesh-list
153399222|NCT02059070|Ropivacaine|ropivacaine|mesh-list
153399223|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
153399224|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
153399225|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399226|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399227|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
153399246|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154259589|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153825006|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
154259590|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154259591|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
154259592|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154259593|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
154259594|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259595|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153733132|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153733133|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733134|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153733135|NCT00155883|Leucovorin|leucovorin|mesh-list
153733136|NCT00155883|Fluorouracil|fluorouracil|mesh-list
153733137|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
153733138|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733139|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393512|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393513|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393514|NCT00002919|Doxorubicin|doxorubicin|mesh-list
153393515|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153393516|NCT00002919|Methotrexate|methotrexate|mesh-list
153393517|NCT00002919|Vinblastine|vinblastine|mesh-list
153393518|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393519|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153393520|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393521|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393522|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393523|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399247|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153399248|NCT00374621|Misoprostol|misoprostol|mesh-list
153399249|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153399250|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
153399251|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153399252|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399253|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153399254|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153399257|NCT00374621|Diuretics|diuretics|mesh-ancestor
153858951|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153825028|NCT01379521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364993|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153364994|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153364995|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858952|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153858953|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153858954|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153858955|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153858956|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153858957|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858966|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
153398404|NCT02295553|Ketamine|ketamine|mesh-list
153393531|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153393532|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393533|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
153393534|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393535|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153393536|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393537|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393538|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853309|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
153853310|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853311|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853312|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153853313|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
153853314|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153853315|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153853316|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393572|NCT00002925|Aldesleukin|aldesleukin|mesh-list
153858967|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
153858971|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858972|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153858973|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153858974|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153858975|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153858976|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858977|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858978|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153858979|NCT04668456|Analgesics|analgesics|mesh-ancestor
153858980|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153858981|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153858982|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153858983|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
153858984|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858985|NCT04668417|Vaccines|vaccines|mesh-list
153858986|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
153858987|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858988|NCT00556413|Leucovorin|leucovorin|mesh-list
153858989|NCT00556413|Fluorouracil|fluorouracil|mesh-list
153858990|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
153858991|NCT00556413|Irinotecan|irinotecan|mesh-list
153858992|NCT00556413|Cetuximab|cetuximab|mesh-list
153858993|NCT00556413|Calcium|calcium|mesh-list
153858994|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
153858995|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153399276|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399278|NCT01967641|Analgesics|analgesics|mesh-ancestor
153399279|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
153399280|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399281|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153399282|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
153399283|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153399284|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
153824263|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364227|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364228|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153364230|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
153364232|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393606|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153825029|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393607|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393608|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393609|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853361|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153853362|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153853363|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
153853364|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364233|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
153364234|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153364235|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
153364236|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364237|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364238|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153364239|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
153364240|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153364241|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153364242|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153364243|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
153859023|NCT00533585|Bevacizumab|bevacizumab|mesh-list
153859024|NCT00533585|Carboplatin|carboplatin|mesh-list
153859025|NCT00533585|Sorafenib|sorafenib|mesh-list
153399304|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153399306|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
153399307|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859027|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859028|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
153859029|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
153859030|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
153859031|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859032|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859033|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153859034|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824271|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153824272|NCT00464165|Rimonabant|rimonabant|mesh-list
153824273|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153824274|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153824275|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153824276|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824278|NCT00464165|Hormones|hormones|mesh-ancestor
153859054|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153859055|NCT04659057|Analgesics|analgesics|mesh-ancestor
153859056|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153824294|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153364260|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364261|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733370|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859088|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
153859089|NCT00533936|Paclitaxel|paclitaxel|mesh-list
153859090|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
153863986|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859091|NCT00533936|Doxorubicin|doxorubicin|mesh-list
153859092|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153859093|NCT00533936|Fluorouracil|fluorouracil|mesh-list
153859094|NCT00533936|Trastuzumab|trastuzumab|mesh-list
153859095|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153859096|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859097|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
153859098|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
153859099|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
153859100|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859101|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153399398|NCT02006108|Hematinics|hematinics|mesh-ancestor
153399399|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153399400|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153399401|NCT02006342|Insulin|insulin|mesh-list
154259597|NCT03404193|Decitabine|decitabine|mesh-list
154259598|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259599|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154259600|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
154259601|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259602|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259603|NCT03381183|Durvalumab|durvalumab|mesh-list
154259604|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153398472|NCT05288075|Charcoal|charcoal|mesh-list
153393685|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153393686|NCT00002967|Octreotide|octreotide|mesh-list
153393687|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393688|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
153393689|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393690|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393691|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153399402|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153399403|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
153399404|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153399405|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399406|NCT01968356|Ethanol|ethanol|mesh-list
153863988|NCT01941836|Ezetimibe|ezetimibe|mesh-list
153399407|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
153399408|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153399409|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153399410|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399411|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399412|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399413|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
153859103|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859104|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859105|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153859106|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
153859107|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153859108|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153859109|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153859110|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153859111|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859112|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
153825046|NCT01371994|Urological Agents|urological agents|mesh-ancestor
153825047|NCT00465608|Propranolol|propranolol|mesh-list
153825048|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153859121|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859122|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153859123|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153859124|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
153859125|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859126|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859136|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153399414|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
153399424|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399425|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399426|NCT02008682|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153399427|NCT01969916|Regadenoson|regadenoson|mesh-list
153399428|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153399429|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153399430|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
153399431|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
153399432|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399433|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399434|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399435|NCT00373919|Erythromycin|erythromycin|mesh-list
154006546|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154259605|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259606|NCT03370133|Ustekinumab|ustekinumab|mesh-list
154259607|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
154259608|NCT03304717|Tenofovir|tenofovir|mesh-list
154259609|NCT03304717|Emtricitabine|emtricitabine|mesh-list
154259610|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
154259611|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259612|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154259613|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154259614|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259615|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259616|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153864082|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864083|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864245|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
153864246|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404638|NCT05620771|Growth Substances|growth substances|mesh-ancestor
153404639|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404640|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
153404641|NCT05620771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154259617|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153733140|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733141|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733142|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
153733143|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733144|NCT00155883|Antidotes|antidotes|mesh-ancestor
153853478|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393740|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393741|NCT00003003|Analgesics|analgesics|mesh-ancestor
153853513|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853514|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
153853520|NCT04196530|Atezolizumab|atezolizumab|mesh-list
153399436|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
153399437|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153399438|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
153859137|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153859138|NCT04667910|Growth Substances|growth substances|mesh-ancestor
153859139|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859140|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
153859141|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859142|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153859143|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
153859144|NCT00556608|Hylan|hylan|mesh-list
153859145|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153859146|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
153859147|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859148|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
153859149|NCT00556608|Protective Agents|protective agents|mesh-ancestor
153859150|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
153859151|NCT00534287|Meropenem|meropenem|mesh-list
153859152|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153859153|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153859154|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859155|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153399451|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399452|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399453|NCT02918357|Edetic Acid|edetic acid|mesh-list
153399454|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153399455|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
154259618|NCT03182296|Exenatide|exenatide|mesh-list
154259619|NCT03182296|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154259620|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154259621|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259622|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154259623|NCT03182296|Incretins|incretins|mesh-ancestor
154259624|NCT03182296|Hormones|hormones|mesh-ancestor
154259625|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259626|NCT02931695|Hormones|hormones|mesh-list
154259627|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259628|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259629|NCT02879617|Durvalumab|durvalumab|mesh-list
153404642|NCT05620771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259630|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154259631|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259632|NCT02734602|Ketamine|ketamine|mesh-list
154259633|NCT02734602|Analgesics|analgesics|mesh-ancestor
154259634|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
154259635|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259636|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259637|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153733145|NCT00155883|Protective Agents|protective agents|mesh-ancestor
153733146|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
153733147|NCT00155883|Vitamins|vitamins|mesh-ancestor
153393793|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393794|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
153393795|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393796|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393797|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393798|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153399456|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
153399457|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399458|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
153399459|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153399460|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153399461|NCT02829983|Clarithromycin|clarithromycin|mesh-list
153399462|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153399463|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399464|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153399465|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399466|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399467|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153399468|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153399469|NCT02012192|Paclitaxel|paclitaxel|mesh-list
153859183|NCT01184872|Floxacillin|floxacillin|mesh-list
154259638|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154259640|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
154259641|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154259642|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154259643|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154259644|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259645|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259646|NCT02627092|Copper|copper|mesh-list
154259647|NCT02627092|Trace Elements|trace elements|mesh-ancestor
154259648|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
154259649|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259650|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
154259651|NCT02316340|Vorinostat|vorinostat|mesh-list
154259652|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
153825053|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259653|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153398533|NCT00372515|Gefitinib|gefitinib|mesh-list
153853600|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
153853601|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153853602|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853603|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
153825057|NCT01371877|Vitamin D|vitamin d|mesh-list
153864287|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153864288|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864289|NCT04608981|Analgesics|analgesics|mesh-ancestor
153864290|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
153864291|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153404684|NCT03228017|Aspirin|aspirin|mesh-list
153853604|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853605|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853606|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853607|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853608|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153853609|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153853610|NCT03798626|Growth Substances|growth substances|mesh-ancestor
153853611|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853612|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
153853613|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
153853614|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153853615|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859184|NCT01184872|Cloxacillin|cloxacillin|mesh-list
153859185|NCT01184872|Oxacillin|oxacillin|mesh-list
153859186|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153859187|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859188|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
153859189|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153859190|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153859191|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
153859192|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259655|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259656|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259657|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259658|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259659|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259660|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154259661|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
154259662|NCT02260505|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154259663|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154259664|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404685|NCT03228017|Atorvastatin|atorvastatin|mesh-list
153404686|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153404687|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153404688|NCT03228017|Analgesics|analgesics|mesh-ancestor
153404689|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
153404690|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404691|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404693|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259665|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259666|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259667|NCT02143401|Sorafenib|sorafenib|mesh-list
154259668|NCT02143401|Navitoclax|navitoclax|mesh-list
154259669|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259670|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154259671|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398545|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
153853628|NCT03611868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853629|NCT03611868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853630|NCT03563716|Atezolizumab|atezolizumab|mesh-list
153853631|NCT03563716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853632|NCT03563716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859193|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859194|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859195|NCT01215721|Urological Agents|urological agents|mesh-ancestor
153859196|NCT00534677|Octreotide|octreotide|mesh-list
153399493|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399495|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
153399496|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399497|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399498|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153399527|NCT02834663|Growth Substances|growth substances|mesh-ancestor
153399528|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399529|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
153399530|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399532|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
153399533|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153859258|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153859259|NCT01183858|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153399534|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399535|NCT02017327|Bimatoprost|bimatoprost|mesh-list
153399536|NCT02017327|Latanoprost|latanoprost|mesh-list
153399537|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153399538|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153399539|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153399540|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154259672|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259673|NCT01972919|Gemcitabine|gemcitabine|mesh-list
154259674|NCT01972919|Capecitabine|capecitabine|mesh-list
154259675|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154259676|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
154259677|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259678|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259679|NCT01782599|Nicotine|nicotine|mesh-list
154259680|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153733148|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
153733149|NCT00506545|Rolapitant|rolapitant|mesh-list
153733150|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153733151|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733152|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733153|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393905|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153393906|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
153393907|NCT00003111|Paclitaxel|paclitaxel|mesh-list
153393908|NCT00003111|Carboplatin|carboplatin|mesh-list
153393909|NCT00003111|Irinotecan|irinotecan|mesh-list
153393910|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393911|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393912|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393913|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393914|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393915|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825072|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153825073|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864352|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864353|NCT01698281|Dexamethasone|dexamethasone|mesh-list
153864354|NCT01698281|Doxorubicin|doxorubicin|mesh-list
153864355|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864356|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
153393916|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153393917|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393918|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853674|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853675|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853676|NCT03467373|Immunoconjugates|immunoconjugates|mesh-ancestor
153853677|NCT03450343|Azacitidine|azacitidine|mesh-list
153853678|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153399541|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153399542|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399543|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
153399544|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
153399545|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
153859263|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259681|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
154259682|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259683|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259684|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154259685|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154259686|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
154259687|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259688|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259689|NCT01765140|Amifampridine|amifampridine|mesh-list
154259690|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153733154|NCT04696393|Mitapivat|mitapivat|mesh-list
153733155|NCT04696393|Enzyme Activators|enzyme activators|mesh-ancestor
153733156|NCT04696393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733157|NCT05143723|Hormones|hormones|mesh-list
153733158|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404752|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404754|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153404755|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
153404756|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404757|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404758|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
153825074|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825075|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153864359|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864360|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153864362|NCT01698281|Hormones|hormones|mesh-ancestor
153864363|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864371|NCT00565461|Vaccines|vaccines|mesh-list
153733159|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733160|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
153733161|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153733162|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733163|NCT05143528|Nilotinib|nilotinib|mesh-list
153733164|NCT05143528|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153853707|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153853709|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853710|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853711|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
153853712|NCT03150329|Vorinostat|vorinostat|mesh-list
153853713|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853714|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853715|NCT03150329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853716|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853717|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153853718|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853719|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
153853720|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153859264|NCT05449522|Vitamin D|vitamin d|mesh-list
153859265|NCT05449522|Vitamins|vitamins|mesh-ancestor
153859266|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
153859267|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259691|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259692|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259693|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154259694|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154259695|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259696|NCT01758328|Fludarabine|fludarabine|mesh-list
154259699|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153733165|NCT05143528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153733166|NCT05143528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570211|NCT01691742|Laxatives|laxatives|mesh-list
153733167|NCT05143528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733169|NCT05142865|Etoposide|etoposide|mesh-list
153733170|NCT05142865|Apatinib|apatinib|mesh-list
153733171|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733172|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153398604|NCT04332497|Ibuprofen|ibuprofen|mesh-list
153853722|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153853723|NCT03057431|Diuretics|diuretics|mesh-ancestor
153853724|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
153853725|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404793|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153404794|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153404795|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
153404796|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
153404797|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404799|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153404800|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404801|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404802|NCT00376493|Metronidazole|metronidazole|mesh-list
153404803|NCT00376493|Doxycycline|doxycycline|mesh-list
153404804|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864393|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153404821|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153393971|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153393972|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153393973|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153393974|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153393976|NCT02210559|Gemcitabine|gemcitabine|mesh-list
153393977|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393978|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393979|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393980|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393981|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393982|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393983|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153859268|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153859269|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153859270|NCT04665141|Omalizumab|omalizumab|mesh-list
153859271|NCT04665141|Benralizumab|benralizumab|mesh-list
153859272|NCT04665141|Reslizumab|reslizumab|mesh-list
153859273|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153859274|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153364340|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
154259700|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259701|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259702|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259703|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
154259704|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259705|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154259706|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
154259707|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154259709|NCT01746849|Thiotepa|thiotepa|mesh-list
154259710|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259711|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
154259712|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259713|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259714|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153404822|NCT05716256|Urinastatin|urinastatin|mesh-list
153404823|NCT05716256|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153404828|NCT00356083|Methadone|methadone|mesh-list
154259715|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
154259716|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259717|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259718|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154259719|NCT01722266|Liraglutide|liraglutide|mesh-list
153825093|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153825094|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825095|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153825096|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153825097|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154259720|NCT01722266|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154259721|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154259722|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259723|NCT01722266|Incretins|incretins|mesh-ancestor
154259724|NCT01722266|Hormones|hormones|mesh-ancestor
153733173|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153733174|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153733175|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733176|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733177|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153733178|NCT00143702|Riboflavin|riboflavin|mesh-list
153733179|NCT00143702|Thiamine|thiamine|mesh-list
153733180|NCT00143702|Abacavir|abacavir|mesh-list
153399554|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
153399555|NCT02923895|Protective Agents|protective agents|mesh-ancestor
153399556|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399557|NCT01973348|Methamphetamine|methamphetamine|mesh-list
153399569|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399570|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153399572|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154259725|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259726|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154259727|NCT01468896|Cetuximab|cetuximab|mesh-list
154259728|NCT01468896|Interleukin-12|interleukin-12|mesh-list
154259729|NCT01468896|Antibodies|antibodies|mesh-list
154259730|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
154259731|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154259732|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
153733200|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
153733201|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153853770|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853771|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853772|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853773|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
153853774|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153853775|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153853776|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
153399573|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864469|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153399574|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
153399575|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399576|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153399577|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
153399578|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153399579|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
153399580|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399581|NCT02925611|Desflurane|desflurane|mesh-list
153399582|NCT02925611|Isoflurane|isoflurane|mesh-list
153859288|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153859289|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859290|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859291|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153859292|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
153859293|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
153859294|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153859295|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
153859296|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859297|NCT03580148|Cortisone|cortisone|mesh-list
153859298|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153859299|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153859300|NCT04664517|Anesthetics|anesthetics|mesh-list
153859301|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399617|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399619|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
153399620|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399621|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153399623|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153399624|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153399625|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153399626|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399627|NCT02021929|Sorafenib|sorafenib|mesh-list
153399628|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399629|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153399630|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399631|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399632|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153399633|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153859323|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154259733|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259734|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259735|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154259736|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154259737|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154259738|NCT01468896|Growth Substances|growth substances|mesh-ancestor
154259739|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
154259740|NCT01261728|Gemcitabine|gemcitabine|mesh-list
154259741|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733202|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825103|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153825104|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825105|NCT01245855|Alprostadil|alprostadil|mesh-list
153825106|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153825107|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
153825108|NCT01245855|Urological Agents|urological agents|mesh-ancestor
153825109|NCT00473603|Heparin|heparin|mesh-list
153825110|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
153825111|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153825112|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153733203|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398676|NCT01387763|Interferons|interferons|mesh-list
153853823|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853824|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153853825|NCT02564978|Minocycline|minocycline|mesh-list
153853826|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394072|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394073|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153394074|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153394075|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394076|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153394077|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153394078|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153394079|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153394080|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153394081|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153394082|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
153853851|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853852|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153853853|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
153853855|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
153859324|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859325|NCT04664010|Vitamins|vitamins|mesh-list
153859336|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
153859337|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859338|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
153859339|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
153859352|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
153859353|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153859354|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
153859355|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859356|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859357|NCT04663386|Budesonide|budesonide|mesh-list
153399634|NCT02023411|Teriparatide|teriparatide|mesh-list
154259742|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154259743|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
154259744|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259745|NCT00953771|Danazol|danazol|mesh-list
153825113|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259746|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154259747|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
154259748|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259749|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259750|NCT00711490|Sirolimus|sirolimus|mesh-list
154259751|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259752|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259753|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154259754|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259755|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
153733204|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153733205|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153733206|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153733207|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153733208|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153733209|NCT00506623|Capecitabine|capecitabine|mesh-list
153733210|NCT00506623|Irinotecan|irinotecan|mesh-list
153733211|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153733212|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
153733213|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733214|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733215|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153733216|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153733217|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733218|NCT00143741|Atorvastatin|atorvastatin|mesh-list
153398691|NCT00373061|Omalizumab|omalizumab|mesh-list
153394105|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
153394106|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153394107|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394108|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394109|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
153394111|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259756|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259757|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
154259758|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259759|NCT00673816|Sunitinib|sunitinib|mesh-list
154259760|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259761|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154259762|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154259763|NCT00673816|Growth Substances|growth substances|mesh-ancestor
154259764|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259765|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
154259766|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154259767|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259768|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259769|NCT00533117|Fluoxetine|fluoxetine|mesh-list
154259770|NCT00533117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154259771|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154259772|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825114|NCT00492765|Interferons|interferons|mesh-list
153825115|NCT00492765|Interferon-beta|interferon-beta|mesh-list
153825116|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
153825117|NCT00492765|Simvastatin|simvastatin|mesh-list
153825118|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825119|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
153864618|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864619|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153864620|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153864621|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
153733219|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153733220|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153733221|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
153733222|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733223|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153733224|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153733225|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733226|NCT00143780|Vaccines|vaccines|mesh-list
153399635|NCT02023411|Hormones|hormones|mesh-list
153399636|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
153399637|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399638|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399639|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153399640|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153399641|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
153399642|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
153399643|NCT02068820|Protective Agents|protective agents|mesh-ancestor
153399644|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399645|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153399646|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
153399647|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399648|NCT02934191|Acetaminophen|acetaminophen|mesh-list
153399649|NCT02934191|Celecoxib|celecoxib|mesh-list
153399650|NCT02934191|Oxycodone|oxycodone|mesh-list
153399651|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
153399652|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399653|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399654|NCT02934191|Analgesics|analgesics|mesh-ancestor
153399655|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
153399656|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399657|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
154259773|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259774|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259775|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
154259776|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259777|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154259778|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
154259779|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154259780|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154259781|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153733237|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
153853914|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153853915|NCT01829568|Growth Substances|growth substances|mesh-ancestor
153853916|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
153853928|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853929|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853930|NCT01693822|Axitinib|axitinib|mesh-list
153365108|NCT02245256|Analgesics|analgesics|mesh-ancestor
153365109|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
153365110|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365111|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153365112|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153365113|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153365114|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
153365115|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405056|NCT00358358|Hormones|hormones|mesh-ancestor
153853931|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853932|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853933|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853934|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853935|NCT01575834|Denosumab|denosumab|mesh-list
153853936|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153853937|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853938|NCT01509742|Liraglutide|liraglutide|mesh-list
153399658|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153399659|NCT02934191|Narcotics|narcotics|mesh-ancestor
153399660|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399661|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153399662|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153859363|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859364|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153859373|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859374|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859375|NCT04663269|Dexamethasone|dexamethasone|mesh-list
153859376|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153859377|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
153859378|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
153859379|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859384|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399663|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399664|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153399665|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153399666|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399667|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399668|NCT02934191|Antacids|antacids|mesh-ancestor
154259783|NCT00026312|Vitamin A|vitamin a|mesh-list
154259784|NCT00026312|Aldesleukin|aldesleukin|mesh-list
154259785|NCT00026312|Interleukin-2|interleukin-2|mesh-list
154259786|NCT00026312|Tretinoin|tretinoin|mesh-list
154259787|NCT00026312|Dinutuximab|dinutuximab|mesh-list
154259788|NCT00026312|Isotretinoin|isotretinoin|mesh-list
154259789|NCT00026312|Sargramostim|sargramostim|mesh-list
154259790|NCT00026312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154259791|NCT00026312|Vitamins|vitamins|mesh-ancestor
154259792|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
154259793|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259794|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259795|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154259796|NCT00026312|Analgesics|analgesics|mesh-ancestor
154259797|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
153405075|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
153864667|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153864668|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864669|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864670|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153864671|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153864672|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153405076|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
153405077|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405078|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405079|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153405080|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
153405082|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733411|NCT05148910|Trace Elements|trace elements|mesh-ancestor
153733412|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
153733238|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
153733239|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153733240|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
153570286|NCT01692678|Dacarbazine|dacarbazine|mesh-list
153733241|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733242|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853957|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153853958|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853959|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153853960|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853961|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853962|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853963|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153853964|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
153853966|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399669|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153399670|NCT02937623|Calcium|calcium|mesh-list
153399671|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153399672|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399673|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
153399674|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153399675|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153399676|NCT01977781|Prednisolone|prednisolone|mesh-list
153399677|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
153399678|NCT01977781|Tacrolimus|tacrolimus|mesh-list
153399679|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153399680|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
153399681|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153399682|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
153399683|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399684|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154259798|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259799|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
154259800|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154259801|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154259802|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
154259803|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259804|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
154259805|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
153403559|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
153864673|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153864674|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
153405102|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405103|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405104|NCT03384329|Resveratrol|resveratrol|mesh-list
153405105|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
153405106|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405107|NCT03384329|Protective Agents|protective agents|mesh-ancestor
153405108|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259806|NCT01089348|Metronidazole|metronidazole|mesh-list
154259807|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259808|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259809|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154259810|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153733243|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
153733244|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733245|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733246|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
153733247|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733248|NCT00143975|Analgesics|analgesics|mesh-ancestor
153733249|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
153733250|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733251|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153733252|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153733253|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733254|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153733255|NCT00143975|Immunotoxins|immunotoxins|mesh-ancestor
153394234|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153394235|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394236|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
153394237|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153854001|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
153854002|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854003|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153854004|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153854005|NCT01054196|Growth Substances|growth substances|mesh-ancestor
153399685|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399686|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399687|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399688|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
154259811|NCT01291316|Clonazepam|clonazepam|mesh-list
154259812|NCT01291316|Clobazam|clobazam|mesh-list
154259813|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154259814|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154259815|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154259816|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
154259817|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405109|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405111|NCT03443063|Lemborexant|lemborexant|mesh-list
153405122|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405123|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405124|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
153405125|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153405126|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153405127|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864716|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153864717|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864718|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
153864719|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864720|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259818|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259819|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733256|NCT00143975|Immunoconjugates|immunoconjugates|mesh-ancestor
153733257|NCT00156312|Docetaxel|docetaxel|mesh-list
153733258|NCT00156312|Capecitabine|capecitabine|mesh-list
153733259|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733260|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
153733261|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
153733262|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
153733263|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733264|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153733265|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
153394254|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
153394255|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394256|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153854008|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153854009|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
153854010|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854011|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153854012|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854013|NCT01041508|Cyclosporine|cyclosporine|mesh-list
153854014|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
153854015|NCT01041508|Clofarabine|clofarabine|mesh-list
153854016|NCT01041508|Cyclosporins|cyclosporins|mesh-list
153854017|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854019|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153399689|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
153399690|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399691|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859404|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859405|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859406|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153859407|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859409|NCT00535340|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
154259820|NCT01291316|Urological Agents|urological agents|mesh-ancestor
154259821|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
154259822|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
154259823|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
154259824|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153365173|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
154259825|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154259826|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154259827|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154259828|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154259829|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
154259830|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
154259831|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154259832|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
153733266|NCT00506701|Tadalafil|tadalafil|mesh-list
153733267|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
153733268|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153733269|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153733270|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733271|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733272|NCT00506701|Urological Agents|urological agents|mesh-ancestor
153733273|NCT05147857|Misoprostol|misoprostol|mesh-list
153733274|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153733275|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
153733276|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153398831|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
153854044|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
153854045|NCT00408005|Dexamethasone|dexamethasone|mesh-list
153854046|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
153854047|NCT00408005|Prednisone|prednisone|mesh-list
153854048|NCT00408005|Cortisone|cortisone|mesh-list
153854049|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
153854050|NCT00408005|Doxorubicin|doxorubicin|mesh-list
153854051|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153854052|NCT00408005|Methotrexate|methotrexate|mesh-list
153394285|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
153394286|NCT01769209|Hormones|hormones|mesh-ancestor
154259833|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259834|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259835|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154259836|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
154259837|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154259838|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
154259839|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259840|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259841|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154259842|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
153864737|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
153864789|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864790|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864791|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153864792|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153864793|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
153864794|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
153864795|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864796|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864797|NCT00566046|Levetiracetam|levetiracetam|mesh-list
153864798|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
153864814|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
153733277|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733278|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153733279|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153733280|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
153733281|NCT00144053|Paclitaxel|paclitaxel|mesh-list
153733282|NCT00144053|Vindesine|vindesine|mesh-list
153733283|NCT00144053|Carboplatin|carboplatin|mesh-list
153733284|NCT00144053|Irinotecan|irinotecan|mesh-list
153733285|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153733286|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733287|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
153398856|NCT02590523|Vancomycin|vancomycin|mesh-list
153854053|NCT00408005|Vincristine|vincristine|mesh-list
153854054|NCT00408005|Daunorubicin|daunorubicin|mesh-list
153854055|NCT00408005|Asparaginase|asparaginase|mesh-list
153854056|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
153854057|NCT00408005|Pegaspargase|pegaspargase|mesh-list
153854058|NCT00408005|Thioguanine|thioguanine|mesh-list
153854059|NCT00408005|BB 1101|bb 1101|mesh-list
153854060|NCT00408005|Calcium|calcium|mesh-list
153854061|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
153854062|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
153854063|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854064|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
153854065|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259843|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
154259844|NCT00060840|Protective Agents|protective agents|mesh-ancestor
154259846|NCT01185860|Ribavirin|ribavirin|mesh-list
154259847|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154259848|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154259849|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154259850|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
154259851|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259852|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259853|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153733288|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
153733289|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
153733290|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398880|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
153854068|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
153394316|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394317|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394322|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394324|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153394325|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153394326|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153394327|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153394328|NCT01771627|Nicotine|nicotine|mesh-list
153399695|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153399696|NCT01977781|Protective Agents|protective agents|mesh-ancestor
153399697|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153399698|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399699|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
153399700|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153825210|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153825211|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153825212|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825213|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825214|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153825215|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
153864818|NCT01159912|Xhance|xhance|mesh-list
153864819|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864820|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153405247|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405248|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405250|NCT03269435|Bupivacaine|bupivacaine|mesh-list
153405251|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
153405252|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
153405253|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399701|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153399702|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153399703|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399704|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399705|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
153399706|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399707|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399708|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153399709|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399711|NCT02938949|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153859426|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859427|NCT00535418|Letrozole|letrozole|mesh-list
153859428|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859429|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153859430|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153859431|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859432|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859433|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153859434|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
153859435|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259854|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154259855|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
154259856|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259857|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154259858|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154259859|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
154259860|NCT01290302|Azacitidine|azacitidine|mesh-list
154259861|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154259862|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
154259863|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259864|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259865|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259866|NCT01089660|Vaccines|vaccines|mesh-list
153825216|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153825217|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825218|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153864842|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864843|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864844|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153864846|NCT04631822|Hormones|hormones|mesh-ancestor
153864847|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864848|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153864850|NCT04605705|Chrysarobin|chrysarobin|mesh-list
154259867|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
154259868|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259869|NCT01182662|Cyclosporine|cyclosporine|mesh-list
154259870|NCT01182662|Cyclosporins|cyclosporins|mesh-list
154259871|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733291|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153733292|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153398895|NCT02802449|Vitamin D|vitamin d|mesh-list
153854087|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153854088|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153854089|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
153854090|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153854091|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153854092|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
153854093|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
153854094|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153854095|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153854096|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
153394330|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153394331|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
153394332|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394333|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394334|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153394335|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154259872|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259873|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259874|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
154259875|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259876|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
154259877|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259878|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
154259879|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154259880|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154259881|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154259882|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153733293|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733295|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
153733296|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
153733297|NCT00144131|Hematinics|hematinics|mesh-ancestor
153854097|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854098|NCT00408005|Antidotes|antidotes|mesh-ancestor
153854099|NCT00408005|Protective Agents|protective agents|mesh-ancestor
153854100|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
153854101|NCT00408005|Vitamins|vitamins|mesh-ancestor
153854102|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
153854103|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153854104|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153854105|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153854106|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153854107|NCT00408005|Hematinics|hematinics|mesh-ancestor
153854108|NCT00075946|Rituximab|rituximab|mesh-list
153854109|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153854110|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854111|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
153854112|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854113|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854114|NCT04682184|Propranolol|propranolol|mesh-list
153854115|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
153854116|NCT04682184|Ephedrine|ephedrine|mesh-list
153854117|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153854118|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153399715|NCT02938949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825228|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
153825229|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153825230|NCT00493077|Interferons|interferons|mesh-list
153399716|NCT02938949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154259884|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
154259885|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259886|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154259887|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154259888|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259889|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154259890|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154259891|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154259892|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
154259893|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154259894|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154259895|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154259896|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154259897|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259898|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
154259899|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154259900|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733298|NCT00144209|Levodopa|levodopa|mesh-list
153854129|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153854130|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
153854131|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
153854132|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153854133|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153854134|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
153854135|NCT04645940|Rabeprazole|rabeprazole|mesh-list
153854136|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153394394|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153394395|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153394396|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
153394397|NCT02652169|Amikacin|amikacin|mesh-list
153394398|NCT02652169|Teicoplanin|teicoplanin|mesh-list
153864888|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153864889|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864890|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153864891|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153864892|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864893|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
153864894|NCT01159171|Bevacizumab|bevacizumab|mesh-list
153864895|NCT01159171|Capecitabine|capecitabine|mesh-list
153864896|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
153825231|NCT00493077|Interferon-beta|interferon-beta|mesh-list
153825232|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
153825233|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825234|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
153825235|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825236|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
153825237|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825238|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153394399|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394400|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394401|NCT02478775|Cetrorelix|cetrorelix|mesh-list
153394402|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153394403|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
153399717|NCT02938949|Protease Inhibitors|protease inhibitors|mesh-ancestor
153399720|NCT02025439|Amantadine|amantadine|mesh-list
153399721|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153399722|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153399723|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
153399724|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399740|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153399741|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399743|NCT02026297|Coagulants|coagulants|mesh-ancestor
153859436|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859438|NCT04679064|Bevacizumab|bevacizumab|mesh-list
153859439|NCT04679064|Gemcitabine|gemcitabine|mesh-list
153364441|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
153859461|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153859462|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859463|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153859464|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153399744|NCT02070692|Tamoxifen|tamoxifen|mesh-list
153399745|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153399746|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
153399747|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399748|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399749|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153399750|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399751|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153399752|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153399753|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153399754|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
153399755|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153859490|NCT01183780|Growth Inhibitors|growth inhibitors|mesh-ancestor
153859491|NCT04679103|Eculizumab|eculizumab|mesh-list
153859492|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153859493|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859494|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
153365224|NCT02243618|Protective Agents|protective agents|mesh-ancestor
153365225|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365226|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365227|NCT02243852|Hormones|hormones|mesh-list
153864926|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
153864927|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
153864928|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864929|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153864930|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153864931|NCT04631315|Protective Agents|protective agents|mesh-ancestor
153864932|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153864933|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
153864934|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
153864936|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
153859495|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859496|NCT00535574|Bexarotene|bexarotene|mesh-list
153859497|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859501|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859503|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153859504|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
153859505|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859515|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859516|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259901|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154259902|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259903|NCT03854942|Naltrexone|naltrexone|mesh-list
154259904|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154259905|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154259906|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259907|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
154259908|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259909|NCT03278626|Paclitaxel|paclitaxel|mesh-list
154259910|NCT03278626|Carboplatin|carboplatin|mesh-list
154259911|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154259912|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259913|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
154259914|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
154259915|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
154259916|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733300|NCT00144209|Benserazide|benserazide|mesh-list
153394469|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394470|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
153394471|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854221|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153854222|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
153854223|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153854224|NCT02905539|Hematinics|hematinics|mesh-ancestor
153859517|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
153859518|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859521|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859522|NCT04678791|Cisplatin|cisplatin|mesh-list
153859523|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
153399799|NCT01979276|Dexamethasone|dexamethasone|mesh-list
153399800|NCT01979276|Pomalidomide|pomalidomide|mesh-list
153399801|NCT01979276|Romidepsin|romidepsin|mesh-list
153399802|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399803|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
153399804|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
153399805|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399806|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399807|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153864968|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864970|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
153864971|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
153864972|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153864973|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864974|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153864975|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
153864976|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153399808|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
153864977|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864978|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153864979|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153405383|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153405385|NCT05071352|Nefopam|nefopam|mesh-list
153405386|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153405387|NCT05071352|Analgesics|analgesics|mesh-ancestor
153405388|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
153405389|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399809|NCT01979276|Hormones|hormones|mesh-ancestor
153399810|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399811|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153399812|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399813|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
153399814|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153399815|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153399816|NCT01979276|Growth Substances|growth substances|mesh-ancestor
153399817|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
153399818|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153399819|NCT01979276|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153399820|NCT01979276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259917|NCT01186094|Sirolimus|sirolimus|mesh-list
154259918|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154259919|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259920|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154259921|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154259922|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
154259923|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154259924|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
154259925|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259926|NCT01287806|Urinastatin|urinastatin|mesh-list
154259927|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154259928|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153733301|NCT00144209|Dexpramipexole|dexpramipexole|mesh-list
153399009|NCT02896907|Antidotes|antidotes|mesh-ancestor
153854258|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854259|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854273|NCT04643483|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153854274|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394506|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
153394507|NCT01805323|Hormones|hormones|mesh-ancestor
153399832|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399833|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153399835|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
153859553|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
153859554|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859555|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153859556|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153859557|NCT03098589|Growth Substances|growth substances|mesh-ancestor
153859558|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
153859559|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399836|NCT02871011|Protective Agents|protective agents|mesh-ancestor
153399837|NCT02344238|Riboflavin|riboflavin|mesh-list
153399838|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
153399839|NCT02344238|Vitamins|vitamins|mesh-ancestor
153825278|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153825279|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825280|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153825281|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153825282|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153825283|NCT01365481|Amlodipine|amlodipine|mesh-list
153825284|NCT01365481|Valsartan|valsartan|mesh-list
153825285|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153399845|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
153399867|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
153399868|NCT02019758|Hormones|hormones|mesh-ancestor
153859579|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153859580|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153859581|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
153859582|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859583|NCT05226299|Capsaicin|capsaicin|mesh-list
153859584|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
153859585|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
153859586|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
153859587|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399875|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399876|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153399877|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
153399878|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399879|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399880|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153399881|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399882|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
153399883|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
153399889|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153399890|NCT02021942|Pasireotide|pasireotide|mesh-list
153399891|NCT02021942|Hormones|hormones|mesh-ancestor
153394542|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
153394543|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394544|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153394545|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153394546|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
153394547|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394548|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153394549|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153394550|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
153394551|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394552|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153394553|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
153399892|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399893|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399894|NCT01981759|Cycloserine|cycloserine|mesh-list
153399895|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153865021|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865022|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865023|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
153865032|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865034|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865035|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153865036|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153865037|NCT01157182|Norethindrone|norethindrone|mesh-list
153865038|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
153865041|NCT01157182|Estrogens|estrogens|mesh-ancestor
153865042|NCT01157182|Hormones|hormones|mesh-ancestor
153865043|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153405449|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153399896|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399897|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153399898|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
153399899|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153399900|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
153399901|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859600|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859601|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
153859602|NCT02797119|Coagulants|coagulants|mesh-ancestor
153859603|NCT05161208|Varenicline|varenicline|mesh-list
153859604|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153859605|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153859606|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
153859607|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859608|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859609|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859610|NCT00538070|Glycine|glycine|mesh-list
153859611|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
153859612|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859613|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399912|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399913|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399914|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399915|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399916|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153399917|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399918|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399920|NCT01982695|Lisinopril|lisinopril|mesh-list
153399944|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153399945|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399946|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399947|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153399948|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153399949|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
153399950|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399951|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153399952|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153399953|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
153399954|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153399955|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
153399956|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
153859669|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
153859670|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859671|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153859672|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153854358|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153854359|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854361|NCT04640870|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153854362|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153854363|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854364|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859673|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
153859674|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
153859675|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153399975|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
153399976|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
153825300|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
153825301|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
153825302|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825303|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
153825304|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825305|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825306|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
153825307|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
153825308|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825309|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405466|NCT05445440|Leucovorin|leucovorin|mesh-list
153399977|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
153399978|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399979|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399980|NCT02348918|Bevacizumab|bevacizumab|mesh-list
153399986|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399987|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
153399988|NCT01985581|Guanfacine|guanfacine|mesh-list
153399989|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153399990|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153824518|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824519|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153824520|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153824521|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
153364491|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
153364492|NCT03005405|Protective Agents|protective agents|mesh-ancestor
153364493|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364495|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
153400006|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153400007|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
153400008|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
153400009|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153859729|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
153859730|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
153859731|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859732|NCT00538382|Artesunate|artesunate|mesh-list
153859733|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
153400011|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153400012|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153400013|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
153400014|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400015|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405526|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153405527|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865136|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865137|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153865138|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153865140|NCT01155661|Serotonin|serotonin|mesh-list
153400016|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
153400017|NCT02024204|Hormones|hormones|mesh-ancestor
153400018|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400019|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
153400020|NCT03930745|TOL-463|tol-463|mesh-list
153400021|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400022|NCT02034019|Dexamethasone|dexamethasone|mesh-list
153400023|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400024|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
153400025|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
153400026|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859745|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859746|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859747|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153859748|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
153859749|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
153400027|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400028|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153400029|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
153400030|NCT02034019|Hormones|hormones|mesh-ancestor
153400031|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400032|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153400033|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400034|NCT02349152|Fentanyl|fentanyl|mesh-list
154259929|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
154259930|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259931|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259932|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154259933|NCT01186172|Ethanol|ethanol|mesh-list
154259934|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154259935|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154259936|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154259937|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259938|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
154259939|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154259940|NCT03854708|Hormones|hormones|mesh-ancestor
154259941|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154259942|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259943|NCT03860870|Clenbuterol|clenbuterol|mesh-list
154259944|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154259945|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154259946|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
153733302|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153399082|NCT02902913|Ibuprofen|ibuprofen|mesh-list
153865222|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153865223|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
153865224|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865225|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854416|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854417|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153854418|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153854419|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
153854420|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854421|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854422|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
153854438|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854439|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153854441|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
153854442|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854443|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153854445|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400035|NCT02349152|Remifentanil|remifentanil|mesh-list
153400036|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153859754|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859755|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859756|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153859757|NCT04661475|Analgesics|analgesics|mesh-ancestor
153854456|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153854457|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153854458|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153854459|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
153854460|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
153854461|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
153854462|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
153854463|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859758|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
153859759|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859760|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153859761|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153859762|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153859763|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
153859764|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859765|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865226|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153825369|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825370|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825371|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365335|NCT02244710|Ticagrelor|ticagrelor|mesh-list
153365336|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153365337|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153365338|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153365339|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153365340|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
153400045|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
153400046|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
153400047|NCT02035345|Carboplatin|carboplatin|mesh-list
153400048|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400049|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
153400050|NCT01986361|Analgesics|analgesics|mesh-ancestor
153859776|NCT00538499|Analgesics|analgesics|mesh-ancestor
153859777|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153859778|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153859779|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
153859780|NCT00538538|Ranibizumab|ranibizumab|mesh-list
153859781|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153859782|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153859783|NCT00538538|Growth Substances|growth substances|mesh-ancestor
153859784|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859785|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
153859786|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859787|NCT00554346|Etoricoxib|etoricoxib|mesh-list
153859788|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153859789|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153859790|NCT00554346|Analgesics|analgesics|mesh-ancestor
153859791|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
153859792|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859793|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859794|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153859795|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364524|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
153364525|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153364526|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153364527|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364528|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153364529|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153400134|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400135|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153859851|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153859852|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153859853|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859854|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153733383|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859861|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
153859862|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859863|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153859864|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
153859865|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153859866|NCT02413827|Ipilimumab|ipilimumab|mesh-list
153859867|NCT02413827|Poly ICLC|poly iclc|mesh-list
153859868|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153859869|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859870|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859871|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153825372|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153825373|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825374|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825375|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153865405|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859872|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400156|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400159|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
153400160|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400161|NCT02037061|Bupivacaine|bupivacaine|mesh-list
153400162|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
153400163|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
153400164|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859877|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153859878|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859880|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153859881|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153859883|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153859884|NCT00539123|Narcotics|narcotics|mesh-ancestor
153859885|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859886|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859887|NCT00539123|Analgesics|analgesics|mesh-ancestor
153859888|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
153859889|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859890|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153859891|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
153859892|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153859893|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
153859894|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859895|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859896|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153859897|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
153859898|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
153859899|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153859900|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
153859901|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859902|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859903|NCT00539396|Insulin|insulin|mesh-list
153859904|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824578|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
153824579|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825376|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
153825377|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
153865432|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153865488|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153865490|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
153865491|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153865526|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153865528|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
153865529|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865530|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865531|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865532|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865533|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153400208|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153400209|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
153859917|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
153859918|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153859919|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859920|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153859921|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859922|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859924|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400236|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400247|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
153854509|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153394762|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153394764|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394765|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394766|NCT02525549|Adapalene|adapalene|mesh-list
153394767|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153394768|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
153394770|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153400248|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859944|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153859945|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153859946|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
153859947|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859948|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
153859949|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859950|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859951|NCT00539786|Rabeprazole|rabeprazole|mesh-list
153859952|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153859953|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153859954|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859955|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859956|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859957|NCT00540098|Paroxetine|paroxetine|mesh-list
153859958|NCT00540098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153859966|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
153859967|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153859968|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153865534|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153400258|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400259|NCT02951195|Ivacaftor|ivacaftor|mesh-list
153400260|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153825389|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153825390|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
153825403|NCT00500253|Miotics|miotics|mesh-ancestor
153400261|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400262|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400263|NCT02037230|Gemcitabine|gemcitabine|mesh-list
153400264|NCT02037230|Adavosertib|adavosertib|mesh-list
153400265|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153400266|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
153400267|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400268|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400269|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400270|NCT02312882|Tofacitinib|tofacitinib|mesh-list
153860005|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860006|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860007|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
153860008|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
153860009|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153860010|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
153860011|NCT00540527|Plasminogen|plasminogen|mesh-list
153860012|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153860013|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153860014|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153860015|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860016|NCT00540605|Tenofovir|tenofovir|mesh-list
153860017|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
153860019|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153860020|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153860021|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860022|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860023|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153860024|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153860025|NCT04659915|Metformin|metformin|mesh-list
153860026|NCT04659915|Prednisone|prednisone|mesh-list
153860043|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153854534|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153854535|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153854536|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153854537|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854539|NCT00559676|Capecitabine|capecitabine|mesh-list
153854540|NCT00559676|Fluorouracil|fluorouracil|mesh-list
153854541|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
153854542|NCT00559676|Irinotecan|irinotecan|mesh-list
153854543|NCT00559676|Calcium|calcium|mesh-list
153854544|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
153854545|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153854546|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825406|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153825407|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153825408|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
153825409|NCT01243788|Fluticasone|fluticasone|mesh-list
153825410|NCT01243788|Xhance|xhance|mesh-list
153365374|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153854547|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153854548|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
153854549|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860045|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153860046|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153860052|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860053|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
153860054|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
153860055|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
153860056|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860057|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153365375|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153365377|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860058|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
153400349|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400353|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400354|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153400355|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153400356|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400357|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400358|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153400359|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
153400360|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860068|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
153860069|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860070|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153860071|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
153860072|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860073|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
153860074|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
153860075|NCT00541073|Pemetrexed|pemetrexed|mesh-list
153860076|NCT00541073|Vitamins|vitamins|mesh-ancestor
153860077|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
153860078|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860079|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860080|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860081|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860082|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153860083|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153860084|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
153860085|NCT00541073|Hematinics|hematinics|mesh-ancestor
153860086|NCT00541112|Leucovorin|leucovorin|mesh-list
153860087|NCT00541112|Capecitabine|capecitabine|mesh-list
153860088|NCT00541112|Fluorouracil|fluorouracil|mesh-list
153400409|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860092|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
153860093|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153860094|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860095|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154259947|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865670|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865689|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153865690|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
153865691|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259948|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259949|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259950|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154259952|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259953|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154259954|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
154259955|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
154259956|NCT01177514|Gabapentin|gabapentin|mesh-list
154259957|NCT01177514|Analgesics|analgesics|mesh-ancestor
153733303|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153733304|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
153399173|NCT01990898|Cyclosporine|cyclosporine|mesh-list
153854577|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153854578|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
153854579|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153854580|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
153854581|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153854582|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854583|NCT04639193|Diuretics|diuretics|mesh-ancestor
153854584|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
153854585|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153854586|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394826|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394827|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
153394828|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153394829|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153394830|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394831|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
153394832|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
153394834|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394835|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394836|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153394837|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394838|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
153854588|NCT01235689|Adalimumab|adalimumab|mesh-list
153854589|NCT01235689|Azathioprine|azathioprine|mesh-list
153854590|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854591|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
153854592|NCT01235689|Hormones|hormones|mesh-ancestor
153854593|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854594|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854595|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153406191|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
153854596|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854597|NCT01235689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153860096|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
153860097|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860098|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860099|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153860100|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
153860146|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860147|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860148|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860149|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860150|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153400440|NCT02410382|Dexamethasone|dexamethasone|mesh-list
153400441|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400442|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
153400443|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
153400444|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400445|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400446|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153824646|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860155|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153860156|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153860163|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153860164|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153860165|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
153860166|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860167|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860168|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153860170|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153860171|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153860172|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
153860173|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
153400463|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153400464|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
153400465|NCT03119831|Ethanol|ethanol|mesh-list
153400466|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
153824662|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153824663|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153824664|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824665|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824666|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153824667|NCT04328194|Thrombin|thrombin|mesh-list
153824668|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
153824669|NCT04328194|Coagulants|coagulants|mesh-ancestor
153824670|NCT00491790|Montelukast|montelukast|mesh-list
153824671|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153824672|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153824673|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153400494|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400495|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400496|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153400497|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
153854628|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
153854629|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854630|NCT02897037|Heparin|heparin|mesh-list
153854631|NCT02897037|Bivalirudin|bivalirudin|mesh-list
153854632|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
153854633|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153854634|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153854635|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854636|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
153854637|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153394876|NCT02417831|Urological Agents|urological agents|mesh-ancestor
153394877|NCT02419547|Midazolam|midazolam|mesh-list
153394878|NCT02419547|Fentanyl|fentanyl|mesh-list
153394879|NCT02419547|Propofol|propofol|mesh-list
153394880|NCT02419547|Sevoflurane|sevoflurane|mesh-list
153825426|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825427|NCT01243827|Carvedilol|carvedilol|mesh-list
153825428|NCT01243827|Bisoprolol|bisoprolol|mesh-list
153825429|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153825430|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153825431|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825432|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825433|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825434|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825436|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
153865791|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394886|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
153400499|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400500|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400501|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
153400502|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153400503|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153400504|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153400505|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
153400506|NCT02044796|Cytarabine|cytarabine|mesh-list
153400507|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
153400508|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
153400509|NCT02044796|Cladribine|cladribine|mesh-list
153865793|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
153400510|NCT02044796|Lenograstim|lenograstim|mesh-list
153400521|NCT02044796|Analgesics|analgesics|mesh-ancestor
153400522|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
153400523|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860216|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860218|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153860219|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153860220|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860221|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153860222|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153860223|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860224|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860225|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153860226|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
153860227|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153860228|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
153860229|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153400524|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153400525|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153400526|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400528|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153400529|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
153400530|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400531|NCT03127943|Lidocaine|lidocaine|mesh-list
153400532|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
153400533|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
153400534|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400535|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400536|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
153400537|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365406|NCT02224313|Hormones|hormones|mesh-ancestor
153400538|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153824693|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
153824694|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860249|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860250|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259958|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
154259959|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154259960|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259961|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
154259962|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154259963|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154259964|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154259965|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154259966|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154259967|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154259968|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399277|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854653|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153854654|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
153394914|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153394916|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153394917|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153394918|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153394919|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153394920|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394921|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
153394922|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
153394923|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
153394924|NCT05328427|Protective Agents|protective agents|mesh-ancestor
153394925|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854673|NCT00553722|Eplerenone|eplerenone|mesh-list
153854674|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153854675|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
153854676|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854677|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854678|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153854679|NCT00553722|Diuretics|diuretics|mesh-ancestor
153854680|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
153854681|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153860251|NCT00542243|Urological Agents|urological agents|mesh-ancestor
153860252|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
153860253|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153399305|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153394963|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153394964|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394965|NCT05326867|Lidocaine|lidocaine|mesh-list
153394966|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
153394967|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
153854724|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854725|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854735|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153854736|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854737|NCT02895672|Exenatide|exenatide|mesh-list
153854738|NCT02895672|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153365418|NCT01633853|Vitamin D|vitamin d|mesh-list
153865871|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865872|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865873|NCT01151098|Analgesics|analgesics|mesh-ancestor
153865874|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
153865875|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865876|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153865877|NCT04619303|Dexamethasone|dexamethasone|mesh-list
153865878|NCT04619303|Bevacizumab|bevacizumab|mesh-list
153865879|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406332|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153406333|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153406334|NCT04736329|Telmisartan|telmisartan|mesh-list
153406335|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153406336|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153406337|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153406338|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406340|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
153406341|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153400550|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400551|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
153824724|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153824726|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
153860286|NCT00542984|Katacalcin|katacalcin|mesh-list
153860287|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153860288|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860289|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153860290|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
153400589|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400590|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400591|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153400593|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153400594|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153400595|NCT02978339|Analgesics|analgesics|mesh-ancestor
153400596|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
153400597|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400598|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400599|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400600|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153400601|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400602|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400603|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400604|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
153400605|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400606|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364728|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153860326|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860327|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860328|NCT03456752|Dexamethasone|dexamethasone|mesh-list
153400624|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153400625|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153400626|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825448|NCT00500409|Vitamin D|vitamin d|mesh-list
153865915|NCT00568503|Bromides|bromides|mesh-list
153865916|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
153865917|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153865918|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
153865919|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865920|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865931|NCT00562835|Thiamine|thiamine|mesh-list
153865932|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
153400627|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400628|NCT02413034|Vancomycin|vancomycin|mesh-list
153400629|NCT02413034|Cefazolin|cefazolin|mesh-list
153400630|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153400631|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400651|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153400652|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153400653|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153400654|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
153400655|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400656|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860348|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860349|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153860598|NCT05824468|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153395004|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153395005|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395006|NCT05318521|Analgesics|analgesics|mesh-ancestor
153395007|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
153860599|NCT05824468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860600|NCT05824468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860601|NCT05824468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860602|NCT05824468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860603|NCT05824455|Irinotecan|irinotecan|mesh-list
153860604|NCT05824455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153860605|NCT05824455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153860606|NCT05824455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860607|NCT05824455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860608|NCT05824455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860609|NCT05824390|Rituximab|rituximab|mesh-list
153400907|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
153400908|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400909|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824796|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153824797|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824798|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824799|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
153824800|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
153865933|NCT00562835|Vitamins|vitamins|mesh-ancestor
153865934|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
153860825|NCT04941105|Protease Inhibitors|protease inhibitors|mesh-ancestor
153733394|NCT00507091|Irinotecan|irinotecan|mesh-list
153860865|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860866|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860867|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153401172|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
153401173|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401174|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401175|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
153401176|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824807|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153824808|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824809|NCT00492258|Sorafenib|sorafenib|mesh-list
153824810|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824811|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153824812|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824814|NCT02955810|Dexamethasone|dexamethasone|mesh-list
153401495|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401496|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
153401497|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153401498|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401499|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
153401500|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861477|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
153861478|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
153861479|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153861480|NCT00548483|Dexamethasone|dexamethasone|mesh-list
153861481|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861482|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
153402373|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824818|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153402659|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153402660|NCT05025605|Analgesics|analgesics|mesh-ancestor
153862308|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153862309|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153862310|NCT04626063|Acetaminophen|acetaminophen|mesh-list
153406425|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
153406426|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
153402723|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862353|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153365485|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153365486|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153866047|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153862354|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153862356|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
153862357|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153862358|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153862359|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153402731|NCT04939480|Atezolizumab|atezolizumab|mesh-list
153402732|NCT04939480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402830|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153402831|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
154259969|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154259970|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
154259971|NCT00073008|Lapatinib|lapatinib|mesh-list
154259972|NCT00073008|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154259973|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154259974|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154259975|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733305|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733306|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733307|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854798|NCT00560300|Calcitriol|calcitriol|mesh-list
153854799|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153854800|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153854801|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
153854802|NCT00560300|Calcium|calcium|mesh-list
153854803|NCT00560300|Sevelamer|sevelamer|mesh-list
153854804|NCT00560300|Vitamins|vitamins|mesh-ancestor
153854805|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
153854806|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854807|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153854808|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153854809|NCT00560300|Antacids|antacids|mesh-ancestor
153854810|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854811|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854812|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153854813|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153854814|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153854815|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
153914627|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914628|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153914629|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153914630|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
153914631|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
153825505|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825506|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153406526|NCT04327024|Protective Agents|protective agents|mesh-ancestor
153406527|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406528|NCT04315272|Azithromycin|azithromycin|mesh-list
153406529|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153395060|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
153395061|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395062|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
153402832|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153854842|NCT02894892|Bismuth|bismuth|mesh-list
153854843|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153854844|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854845|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153395083|NCT05747521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395085|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
153395086|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
153395087|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395088|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395089|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
153395090|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395091|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153395092|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153395093|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153395094|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402833|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402834|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153402835|NCT04751500|Metronidazole|metronidazole|mesh-list
153402836|NCT04751500|Clindamycin|clindamycin|mesh-list
153402837|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153862496|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153862770|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862772|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153862773|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153862774|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153862775|NCT02900729|Diuretics|diuretics|mesh-ancestor
153862812|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153403169|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403170|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153403171|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153403172|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153403173|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153403174|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403175|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153403178|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153403179|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153403180|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153403181|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403182|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403183|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403184|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
153403185|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
153403197|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403199|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
153403200|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403201|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153403202|NCT04109924|Trifluridine|trifluridine|mesh-list
153403203|NCT04109924|Bevacizumab|bevacizumab|mesh-list
153862844|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862846|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153862847|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153403241|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403243|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153733398|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403244|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854861|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854862|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395124|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
153395125|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
153395126|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395127|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153395128|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153395129|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395130|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395135|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
153403245|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
153403246|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403247|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824857|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824858|NCT00467909|Micronutrients|micronutrients|mesh-list
153824859|NCT00467909|Trace Elements|trace elements|mesh-list
153824860|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824861|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153863050|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863051|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153403448|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403449|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153403451|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403452|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
153403453|NCT03688464|Promethazine|promethazine|mesh-list
153403454|NCT03688464|Melatonin|melatonin|mesh-list
153403455|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
153403456|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403457|NCT03688464|Protective Agents|protective agents|mesh-ancestor
153403458|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403459|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403460|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153825535|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825536|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153863081|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153863082|NCT04618107|Anesthetics|anesthetics|mesh-list
153403617|NCT03192995|Dopamine Agents|dopamine agents|mesh-ancestor
153403618|NCT03192995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403619|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
153863445|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863459|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153863461|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153863462|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863463|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153863464|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153863465|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153863466|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863469|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153863470|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153364881|NCT02219321|Lidocaine|lidocaine|mesh-list
153403884|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824924|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824926|NCT01245582|Capecitabine|capecitabine|mesh-list
153404005|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404006|NCT01476787|Rituximab|rituximab|mesh-list
153404029|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153404031|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404032|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153404033|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404034|NCT00993408|Selexipag|selexipag|mesh-list
153404037|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404038|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
153404052|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404055|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
153404057|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404058|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
153364917|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
153364918|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863694|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153863695|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
153863696|NCT00554918|Prednisolone|prednisolone|mesh-list
153863697|NCT00554918|Docetaxel|docetaxel|mesh-list
153863698|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863699|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
153863700|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
153824956|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
153824957|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824959|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
153825537|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824960|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
153364925|NCT04376528|Cyclosporine|cyclosporine|mesh-list
153364926|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
153364927|NCT04376528|Cyclosporins|cyclosporins|mesh-list
153364928|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364929|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364930|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364931|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
153825548|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825549|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
153404122|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404123|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153404134|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
153404135|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404136|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153404137|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153404138|NCT00161213|Gemcitabine|gemcitabine|mesh-list
153404139|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
153404140|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153404141|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
153404142|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404143|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404144|NCT00161213|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153733402|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154259982|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154259983|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
154259984|NCT03856502|Dexamethasone|dexamethasone|mesh-list
154259985|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
154259986|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
154259987|NCT03856502|BB 1101|bb 1101|mesh-list
154259988|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154259989|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
153395306|NCT02434523|Amitriptyline|amitriptyline|mesh-list
153863808|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863809|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153863810|NCT01998035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153863811|NCT04611243|Vaccines|vaccines|mesh-list
153863812|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
153863813|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863814|NCT00564057|Candesartan|candesartan|mesh-list
153863815|NCT00564057|Candesartan cilexetil|candesartan cilexetil|mesh-list
153404197|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404199|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
153404200|NCT02403895|Paclitaxel|paclitaxel|mesh-list
153404201|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153404202|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404203|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
153404204|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404205|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
153404206|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404207|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153404208|NCT02354833|Phenylephrine|phenylephrine|mesh-list
153404209|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
153404210|NCT02354833|Norepinephrine|norepinephrine|mesh-list
153404211|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153404212|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
153404213|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
153404214|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404215|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866193|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
153365530|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153365531|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153365532|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
153365533|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153365534|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365535|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866246|NCT00570726|Growth Substances|growth substances|mesh-ancestor
153866248|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
153404216|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
153404217|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153404218|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
153863817|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153863818|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153863819|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153863820|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863821|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153863822|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153863823|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153863824|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863826|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
153863827|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824999|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
153825000|NCT00468182|Interferons|interferons|mesh-list
153825001|NCT00468182|Interferon-beta|interferon-beta|mesh-list
153395387|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395388|NCT02439281|Analgesics|analgesics|mesh-ancestor
153395392|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153395394|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153395395|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395396|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395397|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395398|NCT02505269|Doxorubicin|doxorubicin|mesh-list
153395399|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153395400|NCT02505269|Dacarbazine|dacarbazine|mesh-list
153825002|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
153825003|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825004|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
153863835|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153863836|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153863852|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863853|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153863854|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154260001|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260002|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
154260003|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
153855428|NCT00448409|Sargramostim|sargramostim|mesh-list
153864282|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864283|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864284|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153864285|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864286|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365032|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
153404718|NCT00356005|Azithromycin|azithromycin|mesh-list
153404719|NCT00356005|Artesunate|artesunate|mesh-list
153404720|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153404721|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404722|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
153404723|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153404724|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153404725|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404726|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
153404727|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
153404728|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153404729|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
153825563|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825564|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153825565|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153825566|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825567|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825568|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153825569|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153406708|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406709|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406710|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153406711|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
153406713|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404730|NCT00376337|Micafungin|micafungin|mesh-list
153404731|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
153404732|NCT00376337|Clotrimazole|clotrimazole|mesh-list
153404733|NCT00376337|Miconazole|miconazole|mesh-list
153404734|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404735|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153404736|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153404737|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153404738|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864315|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
153864316|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864317|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864318|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153864319|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153864320|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864321|NCT04608669|Acetaminophen|acetaminophen|mesh-list
153864322|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864323|NCT04608669|Analgesics|analgesics|mesh-ancestor
153864324|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
153864325|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864326|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864327|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
153864328|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153864339|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864340|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864341|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153864342|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153864343|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
153864345|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864346|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153864347|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153864348|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864349|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864350|NCT01704365|Vaccines|vaccines|mesh-list
153864351|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
153365041|NCT04372082|Diltiazem|diltiazem|mesh-list
153404776|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
153404777|NCT02979223|Cathartics|cathartics|mesh-ancestor
153404778|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404779|NCT01805271|Everolimus|everolimus|mesh-list
153365562|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365563|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404780|NCT01805271|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153404781|NCT01805271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153404788|NCT01768767|Ketamine|ketamine|mesh-list
153404789|NCT01768767|Analgesics|analgesics|mesh-ancestor
153404790|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
153404791|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404792|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825102|NCT01371838|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153864537|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864538|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
153864539|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
153864540|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864541|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365564|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153365565|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153365566|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
153365567|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365568|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365569|NCT02451696|Everolimus|everolimus|mesh-list
153365570|NCT02451696|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153864542|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153864543|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
153864544|NCT00564603|Hormones|hormones|mesh-ancestor
153864545|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864546|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153864547|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864548|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
153864549|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864550|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404952|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
153404953|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404954|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153365080|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365081|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405003|NCT05715788|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153405005|NCT05715788|Gasotransmitters|gasotransmitters|mesh-ancestor
153405006|NCT05715788|Protective Agents|protective agents|mesh-ancestor
153405007|NCT00003225|Irinotecan|irinotecan|mesh-list
153405008|NCT00003225|Amifostine|amifostine|mesh-list
153405009|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153864622|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864623|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864625|NCT04187755|Cefepime|cefepime|mesh-list
153864626|NCT04187755|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153405029|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153405030|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405031|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405033|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153405034|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153405035|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825120|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825121|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153825122|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153825123|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
153825124|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825125|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153365094|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864627|NCT04187755|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153864628|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153405060|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153405062|NCT02265510|Paclitaxel|paclitaxel|mesh-list
153405063|NCT02265510|Gemcitabine|gemcitabine|mesh-list
153825585|NCT00469703|Thalidomide|thalidomide|mesh-list
153405064|NCT02265510|Lenalidomide|lenalidomide|mesh-list
153405065|NCT02265510|Azacitidine|azacitidine|mesh-list
153405066|NCT02265510|Bortezomib|bortezomib|mesh-list
153405067|NCT02265510|Pomalidomide|pomalidomide|mesh-list
153405068|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153405069|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405070|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405071|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405072|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405073|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405074|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825135|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153825136|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825137|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825138|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
153365137|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153365138|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153365140|NCT04371146|Methylphenidate|methylphenidate|mesh-list
153825173|NCT00499707|Metformin|metformin|mesh-list
153864752|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153864753|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864754|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864784|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864785|NCT01160770|Clobazam|clobazam|mesh-list
153405165|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
153864786|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
153864787|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153864788|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153405229|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153405230|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153405231|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405232|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365180|NCT03207347|Niraparib|niraparib|mesh-list
153405256|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405257|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
153405258|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
153405259|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153405260|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153405261|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153405262|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
153864853|NCT04605705|Analgesics|analgesics|mesh-ancestor
153864854|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
153864855|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825587|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
153864856|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864857|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153405263|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405266|NCT00003261|Methotrexate|methotrexate|mesh-list
153405267|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153405268|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
153405269|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153405270|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405271|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405272|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
153864877|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864879|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153864880|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864881|NCT04631627|Analgesics|analgesics|mesh-ancestor
153864882|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
153864883|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864884|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864885|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365586|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153365587|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
153365588|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
153365589|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
153365590|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
153365591|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864886|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864887|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153825239|NCT00474071|Remifentanil|remifentanil|mesh-list
153825240|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153825241|NCT00474071|Narcotics|narcotics|mesh-ancestor
153365207|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864935|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153864937|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
153864938|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153864939|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153864940|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153864941|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
153864942|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864943|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864944|NCT04597203|Hydroquinone|hydroquinone|mesh-list
153864945|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
153864946|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864947|NCT04597203|Protective Agents|protective agents|mesh-ancestor
153864948|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864949|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153864950|NCT01158118|Plerixafor|plerixafor|mesh-list
153864951|NCT01158118|Sargramostim|sargramostim|mesh-list
153864952|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
153365230|NCT04369586|Meplazumab|meplazumab|mesh-list
153825263|NCT00474110|Narcotics|narcotics|mesh-ancestor
153864989|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153864990|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
153365592|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864991|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864992|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864993|NCT00564993|Protective Agents|protective agents|mesh-ancestor
153864994|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
153864995|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153864996|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
153365593|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153365594|NCT02459418|Hormones|hormones|mesh-ancestor
153864997|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864998|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153864999|NCT04604886|Dobutamine|dobutamine|mesh-list
153865014|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
153865015|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153825608|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825610|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153865016|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153865017|NCT04595877|Analgesics|analgesics|mesh-ancestor
153865018|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
153865019|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865020|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405452|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
153405453|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405454|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405455|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405456|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405464|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405465|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865071|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153865072|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153865073|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405514|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405515|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405516|NCT05229614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153405517|NCT05229614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405518|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153405519|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
153405520|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405521|NCT05210582|Afamelanotide|afamelanotide|mesh-list
153405522|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
153405523|NCT05647356|Bicalutamide|bicalutamide|mesh-list
153405524|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
153405525|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
153865216|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
153865218|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
153865219|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865220|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
153865221|NCT04626752|Fludarabine|fludarabine|mesh-list
153405632|NCT05924893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405633|NCT05924893|Sensory System Agents|sensory system agents|mesh-ancestor
153405634|NCT05924893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405635|NCT05924165|Ketorolac|ketorolac|mesh-list
153405636|NCT05924165|Oxycodone|oxycodone|mesh-list
153405637|NCT05924165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153405638|NCT05924165|Narcotics|narcotics|mesh-ancestor
153405639|NCT05924165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365341|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365342|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867243|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153867244|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
153365343|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365344|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
153405839|NCT05893056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153405841|NCT05893056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405842|NCT05893056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405843|NCT05891379|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153865540|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153865541|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153865543|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
153865544|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406031|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
153865614|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865615|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
153865616|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153865617|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153406082|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153406084|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406085|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406086|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153406088|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153406089|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406090|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153406091|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406092|NCT05403138|Daratumumab|daratumumab|mesh-list
153406093|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406094|NCT05353140|Aspirin|aspirin|mesh-list
153406095|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
153865666|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153865667|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153865668|NCT04622111|Metformin|metformin|mesh-list
153865669|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153365380|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365381|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153365382|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153365383|NCT02245022|Tenofovir|tenofovir|mesh-list
153365384|NCT02245022|Lamivudine|lamivudine|mesh-list
153365385|NCT02245022|Efavirenz|efavirenz|mesh-list
153365386|NCT02245022|Dolutegravir|dolutegravir|mesh-list
153365387|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
153865692|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865693|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153865694|NCT04621487|Amoxicillin|amoxicillin|mesh-list
153865695|NCT04621487|Metronidazole|metronidazole|mesh-list
153865696|NCT04621487|Clarithromycin|clarithromycin|mesh-list
153865697|NCT04621487|Pantoprazole|pantoprazole|mesh-list
153865698|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153865699|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865700|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153865701|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153865702|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153733414|NCT00148083|Risperidone|risperidone|mesh-list
153733415|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153733416|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
153733417|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406194|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153406195|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
153406196|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
153406197|NCT05213676|Protective Agents|protective agents|mesh-ancestor
153406198|NCT05206110|Ketorolac|ketorolac|mesh-list
153406199|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153865763|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
153865764|NCT04649697|Hormones|hormones|mesh-ancestor
153865765|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865766|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865767|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153865768|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865769|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
153865770|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865771|NCT04649697|Protective Agents|protective agents|mesh-ancestor
153855841|NCT00450203|Lapatinib|lapatinib|mesh-list
153855842|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153855843|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855844|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153855845|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153855890|NCT00450827|Antibodies|antibodies|mesh-list
153865772|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865773|NCT04621253|Dipyrone|dipyrone|mesh-list
153865774|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153865775|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153865776|NCT04621253|Analgesics|analgesics|mesh-ancestor
153865777|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
153865778|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407773|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
153407829|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407830|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
153865779|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865792|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865794|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153865795|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865796|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153865797|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865798|NCT04691063|Carboplatin|carboplatin|mesh-list
153865799|NCT04691063|Etoposide|etoposide|mesh-list
153865800|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
153406220|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153406221|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406222|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406223|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153406224|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406225|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
153406226|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
153406227|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153406228|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153403820|NCT02409147|Nystatin|nystatin|mesh-list
153406229|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153406230|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
153406231|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406232|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153406233|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
153406234|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
153865811|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153865832|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
153865833|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153865834|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153865835|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153865836|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865837|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153865838|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153865839|NCT04588194|Dexamethasone|dexamethasone|mesh-list
153865840|NCT04588194|Rituximab|rituximab|mesh-list
153865841|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865842|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
153406267|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406268|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406269|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153406270|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406271|NCT05045703|Vitamin A|vitamin a|mesh-list
153406272|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
153406273|NCT05045703|Vitamins|vitamins|mesh-ancestor
153406274|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
153867879|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153867880|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867881|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867882|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867883|NCT00583869|Pregabalin|pregabalin|mesh-list
153867884|NCT00583869|Analgesics|analgesics|mesh-ancestor
153867885|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
153867886|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867887|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406275|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406276|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
153406277|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855911|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855912|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855913|NCT00451061|Urological Agents|urological agents|mesh-ancestor
153855914|NCT02931383|Liraglutide|liraglutide|mesh-list
153855915|NCT02931383|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153855916|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153855917|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855918|NCT02931383|Incretins|incretins|mesh-ancestor
153855919|NCT02931383|Hormones|hormones|mesh-ancestor
153855920|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855921|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
153855922|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
153855923|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153855924|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153855925|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855926|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406278|NCT05045703|Protective Agents|protective agents|mesh-ancestor
153406291|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406292|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406293|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153406294|NCT04927884|Immunoconjugates|immunoconjugates|mesh-ancestor
153406296|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
153406297|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406298|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
153406299|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406300|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153406301|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153865868|NCT01151098|Buprenorphine|buprenorphine|mesh-list
153867888|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
153867889|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153868513|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409017|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153409018|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
153409019|NCT03498014|Narcotics|narcotics|mesh-ancestor
153409020|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409021|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409043|NCT04256603|Analgesics|analgesics|mesh-ancestor
153409044|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
153409045|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865869|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153865870|NCT01151098|Narcotics|narcotics|mesh-ancestor
153406421|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
153406424|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866064|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866065|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866066|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866067|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
153866068|NCT00569712|Hormones|hormones|mesh-ancestor
153866069|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866070|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153866071|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153866072|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153866073|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
153866074|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866103|NCT00567957|Analgesics|analgesics|mesh-ancestor
153866104|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
153866105|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866106|NCT02940002|Betamethasone|betamethasone|mesh-list
153866108|NCT02940002|Calcipotriene|calcipotriene|mesh-list
153866109|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866110|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
153866111|NCT02940002|Hormones|hormones|mesh-ancestor
153866114|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866115|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866116|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
153866117|NCT04618328|Tretinoin|tretinoin|mesh-list
153406546|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
153406547|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
153406548|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
153406549|NCT04297592|Doxycycline|doxycycline|mesh-list
153406550|NCT04297592|Cephalexin|cephalexin|mesh-list
153406672|NCT04085458|Coagulants|coagulants|mesh-ancestor
153406673|NCT04077580|Methenamine|methenamine|mesh-list
153406674|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
153406675|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
153406676|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153406677|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406678|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153406679|NCT03974217|Decitabine|decitabine|mesh-list
153825556|NCT01342510|Analgesics|analgesics|mesh-ancestor
153825557|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
153866247|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866249|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866250|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
153866251|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153866252|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153866253|NCT00563069|Midazolam|midazolam|mesh-list
153866254|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153866255|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153866256|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866257|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866258|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153866259|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153866260|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153866261|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153866262|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
153866263|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
153866264|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
153866265|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
153866266|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866267|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866268|NCT04580355|Amoxicillin|amoxicillin|mesh-list
153866269|NCT04580355|Metronidazole|metronidazole|mesh-list
153866270|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153866271|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866272|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153866273|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153866274|NCT00563108|Basiliximab|basiliximab|mesh-list
153365536|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
153866282|NCT00570882|Growth Substances|growth substances|mesh-ancestor
153866283|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866284|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
153866285|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866286|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866342|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365575|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
153365576|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409057|NCT05721079|Methoxsalen|methoxsalen|mesh-list
153409266|NCT05716945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868808|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868810|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868811|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153868812|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153409392|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409393|NCT04450836|Trifluridine|trifluridine|mesh-list
153409394|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
153409395|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409396|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
153866456|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866457|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866460|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153866461|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153406901|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406902|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153406903|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153406904|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406905|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
153406906|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406907|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406908|NCT03448666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406909|NCT03448666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406910|NCT03439865|Ivacaftor|ivacaftor|mesh-list
154260015|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153396493|NCT01871077|Analgesics|analgesics|mesh-ancestor
153396494|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
153396495|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396496|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396497|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153396498|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856221|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
153856222|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856223|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
153856224|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
153856225|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
153856226|NCT02927015|Iproplatin|iproplatin|mesh-list
153856227|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856228|NCT04680195|Thalidomide|thalidomide|mesh-list
153856229|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153856248|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153856249|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856250|NCT00553995|Analgesics|analgesics|mesh-ancestor
153856251|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
153856252|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856253|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856254|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825593|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153365604|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825643|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825645|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825646|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
153869077|NCT00191451|Carboplatin|carboplatin|mesh-list
153869078|NCT00191451|Gemcitabine|gemcitabine|mesh-list
153869079|NCT00191451|Trastuzumab|trastuzumab|mesh-list
153869080|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409675|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
153825647|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825648|NCT03271502|Anesthetics|anesthetics|mesh-list
154260025|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260026|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260027|NCT00058422|Prednisone|prednisone|mesh-list
154260028|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
154260029|NCT00058422|Rituximab|rituximab|mesh-list
154260030|NCT00058422|Doxorubicin|doxorubicin|mesh-list
154260031|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154260032|NCT00058422|Vincristine|vincristine|mesh-list
154260033|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
154260034|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154260035|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733320|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
153399932|NCT01981772|Lidocaine|lidocaine|mesh-list
153856375|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153856376|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
153856377|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153856378|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
153856379|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153856380|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153856381|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856382|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856383|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153856384|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153396657|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396658|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396659|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153396660|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856415|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
153856416|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
153856417|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153856418|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856419|NCT01228656|Analgesics|analgesics|mesh-ancestor
153396661|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153396662|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396663|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409676|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
153396665|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825649|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825650|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825651|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
153825652|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408106|NCT00360464|Azithromycin|azithromycin|mesh-list
153408107|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153408108|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408109|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
153408110|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153408383|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408385|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408386|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153408387|NCT04662242|Selenium|selenium|mesh-list
153408388|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
153409046|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409047|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
153409048|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153409049|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153409050|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409051|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153409052|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153868864|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868865|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868915|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869072|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869073|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869074|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869075|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869076|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
153365797|NCT02458638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365798|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365799|NCT01607411|Fluorides|fluorides|mesh-list
153365800|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
153365801|NCT01607411|Protective Agents|protective agents|mesh-ancestor
153365802|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365803|NCT01691339|Vaccines|vaccines|mesh-list
153825861|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153825862|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825863|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153825864|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153825865|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
153825866|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153825867|NCT00470015|Aldesleukin|aldesleukin|mesh-list
153825868|NCT00470015|Interleukin-2|interleukin-2|mesh-list
153825869|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365843|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
153365844|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153365845|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153870289|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870290|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153870291|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
153870292|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870293|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870295|NCT01083810|Lopinavir|lopinavir|mesh-list
154260042|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260043|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154260044|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154260045|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154260046|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154260047|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153396777|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396778|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
153396779|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396780|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153396781|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153870296|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153869411|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153869419|NCT04603664|Cystatins|cystatins|mesh-list
153410026|NCT00003423|Vincristine|vincristine|mesh-list
153410027|NCT00003423|Daunorubicin|daunorubicin|mesh-list
153410028|NCT00003423|Asparaginase|asparaginase|mesh-list
153869532|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869533|NCT02277678|Analgesics|analgesics|mesh-ancestor
153869534|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
153869535|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869536|NCT04601675|Dexamethasone|dexamethasone|mesh-list
153869537|NCT04601675|Ranibizumab|ranibizumab|mesh-list
153869538|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869539|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
153869540|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
153869541|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825834|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
153825835|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825836|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
153825837|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825838|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
153870297|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153870298|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
153870299|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870300|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410919|NCT00004887|Mitomycin|mitomycin|mesh-list
153410920|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410921|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410922|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410923|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410924|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410925|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410926|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410927|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
153410928|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153410929|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153870387|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153870388|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411007|NCT00004047|Exatecan|exatecan|mesh-list
153411008|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411031|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411033|NCT00003633|Docetaxel|docetaxel|mesh-list
153411034|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
153411035|NCT00003633|Estramustine|estramustine|mesh-list
153870496|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153870497|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870498|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153870499|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153870500|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
153870501|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153870502|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870503|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870504|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870505|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
153870506|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
154260048|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260049|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260050|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
154260051|NCT00058422|Hormones|hormones|mesh-ancestor
154260052|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260053|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154260054|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153365839|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365840|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365841|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365842|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869642|NCT04576208|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153869643|NCT04576208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153869644|NCT04576208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869645|NCT04576208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869646|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869647|NCT04571151|Halobetasol|halobetasol|mesh-list
153869648|NCT04571151|Calcipotriene|calcipotriene|mesh-list
153410186|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870507|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870510|NCT01085097|Protective Agents|protective agents|mesh-ancestor
153870511|NCT00590837|Lomustine|lomustine|mesh-list
153870512|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153870513|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
153870514|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870515|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870516|NCT01086267|Cetuximab|cetuximab|mesh-list
153870517|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411590|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
153411591|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
153411592|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153411615|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411616|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411617|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
153411618|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411619|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411620|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153870997|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153871000|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871001|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
153871002|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871003|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871004|NCT00191984|Irinotecan|irinotecan|mesh-list
153871005|NCT00191984|Pemetrexed|pemetrexed|mesh-list
153871006|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153871007|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153871008|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871009|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871010|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870022|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153871011|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153871012|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153825849|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825850|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153410596|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410597|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410598|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
153871013|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
153871014|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153871015|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871016|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153871017|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153871018|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153871019|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153871020|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871021|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
153871022|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871023|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871024|NCT00191789|Gemcitabine|gemcitabine|mesh-list
153871025|NCT00191789|Doxorubicin|doxorubicin|mesh-list
153871026|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871070|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871097|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
153871098|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871100|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871101|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153411803|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411804|NCT00385437|Mirtazapine|mirtazapine|mesh-list
153411805|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
153411806|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153411807|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153411808|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
153396932|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153396933|NCT05432843|Pregabalin|pregabalin|mesh-list
153396934|NCT05432843|Analgesics|analgesics|mesh-ancestor
153856688|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153410599|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410601|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
153410602|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153410605|NCT00003549|Methotrexate|methotrexate|mesh-list
153410606|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410607|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
153410608|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410609|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410611|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
153410615|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
153410616|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410617|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153410618|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
153856689|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856690|NCT02081118|Exenatide|exenatide|mesh-list
153856691|NCT02081118|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153856692|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153411809|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
153411810|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411811|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826024|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
153826025|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826026|NCT00600847|Loratadine|loratadine|mesh-list
153826027|NCT00600847|Desloratadine|desloratadine|mesh-list
153826028|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153826029|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
153826030|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826036|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
153826058|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871314|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
153871315|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153871316|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
153871386|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871388|NCT00476996|Methotrexate|methotrexate|mesh-list
153871389|NCT00476996|Leflunomide|leflunomide|mesh-list
153871390|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
153871391|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153871393|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153871394|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871395|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871396|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
153871397|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871398|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871399|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412044|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871419|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
153871420|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871421|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871422|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871423|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153871424|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153871425|NCT00475865|Analgesics|analgesics|mesh-ancestor
153871426|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
153871427|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871428|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871429|NCT00475670|Paclitaxel|paclitaxel|mesh-list
153410848|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153410849|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153410852|NCT00003597|Ifosfamide|ifosfamide|mesh-list
153410853|NCT00003597|Lenograstim|lenograstim|mesh-list
153365863|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365864|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153365865|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365866|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153365867|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
153871430|NCT00475670|Docetaxel|docetaxel|mesh-list
153871431|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153871432|NCT00475670|Trastuzumab|trastuzumab|mesh-list
153871433|NCT00475670|Taxane|taxane|mesh-list
153412045|NCT00004731|Vitamins|vitamins|mesh-ancestor
153412046|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
153412047|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412048|NCT00003891|Lurtotecan|lurtotecan|mesh-list
153412049|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412050|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153412051|NCT00004755|Allopurinol|allopurinol|mesh-list
153412052|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
153412053|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412054|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412055|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
153366122|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
153366123|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153366124|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366125|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
153366126|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
153366127|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
154260056|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
154260057|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
154260058|NCT00058422|Hematinics|hematinics|mesh-ancestor
154260059|NCT01094964|Interferons|interferons|mesh-list
154260060|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
154260061|NCT01094964|Epirubicin|epirubicin|mesh-list
154260062|NCT01094964|Mitomycins|mitomycins|mesh-list
154260063|NCT01094964|Mitomycin|mitomycin|mesh-list
154260064|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260065|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
154260066|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733322|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733323|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733324|NCT00144287|Ritonavir|ritonavir|mesh-list
153733325|NCT00144287|Tipranavir|tipranavir|mesh-list
153733326|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153410854|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410855|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410856|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410857|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410858|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410859|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733327|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153733328|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
153733329|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733330|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856775|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856804|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856805|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
153397076|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153397077|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
153397078|NCT05648526|Ketamine|ketamine|mesh-list
153397079|NCT05648526|Analgesics|analgesics|mesh-ancestor
153397080|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
153397081|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397082|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397083|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153397084|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153397086|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
153366128|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366129|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153366130|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153366131|NCT02158520|Growth Substances|growth substances|mesh-ancestor
153366132|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366133|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
153366134|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
153412122|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154260068|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260069|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154260070|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154260071|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154260072|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260073|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260074|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
154260075|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154260076|NCT01291472|Ketorolac|ketorolac|mesh-list
154260077|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154260078|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154260079|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154260080|NCT01291472|Analgesics|analgesics|mesh-ancestor
153733331|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153856853|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
153412124|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412125|NCT00386061|Hormones|hormones|mesh-ancestor
153412126|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412127|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412128|NCT00386139|Aliskiren|aliskiren|mesh-list
153412129|NCT00386139|Renin Inhibitors|renin inhibitors|mesh-ancestor
153412130|NCT00386139|Protease Inhibitors|protease inhibitors|mesh-ancestor
153412131|NCT00386139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412132|NCT00386139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412133|NCT00005571|Eculizumab|eculizumab|mesh-list
153412134|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153412135|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412136|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
153412137|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412138|NCT00005577|Gemcitabine|gemcitabine|mesh-list
153412139|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412140|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
153412141|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871494|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153871495|NCT00470834|Bicalutamide|bicalutamide|mesh-list
153412161|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412162|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153871527|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412181|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412182|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
153412183|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
153412184|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871545|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153412193|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412194|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412195|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
153365908|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412196|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412197|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
153412198|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412199|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412200|NCT00005607|Leucovorin|leucovorin|mesh-list
153412201|NCT00005607|Fluorouracil|fluorouracil|mesh-list
153412202|NCT00005607|Irinotecan|irinotecan|mesh-list
153412203|NCT00005607|Calcium|calcium|mesh-list
153412204|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
153397141|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
153397142|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397143|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397144|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153397145|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153397146|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153397147|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153397148|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153412205|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153412206|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871564|NCT00474188|Dexamethasone|dexamethasone|mesh-list
153871588|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871589|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153871590|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
153871591|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
153871592|NCT01089647|Hormones|hormones|mesh-ancestor
153871593|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871595|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
153871596|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153871597|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153871598|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825912|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153825913|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
153825914|NCT00501579|Difluprednate|difluprednate|mesh-list
153825915|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825916|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
153825917|NCT00501579|Hormones|hormones|mesh-ancestor
153825918|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871599|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
153871600|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153871601|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153871602|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153871620|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871622|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153871623|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871624|NCT01089413|Bevacizumab|bevacizumab|mesh-list
153366184|NCT04359212|PENTA|penta|mesh-list
153412261|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
153412262|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412263|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412264|NCT00005643|Doxorubicin|doxorubicin|mesh-list
153412265|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153412266|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412267|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412268|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412269|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412270|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412271|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412272|NCT00005649|Paclitaxel|paclitaxel|mesh-list
153412273|NCT00005649|Capecitabine|capecitabine|mesh-list
153412274|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153412275|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412276|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
153412277|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
153871637|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871638|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153871639|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
153871640|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871641|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871642|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153412279|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412281|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
153412282|NCT00005673|Capravirine|capravirine|mesh-list
153412283|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153412284|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153412285|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412286|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412287|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
153412288|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412289|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153856982|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153856983|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153856984|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856985|NCT01999764|Retinol acetate|retinol acetate|mesh-list
153856986|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153856987|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
153856988|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856989|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153826191|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
153871666|NCT04672499|Cortisone|cortisone|mesh-list
153871667|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871668|NCT04554303|Amlodipine|amlodipine|mesh-list
153871669|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153871670|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153871671|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153871672|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871673|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153871674|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870998|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153870999|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153871675|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
153871676|NCT01088048|Rituximab|rituximab|mesh-list
153871677|NCT01088048|Fludarabine|fludarabine|mesh-list
153871678|NCT01088048|Lenalidomide|lenalidomide|mesh-list
153871679|NCT01088048|Everolimus|everolimus|mesh-list
153871680|NCT01088048|Bortezomib|bortezomib|mesh-list
153871681|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153871682|NCT01088048|Ofatumumab|ofatumumab|mesh-list
153366208|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
153366209|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153366210|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153366211|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366212|NCT00944450|Incretins|incretins|mesh-ancestor
153366213|NCT00944450|Hormones|hormones|mesh-ancestor
153366215|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153871717|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153871718|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153871719|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153412364|NCT00386373|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153412365|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153412366|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871751|NCT01086410|Prednisolone|prednisolone|mesh-list
153871752|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871753|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153871754|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
153871755|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871756|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871757|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153871857|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871858|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871859|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871860|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153871861|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153871862|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153871863|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153871864|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153871865|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
153412525|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
153412526|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412527|NCT04829799|Protective Agents|protective agents|mesh-ancestor
153412528|NCT01789333|Riboflavin|riboflavin|mesh-list
153412529|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153412530|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153412531|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
153412532|NCT01789333|Vitamins|vitamins|mesh-ancestor
153412583|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
153871966|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153871967|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871968|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153397319|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153397320|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397321|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397322|NCT05446493|Urological Agents|urological agents|mesh-ancestor
153397323|NCT05445479|Doxycycline|doxycycline|mesh-list
153397324|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153397325|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397326|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
153397327|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153397328|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153397329|NCT02711735|Vaccines|vaccines|mesh-list
153397330|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
153871969|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153871970|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153871988|NCT00556088|Growth Substances|growth substances|mesh-ancestor
153412618|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153412620|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
153412639|NCT02445859|Cefuroxime|cefuroxime|mesh-list
153412640|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
153412641|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153412642|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412644|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153412656|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153412658|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153412659|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412660|NCT04744753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153412662|NCT02420041|Triamcinolone|triamcinolone|mesh-list
153412663|NCT02420041|Lidocaine|lidocaine|mesh-list
153412664|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
153872029|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153412728|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153412729|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
153412730|NCT02492750|Hormones|hormones|mesh-ancestor
153412731|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412732|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153412733|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412734|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
153412735|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153412736|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153872063|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153872064|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153872065|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153872066|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153872067|NCT01081145|Guanfacine|guanfacine|mesh-list
153872068|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153872069|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153872070|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153872071|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153872072|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
153872073|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872074|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412748|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153412749|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872117|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
153872118|NCT01080131|Hormones|hormones|mesh-ancestor
153872119|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872120|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872121|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153872122|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
153872123|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871102|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872124|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872125|NCT00171873|Octreotide|octreotide|mesh-list
153397364|NCT04768231|Rifampin|rifampin|mesh-list
153397365|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153857122|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
153857123|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857124|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857125|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153857126|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153857127|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
153857128|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872126|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872127|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153872128|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872133|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
153872134|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872135|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153872136|NCT00171834|Epothilones|epothilones|mesh-list
153872138|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
153872139|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
153872140|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
153872141|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872142|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872143|NCT04571996|Acetaminophen|acetaminophen|mesh-list
153872144|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153872145|NCT04571996|Analgesics|analgesics|mesh-ancestor
153872146|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
153872147|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872148|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872149|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
153872150|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
153872151|NCT00171249|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153872152|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153412788|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
153871103|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871104|NCT00177164|Olanzapine|olanzapine|mesh-list
153871105|NCT00177164|Risperidone|risperidone|mesh-list
153412789|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
153412805|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412806|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153412807|NCT02532998|Diuretics|diuretics|mesh-ancestor
153412808|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
153412809|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153412810|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412811|NCT02453581|Artefenomel|artefenomel|mesh-list
153412812|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
153412815|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412817|NCT02533466|Fluorides|fluorides|mesh-list
153412818|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
153412819|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
153412820|NCT02533466|Protective Agents|protective agents|mesh-ancestor
153412821|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412822|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153412823|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872181|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872183|NCT00171054|Valsartan|valsartan|mesh-list
153872184|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153872185|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153872186|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153872187|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872188|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872189|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153872190|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872191|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
153412830|NCT02974244|Hormones|hormones|mesh-ancestor
153412831|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871120|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
153871121|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
153871122|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871123|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153871124|NCT00177164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153871125|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153871126|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153871141|NCT02489942|Empagliflozin|empagliflozin|mesh-list
153412832|NCT02436031|Desipramine|desipramine|mesh-list
153412833|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153412834|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
153412835|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153412836|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260081|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
154260082|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260083|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260084|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260085|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260086|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154260087|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260088|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400198|NCT02061397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153397407|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
153397409|NCT04537793|Elexacaftor|elexacaftor|mesh-list
153857165|NCT06227065|Mitomycins|mitomycins|mesh-list
153857166|NCT06227065|Mitomycin|mitomycin|mesh-list
153857167|NCT06227065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153857168|NCT06227065|Antimetabolites|antimetabolites|mesh-ancestor
153857169|NCT06227065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857170|NCT06227065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857171|NCT06227065|Tubulin Modulators|tubulin modulators|mesh-ancestor
153857172|NCT06227065|Antimitotic Agents|antimitotic agents|mesh-ancestor
153857173|NCT06227065|Mitosis Modulators|mitosis modulators|mesh-ancestor
153397445|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397446|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857188|NCT06226532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153857189|NCT06226532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153857190|NCT06226532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153857191|NCT06226532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857192|NCT06226519|Carbon-11 methionine|carbon-11 methionine|mesh-list
153857193|NCT06226519|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153857194|NCT06226519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857195|NCT06226506|Aprepitant|aprepitant|mesh-list
153857196|NCT06226506|Fosaprepitant|fosaprepitant|mesh-list
153857197|NCT06226506|Antiemetics|antiemetics|mesh-ancestor
153857198|NCT06226506|Autonomic Agents|autonomic agents|mesh-ancestor
153857199|NCT06226506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412837|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411812|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412838|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153412839|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153857206|NCT06226363|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153857207|NCT06226363|Immunologic Factors|immunologic factors|mesh-ancestor
153857208|NCT06226363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857210|NCT06226350|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153857211|NCT06226350|Immunologic Factors|immunologic factors|mesh-ancestor
153857212|NCT06226350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857213|NCT06225895|Bupivacaine|bupivacaine|mesh-list
153412840|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153412841|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
153412842|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412843|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412844|NCT02454283|Vanoxerine|vanoxerine|mesh-list
153412845|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153412846|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153412847|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872208|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872209|NCT00479856|Paclitaxel|paclitaxel|mesh-list
153872210|NCT00479856|Docetaxel|docetaxel|mesh-list
153872211|NCT00479856|Capecitabine|capecitabine|mesh-list
153872212|NCT00479856|Lapatinib|lapatinib|mesh-list
153872213|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153412851|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412853|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153412973|NCT04743739|Rituximab|rituximab|mesh-list
153412974|NCT04743739|Cyclosporins|cyclosporins|mesh-list
153412975|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153412976|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872358|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872360|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872361|NCT00477750|Prednisone|prednisone|mesh-list
153872362|NCT00477750|Lenalidomide|lenalidomide|mesh-list
153872363|NCT00477750|Melphalan|melphalan|mesh-list
153872364|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411813|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153411814|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153411815|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153411816|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153411817|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153411850|NCT00004485|Fludarabine|fludarabine|mesh-list
153413005|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413006|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153413007|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
153413008|NCT02431754|Tadalafil|tadalafil|mesh-list
153404493|NCT02376283|Ticagrelor|ticagrelor|mesh-list
153413009|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
153413010|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153413011|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153413012|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413013|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413014|NCT02431754|Urological Agents|urological agents|mesh-ancestor
153413015|NCT02500628|Metformin|metformin|mesh-list
153413016|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153413017|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413018|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
153413019|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153826360|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
153413052|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153413053|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
153413054|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413055|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153413056|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
153413057|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413058|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153413059|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
153413060|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
153413061|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
153413062|NCT02535806|Analgesics|analgesics|mesh-ancestor
153413063|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
153413064|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153413065|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153413066|NCT02536040|Fluorides|fluorides|mesh-list
153413067|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
153413068|NCT02536040|Protective Agents|protective agents|mesh-ancestor
153413069|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413070|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
154260090|NCT02530632|Sevoflurane|sevoflurane|mesh-list
154260091|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
154260092|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260093|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260094|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154260095|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154260096|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
154260097|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154260098|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154260099|NCT01183364|Docetaxel|docetaxel|mesh-list
153733332|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153733333|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
153857254|NCT06224725|Sensory System Agents|sensory system agents|mesh-ancestor
153857255|NCT06224725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857256|NCT06224725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857257|NCT06224725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153857258|NCT06224725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857259|NCT06223854|Folic Acid|folic acid|mesh-list
153857260|NCT06223854|Vitamin B Complex|vitamin b complex|mesh-list
153857262|NCT06223854|Hematinics|hematinics|mesh-ancestor
153857263|NCT06223854|Vitamins|vitamins|mesh-ancestor
153857264|NCT06223854|Micronutrients|micronutrients|mesh-ancestor
153857265|NCT06223854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857266|NCT06223854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153857267|NCT06223854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857268|NCT06223854|Trace Elements|trace elements|mesh-ancestor
153857269|NCT06219226|Chlorhexidine|chlorhexidine|mesh-list
153857271|NCT06219226|Chlorine dioxide|chlorine dioxide|mesh-list
153857272|NCT06219226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153857273|NCT06219226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857274|NCT06219226|Disinfectants|disinfectants|mesh-ancestor
153413071|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
153872402|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153872403|NCT00477633|Norethindrone|norethindrone|mesh-list
153872404|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
153872405|NCT00477633|Estradiol|estradiol|mesh-list
153872440|NCT04571606|Bupivacaine|bupivacaine|mesh-list
153872441|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
153872442|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
153413086|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153413087|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153413088|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153413089|NCT02464033|Analgesics|analgesics|mesh-ancestor
153413090|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
153413091|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260100|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260101|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
154260102|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
154260103|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
154260104|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260106|NCT00072384|Etoposide|etoposide|mesh-list
154260107|NCT00072384|Vincristine|vincristine|mesh-list
154260108|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
154260109|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733334|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400275|NCT02877095|Furosemide|furosemide|mesh-list
153857321|NCT06154824|Histamine|histamine|mesh-list
153857322|NCT06154824|Histamine Agonists|histamine agonists|mesh-ancestor
153857323|NCT06154824|Histamine Agents|histamine agents|mesh-ancestor
153857324|NCT06154824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857325|NCT06154824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857326|NCT06154824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857327|NCT06109662|Cystatins|cystatins|mesh-list
153397572|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397574|NCT02466581|Hormones|hormones|mesh-ancestor
153397575|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397576|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857328|NCT06109662|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153857329|NCT06109662|Protease Inhibitors|protease inhibitors|mesh-ancestor
153857330|NCT06109662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397597|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153397599|NCT02466581|Analgesics|analgesics|mesh-ancestor
153397600|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
153397601|NCT01951963|Ketamine|ketamine|mesh-list
153397602|NCT01951963|Morphine|morphine|mesh-list
153397603|NCT01951963|Analgesics|analgesics|mesh-ancestor
153397604|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
153397605|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397606|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857350|NCT06004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857351|NCT05991817|Anesthetics|anesthetics|mesh-list
153857352|NCT05991817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857353|NCT05991817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857355|NCT05947071|Immunologic Factors|immunologic factors|mesh-ancestor
153857356|NCT05947071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411929|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
153411931|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
153857357|NCT05919472|Iron|iron|mesh-list
153857358|NCT05919472|Vaccines|vaccines|mesh-list
153413092|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413093|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413094|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413095|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153413096|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
153413097|NCT02432456|Acetaminophen|acetaminophen|mesh-list
153413098|NCT02432456|Ibuprofen|ibuprofen|mesh-list
153872456|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872457|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
153872458|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872459|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153872460|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
153872461|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872462|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872463|NCT04541277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153872484|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
153872485|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
153872486|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872487|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872488|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872489|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
153872490|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153872491|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872492|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872493|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872494|NCT04570592|Dexamethasone|dexamethasone|mesh-list
153872495|NCT04570592|Granisetron|granisetron|mesh-list
153872496|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153872497|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872498|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
153413144|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153413159|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413160|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153413161|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413162|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153413163|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153872558|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413206|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
153413207|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
153413208|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413209|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153413210|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
153413211|NCT02436668|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153413212|NCT02436668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153413213|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413214|NCT02503982|Valganciclovir|valganciclovir|mesh-list
153413215|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
153413216|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413217|NCT02438540|Metformin|metformin|mesh-list
153413218|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153413219|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413220|NCT02506634|Esomeprazole|esomeprazole|mesh-list
153413221|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153413222|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872605|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
153872606|NCT04540185|Vaccines|vaccines|mesh-list
153872607|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
153872608|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397661|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397662|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153397663|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
153397664|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
153397665|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153397666|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153872609|NCT04540185|Protective Agents|protective agents|mesh-ancestor
153872610|NCT01130272|Eluxadoline|eluxadoline|mesh-list
153872611|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872612|NCT04546815|Daptomycin|daptomycin|mesh-list
153872613|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153872614|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872615|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153872616|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
153872617|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153872618|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153872619|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366452|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366453|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366454|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153366455|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153366456|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
153366457|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366458|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366459|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
153366460|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153872884|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872885|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872886|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
153872887|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872888|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872890|NCT00637468|Heparin|heparin|mesh-list
153412056|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153872891|NCT00637468|Acetazolamide|acetazolamide|mesh-list
153872892|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153872893|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
153872894|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153872895|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153872896|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872897|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153413558|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
153413559|NCT05247554|Hormones|hormones|mesh-ancestor
153413560|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413561|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413562|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153413563|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413663|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153413664|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153413665|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153413666|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153413667|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873004|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873006|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873007|NCT04558424|Vitamins|vitamins|mesh-ancestor
153873008|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
153873009|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
153366542|NCT03030560|Lidocaine|lidocaine|mesh-list
153873089|NCT02212340|Remifentanil|remifentanil|mesh-list
153873090|NCT02212340|Desflurane|desflurane|mesh-list
153873091|NCT02212340|Propofol|propofol|mesh-list
153873092|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153873093|NCT02212340|Narcotics|narcotics|mesh-ancestor
153873094|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260110|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154260111|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154260112|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154260113|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260114|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260115|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
154260116|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
154260117|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
153873095|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413761|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873097|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
153873098|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873099|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153873100|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
153873101|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
153873102|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153873103|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153873104|NCT01124617|Tapentadol|tapentadol|mesh-list
153873105|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153873106|NCT01124617|Narcotics|narcotics|mesh-ancestor
153873107|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873108|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873109|NCT01124617|Analgesics|analgesics|mesh-ancestor
153873110|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
153873111|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873112|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153413830|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413831|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413832|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153413833|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873145|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873146|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873147|NCT00577109|Antidotes|antidotes|mesh-ancestor
153873148|NCT00577109|Protective Agents|protective agents|mesh-ancestor
153873149|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
153873150|NCT00577109|Vitamins|vitamins|mesh-ancestor
153873151|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
153873152|NCT01124422|Fluticasone|fluticasone|mesh-list
153873153|NCT01124422|Xhance|xhance|mesh-list
153873154|NCT01124422|Bromides|bromides|mesh-list
153873155|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
153413834|NCT04799262|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153873156|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153873157|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153873158|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153873159|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
153413853|NCT02620904|Mifepristone|mifepristone|mesh-list
153413854|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153413855|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
153873211|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153873212|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873213|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
153873238|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153413901|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413902|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153413903|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153413904|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153413961|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413962|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153413963|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153413964|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413965|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414047|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414049|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
153873388|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154260118|NCT01183442|Vitamin D|vitamin d|mesh-list
154260119|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
154260120|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
154260121|NCT01183442|Vitamins|vitamins|mesh-list
154260122|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
154260123|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260124|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154260125|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154260126|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
154260127|NCT01187108|Acetazolamide|acetazolamide|mesh-list
154260128|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154260129|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
154260130|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260131|NCT01187108|Expectorants|expectorants|mesh-ancestor
154260132|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
154260133|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154260134|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
154260135|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260136|NCT01187108|Protective Agents|protective agents|mesh-ancestor
154260137|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260138|NCT01187108|Antidotes|antidotes|mesh-ancestor
154260139|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
154260140|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154260141|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260142|NCT01187108|Diuretics|diuretics|mesh-ancestor
154260143|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
154260144|NCT01187888|Rasagiline|rasagiline|mesh-list
154260145|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154260146|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260147|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260148|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154260149|NCT01187888|Protective Agents|protective agents|mesh-ancestor
154260150|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260151|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
154260152|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154260153|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260154|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153400424|NCT02042534|Warfarin|warfarin|mesh-list
153857577|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857578|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857579|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153857580|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153857581|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153857582|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
153857583|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414080|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412219|NCT00005607|Vitamins|vitamins|mesh-ancestor
153414081|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414082|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153414083|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414084|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153414085|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414086|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414087|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
153414088|NCT04068272|Bosentan|bosentan|mesh-list
153414089|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153414090|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153414091|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414092|NCT02243202|Canagliflozin|canagliflozin|mesh-list
153414093|NCT02243202|Phentermine|phentermine|mesh-list
153414094|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153414095|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414096|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153414097|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873451|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
153873452|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153873453|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873485|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
153873486|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873487|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873488|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153873489|NCT04542759|Besifloxacin|besifloxacin|mesh-list
153873514|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873515|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153873516|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
153873517|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873518|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
153873550|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153873551|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
153873552|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153873583|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
153873584|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873585|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153414254|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
153414255|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153414256|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
153414257|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414258|NCT03926624|Cytarabine|cytarabine|mesh-list
153414259|NCT03926624|Fludarabine|fludarabine|mesh-list
153873599|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873600|NCT02216994|Mineral Oil|mineral oil|mesh-list
153873601|NCT02216994|Lactulose|lactulose|mesh-list
153873602|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153873603|NCT02216994|Emollients|emollients|mesh-ancestor
153873604|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
153873605|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
153414276|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153414277|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414278|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
153414279|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414280|NCT03926624|Analgesics|analgesics|mesh-ancestor
153414281|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
153414282|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857634|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153857635|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153857636|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857638|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857639|NCT04892017|Trametinib|trametinib|mesh-list
153857640|NCT04892017|Sotorasib|sotorasib|mesh-list
153414283|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153414284|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153414309|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153414310|NCT02566369|Trifarotene|trifarotene|mesh-list
153414311|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
153414312|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
153873664|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414335|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153414337|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414338|NCT03678428|Antidotes|antidotes|mesh-ancestor
153414339|NCT03678428|Protective Agents|protective agents|mesh-ancestor
153414340|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414341|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
153414350|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153414352|NCT02577601|Estrogens|estrogens|mesh-ancestor
153414353|NCT02577601|Hormones|hormones|mesh-ancestor
153873665|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826666|NCT03271073|Apatinib|apatinib|mesh-list
153873834|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414581|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414582|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153414584|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
153414585|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414586|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153414587|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153414588|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153414589|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153414590|NCT03019640|Growth Substances|growth substances|mesh-ancestor
153414591|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
153414592|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153414593|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
153414594|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153873906|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153873907|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
153873908|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873979|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153873980|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
153414669|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414670|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153414671|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153414672|NCT00534469|Cytarabine|cytarabine|mesh-list
153414673|NCT00534469|Aldesleukin|aldesleukin|mesh-list
153414674|NCT00534469|Etoposide|etoposide|mesh-list
153414675|NCT00534469|Idarubicin|idarubicin|mesh-list
153414676|NCT00534469|Busulfan|busulfan|mesh-list
153414677|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153414678|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414679|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153414680|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153414681|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414682|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873981|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
153414698|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
153414699|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
153414700|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414701|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414702|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
153414703|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414704|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153414705|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153414706|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154260157|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154260158|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154260159|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
154260160|NCT00054132|Antibodies|antibodies|mesh-list
154260161|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
154260162|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154260163|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
154260164|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733335|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153857675|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
153857676|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
153857677|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
153857678|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857679|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857680|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857681|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857682|NCT04827979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857683|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857684|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857685|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
153857686|NCT04821375|Estrogens|estrogens|mesh-list
153857687|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153397939|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153397940|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397941|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153397942|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153397943|NCT00370721|Growth Substances|growth substances|mesh-ancestor
153412299|NCT02974933|Pemetrexed|pemetrexed|mesh-list
153871683|NCT01088048|Idelalisib|idelalisib|mesh-list
153397944|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397945|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
153397946|NCT01909141|Metformin|metformin|mesh-list
153397947|NCT01909141|Pioglitazone|pioglitazone|mesh-list
153397948|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
153397949|NCT01909141|Letrozole|letrozole|mesh-list
153397950|NCT01909141|Clomiphene|clomiphene|mesh-list
153397951|NCT01909141|Enclomiphene|enclomiphene|mesh-list
153397954|NCT01909141|Estradiol|estradiol|mesh-list
153397955|NCT01909141|Testosterone|testosterone|mesh-list
153397956|NCT01909141|Progesterone|progesterone|mesh-list
153397957|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154260165|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154260166|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154260167|NCT00054132|Growth Substances|growth substances|mesh-ancestor
154260168|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260169|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
154260170|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
154260171|NCT00054132|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154260172|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154260173|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260174|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733336|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153733338|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
153857699|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857700|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857701|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153857702|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153857703|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
153857704|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153857705|NCT04801368|Anesthetics|anesthetics|mesh-list
153857706|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
153857718|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
153857719|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857720|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153414707|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874167|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153414896|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153414897|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
153414898|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414899|NCT04743193|Sevoflurane|sevoflurane|mesh-list
153414900|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
153414901|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414902|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874229|NCT03453281|Growth Substances|growth substances|mesh-ancestor
153874230|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874231|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
153404986|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414934|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414935|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414936|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
153414937|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414938|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153414939|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153414940|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153414941|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414988|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260176|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154260177|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
154260178|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154260179|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260180|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153733339|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153733340|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
153400498|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
153398014|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398016|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
153398017|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398018|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153398019|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153857734|NCT04674813|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153857735|NCT04674813|Fludarabine|fludarabine|mesh-list
153857737|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
153414989|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153414990|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
153414991|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414992|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414993|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153414994|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153414995|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153414996|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153414997|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414998|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
153414999|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
153415000|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415002|NCT05730907|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153415003|NCT05730907|Vasodilator Agents|vasodilator agents|mesh-ancestor
153415004|NCT05730907|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153415005|NCT05730907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153412533|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
153415006|NCT05730907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415008|NCT05730907|Protective Agents|protective agents|mesh-ancestor
153874276|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153874277|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366749|NCT01016678|Naproxen|naproxen|mesh-list
153402760|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402762|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
153402763|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402827|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403555|NCT03421288|Fluorouracil|fluorouracil|mesh-list
153403556|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
153403557|NCT03421288|Atezolizumab|atezolizumab|mesh-list
153404617|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404618|NCT03226223|Methamphetamine|methamphetamine|mesh-list
153783606|NCT00236561|Propranolol|propranolol|mesh-list
153405179|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153405180|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
153405181|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405183|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
153405184|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405185|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153400527|NCT02973503|Grazoprevir|grazoprevir|mesh-list
153857770|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857771|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857772|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857773|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857774|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
153857775|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405186|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153405187|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405188|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153405189|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
153405190|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153405191|NCT00003405|Protective Agents|protective agents|mesh-ancestor
153405192|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153405193|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
153405194|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405195|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153405196|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
153405198|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
153405199|NCT00003243|Doxorubicin|doxorubicin|mesh-list
153405200|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153405201|NCT00003243|Etoposide|etoposide|mesh-list
153783607|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153405202|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153405203|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
153405630|NCT05924893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153405806|NCT05919966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405807|NCT05919966|Disinfectants|disinfectants|mesh-ancestor
153406052|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406053|NCT05558150|Analgesics|analgesics|mesh-ancestor
153406054|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
153407288|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407340|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153407342|NCT01084083|Cetuximab|cetuximab|mesh-list
153407343|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407344|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407345|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
153826264|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153407346|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407347|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407348|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407349|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407350|NCT01079780|Irinotecan|irinotecan|mesh-list
153407351|NCT01079780|Cetuximab|cetuximab|mesh-list
153407352|NCT01079780|Ramucirumab|ramucirumab|mesh-list
153407353|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153407354|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153407451|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407452|NCT00330564|Growth Substances|growth substances|mesh-ancestor
153407453|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407454|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407455|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153783609|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
153407714|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407747|NCT00002525|Fluorouracil|fluorouracil|mesh-list
153407748|NCT00002525|Calcium|calcium|mesh-list
153407749|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
153407750|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153407751|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407752|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
153407753|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407754|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407755|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407756|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407757|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
153407758|NCT00002525|Antidotes|antidotes|mesh-ancestor
153407882|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
153408146|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
153857787|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857788|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857790|NCT04303169|Tretinoin|tretinoin|mesh-list
153857791|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857792|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857793|NCT04303169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153398046|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398057|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
153408147|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408148|NCT04342910|Paclitaxel|paclitaxel|mesh-list
153408149|NCT04342910|Irinotecan|irinotecan|mesh-list
153408150|NCT04342910|Apatinib|apatinib|mesh-list
153408151|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153412418|NCT01680939|Narcotics|narcotics|mesh-ancestor
153366908|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
153366909|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366910|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366911|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153366912|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153413450|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413451|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
153413452|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366273|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153366274|NCT03032666|Velpatasvir|velpatasvir|mesh-list
153366275|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
153413453|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
153413454|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413455|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
153413456|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153413457|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153413458|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413459|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
153413460|NCT02569658|Coagulants|coagulants|mesh-ancestor
153413494|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
153413495|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
153413496|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
153413498|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
153413499|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153414000|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414001|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153414002|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
153414003|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366276|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414004|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414071|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414930|NCT02616523|Fentanyl|fentanyl|mesh-list
153414931|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
153414932|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
153783618|NCT02215330|Eplerenone|eplerenone|mesh-list
153783619|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153783620|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
153415007|NCT05730907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415009|NCT05730907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415010|NCT04340401|Capecitabine|capecitabine|mesh-list
153416052|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153416074|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416075|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153416076|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
153826981|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
153826983|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367005|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153367006|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153367007|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153367013|NCT03018626|Hormones|hormones|mesh-ancestor
153417313|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417314|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260182|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260183|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260185|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260186|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154260187|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154260188|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
154260189|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260190|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153400592|NCT02978339|Curcumin|curcumin|mesh-list
153398062|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398064|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153417395|NCT02958800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153417396|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153417397|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153417398|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
153417399|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
153417400|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153417401|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826289|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153417402|NCT04738045|Ritonavir|ritonavir|mesh-list
153417403|NCT04738045|Lopinavir|lopinavir|mesh-list
153417404|NCT04738045|Remdesivir|remdesivir|mesh-list
153417405|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153417406|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153417407|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
153417408|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417409|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417410|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153417411|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153417412|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
153417413|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417414|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153417431|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153417432|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
153417433|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417434|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417435|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
153417436|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
153417437|NCT02753881|Doxorubicin|doxorubicin|mesh-list
153417438|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153417484|NCT02739698|Paclitaxel|paclitaxel|mesh-list
153417485|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153417486|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417487|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
153417488|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
153417489|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
153417490|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417491|NCT04336904|Favipiravir|favipiravir|mesh-list
153417492|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
153417493|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417494|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
153417495|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153417496|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417497|NCT02767934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153417498|NCT02767934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417499|NCT02194998|Ritonavir|ritonavir|mesh-list
153417500|NCT02194998|Ribavirin|ribavirin|mesh-list
153417501|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153417502|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153417503|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
153417504|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857840|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153857841|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153857842|NCT04137380|Analgesics|analgesics|mesh-ancestor
153857843|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
153857844|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857845|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857846|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417505|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417506|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153417507|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153417508|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
153417509|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417510|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153417511|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153417512|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
153417513|NCT02194062|Fluticasone|fluticasone|mesh-list
153417515|NCT02194062|Budesonide|budesonide|mesh-list
153367038|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
153367059|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
153367060|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367063|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420417|NCT00375596|Ketotifen|ketotifen|mesh-list
153420418|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153420419|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
153420640|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153420641|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
153420642|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420643|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420644|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153420645|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
153420646|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153424010|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
153424011|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424012|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424013|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153424014|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
153424015|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153424016|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
153424379|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424380|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
153424388|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424389|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424390|NCT03378973|Analgesics|analgesics|mesh-ancestor
153412854|NCT02437669|Narcotics|narcotics|mesh-ancestor
153424391|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
153424392|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424393|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153424394|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153424633|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
153424634|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424635|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153424636|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424637|NCT00377468|Analgesics|analgesics|mesh-ancestor
153424638|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
153424639|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424640|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153424641|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153424642|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424643|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424693|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424695|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424696|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153424697|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424698|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424699|NCT03510481|Lumefantrine|lumefantrine|mesh-list
153424738|NCT03767738|Growth Substances|growth substances|mesh-ancestor
153424739|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260192|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
154260193|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260194|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260195|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
154260196|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260197|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260198|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
154260199|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153733341|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398112|NCT05738707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398113|NCT05738629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153398114|NCT05738629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153398115|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
153398116|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153398117|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153398119|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
153398120|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153398121|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
153398122|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398123|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
153398124|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
153398125|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398126|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398127|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153398128|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
153857861|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857864|NCT03944941|Cetuximab|cetuximab|mesh-list
153424740|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
153424741|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424743|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153783625|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
153783626|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153424744|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
153424745|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153424746|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153424747|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424748|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424749|NCT02973620|Protective Agents|protective agents|mesh-ancestor
153424750|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424751|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
153424752|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153424753|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424754|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424879|NCT03415243|Phenylephrine|phenylephrine|mesh-list
153424880|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
154260200|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260201|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154260202|NCT03856112|Dexamethasone|dexamethasone|mesh-list
154260203|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
154260204|NCT03856112|Venetoclax|venetoclax|mesh-list
154260205|NCT03856112|Ixazomib|ixazomib|mesh-list
154260206|NCT03856112|Ichthammol|ichthammol|mesh-list
154260207|NCT03856112|BB 1101|bb 1101|mesh-list
154260208|NCT03856112|Glycine|glycine|mesh-list
154260209|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007153|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
154260210|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
154260211|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
154260212|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260213|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260214|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260215|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
153733342|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733343|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153857877|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857878|NCT03811886|Natalizumab|natalizumab|mesh-list
153857879|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
153857880|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857881|NCT03744468|Tislelizumab|tislelizumab|mesh-list
153857882|NCT03744468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857883|NCT03744468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857884|NCT03725007|Upadacitinib|upadacitinib|mesh-list
153857885|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153857886|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857887|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857888|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857889|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857890|NCT03685890|Nivolumab|nivolumab|mesh-list
153857892|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733344|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
153857893|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857894|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857895|NCT03613532|Fludarabine|fludarabine|mesh-list
153857896|NCT03613532|Azacitidine|azacitidine|mesh-list
153857897|NCT03613532|Busulfan|busulfan|mesh-list
153857898|NCT03613532|Venetoclax|venetoclax|mesh-list
153857899|NCT03613532|Decitabine|decitabine|mesh-list
153857900|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857901|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153424881|NCT03415243|Levomethorphan|levomethorphan|mesh-list
153425026|NCT01211756|Oxytocin|oxytocin|mesh-list
153425027|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
153425028|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153425029|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425030|NCT03591458|Amitriptyline|amitriptyline|mesh-list
153425031|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153425032|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
153425033|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425034|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153425035|NCT03591458|Analgesics|analgesics|mesh-ancestor
153425036|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
153425567|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412987|NCT02461693|Caffeine|caffeine|mesh-list
153413020|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153425568|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153367219|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153367221|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153367222|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
153367223|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367224|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367225|NCT00993200|Warfarin|warfarin|mesh-list
153428044|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428130|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153428131|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
153428132|NCT03758365|Betamethasone|betamethasone|mesh-list
153428133|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
153428134|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153428135|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
153428136|NCT03758365|Clobetasol|clobetasol|mesh-list
153428137|NCT03758365|Desonide|desonide|mesh-list
153428138|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
153428171|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428172|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428173|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428174|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153428175|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
153428176|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428177|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428178|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153428213|NCT00002312|Zidovudine|zidovudine|mesh-list
153428214|NCT00002312|Delavirdine|delavirdine|mesh-list
153428215|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
153428216|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428217|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428491|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428492|NCT00002366|Ritonavir|ritonavir|mesh-list
153428493|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153428827|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153428828|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
153428829|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428830|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367257|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
153367258|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153367259|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153367260|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153367261|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153857922|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857923|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
153857924|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
153857925|NCT03504241|Sirolimus|sirolimus|mesh-list
153857926|NCT03504241|Prednisone|prednisone|mesh-list
153857927|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
153857928|NCT03504241|Abatacept|abatacept|mesh-list
153857929|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153857930|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
153857931|NCT03504241|Hormones|hormones|mesh-ancestor
153398201|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
153398202|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153398203|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153367262|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
153367263|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367265|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153434156|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153434398|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153434399|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153434400|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434424|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153434426|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
153434427|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
153434428|NCT00002077|Fluconazole|fluconazole|mesh-list
153434429|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
153434430|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434542|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
153434576|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
153434577|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434694|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153434695|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
153434889|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435080|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435081|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153435082|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153435083|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435140|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153435141|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153827341|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827381|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827382|NCT00481442|Protective Agents|protective agents|mesh-ancestor
153435844|NCT00003182|Gemcitabine|gemcitabine|mesh-list
153435845|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435846|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435847|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
153435848|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435849|NCT00002587|Paclitaxel|paclitaxel|mesh-list
153435850|NCT00002587|Topotecan|topotecan|mesh-list
153435851|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153827407|NCT04516317|Artesunate|artesunate|mesh-list
153435993|NCT00003440|Paclitaxel|paclitaxel|mesh-list
153435994|NCT00003440|Trastuzumab|trastuzumab|mesh-list
153435995|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435996|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435997|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435998|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435999|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436000|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436001|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153783643|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857944|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857945|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
153857946|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857947|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857948|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857949|NCT03454035|Palbociclib|palbociclib|mesh-list
153857950|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857951|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857952|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857953|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857954|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
153857955|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153436002|NCT00003200|Docetaxel|docetaxel|mesh-list
153436003|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436283|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436284|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436285|NCT00003254|Fluorouracil|fluorouracil|mesh-list
153436286|NCT00003254|Eniluracil|eniluracil|mesh-list
153436287|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
153436401|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153436402|NCT00003542|Interferons|interferons|mesh-list
153436403|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
153436404|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436405|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
153436406|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436407|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
153436408|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436409|NCT00004010|Prednisone|prednisone|mesh-list
153436410|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
153436411|NCT00004010|Dacarbazine|dacarbazine|mesh-list
153436412|NCT00004010|Doxorubicin|doxorubicin|mesh-list
153436413|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436632|NCT00003578|Hormones|hormones|mesh-ancestor
153436633|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436634|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436635|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436636|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436637|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
153437154|NCT00004160|Gemcitabine|gemcitabine|mesh-list
153437190|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437191|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
153437192|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437193|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437194|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
153437213|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153413164|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437214|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153437215|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
153437585|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153437677|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437678|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
153437680|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437681|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153437682|NCT00004904|Protective Agents|protective agents|mesh-ancestor
153437762|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
153437763|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437764|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437765|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437766|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437767|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437768|NCT00003776|Leucovorin|leucovorin|mesh-list
153437769|NCT00003776|Trimetrexate|trimetrexate|mesh-list
153437770|NCT00003776|Doxorubicin|doxorubicin|mesh-list
153398238|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398239|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153398240|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
153398242|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437771|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153437772|NCT00003776|Methotrexate|methotrexate|mesh-list
153437773|NCT00003776|Ifosfamide|ifosfamide|mesh-list
153437774|NCT00003776|Calcium|calcium|mesh-list
153783654|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153438255|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438256|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438257|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
153438258|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438259|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
153438260|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367645|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153367646|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153367647|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367648|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
153827703|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153827704|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153827705|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
153827706|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827707|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827708|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153827710|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367706|NCT01076504|Amrubicin|amrubicin|mesh-list
153367707|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367708|NCT01076972|Ritonavir|ritonavir|mesh-list
153367709|NCT01076972|Lopinavir|lopinavir|mesh-list
153367710|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153367711|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153367712|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
153367713|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367714|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367715|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153367716|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153367717|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
153367718|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827718|NCT04518540|Protective Agents|protective agents|mesh-ancestor
153827719|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827720|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
153827721|NCT04518540|Vitamins|vitamins|mesh-ancestor
153827722|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
153444455|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153444456|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153444460|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444461|NCT02504099|Ritonavir|ritonavir|mesh-list
153444462|NCT02504099|Ribavirin|ribavirin|mesh-list
153444463|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153444464|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153453294|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453866|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153453867|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453868|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453869|NCT01720524|Urological Agents|urological agents|mesh-ancestor
153453870|NCT01720446|Semaglutide|semaglutide|mesh-list
153454776|NCT01547598|Travoprost|travoprost|mesh-list
153454777|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153454778|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153454779|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153454780|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154263531|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263532|NCT05321420|Pirfenidone|pirfenidone|mesh-list
154263533|NCT05321420|Analgesics|analgesics|mesh-ancestor
154263534|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
154263535|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263536|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263537|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153733345|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
153858012|NCT02927301|Antibodies|antibodies|mesh-list
153858013|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153858014|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
153872581|NCT02214498|Enalapril|enalapril|mesh-list
153413301|NCT02511236|Nicotine|nicotine|mesh-list
153858015|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398278|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153398279|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
153398280|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
153398281|NCT05417659|Vitamins|vitamins|mesh-ancestor
153398282|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
153398283|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398284|NCT02762513|Axitinib|axitinib|mesh-list
153398285|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398286|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153398287|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398288|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398289|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
153398290|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153398291|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
153398292|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398293|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
153398294|NCT02958761|Protective Agents|protective agents|mesh-ancestor
153398295|NCT05215535|Liver Extracts|liver extracts|mesh-list
153398296|NCT05215535|Hematinics|hematinics|mesh-ancestor
153858022|NCT02892123|Capecitabine|capecitabine|mesh-list
153858023|NCT02892123|Tucatinib|tucatinib|mesh-list
153454827|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153454828|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
153454829|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454830|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454831|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
153454832|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454833|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454834|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
153454949|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
153455036|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
153413302|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153455037|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153398311|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153398313|NCT02741687|Incretins|incretins|mesh-ancestor
153455038|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455039|NCT04672512|Prednisone|prednisone|mesh-list
153455040|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455041|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
153455042|NCT04672512|Hormones|hormones|mesh-ancestor
153455069|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455070|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455071|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
153455072|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455073|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153455075|NCT01510158|Protective Agents|protective agents|mesh-ancestor
153455076|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455077|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
153455078|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153455079|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153455080|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153455469|NCT06055621|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153455470|NCT06055621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153455471|NCT06055621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455472|NCT06055621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455473|NCT06055621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457261|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457752|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
153457754|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
153457755|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
153457756|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457757|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457937|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153457938|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460082|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460142|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
153460143|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460144|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153460491|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460492|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460493|NCT02957968|Paclitaxel|paclitaxel|mesh-list
153460494|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
153460495|NCT02957968|Carboplatin|carboplatin|mesh-list
153460496|NCT02957968|Doxorubicin|doxorubicin|mesh-list
153460497|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
153460498|NCT02957968|Decitabine|decitabine|mesh-list
153460499|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460500|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460569|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460571|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153460572|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153460573|NCT02369406|Lamivudine|lamivudine|mesh-list
153460574|NCT02369406|Zidovudine|zidovudine|mesh-list
153460575|NCT02369406|Nevirapine|nevirapine|mesh-list
153460576|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154260219|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260220|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260221|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
154260222|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260223|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
154260224|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260225|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
154260227|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733347|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
153858104|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153858105|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153398364|NCT02746991|Hormones|hormones|mesh-ancestor
153398365|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398366|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398367|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
153398368|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153398369|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153398370|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398371|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
153398372|NCT02747615|Coagulants|coagulants|mesh-ancestor
153398373|NCT02775617|Azithromycin|azithromycin|mesh-list
153398374|NCT02775617|Ivermectin|ivermectin|mesh-list
153398375|NCT02775617|Permethrin|permethrin|mesh-list
153398376|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398377|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398378|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153858112|NCT01652092|Melphalan|melphalan|mesh-list
153858113|NCT01652092|Busulfan|busulfan|mesh-list
153858114|NCT01652092|Fludarabine|fludarabine|mesh-list
153858115|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
153858116|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
153858117|NCT01652092|Mesna|mesna|mesh-list
153858118|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858119|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
154260229|NCT01183910|Calcium|calcium|mesh-list
154260230|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154260231|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260232|NCT01183910|Antacids|antacids|mesh-ancestor
154260233|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260234|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260235|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
153733348|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733349|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858120|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858121|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398379|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398380|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398381|NCT00371813|Varenicline|varenicline|mesh-list
153398382|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153398383|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153398384|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
153398385|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398386|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398387|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398388|NCT02748785|Methotrexate|methotrexate|mesh-list
153398389|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153398390|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
153398391|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153398392|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858128|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
153858129|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
153858130|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858131|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858132|NCT01652092|Protective Agents|protective agents|mesh-ancestor
153858133|NCT01566695|Azacitidine|azacitidine|mesh-list
153858134|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858135|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
153398393|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153398394|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
153858219|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153858220|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153858222|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858223|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153858224|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
153858225|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
153858226|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858227|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153858228|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858229|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153858230|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154260252|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260253|NCT01290458|Protective Agents|protective agents|mesh-ancestor
154260254|NCT01184144|Pioglitazone|pioglitazone|mesh-list
154260255|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154260256|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260257|NCT01291628|Copper|copper|mesh-list
154260258|NCT01291628|Trace Elements|trace elements|mesh-ancestor
154260259|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
153733354|NCT02954692|Meglitinide|meglitinide|mesh-list
153400994|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858243|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858244|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153858245|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
153858246|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153858247|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153858248|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153858249|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153858250|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858251|NCT02910206|Sufentanil|sufentanil|mesh-list
153858252|NCT02910206|Propofol|propofol|mesh-list
153858253|NCT02910206|Etomidate|etomidate|mesh-list
153858254|NCT02910206|Cisatracurium|cisatracurium|mesh-list
153858255|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858256|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398513|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153398514|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
153398515|NCT03092011|Clonidine|clonidine|mesh-list
153398516|NCT03092011|Morphine|morphine|mesh-list
153398517|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153398518|NCT03092011|Narcotics|narcotics|mesh-ancestor
153398519|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398520|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398521|NCT03092011|Analgesics|analgesics|mesh-ancestor
153398522|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
153398523|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398524|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154260260|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260261|NCT00053898|Tamoxifen|tamoxifen|mesh-list
154260262|NCT00053898|Anastrozole|anastrozole|mesh-list
154260263|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260264|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154260265|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
154260266|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260267|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260268|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154260269|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260270|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154260271|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154260272|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154260273|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154260274|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154260275|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260276|NCT01293734|Budesonide|budesonide|mesh-list
154260277|NCT01293734|Theophylline|theophylline|mesh-list
154260278|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260279|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154260280|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
154260281|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260282|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401015|NCT03086213|Analgesics|analgesics|mesh-ancestor
153858257|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858258|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153858259|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
153858260|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
153858261|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153858262|NCT02910206|Narcotics|narcotics|mesh-ancestor
154260283|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153413564|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
154260284|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
154260285|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
154260286|NCT01293734|Hormones|hormones|mesh-ancestor
154260287|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260288|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154260289|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260290|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260291|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
154260292|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153733355|NCT02954692|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153733356|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
153858268|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153858269|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
153858270|NCT04675086|Remdesivir|remdesivir|mesh-list
153858271|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
153858272|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153858273|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858274|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
153858275|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858276|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858277|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153858278|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153858279|NCT02909972|Cytarabine|cytarabine|mesh-list
153858280|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858281|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
153858282|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858283|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858284|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
153858285|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858286|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153398544|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398546|NCT02990845|Exemestane|exemestane|mesh-list
153398547|NCT02990845|Leuprolide|leuprolide|mesh-list
153413565|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153413572|NCT02596022|Analgesics|analgesics|mesh-ancestor
153398548|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154260298|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
154260299|NCT01188278|Dasatinib|dasatinib|mesh-list
154260300|NCT01188278|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153401161|NCT04586153|Meplazumab|meplazumab|mesh-list
153858391|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
153858399|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858400|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
153858401|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858402|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858403|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153858404|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858405|NCT02909465|Midazolam|midazolam|mesh-list
153858406|NCT02909465|Ketamine|ketamine|mesh-list
153858407|NCT02909465|Haloperidol|haloperidol|mesh-list
153858408|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
153858409|NCT02909465|Analgesics|analgesics|mesh-ancestor
153858410|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
153398674|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398675|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153398677|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
153398678|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
153398679|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153398680|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153398681|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
153398682|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398683|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
153398684|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398685|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
153398686|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413603|NCT05371574|Clonidine|clonidine|mesh-list
153398687|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
153398688|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260323|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260324|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
154260325|NCT02459392|Protective Agents|protective agents|mesh-ancestor
154260326|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260327|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
154260328|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
154260329|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260330|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260331|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
154260332|NCT02459392|Hormones|hormones|mesh-ancestor
154260333|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260334|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153733361|NCT00506935|Vigabatrin|vigabatrin|mesh-list
153733362|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
153398957|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398958|NCT02004613|Analgesics|analgesics|mesh-ancestor
153858676|NCT01818921|CKD732|ckd732|mesh-list
153858677|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153858678|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153858679|NCT01818921|Growth Substances|growth substances|mesh-ancestor
153858680|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858681|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
153858682|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858683|NCT01810575|Alprostadil|alprostadil|mesh-list
153858684|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153858685|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
153858686|NCT01810575|Urological Agents|urological agents|mesh-ancestor
153858687|NCT01785771|Exenatide|exenatide|mesh-list
153858688|NCT01785771|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153858689|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153398971|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153398972|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
153398973|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
153398975|NCT01754779|Diuretics|diuretics|mesh-ancestor
154260335|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154260336|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260337|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
154260338|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154260339|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154260340|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154260341|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
154260342|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413620|NCT05371340|Protective Agents|protective agents|mesh-ancestor
154260343|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260344|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260345|NCT03852446|Tryptophan|tryptophan|mesh-list
154260346|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154260347|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
154260348|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154260349|NCT03637582|Lidocaine|lidocaine|mesh-list
154260350|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
154260351|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
154260352|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260353|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260354|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
154260355|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260356|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154260357|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153733363|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401409|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153858720|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858721|NCT01780428|Acetaminophen|acetaminophen|mesh-list
153858722|NCT01780428|Promethazine|promethazine|mesh-list
153858723|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
153858724|NCT01780428|Hydrocodone|hydrocodone|mesh-list
153858725|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153858726|NCT01780428|Analgesics|analgesics|mesh-ancestor
153858727|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
153858728|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858729|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733364|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399031|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153399032|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399033|NCT02810873|Copper|copper|mesh-list
153399034|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
153399035|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153399036|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153399037|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399038|NCT02810873|Trace Elements|trace elements|mesh-ancestor
153399039|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
153399040|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399041|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
153399042|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
153399043|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448880|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
153399091|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153399092|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399093|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399094|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
153399096|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
153858808|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
153359772|NCT04112641|Niacinamide|niacinamide|mesh-list
153359773|NCT04112641|Niacin|niacin|mesh-list
153359774|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
154263545|NCT05315713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263546|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263547|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154263548|NCT05295173|Plasminogen|plasminogen|mesh-list
153401502|NCT04525820|Vitamin D|vitamin d|mesh-list
153858825|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858826|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858827|NCT04671069|Clopidogrel|clopidogrel|mesh-list
153858828|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153858829|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153858830|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153858831|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153858832|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
153858833|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858834|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858835|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858836|NCT04322123|Azithromycin|azithromycin|mesh-list
153858837|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
153858838|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153858839|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399128|NCT02815709|Narcotics|narcotics|mesh-ancestor
153399129|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399130|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399131|NCT02815709|Analgesics|analgesics|mesh-ancestor
153399132|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
154260380|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260382|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260383|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260384|NCT03245398|Mebendazole|mebendazole|mesh-list
154260385|NCT03245398|Piperazine|piperazine|mesh-list
154260386|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
154260387|NCT03245398|DMP 777|dmp 777|mesh-list
154260388|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
154260389|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
154260390|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154260391|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260392|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
154260393|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
154260394|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
154260395|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260396|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260397|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260398|NCT01291940|Petrolatum|petrolatum|mesh-list
154260399|NCT01291940|Emollients|emollients|mesh-ancestor
154260400|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
154260401|NCT03244618|Fluorides|fluorides|mesh-list
154260402|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
153733366|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858843|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858851|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858853|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858854|NCT04244630|Protective Agents|protective agents|mesh-ancestor
153858855|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858856|NCT04239053|Bupivacaine|bupivacaine|mesh-list
153399134|NCT02912195|Lidocaine|lidocaine|mesh-list
154260403|NCT03244618|Protective Agents|protective agents|mesh-ancestor
154260404|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260405|NCT03849404|Adalimumab|adalimumab|mesh-list
154260406|NCT03849404|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154260407|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260408|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260409|NCT00051636|Vitamin D|vitamin d|mesh-list
154260410|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
154260411|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
154260412|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
154260413|NCT00051636|Calcium|calcium|mesh-list
154260414|NCT00051636|Vitamins|vitamins|mesh-ancestor
154260415|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
154260416|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260417|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154260418|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153733367|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733368|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153858861|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
153858862|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858863|NCT01718145|Ribavirin|ribavirin|mesh-list
153858864|NCT01718145|Asunaprevir|asunaprevir|mesh-list
153858865|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
153858866|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858867|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
153858868|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858869|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
153858870|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858871|NCT00556257|Cyclosporine|cyclosporine|mesh-list
153858872|NCT00556257|Cyclosporins|cyclosporins|mesh-list
153399146|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399147|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153399148|NCT02912195|Narcotics|narcotics|mesh-ancestor
153399149|NCT02912195|Analgesics|analgesics|mesh-ancestor
153399150|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
153399151|NCT01960075|Levetiracetam|levetiracetam|mesh-list
153399152|NCT01960075|Valproic Acid|valproic acid|mesh-list
153399153|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
153813306|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153813307|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813308|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154260424|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260425|NCT03847922|Lidocaine|lidocaine|mesh-list
154260426|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
154260427|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
154260428|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
154260429|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260430|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260431|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
154260432|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401667|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
153399308|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399309|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399310|NCT01999400|Mesalamine|mesalamine|mesh-list
153399311|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153399312|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399313|NCT01999400|Analgesics|analgesics|mesh-ancestor
153399314|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
153399315|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399316|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399317|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399318|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399319|NCT01969435|Cytarabine|cytarabine|mesh-list
153399320|NCT01969435|Etoposide|etoposide|mesh-list
153399321|NCT01969435|Melphalan|melphalan|mesh-list
153399322|NCT01969435|Carmustine|carmustine|mesh-list
153399323|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
153399324|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153399325|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859026|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154383434|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413916|NCT02629094|Eplerenone|eplerenone|mesh-list
154383435|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383436|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154383437|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
154383438|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154383439|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383440|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154383441|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154383442|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154383443|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
154383444|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
154383445|NCT01357317|Calcium|calcium|mesh-list
154383446|NCT01357317|Calcium acetate|calcium acetate|mesh-list
154383447|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154383448|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383449|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153399330|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153399331|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
153399332|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
153399333|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399334|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153399335|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
153399336|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399340|NCT01965002|Aspirin|aspirin|mesh-list
154383450|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
154383451|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
154383452|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383453|NCT03238612|Clarithromycin|clarithromycin|mesh-list
154383457|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383458|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154383459|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383460|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383461|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154383462|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154383463|NCT03137121|Olanzapine|olanzapine|mesh-list
154383464|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
154383465|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
154383466|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383467|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383468|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154383469|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154383470|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154383471|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383472|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154383473|NCT03137121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154383474|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154383475|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154383476|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383477|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383478|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
154383479|NCT02453776|Infliximab|infliximab|mesh-list
154383480|NCT02453776|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154383481|NCT02453776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383482|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
154383483|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154383484|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154383485|NCT03256864|Everolimus|everolimus|mesh-list
154383486|NCT03256864|Tacrolimus|tacrolimus|mesh-list
154383487|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154383488|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
154383489|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383490|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154383491|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383492|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383493|NCT03256864|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154383494|NCT03256864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154383495|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383496|NCT01317849|Vitamins|vitamins|mesh-list
154383497|NCT01317849|Folic Acid|folic acid|mesh-list
154383498|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
154383499|NCT01317849|Pyridoxine|pyridoxine|mesh-list
154383500|NCT01317849|Pyridoxal|pyridoxal|mesh-list
154383501|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
154383502|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
154383503|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
154383504|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383505|NCT01317849|Hematinics|hematinics|mesh-ancestor
154383506|NCT01317927|Belinostat|belinostat|mesh-list
154383507|NCT01317927|Warfarin|warfarin|mesh-list
153413970|NCT02544607|Ketamine|ketamine|mesh-list
154383508|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
154383509|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383510|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154383511|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383512|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383513|NCT02901483|Cisplatin|cisplatin|mesh-list
154260433|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154260434|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154260435|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154260436|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154260437|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260438|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154260439|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
154260440|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153401709|NCT05993143|Ivermectin|ivermectin|mesh-list
153399352|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399353|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153399354|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153399355|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399356|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
153399357|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
153399358|NCT02304757|Alendronate|alendronate|mesh-list
153399359|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
153859063|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
153859064|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859065|NCT00533741|Antacids|antacids|mesh-ancestor
153859066|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859067|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859068|NCT00533858|Losartan|losartan|mesh-list
153859069|NCT00533858|Lacidipine|lacidipine|mesh-list
153859070|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153859071|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153859072|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153859073|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153859074|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859075|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153859076|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859077|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153859078|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859079|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
154260441|NCT03847922|Analgesics|analgesics|mesh-ancestor
154260442|NCT01194284|Mifamurtide|mifamurtide|mesh-list
154260443|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154260444|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
154260445|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260446|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154260447|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
154260448|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154383514|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383515|NCT02874651|Apatinib|apatinib|mesh-list
154383516|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383517|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154383518|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383519|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383520|NCT02453932|Donepezil|donepezil|mesh-list
154383521|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154383522|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383523|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383524|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
154383525|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383526|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383527|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
154383535|NCT00700570|Growth Substances|growth substances|mesh-ancestor
154383536|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383537|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
154383538|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154383539|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
154383540|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383541|NCT02453698|Methylphenidate|methylphenidate|mesh-list
154383542|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154383543|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383544|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154383545|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154383546|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154383547|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383548|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
154383549|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383550|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154383551|NCT01354275|Hormones|hormones|mesh-ancestor
154383552|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383553|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383554|NCT01318161|Morphine|morphine|mesh-list
154383555|NCT01318161|Ropivacaine|ropivacaine|mesh-list
154383556|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154383557|NCT01318161|Narcotics|narcotics|mesh-ancestor
154383558|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383559|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383560|NCT01318161|Analgesics|analgesics|mesh-ancestor
154383561|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
154383562|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383563|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
154383564|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
154383565|NCT03255226|Tolvaptan|tolvaptan|mesh-list
154383566|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154383567|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383568|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
154383569|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383570|NCT02455726|Pregabalin|pregabalin|mesh-list
154383571|NCT02455726|Oxycodone|oxycodone|mesh-list
154383572|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
154383573|NCT02455726|Analgesics|analgesics|mesh-ancestor
154383574|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
154383575|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873519|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383576|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383577|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
154383578|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154383579|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154260449|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
154260450|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260452|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154260453|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154260454|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260455|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
154260456|NCT01191554|Coagulants|coagulants|mesh-ancestor
154260457|NCT01296464|Carbidopa|carbidopa|mesh-list
154260458|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153859127|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153859128|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153859129|NCT00557544|Analgesics|analgesics|mesh-ancestor
153859130|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
153859131|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153859132|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859133|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153859134|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859135|NCT04667910|Ranibizumab|ranibizumab|mesh-list
154383580|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383581|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154383582|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154383583|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154383584|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383585|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154383586|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154383587|NCT02455726|Narcotics|narcotics|mesh-ancestor
154383588|NCT02455726|Antacids|antacids|mesh-ancestor
154383589|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154383590|NCT04488172|Vitamins|vitamins|mesh-list
154383591|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
154383592|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383593|NCT03239860|Antibodies|antibodies|mesh-list
154383594|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154383595|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
154383605|NCT04486690|Analgesics|analgesics|mesh-ancestor
154383606|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
154383607|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383608|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154383609|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154383610|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154383611|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414285|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383612|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383613|NCT03255148|Oxytocin|oxytocin|mesh-list
154383614|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
154383615|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154383616|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383617|NCT03236818|Bosentan|bosentan|mesh-list
154383618|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
154383619|NCT03236818|Tadalafil|tadalafil|mesh-list
154383620|NCT03236818|Macitentan|macitentan|mesh-list
154129807|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383621|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
154383622|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154383623|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154383624|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383625|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383626|NCT03236818|Urological Agents|urological agents|mesh-ancestor
154260459|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154260460|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
154260461|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260462|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260463|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383627|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154383628|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154383629|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154383630|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154383631|NCT03236974|Fulvestrant|fulvestrant|mesh-list
154383632|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154383633|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383634|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154383635|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154383636|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
154383637|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383638|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383639|NCT03748043|Lactoferrin|lactoferrin|mesh-list
154383640|NCT03748043|Teferrol|teferrol|mesh-list
154383641|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383642|NCT03748043|Hematinics|hematinics|mesh-ancestor
154383643|NCT03750773|Gabapentin|gabapentin|mesh-list
154383644|NCT03750773|Analgesics|analgesics|mesh-ancestor
154383645|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
154383646|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383647|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383648|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
154383649|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154383650|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154383651|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383652|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154383653|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154383654|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154383655|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383656|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383657|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
154383658|NCT02874924|Sirolimus|sirolimus|mesh-list
154383659|NCT02874924|Temsirolimus|temsirolimus|mesh-list
154383660|NCT02874924|MTOR Inhibitors|mtor inhibitors|mesh-list
154383661|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154383669|NCT02874924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154383670|NCT02874924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383671|NCT02874924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383672|NCT04425863|Aspirin|aspirin|mesh-list
154383673|NCT04425863|Ivermectin|ivermectin|mesh-list
154383674|NCT04425863|Dexamethasone|dexamethasone|mesh-list
154383675|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
154383676|NCT04425863|Enoxaparin|enoxaparin|mesh-list
154383677|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154383678|NCT04425863|BB 1101|bb 1101|mesh-list
154383679|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383680|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
154383681|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
154383682|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383683|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383684|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154383685|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
154383686|NCT04425863|Hormones|hormones|mesh-ancestor
154383687|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383688|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154383689|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383690|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
154383691|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383692|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383693|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154383694|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383695|NCT04425863|Analgesics|analgesics|mesh-ancestor
154383696|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
154383697|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154383698|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154260464|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154260465|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260466|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
154260467|NCT00038142|Doxorubicin|doxorubicin|mesh-list
154260468|NCT00038142|Vincristine|vincristine|mesh-list
154260469|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
154260470|NCT00038142|Razoxane|razoxane|mesh-list
154260471|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154260472|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
153401779|NCT05990894|Autonomic Agents|autonomic agents|mesh-ancestor
153859197|NCT00534677|Terlipressin|terlipressin|mesh-list
153859198|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859199|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153859200|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859201|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153859202|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153859203|NCT00556959|Clonidine|clonidine|mesh-list
153399479|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153399480|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
153399481|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153399482|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
153399483|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399484|NCT02922959|Naloxone|naloxone|mesh-list
153399485|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399486|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
153399487|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399488|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153399489|NCT02014363|Amitriptyline|amitriptyline|mesh-list
153399490|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153399491|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
153399492|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153399494|NCT02014363|Analgesics|analgesics|mesh-ancestor
154383699|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154383700|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154383701|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154383702|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
154383703|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
154383704|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154383705|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383706|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
154383707|NCT01370772|Rituximab|rituximab|mesh-list
154383708|NCT01370772|Fludarabine|fludarabine|mesh-list
154383709|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154383710|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
154383711|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383712|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260474|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260475|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154260476|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
154260477|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260478|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260479|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154260480|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154260481|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154260482|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154260483|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260484|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153733377|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859219|NCT01184326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153859220|NCT01184326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859221|NCT01184326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859222|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859223|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
153399500|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399501|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399502|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
153399503|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399504|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
153399505|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
153399506|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
153399507|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399508|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399509|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
153399510|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399511|NCT02833415|Empagliflozin|empagliflozin|mesh-list
153399512|NCT02833415|Glycerol|glycerol|mesh-list
153399513|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153859224|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260485|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
154260486|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
154260487|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
154260488|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154260489|NCT00038142|Protective Agents|protective agents|mesh-ancestor
154260490|NCT00366899|Vaccines|vaccines|mesh-list
154260491|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154260492|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
154260493|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260494|NCT03847376|Rilpivirine|rilpivirine|mesh-list
154260495|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154260496|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154260497|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733378|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153859239|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399514|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399515|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153399516|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399517|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153399518|NCT02833415|Protective Agents|protective agents|mesh-ancestor
153399519|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154383713|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154383714|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
154383715|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383716|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383717|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154383718|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154383719|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
154383720|NCT03234244|Vitamin D|vitamin d|mesh-list
154383721|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
154383722|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154383723|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383724|NCT03234244|Vitamins|vitamins|mesh-ancestor
154383725|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
154383726|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154383727|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154383728|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154383729|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
153745536|NCT04015596|Analgesics|analgesics|mesh-ancestor
154383741|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154383742|NCT03236740|Estradiol|estradiol|mesh-list
154383743|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154383744|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383745|NCT03236740|Estrogens|estrogens|mesh-ancestor
154383746|NCT03236740|Hormones|hormones|mesh-ancestor
154383747|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383748|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154383749|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
154383750|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154383751|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154383752|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154383753|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154383754|NCT02453464|Leucovorin|leucovorin|mesh-list
153399547|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153399548|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399549|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153399550|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859260|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153859261|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859262|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383755|NCT02453464|Irinotecan|irinotecan|mesh-list
154383756|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154383757|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154383758|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383759|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383760|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383761|NCT02453464|Antidotes|antidotes|mesh-ancestor
154383762|NCT02453464|Protective Agents|protective agents|mesh-ancestor
154383763|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383764|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
154383765|NCT02453464|Vitamins|vitamins|mesh-ancestor
154383766|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
154383767|NCT03233932|Leuprolide|leuprolide|mesh-list
154383768|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154383769|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
154383770|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154383771|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383772|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154383773|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383774|NCT03236584|Tenofovir|tenofovir|mesh-list
154383776|NCT03236584|Adefovir|adefovir|mesh-list
154383777|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
154383778|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383779|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154383780|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154383781|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383782|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383783|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154383784|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154383785|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154383786|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154383787|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154383788|NCT04614168|Glycerol|glycerol|mesh-list
154383789|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383790|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154383791|NCT04614168|Protective Agents|protective agents|mesh-ancestor
154383792|NCT01365312|Ethanol|ethanol|mesh-list
154383793|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154383794|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383795|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745600|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154383807|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154383808|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383809|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154383810|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154383811|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154383812|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383813|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154383815|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154383816|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383817|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154383818|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383819|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
154383820|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154383821|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
154383822|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399583|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153399584|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
153399585|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
153859277|NCT04665063|Fludarabine|fludarabine|mesh-list
153859278|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859279|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
153859280|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859281|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859282|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153859283|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
153859284|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859285|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859286|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153859287|NCT04664595|Propofol|propofol|mesh-list
154383823|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154383824|NCT03253276|Cathartics|cathartics|mesh-ancestor
154383825|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154383826|NCT01372644|Pasireotide|pasireotide|mesh-list
154383827|NCT01372644|Hormones|hormones|mesh-ancestor
154383828|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383829|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383830|NCT03253198|Bupivacaine|bupivacaine|mesh-list
154383831|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
154383832|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
154383833|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383834|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383835|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
154383836|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404619|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154383837|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154383838|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154383839|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
154383840|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383841|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383842|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383843|NCT04234464|Budesonide|budesonide|mesh-list
154383844|NCT04234464|Albuterol|albuterol|mesh-list
154383845|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383846|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154383847|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
154130038|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
154383848|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383849|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383851|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
154383852|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
154383853|NCT04234464|Hormones|hormones|mesh-ancestor
154383854|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383855|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
154383856|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154383857|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154383858|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154383859|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154383873|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
154383874|NCT02821026|Sirolimus|sirolimus|mesh-list
154383875|NCT02821026|Etanercept|etanercept|mesh-list
154383876|NCT02821026|Tacrolimus|tacrolimus|mesh-list
154383877|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
154383878|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154383879|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154383880|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
154383881|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383882|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154383883|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260498|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260500|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260501|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154260502|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154260503|NCT01090128|Paclitaxel|paclitaxel|mesh-list
154260504|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
154260505|NCT01090128|Doxorubicin|doxorubicin|mesh-list
154260506|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154260507|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153733379|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733380|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
153859309|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153859310|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
153859311|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859312|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859322|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153366841|NCT01685411|Busulfan|busulfan|mesh-list
153399600|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153399602|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399603|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399604|NCT01973413|Insulin|insulin|mesh-list
153399605|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154383884|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383885|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154383886|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383887|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154383888|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
154383889|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154383890|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383891|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
154383892|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154383893|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383894|NCT02821026|Analgesics|analgesics|mesh-ancestor
154383895|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
154383896|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383897|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383898|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154383899|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154383900|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
154383901|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154383902|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
154383903|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
154383904|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383905|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383906|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383907|NCT03228628|Analgesics|analgesics|mesh-ancestor
154383908|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
154383909|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383910|NCT03232450|Aspirin|aspirin|mesh-list
154383911|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154260508|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260509|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405680|NCT05922800|Gamma-oryzanol|gamma-oryzanol|mesh-list
153405723|NCT05922306|Interferon-alpha|interferon-alpha|mesh-list
153405724|NCT05922306|Interferon alpha-2|interferon alpha-2|mesh-list
153405725|NCT05922306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260510|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
154260511|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
154260512|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260513|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154260514|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
154260515|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260516|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260517|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154260518|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
154260519|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153401879|NCT05986968|Antipyretics|antipyretics|mesh-ancestor
153859333|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859334|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
153859335|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383912|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383913|NCT03232450|Analgesics|analgesics|mesh-ancestor
154383914|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
154383915|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383916|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383917|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383918|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154383919|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154383920|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154383950|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154383951|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383952|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154383953|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154383954|NCT00700180|Growth Substances|growth substances|mesh-ancestor
154383955|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383956|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
154383957|NCT03222544|Methylene Blue|methylene blue|mesh-list
154383958|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383959|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383960|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
154383962|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153745787|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154383974|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383975|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154383976|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154383977|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154383978|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
154383979|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383980|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154383981|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154383982|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383983|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
154383984|NCT03228238|Protective Agents|protective agents|mesh-ancestor
154383985|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154383986|NCT03232216|Vitamin D|vitamin d|mesh-list
154383987|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
154383988|NCT03232216|Vitamins|vitamins|mesh-ancestor
154383989|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
154383990|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383991|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154383992|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154260520|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154260521|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154260522|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154260523|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260524|NCT01292174|Ibalizumab|ibalizumab|mesh-list
154260525|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154260526|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154260527|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154260528|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
154260529|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733381|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153401896|NCT05986201|Coagulants|coagulants|mesh-ancestor
153859380|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859381|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859382|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
154383993|NCT03231982|Amlodipine|amlodipine|mesh-list
154383994|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154383995|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154383996|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154383997|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383998|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154383999|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384000|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
154384001|NCT03222310|Itraconazole|itraconazole|mesh-list
154384002|NCT03222310|Ipatasertib|ipatasertib|mesh-list
154384003|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
154384004|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384005|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154384006|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154384007|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384008|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384009|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154384010|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
154384011|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384012|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384013|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154384014|NCT03222310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384015|NCT03222310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154384016|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
154384017|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153408152|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384018|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384019|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
154384020|NCT03231436|Bupivacaine|bupivacaine|mesh-list
154384021|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
154384022|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
154384023|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384024|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384025|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
154384026|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384027|NCT02452450|Acetaminophen|acetaminophen|mesh-list
154384040|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
154384041|NCT01204684|Resiquimod|resiquimod|mesh-list
154384042|NCT01204684|Poly ICLC|poly iclc|mesh-list
154384043|NCT01204684|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154384044|NCT01204684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384045|NCT01204684|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154384046|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
154384047|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384048|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
154384049|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
153859411|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153859412|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
153859413|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399692|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
153399693|NCT01977781|Hormones|hormones|mesh-ancestor
153399694|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384050|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154384051|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384052|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384053|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154384054|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384055|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154384056|NCT00238420|Paclitaxel|paclitaxel|mesh-list
154384057|NCT00238420|Trastuzumab|trastuzumab|mesh-list
154384058|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154384059|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153410021|NCT00003423|Dexamethasone|dexamethasone|mesh-list
154384060|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154384061|NCT00238420|Antibodies|antibodies|mesh-list
154384062|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
154384063|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154384064|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154384065|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384066|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
154384067|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
154384068|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
154384069|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384070|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
154384071|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384072|NCT03221998|Acetaminophen|acetaminophen|mesh-list
154384073|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154384074|NCT03221998|Analgesics|analgesics|mesh-ancestor
154384075|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
154384076|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384077|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384078|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
154384079|NCT04492475|Interferons|interferons|mesh-list
154384080|NCT04492475|Interferon-beta|interferon-beta|mesh-list
154384081|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
154384082|NCT04492475|Remdesivir|remdesivir|mesh-list
154384083|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384084|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
154384085|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384086|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
154384087|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384088|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154384089|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
154384090|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384091|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
154384115|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154384116|NCT03226210|Insulin|insulin|mesh-list
154384117|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
154384118|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154384119|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384120|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154384121|NCT03229954|Hematinics|hematinics|mesh-ancestor
154384122|NCT03220126|Mirikizumab|mirikizumab|mesh-list
154384123|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153410022|NCT00003423|Prednisolone|prednisolone|mesh-list
153412419|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153412421|NCT01680939|Analgesics|analgesics|mesh-ancestor
154384124|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154384125|NCT03220126|Analgesics|analgesics|mesh-ancestor
154384126|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
154384127|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384128|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384129|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384130|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384131|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154384132|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260530|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
154260531|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260532|NCT01090206|Vitamin D|vitamin d|mesh-list
154260533|NCT01090206|Calcium|calcium|mesh-list
154260534|NCT01090206|Vitamins|vitamins|mesh-ancestor
154260535|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
154260536|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260537|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153733382|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
153401919|NCT05985187|Trastuzumab|trastuzumab|mesh-list
153399725|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
153399726|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399727|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399728|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399729|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399730|NCT02025439|Analgesics|analgesics|mesh-ancestor
153399731|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
153399732|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399739|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153859437|NCT04679064|Paclitaxel|paclitaxel|mesh-list
154384133|NCT02452684|Eszopiclone|eszopiclone|mesh-list
154384134|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154384135|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384136|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384137|NCT03119428|Nivolumab|nivolumab|mesh-list
154384138|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154384139|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384140|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154384141|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384142|NCT04345367|Abrocitinib|abrocitinib|mesh-list
154384143|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745959|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
154384165|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384166|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384167|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384168|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154384169|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154384170|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384171|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154384172|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154384173|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384174|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
154384175|NCT03208270|Antithrombins|antithrombins|mesh-list
154384176|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
154384177|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154384178|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
154384179|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384180|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384181|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
154384182|NCT03208426|Amoxicillin|amoxicillin|mesh-list
154384183|NCT03208426|Metronidazole|metronidazole|mesh-list
154384184|NCT03208426|Clarithromycin|clarithromycin|mesh-list
154384185|NCT03208426|Tetracycline|tetracycline|mesh-list
154384186|NCT03208426|Esomeprazole|esomeprazole|mesh-list
154384187|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154384188|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384189|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154260538|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154260540|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260541|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
154260542|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
154260543|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260544|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260545|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260546|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
154260547|NCT04728646|Hormones|hormones|mesh-ancestor
154260548|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260549|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153401950|NCT05983237|Temozolomide|temozolomide|mesh-list
153859465|NCT01183780|Leucovorin|leucovorin|mesh-list
153859466|NCT01183780|Folic Acid|folic acid|mesh-list
153859467|NCT01183780|Fluorouracil|fluorouracil|mesh-list
153859468|NCT01183780|Irinotecan|irinotecan|mesh-list
153413840|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859469|NCT01183780|Ramucirumab|ramucirumab|mesh-list
153859470|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
153859471|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
153859472|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859473|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153859474|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859475|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859476|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
153859477|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859478|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153859479|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153859480|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399758|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153399759|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399760|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153399761|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399762|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153859486|NCT01183780|Hematinics|hematinics|mesh-ancestor
153859487|NCT01183780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153859488|NCT01183780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153859489|NCT01183780|Growth Substances|growth substances|mesh-ancestor
153859506|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153859507|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
153859508|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153859509|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153859510|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
153859511|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859512|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859513|NCT03245021|Rituximab|rituximab|mesh-list
153859514|NCT03245021|Nivolumab|nivolumab|mesh-list
154384190|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154384191|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154384192|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384193|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154384194|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384195|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384196|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154384197|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153746008|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154384208|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
153414072|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384209|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154384210|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384211|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154384212|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154384213|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154384214|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384215|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384216|NCT02450968|Dexamethasone|dexamethasone|mesh-list
154384217|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384218|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
154384219|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
154384220|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384221|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384222|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384223|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
154384224|NCT02450968|Hormones|hormones|mesh-ancestor
154384225|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384226|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154384227|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384228|NCT03749915|Tetracaine|tetracaine|mesh-list
154384229|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
154384230|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
154384231|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384232|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384233|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
154384234|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384235|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
154384236|NCT03119116|Apixaban|apixaban|mesh-list
154384237|NCT03119116|Dabigatran|dabigatran|mesh-list
154384238|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154384239|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
154384240|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154384241|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
154384242|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384243|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384244|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
154384245|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
154384246|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
154384247|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154384248|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154384249|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384250|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384251|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384252|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384253|NCT04403399|Varenicline|varenicline|mesh-list
153416077|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416078|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
154384254|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154384255|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154384256|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
153859545|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859546|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
153859547|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859548|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153859549|NCT04663035|Tislelizumab|tislelizumab|mesh-list
153859550|NCT04663035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859551|NCT04663035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859552|NCT03098589|Lenalidomide|lenalidomide|mesh-list
154384257|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384258|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384259|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384260|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
154384261|NCT03224572|Vitamins|vitamins|mesh-ancestor
154384262|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
153746061|NCT02913118|Amoxicillin|amoxicillin|mesh-list
154384290|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384291|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
154384292|NCT01561937|Warfarin|warfarin|mesh-list
154384293|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
154384294|NCT03210766|Nabilone|nabilone|mesh-list
154384295|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
154130485|NCT00883506|Lisinopril|lisinopril|mesh-list
154384296|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
154384297|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384298|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384299|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384300|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154384301|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154384302|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384303|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154384304|NCT03747341|Fentanyl|fentanyl|mesh-list
154384305|NCT03747341|Oxycodone|oxycodone|mesh-list
154384306|NCT03747341|Buprenorphine|buprenorphine|mesh-list
154384307|NCT03747341|Ondansetron|ondansetron|mesh-list
154384308|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154384309|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154384310|NCT03747341|Narcotics|narcotics|mesh-ancestor
153416080|NCT02722837|Velpatasvir|velpatasvir|mesh-list
153746128|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384338|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154384339|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384341|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
154384342|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384343|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154384344|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154384345|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384346|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384347|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154384348|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154384349|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154384350|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154384351|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
154384352|NCT03224338|Dolutegravir|dolutegravir|mesh-list
154384353|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154384354|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154384355|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384356|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384357|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154384358|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154384359|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
154384360|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384404|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
154384405|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
154384406|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384407|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384408|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
154384409|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384410|NCT03209206|Docetaxel|docetaxel|mesh-list
154384411|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859561|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153859562|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859563|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859564|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153859565|NCT04662177|Analgesics|analgesics|mesh-ancestor
153859566|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
153859567|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416148|NCT02730247|Growth Substances|growth substances|mesh-ancestor
153859568|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153859569|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153859570|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153859571|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
153859572|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859573|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859574|NCT00537953|Miltefosine|miltefosine|mesh-list
153859575|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153859576|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
153859577|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859578|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384412|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
154384413|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
154384414|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
154384415|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384416|NCT03223402|Lamivudine|lamivudine|mesh-list
154384417|NCT03223402|Nevirapine|nevirapine|mesh-list
154384418|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154384419|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154384420|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384421|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384422|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
154384423|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384424|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154384425|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154384426|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154384427|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154384428|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154384429|NCT03208972|Menotropins|menotropins|mesh-list
154384430|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154384431|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384432|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154384433|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
154384434|NCT03206866|Antibodies|antibodies|mesh-list
154384435|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
154384436|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384437|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
154384438|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
154384439|NCT02451748|Prednisone|prednisone|mesh-list
154384440|NCT02451748|Triamcinolone|triamcinolone|mesh-list
154384441|NCT02451748|Naproxen|naproxen|mesh-list
154384442|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
154384443|NCT02451748|Methotrexate|methotrexate|mesh-list
154384444|NCT02451748|Leflunomide|leflunomide|mesh-list
154384445|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384446|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
154384447|NCT02451748|Hormones|hormones|mesh-ancestor
154384448|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153859590|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859592|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153859593|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153859594|NCT00557232|Growth Substances|growth substances|mesh-ancestor
153859595|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859596|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
153859597|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
153859598|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153859599|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154384449|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384450|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154384451|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384452|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154384453|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
154384454|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154384455|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154384456|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
154384457|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384458|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
154384459|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384460|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154384461|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154384462|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
154384463|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384464|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154384501|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384520|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
154384521|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384522|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154384523|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
154384524|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154384525|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384526|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384527|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154384528|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
154384529|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154384530|NCT04978259|Remdesivir|remdesivir|mesh-list
154384531|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
154384532|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384533|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
154384534|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384535|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
154384536|NCT03208582|Diphosphonates|diphosphonates|mesh-list
154384537|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154384538|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384539|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384540|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154384541|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384542|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154384543|NCT03200938|Zinc|zinc|mesh-list
154384544|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
154384545|NCT03200938|Trace Elements|trace elements|mesh-ancestor
154384546|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
154384547|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384548|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
154384549|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
154384550|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154384551|NCT03200938|Protective Agents|protective agents|mesh-ancestor
154384552|NCT04297241|Isosorbide|isosorbide|mesh-list
154384553|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154384554|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154384555|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154384556|NCT04297241|Diuretics|diuretics|mesh-ancestor
153399938|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859649|NCT04661709|Analgesics|analgesics|mesh-ancestor
153859650|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
153859651|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859652|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153859653|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859654|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153859655|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153859656|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859657|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154384557|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
154384583|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384584|NCT02449954|Ketorolac|ketorolac|mesh-list
154384585|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154384586|NCT02449954|Morphine|morphine|mesh-list
154384587|NCT02449954|Tramadol|tramadol|mesh-list
154384588|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154384589|NCT02449954|Narcotics|narcotics|mesh-ancestor
154384590|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384591|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384592|NCT02449954|Analgesics|analgesics|mesh-ancestor
154384593|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
154384594|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384595|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154384596|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154384597|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384598|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384599|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154384600|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384601|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384602|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
154384603|NCT04393493|Furosemide|furosemide|mesh-list
154384604|NCT04393493|Spironolactone|spironolactone|mesh-list
154384636|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154384637|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154384638|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384639|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384640|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154384641|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154384642|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154384643|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154384644|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
153746463|NCT05467384|Amlodipine|amlodipine|mesh-list
154384668|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
154384669|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154384670|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384671|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
154384672|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
154384673|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384674|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
154384675|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384676|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384677|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
154384678|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154384679|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154384680|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384681|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154384683|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
154384684|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154384685|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
154384686|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384687|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859661|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153859662|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153859663|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
153859664|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153859665|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153859666|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153859667|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153859668|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154384688|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154384689|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
154384690|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384691|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384692|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153418879|NCT05829148|Adrenergic Agents|adrenergic agents|mesh-ancestor
154384693|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154384694|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154384695|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
154384696|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154384705|NCT02447224|Metronidazole|metronidazole|mesh-list
154384706|NCT02447224|Ertapenem|ertapenem|mesh-list
154384707|NCT02447224|Cefdinir|cefdinir|mesh-list
154384708|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384709|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154384710|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154384711|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154384712|NCT02447224|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154384713|NCT02447224|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154384714|NCT03199690|Rifampin|rifampin|mesh-list
154384715|NCT03199690|Dolutegravir|dolutegravir|mesh-list
154384716|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154384717|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
154384718|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154384719|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384720|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
154384721|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154384722|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384723|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384724|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154384725|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154384726|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154384727|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154384728|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154384729|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154384730|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154384731|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154384732|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154384733|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154384734|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
154384735|NCT03204058|Metformin|metformin|mesh-list
154384736|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154384737|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154384738|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384739|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154384740|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154384741|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
154384742|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384743|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154384744|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154384745|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384746|NCT03203746|Lycopene|lycopene|mesh-list
154384747|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384748|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
154384749|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130938|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
154384750|NCT03203746|Protective Agents|protective agents|mesh-ancestor
154384751|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260550|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260551|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154260552|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
154260553|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260554|NCT01295138|Lactulose|lactulose|mesh-list
154260555|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260556|NCT01188824|Cilostazol|cilostazol|mesh-list
154260557|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154260558|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
154260559|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260560|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260561|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153402095|NCT05814640|Serotonin Agents|serotonin agents|mesh-ancestor
153859679|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153859680|NCT04661709|Diuretics|diuretics|mesh-ancestor
153859681|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
153859682|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
153859683|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153859684|NCT02466867|Naftifine|naftifine|mesh-list
153859685|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
153859686|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859687|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
153859688|NCT00538265|Tacrolimus|tacrolimus|mesh-list
153859689|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
153859690|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859691|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
154384752|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154384753|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154384754|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384755|NCT03203668|Choline|choline|mesh-list
154384756|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
154384757|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154384758|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
154384759|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384760|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384761|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154384762|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
154384763|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
154384795|NCT02077166|Lenalidomide|lenalidomide|mesh-list
154384796|NCT02077166|Ibrutinib|ibrutinib|mesh-list
154384797|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154384798|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384799|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
154384800|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384801|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384802|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154384803|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154384804|NCT02077166|Growth Substances|growth substances|mesh-ancestor
154384805|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
153746640|NCT00151541|Dapsone|dapsone|mesh-list
154384817|NCT03198676|Poly I-C|poly i-c|mesh-list
154384818|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
153424700|NCT03510481|Artemether|artemether|mesh-list
154384819|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384820|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
153402117|NCT05810597|Hormones|hormones|mesh-ancestor
153859713|NCT02462811|Narcotics|narcotics|mesh-ancestor
153859714|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859715|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
153859716|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
153859717|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
153859718|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
153859719|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153859720|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
153859721|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
153859722|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859723|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859724|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153859725|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153859726|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153859727|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
154384821|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
154384822|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384823|NCT04484506|Prednisone|prednisone|mesh-list
154384824|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
154384825|NCT04484506|Etoposide|etoposide|mesh-list
154384826|NCT04484506|Vincristine|vincristine|mesh-list
154384827|NCT04484506|Pegaspargase|pegaspargase|mesh-list
154384828|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154384829|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
154384830|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384831|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384832|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154384833|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
154384834|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384835|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384836|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154384837|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384838|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
154384839|NCT04484506|Hormones|hormones|mesh-ancestor
154384840|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153424791|NCT03405259|Protective Agents|protective agents|mesh-ancestor
154384841|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154384842|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154384843|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154384844|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154384845|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384846|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
154384847|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
154384848|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
154384849|NCT02449564|Sirolimus|sirolimus|mesh-list
154384850|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154384851|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384852|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154384853|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384854|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
154384855|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154384856|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
154384857|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384858|NCT02449720|Ropivacaine|ropivacaine|mesh-list
154384859|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
154384860|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
154384861|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384862|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384863|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
153859734|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153859735|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153859736|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859737|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859739|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
153859740|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153859741|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
153859742|NCT00538421|Propofol|propofol|mesh-list
153859743|NCT00538421|Sevoflurane|sevoflurane|mesh-list
153859744|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154384864|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384865|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
154384866|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
153783627|NCT02278510|Topotecan|topotecan|mesh-list
153424882|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
154384867|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154384868|NCT03194620|Procyanidin|procyanidin|mesh-list
154384903|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154384904|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
154384905|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
154384906|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
154384907|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
154384908|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153746728|NCT05293600|Diuretics|diuretics|mesh-ancestor
154384937|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154384938|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154384939|NCT04796714|Analgesics|analgesics|mesh-ancestor
154384940|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
154384941|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384942|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384943|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384944|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384945|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154384946|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154384947|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384948|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154384949|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154384950|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384951|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
154384952|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
154131165|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
154384975|NCT03198130|Cemiplimab|cemiplimab|mesh-list
154384976|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154384977|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384978|NCT04238780|Fentanyl|fentanyl|mesh-list
154384979|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154384980|NCT04238780|Narcotics|narcotics|mesh-ancestor
154384981|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384982|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384983|NCT04238780|Analgesics|analgesics|mesh-ancestor
154384984|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
154384985|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384986|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154384987|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154384988|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
154384989|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
154384990|NCT00944216|Emollients|emollients|mesh-list
154384991|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
154384992|NCT00878462|Asenapine|asenapine|mesh-list
154384993|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153424946|NCT02734940|Lidocaine|lidocaine|mesh-list
154384994|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154384995|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384996|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384997|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154384998|NCT03197818|Budesonide|budesonide|mesh-list
154384999|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
154385000|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385001|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154385002|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
154385003|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385004|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385005|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153746806|NCT00532909|Bevacizumab|bevacizumab|mesh-list
154385017|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154385018|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385019|NCT03442088|Analgesics|analgesics|mesh-ancestor
154385020|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
154385021|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385022|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385023|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385024|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385025|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154385026|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154385027|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385028|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385029|NCT01562405|Dexamethasone|dexamethasone|mesh-list
154385030|NCT01562405|Lenalidomide|lenalidomide|mesh-list
154385031|NCT01562405|Pomalidomide|pomalidomide|mesh-list
154385032|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385033|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
154385034|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
154385035|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385036|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385037|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154385038|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
154385039|NCT01562405|Hormones|hormones|mesh-ancestor
154385040|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385041|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154385042|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385043|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
154385044|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154385045|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154385046|NCT01562405|Growth Substances|growth substances|mesh-ancestor
154385047|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
154385048|NCT03119194|Opicapone|opicapone|mesh-list
154385049|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154131238|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154385051|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385052|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154385053|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154385054|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154385055|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154385056|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385057|NCT03107338|Analgesics|analgesics|mesh-ancestor
154385058|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
154385059|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385060|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385061|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385062|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385063|NCT05581940|Bupivacaine|bupivacaine|mesh-list
154385064|NCT05581940|Anesthetics|anesthetics|mesh-list
154385065|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
154385066|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385067|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385093|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
154385094|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385095|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385096|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154385097|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
154385098|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154385099|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154385100|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154385101|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154385102|NCT03197584|Growth Substances|growth substances|mesh-ancestor
154385103|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
154385104|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154385105|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
154385107|NCT03197584|Protective Agents|protective agents|mesh-ancestor
154385108|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
154385109|NCT03197584|Vitamins|vitamins|mesh-ancestor
154385110|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
154385111|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154385112|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153859796|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153859797|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153859798|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859799|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859800|NCT00538655|Modafinil|modafinil|mesh-list
153859801|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153859802|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400082|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385113|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154385114|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
154385115|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385116|NCT03722576|Calcium|calcium|mesh-list
154385117|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154385118|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385148|NCT03625076|Propofol|propofol|mesh-list
154385149|NCT03625076|Etomidate|etomidate|mesh-list
154385150|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
154385151|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
154385152|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385153|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385154|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
154385155|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385156|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154385157|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154385158|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154385159|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385160|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385161|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154385162|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154385169|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385170|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154385171|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154385173|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
154385174|NCT03693989|Difluprednate|difluprednate|mesh-list
154385175|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
154385176|NCT03693989|Hormones|hormones|mesh-ancestor
154385177|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385178|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385179|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385180|NCT04944212|Vitamin D|vitamin d|mesh-list
154385181|NCT04944212|Vitamins|vitamins|mesh-ancestor
154385182|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
154385183|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385184|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154385185|NCT03197740|Donepezil|donepezil|mesh-list
154385186|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154385187|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385188|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385189|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
154385190|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385191|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385192|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
154385193|NCT03201796|Levofloxacin|levofloxacin|mesh-list
154385194|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
154385195|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154385196|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385197|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154385198|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154385199|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154385200|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385201|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385202|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385203|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153859826|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859840|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859841|NCT04660773|Pregabalin|pregabalin|mesh-list
153859842|NCT04660773|Analgesics|analgesics|mesh-ancestor
153859843|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
153859844|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859845|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859846|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
153859847|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153859848|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859849|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859850|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154385204|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154385205|NCT02727998|Midazolam|midazolam|mesh-list
154385206|NCT02727998|Ketamine|ketamine|mesh-list
154385207|NCT02727998|Analgesics|analgesics|mesh-ancestor
153433461|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153433462|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154385208|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
154385209|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385210|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385211|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154385212|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154385213|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
154385214|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
154385215|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385216|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154385217|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154385218|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385219|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385220|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154385221|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154385222|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154385223|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154385224|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154385225|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
154385226|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
154385227|NCT02636270|Mecasermin|mecasermin|mesh-list
154385228|NCT02636270|Growth Substances|growth substances|mesh-ancestor
154385229|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385230|NCT02108990|Acetaminophen|acetaminophen|mesh-list
154385231|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385232|NCT02108990|Analgesics|analgesics|mesh-ancestor
154385255|NCT04179461|Loratadine|loratadine|mesh-list
154385256|NCT04179461|Azithromycin|azithromycin|mesh-list
154385257|NCT04179461|Budesonide|budesonide|mesh-list
154385258|NCT04179461|Beclomethasone|beclomethasone|mesh-list
154385259|NCT04179461|Emollients|emollients|mesh-list
154385260|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
154385261|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
154385262|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154385263|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154385264|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
154385265|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154385266|NCT04179461|Vitamins|vitamins|mesh-ancestor
154385267|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
154385268|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385269|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154385270|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385271|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154385272|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
154385273|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385274|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154385275|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
154385276|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
154385277|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154260562|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
154385278|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154385280|NCT04179461|Hormones|hormones|mesh-ancestor
154385281|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385282|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154385283|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385284|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154385285|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154385286|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154385287|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
154385288|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385289|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385290|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
154385322|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385323|NCT03196648|Fluorides|fluorides|mesh-list
154385324|NCT03196648|Antioxidants|antioxidants|mesh-list
154385325|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
154385326|NCT03196648|Protective Agents|protective agents|mesh-ancestor
154385327|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385328|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385329|NCT03625310|Listerine|listerine|mesh-list
154385330|NCT03625310|Fluorides|fluorides|mesh-list
154385331|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
154385332|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
154385333|NCT03625310|Protective Agents|protective agents|mesh-ancestor
154385334|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385354|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385355|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154385356|NCT04165031|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154385357|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154385358|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385360|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154385361|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154385362|NCT05480150|Citalopram|citalopram|mesh-list
154385363|NCT05480150|Escitalopram|escitalopram|mesh-list
154385364|NCT05480150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154385365|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154385366|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385367|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385368|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385369|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
154385370|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385371|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154385372|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154385373|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
154385374|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
154385375|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385376|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154385377|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154385378|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
154385379|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154385380|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
154385381|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154385382|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154385383|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154385384|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385385|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154385386|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154385387|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154385388|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
154385389|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154385419|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385420|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385421|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385422|NCT03117790|Analgesics|analgesics|mesh-ancestor
154385423|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
154385424|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385425|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154385426|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154385427|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154385428|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
154260564|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154260565|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260566|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154260567|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
153435142|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153435151|NCT00383474|Tipifarnib|tipifarnib|mesh-list
154260568|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154260569|NCT01188824|Protective Agents|protective agents|mesh-ancestor
154260570|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153733384|NCT00507052|Expectorants|expectorants|mesh-ancestor
153733385|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
153733386|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153733387|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
153402235|NCT05576207|Trace Elements|trace elements|mesh-list
153400210|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153400211|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153400212|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
153400213|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153400214|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153400215|NCT02062177|Midazolam|midazolam|mesh-list
153400216|NCT02062177|Propofol|propofol|mesh-list
153400217|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153400218|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400219|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400220|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153400221|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
153400223|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153859914|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
153859915|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859916|NCT04660461|Lansoprazole|lansoprazole|mesh-list
154385429|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385430|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385431|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154385432|NCT03117790|Narcotics|narcotics|mesh-ancestor
154385433|NCT03193372|Azelaic acid|azelaic acid|mesh-list
154385434|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747242|NCT02935231|Nicotine|nicotine|mesh-list
154385443|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385444|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385445|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154385446|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154385447|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154385448|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154385449|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154385450|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385451|NCT03193606|Fluorides|fluorides|mesh-list
153400237|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400239|NCT02403830|Morphine|morphine|mesh-list
153400240|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
153400241|NCT02403830|Ticagrelor|ticagrelor|mesh-list
153400242|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153400243|NCT02403830|Narcotics|narcotics|mesh-ancestor
153400244|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400245|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400246|NCT02403830|Analgesics|analgesics|mesh-ancestor
154385452|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
154385453|NCT03193606|Protective Agents|protective agents|mesh-ancestor
154385454|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385455|NCT02448784|Donepezil|donepezil|mesh-list
154385456|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154385457|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385458|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385459|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
154385460|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385461|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385462|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
154385463|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
154385464|NCT04050488|Astringents|astringents|mesh-ancestor
154385465|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385466|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
154385467|NCT02449252|Prednisone|prednisone|mesh-list
154385468|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
154385469|NCT02449252|Doxorubicin|doxorubicin|mesh-list
154385470|NCT02449252|Vincristine|vincristine|mesh-list
154385471|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154385472|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
154385473|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385474|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385475|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154385476|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
154385477|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385478|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385479|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154385480|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154385481|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154385482|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154385483|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385484|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385485|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
154385486|NCT02449252|Hormones|hormones|mesh-ancestor
154385487|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385488|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154385489|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154385490|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
154385491|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
154385492|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
154385493|NCT04779554|Mitomycins|mitomycins|mesh-list
154385494|NCT04779554|Mitomycin|mitomycin|mesh-list
154385495|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154385496|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385497|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
154385498|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385499|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154385500|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385501|NCT02444260|Lidocaine|lidocaine|mesh-list
154385502|NCT02444260|Midazolam|midazolam|mesh-list
154385503|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154385532|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
154385533|NCT03195634|Protective Agents|protective agents|mesh-ancestor
153435631|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385534|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154385535|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385536|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153400285|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153400286|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400287|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
153400289|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400290|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400291|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153400292|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
153859982|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859983|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154385537|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
154385538|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154385539|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154385541|NCT02448550|Calcium heparin|calcium heparin|mesh-list
154385542|NCT02448550|Bivalirudin|bivalirudin|mesh-list
154385543|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
154385544|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154385545|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154385546|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385547|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
154385548|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154385560|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385561|NCT03704246|Antibodies|antibodies|mesh-list
154385562|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154385563|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
154385564|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385565|NCT05239910|Tenalisib|tenalisib|mesh-list
154385566|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154385567|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385568|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385569|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
154385570|NCT03701672|Analgesics|analgesics|mesh-list
154385571|NCT03701672|Narcotics|narcotics|mesh-ancestor
154385572|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385573|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385574|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
154385575|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385576|NCT03624530|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154385577|NCT03624530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154385578|NCT03624530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131780|NCT00892476|Calcium|calcium|mesh-list
154385579|NCT03624530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385580|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
154385581|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154385582|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385583|NCT03746249|Lenvatinib|lenvatinib|mesh-list
154385584|NCT03746249|Antibodies|antibodies|mesh-list
154385585|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
154385586|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
154385587|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385588|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385589|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154385590|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385591|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385592|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
154385593|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
154385594|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
154385595|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
154385596|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385597|NCT03698474|Analgesics|analgesics|mesh-ancestor
154385598|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
154385599|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385600|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385601|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
154260571|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154260572|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260573|NCT01060475|Tacrolimus|tacrolimus|mesh-list
154260574|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154260575|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
154260576|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260577|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154260578|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260579|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402289|NCT05493501|Pemetrexed|pemetrexed|mesh-list
153859988|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153859989|NCT04660110|Piperaquine|piperaquine|mesh-list
153859990|NCT04660110|Artenimol|artenimol|mesh-list
153859991|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
153859992|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153859993|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153859994|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859995|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153859996|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435914|NCT00002882|Cisplatin|cisplatin|mesh-list
153436004|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
153859997|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
153859998|NCT00540410|Artesunate|artesunate|mesh-list
153859999|NCT00540410|Lumefantrine|lumefantrine|mesh-list
153860000|NCT00540410|Amodiaquine|amodiaquine|mesh-list
153860001|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153860002|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
153860003|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153860004|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154385602|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385603|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154385604|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
154385605|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154385606|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385607|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154385608|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
154385609|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154385610|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
154385611|NCT03698474|Protective Agents|protective agents|mesh-ancestor
154385612|NCT03698474|Vitamins|vitamins|mesh-ancestor
154385613|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
154385614|NCT03698474|Cathartics|cathartics|mesh-ancestor
154385615|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154385626|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
154385627|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154385628|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154385629|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385630|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385631|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154385632|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154385633|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
154385634|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
154260580|NCT01060631|Propofol|propofol|mesh-list
154260581|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154260582|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260583|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260584|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154260585|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
154260586|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
154260587|NCT03254134|Warfarin|warfarin|mesh-list
154260588|NCT03254134|Dabigatran|dabigatran|mesh-list
154260589|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
153436008|NCT00003446|Leucovorin|leucovorin|mesh-list
153436289|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154260590|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
154260591|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154260592|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
154260593|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402324|NCT05450965|Onvansertib|onvansertib|mesh-list
153860018|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385635|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385636|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154385637|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
154385638|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154385639|NCT02448316|Prednisolone|prednisolone|mesh-list
154385640|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
154385641|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154385642|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
154385643|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385644|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
154385645|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
154385646|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385647|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385648|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154385649|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
154385650|NCT02448316|Hormones|hormones|mesh-ancestor
154385651|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131840|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
154385652|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154385653|NCT02448316|Protective Agents|protective agents|mesh-ancestor
154385654|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154385655|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385656|NCT02443714|Insulin|insulin|mesh-list
154385657|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154385658|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
154385659|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154385660|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385661|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
154385662|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154385663|NCT03703154|Tacrolimus|tacrolimus|mesh-list
154385664|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154385665|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
154385666|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385667|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154385668|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385669|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385670|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
154385671|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
154385672|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385673|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
154385674|NCT02434276|Coagulants|coagulants|mesh-ancestor
154385675|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
154385676|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154385677|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154385678|NCT03190642|Prednisolone|prednisolone|mesh-list
154385679|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
154385680|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154260594|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260595|NCT03953196|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154260596|NCT03953196|Antiviral Agents|antiviral agents|mesh-ancestor
154260597|NCT03953196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260598|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
154260599|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
154260600|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
153402357|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
153860047|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153860048|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860049|NCT00540800|Docetaxel|docetaxel|mesh-list
153860050|NCT00540800|Capecitabine|capecitabine|mesh-list
153860051|NCT00540800|Epirubicin|epirubicin|mesh-list
154385681|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
154385682|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385691|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154385692|NCT03190642|Protective Agents|protective agents|mesh-ancestor
154385693|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154385694|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385695|NCT03702530|Albendazole|albendazole|mesh-list
154385696|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
154385697|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154385698|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385699|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
154385700|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154385701|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154385702|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
154385703|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
154385704|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
154385705|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385706|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385707|NCT02443246|Vitamin D|vitamin d|mesh-list
154385708|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
154385709|NCT02443246|Vitamins|vitamins|mesh-ancestor
154385710|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
153436638|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
154385711|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385712|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154385713|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154385714|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154385715|NCT03031496|Amiloride|amiloride|mesh-list
154385716|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
154385717|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154385718|NCT03031496|Diuretics|diuretics|mesh-ancestor
154385719|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
154385720|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385721|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154385722|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385723|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385724|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154385725|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154385726|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154385727|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154385728|NCT03187912|Riboflavin|riboflavin|mesh-list
154385729|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
154385730|NCT03187912|Vitamins|vitamins|mesh-ancestor
154385731|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
154385732|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385733|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154385734|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
154385735|NCT02443012|Nepafenac|nepafenac|mesh-list
154385736|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154385737|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385739|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
154385740|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385741|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385742|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385743|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385744|NCT03701126|Bupivacaine|bupivacaine|mesh-list
154385745|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
154385746|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
153436643|NCT00003584|Prednisone|prednisone|mesh-list
154385747|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385748|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385749|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
154385757|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385758|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154385759|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385760|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385761|NCT02433808|Neostigmine|neostigmine|mesh-list
154385762|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154385763|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385764|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385765|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
154385766|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385767|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385768|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154385769|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
154385770|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385771|NCT03701984|Lidocaine|lidocaine|mesh-list
154385772|NCT03701984|Tramadol|tramadol|mesh-list
154385773|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
154385774|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
154385775|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385776|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385777|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
154385778|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385779|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154385780|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154385781|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154385782|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385783|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385784|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154385785|NCT03701984|Narcotics|narcotics|mesh-ancestor
154385786|NCT03701984|Analgesics|analgesics|mesh-ancestor
154385787|NCT02439190|Aspirin|aspirin|mesh-list
154385788|NCT02439190|Clopidogrel|clopidogrel|mesh-list
154385789|NCT02439190|BMS-986120|bms-986120|mesh-list
154385790|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154385791|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385792|NCT02439190|Analgesics|analgesics|mesh-ancestor
154385793|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
154385794|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437096|NCT00003662|Melphalan|melphalan|mesh-list
154385795|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385796|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385797|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385798|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154385799|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154385800|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385801|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154385802|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154385803|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385804|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
154385805|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154385806|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154385807|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154385808|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
154385809|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385811|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154385812|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154385813|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154385814|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385815|NCT02439034|Acetaminophen|acetaminophen|mesh-list
154385834|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
154385836|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
154385837|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402404|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
153860127|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153860128|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860129|NCT02333643|Protective Agents|protective agents|mesh-ancestor
153860130|NCT00541463|Nelfinavir|nelfinavir|mesh-list
153860131|NCT00541463|Indinavir|indinavir|mesh-list
153860132|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860133|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153400422|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400438|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860134|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153860135|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
154385838|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154385839|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385840|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154385841|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385842|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154385843|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154385844|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
154385845|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385846|NCT03186742|Eplerenone|eplerenone|mesh-list
154385847|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154385848|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
154385849|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385850|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385851|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154385852|NCT03186742|Diuretics|diuretics|mesh-ancestor
154385853|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
154385854|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154385855|NCT03186664|Nabiximols|nabiximols|mesh-list
154385856|NCT03186664|Analgesics|analgesics|mesh-ancestor
154385857|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
154385858|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385859|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385860|NCT02441842|Atenolol|atenolol|mesh-list
154385861|NCT02441842|Lisinopril|lisinopril|mesh-list
154385862|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154385863|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
154385864|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385865|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385866|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154385867|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154385868|NCT02441842|Protective Agents|protective agents|mesh-ancestor
154385869|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385870|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154385871|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
154385881|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154385882|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385883|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
154385884|NCT02438566|Coagulants|coagulants|mesh-ancestor
154385885|NCT02433652|Vaccines|vaccines|mesh-list
154385886|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
154385887|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385888|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
154385889|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154385890|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
154385891|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154385892|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385893|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154385894|NCT02433418|Diclofenac|diclofenac|mesh-list
154385895|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154385896|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385897|NCT02433418|Analgesics|analgesics|mesh-ancestor
153400452|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153400453|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153400454|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153400455|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400456|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400457|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860153|NCT04659642|Fentanyl|fentanyl|mesh-list
154385898|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
154385899|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385900|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385901|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385902|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385903|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154385904|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385905|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385906|NCT02433730|Testosterone|testosterone|mesh-list
154385907|NCT02433730|Androgens|androgens|mesh-ancestor
154385908|NCT02433730|Hormones|hormones|mesh-ancestor
154385909|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385910|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385911|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
154385912|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154385913|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
154385914|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154385915|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
154385916|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385917|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385918|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
154385919|NCT02441530|Vitamin D|vitamin d|mesh-list
154385920|NCT02441530|Vitamins|vitamins|mesh-list
154385921|NCT02441530|Vitamin E|vitamin e|mesh-list
154385922|NCT02441530|Ibuprofen|ibuprofen|mesh-list
154385923|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
154385924|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385925|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154385926|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154385927|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385928|NCT02441530|Analgesics|analgesics|mesh-ancestor
154385929|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
154385930|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385931|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385932|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385933|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154385934|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385935|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385936|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
154385937|NCT02441530|Protective Agents|protective agents|mesh-ancestor
154385943|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
154385944|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154385945|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385946|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154385947|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
154385948|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385949|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385950|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
154385951|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385952|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154385953|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154385954|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
154385955|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385956|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154385957|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
154385958|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154385959|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154385960|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385961|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153860175|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
153860176|NCT00541814|Cyclosporine|cyclosporine|mesh-list
153860177|NCT00541814|Cyclosporins|cyclosporins|mesh-list
153860178|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860179|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860180|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153860181|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
153860182|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860183|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
153860184|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860185|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
153860186|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860187|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154385962|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385963|NCT02433184|Analgesics|analgesics|mesh-ancestor
154385964|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
154385965|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385966|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385967|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154385968|NCT02438020|Metformin|metformin|mesh-list
154385969|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154385970|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385971|NCT02440750|Dienogest|dienogest|mesh-list
154385972|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
154385973|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154385974|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
154385975|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154385976|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385977|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154385978|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153438346|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385979|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154385980|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154385981|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
154385982|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385983|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154385984|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385985|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
154385986|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154385987|NCT02432872|Cytarabine|cytarabine|mesh-list
154385988|NCT02432872|Daunorubicin|daunorubicin|mesh-list
154385989|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154385990|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
154385991|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385992|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385993|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
154385994|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385995|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154385996|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
154385997|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385998|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154385999|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154386000|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154386001|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386002|NCT02436928|Vaccines|vaccines|mesh-list
154386003|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
154386004|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386005|NCT02436538|Hormones|hormones|mesh-list
154386006|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386007|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386008|NCT02436694|Dexamethasone|dexamethasone|mesh-list
154260601|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154260602|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154260603|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260604|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
154260605|NCT01295294|Coagulants|coagulants|mesh-ancestor
154260606|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154260607|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
154260608|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153733388|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733389|NCT00507052|Protective Agents|protective agents|mesh-ancestor
153733390|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860191|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153860192|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153860193|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153860194|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860195|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153860196|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153860197|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153860198|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860199|NCT02301234|Celecoxib|celecoxib|mesh-list
153860200|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153860201|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153860202|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153860203|NCT02301234|Analgesics|analgesics|mesh-ancestor
153860204|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
153860205|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860206|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386028|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386029|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
154132209|NCT03667443|Inositol|inositol|mesh-list
154386031|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
154386032|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154386033|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154386034|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154386035|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386036|NCT02659020|Gemcitabine|gemcitabine|mesh-list
154386037|NCT02659020|Docetaxel|docetaxel|mesh-list
154386038|NCT02659020|Olaratumab|olaratumab|mesh-list
154386039|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154386040|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
154386041|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386042|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860207|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860208|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860209|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153860210|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153860211|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860212|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860213|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
153860215|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
153860217|NCT01214668|Doxorubicin|doxorubicin|mesh-list
154386043|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
154386044|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
154386045|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
154386046|NCT03482011|Mirikizumab|mirikizumab|mesh-list
154386047|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154386048|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154386049|NCT03482011|Analgesics|analgesics|mesh-ancestor
154386050|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
154386051|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386052|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386053|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154386054|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154386055|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154386056|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154386057|NCT01374126|Azithromycin|azithromycin|mesh-list
154386058|NCT01374126|Artesunate|artesunate|mesh-list
154386059|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154386060|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386061|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
154386062|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154386063|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154386064|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386065|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
153747854|NCT02922166|SRX246|srx246|mesh-list
154386071|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386072|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
154386073|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386074|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154386075|NCT02431936|Prazosin|prazosin|mesh-list
154386076|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154386077|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154386078|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154386079|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154386080|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
154386081|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386082|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386083|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386084|NCT02440828|Tobramycin|tobramycin|mesh-list
154386085|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154386086|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386087|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154386088|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154386089|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386090|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386091|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154386092|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
154386093|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386094|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386095|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
154386096|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154386097|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386098|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153439742|NCT00003565|Docetaxel|docetaxel|mesh-list
153439743|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439832|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
154386099|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
154386100|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154386101|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386102|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260610|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154260611|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154260612|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154260613|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154260614|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154260615|NCT01295294|Analgesics|analgesics|mesh-ancestor
154260616|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
154260617|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154260618|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260619|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260620|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154260621|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260622|NCT01191710|Progesterone|progesterone|mesh-list
154386103|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386104|NCT05160090|Bupropion|bupropion|mesh-list
154386105|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154386106|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
154386107|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154386108|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154386109|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154386110|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154386111|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386112|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
154386113|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386114|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386115|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153439833|NCT00003577|Fluorouracil|fluorouracil|mesh-list
153439834|NCT00003577|Methotrexate|methotrexate|mesh-list
154386116|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154386117|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386118|NCT04516616|Paclitaxel|paclitaxel|mesh-list
154386119|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154386120|NCT04516616|Cisplatin|cisplatin|mesh-list
154386121|NCT04516616|Antibodies|antibodies|mesh-list
154386122|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154386123|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154386124|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386125|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
154386126|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
154386127|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
154386128|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386129|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
154386130|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386131|NCT00511134|Eszopiclone|eszopiclone|mesh-list
154386132|NCT00511134|Bupropion|bupropion|mesh-list
154386133|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153747904|NCT00406250|Bevacizumab|bevacizumab|mesh-list
154386152|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386153|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154386154|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
154386155|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154386156|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154386157|NCT01372384|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154386158|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154386159|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386160|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386161|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386162|NCT03190798|Canagliflozin|canagliflozin|mesh-list
154386163|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153400582|NCT02975297|Incretins|incretins|mesh-ancestor
153400583|NCT02975297|Hormones|hormones|mesh-ancestor
154386164|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386165|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386166|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386167|NCT03696290|Aztreonam|aztreonam|mesh-list
154386168|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154386169|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386170|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
154386171|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386172|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386173|NCT03696212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154386174|NCT03696212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386175|NCT03692546|Bupivacaine|bupivacaine|mesh-list
154132366|NCT01075477|Rituximab|rituximab|mesh-list
154386176|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
154386178|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386179|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386180|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
154386181|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386182|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154386183|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
154386184|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386185|NCT02434822|Vaccines|vaccines|mesh-list
154386211|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386213|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386214|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386215|NCT03626376|Valacyclovir|valacyclovir|mesh-list
154386216|NCT03626376|Acyclovir|acyclovir|mesh-list
154386217|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154386218|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154386219|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
154386220|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386221|NCT03695822|Mirabegron|mirabegron|mesh-list
154386222|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154386223|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154386224|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154386225|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
154386226|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386227|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386228|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386229|NCT03695822|Urological Agents|urological agents|mesh-ancestor
154386230|NCT03718507|Atropine|atropine|mesh-list
154386231|NCT03718507|Fentanyl|fentanyl|mesh-list
154386232|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153748034|NCT04688983|Ponatinib|ponatinib|mesh-list
154386269|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386270|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386271|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
154386272|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386285|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154386286|NCT03453151|Anesthetics|anesthetics|mesh-list
154386287|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
154386288|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386289|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386290|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
154386291|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386292|NCT03433248|Empagliflozin|empagliflozin|mesh-list
154386293|NCT03433248|Gliclazide|gliclazide|mesh-list
154386294|NCT03433248|Linagliptin|linagliptin|mesh-list
154386295|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154386296|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386297|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386298|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386299|NCT03433248|Incretins|incretins|mesh-ancestor
154386300|NCT03433248|Hormones|hormones|mesh-ancestor
154386301|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386302|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154386303|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
154386304|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386305|NCT03691688|Aspirin|aspirin|mesh-list
154386306|NCT03691688|Clopidogrel|clopidogrel|mesh-list
154386307|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153860306|NCT04648917|Protective Agents|protective agents|mesh-ancestor
153860307|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860308|NCT00543179|Lanreotide|lanreotide|mesh-list
153860309|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860310|NCT00543218|Teriparatide|teriparatide|mesh-list
153860311|NCT00543218|Calcitonin|calcitonin|mesh-list
153860312|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
153860313|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153860314|NCT00543218|Katacalcin|katacalcin|mesh-list
153860316|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386308|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154386309|NCT03691688|Analgesics|analgesics|mesh-ancestor
154386310|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
154386311|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386312|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386313|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154386314|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154386315|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154386316|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154386317|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386318|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154386319|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154386320|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386321|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
154386322|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154386323|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154386324|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154386325|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
154386326|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386327|NCT02425462|Dienogest|dienogest|mesh-list
154386328|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154386329|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
154386330|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154386331|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386332|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154386333|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154386334|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154386345|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386347|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386348|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
154386349|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
154386350|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154386351|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
154386352|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386353|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386354|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154386355|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
154386356|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
154386357|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154386358|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
153442119|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154386359|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386360|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386361|NCT02800824|Budesonide|budesonide|mesh-list
154386362|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154386363|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154386364|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
154386365|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386366|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386367|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154386368|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
154386369|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
154386370|NCT02800824|Hormones|hormones|mesh-ancestor
154386371|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386372|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153860333|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860334|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153860336|NCT03456752|Hormones|hormones|mesh-ancestor
153860337|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860338|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153860339|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386373|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154386374|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386375|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386376|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154386377|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154386378|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386379|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
154386380|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386381|NCT03715699|Prednisone|prednisone|mesh-list
154386382|NCT03715699|Leflunomide|leflunomide|mesh-list
154386383|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154386384|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
154386385|NCT03715699|Hormones|hormones|mesh-ancestor
154386386|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386387|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386388|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154386389|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386390|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442121|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
154386391|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386392|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154386393|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
154386394|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
154386395|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154386396|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
154386432|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386433|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748248|NCT00155558|Leucovorin|leucovorin|mesh-list
154386470|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386471|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386472|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154386493|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154386494|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154386495|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154386496|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
154386498|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
154386499|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
154386500|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386501|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386502|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154386503|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154386504|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386505|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154386506|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154386507|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
154386508|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386509|NCT02420938|Rituximab|rituximab|mesh-list
154386510|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386511|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386512|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
154386513|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386514|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154386515|NCT02429440|Molgramostim|molgramostim|mesh-list
154386516|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154386517|NCT02429440|Sargramostim|sargramostim|mesh-list
154386518|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154386519|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
154386520|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386521|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386522|NCT02429518|Miltefosine|miltefosine|mesh-list
153442855|NCT01624194|Oxytocin|oxytocin|mesh-list
154386523|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
154260625|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154260626|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260627|NCT04367740|Antibodies|antibodies|mesh-list
154260628|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
154260629|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
154260630|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260631|NCT03852056|Fluorides|fluorides|mesh-list
154260632|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
154260633|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
153402650|NCT05049213|Povidone|povidone|mesh-list
153400659|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153400660|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153400661|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400662|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400663|NCT02414204|Urological Agents|urological agents|mesh-ancestor
153400664|NCT02989493|Doxazosin|doxazosin|mesh-list
153400665|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153860363|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
153860364|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
153860365|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153860366|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860367|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
153860368|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860369|NCT00543335|Sorafenib|sorafenib|mesh-list
153860370|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860371|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153400666|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153400667|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153400668|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153400669|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
153400670|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386524|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443090|NCT04720716|Sorafenib|sorafenib|mesh-list
153443596|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386525|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386526|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154386527|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154386528|NCT00708526|Anesthetics|anesthetics|mesh-list
154386529|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386561|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386562|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386563|NCT02452554|Immunotoxins|immunotoxins|mesh-ancestor
154386564|NCT02452554|Immunoconjugates|immunoconjugates|mesh-ancestor
154260636|NCT03242434|Mannitol|mannitol|mesh-list
154260637|NCT03242434|Lactulose|lactulose|mesh-list
154260638|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154260639|NCT03242434|Diuretics|diuretics|mesh-ancestor
154260640|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
154260641|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260642|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154260643|NCT04222426|Atezolizumab|atezolizumab|mesh-list
153733392|NCT00507091|Leucovorin|leucovorin|mesh-list
153402669|NCT05020600|Pregabalin|pregabalin|mesh-list
153860372|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860387|NCT00543608|Vancomycin|vancomycin|mesh-list
153860433|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
153860434|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860435|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153400730|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400732|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
153400733|NCT02996591|Dexamethasone|dexamethasone|mesh-list
153400734|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
153400735|NCT02996591|Midazolam|midazolam|mesh-list
153400736|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
153400737|NCT02996591|Ketamine|ketamine|mesh-list
153400738|NCT02996591|Bupivacaine|bupivacaine|mesh-list
153400739|NCT02996591|Mepivacaine|mepivacaine|mesh-list
153400740|NCT02996591|Anesthetics|anesthetics|mesh-list
153400741|NCT02996591|Propofol|propofol|mesh-list
153400742|NCT02996591|Sevoflurane|sevoflurane|mesh-list
153400743|NCT02996591|BB 1101|bb 1101|mesh-list
153400744|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400745|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
153400746|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
153400747|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400748|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400749|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153400750|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
153400751|NCT02996591|Hormones|hormones|mesh-ancestor
153860501|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
153860502|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
153860503|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
153860504|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860505|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153860506|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
153860507|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860522|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153860523|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153860525|NCT01191268|Insulin|insulin|mesh-list
153860526|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153860527|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
153860528|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
153860529|NCT01191268|Dulaglutide|dulaglutide|mesh-list
153860530|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153860533|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
154386565|NCT02452554|Immunologic Factors|immunologic factors|mesh-ancestor
154386566|NCT02452554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386567|NCT03182374|Hylan|hylan|mesh-list
154386568|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
154386569|NCT03182374|Protective Agents|protective agents|mesh-ancestor
154386570|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386571|NCT01319682|Lidocaine|lidocaine|mesh-list
154386572|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
154386573|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
154386574|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386575|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386576|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
154386609|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154386610|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386611|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154386612|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
154386613|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154386614|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
154386615|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
154386616|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386626|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386627|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154386628|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154386629|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
154386630|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386631|NCT05602675|Repaglinide|repaglinide|mesh-list
154386632|NCT05602675|Methotrexate|methotrexate|mesh-list
154386633|NCT05602675|Midazolam|midazolam|mesh-list
154386634|NCT05602675|Levomethorphan|levomethorphan|mesh-list
154386635|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
154386636|NCT05602675|Warfarin|warfarin|mesh-list
154386637|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154386638|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
154386639|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154386640|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386641|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154386642|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
154386643|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386644|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386645|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
154386646|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386647|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154386648|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154386649|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
154386650|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154386651|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154386652|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153400971|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153400973|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400974|NCT03177395|Protective Agents|protective agents|mesh-ancestor
153400975|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400976|NCT03177395|Antidotes|antidotes|mesh-ancestor
153400977|NCT03179345|Pregabalin|pregabalin|mesh-list
153400978|NCT03179345|Gabapentin|gabapentin|mesh-list
153400979|NCT03179345|Analgesics|analgesics|mesh-ancestor
153400980|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
153401056|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
153401061|NCT03096353|Naloxone|naloxone|mesh-list
154386653|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154386654|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386655|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154386656|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154386657|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445286|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154386658|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154386659|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
154386660|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
154386661|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
154386662|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
154386663|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386664|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
154386665|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
154386666|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
154386667|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154386668|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154386669|NCT05602675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154386670|NCT05602675|Narcotics|narcotics|mesh-ancestor
154386671|NCT05602675|Analgesics|analgesics|mesh-ancestor
154386672|NCT05602675|Sensory System Agents|sensory system agents|mesh-ancestor
154386673|NCT05602675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386674|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386675|NCT03714685|Firibastat|firibastat|mesh-list
154386676|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154386677|NCT02705716|Fluorides|fluorides|mesh-list
154386678|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
154386679|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
154386680|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
154386681|NCT02705716|Protective Agents|protective agents|mesh-ancestor
154386682|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386683|NCT02429050|Morphine|morphine|mesh-list
154386690|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386691|NCT02417142|Exenatide|exenatide|mesh-list
154386692|NCT02417142|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154386693|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386694|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386695|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154386696|NCT02417142|Incretins|incretins|mesh-ancestor
154386697|NCT02417142|Hormones|hormones|mesh-ancestor
154386698|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386699|NCT01374750|Cyclosporine|cyclosporine|mesh-list
154386700|NCT01374750|Sirolimus|sirolimus|mesh-list
154132885|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154386701|NCT01374750|Tacrolimus|tacrolimus|mesh-list
153451146|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
154386702|NCT01374750|Cyclosporins|cyclosporins|mesh-list
154386703|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154386704|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
154386705|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386706|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154386707|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386708|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386709|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
154386710|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386711|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
154386712|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154386713|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154260644|NCT04222426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154260645|NCT04222426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260646|NCT04222426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386714|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154386715|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386717|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154386718|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
154386719|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154386720|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386721|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154386722|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154386723|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154386724|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154386725|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154386726|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154386727|NCT01374828|Analgesics|analgesics|mesh-ancestor
154386728|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
154386729|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386730|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386731|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154386732|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154386733|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154386734|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386735|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386736|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
154386737|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386738|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386739|NCT03634332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154386740|NCT03634332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386741|NCT03744767|Spironolactone|spironolactone|mesh-list
154386742|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154386743|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
154386744|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386745|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386746|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154386747|NCT03744767|Diuretics|diuretics|mesh-ancestor
154386748|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
154386749|NCT02428972|Propofol|propofol|mesh-list
154386750|NCT02428972|Sevoflurane|sevoflurane|mesh-list
154386751|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154386761|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386762|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154386763|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
154386764|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386765|NCT03178708|Amantadine|amantadine|mesh-list
154386766|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154386767|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154386768|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
154386769|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386770|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
154386771|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386772|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386773|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386774|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154386775|NCT03178708|Analgesics|analgesics|mesh-ancestor
154386776|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
154386777|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386778|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154386779|NCT00787176|Oxytocin|oxytocin|mesh-list
154386780|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
154386781|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154386782|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386783|NCT03744689|Bupivacaine|bupivacaine|mesh-list
154386784|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
154386785|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
154386786|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386787|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861173|NCT00521222|Xhance|xhance|mesh-list
153401581|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
153453871|NCT01720446|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153454095|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153401623|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153401624|NCT04450355|Analgesics|analgesics|mesh-ancestor
153401625|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
154386788|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
154386789|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386790|NCT02424214|Ionophores|ionophores|mesh-list
154386791|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154386792|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386793|NCT03712111|Norepinephrine|norepinephrine|mesh-list
154386794|NCT03712111|Bupivacaine|bupivacaine|mesh-list
154386795|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154386796|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
154386797|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386798|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386799|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
154386800|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386801|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154386802|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154386803|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
154386804|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386805|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386806|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
154386807|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
154386808|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154386809|NCT02925494|Norethindrone|norethindrone|mesh-list
154386810|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
154386811|NCT02925494|Estradiol|estradiol|mesh-list
154386812|NCT02925494|Estrogens|estrogens|mesh-ancestor
154386813|NCT02925494|Hormones|hormones|mesh-ancestor
154386814|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386815|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386816|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153748597|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
154386827|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154386828|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154386829|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386830|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386831|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386832|NCT04126343|Anticonvulsants|anticonvulsants|mesh-ancestor
154386833|NCT03119610|Oxytocin|oxytocin|mesh-list
154386834|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
154386835|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154386836|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386837|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154386838|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386839|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386840|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386841|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154386842|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
154386843|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154386844|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154386845|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386846|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
154386847|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154386848|NCT02952001|Triamcinolone|triamcinolone|mesh-list
154386849|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154386850|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154386851|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154386852|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154386853|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
154386854|NCT02952001|Hormones|hormones|mesh-ancestor
154386855|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386856|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386857|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154386858|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
154386859|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386860|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861435|NCT00547547|Trace Elements|trace elements|mesh-ancestor
153861436|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
153861455|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153401807|NCT05988788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401808|NCT05988788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153401809|NCT05988177|Spiramycin|spiramycin|mesh-list
153401810|NCT05988177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153401811|NCT05988177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401812|NCT05988177|Coccidiostats|coccidiostats|mesh-ancestor
153401813|NCT05988177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153401814|NCT05988177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154386861|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
154386862|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
154386863|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
154386864|NCT01311739|Vitamins|vitamins|mesh-ancestor
154386865|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
154386866|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386867|NCT01311739|Hematinics|hematinics|mesh-ancestor
154386868|NCT05507359|Benzocaine|benzocaine|mesh-list
154386869|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
154386870|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
154386871|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386872|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386873|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
154386874|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386875|NCT04123067|Pioglitazone|pioglitazone|mesh-list
154386876|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386877|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386879|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
154386880|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154386881|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386882|NCT03688958|Trace Elements|trace elements|mesh-ancestor
154386883|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
153748667|NCT05469529|Analgesics|analgesics|mesh-ancestor
153454816|NCT01524198|Hormones|hormones|mesh-ancestor
154386913|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
154386914|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386915|NCT01319838|Isotretinoin|isotretinoin|mesh-list
154386916|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154386917|NCT05191914|Fulvestrant|fulvestrant|mesh-list
154386918|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154386919|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386920|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154386921|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154386922|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
154386923|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386924|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386925|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
154386926|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386927|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386928|NCT04099277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154386929|NCT04099277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386938|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386939|NCT03693326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386940|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386941|NCT03988907|Midazolam|midazolam|mesh-list
154386942|NCT03988907|Risdiplam|risdiplam|mesh-list
154386943|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154386944|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154386945|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386946|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386947|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154386948|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154386949|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154386950|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153861484|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861485|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861487|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
153401815|NCT05988034|Moxifloxacin|moxifloxacin|mesh-list
153861500|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861501|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153861502|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153861504|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
153401830|NCT05988034|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153401831|NCT05987722|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
153401832|NCT05987722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401833|NCT05987696|Cytarabine|cytarabine|mesh-list
153401834|NCT05987696|Cyclophosphamide|cyclophosphamide|mesh-list
153401835|NCT05987696|Fludarabine|fludarabine|mesh-list
154386951|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
154386952|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
154386953|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
154386954|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
154386955|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386956|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386957|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154386958|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386959|NCT03693248|Paclitaxel|paclitaxel|mesh-list
154386960|NCT03693248|Carboplatin|carboplatin|mesh-list
154386961|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154386962|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386963|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
154386964|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
154386965|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
154386966|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386967|NCT03987191|Insulin|insulin|mesh-list
154386968|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
154386969|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154386970|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386971|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386972|NCT01373970|Pantoprazole|pantoprazole|mesh-list
154386973|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154386974|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154386975|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154386976|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386977|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386978|NCT04050098|Metformin|metformin|mesh-list
153457758|NCT04347486|Atropine|atropine|mesh-list
153457881|NCT03594240|Folic Acid|folic acid|mesh-list
154386979|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386980|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386981|NCT03745625|Propofol|propofol|mesh-list
154386982|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154386983|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386984|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386985|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154386986|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
154386987|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
154386988|NCT03698630|Dexamethasone|dexamethasone|mesh-list
154386989|NCT03698630|Prednisolone|prednisolone|mesh-list
154386990|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154386991|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
154386992|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154386993|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
154386994|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154386995|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
154386996|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260647|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154260648|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
154260649|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
154260650|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154260651|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154260652|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260653|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154260654|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402910|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
153861619|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861706|NCT00550199|Gemcitabine|gemcitabine|mesh-list
153861707|NCT00550199|Panobinostat|panobinostat|mesh-list
153861708|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861709|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
154386997|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
154386998|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
154386999|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387005|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387007|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154387008|NCT03698630|Protective Agents|protective agents|mesh-ancestor
154387009|NCT01375452|Letrozole|letrozole|mesh-list
154387010|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387011|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154387012|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153457882|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
154387013|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387014|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387015|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154387016|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
154387017|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387018|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387019|NCT03046836|Oxytocin|oxytocin|mesh-list
154387020|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
154387021|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387022|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387023|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
154387024|NCT03400033|Hematinics|hematinics|mesh-ancestor
154387025|NCT05123820|Midazolam|midazolam|mesh-list
154387026|NCT05123820|Omeprazole|omeprazole|mesh-list
154387027|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154387028|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154387029|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387030|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387031|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154387032|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154387033|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154387034|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154387035|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
154387036|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
154387037|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
154387038|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
154387039|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387040|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387041|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154387042|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387043|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154387044|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387045|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154387046|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
154387047|NCT02876835|Hematinics|hematinics|mesh-ancestor
154387048|NCT03503318|Risperidone|risperidone|mesh-list
154387049|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154387050|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
154387051|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387052|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387053|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387054|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154387055|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154387056|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387057|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154387058|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154387059|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
154387061|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
154387062|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387063|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387064|NCT03683108|Resveratrol|resveratrol|mesh-list
154387065|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
154387066|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387067|NCT03683108|Protective Agents|protective agents|mesh-ancestor
154387068|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748842|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
154387096|NCT01376076|Cariprazine|cariprazine|mesh-list
154387097|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154387098|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154387099|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387100|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154387101|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154387102|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387103|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387104|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387105|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154387106|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
154387107|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387108|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387109|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154387110|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154387111|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154387112|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154387113|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
154387114|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387115|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154387116|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154387117|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387118|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154387119|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154387149|NCT01375842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387150|NCT01375842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154387151|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387153|NCT03682367|Analgesics|analgesics|mesh-ancestor
154387154|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
154387155|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387156|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387157|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
154387158|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154387159|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154387160|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387161|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748969|NCT00425568|Testosterone|testosterone|mesh-list
154387175|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459802|NCT05972512|Vitamin B Complex|vitamin b complex|mesh-ancestor
153783690|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367922|NCT02386098|Tenofovir|tenofovir|mesh-list
154387176|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387177|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
154387178|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
154387179|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
154387180|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387181|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154387182|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154387183|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154387184|NCT03394885|Growth Substances|growth substances|mesh-ancestor
154387185|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387186|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
154387187|NCT03394885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154387188|NCT01361373|Levodopa|levodopa|mesh-list
154387189|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154387190|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154387191|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
154387192|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260655|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154260656|NCT01295372|Risperidone|risperidone|mesh-list
154260657|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154260658|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
154260659|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154260660|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154260661|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733396|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733397|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153403248|NCT04043195|Nivolumab|nivolumab|mesh-list
154387193|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387194|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387195|NCT03677336|Progesterone|progesterone|mesh-list
154387196|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
154387197|NCT03677336|Progestins|progestins|mesh-ancestor
154387198|NCT03677336|Hormones|hormones|mesh-ancestor
154387199|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387200|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577671|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577672|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577673|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153577674|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
153577675|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
153577676|NCT01719042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153577677|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153577678|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
153577679|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387201|NCT02877927|Linezolid|linezolid|mesh-list
154387202|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154387203|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387204|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154387205|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387206|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387207|NCT02706886|Lumasiran|lumasiran|mesh-list
154387208|NCT02706886|Renal Agents|renal agents|mesh-ancestor
154387209|NCT02809131|Levofloxacin|levofloxacin|mesh-list
154387210|NCT02809131|Clindamycin|clindamycin|mesh-list
154387211|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
154387212|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
154387213|NCT02809131|Cephalexin|cephalexin|mesh-list
154387214|NCT02809131|Polymyxins|polymyxins|mesh-list
154387215|NCT02809131|Bacitracin|bacitracin|mesh-list
154387216|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154387217|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387218|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154387219|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154387220|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154387221|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387222|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387223|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387249|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
154387251|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
154387252|NCT01442649|Hematinics|hematinics|mesh-ancestor
154387253|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
154387254|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154387255|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154387256|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
154387257|NCT04995120|Paclitaxel|paclitaxel|mesh-list
154387258|NCT04995120|Cisplatin|cisplatin|mesh-list
154387259|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154387260|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783691|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783697|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153577680|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577681|NCT01719133|Histamine|histamine|mesh-list
154387261|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
154387262|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
154387263|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
154387264|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387265|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
154387266|NCT01376232|Glycine|glycine|mesh-list
154387267|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154387268|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
154387269|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387270|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154387271|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154387272|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154387273|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387274|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
153403450|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
154387275|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387297|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154387298|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
154387299|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387300|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154387301|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154387302|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
154387303|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154387304|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154387305|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154387307|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
154387308|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387309|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154133482|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
154387311|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154387312|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387313|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387314|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
154387315|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154387316|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
154387317|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387318|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154387319|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387320|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387321|NCT05198856|Thalidomide|thalidomide|mesh-list
154387322|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154387323|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
154387324|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387325|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
154387326|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154387327|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387365|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387367|NCT03677258|Protective Agents|protective agents|mesh-ancestor
154387368|NCT01361763|Dabigatran|dabigatran|mesh-list
154387369|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
154387370|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154387371|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
154387372|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387373|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387374|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
154387375|NCT02420782|Itraconazole|itraconazole|mesh-list
154387376|NCT02420782|Midazolam|midazolam|mesh-list
154387377|NCT02420782|Pilocarpine|pilocarpine|mesh-list
154387378|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154387379|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154387380|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387381|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387382|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154387383|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154387384|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154387385|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154387386|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
154387387|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
154387388|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
154387389|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
154387390|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387391|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387392|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
154387393|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387394|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154387395|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154387396|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827961|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153827962|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153827963|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
154387397|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154387398|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
154387399|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387400|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154387401|NCT02420782|Miotics|miotics|mesh-ancestor
154387402|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
154387403|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387404|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154387405|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154387406|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
154260662|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154260663|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154260664|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154260665|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154260666|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154260667|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
154260668|NCT05283278|Lactoferrin|lactoferrin|mesh-list
154260669|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154260670|NCT05179018|Autoantibodies|autoantibodies|mesh-list
154260671|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
153403000|NCT04495257|Nivolumab|nivolumab|mesh-list
154387407|NCT04054193|Dexamethasone|dexamethasone|mesh-list
154387408|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
154387409|NCT04054193|Aprepitant|aprepitant|mesh-list
154387410|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
154387411|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387412|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
154387413|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
154387414|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387415|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387416|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387417|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
154387418|NCT04054193|Hormones|hormones|mesh-ancestor
154387419|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387420|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387421|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387422|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154387423|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387424|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387425|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154387426|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
154387427|NCT03394027|TIC10 compound|tic10 compound|mesh-list
154387428|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387429|NCT03682172|Glucagon|glucagon|mesh-list
154387440|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
154387441|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387442|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387443|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154387444|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
154387445|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
154387446|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154387447|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
154387448|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154387449|NCT03136107|Protective Agents|protective agents|mesh-ancestor
154387450|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387451|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
154387452|NCT01318395|Aliskiren|aliskiren|mesh-list
154387453|NCT01318395|Renin Inhibitors|renin inhibitors|mesh-ancestor
154387454|NCT01318395|Protease Inhibitors|protease inhibitors|mesh-ancestor
154387455|NCT01318395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387456|NCT01318395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387457|NCT03686774|Memantine|memantine|mesh-list
154387458|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154387459|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154387460|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
154387461|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387462|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387463|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387464|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154387465|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154387466|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
154387467|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154387468|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387469|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154387470|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387471|NCT01562795|Fluorometholone|fluorometholone|mesh-list
154260672|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260673|NCT01295450|Vitamins|vitamins|mesh-list
154260674|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
154260675|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154260676|NCT01297010|Dexamethasone|dexamethasone|mesh-list
154260677|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
154260678|NCT01297010|BB 1101|bb 1101|mesh-list
154260679|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154260680|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
153733400|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
153403023|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
153863482|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154387472|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154387473|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
154387474|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154387475|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154387476|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
154387477|NCT01562795|Hormones|hormones|mesh-ancestor
154387478|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153577682|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
154387479|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387480|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154387481|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
154387482|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
154387483|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154387484|NCT02424136|Antibodies|antibodies|mesh-list
154387485|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
154387486|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387487|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154387488|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
154387489|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387490|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154387491|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
154387492|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154387493|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
154387494|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387525|NCT05759520|Immunologic Factors|immunologic factors|mesh-ancestor
154387526|NCT05759520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387527|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154387528|NCT02427880|Furosemide|furosemide|mesh-list
154387529|NCT02427880|Acetazolamide|acetazolamide|mesh-list
154387530|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154387531|NCT02427880|Diuretics|diuretics|mesh-ancestor
154387532|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
154387533|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387534|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154387535|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387536|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387537|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154387539|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154387548|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387549|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154387550|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
154387551|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
154387552|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
154387553|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154387554|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
154387555|NCT02420080|Brincidofovir|brincidofovir|mesh-list
154387556|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
154387557|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387558|NCT04483258|Sevoflurane|sevoflurane|mesh-list
154387559|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154387560|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154387561|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
154387562|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
154387563|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403967|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153403968|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403969|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403970|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403971|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403972|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403973|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153403974|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
153403975|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403976|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
153403979|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154387564|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387565|NCT01355757|Anesthetics|anesthetics|mesh-list
154387566|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
154387567|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387568|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387569|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
154387570|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387571|NCT02507505|Anesthetics|anesthetics|mesh-list
154387572|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387573|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387574|NCT03181360|Tenecteplase|tenecteplase|mesh-list
154387575|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154387576|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154387577|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387578|NCT04275531|Anesthetics|anesthetics|mesh-list
154387579|NCT04275531|Propofol|propofol|mesh-list
154387580|NCT04275531|Sevoflurane|sevoflurane|mesh-list
154387581|NCT04275531|Isoflurane|isoflurane|mesh-list
154387582|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827999|NCT01241019|Topiramate|topiramate|mesh-list
153577683|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
153577684|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
153577685|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577686|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387583|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387584|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154387585|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154387586|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
154387587|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154387588|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154387589|NCT01361997|Ethanol|ethanol|mesh-list
154387590|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
154387591|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154387592|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387593|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387594|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387595|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
154387596|NCT04750824|Afatinib|afatinib|mesh-list
154387597|NCT04750824|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154387598|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154387599|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387600|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387601|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387602|NCT03180970|Lugol's solution|lugol's solution|mesh-list
154387603|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154387604|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
154387605|NCT03180970|Coagulants|coagulants|mesh-ancestor
154387606|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
154387607|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
153749399|NCT00158405|Ritonavir|ritonavir|mesh-list
154387612|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387613|NCT03631446|Cathartics|cathartics|mesh-ancestor
154387614|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
154387615|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154387616|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
154387617|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
154387618|NCT01362153|Golimumab|golimumab|mesh-list
154387619|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154387620|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153404035|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153577687|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577688|NCT01719159|Rituximab|rituximab|mesh-list
153577689|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153577690|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577691|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
153577692|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577693|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577694|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
153577695|NCT01719185|Phentermine|phentermine|mesh-list
153459136|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153459146|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153577696|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153577697|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577698|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
153577699|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153577701|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
153577702|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577703|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
154387621|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387622|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154387623|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
154387624|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387625|NCT03184324|Esomeprazole|esomeprazole|mesh-list
154387626|NCT03184324|Fexuprazan|fexuprazan|mesh-list
154387627|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154387628|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387629|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154387630|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387631|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387632|NCT02427334|Dienogest|dienogest|mesh-list
154387633|NCT02427334|Fluoxetine|fluoxetine|mesh-list
154387634|NCT02427334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154387635|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154387636|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387637|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387638|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387639|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
154387640|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387641|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154387642|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
154387643|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154387644|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154387645|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154387646|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387647|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153828008|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577704|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387648|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
154387649|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387650|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154387651|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154387652|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154387653|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154387654|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
154387655|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387656|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387657|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387658|NCT03620253|Modafinil|modafinil|mesh-list
154387659|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154387660|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387661|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154387662|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154387663|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154387664|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387665|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
154387666|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154387667|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154387668|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
154387669|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387670|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387671|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154387672|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
154387673|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
154387674|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154387681|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
154387682|NCT01358253|Cytarabine|cytarabine|mesh-list
154133862|NCT00932880|Amlodipine|amlodipine|mesh-list
154387683|NCT01358253|Dexamethasone|dexamethasone|mesh-list
154387684|NCT01358253|Prednisone|prednisone|mesh-list
154387685|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
154387686|NCT01358253|Rituximab|rituximab|mesh-list
154387687|NCT01358253|Doxorubicin|doxorubicin|mesh-list
154387688|NCT01358253|Methotrexate|methotrexate|mesh-list
154387689|NCT01358253|Vincristine|vincristine|mesh-list
153783738|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153577705|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577706|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
153577707|NCT01719185|Vitamins|vitamins|mesh-ancestor
153577708|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
153577709|NCT01719302|Gemcitabine|gemcitabine|mesh-list
153577710|NCT01719302|Docetaxel|docetaxel|mesh-list
153577711|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153577712|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
153577713|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577714|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577715|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
153577716|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
153577717|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
153577718|NCT01719419|Orlistat|orlistat|mesh-list
153577719|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577720|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577721|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153577722|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153577723|NCT01719588|Tapentadol|tapentadol|mesh-list
153577724|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154387690|NCT01358253|Asparaginase|asparaginase|mesh-list
154387691|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
154387692|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154387693|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
154387694|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387695|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154387696|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154260681|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
154260682|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387697|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
154387698|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387699|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387700|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154387701|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387702|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
154387703|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
154387704|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387705|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387706|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
154387707|NCT01358253|Hormones|hormones|mesh-ancestor
154387708|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387709|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387710|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154387711|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154387712|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153577725|NCT01719588|Narcotics|narcotics|mesh-ancestor
153577726|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577727|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813169|NCT00332618|Glycerol|glycerol|mesh-list
153813170|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153813171|NCT00332618|Protective Agents|protective agents|mesh-ancestor
153813172|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813173|NCT00332735|Bupivacaine|bupivacaine|mesh-list
153813174|NCT00332735|Carticaine|carticaine|mesh-list
154028154|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154028155|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154028156|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028157|NCT02640846|Simendan|simendan|mesh-list
154028158|NCT02640846|Milrinone|milrinone|mesh-list
154028159|NCT02640846|Norepinephrine|norepinephrine|mesh-list
154028160|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154028161|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154028162|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028163|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028164|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028165|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028166|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
154028167|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
154028168|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028169|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154028170|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154028171|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
154028172|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154028173|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154028174|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028175|NCT02640846|Protective Agents|protective agents|mesh-ancestor
154028176|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154028177|NCT02644044|Methotrexate|methotrexate|mesh-list
154028178|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154028179|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
154028180|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153814737|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028254|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028257|NCT02825147|Methotrexate|methotrexate|mesh-list
154028258|NCT02825147|Etoposide|etoposide|mesh-list
154028326|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028327|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
154028328|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154028329|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028330|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028331|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028332|NCT04876937|Analgesics|analgesics|mesh-ancestor
154028363|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028364|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028365|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154028366|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
154028367|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571041|NCT05129137|Acetaminophen|acetaminophen|mesh-list
154028368|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028369|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154028370|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028372|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
154028373|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028374|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028375|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
154028376|NCT04243109|Hormones|hormones|mesh-ancestor
154028377|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154028737|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154028738|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028740|NCT04239833|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154028741|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154028742|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028743|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028744|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028745|NCT03513770|Ketorolac|ketorolac|mesh-list
154028746|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154028747|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154028748|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028749|NCT03513770|Analgesics|analgesics|mesh-ancestor
154028785|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154028786|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028787|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
154028788|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
154028823|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
154028824|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
154028825|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154028826|NCT00622622|Gemcitabine|gemcitabine|mesh-list
154028827|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154028861|NCT00681135|Protective Agents|protective agents|mesh-ancestor
154028862|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028863|NCT02821559|Bevacizumab|bevacizumab|mesh-list
154028864|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
154028865|NCT02821559|Raltitrexed|raltitrexed|mesh-list
154028866|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154028867|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028868|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154028944|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154028945|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028946|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
154028947|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028948|NCT02638428|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154028949|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154028978|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028979|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
154028980|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028981|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154028983|NCT05299203|Verapamil|verapamil|mesh-list
154028984|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154256549|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
154028985|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154028986|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028987|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028988|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154028989|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029020|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
154029021|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154029022|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154029023|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154029024|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154029025|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154029026|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154029027|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154029232|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029233|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
154029234|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
154029235|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029236|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029237|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154029238|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
154029274|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
154029275|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029276|NCT02687984|Risperidone|risperidone|mesh-list
154029277|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154029278|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
154029430|NCT04237493|Glimepiride|glimepiride|mesh-list
154029431|NCT04237493|Vildagliptin|vildagliptin|mesh-list
154029432|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154029433|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029434|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154029435|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154029436|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
154029526|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
154029527|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154029528|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029529|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029530|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029531|NCT02809937|Analgesics|analgesics|mesh-ancestor
154029532|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
154029533|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029534|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154029535|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154029536|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154029537|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
154029538|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029539|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029540|NCT02812979|Albuterol|albuterol|mesh-list
154029541|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154029542|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
154029543|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029544|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029607|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
154029608|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029610|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154029611|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154029644|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
154029645|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029646|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154029647|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
154029648|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029649|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029681|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029682|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154029683|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154029684|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154029685|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154029686|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029687|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029688|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
154029755|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029756|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029758|NCT02807441|Aspirin|aspirin|mesh-list
154029759|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154029760|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029761|NCT02807441|Analgesics|analgesics|mesh-ancestor
154029762|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
154029763|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029792|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029793|NCT02682524|Analgesics|analgesics|mesh-ancestor
154029794|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
154029795|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029796|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029814|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
154029815|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154029816|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029817|NCT02807051|Clarithromycin|clarithromycin|mesh-list
154029818|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154029819|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029820|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154029821|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029822|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029823|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154029824|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154029825|NCT02684084|Dexamethasone|dexamethasone|mesh-list
154029826|NCT02684084|Ranibizumab|ranibizumab|mesh-list
154029827|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029852|NCT02806817|Growth Substances|growth substances|mesh-ancestor
154029853|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029854|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
154029855|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154029856|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154029857|NCT04182854|Diuretics|diuretics|mesh-ancestor
154029858|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
154029859|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029860|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154029861|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029862|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029863|NCT02680808|Olorofim|olorofim|mesh-list
154029864|NCT02680808|Midazolam|midazolam|mesh-list
154029865|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154029866|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154029867|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029868|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029869|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154029870|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154029871|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154029872|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154029873|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
154029900|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154029901|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029902|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
154029903|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029904|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
154029905|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029906|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
154029907|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029908|NCT00549601|Rivastigmine|rivastigmine|mesh-list
154029930|NCT02806115|Acetic Acid|acetic acid|mesh-list
154029931|NCT02806115|Retinol acetate|retinol acetate|mesh-list
154029932|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154029933|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029934|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154029935|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
154029936|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029937|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154029938|NCT02806115|Protective Agents|protective agents|mesh-ancestor
153813187|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153813188|NCT00332774|Analgesics|analgesics|mesh-ancestor
153813189|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
153813190|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029939|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029940|NCT02682134|Dexamethasone|dexamethasone|mesh-list
154029941|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
154029944|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029945|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
154029946|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
154029947|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029948|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029949|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154029950|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
154029951|NCT02682134|Hormones|hormones|mesh-ancestor
154029952|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154029953|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154029954|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029955|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
154029956|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029957|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029958|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
154029959|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
154029960|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029961|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
154029989|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
154029990|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029991|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029993|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029994|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
154029995|NCT00956059|Hormones|hormones|mesh-ancestor
154029996|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030008|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
154030009|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
154030010|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030011|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030012|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154030013|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154030014|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030015|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030016|NCT00640640|Bevacizumab|bevacizumab|mesh-list
154030017|NCT00640640|Ranibizumab|ranibizumab|mesh-list
154030046|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154030047|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030048|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
154030049|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154030050|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154030051|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
154030052|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154030053|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030054|NCT00961909|Metformin|metformin|mesh-list
154030055|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154030056|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030057|NCT04115189|Sunitinib|sunitinib|mesh-list
154030074|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030076|NCT02678234|Analgesics|analgesics|mesh-ancestor
154030077|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
154030078|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030079|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
154030080|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030081|NCT02678234|Protective Agents|protective agents|mesh-ancestor
154030082|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154030083|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
154030084|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
154030085|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
154030086|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154030087|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
154030088|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
154030119|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154030121|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030122|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030123|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154030155|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
154030156|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
154030157|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
154030158|NCT00641810|Caffeine|caffeine|mesh-list
154030159|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154030160|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030161|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154030163|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030196|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030197|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154030198|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030199|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
154030201|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154030202|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
154030203|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030204|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030205|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154030206|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
154030207|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154030208|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
154030209|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030273|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030274|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030276|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154030277|NCT05484167|Testosterone|testosterone|mesh-list
154030278|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
154030279|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
154030280|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154030281|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030296|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154030297|NCT02800265|Protective Agents|protective agents|mesh-ancestor
154030298|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030299|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030300|NCT02676986|Exemestane|exemestane|mesh-list
153359717|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153359718|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
153359719|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030301|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030302|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154030303|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154030304|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030305|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030306|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154030307|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
153730792|NCT00142350|Fluorouracil|fluorouracil|mesh-list
154030308|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030309|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030347|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030386|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030387|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030388|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154030414|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030415|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
154030416|NCT02679014|Petesicatib|petesicatib|mesh-list
154030417|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030418|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030420|NCT02801357|Buprenorphine|buprenorphine|mesh-list
154030421|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154030456|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030521|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030523|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
154030524|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030525|NCT03951805|Insulin|insulin|mesh-list
154030526|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154030527|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
154030528|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154030529|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030530|NCT02681198|Lofexidine|lofexidine|mesh-list
154030531|NCT02681198|Paroxetine|paroxetine|mesh-list
154030532|NCT02681198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154030533|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154030534|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154030535|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030568|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030569|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
154030570|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154030571|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154030572|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030573|NCT02798159|Urological Agents|urological agents|mesh-ancestor
154030574|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
154030575|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030607|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030609|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154030610|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154030611|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030612|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030613|NCT02797145|Protective Agents|protective agents|mesh-ancestor
154030614|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030616|NCT02690129|Progestins|progestins|mesh-ancestor
154030640|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154030641|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030642|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030643|NCT02797067|Indomethacin|indomethacin|mesh-list
154030644|NCT02797067|Glycerol|glycerol|mesh-list
154030645|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154030646|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030647|NCT02797067|Analgesics|analgesics|mesh-ancestor
154030648|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
154030649|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030650|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030797|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030798|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030799|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154030800|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154030801|NCT04159896|Nivolumab|nivolumab|mesh-list
154030831|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030832|NCT02537366|Analgesics|analgesics|mesh-ancestor
154030833|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
154030834|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030835|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154030836|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154030837|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154030838|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
154030839|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030840|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030842|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
154030843|NCT00690417|Vitamins|vitamins|mesh-ancestor
154030844|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
154030845|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030846|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154030847|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154030875|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
154030876|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
154030877|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030878|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154030879|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154030880|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154030881|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030883|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154030884|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030885|NCT02790203|Analgesics|analgesics|mesh-ancestor
154030886|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
154030887|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030888|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030889|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030890|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030891|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154030892|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154030929|NCT02789969|Analgesics|analgesics|mesh-ancestor
154030930|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
154030931|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030932|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154030966|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030967|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030968|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
154030969|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154030970|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
154030971|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154030972|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031005|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
154031006|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
154031007|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031008|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
154031009|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154031010|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
154031011|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154031012|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154031013|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031014|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031015|NCT00655590|Urological Agents|urological agents|mesh-ancestor
154031016|NCT02794025|Esmolol|esmolol|mesh-list
154031047|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154031048|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031049|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031051|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031052|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154031053|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154031054|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154031084|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154031086|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154031087|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031088|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031118|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
154031119|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
154031120|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154031121|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154031122|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
154031123|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
154031124|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031125|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031157|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031158|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154031159|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154031161|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031162|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031163|NCT00964639|Ropivacaine|ropivacaine|mesh-list
154031164|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031165|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
154031166|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031167|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031168|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
154031197|NCT06322017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031198|NCT06322017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154031199|NCT06322017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154031200|NCT06322017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154031201|NCT06322017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154031202|NCT06322017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154031241|NCT06321354|Anesthetics|anesthetics|mesh-ancestor
154031265|NCT06321081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154031266|NCT06321081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154031267|NCT06321081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031268|NCT06321081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031269|NCT06321081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031270|NCT06321081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031271|NCT06321068|Paclitaxel|paclitaxel|mesh-list
154031272|NCT06321068|Carboplatin|carboplatin|mesh-list
154031273|NCT06321068|Antibodies|antibodies|mesh-list
154031274|NCT06321068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154031310|NCT06320431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031312|NCT06320405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154031349|NCT06320067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154031350|NCT06320067|Glucocorticoids|glucocorticoids|mesh-ancestor
154031351|NCT06320067|Hormones|hormones|mesh-ancestor
154031383|NCT06319924|Antifoaming Agents|antifoaming agents|mesh-ancestor
154031384|NCT06319924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031385|NCT06319924|Emollients|emollients|mesh-ancestor
154031386|NCT06319924|Dermatologic Agents|dermatologic agents|mesh-ancestor
154031387|NCT06319872|Disulfiram|disulfiram|mesh-list
154031388|NCT06319872|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154031389|NCT06319872|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154031390|NCT06319872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031391|NCT06319872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031460|NCT06319599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031461|NCT06319599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031462|NCT06319599|Sensory System Agents|sensory system agents|mesh-ancestor
154031463|NCT06319599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031492|NCT06319521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031493|NCT06319521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031494|NCT06319521|Sensory System Agents|sensory system agents|mesh-ancestor
154031495|NCT06319521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031496|NCT06319521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031497|NCT06319521|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031498|NCT06319521|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031499|NCT06319521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031500|NCT06319521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031501|NCT06319508|Lidocaine|lidocaine|mesh-list
154031502|NCT06319508|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031503|NCT06319508|Anesthetics|anesthetics|mesh-ancestor
154031504|NCT06319508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031505|NCT06319508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031506|NCT06319508|Sensory System Agents|sensory system agents|mesh-ancestor
154031533|NCT06319469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031534|NCT06319469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031535|NCT06319469|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154031536|NCT06319469|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154031537|NCT06319469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154031539|NCT06319469|Urological Agents|urological agents|mesh-ancestor
154031540|NCT06319456|Cyclophosphamide|cyclophosphamide|mesh-list
154031541|NCT06319456|Chlorambucil|chlorambucil|mesh-list
154031542|NCT06319456|Rituximab|rituximab|mesh-list
154031543|NCT06319456|Fludarabine|fludarabine|mesh-list
154031544|NCT06319456|Acalabrutinib|acalabrutinib|mesh-list
154031545|NCT06319456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154031546|NCT06319456|Immunologic Factors|immunologic factors|mesh-ancestor
154031547|NCT06319456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031548|NCT06319456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031549|NCT06319456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154031550|NCT06319456|Alkylating Agents|alkylating agents|mesh-ancestor
154031551|NCT06319456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031565|NCT06319417|Protective Agents|protective agents|mesh-ancestor
154031566|NCT06319417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031567|NCT06319417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154031568|NCT06319313|Docetaxel|docetaxel|mesh-list
154031569|NCT06319313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031570|NCT06319313|Tubulin Modulators|tubulin modulators|mesh-ancestor
154031571|NCT06319313|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031572|NCT06319313|Mitosis Modulators|mitosis modulators|mesh-ancestor
154031573|NCT06319313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031574|NCT06319300|Insulin|insulin|mesh-list
154031575|NCT06319300|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154031576|NCT06319300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031577|NCT06319300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031578|NCT06319287|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154031579|NCT06319287|Hemostatics|hemostatics|mesh-ancestor
154031580|NCT06319287|Coagulants|coagulants|mesh-ancestor
154031581|NCT06319274|Iloprost|iloprost|mesh-list
154031582|NCT06319274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154031583|NCT06319274|Vasodilator Agents|vasodilator agents|mesh-ancestor
154031584|NCT06319248|Midodrine|midodrine|mesh-list
154031585|NCT06319248|Sympathomimetics|sympathomimetics|mesh-ancestor
154031586|NCT06319248|Autonomic Agents|autonomic agents|mesh-ancestor
154031587|NCT06319248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031588|NCT06319248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031589|NCT06319248|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154031590|NCT06319248|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154031591|NCT06319248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154031592|NCT06319248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154031593|NCT06319248|Adrenergic Agents|adrenergic agents|mesh-ancestor
154031594|NCT06319248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031595|NCT06319248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031596|NCT06318520|Calcium|calcium|mesh-list
154031597|NCT06318520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154031598|NCT06318520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031599|NCT06317415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154031600|NCT06317415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031601|NCT06316843|Valacyclovir|valacyclovir|mesh-list
154031602|NCT06316843|Celecoxib|celecoxib|mesh-list
154031603|NCT06316843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154031604|NCT06316843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154031605|NCT06316843|Analgesics|analgesics|mesh-ancestor
154031606|NCT06316843|Sensory System Agents|sensory system agents|mesh-ancestor
154031607|NCT06316843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031608|NCT06316843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031609|NCT06316843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154031610|NCT06316843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031611|NCT06316843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154031612|NCT06316843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154031613|NCT06316843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031621|NCT06315972|Histamine Antagonists|histamine antagonists|mesh-ancestor
154031622|NCT06315972|Histamine Agents|histamine agents|mesh-ancestor
154031623|NCT06315972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031624|NCT06315972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031625|NCT06315972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031626|NCT06315972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154031627|NCT06313632|Bupivacaine|bupivacaine|mesh-list
154031628|NCT06313632|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031629|NCT06313632|Anesthetics|anesthetics|mesh-ancestor
154031630|NCT06313632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031631|NCT06313632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031632|NCT06313632|Sensory System Agents|sensory system agents|mesh-ancestor
154031633|NCT06313632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031634|NCT06313281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154031635|NCT06313281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031636|NCT06305793|Immunoglobulins|immunoglobulins|mesh-list
154031637|NCT06305793|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154031638|NCT06305793|Antibodies|antibodies|mesh-list
154031639|NCT06305793|gamma-Globulins|gamma-globulins|mesh-list
154031640|NCT06305793|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154031641|NCT06305793|Immunologic Factors|immunologic factors|mesh-ancestor
154031642|NCT06305793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031643|NCT06305780|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154031644|NCT06305780|gamma-Globulins|gamma-globulins|mesh-list
154031645|NCT06305780|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154031646|NCT06305780|Immunologic Factors|immunologic factors|mesh-ancestor
154031647|NCT06305780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031648|NCT06301503|Bupivacaine|bupivacaine|mesh-list
154031649|NCT06301503|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031650|NCT06301503|Anesthetics|anesthetics|mesh-ancestor
154031651|NCT06301503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031652|NCT06301503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031653|NCT06301503|Sensory System Agents|sensory system agents|mesh-ancestor
154031654|NCT06301503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031655|NCT06295120|Penicillin V|penicillin v|mesh-list
154031656|NCT06295120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154031657|NCT06295120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031658|NCT06291857|Vaccines|vaccines|mesh-list
154031659|NCT06291857|Immunologic Factors|immunologic factors|mesh-ancestor
153574352|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
154031660|NCT06291857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031661|NCT06286423|Colchicine|colchicine|mesh-list
153813230|NCT00333008|Vincristine|vincristine|mesh-list
153359723|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898858|NCT05910190|Narcotics|narcotics|mesh-ancestor
154031662|NCT06286423|Gout Suppressants|gout suppressants|mesh-ancestor
154031663|NCT06286423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031664|NCT06286423|Tubulin Modulators|tubulin modulators|mesh-ancestor
154031665|NCT06286423|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031666|NCT06286423|Mitosis Modulators|mitosis modulators|mesh-ancestor
154031667|NCT06286423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031668|NCT06286423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031670|NCT06281756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154031671|NCT06281756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154031672|NCT06281756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031673|NCT06281756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031674|NCT06281756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154031675|NCT06281756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154031676|NCT06281756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154031677|NCT06281756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031678|NCT06281756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031679|NCT06281756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031680|NCT06281756|Serotonin Agents|serotonin agents|mesh-ancestor
154031681|NCT06281756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154031712|NCT06280976|Gout Suppressants|gout suppressants|mesh-ancestor
154256551|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031713|NCT06280976|Tubulin Modulators|tubulin modulators|mesh-ancestor
154031714|NCT06280976|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031715|NCT06280976|Mitosis Modulators|mitosis modulators|mesh-ancestor
154031716|NCT06280976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031717|NCT06271616|Ibrutinib|ibrutinib|mesh-list
154031718|NCT06271616|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154031719|NCT06271616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154031720|NCT06271616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031721|NCT06271616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031722|NCT06269107|Insulin Glargine|insulin glargine|mesh-list
153813231|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782016|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154031723|NCT06269107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031724|NCT06269107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031725|NCT06257147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154031749|NCT06223360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031750|NCT06223360|Chelating Agents|chelating agents|mesh-ancestor
154031751|NCT06223360|Sequestering Agents|sequestering agents|mesh-ancestor
154031752|NCT06223360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031753|NCT06223360|Vitamin B Complex|vitamin b complex|mesh-ancestor
154031754|NCT06223360|Vitamins|vitamins|mesh-ancestor
154031755|NCT06223360|Micronutrients|micronutrients|mesh-ancestor
154031756|NCT06221683|Cytarabine|cytarabine|mesh-list
154031757|NCT06221683|Etoposide|etoposide|mesh-list
154031758|NCT06221683|Homoharringtonine|homoharringtonine|mesh-list
154031759|NCT06221683|Mitoxantrone|mitoxantrone|mesh-list
154031760|NCT06221683|Idarubicin|idarubicin|mesh-list
154031761|NCT06221683|Etoposide phosphate|etoposide phosphate|mesh-list
154031762|NCT06221683|Sorafenib|sorafenib|mesh-list
154031763|NCT06221683|Venetoclax|venetoclax|mesh-list
154031764|NCT06221683|Gilteritinib|gilteritinib|mesh-list
154031765|NCT06221683|Lenograstim|lenograstim|mesh-list
154031766|NCT06221683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154031767|NCT06221683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031768|NCT06221683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154031769|NCT06221683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154031770|NCT06221683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031771|NCT06221683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031772|NCT06221683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154031773|NCT06221683|Antimetabolites|antimetabolites|mesh-ancestor
154031774|NCT06221683|Antiviral Agents|antiviral agents|mesh-ancestor
153736402|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736403|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736404|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
153736405|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736406|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
153736407|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
154031775|NCT06221683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031776|NCT06221683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154031777|NCT06221683|Immunologic Factors|immunologic factors|mesh-ancestor
154031778|NCT06221683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031795|NCT06217757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154031797|NCT06216665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154031798|NCT06216665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031799|NCT06216665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031800|NCT06207981|Mitomycins|mitomycins|mesh-list
154031801|NCT06207981|Mitomycin|mitomycin|mesh-list
154031802|NCT06207981|Capecitabine|capecitabine|mesh-list
154031803|NCT06207981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154031804|NCT06207981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031805|NCT06207981|Alkylating Agents|alkylating agents|mesh-ancestor
154031806|NCT06207981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031807|NCT06207981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154031808|NCT06207981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031809|NCT06207981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154031810|NCT06207981|Antimetabolites|antimetabolites|mesh-ancestor
154031811|NCT06193811|Esomeprazole|esomeprazole|mesh-list
154031812|NCT06193811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154031813|NCT06193811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154031814|NCT06193811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154031815|NCT06193811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031816|NCT06193811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031817|NCT06191887|Cyclophosphamide|cyclophosphamide|mesh-list
154031818|NCT06191887|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154031819|NCT06191887|Fludarabine|fludarabine|mesh-list
154031820|NCT06191887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154031821|NCT06191887|Immunologic Factors|immunologic factors|mesh-ancestor
154031822|NCT06191887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031823|NCT06191887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031824|NCT06191887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154031825|NCT06191887|Alkylating Agents|alkylating agents|mesh-ancestor
154031826|NCT06191887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031827|NCT06191887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031828|NCT06191887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154031829|NCT06182774|Dexamethasone|dexamethasone|mesh-list
154031830|NCT06182774|Lenalidomide|lenalidomide|mesh-list
154031831|NCT06182774|Daratumumab|daratumumab|mesh-list
154031832|NCT06182774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154031833|NCT06182774|Antiemetics|antiemetics|mesh-ancestor
154031834|NCT06182774|Autonomic Agents|autonomic agents|mesh-ancestor
154031835|NCT06182774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031870|NCT06176248|Immunologic Factors|immunologic factors|mesh-ancestor
154031871|NCT06176248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031872|NCT06176248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031873|NCT06175000|Obinutuzumab|obinutuzumab|mesh-list
154031874|NCT06175000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031905|NCT06128356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031906|NCT06128356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031907|NCT06128356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154031909|NCT06128356|Sensory System Agents|sensory system agents|mesh-ancestor
154031910|NCT06128356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031911|NCT06128356|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154031943|NCT06091020|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154031944|NCT06091020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032026|NCT06005610|Estradiol|estradiol|mesh-list
154032027|NCT06005610|Estrogens|estrogens|mesh-ancestor
154032028|NCT06005610|Hormones|hormones|mesh-ancestor
154032056|NCT05933577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032057|NCT05933577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032058|NCT05921760|Nivolumab|nivolumab|mesh-list
154032059|NCT05921760|Ipilimumab|ipilimumab|mesh-list
154032060|NCT05921760|Ivosidenib|ivosidenib|mesh-list
154032061|NCT05921760|Glycine|glycine|mesh-list
154032062|NCT05921760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032129|NCT05818852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154032130|NCT05818852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032131|NCT05818852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154032132|NCT05818852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154032133|NCT05818852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154032134|NCT05813912|Semaglutide|semaglutide|mesh-list
154032168|NCT05742841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154032169|NCT05742841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032201|NCT05711628|Gemcitabine|gemcitabine|mesh-list
154032202|NCT05711628|Doxorubicin|doxorubicin|mesh-list
154032203|NCT05711628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154032204|NCT05711628|Pembrolizumab|pembrolizumab|mesh-list
154032205|NCT05711628|Etoposide|etoposide|mesh-list
154032206|NCT05711628|Etoposide phosphate|etoposide phosphate|mesh-list
154032207|NCT05711628|Vinorelbine|vinorelbine|mesh-list
154032208|NCT05711628|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154032209|NCT05711628|Ifosfamide|ifosfamide|mesh-list
154032210|NCT05711628|Isophosphamide mustard|isophosphamide mustard|mesh-list
154032211|NCT05711628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154032212|NCT05711628|Podophyllotoxin|podophyllotoxin|mesh-list
154032213|NCT05711628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154032214|NCT05711628|Antibodies|antibodies|mesh-list
154032215|NCT05711628|Immunoglobulins|immunoglobulins|mesh-list
154032216|NCT05711628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154032217|NCT05711628|Immunoconjugates|immunoconjugates|mesh-list
153898942|NCT05768191|Isophane Insulin, Human|isophane insulin, human|mesh-list
153898943|NCT05768191|Insulin, Isophane|insulin, isophane|mesh-list
153898944|NCT05768191|Isophane insulin, beef|isophane insulin, beef|mesh-list
153898945|NCT05768191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153898946|NCT05768191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898954|NCT05635110|Rifampin|rifampin|mesh-list
153898955|NCT05635110|Omeprazole|omeprazole|mesh-list
153359724|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153359725|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153359726|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154032218|NCT05711628|Immunologic Factors|immunologic factors|mesh-ancestor
154032219|NCT05711628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032251|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032252|NCT05672342|Dronabinol|dronabinol|mesh-list
154032253|NCT05672342|Cannabidiol|cannabidiol|mesh-list
154032283|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154032284|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154032285|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032286|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032287|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154032288|NCT05644496|Meloxicam|meloxicam|mesh-list
154032289|NCT05644496|Bupivacaine|bupivacaine|mesh-list
154032290|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
154032291|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
154032321|NCT05608291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032322|NCT05600894|Venetoclax|venetoclax|mesh-list
154032323|NCT05600894|Decitabine|decitabine|mesh-list
154032324|NCT05600894|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154032325|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032326|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154032327|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
153453107|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
154032328|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032329|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032330|NCT05558410|Acetaminophen|acetaminophen|mesh-list
154032331|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154032332|NCT05558410|Analgesics|analgesics|mesh-ancestor
154032355|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
154032356|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
154032357|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
154032358|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032359|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032360|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154032361|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154032362|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032363|NCT05541471|Protective Agents|protective agents|mesh-ancestor
154032364|NCT05528588|Furosemide|furosemide|mesh-list
154032365|NCT05528588|Diuretics|diuretics|mesh-list
154032366|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
154032367|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032403|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
154032404|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154032405|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
153440299|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813233|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813235|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153813236|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
154032406|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032407|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032408|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154032409|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
153575104|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
154032410|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032411|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154032446|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032447|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154032448|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154032449|NCT05300490|Prednisolone|prednisolone|mesh-list
154032450|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032451|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
154032452|NCT05300490|Hormones|hormones|mesh-ancestor
154032453|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154032490|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032510|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
154032512|NCT05173714|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154032513|NCT05173714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032514|NCT05173714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032515|NCT05143970|Trastuzumab|trastuzumab|mesh-list
154032516|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032517|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032518|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
154032519|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
154032520|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032521|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154032522|NCT05065671|Tolcapone|tolcapone|mesh-list
154032526|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032527|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032528|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032530|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
154032531|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032532|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
154032533|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154032534|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
154032535|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154032536|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154032537|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154032538|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032539|NCT05056896|Aspirin|aspirin|mesh-list
154032540|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
154032541|NCT05056896|Salicylates|salicylates|mesh-list
154032542|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154032543|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154032544|NCT05056896|Analgesics|analgesics|mesh-ancestor
154032545|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
154032546|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032547|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032548|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032549|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032550|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154032551|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154032552|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032553|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154032554|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154032555|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032556|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
154032557|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032558|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
154032559|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
154032560|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
154032561|NCT05036226|Metformin|metformin|mesh-list
154032562|NCT05036226|Sirolimus|sirolimus|mesh-list
154032563|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
154032564|NCT05036226|Nelfinavir|nelfinavir|mesh-list
154032565|NCT05036226|Temsirolimus|temsirolimus|mesh-list
154032566|NCT05036226|Dasatinib|dasatinib|mesh-list
154032567|NCT05036226|MTOR Inhibitors|mtor inhibitors|mesh-list
154032568|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032569|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032570|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154032571|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032572|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154032573|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032574|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
154032575|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154032576|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
154032577|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154032578|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032579|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032580|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
154032581|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154032582|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154032583|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032584|NCT05036226|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154032585|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154032586|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154032587|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
154032588|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154032589|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154032590|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
154032591|NCT05034536|Infliximab|infliximab|mesh-list
154032592|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
154032593|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032594|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032654|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032655|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154032656|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032657|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154032692|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032693|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154032694|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
154032695|NCT04862585|Hormones|hormones|mesh-ancestor
154032696|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154032697|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154032698|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
154032699|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032700|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154032735|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032736|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032737|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154032738|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154032739|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154032740|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154032741|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032742|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032743|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
154032744|NCT04850495|Hormones|hormones|mesh-ancestor
154032774|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
154032775|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
154032776|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032777|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
154032778|NCT04818177|Antibodies|antibodies|mesh-list
154032779|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
154032804|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032805|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032806|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
154032807|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
154032808|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154032809|NCT04689828|Pluvicto|pluvicto|mesh-list
154032810|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154032811|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032812|NCT04682691|Erythromycin|erythromycin|mesh-list
154032813|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
154032829|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154032831|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
154032832|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
154032833|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032834|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
154032835|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032836|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032837|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154032838|NCT04668144|Cangrelor|cangrelor|mesh-list
154032839|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154032840|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154032841|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154032842|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154032843|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
154032844|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032845|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032846|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032847|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154032848|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154032849|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154032850|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032851|NCT04630964|Niacin|niacin|mesh-list
154032852|NCT04630964|Psilocybin|psilocybin|mesh-list
154032853|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154032854|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
154032855|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032856|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154032858|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
154032859|NCT04630964|Vitamins|vitamins|mesh-ancestor
154032860|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
154032861|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032862|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
154032863|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154032864|NCT04622228|Carboplatin|carboplatin|mesh-list
154032865|NCT04622228|Etoposide|etoposide|mesh-list
154032866|NCT04622228|Atezolizumab|atezolizumab|mesh-list
154032867|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032868|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032869|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154032897|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154032898|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154032900|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032901|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032902|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032903|NCT04266301|Azacitidine|azacitidine|mesh-list
154032904|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154032905|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
154032906|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032907|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032908|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032909|NCT04243785|Azacitidine|azacitidine|mesh-list
154032910|NCT04243785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154032938|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032939|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154032940|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
154032941|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
154032942|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154032943|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154032944|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032945|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032972|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032974|NCT04112823|Dexamethasone|dexamethasone|mesh-list
154032975|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
154032976|NCT04112823|BB 1101|bb 1101|mesh-list
154032977|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032978|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
154032979|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
154032980|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032981|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032982|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154032983|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
154032984|NCT04112823|Hormones|hormones|mesh-ancestor
154032985|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154032986|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154033019|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033020|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033021|NCT03971253|Peficitinib|peficitinib|mesh-list
154033022|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033023|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033024|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033025|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
154033026|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033028|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154033059|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154033061|NCT03897244|Bismuth|bismuth|mesh-list
154033062|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154033063|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033064|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
154033065|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154033066|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154033067|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154033068|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154033069|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033106|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154033107|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
154033108|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154033109|NCT03803553|Fluorouracil|fluorouracil|mesh-list
154033110|NCT03803553|Nivolumab|nivolumab|mesh-list
154033111|NCT03803553|Trastuzumab|trastuzumab|mesh-list
154033112|NCT03803553|Irinotecan|irinotecan|mesh-list
154033113|NCT03803553|Cetuximab|cetuximab|mesh-list
154033114|NCT03803553|Pertuzumab|pertuzumab|mesh-list
154033115|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
154033116|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033117|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033118|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033119|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033120|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
154033121|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033122|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033123|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033124|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154033125|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033151|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033152|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
154033153|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154033154|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154033155|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
154033156|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033157|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033158|NCT03534804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033159|NCT03534804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359735|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
154033160|NCT03527732|Ivermectin|ivermectin|mesh-list
154033161|NCT03527732|Albendazole|albendazole|mesh-list
154033162|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154033163|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033164|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
154033165|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
154033166|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154033167|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154033168|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033169|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033170|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033171|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033196|NCT03500133|Hormones|hormones|mesh-ancestor
154033197|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033198|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154033199|NCT03500133|Protective Agents|protective agents|mesh-ancestor
154033200|NCT03467750|Ketorolac|ketorolac|mesh-list
154033201|NCT03467750|Morphine|morphine|mesh-list
154033202|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154033203|NCT03467750|Narcotics|narcotics|mesh-ancestor
154033204|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033205|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033206|NCT03467750|Analgesics|analgesics|mesh-ancestor
154033207|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
154033208|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033209|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154033210|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033211|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033212|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033213|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154033214|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033215|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033216|NCT03317158|Gemcitabine|gemcitabine|mesh-list
154033217|NCT03317158|Docetaxel|docetaxel|mesh-list
154033218|NCT03317158|Durvalumab|durvalumab|mesh-list
154033219|NCT03317158|Tremelimumab|tremelimumab|mesh-list
154033220|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154033221|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
154033291|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033292|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
154033320|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154033321|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154033322|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033323|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154033324|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154033325|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
154033327|NCT02697448|Sevoflurane|sevoflurane|mesh-list
154033328|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154033329|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033330|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033331|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154033332|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
154033333|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
154033334|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154033335|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154033336|NCT02576574|Paclitaxel|paclitaxel|mesh-list
154033337|NCT02576574|Carboplatin|carboplatin|mesh-list
154033370|NCT02502266|Maleic acid|maleic acid|mesh-list
154033371|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033372|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033373|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033402|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033403|NCT02420912|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154033404|NCT02420912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033405|NCT02420912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033406|NCT02400281|Cytarabine|cytarabine|mesh-list
154033407|NCT02400281|Fludarabine|fludarabine|mesh-list
154033408|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
154033409|NCT02400281|Etoposide|etoposide|mesh-list
154033410|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
154033411|NCT02400281|Azacitidine|azacitidine|mesh-list
154033412|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
154033413|NCT02400281|Idarubicin|idarubicin|mesh-list
154033414|NCT02400281|Crenolanib|crenolanib|mesh-list
154033415|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033416|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033417|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
154033418|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033419|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033420|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
154033455|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033456|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033491|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033493|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154033494|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033495|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033496|NCT01508312|Immunotoxins|immunotoxins|mesh-ancestor
154033497|NCT01508312|Immunoconjugates|immunoconjugates|mesh-ancestor
154033535|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154033536|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154033537|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154033539|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033571|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033572|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033573|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033591|NCT01120249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154033593|NCT01120249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033594|NCT01120249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033595|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033596|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
154033597|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033598|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033599|NCT00981058|Gemcitabine|gemcitabine|mesh-list
154033600|NCT00981058|Necitumumab|necitumumab|mesh-list
154033601|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033602|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033603|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
154033604|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033605|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033606|NCT00877500|Epothilones|epothilones|mesh-list
154033607|NCT00877500|Epothilone B|epothilone b|mesh-list
154033608|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033609|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033610|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033611|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033612|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033613|NCT00863369|Rituximab|rituximab|mesh-list
154033614|NCT00863369|Gemcitabine|gemcitabine|mesh-list
154033615|NCT00863369|Bortezomib|bortezomib|mesh-list
154033616|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033617|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033618|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
154033619|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033620|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033621|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033622|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
154033623|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033624|NCT00093470|Tipifarnib|tipifarnib|mesh-list
154033625|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033626|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154033627|NCT00880620|Carbidopa|carbidopa|mesh-list
154033644|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033645|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033646|NCT00644618|Gemcitabine|gemcitabine|mesh-list
154033647|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033648|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
154033649|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033650|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033651|NCT03967847|Ketorolac|ketorolac|mesh-list
154033652|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154033653|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033654|NCT03967847|Analgesics|analgesics|mesh-ancestor
154033655|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
154033656|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033657|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033658|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033659|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033660|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154033661|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033662|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033663|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
154033664|NCT04175990|Progestins|progestins|mesh-ancestor
154033665|NCT04175990|Hormones|hormones|mesh-ancestor
154033666|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033667|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814805|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154033683|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154033684|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033686|NCT00959725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154033687|NCT00959725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033688|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
154033689|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154033690|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033691|NCT02789189|Gemcitabine|gemcitabine|mesh-list
154033692|NCT02789189|Nedaplatin|nedaplatin|mesh-list
154033693|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033694|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
154033695|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033696|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033697|NCT04234607|Carboplatin|carboplatin|mesh-list
154033713|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154033714|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033715|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033716|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154033717|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
154033718|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
154033719|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154033720|NCT02637726|Narcotics|narcotics|mesh-ancestor
154033721|NCT02637726|Analgesics|analgesics|mesh-ancestor
154033722|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
154033723|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033724|NCT04161768|Norfloxacin|norfloxacin|mesh-list
154033725|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154033726|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033727|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154033728|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033729|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033730|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033731|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033732|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154033733|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154033734|NCT02793011|Dexamethasone|dexamethasone|mesh-list
154033735|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033736|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
154033737|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
154033738|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033739|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033740|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154033741|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
154033742|NCT02793011|Hormones|hormones|mesh-ancestor
154033743|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033744|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154033745|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033746|NCT00965107|Thiopental|thiopental|mesh-list
154033747|NCT00965107|Propofol|propofol|mesh-list
154033748|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154033749|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033750|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033779|NCT03651011|Aflibercept|aflibercept|mesh-list
154033780|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154033781|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154033782|NCT03651011|Growth Substances|growth substances|mesh-ancestor
154033783|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033784|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
154033785|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033786|NCT00880542|Sorafenib|sorafenib|mesh-list
154033787|NCT00880542|Ifosfamide|ifosfamide|mesh-list
154033788|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033814|NCT00885534|Temozolomide|temozolomide|mesh-list
154033815|NCT00885534|Vinblastine|vinblastine|mesh-list
154033816|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813260|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033817|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154033818|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
154033819|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033820|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033821|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033822|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033823|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033824|NCT05277038|Clonidine|clonidine|mesh-list
154033825|NCT05277038|Zopiclone|zopiclone|mesh-list
154033826|NCT05277038|Analgesics|analgesics|mesh-ancestor
154033827|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
154033828|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033829|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033830|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154033832|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
154033833|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154033834|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154033835|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154033836|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
154033837|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154033864|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033866|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033867|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033868|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
154033869|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033870|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154033871|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033904|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033905|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154033906|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154033907|NCT00659022|Growth Substances|growth substances|mesh-ancestor
154033908|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033909|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
154033910|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033911|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
154033912|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033913|NCT02788643|Dimercaprol|dimercaprol|mesh-list
154033914|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
154033915|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
154033916|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033937|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154033938|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033939|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
154033940|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154033941|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
154033943|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
154033944|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033945|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154033946|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033947|NCT00965809|Analgesics|analgesics|mesh-ancestor
154033948|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
154033949|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033950|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154033951|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154033952|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154033953|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033954|NCT00965809|Hormones|hormones|mesh-ancestor
154033955|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033956|NCT00885378|Metformin|metformin|mesh-list
154033957|NCT00885378|Saxagliptin|saxagliptin|mesh-list
154033958|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154033959|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033960|NCT00885378|Incretins|incretins|mesh-ancestor
154033961|NCT00885378|Hormones|hormones|mesh-ancestor
154033962|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033963|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154033964|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
154033979|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033980|NCT02537210|Analgesics|analgesics|mesh-ancestor
154033981|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
154033982|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033983|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033984|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033985|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033986|NCT01563289|Ibuprofen|ibuprofen|mesh-list
154033987|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154033988|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033989|NCT01563289|Analgesics|analgesics|mesh-ancestor
154033990|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
154033991|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033992|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033993|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033994|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033995|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154033996|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033997|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033998|NCT00960973|Menatetrenone|menatetrenone|mesh-list
154033999|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
154034000|NCT00960973|Coagulants|coagulants|mesh-ancestor
154034001|NCT04099849|Zinc|zinc|mesh-list
154034002|NCT04099849|Trace Elements|trace elements|mesh-ancestor
154034003|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
154034004|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034005|NCT00659100|Gabapentin|gabapentin|mesh-list
154034006|NCT00659100|Analgesics|analgesics|mesh-ancestor
154034007|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
154034008|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034009|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034010|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
154034011|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154034012|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154034013|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034014|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154034015|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154034016|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154034017|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034018|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034019|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
154034020|NCT00659178|Doxorubicin|doxorubicin|mesh-list
154034021|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154034022|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154034023|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034024|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154034025|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154034055|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034056|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154034057|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154034058|NCT05238649|Vaccines|vaccines|mesh-list
154034059|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
154034060|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034061|NCT02792153|Estradiol|estradiol|mesh-list
154034062|NCT02792153|Estrogens|estrogens|mesh-ancestor
154034063|NCT02792153|Hormones|hormones|mesh-ancestor
154034064|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034065|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034066|NCT00644540|Vaccines|vaccines|mesh-list
154034067|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
154034068|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034069|NCT02669732|Firuglipel|firuglipel|mesh-list
154034070|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154034071|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034072|NCT05003245|Ranibizumab|ranibizumab|mesh-list
154034108|NCT02791919|Adavosertib|adavosertib|mesh-list
154034133|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154034134|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
154034135|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
154034136|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154034137|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034138|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154034139|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154034140|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034141|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034142|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034143|NCT00659412|Methotrexate|methotrexate|mesh-list
154034144|NCT00659412|Alefacept|alefacept|mesh-list
154034145|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154034146|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
154034147|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154034148|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034149|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034150|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
154034151|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034152|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034153|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
154034154|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034155|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154034156|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034157|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
154034186|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154034187|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154034188|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034189|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034190|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153730892|NCT00152802|Vaccines|vaccines|mesh-list
154034191|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
154034192|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034193|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440603|NCT00003163|Melphalan|melphalan|mesh-list
153813267|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034194|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154034195|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154034196|NCT00659568|Metformin|metformin|mesh-list
154034197|NCT00659568|Sirolimus|sirolimus|mesh-list
154034198|NCT00659568|Temsirolimus|temsirolimus|mesh-list
154034199|NCT00659568|MTOR Inhibitors|mtor inhibitors|mesh-list
154034229|NCT00659958|Zonisamide|zonisamide|mesh-list
154034230|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
154034232|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154034233|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034234|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154034235|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034236|NCT00644774|Azithromycin|azithromycin|mesh-list
154034237|NCT00644774|Cefdinir|cefdinir|mesh-list
154034238|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154034239|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034240|NCT00644774|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154034241|NCT00644774|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154034275|NCT02791373|Vinorelbine|vinorelbine|mesh-list
154034276|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034277|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
154034278|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034279|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034280|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154034281|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
154034282|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
154034283|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
154034284|NCT03102047|Durvalumab|durvalumab|mesh-list
154034312|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034313|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154034314|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
154034315|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154034316|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154034318|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154034319|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
154034320|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034321|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034322|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034323|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154034324|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154034345|NCT03938857|Narcotics|narcotics|mesh-ancestor
154034346|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154034347|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154034348|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
154034349|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
154034350|NCT04160598|Fentanyl|fentanyl|mesh-list
154034351|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154034352|NCT04160598|Narcotics|narcotics|mesh-ancestor
154034353|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034354|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034355|NCT04160598|Analgesics|analgesics|mesh-ancestor
154034356|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
154034357|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034358|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154034359|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154034360|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
154034361|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
154034362|NCT00967837|Insulin|insulin|mesh-list
154034363|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154034364|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154034365|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034366|NCT02668016|Atorvastatin|atorvastatin|mesh-list
154034367|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154034368|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154034369|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154034370|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
154034371|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034372|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154034373|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034374|NCT00966901|Nicotine|nicotine|mesh-list
154034375|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154034376|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
154034377|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034378|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034379|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154034393|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034394|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034396|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034397|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034398|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
154034399|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034400|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
154034401|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034402|NCT04032132|Curcumin|curcumin|mesh-list
154034403|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154034404|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154034405|NCT04032132|Analgesics|analgesics|mesh-ancestor
154034406|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
154034407|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034440|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154034441|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034442|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
154034443|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154034444|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154034445|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154034446|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
154034447|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
154034448|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
154034449|NCT00967057|Analgesics|analgesics|mesh-ancestor
154034450|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
153577132|NCT01715701|Trace Elements|trace elements|mesh-ancestor
154034451|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154034459|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034460|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034461|NCT00656214|Lycopene|lycopene|mesh-list
154034462|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034463|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
154034464|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034465|NCT00656214|Protective Agents|protective agents|mesh-ancestor
154034466|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034467|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154034468|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154034469|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034470|NCT02790671|Firuglipel|firuglipel|mesh-list
154034471|NCT02790671|Itraconazole|itraconazole|mesh-list
154034472|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
154034473|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034474|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154034511|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034512|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034547|NCT00967291|Ifosfamide|ifosfamide|mesh-list
154034548|NCT00967291|Mitomycins|mitomycins|mesh-list
154034549|NCT00967291|Mitomycin|mitomycin|mesh-list
154034550|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154034551|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
154034585|NCT00660582|Leucovorin|leucovorin|mesh-list
154034586|NCT00660582|Folic Acid|folic acid|mesh-list
154034587|NCT00660582|Fluorouracil|fluorouracil|mesh-list
154034588|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
154034589|NCT00660582|Cetuximab|cetuximab|mesh-list
154034590|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
154034591|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
154034622|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154034623|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154034624|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034625|NCT02666534|Lidocaine|lidocaine|mesh-list
154034626|NCT02666534|Prilocaine|prilocaine|mesh-list
154034627|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154034628|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154034629|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154034630|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
154034631|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
154034632|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034633|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034670|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
154034704|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154034705|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034706|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034707|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
154034708|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034738|NCT00973609|Hematinics|hematinics|mesh-ancestor
154034739|NCT00973609|Vitamins|vitamins|mesh-ancestor
154034740|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
154034741|NCT02537054|Aflibercept|aflibercept|mesh-list
154034742|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154034743|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154034744|NCT02537054|Growth Substances|growth substances|mesh-ancestor
154034745|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034746|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
154034747|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034748|NCT00973687|Dexamethasone|dexamethasone|mesh-list
154034749|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034750|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
154034751|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
154034752|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577416|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034753|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034754|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154034755|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
154034756|NCT00973687|Hormones|hormones|mesh-ancestor
154034757|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034765|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034766|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034767|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
154034768|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034769|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034770|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154034771|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
154034772|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034773|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
154034774|NCT02785601|Trazodone|trazodone|mesh-list
154034775|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154034776|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154034777|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034778|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034779|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154034780|NCT02785601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154034814|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034815|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034816|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154034849|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034850|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034851|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
154034852|NCT05276960|Vitamin D|vitamin d|mesh-list
154034853|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154034854|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034876|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034877|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034878|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154034879|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
154034880|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154034881|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034882|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034883|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
154034884|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154034885|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154034908|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034909|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154034910|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154034911|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154034912|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154034913|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154034914|NCT02607215|Vinorelbine|vinorelbine|mesh-list
154034915|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154034916|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034917|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
154034918|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
154034919|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
154034920|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034921|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
154034922|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154034923|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154034924|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034925|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
154034926|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034927|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034928|NCT00968929|Streptokinase|streptokinase|mesh-list
154034929|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154034930|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153730897|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
154034962|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034963|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
154034964|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034965|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154034966|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154034967|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
154034968|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
154034969|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034970|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154034971|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154035002|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154035003|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
154035004|NCT00873093|Doxorubicin|doxorubicin|mesh-list
154035005|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154035006|NCT00873093|Methotrexate|methotrexate|mesh-list
154035007|NCT00873093|Etoposide|etoposide|mesh-list
154035008|NCT00873093|Vincristine|vincristine|mesh-list
154035009|NCT00873093|Bortezomib|bortezomib|mesh-list
154035010|NCT00873093|Asparaginase|asparaginase|mesh-list
154035011|NCT00873093|Pegaspargase|pegaspargase|mesh-list
154035012|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
154035013|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
154035014|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154035015|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
154035016|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035017|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035018|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154035019|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
154035047|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
154035048|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
154035049|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
154035050|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
154035051|NCT00969319|Factor VIII|factor viii|mesh-list
154035052|NCT00969319|Coagulants|coagulants|mesh-ancestor
154035053|NCT02784899|Iloprost|iloprost|mesh-list
154035054|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154035055|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
154035056|NCT00974389|Bevacizumab|bevacizumab|mesh-list
154035057|NCT00974389|Tegafur|tegafur|mesh-list
154035058|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154035059|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035060|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154035061|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154035062|NCT00974389|Growth Substances|growth substances|mesh-ancestor
154035085|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154035086|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154035087|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
154035088|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
154035089|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035090|NCT00647660|Diuretics|diuretics|mesh-ancestor
154035091|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
154035092|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154035093|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035094|NCT00634595|Paclitaxel|paclitaxel|mesh-list
154035095|NCT00634595|Cisplatin|cisplatin|mesh-list
154035096|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154035097|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035098|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
154035099|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
154035100|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
154035101|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035102|NCT00647738|Baclofen|baclofen|mesh-list
154035103|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154035104|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035105|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154035106|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035107|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154035108|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
154035109|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
154035110|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035143|NCT04033250|Citric Acid|citric acid|mesh-list
154035144|NCT04033250|Cathartics|cathartics|mesh-ancestor
154035145|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035146|NCT04033250|Laxatives|laxatives|mesh-ancestor
154035147|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
154035148|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154035149|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
154035150|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
154035151|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035179|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154035180|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
154035181|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035182|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154035183|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154035184|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154035185|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154035186|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154035187|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154035188|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154035189|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154035190|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154035191|NCT00647816|Propranolol|propranolol|mesh-list
154035192|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154035193|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154035194|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035195|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035196|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035197|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035198|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154035199|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154035200|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
154035201|NCT00647894|Alprazolam|alprazolam|mesh-list
154035202|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154035238|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154035239|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035240|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035241|NCT02782403|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154035242|NCT00646178|Adalimumab|adalimumab|mesh-list
154035269|NCT02785055|Hydromorphone|hydromorphone|mesh-list
154035270|NCT02785055|Bupivacaine|bupivacaine|mesh-list
154035271|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
154035272|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
154035273|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035274|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035275|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
154035276|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577942|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
154035277|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154035279|NCT02785055|Analgesics|analgesics|mesh-ancestor
154035280|NCT02624661|Glycerol|glycerol|mesh-list
154035281|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154035282|NCT02624661|Protective Agents|protective agents|mesh-ancestor
154035283|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035284|NCT00648050|Verapamil|verapamil|mesh-list
154035285|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154035286|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154035287|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035288|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035289|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154035290|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035291|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
154035308|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035309|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035311|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035312|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035313|NCT02782481|Levodopa|levodopa|mesh-list
154035314|NCT02782481|Carbidopa|carbidopa|mesh-list
154035315|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154035316|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154035317|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154035318|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
154035319|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035320|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035355|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154035356|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154035377|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153440753|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035378|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154035379|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154035380|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
154035381|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035382|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154035383|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035384|NCT04230083|Androgens|androgens|mesh-ancestor
154035385|NCT04230083|Hormones|hormones|mesh-ancestor
154035386|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
154035387|NCT00645866|Docetaxel|docetaxel|mesh-list
154035388|NCT00645866|Capecitabine|capecitabine|mesh-list
154035389|NCT00645866|Epirubicin|epirubicin|mesh-list
154035390|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035391|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
154035392|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
154035393|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
154035394|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035395|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154035396|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
154035397|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154035398|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154035399|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154035400|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035401|NCT05221151|Pregabalin|pregabalin|mesh-list
154035402|NCT05221151|Ondansetron|ondansetron|mesh-list
154035403|NCT05221151|Melatonin|melatonin|mesh-list
154035404|NCT05221151|Analgesics|analgesics|mesh-ancestor
154035405|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
154035406|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035407|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035408|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
154035409|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154035410|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035411|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035412|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154035449|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035450|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
154035451|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
154035452|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154035453|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035475|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035476|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035477|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154035478|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035479|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154035480|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
154035481|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154035482|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035483|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035484|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154035485|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154035486|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
154035487|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154035488|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035490|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
154035491|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035492|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035493|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154035494|NCT00693381|Protective Agents|protective agents|mesh-ancestor
154035495|NCT00693615|Vaccines|vaccines|mesh-list
154035496|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
154035497|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035498|NCT02663960|Citric Acid|citric acid|mesh-list
154035499|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
154035500|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
154035501|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154035502|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
154035503|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
154035504|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035505|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
154035506|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035541|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035542|NCT00694005|Sirolimus|sirolimus|mesh-list
154035543|NCT00694005|Paclitaxel|paclitaxel|mesh-list
154035544|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154035545|NCT00694005|Everolimus|everolimus|mesh-list
154035546|NCT00694005|Temsirolimus|temsirolimus|mesh-list
154035547|NCT00694005|MTOR Inhibitors|mtor inhibitors|mesh-list
154035548|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154035583|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154035607|NCT04171388|Micronutrients|micronutrients|mesh-list
154035608|NCT04171388|Trace Elements|trace elements|mesh-list
154035609|NCT04171388|Azithromycin|azithromycin|mesh-list
154035610|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154035611|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035612|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035614|NCT00970411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154035615|NCT00970411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035616|NCT00970411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035617|NCT05341193|Bevacizumab|bevacizumab|mesh-list
154035618|NCT05341193|Gemcitabine|gemcitabine|mesh-list
154035619|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154035620|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035621|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154035622|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154035623|NCT05341193|Growth Substances|growth substances|mesh-ancestor
154035624|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035625|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
154035626|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154035627|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
154035628|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035629|NCT04229459|Nivolumab|nivolumab|mesh-list
154035630|NCT04229459|Cetuximab|cetuximab|mesh-list
154035631|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035632|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154035633|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154035664|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154035665|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035666|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154035667|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154035668|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
154035669|NCT02781467|Fludarabine|fludarabine|mesh-list
154035670|NCT02781467|Interleukin-2|interleukin-2|mesh-list
154035671|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154035672|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
154035673|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359758|NCT04199117|Nicotine|nicotine|mesh-list
153359759|NCT04199117|Varenicline|varenicline|mesh-list
153359760|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153359761|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
153359762|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359763|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359764|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153359765|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154035674|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035704|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154035705|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035706|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035707|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035708|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035709|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154035710|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154035712|NCT02784743|Albendazole|albendazole|mesh-list
154035713|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154035714|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035747|NCT04008979|Aspirin|aspirin|mesh-list
154035748|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154035749|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154035750|NCT04008979|Analgesics|analgesics|mesh-ancestor
154035751|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
154035778|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035779|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154035781|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
154035782|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035783|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154035784|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154035785|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154035786|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035787|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035788|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035789|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154035790|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154035793|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153578477|NCT01733030|Cycloserine|cycloserine|mesh-list
154035794|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
154035795|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
154035796|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
154035797|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
154035821|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154035822|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
154035823|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035824|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035825|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154035826|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
154035827|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
154035828|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154035829|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
154035830|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154035831|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035832|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035833|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154035834|NCT05340725|Analgesics|analgesics|mesh-ancestor
154035835|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
154035836|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035837|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154035838|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154035839|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154035840|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035841|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035842|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035843|NCT00970957|Bevacizumab|bevacizumab|mesh-list
154035844|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154035845|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035846|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154035866|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035867|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154035869|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035870|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035871|NCT00971191|Dacomitinib|dacomitinib|mesh-list
154035872|NCT00971191|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154035873|NCT00971191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154035874|NCT00971191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035875|NCT00971191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035876|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
154035877|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
154035878|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035879|NCT00976651|Menotropins|menotropins|mesh-list
154035880|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154035881|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
154035882|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154035883|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035884|NCT00971581|Ketoprofen|ketoprofen|mesh-list
154035885|NCT00971581|Omeprazole|omeprazole|mesh-list
154035886|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154035887|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035888|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154035889|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035890|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035891|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154035892|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154035893|NCT00971581|Analgesics|analgesics|mesh-ancestor
154035894|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
154035895|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035896|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035897|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035898|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035899|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154035900|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154035932|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035933|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154035934|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153813293|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813294|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153813295|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153813296|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153813297|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813298|NCT00333164|Cilostazol|cilostazol|mesh-list
154035935|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
154035936|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
154035938|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154035939|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154035940|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
154035941|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154035967|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035968|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
154035969|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
154035970|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035971|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035972|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035973|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
154035974|NCT00971893|Hormones|hormones|mesh-ancestor
154035975|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035976|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154035977|NCT00971893|Protective Agents|protective agents|mesh-ancestor
154035978|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154035979|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035980|NCT02665208|Nicotine|nicotine|mesh-list
154035981|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154035982|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
154035983|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035984|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035985|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154035986|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154035987|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
154035988|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035989|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036023|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036024|NCT02616861|Praliciguat|praliciguat|mesh-list
154036025|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154036026|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
154036060|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154036061|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
154036062|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036063|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154036064|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154036065|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036066|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036067|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
154036068|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036095|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154036097|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
154036098|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154036099|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154036100|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
154036101|NCT02779283|BB 1101|bb 1101|mesh-list
154036102|NCT02779283|Calcium|calcium|mesh-list
154036103|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
154036104|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036105|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
154036106|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036107|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036108|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154036109|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
154036110|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036111|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036112|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153813299|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153359811|NCT03849651|Blinatumomab|blinatumomab|mesh-list
153359812|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
153448979|NCT02972723|Metformin|metformin|mesh-list
154036113|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154036114|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
154036115|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
154036116|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036117|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154036118|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
154036119|NCT02779283|Hormones|hormones|mesh-ancestor
154036120|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036121|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154036122|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154036123|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036124|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036125|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036155|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
154036156|NCT02616003|Liraglutide|liraglutide|mesh-list
154036158|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154036159|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036161|NCT02616003|Hormones|hormones|mesh-ancestor
154036162|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036163|NCT02661152|Nimorazole|nimorazole|mesh-list
154036164|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154036165|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154036166|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154036167|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036168|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
154036169|NCT00697671|Etoposide|etoposide|mesh-list
154036206|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
154036207|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154036208|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036209|NCT03922477|Atezolizumab|atezolizumab|mesh-list
154036210|NCT03922477|Magrolimab|magrolimab|mesh-list
154036268|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036270|NCT04132479|Clarithromycin|clarithromycin|mesh-list
154036271|NCT04132479|Tinidazole|tinidazole|mesh-list
154036272|NCT04132479|Rabeprazole|rabeprazole|mesh-list
154036273|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154036274|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036275|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154036276|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036277|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036278|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154036279|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154036280|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154036281|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154036282|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154036283|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
154036284|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154036285|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154036286|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154036287|NCT00972985|Lorazepam|lorazepam|mesh-list
154036288|NCT00972985|Methylphenidate|methylphenidate|mesh-list
154036289|NCT00972985|Modafinil|modafinil|mesh-list
154036290|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154036291|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036292|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154036293|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154036294|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036326|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
154036327|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036328|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036329|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036330|NCT02778425|Hormones|hormones|mesh-ancestor
154036331|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036332|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
154036333|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154036334|NCT04228757|Estrogens|estrogens|mesh-ancestor
154036335|NCT04228757|Hormones|hormones|mesh-ancestor
153745621|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154036336|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036338|NCT04227041|Capecitabine|capecitabine|mesh-list
154036369|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036370|NCT04228601|Fluzoparib|fluzoparib|mesh-list
154036371|NCT04228601|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154036372|NCT04228601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036373|NCT04228601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036374|NCT04228601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036375|NCT00978601|Analgesics|analgesics|mesh-list
154036376|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
154036377|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036378|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036379|NCT00883896|Fezakinumab|fezakinumab|mesh-list
154036380|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
154036381|NCT02778191|Carboplatin|carboplatin|mesh-list
154036406|NCT00867009|Pemetrexed|pemetrexed|mesh-list
154036407|NCT00867009|Cetuximab|cetuximab|mesh-list
154036408|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036409|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036410|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036412|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154036413|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154036414|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
154036415|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154036416|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154036417|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154036418|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154036419|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036420|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036421|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036422|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036423|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036424|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036425|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154036426|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
154036427|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154036428|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036429|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154036464|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154036465|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036466|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036467|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154036469|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
154036492|NCT02623504|Carbamazepine|carbamazepine|mesh-list
154036493|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
154036494|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
154036495|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154036496|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036497|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036498|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036499|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154036500|NCT02623504|Analgesics|analgesics|mesh-ancestor
154036501|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
154036502|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036503|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154036504|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036505|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036506|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154036507|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154036508|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
154036509|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154036510|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
154036511|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036512|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
154036513|NCT02777723|Protective Agents|protective agents|mesh-ancestor
154036514|NCT00601250|Linagliptin|linagliptin|mesh-list
154036515|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154036516|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036517|NCT00601250|Incretins|incretins|mesh-ancestor
154036518|NCT00601250|Hormones|hormones|mesh-ancestor
154036519|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036520|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154036521|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
154036522|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036559|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036591|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036592|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154036593|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
154036594|NCT02660762|Hormones|hormones|mesh-ancestor
154036595|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036596|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154036597|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
154036598|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036599|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154036600|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
154036601|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154036602|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154036603|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
154036630|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154036631|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036632|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
154036633|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036634|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154036635|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154036636|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
154036637|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036638|NCT00982891|Morphine|morphine|mesh-list
154036639|NCT00982891|Hydromorphone|hydromorphone|mesh-list
154036640|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154036641|NCT00982891|Narcotics|narcotics|mesh-ancestor
153813332|NCT00333242|Analgesics|analgesics|mesh-ancestor
154036642|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036643|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036644|NCT00982891|Analgesics|analgesics|mesh-ancestor
154036645|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
154036646|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036647|NCT02615223|Bicalutamide|bicalutamide|mesh-list
154036648|NCT02615223|Hormones|hormones|mesh-list
154036649|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154036650|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036677|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036678|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036679|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154036680|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
154036681|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036682|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036683|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154036684|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
154036685|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154036686|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036687|NCT04227509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154036688|NCT04227509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036689|NCT02778659|Zolpidem|zolpidem|mesh-list
154036690|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154036691|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154036692|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036693|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036694|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154036695|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
154036696|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
154036697|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036721|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036722|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154036723|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154036724|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154036725|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036726|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036727|NCT02776163|Docetaxel|docetaxel|mesh-list
154036728|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036729|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154036730|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154036731|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154036732|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036733|NCT05325346|Argatroban|argatroban|mesh-list
154036734|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
154036735|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154036736|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
154036737|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036738|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036739|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
154036772|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036773|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154036774|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036775|NCT00983047|Docetaxel|docetaxel|mesh-list
154036776|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
154036777|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036778|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
154036779|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
154036780|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
154036796|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036797|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
154036798|NCT00988039|Lopinavir|lopinavir|mesh-list
154036799|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154036800|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154036801|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
154036802|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036803|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154036804|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154036805|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036806|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036807|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154036808|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154036809|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
154036810|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154036811|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154036812|NCT04855513|Metformin|metformin|mesh-list
154036813|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154036814|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036815|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154036816|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
154036817|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154036818|NCT00988195|Doxorubicin|doxorubicin|mesh-list
154036819|NCT00988195|BCT-100|bct-100|mesh-list
154036820|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154036821|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036822|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036823|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036824|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036825|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036826|NCT00634985|Eletriptan|eletriptan|mesh-list
154036827|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154036828|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
154036829|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036830|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036831|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036832|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
154036833|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154036834|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153813341|NCT00333281|Urological Agents|urological agents|mesh-ancestor
154036835|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
154036864|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154036865|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036866|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154036868|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
154036869|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
154036870|NCT00582556|Leuprolide|leuprolide|mesh-list
154036871|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154036872|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036873|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154036874|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
154036875|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154036899|NCT01563601|Obatoclax|obatoclax|mesh-list
154036900|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036901|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154036902|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036903|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036904|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036905|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036906|NCT00988507|Artesunate|artesunate|mesh-list
154036907|NCT00988507|Ferroquine|ferroquine|mesh-list
154036908|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
154036909|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154036910|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154036911|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036912|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036913|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
154036914|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
154036915|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154036916|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
154036917|NCT00985855|Etoposide|etoposide|mesh-list
154036918|NCT00985855|Cetuximab|cetuximab|mesh-list
154036919|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036920|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154036921|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036922|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036923|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036924|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036925|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154036926|NCT04226105|Insulin|insulin|mesh-list
154036927|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154036929|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
154036930|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154036931|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154036932|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154036964|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154036965|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154036966|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036967|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036968|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154036969|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154036970|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036971|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154036972|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
154036973|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
154036974|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
154037005|NCT00600938|Siderophores|siderophores|mesh-ancestor
154037006|NCT00988663|Memantine|memantine|mesh-list
154037007|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154037008|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154037009|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
154037010|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037011|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037012|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037013|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154037014|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154037015|NCT04072198|Leucovorin|leucovorin|mesh-list
154037016|NCT04072198|Bevacizumab|bevacizumab|mesh-list
154037017|NCT04072198|Nivolumab|nivolumab|mesh-list
154037018|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
154037019|NCT04072198|Irinotecan|irinotecan|mesh-list
154037020|NCT04072198|Fluorouracil|fluorouracil|mesh-list
154037044|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
154037046|NCT00543439|Coagulants|coagulants|mesh-ancestor
154037047|NCT02772497|Aflibercept|aflibercept|mesh-list
154037048|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154037049|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154037050|NCT02772497|Growth Substances|growth substances|mesh-ancestor
154037051|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037052|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
154037053|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037054|NCT00582166|Rituximab|rituximab|mesh-list
154037055|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154037056|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037057|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037058|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
154037059|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037060|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037061|NCT02775539|Mirabegron|mirabegron|mesh-list
154037062|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154037063|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154037064|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154037065|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
154037066|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037067|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037068|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037069|NCT02775539|Urological Agents|urological agents|mesh-ancestor
154037070|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
154037071|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
154037080|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037081|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154037082|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154037083|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154037084|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154037085|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154037086|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037087|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037089|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
154037090|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037091|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037093|NCT00601172|Ondansetron|ondansetron|mesh-list
154037094|NCT00601172|Casopitant|casopitant|mesh-list
154037095|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037096|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
154037097|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
154037098|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037112|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359827|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154037113|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154037114|NCT02772107|Temozolomide|temozolomide|mesh-list
154037115|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154037116|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
154037117|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037118|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037119|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154037120|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
154037121|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154037122|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154037123|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154037124|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037125|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037126|NCT00988897|Leucovorin|leucovorin|mesh-list
154037127|NCT00988897|Bevacizumab|bevacizumab|mesh-list
154037153|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
154037154|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037155|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037156|NCT02875132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154037157|NCT02875132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037158|NCT00984217|Panitumumab|panitumumab|mesh-list
154037159|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037166|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037167|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
154037168|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037169|NCT04614493|Temozolomide|temozolomide|mesh-list
154037170|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154037171|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
154037172|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037173|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037174|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
154037175|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037176|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037177|NCT02841748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154037178|NCT02841748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037179|NCT04033094|Morphine|morphine|mesh-list
154037180|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154037181|NCT04033094|Narcotics|narcotics|mesh-ancestor
154037215|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037216|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154037217|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
153579897|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037218|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154037220|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037221|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037222|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154037223|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
154037224|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
154037225|NCT00582010|Protective Agents|protective agents|mesh-ancestor
154037226|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
154037227|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154037228|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154037229|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154037230|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154037231|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037232|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
154037233|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037234|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037235|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154037236|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037238|NCT00649922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154037239|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037240|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037241|NCT00986557|Ganciclovir|ganciclovir|mesh-list
154037242|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154037243|NCT00986557|Foscarnet|foscarnet|mesh-list
154037244|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153813350|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813351|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813352|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153813353|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153813354|NCT00333476|Growth Substances|growth substances|mesh-ancestor
154037245|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
154037246|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037247|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037248|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
154037312|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
154037313|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037314|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154037315|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154037316|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037317|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
154037318|NCT02766803|Protective Agents|protective agents|mesh-ancestor
154037319|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037320|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154037350|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154037351|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037352|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037353|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154037354|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
154037384|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
154037385|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037386|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037387|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154037388|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
154037389|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
154037390|NCT00649532|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154037391|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154037392|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
154037393|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037394|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037395|NCT02655614|Midazolam|midazolam|mesh-list
154037396|NCT02655614|Caffeine|caffeine|mesh-list
154037397|NCT02655614|Rabeprazole|rabeprazole|mesh-list
154037398|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154037464|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
154037465|NCT02651636|Inositol|inositol|mesh-list
154037466|NCT02651636|Hematinics|hematinics|mesh-ancestor
154037467|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
154037468|NCT02651636|Vitamins|vitamins|mesh-ancestor
154037469|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
154037498|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037499|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154037500|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154037501|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154037502|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037503|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037504|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
154037505|NCT02771717|Budesonide|budesonide|mesh-list
154037506|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037507|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154037508|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
154037509|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037510|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037511|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154037512|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
154037513|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
153813355|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
154037514|NCT02771717|Hormones|hormones|mesh-ancestor
154037515|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037516|NCT02655380|Ketamine|ketamine|mesh-list
154037546|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037547|NCT02655458|Lenalidomide|lenalidomide|mesh-list
154037548|NCT02655458|Elotuzumab|elotuzumab|mesh-list
154037549|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
154037550|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037551|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154037552|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154037553|NCT02655458|Growth Substances|growth substances|mesh-ancestor
154037554|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
154037555|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037556|NCT04006093|Apixaban|apixaban|mesh-list
154037557|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154037558|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
154037620|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037621|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154037622|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154037623|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037624|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154037625|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154037626|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037627|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
154037628|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154037629|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
154037631|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154037632|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154037633|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037634|NCT02536430|Analgesics|analgesics|mesh-ancestor
154037635|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
154037636|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037637|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037638|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037639|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037640|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154037641|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037675|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
154037676|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037677|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037714|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154037744|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154037745|NCT04225325|Emtricitabine|emtricitabine|mesh-list
154037746|NCT04225325|Darunavir|darunavir|mesh-list
154037747|NCT04225325|Cobicistat|cobicistat|mesh-list
154037748|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154037749|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154037750|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037751|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037752|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154037753|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154037754|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
154037755|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037756|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154037757|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154037758|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154157366|NCT05848713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037782|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037783|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037784|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
154037785|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154037786|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
154037787|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154037788|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154037789|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154037790|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037792|NCT02774525|Ethanol|ethanol|mesh-list
154037793|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154037794|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037795|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037796|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037797|NCT04167566|Artemisinins|artemisinins|mesh-list
154037798|NCT04167566|Artemisinin|artemisinin|mesh-list
154037799|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
154037800|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154037801|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154037802|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037803|NCT00650624|Valdecoxib|valdecoxib|mesh-list
154037804|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154037805|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154037806|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037807|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037808|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154037809|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037831|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154037832|NCT02536352|Vitamins|vitamins|mesh-list
154037833|NCT02536352|Fluorides|fluorides|mesh-list
154037834|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
154037835|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037836|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
154037837|NCT02536352|Protective Agents|protective agents|mesh-ancestor
154037838|NCT02773979|Chloroquine|chloroquine|mesh-list
154037839|NCT02773979|Amebicides|amebicides|mesh-ancestor
154037840|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154037841|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154037842|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037843|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
154037844|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037845|NCT00662844|Vitamin D|vitamin d|mesh-list
154037846|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
154037847|NCT00662844|Vitamins|vitamins|mesh-ancestor
154037848|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
154037849|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037850|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154037851|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154037852|NCT02650544|Mirtazapine|mirtazapine|mesh-list
154037853|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
154037854|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154037855|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153441183|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
154037890|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154037891|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154037920|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
154037921|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037922|NCT00656526|Lidocaine|lidocaine|mesh-list
154037923|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
154037924|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
154037925|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037926|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037927|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
154037928|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037929|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154037930|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154037931|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154037932|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154037933|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037934|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154037935|NCT02765009|Furosemide|furosemide|mesh-list
154037936|NCT02765009|Bumetanide|bumetanide|mesh-list
154037937|NCT02765009|Diuretics|diuretics|mesh-list
154037938|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154037951|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154037953|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
154037954|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037955|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154037956|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154037957|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037958|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154037959|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
154037960|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
154037961|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037962|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154037963|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154037964|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154037965|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154037966|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037968|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037969|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
154037970|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037971|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154037972|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037973|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037974|NCT02764619|Spironolactone|spironolactone|mesh-list
154037975|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154037976|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
154037977|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157367|NCT05845814|Pembrolizumab|pembrolizumab|mesh-list
154037978|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037979|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154037980|NCT02764619|Diuretics|diuretics|mesh-ancestor
154037981|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
154037982|NCT04032210|Zinc|zinc|mesh-list
154037983|NCT04032210|Fluorides|fluorides|mesh-list
154037984|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
154037985|NCT04032210|Protective Agents|protective agents|mesh-ancestor
154037986|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037987|NCT04032210|Trace Elements|trace elements|mesh-ancestor
154037988|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
154037989|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
154037990|NCT04223219|Fentanyl|fentanyl|mesh-list
154037991|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
154037992|NCT04223219|Ketamine|ketamine|mesh-list
154037993|NCT04223219|Propofol|propofol|mesh-list
154037994|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154037995|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037996|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037997|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037998|NCT04223219|Analgesics|analgesics|mesh-ancestor
154037999|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
154038000|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038038|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
154038075|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154038076|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154038077|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154038107|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154038108|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154038109|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038110|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580876|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154038111|NCT02636088|Cetuximab|cetuximab|mesh-list
154038112|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154038113|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038114|NCT02630160|Epinephrine|epinephrine|mesh-list
154038115|NCT02630160|Bupivacaine|bupivacaine|mesh-list
154038116|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
154038117|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
154038118|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038119|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038120|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
154038121|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038149|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154038150|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154038152|NCT00542425|Abaloparatide|abaloparatide|mesh-list
154038153|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
154038154|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154038155|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038156|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154038157|NCT00668538|Miconazole|miconazole|mesh-list
154038158|NCT00668538|Clotrimazole|clotrimazole|mesh-list
154038159|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
154038160|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038161|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154038162|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154038163|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038164|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038165|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154038184|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038185|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038186|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154038187|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
154038188|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154038189|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154038190|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154038191|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154038192|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038193|NCT02763761|Prednisone|prednisone|mesh-list
154038194|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
154038195|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154038196|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154038197|NCT02763761|Prednisolone|prednisolone|mesh-list
154038198|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
154038199|NCT02763761|Infliximab|infliximab|mesh-list
154038200|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154038201|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
154038202|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038203|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
154038204|NCT02763761|Hormones|hormones|mesh-ancestor
154038205|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038206|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038207|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154038208|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038209|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
154038210|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
154038211|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038212|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154038213|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154038214|NCT02763761|Protective Agents|protective agents|mesh-ancestor
154038215|NCT02763761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154038216|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
154038217|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038218|NCT04155918|Allopurinol|allopurinol|mesh-list
154038219|NCT04155918|Febuxostat|febuxostat|mesh-list
154038220|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
153454285|NCT01565148|Ranibizumab|ranibizumab|mesh-list
154038221|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038222|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038223|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
154038243|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154038244|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154038245|NCT00541099|Growth Substances|growth substances|mesh-ancestor
154038246|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038247|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
154038248|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038249|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
154038250|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
154038251|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038253|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154038254|NCT00580606|Protective Agents|protective agents|mesh-ancestor
154038255|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038277|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154038278|NCT00987493|Growth Substances|growth substances|mesh-ancestor
154038279|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
154038280|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154038281|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
154038282|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038283|NCT02579356|Telmisartan|telmisartan|mesh-list
154038284|NCT02579356|Atorvastatin|atorvastatin|mesh-list
154038285|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154038286|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154038287|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
154038288|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038289|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154038290|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154038291|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038292|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154038293|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154038294|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154038295|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
154038296|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154038297|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038298|NCT02577250|Ketamine|ketamine|mesh-list
154038299|NCT02577250|Analgesics|analgesics|mesh-ancestor
154038300|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
154038301|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038332|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
154038333|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038334|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038335|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154038336|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154038337|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154038338|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038339|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154038340|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
154038341|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154038342|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
154038343|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038368|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154038369|NCT04153734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154038370|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038371|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154038372|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154038373|NCT04073680|Canagliflozin|canagliflozin|mesh-list
154038374|NCT04073680|Serabelisib|serabelisib|mesh-list
154038375|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154038376|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038377|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154038378|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038379|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038380|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
154038381|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154038382|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
154038383|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038384|NCT02761577|Expectorants|expectorants|mesh-ancestor
154038385|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
154038386|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154038387|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
154038388|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038389|NCT02761577|Protective Agents|protective agents|mesh-ancestor
154038390|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038391|NCT02761577|Antidotes|antidotes|mesh-ancestor
154038392|NCT00579982|Lamotrigine|lamotrigine|mesh-list
154038393|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
154038394|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154038395|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730935|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038428|NCT02763059|Hormones|hormones|mesh-ancestor
154038429|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038430|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154038431|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038432|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154038433|NCT02763059|Analgesics|analgesics|mesh-ancestor
154038434|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
154038461|NCT02696915|Bupivacaine|bupivacaine|mesh-list
154038462|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
154038463|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
154038464|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038465|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038466|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
154038467|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038468|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154038469|NCT02696915|Narcotics|narcotics|mesh-ancestor
154038470|NCT02696915|Analgesics|analgesics|mesh-ancestor
154038471|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154038472|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154038473|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
154038475|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
154038476|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
154038477|NCT00911664|Vitamins|vitamins|mesh-list
154038478|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
154038479|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038480|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154038481|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154038482|NCT00664170|Docetaxel|docetaxel|mesh-list
154038483|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038484|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038511|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
154038513|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154038514|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
154038515|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038516|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038517|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038518|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154038519|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154038520|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038521|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154038522|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154038523|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
154038524|NCT00669786|Menotropins|menotropins|mesh-list
154038525|NCT00669786|Hormones|hormones|mesh-list
154038526|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154038527|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038528|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038529|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154038530|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
154038558|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038559|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154038560|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
154038561|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154038562|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
154038563|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154038564|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154038565|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154038566|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154038567|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038568|NCT03909295|Valsartan|valsartan|mesh-list
154038569|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154038570|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154038571|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154038572|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154038573|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038574|NCT04153968|Retinol acetate|retinol acetate|mesh-list
154038608|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154038609|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154038610|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
154038611|NCT00599924|Antidotes|antidotes|mesh-ancestor
154038612|NCT00599924|Protective Agents|protective agents|mesh-ancestor
154038613|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
154038614|NCT00599924|Vitamins|vitamins|mesh-ancestor
154038615|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
154038643|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154038644|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038645|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154038646|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154038647|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038648|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038649|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038651|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154038652|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154038653|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154038654|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
154038655|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154038656|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038657|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154038685|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154038686|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154038688|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038689|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038690|NCT02575534|Procainamide|procainamide|mesh-list
154038691|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154038692|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154038693|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154038694|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154038695|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038696|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
154038697|NCT02757443|Anesthetics|anesthetics|mesh-list
154038698|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038699|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038700|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154038701|NCT02757443|Protective Agents|protective agents|mesh-ancestor
154038702|NCT04071262|Prednisolone|prednisolone|mesh-list
154038725|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038726|NCT00670410|Fludarabine|fludarabine|mesh-list
154038728|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
154038729|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038730|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038731|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154038732|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
154038733|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038734|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
154038735|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154038736|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154038737|NCT02756663|Dexamethasone|dexamethasone|mesh-list
154038738|NCT02756663|Panobinostat|panobinostat|mesh-list
154038739|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038740|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
154038741|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
153729893|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729894|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153729895|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153729896|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729897|NCT01248949|Growth Substances|growth substances|mesh-ancestor
153729898|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729899|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729900|NCT00403637|Maleic acid|maleic acid|mesh-list
153729901|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581486|NCT06111079|Analgesics|analgesics|mesh-ancestor
154038753|NCT02654678|Enalapril|enalapril|mesh-list
154038754|NCT02654678|Enalaprilat|enalaprilat|mesh-list
154038755|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154038756|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
154038757|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038758|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038759|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154038760|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154038787|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038788|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038790|NCT00650156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154038791|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038792|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038793|NCT02576782|Dexamethasone|dexamethasone|mesh-list
154038794|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
154038795|NCT02576782|Bupivacaine|bupivacaine|mesh-list
154038796|NCT02576782|BB 1101|bb 1101|mesh-list
154038797|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038798|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
154038799|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
154038800|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038801|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038802|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154038803|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
154038804|NCT02576782|Hormones|hormones|mesh-ancestor
154038805|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038806|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154038837|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154038838|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154038839|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038840|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154038841|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154038842|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
154038843|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
154038844|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
154038845|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
154038846|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
154038878|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
154038879|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154038880|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154038881|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038882|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038883|NCT00665496|Urological Agents|urological agents|mesh-ancestor
154038884|NCT02653898|Artesunate|artesunate|mesh-list
154038885|NCT02653898|Primaquine|primaquine|mesh-list
154038886|NCT02653898|Piperaquine|piperaquine|mesh-list
154038887|NCT02653898|Artenimol|artenimol|mesh-list
154038888|NCT02653898|Mefloquine|mefloquine|mesh-list
154038889|NCT02653898|Permethrin|permethrin|mesh-list
154038890|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
154038919|NCT04071106|Hormones|hormones|mesh-ancestor
154038920|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038921|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038922|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154038923|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
154038924|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
154038925|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
154038926|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038927|NCT04071106|Protective Agents|protective agents|mesh-ancestor
154038928|NCT04071106|Emollients|emollients|mesh-ancestor
154038929|NCT00670722|Insulin|insulin|mesh-list
154038930|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154038931|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
154038932|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
154038933|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154038934|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
154038935|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
153553786|NCT01594866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154038962|NCT02760095|Astringents|astringents|mesh-ancestor
154038963|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
154038964|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154038965|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
154038966|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153449295|NCT00004067|Paclitaxel|paclitaxel|mesh-list
154038967|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038968|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
154038969|NCT02576626|Albuterol|albuterol|mesh-list
154038970|NCT02576626|Ipratropium|ipratropium|mesh-list
154038971|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154038972|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
154038973|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038974|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038975|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154038976|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
154038977|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
154256555|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154038978|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154038979|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154038980|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154038981|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154038982|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
154038983|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038984|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038986|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154039016|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154039017|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
154039018|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
154039019|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039020|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039021|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039022|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
154039023|NCT02644694|Hormones|hormones|mesh-ancestor
154039024|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039025|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154039026|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039027|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154039028|NCT02653742|Ketorolac|ketorolac|mesh-list
154039029|NCT02653742|Fentanyl|fentanyl|mesh-list
154039030|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154039031|NCT02653742|Narcotics|narcotics|mesh-ancestor
153581786|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154039057|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039058|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039059|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154039060|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039061|NCT00680394|Misoprostol|misoprostol|mesh-list
154039062|NCT00680394|Mifepristone|mifepristone|mesh-list
154039063|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154039064|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
154039065|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154039066|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039067|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154039068|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039069|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
154039070|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154039071|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154039072|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154039073|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154039074|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
154039075|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154039110|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154039111|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039112|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359844|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039114|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039115|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039133|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154039134|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039135|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
154039136|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154039137|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039138|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154039139|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154039140|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154039141|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039142|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
154039143|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039145|NCT02644616|Tolvaptan|tolvaptan|mesh-list
154039146|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154039147|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039148|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
154039149|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039150|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154039151|NCT02644616|Diuretics|diuretics|mesh-ancestor
154039152|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154039153|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154039154|NCT02648048|Pirfenidone|pirfenidone|mesh-list
154039155|NCT02648048|Analgesics|analgesics|mesh-ancestor
154039156|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
154039157|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039158|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039159|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154039160|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154039161|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154039162|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039163|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039164|NCT03474679|Ibrutinib|ibrutinib|mesh-list
154039165|NCT03474679|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154039166|NCT03474679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154039167|NCT03474679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039187|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039189|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154039190|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039191|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154039192|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
154039193|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039195|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154039196|NCT02576314|Ledipasvir|ledipasvir|mesh-list
154039197|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
154039198|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039199|NCT00650234|Metformin|metformin|mesh-list
154039200|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154039201|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039202|NCT06262061|Propranolol|propranolol|mesh-list
154039203|NCT06262061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154039204|NCT06262061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154039205|NCT06262061|Adrenergic Agents|adrenergic agents|mesh-ancestor
154039206|NCT06262061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039207|NCT06262061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039208|NCT06262061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039209|NCT06262061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154039210|NCT06262061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154039211|NCT06262061|Vasodilator Agents|vasodilator agents|mesh-ancestor
154039212|NCT06262048|Tamsulosin|tamsulosin|mesh-list
154039213|NCT06262048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154039214|NCT06262048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154039215|NCT06262048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154039216|NCT06262048|Adrenergic Agents|adrenergic agents|mesh-ancestor
154039217|NCT06262048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039244|NCT06261957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039245|NCT06261957|Anesthetics|anesthetics|mesh-ancestor
154039246|NCT06261957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039247|NCT06261840|Metronidazole|metronidazole|mesh-list
154039248|NCT06261840|Secnidazole|secnidazole|mesh-list
154039249|NCT06261840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039250|NCT06261840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154039251|NCT06261840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154039252|NCT06261840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154039253|NCT06261736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154039254|NCT06261736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154039255|NCT06261736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039256|NCT06261736|Antitubercular Agents|antitubercular agents|mesh-ancestor
154039257|NCT06261684|Acyclovir|acyclovir|mesh-list
154039258|NCT06261684|Antiviral Agents|antiviral agents|mesh-ancestor
154039259|NCT06261684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039260|NCT06261671|Antioxidants|antioxidants|mesh-list
154039261|NCT06261671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039262|NCT06261671|Protective Agents|protective agents|mesh-ancestor
154039263|NCT06261671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039264|NCT06261580|Sodium Citrate|sodium citrate|mesh-list
154039265|NCT06261580|Citric Acid|citric acid|mesh-list
154039266|NCT06261580|Anticoagulants|anticoagulants|mesh-ancestor
154039267|NCT06261580|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154039299|NCT06261320|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154039300|NCT06261320|Antidepressive Agents|antidepressive agents|mesh-ancestor
154039301|NCT06261320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154039302|NCT06261320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154039303|NCT06261320|Analgesics|analgesics|mesh-ancestor
154039329|NCT06261203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154039330|NCT06261203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039331|NCT06261203|Antipyretics|antipyretics|mesh-ancestor
154039332|NCT06260982|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154039333|NCT06260982|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154039334|NCT06260982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039336|NCT06260969|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154039337|NCT06260969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154039338|NCT06260969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039339|NCT06260969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154039340|NCT06260904|Prednisolone|prednisolone|mesh-list
154039341|NCT06260904|Apremilast|apremilast|mesh-list
154039342|NCT06260904|Methotrexate|methotrexate|mesh-list
154039343|NCT06260904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154039344|NCT06260904|Abortifacient Agents|abortifacient agents|mesh-ancestor
154039345|NCT06260904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154039346|NCT06260904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039347|NCT06260904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154039348|NCT06260904|Antimetabolites|antimetabolites|mesh-ancestor
154039349|NCT06260904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582081|NCT04518306|Indapamide|indapamide|mesh-list
154039370|NCT06260748|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154039371|NCT06260748|Cathartics|cathartics|mesh-ancestor
154039372|NCT06260748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039373|NCT06260553|Vinorelbine|vinorelbine|mesh-list
154039374|NCT06260553|Tislelizumab|tislelizumab|mesh-list
154039375|NCT06260553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154039376|NCT06260553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039377|NCT06260553|Tubulin Modulators|tubulin modulators|mesh-ancestor
154039378|NCT06260553|Antimitotic Agents|antimitotic agents|mesh-ancestor
154039379|NCT06260553|Mitosis Modulators|mitosis modulators|mesh-ancestor
154039380|NCT06260553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039381|NCT06260553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039382|NCT06260462|Hydrocortisone|hydrocortisone|mesh-list
154039383|NCT06260462|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154039384|NCT06260462|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154039385|NCT06260462|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154039386|NCT06260462|Cortisone|cortisone|mesh-list
154039387|NCT06260462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154039388|NCT06260124|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
154039390|NCT06260124|Antioxidants|antioxidants|mesh-ancestor
154039391|NCT06260124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039392|NCT06260124|Protective Agents|protective agents|mesh-ancestor
154039393|NCT06260124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039394|NCT06260124|Antacids|antacids|mesh-ancestor
154039395|NCT06260124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039396|NCT06260059|Empagliflozin|empagliflozin|mesh-list
154039397|NCT06260059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154039398|NCT06260059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039399|NCT06260059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154039400|NCT06260059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039401|NCT06260046|Sufentanil|sufentanil|mesh-list
154039402|NCT06260046|Remifentanil|remifentanil|mesh-list
154039438|NCT06257316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039439|NCT06257316|Sympathomimetics|sympathomimetics|mesh-ancestor
154039440|NCT06257316|Autonomic Agents|autonomic agents|mesh-ancestor
154039441|NCT06257316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039442|NCT06257316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154039443|NCT06257316|Adrenergic Agents|adrenergic agents|mesh-ancestor
154039444|NCT06257316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039465|NCT06250205|Contraceptive Agents|contraceptive agents|mesh-ancestor
154039466|NCT06250205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154039467|NCT06250205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154039468|NCT06250205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154039469|NCT06250205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154039470|NCT06250205|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154039471|NCT06250205|Hormone Antagonists|hormone antagonists|mesh-ancestor
154039472|NCT06250205|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154039474|NCT06250205|Natriuretic Agents|natriuretic agents|mesh-ancestor
154039475|NCT06236165|Acetylcysteine|acetylcysteine|mesh-list
154039476|NCT06236165|Pentoxifylline|pentoxifylline|mesh-list
154039477|NCT06236165|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154039479|NCT06236165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039480|NCT06236165|Expectorants|expectorants|mesh-ancestor
154039481|NCT06236165|Respiratory System Agents|respiratory system agents|mesh-ancestor
154039482|NCT06236165|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154039483|NCT06236165|Antioxidants|antioxidants|mesh-ancestor
154039484|NCT06236165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039485|NCT06236165|Protective Agents|protective agents|mesh-ancestor
154039486|NCT06236165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039487|NCT06236165|Antidotes|antidotes|mesh-ancestor
154039488|NCT06236165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154039489|NCT06236165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039490|NCT06236165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154039491|NCT06236165|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154039492|NCT06236165|Vasodilator Agents|vasodilator agents|mesh-ancestor
154039493|NCT06229678|Empagliflozin|empagliflozin|mesh-list
154039494|NCT06229678|Acipimox|acipimox|mesh-list
154039495|NCT06229678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154157368|NCT05845814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039496|NCT06229678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039497|NCT06229678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154039498|NCT06229678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039524|NCT06186622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039526|NCT06186622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154039527|NCT06186622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154039528|NCT06186622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154039529|NCT06186622|Anesthetics, General|anesthetics, general|mesh-ancestor
154039530|NCT06186622|Anesthetics|anesthetics|mesh-ancestor
154039531|NCT06186622|GABA Modulators|gaba modulators|mesh-ancestor
154039532|NCT06186622|GABA Agents|gaba agents|mesh-ancestor
154039533|NCT06186622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039534|NCT06186622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039535|NCT06186622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154039536|NCT06186622|Analgesics|analgesics|mesh-ancestor
154039537|NCT06186622|Sensory System Agents|sensory system agents|mesh-ancestor
154039538|NCT06186622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039539|NCT06186622|Antipyretics|antipyretics|mesh-ancestor
154039540|NCT06186622|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154039541|NCT06186622|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154039542|NCT06186622|Antimetabolites|antimetabolites|mesh-ancestor
154039543|NCT06186622|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154039544|NCT06186622|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154039545|NCT06186622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039546|NCT06186622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154039547|NCT06186622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154039548|NCT06186622|Protective Agents|protective agents|mesh-ancestor
154039549|NCT06177964|Lomustine|lomustine|mesh-list
154039567|NCT06052852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154039568|NCT06052852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039569|NCT06052852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039570|NCT06052852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039571|NCT06033547|Cabotegravir|cabotegravir|mesh-list
154039572|NCT06033547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154039573|NCT06033547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154039574|NCT06033547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039575|NCT06033547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039576|NCT06033547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154039577|NCT06033547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154039578|NCT06033547|Antiviral Agents|antiviral agents|mesh-ancestor
154039579|NCT06033547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039580|NCT06029907|Varenicline|varenicline|mesh-list
154039581|NCT06029907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154039582|NCT06029907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154039583|NCT06029907|Cholinergic Agents|cholinergic agents|mesh-ancestor
154039584|NCT06029907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039585|NCT06029907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039586|NCT06029907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039587|NCT06018116|Avelumab|avelumab|mesh-list
154039588|NCT06018116|Bicalutamide|bicalutamide|mesh-list
154039589|NCT06018116|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154039590|NCT06018116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039591|NCT06018116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039592|NCT06018116|Immunologic Factors|immunologic factors|mesh-ancestor
154039593|NCT06018116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039594|NCT06018116|Androgen Antagonists|androgen antagonists|mesh-ancestor
154039595|NCT06018116|Hormone Antagonists|hormone antagonists|mesh-ancestor
154039596|NCT06018116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039597|NCT05998642|Rituximab|rituximab|mesh-list
154039598|NCT05998642|Methotrexate|methotrexate|mesh-list
154039599|NCT05998642|Ibrutinib|ibrutinib|mesh-list
154039600|NCT05998642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039601|NCT05998642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039627|NCT05959447|Antimetabolites|antimetabolites|mesh-ancestor
154039628|NCT05959447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154039629|NCT05959447|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154039630|NCT05959447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154039631|NCT05954143|Pertuzumab|pertuzumab|mesh-list
154039632|NCT05954143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039633|NCT05954143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039634|NCT05899829|Rifampin|rifampin|mesh-list
154039635|NCT05899829|Rabeprazole|rabeprazole|mesh-list
154039636|NCT05899829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154039637|NCT05899829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039638|NCT05899829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154039639|NCT05899829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039640|NCT05899829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039641|NCT05899829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154039642|NCT05899829|Antitubercular Agents|antitubercular agents|mesh-ancestor
154039643|NCT05899829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154039644|NCT05899829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039645|NCT05899829|Leprostatic Agents|leprostatic agents|mesh-ancestor
154039646|NCT05899829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154039647|NCT05899829|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154039648|NCT05899829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154039649|NCT05899829|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154039673|NCT05846880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154039675|NCT05846880|Growth Inhibitors|growth inhibitors|mesh-ancestor
154039676|NCT05846880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039677|NCT05834049|Midazolam|midazolam|mesh-list
154039678|NCT05834049|Anesthetics|anesthetics|mesh-ancestor
154039679|NCT05834049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039680|NCT05834049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039681|NCT05834049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154039682|NCT05834049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154039683|NCT05834049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154039684|NCT05834049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154039685|NCT05834049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154039686|NCT05834049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154039687|NCT05834049|Anesthetics, General|anesthetics, general|mesh-ancestor
154039688|NCT05834049|GABA Modulators|gaba modulators|mesh-ancestor
154039689|NCT05834049|GABA Agents|gaba agents|mesh-ancestor
154039690|NCT05834049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039691|NCT05834049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039692|NCT05746572|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154039693|NCT05746572|Hallucinogens|hallucinogens|mesh-ancestor
154039694|NCT05746572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039695|NCT05746572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154039696|NCT05746572|Serotonin Agents|serotonin agents|mesh-ancestor
154039697|NCT05746572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039698|NCT05746572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039730|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039731|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154039732|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039733|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
154039734|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154039735|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154039736|NCT05669989|Growth Substances|growth substances|mesh-ancestor
154039737|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
154039738|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039773|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039774|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039776|NCT05645718|Hormones|hormones|mesh-ancestor
154039777|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039778|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154039779|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039780|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154039808|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039810|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
154039811|NCT05589896|Fludarabine phosphate|fludarabine phosphate|mesh-list
154039812|NCT05589896|Fludarabine|fludarabine|mesh-list
154039814|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154039815|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
153462357|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
154039816|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039817|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039818|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154039819|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
154039820|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039821|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039822|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154039823|NCT05589896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154039854|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039855|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039856|NCT05500092|Cisplatin|cisplatin|mesh-list
154039857|NCT05500092|Gemcitabine|gemcitabine|mesh-list
154039858|NCT05500092|Docetaxel|docetaxel|mesh-list
154039859|NCT05500092|Nivolumab|nivolumab|mesh-list
154039860|NCT05500092|Pemetrexed|pemetrexed|mesh-list
154039861|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039862|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154039863|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
154039864|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039865|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
154039866|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
154039867|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
154039868|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039901|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
154039902|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
154039903|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039904|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039905|NCT05262205|Anesthetics|anesthetics|mesh-list
154039906|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039907|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039908|NCT05259137|Enalaprilat|enalaprilat|mesh-list
154039910|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154039911|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
154039934|NCT05132504|Folfirinox|folfirinox|mesh-list
154039935|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039936|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039937|NCT05132504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154039938|NCT05132504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039939|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
154039940|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154039941|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
154039942|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039943|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154039944|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039945|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154039946|NCT05028725|Lugol's solution|lugol's solution|mesh-list
154039947|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
154039948|NCT05028725|Coagulants|coagulants|mesh-ancestor
154039949|NCT05023018|Perillyl alcohol|perillyl alcohol|mesh-list
154039951|NCT05023018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039952|NCT05023018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039953|NCT05007132|Trifluridine|trifluridine|mesh-list
154039954|NCT05007132|Bevacizumab|bevacizumab|mesh-list
154039955|NCT05007132|Panitumumab|panitumumab|mesh-list
154039956|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039957|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039958|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154039959|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154039960|NCT05007132|Growth Substances|growth substances|mesh-ancestor
154039961|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039993|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039995|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
154039996|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039997|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154039998|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154039999|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040000|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040001|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154040002|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
154040003|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462475|NCT00980148|Azithromycin|azithromycin|mesh-list
154040032|NCT04788043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040033|NCT04788043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040034|NCT04783857|Progesterone|progesterone|mesh-list
154040035|NCT04783857|Progestins|progestins|mesh-ancestor
154040036|NCT04783857|Hormones|hormones|mesh-ancestor
154040037|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040038|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040039|NCT04774380|Carboplatin|carboplatin|mesh-list
154040040|NCT04774380|Etoposide|etoposide|mesh-list
154040041|NCT04774380|Durvalumab|durvalumab|mesh-list
154040042|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040043|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040044|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154040045|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154040046|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040047|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040048|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040049|NCT04720326|Tacrolimus|tacrolimus|mesh-list
154040082|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040084|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
154040085|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040114|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
154040115|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154040116|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040117|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
154040118|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154040119|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040120|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040121|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154040122|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154040123|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154040124|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154040125|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154040126|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154040127|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
154040128|NCT04428333|Fluorouracil|fluorouracil|mesh-list
154040129|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040130|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040153|NCT04348747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040155|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040156|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154040157|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040158|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040159|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154040160|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154040161|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
154040162|NCT04340505|Hormones|hormones|mesh-ancestor
154040163|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040164|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040165|NCT04260477|Rifampin|rifampin|mesh-list
154040166|NCT04260477|Isoniazid|isoniazid|mesh-list
154040167|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
154040168|NCT04260477|Ethambutol|ethambutol|mesh-list
154040169|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153582932|NCT01752075|Lenalidomide|lenalidomide|mesh-list
154040170|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
154040171|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154040172|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040173|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
154040174|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154040175|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040176|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040177|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154040178|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154040179|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154040199|NCT04227028|Growth Substances|growth substances|mesh-ancestor
154040200|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040201|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
154040202|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
154040203|NCT04224493|Rituximab|rituximab|mesh-list
154040204|NCT04224493|Lenalidomide|lenalidomide|mesh-list
154040205|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040206|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040207|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
153900225|NCT05168865|Hormones|hormones|mesh-ancestor
153900227|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040208|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040209|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040210|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154040211|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154040212|NCT04224493|Growth Substances|growth substances|mesh-ancestor
154040213|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
154040215|NCT04223752|Ceftolozane|ceftolozane|mesh-list
154040216|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
154040217|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154040218|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040219|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154040220|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040221|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040222|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154040223|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154040224|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154040225|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154040226|NCT04205565|Oxiracetam|oxiracetam|mesh-list
154040227|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154040228|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
154040229|NCT04181606|Esmolol|esmolol|mesh-list
154040230|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154040231|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154040232|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154040233|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
154040234|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154040235|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040266|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040267|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040268|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040269|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040270|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040271|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154040272|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154040273|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040274|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154040275|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154040276|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040277|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
154040278|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040279|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
154040280|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
154040281|NCT04068753|Niraparib|niraparib|mesh-list
154040282|NCT04068753|Dostarlimab|dostarlimab|mesh-list
154040283|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154040284|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040304|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040306|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
154040307|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154040308|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154040309|NCT04068597|Growth Substances|growth substances|mesh-ancestor
154040310|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
153441651|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
154040311|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
154040312|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
154040313|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040314|NCT04004507|Phentolamine|phentolamine|mesh-list
154040315|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154040316|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154040317|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154040318|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154040319|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
154040320|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154040321|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040322|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040323|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154040325|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154040326|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
154040327|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154040328|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154040329|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040330|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154040331|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154040332|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154040333|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040334|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
154040335|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154040336|NCT03899155|Nivolumab|nivolumab|mesh-list
154040337|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040338|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040339|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040340|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040367|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154040368|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040369|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
154040370|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040371|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154040372|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154040373|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040374|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154040375|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154040376|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040377|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
154040378|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
154040379|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040380|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040381|NCT03698019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040382|NCT03698019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040383|NCT03634839|Nicotine|nicotine|mesh-list
154040384|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154040385|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
154040386|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154040387|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040388|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154040389|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154040390|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
154040391|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154040392|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040421|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154040422|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153900282|NCT04993677|Carboplatin|carboplatin|mesh-list
153813368|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359851|NCT03703492|Hormones|hormones|mesh-ancestor
154040423|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
154040424|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040425|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040427|NCT03516214|Nazartinib|nazartinib|mesh-list
154040428|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040429|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154040430|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040431|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040432|NCT03476798|Bevacizumab|bevacizumab|mesh-list
154040433|NCT03476798|Rucaparib|rucaparib|mesh-list
154040434|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040435|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040436|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154040451|NCT03399773|Thiotepa|thiotepa|mesh-list
154040452|NCT03399773|Fludarabine|fludarabine|mesh-list
154040453|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040454|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
154040455|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040456|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040457|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040458|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
154040459|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040460|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040461|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154040462|NCT03395197|Talazoparib|talazoparib|mesh-list
154040463|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154040464|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040465|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040466|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583216|NCT01754844|AZD7624|azd7624|mesh-list
154040467|NCT03388346|Edetic Acid|edetic acid|mesh-list
154040468|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154040469|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
154040470|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
154040471|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040472|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
154040473|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154040474|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154040476|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154040477|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
154040478|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040479|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154040481|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154040482|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154040483|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
154040484|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154040485|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040486|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040487|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154040488|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154040489|NCT03190941|Aldesleukin|aldesleukin|mesh-list
154040490|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
154040491|NCT03190941|Fludarabine|fludarabine|mesh-list
154040492|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040493|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
154040494|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040508|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154040509|NCT03018366|Estradiol|estradiol|mesh-list
154040510|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154040511|NCT03018366|Progesterone|progesterone|mesh-list
154040512|NCT03018366|Estrogens|estrogens|mesh-ancestor
154040513|NCT03018366|Hormones|hormones|mesh-ancestor
154040514|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040515|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040516|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154040517|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
154040518|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154040519|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154040520|NCT03018366|Progestins|progestins|mesh-ancestor
154040521|NCT03016533|Lamivudine|lamivudine|mesh-list
154040522|NCT03016533|Dolutegravir|dolutegravir|mesh-list
154040523|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154040524|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154040525|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040526|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040527|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
154040528|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040529|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154040530|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154040531|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154040532|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154040533|NCT02938520|Rilpivirine|rilpivirine|mesh-list
154040534|NCT02938520|Cabotegravir|cabotegravir|mesh-list
154040535|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154040536|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154040537|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040538|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040539|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
154040540|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040541|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154040542|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154040544|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154040545|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
154040546|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040547|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040548|NCT02918162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040549|NCT02918162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040550|NCT02779855|Paclitaxel|paclitaxel|mesh-list
154040551|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154040552|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040553|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040554|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040555|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040556|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040557|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040558|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040573|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
154040574|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040575|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040576|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040577|NCT02595905|Cisplatin|cisplatin|mesh-list
154040578|NCT02595905|Veliparib|veliparib|mesh-list
154040579|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040580|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154040581|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040582|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040583|NCT02520921|Aspirin|aspirin|mesh-list
154040584|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154040585|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154040586|NCT02520921|Analgesics|analgesics|mesh-ancestor
154040587|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
154040588|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154040589|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040590|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154040591|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040592|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154040593|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154040594|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040595|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154040596|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154040597|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040598|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
154040599|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
154040600|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040601|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040602|NCT02504372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040603|NCT02504372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040604|NCT02443077|Cytarabine|cytarabine|mesh-list
154040605|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
154040606|NCT02443077|Melphalan|melphalan|mesh-list
154040607|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
154040608|NCT02443077|Carmustine|carmustine|mesh-list
154040609|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154040610|NCT02443077|Etoposide|etoposide|mesh-list
154040611|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
154040612|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
154040613|NCT02443077|Ibrutinib|ibrutinib|mesh-list
154040614|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040615|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
153583372|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
154040616|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040617|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040646|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
154040647|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040648|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
154040649|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040650|NCT02420613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154040651|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040652|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040653|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154040654|NCT02227199|Carboplatin|carboplatin|mesh-list
154040655|NCT02227199|Etoposide|etoposide|mesh-list
154040656|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
154040657|NCT02227199|Ifosfamide|ifosfamide|mesh-list
154040658|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
154040659|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154040660|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
154040661|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154040662|NCT02227199|Antibodies|antibodies|mesh-list
154040663|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
154040664|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040665|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
154040673|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040674|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040676|NCT02227199|Immunotoxins|immunotoxins|mesh-ancestor
154040677|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
154040678|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
154040679|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040680|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040681|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040682|NCT02180867|Doxorubicin|doxorubicin|mesh-list
154040683|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154040684|NCT02180867|Daunorubicin|daunorubicin|mesh-list
153454855|NCT01571232|Hormones|hormones|mesh-ancestor
154040685|NCT02180867|Ifosfamide|ifosfamide|mesh-list
154040686|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
154040687|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154040688|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040689|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154040690|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154040691|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040692|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040693|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040694|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
154040695|NCT02143414|Prednisone|prednisone|mesh-list
154040696|NCT02143414|Cortisone|cortisone|mesh-list
154040697|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154040698|NCT02143414|Methotrexate|methotrexate|mesh-list
154040699|NCT02143414|Vincristine|vincristine|mesh-list
154040700|NCT02143414|Dasatinib|dasatinib|mesh-list
154040701|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
154040702|NCT02143414|Blinatumomab|blinatumomab|mesh-list
154040703|NCT02143414|Antibodies|antibodies|mesh-list
154040704|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
154040705|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040706|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
154040707|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154040708|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
154040709|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040710|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040711|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154040712|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
154040713|NCT02143414|Hormones|hormones|mesh-ancestor
154040714|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040715|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154040716|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154040717|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
154040718|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154040719|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154040720|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
154040721|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040722|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
154040723|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040724|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154040725|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040726|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040727|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154040728|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040729|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040754|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154040755|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154040756|NCT01997840|Growth Substances|growth substances|mesh-ancestor
154040757|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
154040758|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154040759|NCT01856192|Prednisone|prednisone|mesh-list
154040760|NCT01856192|Cortisone|cortisone|mesh-list
154040761|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
154040762|NCT01856192|Rituximab|rituximab|mesh-list
154040763|NCT01856192|Doxorubicin|doxorubicin|mesh-list
154040764|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154040765|NCT01856192|Vincristine|vincristine|mesh-list
154040766|NCT01856192|Lenalidomide|lenalidomide|mesh-list
154040767|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154040768|NCT01856192|Antibodies|antibodies|mesh-list
154040769|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
154040770|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040771|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040772|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
154040773|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040774|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040775|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040776|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
154040777|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040778|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040779|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154040780|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154040781|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154040782|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154040808|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040811|NCT01386385|Carboplatin|carboplatin|mesh-list
154040812|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154040813|NCT01386385|Veliparib|veliparib|mesh-list
154040814|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040815|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040816|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040817|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040818|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040819|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040820|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154040821|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040822|NCT01275677|Paclitaxel|paclitaxel|mesh-list
154040823|NCT01275677|Docetaxel|docetaxel|mesh-list
154040824|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
154040825|NCT01275677|Doxorubicin|doxorubicin|mesh-list
154040826|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154040827|NCT01275677|Trastuzumab|trastuzumab|mesh-list
154040828|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154040829|NCT01275677|Daunorubicin|daunorubicin|mesh-list
154040830|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154040831|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040863|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040865|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040866|NCT01134614|Ipilimumab|ipilimumab|mesh-list
154040867|NCT01134614|Sargramostim|sargramostim|mesh-list
154040868|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040869|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040870|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153553787|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154040897|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
154040898|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040899|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154040900|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154040901|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040902|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154040903|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
154040904|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040905|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154040906|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154040907|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154040908|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154040909|NCT00561223|Iloprost|iloprost|mesh-list
154040910|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154040911|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
154040912|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
154040913|NCT00217737|Leucovorin|leucovorin|mesh-list
154040914|NCT00217737|Folic Acid|folic acid|mesh-list
154040915|NCT00217737|Bevacizumab|bevacizumab|mesh-list
154040916|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154040917|NCT00217737|Fluorouracil|fluorouracil|mesh-list
154040918|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
154040919|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
154040920|NCT00217737|Antibodies|antibodies|mesh-list
154040921|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
154040983|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154040984|NCT00681174|Narcotics|narcotics|mesh-ancestor
154040985|NCT00681174|Analgesics|analgesics|mesh-ancestor
154040986|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
154040987|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154040988|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154040989|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
154040990|NCT02758769|Abatacept|abatacept|mesh-list
154040991|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040992|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040993|NCT02758769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040994|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040995|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040996|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
154040997|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040998|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040999|NCT04150146|Rebamipide|rebamipide|mesh-list
154041000|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154041001|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154041002|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
154041003|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041004|NCT04150146|Protective Agents|protective agents|mesh-ancestor
154041005|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041006|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041008|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154041009|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154041010|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041041|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041042|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041044|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154041045|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
154041046|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041047|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041048|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041049|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154041050|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154041051|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041052|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154041053|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154041054|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
154041070|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154041071|NCT01563835|Narcotics|narcotics|mesh-ancestor
154041072|NCT01563835|Analgesics|analgesics|mesh-ancestor
154041073|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154041074|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154041075|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
154041076|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
153583812|NCT01757860|Vitamin D|vitamin d|mesh-list
154041077|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154041078|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
154041079|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
154041080|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041081|NCT02768207|Vemurafenib|vemurafenib|mesh-list
154041082|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041083|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154041084|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041085|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041086|NCT02653196|Cyclosporine|cyclosporine|mesh-list
154041087|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
154041088|NCT02653196|Fludarabine|fludarabine|mesh-list
154041089|NCT02653196|Etoposide|etoposide|mesh-list
154041090|NCT02653196|Melphalan|melphalan|mesh-list
154041091|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
154041092|NCT02653196|Thiotepa|thiotepa|mesh-list
154041093|NCT02653196|Tacrolimus|tacrolimus|mesh-list
154041094|NCT02653196|Cyclosporins|cyclosporins|mesh-list
154041095|NCT02653196|Mitogens|mitogens|mesh-list
154041096|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041097|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041098|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154041099|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
154041100|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041101|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153813375|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154041102|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154041103|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154041104|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041105|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154041106|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
154041107|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041108|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
154041109|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154041110|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154041111|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154041112|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
154041113|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041114|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154041115|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
154041116|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154041128|NCT00677118|Fluorouracil|fluorouracil|mesh-list
154041129|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041130|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
154041131|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041132|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154041133|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154041134|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
154041135|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041136|NCT02644226|Sevoflurane|sevoflurane|mesh-list
154041137|NCT02644226|Desflurane|desflurane|mesh-list
154041138|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154041139|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154041140|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
154041141|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
154041142|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041143|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041144|NCT02753855|Telavancin|telavancin|mesh-list
154041145|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041146|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041147|NCT02758691|Insulin|insulin|mesh-list
154041148|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154041149|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041150|NCT00714376|Docetaxel|docetaxel|mesh-list
154041151|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041152|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
154041153|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
154041154|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
154041155|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041156|NCT04068766|Bupivacaine|bupivacaine|mesh-list
154041157|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041158|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
154041159|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041160|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041161|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
154041162|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041163|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154041164|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154041165|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041166|NCT04725695|Lidocaine|lidocaine|mesh-list
154041167|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041168|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
154041169|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041170|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041171|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
154041172|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041173|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154041174|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154041175|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154041188|NCT00677664|Mannitol|mannitol|mesh-list
154041189|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
154041190|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154041191|NCT00677664|Diuretics|diuretics|mesh-ancestor
154041192|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
154041193|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041194|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154041195|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
154041196|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154041197|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154041198|NCT02572492|Dexamethasone|dexamethasone|mesh-list
154041199|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
154041200|NCT02572492|Melphalan|melphalan|mesh-list
154041201|NCT02572492|BB 1101|bb 1101|mesh-list
154041202|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041203|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
154041204|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
154041205|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041206|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041207|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154041208|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
154041209|NCT02572492|Hormones|hormones|mesh-ancestor
154041210|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041211|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154041212|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041213|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
154041214|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041215|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041216|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154041217|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
154041218|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154041219|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154041220|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
154041221|NCT02626884|Ibrutinib|ibrutinib|mesh-list
154041222|NCT02626884|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154041223|NCT02626884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154041224|NCT02626884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041225|NCT02626884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041226|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
154041227|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154041228|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041229|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
154041230|NCT00672282|Bicalutamide|bicalutamide|mesh-list
154041231|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
154041232|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
154041233|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041234|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041235|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041236|NCT02753309|Sirolimus|sirolimus|mesh-list
154041237|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041238|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041239|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154041273|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154041274|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041276|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154041277|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
154041278|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041279|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154041280|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154041299|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154041300|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154041301|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154041302|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153584035|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
154041303|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041304|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
154041305|NCT00719056|Lactams|lactams|mesh-list
154041306|NCT00719056|Cephalosporins|cephalosporins|mesh-list
154041307|NCT00719056|Teicoplanin|teicoplanin|mesh-list
154041308|NCT00719056|beta-Lactams|beta-lactams|mesh-list
154041309|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041310|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041311|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154041312|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154041313|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041314|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041315|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041316|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154041317|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154041318|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154041319|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154041320|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
154041321|NCT02695745|Celecoxib|celecoxib|mesh-list
154041322|NCT02695745|Capsaicin|capsaicin|mesh-list
154041323|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154041324|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154041325|NCT02695745|Analgesics|analgesics|mesh-ancestor
154041326|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
154041327|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041328|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041329|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041330|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154041331|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154041332|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154041333|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041334|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041335|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
154041336|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
154041353|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154041354|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
154041355|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
154041356|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154041357|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
154041358|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041359|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
154041360|NCT00719290|Protective Agents|protective agents|mesh-ancestor
154041362|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154041363|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
154041364|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041365|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041366|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041367|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154041368|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154041369|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041370|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154041371|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154041372|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
154041373|NCT04166006|Interleukin-2|interleukin-2|mesh-list
154041374|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041375|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154041376|NCT04166006|Analgesics|analgesics|mesh-ancestor
153584112|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
154041377|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
154041378|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041379|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041381|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
154041382|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041383|NCT00710086|Remifentanil|remifentanil|mesh-list
154041384|NCT00710086|Hydromorphone|hydromorphone|mesh-list
154041385|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154041386|NCT00710086|Narcotics|narcotics|mesh-ancestor
154041387|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041388|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041389|NCT00710086|Analgesics|analgesics|mesh-ancestor
154041390|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
154041391|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041392|NCT00652886|Oxandrolone|oxandrolone|mesh-list
154041393|NCT00652886|Androgens|androgens|mesh-ancestor
154041405|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041407|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154041408|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041409|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
154041410|NCT02643914|Nicotine|nicotine|mesh-list
154041411|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154041412|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
154041413|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041414|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041415|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154041416|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154041417|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
154041418|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041419|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041420|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
154041421|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154041422|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041423|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154041424|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154041425|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
154041426|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041427|NCT00990223|Eplerenone|eplerenone|mesh-list
154041428|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154041429|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
154041430|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041431|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041432|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154041433|NCT00990223|Diuretics|diuretics|mesh-ancestor
154041434|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
154041435|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154041436|NCT00715780|Insulin|insulin|mesh-list
154041437|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154041438|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
154041439|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
154041440|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154041441|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
154041442|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
154041443|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
154041444|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
154041445|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
154041446|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154041447|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041448|NCT02652884|Betamethasone|betamethasone|mesh-list
154041449|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
153584187|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154041450|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041453|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041454|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041479|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154041481|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041482|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154041483|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154041484|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154041485|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154041486|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154041487|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154041488|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
154041489|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154041490|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041491|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
154041492|NCT04696445|Morphine|morphine|mesh-list
154041493|NCT04696445|Oxycodone|oxycodone|mesh-list
154041494|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154041495|NCT04696445|Narcotics|narcotics|mesh-ancestor
154041496|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041497|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041498|NCT04696445|Analgesics|analgesics|mesh-ancestor
154041499|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
154041500|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041501|NCT05360953|Clonidine|clonidine|mesh-list
154041502|NCT05360953|Doxazosin|doxazosin|mesh-list
154041503|NCT05360953|Analgesics|analgesics|mesh-ancestor
154041504|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
154041529|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
154041530|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041531|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041532|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154041533|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
154041534|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154041535|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154041536|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154041537|NCT02574754|Warfarin|warfarin|mesh-list
154041538|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
154041539|NCT00719602|Ritonavir|ritonavir|mesh-list
154041540|NCT00719602|Lopinavir|lopinavir|mesh-list
154041541|NCT00719602|Lamivudine|lamivudine|mesh-list
154041542|NCT00719602|Zidovudine|zidovudine|mesh-list
154041543|NCT00719602|Nevirapine|nevirapine|mesh-list
154041544|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154041545|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154041546|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
154041547|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041548|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041549|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154041550|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154041551|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
154041552|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041553|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154041554|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154041570|NCT02652650|Estrogens|estrogens|mesh-ancestor
154041571|NCT02652650|Hormones|hormones|mesh-ancestor
154041572|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041573|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154041574|NCT02643602|Theophylline|theophylline|mesh-list
154041575|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154041576|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
154041577|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041578|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041579|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154041580|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
154041581|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154041582|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041583|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441948|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
154041584|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
154041585|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154041586|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154041587|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
153455092|NCT01509846|Vaccines|vaccines|mesh-list
154041588|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041589|NCT00710320|Anesthetics|anesthetics|mesh-list
154041590|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041591|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041592|NCT00716170|Glucagon|glucagon|mesh-list
154041593|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154041594|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154041595|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154041596|NCT00716170|Hormones|hormones|mesh-ancestor
154041597|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584340|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
154041598|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041599|NCT00716170|Incretins|incretins|mesh-ancestor
154041600|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
154041601|NCT02652806|Hematinics|hematinics|mesh-ancestor
154041602|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
154041603|NCT04529135|Remifentanil|remifentanil|mesh-list
154041604|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154041605|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041606|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041607|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154041608|NCT04529135|Analgesics|analgesics|mesh-ancestor
154041609|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
154041610|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041629|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
154041630|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041631|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041632|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041633|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154041634|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154041635|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154041636|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041637|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041638|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041639|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041640|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154041641|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154041642|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041643|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154041644|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154041645|NCT00719758|Beraprost|beraprost|mesh-list
154041646|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154041647|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
154041648|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
154041649|NCT02647268|Oxytocin|oxytocin|mesh-list
154041650|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
154041651|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154041652|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041653|NCT02647268|Analgesics|analgesics|mesh-ancestor
154041654|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
154041655|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041656|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
154041657|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041658|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154041659|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
154041660|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154041661|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154041662|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041663|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154041664|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
154041665|NCT04218149|Bupivacaine|bupivacaine|mesh-list
154041666|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041667|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
154041688|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154041689|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
154041690|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041691|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041692|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
154041693|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041694|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154041695|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154041696|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
154041698|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154041699|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154041700|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154041701|NCT00716248|Analgesics|analgesics|mesh-ancestor
154041702|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
154041703|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041704|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041705|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
154041706|NCT00716248|Protective Agents|protective agents|mesh-ancestor
154041707|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
154041708|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154041709|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
154041710|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154041711|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
154041712|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041713|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041714|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
154041715|NCT02642900|Nystatin|nystatin|mesh-list
154041716|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041717|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041718|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
154041719|NCT02642900|Ionophores|ionophores|mesh-ancestor
154041720|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153553788|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154041729|NCT00720148|Bortezomib|bortezomib|mesh-list
154041730|NCT00720148|Sunitinib|sunitinib|mesh-list
154041731|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041732|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154041733|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154041734|NCT00720148|Growth Substances|growth substances|mesh-ancestor
154041735|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041736|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
154041737|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154041738|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041739|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041740|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
154041741|NCT00710788|Calcium|calcium|mesh-list
154041742|NCT00710788|Sevelamer|sevelamer|mesh-list
154041743|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154041744|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041745|NCT00710788|Antacids|antacids|mesh-ancestor
154041746|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041747|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154041749|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
154041750|NCT02646800|Micafungin|micafungin|mesh-list
154041751|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
154041752|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041753|NCT02749409|Parecoxib|parecoxib|mesh-list
154041754|NCT02749409|Morphine|morphine|mesh-list
154041755|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154041756|NCT02749409|Narcotics|narcotics|mesh-ancestor
154041757|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041758|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041759|NCT02749409|Analgesics|analgesics|mesh-ancestor
154041760|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
154041761|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041762|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154041763|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154041764|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041765|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041766|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154041767|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154041768|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041769|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154041770|NCT03449459|Amikacin|amikacin|mesh-list
154041771|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041772|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041773|NCT00653120|Propranolol|propranolol|mesh-list
154041774|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154041775|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154041776|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
154041777|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041778|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041779|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041780|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154041781|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154041782|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
154041783|NCT00678132|Gemcitabine|gemcitabine|mesh-list
154041784|NCT00678132|Olaparib|olaparib|mesh-list
154041785|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041786|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154041787|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
154041808|NCT00681720|Antidotes|antidotes|mesh-ancestor
154041809|NCT00681720|Protective Agents|protective agents|mesh-ancestor
154041810|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041811|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
154041812|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
154041813|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041814|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041815|NCT00650312|Metformin|metformin|mesh-list
154041816|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154041817|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041818|NCT00538681|Pemetrexed|pemetrexed|mesh-list
154041819|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041820|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041821|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041822|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154041823|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154041824|NCT00650390|Adalimumab|adalimumab|mesh-list
154041825|NCT00650390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154041826|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041827|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154041828|NCT00681876|Bevacizumab|bevacizumab|mesh-list
154041829|NCT00681876|Cetuximab|cetuximab|mesh-list
154041830|NCT00681876|Irinotecan|irinotecan|mesh-list
154041831|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154041832|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041833|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154041834|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154041835|NCT00681876|Growth Substances|growth substances|mesh-ancestor
154041836|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041837|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
154041838|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154041856|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154041857|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041858|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
154041859|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
154041860|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
154041861|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041862|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154041863|NCT02695355|Methylphenidate|methylphenidate|mesh-list
154041864|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154041865|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041866|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154041867|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154041868|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154041869|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041870|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
154041871|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041872|NCT02573038|Aflibercept|aflibercept|mesh-list
154041873|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154041874|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154041875|NCT02573038|Growth Substances|growth substances|mesh-ancestor
154041876|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041877|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
154041878|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041880|NCT01822015|Sirolimus|sirolimus|mesh-list
154041881|NCT01822015|Idarubicin|idarubicin|mesh-list
154041882|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154041883|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
154041884|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041885|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041886|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
154041887|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041902|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154041903|NCT00720304|Docetaxel|docetaxel|mesh-list
154041904|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154041905|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041906|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
154041907|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
153455165|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041908|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
154041909|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041910|NCT00720304|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154041911|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154041912|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041913|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
154041914|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041915|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
154041916|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041917|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041918|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
154041919|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041920|NCT00990691|Desipramine|desipramine|mesh-list
154041921|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154041922|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
154041923|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154041924|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041925|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041926|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154041927|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154041928|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154041929|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
154041930|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041931|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041932|NCT00678522|Atorvastatin|atorvastatin|mesh-list
154041933|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154041934|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154041935|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
154041936|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041937|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154041938|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154041939|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041940|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
154041942|NCT04391855|Ropivacaine|ropivacaine|mesh-list
154041943|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154041944|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041945|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041946|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154041947|NCT04391855|Analgesics|analgesics|mesh-ancestor
154041948|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
154041965|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041967|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154041968|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154041969|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153584715|NCT01762514|Amifostine|amifostine|mesh-list
154041970|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
154041971|NCT00678756|Ketoconazole|ketoconazole|mesh-list
154041972|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
154041973|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041974|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154041975|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154041976|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041977|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041978|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154041979|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
154041980|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041981|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041982|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154041983|NCT02748395|Triamcinolone|triamcinolone|mesh-list
154041984|NCT02748395|Lidocaine|lidocaine|mesh-list
154041985|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041986|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
154041987|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041988|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041989|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
154041990|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041991|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154041992|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154041993|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154041994|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455194|NCT01506726|Analgesics|analgesics|mesh-ancestor
154041995|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041996|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041997|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
154041998|NCT02748395|Hormones|hormones|mesh-ancestor
154041999|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154042000|NCT02629224|Gabapentin|gabapentin|mesh-list
154042001|NCT02629224|Analgesics|analgesics|mesh-ancestor
154042002|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
154042003|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042029|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042030|NCT00720538|Thalidomide|thalidomide|mesh-list
154042031|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154042032|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
154042033|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042034|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
154042035|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154042036|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042037|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154042038|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154042039|NCT00720538|Growth Substances|growth substances|mesh-ancestor
154042040|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
154042041|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042042|NCT00678990|Heparin|heparin|mesh-list
154042043|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
154042044|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154042045|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154042046|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042047|NCT00679068|Bosentan|bosentan|mesh-list
154042048|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154042049|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154042050|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042070|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154042072|NCT02748005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154042073|NCT02748005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042075|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154042076|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
154042077|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042078|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042079|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154042080|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042081|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
154042082|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154042083|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154042084|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154042085|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
154042086|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042087|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042088|NCT00594516|Tapentadol|tapentadol|mesh-list
154042089|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154042090|NCT00594516|Narcotics|narcotics|mesh-ancestor
154042091|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042092|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042093|NCT00594516|Analgesics|analgesics|mesh-ancestor
154042094|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
154042095|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042096|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154042097|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154042132|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154042133|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042134|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154042136|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
154042137|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154042138|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042139|NCT00682656|Azithromycin|azithromycin|mesh-list
154042140|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154042162|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042163|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154042164|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154042165|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
154042166|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154042168|NCT00636311|Gemcitabine|gemcitabine|mesh-list
154042169|NCT00636311|Bortezomib|bortezomib|mesh-list
154042170|NCT00636311|Vinorelbine|vinorelbine|mesh-list
154042171|NCT00636311|Ifosfamide|ifosfamide|mesh-list
154042172|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154042173|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
154042174|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042175|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042176|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154042177|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
154042178|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
154042179|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
154042180|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154042181|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
154042182|NCT00679458|Buprenorphine|buprenorphine|mesh-list
154042183|NCT00679458|Naloxone|naloxone|mesh-list
154042184|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154042185|NCT00679458|Narcotics|narcotics|mesh-ancestor
154042186|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042187|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042188|NCT00679458|Analgesics|analgesics|mesh-ancestor
154042189|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
154042190|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042191|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154042192|NCT04216511|Autoantibodies|autoantibodies|mesh-list
154042193|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
153584950|NCT01763658|Hormones|hormones|mesh-ancestor
154042194|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042195|NCT02747537|Irinotecan|irinotecan|mesh-list
154042196|NCT02747537|Sorafenib|sorafenib|mesh-list
154042197|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154042217|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154042218|NCT00673296|Growth Substances|growth substances|mesh-ancestor
154042219|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042220|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
154042221|NCT04216355|Azacitidine|azacitidine|mesh-list
154042222|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154042223|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
154042224|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042225|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042226|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042227|NCT00683124|Losartan|losartan|mesh-list
154042228|NCT00683124|Nebivolol|nebivolol|mesh-list
154042229|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154042230|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154042231|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154042232|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154042233|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042234|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
154042235|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154042236|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154042237|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154042238|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
154042239|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042240|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042241|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
154042242|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154042243|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042244|NCT00683202|Aspirin|aspirin|mesh-list
154042245|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154042246|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154042247|NCT00683202|Analgesics|analgesics|mesh-ancestor
154042248|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
154042249|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042250|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042251|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154042252|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154042253|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154042275|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
154042276|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154042277|NCT00679614|Acetaminophen|acetaminophen|mesh-list
154042278|NCT00679614|Tramadol|tramadol|mesh-list
154042279|NCT00679614|Naloxone|naloxone|mesh-list
154042280|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154042281|NCT00679614|Analgesics|analgesics|mesh-ancestor
154042282|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
154042283|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042284|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042285|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
153465629|NCT00234078|Rebamipide|rebamipide|mesh-list
154042286|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154042287|NCT00679614|Narcotics|narcotics|mesh-ancestor
154042288|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042289|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154042290|NCT02744417|Bupropion|bupropion|mesh-list
154042291|NCT02744417|Nicotine|nicotine|mesh-list
154042292|NCT02744417|Varenicline|varenicline|mesh-list
154042293|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154042294|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
154042295|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042296|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042297|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154042298|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154042299|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
154042300|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042301|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042302|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154042303|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
154042304|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154042305|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154042306|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154042307|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154042327|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042328|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154042329|NCT02629146|Narcotics|narcotics|mesh-ancestor
154042330|NCT02629146|Analgesics|analgesics|mesh-ancestor
154042331|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
154042332|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042333|NCT02744339|Riociguat|riociguat|mesh-list
154042334|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
154042335|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042336|NCT00991159|Bococizumab|bococizumab|mesh-list
154042337|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154042338|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154042339|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
154042340|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042341|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154042342|NCT00679770|Tavaborole|tavaborole|mesh-list
154042343|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
154042344|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585088|NCT01764867|Citalopram|citalopram|mesh-list
154042345|NCT02744495|Betamethasone|betamethasone|mesh-list
154042346|NCT02744495|Droperidol|droperidol|mesh-list
154042347|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154042348|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
154042349|NCT02744495|Hormones|hormones|mesh-ancestor
154042350|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359867|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154042351|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042352|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154042353|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042354|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154042355|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
154042356|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
154042357|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042358|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154042359|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154042360|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154042361|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042362|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154042363|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154042364|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154042376|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
154042377|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042378|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042379|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154042380|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154042381|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154042382|NCT00989443|Cidofovir|cidofovir|mesh-list
154042383|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
154042384|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042385|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042386|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042387|NCT00683514|Cisplatin|cisplatin|mesh-list
154042388|NCT00683514|Vinorelbine|vinorelbine|mesh-list
154042389|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042390|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154042391|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
154042392|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
154042393|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
154042394|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042395|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
154042396|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154042397|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
154042398|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042399|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154042400|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154042401|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
154042402|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042403|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042404|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154042405|NCT05629325|Buspirone|buspirone|mesh-list
154042406|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154042407|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154042408|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042409|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042410|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154042411|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154042412|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
154042413|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042414|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042415|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
154042416|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154042417|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
154042418|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042419|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
154042420|NCT02629380|Protective Agents|protective agents|mesh-ancestor
154042421|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
154042422|NCT02743247|Tacrolimus|tacrolimus|mesh-list
154042447|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042448|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154042449|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154042450|NCT00537823|Growth Substances|growth substances|mesh-ancestor
154042451|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042452|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
154042453|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
154042454|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042455|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154042456|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154042457|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
154042458|NCT00537823|Antidotes|antidotes|mesh-ancestor
154042459|NCT00537823|Protective Agents|protective agents|mesh-ancestor
154042460|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
154042461|NCT00537823|Vitamins|vitamins|mesh-ancestor
154042462|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
154042463|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
154042464|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
154042465|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042466|NCT04139928|Cathartics|cathartics|mesh-ancestor
154042467|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154042468|NCT04139928|Antacids|antacids|mesh-ancestor
154042469|NCT05589025|Eugenol|eugenol|mesh-list
154042470|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
154042471|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
154042472|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
154042473|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154042474|NCT05589025|Protective Agents|protective agents|mesh-ancestor
154042475|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042506|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
154042507|NCT02742467|Diuretics|diuretics|mesh-ancestor
154042508|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
154042509|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154042510|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154042511|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
154042512|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042514|NCT00684216|Capecitabine|capecitabine|mesh-list
154042515|NCT00684216|Letrozole|letrozole|mesh-list
154042516|NCT00684216|Anastrozole|anastrozole|mesh-list
154042517|NCT00684216|Exemestane|exemestane|mesh-list
154042518|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154042544|NCT00684372|Leflunomide|leflunomide|mesh-list
154042545|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042546|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042547|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154042548|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
154042549|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042550|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154042551|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154042552|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042554|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154042555|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042556|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154042557|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154042558|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
154042559|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042560|NCT00991627|Atropine|atropine|mesh-list
154042561|NCT00991627|Ephedrine|ephedrine|mesh-list
154042562|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
154042563|NCT00991627|Morphine|morphine|mesh-list
154042564|NCT00991627|Bupivacaine|bupivacaine|mesh-list
154042589|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154042590|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154042591|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
154042592|NCT03562871|Carboplatin|carboplatin|mesh-list
154042593|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
154042594|NCT03562871|Pemetrexed|pemetrexed|mesh-list
154042595|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042596|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154042597|NCT03562871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154042598|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042599|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042600|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154042601|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154042602|NCT00690222|Mydriatics|mydriatics|mesh-list
154042603|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
154042604|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042605|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042606|NCT02736071|Celecoxib|celecoxib|mesh-list
154042607|NCT02736071|Tramadol|tramadol|mesh-list
154042608|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154042609|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154042610|NCT02736071|Analgesics|analgesics|mesh-ancestor
154042611|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
154042635|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042636|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154042637|NCT02741219|Analgesics|analgesics|mesh-ancestor
154042638|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
154042639|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042640|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154042641|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154042642|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154042643|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
154042644|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042645|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042646|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154042647|NCT02741219|Narcotics|narcotics|mesh-ancestor
153585383|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042648|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154042649|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154042650|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
154042652|NCT00690534|Insulin|insulin|mesh-list
154042653|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154042654|NCT00690534|Nitroprusside|nitroprusside|mesh-list
154042655|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154042656|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042657|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154042658|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
154042659|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154042660|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042661|NCT00991705|Atorvastatin|atorvastatin|mesh-list
154042662|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154042663|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154042677|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042679|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
154042680|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042681|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154042682|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042683|NCT00991783|Digoxin|digoxin|mesh-list
154042684|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154042685|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154042686|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042687|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042688|NCT00991783|Protective Agents|protective agents|mesh-ancestor
154042689|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042690|NCT00690768|Bevacizumab|bevacizumab|mesh-list
154042691|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154042692|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042693|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154042694|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154042695|NCT00690768|Growth Substances|growth substances|mesh-ancestor
154042696|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042697|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
154042698|NCT00690846|Adalimumab|adalimumab|mesh-list
154042699|NCT00690846|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154042700|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154042701|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154042702|NCT00685464|Abciximab|abciximab|mesh-list
154042703|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
154042704|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154042705|NCT02740829|Glucagon|glucagon|mesh-list
154042706|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154042707|NCT02740829|Hormones|hormones|mesh-ancestor
154042708|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154042709|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042710|NCT00685542|Diacerein|diacerein|mesh-list
154042711|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154042712|NCT02741063|Oxytocin|oxytocin|mesh-list
154042713|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
154042714|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154042715|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042716|NCT04138836|Itraconazole|itraconazole|mesh-list
154042717|NCT04138836|Midazolam|midazolam|mesh-list
154042718|NCT04138836|Esomeprazole|esomeprazole|mesh-list
154042719|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154042720|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154042721|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042722|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042723|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154042724|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154042725|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154042726|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154042758|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042760|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042761|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154042762|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154042763|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
154042780|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154042781|NCT00685854|Ranibizumab|ranibizumab|mesh-list
154042782|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154042783|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154042784|NCT00685854|Growth Substances|growth substances|mesh-ancestor
154042785|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042786|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
154042787|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042788|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
154042789|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
154042790|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154042791|NCT04003207|Hormones|hormones|mesh-list
154042792|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154042793|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042794|NCT05295355|Bromides|bromides|mesh-list
154042795|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
154042796|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154042797|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
154042798|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042799|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042800|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154042801|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042802|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
154042803|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154042804|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
154042805|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042806|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042807|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
154256556|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042808|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
154042809|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154042810|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
154042811|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
154042812|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042813|NCT01564303|Expectorants|expectorants|mesh-ancestor
154042814|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042815|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154042816|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
154042817|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042818|NCT01564303|Protective Agents|protective agents|mesh-ancestor
154042819|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813410|NCT00420524|Epothilone B|epothilone b|mesh-list
153359879|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154042840|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154042841|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154042842|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
154042843|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042844|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154042845|NCT03823300|Aflibercept|aflibercept|mesh-list
154042846|NCT03823300|Faricimab|faricimab|mesh-list
154042847|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154042848|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154042849|NCT03823300|Growth Substances|growth substances|mesh-ancestor
154042850|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042851|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
154042852|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042853|NCT00537745|Naltrexone|naltrexone|mesh-list
154042854|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154042855|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154042856|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042857|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
154042858|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042859|NCT00686322|Paclitaxel|paclitaxel|mesh-list
154042860|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154042861|NCT00686322|Cisplatin|cisplatin|mesh-list
154042862|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154042863|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042864|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
154042865|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
154042866|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
154042867|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042868|NCT02734511|Propofol|propofol|mesh-list
154042869|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154042870|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042871|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042872|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154042873|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
154042874|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
154042875|NCT04003441|Fexuprazan|fexuprazan|mesh-list
154042876|NCT04003441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154042892|NCT00720772|Protective Agents|protective agents|mesh-ancestor
154042893|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042894|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
154042895|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042896|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
154042897|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154042898|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042899|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
154042900|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
154042901|NCT00720850|Lenalidomide|lenalidomide|mesh-list
154042902|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
154042903|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042904|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154042905|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154042906|NCT00720850|Growth Substances|growth substances|mesh-ancestor
154042907|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
154042908|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042909|NCT03785158|Melatonin|melatonin|mesh-list
154042910|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
154042911|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042912|NCT03785158|Protective Agents|protective agents|mesh-ancestor
154042913|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042914|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042915|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154042916|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154042917|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154042918|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042919|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042920|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042921|NCT02733809|Sorafenib|sorafenib|mesh-list
154042922|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042923|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154042924|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042925|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042926|NCT00717340|Paclitaxel|paclitaxel|mesh-list
154042927|NCT00717340|Tivozanib|tivozanib|mesh-list
154042928|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154042929|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042930|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
154042952|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154042953|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042954|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154042955|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154042957|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042958|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154042959|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042960|NCT00691392|Linezolid|linezolid|mesh-list
154042961|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154042962|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042963|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154042964|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042965|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042966|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154042967|NCT02625168|Afatinib|afatinib|mesh-list
154042968|NCT02625168|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154042969|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154042970|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042971|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042972|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042973|NCT00717730|Vitamins|vitamins|mesh-list
154042974|NCT00717730|Folic Acid|folic acid|mesh-list
154042975|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
154042976|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
154042977|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
154042978|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
154042979|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042980|NCT00717730|Hematinics|hematinics|mesh-ancestor
154042981|NCT00691470|Warfarin|warfarin|mesh-list
154042982|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
154042983|NCT05407597|Icatibant|icatibant|mesh-list
154043006|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
154043007|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
154043008|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043009|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154043010|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
154043011|NCT00717808|Tranilast|tranilast|mesh-list
154043012|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
154043013|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154043014|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154043015|NCT00717808|Analgesics|analgesics|mesh-ancestor
154043016|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
154043017|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043018|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043019|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043020|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043021|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154043022|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442296|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154043023|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043024|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153585757|NCT01768390|Fluorides|fluorides|mesh-list
154043025|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154043026|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
154043027|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
154043028|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043029|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154043030|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154043031|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
154043032|NCT02738177|Isosorbide|isosorbide|mesh-list
154043061|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043063|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043064|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154043065|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043066|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043068|NCT02737709|Carboplatin|carboplatin|mesh-list
154043069|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154043070|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043071|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
154043072|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
154043073|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
154043074|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043075|NCT02572960|Vitamin D|vitamin d|mesh-list
154043076|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
154043077|NCT02572960|Valsartan|valsartan|mesh-list
154043078|NCT02572960|Vitamins|vitamins|mesh-ancestor
154043079|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
154043092|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154043093|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
154043094|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154043095|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
154043096|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154043097|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043098|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154043099|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154043100|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585907|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154043101|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154043102|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154043103|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154043104|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
154043105|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043106|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154043107|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154043108|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043109|NCT00721474|Bosutinib|bosutinib|mesh-list
154043110|NCT00721474|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154043111|NCT00721474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043112|NCT00721474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043113|NCT00721474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043114|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154043115|NCT00721552|Prednisolone|prednisolone|mesh-list
154043116|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154043117|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
154043118|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154043119|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
154043120|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154043121|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
154043122|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043123|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
154043124|NCT00721552|Hormones|hormones|mesh-ancestor
154043125|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154043126|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043127|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154043128|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043129|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
154043130|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
154043131|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043132|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043133|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154043134|NCT00721552|Protective Agents|protective agents|mesh-ancestor
154043135|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154043136|NCT00721552|Incretins|incretins|mesh-ancestor
154043137|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154043162|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043163|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043164|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154043165|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154043166|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154043167|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043168|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154043169|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043171|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154043172|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154043173|NCT02732249|Antacids|antacids|mesh-ancestor
154043174|NCT02732249|Diuretics|diuretics|mesh-ancestor
154043175|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
154043176|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043177|NCT02732249|Expectorants|expectorants|mesh-ancestor
154043178|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
154043179|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
154043180|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
154043181|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
154043182|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043183|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154043184|NCT02732093|Lidocaine|lidocaine|mesh-list
154043185|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
154043186|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
154043187|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043188|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043189|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
154043227|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154043228|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
154043251|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
154043253|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154043254|NCT02571712|Timolol|timolol|mesh-list
154043255|NCT02571712|Bimatoprost|bimatoprost|mesh-list
154043256|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154043257|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154043258|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
154043259|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043260|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043261|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043262|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154043263|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154043264|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
154043265|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154043266|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043267|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043268|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154043269|NCT02730845|Analgesics|analgesics|mesh-ancestor
154043270|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
154043271|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043272|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154043273|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154043274|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154043275|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
154043296|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043297|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043298|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043299|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154043300|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154043301|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
154043302|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043303|NCT03214250|Paclitaxel|paclitaxel|mesh-list
154043304|NCT03214250|Gemcitabine|gemcitabine|mesh-list
154043305|NCT03214250|Nivolumab|nivolumab|mesh-list
154043306|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154043307|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043308|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
154043309|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
154043310|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
154043311|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043312|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154043313|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
154043314|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154043315|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154043316|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
154043317|NCT00722098|Vaccines|vaccines|mesh-list
154043318|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
154043319|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043320|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154043321|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043322|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153586065|NCT01769911|Cytarabine|cytarabine|mesh-list
154043323|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
154043324|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043325|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043326|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154043327|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
154043328|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
154043358|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154043359|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154043360|NCT00712504|Growth Substances|growth substances|mesh-ancestor
154043361|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043362|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
154043363|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043364|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043365|NCT00653510|Insulin|insulin|mesh-list
154043366|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154043367|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154043368|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043369|NCT02694653|Acetaminophen|acetaminophen|mesh-list
154043370|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154043371|NCT02694653|Analgesics|analgesics|mesh-ancestor
154043372|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
154043373|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043374|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043397|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154043398|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154043399|NCT02729285|Analgesics|analgesics|mesh-ancestor
154043400|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
154043401|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043402|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043403|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043404|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043405|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154043406|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043407|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043408|NCT00722176|Risperidone|risperidone|mesh-list
154043409|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154043410|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
154043411|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043412|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043413|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043414|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154043415|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154043416|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043417|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154043418|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154043419|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
154043420|NCT02729441|Ramipril|ramipril|mesh-list
154043421|NCT02729441|Perindopril|perindopril|mesh-list
154043422|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154043423|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
154043436|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043438|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154043439|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154043440|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154043441|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154043442|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154043443|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
154043444|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043445|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043446|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043447|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154043448|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154043449|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154043450|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154043451|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154043452|NCT00723268|Prednisolone|prednisolone|mesh-list
154043453|NCT00723268|Colchicine|colchicine|mesh-list
154043454|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043455|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
154043456|NCT00723268|Hormones|hormones|mesh-ancestor
154043457|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154043458|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043459|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154043460|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043461|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
154043462|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043463|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154043464|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154043465|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154043466|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043467|NCT00874770|Ribavirin|ribavirin|mesh-list
154043468|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154043469|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
154043470|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043471|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
154043472|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043474|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
154043475|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
154043476|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154043477|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043478|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
154043479|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043480|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
154043481|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043482|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
154043483|NCT00578344|Busulfan|busulfan|mesh-list
154043484|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
154043485|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154043486|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
154043487|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043518|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154043519|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043520|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043521|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
154043522|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043523|NCT02626104|Lactoferrin|lactoferrin|mesh-list
154043524|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043525|NCT02571166|Valacyclovir|valacyclovir|mesh-list
154043526|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
154043527|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043528|NCT00686478|Interferons|interferons|mesh-list
154043529|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
154043530|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
154043546|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154043547|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
154043548|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043549|NCT02641340|Fentanyl|fentanyl|mesh-list
154043550|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154043551|NCT02641340|Narcotics|narcotics|mesh-ancestor
154043552|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043553|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043554|NCT02641340|Analgesics|analgesics|mesh-ancestor
154043555|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
154043556|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043557|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154043558|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154043559|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
154043560|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
154043561|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
154043562|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154043563|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154043564|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043565|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
154043566|NCT02625948|Coagulants|coagulants|mesh-ancestor
154043567|NCT02571556|Dexamethasone|dexamethasone|mesh-list
154043568|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154043569|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154043570|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043571|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
154043572|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
154043573|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043574|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043575|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043576|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
154043577|NCT02571556|Hormones|hormones|mesh-ancestor
154043578|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154043579|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154043580|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043582|NCT00691548|Cetuximab|cetuximab|mesh-list
154043583|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154043584|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043585|NCT00712738|Nifedipine|nifedipine|mesh-list
154043586|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154043587|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154043603|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043604|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154043605|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
154043606|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043607|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043608|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154043609|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043610|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
154043611|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043612|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154043613|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154043614|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154043615|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154043616|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
154043617|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043618|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154043619|NCT04070482|Tenofovir|tenofovir|mesh-list
154043620|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
154043621|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043622|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154043623|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154043624|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043625|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043626|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154043627|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154043628|NCT04166786|Ethanol|ethanol|mesh-list
154043629|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
154043630|NCT04166786|Petrolatum|petrolatum|mesh-list
154043631|NCT04166786|Testosterone|testosterone|mesh-list
154043632|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
154043633|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
154043634|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154043635|NCT04166786|Androgens|androgens|mesh-ancestor
154043636|NCT04166786|Hormones|hormones|mesh-ancestor
154043637|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154043638|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043639|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154043640|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043641|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
154043642|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154043643|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043644|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043645|NCT04166786|Emollients|emollients|mesh-ancestor
154043646|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
154043647|NCT02727647|Factor VIII|factor viii|mesh-list
154043648|NCT02727647|Coagulants|coagulants|mesh-ancestor
154043667|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154043668|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154043669|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154043670|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154043671|NCT02727881|Growth Substances|growth substances|mesh-ancestor
154043672|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043673|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
154043674|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043675|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043676|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043677|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154043678|NCT02727881|Protective Agents|protective agents|mesh-ancestor
154043679|NCT01564381|Resveratrol|resveratrol|mesh-list
154043680|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
154043681|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043682|NCT01564381|Protective Agents|protective agents|mesh-ancestor
154043683|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043684|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043685|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154043686|NCT04164524|Gentamicins|gentamicins|mesh-list
154043687|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043688|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043689|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154043690|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043691|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043693|NCT00723658|Thalidomide|thalidomide|mesh-list
154043694|NCT00723658|Dexamethasone|dexamethasone|mesh-list
154043695|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
154043696|NCT00723658|Melphalan|melphalan|mesh-list
154043697|NCT00723658|Carmustine|carmustine|mesh-list
154043698|NCT00723658|Rituximab|rituximab|mesh-list
154043699|NCT00723658|Doxorubicin|doxorubicin|mesh-list
154043700|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154043701|NCT00723658|Etoposide|etoposide|mesh-list
154043702|NCT00723658|Bortezomib|bortezomib|mesh-list
154043703|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154043704|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
154043705|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043706|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043707|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154043738|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043740|NCT02638142|Diuretics|diuretics|mesh-ancestor
154043741|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
154043742|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043743|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154043744|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154043745|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043746|NCT02727491|Levomethorphan|levomethorphan|mesh-list
154043747|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
154043748|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
154043749|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
154043778|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
154043779|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043780|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043781|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154043782|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154043783|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043784|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043785|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043786|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154043787|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154043788|NCT02645864|Irinotecan|irinotecan|mesh-list
154043789|NCT02645864|Apatinib|apatinib|mesh-list
154043826|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
154043827|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154043828|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154043860|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043861|NCT00873366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154043862|NCT00873366|Narcotics|narcotics|mesh-ancestor
154043863|NCT00873366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043864|NCT00873366|Analgesics|analgesics|mesh-ancestor
154043865|NCT00873366|Sensory System Agents|sensory system agents|mesh-ancestor
154043866|NCT00873366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043867|NCT00712894|Verapamil|verapamil|mesh-list
154043894|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043895|NCT00536107|Docetaxel|docetaxel|mesh-list
154043896|NCT00536107|Gefitinib|gefitinib|mesh-list
154043897|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043898|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154043899|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154043900|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154043901|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043902|NCT00536107|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154043903|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043904|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043905|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
154043906|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154043907|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
154043908|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043909|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043910|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154043911|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
154043912|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043913|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043914|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154043936|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
154043937|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043939|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154043940|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154043941|NCT00692016|Analgesics|analgesics|mesh-ancestor
154043942|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
154043943|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043944|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043945|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043946|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043947|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
154043948|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154043949|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043950|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043951|NCT02733107|Etoposide|etoposide|mesh-list
154043952|NCT02733107|Apatinib|apatinib|mesh-list
154043953|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154043954|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043955|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154043956|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154043957|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043958|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043959|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043960|NCT00675012|Capecitabine|capecitabine|mesh-list
154043961|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
154043962|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154043963|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
154043964|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043965|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043966|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154043967|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
154043968|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154044000|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044001|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044002|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154044003|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154044004|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044005|NCT00724672|Analgesics|analgesics|mesh-ancestor
154044006|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
154044007|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044008|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044009|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154044010|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
154044011|NCT02624856|Dexamethasone|dexamethasone|mesh-list
154044012|NCT02624856|Bupivacaine|bupivacaine|mesh-list
154044041|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
154044042|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154044043|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154044044|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
154044045|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
154044046|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
154044047|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044048|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154044049|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154044050|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
154044051|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
154044052|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044053|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154044054|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154044055|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044056|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154044057|NCT00992797|Vitamin D|vitamin d|mesh-list
154044058|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
154044059|NCT00992797|Vitamins|vitamins|mesh-ancestor
154044089|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154044090|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154044091|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
154044092|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044093|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044094|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044095|NCT00692172|Alefacept|alefacept|mesh-list
154044096|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044097|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
154044098|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044099|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154044100|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154044102|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
154044103|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044104|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154044105|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154044119|NCT03675139|Progestins|progestins|mesh-ancestor
154044120|NCT03675139|Hormones|hormones|mesh-ancestor
154044121|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044122|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
154044123|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154044124|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154044125|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044126|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
154044127|NCT02645552|Coagulants|coagulants|mesh-ancestor
154044128|NCT00692328|Levodopa|levodopa|mesh-list
154044129|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154044130|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154044131|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
154044132|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044133|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044134|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044135|NCT00687648|Prednisolone|prednisolone|mesh-list
154044136|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
154044137|NCT00687648|Methotrexate|methotrexate|mesh-list
154044138|NCT00687648|Letrozole|letrozole|mesh-list
154044139|NCT00687648|Anastrozole|anastrozole|mesh-list
154044140|NCT00687648|Exemestane|exemestane|mesh-list
154044141|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154044142|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
154044143|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044144|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044145|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154044146|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
154044147|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044148|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044149|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154044150|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154044151|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
154044152|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154044153|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154044154|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
154044155|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044156|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044157|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154044158|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154044159|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044160|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
154044161|NCT00687648|Hormones|hormones|mesh-ancestor
154044162|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044163|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154044164|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154044165|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154044177|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044178|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154044179|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044180|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044182|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154044183|NCT02732795|Narcotics|narcotics|mesh-ancestor
154044184|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044185|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044186|NCT02732795|Analgesics|analgesics|mesh-ancestor
154044187|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
154044188|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044189|NCT05373004|Empagliflozin|empagliflozin|mesh-list
154044190|NCT05373004|Enalapril|enalapril|mesh-list
154044191|NCT05373004|Enalaprilat|enalaprilat|mesh-list
154044192|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153731098|NCT00153114|Laxatives|laxatives|mesh-ancestor
154044193|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044195|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044196|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044197|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154044198|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
154044199|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154044201|NCT00655616|Montelukast|montelukast|mesh-list
154044202|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154044203|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
154044204|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044205|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044206|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154044207|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
154044208|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154044209|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154044210|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154044211|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
154044212|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044213|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044214|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154044215|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
154044216|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044217|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154044218|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154044219|NCT00713440|Acetaminophen|acetaminophen|mesh-list
154044220|NCT00713440|Prednisolone|prednisolone|mesh-list
154044221|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154044222|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
154044223|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154044224|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
154044225|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154044226|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
154044227|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044228|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
154044253|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044254|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
154044255|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
154044256|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154044257|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
154044258|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
154044259|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
154044260|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044261|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044262|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
154044263|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044264|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
154044265|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
154044266|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
154044267|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044268|NCT00675246|Betamethasone|betamethasone|mesh-list
154044269|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
154044270|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044271|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
154044272|NCT00675246|Hormones|hormones|mesh-ancestor
154044273|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044274|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044275|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154044276|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
154044286|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
154044287|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
154044288|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044289|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044290|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154044291|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
154044292|NCT04001725|Hormones|hormones|mesh-ancestor
154044293|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044294|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153587025|NCT01778075|Acetaminophen|acetaminophen|mesh-list
154044295|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044296|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154044297|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154044298|NCT00713674|Mupirocin|mupirocin|mesh-list
154044299|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044300|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154044301|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044302|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044303|NCT00885482|Ritonavir|ritonavir|mesh-list
154044304|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154044305|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154044306|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154044308|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044309|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044310|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154044311|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154044312|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
154044313|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044314|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154044315|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154044316|NCT04139226|CC-11050|cc-11050|mesh-list
154044317|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154044318|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154044319|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044320|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044321|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
154044322|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
154044323|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154044324|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
154044325|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044326|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044327|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154044328|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
154044329|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044330|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044331|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154044332|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154044365|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
154044366|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044367|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154044368|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154044369|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044371|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
154044372|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044373|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154044374|NCT03322267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154044375|NCT03322267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044376|NCT00652496|Bimatoprost|bimatoprost|mesh-list
154044377|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154044396|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
154044397|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154044398|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044399|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154044401|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044402|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044403|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044404|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044405|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154044406|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154044407|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
154044408|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044409|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154044410|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154044411|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
154044412|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044413|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154044414|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154044415|NCT02974049|Ivermectin|ivermectin|mesh-list
154044416|NCT02974049|Albendazole|albendazole|mesh-list
154044417|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
154044418|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154044419|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044420|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
154044421|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
154044422|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154044423|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154044424|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
154044425|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
154044426|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
154044427|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256559|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154044428|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044430|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
154044431|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154044432|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044433|NCT02637284|BPC 157|bpc 157|mesh-list
154044434|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154044435|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154044460|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044461|NCT02721329|Analgesics|analgesics|mesh-ancestor
154044462|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
154044463|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044464|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044465|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
154044466|NCT02637128|Artesunate|artesunate|mesh-list
154044467|NCT02637128|Lumefantrine|lumefantrine|mesh-list
154044468|NCT02637128|Artemether|artemether|mesh-list
154044469|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154044470|NCT02637128|Amodiaquine|amodiaquine|mesh-list
154044471|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
154044472|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154044473|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154044474|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044475|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044476|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
154044477|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
154044478|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154044479|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
154044480|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
154044481|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154044482|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154044483|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044484|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
154044507|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154044508|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154044509|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
154044510|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
154044511|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044512|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044514|NCT00688428|Esomeprazole|esomeprazole|mesh-list
154044515|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154044516|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044517|NCT00688428|Analgesics|analgesics|mesh-ancestor
154044518|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
154044519|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044520|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587252|NCT01779596|Bosentan|bosentan|mesh-list
154044521|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044522|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044523|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154044524|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154044525|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044526|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154044527|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154044528|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044529|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
154044530|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154044531|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154044532|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154044533|NCT02724761|Epinephrine|epinephrine|mesh-list
154044534|NCT02724761|Racepinephrine|racepinephrine|mesh-list
154044535|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
154044536|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154044561|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154044562|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044563|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154044564|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044565|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044566|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154044567|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044568|NCT02721173|Analgesics|analgesics|mesh-ancestor
154044569|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
154044570|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468075|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154044571|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044572|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044573|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044574|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044575|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
154044576|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
154044577|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
154044578|NCT00713986|Protective Agents|protective agents|mesh-ancestor
154044579|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044580|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
154044581|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154044582|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154044583|NCT00692640|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154044584|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154044585|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044586|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044606|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154044607|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044608|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044609|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154044610|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
154044611|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044612|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044613|NCT00714064|Edetic Acid|edetic acid|mesh-list
154044614|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154044615|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
154044616|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
154044617|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044618|NCT00714064|Antidotes|antidotes|mesh-ancestor
154044619|NCT00714064|Protective Agents|protective agents|mesh-ancestor
154044620|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
154044621|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
154044622|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044623|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154044624|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
154044625|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154044626|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
154044627|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154044628|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044629|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044630|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044631|NCT02720705|Analgesics|analgesics|mesh-ancestor
154044632|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
154044633|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044634|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154044635|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154044636|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154044637|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
154044638|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044639|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044640|NCT02720471|Anesthetics|anesthetics|mesh-list
154044641|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
154044642|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044643|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044666|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044667|NCT02724293|Pregabalin|pregabalin|mesh-list
154044668|NCT02724293|Analgesics|analgesics|mesh-ancestor
154044669|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
154044670|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044671|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044672|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
154044673|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154044674|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154044675|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044676|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154044677|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154044678|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154044679|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044680|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154044681|NCT05092828|Morphine|morphine|mesh-list
153468210|NCT04388124|Bosentan|bosentan|mesh-list
154044682|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154044683|NCT05092828|Narcotics|narcotics|mesh-ancestor
154044684|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044685|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044686|NCT05092828|Analgesics|analgesics|mesh-ancestor
154044687|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
154044688|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044689|NCT04137198|Sufentanil|sufentanil|mesh-list
154044690|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154044691|NCT04137198|Narcotics|narcotics|mesh-ancestor
154044692|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044693|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044694|NCT04137198|Analgesics|analgesics|mesh-ancestor
154044695|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
154044713|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154044714|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
154044715|NCT00692952|Nonoxynol|nonoxynol|mesh-list
154044716|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154044717|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044718|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154044719|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044720|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154044721|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154044722|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154044723|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154044724|NCT02639858|Docetaxel|docetaxel|mesh-list
154044725|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044726|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
154044727|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
154044728|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
154044729|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044730|NCT00689208|Atropine|atropine|mesh-list
154044731|NCT00689208|Physostigmine|physostigmine|mesh-list
154044732|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154044733|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154044734|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154044735|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
154044736|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044737|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044738|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154044739|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
154044740|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
154044741|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
154044742|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154044743|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154044744|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
154044745|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044746|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044747|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154044748|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044749|NCT00689208|Miotics|miotics|mesh-ancestor
154044750|NCT00726466|Ranibizumab|ranibizumab|mesh-list
154044751|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154044752|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154044753|NCT00726466|Growth Substances|growth substances|mesh-ancestor
154044754|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044780|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154044781|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044782|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154044783|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
154044784|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154044785|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
154044786|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044787|NCT00653822|Alefacept|alefacept|mesh-list
154044788|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044789|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
154044790|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044791|NCT04137276|Vitamins|vitamins|mesh-list
154044792|NCT04137276|Thiamine|thiamine|mesh-list
154044793|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
154044794|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
154044795|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044796|NCT02723981|Vitamins|vitamins|mesh-list
154044797|NCT02723981|Vitamin K|vitamin k|mesh-list
154044798|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
154044799|NCT02723981|Dabigatran|dabigatran|mesh-list
154044800|NCT02723981|Anticoagulants|anticoagulants|mesh-list
154044803|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044804|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154044805|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154044806|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154044830|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044831|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044832|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154044833|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
154044834|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
154044835|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
154044836|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154044837|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154044838|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154044839|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044840|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
154044841|NCT02644525|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154044842|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154044843|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044844|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044845|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044847|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
154044848|NCT00726700|Rituximab|rituximab|mesh-list
154044849|NCT00726700|Doxorubicin|doxorubicin|mesh-list
154044850|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154044851|NCT00726700|Vincristine|vincristine|mesh-list
154044852|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153450495|NCT05894954|Hormones|hormones|mesh-list
154044853|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
154044854|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044855|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044856|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154044857|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
154044884|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
154044885|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154044886|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154044887|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154044888|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044889|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
154044890|NCT00675714|Itraconazole|itraconazole|mesh-list
154044891|NCT00675714|Fluconazole|fluconazole|mesh-list
154044892|NCT00675714|Ketoconazole|ketoconazole|mesh-list
154044893|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
154044894|NCT00675714|Propranolol|propranolol|mesh-list
154044895|NCT00675714|Metoprolol|metoprolol|mesh-list
154044896|NCT00675714|Hormones|hormones|mesh-list
154044897|NCT00675714|Testosterone|testosterone|mesh-list
154044898|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
154044899|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
154044900|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153587633|NCT01782560|Omeprazole|omeprazole|mesh-list
154044901|NCT00675714|Oxandrolone|oxandrolone|mesh-list
154044902|NCT00675714|Nandrolone|nandrolone|mesh-list
154044928|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044929|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154044930|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154044931|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154044932|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154044933|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154044934|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154044935|NCT00729976|Ibuprofen|ibuprofen|mesh-list
154044936|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154044937|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044938|NCT00729976|Analgesics|analgesics|mesh-ancestor
154044939|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
154044940|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044941|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044942|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044943|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044944|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154044945|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044946|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044947|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
154044948|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
154044969|NCT00730054|Narcotics|narcotics|mesh-ancestor
153455724|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044970|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044971|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044972|NCT00730054|Analgesics|analgesics|mesh-ancestor
154044973|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
154044974|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044975|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154044976|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
154044977|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
154044978|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154044979|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154044980|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154044981|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
154044982|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044983|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044984|NCT00866619|Vaccines|vaccines|mesh-list
154044985|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
154044986|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044987|NCT00693108|Testosterone|testosterone|mesh-list
154044988|NCT00693108|Androgens|androgens|mesh-ancestor
154044989|NCT00693108|Hormones|hormones|mesh-ancestor
154044990|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044991|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044992|NCT00884390|Factor VIII|factor viii|mesh-list
154044993|NCT00884390|Coagulants|coagulants|mesh-ancestor
154044994|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
154044995|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154044996|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
154044997|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044998|NCT02723669|Expectorants|expectorants|mesh-ancestor
154044999|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
154045000|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154045001|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
154045002|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045003|NCT02723669|Protective Agents|protective agents|mesh-ancestor
154045004|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045038|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154045039|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045040|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
154045041|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
154045042|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045043|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045064|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045065|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045067|NCT02615301|Vitamin D|vitamin d|mesh-list
154045068|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
154045069|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
154045070|NCT02615301|Vitamins|vitamins|mesh-list
154045071|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
154045072|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045073|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154045074|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154045075|NCT02570230|Ketamine|ketamine|mesh-list
154045076|NCT02570230|Analgesics|analgesics|mesh-ancestor
154045077|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
154045078|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045079|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045080|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154045081|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154045082|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
154045083|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
154045084|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045085|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154045086|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154045087|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045088|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045089|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154045090|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
154045091|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045092|NCT00697905|Carboplatin|carboplatin|mesh-list
154045093|NCT00697905|Gemcitabine|gemcitabine|mesh-list
154045094|NCT00697905|Fluorouracil|fluorouracil|mesh-list
154045095|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045096|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153455746|NCT05031234|Analgesics|analgesics|mesh-ancestor
154045097|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
154045098|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045099|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045100|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
154045130|NCT02723435|Midostaurin|midostaurin|mesh-list
154045131|NCT02723435|Staurosporine|staurosporine|mesh-list
154045132|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045133|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154045134|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045135|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045136|NCT02718677|Factor VIII|factor viii|mesh-list
154045137|NCT02718677|Coagulants|coagulants|mesh-ancestor
154045138|NCT04132011|Morphine|morphine|mesh-list
154045139|NCT04132011|Oxycodone|oxycodone|mesh-list
154045140|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
154045141|NCT04132011|Hydromorphone|hydromorphone|mesh-list
154045142|NCT04132011|Narcotics|narcotics|mesh-ancestor
154045143|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045144|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045145|NCT04132011|Analgesics|analgesics|mesh-ancestor
154045146|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
154045162|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154045163|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045164|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045165|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
154045166|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045167|NCT00689598|Spironolactone|spironolactone|mesh-list
154045168|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154045169|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
154045170|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154045171|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045172|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154045173|NCT00689598|Diuretics|diuretics|mesh-ancestor
154045174|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
154045175|NCT04163354|Listerine|listerine|mesh-list
154045176|NCT04163354|Fluorides|fluorides|mesh-list
154045177|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
154045178|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
154045179|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
154045180|NCT04163354|Protective Agents|protective agents|mesh-ancestor
154045181|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045182|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154045183|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045184|NCT04131621|Nivolumab|nivolumab|mesh-list
154045185|NCT04131621|Ipilimumab|ipilimumab|mesh-list
154045186|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045187|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045188|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154045189|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045190|NCT00689832|Fluticasone|fluticasone|mesh-list
154045191|NCT00689832|Tacrolimus|tacrolimus|mesh-list
154045192|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045193|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
154045194|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045195|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154045196|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045197|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045198|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154045199|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154045200|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
154045201|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045202|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154045203|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
154045204|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
154045241|NCT04136886|Cisplatin|cisplatin|mesh-list
154045242|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045243|NCT00534313|Abatacept|abatacept|mesh-list
154045244|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154045245|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045272|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
154045273|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045274|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045275|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
154045276|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045280|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154045281|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154045282|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154045283|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154045284|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
154045285|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045286|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045287|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045288|NCT02717819|Vitamin D|vitamin d|mesh-list
154045289|NCT02717819|Vitamins|vitamins|mesh-ancestor
154045290|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
154045291|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045292|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154045293|NCT02007655|Apixaban|apixaban|mesh-list
154045310|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154045311|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045312|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
154045313|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045314|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154045315|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045316|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045317|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154045318|NCT02722343|Tenofovir|tenofovir|mesh-list
154045319|NCT02722343|Emtricitabine|emtricitabine|mesh-list
154045320|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154045321|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
154045322|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045323|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154045324|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154045325|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045326|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045327|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154045328|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154045329|NCT00694590|Plerixafor|plerixafor|mesh-list
154045330|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154045331|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154045332|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
154045333|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045334|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154045335|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045336|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045337|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045338|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154045339|NCT03903406|Dexamethasone|dexamethasone|mesh-list
154045340|NCT03903406|Lenalidomide|lenalidomide|mesh-list
154045341|NCT03903406|Ixazomib|ixazomib|mesh-list
154045342|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154045343|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
154045344|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
154045345|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045346|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045347|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154045348|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
154045349|NCT03903406|Hormones|hormones|mesh-ancestor
154045350|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154045351|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154045352|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045353|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
154045384|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045385|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045386|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045387|NCT02704156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154045388|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154045390|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
154045391|NCT00912678|Tacrolimus|tacrolimus|mesh-list
154045392|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045393|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
154045394|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045395|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154045396|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045416|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045418|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045419|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
154045420|NCT00994513|Vitamins|vitamins|mesh-ancestor
154045421|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
154045422|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
154045423|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154045424|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045426|NCT00995917|Vitamins|vitamins|mesh-ancestor
154045427|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
154045428|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045429|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154045430|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154045431|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045432|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
154045433|NCT00995917|Coagulants|coagulants|mesh-ancestor
154045434|NCT02616822|Resveratrol|resveratrol|mesh-list
154045435|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
154045436|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045437|NCT02616822|Protective Agents|protective agents|mesh-ancestor
154045438|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045439|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045440|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154045442|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154045443|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
154045444|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045445|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045446|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154045447|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
154045448|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154045449|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154045450|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045451|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154045452|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
154045453|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154045454|NCT00912756|Protective Agents|protective agents|mesh-ancestor
154045472|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045474|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
154045475|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045476|NCT00999349|Protective Agents|protective agents|mesh-ancestor
154045477|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045478|NCT02621112|Imiquimod|imiquimod|mesh-list
154045479|NCT02621112|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154045480|NCT02621112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045481|NCT02621112|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154045482|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
154045483|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045484|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154045485|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045486|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
154045487|NCT04000789|Vitamins|vitamins|mesh-list
154045488|NCT04000789|Vitamin E|vitamin e|mesh-list
154045489|NCT04000789|Vitamin A|vitamin a|mesh-list
154045490|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
154045491|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
154045492|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045493|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
154045494|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045495|NCT04000789|Protective Agents|protective agents|mesh-ancestor
154045496|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154045497|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
154045498|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
154045499|NCT00697554|Vaccines|vaccines|mesh-list
154045500|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
154045501|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045502|NCT00731068|Mitogens|mitogens|mesh-list
154045503|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045504|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045505|NCT00866307|Cytarabine|cytarabine|mesh-list
154045506|NCT00866307|Dexamethasone|dexamethasone|mesh-list
154045507|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
154045508|NCT00866307|Prednisone|prednisone|mesh-list
154045509|NCT00866307|Cortisone|cortisone|mesh-list
154045510|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
154045511|NCT00866307|Doxorubicin|doxorubicin|mesh-list
154045512|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154045513|NCT00866307|Methotrexate|methotrexate|mesh-list
154045514|NCT00866307|Vincristine|vincristine|mesh-list
154045515|NCT00866307|Daunorubicin|daunorubicin|mesh-list
154045534|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045537|NCT00866307|Hormones|hormones|mesh-ancestor
154045538|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154045539|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154045540|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
154045541|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045542|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154045543|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154045544|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154045545|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154045546|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
154045547|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154045548|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154045549|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
154045550|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
154045551|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154045552|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154045553|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
154045554|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045555|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154045556|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
154045557|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
154045558|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045559|NCT00731146|Anesthetics|anesthetics|mesh-list
154045560|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045561|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045562|NCT02716415|Menthol|menthol|mesh-list
154045563|NCT02716415|Petrolatum|petrolatum|mesh-list
154045564|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
154045565|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
154045566|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
154045567|NCT02716415|Emollients|emollients|mesh-ancestor
154045568|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
154045569|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154045570|NCT02716415|Protective Agents|protective agents|mesh-ancestor
154045571|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045572|NCT02616354|Imipenem|imipenem|mesh-list
154045573|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154045574|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045605|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045606|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154045607|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154045608|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045609|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
154045610|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154045611|NCT00871728|Itraconazole|itraconazole|mesh-list
154045612|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
154045613|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045614|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154045615|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154045616|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045617|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045618|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154045619|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
154045637|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
154045638|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045639|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045641|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045642|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154045643|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045644|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045645|NCT00868998|Gemcitabine|gemcitabine|mesh-list
154045646|NCT00868998|Capecitabine|capecitabine|mesh-list
154045647|NCT00868998|Docetaxel|docetaxel|mesh-list
154045648|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154045649|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
154045650|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045651|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045652|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
154045653|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
154045654|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045655|NCT00996151|Testosterone|testosterone|mesh-list
154045657|NCT00996151|Hormones|hormones|mesh-ancestor
154045658|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154045659|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045660|NCT04131231|Aldesleukin|aldesleukin|mesh-list
154045661|NCT04131231|Methotrexate|methotrexate|mesh-list
154045662|NCT04131231|Interleukin-2|interleukin-2|mesh-list
154045663|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154045664|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
154045665|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154045666|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045667|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154045668|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
154045669|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045670|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045671|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
154045672|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045673|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154045674|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045675|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
154045676|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045714|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045715|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
154045744|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
154045745|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045746|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045747|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045748|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154045749|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154045751|NCT02752841|Vitamins|vitamins|mesh-ancestor
154045752|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
154045753|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045754|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154045755|NCT02715869|Sevoflurane|sevoflurane|mesh-list
154045756|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154045757|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154045758|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
154045759|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
154045760|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045761|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045762|NCT00532441|Docetaxel|docetaxel|mesh-list
154045763|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154045781|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154045782|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
154045783|NCT00999817|Levomethorphan|levomethorphan|mesh-list
154045784|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
154045785|NCT00999817|Dacomitinib|dacomitinib|mesh-list
154045786|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
154045787|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154045788|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154045789|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154045790|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045791|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045792|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045793|NCT00999817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154045794|NCT00999817|Narcotics|narcotics|mesh-ancestor
154045795|NCT00999817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045796|NCT00999817|Analgesics|analgesics|mesh-ancestor
154045797|NCT00999817|Sensory System Agents|sensory system agents|mesh-ancestor
154045798|NCT00999817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045799|NCT00999817|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154045800|NCT00999817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154045801|NCT00999817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045802|NCT00857259|Everolimus|everolimus|mesh-list
154045803|NCT00857259|Ranibizumab|ranibizumab|mesh-list
154045804|NCT00857259|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154045805|NCT00857259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154045806|NCT00857259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045807|NCT00857259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045808|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045809|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
154045810|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045811|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045812|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154045815|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
154045816|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154045817|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045818|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045819|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154045820|NCT00868608|Immunotoxins|immunotoxins|mesh-ancestor
154045821|NCT00868608|Immunoconjugates|immunoconjugates|mesh-ancestor
153814984|NCT00344513|Carvedilol|carvedilol|mesh-list
154045847|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
154045848|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045849|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154045850|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045851|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045852|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
154045854|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154045855|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
154045856|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045857|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045858|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045859|NCT02620800|Leucovorin|leucovorin|mesh-list
154045860|NCT02620800|Paclitaxel|paclitaxel|mesh-list
154045861|NCT02620800|Bevacizumab|bevacizumab|mesh-list
154045862|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
154045863|NCT02620800|Calcium|calcium|mesh-list
154045864|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
154045865|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154045866|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045867|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
154045868|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
154045869|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045870|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045890|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
154045891|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045892|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154045893|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154045894|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154045895|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
154045896|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045897|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045898|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154045899|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154045900|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154045901|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154045902|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154045903|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
154045904|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
154045905|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
154045906|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
154045907|NCT00996697|Budesonide|budesonide|mesh-list
154045908|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
154045909|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
154045910|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154045911|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154045912|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154045913|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
154045914|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045915|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045916|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154045917|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
154045918|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
154045919|NCT00996697|Hormones|hormones|mesh-ancestor
154045920|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154045921|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154045922|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154045923|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154045924|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
154045952|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045953|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154045954|NCT00856323|Tenofovir|tenofovir|mesh-list
154045955|NCT00856323|Emtricitabine|emtricitabine|mesh-list
154045956|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154045957|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
154045959|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154045960|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154045961|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045962|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045963|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154045964|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154045966|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045967|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045968|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
154045969|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045999|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046000|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
154046001|NCT00994981|Analgesics|analgesics|mesh-ancestor
154046002|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
154046003|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046004|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046005|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
154046006|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046007|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154046008|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
154046009|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154046010|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154046011|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046012|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154046013|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
154046044|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154046045|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154046046|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046047|NCT00997087|Flumazenil|flumazenil|mesh-list
154046048|NCT00997087|Antidotes|antidotes|mesh-ancestor
154046049|NCT00997087|Protective Agents|protective agents|mesh-ancestor
154046050|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046051|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
154046052|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
154046053|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046054|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046055|NCT01000597|Fluticasone|fluticasone|mesh-list
154046056|NCT01000597|Xhance|xhance|mesh-list
154046057|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046058|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154046059|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
154046060|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046061|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046076|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154046077|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046078|NCT00997399|Panobinostat|panobinostat|mesh-list
154046079|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046080|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154046081|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046082|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046083|NCT00997477|Budesonide|budesonide|mesh-list
154046084|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
154046085|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046086|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154046087|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
154046088|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046089|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046090|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154046091|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
154046092|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
154046093|NCT00997477|Hormones|hormones|mesh-ancestor
154046094|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046095|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154046096|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154046097|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154046098|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
154046099|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046100|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046101|NCT01000831|Vaccines|vaccines|mesh-list
154046102|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
154046103|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046104|NCT05170789|Dexamethasone|dexamethasone|mesh-list
154046105|NCT05170789|Elotuzumab|elotuzumab|mesh-list
154046106|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046107|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
154046108|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
154046109|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046110|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046111|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046112|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
154046113|NCT05170789|Hormones|hormones|mesh-ancestor
154046114|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046115|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154046116|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046117|NCT02693951|Cefotiam|cefotiam|mesh-list
154046118|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154046119|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046120|NCT00997711|Sirolimus|sirolimus|mesh-list
154046121|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154046122|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046142|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154046143|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
154046145|NCT02715167|Hormones|hormones|mesh-ancestor
154046146|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046147|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154046148|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154046149|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154046150|NCT02620566|Bupivacaine|bupivacaine|mesh-list
154046151|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
154046152|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
154046153|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046154|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046155|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
154046156|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046157|NCT02714699|Diclofenac|diclofenac|mesh-list
154046158|NCT02714699|Scopolamine|scopolamine|mesh-list
154046159|NCT02714699|Bromides|bromides|mesh-list
154046160|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154046161|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154046162|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154046163|NCT02714699|Analgesics|analgesics|mesh-ancestor
154046164|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
154046165|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046166|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046167|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046168|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046169|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154046170|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046171|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046172|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
154046173|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154046174|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
154046175|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
154046176|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046177|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
154046178|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154046192|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154046193|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
154046194|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154046195|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
154046196|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046197|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046198|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
154046199|NCT02712203|Vaccines|vaccines|mesh-list
154046200|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
154046201|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046202|NCT00696930|Edotreotide|edotreotide|mesh-list
154046203|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154046204|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046205|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
154046206|NCT00598442|Hematinics|hematinics|mesh-ancestor
154046207|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
154046208|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
154046209|NCT02714543|Antioxidants|antioxidants|mesh-list
154046210|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046211|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154046212|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
154046213|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046214|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
154046215|NCT02714543|Protective Agents|protective agents|mesh-ancestor
154046216|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046217|NCT02714231|Diclofenac|diclofenac|mesh-list
154046218|NCT02714231|Scopolamine|scopolamine|mesh-list
154046219|NCT02714231|Bromides|bromides|mesh-list
153443147|NCT02014740|Liraglutide|liraglutide|mesh-list
154046220|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154046221|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154046222|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154046223|NCT02714231|Analgesics|analgesics|mesh-ancestor
154046224|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
154046225|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046226|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046227|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046228|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046229|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154046230|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046231|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046232|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
154046233|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154046234|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
154046235|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
154046236|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046237|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
154046238|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154046239|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
154046240|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046241|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154046250|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
154046251|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046252|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046253|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154046254|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
154046255|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046256|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154046257|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154046258|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046259|NCT04163588|Metolazone|metolazone|mesh-list
154046260|NCT04163588|Diuretics|diuretics|mesh-list
154046261|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153588988|NCT01800019|Nicotine|nicotine|mesh-list
154046262|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
154046263|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046264|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154046265|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046266|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154046267|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154046268|NCT05167513|Metformin|metformin|mesh-list
154046269|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154046270|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154046271|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046272|NCT05167513|Incretins|incretins|mesh-ancestor
154046273|NCT05167513|Hormones|hormones|mesh-ancestor
154046274|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046275|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154046276|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
154046277|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046278|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046279|NCT00654056|Insulin|insulin|mesh-list
154046280|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154046281|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154046282|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046283|NCT00854373|Hormones|hormones|mesh-list
154046284|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154046285|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443156|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154046286|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046287|NCT00611507|Fluorouracil|fluorouracil|mesh-list
154046288|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
154046289|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
154046290|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046291|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154046292|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046293|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154046295|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046296|NCT01001845|Vitamin E|vitamin e|mesh-list
154046297|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
154046298|NCT01001845|Tocopherols|tocopherols|mesh-list
154046299|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
154046300|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046301|NCT01001845|Protective Agents|protective agents|mesh-ancestor
154046302|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046303|NCT01001845|Vitamins|vitamins|mesh-ancestor
154046304|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
154046305|NCT02635334|Montelukast|montelukast|mesh-list
154046306|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154046307|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
154046308|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154046325|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154046326|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
154046327|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046328|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046329|NCT00998101|Carboplatin|carboplatin|mesh-list
154046330|NCT00998101|Cetuximab|cetuximab|mesh-list
154046331|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046332|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154046334|NCT04234217|Niacinamide|niacinamide|mesh-list
154046335|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
154046336|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154046337|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
154046338|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046339|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154046340|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
154046341|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
154046342|NCT04234217|Vitamins|vitamins|mesh-ancestor
154046343|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
154046344|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046345|NCT01002079|Rifampin|rifampin|mesh-list
154046346|NCT01002079|BMS 708163|bms 708163|mesh-list
154046347|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154046348|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
154046349|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154046350|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046351|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
154046352|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154046353|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046354|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046355|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154046356|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154046357|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154046358|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154046359|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154046360|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154046361|NCT01002079|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154046362|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
154046363|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154046383|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046385|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
154046386|NCT01002157|Menaquinone 7|menaquinone 7|mesh-list
154046387|NCT01002157|Vitamins|vitamins|mesh-ancestor
154046388|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
154046389|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046390|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154046391|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154046392|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046393|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
154046394|NCT01002157|Coagulants|coagulants|mesh-ancestor
154046395|NCT01004497|Cytarabine|cytarabine|mesh-list
154046396|NCT01004497|Dexamethasone|dexamethasone|mesh-list
154046397|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
154046398|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
154046399|NCT01004497|Vincristine|vincristine|mesh-list
154046400|NCT01004497|Daunorubicin|daunorubicin|mesh-list
154046401|NCT01004497|Dasatinib|dasatinib|mesh-list
154046402|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
154046403|NCT01004497|BB 1101|bb 1101|mesh-list
154046404|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154046405|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
154046406|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046407|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046408|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153589139|NCT01801046|Cytarabine|cytarabine|mesh-list
154046410|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046411|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046412|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154046413|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046414|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
154046415|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
154046416|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046417|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046418|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
154046419|NCT01004497|Hormones|hormones|mesh-ancestor
154046420|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046421|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154046422|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
154046441|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
154046442|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154046443|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046445|NCT01004575|Chromium|chromium|mesh-list
154046446|NCT01004575|Trace Elements|trace elements|mesh-ancestor
154046447|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
154046448|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046449|NCT02615730|Paclitaxel|paclitaxel|mesh-list
154046450|NCT02615730|GSK2636771|gsk2636771|mesh-list
154046451|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154046452|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046453|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
154046454|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
154046455|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
154046456|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046457|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154046458|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046459|NCT02711891|Loperamide|loperamide|mesh-list
154046460|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
154046461|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046462|NCT02615496|Aflibercept|aflibercept|mesh-list
154046463|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154046464|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154046465|NCT02615496|Growth Substances|growth substances|mesh-ancestor
154046466|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046467|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
154046468|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046469|NCT02714075|Zinc|zinc|mesh-list
154046470|NCT02714075|Iron|iron|mesh-list
154046471|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
154046472|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
154046473|NCT02714075|Citric Acid|citric acid|mesh-list
154046474|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
154046475|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
154046476|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154046477|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
154046478|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
154046479|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046480|NCT02714075|Trace Elements|trace elements|mesh-ancestor
154046481|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
154046482|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046483|NCT02714075|Astringents|astringents|mesh-ancestor
154046499|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
154046500|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154046501|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046502|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046504|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154046505|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
154046506|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154046507|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046508|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154046509|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154046510|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154046511|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
154046512|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154046513|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154046514|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
154046515|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046516|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
154046517|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154046518|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154046520|NCT00656552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154046521|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154046522|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154046523|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046524|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046525|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
154046526|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046527|NCT01004809|Dutasteride|dutasteride|mesh-list
154046528|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154046529|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154046530|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046531|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046532|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
154046533|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046534|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046535|NCT00883688|Bevacizumab|bevacizumab|mesh-list
154046536|NCT00883688|Lapatinib|lapatinib|mesh-list
154046537|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154046538|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046539|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154046558|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154046559|NCT02636348|Vitamin D|vitamin d|mesh-list
154046560|NCT02636348|Calcium|calcium|mesh-list
154046561|NCT02636348|Vitamins|vitamins|mesh-ancestor
154046562|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
154046563|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046564|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154046565|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154046567|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154046568|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
154046569|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046570|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154046571|NCT04219865|Protective Agents|protective agents|mesh-ancestor
154046572|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046573|NCT01002703|Prednisone|prednisone|mesh-list
154046574|NCT01002703|Lenalidomide|lenalidomide|mesh-list
154046575|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154046576|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046577|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
154046578|NCT01002703|Hormones|hormones|mesh-ancestor
154046579|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046580|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046581|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154046582|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046583|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
154046584|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154046585|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154046586|NCT01002703|Growth Substances|growth substances|mesh-ancestor
154046587|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
154046588|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154046589|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
154046590|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046591|NCT02639234|Nivolumab|nivolumab|mesh-list
154046592|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154046593|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046594|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154046595|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046602|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046603|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046605|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154046606|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
154046607|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154046608|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154046609|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154046610|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154046611|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154046612|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046613|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154046614|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154046615|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154046616|NCT02713139|Metronidazole|metronidazole|mesh-list
154046617|NCT02713139|Clotrimazole|clotrimazole|mesh-list
154046618|NCT02713139|Miconazole|miconazole|mesh-list
154046619|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046620|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154046621|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154046622|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154046623|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154046624|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
154046625|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154046626|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154046627|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046628|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046629|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154046630|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
154046631|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046632|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046633|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154046634|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154046635|NCT00853827|Aliskiren|aliskiren|mesh-list
154046636|NCT00853827|Renin Inhibitors|renin inhibitors|mesh-ancestor
154046637|NCT00853827|Protease Inhibitors|protease inhibitors|mesh-ancestor
154046638|NCT00853827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046639|NCT00853827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046640|NCT01005121|Colchicine|colchicine|mesh-list
154046641|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
154046642|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046643|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
154046644|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
154046645|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
154046646|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046647|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046648|NCT02711579|Celecoxib|celecoxib|mesh-list
154046649|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154046650|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154046651|NCT02711579|Analgesics|analgesics|mesh-ancestor
154046652|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
154046653|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046654|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046655|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046656|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046657|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154046658|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154046659|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046660|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046661|NCT00611195|Remifentanil|remifentanil|mesh-list
154046662|NCT00611195|Propofol|propofol|mesh-list
154046673|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046674|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154046675|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154046676|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
154046677|NCT01008709|Hormones|hormones|mesh-ancestor
154046678|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046679|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046680|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046681|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046682|NCT02615574|Interferons|interferons|mesh-list
154046683|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154046684|NCT02615574|Celecoxib|celecoxib|mesh-list
154046685|NCT02615574|Vaccines|vaccines|mesh-list
154046686|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
154046687|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046688|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046689|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
154046690|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046691|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154046692|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154046693|NCT02615574|Analgesics|analgesics|mesh-ancestor
154046694|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
154046695|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046696|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046697|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046698|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154046699|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154046700|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046701|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046702|NCT02708693|Triamcinolone|triamcinolone|mesh-list
154046703|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154046704|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154046705|NCT02708693|Lidocaine|lidocaine|mesh-list
154046706|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154046707|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
154046708|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
153589434|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154046709|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046710|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046711|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
154046712|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046713|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154046714|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154046715|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154046716|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154046717|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046718|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046719|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
154046720|NCT02708693|Hormones|hormones|mesh-ancestor
154046721|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046722|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154046723|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
154046724|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046725|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154046726|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154046748|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154046749|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
154046750|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046751|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046752|NCT02711189|Oxytocin|oxytocin|mesh-list
154046753|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
154046754|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154046755|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046756|NCT02635802|Lidocaine|lidocaine|mesh-list
154046757|NCT02635802|Midazolam|midazolam|mesh-list
154046758|NCT02635802|Remifentanil|remifentanil|mesh-list
154046759|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
154046760|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
154046761|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046762|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046763|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
154046764|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046765|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154046766|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154046767|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154046768|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154046769|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046770|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154046771|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154046772|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154046773|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154046774|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154046775|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154046776|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
154046777|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
154046779|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046780|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154046781|NCT02635802|Narcotics|narcotics|mesh-ancestor
154046782|NCT02635802|Analgesics|analgesics|mesh-ancestor
154046803|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
154046804|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046805|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046806|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046807|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046808|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154046809|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046810|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046811|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
154046812|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154046813|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046814|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046815|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154046817|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
154046818|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046819|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154046820|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154046821|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154046822|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
154046823|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046824|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046825|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154046826|NCT00654446|Simvastatin|simvastatin|mesh-list
154046827|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154046828|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154046829|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
154046830|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046831|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154046832|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154046833|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046834|NCT01003483|Orlistat|orlistat|mesh-list
154046835|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046868|NCT04459871|Thrombin|thrombin|mesh-list
154046869|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
154046870|NCT04459871|Coagulants|coagulants|mesh-ancestor
154046871|NCT02708459|Morphine|morphine|mesh-list
154046872|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154046873|NCT02708459|Narcotics|narcotics|mesh-ancestor
154046874|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046875|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046876|NCT02708459|Analgesics|analgesics|mesh-ancestor
154046877|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
154046878|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046893|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154046894|NCT01005979|Growth Substances|growth substances|mesh-ancestor
154046895|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
154046896|NCT00913029|Timolol|timolol|mesh-list
154046897|NCT00913029|Latanoprost|latanoprost|mesh-list
154046898|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154046899|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154046900|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154046901|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046902|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046903|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046904|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154046905|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154046906|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154046907|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154046908|NCT01006057|Insulin|insulin|mesh-list
154046909|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154046910|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
154046911|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154046912|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046913|NCT00853125|Sunitinib|sunitinib|mesh-list
154046914|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046915|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154046916|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154046917|NCT00853125|Growth Substances|growth substances|mesh-ancestor
154046918|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046919|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
154046920|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154046921|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046922|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046923|NCT02707913|Amlodipine|amlodipine|mesh-list
154046924|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154046925|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154046926|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154046927|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046928|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154046929|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046930|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
154046931|NCT02710877|Sufentanil|sufentanil|mesh-list
154046932|NCT02710877|Dsuvia|dsuvia|mesh-list
154046933|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
154046934|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154046935|NCT02710877|Narcotics|narcotics|mesh-ancestor
154046936|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046937|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046938|NCT02710877|Analgesics|analgesics|mesh-ancestor
154046939|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
154046960|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
154046961|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
154046964|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
154046965|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046966|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154046967|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154046968|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154046969|NCT02706977|Carbidopa|carbidopa|mesh-list
154046970|NCT02706977|Levodopa|levodopa|mesh-list
154046971|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154046972|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
154046973|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046974|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154046975|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154046976|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
154046977|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
154046978|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046979|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046980|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154046981|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046982|NCT02707211|Antibodies|antibodies|mesh-list
154046983|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
154046984|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
154046985|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046986|NCT01006525|Zolpidem|zolpidem|mesh-list
154046987|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154046988|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154046989|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046990|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046991|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154046992|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
154046993|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
154046994|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047020|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
154047021|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047022|NCT04318210|Tenofovir|tenofovir|mesh-list
154047023|NCT04318210|Emtricitabine|emtricitabine|mesh-list
154047024|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
154047025|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047026|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154047027|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154047028|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047029|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047030|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154047031|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154047032|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154047033|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
154047034|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047035|NCT00870870|Carboplatin|carboplatin|mesh-list
154047036|NCT00870870|Gemcitabine|gemcitabine|mesh-list
154047037|NCT00870870|Cetuximab|cetuximab|mesh-list
154047038|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154047039|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047040|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154047041|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
154047042|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047043|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154047044|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
154047045|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047063|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047064|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047065|NCT04134468|Gemcitabine|gemcitabine|mesh-list
154047066|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154047067|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154047068|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
154047069|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047070|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047071|NCT02709863|Propofol|propofol|mesh-list
154047072|NCT02709863|Sevoflurane|sevoflurane|mesh-list
154047073|NCT02709863|Desflurane|desflurane|mesh-list
154047074|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154047075|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047076|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047077|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154047078|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
154047079|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
154047080|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154047081|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154047082|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
154047083|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154047084|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047085|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154047086|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047087|NCT02619786|Colistin|colistin|mesh-list
154047088|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154047089|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047090|NCT00697086|Dronedarone|dronedarone|mesh-list
154047091|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154047092|NCT04066660|Fucoidan|fucoidan|mesh-list
154047093|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154047094|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047095|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
154047096|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047097|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
154047098|NCT00697164|Hematinics|hematinics|mesh-ancestor
154047099|NCT00694980|Etrolizumab|etrolizumab|mesh-list
154047100|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047101|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
154047102|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047103|NCT00612755|Ribavirin|ribavirin|mesh-list
154047104|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154047133|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047134|NCT00732784|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154047135|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154047137|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047138|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047139|NCT00732784|Antacids|antacids|mesh-ancestor
154047140|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047141|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154047142|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
154047143|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154157369|NCT05845814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047144|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047145|NCT02947126|Antidotes|antidotes|mesh-ancestor
154047146|NCT02947126|Protective Agents|protective agents|mesh-ancestor
154047147|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047148|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
154047149|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
154047150|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154047180|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047181|NCT00529789|Analgesics|analgesics|mesh-ancestor
154047182|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
154047183|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047184|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
154047185|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154047186|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
154047187|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154047188|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154047189|NCT00611819|Interferons|interferons|mesh-list
154047190|NCT00611819|Ribavirin|ribavirin|mesh-list
154047191|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154047192|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
154047193|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047217|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
154047219|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047220|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047221|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
154047222|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047223|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154047224|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
154047225|NCT04018690|Hormones|hormones|mesh-ancestor
154047226|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047227|NCT00697866|Vaccines|vaccines|mesh-list
154047228|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
154047229|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456176|NCT03584373|Narcotics|narcotics|mesh-ancestor
154047230|NCT00733564|Lidocaine|lidocaine|mesh-list
154047231|NCT00733564|Propofol|propofol|mesh-list
154047232|NCT00733564|Sevoflurane|sevoflurane|mesh-list
154047233|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
154047234|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
154047235|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047236|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047237|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
154047238|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047239|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154047240|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154047253|NCT01007695|Valproic Acid|valproic acid|mesh-list
154047254|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
154047255|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047256|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047257|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
154047258|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047259|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047260|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
154047261|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154047262|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047263|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154047264|NCT02709473|Remifentanil|remifentanil|mesh-list
154047265|NCT02709473|Propofol|propofol|mesh-list
154047266|NCT02709473|Rocuronium|rocuronium|mesh-list
154047267|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154047268|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047269|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047270|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154047271|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
154047272|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
154047273|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154047274|NCT02709473|Narcotics|narcotics|mesh-ancestor
154047275|NCT02709473|Analgesics|analgesics|mesh-ancestor
154047276|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
154047277|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047278|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154047279|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154047280|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154047281|NCT00866658|Insulin|insulin|mesh-list
154047282|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154047283|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047284|NCT02615340|Melatonin|melatonin|mesh-list
154047285|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
154047286|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047287|NCT02615340|Protective Agents|protective agents|mesh-ancestor
154047288|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047289|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047290|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154047291|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047292|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
154047293|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047294|NCT04899791|Protective Agents|protective agents|mesh-ancestor
154047295|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047296|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154047297|NCT02615106|Endostar protein|endostar protein|mesh-list
154047298|NCT02615106|Endostatins|endostatins|mesh-list
154047299|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154047300|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154047301|NCT02615106|Growth Substances|growth substances|mesh-ancestor
154047336|NCT00733720|Buprenorphine|buprenorphine|mesh-list
154047337|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154047338|NCT00733720|Naloxone|naloxone|mesh-list
154047339|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154047340|NCT00733720|Narcotics|narcotics|mesh-ancestor
154047341|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047342|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047343|NCT00733720|Analgesics|analgesics|mesh-ancestor
154047344|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
154047400|NCT05730673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047401|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
154047402|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154047403|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
154047404|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047405|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047406|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154047407|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
154047408|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154047409|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
154047410|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047411|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047412|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154047413|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
154047414|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
154047415|NCT04134078|Protective Agents|protective agents|mesh-ancestor
154047416|NCT00738556|Sirolimus|sirolimus|mesh-list
154047417|NCT00738556|Paclitaxel|paclitaxel|mesh-list
154047418|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154047419|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047420|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154047421|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154047422|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154047423|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047424|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154047425|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047426|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154047427|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
154047428|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154047429|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
154047430|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047431|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
154047459|NCT00657488|Growth Substances|growth substances|mesh-ancestor
154047460|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
154047461|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047462|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154047463|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154047464|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154047465|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047466|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047467|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
154047468|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047469|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047470|NCT00712270|Risperidone|risperidone|mesh-list
154047471|NCT00712270|Aripiprazole|aripiprazole|mesh-list
154047472|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154047473|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
154047474|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047475|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047476|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047477|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154047478|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154047499|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154047500|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154047501|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
154047502|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047503|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047504|NCT00695604|Fluticasone|fluticasone|mesh-list
154047505|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154047506|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154047507|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
154047508|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047509|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047510|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154047511|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
154047512|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
154047513|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154047514|NCT00654524|Vitamin D|vitamin d|mesh-list
154047515|NCT00654524|Goserelin|goserelin|mesh-list
154047516|NCT00654524|Hormones|hormones|mesh-list
154047517|NCT00654524|Vitamins|vitamins|mesh-ancestor
154047518|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
154047519|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047520|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154047521|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047522|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154047523|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047524|NCT05260619|Lenalidomide|lenalidomide|mesh-list
154047525|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
154047526|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047527|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154047528|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154047529|NCT05260619|Growth Substances|growth substances|mesh-ancestor
154047530|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
154047545|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154047546|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154047547|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047548|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047549|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
154047550|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047551|NCT00738868|Cetuximab|cetuximab|mesh-list
154047552|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154047553|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047554|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154047555|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
154047556|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154047557|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154047558|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047559|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047560|NCT00657644|Urological Agents|urological agents|mesh-ancestor
154047561|NCT00869778|Vaccines|vaccines|mesh-list
154047562|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
154047563|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047564|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
154047565|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154047566|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154047567|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154047568|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
154047569|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047570|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047571|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047572|NCT04162028|Ketamine|ketamine|mesh-list
154047573|NCT04162028|Analgesics|analgesics|mesh-ancestor
154047574|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
154047575|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047576|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047577|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154047578|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154047579|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
154047580|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
154047581|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047582|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154047583|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154047584|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047585|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047586|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
154047587|NCT00656786|Vitamin K|vitamin k|mesh-list
154047588|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154047589|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154047606|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
154047607|NCT00734890|Bevacizumab|bevacizumab|mesh-list
154047608|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154047609|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047610|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153590278|NCT01812538|Diclofenac|diclofenac|mesh-list
154047611|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154047613|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047614|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
154047615|NCT05325190|Granisetron|granisetron|mesh-list
154047616|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
154047617|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
154047618|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047619|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047620|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047621|NCT05325190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154047622|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154047623|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
154047624|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047625|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047626|NCT02624310|Droxidopa|droxidopa|mesh-list
154047628|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154047629|NCT00612521|Adenosine|adenosine|mesh-list
154047630|NCT00612521|Analgesics|analgesics|mesh-ancestor
154047631|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
154047632|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047633|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047634|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154047635|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
154047636|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154047637|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
154047638|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
154047639|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047640|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047641|NCT00735124|Gabapentin|gabapentin|mesh-list
154047642|NCT00735124|Analgesics|analgesics|mesh-ancestor
154047643|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
154047644|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047645|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047646|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
154047647|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154047648|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154047649|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047705|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047706|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047707|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
154047708|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047710|NCT00711880|Analgesics|analgesics|mesh-ancestor
154047711|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
154047712|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047713|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047714|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
154047715|NCT02693483|Povidone|povidone|mesh-list
154047716|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
154047717|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
154047718|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154047719|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047720|NCT04873063|Beclomethasone|beclomethasone|mesh-list
154047721|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154047722|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
154047723|NCT04873063|Hormones|hormones|mesh-ancestor
154047724|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047725|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047726|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154047727|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
154047728|NCT00739414|Panobinostat|panobinostat|mesh-list
154047729|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047730|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154047731|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047732|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047733|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
154047734|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
154047735|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154047736|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047737|NCT00735280|Heparin|heparin|mesh-list
154047738|NCT00735280|Calcium heparin|calcium heparin|mesh-list
154047756|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047757|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047759|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
154047760|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047761|NCT00613145|Capecitabine|capecitabine|mesh-list
154047762|NCT00613145|Sorafenib|sorafenib|mesh-list
154047763|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154047764|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
154047765|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047766|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047767|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154047768|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047769|NCT04570085|Caffeine|caffeine|mesh-list
154047770|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154047771|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047772|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154047773|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047774|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047776|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154047777|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
154047778|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047779|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154047780|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
154047781|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154047782|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
154047783|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047784|NCT00529399|Antacids|antacids|mesh-ancestor
154047785|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047786|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047787|NCT05268419|Ethanol|ethanol|mesh-list
154047788|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154047789|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047790|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047829|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047830|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
154047831|NCT00613457|Hormones|hormones|mesh-ancestor
154047832|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047847|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
154047848|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047849|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
154047850|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
154047851|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
154047852|NCT04131582|Metformin|metformin|mesh-list
154047853|NCT04131582|Empagliflozin|empagliflozin|mesh-list
154047854|NCT04131582|Linagliptin|linagliptin|mesh-list
154047855|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154047856|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047857|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154047858|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047859|NCT04131582|Incretins|incretins|mesh-ancestor
154047860|NCT04131582|Hormones|hormones|mesh-ancestor
154047861|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047862|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154047863|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
154047864|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047865|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154047866|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
154047867|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154047868|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154047869|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154047870|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047871|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047872|NCT00695994|Carboplatin|carboplatin|mesh-list
154047873|NCT00695994|Gemcitabine|gemcitabine|mesh-list
154047874|NCT00695994|Docetaxel|docetaxel|mesh-list
154047875|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047876|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154047877|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
154047878|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047879|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
154047880|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
154047881|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
154047882|NCT00711802|Daptomycin|daptomycin|mesh-list
154047883|NCT00711802|Cloxacillin|cloxacillin|mesh-list
154047884|NCT00711802|Oxacillin|oxacillin|mesh-list
154047885|NCT00711802|Nafcillin|nafcillin|mesh-list
154047886|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154047887|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047888|NCT00851877|Paclitaxel|paclitaxel|mesh-list
154047889|NCT00851877|Cetuximab|cetuximab|mesh-list
154047890|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154047891|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047892|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
154047893|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
154047914|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
154047915|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154047916|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154047917|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154047918|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047919|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047920|NCT03580967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154047921|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154047922|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047923|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047924|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047926|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154047927|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154047928|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154047929|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154047930|NCT00851799|Ritonavir|ritonavir|mesh-list
154047931|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154047932|NCT00851799|Darunavir|darunavir|mesh-list
154047933|NCT00851799|Tenofovir|tenofovir|mesh-list
154047934|NCT00851799|Emtricitabine|emtricitabine|mesh-list
154047935|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
154047936|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154047937|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154047938|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154047939|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
154047940|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047941|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047942|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154047943|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154047944|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
154047945|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047946|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154047983|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047984|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047985|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154047986|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
154048012|NCT02634476|Ethanol|ethanol|mesh-list
154048013|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154048014|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048015|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048016|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048017|NCT04385303|Lorecivivint|lorecivivint|mesh-list
154048018|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154048019|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154048020|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154048021|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154048022|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
154048023|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048024|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154048025|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154048026|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048027|NCT00740194|Estradiol|estradiol|mesh-list
154048028|NCT00740194|Estrogens|estrogens|mesh-ancestor
154048029|NCT00740194|Hormones|hormones|mesh-ancestor
154048030|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048031|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048032|NCT04159142|Paclitaxel|paclitaxel|mesh-list
154048033|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154048034|NCT04159142|Carboplatin|carboplatin|mesh-list
154048035|NCT04159142|Capecitabine|capecitabine|mesh-list
154048036|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154048037|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048062|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154048064|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154048065|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048066|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154048067|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048068|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048069|NCT04064632|Darunavir|darunavir|mesh-list
154048070|NCT04064632|Cobicistat|cobicistat|mesh-list
154048071|NCT04064632|Rilpivirine|rilpivirine|mesh-list
154048072|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154048073|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154048074|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154048075|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
154048076|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048077|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048078|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154048079|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154048080|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
154048081|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048082|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154048083|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154048084|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154048085|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154048086|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
154048087|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154048115|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
154048116|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154048117|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154048118|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154048119|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154048120|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
154048121|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154048122|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154048123|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
154048124|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048125|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154048126|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154048127|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048128|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048129|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154048131|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
154048132|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
154048133|NCT00636935|Dapsone|dapsone|mesh-list
154048134|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154048167|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154048168|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154048169|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048170|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
154048171|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
154048172|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
154048173|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048174|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154048175|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154048176|NCT00654758|Growth Substances|growth substances|mesh-ancestor
154048190|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154048191|NCT04298099|Ropivacaine|ropivacaine|mesh-list
154048192|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
154048193|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
154048194|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048195|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048196|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
154048197|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048198|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154048199|NCT00850395|Maraviroc|maraviroc|mesh-list
154048200|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154048201|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154048202|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048204|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153813446|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153359911|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
154048205|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
154048206|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048207|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154048208|NCT04188431|Dexamethasone|dexamethasone|mesh-list
154048209|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154048210|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
154048211|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
154048212|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048213|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048214|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154048215|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
154048217|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048218|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154048219|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048220|NCT03630809|Vaccines|vaccines|mesh-list
154048221|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
154048222|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048223|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
154048224|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
154048225|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154048226|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048227|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048228|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154048230|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154048231|NCT00736294|Ramipril|ramipril|mesh-list
154048232|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154048233|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
154048234|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048235|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048236|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154048237|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
154048238|NCT00512707|Testosterone|testosterone|mesh-list
154048263|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154048264|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048265|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
154048266|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
154048267|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154048268|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154048269|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154048271|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154048272|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154048273|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048274|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048275|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048276|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048277|NCT00849693|Analgesics|analgesics|mesh-ancestor
154048278|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
154048279|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048280|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
154048281|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154048282|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
154048283|NCT00849693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154048343|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048344|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048345|NCT00913419|Amitriptyline|amitriptyline|mesh-list
154048346|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
154048347|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154048348|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
154048349|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154048350|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154048351|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048352|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154048353|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048354|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154048355|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048356|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154048357|NCT00913419|Analgesics|analgesics|mesh-ancestor
154048358|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
154048359|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154048360|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154048361|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048362|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048363|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
154048395|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154048396|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154048397|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154048398|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
154048399|NCT00614471|Entecavir|entecavir|mesh-list
154048400|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
154048401|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048402|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
154048403|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048404|NCT05742256|Sufentanil|sufentanil|mesh-list
154048405|NCT05742256|Oxycodone|oxycodone|mesh-list
154048406|NCT05742256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154048407|NCT05742256|Narcotics|narcotics|mesh-ancestor
154048408|NCT05742256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048409|NCT05742256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048410|NCT05742256|Analgesics|analgesics|mesh-ancestor
154048440|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
154048441|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048442|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048445|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154048446|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154048447|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
154048449|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
154048450|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048451|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154048452|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
154048453|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
154048454|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154048455|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154048456|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048457|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
154048458|NCT00827931|Coagulants|coagulants|mesh-ancestor
154048496|NCT00827775|Carvedilol|carvedilol|mesh-list
154048521|NCT02544308|Hormones|hormones|mesh-ancestor
154048522|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048523|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154048524|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048525|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
154048526|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154048527|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154048528|NCT02544308|Growth Substances|growth substances|mesh-ancestor
154048529|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
154048530|NCT00707187|Tadalafil|tadalafil|mesh-list
154048531|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048532|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154048533|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154048534|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048535|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048536|NCT00707187|Urological Agents|urological agents|mesh-ancestor
154048537|NCT03998761|Progesterone|progesterone|mesh-list
154048538|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
154048539|NCT03998761|Progestins|progestins|mesh-ancestor
154048540|NCT03998761|Hormones|hormones|mesh-ancestor
154048541|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048542|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048543|NCT00658580|Etoposide|etoposide|mesh-list
154048544|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
154048545|NCT00658580|Epirubicin|epirubicin|mesh-list
154048546|NCT00658580|Ifosfamide|ifosfamide|mesh-list
154048572|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048573|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154048575|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048576|NCT03916601|Insulin|insulin|mesh-list
154048577|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154048578|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
154048579|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
153591246|NCT01818869|Adenosine|adenosine|mesh-list
154048580|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154048581|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048582|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048583|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154048584|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154048585|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154048586|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048587|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048588|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154048589|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154048590|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154048626|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154048656|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154048657|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048658|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048659|NCT00880334|Docetaxel|docetaxel|mesh-list
154048660|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048661|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
154048662|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
154048663|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
154048664|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048665|NCT00658892|Antibodies|antibodies|mesh-list
154048666|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
154048667|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048668|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154048685|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048686|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154048687|NCT02623920|Rituximab|rituximab|mesh-list
154048688|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154048689|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154048690|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154048691|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048692|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
154048693|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048694|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154048695|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154048696|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
154048697|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048698|NCT02623920|Immunotoxins|immunotoxins|mesh-ancestor
154048699|NCT02623920|Immunoconjugates|immunoconjugates|mesh-ancestor
154048700|NCT00525499|Androgens|androgens|mesh-list
154048701|NCT00525499|Hormones|hormones|mesh-ancestor
154048702|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048703|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048704|NCT04576546|Inositol|inositol|mesh-list
154048705|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
154048706|NCT04576546|Vitamins|vitamins|mesh-ancestor
154048707|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
154048708|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048709|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
154048710|NCT02617680|Desflurane|desflurane|mesh-list
154048711|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154048712|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
154048713|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048714|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048715|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154048716|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
154048717|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154048718|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
154048719|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048720|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048721|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154048722|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048723|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
153591394|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048724|NCT02617680|Protective Agents|protective agents|mesh-ancestor
154048725|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154048726|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
154048747|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048748|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154048749|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154048750|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154048751|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154048752|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048753|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154048754|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154048755|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048756|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
154048757|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
154048758|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
154048759|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154048760|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048761|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048762|NCT02617758|Fentanyl|fentanyl|mesh-list
154048763|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154048764|NCT02617758|Narcotics|narcotics|mesh-ancestor
154048765|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048766|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048767|NCT02617758|Analgesics|analgesics|mesh-ancestor
154048768|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
154048769|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048770|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154048771|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154048772|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
154048773|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
154048774|NCT00737542|Lidocaine|lidocaine|mesh-list
153456387|NCT01208662|Hormones|hormones|mesh-ancestor
154048775|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154048776|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
154048777|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048778|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048779|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
154048780|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048781|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154048816|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154048817|NCT00660062|Dexetimide|dexetimide|mesh-list
154048818|NCT00660062|Citalopram|citalopram|mesh-list
154048819|NCT00660062|Nortriptyline|nortriptyline|mesh-list
154048820|NCT00660062|Escitalopram|escitalopram|mesh-list
154048839|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154048840|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154048842|NCT04063540|Amiloride|amiloride|mesh-list
154048843|NCT04063540|Diuretics|diuretics|mesh-ancestor
154048844|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
154048845|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048846|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154048847|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154048848|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048849|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048850|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154048851|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154048852|NCT04161560|Cetuximab|cetuximab|mesh-list
154048853|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154048854|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048855|NCT00518011|Gemcitabine|gemcitabine|mesh-list
154048856|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154048857|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154048858|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
154048859|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048860|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048861|NCT00518011|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154048862|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154048863|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048864|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
154048865|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
154048866|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154048867|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048868|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048869|NCT02633930|Amoxicillin|amoxicillin|mesh-list
154048870|NCT02633930|Clarithromycin|clarithromycin|mesh-list
154048898|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154048899|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154048900|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154048901|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154048902|NCT04161482|Furosemide|furosemide|mesh-list
154048903|NCT04161482|Diuretics|diuretics|mesh-ancestor
154048904|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
154048905|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048906|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154048907|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048908|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048909|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
154048910|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048911|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048912|NCT02633696|Silybin|silybin|mesh-list
154048913|NCT02633696|Silymarin|silymarin|mesh-list
154048914|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
154048915|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048916|NCT02633696|Protective Agents|protective agents|mesh-ancestor
154048963|NCT00517933|Urological Agents|urological agents|mesh-ancestor
154048965|NCT02633384|SMOFlipid|smoflipid|mesh-list
154048966|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154048967|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154048968|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154048969|NCT02633384|Cathartics|cathartics|mesh-ancestor
154048970|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154048971|NCT02633462|Inositol|inositol|mesh-list
153456405|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
154048972|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
154048973|NCT02633462|Vitamins|vitamins|mesh-ancestor
154048974|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
154048975|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048976|NCT02638064|Surgiflo|surgiflo|mesh-list
154048977|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
154048978|NCT02638064|Coagulants|coagulants|mesh-ancestor
154048979|NCT00655148|Vaccines|vaccines|mesh-list
154048980|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
154048981|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048982|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154048983|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154048984|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
154048985|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048986|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048987|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154048988|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
154048989|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
154048990|NCT00857766|Hormones|hormones|mesh-ancestor
154048991|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048992|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
154048993|NCT04161404|Metformin|metformin|mesh-list
154048994|NCT04161404|Andrographolide|andrographolide|mesh-list
154048995|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048996|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048997|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154048998|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154048999|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154049000|NCT04161404|Analgesics|analgesics|mesh-ancestor
154049001|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
154049002|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049003|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049004|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154049005|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154049006|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049007|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
154049008|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154049009|NCT00517699|Cytarabine|cytarabine|mesh-list
154049010|NCT00517699|Rituximab|rituximab|mesh-list
154049011|NCT00517699|Methotrexate|methotrexate|mesh-list
154049012|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049013|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049137|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049138|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049139|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049140|NCT02614482|Urological Agents|urological agents|mesh-ancestor
154049141|NCT04713709|Naloxone|naloxone|mesh-list
154049142|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154049143|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049144|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
154049145|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049146|NCT00879710|Simvastatin|simvastatin|mesh-list
154049147|NCT00879710|Ezetimibe|ezetimibe|mesh-list
154049148|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154049149|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154049150|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
154049170|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049171|NCT00597506|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154049172|NCT00597506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049173|NCT00597506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049174|NCT00597506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049175|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049176|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
154049177|NCT03393611|Cytarabine|cytarabine|mesh-list
154049178|NCT03393611|Fludarabine|fludarabine|mesh-list
154049179|NCT03393611|Melphalan|melphalan|mesh-list
154049180|NCT03393611|Daunorubicin|daunorubicin|mesh-list
154049181|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
154049182|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049183|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049184|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
154049185|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049186|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049187|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
154049188|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049189|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
154049190|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049191|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154049192|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
154049193|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154049194|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154049195|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154049196|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154049197|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049198|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
154049199|NCT04032548|Propolis|propolis|mesh-list
154049200|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154049201|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049202|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
154049203|NCT04032236|Caffeine|caffeine|mesh-list
154049235|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
154049236|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049237|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
154049238|NCT02632916|Denosumab|denosumab|mesh-list
154049239|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154049240|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049241|NCT00881504|Bevacizumab|bevacizumab|mesh-list
154049242|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049243|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049269|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154049270|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154049271|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049272|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049273|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154049274|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154049275|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154049276|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154049277|NCT02632136|Bupivacaine|bupivacaine|mesh-list
154049278|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
154049279|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
154049280|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049281|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049282|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
154049283|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049284|NCT00660920|Ponatinib|ponatinib|mesh-list
154049285|NCT00660920|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154049286|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049287|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049288|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049289|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049290|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
154049315|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049316|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049317|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154049318|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154049319|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049320|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
154049321|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049322|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154049323|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
154049324|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154049325|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154049326|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049327|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049328|NCT00660998|Urological Agents|urological agents|mesh-ancestor
154049329|NCT00657254|Sorafenib|sorafenib|mesh-list
154049330|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049331|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049332|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049333|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049334|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
154049335|NCT01455389|Promethazine|promethazine|mesh-list
154049336|NCT01455389|Dexamethasone|dexamethasone|mesh-list
154049337|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154049338|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154049339|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
154049340|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
154049341|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049342|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049343|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154049377|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154049378|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
154049379|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154049380|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154049381|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049382|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049383|NCT00661700|Urological Agents|urological agents|mesh-ancestor
154049385|NCT00613769|Trimethoprim|trimethoprim|mesh-list
154049436|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154049437|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
154049439|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154049440|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154049441|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049442|NCT00523549|Amlodipine|amlodipine|mesh-list
154049443|NCT00523549|Valsartan|valsartan|mesh-list
154049444|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154049445|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154049446|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154049447|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049448|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154049449|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049450|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
154049451|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154049452|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154049453|NCT04215653|Rabeprazole|rabeprazole|mesh-list
154049454|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154049455|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154049456|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154049457|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049458|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049459|NCT02706119|Insulin|insulin|mesh-list
154049520|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154049521|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154049522|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049523|NCT02704013|Oxybutynin|oxybutynin|mesh-list
154049524|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
154049525|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
154049526|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049527|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049528|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154049529|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154049530|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
154049531|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049532|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049533|NCT02704013|Urological Agents|urological agents|mesh-ancestor
154049534|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
154049535|NCT00665990|Bevacizumab|bevacizumab|mesh-list
154049536|NCT00665990|Sorafenib|sorafenib|mesh-list
154049559|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049560|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049561|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049562|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049563|NCT00700102|Growth Substances|growth substances|mesh-ancestor
154049564|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049565|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049566|NCT02705729|Methamphetamine|methamphetamine|mesh-list
154049567|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154049568|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049569|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
154049570|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
154049571|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049572|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
154049573|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049579|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154049581|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154049582|NCT02705573|Diuretics|diuretics|mesh-ancestor
154049583|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
154049584|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049585|NCT00613847|Trastuzumab|trastuzumab|mesh-list
154049586|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154049587|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049588|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049589|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049590|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
154049591|NCT00516295|Bevacizumab|bevacizumab|mesh-list
154049592|NCT00516295|Vincristine|vincristine|mesh-list
154049593|NCT00516295|Topotecan|topotecan|mesh-list
154049594|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154049595|NCT00516295|Antibodies|antibodies|mesh-list
154049596|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
154049597|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154049598|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049599|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
154049600|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049601|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049602|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154049603|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
154049604|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049605|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049606|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154049607|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049608|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049609|NCT00516295|Growth Substances|growth substances|mesh-ancestor
154049610|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049611|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154049612|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
154049613|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
154049614|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
154049615|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154049616|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154049617|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049618|NCT03362099|Bupropion|bupropion|mesh-list
154049619|NCT03362099|Varenicline|varenicline|mesh-list
154049620|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154049642|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049643|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049644|NCT00738088|Gliclazide|gliclazide|mesh-list
154049645|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154049646|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049647|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
154049648|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154049649|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
154049650|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
154049651|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049652|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049653|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154049654|NCT02703233|Analgesics|analgesics|mesh-ancestor
154049655|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
154049656|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049657|NCT04062760|Diuretics|diuretics|mesh-list
154049658|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
154049659|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049660|NCT02702843|Xenon|xenon|mesh-list
154049661|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154049662|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
154049663|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
154049664|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049665|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049666|NCT00516139|Lamotrigine|lamotrigine|mesh-list
154049696|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049697|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154049698|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049699|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
154049700|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154049701|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049702|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049703|NCT02630888|Memantine|memantine|mesh-list
154049704|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154049705|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154049706|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
154049707|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049708|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049709|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049710|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154049731|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049733|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049734|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049735|NCT00671372|Growth Substances|growth substances|mesh-ancestor
154049736|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049737|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049738|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154049739|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154049740|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049741|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049742|NCT00856986|Metformin|metformin|mesh-list
154049743|NCT00856986|Liraglutide|liraglutide|mesh-list
154049744|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
154049745|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154049746|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049747|NCT00856986|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154049748|NCT00856986|Incretins|incretins|mesh-ancestor
154049749|NCT00856986|Hormones|hormones|mesh-ancestor
154049750|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049751|NCT00666692|Paclitaxel|paclitaxel|mesh-list
154049752|NCT00666692|Bevacizumab|bevacizumab|mesh-list
154049753|NCT00666692|Carboplatin|carboplatin|mesh-list
154049754|NCT00666692|Volociximab|volociximab|mesh-list
154049755|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154049756|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154049757|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049758|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
154049759|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
154049760|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
154049761|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049762|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049763|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049764|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049765|NCT00666692|Growth Substances|growth substances|mesh-ancestor
154049793|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
154049794|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049795|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
154049796|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
154049797|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049799|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049800|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049801|NCT00667082|Vorinostat|vorinostat|mesh-list
154049802|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154049803|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
154049804|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049805|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049806|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049807|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
154049808|NCT05343299|Lidocaine|lidocaine|mesh-list
154049809|NCT05343299|Ropivacaine|ropivacaine|mesh-list
154049810|NCT05343299|Anesthetics|anesthetics|mesh-list
154049811|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
154049812|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049813|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049823|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049824|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
154049825|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049826|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154049827|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049828|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049829|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154049830|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154049831|NCT00667160|Analgesics|analgesics|mesh-ancestor
154049832|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
154049833|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049834|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154049835|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049836|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049837|NCT02701673|Pyridoxine|pyridoxine|mesh-list
154049838|NCT02701673|Gemcitabine|gemcitabine|mesh-list
154049839|NCT02701673|Azacitidine|azacitidine|mesh-list
154049840|NCT02701673|Melphalan|melphalan|mesh-list
154049841|NCT02701673|Busulfan|busulfan|mesh-list
153592510|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
154049843|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049845|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049846|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049847|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049848|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154049849|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
154049850|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154049851|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049852|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
154049853|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049854|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
154049855|NCT02701673|Vitamins|vitamins|mesh-ancestor
154049856|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
154049857|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154049858|NCT00522379|Rotigotine|rotigotine|mesh-list
154049859|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
154049860|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
154049861|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049862|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049863|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049864|NCT00856830|Carboplatin|carboplatin|mesh-list
154049865|NCT00856830|Irinotecan|irinotecan|mesh-list
154049866|NCT00856830|Etoposide|etoposide|mesh-list
154049867|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154049868|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049869|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154049870|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154049871|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049872|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049873|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154049874|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154049891|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049892|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049893|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049895|NCT00662636|Lapatinib|lapatinib|mesh-list
154049896|NCT00662636|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154049897|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049898|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049899|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049900|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049901|NCT00506389|Mirtazapine|mirtazapine|mesh-list
154049902|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
154049903|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154049904|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154049905|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
154049906|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
154049907|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049908|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049909|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049910|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154049911|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154049912|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049913|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154049914|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154049915|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154049916|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
154049917|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154049918|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154049919|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
154049920|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154049921|NCT00667472|Ranibizumab|ranibizumab|mesh-list
154049922|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049923|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049924|NCT00667472|Growth Substances|growth substances|mesh-ancestor
154049925|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049926|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049927|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049928|NCT00662714|Insulin|insulin|mesh-list
154049929|NCT00662714|Repaglinide|repaglinide|mesh-list
154049930|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154049931|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
154049932|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154049933|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050041|NCT02701595|Penicillins|penicillins|mesh-list
154050042|NCT02701595|Penicillin G|penicillin g|mesh-list
154050043|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154050044|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
154050045|NCT02701595|Netilmicin|netilmicin|mesh-list
154050046|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050047|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050048|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154050049|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050050|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050051|NCT02701595|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154050052|NCT02701595|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154050053|NCT02698553|Bupropion|bupropion|mesh-list
154050054|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154050055|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
154050056|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154050057|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154050058|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154050059|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154050060|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050061|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
154050062|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050063|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050064|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154050065|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154050066|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050163|NCT02701127|Niacin|niacin|mesh-list
154050164|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
154050165|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
154050166|NCT02701127|Vitamins|vitamins|mesh-ancestor
154050167|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
154050168|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050169|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154050170|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
154050171|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050172|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154050173|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
154050174|NCT02700893|Atropine|atropine|mesh-list
154050175|NCT02700893|Sufentanil|sufentanil|mesh-list
154050176|NCT02700893|Propofol|propofol|mesh-list
154050177|NCT02700893|Atracurium|atracurium|mesh-list
154050178|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154050199|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
154050200|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050201|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050202|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154050203|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154050204|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154050205|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154050207|NCT04213781|Propofol|propofol|mesh-list
154050208|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154050209|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050210|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050211|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154050212|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
154050213|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
154050214|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154050216|NCT04213781|Analgesics|analgesics|mesh-ancestor
154050217|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
153592899|NCT01833221|Lidocaine|lidocaine|mesh-list
154050218|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050219|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154050220|NCT00505687|Rotigotine|rotigotine|mesh-list
154050221|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
154050222|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
154050223|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050354|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
154050355|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050356|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050357|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154050358|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154050359|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
154050360|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050362|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154050363|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154050364|NCT02697851|Estrogens|estrogens|mesh-ancestor
154050365|NCT02697851|Hormones|hormones|mesh-ancestor
154050366|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050367|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154050368|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154050369|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154050370|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154050371|NCT01012843|Amoxicillin|amoxicillin|mesh-list
154050372|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
154050373|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
154050374|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154050375|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050376|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050404|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154050405|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154050406|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154050407|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154050408|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
154050409|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050410|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050411|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154050413|NCT00669890|Immunoconjugates|immunoconjugates|mesh-ancestor
154050414|NCT02697929|Neostigmine|neostigmine|mesh-list
154050415|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154050416|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050417|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050418|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
154050419|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050420|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050421|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154050422|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
154050423|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050424|NCT00505375|Abatacept|abatacept|mesh-list
154050479|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050480|NCT02701205|Etanercept|etanercept|mesh-list
154050481|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154050482|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154050483|NCT02701205|Analgesics|analgesics|mesh-ancestor
154050484|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
154050485|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050486|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050487|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154050488|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154050489|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050490|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050491|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
154050492|NCT00670436|Paclitaxel|paclitaxel|mesh-list
154050493|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154050494|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154050495|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050496|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154050497|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154050498|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154050499|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050500|NCT02699879|Pirfenidone|pirfenidone|mesh-list
154050501|NCT02699879|Analgesics|analgesics|mesh-ancestor
154050502|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
154050503|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050504|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050505|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154050506|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154050530|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050531|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154050532|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050533|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
154050534|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154050535|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154050536|NCT02699645|Diuretics|diuretics|mesh-ancestor
154050537|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
154050538|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154050539|NCT04152434|Erenumab|erenumab|mesh-list
154050540|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154050541|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050542|NCT04152434|Analgesics|analgesics|mesh-ancestor
154050543|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
154050544|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050545|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050546|NCT00615797|Penicillins|penicillins|mesh-list
154050547|NCT00615797|Penicillin V|penicillin v|mesh-list
154050548|NCT00615797|Haloperidol|haloperidol|mesh-list
154050549|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
154050550|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
154050551|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154050552|NCT00615797|Antibodies|antibodies|mesh-list
154050553|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
154050573|NCT00705016|Cetuximab|cetuximab|mesh-list
154050574|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050575|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
154050576|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050577|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154050578|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050579|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
154050580|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050581|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154050582|NCT00595868|Varenicline|varenicline|mesh-list
154050583|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154050584|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154050585|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
154050586|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050587|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050588|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050589|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
154050590|NCT02699801|Propofol|propofol|mesh-list
154050591|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154050592|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593258|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
154050593|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050594|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154050595|NCT02699801|Analgesics|analgesics|mesh-ancestor
154050596|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
154050597|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050598|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154050599|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154050600|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154050601|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
154050602|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050603|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050604|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154050605|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
154050606|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
154050607|NCT02727907|Interferons|interferons|mesh-list
154050608|NCT02727907|Interferon-beta|interferon-beta|mesh-list
154050623|NCT01009801|Doxorubicin|doxorubicin|mesh-list
154050624|NCT01009801|Everolimus|everolimus|mesh-list
154050625|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154050626|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050627|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154050628|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154050629|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050630|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050631|NCT01009801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154050632|NCT01009801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154050633|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050634|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
154050635|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050636|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154050637|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154050638|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154050639|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154050641|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050642|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050643|NCT00617045|Analgesics|analgesics|mesh-ancestor
154050644|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
154050656|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050657|NCT01009879|Etanercept|etanercept|mesh-list
154050658|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154050659|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154050661|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
154050662|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050663|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050664|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154050665|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153593332|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
154050666|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050667|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050668|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
154050669|NCT01009957|Everolimus|everolimus|mesh-list
154050670|NCT01009957|MTOR Inhibitors|mtor inhibitors|mesh-list
154050671|NCT01009957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154050672|NCT01009957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050673|NCT01009957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050674|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050675|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
154050676|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050677|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050678|NCT04062370|Ranibizumab|ranibizumab|mesh-list
154050679|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154050680|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154050681|NCT04062370|Growth Substances|growth substances|mesh-ancestor
154050682|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050683|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
154050684|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050685|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
154050686|NCT01015183|Astringents|astringents|mesh-ancestor
154050687|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050688|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
154050689|NCT00856284|Metformin|metformin|mesh-list
154050690|NCT00856284|Alogliptin|alogliptin|mesh-list
154050691|NCT00856284|Glipizide|glipizide|mesh-list
154050692|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154050693|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050694|NCT00856284|Incretins|incretins|mesh-ancestor
154050695|NCT00856284|Hormones|hormones|mesh-ancestor
154050696|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050697|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154050698|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
154050699|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050700|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050733|NCT02622906|Hormones|hormones|mesh-ancestor
154050734|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050735|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050737|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154050738|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
154050739|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050740|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154050741|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
154050764|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
154050765|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050766|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154050767|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154050768|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050769|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154050770|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154050771|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154050772|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154050773|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
154050775|NCT04212533|Vitamins|vitamins|mesh-ancestor
154050776|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
154050777|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050778|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154050779|NCT04155554|Tenofovir|tenofovir|mesh-list
154050780|NCT04155554|Lamivudine|lamivudine|mesh-list
154050781|NCT04155554|Emtricitabine|emtricitabine|mesh-list
154050782|NCT04155554|Dolutegravir|dolutegravir|mesh-list
154050783|NCT04155554|Abacavir|abacavir|mesh-list
154050784|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154050785|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
154050786|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050787|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154050788|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154050789|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050790|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050791|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154050792|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154050793|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154050794|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154050795|NCT00663884|Voglibose|voglibose|mesh-list
154050796|NCT00663884|Mitiglinide|mitiglinide|mesh-list
154050811|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154050812|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154050813|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050814|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050815|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154050816|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154050817|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154050818|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050819|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154050821|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154050822|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050823|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050824|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
154050825|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443974|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
154050826|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050827|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050828|NCT00593112|Methylphenidate|methylphenidate|mesh-list
154050829|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154050830|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050831|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154050832|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154050833|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154050834|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050835|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
154050836|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050837|NCT05323565|Dexamethasone|dexamethasone|mesh-list
154050838|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
154050839|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154050840|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
154050841|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
154050842|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050843|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050844|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050845|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
154050846|NCT05323565|Hormones|hormones|mesh-ancestor
154050847|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050848|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154050849|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050909|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050910|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
154050911|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050912|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
154050913|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050914|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
154050915|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
154050916|NCT00674102|Vadimezan|vadimezan|mesh-list
154050917|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050918|NCT00503581|Megestrol|megestrol|mesh-list
154050919|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
154050920|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154050921|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154050922|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154050923|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
154050924|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154050925|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050926|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154050927|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154050990|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050993|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050994|NCT00664586|Protective Agents|protective agents|mesh-ancestor
154050995|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050996|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154050997|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050998|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154051001|NCT00664586|Analgesics|analgesics|mesh-ancestor
154051002|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
154051003|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051004|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051005|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051006|NCT00502801|Doripenem|doripenem|mesh-list
154051007|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154051008|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051009|NCT04154852|Folic Acid|folic acid|mesh-list
154051010|NCT04154852|Adalimumab|adalimumab|mesh-list
154051011|NCT04154852|Methotrexate|methotrexate|mesh-list
154051012|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154051013|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
154051014|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154051015|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051016|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154051017|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
154051018|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051019|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051020|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154051021|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051022|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154051023|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051024|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
154051025|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051026|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154051027|NCT04154852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154051028|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051029|NCT04154852|Hematinics|hematinics|mesh-ancestor
154051030|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
154051031|NCT04154852|Vitamins|vitamins|mesh-ancestor
154051032|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
154051033|NCT00921154|Ivermectin|ivermectin|mesh-list
154051034|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154051035|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051036|NCT01015651|Remifentanil|remifentanil|mesh-list
154051037|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154051038|NCT01015651|Narcotics|narcotics|mesh-ancestor
154051039|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051040|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051041|NCT01015651|Analgesics|analgesics|mesh-ancestor
154051042|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
154051043|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051044|NCT00674414|Trastuzumab|trastuzumab|mesh-list
154051045|NCT00674414|Everolimus|everolimus|mesh-list
154051089|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
154051090|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
154051091|NCT02628860|Hematinics|hematinics|mesh-ancestor
154051092|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154051093|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051094|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051095|NCT00855738|Topiramate|topiramate|mesh-list
154051096|NCT00855738|Pregabalin|pregabalin|mesh-list
154051097|NCT00855738|Lamotrigine|lamotrigine|mesh-list
154051098|NCT00855738|Zonisamide|zonisamide|mesh-list
154051099|NCT00855738|Gabapentin|gabapentin|mesh-list
154051100|NCT00855738|Levetiracetam|levetiracetam|mesh-list
154051101|NCT00855738|Tiagabine|tiagabine|mesh-list
154051102|NCT00855738|Analgesics|analgesics|mesh-ancestor
154051103|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
154051104|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051105|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051106|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
154051107|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154051135|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
154051136|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154051137|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154051138|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051139|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451812|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153359930|NCT02861573|Olaparib|olaparib|mesh-list
154051140|NCT00665054|Urological Agents|urological agents|mesh-ancestor
154051141|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
154051142|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
154051143|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051144|NCT02622672|Vitamins|vitamins|mesh-ancestor
154051145|NCT06157359|Ropivacaine|ropivacaine|mesh-list
154051146|NCT06157359|Anesthetics, Local|anesthetics, local|mesh-ancestor
154051170|NCT06157099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154051171|NCT06157099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154051172|NCT06157099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051173|NCT06156995|Mosapride|mosapride|mesh-list
154051174|NCT06156995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051175|NCT06156995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154051176|NCT06156995|Serotonin Agents|serotonin agents|mesh-ancestor
154051177|NCT06156995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051178|NCT06156995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051179|NCT06156995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051180|NCT06156878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154051181|NCT06156878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051182|NCT06156878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051183|NCT06156878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051185|NCT06156761|Mitoxantrone|mitoxantrone|mesh-list
154051186|NCT06156761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154051187|NCT06156761|Antimetabolites|antimetabolites|mesh-ancestor
154051188|NCT06156761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051189|NCT06156761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051190|NCT06156761|Analgesics|analgesics|mesh-ancestor
154051191|NCT06156761|Sensory System Agents|sensory system agents|mesh-ancestor
154051192|NCT06156761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051193|NCT06156761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051194|NCT06156761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154051195|NCT06156761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154051197|NCT06156709|Anesthetics|anesthetics|mesh-list
154051233|NCT06156085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154051234|NCT06156085|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154051235|NCT06156085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051236|NCT06156085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051261|NCT06151171|Micronutrients|micronutrients|mesh-ancestor
154051262|NCT06151171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051263|NCT06139380|Ketamine|ketamine|mesh-list
154051264|NCT06139380|Analgesics|analgesics|mesh-ancestor
154051265|NCT06139380|Sensory System Agents|sensory system agents|mesh-ancestor
154051266|NCT06139380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051267|NCT06139380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051268|NCT06139380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154051269|NCT06139380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154051270|NCT06139380|Anesthetics, General|anesthetics, general|mesh-ancestor
154051271|NCT06139380|Anesthetics|anesthetics|mesh-ancestor
154051272|NCT06139380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051273|NCT06139380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154051274|NCT06139380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154051275|NCT06139380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051276|NCT06139380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051277|NCT06134375|Pembrolizumab|pembrolizumab|mesh-list
154051278|NCT06134375|Capecitabine|capecitabine|mesh-list
154051279|NCT06134375|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
154051280|NCT06134375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051281|NCT06134375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051282|NCT06134375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153813467|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153813468|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
154051283|NCT06134375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051284|NCT06134375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154051285|NCT06134375|Antimetabolites|antimetabolites|mesh-ancestor
154051345|NCT06005662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154051349|NCT05996471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051350|NCT05996471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051351|NCT05996471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154051352|NCT05996471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154051353|NCT05996471|Antiviral Agents|antiviral agents|mesh-ancestor
154051354|NCT05996471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051356|NCT05974345|Evolocumab|evolocumab|mesh-list
154051357|NCT05974345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154051358|NCT05974345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154051359|NCT05974345|Antimetabolites|antimetabolites|mesh-ancestor
154051360|NCT05974345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051361|NCT05974345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154051362|NCT05974345|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154051363|NCT05974345|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154051364|NCT05974345|Protease Inhibitors|protease inhibitors|mesh-ancestor
154051365|NCT05974345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051366|NCT05952024|Rituximab|rituximab|mesh-list
154051367|NCT05952024|Acalabrutinib|acalabrutinib|mesh-list
154051393|NCT05930028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051394|NCT05930028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154051395|NCT05930028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154051396|NCT05930028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051397|NCT05899140|Clindamycin|clindamycin|mesh-list
154051398|NCT05899140|Clindamycin palmitate|clindamycin palmitate|mesh-list
154051399|NCT05899140|Clindamycin phosphate|clindamycin phosphate|mesh-list
154051400|NCT05899140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154051401|NCT05899140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051402|NCT05899140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154051403|NCT05899140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051404|NCT05899140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051405|NCT05893108|Triamcinolone|triamcinolone|mesh-list
154051406|NCT05893108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154051407|NCT05893108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154051408|NCT05893108|Losartan|losartan|mesh-list
154051409|NCT05893108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154051410|NCT05893108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051411|NCT05893108|Glucocorticoids|glucocorticoids|mesh-ancestor
154051412|NCT05893108|Hormones|hormones|mesh-ancestor
154051413|NCT05893108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051414|NCT05893108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051446|NCT05842330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154051447|NCT05842330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154051448|NCT05842330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051450|NCT05842330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051451|NCT05829655|Suvorexant|suvorexant|mesh-list
154051452|NCT05829655|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154051453|NCT05829655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154051486|NCT05625373|Vancomycin|vancomycin|mesh-list
154051487|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154051488|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051489|NCT05605366|Minocycline|minocycline|mesh-list
154051490|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154051491|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051492|NCT05588388|Bevacizumab|bevacizumab|mesh-list
154051493|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051494|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051532|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
154051569|NCT05292664|Cortisone|cortisone|mesh-list
154051570|NCT05292664|Doxorubicin|doxorubicin|mesh-list
154051571|NCT05292664|Methotrexate|methotrexate|mesh-list
154051572|NCT05292664|Vincristine|vincristine|mesh-list
154051573|NCT05292664|Azacitidine|azacitidine|mesh-list
154051574|NCT05292664|Venetoclax|venetoclax|mesh-list
154051575|NCT05292664|Asparaginase|asparaginase|mesh-list
154051576|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
154051600|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154051601|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154051602|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
154051603|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
154051604|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154051606|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
154051607|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051608|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154051609|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
154051610|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051611|NCT05292664|Antidotes|antidotes|mesh-ancestor
154051612|NCT05292664|Protective Agents|protective agents|mesh-ancestor
154051613|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
154051614|NCT05292664|Vitamins|vitamins|mesh-ancestor
154051615|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
154051616|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154051617|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
154051618|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
154051619|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
154051620|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154051621|NCT05257590|Nivolumab|nivolumab|mesh-list
154051622|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051623|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051624|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154051625|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051626|NCT05244057|Interferons|interferons|mesh-list
154051627|NCT05244057|Tenofovir|tenofovir|mesh-list
154051628|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
154051629|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
154051656|NCT05220462|Midazolam|midazolam|mesh-list
154051657|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154051658|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154051659|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051660|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051661|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154051662|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154051663|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154051664|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154051665|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
154051666|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
154051667|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
154051668|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
154051669|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051670|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051671|NCT05205603|Infliximab|infliximab|mesh-list
154051672|NCT05205603|Mesalamine|mesalamine|mesh-list
154051673|NCT05205603|Vedolizumab|vedolizumab|mesh-list
154051674|NCT05205603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154051675|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051676|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154051677|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051678|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051679|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154051741|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051743|NCT05018221|Vitamin K|vitamin k|mesh-list
154051744|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
154051745|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
154051746|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
154051747|NCT05018221|Citric Acid|citric acid|mesh-list
154051748|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
154051749|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
154051781|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051782|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154051783|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154051784|NCT04920539|Analgesics|analgesics|mesh-ancestor
154051785|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
154051786|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051787|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154051788|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154051789|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051790|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051792|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051793|NCT04894994|Ipilimumab|ipilimumab|mesh-list
154051823|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051824|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051825|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154051827|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051828|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
154051829|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154051830|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051831|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051832|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154051833|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154051834|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
154051835|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154051836|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051837|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
154051838|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
154051839|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051935|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051937|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
154051938|NCT04509115|Narcotics|narcotics|mesh-ancestor
154051939|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051940|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051942|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
154051943|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051944|NCT04469075|Clindamycin|clindamycin|mesh-list
154051945|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
154051946|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
154051947|NCT04469075|Triamcinolone|triamcinolone|mesh-list
154051948|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154051949|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154051950|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154051951|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051982|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051983|NCT04393350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154051984|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051985|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154051986|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051988|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051989|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051990|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154051991|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051992|NCT04341155|Dexamethasone|dexamethasone|mesh-list
154051993|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
154051994|NCT04341155|BB 1101|bb 1101|mesh-list
154052021|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
154052022|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052023|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594692|NCT01851473|Quinine|quinine|mesh-list
154052024|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154052025|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
154052026|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154052027|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
154052028|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052029|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052030|NCT04292873|Vitamin D|vitamin d|mesh-list
154052031|NCT04292873|Vitamins|vitamins|mesh-ancestor
154052032|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
154052033|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052034|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154052035|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
154052036|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052037|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052038|NCT04262089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154052039|NCT04262089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052040|NCT04225598|Buprenorphine|buprenorphine|mesh-list
154052041|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154052115|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052116|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
154052117|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052179|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154052180|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154052181|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154052182|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154052183|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052184|NCT03967977|Carboplatin|carboplatin|mesh-list
154052185|NCT03967977|Gemcitabine|gemcitabine|mesh-list
154052186|NCT03967977|Tislelizumab|tislelizumab|mesh-list
154052187|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052188|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052189|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
154052219|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052222|NCT03820193|Narcotics|narcotics|mesh-ancestor
154052223|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
154052224|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
154052225|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154052226|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
154052227|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
154052228|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154052229|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154052230|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154052231|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154052232|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154052233|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
154052234|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
154052235|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
154052359|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154052360|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052361|NCT03595917|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154052362|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052363|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052364|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052365|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
154052366|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052368|NCT03524235|Fludarabine|fludarabine|mesh-list
154052369|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154052370|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052371|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052372|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
154052373|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052374|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052375|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052376|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154052378|NCT03462342|Olaparib|olaparib|mesh-list
154052437|NCT03095781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052438|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154052524|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154052525|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052526|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154052527|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052528|NCT02598726|Curcumin|curcumin|mesh-list
154052529|NCT02598726|Piperine|piperine|mesh-list
154052557|NCT02501954|Carboplatin|carboplatin|mesh-list
154052558|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154052559|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052560|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
154052561|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
154052562|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
154052563|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052564|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
154052565|NCT02394834|Leucovorin|leucovorin|mesh-list
154052566|NCT02394834|Bevacizumab|bevacizumab|mesh-list
154052567|NCT02394834|Panitumumab|panitumumab|mesh-list
154052568|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
154052569|NCT02394834|Fluorouracil|fluorouracil|mesh-list
154052570|NCT02394834|Calcium|calcium|mesh-list
154052571|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
154052572|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052573|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052574|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154052575|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154052576|NCT02394834|Growth Substances|growth substances|mesh-ancestor
154052606|NCT01897454|Folic Acid|folic acid|mesh-list
154052607|NCT01897454|Gemcitabine|gemcitabine|mesh-list
154052608|NCT01897454|Fluorouracil|fluorouracil|mesh-list
154052609|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
154052610|NCT01897454|Irinotecan|irinotecan|mesh-list
154052611|NCT01897454|Camptothecin|camptothecin|mesh-list
154052612|NCT01897454|Calcium|calcium|mesh-list
154052613|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
154052614|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052615|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
154052616|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052617|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052618|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154052619|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052620|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154052621|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052657|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154052658|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154052659|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154052660|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154052661|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154052662|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154052691|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154052693|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
154052694|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052695|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154052696|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052698|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
154052699|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052700|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154052701|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154052702|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052703|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052704|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154052705|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
154052706|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154052707|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052708|NCT01787487|Azacitidine|azacitidine|mesh-list
154052709|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052710|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
154052711|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052745|NCT00470704|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154052746|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052747|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052748|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052749|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
154052750|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154052751|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
154052752|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052753|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052754|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154052819|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052820|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052822|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052823|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154052824|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154052825|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052826|NCT00665522|Fentanyl|fentanyl|mesh-list
154052827|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154052849|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154052851|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052852|NCT00678704|Urological Agents|urological agents|mesh-ancestor
154052853|NCT00678782|Etanercept|etanercept|mesh-list
154052854|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154052855|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154052856|NCT00678782|Analgesics|analgesics|mesh-ancestor
154052857|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
154052858|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052859|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052860|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052861|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052862|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154052863|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052864|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
154052865|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
154052866|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154052867|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052868|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154052869|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052870|NCT04061200|Semaglutide|semaglutide|mesh-list
154052871|NCT04061200|Empagliflozin|empagliflozin|mesh-list
154052872|NCT04061200|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154052873|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154052874|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052876|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052877|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
154052878|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154052879|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052940|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052942|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
154052943|NCT00679484|Olmesartan|olmesartan|mesh-list
154052944|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154052945|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154052946|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154052947|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154052948|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052949|NCT00679640|Candesartan|candesartan|mesh-list
154052950|NCT00679640|Candesartan cilexetil|candesartan cilexetil|mesh-list
154052951|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154052952|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154053020|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053021|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053022|NCT00684632|Analgesics|analgesics|mesh-ancestor
154053023|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
154053024|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053025|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154053026|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154053027|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
154053028|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
154053029|NCT00855582|Tadalafil|tadalafil|mesh-list
154053030|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
154053054|NCT00684866|Albuterol|albuterol|mesh-list
154053055|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154053056|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
154053057|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053058|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053059|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154053060|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
154053061|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
154053062|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154053063|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154053064|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154053065|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154053066|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
154053067|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053068|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053069|NCT00854724|Puerarin|puerarin|mesh-list
154053070|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
154053071|NCT00619697|Insulin|insulin|mesh-list
154053072|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154053073|NCT00619697|Metformin|metformin|mesh-list
154053074|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
154053075|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
154053076|NCT00619697|Glimepiride|glimepiride|mesh-list
154053077|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
154053078|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154053079|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154053080|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053081|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154053109|NCT00698932|Hormones|hormones|mesh-ancestor
154053110|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053111|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053112|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154053113|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
154053114|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053115|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053116|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154053117|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
154053118|NCT02566252|Albuterol|albuterol|mesh-list
154053119|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
154053120|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154053121|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
154053122|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053123|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053124|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154053125|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
153457075|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154053126|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
154053127|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154053128|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154053152|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154053154|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
154053155|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053199|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053200|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053201|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154053202|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
154053203|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
154053204|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154053205|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154053206|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154053207|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154053208|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
154053209|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053210|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053212|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
154053213|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053214|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
154053215|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154053216|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154053217|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
154053218|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053219|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053220|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359938|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153359939|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
154053221|NCT00685100|Triamcinolone|triamcinolone|mesh-list
154053222|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053223|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
154053225|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053226|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053227|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
154053228|NCT00708903|Neratinib|neratinib|mesh-list
154053229|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154053230|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053231|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154053232|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154053233|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053234|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053266|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154053267|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154053268|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
154053269|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053270|NCT04150172|Protective Agents|protective agents|mesh-ancestor
154053271|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053272|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053273|NCT02325011|Fluconazole|fluconazole|mesh-list
154053274|NCT02325011|Nabiximols|nabiximols|mesh-list
154053275|NCT02325011|Dronabinol|dronabinol|mesh-list
154053276|NCT02325011|Cannabidiol|cannabidiol|mesh-list
154053426|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
154053575|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053576|NCT00685568|Celecoxib|celecoxib|mesh-list
154053577|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154053578|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053579|NCT00685568|Analgesics|analgesics|mesh-ancestor
154053580|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
154053581|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053582|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053583|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053585|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154053586|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154053587|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053588|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053589|NCT02626208|ST 1435|st 1435|mesh-list
154053590|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
154053591|NCT02626208|Estradiol|estradiol|mesh-list
154053592|NCT02626208|Estrogens|estrogens|mesh-ancestor
154053593|NCT02626208|Hormones|hormones|mesh-ancestor
154053594|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053595|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053596|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154053597|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154053598|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154053600|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
154053601|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154053602|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
154053603|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154053604|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
154053605|NCT04210739|Hormones|hormones|mesh-ancestor
154053606|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053607|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813477|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
153813478|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
154053608|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053629|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
154053630|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
154053631|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053632|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053633|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154053634|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
154053635|NCT04212845|Hormones|hormones|mesh-ancestor
154053636|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053637|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154053638|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053639|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
154053640|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
154053641|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053642|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
154053643|NCT00620165|Levetiracetam|levetiracetam|mesh-list
154053644|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
154053645|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
154053646|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
154053647|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
154053648|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154053649|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053650|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
154053651|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053652|NCT00685958|Enoxaparin|enoxaparin|mesh-list
154053653|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
154053655|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154053656|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053657|NCT04138472|Lidocaine|lidocaine|mesh-list
154053658|NCT04138472|Fentanyl|fentanyl|mesh-list
154053659|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
154053660|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
154053661|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
154053662|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053663|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053681|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154053682|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154053683|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
154053685|NCT00620789|Citalopram|citalopram|mesh-list
154053686|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
154053687|NCT00620789|Escitalopram|escitalopram|mesh-list
154053688|NCT00620789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154053689|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154053690|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154053691|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053692|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053693|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
154053694|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053695|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154053696|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154053697|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
154053698|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
154053699|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053700|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154053701|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154053702|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
154053703|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154053704|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154053705|NCT00691184|Terbinafine|terbinafine|mesh-list
154053706|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
154053707|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053708|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053709|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053710|NCT00854100|Cariprazine|cariprazine|mesh-list
154053711|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
154053712|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154053713|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154053714|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154053715|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053716|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053717|NCT00691262|Tacrolimus|tacrolimus|mesh-list
154053718|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053719|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
154053808|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154053809|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154053810|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053811|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
154053812|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
154053813|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
154053814|NCT00922610|Hematinics|hematinics|mesh-ancestor
154053815|NCT04117698|Ethambutol|ethambutol|mesh-list
154053816|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
154053817|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154053818|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054008|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054009|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
154054010|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054011|NCT00622115|Enoxaparin|enoxaparin|mesh-list
154054012|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
154054013|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154054014|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154054015|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054016|NCT02696837|Rocuronium|rocuronium|mesh-list
154054017|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154054018|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154054019|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154054020|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054021|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054022|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
154054023|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154054024|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
154054056|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054057|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054058|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054059|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154054060|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
154054061|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154054062|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054063|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154054064|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154054128|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054130|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
154054131|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154054132|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154054133|NCT05368181|Prednisolone|prednisolone|mesh-list
154054134|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
154054135|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154054136|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
154054137|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154054138|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
154054139|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
154054168|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
154054169|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054170|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
154054171|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054172|NCT00622817|Epinephrine|epinephrine|mesh-list
154054173|NCT00622817|Xylometazoline|xylometazoline|mesh-list
154054174|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154054175|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154054176|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
154054177|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054178|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054179|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054180|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154054206|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054208|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
154054209|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054210|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154054211|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
154054212|NCT00819585|Protective Agents|protective agents|mesh-ancestor
154054213|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054214|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
154054215|NCT00687206|Valsartan|valsartan|mesh-list
154054216|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154054217|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154054218|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154054219|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054220|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
154054221|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154054222|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054223|NCT02358395|Sorafenib|sorafenib|mesh-list
154054224|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054225|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154054226|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054227|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054228|NCT00692354|Tosedostat|tosedostat|mesh-list
154054229|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054230|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054231|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154054232|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
154054233|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054234|NCT03928847|Protective Agents|protective agents|mesh-ancestor
154054235|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054262|NCT02624726|Growth Substances|growth substances|mesh-ancestor
154054263|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
154054264|NCT00681746|Flumazenil|flumazenil|mesh-list
154054265|NCT00681746|Antidotes|antidotes|mesh-ancestor
154054266|NCT00681746|Protective Agents|protective agents|mesh-ancestor
154054267|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054268|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
154054269|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
154054270|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054271|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054272|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154054273|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
154054274|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054275|NCT00819039|Ondansetron|ondansetron|mesh-list
154054276|NCT00819039|Aprepitant|aprepitant|mesh-list
154054277|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
154054278|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
154054279|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054280|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054281|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154054282|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
154054283|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
154054284|NCT00819039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154054285|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153596945|NCT01865318|Insulin|insulin|mesh-list
154054287|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054288|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054309|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054310|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154054311|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154054312|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054313|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154054314|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154054315|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
154054316|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154054317|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154054318|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154054319|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154054320|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
154054321|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154054322|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154054323|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154054325|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154054326|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154054327|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154054328|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
154054329|NCT00692510|Protective Agents|protective agents|mesh-ancestor
154054330|NCT00500539|Omalizumab|omalizumab|mesh-list
154054331|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154054332|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154054333|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
154054335|NCT00687518|Hematinics|hematinics|mesh-ancestor
154054336|NCT02303795|Warfarin|warfarin|mesh-list
154054337|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
154054338|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
154054339|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154054340|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
154054341|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154054342|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
154054343|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054344|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054345|NCT04187417|Tetracaine|tetracaine|mesh-list
154054346|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
154054347|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
154054348|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054410|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154054411|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154054412|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
153813482|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
154054413|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154054414|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154054415|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054416|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154054417|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154054441|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154054442|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054443|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054444|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154054445|NCT04185857|Diuretics|diuretics|mesh-ancestor
154054446|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
154054447|NCT01016509|Insulin|insulin|mesh-list
154054448|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154054449|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154054450|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054451|NCT00639119|Ropinirole|ropinirole|mesh-list
154054452|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154054453|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154054454|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
154054455|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
154054456|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054457|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054458|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054459|NCT01010893|Vaccines|vaccines|mesh-list
154054460|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
154054461|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054462|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154054463|NCT01011127|Pravastatin|pravastatin|mesh-list
154054464|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154054465|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154054490|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
154054491|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054492|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054494|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
154054495|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054496|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054497|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
154054498|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054499|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054500|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
154054501|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154054502|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054503|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154054504|NCT00692900|Docetaxel|docetaxel|mesh-list
154054505|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
154054506|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054508|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
154054509|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054510|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054511|NCT00489853|Budesonide|budesonide|mesh-list
154054535|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054537|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154054538|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054539|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
154054540|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154054541|NCT04145336|Indomethacin|indomethacin|mesh-list
154054542|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154054543|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154054544|NCT04145336|Analgesics|analgesics|mesh-ancestor
154054545|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
154054546|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054547|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054548|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154054549|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154054550|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
154054551|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
154054552|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154054553|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154054554|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054555|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452220|NCT01855074|Risperidone|risperidone|mesh-list
154054556|NCT00499681|Letrozole|letrozole|mesh-list
154054557|NCT00499681|Lapatinib|lapatinib|mesh-list
154054558|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054559|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154054560|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154054561|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054595|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154054596|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054598|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
154054599|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054600|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054601|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054602|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
154054633|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054634|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054635|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154054636|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054637|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154054638|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054639|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
154054640|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
154054641|NCT00693524|Prednisone|prednisone|mesh-list
154054642|NCT00693524|Tacrolimus|tacrolimus|mesh-list
154054643|NCT00693524|Daclizumab|daclizumab|mesh-list
154054644|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154054645|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
154054646|NCT00693524|Hormones|hormones|mesh-ancestor
154054679|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054680|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054682|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154054683|NCT00682292|Daclizumab|daclizumab|mesh-list
154054684|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
154054685|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054686|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054687|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154054754|NCT00689000|Tosedostat|tosedostat|mesh-list
154054755|NCT00689000|Glycine|glycine|mesh-list
154054756|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054757|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054758|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
154054759|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054760|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054761|NCT00489541|Paclitaxel|paclitaxel|mesh-list
154054762|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154054763|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054764|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
154054765|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
154054766|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054767|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054769|NCT00689156|Docetaxel|docetaxel|mesh-list
154054770|NCT00689156|Epirubicin|epirubicin|mesh-list
154054771|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054772|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
154054773|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054774|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154054775|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154054776|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
154054777|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054778|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054779|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154054780|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
154054781|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813483|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154054782|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054783|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154054784|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154054785|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154054786|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054841|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154054843|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
154054844|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
154054845|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054846|NCT02609061|Alendronate|alendronate|mesh-list
154054847|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154054848|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054849|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154054850|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154054851|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054852|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
154054853|NCT00694694|Azithromycin|azithromycin|mesh-list
154054855|NCT00694694|Lumefantrine|lumefantrine|mesh-list
154054856|NCT00694694|Artemether|artemether|mesh-list
154054857|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154054858|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154054859|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054860|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
154054886|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
154054887|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054888|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054889|NCT00594464|Rotigotine|rotigotine|mesh-list
154054890|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
154054891|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
154054892|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054893|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054894|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054895|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
154054896|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154054897|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154054898|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154054899|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154054900|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054901|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
154054902|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054903|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054904|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154054905|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054906|NCT05326269|Terbutaline|terbutaline|mesh-list
154054907|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154054908|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
154054909|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054937|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154054938|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154054939|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
154054940|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054941|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054943|NCT04665453|Protective Agents|protective agents|mesh-ancestor
154054944|NCT00695240|Bupivacaine|bupivacaine|mesh-list
154054945|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
154054946|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
154054947|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054948|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054949|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
154054950|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054951|NCT00689702|Capecitabine|capecitabine|mesh-list
154054952|NCT00689702|Cetuximab|cetuximab|mesh-list
154256560|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054953|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154054954|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
154054955|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055053|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055054|NCT00690170|Analgesics|analgesics|mesh-ancestor
154055055|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
154055056|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154055057|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154055058|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
154055059|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
154055060|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055061|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154055062|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154055063|NCT00689624|Leucovorin|leucovorin|mesh-list
154055064|NCT00689624|Fluorouracil|fluorouracil|mesh-list
154055065|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
154055066|NCT00689624|Irinotecan|irinotecan|mesh-list
154055067|NCT00689624|Cetuximab|cetuximab|mesh-list
154055068|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
154055069|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055070|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154055097|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055099|NCT04135508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154055100|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055101|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153597766|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154055102|NCT02616770|Perflubron|perflubron|mesh-list
154055103|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154055104|NCT00499369|Leucovorin|leucovorin|mesh-list
154055105|NCT00499369|Bevacizumab|bevacizumab|mesh-list
154055106|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154055107|NCT00499369|Cetuximab|cetuximab|mesh-list
154055108|NCT00499369|Fluorouracil|fluorouracil|mesh-list
154055109|NCT00499369|Irinotecan|irinotecan|mesh-list
154055110|NCT00499369|Antibodies|antibodies|mesh-list
154055111|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
154055112|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154055113|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
154055114|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055115|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154055116|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154055117|NCT00499369|Growth Substances|growth substances|mesh-ancestor
154055118|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055119|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
154055206|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
154055207|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055209|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154055210|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154055211|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
154055235|NCT02620124|Hormones|hormones|mesh-list
154055236|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055237|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055238|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
154055239|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154055240|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
154055241|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154055242|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154055243|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154055244|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055245|NCT04134650|Metformin|metformin|mesh-list
154055246|NCT04134650|Linagliptin|linagliptin|mesh-list
154055247|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154055248|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055249|NCT04134650|Incretins|incretins|mesh-ancestor
154055250|NCT04134650|Hormones|hormones|mesh-ancestor
154055251|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055252|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154055253|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
154055254|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055255|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055257|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
154055258|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632540|NCT03876106|LUT014|lut014|mesh-list
154055259|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
154055260|NCT02563288|Esmolol|esmolol|mesh-list
154055261|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
154055262|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
154055263|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
154055264|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
154055295|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154055297|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154055298|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154055299|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
154055300|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
154055301|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055302|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055303|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055304|NCT00286169|Amrubicin|amrubicin|mesh-list
154055305|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055338|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055340|NCT00498433|Renin Inhibitors|renin inhibitors|mesh-ancestor
154055341|NCT00498433|Protease Inhibitors|protease inhibitors|mesh-ancestor
154055342|NCT00498433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055343|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154055344|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154055345|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055346|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
154055347|NCT00746746|Interferons|interferons|mesh-list
154055348|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
154055349|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
154055370|NCT04539223|Protease Inhibitors|protease inhibitors|mesh-ancestor
154055371|NCT04539223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055372|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154055373|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154055374|NCT01011751|Leuprolide|leuprolide|mesh-list
154055375|NCT01011751|Flutamide|flutamide|mesh-list
154055376|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
154055377|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154055378|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
154055379|NCT01011751|Cyproterone|cyproterone|mesh-list
154055380|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154055381|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154055382|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154055383|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055384|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055385|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055386|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154055387|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
154055388|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154055389|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154055390|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154055391|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154055392|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
154055393|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154055394|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154055395|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154055396|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154055397|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154055398|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055399|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153598099|NCT01872546|Adalimumab|adalimumab|mesh-list
154055400|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
154055401|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
154055402|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
154055403|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055404|NCT02686619|Cyclosporine|cyclosporine|mesh-list
154055484|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055485|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055487|NCT04185233|Analgesics|analgesics|mesh-ancestor
154055488|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
154055489|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055490|NCT04185077|Heparin|heparin|mesh-list
154055491|NCT04185077|Calcium heparin|calcium heparin|mesh-list
154055492|NCT04185077|Bivalirudin|bivalirudin|mesh-list
154055493|NCT04185077|Antithrombins|antithrombins|mesh-list
154055494|NCT04185077|Thrombin|thrombin|mesh-list
154055495|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
154055496|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153632589|NCT00006468|Leucovorin|leucovorin|mesh-list
154055497|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154055498|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055499|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
154055500|NCT04185077|Coagulants|coagulants|mesh-ancestor
154055501|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154055502|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
154055503|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055504|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
154055505|NCT02686385|Prednisolone|prednisolone|mesh-list
154055506|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154055507|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055508|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
154055509|NCT02686385|Hormones|hormones|mesh-ancestor
154055510|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055511|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055512|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154055513|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055514|NCT02686385|Protective Agents|protective agents|mesh-ancestor
154055515|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
154055516|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055517|NCT02686385|Expectorants|expectorants|mesh-ancestor
154055518|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
154055519|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154055520|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
154055521|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055522|NCT02686385|Antidotes|antidotes|mesh-ancestor
154055523|NCT02686151|Dexamethasone|dexamethasone|mesh-list
154055524|NCT02686151|Letrozole|letrozole|mesh-list
154055525|NCT02686151|Polygeline|polygeline|mesh-list
154055526|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055527|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
154055528|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
154055529|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055575|NCT01018225|Urological Agents|urological agents|mesh-ancestor
154055576|NCT03528551|Factor VIII|factor viii|mesh-list
154055577|NCT03528551|Coagulants|coagulants|mesh-ancestor
154055578|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
154055579|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055580|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055581|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
154055582|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154055583|NCT01012063|Hematinics|hematinics|mesh-ancestor
154055584|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154055585|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
154055586|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055588|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
154055590|NCT02685059|Epirubicin|epirubicin|mesh-list
154055591|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154055592|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055593|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
154055594|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
154055595|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
154055596|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055597|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055598|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
154055599|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055600|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055601|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154055602|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
154055603|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154055604|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154055605|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154055606|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154055607|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154055608|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055609|NCT00603239|Exenatide|exenatide|mesh-list
154055610|NCT00603239|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154055611|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154055612|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055613|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154055614|NCT00603239|Incretins|incretins|mesh-ancestor
154055615|NCT00603239|Hormones|hormones|mesh-ancestor
154055616|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055617|NCT00699114|Acetaminophen|acetaminophen|mesh-list
154055618|NCT00699114|Ibuprofen|ibuprofen|mesh-list
154055619|NCT00699114|Codeine|codeine|mesh-list
154055651|NCT00852540|Linezolid|linezolid|mesh-list
154055652|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154055653|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055654|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154055655|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055656|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055657|NCT00701298|Interferons|interferons|mesh-list
154055658|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
154055659|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
154055660|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154055661|NCT00701298|Decitabine|decitabine|mesh-list
154055662|NCT00701298|Azacitidine|azacitidine|mesh-list
154055663|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055664|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
154055665|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055666|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
154055667|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055724|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055725|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
154055726|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055727|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154055728|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154055729|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
154055730|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055731|NCT01012141|Docetaxel|docetaxel|mesh-list
154055732|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055733|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
154055734|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
154055735|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
154055736|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055737|NCT00487435|Tapentadol|tapentadol|mesh-list
154055738|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154055739|NCT00487435|Narcotics|narcotics|mesh-ancestor
154055740|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055741|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055742|NCT00487435|Analgesics|analgesics|mesh-ancestor
154055743|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
154055744|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055745|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154055746|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154055747|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154055748|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055749|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
154055750|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055751|NCT00495625|Sunitinib|sunitinib|mesh-list
154055752|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055753|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154055754|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154055755|NCT00495625|Growth Substances|growth substances|mesh-ancestor
154055785|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
154055786|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055787|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
154055788|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
154055789|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154055790|NCT00860262|Amlodipine|amlodipine|mesh-list
154055791|NCT00860262|Telmisartan|telmisartan|mesh-list
154055792|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154055793|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154055794|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154055795|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154055796|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055797|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154055849|NCT00699426|Esomeprazole|esomeprazole|mesh-list
154055850|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153598525|NCT05458375|Estradiol|estradiol|mesh-list
154055851|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154055852|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154055853|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055854|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055856|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
154055857|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
154055858|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055859|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055860|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055864|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154055865|NCT02614118|Analgesics|analgesics|mesh-ancestor
154055866|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
154055867|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055868|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055869|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
154055870|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154055871|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055872|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055873|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154055909|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055910|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055911|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055944|NCT02563054|Fluorouracil|fluorouracil|mesh-list
154055945|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055946|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154055947|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
154055948|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055949|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055950|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
154056005|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
154056006|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056007|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154056008|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154056009|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154056010|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154056011|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056012|NCT04123652|Analgesics|analgesics|mesh-ancestor
154056049|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056050|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056114|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056115|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056116|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056117|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154056118|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
154056120|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056121|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056122|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056123|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056124|NCT00867308|Lenalidomide|lenalidomide|mesh-list
154056125|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
154056126|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056127|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154056227|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
154056228|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154056229|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154056230|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154056231|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
154056232|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056233|NCT04184921|Aspirin|aspirin|mesh-list
154056234|NCT04184921|Osimertinib|osimertinib|mesh-list
154056235|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056236|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056237|NCT04184921|Analgesics|analgesics|mesh-ancestor
154056238|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
154056239|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056240|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056241|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056242|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056243|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154056244|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154056245|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056246|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154056247|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154056248|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056249|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
154056282|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
154056283|NCT02688803|Doxorubicin|doxorubicin|mesh-list
154256561|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
154056284|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154056285|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154056286|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056287|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
154056288|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
154056289|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
154056306|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056309|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154056310|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056311|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154056312|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056313|NCT00861380|Vaccines|vaccines|mesh-list
154056314|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154056315|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
154056316|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056317|NCT00495391|Ribavirin|ribavirin|mesh-list
154056318|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154056319|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
154056320|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
154056321|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056322|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
154056323|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056324|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154056325|NCT04378621|Adalimumab|adalimumab|mesh-list
154056326|NCT04378621|Infliximab|infliximab|mesh-list
154056327|NCT04378621|Golimumab|golimumab|mesh-list
154056328|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
154056329|NCT04378621|Etanercept|etanercept|mesh-list
154056330|NCT04378621|Tofacitinib|tofacitinib|mesh-list
154056331|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154056332|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154056333|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056334|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056335|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
154056336|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154056337|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056338|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056339|NCT04378621|Analgesics|analgesics|mesh-ancestor
154056340|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
154056341|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056342|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056343|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154056344|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
154056345|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056346|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056404|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
153745624|NCT03433755|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154056405|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154056406|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056407|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
154056408|NCT04134026|Hematinics|hematinics|mesh-ancestor
154056409|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
154056411|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154056412|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
154056413|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056414|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056415|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154056416|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
154056417|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056418|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056419|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154056453|NCT00697892|Ritonavir|ritonavir|mesh-list
154056454|NCT00697892|Lopinavir|lopinavir|mesh-list
154056455|NCT00697892|Efavirenz|efavirenz|mesh-list
154056456|NCT00697892|Lumefantrine|lumefantrine|mesh-list
154056457|NCT00697892|Artemether|artemether|mesh-list
154056458|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154056459|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154056460|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154056461|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
154056462|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056611|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
154056612|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
154056613|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154056614|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056616|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154056617|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154056618|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154056619|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154056620|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
154056621|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056622|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056623|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056625|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154056626|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154056627|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
154056628|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056630|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154056642|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056643|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056645|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
154056646|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154056647|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
154056648|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
154056649|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154056650|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
154056651|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154056652|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056653|NCT00640991|Insulin|insulin|mesh-list
154056654|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
154056655|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
154056656|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154056657|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056658|NCT00638807|Celecoxib|celecoxib|mesh-list
154056659|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056660|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056661|NCT00638807|Analgesics|analgesics|mesh-ancestor
153813499|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056662|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
154056663|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056664|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056665|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056666|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056667|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154056668|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154056669|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056670|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056671|NCT00856856|Everolimus|everolimus|mesh-list
154056672|NCT00856856|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154056673|NCT00856856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056674|NCT00856856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056675|NCT00856856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056676|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154056677|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
154056678|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056679|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056680|NCT00782327|Losartan|losartan|mesh-list
154056681|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154056682|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154056683|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154056684|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154056685|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056686|NCT00559091|Ribavirin|ribavirin|mesh-list
154056687|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
154056688|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056689|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
154056690|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056691|NCT02682017|Fucoidan|fucoidan|mesh-list
154056692|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154056693|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154056694|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
154056723|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154056725|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056726|NCT02688023|Antidotes|antidotes|mesh-ancestor
154056727|NCT02688023|Protective Agents|protective agents|mesh-ancestor
154056728|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
154056729|NCT02688023|Vitamins|vitamins|mesh-ancestor
154056730|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
154056731|NCT00910013|Ropivacaine|ropivacaine|mesh-list
154056732|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
154056734|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056735|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056736|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
154056737|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056738|NCT04182191|Tenoxicam|tenoxicam|mesh-list
154056739|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056765|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
154056766|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056767|NCT00641693|Budesonide|budesonide|mesh-list
154056768|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056769|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154056770|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
154056771|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056772|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056773|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154056774|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
154056775|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
154056776|NCT00641693|Hormones|hormones|mesh-ancestor
154056777|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154056778|NCT04183361|Cortisone|cortisone|mesh-list
154056779|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813500|NCT03279978|Midazolam|midazolam|mesh-list
154056780|NCT02687867|Vitamin K|vitamin k|mesh-list
154056782|NCT02687867|Vitamins|vitamins|mesh-ancestor
154056783|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
154056784|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056785|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
154056786|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154056787|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
154056788|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056789|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056790|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
154056895|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154056896|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
154056897|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154056926|NCT00466921|Lenalidomide|lenalidomide|mesh-list
154056927|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
154056928|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056929|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154056930|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154056931|NCT00466921|Growth Substances|growth substances|mesh-ancestor
154056932|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
154056933|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056934|NCT00601523|Pramipexole|pramipexole|mesh-list
154056935|NCT00601523|Dexpramipexole|dexpramipexole|mesh-list
154056936|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
154056937|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056938|NCT00601523|Protective Agents|protective agents|mesh-ancestor
154056939|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056940|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154056941|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154056942|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
154056943|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
154056944|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056974|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056975|NCT00744016|Mesalamine|mesalamine|mesh-list
154056976|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056977|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056978|NCT00744016|Analgesics|analgesics|mesh-ancestor
154056979|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
154056980|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056981|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056982|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056983|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056984|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
154056985|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154056986|NCT04182737|Antibodies|antibodies|mesh-list
154056987|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
154057014|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
154057015|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154057016|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057017|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057018|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154057019|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154057020|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057021|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057022|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154057023|NCT02677571|Morphine|morphine|mesh-list
154057024|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
154057025|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154057026|NCT02677571|Narcotics|narcotics|mesh-ancestor
154057027|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057028|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057029|NCT02677571|Analgesics|analgesics|mesh-ancestor
154057030|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
154057031|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057032|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
154057033|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
154057034|NCT04181567|Agomelatine|agomelatine|mesh-list
154057035|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154057036|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057101|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154057151|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057152|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154057153|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
154057154|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057155|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057156|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154057157|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
154057158|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
154057160|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057161|NCT05663177|Vinorelbine|vinorelbine|mesh-list
154057162|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154057163|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057164|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154057165|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154057166|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154057167|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057168|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
154057170|NCT00642551|Menaquinone 7|menaquinone 7|mesh-list
154057171|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154057172|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154057173|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057174|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
154057175|NCT00642551|Coagulants|coagulants|mesh-ancestor
154057176|NCT00642551|Vitamins|vitamins|mesh-ancestor
154057177|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
154057178|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057179|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154057180|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154057181|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057182|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154057183|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154057184|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057213|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057215|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154057216|NCT01025245|Narcotics|narcotics|mesh-ancestor
154057217|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057218|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057219|NCT01025245|Analgesics|analgesics|mesh-ancestor
154057220|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
154057221|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057222|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154057223|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154057224|NCT02677259|Estradiol|estradiol|mesh-list
154057225|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154057226|NCT02677259|Progesterone|progesterone|mesh-list
154057256|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
154057257|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
154057258|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057259|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057260|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057262|NCT02678585|Nalbuphine|nalbuphine|mesh-list
154057263|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
154057264|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
154057265|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057266|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057267|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
154057268|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057302|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057303|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154057304|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057305|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
154057306|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154057307|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
154057344|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057345|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154057347|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154057348|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057366|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057368|NCT02676323|Cytarabine|cytarabine|mesh-list
154057369|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
154057370|NCT02676323|Methotrexate|methotrexate|mesh-list
154057371|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
154057372|NCT02676323|Fludarabine|fludarabine|mesh-list
154057373|NCT02676323|Panobinostat|panobinostat|mesh-list
154057374|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
154057375|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057376|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154057377|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
154057378|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154057379|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154057380|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
154057381|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057382|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057383|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
154057384|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057385|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154057386|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154057387|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
154057388|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154057389|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154057390|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
154057391|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057392|NCT02676323|Antidotes|antidotes|mesh-ancestor
154057393|NCT02676323|Protective Agents|protective agents|mesh-ancestor
154057394|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
154057395|NCT02676323|Vitamins|vitamins|mesh-ancestor
154057396|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
154057397|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057398|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154057399|NCT00643799|Celecoxib|celecoxib|mesh-list
154057400|NCT00643799|Naproxen|naproxen|mesh-list
154057401|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154057402|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154057403|NCT00643799|Analgesics|analgesics|mesh-ancestor
154057404|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
154057464|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057465|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
154057466|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154057467|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057468|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
154057469|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154057470|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154057471|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
154057472|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
154057473|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154057474|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057475|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057476|NCT01019083|Astringents|astringents|mesh-ancestor
154057477|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
154057478|NCT00463801|Daptomycin|daptomycin|mesh-list
154057479|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057480|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057481|NCT02672345|Sevoflurane|sevoflurane|mesh-list
154057482|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154057483|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154057484|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
154057485|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
154057486|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057487|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057488|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
154057489|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154057491|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057492|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154057493|NCT02537249|Analgesics|analgesics|mesh-ancestor
154057494|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
154057495|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057496|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154057497|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154057498|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154057531|NCT04177043|Antibodies|antibodies|mesh-list
154057532|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
154057533|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
154057534|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057536|NCT02670785|Estrogens|estrogens|mesh-ancestor
154057537|NCT02670785|Hormones|hormones|mesh-ancestor
154057538|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057539|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057540|NCT02670317|Prednisone|prednisone|mesh-list
154057541|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
154057542|NCT02670317|Doxorubicin|doxorubicin|mesh-list
154057543|NCT02670317|Vincristine|vincristine|mesh-list
154057544|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
154057545|NCT02670317|Ibrutinib|ibrutinib|mesh-list
154057600|NCT02669459|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154057601|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
154057602|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057603|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154057604|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057605|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
154057606|NCT04176887|Phenytoin|phenytoin|mesh-list
154057607|NCT04176887|Levetiracetam|levetiracetam|mesh-list
154057608|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
154057609|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
154057610|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154057612|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057732|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154057733|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
154057734|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154057735|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154057736|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154057769|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057770|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057771|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
154057772|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057773|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154057774|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154057775|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154057776|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057844|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057926|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154057928|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154057929|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057930|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057931|NCT00646607|Leucovorin|leucovorin|mesh-list
153444773|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
154057932|NCT00646607|Fluorouracil|fluorouracil|mesh-list
154057933|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
154057934|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
154057935|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
154057936|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057937|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154057938|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057939|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154057940|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
154057941|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057942|NCT00646607|Antidotes|antidotes|mesh-ancestor
154057943|NCT00646607|Protective Agents|protective agents|mesh-ancestor
154057944|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
154057945|NCT00646607|Vitamins|vitamins|mesh-ancestor
154057946|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
154057947|NCT00856544|Tofacitinib|tofacitinib|mesh-list
154057948|NCT00856544|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154058019|NCT04171739|Rifampin|rifampin|mesh-list
154058020|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
154058021|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256562|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058022|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154058023|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154058024|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058025|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058026|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154058308|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
154058309|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058310|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154058311|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154058312|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
154058313|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058314|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154058315|NCT00650195|Metolazone|metolazone|mesh-list
154058316|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600996|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
154058317|NCT00650195|Diuretics|diuretics|mesh-ancestor
154058318|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
154058319|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058320|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154058321|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058322|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058323|NCT04170959|Metformin|metformin|mesh-list
154058324|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154058325|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058326|NCT00848354|Etanercept|etanercept|mesh-list
154058327|NCT00848354|Methotrexate|methotrexate|mesh-list
154058328|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154058329|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
154058330|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154058331|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058460|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058461|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058462|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058463|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
154058486|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058487|NCT00698126|Insulin|insulin|mesh-list
154058488|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154058489|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
154058490|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
154058491|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154058492|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058493|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
154058494|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
154058495|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058496|NCT02656901|Anesthetics|anesthetics|mesh-list
154058497|NCT02656901|Sevoflurane|sevoflurane|mesh-list
154058498|NCT02656901|Desflurane|desflurane|mesh-list
154058499|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058500|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058501|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154058502|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154058503|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
154058504|NCT00847886|Methotrexate|methotrexate|mesh-list
154058505|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154058506|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
154058507|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154058508|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058509|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154058510|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
154058511|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058512|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058513|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
154058514|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058515|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154058516|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154058517|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
154058518|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058583|NCT02656589|Trastuzumab|trastuzumab|mesh-list
154058584|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154058585|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
154058591|NCT00600353|Palonosetron|palonosetron|mesh-list
154058592|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058682|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
154058744|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058745|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058746|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
154058747|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058748|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154058749|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
154058750|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154058751|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154058800|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154058801|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058802|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154058803|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154058804|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058805|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058806|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058807|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154058808|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154058809|NCT02648633|Nivolumab|nivolumab|mesh-list
154058810|NCT02648633|Valproic Acid|valproic acid|mesh-list
154058811|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058812|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058813|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154058814|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058815|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
154058816|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058817|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
154058818|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058819|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058820|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
154058821|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154058822|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058884|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058885|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
154058886|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058887|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154058888|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154058889|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
154058890|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058891|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154058892|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058894|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058895|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154058896|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
154058930|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
154058931|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
154058932|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058933|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058934|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
154058935|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058936|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154058937|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154058938|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154058939|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058976|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058977|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059011|NCT00652925|Celecoxib|celecoxib|mesh-list
154059012|NCT00652925|Naproxen|naproxen|mesh-list
154059013|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154059014|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154059015|NCT00652925|Analgesics|analgesics|mesh-ancestor
154059016|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
154059017|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059018|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059019|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059070|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059071|NCT00651911|Rasburicase|rasburicase|mesh-list
154059072|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
154059073|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059074|NCT02643407|Docetaxel|docetaxel|mesh-list
154059075|NCT02643407|Nedaplatin|nedaplatin|mesh-list
154059076|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059077|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
154059078|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
154059079|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
154059080|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059081|NCT02643329|Gliclazide|gliclazide|mesh-list
154059082|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154059083|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059084|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
154059085|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154059086|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059087|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059088|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154059089|NCT02643017|Analgesics|analgesics|mesh-ancestor
154059090|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
154059091|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059092|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154059093|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154059094|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154059095|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
154059096|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059097|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059098|NCT02643173|Anesthetics|anesthetics|mesh-list
154059365|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059366|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059428|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059429|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
154059430|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154059431|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059432|NCT00883337|Interferons|interferons|mesh-list
154059433|NCT00883337|Interferon-beta|interferon-beta|mesh-list
154059489|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154059490|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059491|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059718|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059816|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154059817|NCT00911261|Narcotics|narcotics|mesh-ancestor
154059818|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059819|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059820|NCT00911261|Analgesics|analgesics|mesh-ancestor
154059821|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
154059822|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059823|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154059824|NCT00686374|Adalimumab|adalimumab|mesh-list
154059922|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154059923|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
154059924|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059925|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059927|NCT00880763|Ribavirin|ribavirin|mesh-list
154059928|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059929|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
154059930|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059931|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
154059932|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059933|NCT00884273|Goserelin|goserelin|mesh-list
154059934|NCT00884273|Bicalutamide|bicalutamide|mesh-list
154059966|NCT00884039|Anecortave|anecortave|mesh-list
154059967|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059968|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154059969|NCT00884039|Growth Substances|growth substances|mesh-ancestor
154059970|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059971|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059972|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059974|NCT00657995|Pancrelipase|pancrelipase|mesh-list
154059975|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059976|NCT02632565|Lidocaine|lidocaine|mesh-list
154059977|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
154060013|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060014|NCT00880685|Memantine|memantine|mesh-list
154060015|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154060052|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060109|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060110|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060112|NCT02632331|Analgesics|analgesics|mesh-ancestor
154060113|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
154060292|NCT05861791|Nefopam|nefopam|mesh-list
154060293|NCT05861791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154060294|NCT05861791|Narcotics|narcotics|mesh-ancestor
154060295|NCT05861791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060296|NCT05861791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060297|NCT05861791|Analgesics|analgesics|mesh-ancestor
154060298|NCT05861791|Sensory System Agents|sensory system agents|mesh-ancestor
154060299|NCT05861791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060300|NCT05861791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154060301|NCT05861791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154060302|NCT05861791|Anesthetics, General|anesthetics, general|mesh-ancestor
154060303|NCT05861791|Anesthetics|anesthetics|mesh-ancestor
154060304|NCT05861791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154060305|NCT05861791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154060306|NCT05861791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154060307|NCT05861791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154060308|NCT05861791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154060309|NCT05861791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060310|NCT05861791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060311|NCT05861713|Dimenhydrinate|dimenhydrinate|mesh-list
154060312|NCT05861713|Antiemetics|antiemetics|mesh-ancestor
154060313|NCT05861713|Autonomic Agents|autonomic agents|mesh-ancestor
154060314|NCT05861713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060315|NCT05861713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060316|NCT05861713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060317|NCT05861713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154060318|NCT05861713|Histamine Antagonists|histamine antagonists|mesh-ancestor
154060319|NCT05861713|Histamine Agents|histamine agents|mesh-ancestor
154060320|NCT05861713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060321|NCT05861713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060322|NCT05861687|Amoxicillin|amoxicillin|mesh-list
154060323|NCT05861687|Clarithromycin|clarithromycin|mesh-list
154060357|NCT05773326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154060358|NCT05773326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060359|NCT05773326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060360|NCT05773326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154060361|NCT05773326|Immunologic Factors|immunologic factors|mesh-ancestor
154060362|NCT05773326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060363|NCT05773326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060364|NCT05773326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154060365|NCT05773326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060366|NCT05773326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154060367|NCT05773326|Antifungal Agents|antifungal agents|mesh-ancestor
154060368|NCT05765071|Botulinum Toxins|botulinum toxins|mesh-list
154060475|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
154060503|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
154060504|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060505|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060506|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154060507|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
154060508|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
154060509|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
154060511|NCT04878406|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154060512|NCT04878406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154060513|NCT04878406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060514|NCT04857398|Insulin|insulin|mesh-list
154060515|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154060516|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060518|NCT04812548|Venetoclax|venetoclax|mesh-list
154060519|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154060520|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
154060557|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060580|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
154060581|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060582|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060583|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060584|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
154060585|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
154060586|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154060587|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154060588|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
154060589|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060590|NCT04560660|Midazolam|midazolam|mesh-list
154060591|NCT04560660|Ketamine|ketamine|mesh-list
154060592|NCT04560660|Analgesics|analgesics|mesh-ancestor
154060593|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
154060594|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060595|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060596|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154060597|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154060598|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
154060599|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
154060600|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060601|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154060602|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154060603|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060604|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060605|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154060606|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154060607|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154060608|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154060609|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154060610|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
154060645|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
154060646|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060647|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060648|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154060649|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154060650|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154060651|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154060712|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
153603389|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
154060713|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060714|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060720|NCT03711604|Tenalisib|tenalisib|mesh-list
154060721|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154060722|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060723|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060724|NCT03708627|Bimatoprost|bimatoprost|mesh-list
154060725|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154060726|NCT03702621|Bupivacaine|bupivacaine|mesh-list
154060727|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
154060728|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
154060729|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060730|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060764|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060766|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060767|NCT03245008|Fasinumab|fasinumab|mesh-list
154060768|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154060769|NCT03245008|Analgesics|analgesics|mesh-ancestor
154060864|NCT01367002|Trastuzumab|trastuzumab|mesh-list
154060865|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154060866|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060867|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
154060868|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
154060869|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
154060870|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060871|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060872|NCT00858273|Insulin|insulin|mesh-list
154060873|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154060874|NCT00858273|Antioxidants|antioxidants|mesh-list
154060875|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154060876|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060877|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060897|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060898|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
154060899|NCT00660257|Vaccines|vaccines|mesh-list
154060900|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
154060901|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060902|NCT00844428|Eculizumab|eculizumab|mesh-list
154060903|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154060904|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154060905|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
154060906|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060907|NCT00660335|Secretin|secretin|mesh-list
154060908|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060909|NCT00660335|Hormones|hormones|mesh-ancestor
154060910|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060911|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060912|NCT00707772|Ribavirin|ribavirin|mesh-list
154060913|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154060914|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
154060915|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
154060916|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060917|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
154060918|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060919|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
154060920|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060921|NCT00834834|Fluoxetine|fluoxetine|mesh-list
154060922|NCT00834834|Citalopram|citalopram|mesh-list
154060923|NCT00834834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154060924|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154060925|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154060926|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060927|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060928|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
154060929|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060930|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154060931|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
154060932|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154060945|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154060946|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060948|NCT00660647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154060949|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154060950|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154060951|NCT04156451|Furosemide|furosemide|mesh-list
154060952|NCT04156451|Diuretics|diuretics|mesh-ancestor
154060953|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
154060954|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060955|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154060956|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154060957|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060958|NCT00660725|Gemcitabine|gemcitabine|mesh-list
154060959|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
154060960|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154060961|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
154060962|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060963|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060964|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154060965|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154060966|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154060967|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154060968|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060969|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060970|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060971|NCT00844194|Analgesics|analgesics|mesh-ancestor
154060972|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
154060973|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060974|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
154060975|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154060976|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
154060977|NCT00660803|Fulvestrant|fulvestrant|mesh-list
154060978|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154060979|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060980|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154060981|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154060982|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
154060983|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060984|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060985|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154060986|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
154060987|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154060988|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154060989|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060990|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060991|NCT00661115|Urological Agents|urological agents|mesh-ancestor
154060992|NCT04157699|Tenofovir|tenofovir|mesh-list
154061010|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061011|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154061012|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154061013|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
154061014|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154061015|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154061017|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154061018|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061019|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061020|NCT00661349|Ritonavir|ritonavir|mesh-list
154061021|NCT00661349|Lopinavir|lopinavir|mesh-list
154061022|NCT00661349|Nevirapine|nevirapine|mesh-list
154061023|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154061024|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154061025|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
154061026|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061027|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061028|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154061029|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154061030|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
154061031|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061032|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154061033|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154061034|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154061035|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154061036|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154061037|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154061038|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154061039|NCT00665873|Amoxicillin|amoxicillin|mesh-list
154061040|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
154061041|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
154061042|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154061043|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061044|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
154061045|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061046|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061047|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154061048|NCT00707850|Ribavirin|ribavirin|mesh-list
154061049|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154061074|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061075|NCT00878969|Valsartan|valsartan|mesh-list
154061076|NCT00878969|Ramipril|ramipril|mesh-list
154061077|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154061078|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154061079|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154061080|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154061081|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061082|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
154061083|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061084|NCT00843492|PENTA|penta|mesh-list
154061085|NCT00843492|Nadroparin|nadroparin|mesh-list
154061086|NCT00843492|Fondaparinux|fondaparinux|mesh-list
154061087|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154061088|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
154061089|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154061090|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
154061091|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061092|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061093|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
154061094|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154061095|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154061096|NCT00666107|Vaccines|vaccines|mesh-list
154061121|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061122|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154061123|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061124|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061125|NCT00666341|Immunomodulating Agents|immunomodulating agents|mesh-list
154061126|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
154061127|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061128|NCT00661973|Budesonide|budesonide|mesh-list
154061129|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154061130|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154061131|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
154061132|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061133|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061134|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154061135|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
154061136|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
154061137|NCT00661973|Hormones|hormones|mesh-ancestor
154061138|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154061139|NCT00666575|Gabapentin|gabapentin|mesh-list
154061140|NCT00666575|Analgesics|analgesics|mesh-ancestor
154061141|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
154061142|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061143|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061144|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
154061145|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154061146|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154061147|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061148|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154061174|NCT00666887|Minocycline|minocycline|mesh-list
154061175|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154061176|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061177|NCT02631473|Ritonavir|ritonavir|mesh-list
154061178|NCT02631473|Lopinavir|lopinavir|mesh-list
154061179|NCT02631473|Efavirenz|efavirenz|mesh-list
154061180|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154061181|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154061182|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
154061183|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061184|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061186|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154061187|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
154061188|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061189|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154061190|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154061191|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154061192|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154061193|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154061194|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154061195|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154061215|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154061216|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061217|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061219|NCT00667433|Emtricitabine|emtricitabine|mesh-list
154061220|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154061221|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
154061222|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
154061223|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061224|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154061225|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154061226|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061227|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061228|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154061229|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154061230|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154061231|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154061232|NCT00662519|Lenograstim|lenograstim|mesh-list
154061233|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154061234|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
154061235|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256565|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154061236|NCT00667901|Riluzole|riluzole|mesh-list
154061237|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
154061238|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154061239|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154061240|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061241|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061242|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061243|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154061244|NCT00667901|Protective Agents|protective agents|mesh-ancestor
154061245|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154061246|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
154061247|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154061248|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154061249|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061281|NCT00668603|Hormones|hormones|mesh-ancestor
154061282|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154061283|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061284|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154061285|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
154061286|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154061287|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154061288|NCT00662987|Amoxicillin|amoxicillin|mesh-list
154061289|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154061290|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061315|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154061316|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154061317|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
154061318|NCT00663221|Vitamin D|vitamin d|mesh-list
154061319|NCT00663221|Calcium|calcium|mesh-list
154061320|NCT00663221|Vitamins|vitamins|mesh-ancestor
154061321|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
154061322|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061323|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154061324|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154061325|NCT00824850|Vaccines|vaccines|mesh-list
154061326|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154061327|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
154061328|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061329|NCT00596687|Insulin|insulin|mesh-list
154061330|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154061331|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
154061332|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
154061333|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154061334|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061335|NCT02631239|Dexamethasone|dexamethasone|mesh-list
154061336|NCT02631239|Methotrexate|methotrexate|mesh-list
154061337|NCT02631239|Etoposide|etoposide|mesh-list
154061338|NCT02631239|Pegaspargase|pegaspargase|mesh-list
154061361|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061362|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154061363|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154061364|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154061365|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154061367|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154061368|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154061369|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154061370|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154061371|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061372|NCT00669149|Aspirin|aspirin|mesh-list
154061373|NCT00669149|Heparin|heparin|mesh-list
154061374|NCT00669149|Enoxaparin|enoxaparin|mesh-list
154061375|NCT00669149|Bivalirudin|bivalirudin|mesh-list
154061376|NCT00669149|Clopidogrel|clopidogrel|mesh-list
154061377|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154061378|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154061379|NCT00669149|Analgesics|analgesics|mesh-ancestor
154061380|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
154061381|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061382|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061383|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154061384|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061385|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154061387|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061388|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154061421|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154061422|NCT00663689|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154061423|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154061424|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061425|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061426|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061428|NCT00669773|Doxorubicin|doxorubicin|mesh-list
154061429|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154061454|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061455|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
154061456|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061457|NCT04155515|Ribavirin|ribavirin|mesh-list
154061458|NCT04155515|Yimitasvir|yimitasvir|mesh-list
154061459|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
154061460|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061462|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061463|NCT00664001|Antioxidants|antioxidants|mesh-list
154061464|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061465|NCT00664001|Protective Agents|protective agents|mesh-ancestor
154061466|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061467|NCT00824382|Olodaterol|olodaterol|mesh-list
154061468|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154061469|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
154061470|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061471|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061472|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154061473|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
154061474|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154061475|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154061503|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154061504|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061505|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061506|NCT04154033|Naltrexone|naltrexone|mesh-list
154061507|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154061508|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154061509|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061510|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
154061511|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061512|NCT05530356|Dextrans|dextrans|mesh-list
154061513|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
154061514|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
154061515|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
154061516|NCT00664313|Linezolid|linezolid|mesh-list
154061517|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154061518|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061519|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154061520|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061521|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061545|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
154061546|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061547|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061548|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154061549|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
154061550|NCT02629835|Hormones|hormones|mesh-ancestor
154061551|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154061552|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154061553|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061554|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
154061555|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061556|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061557|NCT00664469|Atorvastatin|atorvastatin|mesh-list
154061558|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154061559|NCT00664469|Simvastatin|simvastatin|mesh-list
154061560|NCT00664469|Ezetimibe|ezetimibe|mesh-list
154061561|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154061562|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154061563|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
154157370|NCT05845814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154061564|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061565|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154061567|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061569|NCT00843024|Sumatriptan|sumatriptan|mesh-list
154061570|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154061571|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154061572|NCT00843024|Analgesics|analgesics|mesh-ancestor
154061573|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
154061574|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061575|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061576|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154061615|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
154061616|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061617|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154061618|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154061619|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
154061620|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
154061622|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154061623|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154061624|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154061625|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154061626|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154061627|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061628|NCT00670787|Diuretics|diuretics|mesh-ancestor
154061629|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
154061630|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061631|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154061632|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061634|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154061635|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061657|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
154061658|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
154061659|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
154061660|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154061661|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154061662|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061663|NCT00595517|Esomeprazole|esomeprazole|mesh-list
154061664|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154061665|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154061666|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154061667|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061668|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061669|NCT00911651|Bromides|bromides|mesh-list
154061670|NCT00911651|Albuterol|albuterol|mesh-list
154061671|NCT00911651|Ipratropium|ipratropium|mesh-list
154061672|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
154061673|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154061674|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
154061675|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061676|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061677|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154061678|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
154061679|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
153604364|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
154061680|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154061681|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154061682|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154061683|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154061684|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
154061685|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061701|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154061702|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061703|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154061704|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154061705|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154061706|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154061707|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154061708|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154061709|NCT00823836|Ropinirole|ropinirole|mesh-list
154061710|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154061711|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154061712|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
153457681|NCT04263090|Nivolumab|nivolumab|mesh-list
154061713|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
154061714|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061715|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061716|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061717|NCT04154735|Rifaximin|rifaximin|mesh-list
154061718|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
154061719|NCT04154735|Fludarabine|fludarabine|mesh-list
154061720|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
154061721|NCT04154735|Tacrolimus|tacrolimus|mesh-list
154061722|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154061723|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
154061724|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061725|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061726|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154061727|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
154061728|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061729|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061730|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154061731|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154061732|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061733|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154061734|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154061735|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061736|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154061737|NCT00705042|Etanercept|etanercept|mesh-list
154061738|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154061739|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154061740|NCT00705042|Analgesics|analgesics|mesh-ancestor
154061741|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
154061742|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061756|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061757|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
154061758|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
154061759|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061760|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061761|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
154061762|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061763|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
154061764|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154061765|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061766|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154061767|NCT00665639|Caspofungin|caspofungin|mesh-list
154061768|NCT00665639|Micafungin|micafungin|mesh-list
154061769|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
154061770|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061771|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061772|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061773|NCT04153253|Aflibercept|aflibercept|mesh-list
154061774|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154061775|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154061776|NCT04153253|Growth Substances|growth substances|mesh-ancestor
154061777|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061778|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
154061779|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061780|NCT00671645|Bevacizumab|bevacizumab|mesh-list
154061781|NCT00671645|Capecitabine|capecitabine|mesh-list
154061782|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154061783|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061784|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154061785|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154061786|NCT00671645|Growth Substances|growth substances|mesh-ancestor
154061787|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061788|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
154061789|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154061790|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
154061791|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061792|NCT02629523|Afatinib|afatinib|mesh-list
154061793|NCT02629523|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154061794|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154061795|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061796|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061798|NCT00671801|Irinotecan|irinotecan|mesh-list
154061799|NCT00671801|Lenalidomide|lenalidomide|mesh-list
154061800|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154061801|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154061802|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061821|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061822|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154061823|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061825|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
154061826|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154061827|NCT00676637|Timolol|timolol|mesh-list
154061828|NCT00676637|Travoprost|travoprost|mesh-list
154061829|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154061830|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154061831|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154061832|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154061833|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
154061834|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061835|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061836|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061837|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154061838|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154061839|NCT00672347|Clonidine|clonidine|mesh-list
154061840|NCT00672347|Morphine|morphine|mesh-list
154061841|NCT00672347|Bupivacaine|bupivacaine|mesh-list
154061842|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
154061843|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
154061844|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061845|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061846|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
154061847|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061848|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154061849|NCT00672347|Narcotics|narcotics|mesh-ancestor
154061850|NCT00672347|Analgesics|analgesics|mesh-ancestor
154061851|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154061852|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
154061853|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
154061854|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154061855|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154061856|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154061857|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
154061893|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154061894|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
154061895|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
154061896|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061897|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154061898|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154061899|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
154061900|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154061901|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154061902|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154061903|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061904|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154061905|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154061906|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061907|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154061908|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154061909|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061910|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061911|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
154061912|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061913|NCT00677261|Anesthetics|anesthetics|mesh-list
154061914|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
154061915|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061916|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061917|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
154061918|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061919|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
154061920|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154061921|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154061922|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256566|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061924|NCT00912119|Coagulants|coagulants|mesh-ancestor
154061925|NCT00677339|Vitamin D|vitamin d|mesh-list
154061926|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
154061927|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
154061928|NCT00677339|Vitamins|vitamins|mesh-list
154061929|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
154061930|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061931|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154061932|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154061933|NCT00672971|Permethrin|permethrin|mesh-list
154061934|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061935|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061951|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154061952|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154061953|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154061954|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154061955|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
154061956|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061957|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061958|NCT02628197|Vitamin D|vitamin d|mesh-list
154061959|NCT02628197|Calcium|calcium|mesh-list
154061960|NCT02628197|Vitamins|vitamins|mesh-ancestor
154061961|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
154061962|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061963|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154061964|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154061965|NCT00673829|Interleukin-2|interleukin-2|mesh-list
154061966|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061967|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154061968|NCT00673829|Analgesics|analgesics|mesh-ancestor
154061969|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
154061970|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061971|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061972|NCT04152629|Methylphenidate|methylphenidate|mesh-list
154061973|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154061974|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154061975|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061976|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154061977|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154061978|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061979|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061981|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061982|NCT02535299|Metformin|metformin|mesh-list
154061983|NCT02535299|Liraglutide|liraglutide|mesh-list
154061984|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154061985|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061986|NCT02535299|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154061987|NCT02535299|Incretins|incretins|mesh-ancestor
154061988|NCT02535299|Hormones|hormones|mesh-ancestor
154061989|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154061990|NCT00674063|Alefacept|alefacept|mesh-list
154061991|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
154061992|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
154061993|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061994|NCT04151459|Metformin|metformin|mesh-list
154061995|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154062012|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154062014|NCT02627807|Gemcitabine|gemcitabine|mesh-list
154062015|NCT02627807|Docetaxel|docetaxel|mesh-list
154062016|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062017|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062018|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
154062019|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062020|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062021|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062022|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062023|NCT00678431|Resveratrol|resveratrol|mesh-list
154062024|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
154062025|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062026|NCT00678431|Protective Agents|protective agents|mesh-ancestor
154062027|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062028|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062029|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154062030|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154062031|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154062032|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
154062033|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062034|NCT00674687|Gabapentin|gabapentin|mesh-list
154062035|NCT00674687|Analgesics|analgesics|mesh-ancestor
154062036|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
154062037|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062038|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062039|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
154062040|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154062041|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154062042|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062043|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154062044|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154062045|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154062046|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062047|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062048|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
154062049|NCT00656747|Amoxicillin|amoxicillin|mesh-list
154062050|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
154062051|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
154062052|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
153604740|NCT01919346|Eculizumab|eculizumab|mesh-list
154062053|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154062054|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154062072|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154062073|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
154062074|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062075|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154062076|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154062077|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062078|NCT04152317|Misoprostol|misoprostol|mesh-list
154062079|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154062080|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
154062081|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154062082|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062083|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154062084|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154062085|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
154062086|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154062087|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
154062088|NCT02628665|Trioxsalen|trioxsalen|mesh-list
154062089|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
154062090|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062091|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062092|NCT00678977|Gemcitabine|gemcitabine|mesh-list
154062093|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062094|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062095|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
154062096|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062097|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154062098|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154062099|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062100|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154062101|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
154062102|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154062103|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154062104|NCT00674999|Bacitracin|bacitracin|mesh-list
154062105|NCT00674999|Nystatin|nystatin|mesh-list
154062106|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154062107|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062108|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154062109|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
154062110|NCT00674999|Ionophores|ionophores|mesh-ancestor
154062111|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154062112|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062146|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062147|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
154062148|NCT00809133|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154062149|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154062150|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062152|NCT00912275|Lapatinib|lapatinib|mesh-list
154062163|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154062164|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062165|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
154062166|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
154062167|NCT02627573|Busulfan|busulfan|mesh-list
154062168|NCT02627573|Fludarabine|fludarabine|mesh-list
154062169|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
154062170|NCT02627573|Tacrolimus|tacrolimus|mesh-list
154062171|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
154062172|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154062173|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
154062174|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062175|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154062176|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154062177|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
154062178|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062179|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062180|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154062181|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062182|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
154062183|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154062184|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062185|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154062186|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154062187|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
154062188|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154062189|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062190|NCT00675545|Carboplatin|carboplatin|mesh-list
154062191|NCT00675545|Docetaxel|docetaxel|mesh-list
154062192|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062193|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062194|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062195|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062196|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062197|NCT00679523|Tavaborole|tavaborole|mesh-list
154062198|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154062199|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
154062200|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062201|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
154062202|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154062203|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062204|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154062205|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154062206|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062207|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062208|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062209|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
154062210|NCT00808899|Doxorubicin|doxorubicin|mesh-list
154062211|NCT00808899|Irinotecan|irinotecan|mesh-list
154062212|NCT00808899|Etoposide|etoposide|mesh-list
154062213|NCT00808899|Topotecan|topotecan|mesh-list
154062214|NCT00808899|Tretinoin|tretinoin|mesh-list
154062215|NCT00808899|Temsirolimus|temsirolimus|mesh-list
154062216|NCT00808899|Isotretinoin|isotretinoin|mesh-list
154062217|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154062218|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
154062219|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062220|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154062253|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
154062254|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154062255|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062256|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062257|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
154062258|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062259|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062260|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062261|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062278|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062279|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154062280|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154062281|NCT00807573|Growth Substances|growth substances|mesh-ancestor
154062282|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062283|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
154062284|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062285|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154062286|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154062287|NCT00842712|Cisplatin|cisplatin|mesh-list
154062288|NCT00842712|Gemcitabine|gemcitabine|mesh-list
154062289|NCT00842712|Cetuximab|cetuximab|mesh-list
154062290|NCT00842712|Vinorelbine|vinorelbine|mesh-list
154062291|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062292|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062293|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
154062294|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062295|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062296|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062297|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062298|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062299|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062300|NCT00705120|Cyclosporine|cyclosporine|mesh-list
154062301|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
154062303|NCT00705120|Cyclosporins|cyclosporins|mesh-list
154062304|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154062305|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
154062306|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062307|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154062308|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154062309|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
154062310|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062311|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062312|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154062313|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062314|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
154062315|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062316|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062317|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154062318|NCT00842244|Capecitabine|capecitabine|mesh-list
154062319|NCT00842244|Axitinib|axitinib|mesh-list
154062320|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062341|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154062342|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154062343|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154062344|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062345|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154062346|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
154062347|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062348|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154062349|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154062350|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154062351|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154062352|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062353|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062354|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062355|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
154062356|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154062359|NCT00683644|Trace Elements|trace elements|mesh-ancestor
154062360|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
154062361|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062362|NCT00683644|Astringents|astringents|mesh-ancestor
154062363|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062364|NCT00753064|Prazosin|prazosin|mesh-list
154062365|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154062366|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154062367|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154062368|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154062369|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
154062370|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062371|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062372|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062373|NCT00751738|Azimilide|azimilide|mesh-list
154062393|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062394|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062396|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154062397|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062398|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154062399|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154062400|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154062401|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062402|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
154062403|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062404|NCT00823212|Aspirin|aspirin|mesh-list
154062405|NCT00823212|Ticlopidine|ticlopidine|mesh-list
154062406|NCT00823212|Clopidogrel|clopidogrel|mesh-list
154062407|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154062408|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154062409|NCT00823212|Analgesics|analgesics|mesh-ancestor
154062410|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
154062411|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062412|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062413|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154062414|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154062415|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154062416|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154062417|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062418|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154062419|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154062420|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062421|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
154062422|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153605126|NCT01930773|Clopidogrel|clopidogrel|mesh-list
154062423|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154062450|NCT05958277|Vitamins|vitamins|mesh-list
154062451|NCT05958277|Vitamin B 12|vitamin b 12|mesh-list
154062452|NCT05958277|Niacinamide|niacinamide|mesh-list
154062453|NCT05958277|Vitamin B Complex|vitamin b complex|mesh-list
154062454|NCT05958277|Micronutrients|micronutrients|mesh-ancestor
154062455|NCT05958277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062456|NCT05958173|Capsaicin|capsaicin|mesh-list
154062457|NCT05958173|Piperine|piperine|mesh-list
154062458|NCT05958173|Antipruritics|antipruritics|mesh-ancestor
154062459|NCT05958173|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062460|NCT05958173|Sensory System Agents|sensory system agents|mesh-ancestor
154062461|NCT05958173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062489|NCT05957887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154062490|NCT05957887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062492|NCT05957887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062493|NCT05957666|Misoprostol|misoprostol|mesh-list
154062494|NCT05957666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154062495|NCT05957666|Abortifacient Agents|abortifacient agents|mesh-ancestor
153605192|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062496|NCT05957666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154062497|NCT05957666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062498|NCT05957666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154062499|NCT05957666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154062500|NCT05957666|Oxytocics|oxytocics|mesh-ancestor
154062501|NCT05957653|Lidocaine|lidocaine|mesh-list
154062502|NCT05957653|Sufentanil|sufentanil|mesh-list
154062503|NCT05957653|Anesthetics, Local|anesthetics, local|mesh-ancestor
154062504|NCT05957653|Anesthetics|anesthetics|mesh-ancestor
154062523|NCT05957328|Protective Agents|protective agents|mesh-ancestor
154062524|NCT05957328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062526|NCT05957328|Micronutrients|micronutrients|mesh-ancestor
154062527|NCT05957302|Fentanyl|fentanyl|mesh-list
154062528|NCT05957302|Ketamine|ketamine|mesh-list
154062529|NCT05957302|Analgesics|analgesics|mesh-ancestor
154062530|NCT05957302|Sensory System Agents|sensory system agents|mesh-ancestor
154062531|NCT05957302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062532|NCT05957302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062533|NCT05957302|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154062534|NCT05957302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154062535|NCT05957302|Anesthetics, General|anesthetics, general|mesh-ancestor
154062536|NCT05957302|Anesthetics|anesthetics|mesh-ancestor
154062537|NCT05957302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062538|NCT05957302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154062539|NCT05957302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154062540|NCT05957302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062541|NCT05957302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062542|NCT05957302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154062543|NCT05957302|Narcotics|narcotics|mesh-ancestor
154062544|NCT05957302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154062545|NCT05957250|FAPI-46|fapi-46|mesh-list
154062546|NCT05957250|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154062547|NCT05957250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062549|NCT05957094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154062550|NCT05957094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154062551|NCT05957094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154062552|NCT05957094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062553|NCT05957094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062554|NCT05957094|Serotonin Agents|serotonin agents|mesh-ancestor
154062555|NCT05957094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062556|NCT05957094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154062557|NCT05957094|Antidepressive Agents|antidepressive agents|mesh-ancestor
154062558|NCT05957094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154062559|NCT05951712|Acetylcysteine|acetylcysteine|mesh-list
154062560|NCT05951712|Simethicone|simethicone|mesh-list
154062578|NCT05951595|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154062579|NCT05951595|Amodiaquine|amodiaquine|mesh-list
154062580|NCT05951595|Antimalarials|antimalarials|mesh-ancestor
154062581|NCT05951595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154062582|NCT05951595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154062583|NCT05951595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062584|NCT05951595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062585|NCT05951595|Antiviral Agents|antiviral agents|mesh-ancestor
154062586|NCT05951595|Schistosomicides|schistosomicides|mesh-ancestor
154062587|NCT05951595|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154062588|NCT05951595|Anthelmintics|anthelmintics|mesh-ancestor
154062589|NCT05929157|Artesunate|artesunate|mesh-list
154062590|NCT05929157|Pyronaridine|pyronaridine|mesh-list
154062591|NCT05929157|Antimalarials|antimalarials|mesh-ancestor
154062592|NCT05929157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154062593|NCT05929157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154062594|NCT05929157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062595|NCT05929157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062596|NCT05929157|Antiviral Agents|antiviral agents|mesh-ancestor
154062598|NCT05929157|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154062599|NCT05929157|Anthelmintics|anthelmintics|mesh-ancestor
154062600|NCT05861167|Ustekinumab|ustekinumab|mesh-list
154062601|NCT05861167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062602|NCT05828459|Paclitaxel|paclitaxel|mesh-list
154062603|NCT05828459|Bevacizumab|bevacizumab|mesh-list
154062604|NCT05828459|Lenalidomide|lenalidomide|mesh-list
154062605|NCT05828459|Pomalidomide|pomalidomide|mesh-list
154062606|NCT05828459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062607|NCT05828459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062608|NCT05828459|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062609|NCT05828459|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062610|NCT05828459|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062611|NCT05828459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062612|NCT05828459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062613|NCT05828459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154062614|NCT05828459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154062615|NCT05828459|Growth Substances|growth substances|mesh-ancestor
154062616|NCT05828459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062617|NCT05828459|Growth Inhibitors|growth inhibitors|mesh-ancestor
154062618|NCT05828459|Immunologic Factors|immunologic factors|mesh-ancestor
154062619|NCT05809895|Paclitaxel|paclitaxel|mesh-list
154062620|NCT05809895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154062621|NCT05809895|Carboplatin|carboplatin|mesh-list
154062622|NCT05809895|Gemcitabine|gemcitabine|mesh-list
154062623|NCT05809895|Pembrolizumab|pembrolizumab|mesh-list
154062624|NCT05809895|Tislelizumab|tislelizumab|mesh-list
154062625|NCT05809895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062648|NCT05791097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154062650|NCT05791097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154062651|NCT05791097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154062652|NCT05664659|Misoprostol|misoprostol|mesh-list
154062653|NCT05664659|Oxytocin|oxytocin|mesh-list
154062654|NCT05664659|Carbetocin|carbetocin|mesh-list
154062655|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
154062656|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154062657|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062658|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154062659|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
154062660|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154062661|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154062662|NCT05626478|Dexamethasone|dexamethasone|mesh-list
154062663|NCT05626478|Prednisolone|prednisolone|mesh-list
154062664|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154062665|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
153635734|NCT00001084|Lamivudine|lamivudine|mesh-list
154062666|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154062667|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
154062668|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154062669|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154062670|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
154062671|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154062672|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
154062673|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
154062674|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062675|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062676|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154062677|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
154062692|NCT05481645|Carboplatin|carboplatin|mesh-list
154062693|NCT05481645|Gemcitabine|gemcitabine|mesh-list
154062694|NCT05481645|Doxorubicin|doxorubicin|mesh-list
154062695|NCT05481645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154062696|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062697|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062698|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062699|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062700|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062701|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062702|NCT05481645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062703|NCT05481645|Antimetabolites|antimetabolites|mesh-ancestor
154062704|NCT05481645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154062705|NCT05481645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154062706|NCT05481645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154062707|NCT05481645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062708|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
154062709|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154062710|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154062711|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062712|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
154062713|NCT05397652|Coagulants|coagulants|mesh-ancestor
154062714|NCT05397405|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
154062715|NCT05397405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154062716|NCT05397405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154062717|NCT05397405|Antimetabolites|antimetabolites|mesh-ancestor
154062718|NCT05397405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062719|NCT05397405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154062720|NCT05397405|Protease Inhibitors|protease inhibitors|mesh-ancestor
154062721|NCT05397405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062722|NCT05397405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154062723|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154062724|NCT05345522|Antibodies|antibodies|mesh-list
154062725|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
154062726|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154062727|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
154062728|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062729|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062730|NCT05342584|Cytarabine|cytarabine|mesh-list
154062731|NCT05342584|Daunorubicin|daunorubicin|mesh-list
154062732|NCT05342584|Venetoclax|venetoclax|mesh-list
154062733|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062734|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
154062735|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062736|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062737|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
154062738|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062739|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154062740|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
153360256|NCT01355705|Hormones|hormones|mesh-ancestor
154062749|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062750|NCT05340504|Expectorants|expectorants|mesh-ancestor
154062751|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
154062752|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154062753|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
154062754|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062755|NCT05340504|Protective Agents|protective agents|mesh-ancestor
154062756|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062757|NCT05340504|Antidotes|antidotes|mesh-ancestor
154062758|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
154062759|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062760|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062761|NCT05338658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154256567|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
154062762|NCT05338658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062763|NCT05333549|Istradefylline|istradefylline|mesh-list
154062764|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154062765|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154062766|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154062767|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
154062768|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062769|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062770|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062771|NCT05278715|Carboplatin|carboplatin|mesh-list
154062772|NCT05278715|Vincristine|vincristine|mesh-list
154062773|NCT05278715|Endostatins|endostatins|mesh-list
154062774|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062775|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062776|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062777|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062778|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062779|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062780|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154062781|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154062782|NCT05278715|Growth Substances|growth substances|mesh-ancestor
154062783|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062784|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
154062785|NCT05262738|Misoprostol|misoprostol|mesh-list
154062786|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154062787|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
154062788|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154062789|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062790|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154062791|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154062792|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
154062794|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154062795|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062796|NCT05256719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062797|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062798|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154062799|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
154062800|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062801|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154062802|NCT05152901|Epinephrine|epinephrine|mesh-list
154062803|NCT05152901|Racepinephrine|racepinephrine|mesh-list
154062804|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
154062805|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154062806|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154062807|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
154062828|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
154062829|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154062830|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154062831|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062832|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154062833|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154062834|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154062835|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062836|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062837|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
154062838|NCT04952571|Bevacizumab|bevacizumab|mesh-list
154062839|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062840|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062841|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154062842|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154062843|NCT04952571|Growth Substances|growth substances|mesh-ancestor
154062844|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062845|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
154062846|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154062847|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062848|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062849|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
154062850|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154062851|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
154062852|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
154062853|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256569|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154062854|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062855|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062856|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154062857|NCT04940390|Analgesics|analgesics|mesh-ancestor
154062858|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
154062859|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062894|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062895|NCT04557020|Gemcitabine|gemcitabine|mesh-list
154062896|NCT04557020|Antibodies|antibodies|mesh-list
154062897|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
154062898|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062899|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062900|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062901|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
154062902|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062910|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
154062911|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154062912|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
154062913|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
154062914|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062915|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062916|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154062917|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
154062918|NCT04521140|Hormones|hormones|mesh-ancestor
154062919|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154062920|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154062921|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062922|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154062923|NCT04521140|Protective Agents|protective agents|mesh-ancestor
154062924|NCT04507178|Nadroparin|nadroparin|mesh-list
154062925|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
154062926|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154062927|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154062928|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062929|NCT04449861|Durvalumab|durvalumab|mesh-list
154062930|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062931|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062932|NCT04392375|Nifedipine|nifedipine|mesh-list
154062933|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154062934|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154062935|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062936|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154062937|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062938|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
154062939|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
154062940|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154062941|NCT04314570|Ropivacaine|ropivacaine|mesh-list
154062942|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
154062943|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
154062944|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062945|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062946|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
154062947|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062948|NCT04278573|Vitamin D|vitamin d|mesh-list
154062949|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
154062950|NCT04278573|Vitamins|vitamins|mesh-ancestor
154062951|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
154062952|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062953|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153605643|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
154062954|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154062956|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154062996|NCT04016805|Ibrutinib|ibrutinib|mesh-list
154062997|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062998|NCT04016805|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154062999|NCT04016805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154063000|NCT04016805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063001|NCT04016805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063002|NCT03959358|Lenalidomide|lenalidomide|mesh-list
154063003|NCT03959358|Pomalidomide|pomalidomide|mesh-list
154063004|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
154063005|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063006|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154063007|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154063008|NCT03959358|Growth Substances|growth substances|mesh-ancestor
154063009|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
154063010|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063011|NCT03714308|Aflibercept|aflibercept|mesh-list
154063012|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154063013|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154063014|NCT03714308|Growth Substances|growth substances|mesh-ancestor
154063015|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063016|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
154063017|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063018|NCT03702270|Penicillins|penicillins|mesh-list
154063019|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063046|NCT03358706|Warfarin|warfarin|mesh-list
154063047|NCT03358706|Vitamins|vitamins|mesh-ancestor
154063048|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
154063049|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063050|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154063051|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154063052|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063053|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154063054|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154063055|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154063056|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154063057|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
154063058|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
154063059|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
154063060|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
154063061|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063062|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063063|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
154063064|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154063065|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154063066|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063067|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154063068|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154063069|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
154063070|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154063071|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154063093|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063094|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063095|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
154063096|NCT03331289|Exenatide|exenatide|mesh-list
154063097|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154063098|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063099|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154063100|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063101|NCT03331289|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154063102|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154063103|NCT03331289|Incretins|incretins|mesh-ancestor
154063104|NCT03331289|Hormones|hormones|mesh-ancestor
154063105|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063106|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
154063107|NCT03215810|Nivolumab|nivolumab|mesh-list
154063108|NCT03215810|Fludarabine|fludarabine|mesh-list
154063109|NCT03215810|Interleukin-2|interleukin-2|mesh-list
154063110|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063111|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
154063112|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063113|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063114|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154063115|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
154063116|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063117|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063118|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154063119|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063120|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154063121|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154063122|NCT03215810|Analgesics|analgesics|mesh-ancestor
154063123|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
154063124|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636139|NCT00000216|Buprenorphine|buprenorphine|mesh-list
154063125|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
154063142|NCT02565628|PF-06669571|pf-06669571|mesh-list
154063143|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
154063144|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
154063145|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063146|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063147|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063148|NCT02486640|Interferons|interferons|mesh-list
154063149|NCT02486640|Interferon-beta|interferon-beta|mesh-list
154063150|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
154063151|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063152|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
154063153|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063154|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
154063155|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063156|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154063157|NCT02330991|Temozolomide|temozolomide|mesh-list
154063158|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154063159|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
154063160|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063161|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063162|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
154063163|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154063164|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
154063165|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154063166|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
154063167|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063168|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063169|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
154063170|NCT01321567|Rabeprazole|rabeprazole|mesh-list
154063171|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154063172|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154063173|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154063174|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063175|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063176|NCT01290445|Varenicline|varenicline|mesh-list
154063177|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154063178|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154063179|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
154063180|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063181|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063202|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154063203|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154063204|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063205|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154063206|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154063207|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063208|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
154063209|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
154063210|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063211|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
154063212|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
154063213|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154063214|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154063215|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063216|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154063217|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063218|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154063219|NCT00755950|Silymarin|silymarin|mesh-list
154063220|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
154063221|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063222|NCT00755950|Protective Agents|protective agents|mesh-ancestor
154063223|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063224|NCT00705354|Bacitracin|bacitracin|mesh-list
154063225|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154063226|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063227|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063228|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
154063229|NCT00575380|Azithromycin|azithromycin|mesh-list
154063230|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154063231|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153636284|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063232|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154063233|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063234|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063261|NCT00756340|Bevacizumab|bevacizumab|mesh-list
154063262|NCT00756340|Everolimus|everolimus|mesh-list
154063263|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063265|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154063266|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154063267|NCT00756340|Growth Substances|growth substances|mesh-ancestor
154063268|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063269|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
154063270|NCT00756340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154063271|NCT00756340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154063272|NCT00756340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063273|NCT00756340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063274|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063275|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
154063276|NCT00705510|Cyclosporine|cyclosporine|mesh-list
154063277|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154063278|NCT00705510|Cyclosporins|cyclosporins|mesh-list
154063279|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063280|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063281|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063282|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
154063308|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154063309|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063310|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063311|NCT05424796|Hemostatics|hemostatics|mesh-list
154063312|NCT05424796|Coagulants|coagulants|mesh-ancestor
154063313|NCT00757198|Remifentanil|remifentanil|mesh-list
154063314|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154063315|NCT00757198|Narcotics|narcotics|mesh-ancestor
154063316|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063317|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063318|NCT00757198|Analgesics|analgesics|mesh-ancestor
154063319|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
154063320|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063322|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063323|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154063324|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
154063325|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063326|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063327|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153606088|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154063328|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063329|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
154063330|NCT00679432|Hormones|hormones|mesh-ancestor
154063331|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063410|NCT00754858|Belotecan|belotecan|mesh-list
154063411|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063412|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154063413|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154063414|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063415|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063417|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154063418|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063419|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063420|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063421|NCT00705588|Tadalafil|tadalafil|mesh-list
154063422|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154063423|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
154063424|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154063425|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154063426|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063427|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063428|NCT00705588|Urological Agents|urological agents|mesh-ancestor
154063429|NCT00755170|Bevacizumab|bevacizumab|mesh-list
154063430|NCT00755170|Vinorelbine|vinorelbine|mesh-list
154063431|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063432|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063433|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154063434|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154063436|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063437|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
154063438|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154063439|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
154063468|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154063469|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154063470|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154063471|NCT00703170|Sirolimus|sirolimus|mesh-list
154063472|NCT00703170|Doxorubicin|doxorubicin|mesh-list
154063473|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154063474|NCT00703170|Temsirolimus|temsirolimus|mesh-list
154063475|NCT00703170|MTOR Inhibitors|mtor inhibitors|mesh-list
153606170|NCT06070753|Cerebrolysin|cerebrolysin|mesh-list
154063476|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154063477|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063478|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154063479|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154063480|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063481|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063482|NCT00703170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546580|NCT06037330|Sufentanil|sufentanil|mesh-list
154063483|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063508|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154063509|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154063510|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154063511|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
154063512|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063513|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063514|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
154063515|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154063516|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
154063517|NCT00758368|Apomorphine|apomorphine|mesh-list
154063519|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063520|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
154063521|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063522|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154063523|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
154063524|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
154063525|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063526|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063527|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
154063528|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154063529|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063530|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063531|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154063532|NCT05435560|Analgesics|analgesics|mesh-ancestor
154063533|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
154063545|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063546|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154063547|NCT02559154|Thalidomide|thalidomide|mesh-list
154063548|NCT02559154|Dexamethasone|dexamethasone|mesh-list
154063549|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
154063550|NCT02559154|Doxorubicin|doxorubicin|mesh-list
154063551|NCT02559154|Bortezomib|bortezomib|mesh-list
154063552|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063553|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
154063554|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063555|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063556|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154063557|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
154063558|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063559|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063560|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154063561|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063562|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
154063563|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
154063564|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063599|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063600|NCT00822120|Prednisone|prednisone|mesh-list
154063601|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
154063602|NCT00822120|Dacarbazine|dacarbazine|mesh-list
154063603|NCT00822120|Doxorubicin|doxorubicin|mesh-list
154063604|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154063606|NCT00822120|Vincristine|vincristine|mesh-list
154063607|NCT00822120|Bleomycin|bleomycin|mesh-list
154063615|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
154063616|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063617|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063618|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154063619|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154063620|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154063621|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154063623|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063625|NCT00822120|Hormones|hormones|mesh-ancestor
154063626|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063627|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154063628|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154063629|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
154063630|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
154063631|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
154063632|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
154063633|NCT00804687|Ephedrine|ephedrine|mesh-list
154063634|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154063635|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
154063636|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063637|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063638|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154063639|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063640|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
154063641|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154063642|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154063643|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
154063644|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
154063645|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063646|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063647|NCT00678652|Vaccines|vaccines|mesh-list
154063648|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
154063649|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063650|NCT02607657|Eplerenone|eplerenone|mesh-list
154063651|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154063652|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
154063653|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063654|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063655|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154063656|NCT02607657|Diuretics|diuretics|mesh-ancestor
154063657|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
154063658|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154063659|NCT00574912|Insulin|insulin|mesh-list
154063660|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154063661|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
154063662|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154063663|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063664|NCT00922896|Gemcitabine|gemcitabine|mesh-list
154063665|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154063666|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063667|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154063668|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
154063669|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063670|NCT00922896|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154063671|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154063672|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063673|NCT00761020|Mefloquine|mefloquine|mesh-list
154063734|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154063735|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
154063736|NCT03321201|Coagulants|coagulants|mesh-ancestor
154063737|NCT02612220|Hemostatics|hemostatics|mesh-list
154063738|NCT02612220|Coagulants|coagulants|mesh-ancestor
154063739|NCT04627246|Vaccines|vaccines|mesh-list
154063740|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
154063741|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063742|NCT00761644|Sirolimus|sirolimus|mesh-list
154063743|NCT00761644|Bevacizumab|bevacizumab|mesh-list
154063744|NCT00761644|Doxorubicin|doxorubicin|mesh-list
154063745|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154063746|NCT00761644|Temsirolimus|temsirolimus|mesh-list
154063747|NCT00761644|MTOR Inhibitors|mtor inhibitors|mesh-list
154063748|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063749|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636623|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
154063750|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154063751|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154063752|NCT00761644|Growth Substances|growth substances|mesh-ancestor
154063753|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063754|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
154063755|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154063756|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154063757|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154063758|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063759|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063782|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063783|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063784|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063785|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154063786|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154063787|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063788|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063790|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154063791|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
154063792|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063793|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063794|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063795|NCT04507906|Nivolumab|nivolumab|mesh-list
154063796|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063797|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063798|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154063799|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063800|NCT00762190|Insulin|insulin|mesh-list
154063801|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154063802|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154063803|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063804|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
154063805|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154063806|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063807|NCT00762658|Betamethasone|betamethasone|mesh-list
154063808|NCT00762658|Tacrolimus|tacrolimus|mesh-list
154063840|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154063841|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
154063842|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063844|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
154063845|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154063846|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154063877|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154063878|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063879|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154063880|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063881|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063882|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063883|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
154063885|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063886|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063887|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153606639|NCT05224336|Niacin|niacin|mesh-list
154063905|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063906|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154063907|NCT00764062|Amoxicillin|amoxicillin|mesh-list
154063908|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063909|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063910|NCT00758914|Vitamin E|vitamin e|mesh-list
154063911|NCT00758914|Vitamins|vitamins|mesh-ancestor
154063912|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
154063913|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063914|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
154063915|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063916|NCT00758914|Protective Agents|protective agents|mesh-ancestor
154063917|NCT00759070|Ritonavir|ritonavir|mesh-list
154063918|NCT00759070|Lopinavir|lopinavir|mesh-list
154063919|NCT00759070|Tenofovir|tenofovir|mesh-list
154063920|NCT00759070|Emtricitabine|emtricitabine|mesh-list
154063921|NCT00759070|Efavirenz|efavirenz|mesh-list
154063922|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154256571|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063923|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154063924|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
154063925|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063926|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063927|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154063928|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154063929|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
154063930|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063931|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154063932|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154063933|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154063934|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154063935|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154063936|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154063937|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154063938|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154063939|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154063940|NCT00764140|Mitogens|mitogens|mesh-list
154063941|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
154063942|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063943|NCT00672958|Vortioxetine|vortioxetine|mesh-list
154063944|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
154063945|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154063962|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063963|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063964|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
154063965|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063966|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063967|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154063969|NCT00759226|Folic Acid|folic acid|mesh-list
154063970|NCT00759226|Cisplatin|cisplatin|mesh-list
154063971|NCT00759226|Gemcitabine|gemcitabine|mesh-list
154063972|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
154063973|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063974|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154063975|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
154063976|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063977|NCT00759226|Antidotes|antidotes|mesh-ancestor
154063978|NCT00759226|Protective Agents|protective agents|mesh-ancestor
154063979|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063980|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
154063981|NCT00759226|Vitamins|vitamins|mesh-ancestor
154063982|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
154063983|NCT00759226|Hematinics|hematinics|mesh-ancestor
154063984|NCT00672646|Naproxen|naproxen|mesh-list
154063985|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154063986|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154063987|NCT00672646|Analgesics|analgesics|mesh-ancestor
154063988|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
154063989|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063990|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063991|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063992|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063993|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
154063994|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154063995|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063996|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063997|NCT00759460|Olanzapine|olanzapine|mesh-list
154063998|NCT00759460|Sertindole|sertindole|mesh-list
154063999|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
154064000|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
154064001|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064002|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064018|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
154064019|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064020|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064021|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154064022|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154064023|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
154064024|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064025|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154064026|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154064029|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154064030|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154064031|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154064032|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064033|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064034|NCT00770302|Saxagliptin|saxagliptin|mesh-list
154064035|NCT00770302|Incretins|incretins|mesh-ancestor
154064036|NCT00770302|Hormones|hormones|mesh-ancestor
154064037|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154064038|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064039|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154064040|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
154064041|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064042|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064043|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064044|NCT02557984|Naltrexone|naltrexone|mesh-list
154064045|NCT02557984|Amisulpride|amisulpride|mesh-list
154064046|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154064047|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154064048|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064049|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
154064050|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064051|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154064052|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154064053|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064054|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154064055|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154064056|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
154064057|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064058|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064059|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154064090|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064092|NCT00674362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154064093|NCT00674362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064094|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064095|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
154064096|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064097|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064098|NCT00820950|Betamethasone|betamethasone|mesh-list
154064099|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
154064100|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154064101|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
154064102|NCT00820950|Calcipotriene|calcipotriene|mesh-list
154064103|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154064124|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064126|NCT04049344|Decitabine|decitabine|mesh-list
154064127|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064128|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154064129|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
154064130|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064131|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064132|NCT00670306|Cetrorelix|cetrorelix|mesh-list
154064133|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154064134|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
154064135|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064136|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064137|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
154064138|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154064139|NCT00709254|Fentanyl|fentanyl|mesh-list
154064140|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154064141|NCT00709254|Narcotics|narcotics|mesh-ancestor
154064142|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064143|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064144|NCT00709254|Analgesics|analgesics|mesh-ancestor
154064145|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
154064146|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064147|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154064148|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154064149|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
154064150|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
154064151|NCT00760318|Levetiracetam|levetiracetam|mesh-list
154064153|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
154064154|NCT00591630|Cytarabine|cytarabine|mesh-list
154064155|NCT00591630|Rituximab|rituximab|mesh-list
154064156|NCT00591630|Etoposide|etoposide|mesh-list
154064157|NCT00591630|Melphalan|melphalan|mesh-list
154064191|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154064192|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
154064193|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
154064194|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064195|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064196|NCT00766246|Bevacizumab|bevacizumab|mesh-list
154064197|NCT00766246|Carboplatin|carboplatin|mesh-list
154064233|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
154064257|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064258|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064259|NCT00772564|Atorvastatin|atorvastatin|mesh-list
154064260|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154064261|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154064262|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
154064263|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064264|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154064265|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154064266|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064267|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154064268|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154064269|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154064270|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154064271|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064272|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064273|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064274|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154064275|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
154064276|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154064277|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
153606990|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
154064278|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154064279|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154064280|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
154064281|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064329|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064330|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154064331|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154064332|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
154064333|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064334|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154064335|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154064336|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064337|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154064338|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154064339|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154064340|NCT00773188|Bevacizumab|bevacizumab|mesh-list
154064341|NCT00773188|Vinorelbine|vinorelbine|mesh-list
154064342|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154064343|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064344|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154064345|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154064346|NCT00773188|Growth Substances|growth substances|mesh-ancestor
154064347|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064348|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
154064349|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154064350|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
154064351|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
154064352|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
154064353|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064354|NCT00767260|Insulin|insulin|mesh-list
154064355|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064356|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064357|NCT00767494|Travoprost|travoprost|mesh-list
154064358|NCT00767494|Brinzolamide|brinzolamide|mesh-list
154064359|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154064360|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154064362|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064363|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
153637067|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
154064364|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154064365|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
154064366|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064367|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064368|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154064369|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
154064370|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154064371|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
154064372|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064373|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064374|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154064375|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
154064376|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
154064377|NCT00773578|Protective Agents|protective agents|mesh-ancestor
154064378|NCT00775762|Aspirin|aspirin|mesh-list
154064379|NCT00775762|Clopidogrel|clopidogrel|mesh-list
154064400|NCT00775840|Candesartan|candesartan|mesh-list
154064401|NCT00775840|Candesartan cilexetil|candesartan cilexetil|mesh-list
154064402|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154064403|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154064404|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154064405|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064406|NCT00775918|Doxycycline|doxycycline|mesh-list
154064407|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064408|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064409|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
154064410|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154064411|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154064412|NCT00878189|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154064413|NCT00878189|Nirogacestat|nirogacestat|mesh-list
154064414|NCT00878189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064415|NCT00878189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064416|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
154064417|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
154064418|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154064419|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154064420|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064421|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064422|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154064423|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
154064424|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
154064425|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064426|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064427|NCT00773812|Mecamylamine|mecamylamine|mesh-list
154064428|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154064429|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154064430|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
154064431|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064451|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064452|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154064454|NCT02628587|Clopidogrel|clopidogrel|mesh-list
154064455|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154064456|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154064457|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154064458|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154064459|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
154064460|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064461|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064462|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064463|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
154064464|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154064465|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
154064466|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064467|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064468|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154064469|NCT00668200|Vitamin D|vitamin d|mesh-list
154064470|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
154064471|NCT00668200|Calcium|calcium|mesh-list
154064472|NCT00668200|Vitamins|vitamins|mesh-ancestor
154064473|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
154064474|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256573|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
154064475|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154064476|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154064478|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
154064479|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064480|NCT00675779|Atorvastatin|atorvastatin|mesh-list
154064481|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
154064482|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
154064483|NCT00675779|Dacuronium|dacuronium|mesh-list
154064484|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154064485|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154064486|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
154064528|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
154064529|NCT02627417|Hormones|hormones|mesh-ancestor
154064530|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154064531|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064532|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154064533|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064534|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064535|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
154064536|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154064537|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154064538|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154064539|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064540|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064541|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
154064542|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064543|NCT02556892|Ibrutinib|ibrutinib|mesh-list
154064544|NCT02556892|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154064545|NCT02556892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154064546|NCT02556892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064547|NCT02556892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064548|NCT00679679|Metformin|metformin|mesh-list
154064549|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064550|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064551|NCT00838578|Irinotecan|irinotecan|mesh-list
154064552|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154064553|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154064554|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064555|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064556|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064557|NCT02634515|Insulin|insulin|mesh-list
154064558|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154064559|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064560|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064561|NCT00705900|Calcipotriene|calcipotriene|mesh-list
154064562|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
154064563|NCT00679835|Daptomycin|daptomycin|mesh-list
154064564|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064584|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064585|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064586|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
154064587|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154064588|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154064589|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154064590|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
154064591|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
154064592|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064593|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154064594|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064595|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064596|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
154064597|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064598|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154064599|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064600|NCT00881621|Capecitabine|capecitabine|mesh-list
154064601|NCT00881621|Lapatinib|lapatinib|mesh-list
154064602|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154064603|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
154064604|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064605|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064606|NCT00881621|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154064607|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153458362|NCT04022226|Ketamine|ketamine|mesh-list
154064608|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064609|NCT02634281|Varenicline|varenicline|mesh-list
154064610|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154064611|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154064612|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
154064613|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064614|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064615|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064616|NCT00818766|Vancomycin|vancomycin|mesh-list
154064617|NCT00818766|Cefazolin|cefazolin|mesh-list
154064618|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064633|NCT02556970|Acetaminophen|acetaminophen|mesh-list
154064634|NCT02556970|Diclofenac|diclofenac|mesh-list
154064635|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
154064636|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154064637|NCT02556970|Analgesics|analgesics|mesh-ancestor
154064638|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
154064639|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064640|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064641|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
154064642|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154064643|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064644|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064645|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154064646|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064647|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064648|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
154064649|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
154064650|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064651|NCT00594815|Leucovorin|leucovorin|mesh-list
154064652|NCT00594815|Cytarabine|cytarabine|mesh-list
154064653|NCT00594815|Rituximab|rituximab|mesh-list
154064654|NCT00594815|Methotrexate|methotrexate|mesh-list
154064655|NCT00594815|Vincristine|vincristine|mesh-list
154064656|NCT00594815|Procarbazine|procarbazine|mesh-list
154064657|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154064658|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064659|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
154064660|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064661|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064662|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154064663|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
154064664|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064665|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154064666|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
154064667|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064668|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154064669|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064670|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154064671|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064672|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154064673|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
154064674|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064675|NCT00594815|Antidotes|antidotes|mesh-ancestor
154064676|NCT00594815|Protective Agents|protective agents|mesh-ancestor
154064677|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
154064678|NCT00594815|Vitamins|vitamins|mesh-ancestor
154064679|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
154064680|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154064692|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
154064693|NCT00776698|Bevacizumab|bevacizumab|mesh-list
154064694|NCT00776698|Etoposide|etoposide|mesh-list
154064695|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154064696|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064697|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154064698|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154064699|NCT00776698|Growth Substances|growth substances|mesh-ancestor
154064700|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064701|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
154064702|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154064703|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154064704|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154064705|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064706|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064707|NCT04150757|Ketamine|ketamine|mesh-list
154064708|NCT04150757|Analgesics|analgesics|mesh-ancestor
154064709|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
154064710|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064711|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064712|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154064713|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154064714|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
154064715|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
154064716|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064717|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154064718|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154064719|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064720|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064721|NCT04150367|Rifampin|rifampin|mesh-list
154064722|NCT04150367|Isoniazid|isoniazid|mesh-list
154064723|NCT04150367|Ethambutol|ethambutol|mesh-list
154064724|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154064725|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154064726|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
154064727|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064728|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064729|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
154064730|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154064731|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064732|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064733|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154064734|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154064735|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154064736|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154064737|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154064738|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154064739|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154064740|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154064741|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
154064742|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154064743|NCT02634203|Riociguat|riociguat|mesh-list
154064744|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
154064757|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
154064758|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064759|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064760|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064761|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064762|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
154064763|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
154064764|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064765|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154064766|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064767|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064768|NCT00684827|Albuterol|albuterol|mesh-list
154064769|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154064770|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
154064771|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064772|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064773|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154064774|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
154064775|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
154064776|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064777|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154064778|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154064779|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154064780|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
154064781|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064782|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064783|NCT00820170|Paclitaxel|paclitaxel|mesh-list
154064784|NCT00820170|Dasatinib|dasatinib|mesh-list
154064785|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154064786|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064787|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
154064788|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
154064789|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
154064790|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064791|NCT00820170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154064793|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064794|NCT02627027|Metformin|metformin|mesh-list
154064795|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064796|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064797|NCT00709332|Folic Acid|folic acid|mesh-list
154064798|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154064799|NCT00709332|Norgestimate|norgestimate|mesh-list
154064800|NCT00709332|Estradiol|estradiol|mesh-list
154064801|NCT00709332|Estrogens|estrogens|mesh-ancestor
154064802|NCT00709332|Hormones|hormones|mesh-ancestor
154064803|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154064804|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064805|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154064806|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
154064833|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154064834|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064835|NCT02633813|Naftifine|naftifine|mesh-list
154064836|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
154064837|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064838|NCT00818454|Albuterol|albuterol|mesh-list
154064839|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154064840|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
154064841|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064842|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064843|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154064844|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
154064845|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
154064846|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064847|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154064848|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154064849|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154064850|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
154064851|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064852|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064853|NCT02626247|Vitamin A|vitamin a|mesh-list
154064854|NCT02626247|Vitamins|vitamins|mesh-ancestor
154064855|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
154064856|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064857|NCT00828984|Laxatives|laxatives|mesh-list
154064875|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064877|NCT00876395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154064878|NCT00876395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154064880|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064881|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
154064882|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064883|NCT05758662|Listerine|listerine|mesh-list
154064884|NCT05758662|Fluorides|fluorides|mesh-list
154064885|NCT05758662|Sodium Fluoride|sodium fluoride|mesh-list
154064886|NCT05758662|Cariostatic Agents|cariostatic agents|mesh-ancestor
154064887|NCT05758662|Protective Agents|protective agents|mesh-ancestor
154064888|NCT05758662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064889|NCT05758662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154064890|NCT05758662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064891|NCT02633657|Gabapentin|gabapentin|mesh-list
154064892|NCT02633657|Analgesics|analgesics|mesh-ancestor
154064893|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
154064894|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064895|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064896|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
154064897|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154064898|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154064899|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064900|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154064901|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154064902|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154064903|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064904|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064905|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
154064906|NCT02626169|Clopidogrel|clopidogrel|mesh-list
154064907|NCT02626169|Ticagrelor|ticagrelor|mesh-list
154064908|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154064909|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154064910|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154064911|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154064912|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
153637628|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064913|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064914|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064915|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064916|NCT04139915|Dactolisib|dactolisib|mesh-list
154064933|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
154064934|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
154064935|NCT02633579|Atropine|atropine|mesh-list
154064936|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154064937|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154064938|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154064939|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
154064940|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064941|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064942|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154064943|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
154064944|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
154064945|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
154064946|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154064947|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154064948|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
154064949|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064950|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064951|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064952|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064953|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154064954|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154064955|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064956|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
154064957|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154064958|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
154064959|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064960|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064961|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154064962|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
154064963|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154064964|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154064965|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154064966|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154064967|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064968|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064969|NCT00685607|Simethicone|simethicone|mesh-list
154064971|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
154064972|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154064973|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
154064974|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064975|NCT00685607|Emollients|emollients|mesh-ancestor
154064976|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
154064994|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064995|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
154064996|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
154064997|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064998|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154064999|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154065000|NCT00657059|Protective Agents|protective agents|mesh-ancestor
154065001|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154065002|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154065003|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154065004|NCT00667732|Exenatide|exenatide|mesh-list
154065005|NCT00667732|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154065006|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154065007|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065008|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154065009|NCT00667732|Incretins|incretins|mesh-ancestor
154065010|NCT00667732|Hormones|hormones|mesh-ancestor
154065011|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065012|NCT04161209|Citalopram|citalopram|mesh-list
154065013|NCT04161209|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154065014|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154065015|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154065016|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731210|NCT00153270|Valproic Acid|valproic acid|mesh-list
154256574|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
154065017|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065018|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
154065019|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065020|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154065021|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
154065022|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154065023|NCT04161053|Rifaximin|rifaximin|mesh-list
154065024|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
154065025|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154065026|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065027|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065028|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154065029|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154065030|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
154065031|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154065032|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154065080|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
154065081|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065082|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065083|NCT00657137|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154065084|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154065085|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065086|NCT00777244|Mitotane|mitotane|mesh-list
154065087|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154065088|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065089|NCT04160897|Tenofovir|tenofovir|mesh-list
154065090|NCT04160897|Entecavir|entecavir|mesh-list
154065091|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
154065092|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065093|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154065094|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154065095|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065096|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065097|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154065098|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154065099|NCT00777322|Riboflavin|riboflavin|mesh-list
154065100|NCT00777322|Dextrans|dextrans|mesh-list
154065101|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
154065102|NCT00777322|Vitamins|vitamins|mesh-ancestor
154065103|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
153607892|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
154065104|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065105|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154065106|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
154065107|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
154065108|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
154065109|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
154065110|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154065111|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
154065112|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154065113|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154065114|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065115|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065116|NCT00682019|Urological Agents|urological agents|mesh-ancestor
154065117|NCT00779896|Tazarotene|tazarotene|mesh-list
154065118|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
154065119|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
154065120|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154065121|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154065122|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154065123|NCT02556268|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
154065144|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
154065145|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
154065146|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065147|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065148|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
154065149|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065150|NCT00768508|Naltrexone|naltrexone|mesh-list
154065151|NCT00768508|Ondansetron|ondansetron|mesh-list
154065152|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154065153|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154065156|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065157|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
154065158|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
154065159|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065160|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
154065161|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
154065162|NCT00768508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154065163|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154065164|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
154065165|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065166|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065167|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
154065168|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154065169|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154065170|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154065171|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065172|NCT00777478|Sunitinib|sunitinib|mesh-list
154065173|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065174|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154065175|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154065176|NCT00777478|Growth Substances|growth substances|mesh-ancestor
154065177|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065207|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154065208|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065209|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154065210|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065211|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154065212|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
154065213|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
154065214|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065215|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065216|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
154065217|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
154065218|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
154065219|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065278|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
154065279|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065280|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065281|NCT04138901|Ropivacaine|ropivacaine|mesh-list
154065282|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
154065283|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
154065396|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065397|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
154065398|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065399|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065400|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
154065401|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154065402|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065403|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154065404|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
154065405|NCT00667420|Epirubicin|epirubicin|mesh-list
154065406|NCT00667420|Panitumumab|panitumumab|mesh-list
154065407|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065520|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154065522|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
154065523|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
154065524|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065525|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065526|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
154065527|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065528|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
154065529|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154065530|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
154065531|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065532|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065533|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154065534|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
154065535|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065566|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154065567|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065568|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154065570|NCT00781846|Growth Substances|growth substances|mesh-ancestor
154065571|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065572|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
154065573|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154065574|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065575|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154065576|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
154065577|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154065578|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
154065645|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065647|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154065648|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065649|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
154065650|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065651|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154065652|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154065653|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
154065654|NCT02613026|Docetaxel|docetaxel|mesh-list
154065655|NCT02613026|Pirarubicin|pirarubicin|mesh-list
154065685|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065687|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
154065688|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065689|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
154065690|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154065692|NCT00769522|Fludarabine|fludarabine|mesh-list
154065693|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154065694|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
154065695|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065696|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065697|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154065698|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
154065733|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154065734|NCT00782548|Narcotics|narcotics|mesh-ancestor
154065735|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065736|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065737|NCT00782548|Analgesics|analgesics|mesh-ancestor
154065738|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
154065820|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154065821|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065822|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
154065823|NCT00695201|Irinotecan|irinotecan|mesh-list
154065824|NCT00695201|Floxuridine|floxuridine|mesh-list
154065825|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065826|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154065827|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154065828|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065829|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065830|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154065831|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
154065832|NCT00689585|Ethosuximide|ethosuximide|mesh-list
154065833|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
154065835|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154065836|NCT00783016|Narcotics|narcotics|mesh-ancestor
154065837|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065838|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065839|NCT00783016|Analgesics|analgesics|mesh-ancestor
154065840|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
154065841|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065842|NCT00769990|Genistein|genistein|mesh-list
154065843|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154065844|NCT00769990|Protective Agents|protective agents|mesh-ancestor
154065845|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065846|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065847|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154065848|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065849|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065850|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
154065851|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154065852|NCT00769990|Estrogens|estrogens|mesh-ancestor
154065853|NCT00769990|Hormones|hormones|mesh-ancestor
154065854|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065855|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
154065856|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154065857|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154256575|NCT03877718|Promethazine|promethazine|mesh-list
154256576|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
154065858|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
154065859|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065860|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154065888|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
154065889|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154065890|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
154065891|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065892|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065893|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154065894|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
154065895|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
154065896|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154065897|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
154065898|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065899|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065900|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
154065901|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154065902|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154065903|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154065904|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154065905|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
154065907|NCT00783328|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154066163|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154066164|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154066165|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
154066166|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066167|NCT00828672|Bevacizumab|bevacizumab|mesh-list
154066168|NCT00828672|Capecitabine|capecitabine|mesh-list
154066169|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
154066170|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066171|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066172|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154066173|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154066174|NCT00828672|Growth Substances|growth substances|mesh-ancestor
154066175|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066176|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
154066177|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154066178|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
154066179|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066180|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154066181|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154066182|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066183|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066184|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154066185|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
154066186|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154066187|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066188|NCT00873119|Paclitaxel|paclitaxel|mesh-list
154066189|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154066339|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066340|NCT00784186|Misoprostol|misoprostol|mesh-list
154066341|NCT00784186|Mifepristone|mifepristone|mesh-list
154066342|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154066343|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
154066507|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154066508|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066509|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066510|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154066511|NCT04015908|Narcotics|narcotics|mesh-ancestor
154066512|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154066513|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066514|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066515|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154066516|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154066553|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066554|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066555|NCT02623127|Sunitinib|sunitinib|mesh-list
154066620|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154066682|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
154066683|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154066684|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066685|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066686|NCT02620163|Amlodipine|amlodipine|mesh-list
154066687|NCT02620163|Telmisartan|telmisartan|mesh-list
154066688|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
154066689|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154066690|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154066691|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154066692|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154066693|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066694|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154066695|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066696|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
154066822|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
154066823|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066824|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154066825|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154066826|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066827|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
154066858|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
154066859|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066860|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066861|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
154066862|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066863|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154066864|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154066865|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
154066866|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066867|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154066868|NCT00851318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154066869|NCT00851318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067069|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067071|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154067072|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154067073|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067074|NCT00693251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067075|NCT00693251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067076|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067077|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
154067078|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067079|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154067080|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067081|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154067082|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
154067083|NCT00792376|Diclofenac|diclofenac|mesh-list
154067084|NCT00792376|Etoricoxib|etoricoxib|mesh-list
154067085|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154067086|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154067087|NCT00792376|Analgesics|analgesics|mesh-ancestor
154067088|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
154067089|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067090|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067091|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067092|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067093|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154067094|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067116|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
154067117|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
154067118|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067120|NCT00869999|Everolimus|everolimus|mesh-list
154067121|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154067122|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067123|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
154067124|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067125|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067126|NCT00869999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154067127|NCT00869999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067128|NCT00869999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067129|NCT00869999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067130|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256577|NCT03877718|Sumatriptan|sumatriptan|mesh-list
154067131|NCT04030988|Dexamethasone|dexamethasone|mesh-list
154067132|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067133|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
154067134|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
154067135|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067136|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067137|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067138|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
154067140|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067141|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154067142|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067143|NCT00703352|Eplerenone|eplerenone|mesh-list
154067144|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154067145|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
153553789|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067180|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067181|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
154067182|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067183|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067184|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067211|NCT00570232|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154067212|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067214|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067215|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067216|NCT05755854|Cyclophosphamide|cyclophosphamide|mesh-list
154067217|NCT05755854|Fludarabine|fludarabine|mesh-list
154067218|NCT05755854|Fludarabine phosphate|fludarabine phosphate|mesh-list
154067219|NCT05755854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067220|NCT05755854|Immunologic Factors|immunologic factors|mesh-ancestor
154067221|NCT05755854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067222|NCT05755854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067223|NCT05755854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154067224|NCT05755854|Alkylating Agents|alkylating agents|mesh-ancestor
154067225|NCT05755854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067226|NCT05755854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067227|NCT05755854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154067228|NCT05755854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154067229|NCT05755854|Antimetabolites|antimetabolites|mesh-ancestor
154067230|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
154067231|NCT00787384|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154067364|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
154067365|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067366|NCT00809094|Expectorants|expectorants|mesh-ancestor
154067367|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
154067368|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154067369|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
154067370|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067371|NCT00809094|Protective Agents|protective agents|mesh-ancestor
154067372|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067373|NCT00809094|Antidotes|antidotes|mesh-ancestor
154067374|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154067375|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
154067376|NCT02615639|Entecavir|entecavir|mesh-list
154067377|NCT02615639|Telbivudine|telbivudine|mesh-list
154067378|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
154067379|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154067380|NCT02615639|Vaccines|vaccines|mesh-list
154067381|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
154067382|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067383|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
154067384|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067385|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154067386|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067387|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067388|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067389|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
154067390|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154067391|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154067392|NCT00798616|Prednisolone|prednisolone|mesh-list
154067393|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
154067394|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154067395|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
153458633|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
154067396|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067397|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
154067398|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
154067399|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067400|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067401|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067424|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067425|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154067426|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154067428|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
154067429|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
154067430|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154067431|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
154067432|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067433|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067434|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154067435|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
154067436|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154067437|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154067438|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154067439|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154067440|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067441|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067442|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
154067443|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154067444|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
154067445|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
154067446|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
154067447|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154067448|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154067449|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
154067521|NCT04132583|Diclofenac|diclofenac|mesh-list
154067522|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154067523|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154067524|NCT04132583|Analgesics|analgesics|mesh-ancestor
154067525|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
154067526|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067627|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067629|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154067630|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
154067631|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067632|NCT05757336|Paclitaxel|paclitaxel|mesh-list
154067633|NCT05757336|Bevacizumab|bevacizumab|mesh-list
154067634|NCT05757336|Gemcitabine|gemcitabine|mesh-list
154067635|NCT05757336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154067812|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154067813|NCT00827918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154067814|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154067815|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154067816|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067817|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067819|NCT00813150|Dexamethasone|dexamethasone|mesh-list
154067820|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
154067821|NCT00813150|Bortezomib|bortezomib|mesh-list
154067822|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067823|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
154067824|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067825|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067826|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154067827|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
154067828|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067829|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067830|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154067831|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067832|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
154067833|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
154067834|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067835|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067836|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
154067837|NCT00813150|Hormones|hormones|mesh-ancestor
154067838|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067839|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154067864|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
154067865|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067866|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154067867|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154067868|NCT00827606|Atorvastatin|atorvastatin|mesh-list
154067869|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154067870|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154067871|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
154067872|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067873|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154067874|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154067875|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067876|NCT04016220|Budesonide|budesonide|mesh-list
154067877|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067878|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154067879|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
154067880|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067881|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067882|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154067883|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
154067884|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
154067885|NCT04016220|Hormones|hormones|mesh-ancestor
154067886|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067887|NCT00663052|Etanercept|etanercept|mesh-list
154067888|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154067889|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154068031|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068032|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068034|NCT00826514|Analgesics|analgesics|mesh-ancestor
154068035|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
154068036|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068037|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068038|NCT00800566|Clofarabine|clofarabine|mesh-list
154068039|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154068040|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
154068041|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068042|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068043|NCT00793858|Ciclesonide|ciclesonide|mesh-list
154068044|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
154068045|NCT00793858|Hormones|hormones|mesh-ancestor
154068046|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154068047|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068048|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154068049|NCT00800722|Sirolimus|sirolimus|mesh-list
154068050|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068051|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068052|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154068053|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068054|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
154068055|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154068056|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
154068057|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068059|NCT00826280|Regadenoson|regadenoson|mesh-list
154068060|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154068061|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068062|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154068130|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154068131|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068132|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068134|NCT02614937|Ranibizumab|ranibizumab|mesh-list
154068135|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154068136|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154068137|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154068138|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154068164|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153610903|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068165|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154068166|NCT00789646|Lidocaine|lidocaine|mesh-list
154068167|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
154068168|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
154068169|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068170|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068171|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
154256578|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153639219|NCT00016159|Tretinoin|tretinoin|mesh-list
154068172|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068173|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154068174|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154068175|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154068176|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068177|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068178|NCT00856973|Eszopiclone|eszopiclone|mesh-list
154068179|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154068180|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068181|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068182|NCT00794638|Rituximab|rituximab|mesh-list
154068183|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154068184|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154068247|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
154068248|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068249|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154068250|NCT00844376|Atorvastatin|atorvastatin|mesh-list
154068560|NCT00855959|Budesonide|budesonide|mesh-list
154068561|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154068650|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154068651|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154068652|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154068653|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068654|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068655|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
154068656|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068657|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068658|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154068695|NCT00703196|Hematinics|hematinics|mesh-ancestor
154068723|NCT00806442|Borage oil|borage oil|mesh-list
154068724|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068725|NCT02608242|Amlodipine|amlodipine|mesh-list
154068726|NCT02608242|Telmisartan|telmisartan|mesh-list
154068727|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154068728|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154068729|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154068730|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154068731|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068732|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068733|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154068734|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068735|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
154068736|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154068737|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154068738|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
154068739|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154068740|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154068741|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068742|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154068743|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154068777|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068778|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068779|NCT00865709|Leucovorin|leucovorin|mesh-list
154068780|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
154068781|NCT00865709|Fluorouracil|fluorouracil|mesh-list
154068782|NCT00865709|Sorafenib|sorafenib|mesh-list
154068783|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
154068784|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068785|NCT00865709|Antidotes|antidotes|mesh-ancestor
154068818|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154068819|NCT00839072|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154068820|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154068821|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068822|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068823|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068824|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
154068825|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154068826|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
154068827|NCT00704990|Vitamins|vitamins|mesh-list
154068828|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
153458696|NCT03586674|Fenofibrate|fenofibrate|mesh-list
154068829|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
154068860|NCT00838682|Omeprazole|omeprazole|mesh-list
154068861|NCT00838682|Rabeprazole|rabeprazole|mesh-list
154068862|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154068863|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068864|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154068865|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068866|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068867|NCT00913484|Disulfiram|disulfiram|mesh-list
154068868|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154068869|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154068870|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068871|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068872|NCT00803712|Vitamin D|vitamin d|mesh-list
154068873|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
154068874|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
154068967|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
154068968|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
154068969|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154068970|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068971|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068972|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
154068973|NCT00705770|Anecortave|anecortave|mesh-list
154068974|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154068975|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154068976|NCT00705770|Growth Substances|growth substances|mesh-ancestor
154068977|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068978|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
154068979|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068980|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154068981|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
154068982|NCT00796653|Olodaterol|olodaterol|mesh-list
154068983|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154068984|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
154068985|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068986|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068987|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154069062|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069063|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069064|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153611808|NCT04198805|Vitamins|vitamins|mesh-list
154069065|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
154069066|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069067|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069068|NCT00805740|Caspofungin|caspofungin|mesh-list
154069069|NCT00805740|Anidulafungin|anidulafungin|mesh-list
154069070|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
154069071|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069072|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069073|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069074|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
154069075|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154069076|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
154069077|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069078|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
154069079|NCT05613075|Protective Agents|protective agents|mesh-ancestor
154069080|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154069081|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
154069082|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154069083|NCT01227876|Prednisolone|prednisolone|mesh-list
154069084|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
154069085|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154069086|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
154069087|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069088|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
154069089|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
154069090|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069091|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069092|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154069093|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
154069094|NCT01227876|Hormones|hormones|mesh-ancestor
154069095|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069096|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154069129|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154256579|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154069130|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069131|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
154069132|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154069133|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069134|NCT04110093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069135|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069136|NCT00588237|Paclitaxel|paclitaxel|mesh-list
154069137|NCT00588237|Bevacizumab|bevacizumab|mesh-list
154069205|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069206|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069208|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069382|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
154069383|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069384|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069385|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
154069386|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069387|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154069388|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154069389|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154069390|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154069391|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069392|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069393|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
154069395|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069396|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154069397|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
154069398|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069399|NCT00588354|Analgesics|analgesics|mesh-ancestor
154069400|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154069401|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
154069402|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
154069403|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154069404|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154069424|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
154069425|NCT01019395|Daptomycin|daptomycin|mesh-list
154069426|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154069427|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069428|NCT00830960|Clopidogrel|clopidogrel|mesh-list
154069429|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154069430|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154069431|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154069432|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154069433|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154069434|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
154069435|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612173|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154069436|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069437|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069439|NCT01026961|Dimethindene|dimethindene|mesh-list
154069440|NCT01026961|Phenylephrine|phenylephrine|mesh-list
154069441|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
154069442|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069443|NCT01026961|Analgesics|analgesics|mesh-ancestor
154069444|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
154069445|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069446|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069447|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
154069448|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069449|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154069450|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
154069451|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
154069452|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
154069453|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154069454|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
154069455|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
154069456|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154069457|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154069458|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154069459|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
154069460|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256580|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154069493|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069494|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069496|NCT01023919|Paclitaxel|paclitaxel|mesh-list
154069497|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154069498|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069499|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069500|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
154069501|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
154069502|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069503|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154069504|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069505|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154069506|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
154069530|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154069531|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154069532|NCT00789477|Growth Substances|growth substances|mesh-ancestor
154069533|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069534|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
154069535|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069537|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069538|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
154069539|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
154069540|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552674|NCT01579461|Mirabegron|mirabegron|mesh-list
154069541|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069542|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154069543|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
154069544|NCT01024075|Hormones|hormones|mesh-ancestor
154069545|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069546|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154069547|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069548|NCT00913874|Valproic Acid|valproic acid|mesh-list
154069549|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
154069550|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069551|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069552|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
154069553|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069554|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069555|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
154069556|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154069557|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069558|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154069583|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
154069584|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612323|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154069585|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069586|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154069588|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154069589|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
154069590|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069591|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069592|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154069593|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154069594|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154069595|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154069596|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154069598|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
154069599|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069600|NCT02605434|Levodopa|levodopa|mesh-list
154069601|NCT02605434|Carbidopa|carbidopa|mesh-list
154069602|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154069603|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154069604|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154069605|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
154069606|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069607|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069608|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069609|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154069642|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256581|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
153639731|NCT00017758|Efavirenz|efavirenz|mesh-list
154069643|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069644|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154069645|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154069646|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154069647|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154069648|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154069706|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069707|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154069708|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154069709|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154069710|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069711|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069712|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
154069713|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
154069714|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069715|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154069716|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154069717|NCT04118153|Abatacept|abatacept|mesh-list
154069718|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154069719|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069720|NCT04118153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069721|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069722|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154069723|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
154069724|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069725|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069726|NCT00848393|Fentanyl|fentanyl|mesh-list
154069727|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
154069728|NCT00848393|Citric Acid|citric acid|mesh-list
154069729|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
154069730|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154069731|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069732|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612479|NCT01954693|Everolimus|everolimus|mesh-list
154069733|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069772|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069773|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154069774|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154069833|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154069834|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154069835|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154069836|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154069837|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069838|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069839|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
154069840|NCT00787527|Hormones|hormones|mesh-ancestor
154069841|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069842|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154069843|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154069844|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069845|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
154069846|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
154069847|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154069848|NCT00804388|Vitamin E|vitamin e|mesh-list
154069849|NCT00804388|Vitamins|vitamins|mesh-ancestor
154069850|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
154069943|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154069944|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154069945|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069946|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069947|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154069948|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
154069949|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069950|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069951|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
154069952|NCT00807196|Rituximab|rituximab|mesh-list
154069953|NCT00807196|Fludarabine|fludarabine|mesh-list
154069954|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154069955|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
154256582|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069956|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069957|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069958|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154069959|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
154069960|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069961|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069962|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154069963|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154070023|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
154070024|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154070025|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070026|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070027|NCT00800436|Trastuzumab|trastuzumab|mesh-list
154070028|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154070029|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070031|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154070032|NCT00810940|Diuretics|diuretics|mesh-ancestor
154070033|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
154070034|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070035|NCT04109508|Semaglutide|semaglutide|mesh-list
154070036|NCT04109508|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154070037|NCT04109508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154070038|NCT04109508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070039|NCT00655564|Alefacept|alefacept|mesh-list
154070040|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070077|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070096|NCT00800202|Bevacizumab|bevacizumab|mesh-list
154070097|NCT00800202|Carboplatin|carboplatin|mesh-list
154070098|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154070099|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154070100|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070101|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
154070102|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
154070103|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
154070104|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070105|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154070106|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154070107|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154070108|NCT00800202|Growth Substances|growth substances|mesh-ancestor
154070109|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070110|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
154070111|NCT00800202|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154070112|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154070113|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070114|NCT00811096|Chloroquine|chloroquine|mesh-list
154070115|NCT00811096|Tinidazole|tinidazole|mesh-list
154070116|NCT00811096|Amebicides|amebicides|mesh-ancestor
154070117|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154070118|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154070119|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070120|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
154070121|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070122|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
154070123|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070124|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154070125|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154070126|NCT05146804|Sulforaphane|sulforaphane|mesh-list
154070127|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154070128|NCT05146804|Protective Agents|protective agents|mesh-ancestor
154070129|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070130|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070131|NCT00655486|Lacosamide|lacosamide|mesh-list
154070132|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
154070133|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154070134|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154070168|NCT00654940|Pregabalin|pregabalin|mesh-list
154070169|NCT00654940|Analgesics|analgesics|mesh-ancestor
154070170|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
154070171|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070172|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070173|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
154070175|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070206|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154070207|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
154070208|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154070209|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070210|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154070211|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154070212|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154070213|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154070214|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154070215|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154070244|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
154070245|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154070246|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154070247|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154070248|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
154070249|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070250|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070251|NCT01024543|Protective Agents|protective agents|mesh-ancestor
154070252|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154070253|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
154070254|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070256|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154070257|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154070258|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
154070259|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070260|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154070261|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154070331|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154070402|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070403|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070404|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153613152|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
154070405|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154070406|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154070407|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
154070408|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070409|NCT00446563|Losartan|losartan|mesh-list
154070410|NCT00446563|Amlodipine|amlodipine|mesh-list
154070411|NCT00446563|Valsartan|valsartan|mesh-list
154070412|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154070413|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154070414|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154070415|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070416|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070417|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154070418|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070419|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
154070420|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154070421|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154070422|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154070423|NCT00446563|Diuretics|diuretics|mesh-ancestor
154070424|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
154070425|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154070426|NCT00650806|Canagliflozin|canagliflozin|mesh-list
154070427|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154070428|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070429|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154070430|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070431|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154070432|NCT00863057|Methadone|methadone|mesh-list
154070433|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154070434|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154070435|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070436|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070437|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070438|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070439|NCT00863057|Analgesics|analgesics|mesh-ancestor
154070440|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
154070441|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070442|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
154070443|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154070474|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154070475|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
154070476|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
154070477|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
154070478|NCT00829166|Immunotoxins|immunotoxins|mesh-ancestor
154070479|NCT00829166|Immunoconjugates|immunoconjugates|mesh-ancestor
153613215|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070480|NCT00829166|Immunologic Factors|immunologic factors|mesh-ancestor
154070481|NCT00829166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070482|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
154070483|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154070484|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070485|NCT00650104|Ropinirole|ropinirole|mesh-list
154070486|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154070487|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154070488|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
154070489|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
154070490|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553790|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070560|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070562|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
154070563|NCT02605356|Hormones|hormones|mesh-ancestor
154070564|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070565|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154070566|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070567|NCT00812266|Carboplatin|carboplatin|mesh-list
154070568|NCT00812266|Etoposide|etoposide|mesh-list
154070569|NCT00812266|Topotecan|topotecan|mesh-list
154070596|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
154070597|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070598|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070599|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154070600|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
154070601|NCT00446251|Rituximab|rituximab|mesh-list
154070602|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154070603|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070604|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
154070605|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070606|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070607|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154070608|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154070609|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
154070610|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154070611|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070612|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070613|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070614|NCT00812422|Ibuprofen|ibuprofen|mesh-list
153553791|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
154070633|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070634|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154070635|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
154070636|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070637|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070638|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154070639|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
154070640|NCT00812578|Vitamin D|vitamin d|mesh-list
154070641|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154070642|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070643|NCT00812578|Vitamins|vitamins|mesh-ancestor
154070644|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
154070645|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154070646|NCT00796224|Azithromycin|azithromycin|mesh-list
154070647|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154070648|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070649|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
154070650|NCT00808366|Clotrimazole|clotrimazole|mesh-list
154070651|NCT00808366|Miconazole|miconazole|mesh-list
154070652|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
154070653|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070654|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153458807|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
154070655|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154070656|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154070658|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070659|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154070660|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
154070661|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070662|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070663|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154070664|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154070665|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070666|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
154070667|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154070690|NCT00848081|Urological Agents|urological agents|mesh-ancestor
154070691|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
154070692|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070694|NCT04111380|Cisplatin|cisplatin|mesh-list
154070695|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154070696|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070697|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
154070698|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
154070699|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
154070700|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070701|NCT04117919|Triamcinolone|triamcinolone|mesh-list
153613441|NCT01961830|Arbekacin|arbekacin|mesh-list
154070702|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154070703|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154070704|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
154070705|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154070706|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154070707|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154070708|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154070709|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070710|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
154070711|NCT04117919|Hormones|hormones|mesh-ancestor
154070712|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070713|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070714|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070715|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
154070716|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553792|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070782|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070783|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070784|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
154070785|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070786|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070787|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070788|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154070789|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154070790|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154070812|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070813|NCT00647296|Protective Agents|protective agents|mesh-ancestor
154070814|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070815|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
154070816|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070817|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154070818|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154070819|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
154070820|NCT00644878|Nilotinib|nilotinib|mesh-list
154070821|NCT00644878|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154070822|NCT00644878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154070823|NCT00644878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070824|NCT00644878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070825|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154070826|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
154070827|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070828|NCT00646906|Aspirin|aspirin|mesh-list
154070829|NCT00646906|Acetaminophen|acetaminophen|mesh-list
154070830|NCT00646906|Ibuprofen|ibuprofen|mesh-list
154070831|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154070832|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154070833|NCT00646906|Analgesics|analgesics|mesh-ancestor
154070835|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070836|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070837|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070838|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070839|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154070840|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154070841|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070842|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154070843|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154070844|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070845|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
154070846|NCT00813436|Oxytocin|oxytocin|mesh-list
154070847|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
154070960|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
154070961|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154070962|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070963|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
154070964|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
154070965|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154070966|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
154070967|NCT00482053|Hormones|hormones|mesh-ancestor
154070968|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070969|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154070970|NCT00482053|Protective Agents|protective agents|mesh-ancestor
154070971|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154070972|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154070973|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154070974|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071056|NCT00445003|Hormones|hormones|mesh-ancestor
154071057|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071058|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071059|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
154071060|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071061|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071062|NCT00811070|Bosutinib|bosutinib|mesh-list
154071063|NCT00811070|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154071064|NCT00811070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154071065|NCT00811070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071066|NCT00811070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071067|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154071068|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154071069|NCT00642460|Methotrexate|methotrexate|mesh-list
154071070|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154071071|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
154071094|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
154071095|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071096|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071097|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154071098|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
154071099|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071100|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
154071101|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071102|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154071103|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071104|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154071105|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
154071106|NCT00816634|Paclitaxel|paclitaxel|mesh-list
154071107|NCT00816634|Capecitabine|capecitabine|mesh-list
154071108|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154071109|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071110|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
154071111|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
154071112|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
154071113|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071114|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154071115|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
154071116|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
154071117|NCT00642304|Hematinics|hematinics|mesh-ancestor
154071118|NCT00814580|Oxycodone|oxycodone|mesh-list
154071119|NCT00814580|Tapentadol|tapentadol|mesh-list
154071120|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154071121|NCT00814580|Narcotics|narcotics|mesh-ancestor
154071122|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071123|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071140|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071142|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154071143|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154071144|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071145|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071146|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154071147|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
154071148|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
154071149|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071150|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071151|NCT00653224|Levocetirizine|levocetirizine|mesh-list
154071152|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154071153|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154071154|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
154071155|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
154071156|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071157|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071158|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071159|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154071161|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154071162|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154071163|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
154071164|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071165|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071166|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071167|NCT00444925|Urological Agents|urological agents|mesh-ancestor
154071168|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
154071169|NCT00641056|Exenatide|exenatide|mesh-list
154071170|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154071171|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071172|NCT00641056|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154071173|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154071174|NCT00641056|Incretins|incretins|mesh-ancestor
154071175|NCT00641056|Hormones|hormones|mesh-ancestor
154071176|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071177|NCT00569374|Modafinil|modafinil|mesh-list
153553793|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154071205|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071206|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
154071207|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071208|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154071209|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071210|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071211|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
154071212|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071213|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
154071214|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071216|NCT02610686|Amebicides|amebicides|mesh-ancestor
154071217|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154071218|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154071219|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071220|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
154071221|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071222|NCT00816790|Tazobactam|tazobactam|mesh-list
154071223|NCT00816790|Piperacillin|piperacillin|mesh-list
154071224|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154071256|NCT00816868|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154071257|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154071258|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071259|NCT00791700|Maraviroc|maraviroc|mesh-list
154071260|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154071261|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154071262|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071263|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154071285|NCT00797862|Amlodipine|amlodipine|mesh-list
154071286|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154071287|NCT00797862|Aliskiren|aliskiren|mesh-list
154071288|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071289|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154071290|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071291|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071292|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154071293|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640616|NCT05597553|Pemetrexed|pemetrexed|mesh-list
154071294|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
154071295|NCT00797862|Diuretics|diuretics|mesh-ancestor
154071296|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
154071297|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154071298|NCT00797862|Renin Inhibitors|renin inhibitors|mesh-ancestor
154071299|NCT00797862|Protease Inhibitors|protease inhibitors|mesh-ancestor
154071300|NCT00797862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071301|NCT00817258|Cisplatin|cisplatin|mesh-list
154071302|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071303|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
154071304|NCT00794820|Rituximab|rituximab|mesh-list
154071305|NCT00794820|Fludarabine|fludarabine|mesh-list
154071306|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
154071307|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071308|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
154071309|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071310|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071311|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154071312|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
154071313|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071314|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071315|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154071343|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154071344|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071345|NCT00923000|Morphine|morphine|mesh-list
154071346|NCT00923000|Nalbuphine|nalbuphine|mesh-list
154071347|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154071348|NCT00923000|Narcotics|narcotics|mesh-ancestor
154071349|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071350|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071351|NCT00923000|Analgesics|analgesics|mesh-ancestor
154071352|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
154071353|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071354|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
154071355|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071356|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
154071357|NCT00642850|Hematinics|hematinics|mesh-ancestor
154071358|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154071359|NCT00913952|Clomipramine|clomipramine|mesh-list
154071360|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154071361|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
154071362|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154071363|NCT00913952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154071389|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
154071390|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
154071391|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071392|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071393|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071394|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154071395|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154071396|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071397|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154071398|NCT00640510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154071399|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154071400|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071401|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071402|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071403|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
154071405|NCT00913718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154071406|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154071407|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071408|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071409|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071410|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
154071474|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154071475|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071476|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071477|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071478|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154071479|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154071480|NCT00847613|Tofacitinib|tofacitinib|mesh-list
154071481|NCT00847613|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154071482|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154071483|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071484|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071485|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
154071486|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154071488|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154071489|NCT00807092|Metformin|metformin|mesh-list
154071490|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
154071491|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
154071492|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154071526|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071527|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071528|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071529|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071530|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
154071531|NCT00794040|Methylphenidate|methylphenidate|mesh-list
154071582|NCT00797316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071584|NCT05753696|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154071585|NCT05753696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154071586|NCT05753696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071587|NCT05753696|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154071588|NCT05753696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154071589|NCT05753696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071590|NCT04107480|Dopamine|dopamine|mesh-list
154071591|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
154071592|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154071593|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
154071594|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
154071595|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071596|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071597|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
154071598|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071599|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071600|NCT04107480|Protective Agents|protective agents|mesh-ancestor
154071601|NCT00915408|Dexamethasone|dexamethasone|mesh-list
154071602|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
154071603|NCT00915408|Lenalidomide|lenalidomide|mesh-list
154071604|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071605|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
154071606|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071607|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071608|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154071609|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
154071643|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154071644|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
154071645|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154071646|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
154071647|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464187|NCT00273624|Olanzapine|olanzapine|mesh-list
154071648|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071649|NCT00624832|Omalizumab|omalizumab|mesh-list
154071650|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154071684|NCT00819520|Malathion|malathion|mesh-list
154071685|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154071686|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071687|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154071688|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071689|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071690|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
154071691|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071692|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071693|NCT00631696|Pregabalin|pregabalin|mesh-list
154071717|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071718|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154071719|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071720|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
154071721|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071722|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154071724|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
154071725|NCT02549326|Vitamins|vitamins|mesh-ancestor
154071726|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
154071727|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071728|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154071729|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154256583|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256584|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256585|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
154256586|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
154071730|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
154071731|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154071732|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
154071733|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071734|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071735|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154071736|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
154071737|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154071738|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
154071739|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071740|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071741|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154071742|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
154071743|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
154071773|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071774|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154071775|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154071776|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154071777|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071778|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154071780|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
154071781|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154071782|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154071783|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071784|NCT00847145|Vaccines|vaccines|mesh-list
154071785|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
154071786|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071787|NCT00701597|Bosentan|bosentan|mesh-list
154071788|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071789|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154071790|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071791|NCT00700193|Vaccines|vaccines|mesh-list
154071817|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071819|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153614557|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
154071820|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154071821|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154071822|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154071823|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154071824|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154071825|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154071826|NCT00790842|Dexamethasone|dexamethasone|mesh-list
154071827|NCT00790842|Lenalidomide|lenalidomide|mesh-list
154071828|NCT00790842|Heparin|heparin|mesh-list
154071829|NCT00790842|Calcium heparin|calcium heparin|mesh-list
154071830|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154071831|NCT00790842|Tinzaparin|tinzaparin|mesh-list
154071832|NCT00790842|Dalteparin|dalteparin|mesh-list
154071833|NCT00790842|Anticoagulants|anticoagulants|mesh-list
154071834|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071835|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
154071836|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
154071837|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071867|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
154071868|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071869|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071870|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071871|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
154071872|NCT00574288|Hormones|hormones|mesh-ancestor
154071873|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071874|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154071875|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071876|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154071877|NCT00574288|Protective Agents|protective agents|mesh-ancestor
154071879|NCT00790452|Aspirin|aspirin|mesh-list
154071880|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154071881|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154071882|NCT00790452|Analgesics|analgesics|mesh-ancestor
154071883|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
154071950|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071951|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154071952|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
154071953|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154071954|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154071955|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154071956|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154071957|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071958|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154071959|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071960|NCT00624052|Amlodipine|amlodipine|mesh-list
154071961|NCT00624052|Telmisartan|telmisartan|mesh-list
154071962|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071985|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154071986|NCT00821158|Antioxidants|antioxidants|mesh-list
154071987|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071988|NCT00821158|Protective Agents|protective agents|mesh-ancestor
154071989|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071990|NCT00828646|BMS 708163|bms 708163|mesh-list
154071991|NCT00828646|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154071992|NCT00828646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071993|NCT00828646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071994|NCT02548936|Simvastatin|simvastatin|mesh-list
154071995|NCT02548936|Ezetimibe|ezetimibe|mesh-list
154071996|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154071997|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154071998|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154071999|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
154072000|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072001|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154072002|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154072003|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072004|NCT00828802|Lenalidomide|lenalidomide|mesh-list
154072005|NCT00828802|Decitabine|decitabine|mesh-list
154072006|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
154072007|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072008|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154072009|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154072152|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072154|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154072155|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154072157|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072158|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154072159|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072160|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154072161|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154072162|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
154072163|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154072164|NCT00829660|Acarbose|acarbose|mesh-list
154072165|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154072166|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072189|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154072191|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154072192|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
154072193|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072194|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072195|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
154072197|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154072198|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
154072199|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072200|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072201|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154072202|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
154072203|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
154072204|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154072205|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154072206|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154072208|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
154072209|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072210|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072211|NCT02602470|Metronidazole|metronidazole|mesh-list
154072212|NCT02602470|Azelaic acid|azelaic acid|mesh-list
154072213|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154072214|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072215|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154072216|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154072217|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154072218|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154072219|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154072220|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154072253|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154072255|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072256|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
154072257|NCT00830050|Naproxen|naproxen|mesh-list
154072258|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154072259|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154072260|NCT00830050|Analgesics|analgesics|mesh-ancestor
154072293|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072294|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
154072295|NCT00832234|Hormones|hormones|mesh-ancestor
154072296|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072297|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154072298|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072299|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154072300|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
154072301|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072302|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
154072333|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072334|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072335|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
154072336|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
154072337|NCT04102176|Protective Agents|protective agents|mesh-ancestor
154072338|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072339|NCT00783432|Azelastine|azelastine|mesh-list
154072340|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154072341|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
154072342|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072343|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072344|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154072345|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
154072379|NCT00774852|Azathioprine|azathioprine|mesh-list
154072380|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072381|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
154072382|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072383|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072384|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154072385|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
154072386|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072387|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072388|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154072456|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072457|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072459|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
154072460|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072461|NCT00787566|Granisetron|granisetron|mesh-list
154072462|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
154072463|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
154072464|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072519|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072520|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072521|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
154072522|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072523|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072524|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
154072525|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072526|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154072527|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154072528|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154072529|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072530|NCT00773292|Cyclosporine|cyclosporine|mesh-list
154072531|NCT00773292|Cyclosporins|cyclosporins|mesh-list
154072532|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072533|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072534|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072535|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
154072536|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072537|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
154072538|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072539|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
154072540|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072541|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154072542|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
154072543|NCT00838396|Baclofen|baclofen|mesh-list
154072544|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154072545|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072546|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154072547|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072548|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154072549|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
154072550|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
154072551|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072552|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072553|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
154072554|NCT00838864|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154072555|NCT00838864|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154072556|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154072557|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072558|NCT00833326|Docetaxel|docetaxel|mesh-list
154072559|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
154072560|NCT00833326|Mitogens|mitogens|mesh-list
154072593|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072595|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
154072596|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072597|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072598|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072599|NCT00834262|Insulin|insulin|mesh-list
154072600|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154072669|NCT04101474|Analgesics|analgesics|mesh-ancestor
154072670|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
154072671|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072672|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072673|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154072674|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154072675|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
154072676|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
154072677|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072678|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154072679|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154072708|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
154072709|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072710|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154072711|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072712|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
154072713|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072714|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154072715|NCT00840346|Panobinostat|panobinostat|mesh-list
154072716|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072717|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154072718|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072719|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072720|NCT04105140|Oxytocin|oxytocin|mesh-list
154072721|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
154072722|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154072723|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072724|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
154072725|NCT00840580|Levofloxacin|levofloxacin|mesh-list
154072782|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154072784|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154072801|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072802|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154072803|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154072804|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072805|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
154072806|NCT00772668|Hormones|hormones|mesh-ancestor
154072807|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072811|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154072812|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
154072813|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154072814|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154072815|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072817|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154072818|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154072819|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072820|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072821|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154072822|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
154072823|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
154072824|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072825|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072826|NCT00699023|Simvastatin|simvastatin|mesh-list
154072827|NCT00699023|Ezetimibe|ezetimibe|mesh-list
154072828|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154072829|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154072830|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
154072831|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072832|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154072833|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154072834|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072835|NCT00853229|Pregabalin|pregabalin|mesh-list
154072836|NCT00853229|Analgesics|analgesics|mesh-ancestor
154072837|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
154072838|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072839|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072840|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
154072841|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154072897|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072898|NCT00784719|Cyclosporine|cyclosporine|mesh-list
154072899|NCT00784719|Cyclosporins|cyclosporins|mesh-list
154072900|NCT00784719|Tofacitinib|tofacitinib|mesh-list
154072901|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072966|NCT00587457|Immunologic Factors|immunologic factors|mesh-ancestor
154072967|NCT00587457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072968|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072969|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
154072970|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154072971|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072972|NCT04099563|Abrocitinib|abrocitinib|mesh-list
154072973|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154072974|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072975|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072976|NCT00767325|Methotrexate|methotrexate|mesh-list
154073042|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154073043|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154073044|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154073045|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073047|NCT00850499|Fludarabine|fludarabine|mesh-list
154073048|NCT00850499|Bortezomib|bortezomib|mesh-list
154073049|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073179|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
154073180|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465071|NCT00087672|Lenalidomide|lenalidomide|mesh-list
154073181|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073182|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073184|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154073185|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154073186|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154073187|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
154073188|NCT00850343|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154073189|NCT00850343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073190|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154073191|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
154073192|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073193|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073194|NCT00849875|Dacarbazine|dacarbazine|mesh-list
154073195|NCT00849875|Imidazole|imidazole|mesh-list
154073196|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154073199|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073200|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073201|NCT00844415|Dabigatran|dabigatran|mesh-list
154073202|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
154073203|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154073204|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
154073205|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073206|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073238|NCT00842309|Cycloserine|cycloserine|mesh-list
154073239|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154073240|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073241|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154073242|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
154073243|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073244|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
154073245|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073246|NCT00842153|Clobetasol|clobetasol|mesh-list
154073247|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073248|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
154073324|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073326|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
154073349|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154073350|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154073351|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154073352|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
154073353|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073354|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073355|NCT00839423|Vortioxetine|vortioxetine|mesh-list
154073356|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154073357|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154073358|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154073359|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154073360|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073361|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073362|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073363|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154073364|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
154073365|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154073366|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154073367|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154073368|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073369|NCT00839423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154073370|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
154073371|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154073372|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154073373|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154073411|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073412|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729963|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153729964|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153729965|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153729966|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153556610|NCT01614405|Ritonavir|ritonavir|mesh-list
154073444|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073445|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073446|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154073482|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073483|NCT00784836|Interferons|interferons|mesh-list
154073484|NCT00784836|Interferon-beta|interferon-beta|mesh-list
154073485|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
154073486|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073487|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
154073488|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073542|NCT00836693|Tadalafil|tadalafil|mesh-list
154073543|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
154073544|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154073545|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154073546|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073548|NCT00836693|Urological Agents|urological agents|mesh-ancestor
154073549|NCT00770484|Propranolol|propranolol|mesh-list
154073550|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154073551|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154073552|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
154073553|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073554|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073555|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073556|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154073557|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154073558|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
154073559|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154073560|NCT00835679|Cetuximab|cetuximab|mesh-list
154073561|NCT00835679|Dasatinib|dasatinib|mesh-list
154073562|NCT00835679|Antibodies|antibodies|mesh-list
153729992|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154073565|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
154073566|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073567|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073568|NCT00835679|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154073569|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073570|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073571|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073572|NCT00766506|Fentanyl|fentanyl|mesh-list
154073573|NCT00766506|Morphine|morphine|mesh-list
154073574|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154073575|NCT00766506|Narcotics|narcotics|mesh-ancestor
154073576|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073577|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073578|NCT00766506|Analgesics|analgesics|mesh-ancestor
154073579|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
154073580|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073581|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154073582|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154073583|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
154073584|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
154073585|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
154073586|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154073587|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073588|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073589|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154073590|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154073591|NCT00770328|Protective Agents|protective agents|mesh-ancestor
154073592|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073593|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
153729993|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
153729994|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153729995|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154073594|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154073595|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
154073596|NCT00916500|Cisplatin|cisplatin|mesh-list
154073597|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073598|NCT03110094|Adalimumab|adalimumab|mesh-list
154073599|NCT03110094|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154073600|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073635|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073636|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073637|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073638|NCT00707135|Sirolimus|sirolimus|mesh-list
154073639|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073640|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073641|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154073642|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073643|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
154073699|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
153729996|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
153729997|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729998|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
153729999|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153730000|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153730001|NCT00140517|Chloroquine|chloroquine|mesh-list
153730002|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
153730003|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
153459045|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
153730004|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153730006|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153730007|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153730008|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730009|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
153730010|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730011|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153730012|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730013|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782637|NCT00260793|Ropinirole|ropinirole|mesh-list
153730014|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153730016|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153730017|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
153730018|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730019|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073700|NCT00827567|Everolimus|everolimus|mesh-list
154073701|NCT00827567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154073702|NCT00827567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073703|NCT00827567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073704|NCT00827567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073705|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154073706|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
154073707|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073726|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154073727|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
154073728|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154073729|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154073730|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
154073731|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073732|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154073733|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154073734|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073735|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073736|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154073737|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154073738|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073739|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154073740|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154073741|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154073742|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073743|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
154073744|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073745|NCT00756444|Panitumumab|panitumumab|mesh-list
153730090|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153730091|NCT00140751|Ritonavir|ritonavir|mesh-list
154073846|NCT00818441|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154073847|NCT00818441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073848|NCT00818441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073849|NCT00818441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073850|NCT00704639|Carboplatin|carboplatin|mesh-list
154073851|NCT00704639|Cetuximab|cetuximab|mesh-list
154073852|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073853|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073854|NCT00826943|Cetirizine|cetirizine|mesh-list
154073855|NCT00826943|Levocetirizine|levocetirizine|mesh-list
154073856|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154073857|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154073858|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154073859|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
154073860|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
154073861|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073874|NCT00834041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073875|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154073876|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154073877|NCT00760929|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154073878|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073879|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073880|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073881|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073882|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
153459061|NCT01674270|Bicalutamide|bicalutamide|mesh-list
154073883|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073884|NCT00704951|Posaconazole|posaconazole|mesh-list
154073885|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
154073886|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073887|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154073888|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154073889|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154073890|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153730100|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
154073891|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154073892|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073893|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073894|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154073895|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
154073896|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073897|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073898|NCT00759915|Morphine|morphine|mesh-list
154073899|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154073900|NCT00759915|Narcotics|narcotics|mesh-ancestor
154073901|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073902|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073903|NCT00759915|Analgesics|analgesics|mesh-ancestor
154073904|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
154073905|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073906|NCT00759759|Morphine|morphine|mesh-list
153730107|NCT00132587|Protective Agents|protective agents|mesh-ancestor
153730108|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730110|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153730111|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153730112|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153730113|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730114|NCT01245673|Lenalidomide|lenalidomide|mesh-list
153730115|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154073929|NCT04097847|Vitamin E|vitamin e|mesh-list
154073930|NCT04097847|Tocotrienols|tocotrienols|mesh-list
154073931|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
154073932|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
154073933|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154073934|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073935|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073936|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154073937|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154073938|NCT04097847|Protective Agents|protective agents|mesh-ancestor
153730118|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730119|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154073962|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073964|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
154073965|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
153730120|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153730121|NCT01245673|Growth Substances|growth substances|mesh-ancestor
153730122|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
153730123|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730124|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
153730125|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
153730126|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153730127|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153730128|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730129|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
153730130|NCT02261415|Coagulants|coagulants|mesh-ancestor
153730131|NCT00132743|Cilostazol|cilostazol|mesh-list
153730132|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153730133|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
154073966|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073967|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073968|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154073969|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154073970|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073971|NCT00833027|Incretins|incretins|mesh-ancestor
154073972|NCT00833027|Hormones|hormones|mesh-ancestor
154073973|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256587|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154256588|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
154256589|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
153641945|NCT00084448|Celecoxib|celecoxib|mesh-list
154073995|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
154073996|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073997|NCT00754572|Methotrexate|methotrexate|mesh-list
154073998|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154073999|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
154074000|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154074001|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074002|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153730138|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153616957|NCT06029270|Immunoglobulins|immunoglobulins|mesh-list
153730139|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153730140|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730141|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153730142|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
153730143|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153730144|NCT00132743|Protective Agents|protective agents|mesh-ancestor
153730145|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153730146|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153730147|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730149|NCT00132821|Nicotine|nicotine|mesh-list
153730150|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153730151|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
153730155|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153730156|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
153730157|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074020|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154074021|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
154074022|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074023|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074024|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154074025|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153730158|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730159|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153730160|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
153730161|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730162|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153730163|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153730164|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730165|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
153730166|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154074026|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074027|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154074028|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
154074029|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074030|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074031|NCT00708149|Lansoprazole|lansoprazole|mesh-list
154074032|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
153730167|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153730168|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730169|NCT00132860|Azithromycin|azithromycin|mesh-list
153730170|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153730171|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074033|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153730172|NCT01244815|Asenapine|asenapine|mesh-list
153730173|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153730174|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154074055|NCT00758043|Ribavirin|ribavirin|mesh-list
154074056|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154074057|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
154074058|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074059|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
154074060|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074061|NCT00831701|Tamsulosin|tamsulosin|mesh-list
154074062|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154074063|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154074064|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154256590|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153642053|NCT00085150|Immunotoxins|immunotoxins|mesh-list
154074065|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
154074066|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074067|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074068|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074069|NCT00831701|Urological Agents|urological agents|mesh-ancestor
154074070|NCT00705419|Tenofovir|tenofovir|mesh-list
154074071|NCT00705419|Emtricitabine|emtricitabine|mesh-list
154074072|NCT00705419|Maleic acid|maleic acid|mesh-list
154074073|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
154074074|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074075|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154074076|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154074077|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074078|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074079|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154074080|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154074095|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154074096|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074097|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
154074098|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
154074099|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074100|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074101|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
154074102|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154074103|NCT05438277|Triamcinolone|triamcinolone|mesh-list
154074104|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154074105|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154074106|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153730185|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730186|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074107|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074108|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
154074109|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
154074110|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074111|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074112|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154074113|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
154074114|NCT05438277|Hormones|hormones|mesh-ancestor
154074115|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074116|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154074117|NCT05438277|Protective Agents|protective agents|mesh-ancestor
154074118|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154074119|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
154074120|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074121|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074122|NCT00761280|Temozolomide|temozolomide|mesh-list
154074124|NCT00761280|Lomustine|lomustine|mesh-list
154074125|NCT00761280|Trabedersen|trabedersen|mesh-list
154074145|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154074146|NCT02599701|Gabapentin|gabapentin|mesh-list
154074147|NCT02599701|Analgesics|analgesics|mesh-ancestor
154074148|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
154074149|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074150|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074151|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
154074152|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154074153|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154074199|NCT00804908|Temozolomide|temozolomide|mesh-list
154074201|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154074202|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
154074203|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074204|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730235|NCT01154439|Ifosfamide|ifosfamide|mesh-list
153730236|NCT01154439|Carboplatin|carboplatin|mesh-list
153730237|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153730238|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730239|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153730240|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153730241|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256591|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154256592|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154256593|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730242|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730243|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153730245|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
153730246|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730247|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730248|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
153730249|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730250|NCT01154439|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153730251|NCT01154439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074236|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074237|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154074238|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154074239|NCT00589784|Growth Substances|growth substances|mesh-ancestor
154074240|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074241|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
154074242|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074243|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074244|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074245|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154074246|NCT05742854|Oxytocin|oxytocin|mesh-list
154074247|NCT05742854|Carbetocin|carbetocin|mesh-list
154074248|NCT05742854|Oxytocics|oxytocics|mesh-ancestor
154074249|NCT05742854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154074272|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154074273|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074274|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074275|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074276|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
154074277|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
154074278|NCT00823823|Calpastatin|calpastatin|mesh-list
154074279|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154074280|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
154074281|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074282|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074283|NCT02926898|Fenfluramine|fenfluramine|mesh-list
154074304|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
154074305|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
154074306|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074308|NCT02610881|Trace Elements|trace elements|mesh-list
154074309|NCT02610881|Folic Acid|folic acid|mesh-list
154074310|NCT02610881|Micronutrients|micronutrients|mesh-list
154074311|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074312|NCT02610881|Hematinics|hematinics|mesh-ancestor
154074313|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
154074314|NCT02610881|Vitamins|vitamins|mesh-ancestor
154074315|NCT00830765|Progesterone|progesterone|mesh-list
154074316|NCT00830765|Progestins|progestins|mesh-ancestor
154074317|NCT00830765|Hormones|hormones|mesh-ancestor
154074318|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074319|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074320|NCT04093206|Vitamins|vitamins|mesh-list
154074321|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
154074322|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
154074323|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074324|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
154074325|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074326|NCT04093206|Protective Agents|protective agents|mesh-ancestor
154074327|NCT00830375|Memantine|memantine|mesh-list
154074328|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154074329|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154074330|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
154074331|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074332|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074333|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074334|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154074335|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154074336|NCT00708539|Progesterone|progesterone|mesh-list
154074337|NCT00708539|Progestins|progestins|mesh-ancestor
154074396|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074397|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154074398|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074399|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154074400|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154074402|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074403|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154074405|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154074406|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074407|NCT00758160|Methylphenidate|methylphenidate|mesh-list
154074408|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154074409|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074410|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154074411|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154074412|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745627|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
154074413|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074415|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074416|NCT02606552|Aspirin|aspirin|mesh-list
154074417|NCT02606552|Clopidogrel|clopidogrel|mesh-list
154074418|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154074419|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154074420|NCT02606552|Analgesics|analgesics|mesh-ancestor
154074421|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
154074422|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074423|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074466|NCT05693090|Tipifarnib|tipifarnib|mesh-list
154074467|NCT05693090|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154074468|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074469|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074470|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074471|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074472|NCT00751296|Lenalidomide|lenalidomide|mesh-list
154074473|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
154074474|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730307|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153730308|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553821|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154074567|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154074568|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
154074569|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154074570|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074571|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074573|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154074574|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
154074600|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154074601|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074602|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
154074603|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074604|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
154074605|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
154074606|NCT02598414|Protective Agents|protective agents|mesh-ancestor
154074607|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074609|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154074610|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
154074611|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154074612|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154074613|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074614|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074615|NCT04020003|Protective Agents|protective agents|mesh-ancestor
154074666|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074686|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154074807|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154074808|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
154074809|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074810|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154074811|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154074812|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074813|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074814|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
154074816|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074818|NCT04091178|Vitamins|vitamins|mesh-ancestor
154074819|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
154074820|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074821|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154074823|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
154074824|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
154074825|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154074826|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074827|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
154074828|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074829|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
154074830|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074831|NCT00743340|Emtricitabine|emtricitabine|mesh-list
154074832|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
154074833|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074834|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154074835|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154074836|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074837|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074838|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154074839|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154074840|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154074841|NCT00749190|Empagliflozin|empagliflozin|mesh-list
154074842|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154074843|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074844|NCT00749190|Incretins|incretins|mesh-ancestor
154074845|NCT00749190|Hormones|hormones|mesh-ancestor
154074846|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074847|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154074848|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
154074849|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074850|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074851|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154074911|NCT00748098|Analgesics|analgesics|mesh-ancestor
154074912|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
154074913|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074939|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154074940|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154074942|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
154074943|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074944|NCT00813917|Varenicline|varenicline|mesh-list
154074945|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154074946|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154074947|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
154074948|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074949|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074950|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074951|NCT02598102|Diclofenac|diclofenac|mesh-list
154074952|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154074953|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154074954|NCT02598102|Analgesics|analgesics|mesh-ancestor
154074955|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
154074956|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074957|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074958|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074959|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154074960|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154075051|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154075192|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154075227|NCT02593227|Vaccines|vaccines|mesh-list
154075228|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
154075229|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075230|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154075231|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782443|NCT00233792|Sirolimus|sirolimus|mesh-list
154075245|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
154075246|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075247|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154075248|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
154075249|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
154075250|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154075251|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154075252|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154075253|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
154075254|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075255|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075256|NCT00727311|Ribavirin|ribavirin|mesh-list
154075257|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154075258|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
154075259|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
154075260|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075261|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
154075262|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075263|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
154075264|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075265|NCT00726999|Morphine|morphine|mesh-list
154075266|NCT00726999|Gabapentin|gabapentin|mesh-list
154075267|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154075268|NCT00726999|Narcotics|narcotics|mesh-ancestor
154075269|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075270|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075271|NCT00726999|Analgesics|analgesics|mesh-ancestor
154075272|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
154075273|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075274|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
154075275|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154075276|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154075277|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154075278|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154075279|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154075280|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075281|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075282|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
154075283|NCT00585351|Ranitidine|ranitidine|mesh-list
154075284|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154075285|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154075286|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075287|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154075288|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
154075289|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
154075290|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075291|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075292|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075296|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154075297|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154075298|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154075299|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154075300|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154075301|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075302|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075303|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154075304|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
154075305|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075306|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075307|NCT00808028|Vaccines|vaccines|mesh-list
154075308|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
154075309|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075310|NCT03466346|Fluoxetine|fluoxetine|mesh-list
154075311|NCT03466346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154075312|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154075313|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154075314|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075315|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075316|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
154075317|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075318|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154075319|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
154075320|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154075321|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154075322|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154075323|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075324|NCT05754242|Ascorbic Acid|ascorbic acid|mesh-list
154075326|NCT05754242|Micronutrients|micronutrients|mesh-ancestor
154075327|NCT05754242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075328|NCT05754242|Antioxidants|antioxidants|mesh-ancestor
154075329|NCT05754242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075330|NCT05754242|Protective Agents|protective agents|mesh-ancestor
154075331|NCT00809783|Tanezumab|tanezumab|mesh-list
154075332|NCT00809783|Analgesics|analgesics|mesh-ancestor
154075333|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
154075334|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075335|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075336|NCT05675462|Lenvatinib|lenvatinib|mesh-list
154075337|NCT05675462|Tislelizumab|tislelizumab|mesh-list
154075338|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075339|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154075340|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075341|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075342|NCT05675462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154075343|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
154075344|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154075345|NCT02608658|Antibodies|antibodies|mesh-list
154075346|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
154075347|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075348|NCT00807248|Gaboxadol|gaboxadol|mesh-list
154075349|NCT00807248|Dexetimide|dexetimide|mesh-list
154075350|NCT00807248|Citalopram|citalopram|mesh-list
154075351|NCT00807248|Escitalopram|escitalopram|mesh-list
154075352|NCT00807248|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154075353|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154075354|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154075355|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075356|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075357|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
154075358|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075359|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154075360|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154075361|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
154075362|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
154075363|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075372|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
154075373|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
154075374|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
154075375|NCT02607332|Paclitaxel|paclitaxel|mesh-list
154075376|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154075377|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075378|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
154075379|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
154075380|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
154075381|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075382|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154075383|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154075384|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075385|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
154075386|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154075387|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154075388|NCT05297669|Analgesics|analgesics|mesh-ancestor
154075389|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
154075390|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075391|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075392|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075393|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075394|NCT00589628|Infliximab|infliximab|mesh-list
154075395|NCT00589628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154075396|NCT00589628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075397|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
154075398|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075399|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075400|NCT05754983|Immunomodulating Agents|immunomodulating agents|mesh-list
154075401|NCT05754983|Immunologic Factors|immunologic factors|mesh-ancestor
154075402|NCT05754983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075403|NCT00914576|Vitamins|vitamins|mesh-list
154075404|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
154075405|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075406|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
154075407|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154075408|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
154256594|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
154075409|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075410|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075411|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154075412|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
154075413|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154075414|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154075415|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154075416|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
154075417|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075418|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075419|NCT02605772|Metformin|metformin|mesh-list
154075420|NCT02605772|Saxagliptin|saxagliptin|mesh-list
154075421|NCT02605772|Acarbose|acarbose|mesh-list
154075422|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154075423|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075424|NCT02605772|Incretins|incretins|mesh-ancestor
154075425|NCT02605772|Hormones|hormones|mesh-ancestor
154075426|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075427|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154075428|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
154075429|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075430|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075433|NCT04115462|Histamine|histamine|mesh-list
154075434|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
154075435|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154075436|NCT04115462|Narcotics|narcotics|mesh-ancestor
154075437|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075438|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075439|NCT04115462|Analgesics|analgesics|mesh-ancestor
154075440|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
154075441|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075442|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
154075443|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
154075444|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075445|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075446|NCT02605460|Plerixafor|plerixafor|mesh-list
154075447|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
154075448|NCT02605460|Busulfan|busulfan|mesh-list
154075449|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154075450|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
154075451|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075452|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075453|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154075454|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
154075455|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075456|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075457|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154075458|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154075459|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154075460|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
154075461|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075462|NCT00797108|Amoxicillin|amoxicillin|mesh-list
154075463|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
154075464|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
154075465|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
154075466|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154075467|NCT00797108|Lactams|lactams|mesh-list
154075468|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154075469|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075470|NCT00797108|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154075471|NCT00797108|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154075472|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154075473|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075474|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075475|NCT00742560|Dexamethasone|dexamethasone|mesh-list
154075476|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
154075477|NCT00742560|Lenalidomide|lenalidomide|mesh-list
154075478|NCT00742560|Elotuzumab|elotuzumab|mesh-list
154075479|NCT00742560|BB 1101|bb 1101|mesh-list
154075480|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075481|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
154075482|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
154075483|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075484|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075485|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075486|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
154075487|NCT00742560|Hormones|hormones|mesh-ancestor
154075488|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075489|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154075490|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075491|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
154075492|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466638|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075493|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075494|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
154075495|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154075496|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154075497|NCT00742560|Growth Substances|growth substances|mesh-ancestor
154075498|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
154075499|NCT00796718|Capecitabine|capecitabine|mesh-list
154075500|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154075501|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
154075502|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075503|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075504|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
154075505|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154075508|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075509|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154075510|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154075511|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075512|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075513|NCT04025840|Dexamethasone|dexamethasone|mesh-list
154075514|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
154075515|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075516|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
154075517|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
154075518|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075519|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075520|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075521|NCT04025840|Hormones|hormones|mesh-ancestor
154075522|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075523|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154075524|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075525|NCT00589472|Vorinostat|vorinostat|mesh-list
154075526|NCT00589472|Leuprolide|leuprolide|mesh-list
154075527|NCT00589472|Goserelin|goserelin|mesh-list
154075528|NCT00589472|Bicalutamide|bicalutamide|mesh-list
154075529|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075530|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154075531|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075532|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075533|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154075534|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
154075535|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154075536|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075537|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154075538|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
154075539|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
154075540|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075541|NCT02608931|Dronabinol|dronabinol|mesh-list
154075542|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
154075543|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075544|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154075545|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154075546|NCT02608931|Analgesics|analgesics|mesh-ancestor
154075547|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
154075548|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075549|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154075550|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154075551|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075552|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075553|NCT02608931|Hormones|hormones|mesh-ancestor
154075554|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075555|NCT00744978|Varenicline|varenicline|mesh-list
154075556|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154075557|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153459283|NCT01345656|Spironolactone|spironolactone|mesh-list
154075558|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
154075559|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075560|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075561|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075563|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154075564|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
154075565|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075566|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
154075567|NCT02595606|Protective Agents|protective agents|mesh-ancestor
154075568|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
154075569|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
154075570|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154075571|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154075572|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
154075573|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075574|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075575|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075576|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075577|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154075584|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154075585|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154075586|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154075587|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075588|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154075589|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075590|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
154075591|NCT00739596|Diuretics|diuretics|mesh-ancestor
154075592|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
154075593|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154075594|NCT00739596|Renin Inhibitors|renin inhibitors|mesh-ancestor
154075595|NCT00739596|Protease Inhibitors|protease inhibitors|mesh-ancestor
154075596|NCT00739596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075597|NCT00742326|Pioglitazone|pioglitazone|mesh-list
154075598|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154075599|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075600|NCT02597868|Capecitabine|capecitabine|mesh-list
154075601|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154075602|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
154075603|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075604|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075605|NCT00811187|Lidocaine|lidocaine|mesh-list
154075606|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
154075607|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
154075608|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075609|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075610|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
154075611|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075612|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154075613|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154075614|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154075615|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154075616|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075617|NCT00917748|Docetaxel|docetaxel|mesh-list
154075618|NCT00917748|Modafinil|modafinil|mesh-list
154075619|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075620|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
154075621|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
154075622|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
154075623|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075624|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154075625|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075626|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154075627|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154075628|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154075629|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
154075630|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154075631|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075632|NCT00591149|Docetaxel|docetaxel|mesh-list
154075633|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
154075634|NCT00591149|Cetuximab|cetuximab|mesh-list
154256596|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
154075635|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075636|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
154075637|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
154075638|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
154075639|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075640|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154075642|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154075643|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154075644|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075645|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154075646|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154075652|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075654|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
154075655|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154075656|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075657|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
154075658|NCT00796562|Busulfan|busulfan|mesh-list
154075659|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154075660|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
154075661|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075662|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075663|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154075664|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
154075665|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075666|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075667|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154075668|NCT00801632|Prednisone|prednisone|mesh-list
154075669|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
154075670|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
154075671|NCT00801632|Rituximab|rituximab|mesh-list
154075672|NCT00801632|Tacrolimus|tacrolimus|mesh-list
154075673|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154075674|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
154075675|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075676|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075677|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154075678|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
154075679|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075680|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075681|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154075682|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154075683|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075684|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
154075685|NCT00801632|Hormones|hormones|mesh-ancestor
154075686|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075687|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154075688|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154075689|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075690|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
154075691|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
154075692|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075693|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075694|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154075695|NCT00801632|Protective Agents|protective agents|mesh-ancestor
154075696|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
154075697|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154075698|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154075699|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
154075700|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075701|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075702|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154075703|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
154075704|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154075705|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
154075706|NCT04111484|Protective Agents|protective agents|mesh-ancestor
154075707|NCT04111328|Sufentanil|sufentanil|mesh-list
154075708|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
154075710|NCT04111328|Hydromorphone|hydromorphone|mesh-list
154075711|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154075712|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075713|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075714|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153643450|NCT00094549|Valproic Acid|valproic acid|mesh-list
154075715|NCT04111328|Analgesics|analgesics|mesh-ancestor
154075716|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
154075717|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075718|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154075720|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154075721|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
154075722|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075723|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075724|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154075725|NCT04111328|Narcotics|narcotics|mesh-ancestor
154075726|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154075727|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154075728|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
154075729|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
154075731|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
154075732|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
154075733|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
154075734|NCT00806819|Dexamethasone|dexamethasone|mesh-list
154075735|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
154075736|NCT00806819|Pemetrexed|pemetrexed|mesh-list
154075737|NCT00806819|Nintedanib|nintedanib|mesh-list
154075738|NCT00806819|BB 1101|bb 1101|mesh-list
154075739|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075740|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
154075741|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
154075742|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075743|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075744|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075745|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
154075746|NCT00806819|Hormones|hormones|mesh-ancestor
154075747|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075748|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154075749|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075750|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
154075751|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075752|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075753|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154075754|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154075755|NCT00806819|Hematinics|hematinics|mesh-ancestor
154075756|NCT00806819|Vitamins|vitamins|mesh-ancestor
154075757|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
154075758|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154075759|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
154075760|NCT04109534|Miotics|miotics|mesh-ancestor
154075761|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
154075762|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075763|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075764|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154075765|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154075766|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
154075767|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154075768|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154075769|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
154075770|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075771|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075772|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
154075773|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154075774|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154075775|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075776|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
154075777|NCT05326139|Coagulants|coagulants|mesh-ancestor
154075778|NCT02605694|Prednisone|prednisone|mesh-list
154075779|NCT02605694|Rituximab|rituximab|mesh-list
154075780|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154075781|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075782|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
154075783|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075784|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075786|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
154075787|NCT02605694|Hormones|hormones|mesh-ancestor
154075788|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153559332|NCT01631838|Vitamins|vitamins|mesh-ancestor
154075789|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154075790|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
154075791|NCT02604134|Fluorides|fluorides|mesh-list
154075792|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
154075793|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
154075794|NCT02604134|Protective Agents|protective agents|mesh-ancestor
154075795|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075796|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154075801|NCT00800540|Brinzolamide|brinzolamide|mesh-list
154075802|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154075803|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154075804|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154075805|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
154075806|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075807|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075808|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075809|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154075810|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154075811|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154075812|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154075813|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154075814|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154075815|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075816|NCT00796328|Phenylephrine|phenylephrine|mesh-list
154075817|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
154075818|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154075819|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
154075820|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
154075821|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075822|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075823|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
154075824|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154075825|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
154075826|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
154075827|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154075828|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154075829|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154075830|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
154075831|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075832|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075833|NCT00796328|Protective Agents|protective agents|mesh-ancestor
154075834|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
154075835|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154075836|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154075837|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075838|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
154075839|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
154075840|NCT04110860|Voriconazole|voriconazole|mesh-list
154075841|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
154075842|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075843|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154075844|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154075845|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075846|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075847|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154075848|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
154075849|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075850|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075851|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154075852|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
154075853|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154075854|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075855|NCT04114526|Nicotine|nicotine|mesh-list
154075856|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154075857|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
154075858|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075859|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075860|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154075861|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154075862|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
154075863|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075864|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075865|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
154075867|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154075868|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
154075871|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
154075872|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154075873|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
154075874|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075875|NCT00915200|Protective Agents|protective agents|mesh-ancestor
154075876|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075877|NCT00915200|Antidotes|antidotes|mesh-ancestor
154075878|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154075879|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075880|NCT00588146|Interferons|interferons|mesh-list
154075881|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
154075882|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
154075883|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154075884|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075885|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
154075886|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075887|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
154075888|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075889|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154075890|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
154075891|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075892|NCT00799058|Dapivirine|dapivirine|mesh-list
154075893|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154075894|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154075895|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
154075896|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075897|NCT00725985|Cladribine|cladribine|mesh-list
154075898|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075899|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154075900|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
154075901|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075902|NCT00793910|Gabapentin|gabapentin|mesh-list
154075903|NCT00793910|Analgesics|analgesics|mesh-ancestor
154075904|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
154075905|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075906|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075907|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
154075908|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154075909|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154075910|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075911|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154075912|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154075913|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154075914|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075915|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075916|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
154075917|NCT01019941|Docetaxel|docetaxel|mesh-list
154075918|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075919|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
154075920|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
154075921|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
154075922|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075923|NCT04113668|Diflunisal|diflunisal|mesh-list
154075924|NCT04113668|Deucravacitinib|deucravacitinib|mesh-list
154075925|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
154075926|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154075927|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075928|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075929|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154075930|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154075931|NCT04113668|Analgesics|analgesics|mesh-ancestor
154075932|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
154075933|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075934|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075935|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075936|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075937|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154075938|NCT00444145|Lansoprazole|lansoprazole|mesh-list
154075939|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154075941|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154075942|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075943|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075948|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154075950|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075951|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075952|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075953|NCT04107896|Urological Agents|urological agents|mesh-ancestor
154256597|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075955|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
154075956|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
154075957|NCT01024777|Vitamins|vitamins|mesh-list
154075958|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
154075959|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075960|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154075961|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154075962|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154075963|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
154075964|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154075965|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
154075966|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154075967|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154075968|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154075969|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075970|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075971|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075972|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075973|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
154075974|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154075975|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154075976|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154075977|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075978|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154075979|NCT00725205|Ribavirin|ribavirin|mesh-list
154075980|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154075981|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
154075982|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
154075983|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075984|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
154075985|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075986|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
154075987|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075988|NCT00443755|Metformin|metformin|mesh-list
154075989|NCT00443755|Pioglitazone|pioglitazone|mesh-list
154075990|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154075991|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075992|NCT00724971|Rituximab|rituximab|mesh-list
154075993|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154075994|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154075995|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075996|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
154075997|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075998|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075999|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154076000|NCT00724971|Immunotoxins|immunotoxins|mesh-ancestor
154076001|NCT00724971|Immunoconjugates|immunoconjugates|mesh-ancestor
154076002|NCT00443599|Insulin|insulin|mesh-list
154076003|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154076004|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154076005|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076006|NCT04107428|Somatostatin|somatostatin|mesh-list
154076007|NCT04107428|Hormones|hormones|mesh-ancestor
154076008|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076009|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076010|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
154076011|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154076012|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076013|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076015|NCT00455143|Analgesics|analgesics|mesh-ancestor
154076017|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076018|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154076019|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154076020|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154076021|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076022|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076023|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076025|NCT00724893|Ribavirin|ribavirin|mesh-list
154076026|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
154076027|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
154076028|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154076029|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256598|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
154076030|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
154076031|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076032|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
154076033|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076034|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
154076035|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076036|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154076037|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153467580|NCT00439296|Dexamethasone|dexamethasone|mesh-list
154076038|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
154076039|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154076040|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154076041|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154076042|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076043|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076044|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154076045|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154076046|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154076047|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076048|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076049|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076050|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154076051|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154076052|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
154076053|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154076054|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154076055|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
154076056|NCT00724815|Sumatriptan|sumatriptan|mesh-list
154076057|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154076058|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154076059|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154076060|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
154076061|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076062|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076063|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076064|NCT00798590|Glucagon|glucagon|mesh-list
154076065|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154076066|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154076067|NCT00798590|Hormones|hormones|mesh-ancestor
154076068|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076069|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076070|NCT00798590|Incretins|incretins|mesh-ancestor
154076071|NCT00481195|Modafinil|modafinil|mesh-list
154076072|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154076073|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076074|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154076075|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154076076|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154076077|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076078|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
154076079|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076080|NCT01027429|Amoxicillin|amoxicillin|mesh-list
154076081|NCT01027429|Gentamicins|gentamicins|mesh-list
154076082|NCT01027429|Penicillins|penicillins|mesh-list
154076083|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
154076084|NCT01027429|Penicillin G|penicillin g|mesh-list
154076085|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154076086|NCT01027429|Procaine|procaine|mesh-list
154076087|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154076088|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076091|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076093|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
154076094|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076095|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076096|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
154076097|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076098|NCT01020253|Alendronate|alendronate|mesh-list
154076099|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
154076100|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154076101|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154076102|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076103|NCT01020253|Vitamins|vitamins|mesh-ancestor
154076104|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
154076105|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
154076106|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076107|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
154076108|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154076109|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154076110|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076111|NCT00454207|Urological Agents|urological agents|mesh-ancestor
154076112|NCT01020331|Memantine|memantine|mesh-list
154076113|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154076114|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154076115|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
154076116|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076117|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076118|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076119|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154076120|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154076121|NCT00738894|Dipyridamole|dipyridamole|mesh-list
154076122|NCT00738894|Clopidogrel|clopidogrel|mesh-list
154076123|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076124|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076125|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154076126|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076127|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154076128|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154076129|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154076130|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
154076131|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076132|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154076133|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
154076134|NCT00734994|Mitomycins|mitomycins|mesh-list
154076135|NCT00734994|Mitomycin|mitomycin|mesh-list
154076136|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154076137|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076138|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
154076139|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076140|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154076141|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076142|NCT02593734|Olanzapine|olanzapine|mesh-list
154076143|NCT02593734|Risperidone|risperidone|mesh-list
154076144|NCT02593734|Fluoxetine|fluoxetine|mesh-list
154076145|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154076146|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
154076147|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076148|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076149|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076150|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154076151|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154076152|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076153|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154076154|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154076155|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
154076156|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
154076157|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
154076158|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076159|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153553823|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
154076162|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154076163|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154076164|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
154076165|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154076166|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154076167|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076169|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154076170|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154076171|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
154076172|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076173|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076174|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076175|NCT00798434|Urological Agents|urological agents|mesh-ancestor
154076176|NCT04106804|Abatacept|abatacept|mesh-list
154076177|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154076178|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076179|NCT04106804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154076180|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076181|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154076182|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
154076183|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076184|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154076185|NCT00791648|Atorvastatin|atorvastatin|mesh-list
154076186|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154076187|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154076188|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
154076189|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076190|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154076191|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154076192|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076193|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
154076194|NCT05366595|Astringents|astringents|mesh-ancestor
154076195|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076196|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
154076197|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154076198|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
154076199|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076200|NCT04017338|Ezetimibe|ezetimibe|mesh-list
154076201|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154076202|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154076203|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
154076204|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076205|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154076206|NCT04106726|Ivermectin|ivermectin|mesh-list
154076207|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154076208|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076209|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
154076210|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154076211|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076212|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076213|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154076214|NCT00723957|Paclitaxel|paclitaxel|mesh-list
154076215|NCT00723957|Carboplatin|carboplatin|mesh-list
154076216|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154076217|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076218|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
154076219|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
154076220|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
154076221|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076222|NCT02603822|Indomethacin|indomethacin|mesh-list
154076223|NCT02603822|Mannitol|mannitol|mesh-list
154076224|NCT02603822|Lactulose|lactulose|mesh-list
154076225|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154076226|NCT02603822|Diuretics|diuretics|mesh-ancestor
154076227|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
154076228|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076229|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154076230|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154076231|NCT02603822|Analgesics|analgesics|mesh-ancestor
154076232|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
154076236|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
154076237|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
154076238|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154076239|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154076240|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076241|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076242|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154076244|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
154076245|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076246|NCT00723801|Losartan|losartan|mesh-list
154076247|NCT00723801|Atenolol|atenolol|mesh-list
154076248|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154076249|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154076250|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154076251|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154076252|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076253|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
154076254|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
154076255|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076256|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644262|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
154076257|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154076258|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154076259|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154076260|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076261|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076262|NCT00797966|Fluoxetine|fluoxetine|mesh-list
154076263|NCT00797966|Paroxetine|paroxetine|mesh-list
154076264|NCT00797966|Sertraline|sertraline|mesh-list
154076265|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154076266|NCT00797966|Escitalopram|escitalopram|mesh-list
154076267|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
154076268|NCT00797966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154076269|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154076270|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154076271|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076272|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076273|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
154076274|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076275|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154076276|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
154076277|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154076278|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154076279|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154076280|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076281|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154076282|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
154076283|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
154076284|NCT00723255|Sirolimus|sirolimus|mesh-list
154076285|NCT00723255|Bevacizumab|bevacizumab|mesh-list
154076286|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154076287|NCT00723255|Temsirolimus|temsirolimus|mesh-list
154076288|NCT00723255|MTOR Inhibitors|mtor inhibitors|mesh-list
154076289|NCT00723255|Antibodies|antibodies|mesh-list
154076290|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
154076291|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154076292|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076293|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154076294|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154076295|NCT00723255|Growth Substances|growth substances|mesh-ancestor
154076296|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076297|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
154076298|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
154076299|NCT00723255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154076300|NCT00723255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076301|NCT00723255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076305|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154076306|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
154076308|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154076309|NCT00791258|Olmesartan|olmesartan|mesh-list
154076310|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154076311|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154076312|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154076313|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154076314|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076315|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154076316|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076317|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
154076318|NCT00791258|Diuretics|diuretics|mesh-ancestor
154076319|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
154076320|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154076321|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154076322|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154076323|NCT00808067|Dabigatran|dabigatran|mesh-list
154076324|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
154076325|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154076326|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
154076327|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076328|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076329|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
154076330|NCT00723021|Zileuton|zileuton|mesh-list
154256600|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154076331|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154076332|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154076333|NCT00723021|Analgesics|analgesics|mesh-ancestor
154076334|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
154076335|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076336|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076337|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154076338|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154076339|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154076340|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076341|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076342|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154076343|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
154076344|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076345|NCT04309409|Nivolumab|nivolumab|mesh-list
154076346|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154076347|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076348|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154076349|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076350|NCT04086537|Hepcidins|hepcidins|mesh-list
154076351|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076352|NCT02608619|Choline|choline|mesh-list
154076353|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
154076354|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154076355|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
154076356|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076357|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154076358|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154076359|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
154076360|NCT02591667|Bevacizumab|bevacizumab|mesh-list
154076361|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154076362|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076363|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154076364|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154076365|NCT02591667|Growth Substances|growth substances|mesh-ancestor
154076366|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076367|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
154076369|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
154076370|NCT00807599|Lenalidomide|lenalidomide|mesh-list
154076371|NCT00807599|Melphalan|melphalan|mesh-list
154076372|NCT00807599|BB 1101|bb 1101|mesh-list
154076373|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154076374|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
154076375|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
154076377|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076378|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154076379|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
154076381|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076382|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154076383|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076384|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
154076385|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076386|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076387|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
154076388|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154076389|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154076390|NCT00807599|Growth Substances|growth substances|mesh-ancestor
154076391|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
154076392|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154076393|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
154076394|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154076395|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154076396|NCT00788372|Fentanyl|fentanyl|mesh-list
154076397|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154076398|NCT00788372|Narcotics|narcotics|mesh-ancestor
154076399|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076400|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076401|NCT00788372|Analgesics|analgesics|mesh-ancestor
154076402|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
154076403|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076404|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153644467|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
154076405|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154076406|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
154076407|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
154076408|NCT00738582|Pemetrexed|pemetrexed|mesh-list
154076409|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076410|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076411|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076412|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154076413|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154076414|NCT05753657|Pioglitazone|pioglitazone|mesh-list
154076415|NCT05753657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154076416|NCT05753657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076417|NCT00720759|Cycloserine|cycloserine|mesh-list
154076418|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154076419|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076420|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154076421|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
154076422|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154076423|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
154076424|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076425|NCT00918411|Ramosetron|ramosetron|mesh-list
154076426|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
154076427|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
154076428|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076429|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076430|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154076431|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154076432|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
154076433|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076434|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076435|NCT00810407|Rifabutin|rifabutin|mesh-list
154076436|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154076437|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076438|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154076439|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
154076440|NCT00720057|Naproxen|naproxen|mesh-list
154076441|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154076442|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154076444|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
154076445|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076446|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076447|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154076448|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154076449|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
154076451|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076452|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076453|NCT00790868|Cycloserine|cycloserine|mesh-list
154076454|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154076455|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076456|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154076457|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
154076458|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154076459|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
154076460|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076462|NCT00719901|Obatoclax|obatoclax|mesh-list
154076463|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076464|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076465|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076466|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154076467|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
154076468|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076469|NCT00807365|Hormones|hormones|mesh-list
154076470|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154076471|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076472|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076473|NCT02609711|Candesartan|candesartan|mesh-list
154076474|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
154076475|NCT02609711|Atorvastatin|atorvastatin|mesh-list
154076476|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154076477|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154076478|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
154076479|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076481|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154076482|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076483|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154076484|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154076485|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154076486|NCT04016207|Guanfacine|guanfacine|mesh-list
154076487|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154076488|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154076489|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154076490|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154076491|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076492|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076493|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076494|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076495|NCT04030091|Insulin|insulin|mesh-list
154076496|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154076497|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
154076498|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154076499|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076500|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
154076501|NCT00734604|Tadalafil|tadalafil|mesh-list
154076502|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076503|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
154076504|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154076505|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154076506|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076507|NCT00734604|Urological Agents|urological agents|mesh-ancestor
154076508|NCT00590681|Bevacizumab|bevacizumab|mesh-list
154076509|NCT00590681|Temozolomide|temozolomide|mesh-list
154076510|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154076511|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076512|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153399710|NCT02938949|Alirocumab|alirocumab|mesh-list
154076513|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154076514|NCT00590681|Growth Substances|growth substances|mesh-ancestor
154076515|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076516|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
154076517|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154076518|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
154076519|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076520|NCT00727272|Quinine|quinine|mesh-list
154076523|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154076524|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076525|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154076526|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076527|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154076528|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076529|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154076530|NCT00727272|Analgesics|analgesics|mesh-ancestor
154076531|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
154076532|NCT02609477|Phentermine|phentermine|mesh-list
154076533|NCT02609477|Istradefylline|istradefylline|mesh-list
154076534|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154076535|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076536|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
154076537|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154076538|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
154076539|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
154076540|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076541|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076542|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076543|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076544|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154076545|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154076546|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154076547|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
154076548|NCT02592720|Tenecteplase|tenecteplase|mesh-list
154076549|NCT02592720|Tirofiban|tirofiban|mesh-list
154076550|NCT02592720|Bivalirudin|bivalirudin|mesh-list
154076551|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154076552|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154076553|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076554|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
154076555|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154076557|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076558|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
154076559|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154076560|NCT02608073|Capecitabine|capecitabine|mesh-list
154076561|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076562|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154076563|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
154076564|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076565|NCT02605226|Bicalutamide|bicalutamide|mesh-list
154076566|NCT02605226|Hormones|hormones|mesh-list
154076567|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154076568|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076569|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076570|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
154076571|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
154076572|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076573|NCT04088448|Metformin|metformin|mesh-list
154076574|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154076575|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076576|NCT00806351|Caspofungin|caspofungin|mesh-list
154076577|NCT00806351|Anidulafungin|anidulafungin|mesh-list
154076578|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
154076579|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076580|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076581|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076582|NCT03995251|Testosterone|testosterone|mesh-list
154076583|NCT03995251|Androgens|androgens|mesh-ancestor
154076584|NCT03995251|Hormones|hormones|mesh-ancestor
154076585|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076586|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076588|NCT01031017|Progestins|progestins|mesh-ancestor
154076589|NCT01031017|Hormones|hormones|mesh-ancestor
154076590|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076591|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076592|NCT03742531|Oxytocin|oxytocin|mesh-list
154076593|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
154076594|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154076598|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
154076599|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076600|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076601|NCT05737355|Red yeast rice|red yeast rice|mesh-list
154076602|NCT05737355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154076603|NCT05737355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154076604|NCT05737355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154076605|NCT05737355|Antimetabolites|antimetabolites|mesh-ancestor
154076606|NCT05737355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076607|NCT05737355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076608|NCT05737355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154076609|NCT03540017|Cisplatin|cisplatin|mesh-list
154076610|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076611|NCT02606981|Vitamins|vitamins|mesh-list
154076612|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
154076613|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
154076614|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076615|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
154076616|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076617|NCT02606981|Protective Agents|protective agents|mesh-ancestor
154076618|NCT00914888|Metronidazole|metronidazole|mesh-list
154076619|NCT00914888|Clarithromycin|clarithromycin|mesh-list
154076620|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
154076621|NCT00914888|Tigecycline|tigecycline|mesh-list
154076622|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076623|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154076624|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154076625|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154076626|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154076627|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076628|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076629|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154076630|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154076631|NCT00914888|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154076632|NCT00914888|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154076633|NCT02603198|Epinephrine|epinephrine|mesh-list
154076635|NCT02603198|Anesthetics|anesthetics|mesh-list
154076636|NCT02603198|Mepivacaine|mepivacaine|mesh-list
154076637|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076638|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076639|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154076640|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154076641|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076642|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076643|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076644|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154076645|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154076646|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
154076647|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076648|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154076649|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
154076650|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
154076651|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
154076652|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154076653|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
154076654|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
154076655|NCT00719043|Vaccines|vaccines|mesh-list
154076656|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
154076657|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076658|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
154076659|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154076660|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
154076661|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154076662|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
154076663|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076664|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076665|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
154076666|NCT00718887|Entecavir|entecavir|mesh-list
154076667|NCT00718887|Adefovir|adefovir|mesh-list
154076668|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
154076670|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154076671|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154076672|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076673|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076675|NCT00786188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154076676|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154076677|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154076678|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076679|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076680|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
154076681|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076682|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154076683|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
154076684|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154076685|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154076686|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154076687|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076688|NCT00733824|Plerixafor|plerixafor|mesh-list
154076689|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154076690|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154076691|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
154076692|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076693|NCT00718809|Saracatinib|saracatinib|mesh-list
154076694|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076695|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076696|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076697|NCT00585039|Albuterol|albuterol|mesh-list
154076698|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154076699|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
154076700|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076701|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076702|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154076703|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154076704|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
154076705|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154076706|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154076707|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154076708|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154076709|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076710|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076711|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076712|NCT04085913|Lidocaine|lidocaine|mesh-list
154076713|NCT04085913|Epinephrine|epinephrine|mesh-list
154076714|NCT04085913|Racepinephrine|racepinephrine|mesh-list
154076715|NCT04085913|Bupivacaine|bupivacaine|mesh-list
154076716|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
154076717|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
154076718|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
154076719|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076720|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076721|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
154076722|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076723|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154076724|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154076725|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154076726|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154076727|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076728|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154076729|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154076730|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076731|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076732|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154076733|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154076734|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
154076735|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154076736|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
154076737|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
154076739|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154076740|NCT00806195|Vaccines|vaccines|mesh-list
154076741|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154076742|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
154076743|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076744|NCT05728151|Epinephrine|epinephrine|mesh-list
154076745|NCT05728151|Levobupivacaine|levobupivacaine|mesh-list
154076746|NCT05728151|Mepivacaine|mepivacaine|mesh-list
154076748|NCT05728151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154076749|NCT05728151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154076750|NCT05728151|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076751|NCT05728151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076752|NCT05728151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076753|NCT05728151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076754|NCT05728151|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154076755|NCT05728151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154076756|NCT05728151|Autonomic Agents|autonomic agents|mesh-ancestor
154076757|NCT05728151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076758|NCT05728151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154076759|NCT05728151|Respiratory System Agents|respiratory system agents|mesh-ancestor
154076760|NCT05728151|Mydriatics|mydriatics|mesh-ancestor
154076761|NCT05728151|Sympathomimetics|sympathomimetics|mesh-ancestor
154076763|NCT05728151|Anesthetics, Local|anesthetics, local|mesh-ancestor
154076764|NCT05728151|Anesthetics|anesthetics|mesh-ancestor
154076765|NCT05728151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076766|NCT05728151|Sensory System Agents|sensory system agents|mesh-ancestor
154076767|NCT00733746|Gemcitabine|gemcitabine|mesh-list
154076768|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154076769|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154076770|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
154076771|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076772|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076773|NCT00733746|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154076774|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154076775|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076776|NCT03422705|Lisinopril|lisinopril|mesh-list
154076777|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154076778|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
154076779|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076780|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076781|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154076782|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154076783|NCT03422705|Protective Agents|protective agents|mesh-ancestor
154076784|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076785|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153645068|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154076786|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154076787|NCT02607293|Hormones|hormones|mesh-ancestor
154076788|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076789|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076790|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
154076791|NCT02607371|Apixaban|apixaban|mesh-list
154076792|NCT02607371|Edoxaban|edoxaban|mesh-list
154076793|NCT02607371|Dabigatran|dabigatran|mesh-list
154076794|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154076795|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
154076796|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154076797|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
154076798|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076799|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076800|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
154076801|NCT04085757|Dinoprostone|dinoprostone|mesh-list
154076802|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
154076803|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154076804|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076805|NCT00727194|Eculizumab|eculizumab|mesh-list
154076806|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154076807|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154076808|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
154076809|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076810|NCT00717093|Varenicline|varenicline|mesh-list
154076811|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154076812|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154076813|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
154076814|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076815|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076816|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076817|NCT00716859|Timolol|timolol|mesh-list
154076818|NCT00716859|Latanoprost|latanoprost|mesh-list
154076821|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076822|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076823|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076824|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076825|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154076826|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154076827|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154076828|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154076830|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154076831|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154076832|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
154076833|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076834|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154076835|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154076836|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076838|NCT00589667|Pemetrexed|pemetrexed|mesh-list
154076839|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154076840|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
154076841|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076842|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076843|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076844|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154076845|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154076846|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154076847|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154076848|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154076849|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076850|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076851|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
154076852|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076853|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154076854|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154076855|NCT00737100|Bromides|bromides|mesh-list
154076856|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
154076857|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153469008|NCT05691478|Methotrexate|methotrexate|mesh-list
154076858|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
153469009|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076859|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076860|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076861|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154076863|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
154076864|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154076865|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
154076866|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076867|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076868|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
154076869|NCT00732498|Cytarabine|cytarabine|mesh-list
154076870|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
154076871|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154076872|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154076873|NCT00732498|Prednisolone|prednisolone|mesh-list
154076874|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
154076875|NCT00732498|Rituximab|rituximab|mesh-list
154076876|NCT00732498|Etoposide|etoposide|mesh-list
154076877|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154076878|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154076879|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
154076880|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076881|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154076882|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
154076883|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076884|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154076885|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154076886|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154076887|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154076888|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076889|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076891|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
154076892|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
154076893|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076894|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154076895|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154076896|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
154076897|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
154076898|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076899|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154076900|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
154076902|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076903|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154076904|NCT00732498|Protective Agents|protective agents|mesh-ancestor
154076905|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154076906|NCT00790400|Everolimus|everolimus|mesh-list
154076907|NCT00790400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154076908|NCT00790400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154076909|NCT00790400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076910|NCT00790400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076911|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154076912|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
154076913|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076914|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154076915|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154076916|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154076917|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154076918|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076919|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076920|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154076921|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154076922|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154076923|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
154076924|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076925|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076926|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154076927|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154076928|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
154076929|NCT02602652|Vaccines|vaccines|mesh-list
154076930|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
154076931|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076932|NCT02593500|Budesonide|budesonide|mesh-list
154076933|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154076934|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154076935|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
153626871|NCT02019394|Serotonin Agents|serotonin agents|mesh-ancestor
154076936|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076937|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076938|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154076939|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
154076940|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
154076941|NCT02593500|Hormones|hormones|mesh-ancestor
154076942|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154076943|NCT02594358|Caffeine|caffeine|mesh-list
154076944|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154076945|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076946|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154076947|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076948|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076949|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154076950|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154076951|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
154076952|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076953|NCT00785486|Quinine|quinine|mesh-list
154076954|NCT00785486|Midazolam|midazolam|mesh-list
154076955|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154076956|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154076957|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076958|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076959|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154076960|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154076961|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154076962|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154076963|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
154076967|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154076968|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076969|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
154076970|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154076971|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154076972|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076973|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154076974|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154076975|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076976|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154076977|NCT00785486|Analgesics|analgesics|mesh-ancestor
154076978|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
154076979|NCT00917904|Dapivirine|dapivirine|mesh-list
154076980|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154076981|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154076982|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
154076983|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076984|NCT00589979|Lidocaine|lidocaine|mesh-list
154076985|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
154076986|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
154076987|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154076988|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076989|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
154076990|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076991|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154076992|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154076993|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154076994|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154076995|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154076996|NCT02590653|Atorvastatin|atorvastatin|mesh-list
154076997|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154076998|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154076999|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
154077000|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077001|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154077002|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154077003|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077004|NCT00915746|Ketoconazole|ketoconazole|mesh-list
154077005|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
154077006|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077007|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154077008|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154077009|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077010|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077011|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154077012|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
154077013|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154077015|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154077016|NCT00736944|Cisplatin|cisplatin|mesh-list
154077017|NCT00736944|Cetuximab|cetuximab|mesh-list
154077018|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154077019|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077020|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154077021|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
154077022|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154077023|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077024|NCT04084977|Antibodies|antibodies|mesh-list
154077025|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
154077026|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077027|NCT04107194|Amoxicillin|amoxicillin|mesh-list
154077028|NCT04107194|Metronidazole|metronidazole|mesh-list
154077029|NCT04107194|Clarithromycin|clarithromycin|mesh-list
154077030|NCT04107194|Levofloxacin|levofloxacin|mesh-list
154077031|NCT04107194|Tetracycline|tetracycline|mesh-list
154077032|NCT04107194|Rifabutin|rifabutin|mesh-list
154077033|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154077034|NCT04107194|Pantoprazole|pantoprazole|mesh-list
154077035|NCT04107194|Bismuth|bismuth|mesh-list
154077036|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154077037|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077041|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077042|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077043|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154077044|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154077045|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154077046|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154077047|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154077048|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077049|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154077050|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154077051|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154077052|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154077054|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154077055|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
154077056|NCT02590263|Temozolomide|temozolomide|mesh-list
154077057|NCT02590263|ABT-414|abt-414|mesh-list
154077058|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154077059|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
154077060|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077061|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077062|NCT02590263|Immunoconjugates|immunoconjugates|mesh-ancestor
154077063|NCT02590263|Immunologic Factors|immunologic factors|mesh-ancestor
154077064|NCT02590263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077065|NCT00736476|Vaccines|vaccines|mesh-list
154077066|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
154077067|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077068|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
154077069|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154077070|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077071|NCT04019496|Calcitonin|calcitonin|mesh-list
154077072|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
154077073|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154077074|NCT04019496|Antibodies|antibodies|mesh-list
154077075|NCT04019496|Katacalcin|katacalcin|mesh-list
154077076|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
154077077|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077078|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154077079|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154077080|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
154077081|NCT00918489|Vorinostat|vorinostat|mesh-list
154077082|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077083|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154077084|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077085|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077086|NCT02604992|Dronabinol|dronabinol|mesh-list
154077087|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
154077088|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077089|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154077090|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154077091|NCT02604992|Analgesics|analgesics|mesh-ancestor
154077092|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
154077093|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645465|NCT00006968|Cyclosporine|cyclosporine|mesh-list
154077094|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154077095|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154077096|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077097|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077098|NCT02604992|Hormones|hormones|mesh-ancestor
154077099|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154077100|NCT03899597|Oxytocin|oxytocin|mesh-list
154077101|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
154077102|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154077103|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077104|NCT00714285|Vaccines|vaccines|mesh-list
154077105|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
154077106|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077109|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
154077110|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077111|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077112|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077113|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077114|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
154077115|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154077116|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
154077117|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077118|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077119|NCT04015557|Acetaminophen|acetaminophen|mesh-list
154077120|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
154077121|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154077122|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154077123|NCT04015557|Analgesics|analgesics|mesh-ancestor
154077124|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
154077125|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077126|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077127|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
154077128|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
154077129|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077130|NCT04015557|Expectorants|expectorants|mesh-ancestor
154077131|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077132|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154077133|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
154077134|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077135|NCT04015557|Protective Agents|protective agents|mesh-ancestor
154077136|NCT04015557|Antidotes|antidotes|mesh-ancestor
154077137|NCT00784784|Zanamivir|zanamivir|mesh-list
154077138|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
154077139|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077140|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077141|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077142|NCT00587288|Reslizumab|reslizumab|mesh-list
154077143|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077144|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077145|NCT00800735|Interferons|interferons|mesh-list
154077146|NCT00800735|Ribavirin|ribavirin|mesh-list
154077147|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
154077148|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
154077149|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154077150|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077151|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
154077152|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077153|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
154077154|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077155|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
154077156|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077157|NCT05324163|Celecoxib|celecoxib|mesh-list
154077158|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154077159|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154077160|NCT05324163|Analgesics|analgesics|mesh-ancestor
154077161|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
154077162|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077163|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077164|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077165|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154077166|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154077167|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154077168|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077169|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077170|NCT00730158|Irinotecan|irinotecan|mesh-list
154077171|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154077172|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154077173|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077174|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077175|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077176|NCT04114643|Thrombin|thrombin|mesh-list
154077177|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
154077178|NCT04114643|Coagulants|coagulants|mesh-ancestor
154077179|NCT00784550|Fluticasone|fluticasone|mesh-list
154077180|NCT00784550|Xhance|xhance|mesh-list
154077181|NCT00784550|Bromides|bromides|mesh-list
154077182|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
154077186|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
154077187|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077188|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077189|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077190|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077191|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
154077192|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154077193|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
154077194|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154077195|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
154077196|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077197|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077198|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154077199|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154077200|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154077201|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
154077202|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
154077203|NCT00729690|Pregabalin|pregabalin|mesh-list
154077204|NCT00729690|Analgesics|analgesics|mesh-ancestor
154077205|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
154077206|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077207|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077208|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
154077209|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154077210|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154077211|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077212|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154077213|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154077214|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154077215|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077216|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154077218|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154077219|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077220|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077221|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154077222|NCT04027829|Analgesics|analgesics|mesh-ancestor
154077223|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
154077224|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077225|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154077226|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154077227|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154077228|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
154077229|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077230|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077231|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154077232|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154077233|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154077234|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077235|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077236|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154077237|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154077238|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154077239|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
154077240|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077241|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077242|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154077243|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154077244|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
154077245|NCT00729612|Paclitaxel|paclitaxel|mesh-list
154077246|NCT00729612|Carboplatin|carboplatin|mesh-list
154077247|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154077248|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154077249|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077250|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
154077251|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
154077252|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
154077253|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077256|NCT00585546|Clenbuterol|clenbuterol|mesh-list
154077257|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154077258|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154077259|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154077260|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077261|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077262|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400439|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
154077263|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154077264|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
154077265|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077266|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077267|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077268|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
154077269|NCT00768248|Ropivacaine|ropivacaine|mesh-list
154077270|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
154077271|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
154077272|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077273|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077274|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
154077275|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077276|NCT02589717|Atezolizumab|atezolizumab|mesh-list
154077277|NCT02589717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154077278|NCT02589717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077279|NCT02589717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154077280|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077281|NCT02602028|Colchicine|colchicine|mesh-list
154077283|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154077284|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
154077285|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
154077286|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
154077287|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077288|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077289|NCT04103684|Dexamethasone|dexamethasone|mesh-list
154077290|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
154077291|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154077292|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154077293|NCT04103684|Prednisolone|prednisolone|mesh-list
154077294|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
154077295|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154077296|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
154077297|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077298|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
154077299|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
154077300|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077301|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077302|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154077303|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
154077304|NCT04103684|Hormones|hormones|mesh-ancestor
154077305|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154077306|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154077307|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077308|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154077309|NCT04103684|Protective Agents|protective agents|mesh-ancestor
154077310|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154077311|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154077312|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077313|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
154077314|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154077315|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154077316|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
154077317|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154077318|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077319|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154077320|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154077321|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154077322|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154077323|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645803|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154077324|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154077325|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154077326|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077329|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
154077330|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154077331|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
154077332|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077333|NCT00774800|Insulin|insulin|mesh-list
154077334|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154077335|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
154077336|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154077337|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077338|NCT00439309|Thrombin|thrombin|mesh-list
154077339|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154077340|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
154077341|NCT00439309|Coagulants|coagulants|mesh-ancestor
154077342|NCT00479167|Bortezomib|bortezomib|mesh-list
154077343|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
154077344|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077345|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
154077346|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154077347|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154077348|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154077349|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154077350|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077351|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
154077352|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077353|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077354|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154077355|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077356|NCT00725010|Temozolomide|temozolomide|mesh-list
154077357|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154077358|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
154077359|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077360|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077361|NCT05216055|Dexamethasone|dexamethasone|mesh-list
154077362|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
154077363|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
154077364|NCT05216055|Bupivacaine|bupivacaine|mesh-list
154077365|NCT05216055|Ropivacaine|ropivacaine|mesh-list
154077366|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154077367|NCT05216055|BB 1101|bb 1101|mesh-list
154077368|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077369|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
154077370|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
154077371|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077372|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077373|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154077374|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
154077375|NCT05216055|Hormones|hormones|mesh-ancestor
154077376|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154077377|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154077378|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077379|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
154077380|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
154077381|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077382|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
154077383|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154077384|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154077385|NCT05216055|Analgesics|analgesics|mesh-ancestor
154077386|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154077387|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154077388|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154077389|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
154077390|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077391|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077392|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
154077393|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077394|NCT00767000|Metformin|metformin|mesh-list
154077395|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
154077396|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154077397|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077398|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154077399|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077400|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077405|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
154077406|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154077407|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154077408|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154077409|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077410|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077411|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154077412|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154077413|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154077414|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
154077415|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077416|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077417|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
154077418|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
154077419|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154077420|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154077421|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
154077422|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077423|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077424|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154077425|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077426|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154077427|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154077428|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154077429|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077430|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077431|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154077432|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
154077433|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154077434|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077435|NCT04083807|Thrombin|thrombin|mesh-list
154077436|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154077437|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
154077438|NCT04083807|Coagulants|coagulants|mesh-ancestor
154077439|NCT05163483|Bevacizumab|bevacizumab|mesh-list
154077440|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154077441|NCT05163483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154077442|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077443|NCT05163483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154077444|NCT05163483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154077445|NCT05163483|Growth Substances|growth substances|mesh-ancestor
154077446|NCT05163483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077447|NCT05163483|Growth Inhibitors|growth inhibitors|mesh-ancestor
154077448|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077449|NCT00766142|Leucovorin|leucovorin|mesh-list
154077450|NCT00766142|Fluorouracil|fluorouracil|mesh-list
154077451|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
154077452|NCT00766142|Cetuximab|cetuximab|mesh-list
154077453|NCT00766142|Calcium|calcium|mesh-list
154077454|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
154077455|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154077456|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077457|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
154077458|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077459|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154077460|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077461|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154077462|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
154077463|NCT00766142|Antidotes|antidotes|mesh-ancestor
154077464|NCT00766142|Protective Agents|protective agents|mesh-ancestor
154077465|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
154077466|NCT00766142|Vitamins|vitamins|mesh-ancestor
154077467|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
154077468|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154077469|NCT00916526|Mannitol|mannitol|mesh-list
154077470|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154077471|NCT00916526|Diuretics|diuretics|mesh-ancestor
154077472|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
154077473|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077476|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
154077477|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
154077478|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077479|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
154077480|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077481|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
154077482|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256603|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077483|NCT04083651|Bromides|bromides|mesh-list
154077484|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
154077485|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
154077486|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154077487|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077488|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
154077489|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077490|NCT00728988|Atorvastatin|atorvastatin|mesh-list
154077491|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154077492|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154077493|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
154077494|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077495|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154077496|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154077497|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077498|NCT04087746|Ranibizumab|ranibizumab|mesh-list
154077499|NCT04087746|Aflibercept|aflibercept|mesh-list
154077500|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154077501|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154077502|NCT04087746|Growth Substances|growth substances|mesh-ancestor
154077503|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077504|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
154077505|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077506|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154077507|NCT04083417|Penicillins|penicillins|mesh-list
154077508|NCT04083417|Penicillin V|penicillin v|mesh-list
154077509|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077510|NCT02588937|Entecavir|entecavir|mesh-list
154077511|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
154077512|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077513|NCT04083105|Midazolam|midazolam|mesh-list
154077514|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
154077515|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154077516|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154077517|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077518|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077519|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154077520|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154077521|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154077522|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154077523|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
154077524|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
154077525|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
154077526|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
154077527|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077528|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077529|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154077530|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154077531|NCT04083105|Analgesics|analgesics|mesh-ancestor
154077532|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
154077533|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077534|NCT00735696|Paclitaxel|paclitaxel|mesh-list
154077535|NCT00735696|Carboplatin|carboplatin|mesh-list
154077536|NCT00735696|Ramucirumab|ramucirumab|mesh-list
154077537|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154077538|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077539|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
154077540|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
154077541|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
154077542|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077543|NCT00735696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154077544|NCT00735696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154077545|NCT00735696|Growth Substances|growth substances|mesh-ancestor
154077546|NCT00735696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077547|NCT00735696|Growth Inhibitors|growth inhibitors|mesh-ancestor
154077548|NCT02593968|Interferons|interferons|mesh-list
154077549|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077554|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
154077555|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077556|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077557|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154077558|NCT02588547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154077559|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154077560|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
154077561|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077563|NCT00478231|Maraviroc|maraviroc|mesh-list
154077564|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154077565|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154077566|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077567|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154077568|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154077569|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
154077570|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077571|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154077572|NCT00474175|Benzocaine|benzocaine|mesh-list
154077573|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
154077574|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
154077575|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077576|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077577|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
154077578|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077579|NCT03002389|Fluticasone|fluticasone|mesh-list
154077581|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077582|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154077583|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
154077584|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077585|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077586|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077587|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077588|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
154077589|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154077590|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154077591|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
154077592|NCT04082949|Coagulants|coagulants|mesh-ancestor
154077593|NCT01020643|Propofol|propofol|mesh-list
154077594|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154077595|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077596|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077597|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154077598|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
154077599|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
154077600|NCT03537391|Fluorides|fluorides|mesh-list
154077601|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
154077602|NCT03537391|Protective Agents|protective agents|mesh-ancestor
154077603|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077604|NCT04082715|Celecoxib|celecoxib|mesh-list
154077605|NCT04082715|Levodopa|levodopa|mesh-list
154077606|NCT04082715|Carbidopa|carbidopa|mesh-list
154077607|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154077608|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154077609|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154077610|NCT04082715|Analgesics|analgesics|mesh-ancestor
154077611|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
154077612|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077613|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077614|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077615|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154077616|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154077617|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154077618|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077619|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077620|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154077621|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154077622|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
154077628|NCT00443209|Rizatriptan|rizatriptan|mesh-list
154077629|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154077630|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
154077631|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077632|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077633|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077634|NCT02588235|Atorvastatin|atorvastatin|mesh-list
154077635|NCT02588235|Ezetimibe|ezetimibe|mesh-list
154077636|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154077637|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154077638|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
154077639|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077640|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154077641|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154077643|NCT01020955|Mecasermin|mecasermin|mesh-list
154077644|NCT01020955|Growth Substances|growth substances|mesh-ancestor
154077645|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077646|NCT04082793|Diclofenac|diclofenac|mesh-list
154077647|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154077648|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154077649|NCT04082793|Analgesics|analgesics|mesh-ancestor
154077650|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
154077651|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077652|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077653|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077654|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154077655|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154077656|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077657|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077658|NCT00439231|Lenalidomide|lenalidomide|mesh-list
154077659|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
154077660|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077662|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154077663|NCT00439231|Growth Substances|growth substances|mesh-ancestor
154077664|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
154077665|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077666|NCT00783692|Vedolizumab|vedolizumab|mesh-list
154077667|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154077668|NCT04992273|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154077669|NCT04992273|Antiviral Agents|antiviral agents|mesh-ancestor
154077670|NCT04992273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077671|NCT00783224|Fluticasone|fluticasone|mesh-list
154077672|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
154077673|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077674|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154077675|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
154077676|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077677|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077678|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077679|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077680|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
154077681|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154077682|NCT04102124|Fluzoparib|fluzoparib|mesh-list
154077683|NCT04102124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154077684|NCT04102124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077685|NCT04102124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077686|NCT04102124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077687|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154077688|NCT04082559|Metronidazole|metronidazole|mesh-list
154077689|NCT04082559|Doxycycline|doxycycline|mesh-list
154077690|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
154077691|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154077692|NCT04082559|Complement Factor H|complement factor h|mesh-list
154077693|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077696|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154077698|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154077699|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154077700|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077701|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077702|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077703|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154077704|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154077705|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154077706|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154077707|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
154077708|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077709|NCT00782834|Nilotinib|nilotinib|mesh-list
154077710|NCT00782834|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154077711|NCT00782834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154077712|NCT00782834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077713|NCT00782834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077714|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
154077715|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154077716|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154077717|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077720|NCT00765674|Amlodipine|amlodipine|mesh-list
153627985|NCT02026492|Miotics|miotics|mesh-ancestor
154077721|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154077722|NCT00765674|Aliskiren|aliskiren|mesh-list
154077723|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154077724|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154077725|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154077726|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077727|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154077728|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077729|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
154077730|NCT00765674|Diuretics|diuretics|mesh-ancestor
154077731|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
154077732|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154077733|NCT00765674|Renin Inhibitors|renin inhibitors|mesh-ancestor
154077734|NCT00765674|Protease Inhibitors|protease inhibitors|mesh-ancestor
154077735|NCT00765674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077736|NCT00586898|Ketoconazole|ketoconazole|mesh-list
154077737|NCT00586898|Bicalutamide|bicalutamide|mesh-list
154077738|NCT00586898|Testosterone|testosterone|mesh-list
154077739|NCT00586898|Estrogens|estrogens|mesh-list
154077740|NCT00586898|Androgens|androgens|mesh-ancestor
154077741|NCT00586898|Hormones|hormones|mesh-ancestor
154077742|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154077743|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077744|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077745|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
154077746|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077747|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154077748|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154077749|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077750|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077751|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154077752|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
154077753|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154077754|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
154077755|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
154077756|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154077757|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077758|NCT02587455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154077759|NCT02587455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077760|NCT04099238|Warfarin|warfarin|mesh-list
154077761|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
154077762|NCT04099238|Dabigatran|dabigatran|mesh-list
154077763|NCT04099238|Apixaban|apixaban|mesh-list
154077764|NCT04099238|Anticoagulants|anticoagulants|mesh-list
154077765|NCT04099238|Edoxaban|edoxaban|mesh-list
154077766|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
154077770|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154077771|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
154077772|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077773|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077774|NCT04101812|Doxorubicin|doxorubicin|mesh-list
154077775|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154077776|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154077777|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077778|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154077779|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154077780|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077781|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077782|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154077783|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154077784|NCT04923867|Estradiol|estradiol|mesh-list
154077785|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154077786|NCT04923867|Estrogens|estrogens|mesh-ancestor
154077787|NCT04923867|Hormones|hormones|mesh-ancestor
154077788|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154077789|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077790|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154077791|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
154077792|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154077793|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154077794|NCT02587533|Dopamine|dopamine|mesh-list
154077795|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154077796|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
154077797|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
154077799|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628093|NCT02027220|Bortezomib|bortezomib|mesh-list
154077800|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
154077801|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077802|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077803|NCT02587533|Protective Agents|protective agents|mesh-ancestor
154077804|NCT04847661|Mefloquine|mefloquine|mesh-list
154077805|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
154077806|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154077807|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154077808|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077809|NCT00919815|Cyclosporine|cyclosporine|mesh-list
154077810|NCT00919815|Prednisolone|prednisolone|mesh-list
154077811|NCT00919815|Cyclosporins|cyclosporins|mesh-list
154077812|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077813|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077814|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154077815|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
154077816|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077817|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
154077818|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077819|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154077820|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154077821|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154077822|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077823|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
154077824|NCT00919815|Hormones|hormones|mesh-ancestor
154077825|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154077826|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154077827|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077828|NCT00796991|Paclitaxel|paclitaxel|mesh-list
154077829|NCT00796991|Carboplatin|carboplatin|mesh-list
154077830|NCT00796991|Ipilimumab|ipilimumab|mesh-list
154077831|NCT00796991|Dacarbazine|dacarbazine|mesh-list
154077832|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154077833|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077834|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
154077835|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
154077836|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
154077837|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077838|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154077839|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154077843|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
154077844|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077845|NCT00914771|Vaccines|vaccines|mesh-list
154077846|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
154077847|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077848|NCT02586987|Durvalumab|durvalumab|mesh-list
154077849|NCT02586987|Tremelimumab|tremelimumab|mesh-list
154077850|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154077851|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077852|NCT02586753|Paclitaxel|paclitaxel|mesh-list
154077853|NCT02586753|Cisplatin|cisplatin|mesh-list
154077854|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154077855|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077856|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
154077857|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
154077858|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
154077859|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077860|NCT00799487|Methylphenidate|methylphenidate|mesh-list
154077861|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154077862|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077863|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154077864|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154077865|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154077866|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077867|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
154077868|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077869|NCT00799409|Methylphenidate|methylphenidate|mesh-list
154077870|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154077871|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077872|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154077873|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154077874|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154077875|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077876|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
154077877|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077879|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154077880|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
154077881|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077882|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077883|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077884|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077885|NCT01558115|Denosumab|denosumab|mesh-list
154077886|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154077887|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077888|NCT02605265|Capecitabine|capecitabine|mesh-list
154077889|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
154077890|NCT02605265|Irinotecan|irinotecan|mesh-list
154077891|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154077892|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
154077893|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077894|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077895|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154077896|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154077897|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077898|NCT04101500|Aminophylline|aminophylline|mesh-list
154077899|NCT04101500|Bromides|bromides|mesh-list
154077900|NCT04101500|Ipratropium|ipratropium|mesh-list
154077901|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
154077902|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154077903|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
154077904|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077905|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077906|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154077907|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
154077908|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154077909|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
154077910|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077911|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077915|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154077916|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154077917|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
154077918|NCT04101500|Protective Agents|protective agents|mesh-ancestor
154077919|NCT02586441|Bromides|bromides|mesh-list
154077920|NCT02586441|Propofol|propofol|mesh-list
154077921|NCT02586441|Rocuronium|rocuronium|mesh-list
154077922|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154077923|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077924|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077925|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154077926|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
154077927|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
154077928|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
154077929|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154077930|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154077931|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154077932|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077933|NCT02586363|Entecavir|entecavir|mesh-list
154077934|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
154077935|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077936|NCT02586129|Metformin|metformin|mesh-list
154077937|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154077938|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154077939|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077940|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154077941|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154077942|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
153401114|NCT02068027|Clonidine|clonidine|mesh-list
154077943|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077944|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154077945|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154077946|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077947|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
154077948|NCT04081077|Linezolid|linezolid|mesh-list
154077949|NCT04081077|Bedaquiline|bedaquiline|mesh-list
154077950|NCT04081077|Clofazimine|clofazimine|mesh-list
154077951|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154077952|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077953|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154256604|NCT02526914|Vasopressins|vasopressins|mesh-list
154077954|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154077955|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077956|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077957|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077958|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154077959|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
154077960|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077961|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
154077963|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
154077964|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154077965|NCT02586051|Antibodies|antibodies|mesh-list
154077966|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
154077967|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154077968|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
154077969|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077970|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154077971|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077972|NCT00763958|Buprenorphine|buprenorphine|mesh-list
154077973|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154077974|NCT00763958|Narcotics|narcotics|mesh-ancestor
154077975|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154077976|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077977|NCT00763958|Analgesics|analgesics|mesh-ancestor
154077978|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
154077979|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154077980|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154077981|NCT04101578|Cyclosporine|cyclosporine|mesh-list
154077982|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
154077983|NCT04101578|Prednisone|prednisone|mesh-list
154077984|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
154077985|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
154077986|NCT04101578|Methotrexate|methotrexate|mesh-list
154077987|NCT04101578|Azathioprine|azathioprine|mesh-list
154077989|NCT04101578|Tacrolimus|tacrolimus|mesh-list
154077990|NCT04101578|Cyclosporins|cyclosporins|mesh-list
154077991|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154077992|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
154077993|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154077994|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
154077995|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154077996|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154077997|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
154077998|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154077999|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154078000|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154078001|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
154078002|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078003|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078004|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154078005|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154078006|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
154078007|NCT04101578|Hormones|hormones|mesh-ancestor
154078008|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154078009|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154078010|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154078011|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
154078012|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078013|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154078014|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
154078015|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
154078016|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078017|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154078018|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154078019|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154078021|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078022|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154078023|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154078024|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
154078025|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154078026|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
154078027|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
154078028|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078029|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078030|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154078031|NCT04101578|Protective Agents|protective agents|mesh-ancestor
154256605|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
154078032|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
154078033|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154078034|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
154078035|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078036|NCT00763256|Triclosan|triclosan|mesh-list
154078037|NCT00763256|Fluorides|fluorides|mesh-list
154078038|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
154078039|NCT00763256|Protective Agents|protective agents|mesh-ancestor
153561587|NCT01652924|Anesthetics|anesthetics|mesh-list
154078040|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078042|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078043|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154078044|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154078045|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
154078046|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078047|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154078048|NCT02585973|Cisplatin|cisplatin|mesh-list
154078049|NCT02585973|Adavosertib|adavosertib|mesh-list
154078050|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078051|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078052|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078053|NCT00920283|Cobalt|cobalt|mesh-list
154078054|NCT00920283|Trace Elements|trace elements|mesh-ancestor
154078055|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
154078056|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078057|NCT00583947|Albuterol|albuterol|mesh-list
154078058|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
154078059|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154078060|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
154078061|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078062|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078063|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154078064|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
154078069|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154078070|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
154078071|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078072|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078073|NCT00772928|Vaccines|vaccines|mesh-list
154078074|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154078075|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
154078076|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078077|NCT00762164|Simvastatin|simvastatin|mesh-list
154078078|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154078079|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154078080|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154078081|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
154078082|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078083|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154078084|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154078085|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078086|NCT00761774|Brivaracetam|brivaracetam|mesh-list
154078087|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
154078088|NCT04080375|Dinoprostone|dinoprostone|mesh-list
154078089|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
154078090|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078091|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078092|NCT00781274|Ribavirin|ribavirin|mesh-list
154078093|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154078094|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
153401261|NCT03105479|Vancomycin|vancomycin|mesh-list
154078095|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078096|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
154078097|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078098|NCT05520177|Ranibizumab|ranibizumab|mesh-list
154078099|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154078100|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154078101|NCT05520177|Growth Substances|growth substances|mesh-ancestor
154078102|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078103|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
154078104|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078105|NCT00780416|Ribavirin|ribavirin|mesh-list
154078106|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154078107|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
154078108|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
154078109|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078111|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078112|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
154078113|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078114|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
154078115|NCT02584881|Narcotics|narcotics|mesh-ancestor
154078116|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078117|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078118|NCT02584881|Analgesics|analgesics|mesh-ancestor
154078119|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
154078120|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078121|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154078122|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
154078123|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078124|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154078125|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154078126|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078127|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078128|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078129|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154078130|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154078131|NCT00761306|Vortioxetine|vortioxetine|mesh-list
154078132|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
154078133|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154078134|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154078139|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154078140|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078141|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078142|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078143|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
154078144|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154078145|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154078146|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154078147|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154078148|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
154078149|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154078150|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
154078151|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078152|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078153|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154078154|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
154078155|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
154078156|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154078157|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
154078158|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078159|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078160|NCT04079517|Tamoxifen|tamoxifen|mesh-list
154078161|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154078162|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
154078163|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154078164|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078165|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154078166|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078167|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154078168|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154078169|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154078170|NCT00761150|Acetaminophen|acetaminophen|mesh-list
154078171|NCT00761150|Hydrocodone|hydrocodone|mesh-list
154078172|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154078173|NCT00761150|Analgesics|analgesics|mesh-ancestor
154078174|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
154078175|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078176|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078177|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
154078178|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154078179|NCT00761150|Narcotics|narcotics|mesh-ancestor
154078180|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078181|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
154078182|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
154078183|NCT00583557|Belimumab|belimumab|mesh-list
154078184|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154078185|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
154078186|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078187|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
154078188|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154078189|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154078190|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078191|NCT00760838|Azithromycin|azithromycin|mesh-list
154078192|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154078193|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078194|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
154078195|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154078196|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154078197|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154078198|NCT02584335|Lidocaine|lidocaine|mesh-list
154078199|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154078200|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
154078201|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
154078202|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078206|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154078207|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154078208|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154078209|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078210|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078212|NCT00437281|Analgesics|analgesics|mesh-ancestor
154078213|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
154078214|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078215|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078216|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
154078217|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154078218|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078219|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078220|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154078221|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154078222|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154078223|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078224|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154078225|NCT05468073|Aldesleukin|aldesleukin|mesh-list
154078226|NCT05468073|Interleukin-2|interleukin-2|mesh-list
154078227|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078228|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154078229|NCT05468073|Analgesics|analgesics|mesh-ancestor
154078230|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
154078231|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078232|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078233|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154078234|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154078235|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
154078236|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078237|NCT05674695|Omalizumab|omalizumab|mesh-list
154078238|NCT05674695|Cyclosporine|cyclosporine|mesh-list
154078239|NCT05674695|Methotrexate|methotrexate|mesh-list
154078240|NCT05674695|Upadacitinib|upadacitinib|mesh-list
154078241|NCT05674695|Cyclosporins|cyclosporins|mesh-list
154078242|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154078243|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
154078244|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078245|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078246|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154078247|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
154078248|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078249|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078250|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
154078251|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078252|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154078253|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154078254|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
154078255|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154078256|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154078257|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
154078258|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078259|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154078260|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154078261|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154078262|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
154078263|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154078264|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154078265|NCT02596269|Nefopam|nefopam|mesh-list
154078267|NCT02596269|Analgesics|analgesics|mesh-ancestor
154078268|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
154078269|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078270|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078271|NCT00741039|Vaccines|vaccines|mesh-list
154078272|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154078276|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154078277|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078278|NCT04454229|Penicillins|penicillins|mesh-list
154078279|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154078280|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078281|NCT04078659|Lidocaine|lidocaine|mesh-list
154078282|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
154078283|NCT04078659|Fentanyl|fentanyl|mesh-list
154078284|NCT04078659|Propofol|propofol|mesh-list
154078285|NCT04078659|Atracurium|atracurium|mesh-list
154078286|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
154078287|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
154078288|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078289|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078290|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
154078291|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078292|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154078293|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154078294|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154078295|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078296|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078297|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154078298|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154078299|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
154078300|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154078301|NCT04078659|Narcotics|narcotics|mesh-ancestor
154078302|NCT04078659|Analgesics|analgesics|mesh-ancestor
154078303|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154078304|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
154078305|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154078306|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154078307|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
154078308|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078309|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154078310|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154078311|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154078312|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154078313|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154078314|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
154078315|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078316|NCT02583243|Buprenorphine|buprenorphine|mesh-list
153401489|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
154078317|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154078318|NCT02583243|Narcotics|narcotics|mesh-ancestor
154078319|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078320|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078321|NCT02583243|Analgesics|analgesics|mesh-ancestor
154078322|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
154078323|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078324|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154078325|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154078326|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154078327|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154078328|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078329|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078330|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078331|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078332|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
154078333|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154078335|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154078336|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154078337|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
154078338|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078339|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078340|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154078341|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154078342|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154078343|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154078345|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154078347|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154078348|NCT04078425|Diuretics|diuretics|mesh-ancestor
154078349|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
154078350|NCT00638391|Anastrozole|anastrozole|mesh-list
154078351|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154078352|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078353|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154078354|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154078355|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078356|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078357|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154078358|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
154078359|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154078360|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078361|NCT02583633|Nifedipine|nifedipine|mesh-list
154078362|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
154078363|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154078364|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078365|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078366|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154078367|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078368|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
154078369|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
154078370|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078371|NCT02582307|Acetaminophen|acetaminophen|mesh-list
154078372|NCT02582307|Scopolamine|scopolamine|mesh-list
154078373|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
154078374|NCT02582307|Analgesics|analgesics|mesh-list
154078375|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154078376|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
154078377|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078378|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078379|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
154078380|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154078381|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
154078382|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
154078383|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078384|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
154078385|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154078386|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
154078387|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078388|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078389|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154078390|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
154078391|NCT02689245|Tenofovir|tenofovir|mesh-list
154078392|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
154078393|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078394|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154078395|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154078396|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078397|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078398|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154078399|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154078400|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
154078401|NCT00802841|Nilotinib|nilotinib|mesh-list
154078402|NCT00802841|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154078403|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154078404|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078405|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078406|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078407|NCT00772148|Tacrolimus|tacrolimus|mesh-list
154078408|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154078409|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
154078410|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078411|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154078412|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078413|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078414|NCT02689089|Rifapentine|rifapentine|mesh-list
154078419|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
154078421|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154078422|NCT00759902|Narcotics|narcotics|mesh-ancestor
154078423|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078424|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078425|NCT00759902|Analgesics|analgesics|mesh-ancestor
154078426|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
154078427|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078428|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
154078429|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
154078430|NCT04077957|Etanercept|etanercept|mesh-list
154078431|NCT04077957|Methotrexate|methotrexate|mesh-list
154078432|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154078433|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
154078434|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078435|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078436|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154078437|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
154078438|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078439|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078440|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
154078441|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078442|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154078443|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154078444|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
154078445|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154078446|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154078447|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
154078448|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154078449|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154078450|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078451|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154078452|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154078453|NCT04077957|Analgesics|analgesics|mesh-ancestor
154078454|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
154078455|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078456|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154078457|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078458|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
154078459|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078460|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154078461|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
154078462|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
154078463|NCT04102670|Protective Agents|protective agents|mesh-ancestor
154078464|NCT04114097|Betamethasone|betamethasone|mesh-list
154078466|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154078467|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
154078468|NCT04114097|Tacrolimus|tacrolimus|mesh-list
154078469|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154078470|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154078471|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
154078472|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078473|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154078474|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078475|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078476|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154078477|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
154078478|NCT04114097|Hormones|hormones|mesh-ancestor
154078479|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154078480|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154078481|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
154078482|NCT00772070|Vaccines|vaccines|mesh-list
154078483|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
154078484|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078485|NCT00796757|Interferons|interferons|mesh-list
154078486|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
154078487|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
154078488|NCT00796757|Bevacizumab|bevacizumab|mesh-list
154078491|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154078492|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154078493|NCT00796757|Growth Substances|growth substances|mesh-ancestor
154078494|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078495|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
154078496|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
154078497|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078498|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
154078499|NCT00759356|Morphine|morphine|mesh-list
154078500|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154078501|NCT00759356|Narcotics|narcotics|mesh-ancestor
154078502|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078503|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078504|NCT00759356|Analgesics|analgesics|mesh-ancestor
154078505|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
154078506|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078507|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154078508|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154078509|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078510|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078511|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154078512|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078513|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078514|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
154078515|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078516|NCT04102592|Permethrin|permethrin|mesh-list
154078517|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078518|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078519|NCT04113551|Guanfacine|guanfacine|mesh-list
154078520|NCT04113551|Methylphenidate|methylphenidate|mesh-list
154078521|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154078522|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154078523|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154078524|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078525|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078526|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
154078527|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078528|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078529|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154078530|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154078531|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
154078532|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154078533|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154078534|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154078535|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154078536|NCT00798317|Plasminogen|plasminogen|mesh-list
154078537|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153401712|NCT05992987|Adenosine|adenosine|mesh-list
154078538|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154078539|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078540|NCT00771914|Aspirin|aspirin|mesh-list
154078541|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154078542|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154078543|NCT00771914|Analgesics|analgesics|mesh-ancestor
154078544|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
154078545|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078546|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078547|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154078548|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154078549|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154078550|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154078551|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078552|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154078553|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154078554|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078555|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
154078556|NCT00779324|Amantadine|amantadine|mesh-list
154078557|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154078558|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154078559|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
154078563|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078564|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078565|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154078567|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
154078568|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078569|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
154078570|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154078571|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154078572|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078573|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
154078574|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
154078575|NCT02581761|Misoprostol|misoprostol|mesh-list
154078576|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154078577|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
154078578|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078579|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078580|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154078581|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078582|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
154078583|NCT00771758|Oxycodone|oxycodone|mesh-list
154078584|NCT00771758|Tapentadol|tapentadol|mesh-list
154078585|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154078586|NCT00771758|Narcotics|narcotics|mesh-ancestor
154078587|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078588|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078589|NCT00771758|Analgesics|analgesics|mesh-ancestor
154078590|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
154078591|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078592|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154078593|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154078594|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078595|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078596|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
154078597|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078598|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
154078599|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154078600|NCT02581371|Protective Agents|protective agents|mesh-ancestor
154078601|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078602|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
154078603|NCT02688465|Apomorphine|apomorphine|mesh-list
154078604|NCT02688465|Emetics|emetics|mesh-ancestor
154078605|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078606|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
154078607|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078608|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078609|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
154078610|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
154078611|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078612|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078613|NCT00758498|Modafinil|modafinil|mesh-list
154078614|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154078615|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078616|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154078617|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154078618|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154078619|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078620|NCT00798161|Metformin|metformin|mesh-list
154078621|NCT00798161|Linagliptin|linagliptin|mesh-list
154078622|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154078623|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078624|NCT00798161|Incretins|incretins|mesh-ancestor
154078625|NCT00798161|Hormones|hormones|mesh-ancestor
154078626|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154078627|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154078628|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
154078629|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078630|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078635|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078636|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078637|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
154078638|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078639|NCT02581683|Analgesics|analgesics|mesh-ancestor
154078640|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154078641|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
154078642|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154078643|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078644|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078645|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154078646|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
154078647|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078649|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078650|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078651|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
154078652|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154078653|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154078654|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078655|NCT04115423|Adalimumab|adalimumab|mesh-list
154078656|NCT04115423|Infliximab|infliximab|mesh-list
154078657|NCT04115423|Golimumab|golimumab|mesh-list
154078658|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154078659|NCT04115423|Etanercept|etanercept|mesh-list
154078660|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154078661|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154078662|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
154078663|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078664|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154078665|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154078666|NCT04115423|Analgesics|analgesics|mesh-ancestor
154078667|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
154078668|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078669|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078670|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154078671|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
154078672|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154078673|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
154078674|NCT04113005|Coagulants|coagulants|mesh-ancestor
154078675|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154078676|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
154078677|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078678|NCT00588341|Temozolomide|temozolomide|mesh-list
154078679|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154078680|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
154078681|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078682|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078683|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154078684|NCT00914693|Gestodene|gestodene|mesh-list
154078685|NCT00914693|Femovan|femovan|mesh-list
154078686|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154078687|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154078688|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154078689|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
154078690|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078691|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078692|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154078694|NCT00914693|Hormones|hormones|mesh-ancestor
154078695|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154078696|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154078697|NCT00914693|Progestins|progestins|mesh-ancestor
154078698|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154078699|NCT00915083|Amrubicin|amrubicin|mesh-list
154078700|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078701|NCT00802529|Gentamicins|gentamicins|mesh-list
154078702|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
154078703|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154078707|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154078708|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
154078709|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154078710|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
154078711|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
154078712|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078713|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078714|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078715|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
154078716|NCT00802529|Hormones|hormones|mesh-ancestor
154078717|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154078718|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154078719|NCT00802529|Protective Agents|protective agents|mesh-ancestor
154078720|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154078721|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078722|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154078723|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078724|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154078725|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078726|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078727|NCT02605811|Temozolomide|temozolomide|mesh-list
154078728|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154078729|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
154078730|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078731|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078732|NCT00758264|Vaccines|vaccines|mesh-list
154078733|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154078734|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
154078735|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078736|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
154078737|NCT04027517|Hematinics|hematinics|mesh-ancestor
154078738|NCT00588731|Cannabidiol|cannabidiol|mesh-list
154078739|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
154078740|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
154078741|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
154078742|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078743|NCT05629949|Docetaxel|docetaxel|mesh-list
154078744|NCT05629949|Trastuzumab|trastuzumab|mesh-list
154078745|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078746|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
154078747|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
154078748|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
154078749|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078750|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154078751|NCT05628233|Azasetron|azasetron|mesh-list
154078752|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
154078753|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
154078754|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078755|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078756|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078757|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154078758|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
154078759|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078760|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401947|NCT05983952|Antibodies|antibodies|mesh-list
154078761|NCT04109261|Palbociclib|palbociclib|mesh-list
154078762|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078763|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154078764|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078765|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078766|NCT04109339|Oxytocin|oxytocin|mesh-list
154078767|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
154078768|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078769|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078770|NCT00757172|Docetaxel|docetaxel|mesh-list
154078771|NCT00757172|Panitumumab|panitumumab|mesh-list
154078772|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078773|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
154078774|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
154078775|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
154078776|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078777|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154078781|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078782|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078783|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154078784|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078785|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
154078786|NCT05277285|Antidotes|antidotes|mesh-ancestor
154078787|NCT05277285|Protective Agents|protective agents|mesh-ancestor
154078788|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078789|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
154078790|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078791|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
154078792|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154078793|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078794|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
154078795|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
154078796|NCT04110665|Acetaminophen|acetaminophen|mesh-list
154078797|NCT04110665|Morphine|morphine|mesh-list
154078798|NCT04110665|Oxycodone|oxycodone|mesh-list
154078799|NCT04110665|Tramadol|tramadol|mesh-list
154078800|NCT04110665|Nefopam|nefopam|mesh-list
154078801|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154078802|NCT04110665|Narcotics|narcotics|mesh-ancestor
154078803|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078804|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078805|NCT04110665|Analgesics|analgesics|mesh-ancestor
153460241|NCT03969420|Cytarabine|cytarabine|mesh-list
154078806|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
154078807|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078808|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154078809|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
154078810|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154078811|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
154078812|NCT00638859|Telithromycin|telithromycin|mesh-list
154078813|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154078814|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078815|NCT02537847|Ertapenem|ertapenem|mesh-list
154078816|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
154078817|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
154078818|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154078819|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078820|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154078821|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078822|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078823|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154078824|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154078825|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078826|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
154078827|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154078828|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078829|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078830|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154078831|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154078832|NCT02687841|Protective Agents|protective agents|mesh-ancestor
154078833|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078834|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
154078835|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154078836|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
154078837|NCT00778622|Metformin|metformin|mesh-list
154078838|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154078839|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078840|NCT00777920|Ambrisentan|ambrisentan|mesh-list
154078841|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154078842|NCT04236141|Rituximab|rituximab|mesh-list
154078843|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154078844|NCT04236141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154078845|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154078846|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078847|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
154078848|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078849|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154078850|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154078851|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
154078852|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078854|NCT04097444|Leucovorin|leucovorin|mesh-list
154078855|NCT04097444|Bevacizumab|bevacizumab|mesh-list
154078856|NCT04097444|Capecitabine|capecitabine|mesh-list
154078857|NCT04097444|Fluorouracil|fluorouracil|mesh-list
154078858|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
154078859|NCT04097444|Irinotecan|irinotecan|mesh-list
154078860|NCT04097444|Calcium|calcium|mesh-list
154078861|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
154078862|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154078863|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078864|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154078865|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154078866|NCT04097444|Growth Substances|growth substances|mesh-ancestor
154078867|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078868|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
154078869|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154078870|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154078871|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
154078872|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078873|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154078874|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
154078875|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154078876|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154078877|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078878|NCT04097444|Antidotes|antidotes|mesh-ancestor
154078879|NCT04097444|Protective Agents|protective agents|mesh-ancestor
154078880|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
154078881|NCT04097444|Vitamins|vitamins|mesh-ancestor
154078882|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
154078883|NCT04097288|Dexetimide|dexetimide|mesh-list
154078884|NCT04097288|Citalopram|citalopram|mesh-list
154078885|NCT04097288|Reboxetine|reboxetine|mesh-list
154078886|NCT04097288|Escitalopram|escitalopram|mesh-list
154078887|NCT04097288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154078888|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154078889|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078890|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078891|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078892|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
154078893|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629727|NCT02046915|Hormones|hormones|mesh-ancestor
154078894|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154078895|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
154078896|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154078897|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154078898|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154078899|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
154078900|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
154078901|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078902|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154078903|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154078904|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
154078905|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154078906|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
154078907|NCT04219449|Protein C|protein c|mesh-list
154078908|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
154078909|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154078910|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154078911|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078912|NCT04209855|Paclitaxel|paclitaxel|mesh-list
154078913|NCT04209855|Maytansine|maytansine|mesh-list
154078914|NCT04209855|Doxorubicin|doxorubicin|mesh-list
154078915|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154078916|NCT04209855|Topotecan|topotecan|mesh-list
154078917|NCT04209855|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154078918|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154078919|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078920|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
154078921|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
154078922|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
154078923|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078924|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154078925|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154078926|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154078927|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078928|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154078929|NCT04209855|Immunoconjugates|immunoconjugates|mesh-ancestor
154078948|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154078949|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154078950|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078951|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
154078952|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
154078953|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078954|NCT00770588|Gefitinib|gefitinib|mesh-list
154078955|NCT00770588|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154078956|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154078957|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154078958|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078959|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078960|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
154078961|NCT02604719|Ethamsylate|ethamsylate|mesh-list
154078962|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154078963|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154078964|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078965|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
154078966|NCT02604719|Coagulants|coagulants|mesh-ancestor
154078967|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
154078968|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154078969|NCT02604797|Sufentanil|sufentanil|mesh-list
154078970|NCT02604797|Dsuvia|dsuvia|mesh-list
154078971|NCT02604797|Nalbuphine|nalbuphine|mesh-list
154078972|NCT02604797|Ramosetron|ramosetron|mesh-list
154078973|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154078974|NCT02604797|Narcotics|narcotics|mesh-ancestor
154078975|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078976|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078977|NCT02604797|Analgesics|analgesics|mesh-ancestor
154256609|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648084|NCT00020488|Vitamins|vitamins|mesh-ancestor
154078978|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
154078979|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078980|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154078981|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154078982|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
154078983|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
154078984|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154078985|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154078986|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154078987|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154078990|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078991|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
154078992|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
154078993|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154078994|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154078995|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
154078996|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078997|NCT00777608|Donepezil|donepezil|mesh-list
154078998|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154078999|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079000|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079001|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
154079002|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079003|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079004|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
154079005|NCT00792935|Metformin|metformin|mesh-list
154079006|NCT00792935|Glimepiride|glimepiride|mesh-list
154079007|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154079008|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079009|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154079010|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079011|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
154079012|NCT03904563|Bevacizumab|bevacizumab|mesh-list
154079013|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154079014|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079015|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154079016|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154079017|NCT03904563|Growth Substances|growth substances|mesh-ancestor
154079018|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079019|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
154079020|NCT00770510|Zolpidem|zolpidem|mesh-list
154079021|NCT00770510|Eszopiclone|eszopiclone|mesh-list
154079022|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154079023|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154079024|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079025|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079026|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154079027|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
154079028|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
154079029|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079030|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079031|NCT04077255|Paclitaxel|paclitaxel|mesh-list
154079032|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154079033|NCT04077255|Antibodies|antibodies|mesh-list
154079034|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154079035|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079036|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
154079037|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
154079038|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
154079039|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079040|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
154079041|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079042|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154079043|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154079044|NCT00770432|Laxatives|laxatives|mesh-ancestor
154079045|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079046|NCT00792701|Gemcitabine|gemcitabine|mesh-list
154079047|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079048|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079049|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
154079050|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079051|NCT03772353|Letrozole|letrozole|mesh-list
154079052|NCT03772353|Fulvestrant|fulvestrant|mesh-list
154079053|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079054|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154079055|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154079056|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079057|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079058|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154079059|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
153553824|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079064|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
154079065|NCT05559983|Vaccines|vaccines|mesh-list
154079066|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
154079067|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079068|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154079069|NCT05559983|Antacids|antacids|mesh-ancestor
154079070|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079071|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079073|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154079074|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079075|NCT00756470|Paclitaxel|paclitaxel|mesh-list
154079076|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
154079077|NCT00756470|Fluorouracil|fluorouracil|mesh-list
154079078|NCT00756470|Epirubicin|epirubicin|mesh-list
154079079|NCT00756470|Lapatinib|lapatinib|mesh-list
154079080|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154079081|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079082|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154079083|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154079084|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154079085|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079086|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079087|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
154079088|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079089|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079090|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154079091|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
154079092|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154079093|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
154079094|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079095|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154079096|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154079097|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154079098|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079099|NCT00756470|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154079100|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154079101|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
154079102|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154079103|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079105|NCT00727506|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154079106|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154079107|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079108|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079109|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079110|NCT00789815|Midazolam|midazolam|mesh-list
154079111|NCT00789815|Propofol|propofol|mesh-list
154079112|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154079113|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079114|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079115|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154079116|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
154079117|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
154079118|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154079119|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154079120|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154079121|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154079122|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
154079123|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
154079124|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079125|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079126|NCT00721578|Voriconazole|voriconazole|mesh-list
154079127|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
154079128|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079129|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154079130|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154079135|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079136|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079137|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154079138|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154079139|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154079140|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154079141|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
154079142|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079143|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154079144|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
154079145|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154079146|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079147|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154079148|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154079149|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079150|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079151|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079152|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154079153|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154079154|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079155|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079156|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
153562691|NCT01658774|Albendazole|albendazole|mesh-list
154079157|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154079158|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079159|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154079160|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
154079161|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154079162|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079163|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079164|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079165|NCT05600387|Empagliflozin|empagliflozin|mesh-list
154079166|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154079167|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079168|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154079169|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079170|NCT00721110|Lidocaine|lidocaine|mesh-list
154079171|NCT00721110|Ketamine|ketamine|mesh-list
154079172|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
154079173|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
154079174|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079175|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079176|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
154079177|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079178|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154079179|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154079180|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154079181|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154079182|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079183|NCT00721110|Analgesics|analgesics|mesh-ancestor
154079184|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154079185|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154079186|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
154079187|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154079188|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154079189|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079190|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
154079191|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
154079192|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
154079193|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154079194|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079195|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
154079196|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154079197|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154079200|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079202|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154079203|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
154079204|NCT00791999|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154079205|NCT00791999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079206|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079207|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
154079208|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079209|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079210|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
154079211|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154079212|NCT04033263|Fluorides|fluorides|mesh-list
154079213|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
154079214|NCT04033263|Protective Agents|protective agents|mesh-ancestor
154079215|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079216|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154079217|NCT04075227|Dexamethasone|dexamethasone|mesh-list
154079218|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079219|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
154079220|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
153630208|NCT00005964|Etoposide|etoposide|mesh-list
154079221|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079222|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079223|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079224|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
154079225|NCT04075227|Hormones|hormones|mesh-ancestor
154079226|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079227|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154079228|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079229|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154079230|NCT00585078|Capecitabine|capecitabine|mesh-list
154079231|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
154079232|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079233|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
154079234|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079235|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079236|NCT00720876|Rituximab|rituximab|mesh-list
154079237|NCT00720876|Vorinostat|vorinostat|mesh-list
154079238|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154079239|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079240|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
154079241|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079242|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079243|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154079244|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079245|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079246|NCT00789581|Paclitaxel|paclitaxel|mesh-list
154079247|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
154079248|NCT00789581|Doxorubicin|doxorubicin|mesh-list
154079249|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154079250|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154079251|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079252|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
154079253|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
154079254|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
154079255|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079256|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079257|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
154079258|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079259|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079260|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154079261|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
154079262|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154079263|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154079264|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154079265|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154079266|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079267|NCT00717756|Lenalidomide|lenalidomide|mesh-list
154079268|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
154079269|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079271|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154079273|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
154079274|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079275|NCT04111289|Tirofiban|tirofiban|mesh-list
154079276|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154079277|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154079278|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079279|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154079280|NCT04108637|Penicillins|penicillins|mesh-list
154079281|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154079282|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079284|NCT05674539|Fludarabine|fludarabine|mesh-list
154079285|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
154079286|NCT05674539|Melphalan|melphalan|mesh-list
154079287|NCT05674539|Busulfan|busulfan|mesh-list
154079288|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079289|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079290|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
154079291|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079292|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079293|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
154079294|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079295|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
154079296|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079297|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154079298|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
154079299|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154079300|NCT00717522|Pomalidomide|pomalidomide|mesh-list
154079301|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
154079302|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079303|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154079304|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154079305|NCT00717522|Growth Substances|growth substances|mesh-ancestor
154079306|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
154079307|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079308|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
154079309|NCT00791921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154079310|NCT00791921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079311|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079312|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
154079313|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079314|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079315|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154079316|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079317|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154079318|NCT03475953|Avelumab|avelumab|mesh-list
154079319|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154079320|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154079321|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079322|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
154079323|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079324|NCT00582933|Vidarabine|vidarabine|mesh-list
154079325|NCT00582933|Fludarabine|fludarabine|mesh-list
154079326|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
154079327|NCT00582933|Melphalan|melphalan|mesh-list
154079328|NCT00582933|Busulfan|busulfan|mesh-list
154079329|NCT00582933|Lenograstim|lenograstim|mesh-list
154079330|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079331|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079332|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
154079333|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079334|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079335|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
154079336|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079337|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
154079338|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079339|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154079340|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
154079341|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154079342|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154079343|NCT00791765|Etanercept|etanercept|mesh-list
154079344|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154079348|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079349|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079350|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079351|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079352|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079353|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079354|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
154079356|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154079357|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
154079358|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154079359|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079360|NCT00789191|Incretins|incretins|mesh-ancestor
154079361|NCT00789191|Hormones|hormones|mesh-ancestor
154079362|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079363|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154079364|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
154079365|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079366|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079367|NCT02603315|Mitogens|mitogens|mesh-list
154079368|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
154079369|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
154079370|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079371|NCT02603315|Growth Substances|growth substances|mesh-ancestor
154079372|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079373|NCT00789035|Metformin|metformin|mesh-list
154079374|NCT00789035|Empagliflozin|empagliflozin|mesh-list
154079375|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154079376|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079377|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154079378|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079379|NCT04108013|Paclitaxel|paclitaxel|mesh-list
154079380|NCT04108013|Carboplatin|carboplatin|mesh-list
154079381|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154079382|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079383|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
154079384|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
154079385|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
154079386|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079387|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
154079388|NCT04105985|Tetracaine|tetracaine|mesh-list
154079389|NCT04105985|Carticaine|carticaine|mesh-list
154079390|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
154079391|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
154079392|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079393|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079394|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
154079395|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079396|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154079397|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154079398|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
154079399|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079400|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079401|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
154079402|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
154079403|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
154079404|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154079405|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
154079406|NCT04074213|Clozapine|clozapine|mesh-list
154079407|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154079408|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
154079409|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079410|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079411|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079412|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154079413|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154079414|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079415|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154079416|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
154079420|NCT04110587|Analgesics|analgesics|mesh-list
154079421|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
154079422|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079423|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154079424|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
154079425|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079426|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
154079427|NCT04110587|Protective Agents|protective agents|mesh-ancestor
154079428|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
154079429|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079430|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
154079431|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154079432|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079433|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
154079434|NCT02579733|Azathioprine|azathioprine|mesh-list
154079435|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
154079436|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079437|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079438|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079439|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256612|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154079440|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
153402600|NCT05061654|Ceftolozane|ceftolozane|mesh-list
154079441|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079442|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079443|NCT03326193|Bevacizumab|bevacizumab|mesh-list
154079445|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154079446|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079447|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154079448|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154079449|NCT03326193|Growth Substances|growth substances|mesh-ancestor
154079450|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079451|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
154079452|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154079453|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079454|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079455|NCT02517099|Azithromycin|azithromycin|mesh-list
154079456|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154079457|NCT02517099|Beclomethasone|beclomethasone|mesh-list
154079458|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154079459|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079460|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154079461|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079462|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079463|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079464|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
154079466|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079467|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079468|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154079469|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
154079470|NCT02473263|Tazobactam|tazobactam|mesh-list
154079471|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
154079472|NCT02473263|Piperacillin|piperacillin|mesh-list
154079473|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154079474|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
154079475|NCT02473263|Norepinephrine|norepinephrine|mesh-list
154079476|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079477|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154079478|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154079479|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
154079480|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079481|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079482|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079483|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
154079484|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
154079485|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079486|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154079487|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154079488|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079489|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154079492|NCT02473263|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154079494|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079495|NCT00437203|Gemcitabine|gemcitabine|mesh-list
154079496|NCT00437203|PF 00477736|pf 00477736|mesh-list
154079497|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079498|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
154079499|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079500|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079501|NCT00437203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154079502|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079503|NCT02419287|Crizotinib|crizotinib|mesh-list
154079504|NCT02419287|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154079505|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154079506|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079507|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079508|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079509|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154079510|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154079511|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154079512|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154079513|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079516|NCT00437125|Analgesics|analgesics|mesh-ancestor
154079517|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
154079518|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079519|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
154079520|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154079521|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
154079522|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154079523|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154079524|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
154079525|NCT01028287|Hormones|hormones|mesh-ancestor
154079526|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079527|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079528|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079529|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079530|NCT01028443|Cyclosporine|cyclosporine|mesh-list
154079531|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
154079532|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079533|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
154079534|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079535|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079536|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079537|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
154079538|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079539|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079540|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154079542|NCT03116997|Neostigmine|neostigmine|mesh-list
154079543|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154079544|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079545|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079546|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
154079547|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079548|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079549|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154079550|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
154079551|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079552|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154079553|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154079554|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154079555|NCT02600780|Allopurinol|allopurinol|mesh-list
154079556|NCT02600780|Febuxostat|febuxostat|mesh-list
154079557|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
154079558|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079559|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079560|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
154079565|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079566|NCT00582309|Insulin|insulin|mesh-list
154079567|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154079568|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154079569|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079570|NCT00443053|PENTA|penta|mesh-list
154079571|NCT00443053|Fondaparinux|fondaparinux|mesh-list
154079572|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154079573|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
154079574|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154079575|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
154079576|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079577|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079578|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
154079579|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154079580|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154079581|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154079582|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154079583|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
154079584|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154079585|NCT00720798|Analgesics|analgesics|mesh-ancestor
154079586|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
154079587|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079588|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079589|NCT01816971|Dexamethasone|dexamethasone|mesh-list
154079590|NCT01816971|Lenalidomide|lenalidomide|mesh-list
154079591|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079592|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
154079594|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079595|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079596|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079597|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
154079598|NCT01816971|Hormones|hormones|mesh-ancestor
154079599|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079600|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154079601|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079602|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
154079603|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154079604|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154079605|NCT01816971|Growth Substances|growth substances|mesh-ancestor
154079606|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
154079607|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
154079608|NCT01021267|Urological Agents|urological agents|mesh-ancestor
154079609|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
154079610|NCT00717366|Hematinics|hematinics|mesh-ancestor
154079611|NCT02939989|Ribavirin|ribavirin|mesh-list
154079612|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
154079613|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
154079614|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079615|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
154079616|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079617|NCT04096742|Tretinoin|tretinoin|mesh-list
154079618|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079619|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
154079620|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
154079621|NCT04085640|Ropivacaine|ropivacaine|mesh-list
154079622|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
154079623|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
154079624|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079625|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079626|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
154079627|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079628|NCT01031719|Vaccines|vaccines|mesh-list
154079629|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
154079630|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079631|NCT00723606|Haloperidol|haloperidol|mesh-list
154079632|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
154079633|NCT00723606|Ziprasidone|ziprasidone|mesh-list
154079634|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
154079637|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079639|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154079640|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154079641|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079642|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154079643|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154079644|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
154079645|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079646|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079647|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154079648|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154079649|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
154079650|NCT01021501|Nifedipine|nifedipine|mesh-list
154079651|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154079652|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154079653|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079654|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154079655|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079656|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
154079657|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
154079658|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154079659|NCT01021579|Metformin|metformin|mesh-list
154079660|NCT01021579|Simvastatin|simvastatin|mesh-list
154079661|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154079662|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079663|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154079664|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154079665|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
154079666|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079667|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154079668|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154079669|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079670|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154079671|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153460470|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
154079672|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079674|NCT01021735|Etanercept|etanercept|mesh-list
154079675|NCT01021735|Rituximab|rituximab|mesh-list
154079676|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154079677|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079678|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
154079679|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079680|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079681|NCT01021735|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154079682|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079683|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154079684|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154079685|NCT01021735|Analgesics|analgesics|mesh-ancestor
154079686|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
154079687|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079688|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079689|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079690|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
154079691|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079692|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
154079693|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154079694|NCT00436501|Docetaxel|docetaxel|mesh-list
154079695|NCT00436501|Aflibercept|aflibercept|mesh-list
154079696|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
154079697|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079698|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
154079699|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
154079700|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
154079701|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079702|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154079703|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154079704|NCT00436501|Growth Substances|growth substances|mesh-ancestor
154079705|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079706|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
154079707|NCT00755846|Alogliptin|alogliptin|mesh-list
154079711|NCT00755846|Hormones|hormones|mesh-ancestor
154079712|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079713|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154079714|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
154079715|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079716|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079717|NCT03850093|Bisoprolol|bisoprolol|mesh-list
154079718|NCT03850093|Gabapentin|gabapentin|mesh-list
154079719|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079720|NCT03850093|Analgesics|analgesics|mesh-ancestor
154079721|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
154079722|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079723|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
154079724|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154079725|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154079726|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079727|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154079728|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154079729|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154079730|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079731|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079732|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
154079733|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154079734|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
154079735|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
154079736|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154079737|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154079738|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154079739|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
154079740|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
154079741|NCT00442117|Budesonide|budesonide|mesh-list
154079742|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079743|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154079745|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079746|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079747|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154079748|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
154079749|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
154079751|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079752|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
154079753|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154079754|NCT00752726|Orlistat|orlistat|mesh-list
154079755|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079756|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079757|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154079758|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154079760|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
154079761|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
154079762|NCT04072263|Paclitaxel|paclitaxel|mesh-list
154079763|NCT04072263|Carboplatin|carboplatin|mesh-list
154079764|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154079765|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079766|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
154079767|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
154079768|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
154079769|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079770|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
154079771|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079772|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
154079773|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079774|NCT00441727|Esomeprazole|esomeprazole|mesh-list
154079775|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154079776|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079777|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154079778|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079779|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079780|NCT00770120|Everolimus|everolimus|mesh-list
154079781|NCT00770120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153546176|NCT06205381|Fexofenadine|fexofenadine|mesh-list
154079783|NCT00770120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079784|NCT00770120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079785|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079786|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
154079787|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079788|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079789|NCT03996655|Neostigmine|neostigmine|mesh-list
154079790|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154079791|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079792|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079793|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
154079794|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079795|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079796|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154079797|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
154079798|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079799|NCT01032109|Bevacizumab|bevacizumab|mesh-list
154079800|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154079801|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079802|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154079803|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154079804|NCT01032109|Growth Substances|growth substances|mesh-ancestor
154079805|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079806|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
154079807|NCT04100330|Cytarabine|cytarabine|mesh-list
154079808|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079809|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
154079810|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079811|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079812|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
154079813|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079814|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079815|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
154079816|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079817|NCT00436345|Remifentanil|remifentanil|mesh-list
154079819|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154079820|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079821|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079822|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154079823|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
154079826|NCT00436345|Narcotics|narcotics|mesh-ancestor
154079827|NCT00436345|Analgesics|analgesics|mesh-ancestor
154079828|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
154079829|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079830|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154079831|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154079832|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154079833|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
153563347|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
154079834|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079835|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079837|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154079838|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
154079839|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079840|NCT01032187|Amphotericin B|amphotericin b|mesh-list
154079841|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154079842|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
154079843|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154079844|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
154079845|NCT01032187|Amebicides|amebicides|mesh-ancestor
154079846|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154079847|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154079848|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079849|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154079850|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
154079851|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154079852|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079853|NCT00769184|Clobetasol|clobetasol|mesh-list
154079854|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079855|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
154079856|NCT00769184|Hormones|hormones|mesh-ancestor
154079858|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079859|NCT00768560|Nifedipine|nifedipine|mesh-list
154079860|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154079861|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154079862|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079863|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154079864|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079865|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
154079866|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
154079867|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154079868|NCT00468559|Esomeprazole|esomeprazole|mesh-list
154079869|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154079870|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079871|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154079872|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079873|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079874|NCT00754442|Teriparatide|teriparatide|mesh-list
154079875|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154079876|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079877|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154079878|NCT00754052|Donepezil|donepezil|mesh-list
154079879|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154079880|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079881|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079882|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
154079883|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154079884|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079885|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
154079886|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154079887|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
154079888|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154079889|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154079890|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154079891|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079892|NCT02927067|Valganciclovir|valganciclovir|mesh-list
154079893|NCT02927067|Maribavir|maribavir|mesh-list
154079894|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
154079895|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079896|NCT02600468|Abatacept|abatacept|mesh-list
154079897|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154079898|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079899|NCT02600468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154079900|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079901|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079902|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
154079903|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079904|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079905|NCT02598596|Azathioprine|azathioprine|mesh-list
154079906|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
154079907|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079908|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154079909|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079910|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154079911|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
154079912|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079913|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079914|NCT00586508|Bevacizumab|bevacizumab|mesh-list
154079915|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
154079916|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154079917|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079918|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154079919|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154079920|NCT00586508|Growth Substances|growth substances|mesh-ancestor
154079921|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079922|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
154079923|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
154079924|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079925|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
154079926|NCT00581919|Vitamins|vitamins|mesh-ancestor
154079927|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
154079931|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154079932|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
154079933|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154079934|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
154079935|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154079936|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079937|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154079938|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154079939|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079940|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154079941|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154079942|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154079943|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154079944|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
154079945|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079946|NCT00916760|Antacids|antacids|mesh-ancestor
154079947|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079948|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079949|NCT00723450|Lamotrigine|lamotrigine|mesh-list
154079950|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
154079951|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154079952|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154079953|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079954|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154079955|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079956|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154079957|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154079958|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154079959|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154079960|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154079961|NCT02599532|Apixaban|apixaban|mesh-list
154079962|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154079963|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
153403121|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
154079964|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154079965|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
154079966|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079967|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079968|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
154079969|NCT00751400|Naproxen|naproxen|mesh-list
154079970|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154079971|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154079972|NCT00751400|Analgesics|analgesics|mesh-ancestor
154079973|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
154079974|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079975|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079976|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079977|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079978|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
154079979|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154079980|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079981|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079983|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154079984|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154079985|NCT00585312|Analgesics|analgesics|mesh-ancestor
154079986|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
154079987|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079988|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079989|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154079990|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079991|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154079992|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154079993|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079994|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079995|NCT00753506|Artemisinins|artemisinins|mesh-list
154079996|NCT00753506|Artemisinin|artemisinin|mesh-list
154079997|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
154079998|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154079999|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154080000|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080001|NCT00720096|Doxorubicin|doxorubicin|mesh-list
154080002|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154080003|NCT00720096|Topotecan|topotecan|mesh-list
154080004|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154080005|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080006|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154080007|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154080008|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080009|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080010|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154080011|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
154080012|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
154080013|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080014|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080015|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080016|NCT02577783|Dexamethasone|dexamethasone|mesh-list
154080017|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
154080018|NCT02577783|Doxorubicin|doxorubicin|mesh-list
154080019|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154080020|NCT02577783|BB 1101|bb 1101|mesh-list
154080021|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154080022|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
154080023|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
154080024|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080025|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080026|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154080027|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
154080028|NCT02577783|Hormones|hormones|mesh-ancestor
154080029|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080030|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154080031|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080032|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
154080033|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080034|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080035|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154080036|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154080037|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154080038|NCT00918450|Navitoclax|navitoclax|mesh-list
154080039|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080040|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
154080041|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154080042|NCT02591628|Diuretics|diuretics|mesh-ancestor
154080043|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
154080044|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080045|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154080046|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154080047|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080048|NCT04090112|Lidocaine|lidocaine|mesh-list
154080049|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
154080050|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
154080051|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080052|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080053|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
154080054|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080055|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154080056|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154080057|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154080058|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154080059|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080060|NCT00747344|Ustekinumab|ustekinumab|mesh-list
154080061|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080062|NCT00580983|Paclitaxel|paclitaxel|mesh-list
154080063|NCT00580983|Carboplatin|carboplatin|mesh-list
154080064|NCT00580983|Fluorouracil|fluorouracil|mesh-list
154080065|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154080066|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080067|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
154080068|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
154080069|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
154080070|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080071|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
154080072|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080073|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080074|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
154080077|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154080078|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154080079|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
154080080|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080081|NCT02577393|Protective Agents|protective agents|mesh-ancestor
154080082|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080083|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154080084|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154080085|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080086|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154080087|NCT00753896|Exenatide|exenatide|mesh-list
154080088|NCT00753896|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154080089|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154080090|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080091|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154080092|NCT00753896|Incretins|incretins|mesh-ancestor
154080093|NCT00753896|Hormones|hormones|mesh-ancestor
154080094|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080095|NCT02597114|Insulin|insulin|mesh-list
154080096|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154080097|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154080098|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080099|NCT00743444|Lesogaberan|lesogaberan|mesh-list
154080100|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154080101|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154080102|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
154080103|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
154080104|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080105|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080106|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080107|NCT00743366|Riboflavin|riboflavin|mesh-list
154080108|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154080109|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
154080110|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154080111|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154080112|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154080113|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080114|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080115|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
154080116|NCT00743366|Vitamins|vitamins|mesh-ancestor
154080117|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
154080118|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154080119|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080120|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
154080121|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
154080122|NCT01760655|Busulfan|busulfan|mesh-list
154080123|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
154080124|NCT01760655|Fludarabine|fludarabine|mesh-list
154080125|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
154080126|NCT01760655|Tacrolimus|tacrolimus|mesh-list
154080127|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080128|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
154256615|NCT03876938|Olanzapine|olanzapine|mesh-list
154256616|NCT03876938|Aprepitant|aprepitant|mesh-list
154080129|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080130|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080131|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154080132|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
154080133|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080134|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080135|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154080136|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080137|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
154080138|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080139|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154080140|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080141|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154080142|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154080143|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
154080144|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154080145|NCT00743288|Melphalan|melphalan|mesh-list
154080146|NCT00743288|Panobinostat|panobinostat|mesh-list
154080147|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154080148|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
153553825|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
154080175|NCT06240169|Pemetrexed|pemetrexed|mesh-list
154080176|NCT06240169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080177|NCT06240169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080178|NCT06240169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080179|NCT06240169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154080180|NCT06240169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154080181|NCT06240143|Nivolumab|nivolumab|mesh-list
154080182|NCT06240143|Ipilimumab|ipilimumab|mesh-list
154080183|NCT06240143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080184|NCT06240143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080185|NCT06240143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154080186|NCT06240143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080187|NCT06240130|Chlorhexidine|chlorhexidine|mesh-list
154080188|NCT06240130|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154080190|NCT06240130|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154080191|NCT06240130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080192|NCT06240130|Disinfectants|disinfectants|mesh-ancestor
154080193|NCT06240039|Octreotide|octreotide|mesh-list
154080194|NCT06240039|Glucagon|glucagon|mesh-list
154080195|NCT06240039|Somatostatin|somatostatin|mesh-list
154080196|NCT06240039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154081073|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081074|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081076|NCT05035485|Phenylephrine|phenylephrine|mesh-list
154081077|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
154081078|NCT05035485|Norepinephrine|norepinephrine|mesh-list
154081079|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154081080|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154081081|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
154081082|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
154081083|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081084|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081085|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
154081086|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
154081087|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
154081088|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154081089|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154081090|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154081091|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
154081092|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081093|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081094|NCT05035485|Protective Agents|protective agents|mesh-ancestor
154081095|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154081096|NCT04973930|Escitalopram|escitalopram|mesh-list
154081097|NCT04973930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154081098|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154081099|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154081100|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081101|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081102|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
154081103|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081104|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154081105|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
154081106|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154081107|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154081108|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
154081109|NCT04959175|Sirolimus|sirolimus|mesh-list
154081110|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
154081111|NCT04959175|Fludarabine|fludarabine|mesh-list
154081112|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081113|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
154081114|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081115|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081116|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154081117|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
154081118|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081119|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081120|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154081121|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154081122|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154081123|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
154081124|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154081125|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081126|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081127|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
154081128|NCT04946968|Dacomitinib|dacomitinib|mesh-list
154081129|NCT04946968|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154081130|NCT04946968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081131|NCT04946968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081132|NCT04946968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081133|NCT04878016|Carboplatin|carboplatin|mesh-list
154081134|NCT04878016|Etoposide|etoposide|mesh-list
154081135|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081140|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081141|NCT04859621|Vitamin D|vitamin d|mesh-list
154081142|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
154081143|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
154081144|NCT04859621|Vitamins|vitamins|mesh-list
154081145|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154081146|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
154081147|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081148|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154081149|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154081150|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081151|NCT04840615|Acetaminophen|acetaminophen|mesh-list
154081152|NCT04840615|Diphenhydramine|diphenhydramine|mesh-list
154081153|NCT04840615|Promethazine|promethazine|mesh-list
154081154|NCT04840615|Dexamethasone|dexamethasone|mesh-list
154081155|NCT04840615|Ipilimumab|ipilimumab|mesh-list
154081156|NCT04840615|Famotidine|famotidine|mesh-list
154081157|NCT04840615|LMB-100|lmb-100|mesh-list
154081158|NCT04840615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081159|NCT04840615|Antiemetics|antiemetics|mesh-ancestor
154081160|NCT04840615|Autonomic Agents|autonomic agents|mesh-ancestor
154081161|NCT04840615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081162|NCT04840615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081163|NCT04840615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154081164|NCT04840615|Glucocorticoids|glucocorticoids|mesh-ancestor
154081165|NCT04840615|Hormones|hormones|mesh-ancestor
154081166|NCT04840615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081167|NCT04840615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081168|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081169|NCT04840615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154081170|NCT04840615|Analgesics|analgesics|mesh-ancestor
154081171|NCT04840615|Sensory System Agents|sensory system agents|mesh-ancestor
154081172|NCT04840615|Antipyretics|antipyretics|mesh-ancestor
154081173|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081174|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081175|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081176|NCT04840615|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154081177|NCT04840615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154081178|NCT04840615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154081179|NCT04840615|Anesthetics, Local|anesthetics, local|mesh-ancestor
154081180|NCT04840615|Anesthetics|anesthetics|mesh-ancestor
154081181|NCT04840615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154081182|NCT04840615|Histamine Antagonists|histamine antagonists|mesh-ancestor
154081183|NCT04840615|Histamine Agents|histamine agents|mesh-ancestor
154081184|NCT04840615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081185|NCT04840615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154081186|NCT04840615|Antipruritics|antipruritics|mesh-ancestor
154081187|NCT04840615|Dermatologic Agents|dermatologic agents|mesh-ancestor
154081188|NCT04840615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154081189|NCT04840615|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154081190|NCT04840615|Immunoconjugates|immunoconjugates|mesh-ancestor
154081191|NCT04840615|Immunologic Factors|immunologic factors|mesh-ancestor
154081192|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
154081193|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
154081194|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081195|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081196|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081197|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
154081198|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
154081199|NCT04783935|Cladribine|cladribine|mesh-list
154081200|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081201|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081202|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
154081203|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081204|NCT04775953|Vancomycin|vancomycin|mesh-list
154081205|NCT04775953|Cefazolin|cefazolin|mesh-list
154081206|NCT04775953|Daptomycin|daptomycin|mesh-list
154081207|NCT04775953|Dalbavancin|dalbavancin|mesh-list
154081208|NCT04775953|Oxacillin|oxacillin|mesh-list
154081209|NCT04775953|Nafcillin|nafcillin|mesh-list
154081210|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154081217|NCT04767217|Artemether|artemether|mesh-list
154081218|NCT04767217|Piperaquine|piperaquine|mesh-list
154081219|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154081220|NCT04767217|Artenimol|artenimol|mesh-list
154081221|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
154081222|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154081223|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154081224|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081225|NCT04731233|Triamcinolone|triamcinolone|mesh-list
154081226|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154081227|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154081228|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154081229|NCT04731233|Mitogens|mitogens|mesh-list
154081230|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081231|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
154081232|NCT04731233|Hormones|hormones|mesh-ancestor
154081233|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081234|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081235|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081236|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
154081237|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081238|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081239|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
154081240|NCT04718415|Paclitaxel|paclitaxel|mesh-list
154081241|NCT04718415|Carboplatin|carboplatin|mesh-list
154081242|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154081243|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081244|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
154081245|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
154081246|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
154081247|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081248|NCT04695977|Nivolumab|nivolumab|mesh-list
154081249|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081250|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081251|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081252|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081253|NCT04676061|Norethindrone|norethindrone|mesh-list
154081254|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
154081255|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154081256|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154081257|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154081258|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
154081259|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154081260|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081261|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154081262|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154081263|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
154081264|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081265|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081266|NCT04633278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081267|NCT04633278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081269|NCT04633252|Docetaxel|docetaxel|mesh-list
154081270|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081271|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
154081272|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
154081273|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
154081274|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081275|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081276|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
154081277|NCT04633252|Hormones|hormones|mesh-ancestor
153547689|NCT05319730|Glucocorticoids|glucocorticoids|mesh-ancestor
154081287|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081288|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081289|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081290|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081291|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154081292|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154081293|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631856|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081294|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154081295|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154081296|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081298|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154081299|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154081300|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154081301|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
154081302|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081303|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154081304|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154081305|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
154081306|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
154081307|NCT04591210|Giapreza|giapreza|mesh-list
154081308|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154081309|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
154081310|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154081311|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154081312|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081313|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154081314|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154081315|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
154081316|NCT04538378|Durvalumab|durvalumab|mesh-list
154081317|NCT04538378|Olaparib|olaparib|mesh-list
154081318|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081319|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081320|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154081321|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081322|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081323|NCT04519710|Rituximab|rituximab|mesh-list
154081324|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
154081325|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081326|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081327|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
154081328|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081329|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081330|NCT04419519|Venetoclax|venetoclax|mesh-list
154081331|NCT04419519|Antibodies|antibodies|mesh-list
154081332|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154081333|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
154081334|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081335|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081336|NCT04418167|Dabrafenib|dabrafenib|mesh-list
154081337|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081338|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081339|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081340|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081341|NCT04380545|Interferons|interferons|mesh-list
154081342|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
154081348|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154081349|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081350|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081351|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
154081352|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081353|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081354|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081355|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
154081356|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081357|NCT04372108|Ustekinumab|ustekinumab|mesh-list
154081358|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
154081359|NCT04362839|Nivolumab|nivolumab|mesh-list
154081360|NCT04362839|Ipilimumab|ipilimumab|mesh-list
154081361|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081362|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081363|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081364|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081365|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
154081366|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081367|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081368|NCT04358237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081369|NCT04358237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081370|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
154081371|NCT04357873|Vorinostat|vorinostat|mesh-list
154081372|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631963|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
154081373|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081374|NCT04357873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081375|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081376|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154081377|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081378|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154081379|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154081380|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081381|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081382|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
154081383|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081384|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081385|NCT04352166|Buprenorphine|buprenorphine|mesh-list
154081386|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154081387|NCT04352166|Narcotics|narcotics|mesh-ancestor
154081388|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154081389|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081390|NCT04352166|Analgesics|analgesics|mesh-ancestor
154081391|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
154081392|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081393|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154081394|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
154081395|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154081396|NCT04327934|Testosterone|testosterone|mesh-list
154081397|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
154081398|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
154081399|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154081400|NCT04327934|Ganirelix|ganirelix|mesh-list
154081401|NCT04327934|Hormones|hormones|mesh-ancestor
154081402|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081403|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081404|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081405|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081406|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
154081407|NCT04327934|Androgens|androgens|mesh-ancestor
154081408|NCT04327934|Hormone Antagonists|hormone antagonists|mesh-ancestor
154081409|NCT04299373|Ethanol|ethanol|mesh-list
154081410|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154081411|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547827|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
154081425|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
154081426|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081427|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081438|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154081439|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154081440|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081441|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154081442|NCT04176016|Edetic Acid|edetic acid|mesh-list
154081443|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
154081444|NCT04176016|Antidotes|antidotes|mesh-ancestor
154081445|NCT04176016|Protective Agents|protective agents|mesh-ancestor
154081446|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081447|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
154081448|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
154081449|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081450|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154081451|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
154081452|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154081453|NCT04146207|Prednisone|prednisone|mesh-list
154081454|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081455|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
154081456|NCT04146207|Hormones|hormones|mesh-ancestor
154081457|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081458|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081459|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081460|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081461|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154081462|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154081463|NCT04079218|Estradiol|estradiol|mesh-list
154081464|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154081465|NCT04079218|Estrogens|estrogens|mesh-ancestor
154081466|NCT04079218|Hormones|hormones|mesh-ancestor
154081467|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081468|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081469|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154081470|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
154081471|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154081472|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154081473|NCT04074343|Irinotecan|irinotecan|mesh-list
154081474|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154081475|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154081476|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081477|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081478|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081479|NCT04035850|Vortioxetine|vortioxetine|mesh-list
154081480|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
154081481|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154081482|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154081483|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154081490|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081491|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
154081492|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154081493|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154081494|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154081495|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154081496|NCT03989336|Manganese|manganese|mesh-list
154081497|NCT03989336|Paclitaxel|paclitaxel|mesh-list
154081498|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154081499|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154081500|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154081501|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081502|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154081503|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154081504|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154081505|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081506|NCT03989336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081507|NCT03989336|Trace Elements|trace elements|mesh-ancestor
153565016|NCT03517176|Paclitaxel|paclitaxel|mesh-list
154081509|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081510|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
154081511|NCT03942653|Goserelin|goserelin|mesh-list
154081512|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081513|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081514|NCT03942653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081515|NCT03942653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081516|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081517|NCT03911973|Talazoparib|talazoparib|mesh-list
154081518|NCT03911973|Gedatolisib|gedatolisib|mesh-list
154081519|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154081520|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081521|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081522|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081523|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081524|NCT03898986|Vaccines|vaccines|mesh-list
154081525|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
154081526|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081527|NCT03834519|Prednisone|prednisone|mesh-list
154081528|NCT03834519|Prednisolone|prednisolone|mesh-list
154081529|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
154081530|NCT03834519|Olaparib|olaparib|mesh-list
154081531|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
154081533|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081534|NCT03834519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081535|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081536|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081537|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
154081538|NCT03834519|Hormones|hormones|mesh-ancestor
154081539|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081540|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081541|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081542|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154081543|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081544|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154081545|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
154081546|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154081547|NCT03817931|Mirabegron|mirabegron|mesh-list
154081548|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
154081565|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081566|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081567|NCT03808077|Rocuronium|rocuronium|mesh-list
154081568|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154081569|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154081570|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154081571|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081572|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081573|NCT03798678|Dexamethasone|dexamethasone|mesh-list
154081574|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
154081575|NCT03798678|Ichthammol|ichthammol|mesh-list
154081576|NCT03798678|BB 1101|bb 1101|mesh-list
154081577|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081578|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
154081579|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
154081580|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081581|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081582|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154081584|NCT03798678|Hormones|hormones|mesh-ancestor
154081585|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081586|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081587|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081588|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
154081589|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081590|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081591|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
154081592|NCT03773367|Fluorouracil|fluorouracil|mesh-list
154081593|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
154081594|NCT03773367|Irinotecan|irinotecan|mesh-list
154081595|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
154081596|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081597|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154081598|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081599|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081600|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
154081601|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081602|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154081603|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154081604|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081605|NCT03736889|Tislelizumab|tislelizumab|mesh-list
154081606|NCT03736889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548037|NCT05092360|Paclitaxel|paclitaxel|mesh-list
154081618|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
154081619|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081620|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154081621|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154081622|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
154081624|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
154081625|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
154081626|NCT03693170|Cetuximab|cetuximab|mesh-list
154081627|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081628|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081629|NCT03681561|Nivolumab|nivolumab|mesh-list
154081630|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081631|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081632|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081633|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081634|NCT03658785|Aldesleukin|aldesleukin|mesh-list
154081635|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
154081636|NCT03658785|Fludarabine|fludarabine|mesh-list
154081637|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081638|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
154081639|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081640|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081641|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154081642|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
154081643|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081644|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081645|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154081646|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154081647|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154081648|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
154081649|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081650|NCT03623321|Pimavanserin|pimavanserin|mesh-list
154081651|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154081652|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154081653|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154081654|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154081655|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154081656|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081657|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154081658|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154081659|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154081660|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
154081661|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081662|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081663|NCT03615742|Budesonide|budesonide|mesh-list
154081664|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081665|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154081666|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
154081667|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081668|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081669|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154081670|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
154081671|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
154081672|NCT03615742|Hormones|hormones|mesh-ancestor
153548098|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
154081682|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081683|NCT03555578|Leuprolide|leuprolide|mesh-list
154081684|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154081685|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
154081686|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154081687|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081688|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081689|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081690|NCT03525002|Bromocriptine|bromocriptine|mesh-list
154081691|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154081692|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154081693|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
154081694|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081695|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081696|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
154081697|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
154081698|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081699|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081700|NCT03520491|Nivolumab|nivolumab|mesh-list
154081701|NCT03520491|Ipilimumab|ipilimumab|mesh-list
154081702|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081703|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081704|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081705|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081706|NCT03474107|Paclitaxel|paclitaxel|mesh-list
154081707|NCT03474107|Docetaxel|docetaxel|mesh-list
154081708|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154081709|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081710|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154081711|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154081712|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154081713|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081714|NCT03446157|Cetuximab|cetuximab|mesh-list
154081715|NCT03446157|Palbociclib|palbociclib|mesh-list
154081716|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081717|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081718|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081720|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081721|NCT03434678|Fentanyl|fentanyl|mesh-list
154081722|NCT03434678|Bupivacaine|bupivacaine|mesh-list
154081723|NCT03434678|Propofol|propofol|mesh-list
154081724|NCT03434678|Rocuronium|rocuronium|mesh-list
154081725|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
154081726|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
154081727|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154081728|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081729|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
154081730|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081731|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154081732|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154081733|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
154081734|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154081735|NCT03434678|Narcotics|narcotics|mesh-ancestor
154081736|NCT03434678|Analgesics|analgesics|mesh-ancestor
154081737|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154081738|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153548167|NCT05001880|Bevacizumab|bevacizumab|mesh-list
154081744|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081745|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154081746|NCT03420508|Ensartinib|ensartinib|mesh-list
154081747|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081748|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081749|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081750|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081751|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
154081752|NCT03410875|Vemurafenib|vemurafenib|mesh-list
154081753|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081754|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081755|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081756|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081757|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081758|NCT03401853|Rituximab|rituximab|mesh-list
154081759|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154081760|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
154081761|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
154081762|NCT03401853|Antibodies|antibodies|mesh-list
154081763|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
154081764|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154081765|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
154081766|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081767|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081768|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081769|NCT03401853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081770|NCT03401853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081771|NCT03384641|Bedaquiline|bedaquiline|mesh-list
154081772|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
154081773|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154081774|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081775|NCT03345173|Ketamine|ketamine|mesh-list
154081776|NCT03345173|Analgesics|analgesics|mesh-ancestor
154081777|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
154081778|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081779|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081780|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154081781|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154081782|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
154081783|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
154081784|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154081785|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154081786|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154081787|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081788|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081789|NCT03333343|Gefitinib|gefitinib|mesh-list
154081790|NCT03333343|Trametinib|trametinib|mesh-list
153730419|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730420|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153730421|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153730422|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153730423|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154081792|NCT03333343|Naporafenib|naporafenib|mesh-list
153730424|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153730425|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730426|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
153730427|NCT00133640|Vitamin D|vitamin d|mesh-list
154081793|NCT03333343|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154081794|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081795|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081796|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081804|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
154081805|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081806|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154081807|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154081831|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
154081832|NCT03118492|Melphalan|melphalan|mesh-list
154081833|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
154081834|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154081835|NCT03118492|Fludarabine|fludarabine|mesh-list
154081836|NCT03118492|Tacrolimus|tacrolimus|mesh-list
154081837|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081838|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
154081839|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081840|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081841|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154081842|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
154081843|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081844|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081845|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154081846|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154081847|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081848|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154081849|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154081850|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
154081851|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154081852|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081853|NCT03077451|Nelfinavir|nelfinavir|mesh-list
154081854|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154081855|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154081856|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
154081857|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081858|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081859|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154081860|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154081861|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
154081862|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081863|NCT03070301|Everolimus|everolimus|mesh-list
154081864|NCT03070301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154081865|NCT03070301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081866|NCT03070301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081867|NCT03070301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081868|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081869|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
153548313|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
154081877|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
154081878|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081879|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154081880|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
154081881|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154081882|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154081883|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154081884|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154081885|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081886|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
154081887|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081888|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154081889|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154081890|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081891|NCT02991365|Insulin|insulin|mesh-list
154081892|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154081893|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081894|NCT02961881|Blinatumomab|blinatumomab|mesh-list
154081895|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081896|NCT02932410|Macitentan|macitentan|mesh-list
154081897|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154081898|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154081899|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081900|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154081901|NCT02885974|Celecoxib|celecoxib|mesh-list
154081902|NCT02885974|Gemcitabine|gemcitabine|mesh-list
154081903|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081904|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154081905|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
154081906|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081907|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154081908|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154081909|NCT02885974|Analgesics|analgesics|mesh-ancestor
154081910|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
154081911|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081912|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081913|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081914|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081915|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154081916|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154081917|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081918|NCT02860039|Vaccines|vaccines|mesh-list
154081919|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
154081920|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081921|NCT02807636|Carboplatin|carboplatin|mesh-list
154081922|NCT02807636|Gemcitabine|gemcitabine|mesh-list
154081923|NCT02807636|Atezolizumab|atezolizumab|mesh-list
154081924|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081925|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154081926|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
154081927|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081928|NCT02807636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081929|NCT02807636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081930|NCT02657486|Infigratinib|infigratinib|mesh-list
154081931|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081932|NCT02654587|Docetaxel|docetaxel|mesh-list
154081933|NCT02654587|Pemetrexed|pemetrexed|mesh-list
154081934|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081935|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
154081936|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
154081937|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548387|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154081951|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154081953|NCT02520778|Navitoclax|navitoclax|mesh-list
154081954|NCT02520778|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154081955|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081956|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081957|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081958|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081959|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
154081960|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081961|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081962|NCT02473146|Immunotoxins|immunotoxins|mesh-ancestor
154081963|NCT02473146|Immunoconjugates|immunoconjugates|mesh-ancestor
154081964|NCT02473146|Immunologic Factors|immunologic factors|mesh-ancestor
154081965|NCT02473146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081966|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
154081967|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081968|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081969|NCT02316002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154081970|NCT02316002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081971|NCT02288247|Prednisolone|prednisolone|mesh-list
154081972|NCT02288247|Docetaxel|docetaxel|mesh-list
154081973|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081974|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
154081975|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
154081976|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
154081977|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081978|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081979|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
154081980|NCT02288247|Hormones|hormones|mesh-ancestor
154081981|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081982|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081983|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081984|NCT02283177|Cytarabine|cytarabine|mesh-list
154081986|NCT02283177|Idarubicin|idarubicin|mesh-list
154081987|NCT02283177|Crenolanib|crenolanib|mesh-list
154081988|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154081989|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
154081990|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081991|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081992|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
154081993|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081994|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081995|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
154081996|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081997|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154082008|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
154082009|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
154082010|NCT02105766|Pentostatin|pentostatin|mesh-list
154082011|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154082012|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
154082013|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082014|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082015|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154082016|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
154082017|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082018|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082019|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154082020|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154082021|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082022|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154082023|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
154082024|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082025|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082026|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154082027|NCT01906853|Vaccines|vaccines|mesh-list
154082028|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
154082029|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
154082030|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082031|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154082032|NCT01767675|Carboplatin|carboplatin|mesh-list
154082033|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082034|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
154082035|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154082036|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154082037|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082038|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154082039|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154082040|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082041|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082042|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082043|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154082044|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
154082045|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154082046|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082047|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154082048|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154082049|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154082050|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
154082051|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154082052|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154082053|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154082054|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154082055|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082056|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
154082057|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082058|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082059|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154082060|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082061|NCT01598363|Digoxin|digoxin|mesh-list
154082066|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082068|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154082069|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082070|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154082071|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154082072|NCT01598363|Protective Agents|protective agents|mesh-ancestor
154082073|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082074|NCT00565708|Aspirin|aspirin|mesh-list
154082075|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154082076|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154082077|NCT00565708|Analgesics|analgesics|mesh-ancestor
154082078|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
154082079|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082080|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082081|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082082|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082083|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154082084|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154082085|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082086|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154082087|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154082088|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082089|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
154082090|NCT00529113|Gemcitabine|gemcitabine|mesh-list
153632822|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
154082091|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154082092|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
154082093|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082095|NCT05392790|Calcium|calcium|mesh-list
154082096|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154082097|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082098|NCT02597036|Zansecimab|zansecimab|mesh-list
154082099|NCT02597036|Paclitaxel|paclitaxel|mesh-list
154082100|NCT02597036|Ramucirumab|ramucirumab|mesh-list
154082101|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154082102|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082103|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
154082104|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
154082105|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
154082106|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082107|NCT02597036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154082108|NCT02597036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154082109|NCT02597036|Growth Substances|growth substances|mesh-ancestor
154082110|NCT02597036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082111|NCT02597036|Growth Inhibitors|growth inhibitors|mesh-ancestor
154082112|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
154082113|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082114|NCT04071639|Ubiquinone|ubiquinone|mesh-list
154082115|NCT04071639|Haloperidol|haloperidol|mesh-list
154082116|NCT04071639|Risperidone|risperidone|mesh-list
154082117|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
154082118|NCT04071639|Sertraline|sertraline|mesh-list
154082119|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
154082120|NCT04071639|Idebenone|idebenone|mesh-list
154082121|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154082122|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
154082123|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082124|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082125|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082126|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154082127|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154082128|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082129|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154082130|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154082131|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
154082132|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
154082133|NCT04071639|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154082140|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154082141|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
154082142|NCT04071639|Protective Agents|protective agents|mesh-ancestor
154082143|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
154082144|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154082145|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
154082146|NCT04089176|Oxytocin|oxytocin|mesh-list
154082147|NCT04089176|Carbetocin|carbetocin|mesh-list
154082148|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
154082149|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154082150|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082151|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
154082152|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154082153|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082154|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154082156|NCT00749684|Interferons|interferons|mesh-list
154082157|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082158|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
154082159|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082160|NCT02575755|Azithromycin|azithromycin|mesh-list
154082162|NCT02575755|Piperaquine|piperaquine|mesh-list
154082163|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
154082164|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154082165|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154082166|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082167|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
154082168|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154082169|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154082170|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154082171|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082172|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082173|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154082174|NCT00746798|Vaccines|vaccines|mesh-list
154082175|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
154082176|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082177|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154082178|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154082179|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154082180|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154082181|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082182|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
154082183|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082184|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082185|NCT01298193|Phenothiazine|phenothiazine|mesh-list
154082186|NCT01298193|Droperidol|droperidol|mesh-list
154082187|NCT01298193|Haloperidol|haloperidol|mesh-list
154082188|NCT01298193|Aprepitant|aprepitant|mesh-list
154082189|NCT01298193|Metoclopramide|metoclopramide|mesh-list
154082190|NCT01298193|Domperidone|domperidone|mesh-list
154082191|NCT01298193|Alizapride|alizapride|mesh-list
154082192|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
154082193|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
154082194|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
154082195|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082196|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082197|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154082198|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154082199|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082200|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082201|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154082202|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154082203|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082216|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082217|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
154082218|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154082219|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154082220|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082221|NCT02590536|Urological Agents|urological agents|mesh-ancestor
154082222|NCT00719862|Azelastine|azelastine|mesh-list
154082223|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154082224|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
154082225|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082226|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082227|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154082228|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
154082229|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154082230|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082231|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082232|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154082233|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154082234|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153405451|NCT00356941|Docetaxel|docetaxel|mesh-list
154082235|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
154082237|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082238|NCT02578953|Dutasteride|dutasteride|mesh-list
154082239|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154082240|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154082241|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082242|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082243|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
154082244|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082245|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082247|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
154082249|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082250|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082251|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
154082252|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082253|NCT00742508|Carvedilol|carvedilol|mesh-list
154082254|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154082255|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154082256|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
154082257|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082258|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082259|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082260|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154082261|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
154082262|NCT00742508|Protective Agents|protective agents|mesh-ancestor
154082263|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154082264|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154082265|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154082279|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082281|NCT02596334|Abacavir|abacavir|mesh-list
154082282|NCT02596334|Dolutegravir|dolutegravir|mesh-list
154082283|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154082284|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154082285|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082286|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082287|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
154082288|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082289|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154082290|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154082291|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154082292|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154082293|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
154082294|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
154082295|NCT00719706|Vitamins|vitamins|mesh-ancestor
154082296|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
154082297|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082298|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
154082299|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
154082300|NCT02575521|Propofol|propofol|mesh-list
154082301|NCT02575521|Sevoflurane|sevoflurane|mesh-list
154082302|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154082303|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082304|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082305|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154082306|NCT02575521|Analgesics|analgesics|mesh-ancestor
154082307|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
154082308|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082309|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154082310|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154082311|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154082312|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
154082313|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082314|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082315|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154082316|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
154082317|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
154082318|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154082319|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154082320|NCT02576457|BMS-936559|bms-936559|mesh-list
154082321|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082322|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082323|NCT05276102|Emollients|emollients|mesh-list
154082324|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
154082325|NCT01192971|Apatinib|apatinib|mesh-list
154082326|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082327|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154082344|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154082345|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
154256618|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
154082346|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082347|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082348|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154082349|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082350|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154082351|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154082352|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154082353|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082354|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082355|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
154082356|NCT00719472|Hormones|hormones|mesh-ancestor
154082357|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082358|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154082359|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154082360|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
154082361|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
154082362|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
154082363|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
154082364|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082365|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
154082366|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082367|NCT00579501|Dexamethasone|dexamethasone|mesh-list
154082368|NCT00579501|Trabectedin|trabectedin|mesh-list
154082369|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082370|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
154082371|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
154082372|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082373|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082374|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154082375|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
154082376|NCT00579501|Hormones|hormones|mesh-ancestor
154082377|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082378|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154082379|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082380|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154082381|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
154082382|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082383|NCT02576301|Cytarabine|cytarabine|mesh-list
154082384|NCT02576301|Combretastatin|combretastatin|mesh-list
154082385|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154082386|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
154082387|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082399|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
154082400|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
154082401|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082402|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082403|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
154082404|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082405|NCT00741338|Cyclosporine|cyclosporine|mesh-list
154082406|NCT00741338|Azathioprine|azathioprine|mesh-list
154082407|NCT00741338|Cyclosporins|cyclosporins|mesh-list
154082408|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082409|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082410|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154082411|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
154082412|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082413|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
154082414|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082415|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
154082416|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082417|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154082418|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
154082419|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154082420|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082421|NCT02598830|Vitamin D|vitamin d|mesh-list
154082422|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
154082423|NCT02598830|Vitamins|vitamins|mesh-ancestor
154082424|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
154082425|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082426|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154082427|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154082428|NCT02578251|Acetaminophen|acetaminophen|mesh-list
154082429|NCT02578251|Meperidine|meperidine|mesh-list
154082430|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154082431|NCT02578251|Analgesics|analgesics|mesh-ancestor
154082432|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
154082433|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082434|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082435|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
154082436|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154082437|NCT02578251|Narcotics|narcotics|mesh-ancestor
154082438|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082439|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154082440|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
154082441|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
154082442|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154082443|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
154082444|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082445|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082446|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154082447|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
154082448|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154082449|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154082450|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154082451|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
154082452|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548919|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
154082465|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
154082466|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082467|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082468|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154082469|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082470|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082471|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
154082472|NCT00709449|Urological Agents|urological agents|mesh-ancestor
154082473|NCT00746252|Risperidone|risperidone|mesh-list
154082474|NCT00746252|Aripiprazole|aripiprazole|mesh-list
154082475|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154082476|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
154082477|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082478|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082479|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082480|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154082481|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154082482|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082483|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154082484|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154082485|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
154082486|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
154082487|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
154082488|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154082489|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154082490|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154082491|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154082492|NCT02574975|Budesonide|budesonide|mesh-list
154082493|NCT02574975|Adenosine|adenosine|mesh-list
154082494|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
154082495|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
154082496|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082497|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154082498|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
154082499|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082500|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082501|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154082502|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
154082503|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
154082504|NCT02574975|Hormones|hormones|mesh-ancestor
154082505|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082506|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154082507|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154082508|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154082509|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
154082510|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082511|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082512|NCT02574975|Analgesics|analgesics|mesh-ancestor
154082513|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
154082514|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154082515|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
153652056|NCT00014430|Trastuzumab|trastuzumab|mesh-list
154082516|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154082524|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
154082525|NCT00718770|Bexarotene|bexarotene|mesh-list
154082526|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082527|NCT04084158|Paclitaxel|paclitaxel|mesh-list
154082528|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154082529|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154082530|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082531|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
154082532|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
154082533|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
154082534|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082535|NCT00714519|Castor Oil|castor oil|mesh-list
154082536|NCT00714519|Cathartics|cathartics|mesh-ancestor
154082537|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154082538|NCT00714948|Gemcitabine|gemcitabine|mesh-list
154082539|NCT00714948|Sorafenib|sorafenib|mesh-list
154082540|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082541|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154082542|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
154082543|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082544|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154082545|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082546|NCT00714714|Adapalene|adapalene|mesh-list
154082547|NCT00714714|Tretinoin|tretinoin|mesh-list
154082548|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082549|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
154082550|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
154082551|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154082552|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154082553|NCT00714714|Analgesics|analgesics|mesh-ancestor
154082554|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
154082555|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082556|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082557|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082558|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082559|NCT00441337|Nivolumab|nivolumab|mesh-list
154082560|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082561|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082562|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154082563|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082564|NCT00578877|Nonoxynol|nonoxynol|mesh-list
154082565|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154082566|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154082567|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082568|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154082569|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
154082570|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154082571|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154082572|NCT02573727|Terlipressin|terlipressin|mesh-list
154082573|NCT02573727|Epinephrine|epinephrine|mesh-list
154082574|NCT02573727|Racepinephrine|racepinephrine|mesh-list
154082575|NCT02573727|Norepinephrine|norepinephrine|mesh-list
154082576|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
154082577|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154082578|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154082579|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
154082580|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082581|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082582|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082583|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154082584|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154082585|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
153549047|NCT04442919|Narcotics|narcotics|mesh-ancestor
154082595|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154082596|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154082597|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082598|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154082599|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
154082600|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082601|NCT00918528|Mitomycins|mitomycins|mesh-list
154082602|NCT00918528|Mitomycin|mitomycin|mesh-list
154082603|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154082604|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256619|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082605|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
154082606|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082607|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154082608|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082610|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154082611|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154082612|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154082613|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
154082614|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082615|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082616|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154082617|NCT00468481|Diuretics|diuretics|mesh-ancestor
154082618|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
154082619|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154082620|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154082621|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154082622|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
154082623|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154082624|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154082625|NCT00468481|Estrogens|estrogens|mesh-ancestor
154082626|NCT00468481|Hormones|hormones|mesh-ancestor
154082627|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
154082628|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154082629|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082630|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
154082631|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082632|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
154082633|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082634|NCT03949153|Nivolumab|nivolumab|mesh-list
154082635|NCT03949153|Ipilimumab|ipilimumab|mesh-list
154082636|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082637|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082638|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154082639|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082640|NCT00709917|Repaglinide|repaglinide|mesh-list
154082641|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154082642|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082643|NCT02574741|Aripiprazole|aripiprazole|mesh-list
154082644|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
154082645|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154082646|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154082647|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154082648|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082649|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082650|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
154082651|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
154082659|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154082660|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154082662|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
154082663|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082664|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082665|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
154082666|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082667|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082668|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154082669|NCT02589444|Vitamin D|vitamin d|mesh-list
154082670|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
154082671|NCT02589444|Vitamins|vitamins|mesh-ancestor
154082672|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
154082673|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082674|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154082675|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154082676|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154082677|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082678|NCT05325684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082679|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082680|NCT00435487|Heparin|heparin|mesh-list
154082681|NCT00435487|Calcium heparin|calcium heparin|mesh-list
154082682|NCT00435487|Dalteparin|dalteparin|mesh-list
154082683|NCT00435487|Tinzaparin|tinzaparin|mesh-list
154256620|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082684|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154082685|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
154082686|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154082687|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154082688|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082690|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
154082691|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082692|NCT02591004|Nifedipine|nifedipine|mesh-list
154082693|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154082694|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154082695|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082696|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154082697|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082698|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
154082699|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
154082700|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154082701|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
154082702|NCT05310786|Narcotics|narcotics|mesh-ancestor
154082703|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082704|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082705|NCT05310786|Analgesics|analgesics|mesh-ancestor
154082706|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
154082707|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082708|NCT04085562|Amlodipine|amlodipine|mesh-list
154082709|NCT04085562|Bisoprolol|bisoprolol|mesh-list
154082710|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154082711|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154082712|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154082713|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082714|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154082715|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082716|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
154082726|NCT05683626|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154082727|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082728|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082730|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
154082731|NCT02588196|BB 1101|bb 1101|mesh-list
154082732|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082733|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
154082734|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
154082735|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082736|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082737|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154082738|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
154082739|NCT02588196|Hormones|hormones|mesh-ancestor
154082740|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082741|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154082742|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082743|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
154082744|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082745|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082746|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154082747|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
154082748|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082749|NCT00579345|Vaccines|vaccines|mesh-list
154082750|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
154082751|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082752|NCT00715377|Benztropine|benztropine|mesh-list
154082753|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154082754|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154082755|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
154082756|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
154082757|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082758|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405970|NCT05706233|Analgesics|analgesics|mesh-list
154082759|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154082760|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154082761|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
154082762|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082763|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082764|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154082765|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154256621|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154082766|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154082767|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
154082768|NCT00715455|Heparin|heparin|mesh-list
154082769|NCT00715455|Calcium heparin|calcium heparin|mesh-list
154082770|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
154082771|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154082772|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154082773|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082774|NCT02574663|Leucovorin|leucovorin|mesh-list
154082775|NCT02574663|Folic Acid|folic acid|mesh-list
154082776|NCT02574663|Paclitaxel|paclitaxel|mesh-list
154082777|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154082778|NCT02574663|Bevacizumab|bevacizumab|mesh-list
154082779|NCT02574663|Gemcitabine|gemcitabine|mesh-list
154082780|NCT02574663|Fluorouracil|fluorouracil|mesh-list
154082781|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
154082782|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
154082783|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154082797|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154082798|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
154082799|NCT02574663|Antidotes|antidotes|mesh-ancestor
154082800|NCT02574663|Protective Agents|protective agents|mesh-ancestor
154082801|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
154082802|NCT02574663|Vitamins|vitamins|mesh-ancestor
154082803|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
154082804|NCT02574663|Hematinics|hematinics|mesh-ancestor
154082805|NCT04069845|Doxorubicin|doxorubicin|mesh-list
154082806|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154082807|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154082808|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082809|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154082810|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154082811|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082812|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082813|NCT00715689|Hormones|hormones|mesh-list
154082814|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082815|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082816|NCT00919542|Cyclosporine|cyclosporine|mesh-list
154082817|NCT00919542|Prednisolone|prednisolone|mesh-list
154082818|NCT00919542|Cyclosporins|cyclosporins|mesh-list
154082819|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082820|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082821|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154082822|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
154082823|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082824|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
154082825|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082826|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
154082827|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082828|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154082829|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082830|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
154082831|NCT00919542|Hormones|hormones|mesh-ancestor
154082832|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082833|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153406050|NCT05558150|Aceclofenac|aceclofenac|mesh-list
154082834|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082835|NCT00719121|Adapalene|adapalene|mesh-list
154082836|NCT00719121|R 115866|r 115866|mesh-list
154082837|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154082838|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154082839|NCT00719121|Analgesics|analgesics|mesh-ancestor
154082840|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
154082841|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082842|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082843|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082844|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082851|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082852|NCT02589288|Ropivacaine|ropivacaine|mesh-list
154082853|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
154082854|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
154082855|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082856|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082857|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
154082858|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082859|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
154082860|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153652494|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082861|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
154082862|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082863|NCT00716001|Expectorants|expectorants|mesh-ancestor
154082864|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
154082865|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154082866|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
154082867|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082868|NCT00716001|Protective Agents|protective agents|mesh-ancestor
154082869|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082870|NCT00716001|Antidotes|antidotes|mesh-ancestor
154082871|NCT00710229|Bevacizumab|bevacizumab|mesh-list
154082872|NCT00710229|Ranibizumab|ranibizumab|mesh-list
154082873|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082874|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082875|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154082876|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154082877|NCT00710229|Growth Substances|growth substances|mesh-ancestor
154082878|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082879|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
154082880|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
154082881|NCT00710619|Coagulants|coagulants|mesh-ancestor
154082883|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
154082884|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082885|NCT00719433|Armin|armin|mesh-list
154082886|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154082887|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082888|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082889|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
154082890|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082891|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082892|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
154082893|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082894|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
154082895|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154082896|NCT00719745|Tacrolimus|tacrolimus|mesh-list
154082897|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154082898|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
154082899|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082900|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154082901|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082902|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082903|NCT02587416|Atorvastatin|atorvastatin|mesh-list
154082904|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154082905|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154082906|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
154082907|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082908|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154082909|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153406118|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
154082910|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082911|NCT00719823|Maraviroc|maraviroc|mesh-list
153549377|NCT04172597|Loperamide|loperamide|mesh-list
154082921|NCT00919776|Prednisolone|prednisolone|mesh-list
154082922|NCT00919776|Cyclosporins|cyclosporins|mesh-list
154082923|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082924|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082925|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154082926|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
154082927|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082928|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
154082929|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082930|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
154082931|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082932|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154082933|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082934|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
154082935|NCT00919776|Hormones|hormones|mesh-ancestor
154082936|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154082937|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154082938|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082939|NCT00720135|Rituximab|rituximab|mesh-list
154082940|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154082941|NCT00720135|Interleukin-2|interleukin-2|mesh-list
154082942|NCT00720135|Antibodies|antibodies|mesh-list
153652781|NCT00014937|Lopinavir|lopinavir|mesh-list
154082943|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
154082944|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154082945|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
154082946|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082947|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082948|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082949|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154082950|NCT00720135|Analgesics|analgesics|mesh-ancestor
154082951|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
154082952|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082953|NCT02588118|Propofol|propofol|mesh-list
154082954|NCT02588118|Cisatracurium|cisatracurium|mesh-list
154082955|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154082956|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154082957|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082958|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154082959|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
154082960|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
154082961|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154082962|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154082963|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082964|NCT00716391|Cisplatin|cisplatin|mesh-list
154082965|NCT00716391|Cetuximab|cetuximab|mesh-list
154082966|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082967|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082968|NCT00716469|Talaporfin|talaporfin|mesh-list
154082969|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082970|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154082971|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
154082972|NCT04082598|Amoxicillin|amoxicillin|mesh-list
154082973|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
154082974|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
154082975|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154082976|NCT04082598|Lactoferrin|lactoferrin|mesh-list
154082977|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154082978|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082979|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154082988|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082989|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082990|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082991|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082992|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154082993|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154082994|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082995|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082996|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154082997|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
154082998|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
154082999|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154083000|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
154083001|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083002|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
154083003|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083004|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083005|NCT00720291|Metronidazole|metronidazole|mesh-list
154083006|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083007|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154083008|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154083009|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154083010|NCT00578643|Cyclosporine|cyclosporine|mesh-list
154083011|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
154083013|NCT00578643|Fludarabine|fludarabine|mesh-list
154083014|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
154083015|NCT00578643|Cyclosporins|cyclosporins|mesh-list
154083016|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154083017|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
154083018|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083019|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083020|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154083021|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
154083022|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083023|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083024|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154083025|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083026|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
154083027|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083028|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
154083029|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154083030|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154083031|NCT04082286|Antibodies|antibodies|mesh-list
154083032|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154083033|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
154083034|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083035|NCT00720447|Cytarabine|cytarabine|mesh-list
154083036|NCT00720447|Etoposide|etoposide|mesh-list
154083037|NCT00720447|Melphalan|melphalan|mesh-list
154083038|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
154083039|NCT00720447|Carmustine|carmustine|mesh-list
154083040|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154083041|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083042|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154083043|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154083044|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083045|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083046|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154083047|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
154083048|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
154083049|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083067|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
154083068|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154083069|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154083070|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154083071|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154083072|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154083073|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154083074|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083075|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154083076|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154083077|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083078|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083079|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083080|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154083082|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154083083|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083084|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
154083085|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083086|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083087|NCT02572089|Naloxone|naloxone|mesh-list
154083088|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154083089|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083090|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
154083091|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083092|NCT02588742|Melatonin|melatonin|mesh-list
154083093|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
154083094|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083095|NCT02588742|Protective Agents|protective agents|mesh-ancestor
154083096|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083097|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083098|NCT00720603|Plerixafor|plerixafor|mesh-list
154083099|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154083100|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154083101|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
154083102|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083103|NCT04936854|Sirolimus|sirolimus|mesh-list
154083104|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
154083105|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154083106|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154083107|NCT04936854|Prednisolone|prednisolone|mesh-list
154083131|NCT00711789|Giapreza|giapreza|mesh-list
154083132|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
154083133|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154083134|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154083135|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
154083136|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083137|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083138|NCT00741260|Capecitabine|capecitabine|mesh-list
154083139|NCT00741260|Neratinib|neratinib|mesh-list
154083140|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154083141|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
154083142|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083143|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083144|NCT00741260|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154083145|NCT00741260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154083146|NCT00741260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083147|NCT02587260|Clopidogrel|clopidogrel|mesh-list
154083148|NCT02587260|Ticagrelor|ticagrelor|mesh-list
154083149|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154083150|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154083151|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153566403|NCT05456256|Carboplatin|carboplatin|mesh-list
154083152|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154083153|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154083154|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
154083155|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083156|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083157|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083158|NCT02596256|Docetaxel|docetaxel|mesh-list
154083180|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083181|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154083182|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154083183|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083184|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083185|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083186|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154083187|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
154083188|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154083189|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083190|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154083191|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154083192|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154083193|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154083194|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154083195|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154083196|NCT00717561|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154083197|NCT00717561|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154083198|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154083199|NCT00720915|Anticoagulants|anticoagulants|mesh-list
154083200|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
154083201|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154083202|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154083203|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083204|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
154083205|NCT00720915|Coagulants|coagulants|mesh-ancestor
154083206|NCT00712101|Abciximab|abciximab|mesh-list
154083207|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
154083208|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154083209|NCT00712257|Heparin|heparin|mesh-list
154083210|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
154083211|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154083212|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153549691|NCT03918278|Pemetrexed|pemetrexed|mesh-list
154083233|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083234|NCT00721305|Lovastatin|lovastatin|mesh-list
154083235|NCT00721305|L 647318|l 647318|mesh-list
154083236|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
154083237|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154083238|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154083239|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
154083240|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083241|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154083242|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154083243|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083244|NCT00717951|Capecitabine|capecitabine|mesh-list
154083245|NCT00717951|Docetaxel|docetaxel|mesh-list
154083246|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083247|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154083248|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
154083249|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083250|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
154083251|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
154083252|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
154083253|NCT02572947|Dolutegravir|dolutegravir|mesh-list
154083254|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154083255|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154083256|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083257|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083258|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154083259|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154083260|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
154083261|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083262|NCT00712491|Sirolimus|sirolimus|mesh-list
154083263|NCT00712491|Temsirolimus|temsirolimus|mesh-list
154083264|NCT00712491|MTOR Inhibitors|mtor inhibitors|mesh-list
154083265|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154083266|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083267|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154083268|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083269|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
154083270|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154083271|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
154083282|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
154083283|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083284|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083285|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154083286|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
154083288|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083289|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154083290|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083291|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154083293|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083294|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154083295|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
154083296|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154083297|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154083298|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
154083299|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083300|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
154083301|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083302|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154083303|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154083304|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154083305|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
154083306|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083307|NCT05683782|Chitosan|chitosan|mesh-list
154083308|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
154083309|NCT05683782|Hematinics|hematinics|mesh-ancestor
154083310|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154083311|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154083312|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
154083313|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083314|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154083315|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
154083316|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
154083317|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
154083318|NCT05683782|Coagulants|coagulants|mesh-ancestor
154083319|NCT00740714|Vitamins|vitamins|mesh-list
154083320|NCT00740714|Vitamin E|vitamin e|mesh-list
154083321|NCT00740714|Tocopherols|tocopherols|mesh-list
154083322|NCT00740714|Tocotrienols|tocotrienols|mesh-list
154083323|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
154083324|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
154083325|NCT00740714|Ubiquinone|ubiquinone|mesh-list
154083326|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
154083327|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083328|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
154083329|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083330|NCT00740714|Protective Agents|protective agents|mesh-ancestor
154083331|NCT00721773|Valsartan|valsartan|mesh-list
154083332|NCT00721773|Benazepril|benazepril|mesh-list
154083333|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154083334|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154083335|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154083336|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083337|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154083338|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
154083339|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083362|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
154083363|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
154083364|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083365|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083366|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
153406564|NCT04294459|Analgesics|analgesics|mesh-ancestor
154083367|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
154083368|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154083369|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154083370|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154083371|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154083372|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
154083373|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083374|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083375|NCT04067817|Protective Agents|protective agents|mesh-ancestor
154083376|NCT00740636|Temozolomide|temozolomide|mesh-list
154083377|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154083378|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
154083379|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083380|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083381|NCT02603159|Capecitabine|capecitabine|mesh-list
154083382|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154083383|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
154083384|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083385|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083386|NCT02595554|Paclitaxel|paclitaxel|mesh-list
154083387|NCT02595554|Cisplatin|cisplatin|mesh-list
154083388|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154083389|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083390|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
154083391|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
154083392|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
154083393|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083394|NCT04069065|Tacrolimus|tacrolimus|mesh-list
154083395|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154083408|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154083409|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154083410|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154083411|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
154083412|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083413|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083414|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083415|NCT00795509|Urological Agents|urological agents|mesh-ancestor
154083416|NCT02603003|Pemetrexed|pemetrexed|mesh-list
154083417|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083418|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083419|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083420|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154083421|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154083422|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154083423|NCT02603081|Ebselen|ebselen|mesh-list
154083424|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154083425|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154083426|NCT02603081|Analgesics|analgesics|mesh-ancestor
154083427|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
154083428|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083429|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083430|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083431|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083432|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154083433|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154083434|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
154083435|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083436|NCT02603081|Protective Agents|protective agents|mesh-ancestor
154083437|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154083438|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083439|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154083440|NCT00787787|Capecitabine|capecitabine|mesh-list
154083441|NCT00787787|Sunitinib|sunitinib|mesh-list
154083442|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154083443|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
154083444|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083445|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083446|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154083447|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154083448|NCT00787787|Growth Substances|growth substances|mesh-ancestor
154083449|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083450|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
154083451|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154083452|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083453|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
154083454|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154083456|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
154083457|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154083458|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
154083459|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083460|NCT00915239|Pantoprazole|pantoprazole|mesh-list
154083472|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
154083473|NCT02604095|Melatonin|melatonin|mesh-list
154083474|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
154083475|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083476|NCT02604095|Protective Agents|protective agents|mesh-ancestor
154083477|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083478|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083479|NCT02571543|Ibuprofen|ibuprofen|mesh-list
154083480|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154083481|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154083482|NCT02571543|Analgesics|analgesics|mesh-ancestor
154083483|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
154083484|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083485|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083486|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083487|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083488|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154083489|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083490|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083491|NCT04107779|Menthol|menthol|mesh-list
154083492|NCT04107779|Nicotine|nicotine|mesh-list
154083493|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154083494|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
154083495|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083496|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083497|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154083498|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154083499|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
154083500|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083501|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083502|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
154083503|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
154083504|NCT04067505|Nadroparin|nadroparin|mesh-list
154083505|NCT04067505|Warfarin|warfarin|mesh-list
154083506|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
154083507|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
154083508|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154083509|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
154083510|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154083511|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
154083512|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083513|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083514|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154083515|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154083516|NCT00794963|Metformin|metformin|mesh-list
154083517|NCT00794963|Orlistat|orlistat|mesh-list
154083518|NCT00794963|Irbesartan|irbesartan|mesh-list
153406731|NCT03853317|Avelumab|avelumab|mesh-list
154083519|NCT00794963|Fenofibrate|fenofibrate|mesh-list
154083520|NCT00794963|Pravastatin|pravastatin|mesh-list
154083521|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154083522|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083523|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154083524|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
154083525|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083532|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154083533|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154083535|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154083536|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154083537|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154083538|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
154083539|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083540|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083541|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083542|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
154083543|NCT00722709|Ropivacaine|ropivacaine|mesh-list
154083544|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
154083545|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
154083546|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083547|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083548|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
154083549|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083550|NCT04105205|Apramycin|apramycin|mesh-list
154083551|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154083552|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083553|NCT00794573|Varenicline|varenicline|mesh-list
154083554|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154083555|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154083556|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
154083557|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083558|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083559|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083560|NCT04070079|Tenofovir|tenofovir|mesh-list
154083561|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
154083562|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083563|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154083564|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154083565|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083566|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083567|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154083568|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154083569|NCT00739934|Voriconazole|voriconazole|mesh-list
154083570|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
154083571|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083572|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154083573|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154083574|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083575|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083576|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154083577|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
154083578|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083579|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083580|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154083581|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
154083582|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154083583|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
154083584|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083585|NCT02586636|Metformin|metformin|mesh-list
154083586|NCT02586636|Omeprazole|omeprazole|mesh-list
154083587|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154083588|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083589|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154083590|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154083591|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154083592|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083600|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083602|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083603|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
154083604|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
154083605|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154083606|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154083607|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154083608|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154083609|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154083610|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
154083611|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083612|NCT00713739|Urological Agents|urological agents|mesh-ancestor
154083613|NCT02595476|Remifentanil|remifentanil|mesh-list
154083614|NCT02595476|Propofol|propofol|mesh-list
154083615|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154083616|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083617|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083618|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154083619|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
154083620|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
154083621|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154083622|NCT02595476|Narcotics|narcotics|mesh-ancestor
154083623|NCT02595476|Analgesics|analgesics|mesh-ancestor
154083624|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
154083625|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083626|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
154083627|NCT02586402|Hematinics|hematinics|mesh-ancestor
154083628|NCT00734630|Losartan|losartan|mesh-list
154083629|NCT00734630|Lisinopril|lisinopril|mesh-list
154083630|NCT00734630|Nebivolol|nebivolol|mesh-list
154083631|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154083632|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154083633|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154083634|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154083635|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083636|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154083637|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
154083638|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083639|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154083640|NCT00734630|Protective Agents|protective agents|mesh-ancestor
154083641|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083642|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
154083643|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154083644|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154083645|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154083646|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
154083647|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083648|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
154083649|NCT02586246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154083650|NCT02586246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083651|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634850|NCT00000553|Niacin|niacin|mesh-list
154083652|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
154083653|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083654|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083655|NCT00920244|Atropine|atropine|mesh-list
154083656|NCT00920244|Amiodarone|amiodarone|mesh-list
154083657|NCT00920244|Epinephrine|epinephrine|mesh-list
154083658|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154083659|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153550128|NCT03519295|Docetaxel|docetaxel|mesh-list
154083672|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154083673|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154083674|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154083675|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
154083676|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154083677|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154083678|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
154083679|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
154083680|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154083681|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154083682|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154083683|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154083684|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154083685|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083686|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154083687|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154083688|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154083689|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154083690|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
154083691|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083692|NCT00723879|Ribavirin|ribavirin|mesh-list
154083693|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154083694|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
154083695|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083696|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
154083697|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083698|NCT03907605|Hormones|hormones|mesh-list
154083699|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083700|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083701|NCT00435409|Capecitabine|capecitabine|mesh-list
154083702|NCT00435409|Sunitinib|sunitinib|mesh-list
154083703|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154083704|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
154083705|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083706|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083707|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154083708|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154083709|NCT00435409|Growth Substances|growth substances|mesh-ancestor
154083710|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083711|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
154083712|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154083713|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083714|NCT00724035|Midazolam|midazolam|mesh-list
154083715|NCT00724035|Fentanyl|fentanyl|mesh-list
154083716|NCT00724035|Analgesics|analgesics|mesh-list
154083717|NCT00724035|Anesthetics|anesthetics|mesh-list
154083718|NCT00724035|Ropivacaine|ropivacaine|mesh-list
154083719|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
154083720|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083721|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550199|NCT03471143|Betadex|betadex|mesh-list
154083734|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083735|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154083736|NCT00724035|Narcotics|narcotics|mesh-ancestor
154083737|NCT04126824|Triamcinolone|triamcinolone|mesh-list
154083738|NCT04126824|Bupivacaine|bupivacaine|mesh-list
154083739|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
154083740|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
154083741|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083742|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083743|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
154083744|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406945|NCT03248167|Cannabidiol|cannabidiol|mesh-list
154083746|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
154083747|NCT04126824|Hormones|hormones|mesh-ancestor
153634898|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083748|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083749|NCT00724113|Lidocaine|lidocaine|mesh-list
154083750|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
154083751|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
154083752|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083753|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083754|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
154083755|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083756|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154083757|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154083758|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154083759|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154083760|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083761|NCT04070001|Ibuprofen|ibuprofen|mesh-list
154083762|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154083763|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154083764|NCT04070001|Analgesics|analgesics|mesh-ancestor
154083765|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
154083766|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083767|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083768|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083769|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083770|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154083771|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083772|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083773|NCT00435019|Insulin|insulin|mesh-list
154083774|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154083775|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
154083776|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
154083777|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
154083778|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
154083779|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
154083780|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154083781|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083782|NCT00724581|Amiodarone|amiodarone|mesh-list
154083783|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154083784|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
153550261|NCT03386578|Emtricitabine|emtricitabine|mesh-list
154083806|NCT04956627|Phenytoin|phenytoin|mesh-list
154083807|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
154083808|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
154083809|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083810|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154083811|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154083812|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083813|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083814|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154083815|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
154083816|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083817|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083818|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154083819|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
154083820|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154083821|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154083822|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154083823|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154083824|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154083825|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154083826|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
154083827|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154083828|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154083829|NCT00920088|Ritonavir|ritonavir|mesh-list
154083830|NCT00920088|Lopinavir|lopinavir|mesh-list
154083831|NCT00920088|Darunavir|darunavir|mesh-list
154083832|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
154083833|NCT00920088|Midazolam|midazolam|mesh-list
153550333|NCT03337698|Hormones|hormones|mesh-ancestor
154083846|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
154083847|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
154083848|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083849|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083850|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154083851|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154083852|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
154083853|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083854|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154083855|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154083856|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
154083857|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083858|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154083859|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154083860|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
154083861|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
154083862|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154083863|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154083864|NCT00920088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154083865|NCT00920088|Narcotics|narcotics|mesh-ancestor
154083866|NCT00920088|Analgesics|analgesics|mesh-ancestor
154083867|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
154083868|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083869|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154083870|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154083871|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083872|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083873|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154083874|NCT04018833|Ranibizumab|ranibizumab|mesh-list
154083875|NCT04018833|Aflibercept|aflibercept|mesh-list
154083876|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154083877|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154083878|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154083879|NCT04018833|Growth Substances|growth substances|mesh-ancestor
154083880|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083881|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
154083882|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083883|NCT04066803|Folic Acid|folic acid|mesh-list
154083884|NCT04066803|Hematinics|hematinics|mesh-ancestor
154083885|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
154083886|NCT04066803|Vitamins|vitamins|mesh-ancestor
154083887|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
154083888|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083889|NCT00725439|R 115866|r 115866|mesh-list
154083890|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154083891|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083892|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083893|NCT03205761|Olaparib|olaparib|mesh-list
154083894|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154083895|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083896|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083897|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083908|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083909|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083910|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154083911|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154083912|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154083913|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154083914|NCT00794417|Growth Substances|growth substances|mesh-ancestor
154083915|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083916|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
154083919|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154083920|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154083922|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083923|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154083924|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154083925|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083926|NCT02583438|Saxagliptin|saxagliptin|mesh-list
154083927|NCT02583438|Incretins|incretins|mesh-ancestor
154083928|NCT02583438|Hormones|hormones|mesh-ancestor
154083929|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083930|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083931|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154083932|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
154083933|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083934|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083935|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154083936|NCT02603861|Modafinil|modafinil|mesh-list
154083937|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154083938|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083939|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154083940|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154083941|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154083942|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083943|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
154083944|NCT02569905|Parecoxib|parecoxib|mesh-list
154083945|NCT02569905|Analgesics|analgesics|mesh-ancestor
154083946|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
154083947|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083948|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083949|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154083950|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154083951|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083952|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154083953|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154083954|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083955|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083956|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154083957|NCT02603783|Capsaicin|capsaicin|mesh-list
154083958|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
154083959|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
154083960|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
154083961|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083962|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083963|NCT04110275|Plasminogen|plasminogen|mesh-list
154083986|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083987|NCT02583516|Vemurafenib|vemurafenib|mesh-list
154083988|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083989|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154083990|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083991|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083993|NCT00790907|PENTA|penta|mesh-list
154083994|NCT00790907|Fondaparinux|fondaparinux|mesh-list
154083995|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
154083996|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154083997|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154083998|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083999|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154084000|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
154084001|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154084002|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
154084003|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084004|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154084005|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154084006|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
154084007|NCT04066179|Prednisolone|prednisolone|mesh-list
154084008|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084009|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
154084010|NCT04066179|Hormones|hormones|mesh-ancestor
154084011|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084012|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084013|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154084014|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084015|NCT04110119|Diclofenac|diclofenac|mesh-list
154084016|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154084017|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084018|NCT04110119|Analgesics|analgesics|mesh-ancestor
154084041|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
153407246|NCT01390584|Hormones|hormones|mesh-ancestor
154084042|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084044|NCT04080336|Dinoprostone|dinoprostone|mesh-list
154084045|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154084046|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
154084047|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154084048|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084049|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154084050|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084051|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
154084052|NCT00793871|Sunitinib|sunitinib|mesh-list
154084053|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084054|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154084055|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154084056|NCT00793871|Growth Substances|growth substances|mesh-ancestor
154084057|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084058|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
154084059|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154084060|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084068|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154084069|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084070|NCT04066257|Metronidazole|metronidazole|mesh-list
154084071|NCT04066257|Tetracycline|tetracycline|mesh-list
154084072|NCT04066257|Bismuth|bismuth|mesh-list
154084073|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084074|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154084075|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154084076|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154084077|NCT04066257|Antacids|antacids|mesh-ancestor
154084078|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084079|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084080|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154084081|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084082|NCT03655821|Pemetrexed|pemetrexed|mesh-list
154084083|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084084|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084085|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084086|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154084087|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154084088|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
154084089|NCT04524702|Paclitaxel|paclitaxel|mesh-list
154084090|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154084091|NCT04524702|Gemcitabine|gemcitabine|mesh-list
154084092|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154084093|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084094|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
154084095|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
154084096|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
154084097|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084098|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154084099|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
154084100|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
154084101|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154084102|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154084103|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084104|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084105|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084106|NCT00730197|Albuterol|albuterol|mesh-list
154084107|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154084108|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
154084109|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084121|NCT00727545|Chelating Agents|chelating agents|mesh-list
154084122|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
154084123|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084124|NCT02582892|Vitamin D|vitamin d|mesh-list
154084125|NCT02582892|Vitamins|vitamins|mesh-ancestor
154084126|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
154084127|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084128|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154084129|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
154084130|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
154084131|NCT00730509|Vitamins|vitamins|mesh-ancestor
154084132|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
154084133|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084134|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
154084135|NCT00730509|Hematinics|hematinics|mesh-ancestor
154084136|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
154084137|NCT02582736|Haloperidol|haloperidol|mesh-list
154084138|NCT02582736|Pimozide|pimozide|mesh-list
154084139|NCT02582736|Olanzapine|olanzapine|mesh-list
154084140|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
154084141|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
154084142|NCT02582736|Risperidone|risperidone|mesh-list
154084143|NCT02582736|Aripiprazole|aripiprazole|mesh-list
154084144|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154084145|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154084146|NCT02582736|Ziprasidone|ziprasidone|mesh-list
154084147|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
154084148|NCT02582736|Clozapine|clozapine|mesh-list
154084149|NCT02582736|Loxapine|loxapine|mesh-list
154084150|NCT02582736|Perphenazine|perphenazine|mesh-list
154084151|NCT02582736|Fluphenazine|fluphenazine|mesh-list
154084152|NCT02582736|Flupenthixol|flupenthixol|mesh-list
154084153|NCT02582736|Thioridazine|thioridazine|mesh-list
154084154|NCT02582736|Clopenthixol|clopenthixol|mesh-list
154084155|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
154084156|NCT02582736|Fluspirilene|fluspirilene|mesh-list
154084157|NCT02582736|Thiothixene|thiothixene|mesh-list
154084158|NCT02582736|Mesoridazine|mesoridazine|mesh-list
154084159|NCT02582736|Chlormezanone|chlormezanone|mesh-list
154084160|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
154084161|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154084162|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
154084163|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084164|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084165|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084166|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154084167|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084168|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154084169|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154084170|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
154084171|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
154084172|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
154084173|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084174|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084175|NCT02582736|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154084176|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154084177|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154084206|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154084207|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084208|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154084209|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154084210|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154084211|NCT00735345|Docetaxel|docetaxel|mesh-list
154084212|NCT00735345|Cetuximab|cetuximab|mesh-list
154084213|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084214|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
154084215|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
154084216|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
154084217|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084218|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154084219|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
154084220|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153550712|NCT02543983|Ketamine|ketamine|mesh-list
154084241|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154084242|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084244|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154084245|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084246|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084247|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084248|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154084249|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154084250|NCT00577707|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154084251|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154084252|NCT00730821|Nintedanib|nintedanib|mesh-list
154084253|NCT00730821|Afatinib|afatinib|mesh-list
154084254|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084255|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154084256|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084257|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084258|NCT00730821|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154084259|NCT00728559|Bupivacaine|bupivacaine|mesh-list
154084260|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
154084261|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
154084262|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084263|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084264|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
154084265|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084266|NCT00735813|Heparin|heparin|mesh-list
154084267|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
154084268|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154084269|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154084270|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084271|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
154084272|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154084296|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154084297|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154084298|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154084299|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
154084300|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084301|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084302|NCT00731289|Triamcinolone|triamcinolone|mesh-list
154084303|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154084304|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154084305|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
154084306|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154084307|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084308|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
154084309|NCT00731289|Hormones|hormones|mesh-ancestor
154084310|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084311|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084312|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084313|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
154084314|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084315|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084316|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154084317|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
154084318|NCT00731289|Protective Agents|protective agents|mesh-ancestor
154084319|NCT00736515|Insulin|insulin|mesh-list
154084320|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154084321|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
154084322|NCT00736515|Gliclazide|gliclazide|mesh-list
154084323|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154084324|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084325|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154084326|NCT00731367|Laxatives|laxatives|mesh-ancestor
154084352|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084353|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084354|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
154084355|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084356|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154084357|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154084358|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
154084359|NCT00736983|Adalimumab|adalimumab|mesh-list
154084360|NCT00736983|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154084361|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084362|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084363|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154084364|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084365|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154084366|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154084367|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084368|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084369|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084370|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154084371|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154084373|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084404|NCT02569515|Hematinics|hematinics|mesh-ancestor
154084405|NCT00737373|Leucovorin|leucovorin|mesh-list
154084406|NCT00737373|Folic Acid|folic acid|mesh-list
154084407|NCT00737373|Docetaxel|docetaxel|mesh-list
154084408|NCT00737373|Fluorouracil|fluorouracil|mesh-list
154084409|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
154084410|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
154084411|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084412|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
154084413|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
154084414|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
154084415|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084416|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
154084417|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154084418|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084419|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
154084446|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084447|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154084448|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
154084449|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084450|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084451|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154084452|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
154084453|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154084454|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
154084455|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084456|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084457|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154084458|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
154084459|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154084460|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
154084461|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084462|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084463|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154084464|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
154084465|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
154084466|NCT00732537|Protective Agents|protective agents|mesh-ancestor
154084467|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154084492|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084493|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084495|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
154084496|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084497|NCT00732927|Aspirin|aspirin|mesh-list
154084498|NCT00732927|Parnaparin|parnaparin|mesh-list
154084499|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154084500|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084501|NCT00732927|Analgesics|analgesics|mesh-ancestor
154084502|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
154084503|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084504|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084505|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084506|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084507|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154084508|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154084509|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084510|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154084512|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084513|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
154084514|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
154084515|NCT00733083|Dexamethasone|dexamethasone|mesh-list
154084516|NCT00733083|Morphine|morphine|mesh-list
154084517|NCT00733083|Oxycodone|oxycodone|mesh-list
154084518|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084519|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
154084520|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
154084521|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084543|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084544|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154084545|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
154084546|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
154084547|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154084548|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154084549|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154084550|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154084551|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
154084552|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084553|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084554|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
154084555|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084556|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154084557|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154084558|NCT00738621|Dexamethasone|dexamethasone|mesh-list
154084559|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
154084560|NCT00738621|Ondansetron|ondansetron|mesh-list
154084561|NCT00738621|Aprepitant|aprepitant|mesh-list
154084562|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
154084564|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084565|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
154084566|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
154084567|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084568|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084569|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084570|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
154084571|NCT00738621|Hormones|hormones|mesh-ancestor
153407767|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
154084572|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084573|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154084574|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084575|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
154084601|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154084602|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154084603|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084604|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084605|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
154084606|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154084607|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154084608|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154084609|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154084610|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
154084611|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
154084612|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154084613|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154084614|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084615|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154084616|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
154084617|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154084618|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
154084619|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154084620|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154084621|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
154084622|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154084623|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084624|NCT04065165|Lanreotide|lanreotide|mesh-list
154084625|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084626|NCT00577629|Cytarabine|cytarabine|mesh-list
154084627|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
154084628|NCT00577629|Rituximab|rituximab|mesh-list
154084645|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154084646|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154084647|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
154084648|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
154084649|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084650|NCT00733317|Budesonide|budesonide|mesh-list
154084651|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084652|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154084653|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
154084654|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084655|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084656|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154084657|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
154084658|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
154084659|NCT00733317|Hormones|hormones|mesh-ancestor
154084660|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084661|NCT02568735|Etoricoxib|etoricoxib|mesh-list
154084662|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154084663|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154084664|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084665|NCT02568735|Analgesics|analgesics|mesh-ancestor
154084666|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
154084667|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084668|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084669|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084670|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084671|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154084672|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154084673|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084674|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084675|NCT00733473|Budesonide|budesonide|mesh-list
154084676|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084677|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154084678|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
154084679|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084680|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084681|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154084682|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
154084683|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
154084684|NCT00733473|Hormones|hormones|mesh-ancestor
154084685|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084718|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154084720|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154084721|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084722|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084723|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
154084724|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154084725|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084726|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154084727|NCT04063449|Endostar protein|endostar protein|mesh-list
153551237|NCT01570569|Narcotics|narcotics|mesh-ancestor
154084754|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154084755|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154084756|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
154084757|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
154084758|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084759|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084761|NCT00707031|Exenatide|exenatide|mesh-list
154084762|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154084763|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084764|NCT00707031|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154084765|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154084766|NCT00707031|Incretins|incretins|mesh-ancestor
154084767|NCT00707031|Hormones|hormones|mesh-ancestor
154084768|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084769|NCT00711477|Naltrexone|naltrexone|mesh-list
154084770|NCT00711477|Bupropion|bupropion|mesh-list
154084771|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154084772|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154084773|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084774|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
153551262|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
154084797|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
154084798|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084799|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084800|NCT00734474|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154084802|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084803|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
154084804|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084805|NCT00577473|Mesalamine|mesalamine|mesh-list
154084806|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154084807|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084808|NCT00577473|Analgesics|analgesics|mesh-ancestor
154084809|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
154084810|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084811|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084812|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084813|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084814|NCT00740103|Semapimod|semapimod|mesh-list
154084815|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154084816|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084817|NCT00740103|Analgesics|analgesics|mesh-ancestor
154084818|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
154084819|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084820|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084821|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084822|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084823|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084849|NCT00785291|Antibodies|antibodies|mesh-list
154084850|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
154084851|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154084852|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
154084853|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154084854|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084855|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
154084856|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
154084857|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
154084858|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084860|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154084861|NCT00785291|Growth Substances|growth substances|mesh-ancestor
154084862|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084863|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
154084864|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
154084865|NCT00740259|Flunarizine|flunarizine|mesh-list
154084866|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
154084867|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154084868|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154084869|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084870|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154084871|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084872|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153551363|NCT01571323|Misoprostol|misoprostol|mesh-list
154084903|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
154084904|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
154084905|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084906|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084907|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084908|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
154084909|NCT02583594|Hormones|hormones|mesh-ancestor
154084910|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084911|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154084912|NCT02583594|Protective Agents|protective agents|mesh-ancestor
154084913|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084914|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154084915|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
154084916|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084917|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
154084918|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
154084919|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154084920|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154084921|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154084922|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
154084923|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
153551412|NCT01571583|Interferons|interferons|mesh-list
154084958|NCT00740571|Pregabalin|pregabalin|mesh-list
154084959|NCT00740571|Amitriptyline|amitriptyline|mesh-list
154084960|NCT00740571|Analgesics|analgesics|mesh-ancestor
154084961|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
153551439|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
154084981|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
154084982|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084983|NCT02595242|Prednisone|prednisone|mesh-list
154084984|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
154084985|NCT02595242|Vincristine|vincristine|mesh-list
154084986|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084987|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
154084988|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084989|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084990|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154084991|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
154084992|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084993|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084994|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154084995|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084996|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
154084997|NCT02595242|Hormones|hormones|mesh-ancestor
154084998|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084999|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154085000|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154085001|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
154085002|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
154085003|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
154085004|NCT04487106|Azacitidine|azacitidine|mesh-list
154085005|NCT04487106|Venetoclax|venetoclax|mesh-list
154085006|NCT04487106|Trametinib|trametinib|mesh-list
154085007|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154085008|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
154085009|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085010|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085011|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085012|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154085014|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
154085015|NCT02568033|Paclitaxel|paclitaxel|mesh-list
154085016|NCT02568033|Docetaxel|docetaxel|mesh-list
154085017|NCT02568033|Carboplatin|carboplatin|mesh-list
154085044|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085045|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154085046|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154085047|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085048|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085049|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085050|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154085051|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154085052|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154085053|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
154085054|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154085055|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154085056|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154085057|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154085058|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154085059|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154085060|NCT00918086|Vitamin D|vitamin d|mesh-list
154085061|NCT00918086|Vitamins|vitamins|mesh-ancestor
154085062|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
154085063|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085064|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154085065|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
154085092|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154085093|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154085094|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085095|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085096|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
154085097|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085098|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085099|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154085100|NCT04366518|Protective Agents|protective agents|mesh-ancestor
154085101|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154085102|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
154085103|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
154085104|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085105|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154085106|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
154085107|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154085108|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154085109|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
154085110|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
154085111|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154085112|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
154085113|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085115|NCT04076436|Lactams|lactams|mesh-list
154085116|NCT04076436|beta-Lactams|beta-lactams|mesh-list
154085117|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154085135|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
154085136|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154085137|NCT00741195|Bevacizumab|bevacizumab|mesh-list
154085138|NCT00741195|Docetaxel|docetaxel|mesh-list
154085139|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085140|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085141|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085142|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154085143|NCT00741195|Growth Substances|growth substances|mesh-ancestor
154085144|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085145|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
154085146|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
154085147|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
154085148|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
154085149|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085150|NCT05338632|Naloxone|naloxone|mesh-list
154085151|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154085152|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085153|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
154085154|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085155|NCT00732758|Vitamin D|vitamin d|mesh-list
154085156|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
154085157|NCT00732758|Vitamins|vitamins|mesh-ancestor
154085158|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
154085159|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085160|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154085161|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154085162|NCT00741351|Fentanyl|fentanyl|mesh-list
154085163|NCT00741351|Remifentanil|remifentanil|mesh-list
154085164|NCT00741351|Propofol|propofol|mesh-list
154085165|NCT00741351|Sevoflurane|sevoflurane|mesh-list
154085166|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154085167|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085168|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085169|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154085170|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
154085171|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
154085172|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154085173|NCT00741351|Narcotics|narcotics|mesh-ancestor
154085174|NCT00741351|Analgesics|analgesics|mesh-ancestor
154085175|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
154085176|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085196|NCT05742243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085197|NCT05742243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085199|NCT05742243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154085200|NCT05742243|Immunologic Factors|immunologic factors|mesh-ancestor
154085201|NCT05742243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154085202|NCT04076748|Sufentanil|sufentanil|mesh-list
154085203|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154085204|NCT04076748|Narcotics|narcotics|mesh-ancestor
154085205|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085206|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085207|NCT04076748|Analgesics|analgesics|mesh-ancestor
154085208|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
154085209|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085210|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154085211|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154085212|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
154085213|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
154085214|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
154085215|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154085216|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154085217|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154085218|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085219|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085220|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
154085221|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085222|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085223|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154085224|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085225|NCT00738530|Interferons|interferons|mesh-list
154085226|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
154085227|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
154085228|NCT00738530|Bevacizumab|bevacizumab|mesh-list
154085229|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085230|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085231|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085232|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154085255|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154085256|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154085257|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154085259|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154085260|NCT00921219|Ivermectin|ivermectin|mesh-list
154085261|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154085262|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085263|NCT02567331|Capecitabine|capecitabine|mesh-list
154085264|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154085265|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
154085266|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085267|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085268|NCT00577005|Levetiracetam|levetiracetam|mesh-list
154085269|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
154085270|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
154085271|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
154085272|NCT02581566|Bupivacaine|bupivacaine|mesh-list
154085273|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085274|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
154085275|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085276|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085277|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
154085278|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085279|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154085280|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154085281|NCT02581566|Analgesics|analgesics|mesh-ancestor
154085282|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154085283|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154085284|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154085285|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
154085317|NCT00738374|Rituximab|rituximab|mesh-list
154085318|NCT00738374|Chlorambucil|chlorambucil|mesh-list
154085319|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085320|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085321|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
154085322|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085323|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154085324|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154085348|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085349|NCT02580474|Asunaprevir|asunaprevir|mesh-list
154085350|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
154085351|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085352|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085353|NCT00738062|Droxidopa|droxidopa|mesh-list
154085354|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154085355|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154085356|NCT04156074|Vitamin D|vitamin d|mesh-list
154085357|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
154085358|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
154085359|NCT04156074|Vitamins|vitamins|mesh-list
154085360|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
154085361|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085362|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154085363|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154085364|NCT04062045|Ropivacaine|ropivacaine|mesh-list
154085365|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085366|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
154085367|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085368|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085369|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
154085370|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085371|NCT04064073|Metformin|metformin|mesh-list
154085372|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154085373|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085374|NCT04137354|Vitamins|vitamins|mesh-list
154085402|NCT00737438|Epirubicin|epirubicin|mesh-list
154085403|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085404|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085405|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085406|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154085407|NCT00737438|Growth Substances|growth substances|mesh-ancestor
154085408|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085409|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
154085410|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
154085411|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
154085412|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
154085413|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085414|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154085416|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154085417|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154085418|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085419|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154085420|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154085421|NCT00737048|Acetaminophen|acetaminophen|mesh-list
154085422|NCT00737048|Tramadol|tramadol|mesh-list
154085423|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154085424|NCT00737048|Analgesics|analgesics|mesh-ancestor
154085425|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
154085448|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085449|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085450|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154085451|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085452|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154085453|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
154085454|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154085455|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085456|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154085457|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154085458|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154085459|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154085460|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
154085461|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154085462|NCT00731120|Vortioxetine|vortioxetine|mesh-list
154085463|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
154085464|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154085465|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154085466|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154085467|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085468|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085469|NCT00731120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154085470|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154085471|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636302|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154085472|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085473|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085474|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
154085475|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154085476|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154085477|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154085478|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154085504|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154085505|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154085506|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085507|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085508|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154085509|NCT00696657|Liraglutide|liraglutide|mesh-list
154085510|NCT00696657|Semaglutide|semaglutide|mesh-list
154085511|NCT00696657|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154085512|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154085513|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085514|NCT00696657|Incretins|incretins|mesh-ancestor
154085515|NCT00696657|Hormones|hormones|mesh-ancestor
154085516|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154085517|NCT00726752|Axitinib|axitinib|mesh-list
154085518|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085519|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154085520|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085521|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085522|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
154085523|NCT02594462|Etonogestrel|etonogestrel|mesh-list
154085524|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154085525|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085526|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154085527|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154085528|NCT02664558|Ubenimex|ubenimex|mesh-list
154085529|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154085530|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
154085554|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154085556|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154085557|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154085558|NCT04063683|Paclitaxel|paclitaxel|mesh-list
154085559|NCT04063683|Cisplatin|cisplatin|mesh-list
154085560|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154085561|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085562|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
154085563|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
154085564|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
154085565|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085566|NCT00921531|Thalidomide|thalidomide|mesh-list
154085567|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154085568|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
154085569|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085570|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
154085571|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154085572|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085573|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085574|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154085575|NCT00921531|Growth Substances|growth substances|mesh-ancestor
154085576|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
154085577|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085578|NCT04094415|Semaglutide|semaglutide|mesh-list
154085579|NCT04094415|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154085580|NCT04094415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154085581|NCT04094415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085611|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085612|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154085613|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154085614|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085615|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085617|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154085618|NCT02593370|Lidocaine|lidocaine|mesh-list
154085619|NCT02593370|Epinephrine|epinephrine|mesh-list
153636436|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
154085620|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154085621|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085622|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
154085623|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552086|NCT01576263|Ropivacaine|ropivacaine|mesh-list
154085653|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154085654|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085655|NCT00729560|Flutamide|flutamide|mesh-list
154085656|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
154085657|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
154085658|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154085659|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085660|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154085661|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085662|NCT00736190|Tenofovir|tenofovir|mesh-list
154085663|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
154085664|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085665|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154085666|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154085667|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085680|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085681|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085682|NCT00729326|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154085683|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154085685|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085686|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
154085687|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085688|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085689|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
154085690|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085691|NCT00698451|Bevacizumab|bevacizumab|mesh-list
154085692|NCT00698451|Carboplatin|carboplatin|mesh-list
154085693|NCT00698451|Doxorubicin|doxorubicin|mesh-list
154085694|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154085695|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085696|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085697|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085698|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154085699|NCT00698451|Growth Substances|growth substances|mesh-ancestor
154085700|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085701|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
154085702|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154085703|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154085704|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154085705|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085706|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085707|NCT03980925|Carboplatin|carboplatin|mesh-list
154085709|NCT03980925|Etoposide|etoposide|mesh-list
154085710|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085711|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085712|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154085713|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085714|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154085715|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154085716|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154085717|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085719|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154085720|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154085721|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154085722|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
154085723|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154085724|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
154085726|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
154085727|NCT02565693|Dipyridamole|dipyridamole|mesh-list
154085728|NCT02565693|Apixaban|apixaban|mesh-list
154085729|NCT02565693|Clopidogrel|clopidogrel|mesh-list
154085730|NCT02565693|Calcium|calcium|mesh-list
153552172|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
154085758|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
154085759|NCT00728468|Dacomitinib|dacomitinib|mesh-list
154085760|NCT00728468|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154085761|NCT00728468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154085762|NCT00728468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085763|NCT00728468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085764|NCT04061655|Iron|iron|mesh-list
154085765|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154085766|NCT04061655|Trace Elements|trace elements|mesh-ancestor
154085767|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
154085768|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085769|NCT04061655|Hematinics|hematinics|mesh-ancestor
154085770|NCT04061265|Lidocaine|lidocaine|mesh-list
154085771|NCT04061265|Epinephrine|epinephrine|mesh-list
154085772|NCT04061265|Carticaine|carticaine|mesh-list
154085773|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085774|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
154085775|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085776|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552234|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
154085798|NCT00727844|Linezolid|linezolid|mesh-list
154085799|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154085800|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085801|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154085802|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085803|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085804|NCT00735878|Carboplatin|carboplatin|mesh-list
154085805|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085806|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154085807|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
154085808|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154085809|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154085810|NCT00695955|Diuretics|diuretics|mesh-ancestor
154085811|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
154085812|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085813|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154085814|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085815|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085816|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154085817|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154085818|NCT00693225|Omeprazole|omeprazole|mesh-list
154085819|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
154085820|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154085821|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154085822|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154085823|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085824|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085825|NCT00735644|Vaccines|vaccines|mesh-list
154085826|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
154085827|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085828|NCT02591888|Bupivacaine|bupivacaine|mesh-list
153552285|NCT01577849|Vitamin D|vitamin d|mesh-list
154085858|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
154085859|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085860|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085861|NCT00727532|Sorafenib|sorafenib|mesh-list
154085862|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085863|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154085864|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085865|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085867|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154085868|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
154085869|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085870|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085871|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085873|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154085874|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154085900|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
154085901|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085902|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154085903|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154085904|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085905|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085906|NCT00694707|Risperidone|risperidone|mesh-list
154085907|NCT00694707|Cariprazine|cariprazine|mesh-list
154085908|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154085909|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
154085910|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085911|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085912|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085913|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154085914|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154085915|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085916|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154085917|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154085918|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
154085919|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
154085920|NCT00692913|Vitamin D|vitamin d|mesh-list
154085921|NCT00692913|Alendronate|alendronate|mesh-list
154085922|NCT00692913|Calcium|calcium|mesh-list
154085923|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154085924|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085925|NCT00692913|Vitamins|vitamins|mesh-ancestor
154085926|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
154085927|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154085928|NCT00694551|Poly I-C|poly i-c|mesh-list
154085962|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085963|NCT00776009|Methylphenidate|methylphenidate|mesh-list
154085964|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154085965|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154085966|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085967|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154085968|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154085990|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154085991|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085993|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
154085994|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085995|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154085996|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085997|NCT00720278|Azelastine|azelastine|mesh-list
154085998|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154085999|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
154086000|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086001|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086002|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154086003|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
154086004|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154086005|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086006|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086007|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154086008|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154086009|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154086010|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
154086011|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
154086012|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086014|NCT00746031|Cetrorelix|cetrorelix|mesh-list
154086015|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154086016|NCT00746031|Hormones|hormones|mesh-ancestor
154086017|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086018|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086036|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154086037|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
154086038|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086039|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086040|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086041|NCT00717860|Caspofungin|caspofungin|mesh-list
154086042|NCT00717860|Micafungin|micafungin|mesh-list
154086043|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
154086044|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086045|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086046|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086047|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
154086048|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154086049|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154086050|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
154086051|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086052|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154086053|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154086054|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086055|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086056|NCT02592122|Bromides|bromides|mesh-list
154086057|NCT02592122|Albuterol|albuterol|mesh-list
154086058|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
154086059|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154086060|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
154086061|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086062|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086063|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154086064|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
154086065|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
154086066|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154086067|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154086068|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154086069|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154086070|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
154086071|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086072|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086073|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
154086074|NCT00923637|Pemetrexed|pemetrexed|mesh-list
154086075|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086076|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086077|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552521|NCT01578629|Aspirin|aspirin|mesh-list
154086103|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086105|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086106|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086107|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
154086108|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154086109|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154086110|NCT01090089|Growth Substances|growth substances|mesh-ancestor
154086111|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
154086112|NCT00689793|Iron|iron|mesh-list
154086113|NCT00689793|Trace Elements|trace elements|mesh-ancestor
154086114|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
154086115|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086116|NCT04086290|Androgens|androgens|mesh-list
154086117|NCT04086290|Hormones|hormones|mesh-ancestor
154086118|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086119|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086120|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
154086121|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154086122|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154086123|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
154086124|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
154086125|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086126|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086127|NCT02563353|Teriparatide|teriparatide|mesh-list
153552580|NCT01579019|Ritonavir|ritonavir|mesh-list
154086143|NCT00744549|Protective Agents|protective agents|mesh-ancestor
154086144|NCT00744549|Trace Elements|trace elements|mesh-ancestor
154086145|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086146|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154086147|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154086148|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086149|NCT00746655|Cisplatin|cisplatin|mesh-list
154086150|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086151|NCT00741429|Insulin|insulin|mesh-list
154086152|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154086153|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086154|NCT00741507|Ethanol|ethanol|mesh-list
154086155|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154086156|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086157|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086158|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086159|NCT00688623|Everolimus|everolimus|mesh-list
154086160|NCT00688623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154086161|NCT00688623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154086162|NCT00688623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086163|NCT00688623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086164|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154086165|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
154086166|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086167|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086168|NCT02563821|Clonidine|clonidine|mesh-list
154086169|NCT02563821|Sufentanil|sufentanil|mesh-list
154086170|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
154086171|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154086172|NCT02563821|Narcotics|narcotics|mesh-ancestor
154086173|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086174|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086175|NCT02563821|Analgesics|analgesics|mesh-ancestor
154086176|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
154086177|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086178|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154086179|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154086180|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
154086181|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
154086182|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154086183|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
154086184|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
154086185|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154086186|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154086187|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154086188|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
154086189|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086201|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
154086202|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
154086203|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
154086204|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086205|NCT04085354|Hematinics|hematinics|mesh-ancestor
154086206|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
154086207|NCT00719810|Tigecycline|tigecycline|mesh-list
154086208|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
154086209|NCT00719810|Delafloxacin|delafloxacin|mesh-list
154086210|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154086211|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086212|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154086213|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086214|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086215|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154086216|NCT00723710|Interferons|interferons|mesh-list
154086217|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
154086218|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
154086219|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086220|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
154086221|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086222|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
154086223|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086225|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154086226|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154086227|NCT00688545|Analgesics|analgesics|mesh-ancestor
154086228|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
154086229|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086230|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086231|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086232|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086233|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154086234|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154086235|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086236|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086237|NCT04060407|Nivolumab|nivolumab|mesh-list
154086238|NCT04060407|Ipilimumab|ipilimumab|mesh-list
154086239|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154086240|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086241|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154086242|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086243|NCT00741585|Atenolol|atenolol|mesh-list
154086244|NCT00741585|Amlodipine|amlodipine|mesh-list
154086245|NCT00741585|Valsartan|valsartan|mesh-list
154086246|NCT00741585|Telmisartan|telmisartan|mesh-list
154086247|NCT00741585|Carvedilol|carvedilol|mesh-list
154086248|NCT00741585|Candesartan|candesartan|mesh-list
154086249|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
154086250|NCT00741585|Ramipril|ramipril|mesh-list
154086251|NCT00741585|Olmesartan|olmesartan|mesh-list
154086252|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154086253|NCT00741585|Enalapril|enalapril|mesh-list
154086254|NCT00741585|Enalaprilat|enalaprilat|mesh-list
154086255|NCT00741585|Lisinopril|lisinopril|mesh-list
154086256|NCT00741585|Irbesartan|irbesartan|mesh-list
154086257|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
154086291|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086292|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637004|NCT00000711|Zidovudine|zidovudine|mesh-list
154086293|NCT00746967|Urological Agents|urological agents|mesh-ancestor
154086294|NCT02563041|Heparin|heparin|mesh-list
154086295|NCT02563041|Calcium heparin|calcium heparin|mesh-list
154086296|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
154086297|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086316|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154086317|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086318|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086319|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
154086320|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086321|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154086322|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154086323|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154086324|NCT00745173|Estrogens|estrogens|mesh-ancestor
154086326|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086327|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086328|NCT04060095|Anesthetics|anesthetics|mesh-list
154086329|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086330|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086331|NCT00741897|Fexofenadine|fexofenadine|mesh-list
154086332|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154086333|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154086334|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154086335|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
154086336|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
154086337|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086338|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086339|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086340|NCT00745407|Fenofibrate|fenofibrate|mesh-list
154086341|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154086342|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
154086343|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086344|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154086345|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
154086346|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154086347|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086349|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154086350|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086351|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
154086352|NCT00742287|Procyanidin|procyanidin|mesh-list
154086353|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
154086370|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154086371|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086372|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086373|NCT00690573|Adalimumab|adalimumab|mesh-list
154086374|NCT00690573|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154086375|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086376|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086377|NCT00719264|Interferons|interferons|mesh-list
154086378|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
154086379|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
154086380|NCT00719264|Bevacizumab|bevacizumab|mesh-list
154086381|NCT00719264|Everolimus|everolimus|mesh-list
154086382|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154086383|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086384|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154086385|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154086386|NCT00719264|Growth Substances|growth substances|mesh-ancestor
154086387|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086388|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
154086390|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086391|NCT00719264|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153333086|NCT05601830|Cytarabine|cytarabine|mesh-list
154086392|NCT00719264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154086393|NCT00719264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086394|NCT00719264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086395|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154086396|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
154086397|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154086398|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154086399|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154086400|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086401|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086402|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154086403|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086404|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086406|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154086407|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
154086408|NCT00723554|Iloprost|iloprost|mesh-list
154086409|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154086410|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
154086411|NCT00687219|Ribavirin|ribavirin|mesh-list
154086412|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154086433|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
154086434|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086435|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
154086436|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154086437|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154086438|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154086439|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086440|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086441|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154086442|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154086443|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154086444|NCT02562183|Kallikreins|kallikreins|mesh-list
154086445|NCT02562183|Coagulants|coagulants|mesh-ancestor
154086446|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154086447|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
154086448|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154086449|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086450|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154086451|NCT00723398|Pitavastatin|pitavastatin|mesh-list
154086452|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154086453|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154086454|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154086455|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
154086456|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086457|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086458|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154086459|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154086460|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
154086461|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086462|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086463|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154086464|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154086465|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154086466|NCT00716456|Cetuximab|cetuximab|mesh-list
154086472|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086473|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086474|NCT00684645|Sunitinib|sunitinib|mesh-list
154086475|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086476|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154086477|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154086478|NCT00684645|Growth Substances|growth substances|mesh-ancestor
154086479|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086480|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
154086481|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154086482|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086483|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086484|NCT00752037|Ritonavir|ritonavir|mesh-list
154086486|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
154086487|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154086488|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154086489|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
154086490|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086491|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086492|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154086493|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154086494|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
154086495|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086496|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154086497|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154086498|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154086499|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154086501|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154086502|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086503|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086504|NCT00752115|Paclitaxel|paclitaxel|mesh-list
154086505|NCT00752115|Carboplatin|carboplatin|mesh-list
154086506|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
154086507|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154086508|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086509|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
154086510|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
154086511|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
154086512|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086513|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
154086514|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154086515|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154086516|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086517|NCT00752115|Urological Agents|urological agents|mesh-ancestor
154086518|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
154086519|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
154086520|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154086521|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086522|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154086523|NCT00749385|Naproxen|naproxen|mesh-list
154086524|NCT00749385|Esomeprazole|esomeprazole|mesh-list
154086525|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154086526|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154086527|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154086528|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086529|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086530|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154086531|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154086532|NCT00749385|Analgesics|analgesics|mesh-ancestor
154086533|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
154086534|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086554|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086555|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086556|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086557|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154086558|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154086559|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
154086560|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154086561|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
154086562|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
154086563|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086564|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
154086565|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154086566|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
154086567|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
154086568|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154086569|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154086570|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154086571|NCT00748059|Protective Agents|protective agents|mesh-ancestor
154086572|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154086573|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154086574|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154086576|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154086577|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154086578|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
154086579|NCT00748059|Analgesics|analgesics|mesh-ancestor
154086580|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
154086581|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
154086582|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154086583|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
154086584|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154086585|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154086586|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154086587|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
154086588|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154086589|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154086590|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154086591|NCT00748059|Urological Agents|urological agents|mesh-ancestor
154086592|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154086593|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153637287|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
154086594|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154086595|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086608|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154086609|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154086610|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
154086611|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086612|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086614|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086615|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
154086616|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
154086617|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086618|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086619|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154086620|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
154086622|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086623|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154086624|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086625|NCT00749619|Taurolidine|taurolidine|mesh-list
154086626|NCT00749619|Heparin|heparin|mesh-list
154086627|NCT00749619|Calcium heparin|calcium heparin|mesh-list
154086628|NCT00749619|Citric Acid|citric acid|mesh-list
154086629|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
154086630|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154086631|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
154086632|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154086633|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
154086634|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
154086635|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086636|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154086637|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154086638|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086639|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154086640|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086641|NCT00748371|Aspirin|aspirin|mesh-list
154086642|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154086643|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154086644|NCT00748371|Analgesics|analgesics|mesh-ancestor
154086645|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
154086646|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086647|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086648|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086649|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086650|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154086651|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154086652|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086653|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154086654|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154086655|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086656|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
154086657|NCT00749853|Buserelin|buserelin|mesh-list
154086675|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154086676|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154086677|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154086679|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086680|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086681|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154086682|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154086683|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
154086684|NCT04053621|Thiamine|thiamine|mesh-list
154086685|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
154086686|NCT04053621|Metformin|metformin|mesh-list
154086687|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154086688|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086689|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
154086690|NCT04053621|Vitamins|vitamins|mesh-ancestor
154086691|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
154086692|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
154086693|NCT00684411|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154086694|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154086695|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086696|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086697|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086698|NCT02562651|Doxycycline|doxycycline|mesh-list
154086699|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154086700|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086701|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
154086702|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154086703|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154086704|NCT00748527|Carboplatin|carboplatin|mesh-list
154086705|NCT00748527|Decitabine|decitabine|mesh-list
154086706|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086707|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154086708|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
154086709|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086710|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086711|NCT00686829|Maleic acid|maleic acid|mesh-list
154086712|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086713|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086736|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086737|NCT00752739|Protective Agents|protective agents|mesh-ancestor
154086738|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086740|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
154086741|NCT00755781|Cyclosporine|cyclosporine|mesh-list
154086742|NCT00755781|Cyclosporins|cyclosporins|mesh-list
154086743|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086744|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086745|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154086746|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
154086747|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086748|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
154086749|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086750|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
154086751|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086752|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154086753|NCT00755859|Prednisone|prednisone|mesh-list
154086754|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154086755|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154086756|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
154086757|NCT00755859|Prednisolone|prednisolone|mesh-list
154086758|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
154086759|NCT00755859|Azathioprine|azathioprine|mesh-list
154086760|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154086761|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
154086762|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
154086763|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086764|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154086765|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086766|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154086767|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
154086768|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086769|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086789|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
154086790|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086791|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
154086792|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086793|NCT00571701|Celecoxib|celecoxib|mesh-list
154086794|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154086795|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154086796|NCT00571701|Analgesics|analgesics|mesh-ancestor
154086797|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
154086798|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086799|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086800|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086801|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086802|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154086803|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154086804|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086805|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086806|NCT00686127|Lidocaine|lidocaine|mesh-list
154086807|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
154086808|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
154086809|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086810|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086811|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
154086812|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086813|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154086814|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154086815|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154086816|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086817|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086818|NCT00718718|Methotrexate|methotrexate|mesh-list
154086819|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154086820|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154086821|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
154086822|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154086823|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086824|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153553244|NCT01591889|Tinidazole|tinidazole|mesh-list
154086841|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
154086842|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086843|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
154086844|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086845|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086846|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154086847|NCT00750399|Ranibizumab|ranibizumab|mesh-list
154086848|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154086849|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154086850|NCT00750399|Growth Substances|growth substances|mesh-ancestor
154086851|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086852|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
154086853|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086854|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154086855|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154086856|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154086857|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
154086858|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086859|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154086860|NCT00718640|Dexamethasone|dexamethasone|mesh-list
154086861|NCT00718640|Bortezomib|bortezomib|mesh-list
154086862|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086863|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
154086864|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
154086865|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086866|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086867|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154086868|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
154086869|NCT00718640|Hormones|hormones|mesh-ancestor
154086870|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086871|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154086872|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086873|NCT00753051|Haloperidol|haloperidol|mesh-list
154086874|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
154086875|NCT00753051|Clozapine|clozapine|mesh-list
154086876|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
154086877|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
154086878|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086879|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086880|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154086881|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154086882|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154086883|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086884|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153553298|NCT01592136|Ponatinib|ponatinib|mesh-list
153360465|NCT00844298|Cytarabine|cytarabine|mesh-list
153656307|NCT00054340|Busulfan|busulfan|mesh-list
154086910|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086911|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154086912|NCT00718328|Simvastatin|simvastatin|mesh-list
154086913|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154086914|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154086915|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
154086916|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086917|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154086918|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154086919|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086920|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154086921|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154086922|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154086923|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086924|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086925|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086926|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086927|NCT02590874|Analgesics|analgesics|mesh-ancestor
154086928|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
154086929|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086930|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
154086931|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154086932|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
154086933|NCT00715520|Levodopa|levodopa|mesh-list
154086934|NCT00715520|Carbidopa|carbidopa|mesh-list
154086953|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
154086954|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154086955|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154086956|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
154086957|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
154086958|NCT00756873|Etoricoxib|etoricoxib|mesh-list
154086959|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154086960|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154086961|NCT00756873|Analgesics|analgesics|mesh-ancestor
154086962|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
154086963|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086964|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086965|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086966|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086967|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154086968|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154086969|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086970|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086971|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154086972|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154086973|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086974|NCT00790205|Incretins|incretins|mesh-ancestor
154086975|NCT00790205|Hormones|hormones|mesh-ancestor
154086976|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086977|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154086978|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
154086979|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086980|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086982|NCT04056039|Atorvastatin|atorvastatin|mesh-list
154086983|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154086984|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154086985|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
154086986|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086987|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154086988|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154087006|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
154087007|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087008|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087009|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154087010|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087011|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154087012|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154087013|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154087014|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087015|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087017|NCT00715208|Hormones|hormones|mesh-ancestor
154087018|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087019|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154087020|NCT00919178|Vaccines|vaccines|mesh-list
154087021|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
154087022|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087023|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
154087024|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154087025|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154087026|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154087027|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154087028|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087029|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
154087030|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087031|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087032|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154087033|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087034|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
154087035|NCT02589782|Linezolid|linezolid|mesh-list
154087036|NCT02589782|Bedaquiline|bedaquiline|mesh-list
154087037|NCT02589782|Clofazimine|clofazimine|mesh-list
154087038|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154087039|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087040|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154087041|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154087042|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087043|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087044|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087045|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154087046|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
154087047|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153553466|NCT01593137|Metformin|metformin|mesh-list
154087067|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154087068|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087069|NCT00768053|Etanercept|etanercept|mesh-list
154087070|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154087071|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087072|NCT00768053|Analgesics|analgesics|mesh-ancestor
154087073|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
154087074|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087075|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087076|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087077|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087078|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154087079|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087080|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
154087081|NCT00683475|Prednisone|prednisone|mesh-list
154087082|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
154087083|NCT00683475|Ramucirumab|ramucirumab|mesh-list
154087084|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154087085|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087086|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
154087087|NCT00683475|Hormones|hormones|mesh-ancestor
154087088|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087089|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087090|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154087091|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087092|NCT00683475|Analgesics|analgesics|mesh-ancestor
154087093|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
154087094|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087095|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154087096|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154087097|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087098|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087099|NCT00683475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154087100|NCT00683475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154087101|NCT00683475|Growth Substances|growth substances|mesh-ancestor
154087102|NCT00683475|Growth Inhibitors|growth inhibitors|mesh-ancestor
154087103|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
154087104|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154087105|NCT02589158|Darunavir|darunavir|mesh-list
154087106|NCT02589158|Cobicistat|cobicistat|mesh-list
153553526|NCT01593332|Rituximab|rituximab|mesh-list
154087122|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154087123|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154087124|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087125|NCT00757029|Norepinephrine|norepinephrine|mesh-list
154087126|NCT00757029|Methylphenidate|methylphenidate|mesh-list
154087127|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154087128|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087129|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154087130|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154087131|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154087132|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087133|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
154087134|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087135|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154087136|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154087137|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154087138|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
154087139|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
154087140|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087141|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154087143|NCT04101929|Apatinib|apatinib|mesh-list
154087144|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154087145|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154087146|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087147|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087148|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087149|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087150|NCT00918632|Axitinib|axitinib|mesh-list
154087151|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087152|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087153|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087154|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087155|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
154087156|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154087157|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
154087158|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087159|NCT00751257|Expectorants|expectorants|mesh-ancestor
154087160|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
154087161|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154087162|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
154087163|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087186|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
154087187|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087188|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087189|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087190|NCT02561169|Oseltamivir|oseltamivir|mesh-list
154087191|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
154087192|NCT02561169|Antacids|antacids|mesh-ancestor
154087193|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087194|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154087195|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
154087196|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087197|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087198|NCT00753597|Rituximab|rituximab|mesh-list
154087199|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087200|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087201|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
154087202|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087203|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087204|NCT00757341|Bosutinib|bosutinib|mesh-list
154087205|NCT00757341|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154087206|NCT00757341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087207|NCT00757341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087208|NCT00757341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087209|NCT00757419|Lesogaberan|lesogaberan|mesh-list
154087210|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154087211|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154087212|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
154087213|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
154087214|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087215|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087216|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087242|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087243|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
154256626|NCT03876938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154087244|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087245|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087246|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154087247|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154087248|NCT00753909|Growth Substances|growth substances|mesh-ancestor
154087249|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087250|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
154087251|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
154087252|NCT02560155|Mupirocin|mupirocin|mesh-list
154087253|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154087254|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087255|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
154087256|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154087257|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154087258|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087259|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087260|NCT02559921|Vaccines|vaccines|mesh-list
154087261|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
154087262|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087263|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154087264|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
154087280|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087282|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
154087283|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087284|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154087285|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154087286|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154087287|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087288|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
154087289|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087290|NCT02588534|Etanercept|etanercept|mesh-list
154087291|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154087292|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087293|NCT02588534|Analgesics|analgesics|mesh-ancestor
154087294|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
154087295|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087296|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087297|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087298|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087299|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154087300|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087301|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
154087302|NCT00682929|Dronabinol|dronabinol|mesh-list
154087303|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
154087304|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087305|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154087306|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087307|NCT00682929|Analgesics|analgesics|mesh-ancestor
154087308|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
154087309|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087310|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154087311|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154087312|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087313|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087314|NCT00682929|Hormones|hormones|mesh-ancestor
154087315|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087316|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
154087317|NCT00758199|Prednisolone|prednisolone|mesh-list
154087318|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154087319|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
154087320|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154087321|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
154087322|NCT00758199|Bromfenac|bromfenac|mesh-list
153553741|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154087350|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154087351|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154087352|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087354|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
154087355|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087356|NCT05683808|Apixaban|apixaban|mesh-list
154087357|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154087358|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
154087359|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154087360|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
154087361|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087362|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087363|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
154087365|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
154087366|NCT00680745|Pioglitazone|pioglitazone|mesh-list
154087367|NCT00680745|Glimepiride|glimepiride|mesh-list
154087368|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
154087369|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154087391|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154087392|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087394|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154087395|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
154087396|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087397|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
154087398|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
154087399|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087400|NCT00754689|Metformin|metformin|mesh-list
154087401|NCT00754689|Rimonabant|rimonabant|mesh-list
154087402|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154087403|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087404|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154087405|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154087406|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154087407|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087408|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087409|NCT00754689|Hormones|hormones|mesh-ancestor
154087410|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087411|NCT00767819|Everolimus|everolimus|mesh-list
154087412|NCT00767819|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154087413|NCT00767819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087414|NCT00767819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087415|NCT00767819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087416|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087417|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
154087418|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087419|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087420|NCT00758277|Levetiracetam|levetiracetam|mesh-list
154087457|NCT00682539|Ranibizumab|ranibizumab|mesh-list
154087458|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087459|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087460|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154087461|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154087485|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154087486|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154087487|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
154087488|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
154087489|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154087490|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154087491|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154087492|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087493|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087494|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154087495|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
154087496|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154087497|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154087498|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154087499|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087500|NCT00755157|Bevacizumab|bevacizumab|mesh-list
154087501|NCT00755157|Docetaxel|docetaxel|mesh-list
154087502|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087503|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087504|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154087505|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154087506|NCT00755157|Growth Substances|growth substances|mesh-ancestor
154087507|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087508|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
154087509|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
154087510|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087511|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
154087512|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087530|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087531|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
154087532|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087533|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087534|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154087535|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
154087536|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087537|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087538|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154087539|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
154087540|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087541|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
154087542|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154087543|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154087544|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154087545|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087546|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087547|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154087548|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154087549|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154087550|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
154087551|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087552|NCT04082858|Midazolam|midazolam|mesh-list
154087553|NCT04082858|Ketamine|ketamine|mesh-list
154087554|NCT04082858|Analgesics|analgesics|mesh-ancestor
154087555|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
154087556|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087557|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087558|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154087559|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154087560|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
154087561|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
154087562|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730428|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153730429|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730430|NCT00133640|Vitamins|vitamins|mesh-ancestor
153730431|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
153730432|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153730433|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153730434|NCT01244191|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153730435|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153730436|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730437|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730438|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087574|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
154087576|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
154087577|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
153334294|NCT03823976|Anesthetics|anesthetics|mesh-list
154087578|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087579|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087580|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087581|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154087582|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
154087583|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154087584|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
154087585|NCT05122221|Fludarabine|fludarabine|mesh-list
154087586|NCT05122221|Interleukin-2|interleukin-2|mesh-list
154087587|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087588|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
154087589|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087590|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087591|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154087592|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
154087593|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087594|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087595|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154087596|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087597|NCT05122221|Analgesics|analgesics|mesh-ancestor
154087598|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
154087599|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087600|NCT03802305|Anesthetics|anesthetics|mesh-list
154087601|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154087602|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087603|NCT02587052|Tacrolimus|tacrolimus|mesh-list
154087604|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656937|NCT00059722|Gefitinib|gefitinib|mesh-list
154087605|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
154087606|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087607|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154087608|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087609|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087610|NCT02587130|Ketamine|ketamine|mesh-list
154087611|NCT02587130|Analgesics|analgesics|mesh-ancestor
154087612|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
154087613|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087614|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087615|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154087616|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154087617|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
154087618|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
154087619|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154087632|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
154087633|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
154087634|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087635|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154087636|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154087637|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154087638|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154087639|NCT02559141|Protective Agents|protective agents|mesh-ancestor
154087640|NCT02561013|Monensin|monensin|mesh-list
154087641|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
154087642|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087643|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154087644|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154087645|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
154087646|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
154087647|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
154087648|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087649|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087650|NCT02561013|Ionophores|ionophores|mesh-ancestor
154087651|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154087652|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
154087653|NCT00678795|Nabiximols|nabiximols|mesh-list
154087654|NCT00678795|Analgesics|analgesics|mesh-ancestor
154087655|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
154087656|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087657|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087658|NCT03417687|Xenon|xenon|mesh-list
154087659|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154087660|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
154087661|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
154087662|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154087663|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087664|NCT04767698|Belimumab|belimumab|mesh-list
154087665|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
154087666|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087667|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
154087668|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087669|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154087670|NCT03205137|Amlodipine|amlodipine|mesh-list
154087671|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154087672|NCT03205137|Telmisartan|telmisartan|mesh-list
154087673|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154087674|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154087675|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154087676|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154087677|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154087678|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087679|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154087680|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554106|NCT01596413|Granisetron|granisetron|mesh-list
154087707|NCT04504071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087708|NCT02586194|Peficitinib|peficitinib|mesh-list
154087709|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087710|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087711|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087712|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
154087713|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087714|NCT00761241|Interferons|interferons|mesh-list
154087715|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
154087716|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154087717|NCT00761241|Gemcitabine|gemcitabine|mesh-list
154087718|NCT00761241|Docetaxel|docetaxel|mesh-list
154087719|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
154087720|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154087721|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
154087722|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087723|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087724|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
154087725|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087726|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
154087727|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
154087728|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087739|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087740|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154087741|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154087742|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087743|NCT02981979|Prednisone|prednisone|mesh-list
154087744|NCT02981979|Leflunomide|leflunomide|mesh-list
154087745|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087746|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
154087747|NCT02981979|Hormones|hormones|mesh-ancestor
154087748|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087749|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087750|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154087751|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087752|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087753|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087754|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087755|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
154087756|NCT04049409|Trastuzumab|trastuzumab|mesh-list
154087757|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087758|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087759|NCT00920660|Prednisolone|prednisolone|mesh-list
154087760|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087761|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
154087762|NCT00920660|Hormones|hormones|mesh-ancestor
154087763|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087764|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087765|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154087766|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087767|NCT02583464|Tenofovir|tenofovir|mesh-list
154087768|NCT02583464|Emtricitabine|emtricitabine|mesh-list
154087769|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
154087770|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087771|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154087772|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154087773|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087774|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087775|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154087776|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154087777|NCT00675597|Bevacizumab|bevacizumab|mesh-list
154087778|NCT00675597|Docetaxel|docetaxel|mesh-list
154087779|NCT00675597|Vinorelbine|vinorelbine|mesh-list
154087780|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087781|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087782|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154087783|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154087784|NCT00675597|Growth Substances|growth substances|mesh-ancestor
154087785|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087786|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
154087787|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
154087788|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087789|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
153730442|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087790|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087791|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154087806|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154087807|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154087808|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087809|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
154087810|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154087811|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154087812|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154256627|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154087813|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
154087814|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087815|NCT04079426|Dimercaprol|dimercaprol|mesh-list
154087816|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
154087817|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
154087818|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087819|NCT00675441|Lenalidomide|lenalidomide|mesh-list
154087820|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
154087821|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087822|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154087823|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154087824|NCT00675441|Growth Substances|growth substances|mesh-ancestor
154087825|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
154087826|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087827|NCT02559297|Sevoflurane|sevoflurane|mesh-list
154087829|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154087830|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154087831|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
154087832|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
154087833|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154087834|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087835|NCT02558517|Prednisone|prednisone|mesh-list
154087836|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087837|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
154087838|NCT02558517|Hormones|hormones|mesh-ancestor
154087839|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087840|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087841|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154087842|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087843|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154087844|NCT00674973|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154087845|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087846|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087847|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087848|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087849|NCT00673179|Leucovorin|leucovorin|mesh-list
154087850|NCT00673179|Gemcitabine|gemcitabine|mesh-list
154087851|NCT00673179|Doxorubicin|doxorubicin|mesh-list
154087852|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154087866|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154087867|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
154087868|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154087869|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087870|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
154087871|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154087872|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087873|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
154087874|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087875|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154087877|NCT00673179|Protective Agents|protective agents|mesh-ancestor
154087878|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
154087879|NCT00673179|Vitamins|vitamins|mesh-ancestor
154087880|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
154087881|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154087882|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
154087883|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154087884|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087885|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
154087886|NCT00758433|Capsaicin|capsaicin|mesh-list
154087887|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
154087888|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
154087889|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
154087890|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087891|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087892|NCT00584012|Docetaxel|docetaxel|mesh-list
154087893|NCT00584012|Lovastatin|lovastatin|mesh-list
154087894|NCT00584012|L 647318|l 647318|mesh-list
154087895|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
154087896|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087897|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
154087898|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087899|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
154087900|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087901|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153657311|NCT06196853|Autonomic Agents|autonomic agents|mesh-ancestor
154087902|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154087903|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
154087904|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154087905|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154087906|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087907|NCT05435846|Trametinib|trametinib|mesh-list
154087908|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087909|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087910|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087911|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087912|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154087913|NCT00920270|Colistin|colistin|mesh-list
154087914|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087915|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
153554339|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087942|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087943|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
154087944|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154087945|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154087946|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087947|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087948|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154087949|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154087950|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
154087951|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087952|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
154087953|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
154087954|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154087955|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154087956|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154087957|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
154087958|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154087959|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
154087960|NCT02585570|Phenylephrine|phenylephrine|mesh-list
154087961|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
154087962|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154087963|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
154087964|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
154087965|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087966|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087985|NCT00764907|Ifosfamide|ifosfamide|mesh-list
154087986|NCT00764907|Doxorubicin|doxorubicin|mesh-list
154087987|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154087988|NCT00764907|Methotrexate|methotrexate|mesh-list
154087989|NCT00764907|Etoposide|etoposide|mesh-list
154087990|NCT00764907|Vincristine|vincristine|mesh-list
154087991|NCT00764907|Daunorubicin|daunorubicin|mesh-list
154087992|NCT00764907|Asparaginase|asparaginase|mesh-list
154087993|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
154087994|NCT00764907|Thioguanine|thioguanine|mesh-list
154087995|NCT00764907|Vindesine|vindesine|mesh-list
154087996|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
154087997|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087998|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
154087999|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088000|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154088001|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154088002|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
154088003|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088004|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088005|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154088006|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154088007|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
154088008|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
154088009|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088010|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154088011|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
154088012|NCT00764907|Hormones|hormones|mesh-ancestor
154088013|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154088014|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154088015|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154088016|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154088017|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154088018|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088019|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154088020|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
154088021|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154088022|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154088023|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
154088024|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
154088025|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154088026|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154088059|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
154088060|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154088061|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088062|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088063|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154088064|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154088065|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154088066|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088067|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154088069|NCT00762255|Irinotecan|irinotecan|mesh-list
154088070|NCT00762255|Vorinostat|vorinostat|mesh-list
154088095|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154088096|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088097|NCT05332730|Golimumab|golimumab|mesh-list
154088098|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154088099|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154088100|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154088101|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154088102|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
154088103|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088104|NCT02581826|Silodosin|silodosin|mesh-list
154088105|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154088106|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154088107|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154088108|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
154088109|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088110|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088111|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088112|NCT02581826|Urological Agents|urological agents|mesh-ancestor
154088113|NCT00765921|Ranibizumab|ranibizumab|mesh-list
154088114|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154088115|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154088116|NCT00765921|Growth Substances|growth substances|mesh-ancestor
153554555|NCT01598259|Melatonin|melatonin|mesh-list
154088146|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154088147|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154088148|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
154088149|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088150|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088151|NCT00762567|Protective Agents|protective agents|mesh-ancestor
154088152|NCT04338620|Paclitaxel|paclitaxel|mesh-list
154088153|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154088154|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154088155|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088156|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
154088157|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
154088158|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
154088159|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088160|NCT00923234|Lenalidomide|lenalidomide|mesh-list
154088161|NCT00923234|Azacitidine|azacitidine|mesh-list
154088162|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
154088191|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088192|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154088193|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
154088194|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154088195|NCT00766545|Protective Agents|protective agents|mesh-ancestor
154088196|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154088197|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154088198|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088200|NCT02558205|Hematinics|hematinics|mesh-ancestor
154088201|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
154088202|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154088203|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154088204|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154088205|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088206|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088207|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
154088208|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088209|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088210|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153554640|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154088237|NCT00759837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154088238|NCT00759837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088239|NCT00759837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088240|NCT00767091|Rivastigmine|rivastigmine|mesh-list
154088241|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154088242|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088243|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088244|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
154088245|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088246|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088247|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154088249|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
154088250|NCT00767169|Pamidronate|pamidronate|mesh-list
154088251|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154088252|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088253|NCT00767481|Travoprost|travoprost|mesh-list
154088254|NCT00767481|Brinzolamide|brinzolamide|mesh-list
154088255|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154088256|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154088257|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088258|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088285|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088286|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088287|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154088288|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154088289|NCT00767715|Haloperidol|haloperidol|mesh-list
154088290|NCT00767715|Olanzapine|olanzapine|mesh-list
154088291|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
154088292|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
154088293|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
154088294|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088295|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088296|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154088297|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154088298|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154088299|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088300|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154088301|NCT00767715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154088302|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154088303|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088304|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088305|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088306|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
154088307|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154088308|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
154088309|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154088310|NCT00762957|Metformin|metformin|mesh-list
154088341|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088342|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
154088343|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088344|NCT00760149|Rifampin|rifampin|mesh-list
154088345|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154088346|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
154088347|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154088348|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088349|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
154088350|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154088351|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088352|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088353|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154088375|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154088376|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088377|NCT02557581|Terbutaline|terbutaline|mesh-list
154088378|NCT02557581|Clenbuterol|clenbuterol|mesh-list
154088379|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154088380|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
154088381|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088382|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088383|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154088384|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
154088385|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
154088386|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
154088387|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154088388|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154088389|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154088390|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154088391|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154088392|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088393|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088394|NCT04077944|Trace Elements|trace elements|mesh-list
154088395|NCT04077944|Micronutrients|micronutrients|mesh-list
154088396|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088397|NCT02558751|Vaccines|vaccines|mesh-list
154088398|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154088399|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
154088400|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088401|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
154088402|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
154088403|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154088404|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154088405|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088428|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154088429|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
154088430|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088431|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154088432|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
154088433|NCT00760695|Dronabinol|dronabinol|mesh-list
154088434|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
154088435|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088436|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154088437|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154088438|NCT00760695|Analgesics|analgesics|mesh-ancestor
154088439|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
154088440|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088441|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154088442|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154088443|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088444|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088445|NCT00760695|Hormones|hormones|mesh-ancestor
154088446|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154088447|NCT02582372|Fentanyl|fentanyl|mesh-list
154088448|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
154088449|NCT02582372|Bupivacaine|bupivacaine|mesh-list
154088450|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
154088451|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
154088452|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088453|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088454|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
154088455|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088456|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154088457|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154088458|NCT02582372|Analgesics|analgesics|mesh-ancestor
154088459|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154088480|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088481|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
154088482|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154088483|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154088484|NCT00768963|Ranibizumab|ranibizumab|mesh-list
154088485|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154088486|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154088487|NCT00768963|Growth Substances|growth substances|mesh-ancestor
154088488|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088489|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
154088490|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088491|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
154088492|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154088493|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088494|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154088495|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154088496|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088497|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088498|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088499|NCT00770445|Insulin|insulin|mesh-list
154088500|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154088501|NCT00770445|Metformin|metformin|mesh-list
154256628|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088502|NCT00770445|Pioglitazone|pioglitazone|mesh-list
154088503|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154088504|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088505|NCT04077398|Ropivacaine|ropivacaine|mesh-list
154088506|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
154088507|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
154088508|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088509|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088510|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
154088511|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088512|NCT00763893|Losartan|losartan|mesh-list
154088513|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154088514|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154088515|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154088544|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088545|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154088546|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154088547|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154088548|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
154088549|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154088551|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154088552|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154088553|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088554|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
154088555|NCT04048317|Doxorubicin|doxorubicin|mesh-list
154088556|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154088557|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
154088558|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154088559|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088560|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153554993|NCT04563494|Hormones|hormones|mesh-ancestor
154088585|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088586|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088588|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
154088589|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154088590|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
154088591|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154088592|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088593|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154088594|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154088595|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154088596|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088597|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154088598|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154088599|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154088600|NCT00775125|Ritonavir|ritonavir|mesh-list
154088601|NCT00775125|Darunavir|darunavir|mesh-list
154088602|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
154088603|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154088604|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154088605|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
154088606|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088607|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088608|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154088627|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088628|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154088629|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154088630|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
154088631|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088632|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088634|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154088635|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154088636|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088637|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
154088638|NCT00771303|Coagulants|coagulants|mesh-ancestor
154088639|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154088640|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154088641|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088642|NCT00771459|Ropivacaine|ropivacaine|mesh-list
154088643|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
154088644|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
154088645|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088646|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088648|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088649|NCT00775359|Fenofibrate|fenofibrate|mesh-list
154088650|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154088651|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
154088652|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088653|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154088655|NCT05338502|Ranitidine|ranitidine|mesh-list
154088656|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154088657|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154088658|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154088659|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154088660|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088661|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088662|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154088663|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
154088664|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
154088665|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555086|NCT03462251|Growth Substances|growth substances|mesh-ancestor
154088686|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088687|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088688|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154088689|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154088690|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
154088691|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
154088692|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088693|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
154088694|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154088695|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
154088696|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154088697|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154088698|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
154088699|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154088700|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088701|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154088702|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154088704|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154088705|NCT02556411|Estrogens|estrogens|mesh-ancestor
154088706|NCT02556411|Hormones|hormones|mesh-ancestor
154088707|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154088708|NCT04085276|Paclitaxel|paclitaxel|mesh-list
154088709|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154088710|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154088711|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088712|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
154088713|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
154088714|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
154088715|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088716|NCT00775827|Fenofibrate|fenofibrate|mesh-list
154088717|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154088718|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
154088719|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088720|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154088747|NCT00779493|Curcumin|curcumin|mesh-list
154088748|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088749|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154088750|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154088751|NCT00779493|Analgesics|analgesics|mesh-ancestor
154088752|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
154088753|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088754|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154088755|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154088756|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088757|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088758|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088759|NCT02580344|Ibuprofen|ibuprofen|mesh-list
154088760|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154088761|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154088762|NCT02580344|Analgesics|analgesics|mesh-ancestor
154088764|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088780|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154256629|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256630|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256631|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
154256632|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154256633|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154256634|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
154088781|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
154088783|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088784|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088785|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088786|NCT00667875|Naltrexone|naltrexone|mesh-list
154088787|NCT00667875|Aripiprazole|aripiprazole|mesh-list
154088788|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154088789|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154088790|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088791|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
154088792|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088793|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
154088794|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154088795|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154088796|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154088797|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088798|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
154088799|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
154088800|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088801|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088802|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154088803|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154088804|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
154088805|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154088806|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154088807|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154088808|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154088809|NCT02579642|Ketamine|ketamine|mesh-list
154088810|NCT02579642|Analgesics|analgesics|mesh-ancestor
154088811|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
154088812|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088813|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088814|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154088815|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154088816|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
154088817|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
154088818|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088819|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154088820|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154088821|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088822|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088823|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
154088824|NCT00779805|Ephedrine|ephedrine|mesh-list
154088825|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154088843|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088844|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154088845|NCT00667251|Paclitaxel|paclitaxel|mesh-list
154088846|NCT00667251|Docetaxel|docetaxel|mesh-list
154088848|NCT00667251|Lapatinib|lapatinib|mesh-list
154088849|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154088850|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088851|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154088852|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154088853|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154088854|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088855|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154088856|NCT00667251|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154088857|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154088858|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088859|NCT04063124|Dasatinib|dasatinib|mesh-list
154088860|NCT04063124|Quercetin|quercetin|mesh-list
154088861|NCT04063124|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154256635|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154256636|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153658178|NCT04672330|Tislelizumab|tislelizumab|mesh-list
154088862|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154088863|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088864|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088865|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088866|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
154088867|NCT04063124|Protective Agents|protective agents|mesh-ancestor
154088868|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088869|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
154088870|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154088871|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
154088872|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088873|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640188|NCT03960151|Olanzapine|olanzapine|mesh-list
154088874|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088875|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154088876|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154088877|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088878|NCT00780039|Carboplatin|carboplatin|mesh-list
154088879|NCT00780039|Doxorubicin|doxorubicin|mesh-list
154088880|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154088897|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154088898|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154088899|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
154088900|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088901|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154088902|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154088903|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154088904|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
154088905|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088906|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154088907|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154088908|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088909|NCT00776841|Cholic Acids|cholic acids|mesh-list
154088910|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
154088911|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154088912|NCT02556879|Liver Extracts|liver extracts|mesh-list
154088913|NCT02556879|Antibodies|antibodies|mesh-list
154088914|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
154088915|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088916|NCT02556879|Hematinics|hematinics|mesh-ancestor
154088917|NCT00772863|Docetaxel|docetaxel|mesh-list
154088918|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088919|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
154088920|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
154088921|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
154088922|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088923|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154088924|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154088925|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
154088926|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088927|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088928|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088929|NCT00667719|Amlodipine|amlodipine|mesh-list
154088930|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154088931|NCT00667719|Aliskiren|aliskiren|mesh-list
154088932|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154088933|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154088934|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088935|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088936|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154088937|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555350|NCT03499899|Spartalizumab|spartalizumab|mesh-list
154088958|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154088960|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088961|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088962|NCT02579564|Paclitaxel|paclitaxel|mesh-list
154088963|NCT02579564|Vinorelbine|vinorelbine|mesh-list
154088964|NCT02579564|Gemcitabine|gemcitabine|mesh-list
154088965|NCT02579564|Pemetrexed|pemetrexed|mesh-list
154088966|NCT02579564|Endostar protein|endostar protein|mesh-list
154088967|NCT02579564|Endostatins|endostatins|mesh-list
154088968|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154088969|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088970|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
154088971|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
154088972|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
154088973|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088974|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154088975|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
154088976|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088977|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154088978|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154088979|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154088980|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154088981|NCT02579564|Growth Substances|growth substances|mesh-ancestor
154088982|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088983|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
154088984|NCT00467779|Midazolam|midazolam|mesh-list
154088985|NCT00467779|Levomethorphan|levomethorphan|mesh-list
154088986|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
154088987|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154088988|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154088989|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088990|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088991|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154088992|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154088993|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154088994|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153555410|NCT02188121|Losartan|losartan|mesh-list
154089014|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154089015|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089016|NCT01029223|Metoprolol|metoprolol|mesh-list
154089017|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154089018|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154089019|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
154089020|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
154089021|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089022|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089023|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154089024|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154089025|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154089026|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
154089027|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089028|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089029|NCT02556723|Aflibercept|aflibercept|mesh-list
154089030|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154089031|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154089032|NCT02556723|Growth Substances|growth substances|mesh-ancestor
154089033|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089034|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
154089035|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089036|NCT00777543|Ferulic acid|ferulic acid|mesh-list
154089037|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154089038|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154089039|NCT00777543|Analgesics|analgesics|mesh-ancestor
154089040|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
154089041|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089042|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089043|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154089044|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089045|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
154089046|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154089047|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154089048|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089049|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154089050|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
153555466|NCT01746173|Hormones|hormones|mesh-ancestor
154089072|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089073|NCT05673980|Vitamin D|vitamin d|mesh-list
154089075|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
154089076|NCT05673980|Vitamins|vitamins|mesh-ancestor
154089077|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
154089078|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089079|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153658353|NCT04169828|Leucovorin|leucovorin|mesh-list
154089080|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154089081|NCT02581124|Lapatinib|lapatinib|mesh-list
154089082|NCT02581124|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154089083|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154089084|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089085|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089086|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089087|NCT02580968|Flunarizine|flunarizine|mesh-list
154089088|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
154089089|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154089090|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154089091|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089092|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154089093|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089094|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154089095|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
154089096|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
154089097|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089098|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
154089099|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
154089100|NCT00441103|Interferon-beta|interferon-beta|mesh-list
154089101|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154089102|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
154089103|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089104|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089105|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
154089106|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089120|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154089121|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089122|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154089123|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089124|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
154089125|NCT00433537|Dexamethasone|dexamethasone|mesh-list
154089126|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
154089127|NCT00433537|Rituximab|rituximab|mesh-list
154089128|NCT00433537|Doxorubicin|doxorubicin|mesh-list
154089129|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154089130|NCT00433537|Vincristine|vincristine|mesh-list
154089131|NCT00433537|Bortezomib|bortezomib|mesh-list
154089132|NCT00433537|Lenograstim|lenograstim|mesh-list
154089133|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154089134|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
154089135|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089136|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089137|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154089138|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
154089139|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089140|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089141|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154089142|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154089143|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
154089144|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
154089145|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089146|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089147|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
154089149|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089150|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154089151|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154089152|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154089153|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154089154|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154089155|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089156|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154089157|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154089158|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
154089159|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
154089160|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
154089161|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154089162|NCT00570765|Cathartics|cathartics|mesh-ancestor
154089163|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089164|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154089165|NCT00777699|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154089166|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154089167|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658452|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154089168|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089169|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089170|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154089171|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154089193|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
154089194|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089195|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
154089196|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089197|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
154089198|NCT00773331|Hematinics|hematinics|mesh-ancestor
154089199|NCT00778011|Ondansetron|ondansetron|mesh-list
154089200|NCT00778011|Metoclopramide|metoclopramide|mesh-list
154089201|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
154089202|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
154089203|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089204|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089205|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089206|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
154089207|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
154089208|NCT00778011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154089209|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154089210|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
154089211|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089212|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089213|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154089214|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154089216|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154089217|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
154089218|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154089219|NCT00778089|Protective Agents|protective agents|mesh-ancestor
154089220|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089221|NCT00433381|Bevacizumab|bevacizumab|mesh-list
154089222|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154089223|NCT00433381|Irinotecan|irinotecan|mesh-list
154089224|NCT00433381|Temozolomide|temozolomide|mesh-list
154089225|NCT00433381|Camptothecin|camptothecin|mesh-list
154089226|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
154089227|NCT00433381|Antibodies|antibodies|mesh-list
154089257|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089258|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154089259|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154089260|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154089261|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089262|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154089263|NCT00778245|Cefprozil|cefprozil|mesh-list
154089264|NCT00778245|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154089265|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089266|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089267|NCT00778401|Gabapentin|gabapentin|mesh-list
154089268|NCT00778401|Analgesics|analgesics|mesh-ancestor
154089269|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
154089270|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089271|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089272|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
154089293|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154089294|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154089296|NCT04047849|Amoxicillin|amoxicillin|mesh-list
154089297|NCT04047849|Azithromycin|azithromycin|mesh-list
154089298|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089299|NCT00778557|Cefprozil|cefprozil|mesh-list
154089300|NCT00778557|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154089301|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089302|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089303|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154089304|NCT00778713|Fosinopril|fosinopril|mesh-list
154089305|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154089306|NCT00778713|Diuretics|diuretics|mesh-ancestor
154089307|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
154089308|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089309|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154089310|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154089311|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089312|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154089313|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
154089314|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658541|NCT03477500|Cladribine|cladribine|mesh-list
154089315|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
154089316|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154089317|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154089318|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
154089319|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089320|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154089321|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154089322|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089323|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089324|NCT00774111|Dolutegravir|dolutegravir|mesh-list
154089325|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154089326|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154089354|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154089355|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089356|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089357|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154089358|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154089359|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089360|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089361|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089362|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154089363|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089364|NCT00774501|Anesthetics|anesthetics|mesh-list
154089365|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089366|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089368|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154089369|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154089370|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
154089371|NCT00781755|Varenicline|varenicline|mesh-list
154089395|NCT00774813|Citalopram|citalopram|mesh-list
154089396|NCT00774813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154089397|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154089398|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154089399|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089400|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089401|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
154089402|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089403|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154089404|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
154089405|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154089406|NCT00784797|Oxytocin|oxytocin|mesh-list
154089407|NCT00784797|Mifepristone|mifepristone|mesh-list
154089408|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
154089409|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154089410|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089411|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154089412|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
154089413|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154089414|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154089415|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154089416|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
154089417|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154089418|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154089419|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
154089420|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089421|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
154089422|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154089444|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154089445|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154089446|NCT00662025|Growth Substances|growth substances|mesh-ancestor
154089447|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089448|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
154089449|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154089450|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089452|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154089453|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154089454|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089455|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
154089456|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154089457|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154089458|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154391930|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154391931|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391932|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391950|NCT04685135|Adagrasib|adagrasib|mesh-list
154391951|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391952|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
154391953|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
154391954|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
154391955|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391956|NCT04654988|Prednisone|prednisone|mesh-list
154391957|NCT04654988|Azathioprine|azathioprine|mesh-list
154391958|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154391959|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
154391960|NCT04654988|Hormones|hormones|mesh-ancestor
154391961|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391962|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391963|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391965|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
154391966|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391967|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391968|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154391969|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
153629457|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153629458|NCT02045589|Gemcitabine|gemcitabine|mesh-list
153629459|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153629460|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629461|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
153629462|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629463|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629464|NCT02045602|Gemcitabine|gemcitabine|mesh-list
153629465|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153629466|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391970|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154391971|NCT04623931|Temozolomide|temozolomide|mesh-list
154391972|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154391973|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
154391974|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391975|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391976|NCT04604509|Bupropion|bupropion|mesh-list
154391977|NCT04604509|Nicotine|nicotine|mesh-list
154391978|NCT04604509|Varenicline|varenicline|mesh-list
154391979|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154391980|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
154391981|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391982|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391983|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154391984|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154391985|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
154391986|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391987|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391988|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154391989|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
154391990|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154391991|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154391992|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154391993|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154391994|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
154391995|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154391996|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154391997|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629467|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
153629468|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629469|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629471|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153629472|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153629473|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153629474|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153629475|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629476|NCT02045693|Buprenorphine|buprenorphine|mesh-list
153629477|NCT02045693|Methadone|methadone|mesh-list
153629478|NCT02045693|Naloxone|naloxone|mesh-list
153629479|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153629480|NCT02045693|Narcotics|narcotics|mesh-ancestor
153629481|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629482|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629483|NCT02045693|Analgesics|analgesics|mesh-ancestor
153629484|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
154391998|NCT04595266|Leucovorin|leucovorin|mesh-list
154391999|NCT04595266|Bevacizumab|bevacizumab|mesh-list
154392000|NCT04595266|Fluorouracil|fluorouracil|mesh-list
154392001|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
154392002|NCT04595266|Irinotecan|irinotecan|mesh-list
154392003|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392004|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392005|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154392006|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392007|NCT04595266|Growth Substances|growth substances|mesh-ancestor
154392008|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392009|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392010|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
153640884|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
154392011|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392012|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392013|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392014|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
154392015|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154392016|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154392017|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392018|NCT04595266|Antidotes|antidotes|mesh-ancestor
154392019|NCT04595266|Protective Agents|protective agents|mesh-ancestor
154392020|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
154392021|NCT04595266|Vitamins|vitamins|mesh-ancestor
154392022|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
154392023|NCT04589143|Agomelatine|agomelatine|mesh-list
154392024|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154392025|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154392026|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392027|NCT04565990|Selexipag|selexipag|mesh-list
154392028|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154392029|NCT04563520|Coagulants|coagulants|mesh-list
154392030|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
154392031|NCT04547790|Psyllium|psyllium|mesh-list
154392032|NCT04547790|Cathartics|cathartics|mesh-ancestor
154392033|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154392034|NCT04517851|Elotuzumab|elotuzumab|mesh-list
154392035|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392039|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392040|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392041|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392042|NCT04458610|Rituximab|rituximab|mesh-list
154392043|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154392044|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
154392045|NCT04458610|Antibodies|antibodies|mesh-list
154392046|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
154392047|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154392048|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
154392049|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392050|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392051|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154392052|NCT04458610|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154392053|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392054|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392055|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392056|NCT04449874|Bevacizumab|bevacizumab|mesh-list
154392057|NCT04449874|Cetuximab|cetuximab|mesh-list
154392058|NCT04449874|Atezolizumab|atezolizumab|mesh-list
154392059|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154392060|NCT04449874|Inavolisib|inavolisib|mesh-list
154392061|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392062|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392063|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154392064|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392065|NCT04449874|Growth Substances|growth substances|mesh-ancestor
154392066|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392067|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392068|NCT04449874|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154392084|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392085|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392087|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
154392088|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154392089|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
154392090|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392091|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154392092|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154392093|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392094|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392095|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154392096|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154392105|NCT04394624|Pembrolizumab|pembrolizumab|mesh-list
154392106|NCT04394624|Ramucirumab|ramucirumab|mesh-list
154392107|NCT04394624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392108|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392109|NCT04394624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392110|NCT04394624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392111|NCT04394624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153640970|NCT01465438|Adalimumab|adalimumab|mesh-list
154392112|NCT04394624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392113|NCT04394624|Growth Substances|growth substances|mesh-ancestor
154392114|NCT04394624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392115|NCT04394624|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392116|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
154392117|NCT04387084|Nivolumab|nivolumab|mesh-list
154392118|NCT04387084|Atezolizumab|atezolizumab|mesh-list
154392119|NCT04387084|Durvalumab|durvalumab|mesh-list
154392120|NCT04387084|Avelumab|avelumab|mesh-list
154392121|NCT04387084|Cemiplimab|cemiplimab|mesh-list
154392122|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
154392123|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154392124|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
153629485|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629486|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154392125|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392126|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392127|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392128|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392129|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
154392130|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392151|NCT04300114|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154392152|NCT04300114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392153|NCT04300114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392154|NCT04300114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392155|NCT04296305|Hydromorphone|hydromorphone|mesh-list
154392156|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154392157|NCT04296305|Narcotics|narcotics|mesh-ancestor
154392158|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154392159|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392160|NCT04296305|Analgesics|analgesics|mesh-ancestor
154392161|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
154392162|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392163|NCT04288089|Palbociclib|palbociclib|mesh-list
153753906|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
153629487|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
153629488|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
153629489|NCT02045797|Gepotidacin|gepotidacin|mesh-list
153629505|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153629506|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153629507|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629508|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629509|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153629510|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
153629511|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392165|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392166|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392167|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392168|NCT04269902|Venetoclax|venetoclax|mesh-list
154392169|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
154392170|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392171|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392172|NCT04267848|Paclitaxel|paclitaxel|mesh-list
154392173|NCT04267848|Cisplatin|cisplatin|mesh-list
154392174|NCT04267848|Carboplatin|carboplatin|mesh-list
154392175|NCT04267848|Gemcitabine|gemcitabine|mesh-list
154392176|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
154392177|NCT04267848|Pemetrexed|pemetrexed|mesh-list
154392178|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154392179|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154392180|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392181|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
154392182|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
154392183|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
154392184|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392185|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392186|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
154392187|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392188|NCT04267848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392189|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392190|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154392191|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154392193|NCT04240002|Fludarabine|fludarabine|mesh-list
154392194|NCT04240002|Lenograstim|lenograstim|mesh-list
154392195|NCT04240002|Gilteritinib|gilteritinib|mesh-list
154392196|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392197|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392198|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
153629512|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629513|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153629514|NCT02045849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629515|NCT02045849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629516|NCT02045914|Calcium|calcium|mesh-list
153629517|NCT02045914|Ionophores|ionophores|mesh-list
153629518|NCT02045914|Ionomycin|ionomycin|mesh-list
153629520|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154392199|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392200|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392201|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
154392202|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392203|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
154392204|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392205|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154392206|NCT04240002|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154392207|NCT04240002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392208|NCT04240002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392209|NCT04223778|Islatravir|islatravir|mesh-list
154392210|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
154392211|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392212|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392213|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392214|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154392215|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154392216|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154392217|NCT04214262|Deoxyglucose|deoxyglucose|mesh-list
154392218|NCT04214262|Atezolizumab|atezolizumab|mesh-list
154392219|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154392220|NCT04214262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154392221|NCT04214262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392222|NCT04214262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392223|NCT04214262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392224|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392225|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
154392226|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392227|NCT04214262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154392228|NCT04214262|Antimetabolites|antimetabolites|mesh-ancestor
154392229|NCT04214262|Antiviral Agents|antiviral agents|mesh-ancestor
154392230|NCT04214262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392231|NCT04212013|Rituximab|rituximab|mesh-list
154392232|NCT04212013|Ibrutinib|ibrutinib|mesh-list
154392233|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392234|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392236|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392237|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154392238|NCT04212013|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154392239|NCT04212013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392240|NCT04212013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392241|NCT04212013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392242|NCT04207190|Talazoparib|talazoparib|mesh-list
154392243|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
154392244|NCT04207190|Calicheamicins|calicheamicins|mesh-list
154392245|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154392246|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392247|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392248|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392249|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392250|NCT04207190|Immunotoxins|immunotoxins|mesh-ancestor
154392251|NCT04207190|Immunoconjugates|immunoconjugates|mesh-ancestor
154392252|NCT04207190|Immunologic Factors|immunologic factors|mesh-ancestor
154392253|NCT04207190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392254|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154392263|NCT04204941|Doxorubicin|doxorubicin|mesh-list
154392264|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154138430|NCT00874328|Irinotecan|irinotecan|mesh-list
154392265|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154392266|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392267|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154392268|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154392269|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392270|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392271|NCT04200534|Nicotine|nicotine|mesh-list
154392273|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
154392280|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392282|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392283|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392284|NCT04057131|Icatibant|icatibant|mesh-list
154392285|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154392286|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154392287|NCT04057131|Analgesics|analgesics|mesh-ancestor
154392288|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
154392289|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392290|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392291|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392292|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154392293|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154392294|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154392295|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392296|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154392297|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392298|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
154392299|NCT04052880|Dexamethasone|dexamethasone|mesh-list
154392300|NCT04052880|Lenalidomide|lenalidomide|mesh-list
154392301|NCT04052880|Bortezomib|bortezomib|mesh-list
154392302|NCT04052880|Daratumumab|daratumumab|mesh-list
154392303|NCT04052880|Ixazomib|ixazomib|mesh-list
154392304|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392305|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
154392306|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
154392307|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392308|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392309|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154392310|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
154392311|NCT04052880|Hormones|hormones|mesh-ancestor
154182193|NCT05868525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153629521|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629522|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153629523|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629524|NCT02045940|GSK2881078|gsk2881078|mesh-list
153629525|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
153629526|NCT02045940|Hormones|hormones|mesh-ancestor
153629527|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629528|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392312|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392313|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392314|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392315|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
154392316|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154392317|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392318|NCT04052880|Growth Substances|growth substances|mesh-ancestor
154392319|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392320|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
154392321|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392322|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392324|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154392325|NCT04044690|Antibodies|antibodies|mesh-list
154392326|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
154392327|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
154392328|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392329|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154392330|NCT03999411|Nicotine|nicotine|mesh-list
154392331|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
154392332|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392333|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154392334|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
154138500|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
154392335|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392336|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392337|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153629529|NCT02045953|Albuterol|albuterol|mesh-list
153629530|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153629531|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
153629532|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629533|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629534|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153629535|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
153629536|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
153629537|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629538|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153629539|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153629540|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153629541|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
153629542|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629543|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629544|NCT02045992|Caffeine|caffeine|mesh-list
153629545|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153629546|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629547|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153629560|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392338|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154392339|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
154392340|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154392341|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392342|NCT03983824|Cytarabine|cytarabine|mesh-list
154392343|NCT03983824|Etoposide|etoposide|mesh-list
154392344|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
154392345|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
154392346|NCT03983824|Peposertib|peposertib|mesh-list
154392347|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154392348|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392349|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154392350|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154392351|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392352|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392353|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392354|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
154392355|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
154392356|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392357|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392358|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
154392359|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392360|NCT03983824|Analgesics|analgesics|mesh-ancestor
154392361|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
154392362|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392363|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392364|NCT03937830|Bevacizumab|bevacizumab|mesh-list
154392365|NCT03937830|Durvalumab|durvalumab|mesh-list
154392366|NCT03937830|Doxorubicin|doxorubicin|mesh-list
154392367|NCT03937830|Tremelimumab|tremelimumab|mesh-list
154392368|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392369|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392370|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154392371|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392372|NCT03937830|Growth Substances|growth substances|mesh-ancestor
154392373|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392374|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
153629561|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
154392376|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154392377|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154392379|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392380|NCT03904693|Tadalafil|tadalafil|mesh-list
154392381|NCT03904693|Macitentan|macitentan|mesh-list
154392382|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
154392383|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154392384|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154392385|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392386|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392387|NCT03904693|Urological Agents|urological agents|mesh-ancestor
154392388|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154392389|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154392390|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154392391|NCT03856632|Liraglutide|liraglutide|mesh-list
154392432|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392440|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154392441|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392442|NCT03748641|Prednisone|prednisone|mesh-list
154392443|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
154392444|NCT03748641|Niraparib|niraparib|mesh-list
154392445|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392446|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
154392447|NCT03748641|Hormones|hormones|mesh-ancestor
154392448|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392449|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392450|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392451|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392452|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154392453|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392454|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392455|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
154392456|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154392486|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138647|NCT03441893|Analgesics|analgesics|mesh-ancestor
154392487|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392488|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154392489|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154392490|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392491|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392492|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392493|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
154392494|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
154392495|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392496|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392497|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
154392498|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392499|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154392500|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392501|NCT03568994|Immunotoxins|immunotoxins|mesh-ancestor
154392502|NCT03568994|Immunoconjugates|immunoconjugates|mesh-ancestor
154392503|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
154392504|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154392505|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154392506|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
154392507|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154392508|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154392509|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392536|NCT03462719|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154392537|NCT03462719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392538|NCT03462719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392539|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392540|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392541|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154392542|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
154392543|NCT03431350|Prednisone|prednisone|mesh-list
154392544|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
154392545|NCT03431350|Niraparib|niraparib|mesh-list
154392546|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392547|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
154392548|NCT03431350|Hormones|hormones|mesh-ancestor
154392549|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392550|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392552|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392591|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
154392592|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154392593|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392594|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392595|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
154392596|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
154392597|NCT03212469|Durvalumab|durvalumab|mesh-list
154392598|NCT03212469|Tremelimumab|tremelimumab|mesh-list
154392599|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392600|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392601|NCT03201965|Dexamethasone|dexamethasone|mesh-list
154392602|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
154392603|NCT03201965|Bortezomib|bortezomib|mesh-list
154392604|NCT03201965|Daratumumab|daratumumab|mesh-list
154392605|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392606|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
154392607|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392608|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154392609|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154392610|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
154392611|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392612|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392613|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154392614|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392615|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
154392616|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
154392617|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392618|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154392619|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
154392620|NCT03201965|Hormones|hormones|mesh-ancestor
154392621|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392623|NCT03006172|Metformin|metformin|mesh-list
154392635|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154138796|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
154392636|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392637|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392638|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154392639|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
154392640|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392641|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392642|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154392643|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392644|NCT03006172|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154392645|NCT02997228|Leucovorin|leucovorin|mesh-list
154392646|NCT02997228|Bevacizumab|bevacizumab|mesh-list
154392647|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154392648|NCT02997228|Atezolizumab|atezolizumab|mesh-list
154392649|NCT02997228|Fluorouracil|fluorouracil|mesh-list
154392650|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
154392651|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
154392652|NCT02997228|Antibodies|antibodies|mesh-list
154392653|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
154392654|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154392655|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
154392656|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392657|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154392658|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392659|NCT02997228|Growth Substances|growth substances|mesh-ancestor
154392660|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392661|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392662|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
154392663|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
154392664|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392665|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392666|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392675|NCT02951767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392676|NCT02951767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392677|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392678|NCT02941783|Factor VIII|factor viii|mesh-list
154392679|NCT02941783|Coagulants|coagulants|mesh-ancestor
154392680|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
154392681|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392682|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392683|NCT02844075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392684|NCT02844075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392685|NCT02752035|Azacitidine|azacitidine|mesh-list
154392686|NCT02752035|Gilteritinib|gilteritinib|mesh-list
154392687|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392688|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
154392689|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392690|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392691|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392692|NCT02752035|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154392693|NCT02752035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392694|NCT02720068|Leucovorin|leucovorin|mesh-list
154392695|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
154392696|NCT02720068|Fluorouracil|fluorouracil|mesh-list
154392697|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
154392698|NCT02720068|Irinotecan|irinotecan|mesh-list
154392699|NCT02720068|Lenvatinib|lenvatinib|mesh-list
154392700|NCT02720068|Calcium|calcium|mesh-list
154392701|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
154392702|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392703|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392704|NCT02720068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392705|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392706|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154392707|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392708|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
154392715|NCT02720068|Antidotes|antidotes|mesh-ancestor
154392716|NCT02720068|Protective Agents|protective agents|mesh-ancestor
154392717|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
154392718|NCT02720068|Vitamins|vitamins|mesh-ancestor
154392719|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
154392720|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392721|NCT02707042|Amoxicillin|amoxicillin|mesh-list
154392722|NCT02707042|Azithromycin|azithromycin|mesh-list
154392723|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154392724|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392725|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
154392726|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392727|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392728|NCT02706353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392729|NCT02706353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392730|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
154392731|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
154392732|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154392733|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154392734|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392735|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392769|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154392770|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154392771|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
154392772|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154392773|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154392774|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154392775|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392776|NCT02257736|Prednisone|prednisone|mesh-list
154392777|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
154392778|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392779|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
154392780|NCT02257736|Hormones|hormones|mesh-ancestor
154392781|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392782|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392783|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392784|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392785|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154392786|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392787|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392788|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
154392789|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154392791|NCT02252172|Lenalidomide|lenalidomide|mesh-list
154392792|NCT02252172|Daratumumab|daratumumab|mesh-list
154392793|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154392794|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392795|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
154392796|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
154392797|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154392798|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392799|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154392800|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
154392801|NCT02252172|Hormones|hormones|mesh-ancestor
154392802|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392803|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392804|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392805|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
154392806|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154392807|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392808|NCT02252172|Growth Substances|growth substances|mesh-ancestor
154392809|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392810|NCT02194738|Paclitaxel|paclitaxel|mesh-list
154392811|NCT02194738|Cisplatin|cisplatin|mesh-list
154392812|NCT02194738|Carboplatin|carboplatin|mesh-list
154392813|NCT02194738|Gemcitabine|gemcitabine|mesh-list
154392814|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
154392815|NCT02194738|Nivolumab|nivolumab|mesh-list
154392816|NCT02194738|Pemetrexed|pemetrexed|mesh-list
154392817|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154392818|NCT02194738|Crizotinib|crizotinib|mesh-list
154392819|NCT02194738|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154392820|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154392821|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392822|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154392823|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154392824|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154392825|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392826|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154392827|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
154392828|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392829|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392830|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392831|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154392832|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154392856|NCT02076009|Growth Substances|growth substances|mesh-ancestor
154392857|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392858|NCT01792687|Prednisone|prednisone|mesh-list
154392859|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
154139033|NCT00201643|Hormones|hormones|mesh-ancestor
154392860|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392861|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
154392862|NCT01792687|Hormones|hormones|mesh-ancestor
154392863|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392864|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392865|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392866|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392867|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154392868|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392869|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392870|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
154392871|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154392872|NCT01776840|Rituximab|rituximab|mesh-list
154392873|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154392874|NCT01776840|Ibrutinib|ibrutinib|mesh-list
154392875|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392876|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392877|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
154392878|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392879|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154392880|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154392881|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
154392882|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392883|NCT01776840|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154392884|NCT01776840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154392885|NCT01776840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392886|NCT01615029|Dexamethasone|dexamethasone|mesh-list
154392887|NCT01615029|Lenalidomide|lenalidomide|mesh-list
154392888|NCT01615029|Daratumumab|daratumumab|mesh-list
154392891|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
154392895|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154392896|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
154392897|NCT01615029|Hormones|hormones|mesh-ancestor
154392898|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392899|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392900|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392901|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
154392902|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154392903|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154392904|NCT01615029|Growth Substances|growth substances|mesh-ancestor
154392905|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
154392906|NCT01314118|Prednisone|prednisone|mesh-list
154392907|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
154392908|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154392909|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
154392910|NCT01314118|Hormones|hormones|mesh-ancestor
154392911|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154392912|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392913|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154392914|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392915|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153641979|NCT00084604|Bevacizumab|bevacizumab|mesh-list
154392916|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154392917|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392918|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
154392919|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154392920|NCT01032083|Citalopram|citalopram|mesh-list
154392921|NCT01032083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154392922|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154392925|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154392937|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154392938|NCT00903110|Mecasermin|mecasermin|mesh-list
154392939|NCT00903110|Growth Substances|growth substances|mesh-ancestor
154392940|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154392941|NCT00781612|Paclitaxel|paclitaxel|mesh-list
154392942|NCT00781612|Maytansine|maytansine|mesh-list
154392943|NCT00781612|Docetaxel|docetaxel|mesh-list
154392944|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154392945|NCT00781612|Trastuzumab|trastuzumab|mesh-list
154392946|NCT00781612|Atezolizumab|atezolizumab|mesh-list
154392947|NCT00781612|Pertuzumab|pertuzumab|mesh-list
154392948|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154392949|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154392950|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
154392951|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
154392952|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
154392953|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154392954|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154392955|NCT00781612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154392956|NCT00781612|Immunotoxins|immunotoxins|mesh-ancestor
154392957|NCT00781612|Immunoconjugates|immunoconjugates|mesh-ancestor
154392958|NCT00781612|Immunologic Factors|immunologic factors|mesh-ancestor
154392959|NCT00781612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139316|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140001|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140077|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140224|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140445|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
154140594|NCT06088433|Purinergic Agents|purinergic agents|mesh-ancestor
154141055|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
154141363|NCT03897673|Iron|iron|mesh-list
154141495|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
154142027|NCT00582491|Modafinil|modafinil|mesh-list
154142167|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
154146219|NCT02538224|Analgesics|analgesics|mesh-ancestor
154146597|NCT02538926|Hormones|hormones|mesh-ancestor
154027435|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
154147036|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
154147337|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
154147489|NCT06137924|Anesthetics|anesthetics|mesh-list
154147788|NCT06078241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154148013|NCT05868226|Trastuzumab|trastuzumab|mesh-list
154148093|NCT05807932|Venetoclax|venetoclax|mesh-list
154148161|NCT05719714|Dapagliflozin|dapagliflozin|mesh-list
154148398|NCT05527444|Adalimumab|adalimumab|mesh-list
154148762|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154148911|NCT04715230|Lorazepam|lorazepam|mesh-list
154149143|NCT04248452|Calcium|calcium|mesh-list
154027436|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154149895|NCT02733042|Rituximab|rituximab|mesh-list
154027437|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027438|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154027439|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027440|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027441|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154027442|NCT02668770|Ipilimumab|ipilimumab|mesh-list
154027443|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027444|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027445|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154027446|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027447|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
154027448|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027449|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027450|NCT02399085|Lenalidomide|lenalidomide|mesh-list
154027451|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
154027452|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027453|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154027454|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154027455|NCT02399085|Growth Substances|growth substances|mesh-ancestor
153629562|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153629563|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906276|NCT00904033|Vitamins|vitamins|mesh-ancestor
153629566|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153629567|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
153629568|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027456|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
154027457|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027458|NCT00476515|Rituximab|rituximab|mesh-list
154027459|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027460|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027461|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
154027462|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027463|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027464|NCT00261547|Rituximab|rituximab|mesh-list
154027465|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027466|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027467|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
154027468|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027469|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027470|NCT02650596|Liraglutide|liraglutide|mesh-list
154027471|NCT02650596|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154152345|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
154152794|NCT00927563|Tolcapone|tolcapone|mesh-list
154153542|NCT00949598|Tamoxifen|tamoxifen|mesh-list
154027472|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154154139|NCT02976909|Paclitaxel|paclitaxel|mesh-list
154154602|NCT00975078|Prednisone|prednisone|mesh-list
154027473|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155183|NCT00987168|Octreotide|octreotide|mesh-list
154155405|NCT00989274|Vaccines|vaccines|mesh-list
154155628|NCT05874245|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154155852|NCT04865731|Esomeprazole|esomeprazole|mesh-list
154156004|NCT03743636|Niacin|niacin|mesh-list
154156077|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
154156982|NCT06075264|Artesunate|artesunate|mesh-list
154157509|NCT05647343|Ciclopirox|ciclopirox|mesh-list
153629569|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629570|NCT02046304|Gemcitabine|gemcitabine|mesh-list
153629571|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629572|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
153629573|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629574|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629575|NCT02046421|Carboplatin|carboplatin|mesh-list
153629576|NCT02046421|Gemcitabine|gemcitabine|mesh-list
153629577|NCT02046421|Mifepristone|mifepristone|mesh-list
153629578|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629579|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629580|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
153629581|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629582|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153629583|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
153629584|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629585|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629586|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153629587|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154158040|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
154158194|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
154158290|NCT04744883|Naloxone|naloxone|mesh-list
154158353|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
154158564|NCT04384367|Naproxen|naproxen|mesh-list
154159014|NCT03344965|Olaparib|olaparib|mesh-list
154159922|NCT00485589|Methotrexate|methotrexate|mesh-list
154160213|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
154160437|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
154160732|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161423|NCT03765450|Infliximab|infliximab|mesh-list
154161933|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154162008|NCT03963193|Cisplatin|cisplatin|mesh-list
154162164|NCT00966836|Everolimus|everolimus|mesh-list
154162306|NCT00979316|BMS 708163|bms 708163|mesh-list
154162450|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
154162610|NCT00748163|Paclitaxel|paclitaxel|mesh-list
154162910|NCT00987116|Prednisone|prednisone|mesh-list
154163358|NCT01035190|Hormones|hormones|mesh-ancestor
154163507|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
154163656|NCT00768209|Topiramate|topiramate|mesh-list
154163953|NCT02557373|Vitamin A|vitamin a|mesh-list
154164411|NCT00772655|Rituximab|rituximab|mesh-list
154164507|NCT03809611|Choline|choline|mesh-list
154164630|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154164858|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154165325|NCT00785603|Tramadol|tramadol|mesh-list
154165608|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
154165753|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
154166353|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154166427|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
154166502|NCT00661193|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154166655|NCT00802139|Iron|iron|mesh-list
154166726|NCT03953287|Acetaminophen|acetaminophen|mesh-list
154166882|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154167413|NCT00817895|Cisplatin|cisplatin|mesh-list
154167567|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
154172170|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154172171|NCT00640835|Naloxone|naloxone|mesh-list
154172172|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154172173|NCT00640835|Narcotics|narcotics|mesh-ancestor
154172181|NCT03839355|Apixaban|apixaban|mesh-list
154172182|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
154172183|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154172184|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
154172185|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154172186|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
154172187|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172188|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172189|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154172190|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
154172191|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154172192|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154172193|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154172194|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172195|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172196|NCT02551133|Dexamethasone|dexamethasone|mesh-list
154172197|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154172198|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
154172199|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
154172200|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172201|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172202|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154172203|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
154172204|NCT02551133|Hormones|hormones|mesh-ancestor
154172205|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154172206|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154172207|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172208|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
154172209|NCT00452439|Vitamin D|vitamin d|mesh-list
154172210|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
154172211|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
154172212|NCT00452439|Calcium|calcium|mesh-list
154172213|NCT00452439|Vitamins|vitamins|mesh-ancestor
154172222|NCT01023087|Colistin|colistin|mesh-list
154172223|NCT01023087|Polymyxins|polymyxins|mesh-list
154172224|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154172225|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172226|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
154172227|NCT00381940|Bortezomib|bortezomib|mesh-list
154172228|NCT00381940|Vinorelbine|vinorelbine|mesh-list
154172229|NCT00381940|Ifosfamide|ifosfamide|mesh-list
154172230|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172231|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154172232|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
154172233|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
154172234|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
154172235|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172236|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172237|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
154172238|NCT00818675|Sirolimus|sirolimus|mesh-list
154172239|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154172240|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172241|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154172242|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172243|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
154172244|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172245|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
154172246|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172247|NCT00364156|Nicotine|nicotine|mesh-list
154172248|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154172249|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
154172250|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172251|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172252|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154172253|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154172254|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
154172255|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172257|NCT00452361|Cyclosporine|cyclosporine|mesh-list
154172266|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172268|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172269|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
154172270|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172271|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154172272|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154172273|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172274|NCT03334318|Allopurinol|allopurinol|mesh-list
154172275|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
154172276|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172277|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172278|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
154172279|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172280|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154172281|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
154172282|NCT03334318|Protective Agents|protective agents|mesh-ancestor
154172283|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172284|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
154172285|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154172286|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154172287|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172288|NCT01049932|Rilpivirine|rilpivirine|mesh-list
154172289|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154172290|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154172291|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172292|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172293|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
154172294|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172295|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154172296|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154172297|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
154172298|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629588|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153629589|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
153629590|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153629591|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153629592|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
153629593|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629594|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
153629595|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154172299|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
154172300|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154172301|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154172302|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154172303|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172304|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172305|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
154172306|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172307|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172308|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154172309|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172311|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154172312|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154172313|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172314|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172315|NCT01047748|Protective Agents|protective agents|mesh-ancestor
154172316|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172317|NCT00568451|Paclitaxel|paclitaxel|mesh-list
154172318|NCT00568451|Carboplatin|carboplatin|mesh-list
154172319|NCT00568451|Temozolomide|temozolomide|mesh-list
154172320|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154167942|NCT01018251|Alovudine|alovudine|mesh-list
154172321|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172322|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
154172323|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
154172324|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
154172325|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172326|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172327|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
154172343|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172344|NCT00819377|Protective Agents|protective agents|mesh-ancestor
154172345|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172346|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
154172347|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
154172348|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154172349|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172350|NCT01023243|Aspirin|aspirin|mesh-list
154172351|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154172352|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154172353|NCT01023243|Analgesics|analgesics|mesh-ancestor
154172354|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
154172355|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172356|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172357|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154172358|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172359|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154172360|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154172361|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172362|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154172363|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154172364|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172365|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
154172366|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
154172367|NCT00469209|Bortezomib|bortezomib|mesh-list
154172368|NCT00469209|Melphalan|melphalan|mesh-list
154172369|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
154172370|NCT00469209|Vitamins|vitamins|mesh-ancestor
154172371|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
154172389|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172391|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
154172392|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172393|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
154172394|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154172395|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
154172396|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154172397|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154172398|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172399|NCT00635219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154172400|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
154172401|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154172402|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154172403|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154172404|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154172405|NCT01026129|Lidocaine|lidocaine|mesh-list
154172406|NCT01026129|Remifentanil|remifentanil|mesh-list
154172407|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
154172408|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
154172409|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172410|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172411|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
154172412|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172413|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154172414|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154172415|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154172416|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172435|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
154172436|NCT01026363|Calcitriol|calcitriol|mesh-list
154172437|NCT01026363|Vitamins|vitamins|mesh-list
154172438|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
154172439|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172440|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154172441|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154172442|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154172443|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172444|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172445|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154172446|NCT01023399|Artesunate|artesunate|mesh-list
154172447|NCT01023399|Amodiaquine|amodiaquine|mesh-list
154172448|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
154172449|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154172450|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154172451|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172452|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172453|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
154172454|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
154172455|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154172456|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
154172457|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
154172458|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154172459|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154172463|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
154172484|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172486|NCT01026597|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154172487|NCT01026597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154172488|NCT01026597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154172489|NCT01026597|Antimetabolites|antimetabolites|mesh-ancestor
154172490|NCT01026597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172491|NCT01026597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154172492|NCT01026597|Protease Inhibitors|protease inhibitors|mesh-ancestor
154172493|NCT01026597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172494|NCT01026597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154172495|NCT00450801|Leucovorin|leucovorin|mesh-list
154172496|NCT00450801|Cytarabine|cytarabine|mesh-list
154172497|NCT00450801|Thalidomide|thalidomide|mesh-list
154172498|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
154172499|NCT00450801|Ifosfamide|ifosfamide|mesh-list
154172500|NCT00450801|Rituximab|rituximab|mesh-list
154172501|NCT00450801|Doxorubicin|doxorubicin|mesh-list
154172502|NCT00450801|Methotrexate|methotrexate|mesh-list
154172503|NCT00450801|Etoposide|etoposide|mesh-list
154172504|NCT00450801|Vincristine|vincristine|mesh-list
154172505|NCT00450801|Granisetron|granisetron|mesh-list
154172506|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172507|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
154172508|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172509|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172510|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172511|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
154172512|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172513|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172519|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172531|NCT00450801|Antidotes|antidotes|mesh-ancestor
154172532|NCT00450801|Protective Agents|protective agents|mesh-ancestor
154172533|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
154172534|NCT00450801|Vitamins|vitamins|mesh-ancestor
154172535|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
154172536|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
154172537|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
154172538|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
154172539|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
154172540|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
154172541|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172542|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154172543|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
154172544|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154172545|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172546|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172547|NCT00450801|Growth Substances|growth substances|mesh-ancestor
154172548|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172549|NCT00450801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154172550|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154172551|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
154172552|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172553|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
154172554|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172555|NCT00458211|Ziprasidone|ziprasidone|mesh-list
154172556|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154172557|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
154172558|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172559|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172560|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172561|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154172562|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154172563|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172564|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154172565|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153629596|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153629597|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
153629598|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153629599|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153629600|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153629601|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153629602|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
154172566|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
154172567|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154172568|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154172569|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172570|NCT00457821|Ivacaftor|ivacaftor|mesh-list
154172571|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154172572|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172573|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172574|NCT00633893|Apixaban|apixaban|mesh-list
154172575|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154172576|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
154172577|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154172578|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
154172579|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172580|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172581|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
154172582|NCT02550665|Donepezil|donepezil|mesh-list
154172583|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154172584|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172585|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172586|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
154172587|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172588|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172589|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
154172590|NCT00819845|Carvedilol|carvedilol|mesh-list
154172591|NCT00819845|Ramipril|ramipril|mesh-list
154172592|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154172593|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154172594|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154172595|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
154172608|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
154172609|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172610|NCT00457743|Sunitinib|sunitinib|mesh-list
154172611|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172612|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172613|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172614|NCT00457743|Growth Substances|growth substances|mesh-ancestor
154172615|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172616|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172617|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154172618|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172619|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172620|NCT01023867|Donepezil|donepezil|mesh-list
154172621|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154172622|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172623|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172624|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
154172625|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172626|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172627|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
154172628|NCT00820469|Rituximab|rituximab|mesh-list
154172629|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154172630|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172631|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
154172632|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172633|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172634|NCT00815399|Metformin|metformin|mesh-list
154172635|NCT00815399|Pioglitazone|pioglitazone|mesh-list
154172636|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154172637|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172638|NCT00644969|Varenicline|varenicline|mesh-list
154172639|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154172640|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154172650|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172651|NCT00812513|Growth Substances|growth substances|mesh-ancestor
154172652|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172653|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
154172654|NCT00820547|Bevacizumab|bevacizumab|mesh-list
154172655|NCT00820547|Docetaxel|docetaxel|mesh-list
154172656|NCT00820547|Fluorouracil|fluorouracil|mesh-list
154172657|NCT00820547|Epirubicin|epirubicin|mesh-list
154172658|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172659|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
154172660|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172661|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172662|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172663|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
154172664|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172665|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172666|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154172667|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154172668|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172669|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172670|NCT00820547|Growth Substances|growth substances|mesh-ancestor
154172671|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172672|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
154172673|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
154172674|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
154172675|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
154172676|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154172677|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154172678|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154172696|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172697|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154172698|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172700|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
154172702|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172703|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172704|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
154172705|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172706|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154172707|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154172708|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154172709|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172710|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172711|NCT00647699|Riboflavin|riboflavin|mesh-list
154172712|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154172713|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154172714|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
154172715|NCT00647699|Vitamins|vitamins|mesh-ancestor
154172716|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
154172717|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172718|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154172719|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
154172720|NCT00813059|Bevacizumab|bevacizumab|mesh-list
154172721|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154172722|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172723|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172745|NCT00450333|Hematinics|hematinics|mesh-ancestor
154172746|NCT00643565|Bevacizumab|bevacizumab|mesh-list
154172747|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154172748|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172749|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172750|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172751|NCT00643565|Growth Substances|growth substances|mesh-ancestor
154172752|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172753|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172754|NCT00450255|Aflibercept|aflibercept|mesh-list
154172755|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
154172756|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172757|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172758|NCT00450255|Growth Substances|growth substances|mesh-ancestor
154172759|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172760|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172761|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172762|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154172763|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154172764|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172765|NCT00813137|Endostar protein|endostar protein|mesh-list
154172766|NCT00813137|Endostatins|endostatins|mesh-list
154172767|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172768|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172769|NCT00813137|Growth Substances|growth substances|mesh-ancestor
154172770|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172771|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172772|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629603|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629604|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629605|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629606|NCT02046486|Ticagrelor|ticagrelor|mesh-list
153629613|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629615|NCT02046499|Oxytocin|oxytocin|mesh-list
153629616|NCT02046499|Ergonovine|ergonovine|mesh-list
153629617|NCT02046499|Syntometrine|syntometrine|mesh-list
153629618|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
153629619|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629620|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629621|NCT02046538|Leucovorin|leucovorin|mesh-list
153629622|NCT02046538|Fluorouracil|fluorouracil|mesh-list
153629623|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
153629624|NCT02046538|Irinotecan|irinotecan|mesh-list
153629625|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
154172774|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154172775|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172776|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154172777|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172778|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
154172779|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172780|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
154172781|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172782|NCT00821483|Frovatriptan|frovatriptan|mesh-list
154172783|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154172784|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
154172785|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172786|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172787|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172788|NCT02551367|Letrozole|letrozole|mesh-list
154172789|NCT02551367|Clomiphene|clomiphene|mesh-list
154172790|NCT02551367|Enclomiphene|enclomiphene|mesh-list
154172791|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
154172792|NCT02551367|Hormones|hormones|mesh-list
154172793|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172794|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154172795|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172796|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172797|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154172798|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154172799|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172800|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154172801|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
154172802|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154172803|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
154172804|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154172805|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154172806|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154172807|NCT00813449|Dacarbazine|dacarbazine|mesh-list
153629626|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629627|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629628|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629629|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629630|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
154172808|NCT00813449|Endostar protein|endostar protein|mesh-list
154172809|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172810|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
154172811|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172812|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172813|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172814|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172815|NCT00813449|Growth Substances|growth substances|mesh-ancestor
154172816|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172817|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172818|NCT00822029|Alendronate|alendronate|mesh-list
154172819|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154172820|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172821|NCT00467259|Testosterone|testosterone|mesh-list
154172822|NCT00467259|Androgens|androgens|mesh-ancestor
154172823|NCT00467259|Hormones|hormones|mesh-ancestor
154172824|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154172825|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172826|NCT01022151|Aminophylline|aminophylline|mesh-list
154172827|NCT01022151|Doxapram|doxapram|mesh-list
154172828|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154172829|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
154172830|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172831|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172832|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154172833|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
154172834|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154172835|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154172836|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172844|NCT01022229|Vitamins|vitamins|mesh-list
154172852|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154172853|NCT00449787|Analgesics|analgesics|mesh-ancestor
154172854|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
154172855|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154172856|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172857|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154172858|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172859|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
154172860|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154172861|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172862|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172863|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154172864|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154172865|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154172866|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
154172867|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172868|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154172869|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172870|NCT01566279|Everolimus|everolimus|mesh-list
154172871|NCT01566279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154172872|NCT01566279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154172873|NCT01566279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172874|NCT01566279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172875|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172876|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
154172877|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172878|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172879|NCT00449163|Leucovorin|leucovorin|mesh-list
154172880|NCT00449163|Bevacizumab|bevacizumab|mesh-list
154172881|NCT00449163|Irinotecan|irinotecan|mesh-list
154172882|NCT00449163|Floxuridine|floxuridine|mesh-list
154172883|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
154172884|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154172885|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629631|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629632|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153629633|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629634|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629635|NCT02046538|Antidotes|antidotes|mesh-ancestor
153629636|NCT02046538|Protective Agents|protective agents|mesh-ancestor
153629637|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
153629638|NCT02046538|Vitamins|vitamins|mesh-ancestor
154172886|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154172887|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154172888|NCT00449163|Growth Substances|growth substances|mesh-ancestor
154172889|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172890|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
154172891|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154172892|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154172893|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172894|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172895|NCT00449163|Antidotes|antidotes|mesh-ancestor
154172896|NCT00449163|Protective Agents|protective agents|mesh-ancestor
154172897|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
154172898|NCT00449163|Vitamins|vitamins|mesh-ancestor
154172899|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
154172900|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154172901|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
154172902|NCT01026987|Plerixafor|plerixafor|mesh-list
154172903|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154172904|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154172905|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
154172906|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172907|NCT00448539|Rufinamide|rufinamide|mesh-list
154172908|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
154172909|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154172910|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154172911|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172912|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172913|NCT00457665|Efavirenz|efavirenz|mesh-list
154172914|NCT00457665|Nelfinavir|nelfinavir|mesh-list
154172915|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154172916|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154172929|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
154172930|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154172931|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154172932|NCT00447603|Losartan|losartan|mesh-list
154172933|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154172934|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154172935|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154172936|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154172937|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154172938|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172939|NCT00447603|Diuretics|diuretics|mesh-ancestor
154172940|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
154172941|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172942|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154172943|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172944|NCT00447057|Pemetrexed|pemetrexed|mesh-list
154172945|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154172946|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172947|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172948|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172949|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154172950|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154172951|NCT00447057|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154172952|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154172953|NCT01027611|Lidocaine|lidocaine|mesh-list
154172954|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
154172955|NCT01027611|Propoxycaine|propoxycaine|mesh-list
154172956|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
154172957|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
154172958|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172972|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172973|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172974|NCT00446511|Valsartan|valsartan|mesh-list
154172975|NCT00446511|Enalapril|enalapril|mesh-list
154172976|NCT00446511|Enalaprilat|enalaprilat|mesh-list
154172977|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154172978|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154172979|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154172980|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172981|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154172982|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
154172983|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172984|NCT01024491|Paroxetine|paroxetine|mesh-list
154172985|NCT01024491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154172986|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154172987|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154172988|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172989|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172990|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
154172991|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172992|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154172993|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
154172994|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154168628|NCT06326684|Suvorexant|suvorexant|mesh-list
154172995|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154172996|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154172997|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172998|NCT00446199|Drospirenone|drospirenone|mesh-list
153629639|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
153629640|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153629641|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153629642|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153906311|NCT02850445|Olanzapine|olanzapine|mesh-list
153629644|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629645|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
153629646|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629647|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629648|NCT02046577|Vitamin D|vitamin d|mesh-list
153629649|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
153629650|NCT02046577|Vitamins|vitamins|mesh-ancestor
153629651|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
153629652|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629653|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153629654|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154173000|NCT00446199|Estrogens|estrogens|mesh-ancestor
154173001|NCT00446199|Hormones|hormones|mesh-ancestor
154173002|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173003|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173004|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154173005|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
154173006|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154173007|NCT00446199|Diuretics|diuretics|mesh-ancestor
154173008|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
154173009|NCT01027689|Alprazolam|alprazolam|mesh-list
154173010|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154173011|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154173012|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173013|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154173014|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154173015|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154173016|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
154173017|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
154173018|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173019|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173020|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
154173021|NCT01024647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154173022|NCT01024647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173023|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173024|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
154173025|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173026|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173027|NCT01027923|Cytarabine|cytarabine|mesh-list
154173028|NCT01027923|Plerixafor|plerixafor|mesh-list
154173029|NCT01027923|Etoposide|etoposide|mesh-list
154173030|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
153629655|NCT02046629|Teriflunomide|teriflunomide|mesh-list
153629656|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
153629657|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153629658|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153629659|NCT02046629|Analgesics|analgesics|mesh-ancestor
153629660|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
153629661|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629662|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629663|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629664|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153629665|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629666|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
154173031|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154173032|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173033|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154173034|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154173035|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173036|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173037|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173038|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
154173039|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
154173040|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173041|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173042|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
154173043|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173044|NCT01027923|Analgesics|analgesics|mesh-ancestor
154173045|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
154173046|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173047|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154173048|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154173049|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
154173050|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
154173051|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154173052|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154173053|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173054|NCT01027065|Tenofovir|tenofovir|mesh-list
154173055|NCT01027065|Entecavir|entecavir|mesh-list
154173056|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
154173057|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173058|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154173059|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154173060|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173075|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173076|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154173077|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173078|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173079|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154173080|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154173082|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
154173083|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173084|NCT00444795|Sunitinib|sunitinib|mesh-list
154173085|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173086|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154173087|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154173088|NCT00444795|Growth Substances|growth substances|mesh-ancestor
154173089|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173090|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
154173091|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154173092|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173093|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173094|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
154173095|NCT03846219|Calcium|calcium|mesh-list
154173096|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154173097|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173098|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153629667|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153629668|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153629669|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
153629670|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629671|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153629672|NCT02046668|Spironolactone|spironolactone|mesh-list
153629673|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153629686|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
153629687|NCT02046733|Nivolumab|nivolumab|mesh-list
153629688|NCT02046733|Ipilimumab|ipilimumab|mesh-list
153629689|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153629690|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629691|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153629692|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629693|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153629694|NCT02046850|Rifampin|rifampin|mesh-list
153629695|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153629696|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
153629697|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153629698|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629699|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
153629700|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153629701|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629702|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629703|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154173099|NCT00455325|Chloroquine|chloroquine|mesh-list
154173100|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154173101|NCT00455325|Amebicides|amebicides|mesh-ancestor
154173102|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154173103|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154173104|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173105|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
154173106|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173107|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154173108|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154173109|NCT00455325|Analgesics|analgesics|mesh-ancestor
154173110|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
154173111|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173112|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173113|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173114|NCT00455325|Filaricides|filaricides|mesh-ancestor
154173115|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
154173116|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
154173117|NCT01028079|Aspirin|aspirin|mesh-list
154173118|NCT01028079|Ibuprofen|ibuprofen|mesh-list
154173119|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154173120|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154173121|NCT01028079|Analgesics|analgesics|mesh-ancestor
154173122|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
154173123|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173124|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173125|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173126|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173127|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154173128|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154173129|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173130|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154173131|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154173142|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
154173143|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173144|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173145|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154173147|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
154173148|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173149|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154173150|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154173151|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154173152|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154173153|NCT00381706|Leucovorin|leucovorin|mesh-list
154173154|NCT00381706|Cisplatin|cisplatin|mesh-list
154173155|NCT00381706|Fluorouracil|fluorouracil|mesh-list
154173156|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
154173157|NCT00381706|Irinotecan|irinotecan|mesh-list
154173158|NCT00381706|Cetuximab|cetuximab|mesh-list
154173159|NCT00381706|Epirubicin|epirubicin|mesh-list
154173160|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173161|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
154173162|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173163|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173164|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173165|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
154173166|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173167|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154173168|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154173169|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173170|NCT00381706|Antidotes|antidotes|mesh-ancestor
154173171|NCT00381706|Protective Agents|protective agents|mesh-ancestor
154173172|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
154173173|NCT00381706|Vitamins|vitamins|mesh-ancestor
154173174|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
154173175|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173176|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153629704|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153629705|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153629706|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153629707|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153629708|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153629709|NCT02046915|Dexamethasone|dexamethasone|mesh-list
153629710|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
153629711|NCT02046915|Pomalidomide|pomalidomide|mesh-list
153629712|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173177|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154173179|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154173180|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154173181|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154173182|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173183|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173184|NCT05357430|Propofol|propofol|mesh-list
154173185|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154173186|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154173187|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173188|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154173189|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
154173190|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
154173191|NCT00370552|Paclitaxel|paclitaxel|mesh-list
154173192|NCT00370552|Epothilones|epothilones|mesh-list
154173193|NCT00370552|Bevacizumab|bevacizumab|mesh-list
154173194|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154173195|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173196|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
154173197|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
154173198|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
154173200|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173230|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154173231|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154173232|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154173233|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173234|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173235|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154173236|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154173237|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154173238|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154173239|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173240|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
154173241|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173242|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173243|NCT04285866|Durvalumab|durvalumab|mesh-list
154173244|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173245|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173246|NCT01047982|Folic Acid|folic acid|mesh-list
154173247|NCT01047982|Inositol|inositol|mesh-list
154173248|NCT01047982|Hematinics|hematinics|mesh-ancestor
154173249|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
154173250|NCT01047982|Vitamins|vitamins|mesh-ancestor
154173251|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
154173252|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173253|NCT00536874|Gemcitabine|gemcitabine|mesh-list
154173254|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
154173255|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173277|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154173278|NCT00991926|Orlistat|orlistat|mesh-list
154173279|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173280|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173281|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154173282|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154173283|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
154173284|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173285|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173286|NCT04230954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154173287|NCT04230954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173288|NCT00536484|Fesoterodine|fesoterodine|mesh-list
154173289|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154173290|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154173291|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
154173292|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173293|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173294|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173295|NCT00536484|Urological Agents|urological agents|mesh-ancestor
154173296|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154173297|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
154173298|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173299|NCT00992004|Turmeric extract|turmeric extract|mesh-list
154173301|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173302|NCT00992004|Protective Agents|protective agents|mesh-ancestor
154173303|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173304|NCT00992082|Ketorolac|ketorolac|mesh-list
154173305|NCT00992082|Epinephrine|epinephrine|mesh-list
154173306|NCT00992082|Morphine|morphine|mesh-list
154173307|NCT00992082|Ropivacaine|ropivacaine|mesh-list
154173308|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154173309|NCT00992082|Narcotics|narcotics|mesh-ancestor
154173310|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154173311|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173312|NCT00992082|Analgesics|analgesics|mesh-ancestor
153755949|NCT00179712|Topotecan|topotecan|mesh-list
153629713|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
153629714|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173313|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
154173314|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173315|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
154173316|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
154173317|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154173318|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154173319|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
154173320|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173321|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173322|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154173323|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154173324|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
154173325|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154173326|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
154173327|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
154173328|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
154173329|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154173330|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154173331|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154173332|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173333|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173334|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154173335|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173336|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
154173337|NCT00455013|Sirolimus|sirolimus|mesh-list
154173338|NCT00455013|Abatacept|abatacept|mesh-list
154173362|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154173364|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173365|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154173366|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154173367|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
154173368|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173369|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
154168978|NCT06084936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173370|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
154173371|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173372|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
154173373|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154173374|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154173375|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154173376|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154173377|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154173378|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
154173379|NCT05254548|Midazolam|midazolam|mesh-list
154173380|NCT05254548|Omeprazole|omeprazole|mesh-list
154173381|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154173382|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154173383|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154173384|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173385|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154173386|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154173387|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154173388|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154173389|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
154173390|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
154173391|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
154173392|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
153629715|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153629716|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153629717|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
153629718|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629719|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629720|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153629721|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629722|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
153629723|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
153629724|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629725|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153629726|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
154173393|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173394|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173396|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154173397|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154173398|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173399|NCT05254548|Analgesics|analgesics|mesh-ancestor
154173400|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
154173401|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173402|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154173403|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154173404|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173405|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173406|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154173407|NCT00363142|Ritonavir|ritonavir|mesh-list
154173408|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
154173409|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154173414|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154173450|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
154173451|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173453|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
154173454|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173455|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173456|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154173457|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
154173458|NCT01028313|Hormones|hormones|mesh-ancestor
154173459|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173460|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154173461|NCT01028313|Protective Agents|protective agents|mesh-ancestor
154173462|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154173463|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173464|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154173465|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173466|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173467|NCT04001712|Caffeine|caffeine|mesh-list
154173468|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
154173469|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173470|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154173471|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173472|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154173473|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173474|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154173475|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154173476|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
154173477|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173478|NCT01027377|Factor VIII|factor viii|mesh-list
154173479|NCT01027377|Coagulants|coagulants|mesh-ancestor
154173491|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173492|NCT00379912|Hematinics|hematinics|mesh-ancestor
154173493|NCT00379834|Timolol|timolol|mesh-list
154173494|NCT00379834|Dorzolamide|dorzolamide|mesh-list
154173495|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154173496|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154173497|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
154173498|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173499|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173500|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173501|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154173502|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154173503|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154173504|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173505|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
154173506|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
154173507|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
154173508|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173509|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173510|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154173511|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154173512|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154173513|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154173514|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154173515|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153644177|NCT00099970|Dacarbazine|dacarbazine|mesh-list
154173516|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
154173517|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173518|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173519|NCT03453840|Lumefantrine|lumefantrine|mesh-list
154173520|NCT03453840|Artemether|artemether|mesh-list
154173521|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154173522|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
154173523|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154173524|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154173525|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173532|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173533|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173534|NCT03339258|Doxazosin|doxazosin|mesh-list
154173535|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154173536|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154173537|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154173538|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154173539|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
154173540|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173541|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173542|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173543|NCT00992706|Doxorubicin|doxorubicin|mesh-list
154173544|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154173545|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154173546|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173547|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154173548|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154173549|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173550|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173551|NCT00454779|Cisplatin|cisplatin|mesh-list
154173552|NCT00454779|Docetaxel|docetaxel|mesh-list
154173553|NCT00454779|Panitumumab|panitumumab|mesh-list
154173554|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173555|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
154173556|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
154173557|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
154173558|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173559|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173560|NCT00992862|Moexipril|moexipril|mesh-list
154173561|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154173562|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
153756204|NCT00202293|Olanzapine|olanzapine|mesh-list
153629728|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629729|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153629730|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153629731|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153629732|NCT02046915|Growth Substances|growth substances|mesh-ancestor
153629733|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
153629734|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
153629756|NCT02047136|Histamine|histamine|mesh-list
153629757|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
153629758|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
154173563|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173564|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173565|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154173566|NCT00993096|Insulin|insulin|mesh-list
154173567|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154173568|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
154173569|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
154173570|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154173571|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
154173572|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154173573|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
154173574|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154173575|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173576|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154173577|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173578|NCT03994107|Paclitaxel|paclitaxel|mesh-list
154173579|NCT03994107|Doxorubicin|doxorubicin|mesh-list
154173580|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154173581|NCT03994107|Trastuzumab|trastuzumab|mesh-list
154173582|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154173583|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154173584|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173585|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154173586|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154173587|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154173588|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173609|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173611|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173612|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
154173613|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
154173614|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173615|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173616|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154173617|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
154173618|NCT01028547|Hormones|hormones|mesh-ancestor
154173619|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173620|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154173621|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173622|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
154173623|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
154173624|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154173625|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154173626|NCT01031355|Calcium|calcium|mesh-list
154173627|NCT01031355|Estradiol|estradiol|mesh-list
154173628|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154173629|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154173630|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173631|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154173632|NCT01031355|Estrogens|estrogens|mesh-ancestor
154173633|NCT01031355|Hormones|hormones|mesh-ancestor
154173634|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173635|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154173636|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
154173637|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154173638|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154173639|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
154173640|NCT01031355|Vitamins|vitamins|mesh-ancestor
154173641|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
154173642|NCT00993720|Liraglutide|liraglutide|mesh-list
154173643|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154173648|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173650|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
154173651|NCT00425607|Lonafarnib|lonafarnib|mesh-list
154173652|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173653|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173654|NCT00437073|Capecitabine|capecitabine|mesh-list
154173655|NCT00437073|Topotecan|topotecan|mesh-list
154173656|NCT00437073|Lapatinib|lapatinib|mesh-list
154173657|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173658|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
154173659|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173660|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173661|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154173662|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154173663|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173664|NCT00437073|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154173665|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154173666|NCT00425373|Amlodipine|amlodipine|mesh-list
154173667|NCT00425373|Valsartan|valsartan|mesh-list
154173668|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154173669|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154173670|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154173671|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173672|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154173673|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173674|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
154173675|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154173676|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154173677|NCT01031589|Rilpivirine|rilpivirine|mesh-list
154173678|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154173679|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153629759|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629760|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629761|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629762|NCT02047149|Zileuton|zileuton|mesh-list
153629763|NCT02047149|Dasatinib|dasatinib|mesh-list
153629764|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
153629765|NCT02047149|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153629766|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153629767|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173680|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173681|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173682|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
154173683|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173684|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154173685|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154173687|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
154173688|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154173689|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173690|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
154173691|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
154173692|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
154173693|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173694|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173695|NCT03894540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154173696|NCT00993876|Citalopram|citalopram|mesh-list
154173697|NCT00993876|Reboxetine|reboxetine|mesh-list
154173698|NCT00993876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154173699|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154173700|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154173701|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173702|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173703|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
154173704|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173705|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154173706|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
154173707|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154173725|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
154173726|NCT00994344|Ritonavir|ritonavir|mesh-list
154173727|NCT00994344|Lopinavir|lopinavir|mesh-list
154173728|NCT00994344|Darunavir|darunavir|mesh-list
154173729|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154173730|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154173731|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
154173732|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173733|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173734|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154173735|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154173736|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
154173737|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173738|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154173739|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154173740|NCT00994500|Bortezomib|bortezomib|mesh-list
154173741|NCT00994500|Vorinostat|vorinostat|mesh-list
154173742|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173743|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154173744|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173745|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173746|NCT01416636|Treprostinil|treprostinil|mesh-list
154173747|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154173748|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
154173749|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154173750|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154173751|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154173752|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154173753|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173759|NCT00999258|Sirolimus|sirolimus|mesh-list
154173771|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154173772|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173773|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154173774|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154173775|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154173776|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
154173777|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154173778|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154173779|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
154173780|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154173781|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
154173782|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154173783|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154173784|NCT00995826|Laninamivir|laninamivir|mesh-list
154173785|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
154173786|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173787|NCT00994812|Metformin|metformin|mesh-list
154173788|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154173789|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173790|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
154173791|NCT00994968|Docetaxel|docetaxel|mesh-list
154173792|NCT00994968|Doxorubicin|doxorubicin|mesh-list
154173793|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154173794|NCT00994968|Tegafur|tegafur|mesh-list
154173795|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173796|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
154173797|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173798|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173799|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154173800|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
154173801|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173802|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173803|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154173804|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
154173805|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629768|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629769|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629770|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154173807|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154173808|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154173809|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154173810|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173811|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173812|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
154173813|NCT03887442|Paclitaxel|paclitaxel|mesh-list
154173814|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154173815|NCT03887442|Cetuximab|cetuximab|mesh-list
154173816|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154173817|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173818|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
154173819|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
154173820|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
154173821|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173822|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173823|NCT00996060|Hydralazine|hydralazine|mesh-list
154173824|NCT00996060|Valproic Acid|valproic acid|mesh-list
154173825|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
154173826|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173827|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173828|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
154173829|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154173830|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173831|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
154173832|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154173833|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154173834|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154173837|NCT00995046|Factor VIII|factor viii|mesh-list
154173852|NCT00996684|Plasminogen|plasminogen|mesh-list
154173853|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154173854|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154173855|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173856|NCT00996762|Lapatinib|lapatinib|mesh-list
154173857|NCT00996762|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154173858|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154173859|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173860|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173861|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173862|NCT05162196|Niraparib|niraparib|mesh-list
154173863|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154173864|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173865|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173866|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173867|NCT00997074|Ibuprofen|ibuprofen|mesh-list
154173868|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154173869|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154173870|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154173871|NCT00997074|Analgesics|analgesics|mesh-ancestor
154173872|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
154173873|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173874|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173875|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173899|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154173900|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
154173901|NCT00997542|Protective Agents|protective agents|mesh-ancestor
154173902|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173903|NCT01001130|Fluticasone|fluticasone|mesh-list
154173904|NCT01001130|Xhance|xhance|mesh-list
154173905|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173906|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154173907|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
154173908|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173909|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173910|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154173911|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
154173912|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
154173913|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154173914|NCT00424827|Gemcitabine|gemcitabine|mesh-list
154173915|NCT00424827|Fluorouracil|fluorouracil|mesh-list
154173916|NCT00424827|Cetuximab|cetuximab|mesh-list
154173917|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173918|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
154173919|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173920|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173921|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173922|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
154173923|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173924|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154173925|NCT01001364|Budesonide|budesonide|mesh-list
154173926|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
154173927|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154173928|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154173929|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
154173930|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173932|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154173942|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173944|NCT01031667|Probucol|probucol|mesh-list
154173945|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154173946|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
154173947|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154173948|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173949|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154173950|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
154173951|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154173952|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154173953|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173954|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154173955|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
154173956|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154173957|NCT01031667|Protective Agents|protective agents|mesh-ancestor
154173958|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154173959|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154173960|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154173961|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154173962|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154173963|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
154173964|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154173965|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
154173966|NCT03995277|Biotin|biotin|mesh-list
154173967|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
154173968|NCT03995277|Vitamins|vitamins|mesh-ancestor
154169590|NCT05566041|Carboplatin|carboplatin|mesh-list
154173969|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
154173970|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173971|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
154173972|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
154173973|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
154173986|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154173987|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154173988|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
154173989|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154173990|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154173992|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154173993|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154173994|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154173995|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154173996|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
154173997|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154173998|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154173999|NCT00424749|Prednisone|prednisone|mesh-list
154174000|NCT00424749|Rituximab|rituximab|mesh-list
154174001|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174002|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174003|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
154174004|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174005|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174006|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174007|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
154174008|NCT00424749|Hormones|hormones|mesh-ancestor
154174009|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174010|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154174011|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154174012|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154174013|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154174014|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154174015|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174016|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174017|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629771|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153629772|NCT02047149|Analgesics|analgesics|mesh-ancestor
153629773|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
153629774|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629775|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629776|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629777|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174018|NCT00424593|Analgesics|analgesics|mesh-ancestor
154174019|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
154174020|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174021|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
154174022|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154174023|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
154174024|NCT00369382|Cyclosporine|cyclosporine|mesh-list
154174025|NCT00369382|Sirolimus|sirolimus|mesh-list
154174026|NCT00369382|Tacrolimus|tacrolimus|mesh-list
154174027|NCT00369382|Cyclosporins|cyclosporins|mesh-list
154174028|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154174029|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
154174030|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174031|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154174032|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174033|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174034|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
154174035|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174036|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
154174037|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174038|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154174039|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154174040|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174041|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
154174042|NCT00424515|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154174043|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154174044|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174045|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174068|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154174069|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154174070|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154174071|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
154174072|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174073|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174074|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
154174075|NCT00436917|Letrozole|letrozole|mesh-list
154174076|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174077|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154174078|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154174079|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174080|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174081|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154174082|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
154174083|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174084|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174085|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154174086|NCT00436605|Dasatinib|dasatinib|mesh-list
154174087|NCT00436605|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154174088|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154174089|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174090|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174091|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174092|NCT01034787|Tremelimumab|tremelimumab|mesh-list
154174093|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174094|NCT01028781|Thalidomide|thalidomide|mesh-list
154174095|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154174096|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
154174097|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174098|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
154174099|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153629778|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153629779|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153629780|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
153629781|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629782|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
153629783|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153629784|NCT02047162|Bismuth|bismuth|mesh-list
154174100|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174101|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154174102|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154174103|NCT01028781|Growth Substances|growth substances|mesh-ancestor
154174104|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
154174105|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174106|NCT01031901|Sirolimus|sirolimus|mesh-list
154174107|NCT01031901|Temsirolimus|temsirolimus|mesh-list
154174108|NCT01031901|MTOR Inhibitors|mtor inhibitors|mesh-list
154174109|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154174110|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174111|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154174112|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174113|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
154174114|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154174115|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
154174116|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174117|NCT01031901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154174118|NCT01031901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174119|NCT01031901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174120|NCT00368992|Paclitaxel|paclitaxel|mesh-list
154174121|NCT00368992|Bevacizumab|bevacizumab|mesh-list
154174122|NCT00368992|Cetuximab|cetuximab|mesh-list
154174123|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154174124|NCT00368992|Antibodies|antibodies|mesh-list
154174125|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
154174126|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154174149|NCT00375934|Analgesics|analgesics|mesh-ancestor
154174150|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
154174151|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174152|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174153|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174154|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174155|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154174156|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174157|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174158|NCT01052584|Chloroquine|chloroquine|mesh-list
154174159|NCT01052584|Lumefantrine|lumefantrine|mesh-list
154174160|NCT01052584|Artemether|artemether|mesh-list
154174161|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154174162|NCT01052584|Amebicides|amebicides|mesh-ancestor
154174163|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154174164|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154174165|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174166|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
154174167|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174168|NCT02534506|Nivolumab|nivolumab|mesh-list
154174169|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174170|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174171|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154174172|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174173|NCT01050322|Gemcitabine|gemcitabine|mesh-list
154174174|NCT01050322|Capecitabine|capecitabine|mesh-list
154174175|NCT01050322|Vinorelbine|vinorelbine|mesh-list
154174176|NCT01050322|Lapatinib|lapatinib|mesh-list
154174177|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154174178|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
154174179|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174180|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174181|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154174182|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
154174183|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
154174184|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
154174185|NCT01050322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154174187|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174188|NCT00531960|Bevacizumab|bevacizumab|mesh-list
154174189|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154174190|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174191|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174192|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154174193|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154174194|NCT00531960|Growth Substances|growth substances|mesh-ancestor
154174195|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174196|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
154174197|NCT00531960|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154174198|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154174199|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174200|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174201|NCT01001676|Paclitaxel|paclitaxel|mesh-list
154174202|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154174203|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174204|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
154174205|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
154174206|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
154174207|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174208|NCT00816959|Bleomycin|bleomycin|mesh-list
154174209|NCT00816959|Dacarbazine|dacarbazine|mesh-list
154174210|NCT00816959|Vinblastine|vinblastine|mesh-list
154174211|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154174212|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174213|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174214|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154174215|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
154174216|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154174217|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
154174218|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
154174228|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
154174229|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174230|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174231|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154174232|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154174233|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
154174234|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174235|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174236|NCT00361504|Oxycodone|oxycodone|mesh-list
154174237|NCT00361504|Tapentadol|tapentadol|mesh-list
154174238|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154174239|NCT00361504|Narcotics|narcotics|mesh-ancestor
154174240|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174241|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174242|NCT00361504|Analgesics|analgesics|mesh-ancestor
154174243|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
154174244|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174245|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154174246|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154174247|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154174248|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174249|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
154174250|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174251|NCT00361270|Complement Factor H|complement factor h|mesh-list
154174252|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154174253|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154174254|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
154174255|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174256|NCT00826163|Budesonide|budesonide|mesh-list
154174257|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174258|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154174259|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
154174260|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169890|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
154174269|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174270|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174271|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154174272|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154174273|NCT00998166|Growth Substances|growth substances|mesh-ancestor
154174274|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174275|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
154174276|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174277|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174278|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154174279|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154174280|NCT03990922|Morphine|morphine|mesh-list
154174281|NCT03990922|Ropivacaine|ropivacaine|mesh-list
154174282|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154174283|NCT03990922|Narcotics|narcotics|mesh-ancestor
154174284|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174285|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174286|NCT03990922|Analgesics|analgesics|mesh-ancestor
154174287|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
154174288|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174289|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
154174290|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
154174291|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
154174292|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154174293|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
154174294|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174295|NCT00822263|Expectorants|expectorants|mesh-ancestor
154174296|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
154174297|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154174298|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
154174300|NCT00822263|Protective Agents|protective agents|mesh-ancestor
154174310|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154174311|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174312|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
154174313|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
154174314|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154174315|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154174316|NCT00998322|Gemcitabine|gemcitabine|mesh-list
154174317|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154174318|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
154174319|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174320|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174321|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
154174322|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154174323|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174324|NCT01002300|Oxytocin|oxytocin|mesh-list
154174325|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
154174326|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154174327|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174328|NCT00822419|Lidocaine|lidocaine|mesh-list
154174329|NCT00822419|Ketamine|ketamine|mesh-list
154174330|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
154174331|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
154174332|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174333|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174334|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
154174335|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174336|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154174337|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154174338|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154174339|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154174340|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174341|NCT00822419|Analgesics|analgesics|mesh-ancestor
154174342|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154174343|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154174344|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
154174345|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153629785|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153629786|NCT02047162|Antacids|antacids|mesh-ancestor
154174347|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174348|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154174349|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
154174350|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154174351|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154174352|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174353|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174354|NCT01002534|Urological Agents|urological agents|mesh-ancestor
154174355|NCT00817271|Glucagon|glucagon|mesh-list
154174356|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154174357|NCT00817271|Hormones|hormones|mesh-ancestor
154174358|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174359|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174360|NCT01052896|Gabapentin|gabapentin|mesh-list
154174361|NCT01052896|Analgesics|analgesics|mesh-ancestor
154174362|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
154174363|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174364|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174365|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
154174366|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154174367|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154174368|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174369|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154174370|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154174371|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154174372|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174373|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174374|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
154174375|NCT01002690|Etoricoxib|etoricoxib|mesh-list
154174376|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154174377|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154174378|NCT01002690|Analgesics|analgesics|mesh-ancestor
154174379|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
154174380|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174383|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174384|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154174385|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154174386|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174387|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174388|NCT01048684|Mannitol|mannitol|mesh-list
154174389|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154174390|NCT01048684|Diuretics|diuretics|mesh-ancestor
154174391|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
154174392|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174393|NCT01002768|Insulin|insulin|mesh-list
154174394|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154174395|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
154174396|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154174397|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174398|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154174399|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154174400|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154174401|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174402|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174403|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154174404|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154174405|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154174406|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
154174407|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174408|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174409|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154174410|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154174411|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
154174412|NCT00998556|Bromocriptine|bromocriptine|mesh-list
154174413|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154174414|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154174415|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
154174416|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174417|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174418|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
154174420|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174421|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174422|NCT01052974|Ropivacaine|ropivacaine|mesh-list
154174423|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
154174424|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
154174425|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174426|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174427|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
154174428|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174429|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
154174430|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
154174431|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154174432|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174433|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174434|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
154174435|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154174436|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154174437|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174439|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154174440|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154174441|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
154174442|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174443|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174444|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174445|NCT01003158|Paclitaxel|paclitaxel|mesh-list
154174468|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174470|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154174471|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174472|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154174473|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154174474|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154174475|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154174476|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174477|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
154174478|NCT00424047|Dexamethasone|dexamethasone|mesh-list
154174479|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
154174480|NCT00424047|Lenalidomide|lenalidomide|mesh-list
154174481|NCT00424047|BB 1101|bb 1101|mesh-list
154174482|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174483|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
154174484|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
154174485|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174486|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174487|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154174488|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
154174489|NCT00424047|Hormones|hormones|mesh-ancestor
154174490|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174491|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154174492|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457507|NCT01382940|Rituximab|rituximab|mesh-list
153629809|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
153629810|NCT02047175|Vitamins|vitamins|mesh-ancestor
153629811|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
153629813|NCT02047201|Fluorouracil|fluorouracil|mesh-list
153629814|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629815|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629816|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629817|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
153629818|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629819|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
153629820|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629821|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629822|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
153629823|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629824|NCT02047292|Tacrine|tacrine|mesh-list
153629825|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153629826|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629827|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629828|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
153629829|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629830|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174494|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174495|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174496|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
154174497|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154174498|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154174499|NCT00424047|Growth Substances|growth substances|mesh-ancestor
154174500|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
154174501|NCT00530790|Ropinirole|ropinirole|mesh-list
154174502|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154174503|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154174504|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
154174505|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
154174506|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174507|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174508|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174509|NCT01032057|Gemcitabine|gemcitabine|mesh-list
154174510|NCT01032057|Capecitabine|capecitabine|mesh-list
154174511|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154174512|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
154174513|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174514|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174515|NCT01003314|Vaccines|vaccines|mesh-list
154174516|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
154174517|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174518|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
154174541|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174542|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154174543|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174544|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154174545|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
154174546|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
154174547|NCT00436215|Bevacizumab|bevacizumab|mesh-list
154174548|NCT00436215|Sorafenib|sorafenib|mesh-list
154174549|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174550|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174551|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154174552|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154174553|NCT00436215|Growth Substances|growth substances|mesh-ancestor
154174554|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174555|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
154174556|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154174557|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174558|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174559|NCT05734248|Hyaluronic Acid|hyaluronic acid|mesh-list
154174560|NCT05734248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154174561|NCT05734248|Immunologic Factors|immunologic factors|mesh-ancestor
154174562|NCT05734248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174563|NCT05734248|Viscosupplements|viscosupplements|mesh-ancestor
154174564|NCT05734248|Protective Agents|protective agents|mesh-ancestor
154174565|NCT00441363|Bromocriptine|bromocriptine|mesh-list
154174575|NCT00626795|Mupirocin|mupirocin|mesh-list
154174589|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154174590|NCT00826553|Analgesics|analgesics|mesh-ancestor
154174591|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
154174592|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174593|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154174594|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154174595|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154174596|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
154174597|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174598|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174599|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154174600|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
154174601|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
154174602|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154174603|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154174604|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154174605|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154174606|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
154174607|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
154174608|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
154174609|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
154174610|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
154174611|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154174612|NCT00626639|Cisplatin|cisplatin|mesh-list
154174613|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174614|NCT00626561|Paclitaxel|paclitaxel|mesh-list
154174615|NCT00626561|Bevacizumab|bevacizumab|mesh-list
154174616|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154174617|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174618|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
154174619|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
154174620|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
154174621|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174632|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
154174633|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174634|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174635|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174636|NCT00423891|Entecavir|entecavir|mesh-list
154174637|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
154174638|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174639|NCT00830609|Ribavirin|ribavirin|mesh-list
154174640|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154174641|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
154174642|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
154174643|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170270|NCT04930783|Nivolumab|nivolumab|mesh-list
154174644|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
154174645|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174646|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
154174692|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154174693|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174694|NCT00626405|Paclitaxel|paclitaxel|mesh-list
154174695|NCT00626405|Bevacizumab|bevacizumab|mesh-list
154174696|NCT00626405|Carboplatin|carboplatin|mesh-list
154174697|NCT00626405|Temozolomide|temozolomide|mesh-list
154174698|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154174699|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154174700|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174701|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
154174702|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
154174703|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
154174704|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174705|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174706|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154174707|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154174708|NCT00626405|Growth Substances|growth substances|mesh-ancestor
154174709|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174710|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
154174711|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154174712|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
154174713|NCT00826865|Levetiracetam|levetiracetam|mesh-list
154174714|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
154174715|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
154174716|NCT00358150|Eliglustat|eliglustat|mesh-list
154174717|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174718|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174719|NCT01050556|Folic Acid|folic acid|mesh-list
154174720|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
154174721|NCT01050556|Hematinics|hematinics|mesh-ancestor
154174722|NCT01050556|Vitamins|vitamins|mesh-ancestor
154174723|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
154174724|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174725|NCT05889871|Apatinib|apatinib|mesh-list
154174735|NCT05889455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174736|NCT05889455|Urological Agents|urological agents|mesh-ancestor
154174737|NCT05889442|Cromakalim|cromakalim|mesh-list
154174738|NCT05889442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154174739|NCT05889442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154174740|NCT05889442|Autonomic Agents|autonomic agents|mesh-ancestor
154174741|NCT05889442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174742|NCT05889442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174743|NCT05889442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154174744|NCT05889442|Respiratory System Agents|respiratory system agents|mesh-ancestor
154174745|NCT05889442|Parasympatholytics|parasympatholytics|mesh-ancestor
154174746|NCT05889442|Vasodilator Agents|vasodilator agents|mesh-ancestor
154174747|NCT05889390|Paclitaxel|paclitaxel|mesh-list
154174748|NCT05889390|Cyclophosphamide|cyclophosphamide|mesh-list
154174749|NCT05889390|Carboplatin|carboplatin|mesh-list
154174750|NCT05889390|Doxorubicin|doxorubicin|mesh-list
154174751|NCT05889390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154174752|NCT05889390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174753|NCT05889390|Tubulin Modulators|tubulin modulators|mesh-ancestor
153645657|NCT00110851|Metformin|metformin|mesh-list
154174754|NCT05889390|Antimitotic Agents|antimitotic agents|mesh-ancestor
154174755|NCT05889390|Mitosis Modulators|mitosis modulators|mesh-ancestor
154174756|NCT05889390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174757|NCT05889390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154174758|NCT05889390|Immunologic Factors|immunologic factors|mesh-ancestor
154174759|NCT05889390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174760|NCT05889390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174784|NCT05889338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154174785|NCT05889338|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154174786|NCT05889338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174787|NCT05889143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154174788|NCT05889143|Ezetimibe|ezetimibe|mesh-list
154174789|NCT05889143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154174790|NCT05889143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154174791|NCT05889143|Antimetabolites|antimetabolites|mesh-ancestor
154174792|NCT05889143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174793|NCT05889143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154174794|NCT05889143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154174795|NCT05889143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174796|NCT05889026|Botulinum Toxins|botulinum toxins|mesh-list
154174797|NCT05889026|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154174798|NCT05889026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154174799|NCT05889026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174800|NCT05889026|Cholinergic Agents|cholinergic agents|mesh-ancestor
154174801|NCT05889026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174802|NCT05889026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174803|NCT05887947|Nicotine|nicotine|mesh-list
154174804|NCT05887947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154174805|NCT05887947|Autonomic Agents|autonomic agents|mesh-ancestor
154174806|NCT05887947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154174807|NCT05887947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174808|NCT05887947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154174809|NCT05887947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154174813|NCT05887908|Imipenem|imipenem|mesh-list
154174831|NCT05887778|Glucocorticoids|glucocorticoids|mesh-ancestor
154174833|NCT05887778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154174834|NCT05887778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154174835|NCT05887778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174836|NCT05887778|Protease Inhibitors|protease inhibitors|mesh-ancestor
154174837|NCT05887778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174838|NCT05887778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174839|NCT05881382|Lenograstim|lenograstim|mesh-list
154174840|NCT05881382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154174841|NCT05881382|Immunologic Factors|immunologic factors|mesh-ancestor
154174842|NCT05881382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174843|NCT05843708|Ciprofloxacin|ciprofloxacin|mesh-list
154174844|NCT05843708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154174845|NCT05843708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174846|NCT05843708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154174847|NCT05843708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154174848|NCT05843708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174849|NCT05843708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174850|NCT05843708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174851|NCT05843708|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154174852|NCT05843708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154174853|NCT05743946|Ivacaftor|ivacaftor|mesh-list
154174854|NCT05743946|Elexacaftor|elexacaftor|mesh-list
154174855|NCT05743946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154174858|NCT05742789|Propofol|propofol|mesh-list
154174877|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174878|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154174879|NCT05597085|Immunotoxins|immunotoxins|mesh-ancestor
154174880|NCT05597085|Immunoconjugates|immunoconjugates|mesh-ancestor
154174881|NCT05597085|Immunologic Factors|immunologic factors|mesh-ancestor
154174882|NCT05597085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174883|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
154174884|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154174885|NCT05465135|Artenimol|artenimol|mesh-list
154174886|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
154174887|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154174888|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154174889|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174890|NCT05425732|Vaccines|vaccines|mesh-list
153645739|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174891|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154174892|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
154174893|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174894|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
154174895|NCT05389514|Gemcitabine|gemcitabine|mesh-list
154174896|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
154174897|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154174898|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
154174899|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174900|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174901|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154174902|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
154174903|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174904|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174905|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154174906|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154174907|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
154174922|NCT05304546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174923|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154174924|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154174925|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174926|NCT04957758|Varenicline|varenicline|mesh-list
154174927|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154174928|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154174929|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
154174930|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154174931|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174932|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174933|NCT04827134|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
154174934|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154174935|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154174936|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
154174937|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174938|NCT04736953|Sirolimus|sirolimus|mesh-list
154174939|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154174940|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174941|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154174942|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174943|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
154174944|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154174945|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
154174946|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174947|NCT04685421|Bupivacaine|bupivacaine|mesh-list
154174948|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
154174969|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
154174970|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174971|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
154174972|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154174973|NCT04583969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154174974|NCT04575857|Atorvastatin|atorvastatin|mesh-list
154174975|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154174976|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154174977|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
154174978|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154174979|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154174980|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154174981|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154174982|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154174983|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
154174984|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174985|NCT04502706|Rituximab|rituximab|mesh-list
154174986|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154174987|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154174988|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
154174989|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154174990|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154174991|NCT04468776|Zolpidem|zolpidem|mesh-list
154174992|NCT04468776|Trazodone|trazodone|mesh-list
154174993|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154174994|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154174995|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175015|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154175016|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175017|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175018|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
154175019|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175020|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170646|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175021|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
154175023|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
154175024|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175026|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
154175027|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154175028|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
154175029|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175030|NCT04374461|Protective Agents|protective agents|mesh-ancestor
154175031|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175032|NCT04374461|Antidotes|antidotes|mesh-ancestor
154175033|NCT04333420|Vilobelimab|vilobelimab|mesh-list
154175034|NCT04333420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154175035|NCT04333420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154175036|NCT04333420|Immunologic Factors|immunologic factors|mesh-ancestor
154175037|NCT04333420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175038|NCT04247165|Paclitaxel|paclitaxel|mesh-list
154175039|NCT04247165|Gemcitabine|gemcitabine|mesh-list
154175040|NCT04247165|Nivolumab|nivolumab|mesh-list
154175041|NCT04247165|Ipilimumab|ipilimumab|mesh-list
154175042|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154175043|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175044|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
154175045|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
154175052|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
154175060|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154175061|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154175062|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175063|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175065|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175066|NCT04177693|Letrozole|letrozole|mesh-list
154175067|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154175068|NCT04177693|Clomiphene|clomiphene|mesh-list
154175069|NCT04177693|Enclomiphene|enclomiphene|mesh-list
154175070|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
154175071|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175072|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175073|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154175074|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154175075|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175076|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154175077|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
154175078|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175079|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175080|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154175081|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
154175113|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175114|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175115|NCT04105335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154175116|NCT04105335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175117|NCT04072952|Palbociclib|palbociclib|mesh-list
154175118|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175119|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154175120|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175121|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175122|NCT04006522|Atezolizumab|atezolizumab|mesh-list
154175123|NCT04006522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154175124|NCT04006522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175125|NCT04006522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175126|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175127|NCT03922048|Bupivacaine|bupivacaine|mesh-list
154175128|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
154175129|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
154175130|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175131|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175132|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
154175133|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175134|NCT03891667|Disulfiram|disulfiram|mesh-list
154175135|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153645956|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175136|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154175137|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175138|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175139|NCT03866174|Niacin|niacin|mesh-list
154175140|NCT03866174|Psilocybin|psilocybin|mesh-list
154175141|NCT03866174|Vitamins|vitamins|mesh-ancestor
154175142|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
154175157|NCT03740204|Estradiol|estradiol|mesh-list
154175158|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154175159|NCT03740204|Progesterone|progesterone|mesh-list
154175160|NCT03740204|Estrogens|estrogens|mesh-ancestor
154175161|NCT03740204|Hormones|hormones|mesh-ancestor
154175162|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175163|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175164|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154175165|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
154175166|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154175167|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154175168|NCT03740204|Progestins|progestins|mesh-ancestor
154175169|NCT03735563|Fentanyl|fentanyl|mesh-list
154175170|NCT03735563|Ketamine|ketamine|mesh-list
154175171|NCT03735563|Analgesics|analgesics|mesh-ancestor
154175172|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
154175173|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175174|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175175|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154175176|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154175177|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
154175178|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
154175179|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175180|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154175181|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154175182|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175183|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175184|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154175202|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
154175203|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
154175204|NCT03685773|Vitamins|vitamins|mesh-ancestor
154175205|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
154175206|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175207|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154175208|NCT03683277|Dexamethasone|dexamethasone|mesh-list
154175209|NCT03683277|Pomalidomide|pomalidomide|mesh-list
154175210|NCT03683277|Ixazomib|ixazomib|mesh-list
154175211|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175212|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
154175213|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
154175214|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175215|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175216|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154175217|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
154175218|NCT03683277|Hormones|hormones|mesh-ancestor
154175219|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175220|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154175221|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175222|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
154175223|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154175224|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154175225|NCT03683277|Growth Substances|growth substances|mesh-ancestor
154175226|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
154175227|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
154175228|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175229|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175230|NCT03665207|Insulin|insulin|mesh-list
154175231|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175232|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175233|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
154175234|NCT03660683|Saxagliptin|saxagliptin|mesh-list
154175235|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154175236|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175237|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153757869|NCT00176618|Analgesics|analgesics|mesh-ancestor
153629831|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153629832|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
154175238|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175239|NCT03660683|Incretins|incretins|mesh-ancestor
154175240|NCT03660683|Hormones|hormones|mesh-ancestor
154175241|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175242|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154175243|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
154175244|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175245|NCT03566511|Diazoxide|diazoxide|mesh-list
154175246|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154170873|NCT04177108|Paclitaxel|paclitaxel|mesh-list
154175247|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
154175248|NCT03464136|Adalimumab|adalimumab|mesh-list
154175249|NCT03464136|Ustekinumab|ustekinumab|mesh-list
154175250|NCT03464136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154175251|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175252|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175253|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
154175254|NCT03382587|Aflibercept|aflibercept|mesh-list
154175255|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154175256|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154175257|NCT03382587|Growth Substances|growth substances|mesh-ancestor
154175258|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175259|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
154175260|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175261|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
154175262|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154175263|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175264|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175265|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154175266|NCT03325972|Analgesics|analgesics|mesh-ancestor
154175267|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
154175268|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175269|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154175270|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154175271|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154175272|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
154175273|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175275|NCT03247712|Nivolumab|nivolumab|mesh-list
154175276|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175277|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175278|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154175279|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175280|NCT03048825|Colchicine|colchicine|mesh-list
154175281|NCT03048825|Spironolactone|spironolactone|mesh-list
154175282|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
154175283|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175284|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154175285|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154175286|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154175287|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175288|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175289|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154175290|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
154175291|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175292|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175293|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154175294|NCT03048825|Diuretics|diuretics|mesh-ancestor
154175295|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
154175297|NCT03039413|Trace Elements|trace elements|mesh-ancestor
154175298|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
154175299|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175300|NCT03026790|Buprenorphine|buprenorphine|mesh-list
154175301|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154175302|NCT03026790|Naloxone|naloxone|mesh-list
154175303|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154175304|NCT03026790|Narcotics|narcotics|mesh-ancestor
154175305|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175306|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629833|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629834|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
153629835|NCT00005823|Cytarabine|cytarabine|mesh-list
153629836|NCT00005823|Etoposide|etoposide|mesh-list
153629837|NCT00005823|Daunorubicin|daunorubicin|mesh-list
153629838|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
153629871|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629872|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
153629873|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629874|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629875|NCT00005832|Tipifarnib|tipifarnib|mesh-list
153629876|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175308|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
154175309|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175310|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154175311|NCT02637973|Empagliflozin|empagliflozin|mesh-list
154175312|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154175313|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175314|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175315|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175316|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
154175317|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
154175318|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175319|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
154175320|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154175321|NCT02527681|Cephalosporins|cephalosporins|mesh-list
154175322|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154175323|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175324|NCT02516696|Clarithromycin|clarithromycin|mesh-list
154175325|NCT02516696|Dexamethasone|dexamethasone|mesh-list
154175326|NCT02516696|Lenalidomide|lenalidomide|mesh-list
154175327|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175328|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
154175329|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
154175330|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175331|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175332|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154175333|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
154175334|NCT02516696|Hormones|hormones|mesh-ancestor
154175335|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175336|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154175337|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175338|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
154175339|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154175340|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153629877|NCT00005838|Paclitaxel|paclitaxel|mesh-list
153629880|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153629881|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629902|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
153629903|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629904|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154175341|NCT02516696|Growth Substances|growth substances|mesh-ancestor
154175342|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
154175343|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154175344|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175345|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154175346|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175347|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175348|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154175349|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154175350|NCT02513329|Bupivacaine|bupivacaine|mesh-list
154175351|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154175352|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
154175353|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175354|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175355|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
154175356|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175357|NCT02425826|Thalidomide|thalidomide|mesh-list
154175359|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154175360|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154175361|NCT02425826|Analgesics|analgesics|mesh-ancestor
154175362|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
154175363|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175364|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175365|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175366|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175367|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154175368|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154175369|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175370|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629905|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
153629906|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153646285|NCT00008021|Antibodies|antibodies|mesh-list
153629907|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153629908|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153629909|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629910|NCT00005853|Etanercept|etanercept|mesh-list
153629911|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153629912|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153629913|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153629914|NCT00005853|Analgesics|analgesics|mesh-ancestor
153629915|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
153629916|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629917|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175371|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154175372|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
154175373|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
154175374|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154175375|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175376|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154175377|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154175378|NCT02425826|Growth Substances|growth substances|mesh-ancestor
154175379|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
154175380|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175381|NCT02255357|Oxytocin|oxytocin|mesh-list
154175382|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
154175383|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154175384|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175385|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154175386|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175387|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175388|NCT02057107|Docetaxel|docetaxel|mesh-list
154175389|NCT02057107|Cetuximab|cetuximab|mesh-list
154175390|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175391|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154175392|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154175393|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154175394|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175395|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171024|NCT04059562|Irinotecan|irinotecan|mesh-list
154175396|NCT01479075|Insulin|insulin|mesh-list
154175397|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154175398|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175399|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175400|NCT01082679|Buprenorphine|buprenorphine|mesh-list
154175401|NCT01082679|Methadone|methadone|mesh-list
154175402|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154175403|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154175404|NCT01082679|Narcotics|narcotics|mesh-ancestor
154175412|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
154175413|NCT00976963|Fosfomycin|fosfomycin|mesh-list
154175414|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154175415|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175416|NCT00958633|Bupropion|bupropion|mesh-list
154175417|NCT00958633|Escitalopram|escitalopram|mesh-list
154175418|NCT00958633|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154175419|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154175420|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175421|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175422|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175423|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
154175424|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175425|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154175426|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
154175427|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154175428|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154175429|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
154175430|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154175431|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154175432|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175433|NCT00393783|Trastuzumab|trastuzumab|mesh-list
154175434|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175435|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175436|NCT00074269|Cyclosporine|cyclosporine|mesh-list
154175437|NCT00074269|Methotrexate|methotrexate|mesh-list
154175438|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
154175439|NCT00074269|Fludarabine|fludarabine|mesh-list
154175440|NCT00074269|Melphalan|melphalan|mesh-list
154175441|NCT00074269|Cyclosporins|cyclosporins|mesh-list
154175442|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154175443|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153758080|NCT00176813|Celecoxib|celecoxib|mesh-list
154175451|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
154175452|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175453|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154175454|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154175455|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
154175456|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175457|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154175458|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
154175459|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175460|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154175461|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154175462|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
154175463|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154175464|NCT00423735|Dasatinib|dasatinib|mesh-list
154175465|NCT00423735|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154175466|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154175467|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175468|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175469|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175470|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
154175471|NCT01032213|Analgesics|analgesics|mesh-ancestor
154175472|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
154175473|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175474|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175476|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175477|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154175478|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
154175479|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154175480|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175481|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175482|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154175483|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
154175485|NCT00357994|Levodopa|levodopa|mesh-list
154175492|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175493|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175494|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154175495|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175496|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154175497|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
154175498|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
154175499|NCT00823433|Penicillins|penicillins|mesh-list
154175500|NCT00823433|Penicillin V|penicillin v|mesh-list
154175501|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154175502|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175503|NCT00423657|Vancomycin|vancomycin|mesh-list
154175504|NCT00423657|Ceftaroline|ceftaroline|mesh-list
154175505|NCT00423657|Aztreonam|aztreonam|mesh-list
154175506|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154175507|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175508|NCT00423657|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154175509|NCT00831155|Nicotine|nicotine|mesh-list
154175551|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154175552|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
154175553|NCT02548403|Simethicone|simethicone|mesh-list
154175554|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
154175555|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175556|NCT02548403|Emollients|emollients|mesh-ancestor
154175557|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
154175558|NCT00367432|Levetiracetam|levetiracetam|mesh-list
154175559|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
154175560|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
154175561|NCT00623363|Piclozotan|piclozotan|mesh-list
154175562|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154175563|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154175564|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
154175565|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175566|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175567|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175568|NCT00827177|Sorafenib|sorafenib|mesh-list
154175569|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175570|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153646462|NCT00115492|Xhance|xhance|mesh-list
154175571|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175572|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175573|NCT00423267|Fluconazole|fluconazole|mesh-list
154175574|NCT00423267|Posaconazole|posaconazole|mesh-list
154175575|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
154175576|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175599|NCT00357760|Aflibercept|aflibercept|mesh-list
154175600|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
154175601|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154175602|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154175603|NCT00357760|Growth Substances|growth substances|mesh-ancestor
154175604|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175605|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
154175606|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175607|NCT00622739|Ziprasidone|ziprasidone|mesh-list
154175608|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154175609|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
154175610|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175611|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175612|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175613|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154175614|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154175615|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175616|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154175617|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154175618|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
154175620|NCT03742336|Abrocitinib|abrocitinib|mesh-list
154171250|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
154175621|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
154175622|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154175623|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
154175624|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175625|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175626|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
154175627|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154175628|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153629918|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629919|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153629920|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153629921|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629922|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
153629923|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
153629924|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629925|NCT00005859|Tipifarnib|tipifarnib|mesh-list
153629926|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629927|NCT00005862|Semaxinib|semaxinib|mesh-list
153629928|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153629929|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153629930|NCT00005862|Growth Substances|growth substances|mesh-ancestor
153629931|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175629|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
154175630|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175631|NCT00824057|Midazolam|midazolam|mesh-list
154175632|NCT00824057|Caffeine|caffeine|mesh-list
154175633|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154175634|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154175635|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175636|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175637|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154175638|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154175639|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154175640|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154175641|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
154175642|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
154175643|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
154175644|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
154175645|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175646|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175647|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154175648|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154175649|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175653|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
154175686|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175687|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
154175688|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175689|NCT00831545|Temozolomide|temozolomide|mesh-list
154175690|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154175691|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
154175692|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175693|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175694|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
154175695|NCT00824135|Rituximab|rituximab|mesh-list
154175696|NCT00824135|Melphalan|melphalan|mesh-list
154175697|NCT00824135|Thiotepa|thiotepa|mesh-list
154175698|NCT00824135|Clofarabine|clofarabine|mesh-list
154175699|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
154175700|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175701|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175702|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
154175703|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175704|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175705|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154175706|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154175707|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
154175708|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758352|NCT00200460|Nebivolol|nebivolol|mesh-list
153629932|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
153629933|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629934|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153629949|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629950|NCT00005871|Fluorouracil|fluorouracil|mesh-list
153629951|NCT00005871|Rubitecan|rubitecan|mesh-list
153629952|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
153629953|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629954|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629955|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629956|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629957|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
153629958|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629959|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153629960|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629961|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629962|NCT00005874|Rubitecan|rubitecan|mesh-list
153629963|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629964|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153629965|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629966|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629967|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175709|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154175710|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175711|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175712|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154175713|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
154175714|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154175715|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154175716|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154175717|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
154175718|NCT00422799|Rituximab|rituximab|mesh-list
154175719|NCT00422799|Bortezomib|bortezomib|mesh-list
154175720|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175721|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175722|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
154175723|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175724|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175725|NCT00827411|Aspirin|aspirin|mesh-list
154175726|NCT00827411|Clopidogrel|clopidogrel|mesh-list
154175727|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154175728|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154175729|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154175730|NCT00827411|Analgesics|analgesics|mesh-ancestor
154175731|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
154175732|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154175733|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175734|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175735|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175736|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154175737|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153646699|NCT00116662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175738|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175740|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154175752|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175754|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154175755|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175756|NCT00441129|Insulin|insulin|mesh-list
154175757|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175758|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175759|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
154175760|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154175761|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175762|NCT00831857|Bevacizumab|bevacizumab|mesh-list
154175763|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
154175764|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175765|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175766|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154175767|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154175768|NCT00831857|Growth Substances|growth substances|mesh-ancestor
154175769|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175770|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
154175771|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154175773|NCT00832013|Propofol|propofol|mesh-list
154175805|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
154175806|NCT00825071|Hormones|hormones|mesh-ancestor
154175807|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175808|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154175809|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175810|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
154175811|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
154175812|NCT00825071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154175813|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154175814|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
154175815|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175816|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175817|NCT00574847|Escitalopram|escitalopram|mesh-list
154175818|NCT00574847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154175819|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154175820|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175821|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175822|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175823|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
154175824|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175825|NCT00348790|Vatalanib|vatalanib|mesh-list
154175826|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154175827|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175828|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175829|NCT00825149|Prednisone|prednisone|mesh-list
153629969|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629970|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153629971|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629972|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629973|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629974|NCT00005880|Budesonide|budesonide|mesh-list
153629975|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629976|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153629977|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
153629978|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629979|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629980|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153629981|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
153629982|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
153629983|NCT00005880|Hormones|hormones|mesh-ancestor
153629984|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629985|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
153629986|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629987|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629988|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153629989|NCT00005883|Protective Agents|protective agents|mesh-ancestor
154175830|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
154175831|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154175833|NCT00825149|Fludarabine|fludarabine|mesh-list
154175834|NCT00825149|Vincristine|vincristine|mesh-list
154175835|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
154175836|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154175837|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
154175838|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175839|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154175840|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154175841|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
154175842|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175843|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175844|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154175845|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154175846|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154175847|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154175848|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175849|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154175850|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
154175851|NCT00825149|Hormones|hormones|mesh-ancestor
154175852|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175853|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154175854|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154175855|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629990|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629991|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629992|NCT00005886|Tamoxifen|tamoxifen|mesh-list
153629993|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153630014|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630015|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630016|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
153630017|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630018|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630019|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630020|NCT00005898|Cyclosporine|cyclosporine|mesh-list
153630021|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
153630022|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
153630023|NCT00005898|Fludarabine|fludarabine|mesh-list
153630024|NCT00005898|Cyclosporins|cyclosporins|mesh-list
153630025|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153630026|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630027|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
153630028|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630029|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630030|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630031|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
154175856|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
154175857|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
154175858|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154175859|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154175860|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
154175861|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
154175862|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154175863|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
154175864|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154175865|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175866|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154175867|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154175868|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154175869|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154175870|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154175871|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154175872|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175873|NCT02549105|Lidocaine|lidocaine|mesh-list
154175874|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154175875|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
154175876|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
154175877|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154175878|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175879|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
154175904|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
154175905|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175906|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175907|NCT00624065|Carvedilol|carvedilol|mesh-list
154175908|NCT00624065|Lisinopril|lisinopril|mesh-list
154175909|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154175910|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154175911|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
154175912|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175913|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175914|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175915|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154175916|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
154175917|NCT00624065|Protective Agents|protective agents|mesh-ancestor
154175918|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154175919|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175920|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154175921|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
154175922|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154175923|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154175924|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154175925|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
154175926|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154175927|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154175929|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154175930|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
154175931|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153630032|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630033|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630034|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630035|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630036|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
153630037|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630038|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
153630039|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153630040|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630041|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
153630042|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
153630043|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630044|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630045|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
153630046|NCT00005898|Hormones|hormones|mesh-ancestor
153630060|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630061|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630062|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153630063|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154175932|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175933|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154175934|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154175935|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154175936|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
154175937|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154175938|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154175939|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
154175940|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175941|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
154175942|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154175943|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154175944|NCT00825617|Hormones|hormones|mesh-list
154175945|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175946|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175947|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
154175948|NCT00360334|Exenatide|exenatide|mesh-list
154175949|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175950|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175951|NCT00360334|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154175952|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154175953|NCT00360334|Incretins|incretins|mesh-ancestor
154175954|NCT00360334|Hormones|hormones|mesh-ancestor
154175955|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175956|NCT00422097|Epothilones|epothilones|mesh-list
154175957|NCT00422097|Famotidine|famotidine|mesh-list
154175958|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
154175959|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
154175960|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
154175961|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175962|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154175963|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153758608|NCT00178373|Modafinil|modafinil|mesh-list
153630064|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630065|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153630066|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153630067|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630069|NCT00005922|Triamcinolone|triamcinolone|mesh-list
153630070|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153630071|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154175964|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154175965|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154175966|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
154175967|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
154175968|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154175969|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175970|NCT01051102|Insulin|insulin|mesh-list
154175971|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154175972|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
154175973|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
154175974|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154175975|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
154175976|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154175977|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154175978|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175979|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154175980|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
154175981|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175982|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154175983|NCT00434967|Candesartan|candesartan|mesh-list
154175984|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
154175985|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154175986|NCT00434967|Diuretics|diuretics|mesh-ancestor
154175987|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
154175988|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154175989|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154175990|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154175991|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154175992|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154175993|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154175994|NCT00833729|Etanercept|etanercept|mesh-list
154175995|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154175996|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153630072|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153630073|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630074|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
153630075|NCT00005922|Hormones|hormones|mesh-ancestor
153630076|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154175998|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
154175999|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176000|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176001|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176002|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176003|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176004|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176005|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
154176006|NCT00837239|Gemcitabine|gemcitabine|mesh-list
154176007|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154176008|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
154176009|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176010|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176011|NCT00833807|Paclitaxel|paclitaxel|mesh-list
154176012|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154176013|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154176014|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176015|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
154176016|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
154176017|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
154176018|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176019|NCT00833963|Trastuzumab|trastuzumab|mesh-list
154176020|NCT00833963|Pertuzumab|pertuzumab|mesh-list
154176021|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154176022|NCT00833963|Maytansine|maytansine|mesh-list
154176023|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154176024|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176025|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154176026|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
154176034|NCT00837317|Phenol|phenol|mesh-list
154176041|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176042|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176043|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176045|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154176046|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154176047|NCT00356590|Analgesics|analgesics|mesh-ancestor
154176048|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
154176049|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176050|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176051|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176052|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176053|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176054|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176055|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
154176056|NCT00828503|Valganciclovir|valganciclovir|mesh-list
154176057|NCT00828503|Everolimus|everolimus|mesh-list
154176058|NCT00828503|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154176059|NCT00828503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154176060|NCT00828503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176061|NCT00828503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176062|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176063|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
153758704|NCT00559858|Pyridoxine|pyridoxine|mesh-list
153630077|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630078|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630079|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
153630080|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630081|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630082|NCT00005925|Muscimol|muscimol|mesh-list
153630083|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153630084|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
153630085|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
153630086|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153630087|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630088|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630089|NCT00005928|Ramipril|ramipril|mesh-list
153630090|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153630091|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
153630092|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630093|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630094|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153630095|NCT00005931|Semaxinib|semaxinib|mesh-list
153630096|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153630097|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153630098|NCT00005931|Growth Substances|growth substances|mesh-ancestor
153630099|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630100|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
153630101|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630102|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153630103|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176064|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176065|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176066|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
154176067|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176068|NCT00834665|Molgramostim|molgramostim|mesh-list
154176069|NCT00834665|Sargramostim|sargramostim|mesh-list
154176071|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176072|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176073|NCT00837707|Aripiprazole|aripiprazole|mesh-list
154176074|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
154176075|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154176076|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154176077|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154176078|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176079|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176080|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
154176081|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
154176082|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176083|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176084|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154176085|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154176086|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
154176087|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154176088|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154176089|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154176090|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154176091|NCT01055938|Valproic Acid|valproic acid|mesh-list
154176092|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
154176093|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176095|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
154176110|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176111|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154176112|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
154176113|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176114|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
154176115|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176116|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154176117|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176118|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176119|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154176120|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154176121|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154176122|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
154176123|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
154176124|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176125|NCT03991780|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154176126|NCT03991780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154176127|NCT03991780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176128|NCT03991780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176129|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
154176130|NCT00837941|Promethazine|promethazine|mesh-list
154176132|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154176133|NCT00837941|Analgesics|analgesics|mesh-ancestor
154176134|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
154176135|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176136|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176137|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
154176138|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154176139|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154176140|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176141|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154176142|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154176143|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154176144|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176147|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154176148|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176149|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
154176150|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
154176151|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154176152|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154176153|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
154176154|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
154176155|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
154176156|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
154176157|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176158|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154176159|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
154176160|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
154176161|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154176162|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
154176163|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
154176164|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
154176165|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154176205|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176206|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176207|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154176208|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154176209|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176210|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176272|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
154176273|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176274|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154176275|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154176276|NCT01056172|Ribavirin|ribavirin|mesh-list
154176277|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154176278|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
154176279|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
154176280|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176281|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
154176337|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154176338|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154176339|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
154176340|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176341|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176342|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176343|NCT00836381|Urological Agents|urological agents|mesh-ancestor
154176344|NCT02533336|Abamectin|abamectin|mesh-list
154176345|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
154176346|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154176347|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176348|NCT01053910|Ramipril|ramipril|mesh-list
154176349|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154176350|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
154176351|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176352|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176353|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154176354|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154176355|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
154176356|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176357|NCT01008384|Vitamin D|vitamin d|mesh-list
154176358|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
154176359|NCT01008384|Vitamins|vitamins|mesh-ancestor
154176360|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
154176364|NCT02547155|Anesthetics|anesthetics|mesh-list
154176387|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
154176388|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154176389|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176390|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176391|NCT00839501|Diuretics|diuretics|mesh-ancestor
154176392|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
154176393|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176394|NCT00529542|Atorvastatin|atorvastatin|mesh-list
154176395|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154176396|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154176397|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
154176398|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176399|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154176400|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154176401|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176402|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
154176403|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176404|NCT00621959|Levocetirizine|levocetirizine|mesh-list
154176405|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154176406|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154176407|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
154176408|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
154176409|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176410|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176411|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176412|NCT00839657|Warfarin|warfarin|mesh-list
154176413|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
154176414|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
154176415|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
154176430|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154176431|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176432|NCT00840125|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154176433|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154176434|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176435|NCT00830531|Bumetanide|bumetanide|mesh-list
154176436|NCT00830531|Diuretics|diuretics|mesh-ancestor
154176437|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
154176438|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176439|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154176440|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154176441|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027497|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154027498|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027499|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027500|NCT00891371|Lanreotide|lanreotide|mesh-list
154027501|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027502|NCT02829281|Triamcinolone|triamcinolone|mesh-list
154027503|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154027504|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154027505|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
154027506|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154027507|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154027508|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154027509|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154027510|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154027511|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027512|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
153972060|NCT00775528|Pancrelipase|pancrelipase|mesh-list
153972061|NCT00775528|Pancreatin|pancreatin|mesh-list
153972062|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972063|NCT02701179|Lidocaine|lidocaine|mesh-list
153972064|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153972065|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
153972066|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
153972067|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972068|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972126|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153972127|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153972128|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153972129|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972130|NCT00775450|Vaccines|vaccines|mesh-list
153972131|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
153972132|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972133|NCT02700477|Fenugreek seed meal|fenugreek seed meal|mesh-list
153972134|NCT02700477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153972135|NCT02700477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972136|NCT02699385|Domperidone|domperidone|mesh-list
153972137|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
153972138|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
153972139|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972140|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972141|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153972142|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153972143|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
153972144|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972146|NCT02700087|Famotidine|famotidine|mesh-list
153972183|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153972184|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
153972186|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972187|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153972188|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153972189|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972190|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972191|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153972192|NCT03236805|Narcotics|narcotics|mesh-ancestor
153972193|NCT02698995|Acetaminophen|acetaminophen|mesh-list
153972194|NCT02698995|Dexamethasone|dexamethasone|mesh-list
153972246|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972247|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153972248|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
153972249|NCT02698527|Lidocaine|lidocaine|mesh-list
153972250|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
153972251|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
153972252|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972253|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972254|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
153972255|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972256|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153972257|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153972258|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153972259|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972260|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972304|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972305|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153972306|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
153972307|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
153972308|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153972309|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972310|NCT00783796|Everolimus|everolimus|mesh-list
153972311|NCT00783796|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153972312|NCT00783796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972313|NCT00783796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972314|NCT00783796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972315|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153972316|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
153972317|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972318|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972319|NCT00637065|Bosentan|bosentan|mesh-list
153972320|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153972321|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153972322|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972323|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
153972324|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
153972325|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153972327|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972328|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972329|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153972330|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153972331|NCT04079647|Immunomodulating Agents|immunomodulating agents|mesh-list
153972332|NCT04079647|Immunologic Factors|immunologic factors|mesh-ancestor
153972333|NCT04079647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972348|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153972349|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972350|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972351|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153972352|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153972353|NCT02607891|Cannabidiol|cannabidiol|mesh-list
153972354|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
153972355|NCT02607813|Spartalizumab|spartalizumab|mesh-list
153972356|NCT02607813|Naporafenib|naporafenib|mesh-list
153972357|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153972358|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972359|NCT02607813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153972360|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972361|NCT02607813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972362|NCT02607813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972408|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153972409|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
153972410|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
153972411|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153972412|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153972413|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972414|NCT00915460|Interferons|interferons|mesh-list
153972415|NCT00915460|Interferon-beta|interferon-beta|mesh-list
153972416|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
153972417|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972418|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
153972419|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972420|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
153972421|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972422|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153972423|NCT00617643|Nevirapine|nevirapine|mesh-list
153972424|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153972425|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153972426|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972427|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972428|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
153972429|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972462|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972463|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153972464|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
153972465|NCT02584231|Coagulants|coagulants|mesh-ancestor
153972466|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153972467|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
153972468|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972469|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
153972530|NCT05435911|Propofol|propofol|mesh-list
153972531|NCT05435911|Flumazenil|flumazenil|mesh-list
153972532|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153972533|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972534|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972535|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153972536|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
153972537|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
153972538|NCT05435911|Antidotes|antidotes|mesh-ancestor
153972539|NCT05435911|Protective Agents|protective agents|mesh-ancestor
153972540|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
153972541|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
153972542|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972543|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972544|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153972545|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
153972546|NCT02583685|Ribavirin|ribavirin|mesh-list
153972547|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153972548|NCT02583685|Simeprevir|simeprevir|mesh-list
153972549|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
153972550|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176470|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153972585|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153972586|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153972587|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153972588|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972589|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972590|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
153972591|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972592|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972593|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153972594|NCT00583219|Protective Agents|protective agents|mesh-ancestor
153972595|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153972596|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
153972597|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153972598|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972599|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
153972600|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
153972601|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972602|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153972603|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153972604|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
153972605|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972606|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972607|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153972608|NCT02581501|Gemcitabine|gemcitabine|mesh-list
153972630|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
153972631|NCT04426669|Fludarabine|fludarabine|mesh-list
153972632|NCT04426669|Interleukin-2|interleukin-2|mesh-list
153972633|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153972701|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153972702|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
153972703|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
153972704|NCT02583217|Analgesics|analgesics|mesh-ancestor
153972705|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
153972706|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972707|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153972708|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153972709|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153972710|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972711|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972712|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153972713|NCT02583217|Narcotics|narcotics|mesh-ancestor
153972714|NCT00774046|Cytarabine|cytarabine|mesh-list
153972715|NCT00774046|Etoposide|etoposide|mesh-list
153972716|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
153972717|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153972718|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972719|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153972720|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153972721|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972722|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972723|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153972724|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
153972725|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
153972726|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972750|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972751|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153972752|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153972753|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153972754|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
153647723|NCT00009672|Analgesics|analgesics|mesh-ancestor
153972755|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153972756|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972757|NCT04102072|Protective Agents|protective agents|mesh-ancestor
153972758|NCT02875457|Cisplatin|cisplatin|mesh-list
153972759|NCT02875457|Etoposide|etoposide|mesh-list
153972760|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
153972761|NCT02875457|Apatinib|apatinib|mesh-list
153972762|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972763|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153972764|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153972765|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153972766|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972767|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972768|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972769|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
153972770|NCT00773968|Hematinics|hematinics|mesh-ancestor
153972771|NCT04060381|Ibuprofen|ibuprofen|mesh-list
153972772|NCT04060381|Dopamine|dopamine|mesh-list
153972773|NCT04060381|Epinephrine|epinephrine|mesh-list
153972774|NCT04060381|Norepinephrine|norepinephrine|mesh-list
153972775|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153972800|NCT04060381|Protective Agents|protective agents|mesh-ancestor
153972801|NCT00782626|Everolimus|everolimus|mesh-list
153972802|NCT00782626|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153972803|NCT00782626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153972804|NCT00782626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972805|NCT00782626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972806|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153972807|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
153972808|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972809|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972810|NCT04076371|Olanzapine|olanzapine|mesh-list
153972811|NCT04076371|Risperidone|risperidone|mesh-list
153972812|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153972813|NCT04076371|Ziprasidone|ziprasidone|mesh-list
153972814|NCT04076371|Sertraline|sertraline|mesh-list
153972826|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
153972861|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153972862|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972863|NCT04078399|Interferons|interferons|mesh-list
153972864|NCT04078399|Azacitidine|azacitidine|mesh-list
153972865|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972866|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
153972867|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972868|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153972869|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
153972870|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972871|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153972872|NCT05189509|Plasminogen|plasminogen|mesh-list
153972873|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153972874|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153972875|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153972876|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972877|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153972878|NCT01010126|Sirolimus|sirolimus|mesh-list
153972879|NCT01010126|Bevacizumab|bevacizumab|mesh-list
153972880|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153972881|NCT01010126|Temsirolimus|temsirolimus|mesh-list
153972882|NCT01010126|MTOR Inhibitors|mtor inhibitors|mesh-list
153972883|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
153972884|NCT01010126|Antibodies|antibodies|mesh-list
153972885|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
153972886|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153972887|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
153972911|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972913|NCT03879577|Tamoxifen|tamoxifen|mesh-list
153972914|NCT03879577|Docetaxel|docetaxel|mesh-list
153972915|NCT03879577|Trastuzumab|trastuzumab|mesh-list
153972916|NCT03879577|Letrozole|letrozole|mesh-list
153972917|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153972918|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
153972919|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
153972920|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
153972921|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972922|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153972923|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153972924|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153972925|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626532|NCT02017314|Morphine|morphine|mesh-list
153972927|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
153972928|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153972929|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972930|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153972931|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153972932|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153972933|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153972934|NCT00617877|Losartan|losartan|mesh-list
153972935|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153972936|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153972937|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153972938|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153630104|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630105|NCT00005934|Azacitidine|azacitidine|mesh-list
153630126|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
153630127|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630128|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630129|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630130|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153630131|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
153630132|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153630133|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630134|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
153630135|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
153630136|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630137|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153630138|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153630139|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
153972939|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153972940|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972941|NCT00617877|Diuretics|diuretics|mesh-ancestor
153972942|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
153972943|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972944|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153972945|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153972946|NCT00617955|Aprotinin|aprotinin|mesh-list
153972947|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972948|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
153972949|NCT00617955|Coagulants|coagulants|mesh-ancestor
153972950|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153972951|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153972952|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
153972953|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973000|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153973001|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
153973002|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973003|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973004|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153973005|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153973007|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973008|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153973009|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153973010|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153973011|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153973012|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
153973013|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
153973015|NCT03824587|Sevelamer|sevelamer|mesh-list
153973016|NCT03824587|Calcium acetate|calcium acetate|mesh-list
153973017|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153973018|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973019|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153973020|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
153973021|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
153973022|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973023|NCT03824587|Antacids|antacids|mesh-ancestor
153973024|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153973025|NCT00773734|Thalidomide|thalidomide|mesh-list
153630140|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630141|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153630142|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153630143|NCT00005940|Trace Elements|trace elements|mesh-ancestor
153630144|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
153630145|NCT00005943|Aldesleukin|aldesleukin|mesh-list
153630146|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630147|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153630148|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153630149|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
153630150|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630151|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
153630152|NCT00005946|Etoposide|etoposide|mesh-list
153630153|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630154|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
153630155|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630156|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630157|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630158|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
153630159|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630181|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630182|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630183|NCT00005955|Temozolomide|temozolomide|mesh-list
153973026|NCT00773734|Apremilast|apremilast|mesh-list
153973027|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973028|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973029|NCT00773734|Analgesics|analgesics|mesh-ancestor
153973030|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
153973031|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973032|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973033|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973034|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973035|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153973036|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153973037|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973038|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973039|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973040|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
153973087|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973088|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973089|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
153973090|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973091|NCT01001702|Aripiprazole|aripiprazole|mesh-list
153973092|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
153973093|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153973094|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153973095|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153973096|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973097|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973098|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
153973099|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
153973100|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973101|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973102|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153973103|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153973104|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
153973105|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153973106|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153973107|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153973108|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153973109|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
153973110|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153973111|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973112|NCT00618345|Everolimus|everolimus|mesh-list
153973113|NCT00618345|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153973114|NCT00618345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153973115|NCT00618345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973117|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973128|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973129|NCT02601898|Protective Agents|protective agents|mesh-ancestor
153973130|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
153973131|NCT02601898|Vitamins|vitamins|mesh-ancestor
153973132|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
153973133|NCT00618423|Ketamine|ketamine|mesh-list
153973134|NCT00618423|Analgesics|analgesics|mesh-ancestor
153973135|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
153973136|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973137|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973138|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153973139|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153973140|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
153973141|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
153973189|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973190|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973191|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153973192|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153973193|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153973194|NCT01068665|Insulin|insulin|mesh-list
153973195|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153973196|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
153973197|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973198|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973199|NCT00618501|Leucovorin|leucovorin|mesh-list
153973254|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973255|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973256|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
153973257|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153973258|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973259|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973260|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153973261|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153973262|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153973263|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973317|NCT01005602|Digoxin|digoxin|mesh-list
153973318|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153973319|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153973320|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973321|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973322|NCT01005602|Protective Agents|protective agents|mesh-ancestor
153973323|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973324|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153973325|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
153973326|NCT05490940|Coagulants|coagulants|mesh-ancestor
153973327|NCT04304261|Metformin|metformin|mesh-list
153973328|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
153973329|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973330|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973331|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153973332|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973333|NCT00768430|Midazolam|midazolam|mesh-list
153973334|NCT00768430|Ketamine|ketamine|mesh-list
153973335|NCT00768430|Analgesics|analgesics|mesh-ancestor
153973336|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
153973337|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973338|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973370|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153973371|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973372|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153973374|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
153973375|NCT01064297|Valproic Acid|valproic acid|mesh-list
153973376|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153973377|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973378|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973379|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153973380|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973381|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153973382|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153973387|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
153973431|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153973432|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153973433|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153973434|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973435|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973436|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973437|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973438|NCT00767806|Analgesics|analgesics|mesh-ancestor
153973439|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
153973440|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973441|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
153973442|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153973443|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
153973444|NCT00780910|Ribavirin|ribavirin|mesh-list
153973445|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153973446|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
153973447|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973448|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
153973449|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973450|NCT02582203|Vancomycin|vancomycin|mesh-list
153973451|NCT02582203|Ceftaroline|ceftaroline|mesh-list
153973457|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973458|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153973459|NCT00771472|Vorinostat|vorinostat|mesh-list
153973460|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973461|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153973462|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973463|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973464|NCT00771316|Meropenem|meropenem|mesh-list
153973465|NCT00771316|Ertapenem|ertapenem|mesh-list
153973466|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153973480|NCT06184698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973481|NCT06184698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153973482|NCT06184698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973483|NCT06184698|Immunologic Factors|immunologic factors|mesh-ancestor
153973484|NCT06184698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153973485|NCT06184698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153973486|NCT06184698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973487|NCT06184698|Antidotes|antidotes|mesh-ancestor
153973488|NCT06184698|Protective Agents|protective agents|mesh-ancestor
153973489|NCT06184698|Vitamin B Complex|vitamin b complex|mesh-ancestor
153973490|NCT06184698|Vitamins|vitamins|mesh-ancestor
153973491|NCT06184698|Micronutrients|micronutrients|mesh-ancestor
153973492|NCT06184685|Diclofenac|diclofenac|mesh-list
153973493|NCT06184685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973494|NCT06184685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973495|NCT06184685|Analgesics|analgesics|mesh-ancestor
153973496|NCT06184685|Sensory System Agents|sensory system agents|mesh-ancestor
153973497|NCT06184685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973498|NCT06184685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973499|NCT06184685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973500|NCT06184685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973501|NCT06184685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153973502|NCT06184685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973503|NCT06184685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973508|NCT06184334|Tadalafil|tadalafil|mesh-list
153973509|NCT06184334|Mirabegron|mirabegron|mesh-list
153973510|NCT06184334|Vasodilator Agents|vasodilator agents|mesh-ancestor
153973511|NCT06184334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153760622|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
153630184|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630185|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
153630186|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630187|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630189|NCT00005958|Docetaxel|docetaxel|mesh-list
153630190|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630191|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
153630192|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630193|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630194|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
153630195|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
153630196|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
153630197|NCT00005961|Carmustine|carmustine|mesh-list
153630198|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153630199|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630200|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
153630201|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630202|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973512|NCT06184334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153973513|NCT06184334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973514|NCT06184334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973515|NCT06184334|Urological Agents|urological agents|mesh-ancestor
153973516|NCT06184334|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153973517|NCT06184334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153973518|NCT06184334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153973519|NCT06184334|Adrenergic Agents|adrenergic agents|mesh-ancestor
153973520|NCT06184334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973521|NCT06184334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973522|NCT06184321|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153973523|NCT06184321|Plasminogen|plasminogen|mesh-list
153973524|NCT06184321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153973525|NCT06184321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153973526|NCT06184321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973527|NCT06184139|Misoprostol|misoprostol|mesh-list
153973528|NCT06184139|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153973529|NCT06184139|Abortifacient Agents|abortifacient agents|mesh-ancestor
153973530|NCT06184139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153973566|NCT06249867|Cholinergic Agents|cholinergic agents|mesh-ancestor
153973567|NCT06249867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973568|NCT06249867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973569|NCT06249867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973570|NCT06249867|Urological Agents|urological agents|mesh-ancestor
153973571|NCT06249802|Nebivolol|nebivolol|mesh-list
153973572|NCT06249802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153973573|NCT06249802|Vasodilator Agents|vasodilator agents|mesh-ancestor
153973574|NCT06249802|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153973575|NCT06249802|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153973576|NCT06249802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153973577|NCT06249802|Adrenergic Agents|adrenergic agents|mesh-ancestor
153973578|NCT06249802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153973579|NCT06249802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973580|NCT06249802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973581|NCT06249789|Anesthetics|anesthetics|mesh-list
153973582|NCT06249789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153973583|NCT06249789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973584|NCT06249750|Tislelizumab|tislelizumab|mesh-list
153973585|NCT06249750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153973586|NCT06249750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153973587|NCT06249750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973588|NCT06249750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973615|NCT06249191|Prednisone|prednisone|mesh-list
153973616|NCT06249191|Cortisone|cortisone|mesh-list
153973617|NCT06249191|Cyclophosphamide|cyclophosphamide|mesh-list
153973618|NCT06249191|Doxorubicin|doxorubicin|mesh-list
153973619|NCT06249191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153973620|NCT06249191|Etoposide|etoposide|mesh-list
153973621|NCT06249191|Vincristine|vincristine|mesh-list
153973622|NCT06249191|Etoposide phosphate|etoposide phosphate|mesh-list
153973623|NCT06249191|Daunorubicin|daunorubicin|mesh-list
153973624|NCT06249191|Podophyllotoxin|podophyllotoxin|mesh-list
153973625|NCT06249191|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153973626|NCT06249191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973627|NCT06249191|Immunologic Factors|immunologic factors|mesh-ancestor
153973628|NCT06249191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973629|NCT06249191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973641|NCT06249191|Hormones|hormones|mesh-ancestor
153973677|NCT06248749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973678|NCT06248749|Hematinics|hematinics|mesh-ancestor
153973679|NCT06248710|Oxytocin|oxytocin|mesh-list
153973680|NCT06248710|Oxytocics|oxytocics|mesh-ancestor
153973681|NCT06248710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153973682|NCT06248710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973683|NCT06248671|Atorvastatin|atorvastatin|mesh-list
153973684|NCT06248671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153973685|NCT06248671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153973686|NCT06248671|Antimetabolites|antimetabolites|mesh-ancestor
153973687|NCT06248671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973688|NCT06248671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153973689|NCT06248671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153973690|NCT06248671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973691|NCT06248606|Adagrasib|adagrasib|mesh-list
153973692|NCT06248606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973693|NCT06248554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153973695|NCT06248554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153973733|NCT06248112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153973734|NCT06248112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153973735|NCT06248112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153973736|NCT06248112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153648553|NCT00000143|Ganciclovir|ganciclovir|mesh-list
153973737|NCT06248112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973738|NCT06248099|Nebivolol|nebivolol|mesh-list
153973739|NCT06248099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153973740|NCT06248099|Vasodilator Agents|vasodilator agents|mesh-ancestor
153973741|NCT06248099|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153973742|NCT06248099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153973743|NCT06248099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153973793|NCT06247787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153973794|NCT06247787|Immunologic Factors|immunologic factors|mesh-ancestor
153973795|NCT06247787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973796|NCT06247787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153973797|NCT06247787|Antiviral Agents|antiviral agents|mesh-ancestor
153973798|NCT06247787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153973799|NCT06247787|Antidotes|antidotes|mesh-ancestor
153973800|NCT06247787|Protective Agents|protective agents|mesh-ancestor
153973801|NCT06247787|Vitamin B Complex|vitamin b complex|mesh-ancestor
153973802|NCT06247787|Vitamins|vitamins|mesh-ancestor
153973803|NCT06247787|Micronutrients|micronutrients|mesh-ancestor
153973804|NCT06247787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973805|NCT06247787|Hematinics|hematinics|mesh-ancestor
153973806|NCT06247787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153973807|NCT06247748|Metformin|metformin|mesh-list
153973808|NCT06247748|Exenatide|exenatide|mesh-list
153973809|NCT06247748|Digoxin|digoxin|mesh-list
153973810|NCT06247748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153973852|NCT06245980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973853|NCT06245980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973854|NCT06227910|Upadacitinib|upadacitinib|mesh-list
153973855|NCT06227910|Vedolizumab|vedolizumab|mesh-list
153973856|NCT06227910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153973857|NCT06227910|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153973858|NCT06227910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153973859|NCT06227910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153973860|NCT06227910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973861|NCT06227910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153973862|NCT06227650|Insulin|insulin|mesh-list
153973863|NCT06227650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153973864|NCT06227650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973865|NCT06193421|Ambroxol|ambroxol|mesh-list
153973866|NCT06193421|Expectorants|expectorants|mesh-ancestor
153973912|NCT06090500|Dexamethasone acetate|dexamethasone acetate|mesh-list
153973913|NCT06090500|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153973914|NCT06090500|BB 1101|bb 1101|mesh-list
153973915|NCT06090500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973916|NCT06090500|Antiemetics|antiemetics|mesh-ancestor
153973917|NCT06090500|Autonomic Agents|autonomic agents|mesh-ancestor
153973918|NCT06090500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973919|NCT06090500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153973920|NCT06090500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153973921|NCT06090500|Glucocorticoids|glucocorticoids|mesh-ancestor
153973922|NCT06090500|Hormones|hormones|mesh-ancestor
153973923|NCT06090500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153973924|NCT06090500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153973925|NCT06090500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153973926|NCT06090500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153973927|NCT06090500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153973969|NCT06034418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153973970|NCT06034418|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153973971|NCT06034418|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153973972|NCT06034418|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153973973|NCT06034418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153973974|NCT06034418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153973975|NCT06034418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153973977|NCT06034418|Hormones|hormones|mesh-ancestor
153973978|NCT06034418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153973979|NCT06034418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153973980|NCT06034418|Respiratory System Agents|respiratory system agents|mesh-ancestor
153974030|NCT05994534|Protective Agents|protective agents|mesh-ancestor
153974031|NCT05994534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974032|NCT05994534|Antidotes|antidotes|mesh-ancestor
153974033|NCT05994534|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153974034|NCT05993949|Dasatinib|dasatinib|mesh-list
153974035|NCT05993949|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153974036|NCT05993949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974037|NCT05993949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974038|NCT05993949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974039|NCT05993949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974040|NCT05983276|Paclitaxel|paclitaxel|mesh-list
153974041|NCT05983276|Carboplatin|carboplatin|mesh-list
153974042|NCT05983276|Decitabine|decitabine|mesh-list
153974043|NCT05983276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974044|NCT05983276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974045|NCT05983276|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974050|NCT05983276|Antimetabolites|antimetabolites|mesh-ancestor
153974089|NCT05917522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974090|NCT05917522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153974091|NCT05916339|Methylphenidate|methylphenidate|mesh-list
153974092|NCT05916339|Amphetamine|amphetamine|mesh-list
153974093|NCT05916339|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
153974094|NCT05916339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974095|NCT05916339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153974096|NCT05916339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153974097|NCT05916339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974098|NCT05916339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974099|NCT05916339|Dopamine Agents|dopamine agents|mesh-ancestor
153974100|NCT05916339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974101|NCT05916339|Sympathomimetics|sympathomimetics|mesh-ancestor
153974102|NCT05916339|Autonomic Agents|autonomic agents|mesh-ancestor
153974148|NCT05877313|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153974149|NCT05877313|Vasodilator Agents|vasodilator agents|mesh-ancestor
153974150|NCT05877313|Gasotransmitters|gasotransmitters|mesh-ancestor
153974151|NCT05877313|Protective Agents|protective agents|mesh-ancestor
153974152|NCT05875428|Mitoxantrone|mitoxantrone|mesh-list
153974153|NCT05875428|Analgesics|analgesics|mesh-ancestor
153974154|NCT05875428|Sensory System Agents|sensory system agents|mesh-ancestor
153974155|NCT05875428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974156|NCT05875428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974157|NCT05875428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974158|NCT05875428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153974159|NCT05875428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153974213|NCT05806060|Vinorelbine|vinorelbine|mesh-list
153974214|NCT05806060|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153974215|NCT05806060|Bevacizumab|bevacizumab|mesh-list
153974216|NCT05806060|Carboplatin|carboplatin|mesh-list
153974217|NCT05806060|Capecitabine|capecitabine|mesh-list
153974218|NCT05806060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974219|NCT05806060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974220|NCT05806060|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974221|NCT05806060|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974222|NCT05806060|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974223|NCT05806060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974224|NCT05806060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974225|NCT05806060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153974226|NCT05806060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153974227|NCT05806060|Growth Substances|growth substances|mesh-ancestor
153974279|NCT05681039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974280|NCT05672095|Selenium|selenium|mesh-list
153974281|NCT05672095|Niraparib|niraparib|mesh-list
153974282|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153974283|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974284|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974285|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974286|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
153974287|NCT05672095|Protective Agents|protective agents|mesh-ancestor
153974288|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974289|NCT05672095|Trace Elements|trace elements|mesh-ancestor
153974290|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
153974291|NCT05665699|Allopurinol|allopurinol|mesh-list
153974292|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
153974293|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974294|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974295|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
153974296|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153974297|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153974298|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
153974299|NCT05665699|Protective Agents|protective agents|mesh-ancestor
153974300|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974301|NCT05644600|Nintedanib|nintedanib|mesh-list
153974302|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974303|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974304|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974305|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974306|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
153974307|NCT05633602|Ramucirumab|ramucirumab|mesh-list
153974308|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974309|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974310|NCT05633602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974311|NCT05633602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974319|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974320|NCT05619913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974321|NCT05619913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974322|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
153974323|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153974324|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
153974325|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974326|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
153974327|NCT05618496|Protective Agents|protective agents|mesh-ancestor
153974328|NCT05601531|Calcitriol|calcitriol|mesh-list
153974329|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153974330|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974331|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153974332|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974333|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974334|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153974335|NCT05601531|Vitamins|vitamins|mesh-ancestor
153974374|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974375|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
153974376|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974377|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153974378|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
153974379|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153974380|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153974381|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153974382|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974383|NCT05453851|Pancrelipase|pancrelipase|mesh-list
153974385|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153974403|NCT05434377|Vitamin D|vitamin d|mesh-list
153974404|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
153974405|NCT05434377|Vitamins|vitamins|mesh-ancestor
153974433|NCT05389852|Analgesics|analgesics|mesh-ancestor
153974434|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
153974435|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974436|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153974437|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153974438|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153974439|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
153974440|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974441|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974442|NCT05367362|Minocycline|minocycline|mesh-list
153974443|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153974444|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153974445|NCT05357989|Phenserine|phenserine|mesh-list
153974446|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153974447|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974492|NCT05170724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974493|NCT05170724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974494|NCT05108428|Capecitabine|capecitabine|mesh-list
153974495|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974496|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
153974497|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974498|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732055|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
153974499|NCT05072314|Lidocaine|lidocaine|mesh-list
153974500|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
153974501|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
153974502|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153974553|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
153974554|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153974555|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153974556|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
153974557|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974558|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974559|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153974560|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
153974620|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974621|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153974622|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153974623|NCT04855968|Analgesics|analgesics|mesh-list
153974624|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
153974625|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974626|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974627|NCT04848974|Cytarabine|cytarabine|mesh-list
153974628|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
153974685|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153974686|NCT04732286|Growth Substances|growth substances|mesh-ancestor
153974687|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974688|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
153974689|NCT04732286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974690|NCT04732286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974691|NCT04725617|Varenicline|varenicline|mesh-list
153974692|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153974693|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153974694|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
153974695|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974696|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974697|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974698|NCT04711824|Paclitaxel|paclitaxel|mesh-list
153974699|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153974700|NCT04711824|Cisplatin|cisplatin|mesh-list
153974743|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974744|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974745|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153974746|NCT04661150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153974748|NCT04659603|Maytansine|maytansine|mesh-list
153974749|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153974750|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
153974751|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974752|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974754|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974810|NCT04494425|Trastuzumab|trastuzumab|mesh-list
153974811|NCT04494425|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153974812|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153974813|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974814|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
153974815|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
153974816|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
153974817|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974819|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
153974892|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
153974893|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153974894|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153974895|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153974896|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
153974897|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153974898|NCT04360005|Asciminib|asciminib|mesh-list
153974899|NCT04360005|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153974900|NCT04360005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153974901|NCT04360005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153974902|NCT04360005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974903|NCT04351438|Heparin|heparin|mesh-list
153974904|NCT04351438|Citric Acid|citric acid|mesh-list
153974905|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
153974906|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
153974907|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153974908|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
153974909|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
153974930|NCT04297332|Nicotine|nicotine|mesh-list
153974949|NCT04282044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153974950|NCT04282044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153974952|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153974953|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
153974954|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153974955|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974956|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153974957|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153974958|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
153974959|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153974960|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153974961|NCT04265950|Vaccines|vaccines|mesh-list
153974962|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
153974963|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153974964|NCT04250116|Clopidogrel|clopidogrel|mesh-list
153974965|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153975006|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975007|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975008|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975009|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975010|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153975011|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153975012|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975013|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975020|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
153975021|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975022|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975080|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153975081|NCT03765619|Analgesics|analgesics|mesh-ancestor
153975082|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
153975083|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975084|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975085|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975086|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975087|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153975093|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
153975145|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975146|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975147|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153975148|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153975149|NCT03351296|Growth Substances|growth substances|mesh-ancestor
153975150|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975151|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
153975152|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975153|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
153975154|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975155|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153975160|NCT03246529|Lenograstim|lenograstim|mesh-list
153975208|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975209|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153975210|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153975211|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975212|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
153975213|NCT02775773|Coagulants|coagulants|mesh-ancestor
153975214|NCT02595892|Gemcitabine|gemcitabine|mesh-list
153975216|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
153975273|NCT02220985|Tacrolimus|tacrolimus|mesh-list
153975274|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153975275|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
153975276|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975277|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153975278|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153975279|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
153975280|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975281|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975337|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153975338|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
153975339|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153975340|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153975341|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975342|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153975343|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153975344|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
153975346|NCT00727103|Varenicline|varenicline|mesh-list
153975402|NCT06182592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975403|NCT06182592|Antimetabolites|antimetabolites|mesh-ancestor
153975404|NCT06182592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975405|NCT06182592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975406|NCT06182592|Antiviral Agents|antiviral agents|mesh-ancestor
153975407|NCT06182592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153975408|NCT06182592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153975409|NCT06182592|Immunologic Factors|immunologic factors|mesh-ancestor
153975410|NCT06182592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975411|NCT06182592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153975412|NCT06182592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153975413|NCT06182592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153975414|NCT06182592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975415|NCT06180096|Riociguat|riociguat|mesh-list
153975416|NCT06180096|Enzyme Activators|enzyme activators|mesh-ancestor
153975417|NCT06180096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975460|NCT06154447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153975461|NCT06154447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153975462|NCT06154447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153975463|NCT06154447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975464|NCT06154447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153975465|NCT06154447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153975466|NCT06154447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153975467|NCT06154447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153975468|NCT06154447|Anesthetics, General|anesthetics, general|mesh-ancestor
153975469|NCT06154447|Anesthetics|anesthetics|mesh-ancestor
153975470|NCT06154447|GABA Modulators|gaba modulators|mesh-ancestor
153975471|NCT06154447|GABA Agents|gaba agents|mesh-ancestor
153975524|NCT06043674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153975525|NCT06043674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975526|NCT06043674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153975527|NCT06043674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975528|NCT06043674|Immunoconjugates|immunoconjugates|mesh-ancestor
153975529|NCT06043674|Immunologic Factors|immunologic factors|mesh-ancestor
153975530|NCT06043674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975531|NCT06007586|Aprepitant|aprepitant|mesh-list
153975532|NCT06007586|Antiemetics|antiemetics|mesh-ancestor
153975587|NCT05718882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975588|NCT05714839|Dexamethasone|dexamethasone|mesh-list
153975589|NCT05714839|Lenalidomide|lenalidomide|mesh-list
153975590|NCT05714839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153975591|NCT05714839|Antiemetics|antiemetics|mesh-ancestor
153975592|NCT05714839|Autonomic Agents|autonomic agents|mesh-ancestor
153975593|NCT05714839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975594|NCT05714839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975595|NCT05714839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153975596|NCT05714839|Glucocorticoids|glucocorticoids|mesh-ancestor
153975597|NCT05714839|Hormones|hormones|mesh-ancestor
153975598|NCT05714839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153975599|NCT05714839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153975600|NCT05714839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975601|NCT05714839|Immunologic Factors|immunologic factors|mesh-ancestor
153975604|NCT05714839|Growth Substances|growth substances|mesh-ancestor
153975663|NCT05337540|Viscosupplements|viscosupplements|mesh-ancestor
153975664|NCT05337540|Protective Agents|protective agents|mesh-ancestor
153975665|NCT05337540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975666|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
153975667|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153975668|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153975669|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975670|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
153975671|NCT05323149|Coagulants|coagulants|mesh-ancestor
153975672|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153975673|NCT05262400|Letrozole|letrozole|mesh-list
153975674|NCT05262400|Fulvestrant|fulvestrant|mesh-list
153975675|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975676|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153975677|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153975678|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975679|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975680|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153975720|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
153975721|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975722|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
153975723|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153975724|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
153975725|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
153975726|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153975727|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153975728|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153975729|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
153975730|NCT04972123|Protective Agents|protective agents|mesh-ancestor
153975731|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
153975743|NCT04835233|Methyldopa|methyldopa|mesh-list
153975782|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153975783|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975785|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153975786|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153975787|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153975788|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
153975789|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975790|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975791|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975792|NCT04641975|Urological Agents|urological agents|mesh-ancestor
153975793|NCT04527432|Antibodies|antibodies|mesh-list
153975794|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
153975795|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975796|NCT04494958|Palbociclib|palbociclib|mesh-list
153975801|NCT04492033|Paclitaxel|paclitaxel|mesh-list
153975852|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
153975853|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975854|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153975855|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153975856|NCT04234022|Growth Substances|growth substances|mesh-ancestor
153975857|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
153975858|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975859|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
153975860|NCT04233866|Leucovorin|leucovorin|mesh-list
153975861|NCT04233866|Folic Acid|folic acid|mesh-list
153975862|NCT04233866|Paclitaxel|paclitaxel|mesh-list
153975863|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153975864|NCT04233866|Gemcitabine|gemcitabine|mesh-list
153975865|NCT04233866|Fluorouracil|fluorouracil|mesh-list
153975866|NCT04233866|Irinotecan|irinotecan|mesh-list
153975867|NCT04233866|Calcium|calcium|mesh-list
153975868|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
153975869|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153975870|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153975871|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
153975872|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
153975873|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
153975875|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975918|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975919|NCT04196010|Cytarabine|cytarabine|mesh-list
153975920|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
153975921|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
153975922|NCT04196010|Cladribine|cladribine|mesh-list
153975923|NCT04196010|Lenograstim|lenograstim|mesh-list
153975924|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153975925|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
153975926|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975984|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
153975985|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153975986|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153975987|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153975988|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
153975989|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153975990|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153975991|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153975992|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
153975993|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153975994|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153975995|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
153975996|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153975997|NCT03824106|Vitamin D|vitamin d|mesh-list
153975998|NCT03824106|Vitamins|vitamins|mesh-ancestor
153975999|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
153976000|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976001|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153976002|NCT03822468|Letrozole|letrozole|mesh-list
153976003|NCT03822468|Anastrozole|anastrozole|mesh-list
153976004|NCT03822468|Goserelin|goserelin|mesh-list
153976005|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976006|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153976007|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153976008|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649489|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153976009|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976010|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153976030|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153976031|NCT03631199|Carboplatin|carboplatin|mesh-list
153976032|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
153976033|NCT03631199|Pemetrexed|pemetrexed|mesh-list
153976034|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153976035|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153976036|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976037|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
153976038|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
153976099|NCT03318900|Analgesics|analgesics|mesh-ancestor
153976100|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
153976101|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976102|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153976103|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153976104|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
153976105|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976106|NCT03315364|Paclitaxel|paclitaxel|mesh-list
153976107|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153976108|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153976109|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976110|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
153976111|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
153976112|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
153976113|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976114|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
153976115|NCT03263559|Thiotepa|thiotepa|mesh-list
153976116|NCT03263559|Fludarabine|fludarabine|mesh-list
153976117|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
153976118|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
153976119|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976120|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
153976121|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976122|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976123|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153976149|NCT02932280|Neratinib|neratinib|mesh-list
153976150|NCT02932280|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153976151|NCT02932280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153976152|NCT02932280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976153|NCT02932280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976154|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
153976155|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976156|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976157|NCT02907099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976158|NCT02907099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976159|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
153976160|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976161|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976162|NCT02892201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976163|NCT02892201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976164|NCT02873195|Bevacizumab|bevacizumab|mesh-list
153976165|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153976166|NCT02873195|Atezolizumab|atezolizumab|mesh-list
153976167|NCT02873195|Capecitabine|capecitabine|mesh-list
153976203|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
153976204|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976205|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976206|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
153976207|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976208|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976209|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
153976210|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
153976211|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153976212|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153976269|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
153976270|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976271|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153976272|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153976273|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976275|NCT00150969|Coagulants|coagulants|mesh-ancestor
153976276|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153976277|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976278|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
153976279|NCT00770770|Hormones|hormones|mesh-ancestor
153976280|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976281|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976282|NCT00766636|Gemcitabine|gemcitabine|mesh-list
153976283|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153976284|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976285|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
153976291|NCT02581969|Factor VIII|factor viii|mesh-list
153976327|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976328|NCT02579707|Ivosidenib|ivosidenib|mesh-list
153976329|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976330|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976331|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976332|NCT02713009|Vitamin D|vitamin d|mesh-list
153976333|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
153976334|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
153976335|NCT02713009|Vitamins|vitamins|mesh-list
153976336|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
153976337|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976338|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153976339|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153976340|NCT03085225|Durvalumab|durvalumab|mesh-list
153976341|NCT03085225|Trabectedin|trabectedin|mesh-list
153976342|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976343|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976385|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153976386|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153976387|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976388|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976390|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976391|NCT01001234|Rizatriptan|rizatriptan|mesh-list
153976392|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153976393|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
153976394|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976395|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976396|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976397|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
153976398|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153976399|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976400|NCT04073953|Primaquine|primaquine|mesh-list
153976442|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153976443|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
153976444|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976445|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976446|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
153976447|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976448|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976449|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153976450|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
153976451|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153976452|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976453|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
153976454|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976455|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
153976456|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976457|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153976458|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153976459|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153976460|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153976461|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
153976462|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
153976463|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976464|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976465|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
153976466|NCT01000610|Hormones|hormones|mesh-ancestor
153976468|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153976489|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153976490|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
153976491|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976492|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976493|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153976494|NCT01038635|Lenalidomide|lenalidomide|mesh-list
153976495|NCT01038635|Azacitidine|azacitidine|mesh-list
153976496|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
153976497|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976498|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153976499|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153976500|NCT01038635|Growth Substances|growth substances|mesh-ancestor
153976501|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
153976502|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976503|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153976504|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
153976547|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
153976548|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
153976549|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153976550|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153976551|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976552|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976553|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976554|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153976555|NCT00580801|Interferons|interferons|mesh-list
153976556|NCT00580801|Ribavirin|ribavirin|mesh-list
153976557|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
153976558|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
153976559|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153976560|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976561|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
153976562|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976563|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
153976564|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976565|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
153976566|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976567|NCT00619671|Rituximab|rituximab|mesh-list
153976568|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976602|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153976603|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
153976604|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976605|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976606|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153976607|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
153976608|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
153976609|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153976610|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
153976611|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153976612|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976613|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
153976614|NCT02576119|BMS-955176|bms-955176|mesh-list
153976615|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153976616|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976617|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153976618|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153976619|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976659|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
153976660|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
153976661|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
153976662|NCT02389465|Celecoxib|celecoxib|mesh-list
153976664|NCT02389465|Citalopram|citalopram|mesh-list
153976665|NCT02389465|Escitalopram|escitalopram|mesh-list
153976666|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153976667|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153976668|NCT02389465|Analgesics|analgesics|mesh-ancestor
153976669|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
153976670|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153976671|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976725|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
153976726|NCT02575651|Fluzoparib|fluzoparib|mesh-list
153976727|NCT02575651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153976728|NCT02575651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976729|NCT02575651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976730|NCT02575651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976731|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
153976732|NCT01716117|Antacids|antacids|mesh-ancestor
153976733|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976734|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153976735|NCT00579553|Progesterone|progesterone|mesh-list
153976736|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153630358|NCT00005988|Vitamins|vitamins|mesh-ancestor
153976737|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153976783|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153976784|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
153976785|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153976786|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976787|NCT04211103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153976788|NCT04211103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976789|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153976790|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976791|NCT02334865|Lenalidomide|lenalidomide|mesh-list
153976792|NCT02334865|Sargramostim|sargramostim|mesh-list
153976793|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153976794|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
153976795|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
153976846|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
153976847|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976848|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976849|NCT00770146|Mipomersen|mipomersen|mesh-list
153976850|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153976851|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153976852|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
153976917|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153976918|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153976919|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153976920|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153976921|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
153976922|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976923|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976924|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153976925|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153976926|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153976927|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
153976928|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153976929|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
153976930|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153976931|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153976932|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153976933|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153976934|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153976971|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153976973|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976974|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
153976975|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153976976|NCT01056263|Axitinib|axitinib|mesh-list
153976977|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153976979|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977037|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153977038|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153977039|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
153977040|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977041|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977042|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153977043|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
153977044|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
153977045|NCT01008410|Hormones|hormones|mesh-ancestor
153977047|NCT00627653|Fenofibrate|fenofibrate|mesh-list
153977105|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
153977106|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977107|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153977108|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153977109|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
153977110|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977111|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977112|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153977168|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
153977169|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
153977170|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977171|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
153977172|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977173|NCT01023035|Hematinics|hematinics|mesh-ancestor
153977174|NCT01028651|Treprostinil|treprostinil|mesh-list
153977175|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153977176|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
153977177|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153977178|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153977179|NCT00627731|Prednisolone|prednisolone|mesh-list
153977180|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
153977181|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153977182|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
153977183|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153977184|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
153977185|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
153977186|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977197|NCT01028027|Tobramycin|tobramycin|mesh-list
153977226|NCT02870036|Leucovorin|leucovorin|mesh-list
153977227|NCT02870036|Thalidomide|thalidomide|mesh-list
153977228|NCT02870036|Fluorouracil|fluorouracil|mesh-list
153977229|NCT02870036|Calcium|calcium|mesh-list
153977230|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
153977231|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153977232|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977233|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
153977234|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977235|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153977236|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977237|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977238|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
153977239|NCT02870036|Antidotes|antidotes|mesh-ancestor
153977240|NCT02870036|Protective Agents|protective agents|mesh-ancestor
153977241|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
153977242|NCT02870036|Vitamins|vitamins|mesh-ancestor
153977243|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
153977286|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977288|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977289|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153977290|NCT00997334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153977291|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977292|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977293|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977294|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977295|NCT04296578|Selenious Acid|selenious acid|mesh-list
153977296|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
153977297|NCT04296578|Prednisone|prednisone|mesh-list
153977298|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
153977299|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153977300|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
153977301|NCT04296578|Hormones|hormones|mesh-ancestor
153977302|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977303|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977304|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153977305|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977306|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153977337|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
153977338|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153977339|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977340|NCT04301375|Paclitaxel|paclitaxel|mesh-list
153977341|NCT04301375|Trastuzumab|trastuzumab|mesh-list
153977342|NCT04301375|Pertuzumab|pertuzumab|mesh-list
153977343|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153977344|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977345|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
153977346|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
153977348|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977349|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153977350|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
153977354|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
153977397|NCT01020305|Temsirolimus|temsirolimus|mesh-list
153977398|NCT01020305|MTOR Inhibitors|mtor inhibitors|mesh-list
153977399|NCT01020305|Bicalutamide|bicalutamide|mesh-list
153977400|NCT01020305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977401|NCT01020305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977402|NCT01020305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977403|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977404|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
153977405|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977406|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977407|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977408|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977409|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153650163|NCT00012207|Prednisone|prednisone|mesh-list
153977410|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
153977411|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
153977456|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
153977457|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977458|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977459|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153977460|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153977461|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153977462|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153977463|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977465|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
153977466|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153977467|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153977468|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153977469|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
153977470|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977471|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977472|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977473|NCT01018511|Urological Agents|urological agents|mesh-ancestor
153977474|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153977475|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153977476|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
153977477|NCT00996476|Simeprevir|simeprevir|mesh-list
153977478|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
153977479|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977480|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
153977481|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764510|NCT05070403|Afatinib|afatinib|mesh-list
153630203|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630204|NCT00005964|Prednisone|prednisone|mesh-list
153630205|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
153630206|NCT00005964|Doxorubicin|doxorubicin|mesh-list
153630207|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153630209|NCT00005964|Vincristine|vincristine|mesh-list
153630210|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630211|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
153630212|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630213|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630214|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630215|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
153630241|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153630242|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153630243|NCT00005970|Antibodies|antibodies|mesh-list
153630244|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
153630245|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153630246|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153630247|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630248|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630249|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
153977482|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977483|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
153977485|NCT02269267|Nilotinib|nilotinib|mesh-list
153977486|NCT02269267|Bosutinib|bosutinib|mesh-list
153977487|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
153977488|NCT02269267|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153977489|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977490|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977491|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977492|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735070|NCT05355441|Antipyretics|antipyretics|mesh-ancestor
153977493|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
153977494|NCT02269267|Protective Agents|protective agents|mesh-ancestor
153977496|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153977543|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
153977544|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153977546|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153977547|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
153977548|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977549|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977550|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153977551|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
153977552|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977553|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153977554|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153977555|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977556|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977557|NCT01385059|Axitinib|axitinib|mesh-list
153977558|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977559|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977560|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977561|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977562|NCT00769132|Niacin|niacin|mesh-list
153977563|NCT00769132|Niacinamide|niacinamide|mesh-list
153977564|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
153977565|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153977566|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
153735136|NCT05306301|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153977567|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764647|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153764648|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153764649|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153764650|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764651|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977592|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977593|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977594|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
153977595|NCT00991952|Growth Substances|growth substances|mesh-ancestor
153977596|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977597|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977598|NCT00779038|Fentanyl|fentanyl|mesh-list
153977599|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153977600|NCT00779038|Narcotics|narcotics|mesh-ancestor
153977601|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977602|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977603|NCT00779038|Analgesics|analgesics|mesh-ancestor
153977604|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
153977605|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977606|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153977607|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153977608|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
153977609|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
153977610|NCT04292990|Fentanyl|fentanyl|mesh-list
153977611|NCT04292990|Morphine|morphine|mesh-list
153977612|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153977613|NCT04292990|Narcotics|narcotics|mesh-ancestor
153977614|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977615|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977616|NCT04292990|Analgesics|analgesics|mesh-ancestor
153977617|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
153977618|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977619|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153764682|NCT04757363|Nivolumab|nivolumab|mesh-list
153977629|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153977630|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
153977631|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977632|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153977633|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153977634|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977635|NCT00994682|Pioglitazone|pioglitazone|mesh-list
153977636|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153977637|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977638|NCT00994448|Bupropion|bupropion|mesh-list
153977639|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153977640|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
153977642|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153977643|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153977644|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153977645|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977646|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
153977682|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
153977683|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
153977684|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977685|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977686|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153977687|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
153977688|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153977689|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977690|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977691|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153977692|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153977693|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153977694|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977695|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153977696|NCT02576665|Flucytosine|flucytosine|mesh-list
153977697|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
153977698|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977739|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153977740|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977741|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153977742|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153977743|NCT00709657|Growth Substances|growth substances|mesh-ancestor
153977744|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977745|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
153977746|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
153977747|NCT04073173|Analgesics|analgesics|mesh-list
153977748|NCT04073173|Narcotics|narcotics|mesh-ancestor
153977749|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153977750|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977751|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
153977752|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977753|NCT00628121|Cetrorelix|cetrorelix|mesh-list
153977754|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153977755|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
153977756|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153977757|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977758|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
153977759|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977760|NCT00709969|Lumefantrine|lumefantrine|mesh-list
153977761|NCT00709969|Artemether|artemether|mesh-list
153977762|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153977763|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
153977764|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153977765|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153977766|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977767|NCT00710125|Doxorubicin|doxorubicin|mesh-list
153977784|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154176479|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977785|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
153977786|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
153977787|NCT01017029|Everolimus|everolimus|mesh-list
153977788|NCT01017029|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153977789|NCT01017029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153977790|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153977791|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977792|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977801|NCT00714649|Cetuximab|cetuximab|mesh-list
153977848|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
153977849|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153977850|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
153977851|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977852|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
153977853|NCT00710827|Androgens|androgens|mesh-ancestor
153977854|NCT00710827|Hormones|hormones|mesh-ancestor
153977855|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153977856|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977857|NCT01034657|Panobinostat|panobinostat|mesh-list
153977858|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
153977859|NCT01034657|Hematinics|hematinics|mesh-ancestor
153977860|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153977861|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153977864|NCT01014767|Leucovorin|leucovorin|mesh-list
153977909|NCT01014689|Lymecycline|lymecycline|mesh-list
153977910|NCT01014689|Adapalene|adapalene|mesh-list
153977911|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153977912|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153977913|NCT01014689|Analgesics|analgesics|mesh-ancestor
153977914|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
153977915|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977916|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153977917|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153977918|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153977919|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
153977920|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153977921|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153977922|NCT01014533|Gabapentin|gabapentin|mesh-list
153977923|NCT01014533|Analgesics|analgesics|mesh-ancestor
153977924|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
153977925|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153977968|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977969|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153977970|NCT00714961|Clopidogrel|clopidogrel|mesh-list
153977971|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153977972|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153977973|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153977974|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153977975|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
153977976|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153977977|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153977978|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978028|NCT02871869|Prednisone|prednisone|mesh-list
153978029|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
153978030|NCT02871869|Rituximab|rituximab|mesh-list
153978031|NCT02871869|Epirubicin|epirubicin|mesh-list
153978032|NCT02871869|Vindesine|vindesine|mesh-list
153978033|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978034|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
153978035|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978036|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978037|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153978038|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
153978039|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978040|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978041|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153978091|NCT00715351|Insulin|insulin|mesh-list
153978092|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153978093|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
153978094|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
153978095|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
153978096|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
153978097|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153978098|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978099|NCT00711841|Dexamethasone|dexamethasone|mesh-list
153978100|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
153978101|NCT00711841|BB 1101|bb 1101|mesh-list
153978102|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978103|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
153978104|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
153978105|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978106|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978107|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153978150|NCT02572687|Growth Substances|growth substances|mesh-ancestor
153978151|NCT02572687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978152|NCT02572687|Growth Inhibitors|growth inhibitors|mesh-ancestor
153978153|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153978154|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153978155|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153978156|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153978157|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153978158|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
153978159|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978160|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978161|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978162|NCT00603447|Dexamethasone|dexamethasone|mesh-list
153978163|NCT00603447|Lenalidomide|lenalidomide|mesh-list
153978164|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978165|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
153978166|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
153978167|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978168|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978169|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153978170|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
153978171|NCT00603447|Hormones|hormones|mesh-ancestor
153978172|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978173|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153978174|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978175|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
153978176|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153978177|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153978178|NCT00603447|Growth Substances|growth substances|mesh-ancestor
153978179|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
153978180|NCT00718705|Josamycin|josamycin|mesh-list
153978194|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
153978195|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153978196|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153978197|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153978198|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
153978199|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978200|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978201|NCT00639015|Protective Agents|protective agents|mesh-ancestor
153978259|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978260|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978261|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
153978262|NCT00988208|Hormones|hormones|mesh-ancestor
153978263|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978264|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978265|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153978266|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
153978267|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153978268|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153978269|NCT00988208|Growth Substances|growth substances|mesh-ancestor
153978270|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
153978271|NCT00639249|SA 4503|sa 4503|mesh-list
153978322|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153978323|NCT04089553|Durvalumab|durvalumab|mesh-list
153978324|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153978325|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978326|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
153978327|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978328|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153978329|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978330|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978331|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
153978332|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153978333|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978334|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153978335|NCT02686827|Vitamin D|vitamin d|mesh-list
153978382|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978383|NCT00778102|Antidotes|antidotes|mesh-ancestor
153978384|NCT00778102|Protective Agents|protective agents|mesh-ancestor
153978385|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
153978386|NCT00778102|Vitamins|vitamins|mesh-ancestor
153978387|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
153978388|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
153978389|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153978390|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978391|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
153978392|NCT00713557|Tirofiban|tirofiban|mesh-list
153978393|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153735960|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
153978445|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978446|NCT00612495|Fluorouracil|fluorouracil|mesh-list
153978447|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
153978448|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
153978449|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978450|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153978451|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978452|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978453|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
153978454|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978455|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
153978457|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978458|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
153978459|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978460|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978461|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153978463|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978464|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978465|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153978466|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
153978467|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
153978468|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978469|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153978470|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153978471|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978472|NCT00756886|Atorvastatin|atorvastatin|mesh-list
153978473|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153978474|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153978475|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
153978476|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978477|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153765502|NCT05712941|Letrozole|letrozole|mesh-list
153630250|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
153630251|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
153630252|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630253|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630254|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
153630255|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630256|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630257|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153978478|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153978479|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978480|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153978481|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153978482|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153978483|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
153978484|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978485|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978486|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153978487|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153978539|NCT00777946|Protease Inhibitors|protease inhibitors|mesh-ancestor
153978540|NCT00777946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978541|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
153978543|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153978544|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
153978545|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978546|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
153978547|NCT02686047|Protective Agents|protective agents|mesh-ancestor
153978548|NCT00713947|Amoxicillin|amoxicillin|mesh-list
153978549|NCT00713947|Metronidazole|metronidazole|mesh-list
153978550|NCT00713947|Clarithromycin|clarithromycin|mesh-list
153978551|NCT00713947|Pantoprazole|pantoprazole|mesh-list
153978552|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153978553|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978554|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153978601|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153978602|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978603|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978604|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153978605|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153978606|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
153978607|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153978609|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
153978670|NCT00714025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978671|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153978672|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
153978673|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978674|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978675|NCT02685345|Firuglipel|firuglipel|mesh-list
153978676|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153978677|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978678|NCT02869100|Listerine|listerine|mesh-list
153978679|NCT02869100|Fluorides|fluorides|mesh-list
153978680|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
153978681|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
153978682|NCT02869100|Protective Agents|protective agents|mesh-ancestor
153978683|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978686|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
153978728|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978729|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978730|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978732|NCT02600806|Levofloxacin|levofloxacin|mesh-list
153978733|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153978734|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153978735|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153978736|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153978737|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153978796|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153978797|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
153978798|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978799|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978800|NCT00719797|Leucovorin|leucovorin|mesh-list
153978801|NCT00719797|Bevacizumab|bevacizumab|mesh-list
153978802|NCT00719797|Fluorouracil|fluorouracil|mesh-list
153978803|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
153978804|NCT00719797|Irinotecan|irinotecan|mesh-list
153978805|NCT00719797|Calcium|calcium|mesh-list
153978806|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
153978807|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153978808|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153978809|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153978810|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153978811|NCT00719797|Growth Substances|growth substances|mesh-ancestor
153978812|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978856|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978857|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153978858|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153978859|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153978860|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153978861|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153978862|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978863|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978864|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
153978865|NCT02684799|Omeprazole|omeprazole|mesh-list
153978866|NCT02684799|Famotidine|famotidine|mesh-list
153978867|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153978868|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153978869|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153978870|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153978871|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978872|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153978913|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153632521|NCT00387322|Pemetrexed|pemetrexed|mesh-list
154176483|NCT05643846|Bupivacaine|bupivacaine|mesh-list
153978914|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153978915|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153978979|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153978980|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153978981|NCT04095754|Analgesics|analgesics|mesh-ancestor
153978982|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
153978983|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153978984|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153978985|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153978986|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153978987|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
153978988|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153978989|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153978990|NCT00720265|Tacrolimus|tacrolimus|mesh-list
153978991|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736575|NCT01527149|Cytarabine|cytarabine|mesh-list
153979039|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153979041|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
153979042|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979043|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153979044|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153979045|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153979046|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
153979047|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979048|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979049|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
153979050|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153979051|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
153979052|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153979098|NCT02570581|Acetaminophen|acetaminophen|mesh-list
153979099|NCT02570581|Ramipril|ramipril|mesh-list
153979100|NCT02570581|Furosemide|furosemide|mesh-list
153979101|NCT02570581|Memantine|memantine|mesh-list
153979102|NCT02570581|Alprazolam|alprazolam|mesh-list
153979103|NCT02570581|Zopiclone|zopiclone|mesh-list
153979104|NCT02570581|Oxazepam|oxazepam|mesh-list
153979105|NCT02570581|Donepezil|donepezil|mesh-list
153979106|NCT02570581|Clopidogrel|clopidogrel|mesh-list
153979107|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153979108|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153979109|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153979110|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153979111|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
153979163|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979164|NCT02865668|Metformin|metformin|mesh-list
153979165|NCT02865668|Canagliflozin|canagliflozin|mesh-list
153979166|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153979167|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979168|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153979169|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979170|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
153979171|NCT02867930|Ketamine|ketamine|mesh-list
153979172|NCT02867930|Propofol|propofol|mesh-list
153979177|NCT02867930|Analgesics|analgesics|mesh-ancestor
153979229|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153979230|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153979231|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979232|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153979233|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153979234|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979235|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
153979296|NCT00577993|Prednisone|prednisone|mesh-list
153979297|NCT00577993|Prednisolone|prednisolone|mesh-list
153979298|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153979299|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
153979300|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153979301|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
153979302|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
153979303|NCT00577993|Rituximab|rituximab|mesh-list
153979304|NCT00577993|Doxorubicin|doxorubicin|mesh-list
153979305|NCT00577993|Fludarabine|fludarabine|mesh-list
153979306|NCT00577993|Etoposide|etoposide|mesh-list
153979307|NCT00577993|Vincristine|vincristine|mesh-list
153979308|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
153979309|NCT00577993|Bleomycin|bleomycin|mesh-list
153979310|NCT00577993|Procarbazine|procarbazine|mesh-list
153979311|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153979361|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153979362|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979363|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153979364|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153979365|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153979366|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
153979367|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153979368|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153979369|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
153979370|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153979371|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
153979372|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153979373|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153979374|NCT02866370|Paclitaxel|paclitaxel|mesh-list
153979375|NCT02866370|Carboplatin|carboplatin|mesh-list
153979417|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153979418|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
153979419|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979420|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979421|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979422|NCT00629642|Urological Agents|urological agents|mesh-ancestor
153979423|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
153979424|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
153979425|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979426|NCT02865356|Cyclosporine|cyclosporine|mesh-list
153979427|NCT02865356|Cyclosporins|cyclosporins|mesh-list
153979428|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979429|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979430|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979431|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
153979432|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979433|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
153979434|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979438|NCT04287842|Sevoflurane|sevoflurane|mesh-list
153979474|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153979476|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153979477|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153979547|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979549|NCT00722215|Nifedipine|nifedipine|mesh-list
153979550|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
153979551|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153979552|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153979553|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979554|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153979555|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979556|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
153979557|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
153979558|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153979608|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
153979609|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
153979610|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153979611|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979612|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
153979613|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979614|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979615|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
153979617|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153979674|NCT00586846|Methotrexate|methotrexate|mesh-list
153979675|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979676|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153979677|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153979678|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153979679|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979680|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979681|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153979682|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
153979683|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153979684|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979685|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153979686|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
153979687|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
153979688|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153979689|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153979690|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
153979691|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153979692|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153979729|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153979730|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979731|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979732|NCT02865824|Aspirin|aspirin|mesh-list
153979733|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153979734|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153979735|NCT02865824|Analgesics|analgesics|mesh-ancestor
153979736|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
153979737|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979738|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979739|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153979740|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176484|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
153979788|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979789|NCT04290104|Ampicillin|ampicillin|mesh-list
153979790|NCT04290104|Sulbactam|sulbactam|mesh-list
153979791|NCT04290104|Sultamicillin|sultamicillin|mesh-list
153979792|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153979793|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153979794|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153979795|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979796|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979797|NCT02571205|Testosterone|testosterone|mesh-list
153979798|NCT02571205|Androgens|androgens|mesh-ancestor
153979799|NCT02571205|Hormones|hormones|mesh-ancestor
153979800|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153979801|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979802|NCT04290026|Metoclopramide|metoclopramide|mesh-list
153979803|NCT04290026|Granisetron|granisetron|mesh-list
153979804|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
153979805|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
153979806|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153979807|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979808|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153979809|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153979817|NCT00640887|Ritonavir|ritonavir|mesh-list
153979840|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153979841|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153979842|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
153979843|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
153979844|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
153979845|NCT00730093|Vitamins|vitamins|mesh-ancestor
153979846|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
153979847|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979848|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
153979849|NCT00730093|Hematinics|hematinics|mesh-ancestor
153979850|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153979851|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153979852|NCT00727129|Estradiol|estradiol|mesh-list
153979853|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153979900|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153979901|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
153979902|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153979903|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979904|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153979905|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153979906|NCT02682459|Protective Agents|protective agents|mesh-ancestor
153979907|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979908|NCT02620579|Propranolol|propranolol|mesh-list
153979909|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153979910|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153979911|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
153979912|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153979913|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153979960|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153979961|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153979962|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153979963|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153979964|NCT00727753|Growth Substances|growth substances|mesh-ancestor
153979965|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979966|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
153979968|NCT00727831|Methotrexate|methotrexate|mesh-list
153979969|NCT00727831|Calcium|calcium|mesh-list
153979970|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
153979971|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153979972|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153979973|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153979974|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
153979975|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153979976|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153979977|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
153980017|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
153980018|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153980019|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
153980020|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
153980021|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980022|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980023|NCT02681679|Bromfenac|bromfenac|mesh-list
153980024|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153980025|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153980026|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153980027|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153980028|NCT02681679|Analgesics|analgesics|mesh-ancestor
153980029|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
153980030|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980031|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980032|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980033|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980034|NCT04183257|Vitamin D|vitamin d|mesh-list
153980035|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
153980036|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
153630258|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
153630259|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630260|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153630261|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153630262|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630263|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630264|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153630265|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
153630277|NCT00005979|Irinotecan|irinotecan|mesh-list
153630278|NCT00005979|Calcium|calcium|mesh-list
153630279|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
153630280|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153630281|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630282|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
153630283|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630284|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630285|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630286|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630287|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
153630288|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153630289|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630290|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630291|NCT00005979|Antidotes|antidotes|mesh-ancestor
153630292|NCT00005979|Protective Agents|protective agents|mesh-ancestor
153630293|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
153630294|NCT00005979|Vitamins|vitamins|mesh-ancestor
153630295|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
153630296|NCT00005985|Cytarabine|cytarabine|mesh-list
153630297|NCT00005985|Dexamethasone|dexamethasone|mesh-list
153630298|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
153630299|NCT00005985|Carmustine|carmustine|mesh-list
153630300|NCT00005985|Etoposide|etoposide|mesh-list
153630301|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
153630302|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630303|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
153980037|NCT04183257|Vitamins|vitamins|mesh-list
153980038|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
153980039|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980040|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153980041|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153980042|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
153980043|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153980044|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153980045|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980046|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153980047|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153980048|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
153980049|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153980050|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
153980051|NCT00641589|Hematinics|hematinics|mesh-ancestor
153980052|NCT00734383|Propofol|propofol|mesh-list
153980053|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153980054|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980055|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980056|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153980057|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
153980093|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153980094|NCT05663775|Analgesics|analgesics|mesh-ancestor
153980095|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
153980096|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980097|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980098|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980099|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980100|NCT00909987|Bevacizumab|bevacizumab|mesh-list
153980101|NCT00909987|Capecitabine|capecitabine|mesh-list
153980102|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
153980103|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153980104|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980105|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153980106|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153980107|NCT00909987|Growth Substances|growth substances|mesh-ancestor
153980108|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980109|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
153980110|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153980111|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
153980112|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980113|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153980146|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980147|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153980148|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
153980149|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153980150|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153980151|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
153980152|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980153|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
153980154|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980155|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153980156|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153980157|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153980158|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
153980159|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980160|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153980161|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
153980162|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
153980163|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
153980164|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153980166|NCT04289090|Sevoflurane|sevoflurane|mesh-list
153980167|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153980168|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980198|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153980199|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153980200|NCT00735241|Growth Substances|growth substances|mesh-ancestor
153980201|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980202|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
153980203|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
153980204|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980205|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153980206|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153980207|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
153980208|NCT00735241|Antidotes|antidotes|mesh-ancestor
153980209|NCT00735241|Protective Agents|protective agents|mesh-ancestor
153980210|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
153980211|NCT00735241|Vitamins|vitamins|mesh-ancestor
153980212|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
153980213|NCT00735241|Hematinics|hematinics|mesh-ancestor
153980214|NCT00729313|Lanreotide|lanreotide|mesh-list
153980215|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980257|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980258|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980259|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153980260|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
153980261|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
153980262|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153980263|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
153980264|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153980265|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153980266|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153980267|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153980268|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
153980269|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980270|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980271|NCT00642135|Phenylephrine|phenylephrine|mesh-list
153980315|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
153980316|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980317|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
153980318|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153980319|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153980320|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980321|NCT04179747|Urological Agents|urological agents|mesh-ancestor
153980322|NCT02675205|Aspirin|aspirin|mesh-list
153980323|NCT02675205|Clopidogrel|clopidogrel|mesh-list
153980324|NCT02675205|Ticagrelor|ticagrelor|mesh-list
153980380|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980381|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980382|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980383|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153980384|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153980385|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153980386|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980387|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153980388|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153980389|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980390|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
153980391|NCT02601040|Vaccines|vaccines|mesh-list
153980392|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
153980393|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980394|NCT04179513|Methotrexate|methotrexate|mesh-list
153980395|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153980396|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
153980397|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153980398|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980399|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153980400|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
153980402|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980430|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153980431|NCT02674737|Analgesics|analgesics|mesh-ancestor
153980432|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
153980433|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980434|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153980435|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153980436|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153980437|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
153980438|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980439|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980440|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153980494|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980495|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153980496|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980497|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
153980498|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153980499|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
153980500|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980503|NCT02674113|Bupivacaine|bupivacaine|mesh-list
153980504|NCT02674113|Anesthetics|anesthetics|mesh-list
153980505|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
153980506|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980507|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980508|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
153980509|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980557|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980558|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
153980559|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
153980560|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153980561|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
153980562|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
153980563|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980564|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980565|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
153980566|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980567|NCT00736021|Escitalopram|escitalopram|mesh-list
153980568|NCT00736021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153980569|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153980570|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153980571|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980572|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153980573|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
153738166|NCT03646968|Docetaxel|docetaxel|mesh-list
153980574|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980575|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
153980576|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153980577|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153980578|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980579|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
153980580|NCT04178655|Coagulants|coagulants|mesh-ancestor
153980604|NCT05273775|Omeprazole|omeprazole|mesh-list
153980605|NCT05273775|Warfarin|warfarin|mesh-list
153980606|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153980607|NCT05273775|Vitamins|vitamins|mesh-ancestor
153980608|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
153980609|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980610|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153980611|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153980612|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980613|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153980614|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153980615|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153980672|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153980673|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153980674|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980675|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980676|NCT00644631|Urological Agents|urological agents|mesh-ancestor
153980677|NCT02671383|Lopinavir|lopinavir|mesh-list
153980678|NCT02671383|Darunavir|darunavir|mesh-list
153980679|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153980680|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153980737|NCT02671227|Bupivacaine|bupivacaine|mesh-list
153980738|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
153980739|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
153980740|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153980741|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980742|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
153980743|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980744|NCT00644709|Atorvastatin|atorvastatin|mesh-list
153980745|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153980746|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153980747|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
153980748|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980749|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153980750|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153980751|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980752|NCT00738985|Simvastatin|simvastatin|mesh-list
153980753|NCT00738985|Ezetimibe|ezetimibe|mesh-list
153980754|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153980755|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153980756|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153980757|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
153980758|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980759|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153980760|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153980761|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980784|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980785|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980786|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
153980787|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153980788|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153980789|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153980790|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153980791|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153980792|NCT00739453|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153980793|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153980794|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153980795|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980796|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980839|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153980840|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153980841|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980842|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153980843|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
153980844|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153980845|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980846|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
153980847|NCT02667561|Testosterone|testosterone|mesh-list
153980848|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
153980849|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
153980850|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153980851|NCT02667561|Androgens|androgens|mesh-ancestor
153980852|NCT02667561|Hormones|hormones|mesh-ancestor
153980853|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980854|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980855|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153980856|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153980857|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
153980858|NCT00732511|Metoprolol|metoprolol|mesh-list
153980891|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153980892|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
153980893|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
153980894|NCT00739531|Protective Agents|protective agents|mesh-ancestor
153980895|NCT00739609|Tryptophan|tryptophan|mesh-list
153980896|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153980897|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
153980898|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153980899|NCT00645723|Colistin|colistin|mesh-list
153980900|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153980901|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153980955|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153980956|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153980957|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153980959|NCT02666703|Hormones|hormones|mesh-ancestor
153980960|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153980961|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153980962|NCT02666703|Protective Agents|protective agents|mesh-ancestor
153980963|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153980965|NCT04174131|Lidocaine|lidocaine|mesh-list
153981021|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738618|NCT00004198|Vaccines|vaccines|mesh-list
153981023|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153981024|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153981025|NCT02665845|Analgesics|analgesics|mesh-ancestor
153981026|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
153981027|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981028|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981029|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153981030|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981031|NCT00646425|Basiliximab|basiliximab|mesh-list
153981032|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981033|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
153981034|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981035|NCT02665533|Dexamethasone|dexamethasone|mesh-list
153981036|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
153981037|NCT02665533|Diclofenac|diclofenac|mesh-list
153981038|NCT02665533|Codeine|codeine|mesh-list
153981039|NCT02665533|BB 1101|bb 1101|mesh-list
153981040|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153981041|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
153981042|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
153981043|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981044|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981045|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153981046|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
153981047|NCT02665533|Hormones|hormones|mesh-ancestor
153981069|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981070|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981071|NCT04173039|Antibodies|antibodies|mesh-list
153981072|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
153981073|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981074|NCT00646659|Carboplatin|carboplatin|mesh-list
153981075|NCT00646659|Docetaxel|docetaxel|mesh-list
153981076|NCT00646659|Fluorouracil|fluorouracil|mesh-list
153981077|NCT00646659|Cetuximab|cetuximab|mesh-list
153981078|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981079|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
153981135|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153981137|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153981138|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981139|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153981140|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981141|NCT00648921|Olanzapine|olanzapine|mesh-list
153981142|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
153981143|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
153981144|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981145|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981146|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153981147|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153981148|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153981149|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153981150|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153981151|NCT00648921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153981152|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153981153|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153981154|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981156|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
153981188|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153981189|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981190|NCT02661477|Interferons|interferons|mesh-list
153981191|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
153981192|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
153981193|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981194|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
153981195|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981196|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
153981197|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981198|NCT00649077|Meloxicam|meloxicam|mesh-list
153981199|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153981200|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153981201|NCT00649077|Analgesics|analgesics|mesh-ancestor
153981202|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
153981203|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153981204|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981205|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153981206|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981207|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153981208|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153981209|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981210|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981211|NCT02656251|Ethanol|ethanol|mesh-list
153981212|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
153981213|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153981214|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153981215|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981220|NCT02656095|Heparin|heparin|mesh-list
153981235|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153981236|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
153981237|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981238|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981239|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
153981240|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981241|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153981242|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981243|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
153981244|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981245|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153981246|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
153981299|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981300|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
153981301|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
153981302|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
153981303|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981304|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
153981305|NCT00737815|Cathartics|cathartics|mesh-ancestor
153981306|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153981363|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153981364|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
153981365|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153981366|NCT00740545|Enoxaparin|enoxaparin|mesh-list
153981367|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
153981368|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153981369|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153981370|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981371|NCT02653833|Tadalafil|tadalafil|mesh-list
153981372|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
153981373|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153981374|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153981375|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981377|NCT02653833|Urological Agents|urological agents|mesh-ancestor
153981425|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153981427|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153981428|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153981429|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981430|NCT02653131|Incretins|incretins|mesh-ancestor
153981431|NCT02653131|Hormones|hormones|mesh-ancestor
153981433|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981491|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153981492|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153981493|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
153981494|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
153981495|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153981496|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153981497|NCT02652273|Abatacept|abatacept|mesh-list
153981498|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153981499|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981501|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981553|NCT04316169|Anastrozole|anastrozole|mesh-list
153981554|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981555|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153981556|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153981557|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981558|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981559|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153981560|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
153981561|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981562|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981563|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
153981564|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153981565|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153981566|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981567|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981568|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153981569|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153981570|NCT05740969|Fluorouracil|fluorouracil|mesh-list
153981571|NCT05740969|Imiquimod|imiquimod|mesh-list
153981572|NCT05740969|Melatonin|melatonin|mesh-list
153981573|NCT05740969|Antimetabolites|antimetabolites|mesh-ancestor
153981574|NCT05740969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981575|NCT05740969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153981604|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153981605|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981606|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153981607|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
153981608|NCT02647671|Calcium|calcium|mesh-list
153981609|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153981610|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981611|NCT02647671|Antacids|antacids|mesh-ancestor
153981612|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635243|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
153981613|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153981614|NCT04578613|Rituximab|rituximab|mesh-list
153981615|NCT04578613|Chlorambucil|chlorambucil|mesh-list
153981616|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153981617|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981618|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
153981619|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981620|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153981621|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153981622|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
153981623|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981624|NCT02647515|Ranibizumab|ranibizumab|mesh-list
153981625|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153981626|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153981627|NCT02647515|Growth Substances|growth substances|mesh-ancestor
153981628|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981649|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153981650|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981651|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981652|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153981653|NCT02647047|Narcotics|narcotics|mesh-ancestor
153981654|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153981655|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153981656|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
153981657|NCT00651651|Budesonide|budesonide|mesh-list
153981658|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
153981713|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981714|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153981715|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
153981716|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981717|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
153981718|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153981719|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981720|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153981721|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153981722|NCT00652041|Growth Substances|growth substances|mesh-ancestor
153981723|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
153981724|NCT02646111|Ribavirin|ribavirin|mesh-list
153981725|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
153981726|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981727|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
153981728|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981729|NCT00652119|Paclitaxel|paclitaxel|mesh-list
153981730|NCT00652119|Bevacizumab|bevacizumab|mesh-list
153981731|NCT00652119|Carboplatin|carboplatin|mesh-list
153981732|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153981733|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981734|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
153981769|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981771|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
153981772|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
153981773|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153981774|NCT02646189|REP 2139|rep 2139|mesh-list
153981775|NCT02646189|Thymalfasin|thymalfasin|mesh-list
153981776|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981777|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
153981778|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981779|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
153981780|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981781|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153981785|NCT02645565|Prednisolone|prednisolone|mesh-list
153981833|NCT05740345|Metformin|metformin|mesh-list
153981834|NCT05740345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153981835|NCT05740345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981836|NCT02641431|Ajmaline|ajmaline|mesh-list
153981837|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153981838|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153981839|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153981840|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153981841|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981842|NCT00733525|Fluoxetine|fluoxetine|mesh-list
153981896|NCT04288700|Propranolol|propranolol|mesh-list
153981897|NCT04288700|Captopril|captopril|mesh-list
153981898|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153981899|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153981900|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153981901|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153981902|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153981903|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153981904|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
153981905|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153981906|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981907|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153981908|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153981909|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
153981910|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153981911|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
153981954|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981956|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
153981957|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981958|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
153981959|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981960|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
153981961|NCT02640417|Vitamins|vitamins|mesh-ancestor
153981962|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
153981963|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153981964|NCT02640495|Artesunate|artesunate|mesh-list
153981965|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
153981966|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153981967|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153981968|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153981969|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153981970|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
153981971|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
153981974|NCT00653757|Leuprolide|leuprolide|mesh-list
153982014|NCT02639091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982016|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153982017|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153982018|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
153982019|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982020|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153982021|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153982022|NCT00654537|Atorvastatin|atorvastatin|mesh-list
153982023|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153982024|NCT00654537|Simvastatin|simvastatin|mesh-list
153982025|NCT00654537|Pravastatin|pravastatin|mesh-list
153982026|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153982027|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153982028|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
153982033|NCT02638857|Epirubicin|epirubicin|mesh-list
153982076|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982077|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982078|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982079|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153982080|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982081|NCT01842399|Resveratrol|resveratrol|mesh-list
153982082|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
153982083|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982084|NCT01842399|Protective Agents|protective agents|mesh-ancestor
153982085|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982086|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982087|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153982088|NCT00970502|Celecoxib|celecoxib|mesh-list
153982089|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153982090|NCT00970502|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153982091|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153982092|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982093|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982094|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982095|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153982096|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153982097|NCT00970502|Analgesics|analgesics|mesh-ancestor
153982098|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
153982099|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982100|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982101|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982102|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982121|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153982122|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
153982123|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982124|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982125|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153982126|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
153982127|NCT02567773|Hormones|hormones|mesh-ancestor
153982128|NCT00967226|Prednisolone|prednisolone|mesh-list
153982129|NCT00967226|Propranolol|propranolol|mesh-list
153982130|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
153982131|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153982132|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
153982133|NCT00967226|Hormones|hormones|mesh-ancestor
153982134|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982135|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982136|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153982137|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982138|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153982139|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153982140|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
153982141|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982142|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982143|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153982144|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153982169|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153982170|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
153982171|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153982172|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
153982173|NCT00964886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153982174|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
153982240|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982242|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
153982243|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153982244|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153982245|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153982246|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
153982247|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153982248|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
153982249|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153982250|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982251|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153982252|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153982253|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982254|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
153982255|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
153982256|NCT04283162|Calcium|calcium|mesh-list
153982257|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153982258|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982259|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153982260|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
153982261|NCT04283162|Coagulants|coagulants|mesh-ancestor
153982262|NCT00960752|Resiquimod|resiquimod|mesh-list
153982263|NCT00960752|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153982264|NCT00960752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982265|NCT00960752|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153982266|NCT00960752|Immunologic Factors|immunologic factors|mesh-ancestor
153982267|NCT00960752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982285|NCT00757588|Saxagliptin|saxagliptin|mesh-list
153982286|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153982287|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982288|NCT00757588|Incretins|incretins|mesh-ancestor
153982289|NCT00757588|Hormones|hormones|mesh-ancestor
153982290|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982291|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153635919|NCT00001387|Paclitaxel|paclitaxel|mesh-list
153982292|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
153982293|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982294|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982295|NCT00917254|Enoxaparin|enoxaparin|mesh-list
153982296|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
153982297|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153982298|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153982299|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982300|NCT02599792|Ivacaftor|ivacaftor|mesh-list
153982301|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153982302|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153982303|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982338|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153982339|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982340|NCT00751114|Incretins|incretins|mesh-ancestor
153982341|NCT00751114|Hormones|hormones|mesh-ancestor
153982342|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982343|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153982344|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
153982345|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982346|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982347|NCT00960440|Tofacitinib|tofacitinib|mesh-list
153982348|NCT00960440|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153982349|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153982350|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982352|NCT04092478|Anesthetics|anesthetics|mesh-list
153982395|NCT05973071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982396|NCT05972967|Ravulizumab|ravulizumab|mesh-list
153982397|NCT05972967|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153982398|NCT05972967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153982399|NCT05972967|Immunologic Factors|immunologic factors|mesh-ancestor
153982400|NCT05972967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982401|NCT05972928|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153982402|NCT05972928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153982403|NCT05972928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982404|NCT05972928|Incretins|incretins|mesh-ancestor
153982405|NCT05972928|Hormones|hormones|mesh-ancestor
153982406|NCT05972928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153982407|NCT05972928|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153982408|NCT05972928|Protease Inhibitors|protease inhibitors|mesh-ancestor
153982409|NCT05972928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982410|NCT05972928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982452|NCT05972434|Dermatologic Agents|dermatologic agents|mesh-ancestor
153982453|NCT05971680|Vitamins|vitamins|mesh-list
153982454|NCT05971680|Thiamine|thiamine|mesh-list
153982455|NCT05971680|Vitamin B Complex|vitamin b complex|mesh-list
153982456|NCT05971680|Contraceptive Agents|contraceptive agents|mesh-list
153982457|NCT05971680|Micronutrients|micronutrients|mesh-ancestor
153982458|NCT05971680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982459|NCT05971680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153982460|NCT05971654|Azithromycin|azithromycin|mesh-list
153982461|NCT05971654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153982462|NCT05971654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982463|NCT05971563|Caseins|caseins|mesh-list
153982464|NCT05971563|Chelating Agents|chelating agents|mesh-ancestor
153982465|NCT05971563|Sequestering Agents|sequestering agents|mesh-ancestor
153982466|NCT05971563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982468|NCT05971550|Ceftriaxone|ceftriaxone|mesh-list
153982514|NCT05930808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153982516|NCT05930808|Autonomic Agents|autonomic agents|mesh-ancestor
153982517|NCT05930808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153982518|NCT05930808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982519|NCT05930808|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153982520|NCT05930808|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153982521|NCT05930808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153982522|NCT05930808|Adrenergic Agents|adrenergic agents|mesh-ancestor
153982523|NCT05930808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982524|NCT05930808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982525|NCT05916352|Caffeine|caffeine|mesh-list
153982526|NCT05916352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153982527|NCT05916352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982528|NCT05916352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153982529|NCT05916352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982531|NCT05916352|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153982569|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982570|NCT05597462|Minocycline|minocycline|mesh-list
153982571|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153982572|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982573|NCT05484687|Anesthetics|anesthetics|mesh-list
153982574|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153982575|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982576|NCT05480384|Nivolumab|nivolumab|mesh-list
153982638|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982639|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982640|NCT05165433|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982641|NCT05165433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982642|NCT05150431|Parecoxib|parecoxib|mesh-list
153982643|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153982644|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153982645|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982646|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982702|NCT04683939|Gemcitabine|gemcitabine|mesh-list
153982703|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153982704|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982705|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
153982706|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
153982707|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
153982708|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982709|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153982710|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
153982711|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
153982712|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153982713|NCT04669002|Olaparib|olaparib|mesh-list
153982714|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153982715|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982716|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982717|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982718|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
153982719|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153982720|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982721|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153982723|NCT04528173|Ketorolac|ketorolac|mesh-list
153982754|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153982755|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
153982756|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982757|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982758|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
153982760|NCT04430452|Ipilimumab|ipilimumab|mesh-list
153982761|NCT04430452|Tremelimumab|tremelimumab|mesh-list
153982762|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
153982763|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153982764|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
153982765|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982766|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982767|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
153982768|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982769|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982770|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982812|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982813|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982814|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982815|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982816|NCT03735420|Xanthohumol|xanthohumol|mesh-list
153982817|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982818|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153982819|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153982820|NCT03735420|Growth Substances|growth substances|mesh-ancestor
153982876|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982877|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
153982878|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
153982879|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
153982880|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982881|NCT03028350|Ifetroban|ifetroban|mesh-list
153982882|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153982883|NCT02918370|Aripiprazole|aripiprazole|mesh-list
153982884|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
153982885|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153982886|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153982887|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153982888|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740496|NCT05860699|Anticonvulsants|anticonvulsants|mesh-ancestor
153982889|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982890|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
153982891|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
153982892|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153982893|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982894|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153982895|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153982896|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
153982897|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153982898|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153982899|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153982900|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153982902|NCT02914405|Dinutuximab|dinutuximab|mesh-list
153982903|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
153982904|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
153982905|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982906|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982907|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982908|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982909|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
153982910|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982911|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
153630304|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630305|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153982912|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153982913|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153982914|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982916|NCT02723955|Docetaxel|docetaxel|mesh-list
153982917|NCT02723955|Carboplatin|carboplatin|mesh-list
153982918|NCT02723955|Gemcitabine|gemcitabine|mesh-list
153982919|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
153982920|NCT02723955|Fluorouracil|fluorouracil|mesh-list
153982921|NCT02723955|Pemetrexed|pemetrexed|mesh-list
153982922|NCT02723955|Dostarlimab|dostarlimab|mesh-list
153982923|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153982924|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153982925|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
153982926|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
153982927|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
153982928|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153982929|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153982930|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
153982931|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153982932|NCT02723955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153982933|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153982934|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
153982935|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982936|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982961|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153982962|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153982963|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153982964|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
153982965|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153982966|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
153982967|NCT01946529|Temozolomide|temozolomide|mesh-list
153982968|NCT01946529|Ifosfamide|ifosfamide|mesh-list
153982969|NCT01946529|Bevacizumab|bevacizumab|mesh-list
153982970|NCT01946529|Doxorubicin|doxorubicin|mesh-list
153982971|NCT01946529|Etoposide|etoposide|mesh-list
153982972|NCT01946529|Vincristine|vincristine|mesh-list
153982973|NCT01946529|Sorafenib|sorafenib|mesh-list
153982974|NCT01946529|Temsirolimus|temsirolimus|mesh-list
153982975|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153982976|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
153982977|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153982978|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983022|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153983023|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
153983024|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153983025|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153983026|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
153983027|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
153983028|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153983029|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153983030|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153983031|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
153983032|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983033|NCT00878254|Antidotes|antidotes|mesh-ancestor
153983034|NCT00878254|Protective Agents|protective agents|mesh-ancestor
153983035|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
153983036|NCT00878254|Vitamins|vitamins|mesh-ancestor
153983037|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
153983038|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
153983039|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983040|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983041|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
153983042|NCT00813423|Sunitinib|sunitinib|mesh-list
153983057|NCT00146562|Paclitaxel|paclitaxel|mesh-list
153983077|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983078|NCT00146562|Hematinics|hematinics|mesh-ancestor
153983079|NCT04089592|Fentanyl|fentanyl|mesh-list
153983080|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
153983081|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153983082|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983083|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983084|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153983085|NCT04089592|Analgesics|analgesics|mesh-ancestor
153983086|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
153983087|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983088|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153983089|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153983138|NCT02599480|Mirabegron|mirabegron|mesh-list
153983139|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153983140|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153983141|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153983142|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983143|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983144|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983145|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983146|NCT02599480|Urological Agents|urological agents|mesh-ancestor
153983147|NCT03245840|Budesonide|budesonide|mesh-list
153983148|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153983149|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153983150|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
153983151|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983152|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983153|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153983154|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
153983194|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153983195|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983196|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983197|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983198|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153983199|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
153983200|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
153983201|NCT00746590|Tretazicar|tretazicar|mesh-list
153983202|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983203|NCT01032629|Canagliflozin|canagliflozin|mesh-list
153983204|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153983205|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983206|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153983207|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983208|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153983209|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153983210|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153983250|NCT04091074|Ticagrelor|ticagrelor|mesh-list
153983251|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153983252|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153983253|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153983254|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153983255|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
153983256|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983257|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983258|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983259|NCT00749398|Infliximab|infliximab|mesh-list
153983317|NCT00742924|Vitamins|vitamins|mesh-ancestor
153983318|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
153983319|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153983320|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
153983321|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153983322|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153983323|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983324|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983325|NCT02596984|Caspofungin|caspofungin|mesh-list
153983326|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
153983327|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983328|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983329|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983330|NCT00698815|Pemetrexed|pemetrexed|mesh-list
153983331|NCT00698815|Sunitinib|sunitinib|mesh-list
153983332|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983333|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983334|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983335|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153983372|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153983373|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
153983374|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153983375|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
153983376|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983377|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153983378|NCT02596828|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153983380|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983381|NCT02598856|Naloxone|naloxone|mesh-list
153983382|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153983383|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983386|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
153983435|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153983436|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153983437|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983439|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983440|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983441|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153983442|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153983443|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983444|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153983445|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153983446|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
153983447|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
153983448|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153983449|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153983450|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983451|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
153983452|NCT00740116|Coagulants|coagulants|mesh-ancestor
153983453|NCT02567461|Aspirin|aspirin|mesh-list
153983489|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983490|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983491|NCT01023581|Metformin|metformin|mesh-list
153741097|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983492|NCT01023581|Alogliptin|alogliptin|mesh-list
153983493|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153983494|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983495|NCT01023581|Incretins|incretins|mesh-ancestor
153983496|NCT01023581|Hormones|hormones|mesh-ancestor
153983497|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983499|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
153983551|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153983552|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
153983553|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983554|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153983555|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983556|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983557|NCT02567851|Immunotoxins|immunotoxins|mesh-ancestor
153983558|NCT02567851|Immunoconjugates|immunoconjugates|mesh-ancestor
153983559|NCT02567851|Immunologic Factors|immunologic factors|mesh-ancestor
153983560|NCT02567851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983561|NCT00739882|Antibodies|antibodies|mesh-list
153983562|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153983563|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
153983564|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983566|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153983567|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153983568|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
153983569|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983570|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983571|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983606|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153983607|NCT04391569|Ganaxolone|ganaxolone|mesh-list
153983608|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
153983609|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983610|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983611|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983612|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
153983613|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
153983614|NCT05324917|Rituximab|rituximab|mesh-list
153983615|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983616|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983617|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
153983618|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983619|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153983620|NCT00739648|Levofloxacin|levofloxacin|mesh-list
153983621|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153983622|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153983623|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153983660|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983661|NCT00637715|Alfuzosin|alfuzosin|mesh-list
153983662|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153983663|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153983664|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153983665|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983666|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983667|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983668|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983670|NCT02596282|Anesthetics|anesthetics|mesh-list
153983723|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
153983724|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
153983725|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983726|NCT00734032|Darapladib|darapladib|mesh-list
153983727|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153983728|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983729|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983730|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
153983731|NCT04284098|Bupivacaine|bupivacaine|mesh-list
153983732|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
153983733|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
153983734|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153983735|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983784|NCT04298021|Olaparib|olaparib|mesh-list
153983785|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983786|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153983787|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153983788|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983789|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983791|NCT02595190|Tramadol|tramadol|mesh-list
153983792|NCT02595190|Analgesics|analgesics|mesh-ancestor
153983793|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
153983794|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983795|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983847|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153983848|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153983849|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153983850|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
153983851|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153983852|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983853|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153983854|NCT00576823|Urological Agents|urological agents|mesh-ancestor
153983855|NCT00732940|Belimumab|belimumab|mesh-list
153983912|NCT00958724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153983913|NCT00958724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983914|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153983915|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
153983916|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153983917|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153983918|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983919|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153983920|NCT00738400|Urological Agents|urological agents|mesh-ancestor
153983922|NCT00958568|Fluoxetine|fluoxetine|mesh-list
153983923|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
153983924|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
153983928|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153983973|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153983974|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153983975|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
153983976|NCT02858804|Hormones|hormones|mesh-ancestor
153983977|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153983978|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153983979|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153983980|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153983981|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153983982|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153983983|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153983984|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153983985|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153983986|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
153984033|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153984034|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984035|NCT00628667|Esomeprazole|esomeprazole|mesh-list
153984036|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153984037|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984038|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153984039|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984040|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984041|NCT02858258|Ibrutinib|ibrutinib|mesh-list
153984042|NCT02858258|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153984043|NCT02858258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984044|NCT02858258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984045|NCT02858258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984046|NCT01008995|Ustekinumab|ustekinumab|mesh-list
153984047|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
153984048|NCT04295993|Norepinephrine|norepinephrine|mesh-list
153984049|NCT04295993|Methylene Blue|methylene blue|mesh-list
153984050|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153984051|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153984052|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
153984053|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984054|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984055|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984056|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
153984057|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
153984058|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984059|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153984060|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984061|NCT00743587|Naproxen|naproxen|mesh-list
153984078|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984079|NCT00957944|Rotigotine|rotigotine|mesh-list
153984080|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
153984150|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153984151|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153984152|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153984153|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984154|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
153984155|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984156|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
153984157|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984158|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153637794|NCT00001047|Clarithromycin|clarithromycin|mesh-list
153984159|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153984160|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153984161|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153984162|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
153984163|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
153984164|NCT02857166|Antibodies|antibodies|mesh-list
153984165|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153984166|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
153984167|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984168|NCT02856932|Methamphetamine|methamphetamine|mesh-list
153984169|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153984170|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984171|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
153984172|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
153984182|NCT02563951|Granisetron|granisetron|mesh-list
153984201|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984202|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984203|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
153984204|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984205|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153984206|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153984213|NCT01005329|Paclitaxel|paclitaxel|mesh-list
153984265|NCT02856776|Vitamins|vitamins|mesh-ancestor
153984266|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
153984267|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984268|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153984269|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153984270|NCT04296851|Niclosamide|niclosamide|mesh-list
153984271|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
153984272|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153984273|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
153984274|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153984275|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984276|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
153984277|NCT02858024|Dapivirine|dapivirine|mesh-list
153984278|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153984279|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153984280|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
153984281|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984282|NCT02857946|Linagliptin|linagliptin|mesh-list
153984323|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984325|NCT02563795|Bupivacaine|bupivacaine|mesh-list
153984326|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
153984327|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
153984328|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153984329|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984330|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
153984331|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984332|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153984333|NCT02563795|Narcotics|narcotics|mesh-ancestor
153984334|NCT02563795|Analgesics|analgesics|mesh-ancestor
153984335|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153984336|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153984337|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
153984338|NCT04281680|Octreotide|octreotide|mesh-list
153984339|NCT04281680|Pasireotide|pasireotide|mesh-list
153984340|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153984341|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153984342|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984343|NCT04281680|Hormones|hormones|mesh-ancestor
153653291|NCT02970916|Aflibercept|aflibercept|mesh-list
153984344|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984345|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984346|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
153984347|NCT00744445|Hematinics|hematinics|mesh-ancestor
153984348|NCT02857868|Asciminib|asciminib|mesh-list
153984349|NCT02857868|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153984350|NCT02857868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984353|NCT02854748|Empagliflozin|empagliflozin|mesh-list
153984372|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984373|NCT01007435|Methotrexate|methotrexate|mesh-list
153984374|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153984375|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
153984376|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153984377|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984378|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153984379|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
153984380|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984381|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176492|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742001|NCT02947945|Reslizumab|reslizumab|mesh-list
153984429|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984430|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984432|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153984433|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
153984434|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984435|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984436|NCT04060771|Dexamethasone|dexamethasone|mesh-list
153984437|NCT04060771|Palonosetron|palonosetron|mesh-list
153984438|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153984439|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
153984492|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153984493|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
153984494|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984495|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984496|NCT00948428|Imiquimod|imiquimod|mesh-list
153984497|NCT00948428|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153984498|NCT00948428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984499|NCT00948428|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153984500|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
153984501|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984502|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153984503|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984504|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
153984505|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
153984506|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153984507|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
153984550|NCT02856542|Hormones|hormones|mesh-ancestor
153984551|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984552|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984553|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153984554|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
153984555|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
153984556|NCT00688753|Everolimus|everolimus|mesh-list
153984557|NCT00688753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153984558|NCT00688753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984559|NCT00688753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984560|NCT00688753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984561|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984562|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
153984563|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984564|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984565|NCT04204382|Levofloxacin|levofloxacin|mesh-list
153984566|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153984567|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984568|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153984569|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153984570|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153984571|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984572|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984599|NCT00631124|Diuretics|diuretics|mesh-ancestor
153984600|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
153984601|NCT02855684|Insulin|insulin|mesh-list
153984602|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153984603|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
153984604|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153984605|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984606|NCT01667744|Citalopram|citalopram|mesh-list
153984607|NCT01667744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153984608|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153984609|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153984610|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984611|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984612|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
153984613|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984659|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
153984661|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153984662|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153984663|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984664|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153984665|NCT02563405|Doxazosin|doxazosin|mesh-list
153984666|NCT02563405|Nifedipine|nifedipine|mesh-list
153984667|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153984668|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153984669|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984670|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153984671|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984672|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
153984673|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
153984674|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153984675|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153984676|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153984677|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153984678|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153984679|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
153742290|NCT00167817|Aripiprazole|aripiprazole|mesh-list
153984680|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153984681|NCT00513019|Lamotrigine|lamotrigine|mesh-list
153984693|NCT00053677|Naltrexone|naltrexone|mesh-list
153984710|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984711|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153984712|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
153984713|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153984714|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153984715|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153984716|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984717|NCT00954512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153984718|NCT00954512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984719|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984720|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
153984721|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984722|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153984723|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153984725|NCT00954512|Protective Agents|protective agents|mesh-ancestor
153984726|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
153984727|NCT00954512|Vitamins|vitamins|mesh-ancestor
153984728|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
153984729|NCT00954512|Hematinics|hematinics|mesh-ancestor
153984730|NCT00691015|Cytarabine|cytarabine|mesh-list
153984731|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
153984732|NCT00691015|Melphalan|melphalan|mesh-list
153984733|NCT00691015|Busulfan|busulfan|mesh-list
153984734|NCT00691015|Carmustine|carmustine|mesh-list
153984735|NCT00691015|Rituximab|rituximab|mesh-list
153984736|NCT00691015|Fludarabine|fludarabine|mesh-list
153984737|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
153984738|NCT00691015|Etoposide|etoposide|mesh-list
153984739|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
153984740|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153984741|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984742|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
153984743|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984744|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153984753|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153984754|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153984755|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153984756|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984757|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
153742362|NCT02946814|Listerine|listerine|mesh-list
153984758|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153984759|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
153984760|NCT00950300|Docetaxel|docetaxel|mesh-list
153984761|NCT00950300|Fluorouracil|fluorouracil|mesh-list
153984762|NCT00950300|Trastuzumab|trastuzumab|mesh-list
153984763|NCT00950300|Epirubicin|epirubicin|mesh-list
153984764|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984765|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
153984766|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984767|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153984768|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153984769|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
153984770|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984771|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984772|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153984773|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
153984774|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
153984804|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
153984805|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984807|NCT00687193|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153984808|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984809|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984811|NCT00917878|Calcium|calcium|mesh-list
153984872|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153984873|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153984874|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153984875|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
153984876|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153984877|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153984878|NCT00949910|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153984879|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153984880|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984881|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984882|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153984883|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153984884|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153984885|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153984886|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
153984887|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153984888|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153984889|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153984890|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984892|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
153984924|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153984925|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984926|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153984927|NCT04088266|Buprenorphine|buprenorphine|mesh-list
153984928|NCT04088266|Naloxone|naloxone|mesh-list
153984929|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153984930|NCT04088266|Narcotics|narcotics|mesh-ancestor
153984931|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153984932|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984933|NCT04088266|Analgesics|analgesics|mesh-ancestor
153984934|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
153984935|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153984936|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153984937|NCT05311579|Niraparib|niraparib|mesh-list
153984939|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153984983|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984984|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153984985|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
153984986|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
153984987|NCT01410344|Vidarabine|vidarabine|mesh-list
153984988|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
153984989|NCT01410344|Melphalan|melphalan|mesh-list
153984990|NCT01410344|Busulfan|busulfan|mesh-list
153984991|NCT01410344|Fludarabine|fludarabine|mesh-list
153984992|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
153984993|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153984994|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
153984995|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153984996|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153984997|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153984998|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
153984999|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985000|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985001|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153985003|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
153985037|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153985038|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
153985039|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985040|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985041|NCT00728494|Ribavirin|ribavirin|mesh-list
153985042|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153985043|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
153985044|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
153985045|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985046|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
153985047|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985050|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
153985098|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153985099|NCT02857244|Modafinil|modafinil|mesh-list
153985100|NCT02857244|Donepezil|donepezil|mesh-list
153985101|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153985102|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153985103|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153985104|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985105|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985106|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985107|NCT02857244|Analgesics|analgesics|mesh-ancestor
153985108|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
153985109|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985110|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
153985111|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153985112|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
153985113|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153985114|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985115|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
153985116|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
153985117|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153985118|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153985119|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153985120|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153985121|NCT04273256|Inositol|inositol|mesh-list
153985122|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
153985123|NCT04273256|Vitamins|vitamins|mesh-ancestor
153985133|NCT04088032|Durvalumab|durvalumab|mesh-list
153985145|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
153985146|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985147|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985148|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985149|NCT00735904|Gemcitabine|gemcitabine|mesh-list
153985150|NCT00735904|Axitinib|axitinib|mesh-list
153985151|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985218|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985219|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153985220|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153985221|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985222|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985223|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985224|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
153985225|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153985226|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
153985239|NCT00918034|Talaporfin|talaporfin|mesh-list
153985282|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
153985283|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985284|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985285|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
153985286|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
153985287|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
153985288|NCT00631202|Hematinics|hematinics|mesh-ancestor
153985289|NCT02851784|Immunomodulating Agents|immunomodulating agents|mesh-list
153985290|NCT02851784|Immunologic Factors|immunologic factors|mesh-ancestor
153985291|NCT02851784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985292|NCT00721630|Capecitabine|capecitabine|mesh-list
153985294|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153985295|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
153985296|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985297|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985298|NCT00721630|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153985299|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153985300|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985339|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985340|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985341|NCT04055233|Biguanides|biguanides|mesh-list
153985342|NCT04055233|Polihexanide|polihexanide|mesh-list
153985343|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985344|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
153985345|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153985346|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985406|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153985407|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
153985408|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
153985409|NCT02851472|Protective Agents|protective agents|mesh-ancestor
153985410|NCT00687973|Atenolol|atenolol|mesh-list
153985411|NCT00687973|Amlodipine|amlodipine|mesh-list
153985412|NCT00687973|Valsartan|valsartan|mesh-list
153985413|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153985414|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153985415|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153985416|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985417|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153985418|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985419|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
153985420|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153985421|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153985422|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153985423|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
153985424|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
153985425|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985426|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153985460|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153985461|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
153985462|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985463|NCT00943826|Bevacizumab|bevacizumab|mesh-list
153985464|NCT00943826|Temozolomide|temozolomide|mesh-list
153985465|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985466|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985467|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153985468|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153985523|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985524|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985525|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153985526|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
153985527|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
153985528|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
153985529|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985530|NCT00943670|Immunotoxins|immunotoxins|mesh-ancestor
153985531|NCT00943670|Immunoconjugates|immunoconjugates|mesh-ancestor
153985532|NCT00943670|Immunologic Factors|immunologic factors|mesh-ancestor
153985533|NCT00943670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985534|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
153985535|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985536|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985537|NCT02851004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153985583|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153985584|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153985585|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985586|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985587|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153985588|NCT00940316|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153985589|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153985590|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153985591|NCT02850848|Entecavir|entecavir|mesh-list
153985592|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
153985593|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985594|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
153985595|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
153985596|NCT05381168|Calcium|calcium|mesh-list
153985597|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153985644|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
153985645|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985646|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153985647|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153985648|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
153985649|NCT00747487|Idebenone|idebenone|mesh-list
154176494|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153985650|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
153985651|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985652|NCT00747487|Protective Agents|protective agents|mesh-ancestor
153985653|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985654|NCT00750217|Buprenorphine|buprenorphine|mesh-list
153985655|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153985656|NCT00750217|Narcotics|narcotics|mesh-ancestor
153985657|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985658|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985659|NCT00750217|Analgesics|analgesics|mesh-ancestor
153985660|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
153985661|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985662|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153985663|NCT00687739|Leuprolide|leuprolide|mesh-list
153985664|NCT00687739|Estradiol|estradiol|mesh-list
153985665|NCT00687739|Estrogens|estrogens|mesh-ancestor
153985666|NCT00687739|Hormones|hormones|mesh-ancestor
153985667|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985668|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985669|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153985670|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153985671|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
153985689|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153985690|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985691|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
153985692|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153985693|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153985694|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985695|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153985696|NCT00747721|Analgesics|analgesics|mesh-ancestor
153985697|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
153985698|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985699|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153985700|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153985701|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153985702|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
153985703|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985704|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985705|NCT01006889|Exenatide|exenatide|mesh-list
153985706|NCT01006889|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153985707|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153985708|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985709|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153985710|NCT01006889|Incretins|incretins|mesh-ancestor
153985711|NCT01006889|Hormones|hormones|mesh-ancestor
153985712|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985713|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
153985736|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985737|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153985738|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985739|NCT04294823|Esomeprazole|esomeprazole|mesh-list
153985740|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153985741|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153985742|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153985743|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985745|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153985802|NCT00750529|Galantamine|galantamine|mesh-list
153985803|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153985804|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985805|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985807|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985873|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
153985874|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153985875|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985876|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
153985877|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153985878|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153985879|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153985880|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
153653922|NCT00040261|Memantine|memantine|mesh-list
153985881|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985882|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153985883|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153985884|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985885|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985905|NCT00687271|Calcium|calcium|mesh-list
153985931|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153985932|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153985933|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153985934|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153985936|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153985937|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153985938|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
153985939|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153985940|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
153985941|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
153985942|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985943|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
153985944|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153985945|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153985946|NCT01031381|Bevacizumab|bevacizumab|mesh-list
153985947|NCT01031381|Everolimus|everolimus|mesh-list
153985988|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153985989|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153985990|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
153985991|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153985992|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153985993|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153985994|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153985996|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
153985997|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153985998|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153985999|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
153986000|NCT00753103|Hormones|hormones|mesh-ancestor
153986001|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986002|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153986003|NCT00753103|Protective Agents|protective agents|mesh-ancestor
153986004|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153986005|NCT00753103|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153986006|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
153986007|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
153986008|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153986009|NCT00748891|Cediranib|cediranib|mesh-list
153986010|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986011|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153986012|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986013|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986014|NCT00685165|Primidone|primidone|mesh-list
153986015|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
153986016|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
153986017|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
153986018|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986019|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630306|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630307|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
153630308|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630309|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630310|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630311|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630312|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
153630313|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
153630314|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630315|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986021|NCT00749047|Pioglitazone|pioglitazone|mesh-list
153986022|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986023|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986024|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
153986025|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986026|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
153986027|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
153986028|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986029|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986030|NCT00753493|Topiramate|topiramate|mesh-list
153986031|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
153986032|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986033|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986084|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
153986085|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986086|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153986087|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153986088|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986089|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
153986090|NCT00720382|Azelastine|azelastine|mesh-list
153986091|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986092|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
153986093|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153986094|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153986144|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986145|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986146|NCT00725842|Ribavirin|ribavirin|mesh-list
153986147|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
153986148|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153986149|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
153986150|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986151|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
153986152|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986153|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986154|NCT04051723|Dexamethasone|dexamethasone|mesh-list
153986155|NCT04051723|Ropivacaine|ropivacaine|mesh-list
153986156|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986157|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
153986158|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
153986159|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986204|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153986205|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986206|NCT00757315|Triamcinolone|triamcinolone|mesh-list
153986207|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153986208|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153986209|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153986210|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986211|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
153986212|NCT00757315|Hormones|hormones|mesh-ancestor
153986213|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986214|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986215|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153986216|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
153986217|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986218|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986219|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
153986220|NCT00757393|Vitamin D|vitamin d|mesh-list
153986221|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
153986222|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
153986260|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153986262|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986263|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153986264|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153986265|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986266|NCT00725608|Buprenorphine|buprenorphine|mesh-list
153986331|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153986332|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153986333|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
153986334|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986335|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986336|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986337|NCT02590900|Acetaminophen|acetaminophen|mesh-list
153986338|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153986339|NCT02590900|Analgesics|analgesics|mesh-ancestor
153986340|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
153986341|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986342|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986343|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
153986344|NCT02591914|Bevacizumab|bevacizumab|mesh-list
153986345|NCT02591914|Ranibizumab|ranibizumab|mesh-list
153986346|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153986347|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986348|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153986349|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153986350|NCT02591914|Growth Substances|growth substances|mesh-ancestor
153986351|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986352|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
153986353|NCT00723190|Clonidine|clonidine|mesh-list
153986354|NCT00723190|Analgesics|analgesics|mesh-ancestor
153986355|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
153986356|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986357|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986358|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153986359|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
153986360|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
153986361|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153986362|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153986363|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153986373|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986374|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986375|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153986376|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
153986377|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153986378|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153986379|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153986380|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153986381|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153986382|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
153986383|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153986384|NCT00722800|Diuretics|diuretics|mesh-ancestor
153986385|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
153986386|NCT00741598|Galantamine|galantamine|mesh-list
153986397|NCT03947632|Chrysarobin|chrysarobin|mesh-list
153986431|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153986432|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
153986433|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
153986434|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153986435|NCT00741286|Protective Agents|protective agents|mesh-ancestor
153986436|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153986437|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153986438|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153986439|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986440|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153986441|NCT00716092|Linagliptin|linagliptin|mesh-list
153986442|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153986443|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986444|NCT00716092|Incretins|incretins|mesh-ancestor
153986445|NCT00716092|Hormones|hormones|mesh-ancestor
153986446|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986447|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153986448|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
153986449|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986450|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986484|NCT00919282|Protective Agents|protective agents|mesh-ancestor
153986485|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986486|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
153986488|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
153986489|NCT00919282|Hematinics|hematinics|mesh-ancestor
153986490|NCT00757549|Cetuximab|cetuximab|mesh-list
153986491|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153986492|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986493|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153986494|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153986495|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986496|NCT00576199|Bevacizumab|bevacizumab|mesh-list
153986497|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153986498|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986548|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
153986549|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
154176495|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986550|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986551|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986556|NCT04051099|Analgesics|analgesics|mesh-ancestor
153986614|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
153986615|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986616|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986617|NCT00682435|Hydromorphone|hydromorphone|mesh-list
153986618|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153986619|NCT00682435|Narcotics|narcotics|mesh-ancestor
153986620|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986621|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986622|NCT00682435|Analgesics|analgesics|mesh-ancestor
153986623|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
153986624|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986625|NCT05340205|Misoprostol|misoprostol|mesh-list
153986626|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
153986627|NCT05340205|Oxytocin|oxytocin|mesh-list
153986628|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
153986629|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153986630|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986675|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986676|NCT04007809|Hormones|hormones|mesh-ancestor
153986677|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986678|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986679|NCT04083664|Hepcidins|hepcidins|mesh-list
153986680|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986681|NCT05202730|Anesthetics|anesthetics|mesh-list
153986682|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
153986683|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153986684|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986736|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986737|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153986739|NCT02560207|Cefoxitin|cefoxitin|mesh-list
153986740|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153986741|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153986742|NCT00678691|Modafinil|modafinil|mesh-list
153986743|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153986744|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986745|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153986746|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153986747|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153986748|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986749|NCT05003752|Goserelin|goserelin|mesh-list
153986750|NCT05003752|Androgens|androgens|mesh-list
153986753|NCT05003752|Hormones|hormones|mesh-ancestor
153986795|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153986796|NCT00761449|Growth Substances|growth substances|mesh-ancestor
153986797|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
153986798|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986799|NCT04968106|Doxorubicin|doxorubicin|mesh-list
153986800|NCT04968106|Ifosfamide|ifosfamide|mesh-list
153986801|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153986802|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986803|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153986804|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153986805|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153986806|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986807|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153986859|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986860|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986861|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
153986862|NCT04082962|Hormones|hormones|mesh-ancestor
153986863|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986864|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153986865|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986866|NCT02471833|Telmisartan|telmisartan|mesh-list
153986867|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153986868|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153986869|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153986870|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986871|NCT04895410|Dexamethasone|dexamethasone|mesh-list
153986872|NCT04895410|Daratumumab|daratumumab|mesh-list
153986873|NCT04895410|Pomalidomide|pomalidomide|mesh-list
153986874|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153986875|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
153986876|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
153986877|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986878|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986879|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986880|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
153986881|NCT04895410|Hormones|hormones|mesh-ancestor
153654293|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153986882|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153986883|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153986884|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153986885|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
153986886|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153986887|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153986888|NCT04895410|Growth Substances|growth substances|mesh-ancestor
153986889|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
153986890|NCT00675025|Donepezil|donepezil|mesh-list
153630316|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
153986897|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
153986898|NCT00758407|Methylphenidate|methylphenidate|mesh-list
153986899|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153986900|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986901|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153986902|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153986903|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153986904|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153986905|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
153986906|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153986907|NCT00759421|Olanzapine|olanzapine|mesh-list
153986908|NCT00759421|Sertindole|sertindole|mesh-list
153986909|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
153986910|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
153986911|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153986912|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986913|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153986952|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986953|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153986954|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
153986955|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986956|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153986957|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
153986958|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153986959|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153986960|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
153986961|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153986962|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
153986963|NCT00760045|Protective Agents|protective agents|mesh-ancestor
153986964|NCT00678379|Lidocaine|lidocaine|mesh-list
153986965|NCT00678379|Clonidine|clonidine|mesh-list
153987016|NCT04115956|Dexamethasone|dexamethasone|mesh-list
153987017|NCT04115956|Melphalan|melphalan|mesh-list
153987018|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987019|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
153987020|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
153987021|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987022|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987023|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987024|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
153987025|NCT04115956|Hormones|hormones|mesh-ancestor
153987026|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987027|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153987028|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987029|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153987030|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
153987031|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987032|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153987033|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153987034|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
153987035|NCT04081480|Valacyclovir|valacyclovir|mesh-list
153987036|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
153987037|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987038|NCT00678301|Vaccines|vaccines|mesh-list
153987039|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
153987040|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987041|NCT02586454|Morphine|morphine|mesh-list
153987042|NCT02586454|Ropivacaine|ropivacaine|mesh-list
153987043|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153987044|NCT02586454|Narcotics|narcotics|mesh-ancestor
153987047|NCT02586454|Analgesics|analgesics|mesh-ancestor
153987063|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
153987064|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987065|NCT00939692|Topiramate|topiramate|mesh-list
153987066|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
153987067|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987068|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987069|NCT00920608|Methotrexate|methotrexate|mesh-list
153987070|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153987071|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
153987072|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153987073|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987074|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153987075|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
153987076|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987077|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987122|NCT00942734|Everolimus|everolimus|mesh-list
153987123|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153987124|NCT00942734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153987125|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987126|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987127|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987128|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153987129|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
153987130|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987131|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987132|NCT00942734|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153987133|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
153987134|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153987135|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153987136|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153987137|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153987138|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987139|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
153987140|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987141|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987142|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153987144|NCT00919984|Paclitaxel|paclitaxel|mesh-list
153987174|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153987175|NCT00677833|Azithromycin|azithromycin|mesh-list
153987176|NCT00677833|Chloroquine|chloroquine|mesh-list
153987177|NCT00677833|Lumefantrine|lumefantrine|mesh-list
153987178|NCT00677833|Artemether|artemether|mesh-list
153987179|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153987180|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153987181|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987182|NCT00677833|Amebicides|amebicides|mesh-ancestor
153987183|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153987184|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153987185|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
153987186|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153987187|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
153987188|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153987189|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153987190|NCT05086874|Protective Agents|protective agents|mesh-ancestor
153987191|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987192|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
153987193|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987194|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987195|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
153987196|NCT00942266|Leucovorin|leucovorin|mesh-list
153987197|NCT00942266|Fluorouracil|fluorouracil|mesh-list
153987198|NCT00942266|Vorinostat|vorinostat|mesh-list
153987199|NCT00942266|Calcium|calcium|mesh-list
153987200|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
153987201|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153987202|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987223|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153987224|NCT04079374|Analgesics|analgesics|mesh-ancestor
153987225|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
153987226|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987227|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987228|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987229|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640861|NCT01805596|Ticagrelor|ticagrelor|mesh-list
153987230|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987231|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153987232|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
153987233|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
153987234|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153987235|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987236|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987237|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987238|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153987239|NCT02583958|Laxatives|laxatives|mesh-ancestor
153987240|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987241|NCT00604058|Vaccines|vaccines|mesh-list
153987242|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
153987243|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987244|NCT02852798|Docetaxel|docetaxel|mesh-list
153987273|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987274|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
153987275|NCT00672841|Clotrimazole|clotrimazole|mesh-list
153987276|NCT00672841|Miconazole|miconazole|mesh-list
153987277|NCT00672841|Anidulafungin|anidulafungin|mesh-list
153987278|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987279|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153987280|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153987281|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153987282|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987283|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987284|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153987285|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
153987286|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987287|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987290|NCT00920296|Cabotegravir|cabotegravir|mesh-list
153987327|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
153987328|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153987329|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
153987330|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987331|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
153987332|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
153987333|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987334|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987335|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987336|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
153987337|NCT00764413|Hormones|hormones|mesh-ancestor
153987338|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987339|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153987340|NCT00764413|Protective Agents|protective agents|mesh-ancestor
153987341|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153987342|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987343|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
153987344|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987345|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
153987346|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153987347|NCT00583102|Cytarabine|cytarabine|mesh-list
153987348|NCT00583102|Lovastatin|lovastatin|mesh-list
153987349|NCT00583102|L 647318|l 647318|mesh-list
153987350|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
153987351|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153987371|NCT00605930|Niacin|niacin|mesh-list
153987379|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987380|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153987381|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
153987383|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153987384|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153987385|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153987386|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153987387|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
153987388|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987389|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987390|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987391|NCT04204304|Isotretinoin|isotretinoin|mesh-list
153987392|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
153987393|NCT05380778|Anesthetics|anesthetics|mesh-list
153987394|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987395|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987396|NCT02852720|Anesthetics|anesthetics|mesh-list
153987397|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
153987398|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987399|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987400|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
153987401|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
153987402|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987403|NCT05857306|Olvanil|olvanil|mesh-list
153987404|NCT05857306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154176504|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176505|NCT00841373|Ranibizumab|ranibizumab|mesh-list
154176506|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154176507|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154176508|NCT00841373|Growth Substances|growth substances|mesh-ancestor
154176509|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176510|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
154176511|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176512|NCT00851513|Lidocaine|lidocaine|mesh-list
154176513|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
154176514|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
154176515|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176516|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987419|NCT05857267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987420|NCT05857267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987421|NCT05857267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987422|NCT05857267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153987423|NCT05857267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153987427|NCT05857202|Analgesics|analgesics|mesh-list
153987461|NCT05851313|Micronutrients|micronutrients|mesh-ancestor
153987462|NCT05851313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987463|NCT05851313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153987464|NCT05844813|Doxorubicin|doxorubicin|mesh-list
153987465|NCT05844813|Ifosfamide|ifosfamide|mesh-list
153987466|NCT05844813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153987467|NCT05844813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987468|NCT05844813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153987469|NCT05844813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153987470|NCT05844813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987471|NCT05844813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987472|NCT05844813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153987473|NCT05844813|Alkylating Agents|alkylating agents|mesh-ancestor
153987474|NCT05812417|DA-8010|da-8010|mesh-list
153987475|NCT05812417|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153987476|NCT05812417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153987477|NCT05812417|Cholinergic Agents|cholinergic agents|mesh-ancestor
153987478|NCT05812417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153987479|NCT05812417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987480|NCT05812417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987515|NCT05733715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987517|NCT05678647|Trace Elements|trace elements|mesh-ancestor
153987518|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
153987519|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987520|NCT05639907|Ethanol|ethanol|mesh-list
153987521|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153987522|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153987523|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987524|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987525|NCT05614115|Empagliflozin|empagliflozin|mesh-list
153987582|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153987583|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987584|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
153987585|NCT05147558|Lenvatinib|lenvatinib|mesh-list
153987586|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153987587|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987588|NCT05147558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153987589|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987590|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987645|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153987646|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987647|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
153987648|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153987649|NCT04881682|Antibodies|antibodies|mesh-list
153987650|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
153987651|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987652|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153987653|NCT04839185|Hematinics|hematinics|mesh-ancestor
153987654|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153987655|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153987656|NCT04806906|Azacitidine|azacitidine|mesh-list
153987658|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153987659|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
153987660|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987661|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987662|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987704|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987705|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987706|NCT04498780|Valsartan|valsartan|mesh-list
153987707|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153987708|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153987709|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153987710|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153987711|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987712|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
153987713|NCT04493333|Psyllium|psyllium|mesh-list
153987714|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153987715|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153987716|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
153987717|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987718|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
153987762|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153987763|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
153987764|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987765|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987766|NCT03947216|Pimavanserin|pimavanserin|mesh-list
153987767|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153987768|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153987769|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153987770|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153987771|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987772|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987773|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153987774|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153987775|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153987776|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
153987820|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
153987821|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153987822|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
153987823|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153987824|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
153987825|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987826|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987827|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
153987828|NCT03617731|Dexamethasone|dexamethasone|mesh-list
153987829|NCT03617731|Lenalidomide|lenalidomide|mesh-list
153987831|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153987832|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
153987834|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153987835|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987836|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153987837|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
153987838|NCT03617731|Hormones|hormones|mesh-ancestor
153987839|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987840|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153987841|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153987842|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
153987843|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153987875|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153987876|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987878|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153987879|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987880|NCT03232918|Oxytocin|oxytocin|mesh-list
153987881|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
153987882|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153987883|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987884|NCT03212989|Vorinostat|vorinostat|mesh-list
153987886|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153987887|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987889|NCT03137173|Vancomycin|vancomycin|mesh-list
153987890|NCT03137173|Aztreonam|aztreonam|mesh-list
153987937|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
153987938|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153987939|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153987940|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153987941|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153987942|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987944|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
153987945|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153987946|NCT02337634|Protective Agents|protective agents|mesh-ancestor
153987948|NCT02288195|Capecitabine|capecitabine|mesh-list
153988001|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988002|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988003|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153988004|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988005|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
153988006|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
153988007|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988008|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153988009|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
153988010|NCT00572169|Hormones|hormones|mesh-ancestor
153988012|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153988064|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988066|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153988067|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153988069|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
153988070|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988071|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153988072|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988073|NCT04078048|Vitamins|vitamins|mesh-list
153988074|NCT04078048|Vitamin E|vitamin e|mesh-list
153988075|NCT04078048|Antioxidants|antioxidants|mesh-list
153988076|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
153988077|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988078|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988079|NCT04078048|Protective Agents|protective agents|mesh-ancestor
153988080|NCT00673387|Pramlintide|pramlintide|mesh-list
153988082|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153988119|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988120|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988121|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988122|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
153988123|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153988124|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
153988125|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988126|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988127|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
153988128|NCT00574951|Imetelstat|imetelstat|mesh-list
153745715|NCT02425904|Clofarabine|clofarabine|mesh-list
153988184|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988185|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153988186|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153988187|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
153988188|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988189|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153988190|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153988191|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153988192|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153988193|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153988194|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153988195|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
153988196|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153988197|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988198|NCT02583022|Analgesics|analgesics|mesh-ancestor
153988203|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153988240|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
153988241|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988243|NCT04077892|Montelukast|montelukast|mesh-list
153988244|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988245|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153988246|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
153988247|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988248|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988249|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153988250|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
153988251|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
153988252|NCT04077892|Hormones|hormones|mesh-ancestor
153988303|NCT02584582|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153988304|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153988305|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988306|NCT02584582|Incretins|incretins|mesh-ancestor
153988307|NCT02584582|Hormones|hormones|mesh-ancestor
153988308|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988309|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153988310|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153988311|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
153988312|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988313|NCT00765973|Topotecan|topotecan|mesh-list
153988314|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153988316|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988366|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988368|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153988369|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988370|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153988371|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988372|NCT00770731|Sirolimus|sirolimus|mesh-list
153988373|NCT00770731|Bortezomib|bortezomib|mesh-list
153988374|NCT00770731|Topotecan|topotecan|mesh-list
153988375|NCT00770731|Temsirolimus|temsirolimus|mesh-list
153988376|NCT00770731|MTOR Inhibitors|mtor inhibitors|mesh-list
153988377|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988378|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153988379|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153988380|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988426|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988427|NCT04378426|Midazolam|midazolam|mesh-list
153988428|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
153988429|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153988430|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153988431|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988432|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988433|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153988434|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153988435|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153988436|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153988437|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
153988438|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
153988439|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
153988440|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
153988441|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988488|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
153988489|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988490|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
153988491|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153988492|NCT04267250|Estradiol|estradiol|mesh-list
153988493|NCT04267250|PF-06700841|pf-06700841|mesh-list
153988494|NCT04267250|Estrogens|estrogens|mesh-ancestor
153988495|NCT04267250|Hormones|hormones|mesh-ancestor
153988496|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153988497|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988498|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153988499|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
153988500|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153988501|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153988502|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153988503|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153988504|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153746091|NCT00150410|Insulin|insulin|mesh-list
153988505|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153988507|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988508|NCT00775489|Beclomethasone|beclomethasone|mesh-list
153988511|NCT00775489|Hormones|hormones|mesh-ancestor
153988541|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
153988542|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153988543|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
153988544|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
153988545|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153988546|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988547|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988548|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153988549|NCT02557867|Analgesics|analgesics|mesh-ancestor
153988550|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
153988551|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988552|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153988553|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153988602|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
153988603|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988604|NCT00668707|Protective Agents|protective agents|mesh-ancestor
153988605|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988606|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153988607|NCT00766909|Cyclosporine|cyclosporine|mesh-list
153988608|NCT00766909|Tacrolimus|tacrolimus|mesh-list
153988609|NCT00766909|Cyclosporins|cyclosporins|mesh-list
153988610|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153988668|NCT04024072|Brinzolamide|brinzolamide|mesh-list
153988669|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153988670|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988671|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988672|NCT00771511|Capsaicin|capsaicin|mesh-list
153988673|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
153988674|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
153988675|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
153988676|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988677|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988678|NCT00776113|Carvedilol|carvedilol|mesh-list
153988679|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153988680|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153988681|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
153988682|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153988685|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153988726|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988727|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153988728|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153988798|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153988799|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153988800|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988801|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988802|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
153988803|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988804|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
153988805|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153988806|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153988807|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988808|NCT00772135|Urological Agents|urological agents|mesh-ancestor
153988809|NCT00776503|Vorinostat|vorinostat|mesh-list
153988810|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988811|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153988812|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988814|NCT04075006|Ketamine|ketamine|mesh-list
153988857|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154176521|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153988858|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153988859|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153988860|NCT00669955|Antacids|antacids|mesh-ancestor
153988861|NCT00772291|Pregabalin|pregabalin|mesh-list
153988862|NCT00772291|Analgesics|analgesics|mesh-ancestor
153988863|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
153988864|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153988865|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153988866|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
153988867|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153988868|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153988869|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153988870|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153988871|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153988914|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153988915|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153988916|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
153988917|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
153988918|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153988919|NCT04149106|Amodiaquine|amodiaquine|mesh-list
153988920|NCT04149106|Artenimol|artenimol|mesh-list
153988921|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
153988922|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153988923|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153988924|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988925|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153988926|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153988927|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655149|NCT00046306|Protective Agents|protective agents|mesh-ancestor
153988928|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153988929|NCT00768391|Olaratumab|olaratumab|mesh-list
153988930|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988931|NCT00669877|Cytarabine|cytarabine|mesh-list
153988932|NCT00669877|Dexamethasone|dexamethasone|mesh-list
153988933|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
153988934|NCT00669877|Rituximab|rituximab|mesh-list
153988935|NCT00669877|Doxorubicin|doxorubicin|mesh-list
153988936|NCT00669877|Methotrexate|methotrexate|mesh-list
153988937|NCT00669877|Vincristine|vincristine|mesh-list
153988948|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
153988967|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153988968|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153988969|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
153988970|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153988971|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153988972|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
153988973|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
153988974|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
153988976|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153988977|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
153988978|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989031|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
153989032|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989033|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989034|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989035|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153989036|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
153989037|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989038|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153989039|NCT00769093|Hematinics|hematinics|mesh-ancestor
153989040|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153989041|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153989042|NCT00671437|Cetuximab|cetuximab|mesh-list
153989093|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989094|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153989095|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
153989096|NCT00769405|Antidotes|antidotes|mesh-ancestor
153989097|NCT00769405|Protective Agents|protective agents|mesh-ancestor
153989098|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
153989099|NCT00769405|Vitamins|vitamins|mesh-ancestor
153989100|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
153989164|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153989166|NCT02557087|Scopolamine|scopolamine|mesh-list
153989167|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153989168|NCT02557087|Narcotics|narcotics|mesh-ancestor
153989169|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989170|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989171|NCT02557087|Analgesics|analgesics|mesh-ancestor
153989175|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
153989231|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989232|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
153989233|NCT00582790|Interleukin-2|interleukin-2|mesh-list
153989234|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989235|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989302|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989303|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153989304|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
153989306|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153989307|NCT02634255|Narcotics|narcotics|mesh-ancestor
153989308|NCT02634255|Analgesics|analgesics|mesh-ancestor
153989309|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
153989310|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989311|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153989312|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153989313|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153989314|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153989316|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
153989317|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153989318|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989319|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989320|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989321|NCT02634021|Analgesics|analgesics|mesh-ancestor
153989358|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153989359|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989360|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989361|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989362|NCT00934856|Docetaxel|docetaxel|mesh-list
153989363|NCT00934856|Trastuzumab|trastuzumab|mesh-list
153989364|NCT00934856|Pertuzumab|pertuzumab|mesh-list
153989365|NCT00934856|Maytansine|maytansine|mesh-list
153989366|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153989427|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
153989428|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989429|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153989430|NCT00779389|Dasatinib|dasatinib|mesh-list
153989431|NCT00779389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153989432|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153989433|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989434|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989435|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989436|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153989489|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989490|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989491|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989492|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989493|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153989494|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153989495|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989496|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989497|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
153989498|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
153989499|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153989500|NCT00780325|Diuretics|diuretics|mesh-ancestor
153989501|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
153989502|NCT02556229|Aflibercept|aflibercept|mesh-list
153989503|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153989504|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153989505|NCT02556229|Growth Substances|growth substances|mesh-ancestor
153989506|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989507|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
153989508|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989543|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989544|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989545|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989546|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989547|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153989548|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153989549|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989550|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989551|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989552|NCT02633709|Itraconazole|itraconazole|mesh-list
153989553|NCT02633709|Risdiplam|risdiplam|mesh-list
153989554|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
153989603|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153989604|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153989605|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153989606|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989607|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
153989608|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
153989609|NCT00661999|Hematinics|hematinics|mesh-ancestor
154176524|NCT00841841|Acetaminophen|acetaminophen|mesh-list
153989610|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153989611|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989612|NCT04156815|Isotretinoin|isotretinoin|mesh-list
153989613|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
153989614|NCT04156425|Golimumab|golimumab|mesh-list
153989615|NCT04156425|Dexetimide|dexetimide|mesh-list
153989663|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
153989664|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153989665|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153989666|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989667|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153989668|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
153989669|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989670|NCT00780637|Bradykinin|bradykinin|mesh-list
153989671|NCT00780637|Kininogens|kininogens|mesh-list
153989672|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
153989673|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153989674|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
153989675|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989677|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
153989725|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153989726|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153989727|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989728|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989729|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
153989730|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
153989731|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
153989732|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989733|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
153989734|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
153989735|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153989736|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153989737|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
153989738|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
153989739|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989784|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989785|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
153989786|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
153989787|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
153989788|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989789|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989790|NCT00662805|Fluticasone|fluticasone|mesh-list
153989791|NCT00662805|Xhance|xhance|mesh-list
153989792|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153989793|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989794|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153989795|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
153989796|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989797|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989798|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153989845|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153989846|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153989847|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989848|NCT00785551|Analgesics|analgesics|mesh-ancestor
153989849|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
153989850|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153989851|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153989852|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153989853|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153989854|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989855|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153989856|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153747422|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
153989857|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153989859|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989860|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989861|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153989862|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153989900|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153989901|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989902|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153989903|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153989904|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153989905|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153989906|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153989907|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153989908|NCT00664105|Carboplatin|carboplatin|mesh-list
153989909|NCT00664105|Docetaxel|docetaxel|mesh-list
153989910|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153989911|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
153989946|NCT00663741|Sorafenib|sorafenib|mesh-list
153989961|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153989962|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989963|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153989964|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153989965|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
153989966|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153989967|NCT04031859|Aspirin|aspirin|mesh-list
153989968|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153989969|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153989970|NCT04031859|Analgesics|analgesics|mesh-ancestor
153989971|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
153989972|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655494|NCT00048412|Fludarabine|fludarabine|mesh-list
153990026|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990027|NCT00664677|Protective Agents|protective agents|mesh-ancestor
153990028|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990029|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153990030|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990031|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153990032|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153990033|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153990034|NCT00664677|Analgesics|analgesics|mesh-ancestor
153990035|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
153990036|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990037|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990038|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153990083|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990084|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990085|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
153990086|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153990087|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153990088|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
153990089|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990090|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153990091|NCT00666757|Sertraline|sertraline|mesh-list
153990092|NCT00666757|Fluoxetine|fluoxetine|mesh-list
153990093|NCT00666757|Paroxetine|paroxetine|mesh-list
153990094|NCT00666757|Citalopram|citalopram|mesh-list
153990095|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153990099|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990143|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153990144|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153990145|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990146|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990147|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
153990148|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153990149|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153990151|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153990209|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153990211|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153990212|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990213|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
153990214|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990215|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153990216|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990217|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
153990218|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
153990219|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990220|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153990221|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
153747795|NCT02923258|Docetaxel|docetaxel|mesh-list
153990222|NCT00595335|Hormones|hormones|mesh-ancestor
153990223|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990224|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153990225|NCT00595335|Protective Agents|protective agents|mesh-ancestor
153990265|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153990266|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990267|NCT00661531|Estrogens|estrogens|mesh-ancestor
153990268|NCT00661531|Hormones|hormones|mesh-ancestor
153990269|NCT00998309|Azithromycin|azithromycin|mesh-list
153990270|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990271|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990272|NCT02629575|Sirolimus|sirolimus|mesh-list
153990273|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990274|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990275|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153990276|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990277|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
153990278|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153990279|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
153990324|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990325|NCT04152759|Golimumab|golimumab|mesh-list
153990326|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153990327|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990328|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153990329|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
153990330|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990331|NCT00792025|Sunitinib|sunitinib|mesh-list
153990332|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990333|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153990334|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153990335|NCT00792025|Growth Substances|growth substances|mesh-ancestor
153990336|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990337|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
153990338|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990341|NCT02870231|Liraglutide|liraglutide|mesh-list
153990385|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990386|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990387|NCT00792337|Simvastatin|simvastatin|mesh-list
153990388|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153990389|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153990390|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
153990391|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990392|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153990449|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153990450|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990452|NCT00787657|Interferon-beta|interferon-beta|mesh-list
153990453|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
153990454|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990455|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
153990456|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990457|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
153990460|NCT04264676|Metronidazole|metronidazole|mesh-list
153990518|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990519|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153990520|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153748100|NCT02918812|Analgesics|analgesics|mesh-ancestor
153990521|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990523|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153990524|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
153990525|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990526|NCT00787813|Expectorants|expectorants|mesh-ancestor
153990527|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
153990528|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153990529|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
153990530|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176526|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153990578|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
153990579|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
153990580|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153990581|NCT02535273|Lidocaine|lidocaine|mesh-list
153990582|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
153990583|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
153990584|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
153990585|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153990586|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990587|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
153990588|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990589|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153990599|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153990639|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153990640|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
153990641|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990642|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990643|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
153990644|NCT04259606|Antacids|antacids|mesh-ancestor
153990647|NCT00788749|Fluticasone|fluticasone|mesh-list
153990709|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
153990710|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990711|NCT02628951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153990712|NCT02628951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153990713|NCT02628951|Growth Substances|growth substances|mesh-ancestor
153990714|NCT02628951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990715|NCT02628951|Growth Inhibitors|growth inhibitors|mesh-ancestor
153990717|NCT00662311|Vorinostat|vorinostat|mesh-list
153990718|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153990719|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990720|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
153990721|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
153990722|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
153990770|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
153990771|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153990772|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990773|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990774|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153990775|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990837|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990838|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
153990839|NCT00795457|Laxatives|laxatives|mesh-ancestor
153990840|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153990841|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
153990842|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990843|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153990844|NCT00793195|SMOFlipid|smoflipid|mesh-list
153990845|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153990846|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153990847|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153990848|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
153990849|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153990850|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990851|NCT00795613|Doxorubicin|doxorubicin|mesh-list
153990852|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153990853|NCT00795613|Vincristine|vincristine|mesh-list
153990854|NCT00795613|Procarbazine|procarbazine|mesh-list
153990855|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153990856|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990857|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153990858|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153990859|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990860|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990889|NCT00800917|Growth Substances|growth substances|mesh-ancestor
153990890|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153990891|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
153990892|NCT00800917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153990893|NCT00800917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153990894|NCT00800917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990895|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153990896|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
153990897|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153990898|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153990899|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153990900|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
153990950|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154176527|NCT00841841|Analgesics|analgesics|mesh-ancestor
153990951|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153990952|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
153990953|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
153990954|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
153990955|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153990956|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153990957|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
153990958|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
153990959|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153990960|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153990961|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153990962|NCT00610142|Analgesics|analgesics|mesh-ancestor
153990963|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
153990964|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153990965|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991006|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
153991007|NCT05083052|Propolis|propolis|mesh-list
153991008|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991009|NCT04031703|Paclitaxel|paclitaxel|mesh-list
153991010|NCT04031703|Docetaxel|docetaxel|mesh-list
153991011|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
153991012|NCT04031703|Carboplatin|carboplatin|mesh-list
153991013|NCT04031703|Fluorouracil|fluorouracil|mesh-list
153991014|NCT04031703|Epirubicin|epirubicin|mesh-list
153991015|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153991016|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991017|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
153991018|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
153991019|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
153991020|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991021|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153991022|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
153991023|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991024|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153991025|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153991026|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
153991027|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153991028|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
153991029|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153991030|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153991031|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153991032|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153991033|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991034|NCT00795847|Losartan|losartan|mesh-list
153991052|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153991053|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
153991054|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991055|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991056|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153991057|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991058|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153991059|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
153991060|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153991118|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
153991119|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
153991120|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991121|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
153991122|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153991123|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153991124|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
153991125|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991126|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153991127|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
153991128|NCT00629135|Metronidazole|metronidazole|mesh-list
153991183|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
153991184|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991185|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991186|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153991187|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153991188|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
153991189|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
153991190|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153991191|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
153748770|NCT00182364|Heparin|heparin|mesh-list
153991192|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991193|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991246|NCT00793663|Sevoflurane|sevoflurane|mesh-list
153991247|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153991248|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
153991249|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
153991250|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991251|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991252|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153991253|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
153991254|NCT00793663|Hormones|hormones|mesh-ancestor
153991255|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991256|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153991257|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991258|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153991259|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153991260|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
153991261|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
153991263|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
153991303|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991304|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991305|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991306|NCT00677001|R 306465|r 306465|mesh-list
153991307|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153991308|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991309|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991310|NCT00877071|Doxorubicin|doxorubicin|mesh-list
153991311|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153991312|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655972|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
153991364|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991366|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153991367|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991368|NCT00609284|Carboplatin|carboplatin|mesh-list
153991369|NCT00609284|Cetuximab|cetuximab|mesh-list
153991370|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991371|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153991372|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153991373|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991374|NCT00930722|Quinapril|quinapril|mesh-list
153991376|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
153991425|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991426|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153991427|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153991428|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153991429|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
153991430|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153991431|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991432|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153991433|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153991434|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
153991435|NCT00991289|Interferons|interferons|mesh-list
153991490|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153991491|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991492|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
153991493|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
153991494|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
153991495|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991496|NCT00793975|Ramucirumab|ramucirumab|mesh-list
153991497|NCT00793975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153991498|NCT00793975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153991499|NCT00793975|Growth Substances|growth substances|mesh-ancestor
153991500|NCT00793975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991501|NCT00793975|Growth Inhibitors|growth inhibitors|mesh-ancestor
153991555|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991556|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153991557|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153991558|NCT00801853|Interleukin-4|interleukin-4|mesh-list
153991559|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153991560|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
153991561|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749155|NCT00157547|Citalopram|citalopram|mesh-list
153991562|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991563|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153991564|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153991565|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153991566|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
153991567|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153991568|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991569|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153991570|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153991571|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153991608|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153991609|NCT00794209|Narcotics|narcotics|mesh-ancestor
153991610|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991611|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991612|NCT00794209|Analgesics|analgesics|mesh-ancestor
153991613|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
153991615|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153991677|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
153991678|NCT00802009|Hormones|hormones|mesh-ancestor
153991679|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991680|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153991681|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991682|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
153991683|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
153991684|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991685|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
153991686|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
153991742|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991743|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153991745|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153656130|NCT00052936|Hormones|hormones|mesh-ancestor
153991746|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991747|NCT00924950|Calcitriol|calcitriol|mesh-list
153991748|NCT00924950|Betamethasone|betamethasone|mesh-list
153991749|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153991750|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
153991808|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153991809|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153991810|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153991811|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991812|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
153991813|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991814|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991815|NCT00686361|Choline|choline|mesh-list
153991874|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
153991875|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991876|NCT02625753|Acetaminophen|acetaminophen|mesh-list
153991877|NCT02625753|Codeine|codeine|mesh-list
153991878|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153991879|NCT02625753|Analgesics|analgesics|mesh-ancestor
153991880|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
153991881|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153991882|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991883|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
153991884|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153991885|NCT02625753|Narcotics|narcotics|mesh-ancestor
153991886|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153991887|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
153991888|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
153991935|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
153991936|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153991937|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
153991938|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
153749531|NCT00158834|Xhance|xhance|mesh-list
153991939|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153991940|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153991941|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
153991942|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
153991943|NCT00687843|Tegafur|tegafur|mesh-list
153991944|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153991945|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
153991946|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153991947|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153991948|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153991949|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
153991950|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991952|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
153991992|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991993|NCT02625519|Hormones|hormones|mesh-list
153991994|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153991995|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153991996|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153991997|NCT00912483|Heparin|heparin|mesh-list
153991999|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
153992000|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153992001|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153992002|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992003|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153992004|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153992005|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
153992006|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153992007|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
153992008|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
153992009|NCT00924560|Estradiol|estradiol|mesh-list
153992010|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153992011|NCT00924560|Estrogens|estrogens|mesh-ancestor
153992012|NCT00924560|Hormones|hormones|mesh-ancestor
153992013|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153992014|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992015|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153992016|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153992017|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153992018|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153992019|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153992021|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
153992022|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153992028|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
153992036|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153992037|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153992039|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
153992040|NCT00689715|Ethanol|ethanol|mesh-list
153992041|NCT00689715|Paclitaxel|paclitaxel|mesh-list
153992042|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153992043|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153992044|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992045|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
153992046|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
153992047|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
153992048|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992049|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153992050|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992051|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992052|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992053|NCT00689949|Folic Acid|folic acid|mesh-list
153992054|NCT00689949|Hematinics|hematinics|mesh-ancestor
153992055|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
153992056|NCT00689949|Vitamins|vitamins|mesh-ancestor
153992057|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
153992058|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992059|NCT04256642|Morphine|morphine|mesh-list
153992060|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153992061|NCT04256642|Narcotics|narcotics|mesh-ancestor
153992088|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
153992089|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
153749677|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
153992090|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153992091|NCT00694317|Zaleplon|zaleplon|mesh-list
153992092|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
153992093|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153992154|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153992155|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
153992156|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992157|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992158|NCT05833984|Tislelizumab|tislelizumab|mesh-list
153992159|NCT05833984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153992160|NCT05833984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992161|NCT05833919|Capecitabine|capecitabine|mesh-list
153749754|NCT00183807|Analgesics|analgesics|mesh-ancestor
153992220|NCT05833399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153992221|NCT05833399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153992222|NCT05833399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153992223|NCT05833399|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153992224|NCT05833399|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153992225|NCT05832996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153992226|NCT05832996|Lubricant Eye Drops|lubricant eye drops|mesh-list
153992227|NCT05832996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153992228|NCT05832749|Hyaluronic Acid|hyaluronic acid|mesh-list
153992229|NCT05832749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153992230|NCT05832749|Immunologic Factors|immunologic factors|mesh-ancestor
153992231|NCT05832749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992232|NCT05832749|Viscosupplements|viscosupplements|mesh-ancestor
153992233|NCT05832749|Protective Agents|protective agents|mesh-ancestor
153992234|NCT05832697|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153992235|NCT05832697|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153992236|NCT05832697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153992278|NCT05832073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992279|NCT05832073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992280|NCT05832034|Immunoglobulins|immunoglobulins|mesh-list
153992281|NCT05832034|Antibodies|antibodies|mesh-list
153992282|NCT05832034|gamma-Globulins|gamma-globulins|mesh-list
153992283|NCT05832034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153992284|NCT05832034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153992285|NCT05832034|Immunologic Factors|immunologic factors|mesh-ancestor
153992286|NCT05832034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992287|NCT05830539|Doxorubicin|doxorubicin|mesh-list
153992288|NCT05830539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153992345|NCT05737069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153992346|NCT05737069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992347|NCT05737069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992348|NCT05709483|Aspirin|aspirin|mesh-list
153992349|NCT05709483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153992350|NCT05709483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992351|NCT05709483|Analgesics|analgesics|mesh-ancestor
153992352|NCT05709483|Sensory System Agents|sensory system agents|mesh-ancestor
153992353|NCT05709483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992354|NCT05709483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992355|NCT05709483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153992356|NCT05709483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153992357|NCT05709483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153992358|NCT05709483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153992359|NCT05709483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992360|NCT05709483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153992361|NCT05709483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153992362|NCT05709483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992363|NCT05709483|Antipyretics|antipyretics|mesh-ancestor
153992364|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
153992365|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153992366|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153992367|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992368|NCT05594615|Midazolam|midazolam|mesh-list
153992369|NCT05594615|Caffeine|caffeine|mesh-list
153992370|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153992371|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153992380|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
153992391|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153992392|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153992393|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153992394|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153992395|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
153992396|NCT05594602|Itraconazole|itraconazole|mesh-list
153992397|NCT05594602|Quinidine|quinidine|mesh-list
153992398|NCT05594602|Carbamazepine|carbamazepine|mesh-list
153992399|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
153992400|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992401|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153992402|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153992403|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992404|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992405|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153992416|NCT05594602|Analgesics|analgesics|mesh-ancestor
153992447|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992448|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153992449|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153992450|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153992451|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
153992452|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992453|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992454|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153992455|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153992456|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153992457|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153992458|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153992509|NCT05108935|Analgesics|analgesics|mesh-ancestor
153992510|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
153992511|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992512|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153992513|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153992514|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153992515|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992516|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992517|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
153992518|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992519|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153992520|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153992521|NCT05051527|Silymarin|silymarin|mesh-list
153992522|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
153992523|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992524|NCT05051527|Protective Agents|protective agents|mesh-ancestor
153992568|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
153992569|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992570|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153992571|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153992572|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153992573|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
153992574|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153992575|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992576|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153992577|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153992629|NCT03878069|Elapegademase|elapegademase|mesh-list
153992630|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153992631|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153992632|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992633|NCT03876873|Anesthetics|anesthetics|mesh-list
153992698|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
153992699|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153992700|NCT02711670|Diuretics|diuretics|mesh-ancestor
153992701|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
153992702|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992703|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153992765|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992766|NCT01971489|Cisplatin|cisplatin|mesh-list
153992767|NCT01971489|Gemcitabine|gemcitabine|mesh-list
153992768|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992769|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153992770|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
153992771|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992772|NCT01942135|Fulvestrant|fulvestrant|mesh-list
153992773|NCT01942135|Palbociclib|palbociclib|mesh-list
153992774|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153992775|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153992830|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
153992831|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153992832|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153992833|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
153992834|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992835|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750429|NCT00544219|Prednisone|prednisone|mesh-list
153992836|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153992837|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
153992838|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153992839|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153992891|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153992892|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992893|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153992895|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153992896|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153992897|NCT00695643|Mesalamine|mesalamine|mesh-list
153992898|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153992899|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153992900|NCT00695643|Analgesics|analgesics|mesh-ancestor
153992901|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
153992902|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992903|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992904|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153992905|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153992906|NCT02623881|Progesterone|progesterone|mesh-list
153992907|NCT02623881|Progestins|progestins|mesh-ancestor
153992908|NCT02623881|Hormones|hormones|mesh-ancestor
153992909|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153992910|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992911|NCT04135833|Itraconazole|itraconazole|mesh-list
153992912|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153992913|NCT04135833|Rifampin|rifampin|mesh-list
153992914|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
153992915|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153992916|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153992936|NCT00696033|Diazepam|diazepam|mesh-list
153992937|NCT00696033|Lorazepam|lorazepam|mesh-list
153992938|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
153992939|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
153992940|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
153992941|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153992942|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153992943|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153992944|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153992945|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153992946|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153992947|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153992948|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153992949|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
153992950|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
153993000|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
153993001|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993002|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993003|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993004|NCT00928070|Fesoterodine|fesoterodine|mesh-list
153993005|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153993006|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153993007|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
153993008|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993009|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993010|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993011|NCT00928070|Urological Agents|urological agents|mesh-ancestor
153993057|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153993058|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993059|NCT05329454|Analgesics|analgesics|mesh-ancestor
153993060|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
153993061|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993062|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993063|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153993064|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993065|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153993066|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993120|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993121|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
153993122|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153993123|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
153993124|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993125|NCT02865629|Expectorants|expectorants|mesh-ancestor
153993126|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
153993127|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153993128|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
153993129|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993130|NCT02865629|Protective Agents|protective agents|mesh-ancestor
153993131|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993132|NCT02865629|Antidotes|antidotes|mesh-ancestor
153993133|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
153993134|NCT02867345|Interleukin-2|interleukin-2|mesh-list
153993135|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153993136|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
153993137|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993138|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993139|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153993140|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
153993141|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993142|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993143|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153993144|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993145|NCT02867345|Analgesics|analgesics|mesh-ancestor
153993146|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
153993147|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993148|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
153993149|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153993150|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
153993151|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993164|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993165|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153993166|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153993167|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153993168|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153993169|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
153993170|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
153993171|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
153993172|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
153993173|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993174|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993175|NCT00922766|Dalteparin|dalteparin|mesh-list
153993176|NCT00922766|Tinzaparin|tinzaparin|mesh-list
153993177|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153993178|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
153993179|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153993180|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153993181|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993182|NCT04134897|Capecitabine|capecitabine|mesh-list
153993183|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
153993184|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153993185|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
153993219|NCT00696969|Paromomycin|paromomycin|mesh-list
153993220|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153993221|NCT00696969|Miltefosine|miltefosine|mesh-list
153993222|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
153993223|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
153993288|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993289|NCT02619513|Analgesics|analgesics|mesh-ancestor
153993290|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
153993291|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993292|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153993293|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153993294|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153993295|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
153993296|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993297|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993298|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
153993299|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
153993300|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
153993347|NCT02619201|Ondansetron|ondansetron|mesh-list
153993348|NCT02619201|Metoclopramide|metoclopramide|mesh-list
153993349|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
153993350|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
153993351|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993352|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993353|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153993354|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
153993355|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
153993356|NCT02619201|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153993357|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153993358|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
153993359|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993360|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993361|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153993362|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153993363|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
153993364|NCT00975611|Amantadine|amantadine|mesh-list
153993365|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153993366|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153993367|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
153993368|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993369|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
153993370|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993371|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993372|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993373|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993374|NCT00975611|Analgesics|analgesics|mesh-ancestor
153993375|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
153993376|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993377|NCT02865005|Dapsone|dapsone|mesh-list
153993378|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993379|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
153993380|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153993390|NCT02862977|Caffeine|caffeine|mesh-list
153993391|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153993392|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993393|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153993394|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993395|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993396|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153993397|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153993398|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
153993399|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993400|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153993401|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993402|NCT02862977|Analgesics|analgesics|mesh-ancestor
153993403|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
153993404|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993405|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153993406|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993407|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153993408|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153993443|NCT04133961|Protective Agents|protective agents|mesh-ancestor
153993445|NCT02618733|Ticagrelor|ticagrelor|mesh-list
153993446|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153993447|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153993448|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153993449|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153993450|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
153993451|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993452|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993453|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993454|NCT00970307|Vaccines|vaccines|mesh-list
153993506|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153993507|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153993508|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
153993509|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993510|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993511|NCT00697437|Ketoconazole|ketoconazole|mesh-list
153993512|NCT00697437|Docetaxel|docetaxel|mesh-list
153993513|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993514|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
153993515|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
153993569|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153993570|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993572|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993573|NCT05251766|Paclitaxel|paclitaxel|mesh-list
153993574|NCT05251766|Docetaxel|docetaxel|mesh-list
153993575|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153993576|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993577|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
153993578|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
153993579|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
153993580|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993581|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
153993582|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153993583|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993585|NCT00631514|Ibuprofen|ibuprofen|mesh-list
153993629|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993630|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153993631|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
153993632|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993633|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153993634|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993635|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153993636|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153993637|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153993639|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
153993640|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993641|NCT00803725|Fentanyl|fentanyl|mesh-list
153993642|NCT00803725|Mepivacaine|mepivacaine|mesh-list
153993643|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153993644|NCT00803725|Narcotics|narcotics|mesh-ancestor
153993645|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993646|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993647|NCT00803725|Analgesics|analgesics|mesh-ancestor
153993648|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
153993649|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993688|NCT00922129|Cyclosporine|cyclosporine|mesh-list
153993689|NCT00922129|Sirolimus|sirolimus|mesh-list
153993690|NCT00922129|Temsirolimus|temsirolimus|mesh-list
153993691|NCT00922129|MTOR Inhibitors|mtor inhibitors|mesh-list
153993692|NCT00922129|Tacrolimus|tacrolimus|mesh-list
153993693|NCT00922129|Cyclosporins|cyclosporins|mesh-list
153993694|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153993695|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
153993696|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993697|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153993698|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993699|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993700|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
153993701|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993702|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
153993703|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993704|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153993705|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153993706|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993707|NCT00922129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153993708|NCT00806299|Loperamide|loperamide|mesh-list
153993709|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
153993710|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153993711|NCT00804115|Timolol|timolol|mesh-list
153993712|NCT00804115|Latanoprost|latanoprost|mesh-list
153993713|NCT00804115|Pilocarpine|pilocarpine|mesh-list
153993714|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153993715|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153993716|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
153993718|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993719|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993720|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153993736|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993737|NCT02554123|Protective Agents|protective agents|mesh-ancestor
153993738|NCT02554123|Emollients|emollients|mesh-ancestor
153993739|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
153993740|NCT00799045|Clopidogrel|clopidogrel|mesh-list
153993741|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153993742|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153993743|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153993744|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153993745|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
153993746|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993747|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993748|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993749|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
153993750|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153993751|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993752|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153993753|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
153993754|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153993755|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993756|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993757|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993758|NCT00804271|Memantine|memantine|mesh-list
153993759|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153993761|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
153993783|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
153993784|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993785|NCT00806767|Fludarabine|fludarabine|mesh-list
153993786|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
153993787|NCT00806767|Busulfan|busulfan|mesh-list
153993788|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
153993789|NCT00806767|Antibodies|antibodies|mesh-list
153993790|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
153993791|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153993792|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153993793|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993794|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153993796|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993797|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153993798|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
153993799|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993800|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
153993801|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153993802|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153993803|NCT00863655|Everolimus|everolimus|mesh-list
153993839|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993840|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656984|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
153993841|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153993842|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153993843|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153993844|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153993845|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
153993846|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993847|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153993848|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993849|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153993850|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
153993851|NCT04123041|Nicotine|nicotine|mesh-list
153993852|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153993853|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
153993854|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993855|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993856|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153993857|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153993858|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
153993859|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993860|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993861|NCT00698763|Simendan|simendan|mesh-list
153993862|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153993863|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
153993864|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153993865|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153993866|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993867|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993868|NCT00698763|Protective Agents|protective agents|mesh-ancestor
153993869|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993870|NCT00804895|Cortivazol|cortivazol|mesh-list
153993871|NCT00804895|Verapamil|verapamil|mesh-list
153993878|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
153993879|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153993880|NCT00800137|Heparin|heparin|mesh-list
153993881|NCT00800137|Calcium heparin|calcium heparin|mesh-list
153993882|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153993883|NCT00800137|Tinzaparin|tinzaparin|mesh-list
153993884|NCT00800137|Dalteparin|dalteparin|mesh-list
153993885|NCT00800137|Warfarin|warfarin|mesh-list
153993886|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
153993887|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153993888|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153993889|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993890|NCT00807079|Carboplatin|carboplatin|mesh-list
153993891|NCT00807079|Topotecan|topotecan|mesh-list
153993892|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993893|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153993894|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153993895|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993896|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993897|NCT00800293|Betamethasone|betamethasone|mesh-list
153993898|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
153993935|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153993936|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993937|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153993938|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153993939|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
153993940|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993941|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993942|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153993943|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153993944|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
153993945|NCT00657709|Vaccines|vaccines|mesh-list
153993946|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153993947|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
153993948|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993949|NCT00657553|Bortezomib|bortezomib|mesh-list
153993950|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153993951|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
153993952|NCT04253912|Povidone|povidone|mesh-list
153751548|NCT00162188|Efavirenz|efavirenz|mesh-list
153993953|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
153993954|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
153993955|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153993956|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153993957|NCT00800527|Diclofenac|diclofenac|mesh-list
153993958|NCT00800527|Gabapentin|gabapentin|mesh-list
153993959|NCT00800527|Analgesics|analgesics|mesh-ancestor
153993960|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
153993961|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153993962|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993963|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
153993964|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153630317|NCT00005985|Hormones|hormones|mesh-ancestor
153630318|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630319|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153630320|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630321|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153630322|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630323|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630324|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630325|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
153630326|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
153630327|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630328|NCT00005985|Analgesics|analgesics|mesh-ancestor
153630329|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
153630341|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153993965|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153993966|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153993967|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153993968|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153993969|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153993970|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153993971|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153993972|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
153993973|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153993974|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153993975|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153993976|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153993977|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153993978|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153993979|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153993980|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153993981|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153993982|NCT00862719|Incretins|incretins|mesh-ancestor
153993984|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153993985|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153994015|NCT00861471|Docetaxel|docetaxel|mesh-list
153994016|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
153994017|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994018|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
153994019|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
153994020|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
153994021|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994022|NCT00861471|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153994023|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153994024|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994025|NCT02613585|Permethrin|permethrin|mesh-list
153994026|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994027|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994028|NCT04119297|Heparinoids|heparinoids|mesh-list
153994029|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153994030|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
153994031|NCT00699387|Benzonidazole|benzonidazole|mesh-list
153994032|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153751610|NCT00409071|Sinomenine|sinomenine|mesh-list
153994033|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
153994034|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994035|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153994036|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153994037|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153994038|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994039|NCT00699465|Enoxaparin|enoxaparin|mesh-list
153994040|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
153994041|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
153994042|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153994045|NCT00858117|Rituximab|rituximab|mesh-list
153994061|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
153994062|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
153994063|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994064|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153994065|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153994066|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
153994067|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994068|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
153994069|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994070|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
153994071|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
153994072|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
153994073|NCT00805519|Chloroquine|chloroquine|mesh-list
153994074|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153994075|NCT00805519|Prednisolone|prednisolone|mesh-list
153994076|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153994077|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
153994078|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153994079|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
153994080|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153994081|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
153994082|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153994083|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
153994084|NCT00805519|Hormones|hormones|mesh-ancestor
153994085|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994086|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994087|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153994088|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994089|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
153994108|NCT00592683|Aripiprazole|aripiprazole|mesh-list
153994109|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
153994110|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153994111|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153994112|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153994113|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994114|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994115|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
153994116|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
153994117|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994118|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994119|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153994120|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153994121|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
153994122|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153994123|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153994124|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153994125|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153994126|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
153994127|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
153994128|NCT02613039|Estrogens|estrogens|mesh-list
153994129|NCT02613039|Progestins|progestins|mesh-list
153994130|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153994131|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994132|NCT02613039|Hormones|hormones|mesh-ancestor
153994133|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994134|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153994135|NCT00813475|Insulin|insulin|mesh-list
153994136|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153994137|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153994152|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994153|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994154|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153994155|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
153994156|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153994157|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153994159|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
153994160|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994161|NCT00701493|Topiramate|topiramate|mesh-list
153994162|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
153994163|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153994164|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994165|NCT04253678|Vortioxetine|vortioxetine|mesh-list
153994166|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
153994167|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153994168|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153994169|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153994170|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994171|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994172|NCT04253678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153994173|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153994174|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994175|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994176|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994177|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
153994178|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153994179|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153994180|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153994181|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153994194|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153994195|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994196|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153994197|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
153994198|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994199|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994200|NCT00654745|Amlodipine|amlodipine|mesh-list
153994201|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153994202|NCT00654745|Olmesartan|olmesartan|mesh-list
153994203|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153994204|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153994205|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153994206|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994207|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994208|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153994209|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994210|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
153994211|NCT00654745|Diuretics|diuretics|mesh-ancestor
153994212|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
153994213|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153994214|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153994215|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153994216|NCT00809887|Micafungin|micafungin|mesh-list
153994217|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
153994218|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994219|NCT00846027|Paclitaxel|paclitaxel|mesh-list
153994220|NCT00846027|Bevacizumab|bevacizumab|mesh-list
153994221|NCT00846027|Gemcitabine|gemcitabine|mesh-list
153994240|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
153994241|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994242|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153994244|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153994245|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153994246|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153994247|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153994248|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994249|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153994250|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153994251|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153994253|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
153994254|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994255|NCT00810121|Ketoprofen|ketoprofen|mesh-list
153994256|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153994257|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994258|NCT00810121|Analgesics|analgesics|mesh-ancestor
153994259|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
153994260|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994261|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994262|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153994263|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994264|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153994265|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994266|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994287|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994289|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
153994290|NCT00652093|Acetaminophen|acetaminophen|mesh-list
153994291|NCT00652093|Oxymorphone|oxymorphone|mesh-list
153994292|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
153994293|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
153994294|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
153994295|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994296|NCT00652093|Analgesics|analgesics|mesh-ancestor
153994297|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
153994298|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994299|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994300|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
153994301|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153994302|NCT00652093|Narcotics|narcotics|mesh-ancestor
153994303|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994304|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153994305|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
153994306|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
153994307|NCT00651937|Melphalan|melphalan|mesh-list
153994308|NCT00651937|Lenograstim|lenograstim|mesh-list
153994309|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153994310|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
153994311|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994312|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994313|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153994314|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994315|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
153647994|NCT00020254|Vaccines|vaccines|mesh-list
153994316|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781296|NCT00201812|Etanercept|etanercept|mesh-list
153630342|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
153630343|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630344|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630345|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630346|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153630347|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
153630348|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153630349|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630350|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
153630351|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
153630352|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630353|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153994317|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153994318|NCT00654355|Tacrolimus|tacrolimus|mesh-list
153994319|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994320|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
153994321|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994322|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153994323|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994324|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994325|NCT00651313|Lidocaine|lidocaine|mesh-list
153994326|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
153994327|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
153994328|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994329|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994330|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
153994331|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994332|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153994333|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153994334|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153994335|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994336|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994337|NCT00808171|Lidocaine|lidocaine|mesh-list
153994338|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
153994339|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
153994340|NCT00808171|Prilocaine|prilocaine|mesh-list
153994341|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153994342|NCT00808171|Anesthetics|anesthetics|mesh-list
153994343|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994344|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994345|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
153994353|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
153994360|NCT04703257|Analgesics|analgesics|mesh-ancestor
153994361|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
153994362|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994363|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994364|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153994365|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994366|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
153994367|NCT00808327|Fentanyl|fentanyl|mesh-list
153994368|NCT00808327|Bupivacaine|bupivacaine|mesh-list
153994369|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
153994370|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
153994371|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994372|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994373|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
153994374|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994375|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153994376|NCT00808327|Narcotics|narcotics|mesh-ancestor
153994377|NCT00808327|Analgesics|analgesics|mesh-ancestor
153994378|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153994379|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153994380|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
153994381|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153994382|NCT00814723|Ezetimibe|ezetimibe|mesh-list
153994383|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153994384|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153994385|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
153994386|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994387|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153994388|NCT00845871|Deferasirox|deferasirox|mesh-list
153994389|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153994409|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
153994410|NCT04286711|Paclitaxel|paclitaxel|mesh-list
153994411|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153994412|NCT04286711|Apatinib|apatinib|mesh-list
153994413|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153994414|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994415|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
153994416|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
153994417|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
153994418|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994419|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153994420|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994421|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
153994422|NCT02863913|Interleukin-2|interleukin-2|mesh-list
153994423|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994424|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
153994425|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994426|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994427|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153994428|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
153994429|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994430|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994431|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153994432|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994433|NCT02863913|Analgesics|analgesics|mesh-ancestor
153994436|NCT02612649|Ramosetron|ramosetron|mesh-list
153994458|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153994459|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994460|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994461|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994462|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
153994463|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153994464|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
153994465|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153648148|NCT00020800|Rituximab|rituximab|mesh-list
153994466|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153994467|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994468|NCT00702117|Flecainide|flecainide|mesh-list
153994469|NCT00702117|Procainamide|procainamide|mesh-list
153994470|NCT00702117|Ajmaline|ajmaline|mesh-list
153994471|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153994472|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153994473|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153994474|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994475|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994476|NCT00913107|Lamotrigine|lamotrigine|mesh-list
153994477|NCT00913107|Carbamazepine|carbamazepine|mesh-list
153994478|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
153994479|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153994480|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994481|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994482|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153630354|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153630355|NCT00005988|Antidotes|antidotes|mesh-ancestor
153630356|NCT00005988|Protective Agents|protective agents|mesh-ancestor
153630357|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
153630359|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
153630360|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
153630361|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630362|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153630363|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630364|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
153630365|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
153630366|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630367|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630368|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
153630369|NCT00005988|Hormones|hormones|mesh-ancestor
153630370|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630371|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153630372|NCT00005991|Gemcitabine|gemcitabine|mesh-list
153630373|NCT00005991|Doxorubicin|doxorubicin|mesh-list
153630374|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153994484|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153994485|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153994486|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994487|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153994488|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153994489|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
153994490|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994491|NCT00913107|Analgesics|analgesics|mesh-ancestor
153994492|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
153994493|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994494|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153994495|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153994496|NCT00569803|Abatacept|abatacept|mesh-list
153994497|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153994498|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994499|NCT00569803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630375|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630376|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
153630377|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630378|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630379|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153630380|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153630381|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630382|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630383|NCT00005994|Ondansetron|ondansetron|mesh-list
153630384|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
153630385|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
153630386|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630387|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630388|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630389|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
153630390|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
153630391|NCT00005994|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153630392|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153630393|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
153630394|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153630395|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630396|NCT00006000|Irinotecan|irinotecan|mesh-list
153630397|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630406|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630407|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
153630408|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630409|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153630410|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630411|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630412|NCT00006006|Interferons|interferons|mesh-list
153630415|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630416|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
153630417|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630418|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
153630419|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630420|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630421|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
153630422|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153994500|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994501|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994502|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
153994503|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994504|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994505|NCT00920426|Cabotegravir|cabotegravir|mesh-list
153994506|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153994507|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153994508|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994509|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994510|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153994511|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153994512|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
153994513|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994514|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153994515|NCT04046185|Progesterone|progesterone|mesh-list
153994516|NCT04046185|Progestins|progestins|mesh-ancestor
153994517|NCT04046185|Hormones|hormones|mesh-ancestor
153994518|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994519|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994520|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994521|NCT04046185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153994522|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994523|NCT00810589|Insulin|insulin|mesh-list
153994524|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153630423|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153630424|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153630425|NCT00006006|Growth Substances|growth substances|mesh-ancestor
153630426|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
153630427|NCT00006009|Visilizumab|visilizumab|mesh-list
153630428|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
153630429|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630430|NCT00006012|Paclitaxel|paclitaxel|mesh-list
153630431|NCT00006012|Etoposide|etoposide|mesh-list
153630432|NCT00006012|Topotecan|topotecan|mesh-list
153630433|NCT00006012|Amifostine|amifostine|mesh-list
153630434|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630435|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630436|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
153630437|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
153630438|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
153630439|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630440|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153630441|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630442|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630443|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630444|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153630445|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153630446|NCT00006012|Protective Agents|protective agents|mesh-ancestor
153630447|NCT00006015|Leucovorin|leucovorin|mesh-list
153994525|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
153994526|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
153994527|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153994528|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994529|NCT00810667|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
153994530|NCT00810667|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153994531|NCT00810667|Serotonin Agents|serotonin agents|mesh-ancestor
153994532|NCT00810667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994533|NCT00810667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994534|NCT00810667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994535|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
153994536|NCT04253132|Analgesics|analgesics|mesh-ancestor
153994537|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
153994538|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994540|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153994541|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994542|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153994543|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994544|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153994545|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994546|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994547|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153994548|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
153994549|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
153994550|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994551|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153994552|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
153994553|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994554|NCT00914966|Complement C1s|complement c1s|mesh-list
153994566|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153994567|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153994568|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
153994569|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
153994570|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994571|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994572|NCT00914810|Vitamin D|vitamin d|mesh-list
153994573|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
153994574|NCT00914810|Vitamins|vitamins|mesh-ancestor
153994575|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
153994576|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994577|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153994578|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153994579|NCT00808717|Atorvastatin|atorvastatin|mesh-list
153994580|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153994581|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153994582|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
153994583|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994584|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153994585|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153994586|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994587|NCT00914732|Vaccines|vaccines|mesh-list
153994588|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
153994589|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994590|NCT00844545|Eculizumab|eculizumab|mesh-list
153994591|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153994592|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994593|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
153994594|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994595|NCT00815503|Ropivacaine|ropivacaine|mesh-list
153994596|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
153994597|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
153994598|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994599|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618847|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
153630448|NCT00006015|Fluorouracil|fluorouracil|mesh-list
153630449|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
153630450|NCT00006015|Trastuzumab|trastuzumab|mesh-list
153630451|NCT00006015|Calcium|calcium|mesh-list
153630452|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
153630453|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153630454|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994600|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
153994601|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994602|NCT00702819|Bevacizumab|bevacizumab|mesh-list
153994603|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153994604|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994605|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153994606|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153994607|NCT00702819|Growth Substances|growth substances|mesh-ancestor
153994608|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994609|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
153994610|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153994612|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
153994613|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994614|NCT00842985|Dronabinol|dronabinol|mesh-list
153994615|NCT00842985|Modafinil|modafinil|mesh-list
153994616|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153994617|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994618|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153994619|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153994620|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153994621|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994622|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
153994623|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153994624|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994625|NCT00842985|Analgesics|analgesics|mesh-ancestor
153994626|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
153658115|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
153994627|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994628|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153994629|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153630455|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
153630456|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630457|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630458|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630459|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630460|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
153630461|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630462|NCT00006015|Antidotes|antidotes|mesh-ancestor
153630463|NCT00006015|Protective Agents|protective agents|mesh-ancestor
153630464|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
153630465|NCT00006015|Vitamins|vitamins|mesh-ancestor
153630482|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994630|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752206|NCT05709509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994631|NCT00842985|Hormones|hormones|mesh-ancestor
153994632|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994633|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
153994634|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153994635|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
153994636|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994637|NCT00808795|Expectorants|expectorants|mesh-ancestor
153994638|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
153994639|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153994640|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
153994641|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994642|NCT00808795|Protective Agents|protective agents|mesh-ancestor
153994643|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994644|NCT00808795|Antidotes|antidotes|mesh-ancestor
153994645|NCT00808951|Artesunate|artesunate|mesh-list
153994646|NCT00808951|Lumefantrine|lumefantrine|mesh-list
153994647|NCT00808951|Artemether|artemether|mesh-list
153994648|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153994649|NCT00808951|Amodiaquine|amodiaquine|mesh-list
153994650|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
153994651|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153994652|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153994653|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994654|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994655|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
153994656|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
153994657|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153994658|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
153994659|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
153994660|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153994661|NCT00809029|Incretins|incretins|mesh-ancestor
153630483|NCT00006024|Temozolomide|temozolomide|mesh-list
153630484|NCT00006024|Lomustine|lomustine|mesh-list
153630485|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630486|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
153630487|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630488|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630489|NCT00006027|Paclitaxel|paclitaxel|mesh-list
153630490|NCT00006027|Cisplatin|cisplatin|mesh-list
153630491|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630492|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630493|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
153630494|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
153994663|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153994664|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994665|NCT00842829|Fentanyl|fentanyl|mesh-list
153994666|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153994667|NCT00842829|Narcotics|narcotics|mesh-ancestor
153994668|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994669|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994670|NCT00842829|Analgesics|analgesics|mesh-ancestor
153994671|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
153994672|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994673|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153994674|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153994675|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
153994676|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
153994677|NCT04045093|Warfarin|warfarin|mesh-list
153994678|NCT04045093|Dabigatran|dabigatran|mesh-list
153994679|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
153994680|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
153994681|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153994682|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
153994683|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994684|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994685|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
153994686|NCT00811291|Folic Acid|folic acid|mesh-list
153994687|NCT00811291|Calcium|calcium|mesh-list
153994688|NCT00811291|Vitamins|vitamins|mesh-ancestor
153994689|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
153994711|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994712|NCT00811447|Docetaxel|docetaxel|mesh-list
153994713|NCT00811447|Fluorouracil|fluorouracil|mesh-list
153994714|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994715|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
153994716|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
153994717|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
153994718|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994719|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
153994720|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153994721|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994722|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
153994723|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994724|NCT00702975|Paclitaxel|paclitaxel|mesh-list
153994725|NCT00702975|Bevacizumab|bevacizumab|mesh-list
153994726|NCT00702975|Carboplatin|carboplatin|mesh-list
153994727|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153994728|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153994729|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994730|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
153994731|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
153994732|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
153994733|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994734|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153994735|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153994736|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153994758|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994759|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994761|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153994762|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
153994763|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153994764|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153994765|NCT00841035|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153994766|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153994767|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994768|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994769|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994770|NCT00642811|Aspirin|aspirin|mesh-list
153994771|NCT00642811|Clopidogrel|clopidogrel|mesh-list
153994772|NCT00642811|Ticagrelor|ticagrelor|mesh-list
153994773|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153994774|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994775|NCT00642811|Analgesics|analgesics|mesh-ancestor
153994776|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
153994777|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994778|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994779|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153994780|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153994781|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153994782|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153994783|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994784|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153994785|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153994786|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994787|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
153994788|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153994789|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153994790|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153994791|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
153994792|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994793|NCT00838929|Vorinostat|vorinostat|mesh-list
153994796|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994797|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994798|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153994800|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994801|NCT00811681|Pioglitazone|pioglitazone|mesh-list
153994802|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153994803|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994804|NCT00811759|Temozolomide|temozolomide|mesh-list
153994805|NCT00811759|Sorafenib|sorafenib|mesh-list
153994806|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153994807|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
153994808|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994809|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994810|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153994811|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994812|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
153994813|NCT00815893|Propofol|propofol|mesh-list
153994814|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153994815|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994816|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994817|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153994818|NCT00815893|Analgesics|analgesics|mesh-ancestor
153994819|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
153994820|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994821|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153994822|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153994823|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153994824|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
153630495|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
153630496|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630497|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153630498|NCT00386646|Laxatives|laxatives|mesh-ancestor
153630499|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630500|NCT00386685|Trastuzumab|trastuzumab|mesh-list
153630501|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630502|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630503|NCT00006030|Tamoxifen|tamoxifen|mesh-list
153630504|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153630505|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
153630506|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630507|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630508|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153630509|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994825|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994826|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994827|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153994828|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
153994830|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
153994831|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
153994832|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994833|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153994834|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994835|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994836|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
153994837|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994838|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153994839|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994840|NCT04648891|Lidocaine|lidocaine|mesh-list
153994841|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
153994842|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
153994843|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994844|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994845|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
153994846|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994847|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153994848|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153994849|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153994850|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994851|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994852|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
153994853|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153994854|NCT00811837|Midazolam|midazolam|mesh-list
153994855|NCT00811837|Remifentanil|remifentanil|mesh-list
153630510|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153630511|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153630512|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153630513|NCT00006033|Methotrexate|methotrexate|mesh-list
153630514|NCT00006033|Interleukin-2|interleukin-2|mesh-list
153630515|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153630516|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
153630517|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153630518|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630519|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153994856|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153994857|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153994858|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994859|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994860|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153994861|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153994862|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153994863|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153994864|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
153994865|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
153994866|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
153994867|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
153994868|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994869|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994870|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153994871|NCT00811837|Narcotics|narcotics|mesh-ancestor
153994872|NCT00811837|Analgesics|analgesics|mesh-ancestor
153994873|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
153994874|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994875|NCT00811915|Sirolimus|sirolimus|mesh-list
153994876|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153994877|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153994878|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153994879|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994880|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
153994881|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994882|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
153566991|NCT06220266|Hormones|hormones|mesh-ancestor
153630520|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
153630521|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630522|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630523|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
153630524|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630538|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630539|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
153630540|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630541|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
153630542|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630543|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
153630544|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
153630545|NCT00006042|Fludarabine|fludarabine|mesh-list
153630546|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
153630547|NCT00006042|Tacrolimus|tacrolimus|mesh-list
153630548|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630549|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
153630550|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630551|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630552|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630553|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
153630554|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994883|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994884|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153994885|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
153994886|NCT00816127|Coagulants|coagulants|mesh-ancestor
153994887|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153994888|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
153994889|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994890|NCT00916058|Melphalan|melphalan|mesh-list
153994891|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153994892|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153994893|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
153994894|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994895|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153994896|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153994897|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153994898|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
153994899|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994900|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
153994901|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
153994902|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
153994903|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994904|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994905|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
153994906|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994907|NCT00912782|Vitamin D|vitamin d|mesh-list
153994908|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
153994909|NCT00912782|Vitamins|vitamins|mesh-ancestor
153994911|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994912|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153994916|NCT04202978|Apatinib|apatinib|mesh-list
153994929|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
153994930|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994931|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994932|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153994933|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994935|NCT04203368|Verapamil|verapamil|mesh-list
153994936|NCT04203368|Analgesics|analgesics|mesh-ancestor
153994937|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
153994938|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994939|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994940|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153994941|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
153994942|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153994943|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
153994944|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
153994945|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153994946|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994947|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153994948|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994949|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153994950|NCT00911534|Rabeprazole|rabeprazole|mesh-list
153994951|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153994952|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153994953|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153994954|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994955|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994956|NCT00911300|Vitamin K|vitamin k|mesh-list
153994957|NCT00911300|Heparin|heparin|mesh-list
153994958|NCT00911300|Calcium heparin|calcium heparin|mesh-list
153994959|NCT00911300|PENTA|penta|mesh-list
153994960|NCT00911300|Fondaparinux|fondaparinux|mesh-list
153994961|NCT00911300|Vitamins|vitamins|mesh-ancestor
153994962|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
153994963|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994964|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
153630555|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630556|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630557|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630558|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
153630559|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153630560|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994965|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153994966|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153994967|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994968|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153994969|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
153994970|NCT00911300|Coagulants|coagulants|mesh-ancestor
153994971|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153994972|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
153994973|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153994974|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
153994975|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153994976|NCT00911144|Vaccines|vaccines|mesh-list
153994977|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153994978|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
153994979|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994980|NCT04395248|Anesthetics|anesthetics|mesh-list
153994981|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994982|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994983|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
153994984|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153994985|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153994986|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153994987|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153994988|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994989|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153994990|NCT04276298|Metronidazole|metronidazole|mesh-list
153994991|NCT04276298|Lidocaine|lidocaine|mesh-list
153994992|NCT04276298|Diltiazem|diltiazem|mesh-list
153994993|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
153994994|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
153994995|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153994996|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153994997|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
153994998|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153994999|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153995000|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153630561|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153995002|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995003|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995004|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995005|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153995006|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153995007|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153995008|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153995009|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153995010|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153995011|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
153995012|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
153995013|NCT04273880|Methylphenidate|methylphenidate|mesh-list
153995014|NCT04273880|Vitamins|vitamins|mesh-ancestor
153995015|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
153995016|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995017|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
153995018|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995019|NCT04273880|Protective Agents|protective agents|mesh-ancestor
153995020|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153995021|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153995022|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995023|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995024|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
153995025|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995026|NCT00910988|Olanzapine|olanzapine|mesh-list
153995027|NCT00910988|Ziprasidone|ziprasidone|mesh-list
153995028|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
153995029|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
153995030|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567131|NCT05928546|Quercetin|quercetin|mesh-list
153630562|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153630563|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
153630564|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153630565|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630566|NCT05680974|Antibodies|antibodies|mesh-list
153630567|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
153630568|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630569|NCT00386763|Lumefantrine|lumefantrine|mesh-list
153630570|NCT00386763|Artemether|artemether|mesh-list
153630571|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153630572|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
153630573|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153630574|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153630575|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630576|NCT05680662|Metformin|metformin|mesh-list
153995031|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995032|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153995033|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153995034|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153995035|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995036|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153995037|NCT00910988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153995038|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995039|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995040|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995041|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995042|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
153995043|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153995044|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153995045|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
153995046|NCT00644059|Vaccines|vaccines|mesh-list
153995047|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
153995048|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995049|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
153995050|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153995051|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995052|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153995053|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
153995054|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153995055|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567159|NCT05892432|Semaglutide|semaglutide|mesh-list
153630577|NCT05680662|Quercetin|quercetin|mesh-list
153630578|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153630579|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630580|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
153630581|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630582|NCT05680662|Protective Agents|protective agents|mesh-ancestor
153630583|NCT05680389|Minocycline|minocycline|mesh-list
153630584|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153630585|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630586|NCT05680194|Diphosphonates|diphosphonates|mesh-list
153630587|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153630588|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630589|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
153630599|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
153630600|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630601|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630602|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153630603|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153630605|NCT00386841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153630606|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995056|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995057|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995058|NCT00811993|Etoposide|etoposide|mesh-list
153995059|NCT00811993|Docetaxel|docetaxel|mesh-list
153995061|NCT00811993|Carboplatin|carboplatin|mesh-list
153995062|NCT00811993|Gemcitabine|gemcitabine|mesh-list
153995063|NCT00811993|Capecitabine|capecitabine|mesh-list
153995064|NCT00811993|Trastuzumab|trastuzumab|mesh-list
153995065|NCT00811993|Irinotecan|irinotecan|mesh-list
153995066|NCT00811993|Cetuximab|cetuximab|mesh-list
153995067|NCT00811993|Temozolomide|temozolomide|mesh-list
153995068|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153995069|NCT00811993|Sorafenib|sorafenib|mesh-list
153995070|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153995071|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995072|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
153995073|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
153995074|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
153995075|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995076|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153995077|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153995078|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153995079|NCT00811993|Growth Substances|growth substances|mesh-ancestor
153995080|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995081|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
153995082|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153995083|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
153995084|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153995085|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153995086|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995087|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153995088|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153995089|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
153995090|NCT00811993|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153995091|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153995092|NCT00817765|Ritonavir|ritonavir|mesh-list
153995093|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
153630608|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630609|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153630610|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
153995094|NCT00817765|Posaconazole|posaconazole|mesh-list
153995095|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153995096|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153995097|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
153995098|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995099|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995100|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153995101|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153995102|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
153995103|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995104|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153995105|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153995106|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
153995107|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153995108|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153995109|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153995110|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153995111|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153995112|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
153995113|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153995114|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995115|NCT00816205|Nifedipine|nifedipine|mesh-list
153995116|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153995117|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995118|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995119|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153995120|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995121|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
153630611|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630612|NCT05679453|Etodolac|etodolac|mesh-list
153630613|NCT05679453|Lornoxicam|lornoxicam|mesh-list
153630614|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153630615|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153630616|NCT05679453|Analgesics|analgesics|mesh-ancestor
153630617|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
153630618|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630619|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630620|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630621|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630622|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153630623|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153630624|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630625|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995122|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
153995123|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153995124|NCT00816283|Dasatinib|dasatinib|mesh-list
153995125|NCT00816283|Vorinostat|vorinostat|mesh-list
153995126|NCT00816283|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153995127|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153995128|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995129|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995130|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995131|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153995132|NCT00910910|Lenalidomide|lenalidomide|mesh-list
153995133|NCT00910910|Chlorambucil|chlorambucil|mesh-list
153995134|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
153995135|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995136|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153995137|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153995138|NCT00910910|Growth Substances|growth substances|mesh-ancestor
153995139|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
153995140|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995141|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153995142|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
153753894|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995143|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995144|NCT04384562|Methylphenidate|methylphenidate|mesh-list
153995146|NCT04384562|Nicotine|nicotine|mesh-list
153995147|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153995148|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
153995149|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995150|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995151|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153995152|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153995153|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
153630626|NCT05679375|Ketamine|ketamine|mesh-list
153630627|NCT05679375|Analgesics|analgesics|mesh-ancestor
153630628|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
153630629|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630630|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630631|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153630632|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153630633|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
153630634|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
153630635|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153630636|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153630637|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153630638|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995154|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995155|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995156|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153995157|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153752736|NCT01075971|Buprenorphine|buprenorphine|mesh-list
153995158|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995159|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995160|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
153995161|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
153995162|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153995163|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153995164|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
153995166|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
153995167|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
153995168|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995169|NCT04515134|Vitamins|vitamins|mesh-ancestor
153995170|NCT04238390|Meropenem|meropenem|mesh-list
153995171|NCT04238390|Tazobactam|tazobactam|mesh-list
153995172|NCT04238390|Ceftolozane|ceftolozane|mesh-list
153995173|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153995174|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153995175|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995176|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153995177|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995178|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995179|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153995180|NCT04236830|Fluorides|fluorides|mesh-list
153995181|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
153995182|NCT04236830|Protective Agents|protective agents|mesh-ancestor
153995183|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995184|NCT04203212|Goserelin|goserelin|mesh-list
153995185|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153567276|NCT05728944|Aceclidine|aceclidine|mesh-list
153630639|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630640|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
153630641|NCT05679336|Rituximab|rituximab|mesh-list
153630642|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630643|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
153630644|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630645|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630646|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630647|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
153995186|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995187|NCT00637910|Docetaxel|docetaxel|mesh-list
153995188|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153995189|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995190|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
153995191|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
153995192|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
153995193|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995194|NCT00637910|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153995195|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153995196|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995197|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
153995198|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153995199|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153995200|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153995201|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995202|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995203|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
153995204|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995205|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995206|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153995207|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995208|NCT04449536|Mesna|mesna|mesh-list
153995209|NCT04449536|Protective Agents|protective agents|mesh-ancestor
153995210|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995212|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153995213|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995214|NCT04084106|Amoxicillin|amoxicillin|mesh-list
153995215|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
153995216|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
153995217|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153995230|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
153995231|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995232|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
153995233|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153995234|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153995235|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
153995236|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995237|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995238|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995239|NCT00909428|Urological Agents|urological agents|mesh-ancestor
153995241|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
153995242|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995243|NCT00908960|Enoxaparin|enoxaparin|mesh-list
153995244|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
153995245|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153995246|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153995247|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995248|NCT05332106|Dienogest|dienogest|mesh-list
153995249|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153995250|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153995251|NCT05332106|Estradiol|estradiol|mesh-list
153995252|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153995253|NCT05332106|Nandrolone|nandrolone|mesh-list
153995254|NCT05332106|Estrogens|estrogens|mesh-ancestor
153995255|NCT05332106|Hormones|hormones|mesh-ancestor
153995256|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153995257|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995258|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153995259|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
153567360|NCT05656027|Miotics|miotics|mesh-ancestor
153630648|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630649|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630650|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630670|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630671|NCT05550129|Metformin|metformin|mesh-list
153630672|NCT05550129|Sotorasib|sotorasib|mesh-list
153630673|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153630674|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630675|NCT05550129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153630676|NCT05550129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630677|NCT05550129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630678|NCT05550129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630679|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
153995261|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153995262|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153995263|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153995264|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153995265|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
153995266|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153995267|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995268|NCT05332106|Androgens|androgens|mesh-ancestor
153995269|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
153995270|NCT05332028|Fentanyl|fentanyl|mesh-list
153995271|NCT05332028|Bupivacaine|bupivacaine|mesh-list
153995272|NCT05332028|Propofol|propofol|mesh-list
153995273|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
153995274|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
153995275|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995276|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995277|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
153995278|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995279|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153995280|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153995281|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
153995282|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153995283|NCT05332028|Narcotics|narcotics|mesh-ancestor
153995284|NCT05332028|Analgesics|analgesics|mesh-ancestor
153995285|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153995286|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
153995288|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153630680|NCT00386958|Povidone|povidone|mesh-list
153630681|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
153630682|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
153630683|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153630684|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630685|NCT00386997|Amphotericin B|amphotericin b|mesh-list
153630686|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153630687|NCT00386997|Amebicides|amebicides|mesh-ancestor
153630688|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153630689|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153630690|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630691|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153630692|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
153630693|NCT03940131|Panitumumab|panitumumab|mesh-list
153630695|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630696|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
153630697|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153630698|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630699|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
153630700|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630701|NCT04833387|Antibodies|antibodies|mesh-list
153630702|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
153995289|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153995290|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995291|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995292|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
153995293|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995294|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995295|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153995296|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995297|NCT00643201|Enoxaparin|enoxaparin|mesh-list
153995298|NCT00643201|Warfarin|warfarin|mesh-list
153995299|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
153995300|NCT00643201|Apixaban|apixaban|mesh-list
153995350|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153995352|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995353|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995354|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153995355|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995356|NCT00648895|Metoprolol|metoprolol|mesh-list
153995357|NCT00648895|Nebivolol|nebivolol|mesh-list
153995358|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153995359|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153754113|NCT00553423|Lactulose|lactulose|mesh-list
153995360|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
153995361|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
153995362|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995363|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995364|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153995365|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153995366|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153995367|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
153995368|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995369|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995370|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
153995371|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153995372|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153995373|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153995374|NCT00975221|Cinacalcet|cinacalcet|mesh-list
153995375|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153995376|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995377|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153995378|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
153995379|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153995380|NCT02863679|Tetracaine|tetracaine|mesh-list
153567481|NCT05478993|Hormones|hormones|mesh-ancestor
153630703|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630704|NCT04793685|Prazosin|prazosin|mesh-list
153630705|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153630706|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153630707|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153630723|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630724|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630725|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153630726|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153630727|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
153995382|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
153752955|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
153995383|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153995384|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995385|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
153995386|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995387|NCT00906698|Vinorelbine|vinorelbine|mesh-list
153995388|NCT00906698|Afatinib|afatinib|mesh-list
153995389|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153995390|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995391|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
153995392|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
153995393|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
153995394|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995395|NCT00906698|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153995396|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153995397|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995398|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153995399|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153995400|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
153995401|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995402|NCT00971945|Paclitaxel|paclitaxel|mesh-list
153995403|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153995404|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995405|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
153995406|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
153995407|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
153995408|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995409|NCT03672500|Epinephrine|epinephrine|mesh-list
153995424|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
153995425|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153995426|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
153995427|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
153995428|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
153995429|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153995430|NCT00971867|Paclitaxel|paclitaxel|mesh-list
153995431|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153995432|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176532|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153995434|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
153995435|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
153995436|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995437|NCT00812851|Dronabinol|dronabinol|mesh-list
153995438|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
153995439|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995440|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153995441|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153995442|NCT00812851|Analgesics|analgesics|mesh-ancestor
153995443|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
153995444|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995445|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153995446|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153995447|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995448|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995449|NCT00812851|Hormones|hormones|mesh-ancestor
153995450|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153995451|NCT00648037|Rituximab|rituximab|mesh-list
153995452|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153995453|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995454|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
153995455|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995456|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153995459|NCT00817375|Sertraline|sertraline|mesh-list
153995465|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153995466|NCT00817375|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153995467|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995468|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995469|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995470|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995471|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
153995472|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995473|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153995474|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153995475|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153995476|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995477|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153995478|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153995520|NCT00640393|Etanercept|etanercept|mesh-list
153995521|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153995522|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153995523|NCT00640393|Analgesics|analgesics|mesh-ancestor
153995524|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
153995525|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995526|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995527|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153995528|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153995529|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153995530|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153995531|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
153995532|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153995533|NCT05315024|Imiquimod|imiquimod|mesh-list
153995534|NCT05315024|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153995535|NCT05315024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995536|NCT05315024|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153995537|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
153995538|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995539|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153995540|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995541|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
153995542|NCT00627445|Insulin|insulin|mesh-list
153995543|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153995544|NCT00627445|Metformin|metformin|mesh-list
153995545|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
153995546|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
153995547|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153995548|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
153995549|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153995550|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153995551|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995561|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153995562|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
153995564|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153995565|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995566|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153995567|NCT00822055|Timolol|timolol|mesh-list
153995568|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153995569|NCT00822055|Dorzolamide|dorzolamide|mesh-list
153995570|NCT00822055|Maleic acid|maleic acid|mesh-list
153995571|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
153995572|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995573|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995574|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153995575|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153995576|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
153995577|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153649282|NCT00025363|Irinotecan|irinotecan|mesh-list
153995578|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995579|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153995580|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153995581|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153995582|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153995583|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153567734|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153567735|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153567736|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153567737|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567739|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153567740|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153567741|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
153567742|NCT04990804|Analgesics|analgesics|mesh-list
153567743|NCT04990804|Narcotics|narcotics|mesh-ancestor
153567744|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567745|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567746|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
153567747|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995612|NCT04018417|Amphotericin B|amphotericin b|mesh-list
153995652|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
153995653|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153995654|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
153995655|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995656|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995657|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
153995658|NCT00625183|Protective Agents|protective agents|mesh-ancestor
153995659|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995660|NCT00625183|Trace Elements|trace elements|mesh-ancestor
153995661|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
153995662|NCT00826891|Topotecan|topotecan|mesh-list
153995663|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995664|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153995665|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153995666|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995667|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995668|NCT00826969|Ciclesonide|ciclesonide|mesh-list
153995669|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
153995670|NCT00826969|Hormones|hormones|mesh-ancestor
153995671|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153995672|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995673|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153995674|NCT04044547|Rotigotine|rotigotine|mesh-list
153995675|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
153995676|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
153995677|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995678|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995679|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995680|NCT02768948|Losartan|losartan|mesh-list
153995698|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
153995699|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153995700|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153995701|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995702|NCT00904748|Urological Agents|urological agents|mesh-ancestor
153995704|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153995705|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
153995706|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
153995707|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
153995708|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
153995709|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
153995710|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153995711|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995712|NCT00971243|Metformin|metformin|mesh-list
153995713|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153995714|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995715|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153995716|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153995717|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153995718|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995719|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995720|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153995721|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995722|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995726|NCT04400383|Antibodies|antibodies|mesh-list
153995747|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153995748|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995749|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153995750|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995751|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995752|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995753|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
153995754|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995755|NCT00827281|Cycloserine|cycloserine|mesh-list
153995756|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153995757|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995758|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153995759|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
153995760|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153995761|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
153995762|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995763|NCT00823381|Resveratrol|resveratrol|mesh-list
153995764|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
153995765|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995766|NCT00823381|Protective Agents|protective agents|mesh-ancestor
153995767|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995768|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995769|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153995770|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
153995771|NCT00638443|Promethazine|promethazine|mesh-list
153995772|NCT00638443|Pregabalin|pregabalin|mesh-list
153995773|NCT00638443|Analgesics|analgesics|mesh-ancestor
153995774|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
153995775|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995776|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995777|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
153995778|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153995779|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995785|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153995786|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153995787|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153995788|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
153995789|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
153995790|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
153995791|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
153995792|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153995793|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153995794|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
153995795|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
153995796|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995797|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153995798|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
153995799|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
153995800|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
153995801|NCT00568399|Antidotes|antidotes|mesh-ancestor
153995802|NCT00568399|Protective Agents|protective agents|mesh-ancestor
154176533|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153995803|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995804|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
153995805|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995806|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
153995842|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
153995843|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995844|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153995845|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153995846|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153995847|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
153995848|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153995849|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
153995850|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995851|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153995852|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
153995853|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995857|NCT00634933|Prednisone|prednisone|mesh-list
153995858|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
153995859|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153995860|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153995861|NCT00634933|Prednisolone|prednisolone|mesh-list
153995862|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
153995863|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153995864|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
153995865|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153995866|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
153995867|NCT00634933|Hormones|hormones|mesh-ancestor
153995868|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153995869|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995870|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153995871|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995872|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
153995873|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
153995874|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995875|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153995876|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153995877|NCT00634933|Protective Agents|protective agents|mesh-ancestor
153995878|NCT00967499|Ondansetron|ondansetron|mesh-list
153995879|NCT00967499|Palonosetron|palonosetron|mesh-list
153995880|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
153995881|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
153630728|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153630729|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995882|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995883|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995884|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176534|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153995886|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
153995887|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153995888|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153995889|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
153995890|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995891|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995892|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153995893|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
153995894|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153995895|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153995896|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153995897|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153995898|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
153995899|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995900|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995901|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995902|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153995903|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153995930|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153995931|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153995932|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153995933|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153995934|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153995935|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
153995936|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153995937|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
153995939|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153995940|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
153995941|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
153995942|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153995943|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
153995944|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153995945|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995946|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153995947|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153995948|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153995949|NCT02550067|Trace Elements|trace elements|mesh-ancestor
153995950|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
153995951|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153995952|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153995953|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153995954|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153995955|NCT02862509|Budesonide|budesonide|mesh-list
153995956|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153995957|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153995958|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
153995959|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995960|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995975|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153995976|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153995977|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153995978|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153995979|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995980|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995981|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153995983|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
153995984|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153995985|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
153995986|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153995987|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
153995988|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153995989|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153995990|NCT00961649|Brinzolamide|brinzolamide|mesh-list
153995991|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153995992|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153995993|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153995994|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153995995|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153995996|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
153995997|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153995998|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153995999|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996000|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153996002|NCT04267601|Anagliptin|anagliptin|mesh-list
153996021|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153996022|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996023|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
153996024|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
153996025|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
153996026|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996027|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
153996028|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
153996029|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996030|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
153996031|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153996032|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153996033|NCT04283435|Estradiol|estradiol|mesh-list
153996034|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153996035|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996036|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996037|NCT04283435|Estrogens|estrogens|mesh-ancestor
153754818|NCT03187106|Metronidazole|metronidazole|mesh-list
153996039|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996040|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153996041|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
153996042|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153996043|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153996044|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
153996045|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153996047|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996072|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
153996073|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996074|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996075|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
153996076|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996077|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153996078|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
153996079|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153996080|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996081|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996082|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153996083|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
153996084|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153996085|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
153996086|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
153996087|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996088|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153996089|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153996090|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
153996091|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996092|NCT00903344|Vitamin D|vitamin d|mesh-list
153996093|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
153996094|NCT00903344|Vitamins|vitamins|mesh-ancestor
153996095|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
153996096|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996097|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153996098|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153996099|NCT02847338|Amlodipine|amlodipine|mesh-list
153996100|NCT02847338|Lisinopril|lisinopril|mesh-list
153996101|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
153996102|NCT02847338|Amiloride|amiloride|mesh-list
153996103|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153996104|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153996105|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996109|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
153996111|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
153996112|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996113|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153996114|NCT02847338|Protective Agents|protective agents|mesh-ancestor
153996115|NCT02847338|Diuretics|diuretics|mesh-ancestor
153996116|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
153996117|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153996118|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153996119|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153996120|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153996121|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153996122|NCT02847104|Insulin|insulin|mesh-list
153996123|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153996124|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996125|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996126|NCT02849366|Immunomodulating Agents|immunomodulating agents|mesh-list
153996127|NCT02849366|Immunologic Factors|immunologic factors|mesh-ancestor
153996128|NCT02849366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996129|NCT02849132|Entecavir|entecavir|mesh-list
153996130|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
153996131|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996132|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
153996134|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996135|NCT02848508|Metformin|metformin|mesh-list
153996136|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996137|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996138|NCT00902564|Escitalopram|escitalopram|mesh-list
153996139|NCT00902564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153996140|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153996141|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996142|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996143|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996154|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153996155|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
153996156|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996157|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996158|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153996159|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153996160|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153996161|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
153996162|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153996163|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996164|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996166|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153996167|NCT00626275|Naproxen|naproxen|mesh-list
153996168|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153996169|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996170|NCT00626275|Analgesics|analgesics|mesh-ancestor
153996171|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
153996172|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996173|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996174|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996175|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996176|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
153996177|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153996204|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996205|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153996206|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153996207|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996208|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153996209|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153996210|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996211|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
153996212|NCT04043845|Ibrutinib|ibrutinib|mesh-list
153996213|NCT04043845|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153996214|NCT04043845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153996215|NCT04043845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996216|NCT04043845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996217|NCT00828373|Lidocaine|lidocaine|mesh-list
153996218|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
153996219|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
153996220|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996221|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996222|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
153996223|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996224|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153996225|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153996226|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153996227|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996228|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996229|NCT00824239|Midazolam|midazolam|mesh-list
153996230|NCT00824239|Fentanyl|fentanyl|mesh-list
153996231|NCT00824239|Propofol|propofol|mesh-list
153996232|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153996233|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996234|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996235|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153996236|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
153996242|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
153996243|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
153996244|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996245|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996246|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153996247|NCT00824239|Narcotics|narcotics|mesh-ancestor
153996248|NCT00824239|Analgesics|analgesics|mesh-ancestor
153996249|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
153996250|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996251|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153996252|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
153996253|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153996254|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153996255|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153996256|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153996257|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
153996258|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996259|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996260|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153996261|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153996262|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
153996263|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996264|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996265|NCT04044703|Vancomycin|vancomycin|mesh-list
153996266|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153996267|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996268|NCT00824317|Methylphenidate|methylphenidate|mesh-list
153996269|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153996270|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996271|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153996272|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153996273|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996274|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996275|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
153996277|NCT02847806|Insulin|insulin|mesh-list
153996280|NCT02847806|Testosterone|testosterone|mesh-list
153996281|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996282|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996283|NCT02847806|Estrogens|estrogens|mesh-ancestor
153996284|NCT02847806|Hormones|hormones|mesh-ancestor
153996285|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996286|NCT02847806|Androgens|androgens|mesh-ancestor
153996287|NCT00828529|Bedaquiline|bedaquiline|mesh-list
153996288|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
153996289|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153996290|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996291|NCT00632762|Amantadine|amantadine|mesh-list
153996292|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153996293|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153996294|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
153996295|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996296|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
153996297|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996298|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996299|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996300|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996301|NCT00632762|Analgesics|analgesics|mesh-ancestor
153996302|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
153996303|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996304|NCT01351766|Nicotine|nicotine|mesh-list
153996305|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153996306|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
153996307|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996308|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996309|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153630730|NCT03913221|Caffeine|caffeine|mesh-list
153996325|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
153996326|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996327|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996328|NCT00828763|Dolutegravir|dolutegravir|mesh-list
153996329|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153996330|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153996331|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996332|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996333|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153996334|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153996335|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
153996336|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996337|NCT00824707|Entecavir|entecavir|mesh-list
153996338|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
153996384|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
153996385|NCT02548741|Calcium|calcium|mesh-list
153996386|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996387|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996388|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153996389|NCT02548741|Antacids|antacids|mesh-ancestor
153996390|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996391|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996392|NCT02845856|Cetuximab|cetuximab|mesh-list
153996393|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153996394|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996395|NCT00825019|Paroxetine|paroxetine|mesh-list
153996396|NCT00825019|Amibegron|amibegron|mesh-list
153996445|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996446|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996447|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996448|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
153996449|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996450|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153996451|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153996452|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996453|NCT05242718|Hormones|hormones|mesh-ancestor
153996454|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996455|NCT05242718|Expectorants|expectorants|mesh-ancestor
153996456|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
153996457|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153996458|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
153996459|NCT05242718|Protective Agents|protective agents|mesh-ancestor
153996460|NCT05242718|Antidotes|antidotes|mesh-ancestor
153996461|NCT00045968|Immunomodulating Agents|immunomodulating agents|mesh-list
153996462|NCT00045968|Immunologic Factors|immunologic factors|mesh-ancestor
153996463|NCT00045968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996464|NCT02845778|Melatonin|melatonin|mesh-list
153996465|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
153996466|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996467|NCT02845778|Protective Agents|protective agents|mesh-ancestor
153996468|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996469|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996470|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153996471|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153996472|NCT05337332|Triamcinolone|triamcinolone|mesh-list
153996473|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153996490|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
153996491|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996492|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153996493|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
153996494|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
153996495|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996496|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996497|NCT00901394|Analgesics|analgesics|mesh-ancestor
153996498|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
153996499|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996500|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
153996501|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153996502|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
153996503|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
153996504|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996505|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996506|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996507|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996508|NCT05337254|Analgesics|analgesics|mesh-ancestor
153996509|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
153996510|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996511|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
153996543|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153996544|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153996545|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996546|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996547|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153996548|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153996549|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
153996550|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153996551|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153996552|NCT02845388|Estradiol|estradiol|mesh-list
153996553|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153996554|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996555|NCT02845388|Estrogens|estrogens|mesh-ancestor
153996556|NCT02845388|Hormones|hormones|mesh-ancestor
153996560|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
153996600|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996601|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
153996602|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153996603|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
153996605|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153996606|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153996607|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
153996608|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996609|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996610|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996611|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153996612|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
153996613|NCT02993198|Protective Agents|protective agents|mesh-ancestor
153996614|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153996615|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996616|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153996617|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
153996618|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153996619|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153996620|NCT00829231|Sorafenib|sorafenib|mesh-list
153996621|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996622|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153996652|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153996653|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153996654|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996655|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153996656|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996657|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153996658|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996659|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153996660|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996662|NCT00623545|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153996663|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996664|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996665|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153996666|NCT00623545|Incretins|incretins|mesh-ancestor
153996667|NCT00623545|Hormones|hormones|mesh-ancestor
153996668|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996669|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
153996670|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153996671|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996672|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996673|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
153996674|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996675|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996676|NCT02839668|Acetaminophen|acetaminophen|mesh-list
153996677|NCT02839668|Lidocaine|lidocaine|mesh-list
153996678|NCT02839668|Atropine|atropine|mesh-list
153996679|NCT02839668|Tramadol|tramadol|mesh-list
153996680|NCT02839668|Sevoflurane|sevoflurane|mesh-list
153996681|NCT02839668|Neostigmine|neostigmine|mesh-list
153996682|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
153996683|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
153996684|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996685|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996686|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
153630731|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
153630732|NCT03913221|Citric Acid|citric acid|mesh-list
153630733|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
153630734|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
153630735|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153630736|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
153630737|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
153630738|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996687|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996688|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153996689|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153996690|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153996691|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153996692|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996693|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996694|NCT02839668|Analgesics|analgesics|mesh-ancestor
153996695|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
153996696|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153996697|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153996698|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
153996699|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153996700|NCT02839668|Narcotics|narcotics|mesh-ancestor
153996701|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153996702|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153996703|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
153996704|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153996705|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
153996706|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
153996707|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
153996708|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153996709|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153996710|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
153996711|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996712|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153996713|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996714|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153996715|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153996716|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
153996717|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996718|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153996719|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
153568793|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153630739|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153630740|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630741|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153630742|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630743|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153630744|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153996720|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996721|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153996722|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
153996723|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996725|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153996726|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153996727|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
153996728|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153996729|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996730|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996731|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153996732|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153996733|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
153996734|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996735|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153996736|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
153996737|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
153996738|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
153996739|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153996740|NCT02840526|Acetaminophen|acetaminophen|mesh-list
153996741|NCT02840526|Fentanyl|fentanyl|mesh-list
153996742|NCT02840526|Bupivacaine|bupivacaine|mesh-list
153996743|NCT02840526|Propofol|propofol|mesh-list
153996744|NCT02840526|Sevoflurane|sevoflurane|mesh-list
153996745|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
153996746|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
153996747|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996748|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996749|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
153996750|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996751|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153996752|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153996753|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
153996754|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153996755|NCT02840526|Narcotics|narcotics|mesh-ancestor
153996761|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153996762|NCT00825253|Insulin|insulin|mesh-list
153996763|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153996764|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
153996765|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
153996766|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153996767|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996768|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996769|NCT00820885|Teduglutide|teduglutide|mesh-list
153996770|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996771|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153996772|NCT00820885|Protective Agents|protective agents|mesh-ancestor
153996773|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996774|NCT00820963|Temozolomide|temozolomide|mesh-list
153996775|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153996776|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
153996777|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996778|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996779|NCT02834676|Ethanol|ethanol|mesh-list
153996780|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153996781|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996782|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153996783|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996784|NCT00632840|Atorvastatin|atorvastatin|mesh-list
153996785|NCT00632840|Fenofibrate|fenofibrate|mesh-list
153996786|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153996787|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153996788|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
153996789|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996790|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153996791|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153996792|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996793|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153996796|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153996800|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996801|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
153996802|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996803|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996804|NCT02834754|Vedolizumab|vedolizumab|mesh-list
153996805|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996806|NCT02839122|Tadalafil|tadalafil|mesh-list
153996807|NCT02839122|Dutasteride|dutasteride|mesh-list
153996808|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
153996809|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153996810|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153996811|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996812|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996813|NCT02839122|Urological Agents|urological agents|mesh-ancestor
153996814|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153996815|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153996816|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
153996817|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996818|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996853|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
153996854|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
153996855|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996856|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996857|NCT04044079|Misoprostol|misoprostol|mesh-list
154176536|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153996858|NCT04044079|Dinoprostone|dinoprostone|mesh-list
153996859|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153996860|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
153996861|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153996862|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996863|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153996864|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996865|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
153996866|NCT00830323|Oseltamivir|oseltamivir|mesh-list
153996915|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
153996916|NCT02834286|Hormones|hormones|mesh-ancestor
153996917|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996918|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153996919|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996920|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153996921|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
153996922|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153996923|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
153996924|NCT02839044|Vitamin K|vitamin k|mesh-list
153996925|NCT02839044|Menaquinone 7|menaquinone 7|mesh-list
153996926|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153996927|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153996928|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996929|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
153996930|NCT02839044|Coagulants|coagulants|mesh-ancestor
153996931|NCT02839044|Vitamins|vitamins|mesh-ancestor
153996932|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
153996933|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996934|NCT02833506|Sirolimus|sirolimus|mesh-list
153996935|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153996936|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996937|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153996938|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996939|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
153996940|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153996941|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
153996942|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996943|NCT02838576|Estrogens|estrogens|mesh-list
153996944|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153996945|NCT02838576|Hormones|hormones|mesh-ancestor
153996946|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153996947|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996948|NCT00838539|Sirolimus|sirolimus|mesh-list
153996949|NCT00838539|Temsirolimus|temsirolimus|mesh-list
153996951|NCT00838539|Neratinib|neratinib|mesh-list
153996956|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
153996957|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996958|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996959|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153996960|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153996961|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153996962|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
153996963|NCT00838539|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153996965|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153996966|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153996967|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996968|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996970|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
153996971|NCT02836704|Acarbose|acarbose|mesh-list
153996972|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996973|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996974|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153996975|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153996976|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153996977|NCT02833584|Acetaminophen|acetaminophen|mesh-list
153996978|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153996979|NCT02833584|Analgesics|analgesics|mesh-ancestor
153996980|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
153996981|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153996982|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996983|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
153996984|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153996985|NCT00837759|Lansoprazole|lansoprazole|mesh-list
153996986|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
153996987|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153996988|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153996989|NCT00837759|Incretins|incretins|mesh-ancestor
153996990|NCT00837759|Hormones|hormones|mesh-ancestor
153996993|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
153996996|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153996997|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153996998|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153997000|NCT00703365|Sorafenib|sorafenib|mesh-list
153755543|NCT02895529|Itraconazole|itraconazole|mesh-list
153997001|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153997002|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
153997003|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997004|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997005|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153997006|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997007|NCT05878899|Enoxaparin|enoxaparin|mesh-list
153997008|NCT05878899|Anticoagulants|anticoagulants|mesh-ancestor
153997009|NCT05878899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153997010|NCT05878899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153997011|NCT05878899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997012|NCT05878574|Heparin|heparin|mesh-list
153997013|NCT05878574|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153997014|NCT05878574|Tinzaparin|tinzaparin|mesh-list
153997015|NCT05878574|Dalteparin|dalteparin|mesh-list
153997016|NCT05878574|Anticoagulants|anticoagulants|mesh-ancestor
153997017|NCT05878574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153997018|NCT05878574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153997019|NCT05878574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997020|NCT05878561|Indapamide|indapamide|mesh-list
153997021|NCT05878561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153997022|NCT05878561|Diuretics|diuretics|mesh-ancestor
153997023|NCT05878561|Natriuretic Agents|natriuretic agents|mesh-ancestor
153997028|NCT05878379|Iron|iron|mesh-list
153997043|NCT05878262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997044|NCT05878158|Simvastatin|simvastatin|mesh-list
153997045|NCT05878158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153997046|NCT05878158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153997047|NCT05878158|Antimetabolites|antimetabolites|mesh-ancestor
153997048|NCT05878158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997049|NCT05878158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153997050|NCT05878158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153997051|NCT05878158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997052|NCT05878028|Docetaxel|docetaxel|mesh-list
153997053|NCT05878028|Tislelizumab|tislelizumab|mesh-list
153997054|NCT05878028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997055|NCT05878028|Tubulin Modulators|tubulin modulators|mesh-ancestor
153997056|NCT05878028|Antimitotic Agents|antimitotic agents|mesh-ancestor
153997057|NCT05878028|Mitosis Modulators|mitosis modulators|mesh-ancestor
153997058|NCT05878028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997059|NCT05878028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997060|NCT05877911|Sodium sulfate|sodium sulfate|mesh-list
153997061|NCT05877911|Cathartics|cathartics|mesh-ancestor
153997062|NCT05877911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997063|NCT05877872|Immunomodulating Agents|immunomodulating agents|mesh-list
153997064|NCT05877872|Immunologic Factors|immunologic factors|mesh-ancestor
153997065|NCT05877872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997066|NCT05877781|Palmidrol|palmidrol|mesh-list
153997067|NCT05877781|Analgesics|analgesics|mesh-ancestor
153997068|NCT05877781|Sensory System Agents|sensory system agents|mesh-ancestor
153997069|NCT05877781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997070|NCT05877781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997071|NCT05877781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153997072|NCT05877781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153997073|NCT05877781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630745|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
153630746|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153630747|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
153630748|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153755616|NCT05423821|Anesthetics|anesthetics|mesh-list
153630749|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
153630750|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
153630751|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153630752|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630753|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153630754|NCT03869736|Analgesics|analgesics|mesh-ancestor
153630755|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
153997074|NCT05877781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997075|NCT05877781|Antiviral Agents|antiviral agents|mesh-ancestor
153997076|NCT05877781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997077|NCT05877781|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153997078|NCT05877781|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153997079|NCT05877781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997080|NCT05877781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997081|NCT05877781|Hormones|hormones|mesh-ancestor
153997082|NCT05877781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997083|NCT05877690|Bupivacaine|bupivacaine|mesh-list
153997084|NCT05877690|Prilocaine|prilocaine|mesh-list
153997085|NCT05877690|Anesthetics, Local|anesthetics, local|mesh-ancestor
153997086|NCT05877690|Anesthetics|anesthetics|mesh-ancestor
153997087|NCT05877690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997088|NCT05877690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997089|NCT05877690|Sensory System Agents|sensory system agents|mesh-ancestor
153997090|NCT05877690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997091|NCT05877638|Sulfadiazine|sulfadiazine|mesh-list
153997092|NCT05877638|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153997093|NCT05877638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153997094|NCT05877638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997095|NCT05877638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153997096|NCT05877638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153997097|NCT05877638|Coccidiostats|coccidiostats|mesh-ancestor
153997098|NCT05877638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153997099|NCT05877235|Quercetin|quercetin|mesh-list
153997100|NCT05877235|Antioxidants|antioxidants|mesh-ancestor
153997101|NCT05877235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997102|NCT05877235|Protective Agents|protective agents|mesh-ancestor
153997121|NCT05877001|Tislelizumab|tislelizumab|mesh-list
153997122|NCT05877001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997123|NCT05877001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997124|NCT05873777|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153997125|NCT05873777|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153997126|NCT05873777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997127|NCT05790707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153997128|NCT05737121|Lidocaine|lidocaine|mesh-list
153997129|NCT05737121|Heparin|heparin|mesh-list
153997130|NCT05737121|Calcium heparin|calcium heparin|mesh-list
153997131|NCT05737121|Anesthetics, Local|anesthetics, local|mesh-ancestor
153997132|NCT05737121|Anesthetics|anesthetics|mesh-ancestor
153997133|NCT05737121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997134|NCT05737121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997135|NCT05737121|Sensory System Agents|sensory system agents|mesh-ancestor
153997136|NCT05737121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997137|NCT05737121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153997138|NCT05737121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153997139|NCT05737121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153997140|NCT05737121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997141|NCT05737121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997142|NCT05737121|Anticoagulants|anticoagulants|mesh-ancestor
153997143|NCT05737121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153997144|NCT05737121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153997145|NCT05663658|Morphine|morphine|mesh-list
153997146|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153997147|NCT05663658|Narcotics|narcotics|mesh-ancestor
153997148|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997167|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153997168|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153997169|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997170|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153997171|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153997172|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
153997173|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997174|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997175|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
153997176|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
153997177|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997178|NCT05597722|Amphetamine|amphetamine|mesh-list
153997179|NCT05597722|Adderall|adderall|mesh-list
153997180|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
153997181|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153754772|NCT03493178|Glycine|glycine|mesh-list
153997182|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997183|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
153997184|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
153997185|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997186|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
153997187|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997188|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997189|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
153997190|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153997191|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153997192|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997193|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153997194|NCT05555667|Propofol|propofol|mesh-list
153997195|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153997196|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997197|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997207|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997208|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153997209|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153997210|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997211|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153997212|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153997213|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153997214|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
153997215|NCT05398081|Cefuroxime|cefuroxime|mesh-list
153997216|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
153997217|NCT05398081|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153997218|NCT05398081|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153997219|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153997220|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997221|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153997222|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
153997223|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997224|NCT05364008|Protective Agents|protective agents|mesh-ancestor
153997225|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997226|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153997227|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153997228|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997229|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153997230|NCT05307770|Melatonin|melatonin|mesh-list
153997231|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
153997233|NCT05307770|Protective Agents|protective agents|mesh-ancestor
153997253|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997254|NCT05060744|Antacids|antacids|mesh-list
153997255|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
153997256|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997257|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997259|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153997260|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153997261|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153997262|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997263|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997264|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
153997265|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997266|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997267|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153755758|NCT00170768|Darifenacin|darifenacin|mesh-list
153997268|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997269|NCT05047939|Propofol|propofol|mesh-list
153997270|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153997271|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997272|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997273|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153997274|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
153997275|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
153997276|NCT04926285|Venetoclax|venetoclax|mesh-list
153997277|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
153997278|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997279|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153997280|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153997283|NCT04856566|Ethanol|ethanol|mesh-list
153997298|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153997299|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
153997300|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997301|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997302|NCT04774250|Zonisamide|zonisamide|mesh-list
153997303|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
153997304|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153997305|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997306|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997307|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153997308|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997309|NCT04669457|Midazolam|midazolam|mesh-list
153997310|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
153997311|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153997312|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997313|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997314|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153997315|NCT04669457|Analgesics|analgesics|mesh-ancestor
153997316|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
153997317|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997318|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153997319|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153997320|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153997321|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
153997322|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997323|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997324|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153997325|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153997326|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755823|NCT02492776|Omeprazole|omeprazole|mesh-list
153997327|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153997329|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
153997330|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
153997331|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
153997332|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
153997333|NCT04537715|Itraconazole|itraconazole|mesh-list
153997339|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997340|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997341|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153997342|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
153997343|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997344|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997345|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153997346|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153997347|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
153997348|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153997349|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
153997350|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153997351|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153997352|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153997353|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153997354|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153997355|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153997356|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153997357|NCT04532528|Dabigatran|dabigatran|mesh-list
153997358|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
153997359|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153997360|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
153997361|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997362|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997363|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
153997382|NCT04025359|Dronabinol|dronabinol|mesh-list
153997383|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
153997384|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997385|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153997386|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153997387|NCT04025359|Analgesics|analgesics|mesh-ancestor
153997388|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
153997389|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997390|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153997391|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153997392|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997393|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997395|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997396|NCT04005716|Cisplatin|cisplatin|mesh-list
153997397|NCT04005716|Carboplatin|carboplatin|mesh-list
153997398|NCT04005716|Etoposide|etoposide|mesh-list
153997399|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
153997400|NCT04005716|Tislelizumab|tislelizumab|mesh-list
153997401|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997402|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153997403|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153997404|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153997405|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997406|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997407|NCT04005716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997408|NCT03972280|Antibodies|antibodies|mesh-list
153997409|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153630756|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630757|NCT03741933|Apremilast|apremilast|mesh-list
153630758|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153630759|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153630760|NCT03741933|Analgesics|analgesics|mesh-ancestor
153630761|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
153630762|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630763|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630764|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630781|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630782|NCT00387504|Fenretinide|fenretinide|mesh-list
153630783|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630784|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153630785|NCT00387504|Protective Agents|protective agents|mesh-ancestor
153630786|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630787|NCT02936505|Cyclosporine|cyclosporine|mesh-list
153630788|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
153997411|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
153997412|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997413|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153997414|NCT03813108|Lumefantrine|lumefantrine|mesh-list
153997415|NCT03813108|Artemether|artemether|mesh-list
153997416|NCT03813108|Mefloquine|mefloquine|mesh-list
153997417|NCT03813108|Atovaquone|atovaquone|mesh-list
153997418|NCT03813108|Proguanil|proguanil|mesh-list
153997419|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153997420|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153997421|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
153997422|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153997423|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153997424|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997425|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997426|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997427|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
153997428|NCT03621748|Anesthetics|anesthetics|mesh-list
153997429|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997430|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997431|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
153997432|NCT03417154|Nivolumab|nivolumab|mesh-list
153997433|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153997434|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
153997435|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997436|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997437|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153997438|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
153997439|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997440|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997441|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153997442|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997443|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153997444|NCT03221036|Vedolizumab|vedolizumab|mesh-list
153997445|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997446|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
153630790|NCT02936505|Cyclosporins|cyclosporins|mesh-list
153630791|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
153997447|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
153997448|NCT03032783|Tacrolimus|tacrolimus|mesh-list
153997449|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153997450|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
153997451|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997452|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997453|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153997454|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
153997455|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997456|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997457|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153997458|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153997459|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997460|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153997461|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153997462|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
153997463|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153997464|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997465|NCT02740985|Docetaxel|docetaxel|mesh-list
153997466|NCT02740985|Durvalumab|durvalumab|mesh-list
153997467|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
153997468|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997469|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
153997470|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
153755059|NCT00168740|Rituximab|rituximab|mesh-list
153755977|NCT00171587|Vatalanib|vatalanib|mesh-list
153997496|NCT03946358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997497|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997498|NCT02106507|Everolimus|everolimus|mesh-list
153997499|NCT02106507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153997500|NCT02106507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153997501|NCT02106507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997502|NCT02106507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997503|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153997504|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
153997505|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997506|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997507|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153997508|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153997509|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
153997510|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997511|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997512|NCT01264315|Lenalidomide|lenalidomide|mesh-list
153997513|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
153997514|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997549|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997550|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997551|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153997552|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153997553|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
153997554|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997555|NCT00248287|Carboplatin|carboplatin|mesh-list
153997556|NCT00248287|Irinotecan|irinotecan|mesh-list
153997557|NCT00248287|Cetuximab|cetuximab|mesh-list
153997558|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997559|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153997560|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153997561|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997562|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997563|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997564|NCT04249284|Deucravacitinib|deucravacitinib|mesh-list
153997565|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997566|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153997567|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997568|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997569|NCT04474938|Dexamethasone|dexamethasone|mesh-list
153997570|NCT04474938|Bortezomib|bortezomib|mesh-list
153997571|NCT04474938|Daratumumab|daratumumab|mesh-list
153997572|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153997573|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
153997574|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
153997575|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997576|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997577|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997578|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
153997579|NCT04474938|Hormones|hormones|mesh-ancestor
153997580|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997581|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153569675|NCT02567799|Hormones|hormones|mesh-ancestor
153630792|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153630793|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630794|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
153630795|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630796|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153630797|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997582|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997583|NCT00837213|Doxycycline|doxycycline|mesh-list
153997584|NCT00837213|Clindamycin|clindamycin|mesh-list
153997585|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
153997586|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
153997587|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153997588|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153997589|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997590|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
153997591|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153997592|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153997593|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153997594|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997595|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997596|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997597|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
153997598|NCT02833038|Analgesics|analgesics|mesh-ancestor
153997599|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
153997600|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997601|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997602|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
153997603|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997604|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153997605|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
153997606|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153997632|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
153997633|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997634|NCT05333640|Sirolimus|sirolimus|mesh-list
153997635|NCT05333640|Paclitaxel|paclitaxel|mesh-list
153997636|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153997637|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997638|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
153997639|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
153997640|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
153997641|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997642|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153997643|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997644|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153997645|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
153997646|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153997647|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
153997648|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997649|NCT02838264|Itraconazole|itraconazole|mesh-list
153997650|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
153997651|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997652|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153997653|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153997654|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997655|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997656|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153997657|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
153997658|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997659|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997660|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153997661|NCT00633438|Celecoxib|celecoxib|mesh-list
153997662|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153997663|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153997664|NCT00633438|Analgesics|analgesics|mesh-ancestor
153756177|NCT00180024|Irbesartan|irbesartan|mesh-list
153997665|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
153630798|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630799|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
153630800|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630801|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997666|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997667|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997668|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153997669|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997670|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153997671|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153997672|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997673|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997674|NCT02833116|Dexamethasone|dexamethasone|mesh-list
153997675|NCT02833116|Betamethasone|betamethasone|mesh-list
153997676|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153997677|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
153997678|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
153997679|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997680|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997681|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997682|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
154176537|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
153997684|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997685|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153997686|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997687|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153997688|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
153997689|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
153997690|NCT00703989|Benphothiamine|benphothiamine|mesh-list
153997691|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
153997692|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997693|NCT00703989|Protective Agents|protective agents|mesh-ancestor
153997694|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997695|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
153997711|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153997712|NCT02836002|Atovaquone|atovaquone|mesh-list
153997713|NCT02836002|Proguanil|proguanil|mesh-list
153997714|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153997715|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
153997716|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153997717|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153997718|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997719|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153997720|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997721|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997722|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153997723|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
153997724|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
153997725|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153997726|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
153997727|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153997728|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997729|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997768|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997769|NCT00831025|Immunomodulating Agents|immunomodulating agents|mesh-list
153997770|NCT00831025|Immunologic Factors|immunologic factors|mesh-ancestor
153997771|NCT00831025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997773|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
153997774|NCT00835731|Misoprostol|misoprostol|mesh-list
153997775|NCT00835731|Vitamins|vitamins|mesh-ancestor
153997776|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
153997777|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997778|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153997779|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
153997780|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153997781|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153997782|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997783|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
153997784|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
153997785|NCT00835731|Hematinics|hematinics|mesh-ancestor
153997786|NCT03721406|Ropivacaine|ropivacaine|mesh-list
153997787|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
153997788|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
153997789|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997824|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
153997825|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153997826|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997827|NCT00704301|Rivastigmine|rivastigmine|mesh-list
153997828|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153997829|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997830|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997831|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
153997832|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997833|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997834|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153997835|NCT00704301|Protective Agents|protective agents|mesh-ancestor
153997836|NCT00831103|Valacyclovir|valacyclovir|mesh-list
153997838|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153997839|NCT00704444|Ezetimibe|ezetimibe|mesh-list
153997840|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153997841|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153997842|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
153997843|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997844|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153997845|NCT00704691|Lenalidomide|lenalidomide|mesh-list
153997846|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
153997847|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997848|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153997849|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153997850|NCT00704691|Growth Substances|growth substances|mesh-ancestor
153997851|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
153997852|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997853|NCT00704925|Amifampridine|amifampridine|mesh-list
153997854|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153997855|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997856|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997857|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153997858|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997859|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997862|NCT00574249|Calcipotriene|calcipotriene|mesh-list
153997863|NCT00574249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153997864|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153997865|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153997866|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
153997867|NCT00574249|Hormones|hormones|mesh-ancestor
153997868|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997869|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997870|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153997871|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
153997872|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997873|NCT00891228|ST 1435|st 1435|mesh-list
153997874|NCT00891228|Testosterone|testosterone|mesh-list
153997875|NCT00891228|Androgens|androgens|mesh-ancestor
153997876|NCT00891228|Hormones|hormones|mesh-ancestor
153997877|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153997878|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997879|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153997880|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
153997881|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153997882|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153997883|NCT00896168|Infliximab|infliximab|mesh-list
153756323|NCT00198159|Gefitinib|gefitinib|mesh-list
153997913|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153997914|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997915|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997916|NCT00833469|Escitalopram|escitalopram|mesh-list
153997917|NCT00833469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153997918|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153997919|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153997920|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997921|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997922|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
153997923|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997924|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
153997925|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153997926|NCT02831478|Protective Agents|protective agents|mesh-ancestor
153997927|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997928|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
153997929|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
153997930|NCT00837655|Calcium|calcium|mesh-list
153997931|NCT00837655|Sevelamer|sevelamer|mesh-list
153997932|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153997933|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997934|NCT00837655|Antacids|antacids|mesh-ancestor
153997935|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997936|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153997937|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
153997938|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
153997939|NCT00843661|Ezetimibe|ezetimibe|mesh-list
153997940|NCT00843661|Pravastatin|pravastatin|mesh-list
153997941|NCT00843661|Fenofibrate|fenofibrate|mesh-list
153997942|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153997943|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153997944|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
153997945|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997953|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
153997954|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153997955|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997956|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997957|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153997958|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153997959|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153997960|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997961|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153997962|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
153997963|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997964|NCT00705315|Bevacizumab|bevacizumab|mesh-list
153997965|NCT00705315|Docetaxel|docetaxel|mesh-list
153997966|NCT00705315|Epirubicin|epirubicin|mesh-list
153997967|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997968|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153997969|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153997970|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153997971|NCT00705315|Growth Substances|growth substances|mesh-ancestor
153997972|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997973|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
153997974|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153997975|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153997976|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153997977|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153997978|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153997979|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153997980|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153997981|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153997982|NCT00892008|Pregabalin|pregabalin|mesh-list
153997983|NCT00892008|Analgesics|analgesics|mesh-ancestor
153997984|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
153997985|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153997986|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153997988|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153997991|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153997992|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153997993|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153997994|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153997995|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153997996|NCT00623233|Bevacizumab|bevacizumab|mesh-list
153997997|NCT00623233|Gemcitabine|gemcitabine|mesh-list
153997998|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153997999|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998000|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153998001|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153998002|NCT00623233|Growth Substances|growth substances|mesh-ancestor
153998003|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998004|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
153998005|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998006|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
153998007|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998008|NCT00837889|Diuretics|diuretics|mesh-list
153998009|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
153998010|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998011|NCT02841488|Fentanyl|fentanyl|mesh-list
153998012|NCT02841488|Ropivacaine|ropivacaine|mesh-list
153998013|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
153998014|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
153998015|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998016|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998017|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
153998018|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998019|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153998020|NCT02841488|Narcotics|narcotics|mesh-ancestor
153998021|NCT02841488|Analgesics|analgesics|mesh-ancestor
153998022|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153998023|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153998024|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
153998025|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
153998033|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153998034|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153998035|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
153998036|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998037|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153998038|NCT02690870|Tamoxifen|tamoxifen|mesh-list
153998039|NCT02690870|Clomiphene|clomiphene|mesh-list
153998040|NCT02690870|Enclomiphene|enclomiphene|mesh-list
153998041|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
153998042|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153998043|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
153998044|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998045|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998046|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153998047|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998048|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153998049|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153998050|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153998051|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153998052|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
153998053|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153998054|NCT00844207|Azithromycin|azithromycin|mesh-list
153998055|NCT00844207|Chloroquine|chloroquine|mesh-list
153998056|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153998057|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153998058|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998059|NCT00844207|Amebicides|amebicides|mesh-ancestor
153998060|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153998061|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153998062|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
153998063|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998064|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153998065|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998066|NCT00844207|Analgesics|analgesics|mesh-ancestor
153630802|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630803|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153630804|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630805|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153630806|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
153630807|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153998067|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
153998068|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998069|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998070|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998071|NCT00844207|Filaricides|filaricides|mesh-ancestor
153755657|NCT00170456|Antacids|antacids|mesh-ancestor
153998072|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
153998073|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
153998074|NCT02841722|Lenograstim|lenograstim|mesh-list
153998075|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153998076|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
153998077|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998078|NCT02548117|Finasteride|finasteride|mesh-list
153998079|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153998080|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153998081|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998082|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998083|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
153998084|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998085|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998086|NCT02548117|Urological Agents|urological agents|mesh-ancestor
153998087|NCT02841800|Phenobarbital|phenobarbital|mesh-list
153998088|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
153998089|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153998090|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998091|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998092|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153998093|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153998094|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998095|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998096|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
153998097|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
153998098|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153998105|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998106|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153998107|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998108|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153998109|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153998110|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
153998111|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998112|NCT00621751|Carbamazepine|carbamazepine|mesh-list
153998113|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
153998114|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
153998115|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153998116|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998117|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998118|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153998119|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998120|NCT00621751|Analgesics|analgesics|mesh-ancestor
153998121|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
153998122|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998123|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153998124|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153998125|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998126|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153998127|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153998128|NCT02690792|Vitamin E|vitamin e|mesh-list
153998129|NCT02690792|Vitamins|vitamins|mesh-ancestor
153998130|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
153998131|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176538|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998132|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
153998133|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998134|NCT02690792|Protective Agents|protective agents|mesh-ancestor
153998135|NCT00831649|Natalizumab|natalizumab|mesh-list
153998136|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
153570218|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630808|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
153630809|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
153630810|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153630811|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630812|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630813|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
153630814|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153998137|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998138|NCT02841332|Misonidazole|misonidazole|mesh-list
153998139|NCT02841332|Bevacizumab|bevacizumab|mesh-list
153998140|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153998141|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998142|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153998143|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153998144|NCT02841332|Growth Substances|growth substances|mesh-ancestor
153998145|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998146|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
153998147|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153998148|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153998149|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998150|NCT00838357|Plerixafor|plerixafor|mesh-list
153755724|NCT00170690|Treosulfan|treosulfan|mesh-list
153998151|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153998152|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153998153|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
153998154|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998155|NCT00156104|Haloperidol|haloperidol|mesh-list
153998156|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
153998157|NCT00156104|Asenapine|asenapine|mesh-list
153998158|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
153998159|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
153998160|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570251|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153630815|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153630816|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630817|NCT02593110|Telmisartan|telmisartan|mesh-list
153630818|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153630819|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153630820|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153630821|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630832|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630833|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
153630834|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630835|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153630836|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630837|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
153630838|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630839|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153630840|NCT02373813|Hematinics|hematinics|mesh-ancestor
153630841|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
153630842|NCT02373813|Vitamins|vitamins|mesh-ancestor
153630843|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
153630844|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153630845|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153630846|NCT02373813|Analgesics|analgesics|mesh-ancestor
153630847|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
153630848|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630849|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630850|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630851|NCT01959204|Oxycodone|oxycodone|mesh-list
153998161|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998162|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153998163|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153998164|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153998165|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998166|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153998167|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153998168|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
153998169|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998170|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998171|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153998172|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153998173|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153998174|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153998175|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153998176|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998177|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
153998178|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998179|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998180|NCT00891930|Irinotecan|irinotecan|mesh-list
153998181|NCT00891930|Panitumumab|panitumumab|mesh-list
153998182|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153998183|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153998184|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998185|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998186|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998187|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153998188|NCT02831088|Salicylates|salicylates|mesh-list
153998189|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153630852|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153630853|NCT01959204|Narcotics|narcotics|mesh-ancestor
153630854|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153630855|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630856|NCT01959204|Analgesics|analgesics|mesh-ancestor
153630857|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
153630858|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630859|NCT00006045|Cytarabine|cytarabine|mesh-list
153630860|NCT00006045|Etoposide|etoposide|mesh-list
153630861|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
153630862|NCT00006045|Lintuzumab|lintuzumab|mesh-list
153630863|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630864|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630865|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153630866|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153998190|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998191|NCT02831088|Analgesics|analgesics|mesh-ancestor
153998192|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
153998193|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998194|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998195|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998196|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998197|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153998198|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998199|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998200|NCT02841176|Golimumab|golimumab|mesh-list
153998201|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153998202|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998203|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998204|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
153998205|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998206|NCT01615874|Prednisone|prednisone|mesh-list
153998207|NCT01615874|Prednisolone|prednisolone|mesh-list
153998208|NCT01615874|Montelukast|montelukast|mesh-list
153998209|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
153998210|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998211|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
153998212|NCT01615874|Hormones|hormones|mesh-ancestor
153998214|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998241|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998242|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998243|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
153998244|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998246|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153998247|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998248|NCT00140972|Diclofenac|diclofenac|mesh-list
153998249|NCT00140972|Etoricoxib|etoricoxib|mesh-list
153998250|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153998251|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998252|NCT00140972|Analgesics|analgesics|mesh-ancestor
153998253|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
153998254|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998255|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998256|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998257|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998258|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153998259|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998260|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998261|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153998262|NCT02830932|Vaccines|vaccines|mesh-list
153998263|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
153998264|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998265|NCT00895310|Ketoconazole|ketoconazole|mesh-list
153998266|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
153998267|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998268|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
153998269|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998270|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153998271|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153998272|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998273|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998274|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153998275|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
153630867|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630868|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630869|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630870|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
153998276|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998277|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998278|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153998279|NCT04245618|Cisplatin|cisplatin|mesh-list
153998280|NCT04245618|Gemcitabine|gemcitabine|mesh-list
154176539|NCT00841919|Insulin|insulin|mesh-list
153998281|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998282|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998283|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
153998284|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998285|NCT00092768|Celecoxib|celecoxib|mesh-list
153998286|NCT00092768|Etoricoxib|etoricoxib|mesh-list
153998287|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153998288|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998289|NCT00092768|Analgesics|analgesics|mesh-ancestor
153998290|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
153998291|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998292|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998293|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998294|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998295|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153998296|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153998297|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998298|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998299|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
153998300|NCT02831712|Trace Elements|trace elements|mesh-ancestor
153998322|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998323|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998324|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153998325|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
153998326|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998327|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998328|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153998329|NCT02830230|Azithromycin|azithromycin|mesh-list
153998330|NCT02830230|Cefixime|cefixime|mesh-list
153998331|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153998388|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998389|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153998390|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
153998391|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153998392|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
153998393|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153998394|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998395|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153998396|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153998397|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998398|NCT02827578|Tamsulosin|tamsulosin|mesh-list
153998399|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
153998400|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153998401|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153998402|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153998403|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
153998404|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998405|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998406|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998407|NCT02827578|Urological Agents|urological agents|mesh-ancestor
153998408|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153998440|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998441|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998442|NCT00794378|Cetirizine|cetirizine|mesh-list
153998443|NCT00794378|Desloratadine|desloratadine|mesh-list
153998444|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153998445|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153998446|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153998447|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
153998448|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
153998449|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756016|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
153998450|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998452|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153998453|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
153998454|NCT00789152|Levocetirizine|levocetirizine|mesh-list
153998455|NCT00789152|Desloratadine|desloratadine|mesh-list
153998456|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153998457|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153998458|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
153998459|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
153998460|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998461|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998462|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998463|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153998464|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
153998465|NCT00783458|Fluticasone|fluticasone|mesh-list
153998466|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
153630871|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
153630872|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630873|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630874|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
153630875|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630876|NCT00006045|Analgesics|analgesics|mesh-ancestor
153630877|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
153630878|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630879|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630880|NCT00006048|Gemcitabine|gemcitabine|mesh-list
153630881|NCT00006048|Gefitinib|gefitinib|mesh-list
153630882|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630883|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630884|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
153630886|NCT00006048|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153630887|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153630888|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630889|NCT00006051|Fluorouracil|fluorouracil|mesh-list
153630916|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
153630917|NCT00006054|Hormones|hormones|mesh-ancestor
153630918|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998467|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998468|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153998469|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
153998470|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998471|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998472|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153998473|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
153998474|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
153998475|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153998476|NCT00620659|Modafinil|modafinil|mesh-list
153998477|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153998478|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998479|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153998480|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153998481|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153998482|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998483|NCT02829060|Gentamicins|gentamicins|mesh-list
153998484|NCT02829060|Ampicillin|ampicillin|mesh-list
153998485|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
153998486|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153998487|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998488|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153998489|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998490|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998491|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153998492|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153998493|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153998494|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153998495|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998496|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998497|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153998498|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153998499|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153630919|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153630920|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153630921|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
153630922|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153630923|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630924|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
153630925|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
153998501|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998502|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998503|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153998504|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153998505|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
153998506|NCT00783146|Fexofenadine|fexofenadine|mesh-list
153998507|NCT00783146|Desloratadine|desloratadine|mesh-list
153998508|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153998509|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
153998510|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998511|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998512|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998513|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153998514|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153998515|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
153998516|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
153998517|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153998518|NCT00844675|Rabeprazole|rabeprazole|mesh-list
153998519|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153998520|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153998521|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153998522|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998523|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998524|NCT02840006|Anesthetics|anesthetics|mesh-list
153998525|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998526|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998527|NCT02826252|Iloprost|iloprost|mesh-list
153998528|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153998529|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
153630926|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630927|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153630928|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153630929|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630930|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153630931|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630932|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
153630933|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630934|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153630935|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
153630936|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
153630937|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630938|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153998530|NCT02839928|Ketamine|ketamine|mesh-list
153998531|NCT02839928|Analgesics|analgesics|mesh-list
153998532|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153998533|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
153998534|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998535|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998536|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153998537|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153998538|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
153998539|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
153998540|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998541|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153998542|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153998543|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998544|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998545|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
153998546|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153998547|NCT05018520|Prednisone|prednisone|mesh-list
153998548|NCT05018520|Rituximab|rituximab|mesh-list
153998549|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
153998550|NCT05018520|Vincristine|vincristine|mesh-list
153998551|NCT05018520|Doxorubicin|doxorubicin|mesh-list
153998552|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153998553|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998554|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
153998555|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998556|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998557|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998558|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153998575|NCT04321746|Ketamine|ketamine|mesh-list
153998576|NCT04321746|Analgesics|analgesics|mesh-ancestor
154176540|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153998577|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
153998578|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998579|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998580|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153998581|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153998582|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
153998583|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
153998584|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998585|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153998586|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153998587|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998588|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998589|NCT02839694|Celecoxib|celecoxib|mesh-list
153998590|NCT02839694|Decitabine|decitabine|mesh-list
153998591|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
153998592|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153998593|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153998594|NCT02839694|Analgesics|analgesics|mesh-ancestor
153998595|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
153998596|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998597|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998598|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998599|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998600|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153998601|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153998602|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998603|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998604|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998605|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
153998616|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153998617|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
153998618|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998619|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998620|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153998621|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153998622|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153998623|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153998624|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998625|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998626|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
153998627|NCT04243434|Hormones|hormones|mesh-ancestor
153998628|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998629|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153998630|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153998631|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
153998632|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
153998633|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
153998634|NCT00832039|Selenious Acid|selenious acid|mesh-list
153998635|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
153998636|NCT00832039|Trace Elements|trace elements|mesh-ancestor
153998637|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
153998638|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998639|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
153998640|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153998641|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998642|NCT02826564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153998643|NCT02826564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998644|NCT00839059|Lenalidomide|lenalidomide|mesh-list
153998645|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
153998646|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998647|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153630960|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
153630961|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
153630962|NCT00006078|Lycopene|lycopene|mesh-list
153630963|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630964|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
153630965|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630966|NCT00006078|Protective Agents|protective agents|mesh-ancestor
153630967|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630968|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153630969|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153998648|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153998649|NCT00839059|Growth Substances|growth substances|mesh-ancestor
153998650|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
153998651|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998653|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998654|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998655|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153998656|NCT02826174|Anesthetics|anesthetics|mesh-list
153998657|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998658|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998659|NCT00621517|Bupropion|bupropion|mesh-list
153998660|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153998661|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
153998662|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153998663|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153998664|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153998665|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153998666|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998667|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
153998668|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756241|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998669|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998670|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153998671|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153998673|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
153998674|NCT02827266|Hematinics|hematinics|mesh-ancestor
153998675|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
153998676|NCT00845221|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153998677|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153998678|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998679|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998680|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998681|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
153630970|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630971|NCT00006081|Paclitaxel|paclitaxel|mesh-list
153630972|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
153630973|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630974|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630975|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
153998682|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153998683|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998684|NCT02826876|Ropivacaine|ropivacaine|mesh-list
153998685|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
153998686|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
153998687|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998688|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998689|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
153998690|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998691|NCT04244448|Emtricitabine|emtricitabine|mesh-list
153998692|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
153998693|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998694|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153998695|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153998696|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998697|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998698|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153998699|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153998700|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
153998701|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153998702|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153998703|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
153998704|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998705|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153630976|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
153630977|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
153630978|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630979|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153630980|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
153630981|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630982|NCT00006084|Lintuzumab|lintuzumab|mesh-list
153630983|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630984|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630985|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
153630986|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630988|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630989|NCT00006105|Gemcitabine|gemcitabine|mesh-list
153630990|NCT00006105|Amifostine|amifostine|mesh-list
153630991|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630992|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630993|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
153630994|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630995|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153631008|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
153631009|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631010|NCT00006111|Fluorouracil|fluorouracil|mesh-list
153631011|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631012|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
153631013|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631014|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998706|NCT00839371|Midazolam|midazolam|mesh-list
153998707|NCT00839371|Propofol|propofol|mesh-list
153998708|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153998709|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998710|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998711|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153998712|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
153998713|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
153998714|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153998715|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153998716|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153998717|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153998718|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
153998719|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
153998720|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998721|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998722|NCT02826408|Rabeprazole|rabeprazole|mesh-list
153998723|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153998724|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153998725|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153570821|NCT05296005|Antidotes|antidotes|mesh-ancestor
153631015|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631016|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
153631017|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631025|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631026|NCT00006114|Analgesics|analgesics|mesh-ancestor
153631027|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
153631028|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153631029|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631030|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631031|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631032|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631033|NCT00006117|Gemcitabine|gemcitabine|mesh-list
153631034|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
153631035|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631036|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
153631037|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631038|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631039|NCT00006120|Paclitaxel|paclitaxel|mesh-list
153631040|NCT00006120|Docetaxel|docetaxel|mesh-list
153631041|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631042|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631043|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631044|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631045|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631046|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631047|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
153631048|NCT00006123|Thiotepa|thiotepa|mesh-list
153631049|NCT00006123|Carmustine|carmustine|mesh-list
153631050|NCT00006123|Carboplatin|carboplatin|mesh-list
153631051|NCT00006123|Trastuzumab|trastuzumab|mesh-list
153631052|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631053|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
153631054|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631055|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631056|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153998726|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998727|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998729|NCT00573937|Methadone|methadone|mesh-list
153998730|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153998731|NCT00573937|Narcotics|narcotics|mesh-ancestor
153998732|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153998733|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998734|NCT00573937|Analgesics|analgesics|mesh-ancestor
153998735|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
153998736|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998737|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
153998738|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
153998739|NCT00845533|Piperaquine|piperaquine|mesh-list
153998740|NCT00845533|Artenimol|artenimol|mesh-list
153998741|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
153998742|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153998743|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153998744|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998745|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153998746|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153998747|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153998748|NCT04958538|Methotrexate|methotrexate|mesh-list
153998749|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153998750|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
153998751|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153998752|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998753|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998754|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
153998755|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631057|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
153631058|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631097|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153631132|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631134|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
153631145|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631146|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631147|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153631148|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153631149|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153631150|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153631151|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153998756|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998757|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
153998758|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998759|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153998760|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998761|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
153998762|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998763|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153998765|NCT02548195|Capecitabine|capecitabine|mesh-list
153998766|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
153998767|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998768|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
153998769|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998770|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998771|NCT00573859|Methylphenidate|methylphenidate|mesh-list
153998772|NCT00573859|Amphetamine|amphetamine|mesh-list
153998773|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153998774|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
153998775|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153998776|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153998777|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998778|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153998779|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153998780|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153998782|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
153757513|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153998804|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998806|NCT00839683|Valsartan|valsartan|mesh-list
153998807|NCT00839683|Simvastatin|simvastatin|mesh-list
153998808|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153998809|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153998810|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
153998811|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998812|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153998813|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153998814|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998815|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153998816|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153998817|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998818|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153756391|NCT00198354|Paclitaxel|paclitaxel|mesh-list
153998819|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153998820|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153998822|NCT00839761|Trace Elements|trace elements|mesh-ancestor
153998823|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
153998824|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998825|NCT02825394|Ecarin|ecarin|mesh-list
153998826|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153998827|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153998828|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998829|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153998830|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153998831|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
153998832|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998833|NCT00845689|Adenosine|adenosine|mesh-list
153998834|NCT00845689|Analgesics|analgesics|mesh-ancestor
153998835|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
153998836|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153998837|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998838|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153998839|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
153998840|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153631153|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
153998841|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
153998842|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
153998843|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998844|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998845|NCT05660694|Vitamin E|vitamin e|mesh-list
153998846|NCT05660694|Triamcinolone|triamcinolone|mesh-list
153998847|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
153998848|NCT05660694|Vitamins|vitamins|mesh-ancestor
153998849|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
153998850|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998851|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998852|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
153998853|NCT05660694|Hormones|hormones|mesh-ancestor
153998854|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998855|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998856|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998857|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
153998858|NCT05660694|Protective Agents|protective agents|mesh-ancestor
153998859|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153631154|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
153631155|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153631156|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153631157|NCT00006195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153631158|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153631159|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153631160|NCT00006198|Thalidomide|thalidomide|mesh-list
153631161|NCT00006198|Doxorubicin|doxorubicin|mesh-list
153631162|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631163|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631164|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631165|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631166|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631167|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631168|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631169|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
153631170|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631171|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
153631172|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153631173|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631174|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153631175|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153631176|NCT00006198|Growth Substances|growth substances|mesh-ancestor
153631177|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
153631178|NCT00006204|Naltrexone|naltrexone|mesh-list
153631179|NCT00006204|Fluoxetine|fluoxetine|mesh-list
153631180|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153631181|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153631182|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631183|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
153631184|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153631185|NCT00006204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153631186|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153631187|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153631188|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631189|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153998860|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153998861|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153998862|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
153998863|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153998864|NCT02824614|Erythritol|erythritol|mesh-list
153998865|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
153998866|NCT00840229|Triamcinolone|triamcinolone|mesh-list
153998867|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153998868|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153998869|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153998870|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153998871|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
153998872|NCT00840229|Hormones|hormones|mesh-ancestor
153998873|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153998874|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998875|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998876|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
153998877|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998878|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998879|NCT00831441|Apixaban|apixaban|mesh-list
153998880|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153998881|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
153998882|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153998883|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
153998884|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998885|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998886|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
153998887|NCT00840385|Vidarabine|vidarabine|mesh-list
153998888|NCT00840385|Fludarabine|fludarabine|mesh-list
153998889|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
153998890|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998891|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998892|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
153998893|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756465|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998894|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998899|NCT02824458|Apatinib|apatinib|mesh-list
153998900|NCT02824458|Gefitinib|gefitinib|mesh-list
153998901|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998902|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153998903|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998904|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998905|NCT02824458|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153998906|NCT00840931|Lenalidomide|lenalidomide|mesh-list
153998907|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
153998908|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998909|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153998910|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153998911|NCT00840931|Growth Substances|growth substances|mesh-ancestor
153998912|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
153998913|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998914|NCT05659992|Cytarabine|cytarabine|mesh-list
153998915|NCT05659992|Azacitidine|azacitidine|mesh-list
153998916|NCT05659992|Venetoclax|venetoclax|mesh-list
153998917|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998918|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
153757749|NCT00175838|Aspirin|aspirin|mesh-list
153998919|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998920|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998921|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
153998922|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998923|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153998924|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
153998925|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153998926|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998927|NCT00834379|Pravastatin|pravastatin|mesh-list
153998928|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153998944|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998945|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998946|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153998947|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153998948|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
153998949|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998950|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153998951|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153998952|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
153998953|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153998954|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153998955|NCT03851965|Plasminogen|plasminogen|mesh-list
153998956|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153998957|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153998958|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998959|NCT02611635|Warfarin|warfarin|mesh-list
153998960|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
153998961|NCT02611635|Dabigatran|dabigatran|mesh-list
153998962|NCT02611635|Apixaban|apixaban|mesh-list
153998963|NCT02611635|Edoxaban|edoxaban|mesh-list
153998964|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
153998965|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153998966|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
153998967|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153998968|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
153998969|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153998970|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998971|NCT02824926|Ketoconazole|ketoconazole|mesh-list
153998972|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
153998973|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153998988|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153998989|NCT00705549|Cisplatin|cisplatin|mesh-list
153998990|NCT00705549|Gemcitabine|gemcitabine|mesh-list
153998991|NCT00705549|Docetaxel|docetaxel|mesh-list
153998992|NCT00705549|Vinorelbine|vinorelbine|mesh-list
153998993|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153998994|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153998995|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
153998996|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153998997|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
153998998|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
153998999|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999000|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153999001|NCT02824770|Tramadol|tramadol|mesh-list
153999002|NCT02824770|Bupivacaine|bupivacaine|mesh-list
153999003|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999004|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
153999005|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999006|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999007|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
153999008|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999009|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153999010|NCT02824770|Narcotics|narcotics|mesh-ancestor
153999011|NCT02824770|Analgesics|analgesics|mesh-ancestor
153999012|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153999013|NCT02824536|Antibodies|antibodies|mesh-list
153999014|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
153571103|NCT04989621|Rituximab|rituximab|mesh-list
153631190|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
153631191|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153631192|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
153631193|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153631194|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153631195|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153631196|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631211|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153631212|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153631213|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153631214|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
153631215|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631216|NCT00387582|Ranibizumab|ranibizumab|mesh-list
153631217|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153631218|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153631219|NCT00387582|Growth Substances|growth substances|mesh-ancestor
153631220|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631221|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
153631222|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631223|NCT00006228|Aldesleukin|aldesleukin|mesh-list
153631224|NCT00006228|Trastuzumab|trastuzumab|mesh-list
153999015|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153999016|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
153999017|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999018|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999019|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
153999020|NCT00831129|Simvastatin|simvastatin|mesh-list
153999021|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153999022|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153999023|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
153999024|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999025|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153730478|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154176541|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
153999026|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153999027|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999028|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153999029|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999031|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153999032|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
153999033|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999034|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153999035|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999036|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
153999037|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999038|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
153999039|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153999040|NCT00637962|Protective Agents|protective agents|mesh-ancestor
153999041|NCT00913341|Alprazolam|alprazolam|mesh-list
153999042|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999043|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999044|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631225|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631226|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631227|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153631228|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153631229|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
153631230|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631231|NCT00006240|Dexamethasone|dexamethasone|mesh-list
153631232|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153631233|NCT00006240|Sargramostim|sargramostim|mesh-list
153631234|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153631235|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
153631236|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
153631237|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999046|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153999047|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153999048|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
153999049|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
153999050|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999051|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999052|NCT00620113|Vitamin D|vitamin d|mesh-list
153999053|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
153999054|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
153999055|NCT00620113|Calcium|calcium|mesh-list
153999056|NCT00620113|Vitamins|vitamins|mesh-ancestor
153999057|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
153999058|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999059|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153999060|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153999061|NCT00620113|Antacids|antacids|mesh-ancestor
153999062|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999063|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999064|NCT00830115|Pantoprazole|pantoprazole|mesh-list
153999065|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153999066|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999067|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153999068|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999069|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999070|NCT00633672|Esomeprazole|esomeprazole|mesh-list
153999071|NCT00633672|Ranitidine|ranitidine|mesh-list
153999072|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153999073|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153631238|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631239|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153631240|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
153631241|NCT00006240|Hormones|hormones|mesh-ancestor
153631242|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631243|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153631244|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631245|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
153631246|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
153631247|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153631248|NCT02972463|Antibodies|antibodies|mesh-list
153631249|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
153631250|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631251|NCT00006243|Sargramostim|sargramostim|mesh-list
153631252|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
153631253|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
153631254|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631255|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153999074|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999075|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153999076|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999077|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999078|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153999079|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
153999080|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
153999081|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999082|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999083|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
153999084|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153999086|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153999087|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999088|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
153999089|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999090|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153999091|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153999092|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999093|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999094|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153999095|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153999096|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999097|NCT02822586|Immunotoxins|immunotoxins|mesh-ancestor
153999098|NCT02822586|Immunoconjugates|immunoconjugates|mesh-ancestor
153999099|NCT02822586|Immunologic Factors|immunologic factors|mesh-ancestor
153999100|NCT02822586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999101|NCT00848809|Vancomycin|vancomycin|mesh-list
153758014|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
153999103|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999104|NCT00834847|Pravastatin|pravastatin|mesh-list
153631256|NCT00006246|Busulfan|busulfan|mesh-list
153631257|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
153631275|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631276|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
153631277|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631278|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631279|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631280|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
153631281|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631282|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631283|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631284|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631285|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
153631286|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
153631287|NCT00006258|Methotrexate|methotrexate|mesh-list
153631288|NCT00006258|Etoposide|etoposide|mesh-list
153999105|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153999106|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153999107|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
153999108|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999109|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153999110|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153999111|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999112|NCT00841477|Vaccines|vaccines|mesh-list
153999113|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
153999114|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999115|NCT00834925|Diltiazem|diltiazem|mesh-list
153999116|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153999117|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153999118|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999119|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999120|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153999121|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999122|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
153999123|NCT00841633|Norepinephrine|norepinephrine|mesh-list
153999124|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153999125|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153999126|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
153999127|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999128|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999129|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999130|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
153999131|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
153999132|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999133|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153999134|NCT02823912|Capsaicin|capsaicin|mesh-list
153999135|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
153999136|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
153571219|NCT04672772|Paclitaxel|paclitaxel|mesh-list
153631289|NCT00006258|Vincristine|vincristine|mesh-list
153631290|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631291|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
153631292|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631293|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631294|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631295|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
153631296|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999138|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
153999139|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999140|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999141|NCT02823912|Antacids|antacids|mesh-ancestor
153999142|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999143|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999144|NCT00841945|Prednisone|prednisone|mesh-list
153999145|NCT00841945|Rituximab|rituximab|mesh-list
153999146|NCT00841945|Doxorubicin|doxorubicin|mesh-list
153999147|NCT00841945|Vincristine|vincristine|mesh-list
153999148|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153999149|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999150|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
153999151|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999152|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999153|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153999154|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153999155|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153999156|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999157|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999158|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999159|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
153999160|NCT00841945|Hormones|hormones|mesh-ancestor
153999161|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153999162|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153999163|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153999164|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
153999165|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
153999166|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999167|NCT02822196|Lidocaine|lidocaine|mesh-list
153999168|NCT02822196|Bupivacaine|bupivacaine|mesh-list
153999169|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999170|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
153631297|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631298|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631299|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153631300|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
153631301|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153631302|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631303|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
153631304|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999171|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999172|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999173|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
153999174|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999175|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153999176|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153999177|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153999178|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999179|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999180|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
153999181|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153999182|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999184|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153999185|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153999186|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
153999187|NCT00849355|Rituximab|rituximab|mesh-list
153999188|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153999189|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999190|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
153999191|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999192|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999193|NCT00835393|Pantoprazole|pantoprazole|mesh-list
153999194|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153999195|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999196|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153999197|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999198|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631305|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631306|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153631307|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631308|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631309|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631310|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631311|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631312|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631313|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631314|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
153631315|NCT00006261|Docetaxel|docetaxel|mesh-list
153631343|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631344|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153631345|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631346|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631347|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
153999199|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
153999200|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999201|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153999202|NCT02822742|Latanoprost|latanoprost|mesh-list
153999203|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153999204|NCT00835471|Docetaxel|docetaxel|mesh-list
153999205|NCT00835471|Pemetrexed|pemetrexed|mesh-list
153999206|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153999207|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999208|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
153999209|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
153999210|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999211|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999212|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999213|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153999214|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153571313|NCT04464577|Itraconazole|itraconazole|mesh-list
153631348|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631349|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153631350|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153631351|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631352|NCT00006267|Rubitecan|rubitecan|mesh-list
153631353|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631354|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153631355|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631356|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631357|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631358|NCT00006270|Cosyntropin|cosyntropin|mesh-list
153631359|NCT00006270|Metyrapone|metyrapone|mesh-list
153631360|NCT00006270|Hormones|hormones|mesh-ancestor
153631361|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631362|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631363|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
153631364|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631375|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631376|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631377|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631378|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
153631379|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631380|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153631381|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153631382|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153631383|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153631384|NCT00006291|Aldesleukin|aldesleukin|mesh-list
153631385|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631386|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153631387|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153631388|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
153631389|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631390|NCT00006294|Amlodipine|amlodipine|mesh-list
153631391|NCT00006294|Lisinopril|lisinopril|mesh-list
153631392|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
153631393|NCT00006294|Doxazosin|doxazosin|mesh-list
153631394|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153631395|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153631396|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153631397|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631398|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153631399|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999215|NCT00835471|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153999216|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153999217|NCT00849511|Melatonin|melatonin|mesh-list
153999218|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
153999219|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999220|NCT00849511|Protective Agents|protective agents|mesh-ancestor
153999221|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999222|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999223|NCT02546791|Dasatinib|dasatinib|mesh-list
153999224|NCT02546791|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153999225|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153999226|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999227|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999228|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999229|NCT00966875|Ixekizumab|ixekizumab|mesh-list
153999230|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999231|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
153999232|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153999233|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999234|NCT00835627|Sertraline|sertraline|mesh-list
153999235|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
153999236|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153999237|NCT00835627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153999238|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153999239|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999240|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999241|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999242|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
153999243|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631400|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
153631401|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153631402|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
153631403|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631404|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153631405|NCT00006294|Protective Agents|protective agents|mesh-ancestor
153631406|NCT00006294|Diuretics|diuretics|mesh-ancestor
153631407|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
153631408|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153631409|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153631410|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153631411|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153631412|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
153631413|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153631414|NCT00005818|Irinotecan|irinotecan|mesh-list
153999244|NCT00842491|Cisplatin|cisplatin|mesh-list
153999245|NCT00842491|Capecitabine|capecitabine|mesh-list
153999246|NCT00842491|Endostar protein|endostar protein|mesh-list
153999247|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999248|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153999249|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
153999250|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999251|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153999252|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153999253|NCT00842491|Growth Substances|growth substances|mesh-ancestor
153999254|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999255|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
153999256|NCT05659212|Lidocaine|lidocaine|mesh-list
153999257|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
153999258|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
153999259|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999260|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
153999261|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999262|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999263|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
153999264|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999265|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153999266|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153999267|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153999268|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999269|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999270|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999271|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153999272|NCT05659212|Analgesics|analgesics|mesh-ancestor
153999289|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999290|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153999291|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153999292|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153999293|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999294|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999296|NCT00818649|Vorinostat|vorinostat|mesh-list
153999297|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999298|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153999299|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999300|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999301|NCT02861105|Enoxaparin|enoxaparin|mesh-list
153999302|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153999303|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
153999304|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153999305|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153999306|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999307|NCT02820558|Substance P|substance p|mesh-list
153999308|NCT02820558|Neurokinin A|neurokinin a|mesh-list
153999309|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999310|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999311|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999312|NCT00961571|Capecitabine|capecitabine|mesh-list
153999313|NCT00961571|Sunitinib|sunitinib|mesh-list
153999314|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153999315|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
153999316|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999317|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999318|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153999319|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153999331|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999332|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
153999333|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999334|NCT02820948|Protective Agents|protective agents|mesh-ancestor
153999335|NCT02860949|Ketorolac|ketorolac|mesh-list
153999336|NCT02860949|Epinephrine|epinephrine|mesh-list
153999337|NCT02860949|Morphine|morphine|mesh-list
153999338|NCT02860949|Bupivacaine|bupivacaine|mesh-list
153999339|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999340|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
153999341|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999342|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999343|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
153999344|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999345|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153999394|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
153999395|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153999396|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999397|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
153999398|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
153999399|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999400|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999401|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153999402|NCT04238988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153999403|NCT04284215|Paclitaxel|paclitaxel|mesh-list
153999404|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153999405|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153999406|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999407|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
153999408|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
153999409|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999410|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999411|NCT02816970|Vildagliptin|vildagliptin|mesh-list
153999412|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153999413|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999414|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153999415|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
153999416|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999417|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999418|NCT03372941|Dalbavancin|dalbavancin|mesh-list
153999419|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571552|NCT05802290|Nivolumab|nivolumab|mesh-list
153571553|NCT05802290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571554|NCT05802290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571555|NCT05802290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153999439|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153999440|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153999441|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153999442|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153595582|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153758493|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
153999443|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999444|NCT04622904|Analgesics|analgesics|mesh-ancestor
153999445|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153999446|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153999447|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
153999448|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153999449|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153999450|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999451|NCT00634062|Lamotrigine|lamotrigine|mesh-list
153999452|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
153999453|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153999454|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999455|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999456|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153999457|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999458|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153999459|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153999460|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999461|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153999462|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153999463|NCT00634140|Ezetimibe|ezetimibe|mesh-list
153999464|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153999465|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153999466|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
153999467|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999468|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153999469|NCT02819544|Ropivacaine|ropivacaine|mesh-list
153999471|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
153999472|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999473|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999474|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
153999475|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999476|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
153999477|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153999478|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999480|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999482|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999483|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999484|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
153999485|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999486|NCT04238208|Lidocaine|lidocaine|mesh-list
153999487|NCT04238208|Capsaicin|capsaicin|mesh-list
153999488|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999489|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
153999490|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999491|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999492|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
153999493|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999494|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153999495|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153999496|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153999497|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999498|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999499|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
153999500|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999501|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
153999502|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153631415|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153631416|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631417|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631418|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631419|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631420|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153631421|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
153631422|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153631423|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
153631424|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153631425|NCT00006324|Estradiol|estradiol|mesh-list
153631426|NCT00006324|Estrogens|estrogens|mesh-ancestor
153999503|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999504|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153999505|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153999507|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999508|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999509|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153999510|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153999511|NCT02815722|Simvastatin|simvastatin|mesh-list
153999512|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153999513|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153999514|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
153999515|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999516|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153999517|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153999518|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999519|NCT02817750|Zolpidem|zolpidem|mesh-list
153999520|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153999521|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999522|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999523|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999524|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153999525|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
153999526|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
153999527|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999528|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999529|NCT02815410|Levetiracetam|levetiracetam|mesh-list
153999530|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
153999531|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
153999532|NCT02814630|Omalizumab|omalizumab|mesh-list
153999533|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153631427|NCT00006324|Hormones|hormones|mesh-ancestor
153631428|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631443|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631444|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
153631445|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631446|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631447|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631448|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
153631449|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631450|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999535|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
153999537|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153999538|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999539|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999540|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153999541|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999542|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153999543|NCT00961415|Bevacizumab|bevacizumab|mesh-list
153999544|NCT00961415|Pemetrexed|pemetrexed|mesh-list
153999545|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153999546|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999547|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153999548|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153999549|NCT00961415|Growth Substances|growth substances|mesh-ancestor
153999550|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999551|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
153999552|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999553|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999554|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153999555|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153999556|NCT00851227|Conivaptan|conivaptan|mesh-list
153999557|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153571643|NCT05800847|Gabapentin|gabapentin|mesh-list
153631451|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631453|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153631454|NCT00005827|Protective Agents|protective agents|mesh-ancestor
153631455|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631456|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631457|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153631458|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631459|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631460|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
153631461|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153631462|NCT00005827|Estrogens|estrogens|mesh-ancestor
153631463|NCT00005827|Hormones|hormones|mesh-ancestor
153631464|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631466|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153631467|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631468|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631469|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631470|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631471|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631472|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631473|NCT00005833|Tipifarnib|tipifarnib|mesh-list
153999558|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999559|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
153999560|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999562|NCT00963599|Montelukast|montelukast|mesh-list
153999563|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153999564|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
153999565|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153999566|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
153999567|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153999568|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999569|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153999570|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153999571|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999572|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
153999573|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999574|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153999575|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153999576|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153999577|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
153999578|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
153999579|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999580|NCT00851461|Goserelin|goserelin|mesh-list
153999583|NCT04205136|Spironolactone|spironolactone|mesh-list
153999606|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999607|NCT00619801|Levocetirizine|levocetirizine|mesh-list
153999608|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153999609|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153999610|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
153999611|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
153999612|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999613|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999614|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999615|NCT02545777|Diclofenac|diclofenac|mesh-list
153999616|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153999617|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153999618|NCT02545777|Analgesics|analgesics|mesh-ancestor
153999619|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
153999620|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999621|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999622|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999623|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999624|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153999625|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999626|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999627|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153999628|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153999629|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999631|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153999632|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153999633|NCT00962741|Analgesics|analgesics|mesh-ancestor
153999634|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
153999635|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999636|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999637|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999638|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999639|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999640|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153571744|NCT05756504|Ketorolac|ketorolac|mesh-list
153631474|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631476|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631477|NCT00006330|Digoxin|digoxin|mesh-list
153999641|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
153999642|NCT00851773|Semaglutide|semaglutide|mesh-list
153999643|NCT00851773|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153999644|NCT00851773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153999645|NCT00851773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999646|NCT00851929|Ambrisentan|ambrisentan|mesh-list
153999647|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153999648|NCT02813382|Bupivacaine|bupivacaine|mesh-list
153999649|NCT02813382|Prilocaine|prilocaine|mesh-list
153999650|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
153999651|NCT02813382|Procaine|procaine|mesh-list
153999652|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999653|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
153999654|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999655|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999656|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
153999657|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999658|NCT00619645|Cyclosporine|cyclosporine|mesh-list
153999659|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
153999660|NCT00619645|Fludarabine|fludarabine|mesh-list
153999661|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
153999662|NCT00619645|Busulfan|busulfan|mesh-list
153999663|NCT00619645|Cyclosporins|cyclosporins|mesh-list
153999664|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999665|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153999666|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
153999667|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999668|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153999669|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
153999670|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999671|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631478|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153631479|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153631480|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631481|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631482|NCT00006330|Protective Agents|protective agents|mesh-ancestor
153631483|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631484|NCT00005839|Capecitabine|capecitabine|mesh-list
153631485|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
153631486|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631487|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
153631514|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631515|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153631516|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631517|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153631518|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
153999673|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153999674|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999675|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999676|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153999677|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153999678|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153999679|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
153999680|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153999681|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
153999682|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153999683|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153999684|NCT00852163|Busulfan|busulfan|mesh-list
153999685|NCT00852163|Clofarabine|clofarabine|mesh-list
153999686|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
153999687|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999688|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153999689|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
153999690|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999691|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153999692|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999693|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153999694|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631519|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153631521|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
153631522|NCT00005854|Methotrexate|methotrexate|mesh-list
153631523|NCT00005854|Cyclosporins|cyclosporins|mesh-list
153631524|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631525|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
153631526|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631527|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631528|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631529|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
153631530|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631531|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631532|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631533|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153631534|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
153631535|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153631536|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631576|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631577|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
153631590|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
153631591|NCT00005866|Cyclosporine|cyclosporine|mesh-list
153631592|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
153631593|NCT00005866|Busulfan|busulfan|mesh-list
153631594|NCT00005866|Methotrexate|methotrexate|mesh-list
153631595|NCT00005866|Cyclosporins|cyclosporins|mesh-list
153631596|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631597|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
153631598|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631599|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153999696|NCT00855517|Latanoprost|latanoprost|mesh-list
153999697|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153999698|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153999699|NCT02544919|SMOFlipid|smoflipid|mesh-list
153999700|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153999701|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153999702|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153999703|NCT00818259|Dexamethasone|dexamethasone|mesh-list
153999704|NCT00818259|Ondansetron|ondansetron|mesh-list
153999705|NCT00818259|Aprepitant|aprepitant|mesh-list
153999706|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
153999707|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999708|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
153999709|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
153999710|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999711|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999712|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999713|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
153999714|NCT00818259|Hormones|hormones|mesh-ancestor
153999715|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153999716|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153999717|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999718|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
153999719|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999720|NCT00818259|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153999721|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153999722|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
153999723|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999724|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999725|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153999726|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
153999727|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
153999728|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999729|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999737|NCT02809404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999738|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153999739|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
153999740|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999741|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999743|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153999744|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
153999745|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999746|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999747|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999748|NCT02812992|Paclitaxel|paclitaxel|mesh-list
153999749|NCT02812992|Gemcitabine|gemcitabine|mesh-list
153999750|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153758810|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999751|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999752|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153999753|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153999754|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999755|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999756|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153999757|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
153999758|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153999759|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153999760|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153999761|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999762|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999763|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
153999764|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999765|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999766|NCT02812602|Lidocaine|lidocaine|mesh-list
153999767|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999768|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
153999769|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153631600|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631601|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
153631602|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631603|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631604|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631605|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153999770|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999771|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
153999772|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999773|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153999774|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153999775|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153999776|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153999777|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999778|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
153999779|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999780|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999781|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999782|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153999783|NCT00837187|Analgesics|analgesics|mesh-ancestor
153999784|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
153999785|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999786|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153999787|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153999788|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153999789|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
153999790|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999791|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999792|NCT00962585|Equol|equol|mesh-list
153999793|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
153999794|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153999795|NCT00962585|Estrogens|estrogens|mesh-ancestor
153999796|NCT00962585|Hormones|hormones|mesh-ancestor
153999797|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631606|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
153631607|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153631608|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631609|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
153631610|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
153631611|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631612|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153631613|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631614|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
153631615|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631616|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153631617|NCT00005869|Gemcitabine|gemcitabine|mesh-list
153631618|NCT00005869|Rubitecan|rubitecan|mesh-list
153631619|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631620|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
153999798|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999800|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
153999801|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999802|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
153999803|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
153999804|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999805|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999806|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999807|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
153999808|NCT00621985|Hormones|hormones|mesh-ancestor
153999809|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153999810|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153999811|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999812|NCT02812368|Clonidine|clonidine|mesh-list
153999813|NCT02812368|Analgesics|analgesics|mesh-ancestor
153999814|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
153999815|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999816|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999817|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153999818|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
153999819|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
153999820|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153999821|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153999822|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153999823|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
153999824|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999825|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999826|NCT03312257|Atropine|atropine|mesh-list
153999827|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153999828|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153999829|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153999830|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
153999831|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999833|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153999837|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153999838|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153999839|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
153999840|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999841|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999842|NCT00856687|Montelukast|montelukast|mesh-list
153999843|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153999844|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
153999845|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153999846|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
153999847|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153999848|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999849|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153999850|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153999851|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999852|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153999853|NCT02862665|Hematinics|hematinics|mesh-ancestor
153999855|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999856|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999857|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999858|NCT04285073|Paclitaxel|paclitaxel|mesh-list
153999859|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153999860|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999861|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
153999862|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
153999863|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999864|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999865|NCT00861445|Lacosamide|lacosamide|mesh-list
153999866|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
153999871|NCT04284059|Vitamin D|vitamin d|mesh-list
153999872|NCT04284059|Vitamins|vitamins|mesh-list
153999884|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999885|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999886|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153999887|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153999888|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
153999889|NCT00861523|Thiamine|thiamine|mesh-list
153999890|NCT00861523|Promethazine|promethazine|mesh-list
153999891|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
153999892|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
153999893|NCT00861523|Vitamins|vitamins|mesh-ancestor
153999894|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
153999895|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999896|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
153999897|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
153999898|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153999899|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
153999900|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
153999901|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999902|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999903|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153999904|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153999905|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999906|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999907|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
153999908|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
153999909|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
153571995|NCT04042051|Immunoconjugates|immunoconjugates|mesh-ancestor
153631621|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631622|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631623|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153631624|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631625|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631626|NCT00005872|Rubitecan|rubitecan|mesh-list
153631627|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631628|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153631629|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631630|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631631|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631632|NCT00005875|Rubitecan|rubitecan|mesh-list
153631633|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631634|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153631635|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631636|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631637|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631638|NCT00005878|Celecoxib|celecoxib|mesh-list
153631648|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153999910|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999911|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
153999912|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
153999913|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999914|NCT02811978|Dexamethasone|dexamethasone|mesh-list
153999915|NCT02811978|Bortezomib|bortezomib|mesh-list
153999916|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153999917|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
153999918|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
153999919|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999920|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999921|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153999922|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
153999923|NCT02811978|Hormones|hormones|mesh-ancestor
153999924|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153999925|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653675|NCT00038974|Ribavirin|ribavirin|mesh-list
153999926|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999927|NCT00630149|Pemetrexed|pemetrexed|mesh-list
153999928|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999929|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999930|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999931|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153999932|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153999933|NCT04204577|Apatinib|apatinib|mesh-list
153999934|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153999935|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153999936|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153999937|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999954|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153999955|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
153999956|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153999957|NCT04283747|Antibodies|antibodies|mesh-list
153999958|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
153999959|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999960|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
153999961|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153999962|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153999963|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153999964|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153999965|NCT04111926|Analgesics|analgesics|mesh-ancestor
153999966|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
153999967|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153999968|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153999969|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153999970|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153999971|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
153999972|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153999973|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999974|NCT04041349|Mitogens|mitogens|mesh-list
153999975|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
153999976|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153999977|NCT00961181|Paclitaxel|paclitaxel|mesh-list
153999979|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000004|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154000005|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154000006|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154000007|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154000008|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
154000009|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000010|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000011|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000012|NCT00817635|Eplerenone|eplerenone|mesh-list
154000013|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154000014|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
154000015|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000016|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000017|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154000018|NCT00817635|Diuretics|diuretics|mesh-ancestor
154000019|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
154000020|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154000021|NCT00853177|Lidocaine|lidocaine|mesh-list
154000022|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
154000023|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
154000024|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000025|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000026|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
154000027|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000051|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154000052|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000053|NCT00853411|Prednisone|prednisone|mesh-list
154000054|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000055|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
154000056|NCT00853411|Hormones|hormones|mesh-ancestor
154000057|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000058|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000059|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154000060|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000061|NCT04030533|Ustekinumab|ustekinumab|mesh-list
154000062|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154000063|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
154000064|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
154000065|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000066|NCT02807298|Lidocaine|lidocaine|mesh-list
154000067|NCT02807298|Epinephrine|epinephrine|mesh-list
154000068|NCT02807298|Carticaine|carticaine|mesh-list
154000069|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154000070|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154000071|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154000072|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000073|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000074|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000075|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154000076|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154000077|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
154000078|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000099|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
154000100|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
154000101|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
154000102|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000103|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000104|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
154000105|NCT00961961|Fluoxetine|fluoxetine|mesh-list
154000106|NCT00961961|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154000107|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154000108|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154000109|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000110|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000111|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
154000112|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000113|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154000114|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
154000115|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154000116|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154000117|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154000118|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000119|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
154000120|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154000121|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000122|NCT02610933|Vitamin K|vitamin k|mesh-list
154000123|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
154000124|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
154000125|NCT02610933|Vitamins|vitamins|mesh-ancestor
154000126|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
154000127|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000128|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154000129|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
153631650|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631651|NCT00005884|Eflornithine|eflornithine|mesh-list
153631652|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631653|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153631654|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153631655|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153631656|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631657|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153631658|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000130|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154000131|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
154000132|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000133|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000134|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
154000135|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154000136|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154000137|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
154000138|NCT02610933|Coagulants|coagulants|mesh-ancestor
154000139|NCT04042441|Insulin|insulin|mesh-list
154000140|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
154000141|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154000142|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000143|NCT00817089|Naltrexone|naltrexone|mesh-list
154000144|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154000145|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154000146|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000147|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
154000148|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000149|NCT00857779|Immunomodulating Agents|immunomodulating agents|mesh-list
154000150|NCT00857779|Immunologic Factors|immunologic factors|mesh-ancestor
154000151|NCT00857779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000152|NCT00857935|Permethrin|permethrin|mesh-list
154000155|NCT00853879|Vitamins|vitamins|mesh-list
154000185|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154000186|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000187|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154000188|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154000189|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000190|NCT00854035|Incretins|incretins|mesh-ancestor
154000192|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000193|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154000194|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
154000195|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000196|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000197|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
154000198|NCT00957905|Leucovorin|leucovorin|mesh-list
154000199|NCT00957905|Folic Acid|folic acid|mesh-list
154000200|NCT00957905|Fluorouracil|fluorouracil|mesh-list
154000201|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
154000202|NCT00957905|Alvocidib|alvocidib|mesh-list
154000203|NCT00957905|Calcium|calcium|mesh-list
154000204|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
154000205|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154000206|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000207|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154000208|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
153631659|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631660|NCT00005887|Efaproxiral|efaproxiral|mesh-list
153631661|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
153631662|NCT00006339|Ritonavir|ritonavir|mesh-list
153631663|NCT00006339|Indinavir|indinavir|mesh-list
153631664|NCT00006339|Stavudine|stavudine|mesh-list
153631665|NCT00006339|Didanosine|didanosine|mesh-list
153631666|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
153631667|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153631668|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153631669|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
153631670|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631671|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631672|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153631673|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153631674|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
153631675|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631676|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153631677|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153631678|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631679|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
153631680|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631681|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
153631682|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153631683|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153631684|NCT00005890|Hormones|hormones|mesh-ancestor
153631685|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000209|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000210|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154000211|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000212|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154000213|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
154000215|NCT00957905|Protective Agents|protective agents|mesh-ancestor
154000216|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
154000217|NCT00957905|Vitamins|vitamins|mesh-ancestor
154000218|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
154000219|NCT00957905|Hematinics|hematinics|mesh-ancestor
154000220|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
154000221|NCT00957905|Growth Substances|growth substances|mesh-ancestor
154000222|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154000223|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000224|NCT02804646|Carboplatin|carboplatin|mesh-list
154000225|NCT02804646|Pemetrexed|pemetrexed|mesh-list
154000226|NCT02804646|Endostatins|endostatins|mesh-list
154000227|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000228|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000229|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000230|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154000231|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154000232|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154000233|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154000234|NCT02804646|Growth Substances|growth substances|mesh-ancestor
154000235|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000259|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000260|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
154000261|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000262|NCT02804490|Protective Agents|protective agents|mesh-ancestor
154000263|NCT00960323|Colchicine|colchicine|mesh-list
154000264|NCT00960323|Atorvastatin|atorvastatin|mesh-list
154000265|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154000266|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154000267|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
154000268|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000269|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154000270|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154000271|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000272|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
154000273|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000274|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
154000275|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
154000276|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
154000277|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000278|NCT00617929|Rituximab|rituximab|mesh-list
154000279|NCT00617929|Clofarabine|clofarabine|mesh-list
154000280|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
154000281|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154000282|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154000283|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000310|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000311|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000312|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000314|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154000315|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154000316|NCT02806752|Ranibizumab|ranibizumab|mesh-list
154000317|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154000318|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154000319|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154000320|NCT02806752|Growth Substances|growth substances|mesh-ancestor
154000321|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000322|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
154000323|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000324|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000325|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
154000326|NCT02806752|Hormones|hormones|mesh-ancestor
154000327|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000328|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154000329|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
154000330|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000331|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000332|NCT00854425|Asparaginase|asparaginase|mesh-list
154000333|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000334|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154000335|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154000336|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154000337|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
154000338|NCT02544529|Laxatives|laxatives|mesh-ancestor
154000339|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154000340|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153572421|NCT03651102|Thalidomide|thalidomide|mesh-list
153631686|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631687|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
153631688|NCT00005893|Busulfan|busulfan|mesh-list
153631689|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153631690|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631691|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
153631692|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631694|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631695|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
154000342|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000343|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
154000344|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000345|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000346|NCT02544529|Miotics|miotics|mesh-ancestor
154000347|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
154000348|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000349|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154000350|NCT02806596|Sevoflurane|sevoflurane|mesh-list
154000351|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154000352|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154000353|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
154000354|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
154000355|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000356|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000357|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154000358|NCT00854503|Simvastatin|simvastatin|mesh-list
154000359|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154000360|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154000361|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
153760280|NCT00408551|Vitamins|vitamins|mesh-ancestor
154000362|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000363|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153572457|NCT03569475|Milnacipran|milnacipran|mesh-list
153631696|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631697|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631698|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631699|NCT00005896|Lenograstim|lenograstim|mesh-list
153631700|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153631701|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
153631702|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631703|NCT00386503|Artesunate|artesunate|mesh-list
153631721|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631722|NCT00006345|Dexamethasone|dexamethasone|mesh-list
153631723|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
153631724|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153631725|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
153631726|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
153631727|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153631728|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631729|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153631731|NCT00006345|Hormones|hormones|mesh-ancestor
153631732|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631733|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153631734|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631735|NCT00005920|Caspofungin|caspofungin|mesh-list
153631736|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
153631737|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631738|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631739|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000364|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154000365|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000366|NCT00858715|Aspirin|aspirin|mesh-list
154000367|NCT00858715|Clopidogrel|clopidogrel|mesh-list
154000368|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154000369|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154000370|NCT00858715|Analgesics|analgesics|mesh-ancestor
154000371|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
154000372|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000373|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000374|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000375|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000376|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154000377|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154000378|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176542|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
154000379|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154000380|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154000381|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000383|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154000384|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154000385|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154000386|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
154000387|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000388|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154000389|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
154000390|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000391|NCT00960869|Aspirin|aspirin|mesh-list
153572478|NCT03546556|Alovudine|alovudine|mesh-list
153631740|NCT00005926|Gemcitabine|gemcitabine|mesh-list
153631741|NCT00005926|Trastuzumab|trastuzumab|mesh-list
153631742|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631743|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
153631744|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631745|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631746|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631747|NCT00005935|Cyclosporine|cyclosporine|mesh-list
153631748|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
153631749|NCT00005935|Cyclosporins|cyclosporins|mesh-list
153631750|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631751|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631752|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631753|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
154000392|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154000393|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154000394|NCT00960869|Analgesics|analgesics|mesh-ancestor
154000395|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
154000396|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000397|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000398|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000399|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000400|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154000401|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154000402|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000403|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154000404|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154000405|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000406|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
154000407|NCT02799888|Cyclosporine|cyclosporine|mesh-list
154000408|NCT02799888|Maraviroc|maraviroc|mesh-list
154000409|NCT02799888|Methotrexate|methotrexate|mesh-list
154000410|NCT02799888|Tacrolimus|tacrolimus|mesh-list
154000411|NCT02799888|Cyclosporins|cyclosporins|mesh-list
154000412|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154000413|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
154000414|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154000415|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000416|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154000417|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
154000418|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000419|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000420|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
154000421|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000422|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154000423|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154000434|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
154000435|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154000436|NCT00859105|Imiquimod|imiquimod|mesh-list
154000437|NCT00859105|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154000438|NCT00859105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000439|NCT00859105|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154000440|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
154000441|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000442|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154000443|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000444|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
154000445|NCT00859183|Sirolimus|sirolimus|mesh-list
154000446|NCT00859183|Temsirolimus|temsirolimus|mesh-list
154000447|NCT00859183|MTOR Inhibitors|mtor inhibitors|mesh-list
154000448|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154000449|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000450|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154000451|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000452|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
154000453|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154000455|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000456|NCT00859183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154000457|NCT00859183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000458|NCT00859183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000459|NCT02803944|Azithromycin|azithromycin|mesh-list
154000460|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154000461|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000462|NCT05980260|Analgesics, Opioid|analgesics, opioid|mesh-list
154000463|NCT05980260|Narcotics|narcotics|mesh-ancestor
154000464|NCT05980260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000465|NCT05980260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000466|NCT05980260|Analgesics|analgesics|mesh-ancestor
153758050|NCT00554476|Hormones|hormones|mesh-ancestor
154000467|NCT05980260|Sensory System Agents|sensory system agents|mesh-ancestor
154000477|NCT05980156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154000478|NCT05980156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154000479|NCT05980156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000480|NCT05980156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000481|NCT05980156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000482|NCT05980156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000483|NCT05980156|Amebicides|amebicides|mesh-ancestor
154000484|NCT05980156|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154000485|NCT05980156|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154000486|NCT05979961|Cisplatin|cisplatin|mesh-list
154000487|NCT05979961|Gemcitabine|gemcitabine|mesh-list
154000488|NCT05979961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000489|NCT05979961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154000490|NCT05979961|Antimetabolites|antimetabolites|mesh-ancestor
154000491|NCT05979961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000492|NCT05979909|Mitomycins|mitomycins|mesh-list
154000493|NCT05979909|Mitomycin|mitomycin|mesh-list
154000494|NCT05979909|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154000495|NCT05979909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000496|NCT05979909|Alkylating Agents|alkylating agents|mesh-ancestor
154000497|NCT05979909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000498|NCT05979909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154000499|NCT05979909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000500|NCT05979636|Fluorides|fluorides|mesh-list
154000501|NCT05979636|Cariostatic Agents|cariostatic agents|mesh-ancestor
154000502|NCT05979636|Protective Agents|protective agents|mesh-ancestor
154000503|NCT05979636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000504|NCT05979558|Dexmedetomidine|dexmedetomidine|mesh-list
154000505|NCT05979558|Ropivacaine|ropivacaine|mesh-list
154000506|NCT05979558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153572590|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
153631754|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631755|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
153631756|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631757|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
153631758|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631759|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153631760|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631761|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631797|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
153631798|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631799|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
153631800|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000507|NCT05979558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000508|NCT05979558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000509|NCT05979558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154000510|NCT05979558|Analgesics|analgesics|mesh-ancestor
154000511|NCT05979558|Sensory System Agents|sensory system agents|mesh-ancestor
154000512|NCT05979558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000513|NCT05979558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154000514|NCT05979558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154000515|NCT05979558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154000516|NCT05979558|Adrenergic Agents|adrenergic agents|mesh-ancestor
154000517|NCT05979558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000518|NCT05979558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000519|NCT05979558|Anesthetics, Local|anesthetics, local|mesh-ancestor
154000520|NCT05979558|Anesthetics|anesthetics|mesh-ancestor
154000521|NCT05979324|Coal Tar|coal tar|mesh-list
154000522|NCT05979324|Keratolytic Agents|keratolytic agents|mesh-ancestor
154000523|NCT05979324|Dermatologic Agents|dermatologic agents|mesh-ancestor
154000524|NCT05979298|Gemcitabine|gemcitabine|mesh-list
154000525|NCT05979298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154000526|NCT05979298|Antimetabolites|antimetabolites|mesh-ancestor
154000527|NCT05979298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000528|NCT05979298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000529|NCT05979220|Letrozole|letrozole|mesh-list
154000530|NCT05979220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000531|NCT05979220|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154000532|NCT05979220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154000533|NCT05979220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631815|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631816|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631817|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631818|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631819|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
153631821|NCT00005944|Protective Agents|protective agents|mesh-ancestor
153631822|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
153631823|NCT00005944|Vitamins|vitamins|mesh-ancestor
153631824|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
153631825|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631826|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
153631827|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631828|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631829|NCT00387699|Bevacizumab|bevacizumab|mesh-list
153631830|NCT00387699|Etoposide|etoposide|mesh-list
153631831|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631832|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631833|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153631834|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153631835|NCT00387699|Growth Substances|growth substances|mesh-ancestor
153631836|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000534|NCT05979220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000535|NCT05979220|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154000536|NCT05979220|Hormone Antagonists|hormone antagonists|mesh-ancestor
154000537|NCT05979220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000538|NCT05979220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000539|NCT05978726|Aspirin|aspirin|mesh-list
154000540|NCT05978726|Clopidogrel|clopidogrel|mesh-list
154000541|NCT05978726|Ticagrelor|ticagrelor|mesh-list
154000542|NCT05978726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154000543|NCT05978726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154000544|NCT05978726|Analgesics|analgesics|mesh-ancestor
154000545|NCT05978726|Sensory System Agents|sensory system agents|mesh-ancestor
154000546|NCT05978726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000547|NCT05978726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000548|NCT05978726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000549|NCT05978726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000550|NCT05978726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154000551|NCT05978726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154000552|NCT05978726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000553|NCT05978726|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154000554|NCT05978726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154000555|NCT05978726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000556|NCT05978726|Antipyretics|antipyretics|mesh-ancestor
154000557|NCT05978726|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154000558|NCT05978726|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154000559|NCT05978726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154000560|NCT05978726|Purinergic Agents|purinergic agents|mesh-ancestor
154000561|NCT05978726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000562|NCT05978609|Gemcitabine|gemcitabine|mesh-list
154000567|NCT05978505|Reboxetine|reboxetine|mesh-list
154000576|NCT05978505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000578|NCT05978401|Carboplatin|carboplatin|mesh-list
154000579|NCT05978401|Pemetrexed|pemetrexed|mesh-list
154000580|NCT05978401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154000581|NCT05978401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000582|NCT05978401|Tubulin Modulators|tubulin modulators|mesh-ancestor
154000583|NCT05978401|Antimitotic Agents|antimitotic agents|mesh-ancestor
154000584|NCT05978401|Mitosis Modulators|mitosis modulators|mesh-ancestor
154000585|NCT05978401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000586|NCT05978401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000587|NCT05978401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154000588|NCT05978401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154000589|NCT05978193|Immunomodulating Agents|immunomodulating agents|mesh-list
154000590|NCT05978193|Immunologic Factors|immunologic factors|mesh-ancestor
154000591|NCT05978193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000592|NCT05978167|Methylphenidate|methylphenidate|mesh-list
154000593|NCT05978167|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154000594|NCT05978167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000595|NCT05978167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154000596|NCT05978167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154000597|NCT05978167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154000598|NCT05978167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000599|NCT05978167|Dopamine Agents|dopamine agents|mesh-ancestor
154000600|NCT05978167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000601|NCT05978050|Paclitaxel|paclitaxel|mesh-list
154000602|NCT05978050|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154000603|NCT05978050|Nimotuzumab|nimotuzumab|mesh-list
154000604|NCT05978050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631837|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
153631838|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631839|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631840|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631841|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631842|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631843|NCT00005959|Prednisone|prednisone|mesh-list
153631844|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
153631845|NCT00005959|Rituximab|rituximab|mesh-list
153631846|NCT00005959|Doxorubicin|doxorubicin|mesh-list
153631847|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153631848|NCT00005959|Vincristine|vincristine|mesh-list
153631849|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631850|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
153631851|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000606|NCT05978050|Tubulin Modulators|tubulin modulators|mesh-ancestor
154000607|NCT05978050|Antimitotic Agents|antimitotic agents|mesh-ancestor
154000608|NCT05978050|Mitosis Modulators|mitosis modulators|mesh-ancestor
154000609|NCT05978050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000610|NCT05978050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154000611|NCT05977868|Amoxicillin|amoxicillin|mesh-list
154000612|NCT05977868|Moxifloxacin|moxifloxacin|mesh-list
154000613|NCT05977868|Metronidazole|metronidazole|mesh-list
154000614|NCT05977868|Vancomycin|vancomycin|mesh-list
154000615|NCT05977868|Doxycycline|doxycycline|mesh-list
154000616|NCT05977868|Ciprofloxacin|ciprofloxacin|mesh-list
154000617|NCT05977868|Levofloxacin|levofloxacin|mesh-list
154000618|NCT05977868|Rifampin|rifampin|mesh-list
154000619|NCT05977868|Meropenem|meropenem|mesh-list
154000620|NCT05977868|Cefazolin|cefazolin|mesh-list
154000621|NCT05977868|Tazobactam|tazobactam|mesh-list
154000622|NCT05977868|Linezolid|linezolid|mesh-list
154000623|NCT05977868|Piperacillin|piperacillin|mesh-list
154000624|NCT05977868|Clavulanic Acid|clavulanic acid|mesh-list
154000625|NCT05977868|Penicillins|penicillins|mesh-list
154000626|NCT05977868|Daptomycin|daptomycin|mesh-list
154000627|NCT05977868|Ceftazidime|ceftazidime|mesh-list
154000628|NCT05977868|Cephalexin|cephalexin|mesh-list
154000629|NCT05977868|Ampicillin|ampicillin|mesh-list
154000630|NCT05977868|Cefepime|cefepime|mesh-list
154000631|NCT05977868|Ertapenem|ertapenem|mesh-list
154000632|NCT05977868|Tigecycline|tigecycline|mesh-list
154000633|NCT05977868|Ceftaroline|ceftaroline|mesh-list
154000634|NCT05977868|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154000635|NCT05977868|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154000636|NCT05977868|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154000637|NCT05977868|Avibactam|avibactam|mesh-list
154000638|NCT05977868|Sulbactam|sulbactam|mesh-list
154000639|NCT05977868|Dalbavancin|dalbavancin|mesh-list
154000640|NCT05977868|Oritavancin|oritavancin|mesh-list
153572717|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153631852|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631853|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631854|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
153631855|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631857|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631858|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631859|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631860|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631861|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154000641|NCT05977868|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154000642|NCT05977868|Oxacillin|oxacillin|mesh-list
154000643|NCT05977868|Cefadroxil|cefadroxil|mesh-list
154000644|NCT05977868|Cefpodoxime|cefpodoxime|mesh-list
154000645|NCT05977868|Sultamicillin|sultamicillin|mesh-list
154000646|NCT05977868|Trimethoprim|trimethoprim|mesh-list
154000647|NCT05977868|Sulfamethoxazole|sulfamethoxazole|mesh-list
154000648|NCT05977868|Delafloxacin|delafloxacin|mesh-list
154000649|NCT05977868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154000650|NCT05977868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000651|NCT05977868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154000652|NCT05977868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154000653|NCT05977868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000654|NCT05977868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000655|NCT05977868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000656|NCT05977868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154000657|NCT05977868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154000658|NCT05977868|Antimalarials|antimalarials|mesh-ancestor
154000659|NCT05977868|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154000660|NCT05977868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154000661|NCT05977868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154000662|NCT05977868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154000663|NCT05977868|Antitubercular Agents|antitubercular agents|mesh-ancestor
154000664|NCT05977868|Leprostatic Agents|leprostatic agents|mesh-ancestor
154000665|NCT05977868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154000666|NCT05977868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154000667|NCT05977868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154000686|NCT05974241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000688|NCT05974241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000689|NCT05974241|Antidepressive Agents|antidepressive agents|mesh-ancestor
154000690|NCT05974241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154000691|NCT05974241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154000692|NCT05974241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154000693|NCT05974241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000694|NCT05974241|Dopamine Agonists|dopamine agonists|mesh-ancestor
154000695|NCT05974241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154000696|NCT05974241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154000697|NCT05974241|Serotonin Agents|serotonin agents|mesh-ancestor
154000698|NCT05974241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154000699|NCT05974241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154000700|NCT05974241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154000701|NCT05974241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154000703|NCT05969587|Hydroquinone|hydroquinone|mesh-list
154000704|NCT05969587|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154000705|NCT05969587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000706|NCT05969587|Antioxidants|antioxidants|mesh-ancestor
154000707|NCT05969587|Protective Agents|protective agents|mesh-ancestor
154000708|NCT05969587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000709|NCT05969587|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154000710|NCT05836740|Minocycline|minocycline|mesh-list
154000711|NCT05836740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154000712|NCT05836740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000713|NCT05825430|Bupivacaine|bupivacaine|mesh-list
154000714|NCT05825430|Anesthetics|anesthetics|mesh-list
154000715|NCT05825430|Anesthetics, General|anesthetics, general|mesh-list
154000716|NCT05825430|Anesthetics, Local|anesthetics, local|mesh-ancestor
154000717|NCT05825430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000718|NCT05825430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000719|NCT05825430|Sensory System Agents|sensory system agents|mesh-ancestor
154000728|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000729|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000730|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154000731|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
154000732|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
154000733|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154000734|NCT05602519|Narcotics|narcotics|mesh-ancestor
154000735|NCT05602519|Analgesics|analgesics|mesh-ancestor
154000736|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
154000737|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000738|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154000739|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154000740|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154000741|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154000742|NCT05487885|Ketamine|ketamine|mesh-list
154000743|NCT05487885|Analgesics|analgesics|mesh-ancestor
154000744|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
154000745|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000746|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000747|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154000748|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154000749|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
154000750|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
154000751|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000752|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154000753|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153761632|NCT00218517|Selegiline|selegiline|mesh-list
154000754|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000755|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000756|NCT05445609|Nivolumab|nivolumab|mesh-list
154000771|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000772|NCT05406388|Analgesics|analgesics|mesh-ancestor
154000773|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
154000774|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000775|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154000776|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154000777|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
154000778|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
154000779|NCT05403502|Insulin|insulin|mesh-list
154000780|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154000781|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000782|NCT05399550|Balovaptan|balovaptan|mesh-list
154000783|NCT05399550|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154000784|NCT05399550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000785|NCT05399550|Natriuretic Agents|natriuretic agents|mesh-ancestor
154000786|NCT05399550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000787|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154000788|NCT05239468|Bezafibrate|bezafibrate|mesh-list
154000789|NCT05239468|Cathartics|cathartics|mesh-ancestor
154000790|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154000791|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154000792|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
154000793|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000794|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154000795|NCT05193591|Autoantibodies|autoantibodies|mesh-list
154000796|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
154000797|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000798|NCT05168657|Pancrelipase|pancrelipase|mesh-list
154000799|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154000800|NCT05135910|Terbinafine|terbinafine|mesh-list
154000801|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
154000802|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000803|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000804|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000805|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
154000806|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154000812|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
154000813|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000814|NCT05074121|Protective Agents|protective agents|mesh-ancestor
154000815|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000816|NCT05074121|Antidotes|antidotes|mesh-ancestor
154000817|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
154000818|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154000819|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000820|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000821|NCT04960618|Gemcitabine|gemcitabine|mesh-list
154000822|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
154000823|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154000824|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
154000825|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000826|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572920|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
153631880|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153631881|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
153631882|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631884|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631885|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
153631886|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631887|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631888|NCT00387777|Buprenorphine|buprenorphine|mesh-list
153631889|NCT00387777|Analgesics|analgesics|mesh-list
153631890|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153631891|NCT00387777|Narcotics|narcotics|mesh-ancestor
153631892|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153631893|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631894|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
153631895|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153631896|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153631897|NCT00005971|Alvocidib|alvocidib|mesh-list
153631898|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631899|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
153631900|NCT00005971|Growth Substances|growth substances|mesh-ancestor
153631901|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631902|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153631903|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631904|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631905|NCT00005974|Alvocidib|alvocidib|mesh-list
153631906|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631907|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
153631908|NCT00005974|Growth Substances|growth substances|mesh-ancestor
153631909|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631910|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153631911|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631912|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631913|NCT00005977|Leucovorin|leucovorin|mesh-list
153631914|NCT00005977|Cytarabine|cytarabine|mesh-list
153631915|NCT00005977|Dexamethasone|dexamethasone|mesh-list
153631916|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
153631917|NCT00005977|Ifosfamide|ifosfamide|mesh-list
153631918|NCT00005977|Doxorubicin|doxorubicin|mesh-list
153631936|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
153631937|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000827|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154000828|NCT04960618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154000829|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
153654575|NCT00001586|Rituximab|rituximab|mesh-list
154000830|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
154000831|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
154000832|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000833|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000834|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154000835|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154000836|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
154000837|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
154000838|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000839|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000840|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
154000841|NCT04900792|Temozolomide|temozolomide|mesh-list
154000842|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154000843|NCT04900792|Vitamins|vitamins|mesh-ancestor
153758449|NCT03454789|Lidocaine|lidocaine|mesh-list
154000844|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
154000845|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000846|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154000847|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
154000848|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000850|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
154000851|NCT04900792|Protective Agents|protective agents|mesh-ancestor
154000852|NCT04900792|Hematinics|hematinics|mesh-ancestor
154000853|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154000854|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154000855|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
154000856|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154000857|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000858|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154000859|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000860|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
153631938|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153631939|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
153631940|NCT00005977|Hormones|hormones|mesh-ancestor
153631941|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154000861|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000862|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
154000863|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000864|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000865|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154000866|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154000868|NCT04644315|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154000869|NCT04644315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154000870|NCT04644315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000871|NCT04644315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000872|NCT04594694|Bezafibrate|bezafibrate|mesh-list
154000873|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154000874|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
154000875|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000876|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154000877|NCT04586504|Midazolam|midazolam|mesh-list
154000878|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154000879|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154000880|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000881|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000882|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154000883|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154000884|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154000885|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154000886|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
154000887|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
154000888|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
154000889|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
154000890|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000891|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000903|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000904|NCT04449952|Listerine|listerine|mesh-list
154000905|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
154000906|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
154000907|NCT04449952|Protective Agents|protective agents|mesh-ancestor
154000908|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000909|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154000910|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154000911|NCT04419389|Rituximab|rituximab|mesh-list
154000912|NCT04419389|Venetoclax|venetoclax|mesh-list
154000913|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
154000914|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154000915|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000916|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
154000917|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000918|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000919|NCT04419389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154000920|NCT04419389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154000921|NCT04419389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154000922|NCT04419389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000923|NCT04410991|Teriflunomide|teriflunomide|mesh-list
154000924|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154000925|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154000926|NCT04410991|Analgesics|analgesics|mesh-ancestor
154000927|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
154000928|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000929|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000930|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000931|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000932|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154000933|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
154000934|NCT04410978|Teriflunomide|teriflunomide|mesh-list
154000935|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153573026|NCT02787551|Hormones|hormones|mesh-ancestor
153631942|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153631943|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631944|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631945|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631946|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631947|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153631948|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
154000936|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154000937|NCT04410978|Analgesics|analgesics|mesh-ancestor
154000938|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
154000939|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000940|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000941|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154000942|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154000943|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154000944|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
154000945|NCT04373707|Enoxaparin|enoxaparin|mesh-list
154000946|NCT04373707|Dalteparin|dalteparin|mesh-list
154000947|NCT04373707|Tinzaparin|tinzaparin|mesh-list
154000948|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154000949|NCT04373707|Nadroparin|nadroparin|mesh-list
154000950|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
154000951|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
154000952|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154000953|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154000954|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154000955|NCT04335383|Antibodies|antibodies|mesh-list
154000956|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
153762747|NCT06116240|Pemetrexed|pemetrexed|mesh-list
154000957|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000958|NCT04211259|Loratadine|loratadine|mesh-list
154000959|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
154000960|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
154000961|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154000962|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154000963|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154000964|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
154000965|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
154000966|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154000967|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573051|NCT02626962|Ipilimumab|ipilimumab|mesh-list
153631949|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153631950|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631951|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
153631952|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
153631953|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153631954|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631955|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631956|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
153631957|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631958|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153631959|NCT00005977|Antidotes|antidotes|mesh-ancestor
154000968|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000969|NCT04116320|Poly ICLC|poly iclc|mesh-list
154000970|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
154000971|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
154000972|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000973|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154000974|NCT03934905|Sulforaphane|sulforaphane|mesh-list
154000975|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154000976|NCT03934905|Protective Agents|protective agents|mesh-ancestor
154000977|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000978|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154000979|NCT03916263|Metformin|metformin|mesh-list
154000980|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154000981|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000982|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
154000983|NCT03889418|Narcotics|narcotics|mesh-ancestor
154000984|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000985|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000986|NCT03889418|Analgesics|analgesics|mesh-ancestor
154000987|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
154000988|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000989|NCT03788694|Ketamine|ketamine|mesh-list
154000990|NCT03788694|Analgesics|analgesics|mesh-ancestor
154000991|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
154000992|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154000993|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154000994|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154000995|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154000996|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
154000997|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
154000998|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154000999|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154001000|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154001001|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001002|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001003|NCT03749109|Quinagolide|quinagolide|mesh-list
154001008|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001009|NCT03555188|Ondansetron|ondansetron|mesh-list
154001010|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
154001011|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
154001012|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001013|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001014|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001015|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
154001016|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
154001017|NCT03555188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154001018|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154001019|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
154001020|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001021|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001022|NCT03547115|Venetoclax|venetoclax|mesh-list
154001023|NCT03547115|Voruciclib|voruciclib|mesh-list
154001024|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001025|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154001026|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001027|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001028|NCT03497689|Treprostinil|treprostinil|mesh-list
154001029|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154001030|NCT03492437|Tepotinib|tepotinib|mesh-list
154001031|NCT03492437|Dabigatran|dabigatran|mesh-list
153631960|NCT00005977|Protective Agents|protective agents|mesh-ancestor
153631961|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
153631962|NCT00005977|Vitamins|vitamins|mesh-ancestor
153631964|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631965|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631966|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631967|NCT00005980|Doxorubicin|doxorubicin|mesh-list
153631968|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153631969|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631970|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631971|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631972|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631973|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631974|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631975|NCT00005986|Interferons|interferons|mesh-list
153631976|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
153631977|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
153631978|NCT00005986|Busulfan|busulfan|mesh-list
153631997|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
153631998|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631999|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
153632000|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632001|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153632002|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632003|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
154001032|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
154001033|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154001034|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001035|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001036|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001037|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
154001038|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001039|NCT03466294|Azacitidine|azacitidine|mesh-list
154001040|NCT03466294|Venetoclax|venetoclax|mesh-list
154001041|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154001042|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
154001043|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001044|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001045|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001046|NCT03363867|Bevacizumab|bevacizumab|mesh-list
154001047|NCT03363867|Atezolizumab|atezolizumab|mesh-list
154001048|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154001049|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001050|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154001051|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154001052|NCT03363867|Growth Substances|growth substances|mesh-ancestor
154001053|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001054|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
154001055|NCT03363867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154001056|NCT03363867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001057|NCT03310125|Colchicine|colchicine|mesh-list
154001058|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
154001059|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154001060|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
153632004|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632005|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632006|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153632007|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632008|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
153632009|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
153632010|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632011|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632012|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
153632013|NCT00005998|Hormones|hormones|mesh-ancestor
153632014|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153632015|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153763262|NCT06316570|Ticagrelor|ticagrelor|mesh-list
153632016|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632017|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632018|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154001062|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154001063|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001064|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001065|NCT03193853|Paclitaxel|paclitaxel|mesh-list
154001066|NCT03193853|Serabelisib|serabelisib|mesh-list
154001067|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154001068|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001069|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
154001070|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
154001071|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
154001072|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001073|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001074|NCT03191084|Dronabinol|dronabinol|mesh-list
154001075|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
154001076|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001077|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001078|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154001079|NCT03191084|Analgesics|analgesics|mesh-ancestor
154001080|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
154001081|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001082|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154001083|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154001084|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632019|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632020|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632021|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
153632022|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
153632023|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632024|NCT00005998|Analgesics|analgesics|mesh-ancestor
153632025|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
153632026|NCT00006351|Gemcitabine|gemcitabine|mesh-list
153632027|NCT00006351|Lonafarnib|lonafarnib|mesh-list
153632028|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632029|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
153632030|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632031|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632032|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632033|NCT00006001|Semaxinib|semaxinib|mesh-list
153632034|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153632035|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153632036|NCT00006001|Growth Substances|growth substances|mesh-ancestor
153632037|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632050|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153632051|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632052|NCT00006010|Gemcitabine|gemcitabine|mesh-list
153632054|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632055|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
153632056|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632057|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001086|NCT03191084|Hormones|hormones|mesh-ancestor
154001087|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001088|NCT03005366|Flecainide|flecainide|mesh-list
154001089|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154001090|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154001091|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154001092|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001093|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001094|NCT02738866|Fulvestrant|fulvestrant|mesh-list
154001095|NCT02738866|Palbociclib|palbociclib|mesh-list
154001096|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154001097|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001098|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154001099|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154001100|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
154001101|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001102|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001103|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154001104|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001105|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001106|NCT02576912|Dronabinol|dronabinol|mesh-list
154001107|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
154001108|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573201|NCT02325466|Aspirin|aspirin|mesh-list
153632058|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
153632059|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
153632060|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
153632061|NCT00006013|Semaxinib|semaxinib|mesh-list
153632062|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153632063|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153632064|NCT00006013|Growth Substances|growth substances|mesh-ancestor
153632065|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632066|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
153632067|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632069|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632070|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632071|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
153632072|NCT00006357|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153632073|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632074|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632075|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632076|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632077|NCT00006016|Thalidomide|thalidomide|mesh-list
153632078|NCT00006016|Doxorubicin|doxorubicin|mesh-list
153632079|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154001109|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001110|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154001111|NCT02576912|Analgesics|analgesics|mesh-ancestor
154001112|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
154001113|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001114|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154001115|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154001116|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001117|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001118|NCT02576912|Hormones|hormones|mesh-ancestor
154001119|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001120|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
154001121|NCT02232152|Fluorouracil|fluorouracil|mesh-list
154001122|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
154001123|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001124|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154001125|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001126|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154001127|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
154001128|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001129|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
154001131|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
154001132|NCT02232152|Vitamins|vitamins|mesh-ancestor
154001133|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
154001134|NCT02102113|Dronabinol|dronabinol|mesh-list
154001135|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
154001136|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001137|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001138|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154001139|NCT02102113|Analgesics|analgesics|mesh-ancestor
154001140|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
154001141|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001142|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154001143|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154001144|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573222|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632080|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154001145|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001146|NCT02102113|Hormones|hormones|mesh-ancestor
153758717|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
154001147|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001148|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154001149|NCT02070705|Hematinics|hematinics|mesh-ancestor
154001150|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154001151|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154001152|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
154001153|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154001154|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154001155|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001156|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
154001157|NCT01980355|Coagulants|coagulants|mesh-ancestor
154001158|NCT01758432|Apixaban|apixaban|mesh-list
154001159|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154001160|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
154001161|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154001162|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001163|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001164|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001165|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
154001166|NCT01583218|Enoxaparin|enoxaparin|mesh-list
154001167|NCT01583218|Betrixaban|betrixaban|mesh-list
154001168|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
154001169|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154001170|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154001171|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001172|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154001173|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
154001174|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154001175|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001176|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001177|NCT00742859|Warfarin|warfarin|mesh-list
154001186|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001187|NCT00667342|Bevacizumab|bevacizumab|mesh-list
154001188|NCT00667342|Doxorubicin|doxorubicin|mesh-list
154001189|NCT00667342|Methotrexate|methotrexate|mesh-list
154001190|NCT00667342|Etoposide|etoposide|mesh-list
154001191|NCT00667342|Ifosfamide|ifosfamide|mesh-list
154001192|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154001193|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001194|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154001195|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154001196|NCT00667342|Growth Substances|growth substances|mesh-ancestor
154001197|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001198|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
154001199|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154001200|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154001201|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154001202|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001203|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001204|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154001205|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
154001206|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154001207|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154001209|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
154001210|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154001211|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154001212|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
154001213|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154001214|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154001215|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154001216|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154001217|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
154001218|NCT00375609|Enoxaparin|enoxaparin|mesh-list
154001219|NCT00375609|Betrixaban|betrixaban|mesh-list
154001220|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
154001221|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154001222|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153573300|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
154001223|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001225|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
154001226|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154001227|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001228|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001229|NCT02545231|Pitavastatin|pitavastatin|mesh-list
154001230|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154001231|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154001232|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154001233|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
154001234|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001235|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001236|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154001237|NCT02803788|Dexamethasone|dexamethasone|mesh-list
154001238|NCT02803788|Ondansetron|ondansetron|mesh-list
154001240|NCT02803788|Antiemetics|antiemetics|mesh-list
154001241|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154001242|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
154001243|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001244|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001245|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001246|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
154001247|NCT02803788|Hormones|hormones|mesh-ancestor
154001248|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001249|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154001250|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001251|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
154001252|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
154001253|NCT02803788|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154001254|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154001255|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
153573336|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153632081|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632082|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632083|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632084|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632085|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632086|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632087|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
153632088|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001257|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001258|NCT02610153|Vitamin K|vitamin k|mesh-list
154001259|NCT02610153|Vitamins|vitamins|mesh-ancestor
154001260|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
154001261|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001262|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154001263|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154001264|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001265|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
154001266|NCT02610153|Coagulants|coagulants|mesh-ancestor
154001267|NCT00862693|Calcitriol|calcitriol|mesh-list
154001268|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154001269|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001270|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154001271|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001272|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001273|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154001274|NCT00862693|Vitamins|vitamins|mesh-ancestor
154001275|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
154001276|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154001277|NCT02799498|Etanercept|etanercept|mesh-list
154001278|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154001279|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154001280|NCT02799498|Analgesics|analgesics|mesh-ancestor
154001281|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
154001282|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001283|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764452|NCT05203172|Cetuximab|cetuximab|mesh-list
154001284|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632089|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
153632090|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153632091|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632092|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153632093|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153632094|NCT00006016|Growth Substances|growth substances|mesh-ancestor
153632095|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
153632096|NCT00006019|Azacitidine|azacitidine|mesh-list
153632097|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153632098|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632108|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
153632109|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632110|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153632111|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
153632112|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632113|NCT00006025|Irinotecan|irinotecan|mesh-list
154001285|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154001286|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001287|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154001288|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
154001289|NCT00617851|Vaccines|vaccines|mesh-list
154001290|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
154001291|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001292|NCT00913809|Desipramine|desipramine|mesh-list
154001293|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154001294|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
154001295|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001296|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001297|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001298|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154001299|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154001300|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001301|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
154001302|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001303|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001305|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154001306|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154001307|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001308|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001309|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001310|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154001311|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154001312|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
154001313|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001314|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153573396|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153632114|NCT00006025|Temozolomide|temozolomide|mesh-list
153632115|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153632116|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632117|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632118|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632119|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632120|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632121|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
153632122|NCT00386659|Ritonavir|ritonavir|mesh-list
153632123|NCT00386659|Lopinavir|lopinavir|mesh-list
153632124|NCT00386659|Tenofovir|tenofovir|mesh-list
153632125|NCT00386659|Abacavir|abacavir|mesh-list
153632126|NCT00386659|Efavirenz|efavirenz|mesh-list
153632127|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
154001315|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154001317|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154001318|NCT00855049|Analgesics|analgesics|mesh-ancestor
154001319|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
154001320|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001321|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001322|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
154001323|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154001324|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154001325|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
154001326|NCT00812955|Simvastatin|simvastatin|mesh-list
154001327|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154001328|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154001329|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
154001330|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001331|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154001332|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154001333|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001334|NCT04235478|Triamcinolone|triamcinolone|mesh-list
154001335|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154001336|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154001337|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
154001338|NCT04235478|Hormones|hormones|mesh-ancestor
154001339|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001340|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001341|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154001342|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
153632128|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153632129|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153632130|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
153632131|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632132|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632133|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632134|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632135|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
153632136|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632137|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153632138|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153632139|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153632140|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632141|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153632142|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153632143|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154001343|NCT00619489|Vedolizumab|vedolizumab|mesh-list
154001344|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001345|NCT02806206|Prucalopride|prucalopride|mesh-list
154001346|NCT02806206|Laxatives|laxatives|mesh-ancestor
154001347|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001348|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154001349|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154001350|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
154001351|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001352|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001353|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001354|NCT00855205|Rituximab|rituximab|mesh-list
154001355|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154001356|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001357|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
154001358|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001359|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154001360|NCT00859807|Amodiaquine|amodiaquine|mesh-list
154001361|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
154001362|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154001363|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154001364|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001365|NCT00859885|Clopidogrel|clopidogrel|mesh-list
154001366|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001367|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001368|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154001369|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154001370|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154001375|NCT02798874|Ticagrelor|ticagrelor|mesh-list
154001387|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001388|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001389|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154001390|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154001391|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
154001392|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001393|NCT00959699|Interferons|interferons|mesh-list
154001394|NCT00959699|Ribavirin|ribavirin|mesh-list
154001395|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
154001396|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
154001397|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154001398|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001399|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
154001400|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001401|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
153764740|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
154001402|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001403|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
154001404|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001405|NCT02806128|Kallikreins|kallikreins|mesh-list
154001406|NCT02806128|Coagulants|coagulants|mesh-ancestor
154001407|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
154001408|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
154001409|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154001410|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001411|NCT00860119|Alprazolam|alprazolam|mesh-list
154001412|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154001413|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001414|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001415|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154001416|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154001417|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001418|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
154001419|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
154001420|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001421|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001422|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
154001427|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001428|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001429|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001430|NCT02805738|Tenofovir|tenofovir|mesh-list
154001431|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
154176543|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
154001432|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001433|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154001434|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154001435|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001436|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001437|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154001438|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154001439|NCT00855361|Rabeprazole|rabeprazole|mesh-list
154001440|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154001441|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001442|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154001443|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001444|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001445|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
154001446|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154001447|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001448|NCT02798406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154001449|NCT02798406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001451|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154001452|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154001453|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001454|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001455|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154001456|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154001457|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001458|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153573551|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
153632144|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153632145|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153632146|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
153632148|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632149|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154001460|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
154001461|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
154001462|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
154001463|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001464|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001465|NCT02857829|Caffeine|caffeine|mesh-list
154001466|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154001467|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001468|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154001469|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001470|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001471|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153765033|NCT04194944|Pemetrexed|pemetrexed|mesh-list
154001472|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154001473|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
154001474|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001475|NCT00860275|Fluconazole|fluconazole|mesh-list
154001476|NCT00860275|Ketoconazole|ketoconazole|mesh-list
154001477|NCT00860275|BMS 708163|bms 708163|mesh-list
154001478|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
154001479|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001480|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154001481|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154001482|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001483|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001484|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153573576|NCT00066950|Fluorides|fluorides|mesh-list
153632150|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
153632151|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632152|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
153632153|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
153632154|NCT00387933|Vatalanib|vatalanib|mesh-list
153632155|NCT00387933|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153632156|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632157|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632158|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632159|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632160|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
153632161|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632162|NCT00006034|Doxorubicin|doxorubicin|mesh-list
153632163|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153632164|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153632192|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632193|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632194|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632195|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001485|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
154001486|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001487|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001488|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154001489|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154001490|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154001491|NCT00860275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154001492|NCT02798250|Insulin|insulin|mesh-list
154001493|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154001494|NCT02798250|Glucagon|glucagon|mesh-list
154001495|NCT02798250|Hormones|hormones|mesh-list
154001496|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154001497|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001498|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001499|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001500|NCT00865111|Bupropion|bupropion|mesh-list
154001501|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154001502|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
154001503|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001504|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154001505|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154001506|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001507|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573609|NCT01694134|Hormones|hormones|mesh-ancestor
153632196|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632197|NCT00006363|Cytarabine|cytarabine|mesh-list
153632198|NCT00006363|Aldesleukin|aldesleukin|mesh-list
153632199|NCT00006363|Etoposide|etoposide|mesh-list
153632200|NCT00006363|Daunorubicin|daunorubicin|mesh-list
153632201|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
153632202|NCT00006363|Busulfan|busulfan|mesh-list
153632203|NCT00006363|Interleukin-2|interleukin-2|mesh-list
153632204|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632205|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632206|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632207|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632208|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632209|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632210|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632211|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
153632225|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632226|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632227|NCT05680870|Omeprazole|omeprazole|mesh-list
153632228|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153632229|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632230|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153632231|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001509|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001510|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001511|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154001512|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154001513|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001514|NCT02802696|Furosemide|furosemide|mesh-list
154001515|NCT02802696|Diuretics|diuretics|mesh-ancestor
154001516|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
154001517|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759090|NCT04631341|Melatonin|melatonin|mesh-list
154001518|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154001519|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001520|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001521|NCT00865267|Halobetasol|halobetasol|mesh-list
154001522|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154001523|NCT02798172|Metformin|metformin|mesh-list
154001524|NCT02798172|Alogliptin|alogliptin|mesh-list
153632232|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632233|NCT00006366|Fluorouracil|fluorouracil|mesh-list
153632234|NCT00006366|Irinotecan|irinotecan|mesh-list
153632235|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
153632236|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632237|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632238|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632239|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632240|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
153632241|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632242|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153632243|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632244|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632245|NCT00006372|Gemcitabine|gemcitabine|mesh-list
153632246|NCT00006372|Doxorubicin|doxorubicin|mesh-list
153632247|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153632248|NCT00006372|Vinorelbine|vinorelbine|mesh-list
153632249|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632250|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
153632251|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632252|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632253|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153632254|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632255|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632256|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632257|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632258|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
153632259|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
153632260|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
153632261|NCT00006378|Paclitaxel|paclitaxel|mesh-list
153632262|NCT00006378|Carboplatin|carboplatin|mesh-list
153632263|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632264|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632265|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
153632266|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
153632267|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
153632268|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632270|NCT00006381|Trastuzumab|trastuzumab|mesh-list
153632271|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154001526|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001527|NCT02798172|Incretins|incretins|mesh-ancestor
154001528|NCT02798172|Hormones|hormones|mesh-ancestor
154001529|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001530|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154001531|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001532|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001533|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001534|NCT00865423|Gabapentin|gabapentin|mesh-list
154001535|NCT00865423|Analgesics|analgesics|mesh-ancestor
154001536|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
154001537|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001538|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001539|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
154001540|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154001541|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154001542|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001543|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001544|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154001545|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154001546|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001547|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001548|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
154001549|NCT00955721|Gemcitabine|gemcitabine|mesh-list
154001550|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
154001551|NCT00955721|Sorafenib|sorafenib|mesh-list
154001552|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154001553|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
154001554|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632272|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469158|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153632293|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632294|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632295|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632296|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153632297|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632298|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153632299|NCT05678296|Analgesics|analgesics|mesh-list
153632300|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632301|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
154001555|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001556|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154001557|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001559|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
154001560|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
154001561|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001562|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001563|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001564|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154001565|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154001566|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001567|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001568|NCT00865501|Spironolactone|spironolactone|mesh-list
154001569|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154001570|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
154001571|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001572|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001573|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154001574|NCT00865501|Diuretics|diuretics|mesh-ancestor
154001575|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
154001576|NCT02797704|Aflibercept|aflibercept|mesh-list
154001577|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154001578|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153632302|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632303|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632304|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153632305|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632306|NCT00006396|Zidovudine|zidovudine|mesh-list
153632307|NCT00006396|Nevirapine|nevirapine|mesh-list
153632308|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
153632309|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632310|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153632311|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632312|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632313|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
153632314|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632315|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632316|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632317|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153632318|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153632319|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
153632320|NCT03996148|Remifentanil|remifentanil|mesh-list
153632321|NCT03996148|Propofol|propofol|mesh-list
153632322|NCT03996148|Desflurane|desflurane|mesh-list
153632323|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153632324|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153632325|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632339|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153632340|NCT03996148|Narcotics|narcotics|mesh-ancestor
153632341|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154001580|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001581|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
154001582|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001583|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
154001584|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154001585|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154001586|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154001587|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001588|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001589|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
154001590|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001591|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001592|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154001593|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001594|NCT00863161|Lesogaberan|lesogaberan|mesh-list
154001595|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001596|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154001597|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
154001598|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
154001599|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001600|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001601|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001602|NCT00863239|Interferons|interferons|mesh-list
154001603|NCT00863239|Ribavirin|ribavirin|mesh-list
154001604|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
154001605|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
154001606|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154001607|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001608|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
154001609|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001610|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
154001611|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632342|NCT00006399|Donepezil|donepezil|mesh-list
153632343|NCT00006399|Progesterone|progesterone|mesh-list
153632344|NCT00006399|Estrogens|estrogens|mesh-list
153632345|NCT00006399|Progestins|progestins|mesh-ancestor
153632346|NCT00006399|Hormones|hormones|mesh-ancestor
153632347|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153632348|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632349|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153632350|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632351|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632352|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
153632353|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001612|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
154001613|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001614|NCT02802072|Aspirin|aspirin|mesh-list
154001615|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154001616|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154001617|NCT02802072|Analgesics|analgesics|mesh-ancestor
154001618|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
154001619|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001620|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001621|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154001622|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154001623|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154001624|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154001625|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001626|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154001627|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154001628|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001629|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
154001630|NCT00865657|Alprazolam|alprazolam|mesh-list
154001631|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154001632|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001633|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001634|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154001635|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154001636|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001637|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
154001638|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
154001639|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001640|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001641|NCT00863395|Lidocaine|lidocaine|mesh-list
154001642|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
154001643|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
153632354|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
153632355|NCT05660200|Iron|iron|mesh-list
153632356|NCT05660200|Trace Elements|trace elements|mesh-ancestor
153632357|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
153457218|NCT01426854|Nepafenac|nepafenac|mesh-list
153632358|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632359|NCT05552404|Aminophylline|aminophylline|mesh-list
153632360|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153632361|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
153632362|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632363|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632364|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153632365|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
154001644|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001645|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001646|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
154001647|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001648|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154001649|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154001650|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154001651|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001652|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001654|NCT02939183|Pomalidomide|pomalidomide|mesh-list
154001655|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154001656|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
154001657|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
154001658|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001659|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001660|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001661|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
154001663|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001664|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153573755|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
153573758|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632366|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153632367|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153632368|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632369|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632370|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153632372|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
153632374|NCT05552404|Protective Agents|protective agents|mesh-ancestor
153632375|NCT05546320|Aspirin|aspirin|mesh-list
153632376|NCT05546320|Metoprolol|metoprolol|mesh-list
153632377|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
153632378|NCT05546320|Clopidogrel|clopidogrel|mesh-list
153632379|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153632380|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153632381|NCT05546320|Analgesics|analgesics|mesh-ancestor
153632382|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
153632383|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632384|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632385|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632386|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153632387|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153632388|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153632416|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632418|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
153632419|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153632420|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153632421|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001666|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
154001667|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154001668|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154001669|NCT02939183|Growth Substances|growth substances|mesh-ancestor
154001670|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
154001671|NCT02801838|Morphine|morphine|mesh-list
154001672|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154001673|NCT02801838|Narcotics|narcotics|mesh-ancestor
154001674|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001675|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001676|NCT02801838|Analgesics|analgesics|mesh-ancestor
154001677|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
154001678|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001679|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154001680|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154001681|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001682|NCT02797860|Rocuronium|rocuronium|mesh-list
154001683|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153632422|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
153632423|NCT05470816|Coagulants|coagulants|mesh-ancestor
153632424|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153632425|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153632426|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153632427|NCT05431543|Aceclidine|aceclidine|mesh-list
153632428|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153632429|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153632430|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153632431|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153632432|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
153632433|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632457|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632458|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153632459|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153632460|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153632461|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632462|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153632463|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
153632464|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
153632465|NCT05247970|Midazolam|midazolam|mesh-list
153632466|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153632467|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153632468|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153632469|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632470|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153632471|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153632472|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153632473|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153632474|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
153632475|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
153632476|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
153632477|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
153632478|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632479|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632480|NCT00006441|Lamivudine|lamivudine|mesh-list
153632481|NCT00006441|Zidovudine|zidovudine|mesh-list
153632482|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154001684|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154001685|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154001686|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001687|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001688|NCT00860899|Clonidine|clonidine|mesh-list
154001689|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
154001690|NCT00860899|Analgesics|analgesics|mesh-ancestor
154001691|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
154001692|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001693|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001694|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154001695|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
154001696|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
154001697|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154001698|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154001699|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154001700|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
154001701|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001702|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001703|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
154001704|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
154001705|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001706|NCT02797782|Antibodies|antibodies|mesh-list
154001707|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
154001708|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001709|NCT00863629|Insulin|insulin|mesh-list
153573797|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
153632483|NCT00006441|Aldesleukin|aldesleukin|mesh-list
153632484|NCT00006441|Nelfinavir|nelfinavir|mesh-list
153632485|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153632502|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632503|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632504|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632505|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
153632506|NCT05147233|Hormones|hormones|mesh-ancestor
153632507|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153632508|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153632509|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632510|NCT03926845|Thiamidol|thiamidol|mesh-list
153632511|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632512|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632513|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153632514|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632515|NCT00006453|Carboplatin|carboplatin|mesh-list
153632516|NCT00006453|Gemcitabine|gemcitabine|mesh-list
153632517|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632518|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632519|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
153632520|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001710|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154001711|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001712|NCT00860977|Valacyclovir|valacyclovir|mesh-list
154001713|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
154001714|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001715|NCT00865891|Nifedipine|nifedipine|mesh-list
154001716|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154001717|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001718|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001719|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154001720|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001721|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
154001722|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
154001723|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154001724|NCT02797236|Vaccines|vaccines|mesh-list
154001725|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
154001726|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573823|NCT01696370|Trimetazidine|trimetazidine|mesh-list
153632522|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153632523|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632524|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632525|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632526|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153632527|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632528|NCT00387322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153632529|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632530|NCT00006459|Paclitaxel|paclitaxel|mesh-list
153632531|NCT00006459|Gemcitabine|gemcitabine|mesh-list
153632532|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632533|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632534|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
153632535|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
153632536|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
153632537|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632538|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632539|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
153632541|NCT03876106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632542|NCT03876106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632543|NCT03876106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632544|NCT00388011|Morphine|morphine|mesh-list
153632545|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153632557|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632558|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153632559|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632560|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632561|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632563|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153632564|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632565|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153632566|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632567|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632568|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153632569|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153632570|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
153632571|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001728|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154001729|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
154001730|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001731|NCT00863785|Expectorants|expectorants|mesh-ancestor
154001732|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
154001733|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154001734|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
154001735|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001736|NCT00863785|Protective Agents|protective agents|mesh-ancestor
154001737|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001738|NCT00863785|Antidotes|antidotes|mesh-ancestor
154001739|NCT02801526|Amlodipine|amlodipine|mesh-list
154001740|NCT02801526|Candesartan|candesartan|mesh-list
154001741|NCT02801526|Candesartan cilexetil|candesartan cilexetil|mesh-list
154001742|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154001743|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154001744|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001745|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001746|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154001747|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001748|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
154001749|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154001750|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154001751|NCT02805426|Misoprostol|misoprostol|mesh-list
154001752|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
154001753|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154001754|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154001755|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001756|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
154001757|NCT02805426|Coagulants|coagulants|mesh-ancestor
153632572|NCT00006462|Gemcitabine|gemcitabine|mesh-list
153632573|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632574|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
153632575|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632576|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632577|NCT00006465|Capecitabine|capecitabine|mesh-list
153632578|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
153632579|NCT00006465|Irinotecan|irinotecan|mesh-list
153632580|NCT00006465|Camptothecin|camptothecin|mesh-list
153632581|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632582|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
153632583|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632584|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632585|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154001758|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154001760|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154001761|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001762|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154001763|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154001764|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
154001765|NCT02801292|Ketamine|ketamine|mesh-list
154001766|NCT02801292|Analgesics|analgesics|mesh-ancestor
154001767|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
154001768|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001769|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001770|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154001771|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154001772|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
154001773|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
154001774|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001775|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154001776|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154001777|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001778|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001779|NCT02544061|Interleukin-12|interleukin-12|mesh-list
154001780|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154001781|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
154001782|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001783|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154001784|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154001785|NCT02544061|Growth Substances|growth substances|mesh-ancestor
154001805|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154001806|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154001807|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001808|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154001809|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
154001810|NCT03853044|Hormones|hormones|mesh-ancestor
154001811|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001812|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154001813|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154001814|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
154001815|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
154001816|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
154001817|NCT00870337|Everolimus|everolimus|mesh-list
154001818|NCT00870337|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154001819|NCT00870337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154001820|NCT00870337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001821|NCT00870337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001822|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154001823|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
154001824|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001825|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001826|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154001827|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154001828|NCT00866437|Estropipate|estropipate|mesh-list
154001829|NCT00866437|Estradiol|estradiol|mesh-list
153573918|NCT01696825|Diazepam|diazepam|mesh-list
153632586|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632587|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632588|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632590|NCT00006468|Fluorouracil|fluorouracil|mesh-list
153632591|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
153632592|NCT00006468|Calcium|calcium|mesh-list
153632593|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
153632594|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153632595|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632596|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
153632597|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632598|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632599|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632600|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632601|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
153632603|NCT00006468|Protective Agents|protective agents|mesh-ancestor
153632604|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
153632605|NCT00006468|Vitamins|vitamins|mesh-ancestor
153632606|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
153632607|NCT00006471|Fenretinide|fenretinide|mesh-list
153632608|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154001830|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154001831|NCT00866437|Estrone|estrone|mesh-list
154001832|NCT00866437|Progesterone|progesterone|mesh-list
154001833|NCT00866437|Estrogens|estrogens|mesh-ancestor
154001834|NCT00866437|Hormones|hormones|mesh-ancestor
154001835|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001836|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001837|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154001838|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
154001839|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154001840|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154001841|NCT00866437|Progestins|progestins|mesh-ancestor
154001842|NCT00863941|Bupropion|bupropion|mesh-list
154001843|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154001844|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
154001845|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001846|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154001847|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154001848|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001849|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001850|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
154001851|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001852|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001853|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154001854|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154001855|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001856|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
154001857|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154001858|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153632609|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153632628|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153632629|NCT00423397|Gefitinib|gefitinib|mesh-list
153632630|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632631|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
153632632|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632633|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
153632634|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632635|NCT00423397|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153632636|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632637|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632638|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632639|NCT03265405|Prednisolone|prednisolone|mesh-list
153632640|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153632641|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
154001860|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001861|NCT00866515|Ketoconazole|ketoconazole|mesh-list
154001862|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
154001863|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001864|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154001865|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154001866|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001867|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001868|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154001869|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
154001870|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154001871|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001872|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154001873|NCT02795754|Ritonavir|ritonavir|mesh-list
154001874|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
154001875|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154001876|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154001877|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001878|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001879|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001880|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154001881|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632642|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153632643|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
153632644|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153632645|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
153632646|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632647|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
153632648|NCT03265405|Hormones|hormones|mesh-ancestor
153632649|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153632650|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632651|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153632652|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632653|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
153632654|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
153632655|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632656|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632657|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153632658|NCT03265405|Protective Agents|protective agents|mesh-ancestor
153632659|NCT03808480|Nivolumab|nivolumab|mesh-list
153632660|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153632661|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632662|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153632663|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632664|NCT00387517|Aliskiren|aliskiren|mesh-list
153632665|NCT00387517|Renin Inhibitors|renin inhibitors|mesh-ancestor
153632666|NCT00387517|Protease Inhibitors|protease inhibitors|mesh-ancestor
153632678|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001882|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
154001883|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001884|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154001885|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154001887|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
154001888|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001889|NCT00864019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154001890|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154001891|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001892|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001893|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001895|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001896|NCT00812487|Insulin|insulin|mesh-list
154001897|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154001898|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154001899|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001900|NCT04235868|Mitogens|mitogens|mesh-list
154001901|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
154001902|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001903|NCT02800902|Atorvastatin|atorvastatin|mesh-list
154001904|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154001905|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154001906|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154001907|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
154001908|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001909|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153632679|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632680|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153632681|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153632682|NCT02890069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153632684|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153632685|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153632686|NCT02425501|Growth Substances|growth substances|mesh-ancestor
153632687|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632688|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
153632689|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632690|NCT02409238|Metformin|metformin|mesh-list
153632691|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153632692|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632693|NCT00006480|Aldesleukin|aldesleukin|mesh-list
153632694|NCT00006480|Ganciclovir|ganciclovir|mesh-list
153632695|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153632696|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632697|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632698|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632699|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
154001910|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154001911|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001912|NCT05756595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154001914|NCT00617461|Analgesics|analgesics|mesh-ancestor
154001915|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
154001916|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001917|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001918|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
154001919|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154001920|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154001921|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001922|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154001923|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154001924|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154001925|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001926|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001927|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
154001928|NCT00812331|Simeprevir|simeprevir|mesh-list
154001929|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
154001930|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001931|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001932|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001933|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001934|NCT04233996|Meropenem|meropenem|mesh-list
154001935|NCT04233996|Tazobactam|tazobactam|mesh-list
154001936|NCT04233996|Piperacillin|piperacillin|mesh-list
154001937|NCT04233996|Cefepime|cefepime|mesh-list
153632700|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632701|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632702|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632703|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632704|NCT00006483|Sargramostim|sargramostim|mesh-list
153632705|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
153632706|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632708|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632709|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153632710|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153632711|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632712|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153632713|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632714|NCT00006519|Capravirine|capravirine|mesh-list
153632715|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153632716|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632717|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001938|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154001939|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154001940|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154001941|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154001942|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001943|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001944|NCT00870493|Aliskiren|aliskiren|mesh-list
154001945|NCT00870493|Renin Inhibitors|renin inhibitors|mesh-ancestor
154001946|NCT00870493|Protease Inhibitors|protease inhibitors|mesh-ancestor
154001947|NCT00870493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154001948|NCT00870493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001949|NCT00812253|Insulin|insulin|mesh-list
154001950|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154176544|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
154001951|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154001952|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001953|NCT00870571|Amlodipine|amlodipine|mesh-list
154001954|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154001955|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154001956|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153632718|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632719|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
153632720|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632721|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632722|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632723|NCT00006591|Ritonavir|ritonavir|mesh-list
153632724|NCT00006591|Amprenavir|amprenavir|mesh-list
153632725|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153632726|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153632727|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
153632750|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153632751|NCT00006669|Etoposide|etoposide|mesh-list
153632752|NCT00006669|Vincristine|vincristine|mesh-list
153632753|NCT00006669|Sargramostim|sargramostim|mesh-list
153632754|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632755|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
153632756|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632757|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153632758|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632759|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
153632760|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632761|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632762|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153632763|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153632764|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153632765|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632766|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632767|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632768|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632769|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
153632770|NCT00006669|Hormones|hormones|mesh-ancestor
153632771|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153632772|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153632773|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154001957|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001958|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154001959|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001960|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
154001961|NCT05756439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154001962|NCT05756439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001963|NCT05756439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001965|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154001966|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154001967|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001968|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154001969|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
154001970|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
154001971|NCT00866593|Dexetimide|dexetimide|mesh-list
154001972|NCT00866593|Citalopram|citalopram|mesh-list
154001973|NCT00866593|Escitalopram|escitalopram|mesh-list
154001974|NCT00866593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154001975|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154001976|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154001977|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001978|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154001979|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
154001980|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154001981|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154001982|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154001983|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
154001984|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
154001985|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154001986|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154001987|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154001988|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
154001989|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154001990|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
153632774|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
153632775|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
153632776|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
153632777|NCT00006708|Rituximab|rituximab|mesh-list
154001992|NCT02796378|Ubiquinone|ubiquinone|mesh-list
154001993|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
154001994|NCT02796378|Simvastatin|simvastatin|mesh-list
154001995|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154001996|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154001997|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
154001998|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154001999|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154002000|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154002001|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002002|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
154002003|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002004|NCT02796378|Vitamins|vitamins|mesh-ancestor
154002005|NCT00864409|Ropivacaine|ropivacaine|mesh-list
154002006|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
154002007|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
154002008|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002009|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002010|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
154002011|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002012|NCT00864487|Neratinib|neratinib|mesh-list
154002013|NCT00864487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154002014|NCT00864487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154002015|NCT00864487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002016|NCT00864487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002017|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
154002018|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
154002019|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154002020|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154002021|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574102|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632778|NCT00006708|Carboplatin|carboplatin|mesh-list
153632779|NCT00006708|Etoposide|etoposide|mesh-list
153632780|NCT00006708|Ifosfamide|ifosfamide|mesh-list
153632781|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153632782|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632803|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632804|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632805|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
153632806|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632807|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632808|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
154002023|NCT00866983|Urological Agents|urological agents|mesh-ancestor
154002024|NCT05226013|Rasburicase|rasburicase|mesh-list
154002025|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
154002026|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002027|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
154002028|NCT00870961|Vitamin D|vitamin d|mesh-list
154002029|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154002030|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002031|NCT00870961|Vitamins|vitamins|mesh-ancestor
154002032|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
154002033|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154002034|NCT00811941|Nalmefene|nalmefene|mesh-list
154002035|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154002036|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002037|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
154002038|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002039|NCT00864565|Fentanyl|fentanyl|mesh-list
154002040|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154002041|NCT00864565|Narcotics|narcotics|mesh-ancestor
154002042|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002043|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002044|NCT00864565|Analgesics|analgesics|mesh-ancestor
154002045|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
154002046|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002047|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154002048|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154002049|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
154002050|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
154002051|NCT00864643|Atorvastatin|atorvastatin|mesh-list
154002052|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154002053|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153632809|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632810|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153632811|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632812|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
153632813|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153632814|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632815|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632816|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632817|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632818|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
153632819|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002054|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
154002055|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002056|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154002057|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154002058|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002060|NCT00871039|Propofol|propofol|mesh-list
154002061|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154002062|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002063|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002064|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154002065|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
154002066|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
154002067|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154002068|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154002069|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154002070|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154002071|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
154002072|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
154002073|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002074|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002075|NCT00867061|ON 01910|on 01910|mesh-list
154002076|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002077|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154002078|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002079|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002080|NCT00864799|Misoprostol|misoprostol|mesh-list
154002081|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154002082|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
154002083|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154002084|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002085|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154002086|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632820|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153632821|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632823|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153632824|NCT00006786|Leucovorin|leucovorin|mesh-list
153632825|NCT00006786|Bevacizumab|bevacizumab|mesh-list
153632826|NCT00006786|Fluorouracil|fluorouracil|mesh-list
153632827|NCT00006786|Irinotecan|irinotecan|mesh-list
153632828|NCT00006786|Calcium|calcium|mesh-list
153632829|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
153632830|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153632831|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002088|NCT04234776|Ketamine|ketamine|mesh-list
154002089|NCT04234776|Aripiprazole|aripiprazole|mesh-list
154002090|NCT04234776|Escitalopram|escitalopram|mesh-list
154002091|NCT04234776|Analgesics|analgesics|mesh-ancestor
154002092|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
154002093|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002094|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002095|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154002096|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154002097|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
154002098|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
154002099|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002100|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154002101|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154002102|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002103|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002104|NCT04234776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154002105|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154002106|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154002107|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
154002108|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
154002109|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154002110|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153574205|NCT01698645|Fentanyl|fentanyl|mesh-list
153632832|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153632833|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153632834|NCT00006786|Growth Substances|growth substances|mesh-ancestor
153632835|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632836|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
153632858|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632859|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632860|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153632861|NCT00006864|Aldesleukin|aldesleukin|mesh-list
153632862|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632863|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632864|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632865|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
153632866|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632867|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
153632868|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632869|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153632870|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
153632871|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632872|NCT00006981|Immunotoxins|immunotoxins|mesh-list
153632873|NCT00006981|Immunoconjugates|immunoconjugates|mesh-ancestor
153632874|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
153632875|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632876|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
154002111|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154002112|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
154002113|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
154002114|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154002115|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154002116|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154002117|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154002118|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154002119|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154002120|NCT05756049|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154002121|NCT05756049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002122|NCT00871273|Capecitabine|capecitabine|mesh-list
154002123|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154002124|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
154002125|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002126|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002128|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002129|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002131|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002132|NCT04040491|Gemcitabine|gemcitabine|mesh-list
154002133|NCT04040491|Lenalidomide|lenalidomide|mesh-list
154002134|NCT04040491|Antibodies|antibodies|mesh-list
154002135|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
154002136|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
154002137|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002138|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154002139|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
153574223|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
153632877|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153632878|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632879|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153632880|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
153632881|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153632882|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632883|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632884|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632885|NCT00387556|Ondansetron|ondansetron|mesh-list
153632886|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
153632887|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
153632888|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632889|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632890|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632891|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
153632907|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632908|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002140|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002141|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002142|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154002143|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154002144|NCT04040491|Growth Substances|growth substances|mesh-ancestor
154002145|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
154002146|NCT02794584|Sufentanil|sufentanil|mesh-list
154002148|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
154002149|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002150|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002151|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154002152|NCT02794584|Narcotics|narcotics|mesh-ancestor
154002153|NCT02794584|Analgesics|analgesics|mesh-ancestor
154002154|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
154002155|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002156|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154002157|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154002158|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
154002159|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154002160|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
154002161|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154002162|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154002163|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154002164|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153632909|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632910|NCT00006043|Temozolomide|temozolomide|mesh-list
153632911|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632912|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
153632913|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632914|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457317|NCT01422876|Empagliflozin|empagliflozin|mesh-list
153632915|NCT00006049|Paclitaxel|paclitaxel|mesh-list
153632916|NCT00006049|Carboplatin|carboplatin|mesh-list
153632917|NCT00006049|Gefitinib|gefitinib|mesh-list
153632918|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632919|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632920|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
153632921|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
153632922|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
153632923|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632924|NCT00006049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153632925|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632926|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632927|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
153632928|NCT00006052|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153632929|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632930|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632931|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632932|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002165|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002166|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154002167|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154002168|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002170|NCT00871507|Hormones|hormones|mesh-ancestor
154002171|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002172|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154002173|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
154002174|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002175|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002176|NCT00865033|Metformin|metformin|mesh-list
154002177|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154002178|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002179|NCT04234932|Latanoprost|latanoprost|mesh-list
154002180|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154002181|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154002182|NCT02789592|Clonazepam|clonazepam|mesh-list
154002183|NCT02789592|Melatonin|melatonin|mesh-list
154002184|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
154002185|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002186|NCT02789592|Protective Agents|protective agents|mesh-ancestor
154002187|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002188|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002189|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
154002190|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
153759776|NCT00580060|Molgramostim|molgramostim|mesh-list
154002191|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
154002192|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574286|NCT01699347|Picibanil|picibanil|mesh-list
153632934|NCT00006055|Prednisone|prednisone|mesh-list
153632935|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
153632936|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
153632937|NCT00006055|Cyclosporins|cyclosporins|mesh-list
153632938|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153632939|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632940|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
153632941|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632942|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153632943|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632944|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
153632945|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632946|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632947|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153632948|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632949|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
153632950|NCT00006055|Hormones|hormones|mesh-ancestor
154002193|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154002194|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154002195|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154002196|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
154002197|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002198|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002199|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002200|NCT00876421|Urological Agents|urological agents|mesh-ancestor
154002202|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
154002203|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154002204|NCT00872131|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154002205|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154002206|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154002207|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002208|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002209|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
154002210|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002211|NCT04233294|Decitabine|decitabine|mesh-list
154002212|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154002213|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
154002214|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002215|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002216|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632987|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153632988|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633006|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633007|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
153633008|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633009|NCT00006100|Aldesleukin|aldesleukin|mesh-list
153633010|NCT00006100|Fludarabine|fludarabine|mesh-list
153633011|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
153633012|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633013|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633014|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
153633015|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633016|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633017|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
153633018|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633019|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153633020|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153633021|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
153633022|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633023|NCT00006103|Leucovorin|leucovorin|mesh-list
153633024|NCT00006103|Fluorouracil|fluorouracil|mesh-list
153633025|NCT00006103|Irinotecan|irinotecan|mesh-list
153633026|NCT00006103|Calcium|calcium|mesh-list
153633027|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
154002218|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002219|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002220|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154002221|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154002222|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002223|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002224|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002225|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154002226|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154002227|NCT00872365|Micronutrients|micronutrients|mesh-list
154002228|NCT00872365|Trace Elements|trace elements|mesh-list
154002229|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002230|NCT02793648|Vitamins|vitamins|mesh-list
154002231|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
154002232|NCT02793648|Vitamin E|vitamin e|mesh-list
154002233|NCT02793648|Tocopherols|tocopherols|mesh-list
154002234|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
154002235|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
154002236|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002237|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
154002238|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002239|NCT02793648|Protective Agents|protective agents|mesh-ancestor
154002240|NCT02789358|Adenosine|adenosine|mesh-list
154002241|NCT02789358|Analgesics|analgesics|mesh-ancestor
154002242|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
154002243|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002244|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002245|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154002246|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
153574327|NCT01699490|Valsartan|valsartan|mesh-list
153633028|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153633029|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633030|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
153633031|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633032|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633033|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633034|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633035|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
153633036|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153633037|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633038|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633039|NCT00006103|Antidotes|antidotes|mesh-ancestor
153633040|NCT00006103|Protective Agents|protective agents|mesh-ancestor
153633041|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
153633042|NCT00006103|Vitamins|vitamins|mesh-ancestor
154002247|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154002248|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
154002249|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
154002250|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002251|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002253|NCT03847506|Candesartan|candesartan|mesh-list
154002255|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154002256|NCT03847506|Ezetimibe|ezetimibe|mesh-list
154002257|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154002258|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154002259|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154002260|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002261|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154002262|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002263|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
154002264|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154002265|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154002266|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
154002267|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154002268|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154002269|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002270|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154002271|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154002272|NCT00617305|Ambrisentan|ambrisentan|mesh-list
154002273|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
154002274|NCT00617305|Tadalafil|tadalafil|mesh-list
154002275|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
154002276|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153574354|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153633043|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
153633044|NCT00006106|Fluorouracil|fluorouracil|mesh-list
153633045|NCT00006106|Dl1520|dl1520|mesh-list
153633046|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633062|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633063|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633064|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633065|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633066|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
153633067|NCT00006112|Antidotes|antidotes|mesh-ancestor
153633068|NCT00006112|Protective Agents|protective agents|mesh-ancestor
153633069|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
153633070|NCT00006112|Vitamins|vitamins|mesh-ancestor
153633071|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
153633072|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154002277|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154002278|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002279|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002280|NCT00617305|Urological Agents|urological agents|mesh-ancestor
154002281|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154002282|NCT02792712|Clopidogrel|clopidogrel|mesh-list
154002283|NCT02792712|Ticagrelor|ticagrelor|mesh-list
154002284|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154002285|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154002286|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154002287|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154002288|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
154002289|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002290|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002291|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002292|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
154002293|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154002294|NCT00870883|Deferoxamine|deferoxamine|mesh-list
154002295|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
154002296|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002297|NCT00870883|Expectorants|expectorants|mesh-ancestor
154002298|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
154002299|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154002300|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
154002301|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002302|NCT00870883|Protective Agents|protective agents|mesh-ancestor
154002303|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002304|NCT00870883|Antidotes|antidotes|mesh-ancestor
154002305|NCT00870883|Siderophores|siderophores|mesh-ancestor
154002306|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153633073|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
153633074|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633076|NCT00006115|Leucovorin|leucovorin|mesh-list
153633077|NCT00006115|Fluorouracil|fluorouracil|mesh-list
153633078|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
153633079|NCT00006115|Irinotecan|irinotecan|mesh-list
153633080|NCT00006115|Calcium|calcium|mesh-list
153633081|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
153633082|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153633083|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633084|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
153633085|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633086|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633087|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633088|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002307|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
154002308|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
154002309|NCT02789202|Fluorides|fluorides|mesh-list
154002310|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
154002311|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
154002312|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
154002313|NCT02789202|Protective Agents|protective agents|mesh-ancestor
154002314|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002315|NCT00811395|Interferons|interferons|mesh-list
154002316|NCT00811395|Interferon-beta|interferon-beta|mesh-list
154002317|NCT00811395|Teriflunomide|teriflunomide|mesh-list
154002318|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
154002319|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
154002320|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
154002321|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002322|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
154002323|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002324|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154002325|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
154002326|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002327|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002328|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002329|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154002330|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154002331|NCT00811395|Analgesics|analgesics|mesh-ancestor
154002332|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
154002333|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002334|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154002335|NCT02792946|Ambroxol|ambroxol|mesh-list
154002336|NCT02792946|Expectorants|expectorants|mesh-ancestor
154002355|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154002356|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154002357|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154002358|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154002359|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002360|NCT02609997|Dexamethasone|dexamethasone|mesh-list
154002361|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
154002362|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154002363|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
154002364|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
154002365|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002366|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002367|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154002368|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
154002369|NCT02609997|Hormones|hormones|mesh-ancestor
154002370|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002371|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154002372|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002373|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
154002374|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
154002375|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002376|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
154002377|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
154002378|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002379|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002380|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154002381|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
154002382|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
154002383|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002384|NCT04114500|Estradiol|estradiol|mesh-list
154002387|NCT04114500|Hormones|hormones|mesh-ancestor
154002396|NCT05755659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002398|NCT05755659|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154002399|NCT05755659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770253|NCT00206258|Pramlintide|pramlintide|mesh-list
154002400|NCT05755659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002401|NCT00913887|Diclofenac|diclofenac|mesh-list
154002402|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154002403|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154002404|NCT00913887|Analgesics|analgesics|mesh-ancestor
154002405|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
154002406|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002407|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002408|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154002409|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002410|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154002411|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002412|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002413|NCT02792400|Empagliflozin|empagliflozin|mesh-list
154002414|NCT02792400|Linagliptin|linagliptin|mesh-list
154002415|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153574500|NCT01700426|Vitamin E|vitamin e|mesh-list
153633089|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
153633090|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153633091|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633092|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633093|NCT00006115|Antidotes|antidotes|mesh-ancestor
153633094|NCT00006115|Protective Agents|protective agents|mesh-ancestor
153633095|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
153633096|NCT00006115|Vitamins|vitamins|mesh-ancestor
153633097|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
153633098|NCT00006118|Paclitaxel|paclitaxel|mesh-list
153633099|NCT00006118|Gemcitabine|gemcitabine|mesh-list
153633100|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633101|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633102|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
153633103|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
153633104|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
153633105|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633106|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633107|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
153633108|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
153633109|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633110|NCT00006124|Celecoxib|celecoxib|mesh-list
153633138|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153633140|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153633141|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
153633142|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153633143|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153633144|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153633145|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153633146|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153633147|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154002416|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002417|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154002418|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002420|NCT02792400|Hormones|hormones|mesh-ancestor
154002421|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002422|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154002423|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
154002424|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002425|NCT04040023|Vitamins|vitamins|mesh-list
154002426|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
154002427|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002428|NCT05755581|Antineoplastic Agents|antineoplastic agents|mesh-list
154002429|NCT05755581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
154002430|NCT05017155|Mexiletine|mexiletine|mesh-list
154002431|NCT05017155|Lamotrigine|lamotrigine|mesh-list
154002432|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
154002433|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154002434|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154002435|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002436|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153574522|NCT01700478|Coagulants|coagulants|mesh-ancestor
153633148|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153633149|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633150|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
153633151|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
153633152|NCT00006136|Hematinics|hematinics|mesh-ancestor
153633153|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633154|NCT00006145|Valganciclovir|valganciclovir|mesh-list
153633155|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
153633175|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633176|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153633177|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633178|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153633179|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153633180|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153633181|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153633182|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153633183|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
153633184|NCT00006157|Desipramine|desipramine|mesh-list
153633185|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153633186|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
153633187|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153633188|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633189|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633190|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153633191|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153633192|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153633193|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
153633194|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633195|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633196|NCT00006190|Lamivudine|lamivudine|mesh-list
154002437|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002439|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154002440|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002441|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154002442|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154002443|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154002444|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154002445|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
154002446|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154002447|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
154002448|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154002449|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002450|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154002451|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154002452|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154002453|NCT00876889|Riluzole|riluzole|mesh-list
154002454|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
154002455|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154002456|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154002457|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002458|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002459|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002460|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154002461|NCT00876889|Protective Agents|protective agents|mesh-ancestor
154002462|NCT00868465|Lumefantrine|lumefantrine|mesh-list
154002463|NCT00868465|Artemether|artemether|mesh-list
154002464|NCT00868465|Piperaquine|piperaquine|mesh-list
154002465|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154002466|NCT00868465|Artenimol|artenimol|mesh-list
154002467|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
154002468|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153633198|NCT00006190|Stavudine|stavudine|mesh-list
153633199|NCT00006190|Nelfinavir|nelfinavir|mesh-list
153633200|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153633201|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633202|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633203|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633204|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
153633205|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633206|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153633207|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154002469|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154002470|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002472|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154002473|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154002474|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002475|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
154002476|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002477|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002478|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154002479|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
154002480|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002481|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
154002482|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
154002483|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
154002484|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
154002485|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154002486|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
154002487|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002488|NCT00877123|Vitamin D|vitamin d|mesh-list
153760074|NCT00411372|Xhance|xhance|mesh-list
154002489|NCT00877123|Vitamins|vitamins|mesh-ancestor
154002490|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
154002491|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002492|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154002493|NCT00873223|Liraglutide|liraglutide|mesh-list
154002494|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
153574578|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
153633208|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153633209|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153633210|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153633228|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633229|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633231|NCT00006205|Ondansetron|ondansetron|mesh-list
153633232|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
153633233|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
153633234|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633235|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633236|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153633237|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
153633238|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
153633239|NCT00006205|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153633240|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153633241|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
153633242|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633243|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633244|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
154002495|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154002496|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002497|NCT00873223|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154002498|NCT00873223|Incretins|incretins|mesh-ancestor
154002499|NCT00873223|Hormones|hormones|mesh-ancestor
153771188|NCT00234468|Gefitinib|gefitinib|mesh-list
154002500|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002501|NCT00873379|Melatonin|melatonin|mesh-list
154002502|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
154002503|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002504|NCT00873379|Protective Agents|protective agents|mesh-ancestor
154002505|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002506|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002507|NCT00868855|Bradykinin|bradykinin|mesh-list
154002508|NCT00868855|Kininogens|kininogens|mesh-list
154002509|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
154002510|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154002511|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
154002512|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002513|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002514|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
154002515|NCT00615901|Fluorouracil|fluorouracil|mesh-list
154002516|NCT00615901|Methotrexate|methotrexate|mesh-list
154002517|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633245|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153633246|NCT00006208|Emtricitabine|emtricitabine|mesh-list
153633247|NCT00006208|Efavirenz|efavirenz|mesh-list
153633248|NCT00006208|Stavudine|stavudine|mesh-list
153633249|NCT00006208|Didanosine|didanosine|mesh-list
153633250|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
153633251|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633252|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153633253|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633254|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633255|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633256|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153633257|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153633258|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153633259|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153633260|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153633261|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153633262|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153633263|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153633264|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
153633265|NCT00006211|Nelfinavir|nelfinavir|mesh-list
153633266|NCT00006211|Capravirine|capravirine|mesh-list
153633267|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153633268|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153633269|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
153633284|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633285|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
153633287|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633288|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
154002518|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
153771312|NCT00237705|Metoclopramide|metoclopramide|mesh-list
154002519|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002520|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002521|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154002522|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
154002523|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002524|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002525|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154002526|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
154002527|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154002528|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154002529|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
154002530|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154002531|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
154002532|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002533|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154002534|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154002535|NCT00616603|Dexamethasone|dexamethasone|mesh-list
154002536|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
154002537|NCT00616603|Ropivacaine|ropivacaine|mesh-list
154002538|NCT00616603|BB 1101|bb 1101|mesh-list
154002539|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154002540|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
154002541|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
154002542|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002543|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002544|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154002545|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
154002546|NCT00616603|Hormones|hormones|mesh-ancestor
154002547|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002548|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154002554|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
154002560|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
154002561|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002562|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002563|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760150|NCT00584779|Gabapentin|gabapentin|mesh-list
154002564|NCT02790996|Vancomycin|vancomycin|mesh-list
154002565|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002566|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002567|NCT02790840|Omeprazole|omeprazole|mesh-list
154002568|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154002569|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154002570|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154002571|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771370|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002572|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002573|NCT02790684|Firuglipel|firuglipel|mesh-list
154002574|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154002575|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002576|NCT02790450|Benzbromarone|benzbromarone|mesh-list
154002577|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
154002578|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
154002579|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002580|NCT02790528|Atorvastatin|atorvastatin|mesh-list
154002581|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154002582|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154002583|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
154002584|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002585|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154002586|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154002606|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154002607|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
154002608|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002609|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002610|NCT02785614|Trazodone|trazodone|mesh-list
154002611|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154002612|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154002613|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002614|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002615|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154002616|NCT02785614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154002617|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154002618|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154002619|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002620|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002621|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
154002622|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154002623|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
154002624|NCT02787018|Dexamethasone|dexamethasone|mesh-list
154002625|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
154002626|NCT02787018|Ropivacaine|ropivacaine|mesh-list
154002627|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154002628|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
154002629|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
154002630|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002631|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002632|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154002633|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
154002635|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002636|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154002637|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002647|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002648|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002649|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
154002650|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
154002651|NCT00873925|Vitamin D|vitamin d|mesh-list
154002652|NCT00873925|Vitamins|vitamins|mesh-ancestor
154002653|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
154002654|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002655|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154002656|NCT03412266|Cytarabine|cytarabine|mesh-list
154002657|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
154002658|NCT03412266|Busulfan|busulfan|mesh-list
154002659|NCT03412266|Semustine|semustine|mesh-list
154002660|NCT03412266|Fludarabine|fludarabine|mesh-list
154002661|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154002662|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002663|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
154002664|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002665|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002666|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154002667|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
154002668|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002669|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002670|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154002671|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154002672|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
154002673|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
154002674|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002675|NCT00877591|Ritonavir|ritonavir|mesh-list
154002676|NCT00877591|Darunavir|darunavir|mesh-list
154002677|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
154002678|NCT00877591|Rifampin|rifampin|mesh-list
154002679|NCT00877591|Rifabutin|rifabutin|mesh-list
153633289|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
153633290|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
153633291|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153633292|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
153633293|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633294|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153633295|NCT00006223|Protective Agents|protective agents|mesh-ancestor
153633296|NCT03761953|Oritavancin|oritavancin|mesh-list
153633297|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153633298|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633299|NCT00006226|Thalidomide|thalidomide|mesh-list
153633300|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633301|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
153633302|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002680|NCT00877591|Buprenorphine|buprenorphine|mesh-list
154002681|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154002682|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154002683|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
154002684|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002685|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002686|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154002687|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154002688|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
154002689|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002690|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154002691|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154002692|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154002693|NCT00877591|Narcotics|narcotics|mesh-ancestor
154002694|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002695|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002696|NCT00877591|Analgesics|analgesics|mesh-ancestor
154002697|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
154002698|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002699|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154002700|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154002701|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
154002702|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002703|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
154002704|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154002705|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153633303|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
153633304|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153633305|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633306|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153633307|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153633308|NCT00006226|Growth Substances|growth substances|mesh-ancestor
153633309|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
153633310|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633311|NCT00006232|Dexamethasone|dexamethasone|mesh-list
153633312|NCT00006232|Doxorubicin|doxorubicin|mesh-list
153633313|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153633314|NCT00006232|Vincristine|vincristine|mesh-list
153633315|NCT00006232|Idarubicin|idarubicin|mesh-list
153633316|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153633317|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
153633318|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
153633319|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633320|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633321|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153633322|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
153633323|NCT00006232|Hormones|hormones|mesh-ancestor
153633324|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153633325|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154002706|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154002707|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154002708|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154002709|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154002710|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154002711|NCT04200222|Vanadium|vanadium|mesh-list
154002712|NCT04200222|Trace Elements|trace elements|mesh-ancestor
154002713|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
154002714|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002715|NCT00874003|Mirtazapine|mirtazapine|mesh-list
154002716|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
154002717|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154002718|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154002719|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
154002720|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
154002721|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002722|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002723|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002724|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154002725|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154002726|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002727|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154002728|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154002729|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154002730|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
154002731|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154002732|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154002733|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
154002734|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154002735|NCT04915365|Acetazolamide|acetazolamide|mesh-list
154002736|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
154002737|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154002738|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002739|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002740|NCT04915365|Diuretics|diuretics|mesh-ancestor
154002742|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002743|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
154002744|NCT02785146|Leucovorin|leucovorin|mesh-list
154002745|NCT02785146|Fluorouracil|fluorouracil|mesh-list
154002746|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
154002747|NCT02785146|Calcium|calcium|mesh-list
154002748|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
154002749|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154002750|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002751|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154002752|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
154002753|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002754|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154002755|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002756|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002757|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
154002758|NCT02785146|Antidotes|antidotes|mesh-ancestor
154002759|NCT02785146|Protective Agents|protective agents|mesh-ancestor
154002760|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
154002761|NCT02785146|Vitamins|vitamins|mesh-ancestor
154002762|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
154002763|NCT00913965|Atenolol|atenolol|mesh-list
154002764|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154002765|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154002766|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
154002767|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
154002768|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002769|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002770|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154002771|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154002772|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154002773|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
154002774|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002775|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002776|NCT05753865|Paclitaxel|paclitaxel|mesh-list
154002777|NCT05753865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633326|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633327|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153633328|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154002779|NCT05753865|Tubulin Modulators|tubulin modulators|mesh-ancestor
154002780|NCT05753865|Antimitotic Agents|antimitotic agents|mesh-ancestor
154002781|NCT05753865|Mitosis Modulators|mitosis modulators|mesh-ancestor
154002782|NCT05753865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002784|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
154002785|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002786|NCT00869869|Protective Agents|protective agents|mesh-ancestor
153771987|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002787|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002788|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002789|NCT00874315|Cyclosporine|cyclosporine|mesh-list
153760364|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
154002790|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
154002791|NCT00874315|Fludarabine|fludarabine|mesh-list
154002792|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
154002793|NCT00874315|Busulfan|busulfan|mesh-list
154002794|NCT00874315|Tacrolimus|tacrolimus|mesh-list
154002795|NCT00874315|Cyclosporins|cyclosporins|mesh-list
154002796|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
154002797|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154002798|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002799|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154002800|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
154002801|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574881|NCT01702701|Fluticasone|fluticasone|mesh-list
153633329|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633330|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633331|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633348|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633349|NCT00006247|Semaxinib|semaxinib|mesh-list
153633350|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153633351|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153633353|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633354|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
153633355|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633356|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153633357|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633358|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633359|NCT00006250|Dexamethasone|dexamethasone|mesh-list
153633360|NCT00006250|Fludarabine|fludarabine|mesh-list
153633361|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
153633362|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
153633363|NCT00006250|Chlorambucil|chlorambucil|mesh-list
153633364|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153633365|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
153633366|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
153633367|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633368|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633369|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153633370|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
153633371|NCT00006250|Hormones|hormones|mesh-ancestor
154002802|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002803|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
154002804|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002805|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154002806|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002807|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
154002808|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002809|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
154002810|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002811|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154002812|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154002813|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
154002814|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002815|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
154002816|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154002817|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154002818|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
154002819|NCT00874393|Dopamine|dopamine|mesh-list
154002820|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154002821|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154002822|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
154002823|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
154002824|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002825|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002826|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
154002827|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002828|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002829|NCT00874393|Protective Agents|protective agents|mesh-ancestor
154002830|NCT04199364|Poractant alfa|poractant alfa|mesh-list
154002831|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154002832|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
154002833|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153633372|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153633373|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153633374|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633375|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633376|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
153633377|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633378|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633379|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
153633380|NCT00006250|Analgesics|analgesics|mesh-ancestor
153633381|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
154002834|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154002835|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002836|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
154002837|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154002838|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002839|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
154002840|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154002841|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154002842|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154002843|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154002844|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002845|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
154002846|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154002847|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002848|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154002849|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002850|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
154002851|NCT02784054|Melphalan|melphalan|mesh-list
154002852|NCT02784054|Thiotepa|thiotepa|mesh-list
154002853|NCT02784054|Carboplatin|carboplatin|mesh-list
154002854|NCT02784054|Etoposide|etoposide|mesh-list
154002855|NCT02784054|Bleomycin|bleomycin|mesh-list
154002856|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002857|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
154002858|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002859|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002861|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
154002881|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154002882|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154002883|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154002884|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154002885|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002886|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154002887|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
154002889|NCT02066220|Cisplatin|cisplatin|mesh-list
154002890|NCT02066220|Carboplatin|carboplatin|mesh-list
154002891|NCT02066220|Vincristine|vincristine|mesh-list
154002892|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002893|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
154002894|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002895|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154002896|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154002897|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
154002898|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002899|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002900|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154002901|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154002902|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
154002903|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
154002904|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
154002905|NCT00573391|Thalidomide|thalidomide|mesh-list
154002906|NCT00573391|Dexamethasone|dexamethasone|mesh-list
154002907|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
154002908|NCT00573391|Melphalan|melphalan|mesh-list
154002909|NCT00573391|Bortezomib|bortezomib|mesh-list
154002910|NCT00573391|BB 1101|bb 1101|mesh-list
154002911|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154002912|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
154002913|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
154002914|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002915|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633382|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153633383|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633384|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633385|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633386|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
153633387|NCT00006265|Cytarabine|cytarabine|mesh-list
153633388|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
154002916|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154002918|NCT00573391|Hormones|hormones|mesh-ancestor
154002919|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154002920|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154002921|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002922|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
154002923|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002924|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002925|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154002926|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
154002927|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154002928|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154002930|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
154002931|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154002932|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002933|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154002934|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154002935|NCT00573391|Growth Substances|growth substances|mesh-ancestor
154002936|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
154002937|NCT00590967|Cisplatin|cisplatin|mesh-list
154002938|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002939|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
154002940|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
154002941|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154002942|NCT00878371|Morphine|morphine|mesh-list
154002943|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154002944|NCT00878371|Narcotics|narcotics|mesh-ancestor
154002945|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002946|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002947|NCT00878371|Analgesics|analgesics|mesh-ancestor
154002948|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
154002951|NCT00923299|Cetuximab|cetuximab|mesh-list
154002961|NCT00875173|Selenium|selenium|mesh-list
154002962|NCT00875173|Antioxidants|antioxidants|mesh-list
154002963|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002964|NCT00875173|Protective Agents|protective agents|mesh-ancestor
154002965|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002966|NCT00875173|Trace Elements|trace elements|mesh-ancestor
154002967|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
154002968|NCT04029831|Ketamine|ketamine|mesh-list
154002969|NCT04029831|Propofol|propofol|mesh-list
154002970|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154002971|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002972|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002973|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154002974|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
154002975|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
154002976|NCT04029831|Analgesics|analgesics|mesh-ancestor
154002977|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
154002978|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002979|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154002980|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154002981|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154002982|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575063|NCT01703910|Dasatinib|dasatinib|mesh-list
153633389|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633390|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
153633391|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633406|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633407|NCT00007527|Analgesics|analgesics|mesh-ancestor
153633408|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
153633410|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153633411|NCT00006280|Tobramycin|tobramycin|mesh-list
153633412|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153633413|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633414|NCT00006286|Fluoxetine|fluoxetine|mesh-list
153633415|NCT00006286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153633416|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153633417|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153633418|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633419|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633420|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
153633421|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633422|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153633423|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
153633424|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153633425|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153633426|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153633427|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633428|NCT00007605|Amiodarone|amiodarone|mesh-list
153633429|NCT00007605|Sotalol|sotalol|mesh-list
153633430|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154002983|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002984|NCT00878449|Etoposide|etoposide|mesh-list
154002985|NCT00878449|Navitoclax|navitoclax|mesh-list
154002986|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154002987|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154002988|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154002989|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154002990|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154002991|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154002992|NCT06167759|Analgesics, Opioid|analgesics, opioid|mesh-list
154002993|NCT06167759|Narcotics|narcotics|mesh-ancestor
154002994|NCT06167759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154002995|NCT06167759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154002996|NCT06167759|Analgesics|analgesics|mesh-ancestor
154002997|NCT06167759|Sensory System Agents|sensory system agents|mesh-ancestor
154002998|NCT06167759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154002999|NCT06167707|Furosemide|furosemide|mesh-list
154003000|NCT06167707|Diuretics|diuretics|mesh-ancestor
154003001|NCT06167707|Natriuretic Agents|natriuretic agents|mesh-ancestor
154003002|NCT06167707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003003|NCT06167707|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154003004|NCT06167707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154003008|NCT06167187|Ketorolac|ketorolac|mesh-list
154003009|NCT06167187|Fentanyl|fentanyl|mesh-list
154003010|NCT06167187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154003011|NCT06167187|Narcotics|narcotics|mesh-ancestor
153575086|NCT01703910|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153633431|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
153633432|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153633433|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153633434|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633435|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153633436|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153633437|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153633438|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633439|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153633440|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153633441|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153633442|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153633443|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153633444|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
153633445|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633446|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633447|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
153633448|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
153633449|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003012|NCT06167187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003013|NCT06167187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003014|NCT06167187|Analgesics|analgesics|mesh-ancestor
154003015|NCT06167187|Sensory System Agents|sensory system agents|mesh-ancestor
154003016|NCT06167187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003017|NCT06167187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154003018|NCT06167187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154003019|NCT06167187|Anesthetics, General|anesthetics, general|mesh-ancestor
154003020|NCT06167187|Anesthetics|anesthetics|mesh-ancestor
154003021|NCT06167187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154003022|NCT06167187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154003023|NCT06167187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154003024|NCT06167187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003025|NCT06167187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154003026|NCT06167187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003027|NCT06167187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003033|NCT06166615|Psyllium|psyllium|mesh-list
154003034|NCT06166615|Antiemetics|antiemetics|mesh-ancestor
154003035|NCT06166615|Autonomic Agents|autonomic agents|mesh-ancestor
154003036|NCT06166615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003037|NCT06166615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003038|NCT06166615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154003039|NCT06166615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154003040|NCT06166615|Serotonin Agents|serotonin agents|mesh-ancestor
154003041|NCT06166615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003042|NCT06166615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003043|NCT06166615|Cathartics|cathartics|mesh-ancestor
154003044|NCT06166589|Oxaliplatin|oxaliplatin|mesh-list
154003045|NCT06166589|Irinotecan|irinotecan|mesh-list
154003046|NCT06166589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003059|NCT06165822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154003060|NCT06165822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154003061|NCT06165822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003062|NCT06165822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003063|NCT06165822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154003064|NCT06165822|Hormone Antagonists|hormone antagonists|mesh-ancestor
154003065|NCT06165822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154003066|NCT06165822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003067|NCT06165822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154003068|NCT06165822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154003069|NCT06165822|Antitubercular Agents|antitubercular agents|mesh-ancestor
154003070|NCT06165822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003071|NCT06165822|Leprostatic Agents|leprostatic agents|mesh-ancestor
154003072|NCT06165822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154003073|NCT06165822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154003074|NCT06165822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154003075|NCT06165822|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154003076|NCT06165822|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154003077|NCT06165822|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154003078|NCT06165822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154003080|NCT06157541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003081|NCT06157541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003082|NCT06157541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153633450|NCT00006292|Infliximab|infliximab|mesh-list
153633451|NCT00006292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153633472|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153633473|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
153633474|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633475|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153633476|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153633478|NCT00007683|Warfarin|warfarin|mesh-list
153633479|NCT00007683|Clopidogrel|clopidogrel|mesh-list
153633480|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153633481|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153633482|NCT00007683|Analgesics|analgesics|mesh-ancestor
153633483|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
153633484|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633485|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633486|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153633487|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633488|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153633489|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153633490|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633491|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153633492|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154003083|NCT06157541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003084|NCT06151483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154003086|NCT06151483|Adrenergic Agonists|adrenergic agonists|mesh-list
154003087|NCT06151483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003088|NCT06151483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003089|NCT06151483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003090|NCT06124118|Paclitaxel|paclitaxel|mesh-list
153760671|NCT00182741|Vitamins|vitamins|mesh-ancestor
154003091|NCT06124118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154003093|NCT06124118|Durvalumab|durvalumab|mesh-list
154003094|NCT06124118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154003095|NCT06124118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003096|NCT06124118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154003097|NCT06124118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154003098|NCT06124118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154003099|NCT06124118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003100|NCT06124118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003101|NCT06101589|Vitamin D|vitamin d|mesh-list
154003102|NCT06101589|Cholecalciferol|cholecalciferol|mesh-list
154003103|NCT06101589|Calcifediol|calcifediol|mesh-list
154003104|NCT06101589|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154003105|NCT06101589|Alfacalcidol|alfacalcidol|mesh-list
154003106|NCT06101589|Vitamins|vitamins|mesh-ancestor
154003107|NCT06101589|Micronutrients|micronutrients|mesh-ancestor
154003108|NCT06101589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003109|NCT06101589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154003110|NCT06101589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154003111|NCT06076694|Amoxicillin|amoxicillin|mesh-list
154003129|NCT05969730|Antimetabolites|antimetabolites|mesh-ancestor
154003130|NCT05969730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003131|NCT05969730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003132|NCT05969730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003133|NCT05969730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003134|NCT05969730|Immunologic Factors|immunologic factors|mesh-ancestor
154003135|NCT05969730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003136|NCT05969730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003137|NCT05950802|Cyclophosphamide|cyclophosphamide|mesh-list
154003138|NCT05950802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003139|NCT05950802|Immunologic Factors|immunologic factors|mesh-ancestor
154003140|NCT05950802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003141|NCT05950802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003142|NCT05950802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154003143|NCT05950802|Alkylating Agents|alkylating agents|mesh-ancestor
154003144|NCT05950802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003145|NCT05950802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003146|NCT05950802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154003148|NCT05928689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154003149|NCT05928689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154003150|NCT05928689|Adrenergic Agents|adrenergic agents|mesh-ancestor
154003151|NCT05928689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773476|NCT00244998|Fulvestrant|fulvestrant|mesh-list
154003152|NCT05928689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003153|NCT05928689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003157|NCT05904912|Bupivacaine|bupivacaine|mesh-list
154003178|NCT05737628|Immunologic Factors|immunologic factors|mesh-ancestor
154003179|NCT05737628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003180|NCT05737628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003181|NCT05705505|Letrozole|letrozole|mesh-list
154003182|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003183|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154003184|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154003185|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003186|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003187|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154003188|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
154003189|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154003190|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003191|NCT05681650|Paclitaxel|paclitaxel|mesh-list
154003192|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
154003193|NCT05681650|Fludarabine|fludarabine|mesh-list
154003194|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154003195|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154003196|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003197|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
154003198|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
154003199|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
154003200|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003201|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003202|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
154003203|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633493|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633494|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
153633495|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153633496|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153633497|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153633498|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
153633499|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633500|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
153633502|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
153633503|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633505|NCT00006337|Istradefylline|istradefylline|mesh-list
153633519|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
153633520|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633521|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633522|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633523|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633524|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633525|NCT00006229|Paclitaxel|paclitaxel|mesh-list
153633526|NCT00006229|Carboplatin|carboplatin|mesh-list
154003204|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003205|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154003206|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
154003207|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154003208|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
154003209|NCT05672459|Fludarabine|fludarabine|mesh-list
154003210|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
154003211|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003212|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
154003213|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003214|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003215|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154003216|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
154003217|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003218|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003219|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154003220|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003221|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
154003222|NCT05630768|Vitamin D|vitamin d|mesh-list
154003223|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
154003224|NCT05630768|Calcium|calcium|mesh-list
154003225|NCT05630768|Vitamins|vitamins|mesh-ancestor
154003226|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
154003227|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003228|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154003229|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153633527|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633528|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633529|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
153633530|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
153633531|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
153633532|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633533|NCT00006343|Interferons|interferons|mesh-list
153633534|NCT00006343|Cytarabine|cytarabine|mesh-list
153633535|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
153633536|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
153633537|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633538|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
153633539|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633540|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633541|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
153633542|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633543|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633544|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
153633545|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633546|NCT00006343|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153633547|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153633548|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633549|NCT00387868|Etoposide|etoposide|mesh-list
153633550|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003230|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154003231|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154003232|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003234|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154003235|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154003236|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003237|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003238|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154003239|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154003240|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154003241|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154003242|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
154003243|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
154003244|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
154003245|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
154003246|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003247|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003248|NCT05605509|Gemcitabine|gemcitabine|mesh-list
154003249|NCT05605509|Trastuzumab|trastuzumab|mesh-list
154003250|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003251|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
154003252|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003253|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003254|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003255|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
154003256|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003257|NCT05481736|Psilocybin|psilocybin|mesh-list
154003258|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
154003259|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633551|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633552|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153633553|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633554|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633555|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633556|NCT03616717|Modafinil|modafinil|mesh-list
153633557|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153633558|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633559|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153633560|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153633561|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153633562|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633563|NCT00006349|Vitamin E|vitamin e|mesh-list
153633564|NCT00006349|Donepezil|donepezil|mesh-list
153633565|NCT00006349|Vitamins|vitamins|mesh-ancestor
154003261|NCT05481489|Atropine|atropine|mesh-list
154003262|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154003263|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154003264|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154003265|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
154003266|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003267|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003268|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154003269|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
154003270|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
154003271|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
154003272|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154003273|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154003274|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
154003275|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575361|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
153633566|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
153633592|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633593|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633594|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
153633595|NCT00007878|Antidotes|antidotes|mesh-ancestor
153633596|NCT00007878|Protective Agents|protective agents|mesh-ancestor
153633597|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
153633598|NCT00007878|Vitamins|vitamins|mesh-ancestor
153457442|NCT01396512|Vaccines|vaccines|mesh-list
153633599|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
153633600|NCT00006355|NSC 366140|nsc 366140|mesh-list
153633601|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633602|NCT00006358|Thalidomide|thalidomide|mesh-list
153633603|NCT00006358|Temozolomide|temozolomide|mesh-list
153633604|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633605|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
153633606|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633607|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633608|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633609|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
153633610|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633611|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
153633612|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153633613|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633614|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153633615|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153633616|NCT00006358|Growth Substances|growth substances|mesh-ancestor
153633640|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
153633641|NCT00007917|Growth Substances|growth substances|mesh-ancestor
153633642|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633643|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153633644|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633645|NCT00006367|Cytarabine|cytarabine|mesh-list
153633646|NCT00006367|Busulfan|busulfan|mesh-list
153633647|NCT00006367|Idarubicin|idarubicin|mesh-list
153633648|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633649|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
153633650|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633651|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633652|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
153633653|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633654|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633655|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
154003276|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003277|NCT05471830|Apixaban|apixaban|mesh-list
154003278|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154003279|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
154003280|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154003281|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
154003282|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003283|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003284|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
154003285|NCT05470868|Naphazoline|naphazoline|mesh-list
154003286|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154003287|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154003288|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
154003289|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003290|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003291|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003292|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
154003293|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154003294|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
154003295|NCT05465941|Irinotecan|irinotecan|mesh-list
154003296|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154003297|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154003298|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003299|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003300|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003301|NCT05440864|Durvalumab|durvalumab|mesh-list
154003302|NCT05440864|Tremelimumab|tremelimumab|mesh-list
154003303|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003304|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003305|NCT05383560|Vaccines|vaccines|mesh-list
154003306|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
154003307|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003316|NCT05335122|Travoprost|travoprost|mesh-list
154003318|NCT05305313|Propofol|propofol|mesh-list
154003319|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154003320|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003321|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003322|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154003323|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
154003324|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
154003325|NCT05261399|Carboplatin|carboplatin|mesh-list
154003326|NCT05261399|Pemetrexed|pemetrexed|mesh-list
154003327|NCT05261399|Osimertinib|osimertinib|mesh-list
154003328|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003329|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003330|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003331|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154003332|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154003333|NCT05261399|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154003334|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154003335|NCT05247424|Heparin|heparin|mesh-list
154003336|NCT05247424|Calcium heparin|calcium heparin|mesh-list
154003337|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
154003338|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154003339|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154003340|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633656|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633657|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
153633658|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633659|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153633660|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153633661|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153633662|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633663|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633664|NCT00006370|Edotreotide|edotreotide|mesh-list
153633665|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153633695|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633696|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633697|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153633698|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633699|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
153633700|NCT00006385|Interferons|interferons|mesh-list
153633701|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
153633702|NCT00006385|Sargramostim|sargramostim|mesh-list
153633703|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
153633704|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633705|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
153633706|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633707|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
153633708|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633709|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153633710|NCT00007995|Interferons|interferons|mesh-list
153633711|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
154003341|NCT05169957|Nivolumab|nivolumab|mesh-list
154003342|NCT05169957|Ipilimumab|ipilimumab|mesh-list
154003343|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003344|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003345|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153774276|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003346|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003347|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
154003348|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003349|NCT05136898|Mitomycins|mitomycins|mesh-list
154003350|NCT05136898|Mitomycin|mitomycin|mesh-list
154003351|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154003352|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003353|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
154003354|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003355|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154003356|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003357|NCT05132166|Sirolimus|sirolimus|mesh-list
154003358|NCT05132166|Everolimus|everolimus|mesh-list
154003359|NCT05132166|MTOR Inhibitors|mtor inhibitors|mesh-list
154003360|NCT05132166|Temsirolimus|temsirolimus|mesh-list
154003361|NCT05132166|Vedolizumab|vedolizumab|mesh-list
154003362|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154003363|NCT05132166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154003364|NCT05132166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003365|NCT05132166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003366|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003367|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
153633735|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153633736|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153633737|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
153633738|NCT00008034|Capecitabine|capecitabine|mesh-list
153633739|NCT00008034|Epirubicin|epirubicin|mesh-list
153633740|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633741|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
153633742|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633743|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633744|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633745|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
153633746|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633747|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633748|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153633749|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633750|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
153633751|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153633752|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153633753|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633754|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633755|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
153633756|NCT00006391|Topotecan|topotecan|mesh-list
154003368|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003369|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003370|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003371|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003372|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154003373|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
154003374|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154003375|NCT05102162|Meropenem|meropenem|mesh-list
154003376|NCT05102162|Tazobactam|tazobactam|mesh-list
154003377|NCT05102162|Piperacillin|piperacillin|mesh-list
154003378|NCT05102162|Cefepime|cefepime|mesh-list
154003379|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154003380|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003381|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003382|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154003383|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003384|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003385|NCT05058404|Prednisone|prednisone|mesh-list
154003386|NCT05058404|Rituximab|rituximab|mesh-list
154003387|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154003388|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
154003389|NCT05058404|Vincristine|vincristine|mesh-list
154003390|NCT05058404|Doxorubicin|doxorubicin|mesh-list
153760958|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
154003391|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003418|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154003419|NCT04974398|Cisplatin|cisplatin|mesh-list
154003420|NCT04974398|Gemcitabine|gemcitabine|mesh-list
154003421|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003422|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003423|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
154003424|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003425|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
154003426|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154003427|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003428|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154003429|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003430|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154003431|NCT04915729|Tenecteplase|tenecteplase|mesh-list
154003432|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154003433|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154003434|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003435|NCT04901702|Irinotecan|irinotecan|mesh-list
154003436|NCT04901702|Temozolomide|temozolomide|mesh-list
154003437|NCT04901702|Talazoparib|talazoparib|mesh-list
154003438|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154003439|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154003440|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003441|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003442|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003443|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154003444|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
154003445|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154003446|NCT04899349|Metformin|metformin|mesh-list
153633757|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633758|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153633759|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633760|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633761|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633762|NCT00006394|Hormones|hormones|mesh-list
153633794|NCT00006412|Fenofibrate|fenofibrate|mesh-list
153633795|NCT00006412|Pravastatin|pravastatin|mesh-list
153633796|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153633797|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
153633798|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633799|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153633800|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153633801|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153633802|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003448|NCT04899349|Fulvestrant|fulvestrant|mesh-list
154003449|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154003450|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003451|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154003452|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003453|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154003454|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003455|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154003456|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154003457|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
154003458|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154003459|NCT04860960|Betadex|betadex|mesh-list
154003460|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
154003461|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003462|NCT04859764|Betamethasone|betamethasone|mesh-list
154003463|NCT04859764|Bupivacaine|bupivacaine|mesh-list
154003464|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
154003465|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
153761041|NCT00183950|Noscapine|noscapine|mesh-list
154003466|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003467|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003468|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
154003469|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003470|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154003471|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
154003472|NCT04859764|Hormones|hormones|mesh-ancestor
153633803|NCT00008112|Cisplatin|cisplatin|mesh-list
153633804|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633805|NCT00006427|Amitriptyline|amitriptyline|mesh-list
153633820|NCT00008151|Cyclosporine|cyclosporine|mesh-list
153633821|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
153633822|NCT00008151|Methotrexate|methotrexate|mesh-list
153633823|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
153633824|NCT00008151|Fludarabine|fludarabine|mesh-list
153633825|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
153633826|NCT00008151|Cyclosporins|cyclosporins|mesh-list
153633827|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153633828|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
153633829|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153633830|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633831|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633832|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
153633833|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633834|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633835|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
153633836|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003473|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154003474|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154003475|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
154003476|NCT04848220|APD791|apd791|mesh-list
154003477|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154003478|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154003479|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
154003480|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003481|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003482|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003483|NCT04843904|Rituximab|rituximab|mesh-list
154003484|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
154003485|NCT04843904|Venetoclax|venetoclax|mesh-list
154003486|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003487|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003488|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
154003489|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003490|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003491|NCT04814433|Lidocaine|lidocaine|mesh-list
154003492|NCT04814433|Epinephrine|epinephrine|mesh-list
154003493|NCT04814433|Racepinephrine|racepinephrine|mesh-list
154003494|NCT04814433|Bupivacaine|bupivacaine|mesh-list
154003495|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
154003496|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
154003497|NCT04814433|Thrombin|thrombin|mesh-list
154003498|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
153633837|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153633838|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633839|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
153633840|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633841|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633842|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
153633843|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633844|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153633845|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153633846|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153633847|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
153633848|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153633849|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153633850|NCT00008151|Immunotoxins|immunotoxins|mesh-ancestor
153633851|NCT00008151|Immunoconjugates|immunoconjugates|mesh-ancestor
153633852|NCT00006448|Methadone|methadone|mesh-list
153633853|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153633854|NCT00006448|Narcotics|narcotics|mesh-ancestor
153633855|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153633856|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633857|NCT00006448|Analgesics|analgesics|mesh-ancestor
153633858|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
153633859|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633860|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
153633861|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
154003499|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
154003501|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003502|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003503|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
154003504|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003505|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154003506|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154003507|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154003508|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154003509|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003510|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154003511|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154003512|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
154003513|NCT04814433|Coagulants|coagulants|mesh-ancestor
154003514|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154003515|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154003516|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
154003517|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003518|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154003519|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154003520|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
154003521|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154003522|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
154003523|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
154003524|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
154003525|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154003526|NCT04803084|TEMPO|tempo|mesh-list
154003527|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
153575594|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
153633862|NCT00008190|Aldesleukin|aldesleukin|mesh-list
153633863|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
153633864|NCT00008190|Melphalan|melphalan|mesh-list
153633865|NCT00008190|Busulfan|busulfan|mesh-list
153633866|NCT00008190|Etoposide|etoposide|mesh-list
153457468|NCT01383486|Analgesics|analgesics|mesh-ancestor
153633893|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633894|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633895|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
153633896|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633897|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633898|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153633899|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153633900|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
153633901|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153633902|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003528|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003530|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003532|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154176545|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
154176546|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154176547|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176548|NCT00852059|Methylphenidate|methylphenidate|mesh-list
154003533|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154003534|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003535|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154003536|NCT04743804|Ravulizumab|ravulizumab|mesh-list
154003537|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154003538|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003539|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
154003540|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003541|NCT04739813|Prednisone|prednisone|mesh-list
154003542|NCT04739813|Lenalidomide|lenalidomide|mesh-list
154003543|NCT04739813|Venetoclax|venetoclax|mesh-list
154003544|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
154003545|NCT04739813|Ibrutinib|ibrutinib|mesh-list
154003546|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154003547|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
154003548|NCT04739813|Hormones|hormones|mesh-ancestor
154003549|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154003550|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003551|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154003552|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575629|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
153633903|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
153633904|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
153633905|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633906|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153633907|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633909|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633910|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153633911|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153633912|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
153633913|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
153633914|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633915|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153633943|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
153633944|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633945|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
153633946|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153633947|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
154003554|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154003555|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154003556|NCT04739813|Growth Substances|growth substances|mesh-ancestor
154003557|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
154003558|NCT04739813|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154003559|NCT04739813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154003560|NCT04739813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003561|NCT04739813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003562|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003563|NCT04728217|Factor VIII|factor viii|mesh-list
154003564|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154003565|NCT04728217|Coagulants|coagulants|mesh-ancestor
154003566|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
154003567|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003568|NCT04727008|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154003569|NCT04727008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003570|NCT04727008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003571|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
154003572|NCT04724044|Clarithromycin|clarithromycin|mesh-list
153633948|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153633949|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153633950|NCT00006457|Protective Agents|protective agents|mesh-ancestor
153633951|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633952|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633953|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153633954|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633955|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633956|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633958|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
153633959|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633960|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633961|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
153633969|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633970|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633971|NCT00008307|Cyclosporine|cyclosporine|mesh-list
153633972|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
153633973|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
153633974|NCT00008307|Fludarabine|fludarabine|mesh-list
153633975|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
153633976|NCT00008307|Melphalan|melphalan|mesh-list
153633977|NCT00008307|Cyclosporins|cyclosporins|mesh-list
153633978|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153633979|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633980|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633981|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
153633982|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633983|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633984|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
153633985|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633986|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633987|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
154003573|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
154003574|NCT04724044|Lactams|lactams|mesh-list
154003575|NCT04724044|beta-Lactams|beta-lactams|mesh-list
154003576|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154003577|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003578|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003579|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154003580|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154003581|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003582|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003583|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003584|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154003585|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
154003586|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154003587|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003588|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154003589|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154003590|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154003591|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154003592|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154003593|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154003594|NCT04724044|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154003595|NCT04724044|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154003596|NCT04707794|Sevoflurane|sevoflurane|mesh-list
154003597|NCT04707794|Desflurane|desflurane|mesh-list
153633988|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633989|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
153633990|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633991|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153633992|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153633993|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153633994|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
153633995|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153633996|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153633997|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
153633998|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
153633999|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634000|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153634001|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
153634002|NCT00008307|Hormones|hormones|mesh-ancestor
153634003|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634004|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153634005|NCT00008307|Protective Agents|protective agents|mesh-ancestor
153634006|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153634007|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
153634008|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153634009|NCT00006469|Paclitaxel|paclitaxel|mesh-list
153634010|NCT00006469|Carboplatin|carboplatin|mesh-list
154003598|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154003599|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154003600|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
154003601|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
154003602|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003603|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003604|NCT04702789|Timolol|timolol|mesh-list
154003605|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154003606|NCT04702789|Dorzolamide|dorzolamide|mesh-list
154003607|NCT04702789|Latanoprost|latanoprost|mesh-list
154003608|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154003609|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154003610|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
154003611|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003612|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003613|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003614|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154003615|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154003616|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154003617|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154003618|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154003619|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154003620|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154003621|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154003622|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003623|NCT04659161|Xanomeline|xanomeline|mesh-list
154003624|NCT04659161|Trospium chloride|trospium chloride|mesh-list
153634011|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634012|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634013|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634014|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634016|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634017|NCT00006472|Paclitaxel|paclitaxel|mesh-list
153634018|NCT00006472|Carboplatin|carboplatin|mesh-list
153634019|NCT00006472|Fluorouracil|fluorouracil|mesh-list
153634020|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634021|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634022|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634023|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634024|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153634025|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634026|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
153634027|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153634028|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634029|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
153634043|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153634044|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003625|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
154003626|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
154003627|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003628|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003629|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154003630|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154003631|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
154003632|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003633|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003634|NCT04659161|Urological Agents|urological agents|mesh-ancestor
154003635|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154003636|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154003637|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154003638|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154003639|NCT04642820|Methamphetamine|methamphetamine|mesh-list
154003640|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154003641|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003642|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
154003643|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
154003644|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003645|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
154003646|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003647|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003648|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
154003649|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154003650|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154003651|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634045|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634046|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634047|NCT00006484|Paclitaxel|paclitaxel|mesh-list
153634048|NCT00006484|Carboplatin|carboplatin|mesh-list
153634049|NCT00006484|Tirapazamine|tirapazamine|mesh-list
153634050|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634051|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634052|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634053|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634054|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
153634055|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634056|NCT00006487|Etoposide|etoposide|mesh-list
153634057|NCT00006487|Tirapazamine|tirapazamine|mesh-list
153634058|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634059|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634060|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153634061|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153634062|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634063|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003652|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154003653|NCT04497116|Gemcitabine|gemcitabine|mesh-list
154003654|NCT04497116|Talazoparib|talazoparib|mesh-list
154003655|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003656|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
154003657|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003658|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003659|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154003660|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003661|NCT04495855|Dienogest|dienogest|mesh-list
154003662|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154003663|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
154003664|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154003665|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003666|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154003667|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154003668|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154003669|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154003670|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
154003671|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154003672|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154003673|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003674|NCT04471727|Atezolizumab|atezolizumab|mesh-list
154003675|NCT04471727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154003676|NCT04471727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003677|NCT04471727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003679|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
154003680|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003681|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
154003682|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153575757|NCT01708447|Lidocaine|lidocaine|mesh-list
153634064|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
153634065|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153634066|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634067|NCT00008463|Interferons|interferons|mesh-list
153634068|NCT00008463|Ribavirin|ribavirin|mesh-list
153634069|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
153634070|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
153634071|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153634072|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634073|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
153634074|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003683|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154003684|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003685|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
154003686|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003687|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003688|NCT04430738|Leucovorin|leucovorin|mesh-list
154003689|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
154003690|NCT04430738|Trastuzumab|trastuzumab|mesh-list
154003691|NCT04430738|Capecitabine|capecitabine|mesh-list
154003692|NCT04430738|Fluorouracil|fluorouracil|mesh-list
154003693|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
154003694|NCT04430738|Tucatinib|tucatinib|mesh-list
154003695|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003696|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003697|NCT04430738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154003698|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003699|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003700|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
154003701|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003702|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
154003703|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634075|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
153634076|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634077|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
153634078|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634079|NCT00006508|Insulin|insulin|mesh-list
153634080|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153634081|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634082|NCT00006682|Docetaxel|docetaxel|mesh-list
153634083|NCT00006682|Vinorelbine|vinorelbine|mesh-list
153634084|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634085|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634086|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634087|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
153634088|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634089|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634090|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
153634091|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634102|NCT00008736|Metoclopramide|metoclopramide|mesh-list
153634103|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
153634104|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
153634105|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634106|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634107|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153634108|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153634109|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153634110|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
153634111|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634112|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634115|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153634116|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153634117|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153634118|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
153634119|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154003704|NCT04430738|Antidotes|antidotes|mesh-ancestor
154003705|NCT04430738|Protective Agents|protective agents|mesh-ancestor
154003706|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
154003708|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
154003709|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154003710|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003711|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
154003712|NCT04258475|Calcium Carbonate|calcium carbonate|mesh-list
154003713|NCT04258475|Antacids|antacids|mesh-list
154003714|NCT04258475|Calcium|calcium|mesh-list
154003715|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154003716|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003717|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154003718|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154003719|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
154003720|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003721|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154003722|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154003723|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003724|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003725|NCT04258475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154003726|NCT04188418|Fentanyl|fentanyl|mesh-list
154003727|NCT04188418|Morphine|morphine|mesh-list
154003728|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154003729|NCT04188418|Narcotics|narcotics|mesh-ancestor
154003730|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003731|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003732|NCT04188418|Analgesics|analgesics|mesh-ancestor
154003733|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
154003734|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003735|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154003736|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153634120|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634121|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153634122|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153634123|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153634124|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634125|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
153634126|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153634127|NCT00006877|Temozolomide|temozolomide|mesh-list
153634128|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153634129|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
154003737|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
154003738|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
154003739|NCT04166721|Atezolizumab|atezolizumab|mesh-list
154003740|NCT04166721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154003741|NCT04166721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003742|NCT04166721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003743|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003744|NCT04166331|Dobutamine|dobutamine|mesh-list
154003745|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154003746|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
154003747|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
154003748|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154003749|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003750|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154003751|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154003752|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154003753|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
154003754|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003755|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003756|NCT04166331|Protective Agents|protective agents|mesh-ancestor
154003757|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
154003759|NCT04164069|Folic Acid|folic acid|mesh-list
154003760|NCT04164069|Bevacizumab|bevacizumab|mesh-list
154003761|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154003762|NCT04164069|Fluorouracil|fluorouracil|mesh-list
153761337|NCT00210912|Topiramate|topiramate|mesh-list
154003763|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
154003764|NCT04164069|Dasatinib|dasatinib|mesh-list
154003765|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
154003766|NCT04164069|Antibodies|antibodies|mesh-list
154003767|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
154003768|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154003769|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
154003770|NCT04164069|Calcium|calcium|mesh-list
154003771|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
153634130|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634131|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634132|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
153634133|NCT00007033|Analgesics|analgesics|mesh-ancestor
153634134|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
153634135|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634136|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634137|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
154003772|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003773|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154003774|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154003775|NCT04164069|Growth Substances|growth substances|mesh-ancestor
154003776|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003777|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
154003778|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
154003779|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154003780|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154003782|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003783|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003784|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003785|NCT04164069|Antidotes|antidotes|mesh-ancestor
154003786|NCT04164069|Protective Agents|protective agents|mesh-ancestor
154003787|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
154003788|NCT04164069|Vitamins|vitamins|mesh-ancestor
154003789|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
154003790|NCT04164069|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154003791|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154003792|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003793|NCT04164069|Hematinics|hematinics|mesh-ancestor
153634138|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634139|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153634140|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
153634141|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153634142|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634143|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634144|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153634145|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
153634146|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153634147|NCT00388401|Alvimopan|alvimopan|mesh-list
153634148|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153634149|NCT00007189|Celecoxib|celecoxib|mesh-list
153634150|NCT00007189|Naproxen|naproxen|mesh-list
153634151|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153634152|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153634153|NCT00007189|Analgesics|analgesics|mesh-ancestor
153634154|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
153634155|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634167|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634168|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634170|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
153634171|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634172|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153634173|NCT00388258|Alvimopan|alvimopan|mesh-list
153634174|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153634175|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
153634176|NCT00388336|Hematinics|hematinics|mesh-ancestor
153634177|NCT00007306|Hormones|hormones|mesh-list
153634178|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
153634179|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634180|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003794|NCT04120246|Acetic Acid|acetic acid|mesh-list
154003795|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154003796|NCT04120246|Trastuzumab|trastuzumab|mesh-list
154003797|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154003799|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
154003800|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154003801|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
154003802|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003803|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003804|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003805|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003806|NCT04118166|Nivolumab|nivolumab|mesh-list
154003807|NCT04118166|Ipilimumab|ipilimumab|mesh-list
154003808|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003809|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003810|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154003811|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003812|NCT04085250|Nivolumab|nivolumab|mesh-list
154003813|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003814|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003815|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154003816|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634181|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153634182|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
153634183|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153634184|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
153634185|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634186|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153634187|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634188|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
153634189|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634190|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
153634191|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153634192|NCT00007423|Protective Agents|protective agents|mesh-ancestor
153634193|NCT00007774|Haloperidol|haloperidol|mesh-list
153634194|NCT00007774|Olanzapine|olanzapine|mesh-list
153634195|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
153634196|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
153634197|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
153634198|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634199|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634200|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153634201|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153634202|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153634203|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634204|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153634205|NCT00007774|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153634206|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153634207|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634208|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003817|NCT04034251|Paclitaxel|paclitaxel|mesh-list
154003818|NCT04034251|Capecitabine|capecitabine|mesh-list
154003819|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154003820|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003821|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154003822|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
154003823|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
154003824|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003825|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003826|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
153657610|NCT05837455|Taxane|taxane|mesh-list
154003827|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
154003828|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
154003829|NCT04022239|Melphalan|melphalan|mesh-list
154003830|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154003831|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
154003832|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154003833|NCT04022239|Rituximab|rituximab|mesh-list
154003834|NCT04022239|Fludarabine|fludarabine|mesh-list
154003835|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154003836|NCT04022239|Tacrolimus|tacrolimus|mesh-list
154003837|NCT04022239|Antibodies|antibodies|mesh-list
154003838|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
154003839|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154003840|NCT04022239|Lenograstim|lenograstim|mesh-list
154003841|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003842|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
154003843|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003844|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154003845|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154003846|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
153634209|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634210|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
153634211|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153634212|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
153634213|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153634214|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
153634215|NCT00007813|Carboplatin|carboplatin|mesh-list
153634216|NCT00007813|Etoposide|etoposide|mesh-list
153634217|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634218|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
153634219|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634227|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153634228|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153634229|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634230|NCT00007852|Cytarabine|cytarabine|mesh-list
153634231|NCT00007852|Rituximab|rituximab|mesh-list
153634232|NCT00007852|Etoposide|etoposide|mesh-list
153634233|NCT00007852|Melphalan|melphalan|mesh-list
153634234|NCT00007852|Carmustine|carmustine|mesh-list
154003847|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003848|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003849|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154003850|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154003851|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154003852|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003853|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154003854|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154003855|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
154003856|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003857|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003858|NCT03954990|Metronidazole|metronidazole|mesh-list
154003859|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003860|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003861|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154003862|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154003863|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
154003864|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
154003865|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003866|NCT03847428|Bevacizumab|bevacizumab|mesh-list
154003867|NCT03847428|Durvalumab|durvalumab|mesh-list
154003868|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003869|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003870|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154003871|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154003872|NCT03847428|Growth Substances|growth substances|mesh-ancestor
153634235|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153634236|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634237|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
153634238|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634239|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153634240|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634241|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153634242|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153634243|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634244|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634245|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153634246|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
153634247|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
153634248|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634249|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634250|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153634251|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
153634252|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153634253|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153634254|NCT00007891|Antibodies|antibodies|mesh-list
153634255|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
153634256|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154003873|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003874|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
154003875|NCT03840421|Cisplatin|cisplatin|mesh-list
154003876|NCT03840421|Gemcitabine|gemcitabine|mesh-list
154003877|NCT03840421|Fluorouracil|fluorouracil|mesh-list
154003878|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003879|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003880|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
154003881|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003882|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003883|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
154003884|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003885|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
154003886|NCT03840226|Antacids|antacids|mesh-ancestor
154003887|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003888|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154003889|NCT03822351|Durvalumab|durvalumab|mesh-list
154003890|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154003891|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003892|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003893|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
154003894|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003895|NCT03810794|Donepezil|donepezil|mesh-list
154003896|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154003897|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003898|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003899|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
154003900|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003901|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003902|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
153634257|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
153634258|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634259|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634260|NCT00007969|Verteporfin|verteporfin|mesh-list
153634261|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
153634262|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153634263|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
153634264|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153634265|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
153634266|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634267|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
153634268|NCT00008008|Thiotepa|thiotepa|mesh-list
153634269|NCT00008008|Sargramostim|sargramostim|mesh-list
153634270|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634271|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
153634272|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003903|NCT03783429|Digoxin|digoxin|mesh-list
154003904|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154003905|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154003906|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003907|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003908|NCT03783429|Protective Agents|protective agents|mesh-ancestor
154003909|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003910|NCT03778294|Temozolomide|temozolomide|mesh-list
154003911|NCT03778294|Levodopa|levodopa|mesh-list
154003912|NCT03778294|Fluorides|fluorides|mesh-list
154003913|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154003914|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
154003915|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003916|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003917|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
154003918|NCT03778294|Protective Agents|protective agents|mesh-ancestor
154003919|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003920|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
154003921|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003922|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154003923|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153575988|NCT01710072|Aspirin|aspirin|mesh-list
153634273|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153634274|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153634275|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
153634276|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634277|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634278|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153634279|NCT00008047|Paclitaxel|paclitaxel|mesh-list
153634280|NCT00008047|Fluorouracil|fluorouracil|mesh-list
153634281|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
153634282|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634283|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634284|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634285|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634286|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
153634287|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634296|NCT00008086|Calcitriol|calcitriol|mesh-list
153634297|NCT00008086|Carboplatin|carboplatin|mesh-list
153634298|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634299|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153634300|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634301|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153634302|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634303|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634304|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153634305|NCT00008086|Vitamins|vitamins|mesh-ancestor
153634306|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
153634307|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153634308|NCT00008125|Carboplatin|carboplatin|mesh-list
153634309|NCT00008125|Gemcitabine|gemcitabine|mesh-list
153634310|NCT00008125|Docetaxel|docetaxel|mesh-list
153634311|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634312|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154003925|NCT03734601|Tacrolimus|tacrolimus|mesh-list
154003926|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154003927|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003928|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
154003929|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003930|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154003931|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003932|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003933|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154003934|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003935|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154003936|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
154003937|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154003938|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003939|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154003940|NCT03697031|Hormones|hormones|mesh-ancestor
154003941|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154003942|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003943|NCT03662542|Golimumab|golimumab|mesh-list
154003944|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154003945|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154003946|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154003947|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154003948|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
154003949|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003950|NCT03660553|Insulin|insulin|mesh-list
153634313|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
153634314|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634315|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634316|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634317|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
153634318|NCT00008203|Interferons|interferons|mesh-list
153634319|NCT00008203|Aldesleukin|aldesleukin|mesh-list
153634320|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
153634321|NCT00008203|Cyclosporine|cyclosporine|mesh-list
153634322|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
153634323|NCT00008203|Thiotepa|thiotepa|mesh-list
153634324|NCT00008203|Carboplatin|carboplatin|mesh-list
153634325|NCT00008203|Cyclosporins|cyclosporins|mesh-list
153634326|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634327|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
153634328|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634329|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153634330|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153634331|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
153634332|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634333|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003951|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154003952|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
154003953|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
154003954|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
154003955|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154003956|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003957|NCT03654989|Treprostinil|treprostinil|mesh-list
154003958|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154003959|NCT03638375|Interferons|interferons|mesh-list
154003960|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
154003961|NCT03638375|Nivolumab|nivolumab|mesh-list
154003962|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003963|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003964|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154003965|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003966|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
154003967|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154003968|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
153779030|NCT00570934|Vitamins|vitamins|mesh-ancestor
153779031|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
153779032|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
153779033|NCT00254553|Testosterone|testosterone|mesh-list
153779034|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
153779035|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
153779036|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153779037|NCT00254553|Androgens|androgens|mesh-ancestor
153779039|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779040|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779041|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153779042|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779043|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
153779058|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779059|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779060|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153779061|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153779062|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779063|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779064|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154003969|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003970|NCT03635333|Nicotine|nicotine|mesh-list
154003971|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154003972|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
154003973|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634334|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153634335|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
153634336|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634337|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634338|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
153634339|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
153634340|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153634341|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153634342|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153634343|NCT00008242|Thalidomide|thalidomide|mesh-list
153634344|NCT00008242|Dexamethasone|dexamethasone|mesh-list
153634345|NCT00008242|Doxorubicin|doxorubicin|mesh-list
153634346|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153634347|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153634348|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
153634349|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
153634350|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634351|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634352|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153634353|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
153634354|NCT00008242|Hormones|hormones|mesh-ancestor
153634355|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634356|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153634380|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634381|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153634382|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634383|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634384|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
153634385|NCT00008281|Antidotes|antidotes|mesh-ancestor
153634386|NCT00008281|Protective Agents|protective agents|mesh-ancestor
153634387|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
153634388|NCT00008281|Vitamins|vitamins|mesh-ancestor
154003974|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003975|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154003976|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154003977|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
154003978|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154003979|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003980|NCT03617666|Avelumab|avelumab|mesh-list
154003981|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154003982|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003983|NCT03571945|Anesthetics|anesthetics|mesh-list
154003984|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154003985|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003986|NCT03552692|Venetoclax|venetoclax|mesh-list
154003987|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003988|NCT03541902|Sunitinib|sunitinib|mesh-list
154003989|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154003990|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154003991|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154003992|NCT03541902|Growth Substances|growth substances|mesh-ancestor
154003993|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154003994|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
154003995|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154003996|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154003997|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154003998|NCT03496662|Paclitaxel|paclitaxel|mesh-list
154003999|NCT03496662|Gemcitabine|gemcitabine|mesh-list
154004000|NCT03496662|Nivolumab|nivolumab|mesh-list
154004001|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154004002|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004003|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
154004004|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
154004005|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
154004006|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576057|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634389|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
153634390|NCT00008359|Amphotericin B|amphotericin b|mesh-list
153634391|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153634392|NCT00008359|Caspofungin|caspofungin|mesh-list
153634393|NCT00008359|Amebicides|amebicides|mesh-ancestor
153634394|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153634395|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154004007|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004008|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
154004009|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004010|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154004011|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
154004012|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154004013|NCT03480698|Protective Agents|protective agents|mesh-ancestor
154004014|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004015|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
154004016|NCT03472885|Eculizumab|eculizumab|mesh-list
154004017|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154004018|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154004019|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
154004020|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004021|NCT03440385|Ozanimod|ozanimod|mesh-list
154004022|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154004023|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004024|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154004025|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
154004026|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004027|NCT03424525|Trimethoprim|trimethoprim|mesh-list
154004028|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154004029|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004030|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
154004031|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154004032|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154004033|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154004034|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004035|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004036|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154004037|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154004049|NCT03289299|Hormones|hormones|mesh-ancestor
154004050|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004051|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154004052|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004053|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
154004054|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154004055|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154004056|NCT03289299|Growth Substances|growth substances|mesh-ancestor
154004057|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
154004058|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
154004059|NCT03169881|Hematinics|hematinics|mesh-ancestor
154004060|NCT03167437|Vorinostat|vorinostat|mesh-list
154004061|NCT03167437|Ustekinumab|ustekinumab|mesh-list
154004062|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004063|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154004064|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004065|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004066|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
154004067|NCT03121261|Clonidine|clonidine|mesh-list
154004068|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
154004069|NCT03121261|Analgesics|analgesics|mesh-ancestor
154004070|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
154004071|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004072|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004073|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154004075|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
154004076|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154004077|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154004078|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154004079|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
154004080|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004081|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004082|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
154004083|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
153576152|NCT01710748|Everolimus|everolimus|mesh-list
153634396|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634397|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153634398|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
153634399|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634400|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004084|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004086|NCT03117049|Bevacizumab|bevacizumab|mesh-list
154004087|NCT03117049|Carboplatin|carboplatin|mesh-list
154004088|NCT03117049|Nivolumab|nivolumab|mesh-list
154004089|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154004090|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004091|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
154004092|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
154004093|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
154004094|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004095|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004096|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154004097|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154004098|NCT03117049|Growth Substances|growth substances|mesh-ancestor
154004099|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004100|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
154004101|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154004102|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
154004103|NCT03113617|Bombesin|bombesin|mesh-list
154004104|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004105|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004106|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004107|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004108|NCT03069183|Ropivacaine|ropivacaine|mesh-list
154004109|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
154004110|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
154004111|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004112|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576167|NCT01710904|Narcotics|narcotics|mesh-ancestor
153634401|NCT00008398|Sargramostim|sargramostim|mesh-list
153634402|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
153634403|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634404|NCT00008476|Capsaicin|capsaicin|mesh-list
153634405|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
153634406|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
153634407|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
153634408|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634409|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634438|NCT05636566|Analgesics|analgesics|mesh-ancestor
153634439|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
153634440|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634441|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154004114|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004115|NCT02917096|Vidarabine|vidarabine|mesh-list
154004116|NCT02917096|Sirolimus|sirolimus|mesh-list
154004117|NCT02917096|Fludarabine|fludarabine|mesh-list
154004118|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
154004119|NCT02917096|Melphalan|melphalan|mesh-list
154004120|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
154004121|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154004122|NCT02917096|Tacrolimus|tacrolimus|mesh-list
154004123|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004124|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004125|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
154004126|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004127|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154004128|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
154004129|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004130|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
154004131|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004132|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154004133|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004134|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154004135|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153576200|NCT01711112|Docetaxel|docetaxel|mesh-list
153634442|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153634443|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153634444|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
153634445|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634446|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634447|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153634448|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
153634449|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
153634450|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153634451|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153634452|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153634453|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153634454|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634456|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153634471|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634472|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634473|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634474|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
153634475|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634477|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153634478|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
153634479|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634480|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634481|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634482|NCT05639257|Mexiletine|mexiletine|mesh-list
153634483|NCT05639257|Lamotrigine|lamotrigine|mesh-list
153634484|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
153634485|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154004136|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
154004137|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154004138|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
154004139|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154004140|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154004141|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004142|NCT02821013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004143|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004145|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154004146|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004147|NCT02771093|Incretins|incretins|mesh-ancestor
154004148|NCT02771093|Hormones|hormones|mesh-ancestor
154004149|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004150|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154004151|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
154004152|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004153|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004155|NCT02716038|Carboplatin|carboplatin|mesh-list
154004156|NCT02716038|Atezolizumab|atezolizumab|mesh-list
154004157|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153576222|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
153634486|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634487|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634488|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153634489|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634490|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153634491|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153634492|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634493|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153634494|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153457582|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153634495|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153634496|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153634497|NCT00000115|Acetazolamide|acetazolamide|mesh-list
153634498|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
153634499|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153634500|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634501|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634502|NCT00000115|Diuretics|diuretics|mesh-ancestor
153634503|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
153634504|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634505|NCT00000136|Ganciclovir|ganciclovir|mesh-list
153634506|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153634507|NCT00000136|Foscarnet|foscarnet|mesh-list
153634508|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
153634510|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153634511|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634512|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634513|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153634514|NCT00000139|Acyclovir|acyclovir|mesh-list
154004159|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
154004160|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
154004161|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
154004162|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004163|NCT02716038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154004164|NCT02716038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004165|NCT02494258|Azacitidine|azacitidine|mesh-list
154004166|NCT02494258|Cc-486|cc-486|mesh-list
154004167|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004168|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
154004169|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004170|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004171|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004172|NCT02382549|Vaccines|vaccines|mesh-list
154004173|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
154004174|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004175|NCT02312622|Irinotecan|irinotecan|mesh-list
154004176|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
154004177|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154004178|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154004179|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004180|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634530|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634532|NCT00000151|Aspirin|aspirin|mesh-list
153634533|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153634534|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153634535|NCT00000151|Analgesics|analgesics|mesh-ancestor
153634536|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
153634537|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634538|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634539|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153634540|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153634541|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153634542|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153634543|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634544|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153634545|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153634546|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634547|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
153634548|NCT00000157|Aspirin|aspirin|mesh-list
153634549|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153634550|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153634551|NCT00000157|Analgesics|analgesics|mesh-ancestor
153634552|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
153634553|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634554|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634555|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153634556|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154004182|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154004183|NCT02297698|Trastuzumab|trastuzumab|mesh-list
154004184|NCT02297698|Sargramostim|sargramostim|mesh-list
154004185|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004186|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004187|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
154004188|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004189|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154004190|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154004191|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004192|NCT02007044|Rituximab|rituximab|mesh-list
154004193|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154004194|NCT02007044|Antibodies|antibodies|mesh-list
154004195|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
154004196|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154004197|NCT02007044|Ibrutinib|ibrutinib|mesh-list
154004198|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
154004199|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004200|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004201|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154004202|NCT02007044|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154004203|NCT02007044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153634557|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153634558|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153634559|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634560|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153634561|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153634562|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634563|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
153634564|NCT00000172|Galantamine|galantamine|mesh-list
153634565|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153634566|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634567|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634568|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
153634569|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634570|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634571|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153634586|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634587|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153634588|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153634589|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634590|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153634591|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153634592|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153634593|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
153634594|NCT00000205|Buprenorphine|buprenorphine|mesh-list
153634595|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153634596|NCT00000205|Narcotics|narcotics|mesh-ancestor
153634597|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634598|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004204|NCT02007044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004205|NCT02007044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004206|NCT01886404|Efavirenz|efavirenz|mesh-list
154004207|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153729792|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
154004208|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154004209|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004210|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004211|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
154004212|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004213|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154004214|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154004215|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154004216|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154004217|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154004218|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154004219|NCT01864746|Palbociclib|palbociclib|mesh-list
154004220|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004221|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154004222|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004223|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004224|NCT01729091|Lenalidomide|lenalidomide|mesh-list
154004225|NCT01729091|Melphalan|melphalan|mesh-list
153634599|NCT00000205|Analgesics|analgesics|mesh-ancestor
153634600|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
153634601|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634602|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153634603|NCT00000214|Buprenorphine|buprenorphine|mesh-list
153634604|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153634605|NCT00000214|Narcotics|narcotics|mesh-ancestor
153634606|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634607|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634608|NCT00000214|Analgesics|analgesics|mesh-ancestor
153634609|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
153634611|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153634612|NCT00000220|Buprenorphine|buprenorphine|mesh-list
153634613|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153634614|NCT00000220|Narcotics|narcotics|mesh-ancestor
153634615|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634616|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634617|NCT00000220|Analgesics|analgesics|mesh-ancestor
153634618|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
153634619|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634620|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153634621|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
153634622|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153634623|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
153634624|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
153634625|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004226|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
154004227|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154176549|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154176550|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176551|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154176552|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154176553|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154176554|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176555|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
154176556|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176557|NCT00844727|Rofecoxib|rofecoxib|mesh-list
154176558|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154176559|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154176560|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176561|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176562|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154176563|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154176564|NCT00844727|Analgesics|analgesics|mesh-ancestor
154176565|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
154176566|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576313|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634626|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634627|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153634628|NCT00000256|Analgesics|analgesics|mesh-ancestor
153634629|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
153634630|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634632|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153634633|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
153634634|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634660|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634661|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153634662|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153634663|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634664|NCT00388479|Alvimopan|alvimopan|mesh-list
153634665|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153634666|NCT00000463|Warfarin|warfarin|mesh-list
153634667|NCT00000463|Lovastatin|lovastatin|mesh-list
153634668|NCT00000463|L 647318|l 647318|mesh-list
153634669|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
153634670|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
153634671|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
153634672|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153634673|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153634674|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
153634675|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634676|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153634677|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153634678|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634679|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153634680|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
153634681|NCT00000466|Progesterone|progesterone|mesh-list
154176567|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176568|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176570|NCT00528528|Ribavirin|ribavirin|mesh-list
154004228|NCT01729091|Elotuzumab|elotuzumab|mesh-list
154004229|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
154004230|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004231|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154004232|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154004233|NCT01729091|Growth Substances|growth substances|mesh-ancestor
154004234|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
154004235|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004236|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154004237|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
154004238|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004239|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154004240|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154004241|NCT01475500|Dimercaprol|dimercaprol|mesh-list
154004242|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
154004243|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
154004244|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004245|NCT01258296|Fentanyl|fentanyl|mesh-list
154004246|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153634713|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634714|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153634715|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634716|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
153634717|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
153634718|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153634719|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153634720|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153634721|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
153634748|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634749|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153634750|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153634751|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
153634752|NCT00000499|Metoprolol|metoprolol|mesh-list
153634753|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
153634754|NCT00000499|Hydralazine|hydralazine|mesh-list
153634755|NCT00000499|Reserpine|reserpine|mesh-list
153634756|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153634757|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153634758|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
153634759|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
153634760|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634761|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634762|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153634763|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153634764|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153634765|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
153634766|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004247|NCT01258296|Narcotics|narcotics|mesh-ancestor
154004248|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004249|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004250|NCT01258296|Analgesics|analgesics|mesh-ancestor
154004251|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
154004252|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004253|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154004254|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154004255|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
154004256|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
154004257|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154004258|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154004259|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004261|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154004262|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154004263|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
154004264|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004265|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154004266|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154004267|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004268|NCT00375830|Diphosphonates|diphosphonates|mesh-list
154004269|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
154004270|NCT00375830|Listerine|listerine|mesh-list
154004271|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
154004272|NCT00375830|Fluorides|fluorides|mesh-list
154004273|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
154004274|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153576369|NCT01711827|Prednisone|prednisone|mesh-list
153634767|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634770|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153634771|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634803|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153634804|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153634805|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634806|NCT05638425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153634807|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634808|NCT00000517|Warfarin|warfarin|mesh-list
153634809|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
153634810|NCT00000520|Aspirin|aspirin|mesh-list
153634811|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
153634812|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153634813|NCT00000520|Antibodies|antibodies|mesh-list
153634814|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
153634833|NCT00000526|Moricizine|moricizine|mesh-list
153634834|NCT00000526|Encainide|encainide|mesh-list
153634835|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153634836|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154004276|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
154004277|NCT00375830|Protective Agents|protective agents|mesh-ancestor
154004278|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004279|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154004280|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004281|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154004282|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004283|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
154004284|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
154004285|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154004286|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
154004287|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154004288|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
154004289|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004290|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004291|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004292|NCT00875875|Rifaximin|rifaximin|mesh-list
154004293|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154004294|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004295|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004296|NCT01716312|Omalizumab|omalizumab|mesh-list
154004297|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153634837|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153634838|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634839|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634840|NCT00000529|Tamoxifen|tamoxifen|mesh-list
153634841|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153634842|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
153634843|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634844|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634845|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153634846|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634847|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153634848|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153634849|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153634851|NCT00000553|Simvastatin|simvastatin|mesh-list
153634852|NCT00000553|Antioxidants|antioxidants|mesh-list
153634853|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153634854|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153634855|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
153634856|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634857|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153634858|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153634859|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634860|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
154004298|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154004299|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
154004300|NCT00880243|Cytarabine|cytarabine|mesh-list
154004301|NCT00880243|Etoposide|etoposide|mesh-list
154004302|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
154004303|NCT00880243|Daunorubicin|daunorubicin|mesh-list
154004304|NCT00880243|Molgramostim|molgramostim|mesh-list
154004305|NCT00880243|Sargramostim|sargramostim|mesh-list
154004306|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154004307|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004308|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154004309|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154004310|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004311|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004312|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004313|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
154004314|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
154004315|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004316|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154004317|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
154004318|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004319|NCT00880243|Analgesics|analgesics|mesh-ancestor
154004320|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
154004321|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004322|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154004323|NCT02783586|Bupivacaine|bupivacaine|mesh-list
153576409|NCT01712113|Irbesartan|irbesartan|mesh-list
153634861|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
153634862|NCT00000553|Vitamins|vitamins|mesh-ancestor
153634863|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
153634864|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634865|NCT00000553|Protective Agents|protective agents|mesh-ancestor
153634866|NCT00000556|Quinidine|quinidine|mesh-list
153634867|NCT00000556|Digoxin|digoxin|mesh-list
153634868|NCT00000556|Amiodarone|amiodarone|mesh-list
153634869|NCT00000556|Verapamil|verapamil|mesh-list
153634870|NCT00000556|Sotalol|sotalol|mesh-list
153634871|NCT00000556|Flecainide|flecainide|mesh-list
153634872|NCT00000556|Propafenone|propafenone|mesh-list
153634881|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634882|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634883|NCT00000556|Protective Agents|protective agents|mesh-ancestor
153634884|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634885|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
153634886|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153634887|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634888|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153634889|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153634890|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153634891|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153634892|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154004324|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
154004325|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
154004326|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004327|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004328|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
154004329|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004330|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154004331|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154004332|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154004333|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004334|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004335|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154004336|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154004337|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154004338|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
154004339|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004340|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004341|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154004342|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154004343|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
154004344|NCT00880321|Dabrafenib|dabrafenib|mesh-list
154004345|NCT00880321|Midazolam|midazolam|mesh-list
154004346|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154004347|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154004348|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004349|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004350|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154004351|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154004352|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154004353|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153576436|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
153634893|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153634894|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153634895|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153634896|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153634897|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153634899|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
153634900|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
153634901|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634902|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153634903|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153634904|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
153634905|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153634906|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154004354|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
154004356|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
154004357|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
154004358|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004359|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004360|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004361|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154004362|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004363|NCT02608437|Ipilimumab|ipilimumab|mesh-list
154004364|NCT02608437|Guadecitabine|guadecitabine|mesh-list
154004365|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004366|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004367|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154004368|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004369|NCT04230330|Dexamethasone|dexamethasone|mesh-list
154004370|NCT04230330|Gemcitabine|gemcitabine|mesh-list
154004371|NCT04230330|Nivolumab|nivolumab|mesh-list
154004372|NCT04230330|Asparaginase|asparaginase|mesh-list
154004373|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004374|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154004376|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
154004377|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004378|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004379|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004380|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
154004381|NCT04230330|Hormones|hormones|mesh-ancestor
154004382|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004383|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154004384|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004385|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
154004399|NCT02785068|Protective Agents|protective agents|mesh-ancestor
154004400|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
154004402|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
154004403|NCT05752929|Insulin|insulin|mesh-list
154004404|NCT05752929|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154004405|NCT05752929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154004406|NCT05752929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004407|NCT00880477|Edetic Acid|edetic acid|mesh-list
154004408|NCT00880477|Vaccines|vaccines|mesh-list
154004409|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
154004410|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
154004411|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004412|NCT00880477|Antidotes|antidotes|mesh-ancestor
154004413|NCT00880477|Protective Agents|protective agents|mesh-ancestor
154004414|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
154004415|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
154004416|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004417|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154004418|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
153576503|NCT01712568|Ropinirole|ropinirole|mesh-list
153634907|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634908|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153634909|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153634910|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
153634911|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153634912|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
153634914|NCT00000559|Estradiol|estradiol|mesh-list
153634915|NCT00000559|Estrogens|estrogens|mesh-list
153634916|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634917|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634918|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153634919|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
153634920|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153634921|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153634922|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153634923|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153634924|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153634925|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153634926|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153634927|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634928|NCT00000568|Ipratropium|ipratropium|mesh-list
153634929|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153634931|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634932|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634933|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153634934|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
153634935|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153634936|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
153634937|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634938|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634939|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
153634940|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634954|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634955|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634956|NCT00000601|Progestins|progestins|mesh-ancestor
154004419|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154004420|NCT00882739|Clopidogrel|clopidogrel|mesh-list
154004421|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154004422|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154004423|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154004424|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154004425|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
154004426|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004427|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004428|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004429|NCT02783040|Digoxin|digoxin|mesh-list
154004430|NCT02783040|Midazolam|midazolam|mesh-list
154004431|NCT02783040|BI 425809|bi 425809|mesh-list
154004432|NCT02783040|Omeprazole|omeprazole|mesh-list
154004433|NCT02783040|Warfarin|warfarin|mesh-list
154004434|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154004435|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154004436|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004437|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004438|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154004439|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154004440|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154004441|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154004442|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
154004443|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
154004444|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
154004445|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
153576541|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
153634957|NCT00000625|Zidovudine|zidovudine|mesh-list
153634958|NCT00000625|Didanosine|didanosine|mesh-list
153634959|NCT00000625|Zalcitabine|zalcitabine|mesh-list
153634960|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
153634961|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634962|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153634963|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153634964|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634965|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
153634966|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634967|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153634968|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153634969|NCT00000637|Zidovudine|zidovudine|mesh-list
153634970|NCT00000637|Didanosine|didanosine|mesh-list
153634971|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
153634972|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634973|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153634974|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153634975|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634976|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
153634977|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634978|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154004446|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004447|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004448|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
153762016|NCT00212589|Leucovorin|leucovorin|mesh-list
154004449|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154004450|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004451|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154004452|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004453|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154004454|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154004455|NCT02783040|Protective Agents|protective agents|mesh-ancestor
154004456|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
154004457|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154004458|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154004459|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154004460|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004461|NCT05275686|Fluticasone|fluticasone|mesh-list
154004462|NCT05275686|Xhance|xhance|mesh-list
154004463|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154004464|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154004465|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
154004466|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004467|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004468|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154004469|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
154004470|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
154004471|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154004472|NCT01503606|Clarithromycin|clarithromycin|mesh-list
154004473|NCT01503606|Cefazolin|cefazolin|mesh-list
154004474|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154004475|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004476|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154004477|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634979|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153634980|NCT00000640|Clindamycin|clindamycin|mesh-list
153634981|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
153634982|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
153634984|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153634985|NCT00000640|Primaquine|primaquine|mesh-list
153634986|NCT00000640|Trimethoprim|trimethoprim|mesh-list
153634988|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153634989|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634990|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154004478|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004479|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154004480|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154004481|NCT00882973|genexol-PM|genexol-pm|mesh-list
154004482|NCT00882973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004483|NCT00882973|Tubulin Modulators|tubulin modulators|mesh-ancestor
154004484|NCT00882973|Antimitotic Agents|antimitotic agents|mesh-ancestor
154004485|NCT00882973|Mitosis Modulators|mitosis modulators|mesh-ancestor
154004486|NCT00882973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004487|NCT00805935|Leuprolide|leuprolide|mesh-list
154004488|NCT00805935|Menotropins|menotropins|mesh-list
154004489|NCT00805935|Progesterone|progesterone|mesh-list
154004490|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154004491|NCT00805935|Progestins|progestins|mesh-ancestor
154004492|NCT00805935|Hormones|hormones|mesh-ancestor
154004493|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004494|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004495|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154004496|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
154004497|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154004498|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154004499|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004500|NCT00878917|Dorzolamide|dorzolamide|mesh-list
154004501|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153576585|NCT01712997|Bosentan|bosentan|mesh-list
153634991|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634992|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634993|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
153634994|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153634995|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153634996|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153634997|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153634998|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153634999|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153635000|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635001|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
153635003|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153635004|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635014|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153635015|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
153635016|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153635017|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153635018|NCT00389038|Analgesics|analgesics|mesh-ancestor
153635019|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
153635020|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153635021|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635022|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153635023|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154004502|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154004503|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154004504|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154004505|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004506|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004507|NCT00638118|Fexofenadine|fexofenadine|mesh-list
154004508|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154004509|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154004510|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154004511|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
154004512|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
154004513|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004514|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004515|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004516|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154004517|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154004518|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004519|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
154004520|NCT00590031|Irinotecan|irinotecan|mesh-list
154004521|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004522|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153576603|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153635024|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153635025|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635026|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
153635027|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153635029|NCT00000652|Didanosine|didanosine|mesh-list
153635030|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
153635031|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635032|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635033|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635034|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635035|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
153635036|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635037|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635038|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635039|NCT00000676|Fluconazole|fluconazole|mesh-list
153635040|NCT00000676|Clotrimazole|clotrimazole|mesh-list
153635041|NCT00000676|Miconazole|miconazole|mesh-list
153635042|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
153635043|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635044|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153635045|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635046|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635047|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635048|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153635049|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
153635050|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153635051|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004524|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004525|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004526|NCT02783196|Liraglutide|liraglutide|mesh-list
154004527|NCT02783196|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154004528|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154004529|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004530|NCT02783196|Incretins|incretins|mesh-ancestor
154004531|NCT02783196|Hormones|hormones|mesh-ancestor
154004532|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004533|NCT02782338|Diclofenac|diclofenac|mesh-list
154004534|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154004535|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154004536|NCT02782338|Analgesics|analgesics|mesh-ancestor
154004537|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
154004538|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004539|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004540|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154004541|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154004542|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154004543|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004544|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004545|NCT02782260|Dipyridamole|dipyridamole|mesh-list
153576625|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
153635052|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153635053|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153457768|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
153635054|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153635055|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635056|NCT00000679|Zidovudine|zidovudine|mesh-list
153635057|NCT00000679|Zalcitabine|zalcitabine|mesh-list
153635058|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
153635059|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635060|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635061|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635062|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635063|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
153635064|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635065|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635080|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
153635082|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635083|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635084|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635085|NCT00000712|Zidovudine|zidovudine|mesh-list
153635086|NCT00000712|Acyclovir|acyclovir|mesh-list
153635087|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
153635088|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635089|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154004546|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154004547|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004548|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004549|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154004550|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
154004552|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
154004553|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
154004554|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004555|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004556|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
154004557|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004558|NCT03577704|Paclitaxel|paclitaxel|mesh-list
154004559|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154004560|NCT03577704|Cisplatin|cisplatin|mesh-list
154004561|NCT03577704|Carboplatin|carboplatin|mesh-list
154004562|NCT03577704|Gemcitabine|gemcitabine|mesh-list
154004563|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
154004564|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154004565|NCT03577704|Antibodies|antibodies|mesh-list
153576651|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153635090|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635091|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635092|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
153635093|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635094|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635095|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635096|NCT00000715|Trimethoprim|trimethoprim|mesh-list
153635097|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153635098|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
153635099|NCT00000715|Pentamidine|pentamidine|mesh-list
153635100|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153635101|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635102|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
153635103|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153635104|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153635105|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153635106|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635107|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635108|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153635109|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153635110|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635111|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
153635112|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153635113|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635114|NCT00000718|Zidovudine|zidovudine|mesh-list
153635115|NCT00000718|Zalcitabine|zalcitabine|mesh-list
153635116|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
153635117|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635118|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635119|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635120|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635121|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
153635122|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635123|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154004567|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154004568|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154004569|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004570|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
154004571|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
154004572|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
154004573|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004574|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
154004575|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004576|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004577|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
154004578|NCT00615199|Tofacitinib|tofacitinib|mesh-list
154004579|NCT00615199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154004580|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154004581|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004582|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004583|NCT05328024|Immunomodulating Agents|immunomodulating agents|mesh-list
154004584|NCT05328024|Immunologic Factors|immunologic factors|mesh-ancestor
154004585|NCT05328024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004586|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154004587|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154004588|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
154004589|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004590|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004591|NCT00880867|Poly ICLC|poly iclc|mesh-list
154004592|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
153635124|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635125|NCT00000739|Dapsone|dapsone|mesh-list
153635126|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635127|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
153635142|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635143|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
153635144|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635145|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635146|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635147|NCT00000745|Vaccines|vaccines|mesh-list
153635148|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
153635149|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635150|NCT00000748|Trimethoprim|trimethoprim|mesh-list
153635151|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153635152|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
153635153|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153635154|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635155|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
153635156|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153635157|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154004593|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
154004594|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004595|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154004596|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154004597|NCT02782182|Leucovorin|leucovorin|mesh-list
154004598|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
154004599|NCT02782182|Irinotecan|irinotecan|mesh-list
154004601|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004602|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154004603|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154004604|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004605|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004606|NCT02782182|Antidotes|antidotes|mesh-ancestor
154004607|NCT02782182|Protective Agents|protective agents|mesh-ancestor
154004608|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004609|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
154004610|NCT02782182|Vitamins|vitamins|mesh-ancestor
154004611|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
154004612|NCT02780778|Docetaxel|docetaxel|mesh-list
154004613|NCT02780778|Apatinib|apatinib|mesh-list
154004614|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004615|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
153576715|NCT01713803|Naloxone|naloxone|mesh-list
153635158|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153635159|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635160|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635161|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153635162|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153635163|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635164|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635165|NCT00000751|Zidovudine|zidovudine|mesh-list
153635166|NCT00000751|Immune Sera|immune sera|mesh-list
153635167|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
153635168|NCT00000751|Antibodies|antibodies|mesh-list
153635170|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635171|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635172|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635173|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635174|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
153635175|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635176|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635177|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635178|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
153635179|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635180|NCT00000754|Interferons|interferons|mesh-list
153635181|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
153635182|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
153635183|NCT00000754|Zidovudine|zidovudine|mesh-list
153635184|NCT00000754|Zalcitabine|zalcitabine|mesh-list
153635185|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635186|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
153635187|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635188|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
153635189|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635205|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635207|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154004616|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154004617|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154004618|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004619|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154004620|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004621|NCT00881101|Paclitaxel|paclitaxel|mesh-list
154004622|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154004623|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004624|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
154004625|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
154004626|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
154004627|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004628|NCT00883909|Dutasteride|dutasteride|mesh-list
154004629|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154004630|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154004631|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004632|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004633|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
154004634|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004635|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004636|NCT00634686|Vitamin D|vitamin d|mesh-list
153635208|NCT00000790|Thalidomide|thalidomide|mesh-list
153635209|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153635210|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
153635211|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635212|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
153635213|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635214|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635215|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153635216|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153635217|NCT00000790|Growth Substances|growth substances|mesh-ancestor
153635218|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
153635219|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635220|NCT00000793|Mexiletine|mexiletine|mesh-list
153635221|NCT00000793|Amitriptyline|amitriptyline|mesh-list
153635222|NCT00000793|Benztropine|benztropine|mesh-list
153635223|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153635224|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
153635225|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153635226|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153635227|NCT00000793|Analgesics|analgesics|mesh-ancestor
153635228|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
153635229|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153635230|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635231|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153635232|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153635233|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153635234|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635235|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
153635236|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153635237|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153635238|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154004638|NCT00634686|Vitamins|vitamins|mesh-ancestor
154176571|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
154004639|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
154004640|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004641|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154004642|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154004643|NCT05340192|Octreotide|octreotide|mesh-list
154004644|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004645|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154004646|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004647|NCT03955861|Adalimumab|adalimumab|mesh-list
154004648|NCT03955861|Golimumab|golimumab|mesh-list
154004649|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
154004650|NCT03955861|Etanercept|etanercept|mesh-list
154004651|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154004652|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154004653|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154004654|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154004655|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154004656|NCT03955861|Analgesics|analgesics|mesh-ancestor
154004657|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
154004658|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004659|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635239|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153635240|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153635241|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153635242|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
153635244|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153635245|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153635246|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
153635247|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153635248|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
153635249|NCT00000799|Cidofovir|cidofovir|mesh-list
153635267|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153635268|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153635269|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153635270|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635271|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
153635272|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153635273|NCT00000820|Aldesleukin|aldesleukin|mesh-list
153635274|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635275|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635276|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635277|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
153635278|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635279|NCT00000826|Clarithromycin|clarithromycin|mesh-list
153635281|NCT00000826|Rifabutin|rifabutin|mesh-list
153635282|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153635283|NCT00000826|Fluconazole|fluconazole|mesh-list
153635284|NCT00000826|Trimethoprim|trimethoprim|mesh-list
153635285|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
153635286|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154004660|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004661|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154004662|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
154004663|NCT00881179|Clarithromycin|clarithromycin|mesh-list
154004664|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154004665|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004666|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154004667|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004668|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004669|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154004670|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154004671|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
154004672|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154004673|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004674|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004675|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154004676|NCT02781246|Analgesics|analgesics|mesh-ancestor
154004677|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
154004678|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004679|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154004680|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154004681|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154004682|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
154004683|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004684|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004685|NCT00613951|Insulin|insulin|mesh-list
154004686|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154004687|NCT00613951|Metformin|metformin|mesh-list
154004688|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
154004689|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
153635287|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635288|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153635289|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635290|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635291|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635292|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635293|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
153635294|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153635295|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153635296|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
153635297|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153635298|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004690|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154004692|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154004693|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004694|NCT00881413|Esomeprazole|esomeprazole|mesh-list
154004695|NCT00881413|Pantoprazole|pantoprazole|mesh-list
154004696|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154004697|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004698|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154004699|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004700|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004701|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154004702|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154004703|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004704|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
154004705|NCT00958841|Pasireotide|pasireotide|mesh-list
154004706|NCT00958841|Hormones|hormones|mesh-ancestor
154004707|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004708|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004709|NCT02937116|Cisplatin|cisplatin|mesh-list
154004710|NCT02937116|Gemcitabine|gemcitabine|mesh-list
154004711|NCT02937116|Capecitabine|capecitabine|mesh-list
154004712|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
154004713|NCT02937116|Irinotecan|irinotecan|mesh-list
154004715|NCT02937116|Pemetrexed|pemetrexed|mesh-list
154004716|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004717|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004718|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
154004719|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004720|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154004721|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153635299|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153635300|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153635301|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153635302|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
153635303|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153635304|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153635305|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153635328|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635329|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635330|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635331|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635332|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154004722|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004723|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154004724|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154004725|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154004726|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154004727|NCT00613327|Oxybutynin|oxybutynin|mesh-list
154004728|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
154004729|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
154004730|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004731|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004732|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154004733|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154004734|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
154004735|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004736|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004737|NCT00613327|Urological Agents|urological agents|mesh-ancestor
154004738|NCT04273997|Metronidazole|metronidazole|mesh-list
154004739|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004740|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154004741|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154004742|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154004743|NCT05339802|Linezolid|linezolid|mesh-list
154004744|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154004745|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004746|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154004747|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004748|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004749|NCT04649203|Niacinamide|niacinamide|mesh-list
154004750|NCT04649203|Niacin|niacin|mesh-list
154004751|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
154004753|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
153635333|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635334|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
153635335|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635336|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635337|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153635338|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
153635339|NCT00000883|Azithromycin|azithromycin|mesh-list
153635340|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635341|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635342|NCT00000892|Ritonavir|ritonavir|mesh-list
153635343|NCT00000892|Nelfinavir|nelfinavir|mesh-list
153635344|NCT00000892|Saquinavir|saquinavir|mesh-list
153635345|NCT00000892|Delavirdine|delavirdine|mesh-list
153635346|NCT00000892|Adefovir|adefovir|mesh-list
153635347|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154004755|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
154004756|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004757|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154004758|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
154004759|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004760|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154004761|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
154004762|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154004763|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
154004764|NCT00881725|Metformin|metformin|mesh-list
154004765|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154004766|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004767|NCT00954941|Ondansetron|ondansetron|mesh-list
154004768|NCT00954941|Aprepitant|aprepitant|mesh-list
154004769|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
154004770|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
154004771|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004772|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004773|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154004774|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
154004775|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
154004776|NCT00954941|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154004777|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154004778|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
154004779|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004780|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004781|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154004782|NCT05339646|Ritonavir|ritonavir|mesh-list
154004783|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635348|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635349|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635350|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635351|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635352|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635353|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635354|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635355|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
153635356|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635357|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635358|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635359|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635389|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635390|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154004784|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154004786|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004787|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004788|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154004789|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154004790|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
154004791|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004792|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154004793|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154004794|NCT00630695|Lanreotide|lanreotide|mesh-list
154004795|NCT00630695|Somatostatin|somatostatin|mesh-list
154004796|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004797|NCT00630695|Hormones|hormones|mesh-ancestor
154004798|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004799|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004800|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154004801|NCT00954707|Aspirin|aspirin|mesh-list
154004802|NCT00954707|Clopidogrel|clopidogrel|mesh-list
154004803|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154004804|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154004805|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154004806|NCT00954707|Analgesics|analgesics|mesh-ancestor
154004807|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
154004808|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004809|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004810|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154004811|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154004812|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154004813|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154004814|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004815|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153635391|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635392|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
153635393|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153635394|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
153635395|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635396|NCT00389233|Protective Agents|protective agents|mesh-ancestor
153635397|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635398|NCT00389233|Vitamins|vitamins|mesh-ancestor
153635399|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
154004817|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004818|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
154004819|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154004820|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154004821|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154004822|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
154004823|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004824|NCT00630851|Donepezil|donepezil|mesh-list
154004825|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154004826|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004827|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004828|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
154004829|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004830|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004831|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
154004832|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
154004833|NCT00613171|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154004834|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153576912|NCT01714570|Tazobactam|tazobactam|mesh-list
153567090|NCT06071416|Calcium|calcium|mesh-list
153635400|NCT00389233|Laxatives|laxatives|mesh-ancestor
153635401|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153635404|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
153635405|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635424|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
153635425|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635426|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635427|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635428|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635429|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635430|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635431|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635432|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
153635433|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635434|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635435|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635436|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635437|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635438|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
153635439|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153635440|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153635441|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153635442|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153635443|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153635444|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635445|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
153635446|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153635447|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
153635448|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635450|NCT00000922|Efavirenz|efavirenz|mesh-list
153635451|NCT00000922|Nevirapine|nevirapine|mesh-list
153635452|NCT00000922|Abacavir|abacavir|mesh-list
153635453|NCT00000922|Stavudine|stavudine|mesh-list
153635454|NCT00000922|Didanosine|didanosine|mesh-list
154004835|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004836|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004837|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004838|NCT05156892|Tamoxifen|tamoxifen|mesh-list
154004839|NCT05156892|Itraconazole|itraconazole|mesh-list
154004840|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154004841|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
154004842|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154004843|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004844|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154004845|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004846|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154004847|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154004848|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154004849|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
154004850|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004851|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154004852|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154004853|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004854|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004855|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154004856|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154004857|NCT03894345|Prazosin|prazosin|mesh-list
154004858|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154004859|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153576932|NCT01714765|Everolimus|everolimus|mesh-list
153635455|NCT00000922|Nelfinavir|nelfinavir|mesh-list
153635456|NCT00000922|Indinavir|indinavir|mesh-list
153635457|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635458|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635459|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635460|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635461|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
153635462|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635463|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635464|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635465|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153635466|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635467|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153635499|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635500|NCT00000952|Ritonavir|ritonavir|mesh-list
153635501|NCT00000952|Lamivudine|lamivudine|mesh-list
153635502|NCT00000952|Zidovudine|zidovudine|mesh-list
153635503|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635504|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154004861|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154004862|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
154004864|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004865|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004866|NCT02859077|Carboplatin|carboplatin|mesh-list
154004867|NCT02859077|Gemcitabine|gemcitabine|mesh-list
154004868|NCT02859077|Pemetrexed|pemetrexed|mesh-list
154004869|NCT02859077|Gefitinib|gefitinib|mesh-list
154004870|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004871|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154004872|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
154004873|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004874|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004875|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154004876|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154004877|NCT02859077|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154004878|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154004879|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154004880|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
154004881|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154004882|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154004883|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154004884|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004885|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004886|NCT00879385|Decitabine|decitabine|mesh-list
154004887|NCT00879385|Panitumumab|panitumumab|mesh-list
154004888|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153635505|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635506|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635507|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635508|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635509|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635510|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
153635511|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635512|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635530|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153635531|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635532|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153635533|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635534|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635535|NCT00000970|Ganciclovir|ganciclovir|mesh-list
153635536|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153635537|NCT00000970|Foscarnet|foscarnet|mesh-list
153635538|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153635539|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
154004889|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
154004890|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004891|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004892|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004893|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004894|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
154004895|NCT00914121|Bosutinib|bosutinib|mesh-list
153762469|NCT00122837|Analgesics|analgesics|mesh-ancestor
154004896|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154004897|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004898|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154004900|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004901|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004902|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004903|NCT00914121|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154004904|NCT00914121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154004905|NCT00953225|Vitamin D|vitamin d|mesh-list
154004906|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
154176572|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
154176573|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154176574|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154176575|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154176576|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
154004907|NCT00953225|Vitamins|vitamins|mesh-ancestor
154004908|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
154004909|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004910|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154004911|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154004912|NCT03819231|Oxytocin|oxytocin|mesh-list
153635540|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635543|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635544|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635545|NCT00000973|Leucovorin|leucovorin|mesh-list
153635546|NCT00000973|Zidovudine|zidovudine|mesh-list
153635547|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
153635548|NCT00000973|Calcium|calcium|mesh-list
153635549|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
153635550|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153635551|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635552|NCT00000973|Antidotes|antidotes|mesh-ancestor
153635553|NCT00000973|Protective Agents|protective agents|mesh-ancestor
153635554|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
153635555|NCT00000973|Vitamins|vitamins|mesh-ancestor
153635556|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
153635557|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
153635558|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635559|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154004913|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
154004914|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154004915|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004916|NCT00613015|Guanfacine|guanfacine|mesh-list
154004917|NCT00613015|Modafinil|modafinil|mesh-list
154004918|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154004919|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004920|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154004921|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154004922|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154004923|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004924|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154004925|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154004926|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154004927|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154004928|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
154004929|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004930|NCT02779608|Docetaxel|docetaxel|mesh-list
154004931|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004932|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
154004933|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
154004934|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
154004935|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004937|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
154004938|NCT02543671|Vitamins|vitamins|mesh-ancestor
154004939|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
154004940|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577011|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
153635560|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635561|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635562|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
153635563|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635564|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635565|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635566|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
153635567|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153635568|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153635569|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153635570|NCT00000985|Acyclovir|acyclovir|mesh-list
153635571|NCT00000985|Foscarnet|foscarnet|mesh-list
153635572|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153635573|NCT00000985|Vidarabine|vidarabine|mesh-list
153635574|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
153635587|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635588|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635589|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635590|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004941|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154004942|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154004943|NCT02838992|Cyclosporine|cyclosporine|mesh-list
154004944|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
154004945|NCT02838992|Cyclosporins|cyclosporins|mesh-list
154004946|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
154004947|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154004948|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
154004949|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004950|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154004951|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154004952|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
154004953|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004954|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154004955|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154004956|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154004957|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
154004958|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154004959|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
154004960|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154004961|NCT00879541|Factor VIII|factor viii|mesh-list
154004962|NCT00879541|Coagulants|coagulants|mesh-ancestor
154004963|NCT00884299|Antioxidants|antioxidants|mesh-list
154004964|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004965|NCT00884299|Protective Agents|protective agents|mesh-ancestor
154004966|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004967|NCT02843126|Trastuzumab|trastuzumab|mesh-list
154004968|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154004969|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762530|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
154004970|NCT04201652|Anesthetics|anesthetics|mesh-list
154004984|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154004985|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
154004986|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
154004987|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
154004988|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
154004989|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154004990|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154004991|NCT02838758|Lidocaine|lidocaine|mesh-list
154004992|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
154004993|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
154004994|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154004995|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154004996|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
154004997|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154004998|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154004999|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154005000|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154005001|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005002|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635591|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
153635592|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635593|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635594|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635595|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
153635596|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153635597|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153635598|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153635599|NCT00001030|Clarithromycin|clarithromycin|mesh-list
153635600|NCT00001030|Rifabutin|rifabutin|mesh-list
153635601|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635602|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635603|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153635604|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635605|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635606|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635607|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635608|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153635609|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
153635610|NCT05639127|Prednisolone|prednisolone|mesh-list
153635611|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153635612|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
153635613|NCT05639127|Hormones|hormones|mesh-ancestor
153635614|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153635615|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635616|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153635617|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635618|NCT00001033|Pyridoxine|pyridoxine|mesh-list
153635619|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
153635620|NCT00001033|Levofloxacin|levofloxacin|mesh-list
153635621|NCT00001033|Rifampin|rifampin|mesh-list
153635622|NCT00001033|Isoniazid|isoniazid|mesh-list
153635623|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
153635624|NCT00001033|Ethambutol|ethambutol|mesh-list
153635625|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153635626|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635627|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154005004|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
154005005|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005006|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658761|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
154005007|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005008|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
154005009|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154005010|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005011|NCT02843204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154005012|NCT02843204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005013|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
154005014|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154005015|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005016|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
154005017|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
154005018|NCT04227990|Docetaxel|docetaxel|mesh-list
154005019|NCT04227990|Doxorubicin|doxorubicin|mesh-list
154005020|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005021|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
154005022|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005023|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005024|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154005025|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
154005026|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005027|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577103|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635628|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153635629|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153635631|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635632|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635633|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153635634|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635635|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153635636|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
153635637|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
153635665|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635666|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635667|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
153635668|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635669|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635670|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635671|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153635672|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
153635674|NCT00001045|Nevirapine|nevirapine|mesh-list
153635675|NCT00001045|Didanosine|didanosine|mesh-list
153635676|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
154005028|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154005029|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
154005030|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
154005031|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
154005032|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154005033|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154005034|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154005035|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005036|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
154005037|NCT02606409|Propofol|propofol|mesh-list
154005038|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154005039|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005040|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005041|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005042|NCT02606409|Analgesics|analgesics|mesh-ancestor
154005043|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
154005044|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005045|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154005046|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154005048|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
154005049|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005050|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005051|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154005052|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
154005053|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
154005054|NCT00611767|Thiopental|thiopental|mesh-list
154005055|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
154005056|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154005057|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005058|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005059|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154005060|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
154005061|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
154005062|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
154005063|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
154005064|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005065|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635677|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005067|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
154005068|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154005069|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154005070|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154005071|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005072|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005073|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005074|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005075|NCT00803361|Analgesics|analgesics|mesh-ancestor
154005076|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
154005077|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005078|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
154005079|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154005080|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
154005081|NCT02837198|Dotinurad|dotinurad|mesh-list
154005082|NCT02837198|FYX-051|fyx-051|mesh-list
154005083|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
154005084|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
154005085|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005086|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005087|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005088|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154005089|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154005090|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154005091|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005092|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635678|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635679|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635680|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635681|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
153635682|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635683|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635699|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635700|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635701|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635702|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635703|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635704|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635705|NCT00001066|Lamivudine|lamivudine|mesh-list
153635706|NCT00001066|Zidovudine|zidovudine|mesh-list
153635707|NCT00001066|Didanosine|didanosine|mesh-list
153635708|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635709|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635710|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005093|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154005094|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005095|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005097|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005098|NCT04038307|Analgesics|analgesics|mesh-ancestor
154005099|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
154005100|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005101|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005102|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
154005103|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
154005104|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154005105|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005106|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154005107|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154005108|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005109|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005110|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005111|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
154005112|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
154005113|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
154005114|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153635711|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635712|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
153635713|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635714|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635715|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635716|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
153635717|NCT00001075|Ritonavir|ritonavir|mesh-list
153635718|NCT00001075|Lamivudine|lamivudine|mesh-list
153635719|NCT00001075|Zidovudine|zidovudine|mesh-list
153635720|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635721|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635722|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635723|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635724|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635725|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635726|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635727|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
153635728|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635729|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635730|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635731|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635732|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635733|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
153635735|NCT00001084|Zidovudine|zidovudine|mesh-list
153635736|NCT00001084|Stavudine|stavudine|mesh-list
153635737|NCT00001084|Indinavir|indinavir|mesh-list
153635738|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635739|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635740|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635741|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635742|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
153635743|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635744|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154005115|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154005116|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005117|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005118|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005119|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005121|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005122|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005123|NCT02778360|Methylphenidate|methylphenidate|mesh-list
154005124|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154005125|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005126|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154005127|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154005128|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005129|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635745|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635746|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
153635767|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635768|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
153635769|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635770|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635771|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635772|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635773|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635774|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
153635775|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153635776|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153635777|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153635778|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153635779|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153635781|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153635782|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
153635783|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635784|NCT00001111|Zidovudine|zidovudine|mesh-list
153635785|NCT00001111|Nevirapine|nevirapine|mesh-list
153635786|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
153635787|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635788|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635789|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635790|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635791|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
153635792|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635793|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635794|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635795|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153635796|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153635797|NCT00001114|Interferons|interferons|mesh-list
153635798|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
153635799|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
153635800|NCT00001114|Didanosine|didanosine|mesh-list
153635801|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635802|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
153635803|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635804|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
153635805|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635806|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
153635807|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005130|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
154005131|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005132|NCT00953147|Ciclesonide|ciclesonide|mesh-list
154005133|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
154005134|NCT00953147|Hormones|hormones|mesh-ancestor
154005135|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005136|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005137|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154005138|NCT05333744|Prednisone|prednisone|mesh-list
154005139|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005140|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
154005141|NCT05333744|Hormones|hormones|mesh-ancestor
154005142|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005143|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005144|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154005145|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005146|NCT04250246|Nivolumab|nivolumab|mesh-list
154005147|NCT04250246|Ipilimumab|ipilimumab|mesh-list
154005148|NCT04250246|Guadecitabine|guadecitabine|mesh-list
154005149|NCT04250246|Azacitidine|azacitidine|mesh-list
154005150|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154005151|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005152|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154005153|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005154|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005155|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
154005156|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005158|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005159|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
154005160|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005161|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
154005162|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154005163|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635808|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635831|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635832|NCT00389272|Acetaminophen|acetaminophen|mesh-list
153635834|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153635835|NCT00389272|Analgesics|analgesics|mesh-ancestor
153635836|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
153635837|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153635838|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635839|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
154005164|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154005165|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154005166|NCT04273529|Growth Substances|growth substances|mesh-ancestor
154005167|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
154005168|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005170|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154005171|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005172|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005173|NCT02779530|Diclofenac|diclofenac|mesh-list
154005174|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154005175|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005176|NCT02779530|Analgesics|analgesics|mesh-ancestor
154005177|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
154005178|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005179|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005180|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005181|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005182|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154005183|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005184|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005185|NCT00952523|Adapalene|adapalene|mesh-list
153577258|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
153635840|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153635841|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153635842|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153635843|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153635844|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635845|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635846|NCT00389311|Nonoxynol|nonoxynol|mesh-list
153635847|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153635848|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153635849|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458073|NCT03590262|Metformin|metformin|mesh-list
153635850|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153635851|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
153635852|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153635853|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153635854|NCT00001213|Cysteamine|cysteamine|mesh-list
153635855|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153635856|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635857|NCT00000114|Vitamins|vitamins|mesh-list
153635858|NCT00000114|Vitamin E|vitamin e|mesh-list
153635859|NCT00000114|Vitamin A|vitamin a|mesh-list
153635860|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
153635878|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635881|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
153635882|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153635883|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
153635884|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153635885|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005186|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154005188|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154005189|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
154005190|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005191|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
154005192|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154005193|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005194|NCT00952523|Analgesics|analgesics|mesh-ancestor
154005195|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
154005196|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005197|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005198|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005199|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005200|NCT04249154|Leuprolide|leuprolide|mesh-list
154005201|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154005202|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
154005203|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154005204|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005205|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154005206|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005207|NCT02857361|Ketamine|ketamine|mesh-list
153635886|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153635887|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
153635888|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153635889|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
153635890|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635891|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153635892|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153635893|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
153635894|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
153635895|NCT00001303|Protective Agents|protective agents|mesh-ancestor
153635896|NCT00000120|Erythromycin|erythromycin|mesh-list
153635897|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
153635898|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153635899|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
153635900|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
153635901|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635902|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635903|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153635904|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153635905|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635906|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635907|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153635908|NCT00001333|Topotecan|topotecan|mesh-list
153635909|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153635910|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153635911|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635912|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635913|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635914|NCT00001378|Fenretinide|fenretinide|mesh-list
153635915|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635916|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154005208|NCT02857361|Analgesics|analgesics|mesh-ancestor
154005209|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
154005210|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005211|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005212|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154005213|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154005214|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
154005215|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
154005216|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005217|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154005218|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154005219|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005220|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005221|NCT02778126|Prexasertib|prexasertib|mesh-list
154005222|NCT02778126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153577304|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
153635917|NCT00001378|Protective Agents|protective agents|mesh-ancestor
153635929|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153635930|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635932|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635933|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153635934|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
153635935|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153635936|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635937|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635938|NCT00388635|Prednisone|prednisone|mesh-list
153635939|NCT00388635|Melphalan|melphalan|mesh-list
153635940|NCT00388635|Bortezomib|bortezomib|mesh-list
153635941|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153635942|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
153635943|NCT00388635|Hormones|hormones|mesh-ancestor
153635944|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153635945|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635946|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153635947|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635948|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153635949|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
153635950|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635951|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153635952|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153635953|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
153635954|NCT00001474|Interleukin-2|interleukin-2|mesh-list
153635955|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635956|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153635957|NCT00001474|Analgesics|analgesics|mesh-ancestor
153635958|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
153635959|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153635960|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635961|NCT00001483|Sertraline|sertraline|mesh-list
153635962|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153635963|NCT00001483|Bupropion|bupropion|mesh-list
153635964|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
153635965|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153635966|NCT00001483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153635967|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153635968|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005223|NCT02778126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005224|NCT02778126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005226|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154005227|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
154005228|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005229|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005231|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154005232|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
154005233|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005234|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005235|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154005236|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005237|NCT02777814|Entecavir|entecavir|mesh-list
154005238|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
154005239|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005240|NCT02778906|Abatacept|abatacept|mesh-list
154005241|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154005242|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635969|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635970|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153635971|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
153635972|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635973|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153635974|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153635975|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153635976|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
153635986|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153635987|NCT00001507|Antibodies|antibodies|mesh-list
153635988|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
153635989|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153635990|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
153635991|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635992|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635994|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635995|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
153635996|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635997|NCT00001576|Leucovorin|leucovorin|mesh-list
153635998|NCT00001576|Melphalan|melphalan|mesh-list
153635999|NCT00001576|Floxuridine|floxuridine|mesh-list
153636000|NCT00001576|Antidotes|antidotes|mesh-ancestor
153636001|NCT00001576|Protective Agents|protective agents|mesh-ancestor
153636002|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636003|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
153636004|NCT00001576|Vitamins|vitamins|mesh-ancestor
153636005|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
153636006|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153636007|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
153636008|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636009|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636010|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153568049|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
153636011|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153636012|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
153636013|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005243|NCT02778906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154005244|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005245|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005246|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
154005247|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005248|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005250|NCT00630929|Celecoxib|celecoxib|mesh-list
154005251|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154005252|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005253|NCT00630929|Analgesics|analgesics|mesh-ancestor
154005254|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
154005255|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005256|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005257|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005258|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005259|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154005260|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005261|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005262|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154005263|NCT04204928|Pralsetinib|pralsetinib|mesh-list
154005264|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005265|NCT02834546|Sorafenib|sorafenib|mesh-list
154005266|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005267|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153762830|NCT05943496|Obinutuzumab|obinutuzumab|mesh-list
154005268|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005269|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005270|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154005271|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154005272|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
154005273|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005274|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154005275|NCT04227912|Anesthetics|anesthetics|mesh-list
153577340|NCT01717404|Mexiletine|mexiletine|mesh-list
153636014|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
153636015|NCT00000147|Prednisone|prednisone|mesh-list
153636016|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
153636017|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153636018|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153636019|NCT00000147|Prednisolone|prednisolone|mesh-list
153636020|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
154005276|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
154005277|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005278|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005279|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
154005280|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005281|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154005282|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005283|NCT04227912|Analgesics|analgesics|mesh-ancestor
154005284|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005285|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005286|NCT02854787|Phenylephrine|phenylephrine|mesh-list
154005287|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
154005288|NCT02854787|Norepinephrine|norepinephrine|mesh-list
154005289|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154005290|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
154005291|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
154005292|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005293|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005294|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
154005295|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154005296|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
154005297|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
154005298|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153636021|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153636022|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
153636023|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636024|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
153636025|NCT00000147|Hormones|hormones|mesh-ancestor
153636026|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636027|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568202|NCT04159155|Niraparib|niraparib|mesh-list
153636028|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153636029|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636030|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
153636031|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
153636032|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636033|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153458115|NCT04028778|Gefitinib|gefitinib|mesh-list
153636034|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153636035|NCT00000147|Protective Agents|protective agents|mesh-ancestor
153636036|NCT00001624|Insulin|insulin|mesh-list
153636037|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153636038|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636039|NCT00001666|Methamphetamine|methamphetamine|mesh-list
153636040|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153636041|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636042|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
153636043|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
153636044|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636061|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636062|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636063|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636064|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005299|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154005300|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154005301|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
154005302|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659068|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
154005303|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005304|NCT02854787|Protective Agents|protective agents|mesh-ancestor
154005305|NCT02778828|Linezolid|linezolid|mesh-list
154005306|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154005307|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005308|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154005309|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005310|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005311|NCT02777736|Methotrexate|methotrexate|mesh-list
154005312|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154005313|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
154005314|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154005315|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005316|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153577396|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636065|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153636066|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153636068|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636070|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153636071|NCT00001696|Protective Agents|protective agents|mesh-ancestor
153636072|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636073|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636074|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153636075|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636076|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636077|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
153636078|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153636079|NCT00001696|Estrogens|estrogens|mesh-ancestor
153636080|NCT00001696|Hormones|hormones|mesh-ancestor
153636081|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636082|NCT00389428|Cytarabine|cytarabine|mesh-list
153636083|NCT00389428|Daunorubicin|daunorubicin|mesh-list
153636084|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153636085|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
153636086|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636087|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636088|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
153636089|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636090|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153636091|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
153636092|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636093|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153636094|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153636095|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153636096|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636097|NCT00001720|Alendronate|alendronate|mesh-list
153568275|NCT03860038|Hormones|hormones|mesh-ancestor
153636098|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154005318|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005319|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005320|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
154005321|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005322|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154005323|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005324|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
154005325|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005326|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154005327|NCT02836184|Niacin|niacin|mesh-list
154005328|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
154005329|NCT02836184|Niacinamide|niacinamide|mesh-list
154005330|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
154005331|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005332|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154005333|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
154005334|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005335|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154005336|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
154005337|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
154005338|NCT02836184|Vitamins|vitamins|mesh-ancestor
154005339|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
154005340|NCT02836184|Antacids|antacids|mesh-ancestor
153577422|NCT01717950|Antacids|antacids|mesh-ancestor
153636099|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636100|NCT00001723|Orlistat|orlistat|mesh-list
153636101|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636120|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153636121|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636122|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636123|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636124|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
153636125|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636126|NCT00000171|Melatonin|melatonin|mesh-list
153636127|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
153636128|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636129|NCT00000171|Protective Agents|protective agents|mesh-ancestor
153636130|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636131|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153636132|NCT05641636|Hormones|hormones|mesh-list
153636133|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636134|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636135|NCT00000177|Estrogens|estrogens|mesh-list
153636136|NCT00000177|Hormones|hormones|mesh-ancestor
153636137|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636138|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636140|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153636141|NCT00000216|Narcotics|narcotics|mesh-ancestor
153636142|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005341|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154005343|NCT02775474|Methadone|methadone|mesh-list
154005344|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154005345|NCT02775474|Narcotics|narcotics|mesh-ancestor
154005346|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005347|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005348|NCT02775474|Analgesics|analgesics|mesh-ancestor
154005349|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
154005350|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005351|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154005352|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154005353|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
154005354|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
154005355|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
154005356|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
154005357|NCT05158686|Paclitaxel|paclitaxel|mesh-list
153577437|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153636143|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636144|NCT00000216|Analgesics|analgesics|mesh-ancestor
153636145|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
153636146|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636147|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153636148|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
153636149|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153568380|NCT03478488|Gemcitabine|gemcitabine|mesh-list
153636150|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
153636151|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
153636152|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153636153|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636154|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153636166|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
153907559|NCT01228019|Niacin|niacin|mesh-list
153636167|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153636169|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
153636170|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153636171|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
153636172|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
153636173|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153636174|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636175|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153636176|NCT00000255|Analgesics|analgesics|mesh-ancestor
153636177|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
153636178|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636179|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
153636180|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153636181|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
153636182|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
153636183|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153636184|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636185|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153636186|NCT00000258|Analgesics|analgesics|mesh-ancestor
153636187|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
153636188|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636189|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
153636190|NCT00389506|Fludarabine|fludarabine|mesh-list
153636191|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
153636192|NCT00389506|Immunotoxins|immunotoxins|mesh-list
153636193|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153636194|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
153636195|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636196|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005358|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154005360|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
154005361|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
154005362|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
154005363|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005364|NCT02835794|Azacitidine|azacitidine|mesh-list
154005365|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
154005366|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005367|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
154005368|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005369|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005370|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005371|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154005372|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154005373|NCT02836028|Temozolomide|temozolomide|mesh-list
154005374|NCT02836028|Talazoparib|talazoparib|mesh-list
154005375|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153636197|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153636198|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
153636199|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636200|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636201|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153636202|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153636203|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
153636204|NCT00389506|Immunoconjugates|immunoconjugates|mesh-ancestor
153636205|NCT00389584|Irinotecan|irinotecan|mesh-list
153636206|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153636207|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153636208|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636209|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636210|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636211|NCT00000324|Tryptophan|tryptophan|mesh-list
153636212|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153636213|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636214|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153636215|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
153636216|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153636217|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153636251|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153636253|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636279|NCT03295552|Decitabine|decitabine|mesh-list
153636280|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636281|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153636282|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
153636283|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636285|NCT05629468|Azithromycin|azithromycin|mesh-list
153636286|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153636287|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153636288|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636289|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
153636291|NCT00000378|Nortriptyline|nortriptyline|mesh-list
153636292|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636293|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154005376|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
154005377|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005378|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005379|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154005380|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005382|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154005383|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
154005384|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005385|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005386|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154005387|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154005388|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
154005389|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005390|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005391|NCT04227210|Vaccines|vaccines|mesh-list
154005392|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
154005393|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005394|NCT02833766|Doxorubicin|doxorubicin|mesh-list
154005395|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154005396|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005397|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154005398|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154005399|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577472|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636294|NCT00000378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153636295|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153636296|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636297|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636298|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636299|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
153636300|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636301|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153636303|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636304|NCT00000381|Fluoxetine|fluoxetine|mesh-list
153636305|NCT00000381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153636306|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153636307|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636335|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636337|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636338|NCT00000420|Norinyl|norinyl|mesh-list
153636339|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153636340|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153636341|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153636342|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
153636343|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154005400|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005402|NCT04813380|Immunologic Factors|immunologic factors|mesh-ancestor
154005403|NCT04813380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005404|NCT04951362|Ivermectin|ivermectin|mesh-list
154005405|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154005406|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005407|NCT02833610|Denosumab|denosumab|mesh-list
154005408|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154005409|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005410|NCT04225728|Iron|iron|mesh-list
154005411|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154005412|NCT04225728|Teferrol|teferrol|mesh-list
154005413|NCT04225728|Trace Elements|trace elements|mesh-ancestor
154005414|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
154005415|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005416|NCT04225728|Hematinics|hematinics|mesh-ancestor
154005417|NCT02835716|Ustekinumab|ustekinumab|mesh-list
154005418|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
154005419|NCT04247984|Bevacizumab|bevacizumab|mesh-list
154005420|NCT04247984|Capecitabine|capecitabine|mesh-list
154005421|NCT04247984|Fluorouracil|fluorouracil|mesh-list
154005422|NCT04247984|Irinotecan|irinotecan|mesh-list
154005423|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154005424|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005425|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154005426|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153636344|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636345|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153636346|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153636347|NCT00000426|Calcium|calcium|mesh-list
153636348|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153636349|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636350|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153636351|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636352|NCT00000456|Naltrexone|naltrexone|mesh-list
153636353|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153636370|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
153636371|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636372|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636373|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
153636374|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153636375|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153636376|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636377|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636378|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636379|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636380|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153636381|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
153636382|NCT05448820|Doxorubicin|doxorubicin|mesh-list
153636383|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154005427|NCT04247984|Growth Substances|growth substances|mesh-ancestor
154005428|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005429|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
154005430|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005432|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005433|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005434|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
154005435|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154005436|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154005437|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005438|NCT00948389|Dasatinib|dasatinib|mesh-list
154005439|NCT00948389|Lomustine|lomustine|mesh-list
154005440|NCT00948389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154005441|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154005442|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005443|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005444|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005445|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154005446|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
154005447|NCT02775318|Bupivacaine|bupivacaine|mesh-list
153577521|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636384|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636385|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153636386|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153636387|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636388|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636389|NCT00000468|Plasminogen|plasminogen|mesh-list
153636390|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153636391|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153636392|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153636393|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636394|NCT02972476|Fluticasone|fluticasone|mesh-list
153636395|NCT02972476|Xhance|xhance|mesh-list
153636396|NCT02972476|Budesonide|budesonide|mesh-list
153636397|NCT02972476|Bromides|bromides|mesh-list
153636398|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
153636399|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153636400|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153636401|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636402|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153636403|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
153636404|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636405|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636406|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153636407|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
153636408|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
153636426|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153636427|NCT05349838|Dolutegravir|dolutegravir|mesh-list
153636428|NCT05349838|Rilpivirine|rilpivirine|mesh-list
153636429|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
153636430|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153636431|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154005448|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
154005449|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
154005450|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005451|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005452|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
154005453|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005454|NCT00948155|Varenicline|varenicline|mesh-list
154005455|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154005456|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154005457|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
154005458|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005459|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005460|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005461|NCT02776956|Atorvastatin|atorvastatin|mesh-list
154005462|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154005463|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154005464|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
153577544|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636432|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636433|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636434|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153636438|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153636439|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153636441|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
153636442|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
153636443|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636444|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
153636445|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636446|NCT05305456|Protective Agents|protective agents|mesh-ancestor
153636447|NCT00388986|Glyburide|glyburide|mesh-list
153636448|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153636449|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636450|NCT05233696|Paclitaxel|paclitaxel|mesh-list
153636451|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153636452|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
153636453|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153636454|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636455|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
153636456|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
153636457|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
153636458|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636459|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153636460|NCT05233696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153636461|NCT00000492|Propranolol|propranolol|mesh-list
153636462|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153636463|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153636464|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636465|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636492|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636493|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
153636494|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153636495|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636496|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153636497|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153636498|NCT00389935|Growth Substances|growth substances|mesh-ancestor
153636499|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
153636500|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005466|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154005467|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154005468|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005469|NCT04910178|Empagliflozin|empagliflozin|mesh-list
154005470|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
154005471|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154005472|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154005473|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005474|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154005475|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005476|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154005477|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005478|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154005479|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154005480|NCT04910178|Protective Agents|protective agents|mesh-ancestor
154005481|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
154005482|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154005483|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
154005484|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154005485|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154005486|NCT02778594|Levodopa|levodopa|mesh-list
154005487|NCT02778594|Benserazide|benserazide|mesh-list
154005488|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153577564|NCT01718587|Lamivudine|lamivudine|mesh-list
153636501|NCT05116930|Atropine|atropine|mesh-list
153636502|NCT05116930|Neostigmine|neostigmine|mesh-list
153636503|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153636504|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153636505|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153636506|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
153636507|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636508|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636509|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153636510|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
153636511|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
153636512|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
153636526|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
153636527|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636528|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636529|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153636531|NCT00000522|Amlodipine|amlodipine|mesh-list
153636532|NCT00000522|Enalapril|enalapril|mesh-list
153636533|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
153636534|NCT00000522|Doxazosin|doxazosin|mesh-list
153636535|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153636536|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153636537|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636538|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636539|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154005489|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154005490|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
154005491|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005492|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005493|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005494|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005495|NCT02775006|Docetaxel|docetaxel|mesh-list
154005496|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154005497|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005498|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
154005499|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
154005500|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
154005501|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005502|NCT02775006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154005503|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154005504|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005505|NCT04851834|Cisplatin|cisplatin|mesh-list
154005506|NCT04851834|Carboplatin|carboplatin|mesh-list
154005507|NCT04851834|Temozolomide|temozolomide|mesh-list
154005508|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005509|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154005510|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
154005511|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005512|NCT02776722|Tagatose|tagatose|mesh-list
154005513|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154005514|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
154005515|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
154005516|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005517|NCT02776878|Dasatinib|dasatinib|mesh-list
154005518|NCT02776878|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153577585|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153569072|NCT04747795|Vitamins|vitamins|mesh-ancestor
153636540|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636541|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
153636542|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153636543|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
153636544|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636545|NCT00000522|Diuretics|diuretics|mesh-ancestor
153636546|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
153636549|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153636550|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153636551|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636552|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636553|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154005519|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154005520|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005521|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005522|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005523|NCT02772822|Rituximab|rituximab|mesh-list
154005524|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154005525|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005526|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
154005527|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005528|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005529|NCT00635076|Alprazolam|alprazolam|mesh-list
154005530|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154005532|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005533|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154005534|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154005535|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154005536|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
154005537|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
154005538|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005539|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005540|NCT02772744|Ribavirin|ribavirin|mesh-list
154005541|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
154005542|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
154005543|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005544|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
154005545|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005546|NCT02774382|Vancomycin|vancomycin|mesh-list
154005547|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153636554|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
153636555|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
153636556|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636557|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153636558|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153636559|NCT03126799|Bevacizumab|bevacizumab|mesh-list
153636560|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153636561|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153636562|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636563|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153636564|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153636565|NCT03126799|Growth Substances|growth substances|mesh-ancestor
153636566|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636567|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
153636568|NCT03126799|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153636569|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153636570|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636571|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636572|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154005548|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005549|NCT02774460|Amlodipine|amlodipine|mesh-list
154005550|NCT02774460|Candesartan|candesartan|mesh-list
154005551|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
154005552|NCT02774460|Lisinopril|lisinopril|mesh-list
154005553|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154005554|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154005555|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005556|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005557|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154005558|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005559|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
154005560|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154005561|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153569166|NCT04553536|Rocuronium|rocuronium|mesh-list
154005562|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154005563|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
154005564|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005565|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154005566|NCT02774460|Protective Agents|protective agents|mesh-ancestor
154005567|NCT02772354|Metoprolol|metoprolol|mesh-list
153636590|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
153636591|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153636592|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636593|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636594|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153636595|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153636596|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153636597|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636598|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153636599|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153636600|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153636601|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153636602|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153636603|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636604|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636605|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636606|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
153636607|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
153636608|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636609|NCT00000534|Calcium|calcium|mesh-list
153636610|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153636611|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636612|NCT04935814|Vasopressins|vasopressins|mesh-list
153636613|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
153636614|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
153636615|NCT04935814|Coagulants|coagulants|mesh-ancestor
153636616|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153636617|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153636618|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
153636619|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636620|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
153636621|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154005568|NCT02772354|Verapamil|verapamil|mesh-list
154005569|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154005570|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154005571|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
154005572|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
154005573|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005574|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005575|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154005576|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154005577|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154005578|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
154005579|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005580|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005581|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154005582|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005583|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154005584|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
154005586|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005587|NCT02767752|Gemcitabine|gemcitabine|mesh-list
154005588|NCT02767752|Capecitabine|capecitabine|mesh-list
154005589|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005590|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
154005591|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005592|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005593|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154005594|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
154005595|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005596|NCT02835404|Nedaplatin|nedaplatin|mesh-list
154005597|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636622|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636624|NCT00000555|Vitamin E|vitamin e|mesh-list
153636625|NCT00000555|Hormones|hormones|mesh-list
153636626|NCT00000555|Progesterone|progesterone|mesh-list
153636627|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153636628|NCT00000555|Estrogens|estrogens|mesh-list
153636641|NCT00000576|Beclomethasone|beclomethasone|mesh-list
153636642|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636643|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
153636644|NCT00000576|Hormones|hormones|mesh-ancestor
153636645|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636646|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636647|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153636649|NCT00000579|Ketoconazole|ketoconazole|mesh-list
153636650|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
154005598|NCT00885781|SMOFlipid|smoflipid|mesh-list
154005599|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154005600|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154005601|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154005602|NCT02767674|Prednisone|prednisone|mesh-list
154005603|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
154005604|NCT02767674|Rituximab|rituximab|mesh-list
154005605|NCT02767674|Gemcitabine|gemcitabine|mesh-list
154005606|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
154005608|NCT02767674|Vindesine|vindesine|mesh-list
154005609|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005610|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
154005611|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005612|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005613|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154005614|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
154005615|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005616|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005617|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154005618|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154005619|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005620|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
154005621|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005622|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
154005623|NCT02767674|Hormones|hormones|mesh-ancestor
154005624|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005625|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153577700|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
153636651|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153636652|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153636653|NCT00000579|Prednisolone|prednisolone|mesh-list
153636654|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
153636655|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153636656|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
153636657|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636658|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
153636660|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636661|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636662|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153636663|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
153636664|NCT00000579|Hormones|hormones|mesh-ancestor
153636665|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636666|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153636667|NCT00000579|Protective Agents|protective agents|mesh-ancestor
153636668|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153636669|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636670|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
154005626|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154005627|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154005628|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154005629|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005630|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154005631|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
154005632|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
154005633|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
154005635|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154005636|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005637|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005638|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005639|NCT02833688|Analgesics|analgesics|mesh-ancestor
154005640|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
154005641|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005642|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154005643|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154005644|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154005645|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154005646|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005647|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005648|NCT00612313|Fluoxetine|fluoxetine|mesh-list
154005649|NCT00612313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154005650|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154005651|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005652|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005653|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005654|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
154005655|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636671|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636672|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153636673|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153636674|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636675|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636676|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153636677|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
153636678|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153636679|NCT00000588|Pyridoxal|pyridoxal|mesh-list
153636680|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
154005656|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154005657|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
154005658|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154005659|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154005660|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154005661|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005662|NCT00890552|Dexamethasone|dexamethasone|mesh-list
154005663|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
154005664|NCT00890552|Lenalidomide|lenalidomide|mesh-list
154005665|NCT00890552|Melphalan|melphalan|mesh-list
154005666|NCT00890552|BB 1101|bb 1101|mesh-list
154005667|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005668|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
154005669|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
154005670|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005671|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005672|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154005673|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
154005674|NCT00890552|Hormones|hormones|mesh-ancestor
154005675|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005676|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154005677|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577759|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
153636681|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
153636682|NCT00000588|Vitamins|vitamins|mesh-ancestor
153636683|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
153636684|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636685|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
153636686|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
153636687|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636688|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153636689|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
153636690|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153636708|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153636709|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
153636710|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636711|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636712|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153636713|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
153636714|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153636715|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
153636716|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636717|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636718|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153636719|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
153636720|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
153636721|NCT04601077|Protective Agents|protective agents|mesh-ancestor
153636722|NCT00000609|Amiodarone|amiodarone|mesh-list
153636723|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153636724|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
153636725|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153636726|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153458230|NCT03023982|Morphine|morphine|mesh-list
154005679|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005680|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005681|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
154005682|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154005683|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154005684|NCT00890552|Growth Substances|growth substances|mesh-ancestor
154005685|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
154005686|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154005687|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
154005688|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154005689|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005690|NCT02856503|Vitamin D|vitamin d|mesh-list
154005691|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
154005692|NCT02856503|Vitamins|vitamins|mesh-ancestor
154005693|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
154005694|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005695|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154005696|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154005697|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
154005698|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154005699|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005700|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
153636727|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636728|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153636729|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153636730|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153636731|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636732|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153636733|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153636734|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153636736|NCT04547530|Vitamins|vitamins|mesh-ancestor
153636737|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
153636739|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153636741|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153636742|NCT00000612|Hormones|hormones|mesh-ancestor
153636743|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636744|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636745|NCT00000639|Itraconazole|itraconazole|mesh-list
153636746|NCT00000639|Fluconazole|fluconazole|mesh-list
153636747|NCT00000639|Amphotericin B|amphotericin b|mesh-list
153636761|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153636762|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153636764|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153636765|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153636766|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153636767|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
153636768|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
153636769|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
153636770|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636771|NCT00000645|Hypericin|hypericin|mesh-list
154005701|NCT02542813|Oxytocin|oxytocin|mesh-list
154005702|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
154005703|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154005704|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005705|NCT02772120|Progesterone|progesterone|mesh-list
154005706|NCT02772120|Progestins|progestins|mesh-ancestor
154005707|NCT02772120|Hormones|hormones|mesh-ancestor
154005708|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005709|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005710|NCT04248608|Morphine|morphine|mesh-list
154005711|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154005712|NCT04248608|Narcotics|narcotics|mesh-ancestor
154005713|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005714|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005715|NCT04248608|Analgesics|analgesics|mesh-ancestor
154005716|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
154005717|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005718|NCT04783194|Dexamethasone|dexamethasone|mesh-list
154005719|NCT04783194|Bupivacaine|bupivacaine|mesh-list
154005720|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005721|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
154005722|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
154005723|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005724|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005725|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154005727|NCT04783194|Hormones|hormones|mesh-ancestor
154005728|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005729|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154005730|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636772|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636773|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153636774|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636775|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
153636776|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636777|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636778|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636779|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153636780|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
153636781|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636782|NCT04495504|Ropivacaine|ropivacaine|mesh-list
153636783|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
153636784|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
153636785|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153636786|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636787|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
153636788|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005731|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
154005732|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
154005733|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005734|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
154005735|NCT02854241|Liver Extracts|liver extracts|mesh-list
154005736|NCT02854241|Hematinics|hematinics|mesh-ancestor
154005737|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
154005738|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154005739|NCT02835170|Antibodies|antibodies|mesh-list
154005740|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
154005741|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005742|NCT00946985|Risperidone|risperidone|mesh-list
154005743|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154005744|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154005745|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
154005746|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005747|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005748|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005749|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154005750|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154005751|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154005752|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153636789|NCT00390208|Dexamethasone|dexamethasone|mesh-list
153636790|NCT00390208|Ranibizumab|ranibizumab|mesh-list
153636791|NCT00390208|Verteporfin|verteporfin|mesh-list
153636792|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636793|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
153636794|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
153636795|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636796|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636797|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153636798|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
153636799|NCT00390208|Hormones|hormones|mesh-ancestor
153636800|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636801|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153636802|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636803|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153636804|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153636805|NCT00390208|Growth Substances|growth substances|mesh-ancestor
153636806|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
153636826|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153636827|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
153636828|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636829|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
153636830|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153636831|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636832|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153636833|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153636834|NCT00390247|Growth Substances|growth substances|mesh-ancestor
153636835|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
153636836|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636839|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
153636840|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636841|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154005753|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154005754|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
154005755|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154005756|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154005757|NCT00611923|Flutamide|flutamide|mesh-list
154005758|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
154005759|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
154005760|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005761|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005762|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154005763|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005765|NCT04246502|Trastuzumab|trastuzumab|mesh-list
154005766|NCT04246502|Pertuzumab|pertuzumab|mesh-list
154005767|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005768|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
154005769|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005770|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005771|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154005772|NCT02767362|Atorvastatin|atorvastatin|mesh-list
154005773|NCT02767362|Ezetimibe|ezetimibe|mesh-list
154005774|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154005775|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154005776|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
153577848|NCT01719978|Epinephrine|epinephrine|mesh-list
153636842|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153636843|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636844|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
153636845|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636846|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153636847|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636849|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
153636850|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153636851|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153636852|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636853|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153636854|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636855|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636856|NCT00000672|Didanosine|didanosine|mesh-list
153636857|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
153636858|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636859|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153636860|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153636881|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
153636882|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636883|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153636884|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636885|NCT00390403|Acetic Acid|acetic acid|mesh-list
153636886|NCT00390403|Temozolomide|temozolomide|mesh-list
153636887|NCT00390403|Retinol acetate|retinol acetate|mesh-list
153636888|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
153636889|NCT00390403|Gossypol|gossypol|mesh-list
154005777|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005778|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154005779|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154005780|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005781|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
154005782|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154005783|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005784|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154005785|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154005786|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005787|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005788|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005789|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154005790|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153636890|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153636891|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
153636892|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636893|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636894|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153636895|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636896|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153636897|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
153636898|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636899|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153636900|NCT00390403|Protective Agents|protective agents|mesh-ancestor
153636901|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153636902|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
153636903|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153636904|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153636905|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153636906|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153636907|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153636908|NCT00000681|Zidovudine|zidovudine|mesh-list
153636909|NCT00000681|Doxorubicin|doxorubicin|mesh-list
153636910|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153636911|NCT00000681|Bleomycin|bleomycin|mesh-list
153636912|NCT00000681|Vincristine|vincristine|mesh-list
153636950|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636962|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
153636963|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636964|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
153636965|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636966|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
153636967|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636968|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153636969|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153636970|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636971|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153636972|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636973|NCT00000705|Zidovudine|zidovudine|mesh-list
153636974|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
153636975|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636976|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153636977|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153636978|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636979|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
153636980|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005792|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005793|NCT02696694|Progesterone|progesterone|mesh-list
154005794|NCT02696694|Progestins|progestins|mesh-ancestor
154005795|NCT02696694|Hormones|hormones|mesh-ancestor
154005796|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005797|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005799|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
154005800|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
154005801|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005802|NCT04739592|Vitamin D|vitamin d|mesh-list
154005803|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
154005804|NCT04739592|Alendronate|alendronate|mesh-list
154005805|NCT04739592|Vitamins|vitamins|mesh-ancestor
154005806|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
154005807|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005808|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154005809|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154005810|NCT00633386|Celecoxib|celecoxib|mesh-list
154005850|NCT00888901|Protective Agents|protective agents|mesh-ancestor
154005851|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154005852|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005853|NCT00803049|Teriflunomide|teriflunomide|mesh-list
154005854|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154005855|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005856|NCT00803049|Analgesics|analgesics|mesh-ancestor
154005857|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
154005858|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005859|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005860|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005861|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005862|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005863|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
154005864|NCT00884767|Leucovorin|leucovorin|mesh-list
154005865|NCT00884767|Fluorouracil|fluorouracil|mesh-list
154005866|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
154005867|NCT00884767|Calcium|calcium|mesh-list
154005868|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
154005869|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154005870|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005871|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
154005872|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005873|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005874|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005875|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154005876|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
153577941|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153636981|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153636982|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636983|NCT00000708|Fluconazole|fluconazole|mesh-list
153636984|NCT00000708|Amphotericin B|amphotericin b|mesh-list
153636985|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153636986|NCT00000708|Flucytosine|flucytosine|mesh-list
153636987|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
153636988|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636989|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153636990|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153636991|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636992|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636993|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153636994|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
153636995|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636996|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636997|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153636998|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153636999|NCT00000708|Amebicides|amebicides|mesh-ancestor
154005877|NCT00884767|Antidotes|antidotes|mesh-ancestor
154005878|NCT00884767|Protective Agents|protective agents|mesh-ancestor
154005879|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
154005881|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
154005882|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154005883|NCT00890084|Telmisartan|telmisartan|mesh-list
154005884|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
154005885|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154005886|NCT00890084|Diuretics|diuretics|mesh-ancestor
154005887|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
154005888|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005889|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154005890|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005891|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005892|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154005893|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153577974|NCT01727427|PENTA|penta|mesh-list
153637000|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153637001|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153637002|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153637003|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
153637005|NCT00000711|Sargramostim|sargramostim|mesh-list
153637006|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
153637007|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637008|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637009|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637010|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637011|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
153637012|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637013|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637014|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637029|NCT00000720|Zidovudine|zidovudine|mesh-list
153637030|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
153637032|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
153637033|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637034|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637035|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637036|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637037|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
153637038|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637039|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637040|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637041|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
153637042|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637043|NCT04142983|Vaccines|vaccines|mesh-list
153637044|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
153637045|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637046|NCT00000726|Foscarnet|foscarnet|mesh-list
153637047|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153637048|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
153637049|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637050|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637051|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637052|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637053|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637054|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
154005895|NCT00884845|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154005896|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154005897|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005898|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005899|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005900|NCT02773602|Dexamethasone|dexamethasone|mesh-list
154005901|NCT02773602|Clonidine|clonidine|mesh-list
154005902|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005903|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
154005904|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
154005905|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005906|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005907|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154005908|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
154005909|NCT02773602|Hormones|hormones|mesh-ancestor
154005910|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154005911|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154005912|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005913|NCT02773602|Analgesics|analgesics|mesh-ancestor
154005914|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
154005915|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154005916|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
154005917|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153578009|NCT01727778|Antibodies|antibodies|mesh-list
153637055|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153637056|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153637057|NCT00000741|Prednisolone|prednisolone|mesh-list
153637058|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
153637059|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153637060|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
153637061|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153637062|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
153637063|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
153637064|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637065|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637066|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153458314|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
153637068|NCT00000741|Hormones|hormones|mesh-ancestor
153637069|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637070|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153637071|NCT00000741|Protective Agents|protective agents|mesh-ancestor
153637072|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153637073|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637074|NCT00000744|Fluconazole|fluconazole|mesh-list
153637075|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
153637076|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637077|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153570110|NCT01690962|Vitamins|vitamins|mesh-list
153637097|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005918|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154005919|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154005920|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
154005921|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005922|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005923|NCT02770950|Indomethacin|indomethacin|mesh-list
154005924|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154005925|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154005926|NCT02770950|Analgesics|analgesics|mesh-ancestor
154005927|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
154005928|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005929|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005930|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154005931|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154005932|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
154005933|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
154005934|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154005935|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154005936|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005937|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005938|NCT00889057|Sorafenib|sorafenib|mesh-list
154005939|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005940|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154005941|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005942|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005943|NCT02829008|Bevacizumab|bevacizumab|mesh-list
154005944|NCT02829008|Pemetrexed|pemetrexed|mesh-list
154005945|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154005946|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005947|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154005948|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154005949|NCT02829008|Growth Substances|growth substances|mesh-ancestor
153637098|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637101|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637102|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637103|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637104|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637106|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637107|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637108|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154005950|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005952|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005953|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005954|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154005955|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154005956|NCT00889135|Droxidopa|droxidopa|mesh-list
154005957|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154005958|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154005959|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154005960|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
154005961|NCT00889213|Coagulants|coagulants|mesh-ancestor
154005962|NCT00382200|Decitabine|decitabine|mesh-list
154005963|NCT00382200|Tretinoin|tretinoin|mesh-list
154005964|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154005965|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
154005966|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005967|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154005968|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154005969|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
154005970|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
154005971|NCT02696928|Lumefantrine|lumefantrine|mesh-list
154005972|NCT02696928|Primaquine|primaquine|mesh-list
154005973|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
154005974|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154005975|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154005976|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154005977|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
154005978|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
154005979|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153637109|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153637110|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153637111|NCT00000753|Zidovudine|zidovudine|mesh-list
153637112|NCT00000753|Didanosine|didanosine|mesh-list
153637113|NCT00000753|Zalcitabine|zalcitabine|mesh-list
153637114|NCT00000753|Atevirdine|atevirdine|mesh-list
153637115|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
153637116|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637117|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637118|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637119|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637120|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
153637121|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637122|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637123|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637124|NCT03991741|Interleukin-2|interleukin-2|mesh-list
153637125|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637126|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153637127|NCT03991741|Analgesics|analgesics|mesh-ancestor
154005980|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154005981|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154005982|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154005983|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154005984|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154005985|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005986|NCT00889369|Analgesics|analgesics|mesh-ancestor
154005987|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
154005988|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005989|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
154005990|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154005991|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
154005992|NCT02766192|Ketamine|ketamine|mesh-list
154005993|NCT02766192|Analgesics|analgesics|mesh-ancestor
154005994|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
154005995|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154005996|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637128|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
153637129|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637141|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637142|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637143|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637145|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
153637146|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637147|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637148|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637149|NCT00000792|Hypericin|hypericin|mesh-list
153637150|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
153637151|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153637152|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637153|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
153637154|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637155|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637156|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637157|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153637158|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
153637159|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637160|NCT03937609|Infliximab|infliximab|mesh-list
153637161|NCT03937609|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153637162|NCT03937609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153637163|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
153637164|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153637165|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153637166|NCT00390520|Vildagliptin|vildagliptin|mesh-list
153637167|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153637168|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637169|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153637170|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
153458345|NCT04145856|Alverine|alverine|mesh-list
153637171|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637172|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637173|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
153637174|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153637175|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
153637176|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154005999|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
154006000|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
154006001|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006002|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154006003|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154006004|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006005|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006006|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
154006007|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154006008|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
154006009|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006010|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
154006011|NCT05278897|Protective Agents|protective agents|mesh-ancestor
154006012|NCT00889525|Cabergoline|cabergoline|mesh-list
154006013|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154006014|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154006015|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
154006016|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
154006017|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578093|NCT01730508|Interferons|interferons|mesh-list
153637177|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153637178|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637179|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
153637180|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637181|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
153637182|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153637183|NCT00000813|Protective Agents|protective agents|mesh-ancestor
153637184|NCT00390598|Sennosides|sennosides|mesh-list
153637185|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153637189|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153637190|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
153637191|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153637203|NCT03801031|Lidocaine|lidocaine|mesh-list
153637204|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
153637205|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
153637206|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637207|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637208|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
153637209|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637210|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153637211|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153637212|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153637213|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153637214|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637215|NCT00000822|Ritonavir|ritonavir|mesh-list
153637216|NCT00000822|Stavudine|stavudine|mesh-list
153637217|NCT00000822|Didanosine|didanosine|mesh-list
153637218|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637219|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637220|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006018|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006019|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006020|NCT02770794|Infliximab|infliximab|mesh-list
154006021|NCT02770794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154006022|NCT02770794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006023|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
154006024|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006025|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154006026|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
154006027|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154006028|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154006029|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
154006030|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
154006031|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006032|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006033|NCT02766270|Temozolomide|temozolomide|mesh-list
154006034|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154006035|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
154006036|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006037|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006038|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153637221|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637222|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637223|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637224|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637225|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
153637226|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637227|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153637228|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637229|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
153637230|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637231|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637232|NCT03797560|Pregabalin|pregabalin|mesh-list
153637233|NCT03797560|Analgesics|analgesics|mesh-ancestor
153637234|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
153637235|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637236|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637237|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
153637238|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153637239|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153637240|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637241|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153637242|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153637243|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153637244|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637245|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153637246|NCT03574402|Carboplatin|carboplatin|mesh-list
153637247|NCT03574402|Gemcitabine|gemcitabine|mesh-list
153637248|NCT03574402|Pemetrexed|pemetrexed|mesh-list
153637249|NCT03574402|Afatinib|afatinib|mesh-list
153637250|NCT03574402|Crizotinib|crizotinib|mesh-list
153637251|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
153637252|NCT03574402|Ensartinib|ensartinib|mesh-list
153637253|NCT03574402|Maleic acid|maleic acid|mesh-list
154006039|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
154006040|NCT02766348|Gemcitabine|gemcitabine|mesh-list
154006041|NCT02766348|Cisplatin|cisplatin|mesh-list
154006042|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154006043|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
154006044|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006045|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006046|NCT00608569|Ritonavir|ritonavir|mesh-list
154006047|NCT00608569|Lopinavir|lopinavir|mesh-list
154006048|NCT00608569|Tenofovir|tenofovir|mesh-list
154006049|NCT00608569|Emtricitabine|emtricitabine|mesh-list
154006050|NCT00608569|Zidovudine|zidovudine|mesh-list
154006051|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154006052|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154006053|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154006054|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006055|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006056|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006057|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154006058|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154006059|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
154006061|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154006062|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154006063|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154006064|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154006065|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
154006066|NCT04699422|Pirinitramide|pirinitramide|mesh-list
154006067|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154006068|NCT04699422|Narcotics|narcotics|mesh-ancestor
154006069|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006070|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006071|NCT04699422|Analgesics|analgesics|mesh-ancestor
154006072|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
154006073|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006074|NCT02828384|Psyllium|psyllium|mesh-list
154006075|NCT02828384|Cathartics|cathartics|mesh-ancestor
153637254|NCT03574402|Abivertinib|abivertinib|mesh-list
153637255|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637271|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637272|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006076|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006077|NCT00886717|Paclitaxel|paclitaxel|mesh-list
154006078|NCT00886717|genexol-PM|genexol-pm|mesh-list
154006079|NCT00886717|Carboplatin|carboplatin|mesh-list
154006080|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154006081|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006082|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
154006083|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
154006084|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570386|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
154006085|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006086|NCT00889837|Loxapine|loxapine|mesh-list
154006087|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154006088|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154006089|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006090|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006091|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154006092|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154006093|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
154006094|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006095|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006096|NCT02770404|Nafithromycin|nafithromycin|mesh-list
154006097|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154006098|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006099|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154006100|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578172|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
153637273|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
153637274|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637275|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637276|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637277|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
153637278|NCT00000849|Aldesleukin|aldesleukin|mesh-list
153637279|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637280|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637281|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637282|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
153637283|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637284|NCT03357952|Daratumumab|daratumumab|mesh-list
153637285|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637286|NCT00000855|Zidovudine|zidovudine|mesh-list
153637288|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637289|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637290|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637291|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637292|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
153637293|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637294|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637295|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637296|NCT00000867|Memantine|memantine|mesh-list
153637297|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153637298|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154006101|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006102|NCT00886873|Mifepristone|mifepristone|mesh-list
154006103|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154006104|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
154006105|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154006106|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006107|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154006108|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154006109|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154006110|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
154006111|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154006112|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154006113|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
154006114|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006115|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
154006116|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154006117|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154006118|NCT04243850|Empagliflozin|empagliflozin|mesh-list
154006119|NCT04243850|Caffeine|caffeine|mesh-list
154006120|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153637299|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
153637300|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153637301|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637302|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637303|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153637304|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153637305|NCT00390676|Carboplatin|carboplatin|mesh-list
153637306|NCT00390676|Docetaxel|docetaxel|mesh-list
153637307|NCT00390676|Capecitabine|capecitabine|mesh-list
153637308|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637309|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
153637310|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
153637311|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637312|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637313|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153637314|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
153637315|NCT00000870|Lamivudine|lamivudine|mesh-list
153637316|NCT00000870|Zidovudine|zidovudine|mesh-list
153637327|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637328|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637329|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
153637330|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637331|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637332|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637333|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
153637334|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
153637335|NCT00390832|Hematinics|hematinics|mesh-ancestor
153637336|NCT00390871|Fentanyl|fentanyl|mesh-list
153637337|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
153637338|NCT00390871|Propofol|propofol|mesh-list
153637339|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153637340|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637341|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006121|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006122|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154006123|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006124|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006125|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154006126|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154006127|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
154006128|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006129|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154006130|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154006131|NCT00892801|Everolimus|everolimus|mesh-list
154006132|NCT00892801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154006133|NCT00892801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154006134|NCT00892801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006135|NCT00892801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006136|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006137|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
154006138|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006139|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006141|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154006142|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006143|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006144|NCT00633542|Interferons|interferons|mesh-list
154006145|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
154006146|NCT00633542|Thalidomide|thalidomide|mesh-list
154006147|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637342|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153637343|NCT00390871|Analgesics|analgesics|mesh-ancestor
153637344|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
153637345|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637346|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153637347|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153637348|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153637349|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
153637350|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153637351|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637352|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153637353|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
153637354|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
153637355|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153637356|NCT00390871|Narcotics|narcotics|mesh-ancestor
153637357|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153637359|NCT00000882|Zidovudine|zidovudine|mesh-list
153637360|NCT00000882|Stavudine|stavudine|mesh-list
153637361|NCT00000882|Delavirdine|delavirdine|mesh-list
153637362|NCT00000882|Indinavir|indinavir|mesh-list
153637363|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154006148|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
154006149|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006150|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
154006151|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006152|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154006153|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
154006154|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154006155|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154006156|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154006157|NCT00633542|Growth Substances|growth substances|mesh-ancestor
154006158|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
154006159|NCT02766036|Propolis|propolis|mesh-list
154006160|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006161|NCT00610675|Mirtazapine|mirtazapine|mesh-list
154006162|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
154006163|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154006164|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154006165|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
154006166|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
153578246|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
153637364|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637365|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637366|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637367|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
153637368|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637369|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637370|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637371|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
153637372|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637373|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637374|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
153637376|NCT00000888|Lamivudine|lamivudine|mesh-list
153637377|NCT00000888|Zidovudine|zidovudine|mesh-list
153637378|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637379|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637380|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
153637381|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637382|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637383|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637384|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637385|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
153637419|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637420|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637422|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637423|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
153637424|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637425|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637426|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637427|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
153637439|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637440|NCT02939365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153637441|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637442|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153637443|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
153637444|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637445|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154006167|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006168|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006169|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006170|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154006171|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154006172|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763725|NCT06077500|Durvalumab|durvalumab|mesh-list
154006173|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154006175|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154006176|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
154006177|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154006178|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154006179|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
154006180|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154006181|NCT02828228|Vitamin D|vitamin d|mesh-list
154006182|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
154006183|NCT02828228|Vitamins|vitamins|mesh-ancestor
154006184|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
154006185|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006186|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154006187|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154006188|NCT02769936|Cycloserine|cycloserine|mesh-list
154006189|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154006190|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578263|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153637446|NCT00000906|Ritonavir|ritonavir|mesh-list
153637447|NCT00000906|Saquinavir|saquinavir|mesh-list
153637448|NCT00000906|Methadone|methadone|mesh-list
153637449|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637450|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637451|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
153637452|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637453|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637454|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637455|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637456|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
153637457|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637458|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153637459|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637460|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153637461|NCT00000906|Narcotics|narcotics|mesh-ancestor
153637462|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637463|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637464|NCT00000906|Analgesics|analgesics|mesh-ancestor
153637465|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
153637466|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637467|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
153637468|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
153637469|NCT00000951|Fluconazole|fluconazole|mesh-list
154006191|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154006192|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
154006193|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154006194|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
154006195|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006196|NCT00887029|Timolol|timolol|mesh-list
154006197|NCT00887029|Travoprost|travoprost|mesh-list
154006198|NCT00887029|Latanoprost|latanoprost|mesh-list
154006199|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154006200|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154006201|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154006202|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154006203|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006204|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006205|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006206|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154006207|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154006209|NCT00635310|Liver Extracts|liver extracts|mesh-list
154006210|NCT00635310|Hematinics|hematinics|mesh-ancestor
154006211|NCT02762448|Asunaprevir|asunaprevir|mesh-list
154006212|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006213|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006214|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006215|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
154006216|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154006217|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006218|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154006219|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
154006220|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154006221|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006222|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006223|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006224|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154006225|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
154006226|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
154006227|NCT00887107|Sorafenib|sorafenib|mesh-list
154006228|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578306|NCT01731652|Imiquimod|imiquimod|mesh-list
154006230|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006231|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006232|NCT00802737|Ofatumumab|ofatumumab|mesh-list
154006233|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006234|NCT02769390|Clonidine|clonidine|mesh-list
154006235|NCT02769390|Diazepam|diazepam|mesh-list
154006236|NCT02769390|Analgesics|analgesics|mesh-ancestor
154006237|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
154006238|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006239|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006240|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154006241|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
154006242|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
154006243|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154006244|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154006245|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154006246|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
154006247|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006248|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006249|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154006250|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
154006251|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
154006252|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006253|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154006254|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637470|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
153637471|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637472|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153637473|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637474|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637475|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637476|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153637477|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
153637478|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637479|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637480|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153637481|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153637482|NCT00000966|Leucovorin|leucovorin|mesh-list
153637483|NCT00000966|Azithromycin|azithromycin|mesh-list
153637484|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
153637485|NCT00000966|Calcium|calcium|mesh-list
153637486|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
153637487|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153637517|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637518|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006255|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154006256|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154006257|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154006258|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154006259|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154006260|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154006261|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
154006262|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
154006263|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
154006264|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
154006265|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
154006266|NCT00890539|Miotics|miotics|mesh-ancestor
154006267|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
154006268|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006269|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006270|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154006271|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154006272|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
154006273|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154006274|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154006275|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
154006276|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006277|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006278|NCT00887263|Budesonide|budesonide|mesh-list
154006279|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006280|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154006281|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
154006282|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570814|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637519|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637520|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153907808|NCT02833987|Warfarin|warfarin|mesh-list
153637522|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637523|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637524|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153637526|NCT00000978|Zalcitabine|zalcitabine|mesh-list
153637527|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
153637528|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637529|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637530|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637531|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637532|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
153637533|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637562|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
153637563|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
153637564|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637565|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637566|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154006283|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006284|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154006285|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
154006287|NCT00887263|Hormones|hormones|mesh-ancestor
154006288|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006289|NCT00914667|Warfarin|warfarin|mesh-list
154006290|NCT00914667|Fesoterodine|fesoterodine|mesh-list
154006291|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
154006292|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154006293|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154006294|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
154006295|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006296|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006297|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006298|NCT00914667|Urological Agents|urological agents|mesh-ancestor
154006299|NCT00887978|Treprostinil|treprostinil|mesh-list
154006300|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154006301|NCT00608023|Tesamorelin|tesamorelin|mesh-list
154006302|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154006303|NCT00608023|Growth Substances|growth substances|mesh-ancestor
154006304|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006305|NCT00608023|Hormones|hormones|mesh-ancestor
154006306|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006332|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154006333|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006334|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006335|NCT00893269|Zolpidem|zolpidem|mesh-list
154006336|NCT00893269|Eszopiclone|eszopiclone|mesh-list
154006337|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154006338|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154006339|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006340|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006341|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154006342|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
154006343|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
154006344|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006345|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006346|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
154006347|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154006389|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154006390|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006391|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006393|NCT00891163|Tetracaine|tetracaine|mesh-list
154006394|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
153763953|NCT05864846|Cannabidiol|cannabidiol|mesh-list
154006395|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
154006396|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006397|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006398|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
153816554|NCT00458718|Hormones|hormones|mesh-ancestor
154006399|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006400|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154006451|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154006452|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
154006453|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
154006454|NCT04036201|Protective Agents|protective agents|mesh-ancestor
154006455|NCT00801099|Amoxicillin|amoxicillin|mesh-list
154006456|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154006457|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
154006458|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
154006459|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154006460|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006461|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154006487|NCT00923169|Mitogens|mitogens|mesh-list
154006514|NCT04114383|Protective Agents|protective agents|mesh-ancestor
154006515|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006516|NCT04114461|Tofacitinib|tofacitinib|mesh-list
154006517|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006518|NCT04114461|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154006519|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154006520|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006521|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154006522|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006579|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006580|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006581|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154006582|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154006583|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006584|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006585|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154006586|NCT02760888|Narcotics|narcotics|mesh-ancestor
154006646|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154006647|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006648|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154006649|NCT02767596|Insulin|insulin|mesh-list
154006650|NCT02767596|Insulin Glargine|insulin glargine|mesh-list
154006651|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154006652|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006653|NCT02826902|Remifentanil|remifentanil|mesh-list
154006654|NCT02826902|Propofol|propofol|mesh-list
154006655|NCT02826902|Desflurane|desflurane|mesh-list
154006656|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154006657|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154006658|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006659|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154006660|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
154006661|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
154006662|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154006663|NCT02826902|Narcotics|narcotics|mesh-ancestor
154006664|NCT02826902|Analgesics|analgesics|mesh-ancestor
154006665|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
154006666|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006667|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154006669|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154006670|NCT00798759|Latanoprost|latanoprost|mesh-list
154006671|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154006675|NCT00891475|Sunitinib|sunitinib|mesh-list
154006699|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154006700|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154006701|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154006702|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006703|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154006704|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006767|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154006768|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154006769|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154006770|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154006771|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006772|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
154006773|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006774|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006775|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154006776|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006777|NCT00887354|Vitamin D|vitamin d|mesh-list
154006778|NCT00887354|Teriparatide|teriparatide|mesh-list
154006779|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
154006780|NCT00887354|Calcium|calcium|mesh-list
154006781|NCT00887354|Vitamins|vitamins|mesh-ancestor
154006782|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
154006783|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006784|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154006785|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154006786|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154006787|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154006788|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006789|NCT00951041|Vaccines|vaccines|mesh-list
154006790|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
154006791|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006792|NCT02832596|Norepinephrine|norepinephrine|mesh-list
154006793|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154006794|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154006795|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
154006796|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006797|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006798|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006799|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
154006800|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
154006801|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578869|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
153637567|NCT00005819|Protective Agents|protective agents|mesh-ancestor
153637568|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637569|NCT00001005|Zidovudine|zidovudine|mesh-list
154006802|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154006804|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154006805|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006806|NCT04612530|Nivolumab|nivolumab|mesh-list
154006807|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154006808|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006809|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154006811|NCT00945815|Cytarabine|cytarabine|mesh-list
154006868|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
154006869|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154006870|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
154006871|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006872|NCT00895609|Neostigmine|neostigmine|mesh-list
154006873|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154006874|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006875|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006876|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
154006877|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006878|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006879|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154006880|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
154006881|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006882|NCT00894439|Piperacillin|piperacillin|mesh-list
154006883|NCT00894439|BLI-489|bli-489|mesh-list
154006884|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154006885|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154006886|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154006887|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154006888|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006889|NCT04035889|Melatonin|melatonin|mesh-list
154006890|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
154006892|NCT04035889|Protective Agents|protective agents|mesh-ancestor
154006919|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154006920|NCT02762838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154006921|NCT02762838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006922|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006923|NCT02762838|Hematinics|hematinics|mesh-ancestor
154006924|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
154006926|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
154006927|NCT02753166|Dexamethasone|dexamethasone|mesh-list
154006928|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154006929|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
154006930|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
154006931|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154006932|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006933|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006934|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
154006935|NCT02753166|Hormones|hormones|mesh-ancestor
154006936|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006937|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154006938|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154006939|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
154006940|NCT02753088|Mannitol|mannitol|mesh-list
154006941|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
154006942|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154006943|NCT02753088|Diuretics|diuretics|mesh-ancestor
154006944|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
154006945|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006969|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154006970|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
154006971|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154006972|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154006974|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154006975|NCT00797823|Glucagon|glucagon|mesh-list
154006976|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154006977|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154006978|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154006979|NCT00797823|Hormones|hormones|mesh-ancestor
154006980|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154006981|NCT02757144|Esomeprazole|esomeprazole|mesh-list
154006982|NCT02757144|Fexuprazan|fexuprazan|mesh-list
154006983|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154006984|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154007029|NCT01082393|Tacrolimus|tacrolimus|mesh-list
154007030|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007031|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
154007032|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007033|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154007034|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007035|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007036|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007037|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
154007038|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154007041|NCT01082393|Analgesics|analgesics|mesh-ancestor
154007094|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154007095|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
154007096|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154007097|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
154007098|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
154007099|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
154007100|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154007101|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154007102|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
154007110|NCT00894751|Propofol|propofol|mesh-list
154007160|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007161|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007162|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154007163|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154007164|NCT00944645|Niacin|niacin|mesh-list
154007165|NCT00944645|Niacinamide|niacinamide|mesh-list
154007166|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
154007167|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154007168|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
154007169|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007170|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154007171|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
154007172|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
154007173|NCT00944645|Vitamins|vitamins|mesh-ancestor
154007222|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007223|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154007224|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154007225|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
154007226|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007227|NCT00894829|Heparin|heparin|mesh-list
154007228|NCT00894829|Calcium heparin|calcium heparin|mesh-list
154007229|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
154007230|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154007231|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154007234|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
154007286|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007287|NCT02756130|Carboplatin|carboplatin|mesh-list
154007288|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007289|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
154007290|NCT00605293|Hematinics|hematinics|mesh-ancestor
154007291|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154007292|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154007293|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
154007294|NCT00602303|Torsemide|torsemide|mesh-list
154007295|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154007296|NCT00602303|Diuretics|diuretics|mesh-ancestor
154007297|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
154007298|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007299|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154007300|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154007301|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007302|NCT00631085|Tocopherols|tocopherols|mesh-list
154007347|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007348|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
154007349|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007350|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007351|NCT00894985|Heparin|heparin|mesh-list
154007352|NCT00894985|Calcium heparin|calcium heparin|mesh-list
154007353|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
154007354|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154007355|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154007356|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007357|NCT04585152|Rituximab|rituximab|mesh-list
154007411|NCT02603757|Vitamins|vitamins|mesh-ancestor
154007412|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
154007413|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007414|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154007415|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154007417|NCT02758782|Golimumab|golimumab|mesh-list
154007418|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154007420|NCT02758782|Analgesics|analgesics|mesh-ancestor
154007480|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154007481|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007482|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154007483|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154007484|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154007485|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154007486|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154007487|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154007543|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154007544|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007545|NCT04268927|Hormones|hormones|mesh-ancestor
154007546|NCT00790647|Bortezomib|bortezomib|mesh-list
154007547|NCT00790647|Melphalan|melphalan|mesh-list
154007548|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
154007549|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007550|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007551|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154007552|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
154007553|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007554|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154007555|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154007556|NCT00286013|Gemcitabine|gemcitabine|mesh-list
154007557|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
154007558|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007559|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
154007560|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007561|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007562|NCT02754882|Paclitaxel|paclitaxel|mesh-list
154007563|NCT02754882|Bevacizumab|bevacizumab|mesh-list
154007564|NCT02754882|Carboplatin|carboplatin|mesh-list
154007565|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154007594|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154007595|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
154007596|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007597|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007598|NCT00602615|Torsemide|torsemide|mesh-list
154007599|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154007600|NCT00602615|Diuretics|diuretics|mesh-ancestor
154007601|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
154007602|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007603|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154007604|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154007605|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007606|NCT00604253|Insulin|insulin|mesh-list
154007607|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154007608|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
154007609|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
154007610|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
154007651|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154007652|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
154007653|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154007654|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154007655|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154007656|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
154007657|NCT02540395|Hormones|hormones|mesh-ancestor
154007658|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154007659|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154007719|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
154007720|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
154007721|NCT04213404|Spartalizumab|spartalizumab|mesh-list
154007722|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154007723|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007724|NCT04213404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154007725|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007726|NCT00604409|Capecitabine|capecitabine|mesh-list
154007727|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007783|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007784|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
154007785|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
154007786|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
154007787|NCT02602509|Rifampin|rifampin|mesh-list
154007788|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
154007789|NCT02602509|Celecoxib|celecoxib|mesh-list
154007790|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154007791|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154007792|NCT02602509|Analgesics|analgesics|mesh-ancestor
154007793|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
154007794|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007795|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007818|NCT00897871|Etoposide|etoposide|mesh-list
154007844|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
154007845|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154007846|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
154007847|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
154007848|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154007849|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
154007915|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
154007916|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154007917|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007918|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154007919|NCT02852681|Diuretics|diuretics|mesh-ancestor
154007920|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
154007921|NCT02754180|Gemcitabine|gemcitabine|mesh-list
154007922|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154007923|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
154007924|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007925|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154007926|NCT00602849|Sertraline|sertraline|mesh-list
154007927|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
154007928|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154007929|NCT00602849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154007930|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154007931|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154007932|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007933|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154007934|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
154007967|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154007968|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154007969|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154007970|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154007971|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154007972|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154007973|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
154007975|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154008031|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008033|NCT04220892|Pemetrexed|pemetrexed|mesh-list
154008034|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154008035|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008036|NCT04220892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154008037|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008038|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008039|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154008041|NCT02696148|Liraglutide|liraglutide|mesh-list
154008093|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008094|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008095|NCT02831972|Itraconazole|itraconazole|mesh-list
154008096|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
154008097|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008098|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154008099|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154008100|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008101|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008102|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154008103|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
154008104|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154008153|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154008155|NCT00635856|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154008156|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008157|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008158|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008159|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008160|NCT00906685|Bevacizumab|bevacizumab|mesh-list
154008161|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154008216|NCT02750670|Gemcitabine|gemcitabine|mesh-list
154008217|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
154008218|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008219|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008220|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
154008221|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
154008222|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008223|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008283|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008284|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008285|NCT00904111|Lidocaine|lidocaine|mesh-list
154008286|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154008287|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
154008288|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008289|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008290|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
154008291|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008292|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154008293|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154008294|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154008295|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008296|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008297|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
154008298|NCT03240211|Decitabine|decitabine|mesh-list
154008299|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154008300|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008337|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008338|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008339|NCT04241744|Vancomycin|vancomycin|mesh-list
154008340|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154008341|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154008342|NCT02824094|Crizotinib|crizotinib|mesh-list
154008343|NCT02824094|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154008344|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008403|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154008404|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154008405|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008406|NCT02827136|Lidocaine|lidocaine|mesh-list
154008407|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
154008408|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
154008409|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008410|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008411|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
154008412|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008413|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154008414|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154008415|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154008416|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008417|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008418|NCT04102995|Pregnanolone|pregnanolone|mesh-list
154008419|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
154008420|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154008421|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008422|NCT00899821|Aldesleukin|aldesleukin|mesh-list
154008423|NCT00899821|Interleukin-12|interleukin-12|mesh-list
154008424|NCT00899821|Sargramostim|sargramostim|mesh-list
154008425|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
154008453|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154008454|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154008456|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008457|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154008458|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154008459|NCT00904657|Growth Substances|growth substances|mesh-ancestor
154008460|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008461|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
154008462|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008518|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154008519|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
154008520|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154008521|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008522|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154008586|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008587|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008589|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154008590|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154008591|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
154008592|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
154008593|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
154008594|NCT04241276|Paclitaxel|paclitaxel|mesh-list
154008595|NCT04241276|Gemcitabine|gemcitabine|mesh-list
154008596|NCT04241276|Tretinoin|tretinoin|mesh-list
154008597|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154008598|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008651|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008652|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154008653|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154008654|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154008655|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154008656|NCT00633698|Niacin|niacin|mesh-list
154008657|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
154008658|NCT00633698|Niacinamide|niacinamide|mesh-list
154008659|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154008660|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
154008661|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008662|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154008712|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154008713|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154008714|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154008715|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008716|NCT02825186|Dexamethasone|dexamethasone|mesh-list
154008717|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008718|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
154008719|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
154008720|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008781|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
154008782|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154008783|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008784|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154008785|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
154008786|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
153766367|NCT00400946|Etoposide|etoposide|mesh-list
154008787|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154008788|NCT00905593|Nilotinib|nilotinib|mesh-list
154008789|NCT00905593|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154008790|NCT00905593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154008791|NCT00905593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154008793|NCT04217148|Dexamethasone|dexamethasone|mesh-list
154008846|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
154008847|NCT04034173|Hematinics|hematinics|mesh-ancestor
154008848|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154008849|NCT00606203|Milnacipran|milnacipran|mesh-list
154008850|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
154008851|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154008852|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154008853|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008854|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154008910|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154008911|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
154008912|NCT02824718|Vitamins|vitamins|mesh-ancestor
154008913|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
154008914|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154008916|NCT05378711|Fluoxetine|fluoxetine|mesh-list
154008978|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
154008980|NCT04267913|Ramucirumab|ramucirumab|mesh-list
154008981|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154008982|NCT04267913|Antibodies|antibodies|mesh-list
154008983|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
154008984|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154008985|NCT04267913|Lexatumumab|lexatumumab|mesh-list
154008986|NCT04267913|BB 1101|bb 1101|mesh-list
154008987|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
154008988|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154008989|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154008990|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
154008991|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
154008993|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154009043|NCT00908089|Hormones|hormones|mesh-ancestor
154009044|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009045|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009046|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009047|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009048|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
154009049|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
154009050|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009051|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154009052|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154009053|NCT00908089|Protective Agents|protective agents|mesh-ancestor
154009054|NCT00908089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154009106|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
154009107|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009109|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
154009110|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009111|NCT02749032|Metformin|metformin|mesh-list
154009112|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154009113|NCT02749032|Vildagliptin|vildagliptin|mesh-list
154009114|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154009115|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009116|NCT02749032|Incretins|incretins|mesh-ancestor
154009172|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009173|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154009174|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154009175|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009176|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154009177|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
154009178|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
154009179|NCT00909337|Bosentan|bosentan|mesh-list
154009183|NCT00909571|Tacrolimus|tacrolimus|mesh-list
154009242|NCT05658692|Bromides|bromides|mesh-list
154009243|NCT05658692|Propofol|propofol|mesh-list
154009244|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154009245|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154009246|NCT05658692|Simvastatin|simvastatin|mesh-list
154009247|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
153458006|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
154009248|NCT05658692|Succinylcholine|succinylcholine|mesh-list
154009249|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
154009250|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009251|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
154009252|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
154009253|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009306|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154009307|NCT02744508|Dexamethasone|dexamethasone|mesh-list
154009308|NCT02744508|Palonosetron|palonosetron|mesh-list
154009309|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009310|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
154009311|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
154009312|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009313|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009314|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154009370|NCT05379647|Fludarabine|fludarabine|mesh-list
154009371|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009372|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
154009373|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009374|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009375|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154009376|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
154009377|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009378|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009434|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009435|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009436|NCT00776919|Clindamycin|clindamycin|mesh-list
154009437|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
154009438|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
154009439|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154009440|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154009441|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009442|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154009443|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009444|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009445|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
154009446|NCT02747940|Pregabalin|pregabalin|mesh-list
154009447|NCT02747940|Flunarizine|flunarizine|mesh-list
154009448|NCT02747940|Analgesics|analgesics|mesh-ancestor
154009493|NCT05382923|Melatonin|melatonin|mesh-list
154009494|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
154009495|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009496|NCT05382923|Protective Agents|protective agents|mesh-ancestor
154009497|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009498|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009499|NCT02743572|Iron|iron|mesh-list
154009500|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154009501|NCT02743572|Trace Elements|trace elements|mesh-ancestor
154009502|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
154009503|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009504|NCT02743572|Hematinics|hematinics|mesh-ancestor
154009505|NCT00775593|Sirolimus|sirolimus|mesh-list
154009506|NCT00775593|Temsirolimus|temsirolimus|mesh-list
154009507|NCT00775593|MTOR Inhibitors|mtor inhibitors|mesh-list
154009508|NCT00775593|Clofarabine|clofarabine|mesh-list
154009509|NCT00775593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154009510|NCT00775593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009511|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009512|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154009513|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
154009514|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009515|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009516|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154009517|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009518|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154009519|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
154009520|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009521|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
154009523|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154009524|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154009538|NCT02743260|Digoxin|digoxin|mesh-list
154009539|NCT02743260|Pitavastatin|pitavastatin|mesh-list
154009540|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154009541|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009542|NCT02743260|Incretins|incretins|mesh-ancestor
154009543|NCT02743260|Hormones|hormones|mesh-ancestor
154009544|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009545|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154009546|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
154009547|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009548|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009549|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154009550|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154009561|NCT02819648|Prednisolone|prednisolone|mesh-list
154009600|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009601|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009602|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
154009603|NCT02743104|Lidocaine|lidocaine|mesh-list
154009604|NCT02743104|Atropine|atropine|mesh-list
154009605|NCT02743104|Midazolam|midazolam|mesh-list
154009606|NCT02743104|Ketamine|ketamine|mesh-list
154009607|NCT02743104|Propofol|propofol|mesh-list
154009608|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
154009609|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
154009611|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009668|NCT05648708|Prilocaine|prilocaine|mesh-list
154009669|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
154009670|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
154009671|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009672|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009673|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
154009674|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009675|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
154009676|NCT02742948|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154009677|NCT02742948|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154009678|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154009679|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154009680|NCT00636246|Sertraline|sertraline|mesh-list
154009681|NCT00636246|Reboxetine|reboxetine|mesh-list
154009682|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
154009683|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154009684|NCT00636246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154009685|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154009686|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009687|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009688|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009689|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
154009690|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009720|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
154009721|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
154009722|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009723|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154009724|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
154009725|NCT02741232|Lidocaine|lidocaine|mesh-list
154009726|NCT02741232|Epinephrine|epinephrine|mesh-list
154009727|NCT02741232|Racepinephrine|racepinephrine|mesh-list
154009728|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
154009729|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
154009730|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
154009731|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154009732|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009733|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
154009734|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009735|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154009736|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154009737|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154009738|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154009739|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009740|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154009741|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154009742|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
154009743|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154009744|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154009745|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154009746|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
154009747|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154009748|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
154009752|NCT04239014|Olaparib|olaparib|mesh-list
154009765|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153767330|NCT00215748|Hormones|hormones|mesh-ancestor
154009766|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
154009767|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009768|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009769|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
154009770|NCT00774345|Lenalidomide|lenalidomide|mesh-list
154009771|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
154009772|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009773|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154009775|NCT00774345|Growth Substances|growth substances|mesh-ancestor
154009827|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
154009828|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154009829|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154009830|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154009831|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
154009832|NCT00931957|Hormones|hormones|mesh-ancestor
154009833|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009834|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009835|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154009836|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154009891|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154009892|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154009893|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154009894|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154009895|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154009896|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
154009897|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009898|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009899|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
154009900|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154009901|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
154009902|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154009903|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154009904|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154009906|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154009907|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154009908|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
154009909|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009945|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154009946|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154009947|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154009948|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
154009949|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154009950|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154009951|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154009952|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
154010012|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154010013|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010014|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
154010015|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010016|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154010017|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154010018|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
154010019|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010077|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010078|NCT00925327|Riboflavin|riboflavin|mesh-list
154010079|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
154010080|NCT00925327|Vitamins|vitamins|mesh-ancestor
154010081|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
154010082|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010083|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154010084|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
154010085|NCT04237376|Tenofovir|tenofovir|mesh-list
154010086|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
154010094|NCT04015687|Lamotrigine|lamotrigine|mesh-list
154010141|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010142|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010143|NCT05382143|Atosiban|atosiban|mesh-list
154010144|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
154010145|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010146|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010147|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
154010148|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154010209|NCT05786950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154010210|NCT05786950|Autonomic Agents|autonomic agents|mesh-ancestor
154010211|NCT05786950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010212|NCT05786950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767771|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
154010213|NCT05786950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154010214|NCT05786950|Respiratory System Agents|respiratory system agents|mesh-ancestor
154010215|NCT05786950|Tocolytic Agents|tocolytic agents|mesh-ancestor
154010216|NCT05786950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154010217|NCT05786950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154010218|NCT05786950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154010219|NCT05786950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154010220|NCT05786950|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010221|NCT05786950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010223|NCT05786950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154010267|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010268|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010269|NCT05673889|Dabigatran|dabigatran|mesh-list
154010270|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
154010271|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154010272|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
154010273|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010274|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010275|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
154010276|NCT05654298|Sumatriptan|sumatriptan|mesh-list
154010277|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154010278|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154010279|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154010280|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
154010284|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
154010330|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
154010331|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154010332|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010333|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
154010334|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154010335|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154010336|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010337|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
154010338|NCT05427513|Coagulants|coagulants|mesh-ancestor
154010395|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154010396|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
154010397|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154010398|NCT05211804|Ranibizumab|ranibizumab|mesh-list
154010399|NCT05211804|Aflibercept|aflibercept|mesh-list
154010400|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010401|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154010402|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154010403|NCT05211804|Growth Substances|growth substances|mesh-ancestor
154010404|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010405|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
154010407|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154010408|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154010409|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010454|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154010455|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
154010456|NCT04642352|Hormones|hormones|mesh-ancestor
154010457|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154010458|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154010459|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
154010460|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
154010461|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154010522|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154010523|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010524|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010525|NCT04391764|Naltrexone|naltrexone|mesh-list
154010526|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154010527|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154010528|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010529|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
154010530|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010531|NCT04292470|Amitriptyline|amitriptyline|mesh-list
154010532|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154010533|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
154010534|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154010535|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154010536|NCT04292470|Analgesics|analgesics|mesh-ancestor
154010537|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
154010538|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154010539|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010540|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154010579|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154010580|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010581|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010582|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154010583|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154010584|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154010585|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154010642|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154010643|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154010644|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010645|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010646|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154010647|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154010648|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154010649|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154010650|NCT03070886|Docetaxel|docetaxel|mesh-list
154010651|NCT03070886|Leuprolide|leuprolide|mesh-list
154010652|NCT03070886|Goserelin|goserelin|mesh-list
154010653|NCT03070886|Bicalutamide|bicalutamide|mesh-list
154010654|NCT03070886|Flutamide|flutamide|mesh-list
154010655|NCT03070886|Nilutamide|nilutamide|mesh-list
154010704|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010705|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154010706|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
154010707|NCT02540707|Mirabegron|mirabegron|mesh-list
154010708|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
154010709|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154010710|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154010711|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154010712|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
154010713|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010720|NCT02504346|Osimertinib|osimertinib|mesh-list
154010765|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
154010766|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
154010767|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
154010768|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010769|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154010770|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154010771|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154010772|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010773|NCT00472654|Vitamin D|vitamin d|mesh-list
154010774|NCT00472654|Vitamins|vitamins|mesh-ancestor
154010828|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154010829|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010830|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010831|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
154010832|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010833|NCT00925873|Vidarabine|vidarabine|mesh-list
154010834|NCT00925873|Fludarabine|fludarabine|mesh-list
154010835|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
154010836|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010837|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154010838|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
154010839|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010840|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154010841|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
154010843|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
154010890|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154010891|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010892|NCT02734524|Carboplatin|carboplatin|mesh-list
154010893|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010894|NCT04173962|Midazolam|midazolam|mesh-list
154010895|NCT04173962|Ketamine|ketamine|mesh-list
154010957|NCT02812940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154010958|NCT02812940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154010959|NCT02812940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010960|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154010961|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
154010962|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010963|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154010964|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154010965|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154010966|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154010967|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154010968|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154010969|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154010970|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154010971|NCT00933439|Analgesics|analgesics|mesh-ancestor
154010976|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
154011009|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
154011010|NCT00933517|Docetaxel|docetaxel|mesh-list
154011011|NCT00933517|Panitumumab|panitumumab|mesh-list
154011012|NCT00933517|Epirubicin|epirubicin|mesh-list
154011013|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011014|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
154011015|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011016|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011017|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154011018|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
154011019|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011020|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011021|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154011022|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
154011023|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
154011024|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
154011025|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011026|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154011027|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154011028|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153768605|NCT00411333|Hormones|hormones|mesh-ancestor
154011029|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011030|NCT00926341|Pioglitazone|pioglitazone|mesh-list
154011060|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011061|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011062|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011064|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154011065|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154011066|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011067|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011068|NCT00927485|Curcumin|curcumin|mesh-list
154011069|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154011070|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154011071|NCT00927485|Analgesics|analgesics|mesh-ancestor
154011072|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
154011073|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011074|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011075|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011076|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011077|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011078|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011079|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011080|NCT00926653|Escitalopram|escitalopram|mesh-list
154011085|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011112|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011113|NCT02738970|Trastuzumab|trastuzumab|mesh-list
154011114|NCT02738970|Pertuzumab|pertuzumab|mesh-list
154011115|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011116|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011117|NCT00926731|Cytarabine|cytarabine|mesh-list
154011118|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154011119|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
154011120|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011121|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011127|NCT00926809|Amoxicillin|amoxicillin|mesh-list
154011174|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768751|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154011175|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011176|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154011177|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011178|NCT02738814|Propofol|propofol|mesh-list
154011179|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154011180|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011181|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011182|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154011183|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
154011184|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
154011185|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154011186|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154011187|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011188|NCT02729064|Insulin|insulin|mesh-list
154011189|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154011190|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154011228|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011229|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011230|NCT02738658|Everolimus|everolimus|mesh-list
154011231|NCT02738658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154011232|NCT02738658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154011233|NCT02738658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011234|NCT02738658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011235|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011236|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
154011237|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011238|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011239|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
154011240|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154011241|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154011242|NCT02733510|Prednisolone|prednisolone|mesh-list
154011243|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
154011244|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154011245|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
154011246|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011247|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
154011248|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
154011249|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011251|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154011280|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011282|NCT02812394|Carbidopa|carbidopa|mesh-list
154011283|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154011284|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154011285|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154011286|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
154011287|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011288|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011289|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011345|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154011346|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154011347|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011348|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
154011350|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011351|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011411|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011412|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154011413|NCT00932165|Exemestane|exemestane|mesh-list
154011414|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011415|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154011479|NCT05905965|Empagliflozin|empagliflozin|mesh-list
154011480|NCT05905965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154011481|NCT05905965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011482|NCT05905965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154011483|NCT05905965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011484|NCT05905913|Meropenem|meropenem|mesh-list
154011485|NCT05905913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154011486|NCT05905913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011487|NCT05905757|Tramadol|tramadol|mesh-list
154011488|NCT05905757|Dexmedetomidine|dexmedetomidine|mesh-list
154011489|NCT05905757|Bupivacaine|bupivacaine|mesh-list
154011490|NCT05905757|Anesthetics, Local|anesthetics, local|mesh-ancestor
154011491|NCT05905757|Anesthetics|anesthetics|mesh-ancestor
154011492|NCT05905757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011497|NCT05905757|Narcotics|narcotics|mesh-ancestor
154011540|NCT05838703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154011541|NCT05838703|Autonomic Agents|autonomic agents|mesh-ancestor
153571806|NCT05566665|Sequestering Agents|sequestering agents|mesh-ancestor
154011542|NCT05838703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011543|NCT05838703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011544|NCT05838703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154011545|NCT05838703|Respiratory System Agents|respiratory system agents|mesh-ancestor
154011546|NCT05838703|Parasympatholytics|parasympatholytics|mesh-ancestor
154011547|NCT05838703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154011548|NCT05838703|Cholinergic Agents|cholinergic agents|mesh-ancestor
154011549|NCT05838703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011606|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
154011607|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011608|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154011609|NCT05538767|Albendazole|albendazole|mesh-list
154011610|NCT05538767|Emodepside|emodepside|mesh-list
154011611|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
154011612|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154011613|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011614|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
154011615|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154011616|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154011617|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
154011618|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
154011619|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
154011620|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011621|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011622|NCT05524168|Gemcitabine|gemcitabine|mesh-list
154011623|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011624|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154011625|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
154011626|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011627|NCT05431582|Bevacizumab|bevacizumab|mesh-list
154011628|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
154011629|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011630|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011631|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154011632|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154011633|NCT05431582|Growth Substances|growth substances|mesh-ancestor
154011634|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011635|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
154011651|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011652|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154011653|NCT05331027|Sevoflurane|sevoflurane|mesh-list
154011654|NCT05331027|Desflurane|desflurane|mesh-list
154011655|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154011656|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154011657|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
154011658|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
154011659|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154011660|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011661|NCT05299242|Adalimumab|adalimumab|mesh-list
154011662|NCT05299242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154011663|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011664|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011665|NCT05282706|Peppermint oil|peppermint oil|mesh-list
154011666|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
154011667|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
154011668|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011669|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011670|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154011671|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
154011672|NCT05222984|Venetoclax|venetoclax|mesh-list
154011673|NCT05222984|Decitabine|decitabine|mesh-list
154011675|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011680|NCT05177848|Nicotine|nicotine|mesh-list
154011705|NCT04465318|Nicotine|nicotine|mesh-list
154011706|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154011707|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
154011708|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011709|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011710|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154011711|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154011712|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
154011713|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011714|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011715|NCT04462523|Prednisolone|prednisolone|mesh-list
154011716|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011717|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
154011718|NCT04462523|Hormones|hormones|mesh-ancestor
154011719|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154011720|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011721|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154011722|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011723|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
154011724|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154011725|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154011726|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
154011727|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154011728|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011729|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011730|NCT04437108|Urological Agents|urological agents|mesh-ancestor
154011731|NCT04395079|Durvalumab|durvalumab|mesh-list
154011732|NCT04395079|Ipilimumab|ipilimumab|mesh-list
154011733|NCT04395079|Tremelimumab|tremelimumab|mesh-list
154011734|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
154011735|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154011736|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
154011747|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154011749|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154011750|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011751|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154011752|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154011753|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154011754|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011756|NCT04352205|Dexamethasone|dexamethasone|mesh-list
154011757|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
154011758|NCT04352205|Lenalidomide|lenalidomide|mesh-list
154011759|NCT04352205|Bortezomib|bortezomib|mesh-list
154011760|NCT04352205|Daratumumab|daratumumab|mesh-list
154011761|NCT04352205|Ichthammol|ichthammol|mesh-list
154011762|NCT04352205|BB 1101|bb 1101|mesh-list
154011763|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011764|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
154011765|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
154011766|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011769|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
154011806|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011807|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011808|NCT04251117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154011809|NCT04251117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011810|NCT04219774|Aspirin|aspirin|mesh-list
154011811|NCT04219774|Clopidogrel|clopidogrel|mesh-list
154011812|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154011813|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154011814|NCT04219774|Analgesics|analgesics|mesh-ancestor
154011815|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
154011816|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154011817|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011818|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154011819|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154011820|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154011821|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154011822|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011823|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154011846|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154011847|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154011848|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154011849|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154011850|NCT04150289|Panobinostat|panobinostat|mesh-list
154011900|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154011901|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011903|NCT03900715|Hematinics|hematinics|mesh-ancestor
154011904|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154011905|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
154011906|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154011907|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
154011908|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011965|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154011966|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154011967|NCT03509584|Nivolumab|nivolumab|mesh-list
154011968|NCT03509584|Ipilimumab|ipilimumab|mesh-list
154176581|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154011969|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154011970|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012032|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012033|NCT03197506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154012034|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012035|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154012036|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
154012037|NCT03188705|Aspirin|aspirin|mesh-list
154012038|NCT03188705|Clopidogrel|clopidogrel|mesh-list
154012039|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154012040|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154012041|NCT03188705|Analgesics|analgesics|mesh-ancestor
154012042|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
154012043|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012044|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012045|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176582|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012046|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012047|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154012048|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154012067|NCT03003546|Paclitaxel|paclitaxel|mesh-list
154012086|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012087|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012088|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154012089|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154012090|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
154012091|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012092|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012095|NCT02710851|Vaccines|vaccines|mesh-list
154012150|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154012151|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
154012152|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012154|NCT02192359|Camptothecin|camptothecin|mesh-list
154012155|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154012156|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154012157|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012158|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012159|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012160|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012161|NCT02145143|Vemurafenib|vemurafenib|mesh-list
154012162|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012163|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154012164|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012165|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012166|NCT02119468|Dexamethasone|dexamethasone|mesh-list
154012167|NCT02119468|Pomalidomide|pomalidomide|mesh-list
154012168|NCT02119468|Ixazomib|ixazomib|mesh-list
154012169|NCT02119468|Glycine|glycine|mesh-list
154012170|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
154012171|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012172|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
154012173|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
154012174|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012175|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012176|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154012177|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
154012178|NCT02119468|Hormones|hormones|mesh-ancestor
154012179|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012197|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154012198|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
154012199|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012200|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012201|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154012202|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012204|NCT01552434|Bevacizumab|bevacizumab|mesh-list
154012205|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154012207|NCT01552434|Temsirolimus|temsirolimus|mesh-list
154012208|NCT01552434|MTOR Inhibitors|mtor inhibitors|mesh-list
154012209|NCT01552434|Valproic Acid|valproic acid|mesh-list
154012210|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
154012211|NCT01552434|Antibodies|antibodies|mesh-list
154012212|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
154012213|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154012214|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
154012215|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012231|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
154012256|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154012257|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012258|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
154012259|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012260|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012261|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
154012262|NCT00554515|Aldesleukin|aldesleukin|mesh-list
154012263|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012264|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154012265|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154012266|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
154012267|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012322|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
154012323|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012324|NCT00054561|Protective Agents|protective agents|mesh-ancestor
154012325|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
154012326|NCT00049517|Cytarabine|cytarabine|mesh-list
154012327|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
154012328|NCT00049517|Busulfan|busulfan|mesh-list
154012329|NCT00049517|Daunorubicin|daunorubicin|mesh-list
154012330|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
154012331|NCT00049517|Sargramostim|sargramostim|mesh-list
154012332|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012389|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154012390|NCT00027859|Docetaxel|docetaxel|mesh-list
154012391|NCT00027859|Estramustine|estramustine|mesh-list
154012392|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012393|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012394|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012395|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012396|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012397|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154012398|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
154012399|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012400|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154012401|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154012402|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012403|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154012404|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
154012405|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154012406|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012407|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154012442|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012443|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012444|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012445|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154012446|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
154012447|NCT00004860|Leucovorin|leucovorin|mesh-list
154012448|NCT00004860|Tegafur|tegafur|mesh-list
154012449|NCT00004860|Calcium|calcium|mesh-list
154012450|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
154012451|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154012452|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012453|NCT00004860|Antidotes|antidotes|mesh-ancestor
154012454|NCT00004860|Protective Agents|protective agents|mesh-ancestor
154012455|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
154012507|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012509|NCT00003614|Estramustine|estramustine|mesh-list
154012510|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012511|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012512|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012513|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012514|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012515|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012516|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154012517|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
154012518|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154012519|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
154012520|NCT00003519|Docetaxel|docetaxel|mesh-list
154012521|NCT00003519|Doxorubicin|doxorubicin|mesh-list
154012522|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154012523|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154012524|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
154012525|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012526|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154012527|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154012528|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
154012539|NCT00003283|Prednisone|prednisone|mesh-list
154012559|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012560|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012561|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012562|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012563|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012564|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012565|NCT00003010|Marimastat|marimastat|mesh-list
154012566|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154012567|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012568|NCT00003008|Ritonavir|ritonavir|mesh-list
154012569|NCT00003008|Nelfinavir|nelfinavir|mesh-list
154012570|NCT00003008|Indinavir|indinavir|mesh-list
154012571|NCT00003008|Saquinavir|saquinavir|mesh-list
154012572|NCT00003008|Paclitaxel|paclitaxel|mesh-list
154012573|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012574|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012575|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012576|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012577|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012578|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012614|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012615|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154012616|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
154012617|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
154012618|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
154012621|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012682|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012683|NCT00930865|Diuretics|diuretics|mesh-ancestor
154012684|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
154012685|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154012686|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154012687|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154012688|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
154012689|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154012690|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
154012696|NCT00934531|Donepezil|donepezil|mesh-list
154012745|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154012747|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012748|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154012749|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154012750|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
154012751|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154012752|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
154012753|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154012755|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154012808|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154012809|NCT02811692|Growth Substances|growth substances|mesh-ancestor
154012810|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012811|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
154012812|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012814|NCT04004078|Clotrimazole|clotrimazole|mesh-list
154012815|NCT04004078|Miconazole|miconazole|mesh-list
154012816|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012817|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154012818|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154012819|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154012843|NCT02737254|Oxytocin|oxytocin|mesh-list
154012869|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012870|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012871|NCT04013815|Ropivacaine|ropivacaine|mesh-list
154012872|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
154012873|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
154176583|NCT00620555|Gabapentin|gabapentin|mesh-list
154012874|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154012875|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154012937|NCT02726646|Doxycycline|doxycycline|mesh-list
154012938|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154012939|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012940|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
154012941|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154012942|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154012943|NCT02803892|Vildagliptin|vildagliptin|mesh-list
154012944|NCT02803892|Sirolimus|sirolimus|mesh-list
154012945|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154012946|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154012947|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154012948|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154012949|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
154013003|NCT00929201|Hormones|hormones|mesh-ancestor
154013004|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013005|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154013006|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
154013007|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013008|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013009|NCT02800772|Acetic Acid|acetic acid|mesh-list
154013010|NCT02800772|Retinol acetate|retinol acetate|mesh-list
154013011|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154013012|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013065|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154013066|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154013067|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
154013068|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
154013069|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013070|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154013071|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154013072|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013073|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013074|NCT05504876|Midazolam|midazolam|mesh-list
154013079|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154013129|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013130|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013131|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154013132|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
154013133|NCT02795546|Alendronate|alendronate|mesh-list
154013134|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154013135|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013136|NCT03978091|Ceftazidime|ceftazidime|mesh-list
154013137|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154013138|NCT03978091|Avibactam|avibactam|mesh-list
154013139|NCT03978091|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154013146|NCT00610571|Temozolomide|temozolomide|mesh-list
154013189|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154013190|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154013191|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
154013192|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
154013193|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013194|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013195|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154013196|NCT02725164|Analgesics|analgesics|mesh-ancestor
154013256|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154013257|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154013258|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154013259|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154013260|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013261|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154013262|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
154013263|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013264|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154013265|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013266|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154013267|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154013268|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154013269|NCT04258553|Antioxidants|antioxidants|mesh-list
154013270|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013271|NCT04258553|Protective Agents|protective agents|mesh-ancestor
154013272|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013273|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154013274|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154013307|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
154013308|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154013309|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013310|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
154013311|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013312|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154013313|NCT00938821|Narcotics|narcotics|mesh-ancestor
154013314|NCT00938821|Analgesics|analgesics|mesh-ancestor
154013315|NCT04013581|Empagliflozin|empagliflozin|mesh-list
154013316|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154013374|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013375|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
154013376|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013377|NCT00771927|Lacosamide|lacosamide|mesh-list
154013378|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
154013379|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154013380|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154013381|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154013382|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013383|NCT02715492|Enoxaparin|enoxaparin|mesh-list
154013384|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
154013385|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154013386|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154013387|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013402|NCT02724150|Omeprazole|omeprazole|mesh-list
154013442|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013443|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154013444|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154013445|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013447|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013448|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
154013449|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
154013450|NCT02799446|Reslizumab|reslizumab|mesh-list
154013451|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154013452|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
154013453|NCT00564889|Dexamethasone|dexamethasone|mesh-list
154013454|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
154013455|NCT00564889|Lenalidomide|lenalidomide|mesh-list
154013504|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
154013505|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013506|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154013507|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
154013508|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154013509|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154013510|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154013511|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
154013512|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
153572423|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154013570|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154013571|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013572|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154013573|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154013574|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
154013575|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013576|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013577|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
154013635|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013636|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013637|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013639|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154013640|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013641|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
154013642|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
154013643|NCT04235426|Diclofenac|diclofenac|mesh-list
154013644|NCT04235426|Vitamins|vitamins|mesh-ancestor
154013701|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154013702|NCT00925769|Growth Substances|growth substances|mesh-ancestor
154013703|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013704|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
154013705|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154013707|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013708|NCT00925769|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154013709|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154013710|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013766|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
154013767|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013768|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013769|NCT00770679|Atorvastatin|atorvastatin|mesh-list
154013770|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154013771|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154013772|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
154013773|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013774|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154013775|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154013776|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013777|NCT04042116|Nivolumab|nivolumab|mesh-list
154013778|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154013827|NCT02792816|Artesunate|artesunate|mesh-list
154013828|NCT02792816|Artemether|artemether|mesh-list
154013829|NCT02792816|Piperaquine|piperaquine|mesh-list
154013830|NCT02792816|Artenimol|artenimol|mesh-list
154013831|NCT02792816|Mefloquine|mefloquine|mesh-list
154013832|NCT02792816|Antimalarials|antimalarials|mesh-list
154013833|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154013834|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154013835|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013836|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013837|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
154013838|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
154013839|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154013840|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
154013841|NCT00940381|Sirolimus|sirolimus|mesh-list
154013842|NCT00940381|Cetuximab|cetuximab|mesh-list
154013843|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154013844|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013845|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154013846|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154013847|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154013848|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
154013849|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154013850|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
154013884|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154013885|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154013886|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154013887|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154013888|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154013889|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154013890|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154013891|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154013892|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
154013893|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154013894|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013895|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154013896|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154013898|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154013899|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
154013900|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154013901|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154013902|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154013903|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
154013904|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154013905|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154013906|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013908|NCT00611039|Darunavir|darunavir|mesh-list
154013909|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154013934|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154013936|NCT00945373|Coagulants|coagulants|mesh-ancestor
154013937|NCT04100655|Molgramostim|molgramostim|mesh-list
154013938|NCT04100655|Estradiol|estradiol|mesh-list
154013939|NCT04100655|Sargramostim|sargramostim|mesh-list
154013940|NCT04100655|Estrogens|estrogens|mesh-ancestor
154013941|NCT04100655|Hormones|hormones|mesh-ancestor
154014004|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154014005|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154014006|NCT04256525|Aspirin|aspirin|mesh-list
154014007|NCT04256525|Heparin|heparin|mesh-list
154014008|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
154014009|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154014010|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154014011|NCT04256525|Analgesics|analgesics|mesh-ancestor
154014012|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
154014013|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014068|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014069|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154014070|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154014071|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
154014072|NCT00943345|Indomethacin|indomethacin|mesh-list
154014073|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154014074|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154014075|NCT00943345|Analgesics|analgesics|mesh-ancestor
154014076|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
154014077|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014078|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014079|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014080|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014081|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
154014082|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
154014083|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154014084|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154014085|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014086|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014087|NCT02797028|Allopurinol|allopurinol|mesh-list
154014088|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
154014089|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014090|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014091|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
154014092|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014094|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
154014118|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154014119|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154014120|NCT00943501|Liraglutide|liraglutide|mesh-list
154014121|NCT00943501|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154014122|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154014123|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014124|NCT00943501|Incretins|incretins|mesh-ancestor
154014126|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014127|NCT04258241|Bupivacaine|bupivacaine|mesh-list
154014128|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
154014129|NCT04258241|Anesthetics|anesthetics|mesh-list
154014130|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154014131|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014132|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014133|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
154014134|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014135|NCT02796794|Genistein|genistein|mesh-list
154014136|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154014137|NCT02796794|Protective Agents|protective agents|mesh-ancestor
154014138|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014139|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014140|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154014141|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014142|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014143|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
154014144|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154014145|NCT02796794|Estrogens|estrogens|mesh-ancestor
154014146|NCT02796794|Hormones|hormones|mesh-ancestor
154014163|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154014164|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014165|NCT00946387|Ondansetron|ondansetron|mesh-list
154014166|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
154014167|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
154014168|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014169|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014170|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154014171|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
154014172|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
154014173|NCT00946387|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154014174|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154014175|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
154014176|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014177|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014178|NCT00916695|Everolimus|everolimus|mesh-list
154014179|NCT00916695|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154014180|NCT00916695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154014187|NCT00946465|Ramipril|ramipril|mesh-list
154014217|NCT06005363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154014218|NCT06005363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154014219|NCT06005363|Analgesics|analgesics|mesh-ancestor
154014220|NCT06005363|Sensory System Agents|sensory system agents|mesh-ancestor
154014221|NCT06005363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014222|NCT06005363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154014223|NCT06005363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154014224|NCT06005363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154014225|NCT06005363|Adrenergic Agents|adrenergic agents|mesh-ancestor
154014226|NCT06005363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014227|NCT06005363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014228|NCT06005324|Paclitaxel|paclitaxel|mesh-list
154014229|NCT06005324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154014230|NCT06005324|Carboplatin|carboplatin|mesh-list
154014231|NCT06005324|Fluorouracil|fluorouracil|mesh-list
154014232|NCT06005324|Cetuximab|cetuximab|mesh-list
154014233|NCT06005324|Hydroxyurea|hydroxyurea|mesh-list
154014234|NCT06005324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154014274|NCT06005155|GABA Agents|gaba agents|mesh-ancestor
154014275|NCT06005155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014276|NCT06004947|Itraconazole|itraconazole|mesh-list
154014278|NCT06004947|Celecoxib|celecoxib|mesh-list
154014279|NCT06004947|Midazolam|midazolam|mesh-list
154014280|NCT06004947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154014281|NCT06004947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154014282|NCT06004947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014283|NCT06004947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014284|NCT06004947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154014285|NCT06004947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154014286|NCT06004947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154014287|NCT06004947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154014288|NCT06004947|Anesthetics, General|anesthetics, general|mesh-ancestor
154014289|NCT06004947|Anesthetics|anesthetics|mesh-ancestor
154014290|NCT06004947|GABA Modulators|gaba modulators|mesh-ancestor
154014291|NCT06004947|GABA Agents|gaba agents|mesh-ancestor
154014292|NCT06004947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014293|NCT06004947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014294|NCT06004947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154014295|NCT06004947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154014296|NCT06004947|Analgesics|analgesics|mesh-ancestor
154014297|NCT06004947|Sensory System Agents|sensory system agents|mesh-ancestor
154014298|NCT06004947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014299|NCT06004947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014300|NCT06004947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014301|NCT06004947|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154014321|NCT06004947|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154014322|NCT06004947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154014323|NCT06004882|Triamcinolone|triamcinolone|mesh-list
154014324|NCT06004882|Bupivacaine|bupivacaine|mesh-list
154014325|NCT06004882|Anesthetics, Local|anesthetics, local|mesh-ancestor
154014326|NCT06004882|Anesthetics|anesthetics|mesh-ancestor
154014327|NCT06004882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014328|NCT06004882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014329|NCT06004882|Sensory System Agents|sensory system agents|mesh-ancestor
154014330|NCT06004882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014331|NCT06004882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014333|NCT06004882|Hormones|hormones|mesh-ancestor
154014334|NCT06004882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014335|NCT06004843|Propofol|propofol|mesh-list
154014336|NCT06004843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154014337|NCT06004843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014338|NCT06004843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014381|NCT06004401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154014382|NCT06004401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154014383|NCT06004401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154014384|NCT06004401|Antacids|antacids|mesh-ancestor
154014385|NCT06003998|Bevacizumab|bevacizumab|mesh-list
154014386|NCT06003998|Oxaliplatin|oxaliplatin|mesh-list
154014387|NCT06003998|Irinotecan|irinotecan|mesh-list
154014388|NCT06003998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014389|NCT06003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014390|NCT06003998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154014391|NCT06003998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154014392|NCT06003998|Growth Substances|growth substances|mesh-ancestor
154014393|NCT06003998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014394|NCT06003998|Growth Inhibitors|growth inhibitors|mesh-ancestor
154014395|NCT06003998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154014443|NCT05874219|Bacitracin|bacitracin|mesh-list
154014444|NCT05874219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014445|NCT05874219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154014446|NCT05874219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014447|NCT05874219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014448|NCT05874219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154176585|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
154014449|NCT05862194|Lazertinib|lazertinib|mesh-list
154014450|NCT05862194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154014451|NCT05862194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572646|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014452|NCT05862194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014454|NCT05825417|Riociguat|riociguat|mesh-list
154014455|NCT05825417|Enzyme Activators|enzyme activators|mesh-ancestor
154014456|NCT05825417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014457|NCT05825417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154014458|NCT05790044|Clonidine|clonidine|mesh-list
154014459|NCT05790044|Bupivacaine|bupivacaine|mesh-list
154014460|NCT05790044|Anesthetics, Local|anesthetics, local|mesh-ancestor
154014461|NCT05790044|Anesthetics|anesthetics|mesh-ancestor
154014496|NCT05773950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154014497|NCT05773950|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154014498|NCT05773950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014499|NCT05773950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014500|NCT05766553|Nicotine|nicotine|mesh-list
154014501|NCT05766553|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154014502|NCT05766553|Autonomic Agents|autonomic agents|mesh-ancestor
154014503|NCT05766553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014504|NCT05766553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014505|NCT05766553|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154014506|NCT05766553|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154014507|NCT05766553|Cholinergic Agents|cholinergic agents|mesh-ancestor
154014508|NCT05766553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014509|NCT05766553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014510|NCT05755360|Semaglutide|semaglutide|mesh-list
154014511|NCT05755360|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154014512|NCT05755360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154014513|NCT05755360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014550|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154014551|NCT05625503|Verapamil|verapamil|mesh-list
154014552|NCT05625503|Nicardipine|nicardipine|mesh-list
154014553|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
154014554|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154014555|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014556|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154014557|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154014558|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014559|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
154014560|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154014561|NCT05537402|Bevacizumab|bevacizumab|mesh-list
154014562|NCT05537402|Atezolizumab|atezolizumab|mesh-list
154014563|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014609|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154014610|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
154014611|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154014612|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014613|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154014614|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
154014615|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014616|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014617|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
154014618|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154014673|NCT05193071|Analgesics|analgesics|mesh-ancestor
154014674|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
154014675|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014676|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014677|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014678|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154014679|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154014680|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154014681|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014682|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154014741|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
154014742|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154014743|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154014744|NCT04951206|Clobetasol|clobetasol|mesh-list
154014745|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154014746|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
154014747|NCT04951206|Hormones|hormones|mesh-ancestor
154014748|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154014749|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014751|NCT04936126|Pramipexole|pramipexole|mesh-list
154014752|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154014753|NCT04936126|Dexpramipexole|dexpramipexole|mesh-list
154014754|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
154014755|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154014756|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154014757|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154014758|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014759|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014760|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
154014761|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014762|NCT04936126|Protective Agents|protective agents|mesh-ancestor
154014763|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154014764|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154014765|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
154014766|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
154014767|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014768|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
154014769|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014770|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154014771|NCT04936126|Analgesics|analgesics|mesh-ancestor
154014772|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
153637570|NCT00001005|Aldesleukin|aldesleukin|mesh-list
153637571|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
153637572|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637573|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637574|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637575|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637576|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
153637577|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637578|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637579|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637580|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637581|NCT00391105|Remifentanil|remifentanil|mesh-list
153637605|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153637606|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014773|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014774|NCT04839042|Cloricromen|cloricromen|mesh-list
153772306|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
154014775|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154014776|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
154014778|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014779|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
154014780|NCT04541355|Cisplatin|cisplatin|mesh-list
154014781|NCT04541355|Antidotes|antidotes|mesh-list
154014782|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014783|NCT04541355|Protective Agents|protective agents|mesh-ancestor
154014785|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
154014838|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014839|NCT04158713|Piperaquine|piperaquine|mesh-list
154014840|NCT04158713|Artenimol|artenimol|mesh-list
154014841|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
154014842|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154014843|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154014844|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014845|NCT04047836|Nicotine|nicotine|mesh-list
154014908|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154014909|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154014910|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
154014911|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154014912|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014913|NCT03952299|Urological Agents|urological agents|mesh-ancestor
154014914|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154014915|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014916|NCT03908437|Buprenorphine|buprenorphine|mesh-list
154014917|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154014918|NCT03908437|Naloxone|naloxone|mesh-list
154014919|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154014920|NCT03908437|Narcotics|narcotics|mesh-ancestor
154014921|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154014922|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154014923|NCT03908437|Analgesics|analgesics|mesh-ancestor
154014924|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
154014925|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154014926|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154014927|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
154014928|NCT03903185|Ledipasvir|ledipasvir|mesh-list
154014929|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154014930|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
154014931|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154014932|NCT03834948|Paclitaxel|paclitaxel|mesh-list
154014933|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
154014934|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154014935|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014936|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
154014937|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
154014938|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637607|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153637608|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153637609|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637610|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637611|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153637612|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
153637613|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637614|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637615|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153637616|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153637617|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153637618|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154014939|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014940|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014941|NCT03834948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154014942|NCT03695250|Nivolumab|nivolumab|mesh-list
154014943|NCT03695250|Linrodostat|linrodostat|mesh-list
154014944|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154014945|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154014946|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154014947|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154014948|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015004|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015005|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154015006|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154015008|NCT03054831|Oxycodone|oxycodone|mesh-list
154015009|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154015010|NCT03054831|Narcotics|narcotics|mesh-ancestor
154015011|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015012|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015013|NCT03054831|Analgesics|analgesics|mesh-ancestor
154015014|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
154015015|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015016|NCT03003065|Temoporfin|temoporfin|mesh-list
154015017|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015018|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154015019|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
154015020|NCT02906332|Dexamethasone|dexamethasone|mesh-list
154015021|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
154015022|NCT02906332|Lenalidomide|lenalidomide|mesh-list
154015023|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015024|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
154015025|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
154015026|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015027|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015028|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015029|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
154015030|NCT02906332|Hormones|hormones|mesh-ancestor
154015031|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015054|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154015055|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
154015056|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015057|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015058|NCT02755597|Dexamethasone|dexamethasone|mesh-list
154015059|NCT02755597|Bortezomib|bortezomib|mesh-list
154015060|NCT02755597|Venetoclax|venetoclax|mesh-list
154015061|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015062|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
154015063|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
154015064|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015065|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015066|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015067|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
154015068|NCT02755597|Hormones|hormones|mesh-ancestor
154015069|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015115|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015116|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154015117|NCT02044497|Oxycodone|oxycodone|mesh-list
154015118|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154015119|NCT02044497|Narcotics|narcotics|mesh-ancestor
154015120|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015121|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015122|NCT02044497|Analgesics|analgesics|mesh-ancestor
154015123|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
154015124|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015125|NCT02033993|Paclitaxel|paclitaxel|mesh-list
154015126|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154015127|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154015128|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015135|NCT01470417|Gemcitabine|gemcitabine|mesh-list
154015178|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154015179|NCT00999336|Betrixaban|betrixaban|mesh-list
154015180|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154015181|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
154015182|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154015183|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
154015184|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015185|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015186|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
154015187|NCT00992901|Atropine|atropine|mesh-list
154015188|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154015189|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154015190|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154015191|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154015192|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
154015193|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015194|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015195|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154015196|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
154015197|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
154015198|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
154015199|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154015200|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154015201|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
154015202|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015203|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015227|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015228|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015230|NCT00489710|Immunomodulating Agents|immunomodulating agents|mesh-list
154015231|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015232|NCT00489710|Immunologic Factors|immunologic factors|mesh-ancestor
154015233|NCT00489710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015234|NCT00482677|Temozolomide|temozolomide|mesh-list
154015235|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154015236|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
154015237|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015238|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015239|NCT00314756|Imiquimod|imiquimod|mesh-list
154015240|NCT00314756|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154015242|NCT00314756|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154015285|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154015286|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
154015287|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015288|NCT00946621|Ramipril|ramipril|mesh-list
154015289|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154015290|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
154015291|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015293|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154015354|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015356|NCT00950209|Heparin|heparin|mesh-list
154015357|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
154015358|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154015359|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154015360|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015361|NCT00947323|Simvastatin|simvastatin|mesh-list
154015362|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154015363|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154015364|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
154015365|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015366|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154015367|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154015368|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015369|NCT04236050|Rocuronium|rocuronium|mesh-list
154015370|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154015371|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154015372|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154015373|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015374|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015375|NCT02790632|Nimodipine|nimodipine|mesh-list
154015376|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154015377|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154015378|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154015379|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015380|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154015383|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
154015396|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015397|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015398|NCT04200092|Granisetron|granisetron|mesh-list
154015399|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
154015400|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
154015401|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015402|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015403|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015404|NCT04200092|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154015405|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154015406|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
154015407|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015408|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015409|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
154015410|NCT00754065|Dienogest|dienogest|mesh-list
154015411|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154015412|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154015413|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154015414|NCT00754065|Estradiol|estradiol|mesh-list
154015415|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154015416|NCT00754065|Estrogens|estrogens|mesh-ancestor
154015417|NCT00754065|Hormones|hormones|mesh-ancestor
154015418|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015419|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015420|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154015421|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
154015422|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154015423|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154015424|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154015425|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154015437|NCT02787746|Donepezil|donepezil|mesh-list
154015438|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154015439|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015440|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015441|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
153573019|NCT02787551|Dulaglutide|dulaglutide|mesh-list
154015442|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015443|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015444|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
154015446|NCT03254654|Vinorelbine|vinorelbine|mesh-list
154015447|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015449|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015502|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
154015503|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154015504|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
154015505|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015506|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154015507|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154015508|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
154015509|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015510|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015511|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154015513|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
154015514|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
154015515|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015516|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015517|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
154015518|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015519|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154015520|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154015521|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154015522|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154015524|NCT02787278|Otaplimastat|otaplimastat|mesh-list
154015555|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
154015556|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
154015557|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015558|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015559|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015560|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154015561|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154015562|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015563|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
154015564|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154015565|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154015566|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
154015567|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
154015568|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154015614|NCT02783924|Vitamin D|vitamin d|mesh-list
154015615|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154015616|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015617|NCT02783924|Vitamins|vitamins|mesh-ancestor
154015618|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
154015619|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154015620|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
154015621|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154015622|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015623|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015624|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154015625|NCT02783846|Analgesics|analgesics|mesh-ancestor
154015626|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
154015675|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
154015676|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
154015677|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015678|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015679|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
154015680|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015743|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154015744|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154015745|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154015747|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154015749|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
154015750|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154015751|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015752|NCT05133518|Midazolam|midazolam|mesh-list
154015753|NCT05133518|Ketamine|ketamine|mesh-list
154015754|NCT05133518|Analgesics|analgesics|mesh-ancestor
154015755|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
154015756|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015757|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816796|NCT00467883|Amphotericin B|amphotericin b|mesh-list
154015758|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154015759|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154015760|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
154015761|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
154015762|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015763|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154015764|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154015773|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
154015797|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015798|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015800|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015801|NCT02546934|Cisplatin|cisplatin|mesh-list
154015802|NCT02546934|Gemcitabine|gemcitabine|mesh-list
154015803|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015804|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154015805|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
154015806|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015807|NCT00586521|Factor VIII|factor viii|mesh-list
154015808|NCT00586521|Coagulants|coagulants|mesh-ancestor
154015809|NCT02782286|Ketorolac|ketorolac|mesh-list
154015810|NCT02782286|Morphine|morphine|mesh-list
154015812|NCT02782286|Narcotics|narcotics|mesh-ancestor
154015813|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015814|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015815|NCT02782286|Analgesics|analgesics|mesh-ancestor
154015816|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
154015817|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015818|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154015819|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154015820|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015821|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154015822|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154015823|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015824|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015825|NCT02600247|Acetaminophen|acetaminophen|mesh-list
154015826|NCT02600247|Celecoxib|celecoxib|mesh-list
154015827|NCT02600247|Pregabalin|pregabalin|mesh-list
154015828|NCT02600247|Oxycodone|oxycodone|mesh-list
154015829|NCT02600247|Tramadol|tramadol|mesh-list
154015832|NCT02600247|Analgesics|analgesics|mesh-ancestor
154015841|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154015842|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154015843|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154015844|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154015845|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154015846|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154015848|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154015849|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154015850|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154015851|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154015852|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154015853|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015855|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153773418|NCT00216398|Lanreotide|lanreotide|mesh-list
154015904|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154015905|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
154015906|NCT00923273|Hormones|hormones|mesh-ancestor
154015907|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154015908|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154015909|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154015910|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154015911|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154015912|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154015913|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154015914|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154015915|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015916|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154015964|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154015965|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154015966|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
154015967|NCT04256057|Analgesics|analgesics|mesh-ancestor
154015968|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
154015969|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154015970|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154015971|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
154016030|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154016031|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
154016032|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
154016033|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016034|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154176586|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016035|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154016036|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154016037|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154016039|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
154016040|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154016041|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154016042|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
154016090|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016091|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154016092|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
154016093|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154016094|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016095|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
154016096|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154016097|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154016098|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
154016099|NCT02780102|Methylphenidate|methylphenidate|mesh-list
154016100|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154016101|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016102|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154016103|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154016104|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154016105|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016106|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
154016107|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016108|NCT04197050|Valsartan|valsartan|mesh-list
154016109|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154016110|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154016111|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154016112|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154016113|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016114|NCT04090047|Itraconazole|itraconazole|mesh-list
153573181|NCT02363998|Clonidine|clonidine|mesh-list
154016115|NCT04090047|PF-06700841|pf-06700841|mesh-list
154016116|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
154016117|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016118|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154016119|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153588198|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
153637620|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153637621|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637622|NCT00001008|Zidovudine|zidovudine|mesh-list
153637623|NCT00001008|Methadone|methadone|mesh-list
153637624|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
153637625|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637626|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637627|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637629|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
154016120|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016121|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016122|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154016123|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
154016124|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154016125|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016126|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154016127|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154016128|NCT02782052|Bromides|bromides|mesh-list
154016129|NCT02782052|Albuterol|albuterol|mesh-list
153773650|NCT00412100|Oxycodone|oxycodone|mesh-list
154016130|NCT02782052|Ipratropium|ipratropium|mesh-list
154016131|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
154016132|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154016133|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
154016134|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016135|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016136|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154016137|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
154016138|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
154016139|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154016140|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154016141|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154016142|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154016143|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
154016144|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016145|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016146|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154016147|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
154016148|NCT02708628|Heparin|heparin|mesh-list
154016149|NCT02708628|Allantoin|allantoin|mesh-list
154016150|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
154016151|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154016152|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154016153|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016154|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
154016155|NCT00746733|Amphetamine|amphetamine|mesh-list
154016156|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154016157|NCT00746733|Adderall|adderall|mesh-list
154016158|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154016159|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016160|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
154016161|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
154016162|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016163|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
154016164|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016165|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016166|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
154016167|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154016168|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154016169|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154016170|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154016171|NCT00636870|Fexofenadine|fexofenadine|mesh-list
154016172|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154016173|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154016174|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154016175|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
154016176|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
154016177|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016178|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016203|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016204|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
154016205|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016206|NCT02708160|Fluorides|fluorides|mesh-list
154016207|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
154016208|NCT02708160|Protective Agents|protective agents|mesh-ancestor
154016209|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016210|NCT04257461|Capecitabine|capecitabine|mesh-list
154016211|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
154016212|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154016213|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
154016214|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016215|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016216|NCT02712528|Sufentanil|sufentanil|mesh-list
154016217|NCT02712528|Remifentanil|remifentanil|mesh-list
154016218|NCT02712528|Sevoflurane|sevoflurane|mesh-list
154016219|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154016220|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154016221|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
154016222|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
154016223|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016224|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016257|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154016258|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016259|NCT00555217|Losartan|losartan|mesh-list
154016260|NCT00555217|Lisinopril|lisinopril|mesh-list
154016261|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154016262|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154016263|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154016264|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154016265|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016266|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154016267|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
154016268|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016269|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154016270|NCT00555217|Protective Agents|protective agents|mesh-ancestor
154016271|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016272|NCT02711904|Remifentanil|remifentanil|mesh-list
154016273|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154016274|NCT02711904|Narcotics|narcotics|mesh-ancestor
154016275|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016276|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016277|NCT02711904|Analgesics|analgesics|mesh-ancestor
153773805|NCT00217529|Docetaxel|docetaxel|mesh-list
154016278|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
154016279|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016280|NCT05326490|Metformin|metformin|mesh-list
154016281|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154016282|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016283|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
154016303|NCT00745095|Neostigmine|neostigmine|mesh-list
154016304|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154016305|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016306|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016307|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
154016308|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016309|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016310|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154016311|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
154016312|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016313|NCT02623010|Ibrutinib|ibrutinib|mesh-list
154016314|NCT02623010|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154016315|NCT02623010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154016316|NCT02623010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016317|NCT02623010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016318|NCT05181462|Carboplatin|carboplatin|mesh-list
154016319|NCT05181462|Gemcitabine|gemcitabine|mesh-list
154016320|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016321|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154016322|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
154016323|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016324|NCT00612612|Rituximab|rituximab|mesh-list
154016325|NCT00612612|Fludarabine|fludarabine|mesh-list
154016326|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
154016327|NCT00612612|Obatoclax|obatoclax|mesh-list
154016328|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154016329|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016349|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
154016350|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016351|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
154016352|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154016353|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
154016354|NCT02598063|Lamivudine|lamivudine|mesh-list
154016355|NCT02598063|Adefovir|adefovir|mesh-list
154016356|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154016357|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154016358|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154016359|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154016360|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016361|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016362|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
154016363|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016364|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154016365|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154016408|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016410|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016411|NCT02711592|Analgesics|analgesics|mesh-list
154016412|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
154016413|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016414|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016415|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
154016416|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154016417|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
154016418|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
154016419|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016420|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016421|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154016422|NCT00948103|Analgesics|analgesics|mesh-ancestor
154016423|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
154016424|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016425|NCT02012114|Cysteamine|cysteamine|mesh-list
154016426|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
154016427|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016428|NCT05301205|Gabapentin|gabapentin|mesh-list
154016430|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
154016461|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154016462|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
154016463|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016464|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016465|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016466|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154016467|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
154016468|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154016469|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
154016470|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016471|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
153573364|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
154016472|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
154016473|NCT02597829|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154016474|NCT02597829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154016475|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016521|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154016522|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154016523|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154016524|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016525|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016526|NCT00744627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154016527|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154016528|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154016529|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016530|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016531|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
154016532|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154016533|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154016534|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154016578|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016580|NCT00612144|Glimepiride|glimepiride|mesh-list
154016581|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154016582|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016583|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154016584|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016585|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
154016586|NCT00562627|Ketorolac|ketorolac|mesh-list
154016587|NCT00562627|Epinephrine|epinephrine|mesh-list
154016588|NCT00562627|Racepinephrine|racepinephrine|mesh-list
154016589|NCT00562627|Fentanyl|fentanyl|mesh-list
154016590|NCT00562627|Morphine|morphine|mesh-list
154016591|NCT00562627|Bupivacaine|bupivacaine|mesh-list
154016592|NCT00562627|Ropivacaine|ropivacaine|mesh-list
154016593|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
154016594|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
154016595|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
154016596|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016597|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016598|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
154016599|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016600|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154016601|NCT00562627|Narcotics|narcotics|mesh-ancestor
154016602|NCT00562627|Analgesics|analgesics|mesh-ancestor
154016603|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154016604|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154016605|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
154016606|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154016607|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154016608|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154016609|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016610|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016611|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154016612|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154016613|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
154016614|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154016615|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
154016616|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
154016619|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154016620|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154016621|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154016622|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154016623|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153573415|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
154016624|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016625|NCT02597283|Sirolimus|sirolimus|mesh-list
154016626|NCT02597283|Temsirolimus|temsirolimus|mesh-list
154016627|NCT02597283|MTOR Inhibitors|mtor inhibitors|mesh-list
154016628|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154016629|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016630|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154016631|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016632|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
154016633|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016634|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
154016635|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016636|NCT02597283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154016637|NCT02597283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016677|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154016678|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016679|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
154016680|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
154016681|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
154016682|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016683|NCT02780882|Pasireotide|pasireotide|mesh-list
154016684|NCT02780882|Hormones|hormones|mesh-ancestor
154016694|NCT00562159|Xhance|xhance|mesh-list
154016750|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016751|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154016752|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016753|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154016754|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
154016755|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154016756|NCT04848714|Antivenins|antivenins|mesh-list
154016757|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
154016825|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
154016826|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
154016827|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016828|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154016829|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016830|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016831|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
154016832|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016833|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
154016834|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
154016835|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016836|NCT02779634|Vitamins|vitamins|mesh-ancestor
154016837|NCT04255589|Ethanol|ethanol|mesh-list
154016838|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154016839|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016840|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154016841|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016842|NCT00744471|Tanezumab|tanezumab|mesh-list
154016843|NCT00744471|Analgesics|analgesics|mesh-ancestor
154016844|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
154016845|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016847|NCT02776436|Dexamethasone|dexamethasone|mesh-list
154016879|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154016880|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
154016881|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154016882|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016883|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154016884|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
154016885|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154016886|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154016887|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154016888|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
154016889|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016890|NCT02775734|Expectorants|expectorants|mesh-ancestor
154016943|NCT02693574|Clarithromycin|clarithromycin|mesh-list
154016944|NCT02693574|Levofloxacin|levofloxacin|mesh-list
154016945|NCT02693574|Esomeprazole|esomeprazole|mesh-list
154016946|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154016947|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016948|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154016949|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154016950|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154016951|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154016952|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154016953|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154016954|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154016955|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153774466|NCT00219596|Timolol|timolol|mesh-list
154016956|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154016957|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154016958|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154016959|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154016960|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154016961|NCT04179266|Ketamine|ketamine|mesh-list
154016962|NCT04179266|Analgesics|analgesics|mesh-ancestor
154016963|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
154016964|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154016991|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154016992|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154016993|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154016994|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
154016995|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154016996|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
154016997|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154016998|NCT00611910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154016999|NCT00611910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017001|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154017002|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017052|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
154017053|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017054|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
154017055|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
154017056|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017057|NCT02775266|Protective Agents|protective agents|mesh-ancestor
154017058|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017059|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
154017060|NCT02775266|Vitamins|vitamins|mesh-ancestor
154017061|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
154017062|NCT02774876|Insulin|insulin|mesh-list
154017063|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154017064|NCT02774876|Hormones|hormones|mesh-list
154017065|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154017066|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017067|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017068|NCT04225364|Paclitaxel|paclitaxel|mesh-list
154017069|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154017107|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017108|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154017110|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
154017111|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154017112|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154017113|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154017114|NCT00741819|Treprostinil|treprostinil|mesh-list
154017115|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154017116|NCT04457466|Mitogens|mitogens|mesh-list
154017117|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
154017118|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017119|NCT04954742|Riociguat|riociguat|mesh-list
154017120|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
154017121|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589197|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
153637630|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637631|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637654|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637655|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637656|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
153637657|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
153637659|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
153637660|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637661|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637662|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637663|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637664|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
153637665|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637666|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637667|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637668|NCT00001014|Leucovorin|leucovorin|mesh-list
153637669|NCT00001014|Trimethoprim|trimethoprim|mesh-list
153637670|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153637671|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
153637672|NCT00001014|Trimetrexate|trimetrexate|mesh-list
153637673|NCT00001014|Calcium|calcium|mesh-list
153637674|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
153637675|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153637676|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637677|NCT00001014|Antidotes|antidotes|mesh-ancestor
153637678|NCT00001014|Protective Agents|protective agents|mesh-ancestor
153637679|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
153637680|NCT00001014|Vitamins|vitamins|mesh-ancestor
153637681|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
153637682|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153637683|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637684|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
153637685|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153637686|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153637717|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637718|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153637719|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153637720|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
153637721|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637722|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637723|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153637724|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153637725|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
153637726|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
154017122|NCT04193696|Immunomodulating Agents|immunomodulating agents|mesh-list
154017123|NCT04193696|Immunologic Factors|immunologic factors|mesh-ancestor
154017124|NCT04193696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017125|NCT02774096|Xenon|xenon|mesh-list
154017126|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154017127|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
154017128|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
154017129|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017130|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017187|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017188|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017189|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017190|NCT04255121|Lidocaine|lidocaine|mesh-list
154017191|NCT04255121|Epinephrine|epinephrine|mesh-list
154017192|NCT04255121|Racepinephrine|racepinephrine|mesh-list
154017193|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
154017194|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
154017195|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
154017196|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017197|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017228|NCT00924287|Mesna|mesna|mesh-list
154017255|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017256|NCT02677077|Natalizumab|natalizumab|mesh-list
154017257|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
154017258|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017259|NCT02771600|Anesthetics|anesthetics|mesh-list
154017260|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
154017261|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017262|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017263|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
154017264|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017265|NCT02773316|Morphine|morphine|mesh-list
154017266|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154017315|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017316|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
154017317|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154017318|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
154017319|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154017320|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153573615|NCT01694212|Diclofenac|diclofenac|mesh-list
154017321|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154017322|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017323|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
154017324|NCT00642837|Acetaminophen|acetaminophen|mesh-list
154017325|NCT00642837|Tramadol|tramadol|mesh-list
154017326|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017327|NCT00642837|Analgesics|analgesics|mesh-ancestor
154017328|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
154017329|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017330|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774847|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
154017331|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
154017332|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154017333|NCT00642837|Narcotics|narcotics|mesh-ancestor
154017334|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017335|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154017336|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154017337|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154017338|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017339|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017340|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
154017360|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
154017361|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
154017362|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154017363|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
154017364|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017365|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017366|NCT02696720|Lidocaine|lidocaine|mesh-list
154017367|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
154017368|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
154017369|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154017370|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017371|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
154017372|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017378|NCT00643071|Tacrolimus|tacrolimus|mesh-list
154017418|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017419|NCT00613392|Protective Agents|protective agents|mesh-ancestor
154017420|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017421|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
154017422|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154017423|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
154017487|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154017488|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
154017489|NCT02770430|Infliximab|infliximab|mesh-list
154017490|NCT02770430|Basiliximab|basiliximab|mesh-list
154017491|NCT02770430|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154017492|NCT02770430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017493|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
154017494|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154017495|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017496|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154017497|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
154017498|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017499|NCT00918203|Paclitaxel|paclitaxel|mesh-list
154017500|NCT00918203|Carboplatin|carboplatin|mesh-list
154017501|NCT00918203|Olaratumab|olaratumab|mesh-list
154017502|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154017503|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017504|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
154017544|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154017545|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017546|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017547|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017548|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154017549|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154017550|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017551|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154017552|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154017553|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017554|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
154017555|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154017556|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
154017604|NCT04177875|Paclitaxel|paclitaxel|mesh-list
154017605|NCT04177875|Docetaxel|docetaxel|mesh-list
154017606|NCT04177875|Cisplatin|cisplatin|mesh-list
154017607|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154017608|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154017609|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017610|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
154017611|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
154017612|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
154017613|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017615|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154017616|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154017617|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
154017618|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017619|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153573675|NCT01694693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154017620|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154017621|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017622|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154017623|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154017624|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154017625|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154017626|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017627|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
154017628|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154017629|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017630|NCT02766140|Docetaxel|docetaxel|mesh-list
154017631|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017651|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154017652|NCT04178109|Analgesics|analgesics|mesh-ancestor
154017653|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
154017654|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154017655|NCT04178109|Narcotics|narcotics|mesh-ancestor
154017656|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154017657|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017658|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017659|NCT00644475|Candesartan|candesartan|mesh-list
154017660|NCT00644475|Candesartan cilexetil|candesartan cilexetil|mesh-list
154017661|NCT00644475|Imidapril|imidapril|mesh-list
154017662|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154017663|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154017664|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154017665|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017666|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154017709|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154017710|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154017711|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017712|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017713|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
154017714|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
154017715|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154017716|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
154017717|NCT00915473|Hormones|hormones|mesh-ancestor
154017718|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154017719|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154017720|NCT00915473|Protective Agents|protective agents|mesh-ancestor
154017721|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154017722|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017723|NCT04691726|Dipyrone|dipyrone|mesh-list
154017724|NCT04691726|Lidocaine|lidocaine|mesh-list
154017725|NCT04691726|Morphine|morphine|mesh-list
154017726|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
154017727|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
154017765|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154017766|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
154017767|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017768|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017769|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
154017770|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017790|NCT03651804|Acetaminophen|acetaminophen|mesh-list
154017834|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154017835|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154017836|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017837|NCT05147727|Fluconazole|fluconazole|mesh-list
154017838|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
154017839|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154017840|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154017841|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154017842|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017843|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017851|NCT02765594|Valsartan|valsartan|mesh-list
154017898|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154017899|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154017900|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154017901|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154017902|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017903|NCT02669589|Heparin|heparin|mesh-list
154017904|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
154017905|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017906|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154017907|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154017908|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
154017909|NCT02765204|Saxagliptin|saxagliptin|mesh-list
154017962|NCT00645255|Sibutramine|sibutramine|mesh-list
154017963|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
154017964|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154017965|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
154017966|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154017968|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154017969|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154017970|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
154017971|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017972|NCT02765126|Vaccines|vaccines|mesh-list
154017973|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
154017974|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154017975|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154017976|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018022|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154018023|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018024|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
154018025|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
154018026|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
154018027|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018028|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
154018029|NCT00910533|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154018030|NCT00910533|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154018031|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018032|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018033|NCT02696642|Maytansine|maytansine|mesh-list
154018034|NCT02696642|Anetumab ravtansine|anetumab ravtansine|mesh-list
154018035|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154018081|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154018083|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
154018084|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
154018085|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018086|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018087|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
154018088|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018089|NCT04648319|Nivolumab|nivolumab|mesh-list
154018090|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154018094|NCT00647127|Fentanyl|fentanyl|mesh-list
154018147|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018148|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
154018149|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018150|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154018151|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154018152|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154018153|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154018155|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154018156|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018157|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154018158|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018159|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154018160|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
154018161|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
154018162|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018164|NCT00647751|Lamotrigine|lamotrigine|mesh-list
154018204|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018205|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018206|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
154018207|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018208|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154018209|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154018210|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
154018211|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154018212|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154018213|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018214|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018215|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154018216|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
154018262|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018263|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018264|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154018265|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
154018266|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018267|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018268|NCT00648141|Celecoxib|celecoxib|mesh-list
154018269|NCT00648141|Diclofenac|diclofenac|mesh-list
154018270|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154018327|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018328|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018329|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018330|NCT00549445|Azithromycin|azithromycin|mesh-list
154018331|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018332|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018333|NCT00637026|Gefitinib|gefitinib|mesh-list
154018334|NCT00637026|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154018335|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154018336|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018337|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018338|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018339|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
154018340|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018341|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018342|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154018343|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154018344|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573776|NCT01695460|Vitamins|vitamins|mesh-list
154018345|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018346|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018347|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154018348|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154018374|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154018375|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154018376|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018377|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018378|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
154018379|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018380|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154018381|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154018382|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154018383|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154018384|NCT05343546|Copper|copper|mesh-list
154018385|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
154018386|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154018387|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
154018388|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018389|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018390|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154018391|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154018392|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154018393|NCT05343546|Trace Elements|trace elements|mesh-ancestor
154018394|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
154018395|NCT02659917|Methamphetamine|methamphetamine|mesh-list
154018396|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154018397|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018398|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
154018399|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
154018400|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018401|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
154018402|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018403|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018404|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
153590415|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
153637727|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637728|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153637729|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
153637730|NCT00005834|Hormones|hormones|mesh-ancestor
153469159|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637756|NCT00001032|Zidovudine|zidovudine|mesh-list
153637757|NCT00001032|Zalcitabine|zalcitabine|mesh-list
153637758|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
153637759|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637760|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154018406|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154018407|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018408|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154018409|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154018410|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018411|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018412|NCT04500236|Anesthetics|anesthetics|mesh-list
154018413|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018414|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018415|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
154018416|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154018417|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018418|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018419|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154018420|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153637761|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637762|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637763|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
153637764|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637765|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637766|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637767|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
153637768|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637769|NCT00001038|Valacyclovir|valacyclovir|mesh-list
153637770|NCT00001038|Acyclovir|acyclovir|mesh-list
153637771|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
153637772|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637773|NCT00005840|Paclitaxel|paclitaxel|mesh-list
153637774|NCT00005840|Cisplatin|cisplatin|mesh-list
153637775|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153637776|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637777|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
153637778|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
153637779|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637780|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637797|NCT00001047|Clofazimine|clofazimine|mesh-list
153458461|NCT04143282|Metformin|metformin|mesh-list
153637798|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153637799|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637800|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153637801|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637802|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637803|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153637804|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637805|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
153637806|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153637807|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153637808|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
153637809|NCT00005852|Cyclosporine|cyclosporine|mesh-list
153637810|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
153637811|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
153637812|NCT00005852|Cyclosporins|cyclosporins|mesh-list
153637813|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153637814|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
153637815|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153637817|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637818|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154018422|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018423|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018424|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154018425|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
154018426|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018427|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018428|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154018429|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154018430|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154018431|NCT00649233|Metoprolol|metoprolol|mesh-list
154018432|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154018433|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154018434|NCT00649233|Diuretics|diuretics|mesh-ancestor
154018435|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
154018436|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018437|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154018438|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018439|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018440|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154018441|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
154018442|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
153775992|NCT04144933|Dsuvia|dsuvia|mesh-list
154018443|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018444|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154018445|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154018446|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154018447|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
154018448|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018449|NCT00954811|Progesterone|progesterone|mesh-list
154018450|NCT00954811|Progestins|progestins|mesh-ancestor
154018452|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018453|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637819|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153573834|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153637820|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
153637821|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637822|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637823|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154018454|NCT00954889|Tamsulosin|tamsulosin|mesh-list
154018455|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154018456|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154018457|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154018458|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
154018459|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018460|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018461|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018462|NCT00954889|Urological Agents|urological agents|mesh-ancestor
154018463|NCT02692248|Dexamethasone|dexamethasone|mesh-list
154018464|NCT02692248|Rituximab|rituximab|mesh-list
154018465|NCT02692248|Gemcitabine|gemcitabine|mesh-list
154018466|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
154018467|NCT02692248|Ibrutinib|ibrutinib|mesh-list
154018468|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018469|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
154018470|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
154018471|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018472|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018473|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018474|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
154018475|NCT02692248|Hormones|hormones|mesh-ancestor
154018476|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018477|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154018478|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018479|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154018480|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
154018481|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154018482|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154018483|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
154018484|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637824|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637825|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
153637826|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637827|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
153637828|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153637829|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153637830|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
153637831|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
153637832|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637833|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153637834|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
153637835|NCT00005852|Hormones|hormones|mesh-ancestor
154018485|NCT02692248|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154018486|NCT02692248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154018487|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018489|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018490|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018491|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154018492|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154018493|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018494|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018495|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154018496|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154176592|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154018497|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018498|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
154018499|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018500|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
154018501|NCT00601107|Vitamins|vitamins|mesh-ancestor
154018502|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
154018503|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018504|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154018505|NCT00957385|Lenalidomide|lenalidomide|mesh-list
154018506|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
154018507|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018508|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154018509|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154018531|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018532|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018533|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018534|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154018535|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154018536|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018537|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018538|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
154018539|NCT04169919|Povidone|povidone|mesh-list
154018540|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
154018541|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
154018542|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154018543|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018544|NCT02757248|Romidepsin|romidepsin|mesh-list
154018545|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154018546|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018547|NCT02757248|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154018548|NCT02757248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018549|NCT02757248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018550|NCT00649311|Losartan|losartan|mesh-list
154018551|NCT00649311|Eplerenone|eplerenone|mesh-list
154018552|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154018553|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154018554|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154018555|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153637836|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637837|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153637838|NCT00005852|Protective Agents|protective agents|mesh-ancestor
153637839|NCT00001071|Lenograstim|lenograstim|mesh-list
153637840|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153637841|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
153637874|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637875|NCT00001083|Ritonavir|ritonavir|mesh-list
153637876|NCT00001083|Indinavir|indinavir|mesh-list
153637877|NCT00001083|Lamivudine|lamivudine|mesh-list
153637878|NCT00001083|Zidovudine|zidovudine|mesh-list
153637879|NCT00001083|Nevirapine|nevirapine|mesh-list
153637880|NCT00001083|Stavudine|stavudine|mesh-list
153637881|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637882|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637883|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
153637884|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637885|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637922|NCT00700258|Axitinib|axitinib|mesh-list
153637947|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637949|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637950|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637951|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637952|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018556|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018557|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154018558|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
154018559|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018560|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018561|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154018562|NCT00649311|Diuretics|diuretics|mesh-ancestor
154018563|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
154018564|NCT02704494|Losartan|losartan|mesh-list
154018565|NCT02704494|Resveratrol|resveratrol|mesh-list
154018566|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154018567|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154018568|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154018569|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154018570|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018572|NCT02704494|Protective Agents|protective agents|mesh-ancestor
154018573|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018574|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018575|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154018576|NCT00649467|Topiramate|topiramate|mesh-list
154018577|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
154018578|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154018579|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018580|NCT00649545|Adalimumab|adalimumab|mesh-list
154018581|NCT00649545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153590599|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637953|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637954|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637955|NCT00005867|Prednisolone|prednisolone|mesh-list
153637956|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
153637957|NCT00005867|Doxorubicin|doxorubicin|mesh-list
153637958|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153637959|NCT00005867|Etoposide|etoposide|mesh-list
153637960|NCT00005867|Vincristine|vincristine|mesh-list
153637961|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
153637962|NCT00005867|Bleomycin|bleomycin|mesh-list
153637963|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153637964|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
153637965|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637966|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153637967|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153637968|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
153637969|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637970|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637971|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153637972|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154018582|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018584|NCT00635414|Esomeprazole|esomeprazole|mesh-list
154018585|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154018586|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018587|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154018588|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776116|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
154018589|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018590|NCT02658435|Tafenoquine|tafenoquine|mesh-list
154018591|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
154018592|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154018593|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154018594|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018595|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
154018596|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
154018597|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
154018598|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154018599|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
154018600|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018601|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154018602|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154018603|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
154018604|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018605|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590634|NCT01814423|Chloroquine|chloroquine|mesh-list
153638005|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638006|NCT00017407|Paclitaxel|paclitaxel|mesh-list
153638007|NCT00017407|Carboplatin|carboplatin|mesh-list
153638008|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638009|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638010|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638011|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638012|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638013|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638015|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
153638016|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638044|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638047|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153573980|NCT01697098|Hormones|hormones|mesh-ancestor
153638048|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153638049|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153638050|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153638051|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
153638052|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153638053|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153638054|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153638055|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153638056|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154018606|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154018607|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018609|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154018610|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154018611|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018612|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018613|NCT02759666|Fluzoparib|fluzoparib|mesh-list
154018614|NCT02759666|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154018615|NCT02759666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018616|NCT02759666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018617|NCT02759666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018618|NCT02752724|Ketamine|ketamine|mesh-list
154018619|NCT02752724|Methohexital|methohexital|mesh-list
154018620|NCT02752724|Analgesics|analgesics|mesh-ancestor
154018621|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
154018622|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018623|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018624|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154018625|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154018626|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
154018627|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
153590651|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
153590652|NCT01814449|Letrozole|letrozole|mesh-list
153638057|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153638058|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
153638059|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153638060|NCT00009061|Ritonavir|ritonavir|mesh-list
153638061|NCT00009061|Nelfinavir|nelfinavir|mesh-list
153638062|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
153638063|NCT00009061|Lamivudine|lamivudine|mesh-list
153638064|NCT00009061|Abacavir|abacavir|mesh-list
153638065|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153638066|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153638099|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
153638100|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
153638101|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
153638102|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638103|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638104|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153638141|NCT00009763|Antibodies|antibodies|mesh-list
153638170|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153638171|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153638172|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153638174|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
153638175|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153638177|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638178|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638179|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
153638180|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638181|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
153638182|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638183|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638184|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154018628|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018629|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154018630|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154018631|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018632|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018634|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154018635|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154018636|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154018637|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154018638|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018639|NCT02756312|Anesthetics|anesthetics|mesh-list
154018640|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018641|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018642|NCT02657187|Rocuronium|rocuronium|mesh-list
154018643|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154018644|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154018645|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154018646|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018647|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018648|NCT00649779|Albuterol|albuterol|mesh-list
154018649|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154018650|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
153590674|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
153638185|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
153638186|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638187|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638219|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153638220|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153638221|NCT00009997|Tamoxifen|tamoxifen|mesh-list
153638222|NCT00009997|Paclitaxel|paclitaxel|mesh-list
153638223|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
153638224|NCT00009997|Doxorubicin|doxorubicin|mesh-list
153638225|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153638226|NCT00009997|Trastuzumab|trastuzumab|mesh-list
153638227|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638228|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638229|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638230|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638231|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638232|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638267|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638268|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638269|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638270|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638291|NCT00010192|Aldesleukin|aldesleukin|mesh-list
153638292|NCT00010192|Rituximab|rituximab|mesh-list
153638293|NCT00010192|Interleukin-2|interleukin-2|mesh-list
154018651|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018652|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018653|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154018654|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
154018655|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
154018656|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018657|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154018658|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154018659|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154018660|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154018661|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018662|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018663|NCT00615186|Temozolomide|temozolomide|mesh-list
154018664|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154018665|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
154018666|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018667|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018668|NCT00616044|Anesthetics|anesthetics|mesh-list
154018669|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018670|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018671|NCT02536911|Eliglustat|eliglustat|mesh-list
154018672|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638294|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153638295|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638296|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
153638297|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638298|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638299|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153638300|NCT00010192|Analgesics|analgesics|mesh-ancestor
153638301|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
153638303|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638304|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638305|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
153638306|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638307|NCT00005912|Voriconazole|voriconazole|mesh-list
153638308|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
153638309|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638310|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153638311|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153638312|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638313|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638314|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153638315|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
153638316|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638317|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638318|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153638319|NCT00010231|Calcitriol|calcitriol|mesh-list
153638320|NCT00010231|Dexamethasone|dexamethasone|mesh-list
153638321|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638322|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
154018673|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018674|NCT04221152|Empagliflozin|empagliflozin|mesh-list
154018675|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154018676|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018677|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154018678|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018679|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154018680|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018681|NCT02759510|Phenylephrine|phenylephrine|mesh-list
154018682|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
154018683|NCT02759510|Norepinephrine|norepinephrine|mesh-list
154018684|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154018685|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
154018686|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
154018687|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018688|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018689|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
154018690|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154018691|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
154018692|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
153638323|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
153638324|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638325|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638333|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153638334|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153638335|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638336|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153638337|NCT00010231|Vitamins|vitamins|mesh-ancestor
153638338|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
153638339|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153638340|NCT00010270|Immunotoxins|immunotoxins|mesh-list
153638341|NCT00010270|Immunoconjugates|immunoconjugates|mesh-ancestor
153638342|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
153638343|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638344|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
153638345|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638346|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
153638347|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638348|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638349|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638350|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
153638351|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638352|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638353|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638354|NCT00010426|Cysteamine|cysteamine|mesh-list
153638355|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153574104|NCT01697787|Lumefantrine|lumefantrine|mesh-list
153638356|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638357|NCT00386516|Fluorouracil|fluorouracil|mesh-list
153638358|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
153638359|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638360|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638361|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638362|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154018694|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154018695|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154018696|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
154018697|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018698|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018699|NCT02759510|Protective Agents|protective agents|mesh-ancestor
154018700|NCT04220528|Capecitabine|capecitabine|mesh-list
154018701|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154018702|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
154018703|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018704|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018705|NCT02759042|Leronlimab|leronlimab|mesh-list
154018706|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154018707|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154018708|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018709|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154018710|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638363|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
153458517|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
153638364|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638365|NCT00010699|Vitamin E|vitamin e|mesh-list
153638366|NCT00010699|Vitamins|vitamins|mesh-ancestor
153638367|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
153638368|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638369|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
153638370|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638371|NCT00010699|Protective Agents|protective agents|mesh-ancestor
153638372|NCT00386555|Docetaxel|docetaxel|mesh-list
153638373|NCT00386555|Axitinib|axitinib|mesh-list
153638374|NCT00386555|Crenolanib|crenolanib|mesh-list
153638375|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638376|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638377|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638378|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638379|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638380|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153638381|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638382|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153638383|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153638384|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638386|NCT00001191|Pantoprazole|pantoprazole|mesh-list
153638387|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153638388|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153638389|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153638390|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638391|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638420|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638421|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638422|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638423|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
153638424|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638425|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638426|NCT00001212|Cyclosporine|cyclosporine|mesh-list
154018712|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018713|NCT02755532|Bupivacaine|bupivacaine|mesh-list
154018714|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
154018715|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
154018716|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018717|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018718|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
154018719|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018720|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
154018721|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154018722|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
154018723|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018724|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
154018725|NCT02755376|Protective Agents|protective agents|mesh-ancestor
154018726|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
154018728|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
154018729|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
154018730|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018731|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018732|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
154018733|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018734|NCT02752334|Analgesics|analgesics|mesh-ancestor
154018735|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154018736|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
154018737|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154018738|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018739|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590761|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153638427|NCT00001212|Prednisone|prednisone|mesh-list
153638428|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
153638429|NCT00001212|Cyclosporins|cyclosporins|mesh-list
153638430|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638431|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
153638432|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638433|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638434|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638435|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
153638436|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638437|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638438|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638456|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638457|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638458|NCT00011635|Silymarin|silymarin|mesh-list
153638459|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
154018740|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154018741|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
154018742|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154018743|NCT02755298|Acetazolamide|acetazolamide|mesh-list
154018744|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
154018745|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154018746|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018747|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018748|NCT02755298|Diuretics|diuretics|mesh-ancestor
154018749|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
154018750|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018751|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154018752|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154018753|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
154018754|NCT02759198|Celecoxib|celecoxib|mesh-list
154018755|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154018801|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018802|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154018803|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154018804|NCT02754362|Growth Substances|growth substances|mesh-ancestor
154018805|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018806|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
154018807|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
154018808|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
154018809|NCT03373188|Nivolumab|nivolumab|mesh-list
154018810|NCT03373188|Ipilimumab|ipilimumab|mesh-list
154018811|NCT03373188|Antibodies|antibodies|mesh-list
154018812|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154018813|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
154018814|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018815|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154018816|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018817|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154018818|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018819|NCT02698098|Methadone|methadone|mesh-list
154018820|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154018821|NCT02698098|Narcotics|narcotics|mesh-ancestor
154018822|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018823|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018824|NCT02698098|Analgesics|analgesics|mesh-ancestor
154018825|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
154018826|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018827|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
153590846|NCT01815307|Gemcitabine|gemcitabine|mesh-list
153638460|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638461|NCT00011635|Protective Agents|protective agents|mesh-ancestor
153638462|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638464|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638465|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638466|NCT00391417|Estradiol|estradiol|mesh-list
153638467|NCT00391417|Estrogens|estrogens|mesh-ancestor
153638468|NCT00391417|Hormones|hormones|mesh-ancestor
153638469|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638470|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638471|NCT00011908|Epratuzumab|epratuzumab|mesh-list
153638472|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153638473|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638474|NCT00012025|Fulvestrant|fulvestrant|mesh-list
153638475|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638476|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638477|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153638478|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154018829|NCT04220996|Vortioxetine|vortioxetine|mesh-list
154018830|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
154018831|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154018832|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154018833|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154018834|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018835|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018836|NCT04220996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154018837|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154018838|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018839|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018840|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018841|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
154018842|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154018843|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154018844|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154018845|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154018846|NCT02702700|Verteporfin|verteporfin|mesh-list
154018847|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154018848|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
154018849|NCT02702622|Provitamins|provitamins|mesh-list
153638479|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
153638480|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638481|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638482|NCT00005942|Daunorubicin|daunorubicin|mesh-list
153638483|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638484|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153638485|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638486|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153638487|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638488|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638489|NCT00012103|Dimercaprol|dimercaprol|mesh-list
153638490|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
153638491|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
153638492|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638493|NCT00001251|Mafosfamide|mafosfamide|mesh-list
153638494|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153638524|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153638525|NCT00005945|Methotrexate|methotrexate|mesh-list
153638526|NCT00005945|Vincristine|vincristine|mesh-list
153638527|NCT00005945|Daunorubicin|daunorubicin|mesh-list
153638528|NCT00005945|Asparaginase|asparaginase|mesh-list
153638530|NCT00005945|Pegaspargase|pegaspargase|mesh-list
153638531|NCT00005945|Thioguanine|thioguanine|mesh-list
153638532|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638533|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
153638534|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638535|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638536|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154018850|NCT02702622|Beta Carotene|beta carotene|mesh-list
154018851|NCT02702622|Vitamins|vitamins|mesh-ancestor
154018852|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
154018853|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018854|NCT04214808|Dutasteride|dutasteride|mesh-list
154018855|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154018856|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154018857|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018858|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018859|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
154018860|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018861|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018862|NCT02702778|Prednisone|prednisone|mesh-list
154018863|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154018864|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
154018865|NCT02702778|Hormones|hormones|mesh-ancestor
154018866|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018867|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018868|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154018869|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018870|NCT02753738|Escitalopram|escitalopram|mesh-list
154018871|NCT02753738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154018872|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154018873|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018874|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018875|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018876|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
154018877|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018878|NCT02751632|Fluoxetine|fluoxetine|mesh-list
154018879|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
154018880|NCT02751632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153574300|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
153574306|NCT01699412|Clobetasol|clobetasol|mesh-list
154018881|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154018888|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154018889|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154018890|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154018891|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154018892|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154018893|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154018894|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018896|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018897|NCT02705664|Amorolfine|amorolfine|mesh-list
154018898|NCT02705664|Bifonazole|bifonazole|mesh-list
154018899|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
154018900|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018901|NCT02753426|Doxycycline|doxycycline|mesh-list
154018902|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018903|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638537|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
153638538|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638539|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638540|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638541|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638570|NCT01929811|Epirubicin|epirubicin|mesh-list
153638571|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153638572|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638573|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638574|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638575|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638576|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638577|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638578|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153638579|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153638580|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638581|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638582|NCT00012220|Gemcitabine|gemcitabine|mesh-list
153638583|NCT00012220|Docetaxel|docetaxel|mesh-list
153638584|NCT00012220|Irinotecan|irinotecan|mesh-list
153638585|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638586|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638587|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
153638588|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638606|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638607|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
153638608|NCT00012376|Sargramostim|sargramostim|mesh-list
153638609|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
153638610|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638611|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638612|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153638613|NCT00001266|Suramin|suramin|mesh-list
153638614|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
153638615|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
153638616|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153638617|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638618|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638619|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153638620|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153638621|NCT00005948|Interferons|interferons|mesh-list
153638622|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
153638623|NCT00005948|Aldesleukin|aldesleukin|mesh-list
154018904|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
154018905|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154018906|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154018907|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
154018908|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154018909|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018910|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154018911|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018912|NCT02702076|Apomorphine|apomorphine|mesh-list
154018913|NCT02702076|Emetics|emetics|mesh-ancestor
154018914|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018915|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
154018916|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018917|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018918|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
154018919|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
154018920|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018921|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018922|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
154018923|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154018924|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018925|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154018926|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018927|NCT02753114|Ketamine|ketamine|mesh-list
154018928|NCT02753114|Analgesics|analgesics|mesh-ancestor
154018929|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
154018930|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018931|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018932|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154018933|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154018934|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
154018935|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
154018936|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018937|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154018938|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153590950|NCT01816490|Silybin|silybin|mesh-list
154018940|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018942|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154018943|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018944|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154018945|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154018946|NCT02705274|Growth Substances|growth substances|mesh-ancestor
154018947|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018948|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
154018949|NCT00914849|Plerixafor|plerixafor|mesh-list
154018950|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154018951|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154018952|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
154018953|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154018954|NCT02704962|Olanzapine|olanzapine|mesh-list
154018955|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
154018956|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
154018957|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018958|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018959|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154018960|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154018961|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154018962|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018963|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154018964|NCT02704962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153590990|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638624|NCT00005948|Busulfan|busulfan|mesh-list
153638625|NCT00005948|Sargramostim|sargramostim|mesh-list
153638626|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638627|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
153638628|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458599|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638629|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
153638630|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638631|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
153638632|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638633|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638634|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638635|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638636|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638637|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638638|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
153638639|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153638640|NCT00012688|Doxycycline|doxycycline|mesh-list
153638641|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153638642|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638643|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
153638644|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
153638645|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154018966|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154018967|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018968|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154018969|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
154018970|NCT00631943|Pregabalin|pregabalin|mesh-list
154018971|NCT00631943|Analgesics|analgesics|mesh-ancestor
154018972|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
154018973|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154018974|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018975|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
154018976|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154018977|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591015|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
153638646|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
153638647|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153638665|NCT00005954|Temozolomide|temozolomide|mesh-list
153638666|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638667|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
153638668|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638669|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638670|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
153638671|NCT00005960|Docetaxel|docetaxel|mesh-list
153638672|NCT00005960|Doxorubicin|doxorubicin|mesh-list
153638673|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153638674|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638675|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
153638676|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638677|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638678|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638679|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
153638680|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638681|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638682|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638683|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638684|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638685|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638686|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153638687|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153638688|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638689|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638690|NCT00005963|Carboplatin|carboplatin|mesh-list
153638691|NCT00005963|Docetaxel|docetaxel|mesh-list
153638692|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638693|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638694|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638695|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638696|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638697|NCT00013585|Selegiline|selegiline|mesh-list
153638698|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
153638699|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153638700|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153638701|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153638702|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153638703|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638704|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638705|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153638706|NCT00013585|Protective Agents|protective agents|mesh-ancestor
153638707|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018978|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018979|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154018981|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154018982|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154018983|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154018984|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154018985|NCT05429684|Capecitabine|capecitabine|mesh-list
154018986|NCT05429684|Trastuzumab|trastuzumab|mesh-list
154018987|NCT05429684|Everolimus|everolimus|mesh-list
154018988|NCT05429684|Letrozole|letrozole|mesh-list
154018989|NCT05429684|Palbociclib|palbociclib|mesh-list
154018990|NCT05429684|Pertuzumab|pertuzumab|mesh-list
154018991|NCT05429684|Antibodies|antibodies|mesh-list
154018992|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154018993|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154018994|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
154018995|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
154018996|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
154018997|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154018998|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
154018999|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019000|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154019001|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
154019002|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154019003|NCT05429684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154019004|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019005|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019006|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154019007|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154019008|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154019009|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154019010|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
154019011|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019012|NCT05429684|Immunotoxins|immunotoxins|mesh-ancestor
154019013|NCT05429684|Immunoconjugates|immunoconjugates|mesh-ancestor
154019014|NCT05324592|Aflibercept|aflibercept|mesh-list
153638731|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638732|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
154019015|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154019016|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154019017|NCT05324592|Growth Substances|growth substances|mesh-ancestor
154019018|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019019|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
154019020|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019022|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
154019023|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019024|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154019025|NCT02750696|Acetaminophen|acetaminophen|mesh-list
154019026|NCT02750696|Tramadol|tramadol|mesh-list
154019027|NCT02750696|Codeine|codeine|mesh-list
154019028|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154019029|NCT02750696|Analgesics|analgesics|mesh-ancestor
154019030|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
154019031|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019032|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019033|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
154019034|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154019035|NCT02750696|Narcotics|narcotics|mesh-ancestor
153776572|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019036|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019037|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
154019038|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
154019039|NCT02695550|Conteltinib|conteltinib|mesh-list
154019040|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019041|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019042|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638733|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638734|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
153638735|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638736|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638737|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
153638738|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153638739|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153638740|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153638741|NCT00005966|Growth Substances|growth substances|mesh-ancestor
153638742|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
153638743|NCT00005969|Tretinoin|tretinoin|mesh-list
153638744|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638745|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
153638746|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
153638747|NCT00014014|Lamivudine|lamivudine|mesh-list
153638748|NCT00014014|Zidovudine|zidovudine|mesh-list
153638749|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153638750|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153638751|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154019043|NCT00912743|Olaparib|olaparib|mesh-list
154019044|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154019045|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019046|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019047|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019048|NCT04432610|Nebivolol|nebivolol|mesh-list
154019049|NCT04432610|Bisoprolol|bisoprolol|mesh-list
154019050|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154019051|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
154019052|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154019053|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154019054|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154019055|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
154019056|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019057|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019058|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019059|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
154019060|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
154019061|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019062|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154019063|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154019064|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154019065|NCT04643093|Ezetimibe|ezetimibe|mesh-list
154019066|NCT04643093|Pitavastatin|pitavastatin|mesh-list
154019092|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154019093|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154019094|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154019095|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154019096|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154019097|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154019098|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154019100|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019101|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019102|NCT05429294|Paclitaxel|paclitaxel|mesh-list
154019103|NCT05429294|Trastuzumab|trastuzumab|mesh-list
154019104|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019105|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574550|NCT01700790|Ritonavir|ritonavir|mesh-list
154019106|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019107|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019108|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019109|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776645|NCT01087554|Sirolimus|sirolimus|mesh-list
154019110|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154019111|NCT04219046|Naloxegol|naloxegol|mesh-list
154019112|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154019113|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019114|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
154019115|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019116|NCT00912509|Riboflavin|riboflavin|mesh-list
154019117|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
154019118|NCT00912509|Vitamins|vitamins|mesh-ancestor
154019119|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
154019120|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019121|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154019122|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
154019123|NCT02873598|Paclitaxel|paclitaxel|mesh-list
154019124|NCT02873598|Gemcitabine|gemcitabine|mesh-list
154019125|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154019126|NCT02873598|Folfirinox|folfirinox|mesh-list
154019127|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638752|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019128|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019129|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019130|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019131|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019132|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019133|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154019135|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154019136|NCT02749994|Ezetimibe|ezetimibe|mesh-list
154019137|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154019138|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154019139|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
154019140|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019141|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154019142|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154019143|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019144|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
154019145|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154019146|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019147|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019148|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154019149|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154019150|NCT04417049|Protective Agents|protective agents|mesh-ancestor
154019151|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638753|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638754|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
153638755|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638756|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638757|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638758|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
153638759|NCT00014092|Interferons|interferons|mesh-list
153638760|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
153638761|NCT00014092|Aldesleukin|aldesleukin|mesh-list
153638865|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153638866|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638867|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638869|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638870|NCT00014599|Paclitaxel|paclitaxel|mesh-list
153638871|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638872|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638873|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638874|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638875|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638876|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638877|NCT00005981|Carmustine|carmustine|mesh-list
153638878|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153638879|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638880|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
153638902|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154019152|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
154019153|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154019154|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
154019155|NCT05323422|Ketamine|ketamine|mesh-list
154019156|NCT05323422|Analgesics|analgesics|mesh-ancestor
154019157|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
154019158|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019159|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019160|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154019161|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154019162|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
154019163|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
154019164|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019165|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154019166|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154019167|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019168|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638903|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
153638904|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638905|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638906|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638907|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
153638908|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
153638909|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153638910|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153638911|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153638912|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638913|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153638914|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153638915|NCT00005984|Interferons|interferons|mesh-list
153638916|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
153638917|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
153638918|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638919|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
153638920|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638921|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638922|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638923|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
153638924|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638925|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638926|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638927|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
153638928|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638929|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
153638930|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153638959|NCT00005987|Hormones|hormones|mesh-ancestor
153638960|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638961|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638962|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638963|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153638964|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638965|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638966|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
153638967|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638968|NCT00005987|Analgesics|analgesics|mesh-ancestor
153638969|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
153638970|NCT05442450|Semaglutide|semaglutide|mesh-list
154019169|NCT02700906|Lidocaine|lidocaine|mesh-list
154019170|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
154019171|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
154019172|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019173|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019174|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
154019175|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019176|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154019177|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154019178|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154019179|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154019180|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019181|NCT00636038|Beta Carotene|beta carotene|mesh-list
154019182|NCT00636038|Carotenoids|carotenoids|mesh-list
154019183|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
154019184|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019185|NCT00636038|Protective Agents|protective agents|mesh-ancestor
153591233|NCT01818856|Ritonavir|ritonavir|mesh-list
153638971|NCT05442450|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153638972|NCT05442450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153638973|NCT05442450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638974|NCT00014755|Prednisone|prednisone|mesh-list
153638975|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
153638976|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153638977|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638978|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
153638979|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639009|NCT00001344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639010|NCT00001344|Analgesics|analgesics|mesh-ancestor
153639011|NCT00001344|Sensory System Agents|sensory system agents|mesh-ancestor
153639015|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
153639016|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639017|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639018|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
153639019|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639020|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153639107|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639108|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
153639109|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639110|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639111|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153639112|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153639113|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
153639114|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639116|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
153639117|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153639118|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639119|NCT00015769|Levetiracetam|levetiracetam|mesh-list
153639120|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
153639121|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
153639122|NCT00015808|Idebenone|idebenone|mesh-list
153639123|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
153639124|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639125|NCT00015808|Protective Agents|protective agents|mesh-ancestor
153639126|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639127|NCT00015886|Docetaxel|docetaxel|mesh-list
153639128|NCT00015886|Fluorouracil|fluorouracil|mesh-list
154019186|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019187|NCT00636038|Provitamins|provitamins|mesh-ancestor
154019188|NCT00636038|Vitamins|vitamins|mesh-ancestor
154019189|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
154019190|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
154019191|NCT04213716|Calcium|calcium|mesh-list
154019192|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154019193|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019194|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154019195|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
154019196|NCT04218890|Thromboplastin|thromboplastin|mesh-list
154019197|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154019198|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154019199|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019200|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
154019201|NCT04218890|Coagulants|coagulants|mesh-ancestor
154019202|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
154019203|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154019204|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
154019205|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019206|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154019207|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
154019208|NCT00636116|Antivenins|antivenins|mesh-list
154019209|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
153639129|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639130|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639131|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639132|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639133|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574741|NCT01701856|Interferons|interferons|mesh-list
153639134|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
153639135|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153639136|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639137|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
153639138|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639139|NCT00006002|Dexamethasone|dexamethasone|mesh-list
153639140|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153639141|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
153639142|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
153639143|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639144|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639145|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153639146|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
153639147|NCT00006002|Hormones|hormones|mesh-ancestor
153469160|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153639214|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639215|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
153639216|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639218|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
153458667|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
153639220|NCT00016159|Lintuzumab|lintuzumab|mesh-list
153639221|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153639222|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639223|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154019210|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019211|NCT05428670|Rituximab|rituximab|mesh-list
154019212|NCT05428670|Lenalidomide|lenalidomide|mesh-list
154019213|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
154019214|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154019215|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019216|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
154019217|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019218|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154019219|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154019220|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154019221|NCT05428670|Growth Substances|growth substances|mesh-ancestor
154019222|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
154019223|NCT05428670|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154019224|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019225|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019226|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019227|NCT00635726|Cisplatin|cisplatin|mesh-list
154019228|NCT00635726|Gemcitabine|gemcitabine|mesh-list
154019229|NCT00635726|Doxorubicin|doxorubicin|mesh-list
154019230|NCT00635726|Methotrexate|methotrexate|mesh-list
154019231|NCT00635726|Vinblastine|vinblastine|mesh-list
154019232|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019233|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154019234|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
154019235|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019236|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154019237|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154019238|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154019239|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019240|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154019241|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
154019242|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154019244|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
154019250|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019251|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019252|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019253|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019254|NCT04219982|Scopolamine|scopolamine|mesh-list
154019255|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154019256|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154019257|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
154019258|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
154019259|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776799|NCT04613869|Narcotics|narcotics|mesh-ancestor
154019260|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019261|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154019262|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
154019263|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154019264|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
154019265|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019266|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019267|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154019268|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
154019269|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
154019270|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
154019271|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
154019272|NCT04216706|Sympatholytics|sympatholytics|mesh-list
154019273|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154019274|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019275|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154019276|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019277|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
154019278|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019279|NCT00913835|Doxorubicin|doxorubicin|mesh-list
154019280|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154019282|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154019283|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019284|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154019285|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639224|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639225|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639226|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019286|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019287|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019289|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154019290|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019291|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019292|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019293|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019294|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019295|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019296|NCT04213170|Bevacizumab|bevacizumab|mesh-list
154019297|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154019298|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019299|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154019300|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154019301|NCT04213170|Growth Substances|growth substances|mesh-ancestor
154019302|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019303|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
154019304|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
154019305|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154019306|NCT05322564|Narcotics|narcotics|mesh-ancestor
154019307|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019308|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019309|NCT05322564|Analgesics|analgesics|mesh-ancestor
153639227|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
153639252|NCT00016276|Doxorubicin|doxorubicin|mesh-list
153639253|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153639254|NCT00016276|Trastuzumab|trastuzumab|mesh-list
153639255|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
153639256|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153639257|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639258|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639259|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639260|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639261|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639263|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
153639264|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639265|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639266|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153639267|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
153639268|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153639269|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153639270|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153639271|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639272|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639273|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153639274|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153639275|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
153639276|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019310|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
154019311|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019312|NCT02749136|Gemcitabine|gemcitabine|mesh-list
154019313|NCT02749136|Folfirinox|folfirinox|mesh-list
154019314|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154019315|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
154019316|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019317|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019318|NCT00631631|Mifamurtide|mifamurtide|mesh-list
154019319|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154019320|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
154019321|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019322|NCT04238741|Anesthetics|anesthetics|mesh-list
154019323|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019324|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019325|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
154019326|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154019327|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154019328|NCT04218500|Niacinamide|niacinamide|mesh-list
154019329|NCT04218500|Niacin|niacin|mesh-list
154019330|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
154019331|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
154019332|NCT04218500|Vitamins|vitamins|mesh-ancestor
154019333|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
154019334|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019335|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154019336|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
154019337|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019338|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154019339|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
154019341|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154019343|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
154019355|NCT05411978|Ubiquinone|ubiquinone|mesh-list
154019356|NCT05411978|Idebenone|idebenone|mesh-list
154019357|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
154019358|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019359|NCT05411978|Protective Agents|protective agents|mesh-ancestor
154019360|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019361|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
154019362|NCT00617370|Paclitaxel|paclitaxel|mesh-list
154019363|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
154019364|NCT00617370|Epirubicin|epirubicin|mesh-list
154019365|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019366|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019367|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019368|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019369|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019370|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019371|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154019372|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
154019373|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019374|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154019375|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154019376|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
154019377|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153639277|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153574908|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
153639278|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153639279|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153639280|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153639312|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153639313|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639314|NCT00389376|Silymarin|silymarin|mesh-list
153639315|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
153639316|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639317|NCT00389376|Protective Agents|protective agents|mesh-ancestor
153639318|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639319|NCT00016549|Bevacizumab|bevacizumab|mesh-list
153639320|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153639321|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639322|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153639339|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153639340|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153639341|NCT00006026|Rubitecan|rubitecan|mesh-list
153639342|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639343|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153639344|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639345|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639346|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639347|NCT00016666|Propranolol|propranolol|mesh-list
153639348|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153639349|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153639350|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
153639351|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639352|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019379|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154019380|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154019381|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019382|NCT02699658|Levofloxacin|levofloxacin|mesh-list
154019383|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154019384|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019385|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154019386|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154019387|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154019388|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019389|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019390|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019391|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154019392|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154019394|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154019395|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019396|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154019397|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154019398|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
154019399|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019400|NCT04032626|Lenalidomide|lenalidomide|mesh-list
154019401|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
153639353|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639354|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153639355|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153639356|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
153639357|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153639358|NCT00016744|Genistein|genistein|mesh-list
153639359|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639360|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153639361|NCT00016744|Protective Agents|protective agents|mesh-ancestor
153639362|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639363|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153639364|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639365|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639366|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
153639367|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153639368|NCT00016744|Estrogens|estrogens|mesh-ancestor
153639369|NCT00016744|Hormones|hormones|mesh-ancestor
153639370|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153639371|NCT00016861|Irinotecan|irinotecan|mesh-list
153639372|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153639373|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639374|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639375|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639376|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639377|NCT00016900|Paclitaxel|paclitaxel|mesh-list
153639378|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019402|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019403|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154019404|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154019405|NCT04032626|Growth Substances|growth substances|mesh-ancestor
154019406|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
154019407|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019408|NCT04214106|Thiamine|thiamine|mesh-list
154019409|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
154019410|NCT04214106|Vitamins|vitamins|mesh-ancestor
154019411|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
154019412|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019413|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154019414|NCT02747732|Ibrutinib|ibrutinib|mesh-list
154019415|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019416|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154019417|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
154019418|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019419|NCT02747732|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154019420|NCT02747732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019421|NCT02747732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019422|NCT02695862|Terlipressin|terlipressin|mesh-list
154019423|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154019424|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154019425|NCT00617448|Anesthetics|anesthetics|mesh-list
154019426|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019427|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019428|NCT04308863|Chitosan|chitosan|mesh-list
154019429|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019430|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154019431|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154019432|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
154019433|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154019434|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
153639393|NCT00386672|Vitamin D|vitamin d|mesh-list
153639395|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
153639396|NCT00386672|Vitamins|vitamins|mesh-list
153639397|NCT00386672|Calcium|calcium|mesh-list
153639398|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
153639399|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639400|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639401|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153639402|NCT00016978|Leucovorin|leucovorin|mesh-list
153639403|NCT00016978|Fluorouracil|fluorouracil|mesh-list
154019435|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
154019436|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
154019437|NCT04308863|Coagulants|coagulants|mesh-ancestor
154019438|NCT00615810|Efavirenz|efavirenz|mesh-list
154019439|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154019440|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154019441|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154019442|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019443|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019444|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
154019445|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019446|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153575089|NCT01704027|Androgens|androgens|mesh-list
154019447|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154019448|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154019449|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154019450|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154019451|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154019452|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154019453|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154019454|NCT03355157|Tamoxifen|tamoxifen|mesh-list
154019455|NCT03355157|Paclitaxel|paclitaxel|mesh-list
154019456|NCT03355157|Vinorelbine|vinorelbine|mesh-list
153639404|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
153639405|NCT00016978|Calcium|calcium|mesh-list
153639406|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
153639407|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639408|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639409|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
153639410|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639411|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153639412|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639413|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639414|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
153639415|NCT00016978|Antidotes|antidotes|mesh-ancestor
153639416|NCT00016978|Protective Agents|protective agents|mesh-ancestor
153639417|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
153639418|NCT00016978|Vitamins|vitamins|mesh-ancestor
153639419|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
153639420|NCT00017017|Paclitaxel|paclitaxel|mesh-list
153639421|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153639422|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153639423|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639424|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639425|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639426|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639427|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639428|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
153639429|NCT00017095|Docetaxel|docetaxel|mesh-list
153639430|NCT00017095|Fluorouracil|fluorouracil|mesh-list
153639431|NCT00017095|Epirubicin|epirubicin|mesh-list
153639432|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639433|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
154019457|NCT03355157|Capecitabine|capecitabine|mesh-list
154019458|NCT03355157|Letrozole|letrozole|mesh-list
154019459|NCT03355157|Epirubicin|epirubicin|mesh-list
154019460|NCT03355157|Fulvestrant|fulvestrant|mesh-list
154019461|NCT03355157|Palbociclib|palbociclib|mesh-list
154019462|NCT03355157|Exemestane|exemestane|mesh-list
154019463|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019464|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019465|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019466|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019467|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019468|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019469|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154019470|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
154019471|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154019472|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154019473|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019474|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154019475|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
154019476|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019477|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019478|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154019479|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153591509|NCT01820442|Analgesics|analgesics|mesh-ancestor
153639434|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639435|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639436|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153639437|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
153639438|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639439|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639440|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153639441|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639473|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153639474|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153639475|NCT00001482|Lamotrigine|lamotrigine|mesh-list
153639476|NCT00001482|Gabapentin|gabapentin|mesh-list
153639477|NCT00001482|Analgesics|analgesics|mesh-ancestor
153639478|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
153458718|NCT03585738|Folic Acid|folic acid|mesh-list
153639479|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639480|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639481|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
153639482|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153639483|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153639484|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639485|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153639498|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153639499|NCT00017134|Protective Agents|protective agents|mesh-ancestor
153639500|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639501|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
153639502|NCT04734418|Remifentanil|remifentanil|mesh-list
153639503|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154019480|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154019481|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154019482|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154019483|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154019484|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154019485|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154019486|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019488|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019489|NCT02747342|Fluzoparib|fluzoparib|mesh-list
154019490|NCT02747342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154019491|NCT02747342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019492|NCT02747342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019493|NCT02747342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019494|NCT03324035|Tramadol|tramadol|mesh-list
154019495|NCT03324035|Amitriptyline|amitriptyline|mesh-list
154019496|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154019497|NCT03324035|Narcotics|narcotics|mesh-ancestor
153591524|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
153639504|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639505|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639506|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153639507|NCT04734418|Analgesics|analgesics|mesh-ancestor
153639508|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
153639509|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639510|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153639511|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153639512|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153639515|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639516|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153639517|NCT04734418|Narcotics|narcotics|mesh-ancestor
153639519|NCT00006032|Topotecan|topotecan|mesh-list
153639520|NCT00006032|Ifosfamide|ifosfamide|mesh-list
153639521|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153639522|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639523|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153639524|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639525|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639526|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639527|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153639528|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153639529|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
153639530|NCT00017173|Cisplatin|cisplatin|mesh-list
153639531|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639532|NCT00001509|Tretinoin|tretinoin|mesh-list
153639533|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639534|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
153639535|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
153639536|NCT00006035|Bleomycin|bleomycin|mesh-list
153639537|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153639538|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639539|NCT00017212|Exatecan|exatecan|mesh-list
153639540|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153639541|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639542|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639543|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639544|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019498|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019499|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019500|NCT03324035|Analgesics|analgesics|mesh-ancestor
154019501|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
154019502|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019503|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154019504|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
154019505|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154019506|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154019507|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154019508|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154019509|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154019510|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019511|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
154019512|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019513|NCT00616746|Ethanol|ethanol|mesh-list
154019514|NCT00616746|Nicotine|nicotine|mesh-list
154019515|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154019516|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
153591544|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639545|NCT00017251|Carboplatin|carboplatin|mesh-list
153639546|NCT00017251|Etoposide|etoposide|mesh-list
153639547|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
153639568|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
153639569|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153639570|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639571|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
153639572|NCT00006038|Antidotes|antidotes|mesh-ancestor
153639573|NCT00006038|Protective Agents|protective agents|mesh-ancestor
153639574|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
153639575|NCT00006038|Vitamins|vitamins|mesh-ancestor
153639576|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
153639577|NCT00017290|Prednisone|prednisone|mesh-list
153639578|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
153639579|NCT00017290|Vincristine|vincristine|mesh-list
153639580|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
153639581|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153639582|NCT00017290|Antibodies|antibodies|mesh-list
153639583|NCT00017290|Sargramostim|sargramostim|mesh-list
153639584|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153639585|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153639586|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639587|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
153458728|NCT03589326|Cytarabine|cytarabine|mesh-list
153639588|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639589|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639590|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153639591|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
153639592|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639593|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639594|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153639595|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153639596|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
153639597|NCT00017290|Hormones|hormones|mesh-ancestor
153639598|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153639599|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154019517|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019518|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019519|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154019520|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154019521|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
154019522|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019523|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019524|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154019525|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019526|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019527|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
154019528|NCT00632255|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154019529|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019530|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019531|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019532|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019533|NCT04203485|Paclitaxel|paclitaxel|mesh-list
154019534|NCT04203485|Carboplatin|carboplatin|mesh-list
154019535|NCT04203485|Pemetrexed|pemetrexed|mesh-list
154019536|NCT04203485|Apatinib|apatinib|mesh-list
153591564|NCT01820897|Trimethoprim|trimethoprim|mesh-list
153639600|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153639601|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639602|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639603|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639604|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153639621|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639623|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153639624|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
153449773|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
153639626|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639627|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153639628|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153639629|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153639630|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639631|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639632|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153639633|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639634|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639635|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639636|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
153639637|NCT00001524|Thalidomide|thalidomide|mesh-list
153639638|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639639|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
153639640|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639641|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
153639642|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153639643|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639644|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153639645|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153639646|NCT00001524|Growth Substances|growth substances|mesh-ancestor
153639647|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
153639648|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639649|NCT00006041|Vaccines|vaccines|mesh-list
154019537|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019538|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019539|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019540|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019541|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019542|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019543|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019544|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154019545|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154019546|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019547|NCT03116126|Guanfacine|guanfacine|mesh-list
154019548|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154019549|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153591583|NCT01820936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639650|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
153639651|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
153639652|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639653|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153639654|NCT00017602|Dexamethasone|dexamethasone|mesh-list
153639655|NCT00017602|Oblimersen|oblimersen|mesh-list
153639656|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153639657|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
153639658|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
153639659|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639660|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639661|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153639662|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
153639663|NCT00017602|Hormones|hormones|mesh-ancestor
153639664|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153639665|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153639666|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639667|NCT00001533|Cyclosporine|cyclosporine|mesh-list
153639668|NCT00001533|Cyclosporins|cyclosporins|mesh-list
153639669|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639705|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153639706|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639720|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639721|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153639722|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153639723|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639724|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639725|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153639726|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
153639727|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153639728|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639729|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153639730|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153639732|NCT00017758|Nelfinavir|nelfinavir|mesh-list
153639733|NCT00017758|Atorvastatin|atorvastatin|mesh-list
153639734|NCT00017758|Simvastatin|simvastatin|mesh-list
153639735|NCT00017758|Pravastatin|pravastatin|mesh-list
153639736|NCT00017758|Calcium|calcium|mesh-list
153639737|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639738|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639739|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153639740|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153639741|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
153639742|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639743|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154019550|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154019552|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
154019553|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019554|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019555|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019556|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154019557|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
154019558|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154019559|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154019560|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154019561|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019562|NCT04217798|Etoposide|etoposide|mesh-list
154019563|NCT04217798|Niraparib|niraparib|mesh-list
154019564|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019565|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019566|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154019567|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154019568|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019569|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019570|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154019571|NCT02742038|Fluorides|fluorides|mesh-list
154019572|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
153639744|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153639745|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639746|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153639747|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153639749|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639750|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153639751|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153639752|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153639753|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153639754|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153639755|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153639756|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153639757|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153639758|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
153639759|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153639760|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153639761|NCT00017992|Ritonavir|ritonavir|mesh-list
153639762|NCT00017992|Lopinavir|lopinavir|mesh-list
153639763|NCT00017992|Emtricitabine|emtricitabine|mesh-list
153639764|NCT00017992|Stavudine|stavudine|mesh-list
153639765|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153639766|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153639778|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
153639779|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153639780|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019573|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
154019574|NCT02742038|Protective Agents|protective agents|mesh-ancestor
154019575|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019576|NCT02022098|Cisplatin|cisplatin|mesh-list
154019577|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019578|NCT02746250|Amitriptyline|amitriptyline|mesh-list
154019579|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
154019580|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
154019581|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154019582|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154019583|NCT02746250|Analgesics|analgesics|mesh-ancestor
154019584|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
154019585|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019586|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019587|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154019588|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154019589|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154019590|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019591|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
154019592|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019593|NCT02741960|Metformin|metformin|mesh-list
154019594|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154019595|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639781|NCT04734067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153639782|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639783|NCT00018148|Nortriptyline|nortriptyline|mesh-list
153639785|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153639786|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
153639787|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639788|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639789|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153639790|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153639791|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
153639792|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639793|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639794|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153639795|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
153639796|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153639797|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153639798|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153639799|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639800|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
153639801|NCT00001563|Rituximab|rituximab|mesh-list
153639802|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153639803|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639804|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
153639805|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639806|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458757|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639807|NCT00018187|Mecamylamine|mecamylamine|mesh-list
153639808|NCT00018187|Bupropion|bupropion|mesh-list
154019597|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
154019598|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154019599|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154019600|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154019601|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
154019602|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154019603|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019604|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154019605|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154019606|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154019607|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019608|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
154019609|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154019610|NCT04216550|Apatinib|apatinib|mesh-list
154019611|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019612|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019613|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176593|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154019614|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019615|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
154019616|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153639809|NCT00018187|Nicotine|nicotine|mesh-list
153639810|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153639811|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
153639812|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639813|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639814|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153639815|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153639816|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
153639817|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639818|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639819|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153639820|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
153639821|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153639822|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153639823|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153639824|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639825|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
153639826|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153639861|NCT00001575|Edetic Acid|edetic acid|mesh-list
153639862|NCT00001575|Calcium|calcium|mesh-list
153639863|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
153639864|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639866|NCT00001575|Antidotes|antidotes|mesh-ancestor
153639867|NCT00001575|Protective Agents|protective agents|mesh-ancestor
153639868|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
153639869|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
153639896|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639898|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153639899|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154019617|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
154019618|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154019619|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
154019620|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019621|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019622|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
154019623|NCT00909857|Dienogest|dienogest|mesh-list
154019624|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154019625|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154019626|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
154019627|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154019628|NCT00909857|Estradiol|estradiol|mesh-list
154019629|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154019630|NCT00909857|Estrogens|estrogens|mesh-ancestor
154019631|NCT00909857|Hormones|hormones|mesh-ancestor
153777171|NCT04608253|Choline|choline|mesh-list
154019632|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019633|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019634|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154019635|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
154019636|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154019637|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154019638|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154019639|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154019640|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154019641|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154019642|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154019644|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019664|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154019665|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
154019666|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019667|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019668|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154019669|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
154019670|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
154019671|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
154019672|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154019673|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154019674|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
154019675|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019676|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019677|NCT03812588|Escitalopram|escitalopram|mesh-list
154019678|NCT03812588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154019679|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154019680|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154019681|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019682|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019683|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
154019684|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019685|NCT02387099|Everolimus|everolimus|mesh-list
154019686|NCT02387099|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154019687|NCT02387099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019689|NCT02387099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019690|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154019691|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
154019692|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019693|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019694|NCT02745860|Selexipag|selexipag|mesh-list
154019707|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
154019708|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154019709|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154019710|NCT02741414|Amoxicillin|amoxicillin|mesh-list
154019711|NCT02741414|Metronidazole|metronidazole|mesh-list
154019712|NCT02741414|Clarithromycin|clarithromycin|mesh-list
154019713|NCT02741414|Levofloxacin|levofloxacin|mesh-list
154019714|NCT02741414|Tetracycline|tetracycline|mesh-list
154019715|NCT02741414|Furazolidone|furazolidone|mesh-list
154019716|NCT02741414|Esomeprazole|esomeprazole|mesh-list
154019717|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019718|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154019719|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154019720|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154019721|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154019722|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154019723|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019724|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019725|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154019726|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154019727|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154019728|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154019729|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154019730|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154019731|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019732|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154019733|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154019734|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154019735|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154019736|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154019737|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154019739|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
154019750|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019751|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154019752|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
154019753|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154019754|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154019755|NCT02736032|Progestins|progestins|mesh-ancestor
154019756|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
154019757|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154019758|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019759|NCT02744768|Dasatinib|dasatinib|mesh-list
154019760|NCT02744768|Blinatumomab|blinatumomab|mesh-list
154019761|NCT02744768|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154019762|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019764|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019765|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019766|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
154019767|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154019768|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
154019769|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019770|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019771|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154019772|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
154019773|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154019774|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154019775|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154019776|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154019777|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019779|NCT04096391|Analgesics|analgesics|mesh-list
154019795|NCT04318730|Apatinib|apatinib|mesh-list
154019796|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019797|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019798|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019799|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019800|NCT00632333|Fluorouracil|fluorouracil|mesh-list
154019801|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019802|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
154019803|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019804|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154019805|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154019806|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
154019807|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019808|NCT02744456|Losartan|losartan|mesh-list
154019809|NCT02744456|Amlodipine|amlodipine|mesh-list
154019810|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154019811|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154019812|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154019813|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154019814|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019815|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154019816|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639900|NCT00392080|Analgesics|analgesics|mesh-ancestor
153639901|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
153639902|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639903|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639904|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153639905|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639906|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
153639907|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153639908|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639909|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639911|NCT00001644|Zidovudine|zidovudine|mesh-list
153639912|NCT00001644|Nevirapine|nevirapine|mesh-list
153639913|NCT00001644|Indinavir|indinavir|mesh-list
153639914|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153639915|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153639916|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639917|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639943|NCT00001656|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153639944|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153639945|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639946|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639947|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639948|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
153639949|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153639950|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
153639951|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
153639952|NCT05573191|Lidocaine|lidocaine|mesh-list
153639953|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
154019817|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
154019818|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154019819|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154019820|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154019821|NCT02744456|Diuretics|diuretics|mesh-ancestor
154019822|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
154019823|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154019824|NCT02744222|Interferons|interferons|mesh-list
154019825|NCT02744222|Interferon-beta|interferon-beta|mesh-list
154019826|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
154019827|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019828|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
154019829|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019830|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
154019831|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019832|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154019833|NCT02741024|Artesunate|artesunate|mesh-list
154019834|NCT02741024|Lumefantrine|lumefantrine|mesh-list
154019835|NCT02741024|Artemether|artemether|mesh-list
154019836|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154019838|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
154019839|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154019840|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154019841|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019842|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019843|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
154019844|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
154019845|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154019846|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
154019847|NCT02735876|Rituximab|rituximab|mesh-list
154019848|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
154019849|NCT02735876|Ibrutinib|ibrutinib|mesh-list
153591859|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591878|NCT01822808|Isosorbide|isosorbide|mesh-list
153639954|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
153639955|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639956|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639957|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
153639958|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639959|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153639960|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153639961|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153639962|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639963|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019850|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154019851|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019852|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
154019853|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019854|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154019855|NCT02735876|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154019856|NCT02735876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154019857|NCT02735876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019858|NCT02735876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777395|NCT04603729|Dexamethasone|dexamethasone|mesh-list
154019859|NCT00910871|Bedaquiline|bedaquiline|mesh-list
154019860|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
154019861|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154019862|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019863|NCT04230707|Melatonin|melatonin|mesh-list
154019864|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
154019865|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019866|NCT04230707|Protective Agents|protective agents|mesh-ancestor
154019867|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019868|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019869|NCT02735798|Trastuzumab|trastuzumab|mesh-list
154019870|NCT02735798|Gancotamab|gancotamab|mesh-list
154019871|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154019872|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019873|NCT02735798|Immunoconjugates|immunoconjugates|mesh-ancestor
154019874|NCT02735798|Immunologic Factors|immunologic factors|mesh-ancestor
154019875|NCT02735798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019876|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
154019877|NCT03760718|Procaine|procaine|mesh-list
154019878|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
154019879|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
154019880|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575608|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154019881|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639964|NCT05679830|Cannabidiol|cannabidiol|mesh-list
153639965|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
153639966|NCT05572996|Treprostinil|treprostinil|mesh-list
153640001|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153640002|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153640003|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153640004|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640005|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640006|NCT00386828|Bevacizumab|bevacizumab|mesh-list
153640038|NCT00001731|Cyclosporins|cyclosporins|mesh-list
154019882|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
154019883|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019884|NCT05590286|Amoxicillin|amoxicillin|mesh-list
154019885|NCT05590286|Esomeprazole|esomeprazole|mesh-list
154019886|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154019887|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019888|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154019889|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154019890|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154019891|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154019892|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019893|NCT05580029|Triamcinolone|triamcinolone|mesh-list
154019894|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154019895|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
154019897|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019898|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019899|NCT03724994|Paclitaxel|paclitaxel|mesh-list
154019900|NCT03724994|Gemcitabine|gemcitabine|mesh-list
154019901|NCT03724994|Fluorouracil|fluorouracil|mesh-list
154019902|NCT03724994|Folfirinox|folfirinox|mesh-list
154019903|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154019904|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154019905|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
154019906|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
154019907|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
154019908|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019909|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154019910|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
154019911|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154019912|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
154019913|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019915|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153640039|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640040|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640041|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153640042|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
153640043|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640044|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
153640045|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640046|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
153640047|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154019916|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154019917|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019918|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019919|NCT02631941|Budesonide|budesonide|mesh-list
154019920|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
154019921|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154019922|NCT02631941|Charcoal|charcoal|mesh-list
154019923|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154019924|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154019925|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
154019926|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019927|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458642|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
154019928|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153640074|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640076|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640077|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153640078|NCT00001752|Estrogens|estrogens|mesh-list
153640079|NCT00001752|Hormones|hormones|mesh-ancestor
153640080|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640081|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640085|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153640086|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153640087|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640088|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640089|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
153640090|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640091|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153640092|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153640093|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153640113|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640115|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
153640116|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
153640117|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640119|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640120|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640121|NCT04905121|Psilocybin|psilocybin|mesh-list
153640122|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
153640123|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640124|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153640125|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
153640126|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640127|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
153640128|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640129|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640130|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153640131|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
153640132|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
153640133|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640134|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
153640135|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640136|NCT00000102|Nifedipine|nifedipine|mesh-list
153640137|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153640138|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640139|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640140|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153640141|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640142|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
153640143|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
153640144|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154019929|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
154019930|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
154019931|NCT02631941|Hormones|hormones|mesh-ancestor
154019932|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019933|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154019934|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154019935|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154019936|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
154019937|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019938|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019939|NCT02631941|Antidotes|antidotes|mesh-ancestor
154019940|NCT02631941|Protective Agents|protective agents|mesh-ancestor
154019941|NCT02690987|Exenatide|exenatide|mesh-list
153575683|NCT01707940|Ketoconazole|ketoconazole|mesh-list
153575684|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
154019942|NCT02690987|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154019943|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154019944|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019945|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154019946|NCT02690987|Incretins|incretins|mesh-ancestor
154019947|NCT02690987|Hormones|hormones|mesh-ancestor
154019948|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019949|NCT02740166|Propranolol|propranolol|mesh-list
154019950|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154019951|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154019952|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
154019953|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154019954|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019955|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019956|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154019957|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154019958|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
154019959|NCT02735018|Epinephrine|epinephrine|mesh-list
154019960|NCT02735018|Racepinephrine|racepinephrine|mesh-list
154019961|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
154019962|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154019968|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154019969|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154019970|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
154019971|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019972|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154019973|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
154019974|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
154019975|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
154019976|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154019977|NCT00908375|Pregabalin|pregabalin|mesh-list
154019978|NCT00908375|Analgesics|analgesics|mesh-ancestor
154019979|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
154019980|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154019981|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154019982|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
154019983|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154019984|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154019985|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154019986|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154019987|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154019988|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154019989|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154019990|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154019991|NCT04247867|Psyllium|psyllium|mesh-list
154019992|NCT04247867|Cathartics|cathartics|mesh-ancestor
154019993|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154019994|NCT02731664|Glucagon|glucagon|mesh-list
154019995|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154019996|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154019997|NCT02731664|Hormones|hormones|mesh-ancestor
154019998|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154019999|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020000|NCT02731664|Incretins|incretins|mesh-ancestor
154020001|NCT02695004|Donepezil|donepezil|mesh-list
154020002|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154020003|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020005|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
154020006|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020007|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777542|NCT05201144|Urological Agents|urological agents|mesh-ancestor
154020008|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
154020010|NCT00909389|Ezetimibe|ezetimibe|mesh-list
154020011|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154020012|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154020013|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154020014|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
154020015|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020016|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154020017|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154020018|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020019|NCT00910715|Doxycycline|doxycycline|mesh-list
154020020|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154020021|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020022|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
154020023|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154020024|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154020025|NCT02731430|Morphine|morphine|mesh-list
154020026|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154020027|NCT02731430|Narcotics|narcotics|mesh-ancestor
154020028|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020029|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020030|NCT02731430|Analgesics|analgesics|mesh-ancestor
154020031|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
154020032|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020033|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
154020034|NCT03695510|Afatinib|afatinib|mesh-list
154020052|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154020053|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020054|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154020055|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154020056|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154020057|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020058|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
154020059|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176594|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154020060|NCT02730026|Ketoprofen|ketoprofen|mesh-list
154020061|NCT02730026|Omeprazole|omeprazole|mesh-list
154020062|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153640145|NCT05641506|Niraparib|niraparib|mesh-list
153640146|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153640147|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640161|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640162|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
153640163|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640164|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640165|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640166|NCT00392431|Amiodarone|amiodarone|mesh-list
153640167|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153640168|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
153640169|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153640170|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640171|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640172|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153640173|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153640174|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153640175|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640176|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153640177|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153640178|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153640179|NCT00392470|Irinotecan|irinotecan|mesh-list
153640180|NCT00392470|Cetuximab|cetuximab|mesh-list
153640181|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153640182|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153640183|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575766|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153640184|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640185|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640186|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640189|NCT03960151|Palonosetron|palonosetron|mesh-list
153640190|NCT03960151|Rolapitant|rolapitant|mesh-list
153640191|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640192|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
153640193|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
153640194|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640195|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640196|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640197|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
153640198|NCT03960151|Hormones|hormones|mesh-ancestor
153640199|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640200|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153640201|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640202|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153640203|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153640204|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640205|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153640206|NCT03960151|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154020065|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020066|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020067|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154020068|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154020069|NCT02730026|Analgesics|analgesics|mesh-ancestor
154020070|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
154020071|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020072|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020073|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154020074|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154020075|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154020076|NCT02738918|Abatacept|abatacept|mesh-list
153592100|NCT01824524|Analgesics|analgesics|mesh-ancestor
153640207|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153640208|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640209|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640230|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640231|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153640232|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640233|NCT00386984|Hormones|hormones|mesh-ancestor
153640234|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640235|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640236|NCT03959761|Nivolumab|nivolumab|mesh-list
153640237|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640238|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640239|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153640240|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640241|NCT00387179|Melatonin|melatonin|mesh-list
153640242|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
153640243|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640244|NCT00387179|Protective Agents|protective agents|mesh-ancestor
153640245|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640246|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640247|NCT03959332|Baloxavir|baloxavir|mesh-list
153640248|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
153640249|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640250|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640251|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640252|NCT04733521|Cisplatin|cisplatin|mesh-list
153640253|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640254|NCT05640726|Leucovorin|leucovorin|mesh-list
153640255|NCT05640726|Bevacizumab|bevacizumab|mesh-list
153640256|NCT05640726|Fluorouracil|fluorouracil|mesh-list
153640257|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
153640258|NCT05640726|Calcium|calcium|mesh-list
153640259|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
153640260|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640261|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640262|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153640288|NCT03958708|Rifaximin|rifaximin|mesh-list
153640289|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153640290|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640291|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640292|NCT05640609|Bevacizumab|bevacizumab|mesh-list
153640293|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640294|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020077|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154020078|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020079|NCT02738918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154020080|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020081|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020082|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
154020083|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020084|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154020085|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
154020086|NCT03195374|Narcotics|narcotics|mesh-ancestor
154020087|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020088|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020089|NCT03195374|Analgesics|analgesics|mesh-ancestor
154020090|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
154020091|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020093|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154020094|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020095|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154020096|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020097|NCT00636428|Midazolam|midazolam|mesh-list
154020098|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154020099|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153640295|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153640296|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153640297|NCT05640609|Growth Substances|growth substances|mesh-ancestor
153640298|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640299|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
153640300|NCT05411861|Analgesics|analgesics|mesh-list
153640301|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
153640302|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
153640303|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640306|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
153640307|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
153640308|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640309|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640310|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
153640311|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640312|NCT03958396|Remifentanil|remifentanil|mesh-list
153640313|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153640339|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
153640340|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640341|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640342|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153640343|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153640344|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
153640345|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
153640346|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640347|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154020100|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020101|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020102|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154020103|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154020104|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154020105|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154020106|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
154020107|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
154020108|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
154020109|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
154020110|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020111|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020112|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154020113|NCT02729870|Laxatives|laxatives|mesh-ancestor
154020114|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020116|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020117|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020118|NCT02694848|Aspirin|aspirin|mesh-list
154020119|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154020120|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154020121|NCT02694848|Analgesics|analgesics|mesh-ancestor
154020122|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
154020123|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020124|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020125|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154020126|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154020127|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154020128|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154020129|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640348|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153640349|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640350|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640351|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153640352|NCT03933865|Narcotics|narcotics|mesh-ancestor
153640353|NCT05206175|Methamphetamine|methamphetamine|mesh-list
153640354|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153640355|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640356|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
153640357|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
153640358|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640359|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
153640360|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640378|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
154020130|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154020131|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154020132|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020133|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
154020134|NCT02729324|Biafine|biafine|mesh-list
154176595|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020135|NCT02729324|Protective Agents|protective agents|mesh-list
154020136|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
154020137|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020138|NCT02729324|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154020139|NCT02729324|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154020140|NCT02729324|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154020141|NCT02733458|Dexamethasone|dexamethasone|mesh-list
154020142|NCT02733458|Gemcitabine|gemcitabine|mesh-list
154020143|NCT02733458|Etoposide|etoposide|mesh-list
154020144|NCT02733458|Pegaspargase|pegaspargase|mesh-list
154020145|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154020146|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
154020147|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
154020148|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020149|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020150|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020151|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
153640379|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
153640380|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
153640381|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640382|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
153575895|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153640383|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640384|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640385|NCT03432091|Melatonin|melatonin|mesh-list
153640386|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
153640387|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640388|NCT03432091|Protective Agents|protective agents|mesh-ancestor
153640389|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640390|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640391|NCT05634564|Paclitaxel|paclitaxel|mesh-list
153640392|NCT05634564|Gemcitabine|gemcitabine|mesh-list
153640393|NCT05634564|Tislelizumab|tislelizumab|mesh-list
153640394|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153640395|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640396|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
153640397|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
153640398|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
153640399|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640400|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153640401|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
153640402|NCT05634564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640403|NCT03152149|Fluticasone|fluticasone|mesh-list
153640404|NCT03152149|Xhance|xhance|mesh-list
153640405|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
153640406|NCT03152149|Olodaterol|olodaterol|mesh-list
153640407|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640408|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153640409|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
154020152|NCT02733458|Hormones|hormones|mesh-ancestor
154020153|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020154|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153777688|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154020155|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020156|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020157|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020158|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154020159|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
154020160|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154020161|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154020162|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154020163|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154020164|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
154020165|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154020166|NCT02728856|Protective Agents|protective agents|mesh-ancestor
154020167|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020168|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
154020169|NCT02728934|Infliximab|infliximab|mesh-list
154020170|NCT02728934|Golimumab|golimumab|mesh-list
154020171|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154020172|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154020173|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154020174|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020175|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640410|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640411|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640412|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153640413|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
153640414|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
153640415|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153640416|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
153640417|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153449961|NCT00004583|Nelfinavir|nelfinavir|mesh-list
153640435|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640437|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
153640438|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153640439|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
153640440|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640441|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153640442|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153640444|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
153640445|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
153640446|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153640447|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153640448|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153640449|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
153640450|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
153640451|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020176|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020177|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
154020178|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020179|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
154020180|NCT02728700|Sirolimus|sirolimus|mesh-list
154020181|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154020182|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020183|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154020184|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
154020185|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154020186|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020187|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020188|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020189|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
154020190|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020191|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
154020192|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020193|NCT02728622|Tamoxifen|tamoxifen|mesh-list
154020194|NCT02728622|Paclitaxel|paclitaxel|mesh-list
154020195|NCT02728622|Doxorubicin|doxorubicin|mesh-list
154020196|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154020197|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154020198|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020199|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
154020200|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
154020201|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
154020202|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020203|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154020204|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154020205|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154020206|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020207|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154020208|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
154020209|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640452|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640453|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640454|NCT03151603|Fosfomycin|fosfomycin|mesh-list
153640455|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153640456|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640457|NCT03151525|Infliximab|infliximab|mesh-list
153640458|NCT03151525|Azathioprine|azathioprine|mesh-list
154020210|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020211|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154020212|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154020213|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154020214|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154020215|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
154020216|NCT02728466|Procyanidin|procyanidin|mesh-list
154020217|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
154020218|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020219|NCT02728466|Protective Agents|protective agents|mesh-ancestor
153575969|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154020220|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020221|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154020222|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154020223|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020224|NCT02733380|Thalidomide|thalidomide|mesh-list
154020225|NCT02733380|Dexamethasone|dexamethasone|mesh-list
154020226|NCT02733380|Doxorubicin|doxorubicin|mesh-list
154020227|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154020228|NCT02733380|Vinorelbine|vinorelbine|mesh-list
154020229|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
154020230|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154020231|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
154020232|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
154020233|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020234|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020235|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020236|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
154020238|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020239|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154020240|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020241|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154020254|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020255|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154020256|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154020257|NCT02733380|Growth Substances|growth substances|mesh-ancestor
154020258|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
154020259|NCT02733380|Analgesics|analgesics|mesh-ancestor
154020260|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
154020261|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154020262|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
154020263|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154020264|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
154020265|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020266|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154020267|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154020268|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154020269|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020270|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020271|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
154020272|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
154020273|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
154020274|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020275|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020276|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
154020277|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020278|NCT00636584|Nitroprusside|nitroprusside|mesh-list
154020279|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154020280|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
154020281|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154020282|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020283|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
154020284|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154020285|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154020286|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
154020287|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020294|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154020295|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
154020296|NCT02732522|Misoprostol|misoprostol|mesh-list
154020297|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154020298|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
154020299|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154020300|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020301|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154020302|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020303|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
154020304|NCT02732678|Propranolol|propranolol|mesh-list
154020305|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154020306|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153777841|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154020307|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
154020308|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020309|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020310|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020311|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154020312|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154020313|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
154020315|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154020316|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020317|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
154020318|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640459|NCT03151525|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153640460|NCT03151525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640461|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
153640462|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640463|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640464|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
153640465|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640466|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153640467|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640468|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153640469|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
153640470|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640471|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
153640472|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
153640473|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153640474|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153640496|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
153640497|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
153640498|NCT03151369|Morphine|morphine|mesh-list
153640499|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-list
153640500|NCT03151369|Analgesics|analgesics|mesh-list
153640501|NCT03151369|Narcotics|narcotics|mesh-ancestor
153640502|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020319|NCT02727296|Propofol|propofol|mesh-list
154020320|NCT02727296|Sevoflurane|sevoflurane|mesh-list
154020321|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154020322|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020323|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020324|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154020325|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
154020326|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
154020327|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154020328|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154020329|NCT02732132|Midazolam|midazolam|mesh-list
154020330|NCT02732132|Fentanyl|fentanyl|mesh-list
154020331|NCT02732132|Ketamine|ketamine|mesh-list
154020332|NCT02732132|Propofol|propofol|mesh-list
154020333|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154020334|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020335|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020336|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154020337|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
154020338|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
154020339|NCT02732132|Analgesics|analgesics|mesh-ancestor
154020340|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
154020341|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020342|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154020343|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154020344|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153640503|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640504|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
153640505|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640506|NCT04712266|Insulin|insulin|mesh-list
153640507|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153640508|NCT04712266|Glucagon|glucagon|mesh-list
153640509|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153640510|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640511|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640512|NCT04712266|Hormones|hormones|mesh-ancestor
153640513|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640514|NCT03151213|Pregabalin|pregabalin|mesh-list
153640515|NCT03151213|Analgesics|analgesics|mesh-ancestor
153640516|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
153640517|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640518|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640519|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
153640520|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153640521|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640522|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640523|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153640524|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153640525|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153640526|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020345|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020346|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020347|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154020348|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154020349|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154020350|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154020351|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
154020352|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
154020353|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154020354|NCT02732132|Narcotics|narcotics|mesh-ancestor
154020355|NCT02737202|Saracatinib|saracatinib|mesh-list
154020356|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020357|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020358|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020359|NCT02721368|Lidocaine|lidocaine|mesh-list
154020360|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
154020361|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
154020362|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020363|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020364|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
154020365|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020366|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154020367|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154020368|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154020369|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640548|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153640549|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153640550|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640552|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640554|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640556|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153640557|NCT05605665|Sirolimus|sirolimus|mesh-list
153640558|NCT05605665|Aldesleukin|aldesleukin|mesh-list
153640559|NCT05605665|Interleukin-2|interleukin-2|mesh-list
153640560|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153640561|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640562|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153640563|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640564|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
153640565|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153640566|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
153640567|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640568|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153640569|NCT05605665|Analgesics|analgesics|mesh-ancestor
153640570|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
153640571|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640572|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153640573|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153640574|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
154020370|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020371|NCT02737124|Acetaminophen|acetaminophen|mesh-list
154020372|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154020373|NCT02737124|Analgesics|analgesics|mesh-ancestor
154020374|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
154020375|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020376|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020377|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
154020378|NCT02721290|Ropivacaine|ropivacaine|mesh-list
154020379|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
154020380|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
154020381|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020382|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020383|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
154020384|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020385|NCT02720978|Oxytocin|oxytocin|mesh-list
154020386|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
153592410|NCT01827059|Bosentan|bosentan|mesh-list
153640575|NCT03150706|Avelumab|avelumab|mesh-list
153640576|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640577|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640578|NCT03150667|Clopidogrel|clopidogrel|mesh-list
153640579|NCT03150667|Ticagrelor|ticagrelor|mesh-list
153640580|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153640581|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153640582|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153640592|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
153640593|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
153640594|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640595|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640596|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640597|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
153640598|NCT03150316|Hormones|hormones|mesh-ancestor
153640599|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640600|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153640601|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640602|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640603|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640604|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
153640605|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153640606|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153640607|NCT03150316|Growth Substances|growth substances|mesh-ancestor
153640608|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
153640609|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153640610|NCT02972125|Lacosamide|lacosamide|mesh-list
153640611|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
153640612|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153640613|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153640614|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640615|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640617|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640618|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640619|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640620|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153640621|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153640622|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
154020387|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154020388|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020389|NCT02726984|Listerine|listerine|mesh-list
154020390|NCT02726984|Fluorides|fluorides|mesh-list
154020391|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
154020392|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
154020393|NCT02726984|Protective Agents|protective agents|mesh-ancestor
154020394|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020395|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154020396|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020397|NCT02726828|Ketamine|ketamine|mesh-list
154020398|NCT02726828|Morphine|morphine|mesh-list
154020399|NCT02726828|Analgesics|analgesics|mesh-ancestor
154020400|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
154020401|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020402|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020403|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154020404|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154020405|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
154020406|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
154020407|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020408|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154020409|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154020410|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020411|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020412|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154020413|NCT02726828|Narcotics|narcotics|mesh-ancestor
154020414|NCT02799134|Dexamethasone|dexamethasone|mesh-list
154020415|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020416|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154020417|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
154020418|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
154020419|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020420|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592434|NCT01827202|Aliskiren|aliskiren|mesh-list
153640623|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153640624|NCT03086044|Velpatasvir|velpatasvir|mesh-list
153640625|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
153640626|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640627|NCT02866006|Topotecan|topotecan|mesh-list
153640628|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154020421|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
154020422|NCT02799134|Hormones|hormones|mesh-ancestor
154020423|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020424|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154020425|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020426|NCT02720822|Morphine|morphine|mesh-list
154020427|NCT02720822|Laxatives|laxatives|mesh-list
154020428|NCT02720822|Cathartics|cathartics|mesh-list
154020429|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154020430|NCT02720822|Narcotics|narcotics|mesh-ancestor
154020431|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020432|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020433|NCT02720822|Analgesics|analgesics|mesh-ancestor
154020434|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
154020435|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020436|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020437|NCT02757872|Vitamin D|vitamin d|mesh-list
154020438|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
154020439|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
154020440|NCT02757872|Vitamins|vitamins|mesh-list
154020441|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
154020442|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020443|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154020444|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154020445|NCT04167176|Lidocaine|lidocaine|mesh-list
154020446|NCT04167176|Bupivacaine|bupivacaine|mesh-list
154020447|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
154020448|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
154020449|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817371|NCT06188390|Viscosupplements|viscosupplements|mesh-ancestor
154020450|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592480|NCT01827345|Vitamin D|vitamin d|mesh-list
153640629|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153640630|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640631|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640632|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640633|NCT02633098|Artesunate|artesunate|mesh-list
153640634|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
153640636|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153640637|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640638|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640639|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
153640640|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
153640641|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153640642|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
153640644|NCT04796831|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153640645|NCT04796831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153640646|NCT04796831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020451|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
153777989|NCT04593160|Diclofenac|diclofenac|mesh-list
154020452|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020453|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154020454|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154020455|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154020456|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154020457|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020458|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
154020459|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
154020460|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020461|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
154020462|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
154020463|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020464|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
154020465|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020466|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640647|NCT04796831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640648|NCT00393289|Calcium|calcium|mesh-list
153640649|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153640669|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640670|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640671|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153640672|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
153640673|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640674|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640675|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153640676|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153640677|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
153640678|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153640679|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153640680|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
153640681|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
153640682|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640683|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153640684|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153640685|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153640686|NCT00393328|Ritonavir|ritonavir|mesh-list
153640687|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153640688|NCT00393328|Aripiprazole|aripiprazole|mesh-list
153640689|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153640690|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153640691|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
153640692|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640693|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640694|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153640695|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153640696|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
153640697|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640698|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153640699|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153640700|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
153640701|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153640702|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153640703|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154020467|NCT02726126|Fentanyl|fentanyl|mesh-list
154020468|NCT02726126|Melatonin|melatonin|mesh-list
154020469|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154020470|NCT02726126|Narcotics|narcotics|mesh-ancestor
154020471|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020472|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020473|NCT02726126|Analgesics|analgesics|mesh-ancestor
154020474|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
154020475|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020476|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154020477|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154020478|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
154020479|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
154020480|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
154020481|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020482|NCT02726126|Protective Agents|protective agents|mesh-ancestor
154020483|NCT02694458|Vancomycin|vancomycin|mesh-list
154020484|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154020485|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020486|NCT02719808|Tenofovir|tenofovir|mesh-list
154020487|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
154020488|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020489|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154020490|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154020491|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020492|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640704|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640726|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153640727|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
153640729|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640730|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153640731|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153640732|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640733|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640734|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153640736|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153640737|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153640738|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153640739|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153640740|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153640741|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
153640742|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
153640743|NCT01807078|Ezetimibe|ezetimibe|mesh-list
153640744|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153640745|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153640746|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
153640747|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640748|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153640749|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
154020493|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154020494|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154020495|NCT02719418|Tinzaparin|tinzaparin|mesh-list
154020496|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154020497|NCT02719418|Dalteparin|dalteparin|mesh-list
154020498|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
154020499|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154020500|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154020501|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020502|NCT02725736|Nifedipine|nifedipine|mesh-list
154020503|NCT02725736|Atosiban|atosiban|mesh-list
153817388|NCT06188208|Pembrolizumab|pembrolizumab|mesh-list
154020504|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154020505|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154020506|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020507|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154020508|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020509|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
154020510|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
154020511|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154020512|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
154020513|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020514|NCT02716142|Misoprostol|misoprostol|mesh-list
153640750|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153640751|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
153640752|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640754|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153640755|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
153640756|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153640757|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153640758|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153640791|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
153640792|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
153640793|NCT00387413|Vitamins|vitamins|mesh-ancestor
153640794|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
153640795|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153640815|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640816|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640817|NCT01806259|Ketorolac|ketorolac|mesh-list
153640818|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153640819|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153640820|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153640821|NCT01806259|Analgesics|analgesics|mesh-ancestor
153640822|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
153640823|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640824|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640825|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640826|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640827|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153640828|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640829|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640830|NCT00393445|Glucagon|glucagon|mesh-list
153640831|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153640832|NCT00393445|Incretins|incretins|mesh-ancestor
154020515|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154020516|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
154020517|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154020518|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020519|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154020520|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020521|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
154020522|NCT02718950|Liraglutide|liraglutide|mesh-list
154020523|NCT02718950|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154020524|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020525|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020526|NCT02718950|Incretins|incretins|mesh-ancestor
154020527|NCT02718950|Hormones|hormones|mesh-ancestor
154020528|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020529|NCT02725502|Linagliptin|linagliptin|mesh-list
154020530|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020531|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020532|NCT02725502|Incretins|incretins|mesh-ancestor
154020533|NCT02725502|Hormones|hormones|mesh-ancestor
154020534|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020535|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154020536|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
153592555|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640833|NCT00393445|Hormones|hormones|mesh-ancestor
153640834|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640835|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640836|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640837|NCT00393562|Methylphenidate|methylphenidate|mesh-list
153640838|NCT00393562|Modafinil|modafinil|mesh-list
153640839|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153640840|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640841|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153640842|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153640843|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640844|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640845|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
153640846|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640847|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153640848|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153640859|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640860|NCT01805596|Clopidogrel|clopidogrel|mesh-list
153640862|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153640863|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153736416|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736417|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153736418|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153736419|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640864|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154020537|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020538|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020539|NCT01959464|Progesterone|progesterone|mesh-list
154020540|NCT01959464|Progestins|progestins|mesh-ancestor
154020542|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020543|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020544|NCT02718482|Gemcitabine|gemcitabine|mesh-list
154020545|NCT02718482|Docetaxel|docetaxel|mesh-list
154020546|NCT02718482|Ifosfamide|ifosfamide|mesh-list
154020547|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
154020548|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154020549|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
154020550|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020551|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020552|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
154020553|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
154020554|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
154020555|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154020556|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
154020557|NCT02717858|Liraglutide|liraglutide|mesh-list
154020558|NCT02717858|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154020559|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020560|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020561|NCT02717858|Incretins|incretins|mesh-ancestor
154020562|NCT02717858|Hormones|hormones|mesh-ancestor
154020563|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020564|NCT02725112|Pregabalin|pregabalin|mesh-list
154020565|NCT02725112|Analgesics|analgesics|mesh-ancestor
154020566|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
154020567|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020568|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640865|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153640866|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
153640867|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640868|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640869|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640870|NCT04474223|Dexamethasone|dexamethasone|mesh-list
153640871|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640872|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
153640873|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
153640874|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640875|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020569|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
154020570|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154020571|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154020572|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020573|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154020574|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154020575|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154020576|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020577|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154020579|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154020580|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020581|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154020582|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020583|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
154020584|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020585|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
154020586|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020588|NCT02717780|Remifentanil|remifentanil|mesh-list
154020589|NCT02717780|Sevoflurane|sevoflurane|mesh-list
154020590|NCT02717780|Desflurane|desflurane|mesh-list
154020591|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154020592|NCT02717780|Narcotics|narcotics|mesh-ancestor
154020593|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020594|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020595|NCT02717780|Analgesics|analgesics|mesh-ancestor
154020596|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
154020597|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020598|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153592625|NCT01828437|Pyridoxine|pyridoxine|mesh-list
153640876|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640877|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
153640878|NCT04474223|Hormones|hormones|mesh-ancestor
153640879|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640880|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153640881|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640882|NCT01466530|Misoprostol|misoprostol|mesh-list
153640883|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153640885|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153640886|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640887|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153640888|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640889|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
153640890|NCT01466452|Aspirin|aspirin|mesh-list
153640891|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154020599|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154020600|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
154020601|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
154020602|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154020603|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154020604|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
154020605|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154020606|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020607|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020608|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154020609|NCT02724098|Analgesics|analgesics|mesh-ancestor
154020610|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
154020611|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020612|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154020613|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154020614|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154020615|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
154020616|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020617|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458790|NCT03155646|Clonidine|clonidine|mesh-list
154020618|NCT02723942|Immunomodulating Agents|immunomodulating agents|mesh-list
154020619|NCT02723942|Immunologic Factors|immunologic factors|mesh-ancestor
154020620|NCT02723942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020621|NCT04138316|Candesartan|candesartan|mesh-list
154020622|NCT04138316|Candesartan cilexetil|candesartan cilexetil|mesh-list
154020623|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154020624|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154020625|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154020626|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020627|NCT05291390|Pyronaridine|pyronaridine|mesh-list
154020628|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
153640892|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153640893|NCT01466452|Analgesics|analgesics|mesh-ancestor
153640894|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
153640895|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640896|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640897|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640898|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640899|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153640900|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153640901|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640902|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153640903|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154020630|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154020631|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020632|NCT04189484|Evolocumab|evolocumab|mesh-list
154020633|NCT04189484|Alirocumab|alirocumab|mesh-list
154020634|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154020635|NCT04189484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154020636|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154020637|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154020638|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
154020639|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020640|NCT04189484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154020641|NCT04189484|Protease Inhibitors|protease inhibitors|mesh-ancestor
154020642|NCT04189484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020643|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154020644|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
154020645|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020646|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
154020647|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154020648|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020649|NCT02716766|Capecitabine|capecitabine|mesh-list
154020650|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
154020651|NCT02716766|Sorafenib|sorafenib|mesh-list
154020652|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154020653|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
154020654|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020655|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020656|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154020657|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020658|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
153640904|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640905|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
153640906|NCT01466374|Antibodies|antibodies|mesh-list
153640907|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
153640908|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153640909|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
153640910|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640911|NCT01466257|Cetuximab|cetuximab|mesh-list
153640912|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640913|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640914|NCT01466101|Pregabalin|pregabalin|mesh-list
153640915|NCT01466101|Analgesics|analgesics|mesh-ancestor
153640928|NCT01465984|Acetaminophen|acetaminophen|mesh-list
153640929|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153640930|NCT01465984|Analgesics|analgesics|mesh-ancestor
153640931|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
153640932|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020659|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020661|NCT02694224|Paclitaxel|paclitaxel|mesh-list
154020662|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
154020663|NCT02694224|Epirubicin|epirubicin|mesh-list
154020664|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154020665|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020666|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
154020667|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
154020668|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
154020669|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020670|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020671|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
154020672|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020673|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154020674|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154020675|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
154020676|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154020677|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154020678|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154020679|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154020680|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020681|NCT00782288|Digitoxin|digitoxin|mesh-list
154020682|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154020683|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154020684|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020685|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020686|NCT00782288|Protective Agents|protective agents|mesh-ancestor
154020687|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020688|NCT04189094|Etoposide|etoposide|mesh-list
154020689|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020690|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154020691|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154020692|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153592699|NCT01828892|Vancomycin|vancomycin|mesh-list
153640933|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640934|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
153640935|NCT01465906|Bromides|bromides|mesh-list
153640936|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
153640937|NCT01465906|Tulobuterol|tulobuterol|mesh-list
153640938|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153640939|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
154020693|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020694|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020695|NCT02712944|Testosterone|testosterone|mesh-list
154020696|NCT02712944|Androgens|androgens|mesh-ancestor
154020697|NCT02712944|Hormones|hormones|mesh-ancestor
154020698|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154020699|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020700|NCT02712866|Vedolizumab|vedolizumab|mesh-list
154020701|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020702|NCT00600483|Gentamicins|gentamicins|mesh-list
154020703|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154020704|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020705|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154020706|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020707|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020708|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
154020709|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
154020710|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020711|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
153817441|NCT06187922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020747|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154020748|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154020749|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020750|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154020751|NCT02651727|Paclitaxel|paclitaxel|mesh-list
154020752|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154020753|NCT02651727|Gemcitabine|gemcitabine|mesh-list
154020754|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154020755|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020756|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
154020757|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
153778282|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
154020758|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
154020759|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020760|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154020761|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
154020762|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
154020763|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154020764|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154020765|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020766|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
154020767|NCT02650791|Coagulants|coagulants|mesh-ancestor
154020768|NCT04035668|Remibrutinib|remibrutinib|mesh-list
154020769|NCT04035668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154020770|NCT04035668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020771|NCT04035668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020772|NCT02650713|Atezolizumab|atezolizumab|mesh-list
154020773|NCT02650713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154020774|NCT02650713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020776|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020787|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154020788|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154020790|NCT00650637|Lamivudine|lamivudine|mesh-list
154020791|NCT00650637|Zidovudine|zidovudine|mesh-list
154020792|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154020793|NCT00650637|Nelfinavir|nelfinavir|mesh-list
154020794|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
154020795|NCT00650637|Loperamide|loperamide|mesh-list
154020796|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
154020797|NCT00650637|Calcium|calcium|mesh-list
154020798|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154020799|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020800|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154020801|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154020802|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154020803|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020804|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020805|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
154020806|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020808|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154020809|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
154020810|NCT00650637|Antacids|antacids|mesh-ancestor
154020811|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020812|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154020813|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154020815|NCT02650479|Exenatide|exenatide|mesh-list
154020836|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154020837|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154020838|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
154020839|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020840|NCT02722772|Etanercept|etanercept|mesh-list
154020841|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154020842|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154020843|NCT02722772|Analgesics|analgesics|mesh-ancestor
154020844|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
154020845|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020846|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020847|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154020848|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154020849|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020850|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020851|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
154020852|NCT02650245|Lactulose|lactulose|mesh-list
154020853|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020854|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154020855|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154020856|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154020857|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020858|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020859|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154020860|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154020861|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154020862|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
154020863|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592879|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640940|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640941|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640942|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153640943|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
153640944|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
153640945|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153640946|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
153640947|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640948|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640949|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
153640950|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153640951|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153640952|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
153640953|NCT01465867|Selenium|selenium|mesh-list
153640954|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
153640955|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020864|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020865|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154020866|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154020867|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
154020868|NCT00910767|Insulin|insulin|mesh-list
154020869|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020870|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020871|NCT02722694|Methotrexate|methotrexate|mesh-list
154020872|NCT02722694|Abatacept|abatacept|mesh-list
154020873|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154020874|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
154020875|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154020876|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020877|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154020878|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
154020879|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020880|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020881|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
154020882|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020883|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154020884|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020885|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
154020886|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154020887|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154020888|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154020889|NCT02722694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154020890|NCT00650871|Casopitant|casopitant|mesh-list
154020891|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
154020892|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
154020893|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020894|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020895|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020896|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153576558|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
154020897|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020898|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020902|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
154020903|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153778435|NCT00253929|Analgesics|analgesics|mesh-ancestor
154020904|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020905|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020906|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020907|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
154020908|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154020909|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020910|NCT00651105|Vildagliptin|vildagliptin|mesh-list
154020911|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154020912|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020913|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154020914|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
154020915|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154020916|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020917|NCT02694146|Hylan|hylan|mesh-list
154020918|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
154020919|NCT02694146|Protective Agents|protective agents|mesh-ancestor
154020920|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020921|NCT04167267|Fexuprazan|fexuprazan|mesh-list
154020922|NCT04167267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154020923|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
154020924|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154020925|NCT02649075|Antibodies|antibodies|mesh-list
154020926|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
154020927|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020928|NCT02644785|Protamines|protamines|mesh-list
154020929|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
154020930|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640956|NCT01465867|Protective Agents|protective agents|mesh-ancestor
153640957|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640958|NCT01465867|Trace Elements|trace elements|mesh-ancestor
153640959|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
153640960|NCT01465828|Clopidogrel|clopidogrel|mesh-list
153640961|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153640962|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153640963|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153640964|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153640965|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154020933|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
154020934|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020935|NCT02644707|Protective Agents|protective agents|mesh-ancestor
154020936|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020937|NCT02644707|Trace Elements|trace elements|mesh-ancestor
154020938|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
154020939|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
154020940|NCT02711228|Antibodies|antibodies|mesh-list
154020941|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
154020942|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154020943|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154020944|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
154020945|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020946|NCT02644863|Paclitaxel|paclitaxel|mesh-list
154020947|NCT02644863|Cisplatin|cisplatin|mesh-list
154020948|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154020949|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154020950|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
154020951|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
154020952|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
154020953|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020954|NCT00302744|Niacin|niacin|mesh-list
154020955|NCT00302744|Psilocybin|psilocybin|mesh-list
154020956|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154020957|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
153640966|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
153640967|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640968|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450130|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
153640971|NCT01465438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153640972|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640973|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640974|NCT01465399|Mitogens|mitogens|mesh-list
153640975|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
153640993|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153640995|NCT01465009|Acetaminophen|acetaminophen|mesh-list
153640996|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153640997|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153640998|NCT01465009|Analgesics|analgesics|mesh-ancestor
153640999|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
153641000|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641001|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641002|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641003|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641004|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153641005|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153641006|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020958|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020959|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154020960|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
154020961|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
154020963|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
154020964|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020965|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
154020966|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154020967|NCT02644629|Ketamine|ketamine|mesh-list
154020968|NCT02644629|Analgesics|analgesics|mesh-ancestor
154020969|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
154020970|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154020971|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020972|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154020973|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154020974|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
154020975|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
154020976|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154020977|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154020978|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154020979|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154020980|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020981|NCT00652665|Leflunomide|leflunomide|mesh-list
154020982|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592997|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153641007|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153641008|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153641009|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641010|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
153641011|NCT00389766|Topotecan|topotecan|mesh-list
153641012|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153641013|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153641014|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641015|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641016|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641017|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641018|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153641019|NCT01464697|Progesterone|progesterone|mesh-list
153641020|NCT01464697|Progestins|progestins|mesh-ancestor
153641021|NCT01464697|Hormones|hormones|mesh-ancestor
153641022|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641023|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641024|NCT00393679|Artesunate|artesunate|mesh-list
153641025|NCT00393679|Lumefantrine|lumefantrine|mesh-list
153641026|NCT00393679|Artemether|artemether|mesh-list
153641027|NCT00393679|Piperaquine|piperaquine|mesh-list
153641028|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153641029|NCT00393679|Amodiaquine|amodiaquine|mesh-list
154020983|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020984|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154020985|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
154020986|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020987|NCT02644551|Ciclopirox|ciclopirox|mesh-list
154020988|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
154020989|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154020990|NCT02644395|Amlodipine|amlodipine|mesh-list
154020991|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
154020992|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154020993|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154020994|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154020995|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154020996|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154020997|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154020998|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
154020999|NCT02644395|Diuretics|diuretics|mesh-ancestor
154021000|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
154021001|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154021002|NCT04166565|Dexamethasone|dexamethasone|mesh-list
154021003|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
154021004|NCT04166565|Bortezomib|bortezomib|mesh-list
154021005|NCT04166565|Daratumumab|daratumumab|mesh-list
154021006|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154021007|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
154021008|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021009|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021010|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154021011|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
153593023|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
153641030|NCT00393679|Artenimol|artenimol|mesh-list
153641062|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641063|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641064|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
153641065|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641066|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641067|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153641068|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
153641069|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153641070|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153641071|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153641072|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641073|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641074|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153641075|NCT00847834|Irbesartan|irbesartan|mesh-list
154021012|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021013|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021014|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154021015|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021016|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
154021017|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
154021018|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021019|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154021020|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
154021021|NCT04166565|Hormones|hormones|mesh-ancestor
154021022|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021023|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154021024|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
154021025|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154021026|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154021027|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576670|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154021028|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
154021029|NCT02644473|Coagulants|coagulants|mesh-ancestor
154021030|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154021031|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
154021032|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154021033|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
154021034|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021035|NCT04005872|Calcium|calcium|mesh-list
154021036|NCT04005872|Fluorides|fluorides|mesh-list
154021037|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154021038|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021039|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
154021040|NCT04005872|Protective Agents|protective agents|mesh-ancestor
154021041|NCT00652821|Tramadol|tramadol|mesh-list
154021042|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153641076|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153641077|NCT00847834|Diuretics|diuretics|mesh-ancestor
153641078|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
153641100|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153641101|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153641102|NCT00847639|Growth Substances|growth substances|mesh-ancestor
153641103|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
153641104|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641106|NCT00847483|Travoprost|travoprost|mesh-list
153641107|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153641108|NCT00847483|Latanoprost|latanoprost|mesh-list
153641109|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153641110|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153641111|NCT00847366|Tamoxifen|tamoxifen|mesh-list
153641112|NCT00847366|Trastuzumab|trastuzumab|mesh-list
154021043|NCT00652821|Narcotics|narcotics|mesh-ancestor
154021044|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021045|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021046|NCT00652821|Analgesics|analgesics|mesh-ancestor
154021047|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
154021048|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021049|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
154021050|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154021052|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154021053|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021054|NCT02714036|Ibudilast|ibudilast|mesh-list
154021055|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154021056|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
154021057|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021058|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021059|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154021060|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
154021061|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154021062|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021063|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021064|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154021065|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
154021094|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021095|NCT04165629|Aspirin|aspirin|mesh-list
154021096|NCT04165629|Clopidogrel|clopidogrel|mesh-list
154021097|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154021098|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021099|NCT04165629|Analgesics|analgesics|mesh-ancestor
154021100|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
154021101|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021102|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021103|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021104|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021105|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154021106|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154021107|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021108|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154021109|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154021110|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021111|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
154021112|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154021113|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154021114|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154021115|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
154021116|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021117|NCT02642523|Insulin|insulin|mesh-list
154021118|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154021119|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154021120|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154021121|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021122|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
154021123|NCT02713802|Propofol|propofol|mesh-list
154021124|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153641113|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153641115|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153641116|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
153641117|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641118|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641119|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153641120|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153641121|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153641122|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153641143|NCT03969641|Vaccines|vaccines|mesh-list
153641144|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
154021126|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021127|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154021128|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
154021129|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
154021130|NCT02642601|Indomethacin|indomethacin|mesh-list
154021131|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154021132|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021133|NCT02642601|Analgesics|analgesics|mesh-ancestor
154021134|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
154021135|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021136|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021137|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021138|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021139|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
154021140|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
154021141|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154021142|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154021143|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021144|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021145|NCT02709902|Adapalene|adapalene|mesh-list
154021146|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154021147|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154021148|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
154021149|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154021150|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021151|NCT02709902|Analgesics|analgesics|mesh-ancestor
154021152|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
154021153|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021154|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021155|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021156|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021157|NCT02710604|Tenofovir|tenofovir|mesh-list
154021158|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
154021159|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
154021160|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593165|NCT01841125|Escitalopram|escitalopram|mesh-list
154021161|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154021162|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154021163|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021164|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021165|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154021166|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154021167|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
154021168|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154021169|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154021170|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021171|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
154021172|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
154021173|NCT02642367|Rocuronium|rocuronium|mesh-list
154021174|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154021175|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154021176|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154021177|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021178|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021179|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154021180|NCT00653445|Ezetimibe|ezetimibe|mesh-list
154021181|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154021182|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154021183|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
154021184|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021185|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154021212|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
154021213|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154021214|NCT02641899|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154021215|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154021216|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154021217|NCT02641899|Incretins|incretins|mesh-ancestor
154021218|NCT02641899|Hormones|hormones|mesh-ancestor
154021219|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021220|NCT02641821|Nifedipine|nifedipine|mesh-list
154021221|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154021222|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021223|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021224|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154021225|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021226|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
154021227|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
154021228|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154021229|NCT01320345|Fenofibrate|fenofibrate|mesh-list
154021230|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154021231|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
154021232|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021233|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154021234|NCT04164615|Capecitabine|capecitabine|mesh-list
154021235|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154021236|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
154021237|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021238|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021239|NCT04164459|Latanoprost|latanoprost|mesh-list
154021240|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154021241|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154021242|NCT04164693|Heparin|heparin|mesh-list
153593252|NCT01841502|Paroxetine|paroxetine|mesh-list
153641145|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641146|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
153641147|NCT00847210|Lansoprazole|lansoprazole|mesh-list
153641148|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153641149|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153641150|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153641177|NCT00847054|Antibodies|antibodies|mesh-list
153641178|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153641179|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
153641180|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641181|NCT00846976|Bicalutamide|bicalutamide|mesh-list
154021243|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154021244|NCT04164693|Tinzaparin|tinzaparin|mesh-list
154021245|NCT04164693|Dalteparin|dalteparin|mesh-list
154021246|NCT04164693|Warfarin|warfarin|mesh-list
154021247|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
154021248|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154021249|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154021250|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021251|NCT00655785|Gemcitabine|gemcitabine|mesh-list
154021252|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154021253|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
154021254|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021255|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021256|NCT00885495|Ritonavir|ritonavir|mesh-list
154021257|NCT00885495|Darunavir|darunavir|mesh-list
154021258|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154021259|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154021260|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154021261|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
154021262|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021263|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021264|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154021265|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154021266|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
154021267|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021268|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154021269|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154021270|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154021271|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154021272|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
154021273|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154021274|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154021276|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
154021277|NCT02637375|Doxorubicin|doxorubicin|mesh-list
154021286|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021287|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021288|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154021289|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
154021290|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154021291|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154021292|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154021293|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154021294|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021295|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
154021296|NCT04163523|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154021297|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021298|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021299|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021300|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021301|NCT00885105|Vaccines|vaccines|mesh-list
154021302|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
154021303|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021304|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
154021305|NCT02709668|Vitamins|vitamins|mesh-ancestor
154021306|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
154021307|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021308|NCT04188782|Sevoflurane|sevoflurane|mesh-list
154021309|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154021310|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154021311|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
154021312|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
154021313|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021314|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021315|NCT02709590|Diclofenac|diclofenac|mesh-list
153641182|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
153641183|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
153641184|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641185|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641186|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641187|NCT00846859|Varenicline|varenicline|mesh-list
153641188|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153641189|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153641190|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
153641191|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153641192|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641217|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021316|NCT02709590|Lidocaine|lidocaine|mesh-list
154021317|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
154021318|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
154021319|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021320|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021321|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
154021322|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021323|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154021324|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154021325|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154021326|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021327|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021328|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154021329|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021330|NCT02709590|Analgesics|analgesics|mesh-ancestor
154021331|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021332|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021333|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154021334|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021335|NCT02707874|Ropivacaine|ropivacaine|mesh-list
154021336|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
154021337|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
154021338|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021339|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021340|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
154021341|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021342|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
154021343|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154021344|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021345|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021346|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021347|NCT02709200|Analgesics|analgesics|mesh-ancestor
154021348|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
153641218|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153641219|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
153641220|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153641221|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153641222|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
153641223|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641224|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
154021350|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154021351|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154021352|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154021353|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
154021354|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021355|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021356|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154021357|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154021358|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154021359|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021360|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021361|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
153641225|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576873|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641226|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153641227|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641228|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
153641229|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641230|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153641231|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641232|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641233|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641234|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641235|NCT03772964|Metformin|metformin|mesh-list
153641236|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153641237|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641238|NCT00846625|Triamcinolone|triamcinolone|mesh-list
153641239|NCT00846625|Ranibizumab|ranibizumab|mesh-list
153641240|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153641241|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153641242|NCT00846625|Growth Substances|growth substances|mesh-ancestor
153641243|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641244|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
153641279|NCT00846079|Regadenoson|regadenoson|mesh-list
153641280|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153641281|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153641282|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
153641283|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
153641303|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641305|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
153641306|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
153641307|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153641308|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153641309|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153641310|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
153641313|NCT03620942|Protective Agents|protective agents|mesh-ancestor
153641314|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153641315|NCT00277108|Escitalopram|escitalopram|mesh-list
153641316|NCT00277108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153641317|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153641318|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153641319|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641320|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153641321|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
153641322|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641323|NCT00277069|Carboplatin|carboplatin|mesh-list
153641324|NCT00277069|Capecitabine|capecitabine|mesh-list
153641325|NCT00277069|Vinorelbine|vinorelbine|mesh-list
153641326|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021363|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021365|NCT02707328|Gemcitabine|gemcitabine|mesh-list
154021366|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154021367|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021368|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
154021369|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
154021370|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
154021371|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021372|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154021373|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
154021374|NCT00612638|Irinotecan|irinotecan|mesh-list
154021375|NCT00612638|Temozolomide|temozolomide|mesh-list
154021376|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
154021377|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154021378|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153576921|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154021379|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021380|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021381|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021382|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154021383|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
154021384|NCT05151848|Adalimumab|adalimumab|mesh-list
154021385|NCT05151848|Tofacitinib|tofacitinib|mesh-list
154021386|NCT05151848|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154021387|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021388|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021389|NCT05151848|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154021390|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021391|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641327|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153641328|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
153641329|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641330|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641331|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641332|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641333|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641334|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153641335|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
153641336|NCT00276991|Immunomodulating Agents|immunomodulating agents|mesh-list
153641337|NCT00276991|Immunologic Factors|immunologic factors|mesh-ancestor
153641338|NCT00276991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641365|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641367|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154021392|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021394|NCT05134688|Analgesics|analgesics|mesh-ancestor
154021395|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
154021396|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021397|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021398|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
154021399|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021400|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154021401|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
154021402|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154021403|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021404|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021405|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154021406|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
154021407|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154021408|NCT02693288|Anesthetics|anesthetics|mesh-list
154021409|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021410|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021411|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
154021412|NCT02693210|Rituximab|rituximab|mesh-list
154021413|NCT02693210|Methotrexate|methotrexate|mesh-list
154021414|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154021415|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
154021416|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021417|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021418|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154021419|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
153593428|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153641368|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
153641369|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641370|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153641371|NCT00276835|Protective Agents|protective agents|mesh-ancestor
153641372|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153641373|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641374|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641375|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
153641376|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153641377|NCT00276835|Estrogens|estrogens|mesh-ancestor
153641378|NCT00276835|Hormones|hormones|mesh-ancestor
153641379|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641380|NCT00276796|Paclitaxel|paclitaxel|mesh-list
153641381|NCT00276796|Topotecan|topotecan|mesh-list
153817552|NCT06186921|Autonomic Agents|autonomic agents|mesh-ancestor
154021420|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021422|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154021423|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154021424|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154021425|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
154021426|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154021427|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154021428|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
153778961|NCT00224549|Irbesartan|irbesartan|mesh-list
154021429|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
154021430|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021431|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154021432|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154021433|NCT05024006|Interferons|interferons|mesh-list
154021434|NCT05024006|Ritonavir|ritonavir|mesh-list
154021435|NCT05024006|Lopinavir|lopinavir|mesh-list
154021436|NCT05024006|Interferon-beta|interferon-beta|mesh-list
154021437|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
154021438|NCT05024006|Remdesivir|remdesivir|mesh-list
154021439|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
154021440|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
154021441|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021442|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
154021443|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021444|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154021445|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154021446|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
154021447|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641382|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641383|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641384|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641385|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641399|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153641400|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
153641401|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153641402|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153641403|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
153641404|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641405|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641406|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
153641407|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641408|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153641409|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641410|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
153641411|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641412|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153641413|NCT00276757|Antidotes|antidotes|mesh-ancestor
154021448|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021449|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154021450|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154021451|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154021452|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154021453|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
154021454|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154021455|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154021456|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021457|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
154021458|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021459|NCT05024006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154021460|NCT05024006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021461|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154021462|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
154021463|NCT02707250|Meperidine|meperidine|mesh-list
154021464|NCT02707250|Bupivacaine|bupivacaine|mesh-list
154021465|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
154021466|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
154021467|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021468|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021469|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
154021470|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021471|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154021472|NCT02707250|Narcotics|narcotics|mesh-ancestor
154021473|NCT02707250|Analgesics|analgesics|mesh-ancestor
154021474|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154021475|NCT03781544|Acetaminophen|acetaminophen|mesh-list
154021476|NCT03781544|Diclofenac|diclofenac|mesh-list
154021477|NCT03781544|Tramadol|tramadol|mesh-list
154021478|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021479|NCT03781544|Analgesics|analgesics|mesh-ancestor
154021480|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
153593485|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
153641414|NCT00276757|Protective Agents|protective agents|mesh-ancestor
153641415|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
153641416|NCT00276757|Vitamins|vitamins|mesh-ancestor
153641417|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
153641418|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641419|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
153641420|NCT00276757|Hormones|hormones|mesh-ancestor
153641421|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641422|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154021481|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021482|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021483|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
154021484|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154021485|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021486|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021487|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154021488|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021489|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021490|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154021491|NCT03781544|Narcotics|narcotics|mesh-ancestor
154021492|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021493|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
154021494|NCT02707094|Immunomodulating Agents|immunomodulating agents|mesh-list
154021495|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021496|NCT02707016|Sevoflurane|sevoflurane|mesh-list
154021497|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154021498|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154021499|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
154021500|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
154021501|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021502|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021503|NCT04956146|Carboplatin|carboplatin|mesh-list
154021504|NCT04956146|Pemetrexed|pemetrexed|mesh-list
153641423|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641424|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641425|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641426|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641427|NCT00276718|Carboplatin|carboplatin|mesh-list
153641428|NCT00276718|Etoposide|etoposide|mesh-list
153641429|NCT00276718|Bleomycin|bleomycin|mesh-list
153641430|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641431|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641432|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153641433|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641434|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641435|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641436|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153641437|NCT00276679|Temozolomide|temozolomide|mesh-list
153641438|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153641439|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
153641440|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641441|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641442|NCT00276601|Cytarabine|cytarabine|mesh-list
153641443|NCT00276601|Methotrexate|methotrexate|mesh-list
153641444|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
153641445|NCT00276601|Daunorubicin|daunorubicin|mesh-list
153641446|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
153641447|NCT00276601|Tretinoin|tretinoin|mesh-list
153641448|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153641449|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
154021505|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021506|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021507|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021508|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154021509|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154021510|NCT00612794|Exenatide|exenatide|mesh-list
154021511|NCT00612794|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154021512|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154021513|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021514|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154021515|NCT00612794|Incretins|incretins|mesh-ancestor
154021516|NCT00612794|Hormones|hormones|mesh-ancestor
154021517|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021518|NCT03773276|Norepinephrine|norepinephrine|mesh-list
154021519|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154021520|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154021521|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
154021522|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021523|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021524|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021525|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
154021526|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
154021527|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021528|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154021529|NCT02706860|Atorvastatin|atorvastatin|mesh-list
154021530|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153641468|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
153641470|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
153641471|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
153641472|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153641473|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641474|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
153641475|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641476|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
153641477|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641478|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
153641479|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153641480|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
153641481|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641482|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153641483|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153641484|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641485|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641486|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
153641487|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021531|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154021532|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
154021533|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021534|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154021535|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154021536|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021537|NCT02706470|Cyclosporine|cyclosporine|mesh-list
154021538|NCT02706470|Cyclosporins|cyclosporins|mesh-list
154021539|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
154021540|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021541|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021542|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154021543|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
153458954|NCT01671774|Analgesics|analgesics|mesh-ancestor
154021544|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021545|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
154021546|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021547|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
154021548|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021549|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154021550|NCT02706470|Progestins|progestins|mesh-ancestor
154021551|NCT02706470|Hormones|hormones|mesh-ancestor
154021552|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021553|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
154021554|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
154021555|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021556|NCT02706236|Pancrelipase|pancrelipase|mesh-list
154021557|NCT02706236|Pancreatin|pancreatin|mesh-list
154021558|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154021559|NCT00613496|Irbesartan|irbesartan|mesh-list
154021560|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153593567|NCT01843647|Vinorelbine|vinorelbine|mesh-list
153641488|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641489|NCT00389883|Anesthetics|anesthetics|mesh-list
153641490|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641491|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641492|NCT00389922|Vinorelbine|vinorelbine|mesh-list
153641493|NCT00389922|Lapatinib|lapatinib|mesh-list
153641494|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641495|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641496|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641497|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641498|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641499|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641500|NCT00389922|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154021561|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154021562|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154021563|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021564|NCT00612950|Glucagon|glucagon|mesh-list
154021565|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154021566|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154021567|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154021568|NCT00612950|Hormones|hormones|mesh-ancestor
154021569|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021570|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021571|NCT00612950|Incretins|incretins|mesh-ancestor
154021572|NCT00884793|Ritonavir|ritonavir|mesh-list
154021573|NCT00884793|Lopinavir|lopinavir|mesh-list
154021574|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154021575|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
154021576|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
154021577|NCT00884793|Efavirenz|efavirenz|mesh-list
154021578|NCT00884793|Etravirine|etravirine|mesh-list
154021579|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154021580|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154021581|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
154021582|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021583|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021584|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154021585|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154021586|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
154021587|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021588|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154021589|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154021590|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153641501|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153641502|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641503|NCT00276289|Spironolactone|spironolactone|mesh-list
153641504|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153641525|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153641526|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641527|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641528|NCT00276172|Natalizumab|natalizumab|mesh-list
153641529|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
153641530|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641532|NCT00276133|Probucol|probucol|mesh-list
153641533|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153641534|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153641535|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
154021591|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154021592|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154021593|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154021594|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154021595|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154021596|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154021597|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154021598|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154021600|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154021601|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021602|NCT00884325|Levocetirizine|levocetirizine|mesh-list
154021603|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154021604|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154021605|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
154021606|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
154021607|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021608|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021609|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021610|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154021611|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
154021612|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021613|NCT04705844|Adalimumab|adalimumab|mesh-list
154021614|NCT04705844|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154021615|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021616|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021617|NCT00636896|Olanzapine|olanzapine|mesh-list
154021618|NCT00636896|Modafinil|modafinil|mesh-list
154021619|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
153641536|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641537|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153641538|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153641540|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
153641541|NCT00276133|Protective Agents|protective agents|mesh-ancestor
153641542|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641543|NCT00276055|Bevacizumab|bevacizumab|mesh-list
153641544|NCT00276055|Gemcitabine|gemcitabine|mesh-list
153641545|NCT00276055|Docetaxel|docetaxel|mesh-list
153641546|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153641547|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641548|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153641549|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153641550|NCT00276055|Growth Substances|growth substances|mesh-ancestor
153641551|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021620|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
154021621|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021622|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021623|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154021624|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154021625|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154021626|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021627|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154021628|NCT00636896|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154021629|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154021630|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021631|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021632|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021633|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
154021634|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154021635|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154021636|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154021637|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154021639|NCT04470674|Pemetrexed|pemetrexed|mesh-list
154021640|NCT04470674|Durvalumab|durvalumab|mesh-list
154021641|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021642|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021643|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021644|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154021645|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154021646|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154021647|NCT00883779|Carboplatin|carboplatin|mesh-list
153641552|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
153641553|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153641554|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
153641555|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641556|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641557|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641558|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641586|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153641587|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
153641588|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641589|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
153641590|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641591|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
153641592|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641593|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641594|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154021648|NCT00883779|Gemcitabine|gemcitabine|mesh-list
154021649|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154021650|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021651|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154021652|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
154021653|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021654|NCT00883779|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154021655|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021656|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021657|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154021658|NCT05263778|Ezetimibe|ezetimibe|mesh-list
154021659|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154021660|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154021661|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
154021662|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021663|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154021664|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021665|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154021666|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021667|NCT02693444|Lidocaine|lidocaine|mesh-list
154021668|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
154021669|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
154021670|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641595|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
153641596|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153641597|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641598|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153641599|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153641600|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153641601|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153641602|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153641603|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641604|NCT02921555|Prednisone|prednisone|mesh-list
153641605|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
153641606|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153641607|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153641609|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
153641646|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641647|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153641664|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641665|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153641666|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641667|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641668|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153641669|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
153641670|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153641671|NCT04554862|Ketorolac|ketorolac|mesh-list
153641672|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153641673|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
154021671|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021672|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
154021673|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021674|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154021675|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154021676|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154021677|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021678|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021679|NCT04162743|Trazodone|trazodone|mesh-list
154021680|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154021681|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154021682|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021683|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021684|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154021685|NCT04162743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154021686|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154021687|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021688|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021689|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021690|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
154021691|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154021692|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
154021693|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
154021694|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
154021695|NCT04302896|Tenofovir|tenofovir|mesh-list
154021696|NCT04302896|Lamivudine|lamivudine|mesh-list
154021697|NCT04302896|Emtricitabine|emtricitabine|mesh-list
154021698|NCT04302896|Dolutegravir|dolutegravir|mesh-list
154021699|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154021700|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
154021701|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021702|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154021703|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154021706|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154021711|NCT00656643|Temsirolimus|temsirolimus|mesh-list
154021712|NCT00656643|MTOR Inhibitors|mtor inhibitors|mesh-list
154021713|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154021714|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021715|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154021716|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021717|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
154021718|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154021719|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
154021720|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021721|NCT00656643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021722|NCT00656643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021723|NCT00656643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021724|NCT02635971|Gemcitabine|gemcitabine|mesh-list
154021725|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
154021726|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154021727|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
154021728|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021729|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021731|NCT00657423|Docetaxel|docetaxel|mesh-list
154021732|NCT00657423|Endostar protein|endostar protein|mesh-list
154021733|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021734|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
154021735|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
154021736|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
154021737|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641674|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153641675|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153641676|NCT04554862|Analgesics|analgesics|mesh-ancestor
153641677|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
153641678|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641679|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641680|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641681|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641682|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153641683|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641684|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641685|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
153641686|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641687|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153641688|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
153641689|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153641691|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153641692|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
154021738|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154021739|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154021740|NCT00657423|Growth Substances|growth substances|mesh-ancestor
154021741|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021742|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
154021743|NCT00911235|Fluconazole|fluconazole|mesh-list
154021744|NCT00911235|Fesoterodine|fesoterodine|mesh-list
154021745|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
154021746|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021747|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154021748|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154021749|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021750|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021751|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154021752|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
154021753|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021754|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641693|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153641694|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
153641695|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153641696|NCT04230499|Sirolimus|sirolimus|mesh-list
153641697|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153641698|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641699|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153641700|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641701|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
153641702|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641703|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
153641704|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641720|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641721|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153641722|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
153641723|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
153641724|NCT04712357|Tenofovir|tenofovir|mesh-list
153641725|NCT04712357|Emtricitabine|emtricitabine|mesh-list
153641726|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
153641727|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641728|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153641729|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153641730|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641731|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641732|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153641733|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153641734|NCT00390039|Morphine|morphine|mesh-list
153641735|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153641736|NCT00390039|Narcotics|narcotics|mesh-ancestor
153641737|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641738|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641739|NCT00390039|Analgesics|analgesics|mesh-ancestor
153641740|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
153641741|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641742|NCT02832544|Vitamin K|vitamin k|mesh-list
153641743|NCT02832544|Warfarin|warfarin|mesh-list
153641744|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
153641745|NCT02832544|Vitamins|vitamins|mesh-ancestor
153641746|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
153641747|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021755|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154021756|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154021757|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154021758|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154021759|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
154021760|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021761|NCT00911235|Urological Agents|urological agents|mesh-ancestor
154021762|NCT00636974|Anesthetics|anesthetics|mesh-list
154021763|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021764|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021765|NCT02535351|Sunitinib|sunitinib|mesh-list
154021766|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021767|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154021768|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154021769|NCT02535351|Growth Substances|growth substances|mesh-ancestor
154021770|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021771|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
154021772|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021773|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021774|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021775|NCT00613964|Diuretics|diuretics|mesh-list
154021776|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154021777|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
154021778|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021779|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021780|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021781|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
154021782|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153641748|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
153641749|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153641750|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
153641751|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153641752|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
153641753|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641754|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641755|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153641756|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153641757|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
153641758|NCT02832544|Coagulants|coagulants|mesh-ancestor
153641759|NCT00006044|Testosterone|testosterone|mesh-list
153641760|NCT00006044|Androgens|androgens|mesh-ancestor
153641761|NCT00006044|Hormones|hormones|mesh-ancestor
153641762|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641763|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641764|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
154021783|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021784|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021785|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021786|NCT05342870|Analgesics|analgesics|mesh-ancestor
154021787|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
154021788|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021789|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154021790|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154021791|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154021792|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
154021793|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021794|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021795|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154021796|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154021797|NCT05342792|Capecitabine|capecitabine|mesh-list
154021798|NCT05342792|Tislelizumab|tislelizumab|mesh-list
154021799|NCT05342792|Antibodies|antibodies|mesh-list
154021800|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
153779333|NCT00234975|Ritonavir|ritonavir|mesh-list
154021801|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021802|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154021803|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
154021804|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021805|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021806|NCT05342792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154021807|NCT00657891|Omalizumab|omalizumab|mesh-list
154021808|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154021809|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154021810|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
154021811|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
154021812|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154021813|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021814|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021815|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
154021816|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593825|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
154021817|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021818|NCT04159077|Tamsulosin|tamsulosin|mesh-list
154021819|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154021820|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154021821|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154021822|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
154021823|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154021824|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021825|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021826|NCT04159077|Urological Agents|urological agents|mesh-ancestor
154021827|NCT02690480|Fulvestrant|fulvestrant|mesh-list
154021828|NCT02690480|Palbociclib|palbociclib|mesh-list
154021829|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154021830|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021831|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154021832|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154021833|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
153641765|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
153641766|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153641767|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641776|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641777|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641778|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641779|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641780|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641781|NCT00006047|Etoposide|etoposide|mesh-list
153641782|NCT00006047|Rubitecan|rubitecan|mesh-list
153641783|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
153641784|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641785|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641786|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153641787|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641788|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450332|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
153641790|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153641791|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
153641792|NCT00083824|Estrogens|estrogens|mesh-list
153641793|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153641794|NCT00083824|Hormones|hormones|mesh-ancestor
153641795|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641796|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641797|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153641798|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153641799|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153641800|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
153641801|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153641802|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153641803|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153641804|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153641805|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153641806|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641807|NCT00083902|Thalidomide|thalidomide|mesh-list
153641808|NCT00083902|Dexamethasone|dexamethasone|mesh-list
153641809|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641810|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
153641811|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
153641812|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641813|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021834|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021835|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021836|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021837|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021838|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021839|NCT00880269|Panobinostat|panobinostat|mesh-list
154021840|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021841|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154021842|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021843|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021844|NCT00880191|Dexamethasone|dexamethasone|mesh-list
154021845|NCT00880191|Gabapentin|gabapentin|mesh-list
154021846|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021847|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
154021848|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
154021849|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021850|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176596|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021851|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154021852|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
154021854|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021855|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154021856|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021857|NCT00880191|Analgesics|analgesics|mesh-ancestor
154021858|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
154021859|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
154021860|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154021861|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154021862|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154021863|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154021874|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021875|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154021876|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021877|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
154021878|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154021879|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154021880|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154021882|NCT00911313|Letrozole|letrozole|mesh-list
154021883|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154021884|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021885|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021886|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154021887|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154021888|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021889|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021890|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154021891|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
154021892|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154021893|NCT00659685|Ondansetron|ondansetron|mesh-list
154021894|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
154021895|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
154021896|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021897|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021898|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154021899|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
154021900|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
154021919|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154021920|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154021921|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021923|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
154021924|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154021925|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
154021926|NCT00659997|Albendazole|albendazole|mesh-list
154021927|NCT00659997|Levamisole|levamisole|mesh-list
154021928|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
154021929|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154021930|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154021931|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
154021932|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154021933|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154021934|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
154021935|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
154021936|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
154021937|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021938|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021939|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154021940|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
154021941|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021942|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
154021943|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641814|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153641815|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
153641816|NCT00083902|Hormones|hormones|mesh-ancestor
153641817|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641818|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153641819|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641820|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641821|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
153641822|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
153641823|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153641824|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641825|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153641826|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153641827|NCT00083902|Growth Substances|growth substances|mesh-ancestor
153641828|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
153641829|NCT00006050|Leucovorin|leucovorin|mesh-list
153641830|NCT00006050|Fluorouracil|fluorouracil|mesh-list
153641831|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
153641832|NCT00006050|Calcium|calcium|mesh-list
153641834|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153641843|NCT00006050|Protective Agents|protective agents|mesh-ancestor
153641844|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
153641845|NCT00006050|Vitamins|vitamins|mesh-ancestor
153641846|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
154021944|NCT00660153|Tivozanib|tivozanib|mesh-list
154021945|NCT00660153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154021946|NCT00660153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021947|NCT00660153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021948|NCT00660231|Gemcitabine|gemcitabine|mesh-list
154021949|NCT00660231|Bexarotene|bexarotene|mesh-list
154021950|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154021951|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
154021952|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021953|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021954|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
154021955|NCT00597519|Fludarabine|fludarabine|mesh-list
154021956|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154021957|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
154021958|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021959|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021960|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154021961|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
154021962|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021963|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021964|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154021965|NCT00660621|Bevacizumab|bevacizumab|mesh-list
154021966|NCT00660621|Temozolomide|temozolomide|mesh-list
154021967|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153641847|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153641848|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153641849|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153641850|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153641851|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641852|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153641853|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641854|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153641855|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
153641856|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153641857|NCT00084019|Ritonavir|ritonavir|mesh-list
153641858|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153641859|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153641860|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153641861|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
153641862|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641863|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641864|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153641865|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153641866|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
153641867|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641868|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153641869|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153641873|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154021968|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154021969|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153577454|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021970|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154021971|NCT00660621|Growth Substances|growth substances|mesh-ancestor
154021972|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021973|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
154021974|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154021975|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
154021976|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021977|NCT02631993|Furocoumarins|furocoumarins|mesh-list
154021978|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
154021979|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154021980|NCT00660855|Parecoxib|parecoxib|mesh-list
154021981|NCT00660855|Valdecoxib|valdecoxib|mesh-list
154021982|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154021983|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154021984|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154021985|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154021986|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154021987|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154021988|NCT00660855|Analgesics|analgesics|mesh-ancestor
154021989|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
154021990|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154021991|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154021992|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154021993|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154021994|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154021995|NCT00660933|Hematinics|hematinics|mesh-ancestor
154021996|NCT02632071|Paclitaxel|paclitaxel|mesh-list
154021997|NCT02632071|Ricolinostat|ricolinostat|mesh-list
154022012|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
154022013|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022014|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022016|NCT02630823|Carboplatin|carboplatin|mesh-list
154022017|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
154022018|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154022019|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022020|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
154022022|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
154022023|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022024|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022025|NCT02630823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154022026|NCT02630511|Mannitol|mannitol|mesh-list
154022027|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
154022028|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154022029|NCT02630511|Diuretics|diuretics|mesh-ancestor
154022030|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
154022031|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022032|NCT02630511|Miotics|miotics|mesh-ancestor
154022033|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
154022034|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022035|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154022036|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154022037|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
154022038|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154022039|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154022040|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
154022041|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022042|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641874|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153641875|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
153641876|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641877|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641878|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153641879|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153641880|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
153641881|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641882|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153641883|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153641884|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
153641885|NCT00006053|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153641886|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153641887|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022043|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
154022044|NCT00666159|Tacrolimus|tacrolimus|mesh-list
154022045|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154022046|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
154022047|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022048|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154022049|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022050|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022051|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154022052|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154022053|NCT00666159|Analgesics|analgesics|mesh-ancestor
154022054|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
154022055|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022056|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022057|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022058|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
154022059|NCT00666393|Fentanyl|fentanyl|mesh-list
154022060|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154022061|NCT00666393|Narcotics|narcotics|mesh-ancestor
154022062|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022063|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022064|NCT00666393|Analgesics|analgesics|mesh-ancestor
154022065|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
154022066|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641888|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641889|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641890|NCT00084097|Omalizumab|omalizumab|mesh-list
153641891|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153641892|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153641893|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
153641894|NCT00084214|Paclitaxel|paclitaxel|mesh-list
153641895|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641896|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641897|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641898|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641899|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641917|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153641918|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
153641919|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153641920|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153641921|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
153641922|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
153641923|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641924|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153641925|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153641926|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641927|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153641928|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641929|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
153641930|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641931|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154022067|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154022068|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154022069|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
154022070|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
154022071|NCT00666627|Alendronate|alendronate|mesh-list
154022072|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
154022073|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
154022074|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154022075|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022076|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154022077|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022078|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022079|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154022080|NCT00666783|Palonosetron|palonosetron|mesh-list
154022081|NCT00666783|Granisetron|granisetron|mesh-list
154022082|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
154022083|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
154022084|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022085|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022086|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153641933|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153641934|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153641935|NCT00084370|Analgesics|analgesics|mesh-ancestor
153641936|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
153736420|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736421|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153641937|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641938|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641939|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641940|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641941|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153641942|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153641943|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641944|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641946|NCT00084448|Paclitaxel|paclitaxel|mesh-list
153641947|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641948|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641949|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641950|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641951|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641952|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641953|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153641954|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153641955|NCT00084448|Analgesics|analgesics|mesh-ancestor
153641956|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
153641978|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153641981|NCT00084604|Irinotecan|irinotecan|mesh-list
153641982|NCT00084604|Antibodies|antibodies|mesh-list
153641983|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
153641984|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153641985|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641986|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153641987|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154022087|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154022088|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154022089|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
154022090|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022091|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022092|NCT00666939|Gabapentin|gabapentin|mesh-list
154022093|NCT00666939|Analgesics|analgesics|mesh-ancestor
154022094|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
154022095|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022096|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022097|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
154022098|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154022099|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154022100|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022101|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154022102|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154022103|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154022104|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022105|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022106|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
154022107|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154022108|NCT00667407|Albuterol|albuterol|mesh-list
154022109|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154022110|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
154022111|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022112|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022113|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154022114|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
154022115|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
154022116|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154022117|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154022118|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154022119|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154022126|NCT00667485|MTOR Inhibitors|mtor inhibitors|mesh-list
154022127|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022128|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022129|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154022130|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154022131|NCT00667485|Growth Substances|growth substances|mesh-ancestor
154022132|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022133|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
154022134|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154022135|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022136|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154022137|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
154022138|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154022139|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
154022140|NCT00667485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154022141|NCT00667485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022142|NCT00667485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022143|NCT00667641|Paclitaxel|paclitaxel|mesh-list
154022144|NCT00667641|Bortezomib|bortezomib|mesh-list
154022145|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154022146|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022147|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
154022148|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
154022149|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
154022150|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022151|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154022152|NCT00667797|Albuterol|albuterol|mesh-list
154022153|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154022154|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
154022155|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022156|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022157|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154022167|NCT03481556|Dexamethasone|dexamethasone|mesh-list
154022168|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
153779702|NCT00255528|Metoprolol|metoprolol|mesh-list
154022169|NCT03481556|Bortezomib|bortezomib|mesh-list
154022171|NCT03481556|Daratumumab|daratumumab|mesh-list
154022172|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022173|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
154022174|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
154022175|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022176|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022177|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154022178|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
154022179|NCT03481556|Hormones|hormones|mesh-ancestor
154022180|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022181|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154022182|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022183|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154022184|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
154022185|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022186|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154022187|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154022188|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
154022189|NCT00668031|Aprotinin|aprotinin|mesh-list
154022190|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
154022191|NCT00668031|Coagulants|coagulants|mesh-ancestor
154022192|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154022193|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154022194|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
154022195|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022196|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022197|NCT00668109|Tadalafil|tadalafil|mesh-list
154022198|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154022199|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
154022200|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153641988|NCT00084604|Growth Substances|growth substances|mesh-ancestor
153641989|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641990|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
153641991|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
153641992|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153641993|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641994|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022201|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154022202|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022203|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022204|NCT00668109|Urological Agents|urological agents|mesh-ancestor
154022205|NCT00668343|Simvastatin|simvastatin|mesh-list
154022206|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154022207|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154022208|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
154022209|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022210|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154022211|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154022212|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022213|NCT04717700|Dexamethasone|dexamethasone|mesh-list
154022214|NCT04717700|Lenalidomide|lenalidomide|mesh-list
154022215|NCT04717700|Bortezomib|bortezomib|mesh-list
154022216|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022217|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
154022218|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
154022219|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022220|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022221|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154022222|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
154022223|NCT04717700|Hormones|hormones|mesh-ancestor
154022224|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022225|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154022226|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022227|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
153641995|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641996|NCT00084643|Capecitabine|capecitabine|mesh-list
153641997|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
153641998|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153641999|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
153642000|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642001|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642002|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
153642003|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642004|NCT00084721|Celecoxib|celecoxib|mesh-list
153642005|NCT00084721|Irinotecan|irinotecan|mesh-list
153642006|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153642007|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642008|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642009|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642031|NCT00084916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642032|NCT00084916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642033|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642034|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
153642035|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022228|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154022229|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154022230|NCT04717700|Growth Substances|growth substances|mesh-ancestor
154022231|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
154022232|NCT02630277|Aflibercept|aflibercept|mesh-list
154022233|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154022234|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154022235|NCT02630277|Growth Substances|growth substances|mesh-ancestor
154022236|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022237|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
154022238|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022239|NCT00668499|Pemetrexed|pemetrexed|mesh-list
154022240|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022241|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022242|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022243|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153779780|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
154022244|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154022245|NCT05201846|Insulin|insulin|mesh-list
154022246|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154022247|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154022248|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022249|NCT00668967|Verapamil|verapamil|mesh-list
154022250|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154022251|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154022252|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022253|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022254|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154022255|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022256|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
154022257|NCT03583658|Ambroxol|ambroxol|mesh-list
154022258|NCT03583658|Expectorants|expectorants|mesh-ancestor
154022260|NCT03555968|Dronabinol|dronabinol|mesh-list
154022269|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154022270|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022271|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022273|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022274|NCT04593680|Tenofovir|tenofovir|mesh-list
154022275|NCT04593680|Emtricitabine|emtricitabine|mesh-list
154022276|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
154022277|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022278|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154022279|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154022280|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022281|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022282|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154022283|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154022284|NCT00669435|Losartan|losartan|mesh-list
154022285|NCT00669435|Amlodipine|amlodipine|mesh-list
154022286|NCT00669435|Simvastatin|simvastatin|mesh-list
154022287|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154022288|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154022289|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022290|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022291|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154022292|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022293|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
154022294|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154022295|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154022296|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
154022297|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153642036|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642037|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642038|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642039|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642040|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
153642041|NCT00085111|Bevacizumab|bevacizumab|mesh-list
153642042|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153642043|NCT00085111|Antibodies|antibodies|mesh-list
153642044|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
153642045|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153642046|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459082|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642047|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153642048|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153642049|NCT00085111|Growth Substances|growth substances|mesh-ancestor
154022298|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154022300|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154022301|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154022302|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154022303|NCT00669591|Bavituximab|bavituximab|mesh-list
154022304|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022305|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022306|NCT00669747|Carboplatin|carboplatin|mesh-list
154022307|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022308|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154022309|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154022310|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154022311|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
154022312|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022313|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154022314|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
154022315|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154022316|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779851|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
154022317|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154022318|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154022319|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022320|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022321|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022322|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154022323|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154022324|NCT00670293|Raclopride|raclopride|mesh-list
154022325|NCT00670293|Methylphenidate|methylphenidate|mesh-list
154022339|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
154022340|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154022341|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022342|NCT00670761|Misoprostol|misoprostol|mesh-list
154022343|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154022344|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
154022345|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154022346|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022347|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154022348|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154022349|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
154022350|NCT00680433|Ketamine|ketamine|mesh-list
154022351|NCT00680433|Analgesics|analgesics|mesh-ancestor
154022352|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
154022353|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022354|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022355|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154022356|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154022357|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
154022358|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
154022359|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022393|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022394|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154022395|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
154022396|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154022397|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
154022398|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022399|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022400|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154022401|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
154022402|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
154022403|NCT00613808|Protective Agents|protective agents|mesh-ancestor
154022405|NCT05344742|Capecitabine|capecitabine|mesh-list
154022406|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
154022407|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154022408|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022409|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
154022410|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
154022411|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
154022412|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022448|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022449|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022450|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022451|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154022452|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154022453|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022454|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154022455|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154022456|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022457|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
154022458|NCT03794336|Incretins|incretins|mesh-ancestor
154022459|NCT03794336|Hormones|hormones|mesh-ancestor
154022460|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022461|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154022462|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
154022463|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154022464|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
154022465|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022466|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022468|NCT03687554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022469|NCT03687554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022470|NCT03681158|Valproic Acid|valproic acid|mesh-list
154022471|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
154022472|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022473|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022474|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
154022475|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022495|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154022496|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
154022497|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022498|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022499|NCT02704052|Enoxaparin|enoxaparin|mesh-list
154022500|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
154022501|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
154022502|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154022503|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154022504|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022505|NCT02703896|Esomeprazole|esomeprazole|mesh-list
154022506|NCT02703896|Omeprazole|omeprazole|mesh-list
154022507|NCT02703896|Pantoprazole|pantoprazole|mesh-list
154022508|NCT02703896|Lansoprazole|lansoprazole|mesh-list
154022509|NCT02703896|Famotidine|famotidine|mesh-list
154022510|NCT02703896|Ranitidine|ranitidine|mesh-list
154022511|NCT02703896|Cimetidine|cimetidine|mesh-list
154022512|NCT02703896|Nizatidine|nizatidine|mesh-list
154022513|NCT02703896|Lafutidine|lafutidine|mesh-list
154022514|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154022515|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154022516|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154022517|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022518|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022519|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154022520|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
154022521|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
154022522|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022523|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022524|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154022525|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154022526|NCT02737436|Oxytocin|oxytocin|mesh-list
154022527|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
154022528|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153642050|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642051|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
153642052|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
153642054|NCT00085150|Immunoconjugates|immunoconjugates|mesh-ancestor
153642055|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
153642056|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642058|NCT00400075|Azathioprine|azathioprine|mesh-list
153642059|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642060|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
153642061|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022529|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022531|NCT00614978|Lapatinib|lapatinib|mesh-list
154022532|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154022533|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
154022534|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022535|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022536|NCT00614978|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154022537|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154022538|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022539|NCT02703740|Lidocaine|lidocaine|mesh-list
153780072|NCT00256269|Irinotecan|irinotecan|mesh-list
154022540|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
154022541|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
154022542|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
154022543|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022544|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022545|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
154022546|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022547|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154022548|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154022549|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154022550|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022551|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022552|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154022553|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
154022554|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
154022555|NCT02703740|Protective Agents|protective agents|mesh-ancestor
154022556|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
154022557|NCT00615368|Hematinics|hematinics|mesh-ancestor
154022558|NCT00615446|Gemcitabine|gemcitabine|mesh-list
154022559|NCT00615446|Sunitinib|sunitinib|mesh-list
154022571|NCT02703272|Dexamethasone|dexamethasone|mesh-list
154022572|NCT02703272|Rituximab|rituximab|mesh-list
154022573|NCT02703272|Carboplatin|carboplatin|mesh-list
154022574|NCT02703272|Etoposide|etoposide|mesh-list
154022575|NCT02703272|Vincristine|vincristine|mesh-list
154022576|NCT02703272|Ifosfamide|ifosfamide|mesh-list
154022577|NCT02703272|Idarubicin|idarubicin|mesh-list
154022578|NCT02703272|Ibrutinib|ibrutinib|mesh-list
154022579|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022580|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
154022581|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
154022582|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022583|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022584|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154022585|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
154022586|NCT02703272|Hormones|hormones|mesh-ancestor
154022587|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022588|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154022589|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022590|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022591|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
154022592|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022593|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154022594|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154022595|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154022596|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022597|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022598|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
154022599|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
154022600|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
154022601|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154022602|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
153459161|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
154022603|NCT02703272|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154022607|NCT02703194|Prednisolone|prednisolone|mesh-list
154022614|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154022615|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022616|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022617|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022618|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154022619|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
154022620|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
154022621|NCT02702960|Prednisone|prednisone|mesh-list
154022622|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
154022623|NCT02702960|Fludarabine|fludarabine|mesh-list
154022624|NCT02702960|Tacrolimus|tacrolimus|mesh-list
154022625|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154022626|NCT02702960|Mesna|mesna|mesh-list
154022627|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154022628|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
154022629|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022630|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022631|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154022632|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
154022633|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022634|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022635|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154022636|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022637|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
154022638|NCT02702960|Hormones|hormones|mesh-ancestor
154182205|NCT05856695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642062|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642063|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153642089|NCT00085228|Oblimersen|oblimersen|mesh-list
153642090|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642091|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642092|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642093|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642094|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642095|NCT00085306|Interferons|interferons|mesh-list
153642096|NCT00085306|Interferon-beta|interferon-beta|mesh-list
153642097|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642098|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
153642099|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450457|NCT05895526|Fluorides|fluorides|mesh-list
153642100|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
153642101|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642102|NCT00006077|Levodopa|levodopa|mesh-list
153642103|NCT00006077|Domperidone|domperidone|mesh-list
153642104|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153642105|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153642106|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
153642107|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642108|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642109|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642110|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
154022639|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022640|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154022641|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154022642|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022643|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154022644|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154022645|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
154022646|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154022647|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022648|NCT02702960|Protective Agents|protective agents|mesh-ancestor
154022649|NCT02699528|Methylphenidate|methylphenidate|mesh-list
154022650|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154022651|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022652|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154022653|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154022654|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022655|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022656|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
154022657|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022658|NCT04215770|Penicillins|penicillins|mesh-list
153594685|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642111|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
153642112|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642113|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153642141|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153642142|NCT00006080|Protective Agents|protective agents|mesh-ancestor
153642143|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642144|NCT00085462|Aldesleukin|aldesleukin|mesh-list
153642145|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
153642146|NCT00085462|Fludarabine|fludarabine|mesh-list
153642147|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
153642148|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642149|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
153642150|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642151|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642152|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153642153|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
153642154|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642155|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642156|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153642157|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642158|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
153642159|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153642160|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153642161|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
153642162|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642163|NCT00085501|Paclitaxel|paclitaxel|mesh-list
153642164|NCT00085501|Carboplatin|carboplatin|mesh-list
153642165|NCT00085501|Cetuximab|cetuximab|mesh-list
153642189|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642191|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
153642192|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022659|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154022660|NCT04215770|Penicillin G|penicillin g|mesh-list
154022661|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154022662|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
154022663|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154022664|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022665|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154022666|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022667|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022668|NCT02702882|Fenugreek seed meal|fenugreek seed meal|mesh-list
154022669|NCT02702882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154022670|NCT02702882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022671|NCT02699138|Trazodone|trazodone|mesh-list
154022672|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154022673|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154022674|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022675|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022676|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154022677|NCT02699138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154022678|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154022679|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022680|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022681|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022682|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
153642193|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642194|NCT00006086|Carboplatin|carboplatin|mesh-list
153642195|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642196|NCT04798638|Osimertinib|osimertinib|mesh-list
153642197|NCT04798638|Complement Factor H|complement factor h|mesh-list
153736422|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153736423|NCT02690558|Gemcitabine|gemcitabine|mesh-list
153736424|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
153642198|NCT04798638|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153642199|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642200|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642201|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642202|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642203|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153642204|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642205|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
153642206|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642207|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153642208|NCT00006089|Trastuzumab|trastuzumab|mesh-list
153642209|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153642210|NCT00006089|Antibodies|antibodies|mesh-list
153642211|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
153642212|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153642213|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
154022683|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154022684|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
154022685|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
154022686|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154022687|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154022688|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022689|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154022690|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154022691|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
154022692|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022693|NCT01831076|Tamoxifen|tamoxifen|mesh-list
154022694|NCT01831076|Exemestane|exemestane|mesh-list
154022695|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154022696|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
154022697|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022698|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022699|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154022700|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022701|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154022702|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154022703|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154022704|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154022705|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154022706|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022707|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022708|NCT02698982|Anesthetics|anesthetics|mesh-list
154022709|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022710|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022711|NCT00615524|Exemestane|exemestane|mesh-list
154022712|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022724|NCT01246310|Inositol|inositol|mesh-list
154022725|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
154022726|NCT01246310|Vitamins|vitamins|mesh-ancestor
154022727|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
154022728|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022729|NCT00700076|Ketamine|ketamine|mesh-list
154022730|NCT00700076|Analgesics|analgesics|mesh-ancestor
154022731|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
154022732|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022733|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022734|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154022735|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154022736|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
154022737|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
154022738|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022739|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154022740|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154022741|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022742|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022743|NCT02698514|Sevoflurane|sevoflurane|mesh-list
154022744|NCT02698514|Desflurane|desflurane|mesh-list
154022745|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154022746|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154022747|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
154176597|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
154022748|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
154022749|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022750|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022774|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
154022775|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
154022776|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
154022777|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022778|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154022779|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154022780|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154022781|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022782|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
154022783|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154022784|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154022785|NCT02698748|Chloroquine|chloroquine|mesh-list
154022786|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154022787|NCT02698748|Amebicides|amebicides|mesh-ancestor
154022788|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154022789|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154022790|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022791|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
154022792|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022793|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154022794|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154022795|NCT02698748|Analgesics|analgesics|mesh-ancestor
154022796|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
154022797|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022798|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022799|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022800|NCT02698748|Filaricides|filaricides|mesh-ancestor
154022801|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
154022802|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
153642214|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642215|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642216|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153642217|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
153642241|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642242|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
153642243|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642245|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642246|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642247|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
153642248|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642251|NCT00006095|Vincristine|vincristine|mesh-list
153642252|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153642253|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642254|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022804|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
154022805|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
154022806|NCT00615212|Midazolam|midazolam|mesh-list
154022807|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154022808|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154022809|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022810|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022811|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154022812|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154022813|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154022814|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154022815|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
154022816|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
154022817|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
154022818|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
154022819|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022820|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022821|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154022822|NCT00615212|Analgesics|analgesics|mesh-ancestor
154022823|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
154022824|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022825|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154022826|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154022827|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022828|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022829|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154022830|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022831|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
154022832|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154022850|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022852|NCT00906347|Oxytocin|oxytocin|mesh-list
154022853|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
154022854|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154022855|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022856|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154022857|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
154022858|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154022859|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154022860|NCT02705768|Carbamazepine|carbamazepine|mesh-list
154022861|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
154022862|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
154022863|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
154022864|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154022865|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022866|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022867|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154022868|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154022869|NCT02705768|Analgesics|analgesics|mesh-ancestor
154022870|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
154022871|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022872|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154022873|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022874|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022875|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154022876|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153594895|NCT01852604|Ritonavir|ritonavir|mesh-list
153642255|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642256|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642257|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153642258|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642259|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642260|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642261|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153642262|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153642263|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153642264|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642265|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642266|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642267|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153642268|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153642269|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
153642287|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153642288|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
153642289|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022877|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154022879|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
154022880|NCT00616070|Hormones|hormones|mesh-ancestor
154022881|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154022882|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022883|NCT02705534|Ribavirin|ribavirin|mesh-list
154022884|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
154022885|NCT02705534|Ledipasvir|ledipasvir|mesh-list
154022886|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
154022887|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022888|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
154022889|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022890|NCT02701166|Bezafibrate|bezafibrate|mesh-list
154022891|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154022892|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
154022893|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022894|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154022895|NCT03141203|Romidepsin|romidepsin|mesh-list
154022896|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154022897|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022898|NCT03141203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153642290|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153642291|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153642292|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153642293|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153642294|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
153642295|NCT00006098|Bortezomib|bortezomib|mesh-list
153642296|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642297|NCT00086593|Lamotrigine|lamotrigine|mesh-list
153642298|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
153642299|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153642300|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153642301|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642302|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153642303|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642304|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153642305|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153642306|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642307|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642308|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153642309|NCT00387569|Vaccines|vaccines|mesh-list
153642310|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
153642311|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642312|NCT04784637|Insulin|insulin|mesh-list
153642313|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153642314|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642315|NCT00086632|Oregovomab|oregovomab|mesh-list
153642316|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642317|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642318|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
153642319|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153642320|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154022899|NCT03141203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022900|NCT03141203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022901|NCT05320991|Ketamine|ketamine|mesh-list
154022902|NCT05320991|Analgesics|analgesics|mesh-ancestor
154022903|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
154022904|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022905|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022906|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154022907|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154022908|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
154022909|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
154022910|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022911|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154022912|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154022913|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154022914|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022915|NCT04215614|Lidocaine|lidocaine|mesh-list
154022916|NCT04215614|Bupivacaine|bupivacaine|mesh-list
154022917|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
154022918|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
154022919|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154022920|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022921|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
154022922|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022923|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154022924|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154022925|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154022926|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154022927|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022928|NCT00906035|Aspirin|aspirin|mesh-list
153578021|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642321|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642322|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153642323|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153642324|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
153642325|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642326|NCT00006104|Docetaxel|docetaxel|mesh-list
153642327|NCT00006104|Trastuzumab|trastuzumab|mesh-list
153642328|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642347|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642349|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
153642350|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642351|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022929|NCT00906035|Dipyridamole|dipyridamole|mesh-list
154022930|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154022931|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154022932|NCT00906035|Analgesics|analgesics|mesh-ancestor
154022933|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
154022934|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022935|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022936|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154022937|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154022938|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154022939|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154022940|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022941|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154022942|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154022943|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022944|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
154022945|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154022946|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
154022947|NCT02698280|Bevacizumab|bevacizumab|mesh-list
154022948|NCT02698280|Nimustine|nimustine|mesh-list
153594988|NCT01853566|Hormones|hormones|mesh-list
153642352|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153642353|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153642354|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642355|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642356|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642357|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153642358|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153642360|NCT00006107|Docetaxel|docetaxel|mesh-list
153642361|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642362|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642363|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642364|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642365|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642366|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
153642367|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642368|NCT00087100|Pemetrexed|pemetrexed|mesh-list
153642369|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642370|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642371|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642372|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153642373|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153642374|NCT00006113|Interferons|interferons|mesh-list
153642375|NCT00006113|Aldesleukin|aldesleukin|mesh-list
153642376|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
153642377|NCT00006113|Interleukin-4|interleukin-4|mesh-list
153642378|NCT00006113|Sargramostim|sargramostim|mesh-list
153642379|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642380|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
153642381|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642382|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
153642383|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642384|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153642385|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153642386|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154022949|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022950|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022951|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154022952|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154022953|NCT02698280|Growth Substances|growth substances|mesh-ancestor
154022954|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022955|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
154022956|NCT03087773|Empagliflozin|empagliflozin|mesh-list
154022957|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154022958|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022959|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154022960|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022961|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
154022962|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022963|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022964|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
154022965|NCT05333159|Empagliflozin|empagliflozin|mesh-list
154022966|NCT05333159|Canagliflozin|canagliflozin|mesh-list
154022967|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154022968|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022969|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154022970|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022971|NCT02698124|Decitabine|decitabine|mesh-list
154022972|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642420|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
153642421|NCT00087334|Gefitinib|gefitinib|mesh-list
153642422|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642423|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
153642424|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642446|NCT00390078|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153642447|NCT00390078|Antiviral Agents|antiviral agents|mesh-ancestor
153642448|NCT00390078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642450|NCT00006122|Etoposide|etoposide|mesh-list
153642451|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
153642452|NCT00006122|Idarubicin|idarubicin|mesh-list
153642453|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
153642454|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153642455|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642456|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153642457|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642458|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642459|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642460|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642462|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
153642463|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642464|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642465|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
154022974|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022975|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022976|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022977|NCT00905489|Nevirapine|nevirapine|mesh-list
154022978|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154022979|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154022980|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154022981|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022982|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
154022983|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022984|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154022985|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154022986|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154022987|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154022988|NCT02705378|Naloxegol|naloxegol|mesh-list
153642466|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642467|NCT00006122|Analgesics|analgesics|mesh-ancestor
153642468|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
153642469|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642470|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642471|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642472|NCT00006122|Immunotoxins|immunotoxins|mesh-ancestor
153642473|NCT00006122|Immunoconjugates|immunoconjugates|mesh-ancestor
153642474|NCT00087802|Paclitaxel|paclitaxel|mesh-list
153642475|NCT00087802|Carboplatin|carboplatin|mesh-list
153642476|NCT00087802|Gemcitabine|gemcitabine|mesh-list
153642477|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
153642478|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153642498|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642500|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153642501|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
153642502|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642503|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153642504|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153642505|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153642506|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642507|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
153642508|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642520|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153642521|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642522|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642523|NCT00088036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153642524|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153642525|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153642526|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642527|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642528|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
153642529|NCT00088075|Risperidone|risperidone|mesh-list
153642530|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153642531|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
153642545|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642546|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642547|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642548|NCT00006131|Valacyclovir|valacyclovir|mesh-list
153642549|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
153642550|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154022989|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154022990|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154022991|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
154022992|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154022993|NCT03059147|Nivolumab|nivolumab|mesh-list
154022994|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154022995|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154022996|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154022997|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154022998|NCT03356834|Tenofovir|tenofovir|mesh-list
154022999|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
154023000|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023001|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154023002|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154023003|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023004|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023005|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154023006|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154023007|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154023008|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
154023009|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154023010|NCT00615758|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154023011|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023012|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023013|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023014|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023015|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154023016|NCT02704754|Suvorexant|suvorexant|mesh-list
154023017|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154023018|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154023019|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023020|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023021|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153595044|NCT01854073|Scopolamine|scopolamine|mesh-list
153642551|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
153642553|NCT00088231|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153642554|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023022|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023023|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023025|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154023026|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023027|NCT04213898|Paclitaxel|paclitaxel|mesh-list
154023028|NCT04213898|Epirubicin|epirubicin|mesh-list
154023029|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154023030|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154023031|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023032|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
154023033|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
154023034|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
154023035|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023036|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154023037|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154023038|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154023039|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023040|NCT03170882|Dexamethasone|dexamethasone|mesh-list
154023041|NCT03170882|Pomalidomide|pomalidomide|mesh-list
154023042|NCT03170882|Ixazomib|ixazomib|mesh-list
154023043|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154023044|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
154023045|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
154023046|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642555|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642556|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642557|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642558|NCT00088270|Leucovorin|leucovorin|mesh-list
153642559|NCT00088270|Fluorouracil|fluorouracil|mesh-list
153642560|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
153642561|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642562|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642563|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642564|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642565|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
153642566|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642567|NCT00088270|Antidotes|antidotes|mesh-ancestor
153642568|NCT00088270|Protective Agents|protective agents|mesh-ancestor
153642569|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
153642570|NCT00088270|Vitamins|vitamins|mesh-ancestor
153642571|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
153642572|NCT00088387|Valproic Acid|valproic acid|mesh-list
153642573|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642574|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642575|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642576|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
153642577|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153578193|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
153642578|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642579|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023047|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023048|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154023049|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
154023050|NCT03170882|Hormones|hormones|mesh-ancestor
154023051|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023052|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154023053|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023054|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
154023055|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154023056|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154023057|NCT03170882|Growth Substances|growth substances|mesh-ancestor
154023058|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
154023059|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
154023060|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023061|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023062|NCT00616850|Lidocaine|lidocaine|mesh-list
154023063|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
154023064|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
154023065|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023066|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023067|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
154023068|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023069|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154023070|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154023071|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154023072|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153595103|NCT01854489|Analgesics|analgesics|mesh-ancestor
153642580|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
153642581|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
153642582|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642583|NCT00088504|Interferons|interferons|mesh-list
153642584|NCT00088504|Ribavirin|ribavirin|mesh-list
153642585|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
153642586|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
153642587|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153642588|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642591|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
153642592|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642593|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
153642610|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642612|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153642613|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642614|NCT00088816|Tegafur|tegafur|mesh-list
153642615|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642616|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642617|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
154023073|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023075|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154023076|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154023077|NCT00618644|Growth Substances|growth substances|mesh-ancestor
154023078|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023079|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
154023080|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023081|NCT05324774|Aflibercept|aflibercept|mesh-list
154023082|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154023083|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154023084|NCT05324774|Growth Substances|growth substances|mesh-ancestor
154023085|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023086|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
154023087|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023088|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
154023089|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154023090|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154023091|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154023092|NCT05324618|Tacrolimus|tacrolimus|mesh-list
154023093|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154023094|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
154023095|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023096|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153642618|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642619|NCT00088855|Doxorubicin|doxorubicin|mesh-list
153642620|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153642621|NCT00088855|Bortezomib|bortezomib|mesh-list
153642622|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642623|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642624|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153642625|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642626|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642627|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642628|NCT00088894|Bevacizumab|bevacizumab|mesh-list
153642629|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153642630|NCT00088894|Gemcitabine|gemcitabine|mesh-list
153642631|NCT00088894|Antibodies|antibodies|mesh-list
153642632|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
153642633|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153642634|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642635|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153642636|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153642637|NCT00088894|Growth Substances|growth substances|mesh-ancestor
153642638|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642639|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
153642640|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
153642641|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642642|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
153642643|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023097|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023098|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023099|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154023101|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154023102|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
154023103|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023104|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023105|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
154023106|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023107|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154023108|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
154023109|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023110|NCT03043547|Leucovorin|leucovorin|mesh-list
154023111|NCT03043547|Antidotes|antidotes|mesh-ancestor
154023112|NCT03043547|Protective Agents|protective agents|mesh-ancestor
154023113|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023114|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
154023115|NCT03043547|Vitamins|vitamins|mesh-ancestor
154023116|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
154023117|NCT00905021|Sunitinib|sunitinib|mesh-list
154023118|NCT00905021|Exemestane|exemestane|mesh-list
154023119|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642644|NCT00006152|Ritonavir|ritonavir|mesh-list
153642645|NCT00006152|Amprenavir|amprenavir|mesh-list
153642646|NCT00006152|Abacavir|abacavir|mesh-list
153642647|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153642648|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153642649|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
153642650|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642651|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642686|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
153642687|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642688|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
153642689|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642690|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153642722|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
153642724|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153642725|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153642726|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642727|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
153578258|NCT01731431|Glyburide|glyburide|mesh-list
153642728|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153642729|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
153642730|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642731|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153642732|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642733|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
153642734|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642756|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153642757|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642759|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
153642760|NCT00423826|Fludarabine|fludarabine|mesh-list
153642761|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
154023120|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154023121|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154023122|NCT00905021|Growth Substances|growth substances|mesh-ancestor
154023123|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023124|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
154023125|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023126|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023127|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023128|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154023129|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154023130|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154023131|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
154023132|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023133|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
154023134|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154023135|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023136|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154023137|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642762|NCT00423826|Busulfan|busulfan|mesh-list
153642763|NCT00423826|Tacrolimus|tacrolimus|mesh-list
153642764|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642765|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642766|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
153642769|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
153642770|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642771|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
153642772|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642773|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153642774|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642775|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642776|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153642777|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
153642778|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642779|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
153642780|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153642781|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153642782|NCT00423865|Everolimus|everolimus|mesh-list
153642783|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642784|NCT00423865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153642785|NCT00423865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642786|NCT00423865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642787|NCT00423865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642788|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642789|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
153642808|NCT02965261|Fluoxetine|fluoxetine|mesh-list
153642809|NCT02965261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153642810|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153642811|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153642812|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642813|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642814|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
154023138|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
154023139|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154023140|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153780669|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023141|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154023142|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154023143|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023144|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
154023145|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023146|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023147|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154023148|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023149|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154023150|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023152|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154023153|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023154|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
154023155|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
154023156|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023157|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023158|NCT00632645|Olanzapine|olanzapine|mesh-list
154023159|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
154023160|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
154023161|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
154023162|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
153595199|NCT01855009|Antacids|antacids|mesh-ancestor
153642815|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642816|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153642817|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
153642818|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642819|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153642820|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153642821|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642822|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
153642823|NCT00390156|Bevacizumab|bevacizumab|mesh-list
153642824|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
153642825|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642826|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
153642827|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642828|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642829|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153642830|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
153642831|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023163|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023164|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023166|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154023167|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154023168|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023169|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154023170|NCT00632645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154023171|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154023172|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154023173|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023174|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023175|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
154023176|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154023177|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
154023178|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154023179|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
154023180|NCT02849873|Tazarotene|tazarotene|mesh-list
154023181|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
154023182|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
154023183|NCT02849483|Ramosetron|ramosetron|mesh-list
154023184|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
154023185|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
154023186|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023187|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023188|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154023189|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154023190|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
154023191|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023192|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023193|NCT02849327|Immunomodulating Agents|immunomodulating agents|mesh-list
154023194|NCT02849327|Immunologic Factors|immunologic factors|mesh-ancestor
154023195|NCT02849327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642832|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642833|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153642834|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459236|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
153642835|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153642836|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153642837|NCT00390156|Growth Substances|growth substances|mesh-ancestor
154023196|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154023198|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
154023199|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154023200|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
154023201|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023202|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023203|NCT00618852|Furosemide|furosemide|mesh-list
154023204|NCT00618852|Diuretics|diuretics|mesh-ancestor
154023205|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
154023206|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023207|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154023208|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154023209|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023210|NCT02073474|Nabiximols|nabiximols|mesh-list
154023211|NCT02073474|Analgesics|analgesics|mesh-ancestor
154023212|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
154023213|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023214|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023216|NCT00637104|Trace Elements|trace elements|mesh-ancestor
154023217|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
154023218|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642838|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
153642839|NCT00390156|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153642840|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642841|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642855|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153642856|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642857|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642858|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
153642859|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
153642860|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642861|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642862|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153642863|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153642864|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
153642865|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153642867|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153642868|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153642869|NCT00089518|Valsartan|valsartan|mesh-list
153642870|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153642871|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153642872|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153642873|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642874|NCT00089557|Capsaicin|capsaicin|mesh-list
153642875|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
153642876|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
153642877|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
153642878|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642879|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642880|NCT00087451|Sirolimus|sirolimus|mesh-list
153642881|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023219|NCT00617760|Vaccines|vaccines|mesh-list
154023220|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154023221|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
154023222|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023223|NCT00620490|Ropivacaine|ropivacaine|mesh-list
154023224|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154023225|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
154023226|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023227|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023228|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
154023229|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023230|NCT04212078|Levofloxacin|levofloxacin|mesh-list
154023231|NCT04212078|Cefuroxime|cefuroxime|mesh-list
154023232|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
154023233|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154023234|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023235|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023236|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154023237|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154023238|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023239|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023240|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023241|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154023242|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154023243|NCT01898520|Nabiximols|nabiximols|mesh-list
154023244|NCT01898520|Analgesics|analgesics|mesh-ancestor
154023245|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
154023246|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023247|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023248|NCT00903617|Niacin|niacin|mesh-list
154023249|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
153595279|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
153642882|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642883|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642884|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642885|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
153642886|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642887|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
153642888|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642890|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642891|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642892|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153642893|NCT00089830|Protective Agents|protective agents|mesh-ancestor
154023250|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154023251|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
154023252|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023253|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154023254|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
154023255|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
154023256|NCT00903617|Vitamins|vitamins|mesh-ancestor
154023257|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
154023258|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023259|NCT02848937|Citric Acid|citric acid|mesh-list
154023260|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
154023261|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
154023262|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154023263|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
154023264|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
154023265|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023266|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154023267|NCT00343824|Laxatives|laxatives|mesh-ancestor
154023268|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154023269|NCT02849015|Immunomodulating Agents|immunomodulating agents|mesh-list
154023270|NCT02849015|Immunologic Factors|immunologic factors|mesh-ancestor
154023271|NCT02849015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023272|NCT04212000|Ketoconazole|ketoconazole|mesh-list
154023273|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
153642894|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642895|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642896|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153642897|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153642898|NCT00089830|Growth Substances|growth substances|mesh-ancestor
153642899|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
153642900|NCT00089869|Olanzapine|olanzapine|mesh-list
153642901|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153642902|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
153642903|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
153642904|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642939|NCT00090025|Antidotes|antidotes|mesh-ancestor
153642940|NCT00090025|Protective Agents|protective agents|mesh-ancestor
153642941|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
153642943|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
153578623|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642964|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153642965|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642966|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642967|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642968|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642969|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642970|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642971|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642972|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153642973|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153642974|NCT00091039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153642975|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
153642976|NCT00091078|Oblimersen|oblimersen|mesh-list
153642977|NCT00091078|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154023274|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023275|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154023276|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154023277|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023278|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023279|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154023280|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
154023281|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023282|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023283|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154023285|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154023286|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
154023287|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780824|NCT00199979|Nevirapine|nevirapine|mesh-list
154023288|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154023289|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023290|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023291|NCT00620646|Aspirin|aspirin|mesh-list
154023292|NCT00620646|Cilostazol|cilostazol|mesh-list
154023293|NCT00620646|Clopidogrel|clopidogrel|mesh-list
154023294|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154023295|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153642978|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642979|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642980|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642981|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642982|NCT00091117|Bortezomib|bortezomib|mesh-list
153642983|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642984|NCT00091156|Gefitinib|gefitinib|mesh-list
153642985|NCT00091156|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153642986|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642987|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642988|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642989|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642990|NCT00091195|Romidepsin|romidepsin|mesh-list
153642991|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642992|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642993|NCT00091195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153642994|NCT00091195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642995|NCT00091195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642996|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
153642998|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642999|NCT00091234|Immunotoxins|immunotoxins|mesh-ancestor
153643000|NCT00091234|Immunoconjugates|immunoconjugates|mesh-ancestor
153643030|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153643031|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153643032|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643033|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
153643034|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643035|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154023296|NCT00620646|Analgesics|analgesics|mesh-ancestor
154023297|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
154023298|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023299|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023300|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154023301|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154023302|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154023303|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154023304|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023305|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154023306|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154023307|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023308|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
154023309|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154023310|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154176599|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176600|NCT02546141|Caseins|caseins|mesh-list
154176601|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
154023311|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154023312|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
154023313|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023314|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154023315|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
154023316|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154023317|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
154023318|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
154023319|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154023320|NCT00620646|Protective Agents|protective agents|mesh-ancestor
154023321|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153643036|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153643037|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643038|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643040|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153643041|NCT00091429|Ranolazine|ranolazine|mesh-list
153643042|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153643043|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153643044|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643045|NCT00091468|Nicotine|nicotine|mesh-list
153643046|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153643047|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
153643084|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643116|NCT00390195|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153643117|NCT00390195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153643118|NCT00390195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023322|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154023323|NCT00810017|Trastuzumab|trastuzumab|mesh-list
154023324|NCT00810017|Etoposide|etoposide|mesh-list
154023325|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154023326|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023327|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154023328|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154023329|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154023330|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023331|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023332|NCT00620724|Nifedipine|nifedipine|mesh-list
154023333|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154023334|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154023335|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023336|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154023337|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023338|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
154023339|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
154023340|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154023342|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154023343|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023344|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023345|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
154023346|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023347|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023348|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154023349|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
154023350|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643119|NCT00390195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643120|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643121|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
153643122|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643123|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643125|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153643126|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643127|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
153643128|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643129|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643130|NCT00006212|Vinblastine|vinblastine|mesh-list
153643160|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643161|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643162|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643163|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
154023351|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
154023352|NCT00620802|Clopidogrel|clopidogrel|mesh-list
154023353|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154023354|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154023355|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154023356|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154023357|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
154023358|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023359|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023360|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023361|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
154023362|NCT02848157|Ropivacaine|ropivacaine|mesh-list
154023363|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154023364|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023365|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023366|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154023367|NCT02848157|Analgesics|analgesics|mesh-ancestor
154023368|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
154023369|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023370|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154023371|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154023372|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154023373|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
154023374|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023375|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023376|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
154023377|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
154023378|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
153643164|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
153643165|NCT00092170|Ertapenem|ertapenem|mesh-list
153643166|NCT00092170|Ticarcillin|ticarcillin|mesh-list
153643167|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153643168|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643169|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643170|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643171|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643172|NCT00006215|Docetaxel|docetaxel|mesh-list
153643173|NCT00006215|Vinorelbine|vinorelbine|mesh-list
153643211|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153643229|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643230|NCT00093028|Bortezomib|bortezomib|mesh-list
153643231|NCT00093028|Lenalidomide|lenalidomide|mesh-list
153643232|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643233|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
153643234|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643235|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154023379|NCT04211844|Ledipasvir|ledipasvir|mesh-list
154023380|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
154023381|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023382|NCT00619710|Meropenem|meropenem|mesh-list
154023383|NCT00619710|Imipenem|imipenem|mesh-list
154023384|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
154023385|NCT00619710|Cilastatin|cilastatin|mesh-list
154023386|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023387|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023388|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
154023389|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023390|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023391|NCT02846909|Progesterone|progesterone|mesh-list
154023392|NCT02846909|Progestins|progestins|mesh-ancestor
154023393|NCT02846909|Hormones|hormones|mesh-ancestor
154023394|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023395|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023396|NCT00632723|Gefitinib|gefitinib|mesh-list
154023397|NCT00632723|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154023398|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023399|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023400|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023401|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023402|NCT02847143|Oxytocin|oxytocin|mesh-list
154023403|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
154023404|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153595449|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
153643236|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153643237|NCT00093028|Growth Substances|growth substances|mesh-ancestor
153643238|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643239|NCT00093067|Daptomycin|daptomycin|mesh-list
153643240|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643241|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643242|NCT00093184|Anticoagulants|anticoagulants|mesh-list
153643243|NCT00093184|Bivalirudin|bivalirudin|mesh-list
153643244|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
153643245|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153643246|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
153643247|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643248|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643249|NCT00006224|Gemcitabine|gemcitabine|mesh-list
153643250|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643251|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
153643252|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643253|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643254|NCT00093223|Paclitaxel|paclitaxel|mesh-list
153643255|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153643256|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643257|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643258|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
154023406|NCT02847455|Rabeprazole|rabeprazole|mesh-list
154023407|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154023408|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154023409|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154023410|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023411|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023412|NCT03897335|Aminophylline|aminophylline|mesh-list
154023413|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154023414|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
154023415|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023416|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023418|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
154023419|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154023420|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154023421|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023422|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023423|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153595473|NCT01856556|Glycine|glycine|mesh-list
153643259|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643260|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
153643261|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643263|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153643264|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153643265|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643266|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153643267|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643268|NCT00093301|Simendan|simendan|mesh-list
153643269|NCT00093301|Dobutamine|dobutamine|mesh-list
153643270|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153643295|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153643297|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643298|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
153643299|NCT00093652|Gefitinib|gefitinib|mesh-list
153643300|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643301|NCT00093652|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153643302|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153643303|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643304|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643305|NCT00006230|Rubitecan|rubitecan|mesh-list
153643306|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643307|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153643308|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153643309|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643310|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643311|NCT00093769|Rituximab|rituximab|mesh-list
153643312|NCT00093769|Bortezomib|bortezomib|mesh-list
153643313|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153643314|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643315|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
153643316|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643317|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643318|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
154023425|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
154023426|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023427|NCT03897335|Protective Agents|protective agents|mesh-ancestor
154023428|NCT01617096|Dapivirine|dapivirine|mesh-list
154023429|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154023430|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154023431|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
154023432|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023433|NCT00619944|Ritonavir|ritonavir|mesh-list
154023434|NCT00619944|Lopinavir|lopinavir|mesh-list
154023435|NCT00619944|Lumefantrine|lumefantrine|mesh-list
154023436|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154023437|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154023438|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154023439|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
154023440|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023441|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023442|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154023443|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154023444|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
154023445|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595492|NCT01856738|Rivastigmine|rivastigmine|mesh-list
153643319|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643330|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643332|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643333|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643334|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
153643335|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459306|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153643337|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
153643338|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643339|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
153643340|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643341|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153643342|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153643343|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153643344|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
153643345|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643346|NCT02964715|Empagliflozin|empagliflozin|mesh-list
153643347|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153643348|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643349|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153643350|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643351|NCT00093886|Clevidipine|clevidipine|mesh-list
153643352|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
153643353|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
153643354|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153643355|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153643356|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643357|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153643358|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643359|NCT00093925|Nicardipine|nicardipine|mesh-list
154023446|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154023447|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154023448|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
154023449|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154023450|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154023451|NCT00621036|Methotrexate|methotrexate|mesh-list
154023452|NCT00621036|Thiotepa|thiotepa|mesh-list
154023453|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
154023454|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154023455|NCT00621036|Antibodies|antibodies|mesh-list
154023456|NCT00621036|Sargramostim|sargramostim|mesh-list
154023457|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153580328|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154023458|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154023459|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
154023460|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154023461|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023462|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154023463|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
154023464|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023465|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595513|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
153643362|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153643363|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643364|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153643365|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643366|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153643367|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
153643369|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153643370|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643371|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
153643372|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
153643373|NCT00094003|Poly I-C|poly i-c|mesh-list
153643374|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
153643375|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643376|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
153643377|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
153643378|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643379|NCT00094081|Tirapazamine|tirapazamine|mesh-list
153643380|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643381|NCT00094120|Squalamine|squalamine|mesh-list
153643382|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643383|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643384|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153643385|NCT00094120|Protective Agents|protective agents|mesh-ancestor
153643411|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643412|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153643413|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153643414|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153643415|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153643416|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643417|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
153643418|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643419|NCT00094432|Aripiprazole|aripiprazole|mesh-list
153643420|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
154023466|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
154023467|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023468|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154023469|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154023470|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
154023471|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154023472|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154023473|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154023474|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
154023475|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154023476|NCT02846831|Insulin|insulin|mesh-list
154023477|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154023478|NCT02846831|Hormones|hormones|mesh-list
154023479|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154023480|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023481|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023482|NCT01497509|Epinephrine|epinephrine|mesh-list
154023483|NCT01497509|Racepinephrine|racepinephrine|mesh-list
154023484|NCT01497509|Fentanyl|fentanyl|mesh-list
154023485|NCT01497509|Bupivacaine|bupivacaine|mesh-list
154023486|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
154023487|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
154023488|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
154023489|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023490|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023491|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
154023492|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023493|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154023494|NCT01497509|Narcotics|narcotics|mesh-ancestor
154023514|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023515|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023516|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023517|NCT02846519|Rifampin|rifampin|mesh-list
154023518|NCT02846519|Esketamine|esketamine|mesh-list
154023519|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154023520|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
154023521|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023522|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023523|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
154023524|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154023525|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023526|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023527|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154023528|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154023529|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154023530|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154023531|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154023532|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154023533|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
154023534|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154023535|NCT00618228|Balsalazide|balsalazide|mesh-list
154182206|NCT05856695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153643421|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153643422|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153643423|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153643424|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643425|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643426|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
153643427|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
153643428|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643429|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643430|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153643431|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153643432|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
153643448|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
153643449|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643451|NCT00094549|Olanzapine|olanzapine|mesh-list
153643452|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
153643453|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
153643454|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643455|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643456|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153643457|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153643458|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153643459|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643460|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153643461|NCT00094549|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154023536|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154023538|NCT00618228|Analgesics|analgesics|mesh-ancestor
154023539|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
154023540|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023541|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023542|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154023543|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154023544|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154023545|NCT03711305|Carboplatin|carboplatin|mesh-list
154023546|NCT03711305|Etoposide|etoposide|mesh-list
154023547|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023548|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154023549|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154023550|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154023551|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023552|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023553|NCT00618384|Sorafenib|sorafenib|mesh-list
154023554|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023555|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023556|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023557|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023558|NCT02844803|Metformin|metformin|mesh-list
154023559|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154023560|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023561|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
154023562|NCT04211298|Propofol|propofol|mesh-list
154023563|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154023564|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023565|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023566|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154023567|NCT04211298|Analgesics|analgesics|mesh-ancestor
154023568|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
153643462|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153643463|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153643464|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643465|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643466|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
153643467|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
153643468|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023569|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023570|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154023571|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154023572|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154023573|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154023574|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023575|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023576|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154023577|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
154023578|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
154023579|NCT04212702|Everolimus|everolimus|mesh-list
154023580|NCT04212702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154023581|NCT04212702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023582|NCT04212702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023583|NCT04212702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023584|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154023585|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
154023586|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023587|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023588|NCT02691780|Sorafenib|sorafenib|mesh-list
154023589|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023590|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023591|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023592|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023593|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
154023594|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154023595|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023596|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023597|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154023598|NCT02845661|Analgesics|analgesics|mesh-ancestor
154023599|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
154023600|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595638|NCT01857453|Etoposide|etoposide|mesh-list
153643469|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
153643470|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
153643471|NCT00094627|Gaboxadol|gaboxadol|mesh-list
153643472|NCT00094627|Analgesics|analgesics|mesh-ancestor
153643473|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
153643475|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643476|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
153643477|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
153643478|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
154023601|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154023602|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154023603|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154023604|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
154023605|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023606|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023607|NCT02844335|Immunomodulating Agents|immunomodulating agents|mesh-list
154023608|NCT02844335|Immunologic Factors|immunologic factors|mesh-ancestor
154023609|NCT02844335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023611|NCT00880074|Antiviral Agents|antiviral agents|mesh-ancestor
154023612|NCT00880074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023613|NCT04375787|Atorvastatin|atorvastatin|mesh-list
154023614|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154023615|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154023616|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
154023617|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023618|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154023619|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154023620|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023621|NCT00825630|Esomeprazole|esomeprazole|mesh-list
154023622|NCT00825630|Pantoprazole|pantoprazole|mesh-list
154023623|NCT00825630|Lansoprazole|lansoprazole|mesh-list
154023624|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
154023625|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154023626|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154023627|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154023628|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023629|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023630|NCT00620100|Docetaxel|docetaxel|mesh-list
154023631|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023632|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
154023633|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
154023634|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
154023635|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023636|NCT02845349|Vortioxetine|vortioxetine|mesh-list
153643479|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643480|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023639|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154023640|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154176602|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
154023641|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023642|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023643|NCT02845349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154023644|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154023645|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154023646|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023647|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023648|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
154023649|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154023650|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154023651|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154023652|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154023653|NCT03852251|Capecitabine|capecitabine|mesh-list
154023654|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
154023655|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154023656|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
154023657|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023658|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643481|NCT00094666|Gaboxadol|gaboxadol|mesh-list
153643482|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643483|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643484|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643485|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643486|NCT00094666|Analgesics|analgesics|mesh-ancestor
153643487|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
153643488|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
153643489|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
153643490|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
153643491|NCT00006251|Cyclosporine|cyclosporine|mesh-list
153643509|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153643510|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153643511|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
153643512|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643514|NCT00094978|Romidepsin|romidepsin|mesh-list
153643515|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643516|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643517|NCT00094978|Growth Substances|growth substances|mesh-ancestor
153643518|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643519|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153643520|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643521|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643522|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154023659|NCT00620178|Losartan|losartan|mesh-list
154023660|NCT00620178|Candesartan|candesartan|mesh-list
154023661|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
154023662|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154023663|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154023664|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154023665|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154023666|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023667|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
154023668|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154023669|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154023670|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023671|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
154023672|NCT04349982|Coagulants|coagulants|mesh-ancestor
154023673|NCT04315350|Prednisolone|prednisolone|mesh-list
154023674|NCT04315350|Curcumin|curcumin|mesh-list
154023675|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154023676|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
154023677|NCT04315350|Hormones|hormones|mesh-ancestor
154023678|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023679|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023680|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154023681|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023682|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023683|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154023684|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154023685|NCT04315350|Analgesics|analgesics|mesh-ancestor
154023686|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
154023687|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154023688|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023689|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023690|NCT04288206|Cefazolin|cefazolin|mesh-list
154023691|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023701|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154023702|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
154023703|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023704|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023705|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154023706|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154023707|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
154023708|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023709|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154023710|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154023711|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154023712|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
154023713|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023714|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154023715|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154023716|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
154023717|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154023718|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154023719|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
154023720|NCT02771249|Vitamins|vitamins|mesh-ancestor
154023721|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
154023722|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023723|NCT02697318|Timolol|timolol|mesh-list
154023724|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154023725|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154023726|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023727|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154023728|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154023729|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
154023730|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023731|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643523|NCT00094978|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153643524|NCT00095134|Risperidone|risperidone|mesh-list
153643525|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153643526|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
153643527|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643528|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643529|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643530|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153643531|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153643532|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643533|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154023732|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154023733|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154023734|NCT05242133|Interferons|interferons|mesh-list
154023735|NCT05242133|Interferon-beta|interferon-beta|mesh-list
154023736|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
154023737|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023738|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
154023739|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023740|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
154023741|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023742|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154023744|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154023745|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
154023746|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154023747|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023748|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
154023749|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023791|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154023792|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023793|NCT02689362|Incretins|incretins|mesh-ancestor
154023794|NCT02689362|Hormones|hormones|mesh-ancestor
154023795|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023796|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154023797|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
154023798|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023799|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023800|NCT02687256|Heparin|heparin|mesh-list
154023801|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
154023802|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154023803|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154023804|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023805|NCT00622206|Ritonavir|ritonavir|mesh-list
154023806|NCT00622206|Saquinavir|saquinavir|mesh-list
154023807|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154023808|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154023809|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
154023810|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023811|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023812|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154182207|NCT05817656|Sucralfate|sucralfate|mesh-list
153643534|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153643535|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
153643536|NCT00006257|Paclitaxel|paclitaxel|mesh-list
153643537|NCT00006257|Semaxinib|semaxinib|mesh-list
153643538|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643539|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643540|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
153643541|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643542|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
153643543|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643544|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153643545|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153643546|NCT00006257|Growth Substances|growth substances|mesh-ancestor
153643547|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643548|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643571|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153643572|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153643573|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
153643574|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
153643575|NCT00006260|Etoposide|etoposide|mesh-list
153643576|NCT00006260|Ifosfamide|ifosfamide|mesh-list
153643577|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643578|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643579|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153643580|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153643581|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643582|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643583|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153643584|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
154023814|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
154023815|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023816|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154023817|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154023818|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
154023819|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154023820|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154023821|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023823|NCT03582293|Coagulants|coagulants|mesh-ancestor
154023824|NCT03574337|Neostigmine|neostigmine|mesh-list
154023825|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154023826|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582493|NCT02856438|Dexamethasone|dexamethasone|mesh-list
154023827|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023828|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
154023829|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023830|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023831|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154023832|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
154023833|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023834|NCT02689596|Oxytocin|oxytocin|mesh-list
154023835|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
154023836|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153595888|NCT01858207|Doxorubicin|doxorubicin|mesh-list
153643585|NCT00095329|Sirolimus|sirolimus|mesh-list
153643586|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643587|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643588|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153643589|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643591|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643592|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
153643593|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643594|NCT00095368|Amoxicillin|amoxicillin|mesh-list
153643595|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643596|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643597|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
153643598|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153643599|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643600|NCT00006263|Carboplatin|carboplatin|mesh-list
153643601|NCT00006263|Temozolomide|temozolomide|mesh-list
153643602|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643623|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153643624|NCT00095641|Capecitabine|capecitabine|mesh-list
153643625|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643626|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
153643627|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643628|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643629|NCT00006269|Irinotecan|irinotecan|mesh-list
153643630|NCT00006269|Octreotide|octreotide|mesh-list
153643631|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153643632|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154023837|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023839|NCT00423995|Montelukast|montelukast|mesh-list
154023840|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154023841|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
154023842|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154023843|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
154023844|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023845|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023846|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154023847|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154023848|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023849|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
154023850|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
154023851|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154023852|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154023853|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154023854|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
154023855|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
154023856|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023857|NCT00380627|Etoricoxib|etoricoxib|mesh-list
153595911|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
153643633|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643634|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643635|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643636|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153643637|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153643638|NCT00095680|Bortezomib|bortezomib|mesh-list
153643639|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643640|NCT00095719|Aripiprazole|aripiprazole|mesh-list
153643641|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
153643642|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153643643|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153643644|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153643645|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643646|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643647|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
153643648|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
153643649|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643650|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643651|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153643652|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153643653|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
153643669|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153643671|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
153643672|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153643673|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153643674|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153643675|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153643676|NCT00095914|Paclitaxel|paclitaxel|mesh-list
153643677|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154023858|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154023859|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154023860|NCT00380627|Analgesics|analgesics|mesh-ancestor
154023861|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
154023862|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023863|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023864|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154023865|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154023867|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154023868|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023869|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023870|NCT00212771|Olanzapine|olanzapine|mesh-list
154023871|NCT00212771|Asenapine|asenapine|mesh-list
154023872|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
154023873|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
154023874|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023875|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023876|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154023877|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154023878|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154023879|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023880|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154023881|NCT00212771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154023882|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154023883|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154023884|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023885|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023886|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
154023887|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154023888|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154023889|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154023890|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182208|NCT05817656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153643678|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643679|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643680|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
153643681|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643682|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
154023892|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
154023893|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023894|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154023895|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154023896|NCT03822312|Tobramycin|tobramycin|mesh-list
154023897|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023898|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023899|NCT02687178|Canrenone|canrenone|mesh-list
154023900|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154023901|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
154023902|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023903|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595965|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153643683|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643684|NCT04432428|Sufentanil|sufentanil|mesh-list
153643685|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153643686|NCT04432428|Narcotics|narcotics|mesh-ancestor
153643687|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643688|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643689|NCT04432428|Analgesics|analgesics|mesh-ancestor
153643690|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
153643691|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643692|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153643693|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153643694|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
153643695|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
153643696|NCT00096070|Gemcitabine|gemcitabine|mesh-list
153643697|NCT00096070|Fluorouracil|fluorouracil|mesh-list
153643698|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
153643699|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643700|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
153643701|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643702|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643703|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643704|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
153643705|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643706|NCT00006275|Calcitriol|calcitriol|mesh-list
153643707|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153643708|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643709|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153643710|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153643726|NCT00096148|Growth Substances|growth substances|mesh-ancestor
153643727|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643728|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643729|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
153643730|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643731|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
153643732|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643733|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
153643734|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643735|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643736|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153643737|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153643738|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153643739|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643741|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643742|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023904|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154023905|NCT02687178|Diuretics|diuretics|mesh-ancestor
154023906|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
154023907|NCT03711318|Buprenorphine|buprenorphine|mesh-list
154023908|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154023909|NCT03711318|Naloxone|naloxone|mesh-list
154023910|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154023911|NCT03711318|Narcotics|narcotics|mesh-ancestor
154023912|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023913|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023914|NCT03711318|Analgesics|analgesics|mesh-ancestor
154023915|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
154023916|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023917|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154023918|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
154023919|NCT03704298|Fludarabine|fludarabine|mesh-list
154023920|NCT03704298|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154023921|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154023922|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
154023923|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023924|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154023925|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154023926|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
154023927|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023928|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023929|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153595979|NCT01858649|Bevacizumab|bevacizumab|mesh-list
153643743|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643744|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153643745|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153643746|NCT00096304|Docetaxel|docetaxel|mesh-list
153643747|NCT00096304|Epirubicin|epirubicin|mesh-list
153643748|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643749|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
153643750|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643751|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
153643752|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643753|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153643754|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153643755|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153643756|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643757|NCT00096343|Paclitaxel|paclitaxel|mesh-list
153643758|NCT00096343|Carboplatin|carboplatin|mesh-list
153643759|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643760|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643761|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
153459404|NCT03609060|Hormones|hormones|mesh-ancestor
153643762|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643763|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
154023930|NCT03704298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154023931|NCT02687100|Beclomethasone|beclomethasone|mesh-list
154023932|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154023933|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
154023934|NCT02687100|Hormones|hormones|mesh-ancestor
154023935|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154023936|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023937|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154176603|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023938|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
154023939|NCT02153645|Amantadine|amantadine|mesh-list
154023940|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154023941|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154023942|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
154023943|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023944|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
154023945|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154023946|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023947|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023948|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154023949|NCT02153645|Analgesics|analgesics|mesh-ancestor
154023950|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
153596006|NCT01858662|Vitamins|vitamins|mesh-ancestor
153643764|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643765|NCT00096616|Albuterol|albuterol|mesh-list
153643766|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153643767|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
153643768|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643769|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643770|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153643771|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
153643784|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153643785|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643786|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
153643787|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153643788|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
153643789|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153643790|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643791|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153643792|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153643793|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153643794|NCT00006299|Celecoxib|celecoxib|mesh-list
153643795|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153643796|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153643797|NCT00006299|Analgesics|analgesics|mesh-ancestor
153643798|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
153643805|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643806|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643807|NCT00096811|Entecavir|entecavir|mesh-list
153643808|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
153643809|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023951|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154023953|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154023954|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154023955|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
154023956|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154023957|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154023958|NCT00639366|Trastuzumab|trastuzumab|mesh-list
154023959|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153781500|NCT00415779|Docetaxel|docetaxel|mesh-list
154023960|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023961|NCT02686788|Tarenflurbil|tarenflurbil|mesh-list
154023962|NCT02686788|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154023963|NCT02686788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023964|NCT02686788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023965|NCT02686710|Propofol|propofol|mesh-list
154023966|NCT02686710|Sevoflurane|sevoflurane|mesh-list
154023967|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154023968|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154023969|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154023970|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154023971|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
154023972|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
154023973|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153643810|NCT00096850|Ritonavir|ritonavir|mesh-list
153643811|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153643812|NCT00096850|Rifampin|rifampin|mesh-list
153643813|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153643814|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153643815|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
153643816|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643817|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643818|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153643819|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153643820|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
153643821|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643822|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153643823|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153643824|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153643825|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
153643826|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643827|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
153643828|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153643829|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153643830|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153643831|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153643832|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153643865|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
153643866|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643867|NCT00097123|Misoprostol|misoprostol|mesh-list
153643868|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154023974|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154023975|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154023976|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154023977|NCT01773083|Heparin|heparin|mesh-list
154023978|NCT01773083|Calcium heparin|calcium heparin|mesh-list
154023979|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
154023980|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154023981|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154023982|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023983|NCT02354898|Sorafenib|sorafenib|mesh-list
154023984|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154023985|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154023986|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023987|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023988|NCT00110435|Atorvastatin|atorvastatin|mesh-list
154023989|NCT00110435|Simvastatin|simvastatin|mesh-list
154023990|NCT00110435|Ezetimibe|ezetimibe|mesh-list
154023991|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154023992|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154023993|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
154023994|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023995|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154023996|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154023997|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154023998|NCT00093899|Simvastatin|simvastatin|mesh-list
154023999|NCT00093899|Ezetimibe|ezetimibe|mesh-list
154024000|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154024001|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153643869|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
153643870|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153643871|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643872|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153643873|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153643874|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
153643905|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643906|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153643907|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153643908|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
153643909|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643910|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153643911|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153643912|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153643913|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153643914|NCT00390312|Morphine|morphine|mesh-list
153643915|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153643916|NCT00390312|Narcotics|narcotics|mesh-ancestor
153643917|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643918|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024002|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
154024003|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024004|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154024005|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154024006|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024007|NCT00092807|Ezetimibe|ezetimibe|mesh-list
154024008|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154024009|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154024010|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
154024011|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024012|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154024013|NCT00092729|Naproxen|naproxen|mesh-list
154024014|NCT00092729|Etoricoxib|etoricoxib|mesh-list
154024015|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154024016|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154024017|NCT00092729|Analgesics|analgesics|mesh-ancestor
153643919|NCT00390312|Analgesics|analgesics|mesh-ancestor
153643920|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
153643921|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643922|NCT00400387|Riboflavin|riboflavin|mesh-list
153643923|NCT00400387|Thiamine|thiamine|mesh-list
153643924|NCT00400387|Pyridoxine|pyridoxine|mesh-list
153643962|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153643963|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153643965|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643966|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
153643968|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643981|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643982|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643983|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153643984|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153643985|NCT04294836|Curcumin|curcumin|mesh-list
153643986|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153643987|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153643988|NCT04294836|Analgesics|analgesics|mesh-ancestor
153643989|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
153643990|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643991|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643992|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153643993|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643994|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643995|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643996|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643997|NCT00098137|Olmesartan|olmesartan|mesh-list
153643998|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153643999|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153644000|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153644001|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644002|NCT00098488|Rituximab|rituximab|mesh-list
153644003|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153644004|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644005|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
153644006|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644007|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644008|NCT00098527|Romidepsin|romidepsin|mesh-list
153644009|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153644010|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024018|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
154024019|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024020|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024021|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024022|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024023|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
154024024|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154024025|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024026|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024027|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154024028|NCT02686476|Empagliflozin|empagliflozin|mesh-list
154024029|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154024030|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024031|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024032|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024033|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
154024034|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024035|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024036|NCT00616382|Indomethacin|indomethacin|mesh-list
154024037|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
154024038|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154024039|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024040|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024041|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154024042|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154024043|NCT00616382|Protective Agents|protective agents|mesh-ancestor
154024044|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644011|NCT00098527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153644012|NCT00098527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644013|NCT00098527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644014|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153644015|NCT00006347|Antibodies|antibodies|mesh-list
153644016|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
153644017|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153644018|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
153644019|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644020|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644021|NCT00098605|Lapatinib|lapatinib|mesh-list
153644022|NCT00098605|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153644023|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644024|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644025|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644026|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644027|NCT00098683|Amifostine|amifostine|mesh-list
154024045|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
154024046|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154024047|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
154024048|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154024049|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154024050|NCT00616382|Analgesics|analgesics|mesh-ancestor
154024051|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
154024052|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024053|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024054|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024055|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
154024056|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
154024057|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154024058|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154024059|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
154024060|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154024061|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
154024062|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154024063|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
154024064|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024065|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024066|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
154024067|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
154024068|NCT00617474|Hematinics|hematinics|mesh-ancestor
154024069|NCT00619034|Diclofenac|diclofenac|mesh-list
154024070|NCT00619034|Dorzolamide|dorzolamide|mesh-list
154024071|NCT00619034|Latanoprost|latanoprost|mesh-list
153644028|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153644045|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644046|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
153584517|NCT01761487|Gentamicins|gentamicins|mesh-list
153644047|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644048|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153644049|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153644050|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644051|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644052|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
153644053|NCT00099502|Interferons|interferons|mesh-list
153644054|NCT00099502|Interferon-beta|interferon-beta|mesh-list
153644055|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
153644056|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
153644057|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644058|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
153644059|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644060|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
153644061|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644062|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153644063|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644064|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644065|NCT00387920|Sunitinib|sunitinib|mesh-list
153644066|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644067|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154024073|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154024074|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154024075|NCT00619034|Analgesics|analgesics|mesh-ancestor
154024076|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
154024077|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024078|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024079|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024080|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024081|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154024082|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024083|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024084|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154024085|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154024086|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154024088|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154024089|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154024090|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024091|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024092|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154024093|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153644069|NCT00387920|Growth Substances|growth substances|mesh-ancestor
153644070|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644071|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
153644072|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644073|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644074|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644075|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
153644076|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153644077|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644078|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
153644079|NCT00006350|Tacrolimus|tacrolimus|mesh-list
153644080|NCT00006350|Daclizumab|daclizumab|mesh-list
153644081|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644082|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
153644083|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644084|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153644085|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644086|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644087|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153644099|NCT00400621|Acetaminophen|acetaminophen|mesh-list
153644100|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153644101|NCT00400621|Analgesics|analgesics|mesh-ancestor
153644102|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
153644103|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644104|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644105|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
153644106|NCT00006353|Temozolomide|temozolomide|mesh-list
153644107|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153644108|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
154024094|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154024095|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154024096|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
154024097|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024098|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024099|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154024100|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154024101|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
154024102|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154024103|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154024104|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
154024105|NCT00638742|Latanoprost|latanoprost|mesh-list
154024106|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154024107|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154024108|NCT02686242|Anesthetics|anesthetics|mesh-list
154024109|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024110|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024111|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
154024112|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024114|NCT00639522|Capecitabine|capecitabine|mesh-list
154024115|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154024116|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024117|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
153644109|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644110|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644111|NCT00400738|Ritonavir|ritonavir|mesh-list
153644112|NCT00400738|Lopinavir|lopinavir|mesh-list
153644113|NCT00400738|Saquinavir|saquinavir|mesh-list
153644114|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153644115|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153644116|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
153644117|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644118|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644119|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153644120|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153644121|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
153644122|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644123|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153644124|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153644125|NCT00006356|Carboplatin|carboplatin|mesh-list
153644126|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644127|NCT00099619|Insulin|insulin|mesh-list
153644128|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153644129|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
153644130|NCT00099619|Exenatide|exenatide|mesh-list
153644131|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153644132|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644133|NCT00099619|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153644134|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153644135|NCT00099619|Incretins|incretins|mesh-ancestor
153644136|NCT00099619|Hormones|hormones|mesh-ancestor
153644137|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644138|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
154024118|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
154024119|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
154024120|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024121|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154024122|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
154024123|NCT02686086|Albuterol|albuterol|mesh-list
154024124|NCT02686086|Ipratropium|ipratropium|mesh-list
154024125|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154024126|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
154024127|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024128|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024129|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154024130|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
154024131|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
154024132|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154024133|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154024134|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154024135|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154024136|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
154024137|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024138|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024139|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154024140|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
154024141|NCT02685852|Exenatide|exenatide|mesh-list
154024142|NCT02685852|Acarbose|acarbose|mesh-list
153585249|NCT01765829|Haloperidol|haloperidol|mesh-list
154024143|NCT02685852|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154024144|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024145|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024146|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154024147|NCT02685852|Incretins|incretins|mesh-ancestor
154024148|NCT02685852|Hormones|hormones|mesh-ancestor
154024149|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024150|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154024151|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024152|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024155|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024156|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154024157|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154024158|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024159|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
154024160|NCT00622674|Cetuximab|cetuximab|mesh-list
154024161|NCT00622674|Bortezomib|bortezomib|mesh-list
154024162|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154024163|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024164|NCT02687724|Golimumab|golimumab|mesh-list
154024165|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154024166|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024167|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154024168|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
154024169|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024170|NCT02685774|Metformin|metformin|mesh-list
154024171|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024172|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024173|NCT00638976|Eptifibatide|eptifibatide|mesh-list
154024174|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154024175|NCT00639756|Allopurinol|allopurinol|mesh-list
154024176|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
154024177|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024178|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644139|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
153644140|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644141|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644142|NCT00099736|Cyclosporine|cyclosporine|mesh-list
153644143|NCT00099736|Cyclosporins|cyclosporins|mesh-list
153644144|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153644145|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
153644146|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644147|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
153644148|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644149|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644150|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644151|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
153644179|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153644180|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
153644181|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644182|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644183|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153644184|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153644185|NCT00099970|Growth Substances|growth substances|mesh-ancestor
153644186|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644187|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
153644188|NCT00100009|Triamcinolone|triamcinolone|mesh-list
153644189|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153644190|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153644191|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153644192|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024179|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
154024180|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024181|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154024183|NCT00639756|Protective Agents|protective agents|mesh-ancestor
154024184|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024185|NCT00622752|Nicotine|nicotine|mesh-list
154024186|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154024187|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
154024188|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024189|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024190|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154024191|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154024192|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
154024193|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024194|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024195|NCT03451578|alpha-MSH|alpha-msh|mesh-list
154024196|NCT03451578|Hormones|hormones|mesh-ancestor
154024197|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024198|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024199|NCT02686008|Olaparib|olaparib|mesh-list
153596254|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
153644193|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
153644194|NCT00100009|Hormones|hormones|mesh-ancestor
153644195|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644196|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644197|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644198|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
153644199|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644227|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644229|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
153644230|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153644231|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153644232|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153644233|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
153644234|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644235|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
153644236|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644237|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153644238|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153644239|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644240|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644241|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153644242|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
153469161|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644254|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153644255|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153644256|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644257|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644258|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
153644259|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644260|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154024200|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154024201|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024202|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024203|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024204|NCT02685618|Iloprost|iloprost|mesh-list
154024205|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154024206|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
154024207|NCT00602472|Linagliptin|linagliptin|mesh-list
154024208|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024209|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024210|NCT00602472|Incretins|incretins|mesh-ancestor
154024211|NCT00602472|Hormones|hormones|mesh-ancestor
154024212|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024213|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154024214|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
154024215|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024216|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024217|NCT02685462|Digoxin|digoxin|mesh-list
154024218|NCT02685462|Caffeine|caffeine|mesh-list
154024219|NCT02685462|Atorvastatin|atorvastatin|mesh-list
154024220|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154024221|NCT02685462|Simvastatin|simvastatin|mesh-list
154024222|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154024223|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154024224|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
153596274|NCT01860716|Melatonin|melatonin|mesh-list
153644261|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153644263|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153644264|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153644265|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153644266|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153644267|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153644268|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153644270|NCT00006374|Etoposide|etoposide|mesh-list
153644271|NCT00006374|Topotecan|topotecan|mesh-list
153644272|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153644273|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644274|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
153644275|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
153644276|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
153644277|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644278|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153644279|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153644280|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644281|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153644282|NCT00100750|Gemcitabine|gemcitabine|mesh-list
153644283|NCT00100750|Tipifarnib|tipifarnib|mesh-list
153644284|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644285|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
154024225|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024226|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154024227|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154024228|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024229|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154024230|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024231|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154024232|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154024233|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154024234|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
154024235|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024236|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154024237|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154024238|NCT02685462|Protective Agents|protective agents|mesh-ancestor
154024240|NCT02685306|Taxane|taxane|mesh-list
154024241|NCT02685306|Bavituximab|bavituximab|mesh-list
154024242|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154024243|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024244|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
154024245|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
154024246|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
154024247|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024248|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154024249|NCT02680938|Oxytocin|oxytocin|mesh-list
154024250|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
154024251|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154024252|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024253|NCT02685228|Gemcitabine|gemcitabine|mesh-list
154024254|NCT02685228|Decitabine|decitabine|mesh-list
154024255|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154024256|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
154024257|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024265|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024266|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
154024267|NCT00616538|Fluticasone|fluticasone|mesh-list
154024268|NCT00616538|Xhance|xhance|mesh-list
154024269|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024270|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154024271|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
154024272|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024273|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024274|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154024275|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
154024276|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
154024277|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154024278|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
154024279|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154024280|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154024281|NCT02680548|Prednisolone|prednisolone|mesh-list
154024282|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
154024283|NCT02680548|Bupivacaine|bupivacaine|mesh-list
154024284|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154024285|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
154024286|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
154024287|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
154024288|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024289|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024290|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
154024291|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644286|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644287|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644289|NCT00006377|Carboplatin|carboplatin|mesh-list
153644290|NCT00006377|Doxorubicin|doxorubicin|mesh-list
153644291|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153644292|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153644293|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644294|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
153644295|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
153644296|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
153644297|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644298|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153644299|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153644300|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153644301|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644302|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
153644303|NCT01350102|Bacitracin|bacitracin|mesh-list
153644304|NCT01350102|Vitamins|vitamins|mesh-ancestor
153644305|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
153644318|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153644319|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
153644320|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024293|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
154024294|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
154024295|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024296|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
154024297|NCT02680548|Hormones|hormones|mesh-ancestor
154024298|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024299|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154024300|NCT02680548|Protective Agents|protective agents|mesh-ancestor
154024301|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154024302|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024303|NCT05663736|Glimepiride|glimepiride|mesh-list
154024304|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154024305|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024306|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024307|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154024308|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
154024309|NCT02685150|Omeprazole|omeprazole|mesh-list
154024310|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154024311|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154024312|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024313|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024314|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024315|NCT02682186|Ropivacaine|ropivacaine|mesh-list
154024316|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
154024317|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
154024318|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024319|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024320|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
153596362|NCT01861223|Afatinib|afatinib|mesh-list
153644321|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644323|NCT00100906|Interleukin-2|interleukin-2|mesh-list
153644324|NCT00100906|Tretinoin|tretinoin|mesh-list
153644325|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644326|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153644327|NCT00100906|Analgesics|analgesics|mesh-ancestor
153644328|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
153644329|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644330|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644331|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153644332|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153644333|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
153644334|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644335|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
153644336|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
153644337|NCT00100945|Gefitinib|gefitinib|mesh-list
154024321|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024322|NCT00619268|Interferons|interferons|mesh-list
154024323|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
154024324|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
154024325|NCT00619268|Sirolimus|sirolimus|mesh-list
154024326|NCT00619268|Bevacizumab|bevacizumab|mesh-list
154024327|NCT00619268|Sunitinib|sunitinib|mesh-list
154024328|NCT00619268|Temsirolimus|temsirolimus|mesh-list
154024329|NCT00619268|MTOR Inhibitors|mtor inhibitors|mesh-list
153586430|NCT01772381|Dexamethasone|dexamethasone|mesh-list
154024330|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154024331|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024332|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154024333|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154024334|NCT00619268|Growth Substances|growth substances|mesh-ancestor
154024335|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024336|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
154024337|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
154024338|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024339|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
154024340|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154024341|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024342|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596397|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
153644338|NCT00100945|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153644339|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644340|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644341|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644342|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644343|NCT00006383|Vincristine|vincristine|mesh-list
153644344|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153644345|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644346|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
153644347|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
153644348|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
153644349|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644350|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
153459496|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
153644351|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153644352|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153644353|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644354|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153644355|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153644356|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
153644357|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644358|NCT00101062|Celecoxib|celecoxib|mesh-list
153644359|NCT00101062|Letrozole|letrozole|mesh-list
153644360|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644361|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153644362|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153644363|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644364|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644365|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153644366|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
154024343|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154024344|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154024345|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154024346|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
154024348|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154024349|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154024350|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154024351|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024353|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
154024354|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
154024355|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024356|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024357|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
154024358|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024359|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154024360|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154024361|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154024362|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154024363|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024364|NCT00619424|Pemetrexed|pemetrexed|mesh-list
154024365|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154024366|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024367|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024368|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024369|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154024370|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154024371|NCT00619424|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153586667|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
154024372|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644367|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644368|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644393|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
153644394|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644395|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153644396|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
153644397|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153644398|NCT00101179|Azacitidine|azacitidine|mesh-list
153644399|NCT00101179|Entinostat|entinostat|mesh-list
153644403|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644404|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644405|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644407|NCT00400777|Valsartan|valsartan|mesh-list
154024373|NCT00641004|Esomeprazole|esomeprazole|mesh-list
154024374|NCT00641004|Rebamipide|rebamipide|mesh-list
154024375|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154024376|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024377|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154024378|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024379|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024380|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
154024381|NCT00641004|Protective Agents|protective agents|mesh-ancestor
154024382|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024383|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
154024384|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154024385|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024386|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154024387|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154024388|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678264|NCT00202969|Cisplatin|cisplatin|mesh-list
154176604|NCT00845819|Iodine|iodine|mesh-list
154024389|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024390|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024391|NCT04183608|Adalimumab|adalimumab|mesh-list
154024392|NCT04183608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154024393|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024394|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024395|NCT00641082|Adefovir|adefovir|mesh-list
154024396|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154024397|NCT00641082|Clevudine|clevudine|mesh-list
154024398|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
154024399|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644408|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153644409|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153644410|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153644411|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153644412|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644413|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153644414|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644415|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
153644432|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644433|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153644434|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
153644435|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
153644436|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153644437|NCT00101296|Tipifarnib|tipifarnib|mesh-list
153644438|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644439|NCT00006398|Timolol|timolol|mesh-list
153644440|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644441|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153644442|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153644443|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
154024400|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154024401|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154024402|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024403|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024404|NCT00641160|Vinorelbine|vinorelbine|mesh-list
154024405|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154024406|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024407|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
154024408|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
154024409|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
153586939|NCT01777100|Sufentanil|sufentanil|mesh-list
154024410|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024411|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
154024412|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154024413|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
154024414|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024415|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
154024416|NCT02679924|Protective Agents|protective agents|mesh-ancestor
154024418|NCT00618176|Zidovudine|zidovudine|mesh-list
154024419|NCT00618176|Nevirapine|nevirapine|mesh-list
154024420|NCT00618176|Didanosine|didanosine|mesh-list
154024421|NCT00618176|Stavudine|stavudine|mesh-list
154024422|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154024423|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154024424|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596473|NCT01862302|Haloperidol|haloperidol|mesh-list
153644444|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644445|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644446|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153644447|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153644448|NCT00101335|Celecoxib|celecoxib|mesh-list
153644449|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153644450|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153644451|NCT00101335|Analgesics|analgesics|mesh-ancestor
153644452|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
153644453|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644454|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644455|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644456|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644457|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153644458|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153644459|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644460|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644461|NCT00101374|Leflunomide|leflunomide|mesh-list
153644462|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644463|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644464|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644465|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
153644466|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644468|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154024425|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024427|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024428|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154024429|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154024430|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
154024431|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154024432|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154024433|NCT04211558|Ozanimod|ozanimod|mesh-list
154024434|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154024435|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024436|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154024437|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
154024438|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024439|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154024440|NCT00901901|Sorafenib|sorafenib|mesh-list
154024441|NCT00901901|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154024442|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154024443|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024444|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644469|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
153644470|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644471|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644472|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153644473|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
153644474|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153644488|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644489|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
153644490|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
153644491|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644492|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644493|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153644494|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153644495|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
153644496|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153644497|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153644498|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153644500|NCT00101764|Triamcinolone|triamcinolone|mesh-list
153644501|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153644502|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153644503|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153644504|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644505|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
153644507|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644508|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644509|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644510|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
153644511|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644512|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644513|NCT00101803|Vildagliptin|vildagliptin|mesh-list
153644514|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024446|NCT00618254|Granisetron|granisetron|mesh-list
154024447|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
154024448|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
154024449|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024450|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024451|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024452|NCT00618254|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154024453|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154024454|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
154024455|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024456|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024457|NCT04184466|Insulin|insulin|mesh-list
154024458|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154024459|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
154024460|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
154024461|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154024462|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024463|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024464|NCT04201769|Dexamethasone|dexamethasone|mesh-list
154024465|NCT04201769|Palonosetron|palonosetron|mesh-list
154024466|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024467|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
154024468|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
153644515|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644516|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153644517|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
153644518|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644519|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644520|NCT00101842|Gemcitabine|gemcitabine|mesh-list
153644521|NCT00101842|Pemetrexed|pemetrexed|mesh-list
153644522|NCT00101842|Cisplatin|cisplatin|mesh-list
153644523|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644524|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
153644525|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644526|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644527|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644528|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153644529|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153644530|NCT00102115|Talaporfin|talaporfin|mesh-list
153644531|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644532|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153644533|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
153644534|NCT00102154|Gaboxadol|gaboxadol|mesh-list
153644556|NCT00102388|Gliclazide|gliclazide|mesh-list
153644557|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153644558|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644559|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153644560|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
153644561|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644562|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024469|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024470|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024471|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024472|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
154024473|NCT04201769|Hormones|hormones|mesh-ancestor
154024474|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024475|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154024476|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024477|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154024478|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154024479|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
154024480|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024481|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024482|NCT05336825|Lidocaine|lidocaine|mesh-list
154024483|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
154024484|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
154024485|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024486|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024487|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
154024488|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024489|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154024490|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154024491|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154024492|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154024493|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024494|NCT04748783|Listerine|listerine|mesh-list
154024495|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
154024496|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154024497|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154024498|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
154024499|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
154024500|NCT04748783|Protective Agents|protective agents|mesh-ancestor
154024501|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024508|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154024509|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154024510|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154024511|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154024513|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024514|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024515|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024516|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154024517|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154024518|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
154024519|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154024520|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154024521|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
154024522|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024523|NCT00642096|Metoprolol|metoprolol|mesh-list
154024524|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154024525|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154024526|NCT00642096|Diuretics|diuretics|mesh-ancestor
154024527|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
154024528|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024529|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154024530|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154024531|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596579|NCT01863173|Metoprolol|metoprolol|mesh-list
153644563|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
153644564|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644565|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153644566|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
153644567|NCT00102583|Cyclosporine|cyclosporine|mesh-list
153644568|NCT00102583|Cyclosporins|cyclosporins|mesh-list
153644569|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644570|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644571|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644572|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
153644573|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644574|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
153644575|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644576|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
153644577|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644578|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153644579|NCT00102622|Paclitaxel|paclitaxel|mesh-list
153644580|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153644581|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644582|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
153644583|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
153644584|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
153644585|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644586|NCT00006428|Amitriptyline|amitriptyline|mesh-list
154024532|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154024533|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
154024534|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
154024535|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024536|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154024537|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154024538|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154024539|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
154024540|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024541|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154024542|NCT02679456|Fluconazole|fluconazole|mesh-list
154024543|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
154024544|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
154024545|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024546|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154024547|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154024548|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024549|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024550|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154024551|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
154024552|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024553|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024554|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154024555|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153644587|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153644605|NCT00102700|Gemcitabine|gemcitabine|mesh-list
153644606|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644607|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
153644608|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644609|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644610|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644612|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153644613|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644614|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
153644617|NCT00102778|Aplaviroc|aplaviroc|mesh-list
153644618|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153644619|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153644620|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
153644621|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644622|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644623|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153644624|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153644625|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
153644626|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644627|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153644628|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153644629|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154024556|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
154024557|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
154024558|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154024559|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154024560|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024561|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024562|NCT00640458|Urological Agents|urological agents|mesh-ancestor
154024563|NCT00909948|Fludarabine|fludarabine|mesh-list
154024564|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024566|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154024567|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024568|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024569|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024570|NCT00633035|Esomeprazole|esomeprazole|mesh-list
154024572|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154024573|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024574|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154024575|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024576|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024577|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154024578|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
154024579|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
154024580|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024581|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024582|NCT02511132|Gemcitabine|gemcitabine|mesh-list
154024583|NCT02511132|Docetaxel|docetaxel|mesh-list
154024584|NCT02511132|Irinotecan|irinotecan|mesh-list
154024585|NCT02511132|Temozolomide|temozolomide|mesh-list
154024586|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154024587|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
154024588|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644630|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153644631|NCT00101998|Alvimopan|alvimopan|mesh-list
153644632|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153644633|NCT00102856|Pramipexole|pramipexole|mesh-list
153644634|NCT00102856|Rivastigmine|rivastigmine|mesh-list
153644635|NCT00102856|Dexpramipexole|dexpramipexole|mesh-list
153644636|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
153644637|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644638|NCT00102856|Protective Agents|protective agents|mesh-ancestor
153644639|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644640|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153644641|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154024589|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024590|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
154024591|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
154024592|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
154024593|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154024594|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154024595|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024596|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154024597|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
154024598|NCT02678520|Goserelin|goserelin|mesh-list
154024599|NCT02678520|Bicalutamide|bicalutamide|mesh-list
154024600|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024601|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024602|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154024603|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024604|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
154024605|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
154024606|NCT00642252|Fluorides|fluorides|mesh-list
154024607|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
154024608|NCT00642252|Protective Agents|protective agents|mesh-ancestor
154024609|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024610|NCT00642330|Ibuprofen|ibuprofen|mesh-list
154024611|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154024612|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154024613|NCT00642330|Analgesics|analgesics|mesh-ancestor
154024614|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
154024615|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596664|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
153644642|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
153644643|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
153644675|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153644676|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644677|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153644678|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153644679|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153644680|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644681|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644682|NCT00103051|Gemcitabine|gemcitabine|mesh-list
153644684|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644685|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644686|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
153588008|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
153644687|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644688|NCT00103051|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153644716|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644717|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644718|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
154024616|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024617|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024618|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024619|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154024620|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024621|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024622|NCT02681796|Bupivacaine|bupivacaine|mesh-list
154024623|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
154024624|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
154024625|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024626|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024627|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
154024628|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024630|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
154024631|NCT02842931|Doxorubicin|doxorubicin|mesh-list
154024632|NCT02842931|Etoposide|etoposide|mesh-list
154024633|NCT02842931|Vincristine|vincristine|mesh-list
154024634|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154024635|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
154024636|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024637|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024638|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154024639|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
154024640|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024641|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024642|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154024643|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154024644|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154024645|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154024646|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024647|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154024648|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024649|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
154024650|NCT02842931|Hormones|hormones|mesh-ancestor
153596685|NCT01863602|Lamotrigine|lamotrigine|mesh-list
153644719|NCT00103519|Hormones|hormones|mesh-ancestor
153644720|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024651|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024652|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154024653|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
154024654|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
154024655|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154024656|NCT04183296|Propofol|propofol|mesh-list
154024657|NCT04183296|Sevoflurane|sevoflurane|mesh-list
154024658|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154024659|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024660|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024661|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154024662|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
154024663|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
154024664|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154024665|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154024666|NCT00642408|Micronutrients|micronutrients|mesh-list
154024667|NCT00642408|Trace Elements|trace elements|mesh-list
154024668|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024669|NCT02678598|Micafungin|micafungin|mesh-list
154024670|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
154024671|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024672|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
154024673|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154024674|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024675|NCT02359019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154024676|NCT02359019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024677|NCT02678364|Vitamin D|vitamin d|mesh-list
154024678|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
154024679|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154024680|NCT02678364|Calcifediol|calcifediol|mesh-list
154024681|NCT02678364|Vitamins|vitamins|mesh-ancestor
154024682|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
154024683|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024684|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154024685|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154024686|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
154024687|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154024689|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024691|NCT02678208|Coagulants|coagulants|mesh-ancestor
154024692|NCT05551182|Nicergoline|nicergoline|mesh-list
154024693|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154024694|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154024695|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
154024696|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024697|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024698|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024699|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
154024700|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
154024701|NCT02677584|Caffeine|caffeine|mesh-list
154024703|NCT02677584|Citric Acid|citric acid|mesh-list
154024752|NCT00896051|Etravirine|etravirine|mesh-list
154024753|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154024754|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154024755|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154024756|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
154024757|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024758|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024759|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154024760|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154024761|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
154024762|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024763|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154024764|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154024765|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154024766|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154024767|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154024768|NCT02673606|Estradiol|estradiol|mesh-list
154024769|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154024770|NCT02673606|Estrogens|estrogens|mesh-ancestor
154024771|NCT02673606|Hormones|hormones|mesh-ancestor
154024772|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024773|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024774|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154024775|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
154024776|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154024777|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154024778|NCT02675400|Methylphenidate|methylphenidate|mesh-list
154024795|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024797|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
154024798|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154024799|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024800|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154024801|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154024802|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024803|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024804|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024805|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
154024806|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154024807|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
154024808|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024809|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024810|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154024811|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
154024812|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154024813|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
154024814|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024815|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024816|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154024817|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
154024818|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
154024819|NCT04179942|Protective Agents|protective agents|mesh-ancestor
154024820|NCT04250831|Chromium|chromium|mesh-list
154024821|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154024822|NCT04250831|Trace Elements|trace elements|mesh-ancestor
154024823|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
153596864|NCT01864681|Metformin|metformin|mesh-list
153644721|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644722|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
153644723|NCT00103597|Domperidone|domperidone|mesh-list
153644724|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
153644725|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
153644726|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644727|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644728|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153644729|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153644730|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
153644731|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644732|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644733|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644734|NCT00006449|Naltrexone|naltrexone|mesh-list
153644735|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153644736|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154024824|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024825|NCT04250831|Cathartics|cathartics|mesh-ancestor
154024826|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024827|NCT00633191|Immunomodulating Agents|immunomodulating agents|mesh-list
154024828|NCT00633191|Immunologic Factors|immunologic factors|mesh-ancestor
154024829|NCT00633191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024830|NCT00643500|Levetiracetam|levetiracetam|mesh-list
154024831|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
154024832|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
154024833|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
154024834|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154024835|NCT00633269|Olaparib|olaparib|mesh-list
154024836|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154024837|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024838|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024839|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024840|NCT04181346|Pregabalin|pregabalin|mesh-list
154024841|NCT04181346|Analgesics|analgesics|mesh-ancestor
154024842|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
154024843|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024844|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024845|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
154024846|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154024847|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154024848|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024849|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154024850|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154024851|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154024852|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024853|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154024854|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154024855|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154024856|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024857|NCT00642798|Incretins|incretins|mesh-ancestor
153644737|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644755|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153644756|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
153644757|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644758|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644759|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154024858|NCT00642798|Hormones|hormones|mesh-ancestor
154024859|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154024860|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154024861|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
154024863|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024864|NCT05364996|Dimercaprol|dimercaprol|mesh-list
154024865|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
154024866|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
154024867|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024868|NCT00643734|Azithromycin|azithromycin|mesh-list
154024869|NCT00643734|Levofloxacin|levofloxacin|mesh-list
154024870|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154024871|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024872|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154024873|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154024874|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154024875|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024876|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024877|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024878|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154024879|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154024880|NCT02674308|Vedolizumab|vedolizumab|mesh-list
154024881|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024882|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
153644760|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153644761|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153644762|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
153644763|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153644764|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644765|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644766|NCT00103948|Donepezil|donepezil|mesh-list
153644767|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153644768|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644769|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644770|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
153644771|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644772|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644773|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
153644774|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153644775|NCT00006458|Antibodies|antibodies|mesh-list
153644776|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
153644777|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153644778|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
153644779|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644780|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644781|NCT03879408|Acetaminophen|acetaminophen|mesh-list
153644782|NCT03879408|Naproxen|naproxen|mesh-list
153644783|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154024883|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154024884|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154024885|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024886|NCT04178850|Folic Acid|folic acid|mesh-list
154024887|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
154024888|NCT04178850|Infliximab|infliximab|mesh-list
154024889|NCT04178850|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154024890|NCT04178850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024891|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
154024892|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154024893|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024894|NCT04178850|Hematinics|hematinics|mesh-ancestor
154024895|NCT04178850|Vitamins|vitamins|mesh-ancestor
154024896|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
154024897|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024899|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
154024900|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154024901|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024902|NCT02676336|Trace Elements|trace elements|mesh-ancestor
154024903|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
154024904|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024905|NCT05314764|Cefiderocol|cefiderocol|mesh-list
154024906|NCT05314764|Siderophores|siderophores|mesh-ancestor
154024907|NCT05314764|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154024908|NCT05314764|Chelating Agents|chelating agents|mesh-ancestor
154024909|NCT05314764|Sequestering Agents|sequestering agents|mesh-ancestor
154024910|NCT05314764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644784|NCT03879408|Hydrocodone|hydrocodone|mesh-list
153644785|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153644786|NCT03879408|Analgesics|analgesics|mesh-ancestor
153644787|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
153644788|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644789|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644790|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
153644791|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153644792|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644793|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644794|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
153644795|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153644808|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
153644809|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153644810|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644812|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153644813|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153644814|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153644815|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644816|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153644817|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024912|NCT05314764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154024913|NCT05314764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154024915|NCT02672358|Dabrafenib|dabrafenib|mesh-list
154024916|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024917|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154024918|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024919|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024920|NCT02675868|Phenylephrine|phenylephrine|mesh-list
154024921|NCT02675868|Vasopressins|vasopressins|mesh-list
154024922|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
154024923|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
154024924|NCT02675868|Norepinephrine|norepinephrine|mesh-list
154024925|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154024926|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
154024927|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
154024928|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024929|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024930|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
154024931|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154024932|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
154024933|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
154024934|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154024935|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154024936|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154024937|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
153644818|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
153644819|NCT00388076|Paclitaxel|paclitaxel|mesh-list
153644820|NCT00388076|Carboplatin|carboplatin|mesh-list
153644821|NCT00388076|Lapatinib|lapatinib|mesh-list
153644822|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153644823|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644824|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
153644825|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
153644826|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
153644827|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644828|NCT00388076|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153644829|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644830|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644831|NCT00104689|Capecitabine|capecitabine|mesh-list
153644832|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
153644833|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644834|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
153644835|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644836|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644837|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
153644838|NCT00006461|Etoposide|etoposide|mesh-list
153644839|NCT00006461|Vincristine|vincristine|mesh-list
153644840|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
153644841|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154024938|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024939|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024940|NCT02675868|Protective Agents|protective agents|mesh-ancestor
154024941|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
154024942|NCT02675868|Coagulants|coagulants|mesh-ancestor
154024943|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154024944|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
154024945|NCT05279742|Valsartan|valsartan|mesh-list
154024946|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154024947|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154024948|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154024949|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154024950|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024951|NCT02673840|Ketotifen|ketotifen|mesh-list
154024952|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
154024953|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
154024954|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154024955|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
154024956|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
154024957|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024958|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597003|NCT01865916|Vitamins|vitamins|mesh-ancestor
153644842|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
153644843|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644844|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644845|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153644846|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
153644847|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644848|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644849|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153644850|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153644851|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153644852|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153644853|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644854|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
153644855|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
153644856|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
153644857|NCT00104767|Celecoxib|celecoxib|mesh-list
153644883|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
153644885|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
153644886|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153644887|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644888|NCT00104806|Vitamins|vitamins|mesh-ancestor
153644889|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
153644890|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153644891|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644892|NCT00401128|Gemcitabine|gemcitabine|mesh-list
153644893|NCT00401128|Irinotecan|irinotecan|mesh-list
153644894|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644895|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
153644896|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024959|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024960|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154024961|NCT00644124|Aflibercept|aflibercept|mesh-list
154024962|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154024963|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154024964|NCT00644124|Growth Substances|growth substances|mesh-ancestor
154024965|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024966|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
154024967|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154024968|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
154024969|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
154024971|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154024972|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154024973|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024974|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154024975|NCT02670954|Analgesics|analgesics|mesh-ancestor
154024976|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
154024977|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154024978|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153597025|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
153644897|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644898|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153644899|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153644900|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644901|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153644902|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644903|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644904|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644936|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
153644937|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644938|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644939|NCT00105352|Glucagon|glucagon|mesh-list
153644940|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153589203|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644941|NCT00105352|Hormones|hormones|mesh-ancestor
153589204|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
153644942|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644943|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644944|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
153644945|NCT00105547|Tarenflurbil|tarenflurbil|mesh-list
153644946|NCT00105547|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153644947|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644948|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644949|NCT00105547|Analgesics|analgesics|mesh-ancestor
153644960|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153644961|NCT00390624|Diuretics|diuretics|mesh-ancestor
153644962|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
153644963|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644964|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153644965|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
153644966|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459615|NCT06124547|Metformin|metformin|mesh-list
153644967|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153644968|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
153644969|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
154024979|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154024980|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154024981|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
154024982|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154024983|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154024984|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154024985|NCT02670954|Narcotics|narcotics|mesh-ancestor
154024986|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154024987|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154024988|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154024989|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154024990|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024991|NCT00644904|Vitamin D|vitamin d|mesh-list
154024992|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
154024993|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
154024994|NCT00644904|Vitamins|vitamins|mesh-list
154024995|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
154024996|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154024997|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154024998|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154024999|NCT02670564|Busulfan|busulfan|mesh-list
154025000|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
154025001|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025002|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025003|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
154025004|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025005|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154025006|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025008|NCT02672202|Pregabalin|pregabalin|mesh-list
154025023|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154025024|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154025025|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025026|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
154025027|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
154025028|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
154025029|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154025030|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
154025031|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
154025032|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025033|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025034|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154025035|NCT02671578|Analgesics|analgesics|mesh-ancestor
154025036|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
154025037|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025039|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154025040|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
154025041|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025042|NCT00644982|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154025043|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154025044|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025045|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025046|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025047|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
154025048|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025049|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154025050|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154025051|NCT02670642|Esomeprazole|esomeprazole|mesh-list
153644970|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644971|NCT00006476|Suramin|suramin|mesh-list
153644972|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
153644973|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
153644974|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153644975|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644976|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644977|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153644978|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153644979|NCT00105937|Fentanyl|fentanyl|mesh-list
153644980|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153644981|NCT00105937|Narcotics|narcotics|mesh-ancestor
153644982|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153644983|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644985|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
154025052|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154025053|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025054|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154025055|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025056|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025057|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154025058|NCT02670018|Metformin|metformin|mesh-list
154025059|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154025060|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025061|NCT02670096|Acetazolamide|acetazolamide|mesh-list
154025062|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
154025063|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154025064|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025065|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025066|NCT02670096|Diuretics|diuretics|mesh-ancestor
154025067|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
154025068|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025069|NCT00645060|Antibodies|antibodies|mesh-list
154025070|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154025071|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
154025072|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025073|NCT00644670|Atorvastatin|atorvastatin|mesh-list
154025074|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154025075|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154025076|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
154025077|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644986|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644987|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153644988|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153644989|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
153644990|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
153644991|NCT00006479|Leucovorin|leucovorin|mesh-list
153644992|NCT00006479|Fluorouracil|fluorouracil|mesh-list
153644993|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
153644996|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153644997|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644998|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
153644999|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645000|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645001|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645002|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645003|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
153645005|NCT00006479|Protective Agents|protective agents|mesh-ancestor
153645006|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
153645007|NCT00006479|Vitamins|vitamins|mesh-ancestor
153645008|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
153645009|NCT00106054|Leucovorin|leucovorin|mesh-list
153645010|NCT00106054|Bevacizumab|bevacizumab|mesh-list
153645011|NCT00106054|Irinotecan|irinotecan|mesh-list
153645012|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025078|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154025079|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154025080|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025081|NCT02669706|Pentamidine|pentamidine|mesh-list
154025082|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
154025083|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025084|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154025085|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154025086|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154025087|NCT00645138|Anesthetics|anesthetics|mesh-list
154025088|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025089|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025090|NCT00895895|Donepezil|donepezil|mesh-list
154025091|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154025092|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025093|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025094|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
154025095|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025096|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025097|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
154025098|NCT00644748|Gabapentin|gabapentin|mesh-list
154025099|NCT00644748|Analgesics|analgesics|mesh-ancestor
154025100|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
154025101|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025102|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025103|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
154025104|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154025105|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154025106|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025107|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597146|NCT01867268|Acetazolamide|acetazolamide|mesh-list
153645013|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645014|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153645015|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153645016|NCT00106054|Growth Substances|growth substances|mesh-ancestor
153645017|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645042|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153645043|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645044|NCT03815682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153645045|NCT03815682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645046|NCT00106288|Amphotericin B|amphotericin b|mesh-list
153645047|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153645048|NCT00106288|Micafungin|micafungin|mesh-list
153645049|NCT00106288|Amebicides|amebicides|mesh-ancestor
154025108|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154025109|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154025110|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025111|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025112|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
154025113|NCT00910416|Remifentanil|remifentanil|mesh-list
154025114|NCT00910416|Propofol|propofol|mesh-list
154025115|NCT00910416|Sevoflurane|sevoflurane|mesh-list
154025116|NCT00910416|Atracurium|atracurium|mesh-list
154025117|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154025118|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025119|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025120|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154025121|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
154025122|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
154025123|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154025124|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154025125|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154025126|NCT00910416|Narcotics|narcotics|mesh-ancestor
154025127|NCT00910416|Analgesics|analgesics|mesh-ancestor
154025128|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
154025129|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025130|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154025131|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154025132|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154025133|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154025134|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154025135|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
154025136|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025137|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025138|NCT02669238|Etonogestrel|etonogestrel|mesh-list
154025139|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154025140|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
154025141|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154025142|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025143|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154025144|NCT02669004|Morphine|morphine|mesh-list
154025145|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154025146|NCT02669004|Narcotics|narcotics|mesh-ancestor
154025147|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025148|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025149|NCT02669004|Analgesics|analgesics|mesh-ancestor
154025150|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
154025151|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025152|NCT00895661|Rituximab|rituximab|mesh-list
154025153|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025154|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025155|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
154025156|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025157|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025158|NCT00645294|Adefovir|adefovir|mesh-list
154025159|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154025160|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
154025161|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025162|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154025163|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154025164|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025165|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025166|NCT02837003|Aspirin|aspirin|mesh-list
154025167|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154025168|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154025169|NCT02837003|Analgesics|analgesics|mesh-ancestor
154025170|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
154025171|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025172|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025187|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
154025188|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
154025189|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025190|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
154025191|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025192|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025193|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
154025194|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154025195|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154025196|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025197|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154025198|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
154025199|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154025200|NCT02668536|Protective Agents|protective agents|mesh-ancestor
154025201|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025202|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
154025203|NCT00645372|Risperidone|risperidone|mesh-list
154025204|NCT00645372|Ziprasidone|ziprasidone|mesh-list
154025205|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154025206|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
154025207|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025208|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025209|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025210|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154025211|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154025212|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025213|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025214|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154025215|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
154025216|NCT00645918|Clopidogrel|clopidogrel|mesh-list
154025217|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153645050|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153645051|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153645052|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645053|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645054|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
153645055|NCT00006482|Gemcitabine|gemcitabine|mesh-list
153645056|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645057|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645058|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
153645059|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645060|NCT00106366|Insulin|insulin|mesh-list
153645061|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154025218|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154025219|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154025220|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154025221|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
154025222|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025223|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025224|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025225|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
154025226|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
154025227|NCT00646854|Doxorubicin|doxorubicin|mesh-list
154025228|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154025229|NCT00646854|Vincristine|vincristine|mesh-list
154025230|NCT00646854|Lenograstim|lenograstim|mesh-list
154025231|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025232|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
154025233|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025234|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025235|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154025236|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
154025237|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025238|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025239|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153597288|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
153597290|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
153645062|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
153645063|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
153645064|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
153645065|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153645066|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645067|NCT00106405|Memantine|memantine|mesh-list
153645069|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153645091|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645092|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645094|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645095|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645096|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
153645097|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645098|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153645099|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645100|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
153645101|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645102|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645103|NCT00106561|Irbesartan|irbesartan|mesh-list
153645104|NCT00106561|Spironolactone|spironolactone|mesh-list
153645105|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153645106|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
153645107|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645108|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645109|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154025240|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154025241|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025242|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154025243|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154025244|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154025245|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025246|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154025247|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
154025248|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
154025249|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
154025251|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154025252|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025253|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
154025254|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025255|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
154025256|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154025257|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025258|NCT00646932|Vitamins|vitamins|mesh-ancestor
154025259|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
154025260|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154025261|NCT00646152|Poly ICLC|poly iclc|mesh-list
154025262|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
154025263|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
154025264|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025265|NCT00647166|Azathioprine|azathioprine|mesh-list
154025266|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
154025267|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025268|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154025269|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025270|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025271|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
154025272|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025273|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025274|NCT00647244|Tenofovir|tenofovir|mesh-list
154025275|NCT00647244|Abacavir|abacavir|mesh-list
154025276|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
153645110|NCT00106561|Diuretics|diuretics|mesh-ancestor
154025277|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025278|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154025279|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154025280|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025281|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025282|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154025283|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154025284|NCT00895583|Sirolimus|sirolimus|mesh-list
154025285|NCT00895583|Tacrolimus|tacrolimus|mesh-list
154025286|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176605|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
154025287|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
154176606|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154025288|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025289|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154025290|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025291|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025292|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025293|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025294|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154025295|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025296|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
154025297|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
154025298|NCT04174872|Midazolam|midazolam|mesh-list
154025299|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
154025300|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154025301|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025302|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025303|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154025304|NCT04174872|Analgesics|analgesics|mesh-ancestor
154025305|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
154025306|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025307|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154025308|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154025314|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154025315|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154025316|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025317|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154025318|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
154025319|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
154025320|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
154025321|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
154025322|NCT02841137|Progesterone|progesterone|mesh-list
154025323|NCT02841137|Progestins|progestins|mesh-ancestor
154025325|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154025326|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025327|NCT00645606|Rituximab|rituximab|mesh-list
154025328|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025329|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025330|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
154025331|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025332|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025333|NCT02836847|Trastuzumab|trastuzumab|mesh-list
154025334|NCT02836847|Cetuximab|cetuximab|mesh-list
154025335|NCT02836847|Everolimus|everolimus|mesh-list
154025336|NCT02836847|Sorafenib|sorafenib|mesh-list
154025337|NCT02836847|Lapatinib|lapatinib|mesh-list
154025338|NCT02836847|Gefitinib|gefitinib|mesh-list
154025339|NCT02836847|Crizotinib|crizotinib|mesh-list
154025340|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025341|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025342|NCT02836847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154025343|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154025344|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025345|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025346|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025347|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
154025348|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025349|NCT02836847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153645111|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
153645112|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153645113|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153645114|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153645115|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645116|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
153645117|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154025350|NCT02666040|Anesthetics|anesthetics|mesh-list
154025351|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025352|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025353|NCT00894413|Tadalafil|tadalafil|mesh-list
154025354|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
154025355|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154025356|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154025357|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025358|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025359|NCT00894413|Urological Agents|urological agents|mesh-ancestor
154025360|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154025361|NCT04250519|Eusol|eusol|mesh-list
154025362|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
154025363|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025364|NCT02665806|Fluticasone|fluticasone|mesh-list
154025366|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154025367|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154025368|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
154025369|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025370|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025371|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154025372|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
154025373|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
153645118|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469162|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
153645134|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
153645135|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
153645136|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645137|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
153645138|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645139|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645140|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
153645141|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645142|NCT00401362|Naltrexone|naltrexone|mesh-list
153645143|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
153645144|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153645145|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645146|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
153645147|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645148|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153645149|NCT00106834|Infliximab|infliximab|mesh-list
153645150|NCT00106834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153645151|NCT00106834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645152|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
153645153|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645154|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645155|NCT00107107|Pramlintide|pramlintide|mesh-list
153645156|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153645157|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645158|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
153645159|NCT00107263|Letrozole|letrozole|mesh-list
153645160|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645161|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153645162|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154025374|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154025375|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
154025376|NCT02665806|Hormones|hormones|mesh-ancestor
154025377|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154025378|NCT00646386|Adalimumab|adalimumab|mesh-list
154025379|NCT00646386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154025380|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154025381|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025382|NCT00647634|Alprazolam|alprazolam|mesh-list
154025383|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154025384|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025385|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025386|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154025387|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154025388|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025389|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
154025390|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
154025391|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025392|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025393|NCT04172064|Dobutamine|dobutamine|mesh-list
154025394|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154025395|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
154025396|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
154025397|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025398|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025399|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154025400|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154025401|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154025402|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
154025403|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645163|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645164|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645165|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153645166|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
153645167|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645168|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645169|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153645170|NCT02964949|Edoxaban|edoxaban|mesh-list
153645171|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153645172|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
153645173|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153645174|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
153645175|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025404|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025405|NCT04172064|Protective Agents|protective agents|mesh-ancestor
154025406|NCT00647712|Valproic Acid|valproic acid|mesh-list
154025407|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
154025408|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025409|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025410|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
154025411|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025412|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025413|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
154025414|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154025415|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025416|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025417|NCT04173390|Pregabalin|pregabalin|mesh-list
154025418|NCT04173390|Analgesics|analgesics|mesh-ancestor
154025419|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
154025420|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025421|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025422|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
154025423|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154025424|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025425|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025426|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154025427|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154025428|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154025429|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153460718|NCT01677546|Insulin|insulin|mesh-list
153469163|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153645190|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645191|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153645192|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645193|NCT03683667|Azithromycin|azithromycin|mesh-list
153645194|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645195|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645197|NCT00006578|Amprenavir|amprenavir|mesh-list
153645198|NCT00006578|Lamivudine|lamivudine|mesh-list
153645199|NCT00006578|Abacavir|abacavir|mesh-list
153645200|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153645201|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153645202|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
153645203|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645204|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645205|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153645206|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153645207|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
153645208|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025431|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
154025432|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025433|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025434|NCT02665650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154025435|NCT02665650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025436|NCT00647868|Testosterone|testosterone|mesh-list
154025437|NCT00647868|Androgens|androgens|mesh-ancestor
154025438|NCT00647868|Hormones|hormones|mesh-ancestor
154025439|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154025440|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025442|NCT00647946|Abacavir|abacavir|mesh-list
154025443|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
154025444|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025445|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154025446|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154025447|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025448|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025449|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154025450|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154025451|NCT00648024|Anagrelide|anagrelide|mesh-list
154025452|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153590644|NCT01814423|Analgesics|analgesics|mesh-ancestor
154025453|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154025454|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597494|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
153645209|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153645210|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153645211|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153645212|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645213|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153645214|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
153645215|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645216|NCT00107458|Valproic Acid|valproic acid|mesh-list
153645217|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
153645218|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645219|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645220|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
153645221|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645222|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645223|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
153645224|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153645225|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645226|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153645227|NCT00006617|Lamivudine|lamivudine|mesh-list
153645228|NCT00006617|Zidovudine|zidovudine|mesh-list
153645229|NCT00006617|Abacavir|abacavir|mesh-list
153645230|NCT00006617|Amprenavir|amprenavir|mesh-list
153645231|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154025455|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154025456|NCT02665416|Bevacizumab|bevacizumab|mesh-list
154025457|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025458|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025459|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154025460|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154025461|NCT02665416|Growth Substances|growth substances|mesh-ancestor
154025462|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025464|NCT00646620|Fluticasone|fluticasone|mesh-list
154025465|NCT00646620|Budesonide|budesonide|mesh-list
154025466|NCT00646620|Albuterol|albuterol|mesh-list
154025467|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
154025468|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154025469|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154025470|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154025471|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154025472|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154025473|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
154025474|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025475|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025476|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154025477|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
154025478|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
154025479|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154025480|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
154025481|NCT00646620|Hormones|hormones|mesh-ancestor
154025482|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154025483|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154025484|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154025485|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154025486|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
153645232|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645233|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645234|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645235|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
153645236|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645237|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153645262|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645263|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153645264|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153645265|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025487|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025488|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025489|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
154025490|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154025491|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
154025492|NCT00648180|Doxycycline|doxycycline|mesh-list
154025493|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025494|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025495|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
154025496|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154025497|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154025498|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154025499|NCT02664168|Laxatives|laxatives|mesh-ancestor
154025500|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025501|NCT00648492|Metformin|metformin|mesh-list
154025502|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154025503|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025504|NCT00648570|Dexetimide|dexetimide|mesh-list
154025505|NCT00648570|Citalopram|citalopram|mesh-list
154025506|NCT00648570|Escitalopram|escitalopram|mesh-list
154025507|NCT00648570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154025508|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154025509|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154182209|NCT05817656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645266|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645267|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153645268|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
153645269|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645270|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645271|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153645272|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153645273|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645274|NCT00107809|Modafinil|modafinil|mesh-list
153645275|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153645276|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645277|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153645278|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153645279|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153645280|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645281|NCT00006656|Ethanol|ethanol|mesh-list
153645282|NCT00006656|Carmustine|carmustine|mesh-list
153645283|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153645284|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645285|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645286|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645297|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645299|NCT00006695|Cytarabine|cytarabine|mesh-list
153645300|NCT00006695|Etoposide|etoposide|mesh-list
153645301|NCT00006695|Melphalan|melphalan|mesh-list
153645302|NCT00006695|Carmustine|carmustine|mesh-list
153645303|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
154025510|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025511|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025512|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
154025513|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025514|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154025515|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154025516|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
154025517|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
154025518|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025519|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154025520|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154025521|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
154025522|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154025523|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
154025524|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025526|NCT00648258|Valdecoxib|valdecoxib|mesh-list
154025527|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154025528|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154025529|NCT00648258|Analgesics|analgesics|mesh-ancestor
154025530|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
154025531|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025532|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025533|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154025534|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025535|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
154025536|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153645304|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153645305|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645306|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153645307|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153645308|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645309|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645310|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645311|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
153645312|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
153645313|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645314|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645315|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
153645316|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645317|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153645318|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
153645319|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153645320|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153645321|NCT00006695|Trace Elements|trace elements|mesh-ancestor
153645322|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
153645323|NCT00108004|Pramlintide|pramlintide|mesh-list
153645324|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153645325|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025537|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025538|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025539|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154025540|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
154025541|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
154025542|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025543|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154025544|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025545|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025546|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
154025547|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025548|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154025549|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025550|NCT00648414|Fentanyl|fentanyl|mesh-list
154025551|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154025552|NCT00648414|Narcotics|narcotics|mesh-ancestor
154025553|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025554|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025555|NCT00648414|Analgesics|analgesics|mesh-ancestor
154025556|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
154025557|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025558|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154025559|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154025560|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
154025561|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
154025562|NCT02663700|Artesunate|artesunate|mesh-list
154025563|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
153645326|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153645328|NCT00108238|Progesterone|progesterone|mesh-list
153645329|NCT00108238|Estrogens|estrogens|mesh-ancestor
153645330|NCT00108238|Hormones|hormones|mesh-ancestor
153645331|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645332|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645333|NCT00108238|Progestins|progestins|mesh-ancestor
153645334|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153645335|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
153645336|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153645337|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153645338|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153645339|NCT00108316|Fluoxetine|fluoxetine|mesh-list
153645340|NCT00108316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153645341|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153645342|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153645343|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645344|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645345|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
153645346|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025564|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154025565|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154025566|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025567|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025568|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
154025569|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
154025570|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154025571|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
154025572|NCT00648726|Azithromycin|azithromycin|mesh-list
154025573|NCT00648726|Erythromycin|erythromycin|mesh-list
154025574|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
154025575|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154025576|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
154025577|NCT00648726|Cefuroxime|cefuroxime|mesh-list
154025578|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
154025579|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025580|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025581|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025582|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154025583|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025584|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025585|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
154025586|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154025587|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025588|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025589|NCT00648804|Ondansetron|ondansetron|mesh-list
154176607|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
154025590|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
154025591|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
154025592|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025593|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025594|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025595|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
154025596|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
154025597|NCT00648804|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154025598|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154025599|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
154025600|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645347|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153645348|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
153645349|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025601|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025602|NCT02664012|Menthol|menthol|mesh-list
154025603|NCT02664012|Nicotine|nicotine|mesh-list
154025604|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154025605|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
154025606|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025607|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025608|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154025609|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154025610|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
154025611|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025612|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025613|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
154025614|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
154025615|NCT00895037|Factor VIII|factor viii|mesh-list
154025616|NCT00895037|Coagulants|coagulants|mesh-ancestor
154025617|NCT04170504|Methotrexate|methotrexate|mesh-list
154025618|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154025619|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
154025620|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154025621|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025622|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154025623|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
154025624|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025625|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025626|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
154025627|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025628|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154025629|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025630|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
154025631|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025632|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154025633|NCT04170270|Omeprazole|omeprazole|mesh-list
154025634|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154025635|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025636|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154025637|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025638|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025640|NCT00633347|Cetrorelix|cetrorelix|mesh-list
154025641|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154025642|NCT00633347|Hormones|hormones|mesh-ancestor
154025643|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154025644|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025645|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154025646|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
154025647|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154025648|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
154025649|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
154025650|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154025651|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
154025652|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154025653|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154025654|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025655|NCT02838719|Dexamethasone|dexamethasone|mesh-list
154025656|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
154025657|NCT02838719|BB 1101|bb 1101|mesh-list
154025658|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154025659|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
154025660|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
154025661|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025662|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025663|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025664|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
154176608|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
154025665|NCT02838719|Hormones|hormones|mesh-ancestor
153645358|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
153645359|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645360|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153645361|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153645362|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153645363|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645364|NCT00401440|Misoprostol|misoprostol|mesh-list
153590864|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
153645365|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153645366|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
153645367|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153645368|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645369|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153645370|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645371|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
153645372|NCT00108667|Levodopa|levodopa|mesh-list
153645373|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153645374|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154025666|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154025667|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154025668|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025669|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
154025670|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025671|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025672|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154025673|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154025674|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025675|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154025676|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154025677|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025678|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025679|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
154025680|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025681|NCT00649194|Rabeprazole|rabeprazole|mesh-list
154025682|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154025683|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025684|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154025685|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025686|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645375|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
153645376|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645377|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645378|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645379|NCT00006773|Bortezomib|bortezomib|mesh-list
153645380|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645381|NCT00108706|Candesartan|candesartan|mesh-list
153645382|NCT00108706|Candesartan cilexetil|candesartan cilexetil|mesh-list
153645383|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153645384|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153645385|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153645386|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645387|NCT00006812|Capecitabine|capecitabine|mesh-list
153645388|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645389|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
153645390|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645391|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645392|NCT00006890|Thalidomide|thalidomide|mesh-list
153645393|NCT00006890|Prednisone|prednisone|mesh-list
153645394|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645395|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
153645396|NCT00006890|Hormones|hormones|mesh-ancestor
153645397|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645398|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645399|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153645400|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645401|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645402|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
154025688|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154025689|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025690|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154025691|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
154025693|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025694|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025695|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025696|NCT02835833|Bevacizumab|bevacizumab|mesh-list
154025697|NCT02835833|Nintedanib|nintedanib|mesh-list
154025698|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025699|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025700|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154025701|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154025702|NCT02835833|Growth Substances|growth substances|mesh-ancestor
154025703|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025704|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
154025705|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154025706|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025707|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025708|NCT02838329|Ropivacaine|ropivacaine|mesh-list
154025709|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
153645403|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
153645404|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645405|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645406|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153645407|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153645409|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
153645410|NCT00108979|Escitalopram|escitalopram|mesh-list
153645411|NCT00108979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153645412|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153645413|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153645414|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645425|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645426|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
153645427|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645428|NCT00109057|Bevacizumab|bevacizumab|mesh-list
153645429|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153645430|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645431|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153645432|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153645433|NCT00109057|Growth Substances|growth substances|mesh-ancestor
153645434|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645435|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
153645436|NCT00109096|Pemetrexed|pemetrexed|mesh-list
153645437|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645438|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645439|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025710|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
154025711|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025712|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025713|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
154025714|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025715|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
154025716|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154025717|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154025718|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154025719|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025720|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025721|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
154025722|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025723|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025724|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154025725|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025726|NCT02835521|Triamcinolone|triamcinolone|mesh-list
154025727|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154025728|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153590955|NCT01816529|Diltiazem|diltiazem|mesh-list
154025729|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154025730|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154025731|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
154025732|NCT02835521|Hormones|hormones|mesh-ancestor
154025733|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182211|NCT05752201|Immunologic Factors|immunologic factors|mesh-ancestor
153597772|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597773|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645440|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153645441|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645442|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
153645443|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153645444|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153645445|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645446|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645447|NCT00109135|Hormones|hormones|mesh-ancestor
153645448|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645449|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645450|NCT00006929|Suramin|suramin|mesh-list
153645451|NCT00006929|Paclitaxel|paclitaxel|mesh-list
153645452|NCT00006929|Carboplatin|carboplatin|mesh-list
153645453|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153645454|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645455|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
154025734|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025735|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176609|NCT00845819|Nystatin|nystatin|mesh-list
154176610|NCT00845819|Povidone|povidone|mesh-list
154025736|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
154025737|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025738|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025739|NCT00649272|Oxybutynin|oxybutynin|mesh-list
154025740|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
154025741|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
154025742|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025743|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025744|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154025745|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154025746|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
154025747|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025748|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025749|NCT00649272|Urological Agents|urological agents|mesh-ancestor
154025750|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
154025751|NCT02666898|Fludarabine|fludarabine|mesh-list
154025752|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
154025753|NCT02666898|Ibrutinib|ibrutinib|mesh-list
154025754|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025755|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
154025756|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025757|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154025758|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154025759|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
154025760|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025761|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645456|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
153645457|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
153645458|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645459|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
153645460|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
153645461|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153645462|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645463|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153645464|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153645466|NCT00006968|Pentostatin|pentostatin|mesh-list
153645467|NCT00006968|Cyclosporins|cyclosporins|mesh-list
153591005|NCT01816659|Metformin|metformin|mesh-list
153645468|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
153645469|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645470|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645471|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025762|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154025763|NCT02666898|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154025764|NCT02666898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154025765|NCT02666898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025766|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025768|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154025769|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154025770|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025771|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025772|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
154025773|NCT02840279|BPN14770|bpn14770|mesh-list
154025774|NCT02840279|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154025775|NCT02840279|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154025776|NCT02840279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025777|NCT02840279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025778|NCT00648960|Clarithromycin|clarithromycin|mesh-list
154025779|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025780|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025781|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154025782|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025783|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025784|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154025785|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154025786|NCT04437329|Cisplatin|cisplatin|mesh-list
154025787|NCT04437329|Docetaxel|docetaxel|mesh-list
154025788|NCT04437329|Fluorouracil|fluorouracil|mesh-list
154025789|NCT04437329|Nedaplatin|nedaplatin|mesh-list
154025790|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597828|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
153597829|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153645472|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645473|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
153645474|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645475|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
153645531|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153645532|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
153645533|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645534|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
153645535|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645536|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153645537|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645538|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025791|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
154025792|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
154025793|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
154025794|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025795|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
154025796|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154025797|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154025798|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
154025799|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025800|NCT02834507|Levodopa|levodopa|mesh-list
154025801|NCT02834507|Carbidopa|carbidopa|mesh-list
154025802|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154025803|NCT02834507|Entacapone|entacapone|mesh-list
154025804|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154025805|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154025806|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
154025807|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025808|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025809|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025810|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154025811|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025812|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153597858|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153597859|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597860|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153597861|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153597862|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597863|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597864|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597865|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153597866|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
153597867|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153645539|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645540|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
153645541|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
153645542|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645543|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645546|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645547|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153645548|NCT00109993|Protective Agents|protective agents|mesh-ancestor
154025813|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
154025814|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
154025815|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154025816|NCT02831543|Mosapride|mosapride|mesh-list
154025817|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025818|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154025819|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154025820|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
154025821|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025822|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025823|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154025824|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
154025825|NCT02667054|Anesthetics|anesthetics|mesh-list
154025826|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
154025827|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645549|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153645550|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645551|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153645552|NCT00110032|Etanidazole|etanidazole|mesh-list
153645553|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645554|NCT00110071|Iodine|iodine|mesh-list
153645555|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
153645556|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153645557|NCT00110071|Fludarabine|fludarabine|mesh-list
153645558|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
153645559|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
153645560|NCT00110071|Antibodies|antibodies|mesh-list
153645561|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
153645562|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153645563|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
153645564|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645565|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645566|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645567|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
153645568|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645590|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645592|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153645593|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
153645594|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645595|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
153645596|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153645597|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153591085|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153645598|NCT00110344|Sorafenib|sorafenib|mesh-list
153645599|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645600|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153645601|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645602|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645603|NCT00401479|Solabegron|solabegron|mesh-list
153645604|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153645605|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153645606|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153645607|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
153645608|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645609|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645610|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645611|NCT00110578|Aldesleukin|aldesleukin|mesh-list
153645612|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645613|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153645614|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154025829|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
154025830|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025831|NCT02662296|Idelalisib|idelalisib|mesh-list
154025832|NCT02662296|Ibrutinib|ibrutinib|mesh-list
154025833|NCT02662296|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154025834|NCT02662296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154025835|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025836|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568486|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
154025837|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025838|NCT02662374|Nystatin|nystatin|mesh-list
154025839|NCT02662374|Calcium|calcium|mesh-list
154025840|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154025841|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025842|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025843|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025844|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
154025845|NCT02662374|Ionophores|ionophores|mesh-ancestor
154025846|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025847|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025848|NCT05334251|Anesthetics|anesthetics|mesh-list
153645615|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
153645616|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645617|NCT00388193|Rituximab|rituximab|mesh-list
153645618|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153645619|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645633|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
153645634|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
153645635|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645636|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645637|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
153645638|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645639|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153645640|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153645641|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153645642|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153645643|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645644|NCT00110773|Lidocaine|lidocaine|mesh-list
153645645|NCT00110773|Tetracaine|tetracaine|mesh-list
153645646|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
153645647|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
153645648|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645649|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645650|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
153645651|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645652|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153645653|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153645654|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153645655|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025849|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025850|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025851|NCT00649350|Metformin|metformin|mesh-list
154025852|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153591165|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154025853|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025854|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
154025855|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154025856|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025857|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025858|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154025859|NCT00649038|Benazepril|benazepril|mesh-list
154025860|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154025861|NCT00649038|Diuretics|diuretics|mesh-ancestor
154025862|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
154025863|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025864|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154025865|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025866|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025867|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154025868|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
153597917|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153645656|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645658|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
153645659|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153645660|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645661|NCT00110929|Cinacalcet|cinacalcet|mesh-list
153645662|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153645663|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645664|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153645665|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
153645666|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645667|NCT00111046|Ibuprofen|ibuprofen|mesh-list
153645668|NCT00111046|Tramadol|tramadol|mesh-list
153645669|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153645670|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153645671|NCT00111046|Analgesics|analgesics|mesh-ancestor
153645672|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
153645673|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645674|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645675|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645676|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645677|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153645678|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645679|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645690|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645691|NCT00388271|Urological Agents|urological agents|mesh-ancestor
153645692|NCT00111124|Etanercept|etanercept|mesh-list
153645693|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153645694|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153645695|NCT00111124|Analgesics|analgesics|mesh-ancestor
153645696|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
154025869|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025871|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
154025872|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
154025873|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025874|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025875|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
154025876|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025877|NCT02658396|Bortezomib|bortezomib|mesh-list
154025878|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025879|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
154025880|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025881|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025882|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154025883|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154025884|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025885|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025886|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025887|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154025888|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154025890|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154025891|NCT00601458|Naproxen|naproxen|mesh-list
154025892|NCT00601458|Pregabalin|pregabalin|mesh-list
154025893|NCT00601458|Analgesics|analgesics|mesh-ancestor
154025894|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
154025895|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025896|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025897|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
154025898|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154025899|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154025900|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025901|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154025902|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154025903|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154025908|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154025909|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153348591|NCT00210470|Zinc|zinc|mesh-list
153568637|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
154025910|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
154025911|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154025912|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025913|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
154025914|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154025915|NCT02660736|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154025916|NCT02660736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154025917|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025918|NCT02660736|Incretins|incretins|mesh-ancestor
154025919|NCT02660736|Hormones|hormones|mesh-ancestor
154025920|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154025921|NCT00649584|Gemcitabine|gemcitabine|mesh-list
154025922|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154025923|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154025924|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
154025925|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025926|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025927|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025928|NCT00649584|Immunotoxins|immunotoxins|mesh-ancestor
154025929|NCT00649584|Immunoconjugates|immunoconjugates|mesh-ancestor
154025930|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
154025931|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025932|NCT02141282|Venetoclax|venetoclax|mesh-list
154025933|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025934|NCT02657616|Vitamin K|vitamin k|mesh-list
154025935|NCT02657616|Anticoagulants|anticoagulants|mesh-list
154025936|NCT02657616|Vitamins|vitamins|mesh-ancestor
154025937|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
154025938|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025939|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154025940|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153645697|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645698|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645699|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645700|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645701|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645702|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645703|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
154025941|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025942|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
154025943|NCT02657616|Coagulants|coagulants|mesh-ancestor
154025944|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
154025945|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154025946|NCT02657694|Ledipasvir|ledipasvir|mesh-list
154025947|NCT02657694|Velpatasvir|velpatasvir|mesh-list
154025948|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
154025949|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025950|NCT02657460|Cisplatin|cisplatin|mesh-list
154025951|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025952|NCT00649896|Estradiol|estradiol|mesh-list
154025953|NCT00649896|Estrogens|estrogens|mesh-ancestor
154025954|NCT00649896|Hormones|hormones|mesh-ancestor
154025955|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154025956|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025957|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
154025958|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154025959|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154025960|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154025961|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154025962|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025963|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025964|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025965|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154025966|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153645704|NCT00111163|Artesunate|artesunate|mesh-list
153645705|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
153645706|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
153645707|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153645708|NCT00111163|Amodiaquine|amodiaquine|mesh-list
153645709|NCT00111163|Dapsone|dapsone|mesh-list
153645710|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
153645711|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
153645712|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153645713|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153645714|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645715|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645716|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
153645717|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
153645718|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153645719|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
153645720|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153645721|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645722|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645723|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153645724|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
153645725|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645727|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153645728|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645729|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154025967|NCT04188158|Capecitabine|capecitabine|mesh-list
154025968|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
154025969|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154025970|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
154025971|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025972|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025973|NCT02831231|Xanomeline|xanomeline|mesh-list
154025974|NCT02831231|Trospium chloride|trospium chloride|mesh-list
154025975|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
154025976|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
154025977|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154025978|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025979|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154025980|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154025981|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
154025982|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154025983|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025984|NCT02831231|Urological Agents|urological agents|mesh-ancestor
154025985|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154025986|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154025987|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154025988|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154025989|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
154025990|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154025991|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154025992|NCT05234606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182212|NCT05752201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645730|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645731|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
153645732|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645734|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645735|NCT00111397|Interferons|interferons|mesh-list
153645736|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
153645737|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645738|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
153645740|NCT00111436|Etanercept|etanercept|mesh-list
153645741|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153645742|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153645743|NCT00111436|Analgesics|analgesics|mesh-ancestor
153645744|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
153645745|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645746|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645759|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153645761|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645762|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645763|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153645764|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025993|NCT05234606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154025995|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
154025996|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154025997|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154025998|NCT04209920|Chromium|chromium|mesh-list
154025999|NCT04209920|Nickel|nickel|mesh-list
154026000|NCT04209920|Trace Elements|trace elements|mesh-ancestor
154026001|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
154026002|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026003|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
154026004|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154026005|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026006|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026007|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154026008|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026009|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154026010|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
154026011|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154026012|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026013|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026014|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154026015|NCT02660658|Analgesics|analgesics|mesh-ancestor
154026016|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
154026017|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026018|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154026019|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154026020|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154026021|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
153645765|NCT00111748|Thalidomide|thalidomide|mesh-list
153645766|NCT00111748|Dexamethasone|dexamethasone|mesh-list
153645767|NCT00111748|Bortezomib|bortezomib|mesh-list
153645768|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645769|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
153645770|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
153645771|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645772|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645773|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645774|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
153645775|NCT00111748|Hormones|hormones|mesh-ancestor
153645776|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645777|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153645778|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645779|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645780|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
154026022|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026023|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026024|NCT02660502|Insulin|insulin|mesh-list
154026025|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154026026|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
154026027|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026028|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026029|NCT02660346|Vancomycin|vancomycin|mesh-list
154026030|NCT02660346|Daptomycin|daptomycin|mesh-list
154026031|NCT02660346|Ceftaroline|ceftaroline|mesh-list
154026032|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153591335|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026033|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026035|NCT00620438|Efavirenz|efavirenz|mesh-list
154026036|NCT00620438|Nevirapine|nevirapine|mesh-list
154026037|NCT00620438|Rifampin|rifampin|mesh-list
154026038|NCT00620438|Lumefantrine|lumefantrine|mesh-list
154026039|NCT00620438|Artemether|artemether|mesh-list
154026040|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154026041|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154026042|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154026043|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026044|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645781|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
153645782|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645783|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645784|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153645785|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153645786|NCT00111748|Growth Substances|growth substances|mesh-ancestor
153645787|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
153645788|NCT00111787|Paclitaxel|paclitaxel|mesh-list
153645789|NCT00111787|Lapatinib|lapatinib|mesh-list
153645790|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153645791|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645792|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
153645793|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
153645794|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
153645795|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645796|NCT00111787|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153645797|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153645798|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645799|NCT00111904|Paclitaxel|paclitaxel|mesh-list
153645800|NCT00111904|genexol-PM|genexol-pm|mesh-list
153645801|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153645802|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645804|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
153645805|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
153645806|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645807|NCT00111943|Tenofovir|tenofovir|mesh-list
153645808|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
153645834|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
153645835|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
153645836|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645837|NCT00112021|Pramlintide|pramlintide|mesh-list
153645838|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
153645839|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026045|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
154026046|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026047|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154026048|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154026049|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154026050|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154026051|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154026052|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154026053|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154026054|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
154026055|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154026056|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
154026057|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154026058|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154026059|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154026060|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154026061|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154026062|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
154026063|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154026064|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154026065|NCT00891839|Rituximab|rituximab|mesh-list
154026066|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153598120|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
153645840|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645841|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
153645842|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153645843|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
153645844|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645845|NCT00007358|Dexamethasone|dexamethasone|mesh-list
153645846|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645847|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
153645848|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
153645849|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645850|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645851|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645852|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
153645854|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645856|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645857|NCT00112138|Gabapentin|gabapentin|mesh-list
153645875|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
153645876|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645877|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645878|NCT00007436|Tenofovir|tenofovir|mesh-list
153645879|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
153645880|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645881|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153645882|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645883|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645884|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026067|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154026068|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026069|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
154026070|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026071|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154026072|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154026073|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
154026074|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026075|NCT00600756|Risperidone|risperidone|mesh-list
154026076|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154026077|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154026078|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
154026079|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026080|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026081|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026082|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154026083|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154026084|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026085|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026086|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154026087|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
154026088|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
154026089|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
154026090|NCT02657148|Etonogestrel|etonogestrel|mesh-list
154026091|NCT02657148|Desogestrel|desogestrel|mesh-list
154026092|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153645885|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153645886|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153645887|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153645888|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153645889|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
153645890|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645891|NCT00112372|Sirolimus|sirolimus|mesh-list
153645892|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645893|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645894|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153645895|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645896|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
153645897|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645898|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
153645899|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591436|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153645900|NCT00112528|Bevacizumab|bevacizumab|mesh-list
153645901|NCT00112528|Gemcitabine|gemcitabine|mesh-list
153645902|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
153645903|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153645904|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645905|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153645906|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153645907|NCT00112528|Growth Substances|growth substances|mesh-ancestor
154026094|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154026095|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154026096|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154026097|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154026098|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154026099|NCT02657148|Progestins|progestins|mesh-ancestor
154026100|NCT02657148|Hormones|hormones|mesh-ancestor
154026101|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154026102|NCT04247087|Vitamin K|vitamin k|mesh-list
154026103|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
154026104|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154026105|NCT04247087|Vitamins|vitamins|mesh-ancestor
154026106|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
154026107|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026108|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154026109|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154026110|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026111|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
154026112|NCT04247087|Coagulants|coagulants|mesh-ancestor
154026113|NCT00649116|Metoprolol|metoprolol|mesh-list
153645908|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645909|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
153645910|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645911|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
153645912|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645913|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
153645914|NCT00007592|Furosemide|furosemide|mesh-list
153645915|NCT00007592|Diuretics|diuretics|mesh-ancestor
153645926|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
153645927|NCT00112567|Fludarabine|fludarabine|mesh-list
153645928|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
153645930|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645931|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645932|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
153645933|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645934|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645935|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
153645936|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645937|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153645938|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
153645939|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153645940|NCT00112645|Cyclosporine|cyclosporine|mesh-list
153645941|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
153645942|NCT00112645|Methotrexate|methotrexate|mesh-list
153645943|NCT00112645|Melphalan|melphalan|mesh-list
153645944|NCT00112645|Busulfan|busulfan|mesh-list
153645945|NCT00112645|Cyclosporins|cyclosporins|mesh-list
153645946|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153645947|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153645948|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
153645949|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153645950|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645951|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645952|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
154026114|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154026115|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154026116|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
154026117|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
154026118|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026119|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026120|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154026121|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154026122|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154026123|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
154026124|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818195|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026125|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026126|NCT02652234|Endostar protein|endostar protein|mesh-list
154026127|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154026128|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154026129|NCT02652234|Growth Substances|growth substances|mesh-ancestor
154026130|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026131|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
154026132|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026133|NCT04211012|Paclitaxel|paclitaxel|mesh-list
154026134|NCT04211012|Cisplatin|cisplatin|mesh-list
154026135|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154026136|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026137|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
154026138|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
154026139|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
154026140|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026142|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
154026143|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598186|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153645953|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645954|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645955|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
153645957|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153645958|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645959|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
153645960|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645961|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645962|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
153645963|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645964|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153645965|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645966|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
154026144|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154026145|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026147|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026148|NCT02655822|Atezolizumab|atezolizumab|mesh-list
154026149|NCT02655822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154026150|NCT02655822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026151|NCT02655822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154026152|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026153|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154026154|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154026155|NCT00650442|Estradiol|estradiol|mesh-list
154026156|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154026157|NCT00650442|Estrogens|estrogens|mesh-ancestor
154026158|NCT00650442|Hormones|hormones|mesh-ancestor
154026159|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154026160|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026161|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154026162|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
154026163|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154026164|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154026165|NCT00890825|Docetaxel|docetaxel|mesh-list
154026166|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026167|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154026168|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154026169|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154026170|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026171|NCT04760132|Vaccines|vaccines|mesh-list
154026172|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
154026173|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026174|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
154026175|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154026176|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026177|NCT00649818|Lorazepam|lorazepam|mesh-list
153598217|NCT01873001|Pioglitazone|pioglitazone|mesh-list
153591523|NCT01820624|Tretinoin|tretinoin|mesh-list
153645967|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
153645968|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645969|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645970|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
153645971|NCT00112645|Hormones|hormones|mesh-ancestor
154026178|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
154026179|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
154026180|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
154026181|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026182|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026183|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154026184|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154026185|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026186|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154026187|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154026188|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026189|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
154026190|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
154026191|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026192|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026193|NCT02830139|Capecitabine|capecitabine|mesh-list
154026194|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
154026195|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026196|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154026197|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
154026198|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026199|NCT02833025|Thrombin|thrombin|mesh-list
154026200|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
154026201|NCT02833025|Coagulants|coagulants|mesh-ancestor
154026202|NCT02651610|Paclitaxel|paclitaxel|mesh-list
154026203|NCT02651610|Docetaxel|docetaxel|mesh-list
154026205|NCT02651610|Bavituximab|bavituximab|mesh-list
153645972|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645973|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153645974|NCT00112645|Protective Agents|protective agents|mesh-ancestor
153645975|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153645976|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
153645977|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153645978|NCT00112684|Alvocidib|alvocidib|mesh-list
153645993|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
153645994|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
153645995|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645996|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645997|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645998|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
153645999|NCT00112879|Hormones|hormones|mesh-ancestor
153646000|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646001|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153646002|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646003|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
153646004|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646005|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646006|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
154026206|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154026207|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026208|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
154026209|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
154026210|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
154026211|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026212|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154026213|NCT04208594|Propranolol|propranolol|mesh-list
154026214|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154026215|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154026216|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
154026217|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026218|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026219|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026220|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154026221|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154026222|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
154026223|NCT04733144|Dexamethasone|dexamethasone|mesh-list
154026224|NCT04733144|Prednisolone|prednisolone|mesh-list
154026225|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154026226|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
154026227|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
154026228|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026229|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026230|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154026231|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
154026232|NCT04733144|Hormones|hormones|mesh-ancestor
154026233|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646007|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
153646008|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153646009|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646010|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153646011|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153646012|NCT00112879|Growth Substances|growth substances|mesh-ancestor
153646013|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
153646014|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
153646015|NCT00112879|Protective Agents|protective agents|mesh-ancestor
153646016|NCT00112879|Vitamins|vitamins|mesh-ancestor
153646017|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
153646018|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
153646019|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
153459864|NCT05689151|Abrocitinib|abrocitinib|mesh-list
153646020|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646021|NCT00112996|Protective Agents|protective agents|mesh-ancestor
153646022|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646023|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
154026234|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154026235|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026236|NCT04724720|Famotidine|famotidine|mesh-list
154026237|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154026238|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154026239|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154026240|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
154026241|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
154026242|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026243|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026244|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026245|NCT02833103|Pinaverium|pinaverium|mesh-list
154026246|NCT02833103|Bromides|bromides|mesh-list
154026247|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
154026248|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154026249|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026250|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026251|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154026252|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026253|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
154026254|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
153598303|NCT05855018|Mydriatics|mydriatics|mesh-ancestor
153646024|NCT00112996|Vitamins|vitamins|mesh-ancestor
153646025|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
153646026|NCT00113074|Nicotine|nicotine|mesh-list
153646027|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153646028|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
153646029|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646030|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646031|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153646032|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153646033|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
153646034|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646035|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646036|NCT00113113|Rubitecan|rubitecan|mesh-list
153646037|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646038|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153646039|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153646040|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646041|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646063|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646064|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
153646065|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
153646066|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646067|NCT00113347|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153646068|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153646070|NCT00113503|Azathioprine|azathioprine|mesh-list
153646071|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
153646072|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646073|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646074|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646075|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154026255|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026256|NCT02648490|Acetaminophen|acetaminophen|mesh-list
154026257|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
154026258|NCT02648490|Promethazine|promethazine|mesh-list
154026259|NCT02648490|Dexamethasone|dexamethasone|mesh-list
154026260|NCT02648490|Ondansetron|ondansetron|mesh-list
154026261|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154026262|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
154026263|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
154026264|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026265|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026266|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154026267|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
154026268|NCT02648490|Hormones|hormones|mesh-ancestor
154026269|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154026270|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154026271|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026272|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154026273|NCT02648490|Analgesics|analgesics|mesh-ancestor
154026274|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
154026275|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
154026276|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
154026277|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
154026278|NCT02648490|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154026279|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154026280|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
154026281|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026282|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026283|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154026284|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154026285|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026286|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154026287|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
154026288|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153646076|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
153646077|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646078|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646079|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153646080|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
153646081|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
153646082|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646083|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026289|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
154026290|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
154026291|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154026293|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154026294|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154026295|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026296|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026297|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026298|NCT02648412|Ketamine|ketamine|mesh-list
154026299|NCT02648412|Analgesics|analgesics|mesh-ancestor
154026300|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
154026301|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026302|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026303|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154026304|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153591595|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026305|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
154026306|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
154026307|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026308|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154026309|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154026310|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026311|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026312|NCT00650520|Bromocriptine|bromocriptine|mesh-list
154026313|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154026314|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154026315|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
154026316|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154026317|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026318|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
154026319|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
154026320|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026322|NCT00621218|Tretinoin|tretinoin|mesh-list
154026331|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
154026332|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154026333|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
154026334|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154026335|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
154026336|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026337|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026338|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
154026340|NCT00651300|Valdecoxib|valdecoxib|mesh-list
154026341|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154026342|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154026343|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026344|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026345|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154026346|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154026347|NCT00651300|Analgesics|analgesics|mesh-ancestor
154026348|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
154026349|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026350|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026351|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154026352|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154026353|NCT02828033|Rilonacept|rilonacept|mesh-list
154026354|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154026355|NCT00621998|Olanzapine|olanzapine|mesh-list
154026356|NCT00621998|Risperidone|risperidone|mesh-list
154026357|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154026358|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
153646084|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153646085|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153646086|NCT00113542|Growth Substances|growth substances|mesh-ancestor
153646087|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646088|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
153646089|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646090|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153646091|NCT00007826|Vaccines|vaccines|mesh-list
153646092|NCT00007826|Antibodies|antibodies|mesh-list
153646093|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153646094|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
153646095|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
153646096|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
153646097|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646122|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646124|NCT00113737|Fluoxetine|fluoxetine|mesh-list
153646125|NCT00113737|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153646126|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153646127|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153646128|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598427|NCT05755737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153598428|NCT05755737|Serotonin Agents|serotonin agents|mesh-ancestor
153598429|NCT05755737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598430|NCT05755737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598431|NCT05736952|Topotecan|topotecan|mesh-list
153598432|NCT05736952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153598433|NCT05736952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153598434|NCT05736952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598435|NCT05736952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598436|NCT05736952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598437|NCT05732506|Edoxaban|edoxaban|mesh-list
153598438|NCT05732506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153598439|NCT05732506|Antithrombins|antithrombins|mesh-ancestor
154026359|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026360|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026361|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026362|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154026363|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153569011|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
154026364|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026365|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026366|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154026367|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
154026368|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
154026369|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
154026392|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154026393|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026394|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154026395|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154026396|NCT00891527|Growth Substances|growth substances|mesh-ancestor
154026397|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026398|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
154026399|NCT00891527|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154026400|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154026401|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026402|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026403|NCT03861078|Nicotine|nicotine|mesh-list
154026404|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154026405|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
154026406|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026407|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680306|NCT00215722|Cetuximab|cetuximab|mesh-list
154026409|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154026410|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
154026411|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026412|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026413|NCT02829359|Entecavir|entecavir|mesh-list
154026414|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
154026415|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026416|NCT02650752|Capecitabine|capecitabine|mesh-list
154026417|NCT02650752|Lapatinib|lapatinib|mesh-list
154026418|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154026438|NCT02832713|Protective Agents|protective agents|mesh-ancestor
154026439|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154026440|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026441|NCT02832635|Temozolomide|temozolomide|mesh-list
154026442|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154026443|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
154026444|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026445|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026447|NCT00650598|Valdecoxib|valdecoxib|mesh-list
154026448|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154026449|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154026450|NCT00650598|Analgesics|analgesics|mesh-ancestor
154026451|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
154026452|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026453|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026454|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154026455|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154026456|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154026457|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026458|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026459|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154026460|NCT00620204|Atorvastatin|atorvastatin|mesh-list
154026461|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154026462|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154026463|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
154026464|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026465|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154026466|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154026483|NCT06096480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026484|NCT06096480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154026485|NCT06096480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154026486|NCT06096480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026487|NCT06096480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026488|NCT06096480|Antimanic Agents|antimanic agents|mesh-ancestor
154026489|NCT06096454|Metformin|metformin|mesh-list
154026490|NCT06096454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026491|NCT06096454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026492|NCT06096259|Metformin|metformin|mesh-list
154026493|NCT06096259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026494|NCT06096259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026495|NCT06096220|Fluorouracil|fluorouracil|mesh-list
154026496|NCT06096220|Antimetabolites|antimetabolites|mesh-ancestor
154026497|NCT06096220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026498|NCT06096220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154026499|NCT06096220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026500|NCT06096220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154026501|NCT06096220|Immunologic Factors|immunologic factors|mesh-ancestor
154026502|NCT06096220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026503|NCT06096194|Vitamin D|vitamin d|mesh-list
154026504|NCT06096194|Vitamins|vitamins|mesh-ancestor
154026505|NCT06096194|Micronutrients|micronutrients|mesh-ancestor
154026506|NCT06096194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026507|NCT06096194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154026508|NCT06096181|Dexmedetomidine|dexmedetomidine|mesh-list
154026509|NCT06096181|Remifentanil|remifentanil|mesh-list
154026510|NCT06096181|Propofol|propofol|mesh-list
154026512|NCT06096181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026513|NCT06096181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026514|NCT06096181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154026515|NCT06096181|Analgesics|analgesics|mesh-ancestor
154026516|NCT06096181|Sensory System Agents|sensory system agents|mesh-ancestor
154026517|NCT06096181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026524|NCT06096181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154026525|NCT06096181|Anesthetics, General|anesthetics, general|mesh-ancestor
154026526|NCT06096181|Anesthetics|anesthetics|mesh-ancestor
154026527|NCT06096181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154026528|NCT06096181|Narcotics|narcotics|mesh-ancestor
154026529|NCT06096012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154026530|NCT06096012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026531|NCT06095791|Immunologic Factors|immunologic factors|mesh-list
154026532|NCT06095791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154026533|NCT06095791|Immunomodulating Agents|immunomodulating agents|mesh-list
154026534|NCT06095791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026535|NCT06095674|Antibodies|antibodies|mesh-list
154026536|NCT06095674|Immunoglobulins|immunoglobulins|mesh-list
154026537|NCT06095674|Immunologic Factors|immunologic factors|mesh-ancestor
154026538|NCT06095674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026539|NCT06095635|Resveratrol|resveratrol|mesh-list
154026540|NCT06095635|Antioxidants|antioxidants|mesh-ancestor
154026541|NCT06095635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026542|NCT06095635|Protective Agents|protective agents|mesh-ancestor
154026543|NCT06095635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026544|NCT06095635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026545|NCT06095635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154026546|NCT06095622|Fenugreek seed meal|fenugreek seed meal|mesh-list
154026547|NCT06095622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026548|NCT06095622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026549|NCT06095518|Thrombin|thrombin|mesh-list
154026550|NCT06095518|Hemostatics|hemostatics|mesh-ancestor
154026551|NCT06095518|Coagulants|coagulants|mesh-ancestor
154026552|NCT06095453|Narcotics|narcotics|mesh-list
154026553|NCT06095453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153646129|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646130|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
153646131|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646132|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153646133|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
153646134|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153646135|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153646136|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153646137|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646138|NCT03272295|Fenugreek seed meal|fenugreek seed meal|mesh-list
153646139|NCT03272295|Menthol|menthol|mesh-list
153646140|NCT03272295|Sorbitol|sorbitol|mesh-list
153646141|NCT03272295|Glycerol|glycerol|mesh-list
153646142|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
153646143|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
153646144|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153646145|NCT03272295|Protective Agents|protective agents|mesh-ancestor
153646146|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026554|NCT06095453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026555|NCT06095453|Analgesics|analgesics|mesh-ancestor
154026556|NCT06095453|Sensory System Agents|sensory system agents|mesh-ancestor
154026557|NCT06095453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026559|NCT06095427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154026560|NCT06095427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026562|NCT06095362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154026563|NCT06095362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026564|NCT06095362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154026565|NCT06095362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154026566|NCT06095362|Growth Substances|growth substances|mesh-ancestor
154026567|NCT06095362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026568|NCT06095362|Growth Inhibitors|growth inhibitors|mesh-ancestor
154026569|NCT06095167|Cisplatin|cisplatin|mesh-list
154026570|NCT06095167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026571|NCT06094946|Fentanyl|fentanyl|mesh-list
154026572|NCT06094946|Ropivacaine|ropivacaine|mesh-list
154026573|NCT06094946|Anesthetics, Local|anesthetics, local|mesh-ancestor
153598622|NCT05184842|Decitabine|decitabine|mesh-list
153646160|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
153646161|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646162|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646163|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
153646164|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646165|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646166|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153646167|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
153646168|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153646169|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153646170|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153646171|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153646172|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646173|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153646174|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153646175|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
153646176|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646177|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153646178|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153646179|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153646180|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153646182|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
153646183|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153646184|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646185|NCT00113854|Mannitol|mannitol|mesh-list
153646186|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153646187|NCT00113854|Diuretics|diuretics|mesh-ancestor
153646188|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
153646189|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646190|NCT00007943|Gemcitabine|gemcitabine|mesh-list
153646191|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646192|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
153646193|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646194|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646195|NCT00113971|Epratuzumab|epratuzumab|mesh-list
154026574|NCT06094946|Anesthetics|anesthetics|mesh-ancestor
154026575|NCT06094946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026576|NCT06094946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026577|NCT06094946|Sensory System Agents|sensory system agents|mesh-ancestor
154026578|NCT06094946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026579|NCT06094946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154026580|NCT06094946|Narcotics|narcotics|mesh-ancestor
154026581|NCT06094946|Analgesics|analgesics|mesh-ancestor
154026582|NCT06094946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154026583|NCT06094946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154026584|NCT06094946|Anesthetics, General|anesthetics, general|mesh-ancestor
154026585|NCT06094920|Empagliflozin|empagliflozin|mesh-list
154026586|NCT06094920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154026587|NCT06094920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026588|NCT06094920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026589|NCT06094920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026590|NCT06094907|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154026592|NCT06094907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026593|NCT06094907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026594|NCT06094907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154026595|NCT06094907|Serotonin Agents|serotonin agents|mesh-ancestor
154026596|NCT06094907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026597|NCT06094907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026598|NCT06094907|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154026599|NCT06094868|Capecitabine|capecitabine|mesh-list
154026600|NCT06094868|Oxaliplatin|oxaliplatin|mesh-list
154026601|NCT06094868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154026602|NCT06094868|Antimetabolites|antimetabolites|mesh-ancestor
154026603|NCT06094868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026604|NCT06094868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026605|NCT06094790|Cortisone|cortisone|mesh-list
154026606|NCT06094790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153646196|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646197|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646198|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153646199|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153646200|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
153646201|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646202|NCT00114010|Antacids|antacids|mesh-ancestor
153646203|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646204|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154026607|NCT06094738|Cortisone|cortisone|mesh-list
154026608|NCT06094738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154026609|NCT06094478|Methamphetamine|methamphetamine|mesh-list
154026610|NCT06094478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154026611|NCT06094478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026612|NCT06094478|Sympathomimetics|sympathomimetics|mesh-ancestor
154026613|NCT06094478|Autonomic Agents|autonomic agents|mesh-ancestor
154026614|NCT06094478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026615|NCT06094478|Dopamine Agents|dopamine agents|mesh-ancestor
154026616|NCT06094478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026617|NCT06094478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026618|NCT06094478|Adrenergic Agents|adrenergic agents|mesh-ancestor
154026619|NCT06094478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154026620|NCT06094478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154026621|NCT06094478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026622|NCT06094478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154026623|NCT06094309|Botulinum Toxins|botulinum toxins|mesh-list
154026624|NCT06094309|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154026625|NCT06094309|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154026626|NCT06094309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154026627|NCT06094309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026628|NCT06094309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026629|NCT06094309|Cholinergic Agents|cholinergic agents|mesh-ancestor
154026630|NCT06094309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026631|NCT06094309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598672|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
153646205|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
153646206|NCT00007982|Thiotepa|thiotepa|mesh-list
153646207|NCT00007982|Carmustine|carmustine|mesh-list
153646208|NCT00007982|Etoposide|etoposide|mesh-list
153646209|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646210|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
153646211|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646229|NCT00114283|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153646230|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153646231|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646232|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646233|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646235|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153646236|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
153646237|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646238|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
153646239|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646240|NCT00114400|Vitamins|vitamins|mesh-list
153646241|NCT00114400|Folic Acid|folic acid|mesh-list
153646242|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
153646243|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
153646244|NCT00114400|Pyridoxal|pyridoxal|mesh-list
154026632|NCT06094309|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154026633|NCT06094309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026634|NCT06094244|Atorvastatin|atorvastatin|mesh-list
154026635|NCT06094244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154026636|NCT06094244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154026637|NCT06094244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154026638|NCT06094244|Antimetabolites|antimetabolites|mesh-ancestor
154026639|NCT06094244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026640|NCT06094244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154026641|NCT06094244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154026642|NCT06094244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026643|NCT06094231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154026644|NCT06094231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026645|NCT06094231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026646|NCT06094231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026648|NCT06094140|Fluorouracil|fluorouracil|mesh-list
154026649|NCT06094140|Oxaliplatin|oxaliplatin|mesh-list
154026650|NCT06094140|Irinotecan|irinotecan|mesh-list
154026651|NCT06094140|Durvalumab|durvalumab|mesh-list
154026652|NCT06094140|Calcium|calcium|mesh-list
154026653|NCT06094140|Levoleucovorin|levoleucovorin|mesh-list
154026654|NCT06094140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154026655|NCT06094140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026656|NCT06094140|Antimetabolites|antimetabolites|mesh-ancestor
154026657|NCT06094140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598697|NCT04916613|Androgens|androgens|mesh-list
153646245|NCT00114400|Pyridoxine|pyridoxine|mesh-list
153646246|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
153646247|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
153646248|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646249|NCT00114400|Hematinics|hematinics|mesh-ancestor
153646250|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
153646251|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
153646252|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153646253|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646254|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646255|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
153646256|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153646257|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153646258|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646259|NCT00114478|Epinephrine|epinephrine|mesh-list
153646260|NCT00114478|Albuterol|albuterol|mesh-list
153646261|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153646262|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153646263|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
153646264|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646265|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646266|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026658|NCT06094140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153569327|NCT03648905|Dopamine|dopamine|mesh-list
154026659|NCT06094140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026660|NCT06094140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154026661|NCT06094140|Immunologic Factors|immunologic factors|mesh-ancestor
154026662|NCT06094140|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154026663|NCT06094140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154026664|NCT06094140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026665|NCT06094140|Antidotes|antidotes|mesh-ancestor
154026666|NCT06094140|Protective Agents|protective agents|mesh-ancestor
154026667|NCT06094140|Vitamin B Complex|vitamin b complex|mesh-ancestor
154026668|NCT06094140|Vitamins|vitamins|mesh-ancestor
154026669|NCT06094140|Micronutrients|micronutrients|mesh-ancestor
154026670|NCT06094140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154026671|NCT06093971|Propofol|propofol|mesh-list
154026672|NCT06093971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154026673|NCT06093971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026674|NCT06093971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026675|NCT06093971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154026676|NCT06093971|Anesthetics, General|anesthetics, general|mesh-ancestor
154026677|NCT06093971|Anesthetics|anesthetics|mesh-ancestor
154026678|NCT06091735|Interferons|interferons|mesh-list
154026679|NCT06091735|Interferon-alpha|interferon-alpha|mesh-list
154026680|NCT06091735|Magnesium Sulfate|magnesium sulfate|mesh-list
154026681|NCT06091735|Linaclotide|linaclotide|mesh-list
154026682|NCT06091735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154026683|NCT06091735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026684|NCT06091735|Antiviral Agents|antiviral agents|mesh-ancestor
154026685|NCT06091735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026686|NCT06091735|Immunologic Factors|immunologic factors|mesh-ancestor
154026687|NCT06091735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026688|NCT06091735|Analgesics|analgesics|mesh-ancestor
154026689|NCT06091735|Sensory System Agents|sensory system agents|mesh-ancestor
154026690|NCT06091735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026691|NCT06091735|Anesthetics|anesthetics|mesh-ancestor
153646267|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153646268|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153646269|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
153646283|NCT00008021|Paclitaxel|paclitaxel|mesh-list
153909922|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153646284|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153646286|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
153646287|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153646288|NCT00008021|Cyclosporins|cyclosporins|mesh-list
153818315|NCT05040126|Linezolid|linezolid|mesh-list
154026692|NCT06091735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026693|NCT06091735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154026694|NCT06091735|Anticonvulsants|anticonvulsants|mesh-ancestor
154026695|NCT06091735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154026696|NCT06091735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026697|NCT06091735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026698|NCT06091735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154026699|NCT06091735|Tocolytic Agents|tocolytic agents|mesh-ancestor
154026700|NCT06091735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154026701|NCT06091735|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154026702|NCT06091735|Enzyme Activators|enzyme activators|mesh-ancestor
154026703|NCT06091735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154026704|NCT06090565|Azithromycin|azithromycin|mesh-list
154026705|NCT06090565|Doxycycline|doxycycline|mesh-list
154026706|NCT06090565|Ceftriaxone|ceftriaxone|mesh-list
154026707|NCT06090565|Cefixime|cefixime|mesh-list
154026708|NCT06090565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154026709|NCT06090565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026710|NCT06090565|Antimalarials|antimalarials|mesh-ancestor
154026711|NCT06090565|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154026712|NCT06090565|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154026713|NCT06090565|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154026714|NCT06090565|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154026715|NCT06087614|Cisplatin|cisplatin|mesh-list
154026716|NCT06087614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026717|NCT06081257|Vitamins|vitamins|mesh-list
154026718|NCT06081257|Vitamin E|vitamin e|mesh-list
154026719|NCT06081257|Tocopherols|tocopherols|mesh-list
154026720|NCT06081257|Tocotrienols|tocotrienols|mesh-list
154026721|NCT06081257|alpha-Tocopherol|alpha-tocopherol|mesh-list
154026722|NCT06081257|Micronutrients|micronutrients|mesh-ancestor
153598757|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598759|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
153646289|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153646290|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646291|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646292|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
153646293|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
153646294|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646295|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
153646296|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646297|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646298|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646299|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
153646300|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026723|NCT06081257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026725|NCT06081257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026726|NCT06081257|Protective Agents|protective agents|mesh-ancestor
154026727|NCT06006598|Midazolam|midazolam|mesh-list
154026728|NCT06006598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154026729|NCT06006598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154026730|NCT06006598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569396|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026731|NCT06006598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026732|NCT06006598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154026733|NCT06006598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154026734|NCT06006598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026735|NCT06006598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154026736|NCT06006598|Anesthetics, General|anesthetics, general|mesh-ancestor
154026737|NCT06006598|Anesthetics|anesthetics|mesh-ancestor
154026738|NCT06006598|GABA Modulators|gaba modulators|mesh-ancestor
154026739|NCT06006598|GABA Agents|gaba agents|mesh-ancestor
154026740|NCT06006598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026741|NCT06006598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026742|NCT05994703|Cycloserine|cycloserine|mesh-list
154026743|NCT05994703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154026744|NCT05994703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026745|NCT05994703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154026746|NCT05994703|Antitubercular Agents|antitubercular agents|mesh-ancestor
154026747|NCT05994703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154026748|NCT05994703|Antimetabolites|antimetabolites|mesh-ancestor
154026749|NCT05994703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026750|NCT05989503|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154026751|NCT05989503|Valsartan|valsartan|mesh-list
154026753|NCT05989503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154026763|NCT05972018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026764|NCT05972018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026765|NCT05972018|Sensory System Agents|sensory system agents|mesh-ancestor
154026766|NCT05972018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026767|NCT05952882|Metformin|metformin|mesh-list
154026768|NCT05952882|Liraglutide|liraglutide|mesh-list
154026769|NCT05952882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026770|NCT05952882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026771|NCT05952882|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154026772|NCT05952882|Incretins|incretins|mesh-ancestor
154026773|NCT05952882|Hormones|hormones|mesh-ancestor
154026774|NCT05952882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154026775|NCT05927649|Moxifloxacin|moxifloxacin|mesh-list
154026776|NCT05927649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154026777|NCT05927649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026778|NCT05927649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154026779|NCT05927649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154026780|NCT05927649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026781|NCT05927649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026782|NCT05927649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026783|NCT05881265|Venetoclax|venetoclax|mesh-list
154026784|NCT05881265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026785|NCT05879107|Vaccines|vaccines|mesh-list
154026786|NCT05879107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154026788|NCT05879107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646301|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
153646302|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646303|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153646304|NCT03079440|Capecitabine|capecitabine|mesh-list
153646305|NCT03079440|Temozolomide|temozolomide|mesh-list
153646306|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646307|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
153646308|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646309|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646310|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153646311|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
153646312|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153646313|NCT00008060|Leucovorin|leucovorin|mesh-list
153646314|NCT00008060|Fluorouracil|fluorouracil|mesh-list
153646315|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
153646316|NCT00008060|Irinotecan|irinotecan|mesh-list
153646317|NCT00008060|Calcium|calcium|mesh-list
153646318|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
153646319|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153646320|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646321|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
153646322|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646323|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646324|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026789|NCT05808972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154026791|NCT05804123|Ciprofloxacin|ciprofloxacin|mesh-list
154026792|NCT05804123|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154026793|NCT05804123|Cefotaxime|cefotaxime|mesh-list
154026794|NCT05804123|Cefoxitin|cefoxitin|mesh-list
154026795|NCT05804123|Xylometazoline|xylometazoline|mesh-list
154026796|NCT05804123|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154026797|NCT05804123|Antiviral Agents|antiviral agents|mesh-ancestor
154026798|NCT05804123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026799|NCT05804123|Expectorants|expectorants|mesh-ancestor
153818329|NCT04973345|Terbutaline|terbutaline|mesh-list
154026800|NCT05804123|Respiratory System Agents|respiratory system agents|mesh-ancestor
154026801|NCT05804123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154026802|NCT05804123|Antioxidants|antioxidants|mesh-ancestor
154026803|NCT05804123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026804|NCT05804123|Protective Agents|protective agents|mesh-ancestor
154026805|NCT05804123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026806|NCT05804123|Antidotes|antidotes|mesh-ancestor
154026807|NCT05804123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154026808|NCT05804123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154026809|NCT05804123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154026810|NCT05804123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026811|NCT05804123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026812|NCT05804123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153598854|NCT04018313|Omalizumab|omalizumab|mesh-list
153646325|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646326|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
153646327|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153646328|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153646329|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646330|NCT00008060|Antidotes|antidotes|mesh-ancestor
153646331|NCT00008060|Protective Agents|protective agents|mesh-ancestor
153646332|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
153646333|NCT00008060|Vitamins|vitamins|mesh-ancestor
153646346|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646347|NCT00114946|Bevacizumab|bevacizumab|mesh-list
153646348|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646349|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646350|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153646351|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153646352|NCT00114946|Growth Substances|growth substances|mesh-ancestor
153646353|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646354|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
153646355|NCT00115024|Estradiol|estradiol|mesh-list
153646356|NCT00115024|Estrogens|estrogens|mesh-ancestor
153646357|NCT00115024|Hormones|hormones|mesh-ancestor
153646358|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646359|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646361|NCT00008177|Cyclosporine|cyclosporine|mesh-list
153646362|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
153646363|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153646364|NCT00008177|Fludarabine|fludarabine|mesh-list
153646365|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
154026813|NCT05804123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154026814|NCT05804123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154026815|NCT05804123|Nasal Decongestants|nasal decongestants|mesh-ancestor
154026816|NCT05804123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154026817|NCT05735834|Rituximab|rituximab|mesh-list
154026818|NCT05735834|Zanubrutinib|zanubrutinib|mesh-list
154026819|NCT05735834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154026820|NCT05735834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026821|NCT05735834|Immunologic Factors|immunologic factors|mesh-ancestor
154026822|NCT05735834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026823|NCT05735834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154026824|NCT05735834|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154026825|NCT05735834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154026826|NCT05735834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026827|NCT05735834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026828|NCT05733403|Norepinephrine|norepinephrine|mesh-list
154026829|NCT05733403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154026830|NCT05733403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154026831|NCT05733403|Adrenergic Agents|adrenergic agents|mesh-ancestor
154026832|NCT05733403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026833|NCT05733403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026834|NCT05733403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026835|NCT05733403|Sympathomimetics|sympathomimetics|mesh-ancestor
154026836|NCT05733403|Autonomic Agents|autonomic agents|mesh-ancestor
154026837|NCT05733403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026838|NCT05733403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154026839|NCT05657873|Immunomodulating Agents|immunomodulating agents|mesh-list
154026840|NCT05657873|Immunologic Factors|immunologic factors|mesh-ancestor
154026841|NCT05657873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026842|NCT05647551|Lidocaine|lidocaine|mesh-list
154182214|NCT05749393|Calcium heparin|calcium heparin|mesh-list
153646366|NCT00008177|Antibodies|antibodies|mesh-list
153646367|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
153646368|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153646369|NCT00008177|Cyclosporins|cyclosporins|mesh-list
153646370|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
153646371|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646372|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646373|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646375|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646376|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646377|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646378|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
154026844|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
154026846|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026847|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026848|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
154026849|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026850|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154026851|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154026852|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154026853|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026854|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026855|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154026856|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154026857|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
154026858|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026859|NCT05625802|Ropivacaine|ropivacaine|mesh-list
154026860|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
154026861|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
154026862|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026863|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026864|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
154026865|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026866|NCT05593731|Melatonin|melatonin|mesh-list
153646379|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646380|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
153646381|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646382|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153646383|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153646384|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153646385|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
153646386|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153646387|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153646388|NCT00008177|Trace Elements|trace elements|mesh-ancestor
153646389|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
153646390|NCT03007407|Durvalumab|durvalumab|mesh-list
153646391|NCT03007407|Tremelimumab|tremelimumab|mesh-list
153646392|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646393|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646394|NCT00115102|Fentanyl|fentanyl|mesh-list
153646395|NCT00115102|Ketamine|ketamine|mesh-list
153646396|NCT00115102|Esketamine|esketamine|mesh-list
153646397|NCT00115102|Analgesics|analgesics|mesh-ancestor
153646398|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
153646399|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646400|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646411|NCT00115102|Narcotics|narcotics|mesh-ancestor
153646412|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153646413|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
153646414|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154026867|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
154026868|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026869|NCT05593731|Protective Agents|protective agents|mesh-ancestor
154026870|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026871|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026872|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154026873|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
154026874|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154026875|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026876|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026877|NCT05556798|Pomalidomide|pomalidomide|mesh-list
154026878|NCT05556798|Nirogacestat|nirogacestat|mesh-list
154026879|NCT05556798|Immunologic Factors|immunologic factors|mesh-ancestor
154026880|NCT05556798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026881|NCT05556798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154026882|NCT05556798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154026883|NCT05556798|Growth Substances|growth substances|mesh-ancestor
153569544|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154026884|NCT05556798|Growth Inhibitors|growth inhibitors|mesh-ancestor
154026885|NCT05556798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026886|NCT05556798|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154026887|NCT05556798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026888|NCT05556798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026889|NCT05546710|Anesthetics|anesthetics|mesh-list
154026890|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154026891|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026892|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
154026893|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154026894|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154026895|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026896|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026897|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026898|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154026899|NCT05443932|Diuretics|diuretics|mesh-ancestor
154026900|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
153646415|NCT00115141|Resiquimod|resiquimod|mesh-list
153646416|NCT00115141|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154026901|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154026902|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154026903|NCT05429502|Temozolomide|temozolomide|mesh-list
154026904|NCT05429502|Topotecan|topotecan|mesh-list
154026905|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154026906|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
154026907|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026908|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026909|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154026910|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154026911|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026912|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
154026913|NCT05426434|Piperaquine|piperaquine|mesh-list
154026914|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
154026915|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154026916|NCT05426434|Artenimol|artenimol|mesh-list
154026917|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
154026918|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154026919|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154026920|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154026921|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154026922|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026923|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026924|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154026925|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
154026926|NCT05413915|Asciminib|asciminib|mesh-list
154026927|NCT05413915|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154026928|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154026929|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026930|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026931|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026932|NCT05412004|Tirzepatide|tirzepatide|mesh-list
154026933|NCT05412004|Incretins|incretins|mesh-ancestor
154026934|NCT05412004|Hormones|hormones|mesh-ancestor
154026935|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646417|NCT00115141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646418|NCT00115141|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153646419|NCT00115141|Immunologic Factors|immunologic factors|mesh-ancestor
153646420|NCT00115141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026936|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026937|NCT05377333|Dulaglutide|dulaglutide|mesh-list
154026938|NCT05377333|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154026939|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154026940|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026941|NCT05366816|Sunitinib|sunitinib|mesh-list
154026942|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154026943|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154026944|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154026945|NCT05366816|Growth Substances|growth substances|mesh-ancestor
154026946|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026947|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
154026948|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154026949|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154026950|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026951|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
154026952|NCT05364762|Tacrolimus|tacrolimus|mesh-list
154026953|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154026954|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
154026955|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026956|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154026964|NCT05287256|Dronabinol|dronabinol|mesh-list
154026987|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154026988|NCT05204667|Analgesics|analgesics|mesh-ancestor
154026989|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
154026990|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154026991|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154026992|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
154026993|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154026994|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154026995|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154026996|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154026997|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154026998|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154026999|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154027000|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154027001|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027002|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154027003|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154027004|NCT05163561|Vaccines|vaccines|mesh-list
154027005|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
154027006|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027007|NCT05142696|Carboplatin|carboplatin|mesh-list
154027008|NCT05142696|Etoposide|etoposide|mesh-list
154027009|NCT05142696|Tislelizumab|tislelizumab|mesh-list
154027010|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154027011|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154027036|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
154027037|NCT04950465|Protective Agents|protective agents|mesh-ancestor
154027038|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027040|NCT04907825|Anticoagulants|anticoagulants|mesh-list
154027041|NCT04889547|Dexamethasone|dexamethasone|mesh-list
154027042|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
154027043|NCT04889547|BB 1101|bb 1101|mesh-list
154027044|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027045|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
154027104|NCT04887194|Analgesics|analgesics|mesh-ancestor
153569769|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
154027105|NCT04887194|Sensory System Agents|sensory system agents|mesh-ancestor
154027106|NCT04887194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027107|NCT04857320|Insulin|insulin|mesh-list
154027108|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154027109|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154027110|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027111|NCT04807894|Testosterone|testosterone|mesh-list
154027112|NCT04807894|Androgens|androgens|mesh-ancestor
154027113|NCT04807894|Hormones|hormones|mesh-ancestor
154027114|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027115|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027116|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154027117|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
154027163|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818370|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
154027164|NCT04344795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154027165|NCT04344795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027166|NCT04308785|Atezolizumab|atezolizumab|mesh-list
154027167|NCT04308785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154027168|NCT04308785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027169|NCT04308785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027170|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027171|NCT04277858|Cisplatin|cisplatin|mesh-list
154027172|NCT04277858|Docetaxel|docetaxel|mesh-list
154027173|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027174|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
154027227|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
154027228|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
154027229|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
154027230|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027231|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027232|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154027233|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154027234|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
154027291|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027292|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027293|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154027294|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027295|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027296|NCT03777319|Prednisolone|prednisolone|mesh-list
154027297|NCT03777319|Spironolactone|spironolactone|mesh-list
154027298|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027299|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
154027301|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027302|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027303|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154027304|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027305|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154027306|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
154027308|NCT03777319|Diuretics|diuretics|mesh-ancestor
154027309|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
154027325|NCT03532295|Bevacizumab|bevacizumab|mesh-list
154027330|NCT03532295|Growth Substances|growth substances|mesh-ancestor
154027344|NCT03434379|Bevacizumab|bevacizumab|mesh-list
154027345|NCT03434379|Atezolizumab|atezolizumab|mesh-list
154027346|NCT03434379|Sorafenib|sorafenib|mesh-list
154027347|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027348|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027349|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154027350|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154027351|NCT03434379|Growth Substances|growth substances|mesh-ancestor
154027352|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027353|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
154027354|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154027355|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027356|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027357|NCT03434379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154027358|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154027359|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027360|NCT03228186|Docetaxel|docetaxel|mesh-list
154027361|NCT03228186|Pevonedistat|pevonedistat|mesh-list
154027368|NCT03139916|Temozolomide|temozolomide|mesh-list
154176631|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176632|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176633|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154176634|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154176635|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
154176636|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176637|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176638|NCT03998982|Dexamethasone|dexamethasone|mesh-list
154176639|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
154176640|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176641|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
154176642|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
154176643|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176644|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176645|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176646|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
154176647|NCT03998982|Hormones|hormones|mesh-ancestor
153592287|NCT01825850|Irbesartan|irbesartan|mesh-list
154176648|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154176649|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154176650|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176651|NCT00620321|Cytarabine|cytarabine|mesh-list
154176652|NCT00620321|Idarubicin|idarubicin|mesh-list
154176653|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154176654|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
154176655|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176656|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176657|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
154176658|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176659|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176660|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
153646421|NCT00115219|Etanercept|etanercept|mesh-list
153646422|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153646423|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153646424|NCT00115219|Analgesics|analgesics|mesh-ancestor
153646425|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
153646426|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646427|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646428|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153646429|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646430|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153646431|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646432|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
153646433|NCT00115375|Clopidogrel|clopidogrel|mesh-list
153646434|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153646435|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154176661|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176662|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154176663|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154176664|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154176665|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176666|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
154176667|NCT00621023|Decitabine|decitabine|mesh-list
154176668|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
154176669|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154176670|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
154176671|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176672|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176673|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176674|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
154176675|NCT00621023|Protective Agents|protective agents|mesh-ancestor
154176676|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176677|NCT00621023|Vitamins|vitamins|mesh-ancestor
154176678|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
154176679|NCT00848861|Midazolam|midazolam|mesh-list
154176680|NCT00848861|Meperidine|meperidine|mesh-list
154176681|NCT00848861|Propofol|propofol|mesh-list
154176682|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154176683|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154176684|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176685|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153923702|NCT00925600|Denosumab|denosumab|mesh-list
154176686|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
154176687|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
154176688|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154176689|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154176690|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154176692|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
154176708|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154176709|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154176710|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176711|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154176712|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176713|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176714|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154176715|NCT00528372|Metformin|metformin|mesh-list
154176716|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
154176717|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154176718|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176721|NCT01564680|Acetaminophen|acetaminophen|mesh-list
154176769|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154176770|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154176771|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154176772|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176773|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176774|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176775|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
154176776|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154176777|NCT00848939|Treprostinil|treprostinil|mesh-list
154176833|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154176834|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154176835|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154176836|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
154176837|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176838|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176840|NCT00849329|Esomeprazole|esomeprazole|mesh-list
154176841|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154176842|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176843|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154176844|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176845|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176846|NCT00849329|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154176847|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154176849|NCT00852683|Pregabalin|pregabalin|mesh-list
154176893|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
154176894|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154176895|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176896|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154176897|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
154176898|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176899|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176900|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154176901|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
154176902|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
154176903|NCT02546297|Hormones|hormones|mesh-ancestor
154176904|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154176905|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154176906|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154176907|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154176908|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
154176909|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154176910|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176911|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
154176912|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154176913|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
154176914|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
154176916|NCT00618995|Niacinamide|niacinamide|mesh-list
154176917|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
154176918|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154176919|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
154176920|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176921|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154176922|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
154176923|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
154176924|NCT00618995|Vitamins|vitamins|mesh-ancestor
154176925|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
154176926|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176927|NCT03685344|Durvalumab|durvalumab|mesh-list
154176928|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154176929|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153646436|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154176930|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154176931|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176932|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
154176933|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176934|NCT00856271|Losartan|losartan|mesh-list
154176935|NCT00856271|Olmesartan|olmesartan|mesh-list
154176936|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154176937|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154176938|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154176939|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154176940|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154176941|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176942|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
154176943|NCT00856505|Everolimus|everolimus|mesh-list
154176944|NCT00856505|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154176945|NCT00856505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154176946|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154176947|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154176948|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176949|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
154176950|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176951|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154176952|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154176953|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154176954|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
154176955|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154176956|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154176957|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
154176975|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154176976|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154176977|NCT00520572|Analgesics|analgesics|mesh-ancestor
154176978|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
154176979|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154176980|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154176981|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154176982|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154176983|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154176984|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154176985|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
154176986|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
154177038|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154177039|NCT03998826|Analgesics|analgesics|mesh-ancestor
154177040|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
154177041|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177042|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177043|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154177044|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154177045|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154177046|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177047|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177048|NCT00853931|Panitumumab|panitumumab|mesh-list
154177049|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154177050|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177051|NCT00854009|BLI-489|bli-489|mesh-list
154177052|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154177057|NCT03998592|Vaccines|vaccines|mesh-list
154177096|NCT00857753|Fentanyl|fentanyl|mesh-list
154177097|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154177098|NCT00857753|Narcotics|narcotics|mesh-ancestor
154177099|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154177100|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177101|NCT00857753|Analgesics|analgesics|mesh-ancestor
154177102|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
154177103|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177104|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154177105|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154177106|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
154177107|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
154177108|NCT00854321|Rituximab|rituximab|mesh-list
154177109|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154177110|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177111|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
154177112|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177113|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154177114|NCT03684642|Metformin|metformin|mesh-list
154177115|NCT03684642|Dulaglutide|dulaglutide|mesh-list
154177116|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
154177117|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154177118|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177119|NCT03684642|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154177120|NCT00857831|Vitamin D|vitamin d|mesh-list
154177121|NCT00857831|Calcium|calcium|mesh-list
154177122|NCT00857831|Vitamins|vitamins|mesh-ancestor
154177123|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
154177124|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177127|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
154177144|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154177145|NCT00857909|Amiloride|amiloride|mesh-list
154177146|NCT00857909|Spironolactone|spironolactone|mesh-list
154177147|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154177148|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
154177149|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177150|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177151|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154177152|NCT00857909|Diuretics|diuretics|mesh-ancestor
154177153|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
154177154|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154177155|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154177156|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177157|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177158|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154177159|NCT00857987|Expectorants|expectorants|mesh-list
154177160|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
154177161|NCT00854477|Capecitabine|capecitabine|mesh-list
154177162|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154177163|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
154177164|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177165|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177166|NCT00854633|Lactoferrin|lactoferrin|mesh-list
154177167|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
154177168|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177191|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
154177192|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177193|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
154177194|NCT00526890|Protective Agents|protective agents|mesh-ancestor
154177195|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177196|NCT00526890|Trace Elements|trace elements|mesh-ancestor
154177197|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
154177198|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
154177199|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
154177200|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177201|NCT04041167|Protective Agents|protective agents|mesh-ancestor
154177202|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177203|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
154177204|NCT04041167|Vitamins|vitamins|mesh-ancestor
154177205|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
154177206|NCT00858377|Complement Factor H|complement factor h|mesh-list
154177207|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154177208|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154177209|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
154177210|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177211|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
154177212|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154177213|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
154177214|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177215|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177216|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154177217|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
154177219|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
154177238|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177239|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177241|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177242|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154177243|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154177244|NCT00526656|Growth Substances|growth substances|mesh-ancestor
154177245|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177308|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177309|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177310|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154177311|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
154177312|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154177313|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154177314|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
154177315|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
154177316|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154177317|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154177318|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177319|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
154177320|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
154177321|NCT04523688|Temozolomide|temozolomide|mesh-list
153592481|NCT01827345|Vitamins|vitamins|mesh-ancestor
154177322|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154177323|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
154177324|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177325|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177326|NCT00511836|Naltrexone|naltrexone|mesh-list
154177327|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154177328|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154177329|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177330|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
154177331|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177332|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
154177333|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153600143|NCT01880931|Remifentanil|remifentanil|mesh-list
153646437|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153646438|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
153646439|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646440|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646441|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646442|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
153646443|NCT00115414|Docetaxel|docetaxel|mesh-list
153646444|NCT00115414|Doxorubicin|doxorubicin|mesh-list
153646445|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646446|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
153646447|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646448|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646449|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153646450|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
153646451|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646452|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646453|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153646454|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
154177334|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177335|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177336|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154177337|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177338|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154177340|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154177341|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154177342|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154177343|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177344|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177345|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177346|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177347|NCT00855101|Voriconazole|voriconazole|mesh-list
154177348|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
154177349|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177359|NCT00573755|Sorafenib|sorafenib|mesh-list
154177386|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154177387|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154177388|NCT00524316|Growth Substances|growth substances|mesh-ancestor
154177389|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177390|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
154177391|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154177392|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
154177393|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154177394|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154177395|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154177396|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154177451|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177452|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
154177453|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154177454|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154177455|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154177456|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154177457|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
154177458|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154177519|NCT00617669|Docetaxel|docetaxel|mesh-list
154177520|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154177521|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
154177522|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
154177523|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
154177524|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177525|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
154177526|NCT04018157|Ketamine|ketamine|mesh-list
154177527|NCT04018157|Propofol|propofol|mesh-list
154177528|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154177529|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154177530|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177531|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154177532|NCT04018157|Analgesics|analgesics|mesh-ancestor
154177533|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
154177534|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154177535|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154177536|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154177537|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154177538|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177575|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
154177576|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154177577|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154177578|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177579|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154177580|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154177581|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177582|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177594|NCT00861107|Vaccines|vaccines|mesh-list
154177640|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154177641|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154177642|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154177643|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177644|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177645|NCT00863915|Ramipril|ramipril|mesh-list
154177646|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154177647|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
154177648|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177705|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177707|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
154177708|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154177709|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177710|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177711|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
154177712|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154177713|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154177714|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
154177715|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177716|NCT00617591|Dexamethasone|dexamethasone|mesh-list
154177727|NCT00617591|Hormones|hormones|mesh-ancestor
154177770|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
154177839|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177840|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154177842|NCT00516048|Hormones|hormones|mesh-ancestor
154177843|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154177844|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
154177845|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154177846|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154177847|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592552|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154177848|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177849|NCT00865007|Ritonavir|ritonavir|mesh-list
154177850|NCT00865007|Lopinavir|lopinavir|mesh-list
154177851|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154177852|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154177853|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
154177854|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154177897|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154177898|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
154177899|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177900|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154177901|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154177902|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154177903|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
154177904|NCT00872651|Timolol|timolol|mesh-list
154177905|NCT00872651|Travoprost|travoprost|mesh-list
154177963|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154177964|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
154177965|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154177966|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
154177967|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
154177968|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154177969|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154177970|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154177971|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
154177972|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154177973|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178026|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154178027|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154178028|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154178029|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154178030|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154178031|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
154178032|NCT05225831|Fludarabine|fludarabine|mesh-list
154178033|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154178034|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
154178035|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178036|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178037|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154178038|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
154178039|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178040|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178041|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154178042|NCT00873509|Buspirone|buspirone|mesh-list
154178043|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154178044|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154178049|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
154178079|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178080|NCT00867737|Fluticasone|fluticasone|mesh-list
154178081|NCT00867737|Budesonide|budesonide|mesh-list
154178082|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
154178083|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154178084|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154178085|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154178147|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178148|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178149|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154178150|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154178151|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
154178214|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178215|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178216|NCT00434109|Sunitinib|sunitinib|mesh-list
154178217|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178218|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154178219|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154178220|NCT00434109|Growth Substances|growth substances|mesh-ancestor
154178221|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178222|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
154178223|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154178224|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178225|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178274|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178275|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154178276|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
154178277|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
154178278|NCT00433017|Ranibizumab|ranibizumab|mesh-list
154178279|NCT00433017|Verteporfin|verteporfin|mesh-list
154178280|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154178281|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154178282|NCT00433017|Growth Substances|growth substances|mesh-ancestor
154178283|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178284|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
154178285|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178286|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154178287|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
154178288|NCT03726671|Choline|choline|mesh-list
154178289|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
154178290|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154178291|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
154178292|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178293|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178294|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154178295|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
154178296|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
154178297|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154178325|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154178326|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178327|NCT00875849|Cetuximab|cetuximab|mesh-list
154178328|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178329|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154178330|NCT00875927|Zinc|zinc|mesh-list
154178331|NCT00875927|Propolis|propolis|mesh-list
154178332|NCT00875927|Trace Elements|trace elements|mesh-ancestor
154178333|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
154178334|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178335|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178336|NCT00878657|Gemcitabine|gemcitabine|mesh-list
154178337|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154178338|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
154178339|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178340|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178341|NCT00868829|Chromium|chromium|mesh-list
154178342|NCT00868829|Sirolimus|sirolimus|mesh-list
154178343|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154178344|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178380|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
154178381|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178382|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178383|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154178384|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178385|NCT03994965|Pimavanserin|pimavanserin|mesh-list
154178386|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154178387|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154178388|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154178389|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154178406|NCT00531284|Hormones|hormones|mesh-ancestor
154178444|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154178445|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154178446|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178447|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
154178448|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154178449|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154178450|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154178451|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178452|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178453|NCT01005758|Cytarabine|cytarabine|mesh-list
154178454|NCT01005758|Dexamethasone|dexamethasone|mesh-list
154178508|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154178509|NCT01005758|Protective Agents|protective agents|mesh-ancestor
154178510|NCT01005758|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154178511|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154178513|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154178514|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154178515|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178527|NCT01000220|Omeprazole|omeprazole|mesh-list
154178572|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178573|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154178574|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154178575|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154178576|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154178577|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178578|NCT01000688|Vildagliptin|vildagliptin|mesh-list
154178579|NCT01000688|Acarbose|acarbose|mesh-list
154178580|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154178581|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178582|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154178583|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
154178634|NCT05883345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178635|NCT05883332|Nitrous Oxide|nitrous oxide|mesh-list
154178636|NCT05883332|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154178637|NCT05883332|Anesthetics, General|anesthetics, general|mesh-ancestor
154178638|NCT05883332|Anesthetics|anesthetics|mesh-ancestor
154178639|NCT05883332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178640|NCT05883332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178641|NCT05883332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154178642|NCT05883332|Analgesics|analgesics|mesh-ancestor
154178643|NCT05883332|Sensory System Agents|sensory system agents|mesh-ancestor
154178644|NCT05883332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178696|NCT05881525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178697|NCT05881525|Tubulin Modulators|tubulin modulators|mesh-ancestor
154178698|NCT05881525|Antimitotic Agents|antimitotic agents|mesh-ancestor
154178699|NCT05881525|Mitosis Modulators|mitosis modulators|mesh-ancestor
154178700|NCT05881525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178701|NCT05881525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154178702|NCT05881525|Immunologic Factors|immunologic factors|mesh-ancestor
154178703|NCT05881525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178704|NCT05881525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154178705|NCT05881525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154178706|NCT05881525|Alkylating Agents|alkylating agents|mesh-ancestor
154178707|NCT05881525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154178708|NCT05881187|Riboflavin|riboflavin|mesh-list
154178709|NCT05881187|Antifungal Agents|antifungal agents|mesh-list
154178755|NCT05880693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154178756|NCT05880693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154178757|NCT05880693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154178758|NCT05880693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178759|NCT05880693|Anesthetics|anesthetics|mesh-ancestor
154178827|NCT05879627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178828|NCT05879627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154178829|NCT05879536|Tramadol|tramadol|mesh-list
154178830|NCT05879536|Ondansetron|ondansetron|mesh-list
154178831|NCT05879536|Ropivacaine|ropivacaine|mesh-list
154178832|NCT05879536|Anesthetics, Local|anesthetics, local|mesh-ancestor
154178833|NCT05879536|Anesthetics|anesthetics|mesh-ancestor
154178834|NCT05879536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178835|NCT05879536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178836|NCT05879536|Sensory System Agents|sensory system agents|mesh-ancestor
154178837|NCT05879536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154178838|NCT05879536|Antiemetics|antiemetics|mesh-ancestor
154178839|NCT05879536|Autonomic Agents|autonomic agents|mesh-ancestor
154178840|NCT05879536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154178841|NCT05879536|Antipruritics|antipruritics|mesh-ancestor
154178842|NCT05879536|Dermatologic Agents|dermatologic agents|mesh-ancestor
154178843|NCT05879536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154178844|NCT05879536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154178845|NCT05879536|Serotonin Agents|serotonin agents|mesh-ancestor
154178882|NCT05875506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154178883|NCT05875506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154178884|NCT05875506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154178885|NCT05875506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154178886|NCT05875506|Antimetabolites|antimetabolites|mesh-ancestor
154178887|NCT05875506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178888|NCT05875506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154178889|NCT05875506|Chelating Agents|chelating agents|mesh-ancestor
154178890|NCT05875506|Sequestering Agents|sequestering agents|mesh-ancestor
154178891|NCT05875506|Hemostatics|hemostatics|mesh-ancestor
154178892|NCT05875506|Coagulants|coagulants|mesh-ancestor
154178893|NCT05875350|Anesthetics|anesthetics|mesh-list
154178894|NCT05875350|Anesthetics, Local|anesthetics, local|mesh-list
154178895|NCT05875350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154178946|NCT05846906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154178947|NCT05846906|Vasodilator Agents|vasodilator agents|mesh-ancestor
154178948|NCT05846906|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154178949|NCT05846906|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154178950|NCT05846906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154178951|NCT05846906|Urological Agents|urological agents|mesh-ancestor
154178952|NCT05846906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154178953|NCT05846906|Hormone Antagonists|hormone antagonists|mesh-ancestor
154178954|NCT05846906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154178955|NCT05846906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154178956|NCT05846906|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154179007|NCT05794399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179008|NCT05788510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154179009|NCT05788510|Immunologic Factors|immunologic factors|mesh-ancestor
154179010|NCT05788510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179011|NCT05764395|Pembrolizumab|pembrolizumab|mesh-list
154179013|NCT05764395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179014|NCT05764395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179015|NCT05764395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179016|NCT05764395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179017|NCT05764395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154179070|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179071|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
154179073|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179074|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
154179075|NCT05663242|Anesthetics|anesthetics|mesh-list
154179076|NCT05663242|Propofol|propofol|mesh-list
154179077|NCT05663242|Sevoflurane|sevoflurane|mesh-list
154179078|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179079|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179080|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154179081|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154179082|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
154179083|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154179084|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154179085|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154179086|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
154179087|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154179129|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179131|NCT05608200|Chlorotrianisene|chlorotrianisene|mesh-list
154179132|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179133|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154179134|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179135|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179136|NCT05608200|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154179137|NCT05608200|Estrogens|estrogens|mesh-ancestor
154179138|NCT05608200|Hormones|hormones|mesh-ancestor
154179139|NCT05608200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179140|NCT05608200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179141|NCT05608200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179142|NCT05606692|Propofol|propofol|mesh-list
154179143|NCT05606692|Sevoflurane|sevoflurane|mesh-list
154179144|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154179145|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179146|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179147|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154179148|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
154179182|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179183|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
154179184|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179185|NCT05475613|Immunomodulating Agents|immunomodulating agents|mesh-list
154179186|NCT05475613|Immunologic Factors|immunologic factors|mesh-ancestor
154179187|NCT05475613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179188|NCT05440201|Enoxaparin|enoxaparin|mesh-list
154179189|NCT05440201|Anticoagulants|anticoagulants|mesh-list
154179248|NCT06014606|Dopamine Agents|dopamine agents|mesh-ancestor
154179249|NCT06014606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154179250|NCT06014528|Doxorubicin|doxorubicin|mesh-list
154179251|NCT06014528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154179252|NCT06014528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154179253|NCT06014528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179254|NCT06014528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154179255|NCT06014528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154179256|NCT06014528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179257|NCT06014528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179258|NCT06013956|Levodopa|levodopa|mesh-list
154179259|NCT06013956|Carbidopa|carbidopa|mesh-list
154179312|NCT06013150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154179313|NCT06013150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154179314|NCT06013150|Adrenergic Agents|adrenergic agents|mesh-ancestor
154179315|NCT06013150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179316|NCT06013150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179317|NCT06013150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179318|NCT06013150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154179319|NCT06013150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154179321|NCT06013150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179322|NCT06013150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154179323|NCT06013150|Respiratory System Agents|respiratory system agents|mesh-ancestor
154179324|NCT06013150|Mydriatics|mydriatics|mesh-ancestor
154179325|NCT06013150|Sympathomimetics|sympathomimetics|mesh-ancestor
154179326|NCT06013150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154179327|NCT05997004|Glycopyrrolate|glycopyrrolate|mesh-list
154179328|NCT05997004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154179329|NCT05997004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154179330|NCT05997004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154179331|NCT05997004|Cholinergic Agents|cholinergic agents|mesh-ancestor
154179332|NCT05997004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154179333|NCT05997004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179335|NCT05995301|Ropivacaine|ropivacaine|mesh-list
154179365|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154179366|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154179367|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
154179368|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179369|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179370|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154179371|NCT05631886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179372|NCT05631886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179373|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154179374|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
154179427|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179428|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154179429|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154179430|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
154179431|NCT04974970|Immunomodulating Agents|immunomodulating agents|mesh-list
154179432|NCT04974970|Immunologic Factors|immunologic factors|mesh-ancestor
154179433|NCT04974970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179434|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
154179435|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154179436|NCT04946370|Androgens|androgens|mesh-list
154179437|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179438|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179439|NCT04946370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154179440|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179441|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154179442|NCT04946370|Hormones|hormones|mesh-ancestor
154179443|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179444|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179445|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
154179446|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154179491|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154179492|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179494|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179495|NCT04543942|Ethanol|ethanol|mesh-list
154179496|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154179497|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179498|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154179499|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179500|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154179501|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154179502|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179503|NCT04361708|Leucovorin|leucovorin|mesh-list
154179504|NCT04361708|Docetaxel|docetaxel|mesh-list
154179505|NCT04361708|Fluorouracil|fluorouracil|mesh-list
154179506|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
154179507|NCT04361708|Irinotecan|irinotecan|mesh-list
154179508|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179509|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154179510|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154179511|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154179512|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179513|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
154179514|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154179515|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154179516|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
154179517|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179518|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154179519|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154179521|NCT04361708|Antidotes|antidotes|mesh-ancestor
154179578|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154179579|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154179580|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154179581|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179582|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179583|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154179584|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
154179585|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179586|NCT03861390|Prednisone|prednisone|mesh-list
154179587|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179644|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
154179645|NCT03107182|Famotidine|famotidine|mesh-list
154179646|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154179647|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179648|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
154179714|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154179715|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179717|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179718|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179719|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154179720|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154179721|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
154179722|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154179723|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154179724|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154179725|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179726|NCT02670707|Cytarabine|cytarabine|mesh-list
154179727|NCT02670707|Prednisone|prednisone|mesh-list
154179728|NCT02670707|Vinblastine|vinblastine|mesh-list
154179729|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179773|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179774|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179776|NCT02451982|Nivolumab|nivolumab|mesh-list
154179843|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154179844|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179845|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154179846|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154179847|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179848|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179849|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
154179850|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154179851|NCT05304949|Ranibizumab|ranibizumab|mesh-list
154179908|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179909|NCT05245669|Denosumab|denosumab|mesh-list
154179910|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154179911|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179912|NCT05233332|Vemurafenib|vemurafenib|mesh-list
154179913|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179976|NCT04998786|Dexamethasone|dexamethasone|mesh-list
154179978|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154179979|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
154179980|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
154179981|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154179982|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179983|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154179984|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
154179985|NCT04998786|Hormones|hormones|mesh-ancestor
154179986|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179987|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154179988|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154179989|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
154179990|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154179991|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154179992|NCT04998500|Hormones|hormones|mesh-list
154179993|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154179994|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154179995|NCT04964089|Aflibercept|aflibercept|mesh-list
154179996|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154179997|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154179998|NCT04964089|Growth Substances|growth substances|mesh-ancestor
154179999|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180000|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
154180025|NCT04918147|Famotidine|famotidine|mesh-list
154180026|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180027|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
154180028|NCT04918147|Hormones|hormones|mesh-ancestor
154180029|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180030|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180031|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154180032|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180033|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154180034|NCT04918147|Analgesics|analgesics|mesh-ancestor
154180035|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
154180036|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180037|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
154180038|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
154180039|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
154180040|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154180041|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154180042|NCT04918147|Protective Agents|protective agents|mesh-ancestor
154180043|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154180044|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154180045|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180046|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
154180047|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
154180048|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154180076|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180077|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154180078|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180079|NCT04848792|Sulforaphane|sulforaphane|mesh-list
154180080|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154180081|NCT04848792|Protective Agents|protective agents|mesh-ancestor
154180082|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180083|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180084|NCT04805775|Desflurane|desflurane|mesh-list
154180085|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154180086|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
154180087|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
154180088|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180089|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180090|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
154180091|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154180092|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154180093|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
154180094|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180099|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
154180130|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
154180131|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
154180132|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154180133|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180134|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180135|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
154180136|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154180137|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180138|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180194|NCT04400474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180195|NCT04400474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180196|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180197|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153927213|NCT05177614|Trace Elements|trace elements|mesh-list
154180199|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154180200|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180201|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154180202|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154180203|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
154180204|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180205|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154180206|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154180207|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180208|NCT04305496|Fulvestrant|fulvestrant|mesh-list
154180209|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154180210|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180211|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154180212|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154180213|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
154180214|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180216|NCT04281017|Anesthetics|anesthetics|mesh-list
154180243|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
154180244|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180245|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180246|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
154180247|NCT04019327|Temozolomide|temozolomide|mesh-list
154180248|NCT04019327|Talazoparib|talazoparib|mesh-list
154180249|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154180250|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
154180251|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180252|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180253|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154180254|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180255|NCT03970655|Dexamethasone|dexamethasone|mesh-list
154180256|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
154180262|NCT03970655|BB 1101|bb 1101|mesh-list
154180302|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180303|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180304|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180305|NCT03865290|Ondansetron|ondansetron|mesh-list
154180306|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
154180307|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
154180308|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180309|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180310|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154180366|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180367|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180368|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154180369|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154180370|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154180371|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
154180434|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180436|NCT03306446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154180437|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180438|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180439|NCT03292133|Gefitinib|gefitinib|mesh-list
154180440|NCT03292133|Nazartinib|nazartinib|mesh-list
154180441|NCT03292133|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154180446|NCT03289728|Dobutamine|dobutamine|mesh-list
154180500|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180501|NCT03146962|Protective Agents|protective agents|mesh-ancestor
154180502|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
154180503|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
154180504|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180505|NCT02998268|Paclitaxel|paclitaxel|mesh-list
154180506|NCT02998268|Carboplatin|carboplatin|mesh-list
154180507|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
154180508|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154180509|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180510|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154180511|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154180512|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154180565|NCT02813135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154180566|NCT02813135|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154180567|NCT02813135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180568|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154180569|NCT02732288|Melatonin|melatonin|mesh-list
154180570|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
154180571|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180572|NCT02732288|Protective Agents|protective agents|mesh-ancestor
154180573|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180574|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154180575|NCT02687958|Everolimus|everolimus|mesh-list
154180576|NCT02687958|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154180577|NCT02687958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180578|NCT02687958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180579|NCT02687958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180580|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180581|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
154180582|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180583|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180584|NCT02478710|Vancomycin|vancomycin|mesh-list
154180585|NCT02478710|Tobramycin|tobramycin|mesh-list
154180586|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154180587|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154180588|NCT02476279|Indomethacin|indomethacin|mesh-list
154180589|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154180615|NCT02425852|Hormones|hormones|mesh-ancestor
154180616|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154180617|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180618|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154180619|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180620|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154180621|NCT02425852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154180622|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
154180623|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180682|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154180683|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154180684|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180685|NCT01806571|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154180686|NCT01806571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154180687|NCT01633177|Vitamin D|vitamin d|mesh-list
154180688|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
154180751|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180752|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154180753|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
154180754|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154180755|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154180756|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180757|NCT00224393|Etanercept|etanercept|mesh-list
154180758|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154180759|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154180760|NCT00224393|Analgesics|analgesics|mesh-ancestor
154180761|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
154180762|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180815|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
154180816|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
154180817|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154180818|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
154180819|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154180820|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154180821|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
154180822|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180823|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154180824|NCT01007864|Pramipexole|pramipexole|mesh-list
154180825|NCT01007864|Ropinirole|ropinirole|mesh-list
154180826|NCT01007864|Piribedil|piribedil|mesh-list
154180827|NCT01007864|Dexpramipexole|dexpramipexole|mesh-list
154180828|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
154180829|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180830|NCT01007864|Protective Agents|protective agents|mesh-ancestor
154180831|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180832|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154180833|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154180834|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
154180835|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
154180836|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180837|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154180866|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154180867|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154180868|NCT01001624|Hydroquinone|hydroquinone|mesh-list
154180869|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
154180870|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180871|NCT01001624|Protective Agents|protective agents|mesh-ancestor
154180872|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927917|NCT00655837|Rituximab|rituximab|mesh-list
154180873|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154180874|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
154180875|NCT01001780|Rituximab|rituximab|mesh-list
154180876|NCT01001780|Pentostatin|pentostatin|mesh-list
154180877|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154180878|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
154180879|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154180880|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180925|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154180926|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
154180927|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154180928|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154180929|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154180930|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154180931|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154180932|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154180933|NCT01002092|Endostar protein|endostar protein|mesh-list
154180940|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
154180989|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
154180990|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154180991|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154180992|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154180993|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154180994|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
154180995|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154180996|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154180997|NCT00614393|Irinotecan|irinotecan|mesh-list
154180998|NCT00614393|Cetuximab|cetuximab|mesh-list
154180999|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154181000|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154181001|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154181002|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181003|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181004|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181005|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154181006|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
154181007|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181008|NCT00880529|Morphine|morphine|mesh-list
154181009|NCT00880529|Bupivacaine|bupivacaine|mesh-list
154181010|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
154181011|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
154181041|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
154181042|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
154181043|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181044|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181045|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154181046|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
154181047|NCT04366115|Hormones|hormones|mesh-ancestor
154181048|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154181049|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154181050|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181051|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
154181105|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154181106|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
154181107|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154181108|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154181111|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
154181174|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154181175|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154181176|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154181177|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154181179|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
154181246|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154181247|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
154181248|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181249|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181250|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181251|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154181252|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154181253|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
154181254|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154181255|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154181256|NCT00888797|Analgesics|analgesics|mesh-ancestor
154181257|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
154181258|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181259|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181260|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181261|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154181262|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154181263|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181264|NCT00884663|Propranolol|propranolol|mesh-list
154181265|NCT00884663|Candesartan|candesartan|mesh-list
154181266|NCT00884663|Candesartan cilexetil|candesartan cilexetil|mesh-list
154181299|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154181300|NCT00887003|Protective Agents|protective agents|mesh-ancestor
154181301|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154181302|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181304|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
154181305|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
154181306|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154181307|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154181308|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154181309|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
154181310|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181311|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
154181312|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181313|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
154181316|NCT03998696|Cisplatin|cisplatin|mesh-list
154181360|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154181361|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154181362|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181363|NCT00889343|Antidotes|antidotes|mesh-ancestor
154181364|NCT00889343|Protective Agents|protective agents|mesh-ancestor
154181365|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
154181366|NCT00889343|Vitamins|vitamins|mesh-ancestor
154181367|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
154181368|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154181369|NCT00884819|Fenofibrate|fenofibrate|mesh-list
154181370|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154181374|NCT00573131|Paclitaxel|paclitaxel|mesh-list
154181426|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181427|NCT00520676|Carboplatin|carboplatin|mesh-list
154181428|NCT00520676|Docetaxel|docetaxel|mesh-list
154181429|NCT00520676|Pemetrexed|pemetrexed|mesh-list
154181430|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181431|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
154181432|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
154181433|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
154181434|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181435|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181436|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154181437|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154181438|NCT00887627|Conivaptan|conivaptan|mesh-list
154181488|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154181489|NCT00608543|Aripiprazole|aripiprazole|mesh-list
154181490|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
154181491|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154181492|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154181493|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154181494|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181495|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181496|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
154181497|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
154181498|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181499|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181552|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181553|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181554|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154181555|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
154181556|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
154181557|NCT00893009|Theophylline|theophylline|mesh-list
154181558|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154181559|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
154181560|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181561|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181562|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154181563|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
154181564|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154181565|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181566|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181567|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
154181568|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154181569|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154181570|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
154181571|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154181572|NCT00890747|Sunitinib|sunitinib|mesh-list
154181573|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181574|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154181575|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154181576|NCT00890747|Growth Substances|growth substances|mesh-ancestor
154181577|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181578|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
154181579|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154181580|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181582|NCT04017845|Tribenoside|tribenoside|mesh-list
154181595|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154181596|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154181597|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154181598|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181599|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154181600|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
154181601|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154181602|NCT04017845|Cathartics|cathartics|mesh-ancestor
154181663|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154181664|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
154181665|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
154181666|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181667|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154181668|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154181669|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
154181670|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154181671|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
154181672|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154181673|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154181674|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
154181675|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154181676|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154181677|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181678|NCT00431847|Anesthetics|anesthetics|mesh-list
154181679|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181680|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181681|NCT00431067|Afatinib|afatinib|mesh-list
154181682|NCT00431067|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154181683|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154181684|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181686|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154181712|NCT00525902|Adalimumab|adalimumab|mesh-list
154181713|NCT00525902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154181714|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154181715|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181716|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154181717|NCT00525824|Simvastatin|simvastatin|mesh-list
154181718|NCT00525824|Ezetimibe|ezetimibe|mesh-list
154181719|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154181720|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154181721|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
154181723|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154181781|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181782|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181784|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154181785|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154181786|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154181787|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154181788|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181789|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154181790|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
154181791|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
154181792|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154181793|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181794|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154181795|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154181796|NCT03656666|Growth Substances|growth substances|mesh-ancestor
154181797|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
154181839|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
154181840|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154181841|NCT01033149|Expectorants|expectorants|mesh-ancestor
154181842|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
154181843|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154181844|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
154181845|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154181846|NCT01033149|Protective Agents|protective agents|mesh-ancestor
154181847|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181848|NCT01033149|Antidotes|antidotes|mesh-ancestor
154181849|NCT06051344|Zoledronic Acid|zoledronic acid|mesh-list
154181871|NCT06180759|Ketamine|ketamine|mesh-list
154181901|NCT06180720|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154181903|NCT06180707|Pregabalin|pregabalin|mesh-list
154181904|NCT06180707|Fluorides|fluorides|mesh-list
154181905|NCT06180707|Sodium Fluoride|sodium fluoride|mesh-list
154181906|NCT06180707|Cariostatic Agents|cariostatic agents|mesh-ancestor
154181907|NCT06180707|Protective Agents|protective agents|mesh-ancestor
154181908|NCT06180707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181909|NCT06180707|Analgesics|analgesics|mesh-ancestor
154181910|NCT06180707|Sensory System Agents|sensory system agents|mesh-ancestor
154181911|NCT06180707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154181964|NCT06180031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154181966|NCT06179719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154181967|NCT06179719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154181968|NCT06179719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154181969|NCT06179719|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154181970|NCT06179719|Anesthetics, General|anesthetics, general|mesh-ancestor
154181971|NCT06179719|Anesthetics|anesthetics|mesh-ancestor
154181972|NCT06179485|Ketamine|ketamine|mesh-list
154182049|NCT06131593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182050|NCT06131593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154182051|NCT06131593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182052|NCT06131593|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154182053|NCT06131593|Protective Agents|protective agents|mesh-ancestor
154182054|NCT06131593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154182055|NCT06131593|Sensory System Agents|sensory system agents|mesh-ancestor
154182056|NCT06107738|Daratumumab|daratumumab|mesh-list
154182057|NCT06107738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154182058|NCT06107738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182059|NCT06107738|Immunologic Factors|immunologic factors|mesh-ancestor
154182061|NCT06095973|Ropivacaine|ropivacaine|mesh-list
154182113|NCT06060587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182114|NCT06060587|Tubulin Modulators|tubulin modulators|mesh-ancestor
154182115|NCT06060587|Antimitotic Agents|antimitotic agents|mesh-ancestor
154182116|NCT06060587|Mitosis Modulators|mitosis modulators|mesh-ancestor
154182117|NCT06060587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182118|NCT06027229|Vaccines|vaccines|mesh-list
154182119|NCT06027229|Immunologic Factors|immunologic factors|mesh-ancestor
154182120|NCT06027229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182121|NCT06026033|Desflurane|desflurane|mesh-list
154182122|NCT06026033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154182123|NCT06026033|Anesthetics, General|anesthetics, general|mesh-ancestor
154182124|NCT06026033|Anesthetics|anesthetics|mesh-ancestor
154182125|NCT06026033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154182126|NCT06026033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182127|NCT06017297|Gemcitabine|gemcitabine|mesh-list
154182128|NCT06017297|Durvalumab|durvalumab|mesh-list
154182129|NCT06017297|Tremelimumab|tremelimumab|mesh-list
154182130|NCT06017297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182131|NCT06017297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182132|NCT06017297|Antimetabolites|antimetabolites|mesh-ancestor
154182133|NCT06017297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593407|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
154263557|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263558|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263559|NCT05232344|Progestins|progestins|mesh-ancestor
154263560|NCT05222906|Venglustat|venglustat|mesh-list
154263561|NCT05222906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263562|NCT05222906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263563|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154263564|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154263565|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263621|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263622|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263623|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154263624|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263625|NCT05112965|Paclitaxel|paclitaxel|mesh-list
154263626|NCT05112965|Bevacizumab|bevacizumab|mesh-list
154263627|NCT05112965|Pemetrexed|pemetrexed|mesh-list
154263628|NCT05112965|Atezolizumab|atezolizumab|mesh-list
154263629|NCT05112965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154263630|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263631|NCT05112965|Tubulin Modulators|tubulin modulators|mesh-ancestor
154263632|NCT05112965|Antimitotic Agents|antimitotic agents|mesh-ancestor
154263633|NCT05112965|Mitosis Modulators|mitosis modulators|mesh-ancestor
154263634|NCT05112965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263635|NCT05112965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263636|NCT05112965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154263637|NCT05112965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263638|NCT05112965|Growth Substances|growth substances|mesh-ancestor
154263639|NCT05112965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263640|NCT05112965|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263676|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263677|NCT05047250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263678|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263680|NCT05039177|Palbociclib|palbociclib|mesh-list
154263681|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154263682|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263683|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154263684|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263685|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263686|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
154263687|NCT05038202|Bromides|bromides|mesh-list
154263688|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
154263689|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154263698|NCT04929223|Cetuximab|cetuximab|mesh-list
154263736|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154263737|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263738|NCT04867343|Analgesics|analgesics|mesh-ancestor
154263739|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
154263740|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263741|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154263742|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154263743|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
154263744|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
154263745|NCT04865289|Paclitaxel|paclitaxel|mesh-list
154263746|NCT04865289|Carboplatin|carboplatin|mesh-list
154263747|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
154263799|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263800|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263801|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154263802|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263805|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
154263870|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263871|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263872|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154263873|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263874|NCT04539548|Antiemetics|antiemetics|mesh-ancestor
154263875|NCT04539548|Autonomic Agents|autonomic agents|mesh-ancestor
154263876|NCT04539548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263877|NCT04539548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263878|NCT04539548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154263879|NCT04539548|Protective Agents|protective agents|mesh-ancestor
154263880|NCT04539548|Protease Inhibitors|protease inhibitors|mesh-ancestor
154263881|NCT04539548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263882|NCT04539548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263883|NCT04526795|Cytarabine|cytarabine|mesh-list
154263884|NCT04526795|Fludarabine|fludarabine|mesh-list
154263885|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263886|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154263887|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
154263888|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263889|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154263890|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
154263891|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263892|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
154263893|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154263894|NCT04520217|Imipramine|imipramine|mesh-list
154263895|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154263896|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
154263897|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154263898|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154263899|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154263900|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154263901|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263902|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
154263908|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263909|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263910|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263912|NCT04490057|Nicotine|nicotine|mesh-list
154263913|NCT04490057|Varenicline|varenicline|mesh-list
154263914|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154263915|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
154263916|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263917|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263918|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154263919|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154263920|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
154263921|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154263922|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154263923|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154263924|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
154263925|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154263929|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
154263964|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
154263966|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
154263967|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154263968|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263969|NCT04414475|Dexamethasone|dexamethasone|mesh-list
154263970|NCT04414475|Bortezomib|bortezomib|mesh-list
154263971|NCT04414475|Pomalidomide|pomalidomide|mesh-list
154263972|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154263973|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
154263974|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
154263975|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154263976|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263977|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154263978|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
154263979|NCT04414475|Hormones|hormones|mesh-ancestor
154263980|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263981|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153593506|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
154263982|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263983|NCT04414475|Immunologic Factors|immunologic factors|mesh-ancestor
154263984|NCT04414475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154263985|NCT04414475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263986|NCT04414475|Growth Substances|growth substances|mesh-ancestor
154263987|NCT04414475|Growth Inhibitors|growth inhibitors|mesh-ancestor
154263988|NCT04370054|Factor VIII|factor viii|mesh-list
154263989|NCT04370054|Coagulants|coagulants|mesh-ancestor
154263990|NCT04314843|Lenzilumab|lenzilumab|mesh-list
154263991|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
154263992|NCT04314843|Fludarabine|fludarabine|mesh-list
154263993|NCT04314843|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154263994|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154263995|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
154263996|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154263997|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154263998|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154263999|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
154264000|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264001|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264025|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264026|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264048|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
154264049|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
154264050|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154264051|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264052|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
154264053|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264054|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
154264055|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
154264056|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154264057|NCT04205786|Vitamins|vitamins|mesh-ancestor
154264058|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
154264059|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264060|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
154264087|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154264088|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264089|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154264090|NCT04175834|Antipruritics|antipruritics|mesh-ancestor
154264091|NCT04175834|Dermatologic Agents|dermatologic agents|mesh-ancestor
154264092|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
154264093|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264156|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154264157|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154264158|NCT04031027|Analgesics|analgesics|mesh-ancestor
154264159|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
154264160|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264161|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264162|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154264163|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154264223|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154264224|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154264225|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154264226|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264227|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264228|NCT03884101|Paclitaxel|paclitaxel|mesh-list
154264229|NCT03884101|Carboplatin|carboplatin|mesh-list
154264230|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
154264231|NCT03884101|Lenvatinib|lenvatinib|mesh-list
154264232|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154264233|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264234|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
154264235|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
154264236|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
154264237|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264238|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264239|NCT03884101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264240|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264241|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264291|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
153593546|NCT01843309|Diuretics|diuretics|mesh-ancestor
154264292|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154264293|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154264294|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
154264295|NCT03878524|Neratinib|neratinib|mesh-list
154264296|NCT03878524|Dacomitinib|dacomitinib|mesh-list
154264297|NCT03878524|Entrectinib|entrectinib|mesh-list
154264298|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
154264299|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154264310|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
154264356|NCT03869190|Atezolizumab|atezolizumab|mesh-list
154264358|NCT03869190|Magrolimab|magrolimab|mesh-list
154264359|NCT03869190|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154264360|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264361|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154264362|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
154264363|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264364|NCT03869190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154264365|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264366|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154264367|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264368|NCT03869190|Immunoconjugates|immunoconjugates|mesh-ancestor
154264369|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
154264416|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154264417|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264418|NCT03739619|Gemcitabine|gemcitabine|mesh-list
154264419|NCT03739619|Nivolumab|nivolumab|mesh-list
154264420|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154264421|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154264422|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
154264423|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264484|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154264485|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
154264486|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154264487|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154264488|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
154264489|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
154264490|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
154264491|NCT03710772|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264492|NCT03710772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264493|NCT03705351|Temozolomide|temozolomide|mesh-list
154264494|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154264495|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
154264496|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264497|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264498|NCT03678753|Cenobamate|cenobamate|mesh-list
154264499|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
154264500|NCT03672292|Voriconazole|voriconazole|mesh-list
154264501|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
154264502|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
154264539|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154264540|NCT03400423|Caffeine|caffeine|mesh-list
154264541|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154264542|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264543|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154264550|NCT03399539|Dexamethasone|dexamethasone|mesh-list
154264609|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264610|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264611|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264612|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154264613|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154264614|NCT03263572|Cytarabine|cytarabine|mesh-list
154264615|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154264616|NCT03263572|Methotrexate|methotrexate|mesh-list
154264617|NCT03263572|Blinatumomab|blinatumomab|mesh-list
154264618|NCT03263572|Ponatinib|ponatinib|mesh-list
154264619|NCT03263572|Antibodies|antibodies|mesh-list
154264620|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
154264621|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154264622|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
154264623|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154264669|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154264670|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
154264671|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264672|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264673|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154264674|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154264675|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154264676|NCT03070327|Growth Substances|growth substances|mesh-ancestor
154264677|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
154264678|NCT03069326|Thalidomide|thalidomide|mesh-list
154264679|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154264680|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
154264681|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264729|NCT02735343|Ketamine|ketamine|mesh-list
154264730|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
154264731|NCT02735343|Analgesics|analgesics|mesh-ancestor
154264732|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
154264733|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264734|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264735|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154264736|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154264737|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
154264738|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
154264739|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154264740|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154264741|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154264742|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154264743|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264744|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
154264745|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
154264746|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154264785|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264787|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154264788|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
154264789|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264790|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
154264791|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
154264792|NCT02475681|Chlorambucil|chlorambucil|mesh-list
154264793|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264794|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264795|NCT02475681|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264850|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264851|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154264852|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154264853|NCT02143466|Durvalumab|durvalumab|mesh-list
154264854|NCT02143466|Osimertinib|osimertinib|mesh-list
154264855|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154264856|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154264857|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264858|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
154264859|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264860|NCT02143466|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154264861|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154264862|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264863|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264864|NCT02134301|Oritavancin|oritavancin|mesh-list
154264865|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154264909|NCT01120184|Paclitaxel|paclitaxel|mesh-list
154264910|NCT01120184|Maytansine|maytansine|mesh-list
154264911|NCT01120184|Docetaxel|docetaxel|mesh-list
154264912|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154264913|NCT01120184|Trastuzumab|trastuzumab|mesh-list
154264914|NCT01120184|Pertuzumab|pertuzumab|mesh-list
154264915|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154264916|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264917|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
154264918|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
154264919|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
154264920|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154264976|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154264977|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154264978|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154264979|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
154264980|NCT00020202|Romidepsin|romidepsin|mesh-list
154264981|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154264982|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154264983|NCT00020202|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154264984|NCT00020202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154264985|NCT00020202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265040|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154265041|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
154265042|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265043|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154265044|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265045|NCT00019188|Growth Substances|growth substances|mesh-ancestor
154265046|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265047|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265048|NCT00019097|Melphalan|melphalan|mesh-list
154265049|NCT00019097|Sargramostim|sargramostim|mesh-list
154265105|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265107|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154265108|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
154265109|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265110|NCT01882816|Doxorubicin|doxorubicin|mesh-list
154265111|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154265112|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265170|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
154265171|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
154265172|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265173|NCT01642186|Everolimus|everolimus|mesh-list
154265174|NCT01642186|Letrozole|letrozole|mesh-list
154265175|NCT01642186|Leuprolide|leuprolide|mesh-list
154265176|NCT01642186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154265177|NCT01642186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154012077|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
154265178|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265179|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265180|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265181|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
154265182|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265183|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265184|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154265185|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154265186|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154265187|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
154265188|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265189|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154265190|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
154265191|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154265192|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154265193|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
154265194|NCT00423514|Melphalan|melphalan|mesh-list
154265195|NCT00423514|Thiotepa|thiotepa|mesh-list
154265196|NCT00423514|Clofarabine|clofarabine|mesh-list
154265197|NCT00423514|Tacrolimus|tacrolimus|mesh-list
154265198|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
154265202|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265213|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154265214|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
154265216|NCT00120952|Chromium|chromium|mesh-list
154265217|NCT00120952|Trace Elements|trace elements|mesh-ancestor
154265218|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
154265219|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265220|NCT00289991|Itraconazole|itraconazole|mesh-list
153593698|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265221|NCT00289991|Voriconazole|voriconazole|mesh-list
154265222|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
154265223|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265224|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154265278|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154265279|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
154265280|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265281|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154265282|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265283|NCT00268463|Capecitabine|capecitabine|mesh-list
154265284|NCT00268463|Floxuridine|floxuridine|mesh-list
154265285|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
154265286|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154265287|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
154265288|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265289|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265290|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
154265337|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154265338|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154265340|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154265341|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154265342|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265343|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265344|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265345|NCT01333852|Metformin|metformin|mesh-list
154265346|NCT01333852|Paclitaxel|paclitaxel|mesh-list
153606858|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153606859|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154265400|NCT01314586|Estrogens|estrogens|mesh-ancestor
154265401|NCT01314586|Hormones|hormones|mesh-ancestor
154265402|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265403|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265476|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154265477|NCT03054766|Growth Substances|growth substances|mesh-ancestor
154265478|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265479|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265480|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265481|NCT03036748|Amiloride|amiloride|mesh-list
154265482|NCT03036748|Diuretics|diuretics|mesh-ancestor
154265483|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
154265484|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265485|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154265486|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154265487|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154265488|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265489|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153359828|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153359829|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359830|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359831|NCT03810417|Protective Agents|protective agents|mesh-ancestor
153359832|NCT03808818|Nicotine|nicotine|mesh-list
153359833|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153359834|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
154265490|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154265491|NCT03167242|Lumefantrine|lumefantrine|mesh-list
154265492|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154265493|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
154265494|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154265495|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154265496|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154265497|NCT03636178|Daminozide|daminozide|mesh-list
154265498|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
154265499|NCT03636178|Growth Substances|growth substances|mesh-ancestor
154265500|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265501|NCT01330654|Metoprolol|metoprolol|mesh-list
154265553|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593743|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
154265554|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154265555|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
154265557|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154265569|NCT01331902|Nicorandil|nicorandil|mesh-list
154265623|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265624|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265625|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154265626|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154265627|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
154265629|NCT02913664|Amlodipine|amlodipine|mesh-list
154265630|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
154265631|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
154265632|NCT02913664|Giapreza|giapreza|mesh-list
154265633|NCT02913664|Calcium|calcium|mesh-list
154265634|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154265635|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
154265686|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154265687|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265688|NCT02882152|Analgesics|analgesics|mesh-ancestor
154265689|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
154265690|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154265691|NCT05185804|Enoxaparin|enoxaparin|mesh-list
154265692|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
154265693|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
154265754|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154265755|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154265756|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154265757|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265758|NCT05184322|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154265759|NCT05184322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154265760|NCT05184322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265761|NCT00286091|Denosumab|denosumab|mesh-list
154265817|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
154265818|NCT01341262|Melphalan|melphalan|mesh-list
154265819|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154265820|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
154265821|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265822|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154265823|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154265824|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
154265825|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265826|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265827|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154265828|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154265878|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265879|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
154265880|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265881|NCT05182138|Zinc|zinc|mesh-list
154265882|NCT05182138|Trace Elements|trace elements|mesh-ancestor
154265883|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
154265884|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265885|NCT01315990|Cetuximab|cetuximab|mesh-list
154265886|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154265887|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154265888|NCT00265343|Olanzapine|olanzapine|mesh-list
154265889|NCT00265343|Asenapine|asenapine|mesh-list
154265905|NCT01341886|Metformin|metformin|mesh-list
154265942|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
154265943|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154265944|NCT05150782|Protective Agents|protective agents|mesh-ancestor
154265945|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154265946|NCT05150782|Vitamins|vitamins|mesh-ancestor
154265947|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
154265948|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154265949|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154265950|NCT05150782|Analgesics|analgesics|mesh-ancestor
154266008|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266009|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266011|NCT05226442|Calcium heparin|calcium heparin|mesh-list
154266012|NCT05226442|Argatroban|argatroban|mesh-list
154266013|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
154266014|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154266015|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154266016|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266017|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
154266018|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154266019|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
154266020|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266021|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154266022|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
154266023|NCT01316458|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154266024|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266025|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266026|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266027|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266028|NCT05198128|Calcium|calcium|mesh-list
154266029|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154266031|NCT01316848|Tivozanib|tivozanib|mesh-list
154266060|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154266061|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154266062|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266063|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154266064|NCT00546754|Diuretics|diuretics|mesh-ancestor
154266065|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
154266066|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266067|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154266068|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154266123|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266125|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
154266126|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266127|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154266128|NCT00282347|Protective Agents|protective agents|mesh-ancestor
154266129|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154266130|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154266131|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266132|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
154266133|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
154266134|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154266135|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
154266136|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
154266137|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266138|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154266139|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
154266140|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
154266141|NCT01334632|Morphine|morphine|mesh-list
154266142|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154266143|NCT01334632|Narcotics|narcotics|mesh-ancestor
154266144|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266176|NCT00281957|Sirolimus|sirolimus|mesh-list
154266177|NCT00281957|Sorafenib|sorafenib|mesh-list
154266178|NCT00281957|Temsirolimus|temsirolimus|mesh-list
154266179|NCT00281957|Tipifarnib|tipifarnib|mesh-list
153593826|NCT01845142|Vitamins|vitamins|mesh-ancestor
154266180|NCT00281957|MTOR Inhibitors|mtor inhibitors|mesh-list
154266181|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266182|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266192|NCT01071161|Azithromycin|azithromycin|mesh-list
154266246|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
154266247|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266248|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154266249|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266250|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266251|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154266252|NCT00262925|Antidotes|antidotes|mesh-ancestor
154266253|NCT00262925|Protective Agents|protective agents|mesh-ancestor
154266254|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
154266255|NCT00262925|Vitamins|vitamins|mesh-ancestor
154266256|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
154266257|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154266258|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
154266259|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
154266260|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
154266261|NCT01581515|Everolimus|everolimus|mesh-list
154266262|NCT01581515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154266263|NCT01581515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266264|NCT01581515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266265|NCT01581515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266266|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266267|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
154266269|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266299|NCT05329532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154266300|NCT05329532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266301|NCT01303640|Everolimus|everolimus|mesh-list
154266302|NCT01303640|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154266303|NCT01303640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266304|NCT01303640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266305|NCT01303640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266306|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266307|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
154266308|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266362|NCT03800810|Protective Agents|protective agents|mesh-ancestor
154266363|NCT03974867|Prednisone|prednisone|mesh-list
154266364|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
154266365|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154266366|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154266367|NCT03974867|Prednisolone|prednisolone|mesh-list
154266368|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
154266369|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154266370|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
154266371|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266372|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
154266373|NCT03974867|Hormones|hormones|mesh-ancestor
154266375|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266426|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154266427|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266428|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266429|NCT00276419|Diclofenac|diclofenac|mesh-list
154266430|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154266431|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154266432|NCT00276419|Analgesics|analgesics|mesh-ancestor
154266433|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
154266493|NCT03815474|Epirubicin|epirubicin|mesh-list
154266494|NCT03815474|Ifosfamide|ifosfamide|mesh-list
154266495|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154266496|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266497|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154266498|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154266499|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266500|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266501|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154266502|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
154266503|NCT01302158|Glimepiride|glimepiride|mesh-list
154266556|NCT03812120|Coagulants|coagulants|mesh-ancestor
154266557|NCT03795584|Hemostatics|hemostatics|mesh-list
154266558|NCT03795584|Coagulants|coagulants|mesh-ancestor
154266559|NCT03792776|Lidocaine|lidocaine|mesh-list
154266560|NCT03792776|Anesthetics|anesthetics|mesh-list
154266561|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
154266562|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266563|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266564|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
154266565|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266566|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154266567|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154266568|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154266569|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154266570|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266571|NCT03795272|Rucaparib|rucaparib|mesh-list
154266572|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154266573|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266574|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266575|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266576|NCT00956930|Doxorubicin|doxorubicin|mesh-list
154266577|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154266578|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154266579|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266580|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154266581|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154266582|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266583|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266602|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266603|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
154266604|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266605|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154266606|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266607|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266608|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154266609|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266610|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154266611|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
154266612|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154266613|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266614|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266615|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
154266616|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
154266618|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266660|NCT03810872|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154266661|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154266662|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266663|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
154266664|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266665|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
154266666|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266667|NCT00274937|Cisplatin|cisplatin|mesh-list
154266668|NCT00274937|Fluorouracil|fluorouracil|mesh-list
154266669|NCT00274937|Amifostine|amifostine|mesh-list
154266670|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266671|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
154266672|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266673|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154266674|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154266675|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
154266676|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266678|NCT00274937|Protective Agents|protective agents|mesh-ancestor
154266679|NCT03792074|Paclitaxel|paclitaxel|mesh-list
154266680|NCT03792074|Bevacizumab|bevacizumab|mesh-list
154266681|NCT03792074|Carboplatin|carboplatin|mesh-list
154266682|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154266683|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266684|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
154266714|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154266715|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154266716|NCT00250835|Celecoxib|celecoxib|mesh-list
154266717|NCT00250835|Capecitabine|capecitabine|mesh-list
154266718|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
154266719|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154266720|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
154266721|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266722|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266723|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154266725|NCT00250835|Analgesics|analgesics|mesh-ancestor
154266777|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
154266778|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154266779|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154266780|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154266781|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
154266782|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266783|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266785|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
154266786|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154266787|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
154266788|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266789|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
154266790|NCT03791294|Protective Agents|protective agents|mesh-ancestor
154266791|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
154266792|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154266793|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
154266794|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154266795|NCT01567358|Infliximab|infliximab|mesh-list
154266796|NCT01567358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154266797|NCT01567358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154266798|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
154266799|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154266800|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154266801|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
154266802|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154266803|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154266804|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266805|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154266822|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
154266823|NCT01306760|Ketamine|ketamine|mesh-list
154266824|NCT01306760|Propofol|propofol|mesh-list
154266825|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154266826|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266827|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266828|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154266829|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
154266830|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
154266831|NCT01306760|Analgesics|analgesics|mesh-ancestor
154266832|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
154266886|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154266887|NCT03787550|Analgesics|analgesics|mesh-list
154266888|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154266889|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154266890|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
154266891|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154266892|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266893|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154266894|NCT03789890|Itraconazole|itraconazole|mesh-list
154266906|NCT01308554|Bupivacaine|bupivacaine|mesh-list
154266950|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154266951|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154266952|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154266954|NCT03789422|Coagulants|coagulants|mesh-ancestor
154266955|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154266956|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154266957|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
154266958|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
154266959|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154266960|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154266961|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154266962|NCT05690048|Vancomycin|vancomycin|mesh-list
154266963|NCT05690048|Bevacizumab|bevacizumab|mesh-list
154266964|NCT05690048|Atezolizumab|atezolizumab|mesh-list
154266965|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154266966|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154266967|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154266968|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154266969|NCT05690048|Growth Substances|growth substances|mesh-ancestor
154266970|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267003|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267004|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154267005|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154267006|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
154267007|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
154267008|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154267009|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154267010|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267011|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
154267012|NCT03777488|Coagulants|coagulants|mesh-ancestor
154267070|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154267071|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154267072|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154267073|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
154267074|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267075|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267076|NCT03781466|Progesterone|progesterone|mesh-list
154267077|NCT03781466|Progestins|progestins|mesh-ancestor
154267078|NCT03781466|Hormones|hormones|mesh-ancestor
154267079|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154267080|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267081|NCT03150862|Pamiparib|pamiparib|mesh-list
154267082|NCT03150862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154267083|NCT03150862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267084|NCT03150862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267085|NCT03150862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267086|NCT01318928|Metronidazole|metronidazole|mesh-list
154267087|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267088|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267089|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154267090|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154267091|NCT01309178|Mannitol|mannitol|mesh-list
154267092|NCT01309178|Amitriptyline|amitriptyline|mesh-list
154267093|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154267094|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
154267095|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154267096|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154267097|NCT01309178|Analgesics|analgesics|mesh-ancestor
154267098|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
154267099|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267100|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267101|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154267103|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154267111|NCT01335334|Tetracycline|tetracycline|mesh-list
154267112|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154267113|NCT01335334|Omeprazole|omeprazole|mesh-list
154267114|NCT01335334|Bismuth|bismuth|mesh-list
154267115|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267116|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267117|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154267118|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154267179|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267180|NCT03780686|Dopamine|dopamine|mesh-list
154267181|NCT03780686|Norepinephrine|norepinephrine|mesh-list
154267182|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154267183|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154267184|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
154267185|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267186|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267187|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267244|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154267245|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154267246|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154267247|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154267248|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267249|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267250|NCT00307060|Diuretics|diuretics|mesh-ancestor
154267251|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
154267311|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
154267312|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267313|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
154267314|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267315|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154267316|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154267317|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154267318|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
154267322|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267378|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
154267379|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267380|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154267381|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154267382|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154267446|NCT03779360|Hormones|hormones|mesh-ancestor
154267447|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154267448|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267449|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154267450|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267451|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154267452|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267453|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267454|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154267455|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267456|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267457|NCT01320878|Iloprost|iloprost|mesh-list
154267460|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
154267508|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154267509|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154267510|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
154267511|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
154267512|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
154267513|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
154267514|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267577|NCT03768908|Artesunate|artesunate|mesh-list
154267578|NCT03768908|Lumefantrine|lumefantrine|mesh-list
154267579|NCT03768908|Artemether|artemether|mesh-list
154267580|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154267581|NCT03768908|Amodiaquine|amodiaquine|mesh-list
154267582|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
154267583|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154267584|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154267585|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267586|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267587|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
154267588|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
154267589|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154267590|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
154267591|NCT03777878|Oxytocin|oxytocin|mesh-list
154267592|NCT03777878|Carbetocin|carbetocin|mesh-list
154267593|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
154267594|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154267595|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267596|NCT03246958|Nivolumab|nivolumab|mesh-list
154267597|NCT03246958|Ipilimumab|ipilimumab|mesh-list
154267637|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267638|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267639|NCT03770936|Candesartan|candesartan|mesh-list
154267640|NCT03770936|Candesartan cilexetil|candesartan cilexetil|mesh-list
154267641|NCT03770936|Ramipril|ramipril|mesh-list
154267642|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154267643|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154267644|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154267645|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267700|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154267701|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
154267702|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267703|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154267704|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154267705|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
154267706|NCT01345708|Hormones|hormones|mesh-ancestor
154267707|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154267708|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154267709|NCT01345864|Scopolamine|scopolamine|mesh-list
154267710|NCT01345864|Donepezil|donepezil|mesh-list
153594148|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154267711|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154267712|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154267713|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267714|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267715|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
154267716|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267717|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267718|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
154267719|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154267720|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
154267721|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
154267722|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267723|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154267724|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
154267725|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154267726|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154267727|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
154267728|NCT04320602|Eculizumab|eculizumab|mesh-list
154014647|NCT05287035|Hormones|hormones|mesh-ancestor
154267729|NCT04320602|Ravulizumab|ravulizumab|mesh-list
154267745|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267747|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
154267748|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267749|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
154267750|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
154267751|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
154267752|NCT04345666|Testosterone|testosterone|mesh-list
154267753|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
154267754|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
154267755|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154267809|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154267810|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154267811|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
154267813|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154267814|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154267815|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154267816|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
154267817|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267818|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267819|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154267820|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154267826|NCT03902314|Lidocaine|lidocaine|mesh-list
154267870|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154267871|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154267872|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154267873|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154267874|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267875|NCT01321502|Famciclovir|famciclovir|mesh-list
154267876|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
154014777|NCT04664946|Protective Agents|protective agents|mesh-ancestor
154267877|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154267878|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154267879|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267880|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267881|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154267882|NCT01347268|Hormones|hormones|mesh-ancestor
154267883|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154267884|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267922|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154267923|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154267925|NCT00536380|Desloratadine|desloratadine|mesh-list
154267926|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154267927|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
154267928|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154267929|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154267930|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267932|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154267986|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
154267987|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
154267988|NCT01347814|Domperidone|domperidone|mesh-list
154267989|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
154267990|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
154267991|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154267992|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154267993|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154267994|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154267995|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
154267996|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268052|NCT01352572|Mirtazapine|mirtazapine|mesh-list
154268053|NCT01352572|Sertraline|sertraline|mesh-list
154268054|NCT01352572|Fluoxetine|fluoxetine|mesh-list
154268055|NCT01352572|Paroxetine|paroxetine|mesh-list
154268056|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154268057|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
154268121|NCT01343290|Canagliflozin|canagliflozin|mesh-list
154268122|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154268123|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268124|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154268125|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268126|NCT03761264|Amoxicillin|amoxicillin|mesh-list
154268127|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
154268128|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268129|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154268130|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268131|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
154268132|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
154268182|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268183|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154268184|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
154268185|NCT04860518|Hormones|hormones|mesh-ancestor
154268186|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154268187|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154268188|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268189|NCT03110380|Dolutegravir|dolutegravir|mesh-list
154268190|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154268247|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154268249|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154268250|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268251|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
154268252|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154268253|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268254|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154268255|NCT03700892|Protective Agents|protective agents|mesh-ancestor
154268256|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268257|NCT01322282|Cetirizine|cetirizine|mesh-list
154268258|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154268259|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154268260|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154268261|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
154268262|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
154268305|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
154268306|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268307|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154268308|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268309|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268310|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268372|NCT03522844|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154268373|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154268374|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268375|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268376|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268377|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
154268378|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268379|NCT00045942|Itraconazole|itraconazole|mesh-list
154268436|NCT03465280|Acyclovir|acyclovir|mesh-list
154268437|NCT03465280|Cidofovir|cidofovir|mesh-list
154268438|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
154268439|NCT03465280|Artemisinins|artemisinins|mesh-list
154268440|NCT03465280|Artemisinin|artemisinin|mesh-list
154268508|NCT00003702|Cactinomycin|cactinomycin|mesh-list
154268509|NCT00003702|Methotrexate|methotrexate|mesh-list
154268510|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154268511|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
154268512|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154268513|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268514|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154268515|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
154268516|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268517|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268518|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
154268519|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268520|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154268521|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268522|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
154268523|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268524|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268525|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154268526|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268527|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154268528|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154268529|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
154268530|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
154268531|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154268532|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154268533|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268534|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268535|NCT01350154|Urological Agents|urological agents|mesh-ancestor
154268536|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
154268553|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
154268554|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
154268555|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
154268556|NCT01318096|Tenofovir|tenofovir|mesh-list
154268557|NCT01318096|Lamivudine|lamivudine|mesh-list
154268558|NCT01318096|Efavirenz|efavirenz|mesh-list
154268559|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
154268560|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
154268561|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268562|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154268563|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154268564|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268565|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268566|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154268567|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154268568|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154268569|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154268570|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154268571|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154268572|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154268573|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154268574|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154268575|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154268576|NCT02530320|Palbociclib|palbociclib|mesh-list
154268577|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268578|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154268579|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268580|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268581|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154268597|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268598|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154268599|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268600|NCT02532023|Curcumin|curcumin|mesh-list
154268601|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154268602|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154268603|NCT02532023|Analgesics|analgesics|mesh-ancestor
154268604|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
154268605|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268606|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268607|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268608|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268609|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268610|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268611|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268612|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
154268613|NCT01354522|Docetaxel|docetaxel|mesh-list
154268614|NCT01354522|Doxorubicin|doxorubicin|mesh-list
154268615|NCT01354522|Capecitabine|capecitabine|mesh-list
154268616|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268617|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
154268633|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
154268650|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268651|NCT01350622|Diclofenac|diclofenac|mesh-list
154268652|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
154268653|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154268654|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154268655|NCT01350622|Analgesics|analgesics|mesh-ancestor
154268656|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
154268657|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268658|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268660|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268714|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154268715|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154268716|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
154268717|NCT03952260|Anesthetics|anesthetics|mesh-list
154268718|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154268719|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268720|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154268721|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154268722|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
154268723|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268724|NCT01351948|Antacids|antacids|mesh-ancestor
154268725|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268726|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154268727|NCT01352026|Metformin|metformin|mesh-list
154268728|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154268729|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268771|NCT01352338|Hormones|hormones|mesh-ancestor
154268772|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154268773|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154268774|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154268775|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154268776|NCT01352338|Growth Substances|growth substances|mesh-ancestor
154268777|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
154268778|NCT01542736|Carboplatin|carboplatin|mesh-list
154268779|NCT01542736|Vincristine|vincristine|mesh-list
154268780|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268781|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154268782|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
154268783|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
154268784|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
154268785|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268786|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154268787|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154268788|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154268789|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154268790|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
154268791|NCT01361542|Infliximab|infliximab|mesh-list
154268792|NCT01361542|Etanercept|etanercept|mesh-list
154268793|NCT01361542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154268794|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154268795|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
154268796|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154268797|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268798|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154268799|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154268800|NCT01361542|Analgesics|analgesics|mesh-ancestor
154268814|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
154268815|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154268816|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154268817|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154268818|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
154268819|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154268820|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268821|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154268822|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154268823|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
154268826|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
154268879|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268880|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154268881|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268882|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268883|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154268884|NCT01362010|Minocycline|minocycline|mesh-list
154268885|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154268886|NCT02875366|Ivacaftor|ivacaftor|mesh-list
154268887|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154268888|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154268889|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268890|NCT01362400|Docetaxel|docetaxel|mesh-list
154268941|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
154268942|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154268943|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154268944|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154268945|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154268946|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154268947|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154268948|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154268949|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154268950|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154268951|NCT00002766|Cytarabine|cytarabine|mesh-list
154268952|NCT00002766|Dactinomycin|dactinomycin|mesh-list
154268953|NCT00002766|Prednisone|prednisone|mesh-list
154268954|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
154268955|NCT00002766|Carmustine|carmustine|mesh-list
154268956|NCT00002766|Doxorubicin|doxorubicin|mesh-list
154268957|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154268958|NCT00002766|Methotrexate|methotrexate|mesh-list
154268959|NCT00002766|Etoposide|etoposide|mesh-list
154268960|NCT00002766|Vincristine|vincristine|mesh-list
154268961|NCT00002766|Daunorubicin|daunorubicin|mesh-list
154268962|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
154268963|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
154268964|NCT00002766|Pegaspargase|pegaspargase|mesh-list
154268965|NCT00002766|Sargramostim|sargramostim|mesh-list
154268966|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154268967|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
154268968|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154268969|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154268970|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154268971|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
154268972|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154268973|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154268974|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154268975|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154268976|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154268999|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
154269000|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269001|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154269002|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154269003|NCT01355380|Iloprost|iloprost|mesh-list
154269004|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154269005|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
154269006|NCT01355614|Infliximab|infliximab|mesh-list
154269007|NCT01355614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154269008|NCT01355614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269009|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
154269010|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154269011|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154269012|NCT01584492|Beclomethasone|beclomethasone|mesh-list
154269013|NCT01584492|Albuterol|albuterol|mesh-list
154269014|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
154269015|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154269016|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
154269058|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154269059|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
154269060|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154269061|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154269062|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269063|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
154269064|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
154269065|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269066|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154269067|NCT01100346|Hormones|hormones|mesh-ancestor
154269068|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269069|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269070|NCT01103388|Rituximab|rituximab|mesh-list
154269072|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269117|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
154269118|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269119|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154269120|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154269121|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
154269122|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269123|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269124|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154269182|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269183|NCT00026208|Prednisone|prednisone|mesh-list
154269184|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
154269185|NCT00026208|Doxorubicin|doxorubicin|mesh-list
154269186|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154269187|NCT00026208|Etoposide|etoposide|mesh-list
154269188|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
154269189|NCT00026208|Vincristine|vincristine|mesh-list
154269190|NCT00026208|Bleomycin|bleomycin|mesh-list
154269191|NCT00026208|Vinblastine|vinblastine|mesh-list
154269192|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154269207|NCT00026208|Hormones|hormones|mesh-ancestor
154269248|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
154269249|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269250|NCT03756272|Bupivacaine|bupivacaine|mesh-list
154269251|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
154269252|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
154269253|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269254|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269255|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
154269256|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269257|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154269258|NCT03756116|Epinephrine|epinephrine|mesh-list
154269259|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154269260|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269261|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269262|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269263|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269264|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269265|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154269266|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154269267|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
154269268|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269302|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154269303|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154269304|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269305|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
154269306|NCT03951402|Tapentadol|tapentadol|mesh-list
154269307|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154269308|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154269369|NCT06159348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154269370|NCT06159348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154269372|NCT06159348|Sensory System Agents|sensory system agents|mesh-ancestor
154269373|NCT06159348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269374|NCT06159348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269375|NCT06159348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269376|NCT06159348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154269378|NCT06159322|Clozapine|clozapine|mesh-list
154269379|NCT06159322|Antiemetics|antiemetics|mesh-ancestor
154269380|NCT06159322|Autonomic Agents|autonomic agents|mesh-ancestor
154269381|NCT06159322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269433|NCT06158893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269434|NCT06158893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154269435|NCT06158893|Autonomic Agents|autonomic agents|mesh-ancestor
154269436|NCT06158893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269437|NCT06158893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269438|NCT06158893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154269440|NCT06158893|Glucocorticoids|glucocorticoids|mesh-ancestor
154269503|NCT06158048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269504|NCT06158048|Sympathomimetics|sympathomimetics|mesh-ancestor
154269505|NCT06158048|Nasal Decongestants|nasal decongestants|mesh-ancestor
154269506|NCT06158048|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269507|NCT06158048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154269508|NCT06158048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154269509|NCT06158048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269510|NCT06158048|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269511|NCT06158048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269512|NCT06158048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269513|NCT06158048|Protective Agents|protective agents|mesh-ancestor
154269514|NCT06158035|Phenylephrine|phenylephrine|mesh-list
154269515|NCT06158035|Oxymetazoline|oxymetazoline|mesh-list
154269516|NCT06158035|Norepinephrine|norepinephrine|mesh-list
154269517|NCT06158035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154269518|NCT06158035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154269519|NCT06158035|Mydriatics|mydriatics|mesh-ancestor
154269520|NCT06158035|Autonomic Agents|autonomic agents|mesh-ancestor
154269562|NCT06158009|Nasal Decongestants|nasal decongestants|mesh-ancestor
154269563|NCT06158009|Respiratory System Agents|respiratory system agents|mesh-ancestor
154269564|NCT06158009|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154269565|NCT06158009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154269566|NCT06158009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269567|NCT06158009|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269568|NCT06158009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154269569|NCT06158009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269570|NCT06158009|Protective Agents|protective agents|mesh-ancestor
154269571|NCT06157996|Lenvatinib|lenvatinib|mesh-list
154269572|NCT06157996|Tislelizumab|tislelizumab|mesh-list
154269573|NCT06157996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269574|NCT06157996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154269575|NCT06157996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269576|NCT06157996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269577|NCT06157996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154269578|NCT06157918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154269579|NCT06157905|Tofacitinib|tofacitinib|mesh-list
154269580|NCT06157905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269583|NCT06157905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269617|NCT06094881|Obinutuzumab|obinutuzumab|mesh-list
154269618|NCT06094881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154269619|NCT06094881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154269620|NCT06085573|Dexmedetomidine|dexmedetomidine|mesh-list
154269621|NCT06085573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154269622|NCT06085573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269623|NCT06085573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269624|NCT06085573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154269625|NCT06085573|Analgesics|analgesics|mesh-ancestor
154269626|NCT06085573|Sensory System Agents|sensory system agents|mesh-ancestor
154269627|NCT06085573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269628|NCT06085573|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154269629|NCT06085573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154269679|NCT06031454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154269680|NCT06031454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154269681|NCT06031454|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154269682|NCT06031454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154269683|NCT06031454|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154269684|NCT06031454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154269685|NCT06031454|Antitubercular Agents|antitubercular agents|mesh-ancestor
154269686|NCT06031454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154269687|NCT06031454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154269688|NCT06031454|Leprostatic Agents|leprostatic agents|mesh-ancestor
154269689|NCT06031454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154269690|NCT06031454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154269691|NCT06031454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154269692|NCT06031454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154269693|NCT06031454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154269694|NCT06031454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154269695|NCT06031454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154269696|NCT06031454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269697|NCT06031454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154269698|NCT06031454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154269699|NCT06031454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154269700|NCT06031454|Vasodilator Agents|vasodilator agents|mesh-ancestor
154269702|NCT06024928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154269703|NCT06024928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269704|NCT06018883|Paclitaxel|paclitaxel|mesh-list
154269705|NCT06018883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154269706|NCT06018883|Gemcitabine|gemcitabine|mesh-list
154269707|NCT06018883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154269714|NCT06018883|Antimetabolites|antimetabolites|mesh-ancestor
154269720|NCT06003166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154269721|NCT06003166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154269722|NCT06003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269723|NCT05980117|Midazolam|midazolam|mesh-list
154269724|NCT05980117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154269725|NCT05980117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154269726|NCT05980117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269727|NCT05980117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269728|NCT05980117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154269784|NCT05850455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269785|NCT05850455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154269786|NCT05850455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154269787|NCT05850455|Analgesics|analgesics|mesh-ancestor
154269788|NCT05850455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154269789|NCT05850455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154269790|NCT05850455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154269791|NCT05850455|Adrenergic Agents|adrenergic agents|mesh-ancestor
154269850|NCT05752110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269852|NCT05702879|Adalimumab|adalimumab|mesh-list
154269853|NCT05702879|Infliximab|infliximab|mesh-list
154269854|NCT05702879|Etanercept|etanercept|mesh-list
154269855|NCT05702879|Golimumab|golimumab|mesh-list
154269856|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154269922|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269923|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269924|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
154269925|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269926|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269927|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154269928|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154269929|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154269930|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269931|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154269932|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
154269933|NCT05364099|Hormones|hormones|mesh-ancestor
154269934|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154269935|NCT05245006|Antibodies|antibodies|mesh-list
154269936|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
154269939|NCT05217680|Bevacizumab|bevacizumab|mesh-list
154269978|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269979|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
154269980|NCT05166811|Analgesics|analgesics|mesh-ancestor
154269981|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
154269982|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154269983|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154269984|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
154269985|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154269986|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154269987|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
154269988|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154269989|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154269990|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154269991|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154269992|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
154269993|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154270034|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154270035|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270037|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
154270038|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270039|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154270040|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
154270041|NCT04877275|Hormones|hormones|mesh-ancestor
154270042|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270043|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154270044|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154270045|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154270046|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154270097|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154270099|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
154270100|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
154270101|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270102|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270103|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
154270104|NCT04616248|Laxatives|laxatives|mesh-ancestor
154270105|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154270106|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
154270107|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270108|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154270109|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154270110|NCT04616248|Protective Agents|protective agents|mesh-ancestor
154270111|NCT04597372|Tamsulosin|tamsulosin|mesh-list
154270112|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154270113|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154270114|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154270157|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154270158|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270159|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270160|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270161|NCT04551040|Terazosin|terazosin|mesh-list
154270162|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154270163|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154270164|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154270165|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
154270177|NCT04433767|Nicotine|nicotine|mesh-list
154270222|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
154270223|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154270224|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270225|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154270226|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270227|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270228|NCT04223856|Carboplatin|carboplatin|mesh-list
154270229|NCT04223856|Gemcitabine|gemcitabine|mesh-list
154270230|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
154270231|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270232|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154270283|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154270284|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
154270285|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154270286|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270287|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
154270351|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270352|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270353|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270354|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270355|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
154270356|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270358|NCT03582033|Pomalidomide|pomalidomide|mesh-list
154270359|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270415|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270416|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270417|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154270418|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
154270419|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154270420|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
154270421|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270422|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
154270423|NCT03229278|Nivolumab|nivolumab|mesh-list
154270424|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154270425|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270426|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270427|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270429|NCT03193333|Timolol|timolol|mesh-list
154270476|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154270477|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154270478|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
154270479|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270480|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270481|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270482|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
154270483|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154270484|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154270485|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
154270541|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
154270542|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270543|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270544|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154270545|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
154270546|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
154270547|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154270548|NCT02453984|Atezolizumab|atezolizumab|mesh-list
154270549|NCT02453984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154270550|NCT02453984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270551|NCT02453984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154270552|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270553|NCT02395666|Eflornithine|eflornithine|mesh-list
154270554|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270555|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154270556|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154270557|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154270558|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270559|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154270560|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270561|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270564|NCT02223819|Crizotinib|crizotinib|mesh-list
154270594|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
154270595|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
154270596|NCT01788020|Rituximab|rituximab|mesh-list
154270597|NCT01788020|Bortezomib|bortezomib|mesh-list
154270598|NCT01788020|BB 1101|bb 1101|mesh-list
154270599|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154270600|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
154270601|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270602|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270603|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154270604|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
154270605|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270606|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270607|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154270608|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270609|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
154270653|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154270654|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154270655|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270656|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154270657|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
154270658|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270660|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
154270661|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
154270662|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154270663|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270664|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
154270665|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270666|NCT03949842|Fluticasone|fluticasone|mesh-list
154270667|NCT03949842|Xhance|xhance|mesh-list
154270668|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
154270669|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
154270670|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154270671|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270672|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154270673|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
154270674|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270675|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270676|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154270677|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
154270678|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
154270702|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270703|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154270704|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154270705|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154270706|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
154270707|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270708|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154270709|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154270710|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270711|NCT05626140|Diclofenac|diclofenac|mesh-list
154270712|NCT05626140|Lacosamide|lacosamide|mesh-list
154270713|NCT05626140|Codeine|codeine|mesh-list
154270714|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154270715|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154270716|NCT05626140|Analgesics|analgesics|mesh-ancestor
154270717|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
154270737|NCT04813614|Lidocaine|lidocaine|mesh-list
154270756|NCT00234065|Aspirin|aspirin|mesh-list
154270757|NCT00234065|Cilostazol|cilostazol|mesh-list
154270758|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154270759|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154270760|NCT00234065|Analgesics|analgesics|mesh-ancestor
154270761|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
154270762|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154270763|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270764|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154270765|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154270766|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154270767|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154270768|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270769|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154270770|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154270814|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270815|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270816|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154270817|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154270818|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154270819|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154270820|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154270821|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154270822|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154270823|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154270824|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154270825|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
154270876|NCT01363336|Nifedipine|nifedipine|mesh-list
154270877|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154270878|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154270879|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270880|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154270881|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154270882|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
154270883|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
154270884|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154270942|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
154270943|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270944|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154270945|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154270946|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
154270947|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
154270948|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154270949|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154270950|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154270951|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154270952|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154270953|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154270954|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154270955|NCT03944070|Ranibizumab|ranibizumab|mesh-list
154270956|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154271000|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271001|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271002|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
154271003|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271004|NCT04575038|Brequinar|brequinar|mesh-list
154271005|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271006|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271007|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271008|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271009|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
154271010|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271011|NCT03066622|Olanzapine|olanzapine|mesh-list
154271012|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
154271013|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
154271014|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271015|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271016|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271017|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154271018|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154271019|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271051|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154271052|NCT05323214|Narcotics|narcotics|mesh-ancestor
154271053|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154271054|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154271055|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
154271056|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
154271057|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154271058|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271059|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154271060|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154271061|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271062|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271063|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271064|NCT01356862|Pasireotide|pasireotide|mesh-list
154271065|NCT01356862|Hormones|hormones|mesh-ancestor
154271066|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154271067|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271068|NCT03763760|Dexamethasone|dexamethasone|mesh-list
154271069|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271076|NCT03763760|Hormones|hormones|mesh-ancestor
154271106|NCT01365676|Hypericin|hypericin|mesh-list
154271107|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
154271108|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154271109|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271110|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
154271111|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271112|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271113|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271114|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154271115|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
154271116|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271117|NCT03754712|Vitamin D|vitamin d|mesh-list
154271118|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
154271119|NCT03754712|Vitamins|vitamins|mesh-ancestor
154271168|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
154271169|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271170|NCT05191186|Immunomodulating Agents|immunomodulating agents|mesh-list
154271171|NCT05191186|Immunologic Factors|immunologic factors|mesh-ancestor
154271172|NCT05191186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271173|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
154271174|NCT03750656|Tamsulosin|tamsulosin|mesh-list
154271175|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154271176|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154271177|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154271178|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
154271179|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154271180|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271181|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271182|NCT03750656|Urological Agents|urological agents|mesh-ancestor
154271183|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154271184|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154271185|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154271186|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
154271187|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271190|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
154271221|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271222|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154271223|NCT01370434|Dexamethasone|dexamethasone|mesh-list
154271224|NCT01370434|Doxorubicin|doxorubicin|mesh-list
154271225|NCT01370434|Vincristine|vincristine|mesh-list
154271226|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271227|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
154271228|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
154271229|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271230|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271231|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154271232|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
154271233|NCT01370434|Hormones|hormones|mesh-ancestor
154271234|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154018154|NCT02760992|Baclofen|baclofen|mesh-list
154271284|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154271285|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
154271286|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
154271287|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154271288|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154271289|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154271290|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
154271351|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154271352|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154271353|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271354|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271355|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154271356|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154271357|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
154271358|NCT00226811|Sunitinib|sunitinib|mesh-list
154271414|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271415|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154271417|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271418|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271419|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
154271420|NCT03747614|Hormones|hormones|mesh-ancestor
154271422|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154271482|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154271483|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271484|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154271485|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
154271486|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271487|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154271488|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
154271489|NCT03513250|Scopolamine|scopolamine|mesh-list
154271490|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154271491|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154271492|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
154271493|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
154271543|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271544|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154018451|NCT00954811|Hormones|hormones|mesh-ancestor
154271545|NCT01107756|Lenograstim|lenograstim|mesh-list
154271546|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154271547|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
154271548|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271549|NCT03127384|Lidocaine|lidocaine|mesh-list
154271550|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
154271551|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
154271607|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154271608|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271609|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154271610|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
154271611|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
154271612|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154271613|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271614|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
154271615|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154271616|NCT01111734|Expectorants|expectorants|mesh-ancestor
154018516|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154271670|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271671|NCT01319188|Ranibizumab|ranibizumab|mesh-list
154271672|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154271673|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154271674|NCT01319188|Growth Substances|growth substances|mesh-ancestor
154271675|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271678|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
154271738|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271739|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
154271740|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154271741|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154271742|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271743|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154271744|NCT03796728|Lidocaine|lidocaine|mesh-list
154271745|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
154271746|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
154271747|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154271748|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271749|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
154271750|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271795|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154271796|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271798|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154271799|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
154271800|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271802|NCT02529774|Dexamethasone|dexamethasone|mesh-list
154271803|NCT02529774|Capecitabine|capecitabine|mesh-list
154271804|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
154271805|NCT02529774|Fluorouracil|fluorouracil|mesh-list
154271806|NCT02529774|Floxuridine|floxuridine|mesh-list
154271807|NCT02529774|Heparin|heparin|mesh-list
154271808|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
154271809|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271810|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
154271811|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
154271815|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
154271858|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271859|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154271860|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154271861|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
154271862|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154271863|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
154271864|NCT05165992|Fentanyl|fentanyl|mesh-list
154271865|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154271866|NCT05165992|Narcotics|narcotics|mesh-ancestor
154271921|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154271922|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154271923|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154271924|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154271925|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154271926|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154271927|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154271928|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154271929|NCT05191888|Amoxicillin|amoxicillin|mesh-list
154271964|NCT01114542|Insulin|insulin|mesh-list
154271985|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271986|NCT01359514|Pregabalin|pregabalin|mesh-list
154271987|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
154271988|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154271989|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154271990|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154271991|NCT01359514|Analgesics|analgesics|mesh-ancestor
154271992|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
154271993|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154271994|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
154271995|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154271996|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154271997|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154271998|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154272006|NCT01368016|Nicotine|nicotine|mesh-list
154272045|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272046|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154272047|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
154272048|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272049|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
154272051|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
154272052|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154272053|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272054|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
154272055|NCT01359670|Tadalafil|tadalafil|mesh-list
154272056|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272057|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154272058|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154272059|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272105|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
154272106|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154272108|NCT03792672|Analgesics|analgesics|mesh-ancestor
154272109|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
154272110|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272111|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272112|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154272113|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154272114|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
154272115|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
154272116|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272117|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154272118|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154272119|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154272120|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272121|NCT01372540|Filanesib|filanesib|mesh-list
154272122|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272123|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
153595070|NCT01854216|Rotigotine|rotigotine|mesh-list
154272124|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272160|NCT01210482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272161|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154272162|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
154272163|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272164|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272165|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154272166|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272167|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154272168|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
154272169|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
154272170|NCT01360060|Analgesics|analgesics|mesh-ancestor
154272171|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
154272172|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272173|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272221|NCT01369186|Narcotics|narcotics|mesh-ancestor
154272222|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154272223|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272224|NCT01369186|Analgesics|analgesics|mesh-ancestor
154272225|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
154272226|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272227|NCT01115712|Pioglitazone|pioglitazone|mesh-list
154272228|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154272229|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272231|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272232|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272284|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154272285|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
154272286|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
154272287|NCT01328652|Lansoprazole|lansoprazole|mesh-list
154272288|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154272289|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272290|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272291|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154272292|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154272293|NCT01373008|Beclomethasone|beclomethasone|mesh-list
154272294|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154272295|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
154272296|NCT01373008|Hormones|hormones|mesh-ancestor
154272297|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272345|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272419|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
154272420|NCT01119144|Calcium|calcium|mesh-list
154272421|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154272422|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272423|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154272424|NCT01117038|Amlodipine|amlodipine|mesh-list
154272425|NCT01117038|Enalapril|enalapril|mesh-list
154272426|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154272427|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154272428|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154272429|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272430|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154272431|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272432|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272433|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154272434|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
154272435|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272436|NCT01119534|Camphor|camphor|mesh-list
154272437|NCT01119534|Eucalyptol|eucalyptol|mesh-list
154272438|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
154272439|NCT01119534|Menthol|menthol|mesh-list
154272440|NCT01119534|Guaifenesin|guaifenesin|mesh-list
154272442|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
154272472|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154272473|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272475|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
154272476|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
154272477|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154272478|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
154272479|NCT01117116|Hormones|hormones|mesh-ancestor
154272480|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272481|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154272482|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154272537|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
154272538|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154272539|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154272540|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154272541|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272542|NCT04959760|Antibodies|antibodies|mesh-list
154272543|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
154272544|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
154272547|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
154272604|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154272605|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
154272606|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154272607|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
154272608|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272609|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272610|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
154272611|NCT03633994|Heparin|heparin|mesh-list
154272612|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
154272613|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154272614|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154272615|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272616|NCT01328886|Omalizumab|omalizumab|mesh-list
154272617|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154272618|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154272619|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
154272620|NCT01216878|Losartan|losartan|mesh-list
154272663|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272664|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154272665|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272666|NCT01217034|Sorafenib|sorafenib|mesh-list
154272667|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
154272668|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272669|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154272670|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272671|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272672|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154272673|NCT01217034|Estrogens|estrogens|mesh-ancestor
154272674|NCT01217034|Hormones|hormones|mesh-ancestor
154272675|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272676|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272678|NCT01373554|Oltipraz|oltipraz|mesh-list
154272721|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154272722|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272723|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272724|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154272725|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
154272726|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272727|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272728|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154272729|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154272730|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154272731|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153460217|NCT04198727|Capecitabine|capecitabine|mesh-list
154272732|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154272733|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272734|NCT01214772|Heparin|heparin|mesh-list
154272735|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
154272736|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154272737|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154272738|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272739|NCT01125150|Metformin|metformin|mesh-list
154272776|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
154272777|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154272778|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
154272779|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272780|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272781|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154272782|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154272783|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272784|NCT03575572|Colchicine|colchicine|mesh-list
154272785|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
154272786|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154272787|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
154272788|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
154272789|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
154272833|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154272834|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
154272836|NCT01219764|Metronidazole|metronidazole|mesh-list
154272837|NCT01219764|Clarithromycin|clarithromycin|mesh-list
154272838|NCT01219764|Rabeprazole|rabeprazole|mesh-list
154272839|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154272840|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154272841|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154272842|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154272843|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154272844|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272845|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272846|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154272847|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154272894|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154272895|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154272896|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272897|NCT01123278|Testosterone|testosterone|mesh-list
154272899|NCT01123278|Hormones|hormones|mesh-ancestor
154272900|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272901|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272902|NCT01219920|Leucovorin|leucovorin|mesh-list
154272903|NCT01219920|Irinotecan|irinotecan|mesh-list
154272904|NCT01219920|Antidotes|antidotes|mesh-ancestor
154272905|NCT01219920|Protective Agents|protective agents|mesh-ancestor
154272906|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272907|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
154272908|NCT01219920|Vitamins|vitamins|mesh-ancestor
154272909|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
154272910|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154272911|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154272912|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154272913|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154272914|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154272915|NCT01400776|Estradiol|estradiol|mesh-list
154272916|NCT01400776|Estrogens|estrogens|mesh-ancestor
154272917|NCT01400776|Hormones|hormones|mesh-ancestor
154272918|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272919|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272920|NCT01220076|Tamoxifen|tamoxifen|mesh-list
154272921|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154272922|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
154272923|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154272924|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272939|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154272940|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154272941|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154272942|NCT01220154|Growth Substances|growth substances|mesh-ancestor
154272943|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272944|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
154272945|NCT01182766|Topiramate|topiramate|mesh-list
154272946|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
154272947|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154272948|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154272949|NCT01220232|Lamivudine|lamivudine|mesh-list
154273004|NCT01375972|Cisplatin|cisplatin|mesh-list
154273005|NCT01375972|Gemcitabine|gemcitabine|mesh-list
154273006|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273007|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154273008|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
154273009|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273010|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154273011|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
154273012|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273013|NCT01220622|Nimodipine|nimodipine|mesh-list
154273068|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154273069|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154273070|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273071|NCT01376128|Paroxetine|paroxetine|mesh-list
154273072|NCT01376128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154273073|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154273074|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273075|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273076|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273077|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
154273078|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273079|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154273080|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
154273081|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154273082|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154273083|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154273084|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273085|NCT01376206|Fluticasone|fluticasone|mesh-list
154273086|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273087|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154273088|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
154273095|NCT01073501|Pregabalin|pregabalin|mesh-list
154273117|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154020009|NCT00909389|Simvastatin|simvastatin|mesh-list
154273118|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273119|NCT01218750|Bevacizumab|bevacizumab|mesh-list
154273120|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154273121|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273122|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154273123|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154273124|NCT01218750|Growth Substances|growth substances|mesh-ancestor
154273182|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
154273183|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154273184|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154273185|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
154273186|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
154273187|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273188|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
154273189|NCT00220727|Antibodies|antibodies|mesh-list
154273190|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
154273191|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154273192|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154273193|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
154273194|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
154273195|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273196|NCT01072097|Atorvastatin|atorvastatin|mesh-list
154273197|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154273204|NCT05760430|Bevacizumab|bevacizumab|mesh-list
154273242|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273243|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
154273244|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154273245|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
154273246|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154273247|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
154273248|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154273249|NCT01126866|Bevacizumab|bevacizumab|mesh-list
154273250|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154273251|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273252|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154273253|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154273254|NCT01126866|Growth Substances|growth substances|mesh-ancestor
154273255|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273256|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
154273257|NCT03740568|Progesterone|progesterone|mesh-list
154273258|NCT03740568|Progestins|progestins|mesh-ancestor
154273259|NCT03740568|Hormones|hormones|mesh-ancestor
154273260|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273261|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273262|NCT00252239|Plasminogen|plasminogen|mesh-list
154273263|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154273295|NCT05731804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154273296|NCT05731804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154273297|NCT05731804|Protease Inhibitors|protease inhibitors|mesh-ancestor
154273298|NCT05731804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273299|NCT05731804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273301|NCT05731804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154273302|NCT05731804|Antiviral Agents|antiviral agents|mesh-ancestor
154273303|NCT05731804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273304|NCT05731804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154273305|NCT05731804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154273306|NCT01127568|Propranolol|propranolol|mesh-list
154273307|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154273308|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154273309|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
154273310|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273311|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273316|NCT03932292|Calcium|calcium|mesh-list
154273349|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
154273350|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273351|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273352|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273353|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154273354|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
154273355|NCT01221792|Protective Agents|protective agents|mesh-ancestor
154273356|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154273357|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273358|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154273359|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
154273362|NCT03932526|Apatinib|apatinib|mesh-list
154273411|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273413|NCT01131234|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154273414|NCT01131234|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154020314|NCT02727608|Eculizumab|eculizumab|mesh-list
154273415|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273416|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273417|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273418|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154273419|NCT01129596|Donepezil|donepezil|mesh-list
154273420|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154273421|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273422|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273423|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
154273424|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273425|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273465|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
154273466|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273467|NCT01319422|Pomalidomide|pomalidomide|mesh-list
154273468|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
154273469|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273470|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154273471|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154273472|NCT01319422|Growth Substances|growth substances|mesh-ancestor
154273473|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
154273474|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273475|NCT01227174|Propofol|propofol|mesh-list
154273476|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154273477|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273478|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273479|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154273480|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
154273481|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
154273482|NCT03924492|Pregnanolone|pregnanolone|mesh-list
154273530|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154273531|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
154273532|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273533|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273534|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154273535|NCT05415436|Propofol|propofol|mesh-list
154273536|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154273537|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273538|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273539|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154273540|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
154273541|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
154273542|NCT01227408|Paclitaxel|paclitaxel|mesh-list
154273543|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
154273544|NCT01227408|Doxorubicin|doxorubicin|mesh-list
154273545|NCT01227408|Capecitabine|capecitabine|mesh-list
154273546|NCT01227408|Methotrexate|methotrexate|mesh-list
154273547|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
154273548|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154273549|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273550|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
154273551|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813349|NCT00333476|Protective Agents|protective agents|mesh-ancestor
153441084|NCT00004207|Daunorubicin|daunorubicin|mesh-list
154273553|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273554|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154273555|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
154273556|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273557|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154273558|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154273559|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
154273560|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154273561|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154273573|NCT03773796|Nabilone|nabilone|mesh-list
154273614|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273615|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
154273616|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154273617|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273618|NCT03222856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154273619|NCT03222856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273620|NCT01130298|Testosterone|testosterone|mesh-list
154273621|NCT01130298|Androgens|androgens|mesh-ancestor
154273622|NCT01130298|Hormones|hormones|mesh-ancestor
154273623|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273624|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273625|NCT01227720|Nicotine|nicotine|mesh-list
154273626|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154273627|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
154273628|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273629|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273630|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154273669|NCT01130376|Interleukin-2|interleukin-2|mesh-list
154273670|NCT01130376|Hormones|hormones|mesh-list
154273671|NCT01130376|Sargramostim|sargramostim|mesh-list
154273672|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154273673|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273674|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273675|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154273676|NCT01130376|Analgesics|analgesics|mesh-ancestor
154273677|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
154273678|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154273679|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
154273680|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154273681|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154273682|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
154273683|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273684|NCT03740178|Donepezil|donepezil|mesh-list
154273685|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154273686|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273687|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273688|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
154273689|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273690|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273691|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
154273692|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
154273694|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
154273717|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
154273718|NCT01225302|Paclitaxel|paclitaxel|mesh-list
154273719|NCT01225302|Carboplatin|carboplatin|mesh-list
154273720|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154273721|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273722|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
154273723|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
154273724|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
154273725|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273726|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
154273727|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
154273728|NCT01229046|Ticarcillin|ticarcillin|mesh-list
154273729|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
154273730|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154273731|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273732|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273733|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273734|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154273735|NCT03921684|Capecitabine|capecitabine|mesh-list
154273736|NCT03921684|Nivolumab|nivolumab|mesh-list
154273737|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154273738|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
154273739|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273740|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273741|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154273742|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154273743|NCT03929094|Paclitaxel|paclitaxel|mesh-list
154273745|NCT03929094|Gemcitabine|gemcitabine|mesh-list
154273765|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154273766|NCT03925818|Metronidazole|metronidazole|mesh-list
154273767|NCT03925818|Tetracycline|tetracycline|mesh-list
154273768|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154273769|NCT03925818|Pantoprazole|pantoprazole|mesh-list
154273770|NCT03925818|Bismuth|bismuth|mesh-list
154273771|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273772|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154273773|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154273774|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154273775|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154273776|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154273777|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154273778|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273779|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273780|NCT03925818|Antacids|antacids|mesh-ancestor
154273781|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154273782|NCT03925740|Listerine|listerine|mesh-list
154273783|NCT03925740|Fluorides|fluorides|mesh-list
154273784|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
154273785|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
154273786|NCT03925740|Protective Agents|protective agents|mesh-ancestor
154273820|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154273821|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
154273822|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
154273823|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
154273824|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273825|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273826|NCT01229202|Bevacizumab|bevacizumab|mesh-list
154273827|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154273828|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273829|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154273830|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154273831|NCT01229202|Growth Substances|growth substances|mesh-ancestor
154273832|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273833|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
154273834|NCT01229280|Darifenacin|darifenacin|mesh-list
154273835|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154273836|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
154273837|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154273838|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154273839|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273840|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273841|NCT01229280|Urological Agents|urological agents|mesh-ancestor
154273870|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154273871|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154273872|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154273873|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273874|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273875|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154273876|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
154273882|NCT01131000|Ibuprofen|ibuprofen|mesh-list
154273933|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154273934|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273935|NCT01131936|Amlodipine|amlodipine|mesh-list
154273936|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154273937|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154273938|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154273939|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154273940|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154273941|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273942|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
154273996|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154273997|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
154273998|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154273999|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154274000|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274065|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154274066|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154274067|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154274068|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274069|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274070|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154274071|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154274072|NCT01233492|Mannitol|mannitol|mesh-list
154274073|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154274074|NCT01233492|Diuretics|diuretics|mesh-ancestor
154274075|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
154274076|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274077|NCT01135056|Sorafenib|sorafenib|mesh-list
154274078|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274079|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154274080|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274081|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274082|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
154274083|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154274128|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
154274129|NCT01135680|Glycerol|glycerol|mesh-list
154274130|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274131|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274132|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154274133|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154274134|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274135|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274136|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154274137|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274138|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154274139|NCT01135680|Protective Agents|protective agents|mesh-ancestor
154274140|NCT01135758|Ketamine|ketamine|mesh-list
154274141|NCT01135758|Analgesics|analgesics|mesh-ancestor
154274142|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
154274143|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274144|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274145|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154274146|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154274147|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
154274148|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
154274149|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274150|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154274151|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154274152|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274153|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274154|NCT05401032|Tamsulosin|tamsulosin|mesh-list
154274155|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154274156|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154274157|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154274158|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
154274159|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274160|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274161|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274162|NCT05401032|Urological Agents|urological agents|mesh-ancestor
154274163|NCT03768726|Ziprasidone|ziprasidone|mesh-list
154274164|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154274165|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
154274166|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274167|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274168|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274169|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154274170|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154274171|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274172|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154274173|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154274174|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
154274175|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
154274176|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154274177|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
154274178|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274179|NCT01138956|Expectorants|expectorants|mesh-ancestor
154274180|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
154274181|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154274182|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
154274184|NCT01138956|Protective Agents|protective agents|mesh-ancestor
154274194|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274195|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274196|NCT01232244|Incretins|incretins|mesh-ancestor
154274197|NCT03917784|Curcumin|curcumin|mesh-list
154274198|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154274199|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154274200|NCT03917784|Analgesics|analgesics|mesh-ancestor
154274201|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
154274202|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274203|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274204|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274205|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154274256|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154274257|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154274258|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274259|NCT01136850|Azithromycin|azithromycin|mesh-list
154274260|NCT01136850|Chloroquine|chloroquine|mesh-list
154274261|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
154274262|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
154274263|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154274264|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154274265|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274266|NCT01136850|Amebicides|amebicides|mesh-ancestor
154274267|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154274275|NCT01234116|Tenofovir|tenofovir|mesh-list
154274320|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154274321|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
154274322|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274323|NCT01231074|Metformin|metformin|mesh-list
154274324|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154274325|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274327|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154274328|NCT03917394|Trace Elements|trace elements|mesh-ancestor
154274329|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
154274330|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274331|NCT03917394|Hematinics|hematinics|mesh-ancestor
154274332|NCT03769896|Nabilone|nabilone|mesh-list
154274333|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
154274334|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
154274335|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274336|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274337|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154274338|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154274339|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154274340|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274341|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154274342|NCT01234194|Remifentanil|remifentanil|mesh-list
154274343|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154274344|NCT01234194|Narcotics|narcotics|mesh-ancestor
154274347|NCT01234194|Analgesics|analgesics|mesh-ancestor
154274374|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
154274375|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
154274376|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
154274377|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154274378|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274379|NCT01140438|Incretins|incretins|mesh-ancestor
154274380|NCT01140438|Hormones|hormones|mesh-ancestor
154274381|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274382|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154274383|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
154274384|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460266|NCT03914443|Docetaxel|docetaxel|mesh-list
154274385|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274386|NCT01234506|Vitamin D|vitamin d|mesh-list
154274387|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
154274388|NCT01234506|Vitamins|vitamins|mesh-ancestor
154274389|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
154274390|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274391|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154274392|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
154274393|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154274394|NCT01234506|Estrogens|estrogens|mesh-ancestor
154274395|NCT01234506|Hormones|hormones|mesh-ancestor
154274396|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274397|NCT04751604|Niacinamide|niacinamide|mesh-list
154274398|NCT04751604|Niacin|niacin|mesh-list
154274424|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154274425|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154274426|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154274427|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154274428|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154274429|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154274430|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
154274431|NCT01231698|Esmolol|esmolol|mesh-list
154274489|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274490|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
154274491|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154274492|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
154274493|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154274494|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274495|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154274496|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154274497|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154274498|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
154274499|NCT03714594|Saxagliptin|saxagliptin|mesh-list
154274500|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154274501|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274502|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154274503|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274504|NCT03714594|Incretins|incretins|mesh-ancestor
154274505|NCT03714594|Hormones|hormones|mesh-ancestor
154274506|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274544|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274546|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154274547|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274548|NCT01236612|Chloroquine|chloroquine|mesh-list
154274549|NCT01236612|Proguanil|proguanil|mesh-list
154274550|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154274551|NCT01236612|Amebicides|amebicides|mesh-ancestor
154274552|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154274553|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154274554|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274555|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
154274556|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154274557|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
154274558|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274559|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
154274603|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274604|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274605|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153595511|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154274607|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154274608|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
154274609|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274610|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274611|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154274612|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
154274669|NCT05848531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154274670|NCT05848531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154274671|NCT05848531|Adrenergic Agents|adrenergic agents|mesh-ancestor
154274672|NCT05848531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274673|NCT05848531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274675|NCT05848505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154274676|NCT05848505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154274677|NCT05848505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274678|NCT05848505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154274679|NCT05848505|Analgesics|analgesics|mesh-ancestor
154274680|NCT05848505|Sensory System Agents|sensory system agents|mesh-ancestor
154274681|NCT05848505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274728|NCT05846373|Micronutrients|micronutrients|mesh-ancestor
154274729|NCT05846373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274731|NCT05846243|Immunologic Factors|immunologic factors|mesh-ancestor
154274732|NCT05846243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274733|NCT05846139|Chlorhexidine|chlorhexidine|mesh-list
154274734|NCT05846139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154274735|NCT05846139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154274736|NCT05846139|Disinfectants|disinfectants|mesh-ancestor
154274737|NCT05845723|Cyclophosphamide|cyclophosphamide|mesh-list
154274738|NCT05845723|Tofacitinib|tofacitinib|mesh-list
154274739|NCT05845723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154274740|NCT05845723|Immunologic Factors|immunologic factors|mesh-ancestor
154274741|NCT05845723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274742|NCT05845723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154274743|NCT05845723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154274744|NCT05845723|Alkylating Agents|alkylating agents|mesh-ancestor
154274745|NCT05845723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274785|NCT05844930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274786|NCT05844930|Sensory System Agents|sensory system agents|mesh-ancestor
154274787|NCT05844930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154274788|NCT05844930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154274789|NCT05844930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154274790|NCT05844930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154274791|NCT05844930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154274792|NCT05844930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274793|NCT05844930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154274794|NCT05844930|Glucocorticoids|glucocorticoids|mesh-ancestor
154274795|NCT05844930|Hormones|hormones|mesh-ancestor
154274796|NCT05844930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154274797|NCT05844800|Bupivacaine|bupivacaine|mesh-list
153616370|NCT06327321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153616371|NCT06327321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616372|NCT06327321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274843|NCT05843812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154274845|NCT05843617|Ascorbic Acid|ascorbic acid|mesh-list
154274846|NCT05843617|Micronutrients|micronutrients|mesh-ancestor
154274847|NCT05843617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274908|NCT05840848|Carotenoids|carotenoids|mesh-list
154274909|NCT05840848|Antioxidants|antioxidants|mesh-ancestor
154274910|NCT05840848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274911|NCT05840848|Protective Agents|protective agents|mesh-ancestor
154274912|NCT05840848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274913|NCT05840848|Provitamins|provitamins|mesh-ancestor
154274914|NCT05840848|Vitamins|vitamins|mesh-ancestor
154274915|NCT05840848|Micronutrients|micronutrients|mesh-ancestor
154274917|NCT05840835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154274918|NCT05840835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460300|NCT03716349|Anesthetics|anesthetics|mesh-list
154274919|NCT05840562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154274920|NCT05840562|Capsaicin|capsaicin|mesh-list
154274921|NCT05840562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154274922|NCT05840562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154274923|NCT05840562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154274924|NCT05840562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274925|NCT05840562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154274926|NCT05840562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154274927|NCT05840562|Analgesics|analgesics|mesh-ancestor
154274928|NCT05840562|Sensory System Agents|sensory system agents|mesh-ancestor
154274935|NCT05840289|Rituximab|rituximab|mesh-list
154274964|NCT05824494|Antimitotic Agents|antimitotic agents|mesh-ancestor
154274965|NCT05824494|Mitosis Modulators|mitosis modulators|mesh-ancestor
154274966|NCT05824494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274967|NCT05824000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154274968|NCT05824000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154274970|NCT05823506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
154274971|NCT05823506|Vasodilator Agents|vasodilator agents|mesh-ancestor
154274972|NCT05823506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154274973|NCT05823506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154274974|NCT05823506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154274975|NCT05823506|Urological Agents|urological agents|mesh-ancestor
154274976|NCT05822817|Propofol|propofol|mesh-list
154275028|NCT05805072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275029|NCT05805072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275030|NCT05805072|Antiviral Agents|antiviral agents|mesh-ancestor
154275031|NCT05805072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275032|NCT05805072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154275033|NCT05805072|Immunologic Factors|immunologic factors|mesh-ancestor
154275034|NCT05805072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275035|NCT05805072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275036|NCT05805072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154275037|NCT05805072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154275092|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275093|NCT05654818|Vitamin D|vitamin d|mesh-list
154275094|NCT05654818|Vitamins|vitamins|mesh-ancestor
154275095|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
154275096|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275097|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154275098|NCT05613205|Vaccines|vaccines|mesh-list
154275099|NCT05613205|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
154275100|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
154275101|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275102|NCT05613205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154275103|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
154275104|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
154275105|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154275106|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275107|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275108|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275109|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154275110|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
154275111|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154275112|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
154275113|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275143|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275144|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275145|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154275146|NCT05388773|Carboplatin|carboplatin|mesh-list
154275147|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275148|NCT05383521|Tinidazole|tinidazole|mesh-list
154275149|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
154275150|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275151|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154275152|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154275153|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154275154|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154275155|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154275204|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
154275205|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154275206|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154275207|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275208|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
154275209|NCT05248321|Coagulants|coagulants|mesh-ancestor
154275210|NCT05241093|Cytarabine|cytarabine|mesh-list
154275211|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154275212|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
154275220|NCT05233163|Empagliflozin|empagliflozin|mesh-list
154275270|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154275271|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275272|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275273|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154275274|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154275275|NCT05128071|Progesterone|progesterone|mesh-list
154275276|NCT05128071|Progestins|progestins|mesh-ancestor
154275277|NCT05128071|Hormones|hormones|mesh-ancestor
154275278|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154275279|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275280|NCT05121324|Midazolam|midazolam|mesh-list
154275281|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154275282|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154275283|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275284|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275285|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154275286|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154275287|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154275288|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154275289|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
154275290|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
154022170|NCT03481556|Melphalan|melphalan|mesh-list
154275291|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
154275292|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
154275293|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275294|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275296|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154275297|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
154275303|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
154275316|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154275317|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
154275318|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
154275319|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275320|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275321|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154275322|NCT05074992|Ipilimumab|ipilimumab|mesh-list
154275323|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154275324|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275325|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154275326|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275327|NCT05063656|Gabapentin|gabapentin|mesh-list
154275328|NCT05063656|Analgesics|analgesics|mesh-ancestor
154275329|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
154275330|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275331|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275332|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
154275333|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154275334|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154275335|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275336|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154275337|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154275338|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154275339|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275340|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275341|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
154275342|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154275343|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154275344|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
154275345|NCT05047601|Ritonavir|ritonavir|mesh-list
154275346|NCT05047601|Nirmatrelvir|nirmatrelvir|mesh-list
154275358|NCT05022329|Vaccines|vaccines|mesh-list
154275359|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
154275360|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275361|NCT05011760|Amphetamine|amphetamine|mesh-list
154275362|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
154275363|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154275364|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275365|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
154275366|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
154275367|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275368|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
154275369|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275370|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275371|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275381|NCT05006599|Insulin|insulin|mesh-list
153617145|NCT05786521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153617146|NCT05786521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275419|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154275420|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154275421|NCT04937699|Analgesics|analgesics|mesh-ancestor
154275422|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
154275423|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275424|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275485|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
154275486|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275487|NCT04827147|Methamphetamine|methamphetamine|mesh-list
154275488|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154275489|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275490|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
154275491|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
154275492|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275493|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
154275494|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275549|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
154275550|NCT04761614|Antibodies|antibodies|mesh-list
154275551|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
154275552|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154275553|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
154275554|NCT04761614|Calcium|calcium|mesh-list
154275555|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
154275556|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275557|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154275614|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154275615|NCT04688658|Nivolumab|nivolumab|mesh-list
154275616|NCT04688658|Axitinib|axitinib|mesh-list
154275617|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154275618|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275619|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154275620|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275621|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154275622|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275623|NCT04658784|Cyclopropane|cyclopropane|mesh-list
154275624|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
154275625|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275626|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275627|NCT04657640|Iron|iron|mesh-list
154275628|NCT04657640|Trace Elements|trace elements|mesh-list
154275629|NCT04657640|Folic Acid|folic acid|mesh-list
154275675|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275676|NCT04586088|Apatinib|apatinib|mesh-list
154275677|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275678|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154275679|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154275680|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275681|NCT04579510|Vaccines|vaccines|mesh-list
154275682|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
154275683|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275684|NCT04579120|Corticosterone|corticosterone|mesh-list
154275685|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154275686|NCT04527900|Paclitaxel|paclitaxel|mesh-list
154275687|NCT04527900|Carboplatin|carboplatin|mesh-list
154275688|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154275689|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275690|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
154275691|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
154275692|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
154275693|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275694|NCT04549168|Lemborexant|lemborexant|mesh-list
154275695|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154275696|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275697|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275698|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154275699|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154275700|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154275701|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275702|NCT04509050|Ivacaftor|ivacaftor|mesh-list
154275703|NCT04509050|Elexacaftor|elexacaftor|mesh-list
154275704|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154275705|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154275706|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275708|NCT04456439|Promethazine|promethazine|mesh-list
154275715|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275716|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
154275717|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
154275718|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
154275719|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275720|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
154275721|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
154275722|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154275723|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154275724|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
154275725|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
154275726|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275727|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275778|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154275779|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154275780|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
154275781|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
154275782|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275783|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275784|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275785|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
154275786|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154275787|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154275788|NCT04386967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154275789|NCT04386967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275790|NCT04378933|Methamphetamine|methamphetamine|mesh-list
154275791|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154275792|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275793|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
154275794|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
154275795|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275796|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
154275797|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275799|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275830|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275831|NCT04233190|Budesonide|budesonide|mesh-list
154275832|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
154275833|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154275834|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
154275835|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275836|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275837|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154275838|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
154275839|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153595777|NCT01857921|Trimetazidine|trimetazidine|mesh-list
154275840|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154275841|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154275842|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
154275843|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275891|NCT03988530|Scopolamine|scopolamine|mesh-list
154022770|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
154275892|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154275893|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154275895|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
154275896|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154275897|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275898|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154275899|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
154275959|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154275960|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
154275961|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154275962|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154275963|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154275964|NCT03946124|Urological Agents|urological agents|mesh-ancestor
153617965|NCT04216329|Temozolomide|temozolomide|mesh-list
153617966|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153617967|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
153617968|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617969|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276030|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276031|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
154276032|NCT03715972|Acetazolamide|acetazolamide|mesh-list
154276033|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276034|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
154276091|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
154276092|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276093|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276094|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154276095|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
154276096|NCT03578081|Hormones|hormones|mesh-ancestor
154276097|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276098|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154276099|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276100|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
154276101|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
154276102|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154276103|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154276104|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
154276105|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276106|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276107|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154276150|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154276151|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154276152|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276153|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154276154|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154276155|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276156|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276157|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
154276158|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276159|NCT03497143|Lamotrigine|lamotrigine|mesh-list
154276160|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
154276161|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154276162|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276163|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276164|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154276165|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276204|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276205|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154276206|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
154276207|NCT03314636|Hormones|hormones|mesh-ancestor
154276208|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276209|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154276210|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276211|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
154276212|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154276213|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154276214|NCT03314636|Growth Substances|growth substances|mesh-ancestor
154276266|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276267|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154023151|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
154276268|NCT03201939|Lisinopril|lisinopril|mesh-list
154276269|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154276270|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
154276271|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276272|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276273|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154276274|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154276275|NCT03201939|Protective Agents|protective agents|mesh-ancestor
154276276|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276277|NCT03179761|Vaccines|vaccines|mesh-list
154276278|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
154276279|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276280|NCT03158064|Durvalumab|durvalumab|mesh-list
154276281|NCT03158064|Tremelimumab|tremelimumab|mesh-list
154276282|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276283|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276284|NCT03087708|Naloxegol|naloxegol|mesh-list
154276285|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154276286|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276287|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
154276288|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276289|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
154276290|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154276291|NCT03057847|Velpatasvir|velpatasvir|mesh-list
154276292|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
154276293|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276312|NCT02819024|Ichthammol|ichthammol|mesh-list
154276313|NCT02819024|BB 1101|bb 1101|mesh-list
154276314|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276315|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
154276316|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
154276317|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276318|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276319|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154276320|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
154276321|NCT02819024|Hormones|hormones|mesh-ancestor
154276322|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276323|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154276324|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276325|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
154276326|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276375|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
154276376|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
154276377|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276378|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276379|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154276380|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
154276381|NCT02765854|Hormones|hormones|mesh-ancestor
154276382|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276383|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154276384|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276385|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
154276386|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154276387|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154276388|NCT02765854|Growth Substances|growth substances|mesh-ancestor
154276389|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
154276390|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276391|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
154276392|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276393|NCT02761694|Paclitaxel|paclitaxel|mesh-list
154276394|NCT02761694|Fulvestrant|fulvestrant|mesh-list
154276395|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154276396|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276397|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
154276398|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276399|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
154276400|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276401|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154276402|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154276419|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276420|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154276422|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276423|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276424|NCT02641093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154276425|NCT02641093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276426|NCT02578732|Leucovorin|leucovorin|mesh-list
154276427|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
154276428|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276429|NCT02578732|Antidotes|antidotes|mesh-ancestor
154276430|NCT02578732|Protective Agents|protective agents|mesh-ancestor
154276431|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276432|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
154276433|NCT02578732|Vitamins|vitamins|mesh-ancestor
154276434|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
154276437|NCT02505984|Oxytocin|oxytocin|mesh-list
154276438|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
154276439|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154276440|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276441|NCT02477280|Methylphenidate|methylphenidate|mesh-list
154276442|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154276471|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154276472|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154276473|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154276474|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276475|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154276476|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276477|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
154276478|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154276479|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154276480|NCT02332577|Amoxicillin|amoxicillin|mesh-list
154276481|NCT02332577|Pristinamycin|pristinamycin|mesh-list
154276482|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276483|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276534|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276535|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154276536|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
154276537|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154276538|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276539|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276540|NCT02297139|Dasatinib|dasatinib|mesh-list
154276546|NCT02137759|Temozolomide|temozolomide|mesh-list
154276597|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154276598|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276599|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154276600|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154276601|NCT01814813|Growth Substances|growth substances|mesh-ancestor
154276602|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276603|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
154276605|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
154276665|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
154276666|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595947|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154276667|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154276668|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276669|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154276670|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
154276671|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276672|NCT01420874|Antidotes|antidotes|mesh-ancestor
154276673|NCT01420874|Protective Agents|protective agents|mesh-ancestor
154276674|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
154276675|NCT01420874|Vitamins|vitamins|mesh-ancestor
154276676|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
154276677|NCT01405521|Vaccines|vaccines|mesh-list
154276678|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
154276679|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276680|NCT01027000|Sirolimus|sirolimus|mesh-list
154276681|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
154276682|NCT01027000|Busulfan|busulfan|mesh-list
154276683|NCT01027000|Rituximab|rituximab|mesh-list
154276684|NCT01027000|Methotrexate|methotrexate|mesh-list
154276685|NCT01027000|Fludarabine|fludarabine|mesh-list
154276719|NCT00844285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154276720|NCT00844285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276721|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154276723|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276724|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276725|NCT00841789|Etanercept|etanercept|mesh-list
154276726|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154276727|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154276728|NCT00841789|Analgesics|analgesics|mesh-ancestor
154276729|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
154276730|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276731|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276732|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154276733|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154276734|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154276735|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154276736|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
154276737|NCT00711646|Nabiximols|nabiximols|mesh-list
154276738|NCT00711646|Analgesics|analgesics|mesh-ancestor
154276775|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154276776|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
154276777|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276778|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276779|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154276780|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154276781|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154276782|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154276783|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276784|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154276785|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
154276786|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276787|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
154276788|NCT00379340|Keratolytic Agents|keratolytic agents|mesh-ancestor
154276789|NCT00379340|Dermatologic Agents|dermatologic agents|mesh-ancestor
154276790|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154276791|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276792|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154276793|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154276830|NCT05795478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154276831|NCT05795478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154276832|NCT05795478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154276833|NCT05795478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154276834|NCT05795478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154276835|NCT05795478|Narcotics|narcotics|mesh-ancestor
154276836|NCT05795400|Dapagliflozin|dapagliflozin|mesh-list
154276837|NCT05795400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154276838|NCT05795400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276839|NCT05795400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154276841|NCT05795283|Dexetimide|dexetimide|mesh-list
154276894|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
154276895|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
154276896|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154276897|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154276898|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154276899|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276900|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276902|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
154276903|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276904|NCT05588648|Vactosertib|vactosertib|mesh-list
154276905|NCT05588648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276906|NCT05588648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276907|NCT05588648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276908|NCT05550194|Valacyclovir|valacyclovir|mesh-list
154276909|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
154276910|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154276911|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154276912|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
154276913|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276914|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154276915|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154276916|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
154276917|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276918|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276919|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154276920|NCT05426486|Carboplatin|carboplatin|mesh-list
154276921|NCT05426486|Docetaxel|docetaxel|mesh-list
154276922|NCT05426486|Trastuzumab|trastuzumab|mesh-list
154276923|NCT05426486|Pertuzumab|pertuzumab|mesh-list
154276924|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276925|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
154276926|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276927|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
154276928|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154023822|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
154276945|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276946|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154276947|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276948|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154276949|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
154276951|NCT05318248|Analgesics|analgesics|mesh-ancestor
154276952|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
154276953|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276954|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276955|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154276956|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
154276957|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
154276958|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154276959|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154276960|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154276961|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
153646455|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
154276962|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154276963|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276964|NCT05219266|Midostaurin|midostaurin|mesh-list
154276965|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276966|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154276967|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276968|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276969|NCT05204862|Antibodies|antibodies|mesh-list
154276970|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
154276971|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276972|NCT05193851|Ricolinostat|ricolinostat|mesh-list
153596023|NCT01858870|Lacosamide|lacosamide|mesh-list
154276973|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154276974|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154276975|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154276976|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154276977|NCT05193318|Ketamine|ketamine|mesh-list
154276978|NCT05193318|Analgesics|analgesics|mesh-ancestor
154276979|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
154276980|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154276981|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154276985|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
154277014|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277015|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
154277016|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154277017|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154277018|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
154277019|NCT05054725|Sotorasib|sotorasib|mesh-list
154277020|NCT05054725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154277021|NCT05054725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277022|NCT05054725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277023|NCT05054725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277024|NCT05046522|Palmidrol|palmidrol|mesh-list
154277025|NCT05046522|Analgesics|analgesics|mesh-ancestor
154277026|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
154277027|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277028|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277029|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154277030|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154277031|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154277039|NCT05046522|Hormones|hormones|mesh-ancestor
154277067|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
154277068|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277069|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154277070|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
154277071|NCT04716075|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154277072|NCT04716075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277073|NCT04716075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277074|NCT04716075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277075|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277076|NCT04688931|Mitomycins|mitomycins|mesh-list
154277077|NCT04688931|Mitomycin|mitomycin|mesh-list
154277078|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154277079|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277080|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
154277081|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277082|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154277083|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277084|NCT04630769|Interleukin-2|interleukin-2|mesh-list
154277085|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277086|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154277087|NCT04630769|Analgesics|analgesics|mesh-ancestor
154277088|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
154277089|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277090|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277091|NCT04543188|Midazolam|midazolam|mesh-list
154277092|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154277096|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154277115|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277116|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277117|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154277118|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277119|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154277184|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277185|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277186|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154277187|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154277188|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
154277189|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277190|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277193|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154277251|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
154277252|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154277253|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
154277254|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277255|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277256|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277257|NCT03025880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154277317|NCT01345175|Metronidazole|metronidazole|mesh-list
154277318|NCT01345175|Rifaximin|rifaximin|mesh-list
154277319|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154277320|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277321|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
154277322|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154277323|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154277324|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154277325|NCT01257139|Docetaxel|docetaxel|mesh-list
154277326|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277327|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
154277328|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
154277329|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
154277330|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277331|NCT01243190|Ofatumumab|ofatumumab|mesh-list
154277332|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277378|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154277379|NCT05282940|Estradiol|estradiol|mesh-list
154277380|NCT05282940|Estrogens|estrogens|mesh-ancestor
154277381|NCT05282940|Hormones|hormones|mesh-ancestor
154277382|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277383|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277384|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154277385|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
154277386|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154277387|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154277388|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154277389|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154277390|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154277391|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154277392|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154277393|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154277394|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154277395|NCT01238562|Lenograstim|lenograstim|mesh-list
154277396|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154277397|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
154277399|NCT01329666|Vitamin D|vitamin d|mesh-list
154277430|NCT01143948|Insulin|insulin|mesh-list
154277431|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154277432|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154277433|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277434|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
154277435|NCT01145976|Fludarabine|fludarabine|mesh-list
154277436|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
154277437|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154277438|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277439|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
154277440|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277441|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154277442|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154277493|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154277494|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277495|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277496|NCT03971201|Sorafenib|sorafenib|mesh-list
154277497|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277498|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154277499|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277500|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277501|NCT01236144|Plerixafor|plerixafor|mesh-list
154277502|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154277503|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154277504|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
154277505|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277506|NCT02528526|Inositol|inositol|mesh-list
154277507|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
154277508|NCT02528526|Vitamins|vitamins|mesh-ancestor
154277509|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
154277510|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277511|NCT03971279|Dexamethasone|dexamethasone|mesh-list
154277512|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154277513|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
154277514|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
154277515|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154277516|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277517|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154277545|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154277546|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154277547|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154277548|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154024417|NCT00618176|Lamivudine|lamivudine|mesh-list
154277549|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277550|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
154277551|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154277552|NCT00162773|Omalizumab|omalizumab|mesh-list
154277609|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154277610|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277611|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277612|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
154277613|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
154277614|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154277615|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277616|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154277617|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154277618|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
154277619|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154277620|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154277621|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154277622|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154277623|NCT00160667|Brivaracetam|brivaracetam|mesh-list
154277624|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
154277625|NCT00206375|Hormones|hormones|mesh-list
154277626|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277627|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277628|NCT00160199|Progesterone|progesterone|mesh-list
154277661|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154277662|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154277663|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154277664|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
154277665|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154277666|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154277667|NCT01074281|Enalapril|enalapril|mesh-list
154277668|NCT01074281|Enalaprilat|enalaprilat|mesh-list
154277669|NCT01074281|Nitrendipine|nitrendipine|mesh-list
154277670|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277671|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277724|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277725|NCT05418166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154277726|NCT05418166|Protease Inhibitors|protease inhibitors|mesh-ancestor
154277727|NCT05418166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277728|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154277729|NCT01631214|Alendronate|alendronate|mesh-list
154277730|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154277731|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154277732|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277733|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
154277790|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154277791|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154277792|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154277793|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277794|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154277795|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
154277796|NCT01239888|Hormones|hormones|mesh-ancestor
154277797|NCT01318486|Heparin|heparin|mesh-list
154277798|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
154277799|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154277800|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154277801|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277802|NCT03436108|Bisphenol A|bisphenol a|mesh-list
154277803|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154277848|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154277849|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154277850|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154277851|NCT05196256|Sufentanil|sufentanil|mesh-list
154277852|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
154277853|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154277854|NCT05196256|Narcotics|narcotics|mesh-ancestor
154277855|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154277857|NCT05196256|Analgesics|analgesics|mesh-ancestor
154277925|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154277926|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154277927|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
154277928|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154277929|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154277930|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277931|NCT01375816|Antidotes|antidotes|mesh-ancestor
154277932|NCT01375816|Protective Agents|protective agents|mesh-ancestor
154277933|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
154277935|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
154277936|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
154277937|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154277938|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154277939|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277940|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
154277941|NCT03632824|Coagulants|coagulants|mesh-ancestor
154277942|NCT00911820|Bevacizumab|bevacizumab|mesh-list
154277943|NCT00911820|Cisplatin|cisplatin|mesh-list
154277944|NCT00911820|Docetaxel|docetaxel|mesh-list
154277945|NCT00911820|Irinotecan|irinotecan|mesh-list
154277946|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154277947|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154277948|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154277949|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154277950|NCT00911820|Growth Substances|growth substances|mesh-ancestor
154277951|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277952|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
154277953|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
154277954|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
154277955|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
154277956|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154277957|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154277958|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154277959|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154277960|NCT05348122|Dulaglutide|dulaglutide|mesh-list
154277961|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154277962|NCT05348122|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154277963|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154277964|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154277965|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
154277966|NCT05038618|Somatomedin B|somatomedin b|mesh-list
154277967|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154278008|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278009|NCT01245660|Lapatinib|lapatinib|mesh-list
154278010|NCT01245660|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154278011|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154278012|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278013|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278014|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278015|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
154278016|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278074|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
154278075|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278076|NCT03632590|Cathartics|cathartics|mesh-ancestor
154278077|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154278078|NCT03632590|Antacids|antacids|mesh-ancestor
154278079|NCT05376670|Gentamicins|gentamicins|mesh-list
154278080|NCT05376670|Tobramycin|tobramycin|mesh-list
154278081|NCT05376670|Amikacin|amikacin|mesh-list
154278082|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154278083|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154278084|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154278085|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278086|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278087|NCT01242774|Panobinostat|panobinostat|mesh-list
154278088|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278089|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154278092|NCT01243086|Dexamethasone|dexamethasone|mesh-list
154278134|NCT01147692|Simvastatin|simvastatin|mesh-list
154278135|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154278136|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154278137|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
154278138|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278139|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154278140|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154278141|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278198|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154278199|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
154278201|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154278202|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154278203|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278204|NCT01249638|Bevacizumab|bevacizumab|mesh-list
154278205|NCT01249638|Capecitabine|capecitabine|mesh-list
154278206|NCT01249638|Irinotecan|irinotecan|mesh-list
154278207|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278208|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278209|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278260|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
154278261|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154278263|NCT01252056|Probucol|probucol|mesh-list
154278264|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154278265|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
154278266|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278267|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278330|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154278331|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154278332|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154278333|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154278334|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
154278335|NCT01250340|Aspirin|aspirin|mesh-list
154278336|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154278337|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154278338|NCT01250340|Analgesics|analgesics|mesh-ancestor
154278339|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
154278340|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278341|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278397|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278398|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278399|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154278400|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
154278401|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
154278402|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154278403|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154278404|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154278405|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154278406|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
154278407|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278408|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278409|NCT03913884|Mitogens|mitogens|mesh-list
154278410|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
154278411|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278412|NCT01147224|Ciclesonide|ciclesonide|mesh-list
154278413|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
154278414|NCT01147224|Hormones|hormones|mesh-ancestor
154278415|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154278416|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278417|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154278418|NCT03913650|Bupivacaine|bupivacaine|mesh-list
154278448|NCT03909594|Bupivacaine|bupivacaine|mesh-list
154278449|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
154278450|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
154278451|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154025324|NCT02841137|Hormones|hormones|mesh-ancestor
154278453|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
154278454|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278455|NCT03909594|Analgesics|analgesics|mesh-ancestor
154278456|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154278457|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154278513|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154278514|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154278515|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154278516|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154278517|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278518|NCT01256268|Paclitaxel|paclitaxel|mesh-list
154278519|NCT01256268|Carboplatin|carboplatin|mesh-list
154278520|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154278521|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278522|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
154278523|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
154278524|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
154278525|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278526|NCT03902106|Albuterol|albuterol|mesh-list
154278527|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154278528|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
154278529|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154278530|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278533|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
154278569|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278570|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278571|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154278572|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154278573|NCT01256580|Growth Substances|growth substances|mesh-ancestor
154278574|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278575|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
154278577|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
154278637|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154278638|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278639|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
154278640|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278641|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278642|NCT01149018|Dronabinol|dronabinol|mesh-list
154278643|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
154278644|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278645|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154278702|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154278703|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154278705|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154278706|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154278707|NCT01149564|Analgesics|analgesics|mesh-ancestor
154278708|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
154278769|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278770|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278771|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
154278772|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278773|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278774|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
154278775|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154278776|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154278777|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154278778|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154278779|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154278780|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154278781|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154278782|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154278783|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154278824|NCT05942768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154278825|NCT05942768|Antibodies|antibodies|mesh-list
154278826|NCT05942768|Immunologic Factors|immunologic factors|mesh-ancestor
154278827|NCT05942768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278828|NCT05942768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278829|NCT05942768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278830|NCT05942768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278831|NCT05942573|Paclitaxel|paclitaxel|mesh-list
154278832|NCT05942573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154278833|NCT05942573|Apatinib|apatinib|mesh-list
154278834|NCT05942573|Ramucirumab|ramucirumab|mesh-list
154278835|NCT05942573|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154278836|NCT05942573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154278837|NCT05942573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278838|NCT05942573|Tubulin Modulators|tubulin modulators|mesh-ancestor
154278839|NCT05942573|Antimitotic Agents|antimitotic agents|mesh-ancestor
154278840|NCT05942573|Mitosis Modulators|mitosis modulators|mesh-ancestor
154278841|NCT05942573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278842|NCT05942573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154278843|NCT05942573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278881|NCT05941806|Adrenergic Agents|adrenergic agents|mesh-ancestor
154278882|NCT05941806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278883|NCT05941806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278884|NCT05941806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278885|NCT05941806|Urological Agents|urological agents|mesh-ancestor
154278886|NCT05941637|Axitinib|axitinib|mesh-list
154278887|NCT05941637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278888|NCT05941637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154278889|NCT05941637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278890|NCT05941637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278891|NCT05941481|Tislelizumab|tislelizumab|mesh-list
154278892|NCT05941481|Antibodies|antibodies|mesh-list
154278893|NCT05941481|Immunologic Factors|immunologic factors|mesh-ancestor
154278894|NCT05941481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278895|NCT05941481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154278896|NCT05941481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154278897|NCT05941429|Fluorides|fluorides|mesh-list
154278898|NCT05941429|Cariostatic Agents|cariostatic agents|mesh-ancestor
153460440|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
154278935|NCT05939219|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154278937|NCT05939219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278938|NCT05938517|Betahistine|betahistine|mesh-list
154278939|NCT05938517|Selegiline|selegiline|mesh-list
154278940|NCT05938517|Antidepressive Agents|antidepressive agents|mesh-ancestor
154278941|NCT05938517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154278942|NCT05938517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154278943|NCT05938517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154278944|NCT05938517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154278945|NCT05938517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154278946|NCT05938517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278947|NCT05938517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154278948|NCT05938517|Protective Agents|protective agents|mesh-ancestor
154278949|NCT05938517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154278950|NCT05938517|Vasodilator Agents|vasodilator agents|mesh-ancestor
154278951|NCT05938517|Histamine Agonists|histamine agonists|mesh-ancestor
154278952|NCT05938517|Histamine Agents|histamine agents|mesh-ancestor
154278953|NCT05938517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154278954|NCT05935657|Dexmedetomidine|dexmedetomidine|mesh-list
154278990|NCT05904730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154278991|NCT05860270|Vitamin D|vitamin d|mesh-list
154278992|NCT05860270|Cholecalciferol|cholecalciferol|mesh-list
154279065|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279066|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279067|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
154279068|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154279069|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154279070|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279071|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
154279072|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279073|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279074|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
154279075|NCT05676216|Promethazine|promethazine|mesh-list
154279076|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154279077|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154279080|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
154279125|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154279126|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
154279127|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279128|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279129|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279131|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154279132|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279133|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154279134|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279135|NCT05233579|Sulforaphane|sulforaphane|mesh-list
154279136|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154279137|NCT05233579|Protective Agents|protective agents|mesh-ancestor
154279138|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279139|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279140|NCT05227612|Psilocybin|psilocybin|mesh-list
154279141|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
154279142|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279143|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154279144|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
154279145|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154279146|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279147|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279148|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279149|NCT05208892|Analgesics|analgesics|mesh-ancestor
154279174|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279175|NCT05054868|Analgesics|analgesics|mesh-ancestor
154279176|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
154279177|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279178|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154279179|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279180|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154279181|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154279182|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154279183|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279184|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279185|NCT05046535|Nicotine|nicotine|mesh-list
154279186|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154279187|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
154279188|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279189|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279190|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154279191|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154279192|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
154279193|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279229|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154279230|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154279231|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279232|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279233|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
154279234|NCT04612257|Insulin|insulin|mesh-list
154279235|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154279236|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279237|NCT04559581|Nintedanib|nintedanib|mesh-list
154279238|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279289|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154279290|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154279291|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279292|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
154279293|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154279294|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154279295|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154279296|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
154279297|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279298|NCT03997266|Gentamicins|gentamicins|mesh-list
154279299|NCT03997266|Ampicillin|ampicillin|mesh-list
154279300|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154279301|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279349|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154279350|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279351|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
154279352|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154279353|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279354|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279355|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154279356|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154279357|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154279358|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154279359|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154279360|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154279361|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154279362|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154279363|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
154279424|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154279425|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154279426|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
154279427|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279428|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279429|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154279430|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154279431|NCT02436993|Growth Substances|growth substances|mesh-ancestor
154279432|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279433|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
154279435|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153646456|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
154279436|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279437|NCT02011971|Vinpocetine|vinpocetine|mesh-list
154279438|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154279439|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279440|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279441|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
154279442|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154279443|NCT02011971|Protective Agents|protective agents|mesh-ancestor
154279444|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279445|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
154279446|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154279447|NCT01951339|Glimepiride|glimepiride|mesh-list
154279448|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154279449|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279497|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279498|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279500|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
154279501|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279502|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154279504|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279505|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154279506|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279507|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154279508|NCT01591577|Temozolomide|temozolomide|mesh-list
154279509|NCT01591577|Lapatinib|lapatinib|mesh-list
154279510|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154279511|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
154279512|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279513|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279517|NCT01509586|Lobeline|lobeline|mesh-list
154279554|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154279555|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279556|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279557|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
154279558|NCT01039584|Butoconazole|butoconazole|mesh-list
154279559|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
154279560|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279561|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154279562|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
154279563|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279564|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154279565|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154279566|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
154279567|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279568|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279569|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154279612|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154279613|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154279614|NCT01149954|Analgesics|analgesics|mesh-ancestor
154279615|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
154279616|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279617|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279618|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154279619|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154279623|NCT03899610|Durvalumab|durvalumab|mesh-list
154279685|NCT01258686|Silymarin|silymarin|mesh-list
154279686|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
154279687|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279688|NCT01258686|Protective Agents|protective agents|mesh-ancestor
154279689|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279690|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154279691|NCT01258764|Lisinopril|lisinopril|mesh-list
154279692|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154279693|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154279694|NCT01258764|Diuretics|diuretics|mesh-ancestor
154279695|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
154279696|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279697|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154279698|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154279699|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279700|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
154279701|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279702|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154279703|NCT01258764|Protective Agents|protective agents|mesh-ancestor
154279704|NCT03895788|Niraparib|niraparib|mesh-list
154279705|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154279706|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279707|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279708|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279709|NCT01257828|Riluzole|riluzole|mesh-list
154279710|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
154279711|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154279712|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154279713|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154279714|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279715|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279716|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154279717|NCT01257828|Protective Agents|protective agents|mesh-ancestor
154279718|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
154279719|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154026591|NCT06094907|Hallucinogens|hallucinogens|mesh-ancestor
154279720|NCT03899142|Antibodies|antibodies|mesh-list
154279721|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
154279722|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279723|NCT03892902|Zopiclone|zopiclone|mesh-list
154279724|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154279725|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279726|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279727|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
154279728|NCT03892668|Oxytocin|oxytocin|mesh-list
154279729|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
154279730|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154279731|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279732|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154279733|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154279734|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279735|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
154279736|NCT03892668|Coagulants|coagulants|mesh-ancestor
154279752|NCT03898752|Vitamins|vitamins|mesh-ancestor
154279754|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279756|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
154279757|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279758|NCT01255800|Cetuximab|cetuximab|mesh-list
154279759|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154279760|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279761|NCT01257906|Tretinoin|tretinoin|mesh-list
154279762|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279763|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
154279764|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
154279765|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
154279766|NCT03892512|Esmolol|esmolol|mesh-list
154279767|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154279768|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279769|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279827|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154279828|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279829|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
154279830|NCT03892434|Hormones|hormones|mesh-ancestor
154279831|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279832|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154279833|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
154279834|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279835|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279836|NCT03889626|Capecitabine|capecitabine|mesh-list
154279837|NCT03889626|Apatinib|apatinib|mesh-list
154279838|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154279839|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
154279840|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279841|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279842|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154279843|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279844|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
154279863|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
154279864|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154279865|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154279866|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154279867|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
154279868|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154279869|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279870|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154279871|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153813357|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154279884|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
154279885|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279886|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
154279887|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279888|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
154279889|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279890|NCT01153386|Treprostinil|treprostinil|mesh-list
154279891|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154279892|NCT01260012|Praziquantel|praziquantel|mesh-list
154279893|NCT01260012|Antioxidants|antioxidants|mesh-list
154279894|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279895|NCT01260012|Protective Agents|protective agents|mesh-ancestor
154279896|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279897|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
154279898|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154279899|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154279900|NCT03888924|Vaccines|vaccines|mesh-list
154279901|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
154279902|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
154279903|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899791|NCT05876377|Vaccines|vaccines|mesh-list
154279925|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
154279926|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154279927|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
154279928|NCT03891420|Galidesivir|galidesivir|mesh-list
154279929|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
154279930|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359836|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279938|NCT01153854|Racecadotril|racecadotril|mesh-list
154279939|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
154279940|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154279941|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
154279942|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279943|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279944|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154279945|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154279946|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279947|NCT01260246|Incretins|incretins|mesh-ancestor
154279948|NCT01260246|Hormones|hormones|mesh-ancestor
154279949|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154279950|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154279951|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
154279952|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279953|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279954|NCT03888534|Ixazomib|ixazomib|mesh-list
154279955|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154279956|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
154279957|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154279958|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154279959|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
154279960|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154279961|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154279962|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154279986|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154280024|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280025|NCT01262274|Anastrozole|anastrozole|mesh-list
154280026|NCT01262274|Tegafur|tegafur|mesh-list
154280027|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154280028|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280029|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154280030|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154280031|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280032|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280033|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154280034|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
154280035|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280036|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280037|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154280038|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
154280051|NCT01260558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280052|NCT01260558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280054|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
154280055|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
154280056|NCT01260714|Azacitidine|azacitidine|mesh-list
154280057|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
154280058|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280059|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280060|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154280061|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154280062|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280063|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280064|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154280065|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
154280066|NCT01260714|Analgesics|analgesics|mesh-ancestor
154280067|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
154280068|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280069|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280089|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
154280090|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280091|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280092|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280093|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154280094|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154280095|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280096|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154280097|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154280098|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
154280105|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280106|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280107|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
154280108|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154280109|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
154280110|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280111|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280112|NCT01157052|Capecitabine|capecitabine|mesh-list
154280113|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
154280114|NCT01157052|Calcium|calcium|mesh-list
154280115|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280116|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280117|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154280118|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
154280119|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280120|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280121|NCT03887130|Paclitaxel|paclitaxel|mesh-list
154280122|NCT03887130|Vinorelbine|vinorelbine|mesh-list
154280123|NCT03887130|Docetaxel|docetaxel|mesh-list
154280124|NCT03887130|Gemcitabine|gemcitabine|mesh-list
154280125|NCT03887130|Capecitabine|capecitabine|mesh-list
154280126|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280127|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280128|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
154280129|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
154280130|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
154280131|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280132|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153813359|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813360|NCT00435981|Antacids|antacids|mesh-ancestor
154280159|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154280160|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154280161|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154280162|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154280163|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280164|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154280165|NCT03881904|Gestodene|gestodene|mesh-list
154280166|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154280167|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154280168|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154280169|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
154280170|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154280171|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280172|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154280173|NCT03881904|Estrogens|estrogens|mesh-ancestor
154280174|NCT03881904|Hormones|hormones|mesh-ancestor
154280175|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280176|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154280177|NCT03881904|Progestins|progestins|mesh-ancestor
154280178|NCT01262742|Carbetocin|carbetocin|mesh-list
154280179|NCT01262742|Oxytocin|oxytocin|mesh-list
154280180|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
154280181|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154280182|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280183|NCT01261416|Levetiracetam|levetiracetam|mesh-list
154280184|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
154280185|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
154280186|NCT03617172|Misoprostol|misoprostol|mesh-list
154280187|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154280188|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
154280199|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280200|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280201|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154280202|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154280203|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
154280204|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154280205|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280206|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280207|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
154280208|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
154280209|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280210|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154280211|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
154280212|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280213|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
154280214|NCT01263288|Vitamin D|vitamin d|mesh-list
154280215|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280216|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280217|NCT01263288|Vitamins|vitamins|mesh-ancestor
154280218|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
154280219|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154280220|NCT01263834|Bevacizumab|bevacizumab|mesh-list
154280221|NCT01263834|Mitomycins|mitomycins|mesh-list
154280235|NCT01263366|Norepinephrine|norepinephrine|mesh-list
154280236|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154280237|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154280238|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
154280239|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280240|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280241|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280242|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
154280243|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
154280244|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280245|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154280246|NCT01155102|Anastrozole|anastrozole|mesh-list
154280247|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154280248|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280249|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154280250|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153646457|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154280270|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280271|NCT01155258|Sirolimus|sirolimus|mesh-list
154280272|NCT01155258|Vinorelbine|vinorelbine|mesh-list
154280273|NCT01155258|Temsirolimus|temsirolimus|mesh-list
154280274|NCT01155258|MTOR Inhibitors|mtor inhibitors|mesh-list
154280275|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154280276|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280277|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154280301|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154280302|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
154280303|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280304|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280305|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154280306|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154280307|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154280308|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154280309|NCT01159548|Promethazine|promethazine|mesh-list
154280310|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
154280311|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
154280312|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
154280313|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154280314|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
154280315|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
154280316|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280317|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280318|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280319|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154280320|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154280321|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154280322|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280323|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
154280324|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
154280325|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
154280326|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280327|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
154280328|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
154280329|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154280330|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154280331|NCT01156740|Amoxicillin|amoxicillin|mesh-list
154280332|NCT01156740|Penicillins|penicillins|mesh-list
154280333|NCT01156740|beta-Lactams|beta-lactams|mesh-list
154280334|NCT01156740|Penicillin G|penicillin g|mesh-list
154280339|NCT03880968|Etanercept|etanercept|mesh-list
154280345|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280346|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154280347|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154280348|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154280349|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280350|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
154280351|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
154280352|NCT03880734|Vitamin D|vitamin d|mesh-list
154280353|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280354|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280355|NCT03880734|Vitamins|vitamins|mesh-ancestor
154280356|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
154280357|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154280358|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
154280359|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154280360|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
154280361|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154280362|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280363|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154280364|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154280365|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154280366|NCT01265940|Vinblastine|vinblastine|mesh-list
154280367|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280368|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280369|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
154280370|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
154280371|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
154280372|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280373|NCT01264302|Finasteride|finasteride|mesh-list
154280374|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153899944|NCT05694871|Palbociclib|palbociclib|mesh-list
154280376|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280377|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280378|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
154280379|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280380|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280381|NCT01264302|Urological Agents|urological agents|mesh-ancestor
154280382|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154280383|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
154280384|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280385|NCT01161654|Naratriptan|naratriptan|mesh-list
154280386|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154280387|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154280388|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154280389|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
154280390|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280391|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280392|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280393|NCT01266174|Eltoprazine|eltoprazine|mesh-list
154280394|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154027267|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
154280395|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
154280396|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280397|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280398|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280399|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
154280400|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154280401|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280402|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280403|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154280404|NCT01266252|Analgesics|analgesics|mesh-ancestor
154280405|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
154280406|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280407|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154280427|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280429|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154280430|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280431|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280432|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280433|NCT01161966|Zonisamide|zonisamide|mesh-list
154280434|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
154280475|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280476|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
154280477|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280478|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
154280479|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154280480|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154280481|NCT03876444|Prednisolone|prednisolone|mesh-list
154280482|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
154280483|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154280484|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
154280485|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154280486|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
154280487|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
154280502|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280503|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280505|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
154280506|NCT01160328|Leuprolide|leuprolide|mesh-list
154280507|NCT01160328|Testosterone|testosterone|mesh-list
154280508|NCT01160328|Androgens|androgens|mesh-ancestor
154280509|NCT01160328|Hormones|hormones|mesh-ancestor
154280510|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280511|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280512|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154280513|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280514|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154280515|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
154280536|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154280537|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
154280538|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280539|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154280540|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154280541|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819169|NCT03011567|Acetaminophen|acetaminophen|mesh-list
154280554|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280555|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154280556|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
154280557|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154280558|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
154280559|NCT01265004|Coagulants|coagulants|mesh-ancestor
154280560|NCT01162902|Candesartan|candesartan|mesh-list
154280561|NCT01162902|Candesartan cilexetil|candesartan cilexetil|mesh-list
154280562|NCT01162902|Bisoprolol|bisoprolol|mesh-list
154280563|NCT01162902|Diltiazem|diltiazem|mesh-list
154280564|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154280565|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154280566|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154280567|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280568|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
154280569|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
154280570|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280571|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280572|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154280573|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154280574|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154280576|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280577|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154280578|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154280579|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280580|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
154280581|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154280582|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154280583|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154280584|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
154280585|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280586|NCT02526888|Diltiazem|diltiazem|mesh-list
154280587|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154280588|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154280589|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154280590|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280591|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280592|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280593|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
154280594|NCT01158612|Hormones|hormones|mesh-list
154280595|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280596|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280597|NCT03877692|Labetalol|labetalol|mesh-list
154280598|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154280599|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154280600|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
154280601|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280621|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280622|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
154280623|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154280624|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
154280625|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280626|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
154280627|NCT01268670|Ibuprofen|ibuprofen|mesh-list
154280628|NCT01268670|Oxycodone|oxycodone|mesh-list
154280629|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154280630|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154280631|NCT01268670|Analgesics|analgesics|mesh-ancestor
154280632|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
154280633|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280634|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280635|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154280636|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154280637|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154280638|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280639|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280640|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154280641|NCT01268670|Narcotics|narcotics|mesh-ancestor
154280642|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280643|NCT01160718|Fulvestrant|fulvestrant|mesh-list
154280644|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153596709|NCT01863654|Montelukast|montelukast|mesh-list
154280645|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280647|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154280648|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
154280649|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280650|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280651|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
154280652|NCT01159080|Tacrolimus|tacrolimus|mesh-list
154280653|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280654|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
154280655|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280656|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154280657|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280658|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280659|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154280660|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280661|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154280662|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
154280663|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154280664|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280665|NCT01160952|Itraconazole|itraconazole|mesh-list
154280666|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
154280667|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280668|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154280669|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154280670|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280671|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280672|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154280673|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
154280674|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280675|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280676|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154280738|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
154280739|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280740|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280741|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154280742|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154280743|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
154280745|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280746|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154280747|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154280748|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280749|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280750|NCT01581840|Panitumumab|panitumumab|mesh-list
154280751|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154280752|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280753|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
154280754|NCT03879486|Formaldehyde|formaldehyde|mesh-list
154280755|NCT03879486|Povidone|povidone|mesh-list
154280756|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
154280760|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
154280761|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
154280762|NCT01269294|Simeprevir|simeprevir|mesh-list
154280763|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154280764|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154280765|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280766|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154280767|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154280768|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280769|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280770|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280771|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154280772|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
154280773|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154280774|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280775|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154280776|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154280777|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154280778|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
154280779|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
154280780|NCT01163994|Doxycycline|doxycycline|mesh-list
154280781|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
154280782|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154280783|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280784|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
154280785|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154280786|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154280787|NCT01163994|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154280788|NCT01163994|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154280789|NCT01267734|Everolimus|everolimus|mesh-list
154280790|NCT01267734|Clopidogrel|clopidogrel|mesh-list
154280791|NCT01267734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154280792|NCT01267734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154280808|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154280809|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280810|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154280811|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154280812|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
154280813|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280814|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280816|NCT01269450|Progestins|progestins|mesh-ancestor
154280817|NCT01269450|Hormones|hormones|mesh-ancestor
154280818|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154280819|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280820|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
154280841|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
154280842|NCT01268904|Valproic Acid|valproic acid|mesh-list
154280843|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
154280844|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280845|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280846|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
154280847|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154280848|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280849|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
154280850|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154280851|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154280852|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154280854|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154280855|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
154280856|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
154280857|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154280858|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154280859|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280860|NCT03872232|Telmisartan|telmisartan|mesh-list
154280861|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154280862|NCT03872232|Ezetimibe|ezetimibe|mesh-list
154280863|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154280864|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154280865|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
154280866|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280867|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154280868|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154280869|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280886|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154280887|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154280888|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280889|NCT01269684|Everolimus|everolimus|mesh-list
154280890|NCT01269684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154280891|NCT01269684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154280892|NCT01269684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280893|NCT01269684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280894|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154280895|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
154280896|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280897|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280898|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154280899|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
154280900|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154280901|NCT01280526|Romidepsin|romidepsin|mesh-list
154280902|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154280903|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154280904|NCT01280526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154280905|NCT01280526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154280907|NCT01164774|Ramipril|ramipril|mesh-list
154280913|NCT01269138|Thrombin|thrombin|mesh-list
154280961|NCT01281150|Paclitaxel|paclitaxel|mesh-list
154280962|NCT01281150|Carboplatin|carboplatin|mesh-list
154280963|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154280964|NCT01281150|Veliparib|veliparib|mesh-list
154280965|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154280987|NCT01283256|Zonisamide|zonisamide|mesh-list
154280988|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
154280989|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154280990|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154280991|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154280992|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154280993|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154280994|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
154280995|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154280996|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154280997|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154280998|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
154280999|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281000|NCT03874260|Fenofibrate|fenofibrate|mesh-list
154281001|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154281002|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
154281003|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281004|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154281005|NCT01281540|Cisapride|cisapride|mesh-list
154281006|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154281007|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281008|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154281009|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
154281010|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281011|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281012|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281013|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
154281014|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154281015|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154281016|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281017|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154281018|NCT01283412|Analgesics|analgesics|mesh-ancestor
154281019|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
154281020|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281021|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154281022|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154281047|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281048|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
154281049|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154281050|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
154281051|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154281052|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154281053|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
154281054|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281055|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281056|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281057|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154281058|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281059|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
154281060|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281061|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154281062|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154281063|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154281064|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154281066|NCT05835713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154281067|NCT05835713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154281068|NCT05835713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281069|NCT05835713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154281070|NCT05835713|Anesthetics, General|anesthetics, general|mesh-ancestor
154281155|NCT05834361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281156|NCT05834361|Oxytocics|oxytocics|mesh-ancestor
154281158|NCT05834270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154281159|NCT05834270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154281160|NCT05834270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154281161|NCT05834270|Adrenergic Agents|adrenergic agents|mesh-ancestor
154281162|NCT05834270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281163|NCT05834270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281164|NCT05834270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281165|NCT05834270|Urological Agents|urological agents|mesh-ancestor
154281166|NCT05834231|Memantine|memantine|mesh-list
154281167|NCT05834231|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154281177|NCT05830162|Clavulanic Acid|clavulanic acid|mesh-list
154281178|NCT05830162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154281179|NCT05830162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281180|NCT05830162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281181|NCT05830162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281182|NCT05830162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154281183|NCT05829707|Diclofenac|diclofenac|mesh-list
154281184|NCT05829707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154281185|NCT05829707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154281186|NCT05829707|Anesthetics|anesthetics|mesh-list
154281187|NCT05829707|Levobupivacaine|levobupivacaine|mesh-list
154281188|NCT05829707|Anesthetics, Local|anesthetics, local|mesh-list
154281189|NCT05829707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154281190|NCT05829707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281191|NCT05829707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154281192|NCT05829707|Analgesics|analgesics|mesh-ancestor
154281193|NCT05829707|Sensory System Agents|sensory system agents|mesh-ancestor
154281194|NCT05829707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281195|NCT05829707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281196|NCT05829707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154281197|NCT05829707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281198|NCT05829707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281199|NCT05819918|Calcifediol|calcifediol|mesh-list
154281201|NCT05819918|Micronutrients|micronutrients|mesh-ancestor
154281202|NCT05819918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281203|NCT05819918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154281204|NCT05810883|Insulin|insulin|mesh-list
154281205|NCT05810883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154281206|NCT05810883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281207|NCT05807074|Tranexamic Acid|tranexamic acid|mesh-list
154281208|NCT05807074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154281209|NCT05807074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154281210|NCT05807074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281211|NCT05807074|Hemostatics|hemostatics|mesh-ancestor
154281212|NCT05807074|Coagulants|coagulants|mesh-ancestor
154281213|NCT05772273|Azacitidine|azacitidine|mesh-list
154281214|NCT05772273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154281215|NCT05772273|Antimetabolites|antimetabolites|mesh-ancestor
154281216|NCT05772273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281217|NCT05772273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281218|NCT05772273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281219|NCT05753098|Sildenafil Citrate|sildenafil citrate|mesh-list
154281220|NCT05753098|Clomiphene|clomiphene|mesh-list
154281221|NCT05753098|Enclomiphene|enclomiphene|mesh-list
154281222|NCT05753098|Zuclomiphene|zuclomiphene|mesh-list
154281223|NCT05753098|Estrogens|estrogens|mesh-list
154281224|NCT05753098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281225|NCT05753098|Vasodilator Agents|vasodilator agents|mesh-ancestor
154281226|NCT05753098|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154281227|NCT05753098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154281228|NCT05753098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281229|NCT05753098|Urological Agents|urological agents|mesh-ancestor
154281230|NCT05753098|Hormones|hormones|mesh-ancestor
154281231|NCT05753098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281232|NCT05753098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281233|NCT05753098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154281234|NCT05753098|Hormone Antagonists|hormone antagonists|mesh-ancestor
154281235|NCT05753098|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154281236|NCT05753098|Fertility Agents|fertility agents|mesh-ancestor
154281252|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
154281253|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
154281254|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281255|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281256|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
154281257|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281258|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281259|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154281260|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
154281261|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154281262|NCT05699811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281263|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
154281264|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
153813364|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153441546|NCT00004993|Hormones|hormones|mesh-list
153646460|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281294|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154281295|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281296|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281297|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
154281298|NCT05658497|Interferons|interferons|mesh-list
154281299|NCT05658497|Interferon-beta|interferon-beta|mesh-list
154281300|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
154281301|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154281302|NCT05658497|Natalizumab|natalizumab|mesh-list
154281303|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281304|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
154281305|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281306|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
154281307|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281308|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154281309|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281310|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281311|NCT05594680|Methotrexate|methotrexate|mesh-list
154281312|NCT05594680|Cilostazol|cilostazol|mesh-list
154281313|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154281314|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
153813365|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153813366|NCT00432081|Analgesics|analgesics|mesh-ancestor
153813367|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
154281323|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154281324|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281325|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
154281326|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281327|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154281328|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154281329|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
154281330|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281331|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154281332|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
154281333|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154281371|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281372|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154281374|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281375|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
154281376|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281377|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281378|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154281379|NCT04872608|Letrozole|letrozole|mesh-list
154281380|NCT04872608|Palbociclib|palbociclib|mesh-list
154281381|NCT04872608|Onapristone|onapristone|mesh-list
154281382|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281383|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154281384|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154281385|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281386|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281387|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154281388|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
154281389|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281390|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281391|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154281392|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154281393|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
154281394|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154281395|NCT04869501|Atezolizumab|atezolizumab|mesh-list
154281396|NCT04869501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154281397|NCT04869501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281398|NCT04869501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281399|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281400|NCT04831398|Melatonin|melatonin|mesh-list
154281401|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
154281403|NCT04831398|Protective Agents|protective agents|mesh-ancestor
154281449|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359850|NCT03703492|Estrogens|estrogens|mesh-ancestor
154281489|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281490|NCT04201873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154281491|NCT04201873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281492|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
154281493|NCT04201873|Laxatives|laxatives|mesh-ancestor
154281494|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281495|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
154281496|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281497|NCT03785678|Tenecteplase|tenecteplase|mesh-list
154281498|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154281499|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154281500|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281501|NCT03729804|Dexamethasone|dexamethasone|mesh-list
154281502|NCT03729804|Lenalidomide|lenalidomide|mesh-list
154281503|NCT03729804|Bortezomib|bortezomib|mesh-list
154281504|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281505|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
154281506|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
154281507|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281508|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281509|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281510|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
154281511|NCT03729804|Hormones|hormones|mesh-ancestor
154281512|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281513|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281514|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028371|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
154281515|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
154281559|NCT03225547|Mifepristone|mifepristone|mesh-list
153813369|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813370|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281608|NCT02969837|Growth Substances|growth substances|mesh-ancestor
154281609|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
153441729|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
153813372|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
154281631|NCT02659293|Lenalidomide|lenalidomide|mesh-list
154281632|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281633|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
154281634|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
154281635|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281636|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281637|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281652|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281653|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154281654|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154281655|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281656|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281658|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154281659|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154281660|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154281661|NCT02613169|Isoniazid|isoniazid|mesh-list
154281662|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
154028526|NCT04909697|Sivelestat|sivelestat|mesh-list
154281663|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154281664|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281665|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153813373|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
153813374|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154281686|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
154281687|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281688|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281689|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154281690|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
154281691|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281718|NCT02389517|Growth Substances|growth substances|mesh-ancestor
154281719|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
154281720|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281721|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
154281722|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281723|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
154281724|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281725|NCT02366819|Leucovorin|leucovorin|mesh-list
154281726|NCT02366819|Fluorouracil|fluorouracil|mesh-list
154281727|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
154281728|NCT02366819|Irinotecan|irinotecan|mesh-list
154281729|NCT02366819|Calcium|calcium|mesh-list
154281730|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
154281731|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154281732|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281733|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
154281734|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281735|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154281736|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281737|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154281738|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
154281739|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154281740|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154281741|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281742|NCT02366819|Antidotes|antidotes|mesh-ancestor
154281743|NCT02366819|Protective Agents|protective agents|mesh-ancestor
154281744|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
154281745|NCT02366819|Vitamins|vitamins|mesh-ancestor
154281746|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
154281747|NCT02281838|Enalapril|enalapril|mesh-list
154281748|NCT02281838|Labetalol|labetalol|mesh-list
154281749|NCT02281838|Hydralazine|hydralazine|mesh-list
154281750|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154281751|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
154281752|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281753|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281754|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154281781|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281782|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597141|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281783|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154281784|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281785|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154281786|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154281787|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154281788|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281789|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281790|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
154281791|NCT02213913|Hormones|hormones|mesh-ancestor
154281792|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281793|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281794|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154281795|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
154281796|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
154281797|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
154281798|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154281799|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154281800|NCT02213913|Growth Substances|growth substances|mesh-ancestor
154281801|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
154281802|NCT01665794|Dexamethasone|dexamethasone|mesh-list
154281803|NCT01665794|Daratumumab|daratumumab|mesh-list
154281804|NCT01665794|Pomalidomide|pomalidomide|mesh-list
154281805|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281841|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281842|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
154281843|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
154281844|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
154281845|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281847|NCT00071084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154281848|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281849|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281850|NCT00071084|Immunologic Factors|immunologic factors|mesh-ancestor
154281851|NCT00071084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281852|NCT00042406|Zanolimumab|zanolimumab|mesh-list
154281853|NCT00042406|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154281854|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154281855|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281856|NCT00042406|Immunologic Factors|immunologic factors|mesh-ancestor
154281857|NCT00042406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281858|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
154281859|NCT01170078|Hematinics|hematinics|mesh-ancestor
154281860|NCT01283646|Vitamins|vitamins|mesh-list
153813376|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281875|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
154281876|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281877|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281878|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281880|NCT01586442|Spironolactone|spironolactone|mesh-list
154281881|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154281882|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
154281883|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154281884|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281885|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154281886|NCT01586442|Diuretics|diuretics|mesh-ancestor
154281887|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
154281888|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154281889|NCT01587066|Valproic Acid|valproic acid|mesh-list
153441819|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
154281896|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281897|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
154281898|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281899|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281900|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
154281901|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281902|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
154281903|NCT01587144|Lucanthone|lucanthone|mesh-list
154281904|NCT01587144|Temozolomide|temozolomide|mesh-list
154281905|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154281906|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
154281907|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281908|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281909|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
154281910|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154281911|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
154281912|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154281913|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154281914|NCT01587222|Octreotide|octreotide|mesh-list
154281915|NCT01587222|Midodrine|midodrine|mesh-list
154281916|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281917|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154281918|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281919|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
154281920|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
154281921|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281922|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281923|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154281924|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154281925|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154281926|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154281927|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
154281928|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281929|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281931|NCT01167738|Gemcitabine|gemcitabine|mesh-list
154281932|NCT01167738|Capecitabine|capecitabine|mesh-list
154281933|NCT01167738|Epirubicin|epirubicin|mesh-list
154281934|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281935|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154281936|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
154281937|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281938|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154281939|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281940|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154281941|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154281942|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154281943|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281944|NCT01167816|Azacitidine|azacitidine|mesh-list
154281945|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154281946|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
154281947|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281948|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154281949|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154281950|NCT01167894|Simvastatin|simvastatin|mesh-list
154281951|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154281952|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154281953|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
154281954|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281966|NCT01168050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281967|NCT03870594|Chrysarobin|chrysarobin|mesh-list
154281968|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154281969|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154281970|NCT03870594|Analgesics|analgesics|mesh-ancestor
154281971|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
154281972|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281973|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281974|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154281975|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154281976|NCT01165866|Ondansetron|ondansetron|mesh-list
154281977|NCT01165866|Metoclopramide|metoclopramide|mesh-list
154281978|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
154281979|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
154281980|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154281981|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281982|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154281983|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
154281984|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
154281985|NCT01165866|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154281986|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154281987|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
154281988|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154281989|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154281990|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154281991|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154281992|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
154281993|NCT01170468|Vitamin D|vitamin d|mesh-list
154281994|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
154281995|NCT01170468|Vitamins|vitamins|mesh-ancestor
154281996|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
154281997|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154281998|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154281999|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154282000|NCT01273584|Metformin|metformin|mesh-list
154282001|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154282002|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282016|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282017|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154282018|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154282019|NCT01168440|Growth Substances|growth substances|mesh-ancestor
154282020|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282021|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
154282022|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154282023|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282024|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282025|NCT01170780|Dexamethasone|dexamethasone|mesh-list
154282026|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282027|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
154282028|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
154282029|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282030|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282031|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154282032|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
154282039|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282040|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154282041|NCT01170858|Icodextrin|icodextrin|mesh-list
154282042|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
154282043|NCT01171092|Bortezomib|bortezomib|mesh-list
154282044|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282045|NCT01171170|Paclitaxel|paclitaxel|mesh-list
154282046|NCT01171170|Bevacizumab|bevacizumab|mesh-list
154282047|NCT01171170|Carboplatin|carboplatin|mesh-list
154282048|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154282049|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
154282050|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154282051|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282052|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
154282053|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
154282054|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
154282055|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282056|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282057|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154282058|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154282059|NCT01171170|Growth Substances|growth substances|mesh-ancestor
154282060|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282061|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
154282062|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
154282063|NCT01166100|Fluoxetine|fluoxetine|mesh-list
154282064|NCT01166100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154282065|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154282066|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154282085|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282086|NCT01171326|Minocycline|minocycline|mesh-list
154282087|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154282088|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282089|NCT01171482|Fluorouracil|fluorouracil|mesh-list
154282091|NCT01171482|Mitomycins|mitomycins|mesh-list
154282092|NCT01171482|Mitomycin|mitomycin|mesh-list
154282093|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
154282094|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282095|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154282096|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282097|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154282098|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
154282099|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282100|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154282101|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282102|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154282103|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
154282104|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154282105|NCT01282398|Simvastatin|simvastatin|mesh-list
154282106|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154282107|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154282108|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
154282109|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282110|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154282111|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154282112|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282113|NCT01169142|Vitamin D|vitamin d|mesh-list
154282114|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
154282115|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
154282148|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
154282149|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
154282150|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282151|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154282152|NCT01282632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154282153|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154282154|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154282155|NCT01172028|Docetaxel|docetaxel|mesh-list
154282156|NCT01172028|Pemetrexed|pemetrexed|mesh-list
154282157|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282158|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
154282159|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
154282160|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
154282161|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282162|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282163|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154282164|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154282165|NCT01278186|Paclitaxel|paclitaxel|mesh-list
154282166|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154282167|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282168|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154282169|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154282170|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154282171|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282172|NCT01169688|Phenylephrine|phenylephrine|mesh-list
154282173|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
154282174|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
154282175|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154282176|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
154282177|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
154282178|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282179|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282180|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
154282181|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154282182|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
154282190|NCT01169688|Protective Agents|protective agents|mesh-ancestor
154282191|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
154282192|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154282193|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154282194|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
154282195|NCT01278264|Ropivacaine|ropivacaine|mesh-list
154282196|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
154282197|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
154282198|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282199|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282200|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
154282201|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282202|NCT01172652|Ziprasidone|ziprasidone|mesh-list
154282203|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154282204|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
154282205|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282206|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282207|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282208|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154282209|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154282210|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282211|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154282212|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154282213|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
154282214|NCT02526030|Aripiprazole|aripiprazole|mesh-list
153646463|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154282215|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154282216|NCT02526030|Ziprasidone|ziprasidone|mesh-list
154282217|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
154282218|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154282219|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154282220|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154282221|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282222|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282223|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
154282224|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
154282225|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282226|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282227|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154282228|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154282229|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
154282230|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154282231|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154282232|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154282233|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154282234|NCT03867240|Gabapentin|gabapentin|mesh-list
154282235|NCT03867240|Analgesics|analgesics|mesh-ancestor
154282236|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
154282237|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282238|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282239|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
154282240|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154282241|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154282242|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282243|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154282244|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154282245|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154282257|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154282258|NCT01178034|Warfarin|warfarin|mesh-list
154282259|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
154282260|NCT01288170|Tobramycin|tobramycin|mesh-list
154282261|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154282262|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282263|NCT01178112|Carboplatin|carboplatin|mesh-list
154282264|NCT01178112|Trientine|trientine|mesh-list
154282265|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282266|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
154282267|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
153819295|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
154282268|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029116|NCT00875979|Pertuzumab|pertuzumab|mesh-list
154282269|NCT01175460|Nedaplatin|nedaplatin|mesh-list
154282270|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282271|NCT01175538|Lactulose|lactulose|mesh-list
154282272|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154282273|NCT01288326|Liraglutide|liraglutide|mesh-list
154282274|NCT01288326|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154282275|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154282276|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282277|NCT01288326|Incretins|incretins|mesh-ancestor
154282278|NCT01288326|Hormones|hormones|mesh-ancestor
154282279|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154282280|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154282281|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154282282|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
154282283|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154282284|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154282301|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154282302|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
154282303|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154282304|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282305|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154282306|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
154282307|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282308|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282309|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
154282310|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282311|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154282312|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154282313|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
154282314|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154282315|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154282316|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154282317|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154282318|NCT01175772|Analgesics|analgesics|mesh-ancestor
154282319|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
154282320|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282321|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282322|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154282323|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154282324|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154282325|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
154282326|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154282327|NCT01536964|Morphine|morphine|mesh-list
154282328|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154282347|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154282348|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154282349|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
154282350|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154282351|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154282352|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
154282353|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282354|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154282355|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154282356|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154282357|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154282358|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154282359|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282360|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154282361|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282362|NCT01286688|Terbinafine|terbinafine|mesh-list
154282363|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
154282364|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282365|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282366|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282367|NCT01286766|Cisplatin|cisplatin|mesh-list
154282368|NCT01286766|Docetaxel|docetaxel|mesh-list
154282369|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282370|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
154282371|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
154282372|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
154282373|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282374|NCT02525484|Pirfenidone|pirfenidone|mesh-list
154282375|NCT02525484|Analgesics|analgesics|mesh-ancestor
154282376|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
154282377|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282378|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282384|NCT01173978|Prednisolone|prednisolone|mesh-list
154282385|NCT01173978|Hormones|hormones|mesh-list
154282386|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154282387|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282388|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282389|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
154282390|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154282391|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282392|NCT01174056|Pioglitazone|pioglitazone|mesh-list
154282393|NCT01174056|Zileuton|zileuton|mesh-list
154282394|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
154282395|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154282396|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282397|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154282398|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154282399|NCT01174056|Analgesics|analgesics|mesh-ancestor
154282400|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
154282401|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282402|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282403|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154282414|NCT01174212|Vancomycin|vancomycin|mesh-list
154282454|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154282455|NCT03865680|Fluorides|fluorides|mesh-list
154282456|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
154282457|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
154282458|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
154282459|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282460|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
154282461|NCT03865680|Protective Agents|protective agents|mesh-ancestor
154282462|NCT01288716|Baclofen|baclofen|mesh-list
154282463|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154282464|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282465|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154282546|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282548|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154282549|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
154282550|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154282551|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154282552|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
154282553|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282554|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154282555|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282556|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154282557|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154282558|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154282559|NCT01285674|Cisplatin|cisplatin|mesh-list
153813379|NCT00333632|Fentanyl|fentanyl|mesh-list
153813380|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
154282581|NCT03864978|Rifaximin|rifaximin|mesh-list
154282582|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154282583|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282584|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813381|NCT00333632|Propofol|propofol|mesh-list
154282627|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154282629|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282630|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282631|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154282632|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
154282633|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154282639|NCT03864666|Protective Agents|protective agents|mesh-ancestor
154282640|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154282641|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154282642|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282643|NCT03858972|Capecitabine|capecitabine|mesh-list
154282644|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154282645|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
154282646|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282647|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282648|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
154282649|NCT03091348|Testosterone|testosterone|mesh-list
154282650|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
154282651|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
154282652|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154282653|NCT03091348|Androgens|androgens|mesh-ancestor
154282654|NCT03091348|Hormones|hormones|mesh-ancestor
154282655|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154282656|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282657|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154282658|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282659|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
154282660|NCT02525016|Lidocaine|lidocaine|mesh-list
154282661|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
154282662|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
154282663|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282664|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282665|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
154282666|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813382|NCT00333632|Isoflurane|isoflurane|mesh-list
154282688|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282689|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
154282690|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154282691|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
154282692|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
154282693|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153441963|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
154282705|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282706|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282707|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154282708|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282709|NCT01288794|Furosemide|furosemide|mesh-list
154282710|NCT01288794|Diuretics|diuretics|mesh-list
154282711|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
154282712|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282713|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154282714|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154282715|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282716|NCT01288872|Praziquantel|praziquantel|mesh-list
154282717|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
154282718|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154282719|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282720|NCT03864588|Ropivacaine|ropivacaine|mesh-list
154282721|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
154282722|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
154282723|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282735|NCT01174914|Tenofovir|tenofovir|mesh-list
154282736|NCT01174914|Lamivudine|lamivudine|mesh-list
154282737|NCT01174914|Emtricitabine|emtricitabine|mesh-list
154282738|NCT01174914|Efavirenz|efavirenz|mesh-list
154282739|NCT01174914|Lopinavir|lopinavir|mesh-list
154282740|NCT01174914|Nevirapine|nevirapine|mesh-list
154282741|NCT01174914|Stavudine|stavudine|mesh-list
154282742|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
154282743|NCT01174914|Naltrexone|naltrexone|mesh-list
154282744|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
154282745|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282746|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154282747|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154282748|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282749|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282750|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154282751|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154282752|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154282753|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154282754|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282755|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
154282756|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282757|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154282758|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154282759|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154282760|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154282761|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154282762|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154282764|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154282765|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
154282766|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154282767|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
154282768|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
154282830|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154282832|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282833|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282834|NCT03858582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154282835|NCT03858582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282836|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
154282837|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154282838|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154282839|NCT01177566|Analgesics|analgesics|mesh-ancestor
154282840|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
154282841|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282842|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282843|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282844|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154282845|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
154282846|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154282847|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
154282848|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154282862|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
154282863|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282864|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154282865|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154282867|NCT01289496|Ribavirin|ribavirin|mesh-list
154282868|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
154282869|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
154282870|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154282871|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282872|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
154282873|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282874|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
154282875|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282876|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
154282877|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282878|NCT01181232|Zolpidem|zolpidem|mesh-list
154282879|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154282880|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154282881|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154282882|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282883|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154282885|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
154282886|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282887|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282888|NCT01181310|Scopolamine|scopolamine|mesh-list
154282889|NCT01181310|Donepezil|donepezil|mesh-list
154282890|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154282891|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154282892|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282893|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282894|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
154282895|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282896|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282897|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
154282898|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154282899|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
154282900|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
154282901|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282902|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154282903|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
153819348|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282904|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154282905|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154282906|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
154282907|NCT02525250|Lenalidomide|lenalidomide|mesh-list
154282908|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
154282909|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282910|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154282911|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154282912|NCT02525250|Growth Substances|growth substances|mesh-ancestor
154282913|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
154282914|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282931|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282932|NCT01184664|Nicotine|nicotine|mesh-list
154282933|NCT01184664|Varenicline|varenicline|mesh-list
154282934|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154282935|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
154282936|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282937|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282938|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154282939|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154282940|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
154282941|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282942|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282944|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282945|NCT01184820|Factor VIII|factor viii|mesh-list
154282946|NCT01184820|Coagulants|coagulants|mesh-ancestor
154282947|NCT03858270|Memantine|memantine|mesh-list
154282948|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154282949|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154282950|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
154282951|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154282952|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282953|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282954|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154282955|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154282958|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154282959|NCT01289730|Analgesics|analgesics|mesh-ancestor
154282960|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
154282961|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154282962|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282963|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154282964|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154282965|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154282966|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154282967|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
154282968|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
154282969|NCT01290900|Ceftazidime|ceftazidime|mesh-list
154282970|NCT01290900|Ceftaroline|ceftaroline|mesh-list
154282971|NCT01290900|Avibactam|avibactam|mesh-list
154282972|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154282973|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154282974|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154282975|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154282976|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154282977|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282978|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282979|NCT01290900|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154282980|NCT01290900|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154282981|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154282982|NCT03855306|Glyburide|glyburide|mesh-list
154282983|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154282984|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154282985|NCT03855384|Cisplatin|cisplatin|mesh-list
154282986|NCT03855384|Carboplatin|carboplatin|mesh-list
154282987|NCT03855384|Fluorouracil|fluorouracil|mesh-list
154282988|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154282989|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
154282990|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154282991|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154282992|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154283008|NCT01187862|Midazolam|midazolam|mesh-list
154283009|NCT01187862|Caffeine|caffeine|mesh-list
154283010|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
154283011|NCT01187862|Omeprazole|omeprazole|mesh-list
154283012|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153597646|NCT01870440|Dexamethasone|dexamethasone|mesh-list
154283013|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154283014|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283015|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283016|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154283017|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154283018|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154283019|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154283020|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
154283021|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
154283022|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
154283023|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
154283024|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283025|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283026|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154283027|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154283028|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154283029|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154283030|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154283031|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154283032|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283033|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154283034|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154283035|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
154283036|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154283037|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154283073|NCT01185678|Progestins|progestins|mesh-list
154283074|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154283075|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283076|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154283077|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154283078|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154283079|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154283080|NCT01185678|Hormones|hormones|mesh-ancestor
154283081|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154283082|NCT01188174|Clofarabine|clofarabine|mesh-list
154283083|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154283084|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
154283085|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283086|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283087|NCT01588002|Ritonavir|ritonavir|mesh-list
154283088|NCT01588002|Efavirenz|efavirenz|mesh-list
154283089|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154283090|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154283091|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
154283092|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283093|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283094|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154283095|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154283096|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
154283097|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283098|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154283099|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154283100|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154283101|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154283102|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154283125|NCT01182168|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154283126|NCT01182168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154283127|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283128|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154283129|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
154283130|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283131|NCT01182246|Genistein|genistein|mesh-list
154283132|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154283133|NCT01182246|Protective Agents|protective agents|mesh-ancestor
154283134|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283135|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283136|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154283137|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283138|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283139|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
154283140|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154283141|NCT01182246|Estrogens|estrogens|mesh-ancestor
154283142|NCT01182246|Hormones|hormones|mesh-ancestor
154283143|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359854|NCT03568656|Atezolizumab|atezolizumab|mesh-list
154283145|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154283146|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154283147|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154283148|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154283149|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
154283150|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283151|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283152|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283154|NCT01290120|Doxorubicin|doxorubicin|mesh-list
154283155|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154283156|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283157|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
154283158|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283159|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154283160|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154283161|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154283162|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154283163|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283164|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283165|NCT01290198|Fluconazole|fluconazole|mesh-list
154283166|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
154283167|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
154283168|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283169|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154283170|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154283171|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283172|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283173|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154283174|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
154283175|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154283176|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283199|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
154283200|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154283201|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154283202|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283203|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283204|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283228|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813383|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153359855|NCT03568656|Olaparib|olaparib|mesh-list
154283236|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283237|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027387|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
154283238|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154283239|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154283240|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154283241|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154283242|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283243|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154283244|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154283245|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283247|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154283248|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154283249|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154283250|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
154283251|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283252|NCT01186224|Plerixafor|plerixafor|mesh-list
154283253|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154283254|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154283255|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
154283256|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283257|NCT01183494|Irinotecan|irinotecan|mesh-list
154283258|NCT01183494|Bevacizumab|bevacizumab|mesh-list
154283259|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154283260|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154283261|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283262|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283263|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283264|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154283265|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154283266|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154283267|NCT01183494|Growth Substances|growth substances|mesh-ancestor
154283268|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283269|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
154283270|NCT01183572|Iron|iron|mesh-list
154283271|NCT01183572|Folic Acid|folic acid|mesh-list
154283272|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
154283273|NCT01183572|Trace Elements|trace elements|mesh-ancestor
154283274|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
154283275|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283276|NCT01183572|Hematinics|hematinics|mesh-ancestor
154283277|NCT01183572|Vitamins|vitamins|mesh-ancestor
154283278|NCT03856242|Tamsulosin|tamsulosin|mesh-list
154283279|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154283280|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154283281|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154283282|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
154283283|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283284|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283285|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283286|NCT03856242|Urological Agents|urological agents|mesh-ancestor
154283287|NCT01291524|Pregabalin|pregabalin|mesh-list
154283288|NCT01291524|Analgesics|analgesics|mesh-ancestor
154283289|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
154283290|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283291|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283292|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
154283293|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154283294|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154283295|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283296|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154283310|NCT01188954|Doxycycline|doxycycline|mesh-list
154283311|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154283312|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283313|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
154283314|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154283315|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154283316|NCT01183962|Vitamin D|vitamin d|mesh-list
154283317|NCT01183962|Vitamins|vitamins|mesh-ancestor
154283318|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
154283319|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283320|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154283321|NCT01187238|Cisplatin|cisplatin|mesh-list
154283322|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283323|NCT01588314|Gabapentin|gabapentin|mesh-list
154283324|NCT01588314|Analgesics|analgesics|mesh-ancestor
154283325|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
154283326|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283327|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283328|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
154283329|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154283330|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154283339|NCT01290432|Melatonin|melatonin|mesh-list
154283340|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
154283341|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283342|NCT01290432|Protective Agents|protective agents|mesh-ancestor
154283343|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283344|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283345|NCT01290432|Hematinics|hematinics|mesh-ancestor
154283346|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
154283347|NCT01290432|Vitamins|vitamins|mesh-ancestor
154283348|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
154283349|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
154283350|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154283351|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
154283352|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283353|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
154283354|NCT01290510|Protective Agents|protective agents|mesh-ancestor
154283355|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
154283356|NCT01184196|Povidone|povidone|mesh-list
154283357|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
154283358|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
154283359|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154283360|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283361|NCT01292460|Timolol|timolol|mesh-list
154283362|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154283363|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154283364|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
154283377|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283378|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154283379|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
154283380|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283382|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154283383|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
154283384|NCT03851562|Urological Agents|urological agents|mesh-ancestor
154283385|NCT01293630|Paclitaxel|paclitaxel|mesh-list
154283386|NCT01293630|Carboplatin|carboplatin|mesh-list
154283387|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154283388|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283389|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283390|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283391|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
154283392|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283393|NCT01191060|Lenalidomide|lenalidomide|mesh-list
154283395|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
154283419|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153359865|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359866|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359872|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283429|NCT03853512|Petrolatum|petrolatum|mesh-list
154283430|NCT03853512|Emollients|emollients|mesh-ancestor
154283431|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
154283432|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
154283433|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154283434|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283435|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
154283436|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154283437|NCT03853200|Acetic Acid|acetic acid|mesh-list
154283438|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
154283439|NCT03853200|Edetic Acid|edetic acid|mesh-list
154283440|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
154283441|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154283442|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283443|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
154283444|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
154283445|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
154283446|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154283447|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
154283448|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
154283449|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283450|NCT03853200|Antidotes|antidotes|mesh-ancestor
154283451|NCT03853200|Protective Agents|protective agents|mesh-ancestor
154283452|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283453|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153449862|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
154283460|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154283461|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283462|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154283463|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154283464|NCT01293942|Growth Substances|growth substances|mesh-ancestor
154283465|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283466|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
154283467|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154283468|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
154283469|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283470|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154283471|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154283472|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283473|NCT01189656|Vaccines|vaccines|mesh-list
154283474|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
154283475|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283476|NCT01581138|Ribavirin|ribavirin|mesh-list
154283477|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
154283478|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283479|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
154283480|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283481|NCT01191216|Docetaxel|docetaxel|mesh-list
154283482|NCT01191216|Tryptophan|tryptophan|mesh-list
154283483|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283484|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283485|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283486|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
154283487|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283488|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154283498|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
154283499|NCT03847818|Carboplatin|carboplatin|mesh-list
154283500|NCT03847818|Docetaxel|docetaxel|mesh-list
154283501|NCT03847818|Trastuzumab|trastuzumab|mesh-list
154283502|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283503|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283504|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283505|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
154283506|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283507|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154283508|NCT01294410|Antibodies|antibodies|mesh-list
154283509|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
154283510|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
154283511|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283512|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
154283513|NCT01191450|Amiloride|amiloride|mesh-list
154283514|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154283515|NCT01191450|Diuretics|diuretics|mesh-ancestor
154283516|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
154283517|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283518|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154283519|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153813385|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813386|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153813387|NCT00333632|Analgesics|analgesics|mesh-ancestor
153813388|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
153813389|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813390|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154283538|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154283539|NCT01194336|Protective Agents|protective agents|mesh-ancestor
154283540|NCT02660710|Rituximab|rituximab|mesh-list
154283541|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154283542|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283543|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
154283544|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283545|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154283546|NCT01294878|Omalizumab|omalizumab|mesh-list
154283547|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154283566|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
154283567|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154283568|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283569|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
154283570|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283571|NCT01190358|Protective Agents|protective agents|mesh-ancestor
154283572|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283573|NCT01293162|Folic Acid|folic acid|mesh-list
154283574|NCT01293162|Policosanol|policosanol|mesh-list
154283575|NCT01293162|Hematinics|hematinics|mesh-ancestor
153813404|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
153359874|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154283597|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283599|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
154283600|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283601|NCT02659540|Nivolumab|nivolumab|mesh-list
154283602|NCT02659540|Ipilimumab|ipilimumab|mesh-list
154283624|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154283625|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
154283626|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154283627|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283645|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283646|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283647|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
154283648|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283649|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154283650|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154283651|NCT01097746|Growth Substances|growth substances|mesh-ancestor
154283652|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283653|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
154283654|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
154283655|NCT01190748|Galantamine|galantamine|mesh-list
153813405|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153359875|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
154283678|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
154283679|NCT01383538|Vitamins|vitamins|mesh-ancestor
154283680|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
154283681|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
154283682|NCT01383460|Lenograstim|lenograstim|mesh-list
154283693|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283695|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154027388|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283696|NCT01192230|Growth Substances|growth substances|mesh-ancestor
154283697|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283698|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
154283700|NCT05416840|Clonidine|clonidine|mesh-list
154283701|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154283702|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154283703|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154283704|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283705|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154283706|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283707|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
154283708|NCT05416840|Analgesics|analgesics|mesh-ancestor
154283709|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
154283710|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283711|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
154283712|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
154283713|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154283714|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154283716|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
154283717|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154283718|NCT01192308|Tamoxifen|tamoxifen|mesh-list
154283719|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154283720|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
154283721|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154283722|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283723|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154283724|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283725|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154283726|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154283727|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154283728|NCT01190982|Paclitaxel|paclitaxel|mesh-list
154283729|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153819448|NCT01154764|Ketoconazole|ketoconazole|mesh-list
154283730|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283731|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283732|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283733|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
154283734|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283735|NCT03631186|Semaglutide|semaglutide|mesh-list
154283736|NCT03631186|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154283737|NCT03631186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154283738|NCT03631186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283739|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154283740|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
154283741|NCT01196754|Sevoflurane|sevoflurane|mesh-list
154283742|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154283743|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154283744|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
154283745|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
154283746|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283748|NCT01295502|Paclitaxel|paclitaxel|mesh-list
154283768|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283769|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154283770|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
154030615|NCT02690129|Progesterone|progesterone|mesh-list
154283771|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154283772|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154283773|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154283775|NCT03846102|Acetaminophen|acetaminophen|mesh-list
154283776|NCT03846102|Morphine|morphine|mesh-list
154283777|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
154283778|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154283779|NCT03846102|Narcotics|narcotics|mesh-ancestor
154283780|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283781|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283782|NCT03846102|Analgesics|analgesics|mesh-ancestor
154283783|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
154283784|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283786|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
154283787|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
154283788|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
154283789|NCT01383148|Paclitaxel|paclitaxel|mesh-list
154283790|NCT01383148|Cisplatin|cisplatin|mesh-list
154283791|NCT01383148|Carboplatin|carboplatin|mesh-list
154283792|NCT01383148|Gemcitabine|gemcitabine|mesh-list
154283793|NCT01383148|Pemetrexed|pemetrexed|mesh-list
154283794|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154283795|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283796|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
154283797|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
154283798|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
154283799|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283800|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154283801|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
154283802|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283803|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154283804|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154283805|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
154283806|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154283807|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283808|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
154283850|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154283851|NCT01193400|Cytarabine|cytarabine|mesh-list
154283852|NCT01193400|Clofarabine|clofarabine|mesh-list
154283853|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154283854|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
154283855|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283856|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283857|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
154283858|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283859|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154283860|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
154283861|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283862|NCT03904888|Anesthetics|anesthetics|mesh-list
154283863|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
154283864|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283865|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283866|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
153813406|NCT00333632|Narcotics|narcotics|mesh-ancestor
153359876|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
153359877|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154283889|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
153449950|NCT00004997|Antidotes|antidotes|mesh-ancestor
154283891|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
154283892|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
154283893|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154283894|NCT04731376|Androgens|androgens|mesh-ancestor
154283895|NCT04731376|Hormones|hormones|mesh-ancestor
154283896|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154283897|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283898|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154283899|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283900|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
154283901|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154283902|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154283903|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283904|NCT01196208|Immunotoxins|immunotoxins|mesh-ancestor
154283905|NCT01196208|Immunoconjugates|immunoconjugates|mesh-ancestor
154283906|NCT01196208|Immunologic Factors|immunologic factors|mesh-ancestor
154283907|NCT01196208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283908|NCT01295892|Estrogens|estrogens|mesh-list
154283909|NCT01295892|Hormones|hormones|mesh-ancestor
154283910|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154283911|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283912|NCT01296204|Antibodies|antibodies|mesh-list
154283913|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
154283914|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283915|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154283916|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
154030771|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
154283955|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283956|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283958|NCT01199562|Ganciclovir|ganciclovir|mesh-list
154283959|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154283960|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
154283961|NCT01199562|Foscarnet|foscarnet|mesh-list
154283962|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
154283963|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283964|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154283965|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283966|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283967|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154283968|NCT03845322|Curcumin|curcumin|mesh-list
154283969|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154283970|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154283971|NCT03845322|Analgesics|analgesics|mesh-ancestor
154283972|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
154283973|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154283974|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283975|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154283976|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154283977|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154283978|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283979|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283980|NCT03844932|Cyclosporine|cyclosporine|mesh-list
154283981|NCT03844932|Cyclosporins|cyclosporins|mesh-list
154283982|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154283983|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154283984|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154283985|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
154283986|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154283987|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
154283988|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154283989|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
154283990|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154283991|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154283992|NCT03726996|Desipramine|desipramine|mesh-list
154283993|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154283994|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
154284011|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
154284012|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284013|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284014|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154284015|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284016|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154284017|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
154284018|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
154284019|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284020|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
154284021|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
154284022|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
154284023|NCT03842046|Phenylephrine|phenylephrine|mesh-list
154284024|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
154284025|NCT03842046|Norepinephrine|norepinephrine|mesh-list
154284026|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154284027|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
154284028|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
154284029|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284030|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284031|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
154284032|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154284033|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
154284034|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
154284035|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154284036|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154284037|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154284038|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
154284039|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284040|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284041|NCT03842046|Protective Agents|protective agents|mesh-ancestor
154284042|NCT01198236|Itraconazole|itraconazole|mesh-list
154284043|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
154284044|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284045|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154284051|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284052|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284053|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154284055|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
154284056|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284057|NCT03841890|Tolnaftate|tolnaftate|mesh-list
154284058|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
154284059|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284060|NCT01200108|Budesonide|budesonide|mesh-list
154284061|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284062|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154284063|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
154284064|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284065|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284066|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154284067|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
154284068|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
154284069|NCT01200108|Hormones|hormones|mesh-ancestor
154284070|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284071|NCT01200186|Progestins|progestins|mesh-list
154284072|NCT01200186|Hormones|hormones|mesh-ancestor
154284073|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284074|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284075|NCT03841812|Propofol|propofol|mesh-list
154284076|NCT03841812|Sevoflurane|sevoflurane|mesh-list
154284077|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154284078|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284079|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284080|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154284081|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
154284082|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
153598056|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
154284083|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154284084|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154284103|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
154284104|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284105|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284106|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284107|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284108|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154284109|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154284110|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284111|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284112|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
154284113|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154284114|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284116|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154284123|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
154284124|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154284125|NCT01200654|Linezolid|linezolid|mesh-list
154284126|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154284127|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284128|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154284129|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284130|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284131|NCT01200732|Tadalafil|tadalafil|mesh-list
154284132|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
154284133|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154284134|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154284135|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284136|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284137|NCT01200732|Urological Agents|urological agents|mesh-ancestor
154284138|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
154284139|NCT01198860|Tenofovir|tenofovir|mesh-list
154284140|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
154284141|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284142|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154284143|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154284144|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284145|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284146|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154284147|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154284148|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
154284149|NCT01198860|Protective Agents|protective agents|mesh-ancestor
154284150|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284181|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
154284182|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
154284183|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
154284184|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284185|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284186|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
154284187|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284188|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154284189|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154284190|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154284191|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284192|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284193|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154284194|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154284195|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
154284196|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284197|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154284198|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154284199|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
154284200|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154284201|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
154284202|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
154284203|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
154284204|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154284205|NCT01201122|Mesalamine|mesalamine|mesh-list
154284206|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154284207|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154284208|NCT01201122|Analgesics|analgesics|mesh-ancestor
154284209|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
154284210|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284211|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284212|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284213|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284214|NCT03668808|Insulin|insulin|mesh-list
154284215|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154284216|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
154284217|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
154284218|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154284219|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284221|NCT05281926|Poly ICLC|poly iclc|mesh-list
154284222|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154284223|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284224|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154284225|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284226|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
154284227|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
154284228|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284229|NCT03844776|Acetaminophen|acetaminophen|mesh-list
154284230|NCT03844776|Amoxicillin|amoxicillin|mesh-list
154284231|NCT03844776|Metronidazole|metronidazole|mesh-list
154284232|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154284233|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
154284234|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154284235|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284236|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154284237|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
154284242|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284243|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
154284244|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154284245|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154284246|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154284247|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284248|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284249|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
154284250|NCT01566942|Irinotecan|irinotecan|mesh-list
154284251|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284252|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154284253|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154284254|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284255|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284256|NCT01201278|Insulin|insulin|mesh-list
154284257|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154284258|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
154284259|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154284260|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284261|NCT05667948|Immunomodulating Agents|immunomodulating agents|mesh-list
154284262|NCT05667948|Immunologic Factors|immunologic factors|mesh-ancestor
154284263|NCT05667948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284264|NCT01199328|Aspirin|aspirin|mesh-list
154284265|NCT01199328|Esomeprazole|esomeprazole|mesh-list
154284266|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154284267|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154284268|NCT01199328|Analgesics|analgesics|mesh-ancestor
154284269|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
154284270|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284271|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284299|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284300|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284301|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154284302|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284303|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
154284304|NCT01203696|Amlodipine|amlodipine|mesh-list
154284305|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154284306|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153598138|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154284307|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284308|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284309|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154284310|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284311|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
154284312|NCT01203306|Bevacizumab|bevacizumab|mesh-list
154284313|NCT01203306|Capecitabine|capecitabine|mesh-list
154284314|NCT01203306|Octreotide|octreotide|mesh-list
154284315|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154284316|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284380|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
154284381|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284382|NCT01206036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154284383|NCT01206036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284384|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284385|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
154284386|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284387|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154284388|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284389|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154284390|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
154284391|NCT01204320|Paclitaxel|paclitaxel|mesh-list
154284392|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154284393|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154284394|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284395|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
154284396|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
154284397|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
154284398|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284399|NCT03722238|Ibuprofen|ibuprofen|mesh-list
154284400|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154284401|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154284402|NCT03722238|Analgesics|analgesics|mesh-ancestor
154284403|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
154284404|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284405|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284422|NCT01206270|Hormones|hormones|mesh-ancestor
154284423|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284424|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284425|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154284426|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284427|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
154284428|NCT01206270|Cathartics|cathartics|mesh-ancestor
154284429|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154284430|NCT01298310|Lidocaine|lidocaine|mesh-list
154284431|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
154284432|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
154284433|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284434|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284435|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
154284455|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154284456|NCT01206348|Minocycline|minocycline|mesh-list
154284457|NCT01206348|Clindamycin|clindamycin|mesh-list
154284458|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
154284459|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
154284460|NCT01206348|Tretinoin|tretinoin|mesh-list
154284461|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154284477|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284478|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
154284479|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284480|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284481|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154284482|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154284483|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154284484|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284485|NCT04630210|Atezolizumab|atezolizumab|mesh-list
154284486|NCT04630210|Letrozole|letrozole|mesh-list
154284487|NCT04630210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154284488|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284489|NCT04630210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154284490|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284491|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154284492|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154284493|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284494|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154284495|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
154284496|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284497|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284498|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
154284499|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
154284500|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154284501|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154284502|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284503|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284504|NCT01382368|Urological Agents|urological agents|mesh-ancestor
154284505|NCT04546828|Gemcitabine|gemcitabine|mesh-list
154284561|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284562|NCT02155920|Everolimus|everolimus|mesh-list
154284563|NCT02155920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154284564|NCT02155920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154284565|NCT02155920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284566|NCT02155920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284567|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284568|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
154284569|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284570|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284571|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
154284572|NCT01301040|Docetaxel|docetaxel|mesh-list
154284573|NCT01301040|Epirubicin|epirubicin|mesh-list
154284574|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284575|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
154284576|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284577|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284578|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154284579|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
154284588|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154284589|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284590|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
154284591|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
154284592|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284593|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
154284594|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284595|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284596|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154284597|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
154284598|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284599|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284600|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154284601|NCT01206972|Enoxaparin|enoxaparin|mesh-list
154284602|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
154284603|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154284604|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
154284605|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154284606|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
154284607|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284608|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284609|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
154284610|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154284611|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154284612|NCT03817476|BI 425809|bi 425809|mesh-list
153598206|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
154284635|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284637|NCT01207128|Micafungin|micafungin|mesh-list
154284638|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
153813414|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
154284668|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
154284669|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284670|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154284671|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154284672|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284673|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284675|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
154284676|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
154284677|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284678|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
154284679|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284680|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
154284681|NCT01205022|Leucovorin|leucovorin|mesh-list
154284682|NCT01205022|Bevacizumab|bevacizumab|mesh-list
154284683|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154284684|NCT01205022|Fluorouracil|fluorouracil|mesh-list
154284685|NCT01205022|Irinotecan|irinotecan|mesh-list
154284686|NCT01205022|Camptothecin|camptothecin|mesh-list
154284687|NCT01205022|Antibodies|antibodies|mesh-list
154284688|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
154284689|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154284690|NCT01205022|Calcium|calcium|mesh-list
154284691|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
154284692|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284693|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154284694|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154284695|NCT01205022|Growth Substances|growth substances|mesh-ancestor
154284696|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284697|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
154284698|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
154284699|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154284700|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154284701|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
154284702|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284703|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284704|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154284705|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154284706|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154284707|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284708|NCT01205022|Antidotes|antidotes|mesh-ancestor
154284709|NCT01205022|Protective Agents|protective agents|mesh-ancestor
154284710|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
154284711|NCT01205022|Vitamins|vitamins|mesh-ancestor
154284712|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
154284713|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154284714|NCT01205178|Chloroquine|chloroquine|mesh-list
154284715|NCT01205178|Primaquine|primaquine|mesh-list
153598262|NCT05855616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284716|NCT01205178|Tafenoquine|tafenoquine|mesh-list
154284717|NCT01205178|Amebicides|amebicides|mesh-ancestor
154284718|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154284719|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154284720|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284721|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
154284722|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284723|NCT01205256|Methadone|methadone|mesh-list
154284724|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154284733|NCT03823482|Lidocaine|lidocaine|mesh-list
154284758|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153646473|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154284781|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153781781|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154284804|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
154284805|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284806|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284807|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284808|NCT01205724|Factor VIII|factor viii|mesh-list
154284814|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154284815|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154031669|NCT06281756|Trazodone|trazodone|mesh-list
154284816|NCT01301820|Growth Substances|growth substances|mesh-ancestor
154284817|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
154284818|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284819|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284820|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
154284821|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284822|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284823|NCT01297686|Dexamethasone|dexamethasone|mesh-list
154284824|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284825|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
154284826|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
154284827|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284828|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284829|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154284830|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
154284832|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284833|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154284834|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284835|NCT01205880|Calcitriol|calcitriol|mesh-list
154284836|NCT01205880|Clobetasol|clobetasol|mesh-list
154284837|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154284838|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284839|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154284840|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154284841|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284842|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154284843|NCT01205880|Vitamins|vitamins|mesh-ancestor
154284845|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154284846|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284847|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
154284848|NCT01205880|Hormones|hormones|mesh-ancestor
154284849|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284850|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
154284851|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154284852|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154284853|NCT01205958|Analgesics|analgesics|mesh-ancestor
154284854|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
154284855|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284856|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284857|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154284858|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154284859|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
154284860|NCT01297842|Meropenem|meropenem|mesh-list
154284861|NCT01297842|Imipenem|imipenem|mesh-list
154284862|NCT01297842|Ertapenem|ertapenem|mesh-list
154284863|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154284864|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154284865|NCT01297998|Cisplatin|cisplatin|mesh-list
154284866|NCT01297998|Gemcitabine|gemcitabine|mesh-list
154284867|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154284868|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154284895|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154284896|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154284897|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284898|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154284899|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
154284900|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154284901|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284902|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154284903|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154284905|NCT01560390|Analgesics|analgesics|mesh-ancestor
154284906|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
154284907|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284908|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284909|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154284910|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154284911|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
154284912|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
154284913|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154284914|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154284915|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154284916|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284917|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284918|NCT03807882|Clozapine|clozapine|mesh-list
154284919|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154284920|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
154284921|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284922|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284951|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154284952|NCT01303536|Ondansetron|ondansetron|mesh-list
154284953|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
154284954|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
154284955|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154284956|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154284957|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154284958|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
154284959|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
154284960|NCT01303536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154284961|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154284962|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
154284963|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154284987|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
153359881|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285002|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
154285003|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154285004|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285005|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
154285006|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154285007|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285008|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154285009|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285010|NCT03799536|Sotalol|sotalol|mesh-list
154285011|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154285012|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154285013|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
154285014|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285015|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285016|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285037|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
154285038|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154285039|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598340|NCT05854082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154285040|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285041|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
154285042|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285043|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285044|NCT01381510|Urological Agents|urological agents|mesh-ancestor
154285145|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154285146|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154285147|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285148|NCT03798834|Anesthetics|anesthetics|mesh-list
154285149|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285150|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285151|NCT01304784|Paclitaxel|paclitaxel|mesh-list
154285152|NCT01304784|Docetaxel|docetaxel|mesh-list
154285153|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154285154|NCT01304784|Capecitabine|capecitabine|mesh-list
154285155|NCT01304784|Trastuzumab|trastuzumab|mesh-list
154285156|NCT01304784|Lapatinib|lapatinib|mesh-list
154285157|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154285158|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154285159|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285160|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
154285161|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
154285162|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
154285163|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285164|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154285165|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
154285166|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154285167|NCT01304784|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154285168|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154285169|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285170|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
154285171|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285172|NCT03798600|Caspofungin|caspofungin|mesh-list
154285173|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
154285174|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285268|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285269|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
154285270|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285271|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154285272|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154285274|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
154285275|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154285276|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
154285277|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285278|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285279|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154285280|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
153450385|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
153813422|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285302|NCT04893252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154285303|NCT04893252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285304|NCT04893252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285305|NCT03797508|Progesterone|progesterone|mesh-list
154285306|NCT03797508|Progestins|progestins|mesh-ancestor
154285307|NCT03797508|Hormones|hormones|mesh-ancestor
154285313|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
154285314|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154285315|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154285316|NCT01304316|Phenylephrine|phenylephrine|mesh-list
154285317|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
154285318|NCT01304316|Tetracaine|tetracaine|mesh-list
154285319|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
154285320|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
154285321|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285322|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285323|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
154285324|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285325|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154285326|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154285327|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
154285328|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285329|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285330|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
154285331|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
154285332|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
154285333|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154285334|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
154285335|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154285336|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
154285337|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154285338|NCT01304316|Protective Agents|protective agents|mesh-ancestor
154285339|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154285340|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154285341|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154285351|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
154285352|NCT01379326|Mebendazole|mebendazole|mesh-list
154285353|NCT01379326|Piperazine|piperazine|mesh-list
154285354|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
154285355|NCT01379326|DMP 777|dmp 777|mesh-list
154285356|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
154285357|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
154285358|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154285359|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285360|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
154285361|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
154285362|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
154285363|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285364|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285365|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285366|NCT01560546|Testosterone|testosterone|mesh-list
154285367|NCT01560546|Androgens|androgens|mesh-ancestor
154285368|NCT01560546|Hormones|hormones|mesh-ancestor
154285369|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154285370|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285371|NCT03792984|Vitamin D|vitamin d|mesh-list
154285372|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
154285373|NCT03792984|Metformin|metformin|mesh-list
153359888|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154285380|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154285381|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154285382|NCT03792984|Antacids|antacids|mesh-ancestor
154285383|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285384|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154285385|NCT03792906|Norepinephrine|norepinephrine|mesh-list
154285386|NCT03792906|Bupivacaine|bupivacaine|mesh-list
154285387|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
154285388|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
154285389|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285390|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285391|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
154285392|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285393|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154285394|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154285395|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
154285396|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285397|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285398|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
154285399|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
154285400|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154285401|NCT03078556|Lamivudine|lamivudine|mesh-list
154285402|NCT03078556|Dolutegravir|dolutegravir|mesh-list
154285403|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154285404|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154285405|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285406|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285407|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
154285408|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285409|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154285410|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154285411|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154285412|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154285413|NCT03949894|Tolvaptan|tolvaptan|mesh-list
154285414|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153598515|NCT05528198|Montelukast|montelukast|mesh-list
154285415|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285416|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
154285417|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285418|NCT03714672|Diclofenac|diclofenac|mesh-list
154285419|NCT03714672|Tramadol|tramadol|mesh-list
154285420|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154285421|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154285422|NCT03714672|Analgesics|analgesics|mesh-ancestor
154285423|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
154285424|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285425|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285426|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154285427|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154285428|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154285429|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285430|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285431|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154285432|NCT03714672|Narcotics|narcotics|mesh-ancestor
154285433|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285477|NCT03789006|Antibodies|antibodies|mesh-list
154285478|NCT03789006|Basiliximab|basiliximab|mesh-list
154285479|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
154285480|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154285481|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
153450434|NCT00386399|Mitomycins|mitomycins|mesh-list
154285482|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285483|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285484|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154285485|NCT03789006|Analgesics|analgesics|mesh-ancestor
154285486|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
154285487|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285488|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154285489|NCT01306266|Rizatriptan|rizatriptan|mesh-list
154285490|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154285491|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
154285492|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285493|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285494|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285495|NCT03630796|Sevoflurane|sevoflurane|mesh-list
154285496|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154285497|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154285498|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
154285499|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
154285500|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285501|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285502|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154285503|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154285504|NCT01096966|Bupivacaine|bupivacaine|mesh-list
154285505|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
154285506|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
154285507|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285508|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285509|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
154285510|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285511|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
154285512|NCT01379560|Dinoprost|dinoprost|mesh-list
154285513|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154285514|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154285590|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154285592|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
154285593|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285594|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154285595|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154285596|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154285597|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
154285598|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285599|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285600|NCT05320120|Esketamine|esketamine|mesh-list
154285601|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
154285602|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154285603|NCT03077698|Megestrol|megestrol|mesh-list
154285604|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
154285605|NCT03077698|Progestins|progestins|mesh-list
154285606|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
154285607|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154285629|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154285630|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
154285631|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
154285632|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154285633|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
154285677|NCT05764018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154285678|NCT05764018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285679|NCT05764018|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154285680|NCT05764018|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154285681|NCT05764018|Purinergic Agents|purinergic agents|mesh-ancestor
154285815|NCT03790020|Bupivacaine|bupivacaine|mesh-list
154285816|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
154285817|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
154285818|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285819|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285820|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
154285821|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285822|NCT03075826|Guadecitabine|guadecitabine|mesh-list
154285823|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154285825|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
154285826|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285827|NCT04108234|Ketamine|ketamine|mesh-list
154285828|NCT04108234|Analgesics|analgesics|mesh-ancestor
154285829|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
154285830|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285831|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285832|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154285833|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154285834|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
154285835|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
154285836|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154285837|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154285936|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285937|NCT03776916|Emollients|emollients|mesh-ancestor
154285938|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
154285939|NCT01560702|Epinephrine|epinephrine|mesh-list
154285940|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154285941|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154285942|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
154285943|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154285944|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154285945|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285946|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154285947|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154285948|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
154285949|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285993|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154285994|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
154285995|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154285996|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154285997|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154285998|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
154285999|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154286000|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154286001|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286002|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154286003|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
154286004|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154286005|NCT01142284|Protective Agents|protective agents|mesh-ancestor
154286006|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154286007|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154286008|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286009|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154286010|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154286011|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
154286012|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154286013|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
154286014|NCT01309776|Tianeptine|tianeptine|mesh-list
154286015|NCT01309776|Escitalopram|escitalopram|mesh-list
154286016|NCT01309776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154286017|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154286018|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286019|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286020|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286021|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
154286026|NCT03783000|BI 425809|bi 425809|mesh-list
154286061|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286062|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
154286077|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286078|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
154286079|NCT01314300|Lidocaine|lidocaine|mesh-list
154286080|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
154286081|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
154286082|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286083|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286084|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
154286085|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286086|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154286087|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154286088|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154286089|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286090|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359896|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154286142|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286143|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
154286144|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154286145|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286146|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286147|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286148|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286149|NCT01561404|Everolimus|everolimus|mesh-list
154286150|NCT01561404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154286151|NCT01561404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154286152|NCT01561404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286153|NCT01561404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286154|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286155|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
154286156|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286157|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286158|NCT03775590|Acetic Acid|acetic acid|mesh-list
154286159|NCT03775590|Retinol acetate|retinol acetate|mesh-list
154286160|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286161|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286162|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154286225|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286226|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
153598695|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154286227|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
154286228|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
154286229|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286230|NCT05211622|Protective Agents|protective agents|mesh-ancestor
154286231|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286232|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
154286233|NCT05211622|Vitamins|vitamins|mesh-ancestor
154286234|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
154286235|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
154286236|NCT03778008|Gentamicins|gentamicins|mesh-list
154286237|NCT03778008|Dexamethasone|dexamethasone|mesh-list
153359897|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359898|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154286239|NCT03778008|Mitogens|mitogens|mesh-list
154286240|NCT03778008|Vitamins|vitamins|mesh-ancestor
154286241|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
154286242|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286243|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286244|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
154286245|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
154286246|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286247|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154286248|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
154286249|NCT03778008|Hormones|hormones|mesh-ancestor
154286250|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286251|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154286252|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286253|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
154286254|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
154286255|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286256|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
154286257|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154286258|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154286259|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154286260|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286261|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286262|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
154286263|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
154286264|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286265|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286266|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154286267|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286268|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
154286269|NCT05697328|Ephedrine|ephedrine|mesh-list
154286270|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154286271|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
154286272|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286273|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286274|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154286275|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
154286276|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
154286277|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154286278|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154286279|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
154286280|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
154286281|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286282|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286283|NCT03777930|Thalidomide|thalidomide|mesh-list
154286284|NCT03777930|Megestrol|megestrol|mesh-list
154286285|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
154286286|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286287|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
154286288|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286289|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
154286290|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286291|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286292|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153598725|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
154286293|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154286294|NCT03777930|Growth Substances|growth substances|mesh-ancestor
154286295|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
154286296|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286297|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154286298|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154286299|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154286300|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
154286301|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154286302|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154286307|NCT03777696|Misoprostol|misoprostol|mesh-list
154286320|NCT03942094|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154286321|NCT03942094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154286322|NCT03942094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286323|NCT03942094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286324|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
154286325|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
154286326|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154286327|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154286328|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
154286329|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286330|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286331|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286332|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286333|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154286334|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286335|NCT03774108|Metformin|metformin|mesh-list
154286336|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154286337|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286338|NCT03438526|Melatonin|melatonin|mesh-list
154286339|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
154286340|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286341|NCT03438526|Protective Agents|protective agents|mesh-ancestor
154286342|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286343|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286344|NCT02575144|Clarithromycin|clarithromycin|mesh-list
154286345|NCT02575144|Dexamethasone|dexamethasone|mesh-list
154286346|NCT02575144|Lenalidomide|lenalidomide|mesh-list
154286347|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286348|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
154286349|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
154286350|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286351|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286352|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154286353|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
154286364|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286365|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154286366|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286367|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286368|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154286369|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154286370|NCT03768882|Acetaminophen|acetaminophen|mesh-list
154286371|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154286372|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154286373|NCT03768882|Analgesics|analgesics|mesh-ancestor
154286374|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
154286375|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286376|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286377|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
154286378|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154286379|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286380|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154286381|NCT02574286|Vitamin D|vitamin d|mesh-list
154286382|NCT02574286|Vitamins|vitamins|mesh-ancestor
154286383|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
154286384|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286385|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154286386|NCT01321944|Nicotine|nicotine|mesh-list
154286387|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154286388|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
154286389|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286390|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286391|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154286392|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154286393|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
154286394|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286399|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
154286400|NCT03771846|Irinotecan|irinotecan|mesh-list
154286401|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154286402|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
154286403|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286404|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286405|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286406|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
154286407|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286408|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154286409|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154286410|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286411|NCT03771846|Antidotes|antidotes|mesh-ancestor
154286412|NCT03771846|Protective Agents|protective agents|mesh-ancestor
154286413|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
154286414|NCT03771846|Vitamins|vitamins|mesh-ancestor
154286415|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
154286416|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154286417|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154286418|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286419|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
154286420|NCT03771768|Triamcinolone|triamcinolone|mesh-list
154286421|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154286422|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154286423|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154286424|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286425|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
154286426|NCT03771768|Hormones|hormones|mesh-ancestor
154286427|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286428|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286429|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286430|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
154286431|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286432|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286433|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
154286434|NCT03768258|Anastrozole|anastrozole|mesh-list
154286435|NCT03768258|Testosterone|testosterone|mesh-list
154286436|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
154286437|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
154286438|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154286439|NCT03768258|Androgens|androgens|mesh-ancestor
154286440|NCT03768258|Hormones|hormones|mesh-ancestor
154286441|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286442|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286443|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154286444|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286445|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
154286446|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154286447|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154286448|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286449|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286450|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154286451|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
154286452|NCT03771222|Decitabine|decitabine|mesh-list
154286453|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154286454|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
154286455|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286456|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286457|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286458|NCT03771066|Bisphenol A|bisphenol a|mesh-list
154286478|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
154286479|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
154286481|NCT02083354|Dabrafenib|dabrafenib|mesh-list
154286482|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286483|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154286484|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286485|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286486|NCT01399918|Bevacizumab|bevacizumab|mesh-list
154286487|NCT01399918|Everolimus|everolimus|mesh-list
154286488|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154286489|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286490|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154286491|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154286492|NCT01399918|Growth Substances|growth substances|mesh-ancestor
154286493|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286494|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
154286495|NCT01399918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154286496|NCT01399918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154286497|NCT01399918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286498|NCT01399918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286499|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286500|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
154286501|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
154286502|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154286503|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
154286504|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286505|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
154286506|NCT03761472|Protective Agents|protective agents|mesh-ancestor
154286507|NCT03767322|Allopurinol|allopurinol|mesh-list
154286508|NCT03767322|Febuxostat|febuxostat|mesh-list
154286509|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
154286510|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286511|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286512|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
154286513|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154286514|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154286515|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
154286517|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286518|NCT03761004|Levodopa|levodopa|mesh-list
154286519|NCT03761004|Carbidopa|carbidopa|mesh-list
154286520|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154286521|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154286522|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154286523|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
154286524|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286525|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286526|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286527|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154286528|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286529|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154286530|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
154286531|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
154286532|NCT03770208|Lidocaine|lidocaine|mesh-list
154286533|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
154286534|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
154286535|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286536|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286537|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
154286538|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286539|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154286540|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154286541|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154286542|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286543|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286544|NCT03766854|Insulin|insulin|mesh-list
154286545|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154286546|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
154286547|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154286548|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286549|NCT01322100|Bleomycin|bleomycin|mesh-list
154286556|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286557|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286558|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154286559|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154286560|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154286561|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154286562|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
154286564|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
154286565|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
154286566|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286567|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286568|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154286569|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154286570|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
154286571|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154286572|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154286573|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286574|NCT01567488|Everolimus|everolimus|mesh-list
154286575|NCT01567488|Octreotide|octreotide|mesh-list
154286576|NCT01567488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154286577|NCT01567488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154286578|NCT01567488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286579|NCT01567488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286580|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286581|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
154286582|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286583|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286584|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154286585|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154286586|NCT03760770|Riboflavin|riboflavin|mesh-list
154286587|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
154286588|NCT03760770|Vitamins|vitamins|mesh-ancestor
154286589|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
154286590|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286596|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154286597|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154286598|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286599|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286600|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286601|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154286602|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154286603|NCT01322178|Cetuximab|cetuximab|mesh-list
154286604|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154286605|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286606|NCT03760614|Entinostat|entinostat|mesh-list
154286607|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286608|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154286609|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598918|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
154286610|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286611|NCT00112840|Bevacizumab|bevacizumab|mesh-list
154286612|NCT00112840|Temsirolimus|temsirolimus|mesh-list
154286613|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154286614|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286615|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154286616|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154286617|NCT00112840|Growth Substances|growth substances|mesh-ancestor
154286618|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286646|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286647|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
154286648|NCT05223244|Triamcinolone|triamcinolone|mesh-list
154286649|NCT05223244|Heparin|heparin|mesh-list
154286650|NCT05223244|Bupivacaine|bupivacaine|mesh-list
154286651|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154286652|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
154286653|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
154286654|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154286655|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286656|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
154286657|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286658|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
154286659|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154286660|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154286661|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286662|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286663|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
154286664|NCT05223244|Hormones|hormones|mesh-ancestor
154286665|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286666|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154286667|NCT05223244|Protective Agents|protective agents|mesh-ancestor
154286668|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154286669|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
154286670|NCT03760302|Analgesics|analgesics|mesh-list
154286671|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154286672|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
154286673|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286676|NCT03766074|Vitamin D|vitamin d|mesh-list
154286693|NCT05168644|Niclosamide|niclosamide|mesh-list
154286694|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
154286695|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154286696|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
154286697|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154286698|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286699|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
154286700|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
154286701|NCT05412888|Ubiquinone|ubiquinone|mesh-list
154286702|NCT05412888|Vitamins|vitamins|mesh-ancestor
154286703|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
154286704|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286705|NCT05087212|Plerixafor|plerixafor|mesh-list
154286706|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154286707|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154286708|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
154286709|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286710|NCT01532310|Belimumab|belimumab|mesh-list
154286711|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286712|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
154286713|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286714|NCT01321788|Tinzaparin|tinzaparin|mesh-list
154286715|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154286716|NCT01321788|Dalteparin|dalteparin|mesh-list
154286717|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
154286718|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154286719|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154286720|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286721|NCT05053828|Clopidogrel|clopidogrel|mesh-list
154286722|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154286740|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286741|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
154286742|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154286743|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154286744|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
154286745|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154286746|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
154286747|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
154286748|NCT04920838|Hormones|hormones|mesh-ancestor
154286749|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286750|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154286751|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154286752|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154286753|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286754|NCT04920838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154286755|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154286756|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286757|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286758|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
154286759|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154286760|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
154286761|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154286762|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154286763|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154286764|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286765|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154286766|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286785|NCT04678492|Tetracycline|tetracycline|mesh-list
154286786|NCT04678492|Furazolidone|furazolidone|mesh-list
154286787|NCT04678492|Esomeprazole|esomeprazole|mesh-list
154286788|NCT04678492|Bismuth|bismuth|mesh-list
154286789|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154286790|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286791|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154286792|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154286793|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154286794|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286795|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286796|NCT04678492|Antacids|antacids|mesh-ancestor
154286797|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154286798|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154286799|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154286800|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154286801|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154286802|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154286803|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154286804|NCT03176784|Nicotine|nicotine|mesh-list
154286805|NCT03176784|Varenicline|varenicline|mesh-list
154286806|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154286807|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
154286808|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286809|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286810|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154286811|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154286812|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
154286813|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286814|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286815|NCT05091528|Capecitabine|capecitabine|mesh-list
154286816|NCT05091528|Trastuzumab|trastuzumab|mesh-list
154286817|NCT05091528|Tucatinib|tucatinib|mesh-list
154286818|NCT05091528|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154286828|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286829|NCT04236258|Enalapril|enalapril|mesh-list
154286830|NCT04236258|Nifedipine|nifedipine|mesh-list
154286831|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154286832|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286833|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286834|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154286835|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286836|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
154286837|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
154286838|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154286839|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154286840|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
154286841|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286842|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154286843|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154286844|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
154286845|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154286846|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286847|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154286848|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
154286849|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286850|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154033711|NCT02637726|Remifentanil|remifentanil|mesh-list
154286851|NCT05536102|Doxorubicin|doxorubicin|mesh-list
154286852|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154286854|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
154286855|NCT05536102|Tislelizumab|tislelizumab|mesh-list
154286856|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154286857|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286858|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154286859|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154286860|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286861|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286862|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154286863|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
154286864|NCT05536102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154286865|NCT05524714|Xanthohumol|xanthohumol|mesh-list
154286866|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286867|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154286868|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154286869|NCT05524714|Growth Substances|growth substances|mesh-ancestor
154286870|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286871|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
154286872|NCT05692804|Protein S|protein s|mesh-list
154286873|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
154286874|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
154286875|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154286876|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
154286877|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286878|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286879|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154286880|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
154286881|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
154286882|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154286883|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
154286884|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286885|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286886|NCT05692570|Ritonavir|ritonavir|mesh-list
154286887|NCT05692570|Cobicistat|cobicistat|mesh-list
154286888|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154286889|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154286890|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
154286891|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154286892|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286893|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154286894|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154286895|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
154286899|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
154286900|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153599227|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
154286901|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286902|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286903|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
154286904|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286905|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286906|NCT05417308|Minoxidil|minoxidil|mesh-list
154286907|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154286908|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
154286909|NCT04650542|Paroxetine|paroxetine|mesh-list
154286910|NCT04650542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154286911|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154286912|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154286913|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154286914|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154286915|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
154286916|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286917|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154286918|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
154286919|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154286923|NCT04621058|Vitamin D|vitamin d|mesh-list
154286951|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
154286952|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154286953|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154286954|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154286955|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
154286956|NCT03763734|Hormones|hormones|mesh-ancestor
154286957|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154286958|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154286959|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154286960|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154286961|NCT03756324|Cefdinir|cefdinir|mesh-list
154286962|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154286963|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154286964|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
154286965|NCT03756324|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154286966|NCT03756324|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154286967|NCT03751202|Fluticasone|fluticasone|mesh-list
154286968|NCT03751202|Xhance|xhance|mesh-list
154286969|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154286970|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154286987|NCT03751202|Hormones|hormones|mesh-ancestor
154287005|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287007|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
154287008|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287009|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154287010|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154287011|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
154287012|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
154287013|NCT04252586|Cannabidiol|cannabidiol|mesh-list
154287014|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
154287015|NCT04507776|Etanercept|etanercept|mesh-list
154287016|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154287017|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154287018|NCT04507776|Analgesics|analgesics|mesh-ancestor
154287019|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
154287020|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287021|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287022|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154287023|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287024|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154287025|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287026|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
154287027|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
154287028|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154287029|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
154287030|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154287031|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
154287032|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287033|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287034|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
154287035|NCT03746912|Quizartinib|quizartinib|mesh-list
154287036|NCT03746912|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154287037|NCT03746912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154287038|NCT03746912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287039|NCT03746912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287040|NCT03756246|Vaccines|vaccines|mesh-list
154287045|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
154287046|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287047|NCT05460858|Expectorants|expectorants|mesh-ancestor
154287048|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
154287049|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154287050|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
154287051|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287052|NCT05460858|Protective Agents|protective agents|mesh-ancestor
154287053|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287054|NCT05460858|Antidotes|antidotes|mesh-ancestor
154287055|NCT05359224|Clopidogrel|clopidogrel|mesh-list
154287056|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154287057|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154287058|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154287059|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154287060|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154287061|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
154287062|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287063|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287064|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287065|NCT03756090|Paclitaxel|paclitaxel|mesh-list
154287066|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
154287067|NCT03756090|Epirubicin|epirubicin|mesh-list
154287068|NCT03756090|Palbociclib|palbociclib|mesh-list
154287069|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154287070|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287071|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
154287072|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
154287091|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287093|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287094|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
154287095|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154287096|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154287097|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287098|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287099|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
154287100|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154287101|NCT03752736|Protective Agents|protective agents|mesh-ancestor
154287102|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287103|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
154287104|NCT03752658|Tenofovir|tenofovir|mesh-list
154287105|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
154287106|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287107|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154287108|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154287109|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287110|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287111|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154287112|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154287113|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
154287114|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154287115|NCT03755778|Itraconazole|itraconazole|mesh-list
154287116|NCT03755778|Rifampin|rifampin|mesh-list
154287117|NCT03755778|Quinidine|quinidine|mesh-list
153599757|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154287118|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
154287119|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287120|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154287121|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154287122|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287123|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287124|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154287125|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
154287128|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154287129|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154287130|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
154287131|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154287132|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
154287133|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154287134|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154287135|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154287136|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154287137|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154287138|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154287139|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154287140|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154287141|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154287142|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
154287143|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287144|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154287145|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
154287146|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154287147|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154287148|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154287149|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154287150|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
154287151|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154287152|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154287153|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154287154|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154287155|NCT03755700|Vitamin E|vitamin e|mesh-list
154287156|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
154287157|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154287158|NCT03755700|Vitamins|vitamins|mesh-ancestor
154287159|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
154287169|NCT03755700|Antidotes|antidotes|mesh-ancestor
154287170|NCT03757650|Amoxicillin|amoxicillin|mesh-list
154287171|NCT03757650|Clarithromycin|clarithromycin|mesh-list
154287172|NCT03757650|Omeprazole|omeprazole|mesh-list
154287173|NCT03757650|Bismuth|bismuth|mesh-list
154287174|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154287175|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154287176|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287177|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154287178|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154287179|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154287180|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287181|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287182|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154287183|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154287184|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154287185|NCT03757650|Antacids|antacids|mesh-ancestor
154287186|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
154287187|NCT03693404|Ketorolac|ketorolac|mesh-list
154287188|NCT03693404|Morphine|morphine|mesh-list
154287189|NCT03693404|Bupivacaine|bupivacaine|mesh-list
154287190|NCT03693404|Anesthetics|anesthetics|mesh-list
154287191|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
154287192|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
153599763|NCT01878201|Valsartan|valsartan|mesh-list
154287193|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287194|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287195|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
154287196|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287197|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154287198|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154287199|NCT03693404|Analgesics|analgesics|mesh-ancestor
154287200|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154287201|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287202|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154287212|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
154287213|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287214|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154287215|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287216|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
154287217|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154287218|NCT04219358|Protective Agents|protective agents|mesh-ancestor
154287219|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
154287220|NCT04218110|Ethanol|ethanol|mesh-list
154287221|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
154287222|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154287223|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154287224|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287225|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287226|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287227|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
154287228|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
154287229|NCT03752190|Cosyntropin|cosyntropin|mesh-list
154287230|NCT03752190|Hormones|hormones|mesh-ancestor
154287231|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154287232|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287233|NCT04210310|Oxytocin|oxytocin|mesh-list
154287234|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
154287235|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154287236|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287237|NCT03755466|Tofacitinib|tofacitinib|mesh-list
154287238|NCT03755466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154287239|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154287240|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287241|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287242|NCT03755310|Suvorexant|suvorexant|mesh-list
154287243|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154287244|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154287245|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287246|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287251|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
154287252|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154287253|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154287254|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287255|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287256|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287257|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287258|NCT03668392|Asparaginase|asparaginase|mesh-list
154287259|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287260|NCT03695094|Lamotrigine|lamotrigine|mesh-list
154287261|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
154287262|NCT03695094|Levetiracetam|levetiracetam|mesh-list
154287263|NCT03695094|Brivaracetam|brivaracetam|mesh-list
154287264|NCT03695094|Padsevonil|padsevonil|mesh-list
154287265|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
154287266|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
154287267|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154287268|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154287269|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287270|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154287271|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287272|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154287273|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154287274|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287275|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154287276|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154287277|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154287278|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154287279|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154287295|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154287297|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154287298|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287299|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154287300|NCT03752112|Penicillins|penicillins|mesh-list
154287301|NCT03752112|Cefixime|cefixime|mesh-list
154287302|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154287303|NCT03752112|Penicillin G|penicillin g|mesh-list
154287304|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
154287305|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154287306|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287317|NCT04168190|Vaccines|vaccines|mesh-list
154287358|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
154287359|NCT04189952|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154287360|NCT04189952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154287361|NCT04716426|Tetracycline|tetracycline|mesh-list
154287362|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154287363|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287364|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154287365|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287366|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287367|NCT04164758|Pimavanserin|pimavanserin|mesh-list
154287368|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154287369|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
154287370|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154287371|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154287372|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154287373|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287374|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287375|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154287376|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154287377|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154287378|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154034231|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154287379|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
154287380|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287382|NCT03754686|Acetaminophen|acetaminophen|mesh-list
154287406|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287407|NCT03746444|Anesthetics|anesthetics|mesh-list
154287408|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287409|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287410|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
154287411|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154287412|NCT03749096|Antibodies|antibodies|mesh-list
154287413|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
154287414|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154287415|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
154287416|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287417|NCT03748940|Mirikizumab|mirikizumab|mesh-list
154287418|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154287419|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154287420|NCT03748940|Analgesics|analgesics|mesh-ancestor
154287421|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
154287422|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287423|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287424|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154287425|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287426|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154287427|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154287428|NCT04177862|Fentanyl|fentanyl|mesh-list
154287429|NCT04177862|Sufentanil|sufentanil|mesh-list
154287430|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154287431|NCT04177862|Narcotics|narcotics|mesh-ancestor
154287432|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287433|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287434|NCT04177862|Analgesics|analgesics|mesh-ancestor
154287435|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
154287436|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287437|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154287438|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154287439|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
154287448|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287450|NCT04156646|Esomeprazole|esomeprazole|mesh-list
154287451|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154287452|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154287453|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154287454|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287455|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287456|NCT04156646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154287457|NCT04156646|Natriuretic Agents|natriuretic agents|mesh-ancestor
154287458|NCT04156646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287459|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154287460|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154287461|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154287462|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287463|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287464|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154287465|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154287466|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154287467|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
154287468|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287500|NCT04529850|Protective Agents|protective agents|mesh-ancestor
154287501|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287503|NCT04225676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287504|NCT04225676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287505|NCT01561950|Clopidogrel|clopidogrel|mesh-list
154287506|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154287507|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154287508|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154287509|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154287510|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
154287511|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287512|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287513|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287514|NCT04139018|Timolol|timolol|mesh-list
154287515|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154287516|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154287517|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
154287518|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287519|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287520|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287521|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154287522|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154287549|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287550|NCT04003610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154287551|NCT03999554|Vaccines|vaccines|mesh-list
154287552|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
154287553|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287554|NCT05280626|Prednisolone|prednisolone|mesh-list
154287555|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154287556|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
154287557|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154287558|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
154287559|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
154287560|NCT05280626|Rituximab|rituximab|mesh-list
154287561|NCT05280626|Doxorubicin|doxorubicin|mesh-list
154287562|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154287563|NCT05280626|Vincristine|vincristine|mesh-list
154287564|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154287565|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
154287566|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287567|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
154287568|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287569|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287570|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154287571|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
154287572|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287573|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287574|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154287575|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287576|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154287577|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154287578|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287593|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
154287594|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
154287596|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154287597|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
154287598|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287599|NCT03993392|Buprenorphine|buprenorphine|mesh-list
154287600|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154287601|NCT03993392|Narcotics|narcotics|mesh-ancestor
154287602|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287603|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287604|NCT03993392|Analgesics|analgesics|mesh-ancestor
154287605|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
154287606|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287607|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154287608|NCT03751176|Leucovorin|leucovorin|mesh-list
154287609|NCT03751176|Folic Acid|folic acid|mesh-list
154287610|NCT03751176|Fluorouracil|fluorouracil|mesh-list
154287611|NCT03751176|Irinotecan|irinotecan|mesh-list
154287612|NCT03751176|Panitumumab|panitumumab|mesh-list
154287613|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
154287614|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
154287615|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287616|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154287617|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287618|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287619|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
154287620|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287621|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154287622|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287623|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287624|NCT03751176|Antidotes|antidotes|mesh-ancestor
154287638|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287639|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154287640|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
154287641|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154287642|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154287643|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154287644|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287645|NCT03743870|Bupivacaine|bupivacaine|mesh-list
154287646|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
154287647|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
154287648|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
154287649|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287650|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287651|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
154287652|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287653|NCT03988088|Lasmiditan|lasmiditan|mesh-list
154287654|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154287655|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
154287656|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287657|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287658|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287659|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
154287660|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
154287661|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287662|NCT05204524|Temozolomide|temozolomide|mesh-list
154287663|NCT05204524|Epirubicin|epirubicin|mesh-list
154287664|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154287665|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
154287666|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287667|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287668|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154287672|NCT05204056|Epinephrine|epinephrine|mesh-list
154287680|NCT05204056|Analgesics|analgesics|mesh-ancestor
154287681|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
154287682|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287683|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
154287684|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
154287685|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154287686|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154287687|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287688|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
154287689|NCT05204056|Coagulants|coagulants|mesh-ancestor
154287690|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154287691|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154287692|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
154287693|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287694|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154287695|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154287696|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
154287697|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154287698|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
154287699|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
154287700|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
154287701|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154287702|NCT05203744|Tafenoquine|tafenoquine|mesh-list
154287703|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
154287704|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154287705|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154287706|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287707|NCT03987074|Semaglutide|semaglutide|mesh-list
154287708|NCT03987074|Firsocostat|firsocostat|mesh-list
154287709|NCT03987074|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154287710|NCT03987074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154287711|NCT03987074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287726|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287727|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154287728|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154287729|NCT05203354|Acitretin|acitretin|mesh-list
154287730|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
154287731|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
154287732|NCT04439214|Nivolumab|nivolumab|mesh-list
154287733|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287734|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287735|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154287736|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287737|NCT03754062|Haloperidol|haloperidol|mesh-list
154287738|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
154287739|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
154287740|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
154287741|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287742|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287743|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154287744|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154287745|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154287746|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287747|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154287748|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154287777|NCT05760976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287779|NCT03747978|Perindopril|perindopril|mesh-list
154287780|NCT03747978|Indapamide|indapamide|mesh-list
154287781|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
154287782|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154287783|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154287784|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154287785|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287786|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154287787|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287788|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
154287789|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154287790|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
154287791|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287792|NCT03747978|Diuretics|diuretics|mesh-ancestor
154287793|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
154287794|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154287795|NCT04603846|Paclitaxel|paclitaxel|mesh-list
154287796|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154287797|NCT04603846|Antibodies|antibodies|mesh-list
154287798|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154287799|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287800|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
154287801|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
154287802|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
154287803|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287804|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
154287806|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
154287821|NCT04472182|Calcium|calcium|mesh-list
154287822|NCT04472182|Fluorides|fluorides|mesh-list
154287823|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
154287824|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154287825|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287826|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
154287827|NCT04472182|Protective Agents|protective agents|mesh-ancestor
154287828|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
154287829|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154287830|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287831|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154287832|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287833|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287834|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287835|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287836|NCT05759416|Melatonin|melatonin|mesh-list
154287837|NCT05759416|Antioxidants|antioxidants|mesh-ancestor
154287838|NCT05759416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287839|NCT05759416|Protective Agents|protective agents|mesh-ancestor
154287840|NCT05759416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287841|NCT05759416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287842|NCT03746340|Propofol|propofol|mesh-list
154287843|NCT03746340|Sevoflurane|sevoflurane|mesh-list
154287844|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154287845|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287846|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287847|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154287848|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
154287849|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
154287850|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154287851|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154287852|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
154287853|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
154287863|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287864|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154287865|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287866|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
154287867|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287868|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
154287869|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287870|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154287871|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154287872|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287873|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
154287874|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287875|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287876|NCT04764630|Naloxone|naloxone|mesh-list
154287877|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154287878|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287879|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
154287880|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287881|NCT04153188|Phenylephrine|phenylephrine|mesh-list
154287882|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
154287883|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154287884|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154287885|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
154287886|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287887|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287888|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287889|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
154287890|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
154287891|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287892|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
154287903|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287904|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154287905|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154287906|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287907|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
154287908|NCT03749850|Doxorubicin|doxorubicin|mesh-list
154287909|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154287910|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154287911|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
154287912|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287913|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154287914|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154287915|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
154287916|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287917|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154287918|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154287919|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154287920|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154287921|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154287922|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154287923|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
154287924|NCT04357782|Vitamins|vitamins|mesh-ancestor
154287925|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
154287926|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287927|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
154287928|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154287929|NCT04357782|Protective Agents|protective agents|mesh-ancestor
154287930|NCT03980522|Rilonacept|rilonacept|mesh-list
154287931|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154287948|NCT04136548|Narcotics|narcotics|mesh-ancestor
154287949|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287950|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287951|NCT04136548|Analgesics|analgesics|mesh-ancestor
154287952|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
154287953|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287954|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154287955|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154287956|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
154287957|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
154287959|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
154287960|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
154287961|NCT04347954|Povidone|povidone|mesh-list
154287962|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154287963|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154287964|NCT04347954|Trace Elements|trace elements|mesh-ancestor
154287965|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
154287966|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287967|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
154287968|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
154287969|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
154287970|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154287971|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154287972|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287973|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154287974|NCT03065530|Analgesics|analgesics|mesh-ancestor
154287975|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
154287976|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287977|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154287978|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154287979|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154287992|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154287993|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154287994|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154287995|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154287996|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154287997|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
154287998|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154287999|NCT03647488|Docetaxel|docetaxel|mesh-list
154288000|NCT03647488|Spartalizumab|spartalizumab|mesh-list
154288001|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288002|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
154288003|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
154288004|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
154288005|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288006|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154288007|NCT03647488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154288008|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
154288009|NCT03693950|Hematinics|hematinics|mesh-ancestor
154288010|NCT03579160|Timolol|timolol|mesh-list
154288011|NCT03579160|Petrolatum|petrolatum|mesh-list
154288012|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154288013|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154288014|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
154288015|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288016|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288017|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288018|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154288019|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154288020|NCT03579160|Emollients|emollients|mesh-ancestor
154288021|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
154288022|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
154288023|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154288024|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154288025|NCT03745664|Prednisolone|prednisolone|mesh-list
154288026|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
154288033|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288034|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288035|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
154288036|NCT03745664|Hormones|hormones|mesh-ancestor
154288037|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288038|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154288039|NCT03745664|Protective Agents|protective agents|mesh-ancestor
154288040|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154288041|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288042|NCT03447262|Ivacaftor|ivacaftor|mesh-list
154288043|NCT03447262|VX-659|vx-659|mesh-list
154288044|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154288045|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154288046|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288047|NCT04094870|Sertraline|sertraline|mesh-list
154288048|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
154288049|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154288050|NCT04094870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154288051|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154288052|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154288053|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288054|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288055|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
154288056|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288057|NCT04399356|Niclosamide|niclosamide|mesh-list
154288058|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
154288059|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154288060|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
153601976|NCT01901640|Udenafil|udenafil|mesh-list
154288061|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154288062|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288072|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154288073|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
154288074|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288075|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288076|NCT04346628|Favipiravir|favipiravir|mesh-list
154288077|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
154288078|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288079|NCT03681470|Dapsone|dapsone|mesh-list
154288080|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288081|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
154288082|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154288083|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154288084|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154288085|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288086|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288087|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
154288088|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154288089|NCT02414750|Vemurafenib|vemurafenib|mesh-list
154288090|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288091|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154288092|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288093|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288094|NCT04343976|Interferons|interferons|mesh-list
154288095|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288096|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
154288097|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288098|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
154288099|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154288100|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288101|NCT03322540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154288102|NCT03322540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288103|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
154288104|NCT02909452|Entinostat|entinostat|mesh-list
154288105|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154288106|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288111|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154288112|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
154288113|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288114|NCT01935466|Pioglitazone|pioglitazone|mesh-list
154288115|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154288116|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288117|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
154288118|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
154288119|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154288120|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154288121|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288122|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288123|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288124|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288125|NCT04399122|Acetaminophen|acetaminophen|mesh-list
154288126|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154288128|NCT04399122|Codeine|codeine|mesh-list
154288129|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288130|NCT04399122|Analgesics|analgesics|mesh-ancestor
154288131|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
154288132|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288133|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288134|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
154288135|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154288136|NCT04399122|Narcotics|narcotics|mesh-ancestor
154288137|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288138|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
154288139|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
154288140|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154288141|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288142|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288156|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154288157|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154288158|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154288159|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288160|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288161|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
154288162|NCT00826462|Hormones|hormones|mesh-ancestor
154288163|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288164|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154288165|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
154288166|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288167|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154288168|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288169|NCT00826462|Analgesics|analgesics|mesh-ancestor
154288170|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288171|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
154288172|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154288173|NCT04398732|Etanercept|etanercept|mesh-list
154288210|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288212|NCT05668884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154288213|NCT05187208|Niraparib|niraparib|mesh-list
154288214|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154288215|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288216|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288217|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288218|NCT05081206|Propofol|propofol|mesh-list
154288219|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154288220|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288221|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288222|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154288223|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
154288224|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
154288225|NCT04105998|Oxytocin|oxytocin|mesh-list
154288226|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
154288227|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154288228|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288229|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154288230|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
154288231|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288232|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
154288233|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288234|NCT04543968|Protective Agents|protective agents|mesh-ancestor
154288235|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288236|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154288237|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154288238|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
154288239|NCT04368910|Artesunate|artesunate|mesh-list
154288240|NCT04368910|Chloroquine|chloroquine|mesh-list
154288241|NCT04368910|Pyronaridine|pyronaridine|mesh-list
154288242|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
154288243|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154288244|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154288250|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
154288251|NCT04368910|Amebicides|amebicides|mesh-ancestor
154288252|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288253|NCT04249258|Dobutamine|dobutamine|mesh-list
154288254|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154288255|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
154288256|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
154288257|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288258|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288259|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153819614|NCT00226421|Analgesics|analgesics|mesh-ancestor
154288260|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154288261|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154288262|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
154288263|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288264|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288265|NCT04249258|Protective Agents|protective agents|mesh-ancestor
154288266|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
154288267|NCT03938584|Vitamins|vitamins|mesh-ancestor
154288268|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
154288269|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288270|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
154288271|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288272|NCT03938584|Protective Agents|protective agents|mesh-ancestor
154288273|NCT03269344|Gabapentin|gabapentin|mesh-list
154288274|NCT03269344|Analgesics|analgesics|mesh-ancestor
154288275|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
154288276|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288278|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
154288297|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288298|NCT02933944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154288299|NCT02933944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288300|NCT04307940|Acetaminophen|acetaminophen|mesh-list
154288301|NCT04307940|Naproxen|naproxen|mesh-list
154288302|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154288303|NCT04307940|Hydrocodone|hydrocodone|mesh-list
154288304|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288305|NCT04307940|Analgesics|analgesics|mesh-ancestor
154288306|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
154288307|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288308|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288309|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
154288310|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154288311|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288312|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288313|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
154288314|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154288315|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288316|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288317|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154288318|NCT04307940|Narcotics|narcotics|mesh-ancestor
154288319|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288320|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
154288321|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
154288322|NCT02717416|Hemostatics|hemostatics|mesh-list
154288345|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154288347|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288348|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288349|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154288350|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154288351|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
154288352|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288353|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
154288354|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154288355|NCT04181476|Protective Agents|protective agents|mesh-ancestor
154288356|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288357|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
154288358|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154288359|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154288360|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288361|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288362|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154288363|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154288364|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288365|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
154288366|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288368|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
153602761|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
154288369|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288370|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
154288371|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288372|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
154288373|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
154288374|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288375|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
154288388|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288390|NCT01971970|Infliximab|infliximab|mesh-list
154288391|NCT01971970|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154288392|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288393|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288394|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
154288395|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288396|NCT01161394|Pioglitazone|pioglitazone|mesh-list
154288397|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154288398|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288399|NCT04079790|Gepotidacin|gepotidacin|mesh-list
154288400|NCT04079790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154288401|NCT04079790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288402|NCT04079790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288403|NCT04079790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288404|NCT03749226|Aztreonam|aztreonam|mesh-list
154288405|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154288406|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288407|NCT04259346|Ixekizumab|ixekizumab|mesh-list
154288408|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
154288409|NCT03748836|ALPN-101|alpn-101|mesh-list
154288410|NCT03748836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154288411|NCT03748836|Immunologic Factors|immunologic factors|mesh-ancestor
154288412|NCT03748836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288413|NCT01348100|Iloperidone|iloperidone|mesh-list
154288414|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154288415|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154288416|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288417|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288418|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154288419|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
154288433|NCT04369742|Calcium|calcium|mesh-list
154288434|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154288435|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288436|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035278|NCT02785055|Narcotics|narcotics|mesh-ancestor
154288437|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
154288439|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154288440|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288441|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288442|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288443|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
154288444|NCT03745586|Hormones|hormones|mesh-ancestor
154288445|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288446|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288447|NCT03055936|Levodopa|levodopa|mesh-list
154288448|NCT03055936|Carbidopa|carbidopa|mesh-list
154288449|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154288450|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154288451|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
154288452|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288453|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288454|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288455|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154288456|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288484|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
154288485|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288486|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288487|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154288488|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154288489|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
154288490|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
154288491|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288492|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154288493|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154288494|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288495|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288496|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
154288497|NCT02335060|Dronabinol|dronabinol|mesh-list
154288498|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154288499|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
154288500|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288501|NCT02335060|Expectorants|expectorants|mesh-ancestor
154288502|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
154288503|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154288504|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
154288505|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288506|NCT02335060|Protective Agents|protective agents|mesh-ancestor
154288507|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288508|NCT02335060|Antidotes|antidotes|mesh-ancestor
154288509|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
154288510|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154288511|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288512|NCT02335060|Analgesics|analgesics|mesh-ancestor
154288520|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
154288529|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154288530|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288531|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154288532|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288533|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154288534|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154288535|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154288536|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154288537|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
154288538|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288539|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288540|NCT05217238|Remifentanil|remifentanil|mesh-list
154288541|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154288542|NCT05217238|Narcotics|narcotics|mesh-ancestor
154288543|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288544|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288545|NCT05217238|Analgesics|analgesics|mesh-ancestor
154288546|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
154288547|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288548|NCT05217160|Morphine|morphine|mesh-list
154288549|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154288550|NCT05217160|Narcotics|narcotics|mesh-ancestor
154288551|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288552|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288553|NCT05217160|Analgesics|analgesics|mesh-ancestor
154288554|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
154288555|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288556|NCT05052970|Dexamethasone|dexamethasone|mesh-list
154288557|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
154288574|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288576|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
154288577|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154288578|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154288579|NCT04903210|Niacinamide|niacinamide|mesh-list
154288580|NCT04903210|Niacin|niacin|mesh-list
154288581|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
154288582|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
154288583|NCT04903210|Vitamins|vitamins|mesh-ancestor
154288584|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
154288585|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288586|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154288587|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
154288588|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035439|NCT04008043|Hormones|hormones|mesh-ancestor
154288589|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154288590|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
154288592|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154288593|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154288594|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
154288595|NCT04719208|Listerine|listerine|mesh-list
154288596|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154288597|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154288598|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288599|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
154288600|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
154288601|NCT04701190|Norepinephrine|norepinephrine|mesh-list
154288602|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288603|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154288604|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154288605|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
154288606|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288608|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
154288618|NCT04423588|Lansoprazole|lansoprazole|mesh-list
154288619|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154288620|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288621|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154288622|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288623|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288624|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
154288625|NCT04090684|Celecoxib|celecoxib|mesh-list
154288626|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154288627|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154288628|NCT04090684|Analgesics|analgesics|mesh-ancestor
154288629|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
154288630|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288631|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288632|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288633|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288634|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154288635|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154288636|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288637|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288650|NCT04963816|BB 1101|bb 1101|mesh-list
154288672|NCT04933240|Hormones|hormones|mesh-ancestor
154288673|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288674|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288675|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154288676|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
154288677|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154288678|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288679|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154288680|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154288681|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154288682|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
154288683|NCT01317940|Vitamin D|vitamin d|mesh-list
154288684|NCT01317940|Calcitriol|calcitriol|mesh-list
154288685|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154288686|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
154288687|NCT01317940|Calcium|calcium|mesh-list
154288688|NCT01317940|Vitamins|vitamins|mesh-ancestor
154288689|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
154288690|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288691|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154288692|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154288693|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288694|NCT01317940|Antacids|antacids|mesh-ancestor
154288695|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288696|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154288697|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154288718|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154288719|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288720|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288721|NCT01345630|Ritonavir|ritonavir|mesh-list
154288722|NCT01345630|Darunavir|darunavir|mesh-list
154288723|NCT01345630|Tenofovir|tenofovir|mesh-list
154288724|NCT01345630|Emtricitabine|emtricitabine|mesh-list
154288725|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154288726|NCT01345630|Maraviroc|maraviroc|mesh-list
154288727|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154288728|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154288729|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
154288730|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288731|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288732|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154288733|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154288734|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
154288735|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288736|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154288737|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154027389|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154288738|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154288739|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154288740|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154288767|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288768|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
154288769|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288770|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288771|NCT01562808|Aripiprazole|aripiprazole|mesh-list
154288772|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
154288773|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154288774|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154288775|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154288776|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288777|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288778|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
154288793|NCT04067492|Diclofenac|diclofenac|mesh-list
154288830|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288831|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288832|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
154288833|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288834|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154288835|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154288836|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154288837|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154288838|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288839|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154288840|NCT04369950|Narcotics|narcotics|mesh-ancestor
154288841|NCT04369950|Analgesics|analgesics|mesh-ancestor
154288842|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154288843|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154288844|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
154288845|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154288846|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154288847|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154288848|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
154288849|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154288850|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
154288851|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
154288852|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
154288853|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154288854|NCT02955602|Seladelpar|seladelpar|mesh-list
154288855|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154288856|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
154288857|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288858|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154288859|NCT03748290|Pregabalin|pregabalin|mesh-list
154288860|NCT03748290|Analgesics|analgesics|mesh-ancestor
154288872|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154288873|NCT05651074|Omeprazole|omeprazole|mesh-list
154288874|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154288875|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154288876|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154288877|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288878|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288879|NCT03738956|Tofacitinib|tofacitinib|mesh-list
154288880|NCT03738956|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154288881|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154288882|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288883|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288884|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
154288885|NCT05609656|Calcium|calcium|mesh-list
154288886|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154288887|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288888|NCT05609656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154288889|NCT05609656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288890|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154288891|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288893|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154288894|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154288895|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154288896|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154288897|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288898|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288899|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288900|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
154288901|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
154288902|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288903|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
154288904|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
154288905|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288906|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288912|NCT05501860|Carticaine|carticaine|mesh-list
154288913|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
154288914|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
154288915|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154288916|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288917|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
154288918|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154288919|NCT03738176|Triamcinolone|triamcinolone|mesh-list
154288920|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154288921|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
154288922|NCT03738176|Hormones|hormones|mesh-ancestor
154288923|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288924|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288925|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154288926|NCT03051100|Atorvastatin|atorvastatin|mesh-list
154288927|NCT03051100|Ezetimibe|ezetimibe|mesh-list
154288969|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288970|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154288972|NCT02955212|Upadacitinib|upadacitinib|mesh-list
154288973|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154288974|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154288975|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288976|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288977|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154288978|NCT03050398|Letrozole|letrozole|mesh-list
154288979|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154288980|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154288981|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154288982|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154288983|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288984|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154288985|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
154288986|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154288987|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288988|NCT03626506|Amlodipine|amlodipine|mesh-list
154288989|NCT03626506|Indapamide|indapamide|mesh-list
154288990|NCT03626506|Spironolactone|spironolactone|mesh-list
154288991|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154288992|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154288993|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154288994|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154288995|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154288996|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154288997|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
154288998|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154288999|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
154289000|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289007|NCT03737708|Abatacept|abatacept|mesh-list
154289008|NCT03737708|Tacrolimus|tacrolimus|mesh-list
154289009|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154289010|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
154289011|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154289012|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289013|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154289014|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
154289015|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289016|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289017|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
154289018|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289019|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154289020|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154289021|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
154289022|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154289023|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154289024|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154289025|NCT03737708|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154289026|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154289027|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154289028|NCT03737708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154289029|NCT04052204|Avelumab|avelumab|mesh-list
154289030|NCT04052204|Talazoparib|talazoparib|mesh-list
154289031|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154289032|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289055|NCT04049552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289056|NCT04049552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289057|NCT04049552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289058|NCT04049552|Emollients|emollients|mesh-ancestor
154289059|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
154289060|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
154289061|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
154289062|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289063|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289064|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289065|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
154289066|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
154289067|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154289068|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154289069|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154289070|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154289071|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154289072|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
154289073|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289074|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289075|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289076|NCT03047980|Sirolimus|sirolimus|mesh-list
154289077|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289078|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289079|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154289080|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289081|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
154289082|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154289085|NCT03876028|Tisagenlecleucel|tisagenlecleucel|mesh-list
154289099|NCT04047446|Bupivacaine|bupivacaine|mesh-list
154289100|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154289101|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
154289102|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
154289103|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289104|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289105|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289106|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
154289107|NCT04047446|Hormones|hormones|mesh-ancestor
154289108|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289109|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154289110|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289111|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
154289112|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
154289113|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289114|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
154289116|NCT03629054|Empagliflozin|empagliflozin|mesh-list
154289117|NCT03629054|Linagliptin|linagliptin|mesh-list
154289118|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154289119|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289120|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154289121|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289122|NCT03629054|Incretins|incretins|mesh-ancestor
154289123|NCT03629054|Hormones|hormones|mesh-ancestor
154289153|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
154289154|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
154289155|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289156|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154289157|NCT02154490|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154289158|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289159|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289160|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154289161|NCT01512316|Cycloserine|cycloserine|mesh-list
154289162|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154289163|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604630|NCT01918852|Bevacizumab|bevacizumab|mesh-list
154289164|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154289165|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
154289166|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289167|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
154289168|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289169|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154289170|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
154289171|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289172|NCT01048138|Biperiden|biperiden|mesh-list
154289173|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
154289174|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154289175|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154289176|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
154289177|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
154289178|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289179|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289180|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154289181|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154289182|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
154289183|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289184|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289185|NCT00823342|Tenofovir|tenofovir|mesh-list
154289186|NCT00823342|Clevudine|clevudine|mesh-list
154289192|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289193|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154289194|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154289195|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
154289196|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154289197|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
154289198|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289199|NCT01082445|Expectorants|expectorants|mesh-ancestor
154289200|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289201|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154289202|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
154289203|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289204|NCT01082445|Protective Agents|protective agents|mesh-ancestor
154289205|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289206|NCT01082445|Antidotes|antidotes|mesh-ancestor
154289207|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154289208|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154289209|NCT01085877|Estradiol|estradiol|mesh-list
154289210|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154289211|NCT01085877|Estrogens|estrogens|mesh-ancestor
154289212|NCT01085877|Hormones|hormones|mesh-ancestor
154289213|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289214|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289215|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154289216|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
154289217|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154289218|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154289219|NCT01089855|Carbamazepine|carbamazepine|mesh-list
154289220|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
154289221|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
154289222|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154289223|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289224|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289225|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289226|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154289227|NCT01089855|Analgesics|analgesics|mesh-ancestor
154289232|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289233|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154289234|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154289235|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
154289236|NCT03674320|Testosterone|testosterone|mesh-list
154289237|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
154289238|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
154289239|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154289240|NCT03674320|Androgens|androgens|mesh-ancestor
154289241|NCT03674320|Hormones|hormones|mesh-ancestor
154289242|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289243|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289244|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154289245|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289246|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
154289247|NCT05457946|Vaccines|vaccines|mesh-list
154289248|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
154289249|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289250|NCT03625960|Cantharidin|cantharidin|mesh-list
154289251|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289252|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289253|NCT03042910|Talazoparib|talazoparib|mesh-list
154289254|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154289255|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289256|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289257|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289258|NCT03243838|Apatinib|apatinib|mesh-list
154289259|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289260|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289261|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289262|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289264|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154289265|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289266|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154289267|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154289268|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
154289269|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289270|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
154289271|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289272|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289273|NCT02980666|Teduglutide|teduglutide|mesh-list
154289274|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289275|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154289276|NCT02980666|Protective Agents|protective agents|mesh-ancestor
154289277|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289278|NCT02962102|Calcitriol|calcitriol|mesh-list
154289279|NCT02962102|Calcifediol|calcifediol|mesh-list
154289280|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154289281|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289282|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154289283|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289284|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289285|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154289286|NCT02962102|Vitamins|vitamins|mesh-ancestor
154289287|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
154289288|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154289289|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
154289290|NCT02630368|Avelumab|avelumab|mesh-list
154289291|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154289315|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154289316|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
154289317|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
154289318|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289319|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289320|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154289321|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
154289322|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
154289323|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154289324|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154289325|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154289326|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289327|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154289328|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154289329|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
154289330|NCT00096993|Gemcitabine|gemcitabine|mesh-list
154289331|NCT00096993|Pertuzumab|pertuzumab|mesh-list
154289332|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154289333|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
154289334|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289335|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036191|NCT03922945|Topiramate|topiramate|mesh-list
154289336|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154289337|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
154289338|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289339|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289340|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289341|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289359|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289360|NCT03038620|Incretins|incretins|mesh-ancestor
154289361|NCT03038620|Hormones|hormones|mesh-ancestor
154289362|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289363|NCT02032810|Ipilimumab|ipilimumab|mesh-list
154289364|NCT02032810|Panobinostat|panobinostat|mesh-list
154289365|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154289366|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289367|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154289368|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289369|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154289370|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289371|NCT01415674|Afatinib|afatinib|mesh-list
154289372|NCT01415674|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154289373|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289374|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289375|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289415|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289416|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154289417|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154289418|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289419|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154289420|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
154289421|NCT00725374|Hormones|hormones|mesh-ancestor
154289422|NCT03622580|Aflibercept|aflibercept|mesh-list
154289423|NCT03622580|Faricimab|faricimab|mesh-list
154289424|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154289425|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154289426|NCT03622580|Growth Substances|growth substances|mesh-ancestor
154289427|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289428|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
154289429|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289430|NCT00461032|Montelukast|montelukast|mesh-list
154289431|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154289432|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289433|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154289434|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
154289435|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289436|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289464|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154289465|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154289466|NCT00092092|Budesonide|budesonide|mesh-list
154289467|NCT00092092|Montelukast|montelukast|mesh-list
154289468|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154289469|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154289470|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
154289471|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289472|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289473|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154289474|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289475|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
154289476|NCT00092092|Hormones|hormones|mesh-ancestor
154289477|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289478|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154289479|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
154289480|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154036324|NCT02778425|Somatostatin|somatostatin|mesh-list
154289481|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154289482|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289483|NCT00092014|Vitamin D|vitamin d|mesh-list
154289484|NCT00092014|Alendronate|alendronate|mesh-list
154289485|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
154289486|NCT00092014|Calcium|calcium|mesh-list
154289487|NCT00092014|Vitamins|vitamins|mesh-ancestor
154289488|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
154289489|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289490|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154289491|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154289492|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154289493|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289506|NCT00043108|Carboplatin|carboplatin|mesh-list
154289507|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154289508|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289509|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
154289510|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
154289511|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
154289512|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289513|NCT03619408|Antacids|antacids|mesh-list
154289514|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289515|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289516|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
154289517|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154289518|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
154289519|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289520|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289521|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
154289522|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289523|NCT03620708|Nicotine|nicotine|mesh-list
154289524|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154289525|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
154289526|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289527|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289528|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154289529|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154289530|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
154289531|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289532|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289533|NCT03654326|Naproxen|naproxen|mesh-list
154289534|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154289535|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154289536|NCT03654326|Analgesics|analgesics|mesh-ancestor
154289537|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
154289541|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154289545|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289546|NCT03735446|Cytarabine|cytarabine|mesh-list
154289547|NCT03735446|Etoposide|etoposide|mesh-list
154289548|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
154289549|NCT03735446|Prexasertib|prexasertib|mesh-list
154289550|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154289551|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289552|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154289553|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154289554|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289555|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289556|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154289557|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
154289558|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
154289559|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289560|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154289561|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
154289562|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289563|NCT03735446|Analgesics|analgesics|mesh-ancestor
154289564|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
154289565|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289566|NCT03735446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289567|NCT03735368|Pregabalin|pregabalin|mesh-list
154289568|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
154289596|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289597|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289598|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
154289599|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289600|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154289601|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
154289602|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289603|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289604|NCT03615482|Vaccines|vaccines|mesh-list
154289605|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
154289606|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289607|NCT03652610|Vaccines|vaccines|mesh-list
154289608|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
154289609|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289610|NCT03615404|Molgramostim|molgramostim|mesh-list
154289611|NCT03615404|Sargramostim|sargramostim|mesh-list
154289612|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
154289613|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289614|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289615|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
154289616|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154289617|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
154289618|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289619|NCT03730064|Expectorants|expectorants|mesh-ancestor
154289620|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289621|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154289622|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
154289623|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289624|NCT03730064|Protective Agents|protective agents|mesh-ancestor
154289642|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154289643|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289644|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154289645|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289646|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154289647|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154289648|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
154289649|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289650|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
154289651|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154289652|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289653|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
154289654|NCT03735134|Colchicine|colchicine|mesh-list
154289655|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
154289656|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154289657|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
154289658|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
154289659|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
154289660|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289661|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289662|NCT03608774|Azithromycin|azithromycin|mesh-list
154289663|NCT03608774|Doxycycline|doxycycline|mesh-list
154289664|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289665|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289666|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
154289667|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154289668|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154289669|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
154289670|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154289671|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154289672|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154289673|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289674|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
154289675|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
154289676|NCT03729674|Infliximab|infliximab|mesh-list
154289677|NCT03729674|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154289678|NCT03729674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154289679|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
154289680|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289681|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154289682|NCT03731468|Dexamethasone|dexamethasone|mesh-list
154289683|NCT03731468|Anesthetics|anesthetics|mesh-list
154289684|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
154289685|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154289686|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
154289687|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
154289688|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289689|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289690|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289691|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
154289692|NCT03731468|Hormones|hormones|mesh-ancestor
154289693|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154289694|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154289695|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289696|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289697|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
154289698|NCT03600428|Vaccines|vaccines|mesh-list
154289699|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
154289700|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289701|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154289702|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154289703|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154289704|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
154289705|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289706|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036546|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
154289707|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289708|NCT03575702|Urological Agents|urological agents|mesh-ancestor
154289709|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
154289710|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154289711|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289720|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
154289721|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289722|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289723|NCT03573908|Linaclotide|linaclotide|mesh-list
154289724|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154289725|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
154289726|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289727|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289728|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154289729|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154289730|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154289731|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289732|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289733|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289734|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289735|NCT03729284|Analgesics|analgesics|mesh-ancestor
154289736|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
154289737|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289738|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
154289739|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289740|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
154289741|NCT03729128|Levomethorphan|levomethorphan|mesh-list
154289742|NCT03729128|Memantine|memantine|mesh-list
154289743|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
154289744|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154289745|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154289746|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
154289747|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289748|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289749|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289750|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154289759|NCT03729128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289761|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
154289762|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154289763|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154289764|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289765|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289766|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154289767|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154289768|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289769|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154289770|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
154289771|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
154289772|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
154289773|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
154289774|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289775|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289776|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
154289777|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
154289778|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154289779|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
154289780|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
154289782|NCT03730766|Metronidazole|metronidazole|mesh-list
154289783|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
154289784|NCT03730766|Esomeprazole|esomeprazole|mesh-list
154289785|NCT03730766|Bismuth|bismuth|mesh-list
154289786|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289787|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289788|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289789|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154289795|NCT03730766|Antacids|antacids|mesh-ancestor
154289807|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289808|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154289809|NCT03591146|Ropivacaine|ropivacaine|mesh-list
154289810|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
154289811|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
154289812|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289813|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289814|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
154289815|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289816|NCT00096447|Lapatinib|lapatinib|mesh-list
154289817|NCT00096447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154289818|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154289819|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289820|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289821|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289822|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154289823|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154289824|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154289825|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289826|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289827|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289828|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289829|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154289830|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
154289831|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289832|NCT00070941|Escitalopram|escitalopram|mesh-list
154289833|NCT00070941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154289834|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154289835|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289836|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289837|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289838|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
154289844|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289845|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289846|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154289847|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289848|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
154289849|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154289850|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154289851|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154289852|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154289853|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
154289854|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289855|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289856|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154289857|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
154289858|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154289859|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
154289860|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154289861|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289862|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154289863|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289864|NCT00070317|Methylene Blue|methylene blue|mesh-list
154289865|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154289866|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289867|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289868|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154289891|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
154289892|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154289893|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154289894|NCT01090167|Clofarabine|clofarabine|mesh-list
154289895|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154289896|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
154289897|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289898|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289899|NCT03587636|Bupivacaine|bupivacaine|mesh-list
154289900|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
154289901|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
154289902|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289903|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289904|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
154289905|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289906|NCT03053362|Vortioxetine|vortioxetine|mesh-list
154289907|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
154289908|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289909|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154289910|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154289911|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289912|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289913|NCT03053362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154289914|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154289915|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289916|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289917|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289918|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
154289919|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154289922|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154289934|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154289935|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289936|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154289937|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
154289938|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
154289939|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154289940|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154289941|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154289942|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154289943|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
154289944|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289945|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289947|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
154289948|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154289949|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154289950|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154289951|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154289952|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289953|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289954|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289955|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
154289956|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289957|NCT03728192|Camptothecin|camptothecin|mesh-list
154289958|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154289959|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154289960|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154289961|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154289962|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154289963|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289964|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154289965|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154289971|NCT03733340|Imipenem|imipenem|mesh-list
154289972|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289973|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154289974|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
154289975|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154289976|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289977|NCT05137600|Clarithromycin|clarithromycin|mesh-list
154289978|NCT05137600|Midazolam|midazolam|mesh-list
154289979|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154289980|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154289981|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154289982|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154289983|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154289984|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154289985|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154289986|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154289987|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
154289988|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
154289989|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
154289990|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
154289991|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154289992|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154289993|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154289999|NCT00089505|Ritonavir|ritonavir|mesh-list
154290024|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290025|NCT04009824|Antacids|antacids|mesh-ancestor
154290026|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290027|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290028|NCT03555890|Cetirizine|cetirizine|mesh-list
154290029|NCT03555890|Levocetirizine|levocetirizine|mesh-list
154290030|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154290031|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154290032|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
154290033|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
154290034|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290035|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290036|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290037|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154290038|NCT04905862|Antipyretics|antipyretics|mesh-list
154290039|NCT04905862|Analgesics|analgesics|mesh-list
154290040|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
154290041|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290042|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290043|NCT03630120|Sorafenib|sorafenib|mesh-list
154290044|NCT03630120|Lenvatinib|lenvatinib|mesh-list
154290045|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290046|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154290047|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290048|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290049|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
154290050|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
154290051|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290052|NCT03744702|Protective Agents|protective agents|mesh-ancestor
154290053|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290054|NCT03744702|Vitamins|vitamins|mesh-ancestor
154290055|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
154290056|NCT03736980|Psilocybin|psilocybin|mesh-list
154290057|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
154290058|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290059|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154290060|NCT03727646|Niacinamide|niacinamide|mesh-list
154290061|NCT03727646|Niacin|niacin|mesh-list
154290062|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
154290063|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
154290064|NCT03727646|Vitamins|vitamins|mesh-ancestor
154290065|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
154290066|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290067|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154290068|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
154290069|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290070|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154290071|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
154290072|NCT03554486|Insulin|insulin|mesh-list
154290073|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154290074|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
154290075|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
153606939|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290076|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154290077|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154290078|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290079|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
154290080|NCT04787692|Narcotics|narcotics|mesh-ancestor
154290081|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290082|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290083|NCT04787692|Analgesics|analgesics|mesh-ancestor
154290084|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
154290115|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154290116|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154290117|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154290118|NCT03570554|Acetaminophen|acetaminophen|mesh-list
154290119|NCT03570554|Celecoxib|celecoxib|mesh-list
154290120|NCT03570554|Naproxen|naproxen|mesh-list
154290121|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154290122|NCT03570554|Analgesics|analgesics|mesh-ancestor
154290123|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
154290124|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290125|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290126|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
154290127|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154290128|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290129|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154290130|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154290131|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154290132|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290133|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290134|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
154290135|NCT04004208|Aflibercept|aflibercept|mesh-list
154290136|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154290137|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154290167|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
154290168|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290169|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290170|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290171|NCT03725228|Lidocaine|lidocaine|mesh-list
154290172|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
154290173|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
154290174|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
154290175|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290176|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290177|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
154290178|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290179|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154290180|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154290181|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154290182|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290183|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290184|NCT03725228|Analgesics|analgesics|mesh-ancestor
154290185|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
154290186|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154290187|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154290188|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
154290189|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154290190|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
154290219|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154290220|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290221|NCT03628716|Atezolizumab|atezolizumab|mesh-list
154290222|NCT03628716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154290223|NCT03628716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290224|NCT03628716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154290225|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290226|NCT03840616|Fluconazole|fluconazole|mesh-list
154290227|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
154290228|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290229|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154290230|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154290231|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290232|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290233|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154290234|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
154290235|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290236|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290237|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154290238|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154290239|NCT00088413|Molgramostim|molgramostim|mesh-list
154290240|NCT00088413|Sargramostim|sargramostim|mesh-list
154290241|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
154290242|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290243|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290244|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
154290245|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154290246|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154290247|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
154290248|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290249|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290250|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290251|NCT03787654|Urological Agents|urological agents|mesh-ancestor
154290253|NCT00086385|Nicotine|nicotine|mesh-list
154290254|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154290255|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
154290256|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290257|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290258|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154290259|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154290260|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
154290261|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290262|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290263|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154290264|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
154290265|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154290266|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154290267|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154290268|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290269|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
154290270|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154290271|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154290272|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290273|NCT03993288|Iron|iron|mesh-list
154290274|NCT03993288|Trace Elements|trace elements|mesh-ancestor
154290275|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
154290276|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290277|NCT05093608|Bevacizumab|bevacizumab|mesh-list
154290278|NCT05093608|Atezolizumab|atezolizumab|mesh-list
154290279|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154290300|NCT00086307|Dexpramipexole|dexpramipexole|mesh-list
154290301|NCT00086307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154290302|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154290303|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290304|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290305|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290306|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
154290307|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290308|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154290309|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154290310|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
154290311|NCT00086307|Protective Agents|protective agents|mesh-ancestor
154290312|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
154290313|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
154290314|NCT01086579|Paclitaxel|paclitaxel|mesh-list
154290315|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154290316|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154290317|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290318|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
154290319|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
154290320|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
154290321|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290322|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
154290323|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
154290324|NCT03743922|Vitamin D|vitamin d|mesh-list
154290325|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154290326|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290327|NCT03743922|Vitamins|vitamins|mesh-ancestor
154290328|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
154290329|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154290330|NCT03988842|Heparin|heparin|mesh-list
154290331|NCT03988842|Calcium heparin|calcium heparin|mesh-list
154290332|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154290333|NCT03988842|Plasminogen|plasminogen|mesh-list
154290334|NCT03988842|Apixaban|apixaban|mesh-list
154290341|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154290342|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
154290343|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290344|NCT02668822|Ibuprofen|ibuprofen|mesh-list
154290345|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154290346|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154290347|NCT02668822|Analgesics|analgesics|mesh-ancestor
154290348|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
154290349|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290350|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290351|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290352|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154290353|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154290354|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290355|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290356|NCT04112589|Cytarabine|cytarabine|mesh-list
154290357|NCT04112589|Fludarabine|fludarabine|mesh-list
154290358|NCT04112589|Idarubicin|idarubicin|mesh-list
154290359|NCT04112589|Quizartinib|quizartinib|mesh-list
154290360|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290361|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154290362|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
154290363|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290364|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154290365|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
154290366|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290367|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
154290368|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290369|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154290370|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154290371|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154290372|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290375|NCT03547154|Interferons|interferons|mesh-list
154290382|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
154290383|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290385|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154290386|NCT02275546|Desogestrel|desogestrel|mesh-list
154290387|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154290388|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
154290389|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153607770|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
154290390|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290391|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154290392|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154290393|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154290394|NCT02275546|Estrogens|estrogens|mesh-ancestor
154290395|NCT02275546|Hormones|hormones|mesh-ancestor
154290396|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290397|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154290398|NCT02275546|Progestins|progestins|mesh-ancestor
154290399|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154290400|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154290401|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290402|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154290403|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154290404|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290405|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290406|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
154290407|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290408|NCT01096797|Sevoflurane|sevoflurane|mesh-list
154290409|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154290410|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154290411|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
154290412|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
154290413|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290414|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290415|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
154290416|NCT00068601|Goserelin|goserelin|mesh-list
154290417|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154290421|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154290423|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290424|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290425|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154290426|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154290427|NCT01670656|Ibuprofen|ibuprofen|mesh-list
154290428|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
154290429|NCT01670656|Etonogestrel|etonogestrel|mesh-list
154290430|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154290431|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154290432|NCT01670656|Analgesics|analgesics|mesh-ancestor
154290433|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
154290434|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290435|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290436|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290437|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154290438|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154290439|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290440|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290441|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154290442|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154290443|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154290444|NCT00068445|Lamotrigine|lamotrigine|mesh-list
154290445|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
154290446|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154290447|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290448|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290449|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154290450|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290451|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154290452|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154290453|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290454|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154290455|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154290456|NCT03033784|Oxytocin|oxytocin|mesh-list
154290457|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
154290458|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154290459|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290460|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
154290461|NCT00038649|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154290462|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154290463|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290464|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290465|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290466|NCT02926690|OTS167|ots167|mesh-list
154290467|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154290468|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290469|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290470|NCT03652818|Acetaminophen|acetaminophen|mesh-list
154290471|NCT03652818|Pregabalin|pregabalin|mesh-list
154290472|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154290473|NCT03652818|Analgesics|analgesics|mesh-ancestor
154290474|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
154290475|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290476|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290477|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
154290478|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
154290479|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154290497|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154290498|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154290499|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154290500|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154290501|NCT00620464|Progestins|progestins|mesh-ancestor
154290503|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290504|NCT00541684|Atenolol|atenolol|mesh-list
154290505|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
154290506|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290507|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290508|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290509|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
154290510|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290511|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154290512|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154290513|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
154290514|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154290515|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154290516|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154290517|NCT00413764|Tibolone|tibolone|mesh-list
154290518|NCT00413764|Norethindrone|norethindrone|mesh-list
154290519|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
154290520|NCT00413764|Estradiol|estradiol|mesh-list
154290521|NCT00413764|Estrogens|estrogens|mesh-ancestor
154290547|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290548|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290549|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
154290550|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290551|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290552|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154290553|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290554|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290555|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
154290556|NCT03726788|Hormones|hormones|mesh-ancestor
154290557|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290558|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154290559|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
154290560|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290561|NCT03735264|Docetaxel|docetaxel|mesh-list
154290562|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290563|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
154290564|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
154290565|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
154290566|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290567|NCT03560258|Vaccines|vaccines|mesh-list
154290568|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
154290569|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290570|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
154290571|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154290572|NCT02759380|Estrogens|estrogens|mesh-ancestor
154290573|NCT02759380|Hormones|hormones|mesh-ancestor
154290574|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290575|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290576|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
154290577|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154290578|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
154290579|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290580|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154290585|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154290586|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154290587|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154290588|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154290589|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
154290590|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290591|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290592|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290593|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154290594|NCT03033394|Penicillins|penicillins|mesh-list
154290595|NCT03033394|Lactams|lactams|mesh-list
154290596|NCT03033394|beta-Lactams|beta-lactams|mesh-list
154290597|NCT03033394|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
154290598|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290599|NCT03639428|Midazolam|midazolam|mesh-list
154290600|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154290601|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154290602|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290603|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290604|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154290605|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154290606|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154290607|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154290608|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
154290609|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
154290610|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
154290611|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
154290612|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290614|NCT04575688|Bupivacaine|bupivacaine|mesh-list
154290631|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290632|NCT01310738|Amphotericin B|amphotericin b|mesh-list
154290633|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154290634|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
154290635|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154290636|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
154290637|NCT01310738|Amebicides|amebicides|mesh-ancestor
154290638|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154290639|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154290640|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290641|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154290642|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
154290643|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154290644|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290645|NCT03704506|Amoxicillin|amoxicillin|mesh-list
154290646|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154290647|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290648|NCT03615144|Fludarabine|fludarabine|mesh-list
154290649|NCT03615144|Melphalan|melphalan|mesh-list
154290650|NCT03615144|Thiotepa|thiotepa|mesh-list
154290651|NCT03615144|Clofarabine|clofarabine|mesh-list
154290652|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
154290653|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154290654|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290655|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154290656|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
154290657|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290658|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154290659|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
154290660|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290661|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154290662|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
154290663|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154290674|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154290675|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154290676|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154290677|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290679|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154290681|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154290682|NCT03320434|Prednisolone|prednisolone|mesh-list
154290683|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154290684|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
154290685|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290686|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
154290687|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
154290688|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290689|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290690|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290691|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
154290692|NCT03320434|Hormones|hormones|mesh-ancestor
154290693|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290694|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154290695|NCT03320434|Protective Agents|protective agents|mesh-ancestor
154290696|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154290697|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290698|NCT02892734|Nivolumab|nivolumab|mesh-list
154290699|NCT02892734|Ipilimumab|ipilimumab|mesh-list
154290700|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154290701|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290705|NCT05231590|Paraproteins|paraproteins|mesh-list
154290720|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290721|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290723|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154290724|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154290725|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
154290726|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290727|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290728|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154290729|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
154290730|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
154290731|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
154290732|NCT03731988|Lidocaine|lidocaine|mesh-list
154290733|NCT03731988|Prilocaine|prilocaine|mesh-list
154290734|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154290735|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
154290736|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
154290737|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290738|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290739|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
154290740|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290741|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154290770|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154290771|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
154290772|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154290773|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
154290774|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
154290775|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154290776|NCT01094457|Protective Agents|protective agents|mesh-ancestor
154290777|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154290778|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154290779|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
154290780|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154290781|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154290782|NCT03701698|Prednisolone|prednisolone|mesh-list
154290783|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
154290784|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154290785|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
154290786|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290787|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
154290788|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
154290789|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290790|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290791|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290792|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
154290793|NCT03701698|Hormones|hormones|mesh-ancestor
154290794|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290795|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154290796|NCT03701698|Protective Agents|protective agents|mesh-ancestor
154290797|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154290816|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290817|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290819|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
154290820|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290821|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
154290822|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154290823|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290824|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154290825|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290826|NCT03807843|Vaccines|vaccines|mesh-list
154290827|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
154290828|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290829|NCT01094535|Secretin|secretin|mesh-list
154290830|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290831|NCT01094535|Hormones|hormones|mesh-ancestor
154290832|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154290833|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290834|NCT00038103|Celecoxib|celecoxib|mesh-list
154290835|NCT00038103|Exemestane|exemestane|mesh-list
154290836|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154290837|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154290838|NCT00038103|Analgesics|analgesics|mesh-ancestor
154290839|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
154290840|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290841|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290842|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154290843|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154290844|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154290845|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154290846|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290848|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290856|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290857|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290858|NCT03678870|Analgesics|analgesics|mesh-ancestor
154290859|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
154290860|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290861|NCT03032380|Meropenem|meropenem|mesh-list
154290862|NCT03032380|Linezolid|linezolid|mesh-list
154290863|NCT03032380|Cefiderocol|cefiderocol|mesh-list
154290864|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154290865|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290866|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154290867|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290868|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290869|NCT03032380|Siderophores|siderophores|mesh-ancestor
154290870|NCT03032380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154290871|NCT03032380|Chelating Agents|chelating agents|mesh-ancestor
154290872|NCT03032380|Sequestering Agents|sequestering agents|mesh-ancestor
154290873|NCT03032380|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154290874|NCT03519854|Bromides|bromides|mesh-list
154290875|NCT03519854|Rocuronium|rocuronium|mesh-list
154290876|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
154290877|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154290878|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154290879|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154290880|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290881|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290882|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
154290883|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
154290884|NCT03479216|Bupivacaine|bupivacaine|mesh-list
154290885|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
154290886|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
154290902|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154290903|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290904|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154290905|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
154290906|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154290907|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
154290908|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154290909|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290910|NCT03717038|Trifluridine|trifluridine|mesh-list
154290911|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
154290912|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290913|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
154290914|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154290915|NCT00143182|Olanzapine|olanzapine|mesh-list
154290916|NCT00143182|Asenapine|asenapine|mesh-list
154290917|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
154290918|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
154290919|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290920|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290921|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290922|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154290923|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154290924|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290925|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154290926|NCT00143182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154290927|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154290928|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154290929|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290930|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290931|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
154290944|NCT03435692|Oxycodone|oxycodone|mesh-list
154290945|NCT03435692|Lorazepam|lorazepam|mesh-list
154290946|NCT03435692|Ondansetron|ondansetron|mesh-list
154290947|NCT03435692|Ropivacaine|ropivacaine|mesh-list
154290948|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154290949|NCT03435692|Narcotics|narcotics|mesh-ancestor
154290950|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154290951|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154290952|NCT03435692|Analgesics|analgesics|mesh-ancestor
154290953|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
154290954|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154290955|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
154290956|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
154290957|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154290958|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154290959|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
154290960|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154290961|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
154290962|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
154290963|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
154290964|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154290965|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
154290966|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
154290967|NCT03435692|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154290968|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154290969|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
154290970|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154290971|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290972|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154290984|NCT03705442|Loperamide|loperamide|mesh-list
154290994|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154290995|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154290996|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154290997|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154290998|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154290999|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154291000|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154291001|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154291002|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
154291003|NCT03716804|Cefuroxime|cefuroxime|mesh-list
154291004|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
154291005|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
154291006|NCT03716804|Cefixime|cefixime|mesh-list
154291007|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154291008|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291009|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154291010|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154291051|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291052|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154291053|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154291054|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291055|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291056|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154291057|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
154291058|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154291059|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291060|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154291061|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154291062|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154291063|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
154291064|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291065|NCT01311050|Bevacizumab|bevacizumab|mesh-list
154291066|NCT01311050|Capecitabine|capecitabine|mesh-list
154291067|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
154291068|NCT01311050|Irinotecan|irinotecan|mesh-list
154291069|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154291070|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291071|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154291072|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154291073|NCT01311050|Growth Substances|growth substances|mesh-ancestor
154291074|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291075|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
154291076|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154291077|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
154291078|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291093|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
154291094|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154291095|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291096|NCT04491526|Tamsulosin|tamsulosin|mesh-list
154291097|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154291098|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154291099|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154291100|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
154291101|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291102|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291103|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291104|NCT04491526|Urological Agents|urological agents|mesh-ancestor
154291105|NCT03699904|Valacyclovir|valacyclovir|mesh-list
154291106|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
154291107|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291108|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
154291109|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
154291110|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154291111|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291112|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291113|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
154291114|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154291115|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291116|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291117|NCT03696940|Atorvastatin|atorvastatin|mesh-list
154291118|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154291119|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154291120|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
154291121|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291122|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154291123|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154291124|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291125|NCT03731442|Paclitaxel|paclitaxel|mesh-list
154291126|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154291127|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291130|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
154291131|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291132|NCT03702400|Phenylephrine|phenylephrine|mesh-list
154291133|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
154291134|NCT03702400|Norepinephrine|norepinephrine|mesh-list
154291135|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154291136|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
154291137|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
154291138|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291139|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291140|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
154291141|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154291142|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
154291143|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
154291144|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154291145|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154291146|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154291147|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
154291148|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291149|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291150|NCT03702400|Protective Agents|protective agents|mesh-ancestor
154291151|NCT03699202|Ziresovir|ziresovir|mesh-list
154291152|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
154291153|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291154|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
154291155|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291156|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
154291157|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154291158|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154291159|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291160|NCT03598140|Urological Agents|urological agents|mesh-ancestor
154291174|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154291175|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291176|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291177|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154291178|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154291179|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
154291180|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291181|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154291182|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154291184|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154291185|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
154291186|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154291187|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291188|NCT01097265|Capecitabine|capecitabine|mesh-list
154291189|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
154291190|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154291191|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
154291192|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291193|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291194|NCT03731286|Caffeine|caffeine|mesh-list
154291195|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154291196|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291197|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154291198|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291199|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291200|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154291201|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154291202|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
154291204|NCT00066807|Tamoxifen|tamoxifen|mesh-list
154291217|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291218|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153610198|NCT02877550|Venetoclax|venetoclax|mesh-list
154291219|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154291220|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154291221|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154291222|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154291223|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154291224|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
154291225|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154291226|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
154291227|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154291228|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154291229|NCT03619330|Liraglutide|liraglutide|mesh-list
154291230|NCT03619330|Testosterone|testosterone|mesh-list
154291231|NCT03619330|Androgens|androgens|mesh-ancestor
154291232|NCT03619330|Hormones|hormones|mesh-ancestor
154291233|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154291234|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291235|NCT03619330|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154291236|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154291238|NCT00054639|Rituximab|rituximab|mesh-list
154291270|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154291271|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
154291272|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
154291273|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
154291274|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
154291275|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291276|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291277|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
154291278|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
154291279|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291280|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291281|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291282|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
154291284|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
154291285|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154291286|NCT04867928|Azacitidine|azacitidine|mesh-list
154291287|NCT04867928|Venetoclax|venetoclax|mesh-list
154291288|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154291289|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
154291290|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291291|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291292|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291293|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
154291294|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154291295|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291321|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
154291322|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291323|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291324|NCT04070157|Analgesics|analgesics|mesh-ancestor
154291325|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
154291326|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
154291327|NCT01091337|Albuterol|albuterol|mesh-list
154291328|NCT01091337|Procaterol|procaterol|mesh-list
154291329|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154291330|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
154291331|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291332|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291333|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154291334|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
154291335|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
154291336|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154291337|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154291338|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154291339|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154291340|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
154291341|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291342|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291343|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
154291344|NCT03955809|Ketamine|ketamine|mesh-list
154291345|NCT03955809|Analgesics|analgesics|mesh-ancestor
154291346|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
154291347|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291348|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291349|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154291350|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154291351|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
154291352|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
154291358|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
154291362|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291363|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154291364|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
154291365|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291366|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154291367|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291369|NCT03953001|Epinephrine|epinephrine|mesh-list
154291370|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
154291371|NCT03953001|Anesthetics|anesthetics|mesh-list
154291372|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291373|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291374|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
154291375|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291376|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154291377|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154291378|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154291379|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154291380|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291381|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154291382|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154291383|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
154291384|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291385|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154291386|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154291387|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
154291388|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154291389|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
154291390|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
154291391|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
154291392|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154291393|NCT01091415|Calcium|calcium|mesh-list
154291394|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154291403|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
154291404|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
154291405|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154291406|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291407|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154291408|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154291409|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291410|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291411|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291412|NCT03692416|Prednisone|prednisone|mesh-list
154291413|NCT03692416|Ibuprofen|ibuprofen|mesh-list
154291414|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154291415|NCT03692416|Methotrexate|methotrexate|mesh-list
154291416|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291417|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
154291418|NCT03692416|Hormones|hormones|mesh-ancestor
154291419|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154291420|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291421|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154291422|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291423|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154291424|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
154291427|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
154291454|NCT03641508|Dexamethasone|dexamethasone|mesh-list
154291455|NCT03641508|Triamcinolone|triamcinolone|mesh-list
154291456|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291457|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
154291458|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
154291459|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291460|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291461|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154291462|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
154291463|NCT03641508|Hormones|hormones|mesh-ancestor
154291464|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154291465|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154291466|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291467|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
154291468|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154291469|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291470|NCT01091571|Dipyridamole|dipyridamole|mesh-list
154291471|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154291472|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291473|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291474|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154291475|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
154291476|NCT01091649|Ritonavir|ritonavir|mesh-list
154291477|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154291478|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154291479|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
154291480|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291501|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154291503|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291504|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291505|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154291506|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
154291507|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
154291508|NCT03421730|Hormones|hormones|mesh-ancestor
154291509|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154291510|NCT01094925|Gabapentin|gabapentin|mesh-list
154291511|NCT01094925|Analgesics|analgesics|mesh-ancestor
154291512|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
154291513|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291514|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291515|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
154291516|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154291517|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154291518|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291519|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154291520|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154291521|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154291522|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291523|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291524|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
154291525|NCT03718676|Pemetrexed|pemetrexed|mesh-list
154291526|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291527|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291528|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291529|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154291530|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154291531|NCT00054327|Cytarabine|cytarabine|mesh-list
154291533|NCT00054327|Busulfan|busulfan|mesh-list
154291544|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154291545|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154291546|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154291547|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154291548|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291549|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154291550|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
154291551|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
154291552|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291553|NCT03029650|Scopolamine|scopolamine|mesh-list
154291554|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154291555|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154291556|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
154291557|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
154291558|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291559|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291560|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154291561|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
154291562|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154291563|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
154291564|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291565|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291566|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154291567|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
154291568|NCT03462680|Niacin|niacin|mesh-list
154291569|NCT03462680|Vitamins|vitamins|mesh-ancestor
154291578|NCT03692026|Melatonin|melatonin|mesh-list
154291591|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291592|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291593|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154291594|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154291595|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154291596|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291597|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154291598|NCT03624322|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154291599|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154291600|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154291601|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291602|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154291603|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
154291605|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
154291606|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154291607|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
154291608|NCT01097811|Neomycin|neomycin|mesh-list
154291647|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
154291648|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291649|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154291650|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
154291651|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154291652|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154291653|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291654|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154291655|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
154291656|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154291658|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
154291659|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291660|NCT03028870|Naproxen|naproxen|mesh-list
154291661|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154291662|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154291663|NCT03028870|Analgesics|analgesics|mesh-ancestor
154291664|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
154291665|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291666|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291667|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291668|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291669|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
154291670|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154291671|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291672|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291673|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
154291695|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291696|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154291697|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154291698|NCT03730740|Growth Substances|growth substances|mesh-ancestor
154291699|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
154291700|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291701|NCT01098513|Dolutegravir|dolutegravir|mesh-list
154291702|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154291703|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154291704|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291705|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291706|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154291707|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154291708|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
154291709|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291710|NCT03693976|Xylometazoline|xylometazoline|mesh-list
154291711|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
154291712|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154291713|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
154291714|NCT03730584|Ropivacaine|ropivacaine|mesh-list
154291715|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
154291716|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
154291717|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291718|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291719|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
154291720|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291721|NCT03502616|Tofacitinib|tofacitinib|mesh-list
154291722|NCT03502616|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154291723|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154291724|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291725|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291726|NCT04003012|Lidocaine|lidocaine|mesh-list
154291727|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
154291728|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
154291735|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154291736|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154291737|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291738|NCT05666076|Bupivacaine|bupivacaine|mesh-list
154291739|NCT05666076|Prilocaine|prilocaine|mesh-list
154291740|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
154291741|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
154291742|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291743|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291744|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
154291745|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291746|NCT03028012|Dexamethasone|dexamethasone|mesh-list
154291747|NCT03028012|Ketorolac|ketorolac|mesh-list
154291748|NCT03028012|Lidocaine|lidocaine|mesh-list
154291749|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291750|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
154291751|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
154291752|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291753|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291754|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154291755|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
154291756|NCT03028012|Hormones|hormones|mesh-ancestor
154291757|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154291786|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291787|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154291789|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154291790|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
154291791|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291792|NCT03690778|Metformin|metformin|mesh-list
154291793|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154291794|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154291795|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291796|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154291797|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154291798|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
154038635|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154291799|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291800|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154291801|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154291802|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291803|NCT03715634|Buprenorphine|buprenorphine|mesh-list
154291804|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154291805|NCT03715634|Narcotics|narcotics|mesh-ancestor
154291806|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291807|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291808|NCT03715634|Analgesics|analgesics|mesh-ancestor
154291809|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
154291810|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291811|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154291812|NCT03502070|Tobramycin|tobramycin|mesh-list
154291828|NCT03730038|Pitavastatin|pitavastatin|mesh-list
154291829|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154291830|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154291831|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154291832|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
154291833|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291834|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291835|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154291836|NCT03725904|Progesterone|progesterone|mesh-list
154291837|NCT03725904|Progestins|progestins|mesh-ancestor
154291838|NCT03725904|Hormones|hormones|mesh-ancestor
154291839|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154291840|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291841|NCT03730272|Analgesics|analgesics|mesh-list
154291842|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
154291843|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291844|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291845|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
154291846|NCT03585504|Etonogestrel|etonogestrel|mesh-list
154291847|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154291848|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291849|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154291850|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154291851|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
154291852|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154291853|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154291854|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291855|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154291856|NCT03690622|Analgesics|analgesics|mesh-ancestor
154291857|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
154291858|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291861|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154291869|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154291870|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291871|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
154291872|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291874|NCT03576066|Entecavir|entecavir|mesh-list
154291875|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
154291876|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154291877|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154291878|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154291879|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291880|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291881|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154291882|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154291883|NCT03639480|Amlodipine|amlodipine|mesh-list
154291884|NCT03639480|Valsartan|valsartan|mesh-list
154291885|NCT03639480|Atorvastatin|atorvastatin|mesh-list
154291886|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154291887|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154291888|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
154291889|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291890|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154291891|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154291892|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291893|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154291894|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154291895|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154291901|NCT03689998|Melatonin|melatonin|mesh-list
154291916|NCT03687034|Temozolomide|temozolomide|mesh-list
154291917|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154291918|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
154291919|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291920|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291921|NCT03520920|Rituximab|rituximab|mesh-list
154291922|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
154291923|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154291924|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291925|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
154291926|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291927|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291928|NCT03520920|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154291929|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154291930|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291931|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291932|NCT03686878|Lifitegrast|lifitegrast|mesh-list
154291933|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154291934|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154291935|NCT03682198|Phenylephrine|phenylephrine|mesh-list
154291936|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
154291937|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154291938|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
154291939|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
154291940|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291941|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291942|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
154291943|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154291944|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
154291945|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
154291961|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291962|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154291963|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154291964|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
154291965|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
154291966|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
154291968|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154291969|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154291970|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154291971|NCT03554772|Analgesics|analgesics|mesh-ancestor
154291972|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
154291973|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154291974|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154291975|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154291976|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154291977|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154291978|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154291979|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291980|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154291981|NCT03624010|Simendan|simendan|mesh-list
154291982|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154291983|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
154291984|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154291985|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154291986|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154291987|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292006|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292007|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
154292008|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292010|NCT03553758|Analgesics|analgesics|mesh-ancestor
154292011|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
154292012|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292013|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292014|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154292015|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154292016|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
154292017|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
154292018|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292019|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154292020|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154292021|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292022|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292023|NCT02954354|Oseltamivir|oseltamivir|mesh-list
154292024|NCT02954354|Baloxavir|baloxavir|mesh-list
154292025|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
154292026|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292027|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292028|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292029|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
154292030|NCT03519516|Levofloxacin|levofloxacin|mesh-list
154292031|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154292032|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154292033|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154292034|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292035|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154292036|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154292037|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292038|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292039|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292040|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154292043|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
154292045|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292046|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292047|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292048|NCT03519204|Lidocaine|lidocaine|mesh-list
154292049|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
154292050|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
154292051|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292052|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292053|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
154292054|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292055|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154292056|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154292057|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154292058|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154292059|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292060|NCT03624166|Ketamine|ketamine|mesh-list
154292061|NCT03624166|Anesthetics|anesthetics|mesh-list
154292062|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
154292063|NCT03624166|Analgesics|analgesics|mesh-ancestor
154292064|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
154292065|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292066|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292067|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154292068|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154292069|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292070|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154292071|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154292088|NCT03518112|Antibodies|antibodies|mesh-list
154292089|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
154292090|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154292091|NCT03518112|Lenograstim|lenograstim|mesh-list
154292092|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154292093|NCT03518112|BB 1101|bb 1101|mesh-list
154292094|NCT03518112|Calcium|calcium|mesh-list
154292095|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
154292096|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292097|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
154292098|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292099|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292100|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154292101|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
154292102|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292103|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292104|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154292105|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292106|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
154292107|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
154292108|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292109|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292110|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
154292111|NCT03518112|Hormones|hormones|mesh-ancestor
154292112|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292113|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154292114|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
154292115|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292116|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154292117|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154292118|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154292119|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
154292120|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154292121|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154292122|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
154292128|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154292129|NCT03518112|Antidotes|antidotes|mesh-ancestor
154292130|NCT03518112|Protective Agents|protective agents|mesh-ancestor
154292131|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
154292132|NCT03518112|Vitamins|vitamins|mesh-ancestor
154292133|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
153612201|NCT01953172|Vitamins|vitamins|mesh-ancestor
154292134|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292135|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
154292136|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
154292137|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
154292138|NCT03518112|Hematinics|hematinics|mesh-ancestor
154292139|NCT03686254|Bevacizumab|bevacizumab|mesh-list
154292140|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154292141|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292142|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154292143|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154292144|NCT03686254|Growth Substances|growth substances|mesh-ancestor
154292145|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292146|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
154292147|NCT03679780|Nitroprusside|nitroprusside|mesh-list
154292148|NCT03679780|BQ 788|bq 788|mesh-list
154292149|NCT03679780|Nitroarginine|nitroarginine|mesh-list
154292150|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
154292151|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154292152|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
154292153|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154292154|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292155|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154292156|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154292157|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292158|NCT03680716|Ropivacaine|ropivacaine|mesh-list
154292159|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
154292160|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
154292161|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292162|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292169|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292170|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
154038985|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154292171|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292172|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154292173|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
154292174|NCT03680638|Protective Agents|protective agents|mesh-ancestor
154292175|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292176|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154292177|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154292178|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154292179|NCT03680560|Trastuzumab|trastuzumab|mesh-list
154292180|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154292181|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292182|NCT03639610|Dexamethasone|dexamethasone|mesh-list
154292184|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292185|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
154292186|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
154292187|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292188|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292189|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292190|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
154292191|NCT03639610|Hormones|hormones|mesh-ancestor
154292192|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292193|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154292194|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292217|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
154292218|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292219|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292220|NCT03680404|Protective Agents|protective agents|mesh-ancestor
154292221|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
154292222|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292223|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
154292224|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292225|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154292226|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
154292227|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154292228|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154292229|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154292230|NCT03685630|Brivaracetam|brivaracetam|mesh-list
154292231|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
154292232|NCT02954406|Rituximab|rituximab|mesh-list
154292233|NCT02954406|Gemcitabine|gemcitabine|mesh-list
154292234|NCT02954406|Lenalidomide|lenalidomide|mesh-list
154292235|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154292236|NCT02954406|Ibrutinib|ibrutinib|mesh-list
154292237|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154292238|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292239|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
154292240|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292269|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154292270|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
154292271|NCT03721614|Sirolimus|sirolimus|mesh-list
154292272|NCT03721614|Everolimus|everolimus|mesh-list
154292273|NCT03721614|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154292274|NCT03721614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154292275|NCT03721614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292276|NCT03721614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292277|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292278|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
154292279|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292280|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292281|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154292282|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292283|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154292284|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
154292285|NCT03727620|Amoxicillin|amoxicillin|mesh-list
154292286|NCT03727620|Metronidazole|metronidazole|mesh-list
154292287|NCT03727620|Doxycycline|doxycycline|mesh-list
154292288|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154292289|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292290|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154292291|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154292292|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
154292293|NCT03727464|Propofol|propofol|mesh-list
154292294|NCT03727464|Sevoflurane|sevoflurane|mesh-list
154292300|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
154292320|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039144|NCT02644616|Torsemide|torsemide|mesh-list
154292321|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
154292322|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292323|NCT03721380|Methadone|methadone|mesh-list
154292324|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154292325|NCT03721380|Narcotics|narcotics|mesh-ancestor
154292326|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292327|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292328|NCT03721380|Analgesics|analgesics|mesh-ancestor
154292329|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
154292330|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292331|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
154292332|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
154292333|NCT03568500|Olanzapine|olanzapine|mesh-list
154292334|NCT03568500|Risperidone|risperidone|mesh-list
154292335|NCT03568500|Aripiprazole|aripiprazole|mesh-list
154292336|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154292337|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154292338|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
154292339|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292340|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292341|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292342|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154292343|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154292345|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154292369|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292370|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
154292371|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154292373|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292374|NCT03724266|Chitosan|chitosan|mesh-list
154292375|NCT03724266|Calcium|calcium|mesh-list
154292376|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154292377|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292378|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154292379|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154292380|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
154292381|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292382|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154292383|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
154292384|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
154292385|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
154292386|NCT03724266|Coagulants|coagulants|mesh-ancestor
154292387|NCT03679390|Ketamine|ketamine|mesh-list
154292388|NCT03679390|Analgesics|analgesics|mesh-ancestor
154292389|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
154292390|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292391|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292392|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154292393|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154292394|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
154292395|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
154292396|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292397|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154292398|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154292413|NCT03676114|Ketamine|ketamine|mesh-list
154292414|NCT03676114|Analgesics|analgesics|mesh-ancestor
154292415|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
154292416|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292417|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292418|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154292419|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154292420|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
154292421|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
154292422|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292423|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154292424|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154292425|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292426|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292427|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
154292428|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292429|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
154292430|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154292431|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154292432|NCT03025828|Hormones|hormones|mesh-ancestor
154292433|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292434|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292435|NCT03546816|Serlopitant|serlopitant|mesh-list
154292436|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154292437|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292438|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292439|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292440|NCT03675802|Misoprostol|misoprostol|mesh-list
154292441|NCT03675802|Dinoprostone|dinoprostone|mesh-list
154292457|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292458|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292460|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
154292461|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292462|NCT03678532|Midazolam|midazolam|mesh-list
154292463|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154292464|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154292465|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613102|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292466|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292467|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154292468|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154292469|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154292470|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154292471|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
154292472|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
154292473|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
154292474|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
154292475|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292476|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292477|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
154292478|NCT03675178|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154292479|NCT03675178|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154292480|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154292481|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292482|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154292483|NCT03678142|Vancomycin|vancomycin|mesh-list
154292484|NCT03678142|Imipenem|imipenem|mesh-list
154292485|NCT03678142|Floxacillin|floxacillin|mesh-list
154292486|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292487|NCT03674866|Insulin|insulin|mesh-list
154292488|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154292489|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292501|NCT03448406|Empagliflozin|empagliflozin|mesh-list
154292502|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154292503|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292504|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154292505|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292506|NCT00064701|Cyclosporine|cyclosporine|mesh-list
154292507|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
154292508|NCT00064701|Tacrolimus|tacrolimus|mesh-list
154292509|NCT00064701|Cyclosporins|cyclosporins|mesh-list
154292510|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292511|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
154292512|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292513|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154292514|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292515|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292516|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
154292517|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292518|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
154292519|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292520|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154292521|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292522|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154292523|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
154292524|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154292525|NCT00064077|Paclitaxel|paclitaxel|mesh-list
154292526|NCT00064077|Vinorelbine|vinorelbine|mesh-list
154292527|NCT00064077|Cisplatin|cisplatin|mesh-list
154292528|NCT00064077|Gemcitabine|gemcitabine|mesh-list
154292529|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154292530|NCT00064077|Topotecan|topotecan|mesh-list
154292531|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292532|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292533|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
154292534|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
154292535|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
154292542|NCT03674008|Propofol|propofol|mesh-list
154292543|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154292544|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292545|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292546|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154292547|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
154292548|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
154292549|NCT00063999|Paclitaxel|paclitaxel|mesh-list
154292550|NCT00063999|Cisplatin|cisplatin|mesh-list
154292551|NCT00063999|Carboplatin|carboplatin|mesh-list
154292552|NCT00063999|Doxorubicin|doxorubicin|mesh-list
154292553|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154292554|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154292555|NCT00063999|Lenograstim|lenograstim|mesh-list
154292556|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292557|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292558|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
154292559|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
154292560|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
154292561|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292562|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154292563|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154292564|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154292565|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292566|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154292567|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
154292568|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292569|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
154292570|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154292571|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292572|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154292573|NCT03673384|Fluticasone|fluticasone|mesh-list
154292574|NCT03673384|Xhance|xhance|mesh-list
154292575|NCT03673384|Histamine|histamine|mesh-list
154292576|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292585|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
154292586|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
154292587|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292588|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292589|NCT02915302|Vaccines|vaccines|mesh-list
154292590|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
154292591|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292592|NCT03023878|Dexamethasone|dexamethasone|mesh-list
154292593|NCT03023878|Blinatumomab|blinatumomab|mesh-list
154292594|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292595|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
154292596|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
154292597|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292598|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292599|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292600|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
154292601|NCT03023878|Hormones|hormones|mesh-ancestor
154292602|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292603|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154292604|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292605|NCT03670888|Rituximab|rituximab|mesh-list
154292606|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154292607|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292608|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
154292609|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292610|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292611|NCT03023722|Maytansine|maytansine|mesh-list
154292612|NCT03023722|Anetumab ravtansine|anetumab ravtansine|mesh-list
154292613|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292614|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292615|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
154292616|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
154292617|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
153613716|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154292618|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292619|NCT03023722|Immunoconjugates|immunoconjugates|mesh-ancestor
154292625|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
154292626|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292627|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292628|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
154292629|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292630|NCT03669562|Alprostadil|alprostadil|mesh-list
154292631|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154292632|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
154292633|NCT03669562|Urological Agents|urological agents|mesh-ancestor
154292634|NCT03669484|Fentanyl|fentanyl|mesh-list
154292635|NCT03669484|Bromides|bromides|mesh-list
154292636|NCT03669484|Propofol|propofol|mesh-list
154292637|NCT03669484|Rocuronium|rocuronium|mesh-list
154292638|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154292639|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292640|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292641|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154292642|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
154292643|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
154292644|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154292645|NCT03669484|Narcotics|narcotics|mesh-ancestor
154292646|NCT03669484|Analgesics|analgesics|mesh-ancestor
154292647|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
154292648|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292649|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154292650|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
154292651|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154292652|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154292653|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154292654|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
154292673|NCT03668860|Hormones|hormones|mesh-ancestor
154292674|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292675|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154292676|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292677|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
154292678|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292679|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292680|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154292681|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
154292682|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154292683|NCT00062751|Sirolimus|sirolimus|mesh-list
154292684|NCT00062751|Letrozole|letrozole|mesh-list
154292685|NCT00062751|Temsirolimus|temsirolimus|mesh-list
154292686|NCT00062751|MTOR Inhibitors|mtor inhibitors|mesh-list
154292687|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292688|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154292689|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154292690|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292691|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292692|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154292693|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
154292694|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292695|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292696|NCT00062751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154292722|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154292723|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292724|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154292725|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
154292726|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154292727|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154292728|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
154292729|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
154292730|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154292731|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154292732|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
154292733|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292734|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292735|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
154292736|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
154292737|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
154292738|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292739|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
154292740|NCT00945724|Hormones|hormones|mesh-ancestor
154292741|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292742|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154292743|NCT00258310|Capecitabine|capecitabine|mesh-list
154292744|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154292745|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
154292746|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292747|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292748|NCT00062439|Docetaxel|docetaxel|mesh-list
154292749|NCT00062439|Etoposide|etoposide|mesh-list
154292750|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292751|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
154292752|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
154292753|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
154292754|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292758|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292761|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154292762|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292763|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154292764|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154292765|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154292766|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292767|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
154292768|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292769|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154292770|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154292771|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
154292772|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292773|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154292775|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
154292776|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292777|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
154292778|NCT01092741|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154292779|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154292780|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292781|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292782|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292783|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154292784|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
154292785|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292786|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
154292787|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154292788|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292789|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
154292790|NCT00031551|Etanercept|etanercept|mesh-list
154292791|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154292792|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154292800|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292801|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
154292803|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154292804|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292805|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154292806|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
154292807|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292808|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292809|NCT01092975|Phenylephrine|phenylephrine|mesh-list
154292810|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
154292811|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154292812|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
154292813|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
154292814|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292815|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292816|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
154292817|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154292818|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
154292819|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
154292820|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154292821|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154292822|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154292823|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
154292824|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154292825|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292826|NCT01092975|Protective Agents|protective agents|mesh-ancestor
154292827|NCT01584297|Ketoconazole|ketoconazole|mesh-list
154292828|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
154292829|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292830|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154292831|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154292832|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292840|NCT00049257|Carboplatin|carboplatin|mesh-list
154292841|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292842|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292843|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
154292844|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
154292845|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
154292846|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292847|NCT03951987|Charcoal|charcoal|mesh-list
154292848|NCT03951987|Antidotes|antidotes|mesh-ancestor
154292849|NCT03951987|Protective Agents|protective agents|mesh-ancestor
154292850|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292851|NCT03668470|Dulaglutide|dulaglutide|mesh-list
154292852|NCT03668470|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154292853|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154292854|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292855|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
154292856|NCT03020992|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154292857|NCT03020992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292858|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292859|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
154292860|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292861|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292862|NCT03020914|Methamphetamine|methamphetamine|mesh-list
154292863|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154292890|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
154292891|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
154292892|NCT00048165|Cyclosporins|cyclosporins|mesh-list
154292893|NCT00048165|Daclizumab|daclizumab|mesh-list
154292894|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292895|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292896|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154292897|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
154292898|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292899|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
154292900|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154292901|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
154292902|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154292903|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154292904|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154292905|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292906|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154292907|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
154292908|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154292909|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154292910|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
154292911|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
154292912|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292913|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292914|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
154292915|NCT00048165|Hormones|hormones|mesh-ancestor
154292916|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292937|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292938|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
154292939|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154292940|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
154292941|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292942|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
154292943|NCT03955497|Protective Agents|protective agents|mesh-ancestor
154292944|NCT01099605|Bupivacaine|bupivacaine|mesh-list
154292945|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
154292946|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
154292947|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292948|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292949|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
154292950|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292951|NCT00059787|Paclitaxel|paclitaxel|mesh-list
154292952|NCT00059787|Carboplatin|carboplatin|mesh-list
154292953|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154292954|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154292955|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154292956|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
154292957|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
154292958|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
154292959|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154292960|NCT00059787|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154292961|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154292962|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154292963|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
154292964|NCT01099839|Miglitol|miglitol|mesh-list
154292965|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154292982|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
154292983|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154292984|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154292985|NCT03015532|Bupivacaine|bupivacaine|mesh-list
154292986|NCT03015532|Ropivacaine|ropivacaine|mesh-list
154292987|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
154292988|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
154292989|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154292990|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614736|NCT01970046|Metformin|metformin|mesh-list
154292991|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
154292992|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154292993|NCT03954873|Glucagon|glucagon|mesh-list
154292994|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154292995|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154292996|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154292997|NCT03954873|Hormones|hormones|mesh-ancestor
154292998|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154292999|NCT03954873|Incretins|incretins|mesh-ancestor
154293000|NCT03954639|Bupivacaine|bupivacaine|mesh-list
154293001|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293002|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
154293036|NCT03018028|Semaglutide|semaglutide|mesh-list
154293037|NCT03018028|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154293038|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154293039|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293040|NCT03018028|Incretins|incretins|mesh-ancestor
154293041|NCT03018028|Hormones|hormones|mesh-ancestor
154293042|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293043|NCT03667222|Minocycline|minocycline|mesh-list
154293044|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154293045|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154293046|NCT03667300|Linagliptin|linagliptin|mesh-list
154293047|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154293048|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293049|NCT03667300|Incretins|incretins|mesh-ancestor
154293050|NCT03667300|Hormones|hormones|mesh-ancestor
154293051|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293052|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154293053|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
154293054|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293055|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293056|NCT03667066|Clopidogrel|clopidogrel|mesh-list
154293057|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154293058|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154293059|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154293060|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154293061|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
154293062|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293063|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293064|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293065|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
154293066|NCT00021255|Carboplatin|carboplatin|mesh-list
154293067|NCT00021255|Docetaxel|docetaxel|mesh-list
154293068|NCT00021255|Doxorubicin|doxorubicin|mesh-list
154293076|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293078|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154293079|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
154293080|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
154293081|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
154293082|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154293083|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154293084|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154293085|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293086|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293087|NCT03012334|Alprazolam|alprazolam|mesh-list
154293088|NCT03012334|Lasmiditan|lasmiditan|mesh-list
154293089|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154293090|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293091|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293092|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154293093|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154293094|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154293095|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
154293096|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
154293097|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293098|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293099|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154293100|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
154293101|NCT03951285|Niacinamide|niacinamide|mesh-list
154293102|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
154293103|NCT03951285|Vitamins|vitamins|mesh-ancestor
154293104|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
154293105|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293106|NCT04571944|Suvorexant|suvorexant|mesh-list
154293107|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154293108|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154293109|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293110|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293111|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154293114|NCT04052932|Allopurinol|allopurinol|mesh-list
154293115|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
154293116|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293117|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293118|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
154293119|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293120|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154293121|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
154293122|NCT04052932|Protective Agents|protective agents|mesh-ancestor
154293123|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293124|NCT03006562|Heparin|heparin|mesh-list
154293125|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
154293126|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154293127|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154293128|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293129|NCT03666208|Sirolimus|sirolimus|mesh-list
154293130|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154293131|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154293132|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154293133|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293134|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
154293135|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154293136|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
154293137|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293138|NCT03007966|Clonidine|clonidine|mesh-list
154293139|NCT03007966|Epinephrine|epinephrine|mesh-list
154293140|NCT03007966|Bupivacaine|bupivacaine|mesh-list
154293141|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293142|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
154293143|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293161|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154293162|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
154293163|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154293164|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154293165|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154293166|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
154293167|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293168|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154293169|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154293170|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
154293171|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
154293172|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293173|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293174|NCT03541044|Nicotine|nicotine|mesh-list
154293175|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154293176|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
154293177|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293178|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293179|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154293180|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154293181|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
154293182|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293183|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293211|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293212|NCT03540030|Analgesics|analgesics|mesh-ancestor
154293213|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
154293214|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154293215|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154293216|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154293217|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154293218|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293219|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154293220|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154293221|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293222|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
154293223|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154293224|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154293225|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154293226|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154293227|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154293228|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293229|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
154293230|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154293231|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154293232|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154293233|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154293234|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154293235|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
154293236|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
154293237|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
154293238|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154293258|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293259|NCT03665428|Bismuth|bismuth|mesh-list
154293260|NCT03665428|Antacids|antacids|mesh-ancestor
154293261|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293262|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154293263|NCT03669328|Anesthetics|anesthetics|mesh-list
154293264|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293265|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293266|NCT02912650|Acetaminophen|acetaminophen|mesh-list
154293267|NCT02912650|Ibuprofen|ibuprofen|mesh-list
154293268|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293269|NCT02912650|Analgesics|analgesics|mesh-ancestor
154293270|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
154293271|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293272|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293273|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
154293274|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154293275|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154293276|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293277|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154293278|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293279|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293280|NCT03002038|Rituximab|rituximab|mesh-list
154293281|NCT03002038|Azathioprine|azathioprine|mesh-list
154293282|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293283|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293284|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
154293285|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293286|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293287|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
154293289|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154293298|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293299|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
154293300|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154040102|NCT04474353|Temozolomide|temozolomide|mesh-list
154293301|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
154293302|NCT02911948|Insulin|insulin|mesh-list
154293303|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154293304|NCT02911948|Liraglutide|liraglutide|mesh-list
154293305|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
154293306|NCT02911948|Xultophy|xultophy|mesh-list
154293307|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154293308|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293309|NCT02911948|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154293310|NCT02911948|Incretins|incretins|mesh-ancestor
154293311|NCT02911948|Hormones|hormones|mesh-ancestor
154293312|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293313|NCT03622918|Rifampin|rifampin|mesh-list
154293314|NCT03622918|Colistin|colistin|mesh-list
154293315|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154293316|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
154293317|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154293318|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154293319|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
154293320|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154293321|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293322|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293323|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154293324|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154293325|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154293326|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154293327|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154293328|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154293338|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293339|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293340|NCT00046839|Celecoxib|celecoxib|mesh-list
154293341|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154293342|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154293343|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293344|NCT00046839|Analgesics|analgesics|mesh-ancestor
154293345|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
154293346|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293347|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293348|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154293349|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293350|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154293351|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293352|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293353|NCT00006903|Fulvestrant|fulvestrant|mesh-list
154293354|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154293355|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293356|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154293357|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154293358|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
154293359|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293360|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293361|NCT03951597|Gemcitabine|gemcitabine|mesh-list
154293362|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
154293363|NCT03951597|Lenvatinib|lenvatinib|mesh-list
154293364|NCT03951597|Antibodies|antibodies|mesh-list
154293365|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
154293366|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293382|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154293383|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293384|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154293385|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293386|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
154293388|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
154293389|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154293390|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154293391|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154293392|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154293393|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
154293394|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293395|NCT02996500|Tofacitinib|tofacitinib|mesh-list
154293396|NCT02996500|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154293397|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154293398|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293399|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293400|NCT00006489|Naltrexone|naltrexone|mesh-list
154293401|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154293402|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154293403|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293404|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
154293406|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154293431|NCT02998996|Endocine|endocine|mesh-list
154293432|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154293433|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
154293434|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293435|NCT03663478|Ropivacaine|ropivacaine|mesh-list
154293436|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293437|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
154293438|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293439|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293440|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
154293441|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293442|NCT02994940|Acetaminophen|acetaminophen|mesh-list
154293443|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293444|NCT02994940|Analgesics|analgesics|mesh-ancestor
154293445|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
154293446|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293447|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293448|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
154293449|NCT02994394|Tolvaptan|tolvaptan|mesh-list
154293450|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154293451|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293452|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
154293453|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293454|NCT01063270|Rifampin|rifampin|mesh-list
154293481|NCT01069900|Amoxicillin|amoxicillin|mesh-list
154293482|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
154293483|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
154293484|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
154293485|NCT01069900|Ertapenem|ertapenem|mesh-list
154293486|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154293487|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154293488|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154293489|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154293490|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154293491|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154293492|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293493|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293494|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293495|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154293496|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
154293497|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154293498|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293499|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154293500|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154293501|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154293502|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154293503|NCT00006237|Interferons|interferons|mesh-list
154293504|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
154293505|NCT00006237|Aldesleukin|aldesleukin|mesh-list
154293506|NCT00006237|Interleukin-2|interleukin-2|mesh-list
154293507|NCT00006237|Dacarbazine|dacarbazine|mesh-list
154293508|NCT00006237|Vinblastine|vinblastine|mesh-list
154293509|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293510|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
154293511|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154293512|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
154293523|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154293524|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
154293525|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
154293526|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
154293527|NCT04056754|Prednisone|prednisone|mesh-list
154293528|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
154293529|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154293530|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
154293531|NCT04056754|Hormones|hormones|mesh-ancestor
154293532|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293533|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293534|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154293535|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293536|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154293537|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293538|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293539|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
154293540|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154293541|NCT04056442|Cannabidiol|cannabidiol|mesh-list
154293542|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
154293575|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293576|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293577|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154293578|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154293579|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154293580|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
154293581|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293582|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293583|NCT03444584|Metformin|metformin|mesh-list
154293584|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154293585|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293586|NCT03717740|Esomeprazole|esomeprazole|mesh-list
154293587|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154293588|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154293589|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154293590|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293591|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293592|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
154293593|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154293594|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154293595|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293596|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154293597|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293598|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154293599|NCT03717662|Nicotine|nicotine|mesh-list
154293600|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154293601|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
154293602|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293603|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293604|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154293605|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154293606|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
154293607|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293608|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293609|NCT03494816|Axitinib|axitinib|mesh-list
154293611|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154293612|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293613|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293614|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
154293615|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
154293616|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154293617|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293618|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293619|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
154293620|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154293621|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293622|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293623|NCT03713762|Lidocaine|lidocaine|mesh-list
154293624|NCT03713762|Fentanyl|fentanyl|mesh-list
154293625|NCT03713762|Bupivacaine|bupivacaine|mesh-list
154293626|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293627|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
154293628|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293629|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293630|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
154293631|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293632|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154293633|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154293634|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154293635|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154293636|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293637|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154293638|NCT03713762|Narcotics|narcotics|mesh-ancestor
154293639|NCT03713762|Analgesics|analgesics|mesh-ancestor
154293640|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154293641|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154293642|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
154293643|NCT05975411|Anesthetics|anesthetics|mesh-list
154293644|NCT05975411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293645|NCT05975411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293649|NCT05975346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293650|NCT05975346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293652|NCT05975346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154293653|NCT05975346|Anesthetics, General|anesthetics, general|mesh-ancestor
154293654|NCT05975346|Anesthetics|anesthetics|mesh-ancestor
154293655|NCT05975346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293656|NCT05975346|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154293657|NCT05975346|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154293658|NCT05975346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293659|NCT05975346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293660|NCT05975320|Warfarin|warfarin|mesh-list
154293661|NCT05975320|Apixaban|apixaban|mesh-list
154293662|NCT05975320|Anticoagulants|anticoagulants|mesh-ancestor
154293663|NCT05975320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154293664|NCT05975320|Antithrombins|antithrombins|mesh-ancestor
154293665|NCT05975320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154293666|NCT05975320|Protease Inhibitors|protease inhibitors|mesh-ancestor
154293667|NCT05975320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293668|NCT05975320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293669|NCT05975294|Dexamethasone|dexamethasone|mesh-list
154293670|NCT05975294|Ketorolac|ketorolac|mesh-list
154293671|NCT05975294|Fentanyl|fentanyl|mesh-list
154293672|NCT05975294|Nalbuphine|nalbuphine|mesh-list
154293673|NCT05975294|Bupivacaine|bupivacaine|mesh-list
154293674|NCT05975294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154293675|NCT05975294|Antiemetics|antiemetics|mesh-ancestor
154293676|NCT05975294|Autonomic Agents|autonomic agents|mesh-ancestor
154040475|NCT03301506|Seladelpar|seladelpar|mesh-list
154293677|NCT05975294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293678|NCT05975294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293694|NCT05975294|Anesthetics, General|anesthetics, general|mesh-ancestor
154293695|NCT05975294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154293696|NCT05975294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293697|NCT05975294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293698|NCT05975294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154293699|NCT05975294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293700|NCT05975294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293701|NCT05975112|Plasminogen|plasminogen|mesh-list
154293702|NCT05975112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154293703|NCT05975112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154293704|NCT05975112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293705|NCT05974683|Mycophenolic Acid|mycophenolic acid|mesh-list
154293706|NCT05974683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154293707|NCT05974683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293708|NCT05974683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154293709|NCT05974683|Antitubercular Agents|antitubercular agents|mesh-ancestor
154293710|NCT05974683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154293711|NCT05974683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154293712|NCT05974683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293713|NCT05974683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293714|NCT05974527|Dexmedetomidine|dexmedetomidine|mesh-list
154293715|NCT05974527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154293716|NCT05974527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293717|NCT05974527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293718|NCT05974527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293719|NCT05974527|Analgesics|analgesics|mesh-ancestor
154293720|NCT05974527|Sensory System Agents|sensory system agents|mesh-ancestor
154293723|NCT05974527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154293739|NCT05974501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154293740|NCT05974501|Glucocorticoids|glucocorticoids|mesh-ancestor
154293741|NCT05974501|Hormones|hormones|mesh-ancestor
154293742|NCT05974501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293743|NCT05974501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154293744|NCT05974501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293745|NCT05974501|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293746|NCT05974501|Anesthetics|anesthetics|mesh-ancestor
154293747|NCT05974501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293748|NCT05974501|Sensory System Agents|sensory system agents|mesh-ancestor
154040543|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154293749|NCT05974501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293750|NCT05974501|Analgesics|analgesics|mesh-ancestor
154293751|NCT05974501|Antipyretics|antipyretics|mesh-ancestor
154293752|NCT05974501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154293753|NCT05974501|Narcotics|narcotics|mesh-ancestor
154293754|NCT05974501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154293755|NCT05974501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293756|NCT05974501|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154293757|NCT05974501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154293758|NCT05974501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293759|NCT05974501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293760|NCT05974436|Dialysis Solutions|dialysis solutions|mesh-list
154293761|NCT05974436|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154293762|NCT05974423|Acetaminophen|acetaminophen|mesh-list
154293763|NCT05974423|Ibuprofen|ibuprofen|mesh-list
154293764|NCT05974423|Oxycodone|oxycodone|mesh-list
154293765|NCT05974423|Narcotics|narcotics|mesh-list
154293766|NCT05974423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154293767|NCT05974423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154293768|NCT05974423|Analgesics|analgesics|mesh-ancestor
154293769|NCT05974423|Sensory System Agents|sensory system agents|mesh-ancestor
154293784|NCT05974410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293785|NCT05974332|Oncostatin M|oncostatin m|mesh-list
154293786|NCT05974332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293787|NCT05974332|Growth Inhibitors|growth inhibitors|mesh-ancestor
154293788|NCT05974332|Growth Substances|growth substances|mesh-ancestor
154293789|NCT05974332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293790|NCT05974059|Capecitabine|capecitabine|mesh-list
154293791|NCT05974059|Oxaliplatin|oxaliplatin|mesh-list
154293792|NCT05974059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154293793|NCT05974059|Antimetabolites|antimetabolites|mesh-ancestor
154293794|NCT05974059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293795|NCT05974059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293796|NCT05974007|Immunomodulating Agents|immunomodulating agents|mesh-list
154293797|NCT05974007|Immunologic Factors|immunologic factors|mesh-ancestor
154293798|NCT05974007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293799|NCT05973864|Pembrolizumab|pembrolizumab|mesh-list
154293800|NCT05973864|Capecitabine|capecitabine|mesh-list
154293801|NCT05973864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154293802|NCT05973864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293803|NCT05973864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154293804|NCT05973864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293805|NCT05973864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154293806|NCT05973864|Antimetabolites|antimetabolites|mesh-ancestor
154293808|NCT05973552|Trace Elements|trace elements|mesh-ancestor
154293809|NCT05973552|Micronutrients|micronutrients|mesh-ancestor
154293810|NCT05973552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293811|NCT05971667|Sildenafil Citrate|sildenafil citrate|mesh-list
154293812|NCT05971667|Tadalafil|tadalafil|mesh-list
154293813|NCT05971667|Pentoxifylline|pentoxifylline|mesh-list
154293814|NCT05971667|Vasodilator Agents|vasodilator agents|mesh-ancestor
154293815|NCT05971667|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154293816|NCT05971667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154293817|NCT05971667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293818|NCT05971667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293819|NCT05971667|Urological Agents|urological agents|mesh-ancestor
154293820|NCT05971667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154293821|NCT05971667|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154293822|NCT05971667|Protective Agents|protective agents|mesh-ancestor
154293823|NCT05971667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293824|NCT05971667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154293825|NCT05971667|Antioxidants|antioxidants|mesh-ancestor
154293826|NCT05970770|Norepinephrine|norepinephrine|mesh-list
154293827|NCT05970770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154293828|NCT05970770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154293829|NCT05970770|Adrenergic Agents|adrenergic agents|mesh-ancestor
154293830|NCT05970770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293831|NCT05970770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293832|NCT05970770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293833|NCT05970770|Sympathomimetics|sympathomimetics|mesh-ancestor
154293834|NCT05970770|Autonomic Agents|autonomic agents|mesh-ancestor
154293835|NCT05970770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293836|NCT05970770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154293837|NCT05953766|Ropivacaine|ropivacaine|mesh-list
154293838|NCT05953766|Anesthetics, Local|anesthetics, local|mesh-ancestor
154293839|NCT05953766|Anesthetics|anesthetics|mesh-ancestor
154293840|NCT05953766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154293841|NCT05953766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293842|NCT05953766|Sensory System Agents|sensory system agents|mesh-ancestor
154293843|NCT05953766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293844|NCT05951400|Cetrorelix|cetrorelix|mesh-list
154293845|NCT05951400|Dydrogesterone|dydrogesterone|mesh-list
154293846|NCT05951400|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154293847|NCT05951400|Fertility Agents|fertility agents|mesh-ancestor
154293848|NCT05951400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154293849|NCT05951400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293850|NCT05951400|Hormone Antagonists|hormone antagonists|mesh-ancestor
154293851|NCT05951400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154293852|NCT05951400|Progestins|progestins|mesh-ancestor
154293853|NCT05951400|Hormones|hormones|mesh-ancestor
154293854|NCT05806164|Mirabegron|mirabegron|mesh-list
154293855|NCT05806164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154293857|NCT05806164|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
154293858|NCT05806164|Adrenergic Agents|adrenergic agents|mesh-list
154293859|NCT05806164|Adrenergic Agonists|adrenergic agonists|mesh-list
154293860|NCT05806164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154293861|NCT05806164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293862|NCT05806164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293863|NCT05806164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154293864|NCT05806164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154293865|NCT05806164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293866|NCT05806164|Cholinergic Agents|cholinergic agents|mesh-ancestor
154293867|NCT05806164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154293868|NCT05806164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154293869|NCT05806164|Urological Agents|urological agents|mesh-ancestor
154293870|NCT05805761|Anti-Infective Agents|anti-infective agents|mesh-list
154293871|NCT05805761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154293872|NCT05701540|Esomeprazole|esomeprazole|mesh-list
154293873|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154293874|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154293875|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154293876|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293877|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293878|NCT05618353|Colchicine|colchicine|mesh-list
154293879|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
154293880|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293881|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
154293882|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
154293902|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293903|NCT05042440|Factor VIII|factor viii|mesh-list
154293905|NCT05042440|Coagulants|coagulants|mesh-ancestor
154293907|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
154293908|NCT05022563|Dabigatran|dabigatran|mesh-list
154293909|NCT05022563|Apixaban|apixaban|mesh-list
154293910|NCT05022563|Anticoagulants|anticoagulants|mesh-list
154293911|NCT05022563|Edoxaban|edoxaban|mesh-list
154293912|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154293913|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
154293914|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154293915|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
154293916|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154293917|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293918|NCT04950426|Propranolol|propranolol|mesh-list
154293919|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154293920|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154293921|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
154293961|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154293962|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154293963|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154293964|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154293965|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154293966|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293967|NCT04821856|Cannabidiol|cannabidiol|mesh-list
154293968|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
154293970|NCT04764227|Carboplatin|carboplatin|mesh-list
154293971|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154293972|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293973|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
154293974|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154293975|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154293976|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154293977|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
154293978|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154293979|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
154293981|NCT04639245|Atezolizumab|atezolizumab|mesh-list
154293982|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154293983|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154293984|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154293985|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
154293986|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154293987|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154293988|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154293989|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
154293991|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294006|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294007|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154294008|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
154294009|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154294010|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154294011|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154294012|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154294013|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294014|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
154294015|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154294016|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154294017|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154294018|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294019|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154294020|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
154294021|NCT04587843|Naltrexone|naltrexone|mesh-list
154294022|NCT04587843|Bupropion|bupropion|mesh-list
154294023|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154294058|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
154294059|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154294060|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
154294061|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294062|NCT04408664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154294063|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294064|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154294065|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
154294066|NCT04362293|Sirolimus|sirolimus|mesh-list
154294067|NCT04362293|Plerixafor|plerixafor|mesh-list
154294068|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
154294069|NCT04362293|Thiotepa|thiotepa|mesh-list
154294070|NCT04362293|Temsirolimus|temsirolimus|mesh-list
154294071|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
154294072|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
154294073|NCT04362293|Azathioprine|azathioprine|mesh-list
154294074|NCT04362293|MTOR Inhibitors|mtor inhibitors|mesh-list
154294075|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294076|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
154294077|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294078|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294115|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294116|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154294117|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154294119|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294120|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
154294121|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154294122|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
154294123|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154294124|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154294125|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154294126|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
154294127|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154294128|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294129|NCT04183452|Progestins|progestins|mesh-ancestor
154294130|NCT04183452|Hormones|hormones|mesh-ancestor
154294131|NCT04104646|Morphine|morphine|mesh-list
154294132|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154294133|NCT04104646|Narcotics|narcotics|mesh-ancestor
154294134|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294135|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294136|NCT04104646|Analgesics|analgesics|mesh-ancestor
154294137|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
154294138|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294139|NCT03580824|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
154294140|NCT03580824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154294141|NCT03580824|Immunologic Factors|immunologic factors|mesh-ancestor
154294142|NCT03580824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294143|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154294160|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294161|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154294162|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
154294163|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
154294164|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
154294165|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294166|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294167|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154294168|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294169|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154294170|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154294171|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
154294172|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
154294173|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154294174|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294175|NCT03107884|Metformin|metformin|mesh-list
154294176|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294177|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294178|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
154294179|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294180|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294181|NCT03106415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294182|NCT03106415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294183|NCT03024996|Atezolizumab|atezolizumab|mesh-list
154294184|NCT03024996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294185|NCT03024996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294186|NCT03024996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294187|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294188|NCT03003325|Aspirin|aspirin|mesh-list
154294189|NCT03003325|Interferons|interferons|mesh-list
154294190|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294191|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
154294192|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294194|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154294200|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294201|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154041007|NCT00652730|Buspirone|buspirone|mesh-list
154294202|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154294203|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294204|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154294205|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154294206|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294207|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
154294208|NCT02969798|Metformin|metformin|mesh-list
154294209|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
154294210|NCT02969798|Pioglitazone|pioglitazone|mesh-list
154294211|NCT02969798|Saxagliptin|saxagliptin|mesh-list
154294212|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294213|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294214|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154294215|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294216|NCT02969798|Incretins|incretins|mesh-ancestor
154294217|NCT02969798|Hormones|hormones|mesh-ancestor
154294218|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154294219|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154294220|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
154294221|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294222|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
154294223|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294224|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294225|NCT02855203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294226|NCT02855203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294227|NCT02748564|Aldesleukin|aldesleukin|mesh-list
154294228|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
154294229|NCT02748564|Interleukin-2|interleukin-2|mesh-list
154294230|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294231|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294235|NCT02748564|Analgesics|analgesics|mesh-ancestor
154294239|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154294240|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154294241|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
154294242|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294243|NCT02642965|Cytarabine|cytarabine|mesh-list
154294244|NCT02642965|Fludarabine|fludarabine|mesh-list
154294245|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
154294246|NCT02642965|Daunorubicin|daunorubicin|mesh-list
154294247|NCT02642965|Lenograstim|lenograstim|mesh-list
154294248|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294249|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154294250|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
154294251|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294252|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294253|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
154294254|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294255|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
154294256|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294257|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154294258|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154294259|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154294260|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154294261|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294262|NCT01936532|Dexamethasone|dexamethasone|mesh-list
154294263|NCT01936532|Lenalidomide|lenalidomide|mesh-list
154294264|NCT01936532|Ixazomib|ixazomib|mesh-list
154294265|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294266|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
154294267|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
154294288|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294289|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294290|NCT00542308|Zalutumumab|zalutumumab|mesh-list
154294291|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294292|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294294|NCT00488605|Prednisone|prednisone|mesh-list
154294295|NCT00488605|Methotrexate|methotrexate|mesh-list
154294296|NCT00488605|Vinblastine|vinblastine|mesh-list
154294297|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
154294298|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294299|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
154294300|NCT00488605|Hormones|hormones|mesh-ancestor
154294301|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154294302|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294303|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154294304|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294305|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154294306|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
154294307|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154294308|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154294309|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
154294310|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294311|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
154294312|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294313|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154294314|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294315|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
154294316|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294317|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294318|NCT00488605|Antidotes|antidotes|mesh-ancestor
154294319|NCT00488605|Protective Agents|protective agents|mesh-ancestor
154294320|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
154294332|NCT00006734|Vincristine|vincristine|mesh-list
154294333|NCT00006734|Lenograstim|lenograstim|mesh-list
154294334|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294335|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
154294336|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294337|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294338|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294339|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
154294340|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294341|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294342|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154294343|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154294344|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154294345|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154294346|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294347|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294348|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154294349|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294350|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294351|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294352|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154294353|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154294354|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
154294355|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294356|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154294378|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153618220|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
154294379|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294380|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294381|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294382|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
154294383|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154294384|NCT03662620|Amlodipine|amlodipine|mesh-list
154294385|NCT03662620|Telmisartan|telmisartan|mesh-list
154294386|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
154294387|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154294388|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154294389|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154294390|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294391|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154294392|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294393|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
154294394|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154294395|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154294396|NCT03662620|Diuretics|diuretics|mesh-ancestor
154294397|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
154294398|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154294399|NCT03415178|Atorvastatin|atorvastatin|mesh-list
154294400|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154294401|NCT03415178|Alirocumab|alirocumab|mesh-list
154294402|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154294403|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154294404|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
154294405|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294406|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154294407|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154294408|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294409|NCT03415178|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154294412|NCT01068730|Metformin|metformin|mesh-list
154294419|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
154294420|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154294421|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
154294422|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
154294423|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154294424|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294425|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294426|NCT03658720|Ibuprofen|ibuprofen|mesh-list
154027390|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294427|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154294428|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154294430|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
154294431|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294432|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294433|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294434|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294435|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154294436|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294437|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294438|NCT06324357|Trastuzumab|trastuzumab|mesh-list
154294439|NCT06324357|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154294440|NCT06324357|Maytansine|maytansine|mesh-list
154294441|NCT06324357|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154294442|NCT06324357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294443|NCT06324357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294444|NCT06324357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294445|NCT06324357|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294446|NCT06324357|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294447|NCT06324357|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294449|NCT06324357|Immunotoxins|immunotoxins|mesh-ancestor
154294461|NCT06324266|Cyclophosphamide|cyclophosphamide|mesh-list
154294462|NCT06324266|Lenalidomide|lenalidomide|mesh-list
154294463|NCT06324266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294464|NCT06324266|Immunologic Factors|immunologic factors|mesh-ancestor
154294465|NCT06324266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294466|NCT06324266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294467|NCT06324266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294468|NCT06324266|Alkylating Agents|alkylating agents|mesh-ancestor
154294469|NCT06324266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294470|NCT06324266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294471|NCT06324266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154294472|NCT06324266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154294473|NCT06324266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154294474|NCT06324266|Growth Substances|growth substances|mesh-ancestor
154294475|NCT06324266|Growth Inhibitors|growth inhibitors|mesh-ancestor
154294476|NCT06324253|Bupivacaine|bupivacaine|mesh-list
154294477|NCT06324253|Anesthetics, Local|anesthetics, local|mesh-ancestor
154294478|NCT06324253|Anesthetics|anesthetics|mesh-ancestor
154294479|NCT06324253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294480|NCT06324253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294481|NCT06324253|Sensory System Agents|sensory system agents|mesh-ancestor
154294482|NCT06324253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294483|NCT06324240|Pembrolizumab|pembrolizumab|mesh-list
154294484|NCT06324240|Ipilimumab|ipilimumab|mesh-list
154294485|NCT06324240|Vaccines|vaccines|mesh-list
154294486|NCT06324240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294487|NCT06324240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294488|NCT06324240|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294505|NCT06323837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154294506|NCT06323837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154294507|NCT06323837|Adrenergic Agents|adrenergic agents|mesh-ancestor
154294508|NCT06323837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154294509|NCT06323837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154294511|NCT06323837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154294512|NCT06323824|Buprenorphine|buprenorphine|mesh-list
154294513|NCT06323824|Methadone|methadone|mesh-list
154294514|NCT06323824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154294515|NCT06323824|Narcotics|narcotics|mesh-ancestor
154294516|NCT06323824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294517|NCT06323824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294518|NCT06323824|Analgesics|analgesics|mesh-ancestor
154294519|NCT06323824|Sensory System Agents|sensory system agents|mesh-ancestor
154294520|NCT06323824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294521|NCT06323824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154294522|NCT06323824|Antitussive Agents|antitussive agents|mesh-ancestor
154294523|NCT06323824|Respiratory System Agents|respiratory system agents|mesh-ancestor
154294524|NCT06323668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154294525|NCT06323668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294526|NCT06323525|Cyclophosphamide|cyclophosphamide|mesh-list
154294527|NCT06323525|Fludarabine|fludarabine|mesh-list
154294528|NCT06323525|Fludarabine phosphate|fludarabine phosphate|mesh-list
154294529|NCT06323525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294530|NCT06323525|Immunologic Factors|immunologic factors|mesh-ancestor
154294531|NCT06323525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294532|NCT06323525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294533|NCT06323525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294534|NCT06323525|Alkylating Agents|alkylating agents|mesh-ancestor
154294535|NCT06323525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294540|NCT06323460|Paclitaxel|paclitaxel|mesh-list
154294549|NCT06323460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294550|NCT06323395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154294551|NCT06323395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154294552|NCT06323382|Bevacizumab|bevacizumab|mesh-list
154294553|NCT06323382|Atezolizumab|atezolizumab|mesh-list
154294554|NCT06323382|Tislelizumab|tislelizumab|mesh-list
154294555|NCT06323382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294556|NCT06323382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294557|NCT06323382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154294558|NCT06323382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154294559|NCT06323382|Growth Substances|growth substances|mesh-ancestor
154294560|NCT06323382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294561|NCT06323382|Growth Inhibitors|growth inhibitors|mesh-ancestor
154294562|NCT06323382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294563|NCT06323382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294564|NCT06323369|Paclitaxel|paclitaxel|mesh-list
154294565|NCT06323369|Cisplatin|cisplatin|mesh-list
154294566|NCT06323369|Carboplatin|carboplatin|mesh-list
154294567|NCT06323369|Tislelizumab|tislelizumab|mesh-list
154294568|NCT06323369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294569|NCT06323369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294570|NCT06323369|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294571|NCT06323369|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294572|NCT06323369|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294573|NCT06323369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294597|NCT06322719|Keratolytic Agents|keratolytic agents|mesh-ancestor
154294598|NCT06322719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154294600|NCT06322706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154294601|NCT06322706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294602|NCT06322706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154294603|NCT06322706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294604|NCT06322706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294605|NCT06322693|Carboplatin|carboplatin|mesh-list
154294606|NCT06322693|Docetaxel|docetaxel|mesh-list
154294607|NCT06322693|Nivolumab|nivolumab|mesh-list
154294608|NCT06322693|Pemetrexed|pemetrexed|mesh-list
154294609|NCT06322693|Dostarlimab|dostarlimab|mesh-list
154294610|NCT06322693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294611|NCT06322693|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294612|NCT06322693|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294613|NCT06322693|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294614|NCT06322693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294615|NCT06322693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294616|NCT06322693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294617|NCT06322693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294618|NCT06322693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154294619|NCT06322693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294620|NCT06322407|Topiramate|topiramate|mesh-list
154294621|NCT06322407|Ibuprofen|ibuprofen|mesh-list
154294622|NCT06322407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154294623|NCT06322407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154294624|NCT06322407|Analgesics|analgesics|mesh-ancestor
154294625|NCT06322407|Sensory System Agents|sensory system agents|mesh-ancestor
154294626|NCT06322407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294627|NCT06322407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294628|NCT06322407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294642|NCT06319131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154294643|NCT06319131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294644|NCT06318416|Rifampin|rifampin|mesh-list
154294645|NCT06318416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154294646|NCT06318416|Antitubercular Agents|antitubercular agents|mesh-ancestor
154294647|NCT06318416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154294648|NCT06318416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294649|NCT06318416|Leprostatic Agents|leprostatic agents|mesh-ancestor
154294650|NCT06318416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154041451|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
154294651|NCT06318416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294652|NCT06318416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294653|NCT06318416|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154294654|NCT06318416|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154294655|NCT06318416|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154294656|NCT06318416|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154294657|NCT06318416|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154294658|NCT06318416|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154294659|NCT06314906|Antiemetics|antiemetics|mesh-list
154294660|NCT06314906|Autonomic Agents|autonomic agents|mesh-ancestor
154294661|NCT06314906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294662|NCT06314906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294663|NCT06314906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294664|NCT06307548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154294665|NCT06307548|Levulinic acid|levulinic acid|mesh-list
154294666|NCT06307548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154294687|NCT06299813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154294688|NCT06299813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294689|NCT06299813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154294690|NCT06299813|Respiratory System Agents|respiratory system agents|mesh-ancestor
154294691|NCT06299098|Semaglutide|semaglutide|mesh-list
154294692|NCT06299098|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154294693|NCT06299098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294694|NCT06299098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294695|NCT06297096|Mycophenolic Acid|mycophenolic acid|mesh-list
153363972|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294696|NCT06297096|Methotrexate|methotrexate|mesh-list
154294697|NCT06297096|Nintedanib|nintedanib|mesh-list
154294698|NCT06297096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153364414|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
154294699|NCT06297096|Abortifacient Agents|abortifacient agents|mesh-ancestor
154294700|NCT06297096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154294701|NCT06297096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294702|NCT06297096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154294703|NCT06297096|Antimetabolites|antimetabolites|mesh-ancestor
154294704|NCT06297096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294705|NCT06297096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294706|NCT06297096|Dermatologic Agents|dermatologic agents|mesh-ancestor
154294707|NCT06297096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294708|NCT06297096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154294709|NCT06297096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294710|NCT06297096|Immunologic Factors|immunologic factors|mesh-ancestor
154294711|NCT06297096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294712|NCT06297096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294713|NCT06297096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154294714|NCT06297096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154294715|NCT06297096|Antitubercular Agents|antitubercular agents|mesh-ancestor
154294716|NCT06297096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154294728|NCT06284902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294729|NCT06279494|Sirolimus|sirolimus|mesh-list
154294730|NCT06279494|Abatacept|abatacept|mesh-list
154294731|NCT06279494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154294732|NCT06279494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154294733|NCT06279494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154294734|NCT06279494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294735|NCT06279494|Antifungal Agents|antifungal agents|mesh-ancestor
154294736|NCT06279494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294737|NCT06279494|Immunologic Factors|immunologic factors|mesh-ancestor
154294738|NCT06279494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294739|NCT06279494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294740|NCT06279494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294741|NCT06279494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294742|NCT06279494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294743|NCT06268613|Pembrolizumab|pembrolizumab|mesh-list
154294744|NCT06268613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294745|NCT06268613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294746|NCT06268613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294747|NCT06268613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294748|NCT06249282|Sotorasib|sotorasib|mesh-list
154294749|NCT06249282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294750|NCT06249282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294751|NCT06249282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294752|NCT06249282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294753|NCT06247917|Fludarabine|fludarabine|mesh-list
154294754|NCT06247917|Melphalan|melphalan|mesh-list
154294773|NCT06239272|Alkylating Agents|alkylating agents|mesh-ancestor
154294774|NCT06236438|Carboplatin|carboplatin|mesh-list
154294775|NCT06236438|Pembrolizumab|pembrolizumab|mesh-list
154294777|NCT06236438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294778|NCT06236438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294779|NCT06236438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154294780|NCT06236438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294781|NCT06236438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294782|NCT06236438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154294783|NCT06236438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154294784|NCT06230224|Cytarabine|cytarabine|mesh-list
154294785|NCT06230224|Dexamethasone|dexamethasone|mesh-list
154294786|NCT06230224|Rituximab|rituximab|mesh-list
154294787|NCT06230224|Carboplatin|carboplatin|mesh-list
154294788|NCT06230224|Gemcitabine|gemcitabine|mesh-list
154294789|NCT06230224|Etoposide|etoposide|mesh-list
154294790|NCT06230224|Ifosfamide|ifosfamide|mesh-list
154294791|NCT06230224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294792|NCT06230224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154294793|NCT06230224|Antiemetics|antiemetics|mesh-ancestor
154294794|NCT06230224|Autonomic Agents|autonomic agents|mesh-ancestor
154294795|NCT06230224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294796|NCT06230224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294797|NCT06230224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294798|NCT06230224|Glucocorticoids|glucocorticoids|mesh-ancestor
154294799|NCT06230224|Hormones|hormones|mesh-ancestor
154294800|NCT06230224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154294801|NCT06230224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154294802|NCT06230224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294803|NCT06230224|Immunologic Factors|immunologic factors|mesh-ancestor
154294804|NCT06230224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294805|NCT06230224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154294806|NCT06230224|Antimetabolites|antimetabolites|mesh-ancestor
154294807|NCT06230224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294814|NCT06230224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294815|NCT06230224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294816|NCT06230224|Alkylating Agents|alkylating agents|mesh-ancestor
154294817|NCT06220201|Cyclophosphamide|cyclophosphamide|mesh-list
154294818|NCT06220201|Fludarabine|fludarabine|mesh-list
154294819|NCT06220201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294820|NCT06220201|Immunologic Factors|immunologic factors|mesh-ancestor
154294821|NCT06220201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294822|NCT06220201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294823|NCT06220201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294824|NCT06220201|Alkylating Agents|alkylating agents|mesh-ancestor
154294825|NCT06220201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294826|NCT06220201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294827|NCT06220201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154294828|NCT06219902|Zopiclone|zopiclone|mesh-list
154294829|NCT06219902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154294830|NCT06219902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294831|NCT06219902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294832|NCT06213818|Esomeprazole|esomeprazole|mesh-list
154294833|NCT06213818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154294834|NCT06213818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294835|NCT06213818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154294836|NCT06213818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294837|NCT06213818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294838|NCT06212752|Paclitaxel|paclitaxel|mesh-list
154294839|NCT06212752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154294840|NCT06212752|Carboplatin|carboplatin|mesh-list
154294875|NCT06212622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154294876|NCT06212622|Narcotics|narcotics|mesh-ancestor
154294877|NCT06212622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154294878|NCT06212622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294879|NCT06212622|Analgesics|analgesics|mesh-ancestor
154294880|NCT06212622|Sensory System Agents|sensory system agents|mesh-ancestor
154294881|NCT06212622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294882|NCT06212622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154294883|NCT06212622|Anesthetics, General|anesthetics, general|mesh-ancestor
154294884|NCT06212622|Anesthetics|anesthetics|mesh-ancestor
154294885|NCT06205134|Epinephrine|epinephrine|mesh-list
154294886|NCT06205134|Racepinephrine|racepinephrine|mesh-list
154294887|NCT06205134|Epinephryl borate|epinephryl borate|mesh-list
154294888|NCT06205134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154294889|NCT06205134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154294890|NCT06205134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154294891|NCT06205134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154294892|NCT06205134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294893|NCT06205134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294894|NCT06205134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154294895|NCT06205134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154294896|NCT06205134|Autonomic Agents|autonomic agents|mesh-ancestor
154294897|NCT06205134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154294898|NCT06205134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154294899|NCT06205134|Respiratory System Agents|respiratory system agents|mesh-ancestor
154294900|NCT06205134|Mydriatics|mydriatics|mesh-ancestor
154294901|NCT06205134|Sympathomimetics|sympathomimetics|mesh-ancestor
154294902|NCT06205134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154294903|NCT06196788|Paclitaxel|paclitaxel|mesh-list
154294909|NCT06196788|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294910|NCT06196788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294911|NCT06196788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154294912|NCT06196788|Antimetabolites|antimetabolites|mesh-ancestor
154294913|NCT06190275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154294914|NCT06190275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294915|NCT06190275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294916|NCT06190275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294917|NCT06179160|Cetuximab|cetuximab|mesh-list
154294918|NCT06179160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154294919|NCT06179160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294920|NCT06174298|Lenograstim|lenograstim|mesh-list
154294921|NCT06174298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154294922|NCT06174298|Immunologic Factors|immunologic factors|mesh-ancestor
154294923|NCT06174298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294924|NCT06145308|Paclitaxel|paclitaxel|mesh-list
154294925|NCT06145308|Apatinib|apatinib|mesh-list
154294926|NCT06145308|Bicalutamide|bicalutamide|mesh-list
154294927|NCT06145308|Vedolizumab|vedolizumab|mesh-list
154294928|NCT06145308|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154294929|NCT06145308|Androgen Antagonists|androgen antagonists|mesh-list
154294930|NCT06145308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154294931|NCT06145308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294932|NCT06145308|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294933|NCT06145308|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294934|NCT06145308|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294935|NCT06145308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294936|NCT06145308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154294937|NCT06145308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294952|NCT06132958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294953|NCT06132958|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294954|NCT06132958|Antimitotic Agents|antimitotic agents|mesh-ancestor
154294955|NCT06132958|Mitosis Modulators|mitosis modulators|mesh-ancestor
154294956|NCT06132958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294957|NCT06132958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154294958|NCT06132958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154294959|NCT06132958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154294960|NCT06132958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294961|NCT06111586|Insulin|insulin|mesh-list
154294962|NCT06111586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154294963|NCT06111586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294964|NCT06108739|Cyclophosphamide|cyclophosphamide|mesh-list
154294965|NCT06108739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154294966|NCT06108739|Immunologic Factors|immunologic factors|mesh-ancestor
154294967|NCT06108739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294968|NCT06108739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154294969|NCT06108739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154294970|NCT06108739|Alkylating Agents|alkylating agents|mesh-ancestor
154294971|NCT06108739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294972|NCT06108739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294973|NCT06108739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154294974|NCT06105983|Rabeprazole|rabeprazole|mesh-list
154294975|NCT06105983|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154294976|NCT06105983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154294977|NCT06105983|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154294978|NCT06105983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154294979|NCT06105983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294980|NCT06074588|Docetaxel|docetaxel|mesh-list
154294981|NCT06074588|Pemetrexed|pemetrexed|mesh-list
154294982|NCT06074588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154294983|NCT06074588|Tubulin Modulators|tubulin modulators|mesh-ancestor
154294993|NCT06068855|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154294994|NCT06068855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154294995|NCT06068855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154294996|NCT06068855|Cholinergic Agents|cholinergic agents|mesh-ancestor
154294997|NCT06068855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154294998|NCT06068855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154294999|NCT06068855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154295000|NCT06068855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295001|NCT06062628|Ketamine|ketamine|mesh-list
154295002|NCT06062628|Analgesics|analgesics|mesh-ancestor
154295003|NCT06062628|Sensory System Agents|sensory system agents|mesh-ancestor
154295004|NCT06062628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295005|NCT06062628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295006|NCT06062628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154295007|NCT06062628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154295008|NCT06062628|Anesthetics, General|anesthetics, general|mesh-ancestor
154295009|NCT06062628|Anesthetics|anesthetics|mesh-ancestor
154295010|NCT06062628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295011|NCT06062628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154295012|NCT06062628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154295013|NCT06062628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295014|NCT06062628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295015|NCT06052267|Albuterol|albuterol|mesh-list
154295016|NCT06052267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154295017|NCT06052267|Autonomic Agents|autonomic agents|mesh-ancestor
154295018|NCT06052267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295019|NCT06052267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295020|NCT06052267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154295021|NCT06052267|Respiratory System Agents|respiratory system agents|mesh-ancestor
154295023|NCT06052267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154295024|NCT06052267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154295025|NCT06052267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154295026|NCT06052267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154295027|NCT06052267|Adrenergic Agents|adrenergic agents|mesh-ancestor
154295032|NCT06049212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295033|NCT06049212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295034|NCT06049212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295035|NCT06049212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295036|NCT06034561|Dexamethasone|dexamethasone|mesh-list
154295037|NCT06034561|Doxorubicin|doxorubicin|mesh-list
154295038|NCT06034561|Methotrexate|methotrexate|mesh-list
154295039|NCT06034561|Vincristine|vincristine|mesh-list
154295040|NCT06034561|Bortezomib|bortezomib|mesh-list
154295041|NCT06034561|Asparaginase|asparaginase|mesh-list
154295042|NCT06034561|Pegaspargase|pegaspargase|mesh-list
154295043|NCT06034561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154295044|NCT06034561|Antiemetics|antiemetics|mesh-ancestor
154295045|NCT06034561|Autonomic Agents|autonomic agents|mesh-ancestor
154295046|NCT06034561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295047|NCT06034561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295048|NCT06034561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154295049|NCT06034561|Glucocorticoids|glucocorticoids|mesh-ancestor
154295050|NCT06034561|Hormones|hormones|mesh-ancestor
154295051|NCT06034561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295052|NCT06034561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154295053|NCT06034561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295054|NCT06034561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295082|NCT06016985|Purinergic Agents|purinergic agents|mesh-ancestor
154295083|NCT06016985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295084|NCT06015880|Lenalidomide|lenalidomide|mesh-list
154295085|NCT06015880|Antibodies|antibodies|mesh-list
154295086|NCT06015880|Immunoglobulins|immunoglobulins|mesh-list
154295087|NCT06015880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154295088|NCT06015880|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154295089|NCT06015880|Immunoconjugates|immunoconjugates|mesh-list
154295090|NCT06015880|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154295091|NCT06015880|Immunologic Factors|immunologic factors|mesh-ancestor
154295092|NCT06015880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295093|NCT06015880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154295094|NCT06015880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154295095|NCT06015880|Growth Substances|growth substances|mesh-ancestor
154295096|NCT06015880|Growth Inhibitors|growth inhibitors|mesh-ancestor
154295097|NCT06015880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295098|NCT06004661|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154295099|NCT06004661|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154295100|NCT06004661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295101|NCT05998447|Pembrolizumab|pembrolizumab|mesh-list
154295102|NCT05998447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295103|NCT05998447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295104|NCT05998447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295105|NCT05998447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295106|NCT05997979|Capsaicin|capsaicin|mesh-list
154295107|NCT05997979|Antipruritics|antipruritics|mesh-ancestor
154295108|NCT05997979|Dermatologic Agents|dermatologic agents|mesh-ancestor
154295109|NCT05997979|Sensory System Agents|sensory system agents|mesh-ancestor
154295110|NCT05997979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295111|NCT05997979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295112|NCT05990465|Pirtobrutinib|pirtobrutinib|mesh-list
154295113|NCT05990465|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154295114|NCT05990465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295115|NCT05990465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295117|NCT05984277|Paclitaxel|paclitaxel|mesh-list
154295123|NCT05984277|Tubulin Modulators|tubulin modulators|mesh-ancestor
154295124|NCT05984277|Antimitotic Agents|antimitotic agents|mesh-ancestor
154295125|NCT05984277|Mitosis Modulators|mitosis modulators|mesh-ancestor
154295126|NCT05984277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295127|NCT05984277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295128|NCT05984277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295129|NCT05984277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295130|NCT05984277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154295131|NCT05984277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154295132|NCT05972720|Cyclophosphamide|cyclophosphamide|mesh-list
154295133|NCT05972720|Fludarabine|fludarabine|mesh-list
154295134|NCT05972720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295135|NCT05972720|Immunologic Factors|immunologic factors|mesh-ancestor
154295136|NCT05972720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295137|NCT05972720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295138|NCT05972720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154295139|NCT05972720|Alkylating Agents|alkylating agents|mesh-ancestor
154295140|NCT05972720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295141|NCT05972720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295142|NCT05972720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154295143|NCT05970731|Beclomethasone|beclomethasone|mesh-list
154295144|NCT05970731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154295145|NCT05970731|Glucocorticoids|glucocorticoids|mesh-ancestor
154295146|NCT05970731|Hormones|hormones|mesh-ancestor
154295147|NCT05970731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295148|NCT05970731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295149|NCT05970731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154295150|NCT05970731|Respiratory System Agents|respiratory system agents|mesh-ancestor
154295151|NCT05970289|Interferons|interferons|mesh-list
154295152|NCT05970289|Interferon-alpha|interferon-alpha|mesh-list
154295153|NCT05970289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295154|NCT05970289|Antiviral Agents|antiviral agents|mesh-ancestor
154295155|NCT05970289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295156|NCT05970289|Immunologic Factors|immunologic factors|mesh-ancestor
154295157|NCT05970289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295160|NCT05969223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295161|NCT05967182|Gemcitabine|gemcitabine|mesh-list
154295162|NCT05967182|Pembrolizumab|pembrolizumab|mesh-list
154295163|NCT05967182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295164|NCT05967182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295165|NCT05967182|Antimetabolites|antimetabolites|mesh-ancestor
154295166|NCT05967182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295167|NCT05967182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295168|NCT05967182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295169|NCT05961189|Azithromycin|azithromycin|mesh-list
154295170|NCT05961189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154295171|NCT05961189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295172|NCT05959356|Leucovorin|leucovorin|mesh-list
154295173|NCT05959356|Oxaliplatin|oxaliplatin|mesh-list
154295174|NCT05959356|Irinotecan|irinotecan|mesh-list
154295175|NCT05959356|Cetuximab|cetuximab|mesh-list
154295176|NCT05959356|Levoleucovorin|levoleucovorin|mesh-list
154295177|NCT05959356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295178|NCT05959356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154295179|NCT05959356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154295180|NCT05959356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295181|NCT05959356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295182|NCT05959356|Antidotes|antidotes|mesh-ancestor
154295183|NCT05959356|Protective Agents|protective agents|mesh-ancestor
154295184|NCT05959356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295185|NCT05959356|Vitamin B Complex|vitamin b complex|mesh-ancestor
154295209|NCT05935748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295210|NCT05919316|Mometasone Furoate|mometasone furoate|mesh-list
154295211|NCT05919316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154295212|NCT05919316|Dermatologic Agents|dermatologic agents|mesh-ancestor
154295213|NCT05919316|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154295214|NCT05912387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154295215|NCT05912387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154295216|NCT05912387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154295217|NCT05912387|Antimetabolites|antimetabolites|mesh-ancestor
154295218|NCT05912387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295219|NCT05912387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154295220|NCT05912387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154295221|NCT05912387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295223|NCT05836571|Ipilimumab|ipilimumab|mesh-list
154295224|NCT05836571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295230|NCT05806931|Irinotecan|irinotecan|mesh-list
154295265|NCT05773274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295266|NCT05773274|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154295267|NCT05766397|Methoxyflurane|methoxyflurane|mesh-list
154295268|NCT05766397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154295269|NCT05766397|Anesthetics, General|anesthetics, general|mesh-ancestor
154295270|NCT05766397|Anesthetics|anesthetics|mesh-ancestor
154295271|NCT05766397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295272|NCT05766397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295273|NCT05760313|Linaclotide|linaclotide|mesh-list
154295274|NCT05760313|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154295275|NCT05760313|Enzyme Activators|enzyme activators|mesh-ancestor
154295276|NCT05760313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295277|NCT05760313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154295278|NCT05754710|Tofacitinib|tofacitinib|mesh-list
154295279|NCT05754710|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154295280|NCT05754710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295281|NCT05754710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295282|NCT05754710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295283|NCT05732532|Dexamethasone|dexamethasone|mesh-list
154295284|NCT05732532|Lidocaine|lidocaine|mesh-list
154295285|NCT05732532|Bupivacaine|bupivacaine|mesh-list
154295286|NCT05732532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154295287|NCT05732532|Antiemetics|antiemetics|mesh-ancestor
154295288|NCT05732532|Autonomic Agents|autonomic agents|mesh-ancestor
154295289|NCT05732532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295290|NCT05732532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295291|NCT05732532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154295292|NCT05732532|Glucocorticoids|glucocorticoids|mesh-ancestor
154295293|NCT05732532|Hormones|hormones|mesh-ancestor
154295294|NCT05732532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295295|NCT05732532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154295308|NCT05711940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295309|NCT05711940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154295320|NCT05705349|Islatravir|islatravir|mesh-list
154295321|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
154295322|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295323|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295324|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295325|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154295326|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154295327|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154295328|NCT05704933|Nivolumab|nivolumab|mesh-list
154295329|NCT05704933|Ipilimumab|ipilimumab|mesh-list
154295330|NCT05704933|Relatlimab|relatlimab|mesh-list
154295331|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295332|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295333|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295334|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295335|NCT05696691|Ketamine|ketamine|mesh-list
154295336|NCT05696691|Analgesics|analgesics|mesh-ancestor
154295337|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
154295338|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295360|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295361|NCT05688670|Anesthetics, Local|anesthetics, local|mesh-ancestor
154295362|NCT05688670|Sensory System Agents|sensory system agents|mesh-ancestor
154295363|NCT05688670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295364|NCT05685628|Charcoal|charcoal|mesh-list
154295365|NCT05685628|Antidotes|antidotes|mesh-ancestor
154295366|NCT05685628|Protective Agents|protective agents|mesh-ancestor
154295367|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295368|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
154295369|NCT05665062|Fludarabine|fludarabine|mesh-list
154295370|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295371|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
154295372|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295373|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295374|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154295375|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
154295376|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295377|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295378|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154295379|NCT05664711|Bupivacaine|bupivacaine|mesh-list
154295380|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
154295381|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
154295382|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295383|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295384|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
154295385|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295386|NCT05663957|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154295387|NCT05663957|Antiviral Agents|antiviral agents|mesh-ancestor
154295388|NCT05663957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295389|NCT05662228|Lorazepam|lorazepam|mesh-list
154295390|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
154295403|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
154295404|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
154295405|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295406|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154295407|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154295408|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295409|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154295410|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154295411|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154295412|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
154295413|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
154295414|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295415|NCT05649228|Capsaicin|capsaicin|mesh-list
154295416|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
154295417|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
154295418|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
154295419|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295420|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295421|NCT05632133|Ibuprofen|ibuprofen|mesh-list
154295422|NCT05632133|Lacosamide|lacosamide|mesh-list
154295423|NCT05632133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154295424|NCT05632133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154295425|NCT05632133|Analgesics|analgesics|mesh-ancestor
154295426|NCT05632133|Sensory System Agents|sensory system agents|mesh-ancestor
154295427|NCT05632133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295428|NCT05632133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295434|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
154295452|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154295453|NCT05598177|Analgesics|analgesics|mesh-ancestor
154295454|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
154295455|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295456|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154295457|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154295458|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154295459|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
154295460|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295461|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295462|NCT05589363|Bupivacaine|bupivacaine|mesh-list
154295463|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
154295464|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
154295465|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295466|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295467|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
154295468|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295469|NCT05576350|Ethanol|ethanol|mesh-list
154295470|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154295471|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295472|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295473|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295475|NCT05575219|Analgesics|analgesics|mesh-ancestor
154295476|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
154295488|NCT05554380|Paclitaxel|paclitaxel|mesh-list
154295501|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295502|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154295503|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154295504|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
154295505|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295506|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295508|NCT05537233|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154295509|NCT05537233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154295510|NCT05537233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295511|NCT05512819|Vaccines|vaccines|mesh-list
154295512|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154295513|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
154295514|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295515|NCT05493709|Leuprolide|leuprolide|mesh-list
154295516|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154295522|NCT05447286|Oxycodone|oxycodone|mesh-list
154295559|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
154295560|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154295561|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
154295562|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295563|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154295564|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154295565|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
154295566|NCT05382299|Paclitaxel|paclitaxel|mesh-list
154295567|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154295568|NCT05382299|Carboplatin|carboplatin|mesh-list
154295569|NCT05382299|Gemcitabine|gemcitabine|mesh-list
154295570|NCT05382299|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154295571|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154295572|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295573|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
154295574|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
154295575|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
154295576|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295577|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295578|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
154295579|NCT05382299|Immunoconjugates|immunoconjugates|mesh-ancestor
154295580|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
154295581|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295582|NCT05374512|Paclitaxel|paclitaxel|mesh-list
154295583|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154295584|NCT05374512|Carboplatin|carboplatin|mesh-list
154295585|NCT05374512|Capecitabine|capecitabine|mesh-list
154295586|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154295587|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295588|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
154295605|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295606|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295607|NCT05344365|Iloperidone|iloperidone|mesh-list
154295608|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154295609|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154295610|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295611|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295612|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154295613|NCT05342636|Paclitaxel|paclitaxel|mesh-list
154295614|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
154295615|NCT05342636|Irinotecan|irinotecan|mesh-list
154295616|NCT05342636|Lenvatinib|lenvatinib|mesh-list
154295617|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
154295618|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154295619|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295620|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
154295621|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
154295622|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
154042435|NCT00680160|Tavaborole|tavaborole|mesh-list
154295623|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295624|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295625|NCT05342636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295626|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154295627|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154295628|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295629|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
154295630|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295631|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295632|NCT05327010|Talazoparib|talazoparib|mesh-list
154295633|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154295634|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295635|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295636|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295637|NCT05324358|Ketorolac|ketorolac|mesh-list
154295638|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154295639|NCT05324358|Morphine|morphine|mesh-list
154295640|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154295641|NCT05324358|Narcotics|narcotics|mesh-ancestor
154295642|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295643|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295644|NCT05324358|Analgesics|analgesics|mesh-ancestor
154295645|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
154295646|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295647|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154295648|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154295649|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154295650|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295651|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154295652|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295653|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295654|NCT05313529|Metformin|metformin|mesh-list
154295655|NCT05313529|Liraglutide|liraglutide|mesh-list
154295656|NCT05313529|Empagliflozin|empagliflozin|mesh-list
154295657|NCT05313529|Linagliptin|linagliptin|mesh-list
154295658|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154295659|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295660|NCT05313529|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154295661|NCT05313529|Incretins|incretins|mesh-ancestor
154295662|NCT05313529|Hormones|hormones|mesh-ancestor
154295663|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295664|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154295665|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295666|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154295667|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
154295668|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295669|NCT05270213|Pembrolizumab|pembrolizumab|mesh-list
154295670|NCT05270213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295671|NCT05270213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295672|NCT05270213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295673|NCT05270213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295678|NCT05239741|Fluorouracil|fluorouracil|mesh-list
154295679|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
154295680|NCT05239741|Irinotecan|irinotecan|mesh-list
154295681|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295682|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295683|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154295684|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154295685|NCT05239741|Growth Substances|growth substances|mesh-ancestor
154295686|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295687|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
154295688|NCT05239741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295689|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295690|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
154295691|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295692|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295693|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
154295694|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154295695|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154042513|NCT00684216|Tamoxifen|tamoxifen|mesh-list
154295696|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295697|NCT05239741|Antidotes|antidotes|mesh-ancestor
154295698|NCT05239741|Protective Agents|protective agents|mesh-ancestor
154295699|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
154295700|NCT05239741|Vitamins|vitamins|mesh-ancestor
154295701|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
154295702|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
154295703|NCT05217446|Cetuximab|cetuximab|mesh-list
154295728|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
154295729|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295730|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154295731|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154295732|NCT05211323|Growth Substances|growth substances|mesh-ancestor
154295733|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295734|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
154295735|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
154295736|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295737|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
154295738|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295739|NCT05211323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295740|NCT05190094|Letrozole|letrozole|mesh-list
154295741|NCT05190094|Palbociclib|palbociclib|mesh-list
154295742|NCT05190094|Anastrozole|anastrozole|mesh-list
154295743|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154295744|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295745|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154295746|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295747|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295748|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154295749|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
154295750|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295751|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295752|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295753|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154295754|NCT05172570|Gabapentin|gabapentin|mesh-list
154295755|NCT05172570|Analgesics|analgesics|mesh-ancestor
154295756|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
154295757|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295768|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
154295769|NCT05171816|Olaparib|olaparib|mesh-list
154295770|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
154295771|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154295772|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295773|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295774|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295775|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154295776|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
154295777|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154295778|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295779|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154295780|NCT05170438|Paclitaxel|paclitaxel|mesh-list
154295781|NCT05170438|Lenvatinib|lenvatinib|mesh-list
154295782|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154295783|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295784|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
154295785|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
154295786|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
154295787|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295788|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295789|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295790|NCT05147805|Treprostinil|treprostinil|mesh-list
154295791|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154295792|NCT05139017|Rituximab|rituximab|mesh-list
154295793|NCT05139017|Gemcitabine|gemcitabine|mesh-list
154295794|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
154295795|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154295796|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295797|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295810|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295811|NCT05125328|Remifentanil|remifentanil|mesh-list
154295812|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154295813|NCT05125328|Narcotics|narcotics|mesh-ancestor
154295814|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295815|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295816|NCT05125328|Analgesics|analgesics|mesh-ancestor
154295817|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
154295818|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295819|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154295820|NCT05114746|Pluvicto|pluvicto|mesh-list
154295821|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154295822|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295823|NCT05111574|Nivolumab|nivolumab|mesh-list
154295824|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295825|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295828|NCT05103215|Lidocaine|lidocaine|mesh-list
154295867|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154295869|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295870|NCT05081479|Protective Agents|protective agents|mesh-ancestor
154295871|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295872|NCT05081479|Antidotes|antidotes|mesh-ancestor
154295873|NCT05067283|Leucovorin|leucovorin|mesh-list
154295874|NCT05067283|Carboplatin|carboplatin|mesh-list
154295875|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
154295876|NCT05067283|Fluorouracil|fluorouracil|mesh-list
154295877|NCT05067283|Oxaliplatin|oxaliplatin|mesh-list
154295878|NCT05067283|Pemetrexed|pemetrexed|mesh-list
154295879|NCT05067283|Cetuximab|cetuximab|mesh-list
154295880|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295881|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295882|NCT05067283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295883|NCT05067283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295884|NCT05067283|Antimetabolites|antimetabolites|mesh-ancestor
154295885|NCT05067283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154295886|NCT05067283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295887|NCT05067283|Immunologic Factors|immunologic factors|mesh-ancestor
154295888|NCT05067283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295889|NCT05067283|Antidotes|antidotes|mesh-ancestor
154295890|NCT05067283|Protective Agents|protective agents|mesh-ancestor
154295891|NCT05067283|Vitamin B Complex|vitamin b complex|mesh-ancestor
154295892|NCT05067283|Vitamins|vitamins|mesh-ancestor
154295893|NCT05067283|Micronutrients|micronutrients|mesh-ancestor
154295894|NCT05067283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295916|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154295917|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154295918|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154295919|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
154295920|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154295921|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154295922|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
154295923|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154295924|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
154295925|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
154295926|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
154295927|NCT05027945|Sirolimus|sirolimus|mesh-list
154295928|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
154295929|NCT05027945|Busulfan|busulfan|mesh-list
154295930|NCT05027945|Fludarabine|fludarabine|mesh-list
154295931|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154295932|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
154295933|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295934|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154295935|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154295936|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
154295937|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295938|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295939|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154295940|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154295941|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154295942|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
154295943|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154295944|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295945|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154295946|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
154295947|NCT05024747|Nicotine|nicotine|mesh-list
154295948|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154295949|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
154295950|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295952|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154295956|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295957|NCT04962152|Nalbuphine|nalbuphine|mesh-list
154295958|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154295959|NCT04962152|Narcotics|narcotics|mesh-ancestor
154295960|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154295961|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295962|NCT04962152|Analgesics|analgesics|mesh-ancestor
154295963|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
154295964|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295965|NCT04938830|Palivizumab|palivizumab|mesh-list
154295966|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
154295967|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154295968|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
154295969|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295970|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295971|NCT04895722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295972|NCT04895722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295973|NCT04876248|Lenalidomide|lenalidomide|mesh-list
154295974|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
154295975|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154295976|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154295977|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154295978|NCT04876248|Growth Substances|growth substances|mesh-ancestor
154295979|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
154295980|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295981|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
154295982|NCT04869137|Lenvatinib|lenvatinib|mesh-list
154295983|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154295984|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154295985|NCT04869137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154295986|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154295987|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154295998|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154295999|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296000|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
154296001|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154296002|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154296003|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296004|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154296005|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154296006|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154296007|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154296008|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154296009|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154296010|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
154296011|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154296012|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154296013|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
154296014|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154296015|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
154296016|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
154296017|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296018|NCT04827576|Docetaxel|docetaxel|mesh-list
154296019|NCT04827576|Magrolimab|magrolimab|mesh-list
154296020|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296021|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
154296022|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
154296023|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
154296026|NCT04770896|Sorafenib|sorafenib|mesh-list
154296043|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296044|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154296045|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296046|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154296047|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154296048|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154296050|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154296051|NCT04740580|Glycine|glycine|mesh-list
154296052|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
154296053|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296054|NCT04740580|Expectorants|expectorants|mesh-ancestor
154296055|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
154296056|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154296057|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
154296058|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296059|NCT04740580|Protective Agents|protective agents|mesh-ancestor
154296060|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296061|NCT04740580|Antidotes|antidotes|mesh-ancestor
154296099|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296100|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296101|NCT04665739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296102|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154296103|NCT04665739|Antimetabolites|antimetabolites|mesh-ancestor
154296104|NCT04665739|Antiviral Agents|antiviral agents|mesh-ancestor
154296105|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
154296106|NCT04626479|Lenvatinib|lenvatinib|mesh-list
154296107|NCT04626479|Belzutifan|belzutifan|mesh-list
154296108|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296109|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296110|NCT04626479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296111|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296112|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296113|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296114|NCT04610866|Mitapivat|mitapivat|mesh-list
154296115|NCT04610866|Enzyme Activators|enzyme activators|mesh-ancestor
154296116|NCT04610866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296117|NCT04602078|Gemcitabine|gemcitabine|mesh-list
154296118|NCT04602078|Atezolizumab|atezolizumab|mesh-list
154296119|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296120|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296121|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
154296122|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296123|NCT04602078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296124|NCT04602078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296125|NCT04586335|Olaparib|olaparib|mesh-list
154296126|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154042956|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296146|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
154296147|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
154296148|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296149|NCT04579224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154296150|NCT04579224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154296151|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296152|NCT04577755|Thalidomide|thalidomide|mesh-list
154296153|NCT04577755|Pomalidomide|pomalidomide|mesh-list
154296154|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
154296155|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296156|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154296157|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154296158|NCT04577755|Growth Substances|growth substances|mesh-ancestor
154296159|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
154296160|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296161|NCT04577755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296162|NCT04577755|Leprostatic Agents|leprostatic agents|mesh-ancestor
154296163|NCT04577755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154296164|NCT04577755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296165|NCT04574947|Lidocaine|lidocaine|mesh-list
154296166|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
154296167|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
154296168|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154296169|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296170|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
154296171|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296172|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154296173|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154296174|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154296175|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154296176|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296177|NCT04572815|Interleukin-12|interleukin-12|mesh-list
154296178|NCT04572815|Ustekinumab|ustekinumab|mesh-list
154296193|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296194|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296195|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154296234|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296235|NCT04411654|Sirolimus|sirolimus|mesh-list
154296236|NCT04411654|Prednisone|prednisone|mesh-list
154296237|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
154296238|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154296239|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154296240|NCT04411654|Prednisolone|prednisolone|mesh-list
154296241|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
154296242|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154296243|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
154296244|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154296245|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
154296246|NCT04411654|Hormones|hormones|mesh-ancestor
154296247|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154296248|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296249|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154296250|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296251|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154296252|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296253|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154296254|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
154296255|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296256|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
154296257|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
154296258|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
154296259|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296260|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154296261|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154296281|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296282|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296283|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296284|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296285|NCT04300127|Pioglitazone|pioglitazone|mesh-list
154296286|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154296287|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296288|NCT04294264|Trifluridine|trifluridine|mesh-list
154296289|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
154296290|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296291|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
154296292|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296293|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
154296294|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296295|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
154296296|NCT04284787|Azacitidine|azacitidine|mesh-list
154296297|NCT04284787|Venetoclax|venetoclax|mesh-list
154296298|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296299|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296300|NCT04284787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296301|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296302|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296303|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
154296304|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296305|NCT04245215|Ustekinumab|ustekinumab|mesh-list
154296306|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
154296307|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154296308|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154296309|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296310|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
154296311|NCT04157985|Nivolumab|nivolumab|mesh-list
154296312|NCT04157985|Ipilimumab|ipilimumab|mesh-list
154296313|NCT04157985|Atezolizumab|atezolizumab|mesh-list
154296314|NCT04157985|Cemiplimab|cemiplimab|mesh-list
154296317|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296341|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
154296342|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
154296343|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296344|NCT04042935|Protective Agents|protective agents|mesh-ancestor
154296345|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296346|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
154296347|NCT04042935|Vitamins|vitamins|mesh-ancestor
154296348|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
154296349|NCT04019197|Semaglutide|semaglutide|mesh-list
154296350|NCT04019197|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154296351|NCT04019197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154296352|NCT04019197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296353|NCT03975647|Tucatinib|tucatinib|mesh-list
154296354|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296355|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296356|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296357|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296358|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
154296359|NCT03968393|Apixaban|apixaban|mesh-list
154296360|NCT03968393|Edoxaban|edoxaban|mesh-list
154296362|NCT03968393|Anticoagulants|anticoagulants|mesh-list
154296363|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154296364|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
154296365|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154296366|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
154296367|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296368|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296370|NCT03907046|Apixaban|apixaban|mesh-list
154296371|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154296372|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154296373|NCT03907046|Analgesics|analgesics|mesh-ancestor
154296374|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
154296375|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296376|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296377|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154296378|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296379|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154296380|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154296381|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296382|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154296383|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154296384|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296385|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
154296386|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154296387|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
154296388|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154296389|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
154296390|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
154296406|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296407|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296408|NCT03854474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296409|NCT03854474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296411|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
154296412|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154296413|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296414|NCT03842696|Cyclosporine|cyclosporine|mesh-list
154296415|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
154296416|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
154296417|NCT03842696|Methotrexate|methotrexate|mesh-list
154296418|NCT03842696|Vorinostat|vorinostat|mesh-list
154296419|NCT03842696|Tacrolimus|tacrolimus|mesh-list
154296420|NCT03842696|Cyclosporins|cyclosporins|mesh-list
154296421|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296422|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
154296423|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296424|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296425|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154296426|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
154296427|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296428|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296429|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154296430|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154296431|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
154296432|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154296433|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296434|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
154296435|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
154296436|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296437|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154296438|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154296439|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154296440|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
154296445|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154296446|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154296447|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154296448|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154296449|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296451|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154296452|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296453|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154296454|NCT03816176|Isavuconazole|isavuconazole|mesh-list
154296455|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
154296456|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296457|NCT03772925|Belinostat|belinostat|mesh-list
154296458|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154296459|NCT03772925|Pevonedistat|pevonedistat|mesh-list
154296460|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296461|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296462|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154296463|NCT03738228|Cisplatin|cisplatin|mesh-list
154296464|NCT03738228|Atezolizumab|atezolizumab|mesh-list
154296499|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
154296500|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296501|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296502|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154296503|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
154296504|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296505|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296506|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154296507|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
154296508|NCT03486873|Lenvatinib|lenvatinib|mesh-list
154296509|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296510|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296511|NCT03486873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296512|NCT03486873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296513|NCT03486873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296514|NCT03486873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296515|NCT03434262|Gemcitabine|gemcitabine|mesh-list
154296516|NCT03434262|Trametinib|trametinib|mesh-list
154296517|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296518|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
154296519|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296520|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296521|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296522|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296523|NCT03391869|Nivolumab|nivolumab|mesh-list
154296524|NCT03391869|Ipilimumab|ipilimumab|mesh-list
154296525|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296526|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296527|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296528|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296529|NCT03347838|Nivolumab|nivolumab|mesh-list
154296530|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296539|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
154296540|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296541|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296542|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
154296543|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296544|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
154296545|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296546|NCT03204786|Vasopressins|vasopressins|mesh-list
154296547|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
154296548|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
154296549|NCT03204786|Coagulants|coagulants|mesh-ancestor
154296550|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154296551|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154296552|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
153461128|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461129|NCT01679106|Analgesics|analgesics|mesh-ancestor
153461130|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
154296553|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296554|NCT03157804|Plerixafor|plerixafor|mesh-list
154296555|NCT03157804|Lenograstim|lenograstim|mesh-list
154296556|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154296557|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
154296558|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296559|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154296560|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154296561|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
154296562|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296563|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
154296564|NCT03149029|Trametinib|trametinib|mesh-list
154296565|NCT03149029|Dabrafenib|dabrafenib|mesh-list
154296566|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296567|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296568|NCT03149029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296569|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296570|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296571|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296572|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
154296573|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
154296574|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154296575|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154296579|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296580|NCT02978625|Nivolumab|nivolumab|mesh-list
154296581|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154296582|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296583|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296584|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296585|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296586|NCT02965027|Prazosin|prazosin|mesh-list
154296587|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154296588|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154296589|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154296590|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154296591|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
154296592|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154296593|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296594|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296595|NCT02926196|Avelumab|avelumab|mesh-list
154296596|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296597|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296598|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
154296599|NCT02912559|Leucovorin|leucovorin|mesh-list
154296600|NCT02912559|Folic Acid|folic acid|mesh-list
154296601|NCT02912559|Fluorouracil|fluorouracil|mesh-list
154296602|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
154296603|NCT02912559|Atezolizumab|atezolizumab|mesh-list
154296604|NCT02912559|Calcium|calcium|mesh-list
154296605|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154296606|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
154296628|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296629|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296630|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296631|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
154296632|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296633|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
154296634|NCT02875314|Thiotepa|thiotepa|mesh-list
154296635|NCT02875314|Cisplatin|cisplatin|mesh-list
154296636|NCT02875314|Carboplatin|carboplatin|mesh-list
154296637|NCT02875314|Methotrexate|methotrexate|mesh-list
154296638|NCT02875314|Etoposide|etoposide|mesh-list
154296639|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
154296640|NCT02875314|Vincristine|vincristine|mesh-list
154296641|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296642|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
154296643|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296644|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296645|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154296646|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
154296647|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296648|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296649|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154296650|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154296651|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
154296652|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154296653|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154296654|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
154296665|NCT02689440|Venetoclax|venetoclax|mesh-list
154296676|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154296677|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154296678|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296679|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296680|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296681|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154296683|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154296684|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154296685|NCT02631733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154296687|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296688|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296689|NCT02625961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296690|NCT02625961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296691|NCT02576223|Morphine|morphine|mesh-list
154296692|NCT02576223|Ropivacaine|ropivacaine|mesh-list
154296693|NCT02576223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154296694|NCT02576223|Narcotics|narcotics|mesh-ancestor
154296695|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154296696|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296697|NCT02576223|Analgesics|analgesics|mesh-ancestor
154296698|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
154296699|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296700|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
154296701|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
154296702|NCT02567435|Sirolimus|sirolimus|mesh-list
154296703|NCT02567435|Dactinomycin|dactinomycin|mesh-list
154296704|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
154296705|NCT02567435|Irinotecan|irinotecan|mesh-list
154296706|NCT02567435|Vincristine|vincristine|mesh-list
154296707|NCT02567435|Temsirolimus|temsirolimus|mesh-list
154296708|NCT02567435|Vinorelbine|vinorelbine|mesh-list
154296709|NCT02567435|Camptothecin|camptothecin|mesh-list
154296719|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154296720|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154296721|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154296722|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296723|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154296724|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
154296725|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
154296726|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
154296727|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154296728|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296729|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154296730|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
154296731|NCT02567435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296732|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154296733|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154296734|NCT02496663|Osimertinib|osimertinib|mesh-list
154296735|NCT02496663|Necitumumab|necitumumab|mesh-list
154296736|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154296737|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296738|NCT02496663|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154296739|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296740|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296741|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296742|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296743|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
154296744|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461151|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154296745|NCT02407509|Everolimus|everolimus|mesh-list
154296746|NCT02407509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154296747|NCT02407509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296748|NCT02407509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296749|NCT02407509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296750|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296751|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
154296752|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296753|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296757|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154296758|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154296760|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
154296761|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296762|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296763|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154296764|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296765|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154296766|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154296767|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296768|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154296769|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154296770|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296771|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
154296772|NCT02337530|Carboplatin|carboplatin|mesh-list
154296773|NCT02337530|Pemetrexed|pemetrexed|mesh-list
154296774|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296775|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296776|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296777|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154296778|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154296779|NCT02275780|Ritonavir|ritonavir|mesh-list
154296780|NCT02275780|Darunavir|darunavir|mesh-list
154296781|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154296782|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154296783|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154296784|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
154296801|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296803|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296804|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
154296805|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296806|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154296807|NCT02051218|Denosumab|denosumab|mesh-list
154296808|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154296809|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296810|NCT01738139|Ipilimumab|ipilimumab|mesh-list
154296811|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
154296812|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296813|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296814|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154296815|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296816|NCT01738139|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154296817|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296818|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296819|NCT01712620|Spironolactone|spironolactone|mesh-list
154296820|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154296821|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
154296822|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154296823|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296824|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154296825|NCT01712620|Diuretics|diuretics|mesh-ancestor
154296826|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
154296827|NCT01493570|BI 409306|bi 409306|mesh-list
154296828|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154296829|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296845|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154296846|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296847|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296848|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296849|NCT00694850|Riociguat|riociguat|mesh-list
154296850|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
154296851|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296852|NCT00604708|Vaccines|vaccines|mesh-list
154296853|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
154296854|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296855|NCT00600496|Sirolimus|sirolimus|mesh-list
154296856|NCT00600496|Docetaxel|docetaxel|mesh-list
154296857|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154296858|NCT00600496|Temsirolimus|temsirolimus|mesh-list
154296859|NCT00600496|Dacarbazine|dacarbazine|mesh-list
154296860|NCT00600496|MTOR Inhibitors|mtor inhibitors|mesh-list
154296861|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296862|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
154296863|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
154296864|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
154296865|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296866|NCT00600496|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154296867|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154296868|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296869|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296896|NCT00092222|Sirolimus|sirolimus|mesh-list
154296897|NCT00092222|Prednisone|prednisone|mesh-list
154296898|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
154296899|NCT00092222|Rituximab|rituximab|mesh-list
154296900|NCT00092222|Doxorubicin|doxorubicin|mesh-list
154296901|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154296902|NCT00092222|Etoposide|etoposide|mesh-list
154296903|NCT00092222|Vincristine|vincristine|mesh-list
154296904|NCT00092222|Bortezomib|bortezomib|mesh-list
154296905|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154296906|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
154296907|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296908|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154296909|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154296910|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
154296911|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296912|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154296913|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154296914|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154296915|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154296916|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154296917|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154296918|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154296919|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154296920|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
154296921|NCT00092222|Hormones|hormones|mesh-ancestor
154296922|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154296923|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154296924|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154296925|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
154296926|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154296927|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
154296928|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
154296929|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
154296954|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154296955|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154296956|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296957|NCT03658330|Naltrexone|naltrexone|mesh-list
154296958|NCT03658330|Ketamine|ketamine|mesh-list
154296959|NCT03658330|Analgesics|analgesics|mesh-ancestor
154296960|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
154296961|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296962|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296963|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154296964|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154296965|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
154296966|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
154296967|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154296968|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154296969|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154296970|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154296971|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296972|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154296973|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154296974|NCT02920528|Ketamine|ketamine|mesh-list
154296975|NCT02920528|Analgesics|analgesics|mesh-ancestor
154296976|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
154296977|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154296978|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296979|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154296981|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
154296982|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
154296983|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154296984|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154296985|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154296986|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154296987|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154296988|NCT01068418|Vitamin D|vitamin d|mesh-list
154296989|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
154296990|NCT01068418|Vitamins|vitamins|mesh-ancestor
154296991|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
154296992|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296993|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154296994|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154296995|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
154296996|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154296997|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154296998|NCT03657550|Niacin|niacin|mesh-list
154296999|NCT03657550|Amlodipine|amlodipine|mesh-list
154297000|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154297001|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154297002|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154297003|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297004|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154297005|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297006|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
154297007|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154297008|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
154297009|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154297010|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
154297011|NCT03657550|Vitamins|vitamins|mesh-ancestor
154297012|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
154297013|NCT02920450|Paclitaxel|paclitaxel|mesh-list
154297014|NCT02920450|Carboplatin|carboplatin|mesh-list
154297015|NCT02920450|Gedatolisib|gedatolisib|mesh-list
154297016|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154297024|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
154297025|NCT03622450|Levofloxacin|levofloxacin|mesh-list
154297026|NCT03622450|Gentamicins|gentamicins|mesh-list
154297027|NCT03622450|Meropenem|meropenem|mesh-list
154297028|NCT03622450|Amikacin|amikacin|mesh-list
154297029|NCT03622450|Colistin|colistin|mesh-list
154297030|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154297031|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297032|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154297033|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154297034|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297035|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297036|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297037|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154297038|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154297039|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154297040|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154297041|NCT03657862|Fluorides|fluorides|mesh-list
154297042|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
154297043|NCT03657862|Protective Agents|protective agents|mesh-ancestor
154297044|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297045|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
154297046|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154297047|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297048|NCT02730130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154297049|NCT02730130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297050|NCT02919436|Tamsulosin|tamsulosin|mesh-list
154297051|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154297052|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154297053|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154297054|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
154297055|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297058|NCT02919436|Urological Agents|urological agents|mesh-ancestor
154297065|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154297066|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154297067|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297068|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154297069|NCT04438330|Nickel|nickel|mesh-list
154297070|NCT04438330|Trace Elements|trace elements|mesh-ancestor
154297071|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
154297072|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297073|NCT03803475|Edetic Acid|edetic acid|mesh-list
154297074|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154297075|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
154297076|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
154297077|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297078|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
154297079|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154297080|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154297081|NCT02682004|Serotonin|serotonin|mesh-list
154297082|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154297083|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
154297084|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297085|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297086|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297087|NCT00005937|Cyclosporine|cyclosporine|mesh-list
154297088|NCT00005937|Cyclosporins|cyclosporins|mesh-list
154297089|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154297090|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297106|NCT01096329|Hormones|hormones|mesh-ancestor
154297114|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154297115|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297116|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
154297117|NCT02908516|Coagulants|coagulants|mesh-ancestor
154297118|NCT03717350|Meropenem|meropenem|mesh-list
154297119|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154297120|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297121|NCT03713372|Antibodies|antibodies|mesh-list
154297122|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154297123|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
154297124|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297125|NCT03656614|Neostigmine|neostigmine|mesh-list
154297126|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154297127|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297128|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297129|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
154297130|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297173|NCT03712670|Aflibercept|aflibercept|mesh-list
154297174|NCT03712670|Carotenoids|carotenoids|mesh-list
154297175|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154297176|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154297177|NCT03712670|Growth Substances|growth substances|mesh-ancestor
154297178|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297179|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
154297180|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297181|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
154297182|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297183|NCT03712670|Protective Agents|protective agents|mesh-ancestor
154297184|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154297185|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154297186|NCT03712670|Analgesics|analgesics|mesh-ancestor
154297187|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
154297188|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297189|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154297190|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297191|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
154297192|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
154297193|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154297194|NCT03486392|Liraglutide|liraglutide|mesh-list
154297195|NCT03486392|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154297196|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154297197|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297198|NCT03486392|Incretins|incretins|mesh-ancestor
154297199|NCT03486392|Hormones|hormones|mesh-ancestor
154297200|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297201|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
154297202|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
154043995|NCT00724672|Adalimumab|adalimumab|mesh-list
154297203|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
154297204|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297205|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154297206|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297207|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154297208|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
154297209|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297210|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297211|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154297212|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154297213|NCT02981524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154297215|NCT04297150|Apixaban|apixaban|mesh-list
154297216|NCT04297150|Edoxaban|edoxaban|mesh-list
154297217|NCT04297150|Dabigatran|dabigatran|mesh-list
154297218|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154297219|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
154297220|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154297221|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
154297222|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297223|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297224|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
154297225|NCT03486314|Rifampin|rifampin|mesh-list
154297226|NCT03486314|Paclitaxel|paclitaxel|mesh-list
154297227|NCT03486314|Docetaxel|docetaxel|mesh-list
154297228|NCT03486314|Carboplatin|carboplatin|mesh-list
154297229|NCT03486314|Pevonedistat|pevonedistat|mesh-list
154297230|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154297231|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297232|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
154297233|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
154297234|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
154297235|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297236|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154297237|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
154297238|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154297239|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297240|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
154297241|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154297242|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297243|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154297251|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297252|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297253|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297254|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154297255|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154297256|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
154297257|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154297258|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154297259|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154297260|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297261|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297262|NCT02980042|Rituximab|rituximab|mesh-list
154297263|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
154297264|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154297265|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297266|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
154297267|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297268|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297269|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
154297270|NCT01066000|Hematinics|hematinics|mesh-ancestor
154297271|NCT01065844|Nelfinavir|nelfinavir|mesh-list
154297272|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154297273|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154297274|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
154297302|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297303|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297304|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154297305|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
154297306|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297307|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297308|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154297309|NCT03951051|Olmesartan|olmesartan|mesh-list
154297310|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154297311|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154297312|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154297313|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154297314|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297315|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
154297316|NCT01103115|Vitamin D|vitamin d|mesh-list
154297317|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
154297318|NCT01103115|Calcium|calcium|mesh-list
154297319|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154297320|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297321|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154297322|NCT01103115|Vitamins|vitamins|mesh-ancestor
154297323|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
154297324|NCT01103115|Antacids|antacids|mesh-ancestor
153819751|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153819752|NCT00430079|Etanidazole|etanidazole|mesh-list
153819753|NCT00430079|Imidazole|imidazole|mesh-list
154297325|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297326|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154297327|NCT01103193|Remifentanil|remifentanil|mesh-list
154297328|NCT01103193|Sevoflurane|sevoflurane|mesh-list
154297329|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154297330|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154297331|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
154297346|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
154297347|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297348|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297349|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154297350|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
154297351|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
154297352|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
154297353|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154297354|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154297355|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
154297356|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297357|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297358|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
154297359|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154297360|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
154297361|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154297362|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297363|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154297364|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154297365|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154297366|NCT00003645|Leuprolide|leuprolide|mesh-list
154297367|NCT00003645|Goserelin|goserelin|mesh-list
154297368|NCT00003645|Flutamide|flutamide|mesh-list
154297369|NCT00003645|Bicalutamide|bicalutamide|mesh-list
154297370|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154297371|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
154297372|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154297373|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297374|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154297375|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297391|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297392|NCT01065766|Incretins|incretins|mesh-ancestor
154297393|NCT01065766|Hormones|hormones|mesh-ancestor
154297394|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297395|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154297396|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
154297397|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297398|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297399|NCT03653260|Lidocaine|lidocaine|mesh-list
154297400|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
154297401|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
154297402|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297403|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297404|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
154297405|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402379|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461174|NCT01679574|Metformin|metformin|mesh-list
154297406|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154297407|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154297408|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154297409|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154297410|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297411|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154297412|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154297413|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154297414|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297415|NCT04054960|Levodopa|levodopa|mesh-list
154297416|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154297417|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154297418|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
154297419|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297420|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297429|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297430|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
154297431|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297432|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297433|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154297434|NCT02530047|Interferons|interferons|mesh-list
154297435|NCT02530047|Interferon-beta|interferon-beta|mesh-list
154297436|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297437|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
154297438|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297439|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
154297440|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297441|NCT02529969|Curcumin|curcumin|mesh-list
154297442|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154297443|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154297444|NCT02529969|Analgesics|analgesics|mesh-ancestor
154297445|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
154297446|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297447|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297448|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154297449|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297450|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297451|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297452|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297453|NCT01584687|Omalizumab|omalizumab|mesh-list
154297454|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154297455|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154297456|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
154297457|NCT01101789|Triclosan|triclosan|mesh-list
154297473|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154297474|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297475|NCT04054024|Erenumab|erenumab|mesh-list
154297476|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154297477|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297478|NCT04054024|Analgesics|analgesics|mesh-ancestor
154297479|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
154297480|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297481|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297482|NCT00002931|Paclitaxel|paclitaxel|mesh-list
154297483|NCT00002931|Etoposide|etoposide|mesh-list
154297484|NCT00002931|Carboplatin|carboplatin|mesh-list
154297485|NCT00002931|Ifosfamide|ifosfamide|mesh-list
154297486|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154297487|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297488|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
154297489|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
154297490|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
154297491|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297492|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153781764|NCT04559308|Paclitaxel|paclitaxel|mesh-list
153781765|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
153402466|NCT05186779|Progestins|progestins|mesh-list
154297493|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154297494|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297495|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154297496|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
154297497|NCT02918266|Scopolamine|scopolamine|mesh-list
154297498|NCT02918266|Donepezil|donepezil|mesh-list
154297499|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154297500|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154297501|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297502|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297503|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
154297504|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297508|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
154297514|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154297515|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
154297517|NCT00041067|Trastuzumab|trastuzumab|mesh-list
154297518|NCT00041067|Vinorelbine|vinorelbine|mesh-list
154297519|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297520|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
154297521|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
154297522|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
154297523|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297524|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154297525|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154297526|NCT01063036|Tenofovir|tenofovir|mesh-list
154297527|NCT01063036|Entecavir|entecavir|mesh-list
154297528|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
154297529|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297530|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154297531|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154297532|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297572|NCT02974114|Analgesics|analgesics|mesh-ancestor
154297573|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
154297574|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297575|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297576|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
154044370|NCT03322267|Cisplatin|cisplatin|mesh-list
154297577|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154297578|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154297579|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297580|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297581|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154297582|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154297583|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
154297584|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297585|NCT00001959|Pirfenidone|pirfenidone|mesh-list
154297586|NCT00001959|Analgesics|analgesics|mesh-ancestor
154297587|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
154297588|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297589|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297590|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154297591|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154297592|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154297593|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297594|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297595|NCT03950505|Pioglitazone|pioglitazone|mesh-list
154297596|NCT03950505|Alogliptin|alogliptin|mesh-list
154297597|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154297598|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297599|NCT03950505|Incretins|incretins|mesh-ancestor
154297600|NCT03950505|Hormones|hormones|mesh-ancestor
154297601|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297614|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
154297615|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154297616|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297617|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154297618|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154297619|NCT01061866|Growth Substances|growth substances|mesh-ancestor
154297620|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
154297621|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297622|NCT03652714|Anesthetics|anesthetics|mesh-list
154297623|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
154297624|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297625|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297626|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
154297627|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297628|NCT03948477|Pantoprazole|pantoprazole|mesh-list
154297629|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154297630|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154297631|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154297632|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297633|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297634|NCT03953781|Levetiracetam|levetiracetam|mesh-list
154297635|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
154297636|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
154297637|NCT01103817|Vitamin D|vitamin d|mesh-list
154297638|NCT01103817|Vitamins|vitamins|mesh-ancestor
154297639|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
154297640|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297641|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154297642|NCT01102101|Remifentanil|remifentanil|mesh-list
154297643|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154297644|NCT01102101|Narcotics|narcotics|mesh-ancestor
154297645|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297658|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154297659|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297661|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154297662|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
154297663|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154297664|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154297665|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
154297666|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297667|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781766|NCT04559308|Doxorubicin|doxorubicin|mesh-list
154297668|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154297669|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154297670|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
154297671|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297672|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154297673|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154297674|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154297675|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154297676|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154297677|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154297678|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
154297679|NCT01482286|Metformin|metformin|mesh-list
154297680|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154297681|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297682|NCT03651934|Iron|iron|mesh-list
154297683|NCT03651934|Selenium|selenium|mesh-list
154297684|NCT03651934|Trace Elements|trace elements|mesh-ancestor
154297685|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
154297686|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297687|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
154297688|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297689|NCT03651934|Protective Agents|protective agents|mesh-ancestor
154297690|NCT02972632|Vortioxetine|vortioxetine|mesh-list
154297700|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297701|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297703|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154297704|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154297705|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154297706|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154297707|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
154297708|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
154297709|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
154297710|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297711|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297712|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
154297713|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297714|NCT01327521|Cisplatin|cisplatin|mesh-list
154297715|NCT01327521|Gemcitabine|gemcitabine|mesh-list
154297716|NCT01327521|Doxorubicin|doxorubicin|mesh-list
154297717|NCT01327521|Fluorouracil|fluorouracil|mesh-list
154297718|NCT01327521|Epirubicin|epirubicin|mesh-list
154297719|NCT01327521|Mitomycins|mitomycins|mesh-list
154297720|NCT01327521|Mitomycin|mitomycin|mesh-list
154297721|NCT01327521|Maleic acid|maleic acid|mesh-list
154297722|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297723|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154297724|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
154297725|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297726|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154297727|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154297728|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154297747|NCT03944733|Trace Elements|trace elements|mesh-ancestor
154297748|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
154297749|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297750|NCT01060150|Methylphenidate|methylphenidate|mesh-list
154297751|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154297752|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297753|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154297754|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154297755|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154297756|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297757|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
154297758|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297759|NCT03863223|Docetaxel|docetaxel|mesh-list
154297760|NCT03863223|Trastuzumab|trastuzumab|mesh-list
154297761|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297762|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
154297763|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
154297764|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
154297765|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297766|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154297767|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
154297768|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
154297769|NCT02970292|Pimavanserin|pimavanserin|mesh-list
154297770|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154297771|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154297772|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154297773|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154297782|NCT03944655|Anesthetics|anesthetics|mesh-list
154297794|NCT02971228|Pancrelipase|pancrelipase|mesh-list
154297795|NCT02971228|Pancreatin|pancreatin|mesh-list
154297796|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154297797|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154297798|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297799|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154297800|NCT02971228|Hormones|hormones|mesh-ancestor
154027392|NCT03003637|Nivolumab|nivolumab|mesh-list
154297801|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297802|NCT02971228|Incretins|incretins|mesh-ancestor
154297803|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154297804|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154297805|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
154297806|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154297807|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154297808|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297809|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
154297810|NCT03741075|Coagulants|coagulants|mesh-ancestor
154297811|NCT01328223|Sorafenib|sorafenib|mesh-list
154297812|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297813|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154297814|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297815|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297816|NCT01104987|Alendronate|alendronate|mesh-list
154297817|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154297818|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297819|NCT01106235|Aldesleukin|aldesleukin|mesh-list
154297820|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
154297821|NCT01106235|Interleukin-2|interleukin-2|mesh-list
154297822|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154297823|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
154297824|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297825|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297835|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154297836|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154297837|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
154297838|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154297840|NCT02969590|Norethindrone|norethindrone|mesh-list
154297841|NCT02969590|Estradiol|estradiol|mesh-list
154297842|NCT02969590|Estrogens|estrogens|mesh-list
154297843|NCT02969590|Progesterone|progesterone|mesh-list
154297844|NCT02969590|Progestins|progestins|mesh-list
154297845|NCT02969590|Hormones|hormones|mesh-ancestor
154297846|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297847|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297848|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154297849|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
154297850|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154297851|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154297852|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154297853|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
154297854|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154297855|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154297856|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154297857|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154297858|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154297859|NCT03650998|Ropivacaine|ropivacaine|mesh-list
154297860|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
154297861|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
154297862|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297863|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297864|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
154297865|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297880|NCT03345849|Upadacitinib|upadacitinib|mesh-list
154297881|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154297882|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154297883|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297884|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297885|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154297886|NCT01109043|Bisoprolol|bisoprolol|mesh-list
154297887|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154297888|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
154297889|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
154297890|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297891|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297892|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154297893|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154297894|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154297895|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
154297896|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297897|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297898|NCT01109121|Allopurinol|allopurinol|mesh-list
154297899|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
154297900|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297901|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297931|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154297932|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154297933|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297934|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297935|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154297936|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
154297937|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154297938|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297939|NCT03947229|Clopidogrel|clopidogrel|mesh-list
154297940|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154297941|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154297942|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154297943|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154297944|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
154297945|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297946|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297947|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297948|NCT03011307|Oxytocin|oxytocin|mesh-list
154297949|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
154297950|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154297951|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297952|NCT01327755|Selenium|selenium|mesh-list
154297953|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
154297954|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297955|NCT01327755|Protective Agents|protective agents|mesh-ancestor
154297956|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297957|NCT01327755|Trace Elements|trace elements|mesh-ancestor
154297958|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
154297959|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
154297960|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154297961|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
154297971|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154297972|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297973|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297974|NCT00127335|Atorvastatin|atorvastatin|mesh-list
154297975|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154297976|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154297977|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
154297978|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154297979|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154297980|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154297981|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154297982|NCT01109511|Oxycodone|oxycodone|mesh-list
154297983|NCT01109511|Naloxone|naloxone|mesh-list
154297984|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154297985|NCT01109511|Narcotics|narcotics|mesh-ancestor
154297986|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154297987|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297988|NCT01109511|Analgesics|analgesics|mesh-ancestor
154297989|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
154297990|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154297991|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154297992|NCT01112085|Ranibizumab|ranibizumab|mesh-list
154297993|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154297994|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154297995|NCT01112085|Growth Substances|growth substances|mesh-ancestor
154297996|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154297997|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
154297998|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298013|NCT01328457|Paromomycin|paromomycin|mesh-list
154298015|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298016|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298017|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154298018|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154298019|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154298020|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298021|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298022|NCT01109823|Levofloxacin|levofloxacin|mesh-list
154298023|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154298024|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298025|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298026|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154298027|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154298028|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298029|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298030|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298031|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154298032|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154298033|NCT03943407|Imiquimod|imiquimod|mesh-list
154298034|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
154298035|NCT03943407|Doxepin|doxepin|mesh-list
154298036|NCT03943407|Menthol|menthol|mesh-list
154298037|NCT03943407|Histamine|histamine|mesh-list
154298038|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
154298039|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
154298040|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
154298041|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
154298063|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154298064|NCT01209351|Protective Agents|protective agents|mesh-ancestor
154298065|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298066|NCT02529579|Gemcitabine|gemcitabine|mesh-list
154298067|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154298068|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
154298069|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298070|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298071|NCT01209429|Hormones|hormones|mesh-list
154298072|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298073|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298074|NCT01110291|Docetaxel|docetaxel|mesh-list
154298075|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298076|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
154298077|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
154298078|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
154298079|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298080|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154298081|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
154298082|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154298083|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154298084|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298086|NCT01207947|Urological Agents|urological agents|mesh-ancestor
154298113|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154298114|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298115|NCT01107951|Dexamethasone|dexamethasone|mesh-list
154298116|NCT01107951|Rituximab|rituximab|mesh-list
154298117|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154298118|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
154298119|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
154298120|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298121|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298122|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154298123|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
154298124|NCT01107951|Hormones|hormones|mesh-ancestor
154298125|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819788|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819789|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819790|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153819791|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153819792|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153819793|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819794|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154298126|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154298127|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298128|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154298129|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
154298130|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154298131|NCT01108029|Memantine|memantine|mesh-list
154298132|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154298133|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154298134|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
154298135|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298136|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298137|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298138|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154298139|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154298141|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298142|NCT01110603|Paclitaxel|paclitaxel|mesh-list
154298143|NCT01110603|Carboplatin|carboplatin|mesh-list
154298144|NCT01110603|Doxorubicin|doxorubicin|mesh-list
154298157|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154298158|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
154298159|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154298160|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298161|NCT04258683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154298162|NCT04258683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298163|NCT01112787|Tazarotene|tazarotene|mesh-list
154298164|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
154298165|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
154298166|NCT01108107|Capecitabine|capecitabine|mesh-list
154298167|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
154298168|NCT01108107|Panitumumab|panitumumab|mesh-list
154298169|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154298170|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
154298171|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298172|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298173|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154298174|NCT01111227|Propofol|propofol|mesh-list
154298175|NCT01111227|Isoflurane|isoflurane|mesh-list
154298176|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154298177|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298178|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298179|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154298180|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
154298181|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
154298182|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154298183|NCT01111383|Tobramycin|tobramycin|mesh-list
154298184|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298185|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298186|NCT01208649|Exenatide|exenatide|mesh-list
154298187|NCT01208649|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154298188|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154298189|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298190|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154298191|NCT01208649|Incretins|incretins|mesh-ancestor
154298197|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154298198|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
154298199|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298200|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154298201|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154298202|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
154298203|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154298204|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
154298205|NCT01210287|Lamivudine|lamivudine|mesh-list
154298206|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154298207|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154298208|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298209|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298210|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
154298211|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298212|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154298213|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154298214|NCT01211925|Aspirin|aspirin|mesh-list
154298215|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154298216|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154298217|NCT01211925|Analgesics|analgesics|mesh-ancestor
154298249|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154298250|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154298251|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154298252|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154027393|NCT03003637|Ipilimumab|ipilimumab|mesh-list
154298253|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298254|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154298255|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154298256|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298257|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
154298258|NCT01210521|Vitamin D|vitamin d|mesh-list
154298259|NCT01210521|Vitamins|vitamins|mesh-ancestor
154298260|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
154298261|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298262|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154298263|NCT01210599|Pamidronate|pamidronate|mesh-list
154298264|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154298265|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298266|NCT03944889|Capsaicin|capsaicin|mesh-list
154298267|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
154298268|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
154298269|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
154298270|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298271|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298272|NCT01210677|Prednisone|prednisone|mesh-list
154298273|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154298274|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
154298275|NCT01210677|Hormones|hormones|mesh-ancestor
154298277|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298296|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154298297|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298298|NCT01210911|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154298299|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298300|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298301|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
154298302|NCT01115049|Hexetidine|hexetidine|mesh-list
154298303|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154298304|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298305|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
154298306|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
154298307|NCT03941535|Vitamin K|vitamin k|mesh-list
154298308|NCT03941535|Vitamins|vitamins|mesh-ancestor
154298309|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
154298310|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298311|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154298312|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154298313|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298314|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
154298315|NCT03941535|Coagulants|coagulants|mesh-ancestor
154298316|NCT01115127|Inositol|inositol|mesh-list
154298317|NCT01115127|Melatonin|melatonin|mesh-list
154298318|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
154298319|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298320|NCT01115127|Protective Agents|protective agents|mesh-ancestor
154298321|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298322|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298323|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
154298324|NCT01115127|Vitamins|vitamins|mesh-ancestor
154298346|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154298347|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298348|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298349|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
154298350|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
154298351|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154298352|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
154298353|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154298354|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298355|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298356|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154298357|NCT01212315|Triclosan|triclosan|mesh-list
154298358|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154298359|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298360|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154298361|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154298362|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
154298363|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298364|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154298365|NCT03938259|Fentanyl|fentanyl|mesh-list
154298366|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154298367|NCT03938259|Narcotics|narcotics|mesh-ancestor
154298368|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298369|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298370|NCT03938259|Analgesics|analgesics|mesh-ancestor
154298395|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
154298396|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298397|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298398|NCT01213563|Insulin|insulin|mesh-list
154298399|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154298400|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
154298401|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
154298402|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154298403|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298404|NCT01115985|Atorvastatin|atorvastatin|mesh-list
154298405|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154045206|NCT02718521|Isosorbide|isosorbide|mesh-list
154298406|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154298407|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
154298408|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298409|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154298410|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154298411|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298412|NCT01116063|Iloprost|iloprost|mesh-list
154298413|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154298414|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
154298415|NCT01116219|Bevacizumab|bevacizumab|mesh-list
154298416|NCT01116219|Pemetrexed|pemetrexed|mesh-list
154298417|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154298418|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154298419|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298420|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154298421|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154298422|NCT01116219|Growth Substances|growth substances|mesh-ancestor
154298423|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298424|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
154298425|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298431|NCT01213719|Betaine|betaine|mesh-list
154298436|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298437|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154298438|NCT01114191|Ketoconazole|ketoconazole|mesh-list
154298439|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
154298440|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298441|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154298442|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154298443|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298444|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298445|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154298446|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
154298447|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298448|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298449|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154298450|NCT01211691|Antibodies|antibodies|mesh-list
154298451|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154298452|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
154298453|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298454|NCT03937869|Secnidazole|secnidazole|mesh-list
154298455|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154298456|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154298457|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298458|NCT01116531|Pregabalin|pregabalin|mesh-list
154298459|NCT01116531|Tramadol|tramadol|mesh-list
154298460|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154298461|NCT01116531|Analgesics|analgesics|mesh-ancestor
154298462|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
154298475|NCT01116531|Narcotics|narcotics|mesh-ancestor
154298481|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
154298482|NCT03939975|Nivolumab|nivolumab|mesh-list
154298483|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154298484|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298485|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154298486|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298487|NCT01116609|Epinephrine|epinephrine|mesh-list
154298488|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154298489|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154298490|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
154298491|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298492|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298493|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298494|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154298495|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154298496|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
154298497|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298498|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154298499|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
154298500|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
154298501|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
154298502|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154298503|NCT01118403|Ampicillin|ampicillin|mesh-list
154298504|NCT01118403|Sulbactam|sulbactam|mesh-list
154298505|NCT01118403|Sultamicillin|sultamicillin|mesh-list
154298511|NCT01121835|Insulin|insulin|mesh-list
154298530|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298531|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298532|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
154298533|NCT01216371|Sunitinib|sunitinib|mesh-list
154298534|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298535|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154298536|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154298537|NCT01216371|Growth Substances|growth substances|mesh-ancestor
154298538|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298539|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
154298540|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298541|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298542|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298543|NCT01118871|Ritonavir|ritonavir|mesh-list
154298544|NCT01118871|Darunavir|darunavir|mesh-list
154298545|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154298546|NCT01118871|Etravirine|etravirine|mesh-list
154298547|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154298548|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154298549|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
154298550|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298551|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298552|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154298553|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154298554|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
154298555|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298556|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154298557|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154298558|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154298559|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154298570|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154298572|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
154298573|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154298574|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298575|NCT03939273|Metronidazole|metronidazole|mesh-list
154298576|NCT03939273|Vancomycin|vancomycin|mesh-list
154298577|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
154298578|NCT03939273|Fluconazole|fluconazole|mesh-list
154298579|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298580|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298581|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154298582|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154298583|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154298584|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154298585|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298586|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298587|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298588|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154298589|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154298590|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
154298591|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154298592|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154298593|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
154298594|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298595|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298596|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154298616|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
154298617|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298618|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154298619|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
154298620|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154298621|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
154298622|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298623|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
154298624|NCT03938883|Protective Agents|protective agents|mesh-ancestor
154298625|NCT01216839|Everolimus|everolimus|mesh-list
154298626|NCT01216839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154298627|NCT01216839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154045441|NCT00912756|Cilostazol|cilostazol|mesh-list
154298629|NCT01216839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298630|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154298631|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
154298632|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298633|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298634|NCT01119651|Tazarotene|tazarotene|mesh-list
154298635|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
154298636|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
154298637|NCT03971877|Polymyxins|polymyxins|mesh-list
154298638|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298639|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298640|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
154298641|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154298642|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298643|NCT01119885|Fentanyl|fentanyl|mesh-list
154298644|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154298645|NCT01119885|Narcotics|narcotics|mesh-ancestor
154298646|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298647|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298648|NCT01119885|Analgesics|analgesics|mesh-ancestor
154298649|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
154298650|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298651|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154298657|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
154298658|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154298659|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154298660|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298661|NCT01219023|Urological Agents|urological agents|mesh-ancestor
154298662|NCT01124487|Insulin|insulin|mesh-list
154298663|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154298664|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298665|NCT01120119|Calcitriol|calcitriol|mesh-list
154298666|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153819812|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819813|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
153819814|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153819815|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
153819821|NCT00430196|Tizanidine|tizanidine|mesh-list
154298667|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298668|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154298669|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154298670|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298671|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154298672|NCT01120119|Vitamins|vitamins|mesh-ancestor
154298673|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
154298674|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154298675|NCT01219101|Citric Acid|citric acid|mesh-list
154298676|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
154298677|NCT01219101|Clomiphene|clomiphene|mesh-list
154298678|NCT01219101|Enclomiphene|enclomiphene|mesh-list
154298679|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
154298680|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
154298681|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154298682|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
154298683|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
154298684|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298690|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
154298705|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154298706|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154298707|NCT01122615|Growth Substances|growth substances|mesh-ancestor
154298708|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298709|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
154298710|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298711|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298712|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298713|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154298714|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
154298715|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298716|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298717|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154298718|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
154298719|NCT01217697|Prednisone|prednisone|mesh-list
154298720|NCT01217697|Prednisolone|prednisolone|mesh-list
154298721|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
154298722|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154298723|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
154298724|NCT01217697|Hormones|hormones|mesh-ancestor
154298725|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298726|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298727|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154298728|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298729|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154298730|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298731|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298732|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
154298733|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154298734|NCT01214343|Sorafenib|sorafenib|mesh-list
154298735|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298736|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298737|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298738|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298739|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154298740|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
154298741|NCT01124799|Simeprevir|simeprevir|mesh-list
154298742|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298743|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461236|NCT03088254|Telmisartan|telmisartan|mesh-list
153461237|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153461238|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153461239|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153461240|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153461241|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461242|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154298744|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154298745|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154298746|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298747|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298748|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298749|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154298750|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154298751|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
154298752|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
154298753|NCT01124877|Ziprasidone|ziprasidone|mesh-list
154298754|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154298755|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
154298756|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298757|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298758|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298759|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154298760|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154298761|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298765|NCT01219413|Perindopril|perindopril|mesh-list
154298794|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
154298795|NCT01125033|Vitamin E|vitamin e|mesh-list
154298796|NCT01125033|Tocopherols|tocopherols|mesh-list
154298797|NCT01125033|Tocotrienols|tocotrienols|mesh-list
154298798|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
154298799|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
154298800|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298801|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
154298802|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298803|NCT01125033|Protective Agents|protective agents|mesh-ancestor
154298804|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154298805|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154298806|NCT01120665|Estradiol|estradiol|mesh-list
154298807|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154298808|NCT01120665|Hormones|hormones|mesh-ancestor
154298809|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154298810|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298811|NCT01120665|Estrogens|estrogens|mesh-ancestor
154298812|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154298813|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
154298814|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154298815|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154298822|NCT01125423|Milnacipran|milnacipran|mesh-list
154298847|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154298848|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298849|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
154298850|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298851|NCT01121055|Lorazepam|lorazepam|mesh-list
154298852|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
154298853|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
154298854|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
154298855|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154298856|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298857|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154298858|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154298859|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298860|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154298861|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154298862|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154298863|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
154298864|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
154298865|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154298866|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298867|NCT01121133|Rifampin|rifampin|mesh-list
154298868|NCT01121133|Navitoclax|navitoclax|mesh-list
154298869|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154298870|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
154298871|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154298872|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298873|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
154298874|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154298875|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298876|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298877|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154298878|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154298883|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298888|NCT01123317|Oxytocin|oxytocin|mesh-list
154298889|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
154298890|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154298891|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298892|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
154298893|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154298894|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298895|NCT01123473|Capecitabine|capecitabine|mesh-list
154298896|NCT01123473|Fluorouracil|fluorouracil|mesh-list
154298897|NCT01123473|Epirubicin|epirubicin|mesh-list
154298898|NCT01123473|Lapatinib|lapatinib|mesh-list
154298899|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298900|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154298901|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
154298902|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298903|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154298904|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
154298905|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298906|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154298907|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154298908|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154298909|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298910|NCT01123473|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154298911|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298912|NCT01123551|Morphine|morphine|mesh-list
154298913|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154298914|NCT01123551|Narcotics|narcotics|mesh-ancestor
154298915|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154298916|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298937|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153819827|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153819828|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153819829|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
153819830|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
153819831|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153819832|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153819833|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153819834|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
153819835|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820708|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154298938|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154298939|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154298940|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298941|NCT01218711|Diuretics|diuretics|mesh-ancestor
154298942|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
154298943|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298944|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154298945|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154298946|NCT01125891|Gemcitabine|gemcitabine|mesh-list
154298947|NCT01125891|ON 01910|on 01910|mesh-list
154298948|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154298949|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
154298950|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298951|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298952|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154298953|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298954|NCT01124253|Endostatins|endostatins|mesh-list
154298955|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154298956|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154298957|NCT01124253|Growth Substances|growth substances|mesh-ancestor
154298958|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154298959|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
154298960|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154298983|NCT02903914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154298984|NCT02903914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298985|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
154298986|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154298987|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154298988|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
154298989|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154298990|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154298991|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154298992|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154298993|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
154298994|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154298995|NCT03928353|Ticagrelor|ticagrelor|mesh-list
154298996|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154298997|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154298998|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154298999|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154299000|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
154299001|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299002|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045814|NCT00857259|Growth Substances|growth substances|mesh-ancestor
154299003|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299004|NCT03931863|Ondansetron|ondansetron|mesh-list
154299005|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
154299006|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
154299007|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299008|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299009|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154299010|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
154299011|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
154299012|NCT03931863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154299013|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154299014|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
154299015|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299020|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154299021|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299022|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154299023|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299024|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
154299025|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154299026|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
154299027|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299028|NCT01129089|Micronutrients|micronutrients|mesh-list
154299029|NCT01129089|Trace Elements|trace elements|mesh-list
154299030|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299031|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
154299032|NCT01129323|Fludarabine|fludarabine|mesh-list
154299033|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
154299034|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154299035|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
154299036|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299037|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299038|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154299039|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
154299043|NCT01221129|Zinc|zinc|mesh-list
154299075|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299076|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154299077|NCT03927963|Analgesics|analgesics|mesh-ancestor
154299078|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
154299079|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299080|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154299081|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154299082|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154299083|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
154299084|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299085|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299086|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154299087|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
154299088|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
154299089|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154299091|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
154299092|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154299093|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154299094|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299095|NCT01226667|Pregabalin|pregabalin|mesh-list
154299128|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
154299129|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154299130|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299131|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299132|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299134|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
154299135|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
153461256|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
153461257|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
153461258|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
153461259|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153461260|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153461261|NCT05684484|Analgesics|analgesics|mesh-ancestor
153461262|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
153461263|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299136|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299137|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299138|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
154299139|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299140|NCT01129479|Galantamine|galantamine|mesh-list
154299141|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154299142|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299143|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299144|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
154299145|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299146|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299147|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154299148|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
154299151|NCT03647956|Bevacizumab|bevacizumab|mesh-list
154299180|NCT02968576|Emtricitabine|emtricitabine|mesh-list
154299181|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154299182|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
154299183|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299184|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154299185|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154299186|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299187|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299188|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154299189|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154299190|NCT01127217|Losartan|losartan|mesh-list
154299191|NCT01127217|Amlodipine|amlodipine|mesh-list
154299192|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154299193|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154299194|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299195|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299196|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154299197|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299198|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
154299232|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299234|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299235|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154299236|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154299237|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299238|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154299239|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154299240|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299241|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
154299242|NCT01127295|Tamoxifen|tamoxifen|mesh-list
154299243|NCT01127295|Letrozole|letrozole|mesh-list
153461264|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461265|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153461266|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461267|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153820710|NCT01050530|Tolvaptan|tolvaptan|mesh-list
153403198|NCT04123314|Psilocybin|psilocybin|mesh-list
154299244|NCT01127295|Anastrozole|anastrozole|mesh-list
154299245|NCT01127295|Exemestane|exemestane|mesh-list
154299246|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299247|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154299248|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154299249|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299250|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299251|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154299252|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
154299259|NCT01129713|Esomeprazole|esomeprazole|mesh-list
154299285|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299286|NCT03931317|Timolol|timolol|mesh-list
154299287|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299288|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154299289|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154299290|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
154299291|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299292|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299293|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154299294|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154299295|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
154299296|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154299297|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154299298|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299299|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
154299300|NCT01221909|Coagulants|coagulants|mesh-ancestor
154299301|NCT02900092|Ganaxolone|ganaxolone|mesh-list
154299302|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
154299303|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299304|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299305|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299306|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
154299307|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
154299308|NCT01130025|Tinzaparin|tinzaparin|mesh-list
154299309|NCT01130025|Warfarin|warfarin|mesh-list
154299310|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
154299311|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154299312|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154299313|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299314|NCT03925155|Iodine|iodine|mesh-list
154299315|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
154299316|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154299322|NCT01131195|Paclitaxel|paclitaxel|mesh-list
154299329|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
154299330|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
154299331|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299332|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154299333|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
154299334|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299335|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299336|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154299337|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
154299338|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154299339|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154299340|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154299341|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154299342|NCT01131195|Growth Substances|growth substances|mesh-ancestor
154299343|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
154299344|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154299345|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
153626798|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
154299346|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
154299347|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
154299348|NCT01227135|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154299349|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154299350|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299351|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299352|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299353|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
154299354|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154299355|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154299357|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299373|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154299374|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299376|NCT04052854|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154299377|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154299378|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299379|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299380|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299382|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
154299383|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
154299384|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299385|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154299386|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
154299387|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299388|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299389|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154299390|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
154299391|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
154299392|NCT03740373|Hormones|hormones|mesh-ancestor
154299393|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299394|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154299395|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154299396|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154299397|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
154299398|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299399|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299400|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154299401|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154299402|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154299403|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
154299417|NCT01131273|Buprenorphine|buprenorphine|mesh-list
154299418|NCT01131273|Methadone|methadone|mesh-list
154299419|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154299420|NCT01131273|Naloxone|naloxone|mesh-list
154299421|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154299422|NCT01131273|Narcotics|narcotics|mesh-ancestor
154299423|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299424|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299425|NCT01131273|Analgesics|analgesics|mesh-ancestor
154299426|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
154299427|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299428|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154299429|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
154299430|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
154299431|NCT03646318|Ketanserin|ketanserin|mesh-list
154299432|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154299433|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154299434|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154299435|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
154299436|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299437|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299438|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299439|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
154299440|NCT01130181|Vitamin D|vitamin d|mesh-list
154299441|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154299442|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299443|NCT01130181|Vitamins|vitamins|mesh-ancestor
154299444|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
154299445|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154299446|NCT03621514|Lidocaine|lidocaine|mesh-list
154299447|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
154299448|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
154299460|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154299461|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299462|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
154299463|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299464|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299465|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154299466|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
154299467|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299468|NCT01227603|Candesartan|candesartan|mesh-list
154299469|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
154299470|NCT01227603|Nifedipine|nifedipine|mesh-list
154299471|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154299472|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154299473|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154299474|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299475|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154299476|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299477|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154299478|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299512|NCT03926559|Morphine|morphine|mesh-list
154299513|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154299514|NCT03926559|Narcotics|narcotics|mesh-ancestor
154299515|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299516|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299517|NCT03926559|Analgesics|analgesics|mesh-ancestor
154299518|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
154299519|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299520|NCT01228617|Nicotine|nicotine|mesh-list
154299521|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154299522|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
154299523|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299524|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299525|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154299526|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154299527|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
154299528|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299529|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299530|NCT01227759|Tyrothricin|tyrothricin|mesh-list
154299531|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154299532|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299533|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154299534|NCT03923829|Zinc|zinc|mesh-list
154299535|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
154299536|NCT03923829|Trace Elements|trace elements|mesh-ancestor
154299537|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
154299538|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299539|NCT03923829|Astringents|astringents|mesh-ancestor
154299540|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
154299541|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
154299546|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
154299560|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299561|NCT03740295|Protective Agents|protective agents|mesh-ancestor
154299562|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299563|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154299564|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154299565|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299566|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154299567|NCT02965378|Docetaxel|docetaxel|mesh-list
154299568|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299569|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
154299570|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
153819867|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153819868|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
153819869|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153819870|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153819871|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153819872|NCT00430547|Carbimazole|carbimazole|mesh-list
153819873|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
153819874|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819876|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299571|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
154299572|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299573|NCT01224093|Rituximab|rituximab|mesh-list
154299574|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154299575|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299576|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
154299577|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299578|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299579|NCT03772041|Tolvaptan|tolvaptan|mesh-list
154299580|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154299581|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299582|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
154299583|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299584|NCT03922815|Fentanyl|fentanyl|mesh-list
154299585|NCT03922815|Propofol|propofol|mesh-list
154299586|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154299587|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299604|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299605|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299606|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154299607|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154299608|NCT01224405|Docetaxel|docetaxel|mesh-list
154299609|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299610|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
154299611|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
154299612|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
154299613|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299614|NCT02899156|Flumazenil|flumazenil|mesh-list
154299615|NCT02899156|Antidotes|antidotes|mesh-ancestor
154299616|NCT02899156|Protective Agents|protective agents|mesh-ancestor
154299617|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299618|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
154299619|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
154299620|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299621|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299622|NCT01131429|Cisplatin|cisplatin|mesh-list
154299623|NCT01131429|Docetaxel|docetaxel|mesh-list
154299624|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154299625|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299626|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
154299627|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
154299628|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
154299629|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299630|NCT01131429|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154299631|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154299632|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299633|NCT03645304|Ropivacaine|ropivacaine|mesh-list
154299634|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
154299647|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154299648|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299649|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299650|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
154299651|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299652|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299653|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154299654|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299655|NCT03646006|Bupivacaine|bupivacaine|mesh-list
154299656|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
154299657|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
154299658|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299659|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299660|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
154299661|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299662|NCT03854344|Lidocaine|lidocaine|mesh-list
154299663|NCT03854344|Bupivacaine|bupivacaine|mesh-list
154299664|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
154299665|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
154299666|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299668|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
154299698|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299699|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299700|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
154299701|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299702|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
154299703|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154299704|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
154299705|NCT05283850|Calcium|calcium|mesh-list
154299706|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154299707|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299708|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154299709|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
154299710|NCT03925779|Remifentanil|remifentanil|mesh-list
154299711|NCT03925779|Propofol|propofol|mesh-list
154299712|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154299713|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154299714|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299715|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154299716|NCT03925779|Analgesics|analgesics|mesh-ancestor
154299717|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
154299718|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299720|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154299751|NCT03925233|Gemcitabine|gemcitabine|mesh-list
154299752|NCT03925233|Doxorubicin|doxorubicin|mesh-list
154299753|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154299754|NCT03925233|Capecitabine|capecitabine|mesh-list
154299755|NCT03925233|Fluorouracil|fluorouracil|mesh-list
154299756|NCT03925233|Methotrexate|methotrexate|mesh-list
154299757|NCT03925233|Trastuzumab|trastuzumab|mesh-list
154299758|NCT03925233|Letrozole|letrozole|mesh-list
154299759|NCT03925233|Apatinib|apatinib|mesh-list
154299760|NCT03925233|Epirubicin|epirubicin|mesh-list
154299761|NCT03925233|Fulvestrant|fulvestrant|mesh-list
154299762|NCT03925233|Olaparib|olaparib|mesh-list
154299763|NCT03925233|Anastrozole|anastrozole|mesh-list
154299764|NCT03925233|Exemestane|exemestane|mesh-list
154299765|NCT03925233|Endostatins|endostatins|mesh-list
154299766|NCT03925233|Pirarubicin|pirarubicin|mesh-list
154299767|NCT03925233|Citric Acid|citric acid|mesh-list
154299768|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
154299769|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154299770|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299771|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
154299772|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
154299773|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
154299774|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299775|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154299776|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
154299777|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299805|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154299806|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
154299807|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299808|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154299809|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154299810|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154299811|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154299812|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154299813|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154299814|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154299815|NCT01130805|Capecitabine|capecitabine|mesh-list
154299816|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
154299817|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154299818|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
154299819|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299820|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154299821|NCT01345162|Ketorolac|ketorolac|mesh-list
154299822|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154299823|NCT01345162|Tramadol|tramadol|mesh-list
154299824|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154299825|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154299826|NCT01345162|Analgesics|analgesics|mesh-ancestor
154299827|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
154299828|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299836|NCT01345162|Narcotics|narcotics|mesh-ancestor
154299852|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299853|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
154299854|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
154299855|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
154299856|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154299857|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154299858|NCT01229085|Analgesics|analgesics|mesh-ancestor
154299859|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
154299860|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299861|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299862|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299863|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154299864|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154299865|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154299866|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299867|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154299868|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154299869|NCT03643666|Dexamethasone|dexamethasone|mesh-list
154299870|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
154299871|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299872|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
154299873|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
154299874|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299875|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299876|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154299877|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
154299899|NCT03643588|Protective Agents|protective agents|mesh-ancestor
154299900|NCT01224951|Beclomethasone|beclomethasone|mesh-list
154299901|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154299902|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
154299903|NCT01224951|Hormones|hormones|mesh-ancestor
154299904|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154299905|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299906|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154299907|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
154299908|NCT03641404|Ergothioneine|ergothioneine|mesh-list
154299909|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
153819890|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154299910|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819891|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
154299911|NCT03641404|Protective Agents|protective agents|mesh-ancestor
153819892|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819893|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153819894|NCT00461799|Orlistat|orlistat|mesh-list
153819895|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819896|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819897|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154299912|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299913|NCT01131741|Epinephrine|epinephrine|mesh-list
154299914|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154299915|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154299916|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
154299917|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154299954|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299955|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
154299956|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154299957|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
154299958|NCT05252884|Calcitriol|calcitriol|mesh-list
154299959|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
154299960|NCT05252884|Calcium|calcium|mesh-list
154299961|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154299962|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299963|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154299964|NCT05252884|Antacids|antacids|mesh-ancestor
154299965|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299966|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154299967|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154299968|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154299969|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154299970|NCT05252884|Vitamins|vitamins|mesh-ancestor
154299971|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
154299972|NCT03921177|Micronutrients|micronutrients|mesh-list
154299973|NCT03921177|Trace Elements|trace elements|mesh-list
154299974|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154299975|NCT01229319|Imiquimod|imiquimod|mesh-list
154299976|NCT01229319|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154299977|NCT01229319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154299978|NCT01229319|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154300004|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300005|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154300006|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300007|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
154300008|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
154300009|NCT03930069|Coagulants|coagulants|mesh-ancestor
154300010|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154300011|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154300012|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
154300013|NCT01132443|Clindamycin|clindamycin|mesh-list
154300014|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
154300015|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
154300016|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154300017|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300018|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300019|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154300020|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300021|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300022|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
154300023|NCT01132521|Urinastatin|urinastatin|mesh-list
154300024|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
154300025|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154300026|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
154300027|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300028|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300029|NCT01132599|Choline|choline|mesh-list
154300030|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
154300031|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154300032|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
154300033|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300052|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300053|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300054|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300056|NCT01132677|Hormones|hormones|mesh-ancestor
154300057|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300058|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154300059|NCT01132677|Protective Agents|protective agents|mesh-ancestor
154300060|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154300061|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300062|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
154300063|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
154300064|NCT02961790|Oxybutynin|oxybutynin|mesh-list
154300065|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
154300066|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
154300067|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300068|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300069|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154300070|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154300071|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
154300072|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300073|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300074|NCT02961790|Urological Agents|urological agents|mesh-ancestor
154300075|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154300076|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300077|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154300078|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154300079|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154300080|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300081|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300094|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154300095|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154300096|NCT03643900|Analgesics|analgesics|mesh-ancestor
154300097|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
154300098|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300099|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300100|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300101|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154300102|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
154300103|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
154300104|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154300105|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154300106|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300107|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300108|NCT03919383|Lenvatinib|lenvatinib|mesh-list
154300109|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300110|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154300111|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300112|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300113|NCT01131897|Levetiracetam|levetiracetam|mesh-list
154300114|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
154300115|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
154300116|NCT01225419|Plerixafor|plerixafor|mesh-list
154300117|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154300118|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154300119|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
154300120|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300121|NCT03919461|Etodolac|etodolac|mesh-list
154300141|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300142|NCT02528877|Sirolimus|sirolimus|mesh-list
154300143|NCT02528877|Fludarabine|fludarabine|mesh-list
154300144|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
153819916|NCT00470457|Immunomodulating Agents|immunomodulating agents|mesh-list
153819917|NCT00470457|Immunologic Factors|immunologic factors|mesh-ancestor
154300145|NCT02528877|Melphalan|melphalan|mesh-list
154300146|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
154300147|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154300148|NCT02528877|Tacrolimus|tacrolimus|mesh-list
154300149|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300150|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154300151|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
154300152|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300153|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300154|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
154300155|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300156|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154300157|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300158|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300159|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300160|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154300161|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
154300162|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154300163|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
154300164|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154300165|NCT03918993|Tadalafil|tadalafil|mesh-list
154300166|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
154300167|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154300172|NCT03920475|Sertraline|sertraline|mesh-list
154300188|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154300189|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154300190|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154300191|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300192|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300193|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
154300194|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300195|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300196|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154300197|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154300198|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300199|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
154300200|NCT03920397|Vitamin D|vitamin d|mesh-list
154300201|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154300202|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300203|NCT03920397|Vitamins|vitamins|mesh-ancestor
154300204|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
154300205|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154300206|NCT01131975|Lamotrigine|lamotrigine|mesh-list
154300207|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
154300208|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154300209|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300210|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300211|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154300212|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300213|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154300214|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154300215|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300230|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154300231|NCT01128699|Growth Substances|growth substances|mesh-ancestor
154300232|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300233|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
154300234|NCT01329627|Paclitaxel|paclitaxel|mesh-list
154300235|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154300236|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
154300237|NCT01329627|Doxorubicin|doxorubicin|mesh-list
154300238|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154300239|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154300240|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300241|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
154300242|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
154300243|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
153461346|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
153461347|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461348|NCT03085368|Trastuzumab|trastuzumab|mesh-list
154300244|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300245|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300246|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
154300247|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300248|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154300249|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154300250|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
154300251|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154300252|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154300253|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154300281|NCT01134861|Cisplatin|cisplatin|mesh-list
154300282|NCT01134861|Etoposide|etoposide|mesh-list
154300283|NCT01134861|Vinblastine|vinblastine|mesh-list
154300284|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300285|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154300286|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154300287|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154300288|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300289|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300290|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
154300291|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
154300292|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
154300345|NCT03642184|Linagliptin|linagliptin|mesh-list
154300346|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154300347|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300348|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154300349|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300350|NCT03642184|Incretins|incretins|mesh-ancestor
154300351|NCT03642184|Hormones|hormones|mesh-ancestor
154300352|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300353|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154300354|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
154300355|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300356|NCT01137591|Acetaminophen|acetaminophen|mesh-list
154300357|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
154300358|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154300359|NCT01137591|Analgesics|analgesics|mesh-ancestor
154300360|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
154300361|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300362|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300363|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
154300364|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
154300365|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300366|NCT01137591|Expectorants|expectorants|mesh-ancestor
154300367|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
154300368|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154300369|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
154300370|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300371|NCT01137591|Protective Agents|protective agents|mesh-ancestor
154300372|NCT01133457|Finasteride|finasteride|mesh-list
154300373|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154300374|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154300388|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300389|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
154300390|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300391|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300392|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154300393|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
154300394|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
153819922|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300395|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
154300396|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
154300397|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154300398|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154300399|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154300400|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300401|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300402|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
154300403|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300404|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300405|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154300406|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300408|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154300409|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154300410|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300411|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154300412|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300413|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
154300415|NCT01135641|Cyclosporine|cyclosporine|mesh-list
154300433|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300434|NCT01230723|Everolimus|everolimus|mesh-list
154300435|NCT01230723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154300436|NCT01230723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154300437|NCT01230723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300438|NCT01230723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300439|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300440|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
154300441|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300442|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300443|NCT01135953|Cycloserine|cycloserine|mesh-list
154300444|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154300445|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300446|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154300447|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
154300448|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300449|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
154300450|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300451|NCT01136031|Paclitaxel|paclitaxel|mesh-list
154300487|NCT03739671|Vitamin D|vitamin d|mesh-list
154300488|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
154300489|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
154300490|NCT03739671|Vitamins|vitamins|mesh-list
154300491|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
154300492|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300493|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154300494|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154300495|NCT01233453|Umirolimus|umirolimus|mesh-list
154300496|NCT01233453|Everolimus|everolimus|mesh-list
154300497|NCT01233453|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154300498|NCT01233453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154300499|NCT01233453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300500|NCT01233453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300501|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300502|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
154300503|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300504|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300505|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300507|NCT01133925|Paclitaxel|paclitaxel|mesh-list
154300508|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154300509|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300510|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
154300511|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
154300512|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
154300513|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300517|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
154300537|NCT01138137|Expectorants|expectorants|mesh-ancestor
154300538|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
154300539|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154300540|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
154300541|NCT01138137|Protective Agents|protective agents|mesh-ancestor
154300542|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300543|NCT01138137|Antidotes|antidotes|mesh-ancestor
154300544|NCT01231113|Artesunate|artesunate|mesh-list
154300545|NCT01231113|Piperaquine|piperaquine|mesh-list
154300546|NCT01231113|Amodiaquine|amodiaquine|mesh-list
154300547|NCT01231113|Artenimol|artenimol|mesh-list
154300548|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
154300549|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154300550|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154300551|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300552|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300553|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
154300554|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
154300555|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154300556|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
154300557|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
154300558|NCT01136421|Bromides|bromides|mesh-list
154300559|NCT01136421|Ipratropium|ipratropium|mesh-list
154300560|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
154300561|NCT01136421|Analgesics|analgesics|mesh-ancestor
154300562|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
154300563|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300564|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300565|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
154300566|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300567|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154300568|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154300584|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300585|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300586|NCT01231191|Acetaminophen|acetaminophen|mesh-list
154300587|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154300588|NCT01231191|Analgesics|analgesics|mesh-ancestor
154300589|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
154300590|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300591|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300592|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
154300593|NCT01138449|Vitamin A|vitamin a|mesh-list
154300594|NCT01138449|Vitamins|vitamins|mesh-ancestor
154300595|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
154300596|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300597|NCT05402865|Denosumab|denosumab|mesh-list
154300598|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154300599|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300600|NCT01138605|Ritonavir|ritonavir|mesh-list
154300601|NCT01138605|Darunavir|darunavir|mesh-list
154300602|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154300603|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154300604|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
154300605|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300606|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300607|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154300608|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154300636|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300637|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
154300638|NCT01138839|Hormones|hormones|mesh-ancestor
154300639|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300640|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154300641|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300642|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154300643|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154300644|NCT01234701|Liver Extracts|liver extracts|mesh-list
154300645|NCT01234701|Hematinics|hematinics|mesh-ancestor
154300646|NCT05280717|Sotrovimab|sotrovimab|mesh-list
154300647|NCT05280717|Antiviral Agents|antiviral agents|mesh-ancestor
154300648|NCT05280717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300649|NCT05275179|Posaconazole|posaconazole|mesh-list
154300650|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
154300651|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300652|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154300653|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154300654|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154300655|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154300656|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154300657|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300658|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300659|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154300660|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
154300683|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300684|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300685|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154300686|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300687|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154300688|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
154300689|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300690|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
154300691|NCT01233843|Carboplatin|carboplatin|mesh-list
154300692|NCT01233843|Fluorouracil|fluorouracil|mesh-list
154300693|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300694|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
154300695|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300696|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154300697|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154300698|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
154300699|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300700|NCT01234935|Gemcitabine|gemcitabine|mesh-list
154300701|NCT01234935|Dasatinib|dasatinib|mesh-list
154300702|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154300703|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
154300704|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300705|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300706|NCT01234935|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154300707|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154300708|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300709|NCT03674541|Bromides|bromides|mesh-list
154300710|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154300711|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
154300712|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154300713|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300714|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300715|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
154300718|NCT01235013|Maraviroc|maraviroc|mesh-list
154300721|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300722|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154300723|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154300724|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
154300725|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154300726|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154300727|NCT01236495|Morphine|morphine|mesh-list
154300728|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153819945|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153819946|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153819947|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819948|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
153819949|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154300729|NCT01236495|Narcotics|narcotics|mesh-ancestor
154300730|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300731|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300732|NCT01236495|Analgesics|analgesics|mesh-ancestor
154300733|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
154300734|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300735|NCT01143129|Dexamethasone|dexamethasone|mesh-list
154300736|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300737|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
154300738|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
154300739|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300777|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154300778|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154300779|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154300780|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300781|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300783|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154300784|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154300785|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
154300786|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154300787|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154300788|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300789|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154300790|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154300791|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154300792|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154300793|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154300794|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
154300795|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
154300796|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
154300797|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
154300798|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154300799|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300800|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300801|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154300802|NCT03640390|Analgesics|analgesics|mesh-ancestor
154300803|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
154300804|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300805|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154300820|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154300821|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300822|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
154300823|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154300824|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300825|NCT03618316|Cimetidine|cimetidine|mesh-list
154300826|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154300827|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300828|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154300829|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
154300830|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
154300831|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300832|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300833|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300834|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154300835|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154300836|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819950|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300837|NCT03445533|Ipilimumab|ipilimumab|mesh-list
154300838|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154300839|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300840|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154300841|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300842|NCT01336972|Tolvaptan|tolvaptan|mesh-list
154300843|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154300844|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300845|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
154300846|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300847|NCT03618082|Desflurane|desflurane|mesh-list
154300853|NCT01236651|Drotaverin|drotaverin|mesh-list
154300864|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
154300865|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
154300867|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154300868|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154300869|NCT04484025|Analgesics|analgesics|mesh-ancestor
154300870|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
154300871|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300872|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300873|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154300874|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154300875|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154300876|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154300877|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
154300878|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300879|NCT04484025|Protective Agents|protective agents|mesh-ancestor
154300880|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154047686|NCT04902859|Clonidine|clonidine|mesh-list
154300881|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154300882|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154300883|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
154300884|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154300885|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154300886|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154300887|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300888|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300889|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
154300890|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300911|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300912|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300913|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
154300914|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300915|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154300916|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154300917|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154300918|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154300919|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300920|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
154300921|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154300922|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154300923|NCT03617224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154300924|NCT03617224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154300925|NCT03615430|Anesthetics|anesthetics|mesh-list
154300926|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
154300927|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300928|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300929|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
153819967|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819968|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
154300930|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300931|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154300932|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154300933|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154300934|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154300935|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154300936|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154300937|NCT04837768|Progesterone|progesterone|mesh-list
154300938|NCT04837768|Progestins|progestins|mesh-ancestor
154300939|NCT04837768|Hormones|hormones|mesh-ancestor
154300940|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154300941|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300950|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154300951|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
154300952|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154300953|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154300954|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154300955|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154300956|NCT03613558|Analgesics|analgesics|mesh-ancestor
154300957|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
154300958|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154300959|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154300960|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154300961|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154300962|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
154300963|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154300964|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301007|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301008|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154301010|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
154301011|NCT01235325|Vitamin K|vitamin k|mesh-list
154301012|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
154301013|NCT01235325|Vitamins|vitamins|mesh-ancestor
154301014|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
154301015|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301016|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154301017|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154301018|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301019|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
154301020|NCT01235325|Coagulants|coagulants|mesh-ancestor
154301021|NCT01140009|Vaccines|vaccines|mesh-list
154301022|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
154301023|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301024|NCT01235637|Sufentanil|sufentanil|mesh-list
154301025|NCT01235637|Alfentanil|alfentanil|mesh-list
154301026|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154301027|NCT01235637|Narcotics|narcotics|mesh-ancestor
154301028|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301029|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301030|NCT01235637|Analgesics|analgesics|mesh-ancestor
154301031|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
154301032|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301033|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154301034|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154301035|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
154301037|NCT01143831|Vitamins|vitamins|mesh-list
154301038|NCT01143831|Vitamin K|vitamin k|mesh-list
154301058|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301059|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301060|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154301061|NCT01142505|Mannitol|mannitol|mesh-list
154301062|NCT01142505|Montelukast|montelukast|mesh-list
154301063|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154301064|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
154301065|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154301066|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
154301067|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301068|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301069|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154301070|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154301071|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301072|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154301073|NCT01142505|Diuretics|diuretics|mesh-ancestor
154301074|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
154301075|NCT01236963|Listerine|listerine|mesh-list
154301076|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154301077|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301078|NCT02572167|Nivolumab|nivolumab|mesh-list
154301079|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154301080|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154301081|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301082|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154301083|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301084|NCT02572167|Immunotoxins|immunotoxins|mesh-ancestor
154301085|NCT02572167|Immunoconjugates|immunoconjugates|mesh-ancestor
154301086|NCT02572167|Immunologic Factors|immunologic factors|mesh-ancestor
154301098|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301099|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301100|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
154301101|NCT01336738|Vitamins|vitamins|mesh-ancestor
154301102|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
154301103|NCT01140399|Dopamine|dopamine|mesh-list
154301104|NCT01140399|Furosemide|furosemide|mesh-list
154301105|NCT01140399|Diuretics|diuretics|mesh-ancestor
154301106|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
154301107|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301108|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154301109|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301110|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301111|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154301112|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
154301113|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
154301114|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301115|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
154301116|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301117|NCT01140399|Protective Agents|protective agents|mesh-ancestor
154301119|NCT02410317|Ropivacaine|ropivacaine|mesh-list
154301120|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154301121|NCT02410317|Narcotics|narcotics|mesh-ancestor
154301122|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301123|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301124|NCT02410317|Analgesics|analgesics|mesh-ancestor
154301125|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
154301126|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301147|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301148|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154301149|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154301150|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154301151|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301152|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
154301153|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154301154|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154301155|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154301156|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301157|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461398|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461399|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
153461400|NCT04400916|Coagulants|coagulants|mesh-ancestor
153461401|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
153461402|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
153461411|NCT04279938|Rituximab|rituximab|mesh-list
154301158|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
154301159|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301160|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301161|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154301162|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301163|NCT02033434|Ketamine|ketamine|mesh-list
154301164|NCT02033434|Analgesics|analgesics|mesh-ancestor
154301165|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
154301166|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301167|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301168|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154301169|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154301170|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
154301171|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
154301172|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301173|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154301174|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154301175|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301176|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301184|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301185|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301187|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154301188|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301189|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154301190|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301191|NCT01982955|Carboplatin|carboplatin|mesh-list
154301192|NCT01982955|Pemetrexed|pemetrexed|mesh-list
154301193|NCT01982955|Gefitinib|gefitinib|mesh-list
154301194|NCT01982955|Tepotinib|tepotinib|mesh-list
154301195|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301196|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301197|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301198|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154301199|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154301200|NCT01982955|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154301201|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154301240|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154301241|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154301242|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301243|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301245|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154301246|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154301247|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301248|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154301249|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154301250|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
154048063|NCT00729118|Growth Substances|growth substances|mesh-ancestor
154301251|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301252|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154301253|NCT01238133|Paclitaxel|paclitaxel|mesh-list
154301254|NCT01238133|Carboplatin|carboplatin|mesh-list
154301255|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154157371|NCT05845814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301256|NCT01238133|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154301257|NCT01238133|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154301258|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154301259|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301260|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
154301261|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
154301262|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
154301264|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301285|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154301286|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154301287|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301288|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154301289|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301290|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154301291|NCT00396279|Vitamin D|vitamin d|mesh-list
154301292|NCT00396279|Denosumab|denosumab|mesh-list
154301293|NCT00396279|Calcium|calcium|mesh-list
154301294|NCT00396279|Vitamins|vitamins|mesh-ancestor
154301295|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
154301296|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301297|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154301298|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154301299|NCT01238367|Factor VIII|factor viii|mesh-list
154301300|NCT01238367|Coagulants|coagulants|mesh-ancestor
154301301|NCT01347866|Irinotecan|irinotecan|mesh-list
154301302|NCT01347866|Gedatolisib|gedatolisib|mesh-list
154301303|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154301304|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154301305|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301306|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301307|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301308|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154301309|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154301310|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
154301334|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301335|NCT03482882|Pimavanserin|pimavanserin|mesh-list
154301336|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154301337|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154301338|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154301339|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154301340|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301341|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301342|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154301343|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154301344|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154301345|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
154301346|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301347|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301348|NCT03480932|Interferons|interferons|mesh-list
154301349|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
154301350|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
154301351|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154301352|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
154301353|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301354|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
154301355|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301356|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
154301357|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301358|NCT03387020|Everolimus|everolimus|mesh-list
154301359|NCT03387020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154301360|NCT03387020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154301361|NCT03387020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301362|NCT03387020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157372|NCT05823532|Infliximab|infliximab|mesh-list
153404028|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154301363|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154301364|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
154301365|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301366|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301367|NCT03386474|Aflibercept|aflibercept|mesh-list
154301374|NCT03405818|Tavaborole|tavaborole|mesh-list
154301375|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
154301376|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301377|NCT03403634|Interferons|interferons|mesh-list
154301378|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
154301379|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
154301380|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154301381|NCT03403634|Celecoxib|celecoxib|mesh-list
154301382|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301383|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
154301384|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301385|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
154301386|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301387|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154301388|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154301389|NCT03403634|Analgesics|analgesics|mesh-ancestor
154301390|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
154301391|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301392|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154301393|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154301394|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154301395|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154048216|NCT04188431|Hormones|hormones|mesh-ancestor
154301396|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301397|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301427|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154301428|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154301429|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154301430|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301431|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301432|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
154301433|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301434|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154301435|NCT02862574|Methotrexate|methotrexate|mesh-list
154301436|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154301437|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
154301438|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154301439|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301440|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154301441|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
154301442|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301443|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301483|NCT03609814|Clofarabine|clofarabine|mesh-list
154301484|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301485|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154301486|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
154301487|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301488|NCT02859142|Nicotine|nicotine|mesh-list
154301489|NCT02859142|Varenicline|varenicline|mesh-list
154301490|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154301491|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
154301492|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301493|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301494|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154301495|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154301496|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
154301497|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301498|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301499|NCT03351608|Atropine|atropine|mesh-list
154301500|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
154301541|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154301542|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301543|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301544|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154301545|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301546|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
154301547|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154301548|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154301549|NCT02857270|Paclitaxel|paclitaxel|mesh-list
154301550|NCT02857270|Gemcitabine|gemcitabine|mesh-list
154301551|NCT02857270|Cetuximab|cetuximab|mesh-list
154301552|NCT02857270|Midazolam|midazolam|mesh-list
154301553|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154301554|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301555|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
154301556|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
154301557|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
154301558|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301559|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154301561|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154301562|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154301563|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301564|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301565|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154301566|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154301567|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154301568|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154301569|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
154301570|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
154301571|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
154301572|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
154301573|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301574|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154301575|NCT03609190|Ketamine|ketamine|mesh-list
154301581|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154301582|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
154301583|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
154301584|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301585|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154301586|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154301587|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301588|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301589|NCT02856880|Zinc|zinc|mesh-list
154301590|NCT02856880|Trace Elements|trace elements|mesh-ancestor
154301591|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
154301592|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301643|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154301645|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
154301646|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154301647|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154301648|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154301649|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
154301650|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301651|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154301652|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154301653|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
154301654|NCT04125550|Propofol|propofol|mesh-list
154301655|NCT04125550|Sevoflurane|sevoflurane|mesh-list
154301656|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154301657|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301658|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301659|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154301660|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
154301661|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
154301662|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154301663|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154301696|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
154301697|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154301698|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
154301699|NCT02035072|Gemcitabine|gemcitabine|mesh-list
154048509|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
154301700|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
154301701|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154301703|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301704|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301705|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
154301706|NCT00358215|Hematinics|hematinics|mesh-ancestor
154301707|NCT03605056|Dexamethasone|dexamethasone|mesh-list
154301708|NCT03605056|Lenalidomide|lenalidomide|mesh-list
154301709|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154301710|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
154301711|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
154301712|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301713|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301714|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301715|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
154301716|NCT03605056|Hormones|hormones|mesh-ancestor
154301717|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154301718|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154301719|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301720|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
154301721|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154301722|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154301723|NCT03605056|Growth Substances|growth substances|mesh-ancestor
154301724|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
154301734|NCT03604744|Psilocybin|psilocybin|mesh-list
154301742|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301743|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301744|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
154301745|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154301746|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301747|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301748|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154301749|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154301750|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154301751|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301752|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154301753|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154301754|NCT03604354|Narcotics|narcotics|mesh-ancestor
154301755|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154301756|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154301757|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301758|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301759|NCT03603418|Dexamethasone|dexamethasone|mesh-list
154301760|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
154301761|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154301762|NCT03603418|BB 1101|bb 1101|mesh-list
154301763|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154301764|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
154301765|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
154301766|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301767|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301768|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301769|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
154301786|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
154301787|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301788|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154301789|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154301790|NCT02852434|Lidocaine|lidocaine|mesh-list
154301791|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
154301792|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
154301793|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301794|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301795|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
154301796|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301797|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154301798|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154301799|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154301800|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154301801|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301802|NCT03606928|Leucovorin|leucovorin|mesh-list
154301803|NCT03606928|Docetaxel|docetaxel|mesh-list
154301841|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154301842|NCT02237560|Camphor|camphor|mesh-list
154301843|NCT02237560|Salicylates|salicylates|mesh-list
154301844|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
154301845|NCT02237560|Menthol|menthol|mesh-list
154301846|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154301847|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154301848|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
154301849|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
154301850|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154301851|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154301852|NCT02237560|Analgesics|analgesics|mesh-ancestor
154301853|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
154301854|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301855|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301856|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154301857|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154301858|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154301859|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301860|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301861|NCT03601624|Dexamethasone|dexamethasone|mesh-list
154301862|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
154301863|NCT03601624|Pomalidomide|pomalidomide|mesh-list
154301894|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154301895|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154301896|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154301897|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154301898|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301899|NCT02849704|Pancrelipase|pancrelipase|mesh-list
154301900|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301901|NCT03600766|Mirabegron|mirabegron|mesh-list
154301902|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154301903|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154301904|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154301905|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301906|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301907|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301908|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301909|NCT03600766|Urological Agents|urological agents|mesh-ancestor
154301910|NCT03600454|Anesthetics|anesthetics|mesh-list
154157389|NCT05807139|Natriuretic Agents|natriuretic agents|mesh-ancestor
154301911|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154301912|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301913|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
154048729|NCT02568280|Insulin|insulin|mesh-list
154301945|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
154301946|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154301947|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301948|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154301949|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154301950|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
154301951|NCT02721082|Nicotine|nicotine|mesh-list
154301952|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154301953|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
154301954|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301955|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301956|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154301957|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154301958|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
154301959|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301960|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154301961|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154301962|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154301963|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
154301964|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154301965|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154301966|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154301967|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
154301968|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154301969|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154301994|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154301996|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154301997|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
154301998|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154301999|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302000|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
154302001|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154302002|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302003|NCT04773002|Anesthetics|anesthetics|mesh-list
154302004|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302005|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302006|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154302007|NCT02849080|Semaglutide|semaglutide|mesh-list
154302008|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154302009|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302010|NCT02849080|Incretins|incretins|mesh-ancestor
154302011|NCT02849080|Hormones|hormones|mesh-ancestor
154302012|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302013|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154302014|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
154302015|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302016|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302017|NCT02849080|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154302018|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
154302019|NCT03346070|Rocuronium|rocuronium|mesh-list
154302020|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
154302021|NCT03346070|Neostigmine|neostigmine|mesh-list
154302022|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154302023|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154302024|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154302025|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302026|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302027|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154302028|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157390|NCT05805501|Pembrolizumab|pembrolizumab|mesh-list
153461428|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302029|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302030|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
154302031|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302032|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154302033|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
154302034|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154302035|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154302036|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154302037|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154302038|NCT03590626|Dulaglutide|dulaglutide|mesh-list
154302039|NCT03590626|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154302040|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154302041|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302042|NCT02238340|Ketoprofen|ketoprofen|mesh-list
154302043|NCT02238340|Morphine|morphine|mesh-list
154302044|NCT02238340|Oxycodone|oxycodone|mesh-list
154302045|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154302046|NCT02238340|Narcotics|narcotics|mesh-ancestor
154302047|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302084|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154302085|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154302086|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154302087|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302088|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302089|NCT03579082|Decitabine|decitabine|mesh-list
154302090|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154302091|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
154302092|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302093|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302094|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302095|NCT03579004|Paclitaxel|paclitaxel|mesh-list
154302096|NCT03579004|Fluorouracil|fluorouracil|mesh-list
154302097|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154302098|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302103|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
154302141|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302143|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154302144|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302145|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
154048949|NCT00865020|Aliskiren|aliskiren|mesh-list
154302146|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154302147|NCT03574246|Benzydamine|benzydamine|mesh-list
154302148|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154302149|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302150|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
154302151|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
154302152|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302153|NCT02239900|Ipilimumab|ipilimumab|mesh-list
154302154|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154302155|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302156|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154302157|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302158|NCT03573934|Glucagon|glucagon|mesh-list
154302196|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302198|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154302199|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154302200|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302201|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302202|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154302203|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154302204|NCT02244502|Paclitaxel|paclitaxel|mesh-list
154302205|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154302206|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302207|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
154302208|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
154302209|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
154302210|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302211|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
154302212|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154302213|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154302214|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302215|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154302216|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154302217|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
154302218|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302219|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302247|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154302248|NCT03571438|Growth Substances|growth substances|mesh-ancestor
154302249|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302250|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
154302251|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154302252|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302253|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302254|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154302255|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
154302256|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154302257|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302258|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154302259|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
154302260|NCT01874860|Doxycycline|doxycycline|mesh-list
154302261|NCT01874860|Clindamycin|clindamycin|mesh-list
154302262|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
154302263|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
154302264|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
154302265|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
154302266|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154302267|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154302268|NCT01874860|Prednisolone|prednisolone|mesh-list
154302269|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
154302270|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
154302271|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154302272|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
154302273|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302274|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154302275|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302293|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302294|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154302295|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
154302297|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
154302298|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154302299|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154302300|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302301|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302302|NCT03571126|Olanzapine|olanzapine|mesh-list
154302303|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
154302304|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
153820024|NCT00431561|Lomustine|lomustine|mesh-list
153461465|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153461466|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
153461467|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302305|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302306|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302307|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302308|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154302309|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154302310|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302311|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154302312|NCT03571126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154302313|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154302314|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302315|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302316|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302317|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
154302318|NCT03572686|Dexamethasone|dexamethasone|mesh-list
154302319|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
154302320|NCT03572686|Ropivacaine|ropivacaine|mesh-list
154302321|NCT03572686|BB 1101|bb 1101|mesh-list
154302322|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302336|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
154302338|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302339|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
154302340|NCT02523820|Fluticasone|fluticasone|mesh-list
154302341|NCT02523820|Xhance|xhance|mesh-list
154302342|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302343|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154302344|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
154302345|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302346|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302347|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154302348|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
154302349|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
154302350|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154302351|NCT03369704|Omalizumab|omalizumab|mesh-list
154302352|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154302353|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154302354|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
154302355|NCT03709160|Bumetanide|bumetanide|mesh-list
154302356|NCT03709160|Diuretics|diuretics|mesh-ancestor
154302357|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
154302358|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302359|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154302360|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302361|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302362|NCT05332496|Bevacizumab|bevacizumab|mesh-list
154302363|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154302364|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154302365|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302366|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154302367|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154302377|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
154302378|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302379|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154302380|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154302381|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
154302382|NCT05356858|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154302383|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154302384|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302385|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302386|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302387|NCT03566914|Tadalafil|tadalafil|mesh-list
154302388|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
154302389|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154302390|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154302391|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302438|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154302439|NCT03101722|Protective Agents|protective agents|mesh-ancestor
153404486|NCT00354757|Rabeprazole|rabeprazole|mesh-list
154302440|NCT03568474|Fluorides|fluorides|mesh-list
154302441|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
154302442|NCT03568474|Protective Agents|protective agents|mesh-ancestor
154302443|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302444|NCT03345836|Upadacitinib|upadacitinib|mesh-list
154302445|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154302446|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154302447|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302448|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302449|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302450|NCT03708926|Abaloparatide|abaloparatide|mesh-list
154302451|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154302452|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302453|NCT03567928|Propofol|propofol|mesh-list
154302454|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154302455|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302456|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302457|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154302458|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
154302459|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
154302460|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154302461|NCT03565354|Hematinics|hematinics|mesh-ancestor
154302462|NCT03363776|Nivolumab|nivolumab|mesh-list
154302463|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154302464|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302465|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154302466|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302467|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
154302468|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154302469|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154302470|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302471|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
154302472|NCT03565276|Coagulants|coagulants|mesh-ancestor
154302473|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
154302474|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154302475|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
154302476|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302477|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302478|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302479|NCT03708848|Metronidazole|metronidazole|mesh-list
154302480|NCT03708848|Clarithromycin|clarithromycin|mesh-list
154302481|NCT03708848|Levofloxacin|levofloxacin|mesh-list
154302482|NCT03708848|Tetracycline|tetracycline|mesh-list
154302483|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
154302484|NCT03708848|Esomeprazole|esomeprazole|mesh-list
154302485|NCT03708848|Bismuth|bismuth|mesh-list
154302486|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302487|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461469|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153461470|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153461471|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
153461474|NCT03308916|Liver Extracts|liver extracts|mesh-list
154302488|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154302489|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154302490|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154302491|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154302492|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302493|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154302494|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302495|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154302496|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154302497|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154302498|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154302499|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154302500|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154302501|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302502|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154302503|NCT03708848|Antacids|antacids|mesh-ancestor
154302504|NCT03708848|Diuretics|diuretics|mesh-ancestor
154302505|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
154302506|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302511|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302512|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154302513|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154302514|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154302515|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154302516|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
154302517|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154302518|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154302519|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302520|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
154302521|NCT03710330|Coagulants|coagulants|mesh-ancestor
154302523|NCT03710252|Ribavirin|ribavirin|mesh-list
154302524|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154302525|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154302526|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
154302527|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302528|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302529|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154302530|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154302531|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
154302532|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154302533|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154302534|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154302535|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
154302536|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
154302537|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302538|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302539|NCT03705884|Prednisolone|prednisolone|mesh-list
154302540|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302541|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
154302542|NCT03705884|Hormones|hormones|mesh-ancestor
154302543|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302544|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302547|NCT03359174|Tretinoin|tretinoin|mesh-list
154302552|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154302553|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154302554|NCT03564106|Prednisolone|prednisolone|mesh-list
154302555|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
154302556|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154302557|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
154302558|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302559|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
154302560|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
154302561|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302562|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302563|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302564|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
154302565|NCT03564106|Hormones|hormones|mesh-ancestor
154302566|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302567|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154302568|NCT03564106|Protective Agents|protective agents|mesh-ancestor
154302569|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154302610|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154302611|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
154302612|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154302613|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154302614|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154302615|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302616|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302617|NCT01238523|Calpastatin|calpastatin|mesh-list
154302618|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154302619|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
154302620|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302621|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302622|NCT03708536|Bevacizumab|bevacizumab|mesh-list
154302623|NCT03708536|Capecitabine|capecitabine|mesh-list
154302624|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154302635|NCT03705728|Propofol|propofol|mesh-list
154302669|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302670|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302671|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154302672|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302673|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
154302674|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
154302675|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302676|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302677|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
154302678|NCT03342638|Hormones|hormones|mesh-ancestor
154302679|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154302680|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154302681|NCT03342638|Protective Agents|protective agents|mesh-ancestor
154302682|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154302683|NCT01246323|Fentanyl|fentanyl|mesh-list
154302684|NCT01246323|Morphine|morphine|mesh-list
154302685|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
154302686|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302702|NCT05177276|Irinotecan|irinotecan|mesh-list
154302727|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302728|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
154302729|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
154302730|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154302731|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154302732|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302733|NCT01251471|Escitalopram|escitalopram|mesh-list
154302734|NCT01251471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154302735|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154302736|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302737|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302738|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302739|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
154302740|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302741|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
154302742|NCT01247805|Citric Acid|citric acid|mesh-list
154302743|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
154302744|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
154302745|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154302746|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
154302747|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
154302748|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302749|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
154302750|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154302751|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154302752|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302753|NCT01247805|Urological Agents|urological agents|mesh-ancestor
154302754|NCT05631717|Aldesleukin|aldesleukin|mesh-list
154302755|NCT05631717|Interleukin-2|interleukin-2|mesh-list
154302756|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302757|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154302758|NCT05631717|Analgesics|analgesics|mesh-ancestor
154302759|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
154302762|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154302769|NCT01147731|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154302770|NCT01147731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154302771|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302772|NCT03912285|Losartan|losartan|mesh-list
154302773|NCT03912285|Amlodipine|amlodipine|mesh-list
154302774|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154302775|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154302776|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302777|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302778|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154302779|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302780|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
154302781|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154302782|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154302783|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154302784|NCT01251627|Decitabine|decitabine|mesh-list
154302785|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154302786|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
154302787|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302788|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302789|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302790|NCT01146093|Pravastatin|pravastatin|mesh-list
154302791|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154302792|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154302793|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
154302794|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302795|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154302796|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154302797|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302798|NCT02452983|Sertraline|sertraline|mesh-list
154302799|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
154302800|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154302801|NCT02452983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154302805|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302806|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
154302807|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302808|NCT03911817|Midodrine|midodrine|mesh-list
154302809|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
154302810|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
154302811|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302812|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302813|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154302814|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154302815|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154302816|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154302817|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
154302818|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302819|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302820|NCT01239849|Atorvastatin|atorvastatin|mesh-list
154302821|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154302822|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154302823|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
154302824|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302825|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154302826|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154302827|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302828|NCT01252017|Nilotinib|nilotinib|mesh-list
154302829|NCT01252017|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154302830|NCT01252017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154302831|NCT01252017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302832|NCT01252017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302833|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
154302834|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302835|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
154302848|NCT01248195|Amisulpride|amisulpride|mesh-list
154302849|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
154302850|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
154302851|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302852|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302853|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302854|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154302855|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154302856|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154302857|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154302858|NCT01248195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154302859|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154302860|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154302861|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302862|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302863|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
154302864|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154302865|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
154302866|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
154302867|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154302868|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
154302869|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154302870|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
154302871|NCT03910803|Brodalumab|brodalumab|mesh-list
154302872|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
154302873|NCT03910647|Pantoprazole|pantoprazole|mesh-list
154302874|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154302875|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154302876|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154157391|NCT05805501|Axitinib|axitinib|mesh-list
154302892|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154302893|NCT01147029|Growth Substances|growth substances|mesh-ancestor
154302894|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302895|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
154302896|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154302897|NCT01239459|Teriflunomide|teriflunomide|mesh-list
154302898|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
154302899|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154302901|NCT01239459|Analgesics|analgesics|mesh-ancestor
154302902|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
154302903|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302904|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302905|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154302906|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154302907|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154302908|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
154302909|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154302910|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154302911|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
154302912|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302948|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154302949|NCT03907371|Donepezil|donepezil|mesh-list
154302950|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154302951|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154302952|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154302953|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
154302954|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154302955|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154302956|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
154302957|NCT03908619|Esomeprazole|esomeprazole|mesh-list
154302958|NCT03908619|Omeprazole|omeprazole|mesh-list
154302959|NCT03908619|Rabeprazole|rabeprazole|mesh-list
154302960|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154302961|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154303009|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154303010|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303012|NCT01250535|Lovastatin|lovastatin|mesh-list
154303013|NCT01250535|L 647318|l 647318|mesh-list
154303014|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
154303015|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
154303016|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154303017|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154303018|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
154303019|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303020|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154303021|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154303022|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303023|NCT02527941|Metronidazole|metronidazole|mesh-list
154303024|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303025|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303026|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154303027|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154303028|NCT01254825|Ropivacaine|ropivacaine|mesh-list
154303029|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
154303030|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
154303031|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303032|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303033|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
154303034|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781774|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
154303035|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154303036|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154303037|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154303038|NCT03906123|Protective Agents|protective agents|mesh-ancestor
154303039|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303053|NCT03905967|Lenvatinib|lenvatinib|mesh-list
154303054|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303055|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303056|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303057|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303058|NCT03563950|Rifampin|rifampin|mesh-list
154303059|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154303060|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
154303061|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303062|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303063|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
154303064|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154303065|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303066|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303067|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154303068|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154303069|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154303070|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154303071|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154303072|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154303073|NCT03914235|Lidocaine|lidocaine|mesh-list
154303074|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
154303075|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
154303102|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303103|NCT02528019|Glimepiride|glimepiride|mesh-list
154303104|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154303105|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154303106|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154303107|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303108|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303109|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
154303110|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303111|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
154303112|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154303113|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
154303114|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303115|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303116|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154303117|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
154303118|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154303119|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
154303120|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303122|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154303123|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
154303124|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
154303125|NCT01255215|Protective Agents|protective agents|mesh-ancestor
154303126|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
154303127|NCT02527785|Irinotecan|irinotecan|mesh-list
154303128|NCT02527785|Tegafur|tegafur|mesh-list
154303129|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303130|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154303131|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154303132|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303133|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303134|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154303135|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
154303142|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154303143|NCT03904719|Vorolanib|vorolanib|mesh-list
154303144|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303145|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303146|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303147|NCT01148901|Infliximab|infliximab|mesh-list
154303148|NCT01148901|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154303149|NCT01148901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303150|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
154303151|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154303152|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303153|NCT01150617|Insulin|insulin|mesh-list
154303154|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154303155|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
154303156|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154303157|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
154303158|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303159|NCT01256619|Desogestrel|desogestrel|mesh-list
154303160|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154303161|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154303162|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154303163|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
154303164|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154303165|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303168|NCT01256619|Progestins|progestins|mesh-ancestor
154303193|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154303194|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303195|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154303196|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154303197|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154303198|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303199|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
154303200|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
154303201|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154303202|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
154303203|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303204|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303205|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154303206|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303207|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154303208|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
154303209|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303210|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303211|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303212|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303213|NCT01255371|Lopinavir|lopinavir|mesh-list
154303214|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154303215|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154303216|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154303217|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
154303242|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303243|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154303244|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
154303245|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303246|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303247|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154303248|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154303249|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154303250|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154303251|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154303252|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303253|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154303254|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
154303255|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
154303256|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
154303257|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303258|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
154303299|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
154303300|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303301|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303302|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303303|NCT01257009|Atorvastatin|atorvastatin|mesh-list
154303304|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154303305|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154303306|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
154303307|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303308|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154303309|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154303310|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303311|NCT01255527|Bortezomib|bortezomib|mesh-list
154303312|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303313|NCT01151787|Amitriptyline|amitriptyline|mesh-list
154303314|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
154303315|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154303316|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
154303317|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154303318|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154303319|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303320|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154303321|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303322|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154303323|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303324|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154303344|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
154303345|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303346|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303347|NCT03893097|Artesunate|artesunate|mesh-list
154303348|NCT03893097|Mefloquine|mefloquine|mesh-list
154303349|NCT03893097|Praziquantel|praziquantel|mesh-list
154303350|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
154303351|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154303352|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154303353|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303354|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303355|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
154303356|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
154303357|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154303358|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
154303359|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
154303360|NCT01258491|Niacin|niacin|mesh-list
154303361|NCT01258491|Niacinamide|niacinamide|mesh-list
154303362|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
154303363|NCT01258491|Vitamins|vitamins|mesh-ancestor
154303364|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
153404923|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153820083|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154303365|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303366|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154303367|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
154303368|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303396|NCT01259973|Risperidone|risperidone|mesh-list
154303397|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
154303398|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154303399|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
154303400|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303401|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303402|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303403|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154303404|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154303405|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303406|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154303407|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154303408|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
154303409|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
154303410|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
154303411|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303412|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154303413|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154303414|NCT01257243|Potassium iodate|potassium iodate|mesh-list
154303415|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
154303416|NCT01257243|Guaifenesin|guaifenesin|mesh-list
154303417|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
154303418|NCT01257243|Expectorants|expectorants|mesh-ancestor
154303419|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
154303420|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154303422|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154303423|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303424|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303425|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303426|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
154303427|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154303428|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
154303429|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
154303438|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154303439|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154303440|NCT01257399|Analgesics|analgesics|mesh-ancestor
154303441|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
154303442|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303443|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303444|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154303445|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303446|NCT01258959|Anesthetics|anesthetics|mesh-list
154303447|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
154303448|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303449|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303450|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
154303451|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303452|NCT01153659|Esomeprazole|esomeprazole|mesh-list
154303453|NCT01153659|Rabeprazole|rabeprazole|mesh-list
154303454|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153461518|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461519|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461520|NCT03261570|Digoxin|digoxin|mesh-list
153461521|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153461522|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153461523|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154303455|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154303456|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154303457|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303458|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303459|NCT01260129|Silodosin|silodosin|mesh-list
154303460|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154303461|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154303462|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154303463|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
154303464|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303465|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303466|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303475|NCT03888729|Velpatasvir|velpatasvir|mesh-list
154303481|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303482|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
154303483|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303484|NCT02949362|Teduglutide|teduglutide|mesh-list
154303485|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154303486|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154303487|NCT02949362|Protective Agents|protective agents|mesh-ancestor
154303488|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303489|NCT03892161|Ritonavir|ritonavir|mesh-list
154303490|NCT03892161|Darunavir|darunavir|mesh-list
154303491|NCT03892161|Rifampin|rifampin|mesh-list
154303492|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154303493|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154303494|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
154303495|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303496|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303497|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154303498|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154303499|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
154303500|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303501|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154303502|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154303514|NCT01154361|Cortisone|cortisone|mesh-list
154303533|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154303534|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154303535|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303536|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
154303537|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154303538|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154303539|NCT03891615|Niraparib|niraparib|mesh-list
154303540|NCT03891615|Osimertinib|osimertinib|mesh-list
154303541|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154303542|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303543|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303544|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303545|NCT03891615|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154303546|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303547|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
154303548|NCT02947022|Zinc|zinc|mesh-list
154303590|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303591|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303592|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154303593|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
154303594|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303595|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303596|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154303597|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154303598|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154303599|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154303600|NCT01312376|Growth Substances|growth substances|mesh-ancestor
154303601|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
154303602|NCT01260675|Buprenorphine|buprenorphine|mesh-list
154303603|NCT01260675|Naloxone|naloxone|mesh-list
154303604|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154303605|NCT01260675|Narcotics|narcotics|mesh-ancestor
154303606|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154303607|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303608|NCT01260675|Analgesics|analgesics|mesh-ancestor
154303609|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
154303611|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154303643|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303645|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154303646|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
154303647|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303648|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303649|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154303650|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154303651|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
154303652|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303653|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303654|NCT01261065|Carvedilol|carvedilol|mesh-list
154303655|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154303656|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154303657|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
154303658|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303659|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303660|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303661|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154303662|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
154303663|NCT01261065|Protective Agents|protective agents|mesh-ancestor
154303696|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
154303697|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303698|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
154303699|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303700|NCT01152801|Everolimus|everolimus|mesh-list
154303701|NCT01152801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154303702|NCT01152801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303703|NCT01152801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303704|NCT01152801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303705|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303706|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
154303707|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303708|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303709|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
154303710|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
154303711|NCT03887169|Vitamins|vitamins|mesh-ancestor
154303712|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
154303713|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303714|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
154303715|NCT03887169|Hematinics|hematinics|mesh-ancestor
154303716|NCT03886779|Nepafenac|nepafenac|mesh-list
154303717|NCT03886779|Bromfenac|bromfenac|mesh-list
154303718|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154303719|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154303750|NCT01153191|Gentamicins|gentamicins|mesh-list
154303751|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154303752|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303753|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154303754|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303755|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303756|NCT01259817|Aspirin|aspirin|mesh-list
154303757|NCT01259817|Interferons|interferons|mesh-list
154303758|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
154303759|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
154303760|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154303761|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303762|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
154303763|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303764|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154303765|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154303766|NCT01259817|Analgesics|analgesics|mesh-ancestor
154303767|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
154303808|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303810|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
154303811|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303812|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154303813|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154303814|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
154303815|NCT03881787|Cetuximab|cetuximab|mesh-list
154303816|NCT03881787|Antibodies|antibodies|mesh-list
154303817|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154303818|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
154303819|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303820|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154303821|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303822|NCT01157481|Nifedipine|nifedipine|mesh-list
154303823|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154303824|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154303825|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303826|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154303827|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303828|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
154303829|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
154303830|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154303831|NCT03894189|Theophylline|theophylline|mesh-list
154303832|NCT03894189|Doxapram|doxapram|mesh-list
154303833|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154303834|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
154303835|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154303836|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303837|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154303838|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
154303839|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154303840|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303842|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
154303847|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154303848|NCT03886311|Nivolumab|nivolumab|mesh-list
154303849|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154303850|NCT03886311|Trabectedin|trabectedin|mesh-list
154303851|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154303852|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303853|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154303854|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820110|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
153461524|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461525|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461526|NCT03261570|Protective Agents|protective agents|mesh-ancestor
153461527|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461528|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154303855|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154303856|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
154303857|NCT01155453|Trametinib|trametinib|mesh-list
154303858|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303859|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154303860|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303861|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303862|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154303905|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303906|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
154303908|NCT01159587|Coagulants|coagulants|mesh-ancestor
154303909|NCT03885297|Liraglutide|liraglutide|mesh-list
154303910|NCT03885297|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154303911|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154303912|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303913|NCT03885297|Incretins|incretins|mesh-ancestor
154303914|NCT03885297|Hormones|hormones|mesh-ancestor
154303915|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154303916|NCT01159821|Paroxetine|paroxetine|mesh-list
154303917|NCT01159821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154303918|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154303919|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154303920|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303921|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154303922|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
154303923|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303924|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154303925|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
154303926|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154303927|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154303929|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303953|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154303954|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154303955|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303956|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
154303957|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154303958|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
154303959|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154303960|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154303961|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154303962|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
154303963|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154303964|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154303965|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154303966|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154303967|NCT01266213|Fulvestrant|fulvestrant|mesh-list
154303968|NCT01266213|Anastrozole|anastrozole|mesh-list
154303969|NCT01266213|Goserelin|goserelin|mesh-list
154303970|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154303971|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154303972|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154304006|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304007|NCT01264341|Sirolimus|sirolimus|mesh-list
154304008|NCT01264341|Bevacizumab|bevacizumab|mesh-list
154304009|NCT01264341|Temsirolimus|temsirolimus|mesh-list
154304010|NCT01264341|MTOR Inhibitors|mtor inhibitors|mesh-list
153461529|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
153461532|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153461533|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
154304011|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154304012|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304013|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154304014|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154304015|NCT01264341|Growth Substances|growth substances|mesh-ancestor
154304016|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304017|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
154304018|NCT01264341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154304019|NCT01264341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050820|NCT00920998|Z 338|z 338|mesh-list
154304020|NCT01264341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304021|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304022|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
154304023|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154304024|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304025|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154304026|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
154304027|NCT01264497|Tesamorelin|tesamorelin|mesh-list
154304028|NCT01264497|Growth Substances|growth substances|mesh-ancestor
154304029|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304057|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154304058|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154304060|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304061|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154304062|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304063|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154304064|NCT01158105|Bortezomib|bortezomib|mesh-list
154304065|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304066|NCT03337490|Ivermectin|ivermectin|mesh-list
154304067|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154304068|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304069|NCT01158183|Interferons|interferons|mesh-list
154304070|NCT01158183|Interferon-beta|interferon-beta|mesh-list
154304071|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
154304072|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304073|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
154304074|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304075|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
154304076|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304077|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154304078|NCT01264575|Epinephrine|epinephrine|mesh-list
154304079|NCT01264575|Racepinephrine|racepinephrine|mesh-list
154304080|NCT01264575|Bupivacaine|bupivacaine|mesh-list
154304081|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
154304082|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
154304083|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
154304084|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304085|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304086|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
154304087|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304098|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
154304105|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154304106|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154304107|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304108|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154304109|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154304110|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154304111|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304112|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154304113|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154304114|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153820111|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304115|NCT03638648|Capecitabine|capecitabine|mesh-list
154304116|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154304117|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
154304118|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304119|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304120|NCT01266759|NuvaRing|nuvaring|mesh-list
153820112|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154304121|NCT01266759|Norethindrone|norethindrone|mesh-list
154304122|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
154304123|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154304124|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
154304125|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154304126|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304127|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154304128|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154304129|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154304130|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154304131|NCT03707990|Semaglutide|semaglutide|mesh-list
154304132|NCT03707990|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154304133|NCT03707990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154304134|NCT03707990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304142|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304143|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154304144|NCT01264653|Epinephrine|epinephrine|mesh-list
154304145|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154304146|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154304147|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
154304148|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304149|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304150|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304151|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154304152|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154304153|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
154304154|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304155|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154304156|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
154304157|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
154304158|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
154304159|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154304160|NCT01266837|Everolimus|everolimus|mesh-list
154304161|NCT01266837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154304162|NCT01266837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154304163|NCT01266837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304164|NCT01266837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304165|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304166|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
154304191|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304193|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154304194|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304195|NCT01158729|Antithrombins|antithrombins|mesh-list
154304196|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
154304197|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154304198|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
154304199|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157392|NCT05805501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154304200|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304201|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
154304202|NCT01262859|Bevacizumab|bevacizumab|mesh-list
154304203|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154304204|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304205|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154304206|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154304207|NCT01262859|Growth Substances|growth substances|mesh-ancestor
154304208|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304209|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
154304210|NCT02527083|Ketamine|ketamine|mesh-list
154304211|NCT02527083|Remifentanil|remifentanil|mesh-list
154304212|NCT02527083|Propofol|propofol|mesh-list
154304213|NCT02527083|Sevoflurane|sevoflurane|mesh-list
154304245|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154304246|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
154304247|NCT05156684|Astringents|astringents|mesh-ancestor
154304248|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
154304249|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
154304250|NCT03883347|Remifentanil|remifentanil|mesh-list
154304251|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154304252|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304253|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304254|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154304255|NCT03883347|Analgesics|analgesics|mesh-ancestor
154304256|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
154304257|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304258|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154304259|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154304260|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154304261|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
154304302|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154304303|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304304|NCT01263171|Leucovorin|leucovorin|mesh-list
154304305|NCT01263171|Fluorouracil|fluorouracil|mesh-list
154304306|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
154304307|NCT01263171|Calcium|calcium|mesh-list
154304308|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
154304309|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154304310|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304311|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
154304312|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304313|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154304314|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304315|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304316|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
154304317|NCT01263171|Antidotes|antidotes|mesh-ancestor
154304318|NCT01263171|Protective Agents|protective agents|mesh-ancestor
154304319|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
154304320|NCT01263171|Vitamins|vitamins|mesh-ancestor
154304321|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
154304322|NCT01156233|Anesthetics|anesthetics|mesh-list
154304323|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304324|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304325|NCT03883269|Ethanol|ethanol|mesh-list
154304326|NCT03883269|Clindamycin|clindamycin|mesh-list
154304327|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
154304328|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
154304329|NCT03883269|Erythromycin|erythromycin|mesh-list
154304353|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
154304354|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304355|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304356|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
154304357|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154304358|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154304359|NCT02891408|Fenofibrate|fenofibrate|mesh-list
154304360|NCT02891408|Firsocostat|firsocostat|mesh-list
154304361|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154304362|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
154304363|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304364|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154304365|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304366|NCT01160991|Olanzapine|olanzapine|mesh-list
154304367|NCT01160991|Amisulpride|amisulpride|mesh-list
154304368|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
154304369|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
154304370|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304371|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304372|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154304373|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154304374|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154304375|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304376|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304377|NCT01160991|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154304392|NCT01161147|Meloxicam|meloxicam|mesh-list
154304399|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304400|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154304401|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154304402|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154304403|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304404|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304405|NCT01161927|Nizatidine|nizatidine|mesh-list
154304406|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154304407|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154304408|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154304409|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
154304410|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
154304411|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304412|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304413|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304414|NCT01267383|Sertraline|sertraline|mesh-list
154304415|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
154304416|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304417|NCT01267383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154304418|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154304419|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154304420|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304421|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304448|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
154304450|NCT01161459|Tacrolimus|tacrolimus|mesh-list
154304451|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304452|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
154304453|NCT01161459|Hormones|hormones|mesh-ancestor
154304454|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304455|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304456|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154304457|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304458|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304459|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
154304460|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154304461|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304462|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304463|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
154304464|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
154304465|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
154304466|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304467|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304468|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
154304469|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304470|NCT03882099|Vitamin D|vitamin d|mesh-list
154304471|NCT03882099|Vitamins|vitamins|mesh-ancestor
154304472|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
153820129|NCT00431990|Dexamethasone|dexamethasone|mesh-list
153461542|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
153461543|NCT04278378|Folic Acid|folic acid|mesh-list
153461544|NCT04278378|Riboflavin|riboflavin|mesh-list
153461545|NCT04278378|Hematinics|hematinics|mesh-ancestor
153461546|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
153461547|NCT04278378|Vitamins|vitamins|mesh-ancestor
153461548|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
153461549|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304473|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304481|NCT04745780|Inositol|inositol|mesh-list
154304497|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154304499|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154304500|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
154304501|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304502|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
154304503|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154304504|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154304505|NCT02833948|Analgesics|analgesics|mesh-ancestor
154304506|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
154304507|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304508|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304509|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154304510|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154304511|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154304512|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154304513|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
154304514|NCT02527005|Azithromycin|azithromycin|mesh-list
154304515|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
154304516|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
154304517|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154304518|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154304519|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304520|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
154304521|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154304522|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154304523|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154304524|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304526|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154304544|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154304545|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304546|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304547|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
154304549|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304550|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154304551|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
154304552|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304553|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
154304554|NCT01156779|Exenatide|exenatide|mesh-list
154304555|NCT01156779|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154304556|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154304557|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304558|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154304559|NCT01156779|Incretins|incretins|mesh-ancestor
154304560|NCT01156779|Hormones|hormones|mesh-ancestor
154304561|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304562|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
154304563|NCT01156857|Progestins|progestins|mesh-list
154304564|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154304565|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
154304566|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154304567|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304568|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154304569|NCT01156857|Hormones|hormones|mesh-ancestor
154304570|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304571|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
154304572|NCT01269333|Omeprazole|omeprazole|mesh-list
154304573|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154304574|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154304575|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154304576|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304577|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304578|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154304579|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154304582|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304583|NCT01269333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154304584|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154304585|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154304586|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304587|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
154304588|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154304589|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
154304590|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154304591|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154304592|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154304593|NCT01269411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154304594|NCT01269411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154304595|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304596|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304597|NCT03882255|Propranolol|propranolol|mesh-list
154304598|NCT03882255|Ponesimod|ponesimod|mesh-list
154304599|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154304600|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154304601|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
154304602|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304628|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304629|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154304630|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154304631|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304632|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
154304633|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
154304634|NCT01268709|Doxepin|doxepin|mesh-list
154304635|NCT01268709|Nortriptyline|nortriptyline|mesh-list
154304636|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154304637|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
154304638|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304639|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154304640|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154304641|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154304642|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304643|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
154304684|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304685|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304686|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154304687|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304688|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154304689|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154304690|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304691|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154304692|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154304693|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154304694|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304695|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304696|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304697|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154304698|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154304699|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
154304700|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304701|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304703|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154304738|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
154304739|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304740|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154304741|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304742|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304743|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
154304744|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304745|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
154304746|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154304747|NCT02891174|Acetaminophen|acetaminophen|mesh-list
154304748|NCT02891174|Ibuprofen|ibuprofen|mesh-list
154304749|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154304750|NCT02891174|Analgesics|analgesics|mesh-ancestor
154304751|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
154304752|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304753|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304754|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
154304755|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154304756|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304757|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154304758|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154304759|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304788|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
154304789|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304790|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304791|NCT02076620|Doxorubicin|doxorubicin|mesh-list
154304792|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154304793|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304794|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154304795|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154304796|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304797|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304798|NCT01270737|Daidzein|daidzein|mesh-list
154304799|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
154304800|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154304801|NCT01270737|Estrogens|estrogens|mesh-ancestor
154304802|NCT01270737|Hormones|hormones|mesh-ancestor
154304803|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304804|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304805|NCT01270815|Pregabalin|pregabalin|mesh-list
154304806|NCT01270815|Analgesics|analgesics|mesh-ancestor
154304807|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
154304808|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304809|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304810|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
154304811|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154304812|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154304813|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304814|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154304815|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154304816|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154304817|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304818|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154304828|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154304829|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304830|NCT01271361|Sirolimus|sirolimus|mesh-list
154304831|NCT01271361|Umirolimus|umirolimus|mesh-list
154304832|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304833|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304834|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
154304835|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304836|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154304837|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304838|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154051650|NCT05229003|Irinotecan|irinotecan|mesh-list
154304839|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304841|NCT03638726|Atropine|atropine|mesh-list
154304842|NCT03638726|Phenylephrine|phenylephrine|mesh-list
154304843|NCT03638726|Epinephrine|epinephrine|mesh-list
154304844|NCT03638726|Racepinephrine|racepinephrine|mesh-list
154304845|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
154304846|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
154304847|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
154304848|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154304849|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154304850|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
154304851|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304852|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304853|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304854|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154304855|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154304856|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
154304857|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154304858|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154304875|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154304876|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304877|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154304878|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154304879|NCT01164189|Growth Substances|growth substances|mesh-ancestor
154304880|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304881|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
154304882|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154304883|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
154304884|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304885|NCT01164267|Everolimus|everolimus|mesh-list
154304886|NCT01164267|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154304887|NCT01164267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154304888|NCT01164267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304889|NCT01164267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304890|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154304891|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
154304892|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304893|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304894|NCT01164345|Plerixafor|plerixafor|mesh-list
154304895|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154304896|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154304897|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
154304898|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154304899|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
154304923|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304924|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154304925|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304926|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154304927|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154304928|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
154304929|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154304930|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304931|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304932|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
154304933|NCT01587261|Vitamins|vitamins|mesh-ancestor
154304934|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
154304935|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304936|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
154304937|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304938|NCT01587261|Protective Agents|protective agents|mesh-ancestor
154304939|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
154304940|NCT01269021|Prednisone|prednisone|mesh-list
154304941|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304942|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
154304943|NCT01269021|Hormones|hormones|mesh-ancestor
154304944|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154304955|NCT01269099|Fentanyl|fentanyl|mesh-list
154304973|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304974|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154304975|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154304976|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154304977|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154304978|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304979|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304981|NCT01165905|ON 01910|on 01910|mesh-list
154304982|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154304983|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
154304984|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154304985|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304986|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154304987|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154304988|NCT01339000|Vaccines|vaccines|mesh-list
154304989|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154304990|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
154304991|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154304992|NCT01269255|Cisplatin|cisplatin|mesh-list
154304993|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154304994|NCT03563170|Leucovorin|leucovorin|mesh-list
154304995|NCT03563170|Paclitaxel|paclitaxel|mesh-list
154304996|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
154304997|NCT03563170|Capecitabine|capecitabine|mesh-list
154304998|NCT03563170|Fluorouracil|fluorouracil|mesh-list
154304999|NCT03563170|Cetuximab|cetuximab|mesh-list
154305000|NCT03563170|Sorafenib|sorafenib|mesh-list
154305001|NCT03563170|Avelumab|avelumab|mesh-list
154305021|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
154305022|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154305023|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154305024|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305025|NCT01281111|Aspirin|aspirin|mesh-list
154305026|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154305027|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154305028|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154305029|NCT01281111|Analgesics|analgesics|mesh-ancestor
154305030|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
154305031|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305032|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305033|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154305034|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154305035|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154305036|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154305037|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305040|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305078|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305079|NCT01283061|Zafirlukast|zafirlukast|mesh-list
154305080|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154305081|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
154305082|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154305083|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
154305084|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154305085|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305086|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154305087|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305088|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
153820171|NCT00462852|Dalteparin|dalteparin|mesh-list
154305089|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154305090|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
154305091|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154305092|NCT01167465|Protective Agents|protective agents|mesh-ancestor
154305093|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305094|NCT01283217|Cisplatin|cisplatin|mesh-list
154305095|NCT01283217|Docetaxel|docetaxel|mesh-list
154305096|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305097|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
154305098|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
154305099|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
154305101|NCT01276431|Buprenorphine|buprenorphine|mesh-list
154305121|NCT01166451|Iron|iron|mesh-list
154305129|NCT01283763|Imiquimod|imiquimod|mesh-list
154305130|NCT01283763|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154305131|NCT01283763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305132|NCT01283763|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154305133|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
154305134|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305135|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154305136|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305137|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
154305138|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
154305139|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154305140|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305141|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154305142|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
154305143|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154305144|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305145|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305146|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305148|NCT03872661|Carboplatin|carboplatin|mesh-list
154305149|NCT03872661|Pemetrexed|pemetrexed|mesh-list
154305150|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154305151|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154305152|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154305153|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154305154|NCT03872661|Growth Substances|growth substances|mesh-ancestor
154305155|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305156|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
154305157|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305176|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
154305177|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154305178|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154305179|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305180|NCT03869073|Evolocumab|evolocumab|mesh-list
154305181|NCT03869073|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154305182|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154305183|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154305184|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
154305185|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305186|NCT03869073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154305187|NCT03869073|Protease Inhibitors|protease inhibitors|mesh-ancestor
154305188|NCT03869073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305189|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154305190|NCT01587495|Ertapenem|ertapenem|mesh-list
154305191|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154305192|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154305193|NCT01170351|Cyclosporine|cyclosporine|mesh-list
154305233|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154305234|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305236|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
154305237|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154305238|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305239|NCT03868137|Ibuprofen|ibuprofen|mesh-list
154305240|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153820173|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153820174|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154305241|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154305242|NCT03868137|Analgesics|analgesics|mesh-ancestor
154305243|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
154305244|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154305245|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154305246|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154305247|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154305248|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154305249|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305250|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305251|NCT01283919|Pantoprazole|pantoprazole|mesh-list
154305252|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154305253|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154305254|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154305255|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305256|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305257|NCT01167933|Simvastatin|simvastatin|mesh-list
154305258|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154305259|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154305260|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
154305261|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154305262|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154305264|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305275|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
154305348|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
154305349|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154305421|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154305570|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
154305572|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154305642|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
154305643|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154305719|NCT01372150|Fluoxetine|fluoxetine|mesh-list
154305787|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154305934|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154305935|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306011|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154306015|NCT01287741|Prednisone|prednisone|mesh-list
154306085|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154306086|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154306159|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154306235|NCT06007222|Aspirin|aspirin|mesh-list
154306309|NCT06006624|Hormones|hormones|mesh-ancestor
154306313|NCT06006624|Anesthetics, Local|anesthetics, local|mesh-ancestor
154306382|NCT05962957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306383|NCT05962957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154306455|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154306456|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154306460|NCT05410782|Vitamins|vitamins|mesh-list
154306528|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154306529|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
154306531|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154306534|NCT04678895|Naltrexone|naltrexone|mesh-list
154306598|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306599|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306600|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154306601|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154306602|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
154306603|NCT04240821|Theophylline|theophylline|mesh-list
154306604|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154306605|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
154306606|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306607|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306608|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154306609|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
153461611|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153461613|NCT04685538|Tetracaine|tetracaine|mesh-list
153461614|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
153461615|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
153461616|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
153461617|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461618|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461619|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
153461620|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306610|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154306611|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306655|NCT04007224|Oxytocin|oxytocin|mesh-list
154306656|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
154306657|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154306727|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154306728|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154306729|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154306730|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
154306731|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154306732|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154306733|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154306734|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
154306735|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154306736|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154306791|NCT01622543|Protective Agents|protective agents|mesh-ancestor
154306793|NCT01622543|Vitamins|vitamins|mesh-ancestor
154306865|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154306937|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154307012|NCT01186497|Rabeprazole|rabeprazole|mesh-list
154307233|NCT01290549|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154307234|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154307306|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154307307|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
154307380|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307453|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
154307527|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154307528|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
154307529|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154307530|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154307531|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
154307532|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154307533|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154307534|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154307535|NCT01297101|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154307536|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154307537|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154307589|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154307590|NCT01191645|Analgesics|analgesics|mesh-ancestor
154307667|NCT01192503|Protective Agents|protective agents|mesh-ancestor
154307737|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154307738|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
154307811|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
154307812|NCT01199523|Mirabegron|mirabegron|mesh-list
154307961|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154307964|NCT01200537|Norinyl|norinyl|mesh-list
154308111|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154308112|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154308113|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308116|NCT05667987|Lidocaine|lidocaine|mesh-list
154308181|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308183|NCT01202331|Azithromycin|azithromycin|mesh-list
154308326|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154308400|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154308401|NCT01206075|Plerixafor|plerixafor|mesh-list
154308475|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154308476|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308547|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154308548|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
154308620|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
154308621|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308622|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308623|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154308624|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154308625|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154308626|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
154308627|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154308629|NCT01297803|Mitomycins|mitomycins|mesh-list
154308630|NCT01297803|Mitomycin|mitomycin|mesh-list
154308686|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
154308687|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154308688|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308757|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154308758|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154308830|NCT03813771|Analgesics|analgesics|mesh-ancestor
154308831|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
154308832|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154308833|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154308905|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154308906|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154308907|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
154308978|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
154309051|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154309053|NCT03803007|Glenzocimab|glenzocimab|mesh-list
154309127|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309128|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154309129|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
154309130|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154309131|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309132|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154309133|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154309134|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154309135|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154309136|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154309187|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154309261|NCT02037802|Meperidine|meperidine|mesh-list
154309262|NCT02037802|Bupivacaine|bupivacaine|mesh-list
154309335|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154309559|NCT02052934|Vaccines|vaccines|mesh-list
154309560|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
154309561|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309562|NCT03810261|Vitamin D|vitamin d|mesh-list
154309563|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
154309564|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
154309565|NCT03810261|Vitamins|vitamins|mesh-list
154309566|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
154309567|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309568|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154309569|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154309570|NCT02037724|Iron|iron|mesh-list
154309571|NCT02037724|Trace Elements|trace elements|mesh-ancestor
154309572|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
154309573|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309574|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154309575|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154309620|NCT02801578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154309622|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154309623|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154309624|NCT03794505|Prednisolone|prednisolone|mesh-list
154309625|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
154309626|NCT03794505|Lidocaine|lidocaine|mesh-list
154309627|NCT03794505|Ropivacaine|ropivacaine|mesh-list
154309628|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154309629|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
154309630|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
154309631|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
154309632|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154309646|NCT03794505|Hormones|hormones|mesh-ancestor
154309681|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154309682|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154309758|NCT03789123|Estrogens|estrogens|mesh-ancestor
154309832|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154309833|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154309907|NCT03790371|Misoprostol|misoprostol|mesh-list
154309980|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154309984|NCT01308255|Vitamins|vitamins|mesh-list
154310054|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154310055|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154310126|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
154310127|NCT01561209|Amitriptyline|amitriptyline|mesh-list
154310128|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154310129|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
154310130|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154310196|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310197|NCT02054806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154310198|NCT02054806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310199|NCT02054884|Paclitaxel|paclitaxel|mesh-list
154310200|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154310201|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154310202|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310203|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
154310204|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
154310205|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
154310206|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310207|NCT01333072|Risperidone|risperidone|mesh-list
154310258|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310259|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310260|NCT02055274|Rotigotine|rotigotine|mesh-list
154310261|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
154310262|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
154310270|NCT03783897|Estradiol|estradiol|mesh-list
154310329|NCT03560908|Dasatinib|dasatinib|mesh-list
154310330|NCT03560908|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154310331|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154310332|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310333|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310334|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310400|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310401|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154310402|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154310403|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154310405|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310470|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154310471|NCT02060266|Semaglutide|semaglutide|mesh-list
154310472|NCT02060266|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154310473|NCT02060266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154310474|NCT02060266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310475|NCT03777345|Cobalt|cobalt|mesh-list
154310476|NCT03777345|Chromium|chromium|mesh-list
154310477|NCT03777345|Trace Elements|trace elements|mesh-ancestor
154310478|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
154310479|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310535|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
154310536|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154310537|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310538|NCT03308786|Aldesleukin|aldesleukin|mesh-list
154310539|NCT03308786|Interleukin-2|interleukin-2|mesh-list
154310540|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310541|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154310543|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
154310544|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154310545|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310546|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154310547|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154310548|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
154310549|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154310597|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154310598|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310599|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
154310670|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154310671|NCT03774693|Fentanyl|fentanyl|mesh-list
154310745|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310746|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
154310747|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154310748|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154310749|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154310815|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
154310816|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154310817|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310888|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154310889|NCT01370356|Varenicline|varenicline|mesh-list
154310958|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154310959|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
154311031|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154311107|NCT03764241|Vitamins|vitamins|mesh-ancestor
154311177|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154311249|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311250|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311319|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
154311395|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
154311396|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154311470|NCT06264141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154311546|NCT06262581|Tislelizumab|tislelizumab|mesh-list
154311622|NCT06256601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154311693|NCT06137690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154311694|NCT06137690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311695|NCT06137690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311696|NCT06137690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154311697|NCT06137690|Hormone Antagonists|hormone antagonists|mesh-ancestor
154311698|NCT06137690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311759|NCT05959629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154311760|NCT05928390|Pasireotide|pasireotide|mesh-list
154311761|NCT05928390|Hormones|hormones|mesh-ancestor
154311762|NCT05928390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154311763|NCT05928390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311764|NCT05898399|Olaparib|olaparib|mesh-list
154311765|NCT05898399|Talazoparib|talazoparib|mesh-list
154311766|NCT05898399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154311767|NCT05898399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154311768|NCT05898399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311769|NCT05898399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311822|NCT05759000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311823|NCT05754424|Insulin Aspart|insulin aspart|mesh-list
154311824|NCT05754424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154311825|NCT05754424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311826|NCT05743907|Dapagliflozin|dapagliflozin|mesh-list
154311827|NCT05743907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154311828|NCT05743907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311829|NCT05743907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154311830|NCT05743907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311831|NCT05736224|Sunscreening Agents|sunscreening agents|mesh-list
154311832|NCT05736224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154311833|NCT05736224|Protective Agents|protective agents|mesh-ancestor
154311834|NCT05736224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311835|NCT05736224|Dermatologic Agents|dermatologic agents|mesh-ancestor
154311836|NCT05722067|Calcium|calcium|mesh-list
154311837|NCT05722067|Ionophores|ionophores|mesh-list
154311838|NCT05722067|Calcium Ionophores|calcium ionophores|mesh-list
154311839|NCT05722067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154311840|NCT05722067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311841|NCT05722067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154311843|NCT05673785|Prednisone|prednisone|mesh-list
154311874|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311875|NCT05664191|Protective Agents|protective agents|mesh-ancestor
154311876|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311877|NCT05655949|Cisplatin|cisplatin|mesh-list
154311878|NCT05655949|Gemcitabine|gemcitabine|mesh-list
154311879|NCT05655949|Durvalumab|durvalumab|mesh-list
154311880|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154311881|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154311882|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
154311883|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154311884|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154311885|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
154311886|NCT05644873|Analgesics|analgesics|mesh-ancestor
154311887|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
154311888|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154311889|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154311890|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
154311930|NCT05548023|Sirolimus|sirolimus|mesh-list
154312005|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154312006|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154312007|NCT05197270|Growth Substances|growth substances|mesh-ancestor
154312077|NCT04999761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154312078|NCT04999761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154312079|NCT04999761|Growth Substances|growth substances|mesh-ancestor
154312080|NCT04999761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312081|NCT04999761|Growth Inhibitors|growth inhibitors|mesh-ancestor
154312095|NCT04810546|Lactoferrin|lactoferrin|mesh-list
154312096|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312097|NCT04802161|Cytarabine|cytarabine|mesh-list
154312098|NCT04802161|Thalidomide|thalidomide|mesh-list
154312099|NCT04802161|Daunorubicin|daunorubicin|mesh-list
154312100|NCT04802161|Pomalidomide|pomalidomide|mesh-list
154312101|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154312102|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
154312103|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312104|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312105|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
154312106|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312107|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312136|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154312138|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312139|NCT04667078|Cangrelor|cangrelor|mesh-list
154312140|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154312141|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154312142|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154312143|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154312144|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
154312145|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312198|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
154312199|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312200|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154312201|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154312202|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154312203|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312204|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154312205|NCT04522336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154312206|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
154312207|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154312208|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312209|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
154312210|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312211|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
154312216|NCT04283617|Insulin|insulin|mesh-list
154312256|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154312257|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154312258|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154312259|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312260|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
154312261|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312262|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312264|NCT04211675|Temozolomide|temozolomide|mesh-list
154312265|NCT04211675|Dinutuximab|dinutuximab|mesh-list
154312266|NCT04211675|Sargramostim|sargramostim|mesh-list
154312276|NCT04188405|Venetoclax|venetoclax|mesh-list
154312318|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154312319|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154312320|NCT03997786|Analgesics|analgesics|mesh-ancestor
154312321|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
154312322|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154312323|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154312324|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154312325|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154312326|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154312327|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154312328|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
154312329|NCT03967288|Bupivacaine|bupivacaine|mesh-list
154312330|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
154312379|NCT03866668|Esomeprazole|esomeprazole|mesh-list
154312380|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154312381|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154312382|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154312383|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154312448|NCT03539731|Piperazine|piperazine|mesh-list
154312449|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
154312450|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
154312520|NCT03247972|Evolocumab|evolocumab|mesh-list
154312592|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154312668|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
154312669|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
154312670|NCT02681549|Bevacizumab|bevacizumab|mesh-list
154312741|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154312742|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154312743|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154312744|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154312745|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154312746|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
154312747|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154312748|NCT00580437|Dobutamine|dobutamine|mesh-list
154312810|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154312886|NCT02071888|Pomalidomide|pomalidomide|mesh-list
154312887|NCT02071888|BB 1101|bb 1101|mesh-list
154312888|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154312957|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154312958|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154312959|NCT04534491|Urological Agents|urological agents|mesh-ancestor
154312960|NCT02069080|Plerixafor|plerixafor|mesh-list
154312961|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154312962|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154313026|NCT02070406|Fludarabine|fludarabine|mesh-list
154313027|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
154313028|NCT02070406|Interleukin-2|interleukin-2|mesh-list
154313029|NCT02070406|Vaccines|vaccines|mesh-list
154313030|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154313031|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154313032|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
154313033|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313096|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154313097|NCT02079220|Growth Substances|growth substances|mesh-ancestor
154313098|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313099|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
154313100|NCT02079298|Fluconazole|fluconazole|mesh-list
154313101|NCT02079298|Ibuprofen|ibuprofen|mesh-list
154313102|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154313103|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154313104|NCT02079298|Analgesics|analgesics|mesh-ancestor
154313109|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313158|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
154313232|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
154313310|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154313386|NCT02073916|Trastuzumab|trastuzumab|mesh-list
154313388|NCT02073916|Lapatinib|lapatinib|mesh-list
154313462|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154313463|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154313465|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154313466|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154313531|NCT02792218|Analgesics|analgesics|mesh-ancestor
154313532|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
154313603|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154313604|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154313605|NCT03749733|Estradiol|estradiol|mesh-list
154313606|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154313607|NCT03749733|Estrogens|estrogens|mesh-ancestor
154313608|NCT03749733|Hormones|hormones|mesh-ancestor
154313610|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313674|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
154313675|NCT02090920|Nifedipine|nifedipine|mesh-list
154313676|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154313747|NCT02088424|Insulin|insulin|mesh-list
154313748|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154313749|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313750|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154313751|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154313817|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154313818|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154313819|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
154313820|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154313821|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154313822|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154313823|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154313824|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313825|NCT00187889|Eplerenone|eplerenone|mesh-list
154313826|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154313827|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
154313879|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313880|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154313881|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154313952|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154313953|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313954|NCT04292535|Insulin|insulin|mesh-list
154313955|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154313956|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
154313957|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
154313958|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154313959|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154313960|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154313961|NCT03747081|Warfarin|warfarin|mesh-list
154313962|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
154313970|NCT01075841|Cetuximab|cetuximab|mesh-list
154314018|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
154314019|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
154314033|NCT02095834|Ichthammol|ichthammol|mesh-list
154314090|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
154314091|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314115|NCT02089438|Hormones|hormones|mesh-ancestor
154314162|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
154314163|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314164|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314165|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154314166|NCT02094196|Ethanol|ethanol|mesh-list
154314167|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154314168|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154314169|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314170|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314172|NCT02094274|Xhance|xhance|mesh-list
154314226|NCT02095366|Sufentanil|sufentanil|mesh-list
154314227|NCT02095366|Morphine|morphine|mesh-list
154314228|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154314229|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154314230|NCT02095366|Narcotics|narcotics|mesh-ancestor
154314231|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154314232|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314233|NCT02095366|Analgesics|analgesics|mesh-ancestor
154314234|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
154314238|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
154314296|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154314371|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154314373|NCT02098330|Protective Agents|protective agents|mesh-ancestor
154314444|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154314516|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314589|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154314590|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154314591|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
154061461|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
154061537|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
154314741|NCT03258710|Tenofovir|tenofovir|mesh-list
154314807|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154314880|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
154314881|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
154314882|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314883|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154314884|NCT03230864|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154314885|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154314886|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154314887|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
154314888|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154314947|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154314948|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
154314949|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
154314950|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154314951|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
154314952|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154314953|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154314954|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154314955|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
154314956|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
154314957|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154315010|NCT03694197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315012|NCT03694197|Protease Inhibitors|protease inhibitors|mesh-ancestor
154315083|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154315160|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154315306|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154315307|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315308|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154315309|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
154315375|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154315376|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
154315377|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154315378|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154315379|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315380|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
154315381|NCT02117128|Coagulants|coagulants|mesh-ancestor
154315382|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
154315383|NCT00175877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154315384|NCT00175877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154315385|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154315438|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154315439|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154315440|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154315441|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315442|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
154315443|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154315444|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
154315507|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
154315508|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154315579|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154315580|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154315650|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315721|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
154315722|NCT02128360|Letrozole|letrozole|mesh-list
154315723|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154315795|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315796|NCT06149117|Azithromycin|azithromycin|mesh-list
154315872|NCT06148025|Immunologic Factors|immunologic factors|mesh-ancestor
154315948|NCT06119490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154315949|NCT06116201|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154315950|NCT06116201|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154315951|NCT06116201|Estradiol|estradiol|mesh-list
154315952|NCT06116201|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154315953|NCT06116201|Androgens|androgens|mesh-list
154315954|NCT06116201|Androgen Antagonists|androgen antagonists|mesh-list
154315955|NCT06116201|Estrogens|estrogens|mesh-ancestor
154315956|NCT06116201|Hormones|hormones|mesh-ancestor
154315957|NCT06116201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154315958|NCT06116201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154315959|NCT06116201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154315960|NCT06116201|Contraceptive Agents|contraceptive agents|mesh-ancestor
154315961|NCT06116201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154315964|NCT06115538|Levodopa|levodopa|mesh-list
154316006|NCT06077786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154316007|NCT06077786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316008|NCT06077786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154316010|NCT06065176|Immunologic Factors|immunologic factors|mesh-ancestor
154316011|NCT06065176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316012|NCT06056583|Cimetidine|cimetidine|mesh-list
154316013|NCT06056583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154316014|NCT06056583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154316015|NCT06056583|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154316016|NCT06056583|Histamine Antagonists|histamine antagonists|mesh-ancestor
154316017|NCT06056583|Histamine Agents|histamine agents|mesh-ancestor
154316018|NCT06056583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316069|NCT05986773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316070|NCT05986773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153820241|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153820242|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153820243|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
153461661|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
153461662|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461663|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154316071|NCT05986773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154316072|NCT05962424|Ketamine|ketamine|mesh-list
154316142|NCT05665140|Bortezomib|bortezomib|mesh-list
154316143|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154316144|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
154316145|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
154316217|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
154316218|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316219|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316220|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
154316221|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316222|NCT05523661|Dasatinib|dasatinib|mesh-list
154316223|NCT05523661|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154316224|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154316225|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316280|NCT05418556|Clopidogrel|clopidogrel|mesh-list
154316281|NCT05418556|Ticagrelor|ticagrelor|mesh-list
154316282|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154316283|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154316284|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154316285|NCT05418556|Analgesics|analgesics|mesh-ancestor
154316286|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
154316287|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316288|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316289|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154316290|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154316291|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154316292|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154316293|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316294|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154316295|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154316296|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154316297|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
154316298|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154316299|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154316300|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154316301|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
154316302|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154316303|NCT05399602|Anesthetics|anesthetics|mesh-list
154316304|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316305|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316306|NCT05393817|Caffeine|caffeine|mesh-list
154316307|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
154316308|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154316309|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154316321|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
154316322|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316323|NCT05345249|Ropivacaine|ropivacaine|mesh-list
154316324|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
154316325|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
154316326|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154316397|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154316398|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
154316399|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154316470|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
154316471|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316472|NCT04854551|Naltrexone|naltrexone|mesh-list
154316473|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154316474|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154316475|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154316476|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
154316477|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154316478|NCT04817254|Nivolumab|nivolumab|mesh-list
154316479|NCT04817254|Ipilimumab|ipilimumab|mesh-list
154316480|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154316536|NCT04685616|Dacarbazine|dacarbazine|mesh-list
154316537|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154316611|NCT04670679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154316613|NCT04650841|Naloxone|naloxone|mesh-list
154316687|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154316688|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
154316690|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154316759|NCT03805932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154316836|NCT03681275|Tofacitinib|tofacitinib|mesh-list
154316911|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154316986|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317062|NCT02804126|Bupivacaine|bupivacaine|mesh-list
154317063|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
154317064|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
154317065|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317066|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317068|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154317069|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154317070|NCT02804126|Narcotics|narcotics|mesh-ancestor
154317071|NCT02804126|Analgesics|analgesics|mesh-ancestor
154317135|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317136|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
154317148|NCT02181738|Doxorubicin|doxorubicin|mesh-list
154317280|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154317281|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317282|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317283|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
154317284|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154317288|NCT02252614|Narcotics|narcotics|mesh-ancestor
154317348|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
154317349|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154317350|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317351|NCT01074905|Artesunate|artesunate|mesh-list
154317352|NCT01074905|Chloroquine|chloroquine|mesh-list
154317353|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154317354|NCT01074905|Primaquine|primaquine|mesh-list
154317355|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
154317356|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154317357|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154317420|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154317423|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317492|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317500|NCT02252458|Fentanyl|fentanyl|mesh-list
154317566|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154317567|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317715|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
154317716|NCT05578456|Hormones|hormones|mesh-ancestor
154317788|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317789|NCT00129467|Methylphenidate|methylphenidate|mesh-list
154317864|NCT00133991|Vincristine|vincristine|mesh-list
154317865|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154317866|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
154317867|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154317868|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154317869|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154317870|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
154317871|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154317872|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154317873|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154317874|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154317875|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154317876|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
154317877|NCT00133991|Hormones|hormones|mesh-ancestor
154317878|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154317923|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154317924|NCT03549832|Ritonavir|ritonavir|mesh-list
154317925|NCT03549832|Ribavirin|ribavirin|mesh-list
154317926|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
154317927|NCT03549832|Simeprevir|simeprevir|mesh-list
154317997|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154317999|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
154318067|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
154318068|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318069|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154318070|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154318071|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
154318139|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318211|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154318212|NCT02253862|Ritonavir|ritonavir|mesh-list
154318213|NCT02253862|Tipranavir|tipranavir|mesh-list
154318214|NCT02253862|Tadalafil|tadalafil|mesh-list
154318215|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154318216|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154318217|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
154318218|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154318219|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318220|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154318221|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154318222|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
154318223|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154318224|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154318226|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
154065033|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
154318344|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318354|NCT02254018|Immunotoxins|immunotoxins|mesh-ancestor
154318416|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154318492|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318493|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154318496|NCT02143570|Darifenacin|darifenacin|mesh-list
154318565|NCT00108082|Atenolol|atenolol|mesh-list
154318637|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154318638|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154318640|NCT02148094|Tenofovir|tenofovir|mesh-list
154318709|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
154318710|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154318779|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
154318852|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154318930|NCT02254954|Temozolomide|temozolomide|mesh-list
154319001|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154319002|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154319003|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
154319074|NCT02770612|Analgesics|analgesics|mesh-ancestor
154319075|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
154319076|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319077|NCT03542110|Alirocumab|alirocumab|mesh-list
154319078|NCT03542110|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154319141|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154319142|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154319143|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154319144|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154319145|NCT02255266|Liraglutide|liraglutide|mesh-list
154319146|NCT02255266|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154319147|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319148|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319149|NCT02255266|Incretins|incretins|mesh-ancestor
154319151|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319152|NCT00104650|Diphosphonates|diphosphonates|mesh-list
154319153|NCT00104650|Denosumab|denosumab|mesh-list
154319154|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154319155|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319156|NCT02158078|Insulin|insulin|mesh-list
154319157|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154319171|NCT02149888|Tenofovir|tenofovir|mesh-list
154319198|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154319199|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
154319200|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154319201|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319202|NCT01310361|Amoxicillin|amoxicillin|mesh-list
154319203|NCT01310361|Penicillins|penicillins|mesh-list
154319204|NCT01310361|Penicillin G|penicillin g|mesh-list
154319205|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154319206|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
154319266|NCT00121199|Growth Substances|growth substances|mesh-ancestor
154319267|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
154319268|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154319269|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154319270|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154319271|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154319272|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154319273|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
154319274|NCT00121199|Hormones|hormones|mesh-ancestor
154319275|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154319276|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154319277|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154319278|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
154319279|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
154319280|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
154319281|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
154319283|NCT00119015|Fluticasone|fluticasone|mesh-list
154319322|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319396|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
154319471|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154319476|NCT04949516|Aspirin|aspirin|mesh-list
154319543|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154319617|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154319618|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
154319690|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
154319767|NCT01310283|Fluorides|fluorides|mesh-list
154319768|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
154319769|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
154319770|NCT01310283|Protective Agents|protective agents|mesh-ancestor
154319771|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154319772|NCT02161822|Simvastatin|simvastatin|mesh-list
154319774|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154319835|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
154319984|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320057|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154320058|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154320131|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154320132|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154320133|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
154320134|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
153820260|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
153820267|NCT00463203|Irinotecan|irinotecan|mesh-list
154320135|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320201|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320202|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154320203|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154320204|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320205|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320206|NCT03977441|Pramipexole|pramipexole|mesh-list
154320207|NCT03977441|Agomelatine|agomelatine|mesh-list
154320208|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
154066971|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154320209|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320210|NCT03977441|Protective Agents|protective agents|mesh-ancestor
154320211|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320212|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154320213|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154320214|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
154320215|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
154320216|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320217|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154320218|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320256|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320257|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154320258|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154320259|NCT03723291|Tocopherols|tocopherols|mesh-list
154320260|NCT03723291|Vitamin E|vitamin e|mesh-list
154320261|NCT03723291|Tocotrienols|tocotrienols|mesh-list
154320262|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
154320263|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
154320264|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154320265|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320266|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320267|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154320268|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154320269|NCT03723291|Protective Agents|protective agents|mesh-ancestor
154320270|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320271|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
154320272|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154320273|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
154320274|NCT03723291|Vitamins|vitamins|mesh-ancestor
154320275|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
154320276|NCT00111761|Leucovorin|leucovorin|mesh-list
154320277|NCT00111761|Fluorouracil|fluorouracil|mesh-list
154320278|NCT00111761|Irinotecan|irinotecan|mesh-list
154320279|NCT00111761|Panitumumab|panitumumab|mesh-list
154320280|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
154320281|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320282|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154320283|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320284|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154320285|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
154320286|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320303|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320304|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
154320305|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154320306|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320307|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
154320308|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
154320309|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154320310|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154320372|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154320373|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154320374|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153461708|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153461709|NCT05158062|Growth Substances|growth substances|mesh-ancestor
154320375|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154320376|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
154320377|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154320378|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
154320379|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320380|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
154320381|NCT02165020|Protective Agents|protective agents|mesh-ancestor
154320382|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
154320383|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320384|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320385|NCT03539224|Lamivudine|lamivudine|mesh-list
154320386|NCT03539224|Dolutegravir|dolutegravir|mesh-list
154320387|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154320388|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154320389|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320390|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320391|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
154320392|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320393|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154320394|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154320424|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154320425|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320426|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320427|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154320428|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154320429|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154320430|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154320431|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320432|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154320433|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154320435|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154320436|NCT02171494|Warfarin|warfarin|mesh-list
154320437|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
154320438|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
154320439|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154320440|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154320441|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320442|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154320443|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154320444|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320445|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320474|NCT02169154|Menthol|menthol|mesh-list
154320475|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154320476|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154320477|NCT02169154|Analgesics|analgesics|mesh-ancestor
154320478|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
154320479|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320480|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320481|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154320482|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154320483|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154320484|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320485|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320486|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
154320487|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
154320488|NCT00100048|Tenofovir|tenofovir|mesh-list
154320489|NCT00100048|Lamivudine|lamivudine|mesh-list
154320490|NCT00100048|Efavirenz|efavirenz|mesh-list
154320491|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
154320492|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
154320493|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820277|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820278|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820279|NCT00471549|Simvastatin|simvastatin|mesh-list
154320494|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154320495|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154320496|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320497|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320498|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154320499|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154320500|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154320501|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154320502|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154320503|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154320522|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320523|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320524|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320525|NCT02165644|Nimodipine|nimodipine|mesh-list
154320526|NCT02165644|Acetazolamide|acetazolamide|mesh-list
154320527|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
154320528|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154320529|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320530|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320531|NCT02165644|Diuretics|diuretics|mesh-ancestor
154320532|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
154320533|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320534|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154320535|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154320536|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154320537|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154320538|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
154320539|NCT02171806|Olodaterol|olodaterol|mesh-list
154320540|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154320541|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
154320542|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320543|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320544|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154320545|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
154320546|NCT02169544|Abatacept|abatacept|mesh-list
154320547|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154320548|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320549|NCT02169544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154320550|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320551|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154320552|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
154320553|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320554|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154320555|NCT02169856|Cefuroxime|cefuroxime|mesh-list
154320556|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
154320557|NCT02169856|Ketorolac|ketorolac|mesh-list
154320558|NCT02169856|Midazolam|midazolam|mesh-list
154320559|NCT02169856|Propofol|propofol|mesh-list
154320560|NCT02169856|Sevoflurane|sevoflurane|mesh-list
154320561|NCT02169856|Atracurium|atracurium|mesh-list
154320562|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154320563|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320564|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320565|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154320566|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
154320567|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
154320568|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154320569|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154320570|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154320571|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154320572|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
154320573|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
154320574|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320575|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320576|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154320577|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154320578|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154320579|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154320580|NCT02169856|Analgesics|analgesics|mesh-ancestor
154320581|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
154320582|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320583|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154320584|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154320585|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154320586|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067352|NCT00659230|Dopamine|dopamine|mesh-list
154320587|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154320588|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320589|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154320591|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154320592|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154320593|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154320594|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
154320595|NCT02170246|Telmisartan|telmisartan|mesh-list
154320596|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154320597|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154320598|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154320599|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320600|NCT02170324|Exenatide|exenatide|mesh-list
154320601|NCT02170324|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154320602|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320603|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320604|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154320605|NCT02170324|Incretins|incretins|mesh-ancestor
154320606|NCT02170324|Hormones|hormones|mesh-ancestor
154320607|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154320608|NCT02170402|Factor VIII|factor viii|mesh-list
154320609|NCT02170402|Coagulants|coagulants|mesh-ancestor
154320610|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154320611|NCT02172196|Empagliflozin|empagliflozin|mesh-list
154320612|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320613|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320614|NCT02172196|Incretins|incretins|mesh-ancestor
154320615|NCT02172196|Hormones|hormones|mesh-ancestor
154320616|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154320617|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154320618|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
154320619|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320620|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320632|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154320633|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
154320634|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
154320635|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154320636|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
154320637|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320638|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320639|NCT02757352|Ixekizumab|ixekizumab|mesh-list
154320640|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
154320641|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
154320642|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154320643|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
154320644|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320645|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320646|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154320647|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
154320648|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
154320649|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154320650|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
154320651|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320652|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320653|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
154320654|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154320655|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
154320656|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320657|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320658|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154320678|NCT02170636|Pantoprazole|pantoprazole|mesh-list
154320679|NCT02170636|Dabigatran|dabigatran|mesh-list
154320680|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154320681|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154320682|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154320683|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320684|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320685|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
154320686|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154320687|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
154320688|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
154320689|NCT02255734|Acyclovir|acyclovir|mesh-list
154320690|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
154320691|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320692|NCT02170792|Ranitidine|ranitidine|mesh-list
154320693|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154320694|NCT02170792|Dabigatran|dabigatran|mesh-list
154320695|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154320696|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154320697|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154320698|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
154320699|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
154320700|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320701|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320702|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320703|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
154320704|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154320707|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
154320729|NCT02173288|Spironolactone|spironolactone|mesh-list
154320731|NCT02173288|Midodrine|midodrine|mesh-list
154320732|NCT02173288|Diuretics|diuretics|mesh-ancestor
154320733|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
154320734|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320735|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154067500|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
154320736|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154320737|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320738|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154320739|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
154320740|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154320741|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154320742|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154320743|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
154320744|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
154320745|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320746|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154320747|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154320748|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154320749|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154320750|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
154320751|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320752|NCT02175394|Linagliptin|linagliptin|mesh-list
154320753|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154320772|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154320773|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154320774|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154320775|NCT02256124|Lamotrigine|lamotrigine|mesh-list
154320776|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
154320777|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154320778|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154320779|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320780|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154320781|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320782|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154320783|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154320784|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320785|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154320786|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154320787|NCT02173756|Morphine|morphine|mesh-list
154320788|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154320789|NCT02173756|Narcotics|narcotics|mesh-ancestor
154320790|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320791|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320823|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154320824|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154320825|NCT02173990|Growth Substances|growth substances|mesh-ancestor
154320826|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320827|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
154320828|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320830|NCT02255812|Citric Acid|citric acid|mesh-list
154320831|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
154320832|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
154320833|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154320834|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154320835|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154320836|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154320837|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320838|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154320839|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320840|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154320841|NCT02255812|Analgesics|analgesics|mesh-ancestor
154320842|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
154320843|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
154320844|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154320845|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
154320846|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
154320847|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320848|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
154320849|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154320850|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320851|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154320852|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320853|NCT02256280|Neostigmine|neostigmine|mesh-list
154320854|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154320855|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320865|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154320866|NCT02174068|Analgesics|analgesics|mesh-ancestor
154320867|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
154320868|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360281|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
153360282|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
154320869|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320870|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
154320871|NCT02179294|Meperidine|meperidine|mesh-list
154320872|NCT02179294|Remifentanil|remifentanil|mesh-list
154320873|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154320874|NCT02179294|Narcotics|narcotics|mesh-ancestor
154320875|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320876|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320877|NCT02179294|Analgesics|analgesics|mesh-ancestor
154320878|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
154320879|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320880|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154320881|NCT02179528|Etoposide|etoposide|mesh-list
154320882|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154320883|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320884|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154320886|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320887|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320888|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
154320889|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
154320890|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320891|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320892|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154320894|NCT02182102|Pemetrexed|pemetrexed|mesh-list
154320913|NCT02182258|Nintedanib|nintedanib|mesh-list
154320914|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154320915|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154320916|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154320917|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320918|NCT02182336|Vitamin K|vitamin k|mesh-list
154320919|NCT02182336|Digoxin|digoxin|mesh-list
154320920|NCT02182336|Midazolam|midazolam|mesh-list
154320921|NCT02182336|Levomethorphan|levomethorphan|mesh-list
154320922|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
154320923|NCT02182336|Caffeine|caffeine|mesh-list
154320924|NCT02182336|Omeprazole|omeprazole|mesh-list
154320925|NCT02182336|Warfarin|warfarin|mesh-list
154320926|NCT02182336|Vitamins|vitamins|mesh-ancestor
154320927|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
154320928|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320929|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154320930|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154320931|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320932|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154320933|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154320934|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154320935|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154320936|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
154320969|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154320970|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
154320971|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
154320972|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154320973|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154320974|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320975|NCT02182648|Propofol|propofol|mesh-list
154320976|NCT02182648|Etomidate|etomidate|mesh-list
154320977|NCT02182648|Sevoflurane|sevoflurane|mesh-list
154320978|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154320979|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154320980|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320981|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154320982|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
154320983|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
154320984|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154320985|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154320986|NCT02179996|Vaccines|vaccines|mesh-list
154320987|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
154320988|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154320989|NCT02177344|Bromides|bromides|mesh-list
154320990|NCT02177344|Ipratropium|ipratropium|mesh-list
154320991|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
154320992|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154320993|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
154320994|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154320995|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321018|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154321019|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321020|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154321021|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154321022|NCT02182960|Ibuprofen|ibuprofen|mesh-list
154321023|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321024|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321025|NCT02182960|Analgesics|analgesics|mesh-ancestor
154321026|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
154321027|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321028|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321029|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321030|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321031|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154321032|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321033|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321034|NCT05141968|Vitamin D|vitamin d|mesh-list
154321035|NCT05141968|Vitamins|vitamins|mesh-ancestor
154321037|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321038|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154321039|NCT00110357|Irinotecan|irinotecan|mesh-list
154321040|NCT00110357|Cetuximab|cetuximab|mesh-list
154321070|NCT00293033|Analgesics|analgesics|mesh-ancestor
154321071|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
154321072|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321073|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154321074|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154321075|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
154321076|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
154321077|NCT02183116|Meloxicam|meloxicam|mesh-list
154321078|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321079|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321080|NCT02183116|Analgesics|analgesics|mesh-ancestor
154321081|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
154321082|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321083|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321084|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321085|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321086|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154321087|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154321088|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321089|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321090|NCT02183194|Paclitaxel|paclitaxel|mesh-list
154321091|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154321092|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321093|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
154321094|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
154321095|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
154321096|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321097|NCT02183272|Ketamine|ketamine|mesh-list
154321098|NCT02183272|Analgesics|analgesics|mesh-ancestor
154321114|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154321115|NCT02177500|Diuretics|diuretics|mesh-ancestor
154321116|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
154321117|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321118|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154321119|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154321120|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321121|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154321122|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154321123|NCT02183350|Linagliptin|linagliptin|mesh-list
154321124|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321125|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321126|NCT02183350|Incretins|incretins|mesh-ancestor
154321127|NCT02183350|Hormones|hormones|mesh-ancestor
154321128|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321129|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154321130|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
154321131|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321132|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321133|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154321134|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
154321135|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154321136|NCT02183428|Glyburide|glyburide|mesh-list
154321137|NCT02183428|Linagliptin|linagliptin|mesh-list
154321138|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321139|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321140|NCT02183428|Incretins|incretins|mesh-ancestor
154321141|NCT02183428|Hormones|hormones|mesh-ancestor
154321147|NCT01080911|Morphine|morphine|mesh-list
154321159|NCT02183506|Incretins|incretins|mesh-ancestor
154321161|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321162|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154321163|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
154321164|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321165|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321166|NCT02177734|Vaccines|vaccines|mesh-list
154321167|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
154321168|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321169|NCT02183584|Linagliptin|linagliptin|mesh-list
154321170|NCT02183584|Rifampin|rifampin|mesh-list
154321171|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154321172|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
154321173|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154321174|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321175|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
154321176|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154321177|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321178|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321179|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154321180|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154321181|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154321182|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154321183|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154321184|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154321185|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321186|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321187|NCT02183584|Incretins|incretins|mesh-ancestor
154321188|NCT02183584|Hormones|hormones|mesh-ancestor
154321189|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321190|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154321191|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
154321192|NCT01068353|Etanercept|etanercept|mesh-list
154321195|NCT01068353|Analgesics|analgesics|mesh-ancestor
154321196|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
154321197|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321198|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321199|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321200|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321201|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154321202|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154321203|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
154321204|NCT01083251|Vitamin D|vitamin d|mesh-list
154321205|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
154321206|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
154321207|NCT01083251|Vitamins|vitamins|mesh-list
154321208|NCT01083251|Entecavir|entecavir|mesh-list
153820316|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321209|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
153820317|NCT00471588|Pramipexole|pramipexole|mesh-list
153820318|NCT00471588|Amisulpride|amisulpride|mesh-list
154321210|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321211|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154321212|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154321213|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
154321214|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321215|NCT02184052|Meloxicam|meloxicam|mesh-list
154321216|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321217|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321218|NCT02184052|Analgesics|analgesics|mesh-ancestor
154321219|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
154321220|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321221|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321222|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321223|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321224|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154321225|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154321226|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321228|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
154321237|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321238|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154321239|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
154321240|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
154321241|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154321242|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154321243|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321244|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
154321245|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
154321246|NCT02181322|Meloxicam|meloxicam|mesh-list
154321247|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321248|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321249|NCT02181322|Analgesics|analgesics|mesh-ancestor
154321250|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
154321251|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321252|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321253|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321254|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321255|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154321256|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154321257|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321258|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321260|NCT02184286|Saquinavir|saquinavir|mesh-list
154321261|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154321262|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154321263|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321264|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321265|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
154321266|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321267|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154321268|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154321269|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154321270|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154321277|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154321279|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321280|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
154321281|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321282|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321283|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
154321284|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
153820319|NCT00471588|Dexpramipexole|dexpramipexole|mesh-list
153360313|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360314|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154321285|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154321286|NCT02030314|Diuretics|diuretics|mesh-ancestor
154321287|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
154321288|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321289|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154321290|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154321291|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321292|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154321293|NCT02184364|Estrogens|estrogens|mesh-ancestor
154321294|NCT02184364|Hormones|hormones|mesh-ancestor
154321295|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321296|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321297|NCT02181478|Cyclosporine|cyclosporine|mesh-list
154321298|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
154321299|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
154321300|NCT02181478|Fludarabine|fludarabine|mesh-list
154321301|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
154321302|NCT02181478|Cyclosporins|cyclosporins|mesh-list
154321303|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154321304|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
154321306|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321321|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
154321322|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154321323|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
154321324|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154321325|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
154321326|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
154321327|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321328|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321329|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321330|NCT02755090|Analgesics|analgesics|mesh-ancestor
154321331|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
154321332|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321333|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154321334|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
154321335|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321336|NCT02185690|Carboplatin|carboplatin|mesh-list
154321337|NCT02185690|Pemetrexed|pemetrexed|mesh-list
154321338|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321339|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321340|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321341|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154321342|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154321343|NCT03536806|Canrenone|canrenone|mesh-list
154321344|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154321345|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
154321346|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321347|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321367|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321368|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321369|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154321370|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
154321371|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321372|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321373|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154321374|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154321375|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154321376|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154321378|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154321379|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154321380|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153360315|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153360320|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153360321|NCT05089526|Analgesics|analgesics|mesh-ancestor
154321381|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154321382|NCT00107783|Nitisinone|nitisinone|mesh-list
154321383|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321384|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321385|NCT02185768|Idarubicin|idarubicin|mesh-list
154321386|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154321387|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321388|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154321389|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154321390|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321391|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321392|NCT02182024|Dabigatran|dabigatran|mesh-list
154321393|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
154321394|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154321398|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
154321409|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
154321410|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
154321411|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154321412|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321413|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321414|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321415|NCT01083797|Analgesics|analgesics|mesh-ancestor
154321416|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
154321417|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321418|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154321419|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154321420|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154321421|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
154321422|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321423|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321425|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154321426|NCT01068977|Bevacizumab|bevacizumab|mesh-list
154321427|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154321428|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154321429|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321430|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154321431|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154321432|NCT01068977|Growth Substances|growth substances|mesh-ancestor
154321433|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321434|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
154321435|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
154321436|NCT02184910|Gastrins|gastrins|mesh-list
154321437|NCT02184910|Hormones|hormones|mesh-ancestor
154321438|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321440|NCT02185924|Parecoxib|parecoxib|mesh-list
154321452|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321453|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321454|NCT02185924|Analgesics|analgesics|mesh-ancestor
154321455|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321456|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321457|NCT02185066|Metformin|metformin|mesh-list
154321458|NCT02185066|Atorvastatin|atorvastatin|mesh-list
154321459|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321460|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321461|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154321462|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154321463|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
154321464|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321465|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154321466|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154321467|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321468|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
154321469|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
154321470|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321471|NCT01069055|Acetaminophen|acetaminophen|mesh-list
154321472|NCT01069055|Lornoxicam|lornoxicam|mesh-list
154321473|NCT01069055|Piroxicam|piroxicam|mesh-list
154321474|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321475|NCT01069055|Analgesics|analgesics|mesh-ancestor
154321476|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
154321477|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321478|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321479|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
154321480|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321498|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154321499|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321500|NCT02190526|Analgesics|analgesics|mesh-ancestor
154321501|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
154321502|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321503|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321504|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154321505|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154321506|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154321507|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321508|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
154321509|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321510|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321511|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321512|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321513|NCT01084031|Propofol|propofol|mesh-list
154321514|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154321515|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321516|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321517|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154321518|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
154321519|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
154321520|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
154321521|NCT02185222|Vitamin D|vitamin d|mesh-list
154321522|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154321523|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321524|NCT02185222|Vitamins|vitamins|mesh-ancestor
154321525|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
154321526|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154321527|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154321528|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
154321529|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154321530|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154321531|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321532|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321535|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154321536|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154321537|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321538|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321539|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154321540|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154321541|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
154321542|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321543|NCT02190760|Dexamethasone|dexamethasone|mesh-list
154321544|NCT02190760|Bupivacaine|bupivacaine|mesh-list
154321545|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321546|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
154321547|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
154321548|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321549|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321550|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154321551|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
154321552|NCT02190760|Hormones|hormones|mesh-ancestor
154321553|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321554|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154321555|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321557|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
153820354|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154321558|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321559|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
154321560|NCT02190838|Metformin|metformin|mesh-list
154321561|NCT02190838|Dacarbazine|dacarbazine|mesh-list
154321562|NCT02190838|Melatonin|melatonin|mesh-list
154321563|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321564|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321565|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
154321566|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321567|NCT02190838|Protective Agents|protective agents|mesh-ancestor
154321573|NCT02185456|Miconazole|miconazole|mesh-list
154321579|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154321580|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154321581|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321582|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321583|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154321584|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
154321585|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321586|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321587|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154321588|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154321589|NCT02190994|Prednisone|prednisone|mesh-list
154321590|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
154321591|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321592|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
154321593|NCT02190994|Hormones|hormones|mesh-ancestor
154321594|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321595|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321596|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154321597|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321598|NCT02193568|Anesthetics|anesthetics|mesh-list
154321599|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321600|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321601|NCT02191072|Omalizumab|omalizumab|mesh-list
154321602|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154321603|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154321604|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
154321605|NCT02191228|Linagliptin|linagliptin|mesh-list
154321606|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321607|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321608|NCT02191228|Incretins|incretins|mesh-ancestor
154321609|NCT02191228|Hormones|hormones|mesh-ancestor
154321621|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
154321622|NCT02186782|Estradiol|estradiol|mesh-list
154321623|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154321624|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
154321625|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154321626|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
154321627|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
154321628|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321629|NCT02186782|Estrogens|estrogens|mesh-ancestor
154321630|NCT02186782|Hormones|hormones|mesh-ancestor
154321631|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321632|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321633|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154321634|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
154321635|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154321636|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154321637|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154321638|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
154321639|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154321640|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
154321641|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154321642|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154321643|NCT02187250|Metformin|metformin|mesh-list
154321671|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
154321672|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
154321673|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321674|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321675|NCT02187562|Aspirin|aspirin|mesh-list
154321676|NCT02187562|Meloxicam|meloxicam|mesh-list
154321677|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154321678|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321679|NCT02187562|Analgesics|analgesics|mesh-ancestor
154321680|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
154321681|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321682|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321683|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321684|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321685|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154321686|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154321687|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321688|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154321689|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154321690|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321691|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
154321692|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154321693|NCT02187718|Anesthetics|anesthetics|mesh-list
154321694|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321695|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321696|NCT03535168|Midazolam|midazolam|mesh-list
154321697|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154321698|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154321699|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321716|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321717|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321718|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154321719|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
154321720|NCT02192320|Hormones|hormones|mesh-ancestor
154321721|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321722|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154321723|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321724|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154321725|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154321726|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
154321727|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321728|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154321729|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154321730|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321731|NCT02187874|Oxytocin|oxytocin|mesh-list
154321732|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
154321733|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154321734|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321735|NCT04870138|Azithromycin|azithromycin|mesh-list
154321736|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
154321737|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
154321738|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154321765|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321766|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321767|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321768|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321769|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154321771|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154321772|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154321773|NCT03535090|Prednisolone|prednisolone|mesh-list
154321774|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
154321775|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154321776|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
154321777|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321778|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
154321779|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
154321780|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321781|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321783|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
154321784|NCT03535090|Hormones|hormones|mesh-ancestor
154321785|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321786|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154321787|NCT03535090|Protective Agents|protective agents|mesh-ancestor
154321788|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154321789|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321790|NCT03535870|Fluticasone|fluticasone|mesh-list
154321791|NCT03535870|Xhance|xhance|mesh-list
154321792|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154321793|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154321794|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154321795|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154321796|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
154321801|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
154321810|NCT03535870|Hormones|hormones|mesh-ancestor
154321811|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321812|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
154321813|NCT02192710|Midazolam|midazolam|mesh-list
154321814|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154321815|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154321816|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321817|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321818|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154321819|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154321820|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154321821|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154321822|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
154321823|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
154321824|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
154321825|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
154321826|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321827|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321828|NCT02188654|Metformin|metformin|mesh-list
154321829|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321830|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321831|NCT02192944|Chloroquine|chloroquine|mesh-list
154321832|NCT02192944|Piperaquine|piperaquine|mesh-list
154321833|NCT02192944|Artenimol|artenimol|mesh-list
154321834|NCT02192944|Amebicides|amebicides|mesh-ancestor
154321835|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154321836|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154321837|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321838|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
154321839|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154321840|NCT02193022|Miltefosine|miltefosine|mesh-list
154321841|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
154321842|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321843|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154321844|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154321845|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154321850|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154321851|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154321852|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154321853|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
154321854|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154321855|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321858|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154321859|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154321860|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
154321861|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321862|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321863|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154321864|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154321865|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
154321866|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321867|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154321868|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154321869|NCT03535792|Fentanyl|fentanyl|mesh-list
154321870|NCT03535792|Nalbuphine|nalbuphine|mesh-list
154321871|NCT03535792|Bupivacaine|bupivacaine|mesh-list
154321872|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
154321873|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
154321874|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321875|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321876|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
154321877|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321878|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154321879|NCT03535792|Narcotics|narcotics|mesh-ancestor
154321880|NCT03535792|Analgesics|analgesics|mesh-ancestor
154321881|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154321894|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154321895|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154321896|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
154321897|NCT03535558|Azithromycin|azithromycin|mesh-list
154321898|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
154321899|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154321900|NCT03535558|Trimethoprim|trimethoprim|mesh-list
154321901|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
154321902|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154321903|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154321904|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154321905|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
154321906|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154321907|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154321908|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154321909|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154321910|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321911|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154321912|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154321913|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154321914|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154321915|NCT02193334|Mitogens|mitogens|mesh-list
154321916|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
154321917|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321918|NCT02194192|Ephedrine|ephedrine|mesh-list
154321919|NCT02194192|Ondansetron|ondansetron|mesh-list
154321920|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
154321921|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
154321922|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321923|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321924|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154321925|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
154321926|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
154321927|NCT02194192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154321928|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154321929|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
154321931|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321932|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154321933|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
154321934|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154321935|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
154321936|NCT02194270|Ambroxol|ambroxol|mesh-list
154321937|NCT02194270|Expectorants|expectorants|mesh-ancestor
154321938|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
154321939|NCT02190058|DS-1971a|ds-1971a|mesh-list
153360374|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153360379|NCT00806078|Analgesics|analgesics|mesh-ancestor
154321940|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154321941|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154321942|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154321943|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321944|NCT02194348|Olcegepant|olcegepant|mesh-list
154321945|NCT02194348|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154321946|NCT02194348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154321947|NCT02194348|Analgesics|analgesics|mesh-ancestor
154321948|NCT02194348|Sensory System Agents|sensory system agents|mesh-ancestor
154321949|NCT02194348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321950|NCT02194348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321951|NCT02195908|Antiemetics|antiemetics|mesh-list
154321952|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
154321953|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321954|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321955|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154321956|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
154321957|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154321961|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
154321977|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154321978|NCT04308694|Narcotics|narcotics|mesh-ancestor
154321979|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154321980|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321981|NCT04308694|Analgesics|analgesics|mesh-ancestor
154321982|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
154321983|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321984|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
154321985|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
154321986|NCT03534310|Liraglutide|liraglutide|mesh-list
154321987|NCT03534310|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154321988|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154321989|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321990|NCT03534310|Incretins|incretins|mesh-ancestor
154321991|NCT03534310|Hormones|hormones|mesh-ancestor
154321992|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154321993|NCT02194894|Acetaminophen|acetaminophen|mesh-list
154321994|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154321995|NCT02194894|Analgesics|analgesics|mesh-ancestor
154321996|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
154321997|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154321998|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154321999|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
154322000|NCT03534622|Delafloxacin|delafloxacin|mesh-list
154322001|NCT03534622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322002|NCT02197702|Vitamin D|vitamin d|mesh-list
154322003|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
154322004|NCT02197702|Vitamins|vitamins|mesh-ancestor
154322005|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
154322006|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322007|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154322008|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154322009|NCT02031016|Fentanyl|fentanyl|mesh-list
154322019|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154322020|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
154322021|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
154322023|NCT00095147|Methotrexate|methotrexate|mesh-list
154322024|NCT00095147|Abatacept|abatacept|mesh-list
154322025|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154322026|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
154322027|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154322028|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322029|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154322030|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
154157393|NCT05805501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322031|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322032|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322033|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
154322034|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322035|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154322036|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322037|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
154322038|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322039|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154322040|NCT00095147|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154322041|NCT00095147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322042|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154322069|NCT02198248|Hormones|hormones|mesh-ancestor
154322070|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154322071|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154322072|NCT01069133|Rifaximin|rifaximin|mesh-list
154322073|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154322074|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322075|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154322076|NCT02198326|Olcegepant|olcegepant|mesh-list
154322077|NCT02198326|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154322078|NCT02198326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322079|NCT02198326|Analgesics|analgesics|mesh-ancestor
154322080|NCT02198326|Sensory System Agents|sensory system agents|mesh-ancestor
154322081|NCT02198326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322082|NCT02198326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322083|NCT02198482|Cytarabine|cytarabine|mesh-list
154322084|NCT02198482|Daunorubicin|daunorubicin|mesh-list
154322085|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
154322086|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154322087|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
154322088|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322089|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322090|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
154322091|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322092|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322093|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
154322094|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322095|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154322116|NCT02201914|Clomiphene|clomiphene|mesh-list
154322117|NCT02201914|Enclomiphene|enclomiphene|mesh-list
154322118|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
154322119|NCT02201914|Cetrorelix|cetrorelix|mesh-list
154322120|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
154322121|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154322122|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
154322123|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154322124|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322125|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154322126|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154322127|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322128|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154322129|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
154322130|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154322131|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154322132|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
154322133|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154322134|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154322135|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154322136|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154322137|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154322138|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322139|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322140|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154322141|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154322142|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322143|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
154322144|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322145|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
154322162|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154322163|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154322164|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154322165|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154322166|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
154322167|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322168|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322169|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154322170|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
154322171|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
154322172|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154322173|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154322174|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154322175|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154322176|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154322177|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322178|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
154322179|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322180|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322181|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154322182|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322183|NCT02207920|Vaccines|vaccines|mesh-list
154322184|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
154322185|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322186|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
154322187|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154322188|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154322189|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322190|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
154322206|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322207|NCT02208778|Remifentanil|remifentanil|mesh-list
154322208|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154322209|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154322210|NCT02208778|Narcotics|narcotics|mesh-ancestor
154322211|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322212|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322213|NCT02208778|Analgesics|analgesics|mesh-ancestor
154322214|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
154322215|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322216|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154322217|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154322218|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154322219|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322220|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322221|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
154322222|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154322223|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
154322224|NCT02203396|Cyclosporine|cyclosporine|mesh-list
154322225|NCT02203396|Levamisole|levamisole|mesh-list
154322226|NCT02203396|Cyclosporins|cyclosporins|mesh-list
154322227|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
154322228|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322229|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322230|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322231|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
154322232|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322233|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
154322234|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820426|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
153820427|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820428|NCT00433121|Olanzapine|olanzapine|mesh-list
153820429|NCT00433121|Risperidone|risperidone|mesh-list
153820430|NCT00433121|Citalopram|citalopram|mesh-list
153820431|NCT00433121|Escitalopram|escitalopram|mesh-list
154322251|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322252|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154322253|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154322254|NCT02200354|Growth Substances|growth substances|mesh-ancestor
154322255|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820432|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154322256|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
154322257|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322258|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322259|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154322260|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154322261|NCT02204020|Azacitidine|azacitidine|mesh-list
154322262|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154322263|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
154322264|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322265|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322266|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322267|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154322268|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154322269|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
154322273|NCT02220634|Regadenoson|regadenoson|mesh-list
154322299|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154322300|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322301|NCT02204878|Analgesics|analgesics|mesh-ancestor
154322302|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
154322303|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027399|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322304|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322305|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322306|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322307|NCT02210728|Methylphenidate|methylphenidate|mesh-list
154322308|NCT02210728|Amphetamine|amphetamine|mesh-list
154322309|NCT02210728|Adderall|adderall|mesh-list
154322310|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
154322311|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154322312|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322313|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154322314|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154322315|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154322316|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322317|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
154322351|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154322352|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
154322353|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154322354|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
154322355|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
154322356|NCT02213302|Midazolam|midazolam|mesh-list
154322357|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154322358|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154322359|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322360|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322361|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154322362|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154322363|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154322364|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154322365|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
154322366|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
154322367|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
154322368|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
154322369|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322370|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322371|NCT02221180|Metformin|metformin|mesh-list
154322372|NCT02221180|Canagliflozin|canagliflozin|mesh-list
154322373|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154322374|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322375|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154069150|NCT02605746|Ceritinib|ceritinib|mesh-list
154322376|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322377|NCT02205112|Levofloxacin|levofloxacin|mesh-list
154322378|NCT02205112|Nemonoxacin|nemonoxacin|mesh-list
154322379|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154322380|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322395|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154322396|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322397|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
154322398|NCT02257918|Zoliflodacin|zoliflodacin|mesh-list
154322399|NCT02257918|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154322400|NCT02257918|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154322401|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154322402|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322403|NCT02257918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154322404|NCT02257918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154322405|NCT02257918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322406|NCT02257918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322407|NCT02257918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322408|NCT02221414|Metformin|metformin|mesh-list
154322409|NCT02221414|Linagliptin|linagliptin|mesh-list
154322410|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154322411|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322412|NCT02221414|Incretins|incretins|mesh-ancestor
154322413|NCT02221414|Hormones|hormones|mesh-ancestor
154322414|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154322415|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154322416|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
154322417|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322418|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322419|NCT02221492|Plerixafor|plerixafor|mesh-list
154322420|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154322421|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154322442|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
154322443|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322444|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154322445|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154322446|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154322447|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154322448|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322450|NCT02219698|Ibuprofen|ibuprofen|mesh-list
154322451|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154322453|NCT02219698|Analgesics|analgesics|mesh-ancestor
154322454|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
154322455|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322456|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322457|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322458|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322459|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154322460|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157394|NCT05805501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153820451|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153820452|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
153820453|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154322461|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322462|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
154322463|NCT02205580|Sufentanil|sufentanil|mesh-list
154322497|NCT02220400|Ketamine|ketamine|mesh-list
154322498|NCT02220400|Analgesics|analgesics|mesh-ancestor
154322499|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
154322500|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322501|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322502|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154322503|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154322504|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
154322505|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
154322506|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322507|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154322508|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154322509|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322510|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322511|NCT02205892|Lupeol|lupeol|mesh-list
154322512|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322513|NCT02224768|Ipilimumab|ipilimumab|mesh-list
154322514|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154322515|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322516|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154322517|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322518|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
154322519|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154322520|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322521|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322522|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322523|NCT05262166|Analgesics|analgesics|mesh-ancestor
154322524|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
154322525|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322526|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154322538|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154322539|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322540|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322541|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322542|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154322543|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
154322544|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154322545|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322546|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154322547|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154322548|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154322549|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154322551|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154322552|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322553|NCT02222428|Olodaterol|olodaterol|mesh-list
154322554|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154322555|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
154322556|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322557|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322558|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154322559|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
154322560|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154322561|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154322562|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
154322563|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322564|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322565|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154322566|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
154322567|NCT02225470|Vinorelbine|vinorelbine|mesh-list
154322568|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154322569|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322570|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154322571|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154322572|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154322574|NCT02225548|Tadalafil|tadalafil|mesh-list
154322576|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
154322577|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154322578|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154322579|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322580|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322581|NCT02225548|Urological Agents|urological agents|mesh-ancestor
154322582|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
154322583|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154322584|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154322585|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154322586|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154322587|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154322588|NCT02225548|Protective Agents|protective agents|mesh-ancestor
154322589|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322590|NCT02223052|Azacitidine|azacitidine|mesh-list
154322591|NCT02223052|Cc-486|cc-486|mesh-list
154322592|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154322593|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
154322594|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322595|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322596|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322597|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154322598|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154322599|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154027400|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
154322600|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322601|NCT02231788|Amlodipine|amlodipine|mesh-list
154322602|NCT02231788|Telmisartan|telmisartan|mesh-list
154322603|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154322604|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154322605|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154322606|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322607|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154322614|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154322615|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
154322616|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
154322617|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154322618|NCT02258620|Diuretics|diuretics|mesh-ancestor
154322619|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
154322620|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322621|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154322622|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322623|NCT02223598|Dexamethasone|dexamethasone|mesh-list
154322624|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322625|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
154322626|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
154322627|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322628|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322629|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154322630|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
154322631|NCT02223598|Hormones|hormones|mesh-ancestor
154322632|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154322633|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154322634|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322635|NCT00094835|Paclitaxel|paclitaxel|mesh-list
154322636|NCT00094835|Carboplatin|carboplatin|mesh-list
154322637|NCT00094835|Panitumumab|panitumumab|mesh-list
154322638|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
154322639|NCT00094835|Imetelstat|imetelstat|mesh-list
153820464|NCT00591526|Cytarabine|cytarabine|mesh-list
153820465|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153820466|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
153820467|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820468|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820469|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
153820470|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820471|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322640|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154322641|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322642|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
154322643|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
154322644|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
154322645|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322646|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154322647|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154322648|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322654|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322655|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154322656|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
154322657|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
154322658|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154322659|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154322660|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154322661|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154322662|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
154322663|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
154322664|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322665|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322666|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154322667|NCT02226328|Narcotics|narcotics|mesh-ancestor
154322668|NCT02226328|Analgesics|analgesics|mesh-ancestor
154322669|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
154322670|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322671|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
154322672|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154322673|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322674|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
154322675|NCT02226484|Quercetin|quercetin|mesh-list
154069438|NCT01026961|Acetaminophen|acetaminophen|mesh-list
154322676|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
154322677|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322678|NCT02226484|Protective Agents|protective agents|mesh-ancestor
154322679|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322680|NCT04453852|Vaccines|vaccines|mesh-list
154322681|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
154322682|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322683|NCT00094757|Pioglitazone|pioglitazone|mesh-list
154322684|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154322685|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154322686|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322687|NCT00094757|Incretins|incretins|mesh-ancestor
154322688|NCT00094757|Hormones|hormones|mesh-ancestor
154322689|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154322693|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322694|NCT02223832|Ponesimod|ponesimod|mesh-list
154322695|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154322696|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322697|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322698|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
154322699|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322700|NCT02224066|Aspirin|aspirin|mesh-list
154322701|NCT02224066|Clopidogrel|clopidogrel|mesh-list
154322702|NCT02224066|Ticagrelor|ticagrelor|mesh-list
154322703|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154322704|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322705|NCT02224066|Analgesics|analgesics|mesh-ancestor
154322706|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
154322707|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322708|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322709|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322710|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322711|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154322712|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154322713|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322714|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154322715|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154322716|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322717|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
154322718|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154322719|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154322720|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154322721|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
154322722|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322723|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154322724|NCT04378114|Acetaminophen|acetaminophen|mesh-list
154322725|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322726|NCT04378114|Analgesics|analgesics|mesh-ancestor
154322732|NCT00082433|Epothilones|epothilones|mesh-list
154322733|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154322734|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
154322735|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322736|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322737|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
154322738|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
154322739|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
154322740|NCT00094445|Curcumin|curcumin|mesh-list
154322741|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154322742|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322743|NCT00094445|Analgesics|analgesics|mesh-ancestor
154322744|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
154322745|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322746|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322747|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322748|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322749|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069513|NCT00830804|Ritonavir|ritonavir|mesh-list
154322750|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322751|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322752|NCT01081535|Ketorolac|ketorolac|mesh-list
154322753|NCT01081535|Fentanyl|fentanyl|mesh-list
154322754|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154322755|NCT01081535|Narcotics|narcotics|mesh-ancestor
154322756|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322757|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322758|NCT01081535|Analgesics|analgesics|mesh-ancestor
154322759|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
154322760|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322761|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154322762|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154322763|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
154322764|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
154322772|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
154322773|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154322774|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
154322775|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
154322776|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322777|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322778|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322779|NCT01087229|Analgesics|analgesics|mesh-ancestor
153820483|NCT00433277|Cyclosporins|cyclosporins|mesh-list
153820484|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820485|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820486|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322780|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
154322781|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322782|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154322783|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154322784|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154322785|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322786|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154322787|NCT01084577|Laxatives|laxatives|mesh-ancestor
154322788|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154322789|NCT00094055|Axitinib|axitinib|mesh-list
154322790|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322791|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154322792|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322793|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322794|NCT02531165|Aspirin|aspirin|mesh-list
154322795|NCT02531165|Heparin|heparin|mesh-list
154322796|NCT02531165|Fentanyl|fentanyl|mesh-list
154322797|NCT02531165|Morphine|morphine|mesh-list
154322798|NCT02531165|Ticagrelor|ticagrelor|mesh-list
154322799|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154322800|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322801|NCT02531165|Analgesics|analgesics|mesh-ancestor
154322802|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
154322803|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322804|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322805|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322806|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322807|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154322808|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153502060|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154322809|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322810|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154322811|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154322812|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322813|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
154322814|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154322815|NCT02531165|Narcotics|narcotics|mesh-ancestor
154322816|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154322817|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154322818|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154322819|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
154322820|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
154069587|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322821|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
154322822|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154322823|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154322824|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154322825|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
154322826|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322827|NCT00099983|Risperidone|risperidone|mesh-list
154322828|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154322829|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
154322830|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322833|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154322859|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322861|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154322862|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322863|NCT02258542|Benralizumab|benralizumab|mesh-list
154322864|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154322865|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
154322866|NCT00091793|Denosumab|denosumab|mesh-list
154322867|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154322868|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322869|NCT00098813|Romidepsin|romidepsin|mesh-list
153360490|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153360491|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153360492|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
153360493|NCT00845000|Levodopa|levodopa|mesh-list
153360494|NCT00845000|Carbidopa|carbidopa|mesh-list
153360495|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153360496|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154322870|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154322871|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322872|NCT00098813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154322873|NCT00098813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322874|NCT00098813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322875|NCT01081613|Bevacizumab|bevacizumab|mesh-list
154322876|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
154322877|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154322878|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322879|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154322880|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154322881|NCT01081613|Growth Substances|growth substances|mesh-ancestor
154322882|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322883|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
154322884|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154322885|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322886|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
154322887|NCT02227264|Cinacalcet|cinacalcet|mesh-list
154322888|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154322889|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322890|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154322891|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
154322899|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154322900|NCT04772248|Etanercept|etanercept|mesh-list
154322901|NCT04772248|Tofacitinib|tofacitinib|mesh-list
154322902|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154322903|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154322904|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
154322905|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154322906|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154322907|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154322908|NCT04772248|Analgesics|analgesics|mesh-ancestor
154322909|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
154322910|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322911|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322912|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154322913|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
154322914|NCT04772248|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154322915|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154322916|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322917|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322918|NCT00090857|Letrozole|letrozole|mesh-list
154322919|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322920|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154322921|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154322922|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322923|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322924|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154322925|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154322926|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154322927|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322928|NCT01775644|Bevacizumab|bevacizumab|mesh-list
154322929|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154322930|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154322931|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154322938|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154322939|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154322940|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322941|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154322942|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154322943|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322944|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
154322945|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322947|NCT00090779|Lopinavir|lopinavir|mesh-list
154322948|NCT00090779|Tenofovir|tenofovir|mesh-list
154322949|NCT00090779|Emtricitabine|emtricitabine|mesh-list
154322950|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154322951|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154322952|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154322953|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
154322954|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154322955|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322956|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154322957|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154322958|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
154322959|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154322967|NCT01081847|Mannitol|mannitol|mesh-list
154322989|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154322990|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154322991|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
154322992|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154322993|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154322994|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154322996|NCT04174612|Daunorubicin|daunorubicin|mesh-list
154322997|NCT04174612|Midostaurin|midostaurin|mesh-list
154322998|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154322999|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
154323000|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323001|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323002|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
154323003|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323004|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323005|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
154323006|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323007|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154323008|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154323009|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154323010|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323011|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154323012|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
154323013|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154323014|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323015|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323033|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154323034|NCT01082315|Cetuximab|cetuximab|mesh-list
154323035|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154323036|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323037|NCT01082471|Morphine|morphine|mesh-list
154323038|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154323039|NCT01082471|Narcotics|narcotics|mesh-ancestor
154323040|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323041|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323042|NCT01082471|Analgesics|analgesics|mesh-ancestor
154323043|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
154323044|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323045|NCT03553498|Acetaminophen|acetaminophen|mesh-list
154323046|NCT03553498|Hydromorphone|hydromorphone|mesh-list
154323047|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154323048|NCT03553498|Analgesics|analgesics|mesh-ancestor
154069810|NCT00448591|Bevacizumab|bevacizumab|mesh-list
154323049|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
153820501|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153820502|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820503|NCT00433316|Ropivacaine|ropivacaine|mesh-list
153820504|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
154323050|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323051|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323052|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
154323053|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154323054|NCT03553498|Narcotics|narcotics|mesh-ancestor
154323055|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323056|NCT01589393|Enoxaparin|enoxaparin|mesh-list
154323057|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
154323058|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154323082|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323083|NCT01326767|Paclitaxel|paclitaxel|mesh-list
154323084|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154323085|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154323086|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323087|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
154323088|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
154323089|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
154323090|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323091|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
154323092|NCT03963479|Pyridoxal|pyridoxal|mesh-list
154323093|NCT03963479|Pyridoxine|pyridoxine|mesh-list
154323094|NCT03963479|Vitamins|vitamins|mesh-ancestor
154323095|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
154323096|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323097|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
154323098|NCT02228512|Prednisone|prednisone|mesh-list
154323099|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
154323100|NCT02228512|Rituximab|rituximab|mesh-list
154323101|NCT02228512|Doxorubicin|doxorubicin|mesh-list
154323102|NCT02228512|Etoposide|etoposide|mesh-list
154323103|NCT02228512|Vincristine|vincristine|mesh-list
154323104|NCT02228512|Pomalidomide|pomalidomide|mesh-list
154323105|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323106|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
154323108|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323135|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323137|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154323138|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323139|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154323140|NCT01082705|Lumefantrine|lumefantrine|mesh-list
154323141|NCT01082705|Artemether|artemether|mesh-list
154323142|NCT01082705|Piperaquine|piperaquine|mesh-list
154323143|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154323144|NCT01082705|Artenimol|artenimol|mesh-list
154323145|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
154323146|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154323147|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154323148|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323149|NCT01582997|Dabrafenib|dabrafenib|mesh-list
154323150|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323151|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154323152|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323153|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323154|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
154323156|NCT01085981|Niacin|niacin|mesh-list
154323193|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323194|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
154323195|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154323196|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
154323197|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153820505|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
153820506|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323198|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154323199|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323200|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154323201|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323202|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154323203|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323204|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154323205|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154323206|NCT02229058|Paclitaxel|paclitaxel|mesh-list
154323207|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154323208|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154323209|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323210|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
154323211|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
154323212|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
154323213|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323214|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
154323215|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154323216|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154323217|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323218|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
154323219|NCT02229292|Coagulants|coagulants|mesh-ancestor
154323220|NCT00070109|Trabectedin|trabectedin|mesh-list
154323221|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154323222|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
154323223|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323224|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323225|NCT00069953|Paclitaxel|paclitaxel|mesh-list
154323226|NCT00069953|Fluorouracil|fluorouracil|mesh-list
154323227|NCT00069953|Lenograstim|lenograstim|mesh-list
154323228|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154323229|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323230|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154323231|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154323232|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154323233|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323234|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
154323235|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154323236|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323237|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
154323238|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323239|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154323241|NCT02750800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154323242|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154323243|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323244|NCT02229760|Ritonavir|ritonavir|mesh-list
154323245|NCT02229760|Tipranavir|tipranavir|mesh-list
154323246|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154323247|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154323248|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
154323249|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323250|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323251|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154323252|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154323253|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
154323254|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323255|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154323256|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154323257|NCT01329562|Naproxen|naproxen|mesh-list
154323258|NCT01329562|Sumatriptan|sumatriptan|mesh-list
154323259|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154323260|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154323261|NCT01329562|Analgesics|analgesics|mesh-ancestor
154323262|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
154323271|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154323272|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154323273|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153360506|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153360507|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
154323274|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
154323275|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323276|NCT02230228|Vitamin A|vitamin a|mesh-list
154323277|NCT02230228|Retinol acetate|retinol acetate|mesh-list
154323278|NCT02230228|Vitamins|vitamins|mesh-ancestor
154323279|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
154323280|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323281|NCT02230228|Protective Agents|protective agents|mesh-ancestor
154323282|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154323283|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323284|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154323285|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
154323286|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
154323287|NCT01090661|Mipomersen|mipomersen|mesh-list
154323288|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154323289|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154323290|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323291|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154323292|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154323293|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323294|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323295|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323296|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154323297|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
154323298|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154323299|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323300|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154323301|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154323302|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154323303|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154323304|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154323307|NCT05563480|Cisplatin|cisplatin|mesh-list
154323312|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323313|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154323314|NCT05546398|Ezetimibe|ezetimibe|mesh-list
154323315|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154323316|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154323317|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
154323318|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323319|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154323320|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323321|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154323322|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323323|NCT05472766|Anticoagulants|anticoagulants|mesh-list
154323324|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
154323325|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
154323326|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154323327|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
154323328|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323329|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323330|NCT03653026|Upadacitinib|upadacitinib|mesh-list
154323331|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154323332|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154323333|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323334|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323335|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323336|NCT02232724|Choline|choline|mesh-list
154323337|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
154323338|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154323339|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
154323340|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323341|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154323342|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154323343|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
154323344|NCT02234440|Metformin|metformin|mesh-list
154323345|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154323346|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323347|NCT02230618|Insulin|insulin|mesh-list
154323349|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154323350|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323351|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
154323352|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154323353|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323354|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323355|NCT02262520|Digoxin|digoxin|mesh-list
154323356|NCT02262520|Apixaban|apixaban|mesh-list
154323357|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154323358|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
154323359|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154323360|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
154323361|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323362|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323363|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
154323364|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154323365|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154323366|NCT02262520|Protective Agents|protective agents|mesh-ancestor
154323367|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323368|NCT02233504|Deferasirox|deferasirox|mesh-list
154323369|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154323370|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
154323371|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
154323372|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323373|NCT02262598|Telmisartan|telmisartan|mesh-list
154323379|NCT02262598|Diuretics|diuretics|mesh-ancestor
154323397|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323398|NCT01337674|Metoprolol|metoprolol|mesh-list
154323399|NCT01337674|Amlodipine|amlodipine|mesh-list
154323400|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154323401|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154323402|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323403|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323404|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154323405|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323406|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
154323407|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154323408|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
154323409|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
154323410|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323411|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154323412|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154323413|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154323414|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
154323415|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323416|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
154323417|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154323418|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
154323419|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154323420|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
154323421|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323422|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323423|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
154323424|NCT02233582|Ibuprofen|ibuprofen|mesh-list
154323425|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154323426|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154323427|NCT02233582|Analgesics|analgesics|mesh-ancestor
154323428|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
154323429|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502686|NCT03214770|Calcium|calcium|mesh-list
154323436|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
154323437|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154323438|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153360524|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360525|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
153360526|NCT01330355|Besifloxacin|besifloxacin|mesh-list
153360527|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153360528|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360529|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153781782|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154323439|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154323440|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323441|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323442|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
154323443|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323444|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323445|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154323446|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323447|NCT02233816|Vaccines|vaccines|mesh-list
154323448|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
154323449|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323450|NCT02750410|Dulaglutide|dulaglutide|mesh-list
154323451|NCT02750410|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154323452|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154323453|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323454|NCT02750332|Nitisinone|nitisinone|mesh-list
154323455|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323456|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323457|NCT02233894|Ipratropium|ipratropium|mesh-list
154323458|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154323459|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
154323460|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323484|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154323485|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
154323486|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323487|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323488|NCT02263066|Factor VIII|factor viii|mesh-list
154323489|NCT02263066|Coagulants|coagulants|mesh-ancestor
154323490|NCT02235532|Fluorides|fluorides|mesh-list
154323491|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
154323492|NCT02235532|Protective Agents|protective agents|mesh-ancestor
154323493|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323494|NCT00069095|Leucovorin|leucovorin|mesh-list
154323495|NCT00069095|Bevacizumab|bevacizumab|mesh-list
154323496|NCT00069095|Capecitabine|capecitabine|mesh-list
154323497|NCT00069095|Fluorouracil|fluorouracil|mesh-list
154323498|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
154323499|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154323500|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323501|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154070263|NCT00811408|Cidofovir|cidofovir|mesh-list
154323502|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154323503|NCT00069095|Growth Substances|growth substances|mesh-ancestor
154323504|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323505|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
154323506|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154323507|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
154323508|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323509|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323510|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
154323511|NCT00069095|Antidotes|antidotes|mesh-ancestor
154323512|NCT00069095|Protective Agents|protective agents|mesh-ancestor
154323513|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
154323514|NCT00069095|Vitamins|vitamins|mesh-ancestor
154323515|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
154323516|NCT00086411|Bupropion|bupropion|mesh-list
154323517|NCT00086411|Nicotine|nicotine|mesh-list
154323518|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154323527|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154323528|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
154323529|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154323530|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154323531|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154323532|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323533|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
154323534|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154323535|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154323536|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323537|NCT01086527|Montelukast|montelukast|mesh-list
154323538|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154323539|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
154323540|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154323541|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
154323542|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323543|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323544|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154323545|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154323546|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323547|NCT01093937|Varenicline|varenicline|mesh-list
154323548|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154323549|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154323550|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
154323551|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323552|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323553|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323554|NCT01094015|Lidocaine|lidocaine|mesh-list
154323555|NCT01094015|Prilocaine|prilocaine|mesh-list
154323556|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154323557|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
154323558|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
154323563|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154323564|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154323565|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154323566|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323567|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323568|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154323570|NCT01090895|Vitamins|vitamins|mesh-ancestor
154323571|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
154323572|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323573|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
154323574|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323575|NCT01090895|Protective Agents|protective agents|mesh-ancestor
154323576|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
154323577|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
154323578|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
154323579|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323580|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323581|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
154323582|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323583|NCT01094249|Valproic Acid|valproic acid|mesh-list
154323584|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154323585|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154323586|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154323587|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323588|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323589|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154323590|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154323591|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154323592|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
154323593|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154323594|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323595|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154323596|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154323597|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
154323601|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
154323602|NCT00055601|Paclitaxel|paclitaxel|mesh-list
154323603|NCT00055601|Gemcitabine|gemcitabine|mesh-list
154323604|NCT00055601|Fluorouracil|fluorouracil|mesh-list
154323605|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154323606|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323607|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
154323608|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
154323609|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
154323610|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323611|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154323612|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
154323613|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323614|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
154323615|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323616|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
154323617|NCT01583621|Vitamin D|vitamin d|mesh-list
154323618|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154323619|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323620|NCT01583621|Vitamins|vitamins|mesh-ancestor
154323621|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
154323622|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154323623|NCT03806231|Dinoprostone|dinoprostone|mesh-list
154323624|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
154323625|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154323626|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323627|NCT01091051|Ustekinumab|ustekinumab|mesh-list
154323650|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323651|NCT00054275|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154323652|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154323653|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323655|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154323656|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154323657|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
154323658|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323659|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154323660|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154323661|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323662|NCT01583777|Belinostat|belinostat|mesh-list
154323663|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323664|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154323665|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323666|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323667|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
154323668|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154323669|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154323670|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323671|NCT00052715|Poly ICLC|poly iclc|mesh-list
154323672|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
154323673|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
154323674|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323675|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
154323676|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323677|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
154323678|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323694|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323695|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
153360530|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154323696|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323697|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323698|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154323699|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
154323700|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323701|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323702|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154323703|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154323704|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154323705|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154323706|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323707|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154323708|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
154323709|NCT00051311|Hormones|hormones|mesh-ancestor
154323710|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323711|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154323712|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154323713|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
154323714|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154323715|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154323716|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
154323717|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
154323742|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154323743|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323744|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323745|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
154323746|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
154323747|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154323748|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323749|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154323750|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154323751|NCT00049673|Growth Substances|growth substances|mesh-ancestor
154323752|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
154323753|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
154323754|NCT00049127|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154323755|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154323756|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323757|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323758|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323759|NCT00066365|Molgramostim|molgramostim|mesh-list
154323760|NCT00066365|Sargramostim|sargramostim|mesh-list
154323761|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
154323762|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323763|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323764|NCT00048581|Abatacept|abatacept|mesh-list
154323765|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154323767|NCT00048581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154323791|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323792|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154323793|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154323794|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
154323795|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323796|NCT00065507|Entecavir|entecavir|mesh-list
154323797|NCT00065507|Adefovir|adefovir|mesh-list
154323798|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
154323799|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323800|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154323801|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154323802|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323803|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323804|NCT01095575|Morphine|morphine|mesh-list
154323805|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154323806|NCT01095575|Narcotics|narcotics|mesh-ancestor
154323807|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154323808|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323809|NCT01095575|Analgesics|analgesics|mesh-ancestor
154323810|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
154323811|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323812|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
154323813|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154323814|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323815|NCT00065429|Immunotoxins|immunotoxins|mesh-ancestor
154323841|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154323842|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154323843|NCT01095809|Growth Substances|growth substances|mesh-ancestor
154323844|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323845|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
154323846|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154323847|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
154323849|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323850|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154323851|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
154323852|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323853|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323854|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
154323855|NCT00048035|Hematinics|hematinics|mesh-ancestor
154323856|NCT01092221|Allopurinol|allopurinol|mesh-list
154323857|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
154323858|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323859|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323860|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
154323861|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323862|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154323863|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
154323864|NCT01092221|Protective Agents|protective agents|mesh-ancestor
154323865|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323866|NCT00047879|Interferons|interferons|mesh-list
154323867|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
154323868|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
154323890|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154323891|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154323892|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
154323893|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323894|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323895|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154323896|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154323897|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
154323898|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
154323899|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154323900|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154323901|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
154323903|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154323904|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154323905|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
154323906|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154323907|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323908|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154323909|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154323910|NCT00064337|Growth Substances|growth substances|mesh-ancestor
154323911|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
154323912|NCT01096121|Enalapril|enalapril|mesh-list
154323913|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154323914|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
154323915|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323916|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323917|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154323918|NCT00064259|Fluorouracil|fluorouracil|mesh-list
154323919|NCT00064259|Oblimersen|oblimersen|mesh-list
154323927|NCT03954197|Hormones|hormones|mesh-list
153820557|NCT00464256|Hormones|hormones|mesh-ancestor
153820565|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820566|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153820567|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154323933|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
154323934|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323935|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
153820568|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820569|NCT00464295|Capecitabine|capecitabine|mesh-list
154323936|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154323937|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
154323938|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
154323939|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323940|NCT00044213|Antidotes|antidotes|mesh-ancestor
154323941|NCT00044213|Protective Agents|protective agents|mesh-ancestor
154323942|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154323943|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154323944|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
154323945|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154323946|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154323947|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154323948|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
154323949|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154323950|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323951|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154323952|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154323953|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154323954|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154323955|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323956|NCT01096199|Cisplatin|cisplatin|mesh-list
154323957|NCT01096199|Everolimus|everolimus|mesh-list
154323958|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323959|NCT01096199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154323978|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323979|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323980|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
154323981|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154323982|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154323983|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154323984|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154323985|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154323986|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154323987|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154323988|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154323989|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154323990|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
154323991|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154323992|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154323993|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154323994|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154323995|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154323996|NCT01092455|Heparin|heparin|mesh-list
154323997|NCT01092455|Calcium heparin|calcium heparin|mesh-list
154323998|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
154323999|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154324000|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154324001|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324002|NCT02264938|Antioxidants|antioxidants|mesh-list
154324003|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324004|NCT02264938|Protective Agents|protective agents|mesh-ancestor
154324013|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
154324023|NCT00043979|Fludarabine|fludarabine|mesh-list
154324024|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
154324025|NCT00043979|Etoposide|etoposide|mesh-list
154324026|NCT00043979|Vincristine|vincristine|mesh-list
154324027|NCT00043979|Tacrolimus|tacrolimus|mesh-list
154324029|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153360566|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324030|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154324031|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
154324032|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324033|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324034|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154324035|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
154324036|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324037|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324038|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154324039|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154324040|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154324041|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154324042|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324043|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324044|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
154324045|NCT00043979|Hormones|hormones|mesh-ancestor
154324046|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324047|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154324048|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154324049|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
154324050|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154324071|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324072|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324073|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
154324075|NCT01092533|Prednisone|prednisone|mesh-list
154324076|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154324077|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324078|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154324079|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
154324080|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324081|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324082|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324083|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324084|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324085|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
154324086|NCT01092533|Hormones|hormones|mesh-ancestor
154324087|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324088|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324089|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154324090|NCT01431820|Luliconazole|luliconazole|mesh-list
154324091|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154324125|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324126|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
154324127|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324128|NCT02265328|Prednisolone|prednisolone|mesh-list
154324129|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324130|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
154324131|NCT02265328|Hormones|hormones|mesh-ancestor
154324132|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324133|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324134|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154324135|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324136|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
154324137|NCT01421056|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
154324138|NCT01421056|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154324139|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324140|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324141|NCT01416064|Molindone|molindone|mesh-list
154324142|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153360567|NCT01331213|Pregabalin|pregabalin|mesh-list
154324143|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154324144|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324145|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324146|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154324147|NCT01594216|Exemestane|exemestane|mesh-list
154324148|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324149|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154324150|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154324151|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324152|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324153|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154324154|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
154324155|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324156|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324157|NCT02263690|Lidocaine|lidocaine|mesh-list
154324158|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
154324161|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324162|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
154324163|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324164|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154324165|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154324166|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154324167|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154324168|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324169|NCT02265562|Alprostadil|alprostadil|mesh-list
154324170|NCT02265562|Misoprostol|misoprostol|mesh-list
154324171|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154324172|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
154027401|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324174|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324175|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154324176|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154324177|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
154324178|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154324179|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
154324180|NCT02265562|Urological Agents|urological agents|mesh-ancestor
154324182|NCT01399684|Folic Acid|folic acid|mesh-list
154324183|NCT01399684|Bevacizumab|bevacizumab|mesh-list
154324184|NCT01399684|Fluorouracil|fluorouracil|mesh-list
154324185|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
154324186|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
154324187|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154324188|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324189|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154324190|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154324191|NCT01399684|Growth Substances|growth substances|mesh-ancestor
154324206|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
154324207|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154324208|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
154324209|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324210|NCT02265718|Methylphenidate|methylphenidate|mesh-list
154324211|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154324212|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324213|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154324214|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154324215|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154324216|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324217|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
154324218|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324219|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154324220|NCT02266030|Aspirin|aspirin|mesh-list
154324221|NCT02266030|Cilostazol|cilostazol|mesh-list
154324222|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154324223|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154324224|NCT02266030|Analgesics|analgesics|mesh-ancestor
154324225|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
154324226|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324227|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324228|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324229|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324230|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154324231|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154324252|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324254|NCT01373086|Eplerenone|eplerenone|mesh-list
154324255|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154324256|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
154324257|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324258|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324259|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154324260|NCT01373086|Diuretics|diuretics|mesh-ancestor
154324261|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
154324262|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154324263|NCT01519804|Paclitaxel|paclitaxel|mesh-list
154324264|NCT01519804|Carboplatin|carboplatin|mesh-list
154324265|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154324266|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324267|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
154324268|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
154324269|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
154324270|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324271|NCT02263924|Tocotrienols|tocotrienols|mesh-list
154324272|NCT02263924|Vitamin E|vitamin e|mesh-list
154324273|NCT02263924|Tocopherols|tocopherols|mesh-list
154324274|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
154324275|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324276|NCT02263924|Protective Agents|protective agents|mesh-ancestor
154324277|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324278|NCT02263924|Vitamins|vitamins|mesh-ancestor
154324279|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
154324280|NCT02264002|Metoprolol|metoprolol|mesh-list
154324281|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154324282|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154324283|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
154324284|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
154324285|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324286|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324292|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324294|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154324295|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
154324296|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324297|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324298|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
154324299|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154324300|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324301|NCT01516918|Ribavirin|ribavirin|mesh-list
154324302|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154324303|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
154324304|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324305|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
154324306|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324307|NCT01508026|Valsartan|valsartan|mesh-list
154324308|NCT01508026|Nebivolol|nebivolol|mesh-list
154324309|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154324310|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154324311|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154324312|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324313|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
154324314|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154324315|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154324316|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154324317|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
154324318|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324319|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324320|NCT01357642|Epinephrine|epinephrine|mesh-list
154324321|NCT01357642|Racepinephrine|racepinephrine|mesh-list
154324322|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
154027402|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324331|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
154324332|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324333|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154324334|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
154324336|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
154324337|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154324338|NCT03135340|Anesthetics|anesthetics|mesh-list
154324339|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324340|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324341|NCT01356160|Ribavirin|ribavirin|mesh-list
154324342|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154324343|NCT01356160|Ledipasvir|ledipasvir|mesh-list
154324344|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
154324345|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324346|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
154324347|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324348|NCT02264158|Telmisartan|telmisartan|mesh-list
154324349|NCT02264158|Lacidipine|lacidipine|mesh-list
154324350|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154324351|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154324352|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154324353|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324354|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154324355|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154324356|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154324357|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324358|NCT02264236|Vaccines|vaccines|mesh-list
154324361|NCT01476904|Epinephrine|epinephrine|mesh-list
154324378|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154324380|NCT01337752|Bortezomib|bortezomib|mesh-list
154324381|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154324382|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324383|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
154324384|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
154324385|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324386|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324387|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154324388|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
154324389|NCT01337752|Hormones|hormones|mesh-ancestor
154324390|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324391|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154324392|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324393|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
154324394|NCT01318642|Gemcitabine|gemcitabine|mesh-list
154324395|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154324396|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
154071160|NCT00444925|Fesoterodine|fesoterodine|mesh-list
154324397|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324398|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324399|NCT01318252|Latanoprost|latanoprost|mesh-list
154324400|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154324401|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154324402|NCT01313572|Adenosine|adenosine|mesh-list
154324403|NCT01313572|Analgesics|analgesics|mesh-ancestor
154324404|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
154324405|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324406|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324407|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154324408|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
154324409|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154324410|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
154324414|NCT02265484|Rifaximin|rifaximin|mesh-list
154324419|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154324420|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154324421|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154324422|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
154324423|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324424|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324425|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
154324426|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
154324427|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324428|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324429|NCT02264626|Remifentanil|remifentanil|mesh-list
154324430|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154324431|NCT02264626|Narcotics|narcotics|mesh-ancestor
154324432|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324433|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324434|NCT02264626|Analgesics|analgesics|mesh-ancestor
154324435|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
154324436|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324437|NCT02267044|Ropivacaine|ropivacaine|mesh-list
154324438|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
154324439|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
154324440|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324441|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324442|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
154324443|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324468|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
154324469|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
154071230|NCT00818350|Sunitinib|sunitinib|mesh-list
154324470|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324471|NCT02268370|Dasatinib|dasatinib|mesh-list
154324472|NCT02268370|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154324473|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154324474|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324475|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324476|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324477|NCT00039377|Leucovorin|leucovorin|mesh-list
154324478|NCT00039377|Cytarabine|cytarabine|mesh-list
154324479|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
154324480|NCT00039377|Methotrexate|methotrexate|mesh-list
154324481|NCT00039377|Etoposide|etoposide|mesh-list
154324482|NCT00039377|Vincristine|vincristine|mesh-list
154324483|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
154324484|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
154324485|NCT00039377|Tacrolimus|tacrolimus|mesh-list
154324486|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
154324487|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154324488|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
154324489|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324490|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324491|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154324492|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
154324513|NCT00039377|Vitamins|vitamins|mesh-ancestor
154324520|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154324521|NCT01096745|Cisplatin|cisplatin|mesh-list
154324522|NCT01096745|Gemcitabine|gemcitabine|mesh-list
154324523|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324524|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154324525|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
154324526|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324527|NCT03953729|Ibuprofen|ibuprofen|mesh-list
154324528|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154324529|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154324530|NCT03953729|Analgesics|analgesics|mesh-ancestor
154324531|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
154324532|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324533|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324534|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324535|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324536|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154324537|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324538|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324539|NCT01097213|Ethanol|ethanol|mesh-list
154324540|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154324541|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324542|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324543|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324544|NCT00154102|Leucovorin|leucovorin|mesh-list
154324545|NCT00154102|Folic Acid|folic acid|mesh-list
154324546|NCT00154102|Fluorouracil|fluorouracil|mesh-list
154324547|NCT00154102|Irinotecan|irinotecan|mesh-list
154324566|NCT00154102|Hematinics|hematinics|mesh-ancestor
154324567|NCT01269658|Azithromycin|azithromycin|mesh-list
154324568|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154324569|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154324570|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324571|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324572|NCT01229644|Crenolanib|crenolanib|mesh-list
154324573|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324574|NCT02267980|Ketamine|ketamine|mesh-list
154324575|NCT02267980|Sevoflurane|sevoflurane|mesh-list
154324576|NCT02267980|Analgesics|analgesics|mesh-ancestor
154324577|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
154324578|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324579|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324580|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154324581|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154324582|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
154324583|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
154324584|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324585|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154324586|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154324587|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324588|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324589|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154324590|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154324591|NCT01224262|Vaccines|vaccines|mesh-list
154324592|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
154324593|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324594|NCT01222702|Vancomycin|vancomycin|mesh-list
154324595|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
154324596|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324597|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324598|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154324601|NCT01204762|Entecavir|entecavir|mesh-list
154324609|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154324610|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
154324611|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324612|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154324613|NCT01198834|Etodolac|etodolac|mesh-list
154324614|NCT01198834|Lidocaine|lidocaine|mesh-list
154324615|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
154324616|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
154324617|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154324618|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324619|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
154324620|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324621|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154324622|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154324623|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154324624|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154324625|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820633|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820634|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153820635|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820636|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154324626|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154324627|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154324629|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324630|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324631|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154324632|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154324633|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324634|NCT01193140|Temozolomide|temozolomide|mesh-list
154324635|NCT01193140|Veliparib|veliparib|mesh-list
154324636|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154324637|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
154324638|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324639|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324640|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154324641|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324642|NCT01189396|Albuterol|albuterol|mesh-list
154324643|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154324644|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
154324645|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324647|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154324648|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
154324649|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
154324650|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154324651|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154324652|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154324653|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154324654|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
154324655|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324656|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324657|NCT05626972|Tenecteplase|tenecteplase|mesh-list
154324658|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154324659|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154324660|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324661|NCT01174732|Albuterol|albuterol|mesh-list
154324662|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154324663|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
154324664|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324665|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324666|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154324700|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154324701|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154324702|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324703|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324704|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154324705|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
154324706|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154324707|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
154324708|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154324709|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
154324710|NCT01071850|Metformin|metformin|mesh-list
154324711|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
154324712|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154324713|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324714|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154324715|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324716|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
154324717|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154324718|NCT01037062|Entecavir|entecavir|mesh-list
154324719|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
154324720|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324721|NCT01167166|ON 01910|on 01910|mesh-list
154324722|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324723|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154324724|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324725|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324726|NCT01035502|Idarubicin|idarubicin|mesh-list
154324727|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154324728|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324729|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154324730|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154324731|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324732|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324733|NCT01030432|Ribavirin|ribavirin|mesh-list
154324734|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154324735|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
154324738|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324739|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
154324740|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324741|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
154324742|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324743|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
154324744|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324745|NCT02269462|Efavirenz|efavirenz|mesh-list
154324746|NCT02269462|Nevirapine|nevirapine|mesh-list
154324747|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154324748|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154324749|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324750|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324751|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
154324752|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324753|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154324754|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154324755|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154324756|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154324757|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154324758|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154324759|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154324760|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154324761|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154324762|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154324765|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
154324784|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324785|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
154324786|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154324787|NCT01023880|Delanzomib|delanzomib|mesh-list
154324788|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
154324789|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
154324790|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324791|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324792|NCT02269696|Metoprolol|metoprolol|mesh-list
154324793|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154324794|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154324795|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
154324796|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
154324797|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324798|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324799|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154324800|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154324801|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154324802|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
154324803|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324804|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324805|NCT03135184|Coal Tar|coal tar|mesh-list
154324806|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
154324807|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
154324808|NCT05613400|Simvastatin|simvastatin|mesh-list
154324809|NCT05613400|Ezetimibe|ezetimibe|mesh-list
154324810|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154324811|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154324812|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
154324813|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324814|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154324815|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154324816|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324817|NCT02261662|Ribavirin|ribavirin|mesh-list
154324818|NCT02261662|Betamethasone|betamethasone|mesh-list
154324819|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
154324821|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
154324822|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324823|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324825|NCT02261662|Hormones|hormones|mesh-ancestor
154324826|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324827|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324828|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154324829|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
154324830|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
154324831|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154324832|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324833|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154324834|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154324835|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324836|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324837|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324838|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154324839|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154324840|NCT00035555|Cyclosporine|cyclosporine|mesh-list
154324841|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
154324842|NCT00035555|Abatacept|abatacept|mesh-list
154324843|NCT00035555|Cyclosporins|cyclosporins|mesh-list
154324844|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324845|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324846|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154324847|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
154324848|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324849|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
154324861|NCT01093157|Hormones|hormones|mesh-list
154324867|NCT01093235|Docetaxel|docetaxel|mesh-list
154324868|NCT01093235|Fluorouracil|fluorouracil|mesh-list
154324869|NCT01093235|Epirubicin|epirubicin|mesh-list
154324870|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154324871|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
154324872|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324873|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324874|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154324875|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
154324876|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324877|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324878|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154324879|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154324880|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154324881|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154324882|NCT01093235|Growth Substances|growth substances|mesh-ancestor
154324883|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
154324884|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
154324885|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
154324886|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
154324887|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
154324888|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154324889|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154324890|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154324898|NCT01088009|Lamivudine|lamivudine|mesh-list
154324916|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324917|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324918|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154324919|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
154324921|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
154324922|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324923|NCT01143064|Progesterone|progesterone|mesh-list
154324924|NCT01143064|Progestins|progestins|mesh-ancestor
154324925|NCT01143064|Hormones|hormones|mesh-ancestor
154324926|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154324927|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324929|NCT00033371|Celecoxib|celecoxib|mesh-list
154324930|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154324931|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154324932|NCT00033371|Analgesics|analgesics|mesh-ancestor
154324933|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
154324934|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324935|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324936|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324937|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324938|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154324939|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154324940|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324941|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324942|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154324943|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154324944|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154324945|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154324946|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154324947|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154324948|NCT01001338|Allopurinol|allopurinol|mesh-list
154324958|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324959|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
154071747|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
154324960|NCT03952715|Ibuprofen|ibuprofen|mesh-list
154324961|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154324962|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154324963|NCT03952715|Analgesics|analgesics|mesh-ancestor
154324964|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
154324965|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154324966|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324967|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154324968|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154324969|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154324970|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324971|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324972|NCT01137526|Donepezil|donepezil|mesh-list
154324973|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154324974|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154324975|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154324976|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
154324977|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154324978|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154324979|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
154324980|NCT00993382|Amiodarone|amiodarone|mesh-list
154324981|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154324982|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
154324983|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154324984|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154324986|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154325000|NCT05628610|Tislelizumab|tislelizumab|mesh-list
154325001|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154325002|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325003|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
154325004|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
154325005|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
154325006|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325007|NCT05628610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154325008|NCT00079937|Fluticasone|fluticasone|mesh-list
154325009|NCT00079937|Omalizumab|omalizumab|mesh-list
154325010|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325011|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154325012|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
154325013|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325014|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325015|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154325016|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
154325017|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
154325018|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154325019|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154325020|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154325021|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325022|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154325023|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154325024|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
154325025|NCT03126110|Nivolumab|nivolumab|mesh-list
154325026|NCT03126110|Ipilimumab|ipilimumab|mesh-list
154325027|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154325028|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325029|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154325030|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325031|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
154325032|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154325033|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325039|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325041|NCT00906334|Glycine|glycine|mesh-list
154325042|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325043|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154325044|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325045|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325046|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
154325047|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325048|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325049|NCT00905164|Topiramate|topiramate|mesh-list
154325050|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
154325051|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154325052|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325053|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
154325054|NCT00978016|Baclofen|baclofen|mesh-list
154325055|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154325056|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325057|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325058|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154325059|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325060|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154325061|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820654|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820655|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154325062|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154325063|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
154325064|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
154325065|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325066|NCT01129648|Allopurinol|allopurinol|mesh-list
154325067|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
154325068|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325069|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325082|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
154325083|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
154325084|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154325085|NCT03176966|Vitamin E|vitamin e|mesh-list
154325086|NCT03176966|Ropinirole|ropinirole|mesh-list
154325087|NCT03176966|Vitamins|vitamins|mesh-ancestor
154325088|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
154325089|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325090|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
154325091|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325092|NCT03176966|Protective Agents|protective agents|mesh-ancestor
154325093|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154325094|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154325095|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
154325096|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
154325097|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325098|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
154325099|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
154325100|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
154325101|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154325102|NCT03209570|Protective Agents|protective agents|mesh-ancestor
154325103|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325104|NCT03209492|Leuprolide|leuprolide|mesh-list
154071896|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
154325105|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154325106|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
154325107|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154325108|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325109|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325111|NCT00894868|Vildagliptin|vildagliptin|mesh-list
154325112|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154325118|NCT01122784|Vaccines|vaccines|mesh-list
154325129|NCT00892762|Latanoprost|latanoprost|mesh-list
154325130|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154325131|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154325132|NCT00890968|Triamcinolone|triamcinolone|mesh-list
154325133|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154325134|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154325135|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154325136|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325137|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
154325138|NCT00890968|Hormones|hormones|mesh-ancestor
154325139|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325140|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325141|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154325142|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
154325143|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325144|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325145|NCT01098383|Acetylcholine|acetylcholine|mesh-list
154325146|NCT01098383|Donepezil|donepezil|mesh-list
154325147|NCT01098383|Choline|choline|mesh-list
154325148|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154325149|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325150|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325151|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
154325152|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325153|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325154|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
153820658|NCT00434096|Rimonabant|rimonabant|mesh-list
154325155|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
154325156|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154325157|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
154325174|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154325175|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154325177|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154325178|NCT01088477|Estrogens|estrogens|mesh-ancestor
154325179|NCT01088477|Hormones|hormones|mesh-ancestor
154325180|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325181|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325182|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154325183|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
154325184|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154325185|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154325186|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
154325200|NCT00078767|Sertraline|sertraline|mesh-list
154325234|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154325235|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154325236|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154325237|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325238|NCT00886600|Diuretics|diuretics|mesh-ancestor
154325239|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
154325240|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325241|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154325242|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325243|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
154325244|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154325245|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325246|NCT02591654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154325247|NCT02591654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325248|NCT03134872|Carboplatin|carboplatin|mesh-list
154325249|NCT03134872|Pemetrexed|pemetrexed|mesh-list
154325250|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325251|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325252|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325253|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154325254|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154325255|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154325256|NCT03952481|Lifitegrast|lifitegrast|mesh-list
154325257|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154325258|NCT05135312|Etanercept|etanercept|mesh-list
154325259|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154325260|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154325261|NCT05135312|Analgesics|analgesics|mesh-ancestor
154325262|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
154325263|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325264|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325265|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325266|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154325267|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325268|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154325269|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
154325270|NCT00881452|Citric Acid|citric acid|mesh-list
154325271|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
153820668|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153820669|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
154325272|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154325273|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
154325274|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
154325275|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325276|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
154325277|NCT03952325|Nivolumab|nivolumab|mesh-list
154325278|NCT03952325|Atezolizumab|atezolizumab|mesh-list
154325279|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154325280|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325281|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154325282|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325283|NCT00948142|Linezolid|linezolid|mesh-list
154325284|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
154325285|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325286|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325287|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154325288|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325289|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325290|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
154325291|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154325292|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325293|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
154325322|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325323|NCT01102660|Naproxen|naproxen|mesh-list
154325324|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154325325|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154325326|NCT01102660|Analgesics|analgesics|mesh-ancestor
154325327|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
154325328|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325329|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325330|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072118|NCT00829114|Estrogens|estrogens|mesh-ancestor
154325331|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154325332|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
154325333|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154325334|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325335|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325337|NCT03135106|Fluconazole|fluconazole|mesh-list
154325338|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
154325339|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325340|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154325341|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154325342|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325343|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325344|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154325345|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
154325346|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325347|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325348|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154325349|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154325350|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154325351|NCT00872014|Sorafenib|sorafenib|mesh-list
154325352|NCT00872014|Trebananib|trebananib|mesh-list
154325353|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325354|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154325355|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325357|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154325358|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154325359|NCT00872014|Growth Substances|growth substances|mesh-ancestor
154325360|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325361|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
154325362|NCT00870688|Valproic Acid|valproic acid|mesh-list
154325363|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
154325364|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820670|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325365|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325366|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
154325367|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325368|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325369|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
154325370|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154325371|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154325372|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325373|NCT00870454|Pregabalin|pregabalin|mesh-list
154325374|NCT00870454|Analgesics|analgesics|mesh-ancestor
154325375|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
154325376|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325413|NCT00934180|Ondansetron|ondansetron|mesh-list
154325414|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
154325415|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
154325416|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325417|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325418|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154325419|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
154325420|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
154325421|NCT00934180|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154325422|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154325423|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
154325424|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325425|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325426|NCT02576444|Olaparib|olaparib|mesh-list
154325427|NCT02576444|Adavosertib|adavosertib|mesh-list
154325428|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154325429|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325430|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325431|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325432|NCT00929968|Fluticasone|fluticasone|mesh-list
154325433|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325434|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154325435|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
154325436|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325437|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325438|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154325439|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
154325440|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
154325441|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154325442|NCT03957083|Oxytocin|oxytocin|mesh-list
154325443|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
154325446|NCT04945616|Aspirin|aspirin|mesh-list
154325454|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325455|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325457|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154325458|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154325459|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325460|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154325461|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154325462|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325463|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
154325464|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154325465|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154325466|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154325467|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
154325468|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325469|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
154325470|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154325471|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
154325472|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
154325473|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154325506|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325508|NCT01093781|Renin Inhibitors|renin inhibitors|mesh-ancestor
153820672|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153820673|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153820674|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
154325509|NCT01093781|Protease Inhibitors|protease inhibitors|mesh-ancestor
154325510|NCT01093781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325511|NCT01093781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325512|NCT05095064|Irinotecan|irinotecan|mesh-list
154325513|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154325514|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154325515|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325516|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325517|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325518|NCT03169244|Bupropion|bupropion|mesh-list
154325519|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154325520|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
154325521|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325522|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154325523|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154325524|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325525|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325559|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325560|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154325561|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
154325562|NCT00914602|Levodopa|levodopa|mesh-list
154325563|NCT00914602|Carbidopa|carbidopa|mesh-list
154325564|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154325565|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154325566|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154325567|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
154325568|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325569|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325570|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325571|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154325572|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325573|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154325574|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
154325575|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
154325576|NCT00914290|Baclofen|baclofen|mesh-list
154325577|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154325578|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325582|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
154325612|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325613|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325615|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
154325616|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154325617|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154325618|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325619|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325620|NCT02998736|Urological Agents|urological agents|mesh-ancestor
154325621|NCT00075881|Bortezomib|bortezomib|mesh-list
154325622|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325623|NCT00838630|Cilostazol|cilostazol|mesh-list
154325624|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154325625|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
154325626|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325627|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325628|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154325629|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
154325630|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154325631|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154325632|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325633|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154325634|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
154325635|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154325636|NCT00838630|Protective Agents|protective agents|mesh-ancestor
154325637|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153820675|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360669|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325638|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154325639|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325640|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
154325641|NCT02996474|Decitabine|decitabine|mesh-list
154325655|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325656|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325657|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325658|NCT00820300|Latanoprost|latanoprost|mesh-list
154325659|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154325660|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154325662|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154325663|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325664|NCT03134638|Carboplatin|carboplatin|mesh-list
154325665|NCT03134638|Fulvestrant|fulvestrant|mesh-list
154325666|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325667|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154325668|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154325669|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154325670|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
154325671|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154325672|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325673|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
154325674|NCT03205046|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154325675|NCT03205046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154325676|NCT03205046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325677|NCT03205046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325678|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325679|NCT04855526|Dronabinol|dronabinol|mesh-list
154325680|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
154325681|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325682|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325699|NCT05442008|Analgesics|analgesics|mesh-ancestor
154325700|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
154325701|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325702|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325703|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
154325704|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
154325705|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154325706|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325707|NCT03331562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154325708|NCT03331562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325709|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154325710|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325711|NCT03331562|Vitamins|vitamins|mesh-ancestor
154325712|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
154325713|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154325714|NCT00814294|Insulin|insulin|mesh-list
154325715|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154325716|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154325717|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325718|NCT02038634|Betamethasone|betamethasone|mesh-list
154325719|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325720|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
154325750|NCT00836056|Clindamycin|clindamycin|mesh-list
154325751|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
154325752|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
154325753|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154325754|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154325755|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154325756|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325757|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325758|NCT00835666|Finasteride|finasteride|mesh-list
154325759|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154325760|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154325761|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325785|NCT00708292|Bortezomib|bortezomib|mesh-list
154325812|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154325813|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325814|NCT01330472|Alprazolam|alprazolam|mesh-list
154325815|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154325816|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154325817|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325818|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154325819|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154325820|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325821|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
154325822|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
154325823|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325824|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325825|NCT00835276|Fexofenadine|fexofenadine|mesh-list
154325826|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154325827|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154325828|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154325829|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
154325830|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
154325831|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325834|NCT03344536|Fulvestrant|fulvestrant|mesh-list
154325863|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154325865|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154325866|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154325867|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154325868|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154325869|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325870|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325871|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325872|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325873|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154325874|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
154325875|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325876|NCT03070522|Prednisone|prednisone|mesh-list
154325877|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154325878|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
154325879|NCT03070522|Hormones|hormones|mesh-ancestor
154325919|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
154325920|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
154325921|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154325922|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154325923|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325924|NCT00151996|Guanfacine|guanfacine|mesh-list
154325925|NCT00151996|Methylphenidate|methylphenidate|mesh-list
154325926|NCT00151996|Amphetamine|amphetamine|mesh-list
154325927|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154325928|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325929|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154325930|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154325931|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154325932|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325933|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
154325934|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325935|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
154325936|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
154325937|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154325938|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154325939|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154325940|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154325943|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154325970|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
154325971|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325972|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325973|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325974|NCT04472806|Endostar protein|endostar protein|mesh-list
154325975|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154325976|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154325977|NCT04472806|Growth Substances|growth substances|mesh-ancestor
154325978|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325979|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
154325980|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154325981|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
154325982|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
154325983|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154325984|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154325985|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154325986|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154325987|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
154325988|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154325989|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154325993|NCT00770848|Prednisone|prednisone|mesh-list
154326023|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154326024|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
154326025|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154326026|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154326027|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
154326028|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
154326029|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154326030|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154326031|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326032|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326033|NCT01315262|Urological Agents|urological agents|mesh-ancestor
154326034|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
154326035|NCT03197324|Digoxin|digoxin|mesh-list
154326036|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154326037|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154326038|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326039|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326040|NCT03197324|Protective Agents|protective agents|mesh-ancestor
154326041|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326042|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154326043|NCT01330706|Polihexanide|polihexanide|mesh-list
154326044|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
154326045|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326046|NCT01156220|Furosemide|furosemide|mesh-list
154326047|NCT01156220|Diuretics|diuretics|mesh-ancestor
154326053|NCT03192488|Cetirizine|cetirizine|mesh-list
154326073|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154326074|NCT00042289|Darunavir|darunavir|mesh-list
154326075|NCT00042289|Nelfinavir|nelfinavir|mesh-list
154326076|NCT00042289|Indinavir|indinavir|mesh-list
154326077|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
154326078|NCT00042289|Amprenavir|amprenavir|mesh-list
154326079|NCT00042289|Tenofovir|tenofovir|mesh-list
154326080|NCT00042289|Emtricitabine|emtricitabine|mesh-list
154326081|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
154326082|NCT00042289|Nevirapine|nevirapine|mesh-list
154326083|NCT00042289|Dolutegravir|dolutegravir|mesh-list
154326084|NCT00042289|Maraviroc|maraviroc|mesh-list
154326085|NCT00042289|Abacavir|abacavir|mesh-list
154326086|NCT00042289|Didanosine|didanosine|mesh-list
154326087|NCT00042289|Cobicistat|cobicistat|mesh-list
154326088|NCT00042289|Rilpivirine|rilpivirine|mesh-list
154326089|NCT00042289|Tipranavir|tipranavir|mesh-list
154326090|NCT00042289|Elvitegravir|elvitegravir|mesh-list
154326091|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154326092|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
154326093|NCT00042289|Efavirenz|efavirenz|mesh-list
154326094|NCT00042289|Rifampin|rifampin|mesh-list
154326095|NCT00042289|Isoniazid|isoniazid|mesh-list
154326096|NCT00042289|Linezolid|linezolid|mesh-list
154326097|NCT00042289|Cycloserine|cycloserine|mesh-list
154326098|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
154326099|NCT00042289|Amikacin|amikacin|mesh-list
154326100|NCT00042289|Ethambutol|ethambutol|mesh-list
154326101|NCT00042289|Bedaquiline|bedaquiline|mesh-list
154326102|NCT00042289|Etravirine|etravirine|mesh-list
154326103|NCT00042289|Clofazimine|clofazimine|mesh-list
154326104|NCT00042289|Ofloxacin|ofloxacin|mesh-list
154326105|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154326106|NCT00042289|Ethionamide|ethionamide|mesh-list
154326107|NCT00042289|Kanamycin|kanamycin|mesh-list
154326108|NCT00042289|Prothionamide|prothionamide|mesh-list
154326109|NCT00042289|Capreomycin|capreomycin|mesh-list
154326110|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154326111|NCT00042289|Etonogestrel|etonogestrel|mesh-list
154326112|NCT00042289|Estradiol|estradiol|mesh-list
154326113|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154326114|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154326115|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
154326116|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326117|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326118|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154326120|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
154326121|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326122|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154326123|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154326124|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154326125|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154326126|NCT00042289|Estrogens|estrogens|mesh-ancestor
154326127|NCT00042289|Hormones|hormones|mesh-ancestor
154326128|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326129|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326130|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154326131|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
154326132|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154326133|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154326134|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154326164|NCT00039871|Ribavirin|ribavirin|mesh-list
154326175|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326176|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326177|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326178|NCT00015457|Amlodipine|amlodipine|mesh-list
154326179|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
154326180|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154326181|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326182|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326183|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
154326184|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326185|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326186|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154326187|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154326188|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154326189|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
154326190|NCT03564470|Dasatinib|dasatinib|mesh-list
154326191|NCT03564470|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154326192|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154326193|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326194|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326195|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326196|NCT03191396|Liraglutide|liraglutide|mesh-list
154326224|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154326225|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
154326226|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326227|NCT00006289|Analgesics|analgesics|mesh-ancestor
154326228|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
154326229|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326230|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
154326231|NCT05625841|Propolis|propolis|mesh-list
154326232|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326233|NCT01103401|Tobramycin|tobramycin|mesh-list
154326234|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154326235|NCT01103401|Dexamethasone|dexamethasone|mesh-list
154326236|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
154326237|NCT01103401|Ketorolac|ketorolac|mesh-list
154326238|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154326239|NCT01103401|BB 1101|bb 1101|mesh-list
154326240|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154326241|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
154326242|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
154326243|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326244|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326245|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154326246|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
154326247|NCT01103401|Hormones|hormones|mesh-ancestor
154326248|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326249|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154326250|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326251|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
154326252|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326253|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326254|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154326255|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154326256|NCT01103401|Analgesics|analgesics|mesh-ancestor
154326257|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
154326266|NCT00005047|Methotrexate|methotrexate|mesh-list
154326267|NCT00005047|Vinblastine|vinblastine|mesh-list
154326268|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326269|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154326270|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154326271|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154326272|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326273|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326274|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154326275|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
154326276|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154326291|NCT01103635|Ipilimumab|ipilimumab|mesh-list
154326328|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326330|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154326331|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
154326332|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326333|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326334|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154326335|NCT01100203|Diuretics|diuretics|mesh-ancestor
154326336|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
154326337|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154326338|NCT03948685|Carvedilol|carvedilol|mesh-list
154326339|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154326340|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154326341|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
154326342|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326343|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326344|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326345|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154326346|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
154326347|NCT03948685|Protective Agents|protective agents|mesh-ancestor
154326348|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154326349|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326350|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154326351|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
154326352|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154326353|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154326354|NCT01585051|Vitamin D|vitamin d|mesh-list
154326355|NCT01585051|Vitamins|vitamins|mesh-ancestor
154326356|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
154326357|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326358|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154326370|NCT00003631|Melphalan|melphalan|mesh-list
154326371|NCT00003631|Ifosfamide|ifosfamide|mesh-list
154326372|NCT00003631|Carmustine|carmustine|mesh-list
154326373|NCT00003631|Carboplatin|carboplatin|mesh-list
154326374|NCT00003631|Etoposide|etoposide|mesh-list
154326375|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154326376|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
154326377|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326378|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154326379|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154326380|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
154326381|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326382|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326383|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154326384|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154326385|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154326386|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154326387|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326388|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154326389|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
154326390|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
154326391|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326393|NCT01101685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154326394|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154326395|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326396|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326397|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326398|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
154326399|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326400|NCT00030901|Selenium|selenium|mesh-list
154326401|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
154326402|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326403|NCT00030901|Protective Agents|protective agents|mesh-ancestor
154326408|NCT01104259|Veliparib|veliparib|mesh-list
154326411|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
154326412|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
154326413|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
154326414|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326415|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154326416|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326417|NCT01104337|Acetaminophen|acetaminophen|mesh-list
154326418|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154326419|NCT01104337|Analgesics|analgesics|mesh-ancestor
154326420|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
154326421|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326422|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326423|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
154326424|NCT01100359|Carboplatin|carboplatin|mesh-list
154326425|NCT01100359|Doxorubicin|doxorubicin|mesh-list
154326426|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154326427|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326428|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154326429|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154326430|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154326431|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326432|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073234|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326433|NCT00003199|Tamoxifen|tamoxifen|mesh-list
154326434|NCT00003199|Aldesleukin|aldesleukin|mesh-list
154326435|NCT00003199|Melphalan|melphalan|mesh-list
154326436|NCT00003199|Busulfan|busulfan|mesh-list
154326437|NCT00003199|Thiotepa|thiotepa|mesh-list
154326438|NCT00003199|Interleukin-2|interleukin-2|mesh-list
154326439|NCT00003199|Sargramostim|sargramostim|mesh-list
154326440|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326441|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154326442|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
154326443|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326444|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154326451|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326452|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154326453|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
154326454|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326455|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154326456|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154326457|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154326458|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154326459|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154326460|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154326461|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
154326462|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326463|NCT01327261|Levodopa|levodopa|mesh-list
154326464|NCT01327261|Benserazide|benserazide|mesh-list
154326465|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154326466|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154326467|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
154326468|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326469|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326470|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326471|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326472|NCT01101919|Tofacitinib|tofacitinib|mesh-list
154326473|NCT01101919|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154326474|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154326475|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326477|NCT03951415|Durvalumab|durvalumab|mesh-list
154326498|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326499|NCT01104571|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154326500|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154326501|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326502|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326503|NCT01104649|Riluzole|riluzole|mesh-list
154326504|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
154326505|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154326506|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154326507|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326508|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326509|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326510|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154326511|NCT01104649|Protective Agents|protective agents|mesh-ancestor
154326512|NCT01327729|Interferons|interferons|mesh-list
154326513|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
154326514|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
154326515|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154326516|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326517|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
154326518|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326519|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
154326520|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326521|NCT01342952|Ambrisentan|ambrisentan|mesh-list
154326522|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154326523|NCT01104883|Iodine|iodine|mesh-list
154326524|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154326525|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326545|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
154326546|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326547|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326548|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326549|NCT01333982|Amoxicillin|amoxicillin|mesh-list
154326550|NCT01333982|Gentamicins|gentamicins|mesh-list
154326551|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154326552|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326553|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154326554|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326555|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326556|NCT01334060|Vaccines|vaccines|mesh-list
154326557|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
154326558|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326559|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
154326560|NCT04130828|Trace Elements|trace elements|mesh-ancestor
154326561|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
154326562|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326601|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154326602|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
154326603|NCT03162224|Durvalumab|durvalumab|mesh-list
154326604|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154326605|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326606|NCT00904046|Pioglitazone|pioglitazone|mesh-list
154326607|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154326608|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154326609|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326610|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
154326611|NCT01332734|Analgesics|analgesics|mesh-ancestor
154326612|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
154326613|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326614|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326615|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
154326616|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154326617|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154326618|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
154326619|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154326620|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326621|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326652|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326653|NCT03035630|Sunitinib|sunitinib|mesh-list
154326654|NCT03035630|Avelumab|avelumab|mesh-list
154326655|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326656|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154326657|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154326658|NCT03035630|Growth Substances|growth substances|mesh-ancestor
154326659|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326660|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
154326661|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154326662|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326716|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
154326717|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154326718|NCT01335074|Sirolimus|sirolimus|mesh-list
154326719|NCT01335074|Sorafenib|sorafenib|mesh-list
154326720|NCT01335074|Temsirolimus|temsirolimus|mesh-list
154326721|NCT01335074|MTOR Inhibitors|mtor inhibitors|mesh-list
154326722|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326723|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154326724|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326725|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326726|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154326727|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
154326728|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326729|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154326730|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326731|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154326732|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
154326733|NCT01337492|Sorafenib|sorafenib|mesh-list
154326734|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326735|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154326736|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326737|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326738|NCT01337570|Dapivirine|dapivirine|mesh-list
154326739|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154326740|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154326741|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
154326742|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326743|NCT01337804|Omeprazole|omeprazole|mesh-list
154326744|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
154326745|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154326746|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073500|NCT00767520|Exemestane|exemestane|mesh-list
154326761|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154326762|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154326763|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326764|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154326765|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154326766|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326767|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
154326768|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154326769|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
154326770|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154326771|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
154326772|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
154326773|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154326774|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154326775|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154326776|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154326777|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154326778|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
154326784|NCT00642148|Hormones|hormones|mesh-ancestor
154326815|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
154326816|NCT02280694|Capecitabine|capecitabine|mesh-list
154326817|NCT02280694|Methotrexate|methotrexate|mesh-list
154326818|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154326819|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
154326820|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326821|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154326822|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154326823|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
154326824|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326825|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326826|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154326827|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154326829|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154326830|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
154326831|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154326832|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
154326833|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326838|NCT02280694|Analgesics|analgesics|mesh-ancestor
154326872|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
154326874|NCT03799627|Hematinics|hematinics|mesh-ancestor
154326875|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
154326876|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326877|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326878|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326879|NCT02274142|Methamphetamine|methamphetamine|mesh-list
154326880|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154326881|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326882|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
154326883|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
154326884|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326885|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
154326886|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326887|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326888|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
154326889|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154326890|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154326891|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326927|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154326928|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154326929|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154326930|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154326931|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154326932|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326933|NCT01102465|Diuretics|diuretics|mesh-ancestor
154326934|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
154326935|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326936|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154326937|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154326938|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
154326939|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154326940|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326941|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
154326942|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
154326943|NCT00749632|Oxybutynin|oxybutynin|mesh-list
154326944|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
154326945|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
154326946|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154326947|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326948|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154326949|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154326950|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
154326951|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154326952|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326953|NCT00749632|Urological Agents|urological agents|mesh-ancestor
154326954|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154326955|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154326956|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
154326957|NCT01105273|Fludarabine|fludarabine|mesh-list
154326958|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154326959|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154326960|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
154326966|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326967|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154326968|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154326969|NCT00743938|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154326970|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154326972|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326973|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326975|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
154326976|NCT01105351|Hematinics|hematinics|mesh-ancestor
154326977|NCT01105351|Vitamins|vitamins|mesh-ancestor
154326978|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
154326979|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154326980|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
154326981|NCT00662506|Temozolomide|temozolomide|mesh-list
154326982|NCT00662506|Cediranib|cediranib|mesh-list
154326983|NCT00662506|Maleic acid|maleic acid|mesh-list
154326984|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154326985|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154326986|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
154326987|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154326988|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154326989|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154326990|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154326991|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154326992|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
154326993|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
154326995|NCT03947125|Buprenorphine|buprenorphine|mesh-list
154327014|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154327015|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154327016|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154327017|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327019|NCT00658372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154327020|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154327021|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327022|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327023|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327024|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
154327025|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327026|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154327027|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
154327028|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154327029|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154327030|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154327031|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327066|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327067|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154327068|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
154327069|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327070|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327071|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154327072|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
154327073|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
154327074|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154327075|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154327076|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154327077|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327078|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327080|NCT00612742|Androgens|androgens|mesh-ancestor
154327081|NCT00612742|Hormones|hormones|mesh-ancestor
154327082|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327083|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327084|NCT01106131|Pioglitazone|pioglitazone|mesh-list
154327085|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327086|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327087|NCT00612118|Azelastine|azelastine|mesh-list
154327089|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154327090|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
154327106|NCT00743002|Metformin|metformin|mesh-list
154327113|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
154327114|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327115|NCT00603616|Rifaximin|rifaximin|mesh-list
154327116|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154327117|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327118|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154327119|NCT02280070|Leucovorin|leucovorin|mesh-list
154327120|NCT02280070|Fluorouracil|fluorouracil|mesh-list
154327121|NCT02280070|Tegafur|tegafur|mesh-list
154327122|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
154327123|NCT02280070|Antibodies|antibodies|mesh-list
154327124|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
154327125|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
154327126|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
154327127|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327128|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
154327129|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327130|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154327131|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327132|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154327133|NCT02280070|Antidotes|antidotes|mesh-ancestor
154327134|NCT02280070|Protective Agents|protective agents|mesh-ancestor
154327135|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
154327136|NCT02280070|Vitamins|vitamins|mesh-ancestor
154327137|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
154327138|NCT01108783|Desloratadine|desloratadine|mesh-list
154327139|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154327140|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
154327141|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327142|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327161|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
154327162|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154327163|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327164|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154327165|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154327166|NCT00602602|Growth Substances|growth substances|mesh-ancestor
154327167|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327168|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
154327169|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154327170|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
154327171|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327172|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154327173|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
154327174|NCT04177654|Albendazole|albendazole|mesh-list
154327175|NCT04177654|Mebendazole|mebendazole|mesh-list
154327176|NCT04177654|Benzimidazole|benzimidazole|mesh-list
154327177|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
154327178|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154327179|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327180|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
154327181|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154327182|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154327183|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
154327184|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
154327185|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
154327186|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327187|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327188|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
154327189|NCT02281396|Vaccines|vaccines|mesh-list
154327190|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
154327191|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327205|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327206|NCT01111591|Celecoxib|celecoxib|mesh-list
154327207|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
154327208|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154327209|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154327210|NCT01111591|Analgesics|analgesics|mesh-ancestor
154327211|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
154327212|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327213|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327214|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327215|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154327216|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154327217|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327218|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327219|NCT02281474|Nilotinib|nilotinib|mesh-list
154327220|NCT02281474|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154327221|NCT02281474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154327222|NCT02281474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327223|NCT02281474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327224|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
154327225|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154327226|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154327227|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327228|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
154327229|NCT01111669|Coagulants|coagulants|mesh-ancestor
154327230|NCT01108939|Antimalarials|antimalarials|mesh-list
154327231|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154327232|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154327233|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327234|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154327235|NCT00654706|Sertindole|sertindole|mesh-list
154327236|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
154327247|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327248|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327249|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154327250|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
154327251|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327252|NCT03944317|Azithromycin|azithromycin|mesh-list
154327253|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
154327254|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
154327255|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154327256|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154327257|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327258|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
154327259|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154327260|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154327261|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154327262|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327263|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327264|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154327265|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
154327266|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154327267|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
154327301|NCT01111981|Clobetasol|clobetasol|mesh-list
154327302|NCT01111981|Emollients|emollients|mesh-list
154327303|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327304|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
154327305|NCT01111981|Hormones|hormones|mesh-ancestor
154327306|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327307|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327308|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
154327309|NCT02283424|Carboplatin|carboplatin|mesh-list
154327310|NCT02283424|Docetaxel|docetaxel|mesh-list
154327311|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327312|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
154327313|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
154327314|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
154327315|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327316|NCT03942601|Sirolimus|sirolimus|mesh-list
154327317|NCT03942601|Dexamethasone|dexamethasone|mesh-list
154327360|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327361|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327363|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
154327364|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154327365|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
154327366|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
154327367|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
154327368|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327369|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327370|NCT01208935|Nicotine|nicotine|mesh-list
154327371|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154327372|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
154327373|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327374|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327375|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154327376|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154327377|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
154327378|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327390|NCT01107067|Testosterone|testosterone|mesh-list
154327415|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154327417|NCT01107145|Artemether|artemether|mesh-list
154327418|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154327419|NCT01107145|Mefloquine|mefloquine|mesh-list
154327420|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
154327421|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154327422|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153730148|NCT00132821|Bupropion|bupropion|mesh-list
154327423|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327424|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327425|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
154327426|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
154327427|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154327428|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
154327429|NCT01107145|Amebicides|amebicides|mesh-ancestor
154327430|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154327431|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154327432|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154327433|NCT01107145|Analgesics|analgesics|mesh-ancestor
154327434|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
154327435|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327436|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327437|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327438|NCT01107145|Filaricides|filaricides|mesh-ancestor
154327439|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
154327440|NCT03944005|Anesthetics|anesthetics|mesh-list
154327441|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327442|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327443|NCT01209403|Insulin|insulin|mesh-list
154327444|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
154327445|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327446|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327447|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
154327458|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154327459|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154327460|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
154327461|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327462|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154327463|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154327464|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154327465|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327466|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
154327467|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154327468|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154327469|NCT02286544|Atorvastatin|atorvastatin|mesh-list
154327470|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154327471|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154327472|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
154327473|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327474|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154327476|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327514|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327516|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154327517|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
154327518|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154327519|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327520|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154327521|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154327522|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154327523|NCT02286622|Deflazacort|deflazacort|mesh-list
154327524|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327525|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154327526|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
154327527|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327528|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154327529|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154327530|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154327531|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
154327532|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327533|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327534|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327535|NCT00564226|Urological Agents|urological agents|mesh-ancestor
154327536|NCT03635684|Acetaminophen|acetaminophen|mesh-list
154327537|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154327538|NCT03635684|Analgesics|analgesics|mesh-ancestor
154327539|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
154327540|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327541|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327542|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
154327557|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
154327558|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327559|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327560|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327561|NCT05185544|Pemetrexed|pemetrexed|mesh-list
154327562|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327563|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327564|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327565|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154327566|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154327567|NCT00382096|Metformin|metformin|mesh-list
154327568|NCT00382096|Vildagliptin|vildagliptin|mesh-list
154327569|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327570|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327571|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154327572|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
153730184|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
154327573|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327574|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327575|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
154327576|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327577|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
154327607|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327608|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327609|NCT00374296|Mocetinostat|mocetinostat|mesh-list
154327610|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154327611|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327612|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327613|NCT00547066|Veltuzumab|veltuzumab|mesh-list
154327614|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327615|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
154327616|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154327617|NCT01315496|Antibodies|antibodies|mesh-list
154327618|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
154327619|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
154327620|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327621|NCT00544960|Docetaxel|docetaxel|mesh-list
154327622|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327623|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
154327624|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
154327625|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
154327626|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327627|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154327661|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
154327662|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327663|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327664|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327665|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154327666|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
154327667|NCT02286934|Protective Agents|protective agents|mesh-ancestor
154327668|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154327669|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327670|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154327671|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
154327672|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154327673|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154327674|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154327675|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154327676|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154327719|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327720|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327721|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154327722|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154327723|NCT00535366|Fluticasone|fluticasone|mesh-list
154327724|NCT00535366|Ciclesonide|ciclesonide|mesh-list
154327725|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
154327726|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154327727|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154327728|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154327729|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
154327730|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327731|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327732|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154327733|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
154327734|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
154327735|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154327736|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
154327737|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154327738|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
154327739|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327740|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327746|NCT00535366|Hormones|hormones|mesh-ancestor
154327771|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
154327772|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327773|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327774|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154327775|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154327776|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
154327777|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
154327778|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327779|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154327780|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154327781|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327782|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327783|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154327784|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154327785|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154327786|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154327787|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154327788|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
154327789|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
154327790|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154327791|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154327792|NCT01352416|Ranolazine|ranolazine|mesh-list
154327793|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154327794|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327795|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327819|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154327820|NCT00361582|Narcotics|narcotics|mesh-ancestor
154327821|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327822|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327823|NCT00361582|Analgesics|analgesics|mesh-ancestor
154327824|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
154327825|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327826|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154327827|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154327828|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327829|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327830|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
154327831|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327832|NCT00450970|Satraplatin|satraplatin|mesh-list
154327833|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327834|NCT02282800|Vitamin D|vitamin d|mesh-list
154327835|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154327836|NCT02282800|Vitamins|vitamins|mesh-ancestor
154327837|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
154327838|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327839|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154327840|NCT05208034|Methotrexate|methotrexate|mesh-list
154327841|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154327856|NCT02284282|Lidocaine|lidocaine|mesh-list
154327868|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327869|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327870|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154327873|NCT00359086|Mocetinostat|mocetinostat|mesh-list
154327874|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154327875|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154327876|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327877|NCT02282956|Droperidol|droperidol|mesh-list
154327878|NCT02282956|Morphine|morphine|mesh-list
154327879|NCT02282956|Ropivacaine|ropivacaine|mesh-list
154327880|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154327881|NCT02282956|Narcotics|narcotics|mesh-ancestor
154327882|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327883|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327884|NCT02282956|Analgesics|analgesics|mesh-ancestor
154327885|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
154327886|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327887|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
154327888|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
154327889|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154327890|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
154327891|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
154327892|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154327893|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154327921|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154327922|NCT00445198|Navitoclax|navitoclax|mesh-list
154327923|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327924|NCT00345748|Abatacept|abatacept|mesh-list
154327925|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154327926|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327927|NCT00345748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154327928|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327929|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154327930|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
154327931|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327932|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154327933|NCT00439738|Amlodipine|amlodipine|mesh-list
154327934|NCT00439738|Valsartan|valsartan|mesh-list
154327935|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154327936|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154327937|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154327938|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154327939|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327940|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154327941|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327942|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
154327943|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154327944|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154327945|NCT00439738|Diuretics|diuretics|mesh-ancestor
154327946|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
154327947|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154327948|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
154327949|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154327950|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327951|NCT00523042|Insulin|insulin|mesh-list
154327952|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154327953|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
154327954|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327955|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327956|NCT00338104|Insulin|insulin|mesh-list
154327957|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154327958|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
154327959|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327960|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327961|NCT00519142|Mitiglinide|mitiglinide|mesh-list
154327962|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154327963|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327964|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
154327965|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154327966|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154327967|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154327968|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154327969|NCT02284672|Analgesics|analgesics|mesh-ancestor
154327970|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
154327971|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154327972|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154327973|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154327974|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154327975|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
154327976|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154327977|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154327978|NCT02283190|Asparaginase|asparaginase|mesh-list
154327979|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154327980|NCT00333502|Camptothecin|camptothecin|mesh-list
154327998|NCT05982587|Antacids|antacids|mesh-ancestor
154328007|NCT05982522|Mitosis Modulators|mitosis modulators|mesh-ancestor
154328008|NCT05982522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328009|NCT05982522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328010|NCT05982483|Bupivacaine|bupivacaine|mesh-list
154328011|NCT05982483|Anesthetics, Local|anesthetics, local|mesh-ancestor
154328012|NCT05982483|Anesthetics|anesthetics|mesh-ancestor
154328013|NCT05982483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328014|NCT05982483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328015|NCT05982483|Sensory System Agents|sensory system agents|mesh-ancestor
154328016|NCT05982483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328017|NCT05982470|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154328018|NCT05982470|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154328019|NCT05982470|Estradiol|estradiol|mesh-list
154328020|NCT05982470|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154328021|NCT05982470|Progesterone|progesterone|mesh-list
154328022|NCT05982470|Estrogens|estrogens|mesh-ancestor
154328023|NCT05982470|Hormones|hormones|mesh-ancestor
154328024|NCT05982470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154328025|NCT05982470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328026|NCT05982470|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154328027|NCT05982470|Contraceptive Agents|contraceptive agents|mesh-ancestor
154328028|NCT05982470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154328029|NCT05982470|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154328030|NCT05982470|Progestins|progestins|mesh-ancestor
154328031|NCT05982314|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154328032|NCT05982314|Immunologic Factors|immunologic factors|mesh-ancestor
154328033|NCT05982314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328034|NCT05982301|Paclitaxel|paclitaxel|mesh-list
154328035|NCT05982301|Oxaliplatin|oxaliplatin|mesh-list
154328036|NCT05982301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154328037|NCT05982301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328038|NCT05982301|Tubulin Modulators|tubulin modulators|mesh-ancestor
154328039|NCT05982301|Antimitotic Agents|antimitotic agents|mesh-ancestor
154328040|NCT05982301|Mitosis Modulators|mitosis modulators|mesh-ancestor
154328041|NCT05982301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328043|NCT05982197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154328044|NCT05982197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154328045|NCT05982197|Analgesics|analgesics|mesh-ancestor
154328046|NCT05982197|Sensory System Agents|sensory system agents|mesh-ancestor
154328047|NCT05982197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328048|NCT05982197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328049|NCT05982197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154328050|NCT05982197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328051|NCT05982197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328052|NCT05982197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328053|NCT05982197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328054|NCT05981976|Abatacept|abatacept|mesh-list
154328055|NCT05981976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154328056|NCT05981976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328057|NCT05981976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328058|NCT05981976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328059|NCT05981976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328060|NCT05981976|Immunologic Factors|immunologic factors|mesh-ancestor
154328061|NCT05981976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328062|NCT05981976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328095|NCT05981014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328096|NCT05981014|Tubulin Modulators|tubulin modulators|mesh-ancestor
154328097|NCT05981014|Antimitotic Agents|antimitotic agents|mesh-ancestor
154328098|NCT05981014|Mitosis Modulators|mitosis modulators|mesh-ancestor
154328099|NCT05981014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328100|NCT05981014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328101|NCT05981014|Immunologic Factors|immunologic factors|mesh-ancestor
154328102|NCT05981014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328103|NCT05981014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328104|NCT05981014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328105|NCT05981014|Alkylating Agents|alkylating agents|mesh-ancestor
154328106|NCT05981014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328107|NCT05981014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154328108|NCT05981014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154328109|NCT05981014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154328110|NCT05981014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328111|NCT05981014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154328112|NCT05981014|Analgesics|analgesics|mesh-ancestor
154328113|NCT05981014|Sensory System Agents|sensory system agents|mesh-ancestor
154328114|NCT05981014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328116|NCT05981001|Cyclophosphamide|cyclophosphamide|mesh-list
154328117|NCT05981001|Carboplatin|carboplatin|mesh-list
154328118|NCT05981001|Gemcitabine|gemcitabine|mesh-list
154328119|NCT05981001|Fludarabine|fludarabine|mesh-list
154328120|NCT05981001|Interleukin-2|interleukin-2|mesh-list
154328121|NCT05981001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153781793|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
153781794|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
153409938|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328122|NCT05981001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328123|NCT05981001|Tubulin Modulators|tubulin modulators|mesh-ancestor
154328124|NCT05981001|Antimitotic Agents|antimitotic agents|mesh-ancestor
154328143|NCT05980871|Penicillin G|penicillin g|mesh-list
154328144|NCT05980871|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154328145|NCT05980871|Penicillin G Procaine|penicillin g procaine|mesh-list
154328146|NCT05980871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154328147|NCT05980871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328148|NCT05980871|Antimalarials|antimalarials|mesh-ancestor
154328149|NCT05980871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154328150|NCT05980871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154328151|NCT05980871|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154328152|NCT05980871|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154328153|NCT05980715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154328154|NCT05980715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328155|NCT05980715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328156|NCT05980715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328157|NCT05979597|Dexamethasone|dexamethasone|mesh-list
154328158|NCT05979597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154328159|NCT05979597|Antiemetics|antiemetics|mesh-ancestor
154328160|NCT05979597|Autonomic Agents|autonomic agents|mesh-ancestor
154328161|NCT05979597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328162|NCT05979597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328163|NCT05979597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328164|NCT05979597|Glucocorticoids|glucocorticoids|mesh-ancestor
154328165|NCT05979597|Hormones|hormones|mesh-ancestor
154328166|NCT05979597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154328167|NCT05979597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154328168|NCT05979597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328169|NCT05979038|Metformin|metformin|mesh-list
154328170|NCT05979038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328171|NCT05979038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328172|NCT05978219|Mirtazapine|mirtazapine|mesh-list
154328173|NCT05978219|Antidepressive Agents|antidepressive agents|mesh-ancestor
154328174|NCT05978219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154328185|NCT05978219|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154328186|NCT05978219|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154328187|NCT05978219|Adrenergic Agents|adrenergic agents|mesh-ancestor
154328188|NCT05978219|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154328189|NCT05978219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154328190|NCT05978219|Serotonin Agents|serotonin agents|mesh-ancestor
154328191|NCT05978219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154328193|NCT05975489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154328194|NCT05975489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328195|NCT05975489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154328196|NCT05975489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328197|NCT05975489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328198|NCT05975489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154328199|NCT05975489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154328200|NCT05975489|Purinergic Agents|purinergic agents|mesh-ancestor
154328201|NCT05975489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328202|NCT05947201|Paclitaxel|paclitaxel|mesh-list
154328203|NCT05947201|Fluorouracil|fluorouracil|mesh-list
154328204|NCT05947201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154328205|NCT05947201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328206|NCT05947201|Tubulin Modulators|tubulin modulators|mesh-ancestor
154328207|NCT05947201|Antimitotic Agents|antimitotic agents|mesh-ancestor
154328208|NCT05947201|Mitosis Modulators|mitosis modulators|mesh-ancestor
154328209|NCT05947201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328210|NCT05947201|Antimetabolites|antimetabolites|mesh-ancestor
154328211|NCT05947201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328212|NCT05947201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328213|NCT05947201|Immunologic Factors|immunologic factors|mesh-ancestor
154328215|NCT05914389|Capecitabine|capecitabine|mesh-list
153781795|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328230|NCT05909267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328231|NCT05909267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328232|NCT05909267|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154328233|NCT05909267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328234|NCT05906589|Psyllium|psyllium|mesh-list
154328235|NCT05906589|Cathartics|cathartics|mesh-ancestor
154328236|NCT05906589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328237|NCT05886140|Paclitaxel|paclitaxel|mesh-list
154328238|NCT05886140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154328239|NCT05886140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328240|NCT05886140|Tubulin Modulators|tubulin modulators|mesh-ancestor
154328241|NCT05886140|Antimitotic Agents|antimitotic agents|mesh-ancestor
154328242|NCT05886140|Mitosis Modulators|mitosis modulators|mesh-ancestor
154328243|NCT05886140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328244|NCT05870319|Carboplatin|carboplatin|mesh-list
154328245|NCT05870319|Pemetrexed|pemetrexed|mesh-list
154328246|NCT05870319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328247|NCT05870319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328248|NCT05870319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328249|NCT05870319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154328250|NCT05870319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154328251|NCT05863364|Rifaximin|rifaximin|mesh-list
154328281|NCT05801172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154328282|NCT05801172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328283|NCT05801172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154328284|NCT05801172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328286|NCT05758818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154328287|NCT05758818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328288|NCT05758818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154328289|NCT05758818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154328290|NCT05758818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328291|NCT05758818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328292|NCT05758818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328344|NCT06098326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328345|NCT06098326|Immunologic Factors|immunologic factors|mesh-ancestor
154328346|NCT06098326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328347|NCT06098326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328348|NCT06098326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328349|NCT06098326|Alkylating Agents|alkylating agents|mesh-ancestor
154328350|NCT06098326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328351|NCT06098326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328352|NCT06098326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328354|NCT06098313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328355|NCT06098313|Immunologic Factors|immunologic factors|mesh-ancestor
154328356|NCT06098313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328357|NCT06098313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328358|NCT06098313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328359|NCT06098313|Alkylating Agents|alkylating agents|mesh-ancestor
154328360|NCT06098313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328361|NCT06098313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328362|NCT06098313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328363|NCT06098014|Thalidomide|thalidomide|mesh-list
154328395|NCT06097585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328396|NCT06097585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328397|NCT06097585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328398|NCT06093698|Antibodies|antibodies|mesh-list
154328399|NCT06093698|Immunologic Factors|immunologic factors|mesh-ancestor
154328400|NCT06093698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328401|NCT06093659|Nicotine|nicotine|mesh-list
154328402|NCT06093659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154328403|NCT06093659|Autonomic Agents|autonomic agents|mesh-ancestor
154328404|NCT06093659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328405|NCT06093659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328406|NCT06093659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154328407|NCT06093659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154328408|NCT06093659|Cholinergic Agents|cholinergic agents|mesh-ancestor
154328409|NCT06093659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328410|NCT06093659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328411|NCT06093503|Carboplatin|carboplatin|mesh-list
154328412|NCT06093503|Pemetrexed|pemetrexed|mesh-list
154328413|NCT06093503|Osimertinib|osimertinib|mesh-list
154328414|NCT06093503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328415|NCT06093503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328416|NCT06093503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328417|NCT06093503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154328418|NCT06093503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154328419|NCT06093503|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154328420|NCT06093503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154328421|NCT06093477|Melatonin|melatonin|mesh-list
154328422|NCT06093477|Antioxidants|antioxidants|mesh-ancestor
154328423|NCT06093477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328424|NCT06093477|Protective Agents|protective agents|mesh-ancestor
154328425|NCT06093477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328426|NCT06093477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328427|NCT06093464|Corticosterone|corticosterone|mesh-list
154328435|NCT06093451|Analgesics|analgesics|mesh-ancestor
154328436|NCT06093451|Sensory System Agents|sensory system agents|mesh-ancestor
154328437|NCT06093451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328438|NCT06093451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154328439|NCT06093451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154328440|NCT06093451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154328441|NCT06093451|Adrenergic Agents|adrenergic agents|mesh-ancestor
154328442|NCT06093451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328443|NCT06093451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328444|NCT06093451|Anticonvulsants|anticonvulsants|mesh-ancestor
154328445|NCT06093451|Antiemetics|antiemetics|mesh-ancestor
154328446|NCT06093451|Autonomic Agents|autonomic agents|mesh-ancestor
154328447|NCT06093451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328448|NCT06093451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154328449|NCT06093451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154328450|NCT06093451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154328451|NCT06093451|GABA Modulators|gaba modulators|mesh-ancestor
154328452|NCT06093451|GABA Agents|gaba agents|mesh-ancestor
154328453|NCT06093425|Leucovorin|leucovorin|mesh-list
154328454|NCT06093425|Folic Acid|folic acid|mesh-list
154328455|NCT06093425|Capecitabine|capecitabine|mesh-list
154328456|NCT06093425|Fluorouracil|fluorouracil|mesh-list
154328457|NCT06093425|Nivolumab|nivolumab|mesh-list
154328458|NCT06093425|Oxaliplatin|oxaliplatin|mesh-list
154328459|NCT06093425|Levoleucovorin|levoleucovorin|mesh-list
154328460|NCT06093425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328461|NCT06093425|Antimetabolites|antimetabolites|mesh-ancestor
154328462|NCT06093425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328463|NCT06093425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328464|NCT06093425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328465|NCT06093425|Immunologic Factors|immunologic factors|mesh-ancestor
154328466|NCT06093425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328467|NCT06093425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328468|NCT06093425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154328469|NCT06093425|Antidotes|antidotes|mesh-ancestor
154328470|NCT06093425|Protective Agents|protective agents|mesh-ancestor
154328471|NCT06093425|Vitamin B Complex|vitamin b complex|mesh-ancestor
154328472|NCT06093425|Vitamins|vitamins|mesh-ancestor
154328473|NCT06093425|Micronutrients|micronutrients|mesh-ancestor
154328474|NCT06093425|Hematinics|hematinics|mesh-ancestor
154328475|NCT06093412|Anesthetics|anesthetics|mesh-list
154328476|NCT06093412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328477|NCT06093412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328478|NCT06093152|Albuterol|albuterol|mesh-list
154328479|NCT06093152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154328480|NCT06093152|Autonomic Agents|autonomic agents|mesh-ancestor
154328481|NCT06093152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328482|NCT06093152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328483|NCT06093152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154328484|NCT06093152|Respiratory System Agents|respiratory system agents|mesh-ancestor
154328485|NCT06093152|Tocolytic Agents|tocolytic agents|mesh-ancestor
154328486|NCT06093152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154328487|NCT06093152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154328488|NCT06093152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154328489|NCT06093152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154328490|NCT06093152|Adrenergic Agents|adrenergic agents|mesh-ancestor
154328491|NCT06093152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328492|NCT06093152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328493|NCT06093061|Capecitabine|capecitabine|mesh-list
154328494|NCT06093061|Tislelizumab|tislelizumab|mesh-list
154328495|NCT06093061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328496|NCT06093061|Antimetabolites|antimetabolites|mesh-ancestor
154328497|NCT06093061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328498|NCT06093061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328499|NCT06093061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328500|NCT06092684|Ketamine|ketamine|mesh-list
154328501|NCT06092684|Esketamine|esketamine|mesh-list
154328502|NCT06092684|Antidepressive Agents|antidepressive agents|mesh-ancestor
154328503|NCT06092684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154328504|NCT06092684|Analgesics|analgesics|mesh-ancestor
154328511|NCT06092684|Anesthetics|anesthetics|mesh-ancestor
154328518|NCT06092671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153410241|NCT00003465|Temozolomide|temozolomide|mesh-list
154328519|NCT06092671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328520|NCT06092541|Anesthetics|anesthetics|mesh-list
154328521|NCT06092541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328522|NCT06092541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328523|NCT06092515|Zinc|zinc|mesh-list
154328524|NCT06092515|Trace Elements|trace elements|mesh-ancestor
154328525|NCT06092515|Micronutrients|micronutrients|mesh-ancestor
154328526|NCT06092515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328527|NCT06092437|Diuretics|diuretics|mesh-list
154328528|NCT06092437|Natriuretic Agents|natriuretic agents|mesh-ancestor
154328529|NCT06092437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328530|NCT06092242|Bevacizumab|bevacizumab|mesh-list
154328531|NCT06092242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328532|NCT06092242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328533|NCT06092242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154328534|NCT06092242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154328535|NCT06092242|Growth Substances|growth substances|mesh-ancestor
154328536|NCT06092242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328537|NCT06092242|Growth Inhibitors|growth inhibitors|mesh-ancestor
154328538|NCT06092151|Fluorides|fluorides|mesh-list
154328539|NCT06092151|Cariostatic Agents|cariostatic agents|mesh-ancestor
154328540|NCT06092151|Protective Agents|protective agents|mesh-ancestor
154328541|NCT06092151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328542|NCT06092073|Bupivacaine|bupivacaine|mesh-list
154328543|NCT06092073|Anesthetics, Local|anesthetics, local|mesh-ancestor
154328544|NCT06092073|Anesthetics|anesthetics|mesh-ancestor
154328545|NCT06092073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328546|NCT06092073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328547|NCT06092073|Sensory System Agents|sensory system agents|mesh-ancestor
154328564|NCT06091267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328565|NCT06091267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328566|NCT06091267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328567|NCT06085742|Cyclophosphamide|cyclophosphamide|mesh-list
154328568|NCT06085742|Capecitabine|capecitabine|mesh-list
154328569|NCT06085742|Methotrexate|methotrexate|mesh-list
154328570|NCT06085742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328571|NCT06085742|Immunologic Factors|immunologic factors|mesh-ancestor
154328572|NCT06085742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328573|NCT06085742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328574|NCT06085742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154328575|NCT06085742|Alkylating Agents|alkylating agents|mesh-ancestor
154328576|NCT06085742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328577|NCT06085742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328578|NCT06085742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328579|NCT06085742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328580|NCT06085742|Antimetabolites|antimetabolites|mesh-ancestor
154328581|NCT06085742|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154328582|NCT06085742|Abortifacient Agents|abortifacient agents|mesh-ancestor
154328583|NCT06085742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154328584|NCT06085742|Dermatologic Agents|dermatologic agents|mesh-ancestor
154328585|NCT06085742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328586|NCT06085742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154328587|NCT06085742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154328588|NCT06084897|Paclitaxel|paclitaxel|mesh-list
154328589|NCT06084897|Cisplatin|cisplatin|mesh-list
154328590|NCT06084897|Carboplatin|carboplatin|mesh-list
154328591|NCT06084897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154328592|NCT06084897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154328593|NCT06084897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328594|NCT06084897|Tubulin Modulators|tubulin modulators|mesh-ancestor
154328595|NCT06084897|Antimitotic Agents|antimitotic agents|mesh-ancestor
154328596|NCT06084897|Mitosis Modulators|mitosis modulators|mesh-ancestor
154328597|NCT06084897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328602|NCT06081348|Antidepressive Agents|antidepressive agents|mesh-ancestor
154328603|NCT06081348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154328604|NCT06081348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154328605|NCT06081348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154328606|NCT06081348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328607|NCT06081348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328608|NCT06081348|Serotonin Agents|serotonin agents|mesh-ancestor
154328609|NCT06081348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328610|NCT06081348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154328611|NCT06079645|Triamcinolone|triamcinolone|mesh-list
154328612|NCT06079645|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154328613|NCT06079645|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154328614|NCT06079645|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154328615|NCT06079645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154328616|NCT06079645|Glucocorticoids|glucocorticoids|mesh-ancestor
154328617|NCT06079645|Hormones|hormones|mesh-ancestor
154328618|NCT06079645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154328619|NCT06079645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328620|NCT06079645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328624|NCT06075004|Anesthetics|anesthetics|mesh-list
154328653|NCT06048627|Protective Agents|protective agents|mesh-ancestor
154328654|NCT06048627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328655|NCT06039436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154328656|NCT06039436|Thymoglobulin|thymoglobulin|mesh-list
154328657|NCT06039436|Immunologic Factors|immunologic factors|mesh-ancestor
154328658|NCT06039436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328659|NCT06039436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328660|NCT06002438|Micronutrients|micronutrients|mesh-list
154328661|NCT06002438|Trace Elements|trace elements|mesh-list
154328662|NCT06002438|Pyrimethamine|pyrimethamine|mesh-list
154328663|NCT06002438|Sulfadoxine|sulfadoxine|mesh-list
154328664|NCT06002438|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154328665|NCT06002438|Antimalarials|antimalarials|mesh-ancestor
154328666|NCT06002438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154328667|NCT06002438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154328668|NCT06002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328669|NCT06002438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154328670|NCT06002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328671|NCT06002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328672|NCT06002438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154328673|NCT06002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328674|NCT06001320|Letermovir|letermovir|mesh-list
154328675|NCT06001320|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154328679|NCT06001320|Antiviral Agents|antiviral agents|mesh-ancestor
154328705|NCT05960656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328706|NCT05960656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154328707|NCT05960656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328708|NCT06217406|Acyclovir|acyclovir|mesh-list
154328709|NCT06217406|Antiviral Agents|antiviral agents|mesh-ancestor
154328710|NCT06217406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328711|NCT06217367|Diphenhydramine|diphenhydramine|mesh-list
154328712|NCT06217367|Promethazine|promethazine|mesh-list
154328713|NCT06217367|Loratadine|loratadine|mesh-list
154328714|NCT06217367|Desloratadine|desloratadine|mesh-list
154328715|NCT06217367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154328716|NCT06217367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154328717|NCT06217367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328718|NCT06217367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328719|NCT06217367|Anesthetics, Local|anesthetics, local|mesh-ancestor
154328720|NCT06217367|Anesthetics|anesthetics|mesh-ancestor
154328721|NCT06217367|Sensory System Agents|sensory system agents|mesh-ancestor
154328722|NCT06217367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781798|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
154328723|NCT06217367|Antiemetics|antiemetics|mesh-ancestor
154328724|NCT06217367|Autonomic Agents|autonomic agents|mesh-ancestor
154328725|NCT06217367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328726|NCT06217367|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154328727|NCT06217367|Histamine Antagonists|histamine antagonists|mesh-ancestor
154328728|NCT06217367|Histamine Agents|histamine agents|mesh-ancestor
154328729|NCT06217367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328730|NCT06217367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328731|NCT06217367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154328732|NCT06217367|Antipruritics|antipruritics|mesh-ancestor
154328733|NCT06217367|Dermatologic Agents|dermatologic agents|mesh-ancestor
154328734|NCT06217367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154328735|NCT06217367|Cholinergic Agents|cholinergic agents|mesh-ancestor
154328736|NCT06217367|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154328737|NCT06217354|Carbetocin|carbetocin|mesh-list
154328738|NCT06217354|Oxytocics|oxytocics|mesh-ancestor
154328745|NCT06217302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328746|NCT06217055|Sevoflurane|sevoflurane|mesh-list
154328747|NCT06217055|Anesthetics|anesthetics|mesh-ancestor
154328748|NCT06217055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328749|NCT06217055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328750|NCT06217055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154328751|NCT06217055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154328752|NCT06217055|Anesthetics, General|anesthetics, general|mesh-ancestor
154328753|NCT06217042|Leucovorin|leucovorin|mesh-list
154328754|NCT06217042|Gemcitabine|gemcitabine|mesh-list
154328755|NCT06217042|Capecitabine|capecitabine|mesh-list
154328756|NCT06217042|Fluorouracil|fluorouracil|mesh-list
154328757|NCT06217042|Oxaliplatin|oxaliplatin|mesh-list
154328758|NCT06217042|Calcium|calcium|mesh-list
154328759|NCT06217042|Levoleucovorin|levoleucovorin|mesh-list
154328760|NCT06217042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154328761|NCT06217042|Antimetabolites|antimetabolites|mesh-ancestor
154328762|NCT06217042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328763|NCT06217042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328764|NCT06217042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154328765|NCT06217042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328766|NCT06217042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154328767|NCT06217042|Immunologic Factors|immunologic factors|mesh-ancestor
154328768|NCT06217042|Antidotes|antidotes|mesh-ancestor
154328769|NCT06217042|Protective Agents|protective agents|mesh-ancestor
154328770|NCT06217042|Vitamin B Complex|vitamin b complex|mesh-ancestor
154328771|NCT06217042|Vitamins|vitamins|mesh-ancestor
154328772|NCT06217042|Micronutrients|micronutrients|mesh-ancestor
154328773|NCT06216886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154328774|NCT06216886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154328775|NCT06216886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154328776|NCT06216886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328777|NCT06216886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328778|NCT06216886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154328779|NCT06216886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154328780|NCT06216886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328784|NCT06216535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154328785|NCT06216535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154328786|NCT06216535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154328787|NCT06216535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328788|NCT06216535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328789|NCT06216535|Serotonin Agents|serotonin agents|mesh-ancestor
154328790|NCT06216535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328791|NCT06216301|Pembrolizumab|pembrolizumab|mesh-list
154328792|NCT06216301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154328793|NCT06216301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328794|NCT06216301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154328795|NCT06216301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328796|NCT06216262|Propolis|propolis|mesh-list
154328797|NCT06216262|Calcium|calcium|mesh-list
154328798|NCT06216262|Caseins|caseins|mesh-list
154328799|NCT06216262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154328800|NCT06216262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328801|NCT06216262|Chelating Agents|chelating agents|mesh-ancestor
154328802|NCT06216262|Sequestering Agents|sequestering agents|mesh-ancestor
154328803|NCT06216262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328804|NCT06216262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154328805|NCT06216210|Analgesics, Opioid|analgesics, opioid|mesh-list
154328806|NCT06216210|Anesthetics|anesthetics|mesh-list
154328807|NCT06216210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154328808|NCT06216210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328809|NCT06216210|Narcotics|narcotics|mesh-ancestor
154328810|NCT06216210|Analgesics|analgesics|mesh-ancestor
154328811|NCT06216210|Sensory System Agents|sensory system agents|mesh-ancestor
154328827|NCT06216197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328828|NCT06216197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154328829|NCT06216197|Narcotics|narcotics|mesh-ancestor
154328830|NCT06216197|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154328831|NCT06216197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154328832|NCT06216197|Anesthetics, General|anesthetics, general|mesh-ancestor
154328833|NCT06216197|Anesthetics|anesthetics|mesh-ancestor
154328834|NCT06216158|Dexamethasone|dexamethasone|mesh-list
154328835|NCT06216158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154328836|NCT06216158|Antiemetics|antiemetics|mesh-ancestor
154328837|NCT06216158|Autonomic Agents|autonomic agents|mesh-ancestor
154328838|NCT06216158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328839|NCT06216158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328840|NCT06216158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328841|NCT06216158|Glucocorticoids|glucocorticoids|mesh-ancestor
154328842|NCT06216158|Hormones|hormones|mesh-ancestor
154328843|NCT06216158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154328844|NCT06216158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154328845|NCT06216158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328847|NCT06216132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154328848|NCT06216132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154328849|NCT06216132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154328850|NCT06216132|Sensory System Agents|sensory system agents|mesh-ancestor
154328851|NCT06216132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328852|NCT06215989|Colchicine|colchicine|mesh-list
154328853|NCT06215989|Gout Suppressants|gout suppressants|mesh-ancestor
154328854|NCT06215989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154328855|NCT06215989|Tubulin Modulators|tubulin modulators|mesh-ancestor
154328856|NCT06215989|Antimitotic Agents|antimitotic agents|mesh-ancestor
154328857|NCT06215989|Mitosis Modulators|mitosis modulators|mesh-ancestor
154328873|NCT06215768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154328875|NCT06215768|Adrenergic Agents|adrenergic agents|mesh-ancestor
154328876|NCT06215768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328877|NCT06215768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328878|NCT06215768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154328879|NCT06215768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154328880|NCT06215768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154328881|NCT06215768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154328882|NCT06215768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154328883|NCT06215768|Anesthetics, General|anesthetics, general|mesh-ancestor
154328884|NCT06215768|Anesthetics|anesthetics|mesh-ancestor
154328885|NCT06215768|GABA Modulators|gaba modulators|mesh-ancestor
154328886|NCT06215768|GABA Agents|gaba agents|mesh-ancestor
154328887|NCT06215651|Lenvatinib|lenvatinib|mesh-list
154328888|NCT06215651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328889|NCT06215651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154328890|NCT06215651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154328891|NCT06215651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328892|NCT06215638|Bortezomib|bortezomib|mesh-list
154328893|NCT06215638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328894|NCT06215573|Melatonin|melatonin|mesh-list
154328895|NCT06215573|Antioxidants|antioxidants|mesh-ancestor
154328896|NCT06215573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328924|NCT06215430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154328925|NCT06215430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154328926|NCT06215430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328927|NCT06215430|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154328928|NCT06215430|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154328929|NCT06215430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154328930|NCT06215378|Heparin|heparin|mesh-list
154328931|NCT06215378|Protamines|protamines|mesh-list
154328932|NCT06215378|Anticoagulants|anticoagulants|mesh-ancestor
154328933|NCT06215378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154328934|NCT06215378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154328935|NCT06215378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328936|NCT06215378|Heparin Antagonists|heparin antagonists|mesh-ancestor
154328937|NCT06215378|Coagulants|coagulants|mesh-ancestor
154328938|NCT06214728|Hyaluronic Acid|hyaluronic acid|mesh-list
154328939|NCT06214728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154328985|NCT06203912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154328986|NCT06203912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154328987|NCT06203912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154328988|NCT06203912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154328989|NCT06203912|Antiemetics|antiemetics|mesh-ancestor
154328990|NCT06203912|Autonomic Agents|autonomic agents|mesh-ancestor
154328991|NCT06203912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154328992|NCT06203912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154328993|NCT06203912|Glucocorticoids|glucocorticoids|mesh-ancestor
154328994|NCT06203912|Hormones|hormones|mesh-ancestor
154328995|NCT06203912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154328996|NCT06203912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154329049|NCT05958303|Antioxidants|antioxidants|mesh-list
154329050|NCT05958303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329051|NCT05958303|Protective Agents|protective agents|mesh-ancestor
154329052|NCT05958303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329053|NCT05919108|Neratinib|neratinib|mesh-list
154329054|NCT05919108|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154329055|NCT05919108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329056|NCT05919108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329057|NCT05919108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329058|NCT05903859|Probenecid|probenecid|mesh-list
154329059|NCT05903859|Uricosuric Agents|uricosuric agents|mesh-ancestor
154329060|NCT05903859|Gout Suppressants|gout suppressants|mesh-ancestor
154329061|NCT05903859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154329062|NCT05901467|Hormones|hormones|mesh-list
154329063|NCT05901467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154329064|NCT05901467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329065|NCT05809830|Doxorubicin|doxorubicin|mesh-list
154329066|NCT05809830|LB100|lb100|mesh-list
154329067|NCT05809830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154329068|NCT05809830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329069|NCT05809830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154329070|NCT05809830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154329071|NCT05809830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329072|NCT05809830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329073|NCT05646316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154329074|NCT05625724|Aspirin|aspirin|mesh-list
154329075|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154329076|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154329078|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
154329079|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329080|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329081|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154329089|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
154329090|NCT05605639|Bupivacaine|bupivacaine|mesh-list
154329091|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
154329092|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
154329093|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329094|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329095|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
154329096|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329097|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
154329098|NCT05592418|Poly I-C|poly i-c|mesh-list
154329099|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
154329100|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329101|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
154329102|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
154329103|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329104|NCT05591677|Cycloserine|cycloserine|mesh-list
154329105|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154329106|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329107|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154329108|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
154329146|NCT05396742|Ravulizumab|ravulizumab|mesh-list
154329147|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154329148|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329149|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
154329150|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329151|NCT05380934|Methotrexate|methotrexate|mesh-list
154329152|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154329153|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
154329154|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154329155|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329156|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329157|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
154329158|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329159|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329160|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154329161|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329162|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154329163|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329164|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
154329165|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154329166|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154329168|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154329169|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
154329170|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
154329171|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329172|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329173|NCT05286827|Olaparib|olaparib|mesh-list
154329175|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329191|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154329192|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329193|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154329194|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154329195|NCT05178745|Growth Substances|growth substances|mesh-ancestor
154329196|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
154329197|NCT05162131|Ticagrelor|ticagrelor|mesh-list
154329198|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154329199|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154329200|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154329201|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154329202|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
154329203|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329204|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329205|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329206|NCT05108688|Sumatriptan|sumatriptan|mesh-list
154329207|NCT05108688|Mirtazapine|mirtazapine|mesh-list
154329208|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153781799|NCT04559113|Hormones|hormones|mesh-ancestor
154329209|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154329210|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154329211|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
154329212|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329213|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329214|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329215|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
154329238|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
154329239|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329240|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329241|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154329242|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154329243|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154329244|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329245|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329247|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329248|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329249|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329250|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329251|NCT04990128|Triamcinolone|triamcinolone|mesh-list
154329252|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154329253|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
154329254|NCT04990128|Hormones|hormones|mesh-ancestor
154329255|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154329256|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329257|NCT04987931|Talazoparib|talazoparib|mesh-list
154329292|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
154329293|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
154329294|NCT04919395|Etonogestrel|etonogestrel|mesh-list
154329295|NCT04919395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154329296|NCT04919395|Contraceptive Agents|contraceptive agents|mesh-ancestor
154329297|NCT04919395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154329298|NCT04919395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329299|NCT04919395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154329301|NCT04914390|Tislelizumab|tislelizumab|mesh-list
154329302|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154329303|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329304|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
154329305|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
154329306|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
154329354|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329355|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329356|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
154329357|NCT04662710|Antidotes|antidotes|mesh-ancestor
154329358|NCT04662710|Protective Agents|protective agents|mesh-ancestor
154329359|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329360|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
154329361|NCT04662710|Vitamins|vitamins|mesh-ancestor
154329362|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
154329363|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329364|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329365|NCT04629495|Sirolimus|sirolimus|mesh-list
154329366|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154329367|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329368|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154329369|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329370|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
154329371|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329372|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
154329373|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329374|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154329376|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154329377|NCT04587687|Antibodies|antibodies|mesh-list
154329378|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
154329379|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154329380|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
154329381|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
154329382|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329383|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329400|NCT04495621|Cetuximab|cetuximab|mesh-list
154329401|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329402|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329403|NCT04458909|Cisplatin|cisplatin|mesh-list
154329404|NCT04458909|Carboplatin|carboplatin|mesh-list
154329405|NCT04458909|Gemcitabine|gemcitabine|mesh-list
154329406|NCT04458909|Nivolumab|nivolumab|mesh-list
154329407|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329408|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329409|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
154329410|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329411|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329412|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154329413|NCT04450173|Venetoclax|venetoclax|mesh-list
154329414|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
154329415|NCT04450173|Ibrutinib|ibrutinib|mesh-list
154329416|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329417|NCT04450173|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154329418|NCT04450173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329419|NCT04450173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329420|NCT04450173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329421|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329422|NCT04420195|Tacrolimus|tacrolimus|mesh-list
154329423|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329424|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
154329451|NCT04329494|Cisplatin|cisplatin|mesh-list
154329452|NCT04329494|Doxorubicin|doxorubicin|mesh-list
154329453|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154329454|NCT04329494|Fluorouracil|fluorouracil|mesh-list
154329455|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
154329456|NCT04329494|Irinotecan|irinotecan|mesh-list
154329457|NCT04329494|Daunorubicin|daunorubicin|mesh-list
154329458|NCT04329494|Mitomycins|mitomycins|mesh-list
154329459|NCT04329494|Mitomycin|mitomycin|mesh-list
154329460|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329461|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154329462|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154329463|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154329464|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329465|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329466|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
154329467|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329468|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329469|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
154329470|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329471|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154027405|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027406|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027407|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154027409|NCT02937272|Gemcitabine|gemcitabine|mesh-list
154027410|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154027411|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027412|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
154027413|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
154027414|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
154027415|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027416|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154027417|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
154027418|NCT02888067|Bromides|bromides|mesh-list
154027419|NCT02888067|Rocuronium|rocuronium|mesh-list
154027420|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
154027421|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154329507|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329508|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
154329509|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
154329510|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
154329511|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329512|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329513|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
154329514|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154329515|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154329516|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329517|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154329518|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
154329519|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154329520|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329521|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154329532|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154329533|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154329534|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329535|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154329536|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154329537|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329538|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
154329539|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154329540|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
154329541|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154329542|NCT04030559|Niraparib|niraparib|mesh-list
154329543|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154329544|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329545|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329546|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329547|NCT04000529|Spartalizumab|spartalizumab|mesh-list
154329548|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154329549|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329550|NCT04000529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329551|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329552|NCT03952637|Sirolimus|sirolimus|mesh-list
154329553|NCT03952637|Prednisone|prednisone|mesh-list
154329554|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
154329555|NCT03952637|Rituximab|rituximab|mesh-list
154329556|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329557|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329558|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
154329579|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154329580|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329581|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329582|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329583|NCT03705585|Vaccines|vaccines|mesh-list
154329584|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
154329585|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329586|NCT03643510|Fulvestrant|fulvestrant|mesh-list
154329587|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154329588|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329589|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154329590|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154329591|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
154329592|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154329593|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329594|NCT03529110|Trastuzumab|trastuzumab|mesh-list
154329595|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154329596|NCT03529110|Maytansine|maytansine|mesh-list
154329597|NCT03529110|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154329598|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329599|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329600|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154329601|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154329602|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154329603|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154329628|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
154329629|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
154329630|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154329631|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
154329632|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329633|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
154329634|NCT03460158|Protective Agents|protective agents|mesh-ancestor
154329635|NCT03358472|Carboplatin|carboplatin|mesh-list
154329636|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
154329637|NCT03358472|Fluorouracil|fluorouracil|mesh-list
154329638|NCT03358472|Cetuximab|cetuximab|mesh-list
154329639|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329640|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329641|NCT03358472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154329642|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329643|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
154329644|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329645|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329646|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
154329647|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329648|NCT03099382|Docetaxel|docetaxel|mesh-list
154329649|NCT03099382|Irinotecan|irinotecan|mesh-list
154329650|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329651|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
154329652|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
154329653|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
154329654|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329655|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154329656|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154329657|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329674|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329675|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
154329676|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154329677|NCT02802241|Peppermint oil|peppermint oil|mesh-list
154329678|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
154329679|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
154329680|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329681|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329682|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154329683|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
154329684|NCT02748018|Insulin|insulin|mesh-list
154329685|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154329686|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329687|NCT02564900|Camptothecin|camptothecin|mesh-list
154329688|NCT02564900|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154329689|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
154329690|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
154329691|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329692|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154329693|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329694|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154329695|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154329696|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329697|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329698|NCT02470091|Denosumab|denosumab|mesh-list
154329699|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154329700|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329701|NCT02329860|Apatinib|apatinib|mesh-list
154329702|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329703|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329704|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329705|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329706|NCT02163733|Osimertinib|osimertinib|mesh-list
154329707|NCT02163733|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154329708|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329709|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329712|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154329713|NCT01407263|Hemostatics|hemostatics|mesh-list
154329714|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329715|NCT01407263|Coagulants|coagulants|mesh-ancestor
154329716|NCT05922033|Insulin|insulin|mesh-list
154329717|NCT05922033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154329718|NCT05922033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154329719|NCT05922033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329720|NCT05894057|Midazolam|midazolam|mesh-list
154329721|NCT05894057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154329722|NCT05894057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154329723|NCT05894057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329724|NCT05894057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329725|NCT05894057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154329726|NCT05894057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154329727|NCT05894057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154329728|NCT05894057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154329729|NCT05894057|Anesthetics, General|anesthetics, general|mesh-ancestor
154329730|NCT05894057|Anesthetics|anesthetics|mesh-ancestor
154329731|NCT05894057|GABA Modulators|gaba modulators|mesh-ancestor
154329732|NCT05894057|GABA Agents|gaba agents|mesh-ancestor
154329733|NCT05894057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329734|NCT05894057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329735|NCT05877807|Baclofen|baclofen|mesh-list
154329736|NCT05877807|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154329740|NCT05877807|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154329766|NCT05874544|Respiratory System Agents|respiratory system agents|mesh-ancestor
154329768|NCT05857059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154329769|NCT05857059|Abortifacient Agents|abortifacient agents|mesh-ancestor
154329770|NCT05857059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154329771|NCT05857059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329772|NCT05857059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154329773|NCT05857059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154329774|NCT05857059|Oxytocics|oxytocics|mesh-ancestor
154329775|NCT05832827|Paclitaxel|paclitaxel|mesh-list
154329776|NCT05832827|Carboplatin|carboplatin|mesh-list
154329777|NCT05832827|Pembrolizumab|pembrolizumab|mesh-list
154329778|NCT05832827|Lenvatinib|lenvatinib|mesh-list
154329779|NCT05832827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154329780|NCT05832827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329781|NCT05832827|Tubulin Modulators|tubulin modulators|mesh-ancestor
154329782|NCT05832827|Antimitotic Agents|antimitotic agents|mesh-ancestor
154329783|NCT05832827|Mitosis Modulators|mitosis modulators|mesh-ancestor
154329784|NCT05832827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329785|NCT05832827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329786|NCT05832827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154329787|NCT05832827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329788|NCT05832827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329789|NCT05804162|Moxifloxacin|moxifloxacin|mesh-list
154329790|NCT05804162|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154329791|NCT05804162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154329792|NCT05804162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154329813|NCT05718869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329814|NCT05718869|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154329815|NCT05718869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329816|NCT05718869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329817|NCT05718869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329818|NCT05718869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329819|NCT05714631|Lidocaine|lidocaine|mesh-list
154329820|NCT05714631|Anesthetics, Local|anesthetics, local|mesh-ancestor
154329821|NCT05714631|Anesthetics|anesthetics|mesh-ancestor
154329822|NCT05714631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154329823|NCT05714631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329824|NCT05714631|Sensory System Agents|sensory system agents|mesh-ancestor
154329825|NCT05714631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329826|NCT05714631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154329827|NCT05714631|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154329828|NCT05714631|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154329829|NCT05714631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154329830|NCT05714631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329831|NCT05701969|Melatonin|melatonin|mesh-list
154329832|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
154329834|NCT05701969|Protective Agents|protective agents|mesh-ancestor
154329863|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154329864|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154329865|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154329866|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329867|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329868|NCT05681884|Faricimab|faricimab|mesh-list
154329869|NCT05681884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154329870|NCT05681884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154329871|NCT05681884|Growth Substances|growth substances|mesh-ancestor
154329872|NCT05681884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329873|NCT05681884|Growth Inhibitors|growth inhibitors|mesh-ancestor
154329874|NCT05681884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329875|NCT05677919|Venetoclax|venetoclax|mesh-list
154329876|NCT05677919|Pirtobrutinib|pirtobrutinib|mesh-list
154329877|NCT05677919|Pyrazole|pyrazole|mesh-list
154329878|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329879|NCT05677919|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154329880|NCT05677919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154329881|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329882|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329883|NCT05647057|Polygeline|polygeline|mesh-list
154329884|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
154329885|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
154329887|NCT05631262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329888|NCT05631262|Tubulin Modulators|tubulin modulators|mesh-ancestor
154329889|NCT05631262|Antimitotic Agents|antimitotic agents|mesh-ancestor
154329890|NCT05631262|Mitosis Modulators|mitosis modulators|mesh-ancestor
154329892|NCT05624853|Pregabalin|pregabalin|mesh-list
154329911|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154329912|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329913|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154329914|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329915|NCT05573802|Dexamethasone|dexamethasone|mesh-list
154329916|NCT05573802|Lenalidomide|lenalidomide|mesh-list
154329917|NCT05573802|Nirogacestat|nirogacestat|mesh-list
154329918|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154329919|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
154329920|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
154329921|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329922|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329923|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154329924|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
154329925|NCT05573802|Hormones|hormones|mesh-ancestor
154329926|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154329927|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154329928|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329929|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
154329930|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154329931|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154329932|NCT05573802|Growth Substances|growth substances|mesh-ancestor
154329933|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
154329934|NCT05573802|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154329935|NCT05573802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329960|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154329961|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
154329962|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154329963|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154329964|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154329966|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154329967|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154329968|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
154329969|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154329970|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154329971|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154329972|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
154329973|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154329974|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154329975|NCT05543122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154329976|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154329977|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154329978|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154329979|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
154329980|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
154329981|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154329982|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154329983|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
154329984|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154329985|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154329986|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154329987|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154329988|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154329989|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
154330001|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154330002|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154330003|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154330004|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154330005|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154330006|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154330007|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154330008|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154330009|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154330010|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154330011|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
154330012|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154330013|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154330014|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154330015|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
154330016|NCT05499572|Minocycline|minocycline|mesh-list
154330017|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154330018|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330019|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154330020|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
154330021|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330022|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330023|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154330048|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
154330050|NCT05403086|Psilocybin|psilocybin|mesh-list
154330051|NCT05403086|Hallucinogens|hallucinogens|mesh-list
154330052|NCT05403086|Analgesics|analgesics|mesh-ancestor
154330053|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
154330054|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330055|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330056|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154330057|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154330058|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
154330059|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
154330060|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154330061|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154330062|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154330063|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330064|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330065|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154330066|NCT05385367|Anesthetics|anesthetics|mesh-list
154330067|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
154330070|NCT05347134|Gemcitabine|gemcitabine|mesh-list
154330103|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
154076443|NCT00720057|Analgesics|analgesics|mesh-ancestor
154330104|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330105|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154330106|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154330107|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154330108|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
154330109|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330110|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330112|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154330113|NCT05299125|Lazertinib|lazertinib|mesh-list
154330114|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330115|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330116|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330117|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154330118|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154330119|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330120|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330121|NCT05294172|Cisplatin|cisplatin|mesh-list
154330122|NCT05294172|Gemcitabine|gemcitabine|mesh-list
154330123|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330124|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154330125|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
154330126|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330151|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330152|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330153|NCT05172700|Pirtobrutinib|pirtobrutinib|mesh-list
154330154|NCT05172700|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154330155|NCT05172700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330156|NCT05172700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330157|NCT05172700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330158|NCT05161338|Estradiol|estradiol|mesh-list
154330159|NCT05161338|Progesterone|progesterone|mesh-list
154330160|NCT05161338|Estrogens|estrogens|mesh-ancestor
154330161|NCT05161338|Hormones|hormones|mesh-ancestor
154330162|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330163|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330164|NCT05161338|Progestins|progestins|mesh-ancestor
154330165|NCT05153772|Octreotide|octreotide|mesh-list
154330166|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330167|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330168|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330169|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
154330170|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154330171|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330172|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154330173|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
154330174|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154330176|NCT05113901|Prednisolone|prednisolone|mesh-list
154330200|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330201|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154330202|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154330203|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154330204|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154330205|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
154330206|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
154330207|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
154330208|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
154330209|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330210|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330211|NCT05022758|Warfarin|warfarin|mesh-list
154330212|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
154330213|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
154330214|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154330215|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
154330216|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154330217|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
154330218|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330219|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330220|NCT05003258|Dexamethasone|dexamethasone|mesh-list
154330221|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154330222|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
154330223|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
154330224|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330225|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330226|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330227|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
154330228|NCT05003258|Hormones|hormones|mesh-ancestor
154330229|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330230|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330231|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330232|NCT04977986|Cannabidiol|cannabidiol|mesh-list
154330233|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
154330234|NCT04925973|Tofacitinib|tofacitinib|mesh-list
154330235|NCT04925973|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154330236|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330239|NCT04907721|Glucagon|glucagon|mesh-list
154330240|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154330241|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330242|NCT04907721|Hormones|hormones|mesh-ancestor
154330243|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330244|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330245|NCT04907721|Incretins|incretins|mesh-ancestor
154330246|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154330247|NCT04890873|Antacids|antacids|mesh-ancestor
154330248|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330249|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330250|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
154330251|NCT04887805|Lenvatinib|lenvatinib|mesh-list
154330252|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330253|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330254|NCT04887805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330255|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330256|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154076587|NCT01031017|Progesterone|progesterone|mesh-list
154330258|NCT04878432|Azacitidine|azacitidine|mesh-list
154330259|NCT04878432|Decitabine|decitabine|mesh-list
154330260|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154330261|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
154330262|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330263|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330264|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330265|NCT04834024|Antibodies|antibodies|mesh-list
154330266|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154330267|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
154330268|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330269|NCT04811014|Buprenorphine|buprenorphine|mesh-list
154330270|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154330271|NCT04811014|Naloxone|naloxone|mesh-list
154330272|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154330273|NCT04811014|Narcotics|narcotics|mesh-ancestor
154330276|NCT04811014|Analgesics|analgesics|mesh-ancestor
154330279|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154330281|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154330282|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330283|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154330284|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154330285|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330286|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154330287|NCT04801303|Vitamins|vitamins|mesh-ancestor
154330288|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
154330289|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154330290|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154330291|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154330292|NCT04727684|Cetrorelix|cetrorelix|mesh-list
154330293|NCT04727684|Menotropins|menotropins|mesh-list
154330294|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
154330295|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154330296|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
154330297|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154330308|NCT04727671|Cetrorelix|cetrorelix|mesh-list
154330334|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154330335|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
154330336|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
154330337|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330338|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154330339|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154330341|NCT04724343|Menotropins|menotropins|mesh-list
154330342|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
154330343|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154330344|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
154330345|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154330346|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330347|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154330348|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330349|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330350|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154330351|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
154330352|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
154330353|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330354|NCT04704024|Tenofovir|tenofovir|mesh-list
154330355|NCT04704024|Lamivudine|lamivudine|mesh-list
154330356|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
154330357|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330358|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154330359|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154330360|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330361|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330362|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154330363|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154330364|NCT04699461|Idelalisib|idelalisib|mesh-list
154330365|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154330366|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330367|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330375|NCT04651348|Antibodies|antibodies|mesh-list
154330376|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154330377|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
154330378|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330379|NCT04642365|Atezolizumab|atezolizumab|mesh-list
154330380|NCT04642365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330381|NCT04642365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330382|NCT04642365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330383|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330384|NCT04634838|Copper|copper|mesh-list
154330385|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154330386|NCT04634838|Trace Elements|trace elements|mesh-ancestor
154330387|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
154330388|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330389|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330390|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
154330391|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154330432|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154330433|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
154330434|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330435|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
154330436|NCT04358055|Protective Agents|protective agents|mesh-ancestor
154330437|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
154330438|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
154330439|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154330440|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154330441|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330442|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330443|NCT04356716|Urological Agents|urological agents|mesh-ancestor
154330444|NCT04343235|Labetalol|labetalol|mesh-list
154330445|NCT04343235|Furosemide|furosemide|mesh-list
154330446|NCT04343235|Diuretics|diuretics|mesh-ancestor
154330447|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
154330448|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330449|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154330450|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154330451|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330452|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154330453|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154330454|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
154330455|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330481|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330482|NCT04303780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330483|NCT04303780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330484|NCT04302168|Choline|choline|mesh-list
154330485|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
154330486|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154330487|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
154330488|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330489|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330490|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154330491|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
154330492|NCT04299490|Analgesics|analgesics|mesh-list
154330493|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330494|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
154330495|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330496|NCT04294225|Letrozole|letrozole|mesh-list
154330497|NCT04294225|Anastrozole|anastrozole|mesh-list
154330498|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330499|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154330500|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154330501|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330502|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330503|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154330504|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
154330531|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154330532|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330533|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
154330534|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330535|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330536|NCT04157517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330537|NCT04157517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330538|NCT04124432|Nicotine|nicotine|mesh-list
154330539|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154330540|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
154330541|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330542|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330543|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154330544|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154330545|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
154330546|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330547|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330548|NCT04110301|Lenalidomide|lenalidomide|mesh-list
154330549|NCT04110301|Antibodies|antibodies|mesh-list
154330550|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154330551|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
154330552|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330553|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154330554|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154076901|NCT00732498|Hormones|hormones|mesh-ancestor
154330555|NCT04110301|Growth Substances|growth substances|mesh-ancestor
154330556|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
154330557|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330558|NCT04066881|Vaccines|vaccines|mesh-list
154330559|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
154330575|NCT03970746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330576|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330577|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330578|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154330579|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154330580|NCT03945019|Infliximab|infliximab|mesh-list
154330581|NCT03945019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154330582|NCT03945019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154330583|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
154330584|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330585|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154330586|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
154330587|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154330588|NCT03910673|Fosfomycin|fosfomycin|mesh-list
154330589|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154330590|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330591|NCT03906071|Docetaxel|docetaxel|mesh-list
154330592|NCT03906071|Nivolumab|nivolumab|mesh-list
154330593|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330594|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330595|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330596|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
154330597|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330598|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330599|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330600|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
154330601|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154330602|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154330603|NCT03875690|Prednisolone|prednisolone|mesh-list
154330604|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
154330605|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154330606|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
154330608|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
153412058|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
154330617|NCT03875690|Protective Agents|protective agents|mesh-ancestor
154330618|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330619|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330620|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
154330621|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154330622|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154330623|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330624|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
154330625|NCT03868956|Coagulants|coagulants|mesh-ancestor
154330626|NCT03866408|Pioglitazone|pioglitazone|mesh-list
154330627|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154330628|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330629|NCT03842085|Antibodies|antibodies|mesh-list
154330630|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154330631|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154330632|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
154330633|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330634|NCT03836209|Cytarabine|cytarabine|mesh-list
154330635|NCT03836209|Daunorubicin|daunorubicin|mesh-list
154330636|NCT03836209|Midostaurin|midostaurin|mesh-list
154330637|NCT03836209|Gilteritinib|gilteritinib|mesh-list
154330638|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154330639|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
154330640|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330641|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330642|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
154330643|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330644|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154330645|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
154330647|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154330663|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330664|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
154330665|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330666|NCT03771313|Ceftaroline|ceftaroline|mesh-list
154330667|NCT03771313|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154330668|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154330669|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330670|NCT03748134|Paclitaxel|paclitaxel|mesh-list
154330671|NCT03748134|Fluorouracil|fluorouracil|mesh-list
154330672|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154330673|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330674|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330675|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330676|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
154330677|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330678|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
154330679|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154330680|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154330681|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
154330682|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330683|NCT03702582|Warfarin|warfarin|mesh-list
154330684|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
154330685|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
154330686|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154330687|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
154330688|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154330689|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
153782000|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330690|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330691|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330692|NCT03701711|Lenalidomide|lenalidomide|mesh-list
154330693|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
154330694|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330695|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154330696|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154330697|NCT03701711|Growth Substances|growth substances|mesh-ancestor
154330698|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
154330699|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330700|NCT03689712|Manganese|manganese|mesh-list
154330704|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330705|NCT03689712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154330707|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330708|NCT03689712|Protective Agents|protective agents|mesh-ancestor
154330709|NCT03680508|Dostarlimab|dostarlimab|mesh-list
154330711|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
154330712|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
154330713|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330714|NCT03680508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330715|NCT03679624|Daratumumab|daratumumab|mesh-list
154330716|NCT03679624|Ibrutinib|ibrutinib|mesh-list
154330717|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330718|NCT03679624|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154330719|NCT03679624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330720|NCT03679624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330721|NCT03679624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330722|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
154330723|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330724|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330725|NCT03658772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330726|NCT03658772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330727|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
154330728|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330729|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330730|NCT03625323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330731|NCT03625323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330732|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
154330733|NCT03539900|Naltrexone|naltrexone|mesh-list
154330734|NCT03539900|Bupropion|bupropion|mesh-list
154330735|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154330736|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154330737|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330738|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
154330739|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330740|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154330741|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
154330742|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154330743|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154330744|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154330745|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154330746|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330747|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
154330748|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330749|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154330750|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154330751|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330752|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154330753|NCT03480191|Daptomycin|daptomycin|mesh-list
154330754|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154330755|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330756|NCT03402945|Vancomycin|vancomycin|mesh-list
154330757|NCT03402945|Cefazolin|cefazolin|mesh-list
154330758|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154330759|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330760|NCT03399552|Avelumab|avelumab|mesh-list
154330761|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330762|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330763|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154330764|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154330765|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154330766|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
154330767|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154330768|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330769|NCT03292731|Progestins|progestins|mesh-ancestor
154330770|NCT03292731|Hormones|hormones|mesh-ancestor
154330771|NCT03239340|Osimertinib|osimertinib|mesh-list
154330772|NCT03239340|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154330773|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330779|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330780|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330782|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154330783|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154330784|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
154330785|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
154330786|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154330787|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330788|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154330789|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154330790|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154330791|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
154330792|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330793|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330795|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
154330796|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
154330797|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
154330798|NCT02973997|Lenvatinib|lenvatinib|mesh-list
154330799|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330800|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330801|NCT02973997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330803|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330831|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154330832|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
154330833|NCT02905578|Paclitaxel|paclitaxel|mesh-list
154330834|NCT02905578|Gemcitabine|gemcitabine|mesh-list
154330835|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154330836|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330837|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330838|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330839|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
154330840|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330841|NCT02905578|Vitamins|vitamins|mesh-ancestor
154330842|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
154330843|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330844|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154330845|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
154330846|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
154330847|NCT02905578|Protective Agents|protective agents|mesh-ancestor
154330848|NCT02780024|Metformin|metformin|mesh-list
154330849|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154330850|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330851|NCT02688842|Sirolimus|sirolimus|mesh-list
154330852|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154330853|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330854|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154330855|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330856|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
154330857|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154330858|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
154330859|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330861|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
154330862|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154330863|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
154330864|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330876|NCT02520180|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154330877|NCT02520180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154330878|NCT02520180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330879|NCT02520180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330880|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154330881|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
154330882|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330883|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330884|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
154330885|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
154330886|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
154330887|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154330888|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154330889|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
154330890|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
154330891|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154330892|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330893|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330894|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154330895|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
154330896|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154330897|NCT02383433|Gemcitabine|gemcitabine|mesh-list
154330898|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154330899|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
154330900|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330901|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330902|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
154330903|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154330922|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
154330923|NCT02313272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154330924|NCT02313272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330925|NCT02307812|Paclitaxel|paclitaxel|mesh-list
154330926|NCT02307812|Ramucirumab|ramucirumab|mesh-list
154330927|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154330928|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330929|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330930|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330931|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
154330932|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330933|NCT02307812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154330934|NCT02307812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154330935|NCT02307812|Growth Substances|growth substances|mesh-ancestor
154330936|NCT02307812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330937|NCT02307812|Growth Inhibitors|growth inhibitors|mesh-ancestor
154330938|NCT02303821|Cytarabine|cytarabine|mesh-list
154330939|NCT02303821|Dexamethasone|dexamethasone|mesh-list
154330940|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
154330941|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
154330942|NCT02303821|Methotrexate|methotrexate|mesh-list
154330943|NCT02303821|Vincristine|vincristine|mesh-list
154330944|NCT02303821|Daunorubicin|daunorubicin|mesh-list
154330945|NCT02303821|Asparaginase|asparaginase|mesh-list
154330946|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
154330947|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
154330948|NCT02303821|Pegaspargase|pegaspargase|mesh-list
154330949|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154330950|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
154330951|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154330952|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154330953|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154330967|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154330968|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
154330969|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154330970|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154330971|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
154330972|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
154330973|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154330974|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154330975|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154330976|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
154330977|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154330978|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154330979|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330980|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330981|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
154330982|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154330983|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154330984|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154330985|NCT02303821|Analgesics|analgesics|mesh-ancestor
154330986|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
154330987|NCT02254031|Maytansine|maytansine|mesh-list
154330988|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
154330989|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154330990|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154330991|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
154330992|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
154330993|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
154330994|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154330995|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154330996|NCT02254031|Immunotoxins|immunotoxins|mesh-ancestor
154330997|NCT02254031|Immunoconjugates|immunoconjugates|mesh-ancestor
154330998|NCT02254031|Immunologic Factors|immunologic factors|mesh-ancestor
154330999|NCT02254031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331007|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331009|NCT02254005|Immunotoxins|immunotoxins|mesh-ancestor
154331010|NCT02254005|Immunoconjugates|immunoconjugates|mesh-ancestor
154331011|NCT02254005|Immunologic Factors|immunologic factors|mesh-ancestor
154331012|NCT02254005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331013|NCT02231931|Metformin|metformin|mesh-list
154331014|NCT02231931|Digoxin|digoxin|mesh-list
154331015|NCT02231931|Furosemide|furosemide|mesh-list
154331016|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154331017|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154331018|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331019|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154331020|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154331021|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
154331022|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331023|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154331024|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154331025|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331026|NCT02231931|Diuretics|diuretics|mesh-ancestor
154331027|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
154331028|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154331029|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331030|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154331031|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154331032|NCT02231931|Protective Agents|protective agents|mesh-ancestor
154331033|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154331034|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154331035|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154331036|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331038|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331048|NCT02065765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154331049|NCT02065765|Growth Substances|growth substances|mesh-ancestor
154331050|NCT02065765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331051|NCT02065765|Growth Inhibitors|growth inhibitors|mesh-ancestor
154331052|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331054|NCT01920737|Cytarabine|cytarabine|mesh-list
154331055|NCT01920737|Dexamethasone|dexamethasone|mesh-list
154331056|NCT01920737|Prednisone|prednisone|mesh-list
154331057|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
154331058|NCT01920737|Methotrexate|methotrexate|mesh-list
154331059|NCT01920737|Vincristine|vincristine|mesh-list
154331060|NCT01920737|Daunorubicin|daunorubicin|mesh-list
154331061|NCT01920737|Asparaginase|asparaginase|mesh-list
154331062|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
154331063|NCT01920737|Pegaspargase|pegaspargase|mesh-list
154331064|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331065|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
154331066|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331067|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331068|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154331074|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
154331107|NCT01852890|Vitamins|vitamins|mesh-ancestor
154331108|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
154331109|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331110|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154331111|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
154331112|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331113|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331114|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
154331115|NCT01852890|Protective Agents|protective agents|mesh-ancestor
154331116|NCT01788774|Risperidone|risperidone|mesh-list
154331117|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154331118|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
154331119|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331120|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331121|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331122|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154331123|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154331124|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154331125|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154331126|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154331127|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
154331128|NCT01755975|Lenalidomide|lenalidomide|mesh-list
154331129|NCT01755975|Romidepsin|romidepsin|mesh-list
154331130|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
154331131|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331132|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154331133|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154331134|NCT01755975|Growth Substances|growth substances|mesh-ancestor
154331135|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
154331136|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331137|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154331138|NCT01755975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154331139|NCT01755975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331147|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
154331148|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331149|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331150|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
154331151|NCT01752491|Protective Agents|protective agents|mesh-ancestor
154331153|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331154|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
154331155|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
154331156|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
154331157|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331158|NCT01494662|Capecitabine|capecitabine|mesh-list
154331159|NCT01494662|Trastuzumab|trastuzumab|mesh-list
154331160|NCT01494662|Maytansine|maytansine|mesh-list
154331161|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154027422|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154331162|NCT01494662|Neratinib|neratinib|mesh-list
154331163|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154331164|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
154331165|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331166|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331167|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154331168|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154331169|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
154331170|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
154331171|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
154331172|NCT01494662|Immunotoxins|immunotoxins|mesh-ancestor
154331173|NCT01494662|Immunoconjugates|immunoconjugates|mesh-ancestor
154331174|NCT01494662|Immunologic Factors|immunologic factors|mesh-ancestor
154331175|NCT01494662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331176|NCT01494662|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154331181|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
154331190|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331191|NCT00888459|Nicotine|nicotine|mesh-list
154331192|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154331193|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
154331194|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331195|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331196|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154331197|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154331198|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
154331199|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331200|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331201|NCT00736450|Prednisone|prednisone|mesh-list
154331202|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
154331203|NCT00736450|Rituximab|rituximab|mesh-list
154331204|NCT00736450|Doxorubicin|doxorubicin|mesh-list
154331205|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154331206|NCT00736450|Vincristine|vincristine|mesh-list
154331207|NCT00736450|Oblimersen|oblimersen|mesh-list
154331208|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331209|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
154331210|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331211|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331212|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154331213|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
154331214|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331215|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331216|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154331217|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154331218|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154331219|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154331220|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154331221|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331222|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331231|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
154331232|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
154331234|NCT00611351|Tacrolimus|tacrolimus|mesh-list
154331235|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154331236|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154331237|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
154331238|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331239|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331240|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154331241|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
154331242|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331243|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331244|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154331245|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154331246|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331247|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154331248|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154331249|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
154331250|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154331251|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154331253|NCT00572936|Dorzolamide|dorzolamide|mesh-list
154331254|NCT00572936|Latanoprost|latanoprost|mesh-list
154331255|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154331256|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154331257|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
154331258|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331261|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154331280|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154331281|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154331282|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331283|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154331284|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
154331285|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154331286|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154331288|NCT00436254|Sargramostim|sargramostim|mesh-list
154331289|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
154331290|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331291|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331292|NCT00383032|Mifepristone|mifepristone|mesh-list
154331293|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154331294|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
154331295|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154331296|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331297|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154331298|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154331299|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154331300|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
154331301|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154331302|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154331303|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
154331304|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331305|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
154331306|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154331307|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154331308|NCT00310765|Pregabalin|pregabalin|mesh-list
154331309|NCT00310765|Analgesics|analgesics|mesh-ancestor
154331310|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
154331311|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331312|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331313|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
154331314|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154331315|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331317|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154331318|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154331319|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154331320|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154331321|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154331322|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154331323|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154331324|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154331325|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331326|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331327|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331328|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331330|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
154331331|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331332|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
154331333|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154331334|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
154331336|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154331337|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154331338|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154331339|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331340|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
154331341|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331342|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
154331343|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331344|NCT05498675|Valsartan|valsartan|mesh-list
154331345|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154331346|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154331359|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331360|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331361|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331362|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154331363|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331364|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331365|NCT05352516|Denosumab|denosumab|mesh-list
154331366|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154331367|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331368|NCT05345613|Epinephrine|epinephrine|mesh-list
154331369|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
154331370|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154331371|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154331372|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331373|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
154331374|NCT05345613|Coagulants|coagulants|mesh-ancestor
154331375|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154331376|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154331377|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
154331378|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331379|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331380|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154331381|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154331382|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
154077718|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
154331383|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331407|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331408|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
154331409|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331410|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331411|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
154331412|NCT05097651|Cannabidiol|cannabidiol|mesh-list
154331413|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
154331414|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
154331415|NCT05038904|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154331416|NCT05038904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154331417|NCT05038904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331418|NCT05038904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331419|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331420|NCT04996251|Bupivacaine|bupivacaine|mesh-list
154331421|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
154331422|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
154331466|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154331467|NCT04879823|Acetaminophen|acetaminophen|mesh-list
154331468|NCT04879823|Dexamethasone|dexamethasone|mesh-list
154331469|NCT04879823|Ibuprofen|ibuprofen|mesh-list
154331470|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331471|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
154331472|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
154331473|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331474|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331475|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154331476|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
154331477|NCT04879823|Hormones|hormones|mesh-ancestor
154331478|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331479|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154331480|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331481|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154331482|NCT04879823|Analgesics|analgesics|mesh-ancestor
154331483|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
154331484|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
154331485|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154331486|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331487|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154331488|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331489|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331490|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
154331491|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154331514|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331516|NCT04781998|Hormones|hormones|mesh-ancestor
154331517|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331518|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154331519|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154331520|NCT04708613|Corticosterone|corticosterone|mesh-list
154331521|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331522|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154331523|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
154331524|NCT04664738|Coagulants|coagulants|mesh-ancestor
154331525|NCT04601402|Avelumab|avelumab|mesh-list
154331526|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154331527|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331528|NCT04545710|Osimertinib|osimertinib|mesh-list
154331529|NCT04545710|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154331530|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154331531|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027423|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154331532|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331533|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331534|NCT04530981|Repaglinide|repaglinide|mesh-list
154331535|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154331536|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331538|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
154331539|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154331540|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154331541|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
154331542|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331543|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331544|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331558|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154331559|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331560|NCT04398368|Gemcitabine|gemcitabine|mesh-list
154331561|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154331562|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
154331563|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331564|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331565|NCT04378959|Lidocaine|lidocaine|mesh-list
154331566|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
154331567|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
154331568|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154331569|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331570|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
154331571|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154331572|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154331573|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154331574|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154331575|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331576|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331577|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
154331578|NCT04310930|Azithromycin|azithromycin|mesh-list
154331579|NCT04310930|Clarithromycin|clarithromycin|mesh-list
154331580|NCT04310930|Doxycycline|doxycycline|mesh-list
154331581|NCT04310930|Linezolid|linezolid|mesh-list
154331582|NCT04310930|Imipenem|imipenem|mesh-list
154331606|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331607|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
154331608|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154331609|NCT04297995|Carboplatin|carboplatin|mesh-list
154331610|NCT04297995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331611|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
154331612|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331613|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
154331614|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331615|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
154331616|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154331617|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154331618|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154331619|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154331620|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331621|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331622|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331623|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
154331627|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
154331663|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331664|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
154331665|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
154331666|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331667|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331668|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154331669|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154331670|NCT03748784|Aflibercept|aflibercept|mesh-list
154331671|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154331672|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154331673|NCT03748784|Growth Substances|growth substances|mesh-ancestor
154331674|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331675|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
154331676|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331677|NCT03727776|Hormones|hormones|mesh-list
154331678|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154331679|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154331680|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
154078020|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
154331681|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331682|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331683|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331684|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331685|NCT03654274|Norethindrone|norethindrone|mesh-list
154331686|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
154331688|NCT03654274|Relugolix|relugolix|mesh-list
154331689|NCT03654274|Estrogens|estrogens|mesh-ancestor
154331690|NCT03654274|Hormones|hormones|mesh-ancestor
154331691|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331692|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331693|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154331694|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
154331695|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154331696|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154331697|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154331698|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154331699|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154331700|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
154331701|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
154331702|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
154331703|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154331704|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331705|NCT03417882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154331706|NCT03417882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331707|NCT03330457|Betrixaban|betrixaban|mesh-list
154331708|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154331709|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
154331710|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154331711|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
154331712|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331713|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331714|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
154331715|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154331716|NCT03286556|Autoantibodies|autoantibodies|mesh-list
154331717|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154331718|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
154331719|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331720|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154331721|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154331722|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154331723|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331724|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331725|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
154331726|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331742|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
154331743|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154331744|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
154331745|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154331746|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
154331747|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331748|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331749|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
154331750|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154331751|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154331752|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
154331753|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154331754|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331755|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
154331756|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154331757|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154331758|NCT02596100|Betrixaban|betrixaban|mesh-list
154331759|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154331760|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
154331761|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154331762|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
154331763|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331797|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
154331798|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331799|NCT00324220|Mocetinostat|mocetinostat|mesh-list
154331800|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154331801|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331802|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331803|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154331804|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154331805|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331806|NCT00417118|Escitalopram|escitalopram|mesh-list
154331807|NCT00417118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154331808|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154331809|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154331810|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331811|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331812|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
154331813|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331814|NCT02883452|Infliximab|infliximab|mesh-list
154331815|NCT02883452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154331816|NCT02883452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331817|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
154331818|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154331819|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331820|NCT00508066|Bupivacaine|bupivacaine|mesh-list
154331821|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
154331822|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
154331823|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154331824|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331827|NCT01336010|Ribavirin|ribavirin|mesh-list
154331842|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331843|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
154331844|NCT01342016|Hormones|hormones|mesh-ancestor
154331845|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331846|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331847|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154331848|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331849|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331850|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
154331851|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154331852|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331853|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331854|NCT01336166|Vaccines|vaccines|mesh-list
154331855|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
154331856|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331857|NCT04470310|Pioglitazone|pioglitazone|mesh-list
154331858|NCT04470310|Glimepiride|glimepiride|mesh-list
154331859|NCT04470310|Alogliptin|alogliptin|mesh-list
154331860|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154331861|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331862|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154331863|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331864|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
154331865|NCT04470310|Incretins|incretins|mesh-ancestor
154331866|NCT04470310|Hormones|hormones|mesh-ancestor
154331867|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331872|NCT02083250|Fludarabine|fludarabine|mesh-list
154331889|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154331890|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331891|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154331892|NCT00412828|Immunoconjugates|immunoconjugates|mesh-ancestor
154331893|NCT00412828|Immunologic Factors|immunologic factors|mesh-ancestor
154331894|NCT00412828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331895|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154331896|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331897|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
154331898|NCT00315640|Anecortave|anecortave|mesh-list
154331899|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154331900|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154331901|NCT00315640|Growth Substances|growth substances|mesh-ancestor
154331902|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331903|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
154331904|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331905|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154331906|NCT00411892|Insulin|insulin|mesh-list
154331907|NCT00411892|Pioglitazone|pioglitazone|mesh-list
154331908|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154331909|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154331910|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331911|NCT01336322|Metformin|metformin|mesh-list
154331912|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154331913|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154331914|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331915|NCT01336322|Incretins|incretins|mesh-ancestor
154331916|NCT01336322|Hormones|hormones|mesh-ancestor
154331917|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154331934|NCT00313768|Paclitaxel|paclitaxel|mesh-list
154331935|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154331936|NCT00313768|Bevacizumab|bevacizumab|mesh-list
154331937|NCT00313768|Carboplatin|carboplatin|mesh-list
154331938|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154331939|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331940|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
154331941|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
154331942|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
154331943|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331944|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154331945|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154331946|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154331947|NCT00313768|Growth Substances|growth substances|mesh-ancestor
154331948|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331949|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
154331950|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
154331951|NCT01339988|Busulfan|busulfan|mesh-list
154331952|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154331953|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
154331954|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154331955|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154331956|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154331957|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
154331958|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331959|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154331960|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154331961|NCT00406588|Levodopa|levodopa|mesh-list
154331962|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154331979|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154331980|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
154331981|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154331982|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331983|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154331984|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
154331985|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
154331986|NCT00313222|Bosentan|bosentan|mesh-list
154331987|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154331988|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154331989|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331990|NCT05184530|Evolocumab|evolocumab|mesh-list
154331991|NCT05184530|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154331992|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154331993|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154331994|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
154331995|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154331996|NCT05184530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154331997|NCT05184530|Protease Inhibitors|protease inhibitors|mesh-ancestor
154331998|NCT05184530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154331999|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154332000|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154332029|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154332030|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154332031|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154332033|NCT02287870|Lidocaine|lidocaine|mesh-list
154332034|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
154332035|NCT02287870|Procaine|procaine|mesh-list
154332036|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
154332037|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
154332038|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332039|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332040|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
154332041|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332042|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154332043|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154332044|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154332045|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154332046|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332047|NCT01340456|Rifampin|rifampin|mesh-list
154332048|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154332049|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
154332050|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154332051|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332052|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
154332053|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154332054|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332055|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332056|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154332057|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154332071|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154332072|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154332073|NCT00305656|Cediranib|cediranib|mesh-list
154332074|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332075|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332076|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332077|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154332078|NCT02284984|Rituximab|rituximab|mesh-list
154332079|NCT02284984|Belimumab|belimumab|mesh-list
154332080|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154332081|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332082|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
154332083|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332084|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154332085|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154332086|NCT00305188|Leucovorin|leucovorin|mesh-list
154332087|NCT00305188|Fluorouracil|fluorouracil|mesh-list
154332088|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
154332089|NCT00305188|Xaliproden|xaliproden|mesh-list
154332090|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
154332091|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332092|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154332093|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332094|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154332095|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
154332096|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332097|NCT00305188|Antidotes|antidotes|mesh-ancestor
154332098|NCT00305188|Protective Agents|protective agents|mesh-ancestor
154332099|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
154332100|NCT00305188|Vitamins|vitamins|mesh-ancestor
154332101|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
154332102|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154332103|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154332114|NCT00095290|Irbesartan|irbesartan|mesh-list
154332115|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154332116|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
154332117|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332118|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332119|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154332120|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154332121|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154332122|NCT01340846|Ketoconazole|ketoconazole|mesh-list
154332123|NCT01340846|Dabrafenib|dabrafenib|mesh-list
154332124|NCT01340846|Warfarin|warfarin|mesh-list
154332125|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
154078465|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
154332126|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
154332127|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
154332128|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332129|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154332130|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154332131|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332132|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332133|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154332134|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
154332135|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332136|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332137|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154332138|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332139|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154332140|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154332141|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
154332142|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154332143|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154332144|NCT01342874|Inositol|inositol|mesh-list
154332145|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
154332153|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332155|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332156|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332157|NCT02603809|Lisinopril|lisinopril|mesh-list
154332158|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154332159|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
154332160|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332161|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332162|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154332163|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154332164|NCT02603809|Protective Agents|protective agents|mesh-ancestor
154332165|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332166|NCT01341158|Interferons|interferons|mesh-list
154332167|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332168|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
154332169|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332170|NCT00393952|Fluticasone|fluticasone|mesh-list
154332171|NCT00393952|Xhance|xhance|mesh-list
154332172|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
154332173|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332174|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154332175|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
154332176|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332177|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332178|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154332188|NCT02285374|Tenofovir|tenofovir|mesh-list
154332199|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154332200|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154332201|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154332202|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154332203|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154332204|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154332205|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154332206|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154332207|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154332208|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154332210|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
154332211|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332212|NCT01112449|Protective Agents|protective agents|mesh-ancestor
154332213|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332214|NCT01112449|Trace Elements|trace elements|mesh-ancestor
154332215|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
154332216|NCT01341392|Amlodipine|amlodipine|mesh-list
154332217|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154332218|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154332219|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154332220|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332221|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154332222|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332223|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
154332224|NCT04390958|Paclitaxel|paclitaxel|mesh-list
154332225|NCT04390958|Capecitabine|capecitabine|mesh-list
154332226|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154332227|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332228|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
154332229|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
154332230|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
154332233|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
154332240|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154332241|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154332242|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332243|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
154332244|NCT03943459|Protective Agents|protective agents|mesh-ancestor
154332245|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332246|NCT04832438|Carboplatin|carboplatin|mesh-list
154332247|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332248|NCT05182970|Metformin|metformin|mesh-list
154332249|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154332250|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332251|NCT01315886|Fentanyl|fentanyl|mesh-list
154332252|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154332253|NCT01315886|Narcotics|narcotics|mesh-ancestor
154332254|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332255|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332256|NCT01315886|Analgesics|analgesics|mesh-ancestor
154332257|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
154332258|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332259|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154332260|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154332261|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
154332262|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
154332263|NCT00065728|Anecortave|anecortave|mesh-list
154332264|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154332265|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154332266|NCT00065728|Growth Substances|growth substances|mesh-ancestor
154332267|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332289|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332290|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332291|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154332292|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154332293|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154332294|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154332295|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
154332296|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
154332297|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332298|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332299|NCT00292396|Antibodies|antibodies|mesh-list
154332300|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154332301|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
154332302|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332303|NCT03942289|Norepinephrine|norepinephrine|mesh-list
154332304|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154332346|NCT03740893|Durvalumab|durvalumab|mesh-list
154332347|NCT03740893|Olaparib|olaparib|mesh-list
154332348|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154078693|NCT00914693|Estrogens|estrogens|mesh-ancestor
154332350|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154332351|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332352|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332353|NCT00005788|Aldesleukin|aldesleukin|mesh-list
154332354|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332355|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154332356|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154332357|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
154332358|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332359|NCT03945955|Melatonin|melatonin|mesh-list
154332360|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
154332361|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332362|NCT03945955|Protective Agents|protective agents|mesh-ancestor
154332363|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332364|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332365|NCT00005608|Leucovorin|leucovorin|mesh-list
154332366|NCT00005608|Tegafur|tegafur|mesh-list
154332367|NCT00005608|Calcium|calcium|mesh-list
154332368|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
154332369|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154332370|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332371|NCT00005608|Antidotes|antidotes|mesh-ancestor
154332372|NCT00005608|Protective Agents|protective agents|mesh-ancestor
154332373|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
154332374|NCT00005608|Vitamins|vitamins|mesh-ancestor
154332375|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
154332376|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154332377|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
154332378|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332379|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332380|NCT02288338|Atorvastatin|atorvastatin|mesh-list
154332381|NCT02288338|Ezetimibe|ezetimibe|mesh-list
154332382|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154332387|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154332388|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332389|NCT00388960|Etoposide|etoposide|mesh-list
154332390|NCT00388960|Amrubicin|amrubicin|mesh-list
154332391|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332392|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154332393|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154332394|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154332395|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332396|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332397|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
154332398|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
154332399|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
154332400|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332401|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332402|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
154332403|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332404|NCT00004912|Megestrol|megestrol|mesh-list
154332405|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
154332406|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154332419|NCT02529787|Lansoprazole|lansoprazole|mesh-list
154332438|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154332439|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332441|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
154332442|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
154332443|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332444|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332445|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
154332446|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332447|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154332448|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154332449|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154332450|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154332451|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332452|NCT00262990|Doxorubicin|doxorubicin|mesh-list
154332453|NCT00262990|Epothilone B|epothilone b|mesh-list
154332454|NCT00262990|Epothilones|epothilones|mesh-list
154332455|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154332456|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332457|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154332458|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154332459|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332460|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332461|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
154332462|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
154332463|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
154332464|NCT01110031|Ofatumumab|ofatumumab|mesh-list
154332465|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332482|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332483|NCT03147248|Infliximab|infliximab|mesh-list
154332484|NCT03147248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154332485|NCT03147248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332486|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
154332487|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154332488|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154332489|NCT00250822|Gemcitabine|gemcitabine|mesh-list
154332490|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
154332491|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154332492|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
154332493|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332494|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332495|NCT00004096|Carboplatin|carboplatin|mesh-list
154332496|NCT00004096|Vinorelbine|vinorelbine|mesh-list
154332497|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332498|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154332499|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
154332500|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
154332501|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
154332502|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332503|NCT00002224|Nelfinavir|nelfinavir|mesh-list
154332504|NCT00002224|Stavudine|stavudine|mesh-list
154332505|NCT00002224|Didanosine|didanosine|mesh-list
154332506|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154332507|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154332511|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154332532|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
154332533|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154332534|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332535|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154332536|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154332537|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
154332538|NCT03530176|Listerine|listerine|mesh-list
154332539|NCT03530176|Fluorides|fluorides|mesh-list
154332540|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
154332541|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
154332542|NCT03530176|Protective Agents|protective agents|mesh-ancestor
154332543|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332544|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154332545|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332546|NCT03151304|Azacitidine|azacitidine|mesh-list
154332547|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154332548|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
154332549|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332550|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332551|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332552|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
154332553|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
154332554|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154332584|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332585|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332586|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
154332587|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332588|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154332589|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154332590|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
154332591|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154332592|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154332594|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154332595|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154332596|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332597|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332598|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
154332599|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332600|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154332601|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154332602|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154332603|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154332604|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154332605|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154332606|NCT03531970|Dexamethasone|dexamethasone|mesh-list
154332608|NCT03531970|Lidocaine|lidocaine|mesh-list
154332632|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154332633|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154332634|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154332635|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
154332636|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332637|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154332638|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154332639|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154332640|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
154332641|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
154332642|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
154332643|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154332644|NCT01211821|Metoprolol|metoprolol|mesh-list
154332645|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154332646|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154332647|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
154332648|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
154332649|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332650|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332651|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154332652|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154332653|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154332654|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
154332655|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332656|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332658|NCT03527836|Bupivacaine|bupivacaine|mesh-list
154332659|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
154332660|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
154332661|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332662|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332663|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
154332664|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332665|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154332666|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153511854|NCT01409187|Ipilimumab|ipilimumab|mesh-list
154332670|NCT05724862|Anesthetics|anesthetics|mesh-list
154332671|NCT05724862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332672|NCT05724862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332673|NCT03940651|Anesthetics|anesthetics|mesh-list
154332674|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
154332675|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332676|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332677|NCT03152552|Empagliflozin|empagliflozin|mesh-list
154332678|NCT03152552|Licogliflozin|licogliflozin|mesh-list
154332679|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154332680|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332681|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154332682|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332683|NCT01211275|Cisplatin|cisplatin|mesh-list
154332684|NCT01211275|Pemetrexed|pemetrexed|mesh-list
154332729|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332730|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332731|NCT01213381|Carboplatin|carboplatin|mesh-list
154332732|NCT01213381|Gemcitabine|gemcitabine|mesh-list
154332734|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332735|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154332736|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
154332737|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332738|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154332739|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332740|NCT01316978|Ibuprofen|ibuprofen|mesh-list
154332741|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154332742|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154332743|NCT01316978|Analgesics|analgesics|mesh-ancestor
154332744|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
154332745|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332746|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332747|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332748|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154332749|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154332750|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332751|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332752|NCT01317212|Carboplatin|carboplatin|mesh-list
154332753|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332754|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
154332775|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154332776|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
154332777|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332778|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
154332779|NCT04441528|Protective Agents|protective agents|mesh-ancestor
154332780|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
154332781|NCT01344512|Ceftazidime|ceftazidime|mesh-list
154332782|NCT01344512|Voriconazole|voriconazole|mesh-list
154332783|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154332784|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332785|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154332786|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154332787|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332788|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332789|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332790|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154332791|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154332792|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
154332793|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154332794|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154332795|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
154332796|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332797|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332798|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154332802|NCT05064488|Digoxin|digoxin|mesh-list
154332821|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332822|NCT01344590|Ethanol|ethanol|mesh-list
154332823|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154332824|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332825|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332826|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332827|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
154332828|NCT01114087|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154332829|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154332830|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332831|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332832|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332833|NCT01212133|Liraglutide|liraglutide|mesh-list
154332834|NCT01212133|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154332835|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154332836|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332837|NCT01212133|Incretins|incretins|mesh-ancestor
154332838|NCT01212133|Hormones|hormones|mesh-ancestor
154332839|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332840|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
154332841|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154332842|NCT04269356|Antacids|antacids|mesh-ancestor
154332843|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332844|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154332845|NCT01118065|Everolimus|everolimus|mesh-list
154332846|NCT01118065|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154332847|NCT01118065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154332848|NCT01118065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332849|NCT01118065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332850|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154332854|NCT03528616|Propranolol|propranolol|mesh-list
154332864|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332865|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332866|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154332867|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154332868|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
154332869|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154332870|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332871|NCT03528616|Protective Agents|protective agents|mesh-ancestor
154332872|NCT03528616|Analgesics|analgesics|mesh-ancestor
154332873|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
154332874|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332875|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154332876|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
154332877|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
154332878|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154332879|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154332880|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154332881|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154332882|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154332883|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154332884|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154332914|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154332915|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154332916|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332917|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154332918|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
154332919|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
154332920|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154332921|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154332922|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154332923|NCT04468438|Estrogens|estrogens|mesh-list
154332924|NCT04468438|Hormones|hormones|mesh-ancestor
154332925|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154332926|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332927|NCT04468282|Vigabatrin|vigabatrin|mesh-list
154332928|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
154332929|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154332930|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332931|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
154332932|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332933|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332934|NCT01121731|Interferons|interferons|mesh-list
154332935|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
154332936|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154332937|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
154332938|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154332939|NCT01215799|Bafetinib|bafetinib|mesh-list
154332940|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154332961|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332962|NCT01213693|Fluticasone|fluticasone|mesh-list
154332963|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154332964|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332965|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154332966|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
154332967|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332968|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332969|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154332970|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
154332971|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
154332972|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154332973|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154332974|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154332975|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154332976|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154332977|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154332978|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154332979|NCT01213849|Fluticasone|fluticasone|mesh-list
154332980|NCT01213849|Xhance|xhance|mesh-list
154332981|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154332982|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154332983|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
154332984|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154332985|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154332986|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154333009|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154333010|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
154333011|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333012|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154333014|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154333015|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154333016|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154333017|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333018|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333019|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333020|NCT05110144|Analgesics|analgesics|mesh-ancestor
154333021|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
154333022|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333023|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
154333024|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154333025|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
154333026|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154333027|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154333028|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154333029|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
154333030|NCT01212367|Interferons|interferons|mesh-list
154333061|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154333062|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333063|NCT01216267|Lansoprazole|lansoprazole|mesh-list
154333064|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
154333065|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154333066|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154333067|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154333068|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333069|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333070|NCT01216345|Gemcitabine|gemcitabine|mesh-list
154333071|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
154333072|NCT01216345|Cetuximab|cetuximab|mesh-list
154333073|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154333074|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
154333075|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333076|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333077|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154333078|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
154333079|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
154333080|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
154333081|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154333082|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154333083|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333112|NCT01122199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333113|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154333114|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
154333115|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333116|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333117|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154333119|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333120|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154333121|NCT01119079|Anesthetics|anesthetics|mesh-list
154333122|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333123|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333124|NCT01119157|Vaccines|vaccines|mesh-list
154333125|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
154333126|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333127|NCT01120015|Diacerein|diacerein|mesh-list
154333128|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333129|NCT01216579|Mannitol|mannitol|mesh-list
154333130|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154333131|NCT01216579|Diuretics|diuretics|mesh-ancestor
154333132|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
154333133|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333134|NCT03528070|Tranilast|tranilast|mesh-list
154333135|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154333136|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154333137|NCT03528070|Analgesics|analgesics|mesh-ancestor
154333138|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
154333139|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333140|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333141|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333142|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154333143|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154333144|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154333153|NCT03935815|Ropivacaine|ropivacaine|mesh-list
154333154|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
154333155|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
154333156|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333157|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333158|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
154333159|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333160|NCT01216657|Sunitinib|sunitinib|mesh-list
154333161|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333162|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154333163|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154333164|NCT01216657|Growth Substances|growth substances|mesh-ancestor
154333165|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333166|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
154333167|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154333168|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333169|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333170|NCT04400188|Temozolomide|temozolomide|mesh-list
154333171|NCT04400188|Fluzoparib|fluzoparib|mesh-list
154333172|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154333173|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
154333174|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333175|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333176|NCT04400188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154333177|NCT04400188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333178|NCT01115959|Valproic Acid|valproic acid|mesh-list
154333179|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
154333199|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333200|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154333201|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154333202|NCT01217203|Growth Substances|growth substances|mesh-ancestor
154333203|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
154333204|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333206|NCT01120171|Doxorubicin|doxorubicin|mesh-list
154333207|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154333208|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154333209|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
154333210|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333211|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154333212|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154333213|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
154333215|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333258|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333259|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
154333260|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333261|NCT01212679|Mitogens|mitogens|mesh-list
154333262|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
154333263|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333264|NCT03193684|Empagliflozin|empagliflozin|mesh-list
154333265|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154333266|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333267|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154333268|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333269|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
154333270|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154333271|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333272|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333273|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154333274|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154333275|NCT01116583|Gabapentin|gabapentin|mesh-list
154333276|NCT01116583|Analgesics|analgesics|mesh-ancestor
154333277|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
154333278|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333279|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333280|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
154333281|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154333282|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154333307|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154333308|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154333309|NCT03935347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154333310|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154333312|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
154333313|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333314|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154333315|NCT03935347|Analgesics|analgesics|mesh-ancestor
154079673|NCT01021735|Adalimumab|adalimumab|mesh-list
154333316|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
154333317|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333318|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154333319|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154333320|NCT04467346|Temozolomide|temozolomide|mesh-list
154333321|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154333322|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
154333364|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333365|NCT01116817|Ritonavir|ritonavir|mesh-list
154333366|NCT01116817|Lopinavir|lopinavir|mesh-list
154333367|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154333368|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154333369|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
154333370|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333371|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333372|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154333373|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154333374|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
154333375|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333376|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154333377|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154333378|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
154333379|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154333380|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154333381|NCT04467892|Prednisolone|prednisolone|mesh-list
154333382|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
154333419|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
154333420|NCT01123057|Vitamins|vitamins|mesh-ancestor
154333421|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
154333422|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333423|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154333424|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
154333425|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
154333426|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154333427|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333428|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333429|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154333430|NCT03524950|Analgesics|analgesics|mesh-ancestor
154333431|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
154333432|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333433|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154333434|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154333435|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154333474|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333475|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154333477|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
154333478|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
154333479|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333480|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333481|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
154333482|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333483|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
154333484|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154333485|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333486|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333487|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154333488|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154333489|NCT01328821|Protective Agents|protective agents|mesh-ancestor
154333490|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333491|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
154333492|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154333493|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
154333494|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154333495|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154333527|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333528|NCT01218217|Rifampin|rifampin|mesh-list
154333529|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154333530|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
154333531|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154333532|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333533|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
154333534|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154333535|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333536|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333537|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154333538|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154333539|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154333540|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154333541|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154333542|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154333544|NCT03522532|Trace Elements|trace elements|mesh-ancestor
154333545|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
154333546|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333547|NCT01215019|Mannitol|mannitol|mesh-list
154333548|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154333549|NCT01215019|Diuretics|diuretics|mesh-ancestor
154333550|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
154333551|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333552|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
154333553|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
154333554|NCT01215331|Insulin|insulin|mesh-list
154333555|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154333556|NCT01215331|Metformin|metformin|mesh-list
154333557|NCT01215331|Glyburide|glyburide|mesh-list
154333571|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333572|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154333573|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
154333574|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333575|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333576|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154333577|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
154333578|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
154333579|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154333580|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154333581|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154333582|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154333583|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
154333584|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333585|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333586|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
154333587|NCT04466176|Hormones|hormones|mesh-ancestor
154333588|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333589|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
154333590|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154333591|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
154333592|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154333593|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154333594|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333595|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333596|NCT01215409|Urological Agents|urological agents|mesh-ancestor
154333597|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
154333598|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154333599|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333601|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154333612|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154333613|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333614|NCT04674020|Analgesics|analgesics|mesh-ancestor
154333615|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
154333616|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333617|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333618|NCT01123525|Adenosine|adenosine|mesh-list
154333619|NCT01123525|Analgesics|analgesics|mesh-ancestor
154333620|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
154333621|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333622|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333623|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154333624|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
154333625|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154333626|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
154333627|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
154333628|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333629|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333630|NCT01215565|Sunitinib|sunitinib|mesh-list
154333631|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333632|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154333633|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154333634|NCT01215565|Growth Substances|growth substances|mesh-ancestor
154333635|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333647|NCT01121497|Miotics|miotics|mesh-ancestor
154333660|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154333661|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154333662|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154333664|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154333665|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333666|NCT01117129|Rituximab|rituximab|mesh-list
154333667|NCT01117129|Methotrexate|methotrexate|mesh-list
154333668|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154333669|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333670|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
154333671|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333672|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154333673|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154333674|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
154333675|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154333676|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154333677|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
154333678|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333679|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
154333680|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333681|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154333682|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154333683|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154333684|NCT03133988|Margetuximab|margetuximab|mesh-list
154333685|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333686|NCT03934411|Tramadol|tramadol|mesh-list
154333704|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154333705|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333706|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154333707|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154333708|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333709|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333710|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154333711|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
154333712|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333713|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333714|NCT01219153|Hormones|hormones|mesh-ancestor
154333715|NCT03526042|Losartan|losartan|mesh-list
154333716|NCT03526042|Enalapril|enalapril|mesh-list
154333717|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154333718|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154333719|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154333720|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154333721|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154333722|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154333723|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333724|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
154333725|NCT01124539|Camptothecin|camptothecin|mesh-list
154333726|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
154333727|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154333728|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333733|NCT03781375|Etanercept|etanercept|mesh-list
154333749|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154333750|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154333751|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154333752|NCT03781375|Analgesics|analgesics|mesh-ancestor
154333753|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
154333754|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333755|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333756|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154333757|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154333758|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154333759|NCT01123915|Protective Agents|protective agents|mesh-ancestor
154333760|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333761|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154333762|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
153782011|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153414769|NCT02513719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154333763|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333764|NCT01218529|Lapatinib|lapatinib|mesh-list
154333765|NCT01218529|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154333766|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154333767|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333804|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154333805|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333806|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154333807|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333808|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
154333809|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
154333810|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333811|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
154333812|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154333813|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333814|NCT01124383|Lidocaine|lidocaine|mesh-list
154333815|NCT01124383|Ephedrine|ephedrine|mesh-list
154333816|NCT01124383|Midazolam|midazolam|mesh-list
154333817|NCT01124383|Sufentanil|sufentanil|mesh-list
154333819|NCT01124383|Anesthetics|anesthetics|mesh-list
154333820|NCT01124383|Propofol|propofol|mesh-list
154333821|NCT01124383|Sevoflurane|sevoflurane|mesh-list
154333822|NCT01124383|Rocuronium|rocuronium|mesh-list
154333823|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
154333824|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154333825|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333835|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
154333861|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154333862|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
154333863|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333864|NCT01222897|Valacyclovir|valacyclovir|mesh-list
154333865|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
154333866|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154333867|NCT03150056|Prednisone|prednisone|mesh-list
154333868|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333869|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
154333870|NCT03150056|Hormones|hormones|mesh-ancestor
154333871|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333872|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333873|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154333874|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333875|NCT01329367|Antioxidants|antioxidants|mesh-list
154333876|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333877|NCT01329367|Protective Agents|protective agents|mesh-ancestor
154333878|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333879|NCT01222975|Risperidone|risperidone|mesh-list
154080267|NCT06238843|Irinotecan|irinotecan|mesh-list
154333913|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154333914|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333915|NCT03933319|Doxorubicin|doxorubicin|mesh-list
154333916|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154333917|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154333918|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333919|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154333920|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154333921|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333922|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333923|NCT01223053|Ketoprofen|ketoprofen|mesh-list
154333924|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154333925|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154333926|NCT01223053|Analgesics|analgesics|mesh-ancestor
154333927|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
154333928|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154333929|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333930|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154333931|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154333932|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154333933|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333935|NCT01223131|Insulin|insulin|mesh-list
154333965|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333966|NCT02456012|Esomeprazole|esomeprazole|mesh-list
154333967|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154333968|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154333969|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154333970|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333971|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333972|NCT00812006|Rizatriptan|rizatriptan|mesh-list
154333973|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154333974|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
154333975|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154333976|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333977|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154333978|NCT03133234|Osimertinib|osimertinib|mesh-list
154333979|NCT03133234|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154333980|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154333981|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154333982|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333983|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333984|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154333986|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154333987|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154333988|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
154333989|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154333990|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154333991|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
154334010|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154334011|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334012|NCT06130072|Ethiodized Oil|ethiodized oil|mesh-list
154334013|NCT06130072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334014|NCT06130059|Colchicine|colchicine|mesh-list
154334015|NCT06130059|Gout Suppressants|gout suppressants|mesh-ancestor
154334016|NCT06130059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154334017|NCT06130059|Tubulin Modulators|tubulin modulators|mesh-ancestor
154334018|NCT06130059|Antimitotic Agents|antimitotic agents|mesh-ancestor
154334019|NCT06130059|Mitosis Modulators|mitosis modulators|mesh-ancestor
154334020|NCT06130059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334021|NCT06130059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334022|NCT06130007|Docetaxel|docetaxel|mesh-list
154334023|NCT06130007|Trastuzumab|trastuzumab|mesh-list
154334024|NCT06130007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334025|NCT06130007|Tubulin Modulators|tubulin modulators|mesh-ancestor
154334026|NCT06130007|Antimitotic Agents|antimitotic agents|mesh-ancestor
154334030|NCT06129955|Lenvatinib|lenvatinib|mesh-list
154334068|NCT06128967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154334069|NCT06128967|Antidepressive Agents|antidepressive agents|mesh-ancestor
154334070|NCT06128967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154334071|NCT06128967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154334072|NCT06128967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154334074|NCT06128863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334075|NCT06128863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334076|NCT06128863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154334077|NCT06128863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334078|NCT06128434|Fluorides|fluorides|mesh-list
154334079|NCT06128434|Cariostatic Agents|cariostatic agents|mesh-ancestor
154334080|NCT06128434|Protective Agents|protective agents|mesh-ancestor
154334081|NCT06128434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334082|NCT06128408|Olanzapine|olanzapine|mesh-list
154334083|NCT06128408|Risperidone|risperidone|mesh-list
154334084|NCT06128408|Aripiprazole|aripiprazole|mesh-list
154334085|NCT06128408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154334086|NCT06128408|Serotonin Agents|serotonin agents|mesh-ancestor
154334087|NCT06128408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334088|NCT06128408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334089|NCT06128408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334090|NCT06128408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154334091|NCT06128408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154334092|NCT06128408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334093|NCT06128408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154334094|NCT06128408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154334095|NCT06128408|Dopamine Agents|dopamine agents|mesh-ancestor
154334096|NCT06128408|Antiemetics|antiemetics|mesh-ancestor
154334097|NCT06128408|Autonomic Agents|autonomic agents|mesh-ancestor
154334098|NCT06128408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334099|NCT06128408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154334110|NCT06128278|Phytoestrogens|phytoestrogens|mesh-ancestor
154334111|NCT06128278|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154334112|NCT06128278|Estrogens|estrogens|mesh-ancestor
154334113|NCT06128278|Hormones|hormones|mesh-ancestor
154334114|NCT06128278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334115|NCT06128278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334116|NCT06128213|Cycloserine|cycloserine|mesh-list
154334117|NCT06128213|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154334118|NCT06128213|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154334119|NCT06128213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334120|NCT06128213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154334121|NCT06128213|Antitubercular Agents|antitubercular agents|mesh-ancestor
154334122|NCT06128213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154334123|NCT06128213|Antimetabolites|antimetabolites|mesh-ancestor
154334124|NCT06128213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334125|NCT06128213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154334126|NCT06128213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154334127|NCT06128213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334128|NCT06128213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334130|NCT06128213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154334131|NCT06128213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154334132|NCT06128213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154334133|NCT06128213|Adrenergic Agents|adrenergic agents|mesh-ancestor
154334134|NCT06128213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334135|NCT06128213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154334136|NCT06128213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154334137|NCT06128213|Serotonin Agents|serotonin agents|mesh-ancestor
154334138|NCT06128213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154334139|NCT06128213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154334140|NCT06128213|Dopamine Agents|dopamine agents|mesh-ancestor
154334141|NCT06126068|Magnesium Sulfate|magnesium sulfate|mesh-list
154334142|NCT06126068|Analgesics|analgesics|mesh-ancestor
154334152|NCT06126068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334153|NCT06126068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154334154|NCT06126068|Tocolytic Agents|tocolytic agents|mesh-ancestor
154334155|NCT06126068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154334156|NCT06124378|Capecitabine|capecitabine|mesh-list
154334157|NCT06124378|Oxaliplatin|oxaliplatin|mesh-list
154334158|NCT06124378|Tislelizumab|tislelizumab|mesh-list
154334159|NCT06124378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154334160|NCT06124378|Antimetabolites|antimetabolites|mesh-ancestor
154334161|NCT06124378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334162|NCT06124378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334163|NCT06124378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334164|NCT06086691|Caffeine|caffeine|mesh-list
154334165|NCT06086691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154334166|NCT06086691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334167|NCT06086691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154334168|NCT06086691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334169|NCT06086691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334170|NCT06086691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154334171|NCT06086691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154334172|NCT06086691|Purinergic Agents|purinergic agents|mesh-ancestor
154334173|NCT06086691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334174|NCT06086171|Methadone|methadone|mesh-list
154334175|NCT06086171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154334176|NCT06086171|Narcotics|narcotics|mesh-ancestor
154334177|NCT06086171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334199|NCT06022146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154334200|NCT06022146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334201|NCT06022146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080579|NCT05922501|Hormones|hormones|mesh-ancestor
154334202|NCT06022146|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154334203|NCT06022146|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154334204|NCT06022146|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154334205|NCT06022146|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154334206|NCT06022146|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154334207|NCT06022146|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154334208|NCT06022146|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154334209|NCT06022146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154334210|NCT06022146|Antimetabolites|antimetabolites|mesh-ancestor
154334211|NCT06022146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154334212|NCT05998928|Cyclophosphamide|cyclophosphamide|mesh-list
154334213|NCT05998928|Fludarabine|fludarabine|mesh-list
154334214|NCT05998928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334215|NCT05998928|Immunologic Factors|immunologic factors|mesh-ancestor
154334216|NCT05998928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334217|NCT05998928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154334218|NCT05998928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154334219|NCT05998928|Alkylating Agents|alkylating agents|mesh-ancestor
154334220|NCT05998928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334221|NCT05998928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334222|NCT05998928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154334223|NCT05995600|Warfarin|warfarin|mesh-list
154334224|NCT05995600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154334225|NCT05995600|Anticoagulants|anticoagulants|mesh-ancestor
154334226|NCT05968937|Baclofen|baclofen|mesh-list
154334227|NCT05968937|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154334228|NCT05968937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334229|NCT05968937|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154334231|NCT05968937|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154334235|NCT05968937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334237|NCT05930561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154334238|NCT05930561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154334239|NCT05930561|Growth Substances|growth substances|mesh-ancestor
154334240|NCT05930561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334241|NCT05930561|Growth Inhibitors|growth inhibitors|mesh-ancestor
154334242|NCT05930561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334243|NCT05867329|Cyclosporine|cyclosporine|mesh-list
154334244|NCT05867329|Prednisone|prednisone|mesh-list
154334245|NCT05867329|Methylprednisolone|methylprednisolone|mesh-list
154334246|NCT05867329|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154334247|NCT05867329|Upadacitinib|upadacitinib|mesh-list
154334248|NCT05867329|Cyclosporins|cyclosporins|mesh-list
154334249|NCT05867329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334251|NCT05867329|Hormones|hormones|mesh-ancestor
154334295|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154334297|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
154334298|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334299|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334300|NCT05606913|Dulaglutide|dulaglutide|mesh-list
154334301|NCT05606913|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154334302|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154334303|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334304|NCT05528952|Bevacizumab|bevacizumab|mesh-list
154334305|NCT05528952|Atezolizumab|atezolizumab|mesh-list
154334306|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334307|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334308|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154334309|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154334310|NCT05528952|Growth Substances|growth substances|mesh-ancestor
154334311|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334312|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
154334313|NCT05528952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154334314|NCT05528952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334315|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154334316|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154334317|NCT05465876|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154334318|NCT05465876|Antiviral Agents|antiviral agents|mesh-ancestor
154334319|NCT05465876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334320|NCT05385887|Metronidazole|metronidazole|mesh-list
154334321|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
154334322|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334323|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154334324|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154334325|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154334326|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154334327|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154334328|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334329|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513543|NCT01421173|Dexamethasone|dexamethasone|mesh-list
154334330|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334331|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154334332|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154334333|NCT05382312|Bedaquiline|bedaquiline|mesh-list
154334334|NCT05382312|GSK656|gsk656|mesh-list
154334335|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
154334336|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154334337|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334338|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154334339|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
154334340|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334341|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154334342|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154334343|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334344|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154334345|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154334346|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154334347|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334348|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334349|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154080694|NCT05724329|Antioxidants|antioxidants|mesh-ancestor
154334350|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154334351|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334352|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
154334353|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334355|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334356|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
154334374|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154334375|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154334376|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154334377|NCT05127304|Bromides|bromides|mesh-list
154334378|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
154334379|NCT05127304|Olodaterol|olodaterol|mesh-list
154334380|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154334381|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
154334382|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334383|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334384|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154334385|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
154334386|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
154334387|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154334388|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
154334389|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334390|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334391|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
154334392|NCT05121909|Listerine|listerine|mesh-list
154334393|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154334394|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
154334395|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
154334396|NCT05121909|Protective Agents|protective agents|mesh-ancestor
154334397|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334398|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334399|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
154334425|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334426|NCT04849364|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154334427|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334428|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154334429|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
154334430|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154334431|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334432|NCT04849364|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154334433|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
154334434|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154334435|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154334436|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334438|NCT04797156|Coagulants|coagulants|mesh-ancestor
154334439|NCT04776148|Trifluridine|trifluridine|mesh-list
154334440|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
154334442|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334443|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334444|NCT04776148|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154334445|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334446|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334451|NCT04737109|Ipatasertib|ipatasertib|mesh-list
154334476|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334477|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334478|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
154334479|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334480|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334481|NCT04259801|Semaglutide|semaglutide|mesh-list
154334482|NCT04259801|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154334483|NCT04259801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154334484|NCT04259801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334485|NCT04187196|Propofol|propofol|mesh-list
154334486|NCT04187196|Methohexital|methohexital|mesh-list
154334487|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154334488|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334489|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334490|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154334491|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
154334492|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
154334493|NCT04166474|Dolutegravir|dolutegravir|mesh-list
154334494|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154334495|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154334496|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334497|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334498|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154334500|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
154334501|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334502|NCT04091971|Ketamine|ketamine|mesh-list
154334503|NCT04091971|Analgesics|analgesics|mesh-ancestor
154334504|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
154334505|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334506|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334521|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334522|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334523|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
154334524|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334525|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154334526|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154334527|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154334528|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154334529|NCT03955887|Dimercaprol|dimercaprol|mesh-list
154334530|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
154334531|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
154334532|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334533|NCT03950609|Everolimus|everolimus|mesh-list
154334534|NCT03950609|Lenvatinib|lenvatinib|mesh-list
154334535|NCT03950609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154334536|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334537|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334538|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334539|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334540|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
154334541|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334542|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334543|NCT03943901|Prednisone|prednisone|mesh-list
154334544|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
154334545|NCT03943901|Rituximab|rituximab|mesh-list
154334546|NCT03943901|Doxorubicin|doxorubicin|mesh-list
154334547|NCT03943901|Vincristine|vincristine|mesh-list
154334548|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334549|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
154334550|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334551|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154334552|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154334553|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
154334554|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334555|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334561|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334562|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334563|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
154334564|NCT03943901|Hormones|hormones|mesh-ancestor
154334565|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334566|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334567|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154334568|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
154334569|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
154334570|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
154334571|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154334572|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154334573|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154334574|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334575|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334577|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154334578|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154334579|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154334580|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
154334581|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334582|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334583|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154334584|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154334585|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
154334586|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154334587|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154334588|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
154334589|NCT03845894|Bupivacaine|bupivacaine|mesh-list
154334590|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
154334591|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
154334592|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334593|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334594|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
154334595|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334596|NCT03753919|Durvalumab|durvalumab|mesh-list
154334599|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334600|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
154334601|NCT03654768|Dasatinib|dasatinib|mesh-list
154334602|NCT03654768|Nilotinib|nilotinib|mesh-list
154334603|NCT03654768|Bosutinib|bosutinib|mesh-list
154334604|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154334605|NCT03654768|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154334606|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334607|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334608|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334609|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334610|NCT03422731|Alovudine|alovudine|mesh-list
154334611|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
154334612|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334613|NCT03299842|Fenfluramine|fenfluramine|mesh-list
154334614|NCT03299842|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154334615|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154334616|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154334617|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334618|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334619|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
154334620|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334621|NCT03249181|Dolutegravir|dolutegravir|mesh-list
154334622|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154334623|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154334624|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334625|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334626|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154334627|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154334632|NCT03237611|Aprepitant|aprepitant|mesh-list
154334645|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
154334646|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
154334647|NCT03237611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154080971|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
154334648|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154334649|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
154334650|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334651|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334652|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154334653|NCT03104374|Upadacitinib|upadacitinib|mesh-list
154334654|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154334655|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334656|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334657|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334658|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154334660|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154334661|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154334662|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154334663|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
154334664|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
154334665|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334666|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334667|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334668|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154334669|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154334670|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334671|NCT03054363|Letrozole|letrozole|mesh-list
154334672|NCT03054363|Palbociclib|palbociclib|mesh-list
154334687|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334688|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334689|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334690|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334692|NCT02829957|Apixaban|apixaban|mesh-list
154334693|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154334694|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
154334695|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154334696|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
154334697|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334698|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334699|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
154334700|NCT02817958|Paclitaxel|paclitaxel|mesh-list
154334701|NCT02817958|Ifosfamide|ifosfamide|mesh-list
154334702|NCT02817958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154334703|NCT02817958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334704|NCT02817958|Tubulin Modulators|tubulin modulators|mesh-ancestor
154334705|NCT02817958|Antimitotic Agents|antimitotic agents|mesh-ancestor
154334706|NCT02817958|Mitosis Modulators|mitosis modulators|mesh-ancestor
154334707|NCT02817958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334708|NCT02817958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154334709|NCT02817958|Alkylating Agents|alkylating agents|mesh-ancestor
154334710|NCT02342444|Enoxaparin|enoxaparin|mesh-list
154334711|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
154334712|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
154334713|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154334714|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154334715|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334716|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
154334717|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154334718|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
154334719|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
154334720|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
154334724|NCT01787409|Vitamin D|vitamin d|mesh-list
154334728|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334729|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154334730|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154334731|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154334732|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
154334733|NCT00541047|Leuprolide|leuprolide|mesh-list
154334734|NCT00541047|Goserelin|goserelin|mesh-list
154334735|NCT00541047|Bicalutamide|bicalutamide|mesh-list
154334736|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154334737|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
154334738|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154334739|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334740|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334741|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334742|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
154334743|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
154334744|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334745|NCT01352702|Dabigatran|dabigatran|mesh-list
154334746|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
154334747|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
154334748|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154334749|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
154334750|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334751|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334752|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
154334753|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
154334778|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
154334779|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334780|NCT02290054|Anesthetics|anesthetics|mesh-list
154334781|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334782|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334783|NCT01347944|Lenalidomide|lenalidomide|mesh-list
154334784|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
154334785|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334786|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154334787|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154334788|NCT01347944|Growth Substances|growth substances|mesh-ancestor
154334789|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
154334790|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334791|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
154334792|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
154334793|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334794|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334795|NCT01220245|Heparin|heparin|mesh-list
154334796|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
154334797|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154334798|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154334799|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334801|NCT03931135|Morphine|morphine|mesh-list
154334802|NCT03931135|Cyclizine|cyclizine|mesh-list
154334803|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334804|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
154334805|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
154334806|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154334807|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334808|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154334809|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
154334810|NCT03931135|Hormones|hormones|mesh-ancestor
154334811|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154334812|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334813|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334814|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154334815|NCT03931135|Narcotics|narcotics|mesh-ancestor
154334816|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154334817|NCT03931135|Analgesics|analgesics|mesh-ancestor
154334818|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
154334819|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154334820|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
154334821|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
154334822|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334823|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334824|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
154334825|NCT01353170|Calcium|calcium|mesh-list
154334826|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154334827|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334828|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154334829|NCT03620318|Crenolanib|crenolanib|mesh-list
154334830|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334831|NCT01125943|Bevacizumab|bevacizumab|mesh-list
154334832|NCT01125943|Nitroprusside|nitroprusside|mesh-list
154334833|NCT01125943|Acetylcholine|acetylcholine|mesh-list
154334834|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334835|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334836|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154334837|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154334838|NCT01125943|Growth Substances|growth substances|mesh-ancestor
154334870|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334871|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
154334872|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334873|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154334874|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154334875|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
154334876|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334877|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334878|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154334879|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154334880|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
154334881|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154334882|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154334883|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
154334884|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
154334885|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334886|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154334887|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154334888|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154334889|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154334890|NCT03680092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154334892|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334893|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
154334894|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
154334895|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
154334896|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334897|NCT05790070|Betaine|betaine|mesh-list
154334898|NCT05790070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154334899|NCT05790070|Lipotropic Agents|lipotropic agents|mesh-ancestor
154334900|NCT05790070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154334901|NCT05790070|Antimetabolites|antimetabolites|mesh-ancestor
154334902|NCT05790070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334903|NCT05790070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154334904|NCT05789680|Parathyroid Hormone|parathyroid hormone|mesh-list
154334905|NCT05789680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154334907|NCT05789667|Lenvatinib|lenvatinib|mesh-list
154334908|NCT05789667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334909|NCT05789667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154334910|NCT05789667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334911|NCT05789667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334912|NCT05789186|Fluoxetine|fluoxetine|mesh-list
154334913|NCT05789186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154334914|NCT05789186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154334915|NCT05789186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154334916|NCT05789186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334917|NCT05789186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154334918|NCT05789186|Serotonin Agents|serotonin agents|mesh-ancestor
154334919|NCT05789186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154334920|NCT05789186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154334921|NCT05789186|Antidepressive Agents|antidepressive agents|mesh-ancestor
154334922|NCT05789186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154334923|NCT05789186|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154334924|NCT05789186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154334925|NCT05789186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334926|NCT05789030|Prednisone|prednisone|mesh-list
154334927|NCT05789030|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154334928|NCT05789030|Betamethasone|betamethasone|mesh-list
154334929|NCT05789030|Leflunomide|leflunomide|mesh-list
154334930|NCT05789030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154334931|NCT05789030|Glucocorticoids|glucocorticoids|mesh-ancestor
154334932|NCT05789030|Hormones|hormones|mesh-ancestor
154334936|NCT05789030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334951|NCT05789017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154334952|NCT05789017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154334953|NCT05789017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154334954|NCT05789017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154334955|NCT05789017|Antitubercular Agents|antitubercular agents|mesh-ancestor
154334956|NCT05789017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154334957|NCT05789017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334958|NCT05789017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154334959|NCT05789017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154334960|NCT05789017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154334961|NCT05789017|Immunologic Factors|immunologic factors|mesh-ancestor
154334962|NCT05788991|Metronidazole|metronidazole|mesh-list
154334963|NCT05788991|Dequalinium|dequalinium|mesh-list
154334964|NCT05788991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154334965|NCT05788991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154334966|NCT05788991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154334967|NCT05788991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154334968|NCT05788991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154335008|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154335009|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154335010|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154335011|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
154335012|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335013|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154335014|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335015|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154335016|NCT05670561|Sufentanil|sufentanil|mesh-list
154335017|NCT05670561|Esketamine|esketamine|mesh-list
154335018|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154335019|NCT05670561|Narcotics|narcotics|mesh-ancestor
154335020|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154335021|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335022|NCT05670561|Analgesics|analgesics|mesh-ancestor
154335023|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
154335024|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335025|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154335027|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
154335064|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154335065|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154335066|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335067|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154335068|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154335069|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154335070|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335071|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154335072|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154335073|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154335074|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154335075|NCT05499832|Tenecteplase|tenecteplase|mesh-list
154335076|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154335077|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154335078|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335079|NCT05461456|Fexofenadine|fexofenadine|mesh-list
154335080|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154335081|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154335082|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154335083|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
154335084|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
154335085|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335086|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335087|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335107|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335108|NCT05267366|Bevacizumab|bevacizumab|mesh-list
154335109|NCT05267366|Carboplatin|carboplatin|mesh-list
154335110|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154335111|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335112|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335113|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154335114|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154335115|NCT05267366|Growth Substances|growth substances|mesh-ancestor
154335116|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335117|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
154335118|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335119|NCT05267288|Afatinib|afatinib|mesh-list
154335120|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335121|NCT05267288|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154335122|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335123|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335124|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335125|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154335126|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335127|NCT05218629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335128|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335129|NCT05191667|Paclitaxel|paclitaxel|mesh-list
154335130|NCT05191667|Carboplatin|carboplatin|mesh-list
154335131|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154335132|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335133|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
154335134|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
154335135|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154335136|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335137|NCT05112263|Cyclosporine|cyclosporine|mesh-list
154335147|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
154335148|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154335149|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154335150|NCT05112263|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154335151|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335152|NCT05104281|Osimertinib|osimertinib|mesh-list
154335153|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335154|NCT05104281|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154335155|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335156|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335157|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335158|NCT05072249|Naloxone|naloxone|mesh-list
154335159|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154335160|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335161|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
154335162|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335163|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
154335164|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154335165|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335166|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335167|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335168|NCT05040984|Mirabegron|mirabegron|mesh-list
154335169|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
154335170|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154335171|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154335172|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154335173|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
154335174|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335175|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335176|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335190|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335191|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335192|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
154335193|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335194|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154335195|NCT04974879|Osimertinib|osimertinib|mesh-list
154335196|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335197|NCT04974879|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154335198|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335199|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335200|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335201|NCT04974866|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154335202|NCT04974866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335203|NCT04974866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335204|NCT04974866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335205|NCT04933058|Acetaminophen|acetaminophen|mesh-list
154335207|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154335208|NCT04933058|Narcotics|narcotics|mesh-ancestor
154335209|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154335210|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335211|NCT04933058|Analgesics|analgesics|mesh-ancestor
154335212|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
154335213|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335214|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154335215|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154335216|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
154335217|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
154335218|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154335219|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
154335220|NCT04918810|Docetaxel|docetaxel|mesh-list
154335235|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154335236|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154335237|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154335238|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154335239|NCT04849013|Ketanserin|ketanserin|mesh-list
154335240|NCT04849013|Mescaline|mescaline|mesh-list
154335241|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154335242|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154335243|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154335244|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
154335245|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335246|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335247|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335248|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
154335249|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154335250|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154335251|NCT04808245|Atezolizumab|atezolizumab|mesh-list
154335252|NCT04808245|Imiquimod|imiquimod|mesh-list
154335253|NCT04808245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154335254|NCT04808245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335255|NCT04808245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335256|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335257|NCT04808245|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154335258|NCT04808245|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154335259|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
154335261|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154335283|NCT04646837|Carboplatin|carboplatin|mesh-list
154335284|NCT04646837|Durvalumab|durvalumab|mesh-list
154335285|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154335286|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335287|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
154335288|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
154335289|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
154335290|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335291|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335292|NCT04600167|Isoniazid|isoniazid|mesh-list
154335293|NCT04600167|Rifapentine|rifapentine|mesh-list
154335294|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
154335295|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335296|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335297|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154335298|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154335299|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
154335300|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335301|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154335302|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154335303|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
154335304|NCT04522284|Capecitabine|capecitabine|mesh-list
154335305|NCT04522284|Ibrutinib|ibrutinib|mesh-list
154335306|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154335307|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
154335308|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335309|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335310|NCT04522284|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154335311|NCT04522284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335328|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335329|NCT04400110|Amoxicillin|amoxicillin|mesh-list
154335330|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
154335331|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
154335332|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335333|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335334|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335335|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335336|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154335337|NCT04368078|Lenvatinib|lenvatinib|mesh-list
154335338|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335339|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335340|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335341|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335342|NCT04347616|Aldesleukin|aldesleukin|mesh-list
154335343|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335344|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154335345|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154335346|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
154335347|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335348|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
154335349|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154335350|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335351|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154335352|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335353|NCT04247815|Methotrexate|methotrexate|mesh-list
154335354|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154335355|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
154335356|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154335357|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335358|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154335359|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
154335360|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335361|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335362|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154335363|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335364|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154335365|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154335366|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
154335367|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154335368|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154335369|NCT04227522|Rucaparib|rucaparib|mesh-list
154335370|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154335371|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335372|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335373|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335374|NCT04211168|Lenvatinib|lenvatinib|mesh-list
154335375|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335376|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335377|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335378|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335379|NCT04196257|Paclitaxel|paclitaxel|mesh-list
154335380|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154335381|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335382|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
154335383|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
154335419|NCT04073134|Protease Inhibitors|protease inhibitors|mesh-ancestor
154335420|NCT04073134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335421|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154335422|NCT04034485|Evolocumab|evolocumab|mesh-list
154335423|NCT04034485|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154335424|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154335425|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154335426|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
154335427|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335428|NCT04034485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154335429|NCT04034485|Protease Inhibitors|protease inhibitors|mesh-ancestor
154335430|NCT04034485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335431|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154335432|NCT04010071|Axitinib|axitinib|mesh-list
154335433|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335434|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335435|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335436|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335437|NCT03988920|Sevelamer|sevelamer|mesh-list
154335438|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
154335439|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
154335440|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335441|NCT03925402|Ertapenem|ertapenem|mesh-list
154335442|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335443|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335444|NCT03892577|Immunomodulating Agents|immunomodulating agents|mesh-list
154335445|NCT03892577|Immunologic Factors|immunologic factors|mesh-ancestor
154335446|NCT03892577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335447|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
154335448|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335449|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335450|NCT03875079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154335451|NCT03875079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335452|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154335453|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
154335458|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335459|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335460|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154335461|NCT03688451|Rituximab|rituximab|mesh-list
154335462|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335463|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335464|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
154335465|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335466|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154335467|NCT03626064|Nicotine|nicotine|mesh-list
154335468|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154335469|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
154335470|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335471|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335472|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154335473|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154335474|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
154335475|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335476|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335477|NCT03570099|Naloxone|naloxone|mesh-list
154335478|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154335479|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335480|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
154335481|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335482|NCT03529396|Chloroquine|chloroquine|mesh-list
154335483|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154335484|NCT03529396|Primaquine|primaquine|mesh-list
154335485|NCT03529396|Amebicides|amebicides|mesh-ancestor
154335486|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154335487|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154335488|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335489|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
154335490|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154335500|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
154335501|NCT03436563|Atezolizumab|atezolizumab|mesh-list
154335502|NCT03436563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154335503|NCT03436563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335504|NCT03436563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335505|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335506|NCT03426254|Talazoparib|talazoparib|mesh-list
154335507|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154335508|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335509|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335510|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335511|NCT03411031|Thalidomide|thalidomide|mesh-list
154335512|NCT03411031|Dexamethasone|dexamethasone|mesh-list
154335513|NCT03411031|Lenalidomide|lenalidomide|mesh-list
154335514|NCT03411031|Elotuzumab|elotuzumab|mesh-list
154335515|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335516|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
154335517|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
154335518|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335519|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335520|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154335521|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
154335522|NCT03411031|Hormones|hormones|mesh-ancestor
154335523|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335524|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154335525|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335526|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
154335527|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154335528|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154335529|NCT03411031|Growth Substances|growth substances|mesh-ancestor
154335530|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
154335543|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335544|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154335545|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335547|NCT03289351|Piperacillin|piperacillin|mesh-list
154335548|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154335549|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154335550|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335551|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154335552|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335553|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335554|NCT03280667|Denosumab|denosumab|mesh-list
154335555|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
154335556|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335557|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335558|NCT03280667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154335559|NCT03280667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335560|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154335561|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335562|NCT03272347|Tenofovir|tenofovir|mesh-list
154335563|NCT03272347|Lamivudine|lamivudine|mesh-list
154335564|NCT03272347|Islatravir|islatravir|mesh-list
154335565|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
154335566|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335567|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154335568|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154335569|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335589|NCT03108690|Meropenem|meropenem|mesh-list
154335590|NCT03108690|Tazobactam|tazobactam|mesh-list
154335591|NCT03108690|Piperacillin|piperacillin|mesh-list
154335592|NCT03108690|Ampicillin|ampicillin|mesh-list
154335593|NCT03108690|Cefuroxime|cefuroxime|mesh-list
154335594|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154335595|NCT03108690|Lactams|lactams|mesh-list
154335596|NCT03108690|beta-Lactams|beta-lactams|mesh-list
154335597|NCT03108690|Penicillin G|penicillin g|mesh-list
154335598|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
154335599|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154335600|NCT03108690|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
154335601|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335602|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
154335603|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154335604|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335605|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335606|NCT03103152|Aspirin|aspirin|mesh-list
154335607|NCT03103152|Vitamin D|vitamin d|mesh-list
154335608|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
154335609|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
154335610|NCT03103152|Vitamins|vitamins|mesh-list
154335611|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
154335612|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335613|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154335614|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154335615|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154335616|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154335639|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335641|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154335642|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335643|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335644|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
154335645|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154335646|NCT02878785|Decitabine|decitabine|mesh-list
154335647|NCT02878785|Talazoparib|talazoparib|mesh-list
154335648|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154335649|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
154335650|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335651|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335652|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335653|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154335654|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
154335655|NCT02825576|Neostigmine|neostigmine|mesh-list
154335656|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154335657|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335658|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335659|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
154335660|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335661|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335662|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154335663|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
154335664|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335665|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154335666|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154335667|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154335668|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154335669|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154335670|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
154335681|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335683|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154335684|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154335685|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335686|NCT01917877|Dexamethasone|dexamethasone|mesh-list
154335687|NCT01917877|Bevacizumab|bevacizumab|mesh-list
154335688|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335689|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335690|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154335691|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154335692|NCT01917877|Growth Substances|growth substances|mesh-ancestor
154335693|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335694|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
154335695|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335696|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
154335697|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
154335698|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335699|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154335701|NCT01917877|Hormones|hormones|mesh-ancestor
154335702|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335703|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154335704|NCT01570296|Gefitinib|gefitinib|mesh-list
154335705|NCT01570296|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154335706|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335707|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335708|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335709|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335710|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
154335711|NCT00496873|Rituximab|rituximab|mesh-list
154335712|NCT00496873|Pentostatin|pentostatin|mesh-list
154335713|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154335714|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
154335715|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335716|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154335717|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154335718|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
154335719|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335720|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335721|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154335722|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154335723|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154335724|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335725|NCT00492778|Cisplatin|cisplatin|mesh-list
154335726|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335727|NCT03931369|Tolvaptan|tolvaptan|mesh-list
154335728|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154335729|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335730|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
154335778|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
154335779|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335780|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335781|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
154335782|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154335783|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154335784|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
154335785|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154335786|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154335787|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335788|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154335789|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
154335790|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154335791|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154335792|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
154335793|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154335794|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154335836|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154335837|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
154335838|NCT01329289|Hormones|hormones|mesh-ancestor
154335839|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335840|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154335841|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335842|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
154335843|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335844|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335845|NCT02291536|Dronabinol|dronabinol|mesh-list
154335846|NCT02291536|Cannabidiol|cannabidiol|mesh-list
154335847|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
154082161|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
154335848|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
154335849|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335850|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154335851|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154335852|NCT02291536|Analgesics|analgesics|mesh-ancestor
154335853|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
154335854|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335855|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154335856|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154335857|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154335858|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335859|NCT02291536|Hormones|hormones|mesh-ancestor
154335860|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335861|NCT01317992|Ibudilast|ibudilast|mesh-list
154335862|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154335863|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
154335880|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335881|NCT01353794|Sorafenib|sorafenib|mesh-list
154335882|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335883|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154335884|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335885|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335886|NCT01224301|Vaccines|vaccines|mesh-list
154335887|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
154335888|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335889|NCT01221025|Parecoxib|parecoxib|mesh-list
154335890|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154335891|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154335892|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335893|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335894|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154335895|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154335896|NCT01221025|Analgesics|analgesics|mesh-ancestor
154335897|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
154335936|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154335937|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
154335938|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
154335939|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154335940|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154335941|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154335942|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
154335943|NCT03927313|Hormones|hormones|mesh-ancestor
154335944|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154335945|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154335946|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154335947|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154335948|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154335949|NCT03927313|Analgesics|analgesics|mesh-ancestor
154335950|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
154335951|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154335952|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154335953|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154335954|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154335955|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154335956|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154335957|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154335958|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
154335959|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154335972|NCT01224457|Phenobarbital|phenobarbital|mesh-list
154335983|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154335984|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154335985|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154335986|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
154335987|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154335988|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
154335989|NCT03133312|Povidone|povidone|mesh-list
154335990|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154335991|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335992|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
154335993|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
154335994|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
154335995|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
154335996|NCT01318148|Caspofungin|caspofungin|mesh-list
154335997|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
154335998|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154335999|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336000|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336001|NCT01354262|Vitamin D|vitamin d|mesh-list
154336002|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
154336003|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
154336004|NCT01354262|Vitamins|vitamins|mesh-list
154336005|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
154336006|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336007|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154336008|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154336009|NCT01343498|Dactolisib|dactolisib|mesh-list
154336010|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336011|NCT01221337|Heparin|heparin|mesh-list
154336012|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
154336013|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154336014|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154336015|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336016|NCT01354418|Phenylephrine|phenylephrine|mesh-list
154336017|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
154336018|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154336019|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
154336020|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
154336021|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336022|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336023|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
154336024|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154336025|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
154336026|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
154336027|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154336028|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154336029|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154336030|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336031|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336032|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336033|NCT01354418|Protective Agents|protective agents|mesh-ancestor
154336034|NCT02818868|Apixaban|apixaban|mesh-list
154336035|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154336036|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
154336037|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154336038|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
154336039|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336040|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336041|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
154336042|NCT01224535|Micronutrients|micronutrients|mesh-list
154336043|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336044|NCT02289274|Aceclofenac|aceclofenac|mesh-list
154336045|NCT02289274|Eperisone|eperisone|mesh-list
154336046|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154336047|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154336048|NCT02289274|Analgesics|analgesics|mesh-ancestor
154336049|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
154336050|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336051|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336052|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154336053|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154336054|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
154336055|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154336061|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
154336062|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
154336063|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
154336064|NCT01224613|Vaccines|vaccines|mesh-list
154336065|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
154336066|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336067|NCT03930433|Nebivolol|nebivolol|mesh-list
154336068|NCT03930433|Diltiazem|diltiazem|mesh-list
154336069|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154336070|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
154336071|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154336072|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154336073|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154336074|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336075|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336076|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336077|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336078|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154336079|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336080|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154336081|NCT01224769|Rituximab|rituximab|mesh-list
154336082|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154336083|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336112|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336113|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336114|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154336115|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154336116|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154336117|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
154336118|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336119|NCT02289586|Midazolam|midazolam|mesh-list
154336120|NCT02289586|Fentanyl|fentanyl|mesh-list
154336121|NCT02289586|Remifentanil|remifentanil|mesh-list
154336122|NCT02289586|Dezocine|dezocine|mesh-list
154336123|NCT02289586|Propofol|propofol|mesh-list
154336124|NCT02289586|Rocuronium|rocuronium|mesh-list
154336125|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
154336126|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336127|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336128|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154336129|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154336130|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
154336131|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154336132|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154336133|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154336135|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
154336166|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336167|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
154336168|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336169|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336170|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336171|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154336172|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154336173|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336174|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154336175|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
154336176|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154336177|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
154336178|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336179|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154336180|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154336181|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
154336182|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336183|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336184|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154336185|NCT01130311|Vitamin D|vitamin d|mesh-list
154336186|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
154336187|NCT01130311|Vitamins|vitamins|mesh-ancestor
154336188|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
154336192|NCT03926377|Clobetasol|clobetasol|mesh-list
154336216|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336217|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154336218|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336219|NCT02298166|Cytarabine|cytarabine|mesh-list
154336220|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
154336221|NCT02298166|Crenolanib|crenolanib|mesh-list
154027424|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336222|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154336223|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
154336224|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336225|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336226|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
154336227|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336228|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154336229|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
154336230|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336232|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
154336233|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336234|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154336235|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154336236|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336237|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
154336238|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154336239|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336240|NCT01221883|Diazepam|diazepam|mesh-list
154336241|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154336242|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
154336243|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
154336244|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
154336245|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336246|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336247|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154336248|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154336255|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154336256|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
154336257|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
154336258|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
154336259|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
154336260|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336261|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336262|NCT02294656|Triamcinolone|triamcinolone|mesh-list
154336263|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154336264|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154336265|NCT02294656|Ranibizumab|ranibizumab|mesh-list
154336266|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154336267|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154336268|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154336269|NCT02294656|Growth Substances|growth substances|mesh-ancestor
154336270|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336271|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
154336272|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336273|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154336274|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
154336275|NCT02294656|Hormones|hormones|mesh-ancestor
154336276|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336277|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154336278|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
154336279|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336280|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336281|NCT01225237|Ramosetron|ramosetron|mesh-list
154336282|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
154336283|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
154336284|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336285|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336286|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154336287|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154336288|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
154336289|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336291|NCT03517930|Loratadine|loratadine|mesh-list
154336295|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
154336296|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154336297|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154336298|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154336299|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
154336300|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
154336301|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336302|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336303|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336304|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154336305|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
154336306|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336307|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154336308|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154336309|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
154336310|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154336311|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154336312|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
154336313|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336314|NCT01130467|Methylphenidate|methylphenidate|mesh-list
154336315|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154336316|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154336317|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336318|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154336319|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154336320|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336321|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336322|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
154336323|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336326|NCT02295046|Amlodipine|amlodipine|mesh-list
154336336|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154336337|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336338|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154336339|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154336340|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336341|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
154336342|NCT03517618|Leucovorin|leucovorin|mesh-list
154336343|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336344|NCT03517618|Antidotes|antidotes|mesh-ancestor
154336345|NCT03517618|Protective Agents|protective agents|mesh-ancestor
154336346|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
154336347|NCT03517618|Vitamins|vitamins|mesh-ancestor
154336348|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
154336349|NCT02295124|Oxycodone|oxycodone|mesh-list
154336350|NCT02295124|Hydromorphone|hydromorphone|mesh-list
154336351|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154336352|NCT02295124|Narcotics|narcotics|mesh-ancestor
154336353|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336354|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336355|NCT02295124|Analgesics|analgesics|mesh-ancestor
154336356|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
154336392|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154336393|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336394|NCT06142708|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154336395|NCT06142708|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154336396|NCT06142708|Hormones|hormones|mesh-ancestor
154336397|NCT06142708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336398|NCT06142708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336399|NCT06142708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154336400|NCT06142617|Pembrolizumab|pembrolizumab|mesh-list
154336401|NCT06142617|Pemetrexed|pemetrexed|mesh-list
154336402|NCT06142617|Osimertinib|osimertinib|mesh-list
154336403|NCT06142617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336404|NCT06142617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336405|NCT06142617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154336406|NCT06142617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336407|NCT06142617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336408|NCT06142617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154336409|NCT06142617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154336410|NCT06142617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154336411|NCT06142617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154336412|NCT06142604|Flecainide|flecainide|mesh-list
154336413|NCT06142604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154336414|NCT06142604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154336415|NCT06142604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154336416|NCT06142604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336417|NCT06142604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336418|NCT06142591|Oxycodone|oxycodone|mesh-list
154336419|NCT06142591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154336420|NCT06142591|Narcotics|narcotics|mesh-ancestor
154336421|NCT06142591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336422|NCT06142591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336423|NCT06142591|Analgesics|analgesics|mesh-ancestor
154336424|NCT06142591|Sensory System Agents|sensory system agents|mesh-ancestor
154336431|NCT06142474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336432|NCT06142318|Pirfenidone|pirfenidone|mesh-list
154336433|NCT06142318|Analgesics|analgesics|mesh-ancestor
154336434|NCT06142318|Sensory System Agents|sensory system agents|mesh-ancestor
154336435|NCT06142318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336436|NCT06142318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336437|NCT06142318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154336438|NCT06142318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154336439|NCT06142318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154336440|NCT06142318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154336441|NCT06142318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336442|NCT06142136|Vitamin D|vitamin d|mesh-list
154336443|NCT06142136|Ergocalciferols|ergocalciferols|mesh-list
154336444|NCT06142136|Cholecalciferol|cholecalciferol|mesh-list
154336445|NCT06142136|Vitamins|vitamins|mesh-list
154336446|NCT06142136|Micronutrients|micronutrients|mesh-ancestor
154336447|NCT06142136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336448|NCT06142136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154336449|NCT06142136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154336450|NCT06141447|Oxytocin|oxytocin|mesh-list
154336451|NCT06141447|Oxytocics|oxytocics|mesh-ancestor
154336452|NCT06141447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154336453|NCT06141447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336454|NCT06141330|Azithromycin|azithromycin|mesh-list
154336455|NCT06141330|Adapalene|adapalene|mesh-list
154336456|NCT06141330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154336457|NCT06141330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336458|NCT06141330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154336460|NCT06141330|Analgesics|analgesics|mesh-ancestor
154336476|NCT06141265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336478|NCT06141226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336479|NCT06141226|Tubulin Modulators|tubulin modulators|mesh-ancestor
154336480|NCT06141226|Antimitotic Agents|antimitotic agents|mesh-ancestor
154336481|NCT06141226|Mitosis Modulators|mitosis modulators|mesh-ancestor
154336482|NCT06141226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336483|NCT06141200|Captopril|captopril|mesh-list
154336484|NCT06141200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154336485|NCT06141200|Protease Inhibitors|protease inhibitors|mesh-ancestor
154336486|NCT06141200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336487|NCT06141200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336488|NCT06141200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154336489|NCT06141109|Cytarabine|cytarabine|mesh-list
154336490|NCT06141109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154336491|NCT06141109|Antimetabolites|antimetabolites|mesh-ancestor
154336492|NCT06141109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336493|NCT06141109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336494|NCT06141109|Antiviral Agents|antiviral agents|mesh-ancestor
154336495|NCT06141109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336496|NCT06141109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154336497|NCT06141109|Immunologic Factors|immunologic factors|mesh-ancestor
154336498|NCT06141109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336499|NCT06141018|Hyaluronic Acid|hyaluronic acid|mesh-list
154336500|NCT06141018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154336501|NCT06141018|Immunologic Factors|immunologic factors|mesh-ancestor
154336502|NCT06141018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336505|NCT06140953|Niacin|niacin|mesh-list
154336524|NCT06140914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154336525|NCT06140914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336526|NCT06140420|Naltrexone|naltrexone|mesh-list
154336527|NCT06140420|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154336528|NCT06140420|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154336529|NCT06140420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336530|NCT06140420|Sensory System Agents|sensory system agents|mesh-ancestor
154336531|NCT06140420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336532|NCT06139029|Beclomethasone|beclomethasone|mesh-list
154336533|NCT06139029|Albuterol|albuterol|mesh-list
154336534|NCT06139029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154336535|NCT06139029|Autonomic Agents|autonomic agents|mesh-ancestor
154336536|NCT06139029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336537|NCT06139029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336538|NCT06139029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154336539|NCT06139029|Respiratory System Agents|respiratory system agents|mesh-ancestor
154336540|NCT06139029|Tocolytic Agents|tocolytic agents|mesh-ancestor
154336541|NCT06139029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154336542|NCT06139029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154336543|NCT06139029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154336544|NCT06139029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154336545|NCT06139029|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336546|NCT06139029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336574|NCT06134037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336575|NCT06134037|Protective Agents|protective agents|mesh-ancestor
154336576|NCT06112262|Heparin|heparin|mesh-list
154336577|NCT06112262|Hirudins|hirudins|mesh-list
154336578|NCT06112262|Anticoagulants|anticoagulants|mesh-ancestor
154336579|NCT06112262|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154336580|NCT06112262|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154336581|NCT06112262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336582|NCT06112262|Antithrombins|antithrombins|mesh-ancestor
154336583|NCT06112262|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154336584|NCT06112262|Protease Inhibitors|protease inhibitors|mesh-ancestor
154336585|NCT06112262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336586|NCT06098196|Aminophylline|aminophylline|mesh-list
154336587|NCT06098196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154336588|NCT06098196|Autonomic Agents|autonomic agents|mesh-ancestor
154336589|NCT06098196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336590|NCT06098196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336591|NCT06098196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154336592|NCT06098196|Respiratory System Agents|respiratory system agents|mesh-ancestor
154336593|NCT06098196|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154336594|NCT06098196|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154336595|NCT06098196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336596|NCT06098196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336597|NCT06098196|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154336598|NCT06098196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154336599|NCT06098196|Purinergic Agents|purinergic agents|mesh-ancestor
154336600|NCT06098196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336601|NCT06098196|Protective Agents|protective agents|mesh-ancestor
154336602|NCT06045026|Fluorides|fluorides|mesh-list
154336603|NCT06045026|Tin Fluorides|tin fluorides|mesh-list
154336604|NCT06045026|Cariostatic Agents|cariostatic agents|mesh-ancestor
154336605|NCT06045026|Protective Agents|protective agents|mesh-ancestor
154336606|NCT06045026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336607|NCT06030258|Carboplatin|carboplatin|mesh-list
154336616|NCT06030258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336617|NCT06017895|Doxepin|doxepin|mesh-list
154336618|NCT06017895|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154336619|NCT06017895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154336620|NCT06017895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336621|NCT06017895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336622|NCT06017895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154336623|NCT06017895|Antidepressive Agents|antidepressive agents|mesh-ancestor
154336624|NCT06017895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336625|NCT06017895|Histamine Antagonists|histamine antagonists|mesh-ancestor
154336626|NCT06017895|Histamine Agents|histamine agents|mesh-ancestor
154336627|NCT06017895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336628|NCT06017895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336629|NCT05979818|Propranolol|propranolol|mesh-list
154336630|NCT05979818|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154336631|NCT05979818|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154336632|NCT05979818|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336633|NCT05979818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336634|NCT05979818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336635|NCT05979818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336636|NCT05979818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154336637|NCT05979818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154336638|NCT05979818|Vasodilator Agents|vasodilator agents|mesh-ancestor
154336639|NCT05918198|Venetoclax|venetoclax|mesh-list
154336640|NCT05918198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336665|NCT05883150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336667|NCT05880862|Trospium chloride|trospium chloride|mesh-list
154336668|NCT05880862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154336669|NCT05880862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154336670|NCT05880862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154336671|NCT05880862|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336672|NCT05880862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336673|NCT05880862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083012|NCT00578643|Busulfan|busulfan|mesh-list
154336674|NCT05880862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336675|NCT05880862|Urological Agents|urological agents|mesh-ancestor
154336676|NCT05880862|Parasympatholytics|parasympatholytics|mesh-ancestor
154336677|NCT05880862|Autonomic Agents|autonomic agents|mesh-ancestor
154336678|NCT05880862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336679|NCT05880862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154336680|NCT05880862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154336681|NCT05880862|Cholinergic Agents|cholinergic agents|mesh-ancestor
154336682|NCT05851677|Disitamab vedotin|disitamab vedotin|mesh-list
154336683|NCT05851677|Immunoconjugates|immunoconjugates|mesh-ancestor
154336684|NCT05851677|Immunologic Factors|immunologic factors|mesh-ancestor
154336685|NCT05851677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336687|NCT05850091|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154336688|NCT05850091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154336689|NCT05850091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154336690|NCT05850091|Antimetabolites|antimetabolites|mesh-ancestor
154336691|NCT05850091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336692|NCT05850091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154336693|NCT05850091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154336694|NCT05850091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336695|NCT05850091|Gout Suppressants|gout suppressants|mesh-ancestor
154336696|NCT05850091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154336697|NCT05850091|Tubulin Modulators|tubulin modulators|mesh-ancestor
154336698|NCT05850091|Antimitotic Agents|antimitotic agents|mesh-ancestor
154336699|NCT05850091|Mitosis Modulators|mitosis modulators|mesh-ancestor
154336700|NCT05850091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336702|NCT05825924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154336703|NCT05825924|Autonomic Agents|autonomic agents|mesh-ancestor
154336704|NCT05825924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336705|NCT05825924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336706|NCT05825924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154336707|NCT05825924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154336708|NCT05825924|Cholinergic Agents|cholinergic agents|mesh-ancestor
154336709|NCT05825924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336710|NCT05825924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336711|NCT05809271|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154336712|NCT05809271|Hallucinogens|hallucinogens|mesh-ancestor
154336713|NCT05809271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336714|NCT05809271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336715|NCT05809271|Serotonin Agents|serotonin agents|mesh-ancestor
154336716|NCT05809271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336717|NCT05809271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336718|NCT05809271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154336719|NCT05809271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154336720|NCT05809271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154336721|NCT05809271|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336722|NCT05790720|Propofol|propofol|mesh-list
154336723|NCT05790720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154336724|NCT05790720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336725|NCT05790720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336726|NCT05790720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154336727|NCT05790720|Anesthetics, General|anesthetics, general|mesh-ancestor
154336728|NCT05790720|Anesthetics|anesthetics|mesh-ancestor
154336729|NCT05734495|Venetoclax|venetoclax|mesh-list
154336730|NCT05734495|Pirtobrutinib|pirtobrutinib|mesh-list
154336731|NCT05734495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336732|NCT05734495|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154336733|NCT05734495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154336734|NCT05734495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336735|NCT05734495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336736|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154336739|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336740|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154336741|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
154336742|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336743|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336744|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154336745|NCT05685615|Polymyxins|polymyxins|mesh-list
154336746|NCT05685615|Polymyxin B|polymyxin b|mesh-list
154336747|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154336748|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336749|NCT05684718|Itraconazole|itraconazole|mesh-list
154336750|NCT05684718|Rifabutin|rifabutin|mesh-list
154336751|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
154336752|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336753|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154336754|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154336755|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336756|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336757|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154336758|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
154336759|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336760|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336761|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154336762|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154336763|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154336764|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
154336765|NCT05684705|Rifabutin|rifabutin|mesh-list
154336766|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154336767|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336783|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154336784|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336785|NCT05553613|Clopidogrel|clopidogrel|mesh-list
154336786|NCT05553613|Ticagrelor|ticagrelor|mesh-list
154336787|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154336788|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154336789|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154336790|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154336791|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
154336792|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336793|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336794|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336795|NCT05550662|Xenon|xenon|mesh-list
154336796|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154336797|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
154336798|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
154336801|NCT05537090|Midazolam|midazolam|mesh-list
154336841|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154336842|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
154336843|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336844|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336845|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154336846|NCT05461573|Diuretics|diuretics|mesh-ancestor
154336847|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
154336848|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154336849|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154336850|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
154336851|NCT05453916|Rifaximin|rifaximin|mesh-list
154336852|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
154336853|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154336854|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154336855|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154336856|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154336857|NCT05443555|Gabapentin|gabapentin|mesh-list
154336858|NCT05443555|Analgesics|analgesics|mesh-ancestor
154336859|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
154336860|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336861|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336862|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
154336863|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154336864|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154336865|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336866|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154336867|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154336868|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154336869|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336870|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336871|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
154336872|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154336873|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
154336883|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154336884|NCT05298761|Lidocaine|lidocaine|mesh-list
154336885|NCT05298761|Nalbuphine|nalbuphine|mesh-list
154336886|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154336887|NCT05298761|Narcotics|narcotics|mesh-ancestor
154336888|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154336889|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336890|NCT05298761|Analgesics|analgesics|mesh-ancestor
154336891|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
154336892|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336893|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
154336894|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
154336895|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154336896|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154336897|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154336898|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154083216|NCT00740792|Azelastine|azelastine|mesh-list
154336899|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336900|NCT05219435|Nivolumab|nivolumab|mesh-list
154336901|NCT05219435|Ipilimumab|ipilimumab|mesh-list
154336902|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336903|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336904|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154336905|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336906|NCT05211635|Vitamin D|vitamin d|mesh-list
154336907|NCT05211635|Vitamins|vitamins|mesh-ancestor
154336908|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
154336909|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336910|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154336911|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154336912|NCT05173597|Hormones|hormones|mesh-ancestor
154336913|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154336922|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
154336923|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336924|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336925|NCT05119296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154336926|NCT05119296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336927|NCT05065554|Rituximab|rituximab|mesh-list
154336928|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
154336929|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336930|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336931|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
154336932|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336933|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154336934|NCT05065554|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154336935|NCT05065554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154336936|NCT05065554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336937|NCT05065554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336938|NCT05061992|Lactulose|lactulose|mesh-list
154336939|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154336940|NCT05058417|Empagliflozin|empagliflozin|mesh-list
153417514|NCT02194062|Xhance|xhance|mesh-list
154336941|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154336942|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336943|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154336944|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336945|NCT05030623|Tadalafil|tadalafil|mesh-list
154336946|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
154336947|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154336948|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154336949|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154336950|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336951|NCT05030623|Urological Agents|urological agents|mesh-ancestor
154336952|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154336962|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154336963|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154336964|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336965|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336966|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
154336967|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
154336968|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154336969|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154336970|NCT05009082|Paclitaxel|paclitaxel|mesh-list
154083292|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
154336971|NCT05009082|Bevacizumab|bevacizumab|mesh-list
154336972|NCT05009082|Carboplatin|carboplatin|mesh-list
154336973|NCT05009082|Niraparib|niraparib|mesh-list
154336974|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154336975|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154336976|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
154336977|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
154336978|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
154336979|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154336980|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154336981|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154336982|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154336983|NCT05009082|Growth Substances|growth substances|mesh-ancestor
154336984|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154336985|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
154336988|NCT05000710|Durvalumab|durvalumab|mesh-list
154337011|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337012|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154337013|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154337015|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337016|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337017|NCT04726280|Ropivacaine|ropivacaine|mesh-list
154337018|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154337019|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154337020|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
154337021|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337022|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337023|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
154337024|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337025|NCT04677972|Ebselen|ebselen|mesh-list
154337026|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154337027|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154337028|NCT04677972|Analgesics|analgesics|mesh-ancestor
154337029|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
154337030|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337031|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337032|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337033|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337034|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154337035|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154337042|NCT04634877|Paclitaxel|paclitaxel|mesh-list
154337060|NCT04555603|Axitinib|axitinib|mesh-list
154337061|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337062|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337063|NCT04555603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154337064|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337065|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154337066|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337067|NCT04519645|Lacosamide|lacosamide|mesh-list
154337068|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
154337069|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154337070|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154337071|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154337072|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337073|NCT04491383|Tocovid|tocovid|mesh-list
154337074|NCT04491383|Vitamins|vitamins|mesh-ancestor
154337075|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
154337076|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337077|NCT04488315|Dexamethasone|dexamethasone|mesh-list
154337078|NCT04488315|Ropivacaine|ropivacaine|mesh-list
154337079|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337080|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
154337081|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
154337086|NCT04488315|Hormones|hormones|mesh-ancestor
154337112|NCT04429503|Growth Substances|growth substances|mesh-ancestor
154337113|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337114|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
154337115|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337116|NCT04385277|Vitamin A|vitamin a|mesh-list
154337117|NCT04385277|Irinotecan|irinotecan|mesh-list
154337118|NCT04385277|Temozolomide|temozolomide|mesh-list
154337119|NCT04385277|Tretinoin|tretinoin|mesh-list
154337120|NCT04385277|Dinutuximab|dinutuximab|mesh-list
154337121|NCT04385277|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154337122|NCT04385277|Isotretinoin|isotretinoin|mesh-list
154083455|NCT00722475|Antibodies|antibodies|mesh-list
154337124|NCT04385277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154337125|NCT04385277|Vitamins|vitamins|mesh-ancestor
154337126|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
154337127|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337128|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154337129|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154337130|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337131|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337132|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337133|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337134|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
154337135|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
154337136|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
154337137|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
154337138|NCT04385277|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154337139|NCT04379011|Brivaracetam|brivaracetam|mesh-list
154337140|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
154337141|NCT04342715|Paromomycin|paromomycin|mesh-list
154337142|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154337160|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337161|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154337162|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337163|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154337164|NCT04205266|Hematinics|hematinics|mesh-ancestor
154337165|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154337166|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154337167|NCT04103645|Vactosertib|vactosertib|mesh-list
154337168|NCT04103645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154337169|NCT04103645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337170|NCT04103645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337171|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154337172|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337173|NCT04028479|Immunomodulating Agents|immunomodulating agents|mesh-list
154337174|NCT04028479|Immunologic Factors|immunologic factors|mesh-ancestor
154337175|NCT04028479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337176|NCT03944902|Niraparib|niraparib|mesh-list
154337177|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154337178|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337179|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337180|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337181|NCT03917186|Sevoflurane|sevoflurane|mesh-list
154337182|NCT03917186|Desflurane|desflurane|mesh-list
154337183|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154337184|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154337185|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
154337186|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
154337187|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337188|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337189|NCT03916419|Paclitaxel|paclitaxel|mesh-list
154337190|NCT03916419|Carboplatin|carboplatin|mesh-list
154337191|NCT03916419|Durvalumab|durvalumab|mesh-list
154337192|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154337193|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337194|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
154337195|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
154337196|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
154337197|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337198|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337200|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
154337201|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154337202|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154337203|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337204|NCT03861299|Anesthetics|anesthetics|mesh-list
154337205|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337206|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337207|NCT03825380|Bimatoprost|bimatoprost|mesh-list
154337208|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154337209|NCT03759288|Adalimumab|adalimumab|mesh-list
154337210|NCT03759288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154337211|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337212|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337213|NCT03679546|Infliximab|infliximab|mesh-list
154337214|NCT03679546|Vedolizumab|vedolizumab|mesh-list
154337215|NCT03679546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154337216|NCT03679546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337217|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
154337218|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154337219|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337220|NCT03653247|Plerixafor|plerixafor|mesh-list
154337221|NCT03653247|Busulfan|busulfan|mesh-list
154337222|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
154337223|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337224|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337225|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
154337226|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337243|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337244|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154337245|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154337246|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154337247|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337248|NCT03567434|Ethanol|ethanol|mesh-list
154337249|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154337250|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337251|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337252|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337253|NCT03538938|Nicotine|nicotine|mesh-list
154337254|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154337255|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
154337256|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337257|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337258|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154337259|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154337260|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
154337261|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337262|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337263|NCT03481998|Letrozole|letrozole|mesh-list
154337264|NCT03481998|Fulvestrant|fulvestrant|mesh-list
154337265|NCT03481998|Anastrozole|anastrozole|mesh-list
154337266|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337267|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154337268|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154337269|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337271|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154337288|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154337289|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337290|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337291|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
154337292|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337293|NCT03196180|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154337294|NCT03196180|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154337295|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154337296|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
154337297|NCT03174197|Temozolomide|temozolomide|mesh-list
154337298|NCT03174197|Atezolizumab|atezolizumab|mesh-list
154337299|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154337300|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337301|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
154337302|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337303|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337304|NCT03174197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154337305|NCT03174197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337306|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
154337307|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337308|NCT03164980|Trabectedin|trabectedin|mesh-list
154337309|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337310|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
154337311|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337334|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337335|NCT02937571|Dexamethasone|dexamethasone|mesh-list
154337336|NCT02937571|Lenalidomide|lenalidomide|mesh-list
154337337|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337338|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
154337339|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
154337340|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337341|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337342|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154337343|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
154083671|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
154337345|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337346|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337395|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337396|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154337397|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154337398|NCT02739035|Analgesics|analgesics|mesh-ancestor
154337399|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
154337400|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337401|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154337402|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154337403|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337404|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337405|NCT02657434|Carboplatin|carboplatin|mesh-list
154337406|NCT02657434|Pemetrexed|pemetrexed|mesh-list
154337407|NCT02657434|Atezolizumab|atezolizumab|mesh-list
154337408|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337409|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337410|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337411|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154337412|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154337450|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154337451|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
154337452|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337453|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337454|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337455|NCT02390284|Timolol|timolol|mesh-list
154337456|NCT02390284|Bimatoprost|bimatoprost|mesh-list
154337457|NCT02390284|Travoprost|travoprost|mesh-list
154337458|NCT02390284|Dorzolamide|dorzolamide|mesh-list
154337459|NCT02390284|Acetazolamide|acetazolamide|mesh-list
154337460|NCT02390284|Methazolamide|methazolamide|mesh-list
154337461|NCT02390284|Latanoprost|latanoprost|mesh-list
154337462|NCT02390284|Brinzolamide|brinzolamide|mesh-list
154337463|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154337464|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154337465|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
154337466|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337467|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337468|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337469|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154337470|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154337471|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154337472|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154337473|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
154337474|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154337475|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337476|NCT02390284|Diuretics|diuretics|mesh-ancestor
154337477|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
154337500|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337501|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337503|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154337504|NCT01473628|Antibodies|antibodies|mesh-list
154337505|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
154337506|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154337507|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
154337508|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337509|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337510|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337511|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
154337512|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
154337513|NCT01409200|Axitinib|axitinib|mesh-list
154337514|NCT01409200|Hormones|hormones|mesh-list
154337515|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154337516|NCT01409200|Androgens|androgens|mesh-list
154337517|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
154337518|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337519|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337520|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
154337521|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337522|NCT01409200|Protective Agents|protective agents|mesh-ancestor
154337523|NCT01409200|Vitamins|vitamins|mesh-ancestor
154337524|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
154337525|NCT01409200|Estrogens|estrogens|mesh-ancestor
154337526|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337527|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337528|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
154337529|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154337530|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337531|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
154337532|NCT01193842|Prednisone|prednisone|mesh-list
154337533|NCT01193842|Cortisone|cortisone|mesh-list
154337534|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
154337535|NCT01193842|Rituximab|rituximab|mesh-list
154337536|NCT01193842|Doxorubicin|doxorubicin|mesh-list
154337537|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154337543|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154337544|NCT01193842|Antibodies|antibodies|mesh-list
154337545|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
154337546|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154337547|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337548|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
154337549|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337550|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337551|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154337552|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
154337553|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337554|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337555|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154337556|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154337557|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154337558|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154337559|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337560|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337561|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
154337562|NCT01193842|Hormones|hormones|mesh-ancestor
154337563|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337564|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337594|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337595|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
154337596|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154337597|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154337598|NCT00098475|Growth Substances|growth substances|mesh-ancestor
154337599|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
154337600|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337601|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
154337602|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154337603|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337604|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154337606|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154337607|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337608|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
154337609|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154337610|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154337611|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154337612|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154337613|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337614|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
154337615|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337616|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337617|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154337618|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337620|NCT01131247|Ofatumumab|ofatumumab|mesh-list
154337642|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154337643|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337644|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337645|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
154337646|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337647|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154337648|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154337649|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154337650|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337651|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154337652|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154337653|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
154337654|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
154337655|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154337656|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154337657|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337658|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154337659|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154337660|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154337661|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
154337662|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154337663|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154337664|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154337665|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154337666|NCT01228357|Analgesics|analgesics|mesh-ancestor
154337667|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
154337668|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337669|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154337670|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154337671|NCT01130701|Capecitabine|capecitabine|mesh-list
154337672|NCT01130701|Panitumumab|panitumumab|mesh-list
154337673|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154337674|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
154337675|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516874|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154337676|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337677|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337679|NCT02292550|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154337680|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154337681|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337682|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337683|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337684|NCT03925285|Bevacizumab|bevacizumab|mesh-list
154337685|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337686|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337687|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154337688|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154337689|NCT03925285|Growth Substances|growth substances|mesh-ancestor
154337690|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337691|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
154337692|NCT04464694|Ranibizumab|ranibizumab|mesh-list
154337693|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154337694|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154337695|NCT04464694|Growth Substances|growth substances|mesh-ancestor
154337696|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337697|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
154337698|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337699|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154337700|NCT01130779|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154337701|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154337702|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337703|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337704|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337705|NCT03519724|Neostigmine|neostigmine|mesh-list
154337706|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154337716|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154337717|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154337718|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337719|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
154084043|NCT04080336|Misoprostol|misoprostol|mesh-list
154337720|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337721|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337722|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
154337723|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154337724|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337725|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154337726|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
154337727|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154337728|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337729|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337730|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337731|NCT01132027|Tacrolimus|tacrolimus|mesh-list
154337732|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337733|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
154337734|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337735|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154337736|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337737|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337738|NCT03136484|Semaglutide|semaglutide|mesh-list
154337739|NCT03136484|Canagliflozin|canagliflozin|mesh-list
154337740|NCT03136484|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154337741|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154337742|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337743|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154337744|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337745|NCT01132183|Valproic Acid|valproic acid|mesh-list
154337746|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
154337754|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337755|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154337756|NCT03923881|Cetuximab|cetuximab|mesh-list
154337757|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337758|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337759|NCT02295748|Deflazacort|deflazacort|mesh-list
154337760|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337761|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154337762|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
154337763|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337764|NCT03923803|Calcitonin|calcitonin|mesh-list
154337765|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
154337766|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154337767|NCT03923803|Katacalcin|katacalcin|mesh-list
154337768|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154337769|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337770|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154337771|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
154337772|NCT02295826|Aspirin|aspirin|mesh-list
154337773|NCT02295826|Dabigatran|dabigatran|mesh-list
154337774|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154337775|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154337776|NCT02295826|Analgesics|analgesics|mesh-ancestor
154337777|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
154337778|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337779|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337780|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337781|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154337782|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154337783|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154337784|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337785|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154337786|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154337795|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337796|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
154337797|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337798|NCT03519022|Cocaine|cocaine|mesh-list
154337799|NCT03519022|Methylphenidate|methylphenidate|mesh-list
154337800|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154337801|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337802|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154337803|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154337804|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154337805|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337806|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
154337807|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337808|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
154337809|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
154337810|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337811|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
154337812|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337813|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154337814|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154337815|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154337816|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337817|NCT03516526|Natalizumab|natalizumab|mesh-list
154337820|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
154337842|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154337843|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
154337844|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154337845|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154337846|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337847|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337848|NCT01318460|Protective Agents|protective agents|mesh-ancestor
154337849|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337850|NCT02299726|Spironolactone|spironolactone|mesh-list
154337851|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154337852|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
154337853|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337854|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337855|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154337856|NCT02299726|Diuretics|diuretics|mesh-ancestor
154337857|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
154337858|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154337859|NCT01354886|Hormones|hormones|mesh-ancestor
154337860|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337861|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337862|NCT02299882|Vancomycin|vancomycin|mesh-list
154337863|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154337864|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337865|NCT01355120|Ipilimumab|ipilimumab|mesh-list
154027426|NCT02869633|Ibrutinib|ibrutinib|mesh-list
154337866|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154337867|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337868|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154337869|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337870|NCT02300038|Lidocaine|lidocaine|mesh-list
154337871|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
154337881|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337882|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
154337883|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154337884|NCT01355198|Glycine|glycine|mesh-list
154337885|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
154337886|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337887|NCT01355198|Expectorants|expectorants|mesh-ancestor
154337888|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
154337889|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154337890|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
154337891|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337892|NCT01355198|Protective Agents|protective agents|mesh-ancestor
154337893|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337894|NCT01355198|Antidotes|antidotes|mesh-ancestor
154337895|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
154337896|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337897|NCT01355276|Domperidone|domperidone|mesh-list
154337898|NCT01355276|Cinitapride|cinitapride|mesh-list
154337899|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
154337900|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
154337901|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337902|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337903|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154337904|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154337905|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
154337906|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337908|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154337930|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
154337931|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337932|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337933|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337934|NCT01349270|Prednisone|prednisone|mesh-list
154337935|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
154337936|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154337937|NCT01349270|Antibodies|antibodies|mesh-list
154337938|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154337939|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
154337940|NCT01349270|Hormones|hormones|mesh-ancestor
154337941|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154337942|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337943|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154337944|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154337945|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
154337946|NCT01132417|Tigecycline|tigecycline|mesh-list
154337947|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154337948|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337949|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154337950|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337951|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337952|NCT02300194|Morphine|morphine|mesh-list
154337953|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154337954|NCT02300194|Narcotics|narcotics|mesh-ancestor
154337955|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154337956|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337957|NCT02300194|Analgesics|analgesics|mesh-ancestor
154337958|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
154337959|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154337960|NCT01225705|Ritonavir|ritonavir|mesh-list
154337961|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154337962|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
154337963|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154337965|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
154337969|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154337970|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
154337971|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154337972|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154337973|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154337974|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154337975|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154337976|NCT01128985|Canagliflozin|canagliflozin|mesh-list
154337977|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154337978|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337979|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154337980|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154337986|NCT03512860|Valproic Acid|valproic acid|mesh-list
154337987|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
154337988|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154337989|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154337990|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
154337991|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154337992|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338022|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154338023|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338024|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
154338025|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338026|NCT03518320|Gemcitabine|gemcitabine|mesh-list
154338027|NCT03518320|Nivolumab|nivolumab|mesh-list
154338028|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154338029|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
154338030|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338031|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338032|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154338033|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154338034|NCT01134289|Bupivacaine|bupivacaine|mesh-list
154338035|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
154338036|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
154338037|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
154338038|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338039|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338040|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
154338041|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338042|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154338043|NCT02300350|Digoxin|digoxin|mesh-list
154338044|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154338045|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154338046|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338047|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338052|NCT01349348|Tolvaptan|tolvaptan|mesh-list
154338066|NCT02296996|Dabrafenib|dabrafenib|mesh-list
154338067|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338068|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154338069|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338070|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338071|NCT01132729|Valacyclovir|valacyclovir|mesh-list
154338072|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
154338073|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338074|NCT02294110|Anesthetics|anesthetics|mesh-list
154338075|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338076|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338077|NCT03512548|Itraconazole|itraconazole|mesh-list
154338078|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
154338079|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338080|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154338081|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154338082|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338083|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338084|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154338085|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
154338086|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338115|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338116|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
154338117|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338118|NCT01356368|Docetaxel|docetaxel|mesh-list
154338119|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338120|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
154338121|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
154338122|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
154338123|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338124|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
154338125|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154338126|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154338127|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338128|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
154338129|NCT02302456|Coagulants|coagulants|mesh-ancestor
154338130|NCT01356524|Progesterone|progesterone|mesh-list
154338131|NCT01356524|Progestins|progestins|mesh-ancestor
154338132|NCT01356524|Hormones|hormones|mesh-ancestor
154338133|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338134|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338135|NCT01232023|Indobufen|indobufen|mesh-list
154338136|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154338137|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154338138|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338139|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338140|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154338141|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338142|NCT01232023|Analgesics|analgesics|mesh-ancestor
154338143|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
154338144|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338159|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
154338160|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154338161|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154338162|NCT02297386|Testosterone|testosterone|mesh-list
154338163|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
154338164|NCT02297386|Androgens|androgens|mesh-ancestor
154338165|NCT02297386|Hormones|hormones|mesh-ancestor
154338166|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338167|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338168|NCT04464616|Anesthetics|anesthetics|mesh-list
154338169|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338170|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338171|NCT01356680|Prednisone|prednisone|mesh-list
154338172|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
154338173|NCT01356680|Dacarbazine|dacarbazine|mesh-list
154338174|NCT01356680|Etoposide|etoposide|mesh-list
154338175|NCT01356680|Vincristine|vincristine|mesh-list
154338176|NCT01356680|Doxorubicin|doxorubicin|mesh-list
154338177|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154338178|NCT01356680|Bleomycin|bleomycin|mesh-list
154338179|NCT01356680|Vinblastine|vinblastine|mesh-list
154338180|NCT01356680|Procarbazine|procarbazine|mesh-list
154338181|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154338182|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
154338183|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338184|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338185|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154338186|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
154338188|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338209|NCT04464850|Hematinics|hematinics|mesh-ancestor
154338210|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
154338211|NCT04464850|Vitamins|vitamins|mesh-ancestor
154338212|NCT01356758|Adalimumab|adalimumab|mesh-list
154338213|NCT01356758|Infliximab|infliximab|mesh-list
154338214|NCT01356758|Etanercept|etanercept|mesh-list
154338215|NCT01356758|Ustekinumab|ustekinumab|mesh-list
154338216|NCT01356758|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154338217|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338218|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338219|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
154338220|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154338221|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154338222|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338223|NCT01356758|Analgesics|analgesics|mesh-ancestor
154338224|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
154338225|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338226|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338227|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154338228|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
154338268|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154338269|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154338270|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154338271|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154338272|NCT02302768|Selenium|selenium|mesh-list
154338273|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
154338274|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338275|NCT02302768|Protective Agents|protective agents|mesh-ancestor
154338276|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338277|NCT02302768|Trace Elements|trace elements|mesh-ancestor
154338278|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
154338279|NCT03921775|Propofol|propofol|mesh-list
154338280|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154338281|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338282|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338283|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154338284|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
154338285|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
154338286|NCT01356992|Enoxaparin|enoxaparin|mesh-list
154338287|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
154338288|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154338289|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154338290|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338320|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
154338321|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
154338322|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
154338323|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154338324|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338325|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154338326|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338327|NCT03739801|Irinotecan|irinotecan|mesh-list
154338328|NCT03739801|Ramucirumab|ramucirumab|mesh-list
154338329|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154338330|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154338331|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338332|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338333|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338334|NCT03739801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154338335|NCT03739801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154338336|NCT03739801|Growth Substances|growth substances|mesh-ancestor
154338337|NCT03739801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338338|NCT03739801|Growth Inhibitors|growth inhibitors|mesh-ancestor
154338339|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
154338340|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154338341|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338342|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
154338343|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154338344|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154338345|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154338353|NCT02297854|Valganciclovir|valganciclovir|mesh-list
154338368|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
154338369|NCT03515200|Doxorubicin|doxorubicin|mesh-list
154338370|NCT03515200|Methotrexate|methotrexate|mesh-list
154338372|NCT03515200|Dasatinib|dasatinib|mesh-list
154338373|NCT03515200|Palbociclib|palbociclib|mesh-list
154338374|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338375|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
154338376|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
154338377|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338378|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338379|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154338380|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
154338381|NCT03515200|Hormones|hormones|mesh-ancestor
154338382|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338383|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154338384|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338385|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154338386|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154338387|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154338388|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338389|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338390|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154338391|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
154338392|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154338393|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154338394|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
154338401|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
154338416|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154338417|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338418|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
154338419|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
154338420|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154338421|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338422|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154338423|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
154338424|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338425|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154338426|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154338427|NCT02301130|Durvalumab|durvalumab|mesh-list
154338428|NCT02301130|Tremelimumab|tremelimumab|mesh-list
154338429|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
154338430|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154338431|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154338432|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338433|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
154338434|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338435|NCT03920605|Tenofovir|tenofovir|mesh-list
154338436|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154338437|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154338438|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
154338439|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338440|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154338467|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
154338468|NCT01319006|Glycine|glycine|mesh-list
154338469|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
154338470|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338471|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338472|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338473|NCT01358240|Econazole|econazole|mesh-list
154338474|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
154338475|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338476|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154338477|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154338478|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338479|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338480|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154338481|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
154338482|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338483|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338484|NCT01131949|Lamotrigine|lamotrigine|mesh-list
154338485|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
154338486|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154338516|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338517|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338518|NCT01358396|Chrysarobin|chrysarobin|mesh-list
154338519|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154338520|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338521|NCT01358396|Analgesics|analgesics|mesh-ancestor
154338522|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
154338523|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338524|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338525|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338526|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338528|NCT01135615|Sevelamer|sevelamer|mesh-list
154338529|NCT01135615|Calcium acetate|calcium acetate|mesh-list
154338530|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154338531|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338532|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
154338533|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
154338534|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338535|NCT01361516|Anesthetics|anesthetics|mesh-list
154338536|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338537|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338567|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154338568|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
154338569|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338570|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338571|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338572|NCT01133119|Bupivacaine|bupivacaine|mesh-list
154338573|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
154338574|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
154338575|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338576|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338577|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
154338578|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338579|NCT01230541|Udenafil|udenafil|mesh-list
154338580|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154338581|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154338582|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338583|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338584|NCT01229761|Trimethoprim|trimethoprim|mesh-list
154338585|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154338586|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
154338587|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154338588|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338589|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
154338590|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154338591|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154338592|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154338593|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338594|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338595|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154338599|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
154338608|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338609|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338610|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
154338611|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338612|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154338613|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338614|NCT03514810|Analgesics|analgesics|mesh-ancestor
154338615|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
154338616|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338617|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338618|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338619|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154338620|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338621|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
154338622|NCT02301676|Propofol|propofol|mesh-list
154338623|NCT02301676|Sevoflurane|sevoflurane|mesh-list
154338624|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154338625|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338626|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338627|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338628|NCT02301676|Analgesics|analgesics|mesh-ancestor
154338629|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
154338630|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338631|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154338632|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154338633|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154338634|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
154338635|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338636|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338651|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338652|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338654|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154338655|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
154338656|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154338657|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338658|NCT02301910|Tenecteplase|tenecteplase|mesh-list
154338659|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154338660|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154338661|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338662|NCT01585753|Maraviroc|maraviroc|mesh-list
154338663|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154338664|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154338665|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338666|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154338667|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154338668|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
154338669|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338670|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154338671|NCT01136005|Provitamins|provitamins|mesh-list
154338672|NCT01136005|Vitamins|vitamins|mesh-ancestor
154338673|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
154338674|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338675|NCT03509740|Acetaminophen|acetaminophen|mesh-list
154338676|NCT03509740|Tramadol|tramadol|mesh-list
154338677|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338678|NCT03509740|Analgesics|analgesics|mesh-ancestor
154338679|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
154338682|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
154338699|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154338700|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154338701|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
154338702|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
154338703|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
154338704|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338705|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338706|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154338707|NCT03918187|Narcotics|narcotics|mesh-ancestor
154338708|NCT03918187|Analgesics|analgesics|mesh-ancestor
154338709|NCT03507634|Lidocaine|lidocaine|mesh-list
154338710|NCT03507634|Fentanyl|fentanyl|mesh-list
154338711|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
154338712|NCT03507634|Remifentanil|remifentanil|mesh-list
154338713|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
154338714|NCT03507634|Anesthetics|anesthetics|mesh-list
154338715|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
154338716|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338717|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338718|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
154338719|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338720|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154338721|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154338722|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154338723|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154338724|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338725|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154338726|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338727|NCT03507634|Analgesics|analgesics|mesh-ancestor
154338728|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154338729|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154338730|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154338731|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
154338732|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154338733|NCT03507634|Narcotics|narcotics|mesh-ancestor
154338734|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154338740|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
154338741|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338742|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154338743|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154338744|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154338745|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154338746|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154338747|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338748|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338749|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338750|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154338751|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154338752|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154338753|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
154338754|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154338755|NCT03507556|Protective Agents|protective agents|mesh-ancestor
154338756|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338757|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
154338758|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154338759|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
154338760|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338761|NCT01232257|Expectorants|expectorants|mesh-ancestor
154338762|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
154338763|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154338764|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
154338765|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338770|NCT03509662|Thiamine|thiamine|mesh-list
154338786|NCT01133431|Glimepiride|glimepiride|mesh-list
154338787|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154338788|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154338789|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338790|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154338791|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
154338792|NCT05610007|Prilocaine|prilocaine|mesh-list
154338793|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
154338794|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
154338795|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154338796|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338797|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
154338798|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338799|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
154338800|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
154338801|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154338802|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154338803|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154338804|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154338805|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338806|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338807|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338808|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338809|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154338810|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154338811|NCT02303782|Azacitidine|azacitidine|mesh-list
154338812|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154338813|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
154338814|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338815|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338816|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338817|NCT01233505|Capecitabine|capecitabine|mesh-list
154338818|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
154338827|NCT04925180|Cyproterone|cyproterone|mesh-list
154338828|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
154338829|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
154338830|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338831|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338832|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338833|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154338834|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
154338835|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154338836|NCT01133509|Vaccines|vaccines|mesh-list
154338837|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
154338838|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338839|NCT02306902|Fenofibrate|fenofibrate|mesh-list
154338840|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154338841|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
154338842|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338843|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154085180|NCT02582190|Colchicine|colchicine|mesh-list
154338844|NCT01230697|Sorafenib|sorafenib|mesh-list
154338845|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338846|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154338847|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338849|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154338877|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338879|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
154338880|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338881|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338882|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154338883|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
154338884|NCT03507244|Hormones|hormones|mesh-ancestor
154338885|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338886|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154338887|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338888|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154338889|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154338890|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154338891|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154338892|NCT01136395|Rituximab|rituximab|mesh-list
154338893|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154338894|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338895|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
154338896|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338897|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338898|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
154338899|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154338900|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154338901|NCT02304094|Prednisolone|prednisolone|mesh-list
154338902|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
154338903|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154338904|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
154338905|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338906|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
154338907|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
154338908|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338909|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338910|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154338911|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
154338912|NCT02304094|Hormones|hormones|mesh-ancestor
154338915|NCT02304094|Protective Agents|protective agents|mesh-ancestor
154338916|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154338917|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338918|NCT03507166|Trastuzumab|trastuzumab|mesh-list
154338919|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154338920|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338922|NCT01233583|Infliximab|infliximab|mesh-list
154338923|NCT01233583|Etanercept|etanercept|mesh-list
154338924|NCT01233583|Acitretin|acitretin|mesh-list
154338925|NCT01233583|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154338926|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338927|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154338928|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
154338929|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154338930|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153781800|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154338931|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154338932|NCT01233583|Analgesics|analgesics|mesh-ancestor
154338933|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
154338934|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338935|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338936|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154338937|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
154338938|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
154338939|NCT02304250|Dexamethasone|dexamethasone|mesh-list
154338940|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154338941|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
154338942|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
154338943|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338944|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338963|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
154338964|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
154338965|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
154338966|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154338967|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154338968|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154338969|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154338970|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154338971|NCT03132142|Protective Agents|protective agents|mesh-ancestor
154338972|NCT01232647|Vitamins|vitamins|mesh-list
154338973|NCT01232647|Vitamin K|vitamin k|mesh-list
154338974|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
154338975|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
154338976|NCT01232647|Menatetrenone|menatetrenone|mesh-list
154338977|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
154338978|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339025|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339026|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339028|NCT01138423|Protease Inhibitors|protease inhibitors|mesh-ancestor
154339029|NCT01138423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339030|NCT01136863|Felodipine|felodipine|mesh-list
154339031|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154339032|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154339033|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154339034|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339035|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339036|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154339084|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154339085|NCT03504046|Pancrelipase|pancrelipase|mesh-list
154339086|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154339087|NCT01139203|Lamivudine|lamivudine|mesh-list
154339088|NCT01139203|Adefovir|adefovir|mesh-list
154339089|NCT01139203|Entecavir|entecavir|mesh-list
154339090|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154339091|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154339092|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339094|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
154339148|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154339149|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154339150|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339151|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154339152|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154339153|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339154|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
154339155|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154339156|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154339157|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154339212|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
154339213|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154339214|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339215|NCT03506542|Mitomycins|mitomycins|mesh-list
154339216|NCT03506542|Mitomycin|mitomycin|mesh-list
154339217|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154339218|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339219|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
154339220|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339221|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154339222|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339223|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
154339224|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154339225|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339226|NCT02305186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154339227|NCT02305186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339228|NCT02312908|Clonazepam|clonazepam|mesh-list
154339229|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
154339230|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
154339255|NCT02313064|CXA-10|cxa-10|mesh-list
154339268|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154339270|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
154339271|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154339272|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339273|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
154339274|NCT02313220|Exenatide|exenatide|mesh-list
154339275|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154339276|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339277|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154339278|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339279|NCT02313220|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154339280|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154339281|NCT02313220|Incretins|incretins|mesh-ancestor
154339282|NCT02313220|Hormones|hormones|mesh-ancestor
154339283|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339284|NCT02309320|Gontivimab|gontivimab|mesh-list
154339285|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
154339286|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339287|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
154339324|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339325|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154339326|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154339327|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
154339328|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339329|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154339330|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154339331|NCT02309554|Nonoxynol|nonoxynol|mesh-list
154339332|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154339333|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154339388|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154339389|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
154339390|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154339391|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154339392|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339393|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339395|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
154339396|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339456|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339457|NCT02316496|Irinotecan|irinotecan|mesh-list
154339458|NCT02316496|Cetuximab|cetuximab|mesh-list
154339459|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154339460|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154339461|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339462|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339463|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339464|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154339465|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
154339466|NCT01140529|Haloperidol|haloperidol|mesh-list
154339467|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
154339468|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154339469|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339470|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339471|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154339472|NCT01140529|Analgesics|analgesics|mesh-ancestor
154339473|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
154339512|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
154339513|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
154339514|NCT01235143|Sevoflurane|sevoflurane|mesh-list
154339515|NCT01235143|Desflurane|desflurane|mesh-list
154339516|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154339517|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154339518|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
154339519|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
154339520|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339522|NCT01238029|Capecitabine|capecitabine|mesh-list
154339579|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
154339580|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154339581|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339582|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154339583|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
154339584|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
154339585|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154339586|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154339587|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154339588|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154339644|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339645|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339646|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154339647|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154339648|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154339649|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154339650|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154339652|NCT04462666|Etoricoxib|etoricoxib|mesh-list
154339711|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339713|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154339714|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154339715|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
154339716|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339717|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
154339718|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154339719|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339720|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339721|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
154339722|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339723|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339724|NCT03319316|Durvalumab|durvalumab|mesh-list
154339725|NCT03319316|Tremelimumab|tremelimumab|mesh-list
154339726|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154339727|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339739|NCT01141465|Xhance|xhance|mesh-list
154339766|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154339767|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
154339768|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339769|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154339770|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154339771|NCT03300518|Estradiol|estradiol|mesh-list
154339772|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154339773|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154339774|NCT03300518|Ganirelix|ganirelix|mesh-list
154339775|NCT03300518|Estrogens|estrogens|mesh-ancestor
154339776|NCT03300518|Hormones|hormones|mesh-ancestor
154339778|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339830|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154339831|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339832|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339833|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
154339834|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154339835|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339836|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154339895|NCT01360034|Indomethacin|indomethacin|mesh-list
154339896|NCT01360034|Nifedipine|nifedipine|mesh-list
154339897|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154339898|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339899|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339900|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154339901|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339902|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
154339903|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
154339904|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154339905|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154339955|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154339956|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
154339957|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154339958|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154339959|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154339960|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339961|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154339962|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154339963|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154339964|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
154339965|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154339966|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154339967|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
154339968|NCT01360190|Fluoxetine|fluoxetine|mesh-list
154086314|NCT00741741|Rilpivirine|rilpivirine|mesh-list
154339969|NCT01360190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154339970|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154339971|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154339972|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154339973|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154339983|NCT01363934|Hematinics|hematinics|mesh-ancestor
154340005|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154340006|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340078|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154340079|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154340080|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
154340081|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340082|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340083|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340084|NCT01352234|Aspirin|aspirin|mesh-list
154340085|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154340086|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154340087|NCT01352234|Analgesics|analgesics|mesh-ancestor
154340088|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
154340089|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340090|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340091|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340092|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154340093|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154340094|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154340095|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340133|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154340134|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154340135|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
154340136|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340137|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340138|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340139|NCT01236859|Gabapentin|gabapentin|mesh-list
154340140|NCT01236859|Analgesics|analgesics|mesh-ancestor
154340141|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
154340144|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
154340202|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340203|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340204|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
154340205|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340206|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340207|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
154340208|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340209|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340210|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154340211|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154340212|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
154340213|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154340214|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
154340215|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340216|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
154340218|NCT01235455|Interferons|interferons|mesh-list
154340259|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
154340260|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340262|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
154340263|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
154340264|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
154340265|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340266|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340267|NCT02320084|Nitisinone|nitisinone|mesh-list
154340268|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340272|NCT02320240|Citalopram|citalopram|mesh-list
154340323|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340324|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154340325|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340326|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154340327|NCT03492580|Hormones|hormones|mesh-ancestor
154340329|NCT03492580|Incretins|incretins|mesh-ancestor
154340333|NCT01238965|Leucovorin|leucovorin|mesh-list
154340393|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
154340394|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340395|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154340396|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154340397|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154340398|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
154340399|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340400|NCT02115139|Ipilimumab|ipilimumab|mesh-list
154340401|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154340402|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340403|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154340404|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340410|NCT04802356|Bortezomib|bortezomib|mesh-list
154340454|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340455|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
154340456|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340457|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340458|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154340459|NCT01146067|Protective Agents|protective agents|mesh-ancestor
154340460|NCT01237249|Dexamethasone|dexamethasone|mesh-list
154340461|NCT01237249|Prednisone|prednisone|mesh-list
154340462|NCT01237249|Melphalan|melphalan|mesh-list
154340463|NCT01237249|Lenalidomide|lenalidomide|mesh-list
154340520|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340521|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340522|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154340523|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154340525|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
154340526|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340589|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154340590|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
154340591|NCT02431702|Perphenazine|perphenazine|mesh-list
154340592|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154340593|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
154340594|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154340595|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340596|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340630|NCT02321878|Hormones|hormones|mesh-ancestor
154340653|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154340654|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154340655|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340656|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340657|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154340721|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
154340722|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
154340723|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340724|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154087057|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340725|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154340726|NCT03491098|Protective Agents|protective agents|mesh-ancestor
154340727|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
154340788|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
154340789|NCT00924326|Interleukin-2|interleukin-2|mesh-list
154340790|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340791|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
154340792|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340793|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154340794|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154340795|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
154340796|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340797|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340798|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154340799|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154340800|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
154340802|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154340803|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154340804|NCT00924326|Analgesics|analgesics|mesh-ancestor
154340805|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
153520075|NCT06256627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153520076|NCT06256627|Growth Substances|growth substances|mesh-ancestor
153520077|NCT06256627|Growth Inhibitors|growth inhibitors|mesh-ancestor
153520078|NCT06256588|Dostarlimab|dostarlimab|mesh-list
153520079|NCT06256588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340848|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340849|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154340850|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340852|NCT03631004|Olanzapine|olanzapine|mesh-list
154340908|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
154340909|NCT02710084|Oxytocin|oxytocin|mesh-list
154340910|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
154340911|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154340912|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340913|NCT02849990|Prednisone|prednisone|mesh-list
154340914|NCT02849990|Cortisone|cortisone|mesh-list
154340915|NCT02849990|Indomethacin|indomethacin|mesh-list
154340916|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
154340917|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154340918|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
154340919|NCT02849990|Hormones|hormones|mesh-ancestor
154340920|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154340921|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340922|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154340923|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154340924|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154340925|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154340926|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154340927|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
154340928|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154340929|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154340930|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154340931|NCT02849990|Analgesics|analgesics|mesh-ancestor
154340932|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
154340933|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340934|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154340935|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
154340936|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
154340937|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154340938|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154340939|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
154340940|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154340941|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340948|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340949|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
154340950|NCT03490396|Protective Agents|protective agents|mesh-ancestor
154340951|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
154340953|NCT05136040|Bupivacaine|bupivacaine|mesh-list
154340954|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
154340955|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
154340956|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154340957|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340958|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
154340959|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154340960|NCT03496246|Vitamin D|vitamin d|mesh-list
154340961|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154340962|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
154340963|NCT03496246|Calcifediol|calcifediol|mesh-list
154340964|NCT03496246|Calcium|calcium|mesh-list
154340965|NCT03496246|Vitamins|vitamins|mesh-ancestor
154340966|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
154340967|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154340968|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154340969|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154340970|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
154340971|NCT02017964|Carboplatin|carboplatin|mesh-list
154340972|NCT02017964|Methotrexate|methotrexate|mesh-list
154340973|NCT02017964|Etoposide|etoposide|mesh-list
154340974|NCT02017964|Vincristine|vincristine|mesh-list
154340975|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
154340976|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
154340977|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154340978|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
154340997|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154340998|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
154340999|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
154341000|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
154341001|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
154341002|NCT05121298|Upadacitinib|upadacitinib|mesh-list
154341003|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154341004|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154341005|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341006|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341061|NCT01371968|Narcotics|narcotics|mesh-ancestor
154341062|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341063|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341064|NCT01371968|Analgesics|analgesics|mesh-ancestor
154341065|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
154341066|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341067|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154341068|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
154341069|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
154341070|NCT04989322|Carboplatin|carboplatin|mesh-list
154341071|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
154341126|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
154341127|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341128|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341130|NCT02323516|Loperamide|loperamide|mesh-list
154341131|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
154341133|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154341193|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341194|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154341196|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154341197|NCT04580992|Ajmaline|ajmaline|mesh-list
154341198|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154341203|NCT04590274|Azithromycin|azithromycin|mesh-list
154341258|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341259|NCT01319942|Sorafenib|sorafenib|mesh-list
154341260|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341261|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154341262|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341263|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341264|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
154341265|NCT01373138|Ephedrine|ephedrine|mesh-list
153781801|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154341266|NCT01373138|Desloratadine|desloratadine|mesh-list
154341267|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154341268|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
154341275|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
154341321|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341322|NCT02324296|Cisplatin|cisplatin|mesh-list
154341323|NCT02324296|Etoposide|etoposide|mesh-list
154341324|NCT02324296|Ifosfamide|ifosfamide|mesh-list
154341325|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341326|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154341327|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154341328|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154341329|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341330|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341331|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154341332|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
154341333|NCT03494686|Anesthetics|anesthetics|mesh-list
154341336|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
154341382|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341383|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154341384|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
154341385|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154341386|NCT04624958|Rituximab|rituximab|mesh-list
154341387|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
154341388|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154341389|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341390|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
154341397|NCT03485482|Bisoprolol|bisoprolol|mesh-list
154341447|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341448|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341449|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154341451|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154341452|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154341453|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154341454|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
154341455|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154341456|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341457|NCT03115112|Incretins|incretins|mesh-ancestor
154341458|NCT03115112|Hormones|hormones|mesh-ancestor
154341459|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341460|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154341461|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
154341462|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341463|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341464|NCT01373528|Budesonide|budesonide|mesh-list
154341465|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341467|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
154341500|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154341501|NCT03556358|Paclitaxel|paclitaxel|mesh-list
154341502|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
154341503|NCT03556358|Trastuzumab|trastuzumab|mesh-list
154341504|NCT03556358|Epirubicin|epirubicin|mesh-list
154341505|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154341506|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341507|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
154341508|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
154341509|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
154341510|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341511|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154341512|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
154341513|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341514|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341515|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154341516|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
154341517|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154341518|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154341519|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154341520|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154341521|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154341522|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341523|NCT01374308|Interferons|interferons|mesh-list
154341524|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
154341525|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
154341526|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154341527|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341528|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
154341529|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341530|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
154341544|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341545|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154341546|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341547|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154341548|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
154341549|NCT01368068|Hormones|hormones|mesh-ancestor
154341550|NCT01373684|Tenofovir|tenofovir|mesh-list
154341551|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154341552|NCT01373684|Entecavir|entecavir|mesh-list
154341553|NCT01373684|Adefovir|adefovir|mesh-list
154341554|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
154341555|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341556|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154341557|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154341558|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341559|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341560|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154341561|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154341562|NCT02891798|Dexamethasone|dexamethasone|mesh-list
154341563|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
154341564|NCT02891798|Clonidine|clonidine|mesh-list
154341565|NCT02891798|Buprenorphine|buprenorphine|mesh-list
154341566|NCT02891798|Bupivacaine|bupivacaine|mesh-list
154341567|NCT02891798|BB 1101|bb 1101|mesh-list
154341568|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341569|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
154341570|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
154341571|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341572|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341573|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154341574|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
154341575|NCT02891798|Hormones|hormones|mesh-ancestor
154341576|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341577|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154341578|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341579|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
154341580|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341581|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341583|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
154341584|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341585|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
154341586|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154341587|NCT02891798|Narcotics|narcotics|mesh-ancestor
154341588|NCT02891798|Analgesics|analgesics|mesh-ancestor
154341589|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154341590|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341591|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
154341592|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154341593|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154341594|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154341595|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341596|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341597|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
154341598|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
154341599|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
154341600|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341601|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341602|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
154341603|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341604|NCT01374620|Paclitaxel|paclitaxel|mesh-list
154341605|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154341606|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
154341607|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154341608|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341609|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
154341610|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
154341611|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
154341613|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154341630|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154341631|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341632|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154341633|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154341634|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341635|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
154341636|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
154341637|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154341638|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341639|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341640|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154341641|NCT05197088|Tamsulosin|tamsulosin|mesh-list
154341642|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154341643|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154341644|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154341645|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341646|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341647|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341648|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341649|NCT05197088|Urological Agents|urological agents|mesh-ancestor
154341650|NCT01375088|Propolis|propolis|mesh-list
154341651|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341652|NCT01368848|Bevacizumab|bevacizumab|mesh-list
154341653|NCT01368848|Docetaxel|docetaxel|mesh-list
154341665|NCT03604874|Oxytocin|oxytocin|mesh-list
154341680|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
154341681|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341682|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
154341683|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341684|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154341685|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341686|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154341687|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
154341688|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154341689|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
154341690|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154341691|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154341692|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341693|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
154341694|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
154341695|NCT03135262|Rituximab|rituximab|mesh-list
154341696|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
154341697|NCT03135262|Venetoclax|venetoclax|mesh-list
154341698|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154341699|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341700|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
154341701|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341702|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341703|NCT01375244|Lisinopril|lisinopril|mesh-list
154341704|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154341705|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
154341706|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341707|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341708|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341709|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154341710|NCT01375244|Protective Agents|protective agents|mesh-ancestor
154341711|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341712|NCT01375322|Amlodipine|amlodipine|mesh-list
154341723|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154341724|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154341725|NCT01375322|Diuretics|diuretics|mesh-ancestor
154341726|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
154341727|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154341728|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154341729|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
154341730|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341731|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
154341732|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154341733|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154341734|NCT01369238|Analgesics|analgesics|mesh-ancestor
154341735|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
154341736|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341737|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341738|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341739|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341740|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
154341741|NCT03485404|Vitamins|vitamins|mesh-list
154341742|NCT03485404|Folic Acid|folic acid|mesh-list
154341743|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
154341744|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
154341745|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
154341746|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341747|NCT03485404|Hematinics|hematinics|mesh-ancestor
154341748|NCT05195294|Lenvatinib|lenvatinib|mesh-list
154341749|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341753|NCT03535194|Mirikizumab|mirikizumab|mesh-list
154341771|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
154341772|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154341773|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341774|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341775|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154341776|NCT05194904|Analgesics|analgesics|mesh-ancestor
154341777|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
154341778|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154341779|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154341780|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154341781|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154341782|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341783|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341784|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341785|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154341786|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154341787|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154341788|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154341789|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341790|NCT01375400|Aspirin|aspirin|mesh-list
154341791|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154341792|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154341793|NCT01375400|Analgesics|analgesics|mesh-ancestor
154341821|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154341822|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154341823|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
154341824|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341825|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341826|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341827|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154341828|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
154341829|NCT01369472|Protective Agents|protective agents|mesh-ancestor
154341830|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154341831|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341832|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154341833|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
154341834|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154341835|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154341836|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
154341837|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154341838|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
154341839|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
154341840|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
154341841|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341842|NCT05193734|Coagulants|coagulants|mesh-ancestor
154341843|NCT05193578|Semaglutide|semaglutide|mesh-list
154088173|NCT00674661|Riboflavin|riboflavin|mesh-list
154341871|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154341872|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154341873|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
154341874|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
154341875|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
154341876|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
154341877|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154341878|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341879|NCT05388448|Amoxicillin|amoxicillin|mesh-list
154341880|NCT05388448|Rifampin|rifampin|mesh-list
154341881|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
154341882|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
154341883|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154341884|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341885|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154341886|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
154341887|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
154341888|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154341889|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341890|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341891|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154341892|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154341893|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154341930|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341931|NCT05152186|Disinfectants|disinfectants|mesh-list
154341932|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154341933|NCT03485092|Empagliflozin|empagliflozin|mesh-list
154341934|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154341935|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341936|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154341937|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341938|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
154341939|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
154341940|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
154341941|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154341942|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341960|NCT01376180|Lamotrigine|lamotrigine|mesh-list
154341961|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
154341962|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153813435|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
153813436|NCT00420563|Megestrol|megestrol|mesh-list
154341963|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341964|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341965|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154341966|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341967|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154341968|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154341969|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154341970|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154341971|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154341972|NCT03633734|Folfirinox|folfirinox|mesh-list
154341973|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154341974|NCT01376258|Finasteride|finasteride|mesh-list
154341975|NCT01376258|Dutasteride|dutasteride|mesh-list
154341976|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154341977|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154341978|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154341979|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341980|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
154341981|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154341982|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154341983|NCT01376258|Urological Agents|urological agents|mesh-ancestor
154341984|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154341985|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154341986|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154341987|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154341988|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154341989|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
154341990|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342004|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342005|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342006|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342007|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342008|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154342009|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154342010|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342011|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154342012|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154342013|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342014|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
154342015|NCT04460092|Insulin|insulin|mesh-list
154342016|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154342017|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154342018|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342019|NCT03110900|Lorazepam|lorazepam|mesh-list
154342020|NCT03110900|Haloperidol|haloperidol|mesh-list
154342021|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
154342022|NCT03110900|Loxapine|loxapine|mesh-list
154342023|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
154342024|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
154342025|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342026|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342027|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342056|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342057|NCT03867734|Aztreonam|aztreonam|mesh-list
154342058|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154342059|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342060|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154342061|NCT05151016|Mifepristone|mifepristone|mesh-list
154342062|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154342063|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
154342064|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342065|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342066|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154342067|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154342068|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154342069|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
154342070|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154342071|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154342072|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
154342073|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342074|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
154342075|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154342076|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154342077|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154342078|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342079|NCT04459312|Antibodies|antibodies|mesh-list
154342104|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342105|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342106|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154342107|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
154342108|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
154342109|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154342110|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154342111|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154342112|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
154342113|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342114|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342115|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154342116|NCT00702988|Hormones|hormones|mesh-ancestor
154342117|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342118|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342119|NCT05759312|Metformin|metformin|mesh-list
154342120|NCT05759312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154342121|NCT05759312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342122|NCT03446456|Vasopressins|vasopressins|mesh-list
154342123|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
154342124|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
154342125|NCT03446456|Coagulants|coagulants|mesh-ancestor
154342126|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154342127|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154342128|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
154342129|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342130|NCT03396692|Morphine|morphine|mesh-list
154342131|NCT03396692|Ropivacaine|ropivacaine|mesh-list
154342132|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154342133|NCT03396692|Narcotics|narcotics|mesh-ancestor
154342134|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342135|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342136|NCT03396692|Analgesics|analgesics|mesh-ancestor
154342148|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342149|NCT03495102|Dulaglutide|dulaglutide|mesh-list
154342150|NCT03495102|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154342151|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154342152|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342153|NCT04754386|Antibodies|antibodies|mesh-list
154342154|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
154342155|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342156|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154342157|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154342158|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154342159|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342160|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
154342161|NCT03253172|Diuretics|diuretics|mesh-ancestor
154342162|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
154342163|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342164|NCT03253172|Expectorants|expectorants|mesh-ancestor
154342165|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
154342166|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
154342167|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154342168|NCT03480646|Prednisone|prednisone|mesh-list
154342169|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
154342170|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342171|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
154342172|NCT03480646|Hormones|hormones|mesh-ancestor
154342173|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342174|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342175|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154342176|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342177|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342178|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342179|NCT03483142|Misoprostol|misoprostol|mesh-list
154342182|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342183|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342184|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154342185|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342186|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
154342187|NCT03726372|Bromides|bromides|mesh-list
154342188|NCT03726372|Rocuronium|rocuronium|mesh-list
154342189|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
154342190|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154342191|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154342192|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154342193|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342194|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342195|NCT03104816|Acetaminophen|acetaminophen|mesh-list
154342196|NCT03104816|Hydromorphone|hydromorphone|mesh-list
154342197|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154342198|NCT03104816|Analgesics|analgesics|mesh-ancestor
154342199|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
154342200|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342201|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342202|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
154342203|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154342204|NCT03104816|Narcotics|narcotics|mesh-ancestor
154342205|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342206|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
154342207|NCT04720976|Sotorasib|sotorasib|mesh-list
154342208|NCT04720976|Osimertinib|osimertinib|mesh-list
154342209|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154342210|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342211|NCT04720976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154342212|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342216|NCT03480568|Alirocumab|alirocumab|mesh-list
154342227|NCT04707326|Dolutegravir|dolutegravir|mesh-list
154342228|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154342229|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154342230|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342231|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342232|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
154342233|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342234|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154342235|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154342236|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154342237|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154342238|NCT03559062|Ivacaftor|ivacaftor|mesh-list
154342239|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154342240|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342241|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342242|NCT03726216|Dalbavancin|dalbavancin|mesh-list
154342243|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154342244|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342245|NCT00089791|Denosumab|denosumab|mesh-list
154342246|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154342247|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342248|NCT03380455|Cimetidine|cimetidine|mesh-list
154342249|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154342250|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342251|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154342252|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
154342253|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
154342254|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342260|NCT02815280|Minocycline|minocycline|mesh-list
154342273|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154342274|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154342275|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
154342276|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342277|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342278|NCT01310712|Urological Agents|urological agents|mesh-ancestor
154342279|NCT02737930|Fluoxetine|fluoxetine|mesh-list
154342280|NCT02737930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154342281|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154342282|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342283|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342284|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342285|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
154342286|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342287|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154342288|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
154342289|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154088623|NCT00764439|Nicotine|nicotine|mesh-list
154342290|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154342291|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154342292|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342293|NCT01242787|Entecavir|entecavir|mesh-list
154342294|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
154342295|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342296|NCT03476356|Clomiphene|clomiphene|mesh-list
154342297|NCT03476356|Enclomiphene|enclomiphene|mesh-list
154342298|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
154342299|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154342317|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342318|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342319|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
154342320|NCT05626387|Prednisolone|prednisolone|mesh-list
154342321|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154342322|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
154342323|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154342324|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
154342325|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154342326|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
154342327|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154342328|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342329|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154342330|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
154342331|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154342332|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342333|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342334|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342335|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342336|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
154342337|NCT05626387|Hormones|hormones|mesh-ancestor
154342338|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342339|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342340|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154342341|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
154342342|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
154342343|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342344|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342345|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154342346|NCT05626387|Protective Agents|protective agents|mesh-ancestor
154342347|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
154342359|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154342360|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
154342361|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342362|NCT01146925|Deferiprone|deferiprone|mesh-list
154342363|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154342364|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
154342365|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
154342366|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342367|NCT04635254|Histamine|histamine|mesh-list
154342368|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
154342369|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
154342370|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342371|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342372|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342373|NCT03476044|Selenium|selenium|mesh-list
154342374|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
154342375|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342376|NCT03476044|Protective Agents|protective agents|mesh-ancestor
154342377|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342378|NCT03476044|Trace Elements|trace elements|mesh-ancestor
154342379|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
154342380|NCT01250821|Menotropins|menotropins|mesh-list
154342381|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154342382|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
154342385|NCT03493698|Midazolam|midazolam|mesh-list
154342409|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342410|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154342411|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154342412|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154342413|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
154342414|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154342415|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154342416|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
154342417|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342418|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
154342419|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154342420|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154342421|NCT03528174|Pancrelipase|pancrelipase|mesh-list
154342422|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342423|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
154342424|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154342425|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154342426|NCT03482440|Analgesics|analgesics|mesh-ancestor
154342427|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
154342428|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342429|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342430|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342431|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342432|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
154342433|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
154342434|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342435|NCT01253473|Budesonide|budesonide|mesh-list
154342436|NCT01253473|Albuterol|albuterol|mesh-list
154342437|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
154342438|NCT01253473|Ipratropium|ipratropium|mesh-list
154342452|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
154342453|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342454|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342455|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
154342456|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342457|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154342458|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
154342460|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154342461|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
154342462|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
154342463|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342464|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342465|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154342466|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154342467|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154342468|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
154342469|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342470|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342471|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154342472|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342473|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342474|NCT03480100|Xylometazoline|xylometazoline|mesh-list
154342475|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
154342476|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154342478|NCT02348203|Aspirin|aspirin|mesh-list
154342499|NCT03482362|Vinorelbine|vinorelbine|mesh-list
154342500|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154342501|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342502|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
154342503|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
154342504|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
154342505|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342506|NCT04500470|Ketoprofen|ketoprofen|mesh-list
154342507|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154342508|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154342509|NCT04500470|Analgesics|analgesics|mesh-ancestor
154342510|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
154342511|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342512|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342513|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342514|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342515|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154342516|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342517|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342518|NCT03493386|Glycine|glycine|mesh-list
154342519|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
154342545|NCT01248871|Dsuvia|dsuvia|mesh-list
154342551|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154342552|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
154342553|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
154342554|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154342555|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154342556|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154342557|NCT01248871|Narcotics|narcotics|mesh-ancestor
154342558|NCT01248871|Analgesics|analgesics|mesh-ancestor
154342559|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
154342560|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342561|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154342562|NCT01251133|Vaccines|vaccines|mesh-list
154342563|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
154342564|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342565|NCT03720288|Acetazolamide|acetazolamide|mesh-list
154342566|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
154342567|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154342568|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342569|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342570|NCT03720288|Diuretics|diuretics|mesh-ancestor
154342571|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
154342572|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342573|NCT03916393|Denatonium|denatonium|mesh-list
154342574|NCT03916393|Aversive Agents|aversive agents|mesh-ancestor
154342575|NCT03916393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342576|NCT03916393|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
154342577|NCT03916393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342578|NCT03916393|Sensory System Agents|sensory system agents|mesh-ancestor
154342598|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342599|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
154342600|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342601|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342602|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154342603|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342604|NCT03473340|Pirfenidone|pirfenidone|mesh-list
154342605|NCT03473340|Analgesics|analgesics|mesh-ancestor
154342606|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
154342607|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342608|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342609|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154342610|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154342611|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342612|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342613|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342614|NCT01147705|Allopurinol|allopurinol|mesh-list
154342615|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
154342616|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342617|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342618|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
154342619|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342620|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154342621|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
154342622|NCT01147705|Protective Agents|protective agents|mesh-ancestor
154342623|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342624|NCT03907111|Chitosan|chitosan|mesh-list
154342625|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154342626|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154342627|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
154342628|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342630|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
154342641|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
154342642|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
154342643|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154342644|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154342645|NCT03661567|Prednisolone|prednisolone|mesh-list
154342646|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
154342647|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154342648|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
154342649|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342650|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
154342651|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
154342652|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342653|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342654|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342655|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
154342656|NCT03661567|Hormones|hormones|mesh-ancestor
154342657|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342658|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154342659|NCT03661567|Protective Agents|protective agents|mesh-ancestor
154342660|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154342661|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342662|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
154342663|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154342664|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342665|NCT03739138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154342666|NCT03739138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342667|NCT03472326|GS-9131|gs-9131|mesh-list
154342668|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342669|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342670|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154342671|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154342672|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
154342682|NCT04182100|Analgesics|analgesics|mesh-ancestor
154342683|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
154342684|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342685|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342686|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154342687|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342688|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154342689|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154342690|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342691|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154342692|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154342693|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342694|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
154342695|NCT03479320|Lidocaine|lidocaine|mesh-list
154342696|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
154342697|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
154342698|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342699|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342700|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
154342701|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342702|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154342703|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154342704|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154342705|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342706|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342707|NCT03912415|Paclitaxel|paclitaxel|mesh-list
154342708|NCT03912415|Bevacizumab|bevacizumab|mesh-list
154342722|NCT03525834|Everolimus|everolimus|mesh-list
154342727|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154342728|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
154342729|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342730|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342731|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
154342733|NCT00925652|Methotrexate|methotrexate|mesh-list
154342734|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154089065|NCT01022047|Hormones|hormones|mesh-ancestor
154342735|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
154342736|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342737|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154342738|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154342739|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
154342740|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342741|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342742|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154342743|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154342744|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154342745|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154342746|NCT00925652|Growth Substances|growth substances|mesh-ancestor
154342747|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
154342748|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154342749|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
154342750|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154342751|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154342752|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
154342753|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
154342754|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342755|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154342756|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154342757|NCT00481052|Nilotinib|nilotinib|mesh-list
154342758|NCT00481052|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154342767|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154342768|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342769|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154342771|NCT03525444|Elexacaftor|elexacaftor|mesh-list
154342772|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154342773|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342774|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342775|NCT01251835|Rifampin|rifampin|mesh-list
154342776|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
154342777|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154342778|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
154342779|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154342780|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342781|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
154342782|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154342783|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342784|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342785|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154342786|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154342787|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154342788|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154342789|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154342790|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154342791|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154342792|NCT03632876|Vitamin A|vitamin a|mesh-list
154342793|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
154342794|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
154342795|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342796|NCT03632876|Protective Agents|protective agents|mesh-ancestor
154342797|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089148|NCT00433537|Hormones|hormones|mesh-ancestor
154342808|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154342809|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342810|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154342811|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154342812|NCT03905317|Growth Substances|growth substances|mesh-ancestor
154342813|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342814|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
154342815|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
154342816|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
154342817|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154342818|NCT01251991|Psyllium|psyllium|mesh-list
154342819|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
154342820|NCT01251991|Cathartics|cathartics|mesh-ancestor
154342821|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154342822|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
154342823|NCT04458454|Methocarbamol|methocarbamol|mesh-list
154342824|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154342825|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342826|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154342827|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342828|NCT03914677|Mecamylamine|mecamylamine|mesh-list
154342829|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154342830|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154342831|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
154342832|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342833|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342839|NCT03479086|Topiramate|topiramate|mesh-list
154342856|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154342857|NCT01252225|Lidocaine|lidocaine|mesh-list
154342858|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
154342859|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
154342860|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154342861|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342862|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
154342863|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154342864|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154342865|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154342866|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154342867|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342868|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342869|NCT04459702|Ritonavir|ritonavir|mesh-list
154342870|NCT04459702|Lopinavir|lopinavir|mesh-list
154342871|NCT04459702|Azithromycin|azithromycin|mesh-list
154342872|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
154342873|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154342874|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154342875|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
154342876|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342877|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342878|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154342879|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154342880|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
154342881|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089215|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
154342882|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154342901|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154342902|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154342903|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154342904|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154342905|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154342906|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154342907|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342908|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
154342909|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
154342910|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
154342911|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154342912|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154342913|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154342914|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154342915|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
154342916|NCT03904849|Cannabidiol|cannabidiol|mesh-list
154342917|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
154342919|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
154342920|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
154342921|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342922|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
154342924|NCT01250743|Protective Agents|protective agents|mesh-ancestor
154342952|NCT00708448|Bevacizumab|bevacizumab|mesh-list
154342953|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154342954|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154342955|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154342956|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154342957|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154342958|NCT00708448|Growth Substances|growth substances|mesh-ancestor
154342959|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154342960|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
154342961|NCT00708448|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154342962|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154342963|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154342964|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154342965|NCT02892604|Insulin|insulin|mesh-list
154342966|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154342968|NCT03478306|Melatonin|melatonin|mesh-list
154343009|NCT03719820|Clopidogrel|clopidogrel|mesh-list
154343010|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154343011|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343012|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343013|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154343014|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343015|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154343016|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154343017|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154343018|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
154343019|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343020|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154343021|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154343022|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
154343023|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154343024|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154343025|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154343026|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154343027|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154343028|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154343029|NCT01254799|Doxycycline|doxycycline|mesh-list
154343030|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343031|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343059|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343060|NCT03904537|Antibodies|antibodies|mesh-list
154343061|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
154343062|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343063|NCT03904225|Tegafur|tegafur|mesh-list
154343064|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154343065|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
154343066|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343067|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343068|NCT03910231|Tolvaptan|tolvaptan|mesh-list
154343069|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154343070|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343071|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
154343072|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343073|NCT01149109|Temozolomide|temozolomide|mesh-list
154343074|NCT01149109|Lomustine|lomustine|mesh-list
154343075|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154343076|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
154343077|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343078|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343079|NCT05667415|Cisplatin|cisplatin|mesh-list
154343080|NCT05667415|Disulfiram|disulfiram|mesh-list
154343081|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343082|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154343083|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154343084|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343085|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343086|NCT01586143|Acetaminophen|acetaminophen|mesh-list
154343088|NCT01586143|Analgesics|analgesics|mesh-ancestor
154343105|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343106|NCT02527993|Incretins|incretins|mesh-ancestor
154089451|NCT00789945|Insulin|insulin|mesh-list
154343107|NCT02527993|Hormones|hormones|mesh-ancestor
154343108|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154343109|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154343110|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
154343111|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343112|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343113|NCT02527993|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154343114|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154343115|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154343116|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343117|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154343118|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
154343119|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154343120|NCT01149499|Valacyclovir|valacyclovir|mesh-list
154343121|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
154343122|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343123|NCT03900871|Aspirin|aspirin|mesh-list
154343124|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343125|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343126|NCT03900871|Analgesics|analgesics|mesh-ancestor
154343127|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
154343128|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343129|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343130|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343131|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343132|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154343133|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154343134|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343135|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154343136|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154343142|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343143|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343144|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154343145|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154343146|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154343147|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154343148|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154343149|NCT01149577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154343150|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154343151|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343152|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343153|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343154|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
154343155|NCT03894007|Maytansine|maytansine|mesh-list
154343156|NCT03894007|Docetaxel|docetaxel|mesh-list
154343157|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154343158|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
154343159|NCT03894007|Carboplatin|carboplatin|mesh-list
154343160|NCT03894007|Trastuzumab|trastuzumab|mesh-list
154343161|NCT03894007|Atezolizumab|atezolizumab|mesh-list
154343162|NCT03894007|Epirubicin|epirubicin|mesh-list
154343163|NCT03894007|Pertuzumab|pertuzumab|mesh-list
154343164|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154343165|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343166|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
154343167|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
154343168|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
154343169|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343170|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154343188|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343189|NCT01150747|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154343190|NCT01150747|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154343191|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154343192|NCT01258309|Ketorolac|ketorolac|mesh-list
154343193|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154343194|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154343195|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154343196|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343197|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343198|NCT01258309|Analgesics|analgesics|mesh-ancestor
154343199|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
154343200|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343201|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343202|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343203|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343204|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154343205|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343206|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343207|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154343208|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154343209|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154343210|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
154343211|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
154343212|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343213|NCT01256905|Modafinil|modafinil|mesh-list
154343214|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154343215|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343216|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154343217|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153522444|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153522445|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153522446|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153522447|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153522448|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
154343230|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343231|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154343232|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343233|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343234|NCT02874794|Valsartan|valsartan|mesh-list
154343235|NCT02874794|Enalapril|enalapril|mesh-list
154343236|NCT02874794|Enalaprilat|enalaprilat|mesh-list
154343237|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154343238|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154343239|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154343240|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154343241|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343242|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154343243|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
154343244|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343245|NCT03102710|Lidocaine|lidocaine|mesh-list
154343246|NCT03102710|Capsaicin|capsaicin|mesh-list
154343247|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
154343248|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
154343249|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154343250|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343251|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
154343268|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
154343269|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343270|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154343271|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
154343272|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154343273|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154343274|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154343275|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
154343276|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
154343277|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343278|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154343279|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154343280|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
154343281|NCT05505409|Pirfenidone|pirfenidone|mesh-list
154343282|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
154343283|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154343284|NCT05505409|Hormones|hormones|mesh-ancestor
154343285|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154343286|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343287|NCT05505409|Analgesics|analgesics|mesh-ancestor
154343288|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
154343289|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343290|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343291|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343292|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343293|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343294|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343295|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
154343296|NCT04770740|Vitamin K|vitamin k|mesh-list
154343297|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
154343298|NCT04770740|Menaquinone 7|menaquinone 7|mesh-list
154343313|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343314|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
154343315|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343316|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
154343317|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343318|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154343319|NCT01258777|Golimumab|golimumab|mesh-list
154343320|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154343321|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154343322|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343323|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154343324|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
154343325|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343326|NCT03896893|Emollients|emollients|mesh-list
154343327|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
154343328|NCT01257373|Cobalt|cobalt|mesh-list
154343329|NCT01257373|Chromium|chromium|mesh-list
154343330|NCT01257373|Sirolimus|sirolimus|mesh-list
154343331|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343332|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343333|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154343334|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343335|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
154343336|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154343337|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
154343338|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343339|NCT01257373|Trace Elements|trace elements|mesh-ancestor
154343340|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
154343341|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
153522574|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522575|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153522576|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154343363|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343364|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343365|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154343366|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
154343367|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
154343368|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154343369|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154343370|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154343371|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154343372|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
154343373|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343374|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343375|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
154343377|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154343378|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
154343379|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154343380|NCT03101930|Liraglutide|liraglutide|mesh-list
154343381|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154343382|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343383|NCT03101930|Incretins|incretins|mesh-ancestor
154343384|NCT03101930|Hormones|hormones|mesh-ancestor
154343385|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154343386|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154343387|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
154343388|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343389|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343390|NCT03101930|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154343393|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153522614|NCT04780269|Dinoprostone|dinoprostone|mesh-list
153522615|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
153522616|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154343399|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343400|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154343401|NCT05415254|Vitamins|vitamins|mesh-ancestor
154343402|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
154343403|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154343404|NCT01150201|Losartan|losartan|mesh-list
154343405|NCT01150201|Aliskiren|aliskiren|mesh-list
154343406|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154343407|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154343408|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154343409|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154343410|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343411|NCT01150201|Renin Inhibitors|renin inhibitors|mesh-ancestor
154343412|NCT01150201|Protease Inhibitors|protease inhibitors|mesh-ancestor
154343413|NCT01150201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343414|NCT01257451|Vildagliptin|vildagliptin|mesh-list
154343415|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154343416|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343417|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154343418|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
154343419|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343420|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343443|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343444|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154343445|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154343446|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343447|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343448|NCT03100838|Nifedipine|nifedipine|mesh-list
154343449|NCT03100838|Omeprazole|omeprazole|mesh-list
154343450|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
154343451|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154343452|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154343453|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154343454|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343455|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343456|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154343457|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343458|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154343459|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343460|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
154343461|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
154343462|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154343463|NCT01260025|Endostatins|endostatins|mesh-list
154343464|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343465|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154343466|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154343467|NCT01260025|Growth Substances|growth substances|mesh-ancestor
154343490|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154343491|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343492|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343494|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
154343495|NCT03892447|Ferulic acid|ferulic acid|mesh-list
154343496|NCT03892447|Dopamine|dopamine|mesh-list
154343497|NCT03892447|Alprostadil|alprostadil|mesh-list
154343498|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154343499|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
154343500|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
154343501|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343502|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343503|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
154343504|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343505|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343506|NCT03892447|Protective Agents|protective agents|mesh-ancestor
154343507|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154343508|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
154343509|NCT03892447|Urological Agents|urological agents|mesh-ancestor
154343510|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343511|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343512|NCT03892447|Analgesics|analgesics|mesh-ancestor
154343513|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
154343514|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343515|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343516|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
154343517|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154343518|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154343519|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154343520|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154343521|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
154343522|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
154343523|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
154343524|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154343525|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154343526|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
154343527|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343528|NCT05250596|Colchicine|colchicine|mesh-list
154343529|NCT05250596|Atorvastatin|atorvastatin|mesh-list
154343530|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154343531|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154343532|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
154343533|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343534|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154343535|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154343536|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343537|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
154343538|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343539|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
154343540|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
154343541|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
154343542|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343543|NCT04788914|Charcoal|charcoal|mesh-list
154343544|NCT04788914|Antidotes|antidotes|mesh-ancestor
154343545|NCT04788914|Protective Agents|protective agents|mesh-ancestor
154343546|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343547|NCT03716622|Clarithromycin|clarithromycin|mesh-list
154343548|NCT03716622|Furazolidone|furazolidone|mesh-list
154343549|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343550|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343551|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154343552|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343553|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089892|NCT04046679|Bleomycin|bleomycin|mesh-list
154343554|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154343555|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154343556|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154343557|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154343558|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154343559|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154343560|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154343561|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154343562|NCT03892213|Benzonidazole|benzonidazole|mesh-list
154343566|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154343567|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154343568|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154343569|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343570|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
154343571|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154343572|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343573|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
154343574|NCT03891979|Metronidazole|metronidazole|mesh-list
154343575|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
154343576|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
154343577|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154343578|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343579|NCT03891979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154343580|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343581|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343582|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343583|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154343584|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154343585|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154343586|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154343587|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343588|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154343589|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154343590|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
154343591|NCT01260415|Panitumumab|panitumumab|mesh-list
154343592|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343593|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154343594|NCT04608344|Atorvastatin|atorvastatin|mesh-list
154343595|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154343596|NCT04608344|Pravastatin|pravastatin|mesh-list
154343597|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154343604|NCT03891433|Meropenem|meropenem|mesh-list
154343610|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154343611|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343612|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343613|NCT03895411|Sotalol|sotalol|mesh-list
154343614|NCT03895411|Propafenone|propafenone|mesh-list
154343615|NCT03895411|Metoprolol|metoprolol|mesh-list
154343616|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154343617|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154343618|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
154343619|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343620|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343621|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343622|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154343623|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
154343624|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
154343625|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343626|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154343627|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154343628|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343629|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154089976|NCT02598960|Nivolumab|nivolumab|mesh-list
154343630|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154343631|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154343632|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
154343633|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343634|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
154343635|NCT03891277|Hematinics|hematinics|mesh-ancestor
154343636|NCT03888157|Liraglutide|liraglutide|mesh-list
154343637|NCT03888157|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154343638|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154343639|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343640|NCT03888157|Incretins|incretins|mesh-ancestor
154343641|NCT03888157|Hormones|hormones|mesh-ancestor
154343642|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154343643|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
154343644|NCT01154491|Hematinics|hematinics|mesh-ancestor
154343648|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154343650|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
154343651|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343652|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343653|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343654|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343655|NCT01259479|Satraplatin|satraplatin|mesh-list
154343656|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343657|NCT01260727|Vaccines|vaccines|mesh-list
154343658|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
154343659|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343660|NCT03890809|Deucravacitinib|deucravacitinib|mesh-list
154343661|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
154343662|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154343663|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343664|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343665|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
154343666|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154343667|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154343668|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154343669|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343670|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343671|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
154343672|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343673|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343674|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154343675|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343676|NCT01154569|Azithromycin|azithromycin|mesh-list
154343677|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343678|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343679|NCT03891043|Selenium|selenium|mesh-list
154343680|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
154343681|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343689|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154343690|NCT03890341|Betadex|betadex|mesh-list
154343691|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154343692|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154343693|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154343694|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343695|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154343696|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154343697|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154343698|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154343699|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
154343700|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
154343701|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
154343702|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
154343703|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343704|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343705|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154343706|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
154343707|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154343708|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154343709|NCT03890341|Diuretics|diuretics|mesh-ancestor
154343710|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
154343711|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154343712|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154343713|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154343714|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
154343715|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154343716|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154343717|NCT03890341|Estrogens|estrogens|mesh-ancestor
154343718|NCT03890341|Hormones|hormones|mesh-ancestor
154343719|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
154343729|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154343730|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343731|NCT01152853|Dacomitinib|dacomitinib|mesh-list
154343732|NCT01152853|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154343733|NCT01152853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154343734|NCT01152853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343735|NCT01152853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343736|NCT03894085|Paroxetine|paroxetine|mesh-list
154343737|NCT03894085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154343738|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154343739|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343740|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343741|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343742|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
154343743|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343744|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154343745|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
154343746|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154343747|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154343748|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154343749|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343750|NCT01152931|Vitamins|vitamins|mesh-list
154343751|NCT01152931|Vitamin E|vitamin e|mesh-list
154343752|NCT01152931|Tocopherols|tocopherols|mesh-list
154343753|NCT01152931|Tocotrienols|tocotrienols|mesh-list
154343754|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
154343778|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154343779|NCT01261117|Ibuprofen|ibuprofen|mesh-list
154343780|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343781|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343782|NCT01261117|Analgesics|analgesics|mesh-ancestor
154343783|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
154343784|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343785|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343786|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343787|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343788|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154343789|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343790|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343791|NCT03889717|Vitamin D|vitamin d|mesh-list
154343792|NCT03889717|Vitamins|vitamins|mesh-ancestor
154343793|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
154343794|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343795|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154343796|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
154343797|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154343798|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154343799|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343800|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
154343801|NCT03885895|Coagulants|coagulants|mesh-ancestor
154343802|NCT01154647|Citalopram|citalopram|mesh-list
154343803|NCT01154647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154343804|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154343805|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343806|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343807|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343808|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
154343809|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343817|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343818|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343819|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
154343820|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343821|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154343822|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
154343823|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154343824|NCT01155505|Lenalidomide|lenalidomide|mesh-list
154343825|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
154343826|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343827|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154343828|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154343829|NCT01155505|Growth Substances|growth substances|mesh-ancestor
154343830|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
154343831|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343832|NCT01153243|Vitamin D|vitamin d|mesh-list
154343833|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
154343834|NCT01153243|Vitamins|vitamins|mesh-ancestor
154343835|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
154343836|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343837|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154343838|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154343839|NCT03432858|Vancomycin|vancomycin|mesh-list
154343840|NCT03432858|Cefazolin|cefazolin|mesh-list
154343841|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343842|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343843|NCT01261429|Nilotinib|nilotinib|mesh-list
154343844|NCT01261429|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154343845|NCT01261429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154343846|NCT01261429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343847|NCT01261429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343848|NCT01154803|Micronutrients|micronutrients|mesh-list
154343849|NCT01154803|Trace Elements|trace elements|mesh-list
154343850|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343851|NCT03885427|Ketamine|ketamine|mesh-list
154343852|NCT03885427|Analgesics|analgesics|mesh-ancestor
154343856|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154090186|NCT00495716|Acyclovir|acyclovir|mesh-list
154343857|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154343858|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
154343859|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
154343860|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154343861|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154343862|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154343863|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343864|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343865|NCT03456960|Aspirin|aspirin|mesh-list
154343866|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343867|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343868|NCT03456960|Analgesics|analgesics|mesh-ancestor
154343869|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
154343870|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343871|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343872|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343873|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154343874|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154343875|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154343876|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343877|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154343878|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154343879|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343880|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
154343881|NCT03716388|Mesalamine|mesalamine|mesh-list
154343900|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343902|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
154343903|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
154343904|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154343905|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343906|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
154343907|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343908|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154343909|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154343910|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154343911|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154343912|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343913|NCT01261741|Memantine|memantine|mesh-list
154343914|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154343915|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154343916|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
154343917|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343918|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343919|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343920|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154343921|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154343922|NCT01157455|Aspirin|aspirin|mesh-list
154343923|NCT01157455|Everolimus|everolimus|mesh-list
154343924|NCT01157455|Heparin|heparin|mesh-list
154343925|NCT01157455|Bivalirudin|bivalirudin|mesh-list
154343926|NCT01157455|Clopidogrel|clopidogrel|mesh-list
154343927|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154343928|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154343929|NCT01157455|Analgesics|analgesics|mesh-ancestor
154343930|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
154343931|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154343932|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343933|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343940|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343941|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
154343942|NCT01157455|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154343943|NCT01157455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154343944|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154343945|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
154343946|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343947|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154343948|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154343949|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154343950|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
154343951|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154343952|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
154343953|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
154343954|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154343955|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
154343956|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154343957|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343958|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343959|NCT03884881|Meropenem|meropenem|mesh-list
154343960|NCT03884881|Imipenem|imipenem|mesh-list
154343961|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343962|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343963|NCT01154881|Insulin|insulin|mesh-list
154343964|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154343965|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343966|NCT03886441|Beclomethasone|beclomethasone|mesh-list
154343967|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154343968|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
154343969|NCT03886441|Hormones|hormones|mesh-ancestor
154343970|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154343971|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154343972|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154343973|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
154343974|NCT03713346|Caseins|caseins|mesh-list
154343975|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
154343976|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
154343977|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343978|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
154343980|NCT01154959|Isoniazid|isoniazid|mesh-list
154343981|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
154343982|NCT01154959|Ethambutol|ethambutol|mesh-list
154343983|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154343984|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154343985|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154343986|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154343987|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154343988|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154343989|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154343990|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154343991|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
154343992|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
154343993|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154343994|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154343995|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154343996|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154343997|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154343998|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154343999|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154344000|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154344001|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154344002|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
154344003|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154344004|NCT03881293|Lidocaine|lidocaine|mesh-list
154344005|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
154344006|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
154344007|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344008|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344009|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
154344010|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344015|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344016|NCT01155037|Vaccines|vaccines|mesh-list
154344017|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
154344018|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344019|NCT01261897|Ropivacaine|ropivacaine|mesh-list
154344020|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
154344021|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
154344022|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344023|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344024|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
154344025|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344026|NCT03448536|Acetaminophen|acetaminophen|mesh-list
154344027|NCT03448536|Naproxen|naproxen|mesh-list
154344028|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154344029|NCT03448536|Analgesics|analgesics|mesh-ancestor
154344030|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
154344031|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344032|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344033|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
154344035|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344069|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
154344070|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344071|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154344072|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154344073|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344074|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344075|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
154344076|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
154344077|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344078|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090413|NCT00767039|Poractant alfa|poractant alfa|mesh-list
154344079|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154344080|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154344081|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
154344082|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154344083|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154344084|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154344085|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154344086|NCT03884491|Vortioxetine|vortioxetine|mesh-list
154344087|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
154344088|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344089|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154344090|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154344091|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344098|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
154344116|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154344118|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154344119|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154344120|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344121|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344122|NCT03424044|Glucagon|glucagon|mesh-list
154344123|NCT03424044|Pancrelipase|pancrelipase|mesh-list
154344124|NCT03424044|Pancreatin|pancreatin|mesh-list
154344125|NCT03424044|Hormones|hormones|mesh-list
154344126|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344127|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344128|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154344129|NCT03880903|Albuterol|albuterol|mesh-list
154344130|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154344131|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
154344132|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344133|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344134|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154344135|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
154344136|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
154344137|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154344138|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154344139|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154344140|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154344141|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
154344142|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344143|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344144|NCT01155895|Amlodipine|amlodipine|mesh-list
154344145|NCT01155895|Benazepril|benazepril|mesh-list
154344146|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154344147|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154344148|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154344152|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
154344154|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
154344155|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344156|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
154344157|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154344158|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344159|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154344160|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154344161|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344162|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344163|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344164|NCT01589809|Niacinamide|niacinamide|mesh-list
154344166|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
154344167|NCT01589809|Vitamins|vitamins|mesh-ancestor
154344168|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
154344169|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344170|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
154344171|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154344172|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
154344173|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344174|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154344175|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
154344176|NCT01264237|Etoricoxib|etoricoxib|mesh-list
154344177|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154344178|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154344179|NCT01264237|Analgesics|analgesics|mesh-ancestor
154344180|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
154344181|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344182|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344183|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344184|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154344185|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154344189|NCT03880825|Metformin|metformin|mesh-list
154344196|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154344197|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
154344198|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344199|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344200|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344202|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
154344203|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154344204|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
154344205|NCT03880357|Calcipotriene|calcipotriene|mesh-list
154344206|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154344207|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344208|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
154344209|NCT03880357|Hormones|hormones|mesh-ancestor
154344210|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344211|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344212|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154344213|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
154344214|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
154344215|NCT01266031|Bevacizumab|bevacizumab|mesh-list
154344216|NCT01266031|Vorinostat|vorinostat|mesh-list
154344217|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154344218|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344219|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154344220|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154344221|NCT01266031|Growth Substances|growth substances|mesh-ancestor
154344222|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344223|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
154344224|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154344225|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344226|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344227|NCT03880045|Vasopressins|vasopressins|mesh-list
154344228|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
154344237|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
154344238|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344239|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344240|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154344241|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154344242|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
154344243|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344244|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344246|NCT01266187|Cetuximab|cetuximab|mesh-list
154344247|NCT01266187|Fluorouracil|fluorouracil|mesh-list
154344248|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
154344249|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154344250|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344251|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
154344252|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344301|NCT00075725|Thioguanine|thioguanine|mesh-list
154344302|NCT00075725|BB 1101|bb 1101|mesh-list
154344303|NCT00075725|Calcium|calcium|mesh-list
154344304|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
154344305|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
154344306|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154344308|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344309|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154344310|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154344311|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
154344312|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344313|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344314|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154344315|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344316|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
154344317|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
154344318|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344319|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154344320|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
154344321|NCT00075725|Hormones|hormones|mesh-ancestor
154344322|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344323|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154344324|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
154344325|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344326|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154344327|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154344328|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154344329|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154344330|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154344331|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154344332|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
154344344|NCT00075725|Vitamins|vitamins|mesh-ancestor
154344345|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
154344346|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154344347|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
154344348|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
154344349|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
154344350|NCT00075725|Hematinics|hematinics|mesh-ancestor
154344351|NCT02953782|Cetuximab|cetuximab|mesh-list
154344352|NCT02953782|Magrolimab|magrolimab|mesh-list
154344353|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154344354|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344356|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154344357|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154344358|NCT01264783|Analgesics|analgesics|mesh-ancestor
154344359|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
154344360|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344361|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344362|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344363|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154344364|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154344365|NCT01160029|Nateglinide|nateglinide|mesh-list
154344366|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154344367|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344368|NCT00057863|Paclitaxel|paclitaxel|mesh-list
154344369|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
154344370|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154344371|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344372|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
154344373|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
154344374|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
154344375|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344376|NCT01266655|Baclofen|baclofen|mesh-list
154344377|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154344378|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344385|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344386|NCT00075023|Thalidomide|thalidomide|mesh-list
154344387|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154344388|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
154344389|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344390|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
154344391|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154344392|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154344393|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154344394|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154344395|NCT00075023|Growth Substances|growth substances|mesh-ancestor
154344396|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
154344397|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344398|NCT01100801|Cisplatin|cisplatin|mesh-list
154344399|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
154344400|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344401|NCT01263145|Paclitaxel|paclitaxel|mesh-list
154344403|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344443|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154344444|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154344445|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
154344446|NCT01265017|Estradiol|estradiol|mesh-list
154344447|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154344448|NCT01265017|Hormones|hormones|mesh-ancestor
154344449|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344450|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344451|NCT01265017|Estrogens|estrogens|mesh-ancestor
154344506|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154344507|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154344508|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344509|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344510|NCT01266811|Dexamethasone|dexamethasone|mesh-list
154344511|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
154344512|NCT01266811|Bortezomib|bortezomib|mesh-list
154344513|NCT01266811|Siltuximab|siltuximab|mesh-list
154344514|NCT01266811|BB 1101|bb 1101|mesh-list
154344515|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344516|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
154344517|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
154344518|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344519|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344520|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154344521|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
154344522|NCT01266811|Hormones|hormones|mesh-ancestor
154344523|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344524|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154344525|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344526|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
154344527|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344529|NCT01158937|Meropenem|meropenem|mesh-list
154344561|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344562|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344563|NCT01089179|Metformin|metformin|mesh-list
154344564|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154344565|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344566|NCT01160185|Paclitaxel|paclitaxel|mesh-list
154344567|NCT01160185|Topotecan|topotecan|mesh-list
154344568|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154344569|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344570|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
154344571|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
154344572|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
154344573|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344574|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154344575|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154344576|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344577|NCT03419364|Niacinamide|niacinamide|mesh-list
154344578|NCT03419364|Niacin|niacin|mesh-list
154344579|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
154344580|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
154344581|NCT03419364|Vitamins|vitamins|mesh-ancestor
154344582|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
154344583|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344584|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154344585|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
154344587|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154344611|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
154344612|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
154344613|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154344615|NCT01160341|Hormones|hormones|mesh-ancestor
154344616|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344617|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344618|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154344619|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344620|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
154344621|NCT03882775|Heparin|heparin|mesh-list
154344622|NCT03882775|Bivalirudin|bivalirudin|mesh-list
154344623|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
154344624|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154344625|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154344626|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344627|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
154344628|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154344629|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
154344630|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344631|NCT03877705|Listerine|listerine|mesh-list
154344667|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154344668|NCT02954172|Growth Substances|growth substances|mesh-ancestor
154344669|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344670|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
154344671|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
154344672|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344673|NCT02953938|Ranibizumab|ranibizumab|mesh-list
154344674|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154344675|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154344676|NCT02953938|Growth Substances|growth substances|mesh-ancestor
154344677|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344678|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
154344679|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344680|NCT01161667|Naratriptan|naratriptan|mesh-list
154344681|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154344682|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154344683|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154344684|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
154344685|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344686|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344687|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344688|NCT02526979|Mirabegron|mirabegron|mesh-list
154344689|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154344690|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154344691|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154344692|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
154344693|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344694|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344695|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344696|NCT02526979|Urological Agents|urological agents|mesh-ancestor
154344697|NCT03882541|Midazolam|midazolam|mesh-list
154344698|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154344699|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154344700|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344701|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344706|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
154344707|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
154344708|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
154344709|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
154344710|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344711|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344712|NCT01267903|Vaccines|vaccines|mesh-list
154344713|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
154344714|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344715|NCT03576313|Ivermectin|ivermectin|mesh-list
154344716|NCT03576313|Piperaquine|piperaquine|mesh-list
154344717|NCT03576313|Artenimol|artenimol|mesh-list
154344772|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
154344773|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
154344774|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344775|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154344776|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154344777|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344778|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344779|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
154344780|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
154344781|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344782|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344783|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154344784|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154344785|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
154344786|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154344787|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154344788|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154344789|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154344790|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
154344791|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
154344826|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
154344827|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344828|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344829|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154344830|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154344831|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
154344832|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344833|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344834|NCT01268371|Everolimus|everolimus|mesh-list
154344835|NCT01268371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154344836|NCT01268371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154344837|NCT01268371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344887|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154344888|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154344889|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154344890|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154344891|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344892|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
154344893|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154344894|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344895|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154344896|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154344897|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154344898|NCT01167049|Capecitabine|capecitabine|mesh-list
154344899|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154344900|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
154344901|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344902|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344945|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154344946|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344947|NCT01167127|Analgesics|analgesics|mesh-ancestor
154344948|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
154344949|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154344950|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154344951|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154344952|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154344953|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
154344954|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344955|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344956|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154344957|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154344958|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154344959|NCT03872011|Vitamins|vitamins|mesh-list
154344960|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
154344961|NCT03872011|Thiamine|thiamine|mesh-list
154344962|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
154344963|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
154344964|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344965|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154344966|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
154344967|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344968|NCT03872011|Protective Agents|protective agents|mesh-ancestor
154344969|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
154344970|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
154344971|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154344972|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154344990|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154344991|NCT01270789|Liraglutide|liraglutide|mesh-list
154344992|NCT01270789|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154344993|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154344994|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154344995|NCT01270789|Incretins|incretins|mesh-ancestor
154344996|NCT01270789|Hormones|hormones|mesh-ancestor
154344997|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154344998|NCT01164085|Ketorolac|ketorolac|mesh-list
154344999|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154345000|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154345001|NCT01164085|Analgesics|analgesics|mesh-ancestor
154345002|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
154345003|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345004|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345005|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345006|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345007|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154345008|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345044|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154345045|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
154345046|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
154345047|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345048|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154345049|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154345050|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
154345051|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154345052|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
154345053|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154345054|NCT01268761|Cetrorelix|cetrorelix|mesh-list
154345055|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154345056|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
154345057|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154345058|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345102|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345103|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345104|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154345105|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154345106|NCT03756883|Fluticasone|fluticasone|mesh-list
154345107|NCT03756883|Xhance|xhance|mesh-list
154345108|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154345109|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154345110|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345111|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154345168|NCT01268917|Aspirin|aspirin|mesh-list
154345169|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154345170|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154345171|NCT01268917|Analgesics|analgesics|mesh-ancestor
154345172|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
154345173|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345174|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345175|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345176|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345177|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154345178|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154345179|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345180|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154345181|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154345182|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345183|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
154345184|NCT01281163|Lapatinib|lapatinib|mesh-list
154345185|NCT01281163|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154345186|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154345187|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345188|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345189|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345190|NCT01268995|Cyclosporine|cyclosporine|mesh-list
154345191|NCT01268995|Tacrolimus|tacrolimus|mesh-list
154345192|NCT01268995|Cyclosporins|cyclosporins|mesh-list
154345193|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154345194|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
154345195|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345196|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154345197|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345198|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345199|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
154345211|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
154345212|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345213|NCT00009737|Antidotes|antidotes|mesh-ancestor
154345214|NCT00009737|Protective Agents|protective agents|mesh-ancestor
154345215|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
154345216|NCT00009737|Vitamins|vitamins|mesh-ancestor
154345217|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
154345218|NCT03711240|Leucovorin|leucovorin|mesh-list
154345219|NCT03711240|Bevacizumab|bevacizumab|mesh-list
154345220|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
154345221|NCT03711240|Irinotecan|irinotecan|mesh-list
154345222|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154345223|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345224|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154345225|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154345226|NCT03711240|Growth Substances|growth substances|mesh-ancestor
154345227|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345228|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
154345229|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154345230|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154345231|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345232|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345233|NCT03711240|Antidotes|antidotes|mesh-ancestor
154345234|NCT03711240|Protective Agents|protective agents|mesh-ancestor
154345235|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
154345236|NCT03711240|Vitamins|vitamins|mesh-ancestor
154345237|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
154345238|NCT01271881|Heparin|heparin|mesh-list
154345239|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
154345240|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154345241|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154345242|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345243|NCT05459844|Octreotide|octreotide|mesh-list
154345244|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154345245|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345246|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154345247|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345250|NCT03874975|Vitamin D|vitamin d|mesh-list
154345251|NCT03874975|Vitamins|vitamins|mesh-ancestor
154345252|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
154345253|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345254|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154345255|NCT01164709|Nelfinavir|nelfinavir|mesh-list
154345256|NCT01164709|Bortezomib|bortezomib|mesh-list
154345257|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345258|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154345259|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154345260|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
154345261|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345263|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154345317|NCT00028769|Flutamide|flutamide|mesh-list
154345318|NCT00028769|Estramustine|estramustine|mesh-list
154345319|NCT00028769|Nilutamide|nilutamide|mesh-list
154345320|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154345321|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345322|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
154345323|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
154345324|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
154345325|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345328|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345380|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345382|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
154345383|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
154345384|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
154345385|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154345386|NCT01168063|Amoxicillin|amoxicillin|mesh-list
154345387|NCT01168063|Metronidazole|metronidazole|mesh-list
154345388|NCT01168063|Clarithromycin|clarithromycin|mesh-list
154345389|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154345390|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345391|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
154345392|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154345443|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154345444|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154345445|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154345446|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345447|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345448|NCT01168531|Dexamethasone|dexamethasone|mesh-list
154345449|NCT01168531|Pregabalin|pregabalin|mesh-list
154345450|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345451|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
154345452|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
154345453|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345454|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345455|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345456|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
154345504|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154345505|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345506|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345507|NCT03868969|Fosfomycin|fosfomycin|mesh-list
154345508|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154345509|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345510|NCT01311570|Buprenorphine|buprenorphine|mesh-list
154345511|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154345512|NCT01311570|Narcotics|narcotics|mesh-ancestor
154345513|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345514|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345515|NCT01311570|Analgesics|analgesics|mesh-ancestor
154345516|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
154345517|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345518|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154345519|NCT01170325|Valproic Acid|valproic acid|mesh-list
154345520|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
154345521|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345522|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345523|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
154345524|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345525|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345526|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
154345527|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154345528|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345529|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154345530|NCT03355326|Glycerol|glycerol|mesh-list
154345531|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154345532|NCT03355326|Protective Agents|protective agents|mesh-ancestor
154345533|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345534|NCT01170637|Ibuprofen|ibuprofen|mesh-list
154345535|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
154345536|NCT01170637|Ephedrine|ephedrine|mesh-list
154345537|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154345538|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154345539|NCT01170637|Analgesics|analgesics|mesh-ancestor
153524695|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
154345543|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345544|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154345545|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154345546|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345547|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345548|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154345549|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
154345550|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154345551|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
154345552|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
154345553|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154345554|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154345555|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
154345556|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
154345602|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345603|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154345604|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
154345605|NCT03868033|Denosumab|denosumab|mesh-list
154345606|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154345607|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345608|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
154345609|NCT01166815|Astringents|astringents|mesh-ancestor
154345610|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345611|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154345612|NCT03751657|Insulin|insulin|mesh-list
154345613|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154345614|NCT03751657|Metformin|metformin|mesh-list
154345615|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
154345616|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154345617|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154345618|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345619|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
154345620|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345622|NCT03873415|Deucravacitinib|deucravacitinib|mesh-list
154345661|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154345662|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154345663|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154345664|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345665|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154345666|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154345667|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
154345668|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
154345669|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345677|NCT01171651|Sorafenib|sorafenib|mesh-list
154345725|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154345726|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154345727|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
154345728|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
154345729|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
154345730|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154345731|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154345732|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154345733|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154345734|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154345735|NCT03863977|Dexamethasone|dexamethasone|mesh-list
154345736|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
154345737|NCT03863977|Bupivacaine|bupivacaine|mesh-list
154092058|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154345738|NCT03863977|BB 1101|bb 1101|mesh-list
154345739|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154345740|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
154345741|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
154345742|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345743|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345744|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154345745|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
154345746|NCT03863977|Hormones|hormones|mesh-ancestor
154345749|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345776|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345777|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345778|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
154345779|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154345780|NCT01286233|Metformin|metformin|mesh-list
154345781|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154345782|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345784|NCT01175161|Trace Elements|trace elements|mesh-ancestor
154345785|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
154345786|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345841|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345842|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
154345843|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154345844|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
154345845|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345846|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154345847|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345848|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
154345849|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154345853|NCT01285219|Lenograstim|lenograstim|mesh-list
154345907|NCT05625893|Atezolizumab|atezolizumab|mesh-list
154345908|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154345909|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345910|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154345911|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154345912|NCT05625893|Growth Substances|growth substances|mesh-ancestor
154345913|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345914|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
154345915|NCT05625893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154345916|NCT05625893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345917|NCT01178047|Rasagiline|rasagiline|mesh-list
154345918|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154345919|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154345920|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154345921|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154345922|NCT01178047|Protective Agents|protective agents|mesh-ancestor
154345923|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345924|NCT01101113|Cinacalcet|cinacalcet|mesh-list
154345927|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154345961|NCT01288339|Antidotes|antidotes|mesh-ancestor
154345962|NCT01288339|Protective Agents|protective agents|mesh-ancestor
154345963|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
154092280|NCT00714558|Narcotics|narcotics|mesh-ancestor
154345965|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
154345966|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154345968|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154345969|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154345970|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
154345971|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345972|NCT01105481|Amisulpride|amisulpride|mesh-list
154345973|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154345974|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154345975|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154345976|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154345977|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154345978|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154345979|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
154345980|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154345984|NCT01178203|Naproxen|naproxen|mesh-list
154346016|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154346017|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
154346018|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346019|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346020|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
154346021|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346022|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154346023|NCT01284907|Vitamin D|vitamin d|mesh-list
154346024|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
154346025|NCT01284907|Vitamins|vitamins|mesh-ancestor
154346026|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
154346027|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346028|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154346029|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154346030|NCT01286857|Silicon|silicon|mesh-list
154346031|NCT01286857|Trace Elements|trace elements|mesh-ancestor
154346032|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
154346033|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346034|NCT01101269|Lisinopril|lisinopril|mesh-list
154346035|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154346036|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
154346037|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346038|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346039|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154346066|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346067|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346069|NCT03864913|Androgens|androgens|mesh-ancestor
154346070|NCT03864913|Hormones|hormones|mesh-ancestor
154346071|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154346072|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346073|NCT03865147|Acetaminophen|acetaminophen|mesh-list
154346074|NCT03865147|Cetrimonium|cetrimonium|mesh-list
154346075|NCT03865147|Ibuprofen|ibuprofen|mesh-list
154346076|NCT03865147|Lidocaine|lidocaine|mesh-list
154346077|NCT03865147|Epinephrine|epinephrine|mesh-list
154346078|NCT03865147|Racepinephrine|racepinephrine|mesh-list
154346079|NCT03865147|Bupivacaine|bupivacaine|mesh-list
154346080|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154346081|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
154346082|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
154346083|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
154346084|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346085|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346086|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
154346087|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346088|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154346089|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154346090|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154346091|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419025|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
154346092|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346093|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154346095|NCT03865147|Analgesics|analgesics|mesh-ancestor
154346113|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154346114|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154346115|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346116|NCT03722823|Tucatinib|tucatinib|mesh-list
154346117|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346118|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154346119|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346120|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346121|NCT03862651|Cangrelor|cangrelor|mesh-list
154346122|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154346123|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154346124|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154346125|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154346126|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
154346173|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154346175|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346176|NCT01174693|Clopidogrel|clopidogrel|mesh-list
154346177|NCT01174693|Triflusal|triflusal|mesh-list
154346178|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154346179|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154346180|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154346181|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154346182|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
154346238|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346239|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
154346240|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
154346241|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346242|NCT03864523|Pioglitazone|pioglitazone|mesh-list
154346243|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154346244|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346245|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154346246|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
154346247|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346248|NCT05619887|Fentanyl|fentanyl|mesh-list
154346249|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154346250|NCT05619887|Narcotics|narcotics|mesh-ancestor
154346251|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346252|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346253|NCT05619887|Analgesics|analgesics|mesh-ancestor
154346254|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
154346255|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346256|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154346257|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154346258|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
154346259|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
154346260|NCT01174927|Heroin|heroin|mesh-list
154346261|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154346262|NCT01174927|Narcotics|narcotics|mesh-ancestor
154346263|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346264|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346265|NCT01174927|Analgesics|analgesics|mesh-ancestor
154346287|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154346288|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154346289|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154346290|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346291|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
154346292|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346293|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346294|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154346295|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346296|NCT01327859|Donepezil|donepezil|mesh-list
154346297|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154346298|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346299|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346300|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
154346301|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346302|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346303|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
154346304|NCT01176409|Valacyclovir|valacyclovir|mesh-list
154346305|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
154346343|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
154346344|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154346345|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
154346346|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346347|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
154346348|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154346349|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154346350|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
154346351|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346352|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154346353|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154346354|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346355|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346356|NCT03711708|Sertraline|sertraline|mesh-list
154346357|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
154346358|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154346359|NCT03711708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154346360|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154346361|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154346362|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346363|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346364|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
154346365|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346366|NCT01179529|Omalizumab|omalizumab|mesh-list
154346367|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154346368|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154346369|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
154346370|NCT00004859|Thalidomide|thalidomide|mesh-list
154346371|NCT00004859|Paclitaxel|paclitaxel|mesh-list
154346372|NCT00004859|Carboplatin|carboplatin|mesh-list
154346373|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154346386|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154346388|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
154346389|NCT03348930|Tolcapone|tolcapone|mesh-list
154346390|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154346391|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154346392|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154346393|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346394|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346395|NCT03500211|Lidocaine|lidocaine|mesh-list
154346396|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
154346397|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
154346407|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
154346448|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346449|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346450|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154346451|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154346452|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154346453|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154346454|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346455|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154346456|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154346457|NCT01176799|Growth Substances|growth substances|mesh-ancestor
154346458|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
154346459|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154346460|NCT03477903|Metoclopramide|metoclopramide|mesh-list
154346461|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
154346462|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
154346463|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346464|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346465|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154346466|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154346467|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154346468|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
154346469|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346470|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346471|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
154346472|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154346473|NCT04728425|Antibodies|antibodies|mesh-list
154346479|NCT01181401|Cisplatin|cisplatin|mesh-list
154346499|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
154346500|NCT03474081|Albuterol|albuterol|mesh-list
154346501|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
154346502|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154346503|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
154346504|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346505|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346506|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154346507|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
154346508|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
154346509|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154346510|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
154346511|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346512|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346513|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
154346514|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154346515|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154346516|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154346517|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154346518|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
154346519|NCT03393000|Vitamin A|vitamin a|mesh-list
154346520|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
154346521|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
154346522|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346523|NCT03393000|Protective Agents|protective agents|mesh-ancestor
153781802|NCT04559113|Protective Agents|protective agents|mesh-ancestor
154346524|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346525|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154346526|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346527|NCT03393000|Vitamins|vitamins|mesh-ancestor
154346528|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
154346529|NCT01311804|Parecoxib|parecoxib|mesh-list
154346530|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154346531|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154346532|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346533|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346534|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154346535|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154346536|NCT01311804|Analgesics|analgesics|mesh-ancestor
154346537|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
154346538|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346539|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346540|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154346541|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154346542|NCT03370770|Osimertinib|osimertinib|mesh-list
154346543|NCT03370770|Afatinib|afatinib|mesh-list
154346544|NCT03370770|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154346545|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154346546|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346547|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346548|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346549|NCT01180075|Ritonavir|ritonavir|mesh-list
154346550|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154346551|NCT01180075|Tenofovir|tenofovir|mesh-list
154346552|NCT01180075|Emtricitabine|emtricitabine|mesh-list
154346553|NCT01180075|Efavirenz|efavirenz|mesh-list
154346554|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154346555|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154346556|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
154346557|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346558|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346559|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154346572|NCT01311882|Zopiclone|zopiclone|mesh-list
154346579|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346580|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346581|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
154346582|NCT01287793|Tigecycline|tigecycline|mesh-list
154346583|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154346584|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346585|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154346586|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154346587|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346588|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346589|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346590|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154346591|NCT03391284|Acetaminophen|acetaminophen|mesh-list
154346592|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154346593|NCT03391284|Analgesics|analgesics|mesh-ancestor
154346594|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
154346595|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346596|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346597|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
154346598|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
154346599|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346600|NCT03719625|Norepinephrine|norepinephrine|mesh-list
154346601|NCT03719625|Ephedrine|ephedrine|mesh-list
154346602|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154346603|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154346613|NCT01289743|Etanercept|etanercept|mesh-list
154346629|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346630|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
154346631|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346632|NCT03472521|Gabapentin|gabapentin|mesh-list
154346633|NCT03472521|Analgesics|analgesics|mesh-ancestor
154346634|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
154346635|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346636|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346637|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
154346638|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154346694|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154346695|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346696|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154346698|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
154346718|NCT03857581|Olanzapine|olanzapine|mesh-list
154346764|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154346765|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
154346766|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154346767|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346834|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346835|NCT01290133|Vestipitant|vestipitant|mesh-list
154346836|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154346837|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154346838|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346839|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154346840|NCT03467217|Losartan|losartan|mesh-list
154346841|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154346842|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154346843|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154346844|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154346845|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346846|NCT01184599|Aliskiren|aliskiren|mesh-list
154346847|NCT01184599|Renin Inhibitors|renin inhibitors|mesh-ancestor
154346848|NCT01184599|Protease Inhibitors|protease inhibitors|mesh-ancestor
154346849|NCT01184599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346850|NCT01184599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346851|NCT00003875|Aldesleukin|aldesleukin|mesh-list
154346852|NCT00003875|Etoposide|etoposide|mesh-list
154346853|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
154346854|NCT00003875|Busulfan|busulfan|mesh-list
154346855|NCT00003875|Interleukin-2|interleukin-2|mesh-list
154346856|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154346857|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154346879|NCT01290211|Ritonavir|ritonavir|mesh-list
154346884|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
154346885|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154346886|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154346887|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154346888|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154346889|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
154346890|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154346891|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154346892|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154346893|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154346894|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154346895|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154346896|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154346897|NCT03720873|Gefitinib|gefitinib|mesh-list
154346898|NCT03720873|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154346899|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154346941|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154346942|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154346944|NCT01184833|Interferons|interferons|mesh-list
154346945|NCT01184833|Interferon-beta|interferon-beta|mesh-list
154346946|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
154346948|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
154347013|NCT01185223|Ganciclovir|ganciclovir|mesh-list
154347014|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154347015|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
154347016|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347017|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154347018|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347019|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347020|NCT03852979|Paclitaxel|paclitaxel|mesh-list
154347021|NCT03852979|Carboplatin|carboplatin|mesh-list
154347022|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154347023|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347024|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
154347025|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
154347074|NCT01188265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347075|NCT01291069|Tadalafil|tadalafil|mesh-list
154347076|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347077|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
154347078|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154347079|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154347080|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347081|NCT01291069|Urological Agents|urological agents|mesh-ancestor
154347082|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
154347083|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347084|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154347085|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154347086|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347087|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154347088|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347089|NCT01588639|Insulin|insulin|mesh-list
154347090|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154347091|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154347092|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093412|NCT04667312|Durvalumab|durvalumab|mesh-list
154347093|NCT02524639|Sirolimus|sirolimus|mesh-list
154347098|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
154347124|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347125|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347126|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
154347127|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
154347128|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347129|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154347130|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154347131|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154347132|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
154347133|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347134|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154347135|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154347136|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347137|NCT03494985|Muramidase|muramidase|mesh-list
154347138|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347139|NCT01185769|Tocotrienols|tocotrienols|mesh-list
154347140|NCT01185769|Vitamin E|vitamin e|mesh-list
154347141|NCT01185769|Tocopherols|tocopherols|mesh-list
154347142|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
154347143|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347144|NCT01185769|Protective Agents|protective agents|mesh-ancestor
154347145|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347146|NCT01185769|Vitamins|vitamins|mesh-ancestor
154347147|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
154347148|NCT01185847|Gemcitabine|gemcitabine|mesh-list
154347176|NCT01183663|Temsirolimus|temsirolimus|mesh-list
154347177|NCT01183663|MTOR Inhibitors|mtor inhibitors|mesh-list
154347178|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347179|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347180|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154347181|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154347182|NCT01183663|Growth Substances|growth substances|mesh-ancestor
154347183|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347184|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
154347185|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
154347186|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347187|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154347188|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154347189|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
154347238|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154347239|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347240|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347241|NCT03855865|Vortioxetine|vortioxetine|mesh-list
154347242|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
154347243|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154347244|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154347245|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154347246|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347301|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154347302|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
154347303|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347304|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347305|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347306|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
154347307|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154347308|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154347309|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347310|NCT01292161|Silymarin|silymarin|mesh-list
154347311|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
154347312|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347313|NCT01292161|Protective Agents|protective agents|mesh-ancestor
154347314|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347315|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
154347316|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
154347317|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154347356|NCT01107509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154347357|NCT01107509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154347358|NCT01107509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347359|NCT01107509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347360|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154347425|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154347426|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
154347427|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347428|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154347429|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
154347430|NCT01588093|Mecasermin|mecasermin|mesh-list
154347494|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
154347495|NCT03851341|Metformin|metformin|mesh-list
154347496|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154347497|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154347498|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347499|NCT03851341|Incretins|incretins|mesh-ancestor
154347500|NCT03851341|Hormones|hormones|mesh-ancestor
154347501|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347502|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154347503|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
154347504|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347505|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347506|NCT01292785|Hormones|hormones|mesh-list
154347507|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347508|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347509|NCT02323126|Nivolumab|nivolumab|mesh-list
154347510|NCT02323126|Nazartinib|nazartinib|mesh-list
154347511|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347512|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347549|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347550|NCT01328015|Oxybutynin|oxybutynin|mesh-list
154347551|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154347552|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
154347553|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
154347554|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347555|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347556|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154347616|NCT03851263|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154093943|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
154347617|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154347618|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154347619|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
154347620|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347621|NCT03851263|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154347622|NCT03851263|Protease Inhibitors|protease inhibitors|mesh-ancestor
154347623|NCT03851263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347624|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154347683|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347684|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154347685|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154347686|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154347687|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154347688|NCT01294969|Analgesics|analgesics|mesh-ancestor
154347689|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
154347690|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347691|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347692|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154347693|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154347694|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154347695|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154347698|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
154347743|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
154347744|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
154347745|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347746|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154347747|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154347748|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347749|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347750|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154347751|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
154347752|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154347753|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347755|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
154347801|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154347802|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
154347803|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347804|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347805|NCT03947411|Oseltamivir|oseltamivir|mesh-list
154347806|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
154347807|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154347808|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347809|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347810|NCT03257254|Polidocanol|polidocanol|mesh-list
154347811|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154347812|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154347815|NCT01327469|Piperazine|piperazine|mesh-list
154347865|NCT02938624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347866|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
154347867|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154347868|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154347869|NCT03469804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154347870|NCT03469804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347871|NCT03944291|Bupivacaine|bupivacaine|mesh-list
154347872|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
154347873|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
154347874|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154347875|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347876|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
154347878|NCT01102439|Aspirin|aspirin|mesh-list
154347924|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154347925|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
154347926|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154347928|NCT04285684|Analgesics|analgesics|mesh-ancestor
154347929|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
154347930|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154347931|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347993|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154347994|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
154347995|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154347996|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154347997|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154347999|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154348000|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348001|NCT01293097|Atorvastatin|atorvastatin|mesh-list
154348002|NCT01293097|Pravastatin|pravastatin|mesh-list
154348003|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154348004|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154348005|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
154348006|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348007|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154348008|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154348009|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348049|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348050|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
154348051|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
154348052|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154348053|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
154348054|NCT05158426|Propofol|propofol|mesh-list
154348055|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154348056|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348057|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348058|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154348113|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
154348114|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348115|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
154348116|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154348117|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348118|NCT01109615|Gemcitabine|gemcitabine|mesh-list
154348119|NCT01109615|Pemetrexed|pemetrexed|mesh-list
154348120|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154348121|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
154348122|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348123|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348124|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348125|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154348126|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154348127|NCT01209065|Ritonavir|ritonavir|mesh-list
154348128|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
154348129|NCT01209065|Dolutegravir|dolutegravir|mesh-list
154348130|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154348131|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154348132|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
154348166|NCT01193881|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154348167|NCT01193881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154348168|NCT01193881|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154348169|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348170|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348171|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348172|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348173|NCT01194037|Interferons|interferons|mesh-list
154348174|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
154348175|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
154348176|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154348177|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348178|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
154348179|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348180|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
154348181|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348182|NCT03480243|Erythromycin|erythromycin|mesh-list
154348183|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
154348184|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154348185|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
154348186|NCT03480243|Padsevonil|padsevonil|mesh-list
154348187|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154348188|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348189|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154348190|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154348191|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348192|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348193|NCT03480243|Anticonvulsants|anticonvulsants|mesh-ancestor
154348194|NCT01109693|Mirtazapine|mirtazapine|mesh-list
154348195|NCT01109693|Sertraline|sertraline|mesh-list
154348196|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
154348197|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154348198|NCT01109693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154348199|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154348203|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
154348204|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348205|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154348206|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
154348207|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
154348208|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154348209|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154348210|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348211|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154348212|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154348213|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154348214|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154348215|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154348216|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154348217|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154348218|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
154348220|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
154348221|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
154348222|NCT01190683|Vitamins|vitamins|mesh-list
154348223|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
154348224|NCT01190683|Calcium|calcium|mesh-list
154348225|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
154348226|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348227|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348228|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154348229|NCT01190683|Antacids|antacids|mesh-ancestor
154348231|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154348252|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
154348253|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154348254|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154348255|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154348256|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
154348257|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
154348258|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348259|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348260|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
154348261|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
154348262|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154348263|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154348264|NCT01194115|Metronidazole|metronidazole|mesh-list
154348265|NCT01194115|Cephalexin|cephalexin|mesh-list
154348266|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348267|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154348268|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154348269|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154348270|NCT01209533|Iloprost|iloprost|mesh-list
154348271|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154348272|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
154348273|NCT03847363|Anesthetics|anesthetics|mesh-list
154348274|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348275|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348276|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
154348277|NCT01207739|Doxycycline|doxycycline|mesh-list
154348278|NCT01207739|Clarithromycin|clarithromycin|mesh-list
154348279|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
154348280|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154348281|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154348283|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348298|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348299|NCT03942029|Fluconazole|fluconazole|mesh-list
154348300|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
154348301|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348302|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154348303|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154348304|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348305|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348306|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154348307|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
154348308|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154348309|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348310|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154348311|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154348312|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154348313|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154348314|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
154348315|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348316|NCT01192165|Paclitaxel|paclitaxel|mesh-list
154348317|NCT01192165|Docetaxel|docetaxel|mesh-list
154348318|NCT01192165|Carboplatin|carboplatin|mesh-list
154348319|NCT01192165|Pemetrexed|pemetrexed|mesh-list
154348320|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154348321|NCT01192165|Trametinib|trametinib|mesh-list
154348322|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154348333|NCT01192243|Carboplatin|carboplatin|mesh-list
154348346|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348347|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348348|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154348349|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154348350|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
154348351|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
154348352|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348353|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154348354|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154348355|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348356|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348357|NCT01196767|Ropivacaine|ropivacaine|mesh-list
154348358|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
154348359|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
154348360|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348404|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154348405|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154348406|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
154348407|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348408|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154348409|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154348410|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
154348411|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154348412|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
154348413|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
154348414|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
154348415|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154348416|NCT03425253|Lidocaine|lidocaine|mesh-list
154348417|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
154348418|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
154348419|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348420|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348421|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
154348422|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348423|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154348425|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154348457|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154348458|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154348459|NCT01113047|Amlodipine|amlodipine|mesh-list
154348460|NCT01113047|Aliskiren|aliskiren|mesh-list
154348461|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154348462|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154348463|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348464|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348465|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154348466|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348467|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
154348468|NCT01113047|Renin Inhibitors|renin inhibitors|mesh-ancestor
154348469|NCT01113047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154348470|NCT01113047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348471|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
154348472|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154348473|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348474|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154348475|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348476|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348477|NCT01210391|Caseins|caseins|mesh-list
154348478|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
154348479|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
154348480|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348481|NCT03846739|Oxytocin|oxytocin|mesh-list
154348482|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
154348483|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154348484|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348485|NCT03716115|Budesonide|budesonide|mesh-list
154348486|NCT03716115|Teduglutide|teduglutide|mesh-list
154348487|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154348488|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154348489|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
154348495|NCT03716115|Hormones|hormones|mesh-ancestor
154348497|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154348498|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154348499|NCT03716115|Protective Agents|protective agents|mesh-ancestor
154348500|NCT01113281|Vaccines|vaccines|mesh-list
154348501|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
154348502|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348503|NCT01295593|Cladribine|cladribine|mesh-list
154348504|NCT01295593|Valproic Acid|valproic acid|mesh-list
154348505|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
154348506|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348507|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094836|NCT00720408|Tacrolimus|tacrolimus|mesh-list
154348508|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
154348561|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348562|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348563|NCT01211327|Cyclosporine|cyclosporine|mesh-list
154348564|NCT01211327|Dexamethasone|dexamethasone|mesh-list
154348565|NCT01211327|Cyclosporins|cyclosporins|mesh-list
154348566|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154348567|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
154348568|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
154348569|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348570|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348571|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154348572|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
154348573|NCT01211327|Hormones|hormones|mesh-ancestor
154348574|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154348575|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154348576|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348577|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348578|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348579|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154348580|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
154348581|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
154348582|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154348583|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
154348584|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154348585|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154348586|NCT05601895|Sorafenib|sorafenib|mesh-list
154348587|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348588|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348589|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348591|NCT01113671|Vitamin E|vitamin e|mesh-list
154348607|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
154348608|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348609|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154348610|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
154348611|NCT01109927|Insulin|insulin|mesh-list
154348612|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154348613|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348614|NCT01211795|Ketoprofen|ketoprofen|mesh-list
154348615|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154348616|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154348617|NCT01211795|Analgesics|analgesics|mesh-ancestor
154348618|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
154348619|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348620|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348621|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154348664|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348665|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154348666|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
154348667|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154348668|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348669|NCT01208441|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154348670|NCT03718377|Anesthetics|anesthetics|mesh-list
154348671|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348672|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348673|NCT01197469|Tadalafil|tadalafil|mesh-list
154348674|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
154348675|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154348676|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154348677|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348678|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348679|NCT01197469|Urological Agents|urological agents|mesh-ancestor
154348680|NCT01211561|Selenium|selenium|mesh-list
154348681|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
154348682|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348683|NCT01211561|Protective Agents|protective agents|mesh-ancestor
154348684|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348685|NCT01211561|Trace Elements|trace elements|mesh-ancestor
154348686|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
154348687|NCT01213355|Scopolamine|scopolamine|mesh-list
154348688|NCT01213355|Donepezil|donepezil|mesh-list
154348689|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154348690|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154348691|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348692|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348693|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
154348705|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
154348706|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
154348707|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154348708|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154348709|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348710|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
154348711|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348712|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348713|NCT01110473|Azacitidine|azacitidine|mesh-list
154348714|NCT01110473|Ilorasertib|ilorasertib|mesh-list
154348715|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154348716|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
154348717|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348718|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348719|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348720|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154348721|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
154348722|NCT03940391|Midazolam|midazolam|mesh-list
154348762|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
154348763|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348764|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154348765|NCT01296139|Hematinics|hematinics|mesh-ancestor
154348766|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154348767|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154348768|NCT03940469|Dexamethasone|dexamethasone|mesh-list
154348769|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
154348770|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
154348771|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154348772|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
154348773|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
154348774|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348775|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348776|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154348777|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
154348778|NCT03940469|Hormones|hormones|mesh-ancestor
154348779|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154348780|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154348781|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348782|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154348783|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348784|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154348785|NCT03940469|Analgesics|analgesics|mesh-ancestor
154348786|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
154348787|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154348788|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154348789|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154348790|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
154348791|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348793|NCT01110785|Panitumumab|panitumumab|mesh-list
154348805|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
154348806|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154348807|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348808|NCT01110941|Leucovorin|leucovorin|mesh-list
154348809|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
154348810|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348811|NCT01110941|Antidotes|antidotes|mesh-ancestor
154348812|NCT01110941|Protective Agents|protective agents|mesh-ancestor
154348813|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348814|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
154348815|NCT01110941|Vitamins|vitamins|mesh-ancestor
154348816|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
154348817|NCT03448419|Empagliflozin|empagliflozin|mesh-list
154348818|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154348819|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348820|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154348821|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348866|NCT06107673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154348867|NCT06107673|Alkylating Agents|alkylating agents|mesh-ancestor
154348868|NCT06107673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348869|NCT06107673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348870|NCT06107673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154348871|NCT06107673|Tubulin Modulators|tubulin modulators|mesh-ancestor
154348872|NCT06107673|Antimitotic Agents|antimitotic agents|mesh-ancestor
154348873|NCT06107673|Mitosis Modulators|mitosis modulators|mesh-ancestor
154348874|NCT06107673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154348875|NCT06107673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154348876|NCT06107673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154348877|NCT06107673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348878|NCT06107673|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154348879|NCT06107673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154348880|NCT06107673|Hormone Antagonists|hormone antagonists|mesh-ancestor
154348881|NCT06107673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154348882|NCT06107660|Bupivacaine|bupivacaine|mesh-list
154095184|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
154348883|NCT06107660|Anesthetics, Local|anesthetics, local|mesh-ancestor
153782027|NCT00259779|Hormones|hormones|mesh-ancestor
154348884|NCT06107660|Anesthetics|anesthetics|mesh-ancestor
154348885|NCT06107660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348886|NCT06107660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348887|NCT06107660|Sensory System Agents|sensory system agents|mesh-ancestor
154348888|NCT06107660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348890|NCT06107465|Vasodilator Agents|vasodilator agents|mesh-ancestor
154348891|NCT06106971|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
154348892|NCT06106971|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154348893|NCT06106971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154348911|NCT06105840|Antioxidants|antioxidants|mesh-ancestor
154348912|NCT06105840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348913|NCT06105840|Protective Agents|protective agents|mesh-ancestor
154348914|NCT06105840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348915|NCT06105827|Diclofenac|diclofenac|mesh-list
154348916|NCT06105827|Tamsulosin|tamsulosin|mesh-list
154348917|NCT06105827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154348918|NCT06105827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154348919|NCT06105827|Analgesics|analgesics|mesh-ancestor
154348920|NCT06105827|Sensory System Agents|sensory system agents|mesh-ancestor
154348921|NCT06105827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348922|NCT06105827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348923|NCT06105827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154348924|NCT06105827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154348925|NCT06105827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154348926|NCT06105827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348927|NCT06105827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348928|NCT06105827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154348929|NCT06105827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154348930|NCT06105827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154348931|NCT06105827|Adrenergic Agents|adrenergic agents|mesh-ancestor
154348932|NCT06105827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154348933|NCT06105827|Urological Agents|urological agents|mesh-ancestor
154348934|NCT06105671|Mannitol|mannitol|mesh-list
154348935|NCT06105671|Formoterol Fumarate|formoterol fumarate|mesh-list
154348936|NCT06105671|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154348937|NCT06105671|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154348938|NCT06105671|Autonomic Agents|autonomic agents|mesh-ancestor
154348939|NCT06105671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348940|NCT06105671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348941|NCT06105671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154348942|NCT06105671|Respiratory System Agents|respiratory system agents|mesh-ancestor
154348943|NCT06105671|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154348944|NCT06105671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154348945|NCT06105671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154348948|NCT06105671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348949|NCT06105671|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154348951|NCT06105671|Natriuretic Agents|natriuretic agents|mesh-ancestor
154348952|NCT06105658|Azacitidine|azacitidine|mesh-list
154348953|NCT06105658|Venetoclax|venetoclax|mesh-list
154348954|NCT06105658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154348955|NCT06105658|Antimetabolites|antimetabolites|mesh-ancestor
154348956|NCT06105658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348957|NCT06105658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348958|NCT06105658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154348959|NCT06105138|Cannabidiol|cannabidiol|mesh-list
154095273|NCT00723216|Enoxaparin|enoxaparin|mesh-list
154348960|NCT06105138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154348961|NCT06105138|Anticonvulsants|anticonvulsants|mesh-ancestor
154348962|NCT06104345|Vaccines|vaccines|mesh-list
154348963|NCT06104345|Immunologic Factors|immunologic factors|mesh-ancestor
154348964|NCT06104345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348965|NCT06103227|Prednisone|prednisone|mesh-list
154348966|NCT06103227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154348967|NCT06103227|Glucocorticoids|glucocorticoids|mesh-ancestor
154348968|NCT06103227|Hormones|hormones|mesh-ancestor
154348969|NCT06103227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154348970|NCT06103227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348971|NCT06103227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154348972|NCT06103227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348973|NCT06102811|Anesthetics|anesthetics|mesh-list
154348974|NCT06102811|Anesthetics, Local|anesthetics, local|mesh-list
154348975|NCT06102811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154348976|NCT06102811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154348977|NCT06102811|Sensory System Agents|sensory system agents|mesh-ancestor
154348978|NCT06102811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154348979|NCT06102603|Calpastatin|calpastatin|mesh-list
154348991|NCT06102395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154348992|NCT06102395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154348993|NCT06102395|Tubulin Modulators|tubulin modulators|mesh-ancestor
154348994|NCT06102395|Antimitotic Agents|antimitotic agents|mesh-ancestor
154348995|NCT06102395|Mitosis Modulators|mitosis modulators|mesh-ancestor
154348996|NCT06102395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154348997|NCT06102395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154348998|NCT06102395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154349000|NCT06102395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154349001|NCT06102395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349002|NCT06102395|Immunologic Factors|immunologic factors|mesh-ancestor
154349003|NCT06102395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349004|NCT06102382|Norepinephrine|norepinephrine|mesh-list
154349005|NCT06102382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154349006|NCT06102382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154349007|NCT06102382|Adrenergic Agents|adrenergic agents|mesh-ancestor
154349008|NCT06102382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349009|NCT06102382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349010|NCT06102382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349011|NCT06102382|Sympathomimetics|sympathomimetics|mesh-ancestor
154349012|NCT06102382|Autonomic Agents|autonomic agents|mesh-ancestor
154349013|NCT06102382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349014|NCT06102382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154349015|NCT06100367|Metomidate|metomidate|mesh-list
154349016|NCT06100367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154349018|NCT06100367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349037|NCT06080165|Immunologic Factors|immunologic factors|mesh-ancestor
154349038|NCT06080165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349039|NCT06071260|Atropine|atropine|mesh-list
154349040|NCT06071260|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154349041|NCT06071260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154349042|NCT06071260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154349043|NCT06071260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154349044|NCT06071260|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154349045|NCT06071260|Autonomic Agents|autonomic agents|mesh-ancestor
154349046|NCT06071260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349047|NCT06071260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349048|NCT06071260|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154349049|NCT06071260|Respiratory System Agents|respiratory system agents|mesh-ancestor
154349050|NCT06071260|Mydriatics|mydriatics|mesh-ancestor
154349051|NCT06071260|Parasympatholytics|parasympatholytics|mesh-ancestor
154349052|NCT06071260|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154349053|NCT06071260|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154349054|NCT06071260|Cholinergic Agents|cholinergic agents|mesh-ancestor
154349055|NCT06071260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349056|NCT06071260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349057|NCT06062979|Rilpivirine|rilpivirine|mesh-list
154349058|NCT06062979|Cabotegravir|cabotegravir|mesh-list
154349059|NCT06062979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154349060|NCT06062979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154349061|NCT06062979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349062|NCT06062979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349063|NCT06062979|Antiviral Agents|antiviral agents|mesh-ancestor
154349064|NCT06062979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349065|NCT06062979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154349066|NCT06062979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154349067|NCT06062979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154349068|NCT06062979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154349069|NCT06027983|Trastuzumab|trastuzumab|mesh-list
154349070|NCT06027983|Fludarabine|fludarabine|mesh-list
154349071|NCT06027983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154349076|NCT05999344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349077|NCT05999344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349078|NCT05951283|Insulin|insulin|mesh-list
154349079|NCT05951283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154349080|NCT05951283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349081|NCT05935553|Baclofen|baclofen|mesh-list
154349082|NCT05935553|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154349083|NCT05935553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349084|NCT05935553|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154349085|NCT05935553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349086|NCT05935553|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154349087|NCT05935553|GABA Agonists|gaba agonists|mesh-ancestor
154349088|NCT05935553|GABA Agents|gaba agents|mesh-ancestor
154349089|NCT05935553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154349090|NCT05935553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349091|NCT05932303|Itraconazole|itraconazole|mesh-list
154349092|NCT05932303|Carbamazepine|carbamazepine|mesh-list
154349093|NCT05932303|Gemfibrozil|gemfibrozil|mesh-list
154349094|NCT05932303|Antifungal Agents|antifungal agents|mesh-ancestor
154349095|NCT05932303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349096|NCT05932303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154349097|NCT05932303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154349098|NCT05932303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349099|NCT05932303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349127|NCT05922605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349128|NCT05922605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349129|NCT05922605|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154349130|NCT05922605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154349131|NCT05922605|Anesthetics, General|anesthetics, general|mesh-ancestor
154349132|NCT05922605|Anesthetics|anesthetics|mesh-ancestor
154349133|NCT05922605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349134|NCT05922605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154349135|NCT05922605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154349141|NCT05872854|Hypericin|hypericin|mesh-list
154349190|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154349191|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154349193|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349197|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
154349261|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349262|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154349263|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154349264|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
154349265|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349266|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
154349267|NCT05485012|Narcotics|narcotics|mesh-ancestor
154349268|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349269|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349270|NCT05485012|Analgesics|analgesics|mesh-ancestor
154349271|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
154349272|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349273|NCT05378932|Melatonin|melatonin|mesh-list
154349274|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
154349275|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349276|NCT05378932|Protective Agents|protective agents|mesh-ancestor
154349282|NCT05322070|Hormones|hormones|mesh-ancestor
154349318|NCT05051436|Mirabegron|mirabegron|mesh-list
154349319|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
154349320|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154349321|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154349386|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154349387|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154349388|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349389|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154349390|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349391|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349392|NCT04983407|Paclitaxel|paclitaxel|mesh-list
154349393|NCT04983407|Gemcitabine|gemcitabine|mesh-list
154349394|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349395|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349396|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
154349397|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
154349398|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
154349399|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349400|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154349401|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
154349402|NCT04897841|Bupivacaine|bupivacaine|mesh-list
154349403|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
154349404|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
154349405|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349406|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349407|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
154349408|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349409|NCT04893356|Dacarbazine|dacarbazine|mesh-list
154349410|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154349411|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
154349412|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349413|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349414|NCT04875728|Cefazolin|cefazolin|mesh-list
154349415|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154349429|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154349430|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349431|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349432|NCT04766684|Lidocaine|lidocaine|mesh-list
154349433|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
154349434|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
154349435|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349436|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349437|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
154349438|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349439|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154349491|NCT04493138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154349493|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
154349494|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154349495|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154349496|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349498|NCT04323956|Cortisone|cortisone|mesh-list
154349499|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
154349500|NCT04323956|Rituximab|rituximab|mesh-list
154349501|NCT04323956|Doxorubicin|doxorubicin|mesh-list
154349502|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154349560|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154349561|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154349562|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154349563|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154349564|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349566|NCT04172220|Anesthetics|anesthetics|mesh-list
154349567|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349568|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349625|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154349627|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
154349628|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
154349629|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
154349630|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349631|NCT03564678|Folic Acid|folic acid|mesh-list
154349632|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
154349633|NCT03564678|Vitamins|vitamins|mesh-ancestor
154349694|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154349695|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349696|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
154349697|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154349698|NCT02717507|Carvedilol|carvedilol|mesh-list
154349699|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154349700|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154349761|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
154349762|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349763|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154349764|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154349765|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154349766|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
154349829|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
154349830|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154349831|NCT01849263|Ibrutinib|ibrutinib|mesh-list
154349902|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154349903|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154349904|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154349905|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154349906|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154349907|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154349908|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154349909|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154349911|NCT03848533|Melatonin|melatonin|mesh-list
154349912|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154349966|NCT01196455|Mitomycins|mitomycins|mesh-list
154349967|NCT01196455|Mitomycin|mitomycin|mesh-list
154349968|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154349969|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
154349970|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154349971|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154349972|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154349973|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
154349974|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154350029|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154350030|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350031|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350033|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154350034|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350035|NCT05479591|Xultophy|xultophy|mesh-list
154350036|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154350037|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350038|NCT05479591|Incretins|incretins|mesh-ancestor
154350039|NCT05479591|Hormones|hormones|mesh-ancestor
154350090|NCT05156437|Amoxicillin|amoxicillin|mesh-list
154350091|NCT05156437|Vancomycin|vancomycin|mesh-list
154350092|NCT05156437|Levofloxacin|levofloxacin|mesh-list
154350093|NCT05156437|Rifampin|rifampin|mesh-list
154350094|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
154350095|NCT05156437|Linezolid|linezolid|mesh-list
154350096|NCT05156437|Daptomycin|daptomycin|mesh-list
154350097|NCT05156437|Cephalexin|cephalexin|mesh-list
154350098|NCT05156437|Ampicillin|ampicillin|mesh-list
154350099|NCT05156437|Cefepime|cefepime|mesh-list
154350100|NCT05156437|Ceftaroline|ceftaroline|mesh-list
154350101|NCT05156437|Oxacillin|oxacillin|mesh-list
154350102|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
154350133|NCT03715725|Warfarin|warfarin|mesh-list
154350159|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154350160|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
154350161|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350176|NCT03447249|VX-659|vx-659|mesh-list
154350229|NCT01198639|Anesthetics|anesthetics|mesh-list
154096535|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
154350230|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154350231|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350232|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350233|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154350234|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
154350235|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154350236|NCT01198639|Narcotics|narcotics|mesh-ancestor
154350237|NCT01198639|Analgesics|analgesics|mesh-ancestor
154350238|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
154350239|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350240|NCT01116713|Dexamethasone|dexamethasone|mesh-list
154350241|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350242|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
154350243|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
154350244|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350245|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350246|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154350247|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
154350283|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350284|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
154350285|NCT03715413|Tamoxifen|tamoxifen|mesh-list
154350286|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154350287|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
154350288|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350289|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350290|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154350291|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350292|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154350293|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154350294|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154350295|NCT01122251|Valsartan|valsartan|mesh-list
154350296|NCT01122251|Lercanidipine|lercanidipine|mesh-list
154350343|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350344|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154350345|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154350346|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154350347|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154350348|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154350349|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154350350|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350351|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350352|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
154350353|NCT01121237|Hematinics|hematinics|mesh-ancestor
154350354|NCT03841591|Metformin|metformin|mesh-list
154350355|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154350370|NCT01214993|Dolutegravir|dolutegravir|mesh-list
154350406|NCT03843307|Immunomodulating Agents|immunomodulating agents|mesh-list
154350407|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350408|NCT04961281|Triamcinolone|triamcinolone|mesh-list
154350409|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
154350410|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154350411|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350412|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350413|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154350414|NCT04961281|Analgesics|analgesics|mesh-ancestor
154350415|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
154350424|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
154350468|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350469|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154350470|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
154350471|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154350472|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350473|NCT01122407|Trimethaphan|trimethaphan|mesh-list
154350474|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
154350475|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350476|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154350477|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154350478|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
154350479|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
154350529|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350532|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154350533|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154350536|NCT03408873|Aripiprazole|aripiprazole|mesh-list
154350601|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154350602|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154350603|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154350604|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350605|NCT03408483|Epinephrine|epinephrine|mesh-list
154350606|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
154350607|NCT03408483|Bupivacaine|bupivacaine|mesh-list
154350608|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
154350666|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154350667|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
154350668|NCT01217099|Hormones|hormones|mesh-ancestor
154350669|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154350670|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154350671|NCT01217099|Protective Agents|protective agents|mesh-ancestor
154350672|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154350673|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350674|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154350675|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154350676|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
154350677|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154350678|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
154350679|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350680|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350726|NCT03932669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154350727|NCT03932669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350728|NCT03932669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350729|NCT03100058|Licogliflozin|licogliflozin|mesh-list
154350730|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154350731|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350732|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154350733|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350734|NCT03933761|Pamiparib|pamiparib|mesh-list
154350789|NCT01125059|Methadone|methadone|mesh-list
154350790|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154350791|NCT01125059|Narcotics|narcotics|mesh-ancestor
154350792|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350793|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350794|NCT01125059|Analgesics|analgesics|mesh-ancestor
154350795|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
154350796|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350797|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
154350858|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154350859|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350860|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350861|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350863|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154350864|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154350865|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350866|NCT03955211|Acetaminophen|acetaminophen|mesh-list
154350867|NCT03955211|Ibuprofen|ibuprofen|mesh-list
154350868|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154350869|NCT03955211|Analgesics|analgesics|mesh-ancestor
154350870|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
154350871|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154350872|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350873|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
154350874|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154350875|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154350876|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154350914|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154350915|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
154350916|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350917|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350918|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
154350920|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
154350921|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350922|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
154350923|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097289|NCT06145438|Hormones|hormones|mesh-ancestor
154350980|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
154350981|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350982|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154350983|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350984|NCT01219751|Sunitinib|sunitinib|mesh-list
154350985|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154350986|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154350987|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154350988|NCT01219751|Growth Substances|growth substances|mesh-ancestor
154350989|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350990|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
154350991|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154350992|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154350993|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154350994|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
154350995|NCT04823091|Fludarabine|fludarabine|mesh-list
154350996|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154350997|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
154350998|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154350999|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351000|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154351001|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
154351002|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351003|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351004|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154351005|NCT01125527|Vaccines|vaccines|mesh-list
154351006|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
154351007|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351008|NCT01298401|Gemcitabine|gemcitabine|mesh-list
154351009|NCT01298401|Capecitabine|capecitabine|mesh-list
154351010|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154351019|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
154351020|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154351021|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351022|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
154351023|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351024|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154351025|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154351026|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
154351027|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351028|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351029|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154351030|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154351031|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
154351080|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351081|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154351082|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154351083|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351084|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351085|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154351086|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
154351087|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351088|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351089|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154351090|NCT03724981|Semaglutide|semaglutide|mesh-list
154351091|NCT03724981|Dulaglutide|dulaglutide|mesh-list
154351092|NCT03724981|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154351093|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154351094|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351095|NCT01123031|Esomeprazole|esomeprazole|mesh-list
154351096|NCT01123031|Lansoprazole|lansoprazole|mesh-list
154351134|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351136|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
154351137|NCT05665075|Fludarabine|fludarabine|mesh-list
154351138|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154351139|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
154351140|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351141|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351142|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154351143|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
154351144|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351145|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351146|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154351147|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154351148|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
154351193|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351194|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351195|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154351196|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
154351197|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
153489492|NCT04320342|Beclomethasone|beclomethasone|mesh-list
153489493|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
154351198|NCT03359005|Vincristine|vincristine|mesh-list
154351199|NCT03359005|Temozolomide|temozolomide|mesh-list
154351200|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154351201|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097512|NCT05865457|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154351202|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
154351208|NCT04321174|Ritonavir|ritonavir|mesh-list
154351254|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351255|NCT04194814|Betamethasone|betamethasone|mesh-list
154351256|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
154351257|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154351258|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
154351259|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154351260|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154351261|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
154351262|NCT04194814|Hormones|hormones|mesh-ancestor
154351263|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154351319|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351320|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154351321|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
154351322|NCT03819127|Metformin|metformin|mesh-list
154351323|NCT03819127|Vildagliptin|vildagliptin|mesh-list
154351324|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154351325|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351326|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154351327|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
154351328|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351329|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351330|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
154351331|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154351332|NCT01299181|Atorvastatin|atorvastatin|mesh-list
154351333|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154351334|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154351335|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
154351340|NCT03930875|Aspirin|aspirin|mesh-list
154351375|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154351376|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154351377|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351378|NCT01126229|Resveratrol|resveratrol|mesh-list
154351379|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
154351380|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351381|NCT01126229|Protective Agents|protective agents|mesh-ancestor
154351382|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351383|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351384|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154351385|NCT03474640|Antibodies|antibodies|mesh-list
154351386|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154351387|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
154351388|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351433|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351434|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
154351435|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154351436|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
154351437|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
154351438|NCT01218425|Levodopa|levodopa|mesh-list
154351439|NCT01218425|Carbidopa|carbidopa|mesh-list
154351440|NCT01218425|Domperidone|domperidone|mesh-list
154351502|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
154351503|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491163|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351504|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351505|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154351506|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154351507|NCT01126697|Protective Agents|protective agents|mesh-ancestor
154351508|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351570|NCT01224353|Vitamins|vitamins|mesh-ancestor
154351571|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
154351572|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
154351573|NCT01207297|Tacrolimus|tacrolimus|mesh-list
154351575|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
154351576|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351577|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351578|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154351579|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
154351580|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351581|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351637|NCT01224509|Mifepristone|mifepristone|mesh-list
154351638|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154351639|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
154351640|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154351653|NCT01301053|Insulin|insulin|mesh-list
154351705|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
154351707|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
154351708|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154351709|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
154351710|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351711|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351712|NCT01205737|Rituximab|rituximab|mesh-list
154351713|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154351714|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351715|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
154351716|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351717|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351718|NCT01218893|Chloroquine|chloroquine|mesh-list
154351719|NCT01218893|Proguanil|proguanil|mesh-list
154351720|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154098039|NCT04933331|Fluorides|fluorides|mesh-list
154351721|NCT01218893|Amebicides|amebicides|mesh-ancestor
154351725|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
154351763|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154351764|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154351765|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
154351766|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154351767|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154351768|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351769|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154351770|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
154351771|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154351772|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154351773|NCT01226069|Protective Agents|protective agents|mesh-ancestor
154351774|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
154351823|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351824|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154351825|NCT01221935|Serotonin Agents|serotonin agents|mesh-ancestor
154351826|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351827|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
154351828|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153491164|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153491165|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491166|NCT05266404|Incretins|incretins|mesh-ancestor
153491167|NCT05266404|Hormones|hormones|mesh-ancestor
153491168|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491170|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
154351887|NCT01222013|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154351888|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154351889|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351890|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351891|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351893|NCT00741988|Carboplatin|carboplatin|mesh-list
154351894|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154351895|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154351896|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154351897|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154351898|NCT00741988|Growth Substances|growth substances|mesh-ancestor
154351899|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351900|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
154351901|NCT01131377|Acetazolamide|acetazolamide|mesh-list
154351902|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
154351903|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154351904|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154351905|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351906|NCT01131377|Diuretics|diuretics|mesh-ancestor
154351907|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
154351908|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351939|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154351940|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154351941|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154351942|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351943|NCT01226771|Ribavirin|ribavirin|mesh-list
154351944|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
154351945|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154351946|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
154351947|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154351948|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
154351949|NCT03814447|Fludarabine|fludarabine|mesh-list
154351950|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154351951|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
154351952|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154351953|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154351954|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154351955|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
154351959|NCT01129427|Pantoprazole|pantoprazole|mesh-list
154351995|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154351996|NCT05164198|Analgesics|analgesics|mesh-ancestor
154351997|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
154351998|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154351999|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352000|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154352001|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
154352002|NCT03740399|Anesthetics|anesthetics|mesh-list
153491499|NCT05349396|Eszopiclone|eszopiclone|mesh-list
153491500|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153491501|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491503|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
153491550|NCT05273814|Growth Substances|growth substances|mesh-ancestor
153491551|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491552|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
154352003|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352004|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352005|NCT05160220|Psilocybin|psilocybin|mesh-list
154352006|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
154352059|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154352060|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352062|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154352063|NCT05159674|Analgesics|analgesics|mesh-ancestor
154352064|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
154352065|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352066|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154352067|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154352068|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154352069|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
154352070|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352071|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352072|NCT03813979|Dolutegravir|dolutegravir|mesh-list
154352073|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154352074|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154352075|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352076|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352077|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154352078|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154352079|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
154352080|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352081|NCT03901144|Glycerol|glycerol|mesh-list
154352082|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154352083|NCT03901144|Protective Agents|protective agents|mesh-ancestor
154352084|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352085|NCT01129739|Cyclosporine|cyclosporine|mesh-list
154352086|NCT01129739|Cyclosporins|cyclosporins|mesh-list
154352087|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352088|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352089|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154352090|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
154352099|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154352100|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
154352101|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352102|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352103|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352104|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154352166|NCT02618980|Hemostatics|hemostatics|mesh-list
154098485|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
154352167|NCT02618980|Coagulants|coagulants|mesh-ancestor
154352168|NCT02613598|Bortezomib|bortezomib|mesh-list
154352169|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352170|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
154352171|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154352172|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
154352173|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154352174|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
154352175|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352176|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352177|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
154352178|NCT01225523|Paclitaxel|paclitaxel|mesh-list
154352179|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154352180|NCT01225523|Cisplatin|cisplatin|mesh-list
154352181|NCT01225523|Capecitabine|capecitabine|mesh-list
154352182|NCT01225523|Fluorouracil|fluorouracil|mesh-list
154352183|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154352184|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352185|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
154352186|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
154352187|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
154352188|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352189|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154352190|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
154352191|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154352192|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
154352193|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352194|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
154352195|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154352196|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
154352197|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352210|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352211|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154352212|NCT03813277|Analgesics|analgesics|mesh-ancestor
154352213|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
154352214|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352215|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154352216|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154352217|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154352218|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
154352219|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352220|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352221|NCT03815461|Paclitaxel|paclitaxel|mesh-list
154352272|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
154352273|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352274|NCT01302145|Metformin|metformin|mesh-list
154352275|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
154352276|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154352277|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352278|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154352279|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352280|NCT01560091|Tamsulosin|tamsulosin|mesh-list
154352281|NCT01560091|Silodosin|silodosin|mesh-list
154352282|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154352283|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154352284|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154352333|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154352334|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
154352335|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352336|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352337|NCT05481775|Immunomodulating Agents|immunomodulating agents|mesh-list
154352338|NCT05481775|Immunologic Factors|immunologic factors|mesh-ancestor
154352340|NCT05165914|Midazolam|midazolam|mesh-list
154352402|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
154352403|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154352404|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352405|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154352406|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154352407|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154352408|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154352409|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
154352410|NCT01131689|Sorafenib|sorafenib|mesh-list
154352411|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352412|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154352413|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352414|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352462|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154352464|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154352465|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154352466|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
154352467|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352468|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154352469|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154352529|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352530|NCT03710811|Insulin|insulin|mesh-list
154352531|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154352532|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352533|NCT01303549|Amphotericin B|amphotericin b|mesh-list
154352534|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154352535|NCT01303549|Anidulafungin|anidulafungin|mesh-list
154352536|NCT01303549|Amebicides|amebicides|mesh-ancestor
154352537|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154352538|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154352539|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154352540|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154352541|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
154352542|NCT03796975|Metformin|metformin|mesh-list
154352543|NCT03796975|Pioglitazone|pioglitazone|mesh-list
154352544|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154352545|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352546|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154352547|NCT01130753|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154352552|NCT01302613|Leucovorin|leucovorin|mesh-list
154352588|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352589|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352591|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
154352592|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154352593|NCT04453930|Irinotecan|irinotecan|mesh-list
154352594|NCT04453930|Apatinib|apatinib|mesh-list
154352595|NCT04453930|Antibodies|antibodies|mesh-list
154352656|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352657|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352658|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
154352659|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154352660|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352661|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
154352662|NCT05397262|Fluorouracil|fluorouracil|mesh-list
154352663|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352664|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
154352665|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352666|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154352667|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154352668|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
154352718|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154352719|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154352720|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352721|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
154352722|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154352723|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154352724|NCT04211272|Urological Agents|urological agents|mesh-ancestor
154352725|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154352726|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154352727|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154352728|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
154352779|NCT03442972|Teduglutide|teduglutide|mesh-list
154352780|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154352781|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154352782|NCT03442972|Protective Agents|protective agents|mesh-ancestor
154352783|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352784|NCT03921671|Paclitaxel|paclitaxel|mesh-list
154352785|NCT03921671|Carboplatin|carboplatin|mesh-list
154352786|NCT03921671|Ramucirumab|ramucirumab|mesh-list
154352787|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154352788|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154352789|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
154352790|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
154352791|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
154352792|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352793|NCT03921671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154352794|NCT03921671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154352795|NCT03921671|Growth Substances|growth substances|mesh-ancestor
154352839|NCT05341180|Lactulose|lactulose|mesh-list
154352840|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154352841|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154352842|NCT01133483|Fexofenadine|fexofenadine|mesh-list
154352843|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
154352844|NCT01133483|Ephedrine|ephedrine|mesh-list
154352845|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154352846|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154352905|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154352906|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154352907|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352908|NCT03368859|Antidotes|antidotes|mesh-ancestor
154352909|NCT03368859|Protective Agents|protective agents|mesh-ancestor
154352910|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
154352911|NCT03368859|Vitamins|vitamins|mesh-ancestor
154352912|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
154352913|NCT01134965|Digoxin|digoxin|mesh-list
154352914|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154352915|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154352916|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154352917|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154352918|NCT01134965|Protective Agents|protective agents|mesh-ancestor
154352919|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154352920|NCT03810547|Ketamine|ketamine|mesh-list
154352921|NCT03810547|Propofol|propofol|mesh-list
154352964|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
154352965|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
154352967|NCT01232075|Citric Acid|citric acid|mesh-list
154352968|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
154352969|NCT01232075|Clomiphene|clomiphene|mesh-list
154352970|NCT01232075|Enclomiphene|enclomiphene|mesh-list
154352971|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
154352972|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
154352973|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154353030|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
154353031|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
154353032|NCT01230983|Leucovorin|leucovorin|mesh-list
154353033|NCT01230983|Cytarabine|cytarabine|mesh-list
154353034|NCT01230983|Prednisone|prednisone|mesh-list
154353035|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
154353036|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154353037|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154353101|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353102|NCT03707535|Infliximab|infliximab|mesh-list
154353103|NCT03707535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154353104|NCT03707535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353105|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
154353106|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154353107|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154353108|NCT01133795|Midodrine|midodrine|mesh-list
154353109|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
154353110|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
154353111|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353112|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353113|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154353114|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154353115|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154353116|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154353117|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
154353118|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353119|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353120|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
154353121|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
154353122|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154353123|NCT01133873|Narcotics|narcotics|mesh-ancestor
154353124|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353125|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353126|NCT01133873|Analgesics|analgesics|mesh-ancestor
154353127|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
154353128|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495427|NCT00000510|Analgesics|analgesics|mesh-ancestor
154353129|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
154353131|NCT01229813|Bevacizumab|bevacizumab|mesh-list
154353144|NCT01229813|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154353145|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154353146|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353147|NCT03457012|Semaglutide|semaglutide|mesh-list
154353148|NCT03457012|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154353149|NCT03457012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154353150|NCT03457012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353151|NCT04744532|Bosutinib|bosutinib|mesh-list
154353152|NCT04744532|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154353153|NCT04744532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154353154|NCT04744532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099474|NCT00729950|Ipilimumab|ipilimumab|mesh-list
154353155|NCT04744532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353156|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
154353203|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353204|NCT01233167|Clopidogrel|clopidogrel|mesh-list
154353205|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154353206|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154353207|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154353208|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154353209|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
154353210|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353211|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353212|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353213|NCT01304095|Ranolazine|ranolazine|mesh-list
154353214|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154353217|NCT03707457|Nivolumab|nivolumab|mesh-list
154353263|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353264|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
154353265|NCT03382574|Denosumab|denosumab|mesh-list
154353266|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154353267|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353268|NCT01137695|Pramlintide|pramlintide|mesh-list
154353269|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
154353270|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154353271|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353272|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
154353273|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154353276|NCT03451396|Lifitegrast|lifitegrast|mesh-list
154353329|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154353330|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154353331|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353332|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154353333|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154353334|NCT05332821|Growth Substances|growth substances|mesh-ancestor
154353335|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353336|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
154353337|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353338|NCT01134185|Prucalopride|prucalopride|mesh-list
154353339|NCT01134185|Laxatives|laxatives|mesh-ancestor
154353340|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154353341|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154353342|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154353343|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
154353344|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353345|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353346|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495825|NCT00001068|Lamivudine|lamivudine|mesh-list
153495888|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154353347|NCT03829046|Evolocumab|evolocumab|mesh-list
154353348|NCT03829046|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154353381|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154353382|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
154353383|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
154353384|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154353385|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353386|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353388|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154353389|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
154353395|NCT05402735|Uric Acid|uric acid|mesh-list
154353445|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353446|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154353448|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154353449|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353450|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353451|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154353452|NCT03792295|Narcotics|narcotics|mesh-ancestor
154353453|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353454|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
154353455|NCT03449056|Albuterol|albuterol|mesh-list
154353456|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154353457|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
154353458|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353459|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353460|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154353461|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
154353462|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
154353463|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154353464|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154353465|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154353466|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154353467|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
154353468|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353469|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353470|NCT01135433|Metformin|metformin|mesh-list
154353492|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353493|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
154353494|NCT01305187|Protective Agents|protective agents|mesh-ancestor
154353495|NCT01138397|Vaccines|vaccines|mesh-list
154353496|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
154353497|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353498|NCT03448744|Entecavir|entecavir|mesh-list
154353499|NCT03448744|Thymalfasin|thymalfasin|mesh-list
154353500|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
154353501|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353502|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154353503|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
154353504|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353559|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
154353560|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
154353561|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
154353562|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353563|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
154353564|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154353627|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154353628|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353629|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154353630|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
154353631|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353632|NCT03446872|Antidotes|antidotes|mesh-ancestor
154353633|NCT03446872|Protective Agents|protective agents|mesh-ancestor
154353634|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
154353635|NCT03446872|Vitamins|vitamins|mesh-ancestor
154353636|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
154353637|NCT03446638|Cytarabine|cytarabine|mesh-list
154353638|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154353639|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
154353641|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154353691|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353692|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353693|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
154353694|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353763|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
154353764|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154353765|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154353766|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
154353767|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154353768|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
154353769|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154353770|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154353771|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
154353772|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154353774|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154353775|NCT03708861|Maraviroc|maraviroc|mesh-list
154353776|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154353777|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154353778|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
154353779|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353780|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353781|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154353782|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154353783|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
154353784|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154353817|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154353818|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154353819|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154353820|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
154353821|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
154353822|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
154353823|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
154353824|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353825|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353826|NCT01140971|Misoprostol|misoprostol|mesh-list
154353883|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154353885|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154353886|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353887|NCT04595591|Analgesics|analgesics|mesh-ancestor
154353888|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
154353889|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154353890|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154353891|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154353892|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154353893|NCT03709953|Apatinib|apatinib|mesh-list
154353896|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154353946|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
154353947|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353948|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
154353949|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154353950|NCT04749459|Protective Agents|protective agents|mesh-ancestor
154353951|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154353952|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
154353953|NCT01136213|Fluoxetine|fluoxetine|mesh-list
154353954|NCT01136213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154353955|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154353956|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154353957|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154353958|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154353959|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
154354005|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
154354006|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
153498551|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498552|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498553|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
154354007|NCT05679765|Dexamethasone|dexamethasone|mesh-list
154354008|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
154354009|NCT05679765|Lidocaine|lidocaine|mesh-list
154354010|NCT05679765|BB 1101|bb 1101|mesh-list
154354011|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154354018|NCT05679765|Hormones|hormones|mesh-ancestor
154354075|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
154354076|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354077|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
154354078|NCT03437824|Hematinics|hematinics|mesh-ancestor
154354079|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
154354080|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
154354087|NCT01136525|Valacyclovir|valacyclovir|mesh-list
154354144|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354145|NCT05107193|Afatinib|afatinib|mesh-list
154354146|NCT05107193|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154354147|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154354148|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354149|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354150|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354151|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154354152|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154354153|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
154354154|NCT02522650|Amiloride|amiloride|mesh-list
154354155|NCT02522650|Triamterene|triamterene|mesh-list
154354156|NCT02522650|Diuretics|diuretics|mesh-ancestor
154354157|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
154354158|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354159|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154354160|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154354161|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354162|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354163|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154354164|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154354165|NCT05681871|Folic Acid|folic acid|mesh-list
154354166|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
154354167|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
154354168|NCT05681871|Hematinics|hematinics|mesh-ancestor
154354169|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
154354170|NCT05681871|Vitamins|vitamins|mesh-ancestor
154354171|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
154354172|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354173|NCT05681871|Trace Elements|trace elements|mesh-ancestor
154354189|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354190|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354191|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154354192|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
154354193|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154354194|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154354195|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154354196|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354197|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354198|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
154354199|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354200|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354201|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154354202|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354203|NCT01378858|Varenicline|varenicline|mesh-list
154354249|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
154354250|NCT03710304|Oxytocin|oxytocin|mesh-list
154354251|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
154354252|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154354253|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354254|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154354322|NCT01306981|Ranibizumab|ranibizumab|mesh-list
154354323|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154354324|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154354325|NCT01306981|Growth Substances|growth substances|mesh-ancestor
154354326|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354327|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
154354328|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354329|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154354330|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
154354331|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354332|NCT05076799|Lactulose|lactulose|mesh-list
154354333|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354334|NCT03784495|Melatonin|melatonin|mesh-list
154354385|NCT03784261|Abatacept|abatacept|mesh-list
154354386|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154354387|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354388|NCT03784261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154354389|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354390|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154354391|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
154354392|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354393|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154354449|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354450|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354451|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354452|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
154354453|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
154354455|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
154354456|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354457|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
154354458|NCT01306123|Hematinics|hematinics|mesh-ancestor
154354459|NCT03130426|Insulin|insulin|mesh-list
154354460|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154354461|NCT03130426|Metformin|metformin|mesh-list
154354462|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
154354463|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154354464|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354465|NCT00114140|Temozolomide|temozolomide|mesh-list
154354466|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154354467|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
154354468|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354469|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354470|NCT03130582|Etoposide|etoposide|mesh-list
154354471|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154354472|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354473|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154354474|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154354475|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354476|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354499|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
154354501|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354502|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154354503|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354504|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
154354567|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154354568|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354569|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354570|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154354571|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
154354573|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154354574|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154354575|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154354576|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154354577|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
154354578|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
154354579|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354580|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354581|NCT01309633|Bevacizumab|bevacizumab|mesh-list
154354582|NCT01309633|Sunitinib|sunitinib|mesh-list
154354583|NCT01309633|Cisplatin|cisplatin|mesh-list
154354584|NCT01309633|Gemcitabine|gemcitabine|mesh-list
154354585|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154354586|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354587|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154354589|NCT01309633|Growth Substances|growth substances|mesh-ancestor
154354622|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354623|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154354624|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
154354625|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354626|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354627|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154354628|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154354629|NCT02949024|Growth Substances|growth substances|mesh-ancestor
154354630|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
154354631|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354632|NCT04394481|Dexamethasone|dexamethasone|mesh-list
154354633|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
154354634|NCT04394481|Ropivacaine|ropivacaine|mesh-list
154354635|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154354636|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
154354637|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
154354638|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354639|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354640|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354641|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
154354642|NCT04394481|Hormones|hormones|mesh-ancestor
154354649|NCT04394481|Analgesics|analgesics|mesh-ancestor
154354676|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354677|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154354679|NCT04370847|Analgesics|analgesics|mesh-ancestor
154354680|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154354746|NCT03338400|Dexamethasone|dexamethasone|mesh-list
154354747|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154354748|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
154354749|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
154354750|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354751|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354752|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154354753|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
154354754|NCT03338400|Hormones|hormones|mesh-ancestor
154354755|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354756|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154354757|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154354758|NCT03787147|Lidocaine|lidocaine|mesh-list
154354759|NCT03787147|Bupivacaine|bupivacaine|mesh-list
154354760|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
154354761|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
154354762|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354763|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354764|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
154354765|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154354766|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154354767|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154354768|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153499827|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499828|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153499829|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
154354769|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354794|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154354795|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154354796|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354797|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154354798|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
154354799|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154354800|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354801|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154354802|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
154354803|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
154354804|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154354805|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154354806|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154354807|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154354808|NCT05205447|Analgesics|analgesics|mesh-ancestor
154354851|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154354852|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154354853|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154354854|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154354855|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354856|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
154354857|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154354917|NCT05598086|Coagulants|coagulants|mesh-ancestor
154354918|NCT00753532|Vitamin E|vitamin e|mesh-list
154354919|NCT00753532|Tocopherols|tocopherols|mesh-list
154354920|NCT00753532|Tocotrienols|tocotrienols|mesh-list
154354921|NCT00753532|Tocovid|tocovid|mesh-list
154354922|NCT00753532|Vitamins|vitamins|mesh-ancestor
154354923|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
154354924|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154354925|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
154354926|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154354927|NCT00753532|Protective Agents|protective agents|mesh-ancestor
154354985|NCT03337152|Primaquine|primaquine|mesh-list
154354986|NCT03337152|Amebicides|amebicides|mesh-ancestor
154354987|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154354988|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154354989|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154354990|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
154354991|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154354992|NCT03467620|Cannabidiol|cannabidiol|mesh-list
154354993|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
154354994|NCT03780205|Methamphetamine|methamphetamine|mesh-list
154355051|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
154355052|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355053|NCT03466528|Analgesics|analgesics|mesh-ancestor
154355054|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
154355055|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355056|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
154355057|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154355058|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154355059|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
154355060|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154355061|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154355062|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355063|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154355064|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
154355065|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154355067|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154355068|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154355069|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355070|NCT03098654|Metformin|metformin|mesh-list
154355071|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355072|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355073|NCT05175066|Bisoprolol|bisoprolol|mesh-list
154355074|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154355075|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
154355076|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
154355077|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355078|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355079|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154355080|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154355081|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154355082|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
154355083|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355092|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355094|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154355095|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154355096|NCT03780361|Growth Substances|growth substances|mesh-ancestor
154355097|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355098|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
154355099|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355161|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154355162|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154355163|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
154355164|NCT02735200|Vitamin D|vitamin d|mesh-list
154355165|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
154355166|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
154355167|NCT02735200|Vitamins|vitamins|mesh-list
154355168|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
154355169|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355170|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154355172|NCT01312311|Docetaxel|docetaxel|mesh-list
154355227|NCT03464656|Protective Agents|protective agents|mesh-ancestor
154355228|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355229|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
154355230|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154355231|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355232|NCT03705858|Lintuzumab|lintuzumab|mesh-list
154355233|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355234|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355235|NCT03463642|Vitamin D|vitamin d|mesh-list
154355236|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
154355237|NCT03463642|Mineral Oil|mineral oil|mesh-list
154355238|NCT03463642|Vitamins|vitamins|mesh-ancestor
154355239|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
154355240|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355241|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154355288|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
154355289|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154355290|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355291|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154355292|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154355293|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
154355294|NCT03705780|Fentanyl|fentanyl|mesh-list
154355295|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154355326|NCT04188860|Paclitaxel|paclitaxel|mesh-list
154355356|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355357|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355358|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355359|NCT04375228|Rituximab|rituximab|mesh-list
154355360|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355361|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355362|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
154355363|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355364|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154355365|NCT02521714|Lenalidomide|lenalidomide|mesh-list
154355366|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
154355367|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355368|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154355369|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154355370|NCT02521714|Growth Substances|growth substances|mesh-ancestor
154355371|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
154355372|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355373|NCT03768089|Ivacaftor|ivacaftor|mesh-list
154355374|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154355375|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154355376|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355377|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
154355378|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
154355379|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355380|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355381|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355382|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
154355383|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
154355384|NCT01381640|Acetaminophen|acetaminophen|mesh-list
154355385|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154355386|NCT01381640|Analgesics|analgesics|mesh-ancestor
154355387|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
154355388|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355390|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
154355396|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355397|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355398|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154355399|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154355400|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154355401|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154355402|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
154355403|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355404|NCT04483973|Protective Agents|protective agents|mesh-ancestor
154355405|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154355461|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154355462|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154355463|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355464|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355465|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154355466|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
154355468|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355523|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154355524|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355525|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355526|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154355527|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154355528|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355529|NCT03233217|Vaccines|vaccines|mesh-list
154355530|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
154355531|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355587|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355588|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154355589|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
154355590|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
154355591|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154355593|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154355594|NCT03961256|Exenatide|exenatide|mesh-list
153500074|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154355595|NCT03961256|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154355596|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154355597|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355598|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154355599|NCT03961256|Incretins|incretins|mesh-ancestor
154355600|NCT03961256|Hormones|hormones|mesh-ancestor
154355601|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355602|NCT03443518|Remifentanil|remifentanil|mesh-list
154355646|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355647|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
154355648|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
154355649|NCT01140425|PF 232798|pf 232798|mesh-list
154355650|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154355651|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355652|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154355653|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154355654|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355655|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355656|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355657|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154355658|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154355659|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154355660|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
154355707|NCT01235819|Hormones|hormones|mesh-ancestor
154355708|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154355709|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
154355710|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355711|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355712|NCT01235819|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154355713|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154355714|NCT05275569|Antiemetics|antiemetics|mesh-list
154355715|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
154355716|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355717|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355718|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154355719|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154355720|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355721|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355723|NCT03440788|Immunoconjugates|immunoconjugates|mesh-ancestor
154355764|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154355765|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
154355767|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355768|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355769|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355770|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
154355771|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
154355772|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154355773|NCT01380548|Iron|iron|mesh-list
154355774|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154355775|NCT01380548|Trace Elements|trace elements|mesh-ancestor
154355780|NCT01313247|Acetaminophen|acetaminophen|mesh-list
154355831|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154355832|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
154355833|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355834|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154355902|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355903|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
154355904|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154355905|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355906|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154355907|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355909|NCT02927834|Prednisone|prednisone|mesh-list
154355970|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355971|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154355972|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
154355973|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154355974|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154355975|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154355976|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154355977|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154355978|NCT03432598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154355980|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154355981|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355982|NCT01964547|Nabiximols|nabiximols|mesh-list
154355983|NCT01964547|Analgesics|analgesics|mesh-ancestor
154355984|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
154355985|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154355986|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355987|NCT01380314|Miltefosine|miltefosine|mesh-list
154355988|NCT01380314|Imiquimod|imiquimod|mesh-list
154355989|NCT01380314|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154355990|NCT01380314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154355991|NCT01380314|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154355992|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
154355993|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154355994|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154355995|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154355996|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
154355997|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
154355998|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154355999|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154356000|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154356013|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
154356014|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154356015|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154356016|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356017|NCT03110510|Antidotes|antidotes|mesh-ancestor
154102340|NCT01041625|Apremilast|apremilast|mesh-list
154356018|NCT03110510|Protective Agents|protective agents|mesh-ancestor
154356019|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
154356020|NCT03110510|Vitamins|vitamins|mesh-ancestor
154356021|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
154356022|NCT01238237|Cetuximab|cetuximab|mesh-list
154356023|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356024|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356025|NCT03319719|Lidocaine|lidocaine|mesh-list
154356026|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
154356027|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
154356028|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
154356029|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356030|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356031|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
154356032|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356033|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154356034|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154356035|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154356036|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153500317|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500318|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
153500319|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500320|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500321|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
153500322|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500323|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154356037|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356063|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154356064|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154356065|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
154356066|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356067|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356068|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154356069|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
154356070|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
154356071|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154356072|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154356073|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154356074|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154356075|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
154356076|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
154356077|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154356078|NCT02528513|Narcotics|narcotics|mesh-ancestor
154356079|NCT01320007|Furosemide|furosemide|mesh-list
154356080|NCT01320007|Diuretics|diuretics|mesh-ancestor
154356081|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
154356082|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356083|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154356084|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154356085|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356086|NCT03318315|Vaccines|vaccines|mesh-list
154356087|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
154356088|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356112|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154356113|NCT01243697|Progestins|progestins|mesh-ancestor
154356115|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154356116|NCT01145573|Calcium|calcium|mesh-list
154356117|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154356118|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356119|NCT01320709|Piroxicam|piroxicam|mesh-list
154356120|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154356121|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154356122|NCT01320709|Analgesics|analgesics|mesh-ancestor
154356123|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
154356124|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356125|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356126|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154356127|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154356128|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154356131|NCT01238393|Ranibizumab|ranibizumab|mesh-list
154356168|NCT01145807|Terbinafine|terbinafine|mesh-list
154356169|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
154356170|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356171|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356172|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356173|NCT03898895|Antibodies|antibodies|mesh-list
154356174|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
154356175|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356176|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154356177|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154356178|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
154356179|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356180|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356181|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154356182|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
154356183|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
154356184|NCT01245569|Hormones|hormones|mesh-ancestor
154356185|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154356186|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
153500412|NCT00356226|Clonidine|clonidine|mesh-list
154356187|NCT01314859|Nifedipine|nifedipine|mesh-list
154356188|NCT01314859|Atosiban|atosiban|mesh-list
154356220|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154356221|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356222|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154356223|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154356224|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356225|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356226|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
154356227|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
154356230|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
154356285|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154356286|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154356287|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154356289|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
154356290|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356291|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154356292|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154356293|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154356294|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356295|NCT03779035|Gemcitabine|gemcitabine|mesh-list
154356296|NCT03779035|Capecitabine|capecitabine|mesh-list
154356297|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154356298|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
154356299|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356300|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356301|NCT01586117|Amifostine|amifostine|mesh-list
154356302|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154356303|NCT01586117|Protective Agents|protective agents|mesh-ancestor
154356341|NCT03778723|Anesthetics|anesthetics|mesh-list
154356342|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356343|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356344|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154356345|NCT03778723|Narcotics|narcotics|mesh-ancestor
154356346|NCT03778723|Analgesics|analgesics|mesh-ancestor
154356351|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
154356411|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356412|NCT05168683|Rasburicase|rasburicase|mesh-list
154356413|NCT05168683|Uric Acid|uric acid|mesh-list
154356414|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
154356415|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356416|NCT05168683|Protective Agents|protective agents|mesh-ancestor
154356417|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356418|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
154356419|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154356420|NCT03113123|Tenofovir|tenofovir|mesh-list
154356421|NCT03113123|Emtricitabine|emtricitabine|mesh-list
154356422|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154356423|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
154356424|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356425|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154356426|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153500497|NCT00357240|Ritonavir|ritonavir|mesh-list
154356427|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356428|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356429|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154356430|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154356431|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
154356432|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154356433|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356434|NCT01143857|Varenicline|varenicline|mesh-list
154356435|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154356436|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154356459|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356460|NCT03772483|Anesthetics|anesthetics|mesh-list
154356461|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356462|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356463|NCT01236911|Calcium|calcium|mesh-list
154356464|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154356465|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356466|NCT03772561|Durvalumab|durvalumab|mesh-list
154356526|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154356527|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356528|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
154356529|NCT03434704|Clotrimazole|clotrimazole|mesh-list
154356530|NCT03434704|Miconazole|miconazole|mesh-list
154356531|NCT03434704|Fludarabine|fludarabine|mesh-list
154356532|NCT03434704|Thiotepa|thiotepa|mesh-list
154356533|NCT03434704|Treosulfan|treosulfan|mesh-list
154356534|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356535|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356536|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154356537|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
154356538|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356539|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154356540|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
154356541|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154356542|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356543|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154356544|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154356546|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356579|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154356580|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356581|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154356582|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154356583|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
154356648|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356649|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356650|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154356651|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154356652|NCT01321957|Growth Substances|growth substances|mesh-ancestor
154356653|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356659|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
154356712|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
154356713|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356714|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154356715|NCT03763279|Triclosan|triclosan|mesh-list
154356716|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154356717|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356718|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154356719|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154356720|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
154356721|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356722|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154356723|NCT03638037|Vitamin D|vitamin d|mesh-list
154356724|NCT03638037|Vitamins|vitamins|mesh-ancestor
154356725|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
154356726|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356727|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154356728|NCT03763123|Paclitaxel|paclitaxel|mesh-list
154356729|NCT03763123|Topotecan|topotecan|mesh-list
154356730|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154356731|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356732|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
154356739|NCT03429400|Morphine|morphine|mesh-list
154356766|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356767|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356768|NCT02713529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154356769|NCT02713529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356770|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
154356771|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
154356772|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154356773|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154356774|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356775|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356776|NCT03763045|Urological Agents|urological agents|mesh-ancestor
154356777|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
154356778|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356779|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
154356780|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154356781|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154356782|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154356783|NCT01321489|Urological Agents|urological agents|mesh-ancestor
154356784|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
154356785|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154356786|NCT04800627|Pevonedistat|pevonedistat|mesh-list
154356787|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356788|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356789|NCT04800627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154356790|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356791|NCT03768037|Pemetrexed|pemetrexed|mesh-list
154356792|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356810|NCT03762889|Anesthetics|anesthetics|mesh-list
154356811|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356812|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356813|NCT03746041|Abaloparatide|abaloparatide|mesh-list
154356814|NCT03746041|Bevacizumab|bevacizumab|mesh-list
154356815|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154356816|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154356817|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154356818|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154356819|NCT03746041|Growth Substances|growth substances|mesh-ancestor
154356820|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154356821|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
154356822|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154356823|NCT01236989|Liver Extracts|liver extracts|mesh-list
154356872|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356873|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
154356874|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356875|NCT02204254|Doxycycline|doxycycline|mesh-list
154356876|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154356877|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154356878|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
154356879|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154356880|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154356881|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
154356882|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154356940|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
154356941|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
154356942|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154356943|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154356944|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154356945|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
154356946|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
154356947|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
154356948|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154356949|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154356950|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154356951|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154357006|NCT03426982|Calcium heparin|calcium heparin|mesh-list
154357007|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
154357008|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154357009|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154357010|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357011|NCT01546948|Methadone|methadone|mesh-list
154357012|NCT01546948|Hydromorphone|hydromorphone|mesh-list
154357013|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154357014|NCT01546948|Narcotics|narcotics|mesh-ancestor
154357015|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357016|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357017|NCT01546948|Analgesics|analgesics|mesh-ancestor
154357018|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
154357019|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357020|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
154357021|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
154357022|NCT00458003|Phenylephrine|phenylephrine|mesh-list
154357023|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
154357024|NCT00458003|Ephedrine|ephedrine|mesh-list
154357025|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154357064|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357065|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154357066|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
154357067|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
154357068|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154357069|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154357070|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154357071|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154357072|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
154357073|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
154357074|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357075|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357076|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154357077|NCT01567657|Narcotics|narcotics|mesh-ancestor
154357078|NCT01567657|Analgesics|analgesics|mesh-ancestor
154357079|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
154357081|NCT03416062|Niacinamide|niacinamide|mesh-list
154357123|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
154357124|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357125|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357126|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154357127|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
154357128|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
154357129|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
154357130|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154357131|NCT03761329|Lidocaine|lidocaine|mesh-list
154357132|NCT03761329|Anesthetics|anesthetics|mesh-list
154357133|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
154357134|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357135|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781803|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153500760|NCT00362700|Clevudine|clevudine|mesh-list
154357136|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
154357137|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357138|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154357139|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154357140|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154357141|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154357142|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357143|NCT03415906|Valsartan|valsartan|mesh-list
154357144|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154357145|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154357146|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154357147|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154357148|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357149|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
154357151|NCT03415750|Tacrolimus|tacrolimus|mesh-list
154357152|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357153|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
154357154|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357155|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154357156|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357157|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357160|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357161|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154357162|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154357163|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
154357164|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154357165|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357167|NCT01239719|Dexamethasone|dexamethasone|mesh-list
154357168|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
154357169|NCT01239719|BB 1101|bb 1101|mesh-list
154357170|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357171|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
154357224|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
154357225|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357226|NCT01239875|Vaccines|vaccines|mesh-list
154357227|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154357228|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
154357229|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357230|NCT03415594|Glucagon|glucagon|mesh-list
154357231|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154357232|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154357233|NCT03415594|Hormones|hormones|mesh-ancestor
154357234|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154357236|NCT03415594|Incretins|incretins|mesh-ancestor
154357287|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154357288|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154357289|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357290|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154357291|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154357292|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357293|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
154357294|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154357295|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154357296|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154027428|NCT02869633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357298|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154357299|NCT03765931|Amoxicillin|amoxicillin|mesh-list
154357300|NCT03765931|Doxycycline|doxycycline|mesh-list
154357301|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154357302|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357303|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
154357304|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154357305|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154357306|NCT01240265|Vitamin D|vitamin d|mesh-list
153500825|NCT00364572|Analgesics|analgesics|mesh-ancestor
154357307|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
154357308|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
154357309|NCT01240265|Vitamins|vitamins|mesh-list
154357310|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
154357311|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357312|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154357313|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154357335|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
154357336|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357337|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154357338|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154357339|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154357340|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154357341|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357342|NCT03311841|Rifampin|rifampin|mesh-list
154357343|NCT03311841|Midazolam|midazolam|mesh-list
154357344|NCT03311841|Dabigatran|dabigatran|mesh-list
154357345|NCT03311841|Atorvastatin|atorvastatin|mesh-list
154357346|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154357347|NCT03311841|Pitavastatin|pitavastatin|mesh-list
154357348|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154357349|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154357350|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154357351|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357352|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357353|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154357354|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154357355|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154357356|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154357386|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154357387|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154357388|NCT01249937|Ranibizumab|ranibizumab|mesh-list
154357389|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154357390|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154357391|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154357392|NCT01249937|Growth Substances|growth substances|mesh-ancestor
154357393|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357394|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
154357395|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357396|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357397|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
154357398|NCT01249937|Hormones|hormones|mesh-ancestor
154357400|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357446|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154357447|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
154357448|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357449|NCT03414814|Osimertinib|osimertinib|mesh-list
154357450|NCT03414814|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154357451|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357452|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357453|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357454|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357455|NCT03421366|Posaconazole|posaconazole|mesh-list
154357510|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
154357511|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357512|NCT03759301|Cetrorelix|cetrorelix|mesh-list
154357513|NCT03759301|Hormones|hormones|mesh-list
154357514|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154357515|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357516|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154357517|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
154357518|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154103802|NCT00903214|Riluzole|riluzole|mesh-list
154357519|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
154357520|NCT03764215|Nilotinib|nilotinib|mesh-list
154357521|NCT03764215|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154357522|NCT03764215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357523|NCT03764215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357524|NCT03764215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357525|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
154357526|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154357527|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357528|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
154357563|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357564|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357565|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
154357567|NCT03425656|Doxorubicin|doxorubicin|mesh-list
154357568|NCT03425656|Trastuzumab|trastuzumab|mesh-list
154357569|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357586|NCT03413722|Everolimus|everolimus|mesh-list
154357631|NCT03424876|Growth Substances|growth substances|mesh-ancestor
154357632|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357633|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
154357634|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154357635|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357636|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357637|NCT03424876|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154357638|NCT03476577|Ibuprofen|ibuprofen|mesh-list
154357639|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154357696|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154357697|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154357698|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154357699|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357700|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154357701|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154357702|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154357703|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154357704|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154357705|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154357706|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357707|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154357709|NCT03413020|Diuretics|diuretics|mesh-ancestor
154357710|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
154357711|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357712|NCT03413020|Expectorants|expectorants|mesh-ancestor
154357713|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
154357714|NCT03424408|Aspirin|aspirin|mesh-list
154357715|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154357716|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357717|NCT03424408|Analgesics|analgesics|mesh-ancestor
154357718|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
154357719|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357720|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357721|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357722|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357723|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154357724|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154357725|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357726|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154357727|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154357728|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357729|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
154357730|NCT03305055|Fentanyl|fentanyl|mesh-list
154357731|NCT03305055|Ketamine|ketamine|mesh-list
154357732|NCT03305055|Analgesics|analgesics|mesh-ancestor
154357733|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
154357734|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357735|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357736|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154357738|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
154357739|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
154357742|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154357802|NCT03418558|Immunoconjugates|immunoconjugates|mesh-ancestor
154357803|NCT03418558|Immunologic Factors|immunologic factors|mesh-ancestor
154357804|NCT03418558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357805|NCT03412006|Fulacimstat|fulacimstat|mesh-list
154357806|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357807|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357808|NCT03418246|Calcium|calcium|mesh-list
154357809|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154357810|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357811|NCT03411850|Abatacept|abatacept|mesh-list
154357812|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154357813|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357814|NCT03411850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357815|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357816|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154357817|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
154357818|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357820|NCT05170594|Bevacizumab|bevacizumab|mesh-list
154357821|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154357822|NCT05170594|Fluzoparib|fluzoparib|mesh-list
154357823|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357824|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357826|NCT05170594|Growth Substances|growth substances|mesh-ancestor
154357853|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357854|NCT02749968|Bupivacaine|bupivacaine|mesh-list
154357855|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
154357856|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
154357857|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357858|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357859|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
154357860|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357861|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154357862|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154357863|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357864|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
154357865|NCT03417700|Vitamin D|vitamin d|mesh-list
154357866|NCT03417700|Vitamins|vitamins|mesh-ancestor
154357867|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
154357914|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357915|NCT05011149|Analgesics|analgesics|mesh-ancestor
154357916|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
154357917|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357918|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357919|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357920|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357921|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154357922|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501110|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501111|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501112|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153501113|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501115|NCT00370968|Astringents|astringents|mesh-ancestor
153501116|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501117|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
153501118|NCT00371124|Atropine|atropine|mesh-list
153501119|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154357923|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357924|NCT03393988|Fentanyl|fentanyl|mesh-list
154357925|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
154357926|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
154357927|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154357928|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357929|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357973|NCT03393364|Oxycodone|oxycodone|mesh-list
154357974|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154357975|NCT03393364|Narcotics|narcotics|mesh-ancestor
154357976|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154357977|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154357978|NCT03393364|Analgesics|analgesics|mesh-ancestor
154357979|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
154357980|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154357981|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154357982|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154357983|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154357984|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154357985|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154357986|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154357987|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154357988|NCT04632706|Ivermectin|ivermectin|mesh-list
154357989|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154357990|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154357991|NCT03405454|Durvalumab|durvalumab|mesh-list
154357992|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154357993|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154357994|NCT05168176|Dolutegravir|dolutegravir|mesh-list
154357995|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154357996|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154358023|NCT03321396|Calcium|calcium|mesh-list
154358024|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154358025|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358026|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
154358027|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
154358028|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154358029|NCT03321006|Escitalopram|escitalopram|mesh-list
154358030|NCT03321006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154358031|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154358032|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358033|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358034|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358035|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
154358041|NCT03321006|Analgesics|analgesics|mesh-ancestor
154358083|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154358084|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358085|NCT03396250|Analgesics|analgesics|mesh-ancestor
154358086|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
154358087|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358088|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358089|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358090|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358091|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
154358092|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154358093|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358094|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358095|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154358096|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154358097|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501185|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
153501186|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153501187|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501188|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358098|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
154358110|NCT03302559|Vitamin A|vitamin a|mesh-list
154358143|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154358144|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154358145|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358146|NCT04363840|Analgesics|analgesics|mesh-ancestor
154358147|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
154358148|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358149|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358150|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358151|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154358152|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154358153|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358154|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154358155|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154358156|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358157|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
154358200|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154358201|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154358202|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
154358203|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358204|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154358205|NCT03262233|Nicotine|nicotine|mesh-list
154358206|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154358207|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
154358208|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358209|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358210|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154358211|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154358212|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
154358261|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154358262|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
154358263|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358264|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358265|NCT03399604|Treprostinil|treprostinil|mesh-list
154358331|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358332|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154358333|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154358334|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358335|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
154358336|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
154358337|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358338|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358339|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358340|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
154358341|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
154358342|NCT01610700|Nabiximols|nabiximols|mesh-list
154104607|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154358343|NCT01610700|Analgesics|analgesics|mesh-ancestor
154358390|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
154358391|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
154358392|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154358393|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154358394|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154358395|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
154358396|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358397|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501264|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153501265|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501266|NCT00376428|Gentamicins|gentamicins|mesh-list
153501267|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153501268|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501269|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153501270|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501273|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154358398|NCT04623684|Protective Agents|protective agents|mesh-ancestor
154358402|NCT03297021|Ondansetron|ondansetron|mesh-list
154358452|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154358453|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358454|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358455|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154358456|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358457|NCT04572997|Apremilast|apremilast|mesh-list
154358458|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154358459|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358460|NCT04572997|Analgesics|analgesics|mesh-ancestor
154358461|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
154358462|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358463|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358464|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358465|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358508|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154358509|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358511|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
154358512|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358513|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358514|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358515|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154358516|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154358517|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154358571|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358572|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358573|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154358574|NCT01328002|Analgesics|analgesics|mesh-ancestor
154358575|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
154358576|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358577|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
154358578|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154358579|NCT05239078|Anesthetics|anesthetics|mesh-list
154358580|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
154358581|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154358582|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358583|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
154358584|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358585|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154358628|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154358629|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358630|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154358631|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358632|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358633|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154358635|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
154358636|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358637|NCT03289533|Avelumab|avelumab|mesh-list
154358638|NCT03289533|Axitinib|axitinib|mesh-list
154358639|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154358692|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358693|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154358694|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154358695|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153501356|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358696|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154358697|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358699|NCT03697993|Fosfomycin|fosfomycin|mesh-list
154358700|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154358701|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358702|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154358703|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154358704|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154358705|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358706|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358711|NCT05393245|Olodaterol|olodaterol|mesh-list
154358750|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154358751|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
154358752|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358753|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358754|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
154358755|NCT03398122|Apatinib|apatinib|mesh-list
154358756|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358757|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154358758|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358759|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358760|NCT05459857|Menthol|menthol|mesh-list
154358761|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
154358762|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
154358763|NCT03394222|Budesonide|budesonide|mesh-list
154358764|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358765|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154358766|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
154358767|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154358768|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358805|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
154358806|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154358807|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154358808|NCT03750721|Rifampin|rifampin|mesh-list
154358809|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154358810|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
154358811|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154358812|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358813|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
154358814|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154358815|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154358816|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154358817|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154358818|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154358867|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154358868|NCT01380028|Prednisone|prednisone|mesh-list
154358869|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154358870|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
154358871|NCT01380028|Hormones|hormones|mesh-ancestor
153501447|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501448|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501449|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501450|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153501451|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
153501452|NCT00381030|Protective Agents|protective agents|mesh-ancestor
153501453|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154358872|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154358873|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358874|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154358875|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154358876|NCT01305460|Azacitidine|azacitidine|mesh-list
154358933|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154358934|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154358935|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154358936|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
154358937|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
154358938|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154358940|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
154359002|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359003|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
154359004|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154359005|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154359006|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
154105278|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
154359007|NCT03311724|Tirzepatide|tirzepatide|mesh-list
154359008|NCT03311724|Incretins|incretins|mesh-ancestor
154359009|NCT03311724|Hormones|hormones|mesh-ancestor
154359010|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359011|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359012|NCT05213312|Paclitaxel|paclitaxel|mesh-list
154359013|NCT05213312|Fluorouracil|fluorouracil|mesh-list
154359014|NCT05213312|Nivolumab|nivolumab|mesh-list
154359064|NCT03288987|Antidotes|antidotes|mesh-ancestor
154359065|NCT03288987|Protective Agents|protective agents|mesh-ancestor
154359066|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
154359067|NCT03288987|Vitamins|vitamins|mesh-ancestor
154359068|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
154359069|NCT01379846|Vaccines|vaccines|mesh-list
154359070|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
154359071|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359072|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
154359073|NCT01379300|Dabigatran|dabigatran|mesh-list
154359074|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154359131|NCT03083990|Bevacizumab|bevacizumab|mesh-list
154359132|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154359133|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359134|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154359135|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154359136|NCT03083990|Growth Substances|growth substances|mesh-ancestor
154359137|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359138|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
154359139|NCT03252015|Lasmiditan|lasmiditan|mesh-list
154359140|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154359195|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359196|NCT03077438|Vaccines|vaccines|mesh-list
154359197|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
154359198|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359199|NCT01382732|Oxytocin|oxytocin|mesh-list
154359200|NCT01382732|Carbetocin|carbetocin|mesh-list
154359201|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
154359202|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154359203|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359204|NCT02183870|Crizotinib|crizotinib|mesh-list
154359205|NCT02183870|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153781870|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359206|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359260|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359261|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359262|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
154359263|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359264|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154359265|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154359266|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154359267|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154359268|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359269|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
154359271|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154359272|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
154359319|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
154359320|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154359321|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154359322|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359323|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154359324|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154359325|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154359326|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359327|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359328|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
154359329|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
154359330|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154359381|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154105650|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359382|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154359383|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
154359384|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359385|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359386|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154359387|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359388|NCT01378754|Fospropofol|fospropofol|mesh-list
154359389|NCT01378754|Propofol|propofol|mesh-list
154359390|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154359391|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359392|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359443|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359444|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359445|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359446|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359447|NCT01858922|Cytarabine|cytarabine|mesh-list
154359448|NCT01858922|Dexamethasone|dexamethasone|mesh-list
154359449|NCT01858922|Prednisone|prednisone|mesh-list
154359450|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
154359515|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154359516|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359517|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154359518|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
154359519|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359520|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359521|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
154359522|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359581|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154359582|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154359583|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359584|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
153501637|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
154359585|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154359586|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
154359647|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
154359648|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
154359649|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359650|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
154359651|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359652|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359653|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
154359654|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154359655|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154359656|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154359657|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154359658|NCT02714322|Adalimumab|adalimumab|mesh-list
154359659|NCT02714322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154359660|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359661|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359662|NCT03267576|Metformin|metformin|mesh-list
154359663|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154359705|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
154359706|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359708|NCT01345019|Denosumab|denosumab|mesh-list
154359709|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154359710|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359711|NCT03629522|Ondansetron|ondansetron|mesh-list
154359712|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
154359713|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
154359714|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359715|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359716|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154359717|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
154359718|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
154359719|NCT03629522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154359720|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154359721|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
154359722|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359723|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359724|NCT03751111|Naloxone|naloxone|mesh-list
154359725|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154359726|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359727|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
154359728|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359729|NCT05167370|Amifostine|amifostine|mesh-list
154359730|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154359731|NCT05167370|Protective Agents|protective agents|mesh-ancestor
154359732|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359733|NCT01265537|Tacrolimus|tacrolimus|mesh-list
154359734|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154359735|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
154359736|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359737|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154359746|NCT05763836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359747|NCT05763836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359748|NCT05763836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359749|NCT05763836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154359750|NCT05763836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359751|NCT05763836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359753|NCT01237535|Estrogens|estrogens|mesh-list
154359754|NCT01237535|Progestins|progestins|mesh-ancestor
154359755|NCT01237535|Hormones|hormones|mesh-ancestor
154359756|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359757|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359758|NCT04396639|Factor VIII|factor viii|mesh-list
154106022|NCT00621855|Dabigatran|dabigatran|mesh-list
154359759|NCT04396639|Coagulants|coagulants|mesh-ancestor
154359760|NCT01146431|Anesthetics|anesthetics|mesh-list
153501733|NCT00423228|Donepezil|donepezil|mesh-list
153501734|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154359761|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154359762|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359763|NCT01250249|Vaccines|vaccines|mesh-list
154359764|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
154359765|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
154359766|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359767|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154359768|NCT03747679|Mannitol|mannitol|mesh-list
154359769|NCT03747679|Sorbitol|sorbitol|mesh-list
154359770|NCT03747679|Bosutinib|bosutinib|mesh-list
154359771|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154359772|NCT03747679|Diuretics|diuretics|mesh-ancestor
154359773|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
154359774|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359775|NCT03747679|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154359776|NCT03747679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154359777|NCT03747679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359778|NCT03747679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359779|NCT03747679|Cathartics|cathartics|mesh-ancestor
154359780|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154359781|NCT01243385|Metformin|metformin|mesh-list
154359786|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154359787|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154359788|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154359789|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
154359790|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359791|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359792|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359793|NCT04167085|Doxycycline|doxycycline|mesh-list
154359794|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154359795|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359796|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
154359797|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154359798|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154359799|NCT01147289|Meloxicam|meloxicam|mesh-list
154359800|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154359801|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154359802|NCT01147289|Analgesics|analgesics|mesh-ancestor
154359803|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
154359804|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359805|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359806|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359807|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359808|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154359809|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154359810|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154359811|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359812|NCT01237769|Vitamin D|vitamin d|mesh-list
154359813|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
154359814|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
154359815|NCT01237769|Vitamins|vitamins|mesh-list
154106101|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
154359831|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154359832|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359833|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359834|NCT01250951|Deferasirox|deferasirox|mesh-list
154359835|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154359836|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
154359837|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
154359838|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359840|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154359841|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
154359842|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154359843|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359891|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
154359892|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359893|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
153501839|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
154359894|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154359895|NCT01147523|Protective Agents|protective agents|mesh-ancestor
154359896|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154359897|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
154359898|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154359899|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154359900|NCT01147523|Diuretics|diuretics|mesh-ancestor
154359901|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
154359902|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
154359903|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154359904|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
154359905|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359906|NCT01251029|Expectorants|expectorants|mesh-ancestor
154106170|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154359947|NCT01125176|Thalidomide|thalidomide|mesh-list
154359948|NCT01125176|Rituximab|rituximab|mesh-list
154359949|NCT01125176|Lenalidomide|lenalidomide|mesh-list
154359950|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154359951|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154359952|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
154359953|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154359954|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154359955|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154359956|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154359957|NCT01125176|Growth Substances|growth substances|mesh-ancestor
154359958|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
154359959|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154359960|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
154359961|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154359962|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154359963|NCT00882050|Exenatide|exenatide|mesh-list
154360013|NCT01251263|Estradiol|estradiol|mesh-list
154360014|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154360015|NCT01251263|Estrogens|estrogens|mesh-ancestor
154360016|NCT01251263|Hormones|hormones|mesh-ancestor
154360017|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360018|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360019|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154360020|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
154360021|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154360022|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154360035|NCT05761730|Dexamethasone|dexamethasone|mesh-list
154360036|NCT05761730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360037|NCT05761730|Antiemetics|antiemetics|mesh-ancestor
154360038|NCT05761730|Autonomic Agents|autonomic agents|mesh-ancestor
154360039|NCT05761730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360040|NCT05761730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360041|NCT05761730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360042|NCT05761730|Glucocorticoids|glucocorticoids|mesh-ancestor
154360043|NCT05761730|Hormones|hormones|mesh-ancestor
154360044|NCT05761730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539122|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901741|NCT05881083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154360045|NCT05761730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154360046|NCT05761730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360047|NCT04353817|Ivacaftor|ivacaftor|mesh-list
153501916|NCT02992392|Dextrans|dextrans|mesh-list
154360048|NCT04353817|Elexacaftor|elexacaftor|mesh-list
154360049|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154360050|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360051|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360052|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
154360053|NCT00159588|Gabapentin|gabapentin|mesh-list
154360054|NCT00159588|Valproic Acid|valproic acid|mesh-list
154360055|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
154360058|NCT00159588|Analgesics|analgesics|mesh-ancestor
154360108|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154360109|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154360110|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360111|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360112|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154360113|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360114|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360115|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
154360116|NCT01254929|Frovatriptan|frovatriptan|mesh-list
154360117|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154360118|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
154360119|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360121|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360169|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360170|NCT04342897|Zansecimab|zansecimab|mesh-list
154360171|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
154360172|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360173|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
154360174|NCT03263767|Fludarabine|fludarabine|mesh-list
154360175|NCT03263767|Clofarabine|clofarabine|mesh-list
154360176|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
154360191|NCT03908333|Paclitaxel|paclitaxel|mesh-list
154360240|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360241|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360243|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154360244|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154360245|NCT01148303|Analgesics|analgesics|mesh-ancestor
154360246|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
154360247|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360248|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360249|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360250|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360251|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154360252|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154360253|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360254|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360255|NCT03066830|Metformin|metformin|mesh-list
154360256|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154360257|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154360261|NCT01149629|Droxidopa|droxidopa|mesh-list
154360292|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
154360293|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
154360294|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360295|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154360296|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154360297|NCT01253681|Growth Substances|growth substances|mesh-ancestor
154360298|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360299|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
154360300|NCT01149941|Ibuprofen|ibuprofen|mesh-list
154360301|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154360302|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154360303|NCT01149941|Analgesics|analgesics|mesh-ancestor
154360304|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
154360305|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360306|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360307|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360308|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360309|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154360310|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360311|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360312|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
154360313|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360314|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
154360315|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
154360316|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360317|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360319|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
154360338|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360339|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360340|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154360341|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
154360342|NCT03905837|Lidocaine|lidocaine|mesh-list
154360343|NCT03905837|Piperidine|piperidine|mesh-list
154360344|NCT03905837|Remifentanil|remifentanil|mesh-list
154360345|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
154360346|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
154360347|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360348|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360349|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
154360350|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360351|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154360352|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154360397|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154360398|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360399|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154360400|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154360401|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154360403|NCT01255475|Hydralazine|hydralazine|mesh-list
154360404|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154360405|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154360406|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360407|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360408|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154360409|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360410|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
154360411|NCT05208398|Warfarin|warfarin|mesh-list
154360412|NCT05208398|Apixaban|apixaban|mesh-list
154360413|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
154360414|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154360415|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
154360416|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154360417|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
154360418|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360419|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360420|NCT05593601|Neomycin|neomycin|mesh-list
154360421|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154360422|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360423|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154360424|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360426|NCT03629210|Dexamethasone|dexamethasone|mesh-list
153502051|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502061|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502062|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
153502063|NCT01271166|Antidotes|antidotes|mesh-ancestor
153502064|NCT01271166|Protective Agents|protective agents|mesh-ancestor
153502065|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
153502066|NCT01271166|Vitamins|vitamins|mesh-ancestor
153502067|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
153502068|NCT01271166|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153502069|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502070|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360441|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360442|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360443|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360444|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
154360445|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360446|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154360447|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
154360448|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154360449|NCT01254071|Tamsulosin|tamsulosin|mesh-list
154360450|NCT01254071|Dutasteride|dutasteride|mesh-list
154360505|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
154360506|NCT02527811|Urinastatin|urinastatin|mesh-list
154360507|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
154360508|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154360509|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
154360510|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360511|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360512|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154360513|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154360514|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360515|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
154360516|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
154360517|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154360518|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154360519|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360520|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360521|NCT01254383|Urological Agents|urological agents|mesh-ancestor
154360522|NCT03700970|Bupivacaine|bupivacaine|mesh-list
154360523|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
154360524|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
154360525|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360526|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360527|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
154360528|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360529|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
154360553|NCT03747523|Vitamin D|vitamin d|mesh-list
154360554|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
154360555|NCT03747523|Vitamins|vitamins|mesh-ancestor
154360556|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
154360557|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360558|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154360559|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154360560|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
154360561|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154360562|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360563|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154360564|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154360565|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360566|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360567|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360568|NCT03063086|Fluticasone|fluticasone|mesh-list
154360569|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154360611|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
154360612|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
154360613|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154360614|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154360615|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154360616|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360617|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154360618|NCT03898583|Vitamins|vitamins|mesh-ancestor
153502115|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
154360619|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
154360620|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154360621|NCT03898193|Montelukast|montelukast|mesh-list
154360622|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154360623|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
154360624|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154360625|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
154360626|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360631|NCT03321188|Paclitaxel|paclitaxel|mesh-list
154360667|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
154360668|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360669|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360670|NCT03746119|Nicotine|nicotine|mesh-list
154360671|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154360672|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
154360673|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360674|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360675|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154360676|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154360677|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
154360678|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360679|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360680|NCT01149005|Insulin|insulin|mesh-list
154360681|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154360682|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
154360683|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
154360684|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
154360685|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154360686|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360687|NCT03903887|Antibodies|antibodies|mesh-list
154360688|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
154360689|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360690|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154360691|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154360692|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360693|NCT05122130|Melatonin|melatonin|mesh-list
154360694|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
154360695|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360696|NCT05122130|Protective Agents|protective agents|mesh-ancestor
154360697|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360698|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360712|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154360713|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
154360714|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360715|NCT04123405|Protective Agents|protective agents|mesh-ancestor
154360716|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360717|NCT04123405|Antidotes|antidotes|mesh-ancestor
154360718|NCT02611232|Liraglutide|liraglutide|mesh-list
154360719|NCT02611232|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154360720|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154360721|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360722|NCT02611232|Incretins|incretins|mesh-ancestor
154360776|NCT05737862|Vitamin B Complex|vitamin b complex|mesh-ancestor
154360777|NCT05737862|Vitamins|vitamins|mesh-ancestor
154360778|NCT05737862|Micronutrients|micronutrients|mesh-ancestor
154360779|NCT05737862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360780|NCT02097680|Letrozole|letrozole|mesh-list
154360781|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360782|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154360783|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154360784|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360785|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360786|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154360787|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
154360788|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360789|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360790|NCT01150955|Resveratrol|resveratrol|mesh-list
154360791|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
154360792|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360833|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360834|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360835|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
154360836|NCT01560572|Hormones|hormones|mesh-ancestor
154360837|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360838|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154360839|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360840|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154360841|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154360842|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
154360843|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154360844|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360845|NCT05209256|Pemetrexed|pemetrexed|mesh-list
154360846|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360847|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360848|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360849|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154360850|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154360851|NCT05211050|Cromakalim|cromakalim|mesh-list
154360852|NCT05211050|Sumatriptan|sumatriptan|mesh-list
154360853|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154360854|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154360855|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154360856|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
154360857|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154360879|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154360881|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
154360882|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154360883|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360884|NCT01151267|Anesthetics|anesthetics|mesh-list
154360885|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360886|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360887|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
154360888|NCT01259141|Azithromycin|azithromycin|mesh-list
154360889|NCT01259141|Cephalosporins|cephalosporins|mesh-list
154360890|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154360891|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360892|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154360893|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154360894|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360895|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360896|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360898|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
154360899|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
154360900|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154360901|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360902|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
154360903|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360929|NCT03892421|Dexamethasone|dexamethasone|mesh-list
154360930|NCT03892421|Rituximab|rituximab|mesh-list
154360931|NCT03892421|Carboplatin|carboplatin|mesh-list
154360932|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154360933|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
154360934|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
154360935|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154360936|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154360937|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154360938|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
154360939|NCT03892421|Hormones|hormones|mesh-ancestor
154360940|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154360941|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154360942|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154360943|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154360944|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
154360945|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154360946|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154360986|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154360987|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360988|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154360989|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154360990|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154360991|NCT01259219|Rifabutin|rifabutin|mesh-list
154360992|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154360993|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154360994|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154360995|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
154360996|NCT03891095|Oxytocin|oxytocin|mesh-list
154360997|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
154360998|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154360999|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361000|NCT05667077|Amantadine|amantadine|mesh-list
154361001|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154361002|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154361003|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
154361004|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361005|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
154361006|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361007|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361008|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361009|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154361010|NCT05667077|Analgesics|analgesics|mesh-ancestor
154361011|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
154361012|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361013|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
154361014|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154361033|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
154361034|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361035|NCT03894683|Protective Agents|protective agents|mesh-ancestor
154361036|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361037|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361038|NCT01259531|Silodosin|silodosin|mesh-list
154361039|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154361040|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154361041|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154361042|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
154361043|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361044|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361045|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361046|NCT01259531|Urological Agents|urological agents|mesh-ancestor
154361047|NCT01151735|Complement C1s|complement c1s|mesh-list
154361048|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
154361049|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361050|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154361051|NCT03061214|Semaglutide|semaglutide|mesh-list
154361052|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361053|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361054|NCT03061214|Incretins|incretins|mesh-ancestor
154361055|NCT03061214|Hormones|hormones|mesh-ancestor
154361056|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361057|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154361058|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
154361059|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361060|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361061|NCT03061214|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154361074|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361075|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361076|NCT03889145|Amlodipine|amlodipine|mesh-list
154361077|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154361078|NCT03889145|Telmisartan|telmisartan|mesh-list
154361079|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154361080|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154361081|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154361082|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361083|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154361138|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361139|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154361140|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154361141|NCT01147757|Remifentanil|remifentanil|mesh-list
154361142|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154361143|NCT01147757|Narcotics|narcotics|mesh-ancestor
154361144|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361145|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502496|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154361146|NCT01147757|Analgesics|analgesics|mesh-ancestor
154361147|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
154361148|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361149|NCT01251809|Pegaspargase|pegaspargase|mesh-list
154361150|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361151|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
154361199|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361200|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361201|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154361203|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
154361270|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361271|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154361272|NCT01261481|Tolvaptan|tolvaptan|mesh-list
154361273|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154361274|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361275|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
154361276|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361277|NCT01261637|Ropivacaine|ropivacaine|mesh-list
154361278|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
154361279|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
154361280|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361281|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361282|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
154361283|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361284|NCT01262183|Panitumumab|panitumumab|mesh-list
154361285|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361286|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361287|NCT01154933|Exenatide|exenatide|mesh-list
154361288|NCT01154933|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154361289|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154361290|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361291|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154361292|NCT01154933|Incretins|incretins|mesh-ancestor
154361293|NCT01154933|Hormones|hormones|mesh-ancestor
154361294|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361295|NCT01155635|Carvedilol|carvedilol|mesh-list
154361296|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154361297|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154361298|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
154361299|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361301|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361310|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154361311|NCT01155089|Anastrozole|anastrozole|mesh-list
154361312|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361313|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361314|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154361315|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154361316|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361317|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361318|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153502567|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361319|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
154361320|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361321|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361322|NCT01155245|Teriparatide|teriparatide|mesh-list
154361323|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154361324|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361325|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154361326|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
154361327|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154361328|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
154361329|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361330|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
154361331|NCT01262417|Protective Agents|protective agents|mesh-ancestor
154361333|NCT01155791|Docetaxel|docetaxel|mesh-list
154361334|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361335|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
154361336|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
154361337|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
154361338|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361339|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361340|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
154361351|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154361352|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361353|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
154361354|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361356|NCT03881423|Rocuronium|rocuronium|mesh-list
154361357|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154361358|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
154361359|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154361416|NCT03880877|Protective Agents|protective agents|mesh-ancestor
154361417|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361418|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
154361419|NCT03880877|Vitamins|vitamins|mesh-ancestor
154361420|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
154361421|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154361422|NCT05666999|Laxatives|laxatives|mesh-ancestor
154361423|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154361424|NCT01262729|Xenon|xenon|mesh-list
154361425|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154361426|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
154361427|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
154361428|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154361429|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361430|NCT01264289|Finasteride|finasteride|mesh-list
154361478|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154361479|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154361480|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361481|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361482|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361483|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154361484|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154361485|NCT01264367|Interferons|interferons|mesh-list
154361486|NCT01264367|Clevudine|clevudine|mesh-list
154361487|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361488|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
154361490|NCT01262963|Dabrafenib|dabrafenib|mesh-list
154361542|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361543|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361545|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
154361546|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107822|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
154361547|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361548|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154361549|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154361550|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361551|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361552|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361553|NCT03879707|Melatonin|melatonin|mesh-list
154361554|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
154361604|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154361605|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
154361606|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154361607|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154361608|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
154361609|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
154361610|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154361670|NCT01266005|Clevudine|clevudine|mesh-list
154361671|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
154361672|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361673|NCT04292899|Remdesivir|remdesivir|mesh-list
154361674|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
154361675|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361676|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
154361677|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154361678|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
154361679|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154361680|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154361681|NCT03876899|Analgesics|analgesics|mesh-ancestor
154361682|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
154361683|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154361684|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361685|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154361686|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154361687|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154361688|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
154361689|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361690|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154361691|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
154361692|NCT03241173|Nivolumab|nivolumab|mesh-list
154361720|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
154361721|NCT01268033|Rituximab|rituximab|mesh-list
154361722|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361723|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361724|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
154361725|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154361726|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154361727|NCT01162031|Bortezomib|bortezomib|mesh-list
154361728|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361729|NCT02879162|Durvalumab|durvalumab|mesh-list
154361730|NCT02879162|Tremelimumab|tremelimumab|mesh-list
154361731|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361732|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361733|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
154361734|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361735|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361736|NCT02285504|Brexanolone|brexanolone|mesh-list
154361737|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
154361738|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154361739|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361741|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
154361776|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154361777|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154361778|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154361779|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361780|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361781|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154361782|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
154361783|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154361841|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154361842|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361843|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
154361844|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361845|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361846|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154361909|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154361910|NCT03745807|Nivolumab|nivolumab|mesh-list
154361911|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154361912|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154361913|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154361914|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361915|NCT01164059|Haloperidol|haloperidol|mesh-list
154361916|NCT01164059|Olanzapine|olanzapine|mesh-list
154361917|NCT01164059|Aripiprazole|aripiprazole|mesh-list
154361918|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154361919|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
154361920|NCT01164059|Flupenthixol|flupenthixol|mesh-list
154361973|NCT02959918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154361974|NCT02959918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154361975|NCT02959918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154361976|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154361977|NCT01266707|Vaccines|vaccines|mesh-list
154361978|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
154362042|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154362043|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
154362044|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362045|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362046|NCT02940522|Progestins|progestins|mesh-ancestor
154362047|NCT02940522|Hormones|hormones|mesh-ancestor
154362048|NCT01266785|Infliximab|infliximab|mesh-list
154362049|NCT01266785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154362050|NCT01266785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154362051|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
154362052|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154362053|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154362054|NCT03262038|Ondansetron|ondansetron|mesh-list
154362055|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
154362056|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
154362057|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362058|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362059|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154362060|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
154362061|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
154362062|NCT03262038|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154362063|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154362064|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
154362065|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362093|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154362095|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154362096|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
154362097|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
154362098|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362099|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
154362100|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362101|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362102|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
154362103|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154362104|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154362105|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
154362119|NCT01104922|Cetuximab|cetuximab|mesh-list
154362154|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154362155|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154362156|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
154362157|NCT04222699|Mupirocin|mupirocin|mesh-list
154362158|NCT04222699|Calcium|calcium|mesh-list
153502790|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
154362159|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154362160|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362161|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154362162|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362163|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
154362164|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154362165|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154362166|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362167|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362168|NCT01269203|Curcumin|curcumin|mesh-list
154362169|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154362170|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154362171|NCT01269203|Analgesics|analgesics|mesh-ancestor
154362210|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
154362211|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362212|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154362213|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362214|NCT03330249|Cisplatin|cisplatin|mesh-list
154362215|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362216|NCT04652206|Paclitaxel|paclitaxel|mesh-list
154362217|NCT04652206|Gemcitabine|gemcitabine|mesh-list
154362218|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154362219|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362220|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
154362221|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
154362222|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
154362223|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362224|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154362225|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
154362226|NCT01269281|Sumatriptan|sumatriptan|mesh-list
154362227|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154362228|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154362229|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154362230|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
154362231|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362232|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362233|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362234|NCT02778204|Maraviroc|maraviroc|mesh-list
154362235|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154362236|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154362237|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362238|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154362239|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154362240|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
154362241|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154362243|NCT01160705|Docetaxel|docetaxel|mesh-list
154362251|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154362252|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
154362253|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154362254|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362255|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154362256|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154362257|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362258|NCT03261336|Vitamin D|vitamin d|mesh-list
154362259|NCT03261336|Calcitriol|calcitriol|mesh-list
154362260|NCT03261336|Ketoconazole|ketoconazole|mesh-list
154362261|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
154362262|NCT03261336|Vitamins|vitamins|mesh-ancestor
154362263|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
154362264|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362265|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154362266|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154362267|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154362268|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
154362281|NCT03384862|Folic Acid|folic acid|mesh-list
154362307|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154362308|NCT00462748|Simvastatin|simvastatin|mesh-list
154362310|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154362311|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154362312|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
154362313|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362314|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154362315|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153502843|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154362316|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362317|NCT01161017|Topiramate|topiramate|mesh-list
154362318|NCT01161017|Amitriptyline|amitriptyline|mesh-list
154362319|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
154362369|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154362370|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154362371|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362372|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362373|NCT00418834|Atorvastatin|atorvastatin|mesh-list
154362375|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154362376|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154362377|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
154362378|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362379|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154362380|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154362381|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362382|NCT01269671|Peppermint oil|peppermint oil|mesh-list
154362383|NCT01269671|Melatonin|melatonin|mesh-list
154362384|NCT01269671|Simethicone|simethicone|mesh-list
154362385|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
154362386|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362426|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154362427|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154362428|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154362429|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
154362430|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362431|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362432|NCT03297216|Progestins|progestins|mesh-ancestor
154362433|NCT03297216|Hormones|hormones|mesh-ancestor
154362434|NCT03260868|Insulin|insulin|mesh-list
154362435|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154362436|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
154362437|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
154362438|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
154362439|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154362440|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362441|NCT01165385|Cisplatin|cisplatin|mesh-list
154362442|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362443|NCT01267487|Heparin|heparin|mesh-list
154362444|NCT01267487|Calcium heparin|calcium heparin|mesh-list
154108716|NCT00872781|Quinapril|quinapril|mesh-list
154362445|NCT01267487|Protamines|protamines|mesh-list
154362446|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
154362482|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
154362483|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362484|NCT01167101|Pantoprazole|pantoprazole|mesh-list
154362485|NCT01167101|Rebamipide|rebamipide|mesh-list
154362486|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154362487|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154362488|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154362489|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362490|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362491|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
154362492|NCT01167101|Protective Agents|protective agents|mesh-ancestor
154362493|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362547|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154362548|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154362549|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362550|NCT05427669|Antidotes|antidotes|mesh-ancestor
154362551|NCT05427669|Protective Agents|protective agents|mesh-ancestor
154362552|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
154362553|NCT05427669|Vitamins|vitamins|mesh-ancestor
153502951|NCT01839552|Narcotics|narcotics|mesh-ancestor
153502952|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502953|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502954|NCT01839552|Analgesics|analgesics|mesh-ancestor
153502955|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
154362554|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
154362618|NCT04084626|Antibodies|antibodies|mesh-list
154362619|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
154362620|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362621|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154362622|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154362623|NCT04084626|Growth Substances|growth substances|mesh-ancestor
154362624|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
154362625|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362626|NCT03387826|Ticagrelor|ticagrelor|mesh-list
154362627|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154362628|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154362629|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154362681|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362682|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154362683|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362684|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
154362685|NCT03379012|Sunitinib|sunitinib|mesh-list
154362686|NCT03379012|Testosterone|testosterone|mesh-list
154362687|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
154362688|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
154362689|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154362690|NCT03379012|Androgens|androgens|mesh-ancestor
154362691|NCT03379012|Hormones|hormones|mesh-ancestor
154362692|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154362693|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362694|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154362695|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362696|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
154362737|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154362738|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154362739|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
154362740|NCT01281605|Insulin|insulin|mesh-list
154362741|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154362742|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
154362743|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154362744|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362745|NCT01170143|Trastuzumab|trastuzumab|mesh-list
154362748|NCT05171530|Lenvatinib|lenvatinib|mesh-list
154362804|NCT01281761|Irinotecan|irinotecan|mesh-list
154362805|NCT01281761|Cetuximab|cetuximab|mesh-list
154362806|NCT01281761|Simvastatin|simvastatin|mesh-list
154362807|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154362808|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154362809|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362810|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362811|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154362812|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154362813|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154362814|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154362815|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
154362816|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154362818|NCT04280328|Daratumumab|daratumumab|mesh-list
154362868|NCT04058353|Elexacaftor|elexacaftor|mesh-list
154362869|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154362870|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362871|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362872|NCT01167725|Leucovorin|leucovorin|mesh-list
154362873|NCT01167725|Bevacizumab|bevacizumab|mesh-list
154362874|NCT01167725|Cetuximab|cetuximab|mesh-list
154362875|NCT01167725|Capecitabine|capecitabine|mesh-list
154362876|NCT01167725|Fluorouracil|fluorouracil|mesh-list
153503085|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153503086|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
153503087|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153503088|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362877|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
154362936|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154362937|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362938|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
153503173|NCT01725204|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154362939|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154362940|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
154362941|NCT01166087|Fluoxetine|fluoxetine|mesh-list
154362942|NCT01166087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154362943|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154362944|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154362945|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154362946|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154362947|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
154362948|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362949|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154362950|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
154362951|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154362952|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154362953|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154362954|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154362988|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154362989|NCT01275911|Narcotics|narcotics|mesh-ancestor
154362990|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154362991|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154362992|NCT01275911|Analgesics|analgesics|mesh-ancestor
154362993|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
154362994|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154362995|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154363056|NCT03744949|Narcotics|narcotics|mesh-ancestor
154363057|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363058|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363059|NCT03744949|Analgesics|analgesics|mesh-ancestor
154363060|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
154363061|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363062|NCT03870581|Warfarin|warfarin|mesh-list
154363063|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
154363064|NCT04016779|Viloxazine|viloxazine|mesh-list
154363065|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154363066|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
154363120|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154363121|NCT01127256|Analgesics|analgesics|mesh-ancestor
154363122|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
154363123|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363124|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154363125|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154363126|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363127|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154363128|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154363129|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154109387|NCT00958750|Minoxidil|minoxidil|mesh-list
154363130|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154363131|NCT03377842|Leucovorin|leucovorin|mesh-list
154363132|NCT03377842|Apatinib|apatinib|mesh-list
154363133|NCT03377842|Fluorouracil|fluorouracil|mesh-list
154363134|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
154363135|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363136|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154363137|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363138|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363139|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
153503174|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153503175|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503176|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363140|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154363141|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154363142|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
154363143|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363144|NCT03377842|Antidotes|antidotes|mesh-ancestor
154363145|NCT03377842|Protective Agents|protective agents|mesh-ancestor
154363146|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
154363147|NCT03377842|Vitamins|vitamins|mesh-ancestor
154363148|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
154363164|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154363165|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154363166|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363167|NCT03946527|Lanreotide|lanreotide|mesh-list
154363168|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363169|NCT03377608|Tenofovir|tenofovir|mesh-list
154363170|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154363171|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
154363172|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
154363173|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363174|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154363175|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154363176|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363177|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363225|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363226|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363227|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363228|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154363229|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154363230|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
154363231|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
154363232|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
154363233|NCT03377218|Iodine|iodine|mesh-list
154363234|NCT03377218|Selenium|selenium|mesh-list
154363235|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
154363236|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154363237|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363238|NCT03377218|Trace Elements|trace elements|mesh-ancestor
154363239|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
154363240|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363241|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
154363283|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363284|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154363285|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154363286|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154363287|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
154363288|NCT04050865|Dexamethasone|dexamethasone|mesh-list
154363289|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154363290|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
154363349|NCT01171781|Cisplatin|cisplatin|mesh-list
154363350|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363351|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
154363352|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
154363353|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363354|NCT01171859|Doxycycline|doxycycline|mesh-list
154363355|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154363356|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363357|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363358|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
154363359|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154363360|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154363361|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
154363362|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154363363|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154363364|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
154363365|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
154363408|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154363409|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154363410|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363411|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363412|NCT01168817|Urological Agents|urological agents|mesh-ancestor
154363414|NCT01279811|Norepinephrine|norepinephrine|mesh-list
154363415|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154363416|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154363417|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154363418|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
154363419|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363420|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363421|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363422|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
154363423|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
154363424|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363425|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154363426|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
154363427|NCT01279811|Protective Agents|protective agents|mesh-ancestor
154363428|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
154363429|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363430|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363431|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154363459|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
154363460|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363461|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363462|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154363463|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154363464|NCT03745105|Analgesics|analgesics|mesh-ancestor
154363465|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363466|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154363467|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
154363468|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154363469|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154363470|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154363471|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154363472|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363519|NCT02527798|Diuretics|diuretics|mesh-ancestor
154363520|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
154363521|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363522|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154363523|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154363524|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363525|NCT05331911|Propofol|propofol|mesh-list
154363526|NCT05331911|Sevoflurane|sevoflurane|mesh-list
154363527|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154363528|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363529|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363530|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154363531|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
154363532|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
154363533|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154363534|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154363535|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154363536|NCT03857542|Pilocarpine|pilocarpine|mesh-list
154363537|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154363538|NCT03857542|Miotics|miotics|mesh-ancestor
154363572|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363573|NCT03751631|Protective Agents|protective agents|mesh-ancestor
154363574|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154363575|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154363576|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
153503376|NCT01043874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363577|NCT03866681|Sirolimus|sirolimus|mesh-list
154363578|NCT03866681|Warfarin|warfarin|mesh-list
154363579|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363640|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363641|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154363642|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154363643|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
154363644|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363645|NCT01172405|Ibuprofen|ibuprofen|mesh-list
154363646|NCT01172405|Caffeine|caffeine|mesh-list
154363647|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154363648|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154363649|NCT01172405|Analgesics|analgesics|mesh-ancestor
154363704|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154363705|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154363706|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363707|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363708|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
154363709|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154363710|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
154363711|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363712|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363713|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
154363714|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154363715|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154363716|NCT01173107|Colchicine|colchicine|mesh-list
154363717|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
154363718|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154363719|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154363720|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154363721|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154363722|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363723|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363724|NCT03744091|Dronabinol|dronabinol|mesh-list
154363725|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
154363726|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363727|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154363728|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154363729|NCT03744091|Analgesics|analgesics|mesh-ancestor
154363730|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
154109981|NCT05761041|Listerine|listerine|mesh-list
154363731|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363732|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154363733|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154363734|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363735|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363737|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154363738|NCT03376594|Loratadine|loratadine|mesh-list
154363739|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
154363741|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154363742|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154363743|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154363744|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
154363745|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
154363746|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363747|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363748|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503462|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153503465|NCT03402984|Z 338|z 338|mesh-list
154363749|NCT03381664|Quinidine|quinidine|mesh-list
154363750|NCT03381664|Levomethorphan|levomethorphan|mesh-list
154363751|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
154363752|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
154363753|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
154363754|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154363755|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154363756|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363757|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363758|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363759|NCT03381664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154363760|NCT03381664|Narcotics|narcotics|mesh-ancestor
154363762|NCT03381664|Analgesics|analgesics|mesh-ancestor
154363794|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363795|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363796|NCT04024891|Phentolamine|phentolamine|mesh-list
154363797|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154363798|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154363799|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154363800|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154363801|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
154363802|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154363803|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363804|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363805|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154363806|NCT01178021|Chloroquine|chloroquine|mesh-list
154363807|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154363808|NCT01178021|Primaquine|primaquine|mesh-list
154363809|NCT01178021|Amebicides|amebicides|mesh-ancestor
154363810|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154363851|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363852|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154363853|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
154363855|NCT03381430|Gefitinib|gefitinib|mesh-list
154363856|NCT03381430|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154363857|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154363858|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154363859|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154363860|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154363919|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363920|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154363921|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
154363922|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
154363923|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154363924|NCT03732469|Narcotics|narcotics|mesh-ancestor
154363925|NCT03732469|Analgesics|analgesics|mesh-ancestor
154363926|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
154363927|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363928|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154363929|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154363930|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
154363931|NCT03381352|Capecitabine|capecitabine|mesh-list
154363932|NCT03381352|Mitomycins|mitomycins|mesh-list
154363933|NCT03381352|Mitomycin|mitomycin|mesh-list
154363983|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363985|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154363986|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
154363987|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363988|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
154363989|NCT03381040|Protective Agents|protective agents|mesh-ancestor
154363990|NCT03376048|Ropivacaine|ropivacaine|mesh-list
153503553|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
154363991|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
154363992|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
154363993|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154363994|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154363995|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
154363996|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154363997|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
154363998|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
154363999|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154364000|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364001|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154364002|NCT01285037|Gemcitabine|gemcitabine|mesh-list
154364003|NCT01285037|Cetuximab|cetuximab|mesh-list
154364004|NCT01285037|Ramucirumab|ramucirumab|mesh-list
154364005|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364006|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154364007|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
154364008|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364009|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154364010|NCT01285037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154364011|NCT01285037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154364012|NCT01285037|Growth Substances|growth substances|mesh-ancestor
154364013|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364014|NCT01285037|Growth Inhibitors|growth inhibitors|mesh-ancestor
154364015|NCT03732391|Carboplatin|carboplatin|mesh-list
154364016|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
154364023|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364024|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364026|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
154364027|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364028|NCT03207243|Fluticasone|fluticasone|mesh-list
154364029|NCT03207243|Xhance|xhance|mesh-list
154364030|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154364031|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154364032|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154364033|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
154364034|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364035|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364036|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154364037|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
154364038|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
154364039|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154364040|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154364041|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154364042|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154364043|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
154364044|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364045|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364046|NCT01285271|Sevoflurane|sevoflurane|mesh-list
154364047|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154364048|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154364049|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
154364050|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
154364051|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364052|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364053|NCT03982069|Vaccines|vaccines|mesh-list
154364054|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
154364065|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364066|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154364067|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154364069|NCT03628417|Calcium|calcium|mesh-list
154364070|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154364071|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364072|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154364073|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364074|NCT03369964|Atezolizumab|atezolizumab|mesh-list
154364075|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
154364079|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364125|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364126|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364127|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154364128|NCT03369808|Vaccines|vaccines|mesh-list
154364129|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
154364130|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364131|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154364132|NCT03369808|Antacids|antacids|mesh-ancestor
154364133|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364134|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154364135|NCT02525237|Apatinib|apatinib|mesh-list
154364136|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364137|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154364138|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364139|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364140|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
154364141|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364142|NCT03369574|Reslizumab|reslizumab|mesh-list
154364182|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364183|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
154364184|NCT01288547|Theobromine|theobromine|mesh-list
154364185|NCT01288547|Caffeine|caffeine|mesh-list
154364186|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154364187|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364188|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154364189|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364190|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364191|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154364192|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154364193|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
154364194|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364195|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154364196|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
154364197|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364198|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154364199|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
154364200|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
154364201|NCT03373864|Anesthetics|anesthetics|mesh-list
154364202|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364203|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364204|NCT04597320|Midazolam|midazolam|mesh-list
154364205|NCT04597320|Fentanyl|fentanyl|mesh-list
153503763|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503764|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503765|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
153503766|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503767|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503768|NCT02247414|Aspirin|aspirin|mesh-list
153503769|NCT02247414|Heparin|heparin|mesh-list
154364206|NCT04597320|Esketamine|esketamine|mesh-list
154364216|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
154364233|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154364234|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
154364235|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364236|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364237|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154364238|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
154364239|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364240|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364241|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154364242|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154364243|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154364244|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154364245|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154364246|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154364247|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364248|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154364249|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
154364250|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154364251|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154364252|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154364253|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154364254|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154364255|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154364256|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154364257|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154110506|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
154364258|NCT03123952|ABT-414|abt-414|mesh-list
154364276|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154364277|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154364278|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364279|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
154364280|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154364281|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154364282|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154364283|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
154364284|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364285|NCT05181852|Pregabalin|pregabalin|mesh-list
154364286|NCT05181852|Analgesics|analgesics|mesh-ancestor
154364287|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
154364288|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364289|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364290|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
154364291|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154364292|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154364293|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364294|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154364295|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154364296|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154364297|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364298|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154364299|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
154364326|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154364327|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364328|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364329|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154364330|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
154364331|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
154364332|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364394|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154364395|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503822|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154364396|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
154364397|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
154364398|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
154364399|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364400|NCT00165724|Donepezil|donepezil|mesh-list
154364401|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154364402|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364403|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364404|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
154364405|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364406|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364407|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
154364408|NCT01287455|Vitamin D|vitamin d|mesh-list
154364409|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
154364410|NCT01287455|Vitamins|vitamins|mesh-ancestor
154364411|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
154364412|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364413|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154364414|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154364415|NCT03865511|Osimertinib|osimertinib|mesh-list
154364416|NCT03865511|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154364417|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154364418|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364444|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364445|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
154364446|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364447|NCT02525081|Ramipril|ramipril|mesh-list
154364448|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154364449|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
154364450|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364451|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364452|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154364453|NCT05566548|Bilirubin|bilirubin|mesh-list
154364454|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
154364455|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364456|NCT05566548|Protective Agents|protective agents|mesh-ancestor
154364457|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364458|NCT02525003|Vitamin D|vitamin d|mesh-list
154364504|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364505|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364506|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
154364507|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
154364508|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154364509|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
154364510|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154364511|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
154364512|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364515|NCT04523662|Apatinib|apatinib|mesh-list
154364570|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154364572|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
154364573|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
154364574|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364575|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
154364576|NCT02956057|Protective Agents|protective agents|mesh-ancestor
154364577|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364638|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154364639|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154364640|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
154364641|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364642|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153503891|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153503893|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
153503983|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154364643|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154364644|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
154364645|NCT01285661|Vitamin K|vitamin k|mesh-list
154364646|NCT01285661|Warfarin|warfarin|mesh-list
154364647|NCT01285661|Anticoagulants|anticoagulants|mesh-list
154364648|NCT01285661|Vitamins|vitamins|mesh-ancestor
154364649|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
154364650|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364651|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154364652|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154364653|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364654|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
154364655|NCT01285661|Coagulants|coagulants|mesh-ancestor
154364656|NCT03360682|Tenofovir|tenofovir|mesh-list
154364657|NCT03360682|Lamivudine|lamivudine|mesh-list
154364658|NCT03360682|Emtricitabine|emtricitabine|mesh-list
154364659|NCT03360682|Dolutegravir|dolutegravir|mesh-list
154364660|NCT03360682|Abacavir|abacavir|mesh-list
154364661|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
154364662|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364665|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364689|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154364690|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154364691|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364692|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
154364693|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364694|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364695|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
154364696|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154364697|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364698|NCT03867084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154364699|NCT03867084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364700|NCT03860831|Midazolam|midazolam|mesh-list
154364701|NCT03860831|Ketamine|ketamine|mesh-list
154364749|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364750|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154364751|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154364752|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
154364753|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364754|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364755|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
154364756|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153503984|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503985|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153503986|NCT00558636|Paclitaxel|paclitaxel|mesh-list
153503987|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153503988|NCT00558636|Carboplatin|carboplatin|mesh-list
153503989|NCT00558636|Sorafenib|sorafenib|mesh-list
153503990|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153503991|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503993|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
153503994|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
153503995|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503996|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153504017|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364757|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
154364758|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364759|NCT03680911|Expectorants|expectorants|mesh-ancestor
154364760|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
154364761|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154364812|NCT01289327|Narcotics|narcotics|mesh-ancestor
154364813|NCT01289327|Analgesics|analgesics|mesh-ancestor
154364814|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
154364815|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364816|NCT01181063|Budesonide|budesonide|mesh-list
154364817|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
154364818|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154364819|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154364820|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
154364821|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364822|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364823|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154364824|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
154364825|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
154364826|NCT01181063|Hormones|hormones|mesh-ancestor
154364827|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154364828|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154364829|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154364871|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154364872|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154364873|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364875|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364876|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154364877|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154364878|NCT04523272|Growth Substances|growth substances|mesh-ancestor
154364879|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364880|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
154364881|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154364882|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364883|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364884|NCT01289561|Ethanol|ethanol|mesh-list
154364885|NCT01289561|Quinine|quinine|mesh-list
154364886|NCT01289561|Caffeine|caffeine|mesh-list
154364887|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154364888|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154364889|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154364890|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364891|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154364892|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154364893|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364921|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154364923|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154364924|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364925|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364926|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364927|NCT03357874|Clopidogrel|clopidogrel|mesh-list
154364928|NCT03357874|Ticagrelor|ticagrelor|mesh-list
153504047|NCT00553644|Bortezomib|bortezomib|mesh-list
154364929|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154364930|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154364931|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154364932|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154364933|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
154364934|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364935|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364936|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364937|NCT01286051|Ganirelix|ganirelix|mesh-list
154364938|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
154364939|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154364940|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364941|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154364942|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154364943|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154364944|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154364945|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364946|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364947|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364948|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
154364949|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154364950|NCT02359513|Fluoxetine|fluoxetine|mesh-list
154364951|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
154364952|NCT02359513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154364953|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154364955|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364956|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154364957|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
154364958|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364959|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154364960|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154364961|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154364962|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154364963|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364964|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
154364965|NCT01184495|Hematinics|hematinics|mesh-ancestor
154364966|NCT03864575|Celecoxib|celecoxib|mesh-list
154364967|NCT03864575|Nivolumab|nivolumab|mesh-list
154364968|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154364969|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154364970|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154364971|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364972|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154364973|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154364974|NCT03864575|Analgesics|analgesics|mesh-ancestor
154364975|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
154364976|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154364977|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154364978|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504110|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154364979|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154364980|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154364981|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154364982|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154364983|NCT03357718|Midazolam|midazolam|mesh-list
154364984|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
154364997|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154364998|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154364999|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154365000|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154365001|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154365002|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154365003|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
154365004|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
154365005|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
154365006|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
154365007|NCT04521400|Interferons|interferons|mesh-list
154365008|NCT04521400|Ritonavir|ritonavir|mesh-list
154365009|NCT04521400|Lopinavir|lopinavir|mesh-list
154365010|NCT04521400|Interferon-beta|interferon-beta|mesh-list
154365060|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365061|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154365062|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154365064|NCT03733873|Coagulants|coagulants|mesh-ancestor
154365065|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154365066|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
154365067|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365068|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154365069|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
154365070|NCT03733639|Coagulants|coagulants|mesh-ancestor
154365071|NCT03733561|Rotigotine|rotigotine|mesh-list
154365072|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
154365073|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
154365074|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365075|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365076|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365077|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
154365078|NCT03358888|Narcotics|narcotics|mesh-ancestor
154365079|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365080|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365081|NCT03358888|Analgesics|analgesics|mesh-ancestor
154365082|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
154365083|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504197|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504198|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
153504199|NCT03834012|Hormones|hormones|mesh-ancestor
153504200|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153504201|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504202|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153504203|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
153504204|NCT03833466|Metformin|metformin|mesh-list
153504205|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154365084|NCT01291121|Ranibizumab|ranibizumab|mesh-list
154365085|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154365086|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154365087|NCT01291121|Growth Substances|growth substances|mesh-ancestor
154365088|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365089|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
154365091|NCT01187849|Metformin|metformin|mesh-list
154365106|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
154365107|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365108|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154365109|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365110|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
154365111|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365112|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154365113|NCT01185743|Olanzapine|olanzapine|mesh-list
154365114|NCT01185743|Ziprasidone|ziprasidone|mesh-list
154365115|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
154365116|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
154365117|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365118|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365119|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154365120|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154365121|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154365122|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365123|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154365124|NCT01185743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154365125|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154365126|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154365127|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365128|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365129|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
154365130|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154365131|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154365132|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
154365133|NCT01188005|Vitamins|vitamins|mesh-list
154365134|NCT01188005|Vitamin E|vitamin e|mesh-list
154365135|NCT01188005|Vitamin A|vitamin a|mesh-list
154365136|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
154365137|NCT01188005|Allopurinol|allopurinol|mesh-list
154365138|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154365139|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
154365140|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365141|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
154365142|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365143|NCT01188005|Protective Agents|protective agents|mesh-ancestor
154365144|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
154365145|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365146|NCT01188005|Expectorants|expectorants|mesh-ancestor
154365147|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
154365148|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154365149|NCT01188005|Antidotes|antidotes|mesh-ancestor
154365150|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
154365151|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504256|NCT05444556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504257|NCT05444556|Analgesics|analgesics|mesh-ancestor
153504258|NCT05444556|Sensory System Agents|sensory system agents|mesh-ancestor
153504259|NCT05444556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365152|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
154365153|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365155|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
154365156|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365157|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154365158|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
154027430|NCT02869633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365160|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154365161|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365162|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365163|NCT01291199|Urological Agents|urological agents|mesh-ancestor
154365164|NCT04444726|Betamethasone|betamethasone|mesh-list
154365165|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
154365166|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154365167|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
154365171|NCT04444726|Hormones|hormones|mesh-ancestor
154365193|NCT03733171|Hemostatics|hemostatics|mesh-list
154365194|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154365195|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154365196|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
154365197|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365198|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365199|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365200|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154365201|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154365202|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
154365203|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365204|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154365205|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
154365206|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
154365207|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
154365208|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154365209|NCT03733171|Coagulants|coagulants|mesh-ancestor
154365210|NCT03207750|Vaccines|vaccines|mesh-list
154365211|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154365212|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
154365213|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365214|NCT01185977|Fluoxetine|fluoxetine|mesh-list
154365215|NCT01185977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154365216|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154365217|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154365218|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365240|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
153504322|NCT05768243|Viscosupplements|viscosupplements|mesh-ancestor
153504323|NCT05768243|Protective Agents|protective agents|mesh-ancestor
153504324|NCT05768230|Simendan|simendan|mesh-list
153504325|NCT05768230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153504326|NCT05768230|Vasodilator Agents|vasodilator agents|mesh-ancestor
153504327|NCT05768230|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153504328|NCT05768230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154365241|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154365242|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154365243|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365244|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154365245|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154365246|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154365247|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365248|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154365249|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154365250|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154365251|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154365252|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154365253|NCT03847896|Budesonide|budesonide|mesh-list
154365254|NCT03847896|Albuterol|albuterol|mesh-list
154365255|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365256|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154365257|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
154365258|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365259|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365260|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154365261|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
154365262|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
154365263|NCT03847896|Hormones|hormones|mesh-ancestor
154365264|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365265|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
154365266|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154365267|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154365268|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154365281|NCT01291823|Gefitinib|gefitinib|mesh-list
154365282|NCT01291823|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154365283|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154365284|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365285|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365286|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365287|NCT01181765|Infliximab|infliximab|mesh-list
154365288|NCT01181765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154365289|NCT01181765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365290|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
154365291|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154365292|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365293|NCT01186445|Morphine|morphine|mesh-list
154365294|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154365295|NCT01186445|Narcotics|narcotics|mesh-ancestor
154365296|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365297|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365298|NCT01186445|Analgesics|analgesics|mesh-ancestor
154365299|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
154365300|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365301|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
154365302|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154365303|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365304|NCT04520230|Budesonide|budesonide|mesh-list
154365305|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
154365306|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
154365307|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154365308|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365309|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154365310|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
154365311|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365312|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365313|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154365314|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
154365315|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
154365316|NCT04520230|Hormones|hormones|mesh-ancestor
154365319|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154365320|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154365321|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
154365322|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365323|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365324|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
154365325|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154365326|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
154365327|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
154365328|NCT03619837|Velpatasvir|velpatasvir|mesh-list
154365329|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154365330|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
154365331|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365332|NCT03852563|Petrolatum|petrolatum|mesh-list
154365333|NCT03852563|Emollients|emollients|mesh-ancestor
154365334|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
154365335|NCT01188317|Ibuprofen|ibuprofen|mesh-list
154365336|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154365337|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154365338|NCT01188317|Analgesics|analgesics|mesh-ancestor
154365339|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
154365340|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365341|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365342|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365343|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365344|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154365345|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365346|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365347|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
154365348|NCT03206970|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154365349|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154365350|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365351|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365352|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365353|NCT03739021|Ropivacaine|ropivacaine|mesh-list
154365354|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
154365355|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
154365356|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365357|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365358|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
154365359|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365360|NCT03738943|Pyridoxine|pyridoxine|mesh-list
154365361|NCT03738943|Pyridoxal|pyridoxal|mesh-list
154365362|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
154365363|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
154365364|NCT03738943|Adenosine|adenosine|mesh-list
154365365|NCT03738943|Nitroprusside|nitroprusside|mesh-list
154365366|NCT03738943|Acetylcholine|acetylcholine|mesh-list
154365367|NCT03738943|Vitamins|vitamins|mesh-ancestor
154365368|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
154365369|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365370|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
154365371|NCT03738943|Analgesics|analgesics|mesh-ancestor
154365372|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
154365373|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365374|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154365375|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
153504508|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504510|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
153504511|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504512|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153504513|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153504514|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153504515|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504516|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365376|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154365377|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
154365378|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
154365379|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365380|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365381|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154365382|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154365383|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154365384|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
154365386|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154365387|NCT03178851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154365388|NCT03178851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365389|NCT03178851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154365390|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365391|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
154365392|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365393|NCT01291979|Lidocaine|lidocaine|mesh-list
154365394|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
154365395|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
154365396|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365397|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365398|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
154365399|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365400|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154365401|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154365402|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154365403|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154365404|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365405|NCT04443634|Bupivacaine|bupivacaine|mesh-list
154365406|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
154365407|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
154365408|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365409|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365410|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
154365411|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365412|NCT03643159|Aripiprazole|aripiprazole|mesh-list
154365413|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
154365414|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
154365415|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154365416|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154365417|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365418|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365419|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
154365420|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
154365425|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
154365439|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154365440|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154365441|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154365442|NCT01181999|Rituximab|rituximab|mesh-list
154365443|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504591|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504592|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153781894|NCT00232115|Analgesics|analgesics|mesh-ancestor
153504593|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153504594|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504595|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
153504607|NCT05170607|Antibodies|antibodies|mesh-list
154365444|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365445|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
154365446|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365447|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365448|NCT04509232|Fluorides|fluorides|mesh-list
154365449|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
154365450|NCT04509232|Protective Agents|protective agents|mesh-ancestor
154365451|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365452|NCT03732235|Bevacizumab|bevacizumab|mesh-list
154365453|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
154027431|NCT02848820|Amoxicillin|amoxicillin|mesh-list
154365454|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154365455|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365456|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154365457|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154365458|NCT03732235|Growth Substances|growth substances|mesh-ancestor
154365459|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365460|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
154365461|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154365462|NCT03732235|Estrogens|estrogens|mesh-ancestor
154365463|NCT03732235|Hormones|hormones|mesh-ancestor
154365465|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154365487|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
154365488|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
154365489|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365490|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365491|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365492|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365493|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
154365494|NCT03618823|Acetaminophen|acetaminophen|mesh-list
154365495|NCT03618823|Ibuprofen|ibuprofen|mesh-list
154365496|NCT03618823|Oxycodone|oxycodone|mesh-list
154365497|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154365498|NCT03618823|Analgesics|analgesics|mesh-ancestor
154365499|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
154365500|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365501|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365502|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
154365503|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154365504|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365505|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365506|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154365507|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365508|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365509|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154365510|NCT03618823|Narcotics|narcotics|mesh-ancestor
154365511|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154365512|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154365513|NCT01188707|Belinostat|belinostat|mesh-list
154365514|NCT01188707|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154365515|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153504685|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
153504687|NCT04671043|Caffeine|caffeine|mesh-list
154365520|NCT03356158|Cetuximab|cetuximab|mesh-list
154365534|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365536|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
154365537|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
154365538|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
154365539|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154365540|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365541|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
154365542|NCT02937636|Fluorides|fluorides|mesh-list
154365543|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
154365544|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
154365545|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
154365546|NCT02937636|Protective Agents|protective agents|mesh-ancestor
154365547|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365548|NCT03638635|Bupivacaine|bupivacaine|mesh-list
154365598|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
154365599|NCT03204279|Palonosetron|palonosetron|mesh-list
154365600|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
154365601|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
154365602|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365603|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365604|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154365605|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154365606|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154365607|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
154365608|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365609|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365610|NCT02524301|Diprenorphine|diprenorphine|mesh-list
154365611|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154365612|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365613|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
154365614|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365615|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
154365619|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
154365656|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365657|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365658|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
154365659|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365660|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365661|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154365662|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154365663|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154365664|NCT04508452|Bevacizumab|bevacizumab|mesh-list
154365665|NCT04508452|Capecitabine|capecitabine|mesh-list
154365666|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
154365667|NCT04508452|Irinotecan|irinotecan|mesh-list
154365668|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154365669|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365670|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154365671|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153504801|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
153504802|NCT04040959|Vitamins|vitamins|mesh-ancestor
153504803|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
153504804|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504805|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154365672|NCT04508452|Growth Substances|growth substances|mesh-ancestor
154365673|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365674|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
154365675|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154365676|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
154365677|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365678|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154365679|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154365680|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365681|NCT03856853|Pirfenidone|pirfenidone|mesh-list
154365682|NCT03856853|Analgesics|analgesics|mesh-ancestor
154365683|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
154365684|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365685|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365686|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154365688|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365689|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154365690|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365691|NCT03732703|Thalidomide|thalidomide|mesh-list
154365692|NCT03732703|Dexamethasone|dexamethasone|mesh-list
154365694|NCT03732703|Venetoclax|venetoclax|mesh-list
154365696|NCT03732703|Pomalidomide|pomalidomide|mesh-list
154365697|NCT03732703|Ixazomib|ixazomib|mesh-list
154365698|NCT03732703|BB 1101|bb 1101|mesh-list
154365699|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154365700|NCT03732703|Glycine|glycine|mesh-list
154365701|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154365702|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
154365703|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
154365704|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154365705|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365706|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154365707|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
154365708|NCT03732703|Hormones|hormones|mesh-ancestor
154365709|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154365710|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154365711|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365712|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
154365713|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365714|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365715|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
154365716|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154365717|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154365718|NCT03732703|Growth Substances|growth substances|mesh-ancestor
154365719|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
154365720|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365721|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
154365722|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154365723|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365724|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
154365725|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365726|NCT03636555|Oxytocin|oxytocin|mesh-list
154365727|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
154365728|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154365739|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154365740|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154365741|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365742|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365743|NCT03636477|Nivolumab|nivolumab|mesh-list
154365744|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154365745|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365746|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154365747|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365748|NCT03732001|Docetaxel|docetaxel|mesh-list
154365749|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365802|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
154365803|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365804|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154365805|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154365806|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365807|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365808|NCT04597476|Fucoidan|fucoidan|mesh-list
154365809|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154365810|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154365811|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
154365812|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365864|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
154365865|NCT03355612|Apatinib|apatinib|mesh-list
154365866|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154365867|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
154365868|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365869|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365870|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154365871|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365872|NCT03732547|Poly I-C|poly i-c|mesh-list
154365873|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
154365874|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154365875|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
154365876|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
154365927|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154365928|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
154365929|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365930|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154365931|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154365932|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365933|NCT01189019|Ranibizumab|ranibizumab|mesh-list
154365934|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154365935|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154365936|NCT01189019|Growth Substances|growth substances|mesh-ancestor
154365937|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365938|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
154365939|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154365987|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154365988|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154365989|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154365990|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154365991|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154365992|NCT01189097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154365993|NCT01189097|Narcotics|narcotics|mesh-ancestor
154366055|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366056|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154366057|NCT03729973|Lidocaine|lidocaine|mesh-list
154366058|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
154112300|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
154366059|NCT03729973|Ketamine|ketamine|mesh-list
154366060|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154366061|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366062|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
154366063|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366064|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366065|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
154366066|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366067|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154366115|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
154366116|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366117|NCT04443556|Tramadol|tramadol|mesh-list
154366118|NCT04443556|Anesthetics|anesthetics|mesh-list
154366119|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
154366120|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366122|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154366185|NCT05303727|Methotrexate|methotrexate|mesh-list
154366186|NCT05303727|Fludarabine|fludarabine|mesh-list
154366187|NCT05303727|Topotecan|topotecan|mesh-list
154366188|NCT05303727|Tacrolimus|tacrolimus|mesh-list
154366189|NCT05303727|Cyclosporins|cyclosporins|mesh-list
154366190|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154366191|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154366192|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
154366193|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366194|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154366195|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154366196|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
154366253|NCT03235050|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154366254|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154366255|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366256|NCT03235050|Incretins|incretins|mesh-ancestor
154366258|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154366259|NCT04933149|Ketamine|ketamine|mesh-list
154366260|NCT04933149|Analgesics|analgesics|mesh-ancestor
154366261|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
154366262|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366263|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366264|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154366265|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154366315|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154366316|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154366317|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366318|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154366319|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366320|NCT03849833|Vitamin D|vitamin d|mesh-list
154366321|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
154366322|NCT03849833|Vitamins|vitamins|mesh-ancestor
154366323|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
154366324|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366325|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154366326|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154366327|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
154366328|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154366329|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366332|NCT01191203|Copper|copper|mesh-list
154366368|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154366369|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154366370|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
154366371|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154366372|NCT03234036|Ritonavir|ritonavir|mesh-list
154366373|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
154366374|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154366375|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154366376|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
154366377|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366379|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154366429|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366430|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112672|NCT00606801|Galantamine|galantamine|mesh-list
154366431|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
154366432|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366433|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154366434|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154366435|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154366436|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154366491|NCT04454424|Midazolam|midazolam|mesh-list
153505280|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505281|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153505282|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153505283|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
153505284|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505285|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153505286|NCT01384695|Proflavine|proflavine|mesh-list
153505287|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153505288|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505289|NCT01384708|Proflavine|proflavine|mesh-list
153505290|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153505291|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505292|NCT01384799|Cisplatin|cisplatin|mesh-list
153505293|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154366492|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154366493|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154366494|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366495|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366496|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154366497|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154366498|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154366499|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154366500|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
154366501|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
154366502|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
154366503|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
154366504|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366505|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366506|NCT03348046|Infliximab|infliximab|mesh-list
154366507|NCT03348046|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154366508|NCT03348046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154366509|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
154366547|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366548|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
154366549|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366550|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366551|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
154366552|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366553|NCT03347890|Liraglutide|liraglutide|mesh-list
154366554|NCT03347890|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154366614|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154366615|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
154366616|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366617|NCT03122158|Escitalopram|escitalopram|mesh-list
154366618|NCT03122158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154366619|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154366620|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154366621|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366623|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
154366678|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
154366680|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154366681|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
154366682|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366683|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
154366684|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154366685|NCT01195181|Ribavirin|ribavirin|mesh-list
154366686|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
154366687|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366688|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
154366743|NCT03193047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154366744|NCT03193047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154366745|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366746|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154366747|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154366748|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366815|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366816|NCT03346642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154366817|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
154366818|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154366819|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
154366820|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366821|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154366822|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505360|NCT01385527|Hormones|hormones|mesh-ancestor
154366823|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154366879|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154366880|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154366881|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154366882|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
154366883|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154366923|NCT00709228|Ribavirin|ribavirin|mesh-list
154366950|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154366951|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154366952|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113222|NCT01055821|Ribavirin|ribavirin|mesh-list
154366953|NCT03628040|Ropivacaine|ropivacaine|mesh-list
154366954|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
154366956|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154366957|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154366958|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
154366959|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154366960|NCT04715763|Telmisartan|telmisartan|mesh-list
154366961|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154366965|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
154367011|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154367012|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154367013|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367014|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
154367015|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367016|NCT01195805|Amiloride|amiloride|mesh-list
154367017|NCT01195805|Spironolactone|spironolactone|mesh-list
154367018|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154367019|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
154367020|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367021|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367022|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154367023|NCT01195805|Diuretics|diuretics|mesh-ancestor
154367024|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
154367025|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154367026|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154367027|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367028|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367029|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154367031|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154367032|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154367033|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
154367034|NCT03845153|Metformin|metformin|mesh-list
154367035|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154367036|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367037|NCT00198718|Vitamin A|vitamin a|mesh-list
154367038|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
154367039|NCT00198718|Vitamins|vitamins|mesh-ancestor
154367040|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
154367041|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367042|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
154367043|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367044|NCT00198718|Protective Agents|protective agents|mesh-ancestor
154367047|NCT04500808|Macitentan|macitentan|mesh-list
154367051|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154367052|NCT01192763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154367053|NCT01192763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154367054|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367055|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367057|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153505481|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367058|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367059|NCT00708916|Analgesics|analgesics|mesh-ancestor
154367060|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
154367061|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367062|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367063|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367106|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367108|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154367109|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
154367110|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
154367111|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367112|NCT01193387|Insulin|insulin|mesh-list
154367113|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154367114|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
154367115|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154367116|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367117|NCT01198223|Nystatin|nystatin|mesh-list
154027432|NCT02848820|Gentamicins|gentamicins|mesh-list
154367171|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154367172|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367173|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154367174|NCT02517424|Dronabinol|dronabinol|mesh-list
154367175|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
154367176|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367177|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154367178|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367179|NCT02517424|Analgesics|analgesics|mesh-ancestor
154367180|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
154367186|NCT02517424|Hormones|hormones|mesh-ancestor
154367232|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154367233|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367235|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154367236|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367237|NCT01198379|Analgesics|analgesics|mesh-ancestor
154367238|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
154367239|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367240|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367241|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367242|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367243|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154367244|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154113518|NCT00764712|Insulin|insulin|mesh-list
154367293|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367294|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154367296|NCT01198535|Antibodies|antibodies|mesh-list
154367297|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
154367298|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154157395|NCT05805501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505620|NCT01386736|Vitamin D|vitamin d|mesh-list
154367299|NCT01198535|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154367300|NCT01198535|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154367301|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
154367302|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367303|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154367304|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367305|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367306|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
154367307|NCT03844763|Avelumab|avelumab|mesh-list
154367308|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154367309|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
154367346|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367347|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
154367348|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
154367349|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
154367350|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154367351|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367352|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
154367353|NCT01199159|Pyridoxal|pyridoxal|mesh-list
154367354|NCT01199159|Pyridoxine|pyridoxine|mesh-list
154367355|NCT01199159|Misoprostol|misoprostol|mesh-list
154367356|NCT01199159|Vitamins|vitamins|mesh-ancestor
154367357|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
154367358|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367359|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154367360|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
154367361|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154367406|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154367407|NCT05640830|Growth Substances|growth substances|mesh-ancestor
154367408|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367409|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
154367410|NCT03730961|Furosemide|furosemide|mesh-list
154367411|NCT03730961|Diuretics|diuretics|mesh-ancestor
154367412|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
154367413|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367414|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154367415|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367416|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367417|NCT01078454|Dexamethasone|dexamethasone|mesh-list
154367418|NCT01078454|Bortezomib|bortezomib|mesh-list
154367419|NCT01078454|Melphalan|melphalan|mesh-list
154367467|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367468|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154367469|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154367470|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367471|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
154367472|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154367473|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
154367474|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
154367476|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154367477|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
154367478|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154367479|NCT04170972|Insulin|insulin|mesh-list
154367480|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154367481|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367528|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154367529|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367530|NCT02507128|Incretins|incretins|mesh-ancestor
154367531|NCT02507128|Hormones|hormones|mesh-ancestor
154367532|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367533|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367534|NCT03844529|Lidocaine|lidocaine|mesh-list
154367535|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
154367536|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
154367537|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153505663|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154367538|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367539|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
154367590|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367591|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154367592|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
154367593|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154367595|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154367659|NCT03597529|Protective Agents|protective agents|mesh-ancestor
154367660|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367661|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367662|NCT05420454|Paclitaxel|paclitaxel|mesh-list
154367663|NCT05420454|Docetaxel|docetaxel|mesh-list
154367664|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154367665|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
154367666|NCT05420454|Carboplatin|carboplatin|mesh-list
154367667|NCT05420454|Trastuzumab|trastuzumab|mesh-list
154367668|NCT05420454|Epirubicin|epirubicin|mesh-list
154367669|NCT05420454|Pertuzumab|pertuzumab|mesh-list
154367670|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154367672|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
154367724|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
154367725|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154367726|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154367727|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154367728|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154367729|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154367730|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154367731|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154367732|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154367788|NCT03570697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154367789|NCT03570697|Protease Inhibitors|protease inhibitors|mesh-ancestor
154367790|NCT03570697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154367791|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154367792|NCT02511574|Progesterone|progesterone|mesh-list
154367793|NCT02511574|Progestins|progestins|mesh-ancestor
154367794|NCT02511574|Hormones|hormones|mesh-ancestor
154367795|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154367796|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367797|NCT01200641|Gabapentin|gabapentin|mesh-list
154367798|NCT01200641|Melatonin|melatonin|mesh-list
154367799|NCT01200641|Analgesics|analgesics|mesh-ancestor
154367800|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
154367801|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367802|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367848|NCT01318070|Pioglitazone|pioglitazone|mesh-list
154367849|NCT01318070|Alogliptin|alogliptin|mesh-list
154367850|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154367851|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367852|NCT01318070|Incretins|incretins|mesh-ancestor
154367853|NCT01318070|Hormones|hormones|mesh-ancestor
154367855|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154367915|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154367916|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367917|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154367918|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154367919|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154367920|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154367921|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
154367922|NCT04443322|Durvalumab|durvalumab|mesh-list
154367923|NCT04443322|Lenvatinib|lenvatinib|mesh-list
154367981|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
154367982|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
154367983|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154367984|NCT05221736|Ethanol|ethanol|mesh-list
154368050|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368051|NCT03473639|Capecitabine|capecitabine|mesh-list
154368052|NCT03473639|Entinostat|entinostat|mesh-list
154368053|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154368054|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
154368055|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368056|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368057|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154368116|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
154368117|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368118|NCT03344614|Apatinib|apatinib|mesh-list
154368119|NCT03344614|Raltitrexed|raltitrexed|mesh-list
154368120|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368121|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154368122|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368123|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368124|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154368125|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
154368126|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154368127|NCT01205087|Omeprazole|omeprazole|mesh-list
154368179|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368180|NCT02513290|Loratadine|loratadine|mesh-list
154368181|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
154368182|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
154368183|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154368184|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154368185|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154368186|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
154368187|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
154368188|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368189|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368190|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368191|NCT02501200|Ezetimibe|ezetimibe|mesh-list
154368192|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154368193|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154368194|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
154368195|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368196|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154368197|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154368198|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368199|NCT02501278|Cisplatin|cisplatin|mesh-list
154368200|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368201|NCT03176238|Everolimus|everolimus|mesh-list
154368202|NCT03176238|Exemestane|exemestane|mesh-list
154368203|NCT03176238|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154368204|NCT03176238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154368205|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368206|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368207|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368208|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
154368209|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368211|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154368224|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154368225|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368226|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
154368227|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368228|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154368229|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368230|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368231|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
154368288|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154368289|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154368290|NCT03343678|Venetoclax|venetoclax|mesh-list
154368292|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368293|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154368294|NCT05216822|Racecadotril|racecadotril|mesh-list
154368295|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
154368296|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154368297|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
154368298|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368299|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368300|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
154368301|NCT04498936|Ledipasvir|ledipasvir|mesh-list
154368303|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
154368351|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368352|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
153505972|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154368353|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
154368354|NCT03343600|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154368355|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154368356|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368357|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368358|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368359|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154368360|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
154368361|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368362|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
154368363|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154368364|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
154368410|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368411|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368412|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154368413|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154368414|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368415|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368417|NCT03829943|Vitamins|vitamins|mesh-ancestor
154368418|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
154368419|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368420|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154368421|NCT02508142|Scopolamine|scopolamine|mesh-list
154368422|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154368423|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154368424|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
154368471|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154368472|NCT03214380|Insulin|insulin|mesh-list
154368473|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154368474|NCT03214380|Metformin|metformin|mesh-list
154368475|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
154368476|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
154368477|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154368540|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154368541|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154368542|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368543|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154368544|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154368545|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
154368546|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368547|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154368548|NCT01201577|Azithromycin|azithromycin|mesh-list
154368607|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154368608|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368609|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
154368610|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368611|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154368612|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154368613|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154368614|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154368615|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368616|NCT02495662|Prednisolone|prednisolone|mesh-list
154368617|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154368618|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
154368619|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154368620|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
154368621|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154368622|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
154368663|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368664|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154368666|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506119|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
154368667|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368668|NCT03341884|Ipatasertib|ipatasertib|mesh-list
154114927|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154368678|NCT02495272|Oxytocin|oxytocin|mesh-list
154368728|NCT03335956|Prednisone|prednisone|mesh-list
154368729|NCT03335956|Cortisone|cortisone|mesh-list
154368730|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154368731|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
154368732|NCT03335956|Hormones|hormones|mesh-ancestor
154368733|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368734|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368735|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154368736|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368737|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154368738|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
154368739|NCT01206881|Docetaxel|docetaxel|mesh-list
154368740|NCT01206881|Doxorubicin|doxorubicin|mesh-list
154368741|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154368787|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154368788|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
154368789|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
154368790|NCT03341494|Thalidomide|thalidomide|mesh-list
154368791|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368792|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
154368793|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368794|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
154368795|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154368796|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154368797|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154368798|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154368799|NCT03341494|Growth Substances|growth substances|mesh-ancestor
154368800|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
154368801|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154368805|NCT03725995|Lidocaine|lidocaine|mesh-list
154368847|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154368848|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
154368849|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154368850|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154368851|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
154368852|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154368853|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
154368914|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368915|NCT03521635|Protective Agents|protective agents|mesh-ancestor
154368916|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368917|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154368918|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154368919|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
154368920|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
154368921|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154368922|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
154368923|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154368924|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154368925|NCT03813641|Capecitabine|capecitabine|mesh-list
154368926|NCT03813641|Raltitrexed|raltitrexed|mesh-list
154368933|NCT03340558|Atezolizumab|atezolizumab|mesh-list
154368977|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154368978|NCT02492386|Everolimus|everolimus|mesh-list
154368979|NCT02492386|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154368980|NCT02492386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154368981|NCT02492386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154368982|NCT02492386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154368983|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154368984|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
154369045|NCT02499874|Lamivudine|lamivudine|mesh-list
154369046|NCT02499874|Emtricitabine|emtricitabine|mesh-list
154369047|NCT02499874|Zidovudine|zidovudine|mesh-list
154369048|NCT02499874|Efavirenz|efavirenz|mesh-list
154369049|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154369050|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
154369051|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369052|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154369053|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154369054|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369056|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154369110|NCT05864508|Oxytocin|oxytocin|mesh-list
154369111|NCT05864508|Oxytocics|oxytocics|mesh-ancestor
154369112|NCT05864508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154369113|NCT05864508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369114|NCT05864053|Ketamine|ketamine|mesh-list
154369115|NCT05864053|Analgesics|analgesics|mesh-ancestor
154369116|NCT05864053|Sensory System Agents|sensory system agents|mesh-ancestor
154115373|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154369117|NCT05864053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154369118|NCT05864053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369176|NCT05863858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154369177|NCT05863858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369178|NCT05863858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369179|NCT05863858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369180|NCT05863858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154369181|NCT05863858|Contraceptive Agents|contraceptive agents|mesh-ancestor
154369197|NCT05863845|Cytarabine|cytarabine|mesh-list
154369246|NCT05863455|Anesthetics|anesthetics|mesh-ancestor
154369247|NCT05863455|GABA Modulators|gaba modulators|mesh-ancestor
154369248|NCT05863455|GABA Agents|gaba agents|mesh-ancestor
154369249|NCT05863455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154369250|NCT05863455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369251|NCT05863455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154369252|NCT05863455|Narcotics|narcotics|mesh-ancestor
154369253|NCT05863455|Analgesics|analgesics|mesh-ancestor
154369254|NCT05863455|Sensory System Agents|sensory system agents|mesh-ancestor
154369311|NCT05828303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154369312|NCT05828303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369313|NCT05828303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154369314|NCT05828303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154369315|NCT05828303|Protective Agents|protective agents|mesh-ancestor
154369316|NCT05801705|Tamoxifen|tamoxifen|mesh-list
154369317|NCT05801705|Toremifene|toremifene|mesh-list
154369318|NCT05801705|Hormones|hormones|mesh-list
154369319|NCT05801705|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154369320|NCT05801705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154369321|NCT05801705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369322|NCT05801705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154369323|NCT05801705|Hormone Antagonists|hormone antagonists|mesh-ancestor
154369324|NCT05801705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369325|NCT05801705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369326|NCT05801705|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154369327|NCT05801705|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154369328|NCT05801705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154369329|NCT05801705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154369330|NCT05801705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369364|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369365|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369366|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154369367|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154369368|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369369|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154369370|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
154369371|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
154369372|NCT05415228|Edetic Acid|edetic acid|mesh-list
154369373|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154369374|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
154369428|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154369429|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154369430|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369431|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369432|NCT04933721|Berotralstat|berotralstat|mesh-list
154369433|NCT04933721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154369434|NCT04933721|Protease Inhibitors|protease inhibitors|mesh-ancestor
154369435|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369436|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369492|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
154369493|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
154369494|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369495|NCT04672291|Laxatives|laxatives|mesh-ancestor
154369496|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154369497|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
154369498|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369499|NCT04668365|Prednisone|prednisone|mesh-list
154369500|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
154369501|NCT04668365|Rituximab|rituximab|mesh-list
154369502|NCT04668365|Vincristine|vincristine|mesh-list
154369558|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369559|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154369560|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369561|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154369562|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
154369563|NCT04433156|Hormones|hormones|mesh-ancestor
154369566|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154369627|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369629|NCT03596866|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154369630|NCT03596866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154369631|NCT03596866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154369632|NCT03596866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369633|NCT03502785|Atezolizumab|atezolizumab|mesh-list
154369634|NCT03502785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369635|NCT03502785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369636|NCT03502785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369637|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369638|NCT03495960|Rituximab|rituximab|mesh-list
154369639|NCT03495960|Methotrexate|methotrexate|mesh-list
154369640|NCT03495960|Lenalidomide|lenalidomide|mesh-list
154369641|NCT03495960|Temozolomide|temozolomide|mesh-list
154369642|NCT03495960|Procarbazine|procarbazine|mesh-list
154369643|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369644|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369645|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
154369646|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369680|NCT03138161|Trabectedin|trabectedin|mesh-list
154369681|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369682|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369683|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154369684|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369685|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369686|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
154369687|NCT02907359|Guadecitabine|guadecitabine|mesh-list
154369688|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369689|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
154369745|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154369746|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
154369747|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369748|NCT00071071|Zanolimumab|zanolimumab|mesh-list
154369749|NCT00071071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154369750|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154369751|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154369752|NCT00071071|Immunologic Factors|immunologic factors|mesh-ancestor
154369753|NCT00071071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369754|NCT05465278|Alirocumab|alirocumab|mesh-list
154369755|NCT05465278|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154369756|NCT05465278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153506467|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369757|NCT05465278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154369758|NCT05465278|Antimetabolites|antimetabolites|mesh-ancestor
154369759|NCT05465278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369804|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154369805|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
154369806|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154369807|NCT03332602|Urological Agents|urological agents|mesh-ancestor
154369808|NCT01302353|Isoflurane|isoflurane|mesh-list
154369809|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154369810|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
154369811|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
154369812|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369813|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369814|NCT03812315|Propolis|propolis|mesh-list
154369815|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369816|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
154369817|NCT03332524|Ibuprofen|ibuprofen|mesh-list
154369867|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
154369868|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369869|NCT02492230|Warfarin|warfarin|mesh-list
154369870|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
154369871|NCT03169530|Ethanol|ethanol|mesh-list
154369872|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154369873|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154369874|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369875|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369933|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154369934|NCT03723109|Anesthetics|anesthetics|mesh-list
154369935|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154369936|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154369937|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
154369938|NCT03018288|Temozolomide|temozolomide|mesh-list
154369939|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154370001|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370002|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154370003|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370004|NCT04959006|Antioxidants|antioxidants|mesh-list
154370005|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370006|NCT04959006|Protective Agents|protective agents|mesh-ancestor
154370007|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370008|NCT01300637|Metformin|metformin|mesh-list
154370009|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154370012|NCT04851522|Eusol|eusol|mesh-list
154370069|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
154370070|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370071|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
154370072|NCT03815279|Dexamethasone|dexamethasone|mesh-list
154370073|NCT03815279|Lenalidomide|lenalidomide|mesh-list
154370074|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370075|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
154370076|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
154370077|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370078|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370079|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154370080|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
154370081|NCT03815279|Hormones|hormones|mesh-ancestor
154370082|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154370083|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154370084|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370085|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
154370090|NCT03814733|Ketamine|ketamine|mesh-list
154370129|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153506649|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370130|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370131|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154370132|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154370133|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
154370135|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370136|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154370137|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370138|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370139|NCT03528577|Albuterol|albuterol|mesh-list
154370193|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370194|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
154370195|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
154370196|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370197|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370198|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154370199|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154370200|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
154370201|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154370202|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154370203|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154370204|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154370205|NCT03471871|Lemborexant|lemborexant|mesh-list
154370206|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154370207|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370208|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370209|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154370210|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154370211|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370212|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370213|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
154370214|NCT04313153|Hematinics|hematinics|mesh-ancestor
154370215|NCT03337672|Midazolam|midazolam|mesh-list
154370216|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
154370217|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154370218|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370219|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370220|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154370221|NCT03337672|Analgesics|analgesics|mesh-ancestor
154370222|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
154370223|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370224|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154370225|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154370226|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154370230|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154370231|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154370232|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154370233|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154370234|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154370235|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
154370236|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
154370237|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
154370238|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
154370239|NCT03330808|Anesthetics|anesthetics|mesh-list
154370240|NCT03330808|Ropivacaine|ropivacaine|mesh-list
154370241|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370242|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370243|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
154370244|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
154370245|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370246|NCT01303055|Metformin|metformin|mesh-list
154370247|NCT01303055|Alogliptin|alogliptin|mesh-list
154370248|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154116495|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370287|NCT01303601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153506756|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506757|NCT01393912|Crenolanib|crenolanib|mesh-list
153506759|NCT01393925|Parecoxib|parecoxib|mesh-list
154370288|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154370289|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154370290|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370291|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370292|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
154370293|NCT00707980|Vortioxetine|vortioxetine|mesh-list
154370294|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
154370295|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154370296|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154370297|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154370298|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370299|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370300|NCT00707980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154370301|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154370302|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154370303|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370317|NCT03051620|Alendronate|alendronate|mesh-list
154370338|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
154370339|NCT03810209|Analgesics|analgesics|mesh-ancestor
154370340|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
154370341|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370342|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370343|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
154370344|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370345|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154370346|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
154370347|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154370348|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154370349|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370350|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154370351|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
154370352|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154370353|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
154370354|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370355|NCT03337282|Anesthetics|anesthetics|mesh-list
154370356|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370357|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370359|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154370391|NCT05014334|Rabeprazole|rabeprazole|mesh-list
154370393|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116658|NCT00754910|Trioxsalen|trioxsalen|mesh-list
154370394|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370395|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154370396|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370397|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370398|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154370399|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154370400|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154370401|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154370402|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154370403|NCT05014334|Antacids|antacids|mesh-ancestor
154370404|NCT02497378|Dexamethasone|dexamethasone|mesh-list
154370405|NCT02497378|Bortezomib|bortezomib|mesh-list
154370406|NCT02497378|Daratumumab|daratumumab|mesh-list
154370451|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154370452|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154370453|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370454|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370455|NCT03505021|Protective Agents|protective agents|mesh-ancestor
154370456|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370457|NCT03793283|Insulin|insulin|mesh-list
154370458|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154370459|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154370460|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370461|NCT02496988|Temozolomide|temozolomide|mesh-list
154370462|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154370463|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
154370464|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370465|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370466|NCT03793205|Lenograstim|lenograstim|mesh-list
154370467|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154370468|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
154370508|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154370509|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154370510|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370511|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370512|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370513|NCT03792971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154370514|NCT03792971|Narcotics|narcotics|mesh-ancestor
154370515|NCT03792971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370516|NCT03792971|Analgesics|analgesics|mesh-ancestor
154370517|NCT03792971|Sensory System Agents|sensory system agents|mesh-ancestor
154370518|NCT03792971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370519|NCT03792971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154370520|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
154370521|NCT03792971|Protective Agents|protective agents|mesh-ancestor
154370522|NCT03328936|Melphalan|melphalan|mesh-list
154370566|NCT03120442|Propofol|propofol|mesh-list
154370567|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154370568|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154370569|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370570|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154370571|NCT03120442|Analgesics|analgesics|mesh-ancestor
154370572|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
154370573|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370574|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154370575|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154370576|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154370577|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
154370578|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370579|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370580|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154370581|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
154370582|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
154370583|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154370584|NCT03120442|Narcotics|narcotics|mesh-ancestor
154370585|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154370586|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
154370587|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154370588|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154370617|NCT03324490|Narcotics|narcotics|mesh-ancestor
154370618|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154370619|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154370620|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
154370621|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
154370622|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154370686|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154370687|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153507047|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370688|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
154370689|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
154370690|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370691|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370692|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370693|NCT03792503|Pemetrexed|pemetrexed|mesh-list
154370694|NCT03792503|Apatinib|apatinib|mesh-list
154370695|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370750|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154370751|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
154370752|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370753|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154370755|NCT03328312|Neostigmine|neostigmine|mesh-list
154370756|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154370757|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154370758|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154370759|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
154370760|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370761|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370762|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154370763|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
154370764|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
154370765|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
154370766|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154370767|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154370768|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
154370769|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117025|NCT00537940|Pregabalin|pregabalin|mesh-list
154370770|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370771|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154370772|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370773|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154370774|NCT03328234|Paclitaxel|paclitaxel|mesh-list
154370775|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154370776|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154370777|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370778|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
154370779|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
154370780|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
154370781|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370782|NCT03323710|Sunitinib|sunitinib|mesh-list
154370783|NCT03323710|Propranolol|propranolol|mesh-list
154370784|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370788|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370789|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
154370790|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154370791|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370792|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370793|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154370794|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154370795|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
154370796|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154370797|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153507157|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507158|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153507159|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
153507160|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370798|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154370799|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
154370800|NCT03792269|Capecitabine|capecitabine|mesh-list
154370801|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
154370802|NCT03792269|Irinotecan|irinotecan|mesh-list
154370803|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154370804|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
154370805|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370806|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370807|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154370808|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154370809|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370810|NCT02488564|Metformin|metformin|mesh-list
154370811|NCT02488564|Docetaxel|docetaxel|mesh-list
154370812|NCT02488564|Doxorubicin|doxorubicin|mesh-list
154370813|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154370814|NCT02488564|Trastuzumab|trastuzumab|mesh-list
154370815|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154370816|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370817|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154370818|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
154370819|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
154370820|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
154370827|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
154370830|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370831|NCT02966873|Expectorants|expectorants|mesh-ancestor
154370832|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
154370833|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154370834|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
154370835|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370836|NCT02966873|Protective Agents|protective agents|mesh-ancestor
154370837|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370838|NCT02966873|Antidotes|antidotes|mesh-ancestor
154370839|NCT04697186|Amoxicillin|amoxicillin|mesh-list
154370840|NCT04697186|Clarithromycin|clarithromycin|mesh-list
154370841|NCT04697186|Rabeprazole|rabeprazole|mesh-list
154370842|NCT04697186|Bismuth|bismuth|mesh-list
154370843|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154370844|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370845|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154370892|NCT03327766|Vitamins|vitamins|mesh-ancestor
154370893|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
154370894|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370895|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154370896|NCT03798119|Tenofovir|tenofovir|mesh-list
154370897|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
154370898|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370899|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154370900|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154370901|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154370902|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154370903|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154370904|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154370905|NCT03794219|Naproxen|naproxen|mesh-list
154370906|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154370907|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154370908|NCT03794219|Analgesics|analgesics|mesh-ancestor
154370909|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
154370910|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507232|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154370949|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
154370950|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154370951|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154370952|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154370953|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154370954|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
154370955|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
154370956|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154370957|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154370958|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
154371016|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371017|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371018|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154371019|NCT01304069|Etoricoxib|etoricoxib|mesh-list
154371020|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154371021|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154371022|NCT01304069|Analgesics|analgesics|mesh-ancestor
154371023|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
154371024|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371025|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371078|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371079|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371081|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154371082|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
154371083|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
154371084|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371085|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154371086|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371087|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371088|NCT03501277|Pioglitazone|pioglitazone|mesh-list
154371089|NCT03501277|Alogliptin|alogliptin|mesh-list
154371090|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154371091|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371092|NCT03501277|Incretins|incretins|mesh-ancestor
154371093|NCT03501277|Hormones|hormones|mesh-ancestor
154371094|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154371133|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154371134|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
154371135|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
154371136|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154371137|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
154371138|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371139|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371140|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
154371141|NCT02490982|Teriflunomide|teriflunomide|mesh-list
154371142|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154371152|NCT03322150|Atropine|atropine|mesh-list
154371198|NCT01305707|Mianserin|mianserin|mesh-list
154371199|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
154371200|NCT01305707|Escitalopram|escitalopram|mesh-list
154371201|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154371202|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
154371203|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157396|NCT05805501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153507288|NCT01396655|Doxorubicin|doxorubicin|mesh-list
153507298|NCT01396668|Gemcitabine|gemcitabine|mesh-list
153507321|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507322|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507323|NCT01396720|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153507324|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153507327|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371204|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371205|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371206|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154371207|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371208|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154371209|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154371262|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154371263|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154371264|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
154371265|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371267|NCT03467971|Gliclazide|gliclazide|mesh-list
154371268|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154371269|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371270|NCT03791099|Metronidazole|metronidazole|mesh-list
154371271|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371272|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154371273|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154371274|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154371275|NCT03185000|Immunomodulating Agents|immunomodulating agents|mesh-list
154371276|NCT03185000|Immunologic Factors|immunologic factors|mesh-ancestor
154371277|NCT03185000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371278|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
154371279|NCT03791255|Calcium|calcium|mesh-list
154371285|NCT03794297|Trametinib|trametinib|mesh-list
154371318|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
154371319|NCT00908076|Lubiprostone|lubiprostone|mesh-list
154371320|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154371321|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154371322|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371323|NCT01305317|Atorvastatin|atorvastatin|mesh-list
154371324|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154371385|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154371386|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371388|NCT03721081|Lidocaine|lidocaine|mesh-list
154371389|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
154371390|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
154371391|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371392|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371393|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
154371394|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371395|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154371447|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
154371448|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371449|NCT01305395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154371450|NCT01305395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371451|NCT01305395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371452|NCT02886624|Grazoprevir|grazoprevir|mesh-list
154371453|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154371454|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
154371455|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371456|NCT02487316|Crizotinib|crizotinib|mesh-list
154371457|NCT02487316|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154371458|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154371459|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371460|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371461|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371462|NCT02490436|Cetuximab|cetuximab|mesh-list
154371463|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154371464|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371502|NCT02963766|Dulaglutide|dulaglutide|mesh-list
154371503|NCT02963766|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154371504|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154371505|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371506|NCT01334502|Prednisone|prednisone|mesh-list
154371507|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
154371508|NCT01334502|Rituximab|rituximab|mesh-list
154371509|NCT01334502|Doxorubicin|doxorubicin|mesh-list
154371510|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154371511|NCT01334502|Vincristine|vincristine|mesh-list
154371512|NCT01334502|Everolimus|everolimus|mesh-list
154371514|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
154371568|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371569|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371570|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154371571|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154371572|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371573|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154371574|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154371575|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
154371576|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
154371577|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
154371578|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371579|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154371580|NCT03790085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154371589|NCT01306097|Zinc|zinc|mesh-list
154371630|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154371631|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
154371632|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
154371633|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
154371634|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371635|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154371636|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
154371637|NCT01334580|Methadone|methadone|mesh-list
154371638|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154371639|NCT01334580|Narcotics|narcotics|mesh-ancestor
154371640|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154371641|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371642|NCT01334580|Analgesics|analgesics|mesh-ancestor
154371643|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
154371644|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371645|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
154371646|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
154371647|NCT02694588|Infliximab|infliximab|mesh-list
154371648|NCT02694588|Vedolizumab|vedolizumab|mesh-list
154371649|NCT02694588|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154371650|NCT02694588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371651|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
154371652|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154371653|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371654|NCT03789539|Vaccines|vaccines|mesh-list
154371655|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
154371656|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371678|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154371679|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154371680|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371681|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
154371682|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371683|NCT03786029|Acetaminophen|acetaminophen|mesh-list
154371684|NCT03786029|Ibuprofen|ibuprofen|mesh-list
154371685|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154371686|NCT03786029|Analgesics|analgesics|mesh-ancestor
154371687|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
154371688|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371689|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371690|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
154371691|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154371692|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371693|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371737|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154371738|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154371739|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154371740|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153507567|NCT06103188|Anesthetics|anesthetics|mesh-ancestor
154371741|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371742|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154371743|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154371744|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371745|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
154371746|NCT01306721|Fexofenadine|fexofenadine|mesh-list
154371747|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
154371748|NCT01306721|Ephedrine|ephedrine|mesh-list
154371749|NCT01306721|Terfenadine|terfenadine|mesh-list
154371750|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154371751|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154371752|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154371753|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
154371754|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
154371755|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371757|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154371792|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154371793|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154371794|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
154371863|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154371864|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154371865|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154371866|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371867|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
154371868|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154371869|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154371870|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154371871|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154371929|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154371930|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154371933|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
154371934|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
154371935|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
154371936|NCT02486458|Protective Agents|protective agents|mesh-ancestor
154371940|NCT01335516|Terlipressin|terlipressin|mesh-list
154371997|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154371998|NCT03160716|Lidocaine|lidocaine|mesh-list
154371999|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
154372000|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
154372001|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372002|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372003|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
154372004|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372005|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154372006|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154372007|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154372008|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372009|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372010|NCT00092664|Simvastatin|simvastatin|mesh-list
154372011|NCT00092664|Ezetimibe|ezetimibe|mesh-list
154372012|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154372019|NCT02483884|Bombesin|bombesin|mesh-list
154372054|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372055|NCT01332786|Tigecycline|tigecycline|mesh-list
154372056|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154372057|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372058|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154372059|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372060|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507666|NCT05775809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153507667|NCT05597878|Acetaminophen|acetaminophen|mesh-list
153507668|NCT05597878|Ketorolac|ketorolac|mesh-list
153507669|NCT05597878|Ketamine|ketamine|mesh-list
153507670|NCT05597878|Oxycodone|oxycodone|mesh-list
153507671|NCT05597878|Analgesics|analgesics|mesh-ancestor
154372061|NCT01338090|Bevacizumab|bevacizumab|mesh-list
154372062|NCT01338090|Everolimus|everolimus|mesh-list
154372063|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
154372064|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154372065|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372066|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154372067|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154372068|NCT01338090|Growth Substances|growth substances|mesh-ancestor
154372069|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372113|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154372114|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
154372115|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372116|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154372117|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154372118|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372179|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372180|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
154372181|NCT03776279|Analgesics|analgesics|mesh-ancestor
154372182|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
154372183|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372184|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372185|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372186|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154372187|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154372188|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372189|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372190|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
154372191|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154372241|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372242|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154372243|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154372244|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154372245|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154372246|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154372247|NCT03781115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154372248|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154372249|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372250|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372251|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372252|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
154372253|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154372254|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154372255|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
154372256|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154372257|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
154372258|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154372259|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154372297|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372298|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
154372299|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372300|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154372301|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154372302|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
154372303|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372304|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372305|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154372306|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154372307|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154372308|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154372309|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372310|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154372311|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
154372312|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
154372313|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372315|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
154372316|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372317|NCT01338558|Bevacizumab|bevacizumab|mesh-list
154372318|NCT01338558|Cetuximab|cetuximab|mesh-list
153781804|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507727|NCT05509634|BB 1101|bb 1101|mesh-list
154372319|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154372320|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372321|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154372322|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154372323|NCT01338558|Growth Substances|growth substances|mesh-ancestor
154372324|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372325|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
154372326|NCT03780569|Temozolomide|temozolomide|mesh-list
154372327|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154372328|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
154372329|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372330|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372331|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154372334|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372336|NCT01313585|Albuterol|albuterol|mesh-list
154372337|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154372402|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154372403|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154372404|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154372405|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
154372406|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372407|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154372408|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154372409|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372410|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154372411|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154372412|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
154372413|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372414|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372415|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154372416|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154372417|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
154372418|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
154372419|NCT03720067|Protective Agents|protective agents|mesh-ancestor
154118666|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
154372425|NCT01444092|Budesonide|budesonide|mesh-list
154372458|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154372459|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372460|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
154372461|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
154372462|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
154372463|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372464|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154372465|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372466|NCT00116220|Goserelin|goserelin|mesh-list
154372467|NCT00116220|Flutamide|flutamide|mesh-list
154372468|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372469|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154372470|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372471|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
154372472|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
154372473|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372474|NCT03785015|Aspirin|aspirin|mesh-list
154372475|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154372476|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372477|NCT03785015|Analgesics|analgesics|mesh-ancestor
154372478|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
153507830|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153507831|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
153507832|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372479|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372480|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372506|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372507|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154372508|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
154372509|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154372510|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372511|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372514|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
154372574|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372576|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154372577|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154372578|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372579|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154372580|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154372581|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372582|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
154372583|NCT04476420|Betamethasone|betamethasone|mesh-list
154372584|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
154372585|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154372586|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
154372587|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154372588|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372589|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
154372634|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154372635|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154372636|NCT01339026|Clopidogrel|clopidogrel|mesh-list
154372637|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154372638|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154372639|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154372640|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154372641|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154372642|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
154372643|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118891|NCT00941967|Gemcitabine|gemcitabine|mesh-list
154372644|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372645|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372646|NCT03314740|Paclitaxel|paclitaxel|mesh-list
154372693|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372694|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372695|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154372696|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372697|NCT02482090|Analgesics|analgesics|mesh-ancestor
154372698|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
154372699|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372700|NCT02482324|Ibuprofen|ibuprofen|mesh-list
154372701|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153507950|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154372702|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154372703|NCT02482324|Analgesics|analgesics|mesh-ancestor
154372704|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
154372705|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372706|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372707|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372750|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372751|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372752|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372753|NCT02479204|Atenolol|atenolol|mesh-list
154372754|NCT02479204|Diltiazem|diltiazem|mesh-list
154372755|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154372756|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154372818|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154372819|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
154372820|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
154372821|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154372822|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372823|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372824|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154372825|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
154372826|NCT01316952|Protective Agents|protective agents|mesh-ancestor
154372827|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154372828|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154372829|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154372830|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
154372878|NCT02480608|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154372879|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154372880|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154372881|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372882|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372883|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
154372884|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154372885|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
154372886|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
154372887|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372888|NCT02475382|Nivolumab|nivolumab|mesh-list
154372889|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154372890|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154372891|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154372892|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372938|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372939|NCT03783845|Amoxicillin|amoxicillin|mesh-list
154372940|NCT03783845|Metronidazole|metronidazole|mesh-list
154372941|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154372942|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154372943|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154372944|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154372945|NCT01560689|Budesonide|budesonide|mesh-list
154372946|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
154372947|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154372948|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154372949|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
154372950|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154372951|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372952|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154372953|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
154372954|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
154372955|NCT01560689|Hormones|hormones|mesh-ancestor
154372956|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154372957|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154372958|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154372959|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154372960|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
154372961|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508112|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154372962|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154372963|NCT02474914|Octreotide|octreotide|mesh-list
154372988|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
154372989|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154372990|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
154372991|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154372992|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
154372993|NCT03783455|Protective Agents|protective agents|mesh-ancestor
154372994|NCT05305066|Adalimumab|adalimumab|mesh-list
154372995|NCT05305066|Golimumab|golimumab|mesh-list
154372996|NCT05305066|Etanercept|etanercept|mesh-list
154372997|NCT05305066|Upadacitinib|upadacitinib|mesh-list
154372998|NCT05305066|Tofacitinib|tofacitinib|mesh-list
154372999|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154373000|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373001|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373002|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154373003|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154373004|NCT05305066|Analgesics|analgesics|mesh-ancestor
154373005|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
154373008|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154373047|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373048|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154373049|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
154373050|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
154373051|NCT03772223|Hormones|hormones|mesh-ancestor
154373052|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373053|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
154373054|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154373055|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154373056|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154373057|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154373058|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
154373059|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373060|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373061|NCT03783299|Lumefantrine|lumefantrine|mesh-list
154373062|NCT03783299|Artemether|artemether|mesh-list
154373063|NCT03783299|Primaquine|primaquine|mesh-list
154373064|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154373065|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
154373066|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154373067|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154373068|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373069|NCT03771755|Acetaminophen|acetaminophen|mesh-list
154373070|NCT03771755|Ibuprofen|ibuprofen|mesh-list
154373071|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154373072|NCT03771755|Analgesics|analgesics|mesh-ancestor
154373073|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
154373074|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373075|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373076|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
154373077|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154373079|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373089|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154157397|NCT05805501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373090|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154373091|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373092|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
154119338|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
154373093|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373094|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
154373095|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373096|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373097|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154373098|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
154373099|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373100|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373101|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154373103|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154373104|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154373105|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
154373106|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373107|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373144|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154373145|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373146|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
154373147|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
154373148|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
154373149|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373150|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154373151|NCT03766607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154373152|NCT03766607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154373153|NCT03766607|Growth Substances|growth substances|mesh-ancestor
154373154|NCT03766607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373206|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154373207|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373208|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373209|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154373210|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154373211|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154373212|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154373213|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154373214|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154373215|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154373216|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154373217|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154373218|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154373219|NCT01561781|Digoxin|digoxin|mesh-list
154373220|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154373221|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154373222|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373223|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373224|NCT01561781|Protective Agents|protective agents|mesh-ancestor
154373260|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373261|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154373262|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154373263|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154373264|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154373265|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373266|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154373267|NCT03764267|Narcotics|narcotics|mesh-ancestor
154373268|NCT03764267|Analgesics|analgesics|mesh-ancestor
154373269|NCT01321931|Nicotine|nicotine|mesh-list
154373270|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154373271|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
154373272|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373273|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373274|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154373275|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154373276|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
154373277|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373278|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373279|NCT03763409|Losartan|losartan|mesh-list
154373280|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154373281|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154373282|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154373283|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154373284|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373285|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154373286|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154373301|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373302|NCT03758729|Nivolumab|nivolumab|mesh-list
154373303|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154373304|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373305|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154373306|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373370|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
154373371|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154373372|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154373373|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154373374|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154373375|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154373376|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154373377|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
154373378|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373379|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154373380|NCT05460377|Vaccines|vaccines|mesh-list
154373381|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
154373382|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373383|NCT05692856|Clenbuterol|clenbuterol|mesh-list
154373384|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154373385|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154373386|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
154373387|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373388|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119648|NCT00771680|Insulin|insulin|mesh-list
154373389|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373390|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154373391|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
154373420|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373421|NCT03757559|Analgesics|analgesics|mesh-ancestor
154373422|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
154373423|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373424|NCT02658929|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154373425|NCT02658929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154373426|NCT02658929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373427|NCT04784897|Brilacidin|brilacidin|mesh-list
154373487|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373488|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
154373489|NCT05358626|Antibodies|antibodies|mesh-list
154373490|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
153781806|NCT00266721|Pancreatin|pancreatin|mesh-list
153508387|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373491|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
154373492|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373493|NCT03753269|Fasudil|fasudil|mesh-list
154373494|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154373495|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154373496|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373499|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
154373554|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373555|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373556|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154373557|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154373558|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154373559|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
154373560|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373561|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373562|NCT02474134|Interferons|interferons|mesh-list
154373563|NCT02474134|Interferon-beta|interferon-beta|mesh-list
154373564|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
154373565|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373566|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
154373567|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373568|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
154373569|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373570|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154373571|NCT02473900|Oseltamivir|oseltamivir|mesh-list
154373572|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
154373573|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373574|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373576|NCT02471950|Isoflurane|isoflurane|mesh-list
154373607|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373608|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154373609|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
154373610|NCT02477488|Protective Agents|protective agents|mesh-ancestor
154373611|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373612|NCT05163106|Letrozole|letrozole|mesh-list
154373613|NCT05163106|Goserelin|goserelin|mesh-list
154373614|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373615|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154373616|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154373617|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373618|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373619|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154373620|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
154373621|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154373622|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373623|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154373624|NCT02477098|Ropivacaine|ropivacaine|mesh-list
154373625|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
154373626|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
154373627|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373628|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373629|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
154373630|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373631|NCT02473354|Remifentanil|remifentanil|mesh-list
154373632|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154373657|NCT02473198|Analgesics|analgesics|mesh-ancestor
153508524|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
154373658|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154373659|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154373660|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373661|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154373662|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154373663|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373664|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373665|NCT03614728|Azacitidine|azacitidine|mesh-list
154373666|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
154373667|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154373668|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
154373669|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373670|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373671|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373672|NCT05180292|Carvedilol|carvedilol|mesh-list
154373673|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154373680|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
154373710|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373712|NCT01341834|Panobinostat|panobinostat|mesh-list
154373713|NCT01341834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154373714|NCT01341834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154373715|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373716|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373717|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154373718|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
154373719|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373720|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154373721|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154373722|NCT01340118|Budesonide|budesonide|mesh-list
154373723|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154373724|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154373725|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
154373726|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373727|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373728|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154373765|NCT01342146|Hormones|hormones|mesh-list
154373766|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120010|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
154373767|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373768|NCT03212716|Oseltamivir|oseltamivir|mesh-list
154373769|NCT03212716|Diltiazem|diltiazem|mesh-list
154373770|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
154373771|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373772|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373773|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373774|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154373775|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154373776|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154373777|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154373778|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373779|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
154373780|NCT04762836|Cycloserine|cycloserine|mesh-list
154373781|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154373782|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373783|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154373784|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
154373785|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154373786|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
154373787|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373788|NCT00705406|Peramivir|peramivir|mesh-list
154373789|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
154373790|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373791|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373792|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373793|NCT01342224|Gemcitabine|gemcitabine|mesh-list
153508645|NCT05270421|Furosemide|furosemide|mesh-list
154373794|NCT01342224|Tadalafil|tadalafil|mesh-list
154373795|NCT01342224|Sargramostim|sargramostim|mesh-list
154373796|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
154373799|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
154373804|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154373805|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373806|NCT01342224|Urological Agents|urological agents|mesh-ancestor
154373808|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
154373809|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154373810|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154373811|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154373812|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373813|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373814|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
154373815|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
154373816|NCT02470546|Metformin|metformin|mesh-list
154373819|NCT03310762|Silicon|silicon|mesh-list
154373868|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154373869|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
154373870|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373871|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154373872|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
154373873|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
154373874|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373875|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
154373876|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154373877|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154373933|NCT06209398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373934|NCT06209320|Atropine|atropine|mesh-list
154373935|NCT06209320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154373936|NCT06209320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154373937|NCT06209320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154373938|NCT06209320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154373939|NCT06209320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154373940|NCT06209320|Autonomic Agents|autonomic agents|mesh-ancestor
154373941|NCT06209320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154373942|NCT06209320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154373943|NCT06209320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154373944|NCT06209320|Respiratory System Agents|respiratory system agents|mesh-ancestor
154373945|NCT06209320|Mydriatics|mydriatics|mesh-ancestor
154373946|NCT06209320|Parasympatholytics|parasympatholytics|mesh-ancestor
154373947|NCT06209320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154373948|NCT06209320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154373949|NCT06209320|Cholinergic Agents|cholinergic agents|mesh-ancestor
154373950|NCT06209320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154373951|NCT06209320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373990|NCT06209229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154373991|NCT06209229|Protective Agents|protective agents|mesh-ancestor
154373992|NCT06209229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154373993|NCT06209229|Immunologic Factors|immunologic factors|mesh-ancestor
154373994|NCT06209229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154373996|NCT06209229|Interferon Inducers|interferon inducers|mesh-ancestor
154373997|NCT06209203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154373998|NCT06209203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154373999|NCT06209047|Gentamicins|gentamicins|mesh-list
154374000|NCT06209047|Dexamethasone|dexamethasone|mesh-list
154374001|NCT06209047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154374002|NCT06209047|Antiemetics|antiemetics|mesh-ancestor
154374003|NCT06209047|Autonomic Agents|autonomic agents|mesh-ancestor
154374004|NCT06209047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374005|NCT06209047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374006|NCT06209047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374007|NCT06209047|Glucocorticoids|glucocorticoids|mesh-ancestor
154374008|NCT06209047|Hormones|hormones|mesh-ancestor
154374009|NCT06209047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374010|NCT06209047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154374011|NCT06209047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374012|NCT06209047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154374013|NCT06209047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374014|NCT06209047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154374015|NCT06209047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374016|NCT06209047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374017|NCT06208956|Dexmedetomidine|dexmedetomidine|mesh-list
154374018|NCT06208956|Propofol|propofol|mesh-list
154374019|NCT06208956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154374020|NCT06208956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374021|NCT06208956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374022|NCT06208956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154374023|NCT06208956|Analgesics|analgesics|mesh-ancestor
154374031|NCT06208956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374032|NCT06208956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154374033|NCT06208956|Anesthetics, General|anesthetics, general|mesh-ancestor
154374034|NCT06208956|Anesthetics|anesthetics|mesh-ancestor
154374035|NCT06208917|Dexamethasone|dexamethasone|mesh-list
154374036|NCT06208917|Dexamethasone acetate|dexamethasone acetate|mesh-list
154374037|NCT06208917|Ondansetron|ondansetron|mesh-list
154374038|NCT06208917|BB 1101|bb 1101|mesh-list
154374039|NCT06208917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154374040|NCT06208917|Antiemetics|antiemetics|mesh-ancestor
154374041|NCT06208917|Autonomic Agents|autonomic agents|mesh-ancestor
154374042|NCT06208917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374043|NCT06208917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374044|NCT06208917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374045|NCT06208917|Glucocorticoids|glucocorticoids|mesh-ancestor
154374046|NCT06208917|Hormones|hormones|mesh-ancestor
154374047|NCT06208917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374048|NCT06208917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154374049|NCT06208917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374050|NCT06208917|Protease Inhibitors|protease inhibitors|mesh-ancestor
154374051|NCT06208917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374052|NCT06208917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374053|NCT06208917|Antipruritics|antipruritics|mesh-ancestor
154374054|NCT06208917|Dermatologic Agents|dermatologic agents|mesh-ancestor
154374055|NCT06208917|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154374081|NCT06208657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154374082|NCT06208657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154374083|NCT06208657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374084|NCT06208657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374085|NCT06208657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374086|NCT06208657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154374087|NCT06208657|Alkylating Agents|alkylating agents|mesh-ancestor
154374089|NCT06208540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154374090|NCT06208540|Protective Agents|protective agents|mesh-ancestor
154374091|NCT06208540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374092|NCT06208540|Nootropic Agents|nootropic agents|mesh-ancestor
154374093|NCT06208527|Niacinamide|niacinamide|mesh-list
154374094|NCT06208527|Niacin|niacin|mesh-list
154374095|NCT06208527|Nicotinic Acids|nicotinic acids|mesh-list
154374096|NCT06208527|Vitamin B Complex|vitamin b complex|mesh-ancestor
154374097|NCT06208527|Vitamins|vitamins|mesh-ancestor
154374098|NCT06208527|Micronutrients|micronutrients|mesh-ancestor
154374099|NCT06208527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374137|NCT06208072|Diuretics|diuretics|mesh-ancestor
154374138|NCT06208072|Natriuretic Agents|natriuretic agents|mesh-ancestor
154374139|NCT06208033|Paclitaxel|paclitaxel|mesh-list
154374140|NCT06208033|Docetaxel|docetaxel|mesh-list
154374141|NCT06208033|Cisplatin|cisplatin|mesh-list
154374142|NCT06208033|Carboplatin|carboplatin|mesh-list
154374143|NCT06208033|Pemetrexed|pemetrexed|mesh-list
154374144|NCT06208033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154374145|NCT06208033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508888|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153508889|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153508891|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
154374146|NCT06208033|Tubulin Modulators|tubulin modulators|mesh-ancestor
154374147|NCT06208033|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374148|NCT06208033|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374149|NCT06208033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374150|NCT06208033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374151|NCT06208033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154374152|NCT06208033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154374153|NCT06207955|Botulinum Toxins|botulinum toxins|mesh-list
154374154|NCT06207955|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154374155|NCT06207955|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154374156|NCT06207955|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154374157|NCT06207955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374158|NCT06207955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374159|NCT06207955|Cholinergic Agents|cholinergic agents|mesh-ancestor
154374160|NCT06207955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374161|NCT06207955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374162|NCT06207955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154374163|NCT06207955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374164|NCT06207760|Minocycline|minocycline|mesh-list
154374165|NCT06207760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154374184|NCT06207539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374185|NCT06207539|Oxytocics|oxytocics|mesh-ancestor
154374186|NCT06207539|Anticonvulsants|anticonvulsants|mesh-ancestor
154374187|NCT06207539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154374188|NCT06207539|Antiemetics|antiemetics|mesh-ancestor
154374189|NCT06207539|Autonomic Agents|autonomic agents|mesh-ancestor
154374190|NCT06207539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374191|NCT06207539|Mydriatics|mydriatics|mesh-ancestor
154374192|NCT06207539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154374193|NCT06207539|Cholinergic Agents|cholinergic agents|mesh-ancestor
154374194|NCT06207539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374195|NCT06207539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374196|NCT06207539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154374197|NCT06207539|Parasympatholytics|parasympatholytics|mesh-ancestor
154374198|NCT06207292|Immunomodulating Agents|immunomodulating agents|mesh-list
154374199|NCT06207292|Immunologic Factors|immunologic factors|mesh-ancestor
154374200|NCT06207292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374201|NCT06207253|Diclofenac|diclofenac|mesh-list
154374202|NCT06207253|Calcium|calcium|mesh-list
154374203|NCT06207253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154374204|NCT06207253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374205|NCT06207253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154374206|NCT06207253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154374207|NCT06207253|Analgesics|analgesics|mesh-ancestor
154374208|NCT06207253|Sensory System Agents|sensory system agents|mesh-ancestor
154374209|NCT06207253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374234|NCT06207123|Antimetabolites|antimetabolites|mesh-ancestor
154374235|NCT06207123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374236|NCT06207123|Dermatologic Agents|dermatologic agents|mesh-ancestor
154374237|NCT06207123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374238|NCT06207123|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154374239|NCT06207123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154374240|NCT06207123|Immunologic Factors|immunologic factors|mesh-ancestor
154374241|NCT06207123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154374242|NCT06207123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154374243|NCT06207123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154374244|NCT06207123|Tubulin Modulators|tubulin modulators|mesh-ancestor
154374245|NCT06207123|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374246|NCT06207123|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374247|NCT06207123|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154374248|NCT06207123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154374249|NCT06206564|Artesunate|artesunate|mesh-list
154374250|NCT06206564|Artenimol|artenimol|mesh-list
154374294|NCT06205836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374295|NCT06205836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157398|NCT05797805|Pembrolizumab|pembrolizumab|mesh-list
154374296|NCT06205823|Immunomodulating Agents|immunomodulating agents|mesh-list
154374298|NCT06205823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374299|NCT06205797|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154374300|NCT06205797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154374301|NCT06205797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374302|NCT06205797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374303|NCT06205797|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154374304|NCT06205797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374305|NCT06205797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374306|NCT06205797|Cholinergic Agents|cholinergic agents|mesh-ancestor
154374307|NCT06205797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374308|NCT06205732|Immunomodulating Agents|immunomodulating agents|mesh-list
154374309|NCT06205732|Immunologic Factors|immunologic factors|mesh-ancestor
154374310|NCT06205732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374312|NCT06205719|Flumazenil|flumazenil|mesh-list
154374313|NCT06205719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154374314|NCT06205719|Narcotics|narcotics|mesh-ancestor
154374315|NCT06205719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374316|NCT06205719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374317|NCT06205719|Analgesics|analgesics|mesh-ancestor
154374318|NCT06205719|Sensory System Agents|sensory system agents|mesh-ancestor
154374319|NCT06205719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374320|NCT06205719|Antidotes|antidotes|mesh-ancestor
154374321|NCT06205719|Protective Agents|protective agents|mesh-ancestor
154374322|NCT06205719|GABA Modulators|gaba modulators|mesh-ancestor
154374421|NCT06185452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374422|NCT06185452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154374423|NCT06185452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154374424|NCT06185452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154374425|NCT06185452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154374427|NCT06179446|Immunologic Factors|immunologic factors|mesh-ancestor
154374428|NCT06179446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374429|NCT06177457|Midazolam|midazolam|mesh-list
153451507|NCT00003893|Fluorouracil|fluorouracil|mesh-list
153359931|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
153646478|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359983|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153359985|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153359986|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
153359987|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359988|NCT02135419|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153359989|NCT02135419|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153359990|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153359991|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
153359992|NCT01853748|Paclitaxel|paclitaxel|mesh-list
153359993|NCT01853748|Maytansine|maytansine|mesh-list
153359994|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153359995|NCT01853748|Trastuzumab|trastuzumab|mesh-list
153359996|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153813562|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153813563|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
153360000|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
153360027|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153360028|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360029|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360030|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360031|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
153360032|NCT01268111|Vitamin D|vitamin d|mesh-list
153360033|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153813585|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813586|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
153781808|NCT02211976|Bisacodyl|bisacodyl|mesh-list
153781809|NCT02211976|Cathartics|cathartics|mesh-ancestor
153813587|NCT00334646|Casopitant|casopitant|mesh-list
153813588|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813589|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
153813590|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813591|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813592|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153813593|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
153813594|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813595|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813596|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153813597|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
153813598|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
153813599|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813600|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813601|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153813602|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813603|NCT04701606|Artesunate|artesunate|mesh-list
153813604|NCT04701606|Pyronaridine|pyronaridine|mesh-list
153360034|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360036|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
153360040|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
153360041|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360042|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461791|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153461792|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461793|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813618|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
153813619|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461794|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461795|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461796|NCT03392376|Haloperidol|haloperidol|mesh-list
153461797|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
153461798|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
153461799|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
153461800|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461801|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461802|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153461803|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153461804|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153461805|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461806|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153461807|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153461808|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
153461809|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461810|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461811|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153461812|NCT05243628|Insulin|insulin|mesh-list
153461813|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153461814|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153461815|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461816|NCT05249478|Fentanyl|fentanyl|mesh-list
153461817|NCT05249478|Bupivacaine|bupivacaine|mesh-list
153461818|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
153461819|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
153461820|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461821|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461822|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
153461823|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461824|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153461825|NCT05249478|Narcotics|narcotics|mesh-ancestor
153461826|NCT05249478|Analgesics|analgesics|mesh-ancestor
153509215|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153509216|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509217|NCT03276533|Lidocaine|lidocaine|mesh-list
153509218|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
153509219|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
153509220|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
153509235|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153461827|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153461828|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153461829|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
153461830|NCT05244252|Bupivacaine|bupivacaine|mesh-list
153461831|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
153461832|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
153461833|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461858|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
153461859|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461860|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
153461861|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
153461862|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461863|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
153461864|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461865|NCT04276428|Insulin|insulin|mesh-list
153461866|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153461867|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461868|NCT05248932|Norepinephrine|norepinephrine|mesh-list
153461869|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153461870|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153461871|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
153461872|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461873|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461875|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
153461876|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
153461877|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461878|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153919432|NCT02523040|Lenalidomide|lenalidomide|mesh-list
153913875|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153461879|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153461880|NCT02395614|Gentamicins|gentamicins|mesh-list
153461881|NCT02395614|Cefazolin|cefazolin|mesh-list
153461882|NCT02395614|Bacitracin|bacitracin|mesh-list
153461883|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
153461884|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461885|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153360048|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153461886|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
153461887|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153461888|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461889|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461890|NCT04396938|Lamotrigine|lamotrigine|mesh-list
153461891|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
153461892|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153461893|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153461894|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461895|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153461896|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461897|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153461898|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153461913|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153461914|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461915|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153461916|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153461917|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153461918|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153461920|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153461921|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153461922|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461923|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461924|NCT05241132|Paclitaxel|paclitaxel|mesh-list
153461925|NCT05241132|Cisplatin|cisplatin|mesh-list
153461935|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
153461936|NCT05241054|Fentanyl|fentanyl|mesh-list
153461937|NCT05241054|Bupivacaine|bupivacaine|mesh-list
153461938|NCT05241054|Propofol|propofol|mesh-list
153461939|NCT05241054|Sevoflurane|sevoflurane|mesh-list
153461940|NCT05241054|Atracurium|atracurium|mesh-list
153461941|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
153461942|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
153461943|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461944|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461945|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
153461946|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461947|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153461948|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153461949|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
153461950|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153461951|NCT05241054|Narcotics|narcotics|mesh-ancestor
153461952|NCT05241054|Analgesics|analgesics|mesh-ancestor
153461953|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153461954|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153461955|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
153461956|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153461957|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153461958|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
153461959|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153461985|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
153461986|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153461987|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153461988|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153461989|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
153461990|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153461991|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461992|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153461993|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153461994|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153461995|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461996|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
153813620|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374480|NCT06164314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374481|NCT06164314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153813621|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
153461997|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153461998|NCT00637728|Megestrol|megestrol|mesh-list
153461999|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
153462000|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153462001|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153462002|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153462003|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
153462004|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153462005|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462006|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153462007|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153462024|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153462025|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153462026|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
153781912|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
153509449|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153509450|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
153462027|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153462028|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462029|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153462058|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
153462059|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153462060|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153462061|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462062|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153462063|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153462064|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153462065|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462098|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
153462100|NCT00634920|Everolimus|everolimus|mesh-list
153462101|NCT00634920|Cyclosporins|cyclosporins|mesh-list
153462102|NCT00634920|Basiliximab|basiliximab|mesh-list
153462103|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462104|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462105|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153462106|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
153462107|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462108|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
153462109|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462149|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462150|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
153462151|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462152|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462153|NCT00634842|Insulin|insulin|mesh-list
153462154|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153462155|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
153462156|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153462157|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462158|NCT04396548|Midodrine|midodrine|mesh-list
153462159|NCT04396548|Anesthetics|anesthetics|mesh-list
153462160|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462161|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462162|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
153462163|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
153462164|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462165|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153462166|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153462179|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153462180|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
153462181|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462182|NCT04395612|Niraparib|niraparib|mesh-list
153462183|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153462184|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462185|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462186|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462187|NCT01923558|Donepezil|donepezil|mesh-list
153462188|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153462189|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462190|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462223|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153509519|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509520|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509521|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153509522|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509523|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153509524|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
153509525|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374482|NCT06164314|Analgesics|analgesics|mesh-ancestor
153462224|NCT00633750|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153462225|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153462226|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462227|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462228|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462249|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
153462250|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462264|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462265|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462266|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153462267|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
153462268|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153462269|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153462270|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153462272|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153462273|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153462274|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
153462275|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
153462276|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462277|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462278|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462279|NCT01923948|Pregabalin|pregabalin|mesh-list
153462280|NCT01923948|Analgesics|analgesics|mesh-ancestor
153462281|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
153462282|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462283|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462314|NCT01924104|Analgesics|analgesics|mesh-ancestor
153462315|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
153462316|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462317|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462318|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153462319|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462320|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153462321|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153462322|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462323|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153462324|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153462325|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462326|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
153462327|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
153462328|NCT00987402|Ethanol|ethanol|mesh-list
153462336|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462337|NCT00630396|Minocycline|minocycline|mesh-list
153462338|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153462339|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462340|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
153462341|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153462342|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153462343|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462344|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
153462345|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462346|NCT00630552|Conatumumab|conatumumab|mesh-list
153462347|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462348|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462349|NCT01925352|Mitogens|mitogens|mesh-list
153462350|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
153462351|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462352|NCT01920204|Midostaurin|midostaurin|mesh-list
153509616|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153509617|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
153509618|NCT02293109|Hormones|hormones|mesh-ancestor
153509620|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153360053|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
153360054|NCT01350245|Tacrolimus|tacrolimus|mesh-list
153360055|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153360056|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
153360057|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360058|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360059|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153360060|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
153462354|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153462355|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462356|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462358|NCT04275258|Narcotics|narcotics|mesh-ancestor
153462359|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462360|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462362|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
153462363|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462364|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153462365|NCT01925820|Entecavir|entecavir|mesh-list
153462366|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
153462367|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462368|NCT01925898|Midazolam|midazolam|mesh-list
153462369|NCT01925898|Ketamine|ketamine|mesh-list
153462370|NCT01925898|Analgesics|analgesics|mesh-ancestor
153462371|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
153462372|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462373|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462374|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153462375|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153462376|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
153462377|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
153462378|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462379|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153462380|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153462381|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462382|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462383|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153462384|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153462385|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153462386|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153462387|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153462388|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
153462389|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
153462390|NCT00983580|Aspirin|aspirin|mesh-list
153462391|NCT00983580|Eflornithine|eflornithine|mesh-list
153462392|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153462393|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153462394|NCT00983580|Analgesics|analgesics|mesh-ancestor
153462395|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
153462396|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509742|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509743|NCT01591629|Hormones|hormones|mesh-ancestor
153509744|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509772|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
153509773|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509774|NCT01360593|Gemcitabine|gemcitabine|mesh-list
153462397|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462398|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153462421|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153462422|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
153462424|NCT00982488|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153462425|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153462426|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462427|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462428|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813623|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153813624|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813625|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153813626|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153813627|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153462445|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
153462446|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
153462447|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462448|NCT01926132|Protective Agents|protective agents|mesh-ancestor
153462457|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462458|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153462459|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
153462460|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462461|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462463|NCT01926288|Maleic acid|maleic acid|mesh-list
153462464|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462465|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462466|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
153462467|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462468|NCT00981084|Modafinil|modafinil|mesh-list
153462469|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153462470|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462471|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153462472|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153462473|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153462474|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462499|NCT03064854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462500|NCT00983814|Carbidopa|carbidopa|mesh-list
153462501|NCT00983814|Droxidopa|droxidopa|mesh-list
153462502|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153462503|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153462504|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
153462505|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462506|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462507|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813634|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462508|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153462509|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462510|NCT01921920|Omeprazole|omeprazole|mesh-list
153462511|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153462512|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462513|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153462514|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462515|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462516|NCT04275414|Bevacizumab|bevacizumab|mesh-list
153462517|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462529|NCT04395768|Azithromycin|azithromycin|mesh-list
153462530|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
153462531|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
153462532|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462533|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153462534|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462535|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153462536|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153462537|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462553|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153462554|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153462555|NCT01922154|Growth Substances|growth substances|mesh-ancestor
153462556|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462557|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
153462558|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462559|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
153462560|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462561|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153462562|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153462563|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462564|NCT03423342|Niacinamide|niacinamide|mesh-list
153462566|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
153462567|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
153462568|NCT03423342|Vitamins|vitamins|mesh-ancestor
153462569|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
153462570|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462571|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153462572|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
153462573|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462574|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153462575|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
153462576|NCT01928160|Carboplatin|carboplatin|mesh-list
153462577|NCT01928160|Pemetrexed|pemetrexed|mesh-list
153462578|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153462579|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462580|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462581|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462582|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153462583|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153462584|NCT01928160|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153462585|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153462607|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153462608|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462609|NCT01929096|Edaravone|edaravone|mesh-list
153462610|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153462611|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
153813635|NCT00436371|Amisulpride|amisulpride|mesh-list
153462612|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462613|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153360061|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462614|NCT01929096|Protective Agents|protective agents|mesh-ancestor
153462615|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462617|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
154374484|NCT06164314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462618|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462675|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462677|NCT04124094|Antidotes|antidotes|mesh-ancestor
153462678|NCT04124094|Protective Agents|protective agents|mesh-ancestor
153462679|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
153462681|NCT04123392|Decitabine|decitabine|mesh-list
153462683|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
153462684|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462685|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462686|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153462705|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153462707|NCT04760262|Analgesics|analgesics|mesh-ancestor
153462719|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153509935|NCT01397994|Nicorandil|nicorandil|mesh-list
153462720|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153462721|NCT05607810|Growth Substances|growth substances|mesh-ancestor
153462722|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462723|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
153462724|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462725|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153462726|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462727|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
153462728|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
153462729|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462730|NCT04121910|Itraconazole|itraconazole|mesh-list
153462731|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
153813636|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153360062|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462732|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462733|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153462734|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153462735|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462736|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462737|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153462739|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462740|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462741|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153462743|NCT04129788|Cathartics|cathartics|mesh-ancestor
153462744|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462763|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153462764|NCT05606796|Latanoprost|latanoprost|mesh-list
153462765|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153462766|NCT04129710|Rituximab|rituximab|mesh-list
153462767|NCT04129710|Methotrexate|methotrexate|mesh-list
153462768|NCT04129710|Etoposide|etoposide|mesh-list
153462769|NCT04129710|Lenalidomide|lenalidomide|mesh-list
153462770|NCT04129710|Ibrutinib|ibrutinib|mesh-list
153462771|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462772|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462773|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
153462774|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462775|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462776|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153462777|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
153462778|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153462779|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153462780|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
153462781|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462782|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462783|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462784|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153462785|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153462786|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153462787|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153462788|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153462863|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153462864|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153462865|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
153462866|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462867|NCT04127058|Iloperidone|iloperidone|mesh-list
153462868|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153813637|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153455771|NCT04964466|Becaplermin|becaplermin|mesh-list
153360063|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153360064|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153360065|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360066|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153360067|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153360068|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
153360069|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153360070|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360072|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
153509986|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153360073|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462890|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153462891|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462892|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462894|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
153462895|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153462896|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462897|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462898|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153462899|NCT04758936|Analgesics|analgesics|mesh-ancestor
153462900|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
153462901|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462902|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153462903|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153462904|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153462915|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153462916|NCT04126044|Growth Substances|growth substances|mesh-ancestor
153462917|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462918|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
153462919|NCT04758858|Glucagon|glucagon|mesh-list
153462920|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462921|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462922|NCT04758858|Hormones|hormones|mesh-ancestor
153462923|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462924|NCT04125888|Immunomodulating Agents|immunomodulating agents|mesh-list
153462925|NCT04125888|Immunologic Factors|immunologic factors|mesh-ancestor
153462926|NCT04125888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462927|NCT02975310|Anesthetics|anesthetics|mesh-list
153462928|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462929|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813638|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462930|NCT04394208|Silymarin|silymarin|mesh-list
153462932|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462934|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462935|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
153462936|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153462937|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153462938|NCT03829566|Prednisolone|prednisolone|mesh-list
153462939|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
153462940|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
153462941|NCT03829566|Rituximab|rituximab|mesh-list
153462942|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
153462943|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153462944|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153462945|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
153462946|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153462947|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
153462948|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462949|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462950|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153462951|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
153462952|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462953|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462954|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153462955|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462956|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153462957|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
153462958|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
153462959|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462960|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462961|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
153462962|NCT03829566|Hormones|hormones|mesh-ancestor
153462963|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462964|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153462965|NCT03829566|Protective Agents|protective agents|mesh-ancestor
153462966|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153462967|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
153462968|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
153462969|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153462990|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153462991|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153462992|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462993|NCT04393584|Antidotes|antidotes|mesh-ancestor
153462994|NCT04393584|Protective Agents|protective agents|mesh-ancestor
153462995|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462996|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
153462998|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
153462999|NCT03828474|Acetazolamide|acetazolamide|mesh-list
153463000|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
153463001|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153463002|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463095|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153463138|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153463139|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153463140|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153463141|NCT04391478|Protective Agents|protective agents|mesh-ancestor
153463142|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463143|NCT03828006|Red yeast rice|red yeast rice|mesh-list
153463144|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153463145|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153463146|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153463147|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
153463148|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463149|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463150|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153463151|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
153463152|NCT04391868|Citric Acid|citric acid|mesh-list
153463153|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
153463154|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
153463155|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153463156|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
153463157|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
153463158|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463159|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
153463160|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153463161|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153463162|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463163|NCT04391868|Urological Agents|urological agents|mesh-ancestor
153463164|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
153813650|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153360077|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153360078|NCT01350947|Azacitidine|azacitidine|mesh-list
153463174|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153463175|NCT01450176|Analgesics|analgesics|mesh-ancestor
153463203|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463205|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
153463206|NCT01450566|Lidocaine|lidocaine|mesh-list
153463207|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
153463208|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
153463209|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463210|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463211|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
153463212|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463213|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153463214|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153463215|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153463216|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153463217|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463218|NCT03043014|Misoprostol|misoprostol|mesh-list
153463219|NCT03043014|Mifepristone|mifepristone|mesh-list
153463220|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153463221|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
153463222|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153463248|NCT02983344|Narcotics|narcotics|mesh-ancestor
153463249|NCT02983344|Analgesics|analgesics|mesh-ancestor
153463250|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153455843|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153463251|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153463252|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
153463253|NCT03824340|Doxycycline|doxycycline|mesh-list
153463254|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153463255|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463256|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
153463257|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153463258|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153463259|NCT01455246|Meropenem|meropenem|mesh-list
153463260|NCT01455246|Daptomycin|daptomycin|mesh-list
153463261|NCT01455246|Ceftazidime|ceftazidime|mesh-list
153463264|NCT01455246|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153463265|NCT01455246|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153463266|NCT03823950|Lenograstim|lenograstim|mesh-list
153463267|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153463268|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
153463269|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463270|NCT01451268|Panobinostat|panobinostat|mesh-list
153463271|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463272|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153463273|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463291|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153463292|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463293|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153463294|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153463295|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153463296|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463297|NCT01451658|Propranolol|propranolol|mesh-list
153463311|NCT02935374|Amoxicillin|amoxicillin|mesh-list
153463312|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
153463313|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
153463314|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153463315|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463316|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153813651|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813652|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
153463317|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463318|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463319|NCT01452750|Lansoprazole|lansoprazole|mesh-list
153463320|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
153463321|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153463322|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153463323|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153463324|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463325|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463326|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
153463327|NCT01452828|Tedizolid|tedizolid|mesh-list
153463328|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
153463329|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153463330|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463331|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153463424|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463425|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463426|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153463427|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
153463428|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
153463429|NCT01891500|Protective Agents|protective agents|mesh-ancestor
153463430|NCT02862132|Vedolizumab|vedolizumab|mesh-list
153463431|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153463432|NCT02859402|Fludarabine|fludarabine|mesh-list
153463433|NCT02859402|Busulfan|busulfan|mesh-list
153463524|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463525|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153463526|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153463527|NCT01893450|Protective Agents|protective agents|mesh-ancestor
153463528|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463529|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
153463530|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153463531|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
153463532|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153463533|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153463534|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
153463535|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463536|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
153463538|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463549|NCT01458600|Propranolol|propranolol|mesh-list
153463550|NCT01458600|Metoprolol|metoprolol|mesh-list
153463551|NCT01458600|Methimazole|methimazole|mesh-list
153463552|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153463553|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153463554|NCT01458600|Analgesics|analgesics|mesh-ancestor
153463555|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
153463556|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463620|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463622|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153463624|NCT02716974|Docetaxel|docetaxel|mesh-list
153463625|NCT02716974|Leuprolide|leuprolide|mesh-list
153463626|NCT02716974|Bicalutamide|bicalutamide|mesh-list
153463627|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463628|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
153463629|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
153463630|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
153463631|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463632|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153463633|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
153463634|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153463635|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463636|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153463637|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
153463638|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
153463652|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153463653|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153463654|NCT01459380|Growth Substances|growth substances|mesh-ancestor
153463655|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463656|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
153463657|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
153463658|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153463659|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153463660|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153463661|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463662|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510359|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510360|NCT01400737|Ibuprofen|ibuprofen|mesh-list
153463663|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153463664|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153463665|NCT04346004|Hematinics|hematinics|mesh-ancestor
153463666|NCT02680314|Methotrexate|methotrexate|mesh-list
153463667|NCT02680314|Misoprostol|misoprostol|mesh-list
153463668|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153463669|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
153463670|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153463671|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463672|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153463673|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
153463674|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463675|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463676|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
153463677|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463678|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153463696|NCT02703948|Lidocaine|lidocaine|mesh-list
153463697|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
153463698|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
153463699|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463700|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463701|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
153463794|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
153463795|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
153463796|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463797|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463798|NCT02300922|Antibodies|antibodies|mesh-list
153463799|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
153463800|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463801|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
153463802|NCT01453530|Neostigmine|neostigmine|mesh-list
153463803|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153463804|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463805|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463806|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
153455887|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
153463807|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463808|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463809|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153463810|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
153463811|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463812|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153463813|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153463814|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153360079|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153463817|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153463819|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463820|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463821|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153463822|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
153463823|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153463824|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153463825|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463860|NCT01989780|Exemestane|exemestane|mesh-list
153463861|NCT01989780|Goserelin|goserelin|mesh-list
153463862|NCT01989780|Leuprolide|leuprolide|mesh-list
153463863|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153463864|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463865|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
153463866|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
153463867|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
153463868|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463869|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153463870|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153510442|NCT01401179|Clarithromycin|clarithromycin|mesh-list
153463871|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153463872|NCT01989780|Growth Substances|growth substances|mesh-ancestor
153463873|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463874|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
153463875|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153463876|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153463877|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463878|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153463879|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
153463880|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463881|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153463882|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153463914|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153463915|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153463917|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
153463918|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153463919|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
153463920|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153463921|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
153463922|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
153463923|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463924|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463925|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153463926|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
153463927|NCT02283996|Hormones|hormones|mesh-ancestor
153463928|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463975|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153463976|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463977|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463978|NCT01953510|Vaccines|vaccines|mesh-list
153463979|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153463980|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
153463981|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463996|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463997|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153463998|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153463999|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464000|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464001|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153464002|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
153464003|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464004|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464005|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153464006|NCT05586126|Sevoflurane|sevoflurane|mesh-list
153464007|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153464008|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153464010|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
153464020|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153464021|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
153464022|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464023|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464024|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
153464025|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
153464026|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464027|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464028|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
153464029|NCT02442180|Hormones|hormones|mesh-ancestor
153464030|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464031|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153464032|NCT02442180|Protective Agents|protective agents|mesh-ancestor
153464033|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464034|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464035|NCT01924260|Gemcitabine|gemcitabine|mesh-list
153464036|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464037|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
153464038|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464039|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464040|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
153464041|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153464042|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
153464043|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464044|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
153464045|NCT02432742|Protective Agents|protective agents|mesh-ancestor
153464046|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
153464047|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153464048|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153464049|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464050|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
153464065|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
153464066|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
153464067|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153464068|NCT04757532|Danazol|danazol|mesh-list
153464069|NCT04757532|Androgens|androgens|mesh-ancestor
153464070|NCT04757532|Hormones|hormones|mesh-ancestor
153464071|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464072|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464073|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464074|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464075|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
153464076|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153464077|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
153464078|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464133|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464134|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153464135|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153464136|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
153464137|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464138|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464139|NCT01896336|Zolpidem|zolpidem|mesh-list
153464140|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153464141|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153464142|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464143|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464144|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153464145|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
153464146|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
153464147|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464148|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464149|NCT02087748|Diclofenac|diclofenac|mesh-list
153464150|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153464171|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464173|NCT01428024|Protective Agents|protective agents|mesh-ancestor
153464174|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
153464175|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153464178|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
153464179|NCT01412190|Protective Agents|protective agents|mesh-ancestor
153464181|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
153464182|NCT01331148|Vitamins|vitamins|mesh-ancestor
153464183|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
153464184|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464185|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153464186|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153464188|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
153464230|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153464231|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153464232|NCT01212822|Growth Substances|growth substances|mesh-ancestor
153464233|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464234|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
153464235|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
153464236|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
154157399|NCT05797805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153510635|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153464237|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464238|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464239|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464240|NCT01212822|Antidotes|antidotes|mesh-ancestor
153464241|NCT01212822|Protective Agents|protective agents|mesh-ancestor
153464242|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
153464263|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
153464264|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464265|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464266|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464268|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153464269|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
153464270|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464271|NCT02088216|Expectorants|expectorants|mesh-ancestor
153464272|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
153464273|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153464327|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153464329|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
153464330|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
153464331|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464332|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153464333|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153464334|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464335|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464336|NCT04780854|Metformin|metformin|mesh-list
153464337|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153464338|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464339|NCT04780152|Fluoxetine|fluoxetine|mesh-list
153464340|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
153464341|NCT04780152|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153464342|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153464343|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153464344|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464345|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464346|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
153464347|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464362|NCT04777968|Fluorides|fluorides|mesh-list
153464363|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
153464385|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464386|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464387|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
153464388|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464389|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464390|NCT04779060|Dexamethasone|dexamethasone|mesh-list
153464391|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464392|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
153464393|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
153464394|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464395|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464396|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464397|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
153464399|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464400|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464402|NCT04777110|Esketamine|esketamine|mesh-list
153464403|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
153464404|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464405|NCT01895400|Cilostazol|cilostazol|mesh-list
153464421|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464422|NCT05171946|Vaccines|vaccines|mesh-list
153464423|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
153464424|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464425|NCT05605314|Cyclosporine|cyclosporine|mesh-list
153464426|NCT05605314|Cyclosporins|cyclosporins|mesh-list
153464427|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464456|NCT03012984|Morphine|morphine|mesh-list
153464457|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153464458|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464459|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464460|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153464461|NCT03012984|Analgesics|analgesics|mesh-ancestor
153464462|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
153464463|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464464|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153464465|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153464466|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153464467|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
153464468|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464492|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464493|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153464494|NCT01896960|Narcotics|narcotics|mesh-ancestor
153464495|NCT01896960|Analgesics|analgesics|mesh-ancestor
153464496|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153464497|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153464513|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464514|NCT00056472|Olanzapine|olanzapine|mesh-list
153464515|NCT00056472|Sertraline|sertraline|mesh-list
153464516|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
153464517|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
153464518|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464519|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464520|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464521|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153464537|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464539|NCT04771884|Vancomycin|vancomycin|mesh-list
153464540|NCT04771884|Meropenem|meropenem|mesh-list
153464541|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
153464542|NCT04771884|Linezolid|linezolid|mesh-list
153464543|NCT04771884|Ceftazidime|ceftazidime|mesh-list
153464544|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
153464545|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153464546|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464547|NCT04771884|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153464548|NCT04771884|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153464549|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153464550|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464551|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464552|NCT02538744|Doxazosin|doxazosin|mesh-list
153464553|NCT02538744|Cocaine|cocaine|mesh-list
153464554|NCT02538744|Modafinil|modafinil|mesh-list
153464555|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153464556|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464557|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153464558|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153464559|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153464560|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464561|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
153464562|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
153464563|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464564|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
153464565|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464566|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153464567|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153464568|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153464569|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153464570|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
153464571|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374485|NCT06164314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153360081|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464572|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153464573|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153464613|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464614|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153464615|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464616|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464618|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153464619|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153464620|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464621|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
153464622|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
153464623|NCT00064038|Dexamethasone|dexamethasone|mesh-list
153464624|NCT00064038|Lenalidomide|lenalidomide|mesh-list
153464625|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464626|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
153464627|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
153464628|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464643|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153464644|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153464645|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153464646|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464647|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
153464648|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
153464649|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464650|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464651|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464652|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
153464653|NCT01960530|Hormones|hormones|mesh-ancestor
153464654|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464655|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464656|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464657|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
153464658|NCT01897428|Salicylates|salicylates|mesh-list
153464659|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153464660|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153464661|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153464662|NCT01897428|Analgesics|analgesics|mesh-ancestor
153464663|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
153464664|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464665|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511020|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153511021|NCT01404598|Naproxen|naproxen|mesh-list
153511022|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
153511023|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153511024|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511025|NCT01404598|Analgesics|analgesics|mesh-ancestor
153511026|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
153511027|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511028|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511029|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511030|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511031|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
153511032|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153511033|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511034|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511035|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153464666|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464667|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464668|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153464669|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464670|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464671|NCT00024102|Doxorubicin|doxorubicin|mesh-list
153464672|NCT00024102|Capecitabine|capecitabine|mesh-list
153464673|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464674|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464675|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153464676|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153464677|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464678|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464679|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464680|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
153464681|NCT00074802|Paroxetine|paroxetine|mesh-list
153464682|NCT00074802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153464683|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153360085|NCT01269047|Pramlintide|pramlintide|mesh-list
153360086|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153464688|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464723|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464725|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464726|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153464727|NCT00036738|Cyclosporine|cyclosporine|mesh-list
153464728|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
153464738|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464740|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
153464741|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464742|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464743|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
153464744|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464745|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
153464746|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464747|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153464748|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464749|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153464750|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
153464751|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153464752|NCT00036738|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153464753|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153464755|NCT00038610|Dexamethasone|dexamethasone|mesh-list
153464756|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
153464757|NCT00038610|Doxorubicin|doxorubicin|mesh-list
153464758|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153464759|NCT00038610|Methotrexate|methotrexate|mesh-list
153464760|NCT00038610|Vincristine|vincristine|mesh-list
153464761|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
153464762|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464763|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
153464764|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464765|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464766|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153464767|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
153464768|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511073|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464769|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464770|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153464771|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464772|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
153464773|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
153464774|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464775|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464776|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
153464777|NCT00038610|Hormones|hormones|mesh-ancestor
153464778|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464779|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464780|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464781|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153464782|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153464783|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464784|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153464785|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
153464786|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153464787|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464788|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
153464825|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464827|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153464828|NCT00083382|Pamidronate|pamidronate|mesh-list
153464829|NCT00083382|Thalidomide|thalidomide|mesh-list
153464830|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464831|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
153464832|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464833|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
153464834|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153464835|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464836|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153464837|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153464838|NCT00083382|Growth Substances|growth substances|mesh-ancestor
153464839|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
153464840|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464841|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153464842|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
153464843|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464844|NCT00167934|Valproic Acid|valproic acid|mesh-list
153464845|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
153464846|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464847|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464903|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153464904|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464939|NCT00255684|Cyclosporine|cyclosporine|mesh-list
153464940|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
153464941|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
153464942|NCT00255684|Fludarabine|fludarabine|mesh-list
154374486|NCT06164314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153464943|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
153464944|NCT00255684|Cyclosporins|cyclosporins|mesh-list
153464945|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464946|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
153464947|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464949|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153464950|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
153464951|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464952|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464953|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153464954|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464955|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
153464956|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464957|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
153464958|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464959|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
153464960|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153464961|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464962|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153464984|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153464985|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153464986|NCT00256776|Growth Substances|growth substances|mesh-ancestor
153464987|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
153464988|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
153464989|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464990|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
153464991|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464992|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464993|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153464994|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
153464995|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464996|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464997|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153464998|NCT00176202|Valproic Acid|valproic acid|mesh-list
153464999|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
153465000|NCT00176202|Risperidone|risperidone|mesh-list
153465001|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
153465002|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153465003|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
153465004|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465005|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465018|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153465019|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
153465031|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153465032|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
153465034|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153813662|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
153813663|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153465035|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465036|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
153465037|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465038|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465039|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153465040|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
153465041|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465042|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465043|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153465044|NCT00179478|Interferons|interferons|mesh-list
153465045|NCT00179478|Interferon-beta|interferon-beta|mesh-list
153465046|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
153465047|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465048|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
153465049|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465050|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
153465051|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465052|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153465053|NCT00182754|Octreotide|octreotide|mesh-list
153465054|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511269|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511270|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153511271|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153511272|NCT01405430|Growth Substances|growth substances|mesh-ancestor
153511273|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465055|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153465056|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465057|NCT00085410|Bortezomib|bortezomib|mesh-list
153465058|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465059|NCT00186498|Memantine|memantine|mesh-list
153465060|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153465061|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153465062|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
153465063|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465064|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465065|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465066|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153465067|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153465068|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
153465069|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153465070|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465072|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
153465073|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465074|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465075|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153465076|NCT00087672|Growth Substances|growth substances|mesh-ancestor
153465077|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
153465078|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465079|NCT00088218|Cytarabine|cytarabine|mesh-list
153465080|NCT00088218|Clofarabine|clofarabine|mesh-list
153465115|NCT00091260|Growth Substances|growth substances|mesh-ancestor
153465116|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
153465117|NCT00193128|Docetaxel|docetaxel|mesh-list
153360089|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153465118|NCT00193128|Capecitabine|capecitabine|mesh-list
153465119|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
153465120|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465121|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
153465122|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
153465123|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
153465124|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465125|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465126|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
153465127|NCT00193596|Paclitaxel|paclitaxel|mesh-list
153465128|NCT00193596|Etoposide|etoposide|mesh-list
153465129|NCT00193596|Carboplatin|carboplatin|mesh-list
153465130|NCT00193596|Gemcitabine|gemcitabine|mesh-list
153465131|NCT00193596|Irinotecan|irinotecan|mesh-list
153465132|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153465133|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465134|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
153465135|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
153465142|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465143|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153465144|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
153465145|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
153465146|NCT00194532|Cefpodoxime Proxetil|cefpodoxime proxetil|mesh-list
153465147|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153465148|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465149|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153465150|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153465151|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465152|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465153|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511345|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511346|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
153511347|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153511348|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511349|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511350|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153511351|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153511357|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
153465154|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153465165|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153465166|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465167|NCT00093756|Paclitaxel|paclitaxel|mesh-list
153465168|NCT00093756|Carboplatin|carboplatin|mesh-list
153465169|NCT00093756|Bortezomib|bortezomib|mesh-list
153465170|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153465171|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465172|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
153465173|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
153465174|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
153465175|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465176|NCT04118556|Sirolimus|sirolimus|mesh-list
153465177|NCT04118556|Infliximab|infliximab|mesh-list
153465178|NCT04118556|Etanercept|etanercept|mesh-list
153465179|NCT04118556|Everolimus|everolimus|mesh-list
153465180|NCT04118556|Vedolizumab|vedolizumab|mesh-list
153465181|NCT04118556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153465182|NCT04118556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465183|NCT04118556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465184|NCT04118556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465185|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465186|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
153465187|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465188|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465189|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153465190|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465191|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153465193|NCT04118556|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153465194|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153465195|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
153465196|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153465197|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465198|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153465199|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153465200|NCT04118556|Analgesics|analgesics|mesh-ancestor
153465201|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
153465202|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465203|NCT00267696|Bevacizumab|bevacizumab|mesh-list
153813664|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
153360090|NCT01269047|Incretins|incretins|mesh-ancestor
153360091|NCT01269047|Hormones|hormones|mesh-ancestor
153465204|NCT00267696|Carboplatin|carboplatin|mesh-list
153465205|NCT00267696|Gemcitabine|gemcitabine|mesh-list
153465206|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465207|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465208|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465209|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153465210|NCT00267696|Growth Substances|growth substances|mesh-ancestor
153465211|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465212|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
153465232|NCT00195702|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153465233|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153465234|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465236|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
153465237|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465238|NCT00098670|Rituximab|rituximab|mesh-list
153465239|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153465240|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
153465241|NCT00098670|Fludarabine|fludarabine|mesh-list
153465242|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
153465243|NCT00098670|Antibodies|antibodies|mesh-list
153511428|NCT01406301|Fondaparinux|fondaparinux|mesh-list
153511429|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153511430|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
153511431|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153465244|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
153465245|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153465246|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
153465247|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465248|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465249|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465250|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465251|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
153465252|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465253|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465254|NCT00201864|Fulvestrant|fulvestrant|mesh-list
153465255|NCT00201864|Exemestane|exemestane|mesh-list
153465256|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153465257|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465258|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153465259|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153465260|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
153465261|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465262|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465263|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153465264|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153465265|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465266|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465267|NCT00202722|Remifentanil|remifentanil|mesh-list
153465268|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153465269|NCT00202722|Narcotics|narcotics|mesh-ancestor
153465270|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465271|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465272|NCT00202722|Analgesics|analgesics|mesh-ancestor
153465273|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
153465274|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465275|NCT00100698|Hormones|hormones|mesh-list
153465276|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465277|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465278|NCT00103116|Vaccines|vaccines|mesh-list
153465279|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
153465280|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465281|NCT00205374|Cidofovir|cidofovir|mesh-list
153465298|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465300|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465302|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465303|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
153465304|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153465305|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465306|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465307|NCT00106392|Tacrolimus|tacrolimus|mesh-list
153465308|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465309|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
153465310|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465311|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153465312|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465313|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465314|NCT00211692|Interferons|interferons|mesh-list
153465315|NCT00211692|Ribavirin|ribavirin|mesh-list
153465316|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
153511518|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153511519|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153511520|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153511521|NCT01407211|Vitamin A|vitamin a|mesh-list
153511522|NCT01407211|Vitamins|vitamins|mesh-ancestor
153465317|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
153465318|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465319|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
153465320|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465321|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
153465322|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465323|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
153465324|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465325|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153465326|NCT01899690|Clindamycin|clindamycin|mesh-list
153465327|NCT01899690|Cephalexin|cephalexin|mesh-list
153465328|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465329|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153465330|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465331|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465332|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153465333|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153465334|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153465335|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
153465336|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465337|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465338|NCT01899846|Progestins|progestins|mesh-ancestor
153465339|NCT01899846|Hormones|hormones|mesh-ancestor
153465340|NCT00214890|Tenofovir|tenofovir|mesh-list
153465341|NCT00214890|Abacavir|abacavir|mesh-list
153465342|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
153465343|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465344|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153465345|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153465346|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465347|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465348|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153465349|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153465350|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
153465351|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153465383|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465384|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465385|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
153465386|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813668|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153465387|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153465388|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153465389|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
153465390|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
153465392|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153465393|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153465394|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
153465395|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465396|NCT00223236|Choline|choline|mesh-list
153465397|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153465398|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
153465399|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153465400|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
153511622|NCT01408095|Glimepiride|glimepiride|mesh-list
153465401|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465417|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465420|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153465423|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465424|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
153465425|NCT00224952|Carbamazepine|carbamazepine|mesh-list
153465426|NCT00224952|Valproic Acid|valproic acid|mesh-list
153465427|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
153465428|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465429|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465430|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
153465431|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465432|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465433|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
153465434|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153465435|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465436|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465437|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153465439|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
153465440|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465441|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153465442|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153465443|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153465444|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153465445|NCT00225420|Docetaxel|docetaxel|mesh-list
153465446|NCT00225420|Leuprolide|leuprolide|mesh-list
153465447|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465448|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
153465449|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
153465450|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153465451|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465452|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153465453|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
153465474|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153465475|NCT00225498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153465476|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153465477|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153465479|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153465480|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153465481|NCT00225732|Analgesics|analgesics|mesh-ancestor
153465482|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
153465483|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465484|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465485|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153465486|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465487|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153465488|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465489|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465490|NCT02096718|Afatinib|afatinib|mesh-list
153465491|NCT02096718|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153465492|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465493|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465494|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465495|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465496|NCT02097732|Ipilimumab|ipilimumab|mesh-list
153511723|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511724|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511725|NCT01408680|Ubiquinone|ubiquinone|mesh-list
153511726|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
153511727|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
153511728|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511729|NCT01408680|Vitamins|vitamins|mesh-ancestor
153511730|NCT01408797|Bortezomib|bortezomib|mesh-list
153511757|NCT01408836|Protective Agents|protective agents|mesh-ancestor
153511758|NCT01408849|Omeprazole|omeprazole|mesh-list
153465497|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465498|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465499|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153465500|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465501|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
153465502|NCT00286182|Hematinics|hematinics|mesh-ancestor
153465503|NCT00226590|Paclitaxel|paclitaxel|mesh-list
153465504|NCT00226590|Carboplatin|carboplatin|mesh-list
153465505|NCT00226590|Gemcitabine|gemcitabine|mesh-list
153465506|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153465507|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465508|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
153465509|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
153465510|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
153465511|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465512|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465513|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
153465515|NCT00114114|Testosterone|testosterone|mesh-list
153465516|NCT00114114|Androgens|androgens|mesh-ancestor
153465517|NCT00114114|Hormones|hormones|mesh-ancestor
153465518|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465519|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465520|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153465521|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465522|NCT00227760|Cediranib|cediranib|mesh-list
153465523|NCT00227760|Maleic acid|maleic acid|mesh-list
153465524|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465525|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465526|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465546|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153465547|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465554|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465555|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
153465556|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153465557|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465558|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465559|NCT00288366|Aripiprazole|aripiprazole|mesh-list
153465560|NCT00288366|Ziprasidone|ziprasidone|mesh-list
153465561|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
153465562|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465563|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153465564|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153465565|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465566|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465567|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
153465568|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
153465569|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465570|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465571|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153465572|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153465573|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
153465574|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153465575|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153465576|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153465577|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153422632|NCT03089983|Narcotics|narcotics|mesh-ancestor
153511859|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153511860|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153511861|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511862|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
153511863|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465578|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153465579|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
153465580|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153465581|NCT00288600|Antibodies|antibodies|mesh-list
153465582|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
153465601|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153465602|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
153465603|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
153465604|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465605|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465606|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153465607|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
153465608|NCT04752852|Hormones|hormones|mesh-ancestor
153465609|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465610|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153465611|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465612|NCT01899144|Albuterol|albuterol|mesh-list
153465613|NCT01899144|Procaterol|procaterol|mesh-list
153465614|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153465615|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
153465616|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465617|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465618|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153465619|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
153465620|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
153465621|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153465622|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153465623|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153465624|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153465625|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
153465626|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465627|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465628|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
153465630|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153465631|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153465632|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
153465633|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914387|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914388|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153465635|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465677|NCT00296322|Doxifluridine|doxifluridine|mesh-list
153465678|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465679|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153465680|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
153465681|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465682|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153465683|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465684|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465685|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
153465698|NCT00123630|Omalizumab|omalizumab|mesh-list
153465699|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153465700|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153465701|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
153465702|NCT00124176|Albuterol|albuterol|mesh-list
153465703|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153465704|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
153465705|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465706|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465707|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153465708|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
153465709|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
153465710|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153465711|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153813669|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813670|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153465712|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153465713|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153465714|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
153465715|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465716|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465717|NCT00240162|Vatalanib|vatalanib|mesh-list
153465718|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465719|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465720|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465721|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
153465722|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153465723|NCT00299988|Antibodies|antibodies|mesh-list
153465724|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
153465725|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153465726|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
153465727|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465728|NCT04226352|Levomethorphan|levomethorphan|mesh-list
153465729|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
153465730|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
153465731|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
153465732|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153465733|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153465734|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465782|NCT02102100|Menthol|menthol|mesh-list
153465783|NCT02102100|Nicotine|nicotine|mesh-list
153465784|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153465785|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
153465786|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465787|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465788|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153465789|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153465790|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
153512058|NCT01410968|Poly ICLC|poly iclc|mesh-list
153512059|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
153512060|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
153512061|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512062|NCT01411072|Gemcitabine|gemcitabine|mesh-list
153512063|NCT01411072|Fluorouracil|fluorouracil|mesh-list
153512064|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512066|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512067|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512068|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512069|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
153512070|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512071|NCT01411098|Etoposide|etoposide|mesh-list
153465791|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465801|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465802|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465803|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153465804|NCT00242502|Growth Substances|growth substances|mesh-ancestor
153465805|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465806|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
153465807|NCT00242502|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153465808|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465809|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465810|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465811|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
153465812|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153465813|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465814|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
153465815|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465816|NCT04389060|Protective Agents|protective agents|mesh-ancestor
153465817|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465818|NCT01899066|Carboplatin|carboplatin|mesh-list
153465819|NCT01899066|Etoposide|etoposide|mesh-list
153465820|NCT01899066|Vincristine|vincristine|mesh-list
153465821|NCT01899066|Ranibizumab|ranibizumab|mesh-list
153465822|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465823|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153465824|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153465825|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153465826|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465827|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465828|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
153465829|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
153465830|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
153465831|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465832|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153465833|NCT01899066|Growth Substances|growth substances|mesh-ancestor
153465857|NCT00250926|Dexamethasone|dexamethasone|mesh-list
153465873|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
153465874|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465875|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465876|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465877|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
153465878|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512147|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512149|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512150|NCT01411410|Paclitaxel|paclitaxel|mesh-list
153512151|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153512152|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512153|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
153512154|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
153512155|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
153512156|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512157|NCT01411423|Sorafenib|sorafenib|mesh-list
153512158|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512159|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512160|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512162|NCT01411436|Sorafenib|sorafenib|mesh-list
153465879|NCT00303966|Sorafenib|sorafenib|mesh-list
153465880|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465881|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465882|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465883|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465884|NCT00304746|Testosterone|testosterone|mesh-list
153465885|NCT00304746|Androgens|androgens|mesh-ancestor
153465886|NCT00304746|Hormones|hormones|mesh-ancestor
153465887|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465888|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465890|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
153465891|NCT00134004|Fludarabine|fludarabine|mesh-list
153465892|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
153465893|NCT00134004|Tacrolimus|tacrolimus|mesh-list
153465894|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465895|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
153465896|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465897|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465898|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153465899|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
153465900|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465901|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465902|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153465916|NCT02103114|Antithrombins|antithrombins|mesh-list
153465917|NCT02103114|Thrombin|thrombin|mesh-list
153465918|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
153465919|NCT02103114|Coagulants|coagulants|mesh-ancestor
153465920|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153465943|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153465944|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465946|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153465947|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465948|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465949|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465950|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153465951|NCT00140556|Growth Substances|growth substances|mesh-ancestor
153465952|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465953|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
153465954|NCT00140556|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153465955|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465956|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465957|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374488|NCT06164314|Adrenergic Agents|adrenergic agents|mesh-ancestor
154374489|NCT06164314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154374490|NCT06164314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374491|NCT06156982|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154374493|NCT06156982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374494|NCT06155123|Antibodies|antibodies|mesh-list
154374495|NCT06155123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154374496|NCT06155123|Immunologic Factors|immunologic factors|mesh-ancestor
153465958|NCT00142116|Thalidomide|thalidomide|mesh-list
153465959|NCT00142116|Rituximab|rituximab|mesh-list
153465960|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465961|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465963|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465964|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781811|NCT02211976|Laxatives|laxatives|mesh-ancestor
153465965|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465966|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
153465967|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153465968|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465969|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465970|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153465971|NCT00142116|Growth Substances|growth substances|mesh-ancestor
153465972|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
153465998|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
153465999|NCT05266794|Trace Elements|trace elements|mesh-ancestor
153466000|NCT00142818|Naltrexone|naltrexone|mesh-list
153466001|NCT00142818|Modafinil|modafinil|mesh-list
153466002|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153466003|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153466004|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466005|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
153466006|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466007|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153466019|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466020|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466021|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
153466022|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153466023|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153466038|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466040|NCT04528212|Curcumin|curcumin|mesh-list
153466041|NCT04528212|Fenofibrate|fenofibrate|mesh-list
153466042|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153466043|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153466044|NCT04528212|Analgesics|analgesics|mesh-ancestor
153466045|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
153466046|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466047|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466048|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153466049|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466050|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466051|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466052|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466053|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153466054|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153466055|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466056|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
153466057|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153466058|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
153466059|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466060|NCT00148668|Carboplatin|carboplatin|mesh-list
153466061|NCT00148668|Docetaxel|docetaxel|mesh-list
153466062|NCT00148668|Trastuzumab|trastuzumab|mesh-list
153466063|NCT00148668|Vinorelbine|vinorelbine|mesh-list
153466064|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466065|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
153466066|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374497|NCT06155123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466068|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466069|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466070|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153466071|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
153466072|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466073|NCT00324870|Bevacizumab|bevacizumab|mesh-list
153466074|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153466075|NCT00324870|Vorinostat|vorinostat|mesh-list
153466076|NCT00324870|Antibodies|antibodies|mesh-list
153466077|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
153466078|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153466079|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466080|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153466081|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153466082|NCT00324870|Growth Substances|growth substances|mesh-ancestor
153466083|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466107|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466109|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153466110|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153466113|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466114|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466115|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466116|NCT00334074|Cytarabine|cytarabine|mesh-list
153466117|NCT00334074|Clofarabine|clofarabine|mesh-list
153466118|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153466119|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
153466120|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466121|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466122|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
153466123|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466124|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466125|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
153466126|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466127|NCT00335478|Daptomycin|daptomycin|mesh-list
153466128|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153466129|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466130|NCT04345926|Propofol|propofol|mesh-list
153466131|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153466132|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813672|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153466133|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466134|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153466135|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
153466136|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
153466137|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
153466138|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153466139|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466140|NCT00338598|Glycine|glycine|mesh-list
153466141|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
153466142|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466143|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466144|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466145|NCT00338988|Capecitabine|capecitabine|mesh-list
153466146|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
153466147|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153466156|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153466157|NCT00343044|Growth Substances|growth substances|mesh-ancestor
153466158|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466159|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
153466160|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153466161|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153466162|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512435|NCT01413711|Vigabatrin|vigabatrin|mesh-list
153466163|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466176|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
153466177|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466178|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466179|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466180|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153466181|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153466182|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
153914482|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466183|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153466184|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466185|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466186|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153466188|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
153455368|NCT06174285|Hallucinogens|hallucinogens|mesh-list
153466189|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466190|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153466191|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153466192|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153466193|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
153466194|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466195|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466197|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153466198|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153466199|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
153466200|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466201|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466203|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153466204|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153466205|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
153466206|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153466207|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153466208|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466209|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466210|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
153466236|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466238|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153813673|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466239|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466240|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466241|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153466242|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
153466243|NCT00351936|Aripiprazole|aripiprazole|mesh-list
153466244|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
153466245|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466246|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153466247|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466278|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466280|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466281|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
153466282|NCT00353652|Spironolactone|spironolactone|mesh-list
153466283|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153466284|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
153466285|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153466286|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466287|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153466288|NCT00353652|Diuretics|diuretics|mesh-ancestor
153466289|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
153466290|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153466291|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153466292|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153466293|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466294|NCT02982798|Metformin|metformin|mesh-list
153466295|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153466296|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153466297|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466298|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153466299|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153466300|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
153466301|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466302|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466303|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153466304|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466305|NCT03709914|Fosfomycin|fosfomycin|mesh-list
153466306|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153466307|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374498|NCT06132087|Pancrelipase|pancrelipase|mesh-list
153466308|NCT01794078|Ambrisentan|ambrisentan|mesh-list
153466309|NCT01794078|Aminophylline|aminophylline|mesh-list
153466310|NCT01794078|Theophylline|theophylline|mesh-list
153466311|NCT01794078|Ethylene|ethylene|mesh-list
153466312|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153466313|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
153466314|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466315|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466316|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153466326|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153466327|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153466328|NCT01794078|Protective Agents|protective agents|mesh-ancestor
153466329|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153466330|NCT01794078|Growth Substances|growth substances|mesh-ancestor
153466344|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153466345|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466346|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
153466347|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153466348|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153466349|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466353|NCT00354978|Vitamins|vitamins|mesh-ancestor
153466354|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
153466355|NCT00357162|Belinostat|belinostat|mesh-list
153466356|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466357|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153466358|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466359|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466360|NCT03984240|Midazolam|midazolam|mesh-list
153466361|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
153466362|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153466363|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466364|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466365|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153466366|NCT03984240|Analgesics|analgesics|mesh-ancestor
153466367|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
153466368|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466369|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153466370|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153466371|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153466372|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
153466373|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466374|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466375|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153466376|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153466377|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466378|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466379|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153466380|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
153466381|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
153466382|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
153466433|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153466434|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
153466435|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153466436|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153466437|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512771|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
153466438|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153466439|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
153466456|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153466457|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
153813675|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466458|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466459|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153466460|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153466461|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153466462|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466463|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153466464|NCT00360672|Lenalidomide|lenalidomide|mesh-list
153466465|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
153466466|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466467|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153466468|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153466469|NCT00360672|Growth Substances|growth substances|mesh-ancestor
153914525|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153466470|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
153466471|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466472|NCT00360828|Irinotecan|irinotecan|mesh-list
153466473|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153466474|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153466475|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466476|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466477|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466478|NCT00361140|Fludarabine|fludarabine|mesh-list
153466479|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
153466480|NCT00361140|Busulfan|busulfan|mesh-list
153466503|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466504|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
153466505|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466506|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466507|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153466508|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
153466509|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466510|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466511|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153466512|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153466513|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153466514|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
153466515|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153466516|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466517|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466518|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
153466519|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
153466557|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153466558|NCT00365274|Vincristine|vincristine|mesh-list
153466559|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153466560|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466561|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
153466562|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466563|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512863|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466564|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153466565|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
153466566|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466567|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813676|NCT00436761|Cyclosporine|cyclosporine|mesh-list
153466568|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153466569|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153466570|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153466571|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153466572|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466573|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153466574|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
153466576|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153466577|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153466578|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153466579|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
153466580|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
153466581|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
153466582|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466583|NCT00365274|Immunotoxins|immunotoxins|mesh-ancestor
153466584|NCT00365274|Immunoconjugates|immunoconjugates|mesh-ancestor
153466585|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
153466586|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153466587|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153466588|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153466599|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466600|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153466601|NCT00313560|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153466612|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466613|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153466614|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
153466615|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466616|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466617|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153466618|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153466620|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
153466621|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466622|NCT00316524|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153466623|NCT00316524|Antiviral Agents|antiviral agents|mesh-ancestor
153455438|NCT06131905|Propofol|propofol|mesh-list
153466624|NCT00316524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466625|NCT00318708|Fluticasone|fluticasone|mesh-list
153466626|NCT00318708|Xhance|xhance|mesh-list
153466627|NCT00318708|Clarithromycin|clarithromycin|mesh-list
153466628|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153466629|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153466630|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
153466631|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466632|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466633|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153466634|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
153422929|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466635|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
153466636|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153466637|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153466639|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153466640|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466641|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466642|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153466643|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153466644|NCT00319644|Dimercaprol|dimercaprol|mesh-list
153466645|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
153466646|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
153466647|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466648|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153466649|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153466650|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466651|NCT00321594|Belinostat|belinostat|mesh-list
153466666|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813677|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
153360092|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360094|NCT03800264|Bisoprolol|bisoprolol|mesh-list
153360095|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360096|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153360097|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
153466667|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
153466668|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466669|NCT00391716|Gabapentin|gabapentin|mesh-list
153466670|NCT00391716|Analgesics|analgesics|mesh-ancestor
153466671|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
153466672|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466673|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466689|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466691|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153466692|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466693|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466694|NCT01958190|Sirolimus|sirolimus|mesh-list
153466695|NCT01958190|Tacrolimus|tacrolimus|mesh-list
153466696|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466697|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
153466698|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466699|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153466700|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466701|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466702|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153466703|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466704|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153466705|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466706|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
153466708|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153466709|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
153466710|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466711|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153466712|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466721|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153466722|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153466723|NCT00397020|Valproic Acid|valproic acid|mesh-list
153466724|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153466725|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
154374499|NCT06132087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374500|NCT06123494|Paclitaxel|paclitaxel|mesh-list
154374501|NCT06123494|Docetaxel|docetaxel|mesh-list
154374502|NCT06123494|Irinotecan|irinotecan|mesh-list
154374503|NCT06123494|Ramucirumab|ramucirumab|mesh-list
154374504|NCT06123494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154374505|NCT06123494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466726|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466727|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153466728|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466729|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466730|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466731|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
153466732|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466733|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466734|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
153466735|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466736|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
153466737|NCT00397878|Saracatinib|saracatinib|mesh-list
153466738|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813678|NCT00436761|Melphalan|melphalan|mesh-list
153813679|NCT00436761|Busulfan|busulfan|mesh-list
153813680|NCT00436761|Cyclosporins|cyclosporins|mesh-list
153466751|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
153466752|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153466753|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
153466754|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466755|NCT00374088|Protective Agents|protective agents|mesh-ancestor
153466756|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466757|NCT00374088|Antidotes|antidotes|mesh-ancestor
153466758|NCT00374244|Pimozide|pimozide|mesh-list
153466759|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153466760|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466761|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466762|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466763|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466764|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153466765|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
153466766|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466767|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466768|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153466769|NCT00377832|Acetaminophen|acetaminophen|mesh-list
153813690|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
153813691|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813692|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153813693|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813694|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
153813695|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
153813696|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466804|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466805|NCT00381810|Acetaminophen|acetaminophen|mesh-list
153466806|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
153466807|NCT00381810|Promethazine|promethazine|mesh-list
153466808|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
153466809|NCT00381810|Rituximab|rituximab|mesh-list
153466810|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466811|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466812|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
153466813|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466814|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466815|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153466816|NCT00381810|Analgesics|analgesics|mesh-ancestor
153466817|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
153466818|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466819|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
153466820|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153466821|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
153466822|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
153466823|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153466853|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
153466855|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153466856|NCT00459810|Estradiol|estradiol|mesh-list
153466857|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153466858|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466859|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
153466860|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
153466861|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
153466862|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466863|NCT00459810|Estrogens|estrogens|mesh-ancestor
153466864|NCT00459810|Hormones|hormones|mesh-ancestor
153466865|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153466866|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466867|NCT00405522|Remifentanil|remifentanil|mesh-list
153466868|NCT00405522|Propofol|propofol|mesh-list
153466869|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153466870|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466871|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466873|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
153466874|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
153466875|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153466876|NCT00405522|Narcotics|narcotics|mesh-ancestor
153466877|NCT00405522|Analgesics|analgesics|mesh-ancestor
153466878|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
153466879|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466880|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
153466881|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153466882|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153466883|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153466884|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153466885|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466890|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466891|NCT00382590|Cytarabine|cytarabine|mesh-list
153466892|NCT00382590|Azacitidine|azacitidine|mesh-list
153466893|NCT00382590|Valproic Acid|valproic acid|mesh-list
153466894|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153466895|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
153466896|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466897|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466898|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
153466899|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466900|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466901|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
153466902|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466903|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466904|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
153466905|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
153466906|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466907|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
153466908|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466909|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466924|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153466925|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
153466926|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466927|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466928|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466929|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153466930|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153466931|NCT00408564|Gemcitabine|gemcitabine|mesh-list
153466932|NCT00408564|Capecitabine|capecitabine|mesh-list
153466933|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
153466934|NCT00408564|Cetuximab|cetuximab|mesh-list
153466935|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153466936|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
153466937|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466938|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466939|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466940|NCT00383448|Cyclosporine|cyclosporine|mesh-list
153466941|NCT00383448|Melphalan|melphalan|mesh-list
153466942|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
153466943|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
153466944|NCT00383448|Clofarabine|clofarabine|mesh-list
153466945|NCT00383448|Cyclosporins|cyclosporins|mesh-list
153466946|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466947|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466948|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466949|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
153466950|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466951|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
153466953|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
153466954|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466955|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153466956|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153466957|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
153466958|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466959|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153466960|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466961|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
153466962|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153466963|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153466964|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
153466965|NCT00384774|Lasmiditan|lasmiditan|mesh-list
153466966|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153466967|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
153466968|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467004|NCT00385008|Sumatriptan|sumatriptan|mesh-list
153467005|NCT00385008|Eletriptan|eletriptan|mesh-list
153467006|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153467007|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153467008|NCT00385008|Analgesics|analgesics|mesh-ancestor
153467009|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
153467010|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467011|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467012|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467013|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467014|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
153467015|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153467016|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467018|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153467019|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153467020|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153467021|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
153467022|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467023|NCT00410904|Pemetrexed|pemetrexed|mesh-list
153467024|NCT00410904|Cediranib|cediranib|mesh-list
153467049|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153467050|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467051|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
153467052|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467053|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153467054|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153467055|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467056|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
153467057|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153467058|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
153467059|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153513453|NCT01420575|Olanzapine|olanzapine|mesh-list
153467060|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
153467061|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153467062|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467110|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
153467111|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467112|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153813699|NCT00436761|Hormones|hormones|mesh-ancestor
153813700|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813701|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153813702|NCT00436761|Protective Agents|protective agents|mesh-ancestor
153813703|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813704|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153813705|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
153467114|NCT00413166|Immunoconjugates|immunoconjugates|mesh-ancestor
153467115|NCT00413166|Immunologic Factors|immunologic factors|mesh-ancestor
153467116|NCT00413166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467117|NCT00413400|Etanercept|etanercept|mesh-list
153467118|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153467119|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153467120|NCT00413400|Analgesics|analgesics|mesh-ancestor
153467121|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
153467122|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467123|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467124|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467125|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467126|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153467166|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
153467182|NCT00415506|Rituximab|rituximab|mesh-list
153467183|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467184|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467185|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
153467186|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467187|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467188|NCT00389532|Vaccines|vaccines|mesh-list
153467189|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
153467190|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467201|NCT01795170|Vitamins|vitamins|mesh-ancestor
153467202|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
153467203|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467204|NCT00477204|Simvastatin|simvastatin|mesh-list
153467205|NCT00477204|Ezetimibe|ezetimibe|mesh-list
153467206|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153467207|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153467208|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153467209|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
153467210|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467211|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153467212|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153467213|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467214|NCT00528450|Idarubicin|idarubicin|mesh-list
153467215|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
153467216|NCT00528450|Tretinoin|tretinoin|mesh-list
153467219|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153467220|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467221|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467222|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467223|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
153467224|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467225|NCT00478218|Dexamethasone|dexamethasone|mesh-list
153513583|NCT01421368|Tenofovir|tenofovir|mesh-list
153467237|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467238|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
153467239|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
153467240|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467241|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153467242|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
153467244|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467245|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153467246|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467247|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467248|NCT00478218|Growth Substances|growth substances|mesh-ancestor
153467249|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
153467250|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
153467251|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153467252|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153467253|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153467254|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153467255|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467256|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
153467257|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467258|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467259|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153467260|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467261|NCT04270656|Insulin|insulin|mesh-list
153467262|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153467263|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467264|NCT00424554|Temozolomide|temozolomide|mesh-list
153467275|NCT00425802|Cyclosporins|cyclosporins|mesh-list
153467276|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153467277|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467278|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
153467279|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467280|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467281|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467282|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
153467283|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467284|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467285|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153456473|NCT01453374|Naltrexone|naltrexone|mesh-list
153467286|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467287|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467288|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
153467306|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153467307|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153467308|NCT00531882|Analgesics|analgesics|mesh-ancestor
153467309|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
153467310|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467311|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467312|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467313|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467314|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153467315|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467316|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467317|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153467318|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153467319|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
153467320|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153467321|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153467322|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153467323|NCT00428298|Valacyclovir|valacyclovir|mesh-list
153467324|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
153467325|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467329|NCT00486018|Growth Substances|growth substances|mesh-ancestor
153467330|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467331|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
153467332|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467333|NCT00486642|Bicalutamide|bicalutamide|mesh-list
153467334|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
153467335|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
153467336|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467337|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467338|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467339|NCT00428922|Bevacizumab|bevacizumab|mesh-list
153467340|NCT00428922|Trastuzumab|trastuzumab|mesh-list
153467342|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467343|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467344|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467345|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467377|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467378|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467379|NCT01954524|Urological Agents|urological agents|mesh-ancestor
153467380|NCT00535002|Yohimbine|yohimbine|mesh-list
153467381|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
153467382|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
153467383|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467384|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467385|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153467386|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153467387|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153467388|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
153467389|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467390|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467391|NCT00535002|Urological Agents|urological agents|mesh-ancestor
153467392|NCT02117934|Vaccines|vaccines|mesh-list
153467393|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
153467394|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467395|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
153467396|NCT00429702|Promethazine|promethazine|mesh-list
153467397|NCT00429702|Dexamethasone|dexamethasone|mesh-list
153467398|NCT00429702|Lorazepam|lorazepam|mesh-list
153467399|NCT00429702|Ondansetron|ondansetron|mesh-list
153467400|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467401|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
153467402|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
153467403|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467404|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467405|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153467406|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
153467407|NCT00429702|Hormones|hormones|mesh-ancestor
153467423|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
153467424|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153467425|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
153467426|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
154374506|NCT06123494|Tubulin Modulators|tubulin modulators|mesh-ancestor
154374507|NCT06123494|Antimitotic Agents|antimitotic agents|mesh-ancestor
154374508|NCT06123494|Mitosis Modulators|mitosis modulators|mesh-ancestor
154374509|NCT06123494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374510|NCT06123494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154374511|NCT06123494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154374512|NCT06123494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374513|NCT06123494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154374514|NCT06123494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154374515|NCT06123494|Growth Substances|growth substances|mesh-ancestor
154374516|NCT06123494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374517|NCT06123494|Growth Inhibitors|growth inhibitors|mesh-ancestor
154374523|NCT06107543|Lidocaine|lidocaine|mesh-list
154374524|NCT06107543|Anesthetics, Local|anesthetics, local|mesh-ancestor
154374525|NCT06107543|Anesthetics|anesthetics|mesh-ancestor
154374526|NCT06107543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153467427|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153467428|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
153467429|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153467430|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153467431|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513777|NCT01422603|Clofarabine|clofarabine|mesh-list
153467432|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
153467433|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
153467434|NCT00535392|Levetiracetam|levetiracetam|mesh-list
153467435|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
153467436|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
153467437|NCT00535782|Methotrexate|methotrexate|mesh-list
153467438|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153467452|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153467453|NCT00431184|Pentazocine|pentazocine|mesh-list
153467454|NCT00431184|Lorazepam|lorazepam|mesh-list
153467455|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
153467456|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
153467457|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
153467458|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467459|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467460|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153467462|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153467463|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153467464|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153467465|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153467466|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
153467490|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153467491|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467492|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467493|NCT01796028|Metformin|metformin|mesh-list
153467494|NCT01796028|Docetaxel|docetaxel|mesh-list
153467495|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153467496|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467497|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467498|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
153467499|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
153467500|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
153467501|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467502|NCT00491244|Interferons|interferons|mesh-list
153467503|NCT00491244|Ribavirin|ribavirin|mesh-list
153467505|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
153467506|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153467507|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467508|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
153467509|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467510|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
153467511|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467512|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
153467513|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467514|NCT00492336|Rasagiline|rasagiline|mesh-list
153467515|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153467516|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467517|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467518|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153467541|NCT00538824|Growth Substances|growth substances|mesh-ancestor
153467542|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
153467543|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467544|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
153467545|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153467546|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467547|NCT00539526|Bimatoprost|bimatoprost|mesh-list
153467548|NCT00539526|Travoprost|travoprost|mesh-list
153467549|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153467550|NCT00539526|Latanoprost|latanoprost|mesh-list
153467551|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153467552|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153467553|NCT01796106|Fluorides|fluorides|mesh-list
153467554|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
153467555|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
153467556|NCT01796106|Protective Agents|protective agents|mesh-ancestor
153813706|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153813707|NCT00436800|Gemcitabine|gemcitabine|mesh-list
153360119|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467557|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467558|NCT00541242|Bimatoprost|bimatoprost|mesh-list
153467559|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153467560|NCT00541242|Latanoprost|latanoprost|mesh-list
153467561|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153467562|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153467563|NCT00438204|Bevacizumab|bevacizumab|mesh-list
153467564|NCT00438204|Gemcitabine|gemcitabine|mesh-list
153467565|NCT00438204|Pemetrexed|pemetrexed|mesh-list
153467566|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467567|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467568|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467569|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467570|NCT00438204|Growth Substances|growth substances|mesh-ancestor
153467571|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467572|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
153467573|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467574|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
153467575|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467576|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467577|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153467578|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153467579|NCT00439296|Cytarabine|cytarabine|mesh-list
153467582|NCT00439296|Doxorubicin|doxorubicin|mesh-list
153467583|NCT00439296|Methotrexate|methotrexate|mesh-list
153467584|NCT00439296|Asparaginase|asparaginase|mesh-list
153467585|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
153467586|NCT00439296|Thioguanine|thioguanine|mesh-list
153467587|NCT00439296|Pegaspargase|pegaspargase|mesh-list
153467588|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467608|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467609|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467610|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153467611|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
153467624|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153467625|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153467626|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153467627|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
153467628|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467629|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467631|NCT00439374|Hormones|hormones|mesh-ancestor
153467632|NCT00439608|Paclitaxel|paclitaxel|mesh-list
153467633|NCT00439608|Carboplatin|carboplatin|mesh-list
153467634|NCT00439608|Cetuximab|cetuximab|mesh-list
153467635|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153467636|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467637|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
153467638|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
153467639|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
153467640|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467641|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467642|NCT04750122|Carboplatin|carboplatin|mesh-list
153467643|NCT04750122|Docetaxel|docetaxel|mesh-list
153467662|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
153467663|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153467664|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
153467665|NCT00445302|Plerixafor|plerixafor|mesh-list
153467666|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153467667|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153467668|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
153467669|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467670|NCT00504504|Rituximab|rituximab|mesh-list
153813708|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
153467671|NCT00504504|Doxorubicin|doxorubicin|mesh-list
153467672|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153467673|NCT00504504|Dacarbazine|dacarbazine|mesh-list
153467674|NCT00504504|Bleomycin|bleomycin|mesh-list
153467675|NCT00504504|Vinblastine|vinblastine|mesh-list
153467676|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467677|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467678|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
153467679|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467680|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467681|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153467682|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153467683|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467684|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467685|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467686|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467687|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
153467688|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153467689|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
153467690|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
153467691|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
153467692|NCT00504660|Celecoxib|celecoxib|mesh-list
153467723|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
153467724|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467725|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455632|NCT05603650|Listerine|listerine|mesh-list
153467726|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467727|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467728|NCT00447330|Growth Substances|growth substances|mesh-ancestor
153467729|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467730|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
153467731|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467732|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
153467733|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467735|NCT02115048|Afatinib|afatinib|mesh-list
153467736|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467737|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153467738|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153467739|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467740|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467741|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153467742|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
153467743|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467744|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467745|NCT02115048|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153467746|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153467747|NCT00546156|Paclitaxel|paclitaxel|mesh-list
153467748|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
153467749|NCT00546156|Bevacizumab|bevacizumab|mesh-list
153467750|NCT00546156|Doxorubicin|doxorubicin|mesh-list
153467751|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153781813|NCT04558684|Immunologic Factors|immunologic factors|mesh-ancestor
153467752|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467753|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
153467754|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
153467755|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
153467756|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467757|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467758|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
153467759|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467765|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467766|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467767|NCT00546156|Growth Substances|growth substances|mesh-ancestor
153467768|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
153467769|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153467785|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153467787|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153467788|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
153467789|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467790|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467791|NCT00509496|Aldesleukin|aldesleukin|mesh-list
153467792|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
153467793|NCT00509496|Fludarabine|fludarabine|mesh-list
153467794|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
153467795|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467796|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
153467797|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467798|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467799|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467800|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
153467801|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467802|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467803|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153467804|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467805|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
153467806|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153467807|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153467808|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
153467809|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467810|NCT00548418|Bevacizumab|bevacizumab|mesh-list
153467811|NCT00548418|Topotecan|topotecan|mesh-list
153467812|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467813|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467814|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467815|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467816|NCT00548418|Growth Substances|growth substances|mesh-ancestor
153455644|NCT05559476|Vaccines|vaccines|mesh-list
153467817|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467818|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
153467819|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153467820|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467821|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467822|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467823|NCT00511992|Paclitaxel|paclitaxel|mesh-list
153467824|NCT00511992|Bevacizumab|bevacizumab|mesh-list
153467825|NCT00511992|Cisplatin|cisplatin|mesh-list
153905481|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
153467826|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153467827|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467828|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153467829|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153467863|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153467864|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153467909|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153467910|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
153467942|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467943|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467944|NCT00554970|Budesonide|budesonide|mesh-list
153467945|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467946|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153467947|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
153467948|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467949|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467950|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153467951|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
153467952|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
153467953|NCT00554970|Hormones|hormones|mesh-ancestor
153467954|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467955|NCT00524472|Insulin|insulin|mesh-list
153467980|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153467981|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154374527|NCT06107543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467982|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153467983|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467985|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
153467986|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153467987|NCT00525798|Katacalcin|katacalcin|mesh-list
153467988|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153467989|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467990|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153467991|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
153467992|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
153467993|NCT00525876|Rituximab|rituximab|mesh-list
153467994|NCT00525876|Fludarabine|fludarabine|mesh-list
153467995|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
153467996|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
153467997|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467998|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
153467999|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468000|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468001|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468002|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
153468003|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468004|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468005|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153468006|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468030|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153468031|NCT00527124|Prednisone|prednisone|mesh-list
153468032|NCT00527124|Docetaxel|docetaxel|mesh-list
153468033|NCT00527124|Cediranib|cediranib|mesh-list
153468034|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468035|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
153468036|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
153468037|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
153468038|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468068|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468069|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
153468070|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153468071|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153468072|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468073|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153468074|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153468076|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468077|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468078|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
153468079|NCT01797900|Paclitaxel|paclitaxel|mesh-list
153468080|NCT01797900|Cisplatin|cisplatin|mesh-list
153468081|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153468082|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468083|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
153468084|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
153468085|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
153468088|NCT03572790|Laxatives|laxatives|mesh-ancestor
153468089|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153468090|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153468091|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153468092|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
153468093|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468094|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468095|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468096|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
153468097|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468098|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468099|NCT03428802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468100|NCT03428802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468101|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153468102|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468143|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468144|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468146|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468147|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
153813711|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468148|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153468150|NCT02128230|Dexamethasone|dexamethasone|mesh-list
153468151|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
153468152|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
153468153|NCT02128230|Melphalan|melphalan|mesh-list
153468154|NCT02128230|Cisplatin|cisplatin|mesh-list
153468155|NCT02128230|Doxorubicin|doxorubicin|mesh-list
153468156|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153468157|NCT02128230|Etoposide|etoposide|mesh-list
153468158|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
153468159|NCT02128230|Lenalidomide|lenalidomide|mesh-list
153468160|NCT02128230|Lenograstim|lenograstim|mesh-list
153468161|NCT02128230|BB 1101|bb 1101|mesh-list
153468162|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468163|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
153468164|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468174|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468175|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153468177|NCT02128230|Hormones|hormones|mesh-ancestor
153468178|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468179|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153468180|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
153468181|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468182|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153468183|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153468184|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153468195|NCT03416244|Ipilimumab|ipilimumab|mesh-list
153468196|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468197|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468198|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468199|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468200|NCT05560620|Caffeine|caffeine|mesh-list
153468201|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153468202|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468203|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153468204|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468205|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468206|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153468207|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153468208|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
153468209|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468211|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153468212|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153468213|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468214|NCT03172416|Nivolumab|nivolumab|mesh-list
153468215|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
153468216|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468217|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468219|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468220|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
153468221|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153468222|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
153468223|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468224|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
153468225|NCT05559996|Protective Agents|protective agents|mesh-ancestor
153468226|NCT02812212|Diuretics|diuretics|mesh-list
153468227|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
153468228|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468229|NCT05559450|Blinatumomab|blinatumomab|mesh-list
153468230|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360122|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153360123|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360124|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360125|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
153360126|NCT05201612|Olaparib|olaparib|mesh-list
153360127|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468235|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153468236|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153468237|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154157400|NCT05797805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514407|NCT01425658|Narcotics|narcotics|mesh-ancestor
153468238|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468239|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
153470685|NCT05198232|TEMPO|tempo|mesh-list
153468240|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468241|NCT06299462|Cyclophosphamide|cyclophosphamide|mesh-list
153468242|NCT06299462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468243|NCT06299462|Immunologic Factors|immunologic factors|mesh-ancestor
153468244|NCT06299462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468245|NCT06299462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468246|NCT06299462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468247|NCT06299462|Alkylating Agents|alkylating agents|mesh-ancestor
153468258|NCT06299371|Mitosis Modulators|mitosis modulators|mesh-ancestor
153468259|NCT06299371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468260|NCT06299319|Psilocybin|psilocybin|mesh-list
153468261|NCT06299319|Hallucinogens|hallucinogens|mesh-ancestor
153468262|NCT06299319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468263|NCT06299319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153468264|NCT06298968|Gemcitabine|gemcitabine|mesh-list
153468265|NCT06298968|Lenvatinib|lenvatinib|mesh-list
153468266|NCT06298968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468267|NCT06298968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153468268|NCT06298968|Antimetabolites|antimetabolites|mesh-ancestor
153468269|NCT06298968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468270|NCT06298968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153468271|NCT06298968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468272|NCT06298890|Lubricant Eye Drops|lubricant eye drops|mesh-list
153468273|NCT06298890|Hyaluronic Acid|hyaluronic acid|mesh-list
153468274|NCT06298890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153468275|NCT06298890|Immunologic Factors|immunologic factors|mesh-ancestor
153468276|NCT06298890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468277|NCT06298890|Viscosupplements|viscosupplements|mesh-ancestor
153468278|NCT06298890|Protective Agents|protective agents|mesh-ancestor
153813712|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813713|NCT00436839|Prednisone|prednisone|mesh-list
153813714|NCT00436839|Docetaxel|docetaxel|mesh-list
153813715|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
153813716|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813717|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
153813718|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813728|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
153813729|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468279|NCT06298890|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153468280|NCT06298890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153468282|NCT06298383|Diclofenac|diclofenac|mesh-list
153468283|NCT06298383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468284|NCT06298383|Glucocorticoids|glucocorticoids|mesh-ancestor
153468285|NCT06298383|Hormones|hormones|mesh-ancestor
153468286|NCT06298383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468287|NCT06298383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468288|NCT06298383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153468289|NCT06298383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468290|NCT06298383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468291|NCT06298383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153468294|NCT06298383|Sensory System Agents|sensory system agents|mesh-ancestor
153468295|NCT06298383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468296|NCT06298383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153468297|NCT06298383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468298|NCT06298383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468299|NCT06298370|Morphine|morphine|mesh-list
153468300|NCT06298370|Bupivacaine|bupivacaine|mesh-list
153468301|NCT06298370|Anesthetics|anesthetics|mesh-list
153468302|NCT06298370|Anesthetics, Local|anesthetics, local|mesh-ancestor
153468303|NCT06298370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468304|NCT06298370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468305|NCT06298370|Sensory System Agents|sensory system agents|mesh-ancestor
153468306|NCT06298370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468307|NCT06298370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153468308|NCT06298370|Narcotics|narcotics|mesh-ancestor
153468309|NCT06298370|Analgesics|analgesics|mesh-ancestor
153468310|NCT06298344|Thiamine|thiamine|mesh-list
153468311|NCT06298344|Vitamins|vitamins|mesh-ancestor
153468312|NCT06298344|Micronutrients|micronutrients|mesh-ancestor
153468313|NCT06298344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468314|NCT06298344|Vitamin B Complex|vitamin b complex|mesh-ancestor
153468328|NCT06298071|Abortifacient Agents|abortifacient agents|mesh-ancestor
153468329|NCT06298071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153468330|NCT06298071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468332|NCT06298071|Antimetabolites|antimetabolites|mesh-ancestor
153468333|NCT06298071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468334|NCT06298071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468335|NCT06298071|Dermatologic Agents|dermatologic agents|mesh-ancestor
153468336|NCT06298071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468337|NCT06298071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153468338|NCT06298071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468339|NCT06298071|Immunologic Factors|immunologic factors|mesh-ancestor
153468340|NCT06298071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468341|NCT06298071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153468342|NCT06297954|Metoclopramide|metoclopramide|mesh-list
153468343|NCT06297954|Antiemetics|antiemetics|mesh-ancestor
153468344|NCT06297954|Autonomic Agents|autonomic agents|mesh-ancestor
153468345|NCT06297954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468346|NCT06297954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468358|NCT06297915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468359|NCT06297915|Sensory System Agents|sensory system agents|mesh-ancestor
153468360|NCT06297915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468361|NCT06297915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153468362|NCT06297915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153468363|NCT06297915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153468364|NCT06297915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153468365|NCT06297915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468366|NCT06297915|Analgesics|analgesics|mesh-ancestor
153360139|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153360140|NCT01354145|Analgesics|analgesics|mesh-ancestor
153360141|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
153360142|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360143|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360144|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360145|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360146|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153360147|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153360148|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514586|NCT05113615|Bromides|bromides|mesh-list
153514600|NCT04850378|Dalteparin|dalteparin|mesh-list
153468367|NCT06297915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153468369|NCT06297915|Anesthetics, General|anesthetics, general|mesh-ancestor
153468370|NCT06297915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153468371|NCT06297915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153468372|NCT06297915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468373|NCT06297811|Paclitaxel|paclitaxel|mesh-list
153468374|NCT06297811|Carboplatin|carboplatin|mesh-list
153468375|NCT06297811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153468376|NCT06297811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468383|NCT06297681|Bortezomib|bortezomib|mesh-list
153468384|NCT06297681|Daratumumab|daratumumab|mesh-list
153468385|NCT06297681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468386|NCT06297681|Antiemetics|antiemetics|mesh-ancestor
153468390|NCT06297681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153468392|NCT06297681|Hormones|hormones|mesh-ancestor
153468393|NCT06297681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468394|NCT06297681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153468395|NCT06297681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468396|NCT06297681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153468397|NCT06297681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468398|NCT06297681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153468399|NCT06297655|Factor VIII|factor viii|mesh-list
153468400|NCT06297655|Coagulants|coagulants|mesh-ancestor
153468401|NCT06297629|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153468402|NCT06297629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153468403|NCT06297629|Antimetabolites|antimetabolites|mesh-ancestor
153468404|NCT06297629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468405|NCT06297629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468418|NCT06297512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468419|NCT06297512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468420|NCT06297512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468421|NCT06297512|Alkylating Agents|alkylating agents|mesh-ancestor
153468422|NCT06297408|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153468423|NCT06297408|Immunologic Factors|immunologic factors|mesh-ancestor
153468424|NCT06297408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468425|NCT06297369|Acetylcysteine|acetylcysteine|mesh-list
153468426|NCT06297369|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154374529|NCT06107543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813730|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153813731|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153813732|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813734|NCT00335075|Semustine|semustine|mesh-list
153813735|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153813736|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
153813737|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813738|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813739|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
153813740|NCT00436995|Hematinics|hematinics|mesh-ancestor
153468427|NCT06297369|Antiviral Agents|antiviral agents|mesh-ancestor
153468428|NCT06297369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468429|NCT06297369|Expectorants|expectorants|mesh-ancestor
153468430|NCT06297369|Respiratory System Agents|respiratory system agents|mesh-ancestor
153468431|NCT06297369|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153468432|NCT06297369|Antioxidants|antioxidants|mesh-ancestor
153468433|NCT06297369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468434|NCT06297369|Protective Agents|protective agents|mesh-ancestor
153468435|NCT06297369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468436|NCT06297369|Antidotes|antidotes|mesh-ancestor
153468437|NCT06297174|Racecadotril|racecadotril|mesh-list
153468438|NCT06297174|Thiorphan|thiorphan|mesh-list
153468439|NCT06297174|Antidiarrheals|antidiarrheals|mesh-ancestor
153468440|NCT06297174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153468441|NCT06297174|Protease Inhibitors|protease inhibitors|mesh-ancestor
153468442|NCT06297174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468443|NCT06297174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468444|NCT06297161|Bosutinib|bosutinib|mesh-list
153468445|NCT06297161|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153468446|NCT06297161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153468455|NCT06295562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153468456|NCT06295562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468458|NCT06295562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468459|NCT06295562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153468460|NCT06295562|Antidepressive Agents|antidepressive agents|mesh-ancestor
153468461|NCT06295562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153468462|NCT06295562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153468463|NCT06295562|Adrenergic Agents|adrenergic agents|mesh-ancestor
153468464|NCT06295562|Parasympatholytics|parasympatholytics|mesh-ancestor
153468465|NCT06295562|Autonomic Agents|autonomic agents|mesh-ancestor
153468507|NCT06292546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153468508|NCT06292546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468509|NCT06286046|Mitapivat|mitapivat|mesh-list
153468510|NCT06286046|Enzyme Activators|enzyme activators|mesh-ancestor
153468520|NCT06285396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153468521|NCT06285396|Mydriatics|mydriatics|mesh-ancestor
153468522|NCT06285396|Autonomic Agents|autonomic agents|mesh-ancestor
153468523|NCT06285396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468524|NCT06285396|Sympathomimetics|sympathomimetics|mesh-ancestor
153468540|NCT06282848|Autonomic Agents|autonomic agents|mesh-ancestor
153468541|NCT06282848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468542|NCT06282848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468543|NCT06282848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153468544|NCT06282848|Respiratory System Agents|respiratory system agents|mesh-ancestor
153468546|NCT06282848|Parasympatholytics|parasympatholytics|mesh-ancestor
153468547|NCT06282848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153468548|NCT06282848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153468549|NCT06282848|Cholinergic Agents|cholinergic agents|mesh-ancestor
153468550|NCT06282848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468551|NCT06282848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468566|NCT06277609|Aspirin|aspirin|mesh-list
153468567|NCT06277609|Amoxicillin|amoxicillin|mesh-list
153468568|NCT06277609|Clavulanic Acids|clavulanic acids|mesh-list
153468569|NCT06277609|Clavulanic Acid|clavulanic acid|mesh-list
153468570|NCT06277609|Mefenamic Acid|mefenamic acid|mesh-list
153468571|NCT06277609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153468572|NCT06277609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468573|NCT06277609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153468574|NCT06277609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153468575|NCT06277609|Analgesics|analgesics|mesh-ancestor
153468576|NCT06277609|Sensory System Agents|sensory system agents|mesh-ancestor
153468581|NCT06277609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153468582|NCT06277609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153468583|NCT06277609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468601|NCT06261827|Nitric Oxide|nitric oxide|mesh-list
153468602|NCT06261827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153468603|NCT06261827|Autonomic Agents|autonomic agents|mesh-ancestor
153468604|NCT06261827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468605|NCT06261827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468606|NCT06261827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153468607|NCT06261827|Respiratory System Agents|respiratory system agents|mesh-ancestor
153468608|NCT06261827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153468610|NCT06261827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468611|NCT06261827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468612|NCT06261827|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153468613|NCT06261827|Vasodilator Agents|vasodilator agents|mesh-ancestor
153468614|NCT06261827|Gasotransmitters|gasotransmitters|mesh-ancestor
153468615|NCT06261827|Protective Agents|protective agents|mesh-ancestor
153468616|NCT06261060|Sirolimus|sirolimus|mesh-list
153468617|NCT06261060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153468618|NCT06261060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468619|NCT06261060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153468620|NCT06261060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468621|NCT06261060|Antifungal Agents|antifungal agents|mesh-ancestor
153468622|NCT06261060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468623|NCT06261060|Immunologic Factors|immunologic factors|mesh-ancestor
153468624|NCT06261060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468625|NCT06259721|Capecitabine|capecitabine|mesh-list
153468626|NCT06259721|Nimotuzumab|nimotuzumab|mesh-list
153468627|NCT06259721|Antibodies|antibodies|mesh-list
153468628|NCT06259721|Immunologic Factors|immunologic factors|mesh-ancestor
153468629|NCT06259721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468630|NCT06259721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153468631|NCT06259721|Antimetabolites|antimetabolites|mesh-ancestor
153468632|NCT06259721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468633|NCT06259721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468634|NCT06259721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468635|NCT06236425|Aldesleukin|aldesleukin|mesh-list
153468636|NCT06236425|Cyclophosphamide|cyclophosphamide|mesh-list
153468637|NCT06236425|Cisplatin|cisplatin|mesh-list
153468638|NCT06236425|Carboplatin|carboplatin|mesh-list
153468639|NCT06236425|Pembrolizumab|pembrolizumab|mesh-list
153468682|NCT06207799|Growth Substances|growth substances|mesh-ancestor
153468683|NCT06207799|Growth Inhibitors|growth inhibitors|mesh-ancestor
153468684|NCT06207799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468685|NCT06207799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468686|NCT06207799|Alkylating Agents|alkylating agents|mesh-ancestor
153468687|NCT06207799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468688|NCT06207799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153468689|NCT06207799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514793|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153468690|NCT06207799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153468691|NCT06207799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153468692|NCT06207799|Antiviral Agents|antiviral agents|mesh-ancestor
153468693|NCT06207799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468694|NCT06191796|Nivolumab|nivolumab|mesh-list
153468695|NCT06191796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468696|NCT06191796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468697|NCT06191796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468698|NCT06191796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468699|NCT06180382|Adalimumab|adalimumab|mesh-list
153468714|NCT06172257|Glucocorticoids|glucocorticoids|mesh-ancestor
153468715|NCT06172257|Hormones|hormones|mesh-ancestor
153468716|NCT06172257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468717|NCT06172257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153468718|NCT06172257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468719|NCT06172257|Protease Inhibitors|protease inhibitors|mesh-ancestor
153468720|NCT06172257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468721|NCT06172257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468722|NCT06171659|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153468723|NCT06171659|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153468724|NCT06171659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468725|NCT06170788|Pembrolizumab|pembrolizumab|mesh-list
153468726|NCT06170788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468728|NCT06170788|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468729|NCT06170788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468730|NCT06150183|Pembrolizumab|pembrolizumab|mesh-list
153468731|NCT06150183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468732|NCT06150183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468733|NCT06150183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468734|NCT06150183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468735|NCT06125340|Amoxicillin|amoxicillin|mesh-list
153468743|NCT06112314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468745|NCT06094998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153468746|NCT06094998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468747|NCT06093672|Hydroxyurea|hydroxyurea|mesh-list
153468748|NCT06093672|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
153468749|NCT06093672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468750|NCT06093672|Antisickling Agents|antisickling agents|mesh-ancestor
153468751|NCT06093672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468752|NCT06093672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468753|NCT06093672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153468754|NCT06093672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153468755|NCT06085638|Azacitidine|azacitidine|mesh-list
153468756|NCT06085638|Venetoclax|venetoclax|mesh-list
153468757|NCT06085638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153468758|NCT06085638|Antimetabolites|antimetabolites|mesh-ancestor
153468759|NCT06085638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468760|NCT06085638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468768|NCT06058299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514883|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153468769|NCT06058299|Antitubercular Agents|antitubercular agents|mesh-ancestor
153468771|NCT06055244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153468772|NCT06055244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153468773|NCT06055244|Antiviral Agents|antiviral agents|mesh-ancestor
153468774|NCT06055244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468775|NCT06055244|Dopamine Agents|dopamine agents|mesh-ancestor
153468776|NCT06055244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468777|NCT06055244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468778|NCT06055244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468779|NCT06055244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153468780|NCT06055244|Analgesics|analgesics|mesh-ancestor
153468781|NCT06055244|Sensory System Agents|sensory system agents|mesh-ancestor
153468782|NCT06055244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468783|NCT06054555|Nivolumab|nivolumab|mesh-list
153468784|NCT06054555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468785|NCT06054555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468786|NCT06054555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468787|NCT06054555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468789|NCT06053801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153468790|NCT06053801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153468791|NCT06053801|Respiratory System Agents|respiratory system agents|mesh-ancestor
153468792|NCT06036745|Pembrolizumab|pembrolizumab|mesh-list
153468793|NCT06036745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468794|NCT06036745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468795|NCT06036745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468796|NCT06036745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468797|NCT06031233|Bevacizumab|bevacizumab|mesh-list
153468798|NCT06031233|Pembrolizumab|pembrolizumab|mesh-list
153468799|NCT06031233|Nivolumab|nivolumab|mesh-list
153468800|NCT06031233|Trastuzumab|trastuzumab|mesh-list
153468801|NCT06031233|Ipilimumab|ipilimumab|mesh-list
153468802|NCT06031233|Atezolizumab|atezolizumab|mesh-list
153468803|NCT06031233|Durvalumab|durvalumab|mesh-list
153468804|NCT06031233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468805|NCT06031233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468806|NCT06031233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153468807|NCT06031233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153468808|NCT06031233|Growth Substances|growth substances|mesh-ancestor
153468809|NCT06031233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468810|NCT06031233|Growth Inhibitors|growth inhibitors|mesh-ancestor
153468811|NCT06031233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468849|NCT05948267|Anesthetics, Local|anesthetics, local|mesh-ancestor
153468850|NCT05948267|Anesthetics|anesthetics|mesh-ancestor
153468851|NCT05948267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468852|NCT05948267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468853|NCT05948267|Sensory System Agents|sensory system agents|mesh-ancestor
153468854|NCT05948267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468855|NCT05948267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153468856|NCT05948267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153468857|NCT05948267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153468858|NCT05948267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153468859|NCT05948267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468860|NCT05948267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153468861|NCT05948267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153468862|NCT05948267|Anesthetics, General|anesthetics, general|mesh-ancestor
153468863|NCT05948267|Analgesics|analgesics|mesh-ancestor
153468864|NCT05948267|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153468865|NCT05948267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153468866|NCT05948267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153468867|NCT05948267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468868|NCT05948267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153468869|NCT05948267|Narcotics|narcotics|mesh-ancestor
153514946|NCT01426490|Protective Agents|protective agents|mesh-ancestor
153468870|NCT05948267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153468871|NCT05945732|Trastuzumab|trastuzumab|mesh-list
153468872|NCT05945732|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153468873|NCT05945732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468874|NCT05945732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468875|NCT05945732|Immunoconjugates|immunoconjugates|mesh-ancestor
153468876|NCT05945732|Immunologic Factors|immunologic factors|mesh-ancestor
153468877|NCT05945732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468878|NCT05931718|Epoetin Alfa|epoetin alfa|mesh-list
153468879|NCT05931718|Luspatercept|luspatercept|mesh-list
153468907|NCT05901519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468908|NCT05901519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468909|NCT05901519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153468910|NCT05901519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468912|NCT05899816|Dermatologic Agents|dermatologic agents|mesh-ancestor
153468913|NCT05877027|Diclofenac|diclofenac|mesh-list
153468914|NCT05877027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153468915|NCT05877027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153468916|NCT05877027|Analgesics|analgesics|mesh-ancestor
153468917|NCT05877027|Sensory System Agents|sensory system agents|mesh-ancestor
153468918|NCT05877027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468919|NCT05877027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468920|NCT05877027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468921|NCT05877027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468922|NCT05877027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153468923|NCT05877027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468924|NCT05877027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468931|NCT05822830|Semaglutide|semaglutide|mesh-list
153468932|NCT05822830|Tirzepatide|tirzepatide|mesh-list
153468933|NCT05822830|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153468934|NCT05822830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153468935|NCT05822830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468936|NCT05822830|Incretins|incretins|mesh-ancestor
153468937|NCT05822830|Hormones|hormones|mesh-ancestor
153468938|NCT05822830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468939|NCT05813925|Semaglutide|semaglutide|mesh-list
153468940|NCT05813925|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153468941|NCT05813925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153468942|NCT05813925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468943|NCT05780879|Venetoclax|venetoclax|mesh-list
153468944|NCT05780879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468945|NCT05769855|Ropivacaine|ropivacaine|mesh-list
153468946|NCT05769855|Anesthetics, Local|anesthetics, local|mesh-ancestor
153468947|NCT05769855|Anesthetics|anesthetics|mesh-ancestor
153468948|NCT05769855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468949|NCT05769855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468950|NCT05769855|Sensory System Agents|sensory system agents|mesh-ancestor
153468951|NCT05769855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468963|NCT05742438|Morphine|morphine|mesh-list
153468964|NCT05742438|Anesthetics, Local|anesthetics, local|mesh-ancestor
153468965|NCT05742438|Anesthetics|anesthetics|mesh-ancestor
153468966|NCT05742438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468967|NCT05742438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468968|NCT05742438|Sensory System Agents|sensory system agents|mesh-ancestor
153468969|NCT05742438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468995|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468996|NCT05696613|Rituximab|rituximab|mesh-list
153468997|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153468998|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468999|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469000|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
153469001|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469002|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469003|NCT05696613|Hormones|hormones|mesh-ancestor
153469004|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469005|NCT05691478|Cisplatin|cisplatin|mesh-list
153469006|NCT05691478|Doxorubicin|doxorubicin|mesh-list
153469007|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153469052|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153469054|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469055|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153469056|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469057|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360149|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360150|NCT05168462|Norepinephrine|norepinephrine|mesh-list
153360151|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153360152|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153360153|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
153360154|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360155|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360156|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360157|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
153360158|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
153360159|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360160|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153469112|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469113|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
153469114|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469115|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
153469131|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469132|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469133|NCT05549297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469134|NCT05549297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469135|NCT05548647|Semaglutide|semaglutide|mesh-list
153469136|NCT05548647|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153469137|NCT05548647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153469138|NCT05548647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469139|NCT05520775|Semaglutide|semaglutide|mesh-list
153469140|NCT05520775|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153469153|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153469154|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469155|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469157|NCT05501054|Ipilimumab|ipilimumab|mesh-list
153626855|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626856|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626857|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
153626858|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626859|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
153626860|NCT02019355|Emollients|emollients|mesh-ancestor
153626862|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
153626863|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
153626864|NCT02019381|Vitamins|vitamins|mesh-list
153626865|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
153626866|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626867|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153626868|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153626869|NCT02019394|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
153626870|NCT02019394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153626872|NCT02019394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626873|NCT02019394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626874|NCT02019394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626875|NCT02019446|Terbinafine|terbinafine|mesh-list
153626876|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
153626877|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626878|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626879|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626880|NCT02019459|Nicotine|nicotine|mesh-list
153626881|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153626882|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
153626883|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626884|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626885|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153626886|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153626887|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
153626888|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626889|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626919|NCT02019797|Desflurane|desflurane|mesh-list
153626920|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153626921|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
153626922|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
153626923|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626924|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626925|NCT02019810|Dobutamine|dobutamine|mesh-list
153626926|NCT02019810|Norepinephrine|norepinephrine|mesh-list
153626927|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153626928|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153626929|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
153626930|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626931|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626932|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626933|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
153626934|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
153626935|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626936|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153626937|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153626938|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153626939|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153626956|NCT02020122|Pregabalin|pregabalin|mesh-list
153626957|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153626958|NCT02020122|Analgesics|analgesics|mesh-ancestor
153626959|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
153515284|NCT01428427|Trametinib|trametinib|mesh-list
153515285|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626960|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626961|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626962|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
153626963|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153626964|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626965|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626966|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153626967|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153626968|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153626969|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626970|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153626971|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153626972|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153626973|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626974|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
153626975|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
153626976|NCT02020161|Methotrexate|methotrexate|mesh-list
153626977|NCT02020161|Idarubicin|idarubicin|mesh-list
153626978|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153626979|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
153626980|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153626981|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626982|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626983|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
153626984|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626985|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626986|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
153626987|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626988|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153626989|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626990|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
153626991|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153626992|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153626993|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153626994|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153626995|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153626996|NCT02020200|Methylphenidate|methylphenidate|mesh-list
153626997|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153627014|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627015|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153627016|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
153627017|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627018|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627019|NCT02020330|Lumefantrine|lumefantrine|mesh-list
153627021|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153627022|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
153627023|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153627024|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153627025|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627026|NCT02020499|Lanreotide|lanreotide|mesh-list
153627027|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627028|NCT02020551|Lidocaine|lidocaine|mesh-list
153627029|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
153781815|NCT00231959|Pramipexole|pramipexole|mesh-list
153781816|NCT00231959|Dexpramipexole|dexpramipexole|mesh-list
153515412|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
153627030|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
153627031|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627032|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627033|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
153627034|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627035|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153627036|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153627037|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153627038|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627039|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627040|NCT02020603|Epinephrine|epinephrine|mesh-list
153627041|NCT02020603|Racepinephrine|racepinephrine|mesh-list
153627042|NCT02020603|Hemostatics|hemostatics|mesh-list
153627043|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
153627044|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153627045|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153627046|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
153627047|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627048|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627049|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627050|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153627051|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153627052|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
153627053|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627089|NCT02021097|Estradiol|estradiol|mesh-list
153627090|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153627091|NCT02021097|Estrogens|estrogens|mesh-ancestor
153627092|NCT02021097|Hormones|hormones|mesh-ancestor
153627093|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627106|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
153627107|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627109|NCT02021201|Sertindole|sertindole|mesh-list
153627110|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153627111|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
153627112|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627113|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627114|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627115|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153627116|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153627117|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627118|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153627119|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153627120|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
153627121|NCT02021214|Methylphenidate|methylphenidate|mesh-list
153627122|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153627123|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627124|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153781817|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
153627126|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627127|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627128|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
153627129|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627130|NCT02021240|Dexamethasone|dexamethasone|mesh-list
153627131|NCT02021240|Ketamine|ketamine|mesh-list
153627132|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627133|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
153627134|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
153627135|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627136|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627137|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153627138|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
153627139|NCT02021240|Hormones|hormones|mesh-ancestor
153627140|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627141|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153627142|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627143|NCT02021240|Analgesics|analgesics|mesh-ancestor
153627144|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
153627145|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153627146|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153627147|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
153627148|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
153627149|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627150|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153627151|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153627152|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627153|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627168|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
153627169|NCT02021422|Irinotecan|irinotecan|mesh-list
153627170|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153627171|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
153627172|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627173|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627174|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627175|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627176|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
153627177|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627178|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153627179|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153627180|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627181|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153627182|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153627183|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627184|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
153627185|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627186|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627187|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
153627188|NCT02021825|Analgesics|analgesics|mesh-ancestor
153627189|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
153627190|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627191|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627192|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515547|NCT01429870|Triamcinolone|triamcinolone|mesh-list
153627193|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153627194|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153627195|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627196|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627197|NCT02021851|Dexamethasone|dexamethasone|mesh-list
153627198|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
153627199|NCT02021851|Ondansetron|ondansetron|mesh-list
153627200|NCT02021851|Aprepitant|aprepitant|mesh-list
153627201|NCT02021851|BB 1101|bb 1101|mesh-list
153627202|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627203|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
153627204|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
153627205|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627206|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627207|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153627208|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
153627209|NCT02021851|Hormones|hormones|mesh-ancestor
153627210|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627212|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627238|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153627239|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
153627240|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153627241|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
153627242|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627243|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627244|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153627245|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153627246|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815737|NCT03274323|Travoprost|travoprost|mesh-list
153627247|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153627248|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
153627249|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153627250|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
153627251|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627252|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627253|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153627254|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153627255|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627257|NCT02022254|Semaglutide|semaglutide|mesh-list
153627258|NCT02022254|Warfarin|warfarin|mesh-list
153627259|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153627260|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627261|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
153627262|NCT02022254|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153627263|NCT02022293|Atorvastatin|atorvastatin|mesh-list
153627277|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627278|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627279|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627280|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
153627281|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627282|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627283|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
153627284|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627285|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153627286|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627287|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
153627288|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153627289|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153627291|NCT02022358|Protective Agents|protective agents|mesh-ancestor
153627292|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
153627293|NCT02022358|Vitamins|vitamins|mesh-ancestor
153627294|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
153627295|NCT02022358|Hematinics|hematinics|mesh-ancestor
153627296|NCT02022475|Vitamin D|vitamin d|mesh-list
153627297|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
153627298|NCT02022475|Vitamins|vitamins|mesh-ancestor
153627299|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
153627300|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627301|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153627302|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153627303|NCT02022488|Midazolam|midazolam|mesh-list
153627304|NCT02022488|Ketamine|ketamine|mesh-list
153627305|NCT02022488|Alfentanil|alfentanil|mesh-list
153627306|NCT02022488|Analgesics|analgesics|mesh-ancestor
153627307|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
153627308|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627309|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627310|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153627311|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153627312|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
153627313|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
153627314|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627315|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153627316|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153627317|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627318|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627319|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153627320|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153627321|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153627322|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153627323|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153627342|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627343|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153627345|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627346|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
153627347|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
153627348|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627349|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
153627350|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
153627351|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
153627352|NCT02022540|Ranibizumab|ranibizumab|mesh-list
153627353|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153627354|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153627355|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153627356|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153627357|NCT02022540|Growth Substances|growth substances|mesh-ancestor
153627358|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627359|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
153627360|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627361|NCT02022722|Triamcinolone|triamcinolone|mesh-list
153627362|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153627363|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153627364|NCT02022722|Bupivacaine|bupivacaine|mesh-list
153627365|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153627366|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
153627367|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
153627368|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627369|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627370|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
153627371|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627372|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627373|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
153627374|NCT02022722|Hormones|hormones|mesh-ancestor
153627375|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627376|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627377|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
153627378|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627379|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627380|NCT02022761|Laninamivir|laninamivir|mesh-list
153627381|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
153627382|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627383|NCT02022852|Capecitabine|capecitabine|mesh-list
153627384|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627400|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627401|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
153627402|NCT02022930|Hormones|hormones|mesh-ancestor
153627403|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627404|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627405|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627406|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
153627407|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627408|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627409|NCT02023021|Paclitaxel|paclitaxel|mesh-list
153627410|NCT02023021|Gemcitabine|gemcitabine|mesh-list
153627411|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153627412|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627413|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
153627414|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
153627415|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
153627416|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627417|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627418|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
153627419|NCT02023047|Nifedipine|nifedipine|mesh-list
153627420|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153627421|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627422|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627423|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153627424|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627425|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
153627426|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
153627427|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627428|NCT02023086|Tropicamide|tropicamide|mesh-list
153627431|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627432|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627433|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153627434|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153627435|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
153627436|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627437|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627438|NCT02023359|Everolimus|everolimus|mesh-list
153627439|NCT02023359|Exemestane|exemestane|mesh-list
153627440|NCT02023359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153627441|NCT02023359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153627442|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627466|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627468|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153815784|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153627469|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
153627470|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627471|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153627472|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153627473|NCT02023554|Azithromycin|azithromycin|mesh-list
153627474|NCT02023554|Theophylline|theophylline|mesh-list
153627475|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153627476|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627477|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153627478|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
153627479|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627480|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627481|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153627482|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
153627483|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153627484|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627485|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627486|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
153627487|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153627488|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153627489|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
153627490|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627491|NCT02023567|Serotonin|serotonin|mesh-list
153627492|NCT02023567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153627509|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153627510|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153627511|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627512|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627513|NCT02023710|Paclitaxel|paclitaxel|mesh-list
153627514|NCT02023710|Bevacizumab|bevacizumab|mesh-list
153627515|NCT02023710|Carboplatin|carboplatin|mesh-list
153627516|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153627517|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627518|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
153627519|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
153627520|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
153627521|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627522|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153627523|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153627524|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153515882|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
153627525|NCT02023710|Growth Substances|growth substances|mesh-ancestor
153627526|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627527|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
153627528|NCT02023840|Metronidazole|metronidazole|mesh-list
153627529|NCT02023840|Erythritol|erythritol|mesh-list
153627530|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627531|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153627532|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153627533|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153627534|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
153627535|NCT02023853|Metronidazole|metronidazole|mesh-list
153627536|NCT02023853|Erythritol|erythritol|mesh-list
153627537|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627538|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153627539|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153627540|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153627541|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
153627542|NCT02023892|Atorvastatin|atorvastatin|mesh-list
153627543|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153627544|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153627545|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
153627546|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627547|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153627548|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153627549|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627564|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627566|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
153627567|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153627568|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153627569|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
153627570|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627571|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153627573|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
153627574|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627575|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
153627576|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
153627577|NCT02024022|Cathartics|cathartics|mesh-ancestor
153627578|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153627579|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
153627580|NCT02024217|Tegafur|tegafur|mesh-list
153627581|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424145|NCT03961100|Entrectinib|entrectinib|mesh-list
153627582|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627583|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
153627584|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627585|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
153627586|NCT02024256|Analgesics|analgesics|mesh-ancestor
153627587|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
153627588|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627589|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627590|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
153627591|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627592|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153627593|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
153627594|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153627595|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627596|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627597|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153627598|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
153627599|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627600|NCT02024295|Choline|choline|mesh-list
153627601|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
153627602|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
153627603|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153627604|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
153627605|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627606|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153627607|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153627608|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
153627609|NCT02024308|Cytarabine|cytarabine|mesh-list
153627610|NCT02024308|Fludarabine|fludarabine|mesh-list
153627611|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627622|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627623|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627624|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
153627625|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627626|NCT02024373|Atorvastatin|atorvastatin|mesh-list
153627627|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153627628|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153627629|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
153627630|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627631|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153627632|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153627633|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627634|NCT02024425|Antioxidants|antioxidants|mesh-list
153627635|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627636|NCT02024425|Protective Agents|protective agents|mesh-ancestor
153627637|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627638|NCT02024555|Azithromycin|azithromycin|mesh-list
153627639|NCT02024555|Levofloxacin|levofloxacin|mesh-list
153627640|NCT02024555|Rifampin|rifampin|mesh-list
153627641|NCT02024555|Ethambutol|ethambutol|mesh-list
153627642|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153627643|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627644|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153627645|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153627646|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153627647|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627648|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627649|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627650|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153627651|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153360685|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153515997|NCT01432873|Selenium|selenium|mesh-list
153627652|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153627653|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
153627654|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
153627655|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154374530|NCT06107543|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153815830|NCT00449553|Metformin|metformin|mesh-list
153627656|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153627657|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153627658|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153627659|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153627660|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153627661|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153627663|NCT02024568|Analgesics|analgesics|mesh-ancestor
153627664|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
153627665|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627666|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627667|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
153627668|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153627669|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627670|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627671|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153627672|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153627673|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153627695|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627696|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627697|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153627698|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
153627699|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
153627701|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627702|NCT02024841|Docetaxel|docetaxel|mesh-list
153627703|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627704|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
153627705|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
153627706|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
153627707|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627708|NCT02024906|Caseins|caseins|mesh-list
153627709|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
153627710|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
153627711|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627712|NCT02024919|Diltiazem|diltiazem|mesh-list
153782019|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153516126|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
153627713|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153627714|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153627715|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627716|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627717|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153627718|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627719|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
153627720|NCT02024945|Propiverine|propiverine|mesh-list
153627721|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
153627722|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
153627723|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627724|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627725|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153627739|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
153627740|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627741|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153627742|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153627743|NCT02025023|Triamcinolone|triamcinolone|mesh-list
153627744|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153627745|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153627746|NCT02025023|Fluorouracil|fluorouracil|mesh-list
153627747|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153627748|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
153627749|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627750|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627751|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627752|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627753|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
153627754|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627755|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627756|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
153627757|NCT02025023|Hormones|hormones|mesh-ancestor
153627758|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627759|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627760|NCT02025140|Anesthetics|anesthetics|mesh-list
153627761|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627762|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627763|NCT02025166|Acetaminophen|acetaminophen|mesh-list
153627764|NCT02025166|Lornoxicam|lornoxicam|mesh-list
153627765|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153627766|NCT02025166|Analgesics|analgesics|mesh-ancestor
153627767|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
153627768|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627769|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627770|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
153516174|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627771|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153627772|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627773|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153627774|NCT02025192|Capecitabine|capecitabine|mesh-list
153627775|NCT02025192|Trastuzumab|trastuzumab|mesh-list
153627776|NCT02025192|Tucatinib|tucatinib|mesh-list
153627777|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627778|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
153627779|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627780|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627781|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153627782|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153627783|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627784|NCT02025218|Gefitinib|gefitinib|mesh-list
153627785|NCT02025218|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153627786|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153627805|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
153627806|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627807|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627808|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
153627809|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627810|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153627811|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153627812|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153627813|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627814|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627815|NCT02025374|Bupivacaine|bupivacaine|mesh-list
153627816|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
153627817|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
153627818|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
153627819|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627820|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627821|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
153627822|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627823|NCT02025465|Metoprolol|metoprolol|mesh-list
153627824|NCT02025465|Diltiazem|diltiazem|mesh-list
153627825|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153627826|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153627827|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
153627828|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
153627829|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627830|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627831|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153627832|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153627833|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153627834|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
153627835|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627836|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627837|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153627838|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627839|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153627870|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153627871|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153627872|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153627873|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
153627874|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627876|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627877|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
154374531|NCT06107543|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154374532|NCT06107543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154374533|NCT06107543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154374534|NCT06107543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374535|NCT06107153|Metformin|metformin|mesh-list
154374536|NCT06107153|Insulin Glargine|insulin glargine|mesh-list
154374537|NCT06107153|Pioglitazone|pioglitazone|mesh-list
154374538|NCT06107153|Saxagliptin|saxagliptin|mesh-list
154374539|NCT06107153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153626748|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627878|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627879|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627880|NCT02025855|Methadone|methadone|mesh-list
153627881|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153627882|NCT02025855|Narcotics|narcotics|mesh-ancestor
153627883|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627884|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627885|NCT02025855|Analgesics|analgesics|mesh-ancestor
153627886|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
153627913|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627915|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153627916|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153627917|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153627918|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153627919|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627920|NCT02025998|Ibudilast|ibudilast|mesh-list
153627921|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153627922|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
153627923|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627924|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627925|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153627926|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
153627927|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153627928|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627929|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627930|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153627931|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
153627932|NCT02026050|Dexamethasone|dexamethasone|mesh-list
153627933|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
153627934|NCT02026050|BB 1101|bb 1101|mesh-list
153627935|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627952|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153627953|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153627954|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153627955|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
153627956|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627957|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627958|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627959|NCT02026310|Metformin|metformin|mesh-list
153627960|NCT02026310|Glimepiride|glimepiride|mesh-list
153627961|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153627962|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516359|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153516361|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153627963|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153627964|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627965|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
153627966|NCT02026479|Dexamethasone|dexamethasone|mesh-list
153627967|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
153627968|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153627969|NCT02026479|BB 1101|bb 1101|mesh-list
153627970|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627971|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
153627972|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
153627973|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627974|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627976|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
153627977|NCT02026479|Hormones|hormones|mesh-ancestor
153627978|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627979|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153627980|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627981|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
153627982|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627983|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627984|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
153627986|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
153627987|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627988|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627989|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153627990|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153627991|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
153627992|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153627993|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153628006|NCT02026583|Simvastatin|simvastatin|mesh-list
153628007|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153628008|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153628009|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
153628010|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628011|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153628012|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153628013|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628015|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
153628016|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153628017|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153628018|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628019|NCT02026778|Betahistine|betahistine|mesh-list
153628020|NCT02026778|Ondansetron|ondansetron|mesh-list
153628021|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
153516431|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516436|NCT01435837|Caffeine|caffeine|mesh-list
153628022|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
153628023|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628024|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628025|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628026|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
153628027|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
153628028|NCT02026778|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153628029|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153628030|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
153628031|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628032|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628033|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
153628034|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
153628035|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
153628036|NCT02026817|Metformin|metformin|mesh-list
153628037|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153628038|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628039|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628040|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153628041|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153628042|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
153628043|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628044|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153628045|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153628046|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628047|NCT02026856|Selenious Acid|selenious acid|mesh-list
153628048|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
153628049|NCT02026856|Trace Elements|trace elements|mesh-ancestor
153628050|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
153628051|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628052|NCT02026869|Metformin|metformin|mesh-list
153628053|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628054|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628055|NCT02026921|Carboplatin|carboplatin|mesh-list
153628056|NCT02026921|Docetaxel|docetaxel|mesh-list
153628057|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628075|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153628076|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153628077|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628078|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628079|NCT02026973|Hormones|hormones|mesh-ancestor
153628080|NCT02027064|Interferons|interferons|mesh-list
153628082|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628083|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
153628084|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628085|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
153628086|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628087|NCT02027103|Metformin|metformin|mesh-list
153628088|NCT02027103|Pioglitazone|pioglitazone|mesh-list
153628089|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516491|NCT01436123|Everolimus|everolimus|mesh-list
153628090|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628091|NCT02027220|Dexamethasone|dexamethasone|mesh-list
153628092|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
153628094|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628095|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
153628096|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628097|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153628098|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153628099|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
153628100|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628101|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628102|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153628103|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153628104|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
153628105|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
153628106|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628107|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628108|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
153628109|NCT02027220|Hormones|hormones|mesh-ancestor
153628110|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628111|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153628112|NCT02027298|Abatacept|abatacept|mesh-list
153628113|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153628114|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628125|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628126|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
153628127|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
153628128|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
153628129|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
153628130|NCT02027337|Drospirenone|drospirenone|mesh-list
153628131|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153628132|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153628133|NCT02027337|Cyproterone|cyproterone|mesh-list
153628134|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
153628135|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153628136|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
153628137|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628138|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628139|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153628140|NCT02027337|Diuretics|diuretics|mesh-ancestor
153516578|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516579|NCT01436916|Vitamins|vitamins|mesh-ancestor
153628141|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
153628142|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153628143|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153628144|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153628145|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
153628146|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153628147|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153628148|NCT02027337|Estrogens|estrogens|mesh-ancestor
153628149|NCT02027337|Hormones|hormones|mesh-ancestor
153628150|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
153628151|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628152|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153628153|NCT02027363|Capecitabine|capecitabine|mesh-list
153628154|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153628155|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
153628156|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628157|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628158|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
153628159|NCT02027454|Cabotegravir|cabotegravir|mesh-list
153628160|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153628161|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628162|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153628163|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154374541|NCT06107153|Incretins|incretins|mesh-ancestor
154374542|NCT06107153|Hormones|hormones|mesh-ancestor
153471843|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628164|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628165|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628166|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628167|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153628168|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153628169|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153628170|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153628171|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
153628172|NCT02027493|Interferons|interferons|mesh-list
153628173|NCT02027493|Ribavirin|ribavirin|mesh-list
153628174|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
153628175|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
153628176|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153628177|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628178|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
153628179|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628214|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153628215|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628217|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628218|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
153628219|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628249|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628250|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
153628251|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628252|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153628253|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
153628254|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153628255|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153628256|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153628258|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153628259|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628260|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628261|NCT02028234|Omeprazole|omeprazole|mesh-list
153628273|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153628274|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628275|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153628276|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153628277|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
153628278|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153628279|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153628280|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153628281|NCT02028403|BMS-936559|bms-936559|mesh-list
153628282|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153628283|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153628284|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628285|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
153628286|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628287|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
153628288|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
153628289|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628290|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628291|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
153628292|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
153628293|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153628294|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153628295|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628296|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628297|NCT02028429|Urological Agents|urological agents|mesh-ancestor
153628298|NCT02028494|Capecitabine|capecitabine|mesh-list
153628299|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153628300|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
153628301|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628302|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628303|NCT02028507|Capecitabine|capecitabine|mesh-list
153628304|NCT02028507|Fulvestrant|fulvestrant|mesh-list
153628305|NCT02028507|Palbociclib|palbociclib|mesh-list
153628306|NCT02028507|Exemestane|exemestane|mesh-list
153628307|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153628308|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
153628309|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628310|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628311|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153628312|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153628313|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153628314|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
153628315|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628316|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628317|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153628318|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628319|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153628320|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153628321|NCT02028533|Oxytocin|oxytocin|mesh-list
153628322|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
153628341|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153628342|NCT02028598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153628343|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153628344|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153628345|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628346|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
153628347|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628348|NCT02028663|Esomeprazole|esomeprazole|mesh-list
153628349|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153628350|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628351|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153628352|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628353|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628354|NCT02028689|Metformin|metformin|mesh-list
153628355|NCT02028689|Lesinurad|lesinurad|mesh-list
153628356|NCT02028689|Furosemide|furosemide|mesh-list
153628357|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628358|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628359|NCT02028689|Diuretics|diuretics|mesh-ancestor
153628360|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
153628361|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153628362|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153628363|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628364|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
153628365|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153628366|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
153628367|NCT02028819|Dolutegravir|dolutegravir|mesh-list
153628368|NCT02028819|Ibalizumab|ibalizumab|mesh-list
153628369|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153628370|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153628371|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628372|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628373|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153628374|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153628375|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
153628376|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628377|NCT02028910|Ondansetron|ondansetron|mesh-list
153628378|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
153628379|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
153628380|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628408|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628410|NCT02029105|Protective Agents|protective agents|mesh-ancestor
153628411|NCT02029118|Aspirin|aspirin|mesh-list
153628412|NCT02029118|Metoprolol|metoprolol|mesh-list
153628413|NCT02029118|Ramipril|ramipril|mesh-list
153628414|NCT02029118|Atorvastatin|atorvastatin|mesh-list
153628415|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153628416|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153628417|NCT02029118|Analgesics|analgesics|mesh-ancestor
153628418|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
153628419|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628420|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628421|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153628422|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153628423|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153628424|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153628425|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628437|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
153628438|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
153628439|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153628441|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153628442|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
153628443|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628444|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153628445|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
153628446|NCT02029313|Montelukast|montelukast|mesh-list
153628447|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153628448|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
153628449|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153628450|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
153628451|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628452|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628453|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153628454|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153628455|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628456|NCT02029378|Eculizumab|eculizumab|mesh-list
153628457|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153628458|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628459|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
153628460|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628461|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153628462|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153628463|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153628464|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628465|NCT02029482|Ponesimod|ponesimod|mesh-list
153628466|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153516918|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
153628467|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628468|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628469|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
153628470|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628471|NCT02029534|Atorvastatin|atorvastatin|mesh-list
153628472|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153628473|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153628474|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
153628475|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628476|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153628477|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153628478|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628479|NCT02029573|Temozolomide|temozolomide|mesh-list
153628480|NCT02029573|Atorvastatin|atorvastatin|mesh-list
153628481|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153628482|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153628483|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
153628484|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628485|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153628510|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153628511|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628513|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153628514|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153628515|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153628516|NCT02029599|Analgesics|analgesics|mesh-ancestor
153628517|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
153628518|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628519|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
153628520|NCT02029612|Nicotine|nicotine|mesh-list
153628521|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153628522|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
153628523|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628524|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628525|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153628526|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153628527|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
153628528|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628529|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628530|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153628531|NCT02029625|Ezetimibe|ezetimibe|mesh-list
153628532|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153628533|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153628572|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153628573|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153628612|NCT02031692|Calcium|calcium|mesh-list
153628625|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153628626|NCT02031991|Growth Substances|growth substances|mesh-ancestor
153628627|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628628|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
153628630|NCT02032043|Albendazole|albendazole|mesh-list
153628631|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153628632|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628633|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
153628634|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
153628635|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153628636|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153628637|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
153628638|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
153628640|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628641|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628642|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153628643|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153628644|NCT02032134|Protective Agents|protective agents|mesh-ancestor
153628645|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628646|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153628647|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
153628648|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628649|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
153628650|NCT02032186|Cathartics|cathartics|mesh-ancestor
153628651|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628652|NCT02033356|Lidocaine|lidocaine|mesh-list
153628653|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
153628654|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
153628655|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628656|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628657|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
153628658|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628659|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153628660|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153628661|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153628662|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153628663|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628664|NCT02033733|Cisatracurium|cisatracurium|mesh-list
153628665|NCT02033733|Atracurium|atracurium|mesh-list
153628666|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
153628667|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153628668|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517041|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153628669|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628670|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153628671|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153628672|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153628673|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
153628674|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628687|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
153628688|NCT02035020|Interferons|interferons|mesh-list
153628689|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
153628690|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628691|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
153628692|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628693|NCT02035709|Hydromorphone|hydromorphone|mesh-list
153628694|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153628695|NCT02035709|Narcotics|narcotics|mesh-ancestor
153628696|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628697|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628698|NCT02035709|Analgesics|analgesics|mesh-ancestor
153628699|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
153628700|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628701|NCT02035891|Colchicine|colchicine|mesh-list
153628702|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
153628703|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153628704|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
153628705|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
153628706|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
153628707|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628708|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628709|NCT02035956|Vaccines|vaccines|mesh-list
153628710|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
153628711|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628712|NCT02036151|Fluorides|fluorides|mesh-list
153628713|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
153628714|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
153628715|NCT02036151|Protective Agents|protective agents|mesh-ancestor
153628716|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628717|NCT02036255|Taurolidine|taurolidine|mesh-list
153628718|NCT02036255|Heparin|heparin|mesh-list
153628719|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
153628720|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153628721|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153628722|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628723|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628724|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153628725|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628726|NCT02038062|Sevoflurane|sevoflurane|mesh-list
153628727|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153628728|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153628729|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
153628730|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
153628731|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628732|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628733|NCT02039453|Fentanyl|fentanyl|mesh-list
153628734|NCT02039453|Meperidine|meperidine|mesh-list
153628735|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153628736|NCT02039453|Narcotics|narcotics|mesh-ancestor
153628737|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628771|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628772|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
153628773|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628774|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153628775|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628776|NCT02040220|Aflibercept|aflibercept|mesh-list
153628777|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153628778|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153628779|NCT02040220|Growth Substances|growth substances|mesh-ancestor
153628798|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628800|NCT02040285|Laxatives|laxatives|mesh-ancestor
153628801|NCT02040311|Topiramate|topiramate|mesh-list
153628802|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
153628803|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628804|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628805|NCT02040350|Pralidoxime|pralidoxime|mesh-list
153628806|NCT02040350|Antidotes|antidotes|mesh-ancestor
153628807|NCT02040350|Protective Agents|protective agents|mesh-ancestor
153628808|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628809|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
153628810|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
153628811|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628812|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
153628813|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628814|NCT02040402|Vaccines|vaccines|mesh-list
153628815|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
153628816|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628817|NCT02040415|Eperisone|eperisone|mesh-list
153628818|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
153628819|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153628820|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153628821|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628822|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153628823|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628824|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153628825|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153628826|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628827|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
153628828|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
153628829|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
153628830|NCT02040441|Spironolactone|spironolactone|mesh-list
153628831|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153628832|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
153628833|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628834|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628835|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153628836|NCT02040441|Diuretics|diuretics|mesh-ancestor
153628849|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
153628850|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
153628851|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153628852|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
153628853|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628854|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628855|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153628856|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
153628857|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153628858|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153628859|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153628860|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
153628861|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628862|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628863|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153628864|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153628865|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153628866|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
153628867|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153628868|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
153628870|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628872|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
153628873|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628874|NCT02040649|Midazolam|midazolam|mesh-list
153628875|NCT02040649|Propofol|propofol|mesh-list
153628876|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153628877|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628878|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628879|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153628880|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
153628881|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
153628882|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153628883|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153628884|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153628885|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153628886|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
153628887|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
153628888|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628889|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628890|NCT02040662|Morphine|morphine|mesh-list
153628891|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153628892|NCT02040662|Narcotics|narcotics|mesh-ancestor
153628893|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628894|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628895|NCT02040662|Analgesics|analgesics|mesh-ancestor
153628896|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
153628897|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628898|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
153628899|NCT02040818|Tigecycline|tigecycline|mesh-list
153628900|NCT02040818|Heparin|heparin|mesh-list
153628921|NCT02040883|Olanzapine|olanzapine|mesh-list
153628922|NCT02040883|Risperidone|risperidone|mesh-list
153628923|NCT02040883|Aripiprazole|aripiprazole|mesh-list
153628924|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153628925|NCT02040883|Ziprasidone|ziprasidone|mesh-list
153628926|NCT02040883|Tandospirone|tandospirone|mesh-list
153628927|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153628928|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
153628929|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628930|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628931|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628932|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153628933|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153628934|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628935|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153628936|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153628937|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
153628938|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
153628939|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
153628940|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628941|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628942|NCT02040883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153628943|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153472227|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153628944|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153628945|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
153628947|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153628948|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153628949|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153628950|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153628951|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153517362|NCT01439152|Maytansine|maytansine|mesh-list
153628953|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153628954|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628981|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628983|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628984|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153628985|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628986|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628988|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153628989|NCT02041338|Carboplatin|carboplatin|mesh-list
153628990|NCT02041338|Epirubicin|epirubicin|mesh-list
153628991|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153628992|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628993|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
153628994|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
153628995|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
153628996|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628997|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153628998|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153628999|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629000|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629013|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629014|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153629015|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
153629016|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153629017|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153629018|NCT02041455|Analgesics|analgesics|mesh-ancestor
153629019|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
153629020|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629021|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153629022|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153629023|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153629024|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
153629025|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629026|NCT02041481|Leucovorin|leucovorin|mesh-list
153629027|NCT02041481|Fluorouracil|fluorouracil|mesh-list
153629028|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
153629029|NCT02041481|Calcium|calcium|mesh-list
153629030|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
153629031|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153629032|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629033|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
153629034|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629035|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629036|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629037|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629038|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
153629039|NCT02041481|Antidotes|antidotes|mesh-ancestor
153629040|NCT02041481|Protective Agents|protective agents|mesh-ancestor
153629041|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
153629042|NCT02041481|Vitamins|vitamins|mesh-ancestor
153629043|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
153629044|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153629045|NCT02041546|Poractant alfa|poractant alfa|mesh-list
153517420|NCT01439399|Analgesics|analgesics|mesh-ancestor
153629046|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
153629047|NCT02041650|Ticagrelor|ticagrelor|mesh-list
153629048|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153629049|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153629050|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153629051|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153629052|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
153629053|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629054|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472288|NCT04362384|Prednisolone|prednisolone|mesh-list
153816058|NCT00351026|Methadone|methadone|mesh-list
153629055|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629057|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153629058|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629059|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
153629060|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153629061|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629062|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153629063|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
153629072|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629074|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629075|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153629076|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
153629077|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
153629078|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
153629079|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629080|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
153629081|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629082|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629083|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153629085|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
153629086|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
153629087|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629088|NCT02042482|Vitamins|vitamins|mesh-ancestor
153629089|NCT02042495|Metformin|metformin|mesh-list
153629090|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153629091|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629092|NCT02042599|Sevoflurane|sevoflurane|mesh-list
153629093|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153629094|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153629095|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
153629096|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
153629097|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517561|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153517562|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629098|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629099|NCT02042612|Sevoflurane|sevoflurane|mesh-list
153629100|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153629101|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153629102|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
153629103|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
153629104|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629105|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629106|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153629107|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629108|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629109|NCT02042664|Metformin|metformin|mesh-list
153629110|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153629111|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629112|NCT02042690|Dexamethasone|dexamethasone|mesh-list
153629113|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
153629114|NCT02042690|Methotrexate|methotrexate|mesh-list
153629115|NCT02042690|Epirubicin|epirubicin|mesh-list
153629116|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
153629117|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629118|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
153629119|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629120|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153629121|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153629122|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
153629123|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629124|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629125|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153629126|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629127|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
153629128|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
153629129|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629151|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629153|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629154|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153629155|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153629156|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
153629157|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153629158|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154157401|NCT05797805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153629159|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629160|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153629161|NCT02043054|Liraglutide|liraglutide|mesh-list
153629162|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153629163|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629164|NCT02043054|Incretins|incretins|mesh-ancestor
153629165|NCT02043054|Hormones|hormones|mesh-ancestor
153629166|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629167|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153629168|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
153629169|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629170|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629171|NCT02043054|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153629172|NCT02043171|Vitamin D|vitamin d|mesh-list
153629173|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
153629174|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
153629175|NCT02043171|Vitamins|vitamins|mesh-list
153629176|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
153629177|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906197|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
153629178|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153629179|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153629181|NCT02043223|Vitamin A|vitamin a|mesh-list
153629182|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
153629204|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
153629206|NCT02043717|Vitamin D|vitamin d|mesh-list
153629207|NCT02043717|Vitamins|vitamins|mesh-ancestor
153629208|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
153629209|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629210|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153629211|NCT02043730|Paclitaxel|paclitaxel|mesh-list
153629212|NCT02043730|Gemcitabine|gemcitabine|mesh-list
153629213|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153629214|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629215|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629216|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629217|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
153629218|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629219|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629220|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
153629221|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
153629222|NCT02043756|Analgesics|analgesics|mesh-ancestor
153629223|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
153629224|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629225|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629226|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629227|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153629228|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629229|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629230|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629231|NCT02043821|Capecitabine|capecitabine|mesh-list
153629232|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629233|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
153629234|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629257|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153629258|NCT02043977|Propofol|propofol|mesh-list
153629259|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153629260|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629261|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629262|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153629263|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
153629264|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
153629265|NCT02044120|Irinotecan|irinotecan|mesh-list
153629266|NCT02044120|Temozolomide|temozolomide|mesh-list
153629267|NCT02044120|Niraparib|niraparib|mesh-list
153629268|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153629269|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629270|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629271|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629272|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629273|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153629274|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
153629275|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153629276|NCT02044133|Vitamin D|vitamin d|mesh-list
153629277|NCT02044133|Vitamins|vitamins|mesh-ancestor
154374544|NCT06107153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154374545|NCT06107153|Protease Inhibitors|protease inhibitors|mesh-ancestor
154374546|NCT06107153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374547|NCT06107153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374548|NCT06106880|Aspirin|aspirin|mesh-list
154374549|NCT06106880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154374550|NCT06106880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154374551|NCT06106880|Analgesics|analgesics|mesh-ancestor
154374552|NCT06106880|Sensory System Agents|sensory system agents|mesh-ancestor
154374553|NCT06106880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374554|NCT06106880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626764|NCT02018965|Niacin|niacin|mesh-list
153629278|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
153629279|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629280|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153629281|NCT02044146|Clopidogrel|clopidogrel|mesh-list
153629282|NCT02044146|Ticagrelor|ticagrelor|mesh-list
153629283|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153629284|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153629285|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153629286|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153629287|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153629323|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153629324|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153629350|NCT02044601|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153629351|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153629352|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629353|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153629354|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153629356|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629357|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153629358|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629359|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153629360|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629361|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
153517827|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425266|NCT01035944|Chitosan|chitosan|mesh-list
153629362|NCT02044653|Hematinics|hematinics|mesh-ancestor
153629363|NCT02044809|Cannabidiol|cannabidiol|mesh-list
153629364|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
153629365|NCT02044952|Mesalamine|mesalamine|mesh-list
153629366|NCT02044952|Triptolide|triptolide|mesh-list
153629367|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153629368|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153629369|NCT02044952|Analgesics|analgesics|mesh-ancestor
153629370|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
153629371|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629372|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629373|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629374|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153629390|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153629392|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153629393|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153629394|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153629395|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629396|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629397|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153629398|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154374555|NCT06106880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154374556|NCT06106880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154374557|NCT06106880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154374558|NCT06106880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154374559|NCT06106880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374560|NCT06106880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154374561|NCT06106880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154374562|NCT06106880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154374563|NCT06106880|Antipyretics|antipyretics|mesh-ancestor
154374564|NCT06106295|Metyrapone|metyrapone|mesh-list
154374621|NCT06056141|Abortifacient Agents|abortifacient agents|mesh-ancestor
154374622|NCT06056141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154374623|NCT06056141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374624|NCT06056141|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154374625|NCT06056141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154374626|NCT06056141|Oxytocics|oxytocics|mesh-ancestor
154374627|NCT06054750|Ropivacaine|ropivacaine|mesh-list
154374628|NCT06054750|Anesthetics, Local|anesthetics, local|mesh-ancestor
154374629|NCT06054750|Anesthetics|anesthetics|mesh-ancestor
154374630|NCT06054750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374631|NCT06054750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374632|NCT06054750|Sensory System Agents|sensory system agents|mesh-ancestor
154374633|NCT06054750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517903|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
154374634|NCT06053398|Phenylephrine|phenylephrine|mesh-list
154374635|NCT06053398|Oxymetazoline|oxymetazoline|mesh-list
154374636|NCT06053398|Norepinephrine|norepinephrine|mesh-list
154374637|NCT06053398|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154374638|NCT06053398|Mydriatics|mydriatics|mesh-ancestor
154374639|NCT06053398|Autonomic Agents|autonomic agents|mesh-ancestor
154374640|NCT06053398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374641|NCT06053398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374642|NCT06053398|Sympathomimetics|sympathomimetics|mesh-ancestor
154374643|NCT06053398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154374675|NCT06040320|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154374676|NCT06040320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374677|NCT06040320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374678|NCT06040320|Immunologic Factors|immunologic factors|mesh-ancestor
154374679|NCT06040320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374680|NCT06040320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154374681|NCT06040320|Immunoconjugates|immunoconjugates|mesh-ancestor
154374682|NCT06038578|Paclitaxel|paclitaxel|mesh-list
154374683|NCT06038578|Ramucirumab|ramucirumab|mesh-list
154374684|NCT06038578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154374685|NCT06038578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374738|NCT05985681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374740|NCT05972681|Bupivacaine|bupivacaine|mesh-list
154374741|NCT05972681|Anesthetics, Local|anesthetics, local|mesh-ancestor
154374742|NCT05972681|Anesthetics|anesthetics|mesh-ancestor
154374743|NCT05972681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374744|NCT05972681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374745|NCT05972681|Sensory System Agents|sensory system agents|mesh-ancestor
154374746|NCT05972681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374747|NCT05972681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154374806|NCT05905367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374807|NCT05905367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374808|NCT05905367|Analgesics|analgesics|mesh-ancestor
154374809|NCT05905367|Sensory System Agents|sensory system agents|mesh-ancestor
154374810|NCT05905367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374873|NCT05840770|Cemiplimab|cemiplimab|mesh-list
154374874|NCT05840770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154374875|NCT05840770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154374876|NCT05834023|Lidocaine|lidocaine|mesh-list
154374877|NCT05834023|Bupivacaine|bupivacaine|mesh-list
154374878|NCT05834023|Anesthetics, Local|anesthetics, local|mesh-ancestor
154374879|NCT05834023|Anesthetics|anesthetics|mesh-ancestor
154374880|NCT05834023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154374881|NCT05834023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374882|NCT05834023|Sensory System Agents|sensory system agents|mesh-ancestor
154374883|NCT05834023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154374884|NCT05834023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154374889|NCT05826015|Paclitaxel|paclitaxel|mesh-list
154374935|NCT05775939|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154374936|NCT05775939|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154374937|NCT05775939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374939|NCT05775939|Antiviral Agents|antiviral agents|mesh-ancestor
154374940|NCT05775939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374941|NCT05748990|Insulin|insulin|mesh-list
154374942|NCT05748990|Insulin Lispro|insulin lispro|mesh-list
154374943|NCT05748990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154374944|NCT05748990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374945|NCT05744479|Metformin|metformin|mesh-list
154374946|NCT05744479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154374947|NCT05744479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374948|NCT05729568|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154374949|NCT05729568|Antiviral Agents|antiviral agents|mesh-ancestor
154374950|NCT05729568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154374951|NCT05727761|Metformin|metformin|mesh-list
154374952|NCT05727761|Pioglitazone|pioglitazone|mesh-list
154374953|NCT05727761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154374954|NCT05727761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782023|NCT00259779|Budesonide|budesonide|mesh-list
153517963|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
154374955|NCT05715229|Paclitaxel|paclitaxel|mesh-list
154374956|NCT05715229|Carboplatin|carboplatin|mesh-list
154374957|NCT05715229|Nivolumab|nivolumab|mesh-list
154374958|NCT05715229|Pemetrexed|pemetrexed|mesh-list
154374991|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154374992|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154374993|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
154374994|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154374995|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154374996|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
154374997|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
154374999|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
154375000|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
154375001|NCT05666336|Tacrolimus|tacrolimus|mesh-list
154375002|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375003|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
154375013|NCT05666336|Hormones|hormones|mesh-ancestor
154375051|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375052|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375053|NCT05656235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375054|NCT05656235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375055|NCT05653258|Dasatinib|dasatinib|mesh-list
154375056|NCT05653258|Quercetin|quercetin|mesh-list
154375057|NCT05653258|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154375058|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375059|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375060|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375061|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375062|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
154375063|NCT05653258|Protective Agents|protective agents|mesh-ancestor
154375064|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375089|NCT05645757|Ertapenem|ertapenem|mesh-list
154375090|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154375091|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375092|NCT05638867|Aspirin|aspirin|mesh-list
154375093|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
154375094|NCT05638867|Clopidogrel|clopidogrel|mesh-list
154375095|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154375096|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154375097|NCT05638867|Analgesics|analgesics|mesh-ancestor
154375098|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
154375099|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375100|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375101|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375102|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375103|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154375108|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375121|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375122|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
154375123|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
154375124|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375125|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375126|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375127|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
154375128|NCT05638087|Hormones|hormones|mesh-ancestor
154375129|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375130|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375181|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154375182|NCT05560399|Dexamethasone|dexamethasone|mesh-list
153518053|NCT01443104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375184|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375185|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
154375186|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
154375187|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375188|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375189|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375190|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
154375191|NCT05560399|Hormones|hormones|mesh-ancestor
154375193|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375245|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375246|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375247|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375248|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
154375249|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
154375250|NCT05478837|Fludarabine|fludarabine|mesh-list
154375251|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375311|NCT05389046|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154375312|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154375313|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154375314|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375315|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154375316|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
154375317|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375318|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154375319|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154375320|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
154375321|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
154375322|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375323|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154375324|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154375325|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
154375370|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375372|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
154375373|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
154375374|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375375|NCT05344417|Iodine|iodine|mesh-list
154375376|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154375377|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154375378|NCT05344417|Trace Elements|trace elements|mesh-ancestor
154375379|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
154375380|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375381|NCT05335993|Niraparib|niraparib|mesh-list
154375382|NCT05335993|Oregovomab|oregovomab|mesh-list
154375383|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154375384|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375385|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375386|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375387|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375388|NCT05335941|Pemetrexed|pemetrexed|mesh-list
154375389|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375390|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375391|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375421|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154375422|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
154375423|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154375424|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375425|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154375426|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154375427|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154375428|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
154375429|NCT05267600|Prednisone|prednisone|mesh-list
154375430|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375486|NCT05222971|Olaparib|olaparib|mesh-list
154375487|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375488|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375489|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154375490|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375491|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375492|NCT05208294|Sulpiride|sulpiride|mesh-list
154375493|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154375494|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154375495|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375496|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375497|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154375498|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154375499|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
154375500|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154375501|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375502|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154375503|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
154375504|NCT05166304|Rebamipide|rebamipide|mesh-list
154375505|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154375507|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
154375540|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375541|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
154375542|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375543|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154375544|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154375545|NCT05115903|Analgesics|analgesics|mesh-ancestor
154375546|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
154375547|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375548|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375549|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154375550|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
154375551|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
154375552|NCT05114421|Lenvatinib|lenvatinib|mesh-list
154375553|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375554|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375555|NCT05114421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375556|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375557|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375558|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375559|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
154375560|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375561|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375562|NCT05084430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375589|NCT05065021|Growth Substances|growth substances|mesh-ancestor
154375590|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375591|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
154375592|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154375593|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375595|NCT05064735|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154375596|NCT05064735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154375657|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375658|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375659|NCT04987203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154375660|NCT04987203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375661|NCT04975724|Citalopram|citalopram|mesh-list
154375662|NCT04975724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154375663|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154375664|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154375665|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375666|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154375667|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
154375668|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375669|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154375670|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
154375671|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154375672|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
154375673|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375674|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375675|NCT04949191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154375676|NCT04949191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375677|NCT04943224|Trametinib|trametinib|mesh-list
154375678|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375685|NCT04943198|Vemurafenib|vemurafenib|mesh-list
154375703|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375704|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154375705|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154375706|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154375707|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375708|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154375709|NCT04891289|Dexamethasone|dexamethasone|mesh-list
154375710|NCT04891289|Gemcitabine|gemcitabine|mesh-list
154375711|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
154375712|NCT04891289|Floxuridine|floxuridine|mesh-list
154375713|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375714|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
154375715|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
154375716|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375717|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375718|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121964|NCT03879772|Beclomethasone|beclomethasone|mesh-list
154375720|NCT04891289|Hormones|hormones|mesh-ancestor
154375721|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375722|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375723|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375724|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154375725|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
154375755|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
154375756|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375757|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375758|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154375759|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
154375760|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154375761|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375762|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375763|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
154375764|NCT04848337|Lenvatinib|lenvatinib|mesh-list
154375765|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154375818|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154375819|NCT04791761|Analgesics|analgesics|mesh-ancestor
154375820|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
154375821|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375822|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375823|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
154375824|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154375825|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375826|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375827|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154375828|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518523|NCT01446094|Regadenoson|regadenoson|mesh-list
154375829|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375830|NCT04791761|Narcotics|narcotics|mesh-ancestor
154375831|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154375832|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
154375833|NCT04787991|Paclitaxel|paclitaxel|mesh-list
154375834|NCT04787991|Gemcitabine|gemcitabine|mesh-list
154375835|NCT04787991|Nivolumab|nivolumab|mesh-list
154375836|NCT04787991|Ipilimumab|ipilimumab|mesh-list
154375877|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
154375878|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
154375879|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375880|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375881|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154375882|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
154375883|NCT04764942|Hormones|hormones|mesh-ancestor
154375884|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154375885|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154375886|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154375887|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
154375888|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154375889|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154375890|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
154375891|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154375892|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154375893|NCT04764942|Growth Substances|growth substances|mesh-ancestor
154375894|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
154375895|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
154375896|NCT04754061|Psilocybin|psilocybin|mesh-list
154375897|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
154375898|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375899|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154375900|NCT04729322|Metronidazole|metronidazole|mesh-list
154375901|NCT04729322|Vancomycin|vancomycin|mesh-list
154375902|NCT04729322|Neomycin|neomycin|mesh-list
154375903|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
154375904|NCT04729322|Nivolumab|nivolumab|mesh-list
153737850|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737851|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153737852|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153737853|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153737854|NCT04460326|Insulin|insulin|mesh-list
153737855|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153737856|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
153737857|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
153737858|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737859|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737874|NCT04439006|Ibrutinib|ibrutinib|mesh-list
153737879|NCT04401059|Gefitinib|gefitinib|mesh-list
154375925|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375926|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154375974|NCT04611529|Diclofenac|diclofenac|mesh-list
154375975|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154375976|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154375977|NCT04611529|Analgesics|analgesics|mesh-ancestor
154375978|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
154375979|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154375980|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154375981|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154375982|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154375983|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154376037|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376038|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154376039|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154376040|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376041|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
154376042|NCT04569461|Androgens|androgens|mesh-list
154376043|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376044|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376045|NCT04569461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376047|NCT04569461|Hormones|hormones|mesh-ancestor
154376100|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376101|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376102|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376103|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376104|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154376105|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154376106|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154376107|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
154376108|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154376109|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
154376110|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
154376163|NCT04274426|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154376164|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376165|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376166|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376167|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376168|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376169|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376170|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154376171|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
154376176|NCT04274426|Immunoconjugates|immunoconjugates|mesh-ancestor
154376227|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154376228|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
154376229|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376230|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154376231|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376232|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376233|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
154376234|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376235|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376236|NCT04140526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376237|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376238|NCT04134923|Corticosterone|corticosterone|mesh-list
154122504|NCT05243199|Valsartan|valsartan|mesh-list
154376240|NCT04100018|Prednisone|prednisone|mesh-list
154376288|NCT03997123|Paclitaxel|paclitaxel|mesh-list
154376289|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376290|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376291|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376292|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376293|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376294|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376295|NCT03992131|Rucaparib|rucaparib|mesh-list
154376296|NCT03992131|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154376297|NCT03992131|Immunoconjugates|immunoconjugates|mesh-ancestor
154376298|NCT03992131|Immunologic Factors|immunologic factors|mesh-ancestor
154376299|NCT03992131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376301|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376348|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376349|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376350|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376351|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376359|NCT03840902|Paclitaxel|paclitaxel|mesh-list
154376422|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376423|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154376424|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
154376425|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376426|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154376427|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154376428|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376489|NCT03721497|Testosterone|testosterone|mesh-list
154376490|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
154376491|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
154376492|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154376493|NCT03721497|Androgens|androgens|mesh-ancestor
154376494|NCT03721497|Hormones|hormones|mesh-ancestor
154376495|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519219|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376496|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376497|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376498|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376499|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
154376500|NCT03717896|Thiamine|thiamine|mesh-list
154376501|NCT03717896|Vitamins|vitamins|mesh-ancestor
154376502|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
154376503|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376504|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
154376505|NCT03691610|Vaccines|vaccines|mesh-list
154376506|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
154376507|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376508|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
154376509|NCT03675737|Capecitabine|capecitabine|mesh-list
154376510|NCT03675737|Fluorouracil|fluorouracil|mesh-list
154376511|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
154376512|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376513|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376514|NCT03675737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376515|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376516|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154376517|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
154376518|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154376519|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
154376520|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376521|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154376522|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
154376523|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376524|NCT03654053|Simvastatin|simvastatin|mesh-list
154376525|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154376526|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154376527|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
154376528|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376529|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154376530|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154376531|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376532|NCT03635567|Paclitaxel|paclitaxel|mesh-list
154376533|NCT03635567|Bevacizumab|bevacizumab|mesh-list
154376534|NCT03635567|Carboplatin|carboplatin|mesh-list
154376596|NCT03515837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376597|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376598|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376599|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154376600|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154376601|NCT03495713|Nivolumab|nivolumab|mesh-list
154376602|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376603|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376604|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376605|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376606|NCT03400826|Simvastatin|simvastatin|mesh-list
154376607|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154376608|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154376609|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
154376611|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154376656|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376657|NCT03291899|Folfirinox|folfirinox|mesh-list
154376658|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376659|NCT03246347|Docetaxel|docetaxel|mesh-list
154376660|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376661|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376662|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376663|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376664|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376665|NCT03207555|Ibrutinib|ibrutinib|mesh-list
154376666|NCT03207555|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153519630|NCT05867550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154376667|NCT03207555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376668|NCT03207555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376669|NCT03207555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376670|NCT03141177|Nivolumab|nivolumab|mesh-list
154376671|NCT03141177|Ipilimumab|ipilimumab|mesh-list
154376672|NCT03141177|Sunitinib|sunitinib|mesh-list
154376673|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376714|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376715|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376716|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376717|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376718|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376719|NCT03065387|Everolimus|everolimus|mesh-list
154376720|NCT03065387|Palbociclib|palbociclib|mesh-list
154376721|NCT03065387|Trametinib|trametinib|mesh-list
154376722|NCT03065387|Neratinib|neratinib|mesh-list
154376723|NCT03065387|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154376724|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154376725|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376726|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376727|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154376728|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
154376729|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376730|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376731|NCT03065387|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154376732|NCT03044613|Paclitaxel|paclitaxel|mesh-list
154376733|NCT03044613|Carboplatin|carboplatin|mesh-list
154376734|NCT03044613|Nivolumab|nivolumab|mesh-list
154376735|NCT03044613|Relatlimab|relatlimab|mesh-list
154376736|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376737|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376738|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376739|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376740|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376741|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376742|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376759|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376760|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376761|NCT02889809|Fluticasone|fluticasone|mesh-list
154376762|NCT02889809|Xhance|xhance|mesh-list
154376763|NCT02889809|Montelukast|montelukast|mesh-list
154376764|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376765|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154376766|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
154376767|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376768|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376769|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154376770|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
154376771|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
154376772|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154123030|NCT01067365|Clomiphene|clomiphene|mesh-list
154376774|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
154376775|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376776|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154376777|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154376778|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376779|NCT02884648|Bevacizumab|bevacizumab|mesh-list
154376780|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376781|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376782|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154376783|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154376784|NCT02884648|Growth Substances|growth substances|mesh-ancestor
154376785|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376786|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
154376787|NCT02815592|Carboplatin|carboplatin|mesh-list
154376788|NCT02815592|Etoposide|etoposide|mesh-list
154376789|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376790|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376791|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154376792|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154376793|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376794|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376795|NCT02792465|Fulvestrant|fulvestrant|mesh-list
154376796|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376797|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376798|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154376799|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154376800|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
154376801|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376802|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376803|NCT02785224|Vasopressins|vasopressins|mesh-list
154376804|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
154376805|NCT02785224|Epinephrine|epinephrine|mesh-list
154376806|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154376807|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154376808|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
154376856|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376857|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
154376858|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154376859|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154376860|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376861|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154376862|NCT02604940|Analgesics|analgesics|mesh-ancestor
154376863|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
154376864|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376865|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154376866|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154376867|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154376868|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
154376869|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154376870|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376871|NCT02581137|Metformin|metformin|mesh-list
154376872|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154376873|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376874|NCT02530697|Miltefosine|miltefosine|mesh-list
154376875|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154376876|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
154376908|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376909|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154376910|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154376911|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376912|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
154376913|NCT02465736|Cisplatin|cisplatin|mesh-list
154376914|NCT02465736|Docetaxel|docetaxel|mesh-list
154376915|NCT02465736|Vinorelbine|vinorelbine|mesh-list
154376916|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376917|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
154376918|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
154376919|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
154376920|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376921|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376923|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154376924|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154376925|NCT02453594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154376926|NCT02453594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376927|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
154376928|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154376929|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376930|NCT02385110|Dexamethasone|dexamethasone|mesh-list
154376931|NCT02385110|Methotrexate|methotrexate|mesh-list
154376932|NCT02385110|Etoposide|etoposide|mesh-list
154376933|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
154376934|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154376935|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
154376936|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
154376937|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154376938|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154376939|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154376940|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
154376941|NCT02385110|Hormones|hormones|mesh-ancestor
154376942|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154376943|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154376948|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154376949|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
154376950|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154376951|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
154376952|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154376953|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154376954|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154376955|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
154376956|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154376957|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154376958|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154376959|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154376960|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154376962|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
154377009|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154377010|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154377011|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377012|NCT01898793|Aldesleukin|aldesleukin|mesh-list
154377013|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
154377014|NCT01898793|Fludarabine|fludarabine|mesh-list
154377015|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
154377016|NCT01898793|Interleukin-2|interleukin-2|mesh-list
154377017|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377018|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
154377019|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377020|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377021|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154377022|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
153520617|NCT05813288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153520618|NCT05813288|Dopamine Agonists|dopamine agonists|mesh-ancestor
153520619|NCT05775471|Pembrolizumab|pembrolizumab|mesh-list
153520620|NCT05775471|Immunoconjugates|immunoconjugates|mesh-list
153520621|NCT05775471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520622|NCT05775471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520676|NCT05748600|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153520677|NCT05748600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153520678|NCT05748600|Dopamine Agonists|dopamine agonists|mesh-ancestor
153520679|NCT05735639|Enoxaparin|enoxaparin|mesh-list
153520680|NCT05735639|Dalteparin|dalteparin|mesh-list
153520681|NCT05735639|Tinzaparin|tinzaparin|mesh-list
153520682|NCT05735639|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153520683|NCT05735639|Rivaroxaban|rivaroxaban|mesh-list
154377023|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377024|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377025|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154377026|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154377027|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
154377028|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
154377029|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377030|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154377031|NCT01898793|Analgesics|analgesics|mesh-ancestor
154377032|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
154377033|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377034|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154377035|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154377036|NCT01857934|Aldesleukin|aldesleukin|mesh-list
154377037|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
154377038|NCT01857934|Melphalan|melphalan|mesh-list
154377039|NCT01857934|Busulfan|busulfan|mesh-list
154377040|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
154377041|NCT01857934|Doxorubicin|doxorubicin|mesh-list
154377042|NCT01857934|Etoposide|etoposide|mesh-list
154377043|NCT01857934|Vincristine|vincristine|mesh-list
154377044|NCT01857934|Topotecan|topotecan|mesh-list
154377045|NCT01857934|Interleukin-2|interleukin-2|mesh-list
154377046|NCT01857934|Molgramostim|molgramostim|mesh-list
154377047|NCT01857934|Dinutuximab|dinutuximab|mesh-list
154377048|NCT01857934|Levetiracetam|levetiracetam|mesh-list
153629399|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154377049|NCT01857934|Isotretinoin|isotretinoin|mesh-list
154377050|NCT01857934|Antibodies|antibodies|mesh-list
154377051|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
154377052|NCT01857934|Sargramostim|sargramostim|mesh-list
154377053|NCT01857934|Lenograstim|lenograstim|mesh-list
154377054|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377055|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
154377056|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377057|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377058|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154377059|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
154377060|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377061|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377084|NCT01842282|Amlexanox|amlexanox|mesh-list
154377113|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
154377114|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377115|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377116|NCT01589068|Progestins|progestins|mesh-ancestor
154377117|NCT01589068|Hormones|hormones|mesh-ancestor
154377118|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377119|NCT01589055|Nicotine|nicotine|mesh-list
154377120|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154377121|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
154377122|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377123|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377124|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154377125|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154377126|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
154377127|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377128|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377129|NCT01515527|Cytarabine|cytarabine|mesh-list
154377130|NCT01515527|Decitabine|decitabine|mesh-list
154377131|NCT01515527|Cladribine|cladribine|mesh-list
154377132|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154377133|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
154377134|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377135|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377136|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
154377137|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377139|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
154377162|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154377163|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377164|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154377165|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153520795|NCT05581030|Rituximab|rituximab|mesh-list
154377166|NCT01217931|Growth Substances|growth substances|mesh-ancestor
154377167|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377168|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
154377169|NCT01217931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154377170|NCT01217931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154377171|NCT01217931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377172|NCT01217931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377173|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377174|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
154377175|NCT01192568|Oxybutynin|oxybutynin|mesh-list
154377176|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
154377177|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
154377178|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377179|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377180|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154377181|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154377182|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
154377219|NCT00557193|Asparaginase|asparaginase|mesh-list
154377220|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
154377221|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
154377222|NCT00557193|Pegaspargase|pegaspargase|mesh-list
154377223|NCT00557193|Lenograstim|lenograstim|mesh-list
154377224|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154377225|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
154377226|NCT00557193|BB 1101|bb 1101|mesh-list
154377227|NCT00557193|Calcium|calcium|mesh-list
154377228|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
154377229|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377230|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
154377231|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377232|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377233|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154377234|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
154377235|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377236|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377237|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154377238|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154377239|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
154377240|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
154377241|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377242|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154377243|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
154377270|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
154377271|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
154377272|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
154377273|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154377274|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154377275|NCT00557193|Hematinics|hematinics|mesh-ancestor
154377276|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
154377277|NCT00516724|Paclitaxel|paclitaxel|mesh-list
154377278|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154377279|NCT00516724|Carboplatin|carboplatin|mesh-list
153520871|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
154377280|NCT00516724|Olaparib|olaparib|mesh-list
154377281|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154377282|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154377283|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377284|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
154377285|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
154377286|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
154377287|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377288|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377289|NCT00364637|Anesthetics|anesthetics|mesh-list
154377290|NCT00364637|Sevoflurane|sevoflurane|mesh-list
154377291|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377292|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377293|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154377294|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154377295|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
154377296|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
154377297|NCT00186888|Carboplatin|carboplatin|mesh-list
154377298|NCT00186888|Doxorubicin|doxorubicin|mesh-list
154377299|NCT00186888|Etoposide|etoposide|mesh-list
154377300|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
154377301|NCT00186888|Vincristine|vincristine|mesh-list
154377302|NCT00186888|Topotecan|topotecan|mesh-list
154377314|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154377315|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377316|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154377317|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
154377318|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
154377319|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
154377320|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154377322|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154377323|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
154377324|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
154377325|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377326|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377327|NCT00703846|Ketoconazole|ketoconazole|mesh-list
154377328|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
154377329|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377330|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154377331|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154377332|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377333|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377334|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154377335|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
154377336|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377337|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377338|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154377339|NCT03309436|Clomiphene|clomiphene|mesh-list
154377340|NCT03309436|Enclomiphene|enclomiphene|mesh-list
154377361|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377362|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377363|NCT05183334|Analgesics|analgesics|mesh-ancestor
154377364|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
154377365|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377366|NCT06065371|Capecitabine|capecitabine|mesh-list
154377367|NCT06065371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154377368|NCT06065371|Antimetabolites|antimetabolites|mesh-ancestor
154377369|NCT06065371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377370|NCT06065371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377371|NCT06065267|Amoxicillin|amoxicillin|mesh-list
154377372|NCT06065267|Metronidazole|metronidazole|mesh-list
154377373|NCT06065267|Levofloxacin|levofloxacin|mesh-list
154377374|NCT06065267|Esomeprazole|esomeprazole|mesh-list
154377375|NCT06065267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154377376|NCT06065267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377377|NCT06065267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154377378|NCT06065267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153520949|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
154377379|NCT06065267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154123603|NCT00826254|Vitamins|vitamins|mesh-list
154377380|NCT06065267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154377381|NCT06065267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154377382|NCT06065267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377383|NCT06065267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377384|NCT06065267|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154377385|NCT06065267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154377386|NCT06065267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154377387|NCT06065267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377388|NCT06065267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154377389|NCT06065267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154377391|NCT06065137|Fentanyl|fentanyl|mesh-list
154377392|NCT06065137|Sufentanil|sufentanil|mesh-list
154377393|NCT06065137|Ketamine|ketamine|mesh-list
154377394|NCT06065137|Remifentanil|remifentanil|mesh-list
154377395|NCT06065137|Alfentanil|alfentanil|mesh-list
154377403|NCT06065137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377404|NCT06065137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377405|NCT06065137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154377406|NCT06065137|Anesthetics, General|anesthetics, general|mesh-ancestor
154377407|NCT06065137|Anesthetics|anesthetics|mesh-ancestor
154377408|NCT06065137|Analgesics|analgesics|mesh-ancestor
154377409|NCT06065137|Sensory System Agents|sensory system agents|mesh-ancestor
154377410|NCT06065137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377411|NCT06065137|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154377412|NCT06065137|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154377413|NCT06065137|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154377414|NCT06065137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377415|NCT06065137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377416|NCT06065137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154377417|NCT06065137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154377418|NCT06065137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154377419|NCT06065137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154377420|NCT06065137|GABA Modulators|gaba modulators|mesh-ancestor
154377421|NCT06065137|GABA Agents|gaba agents|mesh-ancestor
154377422|NCT06065137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154377423|NCT06065137|Narcotics|narcotics|mesh-ancestor
154377424|NCT06065137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154377425|NCT06065137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154377426|NCT06065137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154377427|NCT06065137|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154377428|NCT06065137|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154377429|NCT06065137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154377430|NCT06065137|Cholinergic Agents|cholinergic agents|mesh-ancestor
154377431|NCT06064669|Metformin|metformin|mesh-list
154377432|NCT06064669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154377433|NCT06064669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377434|NCT06064539|Rifampin|rifampin|mesh-list
154377435|NCT06064539|Gemfibrozil|gemfibrozil|mesh-list
154377436|NCT06064539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154377437|NCT06064539|Antitubercular Agents|antitubercular agents|mesh-ancestor
154377438|NCT06064539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154377441|NCT06064539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154377442|NCT06064539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377443|NCT06064539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377444|NCT06064539|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154377445|NCT06064539|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154377446|NCT06064539|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154377447|NCT06064539|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154377448|NCT06064539|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154377449|NCT06064539|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154377450|NCT06064539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154377451|NCT06064539|Antimetabolites|antimetabolites|mesh-ancestor
154377452|NCT06064539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154377453|NCT06064539|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154377454|NCT06064539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154377455|NCT06064344|Rituximab|rituximab|mesh-list
154377456|NCT06064344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154377457|NCT06064344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377458|NCT06064344|Immunologic Factors|immunologic factors|mesh-ancestor
154377459|NCT06064344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377460|NCT06064344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377461|NCT06064331|Lidocaine|lidocaine|mesh-list
154377462|NCT06064331|Anesthetics, Local|anesthetics, local|mesh-ancestor
154377463|NCT06064331|Anesthetics|anesthetics|mesh-ancestor
154377464|NCT06064331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377465|NCT06064331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377466|NCT06064331|Sensory System Agents|sensory system agents|mesh-ancestor
154377486|NCT06064162|Analgesics|analgesics|mesh-ancestor
154377487|NCT06064162|Sensory System Agents|sensory system agents|mesh-ancestor
154377488|NCT06064162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377489|NCT06064162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377490|NCT06064162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154377491|NCT06064162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154377492|NCT06064162|Anesthetics, General|anesthetics, general|mesh-ancestor
154377493|NCT06064162|Anesthetics|anesthetics|mesh-ancestor
154377494|NCT06064162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377495|NCT06064162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154377496|NCT06064162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154377497|NCT06064162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377498|NCT06064162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377499|NCT06063798|Anesthetics|anesthetics|mesh-list
154377500|NCT06063798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377542|NCT06041932|Protective Agents|protective agents|mesh-ancestor
154377543|NCT06041932|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154377544|NCT06041932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154377545|NCT06041932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154377546|NCT06041932|Vasodilator Agents|vasodilator agents|mesh-ancestor
154377547|NCT06041932|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154377548|NCT06041932|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154377549|NCT06041932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154377550|NCT06041932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377551|NCT06041932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154377552|NCT06041932|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154377553|NCT06041932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154377555|NCT06040424|Ipratropium|ipratropium|mesh-list
154377556|NCT06040424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154377557|NCT06040424|Autonomic Agents|autonomic agents|mesh-ancestor
154377558|NCT06040424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377559|NCT06040424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377560|NCT06040424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154377562|NCT06040424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154377595|NCT06021990|Purinergic Agents|purinergic agents|mesh-ancestor
154377596|NCT06021990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377597|NCT06021990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521172|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377598|NCT06021990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377599|NCT06007378|Fentanyl|fentanyl|mesh-list
154377600|NCT06007378|Ketamine|ketamine|mesh-list
154377601|NCT06007378|Bupivacaine|bupivacaine|mesh-list
154377602|NCT06007378|Anesthetics, Local|anesthetics, local|mesh-ancestor
154377603|NCT06007378|Anesthetics|anesthetics|mesh-ancestor
154377604|NCT06007378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377605|NCT06007378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377606|NCT06007378|Sensory System Agents|sensory system agents|mesh-ancestor
154377607|NCT06007378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377608|NCT06007378|Analgesics|analgesics|mesh-ancestor
154377609|NCT06007378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154377610|NCT06007378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154377611|NCT06007378|Anesthetics, General|anesthetics, general|mesh-ancestor
154377612|NCT06007378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154377613|NCT06007378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154377614|NCT06007378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377615|NCT06007378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377616|NCT06007378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154377617|NCT06007378|Narcotics|narcotics|mesh-ancestor
154377618|NCT06007378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154377619|NCT05907993|Ibuprofen|ibuprofen|mesh-list
154377620|NCT05907993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154377621|NCT05907993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154377622|NCT05907993|Analgesics|analgesics|mesh-ancestor
154377623|NCT05907993|Sensory System Agents|sensory system agents|mesh-ancestor
154377624|NCT05907993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377639|NCT05890898|Sensory System Agents|sensory system agents|mesh-ancestor
154377640|NCT05890898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377642|NCT05875948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154377643|NCT05875948|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154377644|NCT05852041|Fluorides|fluorides|mesh-list
154377645|NCT05852041|Cariostatic Agents|cariostatic agents|mesh-ancestor
154377646|NCT05852041|Protective Agents|protective agents|mesh-ancestor
154377647|NCT05852041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377648|NCT05735717|Rituximab|rituximab|mesh-list
154377649|NCT05735717|Fludarabine|fludarabine|mesh-list
154377650|NCT05735717|Melphalan|melphalan|mesh-list
154377651|NCT05735717|Busulfan|busulfan|mesh-list
154377652|NCT05735717|Levetiracetam|levetiracetam|mesh-list
154377653|NCT05735717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154377654|NCT05735717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377655|NCT05735717|Immunologic Factors|immunologic factors|mesh-ancestor
154377656|NCT05735717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377657|NCT05735717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377658|NCT05735717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377659|NCT05735717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377660|NCT05735717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154377661|NCT05735717|Alkylating Agents|alkylating agents|mesh-ancestor
154377662|NCT05735717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154377663|NCT05735717|Anticonvulsants|anticonvulsants|mesh-ancestor
154377690|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154377691|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
154377692|NCT05613777|BI 425809|bi 425809|mesh-list
154377693|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154377694|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154377695|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154377696|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
154377697|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154377698|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377699|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153521282|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154377700|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154377701|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154377702|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154377703|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154377704|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154377705|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154377706|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154377707|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
154377708|NCT05561725|Dexamethasone|dexamethasone|mesh-list
154377709|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154377710|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
154377711|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
154377712|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377713|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377714|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154377715|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
154377716|NCT05561725|Hormones|hormones|mesh-ancestor
154377735|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154377736|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154377737|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377738|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377739|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154377740|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154377741|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154377742|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154377743|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
154377744|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
154377745|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
154377746|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
154377747|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377748|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377749|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154377750|NCT05500599|Narcotics|narcotics|mesh-ancestor
154377751|NCT05500599|Analgesics|analgesics|mesh-ancestor
154377752|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
154377753|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377754|NCT05475431|Bismuth|bismuth|mesh-list
154377755|NCT05475431|Antacids|antacids|mesh-ancestor
154377756|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377757|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154377758|NCT05456269|Cytarabine|cytarabine|mesh-list
154377759|NCT05456269|Decitabine|decitabine|mesh-list
154377760|NCT05456269|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154377761|NCT05456269|Bisantrene|bisantrene|mesh-list
154377762|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154377763|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
154377764|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377765|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377766|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
154377767|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377768|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377776|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
154377778|NCT05449392|Emollients|emollients|mesh-ancestor
154377779|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
154377780|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154377781|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377782|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154377783|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
154377784|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154377785|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
154377786|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154377787|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
154377788|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377789|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377790|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
154377791|NCT05411237|Paclitaxel|paclitaxel|mesh-list
154377792|NCT05411237|Doxorubicin|doxorubicin|mesh-list
154377793|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154377794|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154377795|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377796|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
154377797|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
154377798|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
154377799|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377800|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154377801|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154377802|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154377803|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377804|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
154377805|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154377806|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377807|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154377808|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377816|NCT05267470|Paclitaxel|paclitaxel|mesh-list
154377817|NCT05267470|Docetaxel|docetaxel|mesh-list
154377818|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154377819|NCT05267470|Carboplatin|carboplatin|mesh-list
154377820|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
154377821|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
154377822|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154377823|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377824|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154377825|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154377826|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154377827|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377828|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154377829|NCT05267470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154377831|NCT05257655|Narcotics|narcotics|mesh-ancestor
154377832|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377833|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377834|NCT05257655|Analgesics|analgesics|mesh-ancestor
154377835|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
154377836|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377837|NCT05218733|Fentanyl|fentanyl|mesh-list
154377838|NCT05218733|Morphine|morphine|mesh-list
154377839|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
154377840|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377841|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377842|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154377843|NCT05218733|Narcotics|narcotics|mesh-ancestor
154377844|NCT05218733|Analgesics|analgesics|mesh-ancestor
154377845|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
154377846|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377864|NCT05147220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377865|NCT05064449|Itraconazole|itraconazole|mesh-list
154377866|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
154377867|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
154377868|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377869|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154377870|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154377871|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377872|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377873|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154377874|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
154377875|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154377876|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377877|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154377878|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154377879|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154377880|NCT05064449|Analgesics|analgesics|mesh-ancestor
154377881|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
154377882|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377883|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154377884|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154377885|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154377886|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
154377887|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154377888|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377889|NCT05059470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154377890|NCT05059470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377891|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
154377892|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154377893|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
154377894|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154377895|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
154377901|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154377902|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154377903|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377904|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154377905|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154377906|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377907|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377908|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
154377909|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
154377910|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154377911|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154377912|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154377913|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154377914|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377915|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154377916|NCT04997811|Valproic Acid|valproic acid|mesh-list
154377917|NCT04997811|Bezafibrate|bezafibrate|mesh-list
154377918|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
154377919|NCT04997811|Danazol|danazol|mesh-list
154377920|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
154377921|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377922|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377923|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
154377924|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377925|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377926|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
154377927|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153521517|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377947|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
154377948|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377949|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377950|NCT04969276|Vaccines|vaccines|mesh-list
154377951|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
154377952|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377953|NCT04969224|Ivacaftor|ivacaftor|mesh-list
154377954|NCT04969224|Elexacaftor|elexacaftor|mesh-list
154377955|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154377956|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154377957|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377958|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
154377959|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154377960|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154377961|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
154377962|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
154377963|NCT04908228|Ibrutinib|ibrutinib|mesh-list
154377964|NCT04908228|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154377965|NCT04908228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154377966|NCT04908228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377967|NCT04908228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377968|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154377969|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377970|NCT04881799|Topiramate|topiramate|mesh-list
154377971|NCT04881799|Phentermine|phentermine|mesh-list
154377972|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
154377973|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154377974|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124196|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
154377975|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154377976|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
154377977|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154377978|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
154377979|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
154377980|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154377981|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
154377982|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154377983|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377984|NCT04856215|Antibodies|antibodies|mesh-list
154377985|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154377986|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
154377987|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377988|NCT04818632|Everolimus|everolimus|mesh-list
154377989|NCT04818632|Palbociclib|palbociclib|mesh-list
154377990|NCT04818632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154377991|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154377992|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154377993|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154377994|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154377995|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
154377996|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154377997|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154377998|NCT04790045|Venetoclax|venetoclax|mesh-list
154377999|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378000|NCT04779216|Alendronate|alendronate|mesh-list
154378001|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154378002|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378003|NCT04754035|Venetoclax|venetoclax|mesh-list
154378004|NCT04754035|Ibrutinib|ibrutinib|mesh-list
154378005|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378006|NCT04754035|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154378007|NCT04754035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154378008|NCT04754035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521628|NCT03475134|Analgesics|analgesics|mesh-ancestor
154378009|NCT04754035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378010|NCT04748419|Durvalumab|durvalumab|mesh-list
154378011|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378012|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378013|NCT04728633|Carmustine|carmustine|mesh-list
154378029|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378030|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
154378031|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378032|NCT04646005|Cemiplimab|cemiplimab|mesh-list
154378033|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378034|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378035|NCT04617535|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154378036|NCT04617535|Antiviral Agents|antiviral agents|mesh-ancestor
154378037|NCT04617535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378038|NCT04591431|Nivolumab|nivolumab|mesh-list
154378039|NCT04591431|Trastuzumab|trastuzumab|mesh-list
154378040|NCT04591431|Ipilimumab|ipilimumab|mesh-list
154378041|NCT04591431|Atezolizumab|atezolizumab|mesh-list
154378042|NCT04591431|Pertuzumab|pertuzumab|mesh-list
154378043|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154378044|NCT04591431|Everolimus|everolimus|mesh-list
154378045|NCT04591431|Palbociclib|palbociclib|mesh-list
154378046|NCT04591431|Lapatinib|lapatinib|mesh-list
154378047|NCT04591431|Vemurafenib|vemurafenib|mesh-list
154378048|NCT04591431|Maytansine|maytansine|mesh-list
154378049|NCT04591431|Talazoparib|talazoparib|mesh-list
154378050|NCT04591431|Ponatinib|ponatinib|mesh-list
154378051|NCT04591431|Ipatasertib|ipatasertib|mesh-list
154378052|NCT04591431|Tepotinib|tepotinib|mesh-list
154378053|NCT04591431|Pralsetinib|pralsetinib|mesh-list
154378054|NCT04591431|Alectinib|alectinib|mesh-list
154378055|NCT04591431|Entrectinib|entrectinib|mesh-list
154378056|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378057|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378058|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154378059|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378071|NCT04591431|Immunotoxins|immunotoxins|mesh-ancestor
154378080|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
154378081|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378082|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378083|NCT04546074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154378084|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378085|NCT04546074|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154378086|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154378087|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378088|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
154378089|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154378090|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
154378091|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378093|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
154378094|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378095|NCT04490018|Vaccines|vaccines|mesh-list
154378096|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
154378097|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378098|NCT04481204|Leucovorin|leucovorin|mesh-list
154378099|NCT04481204|Paclitaxel|paclitaxel|mesh-list
154378100|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154378101|NCT04481204|Cisplatin|cisplatin|mesh-list
154378102|NCT04481204|Gemcitabine|gemcitabine|mesh-list
154378103|NCT04481204|Fluorouracil|fluorouracil|mesh-list
154378104|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
154378105|NCT04481204|Irinotecan|irinotecan|mesh-list
154378106|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154378107|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378108|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
154378109|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
154378110|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
154378111|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378113|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
154378124|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
154378125|NCT04455139|Melphalan|melphalan|mesh-list
154378126|NCT04455139|Topotecan|topotecan|mesh-list
153521721|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
154378127|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154378128|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
154378129|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378130|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378131|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154378132|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378133|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
154378134|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378135|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154378136|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154378137|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378138|NCT04311099|Ropivacaine|ropivacaine|mesh-list
154378187|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378188|NCT04141995|Antidotes|antidotes|mesh-ancestor
154378189|NCT04141995|Protective Agents|protective agents|mesh-ancestor
154378190|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
154378191|NCT04141995|Vitamins|vitamins|mesh-ancestor
154378192|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
154378193|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154378194|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154378195|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154378196|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
154378197|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378198|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378199|NCT04134559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154378200|NCT04134559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378201|NCT04107675|Cyclosporine|cyclosporine|mesh-list
154378202|NCT04107675|Cyclosporins|cyclosporins|mesh-list
154378203|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378204|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378205|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378206|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
154378207|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378208|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
154378209|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378210|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
154378211|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378212|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154378213|NCT03982082|Coal Tar|coal tar|mesh-list
154378214|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
154378215|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
154378216|NCT03915405|Avelumab|avelumab|mesh-list
154378217|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378218|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378219|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
154378220|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378221|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378222|NCT03829254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154378223|NCT03829254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378225|NCT03826589|Axitinib|axitinib|mesh-list
154378226|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378227|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378228|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154378229|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378230|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378231|NCT03781414|Tacrolimus|tacrolimus|mesh-list
154378232|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378233|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
154378234|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378235|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154378236|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378237|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378238|NCT03611556|Leucovorin|leucovorin|mesh-list
154378239|NCT03611556|Folic Acid|folic acid|mesh-list
154378240|NCT03611556|Gemcitabine|gemcitabine|mesh-list
154378241|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
154378242|NCT03611556|Fluorouracil|fluorouracil|mesh-list
154378243|NCT03611556|Durvalumab|durvalumab|mesh-list
154378244|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
154378282|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378284|NCT03426761|Cefazolin|cefazolin|mesh-list
154378285|NCT03426761|Daptomycin|daptomycin|mesh-list
154378286|NCT03426761|Dalbavancin|dalbavancin|mesh-list
154378288|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154378289|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378290|NCT03332667|Vorinostat|vorinostat|mesh-list
154378291|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154378292|NCT03332667|Dinutuximab|dinutuximab|mesh-list
154378293|NCT03332667|Sargramostim|sargramostim|mesh-list
154378294|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
154378295|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378296|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378297|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154378304|NCT03248479|Azacitidine|azacitidine|mesh-list
154378344|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378345|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154378346|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378347|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
154378348|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378419|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154378420|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
154378421|NCT02473042|Promethazine|promethazine|mesh-list
154378422|NCT02473042|Dexamethasone|dexamethasone|mesh-list
154378423|NCT02473042|Ondansetron|ondansetron|mesh-list
154378424|NCT02473042|Famotidine|famotidine|mesh-list
154378425|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154378426|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
154378427|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
154378428|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378429|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378430|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154378431|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
154378432|NCT02473042|Hormones|hormones|mesh-ancestor
154378433|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154378434|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154378435|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378436|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
154378478|NCT02081885|Chitosan|chitosan|mesh-list
154378479|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154378480|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154378481|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
154378482|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378483|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154378484|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
154378485|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
154378486|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
154378487|NCT02081885|Coagulants|coagulants|mesh-ancestor
154378488|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
154378489|NCT01757418|Antibodies|antibodies|mesh-list
154378490|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
154378491|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154378492|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154378493|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
154378494|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378495|NCT01438411|Cholic Acids|cholic acids|mesh-list
154378496|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154378497|NCT01302834|Cetuximab|cetuximab|mesh-list
154378498|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378499|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154378500|NCT01153698|Dabigatran|dabigatran|mesh-list
154378501|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
154378502|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154378503|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
154378504|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378505|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378506|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
154378507|NCT01115582|Cholic Acids|cholic acids|mesh-list
154378508|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154378509|NCT00804856|Cytarabine|cytarabine|mesh-list
154378510|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154378511|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
154378512|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378513|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378514|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
154378518|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378519|NCT00294580|Maloprim|maloprim|mesh-list
154378520|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
154378521|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154378522|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154378523|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378524|NCT03304444|Bupivacaine|bupivacaine|mesh-list
154378525|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
154378526|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
154378527|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378528|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378529|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
154378530|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378582|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378583|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
154378584|NCT04490980|Butorphanol|butorphanol|mesh-list
154378585|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154378586|NCT04490980|Narcotics|narcotics|mesh-ancestor
154378587|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154378588|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378589|NCT04490980|Analgesics|analgesics|mesh-ancestor
154378590|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
154378591|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378592|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
154378593|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
154378594|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154378595|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154378596|NCT03307720|Hormones|hormones|mesh-list
154378597|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154378598|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378599|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154378600|NCT04608786|Capecitabine|capecitabine|mesh-list
154378601|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154378602|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
154378603|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378604|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154378605|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154378606|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154378607|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154378629|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
153521999|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378630|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154378631|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154378632|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
154378633|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378634|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378635|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378636|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
154378637|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
154378638|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378639|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154378640|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154378641|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
154378642|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378643|NCT03312478|Antibodies|antibodies|mesh-list
154378644|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378645|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
154378646|NCT03312244|Bromides|bromides|mesh-list
154378647|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154378648|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
154378649|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154378650|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378652|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
154378680|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154378681|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154378682|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
154378683|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378684|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154378685|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154378686|NCT01343862|Cycloserine|cycloserine|mesh-list
154378687|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154378688|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154378689|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154378690|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
154378744|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154378745|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
154378746|NCT01344174|Hormones|hormones|mesh-ancestor
154378747|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154378814|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
154378815|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
154378816|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378817|NCT04296942|Immunotoxins|immunotoxins|mesh-ancestor
154378818|NCT04296942|Immunoconjugates|immunoconjugates|mesh-ancestor
154378820|NCT04296942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378821|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154378822|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154378823|NCT01344564|Leuprolide|leuprolide|mesh-list
154378824|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154378830|NCT01344720|Etoricoxib|etoricoxib|mesh-list
154378878|NCT05468632|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154378879|NCT05468632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154378880|NCT05468632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378881|NCT02720536|Deferasirox|deferasirox|mesh-list
154378882|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154378883|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
154378884|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
154378885|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378886|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
154378887|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
154378888|NCT03168438|Fludarabine|fludarabine|mesh-list
154378889|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522098|NCT04892732|Budesonide|budesonide|mesh-list
154378890|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
154378891|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378892|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154378893|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154378894|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
154378936|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154378937|NCT01347996|Analgesics|analgesics|mesh-ancestor
154378938|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
154378939|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154378940|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154378941|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
154378942|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
154378943|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378944|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154378945|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154378946|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
154378947|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154378957|NCT01348308|Maraviroc|maraviroc|mesh-list
154378997|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154378998|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379000|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154379001|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154379002|NCT01465334|Prednisolone|prednisolone|mesh-list
154379003|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
154379004|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
154379005|NCT01465334|Ofatumumab|ofatumumab|mesh-list
154379006|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154379007|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
154379008|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154379009|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
154379010|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
154379011|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379012|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379013|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154379014|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
154379015|NCT01465334|Hormones|hormones|mesh-ancestor
154379016|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379017|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154379018|NCT01465334|Protective Agents|protective agents|mesh-ancestor
154379019|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154379020|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379021|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379022|NCT04019262|Temozolomide|temozolomide|mesh-list
154379024|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
154379043|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379044|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154379045|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154379046|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154379047|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
154379048|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379049|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379050|NCT04948814|Vancomycin|vancomycin|mesh-list
154379051|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154379052|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379053|NCT02718898|Ixekizumab|ixekizumab|mesh-list
154379054|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
154379055|NCT05726734|Amoxicillin|amoxicillin|mesh-list
154379056|NCT05726734|Metronidazole|metronidazole|mesh-list
154379057|NCT05726734|Potassium Citrate|potassium citrate|mesh-list
153522231|NCT06039540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154379058|NCT05726734|Esomeprazole|esomeprazole|mesh-list
154379059|NCT05726734|Bismuth|bismuth|mesh-list
154379061|NCT05726734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154379103|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154379104|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154379105|NCT01353846|Estradiol|estradiol|mesh-list
154379106|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154379107|NCT01353846|Progesterone|progesterone|mesh-list
154379108|NCT01353846|Estrogens|estrogens|mesh-ancestor
154379109|NCT01353846|Hormones|hormones|mesh-ancestor
154379110|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379111|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379112|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154379113|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
154379114|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154379116|NCT01353846|Progestins|progestins|mesh-ancestor
154379167|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379168|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379169|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
154379170|NCT04490434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154379171|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
154379172|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154379173|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
154379174|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379175|NCT03143166|Telmisartan|telmisartan|mesh-list
154379176|NCT03143166|Dabigatran|dabigatran|mesh-list
154379177|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154379178|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154379179|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154379180|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379181|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
154379182|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154379183|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
154379184|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379185|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
154379186|NCT02466568|Nivolumab|nivolumab|mesh-list
154379187|NCT02466568|Vaccines|vaccines|mesh-list
154379188|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
154379189|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379190|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379191|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379192|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154379193|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379194|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
154379195|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154379196|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379197|NCT02879994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154379209|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154379210|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154379211|NCT02466022|Analgesics|analgesics|mesh-ancestor
154379212|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154379213|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154379214|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154379215|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
154379216|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379217|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379218|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154379219|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154379271|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154379272|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379273|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
154379274|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154379275|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154379297|NCT00702052|Everolimus|everolimus|mesh-list
154379338|NCT01350024|Epinephrine|epinephrine|mesh-list
154379339|NCT01350024|Racepinephrine|racepinephrine|mesh-list
154379340|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
154379341|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
154379342|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
154379343|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379344|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379345|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
154379346|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379347|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154379348|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154379349|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154379350|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154379351|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379352|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154379353|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154379354|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
154379355|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379356|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154379361|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
154379393|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379394|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154379395|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154379396|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
154379466|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
154379467|NCT05720572|Antazoline|antazoline|mesh-list
154379468|NCT05720572|Propafenone|propafenone|mesh-list
154379469|NCT05720572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154379471|NCT05720572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154379538|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379539|NCT01351272|Methylphenidate|methylphenidate|mesh-list
154379540|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154379541|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379542|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154379543|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154379544|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154379545|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379546|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
154379547|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154379599|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379600|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154379601|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379603|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154379604|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379605|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154379606|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154379607|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
154379665|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154379667|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
154379668|NCT02463682|Insulin|insulin|mesh-list
154379669|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154379670|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379671|NCT01978938|Levofloxacin|levofloxacin|mesh-list
153522410|NCT05799326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154379672|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154379673|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379674|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154379675|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154379676|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154379728|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379729|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154379730|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
154379731|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
154379732|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379733|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
154379734|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154379735|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154379736|NCT05550142|Vaccines|vaccines|mesh-list
154379737|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
154379738|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379739|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
154379740|NCT00116142|Docetaxel|docetaxel|mesh-list
154379741|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
154379742|NCT00116142|Androgens|androgens|mesh-list
154379743|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154379744|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379745|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
154379746|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
154379747|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
154379748|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379749|NCT00116142|Hormones|hormones|mesh-ancestor
154379750|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154379751|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379752|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
154379753|NCT00116142|Protective Agents|protective agents|mesh-ancestor
154379754|NCT00116142|Vitamins|vitamins|mesh-ancestor
154379755|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
154379756|NCT00116142|Estrogens|estrogens|mesh-ancestor
154379757|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154379758|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
154379759|NCT05547256|Vaccines|vaccines|mesh-list
154379760|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
154379761|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379762|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
154379763|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
154379764|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154379769|NCT02023905|Everolimus|everolimus|mesh-list
154379770|NCT02023905|Temozolomide|temozolomide|mesh-list
154379771|NCT02023905|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154379772|NCT02023905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154379773|NCT02023905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379774|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379775|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125996|NCT00965289|Rituximab|rituximab|mesh-list
154379837|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154379838|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154379839|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154379840|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379841|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
154379842|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
154379843|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154379844|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
154379845|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154379846|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379847|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379848|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154379849|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
154379850|NCT01334073|Everolimus|everolimus|mesh-list
154379851|NCT01334073|Axitinib|axitinib|mesh-list
154379852|NCT01334073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154379853|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154379854|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154379856|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154379895|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154379896|NCT01845441|Narcotics|narcotics|mesh-ancestor
154379897|NCT03296488|Fentanyl|fentanyl|mesh-list
154379898|NCT03296488|Nalbuphine|nalbuphine|mesh-list
154379899|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154379900|NCT03296488|Narcotics|narcotics|mesh-ancestor
154379901|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154379902|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154379903|NCT03296488|Analgesics|analgesics|mesh-ancestor
154379904|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
154379962|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154379963|NCT01822275|Temozolomide|temozolomide|mesh-list
154379964|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154379965|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
154379966|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154379967|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379968|NCT01331421|Exemestane|exemestane|mesh-list
154379969|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154379970|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154379971|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154379972|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380026|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380027|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380028|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
154380029|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380030|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380031|NCT03295786|Protective Agents|protective agents|mesh-ancestor
154380032|NCT03194932|Cytarabine|cytarabine|mesh-list
154380033|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
154380034|NCT03194932|Methotrexate|methotrexate|mesh-list
154380035|NCT03194932|Azacitidine|azacitidine|mesh-list
154380092|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
154380093|NCT00897104|Sumatriptan|sumatriptan|mesh-list
154380094|NCT00897104|Rizatriptan|rizatriptan|mesh-list
154380095|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154380096|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154380097|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154380098|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
154380099|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380100|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380101|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380102|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154380103|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154380104|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380105|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380106|NCT03295162|Melatonin|melatonin|mesh-list
154380107|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
154380108|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380109|NCT03295162|Protective Agents|protective agents|mesh-ancestor
154380147|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380148|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380150|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
154380151|NCT03108274|Midazolam|midazolam|mesh-list
154380152|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154380153|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154380154|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380155|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380216|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
154380217|NCT00398606|Calcium|calcium|mesh-list
154380218|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154380219|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522592|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
154380220|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380222|NCT00398606|Antacids|antacids|mesh-ancestor
154380282|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
154380283|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380284|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380285|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154380286|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380287|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
154380288|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
154380289|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380290|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154380346|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380347|NCT03287128|Immunotoxins|immunotoxins|mesh-ancestor
154380348|NCT03287128|Immunoconjugates|immunoconjugates|mesh-ancestor
154380349|NCT03287128|Immunologic Factors|immunologic factors|mesh-ancestor
154380350|NCT03287128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380351|NCT00457275|Ezetimibe|ezetimibe|mesh-list
154380352|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154380353|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154380354|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
154380355|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380356|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154380357|NCT03294070|Amlodipine|amlodipine|mesh-list
154380358|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154380359|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154380364|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
154380406|NCT06029803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154380407|NCT06029803|Autonomic Agents|autonomic agents|mesh-ancestor
154380408|NCT06029803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380409|NCT06029803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154380410|NCT06029803|Respiratory System Agents|respiratory system agents|mesh-ancestor
154380411|NCT06029803|Mydriatics|mydriatics|mesh-ancestor
154380412|NCT06029803|Sympathomimetics|sympathomimetics|mesh-ancestor
154380413|NCT06029803|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154380414|NCT06029569|Sirolimus|sirolimus|mesh-list
154380415|NCT06029569|Paclitaxel|paclitaxel|mesh-list
154380416|NCT06029569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154380417|NCT06029569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380418|NCT06029569|Tubulin Modulators|tubulin modulators|mesh-ancestor
154380419|NCT06029569|Antimitotic Agents|antimitotic agents|mesh-ancestor
154380420|NCT06029569|Mitosis Modulators|mitosis modulators|mesh-ancestor
154380421|NCT06029569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380429|NCT06028737|Leucovorin|leucovorin|mesh-list
154380467|NCT06028256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380468|NCT06028256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380469|NCT06028256|Sympathomimetics|sympathomimetics|mesh-ancestor
154380470|NCT06028256|Autonomic Agents|autonomic agents|mesh-ancestor
154380471|NCT06028256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380472|NCT06028256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154380536|NCT05917067|Parathyroid Hormone|parathyroid hormone|mesh-list
154380537|NCT05917067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154380538|NCT05917067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380540|NCT05821517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154380541|NCT05821517|Anesthetics, General|anesthetics, general|mesh-ancestor
154380542|NCT05821517|Anesthetics|anesthetics|mesh-ancestor
154380543|NCT05821517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153522709|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153522746|NCT03887650|Hormones|hormones|mesh-ancestor
154380544|NCT05821517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380545|NCT05803811|Riboflavin|riboflavin|mesh-list
154380546|NCT05803811|Vitamin B Complex|vitamin b complex|mesh-ancestor
154380547|NCT05803811|Vitamins|vitamins|mesh-ancestor
154380548|NCT05803811|Micronutrients|micronutrients|mesh-ancestor
154380549|NCT05803811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380550|NCT05803811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154380551|NCT05803811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154380552|NCT05764057|Dapagliflozin|dapagliflozin|mesh-list
154380553|NCT05764057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154380554|NCT05764057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380555|NCT05764057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154380556|NCT05764057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380557|NCT05652673|Nivolumab|nivolumab|mesh-list
154380589|NCT05552287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380590|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
154380591|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154380592|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380593|NCT05542407|Atezolizumab|atezolizumab|mesh-list
154380594|NCT05542407|TIC10 compound|tic10 compound|mesh-list
154380595|NCT05542407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154380596|NCT05542407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380597|NCT05542407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380598|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380599|NCT05517642|Vaccines|vaccines|mesh-list
154380600|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
154380601|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380602|NCT05438498|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154380603|NCT05438498|Antiviral Agents|antiviral agents|mesh-ancestor
154380604|NCT05438498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380605|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
154380646|NCT05237687|Sirolimus|sirolimus|mesh-list
154380647|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154380648|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154380649|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154380650|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380651|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
154380652|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154380653|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
154380654|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380655|NCT05200143|Nivolumab|nivolumab|mesh-list
154380656|NCT05200143|Ipilimumab|ipilimumab|mesh-list
154380657|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154380658|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154380659|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154380660|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380661|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
154380662|NCT05142254|Tadalafil|tadalafil|mesh-list
154380663|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
154380704|NCT04970108|Empagliflozin|empagliflozin|mesh-list
154380705|NCT04970108|Telmisartan|telmisartan|mesh-list
154380706|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154380707|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380708|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154380709|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380710|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154380711|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154380712|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154380771|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154380772|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154380773|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154380774|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154380775|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154380776|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
154380777|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154380778|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
154380836|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380837|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380838|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154380839|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
154380840|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154380841|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380842|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380843|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154380844|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154380845|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154380846|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
154380847|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
154380848|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380849|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
154380850|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154380851|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380903|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
154380904|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380905|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380906|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380907|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154380908|NCT04593329|Dipyrone|dipyrone|mesh-list
154380909|NCT04593329|Tramadol|tramadol|mesh-list
154380910|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154380911|NCT04593329|Narcotics|narcotics|mesh-ancestor
154380912|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154380913|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380914|NCT04593329|Analgesics|analgesics|mesh-ancestor
154380915|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
154380916|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154380917|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154380918|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154380919|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154380920|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154380925|NCT04388904|Tenofovir|tenofovir|mesh-list
154380962|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154380963|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154380964|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
154380965|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154380966|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154380967|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154380968|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154380969|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154380970|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154380971|NCT04049539|Cytarabine|cytarabine|mesh-list
154380972|NCT04049539|Daunorubicin|daunorubicin|mesh-list
154380973|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154380974|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
154380986|NCT03976323|Cisplatin|cisplatin|mesh-list
154381023|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154381024|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154381025|NCT03740165|Growth Substances|growth substances|mesh-ancestor
154381026|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381027|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
154381028|NCT03740165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154381029|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154381030|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381031|NCT03737240|Insulin|insulin|mesh-list
154381032|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154381033|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
154381034|NCT03737240|Liraglutide|liraglutide|mesh-list
154381086|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
154381087|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154381088|NCT03452111|ST 1435|st 1435|mesh-list
154381089|NCT03452111|Testosterone|testosterone|mesh-list
154381090|NCT03452111|Androgens|androgens|mesh-ancestor
154381091|NCT03452111|Hormones|hormones|mesh-ancestor
154381092|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381093|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381094|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154381095|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
154381096|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154381097|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154381098|NCT03449901|Gemcitabine|gemcitabine|mesh-list
154381099|NCT03449901|Docetaxel|docetaxel|mesh-list
154381100|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381101|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
154381102|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381103|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381104|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
154381105|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
154381106|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
154381107|NCT03363659|Copper|copper|mesh-list
154381108|NCT03363659|Temozolomide|temozolomide|mesh-list
154381109|NCT03363659|Disulfiram|disulfiram|mesh-list
154381110|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154381111|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
154381112|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381113|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381114|NCT03363659|Trace Elements|trace elements|mesh-ancestor
154381115|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
154381116|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381117|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154381130|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
154381131|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381132|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381133|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
154381134|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381135|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522883|NCT03264131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381136|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381137|NCT03201250|Dexamethasone|dexamethasone|mesh-list
154381138|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381139|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
154381140|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
154381141|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381193|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
154381194|NCT02499120|Cetuximab|cetuximab|mesh-list
154381195|NCT02499120|Palbociclib|palbociclib|mesh-list
154381196|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381197|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381198|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154381199|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381200|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381201|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154381202|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
154381203|NCT02227992|Coagulants|coagulants|mesh-ancestor
154381204|NCT01871766|Dactinomycin|dactinomycin|mesh-list
154381257|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154381259|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381260|NCT01346787|Dexamethasone|dexamethasone|mesh-list
154381261|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
154381262|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381263|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
154381264|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381265|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154381266|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154381267|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
154381268|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381319|NCT01332201|Tacrolimus|tacrolimus|mesh-list
154381320|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381321|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
154381322|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381323|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154381324|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381325|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381326|NCT01332279|Everolimus|everolimus|mesh-list
154381327|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154381328|NCT01332279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154381329|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154381330|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381331|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381332|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381333|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
154381377|NCT05202002|Hormones|hormones|mesh-ancestor
154381378|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381379|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381380|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381381|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381382|NCT02460640|Morphine|morphine|mesh-list
154381383|NCT02460640|Ropivacaine|ropivacaine|mesh-list
154381384|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154381385|NCT02460640|Narcotics|narcotics|mesh-ancestor
154381386|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381388|NCT02460640|Analgesics|analgesics|mesh-ancestor
154381441|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154381442|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
154381443|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381445|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154381512|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154381513|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154381514|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
154381515|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381516|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381517|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154381518|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154381519|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
154381520|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154381578|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
154381579|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381580|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381581|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381582|NCT03107962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154381583|NCT03107962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381584|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
154381585|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154381586|NCT04891172|Antibodies|antibodies|mesh-list
154381587|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
154381588|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154381589|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
154381590|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381591|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
154381592|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381593|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381594|NCT01335321|Triamcinolone|triamcinolone|mesh-list
154381595|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
154381596|NCT01335321|Hylan|hylan|mesh-list
154381598|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
154381634|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381635|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154381636|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154381637|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
154381638|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154381639|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381640|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381641|NCT02885181|Methotrexate|methotrexate|mesh-list
154381642|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154381643|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
154381644|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154381645|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381646|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154381693|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381694|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
154381695|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
154381696|NCT03157089|Afatinib|afatinib|mesh-list
154381697|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381698|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381699|NCT03157089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154381700|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381701|NCT03157089|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154381759|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
154381760|NCT01338675|Busulfan|busulfan|mesh-list
154381761|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
154381762|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381763|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154381764|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
154381765|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381766|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154381767|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381768|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154381769|NCT01338753|Bevacizumab|bevacizumab|mesh-list
154381770|NCT01338753|Docetaxel|docetaxel|mesh-list
154381771|NCT01338753|Doxorubicin|doxorubicin|mesh-list
154381772|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154381773|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381774|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154381819|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
154381820|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154381821|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381822|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
154381823|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154381824|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154381825|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154381826|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154381827|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154381881|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154381882|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154381883|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154381884|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381885|NCT03264274|Aflibercept|aflibercept|mesh-list
154381886|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154381887|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154381888|NCT03264274|Growth Substances|growth substances|mesh-ancestor
154381889|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381890|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
154381891|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381892|NCT02457208|Rifampin|rifampin|mesh-list
154381893|NCT02457208|Isoniazid|isoniazid|mesh-list
154381894|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
154381895|NCT02457208|Ethambutol|ethambutol|mesh-list
154381896|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154381897|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
154381898|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154381899|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381900|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
154381901|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154381902|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381903|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381904|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154381905|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154381911|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154381928|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154381929|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154381930|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154381931|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154381932|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154381933|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381934|NCT03263962|Canrenone|canrenone|mesh-list
154381935|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154381936|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
154381937|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154381938|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381939|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154381940|NCT03263962|Diuretics|diuretics|mesh-ancestor
154381941|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
154381942|NCT05186649|Warfarin|warfarin|mesh-list
154381986|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
154381987|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154381988|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153426541|NCT03714919|Analgesics|analgesics|mesh-ancestor
154381989|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154381991|NCT05183997|Thrombin|thrombin|mesh-list
154381992|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154381993|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154381994|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154381995|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154381996|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154381998|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
154382048|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154382049|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154382050|NCT03276598|Diuretics|diuretics|mesh-ancestor
154382051|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
154382052|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154382053|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
154382054|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
154382055|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382056|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154382057|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154382058|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154382059|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
154382065|NCT03262792|Analgesics|analgesics|mesh-ancestor
154382109|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
154382110|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382111|NCT01359696|Gemcitabine|gemcitabine|mesh-list
154382112|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154382113|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
154382114|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382115|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382116|NCT03268018|Calcium|calcium|mesh-list
154382117|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154382118|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382119|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154382120|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154382121|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154382122|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382170|NCT04235634|Urological Agents|urological agents|mesh-ancestor
154382171|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
154382172|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154382173|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382174|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382175|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154382176|NCT03262090|Analgesics|analgesics|mesh-ancestor
154382177|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
154382235|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154382236|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382237|NCT05074966|Cetuximab|cetuximab|mesh-list
154382238|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154382239|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382240|NCT03266926|Bupivacaine|bupivacaine|mesh-list
154382241|NCT03266926|Estrogens|estrogens|mesh-list
154382242|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154382243|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
154382244|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
154382245|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154382246|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382247|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
154382248|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382249|NCT03266926|Hormones|hormones|mesh-ancestor
154382250|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382251|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
154382252|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154382253|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
154382254|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382255|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382256|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154382257|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
154382258|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154382259|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154382260|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154382261|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
154382262|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382263|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382264|NCT01367418|Sufentanil|sufentanil|mesh-list
154382265|NCT01367418|Morphine|morphine|mesh-list
154382266|NCT01367418|Bupivacaine|bupivacaine|mesh-list
154382267|NCT01367418|Ropivacaine|ropivacaine|mesh-list
154382278|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154382279|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
154382280|NCT01360086|Leucovorin|leucovorin|mesh-list
154382281|NCT01360086|Fluorouracil|fluorouracil|mesh-list
154382282|NCT01360086|Cetuximab|cetuximab|mesh-list
154382283|NCT01360086|Calcium|calcium|mesh-list
154382284|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
154382285|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382286|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154382349|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523229|NCT04507204|Methylphenidate|methylphenidate|mesh-list
154382350|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154382351|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154382352|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382353|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382354|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154382355|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
154382356|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382357|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382358|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154382359|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
154382360|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154382361|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
154382362|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154382363|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382364|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154382365|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154382366|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154382367|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382371|NCT03146403|Vaccines|vaccines|mesh-list
154382399|NCT01363206|Sargramostim|sargramostim|mesh-list
154382400|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154382401|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382402|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154382403|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382404|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
154382405|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382406|NCT01344213|Celecoxib|celecoxib|mesh-list
154382407|NCT01344213|Pregabalin|pregabalin|mesh-list
154382463|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382464|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382465|NCT01367964|Hormones|hormones|mesh-list
154382466|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154382467|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154382468|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
154382469|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382470|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382471|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382472|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382473|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
154382474|NCT04326933|Nilotinib|nilotinib|mesh-list
154382475|NCT04326933|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154382476|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154382477|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382478|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382479|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382480|NCT04733560|Bupivacaine|bupivacaine|mesh-list
154382481|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
154382515|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153426697|NCT00000914|Ritonavir|ritonavir|mesh-list
153523331|NCT04169347|Antidotes|antidotes|mesh-ancestor
154382516|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382517|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154382519|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154382520|NCT02456428|Insulin|insulin|mesh-list
154382521|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154382522|NCT02456428|Metformin|metformin|mesh-list
154382523|NCT02456428|Pioglitazone|pioglitazone|mesh-list
154382524|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154382525|NCT02456428|Liraglutide|liraglutide|mesh-list
154382526|NCT02456428|Exenatide|exenatide|mesh-list
154382527|NCT02456428|Glimepiride|glimepiride|mesh-list
154382528|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
154382529|NCT02456428|Vildagliptin|vildagliptin|mesh-list
154382530|NCT02456428|Saxagliptin|saxagliptin|mesh-list
154382531|NCT02456428|Acarbose|acarbose|mesh-list
154382532|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154382533|NCT02456428|Repaglinide|repaglinide|mesh-list
154382534|NCT02456428|Gliclazide|gliclazide|mesh-list
154382535|NCT02456428|Glipizide|glipizide|mesh-list
154382536|NCT02456428|Biguanides|biguanides|mesh-list
154382537|NCT02456428|Tolbutamide|tolbutamide|mesh-list
154382538|NCT02456428|Voglibose|voglibose|mesh-list
154382539|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154382540|NCT02456428|Nateglinide|nateglinide|mesh-list
154382541|NCT02456428|Miglitol|miglitol|mesh-list
154382575|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
154382576|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382577|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154382578|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154382579|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
154382644|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
154382645|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382646|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382647|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154382649|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154382650|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
154382651|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
154382652|NCT01363752|Sirolimus|sirolimus|mesh-list
154382653|NCT01363752|Tacrolimus|tacrolimus|mesh-list
154382654|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154382655|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
154382670|NCT01360710|Irbesartan|irbesartan|mesh-list
154382707|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154382708|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154382709|NCT02713204|Growth Substances|growth substances|mesh-ancestor
154382710|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382711|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
154382712|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154382713|NCT03695172|Ropivacaine|ropivacaine|mesh-list
154382714|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
154382715|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
154382774|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
154382775|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154382776|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154382777|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154382778|NCT04359147|Yohimbine|yohimbine|mesh-list
154382779|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154382780|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
154382781|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
154382782|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154382783|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382784|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154382785|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154382786|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154382787|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
154382788|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382790|NCT04359147|Urological Agents|urological agents|mesh-ancestor
154382833|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
154382834|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
154382835|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154382836|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
154382837|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382838|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382839|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
154382840|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
154382841|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382896|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154382897|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154382898|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154382899|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154382900|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382901|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382902|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382903|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154382904|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
154382905|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382907|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154382908|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154382909|NCT03251872|Olaparib|olaparib|mesh-list
154382910|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154382911|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154382912|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523497|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153523499|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153523500|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
153523501|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523502|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153523503|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523504|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523505|NCT03648021|Acetaminophen|acetaminophen|mesh-list
153523506|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153523507|NCT03648021|Analgesics|analgesics|mesh-ancestor
153523508|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
153523509|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523510|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523511|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
153523512|NCT03613792|Midazolam|midazolam|mesh-list
153523513|NCT03613792|Fentanyl|fentanyl|mesh-list
153523514|NCT03613792|Ketamine|ketamine|mesh-list
153523515|NCT03613792|Remifentanil|remifentanil|mesh-list
153523516|NCT03613792|Analgesics|analgesics|mesh-ancestor
153523517|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
154382949|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154382950|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154382951|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154382952|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154382953|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154382954|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154382955|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154382956|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154382957|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154382958|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
154382959|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
154382960|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154382961|NCT03251170|Narcotics|narcotics|mesh-ancestor
154382962|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
154382963|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
154382964|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
154383007|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383008|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383009|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154383010|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154383011|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
154383012|NCT01346007|Vaccines|vaccines|mesh-list
154383013|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154383014|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
154383015|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383074|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154383075|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
154383076|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383077|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154383078|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383079|NCT02903823|Baclofen|baclofen|mesh-list
154383080|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154383081|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383082|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154383083|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383084|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154383085|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
154383086|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
154383087|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383088|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383089|NCT03244930|Plerixafor|plerixafor|mesh-list
154383090|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154383091|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154383092|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
153523569|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
153523570|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153523571|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
153523572|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383093|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383094|NCT02855697|Olaparib|olaparib|mesh-list
154383095|NCT02855697|Cediranib|cediranib|mesh-list
154383096|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154383097|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383101|NCT03894501|Methadone|methadone|mesh-list
154383126|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154383127|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383128|NCT03244462|Methotrexate|methotrexate|mesh-list
154383129|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154383130|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
154383131|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154383132|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383133|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154383134|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
154383136|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383190|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154383191|NCT00832455|Montelukast|montelukast|mesh-list
154383192|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154383193|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
154383194|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154383195|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
154383196|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383197|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383198|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154383199|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154383200|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383201|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
154383202|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154383203|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
154383204|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154383205|NCT01350921|Ticagrelor|ticagrelor|mesh-list
154383206|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154383207|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154383208|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154383209|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154383210|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
154383211|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383212|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383213|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383214|NCT00423579|Simvastatin|simvastatin|mesh-list
154383215|NCT00423579|Ezetimibe|ezetimibe|mesh-list
154383216|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154383217|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154383218|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154383219|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
154383230|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383232|NCT01352559|Mirtazapine|mirtazapine|mesh-list
154383233|NCT01352559|Sertraline|sertraline|mesh-list
154383234|NCT01352559|Fluoxetine|fluoxetine|mesh-list
154383235|NCT01352559|Paroxetine|paroxetine|mesh-list
154383236|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154383237|NCT01352559|Nortriptyline|nortriptyline|mesh-list
154383238|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
154383239|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154383240|NCT01352559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154383241|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153523721|NCT02494882|Hormones|hormones|mesh-ancestor
154383242|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154383243|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383245|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
154383290|NCT03778372|Narcotics|narcotics|mesh-ancestor
154383291|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383292|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383293|NCT03778372|Analgesics|analgesics|mesh-ancestor
154383294|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
154383295|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383296|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
154383297|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
154383298|NCT03246880|Tadalafil|tadalafil|mesh-list
154383299|NCT03246880|Tamsulosin|tamsulosin|mesh-list
154383300|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
154383301|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154383302|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154383303|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383304|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383305|NCT03246880|Urological Agents|urological agents|mesh-ancestor
154383306|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154383307|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154383308|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154383309|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
154383310|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383311|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383312|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
154383313|NCT03257722|Idelalisib|idelalisib|mesh-list
154383314|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154383319|NCT03268005|Insulin|insulin|mesh-list
154383337|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383338|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154383339|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383341|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
154383342|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
154383343|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154383344|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
154383345|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154383346|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383347|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154383348|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154383349|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154383350|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154383351|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154383352|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383355|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
154383392|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154383393|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154383394|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383395|NCT01353339|Levofloxacin|levofloxacin|mesh-list
154383397|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154383398|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383399|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154383400|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154383401|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154383402|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383404|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383455|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
154383456|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154383528|NCT00700570|Bevacizumab|bevacizumab|mesh-list
154383529|NCT00700570|Capecitabine|capecitabine|mesh-list
154383530|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
154383531|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154383532|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383533|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154383534|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154383596|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383597|NCT04486690|Ketamine|ketamine|mesh-list
154383598|NCT04486690|Propofol|propofol|mesh-list
154383599|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154383600|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154383601|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383602|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154383603|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
154383604|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
154383662|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383663|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154383664|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383665|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
154383666|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154383667|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
154383668|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383730|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383732|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154383733|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154383734|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
154383735|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383736|NCT03254368|ZGN-1061|zgn-1061|mesh-list
154383737|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383738|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383739|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154383740|NCT03236740|Metformin|metformin|mesh-list
154383796|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383797|NCT04495283|Acetaminophen|acetaminophen|mesh-list
154383798|NCT04495283|Pregabalin|pregabalin|mesh-list
154383799|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383800|NCT04495283|Analgesics|analgesics|mesh-ancestor
154383801|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
154383802|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383803|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383804|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
154383805|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
154383806|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154383814|NCT03634020|Sirolimus|sirolimus|mesh-list
154383860|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
154383861|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383862|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383863|NCT03229096|Apatinib|apatinib|mesh-list
154383864|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154383865|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154383866|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383867|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383868|NCT03123588|Anagrelide|anagrelide|mesh-list
154383869|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154383870|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154383871|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383872|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154383921|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130119|NCT00799760|Oseltamivir|oseltamivir|mesh-list
154383922|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154383923|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154383924|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154383925|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
153524024|NCT01456507|Naltrexone|naltrexone|mesh-list
154383926|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
154383927|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154383928|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154383929|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
154383930|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383931|NCT04358549|Favipiravir|favipiravir|mesh-list
154383932|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
154383933|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154383934|NCT01562483|Dronabinol|dronabinol|mesh-list
154383935|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
154383936|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383937|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154383938|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154383939|NCT01562483|Analgesics|analgesics|mesh-ancestor
154383940|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
154383941|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154383942|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154383943|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154383944|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154383945|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154383946|NCT01562483|Hormones|hormones|mesh-ancestor
154383947|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154383948|NCT00700180|Bevacizumab|bevacizumab|mesh-list
154383949|NCT00700180|Carboplatin|carboplatin|mesh-list
154383963|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154383965|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
154383966|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154383967|NCT03228238|Vitamins|vitamins|mesh-list
154383968|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
154383969|NCT03228238|Vitamin E|vitamin e|mesh-list
154383970|NCT03228238|Tocopherols|tocopherols|mesh-list
154383971|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
154383972|NCT03228238|Atorvastatin|atorvastatin|mesh-list
154383973|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
154384029|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154384030|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154384031|NCT02452450|Analgesics|analgesics|mesh-ancestor
154384032|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
154384033|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384034|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384035|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384036|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384037|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154384038|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384039|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384092|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154384093|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
154384094|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384095|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
154384096|NCT04936763|Protective Agents|protective agents|mesh-ancestor
154384097|NCT03750383|Cyclosporine|cyclosporine|mesh-list
154384098|NCT03750383|Prednisone|prednisone|mesh-list
154384099|NCT03750383|Cyclosporins|cyclosporins|mesh-list
154384100|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384101|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
154384102|NCT03750383|Hormones|hormones|mesh-ancestor
154384103|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153426998|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
153524196|NCT01460693|Dasatinib|dasatinib|mesh-list
154384104|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384105|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154384106|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384107|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384108|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384109|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154384110|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
154384111|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
154384112|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384113|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
154384114|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384144|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384145|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384146|NCT02452606|Levodopa|levodopa|mesh-list
154384147|NCT02452606|Carbidopa|carbidopa|mesh-list
154384149|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154384150|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154384151|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
154384152|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384153|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384154|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384155|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154384156|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384157|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154384158|NCT03225352|Aspirin|aspirin|mesh-list
154384159|NCT03225352|Ibuprofen|ibuprofen|mesh-list
154384160|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154384161|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154384162|NCT03225352|Analgesics|analgesics|mesh-ancestor
154384163|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
154384164|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384198|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154384199|NCT03216070|Dasatinib|dasatinib|mesh-list
154384200|NCT03216070|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154384201|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154384202|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384203|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384204|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384205|NCT03215602|Pyrantel|pyrantel|mesh-list
154384206|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
154384207|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
154384264|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
154384265|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384266|NCT03224572|Protective Agents|protective agents|mesh-ancestor
154384267|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154384268|NCT02452216|Hematinics|hematinics|mesh-ancestor
154384269|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154384270|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154384271|NCT03207334|Cytarabine|cytarabine|mesh-list
154384272|NCT03207334|Midostaurin|midostaurin|mesh-list
154384273|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154384274|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
154384275|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384276|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384277|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
154384278|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384279|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154384280|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
154384281|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384282|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154384283|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384284|NCT03212950|Insulin|insulin|mesh-list
154384285|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154384286|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
154384287|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
154384288|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154384289|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154384311|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384312|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384314|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
154384315|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384316|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154384317|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154384318|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
154384319|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
154384320|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154384321|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
154384322|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
154384323|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384324|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
154384325|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
154384326|NCT03747341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154384327|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154384328|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
154384329|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384330|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384331|NCT04401293|Heparin|heparin|mesh-list
154384332|NCT04401293|Enoxaparin|enoxaparin|mesh-list
154384333|NCT04401293|Calcium heparin|calcium heparin|mesh-list
154384334|NCT04401293|Dalteparin|dalteparin|mesh-list
154384335|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
154384336|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
154384337|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154384340|NCT03209908|Tenofovir|tenofovir|mesh-list
154384362|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
154384363|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384364|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
154384365|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154384366|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
154384367|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154384368|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384369|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154384370|NCT03224416|Ethanol|ethanol|mesh-list
154384371|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154384372|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384373|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384374|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384375|NCT01562561|Repaglinide|repaglinide|mesh-list
154384376|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
154130558|NCT00889356|Amebicides|amebicides|mesh-ancestor
154384377|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
154384378|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
154384379|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154384380|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384381|NCT03206944|Aspirin|aspirin|mesh-list
154384382|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154384383|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154384384|NCT03206944|Analgesics|analgesics|mesh-ancestor
154384385|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
154384386|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384387|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384388|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384389|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154384390|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154384391|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154384392|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384393|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154384394|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154384395|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384396|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
153746223|NCT00150605|Analgesics|analgesics|mesh-ancestor
154384397|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154384398|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154384399|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384400|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384401|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
154384402|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384403|NCT03206554|Ropivacaine|ropivacaine|mesh-list
154384465|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
154384466|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154384467|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154384468|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384469|NCT02451748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154384470|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154384471|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154384472|NCT02451748|Analgesics|analgesics|mesh-ancestor
154384473|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
154384474|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384475|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
154384476|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154384477|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384478|NCT03208894|Furosemide|furosemide|mesh-list
154384479|NCT03208894|Diuretics|diuretics|mesh-ancestor
154384480|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
154384481|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384482|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154384483|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384484|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384485|NCT02450656|Docetaxel|docetaxel|mesh-list
154384486|NCT02450656|Afatinib|afatinib|mesh-list
154384487|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384488|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
154384489|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
154384490|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
154384491|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384492|NCT02450656|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154384493|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154384494|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384495|NCT03206320|Lidocaine|lidocaine|mesh-list
154384496|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
154384497|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
154384498|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384499|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384500|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
153629400|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
154384503|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154384504|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154384505|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384506|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384507|NCT04448561|Morphine|morphine|mesh-list
154384508|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154384509|NCT04448561|Narcotics|narcotics|mesh-ancestor
154384510|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384511|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384512|NCT04448561|Analgesics|analgesics|mesh-ancestor
154384513|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
154384514|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384515|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
154384516|NCT03206008|Analgesics|analgesics|mesh-ancestor
154384517|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
154384518|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384519|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384558|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384559|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
154384560|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154384561|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384562|NCT04292171|Gabapentin|gabapentin|mesh-list
154384563|NCT04292171|Analgesics|analgesics|mesh-ancestor
154384564|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
154384565|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384566|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384567|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
154384568|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154384569|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154384570|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384571|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154384572|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154384573|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154384574|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384575|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384576|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
154384577|NCT03200782|Empagliflozin|empagliflozin|mesh-list
154384578|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154384579|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154384580|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384581|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154384582|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384606|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
154384607|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384608|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154384609|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384610|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384611|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154384612|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
154384613|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384614|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154384615|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154384616|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154384617|NCT02448082|Ichthammol|ichthammol|mesh-list
154384618|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
154384619|NCT03205228|Flupenthixol|flupenthixol|mesh-list
154384620|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154384621|NCT03205228|Omeprazole|omeprazole|mesh-list
154384622|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154384623|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384624|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154384625|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384626|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384627|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154384628|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154384629|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384630|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384631|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154384632|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154384633|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
154384634|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384635|NCT03195946|Midazolam|midazolam|mesh-list
154384646|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
154384647|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
154384648|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384649|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384650|NCT03204760|Dexamethasone|dexamethasone|mesh-list
154384651|NCT03204760|Prednisolone|prednisolone|mesh-list
154384652|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384653|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
154384654|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
154384655|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384656|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384657|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384658|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
154384659|NCT03204760|Hormones|hormones|mesh-ancestor
154384660|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384661|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154384662|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384663|NCT03200392|Chromium|chromium|mesh-list
154384664|NCT03200392|Trace Elements|trace elements|mesh-ancestor
154384665|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
154384666|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384667|NCT03200080|Amphetamine|amphetamine|mesh-list
154130863|NCT00807872|Antibodies|antibodies|mesh-list
154384697|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384698|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384699|NCT02447380|Docetaxel|docetaxel|mesh-list
154384700|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384701|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
154384702|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
154384703|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
154384704|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384764|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154384765|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154384766|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154384767|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154384768|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384769|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
154384770|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154384771|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384772|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154384773|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384775|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384776|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384777|NCT04280705|Remdesivir|remdesivir|mesh-list
154384778|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
154384779|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384780|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
154384781|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384782|NCT03203590|Carboplatin|carboplatin|mesh-list
154384783|NCT03203590|Vinorelbine|vinorelbine|mesh-list
153489099|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525152|NCT06076824|Antiemetics|antiemetics|mesh-ancestor
153525153|NCT06076824|Autonomic Agents|autonomic agents|mesh-ancestor
154384784|NCT03203590|Gefitinib|gefitinib|mesh-list
154384785|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384786|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154384787|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
154384788|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
154384789|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
154384790|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384791|NCT03203590|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154384792|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154384793|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384794|NCT02077166|Rituximab|rituximab|mesh-list
154384806|NCT02077166|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154384807|NCT02077166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154384808|NCT02077166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384809|NCT02077166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384810|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154384811|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
154384812|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154384813|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154384814|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384815|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384816|NCT02450188|Urological Agents|urological agents|mesh-ancestor
154384869|NCT03194620|Theaflavin|theaflavin|mesh-list
154384870|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
154384871|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384872|NCT03194620|Protective Agents|protective agents|mesh-ancestor
154384873|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384874|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154384875|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154384876|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154384877|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154384878|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384879|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
154384880|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154384881|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154384882|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154384883|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154384884|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
154384885|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
154384886|NCT02445976|Seviteronel|seviteronel|mesh-list
154384887|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384888|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154384889|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525273|NCT06072547|Nicotine|nicotine|mesh-list
154384890|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384891|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154384892|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154384893|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154384894|NCT03198208|Fentanyl|fentanyl|mesh-list
154384895|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154384896|NCT03198208|Narcotics|narcotics|mesh-ancestor
154384897|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154384898|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384899|NCT03198208|Analgesics|analgesics|mesh-ancestor
154384900|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
154384901|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384902|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154384909|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154384910|NCT01044056|NuvaRing|nuvaring|mesh-list
154384911|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
154384912|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154384913|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384914|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154384915|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154384916|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154384917|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154384918|NCT01044056|Estrogens|estrogens|mesh-ancestor
154384919|NCT01044056|Hormones|hormones|mesh-ancestor
154384920|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384921|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154384922|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154384923|NCT01005056|Desogestrel|desogestrel|mesh-list
154384924|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154384925|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154384926|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154384927|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
154384928|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154384929|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384930|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154384931|NCT01005056|Estrogens|estrogens|mesh-ancestor
154384932|NCT01005056|Hormones|hormones|mesh-ancestor
154384933|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384934|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154384935|NCT01005056|Progestins|progestins|mesh-ancestor
154384936|NCT04796714|Aspirin|aspirin|mesh-list
154384953|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154384954|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154384955|NCT02445898|Prednisolone|prednisolone|mesh-list
154384956|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
154384957|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154384958|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
154384959|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154384960|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
154384961|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
154384962|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154384963|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154384964|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154384965|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
154384966|NCT02445898|Hormones|hormones|mesh-ancestor
154384967|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154384968|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154384969|NCT02445898|Protective Agents|protective agents|mesh-ancestor
154384970|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154384971|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154384972|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
154384973|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154384974|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154385006|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
154385007|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
154385008|NCT03197818|Hormones|hormones|mesh-ancestor
154385009|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385010|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154385011|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154385012|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154385013|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
154385014|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385015|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385016|NCT03442088|Apremilast|apremilast|mesh-list
154385068|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
154385069|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385070|NCT02445742|Bosutinib|bosutinib|mesh-list
154385071|NCT02445742|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154385072|NCT02445742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154385073|NCT02445742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385074|NCT02445742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385075|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
154385076|NCT02445508|Sevelamer|sevelamer|mesh-list
154385077|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
154385078|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
154385079|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385080|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154385081|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154385082|NCT03197584|Leucovorin|leucovorin|mesh-list
154385083|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
154385084|NCT03197584|Bevacizumab|bevacizumab|mesh-list
154385085|NCT03197584|Capecitabine|capecitabine|mesh-list
154385086|NCT03197584|Fluorouracil|fluorouracil|mesh-list
153489101|NCT05358834|Melatonin|melatonin|mesh-list
154385087|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
154385088|NCT03197584|Fulvestrant|fulvestrant|mesh-list
154385089|NCT03197584|Avelumab|avelumab|mesh-list
154385090|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385091|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385092|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154385106|NCT03197584|Antidotes|antidotes|mesh-ancestor
154385120|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154385121|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385122|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385123|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385124|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
154385125|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154385126|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154385127|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154385128|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385129|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385130|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
154385131|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385132|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385133|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154385134|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385135|NCT02449486|Ropivacaine|ropivacaine|mesh-list
154385136|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
154385137|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
154385138|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385139|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385140|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
154385141|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385142|NCT03202186|Progesterone|progesterone|mesh-list
154385143|NCT03202186|Progestins|progestins|mesh-ancestor
154385144|NCT03202186|Hormones|hormones|mesh-ancestor
154385145|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385146|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385147|NCT03625076|Lidocaine|lidocaine|mesh-list
154385163|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
154385164|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154385165|NCT02445352|Ezetimibe|ezetimibe|mesh-list
154385166|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154385167|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154385168|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
154385172|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385233|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
154385234|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385235|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385236|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
154385237|NCT03194074|Propofol|propofol|mesh-list
153525631|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
154385238|NCT03194074|Desflurane|desflurane|mesh-list
154385239|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154385240|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385241|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385242|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154385243|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
154385244|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
154385245|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154385246|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154385247|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154385248|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154385249|NCT04179461|Vitamin D|vitamin d|mesh-list
154385250|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
154385251|NCT04179461|Fluticasone|fluticasone|mesh-list
154385252|NCT04179461|Xhance|xhance|mesh-list
154385253|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
154385254|NCT04179461|Cetirizine|cetirizine|mesh-list
154385292|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
154385293|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154385294|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
154385295|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
154385296|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
154385297|NCT03196882|Iron|iron|mesh-list
154385298|NCT03196882|Trace Elements|trace elements|mesh-ancestor
154385299|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
154385300|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385301|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
154385302|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154385303|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
154385304|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154385305|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154385306|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385307|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154385308|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385309|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154385310|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385311|NCT01562717|Ibuprofen|ibuprofen|mesh-list
154385312|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154385313|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385314|NCT01562717|Analgesics|analgesics|mesh-ancestor
154385315|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
154385316|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385317|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385318|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385319|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385320|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154385321|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385335|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154385336|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154385337|NCT03118336|Empagliflozin|empagliflozin|mesh-list
154385338|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154385339|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385340|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154385341|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385342|NCT02444572|Enoxaparin|enoxaparin|mesh-list
153525697|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153525698|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153525699|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153525700|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525701|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385343|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
154385344|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154385345|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154385346|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385347|NCT04165031|Docetaxel|docetaxel|mesh-list
154385348|NCT04165031|Cetuximab|cetuximab|mesh-list
154385349|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154385350|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385351|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
154385352|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
154385353|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
154385390|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154385391|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154385392|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154385393|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
154385394|NCT05464628|Atorvastatin|atorvastatin|mesh-list
154385395|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154385396|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154385397|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
154385398|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385399|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154385400|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154385401|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385402|NCT03193918|Paclitaxel|paclitaxel|mesh-list
154385403|NCT03193918|Ramucirumab|ramucirumab|mesh-list
154385404|NCT03193918|Crenolanib|crenolanib|mesh-list
154385405|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154385406|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154385407|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
154385408|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
154385409|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
154385410|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385411|NCT03193918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154385412|NCT03193918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154385413|NCT03193918|Growth Substances|growth substances|mesh-ancestor
154385414|NCT03193918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385415|NCT03193918|Growth Inhibitors|growth inhibitors|mesh-ancestor
154385416|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
154385417|NCT03117790|Morphine|morphine|mesh-list
154385418|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154385436|NCT03034772|Timolol|timolol|mesh-list
154385437|NCT03034772|Dorzolamide|dorzolamide|mesh-list
154385438|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
154385439|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154385440|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154385441|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
154385442|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385504|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154385505|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385506|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385507|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154385508|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154385509|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154385510|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154385511|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
154385513|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
154385514|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
154385515|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525768|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525769|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385516|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385517|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
154385518|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
154385519|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385520|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154385521|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154385522|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154385523|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154385524|NCT03195634|Carvedilol|carvedilol|mesh-list
154385525|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154385526|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154385527|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
154385528|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385529|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385530|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385531|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154385549|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
154385550|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385551|NCT03701750|Heparin|heparin|mesh-list
154385552|NCT03701750|Enoxaparin|enoxaparin|mesh-list
154385553|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154385554|NCT03701750|Tinzaparin|tinzaparin|mesh-list
154385555|NCT03701750|Dalteparin|dalteparin|mesh-list
154385556|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
154385557|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
154385558|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154385559|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154385616|NCT01194622|Fluticasone|fluticasone|mesh-list
154385617|NCT01194622|Xhance|xhance|mesh-list
154385618|NCT01194622|Azelastine|azelastine|mesh-list
154385619|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385620|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154385621|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
154385622|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385623|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385624|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154385625|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
154385683|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
154385684|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
154385685|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385686|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385687|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154385688|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
154385689|NCT03190642|Hormones|hormones|mesh-ancestor
154385690|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154385750|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385751|NCT03702140|Teriparatide|teriparatide|mesh-list
154385752|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154385753|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385754|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154385755|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154385756|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154385816|NCT02439034|Ketoprofen|ketoprofen|mesh-list
154385817|NCT02439034|Codeine|codeine|mesh-list
154385818|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154385819|NCT02439034|Analgesics|analgesics|mesh-ancestor
154385820|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
154385821|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385822|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154385823|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
154385824|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154385825|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154385826|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154385827|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154385828|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154385829|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154385830|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154385831|NCT02439034|Narcotics|narcotics|mesh-ancestor
154385832|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154385833|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
154385835|NCT04483492|Caffeine|caffeine|mesh-list
154385872|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
154385873|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154385874|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154385875|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154385876|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154385877|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
154385878|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154385879|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
154385880|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154385938|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
154385939|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
154385940|NCT02433184|Etanercept|etanercept|mesh-list
154385941|NCT02433184|Methotrexate|methotrexate|mesh-list
154385942|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154386009|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
154386010|NCT02436694|Ropivacaine|ropivacaine|mesh-list
154386011|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
154386012|NCT02436694|Anesthetics|anesthetics|mesh-list
154386013|NCT02436694|BB 1101|bb 1101|mesh-list
154386014|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154386015|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
154386016|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
154386017|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386018|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386019|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154386020|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
154386021|NCT02436694|Hormones|hormones|mesh-ancestor
154386022|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386023|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154386024|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386025|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
154386026|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386027|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386066|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
154386067|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154386068|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
154386069|NCT02584920|Rituximab|rituximab|mesh-list
154386070|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386134|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
154386135|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154386136|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154386137|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154386138|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153526308|NCT04093362|Futibatinib|futibatinib|mesh-list
154386139|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386140|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
154386141|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386142|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386143|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154386144|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154386145|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386146|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154386147|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386148|NCT05103228|Menotropins|menotropins|mesh-list
154386149|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154386150|NCT05103228|Hormones|hormones|mesh-ancestor
154386151|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386186|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
154386187|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386188|NCT01371474|Paroxetine|paroxetine|mesh-list
154386189|NCT01371474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154386190|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154386191|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154386192|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386193|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386194|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
154386195|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386196|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154386197|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
154386198|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154386199|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154386200|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154386201|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386202|NCT03185104|Fluorides|fluorides|mesh-list
154386203|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
154386204|NCT03185104|Protective Agents|protective agents|mesh-ancestor
154386205|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386206|NCT01319994|Metformin|metformin|mesh-list
154386207|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386208|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386209|NCT02430298|Melatonin|melatonin|mesh-list
154386210|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
154386212|NCT02430298|Protective Agents|protective agents|mesh-ancestor
154386233|NCT03718507|Narcotics|narcotics|mesh-ancestor
154386234|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386235|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386236|NCT03718507|Analgesics|analgesics|mesh-ancestor
154386237|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
154386238|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386239|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154386240|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154386241|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
154386242|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
154386243|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154386244|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154386245|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
154386246|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154386247|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
154386248|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
154386249|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
154386250|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154386251|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154386252|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
154386253|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386254|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386255|NCT01374282|Penicillamine|penicillamine|mesh-list
154386256|NCT01374282|Antidotes|antidotes|mesh-ancestor
154386257|NCT01374282|Protective Agents|protective agents|mesh-ancestor
154386258|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386259|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
154386260|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
154386261|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386262|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154386263|NCT03691922|Epinephrine|epinephrine|mesh-list
154386264|NCT03691922|Racepinephrine|racepinephrine|mesh-list
154386265|NCT03691922|Bupivacaine|bupivacaine|mesh-list
154386266|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
154386267|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
154386268|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
154386273|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154386274|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154386275|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
154386276|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386277|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386278|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154386279|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154386280|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
154386281|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154386282|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
154386283|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
154386284|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
154386335|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154386336|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
154386337|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154386338|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154386339|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386340|NCT03452527|Aflibercept|aflibercept|mesh-list
154386341|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
154386342|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154386343|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154386344|NCT03452527|Growth Substances|growth substances|mesh-ancestor
154386346|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
154386397|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386398|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386399|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154386400|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
154386401|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154386403|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386404|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386405|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154386406|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
154386407|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
154386408|NCT04776408|Protective Agents|protective agents|mesh-ancestor
154386409|NCT02429596|Lamotrigine|lamotrigine|mesh-list
154386410|NCT02429596|Carbamazepine|carbamazepine|mesh-list
153526747|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
154386411|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
154386412|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154386413|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154386414|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386415|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154386416|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386417|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154386418|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154386419|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386420|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154386421|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154386422|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
154386423|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154386424|NCT02429596|Analgesics|analgesics|mesh-ancestor
154386425|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
154386426|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386427|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154386428|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154386429|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
154386430|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
154386431|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386434|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
154386435|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
154386436|NCT02653092|Heparin|heparin|mesh-list
154386437|NCT02653092|Anticoagulants|anticoagulants|mesh-list
154386438|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154386439|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154386440|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154386441|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386442|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154386443|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154386444|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154386445|NCT03691454|Docetaxel|docetaxel|mesh-list
154386446|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
154386447|NCT03691454|Trastuzumab|trastuzumab|mesh-list
154386448|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386449|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
154386450|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
154386451|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
154386452|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386453|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386454|NCT03718273|Digoxin|digoxin|mesh-list
153489128|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489129|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
153489130|NCT04567524|Risperidone|risperidone|mesh-list
153489274|NCT05719818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489276|NCT05719506|Ketamine|ketamine|mesh-list
153489349|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153489350|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
153489422|NCT05251038|Antidotes|antidotes|mesh-ancestor
153489423|NCT05251038|Protective Agents|protective agents|mesh-ancestor
153489424|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
153489425|NCT05251038|Vitamins|vitamins|mesh-ancestor
153489426|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
153489429|NCT05027646|Granisetron|granisetron|mesh-list
154386455|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154386456|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154386457|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386458|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386459|NCT03718273|Protective Agents|protective agents|mesh-ancestor
154386460|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386461|NCT02421640|Cisplatin|cisplatin|mesh-list
154386462|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386463|NCT03715387|Bacitracin|bacitracin|mesh-list
154386464|NCT03715387|Polymyxin B|polymyxin b|mesh-list
154386465|NCT03715387|Tacrolimus|tacrolimus|mesh-list
154386466|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154386467|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
154386468|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386469|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153748292|NCT00533611|Vitamins|vitamins|mesh-ancestor
154386473|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386474|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154386476|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
154386477|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386478|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154386479|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154386480|NCT03715309|Growth Substances|growth substances|mesh-ancestor
154386481|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
154386482|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386483|NCT03179254|Metformin|metformin|mesh-list
154386484|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154386485|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386486|NCT04147715|Dolutegravir|dolutegravir|mesh-list
154386487|NCT04147715|Midazolam|midazolam|mesh-list
154386488|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154386489|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154386490|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386491|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386492|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154386497|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
154386530|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386532|NCT03712735|Bupivacaine|bupivacaine|mesh-list
154386533|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
154386534|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
154386535|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386536|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386537|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
154386538|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386539|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154386540|NCT03712735|Narcotics|narcotics|mesh-ancestor
154386541|NCT03712735|Analgesics|analgesics|mesh-ancestor
154386542|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154386543|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154386544|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
154386545|NCT03182218|Heparin|heparin|mesh-list
154386546|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154386547|NCT03182218|Tinzaparin|tinzaparin|mesh-list
154386548|NCT03182218|Dalteparin|dalteparin|mesh-list
154386549|NCT03182218|Anticoagulants|anticoagulants|mesh-list
154386550|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154386551|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154386552|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386553|NCT02452554|Maytansine|maytansine|mesh-list
154386554|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
154386555|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154386556|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154386557|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386558|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
154386559|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
154386560|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
154386577|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386578|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154386579|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154386580|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154386581|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154386582|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386583|NCT04009577|Lemborexant|lemborexant|mesh-list
154386584|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154386585|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154386586|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386587|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154386588|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154386589|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386590|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386591|NCT02176668|Esomeprazole|esomeprazole|mesh-list
154386592|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154386593|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154386594|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154386595|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386596|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386597|NCT03712423|Docetaxel|docetaxel|mesh-list
154386598|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386599|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
154386600|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
154386601|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
154386602|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386603|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
154386604|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
154386605|NCT04620252|Citric Acid|citric acid|mesh-list
154386606|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
154386607|NCT04620252|Calcium|calcium|mesh-list
154386608|NCT04620252|Fluorides|fluorides|mesh-list
154386617|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
154386618|NCT04620252|Protective Agents|protective agents|mesh-ancestor
154386620|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154386621|NCT03694886|Caffeine|caffeine|mesh-list
154386622|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154386623|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386624|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154386625|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132809|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
154386684|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154386686|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386687|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386688|NCT02429050|Analgesics|analgesics|mesh-ancestor
154386689|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
154386752|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386753|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386754|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154386756|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
154386757|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154386758|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154386759|NCT03699332|Labetuzumab|labetuzumab|mesh-list
154386760|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154386817|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
154386818|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154386819|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154386820|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154386821|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154386822|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154386823|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
154386824|NCT04126343|Padsevonil|padsevonil|mesh-list
154386825|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154386826|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386884|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386886|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
154386887|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154386888|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
154386889|NCT03688568|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154386890|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154386891|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386892|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386893|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386894|NCT05192304|Maleic acid|maleic acid|mesh-list
154386895|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154386896|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386897|NCT03693638|Fentanyl|fentanyl|mesh-list
154386898|NCT03693638|Bupivacaine|bupivacaine|mesh-list
154386899|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
154386900|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
154386901|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154386902|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154386903|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
154386904|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154386905|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154386906|NCT03693638|Narcotics|narcotics|mesh-ancestor
154386907|NCT03693638|Analgesics|analgesics|mesh-ancestor
154386908|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154386909|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154386910|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
154386911|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
154386912|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154386930|NCT03743987|Pemetrexed|pemetrexed|mesh-list
153490028|NCT02515890|Analgesics|analgesics|mesh-ancestor
154386931|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154386933|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154386934|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154386935|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154386936|NCT03693326|Spartalizumab|spartalizumab|mesh-list
154386937|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154387000|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387001|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387002|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
154387003|NCT03698630|Hormones|hormones|mesh-ancestor
154387004|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387006|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387069|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387070|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154387071|NCT05137860|Bortezomib|bortezomib|mesh-list
154387072|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387073|NCT03682952|Alprostadil|alprostadil|mesh-list
154387074|NCT03682952|Beraprost|beraprost|mesh-list
154387075|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154387076|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
154387077|NCT03682952|Urological Agents|urological agents|mesh-ancestor
154387078|NCT03682718|Misoprostol|misoprostol|mesh-list
154387079|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154387080|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
154387081|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387082|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387083|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154387084|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387085|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
154387086|NCT03682640|Insulin|insulin|mesh-list
154387087|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154387088|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
154387089|NCT03682640|Azithromycin|azithromycin|mesh-list
154387090|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154387091|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387092|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154387093|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387094|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
154387095|NCT01376076|Risperidone|risperidone|mesh-list
154387120|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
154387121|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154387122|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154387123|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154387124|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387125|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387126|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387127|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387128|NCT03395353|Analgesics|analgesics|mesh-ancestor
154387129|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
154387130|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387131|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
154387132|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154387133|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
154387134|NCT01376154|Lamivudine|lamivudine|mesh-list
154387135|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154387136|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154387137|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387138|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387139|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
154387140|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387141|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154387142|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154387143|NCT01562951|Adalimumab|adalimumab|mesh-list
154387144|NCT01562951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154387145|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387146|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154387147|NCT01375842|Atezolizumab|atezolizumab|mesh-list
154387148|NCT01375842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154387152|NCT03682367|Gabapentin|gabapentin|mesh-list
154387162|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154387163|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154387164|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387165|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387166|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
154387167|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
154387168|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154387169|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387170|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387171|NCT03394885|Paclitaxel|paclitaxel|mesh-list
154387172|NCT03394885|Bevacizumab|bevacizumab|mesh-list
154387173|NCT03394885|Carboplatin|carboplatin|mesh-list
154387174|NCT03394885|Atezolizumab|atezolizumab|mesh-list
154387224|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154387225|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154387226|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154387227|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154387229|NCT01442649|Folic Acid|folic acid|mesh-list
154387230|NCT01442649|Bevacizumab|bevacizumab|mesh-list
154387231|NCT01442649|Cetuximab|cetuximab|mesh-list
154387232|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
154387233|NCT01442649|Irinotecan|irinotecan|mesh-list
154387234|NCT01442649|Fluorouracil|fluorouracil|mesh-list
154387235|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
154387236|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154387237|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387238|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154387239|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154387240|NCT01442649|Growth Substances|growth substances|mesh-ancestor
154387241|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387242|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
154387243|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154387244|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154387245|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387246|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387247|NCT01442649|Antidotes|antidotes|mesh-ancestor
154387248|NCT01442649|Protective Agents|protective agents|mesh-ancestor
154387250|NCT01442649|Vitamins|vitamins|mesh-ancestor
154387276|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387278|NCT01354665|Interferon-beta|interferon-beta|mesh-list
154387279|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
154387280|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387281|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
154387282|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387283|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
154387284|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387285|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154387286|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154387287|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154387288|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387289|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387290|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
154387291|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387292|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387293|NCT05008575|Fludarabine|fludarabine|mesh-list
154387294|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
154387295|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491055|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387296|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387306|NCT03111108|Grazoprevir|grazoprevir|mesh-list
154387328|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154387329|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154387330|NCT05198856|Growth Substances|growth substances|mesh-ancestor
154387331|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
154387332|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387333|NCT02876601|Defibrotide|defibrotide|mesh-list
154387334|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154387335|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154387336|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387337|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154387338|NCT04059536|Aspirin|aspirin|mesh-list
154387339|NCT04059536|Heparin|heparin|mesh-list
154387340|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154387341|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154387342|NCT04059536|Analgesics|analgesics|mesh-ancestor
154387343|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
154387344|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387345|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387346|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387347|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154387348|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154387349|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154387350|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387351|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154387352|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154387353|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387354|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
154387355|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
154387356|NCT03178396|Melatonin|melatonin|mesh-list
154387357|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
154387358|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387359|NCT03178396|Protective Agents|protective agents|mesh-ancestor
153749182|NCT04061161|Bromides|bromides|mesh-list
153629401|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153629402|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629403|NCT02045017|Dexamethasone|dexamethasone|mesh-list
153629404|NCT02045017|Pomalidomide|pomalidomide|mesh-list
153629405|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629406|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
153629407|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
153629408|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629409|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629410|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387361|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154387362|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
154387363|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154387364|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
154387366|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
154387430|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154387431|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387432|NCT03682172|Hormones|hormones|mesh-ancestor
154387433|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387434|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387435|NCT03682172|Incretins|incretins|mesh-ancestor
154387436|NCT03184480|Fluticasone|fluticasone|mesh-list
154387437|NCT03184480|Xhance|xhance|mesh-list
154387438|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387439|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154387495|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387496|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154387497|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
154387498|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
154387499|NCT02424136|Protective Agents|protective agents|mesh-ancestor
154387500|NCT03770676|Selenium|selenium|mesh-list
154387501|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
154387502|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387503|NCT03770676|Protective Agents|protective agents|mesh-ancestor
154387504|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387505|NCT03770676|Trace Elements|trace elements|mesh-ancestor
154387506|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
154387507|NCT01361841|Bimatoprost|bimatoprost|mesh-list
154387508|NCT01361841|Travoprost|travoprost|mesh-list
154387509|NCT01361841|Latanoprost|latanoprost|mesh-list
154387510|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154387511|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154387512|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154387513|NCT02583789|Treprostinil|treprostinil|mesh-list
154387514|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154387515|NCT01355367|Nifedipine|nifedipine|mesh-list
154387516|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154387517|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154387518|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387519|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154387520|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387521|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
154387522|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
154387523|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154387524|NCT05759520|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154387540|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387541|NCT01355445|Irinotecan|irinotecan|mesh-list
154387542|NCT01355445|Vincristine|vincristine|mesh-list
154387543|NCT01355445|Temozolomide|temozolomide|mesh-list
154387544|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154387545|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154387546|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387547|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387608|NCT03631446|Citric Acid|citric acid|mesh-list
154387609|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
154133778|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154387610|NCT03631446|Antacids|antacids|mesh-ancestor
154387611|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387675|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
154387676|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154387677|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387678|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154387679|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154387680|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154387744|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387746|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154387747|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154387748|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387749|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
154387750|NCT02427412|Coagulants|coagulants|mesh-ancestor
154387751|NCT01356303|Docetaxel|docetaxel|mesh-list
154387752|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154387808|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154387809|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
153491172|NCT05063604|Citalopram|citalopram|mesh-list
154387810|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387811|NCT03710863|Vorolanib|vorolanib|mesh-list
154387812|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154387813|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387814|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387815|NCT03178084|Lamivudine|lamivudine|mesh-list
154387816|NCT03178084|Zidovudine|zidovudine|mesh-list
154387817|NCT03178084|Efavirenz|efavirenz|mesh-list
154387818|NCT03178084|Maraviroc|maraviroc|mesh-list
154387819|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154387820|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154387821|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154387822|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154387823|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
154134012|NCT03287271|Paclitaxel|paclitaxel|mesh-list
154387865|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154387867|NCT01356615|Dalteparin|dalteparin|mesh-list
154387868|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
154387869|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
154387937|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154387938|NCT02930343|Hormones|hormones|mesh-ancestor
154387939|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154387940|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154387941|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154387942|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154387943|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
154387944|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154387945|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154387946|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154387947|NCT02930343|Hematinics|hematinics|mesh-ancestor
154387948|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
154387949|NCT02930343|Vitamins|vitamins|mesh-ancestor
154387950|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
154387951|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154387997|NCT05189067|Docetaxel|docetaxel|mesh-list
154387998|NCT05189067|Trastuzumab|trastuzumab|mesh-list
154387999|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154388000|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388001|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
154388002|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
154388003|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
154388004|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388005|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154388063|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388064|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
154388065|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388066|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
154388067|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388070|NCT02417896|Spironolactone|spironolactone|mesh-list
154388132|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388133|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388134|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388135|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154388136|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491370|NCT02714634|Leflunomide|leflunomide|mesh-list
154388137|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388138|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154388139|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154388140|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
154388141|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388143|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
154388144|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
154388145|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154388147|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154388194|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154388195|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154388196|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
154388197|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154388198|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388199|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388200|NCT02422654|Eliglustat|eliglustat|mesh-list
154388201|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388202|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388203|NCT05188833|Paroxetine|paroxetine|mesh-list
154388204|NCT05188833|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154388205|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154388206|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154388207|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388208|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388209|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
154388210|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388211|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154388212|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
154388213|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154388214|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153629411|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
153629413|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629414|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153629415|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629416|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
153629417|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153629418|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153629419|NCT02045017|Growth Substances|growth substances|mesh-ancestor
153629420|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
153629421|NCT02045030|Aflibercept|aflibercept|mesh-list
153629422|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153629423|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153629424|NCT02045030|Growth Substances|growth substances|mesh-ancestor
153491431|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
153629425|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629426|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
153629427|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629428|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
153629429|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153629430|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
153629431|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629432|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153629450|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629451|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
153629452|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629453|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153629454|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629455|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
153629456|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388215|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154388216|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388217|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
154388218|NCT02426164|Epinephrine|epinephrine|mesh-list
154388219|NCT02426164|Morphine|morphine|mesh-list
154388220|NCT02426164|Bupivacaine|bupivacaine|mesh-list
154388221|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
154388222|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
154388223|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388224|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388225|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
154388226|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388227|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154388228|NCT02426164|Narcotics|narcotics|mesh-ancestor
154388229|NCT02426164|Analgesics|analgesics|mesh-ancestor
154388230|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388231|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
154388276|NCT04447287|Analgesics|analgesics|mesh-ancestor
154388277|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
154388278|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388279|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154388280|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
154388281|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
154388282|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388283|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388284|NCT01879319|Evolocumab|evolocumab|mesh-list
154388285|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154388286|NCT01879319|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154388287|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154388288|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154388289|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
154388311|NCT01365897|Modafinil|modafinil|mesh-list
154388338|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
154388339|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388340|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388341|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
154388342|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154388343|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154388344|NCT01359657|Growth Substances|growth substances|mesh-ancestor
154388345|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
154388346|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154388347|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
154388348|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154388349|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154388350|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
154388351|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388352|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
154388353|NCT02417116|Protective Agents|protective agents|mesh-ancestor
154388355|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
154388395|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154388396|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154388397|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388399|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154388400|NCT03177538|Hormones|hormones|mesh-ancestor
154388401|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388402|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388403|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154388404|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
154388405|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154388406|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
154388407|NCT01363323|Naltrexone|naltrexone|mesh-list
154388408|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
154388409|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154388410|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388411|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154388412|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154388413|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388414|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388415|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388416|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388417|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154388418|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
154388419|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388420|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154388443|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388444|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388446|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
154388447|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388448|NCT01338636|Ambrisentan|ambrisentan|mesh-list
154388449|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154388450|NCT02416258|Betamethasone|betamethasone|mesh-list
154388451|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
154388509|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154388510|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388511|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388512|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492046|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
154388513|NCT02416804|Buprenorphine|buprenorphine|mesh-list
154388515|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154388516|NCT02416804|Narcotics|narcotics|mesh-ancestor
154388517|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388518|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388519|NCT02416804|Analgesics|analgesics|mesh-ancestor
154388520|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
154388523|NCT04792320|Charcoal|charcoal|mesh-list
154388572|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154388573|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154388574|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154388575|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388576|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388577|NCT01360437|Ticagrelor|ticagrelor|mesh-list
154388578|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154388579|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154134750|NCT02549924|Resveratrol|resveratrol|mesh-list
154388580|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154388581|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154388582|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154388583|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
154388584|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388585|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388586|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388587|NCT02409862|Oxytocin|oxytocin|mesh-list
154388588|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
154388626|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154388627|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154388628|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388629|NCT04039503|Tirzepatide|tirzepatide|mesh-list
154388630|NCT04039503|Incretins|incretins|mesh-ancestor
154388632|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154388633|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388634|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
154388635|NCT05418114|Analgesics|analgesics|mesh-ancestor
154388636|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
154388637|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388638|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388639|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
154388640|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388641|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154388642|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
154388643|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154388644|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154388645|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388646|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154388647|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
154388648|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154388649|NCT03225716|Ibrutinib|ibrutinib|mesh-list
154388650|NCT03225716|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154388651|NCT03225716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154134819|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
154388652|NCT03225716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388653|NCT03225716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388656|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154388668|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154388669|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
153492763|NCT02844582|Prednisone|prednisone|mesh-list
154388670|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388671|NCT03632772|Mirabegron|mirabegron|mesh-list
154388672|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
154388673|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154388674|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154388675|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154388676|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
154388677|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388678|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388679|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388680|NCT03632772|Urological Agents|urological agents|mesh-ancestor
154388681|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154388682|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154388683|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
154388684|NCT01360749|Lidocaine|lidocaine|mesh-list
154388685|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
154388686|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
154388687|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388688|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388689|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
154388690|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388691|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154388692|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154388717|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388718|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388719|NCT03171610|Analgesics|analgesics|mesh-ancestor
154388720|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
154388721|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388722|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154388723|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154388724|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
154388725|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
154388782|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
154388783|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388784|NCT02409004|Rifampin|rifampin|mesh-list
154388785|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154388786|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
154388787|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154388788|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154388789|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
154388790|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154388791|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154388792|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388793|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153493046|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
154388794|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154388795|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154388796|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154388797|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154388798|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154388799|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
154134966|NCT00504556|Warfarin|warfarin|mesh-list
154388800|NCT03131895|Lansoprazole|lansoprazole|mesh-list
154388801|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154388802|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154388833|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
154388834|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
154388835|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
154388836|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388837|NCT02408926|Vaccines|vaccines|mesh-list
154388838|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
154388839|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388840|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
154388841|NCT00704158|Immunoconjugates|immunoconjugates|mesh-ancestor
154388842|NCT00704158|Immunologic Factors|immunologic factors|mesh-ancestor
154388843|NCT00704158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388844|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154388845|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154388846|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
154388847|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154388848|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154388849|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388850|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
154388851|NCT03738527|Coagulants|coagulants|mesh-ancestor
154388852|NCT02915978|Fentanyl|fentanyl|mesh-list
154388853|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154388854|NCT02915978|Narcotics|narcotics|mesh-ancestor
154388855|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388856|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388857|NCT02915978|Analgesics|analgesics|mesh-ancestor
154388858|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
154388859|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154388860|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154388861|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154388862|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
154388863|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
154388864|NCT02412904|Menotropins|menotropins|mesh-list
154388865|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154388875|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154388876|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154388877|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154388878|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
154388879|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
154388880|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
154388881|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
154388882|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154388883|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154388884|NCT02408146|Celecoxib|celecoxib|mesh-list
154388885|NCT02408146|Parecoxib|parecoxib|mesh-list
154388886|NCT02408146|Fentanyl|fentanyl|mesh-list
154388887|NCT02408146|Ondansetron|ondansetron|mesh-list
154388888|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154388889|NCT02408146|Narcotics|narcotics|mesh-ancestor
154388890|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154388891|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154388936|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154388937|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154388938|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154388939|NCT03175666|Growth Substances|growth substances|mesh-ancestor
154388940|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
154388941|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154388942|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
154388943|NCT03175666|Antidotes|antidotes|mesh-ancestor
154388946|NCT03175666|Vitamins|vitamins|mesh-ancestor
154389004|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154389005|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154389006|NCT03170284|Growth Substances|growth substances|mesh-ancestor
154389007|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389008|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
154389009|NCT02407912|Cisplatin|cisplatin|mesh-list
154389010|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389011|NCT03170050|Lidocaine|lidocaine|mesh-list
154389012|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
154389013|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
154389014|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389015|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389016|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
154389017|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389018|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154389019|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154389020|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154389021|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154389022|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389023|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154389024|NCT02407834|Eusol|eusol|mesh-list
154389025|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
154389026|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389027|NCT03169738|Leucovorin|leucovorin|mesh-list
154389028|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
154389030|NCT03169738|Capecitabine|capecitabine|mesh-list
154389055|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
154389056|NCT03169738|Vitamins|vitamins|mesh-ancestor
154389057|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
154389058|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154389059|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154389060|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154389061|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
154389063|NCT02407600|Aprepitant|aprepitant|mesh-list
154389124|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154389125|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389126|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
154389127|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154389128|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154389129|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389130|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
154389131|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
154389132|NCT03175042|Chrysarobin|chrysarobin|mesh-list
154389133|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154389134|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389135|NCT03175042|Analgesics|analgesics|mesh-ancestor
154389136|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
154389137|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389138|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389178|NCT03116308|Opicapone|opicapone|mesh-list
154389181|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389182|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154389183|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154389184|NCT03665441|Leucovorin|leucovorin|mesh-list
154389185|NCT03665441|Paclitaxel|paclitaxel|mesh-list
154389186|NCT03665441|Gemcitabine|gemcitabine|mesh-list
154389187|NCT03665441|Irinotecan|irinotecan|mesh-list
154389188|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154389189|NCT03665441|Asparaginase|asparaginase|mesh-list
154389190|NCT03665441|Eryaspase|eryaspase|mesh-list
154389191|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154389248|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154389249|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
154389250|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389251|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154389252|NCT03662789|Hematinics|hematinics|mesh-ancestor
154389253|NCT04481932|Trastuzumab|trastuzumab|mesh-list
154389254|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154135416|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154389255|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389256|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
154389312|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
154389313|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389314|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
154389315|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154389316|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154389318|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
154389383|NCT03671174|Analgesics|analgesics|mesh-ancestor
154389384|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
154389385|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389386|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154389387|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154389388|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154389389|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389390|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154389391|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154389392|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389450|NCT05343325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389451|NCT03349333|Folic Acid|folic acid|mesh-list
154389452|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
154389453|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
154389454|NCT03349333|Vitamins|vitamins|mesh-ancestor
154389455|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
154389456|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389457|NCT03349333|Hematinics|hematinics|mesh-ancestor
154389458|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
154389459|NCT03365791|Spartalizumab|spartalizumab|mesh-list
154389460|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154389461|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389462|NCT03365791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389463|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389464|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
154389465|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154389466|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
154389467|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
154389468|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389469|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389505|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389506|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389507|NCT03614975|Vaccines|vaccines|mesh-list
154389508|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
154389509|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389510|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
154389511|NCT03613649|Zoliflodacin|zoliflodacin|mesh-list
154389512|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154389513|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389514|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154389515|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154389516|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389517|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389518|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389519|NCT03096288|Evolocumab|evolocumab|mesh-list
154389520|NCT03096288|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154389521|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154389522|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154389562|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389563|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
154389564|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154389565|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
154389566|NCT03736187|Metronidazole|metronidazole|mesh-list
154389567|NCT03736187|Cephalexin|cephalexin|mesh-list
154389568|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389569|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154389570|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154389624|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389625|NCT05386758|Molnupiravir|molnupiravir|mesh-list
154389626|NCT05386758|Antiviral Agents|antiviral agents|mesh-ancestor
154389627|NCT05386758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389628|NCT03169114|Amikacin|amikacin|mesh-list
154389629|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154389630|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389631|NCT03115762|Bevacizumab|bevacizumab|mesh-list
154389632|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389639|NCT03168958|Methadone|methadone|mesh-list
154389689|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154389690|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389691|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
153494913|NCT04954638|Eusol|eusol|mesh-list
154389693|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
154389694|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389695|NCT05110638|Luliconazole|luliconazole|mesh-list
154389696|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
154389697|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389698|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
154389756|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154389757|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389758|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154389759|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154389760|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154389761|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389762|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154389763|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154389764|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389765|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
154389766|NCT03168568|Valsartan|valsartan|mesh-list
154389767|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154389768|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154389769|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154389770|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154389771|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389772|NCT02400112|Vancomycin|vancomycin|mesh-list
154389773|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154389774|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389806|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154389808|NCT02399800|Triamcinolone|triamcinolone|mesh-list
154389809|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154389810|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154389811|NCT02399800|Bupivacaine|bupivacaine|mesh-list
154389812|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154389813|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
154389814|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
154389815|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154389816|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389817|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
154389871|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
154389872|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154389873|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154389874|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389875|NCT02394652|Metformin|metformin|mesh-list
154389876|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154389877|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154389878|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154389879|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154389880|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389881|NCT02394496|Fulvestrant|fulvestrant|mesh-list
154389882|NCT02394496|Lapatinib|lapatinib|mesh-list
154389937|NCT06336395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389938|NCT06336395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154389939|NCT06336395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154389940|NCT06336395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154389941|NCT06336395|Antiemetics|antiemetics|mesh-ancestor
154389942|NCT06336395|Autonomic Agents|autonomic agents|mesh-ancestor
154389943|NCT06336395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154389944|NCT06336395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154389945|NCT06336395|Glucocorticoids|glucocorticoids|mesh-ancestor
154389946|NCT06336395|Hormones|hormones|mesh-ancestor
154389947|NCT06336395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154389948|NCT06336395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154389949|NCT06336395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154389950|NCT06336395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154389951|NCT06336395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154389952|NCT06336395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154389953|NCT06336395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389954|NCT06336395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154389955|NCT06336395|Abortifacient Agents|abortifacient agents|mesh-ancestor
154389956|NCT06336395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154389957|NCT06336395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154389958|NCT06336395|Antimetabolites|antimetabolites|mesh-ancestor
154389959|NCT06336395|Dermatologic Agents|dermatologic agents|mesh-ancestor
154389960|NCT06336395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154389961|NCT06336395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154389962|NCT06336395|Antiviral Agents|antiviral agents|mesh-ancestor
154389963|NCT06336395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154389964|NCT06336395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154389981|NCT06336213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154389982|NCT06336213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154389984|NCT06336174|Clopidogrel|clopidogrel|mesh-list
154389985|NCT06336174|Atorvastatin|atorvastatin|mesh-list
154389986|NCT06336174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154389987|NCT06336174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154389988|NCT06336174|Analgesics|analgesics|mesh-ancestor
154389989|NCT06336174|Sensory System Agents|sensory system agents|mesh-ancestor
154390048|NCT06335407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154390049|NCT06335407|Adrenergic Agents|adrenergic agents|mesh-ancestor
154390050|NCT06335407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390051|NCT06335407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390052|NCT06335355|Carboplatin|carboplatin|mesh-list
154390053|NCT06335355|Pemetrexed|pemetrexed|mesh-list
154390054|NCT06335355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390055|NCT06335355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390056|NCT06335355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390057|NCT06335355|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154390058|NCT06335355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154390059|NCT06335316|Lidocaine|lidocaine|mesh-list
154390110|NCT06334991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390111|NCT06334991|Immunologic Factors|immunologic factors|mesh-ancestor
154390112|NCT06334991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390113|NCT06334991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154390115|NCT06334965|Lipotropic Agents|lipotropic agents|mesh-ancestor
154390179|NCT06334549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390180|NCT06334549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390181|NCT06334549|Sympathomimetics|sympathomimetics|mesh-ancestor
154390182|NCT06334549|Nasal Decongestants|nasal decongestants|mesh-ancestor
154390183|NCT06334549|Respiratory System Agents|respiratory system agents|mesh-ancestor
154390184|NCT06334549|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154390185|NCT06334549|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154390186|NCT06334549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154390195|NCT06334497|Letermovir|letermovir|mesh-list
154390247|NCT06333041|Anticonvulsants|anticonvulsants|mesh-ancestor
154390248|NCT06332781|Gentamicins|gentamicins|mesh-list
154390249|NCT06332781|Nitrofurantoin|nitrofurantoin|mesh-list
154390250|NCT06332781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154390251|NCT06332781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390252|NCT06332781|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154390253|NCT06332781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390254|NCT06332781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390255|NCT06332781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154390264|NCT06330168|Calcitonin|calcitonin|mesh-list
154390265|NCT06330168|Salmon calcitonin|salmon calcitonin|mesh-list
154390266|NCT06330168|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154390267|NCT06330168|Fentanyl|fentanyl|mesh-list
154390268|NCT06330168|Bupivacaine|bupivacaine|mesh-list
154390269|NCT06330168|Katacalcin|katacalcin|mesh-list
154390270|NCT06330168|Anesthetics, Local|anesthetics, local|mesh-ancestor
154390317|NCT06327256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154390318|NCT06327256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154390319|NCT06327256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390320|NCT06327256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390321|NCT06327256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154390322|NCT06327256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154390323|NCT06327256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154390324|NCT06327256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154390325|NCT06327256|Anesthetics, General|anesthetics, general|mesh-ancestor
154390326|NCT06327256|Anesthetics|anesthetics|mesh-ancestor
154390327|NCT06327256|GABA Modulators|gaba modulators|mesh-ancestor
154390328|NCT06327256|GABA Agents|gaba agents|mesh-ancestor
154390329|NCT06327256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154390330|NCT06327256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390345|NCT06319820|Gemcitabine|gemcitabine|mesh-list
154390346|NCT06319820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154390375|NCT06304974|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154390376|NCT06304974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154390377|NCT06304974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390378|NCT06299540|Ibrutinib|ibrutinib|mesh-list
154390379|NCT06299540|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154390380|NCT06299540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390381|NCT06299540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390382|NCT06299540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390383|NCT06274047|Androgens|androgens|mesh-list
154390384|NCT06274047|Hormones|hormones|mesh-ancestor
154390385|NCT06274047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154390386|NCT06274047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390392|NCT06267001|Atezolizumab|atezolizumab|mesh-list
154390393|NCT06267001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154390394|NCT06267001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390395|NCT06267001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390436|NCT06240455|Methimazole|methimazole|mesh-list
154390437|NCT06240455|Antithyroid Agents|antithyroid agents|mesh-ancestor
154390438|NCT06240455|Hormone Antagonists|hormone antagonists|mesh-ancestor
153495568|NCT00000750|Zidovudine|zidovudine|mesh-list
154390439|NCT06240455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154390440|NCT06240455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390441|NCT06234605|Belzutifan|belzutifan|mesh-list
154390442|NCT06234605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390452|NCT06220604|Deucravacitinib|deucravacitinib|mesh-list
154390453|NCT06220604|Dermatologic Agents|dermatologic agents|mesh-ancestor
154390454|NCT06220604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390455|NCT06220604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390497|NCT06188520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390499|NCT06188520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390500|NCT06184568|Semaglutide|semaglutide|mesh-list
154390501|NCT06184568|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154390502|NCT06184568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154390503|NCT06184568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390504|NCT06178289|Protective Agents|protective agents|mesh-list
154390505|NCT06178289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390506|NCT06171178|Pembrolizumab|pembrolizumab|mesh-list
154390507|NCT06171178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390508|NCT06171178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390509|NCT06171178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154390510|NCT06171178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390563|NCT06143670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154390564|NCT06143670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390565|NCT06131398|Pembrolizumab|pembrolizumab|mesh-list
154390566|NCT06131398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390567|NCT06131398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390568|NCT06131398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154390569|NCT06131398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390570|NCT06122649|Apremilast|apremilast|mesh-list
154390571|NCT06122649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154390572|NCT06122649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154390627|NCT06086275|Analgesics|analgesics|mesh-ancestor
154390628|NCT06086275|Sensory System Agents|sensory system agents|mesh-ancestor
154390629|NCT06086275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390630|NCT06086275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154390631|NCT06083857|Tepotinib|tepotinib|mesh-list
154390632|NCT06083857|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154390633|NCT06083857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390634|NCT06083857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390635|NCT06082986|Ustekinumab|ustekinumab|mesh-list
154390636|NCT06082986|Dermatologic Agents|dermatologic agents|mesh-ancestor
153495578|NCT00000804|Indinavir|indinavir|mesh-list
154390693|NCT05997485|Antiviral Agents|antiviral agents|mesh-ancestor
154390694|NCT05997485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390695|NCT05997485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154390696|NCT05997485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154390697|NCT05997056|Sirolimus|sirolimus|mesh-list
154390698|NCT05997056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154390699|NCT05997056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154390700|NCT05997056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154390701|NCT05997056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390702|NCT05997056|Antifungal Agents|antifungal agents|mesh-ancestor
154390703|NCT05997056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154390704|NCT05997056|Immunologic Factors|immunologic factors|mesh-ancestor
154390705|NCT05997056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390716|NCT05976217|Venetoclax|venetoclax|mesh-list
154390717|NCT05976217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390718|NCT05965492|Acetaminophen|acetaminophen|mesh-list
154390719|NCT05965492|Celecoxib|celecoxib|mesh-list
154390720|NCT05965492|Oxycodone|oxycodone|mesh-list
154390721|NCT05965492|Gabapentin|gabapentin|mesh-list
154390722|NCT05965492|Famotidine|famotidine|mesh-list
154390723|NCT05965492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154390724|NCT05965492|Analgesics|analgesics|mesh-ancestor
154390725|NCT05965492|Sensory System Agents|sensory system agents|mesh-ancestor
154390726|NCT05965492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390727|NCT05965492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390746|NCT05965492|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154390747|NCT05965492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154390748|NCT05965492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154390749|NCT05965492|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154390750|NCT05965492|Histamine Antagonists|histamine antagonists|mesh-ancestor
154390751|NCT05965492|Histamine Agents|histamine agents|mesh-ancestor
154390752|NCT05963074|Venetoclax|venetoclax|mesh-list
154390753|NCT05963074|Ibrutinib|ibrutinib|mesh-list
154390754|NCT05963074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390755|NCT05963074|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154390756|NCT05963074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390757|NCT05963074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390758|NCT05963074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495962|NCT00001680|Thalidomide|thalidomide|mesh-list
154390759|NCT05961709|Cemiplimab|cemiplimab|mesh-list
154390760|NCT05961709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154390804|NCT05900336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154390805|NCT05900336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154390806|NCT05900336|Analgesics|analgesics|mesh-ancestor
154390807|NCT05900336|Sensory System Agents|sensory system agents|mesh-ancestor
154390808|NCT05900336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154390809|NCT05900336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390810|NCT05900336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154390811|NCT05900336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154390812|NCT05900336|Gout Suppressants|gout suppressants|mesh-ancestor
154390813|NCT05900336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154390814|NCT05900336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390831|NCT05894239|Taxane|taxane|mesh-list
154390865|NCT05822752|Sorafenib|sorafenib|mesh-list
154390866|NCT05822752|Lenvatinib|lenvatinib|mesh-list
154390867|NCT05822752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154390868|NCT05822752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154390869|NCT05822752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154390870|NCT05822752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154390871|NCT05802303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154390872|NCT05802303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154390873|NCT05802303|Estradiol|estradiol|mesh-list
154390874|NCT05802303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154390937|NCT05759481|Propofol|propofol|mesh-list
154390938|NCT05759481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154390939|NCT05759481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154390940|NCT05759481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154390941|NCT05759481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154390942|NCT05759481|Anesthetics, General|anesthetics, general|mesh-ancestor
154390943|NCT05759481|Anesthetics|anesthetics|mesh-ancestor
154390944|NCT05756764|Liraglutide|liraglutide|mesh-list
154390945|NCT05756764|Semaglutide|semaglutide|mesh-list
154390998|NCT05734105|Growth Inhibitors|growth inhibitors|mesh-ancestor
154390999|NCT05734105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154391000|NCT05734105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391001|NCT05734105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391017|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154391018|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154391019|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154391020|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
154391021|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
154391022|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154391023|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154391024|NCT05683691|Analgesics|analgesics|mesh-ancestor
154391059|NCT05646862|Fulvestrant|fulvestrant|mesh-list
154391060|NCT05646862|Inavolisib|inavolisib|mesh-list
154391061|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391062|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391063|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154391064|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154391065|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
154391066|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391067|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391068|NCT05646862|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154391069|NCT05646862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391070|NCT05646862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391075|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154391076|NCT05638295|Panitumumab|panitumumab|mesh-list
154391078|NCT05638295|Antibodies|antibodies|mesh-list
154391079|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
154391080|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154391081|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
154391082|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391083|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391084|NCT05638295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391085|NCT05638295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391086|NCT05630781|Suvorexant|suvorexant|mesh-list
154391087|NCT05630781|Methylphenidate|methylphenidate|mesh-list
154391088|NCT05630781|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154391094|NCT05630781|Dopamine Agents|dopamine agents|mesh-ancestor
154391107|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
154391108|NCT05627557|Hormones|hormones|mesh-ancestor
154391109|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391110|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391111|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391112|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391113|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154391114|NCT05627557|Analgesics|analgesics|mesh-ancestor
154391115|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
154391116|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391172|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
154391173|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154391174|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391175|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154391176|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154391177|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391178|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391179|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
154391180|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154391181|NCT05538897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154391182|NCT05538897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391183|NCT05538897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391185|NCT05516914|Gemcitabine|gemcitabine|mesh-list
154391186|NCT05516914|Docetaxel|docetaxel|mesh-list
154391231|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154391232|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391233|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154391234|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
154391235|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154391236|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
154391237|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154391238|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391239|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154391240|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391241|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391242|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
154391243|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
154391244|NCT05457556|Melphalan|melphalan|mesh-list
154391245|NCT05457556|Busulfan|busulfan|mesh-list
154391246|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
154391247|NCT05457556|Thiotepa|thiotepa|mesh-list
154391248|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154391249|NCT05457556|Rituximab|rituximab|mesh-list
154391250|NCT05457556|Methotrexate|methotrexate|mesh-list
154391251|NCT05457556|Fludarabine|fludarabine|mesh-list
154391252|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154391253|NCT05457556|Tacrolimus|tacrolimus|mesh-list
154391254|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
154391255|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154391256|NCT05457556|Antibodies|antibodies|mesh-list
154391257|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
154391258|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154391281|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154391282|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154391283|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
154391284|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154391285|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154391286|NCT05456685|Carboplatin|carboplatin|mesh-list
154391287|NCT05456685|Maytansine|maytansine|mesh-list
154391289|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391290|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391291|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
154391292|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
154391293|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
154391294|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391295|NCT05456685|Immunoconjugates|immunoconjugates|mesh-ancestor
154391296|NCT05456685|Immunologic Factors|immunologic factors|mesh-ancestor
154391297|NCT05456685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391309|NCT05389423|Prednisone|prednisone|mesh-list
154391338|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
154391339|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154391340|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154391341|NCT05389423|Growth Substances|growth substances|mesh-ancestor
154391342|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
154391344|NCT05383352|Folic Acid|folic acid|mesh-list
154391345|NCT05383352|Fluorouracil|fluorouracil|mesh-list
154391346|NCT05383352|Irinotecan|irinotecan|mesh-list
154391347|NCT05383352|Camptothecin|camptothecin|mesh-list
153497955|NCT00002898|Ifosfamide|ifosfamide|mesh-list
154391348|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
154391349|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
154391350|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391351|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391352|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391353|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154391354|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
154391358|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391400|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391401|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391402|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391403|NCT05372614|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154391404|NCT05372614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154391405|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
154391406|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391407|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154391408|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154391409|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154391410|NCT05372393|Anesthetics|anesthetics|mesh-list
154391411|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154391412|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391413|NCT05361447|Diazepam|diazepam|mesh-list
154391414|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154391415|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
154391416|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
154391417|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
154391418|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391419|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391420|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391421|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154391422|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154391451|NCT05329766|Quemliclustat|quemliclustat|mesh-list
154391452|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
154391453|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391454|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391455|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391456|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154391457|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
154391458|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391459|NCT05329766|Antidotes|antidotes|mesh-ancestor
154391460|NCT05329766|Protective Agents|protective agents|mesh-ancestor
154391461|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
154391462|NCT05329766|Vitamins|vitamins|mesh-ancestor
154391463|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
154391464|NCT05329766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391465|NCT05329766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391466|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
154391469|NCT05322577|Nivolumab|nivolumab|mesh-list
154391510|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391511|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
154391512|NCT05286801|Atezolizumab|atezolizumab|mesh-list
154391513|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154391514|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154391515|NCT05286801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391516|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391517|NCT05286801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391523|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
154391580|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391581|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391582|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391583|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
154391584|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154391585|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154391586|NCT05259839|Growth Substances|growth substances|mesh-ancestor
154391587|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
154391588|NCT05259839|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154391589|NCT05259839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391590|NCT05259839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391591|NCT05206773|Venglustat|venglustat|mesh-list
154391593|NCT05206773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391594|NCT05191797|Atezolizumab|atezolizumab|mesh-list
154391595|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
154391596|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154391636|NCT05120960|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154391637|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154391638|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154391639|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391640|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391641|NCT05111626|Nivolumab|nivolumab|mesh-list
154391642|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
154391643|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391644|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391645|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391646|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391647|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
154391648|NCT05104567|Cetuximab|cetuximab|mesh-list
154391649|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391650|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391651|NCT05104567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391652|NCT05104567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391653|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154391654|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154391691|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391692|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391693|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154391694|NCT05018585|Vitamins|vitamins|mesh-ancestor
154391695|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
154391696|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154391697|NCT05009069|Capecitabine|capecitabine|mesh-list
154391698|NCT05009069|Fluorouracil|fluorouracil|mesh-list
154391699|NCT05009069|Atezolizumab|atezolizumab|mesh-list
154391700|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154391701|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
154391702|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391703|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391704|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154391705|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
154391706|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391707|NCT05009069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154391708|NCT05009069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391709|NCT04994717|Blinatumomab|blinatumomab|mesh-list
154391710|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391711|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
154391712|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154391713|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
154391714|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154391715|NCT04987775|Expectorants|expectorants|mesh-ancestor
154391716|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
154391717|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154391718|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
153498555|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391719|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391720|NCT04987775|Protective Agents|protective agents|mesh-ancestor
154391721|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391722|NCT04987775|Antidotes|antidotes|mesh-ancestor
154391723|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
154391724|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154391731|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154391732|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154391733|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154391734|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
154391735|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391736|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154391738|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391798|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
154391799|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154391800|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391801|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154391802|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
154391803|NCT04933539|Hormones|hormones|mesh-ancestor
154391804|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154391805|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154391806|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391821|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
154391822|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154391823|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391861|NCT04884399|Ranibizumab|ranibizumab|mesh-list
154391862|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154391863|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154391864|NCT04884399|Growth Substances|growth substances|mesh-ancestor
154391865|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154391866|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
154391867|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154391868|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154391869|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
154391870|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154391871|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
154391872|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154391873|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925546|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925547|NCT04168099|Cefotaxime|cefotaxime|mesh-list
153925548|NCT04168099|Cefoxitin|cefoxitin|mesh-list
153925549|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
153925550|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925551|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925552|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153925553|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153925554|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498903|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925555|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925556|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925557|NCT04283877|Methylphenidate|methylphenidate|mesh-list
153925558|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153925559|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925564|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
153925606|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153925607|NCT02860923|Incretins|incretins|mesh-ancestor
153925608|NCT02860923|Hormones|hormones|mesh-ancestor
153925609|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925610|NCT01121406|Paclitaxel|paclitaxel|mesh-list
153925611|NCT01121406|Gemcitabine|gemcitabine|mesh-list
153925612|NCT01121406|Doxorubicin|doxorubicin|mesh-list
153925613|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153925614|NCT01121406|Topotecan|topotecan|mesh-list
153925615|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153925616|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925617|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
153925672|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153925673|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925674|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925675|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153925676|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153925677|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153925678|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
153925679|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925680|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153925681|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153925683|NCT00924508|Triamcinolone|triamcinolone|mesh-list
153925734|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925735|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
153925736|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925737|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925739|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
153925740|NCT02656771|Metronidazole|metronidazole|mesh-list
153925741|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925742|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925743|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153925744|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153925745|NCT00917644|Atorvastatin|atorvastatin|mesh-list
153925746|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153925747|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153925748|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
153925749|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925750|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153925751|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153925752|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925753|NCT00625170|Haloperidol|haloperidol|mesh-list
153925754|NCT00625170|Olanzapine|olanzapine|mesh-list
153925755|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
153925756|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
153925757|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
153925758|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925759|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925760|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153499507|NCT00004218|Hormones|hormones|mesh-ancestor
153925761|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153925781|NCT04251364|Atorvastatin|atorvastatin|mesh-list
153925782|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153925783|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153925784|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
153925785|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925786|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153925787|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153925788|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925789|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
153925790|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153925791|NCT04251364|Diuretics|diuretics|mesh-ancestor
153925792|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
153925794|NCT02648425|Leucovorin|leucovorin|mesh-list
153925844|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
153925845|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
153925846|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925847|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925848|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
153925849|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925850|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153925851|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153925852|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153925908|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153925909|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153925910|NCT04015219|Lifitegrast|lifitegrast|mesh-list
153925911|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153925912|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
153925913|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153925914|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925915|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153925916|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925917|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
153925918|NCT01168973|Docetaxel|docetaxel|mesh-list
153925919|NCT01168973|Ramucirumab|ramucirumab|mesh-list
153925920|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153925921|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925922|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
153925923|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
153925924|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
153925925|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925926|NCT01168973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153925927|NCT01168973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153925928|NCT01168973|Growth Substances|growth substances|mesh-ancestor
153925930|NCT01168973|Growth Inhibitors|growth inhibitors|mesh-ancestor
153925959|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
153925960|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
153925961|NCT01168349|Hematinics|hematinics|mesh-ancestor
153925962|NCT00915772|Metformin|metformin|mesh-list
153925963|NCT00915772|Linagliptin|linagliptin|mesh-list
153925964|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153925965|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925966|NCT00915772|Incretins|incretins|mesh-ancestor
153925967|NCT00915772|Hormones|hormones|mesh-ancestor
153925968|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925969|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153925970|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
153925971|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925972|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925973|NCT00632086|Aspirin|aspirin|mesh-list
153925974|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153925975|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153925976|NCT00632086|Analgesics|analgesics|mesh-ancestor
153925977|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
153925978|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925979|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925980|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153925981|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153926010|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926011|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926012|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153926013|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153926014|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
153926015|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926016|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153926017|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153926018|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
153926019|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926020|NCT02647489|Antacids|antacids|mesh-ancestor
153926021|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926022|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926023|NCT00910897|Thalidomide|thalidomide|mesh-list
153926024|NCT00910897|Dexamethasone|dexamethasone|mesh-list
153926025|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
153926026|NCT00910897|Bortezomib|bortezomib|mesh-list
153926027|NCT00910897|BB 1101|bb 1101|mesh-list
153926028|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926029|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
153926030|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
153926031|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926032|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926033|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926034|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
153926035|NCT00910897|Hormones|hormones|mesh-ancestor
153926036|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926037|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153926038|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926051|NCT00651547|Budesonide|budesonide|mesh-list
153926054|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153926055|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
153926056|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926057|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926058|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153926059|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
153926060|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
153926061|NCT00651547|Hormones|hormones|mesh-ancestor
153926062|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926063|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153926064|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153926065|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153926066|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
153926067|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926068|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926069|NCT00912808|Donepezil|donepezil|mesh-list
153926070|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153926071|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926072|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926073|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
153926074|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926075|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926076|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
153926077|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
153926078|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153926079|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153926080|NCT02647255|Prednisolone|prednisolone|mesh-list
153926100|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926101|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153926102|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153926103|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926104|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926105|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153926106|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153926107|NCT04414228|Anesthetics|anesthetics|mesh-list
153926108|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153926109|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926110|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
153926111|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153926112|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
153926113|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926114|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
153926115|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153926116|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
153926117|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926155|NCT00957801|Prednisolone|prednisolone|mesh-list
153926156|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
153926157|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
153926158|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153926159|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
153926160|NCT00957801|Testosterone|testosterone|mesh-list
153926161|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
153926162|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
153926163|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153926164|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926165|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
153926166|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
153926167|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926168|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926169|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926170|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
153926171|NCT00957801|Hormones|hormones|mesh-ancestor
153926172|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926173|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153926186|NCT02646709|Rocuronium|rocuronium|mesh-list
153926213|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926214|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926215|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153926216|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
153926217|NCT02955823|Hormones|hormones|mesh-ancestor
153926218|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926219|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499776|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
153926220|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926221|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153926278|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926279|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
153926280|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153926281|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926282|NCT02639767|Pemetrexed|pemetrexed|mesh-list
153926283|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926284|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926285|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926286|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153926287|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153926288|NCT04829344|Carticaine|carticaine|mesh-list
153926289|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
153926290|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
153926291|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153926292|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926293|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
153926294|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926295|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
153926296|NCT00960063|Temozolomide|temozolomide|mesh-list
153926297|NCT00960063|Ifosfamide|ifosfamide|mesh-list
153926298|NCT00960063|Doxorubicin|doxorubicin|mesh-list
153926299|NCT00960063|Irinotecan|irinotecan|mesh-list
153926300|NCT00960063|Etoposide|etoposide|mesh-list
153926301|NCT00960063|Vincristine|vincristine|mesh-list
153926329|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
153926330|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926331|NCT02646319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153926332|NCT02646319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926333|NCT02646319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926335|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153926336|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153926337|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153926338|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
153926339|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926340|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153926342|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926387|NCT03775525|Capecitabine|capecitabine|mesh-list
153926388|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153926389|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
153926390|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926391|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926392|NCT00654043|Torsemide|torsemide|mesh-list
153926393|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153926394|NCT00654043|Diuretics|diuretics|mesh-ancestor
153926395|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
153926396|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926397|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153926398|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153926399|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926401|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153926402|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
153926446|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926447|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153926448|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926449|NCT02885909|Insulin|insulin|mesh-list
153926450|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153926451|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926452|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
153926453|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153926454|NCT05657171|Estradiol|estradiol|mesh-list
153926455|NCT05657171|Cyproterone|cyproterone|mesh-list
153926456|NCT05657171|Estrogens|estrogens|mesh-ancestor
153926457|NCT05657171|Hormones|hormones|mesh-ancestor
153684049|NCT00145522|Tibolone|tibolone|mesh-list
153926508|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153926509|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153926510|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153926511|NCT01165307|Analgesics|analgesics|mesh-ancestor
153926512|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
153926513|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926514|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926515|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153926516|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
153926517|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153926521|NCT02639143|Clopidogrel|clopidogrel|mesh-list
153926571|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926572|NCT01124838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153926573|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153926574|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153926575|NCT00630435|Estrogens|estrogens|mesh-ancestor
153926576|NCT00630435|Hormones|hormones|mesh-ancestor
153926577|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926578|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926579|NCT02858193|Carbocysteine|carbocysteine|mesh-list
153926580|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153926581|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926582|NCT02858193|Expectorants|expectorants|mesh-ancestor
153926583|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
153926584|NCT02581215|Ramucirumab|ramucirumab|mesh-list
153926585|NCT02581215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153926586|NCT02581215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153926587|NCT02581215|Growth Substances|growth substances|mesh-ancestor
153926588|NCT02581215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926589|NCT02581215|Growth Inhibitors|growth inhibitors|mesh-ancestor
153926628|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153926629|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153926630|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926631|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926632|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926633|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153926634|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153926693|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926694|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153926695|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153926696|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926697|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926698|NCT01136772|Haloperidol|haloperidol|mesh-list
153926699|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153926700|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
153926701|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153926702|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153926703|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153926704|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926705|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153926706|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153926707|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153926708|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
153926709|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926710|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926711|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153926747|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926748|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153926749|NCT02645461|Protective Agents|protective agents|mesh-ancestor
153926750|NCT02645461|Analgesics|analgesics|mesh-ancestor
153926751|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
153926752|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926753|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153926754|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153926755|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926756|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153926757|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
153926758|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153926759|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153926760|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153926761|NCT02645461|Hormones|hormones|mesh-ancestor
153926762|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153926763|NCT00654589|Deferasirox|deferasirox|mesh-list
153926764|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153926765|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
153926766|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
153926767|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926768|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153926769|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153926770|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153926772|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926773|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153926774|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153926775|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926776|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153926777|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153926778|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153926779|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153926780|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153926781|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153926782|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153926783|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
153926784|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926785|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926786|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926787|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
153926788|NCT01119066|Melphalan|melphalan|mesh-list
153926789|NCT01119066|Busulfan|busulfan|mesh-list
153926790|NCT01119066|Thiotepa|thiotepa|mesh-list
153926791|NCT01119066|Fludarabine|fludarabine|mesh-list
153926792|NCT01119066|Clofarabine|clofarabine|mesh-list
153926793|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153926803|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
153926851|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
153926852|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926853|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
153926854|NCT00632476|Vitamins|vitamins|mesh-ancestor
153926855|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
153926856|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926857|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
153926858|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926859|NCT00632476|Protective Agents|protective agents|mesh-ancestor
153926860|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
153926861|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153926862|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926914|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
153926915|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926916|NCT00956943|Nicotine|nicotine|mesh-list
153926917|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153926918|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
153926919|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926920|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926921|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153926922|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153926923|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
153926924|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926925|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926926|NCT01135914|Ranibizumab|ranibizumab|mesh-list
153926927|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153926928|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153926929|NCT01135914|Growth Substances|growth substances|mesh-ancestor
153926930|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926931|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
153926932|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926933|NCT00907738|Vorinostat|vorinostat|mesh-list
153926934|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153926935|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153926936|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153926937|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926938|NCT01123356|Lenalidomide|lenalidomide|mesh-list
153926939|NCT01123356|Ofatumumab|ofatumumab|mesh-list
153926940|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
153926941|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926942|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153926961|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
153926962|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
153926963|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153926964|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153926965|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153499903|NCT00004758|Hormones|hormones|mesh-ancestor
153926966|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
153926967|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
153926968|NCT02883192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153926969|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153926970|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
153926971|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153926972|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153926973|NCT00632554|Prednisolone|prednisolone|mesh-list
153926974|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153926975|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
153926976|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153926977|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
153926978|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153926979|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
153926980|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153926981|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
153926982|NCT00632554|Hormones|hormones|mesh-ancestor
153926984|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927014|NCT05419180|Stiripentol|stiripentol|mesh-list
153927015|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
153927016|NCT04280289|Cannabidiol|cannabidiol|mesh-list
153927017|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
153927018|NCT03302728|Lenalidomide|lenalidomide|mesh-list
153927019|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153927020|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
153927021|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927022|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153927023|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153927024|NCT03302728|Growth Substances|growth substances|mesh-ancestor
153927025|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
153927026|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927027|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153927028|NCT03302728|Immunotoxins|immunotoxins|mesh-ancestor
153927029|NCT03302728|Immunoconjugates|immunoconjugates|mesh-ancestor
153927030|NCT03832972|Estrogens|estrogens|mesh-list
153927031|NCT03832972|Hormones|hormones|mesh-ancestor
153927032|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927033|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927034|NCT02860299|Heparin|heparin|mesh-list
153927035|NCT02860299|Calcium heparin|calcium heparin|mesh-list
153927036|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
153927037|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927038|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153927039|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153927040|NCT02858505|Iron|iron|mesh-list
153927041|NCT02858505|Trace Elements|trace elements|mesh-ancestor
153927042|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
153927043|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927044|NCT02860221|Epinephrine|epinephrine|mesh-list
153927045|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
153927046|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153927047|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153927048|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927049|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
153927050|NCT02860221|Coagulants|coagulants|mesh-ancestor
153927051|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153927054|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927055|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927056|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153927057|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153927058|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
153927059|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927060|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153927061|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
153927062|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
153927063|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
153927064|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153927065|NCT02857569|Nivolumab|nivolumab|mesh-list
153927066|NCT02857569|Ipilimumab|ipilimumab|mesh-list
153927067|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153927068|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927069|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153927070|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927071|NCT04164355|Tadalafil|tadalafil|mesh-list
153927072|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
153927073|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153927074|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153927075|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927076|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927077|NCT04164355|Urological Agents|urological agents|mesh-ancestor
153927078|NCT01605253|Eszopiclone|eszopiclone|mesh-list
153927079|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153927080|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927081|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927082|NCT00655135|Vedolizumab|vedolizumab|mesh-list
153927099|NCT00656695|Cyclosporine|cyclosporine|mesh-list
153927100|NCT00656695|Cyclosporins|cyclosporins|mesh-list
153927101|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
153927102|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927103|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
153927104|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927105|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927106|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153927111|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
153927168|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927169|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153927170|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927171|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153927172|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
153927173|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927174|NCT02856867|Antidotes|antidotes|mesh-ancestor
153927175|NCT02856867|Protective Agents|protective agents|mesh-ancestor
153927176|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
153927177|NCT02856867|Vitamins|vitamins|mesh-ancestor
153927178|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
153927179|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153927180|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927181|NCT00630513|Ampicillin|ampicillin|mesh-list
153927182|NCT00630513|Ertapenem|ertapenem|mesh-list
153927230|NCT02794402|Hormones|hormones|mesh-ancestor
153927231|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927232|NCT00883051|Lasmiditan|lasmiditan|mesh-list
153927233|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153927234|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
153927235|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927236|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927237|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927238|NCT03395587|Temozolomide|temozolomide|mesh-list
153927240|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
153499947|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
153927294|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153927295|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927296|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
153927297|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
153927298|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
153927299|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927300|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153927301|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153927302|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153927303|NCT00948675|Growth Substances|growth substances|mesh-ancestor
153927304|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927305|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
153927355|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927356|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927357|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153927358|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
153927359|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
153927360|NCT02850484|Hormones|hormones|mesh-ancestor
153684979|NCT00082251|Niacin|niacin|mesh-list
153927361|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927362|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153927363|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153927364|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153927365|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
153927366|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927416|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
153927417|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927418|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927419|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153927420|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927421|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153927422|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153927423|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153927424|NCT04202224|Acetaminophen|acetaminophen|mesh-list
153927425|NCT04202224|Ibuprofen|ibuprofen|mesh-list
153927426|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153927477|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927478|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
153927479|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927480|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
153927481|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153927482|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153927483|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153927484|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927485|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
153927486|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
153927487|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153927488|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153927489|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153927490|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153927491|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153927492|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153927493|NCT04202380|Azithromycin|azithromycin|mesh-list
153927495|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927496|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927497|NCT02847442|Levodopa|levodopa|mesh-list
153927498|NCT02847442|Opicapone|opicapone|mesh-list
153927499|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
153927500|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
153927501|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153927502|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153927503|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
153927504|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927505|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927506|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927507|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153927518|NCT01478698|Plasminogen|plasminogen|mesh-list
153927520|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153927521|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153927522|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927523|NCT01199380|Nicotine|nicotine|mesh-list
153927524|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153927525|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
153927526|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927527|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927528|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153927529|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153927530|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
153927531|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927532|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927533|NCT02847286|Dapivirine|dapivirine|mesh-list
153927534|NCT02847286|Clotrimazole|clotrimazole|mesh-list
153927535|NCT02847286|Miconazole|miconazole|mesh-list
153927536|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153927537|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153927576|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153927577|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
153927578|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153927579|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
153927580|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153927581|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153927582|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153927583|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153927584|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927585|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
153927586|NCT04202068|Sulbactam|sulbactam|mesh-list
153927587|NCT04202068|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153927638|NCT02844712|beta-Lactams|beta-lactams|mesh-list
153927639|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927640|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927641|NCT00947349|Interferons|interferons|mesh-list
153927642|NCT00947349|Ribavirin|ribavirin|mesh-list
153927643|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927644|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
153927645|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927646|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
153927647|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927648|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153927649|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153927650|NCT03425812|Analgesics|analgesics|mesh-ancestor
153927656|NCT02845804|Everolimus|everolimus|mesh-list
153927700|NCT00630981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153927701|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153927702|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927703|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927704|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927705|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
153927706|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927707|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
153927708|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153927709|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153927710|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153927711|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927712|NCT00952341|Dexamethasone|dexamethasone|mesh-list
153927713|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
153927714|NCT00952341|Aprepitant|aprepitant|mesh-list
153927715|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
153927716|NCT00952341|Granisetron|granisetron|mesh-list
153927717|NCT00952341|BB 1101|bb 1101|mesh-list
153927718|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153927719|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
153927720|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
153927721|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927722|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927723|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153927724|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
153927725|NCT00952341|Hormones|hormones|mesh-ancestor
153927726|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927727|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153927728|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927729|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
153927730|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927731|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927742|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153927743|NCT02853903|Immunomodulating Agents|immunomodulating agents|mesh-list
153927744|NCT02853903|Immunologic Factors|immunologic factors|mesh-ancestor
153927745|NCT02853903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927746|NCT05242120|Anesthetics|anesthetics|mesh-list
153927747|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927748|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927749|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
153927750|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
153927751|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
153927752|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927753|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927754|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
153927755|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927756|NCT02844790|Insulin|insulin|mesh-list
153927757|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
153927758|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153927800|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927801|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153927802|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927803|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927804|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
153927805|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
153927806|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153927807|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153927808|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153927809|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927811|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153927864|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153927865|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927866|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153927867|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153927869|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153927870|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153500032|NCT00004938|Fluconazole|fluconazole|mesh-list
153927871|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153927872|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153927873|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153927874|NCT04549480|Bosutinib|bosutinib|mesh-list
153927875|NCT04549480|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153927876|NCT04549480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153927877|NCT04549480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927878|NCT04549480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927879|NCT02642419|Aspirin|aspirin|mesh-list
153927880|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
153927881|NCT02642419|Clopidogrel|clopidogrel|mesh-list
153927882|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153927883|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153927884|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153927885|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153927886|NCT02642419|Analgesics|analgesics|mesh-ancestor
153927913|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153927914|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927915|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
153927916|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153927918|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
153927919|NCT00655837|Gemcitabine|gemcitabine|mesh-list
153927920|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153927921|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927922|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
153927923|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927924|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685688|NCT00152893|Niacin|niacin|mesh-list
153927975|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
153927976|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
153927977|NCT00882583|Cisplatin|cisplatin|mesh-list
153927978|NCT00882583|Cetuximab|cetuximab|mesh-list
153927979|NCT00882583|Dasatinib|dasatinib|mesh-list
153927980|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153927981|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153927982|NCT00882583|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153927983|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153927984|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153927985|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153927986|NCT04481308|Fentanyl|fentanyl|mesh-list
153927987|NCT04481308|Propofol|propofol|mesh-list
153927988|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153927989|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153927990|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153927991|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153927992|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
153927993|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
153927994|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153927995|NCT04481308|Narcotics|narcotics|mesh-ancestor
153927996|NCT04481308|Analgesics|analgesics|mesh-ancestor
153927997|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
153927998|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153927999|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153928000|NCT02634541|Adalimumab|adalimumab|mesh-list
153928001|NCT02634541|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153928002|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928003|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928004|NCT04475848|Midazolam|midazolam|mesh-list
153928005|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153928021|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928022|NCT00599521|Analgesics|analgesics|mesh-ancestor
153928023|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
153928024|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928025|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928026|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928027|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928028|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
153928029|NCT04201678|Anesthetics|anesthetics|mesh-list
153928030|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928031|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928088|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153928089|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153928090|NCT00882115|Sulforaphane|sulforaphane|mesh-list
153928091|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153928092|NCT00882115|Protective Agents|protective agents|mesh-ancestor
153928093|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928094|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928095|NCT00653419|Buspirone|buspirone|mesh-list
153928096|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153928097|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153928098|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928099|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928100|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153928101|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153928102|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
153685687|NCT00152893|Chromium|chromium|mesh-list
153928103|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928104|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928105|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153928106|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153928107|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153928108|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928109|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
153928110|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153928111|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
153928112|NCT00656929|Vitamin D|vitamin d|mesh-list
153928114|NCT00656929|Vitamins|vitamins|mesh-ancestor
153928137|NCT03524326|Cetuximab|cetuximab|mesh-list
153928138|NCT03524326|Lenvatinib|lenvatinib|mesh-list
153928139|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153928140|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928141|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153928142|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928143|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928144|NCT01236430|Atorvastatin|atorvastatin|mesh-list
153928145|NCT01236430|Ezetimibe|ezetimibe|mesh-list
153928146|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153928147|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153928148|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
153928149|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928150|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153928151|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153928152|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928153|NCT00726856|Ezetimibe|ezetimibe|mesh-list
153928154|NCT00726856|Fenofibrate|fenofibrate|mesh-list
153928155|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153928156|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153928157|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
153928158|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928189|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153928190|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153928191|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
153928192|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
153928193|NCT00157924|Atorvastatin|atorvastatin|mesh-list
153928194|NCT00157924|Simvastatin|simvastatin|mesh-list
153928195|NCT00157924|Ezetimibe|ezetimibe|mesh-list
153928196|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153928197|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153928199|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928200|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153928201|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153928202|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928203|NCT00794794|Cetirizine|cetirizine|mesh-list
153928204|NCT00794794|Desloratadine|desloratadine|mesh-list
153928205|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153928206|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153928207|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153928208|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
153928209|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
153928210|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928211|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928212|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928213|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153928214|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
153928215|NCT03612466|Plerixafor|plerixafor|mesh-list
153928216|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
153928217|NCT03612466|Calcium|calcium|mesh-list
153500143|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153928218|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153928235|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
153928236|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928237|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928238|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
153928239|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
153928240|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153928241|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153928242|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928243|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153928244|NCT02842294|Bevacizumab|bevacizumab|mesh-list
153928245|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153928246|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928247|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153928248|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153928249|NCT02842294|Growth Substances|growth substances|mesh-ancestor
153928250|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928251|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
153928252|NCT02841982|Morphine|morphine|mesh-list
153928253|NCT02841982|Ropivacaine|ropivacaine|mesh-list
153928254|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153928255|NCT02841982|Narcotics|narcotics|mesh-ancestor
153928256|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928289|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153928290|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928291|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153928292|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153928293|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928294|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928295|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153928296|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
153928297|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153928298|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153928300|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
153928301|NCT01822288|Estradiol|estradiol|mesh-list
153928302|NCT01822288|Estrogens|estrogens|mesh-ancestor
153928303|NCT01822288|Hormones|hormones|mesh-ancestor
153928346|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153928347|NCT01212770|Growth Substances|growth substances|mesh-ancestor
153928348|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
153928349|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928350|NCT05334316|Dexamethasone|dexamethasone|mesh-list
153928351|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928352|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
153928353|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
153928354|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928355|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928356|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928357|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
153928358|NCT05334316|Hormones|hormones|mesh-ancestor
153928359|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928360|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153928361|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928362|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
153928363|NCT00598273|Hematinics|hematinics|mesh-ancestor
153928364|NCT02636491|Insulin|insulin|mesh-list
153928365|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153928366|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153928367|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928368|NCT00657007|Belimumab|belimumab|mesh-list
153928400|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928401|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928402|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
153928403|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153928404|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153686002|NCT00154258|Clozapine|clozapine|mesh-list
153928405|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928406|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153928407|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153928408|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153928409|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928410|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928411|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
153928412|NCT01211522|Haloperidol|haloperidol|mesh-list
153928413|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
153928414|NCT01211522|Ziprasidone|ziprasidone|mesh-list
153928415|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
153928416|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
153928455|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153928456|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
153928457|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153928458|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153928459|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
153928460|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928461|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
153928462|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153928463|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153928464|NCT02633839|Carbidopa|carbidopa|mesh-list
153928465|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153928466|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153928467|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
153928468|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928469|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928512|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928513|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
153928514|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153928515|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153928516|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
153928517|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153928518|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153928519|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928520|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153928521|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153928522|NCT00881569|Efatutazone|efatutazone|mesh-list
153928523|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928524|NCT00657163|Fluoxetine|fluoxetine|mesh-list
153928525|NCT00657163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153928526|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153928527|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153928528|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928529|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928530|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
153928531|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928532|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153928533|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
153928534|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153928535|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153928536|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153928537|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928538|NCT02636101|Betamethasone|betamethasone|mesh-list
153928539|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
153928542|NCT02636101|Calcipotriene|calcipotriene|mesh-list
153928554|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
153500220|NCT00005598|Amifostine|amifostine|mesh-list
153928555|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153928556|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153928557|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928558|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
153928559|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
153928560|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153928561|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153928562|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928563|NCT04159597|Upadacitinib|upadacitinib|mesh-list
153928564|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153928565|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153928566|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928613|NCT00894790|Analgesics|analgesics|mesh-ancestor
153928614|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
153928615|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928616|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928617|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928618|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928619|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153928620|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153928629|NCT00665977|Hormones|hormones|mesh-ancestor
153928679|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928680|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928681|NCT00911287|Analgesics|analgesics|mesh-ancestor
153928682|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
153928683|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928684|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153928685|NCT02631031|Valsartan|valsartan|mesh-list
153928686|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153928687|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153928688|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153928689|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928690|NCT02839408|Azithromycin|azithromycin|mesh-list
153928691|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928692|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928693|NCT02837614|Acetaminophen|acetaminophen|mesh-list
153928694|NCT02837614|Amoxicillin|amoxicillin|mesh-list
153928695|NCT02837614|Dexamethasone|dexamethasone|mesh-list
153928696|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
153928697|NCT02837614|BB 1101|bb 1101|mesh-list
153928698|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928699|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
153686281|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
153928700|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
153928701|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928703|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153500273|NCT00005646|Paclitaxel|paclitaxel|mesh-list
153928704|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
153928705|NCT02837614|Hormones|hormones|mesh-ancestor
153928706|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928707|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153928708|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928709|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
153928710|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928711|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928715|NCT02837614|Analgesics|analgesics|mesh-ancestor
153928720|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928721|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928722|NCT00879229|Ambrisentan|ambrisentan|mesh-list
153928723|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153928724|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
153928725|NCT04249570|Povidone|povidone|mesh-list
153928726|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
153928727|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
153928728|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153928729|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928730|NCT02837770|Diclofenac|diclofenac|mesh-list
153928731|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153928732|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
153928733|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153928734|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153928735|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153928736|NCT02837770|Analgesics|analgesics|mesh-ancestor
153928737|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
153928738|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928739|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928740|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153928741|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153928742|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153928746|NCT00878995|Testosterone|testosterone|mesh-list
153928772|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153928773|NCT00657865|Ramipril|ramipril|mesh-list
153928774|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153928775|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
153928776|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928777|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928778|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153928779|NCT00661765|Varenicline|varenicline|mesh-list
153928780|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153928781|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153928782|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
153928836|NCT02630485|Inositol|inositol|mesh-list
153928837|NCT02630485|Letrozole|letrozole|mesh-list
153928838|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928839|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153928840|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153928841|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153928842|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928843|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153928844|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
153928845|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153928846|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928847|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
153928848|NCT02630485|Vitamins|vitamins|mesh-ancestor
153928849|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
153928850|NCT00894556|Sumatriptan|sumatriptan|mesh-list
153686417|NCT00157066|Vitamin D|vitamin d|mesh-list
153928851|NCT00894556|Rizatriptan|rizatriptan|mesh-list
153928853|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153928854|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153928855|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
153928856|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928857|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928858|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928859|NCT01210352|Oxymorphone|oxymorphone|mesh-list
153928860|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153928861|NCT01210352|Narcotics|narcotics|mesh-ancestor
153928862|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153928863|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928864|NCT01210352|Analgesics|analgesics|mesh-ancestor
153928865|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
153928880|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153928881|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
153928882|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
153928883|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
153928884|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
153928885|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153928886|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928887|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153928946|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928947|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928948|NCT02835742|Sargramostim|sargramostim|mesh-list
153928949|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
153928950|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928951|NCT05326360|Ramosetron|ramosetron|mesh-list
153928952|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
153928953|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
153928954|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153928955|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928956|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153928957|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153928958|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
153928959|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153928960|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153928961|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
153928962|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153928963|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153928964|NCT01207388|Blinatumomab|blinatumomab|mesh-list
153928965|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153928966|NCT02835664|Niacinamide|niacinamide|mesh-list
153928968|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
153928969|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
153928970|NCT02835664|Vitamins|vitamins|mesh-ancestor
153928971|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
153928972|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153928973|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153928996|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
153928997|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
153928998|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
153928999|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929000|NCT02835586|Paclitaxel|paclitaxel|mesh-list
153929001|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153929002|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929023|NCT01206764|Everolimus|everolimus|mesh-list
153929065|NCT00662233|Ifosfamide|ifosfamide|mesh-list
153929066|NCT00662233|Doxorubicin|doxorubicin|mesh-list
153929067|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153929068|NCT00662233|Etoposide|etoposide|mesh-list
153929069|NCT00662233|Vincristine|vincristine|mesh-list
153929070|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929071|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
153929072|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929073|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929074|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153929075|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
153929076|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929077|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929078|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153929079|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153929080|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153929081|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153929082|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929083|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153929084|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
153929085|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
153929086|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
153929087|NCT00658957|Gentamicins|gentamicins|mesh-list
153929088|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929089|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929090|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153929091|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929092|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929093|NCT00662467|Aspirin|aspirin|mesh-list
153929094|NCT00662467|Warfarin|warfarin|mesh-list
153929095|NCT00662467|Clopidogrel|clopidogrel|mesh-list
153929096|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153929097|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153929098|NCT00662467|Analgesics|analgesics|mesh-ancestor
153929099|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
153929100|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929103|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929104|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153929105|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153929106|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929107|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153929108|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153929109|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929110|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
153929111|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153929112|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153929113|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153929114|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
153929115|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929116|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
153929117|NCT00668941|Vitamin D|vitamin d|mesh-list
153929118|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
153929119|NCT00668941|Alendronate|alendronate|mesh-list
153929120|NCT00668941|Teriparatide|teriparatide|mesh-list
153929121|NCT00668941|Calcium|calcium|mesh-list
153929122|NCT00668941|Vitamins|vitamins|mesh-ancestor
153929123|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
153929124|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929157|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929158|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153929159|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
153929160|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153929161|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153929162|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153929163|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
153929165|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929166|NCT02630095|Nadroparin|nadroparin|mesh-list
153929167|NCT02630095|Warfarin|warfarin|mesh-list
153929168|NCT02630095|Calcium|calcium|mesh-list
153929169|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153929220|NCT00894166|Nicotine|nicotine|mesh-list
153929221|NCT00894166|Varenicline|varenicline|mesh-list
153929222|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153929223|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
153929224|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929225|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929226|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153929227|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153929228|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
153929229|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929230|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929231|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153929232|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
153929233|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153929234|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153929235|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153929236|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153929237|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
153929238|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153929239|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153929240|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929241|NCT00659503|Ciclesonide|ciclesonide|mesh-list
153929242|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
153929243|NCT00659503|Hormones|hormones|mesh-ancestor
153929244|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929245|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929246|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153929247|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
153929248|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153929249|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153929250|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929251|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
153929252|NCT00670345|Coagulants|coagulants|mesh-ancestor
153929253|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
153929260|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
153929261|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929262|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153929263|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929264|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929265|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929266|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929267|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929269|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
153929326|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153929327|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929328|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929329|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
153929330|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929331|NCT02887313|Antidotes|antidotes|mesh-ancestor
153929332|NCT02887313|Protective Agents|protective agents|mesh-ancestor
153929333|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
153929335|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
153929336|NCT01206140|Sirolimus|sirolimus|mesh-list
153929337|NCT01206140|Temsirolimus|temsirolimus|mesh-list
153929338|NCT01206140|MTOR Inhibitors|mtor inhibitors|mesh-list
153929339|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929340|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929341|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153929342|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929343|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
153929344|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929345|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
153929346|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929347|NCT01206140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153929379|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929380|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929382|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153929383|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
153929384|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153929385|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929386|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153929387|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
153929388|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929389|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929390|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
153929391|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929392|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153929393|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153929394|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
153929395|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929396|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153929398|NCT01188551|Fentanyl|fentanyl|mesh-list
153929399|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
153929400|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153929401|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929402|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929403|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153929404|NCT01188551|Analgesics|analgesics|mesh-ancestor
153929405|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
153929406|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929407|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153929408|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153929409|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153929410|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
153929411|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929419|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
153929420|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
153929421|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
153929422|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153929423|NCT01188551|Narcotics|narcotics|mesh-ancestor
153929424|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
153929425|NCT01161407|Calcium|calcium|mesh-list
153929426|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153929485|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153929486|NCT01157351|Perphenazine|perphenazine|mesh-list
153929487|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153929488|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
153929489|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929490|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929491|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929492|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153929493|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153929494|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929495|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153929496|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153929497|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
153929498|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
153929499|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
153929500|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929501|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153929502|NCT01157351|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153929503|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153929504|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153929505|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
153929506|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
153929507|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153929508|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153929509|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153929510|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153929511|NCT02831686|Dexamethasone|dexamethasone|mesh-list
153929512|NCT02831686|Ixazomib|ixazomib|mesh-list
153929513|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929514|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
153929528|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929529|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153929531|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929532|NCT02831374|Anesthetics|anesthetics|mesh-list
153929533|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929534|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929535|NCT02831218|Aspirin|aspirin|mesh-list
153929536|NCT02831218|Clopidogrel|clopidogrel|mesh-list
153929537|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153929538|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153929539|NCT02831218|Analgesics|analgesics|mesh-ancestor
153929540|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
153929541|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929542|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929543|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153929544|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153929545|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153929551|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
153929582|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153929583|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929584|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929585|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153929586|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
153929587|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929588|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929589|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153929590|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153929591|NCT01157117|Omalizumab|omalizumab|mesh-list
153929592|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153929593|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153929594|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153687171|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929595|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
153929596|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
153929597|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929598|NCT00891202|Eliglustat|eliglustat|mesh-list
153929599|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929600|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929601|NCT02830906|Ondansetron|ondansetron|mesh-list
153929602|NCT02830906|Ramosetron|ramosetron|mesh-list
153929603|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
153929604|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
153929605|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929606|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929607|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153929608|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
153929609|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
153929610|NCT02830906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153929611|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153929612|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
153929613|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929615|NCT02832778|Tenofovir|tenofovir|mesh-list
153929620|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153929621|NCT02832778|Isoniazid|isoniazid|mesh-list
153929622|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
153929623|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929624|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153929625|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153929626|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929627|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929628|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153929629|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153929683|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
153929684|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
153929685|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929686|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153929687|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153929688|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929689|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929691|NCT04245046|Candesartan|candesartan|mesh-list
153929692|NCT04245046|Candesartan cilexetil|candesartan cilexetil|mesh-list
153929693|NCT04245046|Atorvastatin|atorvastatin|mesh-list
153929694|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153929695|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153929696|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
153929697|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929698|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153929699|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153929700|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929701|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153929702|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153929703|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153929704|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153929705|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929706|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
153929707|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153929731|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929732|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153929733|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153929734|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
153929735|NCT05210764|Analgesics|analgesics|mesh-ancestor
153929736|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
153929737|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929738|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153929739|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153929740|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153929741|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153929747|NCT00889720|Varenicline|varenicline|mesh-list
153929793|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
153929794|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929795|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153929796|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153929797|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929798|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929799|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153929800|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
153929801|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153929802|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929803|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153929804|NCT00663481|Leucovorin|leucovorin|mesh-list
153929805|NCT00663481|Antidotes|antidotes|mesh-ancestor
153929806|NCT00663481|Protective Agents|protective agents|mesh-ancestor
153929807|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929808|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
153929809|NCT00663481|Vitamins|vitamins|mesh-ancestor
153929850|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929851|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153929852|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153929854|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
153929855|NCT04155697|Ethanol|ethanol|mesh-list
153929856|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153929857|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929858|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
153929859|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153929860|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929861|NCT00663559|Sunitinib|sunitinib|mesh-list
153929862|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929863|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153929864|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153929865|NCT00663559|Growth Substances|growth substances|mesh-ancestor
153929866|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929867|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
153929868|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153929869|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929870|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929871|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
153929872|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153929901|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153929902|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
153929903|NCT00671203|Erythromycin|erythromycin|mesh-list
153929904|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
153929905|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153929906|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
153929907|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153929908|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153929909|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153929910|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153929911|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153929923|NCT04157959|Febuxostat|febuxostat|mesh-list
153929964|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153929965|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153929966|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153929968|NCT00671281|Coagulants|coagulants|mesh-ancestor
153929969|NCT04155229|Acetaminophen|acetaminophen|mesh-list
153929970|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153929971|NCT04155229|Oxycodone|oxycodone|mesh-list
153929972|NCT04155229|Hydrocodone|hydrocodone|mesh-list
153929973|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153929974|NCT04155229|Analgesics|analgesics|mesh-ancestor
153929975|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
153929976|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153929977|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153929978|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
153929979|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153929980|NCT04155229|Narcotics|narcotics|mesh-ancestor
153929982|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
153930023|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153930024|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930025|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
153930026|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153930027|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153930028|NCT01104870|Treprostinil|treprostinil|mesh-list
153930029|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153930030|NCT02632279|Tryptophan|tryptophan|mesh-list
153930031|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153930032|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
153930033|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930034|NCT00664417|Vaccines|vaccines|mesh-list
153930035|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
153930036|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930037|NCT04031755|Minocycline|minocycline|mesh-list
153930038|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153930039|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153930040|NCT01104792|Cariprazine|cariprazine|mesh-list
153930041|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153930042|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153930043|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930078|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930079|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
153930080|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930081|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
153930082|NCT00664963|Sirolimus|sirolimus|mesh-list
153930083|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153930087|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
153930147|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930148|NCT00661063|Clonidine|clonidine|mesh-list
153930149|NCT00661063|Ketamine|ketamine|mesh-list
153930150|NCT00661063|Analgesics|analgesics|mesh-ancestor
153930151|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
153930152|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930153|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930216|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153930217|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930218|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930219|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153930220|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
153930284|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930285|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153930286|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930287|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930288|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153930289|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153930290|NCT00676117|Analgesics|analgesics|mesh-ancestor
153930352|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
153930353|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930354|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153930355|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153930356|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930357|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930359|NCT01104246|Androgens|androgens|mesh-ancestor
153930360|NCT01104246|Hormones|hormones|mesh-ancestor
153930361|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153930362|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930363|NCT00676741|Insulin|insulin|mesh-list
153930364|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153930365|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
153930366|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
153930367|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153930368|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
153930369|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
153930370|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153930371|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930372|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930373|NCT01103778|Bortezomib|bortezomib|mesh-list
153930374|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930375|NCT00673621|Albuterol|albuterol|mesh-list
153930376|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
153930377|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930378|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153930379|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
153930380|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930381|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153930382|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
153930383|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
153930384|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153930385|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153930386|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153930390|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930391|NCT00673621|Miotics|miotics|mesh-ancestor
153930392|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153930393|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153930394|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153930395|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153930396|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
153930397|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
153930398|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153930399|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
153930400|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153930401|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
153930402|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930403|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930404|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
153930405|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153930406|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153930407|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153930408|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153930409|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930410|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930411|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930412|NCT00945945|Analgesics|analgesics|mesh-ancestor
153930413|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
153930414|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930415|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
153930416|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930417|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
153930418|NCT01112982|Colchicine|colchicine|mesh-list
153930419|NCT01112982|Febuxostat|febuxostat|mesh-list
153930420|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
153930421|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153930430|NCT01203878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930431|NCT01203878|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153930432|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
153930433|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930434|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153930435|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930436|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
153930437|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153930438|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
153930440|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153930441|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
153930442|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930443|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930491|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153930492|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930493|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153930495|NCT00680563|Hematinics|hematinics|mesh-ancestor
153930496|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
153930497|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930498|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
153930499|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153930500|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930501|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
153930502|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153930503|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153930504|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930505|NCT00680641|Simvastatin|simvastatin|mesh-list
153930550|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930551|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
153930553|NCT00674089|Vitamins|vitamins|mesh-ancestor
153930554|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
153930555|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930556|NCT01200992|Mitomycins|mitomycins|mesh-list
153930557|NCT01200992|Mitomycin|mitomycin|mesh-list
153930558|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153930559|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930560|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
153930561|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930562|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153930563|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930564|NCT02824666|Fallypride|fallypride|mesh-list
153930565|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153930610|NCT02628847|Urological Agents|urological agents|mesh-ancestor
153930611|NCT00677443|Capecitabine|capecitabine|mesh-list
153930612|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
153930613|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153930614|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
153930615|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930616|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930617|NCT00674557|Exemestane|exemestane|mesh-list
153930618|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153930619|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930620|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153930621|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153930674|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153930675|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930676|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153930677|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930678|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
153930679|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153930680|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153930681|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153930682|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153930683|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
153930737|NCT02823808|Glimepiride|glimepiride|mesh-list
153930738|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153930739|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930740|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930741|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153930742|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
153930743|NCT04151719|Bromides|bromides|mesh-list
153930744|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
153930745|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
153930746|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153930747|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930748|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
153930749|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153930799|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930800|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153930801|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
153930802|NCT01200758|Hormones|hormones|mesh-ancestor
153930803|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153930804|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153930805|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153930806|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930807|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930808|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
153930809|NCT02823106|Verapamil|verapamil|mesh-list
153930810|NCT02823106|Choline|choline|mesh-list
153930811|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153930812|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
153930813|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153930814|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
153930816|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153930857|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
153930858|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930859|NCT01107912|Clopidogrel|clopidogrel|mesh-list
153930860|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153930861|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153930862|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153930863|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153930864|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153930865|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
153930866|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153930867|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930868|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930869|NCT00678145|Epinephrine|epinephrine|mesh-list
153930918|NCT04239586|Glipizide|glipizide|mesh-list
153930919|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153930920|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153930921|NCT02628613|Paclitaxel|paclitaxel|mesh-list
153930922|NCT02628613|Vinorelbine|vinorelbine|mesh-list
153930923|NCT02628613|Epirubicin|epirubicin|mesh-list
153930924|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153930925|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930926|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930927|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930928|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
153930929|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930930|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153500550|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153930931|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153930932|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153930933|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930934|NCT01100034|Etanercept|etanercept|mesh-list
153930937|NCT01100034|Analgesics|analgesics|mesh-ancestor
153930977|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153930978|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153930979|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153930980|NCT04769050|Docetaxel|docetaxel|mesh-list
153930981|NCT04769050|Capecitabine|capecitabine|mesh-list
153930982|NCT04769050|Trastuzumab|trastuzumab|mesh-list
153930983|NCT04769050|Pertuzumab|pertuzumab|mesh-list
153930984|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153930985|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
153930986|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
153930987|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
153931039|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931040|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153931041|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153931042|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153931043|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153931044|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153931045|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153931046|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153931047|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153931048|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
153931049|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931050|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931100|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
153931101|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
153931102|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
153931103|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931105|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153931106|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
153931107|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
153931108|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931109|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931110|NCT00876187|Naproxen|naproxen|mesh-list
153931111|NCT00876187|Tanezumab|tanezumab|mesh-list
153931112|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153931113|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153931114|NCT00876187|Analgesics|analgesics|mesh-ancestor
153931115|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
153931116|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931117|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931118|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931119|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931120|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
153931121|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153931122|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931123|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931124|NCT04238884|Voriconazole|voriconazole|mesh-list
153931125|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
153931126|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931127|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153931128|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153931129|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931130|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931142|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153931143|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153931145|NCT05658640|Dexamethasone|dexamethasone|mesh-list
153931146|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
153931147|NCT05658640|Trametinib|trametinib|mesh-list
153931148|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153931149|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
153931150|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931151|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931152|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153931153|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
153931158|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
153931205|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153931206|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153931207|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
153931208|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931209|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931210|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153931211|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153931212|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
153931213|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931269|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153931270|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931271|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
153931272|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153931273|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
153931274|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931275|NCT00678769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153931276|NCT00678769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931277|NCT00678769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931278|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153931279|NCT04146883|Cephalexin|cephalexin|mesh-list
153931280|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931281|NCT02817256|Vitamins|vitamins|mesh-list
153931282|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
153931331|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153931332|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153931333|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153931334|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
153931335|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
153931336|NCT00681733|Pioglitazone|pioglitazone|mesh-list
153931337|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
153931338|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153931339|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931340|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153931341|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931342|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931343|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153931344|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153931345|NCT00681733|Protective Agents|protective agents|mesh-ancestor
153931346|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
153931347|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153931348|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
153931349|NCT00679315|Alfuzosin|alfuzosin|mesh-list
153931350|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153931351|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153931352|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153931353|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
153931354|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931355|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931356|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931357|NCT00679315|Urological Agents|urological agents|mesh-ancestor
153931358|NCT04238962|Semaglutide|semaglutide|mesh-list
153931359|NCT04238962|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153931375|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153931376|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
153931377|NCT04460248|Rituximab|rituximab|mesh-list
153931378|NCT04460248|Lenalidomide|lenalidomide|mesh-list
153931379|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
153931380|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153931381|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931382|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
153931383|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931384|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153931385|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153931386|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153931387|NCT04460248|Growth Substances|growth substances|mesh-ancestor
153931388|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
153931389|NCT04460248|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153931390|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153931391|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931392|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931433|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
153931434|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931435|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153931436|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153931437|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153931438|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
153931439|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931440|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931441|NCT00685633|Bicalutamide|bicalutamide|mesh-list
153931442|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
153931443|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
153931444|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153931445|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931446|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931447|NCT04371952|Doxycycline|doxycycline|mesh-list
153931448|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931449|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931491|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
153931492|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931493|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
153931494|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931495|NCT00682279|Topotecan|topotecan|mesh-list
153931496|NCT00682279|Lapatinib|lapatinib|mesh-list
153931497|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153931498|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153931499|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931500|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931504|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
153931551|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153931553|NCT00680329|Travoprost|travoprost|mesh-list
153931554|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153931555|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153931556|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153931557|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153931558|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
153931559|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931560|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931561|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931562|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153931615|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
153931616|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
153931617|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153931618|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153931620|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
153931621|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
153931622|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153931623|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153931624|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153931625|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153931626|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153931627|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
153931628|NCT01155869|Naltrexone|naltrexone|mesh-list
153931629|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153931630|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153931631|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931632|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
153931633|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931634|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
153931635|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153931636|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931637|NCT02625415|Vitamins|vitamins|mesh-list
153931638|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
153931639|NCT02625415|Pyridoxal|pyridoxal|mesh-list
153931640|NCT02625415|Pyridoxine|pyridoxine|mesh-list
153931641|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
153931642|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
153931643|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931644|NCT02809768|Itraconazole|itraconazole|mesh-list
153931645|NCT02809768|Fluconazole|fluconazole|mesh-list
153931646|NCT02809768|Rifampin|rifampin|mesh-list
153931647|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
153931648|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931662|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153931663|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153931664|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153931665|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153931666|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153931667|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153931668|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153931729|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931730|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
153931731|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
153931732|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153931733|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153931734|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153931735|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
153931736|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931737|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931738|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
153931739|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
153931740|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
153931741|NCT00683059|Paclitaxel|paclitaxel|mesh-list
153931742|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153931743|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931788|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931789|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153931790|NCT04139629|Antibodies|antibodies|mesh-list
153931791|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
153931792|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931793|NCT02813044|Anesthetics|anesthetics|mesh-list
153931794|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153931795|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931796|NCT04236778|Vancomycin|vancomycin|mesh-list
153931797|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153931798|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931799|NCT02812888|Propranolol|propranolol|mesh-list
153931800|NCT02812888|Methimazole|methimazole|mesh-list
153931801|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
153931802|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153931803|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153931804|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
153931805|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931806|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931842|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931844|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153931845|NCT02880462|Protective Agents|protective agents|mesh-ancestor
153931846|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931847|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153931848|NCT00688363|Chrysarobin|chrysarobin|mesh-list
153931849|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153931850|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153931851|NCT00688363|Analgesics|analgesics|mesh-ancestor
153931852|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
153931853|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153931854|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931855|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153931903|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
153931904|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153931905|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931906|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
153931907|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
153931908|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153931909|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931910|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153931911|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153931971|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153931972|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
153931973|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153931974|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153931975|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153931976|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153931977|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
153931978|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153931981|NCT00683995|Fentanyl|fentanyl|mesh-list
153932040|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153932041|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
153932042|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153932043|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153932044|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
153932045|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
153932046|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153932047|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153932048|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153932049|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
153932050|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932051|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
153932052|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
153932053|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932054|NCT00624767|Insulin|insulin|mesh-list
153932055|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153932098|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932099|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932100|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153932101|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153932102|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
153932103|NCT02804776|Gefitinib|gefitinib|mesh-list
153932104|NCT02804776|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153932105|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932106|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932107|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932108|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932109|NCT01154153|Loratadine|loratadine|mesh-list
153932110|NCT01154153|Triamcinolone|triamcinolone|mesh-list
153932111|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153932112|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153932113|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153932114|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153932115|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
153932116|NCT01154153|Hormones|hormones|mesh-ancestor
153932153|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932154|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153932155|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153932156|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153932157|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153932158|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153932159|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932160|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932161|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153932162|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
153932163|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932164|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932215|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932217|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932218|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932219|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932220|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932222|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932223|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932224|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932225|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932226|NCT00691873|Omalizumab|omalizumab|mesh-list
153932227|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153932228|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153932229|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
153932275|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932276|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932277|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153932278|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153932279|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
153932280|NCT02625337|Trametinib|trametinib|mesh-list
153932281|NCT02625337|Dabrafenib|dabrafenib|mesh-list
153932341|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932342|NCT00694837|Nelfinavir|nelfinavir|mesh-list
153932343|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153932344|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153932345|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
153932346|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932347|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932348|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153932349|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153932350|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
153932351|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932352|NCT02800252|Aspirin|aspirin|mesh-list
153932355|NCT02800252|Analgesics|analgesics|mesh-ancestor
153932402|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153932403|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
153932404|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153932405|NCT02800330|Esomeprazole|esomeprazole|mesh-list
153932406|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153932407|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153932408|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153932409|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932410|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932411|NCT02799862|Paclitaxel|paclitaxel|mesh-list
153932412|NCT02799862|Carboplatin|carboplatin|mesh-list
153932413|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153932415|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
153932464|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153932465|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932466|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153932467|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153932468|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153932469|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932470|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932471|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153932472|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153932473|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153932530|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153932531|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153932532|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932533|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932534|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153932535|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
153932536|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932537|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932538|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153932539|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
153932540|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
153932590|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153932591|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153932592|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932593|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932594|NCT00695929|Protective Agents|protective agents|mesh-ancestor
153932595|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932596|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153932597|NCT04235296|Mitogens|mitogens|mesh-list
153932598|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
153932600|NCT02620501|Lidocaine|lidocaine|mesh-list
153932655|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932656|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932657|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
153932658|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932659|NCT02796196|Coal Tar|coal tar|mesh-list
153932660|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
153932661|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
153932662|NCT00693199|Amlodipine|amlodipine|mesh-list
153932663|NCT00693199|Prazosin|prazosin|mesh-list
153932664|NCT00693199|Terazosin|terazosin|mesh-list
153690241|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153932665|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153932666|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153932719|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932720|NCT02801032|Tadalafil|tadalafil|mesh-list
153932721|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
153932722|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153932723|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153932724|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932725|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932726|NCT02801032|Urological Agents|urological agents|mesh-ancestor
153932727|NCT05442190|Hypericin|hypericin|mesh-list
153932728|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
153932729|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153932730|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932731|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
153932732|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932733|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932734|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932735|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932736|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
153932737|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932738|NCT02689960|Prednisone|prednisone|mesh-list
153932739|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153932740|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
153932741|NCT02689960|Hormones|hormones|mesh-ancestor
153932742|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932743|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932744|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153932745|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932746|NCT01150097|Everolimus|everolimus|mesh-list
153932763|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153932764|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
153932765|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932766|NCT02794792|Metformin|metformin|mesh-list
153932767|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
153932768|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153932769|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932770|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153932771|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932772|NCT01149473|Losartan|losartan|mesh-list
153932773|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153932774|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153932775|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153932776|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153932779|NCT01149473|Diuretics|diuretics|mesh-ancestor
153932822|NCT00693433|Hormones|hormones|mesh-ancestor
153932823|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153932824|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153932825|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932826|NCT00693433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153932827|NCT00693433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932828|NCT00693433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932829|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153932830|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
153932831|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153932832|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153932883|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153932884|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153932885|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153932886|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153932887|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932888|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153932889|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
153932890|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153932891|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932893|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153932894|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153932895|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153932897|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153932898|NCT01148537|Analgesics|analgesics|mesh-ancestor
153932899|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
153932900|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153932902|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
153932944|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153932945|NCT04234594|Panitumumab|panitumumab|mesh-list
153932946|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932947|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932948|NCT02789488|Fenugreek seed meal|fenugreek seed meal|mesh-list
153932949|NCT02789488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153932950|NCT02789488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932951|NCT01148459|Vaccines|vaccines|mesh-list
153932952|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
153932953|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153932954|NCT03913234|Trastuzumab|trastuzumab|mesh-list
153932955|NCT03913234|Letrozole|letrozole|mesh-list
153932956|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153932957|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153932958|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153933005|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153933006|NCT04234516|Narcotics|narcotics|mesh-ancestor
153933007|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933008|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933009|NCT04234516|Analgesics|analgesics|mesh-ancestor
153933010|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
153933011|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933012|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153933013|NCT02789566|Primaquine|primaquine|mesh-list
153933014|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
153933015|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153933016|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153933017|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933018|NCT00697021|Aspirin|aspirin|mesh-list
153933019|NCT00697021|Clopidogrel|clopidogrel|mesh-list
153933020|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153933021|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153933022|NCT00697021|Analgesics|analgesics|mesh-ancestor
153933023|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
153933024|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933025|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933026|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153933027|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933028|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153933029|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153933030|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933031|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153933054|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153933055|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
153933056|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933057|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933058|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153933059|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
153933060|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933061|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933062|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153933063|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153933064|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153933065|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153933066|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933067|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153933068|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153933113|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153933114|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933115|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153933117|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153933118|NCT02884115|Penicillin G|penicillin g|mesh-list
153933119|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
153933120|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933121|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933122|NCT01190813|Levodopa|levodopa|mesh-list
153933123|NCT01190813|Carbidopa|carbidopa|mesh-list
153933124|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153933125|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153933126|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
153933175|NCT02788552|Vitamins|vitamins|mesh-list
153933176|NCT02788552|Thiamine|thiamine|mesh-list
153933177|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
153933178|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933179|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
153933180|NCT01147055|Rifampin|rifampin|mesh-list
153933181|NCT01147055|Crizotinib|crizotinib|mesh-list
153933182|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153933183|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
153933184|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933185|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933186|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
153933238|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
153933239|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153933240|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
153933241|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933242|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933243|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153933244|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
153933245|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153933246|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
153933247|NCT03628066|Letrozole|letrozole|mesh-list
153933248|NCT03628066|Palbociclib|palbociclib|mesh-list
153933249|NCT03628066|Goserelin|goserelin|mesh-list
153933250|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933251|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153933252|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153933253|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933297|NCT04133155|Paclitaxel|paclitaxel|mesh-list
153933298|NCT04133155|Gemcitabine|gemcitabine|mesh-list
153933299|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153933300|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933301|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
153933302|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
153933303|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
153933304|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933305|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153933306|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
153933307|NCT01190267|Asenapine|asenapine|mesh-list
153933308|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153933361|NCT02616289|Emollients|emollients|mesh-list
153933362|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
153933363|NCT03421756|Sirolimus|sirolimus|mesh-list
153933364|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
153933365|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933366|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933367|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153933368|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933369|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
153933370|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153933371|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
153933372|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933373|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153933374|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
153933375|NCT00870103|Dexamethasone|dexamethasone|mesh-list
153933422|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153933423|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933424|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153933425|NCT04232332|Mitogens|mitogens|mesh-list
153933426|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
153933427|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933428|NCT02785276|Ropivacaine|ropivacaine|mesh-list
153933429|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
153933430|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
153933431|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933432|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933433|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
153933434|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933435|NCT04316039|Temozolomide|temozolomide|mesh-list
153933436|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153933437|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
153933480|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933481|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933482|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153933483|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
153933484|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933550|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933551|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153933552|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153933553|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153933554|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153933555|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
153933556|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933557|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933558|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153933559|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153933560|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
153933561|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153933562|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153933563|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
153933564|NCT02786446|Naproxen|naproxen|mesh-list
153933565|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153933566|NCT02786446|Lidocaine|lidocaine|mesh-list
153933567|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
153933568|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
153933569|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933602|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
153933603|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153933604|NCT02947516|Liver Extracts|liver extracts|mesh-list
153933605|NCT02947516|Hematinics|hematinics|mesh-ancestor
153933606|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153933607|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153933608|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153933609|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153933610|NCT00864721|Sunitinib|sunitinib|mesh-list
153933611|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933612|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153933613|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153933667|NCT05276908|Bupivacaine|bupivacaine|mesh-list
153933668|NCT05276908|Anesthetics|anesthetics|mesh-list
153933669|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
153933670|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933671|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933672|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
153933673|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153933674|NCT02785978|Levodopa|levodopa|mesh-list
153933675|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153933676|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153933677|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
153933678|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153933679|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933680|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933681|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
153933682|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153933683|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933684|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933695|NCT05273710|Folic Acid|folic acid|mesh-list
153933722|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153933723|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
153933725|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933726|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153933727|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933728|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
153933729|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933730|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933731|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
153933732|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
153933733|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933734|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
153933735|NCT02878512|Anesthetics|anesthetics|mesh-list
153933736|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153933737|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933738|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
153933739|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153933740|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
153933741|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153933742|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
153933743|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933745|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
153933771|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153933772|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
153933773|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
153933774|NCT02782312|Hormones|hormones|mesh-ancestor
153933775|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153933776|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
153933777|NCT04229758|Anticoagulants|anticoagulants|mesh-list
153933778|NCT00698425|Citric Acid|citric acid|mesh-list
153933779|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
153933780|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
153933781|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153933782|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
153933783|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
153933784|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933785|NCT05342272|Lactoferrin|lactoferrin|mesh-list
153933786|NCT05342272|Muramidase|muramidase|mesh-list
153933831|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153933832|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153933833|NCT02782078|Rifampin|rifampin|mesh-list
153933834|NCT02782078|Clindamycin|clindamycin|mesh-list
153933835|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
153933836|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
153933837|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153933838|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
153933839|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933840|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153933841|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
153933842|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153933843|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153933844|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933845|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153933852|NCT01293682|Calcitriol|calcitriol|mesh-list
153933890|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153933891|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153933892|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
153933893|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153933894|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153933895|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153933896|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153933897|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153933955|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
153933956|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153933957|NCT05298163|Calcitriol|calcitriol|mesh-list
153933958|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153933959|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153933960|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153933961|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153933962|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934020|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153934022|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934023|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153934024|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153934025|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934026|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153934027|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934028|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934029|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153934030|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153934031|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153934032|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
153934033|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934035|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153934078|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153934079|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934080|NCT01200368|Vaccines|vaccines|mesh-list
153934081|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153934082|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
153934083|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934084|NCT04125121|Propofol|propofol|mesh-list
153934085|NCT04125121|Sevoflurane|sevoflurane|mesh-list
153934086|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153934087|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934088|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934089|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153934141|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153934142|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153934143|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153934144|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153934145|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934146|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934147|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
153934148|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934149|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153934150|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153934151|NCT02781064|Atorvastatin|atorvastatin|mesh-list
153934152|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153934153|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153934154|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
153934155|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934156|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153934157|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153934158|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934159|NCT04205682|Cannabidiol|cannabidiol|mesh-list
153934160|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
153934161|NCT01134263|Vaccines|vaccines|mesh-list
153934162|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
153934163|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934164|NCT01199822|Olaratumab|olaratumab|mesh-list
153934165|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934166|NCT01096056|Vaccines|vaccines|mesh-list
153934167|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
153934168|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934169|NCT00866359|Apremilast|apremilast|mesh-list
153934170|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934171|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934181|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934182|NCT01199198|Tolvaptan|tolvaptan|mesh-list
153934183|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153934184|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934185|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
153934186|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934187|NCT01095978|Clarithromycin|clarithromycin|mesh-list
153934188|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153934189|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153934190|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153934191|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934192|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934193|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153934195|NCT01134107|Insulin|insulin|mesh-list
153934239|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934240|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934241|NCT00634894|Letrozole|letrozole|mesh-list
153934242|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934243|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153934244|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153934245|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934246|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934247|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153934248|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
153934249|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934250|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934251|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
153934252|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153934253|NCT02779270|Protective Agents|protective agents|mesh-ancestor
153934254|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934256|NCT01078662|Olaparib|olaparib|mesh-list
153934295|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934296|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153934297|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153934298|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
153934299|NCT02779192|Ebselen|ebselen|mesh-list
153691893|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
153934364|NCT02883569|Narcotics|narcotics|mesh-ancestor
153934365|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934366|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
153934367|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
153934368|NCT02883023|Bleomycin|bleomycin|mesh-list
153934369|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153934370|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934371|NCT02778958|Acetaminophen|acetaminophen|mesh-list
153934372|NCT02778958|Ibuprofen|ibuprofen|mesh-list
153934373|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934374|NCT02778958|Analgesics|analgesics|mesh-ancestor
153934375|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
153934376|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934377|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934378|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
153934379|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934380|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934381|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934382|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934383|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934384|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934385|NCT01197560|Rituximab|rituximab|mesh-list
153934386|NCT01197560|Gemcitabine|gemcitabine|mesh-list
153934387|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
153934388|NCT01197560|Etoposide|etoposide|mesh-list
153934389|NCT01197560|Lenalidomide|lenalidomide|mesh-list
153934390|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153934391|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934392|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
153934393|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934394|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934396|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
153934408|NCT01196078|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153934409|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153934411|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934412|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934413|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153934414|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
153934415|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
153934416|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
153934417|NCT05314660|Fluorides|fluorides|mesh-list
153934418|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
153934419|NCT05314660|Protective Agents|protective agents|mesh-ancestor
153934420|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934421|NCT04920292|Oxfendazole|oxfendazole|mesh-list
153934470|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153934471|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153934472|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934473|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934474|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153934475|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
153934476|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153934477|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934478|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153934479|NCT04823052|Sulindac|sulindac|mesh-list
153934480|NCT04823052|Gaboxadol|gaboxadol|mesh-list
153934481|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934482|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934483|NCT04823052|Analgesics|analgesics|mesh-ancestor
153934529|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934530|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934532|NCT01193660|Hematinics|hematinics|mesh-ancestor
153934534|NCT02777788|Vinorelbine|vinorelbine|mesh-list
153934535|NCT02777788|Docetaxel|docetaxel|mesh-list
153934536|NCT02777788|Carboplatin|carboplatin|mesh-list
153934537|NCT02777788|Gemcitabine|gemcitabine|mesh-list
153934538|NCT02777788|Pemetrexed|pemetrexed|mesh-list
153934596|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934597|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934598|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934600|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934601|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934602|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934603|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
153934604|NCT01193348|Eculizumab|eculizumab|mesh-list
153934605|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153934606|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153934607|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
153934608|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934609|NCT00945321|Aprepitant|aprepitant|mesh-list
153934610|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
153934611|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
153934612|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
153934613|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934614|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934615|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153934616|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153934648|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934649|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153934650|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934651|NCT00869401|Temozolomide|temozolomide|mesh-list
153934652|NCT00869401|Dasatinib|dasatinib|mesh-list
153934653|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153934654|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
153934655|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934656|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934657|NCT00869401|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153934658|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153934659|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934660|NCT01076010|Sorafenib|sorafenib|mesh-list
153934661|NCT01076010|Tivozanib|tivozanib|mesh-list
153934662|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934664|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934705|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934706|NCT02617849|Paclitaxel|paclitaxel|mesh-list
153934707|NCT02617849|Carboplatin|carboplatin|mesh-list
153934708|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
153934709|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153934710|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934711|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
153934712|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
153934713|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
153934714|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934715|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153934716|NCT02617849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153934717|NCT00950859|Dolutegravir|dolutegravir|mesh-list
153934718|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153934719|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153934720|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934721|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934765|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934766|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934767|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934768|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934769|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
153934770|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934771|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934772|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934778|NCT02775370|Apatinib|apatinib|mesh-list
153934829|NCT00944697|Oxycodone|oxycodone|mesh-list
153934830|NCT00944697|Naloxone|naloxone|mesh-list
153934831|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153934832|NCT00944697|Narcotics|narcotics|mesh-ancestor
153934833|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153934834|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934835|NCT00944697|Analgesics|analgesics|mesh-ancestor
153934836|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
153934837|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934838|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153934839|NCT02878122|Carboplatin|carboplatin|mesh-list
153934840|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934841|NCT04807348|Metformin|metformin|mesh-list
153934842|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153934843|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934844|NCT04224922|Paclitaxel|paclitaxel|mesh-list
153934845|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
153934846|NCT04224922|Epirubicin|epirubicin|mesh-list
153934847|NCT04224922|Carboplatin|carboplatin|mesh-list
153934848|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153934849|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934865|NCT02877888|Fluorides|fluorides|mesh-list
153934886|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934887|NCT04121611|Aspirin|aspirin|mesh-list
153934888|NCT04121611|Heparin|heparin|mesh-list
153934889|NCT04121611|Calcium heparin|calcium heparin|mesh-list
153934890|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
153934891|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153934892|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153934893|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934894|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153934895|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153934896|NCT04121611|Analgesics|analgesics|mesh-ancestor
153934897|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
153934898|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934899|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934900|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934901|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934902|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153934903|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153934904|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934905|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
153692477|NCT00198094|Alprazolam|alprazolam|mesh-list
153934906|NCT02771860|Denosumab|denosumab|mesh-list
153934907|NCT02771860|Calcium|calcium|mesh-list
153934908|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153934909|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934911|NCT02771782|Vaccines|vaccines|mesh-list
153934937|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153934938|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153934939|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934940|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153934941|NCT02771158|Midodrine|midodrine|mesh-list
153934942|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
153934943|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
153934944|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934945|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934946|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153934947|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153934948|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153934949|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153934950|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153934951|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153934952|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153934953|NCT02770690|Lidocaine|lidocaine|mesh-list
153934954|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
153934955|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
153934993|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
153934994|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153934995|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934996|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153934997|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153934998|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153934999|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153935000|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
153935001|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153935002|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153935003|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
153935004|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935005|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
153935006|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153935007|NCT02770378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153935008|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153935009|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935010|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935011|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
153935012|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153935013|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
153935014|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
153935015|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935039|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
153935040|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153935041|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153935042|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153935043|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153935045|NCT00943917|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153935046|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153935047|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935048|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153935049|NCT00943917|Incretins|incretins|mesh-ancestor
153935050|NCT00943917|Hormones|hormones|mesh-ancestor
153935051|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935052|NCT02876250|Cyclosporine|cyclosporine|mesh-list
153935053|NCT02876250|Cyclosporins|cyclosporins|mesh-list
153935054|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935055|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935056|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153935057|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
153935092|NCT00603135|Levetiracetam|levetiracetam|mesh-list
153935093|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
153935094|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
153935095|NCT02769286|Osimertinib|osimertinib|mesh-list
153935096|NCT02769286|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153935097|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153935098|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935099|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935100|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935101|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
153935102|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153935103|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
153935104|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935105|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
153935106|NCT02855073|Protective Agents|protective agents|mesh-ancestor
153935107|NCT02769130|Losartan|losartan|mesh-list
153935108|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153935109|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153935110|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153935111|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153935112|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935113|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
153935114|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153935115|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153935116|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153935117|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935118|NCT02851095|Metformin|metformin|mesh-list
153935119|NCT02851095|Canagliflozin|canagliflozin|mesh-list
153935120|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153935121|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935137|NCT02768116|MTOR Inhibitors|mtor inhibitors|mesh-list
153935138|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153935139|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935140|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153935141|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935142|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
153935143|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153935144|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
153935145|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935201|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153935202|NCT02696590|Vitamin D|vitamin d|mesh-list
153935203|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
153935204|NCT02696590|Vitamins|vitamins|mesh-ancestor
153935205|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
153935206|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935207|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153935208|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153935210|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153935211|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153935212|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153935213|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
153935214|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
153935215|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935216|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935217|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153935218|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153935219|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153935220|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
153935221|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935222|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935223|NCT02854995|Triamcinolone|triamcinolone|mesh-list
153935224|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935225|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
153935226|NCT02854995|Hormones|hormones|mesh-ancestor
153935227|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935228|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935229|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
153935230|NCT02696512|Minocycline|minocycline|mesh-list
153935231|NCT02696512|Lamotrigine|lamotrigine|mesh-list
153935232|NCT02696512|Flumazenil|flumazenil|mesh-list
153935233|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153935234|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935235|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
153935242|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153935243|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935244|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153935245|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153935246|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
153935247|NCT02696512|Protective Agents|protective agents|mesh-ancestor
153935248|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
153935249|NCT02696512|Vitamins|vitamins|mesh-ancestor
153935250|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
153935251|NCT02696512|Antidotes|antidotes|mesh-ancestor
153935252|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
153935253|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
153935254|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935255|NCT00949533|Oseltamivir|oseltamivir|mesh-list
153935256|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
153935257|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935258|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935259|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935260|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
153935261|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153935262|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153935263|NCT02854761|Vitamin D|vitamin d|mesh-list
153935264|NCT02854761|Vitamins|vitamins|mesh-ancestor
153935265|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
153935266|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935267|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153935268|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153935269|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153935270|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935271|NCT00866047|Immunotoxins|immunotoxins|mesh-ancestor
153935272|NCT00866047|Immunoconjugates|immunoconjugates|mesh-ancestor
153935290|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
153935291|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935292|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153935293|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153935294|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
153935295|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935296|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153935297|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
153935298|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935299|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153935300|NCT01706692|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153935301|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935302|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935303|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153935304|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935349|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
153935350|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153935351|NCT02774200|Apatinib|apatinib|mesh-list
153935352|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935353|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153935354|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935355|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935356|NCT02766634|Lenograstim|lenograstim|mesh-list
153935357|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153935358|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
153935359|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935360|NCT02774044|Beractant|beractant|mesh-list
153935361|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
153935362|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153935363|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
153935364|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
153935365|NCT02766556|Ropivacaine|ropivacaine|mesh-list
153935366|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153935367|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935368|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935369|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935370|NCT02766556|Analgesics|analgesics|mesh-ancestor
153935371|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
153935372|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935373|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153935374|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153935375|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153935376|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
153935377|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935378|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935379|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
153935380|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
153935393|NCT02774512|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153935394|NCT02774512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153935395|NCT02774512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935396|NCT02774512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935397|NCT00940875|Gemcitabine|gemcitabine|mesh-list
153935398|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153935399|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153935400|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
153935401|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935402|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935403|NCT00940875|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153935404|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153935405|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935406|NCT05655728|Metformin|metformin|mesh-list
153935407|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153935408|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935409|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153935410|NCT00940485|Entecavir|entecavir|mesh-list
153935411|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
153935412|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935413|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
153935414|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153935415|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
153935416|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935417|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935418|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153935419|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
153935420|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935421|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935424|NCT05655338|Amoxicillin|amoxicillin|mesh-list
153935439|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
153935440|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
153935441|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935442|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153935443|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153935444|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153935445|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
153935446|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153935447|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
153935448|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935449|NCT04316936|Dexamethasone|dexamethasone|mesh-list
153935502|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
153935503|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
153935504|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935505|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935507|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935508|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153935509|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153693076|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
153935510|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153935564|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935565|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935566|NCT00865189|Leucovorin|leucovorin|mesh-list
153935567|NCT00865189|Folic Acid|folic acid|mesh-list
153935568|NCT00865189|Bevacizumab|bevacizumab|mesh-list
153935569|NCT00865189|Fluorouracil|fluorouracil|mesh-list
153935570|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
153935571|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
153935572|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153935573|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935574|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153935575|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153935576|NCT00865189|Growth Substances|growth substances|mesh-ancestor
153935577|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935584|NCT00865189|Antidotes|antidotes|mesh-ancestor
153935625|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
153935626|NCT01181726|Estradiol|estradiol|mesh-list
153935627|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153935628|NCT01181726|Estrogens|estrogens|mesh-ancestor
153935629|NCT01181726|Hormones|hormones|mesh-ancestor
153935630|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935631|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935632|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153935633|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
153935634|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153935635|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153935636|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153543517|NCT04843761|Remdesivir|remdesivir|mesh-list
153935637|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153935638|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153935639|NCT01137071|Antibodies|antibodies|mesh-list
153935683|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153935684|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
153935685|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935686|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935687|NCT05383131|Pirfenidone|pirfenidone|mesh-list
153935688|NCT05383131|Nintedanib|nintedanib|mesh-list
153935689|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153935690|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153935691|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935692|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935693|NCT05383131|Analgesics|analgesics|mesh-ancestor
153935694|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
153935695|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935696|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935697|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153935698|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935699|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935700|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935701|NCT02761486|Aspirin|aspirin|mesh-list
153935702|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153935703|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935704|NCT02761486|Analgesics|analgesics|mesh-ancestor
153935705|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
153935716|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
153935732|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153935733|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
153935734|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935735|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935736|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153935737|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
153935738|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153935739|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153935740|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153935741|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935742|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935743|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
153935744|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153935745|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935746|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153935747|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935748|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
153935749|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
153935751|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
153935752|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
153935753|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153935754|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935755|NCT00848497|Androgens|androgens|mesh-ancestor
153935756|NCT00848497|Hormones|hormones|mesh-ancestor
153935757|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935758|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935775|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153935776|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153935777|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935778|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935779|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
153935780|NCT01185782|Hormones|hormones|mesh-list
153935781|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153935782|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153935783|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935784|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153935785|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
153935786|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153935787|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153935788|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153935797|NCT02882555|Capsaicin|capsaicin|mesh-list
153935831|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935832|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935833|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153935834|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153935835|NCT04119739|Ibuprofen|ibuprofen|mesh-list
153935836|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153935837|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153935838|NCT04119739|Analgesics|analgesics|mesh-ancestor
153935839|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
153935840|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935841|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935842|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935843|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153935844|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153935845|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935846|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935847|NCT00859573|Modafinil|modafinil|mesh-list
153935848|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153935849|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935850|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153935851|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153935852|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153935853|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935854|NCT02758444|Micronutrients|micronutrients|mesh-list
153935855|NCT02758444|Trace Elements|trace elements|mesh-list
153935856|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935857|NCT01185548|Tolbutamide|tolbutamide|mesh-list
153935860|NCT01128569|Fluticasone|fluticasone|mesh-list
153935876|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
153693451|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
153935877|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
153935878|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153935879|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935880|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
153935881|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153935882|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153935883|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153935884|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153935885|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153935886|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935887|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153935888|NCT02758366|Doxorubicin|doxorubicin|mesh-list
153935934|NCT00858637|Simvastatin|simvastatin|mesh-list
153935935|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153935936|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153935937|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
153935938|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153935939|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153935940|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153935941|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935942|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153935943|NCT02760316|Prednisolone|prednisolone|mesh-list
153935944|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153935945|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
153935946|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153935947|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
153935948|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153935949|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
153935950|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153935991|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153935992|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935993|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
153935994|NCT02757508|Vitamins|vitamins|mesh-list
153935995|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
153935996|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153935997|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
153935998|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153935999|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153936000|NCT02757196|Prednisolone|prednisolone|mesh-list
153936001|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
153936002|NCT02757196|Rituximab|rituximab|mesh-list
153936003|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153936004|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
153936005|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936006|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936007|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
153936008|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936009|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936010|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936011|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
153936012|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
153936013|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936014|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153936042|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153936043|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936044|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936045|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936046|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
153936047|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936049|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153936050|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936051|NCT00837967|Terbutaline|terbutaline|mesh-list
153936052|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153936053|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153936054|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
153936055|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153936056|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
153936057|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936058|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936059|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
153936060|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
153936061|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153936062|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153936063|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153936064|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153936065|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
153936066|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936067|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936068|NCT02759614|Bevacizumab|bevacizumab|mesh-list
153936069|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153936070|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936071|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936072|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153936074|NCT02759614|Growth Substances|growth substances|mesh-ancestor
153936080|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936081|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
153936083|NCT02757040|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153936084|NCT02757040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936085|NCT02757040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936086|NCT02757040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936087|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936088|NCT02759224|Irsogladine|irsogladine|mesh-list
153936089|NCT02759224|Lafutidine|lafutidine|mesh-list
153936090|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936091|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153936092|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153936093|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153936094|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
153936095|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
153936096|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936097|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936098|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936099|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153936100|NCT02759224|Protective Agents|protective agents|mesh-ancestor
153936132|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153936133|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
153936134|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936135|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153936136|NCT02758990|Vitamin D|vitamin d|mesh-list
153936137|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
153936138|NCT02758990|Vitamins|vitamins|mesh-list
153936139|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
153936140|NCT02758990|Vitamin E|vitamin e|mesh-list
153936141|NCT02758990|Tocopherols|tocopherols|mesh-list
153936142|NCT02758990|Vitamin A|vitamin a|mesh-list
153936143|NCT02758990|Niacinamide|niacinamide|mesh-list
153936145|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
153936146|NCT02758990|Pyridoxine|pyridoxine|mesh-list
153936147|NCT02758990|Pyridoxal|pyridoxal|mesh-list
153936148|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
153936149|NCT02758990|Caffeine|caffeine|mesh-list
153936150|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
153936151|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936154|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
153936193|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936194|NCT00942357|Paclitaxel|paclitaxel|mesh-list
153936195|NCT00942357|Cisplatin|cisplatin|mesh-list
153936196|NCT00942357|Carboplatin|carboplatin|mesh-list
153936197|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153936198|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153936199|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936200|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
153936201|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
153936202|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
153936203|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936204|NCT02752828|Insulin|insulin|mesh-list
153936205|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153936206|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
153936207|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153936208|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936209|NCT02753062|Rituximab|rituximab|mesh-list
153936210|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153936212|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936251|NCT00939627|Sorafenib|sorafenib|mesh-list
153936252|NCT00939627|Antibodies|antibodies|mesh-list
153936253|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
153936254|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153936255|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
153936256|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936257|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936258|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936259|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936260|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936261|NCT05382741|Durvalumab|durvalumab|mesh-list
153936262|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936263|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936264|NCT04220476|Letrozole|letrozole|mesh-list
153936265|NCT04220476|Palbociclib|palbociclib|mesh-list
153936266|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936267|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153936307|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153936308|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936309|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
153936310|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
153936311|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936312|NCT02696122|Anesthetics|anesthetics|mesh-list
153936313|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936314|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936315|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153936316|NCT01135511|Tofacitinib|tofacitinib|mesh-list
153936317|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
153936318|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153936319|NCT01135511|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153936320|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936321|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936322|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936323|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153936324|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
153936325|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936326|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
153936327|NCT01135511|Protective Agents|protective agents|mesh-ancestor
153936328|NCT02753140|Docetaxel|docetaxel|mesh-list
153693902|NCT00095667|Lapatinib|lapatinib|mesh-list
153936329|NCT02753140|Cetuximab|cetuximab|mesh-list
153936330|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936331|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
153936332|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
153936333|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
153936354|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153936430|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153936431|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936432|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153500846|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153936433|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153936434|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153936435|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936436|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936437|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936438|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153936439|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153936440|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153936441|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153936442|NCT00636064|Parecoxib|parecoxib|mesh-list
153936443|NCT00636064|Valdecoxib|valdecoxib|mesh-list
153936444|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153936445|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153936446|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936447|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936448|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153936449|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153936450|NCT00636064|Analgesics|analgesics|mesh-ancestor
153936451|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
153936452|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936453|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936454|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936456|NCT02751034|Lidocaine|lidocaine|mesh-list
153936475|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
153936476|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153694049|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153936477|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936479|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
153936480|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153936481|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936482|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936483|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153936484|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936485|NCT04278508|Progesterone|progesterone|mesh-list
153936486|NCT04278508|Progestins|progestins|mesh-ancestor
153936487|NCT04278508|Hormones|hormones|mesh-ancestor
153936488|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936489|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936490|NCT05382351|Tenofovir|tenofovir|mesh-list
153936491|NCT05382351|Entecavir|entecavir|mesh-list
153936492|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
153936493|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936494|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153936495|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153936496|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936497|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936498|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153936499|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153936500|NCT04218760|Isosorbide|isosorbide|mesh-list
153936501|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153936502|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153936503|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153936504|NCT04218760|Diuretics|diuretics|mesh-ancestor
153936520|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936521|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936522|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153936523|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
153936524|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936525|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936526|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153936527|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153936528|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
153936529|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936530|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153936531|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153936532|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153936533|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
153936534|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936536|NCT00941655|Fluorouracil|fluorouracil|mesh-list
153936537|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
153936538|NCT00941655|Irinotecan|irinotecan|mesh-list
153936539|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
153936540|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936541|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153936542|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936543|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153936544|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
153936545|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936546|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153936547|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153936548|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936549|NCT00941655|Antidotes|antidotes|mesh-ancestor
153936550|NCT00941655|Protective Agents|protective agents|mesh-ancestor
153936551|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
153936552|NCT00941655|Vitamins|vitamins|mesh-ancestor
153936553|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
153936565|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153936566|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153936567|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153936568|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936569|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936570|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153936571|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
153936572|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153936573|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936575|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936576|NCT04088500|Nivolumab|nivolumab|mesh-list
153936577|NCT04088500|Ipilimumab|ipilimumab|mesh-list
153936578|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936579|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936580|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153936582|NCT01082874|Clonidine|clonidine|mesh-list
153936621|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153936622|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
153936623|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153936624|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936625|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153936626|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
153936627|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936628|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936629|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
153936639|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
153936687|NCT02749162|Acetaminophen|acetaminophen|mesh-list
153936688|NCT02749162|Dexamethasone|dexamethasone|mesh-list
153936689|NCT02749162|Lidocaine|lidocaine|mesh-list
153936690|NCT02749162|Morphine|morphine|mesh-list
153936691|NCT02749162|Ropivacaine|ropivacaine|mesh-list
153936692|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153936693|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936694|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
153936695|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
153936696|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936697|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936698|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153936699|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
153936751|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153936752|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153936753|NCT02751268|Ropivacaine|ropivacaine|mesh-list
153936754|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
153936755|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
153936756|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936757|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936758|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
153936759|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153936760|NCT02748772|Thalidomide|thalidomide|mesh-list
153936761|NCT02748772|Endostar protein|endostar protein|mesh-list
153936762|NCT02748772|Endostatins|endostatins|mesh-list
153936763|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153936764|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
153936765|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936766|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
153936767|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153936809|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936810|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153936811|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153936812|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936813|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
153936814|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936815|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936816|NCT02746276|Metronidazole|metronidazole|mesh-list
153936817|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
153936818|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936819|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153936820|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153936821|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153936822|NCT02746276|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153936823|NCT02746276|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153936824|NCT02745886|Metformin|metformin|mesh-list
153936825|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153936826|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936827|NCT02742142|Fluorides|fluorides|mesh-list
153936828|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
153936829|NCT02742142|Protective Agents|protective agents|mesh-ancestor
153936830|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936831|NCT00636298|Bevacizumab|bevacizumab|mesh-list
153936832|NCT00636298|Cetuximab|cetuximab|mesh-list
153936833|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936834|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936835|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153936836|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153936838|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936839|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
153936840|NCT02744716|Aspirin|aspirin|mesh-list
153936843|NCT02744716|Analgesics|analgesics|mesh-ancestor
153936852|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153936853|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153936855|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
153936856|NCT02744872|Felodipine|felodipine|mesh-list
153936857|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153936858|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153936859|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153936860|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153936861|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936862|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153936863|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936864|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
153936865|NCT02744638|Metronidazole|metronidazole|mesh-list
153936866|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153936867|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153936868|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153936869|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153936870|NCT02740894|Gefitinib|gefitinib|mesh-list
153936871|NCT02740894|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153936872|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153936873|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936875|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936906|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153936907|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153936909|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153936910|NCT01071798|Rituximab|rituximab|mesh-list
153936911|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153936912|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936913|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
153936914|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936915|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936916|NCT00857311|Vaccines|vaccines|mesh-list
153936917|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
153936918|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936919|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
153936920|NCT02874768|Propofol|propofol|mesh-list
153936921|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153936922|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153936923|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936961|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153936962|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153936963|NCT00856843|Laxatives|laxatives|mesh-ancestor
153936964|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153936965|NCT02743390|Infliximab|infliximab|mesh-list
153936966|NCT02743390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153936967|NCT02743390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153936968|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
153936969|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153936970|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153936971|NCT00856609|Exenatide|exenatide|mesh-list
153936972|NCT00856609|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153936973|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153936974|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936975|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153936976|NCT00856609|Incretins|incretins|mesh-ancestor
153937020|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937021|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153937022|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
153937024|NCT01070784|Hormones|hormones|mesh-ancestor
153937025|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937026|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153937027|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153937028|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153937029|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
153937030|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937032|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153937083|NCT02613013|Miotics|miotics|mesh-ancestor
153937084|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
153937085|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937086|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937087|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153937088|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153937089|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
153937090|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937091|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937092|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
153937093|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
153937094|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937095|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
153937096|NCT02611921|Ketamine|ketamine|mesh-list
153937097|NCT02611921|Analgesics|analgesics|mesh-ancestor
153937098|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
153937099|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937100|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937101|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153937102|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153937137|NCT02736682|Metronidazole|metronidazole|mesh-list
153937138|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153937139|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937140|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
153937141|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153937142|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153937143|NCT02874690|Methylphenidate|methylphenidate|mesh-list
153937144|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153937145|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937146|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153937147|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153937148|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153937224|NCT02737774|Carboplatin|carboplatin|mesh-list
153937225|NCT02737774|Pemetrexed|pemetrexed|mesh-list
153937226|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937227|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937228|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937229|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153937230|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153937231|NCT02735590|Isoniazid|isoniazid|mesh-list
153937232|NCT02735590|Rifapentine|rifapentine|mesh-list
153937233|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
153937234|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153937235|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937236|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153937237|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153937238|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
153937239|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937240|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153937241|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153937242|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
153937243|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
153937244|NCT05626348|Adalimumab|adalimumab|mesh-list
153937245|NCT05626348|Methotrexate|methotrexate|mesh-list
153937246|NCT05626348|Leflunomide|leflunomide|mesh-list
153937247|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153937248|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
153937249|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153937250|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937252|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
153937271|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937273|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
153937274|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937275|NCT02737228|Gemcitabine|gemcitabine|mesh-list
153937276|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153937277|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937335|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937336|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937337|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153937338|NCT02732314|Desonide|desonide|mesh-list
153937339|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937340|NCT01125917|Buprenorphine|buprenorphine|mesh-list
153937341|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153937342|NCT01125917|Narcotics|narcotics|mesh-ancestor
153937343|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937344|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937345|NCT01125917|Analgesics|analgesics|mesh-ancestor
153937346|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
153937347|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937398|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
153937399|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
153937400|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937401|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937402|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937403|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
153937404|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937405|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153937406|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153937407|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153937408|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
153937409|NCT02734732|Trimethoprim|trimethoprim|mesh-list
153937410|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
153937411|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153937412|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937413|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153937414|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153937415|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937416|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937417|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937418|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153937427|NCT02731378|Iron|iron|mesh-list
153937450|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937451|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
153937452|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937453|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
153937454|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937455|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937456|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153937457|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153937458|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153937459|NCT00847015|Gemcitabine|gemcitabine|mesh-list
153937460|NCT00847015|Sunitinib|sunitinib|mesh-list
153937461|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937462|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937463|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
153937464|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937465|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153937466|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153937467|NCT00847015|Growth Substances|growth substances|mesh-ancestor
153937468|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937469|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
153937470|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937504|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153937505|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153937506|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153937507|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937508|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937509|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
153937510|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153937511|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153937512|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937513|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
153937514|NCT02733952|Coagulants|coagulants|mesh-ancestor
153937515|NCT02733640|Pantoprazole|pantoprazole|mesh-list
153937516|NCT02733640|Ranitidine|ranitidine|mesh-list
153937517|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153695095|NCT00232648|Hormones|hormones|mesh-ancestor
153937518|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153937519|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153937520|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153937521|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937522|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937523|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153937524|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
153937525|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
153937526|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937527|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937528|NCT02730676|Menthol|menthol|mesh-list
153937529|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
153937530|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937553|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937554|NCT00855439|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153937555|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153937556|NCT00855439|Incretins|incretins|mesh-ancestor
153937557|NCT00855439|Hormones|hormones|mesh-ancestor
153937558|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937559|NCT01064856|Adalimumab|adalimumab|mesh-list
153937560|NCT01064856|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153937561|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937562|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153937563|NCT02730442|Fluconazole|fluconazole|mesh-list
153937564|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
153937565|NCT02730442|Clotrimazole|clotrimazole|mesh-list
153937566|NCT02730442|Miconazole|miconazole|mesh-list
153937567|NCT02730442|Olorofim|olorofim|mesh-list
153937568|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937569|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153937570|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153937571|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937572|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937573|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153937574|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
153937575|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937576|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937577|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153937578|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153937579|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153937580|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153937581|NCT02733874|Betamethasone|betamethasone|mesh-list
153937582|NCT02733874|Clobetasol|clobetasol|mesh-list
153937583|NCT02733874|Calcipotriene|calcipotriene|mesh-list
153937584|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937595|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
153937596|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937597|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153937598|NCT02730364|Analgesics|analgesics|mesh-ancestor
153937599|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
153937600|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937601|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
153937602|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937603|NCT02730364|Protective Agents|protective agents|mesh-ancestor
153937604|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153937605|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
153937606|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
153937607|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
153937608|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153937609|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
153937610|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
153937611|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153937612|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153937613|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153937614|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
153937615|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937616|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
153937617|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937618|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153937619|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
153937620|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
153937621|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153937623|NCT01042392|Aliskiren|aliskiren|mesh-list
153937624|NCT01042392|Renin Inhibitors|renin inhibitors|mesh-ancestor
153937625|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
153937626|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937627|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937628|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153937637|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153937638|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153937639|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153937640|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
153937641|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937642|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937643|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937644|NCT00913315|Urological Agents|urological agents|mesh-ancestor
153937645|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153937646|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153937647|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
153937648|NCT00701857|Pemetrexed|pemetrexed|mesh-list
153937649|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937650|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937651|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937652|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153937653|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153937654|NCT02729662|Tolvaptan|tolvaptan|mesh-list
153937655|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153937656|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937657|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
153937658|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937659|NCT02733250|Paclitaxel|paclitaxel|mesh-list
153937660|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
153937661|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153937662|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937663|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
153937664|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
153937665|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
153937666|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937667|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153937668|NCT02733250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153937669|NCT03188068|Sirolimus|sirolimus|mesh-list
153937671|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153937672|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646580|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646581|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
153937673|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153937674|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937675|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
153937676|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937677|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
153937678|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937679|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937680|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
153937681|NCT03188068|Hormones|hormones|mesh-ancestor
153937682|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937683|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153937684|NCT01064310|Sunitinib|sunitinib|mesh-list
153937685|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937686|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153937687|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153937688|NCT01064310|Growth Substances|growth substances|mesh-ancestor
153937689|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937690|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
153937691|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937692|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937693|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937694|NCT02726854|Apatinib|apatinib|mesh-list
153937695|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937696|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937697|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937698|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937719|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153937720|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
153937721|NCT02726308|Hormones|hormones|mesh-ancestor
153937722|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937723|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153937724|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937725|NCT01037244|Udenafil|udenafil|mesh-list
153937726|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153937727|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153937728|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937729|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937730|NCT00627432|Gemcitabine|gemcitabine|mesh-list
153937731|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
153937732|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937733|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
153937734|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937735|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937736|NCT02727712|Anesthetics|anesthetics|mesh-list
153937737|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937738|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937739|NCT01042236|Fesoterodine|fesoterodine|mesh-list
153937740|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153937741|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153937742|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
153937743|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937744|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937745|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937746|NCT01042236|Urological Agents|urological agents|mesh-ancestor
153937747|NCT02725918|Pemetrexed|pemetrexed|mesh-list
153937748|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937749|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937750|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937751|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153937753|NCT00592501|Fluorouracil|fluorouracil|mesh-list
153937757|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937758|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937759|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
153937760|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937762|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153937763|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937765|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153937766|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153937767|NCT04304196|TEMPO|tempo|mesh-list
153937768|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
153937769|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937770|NCT04304196|Protective Agents|protective agents|mesh-ancestor
153937771|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937772|NCT02720770|Hormones|hormones|mesh-list
153937773|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937774|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937775|NCT02720926|Capecitabine|capecitabine|mesh-list
153937776|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
153937777|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937778|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
153937779|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937784|NCT00854581|Zidovudine|zidovudine|mesh-list
153937810|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153937811|NCT00833911|Narcotics|narcotics|mesh-ancestor
153937812|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937813|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937814|NCT00833911|Analgesics|analgesics|mesh-ancestor
153937815|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
153937816|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937817|NCT02719756|Metformin|metformin|mesh-list
153937818|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
153937819|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153937820|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937821|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153937822|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937823|NCT01125293|Rituximab|rituximab|mesh-list
153937824|NCT01125293|Everolimus|everolimus|mesh-list
153937825|NCT01125293|Bortezomib|bortezomib|mesh-list
153937826|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153937827|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937828|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
153937829|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937830|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153937831|NCT01125293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153937832|NCT01125293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937833|NCT01125293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937834|NCT01125293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937835|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937859|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937860|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937861|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
153937862|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937863|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153937864|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153937865|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153937866|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153937867|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937868|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153937869|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153937870|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
153937871|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937872|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153937873|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153937874|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
153937875|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153937876|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
153937877|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
153937878|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
153937879|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153937880|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
153937881|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
153937882|NCT02718742|Paclitaxel|paclitaxel|mesh-list
153937883|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153937884|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153937885|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937886|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
153937887|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
153937888|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
153937889|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937901|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937902|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
153937903|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937904|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
153937905|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153937906|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153937907|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937908|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153937909|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153937910|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937911|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153937912|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153937913|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937916|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153937917|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153937918|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
153937919|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937920|NCT01121393|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153937921|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153937922|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937923|NCT02882477|Metformin|metformin|mesh-list
153937924|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153937925|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
153937926|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153937927|NCT02882477|Deferiprone|deferiprone|mesh-list
153937928|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153937929|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937930|NCT02882477|Incretins|incretins|mesh-ancestor
153937931|NCT02882477|Hormones|hormones|mesh-ancestor
153937933|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153937946|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
153937947|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
153937948|NCT04163224|Imidacloprid|imidacloprid|mesh-list
153937949|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
153937950|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937951|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937952|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937953|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
153937954|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153937955|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937956|NCT04964284|Hormones|hormones|mesh-list
153937957|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153937958|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937959|NCT02716090|Adapalene|adapalene|mesh-list
153937960|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153937961|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937962|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153937963|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153937964|NCT02716090|Analgesics|analgesics|mesh-ancestor
153937965|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
153937966|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153937967|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937968|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153937969|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153937970|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153937971|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153937973|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153937974|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153937975|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153937976|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
153937977|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153937978|NCT02714998|Methotrexate|methotrexate|mesh-list
153937979|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153937980|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
153937981|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153937985|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937987|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
153937988|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153937989|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153937990|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153937991|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
153937992|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153937993|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153937994|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
153937995|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
153937996|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938049|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938050|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153938051|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153938052|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153938053|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938054|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938055|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153938056|NCT02714530|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153938057|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938112|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153938113|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153938114|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
153938115|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938116|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
153695703|NCT00236392|Rabeprazole|rabeprazole|mesh-list
153938117|NCT00611416|Protective Agents|protective agents|mesh-ancestor
153938118|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153938119|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153938120|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938121|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153938122|NCT02712658|Terbutaline|terbutaline|mesh-list
153938123|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153938124|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
153938125|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938126|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938127|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153938128|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
153938129|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
153938166|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153938167|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153938168|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153938169|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153938170|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
153938171|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938172|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938173|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938174|NCT02711176|Amoxicillin|amoxicillin|mesh-list
153938175|NCT02711176|Clarithromycin|clarithromycin|mesh-list
153938176|NCT02711176|Tinidazole|tinidazole|mesh-list
153938177|NCT02711176|Esomeprazole|esomeprazole|mesh-list
153938178|NCT02711176|Lansoprazole|lansoprazole|mesh-list
153938179|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938180|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938181|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153938182|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153938183|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153938184|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938185|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938186|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153938187|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153938188|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153938189|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
153938190|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153938191|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153938192|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153938193|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153938194|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
153938195|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938196|NCT00611650|Protective Agents|protective agents|mesh-ancestor
153938208|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938209|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153938210|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938211|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
153938212|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153938213|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
153938214|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938215|NCT02710552|Diuretics|diuretics|mesh-ancestor
153938216|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
153938217|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153938218|NCT02710396|Paclitaxel|paclitaxel|mesh-list
153938219|NCT02710396|Carboplatin|carboplatin|mesh-list
153938220|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
153938221|NCT02710396|Pemetrexed|pemetrexed|mesh-list
153938222|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153938223|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938224|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
153938225|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
153938226|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
153938227|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938228|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153938229|NCT02710396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153938230|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938231|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153938232|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153938233|NCT02710162|Capsaicin|capsaicin|mesh-list
153938234|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
153938235|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
153938236|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
153938239|NCT00611728|Irinotecan|irinotecan|mesh-list
153938251|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938252|NCT02709304|Lidocaine|lidocaine|mesh-list
153938253|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
153938254|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
153938255|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938256|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938257|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
153938258|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938259|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153938260|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153938261|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153938262|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153938263|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938312|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938313|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
153938314|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938316|NCT02708446|Mifepristone|mifepristone|mesh-list
153500851|NCT00365040|Mitomycin|mitomycin|mesh-list
153938317|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153938318|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
153938319|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153938320|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938321|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153938322|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153938323|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
153938324|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153938325|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153938326|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153938327|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153938328|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
153938329|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153938330|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153938331|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
153938332|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938333|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
153938334|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153938335|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153938336|NCT05378919|Folic Acid|folic acid|mesh-list
153938337|NCT05378919|Leucovorin|leucovorin|mesh-list
153938338|NCT05378919|Fluorouracil|fluorouracil|mesh-list
153938339|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
153938340|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
153938341|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
153938342|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938343|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153938344|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938345|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938346|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
153938352|NCT05378919|Antidotes|antidotes|mesh-ancestor
153938353|NCT05378919|Protective Agents|protective agents|mesh-ancestor
153938354|NCT00607581|Dexamethasone|dexamethasone|mesh-list
153938355|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
153938356|NCT00607581|Lenalidomide|lenalidomide|mesh-list
153938357|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938358|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
153938359|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938360|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153938361|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153938362|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
153938363|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938364|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938365|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153938366|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153938368|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
153938369|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938370|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153938371|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
153938372|NCT00607581|Hormones|hormones|mesh-ancestor
153938373|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938374|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153938375|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153938376|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153938377|NCT00607581|Growth Substances|growth substances|mesh-ancestor
153938378|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
153938379|NCT02707900|Vorinostat|vorinostat|mesh-list
153938380|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938381|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153938382|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938383|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938384|NCT05380479|Megestrol|megestrol|mesh-list
153938385|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
153938386|NCT05380479|Mirtazapine|mirtazapine|mesh-list
153938394|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938395|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153938396|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153938397|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938398|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153938399|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153938400|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153938401|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
153938402|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153938403|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153938404|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
153938405|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153938406|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153938407|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153938408|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153938409|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
153938410|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153938411|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153938412|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153938413|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153938414|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938415|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
153938416|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153938419|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
153938420|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
153938421|NCT00936975|Protective Agents|protective agents|mesh-ancestor
153938422|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938423|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153938424|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938425|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153938426|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
153938427|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153938428|NCT02693470|Ustekinumab|ustekinumab|mesh-list
153938429|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
153646582|NCT00401869|Hematinics|hematinics|mesh-ancestor
153646583|NCT00008333|Vinorelbine|vinorelbine|mesh-list
153646584|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153646585|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938431|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
153938432|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153938433|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938435|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
153938436|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
153938437|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153938438|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153938439|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938440|NCT00606333|Sirolimus|sirolimus|mesh-list
153938441|NCT00606333|Paclitaxel|paclitaxel|mesh-list
153938442|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153938443|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153938444|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938445|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
153938446|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
153938447|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
153938448|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938449|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938450|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938451|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153938452|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
153938453|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938454|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
153938455|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938456|NCT05265442|Methadone|methadone|mesh-list
153938457|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153938458|NCT05265442|Narcotics|narcotics|mesh-ancestor
153938461|NCT05265442|Analgesics|analgesics|mesh-ancestor
153938479|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938481|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
153938482|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
153938483|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153938484|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
153938485|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938486|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938487|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
153938488|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153938489|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153938490|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153938491|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153938492|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
153938494|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153938495|NCT00612274|Sirolimus|sirolimus|mesh-list
153938496|NCT00612274|Methotrexate|methotrexate|mesh-list
153938497|NCT00612274|Tacrolimus|tacrolimus|mesh-list
153938498|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153938499|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
153938500|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153938501|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938502|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153938503|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
153938506|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
153938529|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938530|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153938531|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
153938532|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938533|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938534|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
153938535|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938536|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153938537|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938538|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
153938539|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153938540|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153938541|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153938542|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
153938543|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153938544|NCT00935493|Guanfacine|guanfacine|mesh-list
153938545|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153938546|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153938547|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153938548|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153938549|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
153938550|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938551|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938552|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938553|NCT05380245|Clarithromycin|clarithromycin|mesh-list
153938554|NCT05380245|Voriconazole|voriconazole|mesh-list
153938574|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153938575|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938576|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153938577|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153938578|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153938579|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
153938580|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938581|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938583|NCT02937766|Hormones|hormones|mesh-ancestor
153938584|NCT00607971|Renzapride|renzapride|mesh-list
153938585|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153938586|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
153938587|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938588|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938589|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938590|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
153938591|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153938592|NCT02724358|Estrogens|estrogens|mesh-ancestor
153938593|NCT02724358|Hormones|hormones|mesh-ancestor
153938594|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938595|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938596|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153938597|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938598|NCT02724202|Curcumin|curcumin|mesh-list
153938599|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153938600|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153938601|NCT02724202|Analgesics|analgesics|mesh-ancestor
153938602|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
153938603|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938604|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938605|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153938606|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153938608|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938614|NCT00625547|Cabergoline|cabergoline|mesh-list
153938615|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153938616|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153938617|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
153938618|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153938619|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938620|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938621|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
153621607|NCT02000206|Ketamine|ketamine|mesh-list
153938622|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153938623|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938624|NCT05241340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153938625|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938626|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
153938627|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938628|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938629|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153938630|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153938631|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938632|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938633|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938634|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153938635|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153938636|NCT01124045|Prednisolone|prednisolone|mesh-list
153938637|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153938638|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
153938639|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153938640|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
153938641|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153938642|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
153938643|NCT01124045|Difluprednate|difluprednate|mesh-list
153938656|NCT01124045|Protective Agents|protective agents|mesh-ancestor
153938658|NCT01123889|Ropivacaine|ropivacaine|mesh-list
153938659|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
153938660|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
153938661|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153938662|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938663|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
153938664|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153938665|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153938671|NCT00606957|Vitamin D|vitamin d|mesh-list
153938721|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938722|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938723|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
153938724|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153938725|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938726|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938727|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153938734|NCT00607035|Olmesartan|olmesartan|mesh-list
153938784|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153938786|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153938788|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
153938789|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153938790|NCT01119287|Dexamethasone|dexamethasone|mesh-list
153938791|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153938792|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153938793|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
153938799|NCT01119287|Hormones|hormones|mesh-ancestor
153938848|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153938849|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938850|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153938851|NCT04862962|Ezetimibe|ezetimibe|mesh-list
153938852|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153938853|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153938854|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
153938855|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938856|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153938857|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153938858|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938859|NCT01118975|Lapatinib|lapatinib|mesh-list
153938860|NCT01118975|Vorinostat|vorinostat|mesh-list
153938861|NCT01118975|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153938862|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938863|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938867|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
153938906|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938907|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153938908|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153938909|NCT01118351|Growth Substances|growth substances|mesh-ancestor
153938910|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938911|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
153938912|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938913|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938914|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938915|NCT02693392|Metformin|metformin|mesh-list
153938916|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153938917|NCT02693392|Fenugreek seed meal|fenugreek seed meal|mesh-list
153938918|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938919|NCT04175626|Sirolimus|sirolimus|mesh-list
153938920|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938921|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938922|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153938923|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938924|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
153938925|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153938926|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
153938927|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938928|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
153938929|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
153938930|NCT00613054|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153938931|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153938932|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938933|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153938934|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938935|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
153938936|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153938937|NCT00613132|Everolimus|everolimus|mesh-list
153938938|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
153938947|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938948|NCT00613132|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153938949|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
153938950|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153938952|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153938953|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
153938954|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153938955|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153938956|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
153938957|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153939011|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939012|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153939013|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
153939014|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939015|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939016|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
153939017|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939018|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153939019|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939020|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
153939021|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939022|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153939024|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
153939025|NCT01061736|Vitamins|vitamins|mesh-ancestor
153939026|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
153939027|NCT04083820|Semaglutide|semaglutide|mesh-list
153939028|NCT04083820|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153939029|NCT04083820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153939030|NCT04083820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939031|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
153939032|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153939033|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939034|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939059|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939060|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939061|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939062|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939063|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153939064|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153939065|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939066|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939067|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153939068|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153939069|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153939070|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
153939071|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939072|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153939073|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153939074|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939075|NCT02882087|Methotrexate|methotrexate|mesh-list
153939116|NCT01108055|Paclitaxel|paclitaxel|mesh-list
153939117|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153939118|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939119|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
153939120|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
153939121|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
153939122|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939123|NCT00609375|Cefepime|cefepime|mesh-list
153939124|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153939125|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939126|NCT01107899|Clopidogrel|clopidogrel|mesh-list
153939127|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153939128|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153939129|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153939130|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153939131|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153939132|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
153939133|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939134|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939135|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939136|NCT01107743|Amlodipine|amlodipine|mesh-list
153939137|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153939138|NCT01107743|Atorvastatin|atorvastatin|mesh-list
153939139|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153939140|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153939141|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
153939142|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939159|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153939160|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939161|NCT01059864|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153939162|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153939163|NCT01035138|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
153939164|NCT01035138|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153939165|NCT01035138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939166|NCT01035138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939167|NCT03739840|Padsevonil|padsevonil|mesh-list
153939168|NCT03739840|Anticonvulsants|anticonvulsants|mesh-ancestor
153939169|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
153939170|NCT00613600|Cathartics|cathartics|mesh-ancestor
153939171|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153939172|NCT04302402|Rifaximin|rifaximin|mesh-list
153939173|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153939174|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939175|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153939176|NCT03931408|Gentamicins|gentamicins|mesh-list
153939210|NCT03792256|Hormones|hormones|mesh-ancestor
153939211|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153939212|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939213|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153939214|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153939215|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
153939216|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153939218|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
153939274|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153939275|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
153939276|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
153939277|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153939278|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153939279|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153939342|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939343|NCT05244538|Remifentanil|remifentanil|mesh-list
153939344|NCT05244538|Propofol|propofol|mesh-list
153939345|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153939346|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939347|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939348|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153939349|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
153939350|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
153939351|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153939352|NCT05244538|Narcotics|narcotics|mesh-ancestor
153939353|NCT05244538|Analgesics|analgesics|mesh-ancestor
153939406|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153939407|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153939408|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
153939409|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
153939410|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939411|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939412|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939413|NCT03903016|Insulin|insulin|mesh-list
153939414|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153939415|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
153939416|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153939417|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939418|NCT03514732|Melatonin|melatonin|mesh-list
153939419|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
153939420|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939421|NCT03514732|Protective Agents|protective agents|mesh-ancestor
153939422|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939423|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939424|NCT03800836|Paclitaxel|paclitaxel|mesh-list
153939425|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153939461|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939462|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939463|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939464|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939465|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153939466|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153939467|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939468|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939469|NCT03761134|Metformin|metformin|mesh-list
153939471|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153939520|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939521|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697119|NCT00244426|Analgesics|analgesics|mesh-ancestor
153939522|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939523|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939524|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
153939525|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939526|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153939527|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
153939528|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153939529|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
153939532|NCT01052844|Gabapentin|gabapentin|mesh-list
153939582|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153939583|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939584|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939585|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939586|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
153939587|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939588|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939589|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153939590|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153939591|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939592|NCT01032018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153939642|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939643|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153939644|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
153939645|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939646|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939647|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153939648|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939649|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153939650|NCT00609999|Dasatinib|dasatinib|mesh-list
153939651|NCT00609999|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153939652|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153939653|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939654|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939655|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939656|NCT00627250|Amantadine|amantadine|mesh-list
153939657|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153939658|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153939659|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
153939660|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153939661|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
153939697|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153939698|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153939699|NCT00823576|Ropivacaine|ropivacaine|mesh-list
153939700|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
153939701|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
153939702|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153939703|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939704|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
153939705|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939706|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153939707|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153939708|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939713|NCT01028352|Analgesics|analgesics|mesh-ancestor
153939756|NCT04261023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153939757|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153939758|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153939760|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939761|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153939762|NCT01114529|Cyclosporine|cyclosporine|mesh-list
153939763|NCT01114529|Everolimus|everolimus|mesh-list
153939821|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153939823|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153939824|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153939825|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
153939826|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939827|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153939828|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153939829|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153939831|NCT02703064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153939832|NCT02703064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939833|NCT01114373|Melatonin|melatonin|mesh-list
153939834|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
153939835|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939836|NCT01114373|Protective Agents|protective agents|mesh-ancestor
153939883|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153939884|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939885|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
153939886|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153939887|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153939888|NCT01030458|Diuretics|diuretics|mesh-ancestor
153939889|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
153731420|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153939890|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153939892|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
153939893|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939894|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153939895|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153939896|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153939897|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
153939898|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939899|NCT02702674|Propranolol|propranolol|mesh-list
153939901|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
153939902|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153939903|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939904|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153939905|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153939906|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
153939907|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939908|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939909|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153939910|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153939911|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
153939912|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153939927|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
153939928|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939929|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939930|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939931|NCT00627666|Leucovorin|leucovorin|mesh-list
153939932|NCT00627666|Methotrexate|methotrexate|mesh-list
153939933|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
153939934|NCT00627666|Fludarabine|fludarabine|mesh-list
153939935|NCT00627666|Busulfan|busulfan|mesh-list
153939936|NCT00627666|Calcium|calcium|mesh-list
153939937|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153939938|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
153939939|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153939940|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939941|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153939942|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
153939943|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153939985|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153939986|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153939987|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153939988|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
153939989|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153939990|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939991|NCT02702206|Triamcinolone|triamcinolone|mesh-list
153939992|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
153939993|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940050|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
153940051|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153940052|NCT01112267|Narcotics|narcotics|mesh-ancestor
153940053|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940054|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
153940055|NCT00925587|Hematinics|hematinics|mesh-ancestor
153940056|NCT02698306|Dexamethasone|dexamethasone|mesh-list
153940058|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940059|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
153940060|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
153940061|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940062|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940063|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153940114|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153940115|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
153940117|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
153940118|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940119|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153940120|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
153940121|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940122|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153940123|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940124|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153940125|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940126|NCT04260711|Analgesics|analgesics|mesh-ancestor
153940127|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
153940128|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940129|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940130|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
153940131|NCT00610623|Azithromycin|azithromycin|mesh-list
153940132|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153940133|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940134|NCT02697838|Paclitaxel|paclitaxel|mesh-list
153940135|NCT02697838|Apatinib|apatinib|mesh-list
153940136|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153940137|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940138|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
153940139|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
153940140|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
153940141|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940142|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153940143|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940144|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
153940161|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940163|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940164|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153940165|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
153940166|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
153940167|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940168|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940169|NCT04951323|Vaccines|vaccines|mesh-list
153940170|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
153940171|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940172|NCT02705872|Sufentanil|sufentanil|mesh-list
153940173|NCT02705872|Dsuvia|dsuvia|mesh-list
153940174|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
153940175|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153940176|NCT02705872|Narcotics|narcotics|mesh-ancestor
153940177|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940178|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940179|NCT02705872|Analgesics|analgesics|mesh-ancestor
153940180|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
153940181|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940182|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153940183|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153940213|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940214|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940215|NCT00925353|Lidocaine|lidocaine|mesh-list
153940216|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
153940217|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
153940218|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940219|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940220|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
153940221|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940222|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153940223|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153940224|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153940225|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940226|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940274|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153940275|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
153940276|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940277|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940278|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153940279|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
153940280|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940281|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940282|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153940283|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153940284|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153940285|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153940286|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940287|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940288|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
153940289|NCT02700022|Hormones|hormones|mesh-ancestor
153940290|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940331|NCT02691754|Analgesics|analgesics|mesh-ancestor
153940332|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
153940333|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940334|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940335|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
153940336|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
153940337|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153940338|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153940339|NCT01106651|Canagliflozin|canagliflozin|mesh-list
153940340|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153940341|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153940342|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940343|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940392|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153940393|NCT02873520|Immunomodulating Agents|immunomodulating agents|mesh-list
153940394|NCT02873520|Immunologic Factors|immunologic factors|mesh-ancestor
153940395|NCT02873520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940396|NCT01015638|Clindamycin|clindamycin|mesh-list
153940397|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
153940398|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
153940399|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153940400|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153940401|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940402|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153940403|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940404|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940405|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
153940406|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153940453|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153940454|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500858|NCT00365586|Ketoprofen|ketoprofen|mesh-list
153940455|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940456|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153940457|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153940458|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153940459|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153940460|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153940461|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153940462|NCT01022424|Tolvaptan|tolvaptan|mesh-list
153940463|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153940464|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940465|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
153940466|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940467|NCT05329857|Metformin|metformin|mesh-list
153940468|NCT05329857|Vildagliptin|vildagliptin|mesh-list
153940475|NCT01026948|Dinoprostone|dinoprostone|mesh-list
153940507|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940508|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153940509|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940510|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940511|NCT04939467|Analgesics|analgesics|mesh-ancestor
153940512|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
153940513|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940514|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940515|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153940519|NCT01015560|Antibodies|antibodies|mesh-list
153940569|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153940570|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
153940571|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940572|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940573|NCT01098539|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153940574|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
153940575|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153940576|NCT01098461|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153940577|NCT01098461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940578|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940579|NCT01098461|Incretins|incretins|mesh-ancestor
153940580|NCT01098461|Hormones|hormones|mesh-ancestor
153940581|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940631|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
153940632|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153940633|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153940634|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940635|NCT00704743|Calpastatin|calpastatin|mesh-list
153940636|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153940637|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
153940638|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698244|NCT00251914|Esomeprazole|esomeprazole|mesh-list
153940639|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940641|NCT01097057|Rituximab|rituximab|mesh-list
153940642|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153940643|NCT01097057|Carboplatin|carboplatin|mesh-list
153940693|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153940694|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153940695|NCT01014624|Clopidogrel|clopidogrel|mesh-list
153940696|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153940697|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153940698|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153940699|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153940700|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153940701|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
153940757|NCT02872584|Prednisone|prednisone|mesh-list
153940758|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940759|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
153940760|NCT02872584|Hormones|hormones|mesh-ancestor
153940761|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153940762|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940763|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153940764|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940765|NCT00704821|Docetaxel|docetaxel|mesh-list
153940766|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940767|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
153940768|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
153940769|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
153940770|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940771|NCT00704899|Amitriptyline|amitriptyline|mesh-list
153940772|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153940773|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
153940813|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
153940814|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153940815|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940816|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940817|NCT01021332|Urological Agents|urological agents|mesh-ancestor
153940818|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153940819|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153940820|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
153940822|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153940823|NCT00923091|Olmesartan|olmesartan|mesh-list
153940824|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153940825|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
153940826|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153940827|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153940828|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153940829|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940830|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153940838|NCT00853957|Amlodipine|amlodipine|mesh-list
153940867|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
153940868|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940869|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940870|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
153940871|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153940872|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153940873|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153940874|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
153940875|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153940876|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153940877|NCT00833053|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153940878|NCT00833053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153940879|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153940880|NCT01020786|Carboplatin|carboplatin|mesh-list
153940927|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153940928|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
153940929|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940930|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
153940931|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940932|NCT04570410|Gemcitabine|gemcitabine|mesh-list
153940933|NCT04570410|Tislelizumab|tislelizumab|mesh-list
153940934|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940935|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153940936|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
153940937|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940938|NCT04570410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153940939|NCT04203771|Ibuprofen|ibuprofen|mesh-list
153940940|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153940941|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153940987|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153940988|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153940989|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
153940990|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153940991|NCT00832819|Paclitaxel|paclitaxel|mesh-list
153940992|NCT00832819|Carboplatin|carboplatin|mesh-list
153940993|NCT00832819|Lenvatinib|lenvatinib|mesh-list
153940994|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153940995|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153940996|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
153940997|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
153940998|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941049|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941050|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153941051|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941052|NCT00845065|Ribavirin|ribavirin|mesh-list
153941053|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153941054|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
153941055|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941056|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
153941057|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941058|NCT04772001|Carboplatin|carboplatin|mesh-list
153941059|NCT04772001|Cisplatin|cisplatin|mesh-list
153941060|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941061|NCT00702091|Ramipril|ramipril|mesh-list
153941062|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153941063|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
153941064|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941065|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941066|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153941067|NCT00832585|Alefacept|alefacept|mesh-list
153941068|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
153941069|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
153941070|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941102|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941103|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
153941104|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153941105|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941106|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941107|NCT00832117|Cisplatin|cisplatin|mesh-list
153941108|NCT00832117|Epothilones|epothilones|mesh-list
153941109|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941110|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941111|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941112|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941113|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941114|NCT02872272|Amikacin|amikacin|mesh-list
153941115|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153941116|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941117|NCT00831493|Vorinostat|vorinostat|mesh-list
153941118|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941161|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
153941162|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941163|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941164|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153941165|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153941166|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
153941167|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941168|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153941169|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153941170|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
153941171|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153941172|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153941173|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941174|NCT02878421|Nicotine|nicotine|mesh-list
153941175|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153941176|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
153941177|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941178|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941184|NCT01019694|Albuterol|albuterol|mesh-list
153941215|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153941216|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941217|NCT00920907|Ipilimumab|ipilimumab|mesh-list
153941218|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153941219|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941220|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153941221|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941222|NCT00700297|Colchicine|colchicine|mesh-list
153941223|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
153941224|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153941225|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941226|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941227|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941228|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941229|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941230|NCT04307147|Capecitabine|capecitabine|mesh-list
153941231|NCT04307147|Vinorelbine|vinorelbine|mesh-list
153941232|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153941233|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
153941234|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941235|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941236|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153941237|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941238|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941240|NCT00844831|Lubiprostone|lubiprostone|mesh-list
153941262|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941263|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153941264|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941265|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
153941266|NCT04307069|Oxytocin|oxytocin|mesh-list
153941267|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
153941268|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153941269|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941270|NCT02878265|Vitamins|vitamins|mesh-list
153941271|NCT02878265|Vitamin A|vitamin a|mesh-list
153941272|NCT02878265|Zinc|zinc|mesh-list
153941273|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
153941324|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941325|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941327|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153941328|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153941329|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
153941330|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
153941331|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941332|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941333|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941334|NCT00917553|Doxycycline|doxycycline|mesh-list
153941335|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153941336|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941337|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
153941338|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153941339|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153941340|NCT04255251|Fluorides|fluorides|mesh-list
153941341|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
153941342|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
153941343|NCT04255251|Protective Agents|protective agents|mesh-ancestor
153941344|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941352|NCT01018680|Analgesics|analgesics|mesh-ancestor
153941379|NCT02872038|Cefazolin|cefazolin|mesh-list
153941380|NCT02872038|Ceftazidime|ceftazidime|mesh-list
153941381|NCT02872038|Cefepime|cefepime|mesh-list
153941382|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153941383|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941384|NCT02872038|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153941385|NCT02872038|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153941386|NCT00627900|Sirolimus|sirolimus|mesh-list
153941387|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153941388|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941389|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153941446|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941447|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153941448|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153731437|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
153941449|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153941450|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941451|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941452|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153941453|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153941509|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153941510|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941511|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941512|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941513|NCT01091519|Fesoterodine|fesoterodine|mesh-list
153941514|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153941515|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153941516|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
153941517|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941518|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941519|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941520|NCT01091519|Urological Agents|urological agents|mesh-ancestor
153941521|NCT02878031|Amoxicillin|amoxicillin|mesh-list
153941522|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153941523|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941524|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
153941525|NCT02879669|Carboplatin|carboplatin|mesh-list
153941526|NCT02879669|Pemetrexed|pemetrexed|mesh-list
153941527|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153941528|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
153941539|NCT00918333|Everolimus|everolimus|mesh-list
153941565|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153941566|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153941567|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153941568|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153941569|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
153941570|NCT02871648|Eplerenone|eplerenone|mesh-list
153941571|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153941572|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
153941573|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153941574|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941575|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153941576|NCT02871648|Diuretics|diuretics|mesh-ancestor
153941577|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
153941578|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153941579|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153941580|NCT00637845|Esomeprazole|esomeprazole|mesh-list
153941581|NCT00637845|Lansoprazole|lansoprazole|mesh-list
153941582|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
153941583|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153941584|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153941588|NCT02497300|Amiloride|amiloride|mesh-list
153941620|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153941621|NCT00631527|Growth Substances|growth substances|mesh-ancestor
153941622|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941623|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
153941624|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153941625|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153941626|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941627|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153941628|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
153941629|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153941630|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153941631|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
153941632|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
153941633|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153941678|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153941679|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
153941680|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153941681|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941682|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
153941683|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
153699282|NCT00101127|Docetaxel|docetaxel|mesh-list
153941684|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941685|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153941686|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153941687|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941688|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
153941689|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153941690|NCT04766008|Metformin|metformin|mesh-list
153941691|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153941692|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941693|NCT00916149|Lamotrigine|lamotrigine|mesh-list
153941694|NCT00916149|Levetiracetam|levetiracetam|mesh-list
153941695|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
153941696|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
153941697|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153941698|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941699|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941729|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
153941730|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941731|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153941732|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153941733|NCT04555798|Meropenem|meropenem|mesh-list
153941734|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153941735|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941736|NCT00617968|Docetaxel|docetaxel|mesh-list
153941737|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941738|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
153941739|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
153941740|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941741|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941742|NCT00621400|Dexamethasone|dexamethasone|mesh-list
153941743|NCT00621400|Lenalidomide|lenalidomide|mesh-list
153941744|NCT00621400|Melphalan|melphalan|mesh-list
153941745|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153941746|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
153941747|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
153941748|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941749|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941750|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153941751|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
153941753|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153941781|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941782|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941783|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153941784|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153941785|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
153941786|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
153941787|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
153941800|NCT02879513|Paclitaxel|paclitaxel|mesh-list
153941849|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153941850|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941851|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
153941852|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
153941853|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153941854|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153941855|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153941856|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941857|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153941858|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153941910|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
153941911|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153941912|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153941914|NCT04308317|Tetrandrine|tetrandrine|mesh-list
153941915|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
153941916|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153941917|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153941918|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153941919|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153941920|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941921|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
153941929|NCT01009554|Listerine|listerine|mesh-list
153941975|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
153941976|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
153941977|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153941978|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153941979|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
153941980|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153941981|NCT00621790|Fenoldopam|fenoldopam|mesh-list
153941982|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153941983|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
153941984|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
153941985|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
153942038|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942039|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942040|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
153942041|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153942042|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942043|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153942044|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
153942045|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153942046|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942047|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942048|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942049|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
153942050|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
153942051|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942052|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942053|NCT00618202|Balsalazide|balsalazide|mesh-list
153942054|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153942055|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153942056|NCT00618202|Analgesics|analgesics|mesh-ancestor
153942057|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
153942058|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942059|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942060|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942061|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942062|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942063|NCT00626015|Temozolomide|temozolomide|mesh-list
153942085|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942086|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942087|NCT01101191|Analgesics|analgesics|mesh-ancestor
153942088|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
153942089|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942090|NCT00622258|Everolimus|everolimus|mesh-list
153942091|NCT00622258|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153942092|NCT00622258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942093|NCT00622258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942094|NCT00622258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942095|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153942096|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
153942097|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942098|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942148|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
153942149|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153942150|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153942151|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942152|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
153942153|NCT01190150|Coagulants|coagulants|mesh-ancestor
153942154|NCT04315688|Insulin|insulin|mesh-list
153942155|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153942156|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942157|NCT05210062|Succinylcholine|succinylcholine|mesh-list
153942158|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153942159|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153942160|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153942161|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942162|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942163|NCT01001520|Tolcapone|tolcapone|mesh-list
153942164|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153942165|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153942166|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153942167|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942169|NCT00619840|Methylphenidate|methylphenidate|mesh-list
153942199|NCT02697058|Antidotes|antidotes|mesh-ancestor
153942200|NCT02697058|Protective Agents|protective agents|mesh-ancestor
153942201|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
153942202|NCT02697058|Vitamins|vitamins|mesh-ancestor
153942203|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
153942204|NCT00622414|Aflibercept|aflibercept|mesh-list
153942205|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
153942206|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153942207|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153942208|NCT00622414|Growth Substances|growth substances|mesh-ancestor
153942209|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942210|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
153942211|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942212|NCT01008696|Rabeprazole|rabeprazole|mesh-list
153942213|NCT01008696|Lansoprazole|lansoprazole|mesh-list
153942214|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
153942215|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153942216|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942258|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
153942259|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
153942260|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
153942262|NCT00619996|Sorafenib|sorafenib|mesh-list
153942263|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942264|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
153942265|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
153942266|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
153942268|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942325|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153942326|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153942327|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
153942328|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153942329|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
153942330|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
153942331|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
153942332|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153942333|NCT00622648|Enoxaparin|enoxaparin|mesh-list
153942334|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
153942335|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153942338|NCT02687854|Vitamin K|vitamin k|mesh-list
153942393|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942394|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942395|NCT01008618|Analgesics|analgesics|mesh-ancestor
153942396|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
153942397|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942398|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153942399|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153942400|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
153942401|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
153942402|NCT01001208|Etanercept|etanercept|mesh-list
153942458|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
153942459|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
153942460|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942461|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153942462|NCT02537860|Fentanyl|fentanyl|mesh-list
153942463|NCT02537860|Bupivacaine|bupivacaine|mesh-list
153942464|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
153942465|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
153942466|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153942467|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942468|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
153942469|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942476|NCT01162304|Oxycodone|oxycodone|mesh-list
153942521|NCT02885558|Efonidipine|efonidipine|mesh-list
153942522|NCT02885558|Nifedipine|nifedipine|mesh-list
153942523|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153942524|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153942525|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942526|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153942527|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942528|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
153942529|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
153942530|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153942531|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153942532|NCT02885558|Diuretics|diuretics|mesh-ancestor
153942533|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
153942534|NCT01008150|Paclitaxel|paclitaxel|mesh-list
153942535|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
153942536|NCT01008150|Doxorubicin|doxorubicin|mesh-list
153942537|NCT01008150|Trastuzumab|trastuzumab|mesh-list
153942538|NCT01008150|Neratinib|neratinib|mesh-list
153942539|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153942540|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942541|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
153942542|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
153942543|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
153942544|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942572|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153942573|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942574|NCT02689336|Temozolomide|temozolomide|mesh-list
153942575|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153942576|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153942577|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
153942578|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942579|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942580|NCT02689336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153942581|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942582|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942583|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153942584|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153942585|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
153942632|NCT00638560|Antioxidants|antioxidants|mesh-list
153942633|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
153942634|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942635|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942636|NCT00638560|Protective Agents|protective agents|mesh-ancestor
153942637|NCT00638638|Abciximab|abciximab|mesh-list
153942638|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
153942639|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153942640|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
153942641|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153942642|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153942643|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942644|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
153942693|NCT01004172|Growth Substances|growth substances|mesh-ancestor
153942694|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942695|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
153942696|NCT02688322|Sulbactam|sulbactam|mesh-list
153942697|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153942698|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153942699|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153942700|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942701|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942702|NCT02685748|Aspirin|aspirin|mesh-list
153942703|NCT02685748|Pantoprazole|pantoprazole|mesh-list
153942704|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153942705|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153942706|NCT02685748|Analgesics|analgesics|mesh-ancestor
153942753|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942754|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153942755|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
153942756|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
153942757|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153942758|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
153942759|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942760|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942761|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
153942762|NCT00640198|Memantine|memantine|mesh-list
153942763|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153942764|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153942765|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
153942766|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153942767|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942768|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942769|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153942770|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153942771|NCT04293822|Cetirizine|cetirizine|mesh-list
153942772|NCT04293822|Minoxidil|minoxidil|mesh-list
153942773|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153942774|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153942775|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153942804|NCT01174238|Paclitaxel|paclitaxel|mesh-list
153942805|NCT01174238|Carboplatin|carboplatin|mesh-list
153942806|NCT01174238|Axitinib|axitinib|mesh-list
153942807|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153942808|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942809|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
153942810|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
153942811|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
153942812|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942813|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942814|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942816|NCT02928406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153942817|NCT02928406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942818|NCT02928406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153942819|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942820|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
153942821|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
153942863|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153942864|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
153942865|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942866|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
153942867|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942868|NCT00641758|Protective Agents|protective agents|mesh-ancestor
153942869|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153942870|NCT00640276|Pitavastatin|pitavastatin|mesh-list
153942871|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153942872|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153942873|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153942874|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
153942875|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942876|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942877|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153942878|NCT02680132|Esomeprazole|esomeprazole|mesh-list
153942879|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153942880|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153942881|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153942882|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942883|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942884|NCT02683564|Infliximab|infliximab|mesh-list
153942885|NCT02683564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153942886|NCT02683564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942887|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700477|NCT00073814|Albuterol|albuterol|mesh-list
153942910|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942911|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
153942912|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153942913|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942914|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942915|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
153942916|NCT01006980|Dacarbazine|dacarbazine|mesh-list
153942917|NCT01006980|Vemurafenib|vemurafenib|mesh-list
153942918|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153942919|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
153942920|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942921|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153942922|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153942971|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153942973|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
153942974|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153942975|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153942976|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153942977|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153942978|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153942979|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153942980|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153942981|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153942982|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153942983|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153942984|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153942985|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
153942990|NCT00641212|Budesonide|budesonide|mesh-list
153943030|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943031|NCT00641914|Budesonide|budesonide|mesh-list
153943032|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153943033|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153943034|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
153943035|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943036|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943037|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153943038|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
153943039|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
153943040|NCT00641914|Hormones|hormones|mesh-ancestor
153943041|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153943042|NCT00640588|Adefovir|adefovir|mesh-list
153943043|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153943044|NCT00640588|Telbivudine|telbivudine|mesh-list
153943045|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
153943046|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943047|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153943048|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153943049|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943084|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153943085|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153943086|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153943087|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943088|NCT04183114|Vaccines|vaccines|mesh-list
153943089|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
153943090|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943091|NCT00996996|Iodine|iodine|mesh-list
153943092|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
153943093|NCT00996996|Antibodies|antibodies|mesh-list
153943094|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
153943095|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
153943096|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943097|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153943098|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943099|NCT00996996|Trace Elements|trace elements|mesh-ancestor
153943100|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
153943101|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943102|NCT04182568|Paclitaxel|paclitaxel|mesh-list
153943103|NCT04182568|Docetaxel|docetaxel|mesh-list
153943118|NCT00641446|Budesonide|budesonide|mesh-list
153943141|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943142|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153943143|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943144|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
153943145|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153943146|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943147|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943148|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153943149|NCT02678728|Analgesics|analgesics|mesh-ancestor
153943150|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
153943151|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943152|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153943153|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153943154|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153943155|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
153943156|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943157|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943158|NCT04180072|Bevacizumab|bevacizumab|mesh-list
153943159|NCT04180072|Atezolizumab|atezolizumab|mesh-list
153943160|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153943161|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943162|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153943192|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
153943193|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943194|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943195|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153943196|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153943197|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
153943198|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
153943199|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943200|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153943257|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153943259|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943260|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943261|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153943262|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153943263|NCT01160744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153943264|NCT01160744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153700855|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943265|NCT01160744|Growth Substances|growth substances|mesh-ancestor
153943266|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943267|NCT01160744|Growth Inhibitors|growth inhibitors|mesh-ancestor
153943268|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
153943270|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153943272|NCT01160354|Plerixafor|plerixafor|mesh-list
153943317|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
153943318|NCT01160198|Protective Agents|protective agents|mesh-ancestor
153943320|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
153943321|NCT02676934|Anesthetics|anesthetics|mesh-list
153943322|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943323|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943325|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153943326|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
153943327|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
153943328|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943329|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943382|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153943383|NCT01159574|Growth Substances|growth substances|mesh-ancestor
153943384|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
153943385|NCT01158950|Tolcapone|tolcapone|mesh-list
153943386|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153943387|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153943388|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153943389|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943390|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943391|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
153943392|NCT00910234|Hematinics|hematinics|mesh-ancestor
153943393|NCT05652322|Furosemide|furosemide|mesh-list
153943394|NCT05652322|Diuretics|diuretics|mesh-ancestor
153943395|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
153943396|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943400|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
153943443|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153943444|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153943445|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
153943446|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943447|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153943448|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153943449|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943450|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153943451|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153943507|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153943509|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153943510|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153943511|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943512|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
153943513|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943514|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943515|NCT04180384|Paclitaxel|paclitaxel|mesh-list
153943516|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153943517|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153943518|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943519|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
153943520|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
153943521|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
153943523|NCT00643240|Antibodies|antibodies|mesh-list
153943566|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153943567|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943568|NCT02671084|Sevoflurane|sevoflurane|mesh-list
153943569|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153943570|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153943571|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
153943572|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
153943573|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943574|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943575|NCT00644800|Ziprasidone|ziprasidone|mesh-list
153943576|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153943577|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
153943578|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943579|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943580|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943581|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153943582|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153943623|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943624|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153943625|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153943626|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943627|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153943628|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153943629|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
153943630|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
153943631|NCT00644956|Tadalafil|tadalafil|mesh-list
153943632|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
153943633|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153943634|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153943635|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943636|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943684|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153943685|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
153943686|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153943687|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
153943688|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153943689|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153943690|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943691|NCT02870634|Copper|copper|mesh-list
153943692|NCT02870634|Trace Elements|trace elements|mesh-ancestor
153943693|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
153943694|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943695|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
153943746|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943747|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153943748|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153943749|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153943750|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153943751|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943752|NCT00998946|Vitamins|vitamins|mesh-list
153943753|NCT00998946|Folic Acid|folic acid|mesh-list
153943754|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
153943755|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
153943812|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943813|NCT02667262|Analgesics|analgesics|mesh-ancestor
153943814|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
153943815|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943816|NCT00646126|Artesunate|artesunate|mesh-list
153943817|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
153943818|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
153943819|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
153943820|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153943821|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153943822|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943823|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943824|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
153943825|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
153943826|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153943827|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
153943828|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153943829|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943830|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943831|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153943869|NCT00645190|Galantamine|galantamine|mesh-list
153943870|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153943871|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943872|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943873|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
153943874|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943875|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943876|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153943878|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943879|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
153943880|NCT00910390|Ethylene|ethylene|mesh-list
153943933|NCT02666716|Fluconazole|fluconazole|mesh-list
153943934|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
153943935|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153943936|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153943937|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153943938|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943939|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943940|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153943941|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
153943942|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701526|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
153943943|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943944|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153943945|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153943946|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153943947|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153943948|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153943949|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153943950|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943951|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153943952|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153943982|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153943983|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943984|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943985|NCT00645268|Urological Agents|urological agents|mesh-ancestor
153943986|NCT02666014|Neostigmine|neostigmine|mesh-list
153943987|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153943988|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153943989|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153943990|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
153943991|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153943992|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943993|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153943994|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
153943995|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153943997|NCT02665702|Vinorelbine|vinorelbine|mesh-list
153943998|NCT02665702|Endostar protein|endostar protein|mesh-list
153943999|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944000|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153944001|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
153944010|NCT00646750|Rituximab|rituximab|mesh-list
153944036|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153944038|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944039|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944040|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944041|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
153944042|NCT02665624|Sennosides|sennosides|mesh-list
153944043|NCT02665624|Senna Extract|senna extract|mesh-list
153944044|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153944045|NCT02665624|Calcium|calcium|mesh-list
153944046|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153944047|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944048|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153944049|NCT02665624|Laxatives|laxatives|mesh-ancestor
153944050|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153944051|NCT02665624|Cathartics|cathartics|mesh-ancestor
153944052|NCT00646594|Fluticasone|fluticasone|mesh-list
153944053|NCT00646594|Budesonide|budesonide|mesh-list
153944054|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
153944055|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153944056|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153944058|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944089|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944090|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
153944091|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
153944092|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
153944093|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944094|NCT00994890|Tanezumab|tanezumab|mesh-list
153944095|NCT00994890|Analgesics|analgesics|mesh-ancestor
153944096|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
153944097|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944098|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944099|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
153944100|NCT02663830|Clomiphene|clomiphene|mesh-list
153944101|NCT02663830|Enclomiphene|enclomiphene|mesh-list
153944102|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
153944103|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944104|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
153944105|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153944106|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153944107|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944108|NCT02663830|Urological Agents|urological agents|mesh-ancestor
153944109|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153944110|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
153944111|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944112|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944113|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153944114|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
153944115|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153944116|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153944117|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153944118|NCT00648544|Pravastatin|pravastatin|mesh-list
153944119|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153944120|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153944121|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
153944122|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944123|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153944124|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153944126|NCT00648622|Carvedilol|carvedilol|mesh-list
153944127|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153944128|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153944129|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944130|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944131|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944132|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944133|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153944134|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
153944135|NCT00648622|Protective Agents|protective agents|mesh-ancestor
153944136|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153944137|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944142|NCT00994422|Ivermectin|ivermectin|mesh-list
153944188|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153944189|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153944190|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
153944191|NCT02663440|Temozolomide|temozolomide|mesh-list
153944192|NCT02663440|Molgramostim|molgramostim|mesh-list
153944193|NCT02663440|Sargramostim|sargramostim|mesh-list
153944194|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153944195|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
153944196|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452561|NCT01826448|Vemurafenib|vemurafenib|mesh-list
153944197|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944198|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
153944199|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944200|NCT04171180|Budesonide|budesonide|mesh-list
153944201|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
153944202|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944203|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153944204|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
153944205|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944206|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944207|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153944208|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
153944209|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
153944210|NCT04171180|Hormones|hormones|mesh-ancestor
153944211|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944212|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153944213|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153944236|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153944237|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944238|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944239|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
153944240|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944241|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944243|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
153944244|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
153944245|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944246|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944247|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
153944248|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944250|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153944251|NCT00647686|Narcotics|narcotics|mesh-ancestor
153944252|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944295|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944296|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944297|NCT00647842|Analgesics|analgesics|mesh-ancestor
153944298|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
153944299|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944300|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153944301|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153944302|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
153944303|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
153944304|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
153944305|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153944306|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153944307|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153944308|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944309|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944310|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
153944311|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944312|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944313|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153944314|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944315|NCT02662894|Valsartan|valsartan|mesh-list
153944316|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153944317|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153944318|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153944319|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
153944320|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944321|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153944322|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153944323|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944324|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153944326|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153944335|NCT02662660|Dipyrone|dipyrone|mesh-list
153944336|NCT02662660|Bupivacaine|bupivacaine|mesh-list
153944337|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
153944338|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
153944339|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
153944340|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944341|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944342|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
153944343|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944344|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153944345|NCT02662660|Analgesics|analgesics|mesh-ancestor
153944346|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
153944347|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153944348|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944349|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944350|NCT02868606|Insulin|insulin|mesh-list
153944351|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153944352|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153944353|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944354|NCT00647920|Adalimumab|adalimumab|mesh-list
153944393|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153944394|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
153944395|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944396|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944397|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944398|NCT02662426|Oseltamivir|oseltamivir|mesh-list
153944399|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
153944400|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944401|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944402|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944403|NCT00994110|Pasireotide|pasireotide|mesh-list
153944405|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944406|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944407|NCT02662348|Aldesleukin|aldesleukin|mesh-list
153944408|NCT02662348|Interleukin-2|interleukin-2|mesh-list
153944409|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944410|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153944411|NCT02662348|Analgesics|analgesics|mesh-ancestor
153944412|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
153944413|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944414|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944415|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153944416|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153944417|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
153944418|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944419|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
153944420|NCT02868372|Povidone|povidone|mesh-list
153944421|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
153944422|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
153944423|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153944424|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153944425|NCT00629148|Capecitabine|capecitabine|mesh-list
153944426|NCT00629148|Vinorelbine|vinorelbine|mesh-list
153944427|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153944428|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
153944429|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944430|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646586|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646587|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
153944431|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153944432|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
153944433|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
153944434|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
153944435|NCT01157234|Metoprolol|metoprolol|mesh-list
153944436|NCT01157234|Nebivolol|nebivolol|mesh-list
153944437|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153944438|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153944439|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
153944440|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
153944441|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944442|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944443|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153944444|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153944445|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153944446|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944447|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944448|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944449|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
153944450|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153944451|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153944452|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153944454|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
153944455|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
153944456|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153944457|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153944458|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944459|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944460|NCT04170790|Urological Agents|urological agents|mesh-ancestor
153944461|NCT04170790|Incretins|incretins|mesh-ancestor
153944462|NCT04170790|Hormones|hormones|mesh-ancestor
153944463|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944464|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944466|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
153944471|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153944472|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153944473|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
153944474|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944475|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153944476|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153944477|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944478|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153944479|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153944480|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
153944481|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
153944482|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944483|NCT02658838|Heparin|heparin|mesh-list
153944484|NCT02658838|Calcium heparin|calcium heparin|mesh-list
153944485|NCT02658838|Enoxaparin|enoxaparin|mesh-list
153944486|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153944487|NCT02658838|Tinzaparin|tinzaparin|mesh-list
153944488|NCT02658838|Dalteparin|dalteparin|mesh-list
153944489|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
153944490|NCT02658838|Ticagrelor|ticagrelor|mesh-list
153944528|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153944529|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
153944530|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944531|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944532|NCT02664142|Anesthetics|anesthetics|mesh-list
153944533|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944534|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944536|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
153702131|NCT00076544|Analgesics|analgesics|mesh-ancestor
153944538|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944539|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944589|NCT00830167|Pregabalin|pregabalin|mesh-list
153944590|NCT00830167|Analgesics|analgesics|mesh-ancestor
153944591|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
153944592|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944593|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944594|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
153944595|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153944596|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944597|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944598|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153944603|NCT00992394|Etanercept|etanercept|mesh-list
153944655|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153944656|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
153944657|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153944658|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944659|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944660|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153944661|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153944662|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153944663|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944664|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944665|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944666|NCT05367284|Testosterone|testosterone|mesh-list
153944667|NCT05367284|Androgens|androgens|mesh-ancestor
153944668|NCT05367284|Hormones|hormones|mesh-ancestor
153944669|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944670|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944671|NCT00843115|Donepezil|donepezil|mesh-list
153944672|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153944673|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944706|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944707|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153944708|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
153944709|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
153944710|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
153944711|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153944712|NCT01155284|Lansoprazole|lansoprazole|mesh-list
153944713|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
153944714|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153944715|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944716|NCT01155284|Incretins|incretins|mesh-ancestor
153944717|NCT01155284|Hormones|hormones|mesh-ancestor
153944718|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944719|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153944720|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
153944721|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944722|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944723|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153944724|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153944725|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153944760|NCT01169636|Carboplatin|carboplatin|mesh-list
153944763|NCT01169636|Panobinostat|panobinostat|mesh-list
153944764|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944765|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153944766|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153944767|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153944768|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944769|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944770|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153944771|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
153944772|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153944773|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
153944775|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153944776|NCT00706225|Hormones|hormones|mesh-ancestor
153944777|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944778|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944779|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153944780|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153944781|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
153944782|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153944783|NCT04117009|Remifentanil|remifentanil|mesh-list
153944784|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153944785|NCT04117009|Narcotics|narcotics|mesh-ancestor
153944788|NCT04117009|Analgesics|analgesics|mesh-ancestor
153944811|NCT01169558|Growth Substances|growth substances|mesh-ancestor
153944812|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944813|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
153944814|NCT00700687|Aspirin|aspirin|mesh-list
153944815|NCT00700687|Celecoxib|celecoxib|mesh-list
153944816|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153944817|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153944818|NCT00700687|Analgesics|analgesics|mesh-ancestor
153944819|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
153944820|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944821|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944822|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944823|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153944824|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153944825|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153944826|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944827|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153944828|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153944829|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153944830|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
153944831|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153944832|NCT00840463|Ambrisentan|ambrisentan|mesh-list
153944833|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153944834|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
153944835|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153944836|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944838|NCT00839527|Pioglitazone|pioglitazone|mesh-list
153944839|NCT00839527|Glimepiride|glimepiride|mesh-list
153944840|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
153944841|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153944842|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153944843|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944856|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944857|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944858|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944859|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944860|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153944861|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153944862|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153944863|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153944864|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153944865|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153944866|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153944867|NCT00707083|Dexamethasone|dexamethasone|mesh-list
153944868|NCT00707083|Methotrexate|methotrexate|mesh-list
153944869|NCT00707083|Vincristine|vincristine|mesh-list
153944870|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
153944871|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153944872|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
153944873|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
153944874|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944911|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944912|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944913|NCT04116931|Clopidogrel|clopidogrel|mesh-list
153944915|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153944916|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153944917|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153944918|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153944919|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
153944920|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944921|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944922|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944923|NCT00600886|Octreotide|octreotide|mesh-list
153944924|NCT00600886|Pasireotide|pasireotide|mesh-list
153944925|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153944926|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153944927|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153944928|NCT00600886|Hormones|hormones|mesh-ancestor
153944929|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153944963|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153944964|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153944965|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153944966|NCT02658760|Analgesics|analgesics|mesh-ancestor
153944967|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153944968|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153944969|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153944970|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
153944971|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153944972|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153944974|NCT02536690|Remifentanil|remifentanil|mesh-list
153944975|NCT02536690|Propofol|propofol|mesh-list
153944976|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153944977|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153944978|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945023|NCT00648466|Sumatriptan|sumatriptan|mesh-list
153945024|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153945025|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153945026|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153945027|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
153945028|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945029|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945030|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945031|NCT00649402|Amlodipine|amlodipine|mesh-list
153945089|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945090|NCT02658526|Anesthetics|anesthetics|mesh-list
153945091|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945092|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945093|NCT00650494|Valacyclovir|valacyclovir|mesh-list
153945094|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
153945095|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945096|NCT02655874|Vaccines|vaccines|mesh-list
153945097|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
153945098|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945099|NCT00828139|Aflibercept|aflibercept|mesh-list
153945100|NCT00828139|Topotecan|topotecan|mesh-list
153945101|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
153945102|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153945103|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153945104|NCT00828139|Growth Substances|growth substances|mesh-ancestor
153945106|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
153945149|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945151|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
153945152|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945153|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153945154|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
153945155|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153945156|NCT04201756|Afatinib|afatinib|mesh-list
153945157|NCT04201756|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153945158|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153945159|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945160|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945161|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945162|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
153945163|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153945164|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153945165|NCT02651350|Prednisolone|prednisolone|mesh-list
153945166|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
153945167|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153945204|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945205|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153945206|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
153945207|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153945208|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153945209|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153702795|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945210|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945212|NCT04030663|Papaverine|papaverine|mesh-list
153945213|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
153945214|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153945215|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945216|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945217|NCT04030663|Urological Agents|urological agents|mesh-ancestor
153945218|NCT00700921|Lovastatin|lovastatin|mesh-list
153945219|NCT00700921|L 647318|l 647318|mesh-list
153945220|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
153945221|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153945222|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153945223|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
153945224|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945225|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153945226|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153945227|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945228|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153945229|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945230|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945231|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
153945232|NCT02657512|Charcoal|charcoal|mesh-list
153945233|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153945234|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
153945235|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153945240|NCT02657512|Antidotes|antidotes|mesh-ancestor
153945247|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945248|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945249|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945250|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945251|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
153945252|NCT00818779|Renin Inhibitors|renin inhibitors|mesh-ancestor
153945253|NCT00818779|Protease Inhibitors|protease inhibitors|mesh-ancestor
153945254|NCT00818779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945255|NCT00649714|Zonisamide|zonisamide|mesh-list
153945311|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945312|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153945313|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153945314|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
153945315|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
153945316|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153945317|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153945318|NCT00910780|Olanzapine|olanzapine|mesh-list
153945319|NCT00910780|Aripiprazole|aripiprazole|mesh-list
153945320|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
153945321|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153945322|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153945323|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153945324|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945325|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945326|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
153945327|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
153945328|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945330|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153945368|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945369|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
153945370|NCT04167592|Benzydamine|benzydamine|mesh-list
153945371|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153945372|NCT04168294|Propofol|propofol|mesh-list
153945373|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153945374|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945375|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945376|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153945377|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
153945378|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
153945379|NCT04168138|Cytarabine|cytarabine|mesh-list
153945380|NCT04168138|Decitabine|decitabine|mesh-list
153945381|NCT04168138|Aclarubicin|aclarubicin|mesh-list
153945382|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153945383|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
153945384|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945385|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945386|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
153945387|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945422|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
153945423|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153945424|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153945425|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945426|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945427|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945428|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153945429|NCT02645032|Vaccines|vaccines|mesh-list
153945430|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
153945431|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945432|NCT02644954|Metformin|metformin|mesh-list
153945433|NCT02644954|Calcipotriene|calcipotriene|mesh-list
153945434|NCT02644954|Coal Tar|coal tar|mesh-list
153945435|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153945436|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945437|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
153945438|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
153945440|NCT00650338|Latanoprost|latanoprost|mesh-list
153945482|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945484|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153945485|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945486|NCT04166734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153945487|NCT04166734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945488|NCT00651352|Nicotine|nicotine|mesh-list
153945489|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153945490|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
153945491|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945492|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945493|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153945494|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153945495|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
153945496|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945497|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945498|NCT02641210|Albendazole|albendazole|mesh-list
153945499|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
153945500|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153945501|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945502|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
153945503|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153945504|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153945505|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
153945506|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
153945510|NCT02644408|Megestrol|megestrol|mesh-list
153945531|NCT00827359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153945532|NCT00827359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945533|NCT00827359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945534|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153945535|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
153945536|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945537|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945538|NCT02641288|Ropivacaine|ropivacaine|mesh-list
153945539|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
153945540|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
153945541|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945542|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945543|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
153945544|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945545|NCT04165174|Apatinib|apatinib|mesh-list
153945546|NCT04165174|Antibodies|antibodies|mesh-list
153945547|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153945548|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
153945549|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945550|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945551|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153945552|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945554|NCT02613247|Hylan|hylan|mesh-list
153945582|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
153945583|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
153945584|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945586|NCT02644252|Protective Agents|protective agents|mesh-ancestor
153945587|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945588|NCT02644252|Vitamins|vitamins|mesh-ancestor
153945589|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
153945590|NCT00818389|Riluzole|riluzole|mesh-list
153945591|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
153945592|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
153945593|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153945594|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945642|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945643|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945644|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945646|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
153945647|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945648|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
153945649|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153945650|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
153945651|NCT00849901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153945652|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
153945653|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153945654|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153945655|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153945656|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703244|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
153945657|NCT02641054|Levodopa|levodopa|mesh-list
153945658|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153945659|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153945660|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
153945694|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
153945695|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
153945696|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
153945697|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945698|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945699|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945700|NCT01168232|Epothilones|epothilones|mesh-list
153945701|NCT01168232|Epothilone B|epothilone b|mesh-list
153945702|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
153945703|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
153945704|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
153945705|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945706|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945707|NCT00817531|Dasatinib|dasatinib|mesh-list
153945713|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
153945756|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153945757|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945758|NCT00826267|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153945759|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153945760|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945761|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945762|NCT00653848|Docetaxel|docetaxel|mesh-list
153945763|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945764|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
153945765|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
153945766|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
153945767|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945768|NCT00707551|Ketoconazole|ketoconazole|mesh-list
153945769|NCT00707551|Verapamil|verapamil|mesh-list
153945770|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
153945771|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153945772|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153945773|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153945774|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945775|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945776|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153945777|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
153945778|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153945779|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945780|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153945781|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153945782|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153945783|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153945784|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945785|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
153945786|NCT00986154|Heparin|heparin|mesh-list
153945787|NCT00986154|Calcium heparin|calcium heparin|mesh-list
153945789|NCT00986154|Tinzaparin|tinzaparin|mesh-list
153945795|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153945796|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945797|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153945798|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
153945799|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153945800|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
153945801|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945802|NCT00653926|Epinephrine|epinephrine|mesh-list
153945803|NCT00653926|Ropivacaine|ropivacaine|mesh-list
153945804|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
153945805|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
153945806|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153945807|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945808|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
153945809|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945811|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153945812|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
153945813|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153945814|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945815|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153945816|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153945817|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
153945818|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153945848|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153945849|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
153945851|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153945852|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
153945853|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
153945854|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153945855|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153945856|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945857|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945858|NCT00654082|Urological Agents|urological agents|mesh-ancestor
153945859|NCT00654160|Leucovorin|leucovorin|mesh-list
153945860|NCT00654160|Fluorouracil|fluorouracil|mesh-list
153945861|NCT00654160|Irinotecan|irinotecan|mesh-list
153945862|NCT00654160|Calcium|calcium|mesh-list
153945863|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
153945864|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153945865|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945906|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945907|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
153945908|NCT00816595|Bevacizumab|bevacizumab|mesh-list
153945910|NCT00816595|Pentostatin|pentostatin|mesh-list
153945911|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153945912|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
153945913|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945914|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153945915|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153945916|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
153945917|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153945918|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153945919|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153945921|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153945968|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153945969|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153945970|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
153945971|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153945972|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946037|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
153946038|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153946039|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153946040|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153946041|NCT02646592|Narcotics|narcotics|mesh-ancestor
153946042|NCT02646592|Analgesics|analgesics|mesh-ancestor
153946043|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
153946044|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946045|NCT02646670|Ranibizumab|ranibizumab|mesh-list
153946046|NCT02646670|Aflibercept|aflibercept|mesh-list
153946047|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153946048|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153946049|NCT02646670|Growth Substances|growth substances|mesh-ancestor
153946050|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946051|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
153946052|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946053|NCT00651976|Letrozole|letrozole|mesh-list
153946054|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946055|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153946056|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153946057|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946059|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153946088|NCT01152788|Dacarbazine|dacarbazine|mesh-list
153946089|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153946090|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
153946091|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946092|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946093|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
153946094|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153946095|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
153946096|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153946097|NCT00598702|Acetaminophen|acetaminophen|mesh-list
153946098|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153946099|NCT00598702|Analgesics|analgesics|mesh-ancestor
153946100|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
153946101|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946102|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946103|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
153946105|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153946106|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946107|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153946108|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
153946109|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946110|NCT02884310|Remifentanil|remifentanil|mesh-list
153946111|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153946112|NCT02884310|Narcotics|narcotics|mesh-ancestor
153946113|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946114|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946115|NCT02884310|Analgesics|analgesics|mesh-ancestor
153946116|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
153946117|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946118|NCT01164956|Methylphenidate|methylphenidate|mesh-list
153946125|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
153946127|NCT01151540|Rufinamide|rufinamide|mesh-list
153946128|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
153946129|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153946130|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153946131|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946132|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946133|NCT01163786|Bortezomib|bortezomib|mesh-list
153946134|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946135|NCT00984282|Sorafenib|sorafenib|mesh-list
153946136|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946137|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153946138|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946139|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946140|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
153946189|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946190|NCT00629226|Cetuximab|cetuximab|mesh-list
153946191|NCT00629226|Bortezomib|bortezomib|mesh-list
153946192|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946193|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153946194|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
153946195|NCT00629304|Antithrombins|antithrombins|mesh-list
153946196|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153946197|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
153946198|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946199|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946200|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
153946201|NCT05297929|Irbesartan|irbesartan|mesh-list
153946202|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153946203|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153946204|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153946205|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946206|NCT00826111|Eszopiclone|eszopiclone|mesh-list
153946207|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153946208|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946241|NCT02867904|Protective Agents|protective agents|mesh-ancestor
153946242|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153946243|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946244|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
153946245|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
153946246|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946247|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
153946248|NCT04290936|Tenofovir|tenofovir|mesh-list
153946249|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
153946250|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946251|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153946252|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153946253|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946254|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946255|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153946256|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153946257|NCT00707941|Oseltamivir|oseltamivir|mesh-list
153703847|NCT00130000|Eculizumab|eculizumab|mesh-list
153946259|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946260|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946261|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946262|NCT00824473|Azelastine|azelastine|mesh-list
153946294|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153946295|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
153946296|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153946297|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153946298|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
153946299|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946300|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153946301|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153946302|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946303|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946304|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153946305|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
153946306|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153946355|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
153946356|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946357|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153946358|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153946359|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946360|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946361|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153946362|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153946363|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
153946364|NCT00814801|Galantamine|galantamine|mesh-list
153946365|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153946366|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946367|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946368|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
153946369|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946370|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946371|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153946372|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
153946373|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946374|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
153946375|NCT00653458|Ondansetron|ondansetron|mesh-list
153946376|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
153946377|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
153946378|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946379|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946380|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153946381|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
153946382|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
153946383|NCT00653458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153946384|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153946385|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
153946386|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946387|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946388|NCT00708565|Iloprost|iloprost|mesh-list
153357548|NCT04274738|Ibrutinib|ibrutinib|mesh-list
153946389|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153946390|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
153946392|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153946393|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946394|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
153946395|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946396|NCT00599326|Deferasirox|deferasirox|mesh-list
153946397|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153946398|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
153946399|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
153946400|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946401|NCT00978432|Everolimus|everolimus|mesh-list
153946402|NCT00978432|Panobinostat|panobinostat|mesh-list
153704063|NCT00298909|Niacin|niacin|mesh-list
153946403|NCT00978432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153946404|NCT00978432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153946405|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946406|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946407|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153946408|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
153946409|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946410|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946411|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153946412|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
153946420|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
153946445|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153946446|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946447|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946448|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153946449|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
153946450|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
153946451|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153946452|NCT00913861|Narcotics|narcotics|mesh-ancestor
153946453|NCT00913861|Analgesics|analgesics|mesh-ancestor
153946454|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
153946455|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946456|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153946457|NCT00709189|Folic Acid|folic acid|mesh-list
153946458|NCT00709189|Norgestimate|norgestimate|mesh-list
153946459|NCT00709189|Estradiol|estradiol|mesh-list
153946460|NCT00709189|Estrogens|estrogens|mesh-ancestor
153946461|NCT00709189|Hormones|hormones|mesh-ancestor
153946462|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153946463|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946464|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153946465|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
153946466|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153946467|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153946468|NCT00709189|Hematinics|hematinics|mesh-ancestor
153946469|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
153946470|NCT00709189|Vitamins|vitamins|mesh-ancestor
153946471|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
153946472|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153946473|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153946474|NCT00709267|Folic Acid|folic acid|mesh-list
153946475|NCT00709267|Hematinics|hematinics|mesh-ancestor
153946495|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946496|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153946498|NCT01133678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153946499|NCT01133678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946500|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153946501|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
153946502|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946503|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
153946504|NCT00652132|Antidotes|antidotes|mesh-ancestor
153946505|NCT00652132|Protective Agents|protective agents|mesh-ancestor
153946506|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946507|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
153946508|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946509|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
153946510|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946511|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946512|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
153946513|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
153946514|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
153946515|NCT00655174|Sertraline|sertraline|mesh-list
153946516|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
153946517|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153946518|NCT00655174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153500886|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153946519|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153946520|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946521|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946541|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946542|NCT00655018|Protective Agents|protective agents|mesh-ancestor
153946543|NCT02635750|Donepezil|donepezil|mesh-list
153946544|NCT02635750|BI 409306|bi 409306|mesh-list
153946545|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153946546|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946547|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946548|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
153946549|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946550|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946551|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
153946552|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153946553|NCT04164238|Paclitaxel|paclitaxel|mesh-list
153946554|NCT04164238|Carboplatin|carboplatin|mesh-list
153946555|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153946556|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704145|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
153946557|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
153946558|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
153946559|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
153946560|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946561|NCT02645734|Bevacizumab|bevacizumab|mesh-list
153946562|NCT02645734|Aflibercept|aflibercept|mesh-list
153946563|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153946564|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946565|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153946566|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153946567|NCT02645734|Growth Substances|growth substances|mesh-ancestor
153946568|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946569|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
153946570|NCT01133522|Evolocumab|evolocumab|mesh-list
153946571|NCT01133522|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153946574|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
153946583|NCT00655252|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153946584|NCT00655252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153946585|NCT00655252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946586|NCT00655252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946587|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153946588|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
153946589|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946590|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946591|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
153946592|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153946593|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153946648|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153946649|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946650|NCT00652288|Insulin|insulin|mesh-list
153946651|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153946652|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
153946653|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
153946654|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
153946655|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153946656|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
153946657|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
153946658|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153946659|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946660|NCT00911092|Fluorouracil|fluorouracil|mesh-list
153946661|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946662|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
153946663|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946664|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153946665|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153946666|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
153946667|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946668|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
153946669|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946670|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153946671|NCT02635360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153946672|NCT02635360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946673|NCT02635282|Midazolam|midazolam|mesh-list
153946674|NCT02635282|Fentanyl|fentanyl|mesh-list
153946675|NCT02635282|Ketamine|ketamine|mesh-list
153946676|NCT02635282|Analgesics|analgesics|mesh-ancestor
153946677|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
153946678|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946679|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946683|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
153946689|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153946690|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153946691|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153946692|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153946693|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153946694|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
153946695|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
153946696|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153946698|NCT00655798|Antioxidants|antioxidants|mesh-list
153946699|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946700|NCT00655798|Protective Agents|protective agents|mesh-ancestor
153946701|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946702|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
153946703|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153946704|NCT02637700|Antibodies|antibodies|mesh-list
153946705|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
153946706|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153946707|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
153946708|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946709|NCT02637466|Vortioxetine|vortioxetine|mesh-list
153946710|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
153946711|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153946712|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153946713|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153946714|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946715|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946716|NCT02637466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153946717|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153946718|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153946719|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946720|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153946721|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
153946732|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946733|NCT00885352|Metformin|metformin|mesh-list
153946734|NCT00885352|Pioglitazone|pioglitazone|mesh-list
153946735|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153946736|NCT00885352|Glipizide|glipizide|mesh-list
153946737|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153946738|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946739|NCT00885352|Incretins|incretins|mesh-ancestor
153946800|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153946801|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946802|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946803|NCT00656188|Urological Agents|urological agents|mesh-ancestor
153946804|NCT00880906|Fluticasone|fluticasone|mesh-list
153946805|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153946806|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153946807|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153946808|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
153946809|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946810|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946811|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153946812|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
153946813|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
153946814|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153946815|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946816|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946817|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
153946818|NCT04160026|Piperaquine|piperaquine|mesh-list
153946819|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
153946820|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153946821|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
153946822|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153946823|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153946824|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946825|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153946829|NCT04159870|Rifaximin|rifaximin|mesh-list
153946847|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946848|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153946849|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
153946850|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153946851|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946853|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946854|NCT00882310|Gemcitabine|gemcitabine|mesh-list
153946855|NCT00882310|Capecitabine|capecitabine|mesh-list
153946856|NCT00882310|Docetaxel|docetaxel|mesh-list
153946857|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153704442|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946858|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
153946859|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946860|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153946861|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
153946862|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
153946863|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
153946865|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
153946866|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946867|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946868|NCT02636842|Aripiprazole|aripiprazole|mesh-list
153946869|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
153946870|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
153946871|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153946872|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153946873|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153946874|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946875|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946876|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
153946877|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
153946890|NCT00656422|Insulin|insulin|mesh-list
153946891|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153946892|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
153946893|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153946894|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946895|NCT02634034|Pitavastatin|pitavastatin|mesh-list
153946896|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153946897|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153946898|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153946899|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
153946900|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153946901|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153946951|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153946952|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153946953|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
153946954|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
153946955|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153946956|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946958|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153946959|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
153946960|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
153946961|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153946962|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947016|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
153947017|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947018|NCT00979992|Sunitinib|sunitinib|mesh-list
153947019|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947020|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153947021|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153947022|NCT00979992|Growth Substances|growth substances|mesh-ancestor
153947023|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947024|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
153947025|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153947026|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947027|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947028|NCT01079741|Poly I-C|poly i-c|mesh-list
153947029|NCT01079741|Mineral Oil|mineral oil|mesh-list
153947030|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153947031|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153947032|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
153947033|NCT01079741|Poly ICLC|poly iclc|mesh-list
153947034|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153947035|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
153947036|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947073|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
153947074|NCT02865174|Thrombin|thrombin|mesh-list
153947075|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
153947076|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153947077|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153947078|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947079|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153947080|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
153947081|NCT02865174|Coagulants|coagulants|mesh-ancestor
153704666|NCT00201799|Infliximab|infliximab|mesh-list
153947082|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
153947083|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153947084|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153947085|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947135|NCT00820027|Oxycodone|oxycodone|mesh-list
153947136|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153947137|NCT00820027|Narcotics|narcotics|mesh-ancestor
153947138|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947139|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947140|NCT00820027|Analgesics|analgesics|mesh-ancestor
153947141|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
153947142|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947143|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153947144|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153947145|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153947146|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153947147|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153947148|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947149|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947150|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153947151|NCT02876549|Chloroquine|chloroquine|mesh-list
153947152|NCT02876549|Primaquine|primaquine|mesh-list
153947153|NCT02876549|Amebicides|amebicides|mesh-ancestor
153947154|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153947155|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153947156|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947157|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
153947158|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153947159|NCT00913549|Clemastine|clemastine|mesh-list
153704739|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
153947160|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
153947161|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
153947162|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153947163|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
153947164|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
153947165|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947166|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947168|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153947175|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153947176|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153947177|NCT01076075|Metformin|metformin|mesh-list
153947178|NCT01076075|Pioglitazone|pioglitazone|mesh-list
153947179|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153947180|NCT01076075|Glimepiride|glimepiride|mesh-list
153947181|NCT01076075|Gliclazide|gliclazide|mesh-list
153947182|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153947183|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947184|NCT01076075|Incretins|incretins|mesh-ancestor
153947185|NCT01076075|Hormones|hormones|mesh-ancestor
153947186|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947239|NCT02877173|Urological Agents|urological agents|mesh-ancestor
153947240|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153947241|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153947242|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153947243|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947244|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947245|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153947246|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153947247|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947248|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
153947249|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947250|NCT00661180|Sorafenib|sorafenib|mesh-list
153947251|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947252|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153947253|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947254|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947255|NCT01078571|Adalimumab|adalimumab|mesh-list
153947256|NCT01078571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153947257|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153947258|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153947259|NCT04160416|Capecitabine|capecitabine|mesh-list
153947260|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
153947261|NCT04160416|Irinotecan|irinotecan|mesh-list
153947262|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947263|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
153947288|NCT04158700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947289|NCT00657202|Ranibizumab|ranibizumab|mesh-list
153947290|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153947291|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153947292|NCT00657202|Growth Substances|growth substances|mesh-ancestor
153947293|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947294|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
153947295|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947296|NCT00626483|Basiliximab|basiliximab|mesh-list
153947297|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947298|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
153947299|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947300|NCT00626717|Riboflavin|riboflavin|mesh-list
153947301|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
153947302|NCT00626717|Vitamins|vitamins|mesh-ancestor
153947303|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
153947304|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947305|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153947306|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
153947344|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947345|NCT00661648|Pancrelipase|pancrelipase|mesh-list
153947346|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947347|NCT00659074|Ondansetron|ondansetron|mesh-list
153947348|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
153947349|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
153947350|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947351|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947352|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947353|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
153947354|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
153947355|NCT00659074|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153947356|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153947357|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
153947358|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947359|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947360|NCT01077713|Bevacizumab|bevacizumab|mesh-list
153947361|NCT01077713|Gemcitabine|gemcitabine|mesh-list
153947362|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947363|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947364|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153947365|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153947366|NCT01077713|Growth Substances|growth substances|mesh-ancestor
153947367|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947368|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
153947369|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947370|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
153947371|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947372|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
153947373|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153947374|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
153947379|NCT01077323|Exenatide|exenatide|mesh-list
153947386|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947387|NCT03870438|Lamivudine|lamivudine|mesh-list
153947388|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153947389|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153947390|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947391|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947392|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
153947393|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947394|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153947395|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153947396|NCT04287894|Pemetrexed|pemetrexed|mesh-list
153947397|NCT04287894|Durvalumab|durvalumab|mesh-list
153947398|NCT04287894|Tremelimumab|tremelimumab|mesh-list
153947399|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947400|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947401|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947402|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153947403|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153947404|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947405|NCT04287426|Remifentanil|remifentanil|mesh-list
153947406|NCT04287426|Rocuronium|rocuronium|mesh-list
153947407|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153947438|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947439|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153947440|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153947441|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
153947442|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947443|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153947444|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153947445|NCT00629382|Polymyxins|polymyxins|mesh-list
153947456|NCT06200181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947457|NCT06200181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153947458|NCT06200181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153947459|NCT06200181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947460|NCT06200181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153947461|NCT06200181|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153947462|NCT06200181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153947463|NCT06200181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153947464|NCT06200181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947465|NCT06200181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947466|NCT06200181|Serotonin Agents|serotonin agents|mesh-ancestor
153947467|NCT06200168|Antiemetics|antiemetics|mesh-list
153947468|NCT06200168|Autonomic Agents|autonomic agents|mesh-ancestor
153947469|NCT06200168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947470|NCT06200168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947471|NCT06200168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947482|NCT06199921|Atorvastatin|atorvastatin|mesh-list
153947483|NCT06199921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153947484|NCT06199921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153947485|NCT06199921|Antimetabolites|antimetabolites|mesh-ancestor
153947486|NCT06199921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947487|NCT06199921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153947488|NCT06199921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153947489|NCT06199921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947490|NCT06199895|Paclitaxel|paclitaxel|mesh-list
153947496|NCT06199895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947497|NCT06199882|Immunomodulating Agents|immunomodulating agents|mesh-list
153947498|NCT06199882|Immunologic Factors|immunologic factors|mesh-ancestor
153947499|NCT06199882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947500|NCT06199843|Rifaximin|rifaximin|mesh-list
153947501|NCT06199843|Norfloxacin|norfloxacin|mesh-list
153947502|NCT06199843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153947503|NCT06199843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947504|NCT06199843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947505|NCT06199843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153947506|NCT06199843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153947507|NCT06199843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947508|NCT06199843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947509|NCT06199843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947510|NCT06199843|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153947511|NCT06199843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153947512|NCT06199791|Lamotrigine|lamotrigine|mesh-list
153947553|NCT06199544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947555|NCT06199505|Insulin Aspart|insulin aspart|mesh-list
153947556|NCT06199505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153947557|NCT06199505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947558|NCT06199453|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153947559|NCT06199453|Chelating Agents|chelating agents|mesh-ancestor
153947560|NCT06199453|Sequestering Agents|sequestering agents|mesh-ancestor
153947561|NCT06199453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947562|NCT06199427|Cyclophosphamide|cyclophosphamide|mesh-list
153947563|NCT06199427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153947564|NCT06199427|Immunologic Factors|immunologic factors|mesh-ancestor
153947565|NCT06199427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947566|NCT06199427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153947567|NCT06199427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153947568|NCT06199427|Alkylating Agents|alkylating agents|mesh-ancestor
153947569|NCT06199427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947570|NCT06199427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947571|NCT06199427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153947572|NCT06199154|Misoprostol|misoprostol|mesh-list
153947573|NCT06199154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153947574|NCT06199154|Abortifacient Agents|abortifacient agents|mesh-ancestor
153947575|NCT06199154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153947576|NCT06199154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947577|NCT06199154|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153947578|NCT06199154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947579|NCT06199154|Oxytocics|oxytocics|mesh-ancestor
153947580|NCT06199102|Cholecalciferol|cholecalciferol|mesh-list
153947581|NCT06199102|Vitamin D|vitamin d|mesh-list
153947582|NCT06199102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153947583|NCT06199102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947584|NCT06199102|Vitamins|vitamins|mesh-ancestor
153947585|NCT06199102|Micronutrients|micronutrients|mesh-ancestor
153947595|NCT06198842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153947596|NCT06198842|Alkylating Agents|alkylating agents|mesh-ancestor
153947597|NCT06198842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947598|NCT06198842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947599|NCT06198764|Meropenem|meropenem|mesh-list
153947600|NCT06198764|Colistin|colistin|mesh-list
153947601|NCT06198764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153947602|NCT06198764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947603|NCT06198673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153947604|NCT06198465|Paclitaxel|paclitaxel|mesh-list
153947605|NCT06198465|Fluorouracil|fluorouracil|mesh-list
153947606|NCT06198465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153947607|NCT06198465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947608|NCT06198465|Tubulin Modulators|tubulin modulators|mesh-ancestor
153947609|NCT06198465|Antimitotic Agents|antimitotic agents|mesh-ancestor
153947655|NCT06109558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947656|NCT06109558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947657|NCT06109558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947658|NCT06083675|Metformin|metformin|mesh-list
153947659|NCT06083675|Semaglutide|semaglutide|mesh-list
153947660|NCT06083675|Empagliflozin|empagliflozin|mesh-list
153947661|NCT06083675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153947662|NCT06083675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947663|NCT06083675|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153947664|NCT06083675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153947665|NCT06083675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947666|NCT06075771|Levodopa|levodopa|mesh-list
153947715|NCT06040840|Respiratory System Agents|respiratory system agents|mesh-ancestor
153947716|NCT06040840|Mydriatics|mydriatics|mesh-ancestor
153947717|NCT06040840|Sympathomimetics|sympathomimetics|mesh-ancestor
153947718|NCT06040840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153947719|NCT06015022|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153947720|NCT06015022|Antioxidants|antioxidants|mesh-ancestor
153947721|NCT06015022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947722|NCT06015022|Protective Agents|protective agents|mesh-ancestor
153947723|NCT06015022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947724|NCT06015022|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153947725|NCT06015022|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153947726|NCT06015022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947727|NCT06015022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153947729|NCT06011772|Bevacizumab|bevacizumab|mesh-list
153947730|NCT06011772|Cetuximab|cetuximab|mesh-list
153947731|NCT06011772|Fluorouracil|fluorouracil|mesh-list
153947732|NCT06011772|Oxaliplatin|oxaliplatin|mesh-list
153947733|NCT06011772|Irinotecan|irinotecan|mesh-list
153947734|NCT06011772|Vaccines|vaccines|mesh-list
153947735|NCT06011772|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153947736|NCT06011772|Immunologic Factors|immunologic factors|mesh-ancestor
153947771|NCT05945875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947772|NCT05944237|Atezolizumab|atezolizumab|mesh-list
153947773|NCT05944237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153947774|NCT05944237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947775|NCT05944237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947776|NCT05944237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947777|NCT05867849|Cannabidiol|cannabidiol|mesh-list
153947778|NCT05867849|Anticonvulsants|anticonvulsants|mesh-ancestor
153947779|NCT05864677|Cerebrolysin|cerebrolysin|mesh-list
153947780|NCT05864677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153947781|NCT05864677|Protective Agents|protective agents|mesh-ancestor
153947782|NCT05864677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947783|NCT05864677|Nootropic Agents|nootropic agents|mesh-ancestor
153947784|NCT05856227|Ceftobiprole|ceftobiprole|mesh-list
153947785|NCT05856227|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
153947786|NCT05856227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153947787|NCT05856227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947788|NCT05832229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153947789|NCT05832229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153947790|NCT05832229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153947791|NCT05832229|Antimetabolites|antimetabolites|mesh-ancestor
153947792|NCT05832229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947793|NCT05832229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153947794|NCT05832229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153947795|NCT05832229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947796|NCT05832190|Biotin|biotin|mesh-list
153947797|NCT05832190|Vitamin B Complex|vitamin b complex|mesh-ancestor
153947798|NCT05832190|Vitamins|vitamins|mesh-ancestor
153947799|NCT05832190|Micronutrients|micronutrients|mesh-ancestor
153947800|NCT05832190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947801|NCT05818553|Pramoxine|pramoxine|mesh-list
153947802|NCT05818553|Anesthetics, Local|anesthetics, local|mesh-ancestor
153947803|NCT05818553|Anesthetics|anesthetics|mesh-ancestor
153947804|NCT05818553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947806|NCT05818553|Sensory System Agents|sensory system agents|mesh-ancestor
153947813|NCT05804032|Antiemetics|antiemetics|mesh-ancestor
153947814|NCT05804032|Autonomic Agents|autonomic agents|mesh-ancestor
153947815|NCT05804032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947816|NCT05804032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947817|NCT05804032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947818|NCT05804032|Glucocorticoids|glucocorticoids|mesh-ancestor
153947820|NCT05804032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947821|NCT05804032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153947822|NCT05804032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947823|NCT05804032|Immunologic Factors|immunologic factors|mesh-ancestor
153947824|NCT05804032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153947825|NCT05804032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153947826|NCT05804032|Growth Substances|growth substances|mesh-ancestor
153947827|NCT05804032|Growth Inhibitors|growth inhibitors|mesh-ancestor
153947828|NCT05764590|Sevelamer|sevelamer|mesh-list
153947829|NCT05764590|Chelating Agents|chelating agents|mesh-ancestor
153947830|NCT05764590|Sequestering Agents|sequestering agents|mesh-ancestor
153947831|NCT05764590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947832|NCT05741294|Tirbanibulin|tirbanibulin|mesh-list
153947833|NCT05741294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947834|NCT05741294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500924|NCT00367068|Baclofen|baclofen|mesh-list
153705416|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
153947835|NCT05737784|Pramoxine|pramoxine|mesh-list
153947836|NCT05737784|Anesthetics, Local|anesthetics, local|mesh-ancestor
153947837|NCT05737784|Anesthetics|anesthetics|mesh-ancestor
153947838|NCT05737784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947839|NCT05737784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947859|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153947860|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947861|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947862|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153947863|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
153947864|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
153947865|NCT05662397|Cemiplimab|cemiplimab|mesh-list
153947866|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947867|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947868|NCT05662319|Antithrombins|antithrombins|mesh-list
153947869|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
153947870|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153947871|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
153947872|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947873|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947874|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
153947875|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
153947876|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947877|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
153947878|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947879|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947880|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153947881|NCT05632627|Cannabidiol|cannabidiol|mesh-list
153947882|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
153947883|NCT05627466|Magrolimab|magrolimab|mesh-list
153947884|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947885|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947886|NCT05584267|Immunomodulating Agents|immunomodulating agents|mesh-list
153947904|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153947905|NCT05485805|Analgesics|analgesics|mesh-ancestor
153947906|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
153947907|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947908|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153947909|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153947910|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
153947911|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153947912|NCT05446571|Valacyclovir|valacyclovir|mesh-list
153947914|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
153947915|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153947916|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153947917|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947918|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947919|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947920|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
153947921|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947922|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947923|NCT05446298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153947924|NCT05446298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947925|NCT05431777|Avelumab|avelumab|mesh-list
153947926|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947927|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947928|NCT05379166|Azacitidine|azacitidine|mesh-list
153947929|NCT05379166|Venetoclax|venetoclax|mesh-list
153947930|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153947931|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
153947932|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947933|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947934|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153947935|NCT05296603|Lenvatinib|lenvatinib|mesh-list
153947946|NCT05296278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947947|NCT05296278|Growth Inhibitors|growth inhibitors|mesh-ancestor
153947948|NCT05287568|Venetoclax|venetoclax|mesh-list
153947949|NCT05287568|Cc-486|cc-486|mesh-list
153947950|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947951|NCT05285228|Fluorides|fluorides|mesh-list
153947952|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
153947953|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
153947954|NCT05285228|Protective Agents|protective agents|mesh-ancestor
153947955|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947956|NCT05273320|Dronabinol|dronabinol|mesh-list
153947957|NCT05273320|Nabilone|nabilone|mesh-list
153947958|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
153947959|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
153947960|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153947961|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947962|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153947963|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153947964|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153947965|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947966|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153947967|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
153947968|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153947969|NCT05273320|Analgesics|analgesics|mesh-ancestor
153947970|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
153947971|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153947972|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153947973|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153947974|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947975|NCT05273320|Hormones|hormones|mesh-ancestor
153947976|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153947977|NCT05256225|Paclitaxel|paclitaxel|mesh-list
153947978|NCT05256225|Carboplatin|carboplatin|mesh-list
153947979|NCT05256225|Trastuzumab|trastuzumab|mesh-list
153947980|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153947988|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947989|NCT05245474|Tislelizumab|tislelizumab|mesh-list
153947990|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153947991|NCT05245474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153947992|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153947993|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153947994|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
153947995|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153947996|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153947997|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153947998|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153947999|NCT05233605|Analgesics|analgesics|mesh-ancestor
153948050|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948051|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
153948052|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
153948053|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948054|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948055|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153948056|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
153948058|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948059|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948060|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948061|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
153948062|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153948063|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153948064|NCT05090566|Growth Substances|growth substances|mesh-ancestor
153948065|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
153948066|NCT05090566|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153948067|NCT05090566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948068|NCT05090566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948075|NCT05024773|Paclitaxel|paclitaxel|mesh-list
153948076|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
153948077|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948078|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948079|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948080|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948081|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948082|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948083|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153948084|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
153948085|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948091|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948092|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948093|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948094|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948095|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
153948096|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948097|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
153948098|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948099|NCT05020665|Cytarabine|cytarabine|mesh-list
153948100|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948101|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
153948160|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948161|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948162|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
153948163|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153948164|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153948165|NCT04700176|Growth Substances|growth substances|mesh-ancestor
153948166|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
153948167|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
153948168|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
153948175|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948176|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948177|NCT04585490|Paclitaxel|paclitaxel|mesh-list
153948178|NCT04585490|Cisplatin|cisplatin|mesh-list
153948179|NCT04585490|Carboplatin|carboplatin|mesh-list
153948180|NCT04585490|Pemetrexed|pemetrexed|mesh-list
153948181|NCT04585490|Durvalumab|durvalumab|mesh-list
153948182|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153948183|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948184|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948185|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948186|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948187|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948188|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948189|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948190|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153948191|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153948192|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948193|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
153948194|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948195|NCT04575181|Insulin|insulin|mesh-list
153948196|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153948197|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
153948198|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153948207|NCT04508725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153948208|NCT04508725|Mitogens|mitogens|mesh-list
153948209|NCT04508725|Endothelial Growth Factors|endothelial growth factors|mesh-list
153948210|NCT04508725|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153948211|NCT04508725|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948212|NCT04508725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948213|NCT04508725|Growth Substances|growth substances|mesh-ancestor
153948214|NCT04508725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948215|NCT04508725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948216|NCT04508725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948217|NCT04508725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948218|NCT04508725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948220|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153948221|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948222|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
153948223|NCT04469842|Prednisone|prednisone|mesh-list
153948224|NCT04469842|Azathioprine|azathioprine|mesh-list
153948225|NCT04469842|Tacrolimus|tacrolimus|mesh-list
153948226|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948227|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
153948228|NCT04469842|Hormones|hormones|mesh-ancestor
153948229|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948230|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948231|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948232|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948233|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948256|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948257|NCT04341571|Metformin|metformin|mesh-list
153948258|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153948259|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948260|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
153948261|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153948262|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153948263|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948264|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
153948265|NCT04272606|Coagulants|coagulants|mesh-ancestor
153948266|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
153948267|NCT04209660|Lenvatinib|lenvatinib|mesh-list
153948268|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948269|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948270|NCT04209660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948271|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948272|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948273|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948274|NCT04190550|Cytarabine|cytarabine|mesh-list
153948275|NCT04190550|Idarubicin|idarubicin|mesh-list
153948276|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948277|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
153948278|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948279|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948280|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
153948281|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153948282|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948283|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
153948284|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948285|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153948286|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153948298|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153948299|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948300|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948302|NCT04109456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948303|NCT04109456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948304|NCT04109456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948305|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948306|NCT04108468|Golimumab|golimumab|mesh-list
153948307|NCT04108468|Methotrexate|methotrexate|mesh-list
153948308|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153948309|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
153948310|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153948311|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948313|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
153948358|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153948359|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948360|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948361|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948362|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948363|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948364|NCT03958877|Interferons|interferons|mesh-list
153948365|NCT03958877|Interferon-beta|interferon-beta|mesh-list
153948366|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948424|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948425|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948426|NCT03713593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948427|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948428|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948429|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948431|NCT03685188|Oxycodone|oxycodone|mesh-list
153948432|NCT03685188|Dsuvia|dsuvia|mesh-list
153948433|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153948434|NCT03685188|Narcotics|narcotics|mesh-ancestor
153948435|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153948436|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948437|NCT03685188|Analgesics|analgesics|mesh-ancestor
153706046|NCT00088491|Olanzapine|olanzapine|mesh-list
153948438|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
153948439|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948440|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153948441|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153948442|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
153948443|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
153948444|NCT03668041|Eszopiclone|eszopiclone|mesh-list
153948446|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153948447|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153948448|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948475|NCT03610490|Interleukin-2|interleukin-2|mesh-list
153948476|NCT03610490|Mitogens|mitogens|mesh-list
153948477|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948478|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
153948479|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948480|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948481|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153948482|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
153948483|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948484|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948485|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153948486|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153948487|NCT03610490|Analgesics|analgesics|mesh-ancestor
153948488|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
153948489|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948490|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948491|NCT03590652|Dexamethasone|dexamethasone|mesh-list
153948492|NCT03590652|Daratumumab|daratumumab|mesh-list
153948493|NCT03590652|Pomalidomide|pomalidomide|mesh-list
153948494|NCT03590652|Ixazomib|ixazomib|mesh-list
153948495|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948496|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
153948497|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
153948498|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153948499|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948500|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153948501|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
153948502|NCT03590652|Hormones|hormones|mesh-ancestor
153948503|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948504|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948505|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948506|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
153948507|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153948508|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153948509|NCT03590652|Growth Substances|growth substances|mesh-ancestor
153948510|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
153948515|NCT03587662|Doxorubicin|doxorubicin|mesh-list
153948516|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153948517|NCT03587662|Daunorubicin|daunorubicin|mesh-list
153948518|NCT03587662|Ixazomib|ixazomib|mesh-list
153948519|NCT03587662|Glycine|glycine|mesh-list
153948520|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948521|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
153948522|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948523|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948524|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153948525|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153948526|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153948527|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948528|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
153948532|NCT03535259|Sorafenib|sorafenib|mesh-list
153948575|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
153948576|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
153948577|NCT03175432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948578|NCT03175432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948580|NCT03158129|Carboplatin|carboplatin|mesh-list
153948581|NCT03158129|Docetaxel|docetaxel|mesh-list
153948582|NCT03158129|Nivolumab|nivolumab|mesh-list
153948583|NCT03158129|Pemetrexed|pemetrexed|mesh-list
153948584|NCT03158129|Ipilimumab|ipilimumab|mesh-list
153948585|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948586|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
153948587|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
153948588|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
153948589|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948590|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948591|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948592|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948593|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153948594|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153948595|NCT03138499|Nivolumab|nivolumab|mesh-list
153948596|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153948597|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948598|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948599|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948601|NCT03138499|Immunotoxins|immunotoxins|mesh-ancestor
153948623|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948624|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948625|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153948626|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153948627|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
153948628|NCT02985957|Prednisone|prednisone|mesh-list
153948629|NCT02985957|Nivolumab|nivolumab|mesh-list
153948630|NCT02985957|Ipilimumab|ipilimumab|mesh-list
153948631|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948632|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
153948633|NCT02985957|Hormones|hormones|mesh-ancestor
153948634|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948635|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948636|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948637|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948638|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948639|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948640|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948641|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
153948642|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948643|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948644|NCT02955758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948645|NCT02955758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948646|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
153948647|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153948648|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948669|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153948671|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948672|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948673|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948674|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948675|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
153948676|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153948677|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153948735|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948736|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948737|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153948738|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153948739|NCT02568553|Growth Substances|growth substances|mesh-ancestor
153948740|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
153948741|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948742|NCT02567409|Cisplatin|cisplatin|mesh-list
153948743|NCT02567409|Gemcitabine|gemcitabine|mesh-list
153948744|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948745|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153948800|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153948801|NCT02375555|Growth Substances|growth substances|mesh-ancestor
153948802|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
153948803|NCT02330952|Prednisone|prednisone|mesh-list
153948804|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948805|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
153948807|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948808|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948809|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153948810|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948811|NCT02299999|Vincristine|vincristine|mesh-list
153948812|NCT02299999|Vinorelbine|vinorelbine|mesh-list
153948813|NCT02299999|Vinblastine|vinblastine|mesh-list
153948814|NCT02299999|Docetaxel|docetaxel|mesh-list
153948815|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
153706389|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948816|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
153948817|NCT02299999|Bevacizumab|bevacizumab|mesh-list
153948819|NCT02299999|Carboplatin|carboplatin|mesh-list
153948820|NCT02299999|Gemcitabine|gemcitabine|mesh-list
153948821|NCT02299999|Doxorubicin|doxorubicin|mesh-list
153948822|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153948823|NCT02299999|Capecitabine|capecitabine|mesh-list
153948824|NCT02299999|Methotrexate|methotrexate|mesh-list
153948858|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153948860|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153948861|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153948862|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153948863|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
153948864|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
153948865|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153948866|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
153948867|NCT02251548|Rituximab|rituximab|mesh-list
153948868|NCT02251548|Fludarabine|fludarabine|mesh-list
153948869|NCT02251548|Ibrutinib|ibrutinib|mesh-list
153948870|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153948871|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
153948872|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948915|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153948916|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
153948917|NCT02112526|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153948918|NCT02112526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153948919|NCT02112526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153948920|NCT02112526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948921|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948922|NCT02106988|Dexamethasone|dexamethasone|mesh-list
153948923|NCT02106988|Carboplatin|carboplatin|mesh-list
153948924|NCT02106988|Etoposide|etoposide|mesh-list
153948925|NCT02106988|Ifosfamide|ifosfamide|mesh-list
153948926|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
153948927|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153948928|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
153948976|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153948977|NCT02101788|Protective Agents|protective agents|mesh-ancestor
153948978|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153948981|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153948983|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
153948984|NCT01950390|Antibodies|antibodies|mesh-list
153948985|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
153948986|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153948987|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
153948988|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153948989|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153948990|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153948991|NCT01950390|Growth Substances|growth substances|mesh-ancestor
153948992|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948993|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
153948994|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
153948995|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153948996|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153948997|NCT01928394|Nivolumab|nivolumab|mesh-list
153948998|NCT01928394|Ipilimumab|ipilimumab|mesh-list
153948999|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949000|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949003|NCT01864018|Dexamethasone|dexamethasone|mesh-list
153949030|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
153949031|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
153949032|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949033|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
153949034|NCT01850108|Sirolimus|sirolimus|mesh-list
153949035|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
153949036|NCT01850108|Fludarabine|fludarabine|mesh-list
153949037|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
153949038|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949039|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
153949040|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949041|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949042|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153949043|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
153949044|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949092|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949093|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949094|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153949096|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949097|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949098|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153949099|NCT01444469|Azithromycin|azithromycin|mesh-list
153949100|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153949101|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949102|NCT01371981|Cytarabine|cytarabine|mesh-list
153949103|NCT01371981|Etoposide|etoposide|mesh-list
153949104|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
153949105|NCT01371981|Daunorubicin|daunorubicin|mesh-list
153949106|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
153949107|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
153949108|NCT01371981|Bortezomib|bortezomib|mesh-list
153949154|NCT01272037|Tamoxifen|tamoxifen|mesh-list
153949155|NCT01272037|Letrozole|letrozole|mesh-list
153949156|NCT01272037|Anastrozole|anastrozole|mesh-list
153949157|NCT01272037|Exemestane|exemestane|mesh-list
153949158|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949159|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949160|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153949161|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153949162|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949163|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153949164|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
153949165|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949166|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949167|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153949168|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153949169|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153949170|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153949208|NCT00980460|Sirolimus|sirolimus|mesh-list
153949209|NCT00980460|Cisplatin|cisplatin|mesh-list
153949210|NCT00980460|Doxorubicin|doxorubicin|mesh-list
153949211|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153949212|NCT00980460|Fluorouracil|fluorouracil|mesh-list
153949213|NCT00980460|Irinotecan|irinotecan|mesh-list
153949214|NCT00980460|Vincristine|vincristine|mesh-list
153949215|NCT00980460|Temsirolimus|temsirolimus|mesh-list
153949216|NCT00980460|Camptothecin|camptothecin|mesh-list
153949217|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
153949218|NCT00980460|Razoxane|razoxane|mesh-list
153949219|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
153949220|NCT00980460|MTOR Inhibitors|mtor inhibitors|mesh-list
153949221|NCT00980460|Liver Extracts|liver extracts|mesh-list
153949222|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949223|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153949224|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153949225|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153949226|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949227|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949228|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
153949229|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153949230|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949231|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
153949232|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949233|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153949234|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949235|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949236|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949237|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949238|NCT00980460|Hematinics|hematinics|mesh-ancestor
153949239|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153949240|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949241|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
153949242|NCT00980460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153949243|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153949244|NCT00980460|Protective Agents|protective agents|mesh-ancestor
153949245|NCT00977574|Sirolimus|sirolimus|mesh-list
153949246|NCT00977574|Paclitaxel|paclitaxel|mesh-list
153949249|NCT00977574|Bevacizumab|bevacizumab|mesh-list
153949250|NCT00977574|Carboplatin|carboplatin|mesh-list
153949251|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153949252|NCT00977574|Temsirolimus|temsirolimus|mesh-list
153949253|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153949254|NCT00977574|MTOR Inhibitors|mtor inhibitors|mesh-list
153949255|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
153949256|NCT00977574|Antibodies|antibodies|mesh-list
153949257|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
153949258|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153949259|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
153949260|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949261|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949262|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949263|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949264|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949265|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949266|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949267|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949268|NCT00977574|Growth Substances|growth substances|mesh-ancestor
153949269|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949306|NCT00972478|Hormones|hormones|mesh-ancestor
153949307|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949308|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153949309|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949310|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949311|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949312|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949313|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153949314|NCT00843882|Lenalidomide|lenalidomide|mesh-list
153949315|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
153949316|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
153949317|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949318|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949319|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949320|NCT00843882|Growth Substances|growth substances|mesh-ancestor
153949365|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949366|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949367|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
153949368|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949369|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949370|NCT00644228|Growth Substances|growth substances|mesh-ancestor
153949371|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949372|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
153949373|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
153949374|NCT00470223|Doxorubicin|doxorubicin|mesh-list
153949429|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153949431|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
153949432|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949433|NCT00976716|Celecoxib|celecoxib|mesh-list
153949434|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153949435|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153949436|NCT00976716|Analgesics|analgesics|mesh-ancestor
153949437|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
153949438|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949439|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949440|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949441|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153949442|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153949443|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153949444|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949445|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949446|NCT00973674|Estrogens|estrogens|mesh-list
153949447|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153949448|NCT00973674|Hormones|hormones|mesh-ancestor
153949449|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949481|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949482|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949483|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949484|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
153949485|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949486|NCT03762564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949487|NCT03762564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949488|NCT03762564|Growth Substances|growth substances|mesh-ancestor
153949489|NCT03762564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949490|NCT03762564|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949491|NCT00629616|Fulvestrant|fulvestrant|mesh-list
153949492|NCT00629616|Anastrozole|anastrozole|mesh-list
153949543|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
153949544|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949545|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949546|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949548|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153949549|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
153949550|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949551|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153949552|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949553|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949554|NCT02882126|Treprostinil|treprostinil|mesh-list
153949555|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153949556|NCT01145222|Midazolam|midazolam|mesh-list
153949557|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153949558|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153949559|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153949561|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153949599|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949600|NCT02864472|Ranibizumab|ranibizumab|mesh-list
153949601|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153949602|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153949603|NCT02864472|Growth Substances|growth substances|mesh-ancestor
153949604|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949605|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
153949606|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949607|NCT00975000|Cinacalcet|cinacalcet|mesh-list
153949608|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153949609|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949610|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153949611|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
153949613|NCT02863614|Ibuprofen|ibuprofen|mesh-list
153949661|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153949662|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153949663|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153949664|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949665|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949666|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949667|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
153949668|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153949669|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153949670|NCT00969150|Analgesics|analgesics|mesh-ancestor
153949671|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
153949673|NCT00974220|Fentanyl|fentanyl|mesh-list
153949723|NCT05780515|Immunologic Factors|immunologic factors|mesh-ancestor
153949724|NCT05780515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949725|NCT05780320|Amiodarone|amiodarone|mesh-list
153949726|NCT05780320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153949727|NCT05780320|Vasodilator Agents|vasodilator agents|mesh-ancestor
153949728|NCT05780320|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153949729|NCT05780320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153949730|NCT05780320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949731|NCT05780320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153949732|NCT05780320|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153949733|NCT05780320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153949734|NCT05780320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949735|NCT05780320|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153949736|NCT05780320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153949737|NCT05780320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153949738|NCT05780294|Asparaginase|asparaginase|mesh-list
153949739|NCT05780294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949740|NCT05780229|Analgesics|analgesics|mesh-list
153949741|NCT05780229|Sensory System Agents|sensory system agents|mesh-ancestor
153949742|NCT05780229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949743|NCT05780229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949744|NCT05780086|Icodextrin|icodextrin|mesh-list
153949745|NCT05780086|Dialysis Solutions|dialysis solutions|mesh-ancestor
153949746|NCT05780086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153949747|NCT05779514|Mirabegron|mirabegron|mesh-list
153949748|NCT05779514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153949749|NCT05779514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153949750|NCT05779514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153949751|NCT05779514|Adrenergic Agents|adrenergic agents|mesh-ancestor
153949752|NCT05779514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949753|NCT05779514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949754|NCT05779514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949755|NCT05779514|Urological Agents|urological agents|mesh-ancestor
153949756|NCT05779410|Vitamin D|vitamin d|mesh-list
153949757|NCT05779410|Ergocalciferols|ergocalciferols|mesh-list
153949761|NCT05779410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949762|NCT05779410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153949763|NCT05779410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153949764|NCT05779254|Metronidazole|metronidazole|mesh-list
153949765|NCT05779254|Neomycin|neomycin|mesh-list
153949766|NCT05779254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153949767|NCT05779254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153949768|NCT05779254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153949769|NCT05779254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153949770|NCT05779254|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153949771|NCT05779254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949772|NCT05779254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949773|NCT05779059|Ticagrelor|ticagrelor|mesh-list
153949774|NCT05779059|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153949775|NCT05779059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153949776|NCT05779059|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153949777|NCT05779059|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153949778|NCT05779059|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153949779|NCT05779059|Purinergic Agents|purinergic agents|mesh-ancestor
153949814|NCT05712265|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153949815|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153949816|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153949817|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153949818|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153949819|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153949820|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153949821|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
153949822|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949823|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153949824|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153949825|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949827|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949828|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
153949829|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
153949832|NCT05614609|Lidocaine|lidocaine|mesh-list
153949877|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153949878|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153949879|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
153949880|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949881|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153949882|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153949883|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153949884|NCT05409157|Bisacodyl|bisacodyl|mesh-list
153949885|NCT05409157|Cathartics|cathartics|mesh-ancestor
153949886|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153949887|NCT05409157|Laxatives|laxatives|mesh-ancestor
153949888|NCT05407519|Tislelizumab|tislelizumab|mesh-list
153949889|NCT05407519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153949890|NCT05407519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153949891|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
153949892|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
153949893|NCT05355311|Vitamins|vitamins|mesh-ancestor
153949894|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
153949895|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949896|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
153949897|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
153949898|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153949899|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153949931|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949932|NCT05241262|Protective Agents|protective agents|mesh-ancestor
153949933|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949934|NCT05241262|Antidotes|antidotes|mesh-ancestor
153949935|NCT05161936|Lumasiran|lumasiran|mesh-list
153949936|NCT05161936|Renal Agents|renal agents|mesh-ancestor
153949945|NCT05108649|Nicotine|nicotine|mesh-list
153949946|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153949947|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
153949948|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949949|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949950|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153949951|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153949952|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
153949953|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153949954|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949956|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
153949957|NCT05003713|Prednisone|prednisone|mesh-list
153949958|NCT05003713|Cortisone|cortisone|mesh-list
153949959|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153949960|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
153949961|NCT05003713|Hormones|hormones|mesh-ancestor
153949962|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153949963|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949992|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153949993|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153949994|NCT04903054|Protective Agents|protective agents|mesh-ancestor
153949995|NCT04873245|Semaglutide|semaglutide|mesh-list
153949996|NCT04873245|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153949997|NCT04873245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153949998|NCT04873245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949999|NCT04834557|Digoxin|digoxin|mesh-list
153950000|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153950058|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153950059|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950060|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153950061|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153950062|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153950063|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950064|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950065|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950066|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153950067|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153950068|NCT04425473|Esketamine|esketamine|mesh-list
153950069|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
153950070|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950071|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153950072|NCT04387071|Antibodies|antibodies|mesh-list
153950073|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
153950074|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153950075|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
153950076|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950077|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950078|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
153950079|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153950080|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
153950081|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950082|NCT04300920|Expectorants|expectorants|mesh-ancestor
153950083|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
153950084|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153950085|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
153950086|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950087|NCT04300920|Protective Agents|protective agents|mesh-ancestor
153950088|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950089|NCT04300920|Antidotes|antidotes|mesh-ancestor
153950090|NCT04252768|Paclitaxel|paclitaxel|mesh-list
153950091|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153950092|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950093|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
153950096|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950098|NCT04084171|Pancrelipase|pancrelipase|mesh-list
153950099|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153950100|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950101|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950102|NCT04047706|Nivolumab|nivolumab|mesh-list
153950103|NCT04047706|Temozolomide|temozolomide|mesh-list
153950104|NCT04047706|Linrodostat|linrodostat|mesh-list
153950105|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153950106|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950107|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153950108|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950109|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153950110|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
153950111|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950112|NCT03967249|Octreotide|octreotide|mesh-list
153950113|NCT03967249|Lanreotide|lanreotide|mesh-list
153950114|NCT03967249|Somatostatin|somatostatin|mesh-list
153950115|NCT03967249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950116|NCT03967249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153950117|NCT03967249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950118|NCT03967249|Hormones|hormones|mesh-ancestor
153950119|NCT03967249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153950120|NCT03967249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950121|NCT03935139|Glycerol|glycerol|mesh-list
153950122|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153950123|NCT03935139|Protective Agents|protective agents|mesh-ancestor
153950124|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950125|NCT03926403|Anesthetics|anesthetics|mesh-list
153950126|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950127|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950128|NCT03871621|Metformin|metformin|mesh-list
153950129|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
153950130|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153950131|NCT03871621|Meglitinide|meglitinide|mesh-list
153950132|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153950135|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950136|NCT03867188|Bupivacaine|bupivacaine|mesh-list
153950137|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
153950138|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
153950139|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950140|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950141|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
153950142|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950143|NCT03745040|Bupivacaine|bupivacaine|mesh-list
153950144|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
153950145|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
153950146|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950147|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950148|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
153950154|NCT03657810|Oxycodone|oxycodone|mesh-list
153950194|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153950195|NCT03533010|Vitamin D|vitamin d|mesh-list
153950196|NCT03533010|Vitamins|vitamins|mesh-ancestor
153950197|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
153950198|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950199|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153950200|NCT03236987|Azithromycin|azithromycin|mesh-list
153950201|NCT03236987|Clarithromycin|clarithromycin|mesh-list
153950202|NCT03236987|Rifampin|rifampin|mesh-list
153950203|NCT03236987|Ethambutol|ethambutol|mesh-list
153950204|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153950205|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950206|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153950207|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950208|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950209|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153950210|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153950211|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153950212|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
153950213|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
153950249|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153950250|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
153950251|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950252|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950253|NCT02789982|Propranolol|propranolol|mesh-list
153950254|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
153950255|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
153950256|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153950257|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950258|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950259|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950260|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153950261|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153950262|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
153950263|NCT02667886|Axitinib|axitinib|mesh-list
153950264|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950265|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153950266|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950267|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950268|NCT02587195|Teriflunomide|teriflunomide|mesh-list
153950302|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153950303|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950305|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153950306|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950307|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950308|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
153950309|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950310|NCT01993836|Anesthetics|anesthetics|mesh-list
153950311|NCT01993836|Propofol|propofol|mesh-list
153950312|NCT01993836|Isoflurane|isoflurane|mesh-list
153950313|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153950314|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950315|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153950316|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153950317|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
153729834|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729835|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729836|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
153729837|NCT00140010|Hematinics|hematinics|mesh-ancestor
153729838|NCT00131495|Testosterone|testosterone|mesh-list
153729839|NCT00131495|Androgens|androgens|mesh-ancestor
153729840|NCT00131495|Hormones|hormones|mesh-ancestor
153729841|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153707952|NCT05997524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153707967|NCT05997355|Gabapentin|gabapentin|mesh-list
153950414|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153950415|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950416|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950417|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950418|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950419|NCT01118780|Analgesics|analgesics|mesh-ancestor
153950420|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
153950421|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950422|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
153950423|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950474|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153950475|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950477|NCT04283292|Capsaicin|capsaicin|mesh-list
153950478|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
153950479|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
153950480|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
153950481|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153950482|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950483|NCT01144052|Interferons|interferons|mesh-list
153950484|NCT01144052|Interferon-beta|interferon-beta|mesh-list
153950485|NCT01144052|Natalizumab|natalizumab|mesh-list
153950486|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
153950487|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950488|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
153950489|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950490|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
153950491|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950492|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153950493|NCT04283526|Decitabine|decitabine|mesh-list
153950494|NCT04283526|Spartalizumab|spartalizumab|mesh-list
153950495|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153950496|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
153950497|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950498|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950499|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950500|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153950501|NCT04283526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153950502|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
153950503|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950519|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153950520|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
153950521|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153950522|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153950523|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950524|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
153950525|NCT04312880|Coagulants|coagulants|mesh-ancestor
153950526|NCT01117454|Flecainide|flecainide|mesh-list
153950527|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153950528|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153950529|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
153708108|NCT05990985|Prednisolone|prednisolone|mesh-list
153950530|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153950531|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950532|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950533|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153950534|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153950535|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153950536|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950538|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950539|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153950540|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153950541|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950542|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950543|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153950544|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
153950545|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153950546|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950548|NCT01128842|Neratinib|neratinib|mesh-list
153950564|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950565|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
153950566|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153950567|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153950568|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153950569|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153950570|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950571|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
153950629|NCT01142726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153950630|NCT04472637|Atorvastatin|atorvastatin|mesh-list
153950631|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153950632|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153950633|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
153950634|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950635|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153950636|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153950637|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950638|NCT01142336|Simvastatin|simvastatin|mesh-list
153950639|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153950640|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153950641|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
153950642|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950688|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950689|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950690|NCT01141478|Sorafenib|sorafenib|mesh-list
153950691|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950692|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153950693|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950694|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950695|NCT01114880|Adalimumab|adalimumab|mesh-list
153950696|NCT01114880|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153950697|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153950698|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153950699|NCT00625352|Gemcitabine|gemcitabine|mesh-list
153950700|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153950701|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
153950702|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950747|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153950748|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153950749|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153950750|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708345|NCT05741866|Chlorhexidine|chlorhexidine|mesh-list
153950751|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950752|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153950753|NCT03432897|Olaparib|olaparib|mesh-list
153950754|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153950755|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950756|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950758|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
153950808|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950809|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153950810|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153950811|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
153950812|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
153950813|NCT00662896|Ibuprofen|ibuprofen|mesh-list
153950814|NCT00662896|Naproxen|naproxen|mesh-list
153950815|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
153950816|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153950817|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153950818|NCT00662896|Analgesics|analgesics|mesh-ancestor
153950873|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
153950874|NCT00666484|Hormones|hormones|mesh-ancestor
153950875|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153950876|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153950877|NCT00663130|Tadalafil|tadalafil|mesh-list
153950878|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153950879|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
153950880|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153950881|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153950882|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153950883|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950884|NCT00663130|Urological Agents|urological agents|mesh-ancestor
153950885|NCT00965562|Fluoxetine|fluoxetine|mesh-list
153950886|NCT00965562|Calcium|calcium|mesh-list
153950932|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950933|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153950934|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153950935|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
153950936|NCT03500484|Liraglutide|liraglutide|mesh-list
153950937|NCT03500484|Glucagon|glucagon|mesh-list
153950938|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153950939|NCT03500484|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153950940|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153950941|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153950942|NCT03500484|Incretins|incretins|mesh-ancestor
153950943|NCT03500484|Hormones|hormones|mesh-ancestor
153950944|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153950945|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153950946|NCT02631460|Carboplatin|carboplatin|mesh-list
153708542|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153950992|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
153950993|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153950994|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
153950995|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153950996|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153950997|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153950998|NCT04158388|Tryptophan|tryptophan|mesh-list
153950999|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153951000|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
153951001|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153951002|NCT04283136|Padsevonil|padsevonil|mesh-list
153951003|NCT04283136|Anticonvulsants|anticonvulsants|mesh-ancestor
153951004|NCT04283058|Ketamine|ketamine|mesh-list
153951053|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153951054|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153951055|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951056|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153951057|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
153951058|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153951059|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
153951060|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951061|NCT00960570|Efavirenz|efavirenz|mesh-list
153951062|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
153951063|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153951064|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153951065|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951066|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951067|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
153951068|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951076|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153951107|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951109|NCT03773445|Antibodies|antibodies|mesh-list
153951110|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153951111|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
153951112|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951113|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153951114|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951115|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153951116|NCT00630084|Interferons|interferons|mesh-list
153951117|NCT00630084|Ribavirin|ribavirin|mesh-list
153951118|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
153951119|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
153951120|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153951121|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951122|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
153951124|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
153951169|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153951170|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951171|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153951172|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951173|NCT04313036|Defibrotide|defibrotide|mesh-list
153951174|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153951175|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153951176|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951177|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153951178|NCT00879658|Siponimod|siponimod|mesh-list
153951179|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153951180|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951227|NCT02860650|Antiviral Agents|antiviral agents|mesh-ancestor
153951228|NCT02860650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951229|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153951230|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
153951231|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153951232|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153951233|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951234|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951235|NCT00667966|Urological Agents|urological agents|mesh-ancestor
153951236|NCT00911937|Fesoterodine|fesoterodine|mesh-list
153951237|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153951238|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153951239|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
153951240|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951241|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951242|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951243|NCT00911937|Urological Agents|urological agents|mesh-ancestor
153951244|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153951245|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
153951281|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153951282|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153951283|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951284|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951285|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951286|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153951287|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153951288|NCT02860494|Everolimus|everolimus|mesh-list
153951289|NCT02860494|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153951290|NCT02860494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153951291|NCT02860494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951343|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
153951345|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951346|NCT01072877|Polidocanol|polidocanol|mesh-list
153951347|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153951348|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153951349|NCT00630474|Xylometazoline|xylometazoline|mesh-list
153951350|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
153951351|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153951352|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
153951353|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
153951354|NCT00957528|Testosterone|testosterone|mesh-list
153951355|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
153951356|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
153951409|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153951410|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153951411|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153951412|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951413|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153951414|NCT05143164|Gentamicins|gentamicins|mesh-list
153951415|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153951416|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729844|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153951417|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153951418|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951420|NCT00664144|Rasburicase|rasburicase|mesh-list
153951421|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
153951422|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951424|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153951425|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153951426|NCT02819856|Analgesics|analgesics|mesh-ancestor
153951427|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
153951428|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951429|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951430|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951431|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951432|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153951433|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153951459|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951460|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153951461|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153951462|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951463|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
153951464|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153951465|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153951466|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153951467|NCT00664222|Furosemide|furosemide|mesh-list
153951468|NCT00664222|Spironolactone|spironolactone|mesh-list
153951469|NCT00664222|Diuretics|diuretics|mesh-ancestor
153951470|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
153951522|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153951523|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951524|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951525|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
153951526|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153951527|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951528|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951529|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153951530|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153951531|NCT00660868|Protective Agents|protective agents|mesh-ancestor
153951532|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951533|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
153951534|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153951535|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
153951536|NCT00664690|Celecoxib|celecoxib|mesh-list
153951537|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153951538|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153951539|NCT00664690|Analgesics|analgesics|mesh-ancestor
153951540|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
153951541|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951542|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951543|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951544|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951545|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153951546|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153951547|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951548|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951566|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153951567|NCT00664846|Aspirin|aspirin|mesh-list
153951568|NCT00664846|Clopidogrel|clopidogrel|mesh-list
153951569|NCT00664846|Atorvastatin|atorvastatin|mesh-list
153951570|NCT00664846|Simvastatin|simvastatin|mesh-list
153951571|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153951572|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153951573|NCT00664846|Analgesics|analgesics|mesh-ancestor
153951574|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
153951612|NCT00669370|Docetaxel|docetaxel|mesh-list
153951633|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153951634|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951636|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153951637|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
153951638|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153951639|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951640|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951641|NCT00910689|Propranolol|propranolol|mesh-list
153951642|NCT00910689|Nadolol|nadolol|mesh-list
153951643|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153951644|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153951645|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
153951655|NCT04669717|Amoxicillin|amoxicillin|mesh-list
153951697|NCT00811135|Trastuzumab|trastuzumab|mesh-list
153951698|NCT00811135|Capecitabine|capecitabine|mesh-list
153951699|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153951700|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951701|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153951702|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153951703|NCT00811135|Growth Substances|growth substances|mesh-ancestor
153951707|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
153951763|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153951764|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
153951765|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
153951766|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
153951767|NCT00910299|Clopidogrel|clopidogrel|mesh-list
153951768|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153951769|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153951770|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153951771|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153951772|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153951773|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
153951825|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153951826|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
153951827|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
153951828|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951829|NCT00676156|Protective Agents|protective agents|mesh-ancestor
153951830|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951831|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
153951832|NCT00676156|Vitamins|vitamins|mesh-ancestor
153951833|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
153951834|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
153951835|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951836|NCT00914017|Atorvastatin|atorvastatin|mesh-list
153951837|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153951838|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153951839|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
153951840|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951841|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153951842|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153951844|NCT00671320|Diclofenac|diclofenac|mesh-list
153951881|NCT00676702|Vitamins|vitamins|mesh-ancestor
153951882|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
153951883|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951884|NCT05753371|Metformin|metformin|mesh-list
153951885|NCT05753371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153501068|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
153951886|NCT05753371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951887|NCT00671476|Doxorubicin|doxorubicin|mesh-list
153951888|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153951889|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153951890|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951891|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153951892|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153951893|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951894|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153951895|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
153951898|NCT00908583|Prednisolone|prednisolone|mesh-list
153951940|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
153951941|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153951942|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
153951943|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153951946|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951947|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951948|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153951949|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
153951950|NCT00676936|Hormones|hormones|mesh-ancestor
153951951|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153951952|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153951953|NCT00676936|Protective Agents|protective agents|mesh-ancestor
153951954|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153951955|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153951956|NCT02629744|Etrolizumab|etrolizumab|mesh-list
153951957|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153951958|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
153951959|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951960|NCT00677170|Pevonedistat|pevonedistat|mesh-list
153951961|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153951963|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
153951992|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153951993|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951994|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
153951995|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153951996|NCT00677248|Ezetimibe|ezetimibe|mesh-list
153951997|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153951998|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153951999|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
153952000|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952001|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153952002|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153952003|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153952004|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952005|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
153952006|NCT00911716|Bevacizumab|bevacizumab|mesh-list
153952007|NCT00911716|Docetaxel|docetaxel|mesh-list
153952051|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153952052|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952054|NCT00680602|Fluoxetine|fluoxetine|mesh-list
153952055|NCT00680602|Paroxetine|paroxetine|mesh-list
153952056|NCT00680602|Citalopram|citalopram|mesh-list
153952057|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
153952058|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153952059|NCT00680602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153952060|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153952061|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952062|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952063|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952064|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
153952065|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952085|NCT00680758|Paclitaxel|paclitaxel|mesh-list
153952109|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952110|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952111|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
153952112|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952113|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153952114|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952115|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
153952116|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952117|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153952119|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
153952120|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153952121|NCT00877006|Rituximab|rituximab|mesh-list
153952122|NCT00877006|Doxorubicin|doxorubicin|mesh-list
153952123|NCT00877006|Vincristine|vincristine|mesh-list
153952124|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952125|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
153952126|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952127|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952128|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153952129|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
153952130|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952162|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153952163|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153952164|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153952165|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153952166|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
153952167|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952168|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952169|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952170|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
153952171|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
153952172|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952173|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153952174|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153952175|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153952176|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
153952177|NCT00807937|Lorazepam|lorazepam|mesh-list
153952218|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952219|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952220|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
153952221|NCT02627248|Docetaxel|docetaxel|mesh-list
153952222|NCT02627248|Epirubicin|epirubicin|mesh-list
153952223|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952224|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
153952225|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952226|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952227|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153952228|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
153952230|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952284|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153952285|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952286|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153952287|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153952288|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
153952289|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952290|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952291|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153952292|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
153952294|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153952348|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952349|NCT02606773|Vitamins|vitamins|mesh-ancestor
153952350|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
153952351|NCT04310774|Tegafur|tegafur|mesh-list
153952352|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153952353|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
153952354|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952355|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952356|NCT01139450|Tacrolimus|tacrolimus|mesh-list
153952357|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952358|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
153952359|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952360|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153952361|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952362|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952363|NCT00805207|Estradiol|estradiol|mesh-list
153952364|NCT00805207|Estrogens|estrogens|mesh-list
153952365|NCT00805207|Testosterone|testosterone|mesh-list
153952366|NCT00805207|Progesterone|progesterone|mesh-list
153952367|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
153952368|NCT00805207|Hormones|hormones|mesh-ancestor
153952369|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952373|NCT00805675|Tenofovir|tenofovir|mesh-list
153952403|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
153952404|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952405|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952406|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153952407|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153952408|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153952409|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
153952410|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952411|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952412|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
153952462|NCT05745337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952463|NCT05745337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153952464|NCT05745337|Vasodilator Agents|vasodilator agents|mesh-ancestor
153952465|NCT00952380|Dalteparin|dalteparin|mesh-list
153952466|NCT00952380|Tinzaparin|tinzaparin|mesh-list
153952467|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153952469|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153952470|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153952471|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952472|NCT02856750|Gabapentin|gabapentin|mesh-list
153952473|NCT02856750|Analgesics|analgesics|mesh-ancestor
153952474|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
153952475|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952476|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952477|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
153952478|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153952479|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153952480|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952481|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153952482|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153952515|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952516|NCT03635437|Alprazolam|alprazolam|mesh-list
153952517|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
153952518|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153952519|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952520|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952521|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153952522|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153952523|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153952524|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
153952525|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
153952526|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952527|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952528|NCT00803179|Hormones|hormones|mesh-list
153952531|NCT00804193|Ciclopirox|ciclopirox|mesh-list
153952578|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153952579|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153952580|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952581|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952582|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153952583|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
153952584|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952585|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952586|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153952587|NCT05660473|Cytarabine|cytarabine|mesh-list
153952588|NCT05660473|Dexamethasone|dexamethasone|mesh-list
153952589|NCT05660473|Prednisone|prednisone|mesh-list
153952590|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
153952591|NCT05660473|Methotrexate|methotrexate|mesh-list
153952592|NCT05660473|Vincristine|vincristine|mesh-list
153952593|NCT05660473|Daunorubicin|daunorubicin|mesh-list
153952594|NCT05660473|Venetoclax|venetoclax|mesh-list
153952595|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
153952596|NCT05660473|Pegaspargase|pegaspargase|mesh-list
153952597|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952598|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
153501085|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
153952599|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952600|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153952601|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153952602|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
153952603|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952604|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952605|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153952612|NCT05660473|Hormones|hormones|mesh-ancestor
153952623|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153952624|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
153952625|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952626|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153952627|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
153952628|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952629|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952630|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153952631|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153952632|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153952633|NCT00803101|Protein C|protein c|mesh-list
153952634|NCT00803101|Protein S|protein s|mesh-list
153952635|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
153952636|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153952637|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153952639|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153952683|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153952684|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
153952685|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952686|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952687|NCT01113710|Rotigotine|rotigotine|mesh-list
153952688|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
153952689|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
153952690|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952691|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952692|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952693|NCT01124162|Losartan|losartan|mesh-list
153952694|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153952699|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153952745|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153952746|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153952748|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
153952749|NCT00952068|Tramadol|tramadol|mesh-list
153952750|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153952751|NCT00952068|Narcotics|narcotics|mesh-ancestor
153952752|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153952753|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952754|NCT00952068|Analgesics|analgesics|mesh-ancestor
153952757|NCT00951912|Genistein|genistein|mesh-list
153952809|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153952810|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153952811|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153952812|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
153952813|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153952814|NCT01122680|Bromides|bromides|mesh-list
153952815|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
153952816|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153952817|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
153952818|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153952819|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952870|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153952871|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
153952872|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153952873|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153952874|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
153952875|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
153952876|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
153952877|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952878|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952879|NCT02855502|Prednisolone|prednisolone|mesh-list
153952880|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153952881|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
153952935|NCT01137812|Incretins|incretins|mesh-ancestor
153952936|NCT01137812|Hormones|hormones|mesh-ancestor
153952937|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952938|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153952939|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
153952940|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952941|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952942|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153952943|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153952944|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153952945|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153952946|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
153952947|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952948|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153952949|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153952950|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153952951|NCT04146220|Prednisolone|prednisolone|mesh-list
153952952|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153952953|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
153952954|NCT04146220|Hormones|hormones|mesh-ancestor
153952955|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153952956|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153952957|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153952958|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952959|NCT00679666|Riboflavin|riboflavin|mesh-list
153952960|NCT00679666|Vitamins|vitamins|mesh-ancestor
153952979|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952981|NCT00946920|Goserelin|goserelin|mesh-list
153952982|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153952983|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153952984|NCT00679900|SR 46349B|sr 46349b|mesh-list
153952985|NCT00679900|Lormetazepam|lormetazepam|mesh-list
153710581|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153952986|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153952987|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153952988|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153952989|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153953041|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953042|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
153953043|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
153953045|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
153953046|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153953047|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
153953048|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153953049|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953050|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153953051|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153953052|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153953053|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153953054|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153953055|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
153953056|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153953057|NCT01111604|Ramucirumab|ramucirumab|mesh-list
153953058|NCT01111604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153953059|NCT01111604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153953060|NCT01111604|Growth Substances|growth substances|mesh-ancestor
153953061|NCT01111604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953062|NCT01111604|Growth Inhibitors|growth inhibitors|mesh-ancestor
153953065|NCT00950742|Afatinib|afatinib|mesh-list
153953095|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953096|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953097|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
153953098|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953099|NCT01111526|Panobinostat|panobinostat|mesh-list
153953100|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953101|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153953102|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953104|NCT02881346|Betamethasone|betamethasone|mesh-list
153953160|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153953161|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153953162|NCT00944658|Analgesics|analgesics|mesh-ancestor
153953163|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
153953164|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953165|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953166|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153953167|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153953168|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153953169|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153953221|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
153953222|NCT04309058|Vitamin D|vitamin d|mesh-list
153953223|NCT04309058|Vitamins|vitamins|mesh-ancestor
153953224|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
153953225|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953226|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153953227|NCT01136408|Warfarin|warfarin|mesh-list
153953228|NCT01136408|Dabigatran|dabigatran|mesh-list
153953229|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
153953230|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
153953231|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153953232|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
153953233|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953234|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953235|NCT01136174|Nintedanib|nintedanib|mesh-list
153953236|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953237|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153953281|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953282|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153953283|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953284|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953285|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153953286|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153953288|NCT05317689|Psilocin|psilocin|mesh-list
153953346|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
153953347|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
153953348|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153953349|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153953350|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953351|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953352|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153953353|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
153953354|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
153953355|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953357|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
153953409|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
153953410|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153953411|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153953412|NCT04413279|Dexamethasone|dexamethasone|mesh-list
153953413|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153953414|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
153953415|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
153953416|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953417|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953418|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153953419|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
153953420|NCT04413279|Hormones|hormones|mesh-ancestor
153953421|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953422|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153953423|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953424|NCT04975256|Adagrasib|adagrasib|mesh-list
153953425|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153953426|NCT02880800|Morphine|morphine|mesh-list
153953427|NCT02880800|Hydromorphone|hydromorphone|mesh-list
153953428|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153953429|NCT02880800|Narcotics|narcotics|mesh-ancestor
153953430|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953431|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953432|NCT02880800|Analgesics|analgesics|mesh-ancestor
153711036|NCT00316420|Gemcitabine|gemcitabine|mesh-list
153953433|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
153953434|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953435|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
153953436|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153953437|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153953438|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153953441|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
153953452|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
153953453|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953454|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953455|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153953456|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153953457|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
153953458|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
153953459|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953460|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153953461|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153953462|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953463|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953464|NCT05034783|Exenatide|exenatide|mesh-list
153953465|NCT05034783|Edetic Acid|edetic acid|mesh-list
153953466|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
153953467|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
153953468|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953469|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
153953470|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153953472|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953505|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
153953506|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
153953507|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
153953508|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953509|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953512|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153953513|NCT01106690|Canagliflozin|canagliflozin|mesh-list
153953514|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953515|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953516|NCT01106690|Incretins|incretins|mesh-ancestor
153953517|NCT01106690|Hormones|hormones|mesh-ancestor
153953520|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
153953568|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153953569|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153953570|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153953571|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953572|NCT02853552|Misoprostol|misoprostol|mesh-list
153953573|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153953574|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
153953575|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153953576|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953577|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153953578|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153953579|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
153953580|NCT04268472|Darunavir|darunavir|mesh-list
153953581|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153953631|NCT00602316|Chelating Agents|chelating agents|mesh-list
153953632|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
153953633|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953634|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
153953635|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
153953636|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153953637|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953638|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953639|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
153953640|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153953704|NCT05337969|Vildagliptin|vildagliptin|mesh-list
153953705|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953706|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953707|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153953708|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
153953709|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953710|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953711|NCT02844153|Metformin|metformin|mesh-list
153953712|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953713|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953714|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153953720|NCT02844309|Thalidomide|thalidomide|mesh-list
153953721|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153953722|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
153953771|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953772|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953773|NCT02690883|Exenatide|exenatide|mesh-list
153953774|NCT02690883|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153953775|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953776|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953777|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153953778|NCT02690883|Incretins|incretins|mesh-ancestor
153953779|NCT02690883|Hormones|hormones|mesh-ancestor
153953780|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953781|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
153953782|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153953833|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153953834|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153953835|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153953836|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153953837|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153953838|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953839|NCT00319995|Loratadine|loratadine|mesh-list
153953840|NCT00319995|Montelukast|montelukast|mesh-list
153953841|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153953842|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
153953843|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153953844|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
153953845|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153953846|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953891|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153953892|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953893|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153953894|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
153953896|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953897|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953898|NCT00156117|Olanzapine|olanzapine|mesh-list
153953899|NCT00156117|Asenapine|asenapine|mesh-list
153953956|NCT00127179|Urological Agents|urological agents|mesh-ancestor
153953957|NCT00953706|Ivacaftor|ivacaftor|mesh-list
153711558|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153953958|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153953959|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153953960|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953962|NCT02852382|Bupivacaine|bupivacaine|mesh-list
153953963|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
153953964|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
153953965|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153953966|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953967|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
153953968|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153953969|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153953970|NCT02852382|Narcotics|narcotics|mesh-ancestor
153954016|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954017|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954018|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153954019|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153954020|NCT00938964|Lidocaine|lidocaine|mesh-list
153954021|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
153954082|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954083|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954084|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153954085|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153954086|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
153954087|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153954088|NCT00941928|Analgesics|analgesics|mesh-ancestor
153954089|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
153954090|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954091|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153954092|NCT02852694|Adalimumab|adalimumab|mesh-list
153954093|NCT02852694|Methotrexate|methotrexate|mesh-list
153954094|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
153954095|NCT02852694|Azathioprine|azathioprine|mesh-list
153954096|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153954097|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
153954098|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153954099|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954100|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153954101|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
153954102|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954103|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954135|NCT04268394|Methotrexate|methotrexate|mesh-list
153954136|NCT04268394|Digoxin|digoxin|mesh-list
153954137|NCT04268394|Midazolam|midazolam|mesh-list
153954138|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153954139|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954140|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954141|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153954142|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
153954143|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153954144|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153954198|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954199|NCT02851212|Metformin|metformin|mesh-list
153954200|NCT02851212|Canagliflozin|canagliflozin|mesh-list
153954201|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954202|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954203|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153954204|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954264|NCT02626234|Digoxin|digoxin|mesh-list
153954265|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153954266|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153954267|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153954268|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
153954269|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954270|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153954271|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153954272|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954273|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153954274|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153954275|NCT02626234|Protective Agents|protective agents|mesh-ancestor
153954276|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954323|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954324|NCT00940602|Deferasirox|deferasirox|mesh-list
153954325|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153954326|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
153954327|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
153954328|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954329|NCT00686140|Celecoxib|celecoxib|mesh-list
153954330|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153954389|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954390|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954392|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153954393|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153954394|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153954395|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153954396|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153954397|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153954398|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954400|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
153954452|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153954453|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
153954454|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954455|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954456|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153954457|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
153954466|NCT00687388|Celecoxib|celecoxib|mesh-list
153954520|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954521|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954522|NCT00687700|Propranolol|propranolol|mesh-list
153954523|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153954524|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153954525|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
153954526|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954527|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954528|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954587|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153954588|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153954589|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
153954590|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
153954591|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153954592|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954593|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
153954595|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954596|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153954597|NCT01093586|Protective Agents|protective agents|mesh-ancestor
153954651|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153954652|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153954653|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954654|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153954655|NCT00688402|Lesogaberan|lesogaberan|mesh-list
153954656|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954657|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153954658|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
153954659|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
153954660|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153954661|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954662|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954663|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
153954664|NCT04138264|Narcotics|narcotics|mesh-ancestor
153954665|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153954666|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954667|NCT04138264|Analgesics|analgesics|mesh-ancestor
153954668|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
153954670|NCT00688480|Allopurinol|allopurinol|mesh-list
153954708|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153954709|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153954710|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153954711|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
153954715|NCT00688948|Urological Agents|urological agents|mesh-ancestor
153954776|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954779|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153954780|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153954782|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
153954783|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
153954784|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
153954785|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954786|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153954787|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153954788|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153954789|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954790|NCT05382390|Cytarabine|cytarabine|mesh-list
153954791|NCT05382390|Decitabine|decitabine|mesh-list
153954792|NCT05382390|Aclarubicin|aclarubicin|mesh-list
153954793|NCT05382390|Lenograstim|lenograstim|mesh-list
153954794|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153954795|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
153954796|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954797|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954798|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
153954799|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954800|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954801|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
153954802|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954803|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153954829|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
153954830|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153954831|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954832|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
153954833|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153954834|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
153954835|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954836|NCT00690118|Pioglitazone|pioglitazone|mesh-list
153954837|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153954838|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954840|NCT00694252|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153954841|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153954842|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954843|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954844|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954845|NCT00871858|Fulvestrant|fulvestrant|mesh-list
153954846|NCT00871858|Anastrozole|anastrozole|mesh-list
153954847|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153954848|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954883|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153954885|NCT00694408|Hormones|hormones|mesh-ancestor
153954886|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153954887|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153954888|NCT00694408|Protective Agents|protective agents|mesh-ancestor
153954953|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153954954|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
153954955|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954956|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954957|NCT04136470|Nivolumab|nivolumab|mesh-list
153954958|NCT04136470|Ipilimumab|ipilimumab|mesh-list
153954959|NCT04136470|Atezolizumab|atezolizumab|mesh-list
153954960|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153954961|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954962|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153954963|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954964|NCT00673426|Enoxaparin|enoxaparin|mesh-list
153954965|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
153954966|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153954967|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153954968|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954969|NCT00673504|Gemcitabine|gemcitabine|mesh-list
153954970|NCT00673504|Sunitinib|sunitinib|mesh-list
153954971|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153954972|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
153954973|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954974|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954975|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153954976|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153954977|NCT00673504|Growth Substances|growth substances|mesh-ancestor
153954978|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954979|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
153954980|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153954981|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153954982|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153954983|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153954984|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153954985|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
153954986|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153954992|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153954993|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
153954994|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
153954995|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954996|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153954997|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153954998|NCT00695032|Ifosfamide|ifosfamide|mesh-list
153954999|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955000|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153955058|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955059|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955060|NCT02624440|Clarithromycin|clarithromycin|mesh-list
153955061|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153955062|NCT02624440|Trimethoprim|trimethoprim|mesh-list
153955063|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
153955064|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153955065|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955066|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153955067|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955068|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955069|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153955070|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153955071|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153955072|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
153955073|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153955074|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153955075|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153955076|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153955077|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153955078|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153955079|NCT00693862|Levodopa|levodopa|mesh-list
153955080|NCT00693862|Carbidopa|carbidopa|mesh-list
153955081|NCT00693862|Entacapone|entacapone|mesh-list
153955082|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153955083|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153955105|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153955106|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
153955107|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153955108|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153955109|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153955110|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153955111|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
153955112|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955113|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955114|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
153955115|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
153955116|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153955167|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955168|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
153955169|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153955170|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153955171|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
153955172|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
153955173|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
153955174|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955175|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955176|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153955177|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
153955178|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955179|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
153955180|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955181|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955182|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153955183|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
153955184|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955187|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
153955224|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
153955225|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153955226|NCT00696748|Androgens|androgens|mesh-ancestor
153955227|NCT00696748|Hormones|hormones|mesh-ancestor
153955228|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955229|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955230|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153955231|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955232|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
153955234|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
153955240|NCT02623036|Enalapril|enalapril|mesh-list
153955286|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153955287|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153955288|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
153955289|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
153955290|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
153955291|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
153955292|NCT04135378|Vitamins|vitamins|mesh-ancestor
153955293|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
153955294|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955295|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
153955296|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955297|NCT04135378|Protective Agents|protective agents|mesh-ancestor
153955298|NCT02878772|Aspirin|aspirin|mesh-list
153955347|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153955348|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153955349|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955350|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955351|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
153955352|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955353|NCT04267224|Ticagrelor|ticagrelor|mesh-list
153955354|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153955355|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153955356|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153955357|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153955358|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
153955359|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955360|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955361|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955362|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
153955363|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153955402|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955403|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955405|NCT02622802|Azithromycin|azithromycin|mesh-list
153955406|NCT02622802|Erythromycin|erythromycin|mesh-list
153955407|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
153955408|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153955409|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
153955410|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153955411|NCT02622802|Analgesics|analgesics|mesh-ancestor
153955412|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
153955413|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955414|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955415|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
153955416|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153955417|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955418|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153955419|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153955420|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955421|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955422|NCT05158374|Aspirin|aspirin|mesh-list
153955423|NCT05158374|Metformin|metformin|mesh-list
153955424|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153955425|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955426|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153955427|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153955428|NCT05158374|Analgesics|analgesics|mesh-ancestor
153955429|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
153955430|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955431|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153955432|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955433|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153955434|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153955435|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955436|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153955437|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153646588|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
153955438|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955439|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
153955440|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153955441|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
153955442|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153955443|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
153955446|NCT00675688|Hormones|hormones|mesh-ancestor
153955511|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
153955512|NCT00934050|Vitamins|vitamins|mesh-ancestor
153955513|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
153955514|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955515|NCT02620618|Infliximab|infliximab|mesh-list
153955516|NCT02620618|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153955517|NCT02620618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153955518|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
153955519|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153955520|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955521|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
153955522|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955523|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
153955524|NCT05321576|Narcotics|narcotics|mesh-ancestor
153955525|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153955526|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955527|NCT05321576|Analgesics|analgesics|mesh-ancestor
153955528|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
153955529|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955530|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153955567|NCT02614456|Interferons|interferons|mesh-list
153955568|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
153955570|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955571|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955572|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153955573|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955574|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
153955575|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955576|NCT04130230|Choline|choline|mesh-list
153955577|NCT04130230|Neostigmine|neostigmine|mesh-list
153955578|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153955579|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955580|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955581|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
153955582|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955583|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955584|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153955585|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
153955587|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
153955622|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955623|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955624|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153955625|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153955626|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153955627|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153955628|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955629|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153955630|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153955631|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955632|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
153955633|NCT04872218|Abatacept|abatacept|mesh-list
153955682|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153955684|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955685|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153955686|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
153955687|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153955688|NCT01101308|Oxycodone|oxycodone|mesh-list
153955689|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153955690|NCT01101308|Narcotics|narcotics|mesh-ancestor
153955691|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153955692|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955693|NCT01101308|Analgesics|analgesics|mesh-ancestor
153955694|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
153955695|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153955696|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153955697|NCT00926796|Azithromycin|azithromycin|mesh-list
153955698|NCT00926796|Gentamicins|gentamicins|mesh-list
153955699|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
153955700|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153955701|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955702|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153955703|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955704|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955709|NCT00696982|Glyburide|glyburide|mesh-list
153955736|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153955737|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153955738|NCT01079936|Growth Substances|growth substances|mesh-ancestor
153955739|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
153955740|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955741|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153955742|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
153955744|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153955802|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153955803|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
153955804|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153955805|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153955806|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153955807|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153955808|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
153955809|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153955810|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955811|NCT01078922|Ofatumumab|ofatumumab|mesh-list
153955812|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955813|NCT00609570|Calcium|calcium|mesh-list
153955814|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153955815|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955816|NCT00863746|Sorafenib|sorafenib|mesh-list
153955817|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955860|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955861|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
153955862|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
153955863|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
153955864|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955865|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153955866|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153955867|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153955868|NCT02619994|Levofloxacin|levofloxacin|mesh-list
153955869|NCT02619994|Linezolid|linezolid|mesh-list
153955870|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
153955871|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153955872|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955873|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153955874|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153955875|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153955876|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955877|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955878|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917746|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
153955879|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153955880|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153955881|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153955882|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
153955883|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
153955884|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153955885|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153955886|NCT04263402|Prednisolone|prednisolone|mesh-list
153955905|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153955906|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153955907|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153955908|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153955909|NCT00868192|Growth Substances|growth substances|mesh-ancestor
153955910|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955911|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
153955912|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955913|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955914|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153955915|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153955917|NCT02615782|Tamsulosin|tamsulosin|mesh-list
153955930|NCT00930930|Paclitaxel|paclitaxel|mesh-list
153955966|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
153955967|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153955968|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153955969|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153955970|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153955971|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955972|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153955973|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
153955974|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153955975|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955976|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153955977|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153955979|NCT00862654|Hormones|hormones|mesh-ancestor
153955980|NCT00609180|Antioxidants|antioxidants|mesh-list
153955981|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153955982|NCT00609180|Protective Agents|protective agents|mesh-ancestor
153955983|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153955984|NCT00867490|Amlodipine|amlodipine|mesh-list
153956020|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153956021|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956022|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153956023|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153956024|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956025|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153956026|NCT00925704|Vitamins|vitamins|mesh-ancestor
153956027|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
153956028|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153956029|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
153956030|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
153956031|NCT00697138|Amphetamine|amphetamine|mesh-list
153956032|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
153956033|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153956034|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153956035|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153956036|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153713617|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
153713621|NCT05243940|Narcotics|narcotics|mesh-ancestor
153956079|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153956080|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956081|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153956082|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956083|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
153956084|NCT04258644|Paclitaxel|paclitaxel|mesh-list
153956085|NCT04258644|Apatinib|apatinib|mesh-list
153956086|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153956087|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956088|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
153956139|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153956140|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
153956141|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153956142|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956143|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956144|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956145|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
153956146|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
153956147|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
153956206|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153956207|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
153956208|NCT02613676|Bilirubin|bilirubin|mesh-list
153956209|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
153956210|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956211|NCT02613676|Protective Agents|protective agents|mesh-ancestor
153956212|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956213|NCT00860158|Dasatinib|dasatinib|mesh-list
153956214|NCT00860158|Leuprolide|leuprolide|mesh-list
153956215|NCT00860158|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153956216|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956217|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956218|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956219|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956220|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153956221|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
153956222|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153956223|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956224|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153956261|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956262|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153956263|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956264|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153956265|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956266|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956267|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
153956268|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
153956269|NCT02615080|Pemirolast|pemirolast|mesh-list
153956270|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
153956271|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
153956272|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713903|NCT03191864|Xhance|xhance|mesh-list
153956273|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956274|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956275|NCT00859456|Sunitinib|sunitinib|mesh-list
153956277|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153956278|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153956279|NCT00859456|Growth Substances|growth substances|mesh-ancestor
153956280|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956281|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
153956282|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956283|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956284|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956285|NCT01075646|Ropivacaine|ropivacaine|mesh-list
153956286|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153956287|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
153956288|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
153956289|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956290|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956291|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
153956292|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956303|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153956304|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153956305|NCT02876432|Analgesics|analgesics|mesh-ancestor
153956306|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
153501150|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153501157|NCT00372294|Clindamycin|clindamycin|mesh-list
153956307|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956308|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956309|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153956310|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956311|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153956312|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956313|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956314|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
153956315|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153956316|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
153956317|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956318|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
153956319|NCT02876276|Protective Agents|protective agents|mesh-ancestor
153956320|NCT00923130|Bevacizumab|bevacizumab|mesh-list
153956321|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956322|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956323|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153956324|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153956354|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153956355|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
153956356|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
153956357|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
153956358|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153956359|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153956360|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153956361|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956362|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956363|NCT02605915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153956364|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153956366|NCT02605915|Immunoconjugates|immunoconjugates|mesh-ancestor
153956367|NCT04028323|Octreotide|octreotide|mesh-list
153956368|NCT04028323|Terlipressin|terlipressin|mesh-list
153956369|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153956370|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153956371|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956372|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153956373|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153956374|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
153956375|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956376|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956377|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956378|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153956379|NCT02607163|Analgesics|analgesics|mesh-ancestor
153956380|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
153956405|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153956406|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956407|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153956408|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956409|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
153956410|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956411|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153956412|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153956413|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
153956414|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956415|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
153956416|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153956417|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153956418|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
153956419|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
153956420|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956421|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956422|NCT00859222|Bevacizumab|bevacizumab|mesh-list
153956423|NCT00859222|Panobinostat|panobinostat|mesh-list
153956424|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956425|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956458|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153956459|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153956460|NCT02618824|Tryptophan|tryptophan|mesh-list
153956461|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153956462|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
153956463|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956464|NCT00610350|Simendan|simendan|mesh-list
153956465|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153956521|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956522|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956523|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153956524|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
153956525|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
153956526|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
153956527|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153956528|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153956529|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153956530|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153956531|NCT02618668|Ketamine|ketamine|mesh-list
153956532|NCT02618668|Propofol|propofol|mesh-list
153956533|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153956579|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153956580|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153956581|NCT00857584|Sertraline|sertraline|mesh-list
153956582|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
153956583|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956584|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153956585|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956586|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153956587|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956644|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956645|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153956646|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153956647|NCT00798889|Growth Substances|growth substances|mesh-ancestor
153956648|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956649|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
153956650|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956651|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956652|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956709|NCT00796549|Afatinib|afatinib|mesh-list
153956710|NCT00796549|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153956711|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956712|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956713|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956714|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956715|NCT00856492|Paclitaxel|paclitaxel|mesh-list
153956716|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
153956717|NCT00856492|Bevacizumab|bevacizumab|mesh-list
153956718|NCT00856492|Doxorubicin|doxorubicin|mesh-list
153956719|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153956720|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153956721|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153956722|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956769|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153956770|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
153956771|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956772|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153956773|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153956774|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
153956775|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956776|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153956777|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153956778|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153956779|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153956780|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153956781|NCT00856180|Growth Substances|growth substances|mesh-ancestor
153956782|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
153956783|NCT02605213|Vancomycin|vancomycin|mesh-list
153956784|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153956827|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956828|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956829|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153956830|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
153956831|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956832|NCT00914953|Oxytocin|oxytocin|mesh-list
153956833|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
153956834|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153956835|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956836|NCT00869518|Trimethoprim|trimethoprim|mesh-list
153956837|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153956838|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
153956839|NCT00869518|Rifabutin|rifabutin|mesh-list
153956840|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153956841|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956842|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
153956843|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153956844|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153956845|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153956846|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956847|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956848|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153956849|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153956850|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153956851|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153956874|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
153956875|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956876|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153956877|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
153956878|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153956879|NCT02841579|Osimertinib|osimertinib|mesh-list
153956880|NCT02841579|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153956881|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153956882|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956883|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956888|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153956939|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153956940|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714547|NCT04608448|Emollients|emollients|mesh-ancestor
153956941|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153956942|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153956943|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
153956944|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
153956945|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153956946|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153956947|NCT00855166|Metformin|metformin|mesh-list
153956948|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
153956949|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153956950|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153956951|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153956952|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153956954|NCT00855166|Incretins|incretins|mesh-ancestor
153956994|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153956995|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153956996|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153956997|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
153956998|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
153956999|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
153957000|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
153957001|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957002|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957003|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
153957004|NCT00898443|Anesthetics|anesthetics|mesh-list
153957005|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957006|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957007|NCT02614612|Prednisone|prednisone|mesh-list
153957008|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
153957009|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153957010|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153957011|NCT02614612|Prednisolone|prednisolone|mesh-list
153957051|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957052|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957053|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957054|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
153957055|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957056|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153957057|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
153957058|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957059|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153957060|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153957061|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957062|NCT00895245|Dexamethasone|dexamethasone|mesh-list
153957063|NCT00895245|Palonosetron|palonosetron|mesh-list
153957064|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
153957065|NCT00895245|Aprepitant|aprepitant|mesh-list
153957066|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957067|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957068|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
153957069|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
153957070|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957071|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957072|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957073|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
153957074|NCT00895245|Hormones|hormones|mesh-ancestor
153957075|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729856|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729857|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153729859|NCT03117309|Ipilimumab|ipilimumab|mesh-list
153729860|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153729861|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957141|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153957142|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957143|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957144|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
153957145|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153957146|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153957147|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957148|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957149|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153957150|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153957151|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957152|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
153957153|NCT02843607|Immunomodulating Agents|immunomodulating agents|mesh-list
153957154|NCT02843607|Immunologic Factors|immunologic factors|mesh-ancestor
153957155|NCT02843607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957156|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153957157|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957158|NCT00915577|Interferons|interferons|mesh-list
153957159|NCT00915577|Interferon-beta|interferon-beta|mesh-list
153957199|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957200|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
153957201|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153957202|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153957203|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
153957204|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153957205|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153957206|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153957207|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153957208|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957209|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
153957210|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
153957211|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
153957212|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
153957213|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957214|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153957215|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
153957216|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
153957258|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153957259|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957260|NCT02840175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153957261|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957262|NCT02603497|Peficitinib|peficitinib|mesh-list
153957263|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957264|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957265|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957266|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
153957267|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957268|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
153957269|NCT02839941|Tacrolimus|tacrolimus|mesh-list
153957283|NCT02839941|Hormones|hormones|mesh-ancestor
153957320|NCT02837835|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153957321|NCT02837835|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153957322|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153957323|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957324|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153957325|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153957326|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
153957327|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957328|NCT02839161|Antacids|antacids|mesh-ancestor
153957329|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957330|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957331|NCT04249713|Brodalumab|brodalumab|mesh-list
153957332|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
153957333|NCT00610506|Dexetimide|dexetimide|mesh-list
153957334|NCT00610506|Citalopram|citalopram|mesh-list
153957335|NCT00610506|Escitalopram|escitalopram|mesh-list
153957336|NCT00610506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153957337|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153957338|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153957339|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957340|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957341|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
153957342|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957343|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153957344|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153957345|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
153957346|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
153957347|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957348|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153957364|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153957365|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957366|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153957368|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957369|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
153957370|NCT00928746|Bromides|bromides|mesh-list
153957371|NCT00928746|Ipratropium|ipratropium|mesh-list
153957372|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
153957373|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153957374|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
153957375|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957376|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957377|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153957378|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
153957379|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153957380|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
153957381|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957382|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957383|NCT04468815|Esomeprazole|esomeprazole|mesh-list
153957389|NCT00610584|Cetirizine|cetirizine|mesh-list
153957416|NCT00853372|Trebananib|trebananib|mesh-list
153957417|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
153957418|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957419|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153957420|NCT00853372|Growth Substances|growth substances|mesh-ancestor
153957421|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957422|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
153957423|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153957424|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957425|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957426|NCT02836977|Tegafur|tegafur|mesh-list
153957427|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153957428|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
153957429|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957430|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957431|NCT00848536|Travoprost|travoprost|mesh-list
153957432|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153957433|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153957434|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153957435|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
153957436|NCT00922116|Hematinics|hematinics|mesh-ancestor
153957437|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
153957438|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153957439|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
153957440|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153957441|NCT04260516|Expectorants|expectorants|mesh-ancestor
153957442|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
153957443|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153957444|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
153957445|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957446|NCT04260516|Protective Agents|protective agents|mesh-ancestor
153957447|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957460|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153957461|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
153957462|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
153957463|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153957464|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957465|NCT00700492|Progesterone|progesterone|mesh-list
153957466|NCT00700492|Progestins|progestins|mesh-ancestor
153957467|NCT00700492|Hormones|hormones|mesh-ancestor
153957529|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957531|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153957532|NCT00789373|Pemetrexed|pemetrexed|mesh-list
153957533|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957601|NCT04106011|Gabapentin|gabapentin|mesh-list
153957602|NCT04106011|Analgesics|analgesics|mesh-ancestor
153957603|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
153957604|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957605|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957606|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
153957607|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153957608|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153957609|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957610|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957611|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153957612|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153957613|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957614|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957659|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153957660|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153957661|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153957662|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153957663|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153957665|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
153957666|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957667|NCT02836743|Protective Agents|protective agents|mesh-ancestor
153957668|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957669|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153957670|NCT04255368|Choline|choline|mesh-list
153957671|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
153957672|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153957673|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
153957674|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957675|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957676|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153957677|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
153957678|NCT00610818|Mitogens|mitogens|mesh-list
153957679|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
153957680|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957681|NCT00787891|Rabeprazole|rabeprazole|mesh-list
153957682|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153957683|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153957684|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153957685|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957686|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467031|NCT00385788|Gemcitabine|gemcitabine|mesh-list
153957687|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153957688|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153957699|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153957700|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
153957701|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153957702|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153957703|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
153957705|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
153957767|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153957768|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153957769|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153957770|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153957771|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
153957772|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957773|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957774|NCT05326425|Lazertinib|lazertinib|mesh-list
153957775|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153957776|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957778|NCT00784693|Tanezumab|tanezumab|mesh-list
153957827|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957828|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
153957829|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957830|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153957831|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153957832|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153957833|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153957834|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153957835|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
153957836|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153957837|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
153957892|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153957893|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957894|NCT04248621|Hormones|hormones|mesh-ancestor
153957895|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153957896|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153957897|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
153957898|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
153957899|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153957900|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
153957901|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153957902|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153957903|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153957904|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
153957905|NCT00784459|Abatacept|abatacept|mesh-list
153957906|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153957907|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957908|NCT00784459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153957909|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153957910|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153957945|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
153957946|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
153731492|NCT00138242|Docetaxel|docetaxel|mesh-list
153957947|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957948|NCT04254822|Carvedilol|carvedilol|mesh-list
153957949|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153957950|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153957951|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
153957952|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153957953|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153957954|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913358|NCT02730091|Letrozole|letrozole|mesh-list
153957967|NCT00891813|Vitamins|vitamins|mesh-ancestor
153958005|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153958006|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
153958007|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958009|NCT02831205|Chromium|chromium|mesh-list
153958010|NCT02831205|Everolimus|everolimus|mesh-list
153958011|NCT02831205|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153958012|NCT02831205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958013|NCT02831205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958014|NCT02831205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958015|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153958016|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
153958017|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958018|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958019|NCT02831205|Trace Elements|trace elements|mesh-ancestor
153958020|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
153958021|NCT00783289|Benralizumab|benralizumab|mesh-list
153958064|NCT00850564|Tesamorelin|tesamorelin|mesh-list
153958065|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958066|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958067|NCT00850564|Growth Substances|growth substances|mesh-ancestor
153958068|NCT00837148|Sorafenib|sorafenib|mesh-list
153958069|NCT00837148|Dacarbazine|dacarbazine|mesh-list
153958070|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958071|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958072|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958073|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958074|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153958075|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
153958125|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153958126|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958127|NCT00848926|Immunotoxins|immunotoxins|mesh-ancestor
153958128|NCT00848926|Immunoconjugates|immunoconjugates|mesh-ancestor
153958129|NCT00848926|Immunologic Factors|immunologic factors|mesh-ancestor
153958130|NCT00848926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958131|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
153958132|NCT00706888|Pyridoxal|pyridoxal|mesh-list
153958133|NCT00706888|Pyridoxine|pyridoxine|mesh-list
153958134|NCT00706888|Vitamins|vitamins|mesh-ancestor
153958135|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
153958136|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958137|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
153958138|NCT05019534|Cetuximab|cetuximab|mesh-list
153958139|NCT05019534|Vemurafenib|vemurafenib|mesh-list
153958140|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153958186|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153958187|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958188|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153958189|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
153958190|NCT00791557|Infliximab|infliximab|mesh-list
153958191|NCT00791557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153958192|NCT00791557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153958225|NCT02603965|Copper|copper|mesh-list
153958255|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153958256|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153958257|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958258|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
153958259|NCT04669782|Coagulants|coagulants|mesh-ancestor
153958260|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153958261|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153958262|NCT00891735|Ranibizumab|ranibizumab|mesh-list
153958263|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958264|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958265|NCT00891735|Growth Substances|growth substances|mesh-ancestor
153958266|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958267|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958268|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958269|NCT04252248|Decitabine|decitabine|mesh-list
153958270|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153958271|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
153958288|NCT02832999|Hormones|hormones|mesh-ancestor
153958312|NCT00915018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958313|NCT00915018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958314|NCT04246905|Sulforaphane|sulforaphane|mesh-list
153958315|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153958316|NCT04246905|Protective Agents|protective agents|mesh-ancestor
153958317|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958318|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958319|NCT02830347|Amoxicillin|amoxicillin|mesh-list
153958320|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153958321|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958322|NCT00916578|Capecitabine|capecitabine|mesh-list
153958327|NCT04675866|Paclitaxel|paclitaxel|mesh-list
153958376|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958377|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958378|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958379|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153958380|NCT01077518|Ofatumumab|ofatumumab|mesh-list
153958381|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153958382|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153958383|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
153958384|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958385|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958386|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
153958387|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958388|NCT04203186|Lumefantrine|lumefantrine|mesh-list
153958389|NCT04203186|Artemether|artemether|mesh-list
153958390|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153958391|NCT04203186|Atovaquone|atovaquone|mesh-list
153958392|NCT04203186|Proguanil|proguanil|mesh-list
153958393|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153958394|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
153958395|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153958396|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153958397|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958398|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501184|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
153958399|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958400|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
153958401|NCT00835120|Pioglitazone|pioglitazone|mesh-list
153958402|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153958403|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958404|NCT00914316|Ranolazine|ranolazine|mesh-list
153958405|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153958406|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153958419|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958420|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958421|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
153958422|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958423|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153958424|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153958425|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153958426|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153958427|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958428|NCT00704080|Temozolomide|temozolomide|mesh-list
153958429|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153958430|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
153958431|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958432|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958433|NCT05253066|Docetaxel|docetaxel|mesh-list
153958434|NCT05253066|Epirubicin|epirubicin|mesh-list
153958435|NCT05253066|Exemestane|exemestane|mesh-list
153958436|NCT05253066|Goserelin|goserelin|mesh-list
153958437|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958438|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
153958439|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
153958440|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
153958441|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958442|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153958443|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153958444|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153958445|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958446|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153958447|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153958448|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153958461|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958462|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153958463|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153958464|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153958465|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153958466|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153958467|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153958468|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153958469|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153958470|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
153958471|NCT04636086|Vitamin D|vitamin d|mesh-list
153958472|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153958473|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958474|NCT04636086|Vitamins|vitamins|mesh-ancestor
153958518|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153958520|NCT01077284|Protective Agents|protective agents|mesh-ancestor
153958521|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958522|NCT00704314|Simvastatin|simvastatin|mesh-list
153958523|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153958524|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153958525|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
153958526|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958527|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153958528|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153958529|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958530|NCT00704392|XL647|xl647|mesh-list
153958531|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958532|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153958533|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958534|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958535|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
153958536|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153958537|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
153958538|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958571|NCT04303130|Endostar protein|endostar protein|mesh-list
153958572|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958573|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958574|NCT04303130|Growth Substances|growth substances|mesh-ancestor
153958575|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958576|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958577|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958578|NCT00626600|Oxycodone|oxycodone|mesh-list
153958579|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153958635|NCT00707824|Narcotics|narcotics|mesh-ancestor
153958636|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958637|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958639|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
153958640|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958641|NCT00826228|Teriparatide|teriparatide|mesh-list
153958642|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153958643|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958644|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153958645|NCT00791479|Dulaglutide|dulaglutide|mesh-list
153958646|NCT00791479|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153958647|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153958648|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958649|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153958650|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153958651|NCT02831751|Vaccines|vaccines|mesh-list
153958652|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
153958653|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958654|NCT00913458|Etanercept|etanercept|mesh-list
153958655|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153958657|NCT00913458|Analgesics|analgesics|mesh-ancestor
153958690|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153958691|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958692|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958693|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958694|NCT05251662|Growth Substances|growth substances|mesh-ancestor
153958695|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958696|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958697|NCT02829177|Allopurinol|allopurinol|mesh-list
153958698|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
153958699|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958752|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153501195|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
153958753|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153958754|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958755|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153958756|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153958757|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958758|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
153958759|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153958760|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153958761|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153958762|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
153958763|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958764|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153958765|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
153958811|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
153958812|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
153958813|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958814|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153958815|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
153958816|NCT00784927|Hormones|hormones|mesh-ancestor
153958817|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153958818|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153958819|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153958820|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153958821|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153958822|NCT00784927|Growth Substances|growth substances|mesh-ancestor
153958823|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
153958824|NCT00637884|Fexofenadine|fexofenadine|mesh-list
153958825|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153958826|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153958827|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153958828|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
153958829|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
153958830|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958831|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958862|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958863|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958864|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153958865|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153958866|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153958867|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958868|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153958869|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153958870|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
153958871|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153958872|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958873|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153958874|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
153958875|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153958876|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
153958877|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958878|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958879|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153958886|NCT00779467|Fentanyl|fentanyl|mesh-list
153958918|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153958919|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958920|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153958921|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958922|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
153958923|NCT00778921|Renin Inhibitors|renin inhibitors|mesh-ancestor
153958924|NCT00778921|Protease Inhibitors|protease inhibitors|mesh-ancestor
153958925|NCT00778921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153958926|NCT04173312|Bupivacaine|bupivacaine|mesh-list
153958927|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
153958928|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
153958929|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958930|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958931|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
153958932|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958933|NCT00776659|Exemestane|exemestane|mesh-list
153958934|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153958935|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153958974|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
153958975|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153958976|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153958977|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
153958978|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153958979|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153958980|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153958981|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153958982|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153958983|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153958984|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153958985|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958986|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
153958987|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
153958988|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153958990|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153958991|NCT00833794|Narcotics|narcotics|mesh-ancestor
153959031|NCT00777829|Zolpidem|zolpidem|mesh-list
153959032|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153959033|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153959034|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959035|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959036|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153959037|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
153959038|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
153959039|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959040|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959041|NCT00916045|Vidarabine|vidarabine|mesh-list
153959042|NCT00916045|Cyclosporine|cyclosporine|mesh-list
153959043|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
153959044|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
153959045|NCT00916045|Melphalan|melphalan|mesh-list
153959046|NCT00916045|Busulfan|busulfan|mesh-list
153959047|NCT00916045|Thiotepa|thiotepa|mesh-list
153959048|NCT00916045|Fludarabine|fludarabine|mesh-list
153959049|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
153959050|NCT00916045|Cyclosporins|cyclosporins|mesh-list
153959051|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
153959052|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153959053|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959054|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
153959055|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959056|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959057|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153959058|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
153959063|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
153959082|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
153959083|NCT00916123|Hormones|hormones|mesh-ancestor
153959084|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959085|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959086|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153959087|NCT00916201|Cannabidiol|cannabidiol|mesh-list
153959088|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
153959089|NCT00833638|Tadalafil|tadalafil|mesh-list
153959090|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
153959091|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153959092|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153959112|NCT00774787|Imiquimod|imiquimod|mesh-list
153959145|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
153959146|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153959147|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
154157402|NCT05797805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959148|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153959149|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153959151|NCT00888615|Paclitaxel|paclitaxel|mesh-list
153959213|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
153959214|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959215|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959216|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153959217|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153959218|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
153959219|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959220|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153959221|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153959222|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
153959223|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153959224|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153959225|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
153959226|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959227|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959228|NCT00845182|Pioglitazone|pioglitazone|mesh-list
153959229|NCT00845182|Exenatide|exenatide|mesh-list
153959230|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153959231|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959232|NCT00845182|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153959233|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153959235|NCT00845182|Hormones|hormones|mesh-ancestor
153959236|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959237|NCT00833248|Goserelin|goserelin|mesh-list
153959261|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153959262|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
153959263|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
153959264|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959265|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959266|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153959267|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153959268|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153959269|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959270|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153959271|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153959272|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153959273|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
153959274|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959275|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959276|NCT02612272|Ketorolac|ketorolac|mesh-list
153959277|NCT02612272|Betamethasone|betamethasone|mesh-list
153959278|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153959279|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153959280|NCT02612272|Analgesics|analgesics|mesh-ancestor
153959281|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
153959282|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959283|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959284|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153959285|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959286|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153959287|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959288|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959289|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
153959290|NCT02612272|Hormones|hormones|mesh-ancestor
153959291|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959292|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153959293|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
153959294|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153959295|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153959299|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959300|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153959301|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
153959302|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959303|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959304|NCT00913120|Enoxaparin|enoxaparin|mesh-list
153959305|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
153959306|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153959307|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153959308|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959309|NCT00822172|Cilostazol|cilostazol|mesh-list
153959310|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153959311|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
153959312|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959313|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959314|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153959315|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
153959316|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153959317|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153959319|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153959351|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959352|NCT04099771|Ketamine|ketamine|mesh-list
153959353|NCT04099771|Analgesics|analgesics|mesh-ancestor
153959354|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
153959355|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959356|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959357|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153959358|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153959359|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
153959360|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
153959361|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959362|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153959363|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153959364|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959365|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959366|NCT00768469|Paclitaxel|paclitaxel|mesh-list
153959367|NCT00768469|Neratinib|neratinib|mesh-list
153959368|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153959369|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959370|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
153959377|NCT02825121|Iodine|iodine|mesh-list
153959402|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959403|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153959404|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
153959405|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959406|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
153959407|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959408|NCT02826837|Bevacizumab|bevacizumab|mesh-list
153959409|NCT02826837|Cetuximab|cetuximab|mesh-list
153959410|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153959411|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959412|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153959413|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153959414|NCT02826837|Growth Substances|growth substances|mesh-ancestor
153959415|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959416|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
153959417|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153959418|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
153959419|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959462|NCT02603575|Hormones|hormones|mesh-ancestor
153959463|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959464|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153959465|NCT02603575|Protective Agents|protective agents|mesh-ancestor
153959466|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
153959467|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959468|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959469|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959470|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153959471|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
153959472|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
153959473|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153959474|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959475|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959522|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
153959523|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
153959524|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959525|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959526|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153959527|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
153959528|NCT04200885|Hormones|hormones|mesh-ancestor
153959529|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959530|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153959531|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959532|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153959533|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153959534|NCT04200885|Analgesics|analgesics|mesh-ancestor
153959535|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
153959536|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153959537|NCT00766831|Hydromorphone|hydromorphone|mesh-list
153959538|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153959539|NCT00766831|Narcotics|narcotics|mesh-ancestor
153959540|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959541|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959542|NCT00766831|Analgesics|analgesics|mesh-ancestor
153959543|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
153959555|NCT02821533|Cisplatin|cisplatin|mesh-list
153959575|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959576|NCT02820441|Zopiclone|zopiclone|mesh-list
153959577|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153959578|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153959579|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959580|NCT02821377|Furosemide|furosemide|mesh-list
153959581|NCT02821377|Diuretics|diuretics|mesh-ancestor
153959582|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
153959583|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959584|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153959585|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153959586|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959587|NCT02820987|Meropenem|meropenem|mesh-list
153959588|NCT02820987|Tazobactam|tazobactam|mesh-list
153959590|NCT02820987|Cefepime|cefepime|mesh-list
153959591|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153959592|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153959597|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
153959631|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
153959632|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959633|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959634|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153959635|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153959637|NCT02818725|Doxorubicin|doxorubicin|mesh-list
153959638|NCT02818725|Methotrexate|methotrexate|mesh-list
153959639|NCT02818725|Panitumumab|panitumumab|mesh-list
153959640|NCT02818725|Vinblastine|vinblastine|mesh-list
153959641|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959642|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153959643|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153959644|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153959645|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959646|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959647|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153959648|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
153959649|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153959650|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959683|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153959684|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153959685|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153959687|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
153959688|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959689|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153959690|NCT02820051|Narcotics|narcotics|mesh-ancestor
153959691|NCT02820051|Analgesics|analgesics|mesh-ancestor
153959692|NCT02817243|Simvastatin|simvastatin|mesh-list
153959693|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153959694|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153959751|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
153959752|NCT02816853|Domperidone|domperidone|mesh-list
153959753|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153959754|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959755|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153959756|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153959757|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959758|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959759|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959760|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959761|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
153959762|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
153959763|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153959764|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153959765|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153959766|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
153959767|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959768|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
153959769|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
153959770|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153959807|NCT06278727|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153959808|NCT06278727|Angiotensinogen|angiotensinogen|mesh-list
153959809|NCT06278727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153959810|NCT06278727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153959811|NCT06278727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959812|NCT06278727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153959813|NCT06278727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153959814|NCT06278727|Protease Inhibitors|protease inhibitors|mesh-ancestor
153959815|NCT06278493|Gemcitabine|gemcitabine|mesh-list
153959816|NCT06278493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153959817|NCT06278493|Antimetabolites|antimetabolites|mesh-ancestor
153959818|NCT06278493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959819|NCT06278493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959820|NCT06278402|Tofacitinib|tofacitinib|mesh-list
153959867|NCT06277167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959868|NCT06277167|Antiviral Agents|antiviral agents|mesh-ancestor
153959869|NCT06277167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153959870|NCT06277167|Immunologic Factors|immunologic factors|mesh-ancestor
153959871|NCT06277167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959872|NCT06277154|Doxorubicin|doxorubicin|mesh-list
153959873|NCT06277154|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153959874|NCT06277154|Ifosfamide|ifosfamide|mesh-list
153959875|NCT06277154|Isophosphamide mustard|isophosphamide mustard|mesh-list
153959876|NCT06277154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153959877|NCT06277154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959878|NCT06277154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153959879|NCT06277154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153959880|NCT06277154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153959884|NCT06277024|Lenvatinib|lenvatinib|mesh-list
153959927|NCT06276504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959929|NCT06276465|Hormones|hormones|mesh-ancestor
153959930|NCT06276465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153959931|NCT06276465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959932|NCT06276374|Clopidogrel|clopidogrel|mesh-list
153959933|NCT06276374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153959934|NCT06276374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959935|NCT06276374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153959936|NCT06276374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153959937|NCT06276374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153959938|NCT06276374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153959939|NCT06276374|Purinergic Agents|purinergic agents|mesh-ancestor
153959940|NCT06276374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959941|NCT06276010|Nafamostat|nafamostat|mesh-list
153959984|NCT06272461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153959985|NCT06272461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153959986|NCT06272461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959988|NCT06272461|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153959989|NCT06272461|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153959990|NCT06272461|Anesthetics, General|anesthetics, general|mesh-ancestor
153959991|NCT06272461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153959992|NCT06272461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153959993|NCT06272461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959994|NCT06271421|Temozolomide|temozolomide|mesh-list
153959995|NCT06271421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153959996|NCT06271421|Alkylating Agents|alkylating agents|mesh-ancestor
153959997|NCT06271421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153959998|NCT06271421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153959999|NCT06265441|Bupivacaine|bupivacaine|mesh-list
153960000|NCT06265441|Anesthetics, Local|anesthetics, local|mesh-ancestor
153960001|NCT06265441|Anesthetics|anesthetics|mesh-ancestor
153960006|NCT06260683|Nicotine|nicotine|mesh-list
153960036|NCT06255951|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153960037|NCT06255951|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153960038|NCT06255951|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153960039|NCT06255951|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153960040|NCT06233695|Sodium Channel Blockers|sodium channel blockers|mesh-list
153960042|NCT06233695|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
153501241|NCT00373542|Ropinirole|ropinirole|mesh-list
153960043|NCT06233695|Natriuretic Agents|natriuretic agents|mesh-ancestor
153960117|NCT06109779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960118|NCT06106529|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153960119|NCT06106529|Oxybutynin|oxybutynin|mesh-list
153960120|NCT06106529|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153960121|NCT06106529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153960122|NCT06106529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153960123|NCT06106529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960124|NCT06106529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960125|NCT06106529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960126|NCT06106529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153960127|NCT06106529|Antidepressive Agents|antidepressive agents|mesh-ancestor
153960128|NCT06106529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153960129|NCT06106529|Parasympatholytics|parasympatholytics|mesh-ancestor
153960130|NCT06106529|Autonomic Agents|autonomic agents|mesh-ancestor
153960131|NCT06106529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960132|NCT06106529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153960133|NCT06106529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153960134|NCT06106529|Cholinergic Agents|cholinergic agents|mesh-ancestor
153960135|NCT06106529|Urological Agents|urological agents|mesh-ancestor
153960137|NCT06087328|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153960138|NCT06087328|Autonomic Agents|autonomic agents|mesh-ancestor
153960139|NCT06087328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960167|NCT06074185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960168|NCT06049797|Clonidine|clonidine|mesh-list
153960169|NCT06049797|Pregabalin|pregabalin|mesh-list
153960170|NCT06049797|Gabapentin|gabapentin|mesh-list
153960171|NCT06049797|Citalopram|citalopram|mesh-list
153960172|NCT06049797|Paroxetine|paroxetine|mesh-list
153960173|NCT06049797|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153960174|NCT06049797|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153960175|NCT06049797|Oxybutynin|oxybutynin|mesh-list
153960176|NCT06049797|Escitalopram|escitalopram|mesh-list
153960177|NCT06049797|Analgesics|analgesics|mesh-ancestor
153960178|NCT06049797|Sensory System Agents|sensory system agents|mesh-ancestor
153960179|NCT06049797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960180|NCT06049797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960181|NCT06049797|Anticonvulsants|anticonvulsants|mesh-ancestor
153960182|NCT06049797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153960183|NCT06049797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153960184|NCT06049797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960185|NCT06049797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153960186|NCT06049797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153960187|NCT06049797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153960188|NCT06049797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153960189|NCT06049797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153960190|NCT06049797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153960191|NCT06049797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153960192|NCT06049797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960193|NCT06049797|Antimanic Agents|antimanic agents|mesh-ancestor
153960194|NCT06049797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153960195|NCT06049797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153960196|NCT06049797|Serotonin Agents|serotonin agents|mesh-ancestor
153960197|NCT06049797|Parasympatholytics|parasympatholytics|mesh-ancestor
153960198|NCT06049797|Autonomic Agents|autonomic agents|mesh-ancestor
153960199|NCT06049797|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153960200|NCT06049797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153960201|NCT06049797|Cholinergic Agents|cholinergic agents|mesh-ancestor
153960202|NCT06049797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153960206|NCT06049797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153960207|NCT06049797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153960208|NCT06049797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153960209|NCT06049797|Adrenergic Agents|adrenergic agents|mesh-ancestor
153960210|NCT06049797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153960211|NCT06049797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153960212|NCT06049797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960213|NCT06049797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153960214|NCT06049797|Urological Agents|urological agents|mesh-ancestor
153960215|NCT05945823|Calcium, Dietary|calcium, dietary|mesh-list
153960216|NCT05945823|Leucovorin|leucovorin|mesh-list
153960217|NCT05945823|Pembrolizumab|pembrolizumab|mesh-list
153960218|NCT05945823|Oxaliplatin|oxaliplatin|mesh-list
153960219|NCT05945823|Irinotecan|irinotecan|mesh-list
153960220|NCT05945823|Futibatinib|futibatinib|mesh-list
153960221|NCT05945823|Calcium|calcium|mesh-list
153960222|NCT05945823|Levoleucovorin|levoleucovorin|mesh-list
153960223|NCT05945823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960224|NCT05945823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960225|NCT05945823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153960226|NCT05945823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960227|NCT05945823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153960228|NCT05945823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960229|NCT05945823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153960230|NCT05945823|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153960231|NCT05945823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153960232|NCT05945823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960233|NCT05945823|Antidotes|antidotes|mesh-ancestor
153960234|NCT05945823|Protective Agents|protective agents|mesh-ancestor
153960235|NCT05945823|Vitamin B Complex|vitamin b complex|mesh-ancestor
153960236|NCT05945823|Vitamins|vitamins|mesh-ancestor
153960237|NCT05945823|Micronutrients|micronutrients|mesh-ancestor
153960238|NCT05936021|Darbepoetin alfa|darbepoetin alfa|mesh-list
153960239|NCT05936021|Hematinics|hematinics|mesh-ancestor
153960240|NCT05931484|Gemfibrozil|gemfibrozil|mesh-list
153960241|NCT05931484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153960242|NCT05931484|Antimetabolites|antimetabolites|mesh-ancestor
153717823|NCT00431275|Ipilimumab|ipilimumab|mesh-list
153646623|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153960243|NCT05931484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960244|NCT05931484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153960245|NCT05931484|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153960246|NCT05931484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153960247|NCT05931484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960248|NCT05918328|Paclitaxel|paclitaxel|mesh-list
153960249|NCT05918328|Docetaxel|docetaxel|mesh-list
153960250|NCT05918328|Carboplatin|carboplatin|mesh-list
153960251|NCT05918328|Trastuzumab|trastuzumab|mesh-list
153960252|NCT05918328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153960310|NCT05843786|Antiviral Agents|antiviral agents|mesh-ancestor
153960311|NCT05843786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960312|NCT05814146|Dialysis Solutions|dialysis solutions|mesh-list
153960313|NCT05814146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153960314|NCT05798663|Atezolizumab|atezolizumab|mesh-list
153960315|NCT05798663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153960316|NCT05798663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960317|NCT05798663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960318|NCT05798663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960319|NCT05772169|Mifepristone|mifepristone|mesh-list
153960320|NCT05772169|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153960321|NCT05772169|Abortifacient Agents|abortifacient agents|mesh-ancestor
153960322|NCT05772169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153960323|NCT05772169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960324|NCT05772169|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153960325|NCT05772169|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153960326|NCT05772169|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153960327|NCT05772169|Contraceptive Agents|contraceptive agents|mesh-ancestor
153960328|NCT05772169|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153960329|NCT05772169|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153960330|NCT05772169|Hormone Antagonists|hormone antagonists|mesh-ancestor
153960331|NCT05772169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960332|NCT05772169|Luteolytic Agents|luteolytic agents|mesh-ancestor
153960333|NCT05772169|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153960334|NCT05772169|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153960335|NCT05751226|Semaglutide|semaglutide|mesh-list
153960336|NCT05751226|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153960337|NCT05751226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153960352|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960354|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960355|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960356|NCT05574881|Trastuzumab|trastuzumab|mesh-list
153960357|NCT05574881|Pertuzumab|pertuzumab|mesh-list
153960358|NCT05574881|Fulvestrant|fulvestrant|mesh-list
153960359|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960360|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960361|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960362|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153960363|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153960364|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
153960365|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960366|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960367|NCT05572645|Trastuzumab|trastuzumab|mesh-list
153960368|NCT05572645|Pertuzumab|pertuzumab|mesh-list
153960369|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960370|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960371|NCT05554133|Proflavine|proflavine|mesh-list
153960372|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153960373|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960374|NCT05537948|Pitavastatin|pitavastatin|mesh-list
153960375|NCT05537948|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
153960376|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153960377|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153960378|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153960379|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
153960380|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960381|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960382|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153960383|NCT05537948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153960384|NCT05537948|Protease Inhibitors|protease inhibitors|mesh-ancestor
153960385|NCT05533632|Semaglutide|semaglutide|mesh-list
153960387|NCT05533632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153960394|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
153960395|NCT05511415|Oxytocin|oxytocin|mesh-list
153960396|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153960397|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153960398|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960399|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153960400|NCT05511415|Analgesics|analgesics|mesh-ancestor
153960401|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
153960402|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960403|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153960404|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153960405|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153960406|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
153960407|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960408|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960409|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
153960410|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153960411|NCT05480072|Palmidrol|palmidrol|mesh-list
153960412|NCT05480072|Analgesics|analgesics|mesh-ancestor
153960413|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
153960414|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960443|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
153960444|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
153960445|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
153960446|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960447|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153960448|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153960449|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153960450|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960451|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
153960452|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960453|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960454|NCT05405595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153960505|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153960507|NCT05242874|Dexamethasone acetate|dexamethasone acetate|mesh-list
153960508|NCT05242874|Olanzapine|olanzapine|mesh-list
153960509|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
153960510|NCT05242874|Aprepitant|aprepitant|mesh-list
153960511|NCT05242874|Antiemetics|antiemetics|mesh-list
153960512|NCT05242874|Tropisetron|tropisetron|mesh-list
153960513|NCT05242874|BB 1101|bb 1101|mesh-list
153960514|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153960515|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
153960516|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960517|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960518|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153960519|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
153960520|NCT05242874|Hormones|hormones|mesh-ancestor
153960521|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960522|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960523|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960524|NCT05242874|Protease Inhibitors|protease inhibitors|mesh-ancestor
153960525|NCT05242874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960526|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960527|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153960528|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153960529|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153960530|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153960531|NCT05242874|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153960532|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153960533|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153960534|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960535|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
153960549|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960550|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960551|NCT05173896|Urological Agents|urological agents|mesh-ancestor
153960552|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
153960553|NCT05167409|Cetuximab|cetuximab|mesh-list
153960554|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960555|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960556|NCT05167409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153960557|NCT05167409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960558|NCT05166343|Epinephrine|epinephrine|mesh-list
153960559|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153960560|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153960561|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
153960562|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960563|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960564|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960565|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153960566|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153960567|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
153960568|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960569|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153960603|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960604|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
153960605|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960606|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960607|NCT05049525|Itraconazole|itraconazole|mesh-list
153960608|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153960609|NCT05049525|Terbinafine|terbinafine|mesh-list
153960610|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
153960611|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960612|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153960613|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153960614|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960615|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960616|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153960617|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
153960618|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960619|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960620|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153960621|NCT05027594|Dexamethasone|dexamethasone|mesh-list
153960622|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153960623|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
153960624|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
153960625|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960626|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960627|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153960649|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
153960650|NCT04968951|Metronidazole|metronidazole|mesh-list
153960651|NCT04968951|Vancomycin|vancomycin|mesh-list
153960652|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960653|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153960654|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153960655|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153960656|NCT04923620|Cetuximab|cetuximab|mesh-list
153960657|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960658|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960659|NCT04912063|Azacitidine|azacitidine|mesh-list
153960660|NCT04912063|Venetoclax|venetoclax|mesh-list
153960661|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153960662|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
153960663|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960664|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960665|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960666|NCT04900532|Tocotrienols|tocotrienols|mesh-list
153960667|NCT04900532|Vitamin E|vitamin e|mesh-list
153960668|NCT04900532|Tocopherols|tocopherols|mesh-list
153960669|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
153960670|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960671|NCT04900532|Protective Agents|protective agents|mesh-ancestor
153960672|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960673|NCT04900532|Vitamins|vitamins|mesh-ancestor
153960674|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
153960675|NCT04895488|Vortioxetine|vortioxetine|mesh-list
153960699|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153960700|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
153960701|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960702|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960703|NCT04738643|Varenicline|varenicline|mesh-list
153960704|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153960705|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153960706|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
153960707|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153960708|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960709|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960710|NCT04706013|Pyridoxal|pyridoxal|mesh-list
153960711|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
153960712|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
153960713|NCT04706013|Vitamins|vitamins|mesh-ancestor
153960714|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
153960715|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960716|NCT04699188|Tislelizumab|tislelizumab|mesh-list
153960717|NCT04699188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960756|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960757|NCT04617938|Analgesics|analgesics|mesh-ancestor
153960758|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
153960759|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960760|NCT04608903|Sulforaphane|sulforaphane|mesh-list
153960761|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153960762|NCT04608903|Protective Agents|protective agents|mesh-ancestor
153960763|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960764|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960765|NCT04590664|Verteporfin|verteporfin|mesh-list
153960766|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153960767|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
153960768|NCT04585477|Durvalumab|durvalumab|mesh-list
153960769|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960770|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960771|NCT04550104|Durvalumab|durvalumab|mesh-list
153960772|NCT04550104|Olaparib|olaparib|mesh-list
153960773|NCT04550104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960814|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960815|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960816|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153960818|NCT04514029|Hormones|hormones|mesh-ancestor
153960819|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960820|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960821|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960822|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153960823|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153960879|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
153960880|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153960881|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960882|NCT04171219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153960883|NCT04171219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153960884|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153960885|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153960886|NCT04126200|Dexamethasone|dexamethasone|mesh-list
153960887|NCT04126200|Lenalidomide|lenalidomide|mesh-list
153960888|NCT04126200|Pomalidomide|pomalidomide|mesh-list
153960889|NCT04126200|Dostarlimab|dostarlimab|mesh-list
153960890|NCT04126200|Nirogacestat|nirogacestat|mesh-list
153960891|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153960892|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
153960893|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
153960894|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153960895|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960896|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153960897|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
153960898|NCT04126200|Hormones|hormones|mesh-ancestor
153960899|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153960900|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153960901|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153960902|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
153960930|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153960931|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153960932|NCT04094688|Growth Substances|growth substances|mesh-ancestor
153960933|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153960934|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
153961001|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961002|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961003|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153961004|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153961005|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
153961006|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153961007|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961009|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
153961010|NCT03899987|Aspirin|aspirin|mesh-list
153961070|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153961071|NCT03768414|Cisplatin|cisplatin|mesh-list
153961072|NCT03768414|Gemcitabine|gemcitabine|mesh-list
153961073|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153961074|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961075|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
153961076|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
153961077|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
153961078|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961079|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961080|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
153961081|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
153961082|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961083|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961084|NCT03631706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153961085|NCT03631706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961086|NCT03600883|Sotorasib|sotorasib|mesh-list
153961087|NCT03600883|Midazolam|midazolam|mesh-list
153961088|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153961089|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153961090|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961091|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961092|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153961093|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153961094|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153961095|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153961096|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
153961097|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
153961098|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
153961099|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
153961100|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961101|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961102|NCT03600883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153961103|NCT03600883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961108|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961109|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961110|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961111|NCT03576378|Prednisone|prednisone|mesh-list
153961112|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
153961113|NCT03576378|Etoposide|etoposide|mesh-list
153961114|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
153961115|NCT03576378|Procarbazine|procarbazine|mesh-list
153961116|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961117|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
153961118|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961119|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961120|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961121|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
153961122|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961123|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961124|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961125|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961126|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
153961127|NCT03576378|Hormones|hormones|mesh-ancestor
153961128|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961129|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153961130|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153961131|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153961132|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153961133|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961154|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961155|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961156|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961157|NCT03488420|Edoxaban|edoxaban|mesh-list
153961158|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153961159|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
153961160|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153961161|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
153961162|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961163|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961216|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961217|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961218|NCT03149445|Metoprolol|metoprolol|mesh-list
153961219|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153961220|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153961221|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
153961222|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
153961223|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961224|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961278|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961279|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153961280|NCT02954055|Paclitaxel|paclitaxel|mesh-list
153961281|NCT02954055|Vinorelbine|vinorelbine|mesh-list
153961282|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153961283|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
153961284|NCT02954055|Capecitabine|capecitabine|mesh-list
153961285|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153961286|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961287|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
153961288|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
153961348|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961349|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961350|NCT02766582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153961356|NCT02682641|Rituximab|rituximab|mesh-list
153961357|NCT02682641|Ibrutinib|ibrutinib|mesh-list
153961358|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961359|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961360|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
153961361|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961362|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961416|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153961417|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153961418|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
153961419|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961420|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961421|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153961422|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153961424|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153961425|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
153961426|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
153961427|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
153961448|NCT02043678|Prednisone|prednisone|mesh-list
153961478|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961479|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
153961480|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961481|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961482|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961483|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961484|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153961485|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153961486|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153961487|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961488|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153961489|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
153961490|NCT02012088|Hormones|hormones|mesh-ancestor
153961491|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961492|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153961493|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153961494|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
153961495|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
153961496|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
153961497|NCT01526603|Carboplatin|carboplatin|mesh-list
153961498|NCT01526603|Etoposide|etoposide|mesh-list
153961499|NCT01526603|Melphalan|melphalan|mesh-list
153961500|NCT01526603|Tretinoin|tretinoin|mesh-list
153961501|NCT01526603|Isotretinoin|isotretinoin|mesh-list
153961502|NCT01526603|Lenograstim|lenograstim|mesh-list
153961518|NCT01505569|Etoposide|etoposide|mesh-list
153961528|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961530|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153961531|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961532|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153961533|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
153961534|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153961535|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961536|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
153961537|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961538|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153961539|NCT01505569|Protective Agents|protective agents|mesh-ancestor
153961540|NCT01396408|Sirolimus|sirolimus|mesh-list
153961541|NCT01396408|Sunitinib|sunitinib|mesh-list
153961542|NCT01396408|Temsirolimus|temsirolimus|mesh-list
153961543|NCT01396408|MTOR Inhibitors|mtor inhibitors|mesh-list
153961544|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961585|NCT00937924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153961586|NCT00937924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153961587|NCT00937924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153961588|NCT00937924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153961589|NCT00937924|Anesthetics, General|anesthetics, general|mesh-ancestor
153961590|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
153961591|NCT00937924|GABA Modulators|gaba modulators|mesh-ancestor
153961592|NCT00937924|GABA Agents|gaba agents|mesh-ancestor
153961593|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153961594|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961595|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153961596|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
153961597|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
153961598|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961599|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
153961653|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961654|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153961656|NCT00792948|Hormones|hormones|mesh-ancestor
153961657|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961658|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153961659|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
153961660|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961661|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153961662|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153961663|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153961664|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153961665|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153961666|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153961667|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
153961668|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153961669|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961670|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
153961671|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
153961672|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153961673|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153961674|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153961675|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
153961676|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961677|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153961678|NCT00792948|Antidotes|antidotes|mesh-ancestor
153961679|NCT00792948|Protective Agents|protective agents|mesh-ancestor
153961680|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
153961681|NCT00792948|Vitamins|vitamins|mesh-ancestor
153961682|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
153961683|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153961684|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
153961685|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
153961686|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
153961687|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153961688|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
153961689|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961690|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153961691|NCT00792948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153961692|NCT00792948|Hematinics|hematinics|mesh-ancestor
153961693|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
153961694|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
153961695|NCT00740805|Doxorubicin|doxorubicin|mesh-list
153961696|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153961697|NCT00740805|Veliparib|veliparib|mesh-list
153961698|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961699|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
153961700|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961701|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153961717|NCT00268385|Temozolomide|temozolomide|mesh-list
153961749|NCT02817477|Ketamine|ketamine|mesh-list
153961750|NCT02817477|Morphine|morphine|mesh-list
153961751|NCT02817477|Analgesics|analgesics|mesh-ancestor
153961752|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
153961753|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961754|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961755|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153961756|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153961757|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
153961758|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
153961759|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153961760|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153961810|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961811|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
153961812|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961813|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153961814|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153961815|NCT00705562|Caseins|caseins|mesh-list
153961816|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
153961817|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
153961818|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961819|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
153961820|NCT00843856|Tacrolimus|tacrolimus|mesh-list
153961821|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153961822|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
153961823|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961824|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153961825|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961826|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961867|NCT05629923|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
153961869|NCT05629923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961870|NCT00820222|Capecitabine|capecitabine|mesh-list
153961871|NCT00820222|Trastuzumab|trastuzumab|mesh-list
153961872|NCT00820222|Lapatinib|lapatinib|mesh-list
153961873|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153961874|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
153961875|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961876|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153961877|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153961878|NCT00820222|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153961879|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153961880|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153961882|NCT02815449|Trace Elements|trace elements|mesh-ancestor
153961883|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
153961884|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961885|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
153961923|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153961924|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153961925|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
153961926|NCT02812719|Salicylates|salicylates|mesh-list
153961927|NCT02812719|Glycolic acid|glycolic acid|mesh-list
153961928|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153961929|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
153961930|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
153961990|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961991|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153961993|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153961994|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153961995|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961996|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
153961997|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153961998|NCT01038128|Memantine|memantine|mesh-list
153961999|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153962000|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153962001|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
153962002|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962003|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962004|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962005|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153962006|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153962007|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
153962009|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153962010|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
153962043|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153962044|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
153962050|NCT00634413|Budesonide|budesonide|mesh-list
153962115|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153962116|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962117|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962119|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
153962120|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
153962121|NCT02804841|Vitamins|vitamins|mesh-list
153962122|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
153962181|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153962182|NCT03893175|Narcotics|narcotics|mesh-ancestor
153962183|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962185|NCT04236453|Emtricitabine|emtricitabine|mesh-list
153962186|NCT04236453|Darunavir|darunavir|mesh-list
153962187|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153962188|NCT04236453|Cobicistat|cobicistat|mesh-list
153962189|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153962190|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
153962191|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
153962192|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962193|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153962194|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153962195|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962196|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962205|NCT05461339|Antibodies|antibodies|mesh-list
153962238|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
153962239|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962240|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962242|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153962243|NCT00763321|Narcotics|narcotics|mesh-ancestor
153962244|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962245|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
153962246|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
153962247|NCT02799927|Calcium|calcium|mesh-list
154157403|NCT05797233|Cyclophosphamide|cyclophosphamide|mesh-list
153962248|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153962249|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962250|NCT00770653|Metformin|metformin|mesh-list
153962251|NCT00770653|Pioglitazone|pioglitazone|mesh-list
153962252|NCT00770653|Glimepiride|glimepiride|mesh-list
153962253|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153962254|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962255|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153962256|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153962257|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
153962258|NCT02799615|Infliximab|infliximab|mesh-list
153962259|NCT02799615|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153962260|NCT02799615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962261|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
153962262|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153962263|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962264|NCT00819052|Nevirapine|nevirapine|mesh-list
153962265|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153962266|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153962267|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962283|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962285|NCT05477589|Melphalan|melphalan|mesh-list
153962286|NCT05477589|Busulfan|busulfan|mesh-list
153962287|NCT05477589|Fludarabine|fludarabine|mesh-list
153962288|NCT05477589|Clofarabine|clofarabine|mesh-list
153962289|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153962290|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
153962291|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962353|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962354|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
153962355|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
153962356|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962357|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153962358|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
153962359|NCT00908232|Hormones|hormones|mesh-ancestor
153962360|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962361|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153962362|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153962363|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153962364|NCT00908232|Growth Substances|growth substances|mesh-ancestor
153962365|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
153962366|NCT00770341|Vancomycin|vancomycin|mesh-list
153962367|NCT00770341|Daptomycin|daptomycin|mesh-list
153962368|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153962369|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962370|NCT05472753|Selenium|selenium|mesh-list
153962371|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
153962372|NCT05472753|Curcumin|curcumin|mesh-list
153962373|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153962374|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153962375|NCT05472753|Analgesics|analgesics|mesh-ancestor
153962376|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
153962377|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720029|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153962378|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962402|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153962404|NCT02798913|Clopidogrel|clopidogrel|mesh-list
153962405|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153962406|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153962407|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153962408|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153962409|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
153962410|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962411|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962412|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962413|NCT00762463|Celecoxib|celecoxib|mesh-list
153962414|NCT00762463|Diclofenac|diclofenac|mesh-list
153962417|NCT00762463|Analgesics|analgesics|mesh-ancestor
153962461|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153962462|NCT03230604|Z 350|z 350|mesh-list
153962463|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153962464|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153962465|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962466|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962467|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
153962468|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962469|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962470|NCT02798055|Bosentan|bosentan|mesh-list
153962471|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153962472|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153962473|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962474|NCT05331768|Terlipressin|terlipressin|mesh-list
153962522|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153962523|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
153962524|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
153962525|NCT00762073|Hormones|hormones|mesh-ancestor
153962526|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962527|NCT00913588|Fluoxetine|fluoxetine|mesh-list
153962528|NCT00913588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153962529|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153962585|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962586|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153962587|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962588|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
153962589|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153962590|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153962591|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962592|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
153962593|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
153962594|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
153962595|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962596|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
153962597|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
153962598|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
153962600|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729880|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962602|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
153962603|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153962604|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962644|NCT05804721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153962645|NCT05804721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153962646|NCT05804721|Serotonin Agents|serotonin agents|mesh-ancestor
153962647|NCT05804721|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153962648|NCT05804721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153962649|NCT05804721|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153962650|NCT05804721|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153962651|NCT05804630|Lidocaine|lidocaine|mesh-list
153962652|NCT05804630|Anesthetics|anesthetics|mesh-list
153962653|NCT05804630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153962654|NCT05804630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962707|NCT05803642|Antiemetics|antiemetics|mesh-ancestor
153962708|NCT05803642|Autonomic Agents|autonomic agents|mesh-ancestor
153962709|NCT05803642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962710|NCT05803642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962711|NCT05803642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153962777|NCT05802992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153962778|NCT05802992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153962779|NCT05802992|Growth Substances|growth substances|mesh-ancestor
153962780|NCT05802992|Growth Inhibitors|growth inhibitors|mesh-ancestor
153962781|NCT05802992|Gout Suppressants|gout suppressants|mesh-ancestor
153962782|NCT05802992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153962783|NCT05802992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153962784|NCT05802992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153962785|NCT05802992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153962786|NCT05802979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-list
153962787|NCT05802888|Amoxicillin|amoxicillin|mesh-list
153962788|NCT05802888|Tetracycline|tetracycline|mesh-list
153962789|NCT05802888|Esomeprazole|esomeprazole|mesh-list
153962790|NCT05802888|Bismuth|bismuth|mesh-list
153962791|NCT05802888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153962792|NCT05802888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962793|NCT05802888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153962798|NCT05802888|Antacids|antacids|mesh-ancestor
153962838|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153962839|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962841|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
153962842|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153962843|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
153962844|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962845|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153962846|NCT05649540|Amoxicillin|amoxicillin|mesh-list
153962847|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153962848|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153962849|NCT05646693|Sertraline|sertraline|mesh-list
153962850|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
153962851|NCT05646693|Antidepressive Agents|antidepressive agents|mesh-ancestor
153962852|NCT05646693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153962853|NCT05646693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153962854|NCT05646693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153962855|NCT05646693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153962856|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962857|NCT05646693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962892|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
153962893|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
153962894|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153962895|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153962896|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153962897|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
153962898|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962899|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962900|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153962901|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
153962902|NCT05470244|Analgesics|analgesics|mesh-list
153962903|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
153720549|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
153962904|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153962905|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962906|NCT05449548|Lenalidomide|lenalidomide|mesh-list
153962951|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
153962952|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
153962953|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153962954|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153962955|NCT05273359|Benralizumab|benralizumab|mesh-list
153962956|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153962957|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
153962958|NCT05169905|Vaccines|vaccines|mesh-list
153962959|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
153962960|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962961|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
153963014|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153963015|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963016|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963017|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153963018|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153963019|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
153963020|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963021|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963022|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153963023|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
153963024|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
153963025|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
153963026|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963073|NCT04684589|Tadalafil|tadalafil|mesh-list
153963074|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
153963075|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153963076|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153963077|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963078|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963079|NCT04684589|Urological Agents|urological agents|mesh-ancestor
153963080|NCT04527289|Amantadine|amantadine|mesh-list
153963081|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153963082|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153963083|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
153963084|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963085|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
153963086|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963087|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963088|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963090|NCT04527289|Analgesics|analgesics|mesh-ancestor
153963131|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153963132|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153963133|NCT04129502|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153963134|NCT04129502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963135|NCT04055116|Lidocaine|lidocaine|mesh-list
153963136|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
153963137|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
153963138|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153963139|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963140|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
153963141|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963142|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153963143|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153963144|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153963145|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153963146|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963147|NCT04045028|Rituximab|rituximab|mesh-list
153963187|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963188|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963189|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963190|NCT03512262|Abaloparatide|abaloparatide|mesh-list
153963191|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
153963192|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153963193|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963194|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153963195|NCT03396211|Nivolumab|nivolumab|mesh-list
153963196|NCT03396211|Apatinib|apatinib|mesh-list
153963197|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963248|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153963249|NCT03007979|Letrozole|letrozole|mesh-list
153963250|NCT03007979|Fulvestrant|fulvestrant|mesh-list
153963251|NCT03007979|Palbociclib|palbociclib|mesh-list
153963252|NCT03007979|Goserelin|goserelin|mesh-list
153963253|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963254|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153963255|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153963256|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963257|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963258|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153963259|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
153963260|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963261|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963262|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153963263|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153963264|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963265|NCT02912572|Avelumab|avelumab|mesh-list
153963266|NCT02912572|Axitinib|axitinib|mesh-list
153963267|NCT02912572|Talazoparib|talazoparib|mesh-list
153963268|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963269|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963270|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963271|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963272|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963273|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153963274|NCT02867813|Evolocumab|evolocumab|mesh-list
153963275|NCT02867813|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153963276|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153963277|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153963278|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
153963279|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963280|NCT02867813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153963281|NCT02867813|Protease Inhibitors|protease inhibitors|mesh-ancestor
153963282|NCT02867813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720854|NCT00440284|Insulin|insulin|mesh-list
153646624|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153646625|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963283|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153963285|NCT02737787|Vaccines|vaccines|mesh-list
153963286|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
153963287|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963288|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963289|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963290|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153963291|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963292|NCT02494570|Sirolimus|sirolimus|mesh-list
153963293|NCT02494570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153963294|NCT02494570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963295|NCT02494570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153963296|NCT02494570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963297|NCT02494570|Antifungal Agents|antifungal agents|mesh-ancestor
153963298|NCT02494570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963299|NCT02494570|Immunologic Factors|immunologic factors|mesh-ancestor
153963300|NCT02494570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963301|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
153963339|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
153963340|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963341|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963342|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153963344|NCT01439802|Trace Elements|trace elements|mesh-ancestor
153963345|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
153963346|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963347|NCT00646230|Fenretinide|fenretinide|mesh-list
153963348|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963350|NCT00646230|Protective Agents|protective agents|mesh-ancestor
153963353|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153963403|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153963404|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153963405|NCT02796183|Growth Substances|growth substances|mesh-ancestor
153963406|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963407|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
153963409|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
153963410|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153963411|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963412|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153963413|NCT02795949|Amoxicillin|amoxicillin|mesh-list
153963414|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
153963415|NCT02795949|Meropenem|meropenem|mesh-list
153963416|NCT02795949|Tazobactam|tazobactam|mesh-list
153963417|NCT02795949|Piperacillin|piperacillin|mesh-list
153963418|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
153963419|NCT02795949|Imipenem|imipenem|mesh-list
153963420|NCT02795949|Ceftazidime|ceftazidime|mesh-list
153963421|NCT02795949|Ampicillin|ampicillin|mesh-list
153963422|NCT02795949|Cefepime|cefepime|mesh-list
153963423|NCT02795949|Ertapenem|ertapenem|mesh-list
153963424|NCT02795949|Cefuroxime|cefuroxime|mesh-list
153963426|NCT02795949|Lactams|lactams|mesh-list
153963458|NCT00769483|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153963459|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963460|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963461|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
153963462|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153963463|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
153963464|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963465|NCT02794389|Expectorants|expectorants|mesh-ancestor
153963466|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
153963467|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153963525|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963526|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153963527|NCT04100083|Diuretics|diuretics|mesh-ancestor
153963528|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
153963530|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153963531|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
153963532|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153963533|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963534|NCT02793843|Dexamethasone|dexamethasone|mesh-list
153963535|NCT02793843|Ondansetron|ondansetron|mesh-list
153963536|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963537|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
153963538|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
153963543|NCT02793843|Hormones|hormones|mesh-ancestor
153963588|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153963589|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153963590|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153963591|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153963592|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153963593|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963594|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963595|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963596|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153963597|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153963598|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
153501361|NCT00378456|Zinc|zinc|mesh-list
153963599|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153963600|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
153963601|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963602|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
153963648|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963649|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963650|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153963651|NCT02789475|Amlodipine|amlodipine|mesh-list
153963652|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153963653|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153963654|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153963655|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153963656|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963657|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153963658|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963659|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
153963660|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153963707|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153963708|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963709|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
153963710|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963711|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963712|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
153963713|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963714|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153963715|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963716|NCT00816166|Aspirin|aspirin|mesh-list
153963717|NCT00816166|Clopidogrel|clopidogrel|mesh-list
153963768|NCT02786823|Hematinics|hematinics|mesh-ancestor
153963769|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
153963770|NCT05332314|Ibuprofen|ibuprofen|mesh-list
153963771|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153963772|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153963773|NCT05332314|Analgesics|analgesics|mesh-ancestor
153963774|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
153963777|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963836|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153963837|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153963838|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153963839|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
153963840|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
153963841|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
153963842|NCT02611804|Diclofenac|diclofenac|mesh-list
153963843|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153963844|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153963845|NCT02611804|Analgesics|analgesics|mesh-ancestor
153963846|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
153963847|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963848|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963849|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153963850|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963851|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153963852|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963853|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963854|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
153963891|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153963892|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153963893|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153963894|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
153963895|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
153963896|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
153963897|NCT02611492|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153963898|NCT02611492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153963899|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153963900|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
153963901|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963902|NCT00706576|Mitogens|mitogens|mesh-list
153963903|NCT00706576|Enkephalins|enkephalins|mesh-list
153963904|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963905|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153963906|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963907|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963908|NCT00828568|Imiquimod|imiquimod|mesh-list
153963909|NCT00828568|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153963910|NCT00828568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963911|NCT00828568|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153963912|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
153963913|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963914|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153963915|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963916|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
153963917|NCT01038752|Suramin|suramin|mesh-list
153963918|NCT01038752|Carboplatin|carboplatin|mesh-list
153963919|NCT01038752|Docetaxel|docetaxel|mesh-list
153963920|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153963937|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153963938|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153963939|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963940|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
153963941|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963942|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153963943|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153963944|NCT00903630|Growth Substances|growth substances|mesh-ancestor
153963945|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
153963947|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
153963948|NCT04302584|Norepinephrine|norepinephrine|mesh-list
153963949|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153963950|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153963951|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
153963952|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153963953|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153963954|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963955|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
153963956|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
153963957|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963958|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153963959|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
153963989|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153963990|NCT02874248|Diuretics|diuretics|mesh-ancestor
153963991|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
153963992|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153963993|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153963994|NCT02788305|Misoprostol|misoprostol|mesh-list
153963995|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153963996|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
153963997|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153963998|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153963999|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153964000|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153964001|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
153964002|NCT05758012|Oxytocin|oxytocin|mesh-list
153964053|NCT02890212|Selenium|selenium|mesh-list
153964054|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
153964055|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964056|NCT02890212|Protective Agents|protective agents|mesh-ancestor
153964057|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964058|NCT02890212|Trace Elements|trace elements|mesh-ancestor
153964059|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
153964060|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153964061|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153964062|NCT05387577|Estradiol|estradiol|mesh-list
153964063|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153964064|NCT05387577|Estrogens|estrogens|mesh-ancestor
153964065|NCT05387577|Hormones|hormones|mesh-ancestor
153964066|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964067|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964072|NCT01372254|Nicotine|nicotine|mesh-list
153964113|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964114|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153964115|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153964116|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
153964117|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153964118|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964119|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
153964120|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153964180|NCT02786979|Beraprost|beraprost|mesh-list
153964181|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153964182|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964183|NCT02786979|Analgesics|analgesics|mesh-ancestor
153964184|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
153964185|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964186|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964248|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153964249|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964250|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153964251|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
153964252|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964253|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153721898|NCT00454480|Immunotoxins|immunotoxins|mesh-ancestor
153964254|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
153964255|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964256|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
153964257|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964258|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153964259|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153964260|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
153964261|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964262|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153964263|NCT02690922|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153964264|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964266|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153964268|NCT04202406|Acetaminophen|acetaminophen|mesh-list
153964302|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153964303|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153964304|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
153964305|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153964306|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
153964307|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964308|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964309|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
153964310|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
153964311|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153964312|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153964313|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153964314|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153964315|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
153964316|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964317|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964318|NCT00867321|Bevacizumab|bevacizumab|mesh-list
153964319|NCT00867321|Sorafenib|sorafenib|mesh-list
153964320|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964321|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964322|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153964323|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153964324|NCT00867321|Growth Substances|growth substances|mesh-ancestor
153964325|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964326|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
153964350|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964352|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153964353|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153964354|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153964355|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964356|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153964357|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153964358|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964359|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
153964360|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153964361|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153964362|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153964363|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
153964364|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964365|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
153964366|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153964367|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
153964368|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153964369|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
153964370|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964371|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964372|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
153964373|NCT00902304|Amlodipine|amlodipine|mesh-list
153964374|NCT00902304|Valsartan|valsartan|mesh-list
153964400|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153964401|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153964402|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722042|NCT00455416|Selenium|selenium|mesh-list
153964403|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964404|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964405|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964406|NCT04096027|Cabergoline|cabergoline|mesh-list
153964407|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153964408|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153964409|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
153964410|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
153964411|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964412|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964413|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964414|NCT04216134|Edetic Acid|edetic acid|mesh-list
153964415|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153964416|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
153964417|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
153964418|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964453|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964454|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964455|NCT04197219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154157404|NCT05797233|Fludarabine|fludarabine|mesh-list
153964456|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964457|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964459|NCT04834908|Immune Sera|immune sera|mesh-list
153964460|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
153964461|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964462|NCT02512497|Fludarabine|fludarabine|mesh-list
153964463|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
153964464|NCT02512497|Busulfan|busulfan|mesh-list
153964465|NCT02512497|Romidepsin|romidepsin|mesh-list
153964466|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
153964467|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153964468|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964469|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153964470|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
153964471|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964472|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153964473|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
153964474|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964482|NCT00916669|Enoxaparin|enoxaparin|mesh-list
153964507|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964508|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153964509|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153964510|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153964511|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153964512|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964513|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153964514|NCT02601235|Pyrilamine|pyrilamine|mesh-list
153964515|NCT02601235|Phenylephrine|phenylephrine|mesh-list
153964516|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
153964517|NCT02601235|Naphazoline|naphazoline|mesh-list
153964518|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964519|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153964520|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153964521|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
153964522|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964523|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964524|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
153964525|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
153964526|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964527|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
153964528|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153964529|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
153964547|NCT02846142|Estradiol|estradiol|mesh-list
153964558|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153964560|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153964561|NCT00757783|Darunavir|darunavir|mesh-list
153964562|NCT00757783|Tenofovir|tenofovir|mesh-list
153964563|NCT00757783|Emtricitabine|emtricitabine|mesh-list
153964564|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153964565|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153964566|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
153964567|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964568|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964569|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153964624|NCT02784561|Fludarabine|fludarabine|mesh-list
153964625|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
153964626|NCT02784561|Busulfan|busulfan|mesh-list
153964627|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
153964628|NCT02784561|Lenograstim|lenograstim|mesh-list
153964629|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964630|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153964632|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964633|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153964691|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964692|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964693|NCT01022996|Everolimus|everolimus|mesh-list
153964694|NCT01022996|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153964695|NCT01022996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153964696|NCT01022996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964697|NCT01022996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964698|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153964699|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
153964700|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964710|NCT00757237|Aztreonam|aztreonam|mesh-list
153964756|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964757|NCT05241912|Dobutamine|dobutamine|mesh-list
153964758|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153964759|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
153964760|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
153964761|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964762|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964763|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153964764|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153964765|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153964766|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
153964767|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964768|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964769|NCT05241912|Protective Agents|protective agents|mesh-ancestor
153964770|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
153964771|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153964772|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964773|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153964774|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964775|NCT04229355|Sorafenib|sorafenib|mesh-list
153964776|NCT04229355|Lenvatinib|lenvatinib|mesh-list
153964777|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
153964778|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153964779|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964804|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964805|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
153964806|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964807|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153964808|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153964809|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
153964810|NCT05340153|Lumefantrine|lumefantrine|mesh-list
153964811|NCT05340153|Artemether|artemether|mesh-list
153964812|NCT05340153|Piperaquine|piperaquine|mesh-list
153964813|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153964814|NCT05340153|Artenimol|artenimol|mesh-list
153964815|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
153964816|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153964817|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153964818|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153964819|NCT05078502|Vitamin D|vitamin d|mesh-list
153964820|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
153964821|NCT05078502|Vitamins|vitamins|mesh-ancestor
153964822|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
153964823|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964824|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153964825|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153964826|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
153964827|NCT02844894|Esmolol|esmolol|mesh-list
153964828|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153964829|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153964830|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964831|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153964832|NCT02844894|Analgesics|analgesics|mesh-ancestor
153964833|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
153964834|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153964844|NCT04778904|Nivolumab|nivolumab|mesh-list
153964848|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964849|NCT00634725|Gemcitabine|gemcitabine|mesh-list
153964850|NCT00634725|Capecitabine|capecitabine|mesh-list
153964851|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153964852|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153964853|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
153964854|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964855|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153964856|NCT00634725|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153964859|NCT05325489|Budesonide|budesonide|mesh-list
153964912|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153964913|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153964914|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964916|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153964917|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964918|NCT04887402|Clomiphene|clomiphene|mesh-list
153964919|NCT04887402|Enclomiphene|enclomiphene|mesh-list
153964920|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
153964921|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153964922|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
153745629|NCT03433755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153964924|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964973|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153964974|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
153964975|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964976|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
153964977|NCT00752557|Vitamin D|vitamin d|mesh-list
153964978|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
153964979|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
153964980|NCT00752557|Diphosphonates|diphosphonates|mesh-list
153964981|NCT00752557|Vitamins|vitamins|mesh-list
153964982|NCT00752557|Calcium|calcium|mesh-list
153964983|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
153964984|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964985|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153964986|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153964987|NCT04570176|Epinephrine|epinephrine|mesh-list
153964988|NCT04570176|Racepinephrine|racepinephrine|mesh-list
153964989|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
153964990|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153964991|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153964992|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
153964993|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153964994|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153964995|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964996|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153964997|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153964998|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
153964999|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965000|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153965001|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
153965002|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
153965003|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
153965004|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153965005|NCT00751218|Cetirizine|cetirizine|mesh-list
153965006|NCT00751218|Desloratadine|desloratadine|mesh-list
153965007|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153965008|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153965014|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965015|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153965016|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
153965018|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153965019|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
153965020|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965021|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965022|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965023|NCT04095013|Fentanyl|fentanyl|mesh-list
153965024|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
153965025|NCT04095013|Bupivacaine|bupivacaine|mesh-list
153965026|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
153965027|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
153965028|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965029|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965030|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
153965031|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965032|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153965033|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965034|NCT04095013|Analgesics|analgesics|mesh-ancestor
153965037|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153965068|NCT00627692|Laxatives|laxatives|mesh-ancestor
153965069|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965070|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153965071|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153965072|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
153965073|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965074|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965075|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965077|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153965078|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965079|NCT04301882|Interferons|interferons|mesh-list
153965080|NCT04301882|Ribavirin|ribavirin|mesh-list
153722704|NCT02964689|Pemetrexed|pemetrexed|mesh-list
153965081|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
153965082|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965083|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965084|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
153965085|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965086|NCT04300322|Progesterone|progesterone|mesh-list
153965087|NCT04300322|Progestins|progestins|mesh-ancestor
153965088|NCT04300322|Hormones|hormones|mesh-ancestor
153965089|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965090|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965091|NCT01022762|Repaglinide|repaglinide|mesh-list
153965092|NCT01022762|Gliclazide|gliclazide|mesh-list
153965093|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153965094|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965095|NCT00311844|Desloratadine|desloratadine|mesh-list
153965096|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153965097|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
153965098|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965099|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965100|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965109|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965110|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153965111|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153965112|NCT02778789|Adalimumab|adalimumab|mesh-list
153965113|NCT02778789|Infliximab|infliximab|mesh-list
153965114|NCT02778789|Golimumab|golimumab|mesh-list
153965115|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
153965116|NCT02778789|Etanercept|etanercept|mesh-list
153965117|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153965118|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965119|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153965120|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
153965121|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965122|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153965123|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965124|NCT02778789|Analgesics|analgesics|mesh-ancestor
153501431|NCT00380640|Trimethoprim|trimethoprim|mesh-list
153965125|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
153965126|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965127|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965128|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153965129|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
153965130|NCT00212784|Olanzapine|olanzapine|mesh-list
153965164|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965165|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153965166|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153965167|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153965168|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
153965169|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153965170|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965171|NCT02779101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153965226|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965227|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153965229|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153965230|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965231|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153965232|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965233|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
153965234|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153965235|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
153965236|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965238|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153965239|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153965240|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965241|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153965242|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153965243|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
153965244|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965281|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
153965282|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
153965283|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
153965284|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965286|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153965287|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153965288|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
153965289|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965290|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965291|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965292|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
153965293|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153965294|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965295|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965296|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965297|NCT02773017|Analgesics|analgesics|mesh-ancestor
153965298|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
153965335|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
153965336|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153965337|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153965338|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965339|NCT02771925|Gabapentin|gabapentin|mesh-list
153965340|NCT02771925|Analgesics|analgesics|mesh-ancestor
153965341|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
153965404|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153965405|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153965406|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965407|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153965408|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965409|NCT00897390|Metformin|metformin|mesh-list
153965410|NCT00897390|Saxagliptin|saxagliptin|mesh-list
153965411|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153965412|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965413|NCT00897390|Incretins|incretins|mesh-ancestor
153965414|NCT00897390|Hormones|hormones|mesh-ancestor
153965417|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
153965467|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965468|NCT00816972|Urological Agents|urological agents|mesh-ancestor
153965469|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153965470|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501474|NCT00381342|Incretins|incretins|mesh-ancestor
153965471|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153965472|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153965473|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
153965475|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
153965476|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
153965477|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153965478|NCT02841150|Ibrutinib|ibrutinib|mesh-list
153965479|NCT02841150|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153965480|NCT02841150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153965481|NCT02841150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965482|NCT02841150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965483|NCT02774499|Methadone|methadone|mesh-list
153965484|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153965485|NCT02774499|Narcotics|narcotics|mesh-ancestor
153965486|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965487|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965488|NCT02774499|Analgesics|analgesics|mesh-ancestor
153965489|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
153965490|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965491|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
153965492|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
153965493|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153965494|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153965495|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
153965496|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965497|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965498|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965499|NCT02774187|Leucovorin|leucovorin|mesh-list
153965506|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153965507|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153965508|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
153965509|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965510|NCT02774187|Antidotes|antidotes|mesh-ancestor
153965511|NCT02774187|Protective Agents|protective agents|mesh-ancestor
153965512|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
153965513|NCT02774187|Vitamins|vitamins|mesh-ancestor
153965514|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
153965515|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153965572|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
153965573|NCT04224675|Atenolol|atenolol|mesh-list
153965574|NCT04224675|Captopril|captopril|mesh-list
153965575|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153965576|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153965577|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
153965578|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
153965579|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965580|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965581|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153965582|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153965583|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153965584|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
153965585|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965586|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965587|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153965588|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
153965589|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965590|NCT02768493|Ropivacaine|ropivacaine|mesh-list
153965591|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
153965592|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
153965628|NCT02767245|Vitamins|vitamins|mesh-ancestor
153965629|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
153965630|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965631|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
153965632|NCT02767401|Aspirin|aspirin|mesh-list
153965633|NCT02767401|Metoprolol|metoprolol|mesh-list
153965634|NCT02767401|Clopidogrel|clopidogrel|mesh-list
153965635|NCT02767401|Ticagrelor|ticagrelor|mesh-list
153965636|NCT02767401|Atorvastatin|atorvastatin|mesh-list
153965637|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153965638|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153965639|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965640|NCT02767401|Analgesics|analgesics|mesh-ancestor
153965692|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965693|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
153965694|NCT02767635|Hormones|hormones|mesh-ancestor
153965695|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965696|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153965697|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
153965698|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965699|NCT04224441|Temozolomide|temozolomide|mesh-list
153965700|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
153965702|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
153965757|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965758|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153965759|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
153965760|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965761|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965762|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153965763|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153965765|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153965766|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153965767|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153965768|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
153965769|NCT04091815|Anesthetics|anesthetics|mesh-list
153965770|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965771|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965772|NCT00746785|Olanzapine|olanzapine|mesh-list
153965773|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
153965774|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
153965775|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965777|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153965811|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153965812|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
153965813|NCT04223973|Insulin|insulin|mesh-list
153965814|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153965815|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965816|NCT00750919|Mirtazapine|mirtazapine|mesh-list
153965817|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
153965818|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965819|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153965821|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
153965822|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153965823|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965824|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965825|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153965826|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965827|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965828|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153965829|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153965830|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153965836|NCT02761161|Mianserin|mianserin|mesh-list
153965867|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965868|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965869|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153965870|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153965871|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153965872|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153965873|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965874|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153965875|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153965876|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965877|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
153965878|NCT04222491|Immunomodulating Agents|immunomodulating agents|mesh-list
153965879|NCT04222491|Immunologic Factors|immunologic factors|mesh-ancestor
153965880|NCT04222491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965881|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
153965882|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
153965883|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153965884|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965885|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965886|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
153965887|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153965888|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153965889|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965890|NCT04223739|Amiodarone|amiodarone|mesh-list
153965916|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965917|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153965918|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
153965919|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153965920|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153965921|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153965922|NCT02760615|Losartan|losartan|mesh-list
153965923|NCT02760615|Midazolam|midazolam|mesh-list
153965924|NCT02760615|Levomethorphan|levomethorphan|mesh-list
153965925|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
153965926|NCT02760615|Caffeine|caffeine|mesh-list
153965981|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153965982|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965983|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965984|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965985|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153965986|NCT02760381|Acetic Acid|acetic acid|mesh-list
153965987|NCT02760381|Retinol acetate|retinol acetate|mesh-list
153965988|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153965989|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153965990|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153965991|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
153965992|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966043|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153966044|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153966045|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966046|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966047|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153966048|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153966049|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153966050|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153966051|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153966052|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
153966053|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
153966054|NCT02764515|Methotrexate|methotrexate|mesh-list
153966055|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153966056|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
153966057|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153966058|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966059|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966060|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
153966061|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966062|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966063|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966064|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966065|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153966066|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153966067|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
153966068|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966069|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153966071|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153966072|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966073|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
153966074|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153966075|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153966076|NCT02764359|Vancomycin|vancomycin|mesh-list
153966077|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153966078|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966079|NCT02764125|Levodopa|levodopa|mesh-list
153966082|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153966083|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153966084|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
153966085|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966086|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966087|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966088|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153966089|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966090|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153966091|NCT02764281|Dexamethasone|dexamethasone|mesh-list
153966092|NCT02764281|Methotrexate|methotrexate|mesh-list
153966093|NCT02764281|Etoposide|etoposide|mesh-list
153966094|NCT02764281|Pegaspargase|pegaspargase|mesh-list
153966095|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966096|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
153966097|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
153966098|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966099|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966100|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153966101|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
153966102|NCT02764281|Hormones|hormones|mesh-ancestor
153966104|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153966135|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153966136|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
153966137|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
153966138|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966139|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966140|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
153966141|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153966142|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966143|NCT04660929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153966144|NCT04660929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966145|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
153966146|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153966147|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966148|NCT02758587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153966149|NCT02758587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966150|NCT02758509|Interferons|interferons|mesh-list
153966151|NCT02758509|Ritonavir|ritonavir|mesh-list
153966152|NCT02758509|Ribavirin|ribavirin|mesh-list
153966153|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
153966154|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
153966155|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
153966156|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153966157|NCT02758509|Ledipasvir|ledipasvir|mesh-list
153966158|NCT02758509|Simeprevir|simeprevir|mesh-list
153966159|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153966160|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966161|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
153966162|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966181|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153966182|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153966183|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153966184|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966185|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153966186|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153966187|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966188|NCT02752503|Nalmefene|nalmefene|mesh-list
153966189|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153966190|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966191|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
153966192|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966193|NCT04479579|Apixaban|apixaban|mesh-list
153966194|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153966195|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
153966196|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153966197|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
153966198|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966199|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966200|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
153966201|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
153966232|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966233|NCT02756715|Propofol|propofol|mesh-list
153966234|NCT02756715|Desflurane|desflurane|mesh-list
153966235|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153966236|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966237|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966238|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153966239|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
153966240|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
153966241|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153966242|NCT04221321|Atorvastatin|atorvastatin|mesh-list
153966243|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153966244|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153966245|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
153966246|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966291|NCT02755311|Epirubicin|epirubicin|mesh-list
153966292|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
153966293|NCT02755311|Pirarubicin|pirarubicin|mesh-list
153966294|NCT02755311|Doxorubicin|doxorubicin|mesh-list
153966295|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
153966296|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966297|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
153966298|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966299|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966300|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153966301|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
153966302|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966303|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153966304|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153966305|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153966306|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966307|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
153966308|NCT02755311|Coagulants|coagulants|mesh-ancestor
153966309|NCT04554771|Paclitaxel|paclitaxel|mesh-list
153966310|NCT04554771|Carboplatin|carboplatin|mesh-list
153966311|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153966312|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966313|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
153966314|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
153966315|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
153966316|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966317|NCT04090801|Ethanol|ethanol|mesh-list
153966339|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153966340|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
153966341|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153966342|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153966343|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
153966344|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153966345|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153729886|NCT01248949|Bevacizumab|bevacizumab|mesh-list
153966346|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966347|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
153966348|NCT02754687|Nandrolone|nandrolone|mesh-list
153966349|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
153966350|NCT02754687|Androgens|androgens|mesh-ancestor
153966351|NCT02754687|Hormones|hormones|mesh-ancestor
153966352|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966353|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966354|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
153966355|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153966356|NCT05429775|Budesonide|budesonide|mesh-list
153966357|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966358|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153966359|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
153966360|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966361|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966362|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153966363|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
153966364|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
153966365|NCT05429775|Hormones|hormones|mesh-ancestor
153966385|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966386|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153966387|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
153966388|NCT04219995|Hormones|hormones|mesh-ancestor
153966389|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966390|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153966391|NCT04219995|Protective Agents|protective agents|mesh-ancestor
153966392|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153966393|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966394|NCT04200417|Mitomycins|mitomycins|mesh-list
153966395|NCT04200417|Mitomycin|mitomycin|mesh-list
153966396|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
153966397|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153966398|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966399|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
153966400|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966401|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153966402|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966403|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
153966404|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153966405|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966406|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966407|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153966408|NCT02753205|Analgesics|analgesics|mesh-ancestor
153966409|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
153966410|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966411|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153966412|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153966413|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153966414|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
153966415|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966416|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966417|NCT02695641|Bevacizumab|bevacizumab|mesh-list
153966418|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153966419|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966420|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153646626|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
153646627|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966421|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153966422|NCT02695641|Growth Substances|growth substances|mesh-ancestor
153966423|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966425|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
153966426|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153966427|NCT02750475|Protective Agents|protective agents|mesh-ancestor
153966428|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966429|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
153966431|NCT04217265|Misoprostol|misoprostol|mesh-list
153966432|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966433|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153966434|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153966435|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966436|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966437|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153966438|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
153966439|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966440|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966441|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153966442|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
153966443|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153966444|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153966445|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153966446|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
153966447|NCT00635973|Gefitinib|gefitinib|mesh-list
153966448|NCT00635973|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153966449|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153966450|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966451|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966465|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966466|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153966467|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966468|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966470|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153966471|NCT02750163|Analgesics|analgesics|mesh-ancestor
153966472|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
153966473|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966474|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966475|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
153966476|NCT04217421|Allopurinol|allopurinol|mesh-list
153966477|NCT04217421|Mannitol|mannitol|mesh-list
153966478|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
153966479|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966480|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966481|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
153966482|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966483|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153966484|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
153966485|NCT04217421|Protective Agents|protective agents|mesh-ancestor
153966486|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966487|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153966488|NCT04217421|Diuretics|diuretics|mesh-ancestor
153966489|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
153966490|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
153966491|NCT04036929|Estrogens|estrogens|mesh-list
153966492|NCT04036929|Hormones|hormones|mesh-ancestor
153966493|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966496|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153966511|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
153966512|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153966513|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153966514|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153966515|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966516|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153966517|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966518|NCT04218513|Edaravone|edaravone|mesh-list
153966519|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153966520|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
153966521|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966522|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153966523|NCT04218513|Protective Agents|protective agents|mesh-ancestor
153966571|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966572|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153966575|NCT04217733|Alverine|alverine|mesh-list
153966576|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
153966577|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
153966578|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
153966579|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966580|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966581|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153966582|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
153966583|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966584|NCT02746185|Heparin|heparin|mesh-list
153966585|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153966586|NCT02746185|Tinzaparin|tinzaparin|mesh-list
153966587|NCT02746185|Dalteparin|dalteparin|mesh-list
153966588|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
153966589|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
153966590|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153966591|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153966592|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966593|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153966594|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
153966595|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153966596|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
153966597|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966598|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
153966623|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153966624|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153966625|NCT02741817|Aspirin|aspirin|mesh-list
153966626|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153966627|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153966628|NCT02741817|Analgesics|analgesics|mesh-ancestor
153966629|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
153966630|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966631|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966632|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966633|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966634|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153966635|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153966638|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153966684|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966685|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153966686|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153966687|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
153966688|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153966689|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153966690|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153966691|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153966692|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
153966693|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153966694|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153966746|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966747|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
153966748|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966749|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153966750|NCT02744937|Aspirin|aspirin|mesh-list
153966751|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153966752|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153966753|NCT02744937|Analgesics|analgesics|mesh-ancestor
153966754|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
153966755|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966758|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966810|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966811|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153966812|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
153966813|NCT02739477|Favipiravir|favipiravir|mesh-list
153966814|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
153966815|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153966816|NCT02739399|Phenylephrine|phenylephrine|mesh-list
153966817|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
153966818|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153966819|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
153966820|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
153966821|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966822|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966823|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
153966824|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153966825|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
153966826|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
153966827|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153966828|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153966829|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153966830|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
153966831|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966865|NCT06179056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153966866|NCT06179056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153966867|NCT06179056|Analgesics|analgesics|mesh-ancestor
153966868|NCT06179056|Sensory System Agents|sensory system agents|mesh-ancestor
153966869|NCT06179056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966870|NCT06179056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153966871|NCT06179056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153966872|NCT06179056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153966873|NCT06179056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966874|NCT06178926|Propofol|propofol|mesh-list
153966875|NCT06178926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153966876|NCT06178926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966877|NCT06178926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966878|NCT06178926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153966879|NCT06178926|Anesthetics, General|anesthetics, general|mesh-ancestor
153966880|NCT06178926|Anesthetics|anesthetics|mesh-ancestor
153966881|NCT06178874|Insulin|insulin|mesh-list
153966882|NCT06178874|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153966883|NCT06178874|Insulin Glargine|insulin glargine|mesh-list
153966884|NCT06178874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153966885|NCT06178874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966886|NCT06178848|Propofol|propofol|mesh-list
153966887|NCT06178848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153966888|NCT06178848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153966919|NCT06178523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153966920|NCT06178523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966921|NCT06178523|Urological Agents|urological agents|mesh-ancestor
153966922|NCT06178523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153966923|NCT06178523|Hormone Antagonists|hormone antagonists|mesh-ancestor
153966924|NCT06178523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153966925|NCT06178523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966926|NCT06178523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153966927|NCT06178523|Fertility Agents|fertility agents|mesh-ancestor
153966928|NCT06178523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153966929|NCT06178523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153966930|NCT06178523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153966981|NCT06166498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153966982|NCT06166498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966983|NCT06166498|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153966985|NCT06163352|Norepinephrine|norepinephrine|mesh-list
153501647|NCT00386178|Vitamin E|vitamin e|mesh-list
153966986|NCT06163352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153966987|NCT06163352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153966988|NCT06163352|Adrenergic Agents|adrenergic agents|mesh-ancestor
153966989|NCT06163352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966990|NCT06163352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153966991|NCT06163352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153966992|NCT06163352|Sympathomimetics|sympathomimetics|mesh-ancestor
153966993|NCT06163352|Autonomic Agents|autonomic agents|mesh-ancestor
153966994|NCT06163352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153966995|NCT06163352|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153966996|NCT06163352|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153966997|NCT06163352|Dopamine Agents|dopamine agents|mesh-ancestor
153966998|NCT06163352|Protective Agents|protective agents|mesh-ancestor
153966999|NCT06150014|Tenofovir|tenofovir|mesh-list
153967000|NCT06150014|Entecavir|entecavir|mesh-list
153967036|NCT06017479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153967038|NCT06017479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967039|NCT06017479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967040|NCT06017479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967041|NCT06017479|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153967042|NCT06017479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153967043|NCT06016920|Pembrolizumab|pembrolizumab|mesh-list
153967044|NCT06016920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967045|NCT06016920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967046|NCT06016920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153967047|NCT06016920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967048|NCT05995444|Moxifloxacin|moxifloxacin|mesh-list
153967049|NCT05995444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153967050|NCT05995444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967051|NCT05995444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153967052|NCT05995444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967053|NCT05995444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967054|NCT05995444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967055|NCT05995444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967056|NCT05975268|Antibodies|antibodies|mesh-list
153967057|NCT05975268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153967058|NCT05975268|Immunologic Factors|immunologic factors|mesh-ancestor
153967059|NCT05975268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967084|NCT05917340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153967085|NCT05917340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153967086|NCT05917340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967088|NCT05917340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153967089|NCT05917340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967090|NCT05917340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153967091|NCT05917340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967092|NCT05917340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967093|NCT05917340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153967094|NCT05917340|Antitubercular Agents|antitubercular agents|mesh-ancestor
153967095|NCT05917340|Leprostatic Agents|leprostatic agents|mesh-ancestor
153967096|NCT05917340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153967097|NCT05917340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153967098|NCT05917340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153967099|NCT05917340|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153967100|NCT05917340|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153967101|NCT05917340|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153967102|NCT05917340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153967103|NCT05917340|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153967104|NCT05917340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153967105|NCT05917340|Antimetabolites|antimetabolites|mesh-ancestor
153967106|NCT05917340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153967107|NCT05902819|Minocycline|minocycline|mesh-list
153967108|NCT05902819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153967132|NCT05767047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153967133|NCT05767047|Analgesics|analgesics|mesh-ancestor
153967134|NCT05767047|Sensory System Agents|sensory system agents|mesh-ancestor
153967135|NCT05767047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967136|NCT05767047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967137|NCT05767047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967138|NCT05767047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967139|NCT05767047|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153967140|NCT05767047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153967141|NCT05767047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967142|NCT05767047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967143|NCT05700266|Aspirin|aspirin|mesh-list
153967144|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
153967145|NCT05700266|Clopidogrel|clopidogrel|mesh-list
153967146|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153967147|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153967148|NCT05700266|Analgesics|analgesics|mesh-ancestor
153967149|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
153967150|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967151|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967152|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967153|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967154|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153967155|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153967156|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967157|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153967158|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153967159|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967160|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
153967161|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153967162|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153967163|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153967172|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153967173|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967175|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
153967176|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153967177|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153967178|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153967179|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967180|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967181|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967182|NCT05438329|Pembrolizumab|pembrolizumab|mesh-list
153967183|NCT05438329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967184|NCT05438329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967231|NCT05238883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967232|NCT05238883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967233|NCT05179499|Norepinephrine|norepinephrine|mesh-list
153967234|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153967235|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153967236|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
153967237|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967238|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967239|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967240|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
153967241|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
153967242|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967243|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153967244|NCT05157126|Gentamicins|gentamicins|mesh-list
153967245|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153967246|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967247|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153967248|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967249|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967250|NCT05153668|Everolimus|everolimus|mesh-list
153967251|NCT05153668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153967253|NCT05153668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967283|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967284|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153967285|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
153967286|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
153967287|NCT05040568|Fludarabine|fludarabine|mesh-list
153967288|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
153967289|NCT05040568|Cetuximab|cetuximab|mesh-list
153967290|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967291|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
153967292|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967293|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967294|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153967295|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
153967296|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967343|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153967344|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967345|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
153967346|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
153967347|NCT04777643|Cannabidiol|cannabidiol|mesh-list
153967348|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
153967349|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
153967350|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153967351|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153967352|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153967353|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153967354|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153967355|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967356|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
153967357|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967358|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967359|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153967360|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967361|NCT04714190|Paclitaxel|paclitaxel|mesh-list
153967362|NCT04714190|Irinotecan|irinotecan|mesh-list
153967363|NCT04714190|Apatinib|apatinib|mesh-list
153967364|NCT04714190|Trastuzumab|trastuzumab|mesh-list
153967365|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153967366|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967367|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
153967368|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
153967369|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
153967370|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967376|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
153967390|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
153967391|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153967392|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153967393|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967394|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967395|NCT04645550|Aspirin|aspirin|mesh-list
153967396|NCT04645550|Heparin|heparin|mesh-list
153967397|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153967398|NCT04645550|Tinzaparin|tinzaparin|mesh-list
153967399|NCT04645550|Dalteparin|dalteparin|mesh-list
153967400|NCT04645550|Dipyridamole|dipyridamole|mesh-list
153967401|NCT04645550|Warfarin|warfarin|mesh-list
153967402|NCT04645550|Apixaban|apixaban|mesh-list
153967403|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153967404|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153967405|NCT04645550|Analgesics|analgesics|mesh-ancestor
153967406|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
153501688|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
153967407|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967408|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967409|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967410|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967411|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153967412|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153967413|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967414|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153967415|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153967416|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967417|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
153967418|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
153967419|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153967420|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
153967421|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153967422|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
153967423|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153967424|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
153967425|NCT04592744|Vasopressins|vasopressins|mesh-list
153967426|NCT04592744|Epinephrine|epinephrine|mesh-list
153967432|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153967433|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
153967434|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967435|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967436|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967437|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153967438|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153967439|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
153967440|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967441|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153967442|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
153967443|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
153967444|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
153967445|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153967446|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
153967447|NCT04592744|Coagulants|coagulants|mesh-ancestor
153967448|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153967449|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
153967450|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153967451|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
153967452|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967453|NCT04588285|Ambroxol|ambroxol|mesh-list
153967454|NCT04588285|Expectorants|expectorants|mesh-ancestor
153967455|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
153967456|NCT04567160|Propofol|propofol|mesh-list
153967457|NCT04567160|Sevoflurane|sevoflurane|mesh-list
153967458|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153967459|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153967460|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967461|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153967462|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
153967463|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
153967464|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153967465|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153967466|NCT04530058|Metformin|metformin|mesh-list
153967467|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153967473|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967474|NCT04526236|Analgesics|analgesics|mesh-ancestor
153967475|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
153967476|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967477|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
153967478|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
153967479|NCT04521348|Antibodies|antibodies|mesh-list
153967480|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
153967481|NCT04521348|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153967482|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
153967483|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967484|NCT04521348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967485|NCT04521348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967486|NCT04521348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967487|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153967488|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153967489|NCT04425629|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
153967491|NCT04425629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967492|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
153967493|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967494|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967495|NCT04317066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153967496|NCT04317066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967497|NCT04292743|Leucovorin|leucovorin|mesh-list
153967498|NCT04292743|Fluorouracil|fluorouracil|mesh-list
153967499|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
153967500|NCT04292743|Irinotecan|irinotecan|mesh-list
153967501|NCT04292743|Folfirinox|folfirinox|mesh-list
153967502|NCT04292743|Eryaspase|eryaspase|mesh-list
153967503|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
153967504|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967505|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153967506|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967507|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153967508|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
153967509|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646628|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153646658|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646659|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153646660|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153967511|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967512|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967513|NCT04292743|Antidotes|antidotes|mesh-ancestor
153967514|NCT04292743|Protective Agents|protective agents|mesh-ancestor
153967515|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
153967516|NCT04292743|Vitamins|vitamins|mesh-ancestor
153967517|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
153967518|NCT04267939|Niraparib|niraparib|mesh-list
153967519|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153967520|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967521|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967522|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967523|NCT04251819|Baclofen|baclofen|mesh-list
153967524|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153967525|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967526|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153967527|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967528|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153967529|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
153967530|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
153967531|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967532|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967533|NCT04232969|Exenatide|exenatide|mesh-list
153967534|NCT04232969|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153967535|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153967536|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967537|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153967538|NCT04232969|Incretins|incretins|mesh-ancestor
153967539|NCT04232969|Hormones|hormones|mesh-ancestor
153967540|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967541|NCT04091022|Eflornithine|eflornithine|mesh-list
153967542|NCT04091022|Diclofenac|diclofenac|mesh-list
153967543|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153967544|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153967545|NCT04091022|Analgesics|analgesics|mesh-ancestor
153967546|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
153967548|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967549|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967550|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153967551|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153967552|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967553|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967554|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967555|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153967556|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153967557|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153967558|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967559|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153967561|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
153967562|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
153967563|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967564|NCT04028063|Doxorubicin|doxorubicin|mesh-list
153967565|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153967566|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967567|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153967568|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967569|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967570|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967571|NCT03964532|Avelumab|avelumab|mesh-list
153967572|NCT03964532|Talazoparib|talazoparib|mesh-list
153967573|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967574|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967575|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153967576|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967577|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967578|NCT03854903|Fulvestrant|fulvestrant|mesh-list
153967579|NCT03854903|Palbociclib|palbociclib|mesh-list
153967580|NCT03854903|Bosutinib|bosutinib|mesh-list
153967581|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153967587|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967588|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967589|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967590|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967591|NCT03854903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153967592|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
153967593|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153967594|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153967595|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967596|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
153967597|NCT03849443|Coagulants|coagulants|mesh-ancestor
153967598|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153967649|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153967650|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967651|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967652|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967653|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
153967655|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967656|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153967657|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153967658|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
153967659|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153967660|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153967661|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
153967662|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
153967663|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153967664|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153967665|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
153967666|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967667|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153967668|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
153967669|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
153967670|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
153967676|NCT03219268|Margetuximab|margetuximab|mesh-list
153967677|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967678|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
153967679|NCT03153202|Ibrutinib|ibrutinib|mesh-list
153967680|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967681|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967682|NCT03153202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153967683|NCT03153202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967698|NCT03088878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967699|NCT03088878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967700|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153967701|NCT03087071|Panitumumab|panitumumab|mesh-list
153967702|NCT03087071|Trametinib|trametinib|mesh-list
153967703|NCT03087071|Antibodies|antibodies|mesh-list
153967704|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
153967705|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153967706|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
153967707|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967708|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967709|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967710|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967711|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967712|NCT03085485|Ivacaftor|ivacaftor|mesh-list
153967713|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153967714|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153967715|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967716|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
153967717|NCT03071861|Hematinics|hematinics|mesh-ancestor
153967718|NCT03043872|Carboplatin|carboplatin|mesh-list
153967719|NCT03043872|Etoposide|etoposide|mesh-list
153967720|NCT03043872|Durvalumab|durvalumab|mesh-list
153967721|NCT03043872|Tremelimumab|tremelimumab|mesh-list
153967722|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967723|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153967724|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153967725|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967744|NCT03005860|Analgesics|analgesics|mesh-ancestor
153967745|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
153967746|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967747|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153967748|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153967749|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
153967750|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
153967751|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967752|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153967753|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153967754|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153967755|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153967756|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153967757|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153967758|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153967759|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
153967760|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967761|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153967762|NCT02928224|Leucovorin|leucovorin|mesh-list
153967763|NCT02928224|Folic Acid|folic acid|mesh-list
153967797|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967798|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967799|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967801|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153967802|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
153967803|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967804|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967805|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153967810|NCT02678572|Melphalan|melphalan|mesh-list
153967863|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967864|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153967865|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153967866|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153967867|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153967868|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967869|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153967870|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
153967871|NCT02166463|Hormones|hormones|mesh-ancestor
153967872|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153967873|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153967874|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153967875|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
153967876|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
153967877|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
153967878|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
153967879|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
153967880|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153967881|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153967882|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153967883|NCT02166463|Protective Agents|protective agents|mesh-ancestor
153967884|NCT02166463|Immunotoxins|immunotoxins|mesh-ancestor
153967885|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
153967886|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
153967887|NCT02118467|Phenylephrine|phenylephrine|mesh-list
153967888|NCT02118467|Vasopressins|vasopressins|mesh-list
153967889|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
153967890|NCT02118467|Epinephrine|epinephrine|mesh-list
153967891|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
153967892|NCT02118467|Norepinephrine|norepinephrine|mesh-list
153967893|NCT02118467|Synephrine|synephrine|mesh-list
153967894|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153967895|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153967907|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
153967908|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153967909|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153967910|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
153967911|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153967912|NCT02118467|Protective Agents|protective agents|mesh-ancestor
153967913|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
153967914|NCT02118467|Coagulants|coagulants|mesh-ancestor
153967915|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153967916|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
153967917|NCT02101034|Cetuximab|cetuximab|mesh-list
153967918|NCT02101034|Palbociclib|palbociclib|mesh-list
153967919|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153967920|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967921|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153967922|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967923|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967925|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153967926|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967927|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967928|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153967929|NCT00965991|Metformin|metformin|mesh-list
153967930|NCT00965991|Glyburide|glyburide|mesh-list
153967931|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153967932|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967934|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
153967935|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153967936|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153967937|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153967938|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153967939|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967949|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967950|NCT00579969|Timolol|timolol|mesh-list
153967951|NCT00579969|Latanoprost|latanoprost|mesh-list
153967952|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153967953|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153967954|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
153967955|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153967956|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153967957|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967958|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153967959|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153967960|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153967961|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153967962|NCT00135226|Aspirin|aspirin|mesh-list
153968007|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153968008|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
153968009|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153968010|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153968011|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153968012|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968013|NCT02742285|Lumefantrine|lumefantrine|mesh-list
153968014|NCT02742285|Artemether|artemether|mesh-list
153968015|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153968016|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
153968017|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153968018|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153968019|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968020|NCT03673527|Tacrolimus|tacrolimus|mesh-list
153968021|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153968022|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
153968023|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968024|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153968025|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968026|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968027|NCT02738931|Lamivudine|lamivudine|mesh-list
153815390|NCT00347048|Tacrolimus|tacrolimus|mesh-list
153968060|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968061|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968062|NCT02736435|Leuprolide|leuprolide|mesh-list
153968063|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153968064|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
153968065|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153968066|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968068|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968069|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153968070|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
153968071|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153968072|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
153968073|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968074|NCT00748189|Ofatumumab|ofatumumab|mesh-list
153968075|NCT00748189|Chlorambucil|chlorambucil|mesh-list
153968076|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968077|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153968118|NCT03967483|Analgesics|analgesics|mesh-ancestor
153968119|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
153968120|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968121|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968122|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153968123|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153968124|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
153968125|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
153968126|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153968127|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153968128|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968129|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968130|NCT00740779|Silodosin|silodosin|mesh-list
153968131|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153968132|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153968133|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153968134|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968135|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968136|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968137|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968138|NCT00740779|Urological Agents|urological agents|mesh-ancestor
153968139|NCT00735475|Vaccines|vaccines|mesh-list
153968140|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
153968141|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968142|NCT01026818|Tadalafil|tadalafil|mesh-list
153968143|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
153968144|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153968145|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153968146|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968163|NCT00743509|MTOR Inhibitors|mtor inhibitors|mesh-list
153968164|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153968165|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
153968166|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968167|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153968168|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153968169|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
153968170|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968171|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968172|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153968173|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153968174|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968175|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153968176|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
153968177|NCT00743509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153968178|NCT00743509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968179|NCT00734929|Dexamethasone|dexamethasone|mesh-list
153968180|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
153968181|NCT00734929|Ondansetron|ondansetron|mesh-list
153968182|NCT00734929|Aprepitant|aprepitant|mesh-list
153968183|NCT00734929|BB 1101|bb 1101|mesh-list
153968184|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153968185|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
153968186|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
153968187|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968188|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968189|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153968190|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
153968191|NCT00734929|Hormones|hormones|mesh-ancestor
153968195|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
153968207|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968208|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
153968209|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
153968210|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
153968211|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968212|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153968213|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153968214|NCT00734851|Growth Substances|growth substances|mesh-ancestor
153968215|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968216|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
153968217|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153968218|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968219|NCT00734617|Nicotine|nicotine|mesh-list
153968220|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153968221|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
153968222|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968223|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968224|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153968225|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153968226|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
153968227|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968228|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968229|NCT00743431|Doxorubicin|doxorubicin|mesh-list
153968230|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153968231|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968232|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153968233|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153968234|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968235|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968253|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153968254|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153968255|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968256|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968257|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153968258|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
153968259|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968260|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968261|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153968262|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153968263|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
153968264|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
153968265|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
153968266|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968267|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501744|NCT01799850|Pioglitazone|pioglitazone|mesh-list
153968268|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
153968269|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968270|NCT00734539|Fluconazole|fluconazole|mesh-list
153968271|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
153968272|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968273|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153968274|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153968275|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968276|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968277|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153968278|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
153968279|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968280|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968281|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153968282|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153968283|NCT02737059|Codeine|codeine|mesh-list
153968284|NCT02737059|Naloxegol|naloxegol|mesh-list
153968285|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153968287|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968288|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968289|NCT02737059|Analgesics|analgesics|mesh-ancestor
153968290|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
153968291|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968292|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
153968293|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
153968294|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153968295|NCT02731911|Dexamethasone|dexamethasone|mesh-list
153968296|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153968297|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
153968298|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
153968299|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968300|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968301|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153968302|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
153968303|NCT02731911|Hormones|hormones|mesh-ancestor
153968304|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968305|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153968307|NCT04089163|Flucytosine|flucytosine|mesh-list
153968341|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968342|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153968343|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153968344|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968345|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968346|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968347|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153968348|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153968349|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
153968350|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968351|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153968352|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968353|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968354|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
153968355|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968356|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968357|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153968358|NCT00734071|Vortioxetine|vortioxetine|mesh-list
153968359|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
153968360|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153968361|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153968362|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153968363|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968364|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968365|NCT00734071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153968366|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153968367|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153725896|NCT00477061|Morphine|morphine|mesh-list
153968382|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
153968383|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153968384|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
153968385|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968386|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968387|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153968388|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153968389|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968390|NCT05430243|Empagliflozin|empagliflozin|mesh-list
153968392|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153968393|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968394|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153968395|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968396|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
153968397|NCT02730117|Cephalosporins|cephalosporins|mesh-list
153968398|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153968399|NCT02730117|Dobutamine|dobutamine|mesh-list
153968400|NCT02730117|Dopamine|dopamine|mesh-list
153968401|NCT02730117|Milrinone|milrinone|mesh-list
153968402|NCT02730117|Norepinephrine|norepinephrine|mesh-list
153968403|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153968404|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153968405|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153968406|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968407|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968408|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968409|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968410|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
153968411|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
153968412|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968413|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153968414|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153968423|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968424|NCT02595463|Lidocaine|lidocaine|mesh-list
153968425|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
153968426|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
153968427|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968428|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968429|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
153968430|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968431|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153968432|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153968433|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153968434|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968435|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968436|NCT02593669|Dexamethasone|dexamethasone|mesh-list
153968437|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153968438|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
153968439|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
153968440|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968441|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968479|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153968480|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153968481|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153968482|NCT02595541|Protective Agents|protective agents|mesh-ancestor
153968483|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968484|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153968485|NCT00739063|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153968486|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153968487|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968488|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968489|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968490|NCT01026194|Pioglitazone|pioglitazone|mesh-list
153968491|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153968492|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968493|NCT02734875|Anticoagulants|anticoagulants|mesh-list
153968494|NCT04088461|Metformin|metformin|mesh-list
153968495|NCT04088461|Linagliptin|linagliptin|mesh-list
153968496|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153968497|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968498|NCT04088461|Incretins|incretins|mesh-ancestor
153968499|NCT04088461|Hormones|hormones|mesh-ancestor
153968500|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968501|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153968502|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
153968505|NCT00811954|Ritonavir|ritonavir|mesh-list
153968525|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153968526|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153968527|NCT00917839|Lamotrigine|lamotrigine|mesh-list
153968528|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
153968529|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153968530|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153968531|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968532|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153968533|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968534|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153968535|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153968536|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968537|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153968538|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153968539|NCT01032200|Modafinil|modafinil|mesh-list
153968540|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153968581|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968582|NCT02734173|Ritonavir|ritonavir|mesh-list
153968583|NCT02734173|Ribavirin|ribavirin|mesh-list
153968584|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153968585|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153968586|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
153968587|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968588|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968589|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153968590|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153968591|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
153968592|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726232|NCT00117702|Everolimus|everolimus|mesh-list
153968595|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
153968643|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968644|NCT02733705|Fentanyl|fentanyl|mesh-list
153968645|NCT02733705|Propofol|propofol|mesh-list
153968646|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153968647|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968648|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968649|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153968650|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
153968651|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
153968652|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153968653|NCT02733705|Narcotics|narcotics|mesh-ancestor
153968654|NCT02733705|Analgesics|analgesics|mesh-ancestor
153968655|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
153968656|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968658|NCT02597257|Lidocaine|lidocaine|mesh-list
153968704|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968706|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968707|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968708|NCT00811642|Posaconazole|posaconazole|mesh-list
153968709|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
153968710|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968711|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153968712|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153968713|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153968714|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153968715|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153968716|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968717|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968718|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153968719|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
153968760|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
153968761|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968762|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153968763|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968764|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153968765|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153968766|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968767|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
153968769|NCT05753722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153968770|NCT05753722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968771|NCT05753722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153968772|NCT05753722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968773|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
153968774|NCT02727621|Propofol|propofol|mesh-list
153968775|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153968776|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968777|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968778|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153968779|NCT02727621|Analgesics|analgesics|mesh-ancestor
153968780|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
153968781|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968782|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153968783|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153968784|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153968785|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968786|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968787|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968805|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153968806|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968807|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968809|NCT05755750|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153968810|NCT05755750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153968811|NCT02732067|Anesthetics|anesthetics|mesh-list
153968812|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968813|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726448|NCT00481819|Tacrolimus|tacrolimus|mesh-list
153968814|NCT02609932|Interferons|interferons|mesh-list
153968815|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
153968816|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968817|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
153968818|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153968819|NCT02726919|Clobazam|clobazam|mesh-list
153968820|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
153968821|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153968822|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153968823|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153968824|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968825|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153968826|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153968827|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
153968828|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
153968829|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968830|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968831|NCT05753566|Androgens|androgens|mesh-list
153968832|NCT05753566|Hormones|hormones|mesh-ancestor
153968833|NCT05753566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968834|NCT05753566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968835|NCT00590824|Interleukin-2|interleukin-2|mesh-list
153968836|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968837|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153968838|NCT00590824|Analgesics|analgesics|mesh-ancestor
153968846|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153968847|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968848|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153968849|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153968850|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
153968851|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153968852|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153968853|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153968854|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153968855|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
153968856|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153968857|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153968858|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
154157405|NCT05797233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153968859|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153968860|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
153968861|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153968903|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968904|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968905|NCT02693769|Fluticasone|fluticasone|mesh-list
153968906|NCT02693769|Xhance|xhance|mesh-list
153968907|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
153968908|NCT02693769|Bromides|bromides|mesh-list
153968909|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
153968910|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153968911|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153968912|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
153968913|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153968914|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153968915|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153968916|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
153968917|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
153968918|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153968919|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153968920|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153968921|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153968922|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
153968923|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153968924|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968925|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
153968926|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153968927|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153968928|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153968929|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
153968930|NCT02725359|Tizanidine|tizanidine|mesh-list
153968931|NCT02725359|Bupivacaine|bupivacaine|mesh-list
153968950|NCT00731731|Temozolomide|temozolomide|mesh-list
153968951|NCT00731731|Vorinostat|vorinostat|mesh-list
153968952|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153968954|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968955|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153968956|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153968957|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153968958|NCT02719431|Warfarin|warfarin|mesh-list
153968959|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
153969017|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969018|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969019|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
153969020|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153969021|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969022|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153969023|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969024|NCT02718261|Pantoprazole|pantoprazole|mesh-list
153969025|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153969054|NCT02717871|Ofloxacin|ofloxacin|mesh-list
153969085|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969086|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153969087|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153969088|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969089|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969090|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153969096|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
153969151|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969152|NCT02716233|Pegaspargase|pegaspargase|mesh-list
153969153|NCT02716233|Asparaginase|asparaginase|mesh-list
153969154|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969156|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969157|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153969158|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153969159|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969160|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969216|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153969217|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969218|NCT04037085|Ketamine|ketamine|mesh-list
153969219|NCT04037085|Analgesics|analgesics|mesh-ancestor
153969220|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
153969221|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969222|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969223|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153969284|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969285|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
153969286|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969287|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969288|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
153969289|NCT04777929|Progesterone|progesterone|mesh-list
153969290|NCT04777929|Estrogens|estrogens|mesh-list
153969291|NCT04777929|Progestins|progestins|mesh-ancestor
153969292|NCT04777929|Hormones|hormones|mesh-ancestor
153969293|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153969294|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969295|NCT00590044|Insulin|insulin|mesh-list
153969296|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153969297|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
153969298|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
153969299|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153969300|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969301|NCT02714361|Vitamin D|vitamin d|mesh-list
153969302|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
153969303|NCT02714361|Vitamins|vitamins|mesh-ancestor
153969304|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
153969308|NCT00248703|Docetaxel|docetaxel|mesh-list
153969337|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969338|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969339|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153969340|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
153969341|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153969342|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153969343|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153969344|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153969345|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153969346|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153969347|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
153969348|NCT00729859|Anastrozole|anastrozole|mesh-list
153969349|NCT00729859|Testosterone|testosterone|mesh-list
153969398|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153969400|NCT00808444|Vaccines|vaccines|mesh-list
153969401|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153969402|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
153969403|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969404|NCT00914134|Levodopa|levodopa|mesh-list
153969405|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153969406|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153969407|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
153969408|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969409|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969410|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969411|NCT05754736|Bevacizumab|bevacizumab|mesh-list
153969412|NCT05754736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153969460|NCT02713191|Analgesics|analgesics|mesh-ancestor
153969461|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
153969462|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969463|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153969464|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153969465|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153969466|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
153969467|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969468|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969524|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969525|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969526|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153969528|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
153969529|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969530|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153969531|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153969590|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153969591|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153969592|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153969593|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153969594|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153969595|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153969596|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153969597|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153969598|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
153969599|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969600|NCT00635037|Bupivacaine|bupivacaine|mesh-list
153969601|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
153969602|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
153969603|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969604|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969605|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
153969645|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
153969646|NCT02711241|Urological Agents|urological agents|mesh-ancestor
153969647|NCT02711007|Apatinib|apatinib|mesh-list
153969648|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969649|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153969650|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969651|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969713|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
153969714|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969715|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153969716|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153969717|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153969718|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153969719|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969720|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
153969721|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153969722|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
153969723|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
153969724|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153969725|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
153969726|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153969727|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
153969728|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969729|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153969730|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
153969731|NCT02708511|Copper|copper|mesh-list
153969771|NCT02593201|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153969772|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
153969773|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153969774|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501827|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
153969775|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969776|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153969777|NCT02707809|Analgesics|analgesics|mesh-ancestor
153969778|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
153969779|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969780|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153969781|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153969782|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153969783|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
153969784|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969785|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969786|NCT00585325|Lidocaine|lidocaine|mesh-list
153969787|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
153969788|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
153969789|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969790|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969826|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969827|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969828|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153969829|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
153969830|NCT00611793|Bevacizumab|bevacizumab|mesh-list
153969831|NCT00611793|Vatalanib|vatalanib|mesh-list
153969832|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153969833|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969834|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153969835|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153969836|NCT00611793|Growth Substances|growth substances|mesh-ancestor
153969837|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969838|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
153969839|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153501845|NCT02996058|Analgesics|analgesics|mesh-ancestor
153969840|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969841|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969842|NCT00611871|Propranolol|propranolol|mesh-list
153969843|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153969844|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153969845|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
153969846|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969847|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969848|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969849|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153969850|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153969874|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153969875|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969876|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969877|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153969878|NCT00741013|Protein C|protein c|mesh-list
153969879|NCT00741013|Lovastatin|lovastatin|mesh-list
153969880|NCT00741013|L 647318|l 647318|mesh-list
153969881|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
153969882|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153969883|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153969884|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
153969885|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969886|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153969887|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153969888|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969889|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
153969890|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153969891|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153969892|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969893|NCT04087759|Bedaquiline|bedaquiline|mesh-list
153969894|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
153969895|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
153969896|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153969897|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153969898|NCT00740857|Ibuprofen|ibuprofen|mesh-list
153969899|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153969900|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153969901|NCT00740857|Analgesics|analgesics|mesh-ancestor
153969902|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
153969903|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153969904|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969905|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153969906|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153969907|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153969908|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969910|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
153969912|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
153969913|NCT00808132|Estrogens|estrogens|mesh-list
153969914|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153969915|NCT00808132|Hormones|hormones|mesh-ancestor
153969916|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153969917|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969918|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153969919|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153969920|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153969921|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
153969922|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153969923|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153969924|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153969925|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153969926|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153969927|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153969928|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153969929|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153969930|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
153969931|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153969932|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
153969961|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
153969962|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969963|NCT02692989|Anesthetics|anesthetics|mesh-list
153969964|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153969965|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153969966|NCT04882293|Atorvastatin|atorvastatin|mesh-list
153969967|NCT04882293|Fenofibrate|fenofibrate|mesh-list
153969968|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153969969|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153969970|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
153969971|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153969972|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153969973|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153969974|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153969975|NCT04856475|Neratinib|neratinib|mesh-list
153969976|NCT04856475|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153969977|NCT04856475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153969978|NCT04856475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970017|NCT00803452|Minocycline|minocycline|mesh-list
153970018|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153970019|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970020|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
153970021|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153970022|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153970023|NCT04546113|Ropivacaine|ropivacaine|mesh-list
153970024|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
153970025|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
153970026|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153970027|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970028|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
153970029|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970030|NCT05737342|Red yeast rice|red yeast rice|mesh-list
153970031|NCT05737342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153970032|NCT05737342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153970033|NCT05737342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153970034|NCT05737342|Antimetabolites|antimetabolites|mesh-ancestor
153970036|NCT05737342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970074|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153970075|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153970076|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
153970077|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970078|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970079|NCT02607436|Aspirin|aspirin|mesh-list
153970080|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
153970081|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153970082|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153970083|NCT02607436|Analgesics|analgesics|mesh-ancestor
153970084|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
153970085|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970086|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970087|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153970088|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153727708|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
153970089|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153970090|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153970091|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970092|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153970093|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153970094|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970095|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
153970096|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153970097|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
153970098|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970099|NCT02607592|Pemetrexed|pemetrexed|mesh-list
153970100|NCT02607592|Nedaplatin|nedaplatin|mesh-list
153970101|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970102|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970103|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970104|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153970105|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153970106|NCT04356339|Interferons|interferons|mesh-list
153970113|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970114|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153970115|NCT04331145|Ticagrelor|ticagrelor|mesh-list
153970116|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153970117|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153970118|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153970119|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153970120|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
153970121|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970123|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970177|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
153970178|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970179|NCT04811625|Aspirin|aspirin|mesh-list
153970180|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153970181|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153970182|NCT04811625|Analgesics|analgesics|mesh-ancestor
153970183|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
153970184|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970185|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970186|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153970187|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153970188|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153970189|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153970190|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970191|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153970192|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153970193|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970194|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
153970195|NCT02764593|Nivolumab|nivolumab|mesh-list
153970196|NCT02764593|Cetuximab|cetuximab|mesh-list
153970197|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970230|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970231|NCT02707653|Misoprostol|misoprostol|mesh-list
153970232|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153970233|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
153970234|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153970235|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970236|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153970237|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153970238|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
153727855|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153970239|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153970240|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153970241|NCT03901131|Norethindrone|norethindrone|mesh-list
153970242|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
153970243|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
153970244|NCT03901131|Estradiol|estradiol|mesh-list
153970245|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153970246|NCT03901131|Estrogens|estrogens|mesh-ancestor
153970247|NCT03901131|Hormones|hormones|mesh-ancestor
153970248|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970249|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970282|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
153970283|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970284|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970285|NCT00914524|Olmesartan|olmesartan|mesh-list
153970286|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153970287|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153970288|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153970289|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153970290|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970291|NCT03787095|Cemiplimab|cemiplimab|mesh-list
153970292|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970293|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970294|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
153970295|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153970296|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970297|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970298|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153970299|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970300|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153970301|NCT00796978|Trastuzumab|trastuzumab|mesh-list
153970302|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970303|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970304|NCT03779295|Clindamycin|clindamycin|mesh-list
153970305|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
153501862|NCT02994888|Cetuximab|cetuximab|mesh-list
153970306|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
153970307|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153970308|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970309|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153970310|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970311|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970321|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970322|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153970323|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153970324|NCT00796822|Protective Agents|protective agents|mesh-ancestor
153970325|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970326|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
153970327|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153970328|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
153970329|NCT03822507|Cinacalcet|cinacalcet|mesh-list
153970330|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153970331|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970332|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153970333|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
153970334|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970377|NCT00724711|Tenofovir|tenofovir|mesh-list
153970378|NCT00724711|Lamivudine|lamivudine|mesh-list
153970379|NCT00724711|Emtricitabine|emtricitabine|mesh-list
153970380|NCT00724711|Abacavir|abacavir|mesh-list
153970381|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
153970382|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153970383|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153728001|NCT01244659|Tacrolimus|tacrolimus|mesh-list
153970384|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153970385|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970386|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970387|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153970388|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153970389|NCT00721279|Pramipexole|pramipexole|mesh-list
153970390|NCT00721279|Dexpramipexole|dexpramipexole|mesh-list
153970391|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
153970392|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970393|NCT00721279|Protective Agents|protective agents|mesh-ancestor
153970394|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970395|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153970396|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153970397|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
153970398|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
153970399|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970400|NCT01030952|Acarbose|acarbose|mesh-list
153970401|NCT01030952|Nateglinide|nateglinide|mesh-list
153970402|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153970403|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970404|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970424|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153970425|NCT00613743|Narcotics|narcotics|mesh-ancestor
153970426|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153970427|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970428|NCT00613743|Analgesics|analgesics|mesh-ancestor
153970429|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
153970430|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970431|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
153970486|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153970487|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153970488|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970556|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153970557|NCT00720109|Cortisone|cortisone|mesh-list
153970558|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
153970559|NCT00720109|Ifosfamide|ifosfamide|mesh-list
153970560|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
153970561|NCT00720109|Methotrexate|methotrexate|mesh-list
153970562|NCT00720109|Etoposide|etoposide|mesh-list
153970563|NCT00720109|Vincristine|vincristine|mesh-list
153970564|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
153970565|NCT00720109|Daunorubicin|daunorubicin|mesh-list
153970626|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
153970627|NCT02590627|Lumefantrine|lumefantrine|mesh-list
153970628|NCT02590627|Artemether|artemether|mesh-list
153970629|NCT02590627|Piperaquine|piperaquine|mesh-list
153970631|NCT02590627|Artenimol|artenimol|mesh-list
153970703|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153970704|NCT01743651|Baclofen|baclofen|mesh-list
153970705|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153970706|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970707|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153970773|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970847|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153970849|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153970850|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970851|NCT04301336|Analgesics|analgesics|mesh-ancestor
153970852|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
153970853|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153970854|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153970855|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153970856|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
153970857|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970858|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153970859|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153970860|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970861|NCT04301336|Trace Elements|trace elements|mesh-ancestor
153970862|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
153970863|NCT04301336|Hematinics|hematinics|mesh-ancestor
153970864|NCT04301336|Vitamins|vitamins|mesh-ancestor
153970865|NCT04301336|Astringents|astringents|mesh-ancestor
153970866|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
153970867|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153970901|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153501882|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
153970902|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970903|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153970904|NCT01012622|Methylphenidate|methylphenidate|mesh-list
153970905|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153970906|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970907|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153970908|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153728468|NCT01245205|Lapatinib|lapatinib|mesh-list
153970909|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153970910|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970911|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
153970912|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153970913|NCT00722371|Metformin|metformin|mesh-list
153970914|NCT00722371|Pioglitazone|pioglitazone|mesh-list
153970915|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153970916|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153970917|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970918|NCT00722371|Incretins|incretins|mesh-ancestor
153970919|NCT00722371|Hormones|hormones|mesh-ancestor
153970920|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970921|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153970951|NCT00722137|Hormones|hormones|mesh-ancestor
153970952|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153970953|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153970954|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153970955|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
153970956|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
153970957|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
153970958|NCT04114396|Antibodies|antibodies|mesh-list
153970959|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
153970960|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153970961|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
153970962|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
153970963|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
153970964|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153970965|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153501900|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970966|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153970967|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971007|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
153971008|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
153971009|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153971010|NCT01016912|Ribavirin|ribavirin|mesh-list
153971011|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153971012|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
153971013|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971014|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
153971015|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971016|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
153971017|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
153971018|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971019|NCT00802672|Ciclopirox|ciclopirox|mesh-list
153971020|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
153971021|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971022|NCT04113772|Nitisinone|nitisinone|mesh-list
153971023|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971024|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971025|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
153971026|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
153971027|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971028|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153971029|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971063|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153971064|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153971065|NCT04115410|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153971066|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153971067|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153971068|NCT04115410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153971069|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153971070|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
153971071|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153971072|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971074|NCT02604784|Doxorubicin|doxorubicin|mesh-list
153971075|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153971076|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
153971077|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971078|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153971079|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153971080|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153971081|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971082|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971083|NCT04110808|Phentolamine|phentolamine|mesh-list
153971084|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
153971085|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
153971086|NCT04110808|Anesthetics|anesthetics|mesh-list
153971087|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971088|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971089|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
153971090|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153971091|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153971092|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
153971093|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971094|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971095|NCT00714259|Fludarabine|fludarabine|mesh-list
153971096|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971097|NCT00796120|Doxorubicin|doxorubicin|mesh-list
153971098|NCT00796120|Ifosfamide|ifosfamide|mesh-list
153971099|NCT00796120|Trabectedin|trabectedin|mesh-list
153971100|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153646661|NCT00116506|Growth Substances|growth substances|mesh-ancestor
153971101|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971102|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153971103|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153971105|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971106|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153971107|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
153971108|NCT00795886|Sirolimus|sirolimus|mesh-list
153971109|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153971110|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971111|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153457246|NCT01389102|Estradiol|estradiol|mesh-list
153971112|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971113|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
153971114|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153971115|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
153971116|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971117|NCT04110418|Terlipressin|terlipressin|mesh-list
153971118|NCT04110418|Methylene Blue|methylene blue|mesh-list
153971119|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971120|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971121|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153971122|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153971123|NCT02589457|Tenofovir|tenofovir|mesh-list
153971124|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
153971125|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971126|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153971127|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153971128|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971129|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971130|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153971131|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153971132|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
153971142|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153971143|NCT01016600|Lenalidomide|lenalidomide|mesh-list
153971144|NCT01016600|Azacitidine|azacitidine|mesh-list
153971145|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
153971146|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971147|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153971148|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153971149|NCT01016600|Growth Substances|growth substances|mesh-ancestor
153971150|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
153971151|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971152|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153971153|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
153971154|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971155|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971156|NCT05175235|Pembrolizumab|pembrolizumab|mesh-list
153971158|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153971159|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971160|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153971161|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971162|NCT04298684|Metformin|metformin|mesh-list
153971163|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153971164|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153971165|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971166|NCT04298684|Incretins|incretins|mesh-ancestor
153971167|NCT04298684|Hormones|hormones|mesh-ancestor
153971168|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153971191|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153971192|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
153971193|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971194|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153971195|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153971196|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
153971197|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971198|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971199|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154157406|NCT05797233|Immunologic Factors|immunologic factors|mesh-ancestor
153971200|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153971201|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
153971202|NCT00793624|Olodaterol|olodaterol|mesh-list
153971203|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153971204|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
153971205|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971206|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971207|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153971208|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
153971209|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153971210|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153971211|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153971212|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
153971241|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971242|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153971244|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
153971245|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153971246|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
153971247|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153971248|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153971249|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
153971250|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971251|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971252|NCT00793546|Exemestane|exemestane|mesh-list
153971253|NCT00793546|Bosutinib|bosutinib|mesh-list
153971254|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971255|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153971256|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153971257|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971258|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971259|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153971260|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
153971261|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153971262|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971263|NCT00793546|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153971264|NCT00793546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153971265|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153971266|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153971267|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153971268|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971285|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153971286|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971287|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153971288|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153971290|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
153971291|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971292|NCT04109872|Lenalidomide|lenalidomide|mesh-list
153971293|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
153971294|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971295|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153971296|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153971297|NCT04109872|Growth Substances|growth substances|mesh-ancestor
153971298|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
153971299|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971300|NCT00793780|Naltrexone|naltrexone|mesh-list
153971301|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153971302|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153971303|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971304|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
153971305|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971306|NCT04107220|Valsartan|valsartan|mesh-list
153971307|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153971308|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153971309|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153971310|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153971311|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971312|NCT02591017|Ketamine|ketamine|mesh-list
153971313|NCT02591017|Morphine|morphine|mesh-list
153971314|NCT02591017|Chitosan|chitosan|mesh-list
153971315|NCT02591017|Analgesics|analgesics|mesh-ancestor
153501926|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153501929|NCT02991768|Hormones|hormones|mesh-ancestor
153971316|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
153971317|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971318|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971319|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153971324|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153971325|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153971326|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357786|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971327|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971328|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153971329|NCT02591017|Narcotics|narcotics|mesh-ancestor
153971330|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153971331|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153971332|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
153971333|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153971334|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
153971335|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
153971336|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
153971337|NCT02591017|Coagulants|coagulants|mesh-ancestor
153971338|NCT02591095|Navitoclax|navitoclax|mesh-list
153971339|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971340|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
153971341|NCT02588755|Tegafur|tegafur|mesh-list
153971342|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153971343|NCT02588755|Estrogens|estrogens|mesh-ancestor
153971344|NCT02588755|Hormones|hormones|mesh-ancestor
153971345|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153971346|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971347|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153971375|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
153971376|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
153971377|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153971378|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153971379|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971380|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
153971381|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153971382|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971383|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153971384|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153971385|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153971386|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153971387|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153971388|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153971389|NCT00790036|Everolimus|everolimus|mesh-list
153971390|NCT00790036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153971391|NCT00790036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153971392|NCT00790036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971393|NCT00790036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971394|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153971395|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
153971396|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971397|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971398|NCT05563168|Diltiazem|diltiazem|mesh-list
153971399|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153971400|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153971401|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745632|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153971418|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153971419|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153971420|NCT00915616|Melatonin|melatonin|mesh-list
153971421|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
153971422|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971423|NCT00915616|Protective Agents|protective agents|mesh-ancestor
153971424|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971425|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971426|NCT00914836|Betamethasone|betamethasone|mesh-list
153971427|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
153971428|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153971429|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
153971430|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
153971431|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153971432|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153971433|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
153971434|NCT00914836|Hormones|hormones|mesh-ancestor
153729891|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
153971435|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153971436|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971437|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153971438|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
153971439|NCT04106752|Caffeine|caffeine|mesh-list
153971440|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153971441|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971442|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153971443|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971444|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971445|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153971446|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153501952|NCT02999958|Antioxidants|antioxidants|mesh-list
153501958|NCT02999958|Vitamins|vitamins|mesh-ancestor
153971447|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
153971455|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971456|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971457|NCT02603068|Treprostinil|treprostinil|mesh-list
153971458|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153971459|NCT00718081|Sufentanil|sufentanil|mesh-list
153971460|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153971461|NCT00718081|Narcotics|narcotics|mesh-ancestor
153971462|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971463|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971464|NCT00718081|Analgesics|analgesics|mesh-ancestor
153971465|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
153971466|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971467|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153971468|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153971469|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
153971470|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
153971471|NCT00788710|Etoricoxib|etoricoxib|mesh-list
153971472|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153971473|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153971474|NCT00788710|Analgesics|analgesics|mesh-ancestor
153971475|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
153971476|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971477|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971478|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153971479|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153971480|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153971481|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153971482|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971483|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971484|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153971485|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
153971486|NCT04083625|Carbetocin|carbetocin|mesh-list
153971497|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
153971498|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153971499|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971500|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153971501|NCT04106050|Lidocaine|lidocaine|mesh-list
153971502|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
153971503|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
153971504|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971505|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971506|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
153971507|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729073|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
153971509|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153971510|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153971511|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153971512|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971513|NCT00588094|Rituximab|rituximab|mesh-list
153971514|NCT00588094|Carboplatin|carboplatin|mesh-list
153971515|NCT00588094|Etoposide|etoposide|mesh-list
153971516|NCT00588094|Ifosfamide|ifosfamide|mesh-list
153971517|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153971518|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971519|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
153971520|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971521|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153971522|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153971523|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153971524|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153971525|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971526|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457361|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
153971541|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971542|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153971543|NCT02706015|Dipyrone|dipyrone|mesh-list
153971544|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
153971545|NCT02706015|Caffeine|caffeine|mesh-list
153971546|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153971547|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971548|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153971549|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971550|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971551|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153971552|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153971553|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
153971554|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971555|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153971557|NCT02706015|Analgesics|analgesics|mesh-ancestor
153971597|NCT02588287|Tenofovir|tenofovir|mesh-list
153971598|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
153971599|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971600|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153971601|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153971602|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971603|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971604|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153971605|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153971606|NCT02707107|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
153971607|NCT02707107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153971608|NCT02707107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971609|NCT02707263|Heparin|heparin|mesh-list
153971610|NCT02707263|Calcium heparin|calcium heparin|mesh-list
153971611|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
153971612|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153971613|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153971614|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971615|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153971616|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153971617|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153971618|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
153971619|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971620|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153971621|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153971622|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971623|NCT00615303|Simethicone|simethicone|mesh-list
153971624|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
153971625|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971626|NCT00615303|Emollients|emollients|mesh-ancestor
153971627|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
153971628|NCT00787150|Warfarin|warfarin|mesh-list
153971629|NCT00787150|Apixaban|apixaban|mesh-list
153971630|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
153971631|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153971632|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
153971633|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153971634|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
153971636|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971637|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153971638|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153971639|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971640|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153971641|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153971642|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971643|NCT00786838|Trabectedin|trabectedin|mesh-list
153971644|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153971645|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
153971646|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971647|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971648|NCT02604004|Lamivudine|lamivudine|mesh-list
153971649|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153971650|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153971651|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729215|NCT01248442|Vitamins|vitamins|mesh-ancestor
153971652|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971653|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
153971654|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971655|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153971656|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153971657|NCT03354039|Tamoxifen|tamoxifen|mesh-list
153971658|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153971659|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
153971660|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153971661|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971662|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153971663|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971664|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153971665|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153971667|NCT04105426|Antioxidants|antioxidants|mesh-list
153971673|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153971674|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153971675|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153971676|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153971677|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
153971678|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971679|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971680|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153971681|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
153971682|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
153971683|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
153971684|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153971685|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153971686|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
153971687|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971688|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971689|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
153971690|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
153971691|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153971692|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153971693|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153971694|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153971695|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971696|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
153971697|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971698|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971699|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153971700|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971701|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153971702|NCT02704767|Apatinib|apatinib|mesh-list
153971703|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153971704|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971705|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153971706|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971708|NCT02704767|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153971711|NCT02587273|Narcotics|narcotics|mesh-ancestor
153971712|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971713|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971714|NCT02587273|Analgesics|analgesics|mesh-ancestor
153971715|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
153971716|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971717|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153971718|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153971719|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
153971720|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
153971721|NCT02704299|Immunomodulating Agents|immunomodulating agents|mesh-list
153971722|NCT02704299|Immunologic Factors|immunologic factors|mesh-ancestor
153971723|NCT02704299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971724|NCT02587741|Metformin|metformin|mesh-list
153971725|NCT02587741|Acarbose|acarbose|mesh-list
153971727|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153971728|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153971729|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971730|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153971731|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153971765|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153971766|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153971767|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153971768|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971769|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153971770|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971771|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153971772|NCT00785980|Analgesics|analgesics|mesh-ancestor
153971773|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
153971774|NCT04805073|Promethazine|promethazine|mesh-list
153971775|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
153971776|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
153971777|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
153971778|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153971779|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
153971780|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
153971781|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971782|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971783|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501982|NCT02990364|Anesthetics|anesthetics|mesh-list
153971784|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153971785|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153971786|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153971787|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971788|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
153971789|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
153971790|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
153971791|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971792|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
153971793|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
153971794|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153971796|NCT00915694|Temozolomide|temozolomide|mesh-list
153971797|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153971805|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153971807|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
153971808|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971809|NCT02703051|Lenograstim|lenograstim|mesh-list
153971810|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153971811|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
153971812|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971813|NCT00785512|Nebivolol|nebivolol|mesh-list
153971814|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153971815|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
153971816|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153971817|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153971818|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153971819|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
153971820|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971870|NCT04104334|Narcotics|narcotics|mesh-ancestor
153971871|NCT04104334|Analgesics|analgesics|mesh-ancestor
153971872|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
153971873|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153971874|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153971875|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
153971876|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153971877|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153971878|NCT02602600|Liraglutide|liraglutide|mesh-list
153971879|NCT02602600|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153971880|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153971881|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971882|NCT02602600|Incretins|incretins|mesh-ancestor
153971883|NCT02602600|Hormones|hormones|mesh-ancestor
153971884|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153971885|NCT00615615|Levetiracetam|levetiracetam|mesh-list
153971930|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971931|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153971932|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153971933|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
153971935|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153971936|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153971937|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153971938|NCT04081909|Narcotics|narcotics|mesh-ancestor
153971939|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153971940|NCT03272217|Bevacizumab|bevacizumab|mesh-list
153971941|NCT03272217|Atezolizumab|atezolizumab|mesh-list
153971942|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153971943|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971944|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153971945|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153971946|NCT03272217|Growth Substances|growth substances|mesh-ancestor
153971947|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971948|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
153971949|NCT03272217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153971950|NCT03272217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971951|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153971952|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153971953|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153971955|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971956|NCT05344443|Lemborexant|lemborexant|mesh-list
153971957|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153971958|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971959|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971960|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153971961|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153971962|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153971963|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971964|NCT00919555|Pioglitazone|pioglitazone|mesh-list
153971971|NCT02979093|Oxytocin|oxytocin|mesh-list
153971972|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
153971973|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153971974|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971975|NCT02588131|Durvalumab|durvalumab|mesh-list
153971976|NCT02588131|Tremelimumab|tremelimumab|mesh-list
153971977|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153971978|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971979|NCT04766983|Dimercaprol|dimercaprol|mesh-list
153971980|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
153971981|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
153971982|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971983|NCT04766437|Ticagrelor|ticagrelor|mesh-list
153971984|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153971985|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153971986|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153971987|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153971988|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153971989|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
153971990|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153971991|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153971992|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971993|NCT00776230|Vaccines|vaccines|mesh-list
153971994|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
153971995|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153971996|NCT02586259|Budesonide|budesonide|mesh-list
153971997|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153971998|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153971999|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
153972000|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153972001|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153972014|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153972015|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153972016|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153972017|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
153972018|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153972019|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153972020|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153972021|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153972022|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153972023|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153972024|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153972025|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153972026|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153731319|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
153786162|NCT00240773|Naproxen|naproxen|mesh-list
153786384|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153786543|NCT00264654|Paroxetine|paroxetine|mesh-list
153786832|NCT00243464|Betamethasone|betamethasone|mesh-list
153786905|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
153787420|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334172|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
153731320|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788925|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
153731321|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789376|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789676|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
153336508|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
153790339|NCT00255554|Escitalopram|escitalopram|mesh-list
153791093|NCT00290667|Hormones|hormones|mesh-ancestor
153791240|NCT00271323|Docetaxel|docetaxel|mesh-list
153793703|NCT00334815|Growth Substances|growth substances|mesh-ancestor
153794667|NCT00261482|Hormones|hormones|mesh-ancestor
153795045|NCT06259656|Antibodies|antibodies|mesh-list
153795335|NCT06080100|Antipruritics|antipruritics|mesh-ancestor
153795712|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
153731325|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153795934|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
153796026|NCT04947085|Ketamine|ketamine|mesh-list
153796302|NCT03932409|Paclitaxel|paclitaxel|mesh-list
153731326|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796742|NCT02560805|Protective Agents|protective agents|mesh-ancestor
153797273|NCT00264407|Hormones|hormones|mesh-list
153344096|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153797624|NCT00266162|Bosentan|bosentan|mesh-list
153797699|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
153797992|NCT00296127|Analgesics|analgesics|mesh-ancestor
153798429|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798727|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
153799391|NCT00308607|Growth Substances|growth substances|mesh-ancestor
153800084|NCT00310128|Hormones|hormones|mesh-ancestor
153800289|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
153800589|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
153801338|NCT00313482|Prednisone|prednisone|mesh-list
153348725|NCT01790672|Ethanol|ethanol|mesh-list
153802228|NCT05799144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802379|NCT05278494|Narcotics|narcotics|mesh-ancestor
153803053|NCT03288974|Pomalidomide|pomalidomide|mesh-list
153349908|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153803879|NCT00304317|Celecoxib|celecoxib|mesh-list
153350791|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
153804245|NCT00325689|Risperidone|risperidone|mesh-list
153804317|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153804465|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153804632|NCT00418067|Sirolimus|sirolimus|mesh-list
153804985|NCT00298571|Epinephrine|epinephrine|mesh-list
153805207|NCT05373303|Hematinics|hematinics|mesh-ancestor
153731327|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731329|NCT00137657|Trimethoprim|trimethoprim|mesh-list
153810629|NCT00346866|Anecortave|anecortave|mesh-list
153731330|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153731331|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
153731332|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153731333|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731334|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
153731335|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153731336|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153731337|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153731338|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731339|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731340|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153731341|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153731342|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153731343|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153731344|NCT00153699|Topiramate|topiramate|mesh-list
153731345|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
153731346|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153731347|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731348|NCT00160290|Lactulose|lactulose|mesh-list
153731349|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731350|NCT00137735|Gabapentin|gabapentin|mesh-list
153731351|NCT00137735|Analgesics|analgesics|mesh-ancestor
153731352|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
153731353|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646662|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646663|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
153731354|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731355|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
153731356|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153731357|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153731358|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731359|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153731360|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153731361|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153731363|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731364|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
153731365|NCT00137774|Bevacizumab|bevacizumab|mesh-list
153731366|NCT00137774|Temozolomide|temozolomide|mesh-list
153357264|NCT01270802|Efavirenz|efavirenz|mesh-list
153731367|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153731368|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731369|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153731370|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153731372|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731373|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
153731374|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153731375|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
153731376|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731377|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153731378|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153731379|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153731380|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
153731381|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157407|NCT05797233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731382|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731383|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153731384|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153731385|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
153731386|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731387|NCT00137813|Bevacizumab|bevacizumab|mesh-list
153731388|NCT00137813|Docetaxel|docetaxel|mesh-list
153646664|NCT00116506|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153646665|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153459985|NCT05171179|Lidocaine|lidocaine|mesh-list
153646666|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357329|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357357|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
153731391|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153731407|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731408|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731409|NCT00137852|Analgesics|analgesics|mesh-ancestor
153731410|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
153731411|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731412|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731413|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731414|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731415|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153731416|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153731417|NCT00160407|Orlistat|orlistat|mesh-list
153731418|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357420|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357428|NCT04385264|Mannitol|mannitol|mesh-list
153357429|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
153731440|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731441|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
153731442|NCT00160485|Glyburide|glyburide|mesh-list
153731443|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153731444|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731445|NCT00404183|Acetaminophen|acetaminophen|mesh-list
153731446|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153731447|NCT00404183|Hydrocodone|hydrocodone|mesh-list
153731448|NCT00404183|Oxycodone|oxycodone|mesh-list
153731449|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731450|NCT00404183|Analgesics|analgesics|mesh-ancestor
153357513|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
153357521|NCT00724568|Bortezomib|bortezomib|mesh-list
153731451|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
153731452|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731453|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731454|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
153731456|NCT00404183|Narcotics|narcotics|mesh-ancestor
153357660|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731474|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731476|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153731477|NCT00404222|Narcotics|narcotics|mesh-ancestor
153731478|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731479|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
153731480|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
153731481|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731482|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731483|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731484|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
153731485|NCT00160602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153731486|NCT00160602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731487|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153731488|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
153731489|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731490|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731491|NCT00138242|Carboplatin|carboplatin|mesh-list
153731493|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731494|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731495|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
153731496|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
153357717|NCT00243932|Ubiquinone|ubiquinone|mesh-list
153357718|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
153357719|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
153646667|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646668|NCT00116545|Troglitazone|troglitazone|mesh-list
153646669|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153646670|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646671|NCT00116623|Indomethacin|indomethacin|mesh-list
153737430|NCT05302388|Dexamethasone|dexamethasone|mesh-list
153731497|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731499|NCT00154050|Candesartan cilexetil|candesartan cilexetil|mesh-list
153731500|NCT00154050|Quinapril|quinapril|mesh-list
153731501|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153731502|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153357747|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811250|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
153731503|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153357775|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357782|NCT03806582|Norepinephrine|norepinephrine|mesh-list
153731504|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731505|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153731506|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
153731507|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731508|NCT00154089|Masoprocol|masoprocol|mesh-list
153731509|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
153731510|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646681|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153646682|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153646683|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646684|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153646685|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
153646686|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153646687|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153646688|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153646689|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153646690|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646691|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
153646692|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153646693|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646694|NCT00116662|Resiquimod|resiquimod|mesh-list
153646695|NCT00116662|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153646696|NCT00116662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731513|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153731514|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731515|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153731516|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731517|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731519|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
153357789|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
153357801|NCT01301183|Estradiol|estradiol|mesh-list
153357804|NCT01301183|Estrogens|estrogens|mesh-ancestor
153730752|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153730753|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730754|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730755|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730756|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
153730757|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153730758|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730759|NCT04725357|Meloxicam|meloxicam|mesh-list
153730796|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730797|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153730798|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730799|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
153730800|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730801|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153730802|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153730803|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730804|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
153730806|NCT00152646|Clopidogrel|clopidogrel|mesh-list
153730807|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153730809|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153730810|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153730820|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
153730821|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730822|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730823|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153730824|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153730825|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
153730826|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730827|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153737645|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
153730828|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153730829|NCT00135473|Insulin|insulin|mesh-list
153730830|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153730831|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153730833|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730834|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
153730835|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
153730836|NCT00142428|Cetuximab|cetuximab|mesh-list
153730837|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153730838|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730839|NCT00135551|Benidipine|benidipine|mesh-list
153730840|NCT00135551|Diuretics|diuretics|mesh-list
153730841|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153730842|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
153730843|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153730844|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
153730845|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730846|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730847|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730848|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153730869|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153730870|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153730871|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730872|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153730873|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153730874|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730875|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
153730876|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153730877|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153730879|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
153730880|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730881|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153730882|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
153730883|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
153730884|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
153730885|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
153730886|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153730887|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153730888|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
153730889|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153730890|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153730891|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
153730893|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
153730895|NCT00135746|Nicotine|nicotine|mesh-list
153730910|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153730911|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730912|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730913|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
153730914|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730915|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730916|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153730917|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153730918|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730919|NCT00159081|Haloperidol|haloperidol|mesh-list
153730920|NCT00159081|Risperidone|risperidone|mesh-list
153730921|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
153730922|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153730924|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730925|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730926|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730927|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153730928|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153730929|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730930|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730931|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153730933|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
153730943|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730945|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
153730946|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153730947|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730948|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730949|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730950|NCT00159159|Cyclosporine|cyclosporine|mesh-list
153730951|NCT00159159|Cyclosporins|cyclosporins|mesh-list
153730952|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730953|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730954|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730955|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
153730956|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730957|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
153730958|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730959|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
153730960|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731523|NCT00138359|Niclosamide|niclosamide|mesh-list
153730961|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153730962|NCT00135824|Povidone|povidone|mesh-list
153730963|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153730964|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153730972|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153730973|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730974|NCT00135902|Progesterone|progesterone|mesh-list
153730975|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153730976|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153730978|NCT00135902|Hormones|hormones|mesh-ancestor
153730979|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153730980|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730982|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
153730983|NCT00135941|Insulin|insulin|mesh-list
153730984|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153730985|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
153730986|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
153730987|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153730988|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730989|NCT00152919|Meloxicam|meloxicam|mesh-list
153730990|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153730991|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153730992|NCT00152919|Analgesics|analgesics|mesh-ancestor
153730993|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
153730994|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731020|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153731021|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153731022|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731023|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153731024|NCT00152958|Pramipexole|pramipexole|mesh-list
153731025|NCT00152958|Dexpramipexole|dexpramipexole|mesh-list
153731026|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
153731027|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731028|NCT00152958|Protective Agents|protective agents|mesh-ancestor
153731029|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731030|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153731031|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153731032|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
153731033|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
153731034|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731035|NCT00136175|Paclitaxel|paclitaxel|mesh-list
153731037|NCT00136175|Gemcitabine|gemcitabine|mesh-list
153731038|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153731039|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731040|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731041|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
153731042|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
153731043|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731044|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153731046|NCT00152997|Pramipexole|pramipexole|mesh-list
153731047|NCT00152997|Dexpramipexole|dexpramipexole|mesh-list
153731048|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
153731049|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731069|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
153731070|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
153731071|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153731072|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731073|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
153731074|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
153731075|NCT00159510|Methylene Blue|methylene blue|mesh-list
153731076|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153731077|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
153731078|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731079|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731080|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153731082|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153731083|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
153731087|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
153731133|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153731134|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731135|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731136|NCT00153192|Dronabinol|dronabinol|mesh-list
153731137|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
153731138|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731139|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153782462|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
153360255|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
153731186|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731187|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153731188|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153731189|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731190|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
153731191|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
153731192|NCT00159627|Rolofylline|rolofylline|mesh-list
153731193|NCT00159627|Diuretics|diuretics|mesh-ancestor
153545984|NCT06275087|Anesthetics|anesthetics|mesh-ancestor
153731194|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
153546143|NCT06207344|Propofol|propofol|mesh-list
153546355|NCT06134349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153731195|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546724|NCT05952804|Immunoglobulins|immunoglobulins|mesh-list
153731196|NCT00159666|Pregabalin|pregabalin|mesh-list
153731197|NCT00159666|Analgesics|analgesics|mesh-ancestor
153547052|NCT05775289|Paclitaxel|paclitaxel|mesh-list
153547535|NCT05419050|Denosumab|denosumab|mesh-list
153731198|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
153731199|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731200|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731201|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
153731202|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153731203|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153731204|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731205|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153731206|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153547684|NCT05319730|Antiemetics|antiemetics|mesh-ancestor
153547813|NCT05281471|Taxane|taxane|mesh-list
153731207|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153731208|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357813|NCT00758420|Polidocanol|polidocanol|mesh-list
153731209|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153731211|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
153731212|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731229|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549788|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153731230|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153731232|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153731233|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731234|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153550260|NCT03386578|Tenofovir|tenofovir|mesh-list
153731235|NCT00136994|Ziprasidone|ziprasidone|mesh-list
153550605|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153550770|NCT02465060|Immunotoxins|immunotoxins|mesh-ancestor
153551062|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153551136|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551214|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
153551305|NCT01570985|Triamcinolone|triamcinolone|mesh-list
153551492|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
153551718|NCT01572753|Semaglutide|semaglutide|mesh-list
153551860|NCT01573806|Incretins|incretins|mesh-ancestor
153552017|NCT01575639|Hormones|hormones|mesh-ancestor
153731236|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153731237|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
153731238|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731239|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731240|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552544|NCT01578668|Pemetrexed|pemetrexed|mesh-list
153731241|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153552961|NCT01589432|Lidocaine|lidocaine|mesh-list
153731242|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153553422|NCT01592981|Rituximab|rituximab|mesh-list
153553484|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
153553557|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153553703|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
153556685|NCT01615055|Fluoxetine|fluoxetine|mesh-list
153557339|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
153557414|NCT01619345|Semaglutide|semaglutide|mesh-list
153557727|NCT01621308|Insulin|insulin|mesh-list
153558004|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
153782651|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
153558524|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153558597|NCT01627236|Protective Agents|protective agents|mesh-ancestor
153558676|NCT01627626|Miotics|miotics|mesh-ancestor
153558737|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153558889|NCT01629225|Candesartan|candesartan|mesh-list
153558967|NCT01629628|Adalimumab|adalimumab|mesh-list
153559039|NCT01630096|Laxatives|laxatives|mesh-ancestor
153559182|NCT01631201|KRM 1648|krm 1648|mesh-list
153782665|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
153559632|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
153559858|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
153560081|NCT01635426|Aspirin|aspirin|mesh-list
153782672|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153560463|NCT01638299|Insulin|insulin|mesh-list
153560530|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
153560682|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
153561204|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
153335080|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335237|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
153335442|NCT04758260|Protective Agents|protective agents|mesh-ancestor
153335517|NCT04138212|Paclitaxel|paclitaxel|mesh-list
153335596|NCT02758132|Denosumab|denosumab|mesh-list
153335666|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
153335898|NCT01182610|Paclitaxel|paclitaxel|mesh-list
153336182|NCT02027272|Hormones|hormones|mesh-ancestor
153336259|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153336333|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
153336415|NCT00843310|Melphalan|melphalan|mesh-list
153336511|NCT00731770|Xhance|xhance|mesh-list
153337093|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
153337550|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153337776|NCT00000280|Nimodipine|nimodipine|mesh-list
153337927|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
153338221|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
153338520|NCT00000496|Aspirin|aspirin|mesh-list
153338592|NCT00002092|Cimetidine|cimetidine|mesh-list
153338808|NCT00001534|Losartan|losartan|mesh-list
153339032|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
153339260|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339338|NCT01198327|Ranibizumab|ranibizumab|mesh-list
153339490|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
153339790|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153340097|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153340261|NCT05750446|Riociguat|riociguat|mesh-list
153340626|NCT00382330|Ciclopirox|ciclopirox|mesh-list
153783271|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
153341236|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
153341387|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341620|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
153341766|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
153341993|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342065|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
153783288|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153342593|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342671|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342742|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342816|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153343116|NCT00002812|Idarubicin|idarubicin|mesh-list
153343343|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
153344180|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344551|NCT00004900|Thiotepa|thiotepa|mesh-list
153344776|NCT05774964|Folic Acid|folic acid|mesh-list
153344850|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153345007|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345086|NCT02840539|Hormones|hormones|mesh-ancestor
153345157|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345234|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345319|NCT01215643|Ribavirin|ribavirin|mesh-list
153345325|NCT00004924|Paclitaxel|paclitaxel|mesh-list
153345393|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153345469|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345622|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
153345699|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
153345856|NCT00004288|Olsalazine|olsalazine|mesh-list
153345927|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346020|NCT00385450|Nelfinavir|nelfinavir|mesh-list
153346151|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153783324|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153346437|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
153346518|NCT00102518|Aripiprazole|aripiprazole|mesh-list
153346587|NCT01402375|Codeine|codeine|mesh-list
153346666|NCT00108524|Orlistat|orlistat|mesh-list
153346895|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153348232|NCT05307341|Sufentanil|sufentanil|mesh-list
153349644|NCT01183169|Ribavirin|ribavirin|mesh-list
153349783|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153350746|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
153731249|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731250|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731251|NCT00137033|Analgesics|analgesics|mesh-ancestor
153731252|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
153731253|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731254|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731255|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731256|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153350905|NCT04527887|Hormones|hormones|mesh-ancestor
153731257|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153352841|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352991|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
153353218|NCT00503750|Vinorelbine|vinorelbine|mesh-list
153353363|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153353586|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353732|NCT01797848|Ribavirin|ribavirin|mesh-list
153354035|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
153354181|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153354558|NCT05245604|Cyclosporine|cyclosporine|mesh-list
153354944|NCT00612560|Anastrozole|anastrozole|mesh-list
153355096|NCT01585207|Vigabatrin|vigabatrin|mesh-list
153355159|NCT00619190|Aripiprazole|aripiprazole|mesh-list
153783442|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
153355834|NCT00594308|Cyclosporine|cyclosporine|mesh-list
153356357|NCT02996942|Factor VIII|factor viii|mesh-list
153356736|NCT01295879|Vitamin D|vitamin d|mesh-list
153356821|NCT01276496|Paclitaxel|paclitaxel|mesh-list
153357098|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358057|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783485|NCT00236327|Fentanyl|fentanyl|mesh-list
153357816|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
153358487|NCT01258049|Artemether|artemether|mesh-list
153783508|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
153783516|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
153359520|NCT05032235|Fluzoparib|fluzoparib|mesh-list
153731258|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153731259|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731260|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731261|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
153731262|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
153386533|NCT02318901|Cetuximab|cetuximab|mesh-list
153387117|NCT01692171|Heparin|heparin|mesh-list
153387581|NCT02294604|Povidone|povidone|mesh-list
153387924|NCT00000291|Labetalol|labetalol|mesh-list
153409490|NCT02729714|Suvorexant|suvorexant|mesh-list
153416085|NCT02710526|Narcotics|narcotics|mesh-ancestor
153417566|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
153731271|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731272|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
153433430|NCT00000865|Abacavir|abacavir|mesh-list
153434905|NCT00003086|Melphalan|melphalan|mesh-list
153435703|NCT05720767|Rifampin|rifampin|mesh-list
153437302|NCT00004184|Antacids|antacids|mesh-ancestor
153731293|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153731294|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153731295|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
153731296|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731297|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153731298|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153731299|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731301|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153731302|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
153731303|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731304|NCT00137501|Nifedipine|nifedipine|mesh-list
153731305|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153731306|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153646697|NCT00116662|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153731315|NCT00153660|Naproxen|naproxen|mesh-list
153731316|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731317|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731318|NCT00153660|Analgesics|analgesics|mesh-ancestor
153733798|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153733799|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153733835|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
153733836|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733837|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
153733838|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153733839|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153733841|NCT00148746|Hormones|hormones|mesh-ancestor
153733888|NCT00466609|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153733889|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153733916|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153733918|NCT00148863|Ribavirin|ribavirin|mesh-list
153733919|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
153733920|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
153733921|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
153733922|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153733923|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733924|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
153733925|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733926|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
153733927|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733928|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
153733929|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733930|NCT00466999|Misoprostol|misoprostol|mesh-list
153733931|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153733932|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
153733933|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153733934|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733935|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153733936|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153734058|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734059|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734060|NCT00468364|Insulin|insulin|mesh-list
153734061|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153734062|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
153734063|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
153734064|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
153734065|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
153734066|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734067|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734068|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
153734069|NCT00149058|Hematinics|hematinics|mesh-ancestor
153734070|NCT00468520|Oxytocin|oxytocin|mesh-list
153734071|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
153734072|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153734073|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734074|NCT03271450|Warfarin|warfarin|mesh-list
153734107|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734109|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153734110|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734111|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
153734112|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153734113|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153734114|NCT00469300|Acyclovir|acyclovir|mesh-list
153734115|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
153734116|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734117|NCT04697641|Amoxicillin|amoxicillin|mesh-list
153734118|NCT04697641|Clarithromycin|clarithromycin|mesh-list
153734344|NCT06245707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734345|NCT06245707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734346|NCT06245707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153734347|NCT06245707|Alkylating Agents|alkylating agents|mesh-ancestor
153734348|NCT06245707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734349|NCT06245707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734350|NCT06245707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153734351|NCT06245707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734352|NCT06245707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153734355|NCT06245707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734356|NCT06245707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153734387|NCT06245551|Autonomic Agents|autonomic agents|mesh-ancestor
153734388|NCT06245551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734389|NCT06245551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734390|NCT06245551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153734391|NCT06245551|Respiratory System Agents|respiratory system agents|mesh-ancestor
153734392|NCT06245551|Glucocorticoids|glucocorticoids|mesh-ancestor
153734393|NCT06245551|Hormones|hormones|mesh-ancestor
153734394|NCT06245551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734395|NCT06245551|Tocolytic Agents|tocolytic agents|mesh-ancestor
153734396|NCT06245551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153739092|NCT05262452|Folfirinox|folfirinox|mesh-list
153734397|NCT06245551|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153734398|NCT06245551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153734494|NCT06217562|Coagulants|coagulants|mesh-ancestor
153734551|NCT06178991|Vaccines|vaccines|mesh-list
153734552|NCT06178991|Immunologic Factors|immunologic factors|mesh-ancestor
153734553|NCT06178991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734554|NCT06158451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153734555|NCT06158451|Propolis|propolis|mesh-list
153734556|NCT06158451|Zinc Oxide|zinc oxide|mesh-list
153734557|NCT06158451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734558|NCT06158451|Dermatologic Agents|dermatologic agents|mesh-ancestor
153734559|NCT06158451|Sunscreening Agents|sunscreening agents|mesh-ancestor
153734560|NCT06158451|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153734561|NCT06158451|Protective Agents|protective agents|mesh-ancestor
153734562|NCT06158451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734563|NCT06133062|Bevacizumab|bevacizumab|mesh-list
153734564|NCT06133062|Atezolizumab|atezolizumab|mesh-list
153734565|NCT06133062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153734566|NCT06133062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734567|NCT06133062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153734568|NCT06133062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153734569|NCT06133062|Growth Substances|growth substances|mesh-ancestor
153734570|NCT06133062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734571|NCT06133062|Growth Inhibitors|growth inhibitors|mesh-ancestor
153734572|NCT06133062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153734573|NCT06133062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734658|NCT06012266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734660|NCT06012266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734661|NCT06002789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153734662|NCT06002789|Antibodies|antibodies|mesh-list
153734663|NCT06002789|Immunoglobulins|immunoglobulins|mesh-list
153734690|NCT05986422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734691|NCT05980689|Capecitabine|capecitabine|mesh-list
153734692|NCT05980689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153734693|NCT05980689|Antimetabolites|antimetabolites|mesh-ancestor
153734694|NCT05980689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734695|NCT05980689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734700|NCT05956899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153734701|NCT05956899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734702|NCT05956899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153734703|NCT05956899|Antipruritics|antipruritics|mesh-ancestor
153734704|NCT05956899|Dermatologic Agents|dermatologic agents|mesh-ancestor
153734705|NCT05956899|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153734706|NCT05956899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153734707|NCT05956899|Serotonin Agents|serotonin agents|mesh-ancestor
153734708|NCT05956899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153734709|NCT05956899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734710|NCT05932966|Insulin|insulin|mesh-list
153734711|NCT05932966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734712|NCT05932966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734713|NCT05915169|Chrysarobin|chrysarobin|mesh-list
153734714|NCT05915169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153412869|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
153734742|NCT05891171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734743|NCT05891171|Antimetabolites|antimetabolites|mesh-ancestor
153734744|NCT05891171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734745|NCT05891171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153734746|NCT05891171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153734747|NCT05891171|Immunologic Factors|immunologic factors|mesh-ancestor
153734748|NCT05891171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734749|NCT05891171|Antidotes|antidotes|mesh-ancestor
153734750|NCT05891171|Protective Agents|protective agents|mesh-ancestor
153734751|NCT05891171|Vitamin B Complex|vitamin b complex|mesh-ancestor
153734752|NCT05891171|Vitamins|vitamins|mesh-ancestor
153734753|NCT05891171|Micronutrients|micronutrients|mesh-ancestor
153734754|NCT05891171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734755|NCT05891171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153734756|NCT05891171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153734757|NCT05888389|Anesthetics|anesthetics|mesh-list
153734758|NCT05888389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153734759|NCT05888389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734760|NCT05888389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734764|NCT05886972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734765|NCT05886972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153412886|NCT02519023|Ibuprofen|ibuprofen|mesh-list
153734842|NCT05713877|Protective Agents|protective agents|mesh-ancestor
153734843|NCT05713877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734844|NCT05713877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153734845|NCT05703659|Sulfalene|sulfalene|mesh-list
153734846|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734847|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153734848|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
153734849|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153734850|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153734851|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
153734852|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
153734853|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153734854|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153734855|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734856|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734857|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734858|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153734859|NCT05671991|Empagliflozin|empagliflozin|mesh-list
153734860|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153734861|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734862|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734863|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734864|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153734865|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734866|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153734867|NCT05659147|Secretin|secretin|mesh-list
153734868|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153734869|NCT05659147|Hormones|hormones|mesh-ancestor
153734870|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153734871|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734872|NCT05653050|Insulin|insulin|mesh-list
153734873|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153734878|NCT05624996|Etoposide|etoposide|mesh-list
153734879|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
153734880|NCT05624996|Cisplatin|cisplatin|mesh-list
153734918|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153734954|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153734955|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153734956|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153734957|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153734958|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735037|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735038|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153735040|NCT05400148|Bupivacaine|bupivacaine|mesh-list
153735041|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
153735042|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
153735043|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153735044|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735045|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
153735046|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735047|NCT05360615|Empagliflozin|empagliflozin|mesh-list
153735048|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153735049|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735050|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153735051|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735207|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735208|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153735209|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
153735210|NCT05136560|Hormones|hormones|mesh-ancestor
153735211|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153735212|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153735213|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735214|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
153735215|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735216|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735217|NCT05125016|Cemiplimab|cemiplimab|mesh-list
153735218|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735219|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735220|NCT05117554|Midazolam|midazolam|mesh-list
153735243|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153735244|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153735245|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153739347|NCT02953210|Ketorolac|ketorolac|mesh-list
153735246|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735247|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735248|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735249|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153735400|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735401|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735402|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153735403|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753751|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153753752|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153753753|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153753754|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
153753755|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
153753756|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153753819|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
153753820|NCT00532090|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153753850|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153753851|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
153753852|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153753853|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753855|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753856|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753857|NCT00167687|Prazosin|prazosin|mesh-list
153753858|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153753859|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153753860|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153753861|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153753862|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
153753863|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753864|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753899|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
153753900|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153753901|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153753935|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153753936|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753937|NCT02905864|Incretins|incretins|mesh-ancestor
153753939|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753940|NCT00167882|Mesalamine|mesalamine|mesh-list
153753941|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153753942|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153754041|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754042|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754043|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
153754044|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153754045|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754046|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153754047|NCT00178035|Paroxetine|paroxetine|mesh-list
153754048|NCT00178035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153754049|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153754050|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153754051|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754052|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754053|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
153754152|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754170|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153754171|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754178|NCT02904031|Vitamins|vitamins|mesh-ancestor
153754198|NCT02903524|Doxorubicin|doxorubicin|mesh-list
153754199|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153754200|NCT02903524|Pirarubicin|pirarubicin|mesh-list
153754201|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754202|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
153754203|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754204|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754205|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153754206|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
153754207|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754208|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754209|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153754210|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153754211|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153754232|NCT05995912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754233|NCT05995912|Analgesics|analgesics|mesh-ancestor
153754234|NCT05995912|Sensory System Agents|sensory system agents|mesh-ancestor
153754235|NCT05995912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754236|NCT05995912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153754237|NCT05995912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153754245|NCT05995691|Adalimumab|adalimumab|mesh-list
153754297|NCT05994547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754298|NCT05994547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754299|NCT05994547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153754300|NCT05994547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153754301|NCT05994547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153754302|NCT05994547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153754303|NCT05994547|Anesthetics, General|anesthetics, general|mesh-ancestor
153754304|NCT05994547|Anesthetics|anesthetics|mesh-ancestor
153754305|NCT05994547|GABA Modulators|gaba modulators|mesh-ancestor
153754306|NCT05994547|GABA Agents|gaba agents|mesh-ancestor
153754307|NCT05994547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754308|NCT05994547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754309|NCT05994456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153754310|NCT05994456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754311|NCT05994456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754312|NCT05994456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754313|NCT05994131|Aflutinib|aflutinib|mesh-list
153754314|NCT05994131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153754315|NCT05994131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754316|NCT05994131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754335|NCT05880459|Sensory System Agents|sensory system agents|mesh-ancestor
153754336|NCT05880459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754337|NCT05880459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153754338|NCT05880459|Anticonvulsants|anticonvulsants|mesh-ancestor
153754339|NCT05880459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153754340|NCT05880459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153754341|NCT05880459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754342|NCT05880459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153754343|NCT05880459|Tocolytic Agents|tocolytic agents|mesh-ancestor
153754344|NCT05880459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153754345|NCT05880459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153754346|NCT05880459|Narcotics|narcotics|mesh-ancestor
153754347|NCT05864417|Sunscreening Agents|sunscreening agents|mesh-list
153754348|NCT05864417|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153754349|NCT05864417|Protective Agents|protective agents|mesh-ancestor
153754351|NCT05864417|Dermatologic Agents|dermatologic agents|mesh-ancestor
153754352|NCT05856136|Fentanyl|fentanyl|mesh-list
153754353|NCT05856136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153754354|NCT05856136|Narcotics|narcotics|mesh-ancestor
153754355|NCT05856136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754356|NCT05856136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754357|NCT05856136|Analgesics|analgesics|mesh-ancestor
153754358|NCT05856136|Sensory System Agents|sensory system agents|mesh-ancestor
153754359|NCT05856136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754360|NCT05856136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153754361|NCT05856136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153754362|NCT05856136|Anesthetics, General|anesthetics, general|mesh-ancestor
153754363|NCT05856136|Anesthetics|anesthetics|mesh-ancestor
153754364|NCT05812300|Hyaluronic Acid|hyaluronic acid|mesh-list
153754365|NCT05812300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153754366|NCT05812300|Immunologic Factors|immunologic factors|mesh-ancestor
153754367|NCT05812300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754368|NCT05812300|Viscosupplements|viscosupplements|mesh-ancestor
153754369|NCT05812300|Protective Agents|protective agents|mesh-ancestor
153754370|NCT05788016|Analgesics, Opioid|analgesics, opioid|mesh-list
153754371|NCT05788016|Narcotics|narcotics|mesh-ancestor
153754372|NCT05788016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754373|NCT05788016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754374|NCT05788016|Analgesics|analgesics|mesh-ancestor
153754375|NCT05788016|Sensory System Agents|sensory system agents|mesh-ancestor
153754408|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754409|NCT05583708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153754410|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754411|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153754412|NCT05470699|Fluorides|fluorides|mesh-list
153754413|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
153754414|NCT05470699|Protective Agents|protective agents|mesh-ancestor
153754415|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754416|NCT05458453|Esketamine|esketamine|mesh-list
153754495|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754496|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754497|NCT04929392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153754498|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153754499|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754500|NCT04831294|Cannabidiol|cannabidiol|mesh-list
153754522|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153754523|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153754524|NCT04801589|Midazolam|midazolam|mesh-list
153754525|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
153754526|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153754527|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754528|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754529|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153754530|NCT04801589|Analgesics|analgesics|mesh-ancestor
153754531|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
153754532|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754533|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153754534|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153754535|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153754536|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
153754537|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754538|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754539|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153754540|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153754541|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153754542|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153754543|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153754544|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
153754545|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
153754546|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
153754547|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
153754548|NCT04796948|Leucovorin|leucovorin|mesh-list
153754549|NCT04796948|Fluorouracil|fluorouracil|mesh-list
153754550|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
153754551|NCT04796948|Irinotecan|irinotecan|mesh-list
153754552|NCT04796948|Calcium|calcium|mesh-list
153754618|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153754619|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
153754620|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754621|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
153754622|NCT04464629|Hormones|hormones|mesh-ancestor
153754623|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153754624|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754625|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153754626|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754627|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
153754628|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
153754629|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754630|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153754631|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153754632|NCT04464629|Protective Agents|protective agents|mesh-ancestor
153754633|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
153754634|NCT04459416|Narcotics|narcotics|mesh-ancestor
153754635|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754636|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754637|NCT04459416|Analgesics|analgesics|mesh-ancestor
153754638|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
153754639|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754640|NCT04432935|Lactoferrin|lactoferrin|mesh-list
153754641|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754675|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754676|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153754678|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754679|NCT04229368|Vitamin D|vitamin d|mesh-list
153754710|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153754712|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
153754713|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153754714|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153754721|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
153754722|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153754723|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
153754724|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
154157445|NCT05784844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153754761|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754762|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
153754763|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153754764|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153754765|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153754766|NCT03535298|Analgesics|analgesics|mesh-ancestor
153754767|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
153754768|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754769|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754770|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
153754872|NCT02589600|Calcium|calcium|mesh-list
153755068|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755069|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153755070|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153755071|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755072|NCT00168779|Diuretics|diuretics|mesh-ancestor
153755073|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
153755074|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755075|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153755076|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755077|NCT00196131|Morphine|morphine|mesh-list
153755078|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153755079|NCT00196131|Narcotics|narcotics|mesh-ancestor
153755082|NCT00196131|Analgesics|analgesics|mesh-ancestor
153755212|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755213|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153755214|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
153755215|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755216|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
153755217|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755219|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755220|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755221|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153755222|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
153755286|NCT02898376|Protective Agents|protective agents|mesh-ancestor
153755287|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755288|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
153755289|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153755290|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
153755291|NCT02898376|Vitamins|vitamins|mesh-ancestor
153755292|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
153755293|NCT00408174|Balsalazide|balsalazide|mesh-list
153755294|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153755295|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153755296|NCT00408174|Analgesics|analgesics|mesh-ancestor
153755297|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
153755298|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755299|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755332|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755333|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153755334|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
153755335|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153755336|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755337|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755380|NCT04681027|Oxymorphone|oxymorphone|mesh-list
153755381|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153755382|NCT04681027|Narcotics|narcotics|mesh-ancestor
153755383|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755384|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755385|NCT04681027|Analgesics|analgesics|mesh-ancestor
153755386|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
153755387|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755415|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755416|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153755417|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
153755418|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755419|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755420|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
153755421|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755422|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153755423|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755424|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
153755425|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755426|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153755428|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153755429|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755430|NCT00196599|Emtricitabine|emtricitabine|mesh-list
153592499|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
153755431|NCT00196599|Efavirenz|efavirenz|mesh-list
153755432|NCT00196599|Didanosine|didanosine|mesh-list
153755433|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
153755434|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755525|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755527|NCT00169988|Sertraline|sertraline|mesh-list
153755528|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153755529|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
153755530|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755538|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
153755599|NCT00409890|Scopolamine|scopolamine|mesh-list
153755601|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153755602|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
153755603|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153755604|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
153755605|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
153755606|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755607|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755608|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755609|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
153755610|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153755611|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
153755612|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755641|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
153755642|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755872|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153755873|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153755874|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153755875|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
153755876|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755877|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755878|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153755879|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
153755880|NCT05349448|Hormones|hormones|mesh-ancestor
153755881|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153755882|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755883|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
153755884|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755885|NCT00171353|Valsartan|valsartan|mesh-list
153755886|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755887|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153755888|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153755889|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755890|NCT01656343|Abatacept|abatacept|mesh-list
153755891|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153755892|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153755893|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755894|NCT01656343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755895|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755896|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755922|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755923|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153755924|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153755925|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153755926|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755927|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755928|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153755936|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755937|NCT00171509|Cyclosporine|cyclosporine|mesh-list
153755938|NCT00171509|Cyclosporins|cyclosporins|mesh-list
153755939|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755940|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755941|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153593047|NCT01837446|Antacids|antacids|mesh-ancestor
153755942|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
153755943|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756004|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756006|NCT00179751|Lenalidomide|lenalidomide|mesh-list
153756007|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756008|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
153756009|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756010|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756011|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
153756012|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756013|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153756014|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153593101|NCT01840449|Lanreotide|lanreotide|mesh-list
153756015|NCT00179751|Growth Substances|growth substances|mesh-ancestor
153756017|NCT00171743|Cyclosporine|cyclosporine|mesh-list
153756018|NCT00171743|Cyclosporins|cyclosporins|mesh-list
153756019|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756020|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756021|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756022|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
153756023|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756024|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
153756025|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756026|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
153756075|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756084|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
153756085|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
153756086|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153756087|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756088|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
153756089|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756090|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
153756091|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756092|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
153756093|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756094|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
153756095|NCT00171899|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756096|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756097|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756098|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756099|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756100|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
153756101|NCT00171938|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756102|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756103|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756104|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756105|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756106|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
153756107|NCT00171977|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756109|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756257|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
153756258|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756259|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756260|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153756261|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
153756262|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756263|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756264|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153756265|NCT00197886|Norepinephrine|norepinephrine|mesh-list
153756266|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153756267|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153756268|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
153756269|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756270|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756271|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756272|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
153756273|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
153756274|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756275|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153756276|NCT02908165|Sorafenib|sorafenib|mesh-list
153756310|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
153756311|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153756312|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153756313|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153756314|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153756375|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153756377|NCT02206087|Calcium heparin|calcium heparin|mesh-list
153756378|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
153756379|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153756380|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153756381|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756382|NCT00198237|Docetaxel|docetaxel|mesh-list
153756392|NCT00198354|Gemcitabine|gemcitabine|mesh-list
153756393|NCT00198354|Carboplatin|carboplatin|mesh-list
153756422|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153756423|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
153756424|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153756425|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
153756426|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
153756427|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
153756428|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153756429|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
153756430|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756431|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756432|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756433|NCT04677868|Methotrexate|methotrexate|mesh-list
153756434|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153756435|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
153811580|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153756436|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153756437|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756438|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756506|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153756507|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756508|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
153756509|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756562|NCT02057380|Hormones|hormones|mesh-ancestor
153756563|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756564|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153756565|NCT02057380|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756566|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756567|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756600|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756601|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153756602|NCT01989325|Dexamethasone|dexamethasone|mesh-list
153756604|NCT01989325|Lenograstim|lenograstim|mesh-list
153756605|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
153756606|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756607|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
153756608|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
153756609|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756610|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756804|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
153756805|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756806|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
153756807|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756808|NCT00173888|Cisplatin|cisplatin|mesh-list
153756809|NCT00173888|Gemcitabine|gemcitabine|mesh-list
153756810|NCT00173888|Docetaxel|docetaxel|mesh-list
153756811|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756812|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756813|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
153756814|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756815|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
153756816|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756817|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756818|NCT00555022|Bromides|bromides|mesh-list
153756856|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
153756890|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153756891|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
153756892|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
153756893|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756894|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756895|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756896|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
153756897|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153756898|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153756932|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756933|NCT01777555|Levodopa|levodopa|mesh-list
153756934|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153756935|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153756936|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
153756937|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756938|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756978|NCT01756924|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153756979|NCT01756924|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153756980|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153756981|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
153757055|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
153757057|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
153757121|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153757122|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
153757123|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757124|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
153757125|NCT00174434|Paclitaxel|paclitaxel|mesh-list
153757126|NCT00174434|Sunitinib|sunitinib|mesh-list
153757127|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757128|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757129|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757130|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757131|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
153757132|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757133|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153757134|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153757135|NCT00174434|Growth Substances|growth substances|mesh-ancestor
153757136|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757137|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
153757138|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153757139|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757140|NCT00203814|Artesunate|artesunate|mesh-list
153757141|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
153757142|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
153594228|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757195|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
153757196|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757197|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757198|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153757199|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757200|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
153757201|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
153757202|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757206|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757207|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153757208|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153757209|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
153757210|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153757211|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757212|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
153757213|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
153757214|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757215|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153757241|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153757242|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153757243|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
153757244|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757245|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757246|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757247|NCT04676659|Tenecteplase|tenecteplase|mesh-list
153757248|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153757249|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153757250|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757251|NCT00174590|Risperidone|risperidone|mesh-list
153757252|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153757253|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
153757328|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153757329|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
153757330|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757331|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757332|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153757333|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757334|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757335|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
153757336|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153757337|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
153757338|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153757339|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757340|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
153757341|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
153757342|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757343|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153757344|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153757345|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
153757346|NCT01235923|Hematinics|hematinics|mesh-ancestor
153757347|NCT00199134|Letrozole|letrozole|mesh-list
153757348|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757349|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153757350|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153757351|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757352|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757353|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153757354|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
153757355|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757356|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757402|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153757403|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153757404|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757405|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153757406|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153757434|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757435|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
153757436|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757437|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
153757438|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757439|NCT00555412|Loxapine|loxapine|mesh-list
153757440|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153757441|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153757442|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757540|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153757541|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153757542|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153757543|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153757544|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
153757545|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
153757546|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
153757547|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
153757548|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
153757549|NCT04424602|Dimethoate|dimethoate|mesh-list
153757578|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757579|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
153757580|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153757581|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
153757582|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757583|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757584|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153757585|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
153757586|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153757587|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
153757588|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757589|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757590|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153757591|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
153757626|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
153757677|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757678|NCT04173364|Ropivacaine|ropivacaine|mesh-list
153757679|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153757680|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
153757681|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
153757682|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757683|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757684|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
153757685|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757686|NCT04171453|Pregabalin|pregabalin|mesh-list
153757715|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757716|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757718|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
153757719|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757720|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757721|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
153757722|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757723|NCT02962830|Sufentanil|sufentanil|mesh-list
153757724|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153757725|NCT02962830|Narcotics|narcotics|mesh-ancestor
153757726|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757727|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757728|NCT02962830|Analgesics|analgesics|mesh-ancestor
153757729|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
153757730|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757754|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
153757755|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757756|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757757|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757758|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757759|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153757768|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153757770|NCT00204555|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153757771|NCT00204555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757772|NCT00204555|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153757773|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
153757774|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757775|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153757776|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757777|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
153757778|NCT00175955|Levetiracetam|levetiracetam|mesh-list
153757779|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
153757780|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
153757781|NCT03758287|Gefitinib|gefitinib|mesh-list
153757782|NCT03758287|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153757783|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153757815|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153757816|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
153757817|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757818|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757819|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153594903|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
153757820|NCT00199953|Rabeprazole|rabeprazole|mesh-list
153757821|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153757822|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153757823|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153757824|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757853|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
153757854|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153757868|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153758073|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758074|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153758076|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153758077|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758078|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153758112|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758113|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758114|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153758115|NCT02309671|Hormones|hormones|mesh-ancestor
153758116|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758117|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758118|NCT02296645|Ethanol|ethanol|mesh-list
153758153|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
153758154|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
153758155|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758156|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758157|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153758158|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153758177|NCT00554632|Estradiol|estradiol|mesh-list
153758178|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153758179|NCT00554632|Estrogens|estrogens|mesh-ancestor
153758180|NCT00554632|Hormones|hormones|mesh-ancestor
153758181|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758182|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758183|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153758184|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
153758185|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153758194|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153758195|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
153758196|NCT02236195|Mocetinostat|mocetinostat|mesh-list
153758197|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153758198|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758199|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758200|NCT02236156|Metronidazole|metronidazole|mesh-list
153758201|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758202|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758203|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153758204|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153758205|NCT00177086|Alfuzosin|alfuzosin|mesh-list
153758206|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153758207|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153758208|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153758209|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
153758210|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758211|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758212|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758213|NCT00177086|Urological Agents|urological agents|mesh-ancestor
153758214|NCT02207257|Edoxaban|edoxaban|mesh-list
153758215|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153758216|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
153758217|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153758244|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
153758245|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758246|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153758247|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758248|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
153758249|NCT00200187|Anesthetics|anesthetics|mesh-list
153758250|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758251|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758252|NCT04659109|Glenzocimab|glenzocimab|mesh-list
153758253|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
153758254|NCT00177242|Gefitinib|gefitinib|mesh-list
153758255|NCT00177242|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153786587|NCT02212015|Paclitaxel|paclitaxel|mesh-list
153758257|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758258|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758259|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758260|NCT04659070|Telmisartan|telmisartan|mesh-list
153758261|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153758262|NCT04659070|Ezetimibe|ezetimibe|mesh-list
153758263|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153758264|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153758265|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
153758266|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758267|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153758320|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
153758321|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
153758322|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758323|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758324|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153758325|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153758326|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153758327|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
153758328|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758329|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758330|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
153758331|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153758332|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153758333|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153758334|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153758335|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153758336|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758337|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
153758338|NCT04656262|Doxorubicin|doxorubicin|mesh-list
153758339|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758340|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
153758341|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758342|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758343|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153758345|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758346|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758347|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153758348|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153758349|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153758350|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153758405|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153758406|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758407|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758408|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758409|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758410|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153758411|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
153758412|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153758414|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758415|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758436|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758437|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758438|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153758439|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
153758440|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758441|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758442|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153758443|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153758444|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153758445|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153758446|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758462|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153758463|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153758464|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
153758465|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758466|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153758538|NCT04653415|Analgesics|analgesics|mesh-ancestor
153758539|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
153758540|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
153758541|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153758542|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153758543|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758544|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153758545|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153758546|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153758547|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758548|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758549|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
153758550|NCT00557791|Ranibizumab|ranibizumab|mesh-list
153758551|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153758552|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153758553|NCT00557791|Growth Substances|growth substances|mesh-ancestor
153758554|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758555|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
153758556|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758557|NCT04652284|Amoxicillin|amoxicillin|mesh-list
153758558|NCT04652284|Clarithromycin|clarithromycin|mesh-list
153758759|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758760|NCT00408239|Enoxaparin|enoxaparin|mesh-list
153758761|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
153758762|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153758763|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153758764|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758765|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153758766|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758767|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
153758768|NCT00408278|Analgesics|analgesics|mesh-ancestor
153758769|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
153758804|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153758805|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153758824|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758825|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758826|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758827|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153758828|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
153758829|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153758830|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153758831|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758832|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758833|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153758834|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153758835|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758836|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758837|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758838|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153758840|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153758854|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153758855|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153758856|NCT00560443|Analgesics|analgesics|mesh-ancestor
153758857|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
153758858|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758859|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758860|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153758867|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758869|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
153758870|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153758926|NCT00201396|Mitomycins|mitomycins|mesh-list
153758927|NCT00201396|Mitomycin|mitomycin|mesh-list
153758928|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758929|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
153758941|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153758942|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153758943|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758944|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
153758945|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153758946|NCT00201435|Paclitaxel|paclitaxel|mesh-list
153758947|NCT00201435|Docetaxel|docetaxel|mesh-list
153758948|NCT00201435|Capecitabine|capecitabine|mesh-list
153758949|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153758950|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758951|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
153758952|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
153758953|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
153758954|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758955|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153758956|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
153758957|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
153758958|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153758988|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758989|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153758990|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758991|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153758992|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153758993|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153758994|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153759019|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153759020|NCT00179231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153759021|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153759022|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153759023|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759024|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759025|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
153759026|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153759027|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
153759028|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
153759029|NCT00201669|Clofarabine|clofarabine|mesh-list
153759030|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759031|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
153759032|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759033|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759034|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
153759035|NCT00201708|Docetaxel|docetaxel|mesh-list
153759036|NCT00201708|Doxorubicin|doxorubicin|mesh-list
153759037|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759038|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
153759039|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759085|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153759086|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153759087|NCT00179738|Growth Substances|growth substances|mesh-ancestor
153759088|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
153759101|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759102|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759103|NCT04723238|Analgesics|analgesics|mesh-ancestor
153759104|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
153759105|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759106|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
153759107|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153759175|NCT00561067|Protective Agents|protective agents|mesh-ancestor
153759176|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153759177|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759178|NCT00561067|Hematinics|hematinics|mesh-ancestor
153759179|NCT00561106|Valacyclovir|valacyclovir|mesh-list
153759180|NCT00561106|Prednisone|prednisone|mesh-list
153759181|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759182|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
153759183|NCT00561106|Hormones|hormones|mesh-ancestor
153759184|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759185|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759186|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153759187|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759188|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
153759189|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759190|NCT00561184|Vaccines|vaccines|mesh-list
153759191|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
153759192|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759193|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
153759194|NCT00186849|Ifosfamide|ifosfamide|mesh-list
153759195|NCT00186849|Carboplatin|carboplatin|mesh-list
153759196|NCT00186849|Doxorubicin|doxorubicin|mesh-list
153759197|NCT00186849|Etoposide|etoposide|mesh-list
153759198|NCT00186849|Topotecan|topotecan|mesh-list
153759199|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759237|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759238|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759239|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
153759240|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759241|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759242|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759243|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759244|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
153759245|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759246|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759247|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759248|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759249|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
153759250|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759251|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759252|NCT00180050|Budesonide|budesonide|mesh-list
153759253|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759254|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153759255|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
153759256|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759257|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759258|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153759259|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153759306|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759307|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759308|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759309|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759310|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759311|NCT00180128|Analgesics|analgesics|mesh-ancestor
153759312|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
153759313|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759314|NCT00575614|Prucalopride|prucalopride|mesh-list
153759315|NCT00575614|Laxatives|laxatives|mesh-ancestor
153759316|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759380|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759381|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153759382|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
153759383|NCT00576706|Misoprostol|misoprostol|mesh-list
153759384|NCT00576706|Rebamipide|rebamipide|mesh-list
153759385|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153759386|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
153759387|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153759388|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759389|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153759390|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759391|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
153759392|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
153759393|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759411|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
153759412|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759413|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759414|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759415|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759422|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
153759452|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759453|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759486|NCT00187005|Hormones|hormones|mesh-ancestor
153759487|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759488|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153759489|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153759490|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
153759491|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153759492|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759493|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
153759494|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
153759495|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759496|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153759497|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153759498|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759499|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759515|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759517|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
153759518|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759519|NCT00187083|Dexamethasone|dexamethasone|mesh-list
153759520|NCT00187083|Methotrexate|methotrexate|mesh-list
153759521|NCT00187083|Fludarabine|fludarabine|mesh-list
153759522|NCT00187083|Etoposide|etoposide|mesh-list
153759523|NCT00187083|Vincristine|vincristine|mesh-list
153759524|NCT00187083|Asparaginase|asparaginase|mesh-list
153759525|NCT00187083|Topotecan|topotecan|mesh-list
153759526|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
153759527|NCT00187083|Idarubicin|idarubicin|mesh-list
153759528|NCT00187083|Pegaspargase|pegaspargase|mesh-list
153759529|NCT00187083|Teniposide|teniposide|mesh-list
153759530|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759531|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
153759532|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
153759533|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759534|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759535|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759542|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
153759543|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153759544|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759545|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
153759546|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759547|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
153759548|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759635|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
153759636|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759637|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
153759638|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759639|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759640|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759641|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
153759642|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759643|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759644|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759645|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153759646|NCT04578496|Afamelanotide|afamelanotide|mesh-list
153759647|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
153759648|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
153759649|NCT00579046|Hematinics|hematinics|mesh-ancestor
153759650|NCT00579085|Ketamine|ketamine|mesh-list
153759651|NCT00579085|Analgesics|analgesics|mesh-ancestor
153759652|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
153759711|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153759712|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153759713|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
153759714|NCT00579592|Rituximab|rituximab|mesh-list
153759715|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
153759716|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153759717|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759718|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
153759719|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759720|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742794|NCT02448095|Ponatinib|ponatinib|mesh-list
153759721|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759805|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
153759806|NCT00580450|Thymalfasin|thymalfasin|mesh-list
153759807|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153759808|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
153759809|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759810|NCT00180947|Vinorelbine|vinorelbine|mesh-list
153759811|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759812|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759813|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759814|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759820|NCT00581425|Interferons|interferons|mesh-list
153759895|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759896|NCT00209352|Acyclovir|acyclovir|mesh-list
153759897|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
153759898|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759899|NCT00181142|Daclizumab|daclizumab|mesh-list
153759900|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759901|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
153759902|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759903|NCT00582985|Antibodies|antibodies|mesh-list
153759929|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
153759930|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153759931|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153759932|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153759933|NCT00583063|Sirolimus|sirolimus|mesh-list
153759996|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153759997|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153759998|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
153759999|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760000|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760001|NCT00181571|Methylphenidate|methylphenidate|mesh-list
153760002|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153760003|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760128|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760130|NCT00216372|Lanreotide|lanreotide|mesh-list
153760131|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760132|NCT00584662|Phenylephrine|phenylephrine|mesh-list
153760133|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
153760134|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153760135|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153760136|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
153760137|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760138|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760139|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760140|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
153760141|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
153760142|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760143|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
153760185|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
153760186|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
153760187|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153760188|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153760189|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153760190|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
153760191|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760192|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760193|NCT00585091|Protective Agents|protective agents|mesh-ancestor
153760194|NCT00216450|Rabeprazole|rabeprazole|mesh-list
153760214|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760216|NCT00216489|Rabeprazole|rabeprazole|mesh-list
153760217|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153760218|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153760219|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153760220|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760221|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760222|NCT00585754|Guanfacine|guanfacine|mesh-list
153760223|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153760224|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153760225|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153760226|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153760227|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
153760228|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743093|NCT00144911|Xhance|xhance|mesh-list
153760259|NCT00408551|Leucovorin|leucovorin|mesh-list
153760260|NCT00408551|Fluorouracil|fluorouracil|mesh-list
153760261|NCT00408551|Floxuridine|floxuridine|mesh-list
153760262|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
153760263|NCT00408551|Irinotecan|irinotecan|mesh-list
153760264|NCT00408551|Calcium|calcium|mesh-list
153760265|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
153760266|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153760267|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760268|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
153760269|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760270|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153760287|NCT04575415|Dacomitinib|dacomitinib|mesh-list
153760288|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153760289|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760290|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153760291|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153760292|NCT04575415|Growth Substances|growth substances|mesh-ancestor
153760294|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
153760297|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760298|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760299|NCT00209625|Leucovorin|leucovorin|mesh-list
153760300|NCT00209625|Fluorouracil|fluorouracil|mesh-list
153760301|NCT00209625|Irinotecan|irinotecan|mesh-list
153760302|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
153760303|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760304|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153760305|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760306|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153760307|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
153760308|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760309|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153760310|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153760311|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760312|NCT00209625|Antidotes|antidotes|mesh-ancestor
153760313|NCT00209625|Protective Agents|protective agents|mesh-ancestor
153760314|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
153760315|NCT00209625|Vitamins|vitamins|mesh-ancestor
153760316|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
153760317|NCT00216528|Risperidone|risperidone|mesh-list
153760318|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153760319|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
153760320|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760321|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760322|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760323|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153760324|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760326|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760354|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153760355|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153760357|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760358|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153760359|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
153760360|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760361|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760362|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153760363|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
153597467|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
153760365|NCT00587119|Hormones|hormones|mesh-ancestor
153760366|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760367|NCT00216567|Topiramate|topiramate|mesh-list
153760368|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
153760369|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153760370|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760371|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
153760372|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153760373|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153760374|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760375|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
153760376|NCT00182351|Coagulants|coagulants|mesh-ancestor
153760377|NCT00587470|Candesartan|candesartan|mesh-list
153359683|NCT04409834|Heparin|heparin|mesh-list
153760378|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
153760379|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153760380|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153760381|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154157446|NCT05784844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760382|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760383|NCT00209703|Leucovorin|leucovorin|mesh-list
153760384|NCT00209703|Fluorouracil|fluorouracil|mesh-list
153760385|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
153760386|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
153760387|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
153760388|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760393|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760394|NCT00209703|Antidotes|antidotes|mesh-ancestor
153760395|NCT00209703|Protective Agents|protective agents|mesh-ancestor
153760407|NCT00216606|Topiramate|topiramate|mesh-list
153760408|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
153760409|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153760410|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760411|NCT00587665|Ketamine|ketamine|mesh-list
153760412|NCT00587665|Analgesics|analgesics|mesh-ancestor
153760413|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
153760414|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760415|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760416|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153760417|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153760418|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
153760419|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
153760420|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760421|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153760422|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153760423|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760424|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760425|NCT00182429|Metronidazole|metronidazole|mesh-list
153760426|NCT00182429|Rifampin|rifampin|mesh-list
153760427|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760428|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153760429|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153760430|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153760431|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153760432|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
153760447|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153760448|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153760449|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760450|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760451|NCT00588016|Itraconazole|itraconazole|mesh-list
153760452|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
153760453|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760454|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153760455|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153760456|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760457|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760458|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153760480|NCT00588133|Coagulants|coagulants|mesh-ancestor
153760481|NCT00588172|Metformin|metformin|mesh-list
153760482|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153760483|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760484|NCT00182507|Olanzapine|olanzapine|mesh-list
153760485|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
153760486|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
153760487|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760488|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760489|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153760490|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153760491|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760493|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760530|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760531|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760532|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153760533|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153760534|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
153760535|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153760536|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153760537|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153760538|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153760540|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
153760541|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153760542|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
153760543|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153760544|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153760545|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760546|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153760547|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760548|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760549|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153760550|NCT00182663|Clarithromycin|clarithromycin|mesh-list
153760551|NCT00182663|Thalidomide|thalidomide|mesh-list
153760552|NCT00182663|Dexamethasone|dexamethasone|mesh-list
153760553|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760554|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
153760555|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
153760556|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760557|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760558|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153760559|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
153760560|NCT00182663|Hormones|hormones|mesh-ancestor
153760561|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760562|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153760563|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760564|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153760568|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760569|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153760570|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153760571|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153760603|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153760604|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760606|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
153760607|NCT00588835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153760608|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153760609|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
153760610|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760611|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760612|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153760613|NCT00209859|Cyclosporine|cyclosporine|mesh-list
153760614|NCT00209859|Betamethasone|betamethasone|mesh-list
153760615|NCT00209859|Methotrexate|methotrexate|mesh-list
153760616|NCT00209859|Cyclosporins|cyclosporins|mesh-list
153760663|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153760664|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153760665|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760666|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760667|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153760668|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153760669|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153760670|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153760672|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
153760673|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153760675|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153760676|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153760677|NCT00589186|Analgesics|analgesics|mesh-ancestor
153760678|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
153760686|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760688|NCT00589264|Trace Elements|trace elements|mesh-ancestor
153760689|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
153760690|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760691|NCT00589381|Fenretinide|fenretinide|mesh-list
153760692|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760693|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153760694|NCT00589381|Protective Agents|protective agents|mesh-ancestor
153760695|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760696|NCT00182819|Temozolomide|temozolomide|mesh-list
153760697|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153760698|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
153760722|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153760724|NCT00216879|Calcipotriene|calcipotriene|mesh-list
153760725|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153760726|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760727|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
153760728|NCT00216879|Hormones|hormones|mesh-ancestor
153760729|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760730|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760731|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153760732|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
153760733|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
153760734|NCT00589927|Cilostazol|cilostazol|mesh-list
153760735|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153760736|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
153760737|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760738|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760769|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153760770|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153760771|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153760772|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760773|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
153760774|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760775|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760776|NCT04574791|Tizanidine|tizanidine|mesh-list
153760777|NCT04574791|Analgesics|analgesics|mesh-ancestor
153760778|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
153760779|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760780|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760781|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
153760782|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153760783|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153760784|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
153760785|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
153760786|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153760787|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153760788|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153760789|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
153760790|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760791|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760792|NCT00590629|Niacin|niacin|mesh-list
153760793|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
153760794|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153760795|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
153760796|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760797|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153760798|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
153760828|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760829|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153760830|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153760831|NCT00477295|Carbamazepine|carbamazepine|mesh-list
153760833|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
153760834|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
153760835|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760836|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760837|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760838|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760839|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153760840|NCT00477295|Analgesics|analgesics|mesh-ancestor
153760841|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
153760842|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760843|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153760844|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153760845|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760846|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153760896|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760897|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
153760898|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153760899|NCT00476476|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153760900|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153760901|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760902|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760903|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760904|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
153760905|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760906|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
153760907|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153760908|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760909|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153760910|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
153760911|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153760912|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760913|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760914|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760915|NCT00210210|Ketamine|ketamine|mesh-list
153760916|NCT00210210|Analgesics|analgesics|mesh-ancestor
153760917|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
153760918|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760919|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760920|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153760921|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153760922|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
153760939|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153760940|NCT00217191|Analgesics|analgesics|mesh-ancestor
153760941|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
153760942|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760943|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760944|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760945|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153760952|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
153760953|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760954|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760955|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760956|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153760957|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153760959|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153760960|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153760961|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153760962|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153760963|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760964|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
153760965|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760966|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760967|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153760968|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760969|NCT00183833|Capecitabine|capecitabine|mesh-list
153760970|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
153760971|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153760972|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
153760973|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760974|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760975|NCT00183833|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153760976|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153760977|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760978|NCT00183911|Leucovorin|leucovorin|mesh-list
153760979|NCT00183911|Fluorouracil|fluorouracil|mesh-list
153760995|NCT00412152|Narcotics|narcotics|mesh-ancestor
153760998|NCT00412152|Analgesics|analgesics|mesh-ancestor
153761011|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153761012|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
153761013|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761014|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153761015|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153761016|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
153761017|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761018|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761019|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153761020|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
153761021|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
153761022|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
153761023|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
153761024|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153761025|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153761026|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153761027|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761028|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761029|NCT00412191|Lamotrigine|lamotrigine|mesh-list
153761030|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
153761031|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153761032|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761033|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761034|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153761071|NCT00475657|Pemetrexed|pemetrexed|mesh-list
153761074|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761075|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153761076|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153761077|NCT00210405|Micronutrients|micronutrients|mesh-list
153761078|NCT00210405|Trace Elements|trace elements|mesh-list
153761079|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761080|NCT00408941|Propofol|propofol|mesh-list
153761081|NCT00408941|Prilocaine|prilocaine|mesh-list
153761082|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153761083|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761084|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761085|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153761086|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
153761087|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
153761088|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
153761091|NCT00475423|Rituximab|rituximab|mesh-list
153761147|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761149|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761150|NCT00183989|Analgesics|analgesics|mesh-ancestor
153761151|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
153761152|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761153|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153761154|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761155|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761156|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153761157|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153761158|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
153761159|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761160|NCT00184106|Paroxetine|paroxetine|mesh-list
153761161|NCT00184106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153761176|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
153761177|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761178|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761179|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761181|NCT00210561|Tramadol|tramadol|mesh-list
153761182|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153761183|NCT00210561|Analgesics|analgesics|mesh-ancestor
153761184|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
153761185|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761186|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761187|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
153761188|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153761189|NCT00210561|Narcotics|narcotics|mesh-ancestor
153761193|NCT00217386|Etanercept|etanercept|mesh-list
153761206|NCT00217503|Zidovudine|zidovudine|mesh-list
153761207|NCT00217503|Valganciclovir|valganciclovir|mesh-list
153761208|NCT00217503|Ganciclovir|ganciclovir|mesh-list
153761209|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
153761210|NCT00217503|Bevacizumab|bevacizumab|mesh-list
153761211|NCT00217503|Doxorubicin|doxorubicin|mesh-list
153761212|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153761213|NCT00217503|Etoposide|etoposide|mesh-list
153761214|NCT00217503|Bortezomib|bortezomib|mesh-list
153761215|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153761216|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
153761217|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761218|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153761219|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153761220|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
153761221|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761236|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153761237|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
153761238|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761239|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153761240|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153761241|NCT00217542|Interferons|interferons|mesh-list
153761242|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
153761243|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
153761244|NCT00217542|Azacitidine|azacitidine|mesh-list
153761245|NCT00217542|Amifostine|amifostine|mesh-list
153761246|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761247|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
153761248|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761249|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153761250|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
153761251|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761252|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761253|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
153761264|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153761265|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
153761266|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761267|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761268|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153761269|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153761270|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
153761271|NCT00184496|Methadone|methadone|mesh-list
153761272|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153761273|NCT00184496|Narcotics|narcotics|mesh-ancestor
153761274|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761275|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761276|NCT00184496|Analgesics|analgesics|mesh-ancestor
153761277|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
153761278|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761279|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
153761280|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
153761281|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
153761282|NCT00210756|Hematinics|hematinics|mesh-ancestor
153761294|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761296|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
153761297|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
153761298|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761299|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761300|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
153761301|NCT00210795|Hematinics|hematinics|mesh-ancestor
153761302|NCT00217698|Gemcitabine|gemcitabine|mesh-list
153761303|NCT00217698|Gefitinib|gefitinib|mesh-list
153761304|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761305|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153761306|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
153761307|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761308|NCT00217698|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153761309|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153761310|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761318|NCT00210834|Hematinics|hematinics|mesh-ancestor
153761319|NCT00217815|Efungumab|efungumab|mesh-list
153761320|NCT00217815|Docetaxel|docetaxel|mesh-list
153761321|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761322|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
153761323|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
153761324|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
153761325|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761326|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
153761327|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761328|NCT04722471|Progesterone|progesterone|mesh-list
153761329|NCT04722471|Progestins|progestins|mesh-ancestor
153761330|NCT04722471|Hormones|hormones|mesh-ancestor
153761331|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761332|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761333|NCT00210873|Topiramate|topiramate|mesh-list
153761334|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
153761335|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761336|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761338|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
153761339|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761340|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761341|NCT00184847|Adenosine|adenosine|mesh-list
153761342|NCT00184847|Acetylcholine|acetylcholine|mesh-list
153761343|NCT00184847|Caffeine|caffeine|mesh-list
153761344|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153761345|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761346|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153761347|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761348|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761363|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153761365|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153761366|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761367|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153761373|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153761374|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153761375|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
153761376|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153761377|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153761378|NCT00217932|Valproic Acid|valproic acid|mesh-list
153761379|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
153761380|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761381|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761382|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
153761383|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761384|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761385|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
153761386|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153761387|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761388|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761389|NCT00210990|Doripenem|doripenem|mesh-list
153761390|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153761391|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761392|NCT00185003|Tolbutamide|tolbutamide|mesh-list
153761393|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
153761394|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761395|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761398|NCT00185120|Amlodipine|amlodipine|mesh-list
153761476|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153761477|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153761478|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761479|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761480|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153761481|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153761482|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
153761483|NCT00211146|Hematinics|hematinics|mesh-ancestor
153761484|NCT00211224|Riluzole|riluzole|mesh-list
153761485|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
153761486|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153761487|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153761488|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761489|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761490|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761491|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153761492|NCT00211224|Protective Agents|protective agents|mesh-ancestor
153761493|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
153761494|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761495|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761496|NCT00218205|Celecoxib|celecoxib|mesh-list
153761497|NCT00218205|Epirubicin|epirubicin|mesh-list
153761498|NCT00218205|Estramustine|estramustine|mesh-list
153761499|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153761500|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153761501|NCT00218205|Analgesics|analgesics|mesh-ancestor
153761502|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
153761503|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761504|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761505|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153761521|NCT00185510|Prednisolone|prednisolone|mesh-list
153761534|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761535|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153761536|NCT00185510|Protective Agents|protective agents|mesh-ancestor
153761537|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153761538|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761540|NCT00218244|Nicotine|nicotine|mesh-list
153761541|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153761542|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
153761543|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761544|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761545|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153761546|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153761547|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
153761548|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761549|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761550|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
153761551|NCT00211302|Aripiprazole|aripiprazole|mesh-list
153761552|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
153761553|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761554|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153761555|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153761556|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761557|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761558|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
153761559|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
153761560|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781936|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157447|NCT05784844|Antifungal Agents|antifungal agents|mesh-ancestor
153761561|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761562|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153761589|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153761590|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
153761591|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761592|NCT00211380|Aripiprazole|aripiprazole|mesh-list
153761593|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
153761594|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761595|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153761596|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153761597|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761598|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761599|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
153761600|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
153761601|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761602|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761603|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153761604|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153761605|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
153761606|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153761607|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153761608|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153761609|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153761610|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153761611|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153761612|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761649|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761650|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761651|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153761652|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
153761653|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153761654|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153761655|NCT00211419|Growth Substances|growth substances|mesh-ancestor
153761656|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
153761657|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761658|NCT00211458|Anecortave|anecortave|mesh-list
153761659|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153761660|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153761661|NCT00211458|Growth Substances|growth substances|mesh-ancestor
153761662|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761663|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
153761664|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761665|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
153761666|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761667|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153761668|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
153761669|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761670|NCT00211614|Lansoprazole|lansoprazole|mesh-list
153761671|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
153761672|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153761677|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
153761705|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761706|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761707|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761708|NCT00187070|Cytarabine|cytarabine|mesh-list
153761709|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153761710|NCT00187070|Dexamethasone|dexamethasone|mesh-list
153761711|NCT00187070|Prednisone|prednisone|mesh-list
153761712|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
153761713|NCT00187070|Ifosfamide|ifosfamide|mesh-list
153761714|NCT00187070|Carboplatin|carboplatin|mesh-list
153761715|NCT00187070|Doxorubicin|doxorubicin|mesh-list
153761716|NCT00187070|Methotrexate|methotrexate|mesh-list
153761717|NCT00187070|Etoposide|etoposide|mesh-list
153761718|NCT00187070|Vincristine|vincristine|mesh-list
153761719|NCT00187070|Vinblastine|vinblastine|mesh-list
153761720|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153761721|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
153761722|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761723|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153761724|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153761725|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
153761726|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761727|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761728|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153761729|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153761730|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
153761731|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
153761732|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761733|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153761763|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761764|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
153761765|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761766|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
153761767|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761768|NCT00412347|Insulin|insulin|mesh-list
153761769|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761770|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761771|NCT00219024|Aliskiren|aliskiren|mesh-list
153761772|NCT00219024|Renin Inhibitors|renin inhibitors|mesh-ancestor
153761773|NCT00219024|Protease Inhibitors|protease inhibitors|mesh-ancestor
153761774|NCT00219024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761775|NCT00219024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761776|NCT00187499|Fluticasone|fluticasone|mesh-list
153761777|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153761778|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153761779|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
153761780|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761781|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761782|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153761783|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
153761784|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
153761785|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153761786|NCT00212004|Pioglitazone|pioglitazone|mesh-list
153761787|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761788|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761789|NCT00219063|Aliskiren|aliskiren|mesh-list
153761790|NCT00219063|Renin Inhibitors|renin inhibitors|mesh-ancestor
153761791|NCT00219063|Protease Inhibitors|protease inhibitors|mesh-ancestor
153761792|NCT00219063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761793|NCT00219063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761794|NCT00187577|Bimatoprost|bimatoprost|mesh-list
153761795|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153761796|NCT00187577|Latanoprost|latanoprost|mesh-list
153761797|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153761798|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153761801|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761802|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153761803|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
153761804|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761805|NCT00219102|Aliskiren|aliskiren|mesh-list
153761806|NCT00219102|Renin Inhibitors|renin inhibitors|mesh-ancestor
153761807|NCT00219102|Protease Inhibitors|protease inhibitors|mesh-ancestor
153761808|NCT00219102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761809|NCT00219102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761810|NCT00212082|Docetaxel|docetaxel|mesh-list
153761811|NCT00212082|Doxorubicin|doxorubicin|mesh-list
153761812|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761813|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
153761814|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
153761815|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
153761816|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761817|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153761818|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153761835|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761836|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153761837|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153761838|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
153761839|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153761840|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761842|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
153761843|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153761844|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153761845|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761846|NCT00188045|Propranolol|propranolol|mesh-list
153761847|NCT00188045|Spironolactone|spironolactone|mesh-list
153761848|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153761849|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153761850|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
153761851|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761852|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761853|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646698|NCT00116662|Immunologic Factors|immunologic factors|mesh-ancestor
153761854|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153761855|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153761856|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
153761857|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153761858|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
153761859|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761860|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153761862|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
153761863|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153761864|NCT00212277|Norethindrone|norethindrone|mesh-list
153761865|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
153761866|NCT00212277|Estradiol|estradiol|mesh-list
153761867|NCT00212277|Estrogens|estrogens|mesh-ancestor
153761868|NCT00212277|Hormones|hormones|mesh-ancestor
153761869|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761870|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761871|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153761872|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
153761873|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153761874|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153761875|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153761876|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153761877|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153761890|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
153761891|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761892|NCT00188396|Citalopram|citalopram|mesh-list
153761893|NCT00188396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153761894|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153761911|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761912|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153761913|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761914|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761915|NCT00212472|Factor VIII|factor viii|mesh-list
153761916|NCT00212472|Coagulants|coagulants|mesh-ancestor
153761917|NCT00188552|Tocopherols|tocopherols|mesh-list
153761918|NCT00188552|Vitamin E|vitamin e|mesh-list
153761919|NCT00188552|Tocotrienols|tocotrienols|mesh-list
153761920|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
153761921|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
153761922|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153761923|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761924|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761925|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153761926|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153761927|NCT00188552|Protective Agents|protective agents|mesh-ancestor
153761928|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761929|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
153761930|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153761931|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
153761932|NCT00188552|Vitamins|vitamins|mesh-ancestor
153761933|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
153761934|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
153761976|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
153761977|NCT00219726|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153761978|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153761979|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761980|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761981|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761982|NCT00409253|Nicardipine|nicardipine|mesh-list
153761983|NCT00409253|Urapidil|urapidil|mesh-list
153761984|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153761985|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153761986|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761987|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761988|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153761989|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761990|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153761991|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153761992|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
153761993|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761994|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153761995|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153761996|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153761997|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
153761998|NCT00219765|Cytarabine|cytarabine|mesh-list
153761999|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
153762000|NCT00219765|Daunorubicin|daunorubicin|mesh-list
153762001|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762002|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
153762003|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762004|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762039|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153762040|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762041|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762042|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762043|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
153762044|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762045|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762047|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153762048|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
153762049|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
153762050|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762051|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762052|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153762053|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
153762054|NCT00188864|Hormones|hormones|mesh-ancestor
153762055|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153762056|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153762057|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762058|NCT00188942|Olanzapine|olanzapine|mesh-list
153762059|NCT00188942|Fluoxetine|fluoxetine|mesh-list
153762060|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
153762061|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
153762062|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762063|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762064|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153762065|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153762066|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153762082|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762083|NCT00219882|Protective Agents|protective agents|mesh-ancestor
153762084|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762085|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153762086|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
153762092|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762093|NCT00219921|Analgesics|analgesics|mesh-ancestor
153762094|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
153762095|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762096|NCT00212823|Almotriptan|almotriptan|mesh-list
153762097|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153762098|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
153762099|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762100|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762101|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762102|NCT00189059|Amitriptyline|amitriptyline|mesh-list
153762103|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153762104|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
153762105|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762106|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153762107|NCT00189059|Analgesics|analgesics|mesh-ancestor
153762108|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
153762109|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762110|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762111|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153762112|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762113|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762114|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762115|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
153762116|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762117|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153762118|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
153762119|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
153762120|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762121|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762134|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
153762135|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
153762136|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762138|NCT00189410|Carboplatin|carboplatin|mesh-list
153762139|NCT00189410|Doxorubicin|doxorubicin|mesh-list
153762140|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153646702|NCT02909322|Ropivacaine|ropivacaine|mesh-list
153646703|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
153762141|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762142|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153762143|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153762144|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153762145|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762146|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762147|NCT00189566|Paclitaxel|paclitaxel|mesh-list
153762148|NCT00189566|Carboplatin|carboplatin|mesh-list
153762149|NCT00189566|Topotecan|topotecan|mesh-list
153762150|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153762151|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762152|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
153762153|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
153762154|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
153762155|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762156|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153762157|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153762158|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762159|NCT00220116|Capecitabine|capecitabine|mesh-list
153762160|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
153762161|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762162|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
153762163|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762164|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762165|NCT02963129|Mupirocin|mupirocin|mesh-list
153762166|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153762167|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762168|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153762195|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762196|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
153762197|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762198|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762199|NCT00189722|Tacrolimus|tacrolimus|mesh-list
153762200|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762201|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
153762202|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762203|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153762204|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762205|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762206|NCT00220194|Leuprolide|leuprolide|mesh-list
153762207|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153762208|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
153762209|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153762210|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762211|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153762212|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762213|NCT00189761|Tacrolimus|tacrolimus|mesh-list
153762214|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762215|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
153762216|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762217|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153762218|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762244|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762245|NCT00189800|Urological Agents|urological agents|mesh-ancestor
153762247|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153762248|NCT00220233|Olmesartan|olmesartan|mesh-list
153762249|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153762261|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153762262|NCT00189839|Tacrolimus|tacrolimus|mesh-list
153762263|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762264|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
153762265|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762266|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153762267|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762268|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762269|NCT00189878|Methotrexate|methotrexate|mesh-list
153762270|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153762271|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
153762272|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153762273|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762274|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762275|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
153762276|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762277|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762278|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
153762279|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762280|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153762281|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762282|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
153762283|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153762301|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153762302|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
153762303|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153762304|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
153762305|NCT00213252|Montelukast|montelukast|mesh-list
153762306|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153762307|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
153762308|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153762316|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
153762317|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762318|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153762319|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153762320|NCT00213252|Protective Agents|protective agents|mesh-ancestor
153762321|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153762322|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
153762323|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153762324|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
153762325|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153762364|NCT00412503|Topotecan|topotecan|mesh-list
153762365|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153762366|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
153762367|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762368|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762369|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153762370|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153762371|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762372|NCT00412581|Lenalidomide|lenalidomide|mesh-list
153762373|NCT00412581|Dacarbazine|dacarbazine|mesh-list
153762374|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
153762375|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762376|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153762377|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153762386|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762387|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153762388|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153762389|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762390|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762391|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762392|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153762393|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153762394|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
153762395|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762396|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
153762397|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762398|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153762416|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153762417|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762419|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153762420|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153762421|NCT00190307|Analgesics|analgesics|mesh-ancestor
153762422|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
153762423|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762424|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762425|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153762426|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153762427|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153762428|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153762429|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762430|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153762431|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153762432|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762433|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
153762434|NCT02963168|Docetaxel|docetaxel|mesh-list
153762435|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762436|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
153762437|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
153762438|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
153762439|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762452|NCT00213486|Irinotecan|irinotecan|mesh-list
153762474|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
153762475|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153762476|NCT00190580|Valsartan|valsartan|mesh-list
153762477|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
153762478|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153762479|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153762480|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762481|NCT00220506|Modafinil|modafinil|mesh-list
153762482|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153762483|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762484|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153762485|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153762486|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153762487|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762488|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153762489|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153762490|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762491|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762492|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762493|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762494|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762495|NCT00190619|Analgesics|analgesics|mesh-ancestor
153762496|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
153762497|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762498|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
153762499|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762500|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
153762501|NCT00213564|Infliximab|infliximab|mesh-list
153762531|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762532|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762533|NCT00220584|Donepezil|donepezil|mesh-list
153762534|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153762535|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762536|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762537|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
153762538|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762539|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762540|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
153762541|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153762542|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153762543|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762544|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762545|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762546|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762547|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762548|NCT00190814|Analgesics|analgesics|mesh-ancestor
153762549|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
153762550|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762551|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
153762552|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762553|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
153762554|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
153762555|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762589|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762591|NCT00190892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153762592|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762593|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762594|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762595|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762596|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
153762597|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
153762598|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
153762599|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153762600|NCT00190892|Analgesics|analgesics|mesh-ancestor
153762601|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
153599706|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
153762602|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153762603|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153762604|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153762605|NCT00220857|Rabeprazole|rabeprazole|mesh-list
153762606|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153762607|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153762608|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153762609|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762610|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762611|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153762612|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153762613|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762614|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762615|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762616|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
153762617|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762618|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762619|NCT00220896|Donepezil|donepezil|mesh-list
153762629|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762631|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153762632|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762633|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762634|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762635|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
153762636|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762637|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762638|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153762639|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153762640|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762641|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762642|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762643|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
153762644|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762645|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762646|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
153762647|NCT00123149|Hematinics|hematinics|mesh-ancestor
153762700|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
153762701|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
153762702|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
153762703|NCT00214032|Pycnogenols|pycnogenols|mesh-list
153762704|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153762705|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
153762706|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762707|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
153762708|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762709|NCT00214032|Protective Agents|protective agents|mesh-ancestor
153762710|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153762711|NCT00123266|Plasminogen|plasminogen|mesh-list
153762712|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153762713|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153762714|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762715|NCT06117137|Dapagliflozin|dapagliflozin|mesh-list
153762716|NCT06117137|Empagliflozin|empagliflozin|mesh-list
153762717|NCT06117137|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153762718|NCT06117137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762719|NCT06117137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153762720|NCT06117137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762721|NCT06116994|Anesthetics|anesthetics|mesh-list
153762722|NCT06116994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762723|NCT06116994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762724|NCT06116825|Fluorides|fluorides|mesh-list
153762725|NCT06116825|Cariostatic Agents|cariostatic agents|mesh-ancestor
153762726|NCT06116825|Protective Agents|protective agents|mesh-ancestor
153762727|NCT06116825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762728|NCT06116682|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
153762729|NCT06116682|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153762730|NCT06116682|Immunologic Factors|immunologic factors|mesh-ancestor
153762731|NCT06116682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762732|NCT06116682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153762733|NCT06116682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762734|NCT06116461|Nivolumab|nivolumab|mesh-list
153762757|NCT06115733|Capecitabine|capecitabine|mesh-list
153762758|NCT06115733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762759|NCT06115733|Antimetabolites|antimetabolites|mesh-ancestor
153762760|NCT06115733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762761|NCT06115733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762762|NCT06115421|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153762763|NCT06115421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762764|NCT06115408|Acetylcysteine|acetylcysteine|mesh-list
153762765|NCT06115408|Dienogest|dienogest|mesh-list
153762766|NCT06115408|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153762767|NCT06115408|Antiviral Agents|antiviral agents|mesh-ancestor
153762768|NCT06115408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762769|NCT06115408|Expectorants|expectorants|mesh-ancestor
153762770|NCT06115408|Respiratory System Agents|respiratory system agents|mesh-ancestor
153762771|NCT06115408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153762772|NCT06115408|Antioxidants|antioxidants|mesh-ancestor
153762773|NCT06115408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762774|NCT06115408|Protective Agents|protective agents|mesh-ancestor
153762775|NCT06115408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762776|NCT06115408|Antidotes|antidotes|mesh-ancestor
153762777|NCT06115408|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153762778|NCT06115408|Contraceptive Agents|contraceptive agents|mesh-ancestor
153762779|NCT06115408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153762780|NCT06115408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153762781|NCT06115408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153762782|NCT06115408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153762813|NCT06097611|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153762814|NCT06097611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153762815|NCT06097611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762816|NCT06097611|Hemostatics|hemostatics|mesh-ancestor
153762817|NCT06097611|Coagulants|coagulants|mesh-ancestor
153762818|NCT05965583|Itraconazole|itraconazole|mesh-list
153762819|NCT05965583|Antifungal Agents|antifungal agents|mesh-ancestor
153762820|NCT05965583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762821|NCT05965583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153762822|NCT05965583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153762823|NCT05965583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762824|NCT05965583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762825|NCT05965583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153762826|NCT05965583|Hormone Antagonists|hormone antagonists|mesh-ancestor
153762827|NCT05965583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153762828|NCT05965583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762829|NCT05965583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153762831|NCT05943496|Acalabrutinib|acalabrutinib|mesh-list
153762832|NCT05943496|Immunoglobulins|immunoglobulins|mesh-list
153762833|NCT05943496|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153762834|NCT05943496|Immunologic Factors|immunologic factors|mesh-ancestor
153762835|NCT05943496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762836|NCT05943496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153762837|NCT05943496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762838|NCT05943496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153762839|NCT05943496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762840|NCT05943496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762841|NCT05925686|Tramadol|tramadol|mesh-list
153762842|NCT05925686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153762843|NCT05925686|Narcotics|narcotics|mesh-ancestor
153762846|NCT05925686|Analgesics|analgesics|mesh-ancestor
153762870|NCT05895513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762872|NCT05894538|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153762873|NCT05894538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762874|NCT05855798|Magnesium Sulfate|magnesium sulfate|mesh-list
153762875|NCT05855798|Ketamine|ketamine|mesh-list
153762876|NCT05855798|Bupivacaine|bupivacaine|mesh-list
153762877|NCT05855798|Anesthetics, Local|anesthetics, local|mesh-ancestor
153762878|NCT05855798|Anesthetics|anesthetics|mesh-ancestor
153762879|NCT05855798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762880|NCT05855798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762881|NCT05855798|Sensory System Agents|sensory system agents|mesh-ancestor
153762882|NCT05855798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762949|NCT06318897|Tubulin Modulators|tubulin modulators|mesh-ancestor
153762950|NCT06318897|Antimitotic Agents|antimitotic agents|mesh-ancestor
153762951|NCT06318897|Mitosis Modulators|mitosis modulators|mesh-ancestor
153762952|NCT06318897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762953|NCT06318897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762954|NCT06318897|Immunologic Factors|immunologic factors|mesh-ancestor
153762955|NCT06318897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762956|NCT06318897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153762957|NCT06318897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153762958|NCT06318897|Alkylating Agents|alkylating agents|mesh-ancestor
153762959|NCT06318897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153762960|NCT06318897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153762961|NCT06318897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153762962|NCT06318897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153762963|NCT06318897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762964|NCT06318897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153762977|NCT06318546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153762978|NCT06318546|Adrenergic Agents|adrenergic agents|mesh-ancestor
153762979|NCT06318546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762980|NCT06318546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762981|NCT06318546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153762983|NCT06318546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153762984|NCT06318546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153762985|NCT06318546|Anesthetics, General|anesthetics, general|mesh-ancestor
153762986|NCT06318546|Anesthetics|anesthetics|mesh-ancestor
153762987|NCT06318481|Clopidogrel|clopidogrel|mesh-list
153762988|NCT06318481|Ticagrelor|ticagrelor|mesh-list
153762989|NCT06318481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153762990|NCT06318481|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153762991|NCT06318481|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153762992|NCT06318481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153762993|NCT06318481|Purinergic Agents|purinergic agents|mesh-ancestor
153762994|NCT06318481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762995|NCT06318481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762997|NCT06318442|Metformin|metformin|mesh-list
153762999|NCT06318442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153763000|NCT06318442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763001|NCT06318442|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153763006|NCT06318286|Carboplatin|carboplatin|mesh-list
153763007|NCT06318286|Pembrolizumab|pembrolizumab|mesh-list
153763008|NCT06318286|Pemetrexed|pemetrexed|mesh-list
153763009|NCT06318286|Lenvatinib|lenvatinib|mesh-list
153763010|NCT06318286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763011|NCT06318286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763012|NCT06318286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153763013|NCT06318286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763014|NCT06318286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763015|NCT06318286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153763016|NCT06318286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153763017|NCT06318286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153763018|NCT06318260|Dobutamine|dobutamine|mesh-list
153763019|NCT06318260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153763020|NCT06318260|Sympathomimetics|sympathomimetics|mesh-ancestor
153763021|NCT06318260|Autonomic Agents|autonomic agents|mesh-ancestor
153763022|NCT06318260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763023|NCT06318260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763024|NCT06318260|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153763025|NCT06318260|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153763026|NCT06318260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153763027|NCT06318260|Adrenergic Agents|adrenergic agents|mesh-ancestor
153763028|NCT06318260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763029|NCT06318260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763030|NCT06318260|Protective Agents|protective agents|mesh-ancestor
153763031|NCT06318234|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153763060|NCT06317662|Hydrocortisone|hydrocortisone|mesh-list
153763061|NCT06317662|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153763062|NCT06317662|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153763063|NCT06317662|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153763064|NCT06317662|Cortisone|cortisone|mesh-list
153763073|NCT06317662|Mercaptopurine|mercaptopurine|mesh-list
153763074|NCT06317662|Pegaspargase|pegaspargase|mesh-list
153763075|NCT06317662|Thioguanine|thioguanine|mesh-list
153763076|NCT06317662|Blinatumomab|blinatumomab|mesh-list
153763077|NCT06317662|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
153763078|NCT06317662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153763079|NCT06317662|Muromonab-CD3|muromonab-cd3|mesh-list
153763080|NCT06317662|Antibodies|antibodies|mesh-list
153763081|NCT06317662|Immunoglobulins|immunoglobulins|mesh-list
153763090|NCT06317662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763091|NCT06317662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763092|NCT06317662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153763093|NCT06317662|Alkylating Agents|alkylating agents|mesh-ancestor
153763094|NCT06317662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763095|NCT06317662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763096|NCT06317662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153763097|NCT06317662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763099|NCT06317662|Autonomic Agents|autonomic agents|mesh-ancestor
153763100|NCT06317662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763101|NCT06317662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763102|NCT06317662|Glucocorticoids|glucocorticoids|mesh-ancestor
153763103|NCT06317662|Hormones|hormones|mesh-ancestor
153763134|NCT06317649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153763135|NCT06317649|Antimetabolites|antimetabolites|mesh-ancestor
153763136|NCT06317649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763137|NCT06317649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763138|NCT06317649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763139|NCT06317649|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153763140|NCT06317649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153763141|NCT06317636|Ketamine|ketamine|mesh-list
153763142|NCT06317636|Analgesics|analgesics|mesh-ancestor
153763143|NCT06317636|Sensory System Agents|sensory system agents|mesh-ancestor
153763144|NCT06317636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763145|NCT06317636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763146|NCT06317636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153763147|NCT06317636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153763148|NCT06317636|Anesthetics, General|anesthetics, general|mesh-ancestor
153763149|NCT06317636|Anesthetics|anesthetics|mesh-ancestor
153763173|NCT06317597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763174|NCT06317558|Immunomodulating Agents|immunomodulating agents|mesh-list
153763175|NCT06317558|Immunologic Factors|immunologic factors|mesh-ancestor
153763176|NCT06317558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763177|NCT06317311|Paclitaxel|paclitaxel|mesh-list
153763178|NCT06317311|Carboplatin|carboplatin|mesh-list
153763179|NCT06317311|Dostarlimab|dostarlimab|mesh-list
153763180|NCT06317311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153763181|NCT06317311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763182|NCT06317311|Tubulin Modulators|tubulin modulators|mesh-ancestor
153763183|NCT06317311|Antimitotic Agents|antimitotic agents|mesh-ancestor
153763184|NCT06317311|Mitosis Modulators|mitosis modulators|mesh-ancestor
153359731|NCT04254107|Immunotoxins|immunotoxins|mesh-ancestor
153763186|NCT06317298|Everolimus|everolimus|mesh-list
153763198|NCT06317142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153763199|NCT06317142|Antimetabolites|antimetabolites|mesh-ancestor
153763219|NCT06317064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763220|NCT06317051|Dapagliflozin|dapagliflozin|mesh-list
153763221|NCT06317051|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153763223|NCT06317051|Pitavastatin|pitavastatin|mesh-list
153763224|NCT06317051|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153763225|NCT06317051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153763226|NCT06317051|Antimetabolites|antimetabolites|mesh-ancestor
153763227|NCT06317051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763228|NCT06317051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153763229|NCT06317051|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153763230|NCT06317051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763231|NCT06317051|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153763232|NCT06317051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153763233|NCT06317051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763234|NCT06317025|Anesthetics|anesthetics|mesh-list
153763235|NCT06317025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763236|NCT06317025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763237|NCT06316960|Cytarabine|cytarabine|mesh-list
153763238|NCT06316960|Azacitidine|azacitidine|mesh-list
153763239|NCT06316960|Decitabine|decitabine|mesh-list
153763240|NCT06316960|Idarubicin|idarubicin|mesh-list
153763241|NCT06316960|Lenograstim|lenograstim|mesh-list
153763242|NCT06316960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153763243|NCT06316960|Antimetabolites|antimetabolites|mesh-ancestor
153763244|NCT06316960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763245|NCT06316960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763246|NCT06316960|Antiviral Agents|antiviral agents|mesh-ancestor
153763247|NCT06316960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763248|NCT06316960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763272|NCT06316570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153763273|NCT06316570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763274|NCT06316570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153763275|NCT06316570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153763276|NCT06316570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763277|NCT06316570|Antipyretics|antipyretics|mesh-ancestor
153763278|NCT06316570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153763279|NCT06316570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153763280|NCT06316570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153763281|NCT06316570|Purinergic Agents|purinergic agents|mesh-ancestor
153763282|NCT06316570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763283|NCT06315959|Morphine|morphine|mesh-list
153763284|NCT06315959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153763285|NCT06315959|Narcotics|narcotics|mesh-ancestor
153763286|NCT06315959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763287|NCT06315959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763288|NCT06315959|Analgesics|analgesics|mesh-ancestor
153359733|NCT04254107|Immunologic Factors|immunologic factors|mesh-ancestor
153763289|NCT06315959|Sensory System Agents|sensory system agents|mesh-ancestor
153763290|NCT06315959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763341|NCT06289504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153763342|NCT06289504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153763343|NCT06289504|Antimetabolites|antimetabolites|mesh-ancestor
153763344|NCT06289504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763345|NCT06289504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153763346|NCT06289504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153763347|NCT06289504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763348|NCT06289504|Anticoagulants|anticoagulants|mesh-ancestor
153763349|NCT06289504|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153763350|NCT06289504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153763351|NCT06289504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763358|NCT06277882|Immunologic Factors|immunologic factors|mesh-ancestor
153763359|NCT06277882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763360|NCT06276231|Diclofenac|diclofenac|mesh-list
153763361|NCT06276231|Albuterol|albuterol|mesh-list
153763362|NCT06276231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153763363|NCT06276231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153763364|NCT06276231|Analgesics|analgesics|mesh-ancestor
153763365|NCT06276231|Sensory System Agents|sensory system agents|mesh-ancestor
153763366|NCT06276231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763367|NCT06276231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763368|NCT06276231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763369|NCT06276231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763370|NCT06276231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153763371|NCT06276231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763410|NCT06244004|Androgens|androgens|mesh-list
153763411|NCT06244004|Androgen Antagonists|androgen antagonists|mesh-list
153763412|NCT06244004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763413|NCT06244004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763414|NCT06244004|Antioxidants|antioxidants|mesh-ancestor
153763415|NCT06244004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763416|NCT06244004|Protective Agents|protective agents|mesh-ancestor
153763417|NCT06244004|Vitamins|vitamins|mesh-ancestor
153763418|NCT06244004|Micronutrients|micronutrients|mesh-ancestor
153763419|NCT06244004|Estrogens|estrogens|mesh-ancestor
153763420|NCT06244004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153763421|NCT06244004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763422|NCT06244004|Anabolic Agents|anabolic agents|mesh-ancestor
153763423|NCT06244004|Hormone Antagonists|hormone antagonists|mesh-ancestor
153763424|NCT06241118|Pimecrolimus|pimecrolimus|mesh-list
153763425|NCT06241118|Tacrolimus|tacrolimus|mesh-list
153763426|NCT06241118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763427|NCT06241118|Immunologic Factors|immunologic factors|mesh-ancestor
153763428|NCT06241118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763429|NCT06241118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153763430|NCT06241118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763431|NCT06241118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763461|NCT06225999|Leucovorin|leucovorin|mesh-list
153763483|NCT06225622|Irinotecan|irinotecan|mesh-list
153763484|NCT06225622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763485|NCT06225622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763486|NCT06225622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153763487|NCT06225622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153763488|NCT06225622|Growth Substances|growth substances|mesh-ancestor
153763489|NCT06225622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763490|NCT06225622|Growth Inhibitors|growth inhibitors|mesh-ancestor
153763491|NCT06225622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153763492|NCT06225622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763493|NCT06225622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763517|NCT06200467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153763518|NCT06200467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153763520|NCT06192108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153763521|NCT06192108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763522|NCT06192108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153763523|NCT06192108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763524|NCT06191458|Primaquine|primaquine|mesh-list
153763525|NCT06191458|Antimalarials|antimalarials|mesh-ancestor
153763526|NCT06191458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153763527|NCT06191458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153763528|NCT06191458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763529|NCT06184204|Rivaroxaban|rivaroxaban|mesh-list
153763530|NCT06184204|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153763531|NCT06184204|Antithrombins|antithrombins|mesh-ancestor
153763532|NCT06184204|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153763533|NCT06184204|Protease Inhibitors|protease inhibitors|mesh-ancestor
153763534|NCT06184204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763535|NCT06184204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763536|NCT06184204|Anticoagulants|anticoagulants|mesh-ancestor
153763537|NCT06179303|Tamoxifen|tamoxifen|mesh-list
153763538|NCT06179303|Deoxyglucose|deoxyglucose|mesh-list
153763539|NCT06179303|Letrozole|letrozole|mesh-list
153763540|NCT06179303|Fulvestrant|fulvestrant|mesh-list
153763541|NCT06179303|Anastrozole|anastrozole|mesh-list
153763559|NCT06179303|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153763563|NCT06179303|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153763564|NCT06179303|Hormone Antagonists|hormone antagonists|mesh-ancestor
153763565|NCT06179303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153763566|NCT06179303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153763567|NCT06179303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153763568|NCT06179303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153763569|NCT06179303|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153763570|NCT06179303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153763571|NCT06179303|Cariostatic Agents|cariostatic agents|mesh-ancestor
153763572|NCT06179303|Protective Agents|protective agents|mesh-ancestor
153763573|NCT06179303|Antimetabolites|antimetabolites|mesh-ancestor
153763574|NCT06179303|Antiviral Agents|antiviral agents|mesh-ancestor
153763575|NCT06179303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763576|NCT06176794|Torsemide|torsemide|mesh-list
153763577|NCT06176794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153763578|NCT06176794|Diuretics|diuretics|mesh-ancestor
153763579|NCT06176794|Natriuretic Agents|natriuretic agents|mesh-ancestor
153763580|NCT06176794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763581|NCT06176794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153763582|NCT06176794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153763583|NCT06176794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763584|NCT06176352|Ranibizumab|ranibizumab|mesh-list
153763585|NCT06176352|Faricimab|faricimab|mesh-list
153763586|NCT06176352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153763587|NCT06176352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153763588|NCT06176352|Growth Substances|growth substances|mesh-ancestor
153763589|NCT06176352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763590|NCT06176352|Growth Inhibitors|growth inhibitors|mesh-ancestor
153763591|NCT06176352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763592|NCT06152653|Acetylcysteine|acetylcysteine|mesh-list
153763593|NCT06152653|Albuterol|albuterol|mesh-list
153763594|NCT06152653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153763595|NCT06152653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153763596|NCT06152653|Autonomic Agents|autonomic agents|mesh-ancestor
153763624|NCT06151574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153763625|NCT06151574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153763627|NCT06149286|Lenalidomide|lenalidomide|mesh-list
153763628|NCT06149286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763629|NCT06149286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763630|NCT06149286|Immunologic Factors|immunologic factors|mesh-ancestor
153763631|NCT06149286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763632|NCT06149286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763633|NCT06149286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153763634|NCT06149286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153763635|NCT06149286|Growth Substances|growth substances|mesh-ancestor
153763636|NCT06149286|Growth Inhibitors|growth inhibitors|mesh-ancestor
153763637|NCT06136585|Neostigmine|neostigmine|mesh-list
153763638|NCT06136585|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153763639|NCT06136585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763640|NCT06136585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763641|NCT06136585|Cholinergic Agents|cholinergic agents|mesh-ancestor
153763645|NCT06136585|Autonomic Agents|autonomic agents|mesh-ancestor
153763700|NCT06091657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153763701|NCT06091657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763702|NCT06091657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763703|NCT06091657|Analgesics|analgesics|mesh-ancestor
153763704|NCT06091657|Sensory System Agents|sensory system agents|mesh-ancestor
153763705|NCT06091657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153763706|NCT06091657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153763707|NCT06091657|Anesthetics, General|anesthetics, general|mesh-ancestor
153763708|NCT06091657|Anesthetics|anesthetics|mesh-ancestor
153763709|NCT06091657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763721|NCT06086626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763722|NCT06077500|Carboplatin|carboplatin|mesh-list
153763723|NCT06077500|Etoposide|etoposide|mesh-list
153763724|NCT06077500|Atezolizumab|atezolizumab|mesh-list
153763726|NCT06077500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763773|NCT06073184|Hormones|hormones|mesh-ancestor
153763789|NCT06050252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763790|NCT06050252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153763791|NCT06050252|Antimetabolites|antimetabolites|mesh-ancestor
153763792|NCT06050252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763793|NCT06050252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763794|NCT06050252|Immunologic Factors|immunologic factors|mesh-ancestor
153763795|NCT06050252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763796|NCT06047977|Cyclophosphamide|cyclophosphamide|mesh-list
153600909|NCT01887405|Racepinephrine|racepinephrine|mesh-list
153763797|NCT06047977|Fludarabine|fludarabine|mesh-list
153763798|NCT06047977|Interleukin-2|interleukin-2|mesh-list
153763799|NCT06047977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763800|NCT06047977|Immunologic Factors|immunologic factors|mesh-ancestor
153763801|NCT06047977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763802|NCT06047977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763803|NCT06047977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153763804|NCT06047977|Alkylating Agents|alkylating agents|mesh-ancestor
153763806|NCT06047977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763855|NCT06013020|Sensory System Agents|sensory system agents|mesh-ancestor
153763856|NCT06013020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763857|NCT06013020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763858|NCT06013020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763859|NCT06013020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763860|NCT06013020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153763861|NCT06013020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153763862|NCT06013020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763863|NCT06013020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153763864|NCT06013020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153763865|NCT06013020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763866|NCT06013020|Antipyretics|antipyretics|mesh-ancestor
153763867|NCT06013020|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153763868|NCT06013020|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153763869|NCT06013020|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153763870|NCT06013020|Purinergic Agents|purinergic agents|mesh-ancestor
153763871|NCT06013020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763872|NCT06013020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153763873|NCT06013020|Antithrombins|antithrombins|mesh-ancestor
153763874|NCT06013020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153763875|NCT06013020|Protease Inhibitors|protease inhibitors|mesh-ancestor
153763876|NCT06013020|Anticoagulants|anticoagulants|mesh-ancestor
153763934|NCT05918718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763935|NCT05904080|Nivolumab|nivolumab|mesh-list
153763936|NCT05904080|Ipilimumab|ipilimumab|mesh-list
153763937|NCT05904080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763938|NCT05904080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763939|NCT05904080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153763940|NCT05904080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763941|NCT05870111|Choline|choline|mesh-list
153763942|NCT05870111|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153763943|NCT05870111|Lipotropic Agents|lipotropic agents|mesh-ancestor
153763944|NCT05870111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153763945|NCT05870111|Antimetabolites|antimetabolites|mesh-ancestor
153763946|NCT05870111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157448|NCT05782712|Adenosine|adenosine|mesh-list
153763947|NCT05870111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763948|NCT05870111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153763949|NCT05870111|Nootropic Agents|nootropic agents|mesh-ancestor
153763950|NCT05867056|Cysteamine|cysteamine|mesh-list
153763951|NCT05867056|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153763952|NCT05867056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763954|NCT05864846|Anticonvulsants|anticonvulsants|mesh-ancestor
153763955|NCT05856526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153763956|NCT05848011|Prednisone|prednisone|mesh-list
153764007|NCT05769309|Fentanyl|fentanyl|mesh-list
153764008|NCT05769309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153764009|NCT05769309|Narcotics|narcotics|mesh-ancestor
153764010|NCT05769309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764011|NCT05769309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764012|NCT05769309|Analgesics|analgesics|mesh-ancestor
153764013|NCT05769309|Sensory System Agents|sensory system agents|mesh-ancestor
153764014|NCT05769309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764015|NCT05769309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153764016|NCT05769309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153764017|NCT05769309|Anesthetics, General|anesthetics, general|mesh-ancestor
153764018|NCT05769309|Anesthetics|anesthetics|mesh-ancestor
153764019|NCT05768139|Fulvestrant|fulvestrant|mesh-list
153764020|NCT05768139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153764021|NCT05768139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764022|NCT05768139|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153764023|NCT05768139|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153764031|NCT05761171|Methylprednisolone|methylprednisolone|mesh-list
153764032|NCT05761171|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153764033|NCT05761171|Prednisolone acetate|prednisolone acetate|mesh-list
153764034|NCT05761171|Hydrocortisone|hydrocortisone|mesh-list
153764035|NCT05761171|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153764036|NCT05761171|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153764037|NCT05761171|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153764038|NCT05761171|Cortisone|cortisone|mesh-list
153764039|NCT05761171|Methotrexate|methotrexate|mesh-list
153764040|NCT05761171|Fludarabine|fludarabine|mesh-list
153764041|NCT05761171|Fludarabine phosphate|fludarabine phosphate|mesh-list
153764042|NCT05761171|Vincristine|vincristine|mesh-list
153764043|NCT05761171|Asparaginase|asparaginase|mesh-list
153764044|NCT05761171|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153764060|NCT05761171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764061|NCT05761171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153764062|NCT05761171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764063|NCT05761171|Immunologic Factors|immunologic factors|mesh-ancestor
153764064|NCT05761171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764065|NCT05761171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153764066|NCT05761171|Antiviral Agents|antiviral agents|mesh-ancestor
153764067|NCT05761171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764068|NCT05761171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764069|NCT05761171|Tubulin Modulators|tubulin modulators|mesh-ancestor
153764070|NCT05761171|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764071|NCT05761171|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764072|NCT05761171|Antiemetics|antiemetics|mesh-ancestor
153764073|NCT05761171|Autonomic Agents|autonomic agents|mesh-ancestor
153764074|NCT05761171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764075|NCT05761171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153764076|NCT05761171|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153764077|NCT05761171|Protective Agents|protective agents|mesh-ancestor
153764078|NCT05752799|Analgesics, Opioid|analgesics, opioid|mesh-list
153764079|NCT05752799|Anesthetics|anesthetics|mesh-list
153764080|NCT05752799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764081|NCT05752799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764082|NCT05752799|Narcotics|narcotics|mesh-ancestor
153764083|NCT05752799|Analgesics|analgesics|mesh-ancestor
153764084|NCT05752799|Sensory System Agents|sensory system agents|mesh-ancestor
153764085|NCT05752799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764086|NCT05748171|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153764087|NCT05748171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764088|NCT05748171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764089|NCT05748171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153764090|NCT05748171|Immunotoxins|immunotoxins|mesh-ancestor
153764091|NCT05748171|Immunoconjugates|immunoconjugates|mesh-ancestor
153764102|NCT05724134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764112|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153764113|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764114|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764115|NCT05707377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153764116|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764117|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764118|NCT05703971|Atezolizumab|atezolizumab|mesh-list
153764119|NCT05703971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764120|NCT05703971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764121|NCT05703971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764122|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764123|NCT05694858|Lidocaine|lidocaine|mesh-list
153764124|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
153764125|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
153764126|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764127|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764128|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
153764129|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764130|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153764131|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153764132|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153764133|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153764134|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764135|NCT05687136|Peposertib|peposertib|mesh-list
153764136|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764137|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764138|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764139|NCT05685225|Acetaminophen|acetaminophen|mesh-list
153764140|NCT05685225|Naltrexone|naltrexone|mesh-list
153764141|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153764142|NCT05685225|Analgesics|analgesics|mesh-ancestor
153764143|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
153764144|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764145|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764146|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
153764147|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153646704|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
153764148|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153764150|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
153764151|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764152|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
153764153|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764154|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764155|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153764165|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153764166|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153764168|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764169|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153764170|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153764171|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764172|NCT05661552|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153764173|NCT05661552|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153764174|NCT05661552|Protease Inhibitors|protease inhibitors|mesh-ancestor
153764175|NCT05626530|Letermovir|letermovir|mesh-list
153601278|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
153764176|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153764177|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764178|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764179|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764180|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
153764181|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764182|NCT05624190|Plasminogen|plasminogen|mesh-list
153764183|NCT05624190|Tenecteplase|tenecteplase|mesh-list
153764184|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153764185|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153764186|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153764199|NCT05567406|Belumosudil|belumosudil|mesh-list
153764211|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764212|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764213|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
153764214|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764215|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764216|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
153764217|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764218|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764219|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153764220|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153764240|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764241|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764242|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153764243|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153764244|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764245|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764246|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153764247|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
153764248|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
153764249|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764250|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764251|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
153764252|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764253|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
153764254|NCT05514535|Semaglutide|semaglutide|mesh-list
153764255|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153764256|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764257|NCT05514535|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153764258|NCT05513001|Remibrutinib|remibrutinib|mesh-list
153764259|NCT05513001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764260|NCT05513001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764262|NCT05490888|Terlipressin|terlipressin|mesh-list
153764271|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
153764272|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764273|NCT05450328|Epoprostenol|epoprostenol|mesh-list
153764274|NCT05450328|Milrinone|milrinone|mesh-list
153764275|NCT05450328|Tezosentan|tezosentan|mesh-list
153764276|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153764293|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153764294|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
153764295|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
153764296|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153764297|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153764298|NCT05429970|Analgesics|analgesics|mesh-ancestor
153764299|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
153764300|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764301|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764302|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764303|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153764304|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153764305|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764306|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764307|NCT05425940|Atezolizumab|atezolizumab|mesh-list
153764308|NCT05425940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764309|NCT05425940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764358|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764360|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764361|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764362|NCT05346484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764376|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764377|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153764378|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
153764379|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
153764380|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
153764381|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153764382|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
153764383|NCT05327023|Sirolimus|sirolimus|mesh-list
153764384|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
153764385|NCT05327023|Busulfan|busulfan|mesh-list
153764386|NCT05327023|Fludarabine|fludarabine|mesh-list
153764387|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764388|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
153764389|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764390|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764404|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153764405|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153764406|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764407|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764408|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153764409|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153764410|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153764411|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
153764412|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153764413|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764414|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153764415|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153764431|NCT05271292|Chiauranib|chiauranib|mesh-list
153764439|NCT05265299|Analgesics|analgesics|mesh-ancestor
153764440|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
153764441|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764442|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764443|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764444|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764445|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153764446|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153764447|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764448|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153764449|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153764465|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153764467|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764468|NCT05151744|Ranibizumab|ranibizumab|mesh-list
153764469|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153764470|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153764471|NCT05151744|Growth Substances|growth substances|mesh-ancestor
153764472|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764473|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
153764474|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764475|NCT05132582|Trastuzumab|trastuzumab|mesh-list
153764476|NCT05132582|Pertuzumab|pertuzumab|mesh-list
153764477|NCT05132582|Tucatinib|tucatinib|mesh-list
153601581|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153764504|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764505|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764506|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
153764507|NCT05078866|Vaccines|vaccines|mesh-list
153764508|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
153764551|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764552|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764553|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153764554|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153764555|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
153764556|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153764557|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764558|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
153764559|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
153764560|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764561|NCT04994132|Dactinomycin|dactinomycin|mesh-list
153764562|NCT04994132|Cactinomycin|cactinomycin|mesh-list
153764563|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
153764564|NCT04994132|Vincristine|vincristine|mesh-list
153764565|NCT04994132|Vinorelbine|vinorelbine|mesh-list
153764566|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764567|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
153764568|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764569|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764570|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153764571|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
153764572|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764573|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764574|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153764575|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764576|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
153764577|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764578|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764582|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153764629|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153764630|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764631|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153764632|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
153764633|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153764634|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764635|NCT04931342|Immunotoxins|immunotoxins|mesh-ancestor
153764636|NCT04931342|Immunoconjugates|immunoconjugates|mesh-ancestor
153764637|NCT04931342|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153764639|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153764640|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764641|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764642|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764643|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
153764644|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764645|NCT04868409|Rocuronium|rocuronium|mesh-list
153764646|NCT04868409|Succinylcholine|succinylcholine|mesh-list
153764699|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764700|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153764701|NCT04665856|Carboplatin|carboplatin|mesh-list
153764703|NCT04665856|Atezolizumab|atezolizumab|mesh-list
153764704|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764705|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764730|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153764731|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764732|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153764755|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764756|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764757|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153764758|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153764759|NCT04607421|Growth Substances|growth substances|mesh-ancestor
153764760|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764761|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
153764762|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153764763|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
153764764|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764765|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764766|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
153764767|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153764768|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153764769|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764771|NCT04607421|Protective Agents|protective agents|mesh-ancestor
153764772|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
153764773|NCT04607421|Vitamins|vitamins|mesh-ancestor
153764774|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
153764834|NCT04488081|Cyclosporins|cyclosporins|mesh-list
153764835|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764836|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
153764837|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
153764838|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764848|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764849|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
153764850|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
153764851|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764852|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
153764853|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764854|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153764855|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153764856|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153764857|NCT04488081|Analgesics|analgesics|mesh-ancestor
153764858|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
153764859|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153764860|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153764861|NCT04488081|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153764862|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764863|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153750046|NCT00159575|Metformin|metformin|mesh-list
153764864|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153764865|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153764866|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153764867|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
153764868|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
153764890|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
153764891|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764892|NCT04481035|Protective Agents|protective agents|mesh-ancestor
153764893|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764894|NCT04481035|Antidotes|antidotes|mesh-ancestor
153764895|NCT04449549|Paclitaxel|paclitaxel|mesh-list
153764896|NCT04449549|Nilotinib|nilotinib|mesh-list
153764897|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764898|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764899|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
153764900|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764901|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764902|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764903|NCT04449549|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153764919|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
153764920|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764921|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764922|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153764923|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
153764924|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153764925|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153764926|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153764927|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153764928|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764929|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764930|NCT04443348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764931|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153764932|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
153764933|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
153764934|NCT04432662|Hematinics|hematinics|mesh-ancestor
153764935|NCT04420936|Benzocaine|benzocaine|mesh-list
153764936|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
153764937|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
153764938|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764939|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764942|NCT04389632|Carboplatin|carboplatin|mesh-list
153764944|NCT04389632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764945|NCT04389632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764946|NCT04389632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764947|NCT04389632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764948|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
153764949|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764950|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
153764951|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764952|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764953|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153764954|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
153764955|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764958|NCT04355572|Vitamin D|vitamin d|mesh-list
153765022|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
153765023|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765037|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765038|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765039|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153765040|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153765041|NCT04191187|Fludarabine|fludarabine|mesh-list
153765042|NCT04191187|Melphalan|melphalan|mesh-list
153765043|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765044|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765045|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153765046|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
153765047|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765048|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153765049|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
153765050|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153765051|NCT04148911|Paclitaxel|paclitaxel|mesh-list
153765052|NCT04148911|Atezolizumab|atezolizumab|mesh-list
153765053|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153765054|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765055|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
153765056|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
153765057|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
153765058|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765059|NCT04148911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765060|NCT04148911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765061|NCT04083898|Prednisone|prednisone|mesh-list
153765062|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153765063|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765064|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
153765065|NCT04083898|Hormones|hormones|mesh-ancestor
153765066|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765072|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765074|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153765075|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765076|NCT03990896|Talazoparib|talazoparib|mesh-list
153765077|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153765078|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765079|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765080|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765081|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153765082|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765083|NCT03924440|Nonoxynol|nonoxynol|mesh-list
153765084|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153765085|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153765098|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765099|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153765100|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153765102|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765103|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
153765104|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
153765105|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765106|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765107|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153765135|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765136|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765137|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153765138|NCT03789318|Acetaminophen|acetaminophen|mesh-list
153765139|NCT03789318|Fentanyl|fentanyl|mesh-list
153765140|NCT03789318|Oxycodone|oxycodone|mesh-list
153765141|NCT03789318|Hydromorphone|hydromorphone|mesh-list
153765142|NCT03789318|Bupivacaine|bupivacaine|mesh-list
153765143|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
153765144|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
153765145|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153765146|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765147|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
153765148|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765149|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153765168|NCT03768063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765169|NCT03768063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765171|NCT03768063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153765172|NCT03768063|Growth Substances|growth substances|mesh-ancestor
153765173|NCT03768063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765174|NCT03768063|Growth Inhibitors|growth inhibitors|mesh-ancestor
153765175|NCT03768063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765176|NCT03768063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765177|NCT03768063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153765178|NCT03768063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153765179|NCT03768063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765180|NCT03768063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153765199|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153765200|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153765201|NCT03684980|Antidotes|antidotes|mesh-ancestor
153765202|NCT03684980|Protective Agents|protective agents|mesh-ancestor
153765203|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
153765204|NCT03684980|Vitamins|vitamins|mesh-ancestor
153765205|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
153765206|NCT03642067|Nivolumab|nivolumab|mesh-list
153765207|NCT03642067|Relatlimab|relatlimab|mesh-list
153765208|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765209|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765210|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765211|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765242|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153765243|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765244|NCT03485209|Carboplatin|carboplatin|mesh-list
153765245|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
153765246|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
153765247|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765248|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765249|NCT03485209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765250|NCT03485209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765251|NCT03464305|Aspirin|aspirin|mesh-list
153765252|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153765262|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765263|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153765264|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153765265|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765266|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
153765267|NCT03361852|Rituximab|rituximab|mesh-list
153765268|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
153765269|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765270|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765271|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
153765272|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765273|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765274|NCT03361852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765275|NCT03361852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765276|NCT03361436|Halichondrin B|halichondrin b|mesh-list
153765277|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
153765278|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
153765279|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
153765280|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765281|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765282|NCT03237286|Ketamine|ketamine|mesh-list
153765283|NCT03237286|Analgesics|analgesics|mesh-ancestor
153765284|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
153765285|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765286|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765287|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153765288|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153765289|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
153765290|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
153765291|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153765292|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153765293|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153765294|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153765295|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765296|NCT03103750|Calcitriol|calcitriol|mesh-list
153765297|NCT03103750|Amphetamine|amphetamine|mesh-list
153765298|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
153765299|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153765300|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765301|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153765302|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153765303|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765304|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153765305|NCT03103750|Vitamins|vitamins|mesh-ancestor
153765306|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
153765315|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153765316|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153765317|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153765331|NCT02675231|Fulvestrant|fulvestrant|mesh-list
153765332|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765333|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765334|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765335|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153765336|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153765337|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
153765338|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765339|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765340|NCT02648477|Doxorubicin|doxorubicin|mesh-list
153765341|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153765342|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
153765343|NCT02648477|Letrozole|letrozole|mesh-list
153765344|NCT02648477|Anastrozole|anastrozole|mesh-list
153765345|NCT02648477|Exemestane|exemestane|mesh-list
153765346|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153765347|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765348|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153765349|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153765350|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765351|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765352|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765353|NCT02648477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765354|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153765361|NCT02632721|Decitabine|decitabine|mesh-list
153765372|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765373|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765374|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765390|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765391|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153765392|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153765394|NCT02374242|Ipilimumab|ipilimumab|mesh-list
153765395|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765396|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765397|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765398|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765399|NCT02342782|Cytarabine|cytarabine|mesh-list
153765400|NCT02342782|Etoposide|etoposide|mesh-list
153765401|NCT02342782|Melphalan|melphalan|mesh-list
153765402|NCT02342782|Carmustine|carmustine|mesh-list
153765403|NCT02342782|Basiliximab|basiliximab|mesh-list
153765404|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153765405|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765406|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153765407|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153765408|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765409|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765410|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765411|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
153765412|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
153765413|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765431|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765432|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153765433|NCT02157883|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153765434|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765435|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765448|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153765449|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765450|NCT02022982|Palbociclib|palbociclib|mesh-list
153765451|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765452|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765453|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765454|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765455|NCT01089517|Ranibizumab|ranibizumab|mesh-list
153765456|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153765457|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153765458|NCT01089517|Growth Substances|growth substances|mesh-ancestor
153602563|NCT01905501|Anesthetics|anesthetics|mesh-list
153765459|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765460|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
153765461|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765462|NCT00861367|Aspirin|aspirin|mesh-list
153765463|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153765464|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153765465|NCT00861367|Analgesics|analgesics|mesh-ancestor
153765466|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
153765467|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765468|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765469|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765470|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765471|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153765472|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153765485|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153765486|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
153765487|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765488|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765489|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153765490|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153765491|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153765492|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153765493|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765494|NCT00585507|Fulvestrant|fulvestrant|mesh-list
153765495|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765496|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765497|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153765498|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153765542|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153765543|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153765544|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153765549|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
153765550|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765551|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153765552|NCT05630209|Doxorubicin|doxorubicin|mesh-list
153765553|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153765554|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765555|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153765556|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153765557|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765558|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765559|NCT05615623|Doxorubicin|doxorubicin|mesh-list
153765560|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153765561|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765562|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153765563|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153765572|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
153765573|NCT05487586|Avibactam|avibactam|mesh-list
153765574|NCT05487586|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153765575|NCT05487586|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153765576|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153765577|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765578|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153765579|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765580|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765581|NCT05408429|Vaccines|vaccines|mesh-list
153765582|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153765583|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
153765584|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765585|NCT05405439|Prednisone|prednisone|mesh-list
153765586|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
153765587|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765588|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
153765589|NCT05405439|Hormones|hormones|mesh-ancestor
153765590|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765591|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765592|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765593|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765594|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153765609|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153765611|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153765612|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
153765613|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153765614|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765630|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765631|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765632|NCT05290857|Hemostatics|hemostatics|mesh-list
153765633|NCT05290857|Coagulants|coagulants|mesh-ancestor
153765634|NCT05244525|Epinephrine|epinephrine|mesh-list
153765635|NCT05244525|Bupivacaine|bupivacaine|mesh-list
153765636|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
153765637|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
153765638|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153765639|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765640|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
153765641|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765642|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153765643|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153765644|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
153765645|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153765646|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765647|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153765648|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153765649|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
153765650|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153765651|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
153765652|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
153765653|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
153765654|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153765662|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765664|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
153765665|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153765666|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153765667|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765668|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765669|NCT05206955|Urological Agents|urological agents|mesh-ancestor
153765670|NCT05182112|Gemcitabine|gemcitabine|mesh-list
153765671|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765678|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153765679|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153765680|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
153602784|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
153765681|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153765682|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765683|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765684|NCT05149898|Cannabidiol|cannabidiol|mesh-list
153765685|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
153765686|NCT05125380|Acetic Acid|acetic acid|mesh-list
153765687|NCT05125380|Retinol acetate|retinol acetate|mesh-list
153765688|NCT05125380|Lugol's solution|lugol's solution|mesh-list
153765689|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153765690|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765691|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153765692|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
153765693|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765694|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153765695|NCT05125380|Protective Agents|protective agents|mesh-ancestor
153765696|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765697|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
153765698|NCT05125380|Coagulants|coagulants|mesh-ancestor
153765699|NCT04979052|Interferons|interferons|mesh-list
153765700|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
153765701|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765702|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
153765703|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765704|NCT04934683|Propofol|propofol|mesh-list
153765705|NCT04934683|Etomidate|etomidate|mesh-list
153765706|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153765707|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153765708|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765710|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
153765738|NCT04862221|Protective Agents|protective agents|mesh-ancestor
153765739|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765740|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765741|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
153765742|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153765743|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153765744|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153765745|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153765746|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
153765748|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
153765749|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153765750|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
153765751|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
153765752|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153765753|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765754|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153765755|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
153765756|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
153765757|NCT04854434|Trifluridine|trifluridine|mesh-list
153765758|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
153765759|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765760|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765761|NCT04854434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765762|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765763|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
153765764|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
153751523|NCT00162110|Cetuximab|cetuximab|mesh-list
153765765|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765767|NCT04739826|Flumatinib|flumatinib|mesh-list
153765768|NCT04739826|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153765769|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765770|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765771|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765772|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
153765773|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153765777|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765778|NCT04677387|Naloxone|naloxone|mesh-list
153765779|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153765780|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765781|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
153765782|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765783|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153765794|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
153765796|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153765869|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153765870|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
153765871|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153765872|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153765873|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
153765874|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765875|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153765876|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765877|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153765878|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153765879|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765880|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153731525|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153765881|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
153765882|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
153765884|NCT04232085|Fludarabine|fludarabine|mesh-list
153765885|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
153765886|NCT04232085|Tacrolimus|tacrolimus|mesh-list
153765887|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153765888|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
153765889|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765890|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765891|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153765892|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
153791685|NCT06294561|Itraconazole|itraconazole|mesh-list
153791686|NCT06294561|Efavirenz|efavirenz|mesh-list
153791687|NCT06294561|Antifungal Agents|antifungal agents|mesh-ancestor
153791688|NCT06294561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791689|NCT06294561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153765936|NCT03905941|Metformin|metformin|mesh-list
153765937|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
153765938|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153765939|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765940|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153765941|NCT03905603|Cosyntropin|cosyntropin|mesh-list
153765942|NCT03905603|Hormones|hormones|mesh-ancestor
153765943|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765944|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765945|NCT03797014|Tenofovir|tenofovir|mesh-list
153765946|NCT03797014|Emtricitabine|emtricitabine|mesh-list
153765947|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153765948|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
153765949|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765950|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153765951|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153765989|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153765990|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
153765992|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765993|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765994|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765995|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
153765996|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765997|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765998|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
153765999|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153766000|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153766001|NCT03713294|Growth Substances|growth substances|mesh-ancestor
153766002|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
153766003|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
153766004|NCT03605342|Buprenorphine|buprenorphine|mesh-list
153766060|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
153766061|NCT03389620|Hormones|hormones|mesh-ancestor
153766062|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766063|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153766064|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766065|NCT03300817|Poly ICLC|poly iclc|mesh-list
153766066|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
153766067|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
153766068|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766069|NCT03260712|Gemcitabine|gemcitabine|mesh-list
153766070|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
153766071|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766072|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766073|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
153766074|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766075|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766076|NCT03260712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153766077|NCT03255915|Tenofovir|tenofovir|mesh-list
153766078|NCT03255915|Emtricitabine|emtricitabine|mesh-list
153766079|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
153766080|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766081|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153766082|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153766083|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766084|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766087|NCT03235245|Nivolumab|nivolumab|mesh-list
153766123|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766124|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153766125|NCT03088059|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153766126|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
153766127|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153766128|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
153766129|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766130|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
153766131|NCT03003130|Protective Agents|protective agents|mesh-ancestor
153766133|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766134|NCT02782468|Azacitidine|azacitidine|mesh-list
153766135|NCT02782468|Pevonedistat|pevonedistat|mesh-list
153766136|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766137|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
153766138|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766139|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766140|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766142|NCT02664181|Decitabine|decitabine|mesh-list
153766143|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
153766144|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766145|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766146|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153766147|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766148|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766149|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
153766184|NCT02420717|Cortisone|cortisone|mesh-list
153766185|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
153766186|NCT02420717|Rituximab|rituximab|mesh-list
153766187|NCT02420717|Doxorubicin|doxorubicin|mesh-list
153766188|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153766189|NCT02420717|Methotrexate|methotrexate|mesh-list
153766190|NCT02420717|Vincristine|vincristine|mesh-list
153766191|NCT02420717|Daunorubicin|daunorubicin|mesh-list
153766192|NCT02420717|Dasatinib|dasatinib|mesh-list
153766193|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
153766194|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153766195|NCT02420717|Antibodies|antibodies|mesh-list
153766196|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
153766197|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153766198|NCT02420717|BB 1101|bb 1101|mesh-list
153766199|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153766200|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
153766201|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766202|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153766203|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153766204|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
153766205|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766206|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766207|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153766208|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153766209|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
153766210|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
153766211|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766212|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766213|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
153766214|NCT02420717|Hormones|hormones|mesh-ancestor
153766215|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766235|NCT02420717|Vitamins|vitamins|mesh-ancestor
153766241|NCT02420717|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153766242|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153766243|NCT02257138|Decitabine|decitabine|mesh-list
153766244|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766245|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
153766246|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766247|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766248|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766249|NCT02188368|Clarithromycin|clarithromycin|mesh-list
153766250|NCT02188368|Dexamethasone|dexamethasone|mesh-list
153766251|NCT02188368|Prednisone|prednisone|mesh-list
153766252|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
153766253|NCT02188368|Bortezomib|bortezomib|mesh-list
153766254|NCT02188368|Pomalidomide|pomalidomide|mesh-list
153766255|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153766256|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
153766257|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766258|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153766259|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153766260|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
153766261|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766262|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766263|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153766264|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153766301|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
153766302|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766303|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
153766304|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153766305|NCT01795313|Imiquimod|imiquimod|mesh-list
153766306|NCT01795313|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153766307|NCT01795313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766308|NCT01795313|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153766309|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
153766310|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766311|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153766312|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766313|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
153766314|NCT01709292|Vemurafenib|vemurafenib|mesh-list
153766315|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766316|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153766317|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766318|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766319|NCT01574274|Pegaspargase|pegaspargase|mesh-list
153766320|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766321|NCT01375140|Prednisone|prednisone|mesh-list
153766322|NCT01375140|Lenalidomide|lenalidomide|mesh-list
153766323|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153766324|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
153766325|NCT01375140|Hormones|hormones|mesh-ancestor
153766326|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766327|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766328|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153766329|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766347|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766348|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153766349|NCT00625586|Gemcitabine|gemcitabine|mesh-list
153766350|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766351|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
153766352|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766368|NCT00400946|Vincristine|vincristine|mesh-list
153766369|NCT00400946|Asparaginase|asparaginase|mesh-list
153766370|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
153766371|NCT00400946|Pegaspargase|pegaspargase|mesh-list
153766372|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
153766373|NCT00400946|Razoxane|razoxane|mesh-list
153766374|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
153766375|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153766376|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
153766377|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766378|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153766379|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153766380|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
153766381|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766382|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766383|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153766384|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153766385|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
153766386|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
153766387|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766388|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766389|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
153766390|NCT00400946|Hormones|hormones|mesh-ancestor
153766391|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766392|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153766393|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153766394|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153766395|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153766396|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766403|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153766404|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153766405|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153766406|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
153766407|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766408|NCT00400946|Antidotes|antidotes|mesh-ancestor
153766409|NCT00400946|Protective Agents|protective agents|mesh-ancestor
153766410|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
153766411|NCT00400946|Vitamins|vitamins|mesh-ancestor
153766412|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
153766413|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
153766414|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
153766415|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
153766416|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153766417|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153766418|NCT00191321|Teriparatide|teriparatide|mesh-list
153766435|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153766436|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153766437|NCT00191399|Olanzapine|olanzapine|mesh-list
153766438|NCT00191399|Fluoxetine|fluoxetine|mesh-list
153766439|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
153766440|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
153766441|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766442|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766471|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
153766472|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
153766473|NCT00221286|Emtricitabine|emtricitabine|mesh-list
153766474|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153766492|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766494|NCT00214266|Rituximab|rituximab|mesh-list
153766495|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
153766496|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766497|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766498|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
153766499|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766500|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153766501|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153766502|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153766503|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
153766504|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153766505|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766506|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766507|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766508|NCT00221325|Rituximab|rituximab|mesh-list
153766509|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766510|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766511|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
153766512|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766513|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781939|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153766515|NCT00123461|Vitamins|vitamins|mesh-ancestor
153766536|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153766537|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752985|NCT04974814|Atorvastatin|atorvastatin|mesh-list
153766538|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766539|NCT00191555|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153766540|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766541|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766542|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766543|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766544|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
153766545|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153766546|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
153766547|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153766548|NCT00221364|Azithromycin|azithromycin|mesh-list
153766549|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153766550|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766552|NCT00123539|Hormones|hormones|mesh-ancestor
153766553|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766554|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766555|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153766556|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153766557|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766558|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766559|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766560|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766561|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766562|NCT00191594|Analgesics|analgesics|mesh-ancestor
153766563|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
153766564|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766579|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
153766580|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766581|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766582|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766583|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153766584|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603688|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153766585|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153766586|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153766587|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766588|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
153766589|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
153766590|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766591|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766592|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153766593|NCT00221481|Valproic Acid|valproic acid|mesh-list
153766594|NCT00221481|Olanzapine|olanzapine|mesh-list
153766595|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
153766596|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
153766597|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766609|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
153766610|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
153766611|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766613|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
153766614|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153766615|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153766616|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766617|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766618|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766619|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
153766620|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766621|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766622|NCT00221520|Midazolam|midazolam|mesh-list
153766623|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153766627|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153766630|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153766631|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
153766632|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
153766633|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
153766634|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
153766635|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766636|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766637|NCT00191672|Paclitaxel|paclitaxel|mesh-list
153766638|NCT00191672|Docetaxel|docetaxel|mesh-list
153766639|NCT00191672|Gemcitabine|gemcitabine|mesh-list
153766640|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153766641|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766642|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
153766643|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
153766644|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
153766645|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766646|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766647|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
153766648|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153766649|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
153766650|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766651|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153766652|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153766653|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766654|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766655|NCT00191711|Gemcitabine|gemcitabine|mesh-list
153766656|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766657|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
153766658|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766668|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153766669|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766670|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766672|NCT00123656|Esomeprazole|esomeprazole|mesh-list
153766673|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153766675|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
153766680|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
153766681|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153766682|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153766683|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766684|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153766685|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766686|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766687|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153766688|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153766689|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153766690|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
153766691|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766692|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153766693|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153766694|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766695|NCT00191750|Pemetrexed|pemetrexed|mesh-list
153766696|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766697|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766698|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766699|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153766700|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153766701|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
153766702|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153766703|NCT00221754|Pravastatin|pravastatin|mesh-list
153766704|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153766705|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153766706|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
153766707|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766708|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153766709|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153766710|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766712|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
153766713|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
153766714|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766715|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766719|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766720|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766721|NCT00191828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153766722|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766741|NCT00123890|Aplaviroc|aplaviroc|mesh-list
153766742|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153766743|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153766744|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766745|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153766746|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153766747|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
153766748|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766749|NCT00412698|Rimonabant|rimonabant|mesh-list
153766750|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153766751|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153766752|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153766753|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766754|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766755|NCT00412698|Hormones|hormones|mesh-ancestor
153766756|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766757|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766758|NCT00123929|Docetaxel|docetaxel|mesh-list
153766759|NCT00123929|Doxorubicin|doxorubicin|mesh-list
153766760|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766761|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
153766762|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
153766763|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
153766765|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153766790|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766791|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153766792|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153766793|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153766794|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766795|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766796|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766797|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153766798|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153766800|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766801|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153766802|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153766803|NCT00474994|Growth Substances|growth substances|mesh-ancestor
153766804|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766805|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
153603912|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153766806|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153766807|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766808|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766809|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153766810|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
153766811|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766812|NCT00215046|Methotrexate|methotrexate|mesh-list
153766813|NCT00215046|Vinblastine|vinblastine|mesh-list
153766814|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153766815|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
153766816|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153766817|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766818|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766819|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
153766820|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766821|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766822|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
153766823|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766824|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153792360|NCT05567458|Hematinics|hematinics|mesh-ancestor
153766825|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153766826|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
153766827|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153766828|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153766829|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153766830|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
153766831|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
153766832|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
153766834|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
153766835|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766858|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153766859|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153766860|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766861|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766862|NCT00474058|Rotigotine|rotigotine|mesh-list
153766863|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
153766864|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
153766865|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766866|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766867|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766868|NCT02277730|Phenylephrine|phenylephrine|mesh-list
153766869|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
153766870|NCT02277730|Ephedrine|ephedrine|mesh-list
153766871|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153766872|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153766873|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
153766874|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
153766875|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766876|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766877|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
153766878|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
153766879|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
153766902|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153766903|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
153766904|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766905|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
153766906|NCT00473824|Antibodies|antibodies|mesh-list
153766907|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
153766908|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153766909|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153766910|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
153766911|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766912|NCT00215163|Paroxetine|paroxetine|mesh-list
153766913|NCT00215163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153766914|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766915|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766916|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766917|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766918|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
153766919|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766920|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153766921|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
153766922|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766923|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153766924|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153766925|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766927|NCT00215202|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153766928|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153766929|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766930|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766931|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766932|NCT00215241|Risperidone|risperidone|mesh-list
153766945|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
153766946|NCT00215241|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153766947|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766963|NCT00124280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766964|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153766965|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
153766966|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766967|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766968|NCT00215280|Ivermectin|ivermectin|mesh-list
153766969|NCT00215280|Albendazole|albendazole|mesh-list
153766970|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153766971|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766972|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
153766973|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
153766974|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153766975|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153766976|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
153766977|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
153766978|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
153766979|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766980|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766981|NCT00192413|Vaccines|vaccines|mesh-list
153766982|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
153766983|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766984|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
153766985|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153766986|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
153766987|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766988|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766989|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153766990|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
153766991|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153766992|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153766993|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153766994|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
153766995|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766996|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766997|NCT00192569|Interferons|interferons|mesh-list
153766998|NCT00192569|Ribavirin|ribavirin|mesh-list
153766999|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
153767000|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
153767001|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153767002|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767003|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
153767004|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767005|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
153767006|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767007|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
153767008|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767027|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767028|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153767029|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153767030|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
153767031|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767032|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153767033|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153767034|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
153767035|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153767036|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
153767037|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767038|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767039|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153767040|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
153767041|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153767042|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153767043|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153792580|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153792581|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792582|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
153792583|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792584|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792585|NCT05286060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792586|NCT05286060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792587|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
153792588|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153767056|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153767057|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153767058|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767059|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767060|NCT00192725|Tryptophan|tryptophan|mesh-list
153767061|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153767062|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
153767163|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153767164|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153767165|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767166|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
153767167|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153767168|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153767169|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153767170|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
153767171|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767172|NCT00192959|Propofol|propofol|mesh-list
153767173|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153767174|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767175|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767176|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153767177|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
153767178|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
153767179|NCT00215631|Tadalafil|tadalafil|mesh-list
153767180|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
153767181|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153767182|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153767183|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767184|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767185|NCT00215631|Urological Agents|urological agents|mesh-ancestor
153767186|NCT00193076|Carboplatin|carboplatin|mesh-list
153767187|NCT00193076|Gemcitabine|gemcitabine|mesh-list
153767188|NCT00193076|Trastuzumab|trastuzumab|mesh-list
153767212|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767213|NCT00193154|Bevacizumab|bevacizumab|mesh-list
153767214|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153767215|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153767216|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767217|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153767229|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153767230|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767231|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767232|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767233|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767234|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767235|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153767236|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
153767237|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153767238|NCT00193232|Docetaxel|docetaxel|mesh-list
153767256|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153767257|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153767258|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
153767259|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
153767260|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
153767261|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767262|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153767263|NCT00222495|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153767264|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153767265|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153767266|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
153767267|NCT00193271|Docetaxel|docetaxel|mesh-list
153767268|NCT00193271|Estramustine|estramustine|mesh-list
153767269|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767270|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767271|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767272|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767273|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767274|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153767275|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
153767276|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153767277|NCT00222534|Acetazolamide|acetazolamide|mesh-list
153767278|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
153767286|NCT00193310|Carboplatin|carboplatin|mesh-list
153767287|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153767288|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767289|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767290|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767291|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767292|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767293|NCT00193349|Carboplatin|carboplatin|mesh-list
153767295|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
153767296|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767315|NCT00193466|Rituximab|rituximab|mesh-list
153767375|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
153767376|NCT00215982|Irinotecan|irinotecan|mesh-list
153767377|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767378|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
153767379|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767380|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767381|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153767382|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767383|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767384|NCT00124397|Atorvastatin|atorvastatin|mesh-list
153767385|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153767386|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153767387|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
153767388|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767389|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153767390|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153767391|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767392|NCT00216021|Capecitabine|capecitabine|mesh-list
153767393|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
153767394|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767395|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
153767396|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767397|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767398|NCT00409526|Iloprost|iloprost|mesh-list
153767399|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153767400|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
153767402|NCT00216138|Capecitabine|capecitabine|mesh-list
153767403|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767445|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153767446|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153767447|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153767448|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767449|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153767450|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767451|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
153767452|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153767453|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153767455|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153767456|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153767457|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
153767458|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767459|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767460|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767461|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153767462|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153767463|NCT00193622|Bevacizumab|bevacizumab|mesh-list
153767464|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153767465|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153767466|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767467|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153767468|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153767469|NCT00193622|Growth Substances|growth substances|mesh-ancestor
153767470|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767471|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
153767483|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767484|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
153767485|NCT00223275|Naltrexone|naltrexone|mesh-list
153767486|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153767487|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153767488|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767489|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
153767490|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767491|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
153767492|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
153767493|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
153767494|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767495|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767496|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153767497|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153767498|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
153767499|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
153767500|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767501|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767502|NCT00193661|Testosterone|testosterone|mesh-list
153767503|NCT00193661|Androgens|androgens|mesh-ancestor
153767504|NCT00193661|Hormones|hormones|mesh-ancestor
153767505|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767506|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767507|NCT00206232|Spironolactone|spironolactone|mesh-list
153767508|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153767509|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
153767510|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767511|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767512|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153767513|NCT00206232|Diuretics|diuretics|mesh-ancestor
153767514|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
153767515|NCT00193700|Testosterone|testosterone|mesh-list
153767516|NCT00193700|Androgens|androgens|mesh-ancestor
153767517|NCT00193700|Hormones|hormones|mesh-ancestor
153767518|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767519|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767520|NCT00124826|Insulin|insulin|mesh-list
153767521|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153767522|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767523|NCT00193739|Paclitaxel|paclitaxel|mesh-list
153767524|NCT00193739|Carboplatin|carboplatin|mesh-list
153767534|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
153767548|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153767549|NCT00125021|Capecitabine|capecitabine|mesh-list
153767550|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153767551|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767552|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
153767553|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767554|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767555|NCT00125021|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153767556|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153767557|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767558|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
153767559|NCT00193856|Leuprolide|leuprolide|mesh-list
153767560|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153767561|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767562|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153767563|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
153767564|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153767565|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153767566|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767567|NCT00223509|Lamotrigine|lamotrigine|mesh-list
153767568|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
153767569|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153767579|NCT00193895|Carboplatin|carboplatin|mesh-list
153767619|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153767620|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153767621|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153767622|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767623|NCT00411879|Vasopressins|vasopressins|mesh-list
153767624|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
153767625|NCT00411879|Epinephrine|epinephrine|mesh-list
153767626|NCT00411879|Racepinephrine|racepinephrine|mesh-list
153767627|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
153767628|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153767629|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153767630|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
153767631|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767632|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767633|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767634|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153767635|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153767636|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
153767637|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767638|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153767639|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
153767640|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
153767653|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
153767654|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767655|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767656|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153767657|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153767678|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153767679|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153767680|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153767681|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767682|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
153767683|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
153767684|NCT00223938|Hematinics|hematinics|mesh-ancestor
153767685|NCT00125294|Methadone|methadone|mesh-list
153767686|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153767687|NCT00125294|Narcotics|narcotics|mesh-ancestor
153767688|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767689|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767690|NCT00125294|Analgesics|analgesics|mesh-ancestor
153767691|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
153767692|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767693|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
153767694|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
153767695|NCT00206466|Docetaxel|docetaxel|mesh-list
153767696|NCT00206466|Doxorubicin|doxorubicin|mesh-list
153767697|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
153767698|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153767699|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767700|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767701|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767702|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767703|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767704|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154157449|NCT05782712|Analgesics|analgesics|mesh-ancestor
153767705|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153767715|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153767717|NCT00224094|Hormones|hormones|mesh-ancestor
153767718|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767730|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767731|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767732|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767733|NCT00206544|Tamoxifen|tamoxifen|mesh-list
153767734|NCT00206544|Progesterone|progesterone|mesh-list
153767735|NCT00206544|Progestins|progestins|mesh-ancestor
153767736|NCT00206544|Hormones|hormones|mesh-ancestor
153767737|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767738|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767739|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153767740|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
153767741|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153767742|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767743|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153767744|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153767745|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153767746|NCT00194324|Miconazole|miconazole|mesh-list
153767747|NCT00194324|Clotrimazole|clotrimazole|mesh-list
153767748|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
153767749|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767750|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153767751|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153767752|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767753|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767754|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153767755|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
153767756|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767757|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767758|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153767799|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153767800|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
153767802|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767803|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153767804|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767805|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153767806|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767807|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767808|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
153767809|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153767811|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153767812|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
153767813|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
153767814|NCT00125489|Amebicides|amebicides|mesh-ancestor
153767815|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153767816|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153767817|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767818|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
153767819|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767820|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153767837|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767838|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767839|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153767840|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153767841|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153767842|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767843|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767844|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153767845|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153604968|NCT01927679|Vitamin E|vitamin e|mesh-list
153767846|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153767856|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153767857|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153767858|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
153767859|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767860|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767861|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157450|NCT05782712|Sensory System Agents|sensory system agents|mesh-ancestor
153767862|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153767863|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767864|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153767866|NCT00473083|Clindamycin|clindamycin|mesh-list
153767867|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
153767868|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
153767869|NCT00473083|Triamcinolone|triamcinolone|mesh-list
153767870|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153767871|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153767872|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
153767873|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153767874|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767875|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767876|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767877|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
153767878|NCT00473083|Hormones|hormones|mesh-ancestor
153767927|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767928|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153767929|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767930|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767931|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153767932|NCT00206778|Lamotrigine|lamotrigine|mesh-list
153767943|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153767944|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153767945|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767946|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
153767947|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767948|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
153767949|NCT00125801|Hydromorphone|hydromorphone|mesh-list
153767950|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153767951|NCT00125801|Narcotics|narcotics|mesh-ancestor
153767952|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767953|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767954|NCT00125801|Analgesics|analgesics|mesh-ancestor
153767955|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
153767956|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767957|NCT00125840|Clofarabine|clofarabine|mesh-list
153767958|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767959|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
153767960|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767962|NCT00224445|Ritonavir|ritonavir|mesh-list
153767986|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767987|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767988|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
153767989|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767990|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767991|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153767992|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
153767993|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153767994|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153767995|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153768006|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768007|NCT00125918|Urological Agents|urological agents|mesh-ancestor
153768009|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768010|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
153768011|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153768013|NCT00472303|Tapentadol|tapentadol|mesh-list
153768014|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153768015|NCT00472303|Narcotics|narcotics|mesh-ancestor
153768016|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768017|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768018|NCT00472303|Analgesics|analgesics|mesh-ancestor
153768019|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
153768020|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768021|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153768045|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153768046|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
153768047|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153768048|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
153768049|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768051|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
153768052|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153768053|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153768054|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768055|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768056|NCT00194909|Urological Agents|urological agents|mesh-ancestor
153768057|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
153768058|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
153768059|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
153768085|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153768086|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153768087|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768088|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768089|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153768090|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
153768091|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768092|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153768093|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153768094|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153768095|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153768096|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
153768097|NCT00207051|Cetuximab|cetuximab|mesh-list
153768119|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768120|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768121|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153768122|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153768123|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768124|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153768125|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153768126|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768127|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
153768128|NCT00402506|Pyridoxal|pyridoxal|mesh-list
153768129|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
153768130|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
153768131|NCT00402506|Vitamins|vitamins|mesh-ancestor
153768132|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
153768133|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768134|NCT00207129|Capecitabine|capecitabine|mesh-list
153768135|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768199|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768200|NCT00207363|Interferons|interferons|mesh-list
153768201|NCT00207363|Ribavirin|ribavirin|mesh-list
153768202|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
153768203|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
153768204|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153768205|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768206|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
153768207|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768208|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
153768209|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768210|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
153768211|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768212|NCT00126269|Gemcitabine|gemcitabine|mesh-list
153768213|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768219|NCT00207402|Ribavirin|ribavirin|mesh-list
153768302|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
153768303|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768304|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768305|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
153768306|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153768307|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
153768308|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768309|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153768310|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
153768311|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153768312|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768313|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
153768314|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153768315|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768317|NCT00225264|Glimepiride|glimepiride|mesh-list
153768318|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153768319|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768320|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153768321|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768322|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
153768323|NCT00126464|Tamoxifen|tamoxifen|mesh-list
153768324|NCT00126464|Fulvestrant|fulvestrant|mesh-list
153768325|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153768326|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
153768327|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153768364|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
153768366|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153768367|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153768368|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768369|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768370|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
153768371|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768372|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
153605489|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
153768373|NCT00225342|Gliclazide|gliclazide|mesh-list
153768374|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153768375|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768376|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153768377|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
153768378|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768379|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
153768380|NCT00470470|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153768381|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153768382|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768432|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153768433|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768434|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768435|NCT00195767|Valproic Acid|valproic acid|mesh-list
153768436|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
153768437|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768438|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768439|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
153768440|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768441|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768442|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
153768443|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153768444|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768445|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768446|NCT00207675|Infliximab|infliximab|mesh-list
153768500|NCT00478972|Rimonabant|rimonabant|mesh-list
153768501|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153768502|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153768503|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153768504|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768505|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768506|NCT00478972|Hormones|hormones|mesh-ancestor
153768507|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153768508|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768509|NCT00207792|Lenograstim|lenograstim|mesh-list
153768510|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153768511|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
153768512|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768513|NCT00195806|Valproic Acid|valproic acid|mesh-list
153768514|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
153768515|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768568|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
153768569|NCT00195923|Gentamicins|gentamicins|mesh-list
153768570|NCT00195923|Ceftazidime|ceftazidime|mesh-list
153768571|NCT00195923|Ampicillin|ampicillin|mesh-list
153768572|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153768573|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768574|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153768575|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768576|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768577|NCT00195923|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153768578|NCT00195923|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153768579|NCT00225615|Verapamil|verapamil|mesh-list
153768580|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153768581|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153768582|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153768586|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
153768677|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768679|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768680|NCT00207948|Ritonavir|ritonavir|mesh-list
153768681|NCT00207948|Lopinavir|lopinavir|mesh-list
153768682|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153768683|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153768684|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
153768685|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157451|NCT05782712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768686|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768687|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153768688|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153768689|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
153768749|NCT00203099|Expectorants|expectorants|mesh-ancestor
153768750|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
153768752|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
153768753|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768754|NCT00203099|Protective Agents|protective agents|mesh-ancestor
153768755|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768756|NCT00203099|Antidotes|antidotes|mesh-ancestor
153768757|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153768758|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
153768779|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153768780|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153768781|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768783|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153768784|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768804|NCT00196586|Ribavirin|ribavirin|mesh-list
153768841|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153768842|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
153768843|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768844|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153768845|NCT00208182|Risperidone|risperidone|mesh-list
153768846|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153768847|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
153768848|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768849|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768850|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768851|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153768852|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153768853|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768854|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768855|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153768856|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
153768857|NCT00208221|Telmisartan|telmisartan|mesh-list
153768858|NCT00208221|Ramipril|ramipril|mesh-list
153768859|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153768860|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153768861|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153745634|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153768906|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768907|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153768908|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
153768909|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
153768910|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
153768912|NCT00208299|Regadenoson|regadenoson|mesh-list
153768913|NCT00208299|Analgesics|analgesics|mesh-ancestor
153768986|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768987|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153768989|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153768990|NCT00196820|Capecitabine|capecitabine|mesh-list
153768991|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768992|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
153768993|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731531|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153731532|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
153731533|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
153731534|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
153731535|NCT00154167|Phentolamine|phentolamine|mesh-list
153731536|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153769068|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153769070|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
153769071|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153769072|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153769073|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153769074|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153769075|NCT00203450|Zonisamide|zonisamide|mesh-list
153769076|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
153769185|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769186|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153769187|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153769188|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153769189|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
153769262|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
153769263|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153769264|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
153769265|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153769266|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769267|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769268|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153769269|NCT00197327|Bupivacaine|bupivacaine|mesh-list
153769270|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
153769271|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
153769272|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334178|NCT02972294|Iron|iron|mesh-list
153769273|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769274|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
153769275|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769276|NCT00227097|Anticoagulants|anticoagulants|mesh-list
153769368|NCT00197639|Ritonavir|ritonavir|mesh-list
153769369|NCT00197639|Indinavir|indinavir|mesh-list
153769370|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153769371|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153769372|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
153769373|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769374|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769375|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153769391|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153769392|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
153769393|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
153769394|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153769395|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153769396|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153769397|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
153769398|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769400|NCT00227448|Protective Agents|protective agents|mesh-ancestor
153769458|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769459|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153769460|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
153769461|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
153769462|NCT00227682|Thalidomide|thalidomide|mesh-list
153769463|NCT00227682|Dexamethasone|dexamethasone|mesh-list
153769464|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
153769465|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769466|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
153769467|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
153769468|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769469|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769470|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769471|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
153769472|NCT00227682|Hormones|hormones|mesh-ancestor
153769473|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769474|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153769475|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769488|NCT00227682|Vitamins|vitamins|mesh-ancestor
153769532|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153769533|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153769534|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153769535|NCT00197912|Analgesics|analgesics|mesh-ancestor
153769536|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
153769537|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769538|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769539|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153769540|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153769541|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769542|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153769543|NCT02962323|Calcium|calcium|mesh-list
153769544|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153769545|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769546|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153769547|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153769548|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
153769549|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769550|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153769551|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153769552|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769553|NCT00204503|Valproic Acid|valproic acid|mesh-list
153769554|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
153769555|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769596|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769597|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
153769598|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769599|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769600|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
153769601|NCT00228033|Calcium|calcium|mesh-list
153769602|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153769603|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769604|NCT00228033|Antacids|antacids|mesh-ancestor
153769605|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769606|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769607|NCT00230997|Galantamine|galantamine|mesh-list
153769608|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153769609|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769610|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769611|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
153769612|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769621|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153769622|NCT00204581|Analgesics|analgesics|mesh-ancestor
153769623|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
153769624|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769625|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769626|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153769627|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153769628|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
153769629|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769630|NCT00231075|Paclitaxel|paclitaxel|mesh-list
153769649|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
153606813|NCT04759664|LUT014|lut014|mesh-list
153769650|NCT02962518|Hormones|hormones|mesh-ancestor
153769651|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769652|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769653|NCT00204659|Rituximab|rituximab|mesh-list
153769654|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153769655|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769656|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
153769657|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769658|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769705|NCT00198536|Ecabet|ecabet|mesh-list
153769720|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769721|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
153769722|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769723|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
153769724|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769726|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153769728|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
153769729|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
153769730|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
153769731|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769732|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769825|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
153769826|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769827|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153769828|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153769829|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769830|NCT00199004|Cytarabine|cytarabine|mesh-list
153769831|NCT00199004|Dexamethasone|dexamethasone|mesh-list
153769832|NCT00199004|Prednisolone|prednisolone|mesh-list
153769833|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
153769834|NCT00199004|Rituximab|rituximab|mesh-list
153769835|NCT00199004|Methotrexate|methotrexate|mesh-list
153769836|NCT00199004|Vincristine|vincristine|mesh-list
153769837|NCT00199004|Doxorubicin|doxorubicin|mesh-list
153769896|NCT00228891|Insulin|insulin|mesh-list
153769897|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153769898|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769899|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769900|NCT00477412|Cytarabine|cytarabine|mesh-list
153769901|NCT00477412|Dexamethasone|dexamethasone|mesh-list
153769902|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
153769903|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
153769904|NCT00477412|Rituximab|rituximab|mesh-list
153769905|NCT00477412|Doxorubicin|doxorubicin|mesh-list
153769906|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153769907|NCT00477412|Methotrexate|methotrexate|mesh-list
153769908|NCT00477412|Vincristine|vincristine|mesh-list
153769909|NCT00477412|Bortezomib|bortezomib|mesh-list
153769910|NCT00477412|Daunorubicin|daunorubicin|mesh-list
153769911|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153769912|NCT00477412|Antibodies|antibodies|mesh-list
153769913|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
153769914|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153769915|NCT00477412|BB 1101|bb 1101|mesh-list
153769916|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769917|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
153770029|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770030|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
153770031|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153770032|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770033|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770034|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770035|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153770036|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153770037|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770038|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770039|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
153770040|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
153770041|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
153770042|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770043|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153770044|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
153770045|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
153770046|NCT00205283|Nelfinavir|nelfinavir|mesh-list
153770047|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153770048|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153770049|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
153770050|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770051|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770052|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153770053|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153770054|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
153770055|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770056|NCT00232167|Indiplon|indiplon|mesh-list
153770057|NCT00232167|Sertraline|sertraline|mesh-list
153770058|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770059|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770095|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770096|NCT00232284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153770097|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770098|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770099|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770100|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770101|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
153770102|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770103|NCT00205634|Clarithromycin|clarithromycin|mesh-list
153770104|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153770105|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770106|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153770107|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770108|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770109|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153770110|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153770111|NCT00232362|Pioglitazone|pioglitazone|mesh-list
153770112|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
153770113|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153770114|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770115|NCT00205751|Thalidomide|thalidomide|mesh-list
153770158|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770159|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770160|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770161|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
153770162|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770163|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770164|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153770165|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153770167|NCT00229515|Sirolimus|sirolimus|mesh-list
153770240|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153770241|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
153770259|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153770260|NCT00206297|Pramlintide|pramlintide|mesh-list
153770261|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153770262|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770263|NCT00411047|Gefitinib|gefitinib|mesh-list
153770264|NCT00411047|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153770265|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153770266|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770267|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770268|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770269|NCT00411125|Calcitonin|calcitonin|mesh-list
153770270|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
153770317|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770318|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770319|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153770320|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153770321|NCT00232674|Budesonide|budesonide|mesh-list
153770322|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153770323|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153770324|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
153770325|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607435|NCT02684162|Azacitidine|azacitidine|mesh-list
153770326|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770327|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153770328|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
153770329|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
153770330|NCT00232674|Hormones|hormones|mesh-ancestor
153770332|NCT00206453|Docetaxel|docetaxel|mesh-list
153770391|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153770392|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770393|NCT00424710|Ranibizumab|ranibizumab|mesh-list
153770394|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153770395|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153770396|NCT00424710|Growth Substances|growth substances|mesh-ancestor
153770397|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770398|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
153770399|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770401|NCT00206960|Clopenthixol|clopenthixol|mesh-list
153770402|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153770403|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
153770404|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770407|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153770465|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770466|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770467|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770468|NCT00230217|Rasburicase|rasburicase|mesh-list
153770526|NCT00207662|Infliximab|infliximab|mesh-list
153770565|NCT00411320|Dexamethasone|dexamethasone|mesh-list
153770566|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153770567|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
153770568|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
153770569|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770570|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770571|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770572|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
153770573|NCT00411320|Hormones|hormones|mesh-ancestor
153770574|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770575|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770576|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770577|NCT00233337|Artemether|artemether|mesh-list
153770578|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153770579|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
153770580|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153770581|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153770583|NCT00230490|Adefovir|adefovir|mesh-list
153770641|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153770642|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
153770643|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770644|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770645|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153745636|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
153770664|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153770665|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
153770666|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770667|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153770669|NCT00233571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153770727|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153770728|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770729|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
153770730|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153770731|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
153770732|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770733|NCT00208208|Ziprasidone|ziprasidone|mesh-list
153770734|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153770735|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
153770736|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770737|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770738|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770739|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153770802|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
153770803|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153770804|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770805|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770806|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153770807|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770808|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153770809|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770810|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770878|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153770879|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770880|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153770881|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153770882|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153770883|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770884|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
153770885|NCT00208793|Vitamin D|vitamin d|mesh-list
153770886|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
153770949|NCT00209222|Melphalan|melphalan|mesh-list
153770950|NCT00209222|Rituximab|rituximab|mesh-list
153770951|NCT00209222|Doxorubicin|doxorubicin|mesh-list
153770952|NCT00209222|Etoposide|etoposide|mesh-list
153770953|NCT00209222|Vincristine|vincristine|mesh-list
153770954|NCT00209222|Cisplatin|cisplatin|mesh-list
153770955|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770969|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
153771045|NCT00234312|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153771046|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153771047|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771048|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771049|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771051|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771052|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
153771053|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771054|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
153771055|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153771056|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771057|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153771058|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
153771059|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153771065|NCT00237627|Bortezomib|bortezomib|mesh-list
153771134|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771135|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771136|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771137|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153771138|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
153771139|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153771140|NCT00209651|Irinotecan|irinotecan|mesh-list
153771141|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153771142|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153771143|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608271|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771144|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771145|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771146|NCT02961855|Diclofenac|diclofenac|mesh-list
153771147|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153771148|NCT02961855|Lidocaine|lidocaine|mesh-list
153771149|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
153771150|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
153771151|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771152|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771153|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
153771154|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771155|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153771156|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153771157|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153771158|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771160|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153771180|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153771181|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153771182|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153771183|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153771184|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
153771185|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771186|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771211|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153771212|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153771213|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
153771214|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153771215|NCT01080625|Protective Agents|protective agents|mesh-ancestor
153771216|NCT00209729|Docetaxel|docetaxel|mesh-list
153771217|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608353|NCT01940172|Conatumumab|conatumumab|mesh-list
153771218|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
153771219|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
153771220|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
153771221|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771222|NCT00414180|Bupropion|bupropion|mesh-list
153771223|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153771260|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
153771261|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
153771262|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
153771263|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771264|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153771265|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153771266|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771267|NCT00209807|Reboxetine|reboxetine|mesh-list
153771268|NCT00209807|Escitalopram|escitalopram|mesh-list
153771269|NCT00209807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153771270|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153771271|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771272|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771273|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771274|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
153771275|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771276|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
153771277|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771278|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153771279|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
153771280|NCT00209846|Gaboxadol|gaboxadol|mesh-list
153771281|NCT00209846|Analgesics|analgesics|mesh-ancestor
153771282|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
153771283|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771284|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771285|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
153771286|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
153771287|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
153771288|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771289|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771290|NCT01082068|Letrozole|letrozole|mesh-list
153771319|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153771320|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
153771321|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771322|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781940|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153781941|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781942|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153781943|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153781944|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781945|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
153781946|NCT00232271|Enoxaparin|enoxaparin|mesh-list
153781947|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
153781948|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153781949|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153781950|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781951|NCT04557397|Itraconazole|itraconazole|mesh-list
153771362|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153771376|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
153771377|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
153771378|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
153771379|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771380|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771381|NCT00209963|Gaboxadol|gaboxadol|mesh-list
153771382|NCT00209963|Analgesics|analgesics|mesh-ancestor
153771383|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
153771452|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771453|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771454|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153771456|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
153771457|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771458|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153771459|NCT00413790|Darifenacin|darifenacin|mesh-list
153771460|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153771461|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153771462|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
153771463|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771464|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771465|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771466|NCT00413790|Urological Agents|urological agents|mesh-ancestor
153771467|NCT01059903|Rotigotine|rotigotine|mesh-list
153771473|NCT04996771|Cisplatin|cisplatin|mesh-list
153771525|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771526|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153771527|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153771528|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153771529|NCT00210509|Almotriptan|almotriptan|mesh-list
153771530|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153771531|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
153771532|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771533|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771534|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771536|NCT02210260|Bupivacaine|bupivacaine|mesh-list
153771537|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
153771538|NCT02210260|Anesthetics|anesthetics|mesh-list
153771539|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771540|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771622|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
153771623|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153771624|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
153771625|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771626|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153771627|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153771628|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
153771629|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771630|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771744|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153771745|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153771770|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
153608952|NCT01943877|Propolis|propolis|mesh-list
153771771|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771772|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771773|NCT04566952|Olaparib|olaparib|mesh-list
153771774|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153771775|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771776|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771777|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771778|NCT04567069|Vaccines|vaccines|mesh-list
153771779|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
153771780|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771781|NCT04566796|Neostigmine|neostigmine|mesh-list
153771782|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153771783|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771784|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771785|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
153771786|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771787|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795970|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153795971|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153795972|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795973|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
153795974|NCT05082142|Coagulants|coagulants|mesh-ancestor
153795981|NCT05043116|Vitamin D|vitamin d|mesh-list
153771825|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
153771826|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
153771827|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
153796029|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796030|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796031|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153796032|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153771910|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771911|NCT00238368|Cytarabine|cytarabine|mesh-list
153771912|NCT00238368|Prednisone|prednisone|mesh-list
153771913|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
153771914|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
153771915|NCT00238368|Busulfan|busulfan|mesh-list
153771916|NCT00238368|Rituximab|rituximab|mesh-list
153771917|NCT00238368|Doxorubicin|doxorubicin|mesh-list
153771918|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153771919|NCT00238368|Etoposide|etoposide|mesh-list
153771920|NCT00238368|Vincristine|vincristine|mesh-list
153771921|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153771922|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153771923|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
153771924|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771939|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153771941|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153771942|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153771943|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
153771944|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
153771945|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771946|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
153771947|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
153771948|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
153771949|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
153771950|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
153771954|NCT00238368|Protective Agents|protective agents|mesh-ancestor
153771967|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
153771968|NCT02894593|Protective Agents|protective agents|mesh-ancestor
153771969|NCT00211406|Anecortave|anecortave|mesh-list
153771970|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153771971|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153771972|NCT00211406|Growth Substances|growth substances|mesh-ancestor
153771973|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771974|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
153771975|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771976|NCT02894554|Lamivudine|lamivudine|mesh-list
153771977|NCT02894554|Telbivudine|telbivudine|mesh-list
153771978|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153771979|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153771980|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771981|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771982|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
153771983|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771984|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153771985|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153771986|NCT00238407|Docetaxel|docetaxel|mesh-list
153772005|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772007|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772008|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153772009|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153772010|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153772011|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772013|NCT00211484|Anecortave|anecortave|mesh-list
153772033|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153772034|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772035|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
153772036|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
153772037|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772038|NCT00211562|Vitamin E|vitamin e|mesh-list
153772039|NCT00211562|Olanzapine|olanzapine|mesh-list
153772052|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153772053|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772054|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772055|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772056|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
153772058|NCT00211562|Protective Agents|protective agents|mesh-ancestor
153772060|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772061|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153772062|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
153772063|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
153772064|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
153772065|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153772066|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153772067|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153772070|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
153772098|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
153772099|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772100|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772101|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153772127|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153772128|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153772129|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153772130|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772131|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772132|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772133|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772134|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153772135|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
153772136|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153772137|NCT04680208|Anesthetics|anesthetics|mesh-list
153772138|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772139|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772185|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
153772186|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772187|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772188|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153772189|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153772190|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153772191|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
153772192|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
153772193|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
153772194|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153772195|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153772196|NCT05425654|Growth Substances|growth substances|mesh-ancestor
153772197|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
153772198|NCT00238914|Naltrexone|naltrexone|mesh-list
153772199|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153772200|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153772201|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772202|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
153772203|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772204|NCT04668976|Gemcitabine|gemcitabine|mesh-list
153772205|NCT04668976|Fluorouracil|fluorouracil|mesh-list
153772206|NCT04668976|Floxuridine|floxuridine|mesh-list
153772207|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
153772208|NCT04668976|Irinotecan|irinotecan|mesh-list
153772209|NCT04668976|Cetuximab|cetuximab|mesh-list
153772210|NCT04668976|Panitumumab|panitumumab|mesh-list
153772211|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153772212|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
153772213|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772214|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772215|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153772216|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
153772217|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772227|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772237|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772238|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
153772239|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153772242|NCT04721301|Maraviroc|maraviroc|mesh-list
153772330|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
153772331|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772332|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772333|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772334|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772335|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153772336|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153772337|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772338|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772339|NCT00239109|Olanzapine|olanzapine|mesh-list
153772340|NCT00239109|Ziprasidone|ziprasidone|mesh-list
153772400|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772401|NCT00414336|Antacids|antacids|mesh-ancestor
153772402|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772403|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153772404|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153772405|NCT00212342|Norethindrone|norethindrone|mesh-list
153772406|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
153772498|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772499|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153772500|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
153772501|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772502|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772503|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153772504|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
153772505|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772506|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153772507|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
153772508|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153772509|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
153772510|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772511|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772512|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153772513|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153772514|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153772515|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
153772516|NCT00212615|Capecitabine|capecitabine|mesh-list
153772517|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
153772518|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153772565|NCT00222651|Tenecteplase|tenecteplase|mesh-list
153772566|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153772567|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153772568|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772569|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153772570|NCT00239616|Hematinics|hematinics|mesh-ancestor
153772571|NCT00213122|Miglitol|miglitol|mesh-list
153772572|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772573|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772574|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153772575|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772576|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153772577|NCT00213200|Morphine|morphine|mesh-list
153772578|NCT00213200|Tetracaine|tetracaine|mesh-list
153772641|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772642|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772643|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772673|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
153772674|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609848|NCT05414942|Analgesics|analgesics|mesh-ancestor
153772675|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153772676|NCT00243711|Glycerol|glycerol|mesh-list
153772677|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153772678|NCT00243711|Protective Agents|protective agents|mesh-ancestor
153772679|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772680|NCT00243711|Laxatives|laxatives|mesh-ancestor
153772681|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153772682|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
153772759|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
153772760|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153772761|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772762|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153772763|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153772764|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772765|NCT00240396|Narcotics|narcotics|mesh-list
153772766|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772767|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772768|NCT00240396|Analgesics|analgesics|mesh-ancestor
153772769|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
153772771|NCT00214331|Azithromycin|azithromycin|mesh-list
153772830|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153772831|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153772832|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772833|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772834|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153772835|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772836|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
153772837|NCT00240474|Diuretics|diuretics|mesh-ancestor
153772838|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
153772839|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153772840|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153772842|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153772909|NCT00244179|Interferons|interferons|mesh-list
153772910|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
153772911|NCT00244179|Infliximab|infliximab|mesh-list
153772912|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772913|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
153772914|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772915|NCT00244179|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153772916|NCT00244179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772917|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772918|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153772919|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772920|NCT00214994|Tiagabine|tiagabine|mesh-list
153772921|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
153772922|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153772923|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153772924|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772925|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772926|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
153772927|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772944|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153772978|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
153772979|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153772980|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772981|NCT00240708|Risperidone|risperidone|mesh-list
153772982|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153772983|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
153773027|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
153773028|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773029|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773030|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
153773031|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153773032|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
153773033|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773034|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773035|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153773036|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
153773037|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153773038|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153773039|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153773040|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
153773041|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773042|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773043|NCT04668352|Dactolisib|dactolisib|mesh-list
153773044|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773045|NCT00215462|Vinorelbine|vinorelbine|mesh-list
153610232|NCT02034110|Trametinib|trametinib|mesh-list
153773046|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153773047|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773052|NCT00215501|Capecitabine|capecitabine|mesh-list
153773063|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153773064|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773065|NCT00240786|Acetaminophen|acetaminophen|mesh-list
153773066|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153773067|NCT00240786|Analgesics|analgesics|mesh-ancestor
153773068|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
153773069|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773070|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773071|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
153773072|NCT00215579|Risperidone|risperidone|mesh-list
153773073|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153773074|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
153773075|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773088|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773089|NCT00244452|Cetrorelix|cetrorelix|mesh-list
153773090|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153773091|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
153773092|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153773093|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773094|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
153502026|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
153773095|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773096|NCT00556699|Rituximab|rituximab|mesh-list
153773130|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
153773131|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773132|NCT04667299|Expectorants|expectorants|mesh-ancestor
153773133|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
153773134|NCT04667143|Metformin|metformin|mesh-list
153773135|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153773136|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773137|NCT00240825|Acetaminophen|acetaminophen|mesh-list
153773138|NCT00240825|Ibuprofen|ibuprofen|mesh-list
153773153|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153773226|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
153773227|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773228|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773229|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
153773230|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
153773231|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153773232|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
153773233|NCT04666168|Fludarabine|fludarabine|mesh-list
153773234|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773235|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
153773236|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773237|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773239|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
153773293|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773294|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153773295|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773296|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
153773297|NCT02961816|Vitamins|vitamins|mesh-ancestor
153773298|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
153773299|NCT04665232|Progesterone|progesterone|mesh-list
153773300|NCT04665232|Progestins|progestins|mesh-ancestor
153773301|NCT04665232|Hormones|hormones|mesh-ancestor
153773302|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773303|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773304|NCT00216008|Docetaxel|docetaxel|mesh-list
153773305|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773306|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
153773307|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
153773308|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
153773309|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773310|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
153773311|NCT04665076|Fludarabine|fludarabine|mesh-list
153773312|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773313|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
153773314|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773315|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773316|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153773317|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
153773318|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773350|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153773351|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773352|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
153773353|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773354|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773355|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153773356|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
153773379|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153773380|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
153773381|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
153773382|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
153773383|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153773384|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773385|NCT00216281|Clozapine|clozapine|mesh-list
153773386|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153773387|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153773388|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153773389|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153773390|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773401|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
153773461|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153773462|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
153773463|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773464|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
153773465|NCT00244959|Anastrozole|anastrozole|mesh-list
153773466|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153773467|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773468|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153773469|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153773470|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773471|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773484|NCT00216554|Risperidone|risperidone|mesh-list
153773485|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153773486|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
153773487|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773488|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773489|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773490|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153773529|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773530|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153773531|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153773539|NCT04662658|Xenon|xenon|mesh-list
153773540|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153773541|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
153773542|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
153773543|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773544|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773545|NCT00216788|Esomeprazole|esomeprazole|mesh-list
153773546|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153773547|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773548|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153773549|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773550|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773551|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
153773552|NCT00245115|Busulfan|busulfan|mesh-list
153773553|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773554|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
153773555|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773556|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773557|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153773558|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
153773559|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773560|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773561|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153773562|NCT04662385|Listerine|listerine|mesh-list
153773563|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
153773564|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
153773565|NCT04662385|Protective Agents|protective agents|mesh-ancestor
153773566|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773569|NCT00216827|Betamethasone|betamethasone|mesh-list
153773579|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773580|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153773581|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
153773582|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
153773584|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153773585|NCT00241332|Narcotics|narcotics|mesh-ancestor
153773586|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773587|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773588|NCT00241332|Analgesics|analgesics|mesh-ancestor
153773589|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
153773590|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773591|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153773592|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153773593|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
153773594|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
153773595|NCT00216866|Dalteparin|dalteparin|mesh-list
153773596|NCT00216866|Tinzaparin|tinzaparin|mesh-list
153773597|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153773598|NCT00216866|Warfarin|warfarin|mesh-list
153773599|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
153773600|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153773601|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153773602|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773620|NCT04660786|Vitamins|vitamins|mesh-ancestor
153773647|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153773648|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153773649|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153773651|NCT00412100|Naloxone|naloxone|mesh-list
153773652|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153773653|NCT00412100|Narcotics|narcotics|mesh-ancestor
153502027|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773654|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773655|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773656|NCT00412100|Analgesics|analgesics|mesh-ancestor
153773657|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
153773658|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773659|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153773660|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153773661|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153773672|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
153773673|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
153773674|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773676|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153773677|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773678|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153773679|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773681|NCT04648813|Bromides|bromides|mesh-list
153773712|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
153773713|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773714|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773715|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610897|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
153773716|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
153773717|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
153773718|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773719|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773720|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
153773721|NCT00558181|Hormones|hormones|mesh-ancestor
153773722|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773723|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153773724|NCT00558181|Protective Agents|protective agents|mesh-ancestor
153773741|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153773742|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
153773743|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773744|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773745|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773746|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153773747|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153773748|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773749|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773750|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153773751|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
153773752|NCT00245505|Mesalamine|mesalamine|mesh-list
153773753|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153773754|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153773755|NCT00245505|Analgesics|analgesics|mesh-ancestor
153773756|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
153773757|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773758|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773761|NCT04647838|Tepotinib|tepotinib|mesh-list
153773771|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773773|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773774|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153773775|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153773776|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153773777|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
153773778|NCT00241605|Metformin|metformin|mesh-list
153773779|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
153773780|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153773781|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773782|NCT00217412|Vorinostat|vorinostat|mesh-list
153773783|NCT00217412|Isotretinoin|isotretinoin|mesh-list
153773784|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773785|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153773786|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773800|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773801|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153773802|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773803|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773804|NCT00217529|Carboplatin|carboplatin|mesh-list
153773806|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153773807|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773808|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
153773809|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
153773810|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
153773811|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773812|NCT00217529|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153773813|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153773815|NCT00245661|Temazepam|temazepam|mesh-list
153773827|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153773828|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773829|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773830|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153773831|NCT04646317|Analgesics|analgesics|mesh-ancestor
153773832|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
153773833|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773834|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153773835|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153773836|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153773837|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
153773840|NCT00217568|Carboplatin|carboplatin|mesh-list
153773961|NCT04643821|Expectorants|expectorants|mesh-ancestor
153773962|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
153773963|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153773964|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
153773965|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773966|NCT04643821|Protective Agents|protective agents|mesh-ancestor
153773967|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773968|NCT04643821|Antidotes|antidotes|mesh-ancestor
153773969|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153773970|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153773971|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153773972|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153773973|NCT04643821|Vitamins|vitamins|mesh-ancestor
153773974|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
153773975|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153773976|NCT00218075|Levodopa|levodopa|mesh-list
153774042|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153774043|NCT00218309|Narcotics|narcotics|mesh-ancestor
153774044|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774045|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774046|NCT00218309|Analgesics|analgesics|mesh-ancestor
153774047|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
153774048|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774049|NCT00218348|Amphetamine|amphetamine|mesh-list
153774050|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
153774051|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153774052|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774053|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
153774054|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
153774055|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774071|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774072|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153774073|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774136|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
153774137|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774138|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774139|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
153774140|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153774141|NCT00246168|Narcotics|narcotics|mesh-ancestor
153774142|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774143|NCT00218660|Naltrexone|naltrexone|mesh-list
153774144|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153774145|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153774146|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774147|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
153774148|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774246|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153774247|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153774248|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774249|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774250|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153774251|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153774252|NCT00246285|Risperidone|risperidone|mesh-list
153774253|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153774254|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
153774255|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774256|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774257|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774258|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153774259|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153774260|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774261|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153774262|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153774319|NCT00219128|Aliskiren|aliskiren|mesh-list
153774320|NCT00219128|Renin Inhibitors|renin inhibitors|mesh-ancestor
153774345|NCT00219167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774346|NCT00219167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774347|NCT00242346|Candesartan|candesartan|mesh-list
153774348|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
153774349|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153774350|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153774351|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153774352|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774353|NCT00219245|Rivastigmine|rivastigmine|mesh-list
153774354|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153774355|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774446|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153774447|NCT00242463|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
153774448|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
153774449|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153774450|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
153774451|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774452|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774453|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153774454|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774455|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153774456|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153774457|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153774458|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
153774459|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774460|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774462|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153774463|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153774464|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153774465|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774467|NCT00219596|Latanoprost|latanoprost|mesh-list
153774518|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774519|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
153774520|NCT00219752|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153774521|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153774522|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774523|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774534|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774535|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153774536|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
153774537|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
153774538|NCT02962232|Paclitaxel|paclitaxel|mesh-list
153774539|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153774540|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774541|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
153774542|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
153774543|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
153774545|NCT00246909|Pantoprazole|pantoprazole|mesh-list
153774586|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153774587|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153774598|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774599|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153774600|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774601|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774602|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153774603|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
153774674|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774677|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
153774678|NCT01580683|Vitamins|vitamins|mesh-ancestor
153774679|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
153774680|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774681|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
153774682|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774683|NCT01580683|Protective Agents|protective agents|mesh-ancestor
153774684|NCT04623385|Tretinoin|tretinoin|mesh-list
153774685|NCT04623385|Isotretinoin|isotretinoin|mesh-list
153774686|NCT04623385|Testosterone|testosterone|mesh-list
153774687|NCT04623385|Androgens|androgens|mesh-ancestor
153774688|NCT04623385|Hormones|hormones|mesh-ancestor
153774753|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153774754|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774755|NCT04622488|Diclofenac|diclofenac|mesh-list
153774756|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153774757|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774758|NCT04622488|Analgesics|analgesics|mesh-ancestor
153774759|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
153774760|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774761|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774762|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774763|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774764|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153774853|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774854|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774855|NCT04620967|Insulin|insulin|mesh-list
153774856|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153774857|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
153774858|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
153774859|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153774860|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153774861|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774862|NCT00220493|Methylphenidate|methylphenidate|mesh-list
153774863|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153774864|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774865|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153774866|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153774867|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153774927|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
153774928|NCT00220649|Vitamins|vitamins|mesh-ancestor
153774929|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
153774930|NCT04619758|Emollients|emollients|mesh-list
153774931|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774932|NCT04619914|Letrozole|letrozole|mesh-list
153774933|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774934|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153774935|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153774936|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774937|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774938|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153774939|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
153774940|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774941|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774942|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
153774943|NCT00220766|Antibodies|antibodies|mesh-list
153774956|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774957|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
153774958|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
153774959|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
153774960|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774961|NCT00220844|Amitriptyline|amitriptyline|mesh-list
153774962|NCT00220844|Desipramine|desipramine|mesh-list
153774963|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153774964|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
153774965|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153774966|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774967|NCT00220844|Analgesics|analgesics|mesh-ancestor
153774968|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
153774969|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774970|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774971|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153774980|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774981|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153774982|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
153774983|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153774984|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774985|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774986|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774987|NCT00243399|Oxandrolone|oxandrolone|mesh-list
153774988|NCT00243399|Androgens|androgens|mesh-ancestor
153774989|NCT00243399|Hormones|hormones|mesh-ancestor
153612170|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
153775050|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153775051|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
153775052|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153775053|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153775054|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153775055|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775056|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153775057|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153775058|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153775059|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775060|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
153775061|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775062|NCT00221312|Alendronate|alendronate|mesh-list
153775063|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153775065|NCT04616872|Methotrexate|methotrexate|mesh-list
153775122|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153775133|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775134|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153775135|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
153775136|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153775137|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153775219|NCT06178068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745639|NCT03283150|Remifentanil|remifentanil|mesh-list
153775220|NCT06178068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775221|NCT06178068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153775222|NCT06178068|Respiratory System Agents|respiratory system agents|mesh-ancestor
153775223|NCT06177938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153775225|NCT06177925|Etoposide|etoposide|mesh-list
153775226|NCT06177925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775227|NCT06177925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153775228|NCT06177925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153775229|NCT06177925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153775230|NCT06177925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775231|NCT06177925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775232|NCT06177678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153775233|NCT06177678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153775234|NCT06177522|Paclitaxel|paclitaxel|mesh-list
153775235|NCT06177522|Gemcitabine|gemcitabine|mesh-list
153775236|NCT06177522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153775237|NCT06177522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153775238|NCT06177522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775239|NCT06177522|Tubulin Modulators|tubulin modulators|mesh-ancestor
153775240|NCT06177522|Antimitotic Agents|antimitotic agents|mesh-ancestor
153775283|NCT06177119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153775307|NCT06177028|Lenalidomide|lenalidomide|mesh-list
153775308|NCT06177028|Immunologic Factors|immunologic factors|mesh-ancestor
153775309|NCT06177028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775310|NCT06177028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153775325|NCT06176911|Danazol|danazol|mesh-list
153775326|NCT06176911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153775327|NCT06176911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153775328|NCT06176911|Analgesics|analgesics|mesh-ancestor
153775329|NCT06176911|Sensory System Agents|sensory system agents|mesh-ancestor
153775330|NCT06176911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775331|NCT06176911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775332|NCT06176911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775333|NCT06176911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153775334|NCT06176911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153775335|NCT06176911|Immunologic Factors|immunologic factors|mesh-ancestor
153775336|NCT06176911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153775337|NCT06176911|Hormone Antagonists|hormone antagonists|mesh-ancestor
153775338|NCT06176911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775353|NCT06176729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153775354|NCT06176729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153775355|NCT06176729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153775356|NCT06176729|Growth Substances|growth substances|mesh-ancestor
153775357|NCT06176729|Growth Inhibitors|growth inhibitors|mesh-ancestor
153775358|NCT06176729|Immunoconjugates|immunoconjugates|mesh-ancestor
153775359|NCT06171802|Empagliflozin|empagliflozin|mesh-list
153775360|NCT06171802|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153775361|NCT06171802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775362|NCT06171802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153775363|NCT06171802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775364|NCT06171269|Androgens|androgens|mesh-list
153775365|NCT06171269|Hormones|hormones|mesh-ancestor
153689837|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
153775366|NCT06171269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775367|NCT06171269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775368|NCT06170697|Carboplatin|carboplatin|mesh-list
153775369|NCT06170697|Nedaplatin|nedaplatin|mesh-list
153775370|NCT06170697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775371|NCT06170463|Metformin|metformin|mesh-list
153775372|NCT06170463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153775422|NCT06140186|Betamethasone benzoate|betamethasone benzoate|mesh-list
153775423|NCT06140186|Timolol|timolol|mesh-list
153775424|NCT06140186|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153775425|NCT06140186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153775426|NCT06140186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153775427|NCT06140186|Adrenergic Agents|adrenergic agents|mesh-ancestor
153775428|NCT06140186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775429|NCT06140186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775430|NCT06140186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775431|NCT06140186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153775448|NCT06097273|Immunologic Factors|immunologic factors|mesh-ancestor
153775449|NCT06097273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775516|NCT06015750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153775518|NCT06015750|Vitamin B Complex|vitamin b complex|mesh-ancestor
153775519|NCT06015750|Vitamins|vitamins|mesh-ancestor
153775520|NCT06015750|Micronutrients|micronutrients|mesh-ancestor
153775521|NCT06015659|Gemcitabine|gemcitabine|mesh-list
153775522|NCT06015659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153775523|NCT06015659|Antimetabolites|antimetabolites|mesh-ancestor
153775524|NCT06015659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775525|NCT06015659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775526|NCT06007352|Gentamicins|gentamicins|mesh-list
153775527|NCT06007352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153775528|NCT06007352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775529|NCT06007352|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153775530|NCT06007352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775531|NCT06007352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775532|NCT06004479|Carotenoids|carotenoids|mesh-list
153775533|NCT06004479|Antioxidants|antioxidants|mesh-ancestor
153775534|NCT06004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775535|NCT06004479|Protective Agents|protective agents|mesh-ancestor
153775536|NCT06004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775537|NCT05950841|Locust bean gum|locust bean gum|mesh-list
153775538|NCT05950841|Antidiarrheals|antidiarrheals|mesh-ancestor
153775539|NCT05950841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775540|NCT05887609|Olaparib|olaparib|mesh-list
153775541|NCT05887609|Maytansine|maytansine|mesh-list
153775554|NCT05837845|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153775556|NCT05837845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775557|NCT05837845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153775558|NCT05837845|Serotonin Agents|serotonin agents|mesh-ancestor
153775559|NCT05837845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775560|NCT05837845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775561|NCT05837845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153775569|NCT05677282|Rifaximin|rifaximin|mesh-list
153775570|NCT05677282|Loperamide|loperamide|mesh-list
153775571|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
153775572|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153775573|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775574|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775575|NCT05654662|Listerine|listerine|mesh-list
153775576|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
153775577|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153775646|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
153775648|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
153775649|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
153775650|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153775651|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775652|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775653|NCT05313243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153775654|NCT05313243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775655|NCT05313243|Immunotoxins|immunotoxins|mesh-ancestor
153775656|NCT05313243|Immunoconjugates|immunoconjugates|mesh-ancestor
153775657|NCT05313243|Immunologic Factors|immunologic factors|mesh-ancestor
153775658|NCT05313243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775659|NCT05221645|Rituximab|rituximab|mesh-list
153775660|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
153775661|NCT05221645|Carboplatin|carboplatin|mesh-list
153775662|NCT05221645|Etoposide|etoposide|mesh-list
153775663|NCT05221645|Ifosfamide|ifosfamide|mesh-list
153775664|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775665|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775666|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
153775667|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775668|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153775685|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
153775686|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153775687|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775688|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
153775689|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
153775690|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
153775691|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775692|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775706|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775707|NCT05130463|Incretins|incretins|mesh-ancestor
153775708|NCT05130463|Hormones|hormones|mesh-ancestor
153775709|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775710|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153775711|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
153775712|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775714|NCT05129358|Diuretics|diuretics|mesh-ancestor
153775715|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
153775716|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775717|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153775718|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153775719|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775732|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
153775733|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153775734|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
153775735|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
153775736|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775737|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153775738|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
153775739|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612913|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
153775740|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775741|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153775742|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
153775756|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153775757|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153775758|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153775759|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775760|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
153775761|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775762|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775763|NCT05071014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153775764|NCT05071014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775765|NCT05023369|Dexamethasone|dexamethasone|mesh-list
153775766|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775767|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
153775768|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
153775769|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775770|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775771|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775772|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
153775774|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775775|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153775776|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775778|NCT05001776|Fondaparinux|fondaparinux|mesh-list
153775779|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153775823|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153775824|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
153775825|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775826|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775827|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
153775828|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153775829|NCT04910269|Antibodies|antibodies|mesh-list
153775830|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
153775831|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775832|NCT04681105|Acetaminophen|acetaminophen|mesh-list
153775833|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
153775834|NCT04681105|Promethazine|promethazine|mesh-list
153775835|NCT04681105|Dexamethasone|dexamethasone|mesh-list
153775836|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
153775837|NCT04681105|Ibuprofen|ibuprofen|mesh-list
153775838|NCT04681105|Ranitidine|ranitidine|mesh-list
153775839|NCT04681105|Antibodies|antibodies|mesh-list
153775840|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
153775841|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153775842|NCT04681105|BB 1101|bb 1101|mesh-list
153775843|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
153775844|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775845|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775846|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
153775847|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
153775848|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775849|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775850|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
153775851|NCT04681105|Hormones|hormones|mesh-ancestor
153775852|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775853|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153775888|NCT04609020|Lidocaine|lidocaine|mesh-list
153775889|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
153775890|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
153775891|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775892|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775893|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
153775894|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775895|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153775896|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153775897|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153775898|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153775899|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775901|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775902|NCT04517435|Prednisone|prednisone|mesh-list
153775903|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
153775904|NCT04517435|Rituximab|rituximab|mesh-list
153775905|NCT04517435|Doxorubicin|doxorubicin|mesh-list
153775906|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153775907|NCT04517435|Vincristine|vincristine|mesh-list
153775963|NCT04392011|Sensory System Agents|sensory system agents|mesh-ancestor
153775964|NCT04392011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153775965|NCT04329429|Trastuzumab|trastuzumab|mesh-list
153775966|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775967|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775968|NCT04324294|Pancrelipase|pancrelipase|mesh-list
153775969|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775980|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153775981|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775982|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
153775983|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775984|NCT04144933|Acetaminophen|acetaminophen|mesh-list
153775985|NCT04144933|Dexamethasone|dexamethasone|mesh-list
153775986|NCT04144933|Lidocaine|lidocaine|mesh-list
153775987|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
153775988|NCT04144933|Sufentanil|sufentanil|mesh-list
153776047|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153776048|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153776049|NCT04092673|Trastuzumab|trastuzumab|mesh-list
153776051|NCT04092673|Fulvestrant|fulvestrant|mesh-list
153776052|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776053|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776054|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153776055|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153776056|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153776057|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
153776058|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153776059|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776060|NCT04092673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153776061|NCT04092673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776062|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
153776063|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776115|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153776117|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776118|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776119|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153776120|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
153776121|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
153776122|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
153776123|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153776124|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153776125|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
153776126|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776187|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776188|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776189|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776190|NCT03609580|Urological Agents|urological agents|mesh-ancestor
153776191|NCT03583710|Cisplatin|cisplatin|mesh-list
153776192|NCT03583710|Etoposide|etoposide|mesh-list
153776193|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
153776194|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
153776195|NCT03583710|Mitotane|mitotane|mesh-list
153776196|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776197|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776198|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153776199|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153776200|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776202|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
153776252|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776253|NCT03412747|Adalimumab|adalimumab|mesh-list
153776254|NCT03412747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153776255|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153776256|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776257|NCT03342404|Luspatercept|luspatercept|mesh-list
153776339|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776340|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776341|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776342|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776417|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153776418|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776419|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153776420|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153776421|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153776422|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153776423|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776425|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776426|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153776427|NCT02626338|Cytarabine|cytarabine|mesh-list
153776428|NCT02626338|Fludarabine|fludarabine|mesh-list
153776429|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
153776430|NCT02626338|Etoposide|etoposide|mesh-list
153776442|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
153776443|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776444|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776445|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153776446|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153776447|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776448|NCT02626338|Analgesics|analgesics|mesh-ancestor
153776449|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
153776450|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776451|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153776452|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
153776475|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153776476|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153776477|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
153776478|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776479|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776480|NCT02452918|Oritavancin|oritavancin|mesh-list
153776481|NCT02452918|Warfarin|warfarin|mesh-list
153776482|NCT02452918|Anticoagulants|anticoagulants|mesh-ancestor
153776483|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153776484|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776485|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
153776486|NCT02379520|Nivolumab|nivolumab|mesh-list
153776487|NCT02379520|Fludarabine|fludarabine|mesh-list
153776488|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776489|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
153776490|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776491|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776492|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153776493|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
153776494|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776495|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776496|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153776518|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776519|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776520|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776521|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776522|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776523|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776524|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153776525|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
153776527|NCT02229084|Docetaxel|docetaxel|mesh-list
153776528|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
153776539|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
153776540|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776541|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776542|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153776543|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
153776544|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153776545|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153776546|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153776547|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153776630|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776631|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776632|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776633|NCT01294072|Curcumin|curcumin|mesh-list
153776634|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153776635|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776636|NCT01294072|Analgesics|analgesics|mesh-ancestor
153776637|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
153776638|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776639|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776640|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153776641|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776642|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776643|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776644|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776646|NCT01087554|Everolimus|everolimus|mesh-list
153776647|NCT01087554|MTOR Inhibitors|mtor inhibitors|mesh-list
153776648|NCT01087554|Temsirolimus|temsirolimus|mesh-list
153776649|NCT01087554|Vorinostat|vorinostat|mesh-list
153776650|NCT01087554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776651|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776652|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776653|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776654|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
153776655|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776656|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776657|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153776658|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776659|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153776660|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
153776674|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153776675|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776677|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
153776691|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
153776692|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153776693|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
153776694|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153776695|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
153776696|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776770|NCT00563446|Hematinics|hematinics|mesh-ancestor
153776772|NCT00563485|Terazosin|terazosin|mesh-list
153776773|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153776774|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153776775|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153776776|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153776777|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
153776778|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776779|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776780|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776850|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153776851|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776852|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
153776853|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776854|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776855|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153776856|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153776857|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776859|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776860|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776861|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776862|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776863|NCT00251394|Rituximab|rituximab|mesh-list
153776881|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153776882|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153776883|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153776885|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776886|NCT04612582|Thalidomide|thalidomide|mesh-list
153776887|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
153776888|NCT04612582|Bortezomib|bortezomib|mesh-list
153776889|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776934|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
153776935|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776936|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776937|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
153776938|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776939|NCT00412919|Azacitidine|azacitidine|mesh-list
153776940|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153776941|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
153776942|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776943|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776944|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614114|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
153776945|NCT00222170|Rabeprazole|rabeprazole|mesh-list
153776946|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153777006|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777007|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777008|NCT00563992|Valproic Acid|valproic acid|mesh-list
153777009|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777010|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777011|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777012|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
153777013|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153777014|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777015|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777016|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
153777017|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
153777018|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777019|NCT00251550|Pemetrexed|pemetrexed|mesh-list
153777020|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777021|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777025|NCT04611373|Levamisole|levamisole|mesh-list
153777080|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
153777081|NCT04610125|Fludarabine|fludarabine|mesh-list
153777082|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777083|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
153777084|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777085|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153777086|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153777087|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
153777088|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777089|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777090|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153777091|NCT00564148|Bevacizumab|bevacizumab|mesh-list
153777092|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153777093|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777094|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153777149|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153777150|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777151|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777152|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153777153|NCT04609033|Narcotics|narcotics|mesh-ancestor
153777154|NCT00248313|Sirolimus|sirolimus|mesh-list
153777155|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153777156|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777157|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153777158|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777159|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
153777160|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777161|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
153777216|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153777217|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153777218|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153777220|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
153777221|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777222|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153777223|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153777224|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777225|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
153777226|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777227|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153777245|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777246|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153777247|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
153777248|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777306|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153777307|NCT00251823|Eptifibatide|eptifibatide|mesh-list
153777308|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153777309|NCT04606225|Losartan|losartan|mesh-list
153777310|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153777311|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153777312|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153777313|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153777314|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777315|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153777316|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777317|NCT04606108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153777318|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777320|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153777321|NCT04719507|Narcotics|narcotics|mesh-ancestor
153777322|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777323|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777324|NCT04719507|Analgesics|analgesics|mesh-ancestor
153777325|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
153777371|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777373|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153777374|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153777375|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
153777376|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777377|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153777378|NCT00565123|Levofloxacin|levofloxacin|mesh-list
153777379|NCT00565123|Ofloxacin|ofloxacin|mesh-list
153777380|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153777381|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153777382|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153777383|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777384|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153777385|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153777386|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153777387|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777388|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777389|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777390|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153777391|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153777392|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
153777393|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153777394|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777396|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
153777397|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153777398|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153777399|NCT04603729|Prednisolone|prednisolone|mesh-list
153777400|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
153777401|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153777402|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
153777422|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359903|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153777423|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153777424|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777425|NCT05361824|Acetaminophen|acetaminophen|mesh-list
153777426|NCT05361824|Ketorolac|ketorolac|mesh-list
153777427|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153777428|NCT05361824|Analgesics|analgesics|mesh-ancestor
153777429|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
153777430|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777431|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777432|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
153777433|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153777434|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777435|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153777436|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153777437|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777439|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
153777484|NCT04602247|Urological Agents|urological agents|mesh-ancestor
153777485|NCT00252330|Amibegron|amibegron|mesh-list
153777486|NCT00252330|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153777487|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153777488|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153777489|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
153777490|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777491|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777492|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777493|NCT00252330|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153777494|NCT04602013|Paclitaxel|paclitaxel|mesh-list
153777495|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153777496|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153777497|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777498|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
153777499|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
153777500|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
153777501|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359904|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777502|NCT04601701|Dexamethasone|dexamethasone|mesh-list
153777503|NCT04601701|Bevacizumab|bevacizumab|mesh-list
153777504|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153777505|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777506|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153777534|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
153777548|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153777549|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153777550|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
153777551|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
153777552|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777553|NCT00565396|Losartan|losartan|mesh-list
153777554|NCT00565396|Fosinopril|fosinopril|mesh-list
153777555|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153777556|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153777620|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777621|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777623|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153777624|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777625|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777626|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
153777627|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777628|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777629|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153777630|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
153777631|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777632|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
153777633|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
153777634|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153777635|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153777636|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777637|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153777638|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153777639|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777640|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777641|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777642|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153777674|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153777675|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
153777676|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777677|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777679|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153777680|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
153777681|NCT00249171|Risperidone|risperidone|mesh-list
153777754|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153777755|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153777756|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153777757|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777758|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777759|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777760|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153614928|NCT01971632|Narcotics|narcotics|mesh-ancestor
153777761|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153359906|NCT02983682|Lidocaine|lidocaine|mesh-list
153777762|NCT00252798|Paclitaxel|paclitaxel|mesh-list
153777763|NCT00252798|Carboplatin|carboplatin|mesh-list
153777764|NCT00252798|Gefitinib|gefitinib|mesh-list
153777765|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153777766|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777767|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
153777768|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
153777769|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
153777770|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777771|NCT00252798|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153777772|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153777773|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777774|NCT02961660|Odalasvir|odalasvir|mesh-list
153777775|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
153777776|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777777|NCT00403013|Anesthetics|anesthetics|mesh-list
153777778|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777806|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777807|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
153777808|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153777809|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777810|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
153777811|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777812|NCT04595929|Antidotes|antidotes|mesh-ancestor
153777813|NCT04595929|Protective Agents|protective agents|mesh-ancestor
153777814|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
153777815|NCT04595929|Vitamins|vitamins|mesh-ancestor
153777816|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
153777817|NCT00252954|Levetiracetam|levetiracetam|mesh-list
153777818|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
153777819|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
153777820|NCT04595812|Misoprostol|misoprostol|mesh-list
153777821|NCT04595812|Hemostatics|hemostatics|mesh-list
153777822|NCT04595812|Oxytocin|oxytocin|mesh-list
153777823|NCT04595812|Carbetocin|carbetocin|mesh-list
153777824|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
153777825|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153777826|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777885|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777886|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777887|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153777888|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
153777889|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
153777890|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
153777891|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777892|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777893|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153777895|NCT00566683|Diazepam|diazepam|mesh-list
153777896|NCT00566683|Alfentanil|alfentanil|mesh-list
153777897|NCT00566683|Propofol|propofol|mesh-list
153777898|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153777899|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777900|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777901|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153777960|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153777961|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153777962|NCT04593706|BB 1101|bb 1101|mesh-list
153777963|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777964|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
153777965|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
153777982|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
153777983|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153777984|NCT04593238|Calcium|calcium|mesh-list
153777985|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153777986|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777987|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777988|NCT04593160|Acetaminophen|acetaminophen|mesh-list
153777990|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153777991|NCT04593160|Analgesics|analgesics|mesh-ancestor
153777992|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
153777993|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777994|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777995|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
153777996|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153777997|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777998|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153777999|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153778000|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778002|NCT00253149|Risperidone|risperidone|mesh-list
153778053|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778054|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153778055|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
153778056|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778057|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
153778058|NCT04591795|Diclofenac|diclofenac|mesh-list
153778059|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153615229|NCT01973816|Estradiol|estradiol|mesh-list
153778060|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153778061|NCT04591795|Analgesics|analgesics|mesh-ancestor
153778062|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
153778063|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778087|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
153778121|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778122|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778123|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153778124|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153778125|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778126|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778127|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778128|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153778129|NCT00253305|Terbinafine|terbinafine|mesh-list
153778141|NCT04590742|Protective Agents|protective agents|mesh-ancestor
153778193|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778194|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778206|NCT00567697|Growth Substances|growth substances|mesh-ancestor
153778207|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778208|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
153778209|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778210|NCT04589494|Morphine|morphine|mesh-list
153778211|NCT04589494|Tramadol|tramadol|mesh-list
153778212|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153778213|NCT04589494|Narcotics|narcotics|mesh-ancestor
153778214|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778215|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778216|NCT04589494|Analgesics|analgesics|mesh-ancestor
153778217|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
153778218|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778219|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
153778220|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153778221|NCT04589299|Antibodies|antibodies|mesh-list
153778279|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153778280|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781980|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778281|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778283|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153778284|NCT00253617|Trioxsalen|trioxsalen|mesh-list
153778285|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778286|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
153778287|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153778288|NCT04587505|Morphine|morphine|mesh-list
153778289|NCT04587505|Tramadol|tramadol|mesh-list
153778290|NCT04587505|Anesthetics|anesthetics|mesh-list
153778291|NCT04587505|Ropivacaine|ropivacaine|mesh-list
153778292|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778293|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778294|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153778295|NCT04587505|Narcotics|narcotics|mesh-ancestor
153778296|NCT04587505|Analgesics|analgesics|mesh-ancestor
153778297|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
153778298|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778299|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
153778300|NCT04587115|Oxycodone|oxycodone|mesh-list
153778301|NCT04587115|Risperidone|risperidone|mesh-list
153778302|NCT04587115|Ziprasidone|ziprasidone|mesh-list
153778344|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
153778345|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
153778346|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153778347|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153778348|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153778349|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153778350|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
153778351|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778352|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778419|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153778420|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778421|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778423|NCT00253929|Nitroprusside|nitroprusside|mesh-list
153778424|NCT00253929|Acetylcholine|acetylcholine|mesh-list
153778425|NCT00253929|Caffeine|caffeine|mesh-list
153778426|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153778427|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778428|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153778429|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778430|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615608|NCT01976208|Omalizumab|omalizumab|mesh-list
153778431|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153778432|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153778433|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
153778434|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778436|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
153778437|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778438|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153778439|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
153778440|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153778441|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
153778442|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153778443|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153778444|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153778445|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
153778477|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778478|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778479|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778480|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
153778481|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
153778482|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778483|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778484|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153778485|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153778486|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
153778487|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153778488|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153502048|NCT01271166|Fluorouracil|fluorouracil|mesh-list
153778489|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153778547|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778548|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153778549|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
153778550|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778551|NCT00223613|Insulin|insulin|mesh-list
153778552|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153778553|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778554|NCT04583137|Lidocaine|lidocaine|mesh-list
153778555|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
153778556|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
153778557|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778558|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778559|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
153778560|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778561|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153778562|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153778563|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153778564|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778565|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778566|NCT00223691|Acarbose|acarbose|mesh-list
153778567|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
153778568|NCT00223691|Promethazine|promethazine|mesh-list
153778593|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153778594|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153778595|NCT00223691|Analgesics|analgesics|mesh-ancestor
153778596|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
153778597|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778598|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778599|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778600|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153778601|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153778602|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778603|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778604|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153778605|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153778606|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153778607|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153778608|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153778609|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
153778610|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778611|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153778612|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153778613|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778614|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
153778615|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
153778616|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153778617|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153778618|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153778619|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153778620|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778621|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153778622|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153778623|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153778624|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778625|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
153778626|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
153778627|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
153778628|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
153778636|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
153778665|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
153778666|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153778667|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153778668|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153778669|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153778670|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153778671|NCT00223691|Urological Agents|urological agents|mesh-ancestor
153778672|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
153778673|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778674|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153778675|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153778676|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778677|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
153778678|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153778679|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
153778680|NCT04583020|Temozolomide|temozolomide|mesh-list
153778681|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153778682|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
153778683|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778684|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778730|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153778731|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
153778732|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778733|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153778734|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153778735|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
153778736|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778737|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778738|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153778739|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153778740|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153778741|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153778742|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778743|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
153778744|NCT00223964|Hematinics|hematinics|mesh-ancestor
153778745|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
153778746|NCT00224081|Hematinics|hematinics|mesh-ancestor
153778747|NCT04581265|Paclitaxel|paclitaxel|mesh-list
153778748|NCT04581265|Ifosfamide|ifosfamide|mesh-list
153778749|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153778750|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153778751|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778752|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
153778753|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
153778754|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
153778755|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778756|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153778757|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
153778758|NCT04580797|PF-06700841|pf-06700841|mesh-list
153778759|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153778760|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778761|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778762|NCT00568477|Rituximab|rituximab|mesh-list
153778763|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153778774|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153778778|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153778779|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778780|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778781|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153778782|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153778783|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153778784|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153778785|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153778786|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153778851|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778852|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153778853|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
153778854|NCT00569101|Tacrolimus|tacrolimus|mesh-list
153778855|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153778856|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
153778857|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778858|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153778859|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778860|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778861|NCT00224354|Interleukin-2|interleukin-2|mesh-list
153778932|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153778933|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778934|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
153778935|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778936|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778937|NCT00224510|Lamotrigine|lamotrigine|mesh-list
153778938|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
153778939|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153778940|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778941|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779011|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153779044|NCT00571129|Mitomycins|mitomycins|mesh-list
153779045|NCT00571129|Mitomycin|mitomycin|mesh-list
153779046|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153779047|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779048|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
153779049|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779050|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153779051|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779052|NCT00571246|Topiramate|topiramate|mesh-list
153779053|NCT00571246|Lamotrigine|lamotrigine|mesh-list
153779054|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
153779055|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153779056|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779057|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153779083|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153779084|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
153779085|NCT00571636|Fentanyl|fentanyl|mesh-list
153779086|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153779087|NCT00571636|Narcotics|narcotics|mesh-ancestor
153779088|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779089|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779090|NCT00571636|Analgesics|analgesics|mesh-ancestor
153779091|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
153779092|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779093|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153779094|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153779095|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
153779123|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779124|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
153779125|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153779126|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
153779127|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779128|NCT00224822|Aripiprazole|aripiprazole|mesh-list
153779129|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
153779130|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779194|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779195|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153779196|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779197|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153779198|NCT00234936|Adalimumab|adalimumab|mesh-list
153779199|NCT00234936|Methotrexate|methotrexate|mesh-list
153779200|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153779201|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
153779202|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153779203|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779204|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153779205|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
153779206|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779207|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779208|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
153779209|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779210|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153779211|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153779212|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
153779213|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153779214|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153779215|NCT00234936|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153779216|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779217|NCT00413075|Belinostat|belinostat|mesh-list
153779218|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779219|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153779220|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779221|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779222|NCT00572650|Vildagliptin|vildagliptin|mesh-list
153779223|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153779253|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779254|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779255|NCT00573001|Ritonavir|ritonavir|mesh-list
153616429|NCT06326983|Narcotics|narcotics|mesh-ancestor
153779256|NCT00573001|Lopinavir|lopinavir|mesh-list
153779257|NCT00573001|Tenofovir|tenofovir|mesh-list
153779258|NCT00573001|Emtricitabine|emtricitabine|mesh-list
153779259|NCT00573001|Zidovudine|zidovudine|mesh-list
153779260|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153779261|NCT00573001|Nevirapine|nevirapine|mesh-list
153779262|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153779263|NCT00573001|Efavirenz|efavirenz|mesh-list
153779264|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153779265|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153779266|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
153779267|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779268|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779269|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153779270|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153779271|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
153779317|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153779318|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153779319|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
153779320|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153779321|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153779322|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153779323|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779324|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779325|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
153779326|NCT00225173|Hormones|hormones|mesh-ancestor
153779327|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779328|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153779329|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153779330|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
153779331|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
153779332|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
153779334|NCT00234975|Lopinavir|lopinavir|mesh-list
153779335|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153779336|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153779337|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
153779338|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779339|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779340|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153779341|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153779342|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
153779395|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153779396|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153779397|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779398|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779399|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
153779400|NCT00573742|Candesartan|candesartan|mesh-list
153779401|NCT00573742|Candesartan cilexetil|candesartan cilexetil|mesh-list
153779418|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153779419|NCT00574015|Acetaminophen|acetaminophen|mesh-list
153779420|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153779421|NCT00574015|Hydrocodone|hydrocodone|mesh-list
153779422|NCT00574015|Bupivacaine|bupivacaine|mesh-list
153779423|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
153779424|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
153779425|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779426|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779427|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
153779428|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779429|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153779430|NCT00574015|Analgesics|analgesics|mesh-ancestor
153779431|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
153779432|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153779433|NCT00574015|Narcotics|narcotics|mesh-ancestor
153779434|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
153779435|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
153779436|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153779437|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779438|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153779439|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153779440|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153779441|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153779445|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779446|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153779448|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779449|NCT00574093|Ranibizumab|ranibizumab|mesh-list
153779450|NCT00574093|Verteporfin|verteporfin|mesh-list
153779451|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153779452|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153779453|NCT00574093|Growth Substances|growth substances|mesh-ancestor
153779454|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779455|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
153779456|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779457|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153779458|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
153779472|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153779473|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779474|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779475|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779476|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779477|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153779478|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
153779479|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779480|NCT00574483|Quinacrine|quinacrine|mesh-list
153779481|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
153779482|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153779483|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
153779484|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153779485|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779486|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
153779487|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153779488|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
153779489|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779490|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779491|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779492|NCT00235092|Sirolimus|sirolimus|mesh-list
153779497|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
153779498|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
153779499|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779500|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153779501|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779502|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153779503|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
153779504|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153779505|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
153779506|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779507|NCT00574600|Vaccines|vaccines|mesh-list
153779508|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
153779509|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779510|NCT00574639|Alprazolam|alprazolam|mesh-list
153779511|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153779512|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779513|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779514|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153779515|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779516|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779517|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
153779518|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
153779519|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779535|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153779557|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
153779558|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779559|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
153779560|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153779561|NCT00591487|Lidocaine|lidocaine|mesh-list
153779562|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
153779563|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
153779564|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779565|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779566|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
153779567|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779568|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153779569|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153779570|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153779571|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779572|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779625|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779626|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
153779627|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
153779628|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779629|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
153779630|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153779631|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
153779632|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779698|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779699|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153779701|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153779703|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153779704|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153779705|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
153779706|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
153779707|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779708|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779709|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153779715|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153779716|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153779717|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779718|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779719|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779720|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779721|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153779722|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153779724|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779725|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779726|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153779727|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153779728|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
153779729|NCT04572724|Valsartan|valsartan|mesh-list
153502227|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153779730|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153779731|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153779732|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153779746|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153779747|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779749|NCT00255606|Docetaxel|docetaxel|mesh-list
153779750|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779751|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
153779752|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
153779753|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
153779754|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779755|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779756|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
153779757|NCT00255606|Hormones|hormones|mesh-ancestor
153779758|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779759|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779760|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153779761|NCT00226343|Valproic Acid|valproic acid|mesh-list
153779762|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
153779763|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779764|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779765|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
153779766|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779767|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779768|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
153779769|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779770|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779771|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779772|NCT03450499|Ketamine|ketamine|mesh-list
153779773|NCT03450499|Analgesics|analgesics|mesh-ancestor
153779774|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
153779775|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359918|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
153779776|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779799|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779800|NCT03450226|Bupivacaine|bupivacaine|mesh-list
153779801|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
153779802|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
153779803|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779804|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779805|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
153779806|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779807|NCT04572373|SMOFlipid|smoflipid|mesh-list
153779808|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153779809|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153779810|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153779811|NCT03450109|Goserelin|goserelin|mesh-list
153779812|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153779813|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779814|NCT00413387|Budesonide|budesonide|mesh-list
153779815|NCT00413387|Beclomethasone|beclomethasone|mesh-list
153779816|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
153779868|NCT00255879|Risperidone|risperidone|mesh-list
153779869|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153779870|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153779871|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
153779872|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779873|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779874|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779875|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153779876|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153779877|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779878|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779879|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153779880|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
153779881|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
153779882|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
153779883|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779884|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153779885|NCT00255879|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153779947|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
153779948|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779949|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779950|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779951|NCT00226694|Citalopram|citalopram|mesh-list
153779964|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779965|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153779966|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779967|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779968|NCT00226889|Bosentan|bosentan|mesh-list
153779969|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153779970|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153779971|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780028|NCT00227474|Vaccines|vaccines|mesh-list
153780029|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
153780030|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780031|NCT00227513|Bortezomib|bortezomib|mesh-list
153780032|NCT00227513|Vorinostat|vorinostat|mesh-list
153780033|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780034|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153780035|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780036|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780037|NCT00227630|Pemetrexed|pemetrexed|mesh-list
153780038|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780039|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780040|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780041|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153780042|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153780043|NCT00256230|Disulfiram|disulfiram|mesh-list
153780044|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153780045|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153780046|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780047|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780048|NCT00227669|Gemcitabine|gemcitabine|mesh-list
153780049|NCT00227669|Docetaxel|docetaxel|mesh-list
153780050|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780051|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
153780052|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780053|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780086|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780087|NCT00235911|Budesonide|budesonide|mesh-list
153780088|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
153780089|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780090|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153780091|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
153780092|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780093|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780094|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153780095|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
153780096|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
153780097|NCT00235911|Hormones|hormones|mesh-ancestor
153780105|NCT00256347|Morphine|morphine|mesh-list
153780199|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780200|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153780201|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
153780202|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
153780203|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780204|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
153780205|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780206|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153780207|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153780208|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153780209|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
153780210|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780211|NCT00236067|Tiagabine|tiagabine|mesh-list
153780212|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
153780213|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153780214|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153780215|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153780216|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780217|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
153780218|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780219|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780220|NCT00195715|Adalimumab|adalimumab|mesh-list
153780221|NCT00195715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153780222|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780223|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780224|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
153780225|NCT00236106|Tacrolimus|tacrolimus|mesh-list
153780226|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153780227|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
153780228|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780250|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780251|NCT00195676|Adalimumab|adalimumab|mesh-list
153780252|NCT00195676|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153780253|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780254|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780255|NCT00194077|Aripiprazole|aripiprazole|mesh-list
153780256|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
153780257|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153780258|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153780259|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153780326|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
153780327|NCT00228605|Fentanyl|fentanyl|mesh-list
153780328|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153780329|NCT00228605|Narcotics|narcotics|mesh-ancestor
153780330|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780331|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780332|NCT00228605|Analgesics|analgesics|mesh-ancestor
153780333|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
153780334|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780335|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153780336|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153780337|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
153780338|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
153780339|NCT00191815|Gemcitabine|gemcitabine|mesh-list
153780340|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780341|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780342|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
153780343|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780344|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153780345|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153780346|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153780347|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153780348|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780349|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
153780350|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780351|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780352|NCT00191308|Pemetrexed|pemetrexed|mesh-list
153780425|NCT00236223|Ketamine|ketamine|mesh-list
153780426|NCT00236223|Gabapentin|gabapentin|mesh-list
153780427|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780428|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
153780429|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
153780430|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780431|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780432|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780433|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
153780503|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153780504|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
153780505|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153780506|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153780507|NCT00229697|Tamoxifen|tamoxifen|mesh-list
153780508|NCT00229697|Gefitinib|gefitinib|mesh-list
153780509|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153780510|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
153780511|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780512|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780513|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153780522|NCT00236379|Olanzapine|olanzapine|mesh-list
153780523|NCT00236379|Risperidone|risperidone|mesh-list
153780524|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153780525|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
153780526|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780527|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780528|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780529|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153780530|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153780531|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780532|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153780533|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153780534|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
153780535|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
153780536|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
153780537|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780538|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780539|NCT00236379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153780540|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153780541|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153780542|NCT00229775|Chloroquine|chloroquine|mesh-list
153780543|NCT00229775|Artemether|artemether|mesh-list
153780544|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
153780545|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
153780551|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
153780552|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780553|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153780554|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780555|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780556|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153780557|NCT00257127|Vaccines|vaccines|mesh-list
153780558|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153780559|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
153780560|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780561|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153780562|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153780563|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153780564|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153780565|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780566|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
153780569|NCT00236418|Topiramate|topiramate|mesh-list
153780625|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
153780626|NCT00193219|Antidotes|antidotes|mesh-ancestor
153780627|NCT00193219|Protective Agents|protective agents|mesh-ancestor
153780628|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
153780629|NCT00193219|Vitamins|vitamins|mesh-ancestor
153780630|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
153780631|NCT00199316|Morphine|morphine|mesh-list
153780632|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153780633|NCT00199316|Narcotics|narcotics|mesh-ancestor
153780634|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780635|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780636|NCT00199316|Analgesics|analgesics|mesh-ancestor
153780637|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
153780638|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780658|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153780659|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153780660|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153780661|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
153780662|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780663|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780664|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780665|NCT00179959|Mupirocin|mupirocin|mesh-list
153780666|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153780668|NCT00179959|Petrolatum|petrolatum|mesh-list
153780670|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780671|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153780672|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780673|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780674|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
153780675|NCT00179959|Emollients|emollients|mesh-ancestor
153780676|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
153780677|NCT00199394|Istradefylline|istradefylline|mesh-list
153780678|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153780679|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153780680|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153780681|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
153780683|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502430|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153780684|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780685|NCT00236574|Galantamine|galantamine|mesh-list
153780686|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153780687|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780688|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780689|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
153780825|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153780826|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153780827|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780828|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780829|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
153780830|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780831|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153780832|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153780833|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153780834|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153780835|NCT00257634|Dexamethasone|dexamethasone|mesh-list
153780836|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780837|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
153780838|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
153780839|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780840|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780875|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780876|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780877|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
153780878|NCT00179647|Hormones|hormones|mesh-ancestor
153780879|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780880|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153780881|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780903|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
153780904|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780905|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
153780906|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780907|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
153780926|NCT00177307|Capecitabine|capecitabine|mesh-list
153780927|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
153780928|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153780929|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780930|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153780931|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153780932|NCT00177307|Growth Substances|growth substances|mesh-ancestor
153780933|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780934|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
153780935|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780936|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
153780937|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780938|NCT00257829|Methazolamide|methazolamide|mesh-list
153780939|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153780989|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780991|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153781060|NCT00174265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153781061|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153781062|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781063|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781064|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781094|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153781095|NCT00265278|Modafinil|modafinil|mesh-list
153781096|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153781097|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781098|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153781099|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153781100|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153781101|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781102|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
153781105|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
153781236|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781237|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781238|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153781239|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
153781240|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
153781241|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
153781242|NCT00410345|Mifepristone|mifepristone|mesh-list
153781269|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781270|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153781271|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153781272|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781438|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153781439|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
153781440|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781441|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781442|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153781443|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
153781444|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781445|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781446|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153781447|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153781448|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
153781449|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
153781450|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781451|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153781452|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153781453|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153781454|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781455|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153781456|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
153781559|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781560|NCT00266214|Lidocaine|lidocaine|mesh-list
153781561|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
153781562|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
153566835|NCT06233084|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153566862|NCT06233058|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153566863|NCT06233058|Hormone Antagonists|hormone antagonists|mesh-ancestor
153566864|NCT06233058|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153566865|NCT06233058|Diuretics|diuretics|mesh-ancestor
153566866|NCT06233058|Natriuretic Agents|natriuretic agents|mesh-ancestor
153566872|NCT06233032|Ephedrine|ephedrine|mesh-list
153567433|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153567434|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
153567435|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153567436|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153567437|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153567438|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153567439|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567441|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567442|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153567443|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153567444|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567632|NCT05195775|Urological Agents|urological agents|mesh-ancestor
153567634|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153567635|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153567636|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153567637|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153567638|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567639|NCT05184816|Deferoxamine|deferoxamine|mesh-list
153567640|NCT05184816|Siderophores|siderophores|mesh-ancestor
153567641|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153567642|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
153567643|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
153567675|NCT05107856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153567676|NCT05107856|Antimetabolites|antimetabolites|mesh-ancestor
153567677|NCT05107856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567678|NCT05107856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567679|NCT05107856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567680|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153567681|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
153567682|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567683|NCT05067634|Cenobamate|cenobamate|mesh-list
153567708|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567709|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153567710|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153567711|NCT05024214|Growth Substances|growth substances|mesh-ancestor
153567712|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567713|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
153567717|NCT05022654|Irinotecan|irinotecan|mesh-list
153567732|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567774|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
153567802|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
153567803|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153567804|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153567805|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153567806|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
153567807|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153567808|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567809|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153567810|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153567811|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153567812|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153567813|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567938|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153567939|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
153567940|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
153567946|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
153567947|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567948|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567949|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567950|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567951|NCT04628663|Analgesics|analgesics|mesh-ancestor
153567952|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
153567953|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567954|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153567955|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153567956|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153567957|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
153568017|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153568018|NCT04481451|Ropivacaine|ropivacaine|mesh-list
153568019|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
153568020|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
153568021|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568022|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568023|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
153568024|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568025|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153568026|NCT04466475|Melphalan|melphalan|mesh-list
153568027|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
153568028|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153568029|NCT04466475|Daratumumab|daratumumab|mesh-list
153568078|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153568079|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568080|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568081|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568082|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568083|NCT04322357|Prednisone|prednisone|mesh-list
153568084|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
153568111|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568112|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
153502481|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153568113|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153568114|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
153568115|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153568116|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153568117|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153568118|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153568119|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
153568120|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153568121|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153568122|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
153568123|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568124|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
153568125|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153568126|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153568178|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153568179|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153568213|NCT03977467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568214|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568215|NCT03952091|Dexamethasone|dexamethasone|mesh-list
153568216|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
153568217|NCT03952091|Lenalidomide|lenalidomide|mesh-list
153568218|NCT03952091|BB 1101|bb 1101|mesh-list
153568251|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568252|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
153568253|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153568254|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568255|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153568256|NCT03919292|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153568257|NCT03919292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153568421|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568422|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568423|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153568424|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153568425|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153568426|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153568427|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568428|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
153568429|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153568445|NCT03152409|Analgesics|analgesics|mesh-ancestor
153568446|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
153568447|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568448|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568449|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568450|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568451|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153568452|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153568453|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568454|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153568455|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153568456|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568457|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
153568458|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568481|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568482|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568483|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
153568484|NCT03016377|Fludarabine|fludarabine|mesh-list
153568485|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568487|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568488|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568489|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153568490|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
153568503|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568504|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
153568505|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568506|NCT02966548|Nivolumab|nivolumab|mesh-list
153568507|NCT02966548|Relatlimab|relatlimab|mesh-list
153568508|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568509|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568510|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568511|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568512|NCT02866136|Carboplatin|carboplatin|mesh-list
153568513|NCT02866136|Etoposide|etoposide|mesh-list
153568514|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
153568515|NCT02866136|Melphalan|melphalan|mesh-list
153568516|NCT02866136|Vincristine|vincristine|mesh-list
153568517|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568518|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153568545|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
153568546|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568547|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153568548|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
153568549|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153568550|NCT02840409|Bevacizumab|bevacizumab|mesh-list
153568551|NCT02840409|Vinblastine|vinblastine|mesh-list
153568581|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
153568582|NCT02690064|Ubiquinone|ubiquinone|mesh-list
153568583|NCT02690064|Resveratrol|resveratrol|mesh-list
153568584|NCT02690064|Antioxidants|antioxidants|mesh-list
153568585|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
153568586|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568587|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568588|NCT02690064|Protective Agents|protective agents|mesh-ancestor
153568589|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568590|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153568591|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
153568592|NCT02671435|Bevacizumab|bevacizumab|mesh-list
153568593|NCT02671435|Cetuximab|cetuximab|mesh-list
153568594|NCT02671435|Durvalumab|durvalumab|mesh-list
153568595|NCT02671435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568596|NCT02671435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568619|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153568620|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153568621|NCT02543255|Prednisone|prednisone|mesh-list
153568622|NCT02543255|Leuprolide|leuprolide|mesh-list
153568623|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
153568639|NCT02340676|Interleukin-2|interleukin-2|mesh-list
153568640|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568641|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153568642|NCT02340676|Analgesics|analgesics|mesh-ancestor
153568643|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
153568644|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568645|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568646|NCT02116335|Bosentan|bosentan|mesh-list
153568647|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153568648|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153568649|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568665|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568666|NCT01932125|Bevacizumab|bevacizumab|mesh-list
153568667|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568668|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568669|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568733|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153568734|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153568735|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568736|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568737|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
153568738|NCT01661400|Thalidomide|thalidomide|mesh-list
153568739|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
153568740|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568741|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
153568742|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568743|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568744|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153568745|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
153568746|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568747|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568748|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153568749|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
153568750|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153568751|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568752|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568753|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568754|NCT01661400|Growth Substances|growth substances|mesh-ancestor
153568755|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
153568756|NCT01366092|Interleukin-2|interleukin-2|mesh-list
153568935|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153568936|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568937|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568939|NCT05098210|Nivolumab|nivolumab|mesh-list
153568940|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153568941|NCT05098210|Poly ICLC|poly iclc|mesh-list
153568942|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568943|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568944|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568945|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568946|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
153568947|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
153568948|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568949|NCT05098210|Laxatives|laxatives|mesh-ancestor
153568950|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153568951|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
153568952|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568953|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
153568954|NCT05096390|Axitinib|axitinib|mesh-list
153568955|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568956|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568957|NCT05096390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568974|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569002|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
153569003|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
153569004|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
153569005|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
153569006|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569007|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569008|NCT04923542|Hormones|hormones|mesh-list
153545895|NCT06297499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569009|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569010|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569012|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569013|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569014|NCT04897022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569015|NCT04897022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569016|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
153569017|NCT04895761|Letrozole|letrozole|mesh-list
153569018|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569053|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
153569054|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569055|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569056|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153569057|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153569094|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569095|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153569097|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
153569098|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153569099|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
153569128|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569129|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
153569130|NCT04632238|Metronidazole|metronidazole|mesh-list
153569131|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569132|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153569133|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153502503|NCT05740332|Hand Sanitizers|hand sanitizers|mesh-list
153569134|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153569137|NCT04562129|Ipilimumab|ipilimumab|mesh-list
153569138|NCT04562129|Interleukin-2|interleukin-2|mesh-list
153569139|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569140|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569141|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569142|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569143|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153569144|NCT04562129|Analgesics|analgesics|mesh-ancestor
153569145|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
153569146|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569210|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
153569211|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569212|NCT04474847|Abatacept|abatacept|mesh-list
153569213|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569214|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569215|NCT04474847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569216|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569217|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569218|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
153569219|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569346|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153569347|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
153569348|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569349|NCT03511118|Metformin|metformin|mesh-list
153569350|NCT03511118|Topiramate|topiramate|mesh-list
153569351|NCT03511118|Amoxicillin|amoxicillin|mesh-list
153569352|NCT03511118|Azithromycin|azithromycin|mesh-list
153569353|NCT03511118|Doxycycline|doxycycline|mesh-list
153569354|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
153569355|NCT03511118|Levofloxacin|levofloxacin|mesh-list
153569356|NCT03511118|Clindamycin|clindamycin|mesh-list
153569357|NCT03511118|Valganciclovir|valganciclovir|mesh-list
153569358|NCT03511118|Remdesivir|remdesivir|mesh-list
153569359|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
153569360|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153569361|NCT03511118|Verapamil|verapamil|mesh-list
153569362|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153569363|NCT03511118|Labetalol|labetalol|mesh-list
153569364|NCT03511118|Nifedipine|nifedipine|mesh-list
153569365|NCT03511118|Furosemide|furosemide|mesh-list
153569366|NCT03511118|Sumatriptan|sumatriptan|mesh-list
153569367|NCT03511118|Oxycodone|oxycodone|mesh-list
153569368|NCT03511118|Buprenorphine|buprenorphine|mesh-list
153569401|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153569403|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569404|NCT03511118|Analgesics|analgesics|mesh-ancestor
153569405|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
153569406|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569407|NCT03511118|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153569408|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
153569415|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
153569494|NCT03377023|Nivolumab|nivolumab|mesh-list
153569495|NCT03377023|Ipilimumab|ipilimumab|mesh-list
153569496|NCT03377023|Nintedanib|nintedanib|mesh-list
153569497|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569498|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502515|NCT03467256|Cytarabine|cytarabine|mesh-list
153569499|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569500|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569501|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569590|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569591|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153569592|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153569593|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
153569594|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569595|NCT02931253|Metformin|metformin|mesh-list
153569596|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153569597|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569598|NCT02812524|Ipilimumab|ipilimumab|mesh-list
153569599|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569600|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569601|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569602|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569603|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153569604|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569605|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569606|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569608|NCT02734004|Durvalumab|durvalumab|mesh-list
153569649|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153569650|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
153569651|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
153569652|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
153569653|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
153569654|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153569655|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153569656|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153569657|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569658|NCT02567799|Paclitaxel|paclitaxel|mesh-list
153569659|NCT02567799|Carboplatin|carboplatin|mesh-list
153569660|NCT02567799|Genistein|genistein|mesh-list
153569661|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153569662|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569663|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
153569664|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
153569665|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
153569666|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569667|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153569668|NCT02567799|Protective Agents|protective agents|mesh-ancestor
153569669|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569728|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569729|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153569730|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153569731|NCT01684813|Clopidogrel|clopidogrel|mesh-list
153569732|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153569733|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153569741|NCT01684982|Sirolimus|sirolimus|mesh-list
153569818|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153569819|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153569820|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153569821|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153569822|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
153569823|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
153569824|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
153569825|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
153569826|NCT01688362|Dexamethasone|dexamethasone|mesh-list
153569827|NCT01688362|Bupivacaine|bupivacaine|mesh-list
153569828|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569830|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
153569831|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569832|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569852|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569854|NCT01690039|Furosemide|furosemide|mesh-list
153569855|NCT01690039|Diuretics|diuretics|mesh-ancestor
153569856|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
153569857|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569858|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153569862|NCT01690065|Nilotinib|nilotinib|mesh-list
153569913|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569915|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569916|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569917|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569918|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
153569919|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569920|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570105|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153570140|NCT01691053|Diuretics|diuretics|mesh-ancestor
153570141|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
153570142|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
153570143|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
153570144|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570145|NCT01691365|Vitamins|vitamins|mesh-list
153570209|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
153570210|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153570212|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153570213|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153570215|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153570216|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
153570329|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153570330|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
153570331|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
153570332|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153570333|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
153570334|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570335|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570336|NCT01693081|Apomorphine|apomorphine|mesh-list
153570337|NCT01693081|Emetics|emetics|mesh-ancestor
153570338|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570339|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
153570340|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570341|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153570342|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
153570421|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570423|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153570424|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570425|NCT01693640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153570426|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570427|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570428|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
153570429|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570430|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570431|NCT01693679|Lamivudine|lamivudine|mesh-list
153570432|NCT01693679|Adefovir|adefovir|mesh-list
153570433|NCT01693679|Telbivudine|telbivudine|mesh-list
153570434|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153570435|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153570436|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570437|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570438|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
153570448|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153570449|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153570451|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570452|NCT01694017|Tenofovir|tenofovir|mesh-list
153570453|NCT01694017|Zidovudine|zidovudine|mesh-list
153570454|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
153570468|NCT05288738|Analgesics|analgesics|mesh-ancestor
153570480|NCT05288725|Hormones|hormones|mesh-ancestor
153570481|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570482|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570483|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570484|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
153570485|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
153570486|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153570487|NCT05288465|Protective Agents|protective agents|mesh-ancestor
153570488|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570489|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
153570490|NCT05288192|Triamcinolone|triamcinolone|mesh-list
153570491|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153570492|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153570493|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153570494|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570495|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
153570496|NCT05288192|Hormones|hormones|mesh-ancestor
153570497|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570498|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570499|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570500|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
153570501|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570523|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570525|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153570544|NCT05291104|Vitamins|vitamins|mesh-ancestor
153570545|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
153570546|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570547|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
153570548|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153570549|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
153570550|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570673|NCT05294926|Rocuronium|rocuronium|mesh-list
153571052|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153571053|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153571054|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153571055|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571056|NCT05110898|Diuretics|diuretics|mesh-ancestor
153571087|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153571088|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153571089|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153571090|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
153571091|NCT05013567|Ibuprofen|ibuprofen|mesh-list
153571092|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153571093|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153571094|NCT05013567|Analgesics|analgesics|mesh-ancestor
153571095|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
153571096|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571097|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571098|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571099|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571100|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153571470|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
153571471|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571472|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571473|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
153571474|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571475|NCT04012177|Niacinamide|niacinamide|mesh-list
153571476|NCT04012177|Niacin|niacin|mesh-list
153571477|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
153571478|NCT04012177|Azithromycin|azithromycin|mesh-list
153571479|NCT04012177|Choline|choline|mesh-list
153571480|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571481|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571482|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
153571483|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153571484|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
153571485|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571486|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571490|NCT04012177|Vitamins|vitamins|mesh-ancestor
153571710|NCT05794750|Oxaliplatin|oxaliplatin|mesh-list
153571711|NCT05794750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153571712|NCT05794750|Antimetabolites|antimetabolites|mesh-ancestor
154157452|NCT05782712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571713|NCT05794750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571714|NCT05794750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571715|NCT05792293|Atorvastatin|atorvastatin|mesh-list
153571716|NCT05792293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153571844|NCT05161468|Lidocaine|lidocaine|mesh-list
153572113|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
153572114|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153572115|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572116|NCT03227705|Progesterone|progesterone|mesh-list
153572117|NCT03227705|Progestins|progestins|mesh-ancestor
153572144|NCT03082534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572145|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
153572146|NCT03056339|Fludarabine|fludarabine|mesh-list
153572147|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
153572148|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572149|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
153572150|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572151|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153572152|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153572153|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
153572154|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572155|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572156|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153572157|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572158|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
153572159|NCT02351869|Midazolam|midazolam|mesh-list
153572160|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
153572161|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153572162|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153572163|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572267|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572269|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153572270|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
153572271|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572272|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572273|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153572274|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572275|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572277|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153572407|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572408|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572409|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
153572410|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572411|NCT03660839|Artefenomel|artefenomel|mesh-list
153572412|NCT03660839|Ferroquine|ferroquine|mesh-list
153572413|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
153572414|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153572415|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153572416|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572417|NCT03660241|Abrocitinib|abrocitinib|mesh-list
153572418|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153572419|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572539|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153572540|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572541|NCT03383380|Sirolimus|sirolimus|mesh-list
153572542|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153572543|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572544|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153572545|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572546|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
153572547|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572548|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
153572582|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572583|NCT03223974|Paclitaxel|paclitaxel|mesh-list
153572684|NCT04895046|Niraparib|niraparib|mesh-list
153572780|NCT02333292|Velpatasvir|velpatasvir|mesh-list
153572781|NCT02333292|Simeprevir|simeprevir|mesh-list
153572782|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153572783|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153572784|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
153572785|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572786|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572787|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153572788|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153572789|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
153572790|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572791|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153572792|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153572793|NCT02203773|Posaconazole|posaconazole|mesh-list
153572794|NCT02203773|Azacitidine|azacitidine|mesh-list
153572829|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153572830|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153572831|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572832|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573295|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573296|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153573297|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153573298|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153573299|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153573485|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
153573486|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
153573487|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573488|NCT01098032|Expectorants|expectorants|mesh-ancestor
153573489|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
153573490|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153573491|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
153573492|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573493|NCT01098032|Protective Agents|protective agents|mesh-ancestor
153573494|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573495|NCT00945009|Dactinomycin|dactinomycin|mesh-list
153573496|NCT00945009|Cactinomycin|cactinomycin|mesh-list
153573497|NCT00945009|Doxorubicin|doxorubicin|mesh-list
153573498|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153573499|NCT00945009|Vincristine|vincristine|mesh-list
153573500|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153573501|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573537|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573538|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153574443|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574445|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153574446|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153574447|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574448|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574449|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153574450|NCT01700270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153574451|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153574452|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153574453|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574963|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574964|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
153574965|NCT01703325|Hormones|hormones|mesh-ancestor
153574966|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574967|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574968|NCT01703351|Fentanyl|fentanyl|mesh-list
153574969|NCT01703351|Ropivacaine|ropivacaine|mesh-list
153574970|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
153574971|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
153574972|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574973|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574974|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
153574975|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574976|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153574977|NCT01703351|Narcotics|narcotics|mesh-ancestor
153574978|NCT01703351|Analgesics|analgesics|mesh-ancestor
153574979|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153574980|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153574981|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
153574982|NCT01703364|Lenalidomide|lenalidomide|mesh-list
153574983|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
153574984|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575051|NCT01703910|Doxorubicin|doxorubicin|mesh-list
153575052|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153575053|NCT01703910|Capecitabine|capecitabine|mesh-list
153575054|NCT01703910|Fluorouracil|fluorouracil|mesh-list
153575055|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
153575056|NCT01703910|Irinotecan|irinotecan|mesh-list
153575058|NCT01703910|Pemetrexed|pemetrexed|mesh-list
153575217|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575218|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153575219|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153575220|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153575221|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153575222|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575223|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153575224|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
153575225|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
153575226|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
153575227|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575228|NCT01704716|Analgesics|analgesics|mesh-ancestor
153575229|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
153781617|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153575258|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153575259|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153575260|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153575261|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153575262|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153575263|NCT01705002|Bevacizumab|bevacizumab|mesh-list
153575498|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575499|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575500|NCT01706874|Listerine|listerine|mesh-list
153575501|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153575502|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575503|NCT01706887|Amiloride|amiloride|mesh-list
153575504|NCT01706887|Diuretics|diuretics|mesh-ancestor
153575505|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
153575506|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575507|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153575508|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153575509|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575510|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576123|NCT01710696|Estrogens|estrogens|mesh-ancestor
153576124|NCT01710696|Hormones|hormones|mesh-ancestor
153576125|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153576126|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576127|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153576128|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
153576129|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576130|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153576131|NCT01710722|Ephedrine|ephedrine|mesh-list
153576132|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
153576133|NCT01710722|Caffeine|caffeine|mesh-list
153576489|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
153576490|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
153576491|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576493|NCT01710761|Caffeine|caffeine|mesh-list
153577074|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577075|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153577076|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153577077|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
153577078|NCT01715584|Sevoflurane|sevoflurane|mesh-list
153577079|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153577080|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153577081|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
153577904|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578422|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578423|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153578424|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153578425|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578426|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578427|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153578428|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153578429|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
153578447|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578448|NCT01732666|Analgesics|analgesics|mesh-ancestor
153578449|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
153578450|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578453|NCT01732744|Eusol|eusol|mesh-list
153578513|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153578514|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153578515|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153578516|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153578517|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578518|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
153578519|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578520|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578521|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153578522|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578523|NCT01733342|Anesthetics|anesthetics|mesh-list
153578524|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578525|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578526|NCT01733394|Lamotrigine|lamotrigine|mesh-list
153578527|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
153578528|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153578529|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153578530|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578531|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153578532|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578533|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153578534|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153578535|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578536|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153578537|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153578538|NCT01733459|Metformin|metformin|mesh-list
153578539|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153578540|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578541|NCT01733485|Aspirin|aspirin|mesh-list
153578542|NCT01733485|Indomethacin|indomethacin|mesh-list
153578545|NCT01733485|Analgesics|analgesics|mesh-ancestor
153578566|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153578567|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153578568|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578569|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578570|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153578571|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153578572|NCT01733589|Growth Substances|growth substances|mesh-ancestor
153578573|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578574|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
153578575|NCT01733706|Nicotine|nicotine|mesh-list
153578576|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153578577|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
153578578|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578579|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578580|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153578581|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153578582|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
153578583|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578584|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578585|NCT01733823|Nimorazole|nimorazole|mesh-list
153578586|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153578587|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153578588|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153578589|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578590|NCT01733836|Metformin|metformin|mesh-list
153578628|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578629|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153578630|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578631|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
153578632|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578633|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578635|NCT01734057|Rituximab|rituximab|mesh-list
153578636|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578638|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
153578639|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578640|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578641|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578642|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
153578692|NCT01734564|Laxatives|laxatives|mesh-ancestor
153578693|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578694|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
153578695|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578696|NCT01734798|Gemcitabine|gemcitabine|mesh-list
153578697|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578698|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153578699|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
153358567|NCT02199041|Lenograstim|lenograstim|mesh-list
153578700|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578702|NCT01734824|Teriparatide|teriparatide|mesh-list
153578703|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
153578704|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153578707|NCT01734915|Iproplatin|iproplatin|mesh-list
153578781|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
153578782|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578783|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153578784|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153578785|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578786|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578787|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153578788|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
153578789|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578790|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578791|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153578792|NCT01735318|Lisinopril|lisinopril|mesh-list
153578793|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153578794|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
153578795|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578796|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578797|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153578805|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578806|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153578807|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153578808|NCT01735344|Protective Agents|protective agents|mesh-ancestor
153578809|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578835|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578836|NCT01735487|Nicotine|nicotine|mesh-list
153578837|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153578838|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
153578839|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578840|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578841|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153578842|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153578843|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
153578844|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578845|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578846|NCT01735669|Remifentanil|remifentanil|mesh-list
153578847|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
153578848|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153578850|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578851|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578852|NCT01735669|Analgesics|analgesics|mesh-ancestor
153578853|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
153578854|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578855|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153578856|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
153578857|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
153578858|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578859|NCT01735747|Vincristine|vincristine|mesh-list
153578860|NCT01735747|Temozolomide|temozolomide|mesh-list
153578928|NCT01736163|Hormones|hormones|mesh-list
153578929|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578930|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578931|NCT01736371|Propofol|propofol|mesh-list
153578932|NCT01736371|Sevoflurane|sevoflurane|mesh-list
153578933|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153578934|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578935|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578936|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153578937|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
153578938|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
153578939|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153578940|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153578941|NCT01736410|Trastuzumab|trastuzumab|mesh-list
153578942|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578943|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153578944|NCT01736423|Ramosetron|ramosetron|mesh-list
153578945|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
153578946|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
153578947|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578948|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578949|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578950|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153578951|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
153578952|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578953|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578954|NCT01736449|Bevacizumab|bevacizumab|mesh-list
153578955|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153578996|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
153578997|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578998|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579001|NCT01736761|Rilpivirine|rilpivirine|mesh-list
153579002|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153579003|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153579004|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
153579005|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579006|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579007|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153579008|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153579009|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
153579011|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153579012|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153579094|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579095|NCT01737307|Fluorides|fluorides|mesh-list
153579096|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
153579097|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
153579098|NCT01737307|Protective Agents|protective agents|mesh-ancestor
153579099|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579100|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153579101|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153579102|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579103|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
153579104|NCT01737346|Lomustine|lomustine|mesh-list
153579105|NCT01737346|Procarbazine|procarbazine|mesh-list
153579106|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153579107|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
153579108|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579109|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579110|NCT01737359|Tenofovir|tenofovir|mesh-list
153579111|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
153579112|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579113|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153579114|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153579115|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579116|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579117|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153579118|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153579119|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
153579120|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153579121|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153579122|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
153579123|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745641|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153579124|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579134|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579135|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153579137|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153579138|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153579139|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153579140|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579142|NCT01737580|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153579143|NCT01737580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579144|NCT01737580|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153579145|NCT01737580|Immunologic Factors|immunologic factors|mesh-ancestor
153579146|NCT01737580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579147|NCT01737671|Leucovorin|leucovorin|mesh-list
153579148|NCT01737671|Methotrexate|methotrexate|mesh-list
153579149|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153579150|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
153579151|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153579152|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579153|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153579154|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
153579155|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579157|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579158|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579159|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153579160|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153579161|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
153579162|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579163|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153579164|NCT01737671|Antidotes|antidotes|mesh-ancestor
153579165|NCT01737671|Protective Agents|protective agents|mesh-ancestor
153579166|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
153579167|NCT01737671|Vitamins|vitamins|mesh-ancestor
153579168|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
153579169|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
153579170|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153579171|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153579172|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
153579173|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579176|NCT01737918|Urological Agents|urological agents|mesh-ancestor
153579179|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153579181|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579182|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579183|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153579184|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
153579185|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
153579186|NCT01738035|Hormones|hormones|mesh-ancestor
153579187|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579188|NCT01738087|Fluticasone|fluticasone|mesh-list
153579198|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579199|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153579200|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153579201|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153579202|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153579203|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
153579204|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579205|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579206|NCT01738100|Morphine|morphine|mesh-list
153579207|NCT01738100|Clopidogrel|clopidogrel|mesh-list
153579208|NCT01738100|Ticagrelor|ticagrelor|mesh-list
153579209|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153579241|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579242|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153579243|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579244|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153579245|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
153579247|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579249|NCT01738295|Donepezil|donepezil|mesh-list
153579333|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153579334|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153579335|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153579336|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579337|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579338|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
153579340|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153579341|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153579342|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153579343|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579344|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153579345|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579346|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
153579347|NCT01739049|Liraglutide|liraglutide|mesh-list
153579348|NCT01739049|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153579349|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153579350|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579351|NCT01739049|Incretins|incretins|mesh-ancestor
153579352|NCT01739049|Hormones|hormones|mesh-ancestor
153579354|NCT01739127|Risperidone|risperidone|mesh-list
153579398|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153579399|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153579400|NCT01739218|Growth Substances|growth substances|mesh-ancestor
153579401|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579402|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
153579403|NCT01739413|Anesthetics|anesthetics|mesh-list
153579404|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579405|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579406|NCT01739439|Gemcitabine|gemcitabine|mesh-list
153579407|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153579408|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
153579409|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579410|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579411|NCT01739504|Anesthetics|anesthetics|mesh-list
153579412|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579413|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579414|NCT01739556|Aspirin|aspirin|mesh-list
153579415|NCT01739556|Ticagrelor|ticagrelor|mesh-list
153579416|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153579418|NCT01739556|Analgesics|analgesics|mesh-ancestor
153579464|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579465|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153579467|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
153579468|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153579469|NCT01739894|Paclitaxel|paclitaxel|mesh-list
153579470|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153579471|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579472|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
153579473|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
153579474|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
153579475|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579476|NCT01739907|Vitamin D|vitamin d|mesh-list
153579477|NCT01739907|Vitamins|vitamins|mesh-ancestor
153579478|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
153579479|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579480|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153579481|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
153579482|NCT01739920|Povidone|povidone|mesh-list
153579483|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
153579484|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
153579485|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153579486|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579487|NCT01739985|Dexamethasone|dexamethasone|mesh-list
153579488|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
153579489|NCT01739985|Droperidol|droperidol|mesh-list
153579490|NCT01739985|Ondansetron|ondansetron|mesh-list
153579492|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579493|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
153579494|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
153579498|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
153579522|NCT01740245|Polihexanide|polihexanide|mesh-list
153579523|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153579524|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579525|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
153579526|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153579527|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579528|NCT01740271|Epirubicin|epirubicin|mesh-list
153579529|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153579530|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579531|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153579532|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153579533|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579534|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579535|NCT01740336|Paclitaxel|paclitaxel|mesh-list
153579536|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153579537|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579538|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
153579539|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
153579540|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
153579541|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579542|NCT01740453|Ropivacaine|ropivacaine|mesh-list
153579543|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
153579544|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
153579545|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579546|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579547|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
153579549|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
153579565|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579566|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153579567|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153579568|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579569|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153579570|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153579580|NCT01740947|Colistin|colistin|mesh-list
153579581|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153579582|NCT01740947|Amebicides|amebicides|mesh-ancestor
153579583|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153579584|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153579585|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579586|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153579587|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
153579588|NCT01740960|Dronabinol|dronabinol|mesh-list
153579589|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
153579590|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579591|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153579592|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153579593|NCT01740960|Analgesics|analgesics|mesh-ancestor
153579594|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
153579595|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579596|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153579597|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153579600|NCT01740960|Hormones|hormones|mesh-ancestor
153579625|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153579626|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153579627|NCT01741285|Fluticasone|fluticasone|mesh-list
153579628|NCT01741285|Beclomethasone|beclomethasone|mesh-list
153579629|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579630|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153579631|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
153579632|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579633|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579634|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153579635|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
153579636|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579637|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153579638|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
153579662|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153579663|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153579664|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579665|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579666|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579668|NCT01741506|Tinzaparin|tinzaparin|mesh-list
153579669|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153579670|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
153579671|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153579672|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153579673|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579675|NCT01741519|Esmolol|esmolol|mesh-list
153579715|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579716|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579717|NCT01741649|Povidone|povidone|mesh-list
153579718|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
153579719|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
153579720|NCT01741727|ABT-414|abt-414|mesh-list
153579721|NCT01741727|Immunoconjugates|immunoconjugates|mesh-ancestor
153579722|NCT01741727|Immunologic Factors|immunologic factors|mesh-ancestor
153579723|NCT01741727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579724|NCT01741753|Prednisone|prednisone|mesh-list
153579725|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579726|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
153579727|NCT01741753|Hormones|hormones|mesh-ancestor
153579788|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
153579789|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579790|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153579791|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153579792|NCT01742338|Protective Agents|protective agents|mesh-ancestor
153579793|NCT01742390|Risperidone|risperidone|mesh-list
153579794|NCT01742390|Aripiprazole|aripiprazole|mesh-list
153579795|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153579796|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153579797|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
153579798|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579799|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579800|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579801|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153579802|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153579803|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579804|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153579805|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153579855|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579856|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153579857|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153579858|NCT01742637|Analgesics|analgesics|mesh-ancestor
153579859|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
153579860|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579861|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579862|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579863|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579935|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579936|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153579937|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153579938|NCT01742793|Lenalidomide|lenalidomide|mesh-list
153579939|NCT01742793|Romidepsin|romidepsin|mesh-list
153579940|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
153579941|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579942|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153579947|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153579948|NCT01742793|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153579949|NCT01742793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579950|NCT01742793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579951|NCT01742845|Ropivacaine|ropivacaine|mesh-list
153579952|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
153579953|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
153579954|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579955|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579956|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
153579957|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579958|NCT01742988|Rituximab|rituximab|mesh-list
153579988|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153579989|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153579990|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579991|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579992|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
153579993|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579994|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153579995|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153579996|NCT01743118|Calcipotriene|calcipotriene|mesh-list
153579997|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579998|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
153579999|NCT01743144|Analgesics|analgesics|mesh-ancestor
153580000|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
153580001|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580002|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580003|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
153580004|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580005|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153580006|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
153580007|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153580008|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153580009|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580010|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153580011|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
153580012|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153580013|NCT01743157|Bevacizumab|bevacizumab|mesh-list
153580035|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153580036|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580037|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580038|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580039|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153580040|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
153580041|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580042|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580047|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580048|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580049|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153580050|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580051|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580052|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153580053|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
153580055|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
153580057|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580058|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580059|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580060|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153580061|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153580062|NCT01743300|Growth Substances|growth substances|mesh-ancestor
153580063|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
153580064|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580065|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580066|NCT01743326|Anesthetics|anesthetics|mesh-list
153580067|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580077|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
153580078|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580079|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580080|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
153580081|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580082|NCT01743456|Anesthetics|anesthetics|mesh-list
153580083|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580084|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580085|NCT01743508|Misoprostol|misoprostol|mesh-list
153580086|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153580087|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
153580088|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153580089|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580090|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153580091|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580092|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
153580093|NCT01743690|Nystatin|nystatin|mesh-list
153580095|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580096|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
153580097|NCT01743690|Hormones|hormones|mesh-ancestor
153580098|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153580099|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580100|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153580101|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153580102|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
153580103|NCT01743690|Ionophores|ionophores|mesh-ancestor
153580104|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153580105|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580106|NCT01743755|Dexamethasone|dexamethasone|mesh-list
153580107|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580108|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
153580109|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
153580110|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580111|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580112|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580113|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
153580114|NCT01743755|Hormones|hormones|mesh-ancestor
153580115|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153580116|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153580117|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580118|NCT01743794|Ropivacaine|ropivacaine|mesh-list
153580119|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
153580120|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
153580156|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
153580157|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153580158|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153580159|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580160|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580161|NCT01743911|Urological Agents|urological agents|mesh-ancestor
153580162|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
153580163|NCT01744106|Ephedrine|ephedrine|mesh-list
153580164|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153580165|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
153580166|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580167|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580168|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153580169|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
153580170|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
153580171|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153580172|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153580173|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
153580174|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580175|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580176|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580177|NCT01744184|Midazolam|midazolam|mesh-list
153580178|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
153580179|NCT01744184|Entonox|entonox|mesh-list
153580180|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153580181|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153580182|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580183|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580217|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580218|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580219|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580220|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580221|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153580223|NCT01744288|Ticagrelor|ticagrelor|mesh-list
153580224|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153580225|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153580226|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153580227|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153580228|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
153580229|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580230|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580231|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580232|NCT01744314|Indomethacin|indomethacin|mesh-list
153580233|NCT01744314|Pantoprazole|pantoprazole|mesh-list
153580234|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153580235|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580236|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153580237|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580238|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580239|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153580240|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153580241|NCT01744314|Analgesics|analgesics|mesh-ancestor
153580242|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
153580243|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580244|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580245|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580246|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580251|NCT01744366|Goserelin|goserelin|mesh-list
153580259|NCT01744444|Memantine|memantine|mesh-list
153580260|NCT01744444|Analgesics|analgesics|mesh-ancestor
153580261|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
153580262|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580272|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580273|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
153580274|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153580275|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153580276|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
153580277|NCT01744470|Tacrolimus|tacrolimus|mesh-list
153580278|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153580279|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
153580280|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580281|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153580282|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580316|NCT01744886|Benzocaine|benzocaine|mesh-list
153580337|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580338|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580340|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153580341|NCT01745081|Diuretics|diuretics|mesh-ancestor
153580342|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
153580343|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580344|NCT01745159|Tacrolimus|tacrolimus|mesh-list
153580345|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153580346|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
153580347|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580348|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153580349|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580350|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580352|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
153580353|NCT01745263|Vitamins|vitamins|mesh-ancestor
153580354|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
153580396|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580416|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580417|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153580418|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153580419|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
153580420|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153580421|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
153580422|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580423|NCT01745614|Nimesulide|nimesulide|mesh-list
153580424|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153580425|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153580427|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
153580428|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580429|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580430|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580431|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580432|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153580433|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580434|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580435|NCT01745640|Dexamethasone|dexamethasone|mesh-list
153580436|NCT01745640|Pomalidomide|pomalidomide|mesh-list
153580437|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580438|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
153580439|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
153580440|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580441|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580442|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580444|NCT01745640|Hormones|hormones|mesh-ancestor
153580466|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
153580467|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
153580468|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153580469|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
153580470|NCT01745679|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153580471|NCT01745679|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153580472|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153580473|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153580474|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153580475|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153580476|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153580477|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580478|NCT01745770|Mesalamine|mesalamine|mesh-list
153580479|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153580480|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153580547|NCT01746641|Propofol|propofol|mesh-list
153580548|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153580549|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580550|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580551|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153580552|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
153580553|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
153580554|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153580555|NCT01746641|Narcotics|narcotics|mesh-ancestor
153580556|NCT01746641|Analgesics|analgesics|mesh-ancestor
153580557|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
153580558|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580559|NCT01746680|Methotrexate|methotrexate|mesh-list
153580560|NCT01746680|Tacrolimus|tacrolimus|mesh-list
153580561|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153580562|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
153580563|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153580564|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580565|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153580566|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
153580567|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580568|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580569|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
153580570|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580582|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580583|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580584|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580585|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580586|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153580590|NCT01746771|Paclitaxel|paclitaxel|mesh-list
153580602|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580603|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153580604|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
153580605|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580606|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
153580607|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153580608|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
153580609|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580610|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153580611|NCT01746875|Aflibercept|aflibercept|mesh-list
153580612|NCT01746875|Verteporfin|verteporfin|mesh-list
153580613|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153580614|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153580615|NCT01746875|Growth Substances|growth substances|mesh-ancestor
153580616|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580617|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
153580618|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580619|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153580620|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
153580621|NCT01746992|Prednisone|prednisone|mesh-list
153580622|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
153580623|NCT01746992|Ifosfamide|ifosfamide|mesh-list
153580624|NCT01746992|Doxorubicin|doxorubicin|mesh-list
153580625|NCT01746992|Methotrexate|methotrexate|mesh-list
153580626|NCT01746992|Etoposide|etoposide|mesh-list
153580627|NCT01746992|Vincristine|vincristine|mesh-list
153580660|NCT01747044|Milnacipran|milnacipran|mesh-list
153580661|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
153580662|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153580663|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153580664|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153580665|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580666|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580667|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580668|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153580669|NCT01747044|Analgesics|analgesics|mesh-ancestor
153580670|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
153580671|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580672|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
153580673|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580674|NCT01747083|Metformin|metformin|mesh-list
153580675|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153580676|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580677|NCT01747135|Betadex|betadex|mesh-list
153580678|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
153580679|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580680|NCT01747148|Radavirsen|radavirsen|mesh-list
153580681|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
153580682|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153580683|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
153580684|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153580685|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153580686|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580687|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
153580688|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580689|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580690|NCT01747174|Adenosine|adenosine|mesh-list
153580691|NCT01747174|Nitroprusside|nitroprusside|mesh-list
153580692|NCT01747174|Analgesics|analgesics|mesh-ancestor
153580693|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
153580694|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806548|NCT00334386|Torsemide|torsemide|mesh-list
153580697|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
153580698|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153580699|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
153580700|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
153580701|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580702|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580703|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153580704|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153580718|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153580719|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153580720|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
153580721|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153580722|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153580723|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153580724|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545896|NCT06297499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580725|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580726|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153580727|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153580728|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153580730|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153580731|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153580732|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153580733|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580734|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580735|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580736|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580755|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
153580756|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153580757|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580758|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580759|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
153580760|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
153580761|NCT01747616|Chitosan|chitosan|mesh-list
153580762|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153580763|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153580764|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153580765|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
153580766|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153580780|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
153580781|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
153580782|NCT01747616|Coagulants|coagulants|mesh-ancestor
153580783|NCT01747642|Sorafenib|sorafenib|mesh-list
153580784|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580785|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580786|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580827|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153580828|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580829|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580830|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580831|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580840|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580842|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153580843|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
153580844|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153580845|NCT01748123|Diuretics|diuretics|mesh-ancestor
153580846|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
153580847|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580848|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153580849|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153580850|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580893|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153580894|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
153580895|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
153580908|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
153580909|NCT01748396|Calcium|calcium|mesh-list
153580910|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153580911|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580912|NCT01748396|Antacids|antacids|mesh-ancestor
153580913|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580914|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580915|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153580916|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153580917|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153580918|NCT01748396|Vitamins|vitamins|mesh-ancestor
153580919|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
153580920|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153580921|NCT01748422|Capsaicin|capsaicin|mesh-list
153580922|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
153580923|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
153580924|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
153580925|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580926|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580927|NCT01748435|Capsaicin|capsaicin|mesh-list
153580933|NCT01748487|Dexamethasone|dexamethasone|mesh-list
153580953|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153580954|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580955|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580956|NCT01748526|Canagliflozin|canagliflozin|mesh-list
153580957|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153580958|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580970|NCT01748630|Analgesics|analgesics|mesh-ancestor
153580971|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
153580972|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580973|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153580974|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153580975|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153580976|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580977|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580978|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580979|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153580980|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153580981|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580982|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580983|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153580984|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
153580986|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
153580987|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
153580988|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153580989|NCT01748630|Narcotics|narcotics|mesh-ancestor
153580990|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
153580991|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
153580992|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580993|NCT01748669|Protective Agents|protective agents|mesh-ancestor
153580994|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580995|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153580996|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581007|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581008|NCT01748747|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153581009|NCT01748747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581010|NCT01748747|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153581012|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
153581013|NCT01748773|Trastuzumab|trastuzumab|mesh-list
153581014|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581015|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
153581016|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581017|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581018|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581019|NCT01748838|Mannitol|mannitol|mesh-list
153581020|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153581021|NCT01748838|Diuretics|diuretics|mesh-ancestor
153581022|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
153581023|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581024|NCT01748929|Albendazole|albendazole|mesh-list
153581070|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
153581071|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581072|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153581073|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153581074|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581075|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581076|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
153581077|NCT01749111|Methotrexate|methotrexate|mesh-list
153581078|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153581079|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581080|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
153581081|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581082|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581083|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581084|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
153581085|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581086|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581087|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153581088|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153581089|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
153581090|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153581091|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581092|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
153581107|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153581129|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581130|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153581131|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153581132|NCT01749319|Baclofen|baclofen|mesh-list
153581133|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153581134|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581135|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153581136|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581137|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153581138|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
153581139|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
153581140|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581141|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581204|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581206|NCT01749514|Hematinics|hematinics|mesh-ancestor
153581207|NCT01749540|Luspatercept|luspatercept|mesh-list
153581208|NCT01749540|Hematinics|hematinics|mesh-ancestor
153581209|NCT01749566|Maraviroc|maraviroc|mesh-list
153581210|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153581211|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153581212|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581213|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153581214|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153581215|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
153581216|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581217|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153581218|NCT01749579|Midazolam|midazolam|mesh-list
153581229|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153581277|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153581278|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
153581279|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581280|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153581281|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153581282|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
153581283|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153581284|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
153581285|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
153581286|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
153581287|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153581331|NCT06176157|Vitamin D|vitamin d|mesh-list
153581353|NCT06175806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153581354|NCT06175806|Antipruritics|antipruritics|mesh-ancestor
153581355|NCT06175806|Dermatologic Agents|dermatologic agents|mesh-ancestor
153581356|NCT06175806|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153581370|NCT06175702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581371|NCT06175702|Immunologic Factors|immunologic factors|mesh-ancestor
153581372|NCT06175702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581373|NCT06175702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581374|NCT06175702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581375|NCT06175702|Alkylating Agents|alkylating agents|mesh-ancestor
153581376|NCT06175702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581377|NCT06175702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581378|NCT06175702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153581379|NCT06175702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581380|NCT06175702|Antiemetics|antiemetics|mesh-ancestor
153581381|NCT06175702|Autonomic Agents|autonomic agents|mesh-ancestor
153581382|NCT06175702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581383|NCT06175702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153581384|NCT06175702|Glucocorticoids|glucocorticoids|mesh-ancestor
153581386|NCT06175702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581387|NCT06175702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153581388|NCT06175702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153581389|NCT06175702|Abortifacient Agents|abortifacient agents|mesh-ancestor
153581390|NCT06175702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153581391|NCT06175702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581392|NCT06175702|Antimetabolites|antimetabolites|mesh-ancestor
153581393|NCT06175702|Dermatologic Agents|dermatologic agents|mesh-ancestor
153581394|NCT06175702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581395|NCT06175702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153581396|NCT06175702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153581397|NCT06175702|Antiviral Agents|antiviral agents|mesh-ancestor
153581398|NCT06175702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581405|NCT06175676|Fluorouracil|fluorouracil|mesh-list
153581406|NCT06175676|Chitosan|chitosan|mesh-list
153581407|NCT06175676|Antimetabolites|antimetabolites|mesh-ancestor
153581408|NCT06175676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581409|NCT06175676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581410|NCT06175676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581411|NCT06175676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581412|NCT06175676|Immunologic Factors|immunologic factors|mesh-ancestor
153581413|NCT06175676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581414|NCT06175676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153581415|NCT06175676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153581416|NCT06175676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153581417|NCT06175676|Chelating Agents|chelating agents|mesh-ancestor
153581418|NCT06175676|Sequestering Agents|sequestering agents|mesh-ancestor
153581419|NCT06175676|Hemostatics|hemostatics|mesh-ancestor
153581420|NCT06175676|Coagulants|coagulants|mesh-ancestor
153581430|NCT06175507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581431|NCT06175507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581433|NCT06174883|Hematinics|hematinics|mesh-ancestor
153581434|NCT06174883|Vitamin B Complex|vitamin b complex|mesh-ancestor
153581435|NCT06174883|Vitamins|vitamins|mesh-ancestor
153581436|NCT06174883|Micronutrients|micronutrients|mesh-ancestor
153581437|NCT06174883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581438|NCT06168214|Amoxicillin|amoxicillin|mesh-list
153581439|NCT06168214|Clarithromycin|clarithromycin|mesh-list
153581440|NCT06168214|Tetracycline|tetracycline|mesh-list
153581441|NCT06168214|Furazolidone|furazolidone|mesh-list
153581462|NCT06162611|Contraceptive Agents|contraceptive agents|mesh-ancestor
153581463|NCT06162611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153581464|NCT06162611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581465|NCT06162611|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153581466|NCT06162611|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153581467|NCT06162611|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153581468|NCT06162611|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153581469|NCT06162611|Progestins|progestins|mesh-ancestor
153581470|NCT06162611|Hormones|hormones|mesh-ancestor
153581471|NCT06162611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581472|NCT06152172|Cyclophosphamide|cyclophosphamide|mesh-list
153581473|NCT06152172|Fludarabine|fludarabine|mesh-list
153581474|NCT06152172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581475|NCT06152172|Immunologic Factors|immunologic factors|mesh-ancestor
153581476|NCT06152172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581477|NCT06152172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581478|NCT06152172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581479|NCT06152172|Alkylating Agents|alkylating agents|mesh-ancestor
153581480|NCT06152172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581481|NCT06152172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581482|NCT06152172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153581483|NCT06111079|Aspirin|aspirin|mesh-list
153581484|NCT06111079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153581485|NCT06111079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581487|NCT06111079|Sensory System Agents|sensory system agents|mesh-ancestor
153581488|NCT06111079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581497|NCT06111079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581498|NCT06111079|Antipyretics|antipyretics|mesh-ancestor
153581499|NCT06109402|Paclitaxel|paclitaxel|mesh-list
153581500|NCT06109402|Carboplatin|carboplatin|mesh-list
153581516|NCT06100432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581518|NCT06100432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581519|NCT06100432|Protective Agents|protective agents|mesh-ancestor
153581520|NCT06100432|Provitamins|provitamins|mesh-ancestor
153581548|NCT06060847|Liver Extracts|liver extracts|mesh-list
153581549|NCT06060847|Hematinics|hematinics|mesh-ancestor
153581550|NCT06028464|Carbamazepine|carbamazepine|mesh-list
153581551|NCT06028464|Anticonvulsants|anticonvulsants|mesh-ancestor
153581552|NCT06028464|Antimanic Agents|antimanic agents|mesh-ancestor
153581553|NCT06028464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153581554|NCT06028464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581555|NCT06028464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581556|NCT06028464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153581557|NCT06028464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581558|NCT06028464|Analgesics|analgesics|mesh-ancestor
153581559|NCT06028464|Sensory System Agents|sensory system agents|mesh-ancestor
153581560|NCT06028464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581561|NCT06028464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153581562|NCT06028464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153581563|NCT06028464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581564|NCT06028464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153581565|NCT06028464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153581566|NCT06011629|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153581567|NCT06011629|Laxatives|laxatives|mesh-ancestor
153581568|NCT06011629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153581569|NCT05996133|Dexamethasone|dexamethasone|mesh-list
153581570|NCT05996133|Epinephrine|epinephrine|mesh-list
153581571|NCT05996133|Bupivacaine|bupivacaine|mesh-list
153581572|NCT05996133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581573|NCT05996133|Antiemetics|antiemetics|mesh-ancestor
153581601|NCT05975307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581602|NCT05975307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581603|NCT05975307|Antimetabolites|antimetabolites|mesh-ancestor
153581604|NCT05975307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581606|NCT05924971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153581607|NCT05924971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581608|NCT05924971|Analgesics|analgesics|mesh-ancestor
153581609|NCT05924971|Sensory System Agents|sensory system agents|mesh-ancestor
153581610|NCT05924971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581611|NCT05924971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581612|NCT05924971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581613|NCT05924971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581614|NCT05924971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153581615|NCT05924971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153581616|NCT05924971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581617|NCT05924971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153581618|NCT05924971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153581619|NCT05924971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581620|NCT05924971|Antipyretics|antipyretics|mesh-ancestor
153581621|NCT05924815|Moxifloxacin|moxifloxacin|mesh-list
153581622|NCT05924815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153581623|NCT05924815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581624|NCT05924815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153581625|NCT05924815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153581626|NCT05924815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581627|NCT05924815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581628|NCT05924815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581629|NCT05898724|Zinc Oxide|zinc oxide|mesh-list
153581630|NCT05898724|Dermatologic Agents|dermatologic agents|mesh-ancestor
153581631|NCT05898724|Sunscreening Agents|sunscreening agents|mesh-ancestor
153581632|NCT05898724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153581639|NCT05781620|Vitamin D|vitamin d|mesh-list
153581641|NCT05781620|Micronutrients|micronutrients|mesh-ancestor
153581642|NCT05781620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581671|NCT05701527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153581672|NCT05701527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581674|NCT05661461|Temsirolimus|temsirolimus|mesh-list
153581675|NCT05661461|MTOR Inhibitors|mtor inhibitors|mesh-list
153581676|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153581677|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581678|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153581679|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581680|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
153581681|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581682|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
153581683|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581684|NCT05661461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153581698|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581703|NCT05533892|Lenvatinib|lenvatinib|mesh-list
153581740|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581741|NCT05427383|Paclitaxel|paclitaxel|mesh-list
153581742|NCT05427383|Docetaxel|docetaxel|mesh-list
153581743|NCT05427383|Irinotecan|irinotecan|mesh-list
153581744|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153581745|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581746|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
153581747|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
153581757|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153581758|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581759|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
153581760|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581761|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
153581762|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581763|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581764|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153581765|NCT05426252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581766|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581767|NCT05366777|Acetaminophen|acetaminophen|mesh-list
153581768|NCT05366777|Ibuprofen|ibuprofen|mesh-list
153581804|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581805|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
153581806|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581808|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581809|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
153581810|NCT05249959|Cytarabine|cytarabine|mesh-list
153581811|NCT05249959|Rituximab|rituximab|mesh-list
153581812|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153581813|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153581838|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581839|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581840|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153581841|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
153581929|NCT05094128|Upadacitinib|upadacitinib|mesh-list
153581930|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153581931|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153581932|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581933|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581934|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581935|NCT05087030|Denosumab|denosumab|mesh-list
153581936|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153581937|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581938|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153581939|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153581940|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581941|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
153581942|NCT05003895|Fludarabine|fludarabine|mesh-list
153581943|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581944|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
153581945|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581946|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581947|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581948|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
153581949|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581950|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581951|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153581952|NCT04965155|Dexamethasone|dexamethasone|mesh-list
153581989|NCT04944888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581990|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581991|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581992|NCT04924101|Cisplatin|cisplatin|mesh-list
153581993|NCT04924101|Carboplatin|carboplatin|mesh-list
153581994|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
153581995|NCT04924101|Etoposide|etoposide|mesh-list
153581996|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
153581997|NCT04924101|Lenvatinib|lenvatinib|mesh-list
153581998|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581999|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582000|NCT04924101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582001|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582002|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582003|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153582004|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153582005|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582006|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153582007|NCT04921943|Azithromycin|azithromycin|mesh-list
153582008|NCT04921943|Rifampin|rifampin|mesh-list
153582010|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582058|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153582059|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153582060|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582061|NCT04622319|Trastuzumab|trastuzumab|mesh-list
153582062|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153582063|NCT04622319|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153582064|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582065|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582066|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582067|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582068|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582069|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582070|NCT04622319|Immunotoxins|immunotoxins|mesh-ancestor
153582071|NCT04622319|Immunoconjugates|immunoconjugates|mesh-ancestor
153582103|NCT04408118|Paclitaxel|paclitaxel|mesh-list
153582129|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582130|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582131|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582132|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582133|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582134|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582135|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582136|NCT04380636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582137|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153582138|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153582139|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582140|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153582200|NCT04151563|Docetaxel|docetaxel|mesh-list
153582201|NCT04151563|Nivolumab|nivolumab|mesh-list
153582202|NCT04151563|Ipilimumab|ipilimumab|mesh-list
153582203|NCT04151563|Ramucirumab|ramucirumab|mesh-list
153582204|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582205|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582206|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582207|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582208|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582209|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582210|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582211|NCT04151563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153582212|NCT04151563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153582213|NCT04151563|Growth Substances|growth substances|mesh-ancestor
153582272|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582273|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582274|NCT03845270|Docetaxel|docetaxel|mesh-list
153582275|NCT03845270|Trastuzumab|trastuzumab|mesh-list
153582276|NCT03845270|Pertuzumab|pertuzumab|mesh-list
153582277|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582278|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582279|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582280|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582281|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582282|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582283|NCT03831464|Metformin|metformin|mesh-list
153582284|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153582285|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582286|NCT03783936|Leucovorin|leucovorin|mesh-list
153582287|NCT03783936|Fluorouracil|fluorouracil|mesh-list
153582288|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
153582289|NCT03783936|Trastuzumab|trastuzumab|mesh-list
153582298|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582299|NCT03783936|Antidotes|antidotes|mesh-ancestor
153582300|NCT03783936|Protective Agents|protective agents|mesh-ancestor
153582301|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
153582302|NCT03783936|Vitamins|vitamins|mesh-ancestor
153582303|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
153582304|NCT03742986|Paclitaxel|paclitaxel|mesh-list
153582305|NCT03742986|Docetaxel|docetaxel|mesh-list
153582306|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153582333|NCT03736720|Irinotecan|irinotecan|mesh-list
153582334|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
153582335|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582336|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153582337|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582338|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153582339|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
153582340|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582341|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153582342|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153582343|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582345|NCT03736720|Protective Agents|protective agents|mesh-ancestor
153582346|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
153582347|NCT03736720|Vitamins|vitamins|mesh-ancestor
153582348|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
153582349|NCT03703167|Rituximab|rituximab|mesh-list
153582350|NCT03703167|Lenalidomide|lenalidomide|mesh-list
153582442|NCT03169972|Coagulants|coagulants|mesh-ancestor
153582443|NCT03080883|Apixaban|apixaban|mesh-list
153582444|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153582445|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
153582446|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153582447|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
153582448|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582449|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582450|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
153582451|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
153582452|NCT03025035|Olaparib|olaparib|mesh-list
153582453|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582454|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582455|NCT03025035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582456|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582457|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153582458|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582459|NCT02953509|Rituximab|rituximab|mesh-list
153582460|NCT02953509|Magrolimab|magrolimab|mesh-list
153582461|NCT02953509|Gemcitabine|gemcitabine|mesh-list
153582462|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
153582463|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582464|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582465|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
153582466|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582467|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582500|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582502|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
153582503|NCT02856438|Hormones|hormones|mesh-ancestor
153582504|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582505|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153582506|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582507|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
153582508|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153582509|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153582510|NCT02856438|Growth Substances|growth substances|mesh-ancestor
153582511|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
153582512|NCT02647099|Aspirin|aspirin|mesh-list
153582513|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153582514|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582515|NCT02647099|Analgesics|analgesics|mesh-ancestor
153582576|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582578|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153582579|NCT01801072|Levetiracetam|levetiracetam|mesh-list
153582580|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
153582581|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
153582582|NCT01784536|Oritavancin|oritavancin|mesh-list
153582583|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582584|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582585|NCT01718743|Lenalidomide|lenalidomide|mesh-list
153582586|NCT01718743|Ixazomib|ixazomib|mesh-list
153582587|NCT01718743|Glycine|glycine|mesh-list
153582588|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
153582589|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582590|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153582649|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
153582650|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
153582651|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582652|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153582653|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
153582654|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582655|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153582656|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
153582657|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153582730|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582731|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153582732|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
153582742|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582743|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153582744|NCT01750541|Valproic Acid|valproic acid|mesh-list
153582745|NCT01750541|Haloperidol|haloperidol|mesh-list
153582746|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
153582747|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
153582748|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
153582749|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582750|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582751|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153582752|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153582753|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153582754|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153582755|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153582756|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153582757|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
153582758|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582759|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582760|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153582761|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
153582762|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582763|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
153582764|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
153582765|NCT01750580|Ipilimumab|ipilimumab|mesh-list
153582766|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582767|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582768|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582769|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582770|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
153582772|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153582773|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582774|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
153582775|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582776|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582777|NCT01750723|Acetazolamide|acetazolamide|mesh-list
153582778|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
153582779|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153582780|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582781|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582782|NCT01750723|Diuretics|diuretics|mesh-ancestor
153582783|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
153701492|NCT00277537|Mannitol|mannitol|mesh-list
153582784|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582785|NCT01750762|Lenalidomide|lenalidomide|mesh-list
153582786|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
153582787|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582788|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153582789|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153582790|NCT01750762|Growth Substances|growth substances|mesh-ancestor
153582791|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
153582792|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582793|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
153582794|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153582795|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
153582796|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153582797|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
153582798|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582812|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582813|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153582814|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582815|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153582816|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
153582818|NCT01750983|Ipilimumab|ipilimumab|mesh-list
153582819|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
153582820|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582821|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153582835|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582836|NCT01751009|Protective Agents|protective agents|mesh-ancestor
153582837|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153582838|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582839|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153582840|NCT01751074|Darapladib|darapladib|mesh-list
153582841|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153582842|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153582843|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
153582844|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582845|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153582846|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153582848|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153582849|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
153582851|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153582852|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582853|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153582854|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
153582855|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582856|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582857|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582858|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582859|NCT01751295|Atorvastatin|atorvastatin|mesh-list
153582860|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153582861|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153582872|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582877|NCT01751347|Lidocaine|lidocaine|mesh-list
153582891|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153582892|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153582893|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153582894|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582895|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
153582896|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582897|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582898|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153582899|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582900|NCT01751763|Sorafenib|sorafenib|mesh-list
153582901|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582902|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153582959|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153582960|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582961|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
153582962|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153582963|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153582964|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582966|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
153582967|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
153582968|NCT01752270|Cyproterone|cyproterone|mesh-list
154157453|NCT05782712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153582969|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
153582970|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
153582971|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
153582972|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582973|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582974|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582975|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153582976|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
153582977|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153582978|NCT01752322|Lidocaine|lidocaine|mesh-list
153582979|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
153582980|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
153582981|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153582982|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583021|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153583022|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583023|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583024|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
153583025|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583026|NCT01752881|Vaccines|vaccines|mesh-list
153583027|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
153583028|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583029|NCT01752959|Remifentanil|remifentanil|mesh-list
153583030|NCT01752959|Esmolol|esmolol|mesh-list
153583031|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153583032|NCT01752959|Narcotics|narcotics|mesh-ancestor
153583033|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583034|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583035|NCT01752959|Analgesics|analgesics|mesh-ancestor
153583036|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
153583037|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583038|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153583082|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583083|NCT01753375|Vitamin D|vitamin d|mesh-list
153583084|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
153583085|NCT01753375|Vitamins|vitamins|mesh-ancestor
153583086|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
153583087|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583088|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153583089|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153583090|NCT01753453|Plerixafor|plerixafor|mesh-list
153583191|NCT01754701|Trace Elements|trace elements|mesh-ancestor
153583192|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
153583193|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583194|NCT01754805|Methotrexate|methotrexate|mesh-list
153583195|NCT01754805|Peficitinib|peficitinib|mesh-list
153583196|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153583197|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
153583198|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153583199|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583200|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153583201|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
153583202|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583203|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583204|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
153583205|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583289|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583290|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153583291|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153583292|NCT01755299|Caffeine|caffeine|mesh-list
153583293|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153583294|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583295|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153583296|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583297|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583298|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153583299|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153583300|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
153583301|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583302|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
153583303|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153583304|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153583305|NCT01755338|Prednisolone|prednisolone|mesh-list
153701864|NCT00109356|AQ4N|aq4n|mesh-list
153583306|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
153583307|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153583308|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
153583309|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583310|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
153583311|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
153583312|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583314|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153583331|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583332|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
153583333|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583334|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153583335|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153583355|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583358|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153583359|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153583360|NCT01755520|Analgesics|analgesics|mesh-ancestor
153583361|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
153583362|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583363|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583364|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583378|NCT01755559|Artesunate|artesunate|mesh-list
153583436|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583437|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583438|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153583439|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583440|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583442|NCT01755845|Cisplatin|cisplatin|mesh-list
153583443|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153583444|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583445|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
153583446|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
153583455|NCT01755884|Immunomodulating Agents|immunomodulating agents|mesh-list
153583456|NCT01755884|Immunologic Factors|immunologic factors|mesh-ancestor
153583457|NCT01755884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583460|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583461|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
153583462|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
153583463|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
153583464|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583465|NCT01755923|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153583466|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153583467|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583468|NCT01756105|Insulin|insulin|mesh-list
153583469|NCT01756105|Metformin|metformin|mesh-list
153583470|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
153583471|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
153583472|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
153583473|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583474|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583475|NCT01756131|Cabotegravir|cabotegravir|mesh-list
153583491|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583492|NCT01756183|Paclitaxel|paclitaxel|mesh-list
153583493|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153583494|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583495|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
153583496|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
153583497|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
153583498|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583499|NCT01756261|Aflibercept|aflibercept|mesh-list
153583500|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153583501|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153583502|NCT01756261|Growth Substances|growth substances|mesh-ancestor
153583557|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
153583558|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
153583559|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
153583560|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153583561|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
153583562|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153583563|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153583564|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583565|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153583566|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153583567|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583568|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583569|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583570|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153583571|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
153583572|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153583573|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583574|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153583575|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153583581|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583582|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
153583583|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153583584|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583585|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153583586|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153583587|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583588|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583589|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583603|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583604|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153583605|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583606|NCT01756651|Fentanyl|fentanyl|mesh-list
153583607|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153583608|NCT01756651|Narcotics|narcotics|mesh-ancestor
153583609|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583610|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583611|NCT01756651|Analgesics|analgesics|mesh-ancestor
153583612|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
153583613|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583614|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153583615|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153583616|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
153583617|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
153583618|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
153583619|NCT01756664|Petrolatum|petrolatum|mesh-list
153583620|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153583621|NCT01756664|Protective Agents|protective agents|mesh-ancestor
153583622|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583623|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
153583624|NCT01756664|Emollients|emollients|mesh-ancestor
153583625|NCT01756768|Palbociclib|palbociclib|mesh-list
153583626|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583627|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153583628|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583629|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583630|NCT01756781|Palbociclib|palbociclib|mesh-list
153583631|NCT01756781|Midazolam|midazolam|mesh-list
153583632|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153583633|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153583634|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583635|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583636|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153583645|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583646|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583662|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
153583663|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583664|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583665|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583666|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583667|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153583668|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153583669|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583670|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
153583671|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
153583730|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
153583731|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153583732|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153583733|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583734|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153583735|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153583736|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153583737|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153583738|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153583739|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153583740|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153583741|NCT01757262|Clopidogrel|clopidogrel|mesh-list
153583742|NCT01757262|Ticagrelor|ticagrelor|mesh-list
153583743|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153583744|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153583754|NCT01757431|Eculizumab|eculizumab|mesh-list
153583838|NCT01758029|Testosterone|testosterone|mesh-list
153583839|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
153583840|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
153583841|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153583842|NCT01758029|Androgens|androgens|mesh-ancestor
153583843|NCT01758029|Hormones|hormones|mesh-ancestor
153583844|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583845|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583846|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153583847|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583848|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
153583849|NCT01758094|Testosterone|testosterone|mesh-list
153583850|NCT01758094|Androgens|androgens|mesh-ancestor
153583851|NCT01758094|Hormones|hormones|mesh-ancestor
153583852|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583853|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583854|NCT01758107|Cyclosporine|cyclosporine|mesh-list
153583855|NCT01758107|Cyclosporins|cyclosporins|mesh-list
153583856|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583857|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583858|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583859|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
153583860|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583861|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
153583862|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583863|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
153583864|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583894|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153583895|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153583896|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153583897|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153583898|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
153583899|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
153583901|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
153583904|NCT01758198|Abatacept|abatacept|mesh-list
153583905|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153583925|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153583926|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
153583927|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
153583928|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583929|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583930|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153583931|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153583932|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153583933|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
153583934|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583935|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583936|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
153583937|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153583938|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153583939|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153583940|NCT01758367|Decitabine|decitabine|mesh-list
153583941|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153583942|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
153583943|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583944|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583945|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583946|NCT01758380|Metformin|metformin|mesh-list
153583947|NCT01758380|Vildagliptin|vildagliptin|mesh-list
153583948|NCT01758380|Gliclazide|gliclazide|mesh-list
153583949|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583952|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
153583993|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
153583994|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583995|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153583996|NCT01758666|Antidotes|antidotes|mesh-ancestor
153583997|NCT01758666|Protective Agents|protective agents|mesh-ancestor
153583998|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
153583999|NCT01758666|Vitamins|vitamins|mesh-ancestor
153584000|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
153584001|NCT01758744|Treprostinil|treprostinil|mesh-list
153584002|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153584003|NCT01758809|Bupivacaine|bupivacaine|mesh-list
153584004|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
153584005|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
153584006|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584007|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584008|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
153584009|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584010|NCT01758835|Calpastatin|calpastatin|mesh-list
153584011|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153584021|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584022|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584023|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584054|NCT01759485|Vitamin D|vitamin d|mesh-list
153584055|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
153584056|NCT01759485|Vitamins|vitamins|mesh-ancestor
153584057|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
153584058|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584059|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153584060|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153584061|NCT01759524|Lidocaine|lidocaine|mesh-list
153584062|NCT01759524|Clonidine|clonidine|mesh-list
153584063|NCT01759524|Bupivacaine|bupivacaine|mesh-list
153584064|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
153584065|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
153584066|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584067|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584068|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
153584069|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584070|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153584071|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153584075|NCT01759524|Analgesics|analgesics|mesh-ancestor
153584120|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153584121|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584122|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584123|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
153584124|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
153584125|NCT01759706|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153584126|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153584127|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
153584128|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584129|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584130|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153584131|NCT01759706|Narcotics|narcotics|mesh-ancestor
153584132|NCT01759706|Analgesics|analgesics|mesh-ancestor
153584203|NCT01760096|Cyclosporins|cyclosporins|mesh-list
153584204|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
153584205|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584206|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584216|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584218|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
153584219|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
153584220|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153584221|NCT01760109|Piperacillin|piperacillin|mesh-list
153584222|NCT01760109|Sulbactam|sulbactam|mesh-list
153584223|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584224|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584225|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153584305|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584306|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153584307|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153584308|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
153584309|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584310|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153584311|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153584312|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584313|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
153584314|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153584315|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153584316|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
153584317|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153584318|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153584337|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153584338|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153584339|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153584342|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
153584343|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
153584344|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584345|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584346|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153584347|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
153584348|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584349|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584350|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
153584351|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153584352|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584353|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153584354|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153584355|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153584356|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153584357|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153584358|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153584359|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
153584360|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153584361|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153584362|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153584363|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
153584364|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584365|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153584366|NCT01760694|Leucovorin|leucovorin|mesh-list
153584367|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
153584368|NCT01760694|Irinotecan|irinotecan|mesh-list
153584369|NCT01760694|Folfirinox|folfirinox|mesh-list
153584435|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153584436|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153584437|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584446|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584448|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
153584449|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584450|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584451|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584452|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584453|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153584454|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584455|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584456|NCT01761110|Buprenorphine|buprenorphine|mesh-list
153584457|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153584458|NCT01761110|Narcotics|narcotics|mesh-ancestor
153584459|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584460|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584461|NCT01761110|Analgesics|analgesics|mesh-ancestor
153502690|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
153584497|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584498|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584499|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153584500|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153584501|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584502|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584503|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584524|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584525|NCT01761513|Esomeprazole|esomeprazole|mesh-list
153584526|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153584527|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584528|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153584529|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584530|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584532|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
153584533|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
153584534|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584535|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584536|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584537|NCT01761552|Atropine|atropine|mesh-list
153584538|NCT01761552|Neostigmine|neostigmine|mesh-list
153584539|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153584540|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153584541|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153584542|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
153584543|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584544|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584545|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153584546|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
153584547|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
153584548|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
153584549|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153584550|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153584551|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
153584552|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809414|NCT03579446|Hydromorphone|hydromorphone|mesh-list
153646705|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584553|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584554|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153584555|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584556|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153584558|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153584573|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
153584574|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584575|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584576|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153584577|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
153584578|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
153584579|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153584580|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153584581|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153584582|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
153584583|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584644|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584645|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153584646|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
153584647|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584648|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584649|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153584650|NCT01762306|Folic Acid|folic acid|mesh-list
153584651|NCT01762306|Diclofenac|diclofenac|mesh-list
153584652|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153584653|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584654|NCT01762306|Analgesics|analgesics|mesh-ancestor
153584655|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
153584656|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584657|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584658|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584659|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584660|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153584661|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584662|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584663|NCT01762306|Hematinics|hematinics|mesh-ancestor
153584664|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
153584665|NCT01762306|Vitamins|vitamins|mesh-ancestor
153584666|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
153584667|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
153584668|NCT01762319|Pyridoxal|pyridoxal|mesh-list
153584669|NCT01762319|Pyridoxine|pyridoxine|mesh-list
153584670|NCT01762319|Misoprostol|misoprostol|mesh-list
153584671|NCT01762319|Vitamins|vitamins|mesh-ancestor
153584672|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
153584673|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584694|NCT01762436|Atenolol|atenolol|mesh-list
153584695|NCT01762436|Bisoprolol|bisoprolol|mesh-list
153584696|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153584697|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153584698|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
153584699|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
153584706|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584707|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584708|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
153584709|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
153584710|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153584711|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153584712|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584713|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584714|NCT01762475|Urological Agents|urological agents|mesh-ancestor
153584716|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153584717|NCT01762514|Protective Agents|protective agents|mesh-ancestor
153584718|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584719|NCT01762540|Prednisolone|prednisolone|mesh-list
153584720|NCT01762540|Calcium|calcium|mesh-list
153584721|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
153584722|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153584774|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153584775|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
153584776|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153584777|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584778|NCT01762787|Analgesics|analgesics|mesh-ancestor
153584779|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
153584780|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584781|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584782|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584783|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584784|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153584785|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153584786|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584787|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153584788|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153584789|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584790|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
153584791|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
153584792|NCT01762787|Hormones|hormones|mesh-ancestor
153584793|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584794|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153584795|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584796|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
153584807|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153584808|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
153584809|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584811|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153584812|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584813|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584814|NCT01762891|Acetaminophen|acetaminophen|mesh-list
153584815|NCT01762891|Celecoxib|celecoxib|mesh-list
153584816|NCT01762891|Rofecoxib|rofecoxib|mesh-list
153584817|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584818|NCT01762891|Analgesics|analgesics|mesh-ancestor
153584819|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
153584820|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584821|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584822|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
153584823|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153584824|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584825|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584826|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153584827|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153584828|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584829|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584830|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
153584831|NCT01762995|Dolutegravir|dolutegravir|mesh-list
153584832|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
153584833|NCT01762995|Calcium|calcium|mesh-list
153584834|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153584835|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584836|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153584837|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153584838|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584839|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584840|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153584841|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153584842|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
153584843|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584874|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584875|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584876|NCT01763437|Tetracycline|tetracycline|mesh-list
153584877|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584878|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584879|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153584880|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584881|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584882|NCT01763450|Bevacizumab|bevacizumab|mesh-list
153584883|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153584884|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584885|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153584886|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153584887|NCT01763450|Growth Substances|growth substances|mesh-ancestor
153584888|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584889|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
153584890|NCT01763463|Fluticasone|fluticasone|mesh-list
153584941|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153584943|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584945|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
153584946|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584947|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584948|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584949|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
153584951|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584952|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153584953|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584954|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584955|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153584956|NCT01763658|Protective Agents|protective agents|mesh-ancestor
153584957|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
153584958|NCT01763710|Paclitaxel|paclitaxel|mesh-list
153584959|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153584960|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153584961|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584962|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
153584963|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
153584964|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
153584965|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584967|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153584968|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153584969|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153584970|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153584971|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
153584975|NCT01763788|Gemcitabine|gemcitabine|mesh-list
153584997|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584998|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153585000|NCT01764178|Pitavastatin|pitavastatin|mesh-list
153585001|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153585002|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153585003|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153585004|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585005|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153585006|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153585007|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153585008|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
153585009|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585010|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153585011|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153585012|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
153585013|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153585014|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
153585015|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153585016|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585017|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153585018|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153585019|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585021|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153585022|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153585023|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153585024|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
153585025|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585026|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153585027|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153585032|NCT01763424|Calcitriol|calcitriol|mesh-list
153585037|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
153585038|NCT01763424|Vitamins|vitamins|mesh-ancestor
153585039|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
153585040|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585041|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153585042|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
153585043|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585044|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153585045|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
153585046|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
153585047|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153585048|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153585049|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585050|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153585051|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153585052|NCT01764555|Acetaminophen|acetaminophen|mesh-list
153585053|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153585054|NCT01764555|Analgesics|analgesics|mesh-ancestor
153585055|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
153585067|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153585068|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585069|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153585070|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153585101|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585102|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153585103|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153585104|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
153585105|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
153585106|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585107|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153585108|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153585109|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
153585110|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153585111|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
153585112|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153585113|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153585114|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
153585115|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153585116|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153585117|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585118|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153585119|NCT01764867|Analgesics|analgesics|mesh-ancestor
153585131|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153585132|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153585133|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153585161|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585162|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153585163|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153585164|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
153585165|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585166|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154157454|NCT05782712|Vasodilator Agents|vasodilator agents|mesh-ancestor
153585167|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153585168|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585169|NCT01765088|Temozolomide|temozolomide|mesh-list
153585170|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153585171|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
153585172|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585173|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585174|NCT01765231|Entecavir|entecavir|mesh-list
153585175|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
153585176|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585177|NCT01765257|Rasagiline|rasagiline|mesh-list
153585178|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153585179|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585180|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585192|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153585193|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585194|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
153585195|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585196|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585197|NCT01765452|Clopidogrel|clopidogrel|mesh-list
153585198|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153585199|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153585200|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153585213|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585214|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153585215|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
153585216|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585217|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585218|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153585219|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585220|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153585221|NCT01765608|Zonisamide|zonisamide|mesh-list
153585222|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
153585229|NCT01765738|Rifampin|rifampin|mesh-list
153585289|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153585290|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153585291|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153585292|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
153585293|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
153585294|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153585295|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153585296|NCT01765842|Rituximab|rituximab|mesh-list
153585297|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153585298|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585302|NCT01765881|Misoprostol|misoprostol|mesh-list
153585361|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585362|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585363|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153585365|NCT01766323|Modafinil|modafinil|mesh-list
153585366|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153585367|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585368|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153585369|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153585370|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153585391|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
153585392|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585393|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153585394|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153585395|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153585447|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
153585448|NCT01766843|Hormones|hormones|mesh-ancestor
153585449|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585450|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
153585451|NCT01766843|Antidotes|antidotes|mesh-ancestor
153585452|NCT01766843|Protective Agents|protective agents|mesh-ancestor
153585453|NCT01766960|Morphine|morphine|mesh-list
153585454|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153585455|NCT01766960|Narcotics|narcotics|mesh-ancestor
153585456|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585457|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585459|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
153585460|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585461|NCT01767025|Oxytocin|oxytocin|mesh-list
153585509|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585510|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153585511|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585512|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
153585513|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585514|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153585515|NCT01767389|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153585516|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
153585517|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585518|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585519|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153585520|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585521|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153585522|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
153585523|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585524|NCT01767428|Acetaminophen|acetaminophen|mesh-list
153585525|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153585526|NCT01767428|Analgesics|analgesics|mesh-ancestor
153585527|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
153585528|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585529|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585530|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
153585575|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
153585576|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585577|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153585578|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153585579|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
153585580|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585581|NCT01767896|Vaccines|vaccines|mesh-list
153585582|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
153585583|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585584|NCT01767948|Ibrutinib|ibrutinib|mesh-list
153585585|NCT01767948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153585586|NCT01767948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153585587|NCT01767948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585588|NCT01767948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585589|NCT01768039|Vitamin D|vitamin d|mesh-list
153585590|NCT01768039|Vitamins|vitamins|mesh-ancestor
153585591|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
153585645|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153585646|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585647|NCT01768260|Aspirin|aspirin|mesh-list
153585648|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153585649|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153585650|NCT01768260|Analgesics|analgesics|mesh-ancestor
153585651|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
153585652|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585653|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585654|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153585655|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585656|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153585657|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153585658|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585659|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153585660|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153585661|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585662|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
153585663|NCT01768273|Midazolam|midazolam|mesh-list
153585664|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153585665|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153585666|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585667|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585668|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153585669|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153585670|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153585671|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153585672|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
153585673|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
153585674|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
153585675|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
153585697|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153585698|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153585699|NCT01768312|Cyclosporine|cyclosporine|mesh-list
153585700|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153585701|NCT01768312|Cyclosporins|cyclosporins|mesh-list
153585702|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585703|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585704|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153585705|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
153585706|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585707|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
153585708|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585709|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
153585710|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585711|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153585767|NCT01768481|Atorvastatin|atorvastatin|mesh-list
153585768|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153585769|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153585770|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
153585771|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585772|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153585773|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153585774|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585775|NCT01768507|Resveratrol|resveratrol|mesh-list
153585776|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
153585777|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585778|NCT01768507|Protective Agents|protective agents|mesh-ancestor
153585779|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585780|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585781|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153585782|NCT01768663|Itraconazole|itraconazole|mesh-list
153585783|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
153585784|NCT01768663|Rifampin|rifampin|mesh-list
153585785|NCT01768663|Ivacaftor|ivacaftor|mesh-list
153585786|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
153585787|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585788|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153585789|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153585790|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585791|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585792|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153585793|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
153585794|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585795|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585796|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153585797|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585798|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153585799|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153810438|NCT00421512|Sunitinib|sunitinib|mesh-list
153585805|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153585806|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153585807|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153585808|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153585809|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153585810|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153585811|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153585822|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585824|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585826|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153585827|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
153585828|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365685|NCT02487108|Acetaminophen|acetaminophen|mesh-list
153585829|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585830|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
153585831|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153585832|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
153585833|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585834|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585835|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153585836|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
153585837|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153585838|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
153585859|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585860|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153585861|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153585862|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585863|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
153585864|NCT01768897|Protective Agents|protective agents|mesh-ancestor
153585865|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
153585866|NCT01768897|Vitamins|vitamins|mesh-ancestor
153585867|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
153585868|NCT01768988|Pregabalin|pregabalin|mesh-list
153585869|NCT01768988|Analgesics|analgesics|mesh-ancestor
153585870|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
153585871|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585872|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585873|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
153585874|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153585875|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585876|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585891|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153585892|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153585893|NCT01769066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153585894|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153585895|NCT01769079|Isosorbide|isosorbide|mesh-list
153585896|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153585897|NCT01769079|Diuretics|diuretics|mesh-ancestor
153585898|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
153585899|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585900|NCT01769118|Caffeine|caffeine|mesh-list
153585910|NCT01769183|Squalamine|squalamine|mesh-list
153585920|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153585921|NCT01769183|Growth Substances|growth substances|mesh-ancestor
153585922|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
153585923|NCT01769235|Clindamycin|clindamycin|mesh-list
153585924|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
153585925|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
153585926|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153585927|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585928|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585929|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153585930|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585931|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585932|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
153585933|NCT01769482|Udenafil|udenafil|mesh-list
153585934|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153585935|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153585936|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585937|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585938|NCT01769625|Vitamin D|vitamin d|mesh-list
153585960|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585967|NCT01769664|Clindamycin|clindamycin|mesh-list
153586021|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
153586022|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
153586023|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586024|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586025|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586026|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
153586027|NCT01769820|Hormones|hormones|mesh-ancestor
153586028|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586029|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153586030|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586031|NCT01769833|Interferons|interferons|mesh-list
153586032|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
153586033|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
153586034|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153586035|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586036|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
153586037|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586038|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
153586039|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586040|NCT01769898|Budesonide|budesonide|mesh-list
153586041|NCT01769898|Theophylline|theophylline|mesh-list
153586048|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153586049|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
153586050|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
153586051|NCT01769898|Hormones|hormones|mesh-ancestor
153586052|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586053|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153586054|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153586077|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153586078|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
153586079|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
153586080|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586081|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586082|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
153586083|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586084|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153586085|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
153586086|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153586087|NCT01769950|Choline|choline|mesh-list
153586088|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
153586089|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153586090|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
153586091|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586092|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586093|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153586094|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
153586095|NCT01770041|Acetaminophen|acetaminophen|mesh-list
153586096|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153586097|NCT01770041|Analgesics|analgesics|mesh-ancestor
153586098|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
153586099|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586100|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586101|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
153586102|NCT01770080|Peppermint oil|peppermint oil|mesh-list
153586103|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153586104|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
153586105|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
153586106|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586110|NCT01770106|Denosumab|denosumab|mesh-list
153586123|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153586124|NCT01770171|Paclitaxel|paclitaxel|mesh-list
153586125|NCT01770171|Bevacizumab|bevacizumab|mesh-list
153586126|NCT01770171|Carboplatin|carboplatin|mesh-list
153586127|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153586128|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586129|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
153586130|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
153586131|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
153586132|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586133|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153586134|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153586135|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153586136|NCT01770171|Growth Substances|growth substances|mesh-ancestor
153586137|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586138|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
153586139|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153586143|NCT01770210|Atorvastatin|atorvastatin|mesh-list
153586206|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153586207|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586208|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153586209|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153586210|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
153586211|NCT01770769|Cloxacillin|cloxacillin|mesh-list
153586212|NCT01770769|Cephalothin|cephalothin|mesh-list
153586213|NCT01770769|Dalteparin|dalteparin|mesh-list
153586214|NCT01770769|Tinzaparin|tinzaparin|mesh-list
153586215|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153586216|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
153586217|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153586218|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153586222|NCT01770795|Gemcitabine|gemcitabine|mesh-list
153586314|NCT01771458|Dasatinib|dasatinib|mesh-list
153586315|NCT01771458|Lapatinib|lapatinib|mesh-list
153586316|NCT01771458|Vemurafenib|vemurafenib|mesh-list
153586317|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153586318|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586319|NCT01771458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153586320|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153586321|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586322|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586323|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586324|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
153586325|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586342|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153586343|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586344|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
153586345|NCT01771822|Ibuprofen|ibuprofen|mesh-list
153586346|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153586347|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153586348|NCT01771822|Analgesics|analgesics|mesh-ancestor
153586408|NCT01772251|Insulin|insulin|mesh-list
153586409|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153586410|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586411|NCT01772290|Itraconazole|itraconazole|mesh-list
153586412|NCT01772290|Fluconazole|fluconazole|mesh-list
153586413|NCT01772290|Rabeprazole|rabeprazole|mesh-list
153586414|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
153586415|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586416|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153586417|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153586418|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586419|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586420|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153586421|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
153586422|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586423|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586424|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153586425|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153586441|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586443|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
153586444|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
153586445|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
153586446|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586447|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586448|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153586449|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153586450|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586451|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586452|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586453|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153586454|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153586455|NCT01772641|Varenicline|varenicline|mesh-list
153586456|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153586457|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153586458|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
153586461|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586462|NCT01772797|Ceritinib|ceritinib|mesh-list
153586463|NCT01772797|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153586464|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153586465|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586466|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586467|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586468|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
153586469|NCT01772836|Biapenem|biapenem|mesh-list
153586470|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586471|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586472|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586473|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586474|NCT01772940|Ritonavir|ritonavir|mesh-list
153586475|NCT01772940|Lopinavir|lopinavir|mesh-list
153586476|NCT01772940|Tenofovir|tenofovir|mesh-list
153586477|NCT01772940|Lamivudine|lamivudine|mesh-list
153586478|NCT01772940|Emtricitabine|emtricitabine|mesh-list
153586479|NCT01772940|Zidovudine|zidovudine|mesh-list
153586480|NCT01772940|Nevirapine|nevirapine|mesh-list
153586481|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153586482|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153586483|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
153586497|NCT01772953|Treosulfan|treosulfan|mesh-list
153586498|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153586499|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
153586500|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586501|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586524|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586525|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586526|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
153586527|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586528|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153586529|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153586530|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153586531|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153586532|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586533|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
153586534|NCT01773096|Bisacodyl|bisacodyl|mesh-list
153586535|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153586536|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
153586537|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153586538|NCT01773096|Cathartics|cathartics|mesh-ancestor
153586539|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586540|NCT01773096|Laxatives|laxatives|mesh-ancestor
153586541|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153586542|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586543|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
153586564|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586565|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
153586570|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586595|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153586596|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
153586597|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153586598|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
153586599|NCT01773616|Rituximab|rituximab|mesh-list
153586618|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153586619|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
153586620|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
153586621|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586622|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586623|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153586624|NCT01773616|Protective Agents|protective agents|mesh-ancestor
153586625|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
153586626|NCT01773681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153586627|NCT01773681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586628|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586629|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
153586630|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586631|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586632|NCT01773772|Progesterone|progesterone|mesh-list
153586633|NCT01773772|Progestins|progestins|mesh-ancestor
153586635|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586636|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586637|NCT01773798|Insulin|insulin|mesh-list
153586638|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153586639|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
153586640|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
153586641|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153586642|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153586643|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586644|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153586646|NCT01773837|Methylphenidate|methylphenidate|mesh-list
153586672|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153586673|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153586674|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153586675|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153586676|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586677|NCT01774474|Dexamethasone|dexamethasone|mesh-list
153586678|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
153586679|NCT01774474|Triamcinolone|triamcinolone|mesh-list
153586680|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153586681|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153586682|NCT01774474|Bromfenac|bromfenac|mesh-list
153586683|NCT01774474|Bevacizumab|bevacizumab|mesh-list
153586684|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153586685|NCT01774474|BB 1101|bb 1101|mesh-list
153586686|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153586687|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153586688|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586700|NCT01774474|Hormones|hormones|mesh-ancestor
153586740|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586741|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586742|NCT01774877|Leflunomide|leflunomide|mesh-list
153586743|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586744|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586745|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586746|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
153586747|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586748|NCT01775098|Allopurinol|allopurinol|mesh-list
153586749|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
153586750|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586751|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586752|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
153586753|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586755|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
153586803|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153586804|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586805|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586806|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586807|NCT01775839|Aspirin|aspirin|mesh-list
153586808|NCT01775839|Digoxin|digoxin|mesh-list
153586809|NCT01775839|Clopidogrel|clopidogrel|mesh-list
153586810|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153586811|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153586812|NCT01775839|Analgesics|analgesics|mesh-ancestor
153586813|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
153586814|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586815|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586816|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586817|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586818|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153586819|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153586820|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586899|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153586900|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586901|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153586902|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153586903|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153586904|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586905|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586906|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
153586907|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153586908|NCT01776684|Gefitinib|gefitinib|mesh-list
153586909|NCT01776684|Afatinib|afatinib|mesh-list
153586910|NCT01776684|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153586911|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153586912|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586913|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586914|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586915|NCT01776788|Insulin|insulin|mesh-list
153586916|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153586917|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
153586918|NCT01776788|Exenatide|exenatide|mesh-list
153586919|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153586920|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586921|NCT01776788|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153586922|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153586923|NCT01776788|Incretins|incretins|mesh-ancestor
153586953|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
153586954|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
153586955|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586956|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586957|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586958|NCT01777477|Chloroquine|chloroquine|mesh-list
153586959|NCT01777477|Gemcitabine|gemcitabine|mesh-list
153586960|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153586961|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
153586963|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587061|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153587063|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
153587064|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587065|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
153587066|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587067|NCT01778244|Metformin|metformin|mesh-list
153587068|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153587069|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587070|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
153587071|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153587072|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
153587166|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587167|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153587168|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153587170|NCT01779284|Travoprost|travoprost|mesh-list
153587171|NCT01779284|Latanoprost|latanoprost|mesh-list
153587172|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153587173|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153587174|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
153587175|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587176|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587177|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587178|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153587179|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153587180|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153587181|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153587183|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
153587185|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153587186|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587187|NCT01779362|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153587188|NCT01779362|Incretins|incretins|mesh-ancestor
153587189|NCT01779362|Hormones|hormones|mesh-ancestor
153587190|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587191|NCT01779401|Aspirin|aspirin|mesh-list
153587192|NCT01779401|Cilostazol|cilostazol|mesh-list
153587193|NCT01779401|Clopidogrel|clopidogrel|mesh-list
153587194|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153587195|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153587196|NCT01779401|Analgesics|analgesics|mesh-ancestor
153587197|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
153587198|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587204|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587206|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153587207|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587221|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153587222|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153587223|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153587225|NCT01779466|Coagulants|coagulants|mesh-ancestor
153587226|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153587227|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
153587228|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587229|NCT01779479|Paclitaxel|paclitaxel|mesh-list
153587230|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153587231|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587232|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
153587233|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
153587234|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
153587235|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587236|NCT01779492|Oxycodone|oxycodone|mesh-list
153587237|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153587238|NCT01779492|Narcotics|narcotics|mesh-ancestor
153587298|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153587299|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
153587300|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587301|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153587302|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153587303|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153587304|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587306|NCT01779882|Busulfan|busulfan|mesh-list
153587307|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153587308|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
153587309|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587310|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153587311|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153587312|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
153587313|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587314|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587315|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153587316|NCT01779908|Vitamin D|vitamin d|mesh-list
153587317|NCT01779908|Vitamins|vitamins|mesh-ancestor
153587318|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
153587319|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587340|NCT01780233|Naltrexone|naltrexone|mesh-list
153587372|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587373|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587375|NCT01780311|Flecainide|flecainide|mesh-list
153587376|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153587377|NCT01780311|Propafenone|propafenone|mesh-list
153587378|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153587379|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153587380|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
153587381|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587388|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153587389|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153587391|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153587392|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
153587393|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
153587431|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153587432|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153587433|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153587434|NCT01780610|Hormones|hormones|mesh-list
153587435|NCT01780610|Estradiol|estradiol|mesh-list
153587436|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153587437|NCT01780610|Progesterone|progesterone|mesh-list
153587438|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587439|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587440|NCT01780610|Estrogens|estrogens|mesh-ancestor
153587441|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153587442|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
153587443|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153587444|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153587445|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587446|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153587447|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153587478|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587479|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153587480|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587481|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153587482|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153587483|NCT01780948|Everolimus|everolimus|mesh-list
153587484|NCT01780948|Atorvastatin|atorvastatin|mesh-list
153587485|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153587486|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153587552|NCT01781702|Analgesics|analgesics|mesh-ancestor
153587553|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
153587554|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587555|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587556|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153587557|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153587558|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153587559|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153587560|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587561|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587562|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153587563|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
153587564|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587565|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
153587566|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
153587567|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587568|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587569|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587570|NCT01781897|Mosapride|mosapride|mesh-list
153587571|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153587572|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153587573|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
153587574|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587577|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153587619|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587621|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153587622|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587623|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
153587624|NCT01782508|Interferons|interferons|mesh-list
153587625|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
153587626|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587627|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
153587628|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587629|NCT01782508|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153587630|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587631|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587632|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587634|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153587635|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153587645|NCT01782612|Analgesics|analgesics|mesh-list
153587692|NCT01782911|Protective Agents|protective agents|mesh-ancestor
153587693|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587694|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587695|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153587696|NCT01782924|Brodalumab|brodalumab|mesh-list
153587697|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153587698|NCT01782937|Brodalumab|brodalumab|mesh-list
153587699|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
153587700|NCT01782950|Rifampin|rifampin|mesh-list
153587701|NCT01782950|Isoniazid|isoniazid|mesh-list
153587702|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
153587703|NCT01782950|Ethambutol|ethambutol|mesh-list
153587704|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153587767|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
153587768|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
153587769|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587770|NCT01783717|Exenatide|exenatide|mesh-list
153587771|NCT01783717|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153587772|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153587773|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587774|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153587775|NCT01783717|Incretins|incretins|mesh-ancestor
153587776|NCT01783717|Hormones|hormones|mesh-ancestor
153587784|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587785|NCT01783756|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153587786|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587787|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587788|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153587789|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
153587790|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587791|NCT01783756|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153587792|NCT01783834|Pemetrexed|pemetrexed|mesh-list
153587793|NCT01783834|Gefitinib|gefitinib|mesh-list
153587794|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587830|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153587831|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587832|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587833|NCT01784120|Tubulin Modulators|tubulin modulators|mesh-ancestor
153587834|NCT01784120|Antimitotic Agents|antimitotic agents|mesh-ancestor
153587835|NCT01784120|Mitosis Modulators|mitosis modulators|mesh-ancestor
153587836|NCT01784250|Propranolol|propranolol|mesh-list
153587837|NCT01784250|Clonidine|clonidine|mesh-list
153587838|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153587839|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153587840|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
153587841|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587842|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587843|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587844|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153587939|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
153587940|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587942|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
153587943|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587944|NCT01784978|Everolimus|everolimus|mesh-list
153587960|NCT01785004|Vitamins|vitamins|mesh-ancestor
153587961|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
153587962|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587963|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153587964|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153587965|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
153587966|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153587967|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
153587968|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
153588029|NCT01785329|Antimetabolites|antimetabolites|mesh-ancestor
153588030|NCT01785329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588031|NCT01785329|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153588032|NCT01785329|Protease Inhibitors|protease inhibitors|mesh-ancestor
153588033|NCT01785329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588034|NCT01785329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153588035|NCT01785446|Sufentanil|sufentanil|mesh-list
153588036|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
153588037|NCT01785446|Dsuvia|dsuvia|mesh-list
153588038|NCT01785446|Atracurium|atracurium|mesh-list
153588039|NCT01785446|Cisatracurium|cisatracurium|mesh-list
153588040|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153588041|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588042|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588043|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588044|NCT01785446|Analgesics|analgesics|mesh-ancestor
153588045|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
153588046|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588047|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153588048|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153588049|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153588050|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
153588051|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588052|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588053|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153588054|NCT01785446|Narcotics|narcotics|mesh-ancestor
153588055|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153588056|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153588057|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
153588058|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
153588059|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153588060|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153588061|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153588062|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153588063|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153588078|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
153588079|NCT01785693|Analgesics|analgesics|mesh-ancestor
153588080|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
153588081|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588082|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588083|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153588084|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
153588085|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
153588086|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153588087|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153588088|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153588089|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
153588090|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588091|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588092|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
153588093|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
153588094|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588095|NCT01785797|Silicon|silicon|mesh-list
153588096|NCT01785797|Trace Elements|trace elements|mesh-ancestor
153588133|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153588150|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153588151|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
153588152|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588153|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588154|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153588155|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
153588156|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588157|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588158|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
153588159|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588160|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153588161|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153588162|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
153588163|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588164|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153588165|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
153588166|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153588168|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
153588293|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
153588294|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153588295|NCT01787123|Protective Agents|protective agents|mesh-ancestor
153588296|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588297|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
153588298|NCT01787136|Levomethorphan|levomethorphan|mesh-list
153588299|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
153588300|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
153588301|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
153588302|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153588303|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153588304|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588305|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588306|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588307|NCT01787136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153588308|NCT01787136|Narcotics|narcotics|mesh-ancestor
153588309|NCT01787136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588310|NCT01787136|Analgesics|analgesics|mesh-ancestor
153588311|NCT01787136|Sensory System Agents|sensory system agents|mesh-ancestor
153588312|NCT01787136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588313|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
153588394|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
153588395|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588396|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153588397|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153588398|NCT01788189|Growth Substances|growth substances|mesh-ancestor
153588399|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
153588400|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588402|NCT01788254|Torsemide|torsemide|mesh-list
153588403|NCT01788254|Midazolam|midazolam|mesh-list
153588404|NCT01788254|Codeine|codeine|mesh-list
153588405|NCT01788254|Pravastatin|pravastatin|mesh-list
153588406|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153588407|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153588408|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588410|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153588500|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153588502|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153588503|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153588504|NCT01788605|Ramosetron|ramosetron|mesh-list
153588505|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
153588506|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
153588507|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588508|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588509|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153588510|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153588511|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
153588512|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588513|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588514|NCT01788670|Ethanol|ethanol|mesh-list
153588515|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153588516|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153588517|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588518|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588519|NCT01788722|Dienogest|dienogest|mesh-list
153588541|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588542|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153588543|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588545|NCT01789086|Liraglutide|liraglutide|mesh-list
153588568|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153588569|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588570|NCT01789216|Analgesics|analgesics|mesh-ancestor
153588571|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
153588586|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153588587|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153588588|NCT01789242|Dexamethasone|dexamethasone|mesh-list
153588589|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588590|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
153588591|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
153588592|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588593|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588594|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153588595|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
153588596|NCT01789242|Hormones|hormones|mesh-ancestor
153745644|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588597|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588598|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153588599|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588601|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153588602|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588603|NCT01789294|Analgesics|analgesics|mesh-ancestor
153588649|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153588650|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
153588651|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588652|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588653|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153588654|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
153588655|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153588656|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153588657|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153588658|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153588659|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
153588660|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153588661|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153588662|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588664|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
153588665|NCT01789723|Antidotes|antidotes|mesh-ancestor
153588666|NCT01789723|Protective Agents|protective agents|mesh-ancestor
153588667|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588668|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
153588669|NCT01789723|Vitamins|vitamins|mesh-ancestor
153588670|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
153588671|NCT01789827|Interleukin-2|interleukin-2|mesh-list
153588672|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588673|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588674|NCT01789827|Analgesics|analgesics|mesh-ancestor
153588675|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
153588676|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588677|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588678|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
153588750|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153588751|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153588752|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153588753|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153588754|NCT01793038|Clomiphene|clomiphene|mesh-list
153588755|NCT01793038|Enclomiphene|enclomiphene|mesh-list
153588756|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
153588757|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153588758|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588759|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153588760|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
153588825|NCT01796132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153588826|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153588827|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153588828|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588829|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588830|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
153588831|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588832|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588833|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153588834|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
153588835|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153588836|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153588837|NCT01796132|Analgesics|analgesics|mesh-ancestor
153588838|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
153588839|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
153588840|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153588841|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153588842|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588843|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153588844|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153588845|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588856|NCT01796522|Nifedipine|nifedipine|mesh-list
153588871|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
153588872|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588873|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588874|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153588875|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
153588876|NCT01796808|Lidocaine|lidocaine|mesh-list
153588877|NCT01796808|Epinephrine|epinephrine|mesh-list
153588878|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
153588879|NCT01796808|Anesthetics|anesthetics|mesh-list
153588880|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588881|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588882|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
153588883|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588884|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153588885|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153588886|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153588887|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153588888|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588889|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153588890|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153588945|NCT01798836|Estrogens|estrogens|mesh-ancestor
153588946|NCT01798836|Hormones|hormones|mesh-ancestor
153588947|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588948|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588949|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153588950|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
153588951|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588952|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153588953|NCT01798901|Decitabine|decitabine|mesh-list
153588954|NCT01798901|Azacitidine|azacitidine|mesh-list
153588955|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153588956|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153588957|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
153588958|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588959|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588960|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588961|NCT01799863|Ketorolac|ketorolac|mesh-list
153589016|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
153589017|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153589018|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153589019|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589020|NCT01800292|Urological Agents|urological agents|mesh-ancestor
153589021|NCT01800357|Aspirin|aspirin|mesh-list
153589022|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
153589023|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153589024|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153589025|NCT01800357|Analgesics|analgesics|mesh-ancestor
153589026|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
153589050|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
153589051|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153589052|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153589053|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589054|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
153589055|NCT01800435|Coagulants|coagulants|mesh-ancestor
153589057|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
153368927|NCT02491437|Hormones|hormones|mesh-ancestor
153589058|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589059|NCT01800487|Protective Agents|protective agents|mesh-ancestor
153589060|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589061|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
153589062|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153589063|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
153589064|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589065|NCT01800526|Expectorants|expectorants|mesh-ancestor
153589066|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
153589067|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153589092|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589093|NCT01800695|Immunoconjugates|immunoconjugates|mesh-ancestor
153589094|NCT01800695|Immunologic Factors|immunologic factors|mesh-ancestor
153589095|NCT01800695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589096|NCT01800708|Prednisolone|prednisolone|mesh-list
153589097|NCT01800708|Triamcinolone|triamcinolone|mesh-list
153589098|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153589099|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153589100|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153589101|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153589102|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
153589103|NCT01800708|Hormones|hormones|mesh-ancestor
153589104|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589105|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589106|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153589107|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589108|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589109|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
153589110|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589111|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589112|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153589113|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589114|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
153589115|NCT01800799|Celecoxib|celecoxib|mesh-list
153589116|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153589117|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153589118|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153589119|NCT01800799|Analgesics|analgesics|mesh-ancestor
153589120|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
153589122|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589123|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589135|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589136|NCT01800942|Azithromycin|azithromycin|mesh-list
153589137|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589138|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589158|NCT01801137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589159|NCT01801137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589160|NCT01801137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589161|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589162|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
153589163|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589164|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589165|NCT01801163|Sorafenib|sorafenib|mesh-list
153589166|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589167|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589168|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589169|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589170|NCT01801228|Eplerenone|eplerenone|mesh-list
153589171|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153589176|NCT01801228|Diuretics|diuretics|mesh-ancestor
153589232|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589233|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
153589234|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589235|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153589236|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360093|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
153589237|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589238|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589239|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589240|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153589241|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589242|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
153589243|NCT01802450|Dasatinib|dasatinib|mesh-list
153589244|NCT01802450|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153589245|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589246|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589247|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589248|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589249|NCT01802476|Palbociclib|palbociclib|mesh-list
153589250|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589251|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589252|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157455|NCT05782712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153706151|NCT00418873|Risperidone|risperidone|mesh-list
153589253|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589254|NCT01802489|Amiloride|amiloride|mesh-list
153589255|NCT01802489|Diuretics|diuretics|mesh-ancestor
153589288|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589289|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589290|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
153589291|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589292|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153589293|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589294|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
153589295|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589296|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153589297|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
153589298|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153589299|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
153589300|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589301|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589302|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153589303|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
153589304|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153589305|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
153589306|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589307|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589308|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153589309|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
153589310|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
153589311|NCT01802619|Protective Agents|protective agents|mesh-ancestor
153589312|NCT01802645|Leucovorin|leucovorin|mesh-list
153589313|NCT01802645|Folic Acid|folic acid|mesh-list
153589314|NCT01802645|Bevacizumab|bevacizumab|mesh-list
153589315|NCT01802645|Cetuximab|cetuximab|mesh-list
153589316|NCT01802645|Fluorouracil|fluorouracil|mesh-list
153589317|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
153589318|NCT01802645|Irinotecan|irinotecan|mesh-list
153589319|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
153589333|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153589334|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589335|NCT01802645|Antidotes|antidotes|mesh-ancestor
153589336|NCT01802645|Protective Agents|protective agents|mesh-ancestor
153589337|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
153589338|NCT01802645|Vitamins|vitamins|mesh-ancestor
153589353|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153589354|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
153589355|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589356|NCT01802918|Ritonavir|ritonavir|mesh-list
153589357|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
153589358|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153589359|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153589360|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
153589361|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589362|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589430|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153589432|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589433|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589437|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589438|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
153589439|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
153589440|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
153589441|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589442|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153589443|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153589444|NCT01803503|Growth Substances|growth substances|mesh-ancestor
153589445|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589446|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
153589447|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589463|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
153589464|NCT01803828|Tadalafil|tadalafil|mesh-list
153589465|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
153589466|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153589467|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153589468|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157456|NCT05782712|Purinergic Agonists|purinergic agonists|mesh-ancestor
153589469|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589470|NCT01803828|Urological Agents|urological agents|mesh-ancestor
153589471|NCT01804127|Rituximab|rituximab|mesh-list
153589472|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153589473|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589474|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
153589475|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589476|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589477|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
153589478|NCT01804205|Analgesics|analgesics|mesh-ancestor
153589479|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
153589480|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589481|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589483|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589484|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153589485|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
153589486|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153589487|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153589488|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589489|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153589490|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
153589491|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153589492|NCT01804218|Nadolol|nadolol|mesh-list
153589493|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153589494|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153589495|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
153589496|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589497|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589498|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589504|NCT01804244|Rilpivirine|rilpivirine|mesh-list
153781670|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781671|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781672|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153781673|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781674|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153781675|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
153781676|NCT00477490|Coagulants|coagulants|mesh-ancestor
153781677|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153781678|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
153781679|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781680|NCT00231530|Topiramate|topiramate|mesh-list
153781681|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
153781682|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153781683|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781684|NCT00231569|Mipomersen|mipomersen|mesh-list
153781685|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153781686|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153781687|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
153781688|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589554|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589555|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589556|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153589557|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153589558|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589559|NCT01804413|Insulin|insulin|mesh-list
153589561|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153589562|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589563|NCT01804543|Ranolazine|ranolazine|mesh-list
153589564|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153589565|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153589566|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589629|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589657|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589658|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153589659|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589660|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589661|NCT01807767|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153589662|NCT01807767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589663|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589664|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153589665|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153589666|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
153589667|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589668|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589669|NCT01807832|Capsaicin|capsaicin|mesh-list
153589732|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589734|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589735|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153589756|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589757|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153589758|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
153589759|NCT01808586|Hormones|hormones|mesh-ancestor
153589760|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589761|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153589762|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589763|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
153589764|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
153589765|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589766|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
153589767|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153589768|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153589769|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153589770|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153589771|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589772|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153589773|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
153589774|NCT01808638|Gemcitabine|gemcitabine|mesh-list
153589775|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589776|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
153589777|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589778|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589779|NCT01808768|Alcaftadine|alcaftadine|mesh-list
153589780|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153589787|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
153589789|NCT01808898|Anesthetics|anesthetics|mesh-list
153589790|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589791|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589799|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589800|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153589801|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
153589802|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589803|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589804|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153589805|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153589806|NCT01809158|Minocycline|minocycline|mesh-list
153589807|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589808|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589809|NCT01809171|Vitamin D|vitamin d|mesh-list
153589810|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
153589811|NCT01809171|Vitamins|vitamins|mesh-ancestor
153589812|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
153589813|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589814|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153589815|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153589816|NCT01809184|Insulin|insulin|mesh-list
153589817|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153589818|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
153589819|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153589820|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589822|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
153589823|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153589824|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
153589825|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589826|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153589827|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
153502774|NCT03210324|Mifepristone|mifepristone|mesh-list
153589828|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
153589829|NCT01809301|Vitamins|vitamins|mesh-ancestor
153589830|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
153646706|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646707|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
153589831|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589832|NCT01809340|Minocycline|minocycline|mesh-list
153589833|NCT01809340|Ketamine|ketamine|mesh-list
153589834|NCT01809340|Analgesics|analgesics|mesh-ancestor
153589835|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
153589836|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589837|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589838|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153589839|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153589840|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
153589841|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
153589842|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589843|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153589844|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153589845|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589846|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589847|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589848|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589849|NCT01809392|Decitabine|decitabine|mesh-list
153589850|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589851|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
153589852|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589853|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589854|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589855|NCT01809444|Doxycycline|doxycycline|mesh-list
153589856|NCT01809444|Prednisone|prednisone|mesh-list
153589891|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589892|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153589893|NCT01809847|Ofatumumab|ofatumumab|mesh-list
153589894|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589895|NCT01809860|Sirolimus|sirolimus|mesh-list
153589896|NCT01809860|Isavuconazole|isavuconazole|mesh-list
153589897|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589898|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589899|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153589900|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589901|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
153589902|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589903|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
153589904|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589905|NCT01809886|Neostigmine|neostigmine|mesh-list
153589906|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153589907|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589908|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589909|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
153589910|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589911|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589912|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153589913|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
153589951|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153589953|NCT01810458|Midazolam|midazolam|mesh-list
153589954|NCT01810458|Fentanyl|fentanyl|mesh-list
153589955|NCT01810458|Oxycodone|oxycodone|mesh-list
153589956|NCT01810458|Lorazepam|lorazepam|mesh-list
153589957|NCT01810458|Ondansetron|ondansetron|mesh-list
153589958|NCT01810458|Liver Extracts|liver extracts|mesh-list
153589959|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
153589960|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
153589961|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589962|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589963|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
153589964|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589965|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153589967|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153590029|NCT01810848|Protective Agents|protective agents|mesh-ancestor
153590030|NCT01810887|Ritonavir|ritonavir|mesh-list
153590031|NCT01810887|Darunavir|darunavir|mesh-list
153590032|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153590033|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153590034|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
153590035|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590036|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590037|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153590038|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153590039|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
153590043|NCT01810926|Cyclosporine|cyclosporine|mesh-list
153590106|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153590107|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590109|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
153590110|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
153590111|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153590112|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153590122|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153590124|NCT01811381|Analgesics|analgesics|mesh-ancestor
153590125|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
153590126|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590127|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590128|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590129|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590130|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590131|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590133|NCT01811459|Haloperidol|haloperidol|mesh-list
153590173|NCT01811849|Insulin|insulin|mesh-list
153590174|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153590175|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
153590176|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153590177|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590178|NCT01812018|Gemcitabine|gemcitabine|mesh-list
153590197|NCT01812122|Vildagliptin|vildagliptin|mesh-list
153590198|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370041|NCT04002674|Nilotinib|nilotinib|mesh-list
153590199|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153590200|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590201|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153590202|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
153590203|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153590268|NCT01812382|Retapamulin|retapamulin|mesh-list
153590269|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153590270|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590271|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
153590272|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
153590273|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153781706|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153590274|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153590275|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590276|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590277|NCT01812434|Urological Agents|urological agents|mesh-ancestor
153590279|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153590280|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153590281|NCT01812538|Analgesics|analgesics|mesh-ancestor
153590282|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
153590283|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590334|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153590335|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
153590336|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153590337|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590338|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590339|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
153590340|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590341|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590342|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
153590343|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590344|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153590345|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153590346|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
153590347|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590348|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153590349|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
153590350|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590351|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153590352|NCT01812954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153590353|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590413|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590414|NCT01813487|Entecavir|entecavir|mesh-list
153590555|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
153590556|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153590557|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
153590558|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590559|NCT01814085|Escitalopram|escitalopram|mesh-list
153590560|NCT01814085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153590561|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153590564|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590930|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590932|NCT01816334|Protective Agents|protective agents|mesh-ancestor
153590933|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153590934|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591117|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591118|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591700|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591701|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153591702|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
153591703|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
153591704|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
153591705|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153591706|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153591740|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591741|NCT01821703|Spironolactone|spironolactone|mesh-list
153591742|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153591743|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
153591745|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592080|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153592081|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592082|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592083|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592084|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
153592085|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592086|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153592279|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592280|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592281|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592282|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153592283|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153592284|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
153592785|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153592786|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153468281|NCT06298383|Prednisolone|prednisolone|mesh-list
153592816|NCT01830153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592817|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153592819|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592820|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592821|NCT01830244|Paclitaxel|paclitaxel|mesh-list
153592822|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153592823|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592824|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
153592825|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
153592826|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
153592827|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592828|NCT01830270|Paclitaxel|paclitaxel|mesh-list
153592854|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
153592855|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592856|NCT01831050|Vaccines|vaccines|mesh-list
153592857|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
153592858|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592859|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
153593122|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153593123|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
153593125|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593126|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153593127|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153593128|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593129|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593130|NCT01840800|Ropivacaine|ropivacaine|mesh-list
153593131|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
153593132|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
153593198|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153593224|NCT01841411|Metronidazole|metronidazole|mesh-list
153593225|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
153593226|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153593227|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593228|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593229|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153593230|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153593231|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
153593232|NCT01841411|Expectorants|expectorants|mesh-ancestor
153593233|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
153593234|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153593235|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
153593236|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593747|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153593748|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153593749|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
153593910|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
153593911|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153593912|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593913|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593914|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153593915|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153594313|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
153594314|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
153594315|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
153594316|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594317|NCT01848652|Doxorubicin|doxorubicin|mesh-list
153594318|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153594319|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594378|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153594379|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153594380|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153594381|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594382|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153594383|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594384|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
153594385|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
153594386|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594388|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594389|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594441|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153594442|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153594443|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594467|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
153594468|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594469|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594470|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153594471|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594472|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153594473|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594474|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594475|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153594476|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594477|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153502802|NCT01832922|Rituximab|rituximab|mesh-list
153594478|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153594481|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
153594611|NCT01850979|Tacrolimus|tacrolimus|mesh-list
153594612|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153594613|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
153594614|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594615|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153594616|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594617|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594654|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595560|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153595561|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153595562|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595563|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153595564|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
153595565|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
153595566|NCT01857011|Iron|iron|mesh-list
153595567|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153595568|NCT01857011|Teferrol|teferrol|mesh-list
153596230|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596330|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
153596331|NCT01861015|Epinephrine|epinephrine|mesh-list
153596332|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153596333|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153596334|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
153596573|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153596574|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153596576|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596577|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596752|NCT01863888|Teriflunomide|teriflunomide|mesh-list
153596766|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
153596767|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153596768|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153596769|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
153596770|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596771|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153596772|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153596774|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153596801|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596802|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
153596803|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153596804|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596805|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596806|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153596807|NCT01864187|Analgesics|analgesics|mesh-ancestor
153597974|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153597976|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597977|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598390|NCT05852730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598391|NCT05852730|Anesthetics, Local|anesthetics, local|mesh-ancestor
153598392|NCT05852730|Anesthetics|anesthetics|mesh-ancestor
153598393|NCT05852730|Sensory System Agents|sensory system agents|mesh-ancestor
153598394|NCT05845489|Anticoagulants|anticoagulants|mesh-list
153598395|NCT05845489|Clopidogrel|clopidogrel|mesh-list
153598821|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153598822|NCT04319328|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153598823|NCT04319328|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153598825|NCT04255160|Estrogens|estrogens|mesh-ancestor
153598826|NCT04255160|Hormones|hormones|mesh-ancestor
153598827|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599020|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599021|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153599023|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599025|NCT02450773|Furosemide|furosemide|mesh-list
153599094|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
153599095|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153599096|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599106|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153599108|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
153599109|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
153599110|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
153599112|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599183|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153599184|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599185|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153599186|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
153599187|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153599188|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
153599189|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153599190|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599262|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
153599264|NCT01874002|Temsirolimus|temsirolimus|mesh-list
153599265|NCT01874002|MTOR Inhibitors|mtor inhibitors|mesh-list
153599266|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599267|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599268|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153599269|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599270|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
153599271|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599272|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
153599273|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599274|NCT01874002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153599275|NCT01874002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599276|NCT01874002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599277|NCT01874028|Trientine|trientine|mesh-list
153599278|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
153599322|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599323|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153599324|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599325|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599326|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599327|NCT01874574|Triamcinolone|triamcinolone|mesh-list
153599328|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153599329|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153599330|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153781724|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599401|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599402|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599403|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153599404|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153599405|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599424|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599426|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599427|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153599428|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599429|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599433|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599551|NCT01876186|Urological Agents|urological agents|mesh-ancestor
153599553|NCT01876290|Ondansetron|ondansetron|mesh-list
153599554|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599555|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
153599556|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
153599557|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599558|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599559|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153599562|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599563|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153599564|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599565|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
153599566|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
153599567|NCT01876290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153599568|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153599569|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
153599570|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599571|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599572|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
153599617|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153599618|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
153599619|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599620|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599621|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599622|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153599623|NCT01876797|Ticagrelor|ticagrelor|mesh-list
153599624|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153599625|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154157457|NCT05782712|Purinergic Agents|purinergic agents|mesh-ancestor
153599626|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153599627|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153599628|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153599629|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
153599630|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599691|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599692|NCT01877356|Anesthetics|anesthetics|mesh-list
153599693|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599694|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599695|NCT01877512|Hormones|hormones|mesh-list
153599696|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599697|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599698|NCT01877577|Vitamin D|vitamin d|mesh-list
153599699|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
153599700|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
153599701|NCT01877577|Vitamins|vitamins|mesh-list
153599702|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
153599703|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599704|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153599705|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153599708|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599709|NCT01877590|Protective Agents|protective agents|mesh-ancestor
153599710|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599826|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599827|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153599828|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153599829|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
153599830|NCT01878539|Anticoagulants|anticoagulants|mesh-list
153599831|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153599833|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
153599834|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153599835|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153599836|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153599837|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599840|NCT01878643|Vancomycin|vancomycin|mesh-list
153599904|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599905|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599906|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599907|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153599908|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600054|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153600055|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153600057|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
153600058|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600059|NCT01880372|Protective Agents|protective agents|mesh-ancestor
153600060|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600061|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
153600062|NCT01880372|Vitamins|vitamins|mesh-ancestor
153600063|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
153600064|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
153600065|NCT01880385|Bevacizumab|bevacizumab|mesh-list
153600066|NCT01880385|Docetaxel|docetaxel|mesh-list
153600125|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
153600126|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600127|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600128|NCT01880775|Bupivacaine|bupivacaine|mesh-list
153600129|NCT01880775|Prilocaine|prilocaine|mesh-list
153600130|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
153600131|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
153600132|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600133|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600134|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
153600135|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600136|NCT01879241|Rasagiline|rasagiline|mesh-list
153600137|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153600138|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600139|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600140|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153600141|NCT01879241|Protective Agents|protective agents|mesh-ancestor
153600190|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
153600191|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153600192|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153600193|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600194|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
153600238|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153600239|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
153600240|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
153600241|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600242|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600243|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153600244|NCT01882179|Diuretics|diuretics|mesh-ancestor
153600246|NCT01882179|Hormones|hormones|mesh-ancestor
153600308|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600309|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153600310|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600311|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153600313|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153600314|NCT01883011|Protective Agents|protective agents|mesh-ancestor
153600315|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600316|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
153600317|NCT01883102|Capsaicin|capsaicin|mesh-list
153600318|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
153600319|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
153600320|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
153600321|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600322|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600323|NCT01883167|Febuxostat|febuxostat|mesh-list
153600324|NCT01883167|Verinurad|verinurad|mesh-list
153600388|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153600389|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153600390|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153600391|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153600392|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
153600393|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600394|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600395|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600396|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
153600397|NCT01883882|Narcotics|narcotics|mesh-ancestor
153600398|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600399|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600400|NCT01883882|Analgesics|analgesics|mesh-ancestor
153600401|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
153600402|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600403|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
153600404|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153600453|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600454|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600455|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
153600456|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600457|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153600458|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153600459|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153600460|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153600461|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600462|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153600463|NCT01884298|Narcotics|narcotics|mesh-ancestor
153600464|NCT01884298|Analgesics|analgesics|mesh-ancestor
153600466|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153600467|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
153600468|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600469|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
153600470|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600471|NCT01884415|Vaccines|vaccines|mesh-list
153600472|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
153600473|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600474|NCT01884428|Prednisolone|prednisolone|mesh-list
153600475|NCT01884428|Gemcitabine|gemcitabine|mesh-list
153600476|NCT01884428|Vinorelbine|vinorelbine|mesh-list
153600477|NCT01884428|Ifosfamide|ifosfamide|mesh-list
153600478|NCT01884428|Panobinostat|panobinostat|mesh-list
153600487|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600488|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153600506|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
153600507|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
153600508|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153600509|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
153600510|NCT01884467|Gentamicins|gentamicins|mesh-list
153600511|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153600512|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600513|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153600514|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600515|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600517|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
153600518|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153600519|NCT01884506|Trace Elements|trace elements|mesh-ancestor
153600520|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
153600521|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600522|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
153600523|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600524|NCT01884506|Protective Agents|protective agents|mesh-ancestor
153600526|NCT01884558|Metformin|metformin|mesh-list
153600527|NCT01884558|Isavuconazole|isavuconazole|mesh-list
153600528|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153600529|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600530|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
153600531|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600532|NCT01884636|Isavuconazole|isavuconazole|mesh-list
153600533|NCT01884636|Methotrexate|methotrexate|mesh-list
153600534|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153600535|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
153600536|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153600537|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600538|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153380406|NCT01916681|Misoprostol|misoprostol|mesh-list
153600539|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
153600540|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600541|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600558|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153600559|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153600560|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153600561|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600562|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600563|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600564|NCT01884896|Metoprolol|metoprolol|mesh-list
153600565|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153600566|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600567|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
153600568|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
153600622|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600623|NCT01885338|Protective Agents|protective agents|mesh-ancestor
153600624|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600625|NCT01885338|Antidotes|antidotes|mesh-ancestor
153600626|NCT01885364|Remifentanil|remifentanil|mesh-list
153600627|NCT01885364|Propofol|propofol|mesh-list
153600628|NCT01885364|Esmolol|esmolol|mesh-list
153600629|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153600630|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600631|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600632|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153600633|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
153600634|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
153600635|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153600636|NCT01885364|Narcotics|narcotics|mesh-ancestor
153600637|NCT01885364|Analgesics|analgesics|mesh-ancestor
153600638|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
153600639|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600640|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153600641|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153600642|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153600643|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600644|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600646|NCT01885481|Dexamethasone|dexamethasone|mesh-list
153600674|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
153600675|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600676|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600677|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
153600678|NCT01885598|Apixaban|apixaban|mesh-list
153600679|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153600680|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
153600695|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600696|NCT01885988|Nebivolol|nebivolol|mesh-list
153600697|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600698|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
153600699|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153600700|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153600759|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
153600761|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600762|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600763|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153600764|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600765|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
153600766|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
153600767|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600768|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153600769|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153600770|NCT01886209|Protective Agents|protective agents|mesh-ancestor
153600771|NCT01886248|Antithrombins|antithrombins|mesh-list
153600772|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
153600773|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153600774|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
153600775|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600776|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600777|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
153600778|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
153600779|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
153600780|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
153600781|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600782|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600783|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
153600784|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600785|NCT01886365|Insulin|insulin|mesh-list
153600786|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153600820|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153600821|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153600823|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
153600824|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600825|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600826|NCT01886768|Anesthetics|anesthetics|mesh-list
153600827|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600828|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600829|NCT01887119|Eplerenone|eplerenone|mesh-list
153600830|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153600831|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
153600835|NCT01887119|Diuretics|diuretics|mesh-ancestor
153600899|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600900|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600902|NCT01887379|Diuretics|diuretics|mesh-ancestor
153600903|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
153600904|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600905|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153600906|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153600907|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600908|NCT01887405|Epinephrine|epinephrine|mesh-list
153600910|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
153600911|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153600912|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153600913|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600914|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600915|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600919|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
153600960|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153600961|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153600962|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153600963|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153600964|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
153600965|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600966|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600967|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600968|NCT01887691|Eszopiclone|eszopiclone|mesh-list
153600969|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153601031|NCT01887847|Nicotine|nicotine|mesh-list
153601032|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153601033|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
153601034|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601035|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601036|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153601037|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153601038|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
153601039|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601040|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601041|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
153601042|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153601043|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
153601044|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601045|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
153601046|NCT01887873|Protective Agents|protective agents|mesh-ancestor
153601047|NCT01887951|Tramadol|tramadol|mesh-list
153601048|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153601049|NCT01887951|Narcotics|narcotics|mesh-ancestor
153601050|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601095|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153601096|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601097|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153601098|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601099|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601100|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601101|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153601102|NCT01888263|Lamotrigine|lamotrigine|mesh-list
153601103|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
153601104|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153601105|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601106|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601107|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153601108|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601197|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
153601198|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153601199|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601200|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601201|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153601275|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
153601276|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153601277|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
153601279|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601280|NCT01888861|Protective Agents|protective agents|mesh-ancestor
153601281|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601282|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
153601362|NCT01889368|Protective Agents|protective agents|mesh-ancestor
153601363|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601364|NCT01889407|Idarubicin|idarubicin|mesh-list
153601365|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153601366|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601367|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153601368|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153601369|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601370|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601371|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153601372|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
153601373|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601374|NCT01889446|Calcium|calcium|mesh-list
153601375|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153601436|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
153601437|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153601438|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153601439|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601440|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601441|NCT01889966|Urological Agents|urological agents|mesh-ancestor
153601442|NCT01889979|Tramadol|tramadol|mesh-list
153601443|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153601444|NCT01889979|Narcotics|narcotics|mesh-ancestor
153601445|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601509|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601511|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
153601512|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
153601513|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153601514|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153601515|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
153601516|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153601517|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153601518|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153601519|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153601520|NCT01894269|Lamivudine|lamivudine|mesh-list
153601521|NCT01894269|Entecavir|entecavir|mesh-list
153601524|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601586|NCT01896622|Ritonavir|ritonavir|mesh-list
153601587|NCT01896622|Cobicistat|cobicistat|mesh-list
153601588|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153601589|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153601590|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
153601591|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601592|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601593|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153601594|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153601595|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
153601596|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601597|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153601598|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153601599|NCT01897051|Rifaximin|rifaximin|mesh-list
153601600|NCT01897051|Propranolol|propranolol|mesh-list
153601601|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153601649|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153601650|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153601651|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153601652|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153601653|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153601654|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153601656|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153601657|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153601658|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153601659|NCT01900028|Itraconazole|itraconazole|mesh-list
153601660|NCT01900028|Olaparib|olaparib|mesh-list
153601661|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153601662|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601664|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601726|NCT01900327|Gemcitabine|gemcitabine|mesh-list
153601727|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153601728|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
153601742|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
153601743|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601744|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601745|NCT01900496|Rituximab|rituximab|mesh-list
153601746|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153601747|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153601748|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601749|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
153601750|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601751|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153601752|NCT01900496|Immunotoxins|immunotoxins|mesh-ancestor
153601753|NCT01900496|Immunoconjugates|immunoconjugates|mesh-ancestor
153601754|NCT01900509|Dexamethasone|dexamethasone|mesh-list
153601755|NCT01900509|Etoposide|etoposide|mesh-list
153601756|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
153601757|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153601758|NCT01900509|Clofarabine|clofarabine|mesh-list
153601807|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601808|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
153601809|NCT01900717|Leucovorin|leucovorin|mesh-list
153601810|NCT01900717|Bevacizumab|bevacizumab|mesh-list
153601811|NCT01900717|Fluorouracil|fluorouracil|mesh-list
153601812|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
153601813|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153601814|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601815|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153601816|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153601817|NCT01900717|Growth Substances|growth substances|mesh-ancestor
153601818|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601881|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601882|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601883|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601884|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153601885|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601887|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601888|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601889|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
153601890|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
153601891|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601892|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601963|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153601964|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153601965|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
153601966|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601967|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601968|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153601969|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
153601970|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601999|NCT01902108|Clonidine|clonidine|mesh-list
153602057|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153602058|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153602059|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153602060|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153602061|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153602062|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153602063|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153602064|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602065|NCT01901861|Incretins|incretins|mesh-ancestor
153602066|NCT01901861|Hormones|hormones|mesh-ancestor
153602067|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153602068|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153602069|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
153602070|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602071|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602072|NCT01902225|Doxorubicin|doxorubicin|mesh-list
153602073|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153602074|NCT01902225|Romidepsin|romidepsin|mesh-list
153602075|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153602076|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602077|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153602078|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153602079|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602080|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602081|NCT01902225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153602082|NCT01902238|Ethanol|ethanol|mesh-list
153602083|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
153602084|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153602113|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153602114|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602115|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153602116|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153502824|NCT01833312|Narcotics|narcotics|mesh-ancestor
153602117|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602118|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
153602119|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
153602120|NCT01902511|Lenograstim|lenograstim|mesh-list
153602121|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153602122|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
153602123|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602124|NCT01902511|Hematinics|hematinics|mesh-ancestor
153602125|NCT01902524|Fentanyl|fentanyl|mesh-list
153602126|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153602127|NCT01902524|Narcotics|narcotics|mesh-ancestor
153602195|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602196|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
153602197|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602198|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153602199|NCT01902875|Paclitaxel|paclitaxel|mesh-list
153602200|NCT01902875|Cisplatin|cisplatin|mesh-list
153602201|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153602202|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602203|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
153602204|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
153602205|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
153602206|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602207|NCT01903018|Cisplatin|cisplatin|mesh-list
153602208|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602221|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
153602268|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
153602269|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153602270|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153602271|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153602293|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602294|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153602295|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153602296|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
153602297|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153602298|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153602299|NCT01903785|Albuterol|albuterol|mesh-list
153602300|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153602301|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
153602302|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602306|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
153602384|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602385|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
153602386|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153602387|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153602388|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153602390|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153602391|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602392|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153602393|NCT01904539|Cathartics|cathartics|mesh-ancestor
153602458|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153602459|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602460|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602462|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
153602463|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602464|NCT01904786|Protective Agents|protective agents|mesh-ancestor
153602465|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602466|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602467|NCT01904981|Atenolol|atenolol|mesh-list
153602468|NCT01904981|Valsartan|valsartan|mesh-list
153602469|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153602470|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153602471|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153602472|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153602473|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602474|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153602521|NCT01905150|Mitomycin|mitomycin|mesh-list
153602522|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
153602523|NCT01905150|Vitamins|vitamins|mesh-ancestor
153602524|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
153602525|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602526|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153602527|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
153745647|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502825|NCT01833312|Analgesics|analgesics|mesh-ancestor
153602528|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602529|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602530|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
153602531|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
153602532|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
153602594|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602595|NCT01905696|Protective Agents|protective agents|mesh-ancestor
153602596|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602597|NCT01905696|Antidotes|antidotes|mesh-ancestor
153602598|NCT01905774|Deferasirox|deferasirox|mesh-list
153602599|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153602600|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
153602601|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
153602602|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602603|NCT01905904|Sevoflurane|sevoflurane|mesh-list
153602604|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153602605|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153602606|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
153602607|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
153602608|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602609|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602610|NCT01906073|Fentanyl|fentanyl|mesh-list
153602611|NCT01906073|Morphine|morphine|mesh-list
153602658|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153602659|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153602660|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153602661|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602662|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602663|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153602665|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
153602666|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602667|NCT01906632|Immunomodulating Agents|immunomodulating agents|mesh-list
153602668|NCT01906632|Immunologic Factors|immunologic factors|mesh-ancestor
153602669|NCT01906632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602670|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
153602671|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
153602732|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
153602733|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602734|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602735|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
153602736|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
153602737|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153602738|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
153602739|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602740|NCT01907061|Expectorants|expectorants|mesh-ancestor
153602741|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
153602742|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153602743|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
153602744|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602745|NCT01907061|Protective Agents|protective agents|mesh-ancestor
153602746|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602747|NCT01907061|Antidotes|antidotes|mesh-ancestor
153602749|NCT01907165|Temozolomide|temozolomide|mesh-list
153602751|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153602752|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
153602753|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602754|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602755|NCT01907165|Trace Elements|trace elements|mesh-ancestor
153602764|NCT01907204|Prednisolone|prednisolone|mesh-list
153602788|NCT01907308|Docetaxel|docetaxel|mesh-list
153602789|NCT01907308|Trebananib|trebananib|mesh-list
153602790|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602791|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
153602792|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
153602793|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
153602794|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602795|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153602796|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153602797|NCT01907308|Growth Substances|growth substances|mesh-ancestor
153602798|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602799|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
153602876|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602877|NCT01907802|Dabrafenib|dabrafenib|mesh-list
153602900|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602902|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153602903|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153602904|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153602905|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
153602906|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
153602907|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
153602908|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
153602909|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602910|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602911|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153602912|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153602913|NCT01907984|Analgesics|analgesics|mesh-ancestor
153602914|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
153602915|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602916|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153602917|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153602918|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153602919|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602921|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
153602922|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
153602923|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602924|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602968|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153602969|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602970|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602971|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153602972|NCT01908296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153602973|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153602974|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153602975|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602977|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
153603040|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
153603041|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603042|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603043|NCT01909037|Curcumin|curcumin|mesh-list
153603044|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153603070|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
153603071|NCT01909115|Vitamins|vitamins|mesh-list
153603072|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
153603073|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603146|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153603147|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
153603148|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603149|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153603150|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603151|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603153|NCT01910090|Famotidine|famotidine|mesh-list
153603154|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153603155|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603156|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153603157|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
153603158|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
153603166|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153603167|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153603168|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603169|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153603170|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603171|NCT01910142|Vitamin K|vitamin k|mesh-list
153603172|NCT01910142|Calcium|calcium|mesh-list
153603173|NCT01910142|Vitamins|vitamins|mesh-ancestor
153603174|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
153603175|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603176|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603177|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153603178|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153603179|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603201|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153603202|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153603203|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
153603204|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603205|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603206|NCT01910246|Metformin|metformin|mesh-list
153603207|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603208|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603209|NCT01910259|Amiloride|amiloride|mesh-list
153603210|NCT01910259|Riluzole|riluzole|mesh-list
153603211|NCT01910259|Fluoxetine|fluoxetine|mesh-list
153603269|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603270|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603271|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153603272|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
153603273|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153603274|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603275|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153603276|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153603277|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153603278|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153603279|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603281|NCT01910428|Eryaspase|eryaspase|mesh-list
153603282|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603283|NCT01910480|Ketoconazole|ketoconazole|mesh-list
153603284|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
153603285|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603286|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153603287|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153603288|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603296|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
153603297|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603298|NCT01910532|Clevidipine|clevidipine|mesh-list
153603299|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153603300|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603301|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603302|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603320|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153603321|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153603322|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
153603323|NCT01910766|Vitamins|vitamins|mesh-ancestor
153603324|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
153603325|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153603326|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
153603327|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603328|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603329|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153603330|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
153603331|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603332|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603333|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153603334|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
153603335|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153603336|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
153603337|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603338|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603339|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153603340|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
153603341|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603342|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603343|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153603344|NCT01910883|Finafloxacin|finafloxacin|mesh-list
153603345|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
153603346|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153603347|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153603348|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603366|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
153603375|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153603376|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
153603377|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603378|NCT01911247|Metformin|metformin|mesh-list
153603379|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603380|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603381|NCT01911299|Choline|choline|mesh-list
153603382|NCT01911299|Glycerol|glycerol|mesh-list
153603383|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
153603384|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153603385|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
153603393|NCT01911325|Docetaxel|docetaxel|mesh-list
153603475|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
153502830|NCT01834014|Cetuximab|cetuximab|mesh-list
153603476|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153603477|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153603478|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603479|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
153603480|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153603481|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
153603482|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603483|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
153603484|NCT01911624|Coagulants|coagulants|mesh-ancestor
153603485|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153603486|NCT01911728|Pioglitazone|pioglitazone|mesh-list
153603487|NCT01911728|Midazolam|midazolam|mesh-list
153603488|NCT01911728|Omeprazole|omeprazole|mesh-list
153603489|NCT01911728|Warfarin|warfarin|mesh-list
153603490|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153603491|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153603492|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603493|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603494|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153603495|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153603496|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153603497|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153603498|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
153603499|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
153603500|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
153603501|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
153603502|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603503|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603504|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603505|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
153603506|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153603507|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603508|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153603518|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153603519|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153603520|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
153603521|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603522|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603523|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153603524|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153603525|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
153603526|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153603528|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
153603589|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603591|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153603592|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603593|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153603594|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153603595|NCT01912443|Growth Substances|growth substances|mesh-ancestor
153603596|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603597|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
153603598|NCT01912534|Valsartan|valsartan|mesh-list
153603599|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153603600|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153603601|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153603613|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603615|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
153603616|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153603617|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
153603618|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603619|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
153603620|NCT01912638|Protective Agents|protective agents|mesh-ancestor
153603621|NCT01912677|Labetalol|labetalol|mesh-list
153603622|NCT01912677|Methyldopa|methyldopa|mesh-list
153603623|NCT01912677|Nifedipine|nifedipine|mesh-list
153603624|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153603625|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603626|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603630|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
153603646|NCT01912755|Lidocaine|lidocaine|mesh-list
153603647|NCT01912755|Epinephrine|epinephrine|mesh-list
153603648|NCT01912755|Racepinephrine|racepinephrine|mesh-list
153603649|NCT01912755|Carticaine|carticaine|mesh-list
153603650|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
153603651|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
153603652|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
153603653|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603654|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603655|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
153603656|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603657|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153603747|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153603748|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153603749|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
153603750|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153603751|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153603753|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
153603754|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603755|NCT01913444|Antithrombins|antithrombins|mesh-list
153603756|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
153603757|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153603758|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
153603759|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603760|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603820|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153603822|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603823|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603824|NCT01914042|Analgesics|analgesics|mesh-ancestor
153603825|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
153603826|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603827|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153603828|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153603829|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603830|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603831|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603832|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153603833|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
153603834|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153603835|NCT01914081|Resveratrol|resveratrol|mesh-list
153603836|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
153603909|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
153603910|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603911|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603913|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603914|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153603915|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603916|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603917|NCT01914692|Somatostatin|somatostatin|mesh-list
153603918|NCT01914692|Hormones|hormones|mesh-ancestor
153603919|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603920|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603921|NCT01914718|Rituximab|rituximab|mesh-list
153603922|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153603923|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603924|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
153603925|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603926|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603927|NCT01914744|Lamivudine|lamivudine|mesh-list
153603928|NCT01914744|Entecavir|entecavir|mesh-list
153603929|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153603930|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153603931|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603964|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603965|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153603966|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153603967|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603968|NCT01915069|Cilostazol|cilostazol|mesh-list
153603969|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153603970|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
153603971|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603972|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603973|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153603974|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
153603975|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153603976|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153604030|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604032|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604033|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604034|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153604035|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604036|NCT01915472|Irinotecan|irinotecan|mesh-list
153604037|NCT01915472|Labetuzumab|labetuzumab|mesh-list
153604038|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
153604039|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
153604040|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604041|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153604042|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153604043|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604044|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604092|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
153604093|NCT01915979|Hormones|hormones|mesh-ancestor
153604094|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153604116|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153604117|NCT01916200|Paroxetine|paroxetine|mesh-list
153604118|NCT01916200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153604119|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153604120|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153604121|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604122|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604123|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
153604124|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604125|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153604126|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
153604127|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153604128|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153604129|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153604130|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604140|NCT01916252|Bortezomib|bortezomib|mesh-list
153604181|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604183|NCT01916408|Wobenzym|wobenzym|mesh-list
153604184|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153604185|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
153604186|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604187|NCT01916447|Bevacizumab|bevacizumab|mesh-list
153604188|NCT01916447|Irinotecan|irinotecan|mesh-list
153604189|NCT01916447|Camptothecin|camptothecin|mesh-list
153604190|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604191|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604192|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153604193|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153604194|NCT01916447|Growth Substances|growth substances|mesh-ancestor
153604195|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604196|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
153604197|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153604198|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153604199|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604200|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604201|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153604202|NCT01916577|Plerixafor|plerixafor|mesh-list
153604241|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153604242|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153604243|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153604244|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153604245|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153604246|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153604247|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604248|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153604249|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604250|NCT01916863|Canagliflozin|canagliflozin|mesh-list
153604251|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153604252|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153604253|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604254|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153604255|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604256|NCT01916902|Ticagrelor|ticagrelor|mesh-list
153604257|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153604304|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604305|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604306|NCT01917045|Analgesics|analgesics|mesh-ancestor
153604307|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
153604308|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604309|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153604310|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153604311|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
153604312|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
153604313|NCT01917058|Abatacept|abatacept|mesh-list
153604314|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153604315|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604316|NCT01917058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604317|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604376|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604377|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604378|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153604379|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
153604380|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153604381|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153604382|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153604383|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
153604384|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604385|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604386|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153604387|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153604388|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153604477|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
153604478|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604479|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604480|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153604481|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153604482|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604483|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604484|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604485|NCT01918098|Oxycodone|oxycodone|mesh-list
153604486|NCT01918098|Naloxone|naloxone|mesh-list
153604487|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153604488|NCT01918098|Narcotics|narcotics|mesh-ancestor
153604489|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604490|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604491|NCT01918098|Analgesics|analgesics|mesh-ancestor
153604492|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
153604494|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153604567|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153604568|NCT01918384|Arbekacin|arbekacin|mesh-list
153604569|NCT01918384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153604570|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604571|NCT01918475|Carbetocin|carbetocin|mesh-list
153604572|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
153604573|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153604574|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604575|NCT01918488|Amiloride|amiloride|mesh-list
153604576|NCT01918488|Triamterene|triamterene|mesh-list
153604577|NCT01918488|Diuretics|diuretics|mesh-ancestor
153604578|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
153604579|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604580|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153604581|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153332310|NCT03889444|Hormones|hormones|mesh-ancestor
153604582|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153604583|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604584|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153604585|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153604586|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
153604620|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153604621|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153502834|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604622|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153604641|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604642|NCT01918865|Metformin|metformin|mesh-list
153604643|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153604713|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
153604714|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604715|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
153604716|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
153604717|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
153604718|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
153604719|NCT01919255|Citric Acid|citric acid|mesh-list
153604720|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
153604721|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153604722|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
153604793|NCT01919918|Adenosine|adenosine|mesh-list
153604794|NCT01919918|Analgesics|analgesics|mesh-ancestor
153604795|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
153604796|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604797|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604798|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153604799|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
153604800|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153604801|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
153604802|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
153604803|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604804|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604805|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
153604806|NCT01920022|Mifepristone|mifepristone|mesh-list
153332518|NCT03018821|Tenofovir|tenofovir|mesh-list
153604807|NCT01920022|Etonogestrel|etonogestrel|mesh-list
153604808|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153604809|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604810|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153604818|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153604824|NCT01920516|Melphalan|melphalan|mesh-list
153604852|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153604853|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153604854|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
153604855|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153604856|NCT01921374|Antibodies|antibodies|mesh-list
153604857|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
153604858|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
153604859|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
153604860|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
153604861|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
153604862|NCT01921374|Uric Acid|uric acid|mesh-list
153604863|NCT01921374|Vitamins|vitamins|mesh-ancestor
153604864|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
153604866|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604927|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604928|NCT01924013|Vitamin D|vitamin d|mesh-list
153604929|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
153604930|NCT01924013|Vitamins|vitamins|mesh-ancestor
153604931|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
153604932|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604933|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153604934|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153604935|NCT01924676|Oxycodone|oxycodone|mesh-list
153604936|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153605040|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
153605041|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153605042|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153605043|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605044|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153605045|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
153605046|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
153605047|NCT01930396|Heparin|heparin|mesh-list
153605048|NCT01930396|Calcium heparin|calcium heparin|mesh-list
153605049|NCT01930396|Tinzaparin|tinzaparin|mesh-list
153605050|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153605124|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605125|NCT01930734|Protective Agents|protective agents|mesh-ancestor
153605127|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153605128|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153605129|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153605130|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153605144|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153605145|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605147|NCT01930812|Fluorides|fluorides|mesh-list
153605148|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
153605149|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
153605150|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
153605151|NCT01930812|Protective Agents|protective agents|mesh-ancestor
153605152|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605153|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153605154|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605155|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153605156|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605157|NCT01930864|Metformin|metformin|mesh-list
153605207|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
153605208|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605209|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605210|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153605211|NCT01931215|Narcotics|narcotics|mesh-ancestor
153605212|NCT01931215|Analgesics|analgesics|mesh-ancestor
153605213|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
153605214|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605215|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
153605216|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153605225|NCT01931293|Folic Acid|folic acid|mesh-list
153605275|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605276|NCT01931514|Montelukast|montelukast|mesh-list
153605277|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153605278|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
153605279|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153605280|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
153605281|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153605282|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605283|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153605284|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153605285|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605286|NCT01931592|Gentamicins|gentamicins|mesh-list
153605289|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153605290|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605291|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153605292|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605294|NCT01931657|Mifepristone|mifepristone|mesh-list
153605385|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153605386|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605387|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605388|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153605389|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153605390|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153605391|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153605394|NCT01932320|Ketoconazole|ketoconazole|mesh-list
153605519|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605520|NCT01932931|Vitamin D|vitamin d|mesh-list
153605521|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
153605522|NCT01932931|Vitamins|vitamins|mesh-ancestor
153605523|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
153605524|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605525|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153605526|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153605596|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605597|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
153605598|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605599|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605601|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
153605602|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
153605603|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153605604|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605605|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
153605668|NCT01934205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605669|NCT01934205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605670|NCT01934361|Carboplatin|carboplatin|mesh-list
153605671|NCT01934361|Lomustine|lomustine|mesh-list
153605672|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605673|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153605674|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
153605695|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153605696|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153605697|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153605701|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605763|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153605764|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153605765|NCT01934933|Analgesics|analgesics|mesh-ancestor
153605766|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
153605767|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605768|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605769|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605770|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605771|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153605772|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153605773|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605775|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605836|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
153605837|NCT01935492|Paclitaxel|paclitaxel|mesh-list
153605838|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153605839|NCT01935492|Bevacizumab|bevacizumab|mesh-list
153605840|NCT01935492|Doxorubicin|doxorubicin|mesh-list
153605841|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153605842|NCT01935492|Capecitabine|capecitabine|mesh-list
153605843|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153605844|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605845|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
153605909|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
153605910|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153605911|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153605912|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605913|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
153605914|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605915|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605917|NCT01935557|Calcium heparin|calcium heparin|mesh-list
153605918|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
153605919|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153605920|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153605941|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
153605997|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153605998|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153605999|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606000|NCT01935908|Levetiracetam|levetiracetam|mesh-list
153606001|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
153606002|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
153606003|NCT01935973|Trametinib|trametinib|mesh-list
153606004|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606005|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153606006|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606008|NCT01936012|Lisinopril|lisinopril|mesh-list
153606073|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
153606074|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
153606075|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153606076|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
153606077|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606078|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606079|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606080|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
153606081|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153606158|NCT06070766|Sensory System Agents|sensory system agents|mesh-ancestor
153606159|NCT06070766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606160|NCT06070766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606161|NCT06070766|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153606162|NCT06070766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153606163|NCT06070766|Anesthetics, General|anesthetics, general|mesh-ancestor
153606165|NCT06070766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606166|NCT06070766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153606167|NCT06070766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153606168|NCT06070766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606187|NCT06070636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606246|NCT06065592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153606247|NCT06065592|Protease Inhibitors|protease inhibitors|mesh-ancestor
153606248|NCT06065592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606249|NCT06065592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606250|NCT06065592|Anticoagulants|anticoagulants|mesh-ancestor
153606251|NCT06065592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606252|NCT06065592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153606253|NCT06062602|Paclitaxel|paclitaxel|mesh-list
153606254|NCT06062602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153606255|NCT06062602|Carboplatin|carboplatin|mesh-list
153606256|NCT06062602|Fluorouracil|fluorouracil|mesh-list
153606257|NCT06062602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153606258|NCT06062602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606259|NCT06062602|Tubulin Modulators|tubulin modulators|mesh-ancestor
153606338|NCT05883358|Analgesics|analgesics|mesh-ancestor
153606339|NCT05883358|Sensory System Agents|sensory system agents|mesh-ancestor
153606340|NCT05883358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606341|NCT05883358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153606342|NCT05883358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153606343|NCT05883358|Sympatholytics|sympatholytics|mesh-ancestor
153606344|NCT05883358|Autonomic Agents|autonomic agents|mesh-ancestor
153606345|NCT05883358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153606346|NCT05883358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153606347|NCT05883358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153606348|NCT05883358|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606349|NCT05883358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606351|NCT05866315|Remifentanil|remifentanil|mesh-list
153606414|NCT05741502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153606415|NCT05741502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153606416|NCT05741502|Dopamine Agents|dopamine agents|mesh-ancestor
153606417|NCT05741502|Antiemetics|antiemetics|mesh-ancestor
153606418|NCT05741502|Autonomic Agents|autonomic agents|mesh-ancestor
153606419|NCT05741502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606420|NCT05741502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153606421|NCT05741502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153606425|NCT05741502|Dopamine Agonists|dopamine agonists|mesh-ancestor
153606493|NCT05628038|Antidotes|antidotes|mesh-ancestor
153606494|NCT05628038|Protective Agents|protective agents|mesh-ancestor
153606495|NCT05628038|Vitamin B Complex|vitamin b complex|mesh-ancestor
153606506|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606507|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153606508|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606509|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153606510|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153606511|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606512|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153606513|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153606514|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
153606515|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
153606516|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606517|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153606518|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153606519|NCT05617625|Fludarabine|fludarabine|mesh-list
153606520|NCT05617625|Melphalan|melphalan|mesh-list
153606521|NCT05617625|Busulfan|busulfan|mesh-list
153606522|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606523|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606524|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606525|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
153606526|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606553|NCT05526924|Fluorouracil|fluorouracil|mesh-list
153606554|NCT05526924|Tislelizumab|tislelizumab|mesh-list
153606555|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
153606556|NCT05526924|Pamiparib|pamiparib|mesh-list
153606557|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
153606558|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606559|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153606560|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606561|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606569|NCT05517122|Niacinamide|niacinamide|mesh-list
153606571|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
153606572|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
153606573|NCT05517122|Vitamins|vitamins|mesh-ancestor
153606574|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
153606575|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606576|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153606577|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
153606578|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606579|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153606580|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
153606581|NCT05515575|Niraparib|niraparib|mesh-list
153606582|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153606583|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606584|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606585|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606586|NCT05488522|Bevacizumab|bevacizumab|mesh-list
153606587|NCT05488522|Atezolizumab|atezolizumab|mesh-list
153606588|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606607|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606608|NCT05360160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153606609|NCT05360160|Antimetabolites|antimetabolites|mesh-ancestor
153606610|NCT05360160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606611|NCT05356936|Vitamin D|vitamin d|mesh-list
153606612|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
153606613|NCT05356936|Vitamins|vitamins|mesh-list
153606614|NCT05356936|Vitamin K|vitamin k|mesh-list
153606615|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
153606616|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
153386501|NCT03673124|Letrozole|letrozole|mesh-list
153606617|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606618|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153606619|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153606620|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153606621|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153606622|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606623|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
153606624|NCT05356936|Coagulants|coagulants|mesh-ancestor
153606625|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
153606701|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606702|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153606703|NCT04905277|Atenolol|atenolol|mesh-list
153606704|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153606705|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153606706|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
153606707|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
153606708|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606709|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606710|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153606711|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153606712|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153606713|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606714|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606715|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606716|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
153606717|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606718|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606719|NCT04892472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153606720|NCT04892472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606721|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153606757|NCT04825678|Erenumab|erenumab|mesh-list
153731562|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606763|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606764|NCT04808505|Miglustat|miglustat|mesh-list
153606765|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606766|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606767|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153606768|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153606769|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
153606770|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153606771|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153606772|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153606773|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606774|NCT04788654|Acetaminophen|acetaminophen|mesh-list
153606775|NCT04788654|Dexamethasone|dexamethasone|mesh-list
153606776|NCT04788654|Celecoxib|celecoxib|mesh-list
153606777|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153606778|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
153606779|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
153606780|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606781|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606782|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153606783|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
153606784|NCT04788654|Hormones|hormones|mesh-ancestor
153606787|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606825|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606826|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606827|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153606828|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
153606829|NCT04711837|Propofol|propofol|mesh-list
153606830|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153606831|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606832|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606833|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153606834|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
153606835|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
153606836|NCT04652765|Bicalutamide|bicalutamide|mesh-list
153606837|NCT04652765|Camostat|camostat|mesh-list
153606838|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
153606839|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
153606840|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153606841|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606842|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606843|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
153606849|NCT04642430|Apixaban|apixaban|mesh-list
153606907|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334630|NCT01456208|Norepinephrine|norepinephrine|mesh-list
153606908|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153606909|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153781741|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153606910|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153606911|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153606912|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606913|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606914|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607011|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607012|NCT04265274|Copper|copper|mesh-list
153607019|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153607020|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607021|NCT04264260|Colchicine|colchicine|mesh-list
153607022|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
153607023|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607024|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
153607025|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607026|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607027|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607028|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607029|NCT04218708|Nicotine|nicotine|mesh-list
153607030|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153607031|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
153607032|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607033|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607034|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153607035|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153607036|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
153607037|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607038|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607039|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
153607040|NCT04189588|Promethazine|promethazine|mesh-list
153607041|NCT04189588|Cetirizine|cetirizine|mesh-list
153607042|NCT04189588|Paclitaxel|paclitaxel|mesh-list
153607043|NCT04189588|Rituximab|rituximab|mesh-list
153607044|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607058|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
153607063|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607064|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153607065|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
153607066|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
153607067|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607068|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153607069|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
153607070|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
153607071|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153607073|NCT04176419|Celecoxib|celecoxib|mesh-list
153607074|NCT04176419|Lidocaine|lidocaine|mesh-list
153607075|NCT04176419|Ketamine|ketamine|mesh-list
153607076|NCT04176419|Gabapentin|gabapentin|mesh-list
153607077|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
153607078|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
153607079|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153607080|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607081|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
153607082|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607094|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607095|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153607096|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
153607097|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153607098|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607099|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607126|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
153607127|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153607128|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153607129|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607131|NCT04149171|Coagulants|coagulants|mesh-ancestor
153607132|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
153607133|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153607134|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153607135|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607136|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
153607137|NCT04111822|Coagulants|coagulants|mesh-ancestor
153607138|NCT04086264|Azacitidine|azacitidine|mesh-list
153607139|NCT04086264|Decitabine|decitabine|mesh-list
153607140|NCT04086264|Venetoclax|venetoclax|mesh-list
153607195|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607196|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607197|NCT03971734|Regadenoson|regadenoson|mesh-list
153607198|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153607199|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153607200|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
153607201|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
153607202|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607203|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607204|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607205|NCT03875092|Paclitaxel|paclitaxel|mesh-list
153607206|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153607207|NCT03875092|Carboplatin|carboplatin|mesh-list
153607208|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
153607209|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607210|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607211|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
153607212|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607223|NCT03829319|Lenvatinib|lenvatinib|mesh-list
153607260|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153607261|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153607262|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
153607263|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607264|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607265|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153607266|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607267|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607268|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153607275|NCT03605719|Dexamethasone|dexamethasone|mesh-list
153607289|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607290|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607291|NCT03454646|Rivastigmine|rivastigmine|mesh-list
153607340|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
153607352|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153607353|NCT03219359|Protective Agents|protective agents|mesh-ancestor
153607354|NCT03180034|Vaccines|vaccines|mesh-list
153607355|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
153607356|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607364|NCT03121352|Paclitaxel|paclitaxel|mesh-list
153607365|NCT03121352|Carboplatin|carboplatin|mesh-list
153607366|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
153607367|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607368|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607369|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
153607370|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607371|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607372|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502855|NCT01835340|Anesthetics|anesthetics|mesh-list
153607373|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607427|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607428|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
153607429|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153607430|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153607431|NCT02685826|Growth Substances|growth substances|mesh-ancestor
153607432|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
153607433|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335151|NCT03527264|Nivolumab|nivolumab|mesh-list
153607434|NCT02684162|Guadecitabine|guadecitabine|mesh-list
153607436|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607437|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153607438|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
153607515|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607516|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
153607517|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607518|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153607519|NCT01919619|Lenalidomide|lenalidomide|mesh-list
153607520|NCT01919619|Ipilimumab|ipilimumab|mesh-list
153607521|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
153607522|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607523|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153607524|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153607525|NCT01919619|Growth Substances|growth substances|mesh-ancestor
153607535|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607537|NCT01731236|Aspirin|aspirin|mesh-list
153607538|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153607539|NCT01731236|Vancomycin|vancomycin|mesh-list
153607583|NCT01529593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153607584|NCT01529593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607585|NCT01529593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607586|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607587|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
153607588|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607589|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153781743|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
153607590|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607613|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607614|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607615|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607616|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607618|NCT01234025|Hormones|hormones|mesh-ancestor
153607619|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607620|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607621|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153607666|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607667|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607668|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607669|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
153607670|NCT01084252|Hormones|hormones|mesh-ancestor
153607671|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607672|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153607677|NCT00993044|Bevacizumab|bevacizumab|mesh-list
153607752|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153607754|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
153607755|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607756|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607757|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153607758|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
153607759|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153607760|NCT01936636|Fentanyl|fentanyl|mesh-list
153607761|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153607762|NCT01936636|Narcotics|narcotics|mesh-ancestor
153607763|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153607825|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
153607826|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153607827|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153607828|NCT01937234|Metoclopramide|metoclopramide|mesh-list
153607841|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153607842|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607844|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153607845|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607846|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607913|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153607914|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
153607915|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607916|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607917|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153607918|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
153607919|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153607920|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
153607986|NCT01938144|Acetaminophen|acetaminophen|mesh-list
153607987|NCT01938144|Ibuprofen|ibuprofen|mesh-list
153607988|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153607989|NCT01938144|Analgesics|analgesics|mesh-ancestor
153607990|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
153607991|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607992|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607993|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
153607994|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153607995|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607996|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607997|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153607998|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607999|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608000|NCT01938183|Metronidazole|metronidazole|mesh-list
153608001|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608002|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153608003|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153608004|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153608006|NCT01938235|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153608007|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153608072|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608073|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608091|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608092|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
153608093|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
153608094|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
153608095|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608096|NCT01938911|Oxytocin|oxytocin|mesh-list
153608097|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
153608098|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608099|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608100|NCT01939054|Docetaxel|docetaxel|mesh-list
153608101|NCT01939054|Capecitabine|capecitabine|mesh-list
153608102|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
153608103|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608104|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
153608105|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
153608106|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
153608171|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
153608172|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
153608173|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153608174|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153608175|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153608176|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153608177|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
153608178|NCT01939418|Gemcitabine|gemcitabine|mesh-list
153608180|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608181|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608182|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
153608183|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608184|NCT01939418|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153608185|NCT01939418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153608186|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608187|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153608198|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608199|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608200|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153608201|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153608235|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153608236|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153608237|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608238|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153608239|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153608240|NCT01939574|Bevacizumab|bevacizumab|mesh-list
153608241|NCT01939574|Temozolomide|temozolomide|mesh-list
153608242|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608243|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608244|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153608245|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153608246|NCT01939574|Growth Substances|growth substances|mesh-ancestor
153608247|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608248|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
153608280|NCT01939691|Analgesics|analgesics|mesh-ancestor
153608332|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
153608333|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153608334|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
153608335|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
153608336|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608337|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608338|NCT01939990|Nebivolol|nebivolol|mesh-list
153608339|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153608340|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
153608341|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153608342|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153608343|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153608344|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
153336050|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153608345|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608346|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608400|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153608401|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
153608402|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
153608403|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153608404|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153608405|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608406|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
153608407|NCT01940419|Coagulants|coagulants|mesh-ancestor
153608408|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
153608409|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153608410|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153608411|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608490|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608492|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
153608493|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608494|NCT01941056|Vaccines|vaccines|mesh-list
153608495|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
153336198|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153608496|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608497|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
153608498|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153608499|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153608500|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
153608501|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
153608502|NCT01941134|Estradiol|estradiol|mesh-list
153608503|NCT01941134|Estrogens|estrogens|mesh-ancestor
153608504|NCT01941134|Hormones|hormones|mesh-ancestor
153608505|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153608506|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608507|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153608579|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
153608580|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608582|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
153608583|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153608584|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153608585|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608586|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
153608587|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
153608595|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608596|NCT01941771|Capecitabine|capecitabine|mesh-list
153608597|NCT01941771|Vinorelbine|vinorelbine|mesh-list
153608598|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608599|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
153608600|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502862|NCT01836120|Docetaxel|docetaxel|mesh-list
153608601|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608602|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153608603|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
153608604|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
153608605|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
153608606|NCT01941810|Lactoferrin|lactoferrin|mesh-list
153608607|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608608|NCT01941888|Midazolam|midazolam|mesh-list
153608609|NCT01941888|Propofol|propofol|mesh-list
153608610|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153608611|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608638|NCT01941953|Fluorouracil|fluorouracil|mesh-list
153608639|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153608640|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608641|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
153608642|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608643|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608644|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608645|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153608646|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
153608647|NCT01941966|Capecitabine|capecitabine|mesh-list
153608712|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153608713|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608714|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608716|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608717|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608718|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153608719|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153608783|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153608784|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
153608785|NCT01942447|Vancomycin|vancomycin|mesh-list
153608786|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153608795|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153608796|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153608798|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388647|NCT00002073|Hematinics|hematinics|mesh-ancestor
153781747|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
153608800|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153608860|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608861|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608862|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153608863|NCT01943240|Ropivacaine|ropivacaine|mesh-list
153608864|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
153608865|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
153608866|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608867|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608868|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
153608938|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153608939|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153608940|NCT01943812|Estradiol|estradiol|mesh-list
153608941|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153608942|NCT01943812|Progesterone|progesterone|mesh-list
153608943|NCT01943812|Estrogens|estrogens|mesh-ancestor
153608944|NCT01943812|Hormones|hormones|mesh-ancestor
153608945|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153608946|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608947|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153608948|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
153609005|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153609006|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609007|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153609008|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
153609009|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153609010|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153609011|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609012|NCT01944215|Caffeine|caffeine|mesh-list
153609013|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153609014|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609015|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153609016|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609017|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609019|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153609079|NCT01945021|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153609080|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153609081|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609082|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609083|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609084|NCT01945047|Midazolam|midazolam|mesh-list
153609085|NCT01945047|Ketamine|ketamine|mesh-list
153609086|NCT01945047|Analgesics|analgesics|mesh-ancestor
153609087|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
153609088|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609089|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609090|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153609091|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153609092|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
153336806|NCT00000772|Ribavirin|ribavirin|mesh-list
153609094|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609095|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153609096|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153609105|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
153609145|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153609146|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
153609147|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
153609148|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
153609149|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
153609150|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609151|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609152|NCT01945528|Lidocaine|lidocaine|mesh-list
153609153|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
153609154|NCT01945528|Anesthetics|anesthetics|mesh-list
153609155|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609156|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609164|NCT01945554|Bupivacaine|bupivacaine|mesh-list
153609246|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609247|NCT05410093|Protective Agents|protective agents|mesh-ancestor
153609248|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609249|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153609250|NCT05409820|Anesthetics|anesthetics|mesh-list
153609251|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609252|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609253|NCT05409339|Mannitol|mannitol|mesh-list
153609254|NCT05409339|Caffeine|caffeine|mesh-list
153609257|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153609325|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153609326|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
153609327|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
153609328|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609329|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609330|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153609331|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
153609332|NCT04476979|Hormones|hormones|mesh-ancestor
153609334|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153609418|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153609419|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153609420|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
153609421|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153609422|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
153609423|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153609424|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153609448|NCT03333005|Miconazole|miconazole|mesh-list
153609491|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153609492|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609493|NCT03069703|Rituximab|rituximab|mesh-list
153609494|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609495|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609496|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
153609497|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609498|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153609499|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
153609500|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609501|NCT02818738|Levamisole|levamisole|mesh-list
153609502|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153609503|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
153609558|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
153609559|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609560|NCT05412472|Protective Agents|protective agents|mesh-ancestor
153609561|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609562|NCT05412147|Vitamins|vitamins|mesh-list
153609563|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
153609564|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609565|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153609566|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153609567|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609568|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609569|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153609570|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609571|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609572|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609573|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609574|NCT05411757|Bevacizumab|bevacizumab|mesh-list
153609575|NCT05411757|Lenvatinib|lenvatinib|mesh-list
153609576|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609577|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609624|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609625|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609626|NCT04655391|Venetoclax|venetoclax|mesh-list
153609627|NCT04655391|Decitabine|decitabine|mesh-list
153609628|NCT04655391|Ivosidenib|ivosidenib|mesh-list
153609629|NCT04655391|Maleic acid|maleic acid|mesh-list
153609630|NCT04655391|Bosutinib|bosutinib|mesh-list
153609631|NCT04655391|Gilteritinib|gilteritinib|mesh-list
153609632|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609633|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153609634|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
153609635|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609636|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609637|NCT04655391|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153609638|NCT04655391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153609639|NCT04609098|Piperaquine|piperaquine|mesh-list
153609640|NCT04609098|Artenimol|artenimol|mesh-list
153609695|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609696|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609697|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153609698|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
153609700|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153609701|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153609702|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153609703|NCT03817125|Vancomycin|vancomycin|mesh-list
153609704|NCT03817125|Nivolumab|nivolumab|mesh-list
153609705|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609706|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609707|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153609772|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609773|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153609774|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153609775|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153609776|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153609777|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153609778|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153609779|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
153609847|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609849|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
153609850|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609861|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
153609862|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153609863|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153609864|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
153609865|NCT05414669|Protective Agents|protective agents|mesh-ancestor
153609866|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609867|NCT05414149|Ranibizumab|ranibizumab|mesh-list
153609868|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153609869|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153609870|NCT05414149|Growth Substances|growth substances|mesh-ancestor
153609925|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609926|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153609928|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153609929|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609930|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153609931|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153609932|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153609933|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153609934|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
153609935|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153609936|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153609937|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609938|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
153609983|NCT05233709|Urological Agents|urological agents|mesh-ancestor
153609984|NCT05111821|Deferiprone|deferiprone|mesh-list
153609985|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153609986|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
153609987|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
153609988|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610129|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610130|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153610131|NCT03578276|Protective Agents|protective agents|mesh-ancestor
153610142|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153610143|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610144|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610145|NCT03491267|Tretinoin|tretinoin|mesh-list
153610146|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610215|NCT02518009|Hormones|hormones|mesh-ancestor
153610216|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610217|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610218|NCT02238496|Sirolimus|sirolimus|mesh-list
153610219|NCT02238496|Temsirolimus|temsirolimus|mesh-list
153610220|NCT02238496|MTOR Inhibitors|mtor inhibitors|mesh-list
153610221|NCT02238496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153610222|NCT02238496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610223|NCT02238496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610225|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
153610226|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610227|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610228|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610229|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610230|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153610231|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
153610233|NCT02034110|Dabrafenib|dabrafenib|mesh-list
153610234|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610235|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153610236|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610237|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610238|NCT01968213|Rucaparib|rucaparib|mesh-list
153610239|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153610240|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610241|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610242|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610243|NCT01498458|Capecitabine|capecitabine|mesh-list
153610293|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610294|NCT01945957|Oxytocin|oxytocin|mesh-list
153610295|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
153610307|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610308|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153610310|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
153610311|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610312|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610313|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610314|NCT01946035|Doxazosin|doxazosin|mesh-list
153610315|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153610316|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153610377|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153610379|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610380|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610381|NCT01946555|Analgesics|analgesics|mesh-ancestor
153610382|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
153610383|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610384|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153610385|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153610386|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
153610387|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
153610388|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153610389|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
153610390|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
153610391|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153610392|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153610393|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153610502|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
153610503|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610504|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610505|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
153610506|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153610507|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610508|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153610509|NCT01947309|Lenalidomide|lenalidomide|mesh-list
153610510|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
153610511|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610512|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153610513|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153610514|NCT01947309|Growth Substances|growth substances|mesh-ancestor
153610515|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
153610579|NCT01947933|Analgesics|analgesics|mesh-ancestor
153610580|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
153610581|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610582|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610583|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610584|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153610585|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153610586|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610587|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
153610588|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153610589|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
153610590|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153610591|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
153610592|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610593|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610594|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
153610595|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
153610596|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153610606|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
153610607|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153610608|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
153610609|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153610640|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
153610641|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610642|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153610643|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153610644|NCT01948232|Perindopril|perindopril|mesh-list
153610645|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153610646|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
153610647|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610650|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
153610715|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610716|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610719|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
153610720|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153610721|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153610722|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153610723|NCT01948817|Deferasirox|deferasirox|mesh-list
153610724|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153610725|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
153610726|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
153610727|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610749|NCT01948960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610750|NCT01948960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610751|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153610752|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
153610753|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610799|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153610800|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610801|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
153610802|NCT01949454|Hormones|hormones|mesh-ancestor
153610803|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610804|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610805|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153610806|NCT01949519|Lycopene|lycopene|mesh-list
153610807|NCT01949519|Docetaxel|docetaxel|mesh-list
153610843|NCT01949766|Glycerol|glycerol|mesh-list
153610880|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610881|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153610882|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153610883|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153610884|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153610885|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610886|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610887|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
153610889|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610890|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153610949|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610950|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153610951|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610952|NCT01950416|Clopidogrel|clopidogrel|mesh-list
153610953|NCT01950416|Ticagrelor|ticagrelor|mesh-list
153610954|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153610955|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153610956|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153610957|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153610958|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
153610959|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610960|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610961|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611026|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611027|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611028|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153611029|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
153611030|NCT01950793|Protective Agents|protective agents|mesh-ancestor
153611032|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153611033|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153611034|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
153611035|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611036|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153611037|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
153611057|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611059|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
153611060|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611061|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153611062|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
153611063|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153611064|NCT01951079|Digoxin|digoxin|mesh-list
153611065|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153611066|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153611067|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611108|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
153611109|NCT01951430|Clotrimazole|clotrimazole|mesh-list
153611111|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611112|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153611113|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153611114|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611115|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611116|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153611117|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
153611118|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611119|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611120|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153611121|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153611122|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153611123|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153611124|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153611125|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153611126|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153611127|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153611128|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
153611129|NCT01951482|Bevacizumab|bevacizumab|mesh-list
153611130|NCT01951482|Cisplatin|cisplatin|mesh-list
153611131|NCT01951482|Pemetrexed|pemetrexed|mesh-list
153611132|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153611188|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
153611189|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
153611190|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
153611191|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153611192|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153611193|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
153611194|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611205|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611206|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611253|NCT01952561|Dapivirine|dapivirine|mesh-list
153611254|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153611255|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153611256|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
153611257|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611267|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153611269|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
153611270|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611271|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611273|NCT01952652|Codeine|codeine|mesh-list
153611275|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153611333|NCT05876481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153611334|NCT05876195|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153611335|NCT05876195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153611336|NCT05876195|Freund's Adjuvant|freund's adjuvant|mesh-list
153611337|NCT05876195|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153611338|NCT05876195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153611339|NCT05876195|Immunologic Factors|immunologic factors|mesh-ancestor
153611340|NCT05876195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611342|NCT05876195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611343|NCT05876195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153611344|NCT05876169|Salicylic Acid|salicylic acid|mesh-list
153611345|NCT05876169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611346|NCT05876169|Antifungal Agents|antifungal agents|mesh-ancestor
153611348|NCT05876169|Dermatologic Agents|dermatologic agents|mesh-ancestor
153611349|NCT05876039|Remifentanil|remifentanil|mesh-list
153611350|NCT05876039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153611351|NCT05876039|Narcotics|narcotics|mesh-ancestor
153611352|NCT05876039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611353|NCT05876039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611391|NCT05875610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153611392|NCT05875610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153611393|NCT05875610|Antidepressive Agents|antidepressive agents|mesh-ancestor
153611394|NCT05875519|Nordefrin|nordefrin|mesh-list
153611412|NCT05875285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611413|NCT05875285|Dermatologic Agents|dermatologic agents|mesh-ancestor
153611414|NCT05875285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611415|NCT05875285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153611416|NCT05875285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153611417|NCT05875285|Immunologic Factors|immunologic factors|mesh-ancestor
153611418|NCT05875285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611419|NCT05875285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153611421|NCT05874882|Chlorhexidine|chlorhexidine|mesh-list
153611422|NCT05874882|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153611423|NCT05874882|Resveratrol|resveratrol|mesh-list
153611424|NCT05874882|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153611425|NCT05874882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611426|NCT05874882|Disinfectants|disinfectants|mesh-ancestor
153611427|NCT05874882|Dermatologic Agents|dermatologic agents|mesh-ancestor
153611477|NCT05874674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611478|NCT05874674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611479|NCT05874674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611480|NCT05874674|Anticoagulants|anticoagulants|mesh-ancestor
153611481|NCT05874674|Protease Inhibitors|protease inhibitors|mesh-ancestor
153611482|NCT05874674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611483|NCT05874674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611484|NCT05874674|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153611485|NCT05874674|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153611486|NCT05874674|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153611487|NCT05874674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153611488|NCT05874674|Immunologic Factors|immunologic factors|mesh-ancestor
153611489|NCT05874583|Tranexamic Acid|tranexamic acid|mesh-list
153611490|NCT05874583|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153611491|NCT05874583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153611492|NCT05874583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611494|NCT05874583|Coagulants|coagulants|mesh-ancestor
153611495|NCT05874518|Letrozole|letrozole|mesh-list
153611547|NCT05823675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611548|NCT05823675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153611550|NCT05823675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153611551|NCT05823675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611552|NCT05874869|Piperaquine|piperaquine|mesh-list
153611553|NCT05874869|Artenimol|artenimol|mesh-list
153611554|NCT05874869|Antimalarials|antimalarials|mesh-ancestor
153611555|NCT05874869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153611556|NCT05874869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153611557|NCT05874869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611558|NCT05799820|Bevacizumab|bevacizumab|mesh-list
153611559|NCT05799820|Capecitabine|capecitabine|mesh-list
153611560|NCT05799820|Oxaliplatin|oxaliplatin|mesh-list
153611561|NCT05799820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153611562|NCT05799820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611563|NCT05799820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153611564|NCT05799820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153611621|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611622|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153611623|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153611624|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611625|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611626|NCT05323708|Denosumab|denosumab|mesh-list
153611627|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153611628|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611629|NCT05285566|Lidocaine|lidocaine|mesh-list
153611630|NCT05285566|Bupivacaine|bupivacaine|mesh-list
153611640|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153611641|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611642|NCT05129722|Empagliflozin|empagliflozin|mesh-list
153611643|NCT05129722|Eplerenone|eplerenone|mesh-list
153611688|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153611689|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
153611690|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611691|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611692|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611705|NCT04853446|BB 1101|bb 1101|mesh-list
153611706|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611707|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
153611708|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
153611709|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611710|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611711|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339446|NCT00995501|Dexamethasone|dexamethasone|mesh-list
153611712|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
153611713|NCT04853446|Hormones|hormones|mesh-ancestor
153611714|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611715|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153611716|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611717|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
153611718|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611719|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611720|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153611721|NCT04846231|Red yeast rice|red yeast rice|mesh-list
154157458|NCT05782712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611750|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611751|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
153611752|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611753|NCT04660760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153611754|NCT04660760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153611761|NCT04507217|Pemetrexed|pemetrexed|mesh-list
153611762|NCT04507217|Tislelizumab|tislelizumab|mesh-list
153611763|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611764|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611765|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611766|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153611767|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153611768|NCT04507217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153611769|NCT04447846|Cannabidiol|cannabidiol|mesh-list
153611770|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
153611771|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153611772|NCT04405245|Latanoprost|latanoprost|mesh-list
153611773|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153611774|NCT04335968|Melatonin|melatonin|mesh-list
153611775|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
153611776|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482158|NCT01410084|Vitamin D|vitamin d|mesh-list
153611777|NCT04335968|Protective Agents|protective agents|mesh-ancestor
153611778|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611779|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611780|NCT04262024|Cabergoline|cabergoline|mesh-list
153611781|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153611802|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611803|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153611804|NCT04201964|Tenecteplase|tenecteplase|mesh-list
153611805|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153611806|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153611807|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611809|NCT04198805|Vitamin E|vitamin e|mesh-list
153611810|NCT04198805|Tocopherols|tocopherols|mesh-list
153611811|NCT04198805|Tocotrienols|tocotrienols|mesh-list
153611812|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
153611813|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
153611814|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611815|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
153611816|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611817|NCT04198805|Protective Agents|protective agents|mesh-ancestor
153611818|NCT04179890|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153611873|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
153611874|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611875|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611876|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611877|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
153611878|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
153611879|NCT03486106|Propofol|propofol|mesh-list
153611880|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153611881|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611882|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611883|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153611884|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
153611885|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
153611886|NCT03434275|Meloxicam|meloxicam|mesh-list
153611887|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153611888|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153611889|NCT03434275|Analgesics|analgesics|mesh-ancestor
153611890|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
153611891|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611942|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611943|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
153611944|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
153611946|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611947|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153611948|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
153611949|NCT03114865|Hormones|hormones|mesh-ancestor
153611950|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153611951|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153611952|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611953|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
153611954|NCT02920008|Guadecitabine|guadecitabine|mesh-list
153611967|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
153611968|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612014|NCT02344810|Fluorouracil|fluorouracil|mesh-list
153612015|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
153612016|NCT02344810|Calcium|calcium|mesh-list
153612017|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
153612018|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153612019|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612020|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
153391899|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
153612045|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153612046|NCT02278185|Tryptophan|tryptophan|mesh-list
153612047|NCT02278185|Androgens|androgens|mesh-list
153612048|NCT02278185|Hormones|hormones|mesh-ancestor
153612049|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612050|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612051|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153612052|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
153612053|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153612054|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153612055|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612056|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
153612057|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153612058|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
153612059|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153612060|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153612061|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
153612092|NCT01840566|Carmustine|carmustine|mesh-list
153612103|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612104|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
153612105|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612106|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153612107|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
153612108|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153612110|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
153612111|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
153612112|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
153612217|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
153612218|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153612219|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612220|NCT01953419|Pemetrexed|pemetrexed|mesh-list
153612221|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612222|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612223|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612224|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153612225|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153612226|NCT01953445|Paclitaxel|paclitaxel|mesh-list
153612227|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153612228|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612229|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
153612230|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612231|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612232|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612233|NCT01953536|Folic Acid|folic acid|mesh-list
153612234|NCT01953536|Paclitaxel|paclitaxel|mesh-list
153612235|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153612236|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153612237|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612238|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
153612239|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612240|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612241|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612242|NCT01953536|Hematinics|hematinics|mesh-ancestor
153612259|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153612260|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
153612261|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153612262|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612263|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
153612264|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153612265|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153612266|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153612270|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153612271|NCT01953744|Fluconazole|fluconazole|mesh-list
153612272|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153612273|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
153612274|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612275|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153612277|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612352|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612353|NCT01953848|Urological Agents|urological agents|mesh-ancestor
153612354|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153612355|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153612356|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
153612357|NCT01953887|Tamsulosin|tamsulosin|mesh-list
153612358|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
153612359|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153612360|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153612361|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153612443|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612444|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
153612445|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153612446|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
153612447|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153612448|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
153612449|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612450|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612451|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
153612452|NCT01954290|Mannitol|mannitol|mesh-list
153612453|NCT01954290|Conivaptan|conivaptan|mesh-list
153612454|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153612526|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612528|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612529|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612530|NCT01955070|Ketamine|ketamine|mesh-list
153612531|NCT01955070|Analgesics|analgesics|mesh-ancestor
153612532|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
153612533|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612534|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612535|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153612536|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153612537|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
153612538|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
153612539|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612540|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153612541|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153612614|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153612615|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
153612616|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612617|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153612618|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
153612619|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153612621|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
153612622|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153612702|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
153612703|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153612704|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153612705|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153612706|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153612707|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153612708|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153612722|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502917|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612723|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153612782|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
153612783|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612784|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612785|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153612786|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153612787|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
153612788|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612789|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612853|NCT01956981|Analgesics|analgesics|mesh-ancestor
153612854|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
153612855|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612856|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153612857|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153612858|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153612859|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
153612860|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612861|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612862|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
153612863|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153612864|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
153612865|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153612866|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153612867|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153612868|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
153612876|NCT01957046|Laxatives|laxatives|mesh-list
153612920|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153612921|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153612922|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
153612923|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612924|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612925|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612926|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153612927|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153612928|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
153612929|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
153612930|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
153612931|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612932|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153612933|NCT01957540|Ticagrelor|ticagrelor|mesh-list
153612946|NCT01957631|Prednisolone|prednisolone|mesh-list
153612992|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612993|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612994|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153612995|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
153612996|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
153612997|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153612998|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153613001|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153613070|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
153613071|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613072|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613073|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153613074|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
153613075|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153613076|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
153613077|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613078|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613079|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153613143|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613144|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153613145|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153613146|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153613147|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153613148|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613149|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153613150|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153613151|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613153|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153613154|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153613163|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153613164|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153613165|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
153613166|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613167|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153613168|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153613169|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613170|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153613171|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
153613172|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613201|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153613202|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153613203|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153613204|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613205|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
153613206|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153613207|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
153613208|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613209|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613210|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153613211|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
153613212|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153613213|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
153613216|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153613275|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
153613276|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613277|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153613278|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153613279|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
153613280|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153613281|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153613282|NCT01960426|Adalimumab|adalimumab|mesh-list
153613283|NCT01960426|Infliximab|infliximab|mesh-list
153613299|NCT01960543|Narcotics|narcotics|mesh-ancestor
153613300|NCT01960543|Analgesics|analgesics|mesh-ancestor
153613301|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153613302|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153613361|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613362|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613363|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
153613364|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613365|NCT01961193|Silicon|silicon|mesh-list
153613366|NCT01961193|Trace Elements|trace elements|mesh-ancestor
153613367|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
153613368|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613369|NCT01961336|Testosterone|testosterone|mesh-list
153613370|NCT01961336|Androgens|androgens|mesh-ancestor
153613371|NCT01961336|Hormones|hormones|mesh-ancestor
153613372|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613373|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613374|NCT01961388|Metformin|metformin|mesh-list
153613375|NCT01961388|Acarbose|acarbose|mesh-list
153613381|NCT01961414|Aflibercept|aflibercept|mesh-list
153613430|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613431|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
153613432|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613433|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153613434|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
153613435|NCT01961752|Hormones|hormones|mesh-ancestor
153613436|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613437|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153613438|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
153613439|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341276|NCT01050647|Progestins|progestins|mesh-ancestor
153502949|NCT01839552|Fentanyl|fentanyl|mesh-list
153613509|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613510|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
153613511|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153613512|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
153613513|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613514|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
153613515|NCT01962454|Testosterone|testosterone|mesh-list
153613516|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
153613517|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
153613518|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153613519|NCT01962454|Androgens|androgens|mesh-ancestor
153613520|NCT01962454|Hormones|hormones|mesh-ancestor
153613525|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
153613581|NCT01963442|Lactams|lactams|mesh-list
153613582|NCT01963442|beta-Lactams|beta-lactams|mesh-list
153613583|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153613584|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153613585|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153613586|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781989|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393458|NCT04341935|Hormones|hormones|mesh-ancestor
153613587|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613589|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613590|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613591|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153613592|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153613612|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153613613|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153613614|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613618|NCT01963663|Pioglitazone|pioglitazone|mesh-list
153613671|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153613672|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153613673|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613675|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153613676|NCT01963910|Diuretics|diuretics|mesh-ancestor
153613677|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
153613678|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613679|NCT01963962|Copper|copper|mesh-list
153613680|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
153613681|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153613682|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
153613683|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153613684|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613685|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153613686|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153613687|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153613688|NCT01963962|Trace Elements|trace elements|mesh-ancestor
153613690|NCT01964001|Vitamins|vitamins|mesh-list
153613741|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613742|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613743|NCT01964170|Goserelin|goserelin|mesh-list
153613744|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153613745|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613746|NCT01964183|Mirabegron|mirabegron|mesh-list
153613747|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153613748|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153613749|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153613750|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153613751|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613752|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502994|NCT01836432|Leucovorin|leucovorin|mesh-list
153613753|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613754|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613816|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613817|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153613818|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
153613819|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613820|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153613821|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153613822|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
153613823|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153613824|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153613825|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153613826|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153613827|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613828|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153613829|NCT01964404|Dronabinol|dronabinol|mesh-list
153613830|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
153613832|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153613874|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153613875|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153484688|NCT05683548|REP 2139|rep 2139|mesh-list
153613876|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153613877|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613878|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613879|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153613880|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153613881|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
153613882|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153613883|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
153613884|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
153613885|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
153613886|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153613887|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
153613888|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613955|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
153613956|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153613957|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613958|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153613959|NCT01965275|Gefitinib|gefitinib|mesh-list
153613960|NCT01965275|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153613972|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
153613973|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
153613974|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613975|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
153613976|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
153613986|NCT01965353|Dexamethasone|dexamethasone|mesh-list
153614041|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153614043|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
153614044|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614045|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614046|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614047|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
153614048|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153614049|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153614050|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614053|NCT01965405|Bupropion|bupropion|mesh-list
153614120|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614121|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614123|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614124|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
153614125|NCT01966289|Guadecitabine|guadecitabine|mesh-list
153614126|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
153614127|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614128|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153614129|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614130|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153614131|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
153614132|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614196|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
153614197|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
153614198|NCT01966783|Hormones|hormones|mesh-ancestor
153614199|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614200|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153614201|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153614202|NCT01966783|Analgesics|analgesics|mesh-ancestor
153614203|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
153614204|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614205|NCT01966822|Ritonavir|ritonavir|mesh-list
153614206|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153614207|NCT01966822|Dolutegravir|dolutegravir|mesh-list
153614208|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
153614210|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614290|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614291|NCT01967459|Vitamins|vitamins|mesh-ancestor
153614292|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
153614293|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153614294|NCT01967472|Artesunate|artesunate|mesh-list
153614295|NCT01967472|Lumefantrine|lumefantrine|mesh-list
153614296|NCT01967472|Artemether|artemether|mesh-list
153614297|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153614372|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
153614373|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614374|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153614376|NCT01967927|Imidazole|imidazole|mesh-list
153614377|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614378|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614379|NCT01967979|Itraconazole|itraconazole|mesh-list
153614408|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614409|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153614410|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153614411|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153614412|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614413|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614414|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153614415|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153614417|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614418|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614437|NCT01968044|Hormones|hormones|mesh-ancestor
153614465|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153614466|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153614467|NCT01968486|Growth Substances|growth substances|mesh-ancestor
153614468|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614469|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
153614470|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614472|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153614473|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503136|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614474|NCT01968564|Analgesics|analgesics|mesh-ancestor
153614475|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
153614476|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614477|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614500|NCT01968759|Ramipril|ramipril|mesh-list
153614535|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153614536|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614537|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
153614538|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
153614539|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
153614540|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614541|NCT01969006|Bupivacaine|bupivacaine|mesh-list
153614542|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
153614543|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
153614546|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
153614632|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614634|NCT01969357|Hormones|hormones|mesh-ancestor
153614635|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614636|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153614637|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
153614638|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614639|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614640|NCT01969617|Naltrexone|naltrexone|mesh-list
153614641|NCT01969617|Nalmefene|nalmefene|mesh-list
153614642|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153614643|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614707|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614708|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153614710|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
153614711|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614712|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153614713|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153614714|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153614715|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
153614716|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614717|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614719|NCT01969942|Busulfan|busulfan|mesh-list
153614720|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153614721|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
153614722|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614723|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614806|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614807|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614808|NCT01970579|Paclitaxel|paclitaxel|mesh-list
153614809|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153614810|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614811|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
153614812|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
153614813|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
153614814|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614815|NCT01970748|Propranolol|propranolol|mesh-list
153614816|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153614817|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153614818|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
153614819|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614879|NCT01971281|Gemcitabine|gemcitabine|mesh-list
153614880|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153614881|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614882|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
153614883|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
153614884|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
153614885|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614886|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153614887|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
153614888|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
153614889|NCT01971411|Vitamin D|vitamin d|mesh-list
153614890|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
153614891|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
153614893|NCT01971411|Calcium|calcium|mesh-list
153614978|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153614979|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
153614980|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153614981|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153614982|NCT01971801|Vitamin D|vitamin d|mesh-list
153614983|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
153614984|NCT01971801|Vitamins|vitamins|mesh-ancestor
153614985|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
153614986|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614987|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153614988|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153614989|NCT01971814|Infliximab|infliximab|mesh-list
153614990|NCT01971814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153614991|NCT01971814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614992|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
153614993|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153614994|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614995|NCT01971918|Antibodies|antibodies|mesh-list
153614996|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
153614997|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614998|NCT01972113|Vitamins|vitamins|mesh-list
153614999|NCT01972113|Vitamin K|vitamin k|mesh-list
153615000|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
153615001|NCT01972113|Menaquinone 7|menaquinone 7|mesh-list
153615002|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
153615003|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615011|NCT01972230|Propofol|propofol|mesh-list
153615073|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615074|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615075|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615076|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153615077|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
153615078|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615079|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615080|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153615082|NCT01972763|Ranibizumab|ranibizumab|mesh-list
153615083|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153615084|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153615085|NCT01972763|Growth Substances|growth substances|mesh-ancestor
153615086|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615087|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
153615088|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615089|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153615090|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
153615091|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
153615092|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
153615093|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153615094|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615095|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153615096|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615097|NCT01972906|Ibuprofen|ibuprofen|mesh-list
153615098|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153615099|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153615100|NCT01972906|Analgesics|analgesics|mesh-ancestor
153615101|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
153615102|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615132|NCT01973101|Cisplatin|cisplatin|mesh-list
153615133|NCT01973101|Gemcitabine|gemcitabine|mesh-list
153615134|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615135|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153615136|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
153745649|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153615137|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615139|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153615140|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153615141|NCT01973140|Tolvaptan|tolvaptan|mesh-list
153615142|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153615143|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615144|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
153615145|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615146|NCT01973309|Paclitaxel|paclitaxel|mesh-list
153615147|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153615148|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615149|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
153615150|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
153615151|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
153615152|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615153|NCT01973322|Vaccines|vaccines|mesh-list
153615154|NCT01973322|Complement Factor H|complement factor h|mesh-list
153615155|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
153615156|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615158|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153615205|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153615206|NCT01973751|Budesonide|budesonide|mesh-list
153615207|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615208|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153615209|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
153615210|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615211|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615212|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153615213|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
153615214|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
153615215|NCT01973751|Hormones|hormones|mesh-ancestor
153626789|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615244|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
153615245|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615246|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153615247|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
153615248|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153615249|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
153615250|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153615251|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615252|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153615253|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615254|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615255|NCT01973855|Ribavirin|ribavirin|mesh-list
153615260|NCT01973868|Cetuximab|cetuximab|mesh-list
153615305|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
153615306|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153615307|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615308|NCT01974167|Vitamins|vitamins|mesh-ancestor
153615310|NCT01974258|Vemurafenib|vemurafenib|mesh-list
153615311|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615312|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153615313|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615314|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615315|NCT01974297|Atorvastatin|atorvastatin|mesh-list
153615316|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
153615317|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153615318|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153615340|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153615342|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153615343|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615344|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
153615345|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
153615346|NCT01974518|Rituximab|rituximab|mesh-list
153615347|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153615348|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
153615385|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615386|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615387|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615388|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
153615389|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615391|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153615392|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153731566|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731568|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153503446|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153731569|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615393|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615394|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615395|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
153615396|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615397|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153615398|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153615399|NCT01975051|Miltefosine|miltefosine|mesh-list
153615400|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
153615401|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615402|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615403|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153615404|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153615405|NCT01975129|Oxytocin|oxytocin|mesh-list
153615432|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615444|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615445|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615446|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153615447|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615448|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615449|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615451|NCT01975441|Albendazole|albendazole|mesh-list
153615452|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
153615453|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153615454|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615455|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
153615456|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
153615457|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153615458|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153615459|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
153615460|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
153615461|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
153615462|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615463|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615464|NCT01975441|Filaricides|filaricides|mesh-ancestor
153615465|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
153615504|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615505|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153615507|NCT01975727|Hormones|hormones|mesh-ancestor
153615508|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615509|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615510|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615511|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
153615512|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615513|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615514|NCT01975753|Fentanyl|fentanyl|mesh-list
153615515|NCT01975753|Morphine|morphine|mesh-list
153615516|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153615517|NCT01975753|Narcotics|narcotics|mesh-ancestor
153615518|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615519|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615520|NCT01975753|Analgesics|analgesics|mesh-ancestor
153615521|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
153615522|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615523|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153615524|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153615555|NCT01976078|Midazolam|midazolam|mesh-list
153615556|NCT01976078|Esomeprazole|esomeprazole|mesh-list
153615557|NCT01976078|Ranitidine|ranitidine|mesh-list
153615558|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153615559|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153615560|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153615561|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615562|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615563|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153615564|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153615565|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615566|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153615567|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
153615588|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615589|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
153615590|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
153615591|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615592|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615593|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153615594|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
153615595|NCT01976195|Hormones|hormones|mesh-ancestor
153615596|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615597|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615598|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615599|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153615600|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
153615601|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
153615602|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153615603|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615604|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153503554|NCT03400020|Vitamins|vitamins|mesh-ancestor
153615605|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153615606|NCT01976195|Growth Substances|growth substances|mesh-ancestor
153615607|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
153615620|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615621|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
153615622|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615623|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615692|NCT01977300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153615693|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153615694|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615695|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
153615696|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615697|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
153615698|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
153615699|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
153615700|NCT01977339|Bupivacaine|bupivacaine|mesh-list
153615701|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
153615713|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615714|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615715|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153615716|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
153615717|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615718|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153615719|NCT01977430|Furosemide|furosemide|mesh-list
153615720|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153615721|NCT01977430|Diuretics|diuretics|mesh-ancestor
153615722|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
153615723|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615724|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153615725|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615728|NCT01977235|Irinotecan|irinotecan|mesh-list
153615739|NCT01977989|Vancomycin|vancomycin|mesh-list
153615740|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153615741|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615742|NCT01978015|Timolol|timolol|mesh-list
153615743|NCT01978015|Bimatoprost|bimatoprost|mesh-list
153615744|NCT01978015|Travoprost|travoprost|mesh-list
153615745|NCT01978015|Dextrans|dextrans|mesh-list
153615746|NCT01978015|Latanoprost|latanoprost|mesh-list
153615747|NCT01978015|Maleic acid|maleic acid|mesh-list
153615748|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343536|NCT00003682|Prednisolone|prednisolone|mesh-list
153615749|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615750|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153615751|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153615752|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
153615753|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615754|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615755|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153615756|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153615757|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153615758|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153615759|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
153615760|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
153615761|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
153615774|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615775|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153615776|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
153615777|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615778|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615779|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
153615780|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
153615781|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615782|NCT01978405|Protective Agents|protective agents|mesh-ancestor
153615791|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615792|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153615793|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
153615794|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
153615795|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153615796|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153615797|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153615798|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153615799|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
153615800|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615801|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615802|NCT01978457|Propranolol|propranolol|mesh-list
153615804|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153615805|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153615806|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
153615807|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615808|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615809|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615810|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153615811|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153615812|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
153615813|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
153615815|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615816|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
153615817|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615818|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153615819|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153615820|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153615822|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
153615856|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615857|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615858|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
153615859|NCT01978782|Citalopram|citalopram|mesh-list
153615860|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153615861|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153615862|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
153615863|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615864|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153615865|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153615866|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615867|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615868|NCT01978782|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153615869|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153615870|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615871|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615872|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
153615942|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153615943|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153615944|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615945|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153615946|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
153615948|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
153615949|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
153615950|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153615951|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153615952|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153615953|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615954|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615955|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615956|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153615957|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153615958|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153615959|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
153615960|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616014|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153616015|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153616016|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616017|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153616018|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153616019|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
153616020|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153616021|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153616022|NCT01980407|Leucovorin|leucovorin|mesh-list
153616023|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153616024|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
153616025|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616026|NCT01980407|Antidotes|antidotes|mesh-ancestor
153616027|NCT01980407|Protective Agents|protective agents|mesh-ancestor
153616028|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616029|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
153616030|NCT01980407|Vitamins|vitamins|mesh-ancestor
153616031|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
153616032|NCT01980472|Paclitaxel|paclitaxel|mesh-list
153616033|NCT01980472|Bevacizumab|bevacizumab|mesh-list
153616034|NCT01980472|Carboplatin|carboplatin|mesh-list
153616040|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616041|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616042|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153616043|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153616044|NCT01980472|Growth Substances|growth substances|mesh-ancestor
153626790|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
153616094|NCT06329063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153616095|NCT06329063|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153616096|NCT06329063|Natriuretic Agents|natriuretic agents|mesh-ancestor
153616097|NCT06329050|Losartan|losartan|mesh-list
153616098|NCT06329050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153616099|NCT06329050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153616100|NCT06329050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153616101|NCT06329050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153616102|NCT06329050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616103|NCT06329037|Vasopressins|vasopressins|mesh-list
153503770|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153616104|NCT06329037|Arginine Vasopressin|arginine vasopressin|mesh-list
153616116|NCT06328998|Sensory System Agents|sensory system agents|mesh-ancestor
153616117|NCT06328998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616118|NCT06328998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153616119|NCT06328998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153616120|NCT06328998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153616121|NCT06328998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153616122|NCT06328998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616151|NCT06328556|Botulinum Toxins|botulinum toxins|mesh-list
153616152|NCT06328556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153616153|NCT06328556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153616154|NCT06328556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153616155|NCT06328556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153616156|NCT06328556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616157|NCT06328556|Cholinergic Agents|cholinergic agents|mesh-ancestor
153616158|NCT06328556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616159|NCT06328556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616160|NCT06328556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153616161|NCT06328556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616163|NCT06328543|Histamine Agonists|histamine agonists|mesh-ancestor
153616164|NCT06328543|Histamine Agents|histamine agents|mesh-ancestor
153616173|NCT06328530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616174|NCT06328504|Immunomodulating Agents|immunomodulating agents|mesh-list
153616175|NCT06328504|Immunologic Factors|immunologic factors|mesh-ancestor
153616176|NCT06328504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616177|NCT06328426|Vitamin D|vitamin d|mesh-list
153616178|NCT06328426|Metformin|metformin|mesh-list
153616179|NCT06328426|Vitamins|vitamins|mesh-ancestor
153616180|NCT06328426|Micronutrients|micronutrients|mesh-ancestor
153616181|NCT06328426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616182|NCT06328426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153616183|NCT06328426|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153616184|NCT06328387|Hydroxychloroquine|hydroxychloroquine|mesh-list
153616185|NCT06328387|Trastuzumab|trastuzumab|mesh-list
153616186|NCT06328387|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153616187|NCT06328387|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153616188|NCT06328387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616189|NCT06328387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616190|NCT06328387|Antimalarials|antimalarials|mesh-ancestor
153616204|NCT06328205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616205|NCT06328205|Sensory System Agents|sensory system agents|mesh-ancestor
153616206|NCT06328205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616207|NCT06328205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153616208|NCT06328205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153616209|NCT06328205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153616210|NCT06328205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153616211|NCT06328205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616212|NCT06328179|Cytarabine|cytarabine|mesh-list
153616213|NCT06328179|Etoposide|etoposide|mesh-list
153616214|NCT06328179|Venetoclax|venetoclax|mesh-list
153616216|NCT06328179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616230|NCT06328153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153616231|NCT06328153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153616232|NCT06328153|Analgesics|analgesics|mesh-ancestor
153616233|NCT06328153|Sensory System Agents|sensory system agents|mesh-ancestor
153616234|NCT06328153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616235|NCT06328153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616236|NCT06328153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153616237|NCT06328153|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153616238|NCT06328153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153616239|NCT06328153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616240|NCT06328153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616241|NCT06328140|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153616242|NCT06328140|Antidepressive Agents|antidepressive agents|mesh-list
153616243|NCT06328140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153616244|NCT06328140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153616245|NCT06328140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153616246|NCT06328140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616247|NCT06328140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616248|NCT06328140|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153616267|NCT06328062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153616268|NCT06328062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616269|NCT06328062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153616270|NCT06328062|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153616271|NCT06328062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153616272|NCT06328062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616273|NCT06328062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153616274|NCT06328036|Atezolizumab|atezolizumab|mesh-list
153616275|NCT06328036|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153616276|NCT06328036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153616289|NCT06327815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153616290|NCT06327815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616291|NCT06327815|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153503863|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153616292|NCT06327815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616294|NCT06327724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153616295|NCT06327724|Immunologic Factors|immunologic factors|mesh-ancestor
153616296|NCT06327724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616303|NCT06327646|Folic Acid|folic acid|mesh-list
153616304|NCT06327646|Micronutrients|micronutrients|mesh-list
153616305|NCT06327646|Trace Elements|trace elements|mesh-list
153616306|NCT06327646|Hematinics|hematinics|mesh-ancestor
153616307|NCT06327646|Vitamin B Complex|vitamin b complex|mesh-ancestor
153616308|NCT06327646|Vitamins|vitamins|mesh-ancestor
153616309|NCT06327646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616310|NCT06327581|Triamcinolone|triamcinolone|mesh-list
153616325|NCT06327451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153616326|NCT06327451|Antimetabolites|antimetabolites|mesh-ancestor
153616327|NCT06327451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616328|NCT06327451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153616329|NCT06327451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153616330|NCT06327451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616331|NCT06327399|Atropine|atropine|mesh-list
153616332|NCT06327399|Ephedrine|ephedrine|mesh-list
153616333|NCT06327399|Dexmedetomidine|dexmedetomidine|mesh-list
153616334|NCT06327399|Propofol|propofol|mesh-list
153616335|NCT06327399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153616336|NCT06327399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616357|NCT06327399|Mydriatics|mydriatics|mesh-ancestor
153616358|NCT06327399|Parasympatholytics|parasympatholytics|mesh-ancestor
153616359|NCT06327399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153616360|NCT06327399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153616361|NCT06327399|Cholinergic Agents|cholinergic agents|mesh-ancestor
153616362|NCT06327399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153616407|NCT06326996|Vitamins|vitamins|mesh-ancestor
153616408|NCT06326996|Micronutrients|micronutrients|mesh-ancestor
153616409|NCT06326996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616410|NCT06326996|Vitamin B Complex|vitamin b complex|mesh-ancestor
153616411|NCT06326983|Acetaminophen|acetaminophen|mesh-list
153616412|NCT06326983|Ketorolac|ketorolac|mesh-list
153616413|NCT06326983|Dexmedetomidine|dexmedetomidine|mesh-list
153616414|NCT06326983|Morphine|morphine|mesh-list
153616415|NCT06326983|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153616416|NCT06326983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616417|NCT06326983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616418|NCT06326983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153616419|NCT06326983|Analgesics|analgesics|mesh-ancestor
153616420|NCT06326983|Sensory System Agents|sensory system agents|mesh-ancestor
153616496|NCT06306300|Velpatasvir|velpatasvir|mesh-list
153616497|NCT06306300|Antiviral Agents|antiviral agents|mesh-ancestor
153616498|NCT06306300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153616499|NCT06305767|Pembrolizumab|pembrolizumab|mesh-list
153616500|NCT06305767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616501|NCT06305767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616502|NCT06305767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153616503|NCT06305767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616504|NCT06301737|Lidocaine|lidocaine|mesh-list
153616505|NCT06301737|Anesthetics, Local|anesthetics, local|mesh-ancestor
153616506|NCT06301737|Anesthetics|anesthetics|mesh-ancestor
153616507|NCT06301737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616508|NCT06301737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616509|NCT06301737|Sensory System Agents|sensory system agents|mesh-ancestor
153616510|NCT06301737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616511|NCT06301737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153616512|NCT06301737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153616565|NCT06265584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153616566|NCT06265584|Antimetabolites|antimetabolites|mesh-ancestor
153616567|NCT06265584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616568|NCT06265584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616569|NCT06265584|Dermatologic Agents|dermatologic agents|mesh-ancestor
153616570|NCT06265584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616571|NCT06265584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153616572|NCT06265584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153616573|NCT06265584|Immunologic Factors|immunologic factors|mesh-ancestor
153616574|NCT06265584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153616575|NCT06265584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153616576|NCT06265584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153616611|NCT06250283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616613|NCT06250283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616614|NCT06250283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616615|NCT06250283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153616625|NCT06222593|Sunitinib|sunitinib|mesh-list
153616626|NCT06222593|Bicalutamide|bicalutamide|mesh-list
153616627|NCT06222593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616628|NCT06222593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153616660|NCT06196203|Azacitidine|azacitidine|mesh-list
153616661|NCT06196203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153616662|NCT06196203|Antimetabolites|antimetabolites|mesh-ancestor
153616663|NCT06196203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616664|NCT06196203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616665|NCT06196203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616675|NCT06186141|Morphine|morphine|mesh-list
153616676|NCT06186141|Oxycodone|oxycodone|mesh-list
153616677|NCT06186141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153616678|NCT06186141|Narcotics|narcotics|mesh-ancestor
153616679|NCT06186141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616680|NCT06186141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616742|NCT06158126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153616743|NCT06158126|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153616744|NCT06158126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153616745|NCT06158126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616746|NCT06158126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616747|NCT06158126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153616748|NCT06158126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153616749|NCT06146972|Tofacitinib|tofacitinib|mesh-list
153616750|NCT06146972|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153503938|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153616751|NCT06146972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153616752|NCT06146972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616763|NCT06144177|Midazolam|midazolam|mesh-list
153616819|NCT06104280|Protective Agents|protective agents|mesh-ancestor
153616820|NCT06104280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616821|NCT06104280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616825|NCT06103656|Omalizumab|omalizumab|mesh-list
153616826|NCT06103656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153616827|NCT06103656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153616828|NCT06103656|Respiratory System Agents|respiratory system agents|mesh-ancestor
153616848|NCT06088290|Doxorubicin|doxorubicin|mesh-list
153616862|NCT06063421|Autonomic Agents|autonomic agents|mesh-ancestor
153616863|NCT06063421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616864|NCT06063421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616865|NCT06063421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153616866|NCT06063421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153616867|NCT06063421|Cholinergic Agents|cholinergic agents|mesh-ancestor
153616868|NCT06063421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616869|NCT06063421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616898|NCT06053749|Interferon-beta|interferon-beta|mesh-list
153616899|NCT06053749|Interferon beta-1b|interferon beta-1b|mesh-list
153616900|NCT06053749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153616901|NCT06053749|Immunologic Factors|immunologic factors|mesh-ancestor
153616902|NCT06053749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616903|NCT06053749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616904|NCT06053749|Antiviral Agents|antiviral agents|mesh-ancestor
153616905|NCT06053749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153616908|NCT06044935|Nicotinic Acids|nicotinic acids|mesh-list
153616909|NCT06044935|Vitamin B Complex|vitamin b complex|mesh-ancestor
153616910|NCT06044935|Vitamins|vitamins|mesh-ancestor
153616911|NCT06044935|Micronutrients|micronutrients|mesh-ancestor
153616912|NCT06044935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616913|NCT06044935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153616914|NCT06044935|Antimetabolites|antimetabolites|mesh-ancestor
153616915|NCT06044935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616934|NCT06039826|Drospirenone|drospirenone|mesh-list
153616974|NCT06013241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153616989|NCT05985954|Cetuximab|cetuximab|mesh-list
153616990|NCT05985954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616991|NCT05985954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616997|NCT05980598|Pembrolizumab|pembrolizumab|mesh-list
153616998|NCT05980598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616999|NCT05980598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617000|NCT05980598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617001|NCT05980598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617006|NCT05960773|Decitabine|decitabine|mesh-list
153617007|NCT05960773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153617054|NCT05890027|Respiratory System Agents|respiratory system agents|mesh-ancestor
153617055|NCT05890027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153617056|NCT05890027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153617057|NCT05890027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153617058|NCT05890027|Adrenergic Agents|adrenergic agents|mesh-ancestor
153617059|NCT05890027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617060|NCT05890027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617061|NCT05890027|Protective Agents|protective agents|mesh-ancestor
153617067|NCT05856331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153617068|NCT05856331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153617100|NCT05797246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617101|NCT05797246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153396992|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153617102|NCT05797246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153617103|NCT05797246|Growth Substances|growth substances|mesh-ancestor
153617104|NCT05797246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617105|NCT05797246|Growth Inhibitors|growth inhibitors|mesh-ancestor
153617123|NCT05789173|Narcotics|narcotics|mesh-ancestor
153617124|NCT05789173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153617125|NCT05789173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617126|NCT05789173|Analgesics|analgesics|mesh-ancestor
153617127|NCT05789173|Sensory System Agents|sensory system agents|mesh-ancestor
153617128|NCT05789173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617129|NCT05789173|Antitussive Agents|antitussive agents|mesh-ancestor
153617130|NCT05789173|Respiratory System Agents|respiratory system agents|mesh-ancestor
153617131|NCT05789173|Anticonvulsants|anticonvulsants|mesh-ancestor
153617132|NCT05789173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153617133|NCT05789173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153617134|NCT05789173|Parasympatholytics|parasympatholytics|mesh-ancestor
153617135|NCT05789173|Autonomic Agents|autonomic agents|mesh-ancestor
153617136|NCT05789173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153617137|NCT05789173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153617138|NCT05789173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153617139|NCT05789173|Adrenergic Agents|adrenergic agents|mesh-ancestor
153617140|NCT05789173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617141|NCT05789173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153617142|NCT05789173|Sympatholytics|sympatholytics|mesh-ancestor
153617143|NCT05786521|Semaglutide|semaglutide|mesh-list
153617144|NCT05786521|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153344971|NCT04273165|Etravirine|etravirine|mesh-list
153397066|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153781990|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617179|NCT05761327|Resveratrol|resveratrol|mesh-list
153617180|NCT05761327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153617181|NCT05761327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153617189|NCT05761327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617190|NCT05761327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617192|NCT05761327|Protective Agents|protective agents|mesh-ancestor
153617193|NCT05761327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153617194|NCT05744375|Trastuzumab|trastuzumab|mesh-list
153617195|NCT05744375|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153617196|NCT05744375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617197|NCT05744375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617198|NCT05744375|Immunoconjugates|immunoconjugates|mesh-ancestor
153617199|NCT05744375|Immunologic Factors|immunologic factors|mesh-ancestor
153617200|NCT05744375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617201|NCT05733546|Psilocybin|psilocybin|mesh-list
153617202|NCT05733546|Hallucinogens|hallucinogens|mesh-ancestor
153617203|NCT05733546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617204|NCT05733546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153617232|NCT05702905|Metformin|metformin|mesh-list
153617233|NCT05702905|Semaglutide|semaglutide|mesh-list
153617234|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153617244|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
153617245|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
153617246|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153617248|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617304|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153617305|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617306|NCT05589181|Analgesics|analgesics|mesh-ancestor
153617307|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
153617308|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617309|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153617310|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
153617311|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617312|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617313|NCT05570825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153626791|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617371|NCT05544929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617372|NCT05544929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617392|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617393|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617394|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617395|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617396|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
153617397|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617398|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617399|NCT05491226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617400|NCT05491226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617401|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
153617402|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
153617562|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153617563|NCT05137119|Vancomycin|vancomycin|mesh-list
153617564|NCT05137119|Clindamycin|clindamycin|mesh-list
153617565|NCT05137119|Cefazolin|cefazolin|mesh-list
153617566|NCT05137119|Penicillins|penicillins|mesh-list
153617567|NCT05137119|Daptomycin|daptomycin|mesh-list
153617568|NCT05137119|Penicillin G|penicillin g|mesh-list
153617569|NCT05137119|Lincomycin|lincomycin|mesh-list
153617570|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617571|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153617572|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617573|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617574|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
153617575|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617576|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617577|NCT05101070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617578|NCT05101070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617579|NCT05098938|Acyclovir|acyclovir|mesh-list
153617580|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
153617581|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617582|NCT05092958|Avelumab|avelumab|mesh-list
153617583|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153617584|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617585|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617586|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
153617587|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617588|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
153617589|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153617590|NCT05085327|Protective Agents|protective agents|mesh-ancestor
153617591|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617592|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
153617593|NCT05065801|Folfirinox|folfirinox|mesh-list
153617594|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617619|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
153617620|NCT05036278|Factor VIII|factor viii|mesh-list
153617645|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617646|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153617647|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153617648|NCT04992624|Analgesics|analgesics|mesh-ancestor
153617649|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
153617650|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617651|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153617652|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153504116|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
153617653|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617654|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617655|NCT04992624|Hormones|hormones|mesh-ancestor
153617656|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153617657|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
153617658|NCT04971226|Dasatinib|dasatinib|mesh-list
153617659|NCT04971226|Nilotinib|nilotinib|mesh-list
153617660|NCT04971226|Bosutinib|bosutinib|mesh-list
153617661|NCT04971226|Asciminib|asciminib|mesh-list
153617662|NCT04971226|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153617663|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617664|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617665|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617666|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617670|NCT04925284|Nivolumab|nivolumab|mesh-list
153617671|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617672|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617673|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617674|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617683|NCT04903197|Lenalidomide|lenalidomide|mesh-list
153617724|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617725|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
153617726|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617727|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153617729|NCT04751669|Micronutrients|micronutrients|mesh-list
153617730|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617731|NCT04751370|Nivolumab|nivolumab|mesh-list
153617732|NCT04751370|Ipilimumab|ipilimumab|mesh-list
153617733|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617734|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617735|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617736|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617737|NCT04739566|Trametinib|trametinib|mesh-list
153617738|NCT04739566|Dabrafenib|dabrafenib|mesh-list
153617739|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617740|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617741|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617742|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617743|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
153617744|NCT04731740|Lenvatinib|lenvatinib|mesh-list
153617745|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617746|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617747|NCT04731740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617748|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617749|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153504209|NCT03830034|Iron|iron|mesh-list
153617750|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617751|NCT04729179|Cannabidiol|cannabidiol|mesh-list
153617792|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153617794|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617795|NCT04584684|Ethanol|ethanol|mesh-list
153617796|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153617797|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
153617798|NCT04584684|Povidone|povidone|mesh-list
153617799|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153617800|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617801|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153617802|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617803|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
153617804|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
153617812|NCT04575519|Aspirin|aspirin|mesh-list
153617813|NCT04575519|Ibuprofen|ibuprofen|mesh-list
153617814|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153617815|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153617816|NCT04575519|Analgesics|analgesics|mesh-ancestor
153617817|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
153617818|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617819|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617820|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153617821|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153617823|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617824|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617825|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153617826|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153617827|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153617829|NCT04567303|Ranibizumab|ranibizumab|mesh-list
153617830|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153617831|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153617832|NCT04567303|Growth Substances|growth substances|mesh-ancestor
153617833|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617834|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
153617846|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
153617847|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617849|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153617850|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153617851|NCT04519619|Growth Substances|growth substances|mesh-ancestor
153617852|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617853|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
153617854|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617855|NCT04515238|Venetoclax|venetoclax|mesh-list
153617856|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153617857|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
153617858|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
153617859|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617860|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153617861|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
153617862|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617863|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617864|NCT04515238|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153617865|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617866|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617867|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
153617917|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153617918|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
153617919|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617985|NCT04199468|Dronabinol|dronabinol|mesh-list
153617986|NCT04199468|Analgesics|analgesics|mesh-ancestor
153617987|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
153617988|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617989|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617990|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153617991|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153617992|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
153617993|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
153617994|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153617995|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153617996|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153617997|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617998|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617999|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
153618000|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153618001|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153618002|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153618068|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153618069|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618070|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618071|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
153618072|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
153618073|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618074|NCT04085172|Guanfacine|guanfacine|mesh-list
153618075|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153618076|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153618077|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153618094|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618095|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618096|NCT04005690|Olaparib|olaparib|mesh-list
153618097|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153618098|NCT04005690|Onvansertib|onvansertib|mesh-list
153618099|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745652|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488023|NCT02059902|Lidocaine|lidocaine|mesh-list
153618100|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618101|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618102|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153618103|NCT03930953|Rituximab|rituximab|mesh-list
153618104|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
153618105|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618106|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618107|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
153618108|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618109|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618126|NCT03876769|Tisagenlecleucel|tisagenlecleucel|mesh-list
153618127|NCT03876769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618153|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
153618154|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153618155|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781994|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
153618156|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153618157|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153618158|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153618159|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618160|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618161|NCT03811002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618162|NCT03811002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618163|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
153618164|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618165|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
153618166|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
153618167|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618168|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
153618169|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
153618171|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618172|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618173|NCT03804944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618174|NCT03804944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618181|NCT03779854|Vidarabine|vidarabine|mesh-list
153618182|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
153618183|NCT03779854|Busulfan|busulfan|mesh-list
153618184|NCT03779854|Thiotepa|thiotepa|mesh-list
153618185|NCT03779854|Methotrexate|methotrexate|mesh-list
153618204|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618235|NCT03762915|Minocycline|minocycline|mesh-list
153781995|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
153618236|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153618246|NCT03701308|Cytarabine|cytarabine|mesh-list
153618247|NCT03701308|Daunorubicin|daunorubicin|mesh-list
153618248|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618249|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
153618250|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618267|NCT03606967|Tremelimumab|tremelimumab|mesh-list
153618268|NCT03606967|Ipilimumab|ipilimumab|mesh-list
153618269|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153618270|NCT03606967|Vaccines|vaccines|mesh-list
153618271|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
153618272|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153618273|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
153618274|NCT03606967|Poly ICLC|poly iclc|mesh-list
153618275|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
153618276|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618277|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153618278|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618279|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618280|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
153618281|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
153618282|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618283|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618284|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
153618285|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618286|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618288|NCT03606967|Laxatives|laxatives|mesh-ancestor
153618307|NCT03571737|Ibuprofen|ibuprofen|mesh-list
153618308|NCT03571737|Lidocaine|lidocaine|mesh-list
153618309|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
153618310|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
153618311|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153618312|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618341|NCT03564691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618342|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618343|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153618344|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153618345|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153618346|NCT03527043|Escitalopram|escitalopram|mesh-list
153618347|NCT03527043|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153618348|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153618349|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153618350|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618351|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153618460|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
153618461|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618462|NCT03026062|Durvalumab|durvalumab|mesh-list
153618463|NCT03026062|Ipilimumab|ipilimumab|mesh-list
153618464|NCT03026062|Tremelimumab|tremelimumab|mesh-list
153618465|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
153618466|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153618467|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
153618468|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618469|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618470|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
153618507|NCT02936752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618508|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618509|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618511|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
153618512|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618513|NCT02891603|Sirolimus|sirolimus|mesh-list
153618514|NCT02891603|Tacrolimus|tacrolimus|mesh-list
153618515|NCT02891603|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153618516|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618517|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
153618518|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618519|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153618520|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618521|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618522|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153618523|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618524|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153618557|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
153618558|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
153618559|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618560|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
153618561|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618562|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618563|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153618564|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
153618565|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618566|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618567|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153618568|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153618569|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
153618570|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
153618571|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618572|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153618573|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
153618574|NCT02828358|Hormones|hormones|mesh-ancestor
153618575|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618576|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618577|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
153618578|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618579|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153618580|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153618581|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153618582|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
153618583|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153618584|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618585|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
153618589|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
153618600|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153618601|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153618602|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153618603|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153618604|NCT02828358|Hematinics|hematinics|mesh-ancestor
153618605|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
153346390|NCT00004696|Morphine|morphine|mesh-list
153618606|NCT02779751|Anastrozole|anastrozole|mesh-list
153618607|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618626|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153618627|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
153618628|NCT02649790|Hormones|hormones|mesh-ancestor
153618629|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618630|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618631|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618632|NCT02649790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618633|NCT02649790|Antimetabolites|antimetabolites|mesh-ancestor
153618634|NCT02649790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618635|NCT02619448|Paclitaxel|paclitaxel|mesh-list
153618636|NCT02619448|Carboplatin|carboplatin|mesh-list
153618637|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153618638|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618639|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618640|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
153618641|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
153618642|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618652|NCT02319837|Leuprolide|leuprolide|mesh-list
153618653|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153618654|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
153618713|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
153618754|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618755|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
153618756|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153618757|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153618758|NCT01572480|Growth Substances|growth substances|mesh-ancestor
153618759|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
153618793|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618794|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618795|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618796|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618797|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153618798|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
153618799|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618800|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618801|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153618802|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
153618803|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618804|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153731594|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731595|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153731629|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731631|NCT00154401|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153731632|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153731633|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731634|NCT00154401|Incretins|incretins|mesh-ancestor
153489112|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
153489113|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489116|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
153489117|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489118|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
153489119|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489120|NCT04840992|Vaccines|vaccines|mesh-list
153489121|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
153489122|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489123|NCT04793022|Anesthetics|anesthetics|mesh-list
153489124|NCT04793022|Propofol|propofol|mesh-list
153489125|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489126|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489127|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153489131|NCT04567524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153489132|NCT04567524|Serotonin Agents|serotonin agents|mesh-ancestor
153489133|NCT04567524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489134|NCT04567524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489135|NCT04567524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489136|NCT04567524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153489137|NCT04567524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153489138|NCT04567524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489139|NCT04567524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153489140|NCT04567524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153489141|NCT04567524|Dopamine Agents|dopamine agents|mesh-ancestor
153489142|NCT04481412|Cetirizine|cetirizine|mesh-list
153489143|NCT04481412|Ethanol|ethanol|mesh-list
153489144|NCT04481412|Minoxidil|minoxidil|mesh-list
153489145|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153489146|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489147|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489148|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489158|NCT04317300|Varenicline|varenicline|mesh-list
153489159|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153489160|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153489161|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
153489162|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489163|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489164|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489166|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153489167|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489168|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
153489169|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153489170|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
153489171|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153489172|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
153489173|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489174|NCT03252522|Micronutrients|micronutrients|mesh-list
153489175|NCT03252522|Trace Elements|trace elements|mesh-list
153489176|NCT03252522|Antioxidants|antioxidants|mesh-list
153489177|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489178|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489179|NCT03252522|Protective Agents|protective agents|mesh-ancestor
153489180|NCT03191370|Anesthetics|anesthetics|mesh-list
153489181|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
153489182|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489183|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489184|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
153489185|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489186|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
153489187|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489189|NCT03179436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153489190|NCT03179436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489191|NCT03149874|Vaccines|vaccines|mesh-list
153489192|NCT03149874|Immunologic Factors|immunologic factors|mesh-ancestor
153504588|NCT05284019|Analgesics|analgesics|mesh-ancestor
153489199|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489200|NCT02834052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153489201|NCT02834052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489202|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
153489203|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
153489204|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489206|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489207|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
153489208|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489210|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153489211|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489212|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153489213|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153489214|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
153489215|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153489216|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489217|NCT02519322|Nivolumab|nivolumab|mesh-list
153489218|NCT02519322|Ipilimumab|ipilimumab|mesh-list
153489219|NCT02519322|Relatlimab|relatlimab|mesh-list
153489220|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
153489221|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
153489251|NCT05721456|Immunologic Factors|immunologic factors|mesh-ancestor
153489252|NCT05721456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489253|NCT05721300|Interferons|interferons|mesh-list
153489254|NCT05721300|Tenofovir|tenofovir|mesh-list
153489255|NCT05721300|Entecavir|entecavir|mesh-list
153489256|NCT05721300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489257|NCT05721300|Antiviral Agents|antiviral agents|mesh-ancestor
153489258|NCT05721300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489259|NCT05721300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153489260|NCT05721300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153489261|NCT05721300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489262|NCT05721300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489263|NCT05721300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153489264|NCT05721300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153489265|NCT05720442|Mosapride|mosapride|mesh-list
153489266|NCT05720442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504655|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489267|NCT05720442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489268|NCT05720442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153489269|NCT05720442|Serotonin Agents|serotonin agents|mesh-ancestor
153489270|NCT05720442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489271|NCT05720442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489272|NCT05719818|Diphosphonates|diphosphonates|mesh-list
153489273|NCT05719818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153489275|NCT05719506|Dexmedetomidine|dexmedetomidine|mesh-list
153489302|NCT05716932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489303|NCT05715840|Paclitaxel|paclitaxel|mesh-list
153489304|NCT05715840|Bevacizumab|bevacizumab|mesh-list
153489305|NCT05715840|Carboplatin|carboplatin|mesh-list
153489306|NCT05715840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153489307|NCT05715840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489308|NCT05715840|Tubulin Modulators|tubulin modulators|mesh-ancestor
153489309|NCT05715840|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489310|NCT05715840|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489311|NCT05715840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489312|NCT05715840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489313|NCT05715840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153489314|NCT05715840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153489315|NCT05715840|Growth Substances|growth substances|mesh-ancestor
153489316|NCT05715840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489317|NCT05715840|Growth Inhibitors|growth inhibitors|mesh-ancestor
153489318|NCT05713734|Thrombin|thrombin|mesh-list
153489319|NCT05713734|Hemostatics|hemostatics|mesh-ancestor
153489320|NCT05713734|Coagulants|coagulants|mesh-ancestor
153489321|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
153489322|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153489323|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489324|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489325|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153489326|NCT05698758|Analgesics|analgesics|mesh-ancestor
153489327|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
153489328|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489329|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153489330|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153489351|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489352|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489353|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
153489354|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489355|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489356|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153489357|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489359|NCT05436678|Celecoxib|celecoxib|mesh-list
153489360|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153489361|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153489362|NCT05436678|Analgesics|analgesics|mesh-ancestor
153489363|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
153489364|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489412|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489413|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489414|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153489415|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
153489416|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153489417|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
153489418|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489419|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153489420|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153489421|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489427|NCT05251038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153489428|NCT05251038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489478|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153489479|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153489480|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489481|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489482|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489483|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153489484|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153489485|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153489486|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153489487|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489488|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
153489489|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
153489490|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
153489491|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
153489504|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153489505|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
153489506|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489507|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489508|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
153489509|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489510|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
153489512|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153489513|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153489514|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153489515|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153489533|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489534|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153489535|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153489536|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
153489537|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153489538|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153489539|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153489541|NCT03937986|Suvorexant|suvorexant|mesh-list
153489542|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489543|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
153489544|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489545|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489546|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
153489547|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489548|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153489549|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153357569|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489590|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489591|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489592|NCT03122262|Tenofovir|tenofovir|mesh-list
153489593|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153489594|NCT03122262|Dolutegravir|dolutegravir|mesh-list
153489595|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153489596|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
153489597|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489598|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153489600|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153489653|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153489654|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
153489655|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489656|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489657|NCT01768338|Ofatumumab|ofatumumab|mesh-list
153489658|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489659|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153489660|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
153489661|NCT00596154|Busulfan|busulfan|mesh-list
153489662|NCT00596154|Thiotepa|thiotepa|mesh-list
153489663|NCT00596154|Rituximab|rituximab|mesh-list
153489664|NCT00596154|Methotrexate|methotrexate|mesh-list
153781831|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489665|NCT00596154|Vincristine|vincristine|mesh-list
153489666|NCT00596154|Procarbazine|procarbazine|mesh-list
153489667|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153489668|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
153489669|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489716|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
153489717|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
153489718|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489719|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489720|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489721|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
153489722|NCT02421354|Nivolumab|nivolumab|mesh-list
153489723|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489792|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
153489793|NCT02462148|Epinephrine|epinephrine|mesh-list
153489794|NCT02462148|Bupivacaine|bupivacaine|mesh-list
153489795|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153489796|NCT02462148|BB 1101|bb 1101|mesh-list
153489797|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153489798|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
153489799|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
153489800|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489801|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489802|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489804|NCT02462148|Hormones|hormones|mesh-ancestor
153489805|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153489807|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489871|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
153489872|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489873|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489874|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489875|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
153489876|NCT02468700|Hormones|hormones|mesh-ancestor
153489877|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153489878|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153489879|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489880|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
153489881|NCT02472522|Ropivacaine|ropivacaine|mesh-list
153489882|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
153489883|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153489886|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153489887|NCT02472522|Analgesics|analgesics|mesh-ancestor
153489888|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
153489889|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489890|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153489926|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
153489927|NCT02486328|Midazolam|midazolam|mesh-list
153489928|NCT02486328|Meperidine|meperidine|mesh-list
153489929|NCT02486328|Remifentanil|remifentanil|mesh-list
153489930|NCT02486328|Propofol|propofol|mesh-list
153489931|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153489932|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489933|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489934|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489995|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489996|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
153489997|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489998|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153489999|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153490000|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153490001|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490068|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490069|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490070|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
153490071|NCT02525718|Hormones|hormones|mesh-ancestor
153490072|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490073|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153490074|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490075|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
153490076|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
153490077|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490078|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
153490079|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153490080|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153490081|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
153490082|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490084|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153490130|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490131|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153490132|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153490133|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
153490134|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490135|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490136|NCT02538354|Riboflavin|riboflavin|mesh-list
153490137|NCT02538354|Vitamins|vitamins|mesh-ancestor
153490138|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
153490139|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490140|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
153490141|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153490142|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
153490143|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
153490144|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153490145|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153490146|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490147|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
153490148|NCT02540226|Coagulants|coagulants|mesh-ancestor
153490149|NCT02541864|Amoxicillin|amoxicillin|mesh-list
153490150|NCT02541864|Metronidazole|metronidazole|mesh-list
153490151|NCT02541864|Clarithromycin|clarithromycin|mesh-list
153490186|NCT02544984|Azithromycin|azithromycin|mesh-list
153490187|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153490188|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490189|NCT02547012|Amoxicillin|amoxicillin|mesh-list
153490190|NCT02547012|Levofloxacin|levofloxacin|mesh-list
153490191|NCT02547012|Ofloxacin|ofloxacin|mesh-list
153490192|NCT02547012|Tetracycline|tetracycline|mesh-list
153490193|NCT02547012|Esomeprazole|esomeprazole|mesh-list
153490194|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153490195|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490196|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153490197|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490198|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153490199|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490200|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490201|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153505181|NCT00309192|Hormones|hormones|mesh-ancestor
153490202|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153490203|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153490204|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490205|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153490206|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153490207|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153490208|NCT02548728|Oxytocin|oxytocin|mesh-list
153490209|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
153490210|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153490211|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490212|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
153490213|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153490214|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153490215|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153490216|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
153490217|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490218|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490219|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490220|NCT02560038|Paclitaxel|paclitaxel|mesh-list
153490221|NCT02560038|Gemcitabine|gemcitabine|mesh-list
153490227|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490228|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153490229|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
153490230|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153490231|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153490232|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
153490233|NCT02561130|Metformin|metformin|mesh-list
153490234|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
153490235|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
153490236|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153490237|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490238|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153490239|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490240|NCT02562066|Amifampridine|amifampridine|mesh-list
153490241|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153490242|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490243|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490244|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153490245|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490248|NCT02562924|Budesonide|budesonide|mesh-list
153490249|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153490250|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
153490251|NCT02562924|Hormones|hormones|mesh-ancestor
153490252|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490253|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490254|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153490255|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490256|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153490272|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490273|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490274|NCT02570022|Bupivacaine|bupivacaine|mesh-list
153490275|NCT02570022|Ropivacaine|ropivacaine|mesh-list
153490276|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
153490277|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
153490278|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490279|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490280|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
153490281|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490283|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490284|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153490285|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490286|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490287|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
153490288|NCT02577042|Atorvastatin|atorvastatin|mesh-list
153490289|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153490290|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153490291|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
153490292|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490293|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153490294|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153490295|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490296|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153490297|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153490298|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
153490299|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490300|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153490301|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153490302|NCT02582970|Bevacizumab|bevacizumab|mesh-list
153505355|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153490303|NCT02582970|Fluorouracil|fluorouracil|mesh-list
153490304|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
153490305|NCT02582970|Irinotecan|irinotecan|mesh-list
153490306|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153490311|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490312|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
153490313|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
153490314|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490315|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153490316|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153490317|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
153490318|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153490319|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153490321|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
153490322|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
153490323|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490324|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
153490325|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153490326|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153490371|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
153490372|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490373|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153490374|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153490375|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
153490376|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490378|NCT03907176|Ibuprofen|ibuprofen|mesh-list
153490379|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153490380|NCT03907176|Analgesics|analgesics|mesh-ancestor
153490381|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
153490382|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490438|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153490439|NCT04945122|Atorvastatin|atorvastatin|mesh-list
153490440|NCT04945122|Pitavastatin|pitavastatin|mesh-list
153490441|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153490442|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153490443|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
153490444|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490445|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153490446|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153490447|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490448|NCT04227366|Methotrexate|methotrexate|mesh-list
153490449|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153490450|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
153490451|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153490452|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490453|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153490454|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
153490499|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490500|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153490501|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490502|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490503|NCT05732064|Dexmedetomidine|dexmedetomidine|mesh-list
153490504|NCT05732064|Esketamine|esketamine|mesh-list
153490505|NCT05732064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153490506|NCT05732064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490507|NCT05732064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490508|NCT05732064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153490509|NCT05732064|Analgesics|analgesics|mesh-ancestor
153490510|NCT05732064|Sensory System Agents|sensory system agents|mesh-ancestor
153490565|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153490566|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490567|NCT04787562|Imipenem|imipenem|mesh-list
153490568|NCT04787562|Cilastatin|cilastatin|mesh-list
153490569|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153490570|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433472|NCT00000505|Plasminogen|plasminogen|mesh-list
153490571|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
153490572|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490573|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490574|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
153490575|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
153490576|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490577|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
153490578|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
153490579|NCT04355130|Vitamins|vitamins|mesh-ancestor
153490627|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
153490628|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153490630|NCT02960646|Antibodies|antibodies|mesh-list
153490631|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
153490632|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153490633|NCT02960646|Lenograstim|lenograstim|mesh-list
153490634|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153490635|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
153490636|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490637|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153490638|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153490639|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
153490640|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490641|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490642|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153490643|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153490644|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
153490645|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153490646|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153490647|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781832|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433558|NCT03015896|Nivolumab|nivolumab|mesh-list
153490648|NCT01448616|Tenofovir|tenofovir|mesh-list
153490649|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
153490650|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490651|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153490652|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153490653|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490654|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490655|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153490656|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153490657|NCT00074412|Nevirapine|nevirapine|mesh-list
153490666|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153490667|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153490668|NCT02618772|Midazolam|midazolam|mesh-list
153505478|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
153490669|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153490670|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153490671|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490672|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490673|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153490674|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153490675|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153490676|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153490677|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
153490678|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
153490679|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
153490680|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
153490681|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490724|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
153490725|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153490726|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490727|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
153490728|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
153490729|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490730|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
153490731|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490732|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490733|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
153490734|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153490735|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153490736|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153490737|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153490738|NCT02635542|Cisatracurium|cisatracurium|mesh-list
153490739|NCT02635542|Succinylcholine|succinylcholine|mesh-list
153490740|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153490741|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153490776|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490777|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490779|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153490780|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490781|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490782|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153490783|NCT05225610|Analgesics|analgesics|mesh-ancestor
153490784|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
153490785|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490786|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153490787|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153490788|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153490789|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
153490792|NCT03693846|Nivolumab|nivolumab|mesh-list
153490837|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490839|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
153490840|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490841|NCT02653560|Expectorants|expectorants|mesh-ancestor
153490842|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
153490843|NCT02653560|Cathartics|cathartics|mesh-ancestor
153490844|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490845|NCT02653872|Itraconazole|itraconazole|mesh-list
153490847|NCT02653872|Diltiazem|diltiazem|mesh-list
153490848|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
153490849|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490850|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153490851|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153490852|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490853|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490854|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153490855|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
153490856|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153490857|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490858|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153490859|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153490860|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153490865|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
153490885|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490886|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
153490887|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153490888|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
153490889|NCT02655354|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153490890|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
153490891|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153490892|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153490893|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153490894|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490895|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
153490896|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153490897|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153490898|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490899|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
153490900|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
153490901|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
153490902|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153490922|NCT02657928|Letrozole|letrozole|mesh-list
153490941|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153433851|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
153490942|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
153490943|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490944|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490945|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153490946|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153490947|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
153490948|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153505579|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
153490949|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
153490950|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
153490951|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
153490952|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153490953|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
153490954|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
153490955|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153490956|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
153490957|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153490958|NCT02665260|Cantharidin|cantharidin|mesh-list
153490959|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490963|NCT02666352|Ruzasvir|ruzasvir|mesh-list
153491002|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491003|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491004|NCT02695290|Afatinib|afatinib|mesh-list
153491005|NCT02695290|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153491006|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153491007|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491008|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491009|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491010|NCT02695446|Minocycline|minocycline|mesh-list
153491011|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153491012|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491013|NCT02698566|Ranibizumab|ranibizumab|mesh-list
153491014|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153491015|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153781834|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153491016|NCT02698566|Growth Substances|growth substances|mesh-ancestor
153491017|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491018|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
153491019|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491020|NCT02701062|Warfarin|warfarin|mesh-list
153491021|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
153491022|NCT02701062|Dabigatran|dabigatran|mesh-list
153491023|NCT02701062|Apixaban|apixaban|mesh-list
153491024|NCT02701062|Anticoagulants|anticoagulants|mesh-list
153491025|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153491026|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
153491063|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153491064|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
153491065|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
153491066|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153505621|NCT01386736|Vitamins|vitamins|mesh-ancestor
153491067|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153491068|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153491069|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153491070|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491071|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491072|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491073|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153491074|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
153491075|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153491136|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153491137|NCT05444088|Growth Substances|growth substances|mesh-ancestor
153491138|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491139|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
153491140|NCT05443308|Acetazolamide|acetazolamide|mesh-list
153491141|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
153491142|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153491143|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491144|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491145|NCT05443308|Diuretics|diuretics|mesh-ancestor
153491146|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
153491147|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491148|NCT05442996|Antibodies|antibodies|mesh-list
153491149|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
153491150|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153491151|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
153491152|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491153|NCT05441046|Tislelizumab|tislelizumab|mesh-list
153491154|NCT05441046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491155|NCT05441046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491156|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153491157|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491158|NCT05340270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491159|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491160|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
153491175|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153491176|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491177|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491178|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
153491179|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491180|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153491181|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
153491182|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153491183|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
153491184|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153491186|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491187|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153491188|NCT03770130|Analgesics|analgesics|mesh-ancestor
153491189|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
153491190|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491191|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153505660|NCT01387048|Adapalene|adapalene|mesh-list
153491192|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153491193|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153491194|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
153491195|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491196|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491198|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153491199|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153491200|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153491201|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
153491246|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
153491247|NCT04415892|Capsaicin|capsaicin|mesh-list
153491248|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
153491249|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
153491250|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
153491251|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491252|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491253|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153491254|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491255|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153491256|NCT04415892|Protective Agents|protective agents|mesh-ancestor
153491257|NCT04176354|Letrozole|letrozole|mesh-list
153491258|NCT04176354|Palbociclib|palbociclib|mesh-list
153491259|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153491260|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491261|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153491262|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491263|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491264|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153491265|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
153491266|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491267|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491268|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153491269|NCT04128540|Fentanyl|fentanyl|mesh-list
153491270|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153491271|NCT04128540|Narcotics|narcotics|mesh-ancestor
153491272|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491273|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491274|NCT04128540|Analgesics|analgesics|mesh-ancestor
153491275|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
153491276|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491277|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153491278|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153491279|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
153491280|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
153491281|NCT04104438|Everolimus|everolimus|mesh-list
153491285|NCT04104438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491286|NCT04104438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491287|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153491288|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
153491289|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491290|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505679|NCT01387191|Tezosentan|tezosentan|mesh-list
153491293|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491294|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491296|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491297|NCT03086616|Irinotecan|irinotecan|mesh-list
153491298|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153491299|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153491300|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491301|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491302|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491303|NCT02952924|Midazolam|midazolam|mesh-list
153491304|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153491305|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153491306|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491307|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491308|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153491309|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153491310|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153491311|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153491312|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
153491313|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
153491314|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
153491315|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
153491316|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491317|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491330|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
153491331|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491332|NCT05354466|Neostigmine|neostigmine|mesh-list
153491333|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153491334|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491335|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491336|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
153491337|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491338|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491339|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153491340|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
153491341|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491342|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
153491343|NCT04095624|Narcotics|narcotics|mesh-ancestor
153491344|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491406|NCT00553800|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153491407|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153491408|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491409|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491410|NCT02747628|Melatonin|melatonin|mesh-list
153491411|NCT02747628|Nicotine|nicotine|mesh-list
153491412|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153491413|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
153491414|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491415|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491416|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153491417|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153491418|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
153491419|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491420|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491432|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491433|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491434|NCT02767128|Citric Acid|citric acid|mesh-list
153491435|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
153491437|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153491438|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
153491439|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
153491440|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491441|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153491442|NCT02769702|Hormones|hormones|mesh-ancestor
153491443|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491444|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491445|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153491446|NCT02770014|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153491447|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153491448|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491449|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491450|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491451|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
153491453|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491455|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
153491456|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
153491457|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
153491458|NCT02773758|Protective Agents|protective agents|mesh-ancestor
153491459|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491460|NCT02774226|Vitamins|vitamins|mesh-list
153491461|NCT02774226|Vitamin E|vitamin e|mesh-list
153491462|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
153491463|NCT02774226|Antioxidants|antioxidants|mesh-list
153491464|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
153491465|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491466|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491467|NCT02774226|Protective Agents|protective agents|mesh-ancestor
153491468|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
153491469|NCT02775240|Maribavir|maribavir|mesh-list
153491470|NCT02775240|Digoxin|digoxin|mesh-list
153491471|NCT02775240|Levomethorphan|levomethorphan|mesh-list
153491472|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
153491473|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153491474|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153491504|NCT05348148|Cetirizine|cetirizine|mesh-list
153491524|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
153491525|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153491526|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
153491527|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153491528|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
153491529|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153491530|NCT05348148|Protective Agents|protective agents|mesh-ancestor
153491531|NCT05456022|Doxorubicin|doxorubicin|mesh-list
153491532|NCT05456022|Quercetin|quercetin|mesh-list
153491533|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153491534|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491535|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153491536|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153491537|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491538|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491540|NCT05456022|Protective Agents|protective agents|mesh-ancestor
153491541|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491542|NCT05273814|Bevacizumab|bevacizumab|mesh-list
153491543|NCT05273814|Tislelizumab|tislelizumab|mesh-list
153491544|NCT05273814|Pemetrexed|pemetrexed|mesh-list
153491545|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153491546|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491547|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491548|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153491559|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491561|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491562|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491563|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153491564|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491565|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
153491566|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153491567|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153491568|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153491575|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491576|NCT02529930|Vaccines|vaccines|mesh-list
153491577|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
153491578|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491579|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
153491580|NCT00039780|Protective Agents|protective agents|mesh-ancestor
153491581|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491582|NCT04763226|Furosemide|furosemide|mesh-list
153491583|NCT04763226|Diuretics|diuretics|mesh-ancestor
153491584|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
153491585|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491586|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153491587|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153491588|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491589|NCT04549428|Atezolizumab|atezolizumab|mesh-list
153491590|NCT04549428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153491591|NCT04549428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491592|NCT04549428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491593|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491594|NCT06085378|Kallikreins|kallikreins|mesh-list
153491595|NCT06085378|Coagulants|coagulants|mesh-ancestor
153491596|NCT06085378|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153491597|NCT06085378|Fertility Agents|fertility agents|mesh-ancestor
153491598|NCT06085378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153491639|NCT06084780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491640|NCT06084780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153491641|NCT06084780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491642|NCT06084780|Antifungal Agents|antifungal agents|mesh-ancestor
153491643|NCT06084780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491644|NCT06084624|Betamethasone|betamethasone|mesh-list
153491645|NCT06084624|Betamethasone Valerate|betamethasone valerate|mesh-list
153491646|NCT06084624|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153491647|NCT06084624|Betamethasone benzoate|betamethasone benzoate|mesh-list
153491648|NCT06084624|Rebamipide|rebamipide|mesh-list
153491649|NCT06084624|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153491651|NCT06084624|Glucocorticoids|glucocorticoids|mesh-ancestor
153491707|NCT06083688|Chloroquine|chloroquine|mesh-list
153491708|NCT06083688|Pyrimethamine|pyrimethamine|mesh-list
153491709|NCT06083688|Piperaquine|piperaquine|mesh-list
153491710|NCT06083688|Sulfadoxine|sulfadoxine|mesh-list
153491711|NCT06083688|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153491712|NCT06083688|Amodiaquine|amodiaquine|mesh-list
153491714|NCT06083688|Antimalarials|antimalarials|mesh-ancestor
153491715|NCT06083688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153491716|NCT06083688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153491717|NCT06083688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491718|NCT06083688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491719|NCT06083688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491720|NCT06083688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153491721|NCT06083688|Amebicides|amebicides|mesh-ancestor
153491722|NCT06083688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153491723|NCT06083688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153491724|NCT06083415|Endocrine Disruptors|endocrine disruptors|mesh-list
153491725|NCT06083415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491726|NCT06082817|Methyltestosterone|methyltestosterone|mesh-list
153491727|NCT06082817|Testosterone|testosterone|mesh-list
153491765|NCT06077214|Anesthetics, Local|anesthetics, local|mesh-ancestor
153491766|NCT06077214|Anesthetics|anesthetics|mesh-ancestor
153491767|NCT06077214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491768|NCT06077214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491769|NCT06077214|Sensory System Agents|sensory system agents|mesh-ancestor
153491770|NCT06077214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491772|NCT06077032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153491773|NCT06077032|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153491774|NCT06077032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491775|NCT06077032|Disinfectants|disinfectants|mesh-ancestor
153491776|NCT06058572|Rifaximin|rifaximin|mesh-list
153491777|NCT06058572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153491778|NCT06058572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491779|NCT06058572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153491780|NCT05942352|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
153491781|NCT05942352|Vasodilator Agents|vasodilator agents|mesh-ancestor
153491782|NCT05936489|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153491783|NCT05936489|Aceclidine|aceclidine|mesh-list
153491784|NCT05936489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153491785|NCT05936489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153491786|NCT05936489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153491787|NCT05936489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153491788|NCT05936489|Adrenergic Agents|adrenergic agents|mesh-ancestor
153491789|NCT05936489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153491790|NCT05936489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491815|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153491817|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491818|NCT05612984|Aspirin|aspirin|mesh-list
153491819|NCT05612984|Folic Acid|folic acid|mesh-list
153491820|NCT05612984|Micronutrients|micronutrients|mesh-list
153491821|NCT05612984|Trace Elements|trace elements|mesh-list
153491822|NCT05612984|Calcium|calcium|mesh-list
153491823|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153491824|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491825|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153491826|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153491827|NCT05612984|Analgesics|analgesics|mesh-ancestor
153491828|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
153491829|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491830|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491831|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153491832|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153491833|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153491834|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491837|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491869|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153491870|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
153491871|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491872|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153491873|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153491874|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153491875|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491876|NCT05476796|Trifluridine|trifluridine|mesh-list
153491878|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
153491879|NCT05476796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153491880|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491881|NCT05476796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153491882|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491883|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
153491884|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
153491885|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491886|NCT05427084|Canagliflozin|canagliflozin|mesh-list
153491931|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153491932|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491933|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153491934|NCT05039801|Paclitaxel|paclitaxel|mesh-list
153491935|NCT05039801|Bevacizumab|bevacizumab|mesh-list
153491936|NCT05039801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153491937|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153491938|NCT05039801|Endothelial Growth Factors|endothelial growth factors|mesh-list
153491939|NCT05039801|Antibodies|antibodies|mesh-list
153491940|NCT05039801|Immunoglobulins|immunoglobulins|mesh-list
153491941|NCT05039801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153491942|NCT05039801|Immunoglobulin G|immunoglobulin g|mesh-list
153492001|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
153492002|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492003|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153492005|NCT05032183|Protective Agents|protective agents|mesh-ancestor
153492006|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
153492007|NCT05032183|Vitamins|vitamins|mesh-ancestor
153492008|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
153492009|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153492010|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
153492011|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
153492012|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
153492013|NCT05026125|Remifentanil|remifentanil|mesh-list
153492014|NCT05026125|Anesthetics|anesthetics|mesh-list
153492015|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492016|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492017|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153492018|NCT05026125|Narcotics|narcotics|mesh-ancestor
153492019|NCT05026125|Analgesics|analgesics|mesh-ancestor
153492020|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
153492065|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
153492066|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
153492067|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
153492068|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492069|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434984|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
153492070|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492077|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
153492078|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
153492079|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
153492080|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153492081|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
153492082|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
153492083|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492084|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492085|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492086|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153492095|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492228|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492229|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492230|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492231|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
153492232|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153492233|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153492235|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153492236|NCT03992456|Panitumumab|panitumumab|mesh-list
153492237|NCT03992456|Antibodies|antibodies|mesh-list
153492238|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
153492239|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153492240|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
153492241|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492242|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492243|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
153492244|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492245|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
153492246|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492247|NCT03945812|Lenograstim|lenograstim|mesh-list
153492248|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153506322|NCT01391052|Norethindrone|norethindrone|mesh-list
153492249|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
153492250|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492252|NCT03776487|Ipilimumab|ipilimumab|mesh-list
153492253|NCT03776487|Fluorouracil|fluorouracil|mesh-list
153492254|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
153492259|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
153492283|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153492284|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492285|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153492286|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153492287|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492288|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
153492289|NCT03450122|Aldesleukin|aldesleukin|mesh-list
153492290|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
153492291|NCT03450122|Interleukin-2|interleukin-2|mesh-list
153492292|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492293|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
153781837|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
153435206|NCT05751733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492294|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492295|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492296|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153492309|NCT03382834|Tamoxifen|tamoxifen|mesh-list
153492347|NCT03348670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492348|NCT03348670|Hormone Antagonists|hormone antagonists|mesh-ancestor
153492349|NCT03348670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153492350|NCT03348670|Androgen Antagonists|androgen antagonists|mesh-ancestor
153492351|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
153492353|NCT03308942|Dostarlimab|dostarlimab|mesh-list
153492354|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492355|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492356|NCT03308942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153492357|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492358|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153492359|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492360|NCT03301857|Denosumab|denosumab|mesh-list
153492361|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
153492362|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
153492363|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
153492364|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492365|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153781838|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153492414|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492416|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
153492417|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492418|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153492419|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492420|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153492421|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153492422|NCT02933255|Nivolumab|nivolumab|mesh-list
153492423|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492424|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492425|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153492426|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492471|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492472|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
153492474|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492475|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492476|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492477|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492478|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
153492479|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
153492480|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492481|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153492482|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153492483|NCT02416128|Protective Agents|protective agents|mesh-ancestor
153492484|NCT02218606|Prednisone|prednisone|mesh-list
153492485|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
153492486|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492487|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
153492488|NCT02218606|Hormones|hormones|mesh-ancestor
153492489|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492490|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492525|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492526|NCT00942331|Bevacizumab|bevacizumab|mesh-list
153492527|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153492528|NCT00942331|Cisplatin|cisplatin|mesh-list
153492529|NCT00942331|Gemcitabine|gemcitabine|mesh-list
153492530|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
153492531|NCT00942331|Antibodies|antibodies|mesh-list
153492532|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
153492533|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153492534|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
153492535|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492536|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153492537|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153492539|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492540|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
153492541|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
153492542|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153492543|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
153492544|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492545|NCT00828919|Axitinib|axitinib|mesh-list
153492546|NCT00828919|Crizotinib|crizotinib|mesh-list
153492547|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492548|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492549|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492550|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492574|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153492575|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153492576|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
153492577|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
153492578|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492579|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153492580|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153492583|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492584|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153492585|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153492586|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153492587|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
153492588|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153492592|NCT00419770|Amphotericin B|amphotericin b|mesh-list
153492636|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781899|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492637|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492638|NCT04040790|Protective Agents|protective agents|mesh-ancestor
153492639|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153492640|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153492641|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
153492642|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153492643|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153492644|NCT03556800|Estradiol|estradiol|mesh-list
153492645|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153492646|NCT03556800|Estrogens|estrogens|mesh-ancestor
153492647|NCT03556800|Hormones|hormones|mesh-ancestor
153492648|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492654|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
153492699|NCT02791308|Analgesics|analgesics|mesh-ancestor
153492700|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
153492701|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492702|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492703|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492704|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492705|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
153492706|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492768|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492769|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492770|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492771|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492773|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
153492774|NCT02845752|Olodaterol|olodaterol|mesh-list
153492775|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153492776|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
153492777|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492778|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492779|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153492780|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
153492781|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
153492782|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153492783|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
153492784|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492785|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492786|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
153492787|NCT02849184|Suvorexant|suvorexant|mesh-list
153492788|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153506612|NCT01392898|Liraglutide|liraglutide|mesh-list
153492789|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153492790|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492791|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492792|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153492817|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
153492818|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492819|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
153492820|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153492821|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
153492822|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492823|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153492824|NCT02864706|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153492825|NCT02864706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492826|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492827|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153492828|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153492829|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
153492830|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153492831|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153492834|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
153492835|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492836|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
153492837|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153492873|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492874|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
153492875|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492876|NCT02887404|Analgesics|analgesics|mesh-list
153492877|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
153492878|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492879|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492880|NCT02889510|Liraglutide|liraglutide|mesh-list
153492881|NCT02889510|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153492882|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153492883|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492884|NCT02889510|Incretins|incretins|mesh-ancestor
153492885|NCT02889510|Hormones|hormones|mesh-ancestor
153492886|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492887|NCT02902770|Ketorolac|ketorolac|mesh-list
153506658|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153492888|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153492889|NCT02902770|Lidocaine|lidocaine|mesh-list
153492890|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
153492891|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
153492892|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492893|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492894|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
153492895|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492896|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153492897|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153492898|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153492899|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153492900|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492901|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153492902|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153492903|NCT02902770|Analgesics|analgesics|mesh-ancestor
153492911|NCT02907918|Goserelin|goserelin|mesh-list
153492912|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153492913|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492917|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492918|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153492919|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
153492920|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492921|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492922|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153492923|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153492924|NCT02908620|Anesthetics|anesthetics|mesh-list
153492925|NCT02908620|Tetracaine|tetracaine|mesh-list
153492926|NCT02908620|Benzocaine|benzocaine|mesh-list
153492927|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153492980|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492981|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492983|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492984|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
153492985|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153492986|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153492987|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492988|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
153492989|NCT02922582|Coagulants|coagulants|mesh-ancestor
153492990|NCT02925858|Ketamine|ketamine|mesh-list
153492991|NCT02925858|Analgesics|analgesics|mesh-ancestor
153492992|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
153492993|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493042|NCT02956044|Incretins|incretins|mesh-ancestor
153493043|NCT02956044|Hormones|hormones|mesh-ancestor
153626813|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153493048|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506705|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
153506706|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
153493049|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153493050|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153493051|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
153493052|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
153493053|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153493054|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153493055|NCT02956122|Prednisolone|prednisolone|mesh-list
153493056|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
153493057|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153493058|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
153493059|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
153493060|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153493061|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153493062|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
153493063|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
153493064|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493065|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493066|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493067|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
153493068|NCT02956122|Hormones|hormones|mesh-ancestor
153493069|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493070|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153493071|NCT02956122|Protective Agents|protective agents|mesh-ancestor
153493072|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153493073|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493093|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153493094|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153493095|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153493096|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153493097|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153493098|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493099|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493100|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153493101|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
153493102|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493103|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493104|NCT02968368|Ferric maltol|ferric maltol|mesh-list
153493105|NCT02968368|Hematinics|hematinics|mesh-ancestor
153493106|NCT02968914|Benralizumab|benralizumab|mesh-list
153493107|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153493108|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
153493109|NCT02970162|Amifampridine|amifampridine|mesh-list
153493110|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153493111|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493112|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493125|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
153493126|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493154|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153493155|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493156|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493157|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153493158|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153493159|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153493160|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
153493161|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153493162|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
153493163|NCT03012594|Lanreotide|lanreotide|mesh-list
153493164|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493165|NCT03017508|Riluzole|riluzole|mesh-list
153493217|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493218|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
153493219|NCT03036384|Sufentanil|sufentanil|mesh-list
153493220|NCT03036384|Morphine|morphine|mesh-list
153493221|NCT03036384|Prilocaine|prilocaine|mesh-list
153493222|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153493223|NCT03036384|Narcotics|narcotics|mesh-ancestor
153493224|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493225|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493226|NCT03036384|Analgesics|analgesics|mesh-ancestor
153493227|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
153493228|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493229|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153493230|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153493234|NCT03040362|Lasmiditan|lasmiditan|mesh-list
153493289|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153493290|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493291|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153493292|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153493293|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493294|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493295|NCT03061812|Immunoconjugates|immunoconjugates|mesh-ancestor
153493296|NCT03061812|Immunologic Factors|immunologic factors|mesh-ancestor
153493298|NCT03070470|Lopinavir|lopinavir|mesh-list
153493299|NCT03070470|Chloroquine|chloroquine|mesh-list
153493300|NCT03070470|Verapamil|verapamil|mesh-list
153493301|NCT03070470|Dofetilide|dofetilide|mesh-list
153493302|NCT03070470|Diltiazem|diltiazem|mesh-list
153493303|NCT03070470|Ranolazine|ranolazine|mesh-list
153493304|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153493305|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153493306|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
153493307|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493308|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493309|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153493310|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153493311|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
153493312|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493313|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153493316|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153493341|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493342|NCT03088800|Ibuprofen|ibuprofen|mesh-list
153493343|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153493344|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153493345|NCT03088800|Analgesics|analgesics|mesh-ancestor
153493346|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
153493347|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493348|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493349|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153493350|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153493351|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153493352|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493353|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493354|NCT03096444|Lidocaine|lidocaine|mesh-list
153493355|NCT03096444|Ketamine|ketamine|mesh-list
153493356|NCT03096444|Amitriptyline|amitriptyline|mesh-list
153493357|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
153493358|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
153493359|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493360|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493361|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
153493362|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493363|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153493364|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153493365|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153493366|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493367|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493389|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153493390|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153493391|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153493392|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493393|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493394|NCT03124758|Chrysarobin|chrysarobin|mesh-list
153493395|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153493396|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153493397|NCT03124758|Analgesics|analgesics|mesh-ancestor
153493398|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
153493399|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493400|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506909|NCT01394731|Acetaminophen|acetaminophen|mesh-list
153493401|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153493402|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153493403|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
153493404|NCT03148236|Vitamins|vitamins|mesh-ancestor
153493405|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
153493406|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493407|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
153493408|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493409|NCT03148236|Protective Agents|protective agents|mesh-ancestor
153493410|NCT03174366|Denosumab|denosumab|mesh-list
153493413|NCT03177798|Icatibant|icatibant|mesh-list
153493437|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
153493438|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153493439|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493440|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153493441|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
153493442|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493443|NCT02856126|Sorafenib|sorafenib|mesh-list
153493444|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493445|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153493446|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493447|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493448|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
153493449|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153493450|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153493451|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153493452|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493483|NCT03883074|Antacids|antacids|mesh-ancestor
153493504|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153493505|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
153493506|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153493507|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153493508|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
153493509|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493510|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
153493511|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153493512|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153493514|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
153493515|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493516|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153493517|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153493518|NCT01463670|Growth Substances|growth substances|mesh-ancestor
153493519|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
153493520|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493530|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153493531|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493532|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153493533|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493534|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
153493535|NCT03202134|Anesthetics|anesthetics|mesh-list
153493536|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493537|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493538|NCT03202134|Narcotics|narcotics|mesh-ancestor
153493539|NCT03202134|Analgesics|analgesics|mesh-ancestor
153493540|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
153493541|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493542|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153493556|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153493557|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153493558|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493559|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493560|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153493561|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153493562|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153493622|NCT03278886|Naltrexone|naltrexone|mesh-list
153493623|NCT03278886|Nalmefene|nalmefene|mesh-list
153493624|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153493625|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153493626|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493627|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
153493628|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493629|NCT03285984|Listerine|listerine|mesh-list
153493630|NCT03285984|Fluorides|fluorides|mesh-list
153493631|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
153493632|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
153493633|NCT03285984|Protective Agents|protective agents|mesh-ancestor
153493634|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493689|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493690|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493692|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153493693|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493694|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
153493695|NCT03341910|Tazarotene|tazarotene|mesh-list
153493696|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493697|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
153493698|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
153493699|NCT03341910|Vitamins|vitamins|mesh-ancestor
153493700|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
153493701|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493702|NCT03343080|Lidocaine|lidocaine|mesh-list
153493703|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
153493704|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
153493705|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493706|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493707|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
153493708|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493709|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153493710|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153493711|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153493712|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493713|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493714|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
153493715|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153493716|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
153493717|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
153493733|NCT03395886|Remifentanil|remifentanil|mesh-list
153493734|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153493735|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493737|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153493739|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
153493740|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493741|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153493742|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153493743|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153493744|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
153493745|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507018|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
153493746|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493747|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153493748|NCT03395886|Narcotics|narcotics|mesh-ancestor
153493749|NCT03426228|Progesterone|progesterone|mesh-list
153493750|NCT03426228|Estrogens|estrogens|mesh-list
153493751|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493752|NCT03426228|Hormones|hormones|mesh-ancestor
153493754|NCT03426228|Progestins|progestins|mesh-ancestor
153493790|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493791|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493792|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
153493793|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
153493794|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
153493795|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493796|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
153493797|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
153493798|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153493799|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153493800|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
153493856|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
153493857|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493858|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153493859|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153493860|NCT03509766|Histamine|histamine|mesh-list
153493861|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
153493862|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
153493863|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493864|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493865|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493866|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
153493867|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153493920|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153493921|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493922|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153493924|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
153493925|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
153493926|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153493927|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493928|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
153493929|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493930|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153493931|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153493932|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153493933|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493935|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153493980|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493981|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
153493982|NCT03889158|Vaccines|vaccines|mesh-list
153493983|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
153493984|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493985|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
153493986|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493987|NCT03889158|Protective Agents|protective agents|mesh-ancestor
153493988|NCT03889158|Vitamins|vitamins|mesh-ancestor
153493989|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
153493990|NCT04138758|Bromides|bromides|mesh-list
153493991|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
153493992|NCT04138758|Olodaterol|olodaterol|mesh-list
153493993|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153493994|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
153493995|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493996|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493997|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153493998|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
153493999|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
153494000|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153494001|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
153494002|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494003|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494004|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
153494005|NCT04323852|Vitamin D|vitamin d|mesh-list
153494006|NCT04323852|Vitamins|vitamins|mesh-ancestor
153494007|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
153494013|NCT04420572|Hormones|hormones|mesh-ancestor
153494026|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
153494027|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
153494028|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153494031|NCT04335552|Azithromycin|azithromycin|mesh-list
153494032|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
153494033|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153494034|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494035|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
153494036|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153494037|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153494038|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494039|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494040|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153494041|NCT04284930|Bupivacaine|bupivacaine|mesh-list
153494042|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
153494044|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494045|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494046|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
153494047|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494048|NCT04267770|Insulin|insulin|mesh-list
153494049|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153494050|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153494051|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494052|NCT04204200|Vitamins|vitamins|mesh-list
153494082|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153494083|NCT03976752|Elvitegravir|elvitegravir|mesh-list
153494084|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
153494085|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494086|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153494087|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153494088|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494089|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494090|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153494091|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153494092|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153494093|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153494094|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153494095|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
153494096|NCT03962634|Tetracaine|tetracaine|mesh-list
153494097|NCT03962634|Carticaine|carticaine|mesh-list
153494098|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
153494099|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
153494100|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494101|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494102|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
153494103|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494105|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153494106|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494107|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494108|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494109|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
153494129|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
153494130|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494131|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494132|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153494133|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
153494134|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153494135|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153494136|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153494137|NCT03930264|Azathioprine|azathioprine|mesh-list
153494138|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
153494139|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494140|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153494141|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494142|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153494143|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
153494144|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494145|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153494147|NCT03861000|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153494193|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494194|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494195|NCT03796182|Metformin|metformin|mesh-list
153494196|NCT03796182|Abrocitinib|abrocitinib|mesh-list
153494197|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153494198|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494199|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494200|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494201|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494202|NCT03730116|Bisoprolol|bisoprolol|mesh-list
153494203|NCT03730116|Perindopril|perindopril|mesh-list
153494204|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153494205|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
153494206|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
153494207|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494212|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494264|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
153494265|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494266|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494267|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
153494268|NCT02974686|Everolimus|everolimus|mesh-list
153494269|NCT02974686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153494270|NCT02974686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494271|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494272|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494273|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153494274|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
153494275|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494276|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494327|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
153494328|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494329|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494330|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
153494331|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153494332|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
153494333|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494334|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153494335|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153494336|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153494337|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
153494338|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494339|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494340|NCT02434146|Protective Agents|protective agents|mesh-ancestor
153494341|NCT02382588|Ganciclovir|ganciclovir|mesh-list
153494342|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
153494343|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494344|NCT02345460|Leucovorin|leucovorin|mesh-list
153494345|NCT02345460|Fluorouracil|fluorouracil|mesh-list
153494346|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
153781840|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494384|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494385|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
153494386|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
153494387|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
153494388|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494390|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153494391|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153494392|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
153494393|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494394|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153494395|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153494396|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494397|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153494398|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153494399|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494400|NCT02015910|Incretins|incretins|mesh-ancestor
153494436|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153494437|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153494438|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
153494439|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153494440|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494441|NCT01851174|Paclitaxel|paclitaxel|mesh-list
153494442|NCT01851174|Gemcitabine|gemcitabine|mesh-list
153494443|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153494444|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494445|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
153494446|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
153494447|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
153494448|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494449|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153494450|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
153494452|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153494453|NCT01846182|Analgesics|analgesics|mesh-ancestor
153494454|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
153494455|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494456|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494457|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
153494458|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153494459|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494460|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494461|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153494470|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
153494484|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
153494485|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153494486|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153494487|NCT01756560|Bupivacaine|bupivacaine|mesh-list
153494488|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
153494489|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
153494490|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494491|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494492|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
153494493|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494494|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153494495|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153494496|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494497|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153494498|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153494499|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494500|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494501|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
153494502|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494503|NCT01717482|Metformin|metformin|mesh-list
153494504|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153494505|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494506|NCT01702896|Interleukin-2|interleukin-2|mesh-list
153494507|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494508|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153494509|NCT01702896|Analgesics|analgesics|mesh-ancestor
153494510|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
153494511|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494512|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494514|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494515|NCT01608906|Heparin|heparin|mesh-list
153494516|NCT01608906|Calcium heparin|calcium heparin|mesh-list
153494517|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
153494518|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153494522|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153494523|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494524|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494526|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494527|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494528|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153494529|NCT01602198|Protective Agents|protective agents|mesh-ancestor
153494530|NCT01545648|Denosumab|denosumab|mesh-list
153494590|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153494591|NCT01302444|Tadalafil|tadalafil|mesh-list
153494592|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
153494593|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153494594|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153494595|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494596|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494597|NCT01302444|Urological Agents|urological agents|mesh-ancestor
153494598|NCT01292070|Histamine|histamine|mesh-list
153494603|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507284|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507285|NCT01396642|Emollients|emollients|mesh-list
153494605|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153494606|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153494607|NCT01284504|Analgesics|analgesics|mesh-ancestor
153494608|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
153494612|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153494655|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494656|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494657|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153494658|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153494659|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153494660|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153494661|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153494663|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153494664|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
153494665|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153494666|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153494667|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153494668|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494681|NCT00986310|Fluoxetine|fluoxetine|mesh-list
153781841|NCT00266838|Dexamethasone|dexamethasone|mesh-list
153494682|NCT00986310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153494683|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153494684|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494685|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494686|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494687|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
153494688|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494689|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153494690|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
153494691|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153494692|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153494693|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153494694|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494695|NCT00907218|Varenicline|varenicline|mesh-list
153494696|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153494706|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494707|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153494708|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153494709|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153494710|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
153494711|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494712|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494713|NCT00875394|Metformin|metformin|mesh-list
153494714|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153494715|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153494716|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494717|NCT00875394|Incretins|incretins|mesh-ancestor
153494718|NCT00875394|Hormones|hormones|mesh-ancestor
153494719|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153494720|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153494721|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
153494722|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494724|NCT00832572|Ranolazine|ranolazine|mesh-list
153494765|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494766|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153494767|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153494768|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153494769|NCT00726180|Trastuzumab|trastuzumab|mesh-list
153494770|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153494771|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494772|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
153494773|NCT00704496|Ephedrine|ephedrine|mesh-list
153494774|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153494787|NCT00692094|Melatonin|melatonin|mesh-list
153494827|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
153494828|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153494830|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494831|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494832|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494833|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494834|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153494835|NCT00601848|Trioxsalen|trioxsalen|mesh-list
153494836|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494837|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
153494838|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153494839|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
153494840|NCT00586716|Antibodies|antibodies|mesh-list
153494841|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
153494889|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153494890|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494891|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153494892|NCT05001048|Phenylephrine|phenylephrine|mesh-list
153494893|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
153494894|NCT05001048|Synephrine|synephrine|mesh-list
153494895|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153494896|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
153494898|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494899|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781843|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
153494957|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507383|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
153494958|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494959|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494961|NCT00558870|Methadone|methadone|mesh-list
153494962|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153494963|NCT00558870|Narcotics|narcotics|mesh-ancestor
153494964|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494965|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494966|NCT00558870|Analgesics|analgesics|mesh-ancestor
153494967|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
153494968|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494969|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
153494970|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
153494971|NCT00548886|Epinephrine|epinephrine|mesh-list
153494972|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153494973|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153495012|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153495013|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495017|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
153495018|NCT00145704|Diphosphonates|diphosphonates|mesh-list
153495019|NCT00145704|Vitamins|vitamins|mesh-list
153495020|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
153495021|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495022|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153495023|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153495024|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153495025|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153495026|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495076|NCT00003726|Lepirudin|lepirudin|mesh-list
153495077|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
153495078|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153495079|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
153495080|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495081|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495082|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
153495083|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153495084|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153495085|NCT02595996|Propranolol|propranolol|mesh-list
153495086|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153495089|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495090|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495091|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495136|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495137|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153495138|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153495139|NCT00000138|Protective Agents|protective agents|mesh-ancestor
153495140|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
153495141|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495142|NCT00000174|Rivastigmine|rivastigmine|mesh-list
153495143|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153495144|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495145|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495146|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
153495147|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495148|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495149|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153495150|NCT00000174|Protective Agents|protective agents|mesh-ancestor
153495151|NCT00000192|Lamotrigine|lamotrigine|mesh-list
153495152|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
153495153|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153495154|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153495155|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495156|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153495157|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495159|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153495160|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495161|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153495162|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153495163|NCT00000198|Piracetam|piracetam|mesh-list
153495184|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495185|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495186|NCT00000222|Buprenorphine|buprenorphine|mesh-list
153495187|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153495188|NCT00000222|Narcotics|narcotics|mesh-ancestor
153495189|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495190|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495191|NCT00000222|Analgesics|analgesics|mesh-ancestor
153495192|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
153495193|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495194|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495195|NCT00000228|Buprenorphine|buprenorphine|mesh-list
153495196|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153495197|NCT00000228|Narcotics|narcotics|mesh-ancestor
153495198|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495199|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495200|NCT00000228|Analgesics|analgesics|mesh-ancestor
153495201|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
153495202|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507468|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
153495203|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495204|NCT00000234|Buprenorphine|buprenorphine|mesh-list
153495205|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153495206|NCT00000234|Narcotics|narcotics|mesh-ancestor
153495207|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495208|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495209|NCT00000234|Analgesics|analgesics|mesh-ancestor
153495210|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
153495211|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495212|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495213|NCT00000240|Buprenorphine|buprenorphine|mesh-list
153495229|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495231|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
153495232|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153495233|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495234|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495250|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153495251|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153495252|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153495253|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153495254|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495255|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
153495256|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495258|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153495259|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
153495260|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153495261|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153495262|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153495265|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
153495305|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
153495306|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495307|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153495308|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
153495309|NCT00000330|Narcotics|narcotics|mesh-ancestor
153495310|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495311|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495312|NCT00000330|Analgesics|analgesics|mesh-ancestor
153495313|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
153495314|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495316|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
153495317|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153495318|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153495319|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153495320|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153495321|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495322|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495323|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153495324|NCT00000336|Protective Agents|protective agents|mesh-ancestor
153495325|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495326|NCT00000342|Risperidone|risperidone|mesh-list
153495360|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495361|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153495362|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
153495363|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495364|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
153495365|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495366|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153495367|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
153495368|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495369|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495370|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153495371|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153495422|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495424|NCT00000510|Dipyridamole|dipyridamole|mesh-list
153495428|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
153495429|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495430|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495431|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153495432|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153495433|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153495434|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153495435|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495436|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153495437|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153495438|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495439|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
153495440|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153495441|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
153495442|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153495443|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
153495444|NCT00000600|Vitamins|vitamins|mesh-list
153495445|NCT00000600|Vitamin E|vitamin e|mesh-list
153495446|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
153495447|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495448|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
153495449|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495450|NCT00000600|Protective Agents|protective agents|mesh-ancestor
153495475|NCT00000636|Vitamins|vitamins|mesh-ancestor
153495476|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
153495477|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495478|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
153495479|NCT00000648|Penicillins|penicillins|mesh-list
153495480|NCT00000648|Penicillin G|penicillin g|mesh-list
153495481|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153495482|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
153495483|NCT00000648|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153495484|NCT00000648|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153495485|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495486|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495488|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
153495489|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495490|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495491|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495492|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495493|NCT00000660|Etoposide|etoposide|mesh-list
153495494|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153495495|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495496|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153626816|NCT02019186|Vitamin E|vitamin e|mesh-list
153495504|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495506|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
153495507|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495508|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495509|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495510|NCT00000714|Leucovorin|leucovorin|mesh-list
153495511|NCT00000714|Trimetrexate|trimetrexate|mesh-list
153495528|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495529|NCT00000732|Zidovudine|zidovudine|mesh-list
153495530|NCT00000732|Trimethoprim|trimethoprim|mesh-list
153495531|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
153495532|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153495533|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
153495534|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495535|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495536|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495537|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495539|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495540|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495541|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495542|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153495543|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
153495544|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153495545|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153495546|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153495547|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153495548|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153495549|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153495550|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495551|NCT00000738|Zidovudine|zidovudine|mesh-list
153495552|NCT00000738|Nimodipine|nimodipine|mesh-list
153495553|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
153495554|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495557|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495609|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495610|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495611|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
153495612|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495613|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153495614|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495615|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
153495616|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153495617|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495618|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495619|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
153495620|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495621|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495622|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495623|NCT00000864|Zidovudine|zidovudine|mesh-list
153495624|NCT00000864|Abacavir|abacavir|mesh-list
153495625|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
153495629|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495667|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153495668|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153495669|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495670|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495671|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153495672|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153495673|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
153495674|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153495675|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153495676|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
153495680|NCT00000918|Saquinavir|saquinavir|mesh-list
153495681|NCT00000918|Amprenavir|amprenavir|mesh-list
153495682|NCT00000918|Lamivudine|lamivudine|mesh-list
153495683|NCT00000918|Zidovudine|zidovudine|mesh-list
153495684|NCT00000918|Stavudine|stavudine|mesh-list
153495685|NCT00000918|Didanosine|didanosine|mesh-list
153495686|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153495687|NCT00000918|Efavirenz|efavirenz|mesh-list
153495710|NCT00000924|Ritonavir|ritonavir|mesh-list
153495726|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495727|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495728|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153495729|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153495730|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
153507726|NCT05509634|Aprepitant|aprepitant|mesh-list
153495731|NCT00000936|Cyclosporine|cyclosporine|mesh-list
153495732|NCT00000936|Cyclosporins|cyclosporins|mesh-list
153495733|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495734|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495735|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495736|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
153495737|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495738|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
153495739|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495740|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
153495741|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153495742|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153495743|NCT00000942|Nevirapine|nevirapine|mesh-list
153495744|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495745|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495746|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495748|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
153495791|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495792|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495793|NCT00000990|Zidovudine|zidovudine|mesh-list
153495794|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
153495795|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495796|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495797|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495798|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495799|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
153495800|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495801|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495802|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495803|NCT00000996|Doxorubicin|doxorubicin|mesh-list
153495804|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153495805|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153495806|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495807|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153495809|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495849|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495850|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495851|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495853|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
153495854|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495855|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495856|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495857|NCT00001110|Dimercaprol|dimercaprol|mesh-list
153495858|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
153495859|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
153495860|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495861|NCT00001122|Efavirenz|efavirenz|mesh-list
153495862|NCT00001122|Stavudine|stavudine|mesh-list
153495863|NCT00001122|Didanosine|didanosine|mesh-list
153495864|NCT00001122|Nelfinavir|nelfinavir|mesh-list
153495865|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495866|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495867|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495868|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495869|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
153495870|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495871|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153495872|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153495873|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153495874|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153495875|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153495876|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153495877|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153495878|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153495879|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
153495880|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495881|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495882|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
153495883|NCT00001128|Azithromycin|azithromycin|mesh-list
153495885|NCT00001128|Interleukin-12|interleukin-12|mesh-list
153495886|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495887|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495889|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
153495890|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495891|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153495892|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153495893|NCT00001128|Growth Substances|growth substances|mesh-ancestor
153495894|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
153495895|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495896|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153495897|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153495898|NCT00001296|Interferons|interferons|mesh-list
153495899|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
153495900|NCT00001296|Melphalan|melphalan|mesh-list
153495901|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495902|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
153495903|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495904|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153495905|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
153495906|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495907|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153495940|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
153495941|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153495942|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
153495943|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495944|NCT00001626|Cyclosporine|cyclosporine|mesh-list
153495945|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
153495946|NCT00001626|Cyclosporins|cyclosporins|mesh-list
153495947|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153495948|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495949|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
153495950|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495951|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507799|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
153438929|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153496003|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496004|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496005|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
153496006|NCT00001812|Ionophores|ionophores|mesh-ancestor
153496007|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153496008|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496009|NCT00001842|Dexamethasone|dexamethasone|mesh-list
153496010|NCT00001842|Lenograstim|lenograstim|mesh-list
153496011|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153496012|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
153496013|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
153496014|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153496015|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496016|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153496017|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
153496019|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496020|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153496021|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496057|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496058|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496059|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496060|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496061|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496062|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496063|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
153496064|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496065|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496066|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496067|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496068|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496069|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153496070|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
153496071|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496072|NCT00001998|Nystatin|nystatin|mesh-list
153496073|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496074|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496075|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
153496076|NCT00001998|Ionophores|ionophores|mesh-ancestor
153496077|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153496078|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496079|NCT00002010|Fluconazole|fluconazole|mesh-list
153496080|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
153496081|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496082|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153496083|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496084|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496085|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496086|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153496087|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
153496088|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496095|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
153781849|NCT00266838|Hormones|hormones|mesh-ancestor
153496096|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496097|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496098|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496099|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496100|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
153496101|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496102|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496103|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496104|NCT00002034|Zidovudine|zidovudine|mesh-list
153496106|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153496107|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
153496157|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153496159|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496160|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
153496161|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153496162|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153496163|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153496164|NCT00002070|Ganciclovir|ganciclovir|mesh-list
153496165|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153496166|NCT00002070|Sargramostim|sargramostim|mesh-list
153496221|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153496222|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
153496223|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496224|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496225|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153496226|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153496227|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496228|NCT00002112|Ionophores|ionophores|mesh-ancestor
153496229|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153496230|NCT00002118|Zalcitabine|zalcitabine|mesh-list
153496286|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496287|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496288|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153496289|NCT00002154|Protective Agents|protective agents|mesh-ancestor
153496290|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496291|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
153496292|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
153496293|NCT00002154|Vitamins|vitamins|mesh-ancestor
153496294|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
153496295|NCT00002160|Ziconotide|ziconotide|mesh-list
153496296|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153496297|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153496298|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496299|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153496300|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496301|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153496302|NCT00002160|Protective Agents|protective agents|mesh-ancestor
153496303|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153496304|NCT00002160|Analgesics|analgesics|mesh-ancestor
153496305|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
153496306|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153496307|NCT00002166|Nevirapine|nevirapine|mesh-list
153496308|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496310|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496339|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153496340|NCT00002184|Nelfinavir|nelfinavir|mesh-list
153496341|NCT00002184|Saquinavir|saquinavir|mesh-list
153496342|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496343|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496344|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496345|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496346|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
153496347|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496348|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496349|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496350|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
153496351|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496352|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496403|NCT00002214|Capravirine|capravirine|mesh-list
153496404|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496405|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496406|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496407|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496408|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
153496409|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496410|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496411|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496412|NCT00002220|Efavirenz|efavirenz|mesh-list
153496413|NCT00002220|Adefovir|adefovir|mesh-list
153507953|NCT04160052|Azacitidine|azacitidine|mesh-list
153496414|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153496415|NCT00002220|Indinavir|indinavir|mesh-list
153496416|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496417|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496418|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496420|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
153496456|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496457|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
153496458|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496459|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153496460|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
153496461|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
153496462|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496463|NCT00002256|Zalcitabine|zalcitabine|mesh-list
153496464|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
153496465|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496466|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496467|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496468|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496469|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
153496470|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496471|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496472|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496473|NCT00002274|Didanosine|didanosine|mesh-list
153496474|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
153496475|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496476|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496477|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496478|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496479|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
153496480|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496481|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496482|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496483|NCT00002280|Didanosine|didanosine|mesh-list
153496485|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496486|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496487|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496488|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496489|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
153496490|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496491|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496492|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496493|NCT00002286|Zidovudine|zidovudine|mesh-list
153496494|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
153496495|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496496|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496497|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496498|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496499|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
153496500|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496501|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496569|NCT00002340|Pentamidine|pentamidine|mesh-list
153496570|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496571|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
153496572|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153496573|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153496574|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496575|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496576|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
153496577|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153496578|NCT00002346|Adefovir|adefovir|mesh-list
153496579|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153496580|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
153496586|NCT00002352|Lobucavir|lobucavir|mesh-list
153496642|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496643|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496644|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496645|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
153496646|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496647|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496648|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153496649|NCT00002388|Abacavir|abacavir|mesh-list
153496650|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496712|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496714|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496715|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496716|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496717|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153496718|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153496719|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496720|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
153496721|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
153496722|NCT00002424|Lamivudine|lamivudine|mesh-list
153496723|NCT00002424|Stavudine|stavudine|mesh-list
153496724|NCT00002424|Indinavir|indinavir|mesh-list
153496725|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496726|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496727|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496728|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731640|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731641|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731642|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153731644|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
153496729|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
153496730|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496731|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496732|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496733|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
153496734|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496735|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496736|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496737|NCT00002430|Lamivudine|lamivudine|mesh-list
153496738|NCT00002430|Stavudine|stavudine|mesh-list
153496739|NCT00002430|Nelfinavir|nelfinavir|mesh-list
153496751|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496752|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
153496753|NCT00002436|Lamivudine|lamivudine|mesh-list
153496754|NCT00002436|Zidovudine|zidovudine|mesh-list
153496755|NCT00002436|Zalcitabine|zalcitabine|mesh-list
153496756|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153626817|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
153496759|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496760|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
153496761|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496762|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496763|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496764|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
153496765|NCT00002442|Lamivudine|lamivudine|mesh-list
153496766|NCT00002442|Stavudine|stavudine|mesh-list
153496767|NCT00002442|Nelfinavir|nelfinavir|mesh-list
153496768|NCT00002442|Indinavir|indinavir|mesh-list
153496769|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153496770|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496771|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439759|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
153496772|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496773|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
153496774|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496775|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496776|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496777|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153496778|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153496779|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496780|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
153496781|NCT00002448|Ritonavir|ritonavir|mesh-list
153496782|NCT00002448|Saquinavir|saquinavir|mesh-list
153496797|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153496798|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153496799|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153496800|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153496801|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153496802|NCT00002460|Tamoxifen|tamoxifen|mesh-list
153496803|NCT00002460|Goserelin|goserelin|mesh-list
153496804|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153496805|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
153496806|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496807|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496808|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153496809|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496810|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153496811|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153496812|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153496813|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
153496814|NCT00002466|Ifosfamide|ifosfamide|mesh-list
153496815|NCT00002466|Doxorubicin|doxorubicin|mesh-list
153496816|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153496817|NCT00002466|Etoposide|etoposide|mesh-list
153496818|NCT00002466|Vincristine|vincristine|mesh-list
153496819|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153496820|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
153496846|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153496847|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153496848|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496849|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496850|NCT00002490|Mitomycins|mitomycins|mesh-list
153496851|NCT00002490|Mitomycin|mitomycin|mesh-list
153496852|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
153496853|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153496854|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496855|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
153496856|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496857|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496858|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496859|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153496860|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
153496861|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496862|NCT00002496|Cobalt|cobalt|mesh-list
153496863|NCT00002496|Fluorouracil|fluorouracil|mesh-list
153496864|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496865|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
153496866|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496867|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153496868|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153496869|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
153496870|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496871|NCT00002496|Trace Elements|trace elements|mesh-ancestor
153496872|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
153496873|NCT00002502|Cytarabine|cytarabine|mesh-list
153496874|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
153496875|NCT00002502|Busulfan|busulfan|mesh-list
153496876|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153496877|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
153496878|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496879|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153496886|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
153496887|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
153496888|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496889|NCT00002508|Carboplatin|carboplatin|mesh-list
153496890|NCT00002508|Etoposide|etoposide|mesh-list
153496891|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496892|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153496893|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153496894|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153496895|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496896|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496897|NCT00002526|Doxorubicin|doxorubicin|mesh-list
153496898|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153496899|NCT00002526|Ifosfamide|ifosfamide|mesh-list
153496948|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496949|NCT00002532|Antidotes|antidotes|mesh-ancestor
153496950|NCT00002532|Protective Agents|protective agents|mesh-ancestor
153496951|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
153496952|NCT00002532|Vitamins|vitamins|mesh-ancestor
153496953|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
153496954|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153496955|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153496956|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
153496957|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
153496958|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
153496959|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
153496960|NCT00002544|Docetaxel|docetaxel|mesh-list
153496961|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
153496962|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496963|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
153496964|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
153496965|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
153496966|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496967|NCT00002544|Analgesics|analgesics|mesh-ancestor
153496968|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
153496969|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153496970|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496971|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153496972|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153496973|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496974|NCT00002550|Etoposide|etoposide|mesh-list
153496975|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496976|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153496977|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153496979|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496995|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496996|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496997|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153496998|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153496999|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
153497000|NCT00002556|Hormones|hormones|mesh-ancestor
153497001|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497002|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497003|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
153497004|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497005|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497006|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497007|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497008|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497009|NCT00002562|Paclitaxel|paclitaxel|mesh-list
153497010|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497011|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497012|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497013|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497014|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497015|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497016|NCT00002568|Paclitaxel|paclitaxel|mesh-list
153497017|NCT00002568|Cisplatin|cisplatin|mesh-list
153497018|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153731646|NCT00161070|Aspirin|aspirin|mesh-list
153731647|NCT00161070|Dipyridamole|dipyridamole|mesh-list
153731648|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153508171|NCT03281369|Vitamins|vitamins|mesh-ancestor
153731649|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731650|NCT00161070|Analgesics|analgesics|mesh-ancestor
153731651|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
153731652|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497026|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
153497027|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497028|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
153497029|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497030|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
153497031|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497032|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497033|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153497034|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497094|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497095|NCT00002598|Interferons|interferons|mesh-list
153497096|NCT00002598|Cytarabine|cytarabine|mesh-list
153497097|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
153497098|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
153497099|NCT00002598|Methotrexate|methotrexate|mesh-list
153497100|NCT00002598|Etoposide|etoposide|mesh-list
153497101|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
153497102|NCT00002598|Sargramostim|sargramostim|mesh-list
153497103|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497104|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
153497105|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497106|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497107|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497108|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
153497109|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497110|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497111|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497169|NCT00002616|Carboplatin|carboplatin|mesh-list
153497170|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497171|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
153497172|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497173|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497174|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497175|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
153497176|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497177|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497178|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497179|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153497180|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153497181|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
153497182|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497183|NCT00002634|Cobalt|cobalt|mesh-list
153497184|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
153497185|NCT00002634|Doxorubicin|doxorubicin|mesh-list
153497186|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153497187|NCT00002634|Etoposide|etoposide|mesh-list
153497188|NCT00002634|Vincristine|vincristine|mesh-list
153497189|NCT00002634|Antibodies|antibodies|mesh-list
153508225|NCT02402920|Carboplatin|carboplatin|mesh-list
153497190|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153497194|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497195|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497196|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
153497197|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497198|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497203|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497219|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153497220|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153497221|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153497222|NCT00002646|Protective Agents|protective agents|mesh-ancestor
153497223|NCT00002652|Suramin|suramin|mesh-list
153497224|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
153497225|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
153497226|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153497227|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497228|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497229|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153497230|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153497231|NCT00002658|Cytarabine|cytarabine|mesh-list
153497232|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
153497233|NCT00002658|Etoposide|etoposide|mesh-list
153497234|NCT00002658|Daunorubicin|daunorubicin|mesh-list
153497235|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
153497236|NCT00002658|Idarubicin|idarubicin|mesh-list
153497237|NCT00002658|Thioguanine|thioguanine|mesh-list
153497238|NCT00002658|Tretinoin|tretinoin|mesh-list
153497239|NCT00002658|Amsacrine|amsacrine|mesh-list
153497240|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497241|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
153497242|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497243|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497244|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153731656|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153497245|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
153497246|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497247|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497248|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497258|NCT00002658|Analgesics|analgesics|mesh-ancestor
153497268|NCT00002670|Cobalt|cobalt|mesh-list
153497269|NCT00002670|Trace Elements|trace elements|mesh-ancestor
153497270|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
153497271|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497272|NCT00002676|Cobalt|cobalt|mesh-list
153497273|NCT00002676|Cytarabine|cytarabine|mesh-list
153497274|NCT00002676|Dexamethasone|dexamethasone|mesh-list
153497275|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
153497276|NCT00002676|Carmustine|carmustine|mesh-list
153497277|NCT00002676|Doxorubicin|doxorubicin|mesh-list
153497278|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153497279|NCT00002676|Methotrexate|methotrexate|mesh-list
153497280|NCT00002676|Vincristine|vincristine|mesh-list
153497281|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497282|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
153497283|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497284|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497285|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497286|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
153497287|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497288|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497289|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497290|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153497291|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
153497292|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
153497293|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497294|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153497295|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
153497296|NCT00002676|Hormones|hormones|mesh-ancestor
153497299|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497315|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497316|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497317|NCT00002676|Trace Elements|trace elements|mesh-ancestor
153497318|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
153497319|NCT00002682|Amoxicillin|amoxicillin|mesh-list
153497320|NCT00002682|Metronidazole|metronidazole|mesh-list
153497321|NCT00002682|Clarithromycin|clarithromycin|mesh-list
153497322|NCT00002682|Tetracycline|tetracycline|mesh-list
153497324|NCT00002682|Bismuth|bismuth|mesh-list
153497325|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153497326|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153497327|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497328|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153497329|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153497330|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153497331|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153497332|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153497333|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497384|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497385|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
153497386|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497387|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497388|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497389|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153497390|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
153497391|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
153497392|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497393|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153497394|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
153497395|NCT00002700|Hormones|hormones|mesh-ancestor
153497396|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497397|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497398|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497399|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497400|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497401|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497402|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153497403|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
153497406|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
153497440|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497441|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153497442|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
153497443|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
153497444|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497445|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153497446|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
153497447|NCT00002718|Hormones|hormones|mesh-ancestor
153497448|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497449|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153497450|NCT00002718|Protective Agents|protective agents|mesh-ancestor
153497451|NCT00002730|Melphalan|melphalan|mesh-list
153497452|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
153497453|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497454|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
153497455|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497456|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497457|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497458|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497459|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
153497460|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497461|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
153497462|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497488|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497504|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153497505|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153497506|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497507|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497508|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153497509|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
153497510|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497511|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497512|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153497514|NCT00002772|Paclitaxel|paclitaxel|mesh-list
153497515|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
153497516|NCT00002772|Carboplatin|carboplatin|mesh-list
153497517|NCT00002772|Doxorubicin|doxorubicin|mesh-list
153497518|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153497519|NCT00002772|Thiotepa|thiotepa|mesh-list
153497520|NCT00002772|Carmustine|carmustine|mesh-list
153497521|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497522|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497523|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497524|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
153497525|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
153497526|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497527|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497528|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
153497529|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497550|NCT00002784|Doxorubicin|doxorubicin|mesh-list
153497551|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153497552|NCT00002784|Fluorouracil|fluorouracil|mesh-list
153497553|NCT00002784|Methotrexate|methotrexate|mesh-list
153497554|NCT00002784|Epirubicin|epirubicin|mesh-list
153497555|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497556|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
153497557|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497558|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497559|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497560|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
153497561|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497562|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497563|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497564|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153508391|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
153497565|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497566|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497567|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497568|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
153497569|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497570|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153497571|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
153497572|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153497573|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497574|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153497575|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497576|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153497577|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
153497578|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497594|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497595|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497596|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497597|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153497598|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497599|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
153497600|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497601|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153497602|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
153497603|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497604|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153497605|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153497606|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153497607|NCT05751876|Dienogest|dienogest|mesh-list
153497608|NCT05751876|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153497609|NCT05751876|Contraceptive Agents|contraceptive agents|mesh-ancestor
153497610|NCT05751876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153497611|NCT05751876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497612|NCT05751876|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153497613|NCT05751876|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153497614|NCT05751876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153497615|NCT05751876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153497616|NCT05751876|Hormone Antagonists|hormone antagonists|mesh-ancestor
153497617|NCT05751876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497618|NCT05751876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497619|NCT05751876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497620|NCT05751252|Ganirelix|ganirelix|mesh-list
153497621|NCT05751252|Hormone Antagonists|hormone antagonists|mesh-ancestor
153497624|NCT00002628|Paclitaxel|paclitaxel|mesh-list
153497625|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
153497626|NCT00002628|Carboplatin|carboplatin|mesh-list
153497627|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497628|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497629|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
153497636|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497637|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497638|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
153497639|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497641|NCT05749614|Anesthetics, Local|anesthetics, local|mesh-ancestor
153497642|NCT05749614|Anesthetics|anesthetics|mesh-ancestor
153497643|NCT05749614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153497644|NCT05749614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497645|NCT05749614|Sensory System Agents|sensory system agents|mesh-ancestor
153497646|NCT05749614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497647|NCT05749614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153497648|NCT05749614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153497649|NCT05749614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153497650|NCT05749614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153497651|NCT05749614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497652|NCT05749380|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153497653|NCT05749380|Antifungal Agents|antifungal agents|mesh-ancestor
153497654|NCT05749380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497655|NCT05749380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153497656|NCT05749380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153497657|NCT05677698|Peppermint oil|peppermint oil|mesh-list
153497685|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497686|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497687|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
153497688|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497689|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153497690|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
153497691|NCT05360628|Protective Agents|protective agents|mesh-ancestor
153497693|NCT05312112|Venetoclax|venetoclax|mesh-list
153497694|NCT05312112|Gilteritinib|gilteritinib|mesh-list
153497695|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497696|NCT05312112|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153497697|NCT05312112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153497698|NCT05312112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497700|NCT05218668|Fasudil|fasudil|mesh-list
153497747|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153497748|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497749|NCT04471974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153497750|NCT04471974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497751|NCT04360824|Enoxaparin|enoxaparin|mesh-list
153497752|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
153497753|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153497754|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153781856|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153440755|NCT00003781|Docetaxel|docetaxel|mesh-list
153497755|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497756|NCT04331652|Anesthetics|anesthetics|mesh-list
153497757|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153497758|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497759|NCT03846570|Beclomethasone|beclomethasone|mesh-list
153497760|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
153497761|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153497762|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
153497764|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497765|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153497766|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
153497767|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153497768|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153497770|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
153497775|NCT03846570|Hormones|hormones|mesh-ancestor
153497793|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497795|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497796|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497797|NCT03701490|Progesterone|progesterone|mesh-list
153497798|NCT03701490|Progestins|progestins|mesh-ancestor
153497799|NCT03701490|Hormones|hormones|mesh-ancestor
153497800|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497801|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497802|NCT03691974|Fasinumab|fasinumab|mesh-list
153497803|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153497804|NCT03691974|Analgesics|analgesics|mesh-ancestor
153497805|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
153497806|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497807|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497808|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
153497809|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153497810|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497811|NCT02972034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153497812|NCT02972034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497813|NCT01394016|Fulvestrant|fulvestrant|mesh-list
153497814|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153497815|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497816|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153497817|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153497818|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
153497820|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497840|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497841|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153497842|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153497843|NCT00002796|Analgesics|analgesics|mesh-ancestor
153497844|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
153497845|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497846|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153497847|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497848|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
153497849|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
153497850|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153497851|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153497852|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497854|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
153497855|NCT00002802|Melphalan|melphalan|mesh-list
153497856|NCT00002802|Ifosfamide|ifosfamide|mesh-list
153497857|NCT00002802|Dacarbazine|dacarbazine|mesh-list
153497858|NCT00002802|Carboplatin|carboplatin|mesh-list
153497859|NCT00002802|Doxorubicin|doxorubicin|mesh-list
153497860|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153497861|NCT00002802|Etoposide|etoposide|mesh-list
153497862|NCT00002802|Vincristine|vincristine|mesh-list
153497863|NCT00002802|Vindesine|vindesine|mesh-list
153497883|NCT00002814|Paclitaxel|paclitaxel|mesh-list
153497896|NCT00002832|Cyclosporins|cyclosporins|mesh-list
153497897|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
153497898|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497899|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497900|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497901|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497902|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
153497903|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497904|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
153497905|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497906|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153497907|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497908|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
153497909|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497910|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
153497912|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
153497915|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497916|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153497917|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497918|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
153497919|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497920|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497921|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153497922|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153497923|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
153497924|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
153497925|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497926|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
153497927|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497941|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497942|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153497943|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497944|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508604|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497945|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497946|NCT00002892|Interferons|interferons|mesh-list
153497947|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
153497948|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497949|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
153497950|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497951|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
153497952|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497953|NCT00002898|Dactinomycin|dactinomycin|mesh-list
153497954|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
153497956|NCT00002898|Carboplatin|carboplatin|mesh-list
153498003|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
153498004|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498005|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153498006|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153498007|NCT00002952|Growth Substances|growth substances|mesh-ancestor
153498008|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
153498009|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498010|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153498012|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498013|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
153498014|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153498015|NCT00002970|Cytarabine|cytarabine|mesh-list
153498016|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
153498017|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153498018|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153498019|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153498020|NCT00002970|Methotrexate|methotrexate|mesh-list
153498022|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
153498061|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
153498062|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498063|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498064|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
153498065|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498067|NCT00002988|Carmustine|carmustine|mesh-list
153498068|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153498069|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498070|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498071|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498072|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498073|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498074|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
153498075|NCT00002994|Interleukin-2|interleukin-2|mesh-list
153498076|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498077|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153498078|NCT00002994|Analgesics|analgesics|mesh-ancestor
153498079|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
153498080|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153498081|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498082|NCT00003000|Fentanyl|fentanyl|mesh-list
153498083|NCT00003000|Morphine|morphine|mesh-list
153498084|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153498085|NCT00003000|Narcotics|narcotics|mesh-ancestor
153498086|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153498087|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498088|NCT00003000|Analgesics|analgesics|mesh-ancestor
153498089|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
153498090|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153498091|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153498092|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153498093|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
153498103|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498104|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
153498105|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498106|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498107|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498108|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
153498109|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498110|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153498111|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
153498112|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153498113|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
153498114|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498115|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153498116|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153498117|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498120|NCT00003048|Amifostine|amifostine|mesh-list
153498163|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498164|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498165|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
153498166|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153498167|NCT00003072|Paclitaxel|paclitaxel|mesh-list
153498168|NCT00003072|Carboplatin|carboplatin|mesh-list
153498169|NCT00003072|Amifostine|amifostine|mesh-list
153498170|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498171|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498172|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498173|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498174|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
153731658|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498175|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498176|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153498177|NCT00003072|Protective Agents|protective agents|mesh-ancestor
153498188|NCT00003084|Paclitaxel|paclitaxel|mesh-list
153498217|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498218|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153498219|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153498220|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
153498221|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498222|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
153498223|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498224|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153498225|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
153498226|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498227|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
153498228|NCT00003114|Lomustine|lomustine|mesh-list
153498229|NCT00003114|Etoposide|etoposide|mesh-list
153498230|NCT00003114|Procarbazine|procarbazine|mesh-list
153498231|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498232|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
153498233|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498234|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498235|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498275|NCT00003144|Protective Agents|protective agents|mesh-ancestor
153498276|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498278|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
153498279|NCT00003150|Rituximab|rituximab|mesh-list
153498280|NCT00003150|Doxorubicin|doxorubicin|mesh-list
153498281|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153498284|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
153498285|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498286|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498287|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498288|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
153498289|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498290|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498291|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498292|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153498293|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498294|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498295|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498296|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498297|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153498298|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
153498299|NCT00003150|Hormones|hormones|mesh-ancestor
153498300|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153498301|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153498302|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498303|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498304|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498306|NCT00003156|Topotecan|topotecan|mesh-list
153498326|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153498327|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498328|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
153498329|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498330|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498331|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498332|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498333|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
153498334|NCT00003018|Antidotes|antidotes|mesh-ancestor
153498335|NCT00003018|Protective Agents|protective agents|mesh-ancestor
153498336|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
153498337|NCT00003018|Vitamins|vitamins|mesh-ancestor
153498338|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
153498339|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498340|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
153498341|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153498342|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498343|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153498344|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153498345|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
153498346|NCT00003198|Topotecan|topotecan|mesh-list
153498347|NCT00003198|Ifosfamide|ifosfamide|mesh-list
153498348|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153498349|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498350|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498351|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498352|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498353|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498354|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
153498362|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
153498363|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498364|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498365|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498367|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498368|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498369|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498370|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153498371|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153498372|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
153498374|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153498375|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153498376|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498377|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
153498378|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498379|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498380|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498381|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498382|NCT00003210|Interleukin-12|interleukin-12|mesh-list
153498383|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153498384|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
153498385|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498386|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153498387|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153498388|NCT00003210|Growth Substances|growth substances|mesh-ancestor
153498418|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498419|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498420|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
153498421|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498422|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153498423|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498425|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153498443|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498445|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498446|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
153498447|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498448|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498449|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498450|NCT00003294|Paclitaxel|paclitaxel|mesh-list
153498505|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498506|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498507|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
153498508|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498509|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498510|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498511|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498512|NCT00003348|Carmustine|carmustine|mesh-list
153498513|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153498514|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498515|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
153498516|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498517|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498518|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498519|NCT00003360|Antibodies|antibodies|mesh-list
153498520|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153498523|NCT00003372|Topotecan|topotecan|mesh-list
153498572|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498573|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498574|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
153498575|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498576|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153498578|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
153498579|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153498580|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153498581|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
153498582|NCT00003402|Hormones|hormones|mesh-ancestor
153498583|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153498584|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153498585|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498586|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498587|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498588|NCT00003408|Interferons|interferons|mesh-list
153498589|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
153498590|NCT00003408|Aldesleukin|aldesleukin|mesh-list
153498591|NCT00003408|Sargramostim|sargramostim|mesh-list
153498592|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498593|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
153498594|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498595|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
153498596|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498597|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153498598|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153498623|NCT00003426|Gemcitabine|gemcitabine|mesh-list
153498624|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498625|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
153498626|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498627|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498628|NCT00003462|Busulfan|busulfan|mesh-list
153498629|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
153498630|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498690|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498691|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
153498692|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498693|NCT00003582|Paclitaxel|paclitaxel|mesh-list
153498694|NCT00003582|Fluorouracil|fluorouracil|mesh-list
153498695|NCT00003582|Amifostine|amifostine|mesh-list
153498696|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498697|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498698|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498699|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498700|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498701|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498702|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
153498703|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498704|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498705|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
153498706|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498707|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153498708|NCT00003582|Protective Agents|protective agents|mesh-ancestor
153498709|NCT00003594|Leucovorin|leucovorin|mesh-list
153498746|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498748|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498749|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498750|NCT00003612|Paclitaxel|paclitaxel|mesh-list
153498751|NCT00003612|Carboplatin|carboplatin|mesh-list
153498752|NCT00003612|Trastuzumab|trastuzumab|mesh-list
153498753|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498754|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498755|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498756|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498757|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498758|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498761|NCT00003624|Amifostine|amifostine|mesh-list
153498762|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498763|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498764|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498765|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498766|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498767|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498768|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153498769|NCT00003624|Protective Agents|protective agents|mesh-ancestor
153498771|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
153498798|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153508866|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153498799|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153498800|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153498801|NCT00003684|Theophylline|theophylline|mesh-list
153498802|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153498803|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
153498804|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153498805|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781860|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153498806|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153498807|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
153498859|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498861|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498862|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153498863|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498864|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498865|NCT00003732|Paclitaxel|paclitaxel|mesh-list
153498866|NCT00003732|Carboplatin|carboplatin|mesh-list
153498867|NCT00003732|Topotecan|topotecan|mesh-list
153498868|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498869|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498870|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498871|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498872|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498877|NCT00003744|Gemcitabine|gemcitabine|mesh-list
153498920|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153498921|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498922|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498923|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153498924|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498925|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153498926|NCT00003828|Vinorelbine|vinorelbine|mesh-list
153498927|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498928|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498929|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498930|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498931|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498932|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498933|NCT00003834|Leucovorin|leucovorin|mesh-list
153498934|NCT00003834|Fluorouracil|fluorouracil|mesh-list
153498935|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
153498936|NCT00003834|Calcium|calcium|mesh-list
153498937|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
153498938|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153498939|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498940|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
153498941|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498975|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498976|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498977|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498978|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498979|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
153498980|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731661|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498981|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498982|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
153498983|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498984|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498985|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153498986|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
153498987|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498988|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498989|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498990|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498991|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153498993|NCT00003858|Analgesics|analgesics|mesh-ancestor
153498994|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
153498995|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153498996|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498997|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498998|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153498999|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499000|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499001|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499002|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
153499003|NCT00003870|Methotrexate|methotrexate|mesh-list
153499004|NCT00003870|Antibodies|antibodies|mesh-list
153646712|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
153499017|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153499018|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499020|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
153499021|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499022|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153499023|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153499024|NCT00003876|Carmustine|carmustine|mesh-list
153499025|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499026|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
153499027|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499028|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499029|NCT00003888|Docetaxel|docetaxel|mesh-list
153499030|NCT00003888|Fluorouracil|fluorouracil|mesh-list
153442039|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153499031|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499032|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499033|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499034|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499076|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153499077|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499078|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499079|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499080|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499081|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499082|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499083|NCT00003924|Interferons|interferons|mesh-list
153499084|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
153499085|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499086|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
153499087|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499088|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
153499089|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499090|NCT00003930|Paclitaxel|paclitaxel|mesh-list
153499091|NCT00003930|Gemcitabine|gemcitabine|mesh-list
153499092|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499099|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
153499133|NCT00003960|Busulfan|busulfan|mesh-list
153499134|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153499135|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
153499136|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499137|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
153499138|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499139|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499140|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499141|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
153499142|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499143|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499144|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499145|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153499146|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
153499147|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
153499148|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499149|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153499150|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
153499190|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153499191|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499192|NCT00003996|Etoposide|etoposide|mesh-list
153499193|NCT00003996|Carmustine|carmustine|mesh-list
153499194|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499195|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499196|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499197|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499198|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499199|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499200|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499201|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
153499202|NCT00004002|Bortezomib|bortezomib|mesh-list
153499203|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499204|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
153499205|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153499206|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
153499249|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499250|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499251|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499252|NCT00004062|Azacitidine|azacitidine|mesh-list
153509009|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
153499253|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499254|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
153499255|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442265|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499256|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499257|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499259|NCT00004068|Temozolomide|temozolomide|mesh-list
153499260|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153499261|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499262|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499263|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499264|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499308|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153499309|NCT00004104|Analgesics|analgesics|mesh-ancestor
153499310|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
153499311|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499312|NCT00004110|Etoposide|etoposide|mesh-list
153499313|NCT00004110|Isotretinoin|isotretinoin|mesh-list
153499314|NCT00004110|Antibodies|antibodies|mesh-list
153499315|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153499316|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
153499317|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499318|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499319|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499320|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499321|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499322|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499323|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499324|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
153499325|NCT00004122|Interferons|interferons|mesh-list
153499326|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
153499327|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
153499329|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
153499364|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499365|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
153499366|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499367|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499368|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499369|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499370|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
153499440|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
153731666|NCT00138983|Alendronate|alendronate|mesh-list
153499441|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499442|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499443|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
153499444|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499445|NCT00004200|Temozolomide|temozolomide|mesh-list
153499446|NCT00004200|Prinomastat|prinomastat|mesh-list
153499447|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153499448|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
153499449|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499450|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499521|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499522|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499523|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499524|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499525|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499526|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499527|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499528|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499529|NCT00004236|Doxorubicin|doxorubicin|mesh-list
153499530|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153499531|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499532|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499533|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499534|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499535|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499536|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499537|NCT00004242|Gemcitabine|gemcitabine|mesh-list
153499538|NCT00004242|Fluorouracil|fluorouracil|mesh-list
153499539|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
153499540|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499541|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
153499542|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499543|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499544|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499545|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
153499546|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499578|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
153499579|NCT00004266|Lisinopril|lisinopril|mesh-list
153499581|NCT00004266|Simvastatin|simvastatin|mesh-list
153499582|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153499584|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
153499604|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499605|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153499606|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499607|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499608|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
153499609|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
153499610|NCT00004284|Diuretics|diuretics|mesh-ancestor
153499611|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
153499612|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499613|NCT00004284|Expectorants|expectorants|mesh-ancestor
153499614|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
153499615|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
153499616|NCT00004284|Protective Agents|protective agents|mesh-ancestor
153499617|NCT00004344|Leuprolide|leuprolide|mesh-list
153499618|NCT00004344|Testosterone|testosterone|mesh-list
153499619|NCT00004344|Androgens|androgens|mesh-ancestor
153499620|NCT00004344|Hormones|hormones|mesh-ancestor
153499685|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499687|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153499688|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153499689|NCT00004440|Analgesics|analgesics|mesh-ancestor
153499690|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
153499691|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499692|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499693|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153499694|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499695|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153499696|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499697|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499698|NCT00004446|Fluoxetine|fluoxetine|mesh-list
153499802|NCT00004650|Hormones|hormones|mesh-ancestor
153499803|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499876|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153509100|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499910|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499912|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499913|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
153499914|NCT00004770|Vitamins|vitamins|mesh-ancestor
153499915|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
153499916|NCT00004776|Topiramate|topiramate|mesh-list
153499917|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
153499918|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153499919|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499920|NCT00004794|Cidofovir|cidofovir|mesh-list
153499921|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
153499922|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499923|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499950|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153499951|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153499952|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
153499955|NCT00004866|Exatecan|exatecan|mesh-list
153500012|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500013|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
153500014|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500015|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153500016|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500017|NCT00004926|Vitamin D|vitamin d|mesh-list
153500018|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
153500044|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153500046|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153500047|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500048|NCT00004992|Metformin|metformin|mesh-list
153500049|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153500050|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500051|NCT00004998|Lamivudine|lamivudine|mesh-list
153500052|NCT00004998|Zidovudine|zidovudine|mesh-list
153500053|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153500054|NCT00004998|Capravirine|capravirine|mesh-list
153500055|NCT00004998|Nelfinavir|nelfinavir|mesh-list
153500056|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153500057|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153500058|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500059|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500060|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
153500061|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500062|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153500063|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500087|NCT00005028|Paclitaxel|paclitaxel|mesh-list
153500108|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500109|NCT00005070|Irofulven|irofulven|mesh-list
153500110|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153500111|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
153500112|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500113|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500114|NCT00005076|Irinotecan|irinotecan|mesh-list
153500115|NCT00005076|Cetuximab|cetuximab|mesh-list
153500116|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153500149|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153500150|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500151|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
153500152|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153500153|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153500154|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
153500155|NCT00005118|Ritonavir|ritonavir|mesh-list
153500156|NCT00005118|Indinavir|indinavir|mesh-list
153500157|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153500158|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153500184|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500185|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500187|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
153500188|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
153500189|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500190|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500191|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
153500192|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500193|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500194|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
153500195|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500196|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153500197|NCT00005586|Leucovorin|leucovorin|mesh-list
153500198|NCT00005586|Fluorouracil|fluorouracil|mesh-list
153500199|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
153500200|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
153500201|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500228|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500229|NCT00005604|Aldesleukin|aldesleukin|mesh-list
153500230|NCT00005604|Interleukin-2|interleukin-2|mesh-list
153500231|NCT00005604|Interleukin-12|interleukin-12|mesh-list
153731667|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
153731668|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153500232|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500233|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153500234|NCT00005604|Analgesics|analgesics|mesh-ancestor
153500235|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
153500236|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781864|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153509156|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500237|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500238|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153500239|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500240|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
153500241|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500242|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153500329|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153500331|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
153500332|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500333|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500334|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153500335|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500336|NCT00005802|Analgesics|analgesics|mesh-ancestor
153500337|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
153500338|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500339|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
153500340|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153500341|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
153500342|NCT00005814|Cetuximab|cetuximab|mesh-list
153500343|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500344|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153500345|NCT00354900|Aprotinin|aprotinin|mesh-list
153500346|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
153500347|NCT00354900|Coagulants|coagulants|mesh-ancestor
153500348|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153500349|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153731670|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
153500350|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
153500351|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500352|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500435|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500436|NCT00356616|Tenofovir|tenofovir|mesh-list
153500437|NCT00356616|Abacavir|abacavir|mesh-list
153500438|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
153500439|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500440|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153500441|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153500442|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500443|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500444|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153500481|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500515|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153500517|NCT00357318|Antibodies|antibodies|mesh-list
153500518|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
153500519|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153500520|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500521|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153500522|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153500523|NCT00357318|Growth Substances|growth substances|mesh-ancestor
153500557|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500558|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500559|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153500560|NCT00357864|Analgesics|analgesics|mesh-ancestor
153500561|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
153500562|NCT00357864|Protective Agents|protective agents|mesh-ancestor
153500563|NCT00357942|Morphine|morphine|mesh-list
153500593|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
153500638|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
153500639|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500640|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
153500641|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500642|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153500643|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500645|NCT00359658|Hormones|hormones|mesh-ancestor
153500646|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153500647|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153500648|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500649|NCT00359814|Cyclosporine|cyclosporine|mesh-list
153500650|NCT00359814|Cyclosporins|cyclosporins|mesh-list
153500651|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500652|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500685|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153500686|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153500790|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153500827|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500860|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153500861|NCT00365586|Analgesics|analgesics|mesh-ancestor
153500862|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
153500863|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509286|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
153509342|NCT03012672|Cladribine|cladribine|mesh-list
153500864|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500865|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500866|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500867|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153500868|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500900|NCT00366834|Ondansetron|ondansetron|mesh-list
153731671|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500996|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153500997|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153500998|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
153500999|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501000|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501001|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501002|NCT00368706|Urological Agents|urological agents|mesh-ancestor
153501004|NCT00368862|Escitalopram|escitalopram|mesh-list
153501029|NCT00369408|Naltrexone|naltrexone|mesh-list
153501030|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153501031|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153501032|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501033|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
153501034|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501035|NCT00369798|Rolipram|rolipram|mesh-list
153501036|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
153501037|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153501038|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153501042|NCT00369954|Carboplatin|carboplatin|mesh-list
153501172|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501173|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153501174|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501175|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153501176|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501177|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153501178|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501179|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501214|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153501215|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501247|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501248|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501249|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
153501250|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153501347|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
153501348|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153501349|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
153501350|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
153501351|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153501352|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153501382|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153501383|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
153501384|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501549|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153501550|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501551|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501553|NCT00383994|Sargramostim|sargramostim|mesh-list
153509360|NCT03011775|Aspirin|aspirin|mesh-list
153501554|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153501555|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501556|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
153501557|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501558|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501559|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
153501560|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153501561|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153501562|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
153501563|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501564|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501565|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153501566|NCT00384228|Nilotinib|nilotinib|mesh-list
153501567|NCT00384228|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153501568|NCT00384228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153501569|NCT00384228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501570|NCT00384228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501571|NCT00384306|Prednisolone|prednisolone|mesh-list
153501574|NCT00384306|Hormones|hormones|mesh-ancestor
153501620|NCT00385398|Temozolomide|temozolomide|mesh-list
153501621|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153501622|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153501623|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
153501624|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501625|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501626|NCT00385398|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153501627|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153501628|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501629|NCT00385554|UC-781|uc-781|mesh-list
153501630|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153501631|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
153501632|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501633|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153501666|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153501667|NCT00421980|Analgesics|analgesics|mesh-ancestor
153501710|NCT00422682|Iniparib|iniparib|mesh-list
153501761|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501762|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
153501763|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501764|NCT01799460|Cyclosporine|cyclosporine|mesh-list
153501765|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
153501766|NCT01799460|Tacrolimus|tacrolimus|mesh-list
153501767|NCT01799460|Cyclosporins|cyclosporins|mesh-list
153501768|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153501769|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
153501770|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
153501771|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501772|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501773|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153501774|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
153501775|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501776|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501777|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153501778|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153501779|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501780|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
153501781|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501811|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
153501812|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502015|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153502016|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
153502017|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
153502052|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502053|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153502054|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153502055|NCT01271166|Growth Substances|growth substances|mesh-ancestor
153502056|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502266|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
153502267|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502268|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502269|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153502270|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502271|NCT01270620|Propofol|propofol|mesh-list
153502272|NCT01270620|Desflurane|desflurane|mesh-list
153502273|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153502274|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502275|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502276|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153502277|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
153502278|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
153502279|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153502310|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502311|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502312|NCT01274988|Analgesics|analgesics|mesh-ancestor
153502313|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
153502314|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502315|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
153502316|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
153502317|NCT01278498|Escitalopram|escitalopram|mesh-list
153502318|NCT01278498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153502319|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153502369|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502370|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502371|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153502372|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502373|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502397|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
153502398|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502399|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502400|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502403|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153502404|NCT00245856|Warfarin|warfarin|mesh-list
153502405|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
153502468|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153502469|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502470|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
153502471|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502472|NCT03802032|Lidocaine|lidocaine|mesh-list
153502473|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
153502474|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
153502475|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502476|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502545|NCT03467256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502546|NCT03265080|Pembrolizumab|pembrolizumab|mesh-list
153502547|NCT03265080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502548|NCT03265080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502549|NCT03265080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153502550|NCT03265080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502551|NCT05313282|Apatinib|apatinib|mesh-list
153502587|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153502588|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153502589|NCT03215940|Analgesics|analgesics|mesh-ancestor
153502590|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
153502591|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502627|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153502628|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502654|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153502676|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153502710|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153502711|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502712|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153502714|NCT03211728|Analgesics|analgesics|mesh-ancestor
153502715|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
153502739|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153502741|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502742|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
153502743|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153502744|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
153502745|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502746|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
153502747|NCT03211650|Protective Agents|protective agents|mesh-ancestor
153502748|NCT03211104|Curcumin|curcumin|mesh-list
153502749|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153502750|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153502751|NCT03211104|Analgesics|analgesics|mesh-ancestor
153502752|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
153502753|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502754|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502755|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153502756|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781879|NCT00232076|Cyclosporine|cyclosporine|mesh-list
153502875|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
153502876|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502877|NCT01836900|Hemostatics|hemostatics|mesh-list
153502878|NCT01836900|Coagulants|coagulants|mesh-ancestor
153502879|NCT01837992|Primaquine|primaquine|mesh-list
153502880|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
153502881|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153502882|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153502883|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502884|NCT01838460|Lobeline|lobeline|mesh-list
153781891|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
153502885|NCT01838460|Nicotine|nicotine|mesh-list
153502886|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153502887|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
153502888|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502889|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502920|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
153502921|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502922|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502923|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
153502924|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502926|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153502927|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
153502928|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
153502929|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502930|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502931|NCT01839240|Cytarabine|cytarabine|mesh-list
153502932|NCT01839240|Azacitidine|azacitidine|mesh-list
153502933|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
153502934|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153502960|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
153502961|NCT01839630|Sorafenib|sorafenib|mesh-list
153502962|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502963|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502964|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502965|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502971|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502972|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502973|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153502974|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502975|NCT01834248|Poly I-C|poly i-c|mesh-list
153502976|NCT01834248|Decitabine|decitabine|mesh-list
153502977|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153502978|NCT01834248|Poly ICLC|poly iclc|mesh-list
153502979|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153503114|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503115|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
153503116|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503117|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153503118|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503119|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
153503120|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503121|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153503122|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503124|NCT01724268|Hormones|hormones|mesh-ancestor
153503125|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503126|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153503127|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
153503128|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503129|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153503159|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153503160|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
153503162|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153503163|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153503164|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503165|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153503166|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153503167|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153503168|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
153503217|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503247|NCT01728480|Cisplatin|cisplatin|mesh-list
153503248|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503249|NCT01728948|Sorafenib|sorafenib|mesh-list
153503250|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503251|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153503252|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503253|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503254|NCT01729104|Rituximab|rituximab|mesh-list
153503255|NCT01729104|Lenalidomide|lenalidomide|mesh-list
153503256|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153503257|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503258|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
153503259|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503260|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503261|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153503262|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153503292|NCT01724658|Testosterone|testosterone|mesh-list
153503352|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503353|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
153503354|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503355|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153503356|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153503357|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503358|NCT01046682|Analgesics|analgesics|mesh-ancestor
153503359|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
153503360|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503361|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503396|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503398|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153503399|NCT03405870|SMOFlipid|smoflipid|mesh-list
153503569|NCT02240238|Gemcitabine|gemcitabine|mesh-list
153503570|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153503571|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
153503572|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503601|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153503602|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503603|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153503604|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
153503605|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
153503606|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153503607|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
153503743|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153503745|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503746|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503747|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
153503748|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503749|NCT02246712|Tramadol|tramadol|mesh-list
153503750|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153503751|NCT02246712|Narcotics|narcotics|mesh-ancestor
153503752|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503753|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503754|NCT02246712|Analgesics|analgesics|mesh-ancestor
153503920|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
153503921|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503922|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153503923|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153503924|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503925|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503926|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153503927|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
153503928|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503929|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503930|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153503931|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153503932|NCT02245308|Bupropion|bupropion|mesh-list
153503933|NCT02245308|Nicotine|nicotine|mesh-list
153503969|NCT00559104|Carmustine|carmustine|mesh-list
153503970|NCT00559104|Etoposide|etoposide|mesh-list
153503997|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503998|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
153503999|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504000|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
153504001|NCT00558558|Hormones|hormones|mesh-ancestor
153504002|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153504003|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447043|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153504004|NCT00557622|Paroxetine|paroxetine|mesh-list
153504005|NCT00557622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153504006|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153504089|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153504090|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153504091|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504092|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504093|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504094|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504095|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153504096|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
153504121|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153504122|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
153504123|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153504124|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153504126|NCT00556374|Denosumab|denosumab|mesh-list
153504127|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153504128|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153504129|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504130|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153504131|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504226|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153504227|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504228|NCT05444556|Repaglinide|repaglinide|mesh-list
153504229|NCT05444556|Quinidine|quinidine|mesh-list
153504230|NCT05444556|Digoxin|digoxin|mesh-list
153504231|NCT05444556|Levomethorphan|levomethorphan|mesh-list
153504232|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
153504233|NCT05444556|Omeprazole|omeprazole|mesh-list
153504234|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153504269|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153504270|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
153504271|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153504272|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153504273|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504304|NCT05768542|Autonomic Agents|autonomic agents|mesh-ancestor
153504305|NCT05768542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504306|NCT05768542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504307|NCT05768542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153504308|NCT05768542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153504309|NCT05768542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153504310|NCT05768542|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504311|NCT05768542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504400|NCT05767723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153504401|NCT05767723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153504402|NCT05767723|Purinergic Agents|purinergic agents|mesh-ancestor
153504403|NCT05767723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504404|NCT05767723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626821|NCT02019186|Protective Agents|protective agents|mesh-ancestor
153504418|NCT05767632|Solifenacin Succinate|solifenacin succinate|mesh-list
153504420|NCT05767632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153504421|NCT05767632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153504422|NCT05767632|Cholinergic Agents|cholinergic agents|mesh-ancestor
153504423|NCT05767632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504424|NCT05767632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504425|NCT05767632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504426|NCT05767632|Urological Agents|urological agents|mesh-ancestor
153504427|NCT05767632|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153504428|NCT05767632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153504429|NCT05767632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153504430|NCT05767632|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504432|NCT05767255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153504433|NCT05767255|Insulin Glargine|insulin glargine|mesh-list
153504434|NCT05767255|Insulin Aspart|insulin aspart|mesh-list
153504435|NCT05767255|Liraglutide|liraglutide|mesh-list
153504436|NCT05767255|Xultophy|xultophy|mesh-list
153504437|NCT05767255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504438|NCT05767255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504458|NCT05767229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153504459|NCT05767060|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153504460|NCT05767060|Immunologic Factors|immunologic factors|mesh-ancestor
153504461|NCT05767060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504462|NCT05753267|Mesalamine|mesalamine|mesh-list
153504463|NCT05753267|Fenofibrate|fenofibrate|mesh-list
153504464|NCT05753267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153504465|NCT05753267|Antimetabolites|antimetabolites|mesh-ancestor
153504502|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
153504526|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504527|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504528|NCT05604599|Analgesics|analgesics|mesh-ancestor
153504529|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
153504530|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504531|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153504532|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153504533|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153504534|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504535|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504536|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504537|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153504538|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
153504623|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504625|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153504626|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504627|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504628|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504629|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153504630|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153504631|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153504632|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504633|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504634|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504635|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504636|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504637|NCT04854512|Metformin|metformin|mesh-list
153504638|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504639|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504674|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504675|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153504676|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
153504677|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
153504678|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153504679|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153504722|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153504723|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153504724|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153504725|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504726|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504727|NCT04501120|Azacitidine|azacitidine|mesh-list
153504728|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153504729|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
153504730|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504731|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504732|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504733|NCT04477317|Epinephrine|epinephrine|mesh-list
153504734|NCT04477317|Racepinephrine|racepinephrine|mesh-list
153504756|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504758|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
153504759|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504760|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504761|NCT04330638|Siltuximab|siltuximab|mesh-list
153504762|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153504763|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153504764|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504765|NCT04280601|Vitamin D|vitamin d|mesh-list
153504766|NCT04280601|Vitamins|vitamins|mesh-ancestor
153504817|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504818|NCT03786783|Vitamin A|vitamin a|mesh-list
153504819|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
153504820|NCT03786783|Melphalan|melphalan|mesh-list
153504821|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
153504823|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153504824|NCT03786783|Cisplatin|cisplatin|mesh-list
153504825|NCT03786783|Carboplatin|carboplatin|mesh-list
153504826|NCT03786783|Doxorubicin|doxorubicin|mesh-list
153504827|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153504828|NCT03786783|Etoposide|etoposide|mesh-list
153504829|NCT03786783|Vincristine|vincristine|mesh-list
153504830|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
153504831|NCT03786783|Daunorubicin|daunorubicin|mesh-list
153504832|NCT03786783|Topotecan|topotecan|mesh-list
153504833|NCT03786783|Tretinoin|tretinoin|mesh-list
153504834|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
153504835|NCT03786783|Dinutuximab|dinutuximab|mesh-list
153504836|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
153504837|NCT03786783|Razoxane|razoxane|mesh-list
153504838|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
153504839|NCT03786783|Isotretinoin|isotretinoin|mesh-list
153504840|NCT03786783|Sargramostim|sargramostim|mesh-list
153504841|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153504842|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
153504843|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504844|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153504845|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153504846|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
153504847|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504880|NCT03654833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153504881|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504882|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153504883|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504885|NCT03426904|Fluorouracil|fluorouracil|mesh-list
153626822|NCT02019290|Midazolam|midazolam|mesh-list
153504922|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
153504923|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504924|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153504925|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153504927|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
153504928|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504929|NCT03030131|Durvalumab|durvalumab|mesh-list
153504930|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504931|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504932|NCT03011021|Liraglutide|liraglutide|mesh-list
153504933|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504934|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504935|NCT03011021|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153504936|NCT03011021|Incretins|incretins|mesh-ancestor
153504937|NCT03011021|Hormones|hormones|mesh-ancestor
153504938|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153504939|NCT02995252|Tenofovir|tenofovir|mesh-list
153504940|NCT02995252|Liver Extracts|liver extracts|mesh-list
153504967|NCT02817360|Fosinopril|fosinopril|mesh-list
153504968|NCT02817360|Eprosartan|eprosartan|mesh-list
153504969|NCT02817360|Zofenopril|zofenopril|mesh-list
153504970|NCT02817360|Spirapril|spirapril|mesh-list
153504971|NCT02817360|Cilazapril|cilazapril|mesh-list
153504972|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153504973|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153505010|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153505011|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505012|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153505013|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153505014|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153505015|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505016|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505017|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153505018|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153505019|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505020|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
153505021|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505022|NCT02659384|Aspirin|aspirin|mesh-list
153505095|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153731678|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153505096|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505097|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153505098|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153505099|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153505100|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505101|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505102|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
153505103|NCT01992653|Hormones|hormones|mesh-ancestor
153505104|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505105|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153505106|NCT01992653|Immunoconjugates|immunoconjugates|mesh-ancestor
153505107|NCT01850303|Gemcitabine|gemcitabine|mesh-list
153505108|NCT01850303|Pemetrexed|pemetrexed|mesh-list
153505109|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153505110|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
153505111|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505112|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505113|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505114|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153505133|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
153505135|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
153505136|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505137|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153505138|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153505139|NCT01681264|Guanfacine|guanfacine|mesh-list
153505140|NCT01681264|Morphine|morphine|mesh-list
153505158|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153505159|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
153505160|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505161|NCT00590122|Levodopa|levodopa|mesh-list
153505162|NCT00590122|Carbidopa|carbidopa|mesh-list
153505163|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153505164|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153505165|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153505166|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
153505167|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505168|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505169|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505170|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153505171|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505195|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505196|NCT01689246|Methylene Blue|methylene blue|mesh-list
153505197|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509940|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
153505198|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505199|NCT01685268|Prednisone|prednisone|mesh-list
153505200|NCT01685268|Prednisolone|prednisolone|mesh-list
153781895|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
153505201|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
153505202|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505250|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505251|NCT01384448|Protective Agents|protective agents|mesh-ancestor
153505253|NCT01384578|Vitamin E|vitamin e|mesh-list
153505254|NCT01384578|Tocopherols|tocopherols|mesh-list
153505255|NCT01384578|Tocotrienols|tocotrienols|mesh-list
153505256|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
153505257|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
153505258|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
153505259|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505260|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
153505261|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505262|NCT01384578|Protective Agents|protective agents|mesh-ancestor
153505263|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153505264|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505265|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153505266|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153505267|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
153505268|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153505269|NCT01384643|Propofol|propofol|mesh-list
153505270|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153505271|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153505383|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153505384|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505385|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505386|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153505387|NCT01385735|Protective Agents|protective agents|mesh-ancestor
153505388|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505390|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153505391|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
153505392|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505393|NCT01385891|Etoposide|etoposide|mesh-list
153505394|NCT01385891|Clofarabine|clofarabine|mesh-list
153505395|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153505396|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505397|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153505398|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153505399|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505400|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505401|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153505402|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
153505403|NCT01385956|Gemcitabine|gemcitabine|mesh-list
153505404|NCT01385956|Pasireotide|pasireotide|mesh-list
153505405|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153505456|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505457|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505458|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153505459|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153505460|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
153505461|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
153505462|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153505463|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153505464|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153505465|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505466|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505467|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153505468|NCT01386242|Interferons|interferons|mesh-list
153505503|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505504|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505505|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505506|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153505507|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153505508|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153505509|NCT01386372|Tolvaptan|tolvaptan|mesh-list
153505521|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505522|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505523|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
153505551|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153505552|NCT01386580|Doxorubicin|doxorubicin|mesh-list
153505553|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153505554|NCT01386580|Trastuzumab|trastuzumab|mesh-list
153505555|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153505556|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505557|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153505558|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153505559|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505560|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505561|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505562|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
153505563|NCT01386593|Rifampin|rifampin|mesh-list
153505564|NCT01386593|Fluconazole|fluconazole|mesh-list
153505565|NCT01386593|Paroxetine|paroxetine|mesh-list
153510017|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
153505566|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153505567|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505568|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153505569|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153505570|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505571|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505723|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153505724|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
153505725|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505726|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
153505727|NCT01387620|Protective Agents|protective agents|mesh-ancestor
153505729|NCT01387880|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153505730|NCT01387880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153505731|NCT01387880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505732|NCT01387880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505733|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153505734|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
153505735|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505736|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505737|NCT01387906|Bimatoprost|bimatoprost|mesh-list
153505738|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153505767|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153505768|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505769|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505770|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153505771|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153505772|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153505773|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153505774|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153505775|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153505777|NCT01388088|Spironolactone|spironolactone|mesh-list
153505778|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153505779|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
153505780|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505783|NCT01388088|Diuretics|diuretics|mesh-ancestor
153510084|NCT01398501|Sorafenib|sorafenib|mesh-list
153505811|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153505812|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505813|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153505814|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505815|NCT01388439|Oseltamivir|oseltamivir|mesh-list
153505816|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
153505817|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505818|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505819|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505820|NCT01388517|Vitamin D|vitamin d|mesh-list
153505821|NCT01388517|Calcitriol|calcitriol|mesh-list
153505822|NCT01388517|Petrolatum|petrolatum|mesh-list
153505823|NCT01388517|Tacrolimus|tacrolimus|mesh-list
153505824|NCT01388517|Vitamins|vitamins|mesh-ancestor
153505825|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
153505826|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505827|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153505828|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153505829|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
153505830|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153505831|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505832|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505833|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153505834|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153505835|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153505836|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153505837|NCT01388517|Emollients|emollients|mesh-ancestor
153505838|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
153505839|NCT01388582|Copper|copper|mesh-list
153505879|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153505880|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
153505881|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505882|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153505883|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153505884|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153505885|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505886|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505887|NCT01388660|Clopidogrel|clopidogrel|mesh-list
153505952|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153505953|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505954|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505955|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153505987|NCT01389414|Panitumumab|panitumumab|mesh-list
153505988|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153505989|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
153505990|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505991|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505992|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505993|NCT01389427|Sirolimus|sirolimus|mesh-list
153505994|NCT01389427|Prednisone|prednisone|mesh-list
153505995|NCT01389427|Temsirolimus|temsirolimus|mesh-list
153505996|NCT01389427|MTOR Inhibitors|mtor inhibitors|mesh-list
153505997|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
153505998|NCT01389427|Vincristine|vincristine|mesh-list
153505999|NCT01389427|Rituximab|rituximab|mesh-list
153506000|NCT01389427|Doxorubicin|doxorubicin|mesh-list
153506019|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506020|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153506021|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153506022|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
153506023|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
153506024|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
153506025|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153506026|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153506027|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153506028|NCT01389440|Gemcitabine|gemcitabine|mesh-list
153506029|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153506030|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153506031|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
153506032|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506033|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506041|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153506042|NCT01389505|Growth Substances|growth substances|mesh-ancestor
153506043|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506044|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
153506045|NCT01389544|Ritonavir|ritonavir|mesh-list
153506046|NCT01389544|Methadone|methadone|mesh-list
153506047|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153506048|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153506049|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506050|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506051|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506052|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153506072|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153506073|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506075|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153506076|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153506077|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153506078|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153506079|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
153506080|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506081|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506082|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506083|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153506084|NCT01389713|Clomiphene|clomiphene|mesh-list
153506085|NCT01389713|Enclomiphene|enclomiphene|mesh-list
153506086|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
153506087|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153506088|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
153506089|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506090|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506102|NCT01389778|Metformin|metformin|mesh-list
153506104|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506106|NCT01389791|Rocuronium|rocuronium|mesh-list
153506107|NCT01389791|Analgesics|analgesics|mesh-ancestor
153506108|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
153506128|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506130|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153506131|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153506132|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506133|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153506134|NCT01389908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153506135|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153506136|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153506137|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506138|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506139|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
153506140|NCT01390012|Dexamethasone|dexamethasone|mesh-list
153506141|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
153506142|NCT01390012|BB 1101|bb 1101|mesh-list
153506143|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153506144|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
153506145|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
153506146|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506147|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506148|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510204|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
153506149|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
153506150|NCT01390012|Hormones|hormones|mesh-ancestor
153506151|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506152|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153506153|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506154|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506155|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506200|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506201|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153506230|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153506231|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
153506232|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506233|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506234|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153506235|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506236|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
153506237|NCT01390623|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153506238|NCT01390623|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153506239|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153506240|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506241|NCT01390662|Vitamin D|vitamin d|mesh-list
153506242|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
153506243|NCT01390662|Vitamins|vitamins|mesh-ancestor
153506244|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
153506245|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506246|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153506247|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153506249|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
153506250|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506272|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506298|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153506300|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506301|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506302|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153506303|NCT01390935|Diuretics|diuretics|mesh-ancestor
153506304|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
153506305|NCT01390961|Pheniramine|pheniramine|mesh-list
153506330|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153506331|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153506333|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
153506334|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153506335|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153506336|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506337|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506338|NCT01391104|Urological Agents|urological agents|mesh-ancestor
153506340|NCT01391156|Finasteride|finasteride|mesh-list
153506341|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153506342|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
153506343|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153506344|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153506345|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506346|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506347|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
153506348|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506349|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506350|NCT01391156|Urological Agents|urological agents|mesh-ancestor
153506351|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153506352|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153506353|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153506382|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506384|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506386|NCT01391403|Artemisinins|artemisinins|mesh-list
153506387|NCT01391403|Artemisinin|artemisinin|mesh-list
153506388|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
153506389|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153506390|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153506391|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506392|NCT01391520|Deferiprone|deferiprone|mesh-list
153506393|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153506394|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
153449475|NCT00003269|Protective Agents|protective agents|mesh-ancestor
153506395|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
153506396|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506397|NCT01391572|Fluorouracil|fluorouracil|mesh-list
153506398|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506429|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506430|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506431|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
153506432|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153506433|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
153506437|NCT01392014|Primaquine|primaquine|mesh-list
153506521|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
153506522|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506523|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153506524|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153506525|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506526|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153506527|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153506528|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
153506529|NCT01392612|Hematinics|hematinics|mesh-ancestor
153506530|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
153510335|NCT01400646|Coagulants|coagulants|mesh-ancestor
153506531|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
153506532|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153506533|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153506534|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506552|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153506553|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153506554|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
153506555|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506556|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153506557|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153506558|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153506559|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506560|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153506563|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
153506589|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
153506590|NCT01392833|Azathioprine|azathioprine|mesh-list
153506591|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153506592|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
153506593|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153506594|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
153506595|NCT01392833|Hormones|hormones|mesh-ancestor
153506615|NCT01392898|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153506616|NCT01392898|Incretins|incretins|mesh-ancestor
153449703|NCT00003335|Protective Agents|protective agents|mesh-ancestor
153506617|NCT01392898|Hormones|hormones|mesh-ancestor
153506618|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506619|NCT01392911|Rifampin|rifampin|mesh-list
153506620|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153506621|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
153506622|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153506623|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506624|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
153506626|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506708|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506710|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153506711|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
153506712|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506713|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153506714|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153506715|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153506716|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
153506717|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506718|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506719|NCT01393548|Protective Agents|protective agents|mesh-ancestor
153506720|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153506721|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153506722|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153506723|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153506724|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
153506725|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
153506726|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153506815|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506816|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506817|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506818|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
153506819|NCT01394354|Hormones|hormones|mesh-ancestor
153506820|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506821|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153506822|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506823|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153506824|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153506825|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153506826|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506827|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506828|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153506829|NCT01394406|Ketamine|ketamine|mesh-list
153506830|NCT01394406|Analgesics|analgesics|mesh-ancestor
153506831|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
153506832|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506833|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506890|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
153506891|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506908|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506910|NCT01394731|Meperidine|meperidine|mesh-list
153506911|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153506912|NCT01394731|Analgesics|analgesics|mesh-ancestor
153506913|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
153506914|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506915|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506916|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
153506917|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153506918|NCT01394731|Narcotics|narcotics|mesh-ancestor
153506919|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506920|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153506921|NCT01394757|Ketamine|ketamine|mesh-list
153506922|NCT01394757|Esketamine|esketamine|mesh-list
153506923|NCT01394757|Analgesics|analgesics|mesh-ancestor
153506924|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
153506925|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506926|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506927|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153506980|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506981|NCT01394887|Metformin|metformin|mesh-list
153506982|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153506983|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506984|NCT01394913|Etanercept|etanercept|mesh-list
153506985|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153506986|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153506987|NCT01394913|Analgesics|analgesics|mesh-ancestor
153506988|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
153506989|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506990|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506991|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153506992|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153506993|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506994|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506995|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
153506996|NCT01395069|Ketorolac|ketorolac|mesh-list
153506997|NCT01395069|Nepafenac|nepafenac|mesh-list
153506998|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153506999|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153507000|NCT01395069|Analgesics|analgesics|mesh-ancestor
153507025|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153507026|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153507027|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507029|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
153507030|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153507031|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153507032|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153507033|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153507034|NCT01395199|Amlodipine|amlodipine|mesh-list
153507035|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153507036|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153510361|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153510363|NCT01400737|Analgesics|analgesics|mesh-ancestor
153507037|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153507038|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646713|NCT00116701|Hematinics|hematinics|mesh-ancestor
153507039|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153507040|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507041|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
153507042|NCT01395251|Prednisolone|prednisolone|mesh-list
153507043|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
153507044|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507045|NCT01395251|Hormones|hormones|mesh-ancestor
153507046|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507072|NCT01395420|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153507073|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507074|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507075|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153507076|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507077|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507079|NCT01395433|Citalopram|citalopram|mesh-list
153507080|NCT01395433|Escitalopram|escitalopram|mesh-list
153507081|NCT01395433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153507135|NCT01395667|Leucovorin|leucovorin|mesh-list
153507144|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
153507145|NCT01395667|Antidotes|antidotes|mesh-ancestor
153507146|NCT01395667|Protective Agents|protective agents|mesh-ancestor
153507147|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
153507184|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153507208|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
153507210|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153507211|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153507212|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153507213|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153507214|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
153507215|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507216|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507217|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
153507218|NCT01395927|Canagliflozin|canagliflozin|mesh-list
153507219|NCT01395927|Rifampin|rifampin|mesh-list
153507220|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153507221|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
153507222|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507223|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507224|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
153507225|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153507226|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507227|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507228|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153507229|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153507230|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153507306|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153507307|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
153507308|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507309|NCT01396707|Capecitabine|capecitabine|mesh-list
153507310|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
153507311|NCT01396707|Trastuzumab|trastuzumab|mesh-list
153510384|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
153507312|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153507313|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
153507314|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507315|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507316|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507317|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
153507318|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153507319|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153507320|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507347|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507349|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153507448|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
153507449|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507450|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153507476|NCT05092698|Vitamins|vitamins|mesh-ancestor
153507477|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
153507478|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507479|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153507480|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153507481|NCT04965870|Trifluridine|trifluridine|mesh-list
153507482|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
153507483|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507484|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
153507485|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507486|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
153507487|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
153507488|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153507489|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153507490|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507491|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507492|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507493|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507494|NCT06105112|Hyaluronic Acid|hyaluronic acid|mesh-list
153507495|NCT06105112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153507496|NCT06105112|Immunologic Factors|immunologic factors|mesh-ancestor
153507497|NCT06105112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507533|NCT06104059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507534|NCT06104059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153507535|NCT06104059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153507536|NCT06104059|Anesthetics, General|anesthetics, general|mesh-ancestor
153507537|NCT06104059|Anesthetics|anesthetics|mesh-ancestor
153507538|NCT06103747|Metformin|metformin|mesh-list
153507539|NCT06103747|Vildagliptin|vildagliptin|mesh-list
153507540|NCT06103747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153507541|NCT06103747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507542|NCT06103747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153507543|NCT06103747|Protease Inhibitors|protease inhibitors|mesh-ancestor
153507544|NCT06103747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507545|NCT06103747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507546|NCT06103188|Diazepam|diazepam|mesh-list
153507547|NCT06103188|Melatonin|melatonin|mesh-list
153507548|NCT06103188|Antioxidants|antioxidants|mesh-ancestor
153507549|NCT06103188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507550|NCT06103188|Protective Agents|protective agents|mesh-ancestor
153507551|NCT06103188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507552|NCT06103188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507553|NCT06103188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153507554|NCT06103188|Anticonvulsants|anticonvulsants|mesh-ancestor
153507555|NCT06103188|Antiemetics|antiemetics|mesh-ancestor
153507556|NCT06103188|Autonomic Agents|autonomic agents|mesh-ancestor
153507557|NCT06103188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507558|NCT06103188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153507559|NCT06103188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153507560|NCT06103188|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153507561|NCT06103188|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153507562|NCT06103188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153507563|NCT06103188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153507600|NCT06044142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507601|NCT06044142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507602|NCT06044142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507603|NCT06044142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507604|NCT06044142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507605|NCT06044142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507606|NCT06037876|Ivermectin|ivermectin|mesh-list
153507607|NCT06037876|Albendazole|albendazole|mesh-list
153507608|NCT06037876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153507609|NCT06037876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507610|NCT06037876|Anthelmintics|anthelmintics|mesh-ancestor
153507611|NCT06037876|Anticestodal Agents|anticestodal agents|mesh-ancestor
153507612|NCT06037876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153507613|NCT06037876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153507614|NCT06037876|Tubulin Modulators|tubulin modulators|mesh-ancestor
153507615|NCT06037876|Antimitotic Agents|antimitotic agents|mesh-ancestor
153507616|NCT06037876|Mitosis Modulators|mitosis modulators|mesh-ancestor
153507617|NCT06037876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507618|NCT06037876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507619|NCT06037590|Levodopa|levodopa|mesh-list
153507620|NCT06037590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153507621|NCT06037590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153507655|NCT05878288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507656|NCT05876273|Pancrelipase|pancrelipase|mesh-list
153507657|NCT05876273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153507658|NCT05775809|Serotonin|serotonin|mesh-list
153507659|NCT05775809|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153507660|NCT05775809|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153507661|NCT05775809|Serotonin Agents|serotonin agents|mesh-ancestor
153507697|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153507730|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
153507731|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507732|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507733|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153507735|NCT05509634|Hormones|hormones|mesh-ancestor
153507739|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
153507740|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507741|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507742|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153507771|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507772|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153507773|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153507774|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507776|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
153507779|NCT05286528|Dasatinib|dasatinib|mesh-list
153510443|NCT01401179|Cefazolin|cefazolin|mesh-list
153507910|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507911|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153507912|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507913|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
153507914|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
153507915|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153507916|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153507917|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
153507918|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
153507919|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
153507920|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508105|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
153508129|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
153508130|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508131|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153508132|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153508133|NCT03456063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508134|NCT03456063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508135|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153508136|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153508137|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508138|NCT03417284|Melphalan|melphalan|mesh-list
153508139|NCT03417284|Lenograstim|lenograstim|mesh-list
153508140|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153508141|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
153508142|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508143|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153508144|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
153508145|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508146|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508147|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153508148|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508149|NCT03281369|Leucovorin|leucovorin|mesh-list
153508150|NCT03281369|Linagliptin|linagliptin|mesh-list
153508151|NCT03281369|Paclitaxel|paclitaxel|mesh-list
153508152|NCT03281369|Fluorouracil|fluorouracil|mesh-list
153508153|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
153508194|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508195|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508196|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508197|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153508198|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153508199|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153508200|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508201|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153508202|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
153508203|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
153508204|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
153508205|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
153508206|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
153508207|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
153508266|NCT01545141|Poly I-C|poly i-c|mesh-list
153508267|NCT01545141|Celecoxib|celecoxib|mesh-list
153508268|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508269|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
153508270|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508271|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
153508272|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508273|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153508274|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153508275|NCT01545141|Analgesics|analgesics|mesh-ancestor
153508276|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
153508277|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508310|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508311|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508312|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
153508313|NCT00777998|Thalidomide|thalidomide|mesh-list
153508314|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508315|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
153508401|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153508402|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153508403|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
153508404|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508405|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153508406|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153508407|NCT02564523|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153508408|NCT02564523|Antiviral Agents|antiviral agents|mesh-ancestor
153508409|NCT02564523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508410|NCT02499666|Clopidogrel|clopidogrel|mesh-list
153508411|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153508412|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153508413|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153508414|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153508415|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
153508416|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508506|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508507|NCT05273398|Diazepam|diazepam|mesh-list
153508508|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153508509|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
153508510|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
153508511|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
153508512|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508513|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508533|NCT05271539|Dexamethasone|dexamethasone|mesh-list
153508616|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508617|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153508618|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153508619|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153508620|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508621|NCT05270889|Tislelizumab|tislelizumab|mesh-list
153508622|NCT05270889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508623|NCT05270889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508624|NCT05270824|Immunomodulating Agents|immunomodulating agents|mesh-list
153451731|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508625|NCT05270824|Immunologic Factors|immunologic factors|mesh-ancestor
153508650|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153508651|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508718|NCT05173142|Gemcitabine|gemcitabine|mesh-list
153508719|NCT05173142|Docetaxel|docetaxel|mesh-list
153508720|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508721|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153508722|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
153508723|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508724|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
153508725|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
153508726|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
153508727|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
153508728|NCT05165875|Lidocaine|lidocaine|mesh-list
153508729|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
153508730|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
153508762|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153508763|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508764|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
153508765|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508766|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508802|NCT05067439|Caffeine|caffeine|mesh-list
153508856|NCT05051150|Epinephrine|epinephrine|mesh-list
153508857|NCT05051150|Racepinephrine|racepinephrine|mesh-list
153508858|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
153508859|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153508860|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153508861|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
153508862|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508863|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509037|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
153509038|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153509039|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153509040|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153509042|NCT04238845|Vitamins|vitamins|mesh-ancestor
153509043|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
153509044|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509045|NCT04223037|Vaccines|vaccines|mesh-list
153509046|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
153731682|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509069|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509175|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509176|NCT03386162|Fulvestrant|fulvestrant|mesh-list
153509177|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153509178|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509179|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153509180|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153509181|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
153509182|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509183|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509184|NCT03360214|Bupivacaine|bupivacaine|mesh-list
153509185|NCT03360214|Ropivacaine|ropivacaine|mesh-list
153509186|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
153509187|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
153509188|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509189|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509190|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
153509304|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153509305|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153509306|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153509307|NCT03061903|Laxatives|laxatives|mesh-ancestor
153509308|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153509309|NCT03061643|Docetaxel|docetaxel|mesh-list
153509310|NCT03061643|Androgens|androgens|mesh-list
153509311|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510517|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509312|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
153509313|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
153509314|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
153509315|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509316|NCT03061643|Hormones|hormones|mesh-ancestor
153509317|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509318|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509319|NCT03061630|Gemcitabine|gemcitabine|mesh-list
153509320|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509321|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153509322|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
153509323|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509324|NCT03055390|Scopolamine|scopolamine|mesh-list
153509325|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153509326|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153509327|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
153509328|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
153509329|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509330|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509331|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153509332|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
153509333|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153509334|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
153509368|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
153452475|NCT01803282|Irinotecan|irinotecan|mesh-list
153509375|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509376|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153509377|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153509378|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509379|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153509380|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153509381|NCT03011775|Analgesics|analgesics|mesh-ancestor
153509382|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
153509383|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509384|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153509385|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153509386|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153509414|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
153509415|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
153509416|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509417|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509418|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
153510533|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
153509419|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509420|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153509421|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153509422|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153509423|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509424|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509425|NCT02924064|Metformin|metformin|mesh-list
153509426|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153509428|NCT02889900|Olaparib|olaparib|mesh-list
153509538|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509539|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
153509540|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
153509541|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
153509542|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509543|NCT02539225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153509544|NCT02539225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153509545|NCT02539225|Growth Substances|growth substances|mesh-ancestor
153509546|NCT02539225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509547|NCT02539225|Growth Inhibitors|growth inhibitors|mesh-ancestor
153509549|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509550|NCT02526017|Nivolumab|nivolumab|mesh-list
153509551|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153509552|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509553|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153509554|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509555|NCT02516657|Liraglutide|liraglutide|mesh-list
153509556|NCT02516657|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153509557|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153509558|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509559|NCT02516657|Incretins|incretins|mesh-ancestor
153509560|NCT02516657|Hormones|hormones|mesh-ancestor
153509561|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509562|NCT02427581|Poly I-C|poly i-c|mesh-list
153509563|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153509564|NCT02427581|Poly ICLC|poly iclc|mesh-list
153509565|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
153509566|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
153509567|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509568|NCT02427581|Laxatives|laxatives|mesh-ancestor
153509569|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153509570|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
153509631|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
153509632|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153509633|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153510580|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509634|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
153509635|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509636|NCT02293109|Antidotes|antidotes|mesh-ancestor
153509637|NCT02293109|Protective Agents|protective agents|mesh-ancestor
153509638|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
153509639|NCT02293109|Vitamins|vitamins|mesh-ancestor
153509640|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
153509641|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153509642|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
153509643|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
153509644|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
153509645|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153509646|NCT02195986|Estradiol|estradiol|mesh-list
153509647|NCT02195986|Estrogens|estrogens|mesh-ancestor
153509648|NCT02195986|Hormones|hormones|mesh-ancestor
153509649|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509650|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509651|NCT01982630|Liraglutide|liraglutide|mesh-list
153509652|NCT01982630|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153509653|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153509654|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509655|NCT01982630|Incretins|incretins|mesh-ancestor
153509656|NCT01982630|Hormones|hormones|mesh-ancestor
153509657|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509658|NCT01951469|Pemetrexed|pemetrexed|mesh-list
153509659|NCT01951469|Gefitinib|gefitinib|mesh-list
153509660|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509661|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509662|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509697|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153509698|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153509699|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153509700|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509701|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
153509702|NCT01622998|Nicotine|nicotine|mesh-list
153509703|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153509704|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
153509705|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509706|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509708|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153509709|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
153509710|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509711|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509712|NCT01595620|Dronabinol|dronabinol|mesh-list
153509713|NCT01595620|Capsaicin|capsaicin|mesh-list
153509714|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
153509715|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509716|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153509717|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153509718|NCT01595620|Analgesics|analgesics|mesh-ancestor
153509719|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
153509720|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509721|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153509803|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
153509804|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509805|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509806|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153509807|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
153509808|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153509809|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153509810|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153509811|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509812|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
153509813|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153509814|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153509846|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509847|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153509849|NCT00600015|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153509850|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509851|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509852|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510042|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
153510043|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510044|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510045|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153510046|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153510047|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
153510048|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510049|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153510050|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153510051|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510052|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153510053|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153510054|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510055|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153510056|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
153510057|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153510058|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510059|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153510060|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153510180|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510181|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510182|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153510183|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153510184|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
153510185|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510186|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510187|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153510188|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153510189|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
153510191|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153510192|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510193|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
153510226|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510228|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
153510229|NCT01400009|Vitamins|vitamins|mesh-ancestor
153510230|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
153510231|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510232|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153626824|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153510264|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153510314|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153510315|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
153510316|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510317|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510318|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510319|NCT01400646|Vitamins|vitamins|mesh-list
153510320|NCT01400646|Vitamin K|vitamin k|mesh-list
153510321|NCT01400646|Warfarin|warfarin|mesh-list
153510322|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
153510323|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
153510324|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510325|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
153510326|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153510327|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
153510328|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153510329|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
153510330|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510364|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
153510365|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510366|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510367|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510368|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153510369|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153510370|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510489|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153510490|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510491|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153510492|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153510493|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153618877|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510494|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153510495|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510496|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
153510497|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510498|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510499|NCT01401933|Rifampin|rifampin|mesh-list
153510500|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153510534|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
153510535|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
153510536|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
153510566|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153510567|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153510568|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153510570|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
153510643|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510644|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510646|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
153510647|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510648|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510649|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153510650|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153510651|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
153510652|NCT01402674|Phentermine|phentermine|mesh-list
153510653|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153510654|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510655|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
153510656|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153510657|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
153510658|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
153510659|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510660|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
153510661|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510662|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510663|NCT01402843|Valsartan|valsartan|mesh-list
153510664|NCT01402843|Pitavastatin|pitavastatin|mesh-list
153510665|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153510666|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153510667|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153510670|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153453824|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510716|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
153510717|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510718|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510719|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153510720|NCT01403285|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153510721|NCT01403285|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153510722|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153510723|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
153510725|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153510726|NCT01403363|Narcotics|narcotics|mesh-ancestor
153510727|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510728|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510729|NCT01403363|Analgesics|analgesics|mesh-ancestor
153510730|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
153510731|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510732|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153510766|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153510767|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
153510768|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510769|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
153510770|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510771|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153510772|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510773|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
153510774|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153510775|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153510776|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153510777|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
153510804|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153510816|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510817|NCT01403740|Cyclosporine|cyclosporine|mesh-list
153510818|NCT01403740|Rituximab|rituximab|mesh-list
153510819|NCT01403740|Azathioprine|azathioprine|mesh-list
153510820|NCT01403740|Cyclosporins|cyclosporins|mesh-list
153510821|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153510822|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510823|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
153510824|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510825|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153510826|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510845|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510847|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510848|NCT01403896|Plerixafor|plerixafor|mesh-list
153510849|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153510850|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153510851|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
153510852|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510853|NCT01403948|BI 836826|bi 836826|mesh-list
153510854|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153510855|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510856|NCT01404000|Charcoal|charcoal|mesh-list
153510857|NCT01404000|Antidotes|antidotes|mesh-ancestor
153510858|NCT01404000|Protective Agents|protective agents|mesh-ancestor
153510859|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510860|NCT01404013|Montelukast|montelukast|mesh-list
153510861|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153510880|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510951|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
153510952|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510953|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153510954|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153510955|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
153510956|NCT01404338|Halobetasol|halobetasol|mesh-list
153510957|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153510958|NCT01404364|Triamcinolone|triamcinolone|mesh-list
153510959|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
153510960|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510961|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
153510962|NCT01404364|Hormones|hormones|mesh-ancestor
153510963|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510964|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510987|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
153510988|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510989|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510990|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153510991|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153510992|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
153510993|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
153510994|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510995|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153510996|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153510997|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510998|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510999|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153511000|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153511001|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153511002|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153511003|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153511004|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
153511005|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
153511006|NCT01404468|Lidocaine|lidocaine|mesh-list
153511008|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
153511010|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511011|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
153511012|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511013|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153511014|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153511015|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153511016|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153511017|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511048|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511049|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511050|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153511051|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
153511052|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153511053|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
153510892|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
153511054|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511055|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511056|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
153511057|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153511058|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511059|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511060|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511138|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153511140|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
153511141|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
153511142|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153511143|NCT01405079|Vinorelbine|vinorelbine|mesh-list
153511144|NCT01405079|Gefitinib|gefitinib|mesh-list
153511145|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511146|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153511147|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
153511148|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
153511149|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
153511150|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511151|NCT01405079|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153511181|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511182|NCT01405144|Fluorouracil|fluorouracil|mesh-list
153511183|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
153511184|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511185|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153511186|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511187|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153511188|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
153511189|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511190|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
153511191|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153511193|NCT01405157|Prednisolone|prednisolone|mesh-list
153511238|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
153454350|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
153511239|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153511240|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153511241|NCT01405248|Protective Agents|protective agents|mesh-ancestor
153511242|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511243|NCT01405326|Adalimumab|adalimumab|mesh-list
153511244|NCT01405326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153511245|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511246|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511247|NCT01405339|Budesonide|budesonide|mesh-list
153511248|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511279|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153511280|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511282|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511283|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511284|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153511285|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511286|NCT01405573|Sorafenib|sorafenib|mesh-list
153511287|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511288|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153511289|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511408|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
153511409|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153511410|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511411|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153511412|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153511413|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511414|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511415|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511416|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511417|NCT01406262|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153511452|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153511453|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511493|NCT01406639|Ranibizumab|ranibizumab|mesh-list
153511547|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
153511548|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511549|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511550|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153511551|NCT01407471|Diuretics|diuretics|mesh-ancestor
153511552|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
153511553|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511554|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
153511555|NCT01407471|Hormones|hormones|mesh-ancestor
153511556|NCT01407484|Prednisone|prednisone|mesh-list
153511557|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511558|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
153511559|NCT01407484|Hormones|hormones|mesh-ancestor
153511560|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511565|NCT01407679|Alitretinoin|alitretinoin|mesh-list
153511693|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
153511694|NCT01408498|Testosterone|testosterone|mesh-list
153511695|NCT01408498|Androgens|androgens|mesh-ancestor
153511696|NCT01408498|Hormones|hormones|mesh-ancestor
153511697|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510979|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
153511698|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511699|NCT01408524|Diltiazem|diltiazem|mesh-list
153511700|NCT01408524|Labetalol|labetalol|mesh-list
153511701|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153511702|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153511703|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153511704|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511705|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153511731|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511732|NCT01408810|Infliximab|infliximab|mesh-list
153511733|NCT01408810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153511734|NCT01408810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511735|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
153511736|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511737|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511738|NCT01408836|Prednisolone|prednisolone|mesh-list
153511792|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511793|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
153511794|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511795|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153511796|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
153511797|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153511798|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153511799|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511800|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153511801|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
153511802|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153511923|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
153511924|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
153511926|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
153511927|NCT01409616|Salicylates|salicylates|mesh-list
153511928|NCT01409616|Darexaban|darexaban|mesh-list
153511929|NCT01409616|Clopidogrel|clopidogrel|mesh-list
153511930|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153511931|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511932|NCT01409616|Analgesics|analgesics|mesh-ancestor
153511933|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
153511934|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511935|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511936|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512039|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
153512040|NCT01410708|Dasatinib|dasatinib|mesh-list
153512041|NCT01410708|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153512042|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512043|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512044|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512045|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512046|NCT01410747|Tacrolimus|tacrolimus|mesh-list
153512047|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512048|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
153512081|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153512082|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
153512083|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512084|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153512085|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153512086|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512087|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
153512088|NCT01411124|Promethazine|promethazine|mesh-list
153512089|NCT01411124|Gabapentin|gabapentin|mesh-list
153512090|NCT01411124|Analgesics|analgesics|mesh-ancestor
153512091|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
153512114|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153512115|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
153512116|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
153512118|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
153512119|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
153512120|NCT01411189|Menthol|menthol|mesh-list
153512121|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
153512122|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
153512123|NCT01411202|Doxycycline|doxycycline|mesh-list
153512124|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153512125|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512126|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
153512129|NCT01411254|Betamethasone|betamethasone|mesh-list
153512138|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512139|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153512141|NCT01411280|Methylphenidate|methylphenidate|mesh-list
153512142|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153512143|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512144|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153512145|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153512172|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512173|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153512174|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512175|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153512177|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
153511154|NCT01405118|Metformin|metformin|mesh-list
153512178|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153512179|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153512180|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512181|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512182|NCT01411735|Enalapril|enalapril|mesh-list
153512267|NCT01412385|Antibodies|antibodies|mesh-list
153512268|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
153512269|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153512270|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
153512271|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
153512272|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512273|NCT01412411|Micronutrients|micronutrients|mesh-list
153512274|NCT01412411|Trace Elements|trace elements|mesh-list
153512275|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512276|NCT01412437|Verapamil|verapamil|mesh-list
153731689|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153731690|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153512277|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153512278|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153512279|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512280|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512381|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153512382|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512383|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153512384|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
153512385|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153626827|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153512413|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153512415|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
153512416|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153512417|NCT01413490|Rimantadine|rimantadine|mesh-list
153512418|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
153512484|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153512485|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153512486|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153512487|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
153512488|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512489|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
153512490|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
153512517|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153512518|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512519|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
153512520|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
153512521|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
153512522|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512523|NCT01414816|Interferons|interferons|mesh-list
153512524|NCT01414816|Interferon-beta|interferon-beta|mesh-list
153512525|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
153512526|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512527|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
153512528|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512529|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
153512530|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512531|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153512532|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
153512533|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153512534|NCT01414868|Montelukast|montelukast|mesh-list
153512535|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
153512536|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153512537|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
153512538|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
153512539|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512540|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512558|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731693|NCT00154440|Clarithromycin|clarithromycin|mesh-list
153731694|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153512563|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512564|NCT01415011|Afatinib|afatinib|mesh-list
153512565|NCT01415011|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153512566|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512567|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512568|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512569|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512570|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
153512571|NCT01415128|Desipramine|desipramine|mesh-list
153512572|NCT01415128|Omeprazole|omeprazole|mesh-list
153512573|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153512574|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512575|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153512576|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512577|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512578|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153512636|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153512637|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
153512638|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512639|NCT01415557|Micronutrients|micronutrients|mesh-list
153512640|NCT01415557|Trace Elements|trace elements|mesh-list
153512641|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512642|NCT01415596|Albuterol|albuterol|mesh-list
153512643|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153512644|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
153512645|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512646|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512647|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153512648|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
153512649|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
153512650|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153512666|NCT01415687|Cathartics|cathartics|mesh-ancestor
153512735|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153512736|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153512737|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153512738|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
153512739|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512740|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512741|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
153512742|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512743|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
153512744|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512745|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512746|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153512747|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
153512748|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512749|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512750|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153512751|NCT01416116|Lidocaine|lidocaine|mesh-list
153512752|NCT01416116|Tramadol|tramadol|mesh-list
153512753|NCT01416116|Capsaicin|capsaicin|mesh-list
153512754|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
153512755|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
153512874|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
153512875|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512876|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
153512877|NCT01416961|Etoposide|etoposide|mesh-list
153512878|NCT01416961|Cisplatin|cisplatin|mesh-list
153512879|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
153512880|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153512881|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512882|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153512883|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153512884|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512885|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512886|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
153512887|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512888|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
153512889|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512890|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512891|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153512892|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
153512893|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512894|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512925|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512926|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153512927|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153512980|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
153512981|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512982|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512983|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512984|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
153512985|NCT01417494|Antidotes|antidotes|mesh-ancestor
153512986|NCT01417494|Protective Agents|protective agents|mesh-ancestor
153512987|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
153512988|NCT01417494|Vitamins|vitamins|mesh-ancestor
153512989|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
153512990|NCT01417572|Lidocaine|lidocaine|mesh-list
153512991|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
153512992|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
153512993|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513010|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513012|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153513013|NCT01417767|Decitabine|decitabine|mesh-list
153513076|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
153513077|NCT01418131|Tacrolimus|tacrolimus|mesh-list
153513078|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153513079|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153513080|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
153513081|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513082|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513083|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513084|NCT01418144|Ropivacaine|ropivacaine|mesh-list
153513086|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
153513087|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513088|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513089|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
153513090|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513091|NCT01418157|Acetazolamide|acetazolamide|mesh-list
153513092|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
153513093|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153513094|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513096|NCT01418157|Diuretics|diuretics|mesh-ancestor
153513154|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513177|NCT01418599|Alfuzosin|alfuzosin|mesh-list
153513178|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153513179|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153513180|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153513181|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
153513182|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513183|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513184|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513185|NCT01418599|Urological Agents|urological agents|mesh-ancestor
153513186|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153513276|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153513278|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153513279|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513280|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513281|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
153513282|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513283|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513284|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
153513287|NCT01419353|Estradiol|estradiol|mesh-list
153513433|NCT01420471|Hormones|hormones|mesh-ancestor
153513434|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513435|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513436|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153513437|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
153513438|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513439|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513475|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513476|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
153513477|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153513478|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513494|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
153513495|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
153513496|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153513497|NCT01420900|Tacrine|tacrine|mesh-list
153513498|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153513499|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513500|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513501|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
153513502|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513503|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513504|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153513505|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
153513506|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513507|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
153513508|NCT01420913|Pregabalin|pregabalin|mesh-list
153513509|NCT01420913|Analgesics|analgesics|mesh-ancestor
153513510|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
153513511|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513512|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513513|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
153513514|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153513515|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513516|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513517|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153513520|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513521|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513522|NCT01421043|Triazolam|triazolam|mesh-list
153513523|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153513524|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153513525|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153513526|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513527|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513528|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513529|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
153513530|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
153513531|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513532|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513533|NCT01421121|Vaccines|vaccines|mesh-list
153513534|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
153513535|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513536|NCT01421160|Citric Acid|citric acid|mesh-list
153513668|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153513669|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153513670|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
153513671|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513672|NCT01421992|Methylphenidate|methylphenidate|mesh-list
153513694|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153513696|NCT01422109|Aspirin|aspirin|mesh-list
153513697|NCT01422109|Clopidogrel|clopidogrel|mesh-list
153513698|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153513699|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153513700|NCT01422109|Analgesics|analgesics|mesh-ancestor
153513701|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
153513702|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513703|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513704|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513705|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513706|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153513707|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153513708|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513709|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153513848|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153513878|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513880|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
153513881|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
153513882|NCT01423032|Fludarabine|fludarabine|mesh-list
153513883|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153513884|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513885|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513886|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153513887|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
153513888|NCT01423123|Paclitaxel|paclitaxel|mesh-list
153513889|NCT01423123|Trastuzumab|trastuzumab|mesh-list
153513890|NCT01423123|Neratinib|neratinib|mesh-list
153513891|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153513892|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513893|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
153513894|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
153513922|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153513923|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
153514020|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514021|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514022|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514023|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
153514024|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514083|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514084|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514085|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153514086|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153514087|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514088|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153514222|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153514223|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153514224|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153514225|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153514226|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153514227|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153514228|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153514229|NCT01424839|Cisplatin|cisplatin|mesh-list
153514230|NCT01424839|Carboplatin|carboplatin|mesh-list
153514231|NCT01424839|Etoposide|etoposide|mesh-list
153514232|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
153514233|NCT01424839|Ifosfamide|ifosfamide|mesh-list
153514234|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
153514235|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514236|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153514237|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153514238|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153514239|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514240|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514241|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153514242|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
153514243|NCT01424891|Simvastatin|simvastatin|mesh-list
153514244|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153514245|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153514246|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
153514247|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514248|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153514249|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153514282|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514283|NCT01425164|Carvedilol|carvedilol|mesh-list
153514284|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153514285|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153514286|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
153514287|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514288|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514289|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514290|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153514291|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
153514292|NCT01425164|Protective Agents|protective agents|mesh-ancestor
153514293|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153514294|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153514295|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153514296|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
153514297|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153514298|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153514299|NCT01425216|Sorafenib|sorafenib|mesh-list
153514300|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514301|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153514302|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514303|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514304|NCT01425242|Amlodipine|amlodipine|mesh-list
153514305|NCT01425242|Aliskiren|aliskiren|mesh-list
153514389|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514390|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
153514392|NCT01425619|Prilocaine|prilocaine|mesh-list
153514393|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
153514394|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
153514395|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514396|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514428|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153514429|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514430|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
153514431|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
153514432|NCT01425736|Cisplatin|cisplatin|mesh-list
153514433|NCT01425736|Docetaxel|docetaxel|mesh-list
153514434|NCT01425736|Fluorouracil|fluorouracil|mesh-list
153514435|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
153514436|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514437|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
153514568|NCT05379374|Bupivacaine|bupivacaine|mesh-list
153514569|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
153514570|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
153514571|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514572|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514573|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
153514574|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514575|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153514576|NCT05379374|Narcotics|narcotics|mesh-ancestor
153514615|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153514637|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514638|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514639|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
153514640|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514641|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514642|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153514643|NCT04765371|Protective Agents|protective agents|mesh-ancestor
153514644|NCT04744363|Ustekinumab|ustekinumab|mesh-list
153514645|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
153514781|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153514782|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514783|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153514784|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153514785|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153514786|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153514787|NCT02197221|Bortezomib|bortezomib|mesh-list
153514788|NCT02197221|Melphalan|melphalan|mesh-list
153514789|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514790|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153514791|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
153514820|NCT00223145|Bicalutamide|bicalutamide|mesh-list
153514821|NCT00223145|Androgens|androgens|mesh-list
153514822|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514823|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514824|NCT00223145|Hormones|hormones|mesh-ancestor
153514825|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514826|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514827|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
153514828|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
153514829|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153514830|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153457949|NCT03596892|Busulfan|busulfan|mesh-list
153514879|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514880|NCT01426100|Telmisartan|telmisartan|mesh-list
153514912|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153514913|NCT01426334|Cyclosporine|cyclosporine|mesh-list
153514914|NCT01426334|Dasatinib|dasatinib|mesh-list
153514915|NCT01426334|Cyclosporins|cyclosporins|mesh-list
153514916|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514917|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514918|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514919|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
153514920|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514974|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514975|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514977|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153514978|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514979|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514980|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
153514981|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514982|NCT01426880|Paclitaxel|paclitaxel|mesh-list
153514983|NCT01426880|Carboplatin|carboplatin|mesh-list
153515014|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
153515015|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515016|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515017|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153515018|NCT01426971|Ibuprofen|ibuprofen|mesh-list
153515019|NCT01426971|Caffeine|caffeine|mesh-list
153515036|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515037|NCT01426984|Methylphenidate|methylphenidate|mesh-list
153515038|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153515039|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515040|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153515041|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153515042|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153515043|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515044|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
153515045|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515046|NCT01427114|Prednisolone|prednisolone|mesh-list
153515047|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
153515048|NCT01427114|Rituximab|rituximab|mesh-list
153515114|NCT01427387|Linaclotide|linaclotide|mesh-list
153515115|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153515116|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
153515117|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515118|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153515119|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
153626831|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
153515137|NCT01427491|Laxatives|laxatives|mesh-ancestor
153515138|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153515139|NCT01427582|Trabectedin|trabectedin|mesh-list
153515140|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153515141|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
153515142|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515143|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515145|NCT01427686|Dopamine|dopamine|mesh-list
153515146|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153515147|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
153515148|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
153515149|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515150|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515151|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153515152|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153515153|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153515154|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
153515155|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515156|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515157|NCT01427686|Protective Agents|protective agents|mesh-ancestor
153515158|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
153515159|NCT01427699|Antibodies|antibodies|mesh-list
153515160|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
153515161|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515173|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515200|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
153515201|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515202|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515203|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153515204|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153515205|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153515207|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153515208|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
153515209|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153515210|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515211|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153515212|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153515213|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
153515214|NCT01427127|Ramosetron|ramosetron|mesh-list
153515215|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
153515216|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
153515217|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515218|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515219|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153515221|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
153515343|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515344|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515345|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153515346|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515348|NCT01428817|Oxytocin|oxytocin|mesh-list
153515349|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
153515350|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153515351|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515353|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
153515354|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515355|NCT01428986|Maraviroc|maraviroc|mesh-list
153515377|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
153515378|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515379|NCT01429090|Methantheline|methantheline|mesh-list
153515380|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153515381|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153515382|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
153515386|NCT01429129|Nicotine|nicotine|mesh-list
153515444|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153515445|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515446|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
153515447|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
153515448|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153515449|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
153515450|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515451|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
153515452|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153515453|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153515454|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515455|NCT01429610|Cytarabine|cytarabine|mesh-list
153515456|NCT01429610|Rituximab|rituximab|mesh-list
153515491|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515492|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
153515493|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
153515494|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515495|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
153515496|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
153515532|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153515533|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153515616|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
153515617|NCT01430520|Escitalopram|escitalopram|mesh-list
153515618|NCT01430520|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153515619|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153515620|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153515621|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515622|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515623|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
153515624|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515625|NCT01430533|Azelaic acid|azelaic acid|mesh-list
153515626|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515627|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
153515628|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
153515629|NCT01430650|Urological Agents|urological agents|mesh-ancestor
153515631|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
153515632|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515667|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515668|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153515669|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153515670|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515671|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
153515701|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515702|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515703|NCT01431352|Letrozole|letrozole|mesh-list
153515704|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515705|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153515706|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153515707|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515708|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515709|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153515710|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
153515747|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515748|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515749|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
153515750|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153515751|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153515753|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153515754|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153515755|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153515756|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153515757|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
153515758|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515759|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511877|NCT01409369|Charcoal|charcoal|mesh-list
153515889|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153515890|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515891|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515892|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153515893|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
153515894|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516075|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516076|NCT01433770|Alefacept|alefacept|mesh-list
153516077|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
153516078|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
153516079|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516080|NCT01433887|Ribavirin|ribavirin|mesh-list
153516081|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153516082|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
153626835|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516117|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
153731699|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153516118|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516119|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153516120|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153516121|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153516122|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516123|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153516124|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153516159|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153516160|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153516251|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516252|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516278|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516279|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153516280|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153516281|NCT01434862|Pramlintide|pramlintide|mesh-list
153516282|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
153516283|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516284|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516285|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
153516286|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153516287|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
153516288|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516289|NCT01434888|Timolol|timolol|mesh-list
153516290|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153516291|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153516292|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153516293|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153516352|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516381|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
153511889|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
153516382|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516383|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153516384|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153516385|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153516386|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516387|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153516388|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153516389|NCT01435395|Bevacizumab|bevacizumab|mesh-list
153516390|NCT01435395|Temozolomide|temozolomide|mesh-list
153516391|NCT01435395|Bortezomib|bortezomib|mesh-list
153516392|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153516393|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516394|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153516395|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153516396|NCT01435395|Growth Substances|growth substances|mesh-ancestor
153516397|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516398|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
153516434|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516462|NCT01435954|Doxazosin|doxazosin|mesh-list
153516463|NCT01435954|Tamsulosin|tamsulosin|mesh-list
153516464|NCT01435954|Finasteride|finasteride|mesh-list
153516465|NCT01435954|Silodosin|silodosin|mesh-list
153516466|NCT01435954|Terazosin|terazosin|mesh-list
153516467|NCT01435954|Alfuzosin|alfuzosin|mesh-list
153516468|NCT01435954|Dutasteride|dutasteride|mesh-list
153516469|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153516515|NCT01435902|Fluticasone|fluticasone|mesh-list
153516517|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153516518|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153516519|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
153516520|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516521|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516522|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153516546|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516547|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153516548|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
153516549|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153516550|NCT01436578|Posaconazole|posaconazole|mesh-list
153516551|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
153516552|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516553|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153516554|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153516555|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153516556|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153516557|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153516558|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516559|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516560|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153516561|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
153516564|NCT01436825|Factor VIII|factor viii|mesh-list
153516603|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153516605|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153516606|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153516607|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153516608|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153516609|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
153516610|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511975|NCT01409733|Doxorubicin|doxorubicin|mesh-list
153516611|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516612|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516613|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
153516614|NCT01437228|Povidone|povidone|mesh-list
153516615|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
153516616|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
153516617|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153516618|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516619|NCT01437293|Carbidopa|carbidopa|mesh-list
153618895|NCT01980680|Progestins|progestins|mesh-ancestor
153516620|NCT01437293|Entacapone|entacapone|mesh-list
153516621|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153516622|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153516623|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
153731701|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516624|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516625|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516669|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153516670|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
153516671|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516672|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516673|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
153516674|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153516675|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153516676|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516677|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
153516678|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516679|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516680|NCT01437592|Insulin|insulin|mesh-list
153516681|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516682|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516683|NCT01437618|Bevacizumab|bevacizumab|mesh-list
153516684|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153516685|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516713|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153516714|NCT01437748|Bromides|bromides|mesh-list
153516715|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
153516716|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153516717|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
153516718|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516719|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516720|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153516721|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
153516722|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
153516723|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153516724|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
153516725|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516727|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
153516772|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
153516796|NCT01438086|Growth Substances|growth substances|mesh-ancestor
153516797|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516798|NCT01438112|Interferons|interferons|mesh-list
153516799|NCT01438112|Gemcitabine|gemcitabine|mesh-list
153516800|NCT01438112|Mitomycins|mitomycins|mesh-list
153516801|NCT01438112|Mitomycin|mitomycin|mesh-list
153516802|NCT01438112|Valrubicin|valrubicin|mesh-list
153516803|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153516804|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
153516805|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516806|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516807|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
153516808|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516809|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153516810|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
153516811|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153516812|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516813|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153516814|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153516815|NCT01438190|Metformin|metformin|mesh-list
153516816|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516817|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516818|NCT01438320|Quercetin|quercetin|mesh-list
153516819|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
153516820|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516821|NCT01438320|Protective Agents|protective agents|mesh-ancestor
153516822|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516824|NCT05578859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153516825|NCT05578859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516849|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516851|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153516852|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516853|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516857|NCT05164146|Propofol|propofol|mesh-list
153516858|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153516859|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516860|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516861|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153516862|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
153516863|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
153516864|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
153516865|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153516866|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516867|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516868|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153516869|NCT05111431|Analgesics|analgesics|mesh-ancestor
153516870|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
153516941|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
153516942|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
153516943|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516944|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516945|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153516946|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153516947|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516948|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516949|NCT04545060|Sotrovimab|sotrovimab|mesh-list
153516985|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516986|NCT04234061|Tisagenlecleucel|tisagenlecleucel|mesh-list
153516987|NCT04234061|Ibrutinib|ibrutinib|mesh-list
153516988|NCT04234061|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153516989|NCT04234061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153516990|NCT04234061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517024|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
153517025|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517026|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517027|NCT03558724|Bevacizumab|bevacizumab|mesh-list
153517028|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517059|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517060|NCT03232346|Analgesics|analgesics|mesh-ancestor
153517061|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
153517062|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517063|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153517064|NCT03227731|Tenofovir|tenofovir|mesh-list
153517065|NCT03227731|Emtricitabine|emtricitabine|mesh-list
153618898|NCT01980745|Amebicides|amebicides|mesh-ancestor
153517066|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153517067|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
153517068|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517069|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153517070|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153517071|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517072|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517073|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153517074|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153517075|NCT03200015|Metformin|metformin|mesh-list
153517145|NCT02275156|Evolocumab|evolocumab|mesh-list
153517166|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517202|NCT01375764|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153517203|NCT01375764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153517204|NCT01375764|Protease Inhibitors|protease inhibitors|mesh-ancestor
153517205|NCT01375764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517206|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
153517226|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517227|NCT01438359|Furosemide|furosemide|mesh-list
153517228|NCT01438359|Diuretics|diuretics|mesh-ancestor
153517229|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
153517230|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517231|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153517232|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153517233|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517234|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153517235|NCT01438372|Hematinics|hematinics|mesh-ancestor
153517236|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
153517237|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153517238|NCT01438515|Doxycycline|doxycycline|mesh-list
153517239|NCT01438515|Rifampin|rifampin|mesh-list
153517240|NCT01438515|Mupirocin|mupirocin|mesh-list
153517241|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153517242|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517243|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
153517244|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
153517245|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153517246|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
153517247|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153517248|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153517249|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153517295|NCT01438632|Insulin|insulin|mesh-list
153517296|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517297|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517298|NCT01438723|Metformin|metformin|mesh-list
153517299|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517300|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517301|NCT01438736|Etonogestrel|etonogestrel|mesh-list
153517302|NCT01438736|Desogestrel|desogestrel|mesh-list
153517303|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153517304|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
153517305|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153517306|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517307|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153517331|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
153517332|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
153517333|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
153517334|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517335|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517336|NCT01438866|Fluorides|fluorides|mesh-list
153517337|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
153517338|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
153517339|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
153517340|NCT01438866|Protective Agents|protective agents|mesh-ancestor
153517341|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517342|NCT01438944|Nicotine|nicotine|mesh-list
153517343|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153517344|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
153517345|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517346|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517347|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153517348|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153517349|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
153517350|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517351|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517352|NCT01439100|Oxycodone|oxycodone|mesh-list
153517353|NCT01439100|Naloxone|naloxone|mesh-list
153517360|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517392|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153517393|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517394|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517395|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
153517396|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517397|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517398|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
153517399|NCT01439243|Donepezil|donepezil|mesh-list
153517400|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153517401|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517402|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517403|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
153517430|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517431|NCT01439542|Hormones|hormones|mesh-list
153517432|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153517433|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153517434|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517435|NCT01439750|Rituximab|rituximab|mesh-list
153517436|NCT01439750|Bortezomib|bortezomib|mesh-list
153517437|NCT01439750|Cladribine|cladribine|mesh-list
153517438|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517439|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517440|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
153517441|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517442|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153517443|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153517444|NCT01439984|Clomipramine|clomipramine|mesh-list
153517445|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153517446|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
153517447|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153512247|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517448|NCT01439984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153517449|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153517450|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153517473|NCT01440114|Narcotics|narcotics|mesh-ancestor
153517474|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517475|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517476|NCT01440114|Analgesics|analgesics|mesh-ancestor
153517477|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
153517478|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517479|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153517480|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153517481|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
153517482|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
153517483|NCT01440127|Metformin|metformin|mesh-list
153517484|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517485|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517486|NCT01440140|Insulin|insulin|mesh-list
153517487|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517488|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517489|NCT01440270|Cetuximab|cetuximab|mesh-list
153517490|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517491|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517492|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153517493|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153517494|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517495|NCT01440335|Fenoterol|fenoterol|mesh-list
153517496|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153517497|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
153517498|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517499|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517500|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153517501|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
153517502|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
153517503|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
153517504|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153517505|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153517506|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153517536|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153517537|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153517538|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517539|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
153731702|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153517540|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153512352|NCT01413022|Leucovorin|leucovorin|mesh-list
153517541|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153517542|NCT01440582|Growth Substances|growth substances|mesh-ancestor
153517543|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
153517544|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153517545|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517546|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517547|NCT01440608|Albendazole|albendazole|mesh-list
153517548|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
153517549|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153517550|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517551|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
153517552|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153517553|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153517554|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
153517555|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
153517556|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
153517557|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517558|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517559|NCT01440621|Pyridoxine|pyridoxine|mesh-list
153517560|NCT01440621|Modafinil|modafinil|mesh-list
153517587|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517588|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153517589|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517590|NCT01440790|Vitamins|vitamins|mesh-list
153517591|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
153517592|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
153517593|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517598|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153517599|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153517600|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517601|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517602|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517604|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153517605|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517606|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517607|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
153517635|NCT01440998|Dasatinib|dasatinib|mesh-list
153517636|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153517637|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517638|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
153517639|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
153517640|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
153517641|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512376|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517642|NCT01440998|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153517643|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153517644|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517645|NCT01441128|Crizotinib|crizotinib|mesh-list
153517646|NCT01441128|Dacomitinib|dacomitinib|mesh-list
153517647|NCT01441128|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153517648|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153517649|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517650|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517651|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517652|NCT01441193|Vaccines|vaccines|mesh-list
153517653|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
153517676|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153517677|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153517678|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
153517685|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517687|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517688|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153517689|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153517690|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
153517691|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
153517692|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517693|NCT01441297|Nintedanib|nintedanib|mesh-list
153517694|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517695|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153517696|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517697|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517698|NCT01441388|Bevacizumab|bevacizumab|mesh-list
153517699|NCT01441388|Sunitinib|sunitinib|mesh-list
153517700|NCT01441388|Sorafenib|sorafenib|mesh-list
153517724|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153517725|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153517726|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
153517728|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517729|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153517730|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153517735|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153517782|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
153517783|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517784|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517785|NCT01441908|Pravastatin|pravastatin|mesh-list
153517786|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153517787|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153517788|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
153517789|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517790|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153517791|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153517792|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517793|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
153517794|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517795|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
153517796|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153517797|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153517798|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517799|NCT01441934|Urological Agents|urological agents|mesh-ancestor
153517800|NCT01441986|Amantadine|amantadine|mesh-list
153517801|NCT01441986|Levomethorphan|levomethorphan|mesh-list
153517802|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
153517803|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
153517804|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
153517805|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153517838|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517839|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153731703|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153517890|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
153517891|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517892|NCT01442532|Midazolam|midazolam|mesh-list
153517893|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153517923|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517924|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153517925|NCT01442610|Protective Agents|protective agents|mesh-ancestor
153517926|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517927|NCT01442662|Gemcitabine|gemcitabine|mesh-list
153517928|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153517929|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
153517930|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517931|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517932|NCT01442701|Triclosan|triclosan|mesh-list
153517933|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153517934|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518091|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518092|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
153518093|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153518094|NCT01443221|Metformin|metformin|mesh-list
153518095|NCT01443221|Mitiglinide|mitiglinide|mesh-list
153518096|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153518097|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518098|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
153518099|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153518101|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
153518102|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518103|NCT01443325|Lidocaine|lidocaine|mesh-list
153518104|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
153518105|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
153518106|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518107|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518108|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
153518109|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518110|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153512493|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153518111|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153518112|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153518113|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153518114|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518115|NCT01443338|Acitretin|acitretin|mesh-list
153518116|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
153518117|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
153518118|NCT01443377|Panitumumab|panitumumab|mesh-list
153518204|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
153518205|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518220|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153518221|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153518222|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
153518223|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518224|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518225|NCT01444196|Desloratadine|desloratadine|mesh-list
153518226|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153518227|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
153518228|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518229|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518230|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518231|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153518232|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153518233|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
153518234|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
153518236|NCT01444248|Glimepiride|glimepiride|mesh-list
153518237|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153518238|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518239|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153731707|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153731708|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518240|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518241|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
153518242|NCT01444339|Vaccines|vaccines|mesh-list
153518243|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153518244|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
153518245|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518246|NCT01444352|Vaccines|vaccines|mesh-list
153518257|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153518258|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153518259|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518260|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
153518261|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
153518262|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
153518263|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518278|NCT01444612|PENTA|penta|mesh-list
153518279|NCT01444612|Fondaparinux|fondaparinux|mesh-list
153518280|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
153518281|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153518282|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153518283|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518284|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153518285|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
153518286|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153518287|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518288|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518289|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
153518290|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518291|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153518292|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153518293|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518294|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518295|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
153518296|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153518297|NCT01444807|Sorafenib|sorafenib|mesh-list
153518298|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518299|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153518300|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518301|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518302|NCT01444833|Candesartan|candesartan|mesh-list
153518303|NCT01444833|Candesartan cilexetil|candesartan cilexetil|mesh-list
153518304|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518305|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153518307|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518309|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153518310|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153518311|NCT01444846|Analgesics|analgesics|mesh-ancestor
153518312|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
153518313|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518314|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518315|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153518316|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518317|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153518318|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153518319|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
153518320|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518321|NCT01444846|Protective Agents|protective agents|mesh-ancestor
153518322|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153731709|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
153518323|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518324|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153518333|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
153518334|NCT01444976|Midazolam|midazolam|mesh-list
153518335|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
153518336|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518337|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518345|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
153518362|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
153518363|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
153518364|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518365|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518366|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
153518367|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518369|NCT01445223|Lopinavir|lopinavir|mesh-list
153518370|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153518371|NCT01445223|Efavirenz|efavirenz|mesh-list
153518372|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153518373|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153518374|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518375|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518376|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518377|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153518378|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153518379|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
153518380|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518381|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153518382|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153518403|NCT01445262|Levocetirizine|levocetirizine|mesh-list
153518421|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518423|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153518424|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518425|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518426|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518427|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153518428|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153518429|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
153518430|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518431|NCT01445405|Cetuximab|cetuximab|mesh-list
153518432|NCT01445405|Bortezomib|bortezomib|mesh-list
153518433|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518434|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518435|NCT01445418|Carboplatin|carboplatin|mesh-list
153518436|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518437|NCT01445431|Mineral Oil|mineral oil|mesh-list
153518438|NCT01445431|Emollients|emollients|mesh-ancestor
153518439|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
153518440|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
153518441|NCT01445522|Veliparib|veliparib|mesh-list
153518442|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518443|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
153518444|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518445|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518446|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153518447|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
153518448|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518449|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518450|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153518471|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
153518472|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518473|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153518474|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153518475|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153518476|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
153646715|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518477|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518478|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518479|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153518480|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153518481|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
153518483|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
153518484|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518485|NCT01445756|Lidocaine|lidocaine|mesh-list
153518486|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
153518487|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
153518488|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518489|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518490|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
153518491|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518492|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153518493|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153518494|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153518495|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153518496|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518497|NCT01445860|Simvastatin|simvastatin|mesh-list
153518498|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518499|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518500|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
153731712|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153731713|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518501|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518502|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518503|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153518537|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153518538|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
153518539|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
153518540|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
153518541|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153518542|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518543|NCT01446211|Gusperimus|gusperimus|mesh-list
153518544|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
153518545|NCT01446211|Methotrexate|methotrexate|mesh-list
153518546|NCT01446211|Azathioprine|azathioprine|mesh-list
153518547|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
153518548|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518549|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
153518550|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518551|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518552|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153518553|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
153518554|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518555|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518556|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153518557|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153646716|NCT02752815|Prednisone|prednisone|mesh-list
153518602|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153518603|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153518604|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153518605|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153518606|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153518607|NCT01446445|Valganciclovir|valganciclovir|mesh-list
153518608|NCT01446445|Ganciclovir|ganciclovir|mesh-list
153518609|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153518610|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
153518611|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518612|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153518613|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518614|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518615|NCT01446458|Folfirinox|folfirinox|mesh-list
153518616|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518617|NCT01446484|Cyclosporine|cyclosporine|mesh-list
153518618|NCT01446484|Sirolimus|sirolimus|mesh-list
153518619|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
153518620|NCT01446484|Everolimus|everolimus|mesh-list
153518621|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
153518622|NCT01446484|Tacrolimus|tacrolimus|mesh-list
153518623|NCT01446484|Cyclosporins|cyclosporins|mesh-list
153512826|NCT01416649|Exenatide|exenatide|mesh-list
153518624|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518634|NCT01446484|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153518635|NCT01446484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153518636|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518637|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153518638|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153518656|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153518657|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153518658|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
153518659|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518660|NCT01446679|Atorvastatin|atorvastatin|mesh-list
153518661|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518662|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518663|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
153518664|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518665|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518666|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153518667|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518668|NCT01446731|Docetaxel|docetaxel|mesh-list
153518669|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518670|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
153518671|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
153518672|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
153518673|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518674|NCT01446783|Mecasermin|mecasermin|mesh-list
153518675|NCT01446783|Growth Substances|growth substances|mesh-ancestor
153518676|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518677|NCT01446900|Rituximab|rituximab|mesh-list
153518678|NCT01446900|Cladribine|cladribine|mesh-list
153518679|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518680|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518681|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
153518682|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518683|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518684|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518685|NCT01446926|Vaccines|vaccines|mesh-list
153731714|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
153518686|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153518715|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
153518716|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153518717|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153518718|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153518719|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153518720|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
153518721|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518722|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518723|NCT01447095|Epoprostenol|epoprostenol|mesh-list
153518724|NCT01447095|Tezosentan|tezosentan|mesh-list
153518725|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518726|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153518727|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
153518728|NCT01447160|Cortisone|cortisone|mesh-list
153518729|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153518730|NCT01447173|Vitamin D|vitamin d|mesh-list
153518731|NCT01447173|Vitamins|vitamins|mesh-ancestor
153518732|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
153518733|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518734|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153518735|NCT01447212|Hydromorphone|hydromorphone|mesh-list
153518737|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153518738|NCT01447212|Narcotics|narcotics|mesh-ancestor
153518739|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518775|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518776|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153518777|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518778|NCT01447563|Clopidogrel|clopidogrel|mesh-list
153518779|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153518780|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153518781|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153518782|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153518783|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
153731715|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153518784|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518785|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518786|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518787|NCT01447589|Nelfinavir|nelfinavir|mesh-list
153518788|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153518789|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153518790|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518791|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518792|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518793|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153518794|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153518795|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
153518796|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518797|NCT01447654|Losartan|losartan|mesh-list
153518798|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153518799|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518800|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153518801|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153512950|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518802|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518823|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
153518824|NCT01447979|Pancrelipase|pancrelipase|mesh-list
153518825|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153518826|NCT01448018|Ranibizumab|ranibizumab|mesh-list
153518827|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153518828|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153518829|NCT01448018|Growth Substances|growth substances|mesh-ancestor
153518830|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518831|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
153518832|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518833|NCT01448031|Esomeprazole|esomeprazole|mesh-list
153518834|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153518835|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153518836|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153518837|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518838|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518840|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153518841|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153518842|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518843|NCT01448096|Rituximab|rituximab|mesh-list
153518844|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518845|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518846|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
153518847|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518848|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518849|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
153518850|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153518851|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153518852|NCT01448174|Atorvastatin|atorvastatin|mesh-list
153518869|NCT01448239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518870|NCT01448239|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518871|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
153518872|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518873|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153518874|NCT01448291|Etonogestrel|etonogestrel|mesh-list
153518875|NCT01448291|NuvaRing|nuvaring|mesh-list
153518876|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
153518877|NCT01448291|Estradiol|estradiol|mesh-list
153518878|NCT01448291|Estrogens|estrogens|mesh-ancestor
153518879|NCT01448291|Hormones|hormones|mesh-ancestor
153518886|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153512999|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153518887|NCT01448304|Alirocumab|alirocumab|mesh-list
153518888|NCT01448304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153518889|NCT01448304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518890|NCT01448304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518891|NCT01448304|Antimetabolites|antimetabolites|mesh-ancestor
153518892|NCT01448304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518893|NCT01448304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153518894|NCT01448304|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518895|NCT01448304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518896|NCT01448304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518897|NCT01448317|Alirocumab|alirocumab|mesh-list
153518930|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153518931|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
153518932|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518934|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153518935|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518936|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518937|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153518938|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518939|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
153518940|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153518941|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153518942|NCT01448499|Clozapine|clozapine|mesh-list
153518943|NCT01448499|Amisulpride|amisulpride|mesh-list
153518944|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153518945|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
153518964|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518965|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153518966|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518967|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153518968|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153518969|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153518970|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153519001|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519013|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519014|NCT01448772|Hormones|hormones|mesh-ancestor
153618904|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153519015|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519016|NCT01448798|Hemostatics|hemostatics|mesh-list
153519017|NCT01448798|Thrombin|thrombin|mesh-list
153519018|NCT01448798|Coagulants|coagulants|mesh-ancestor
153519019|NCT01448837|Timolol|timolol|mesh-list
153519020|NCT01448837|Bimatoprost|bimatoprost|mesh-list
153519021|NCT01448837|Latanoprost|latanoprost|mesh-list
153519022|NCT01448837|Cloprostenol|cloprostenol|mesh-list
153519023|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153519024|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153519025|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
153519026|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519027|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519028|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519029|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153519030|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153519031|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153519032|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153519033|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
153519034|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153519035|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
153519036|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153519060|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153519061|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519062|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
153519063|NCT01449188|Ondansetron|ondansetron|mesh-list
153519064|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153519065|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519066|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153519075|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519076|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
153519077|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
153519078|NCT01449188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153519079|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153519080|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
153519081|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519082|NCT01449201|Dacomitinib|dacomitinib|mesh-list
153519083|NCT01449201|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153519084|NCT01449201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153519085|NCT01449201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519086|NCT01449201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519087|NCT01449253|Bosentan|bosentan|mesh-list
153519088|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
153519089|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153519090|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153519091|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153519092|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519093|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519094|NCT01449253|Urological Agents|urological agents|mesh-ancestor
153519095|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153519096|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153519098|NCT01449344|Dexamethasone|dexamethasone|mesh-list
153519099|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
153519100|NCT01449344|Rituximab|rituximab|mesh-list
153519101|NCT01449344|Bortezomib|bortezomib|mesh-list
153519102|NCT01449344|BB 1101|bb 1101|mesh-list
153519112|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153519113|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519114|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
153519115|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519116|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519117|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519118|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
153519119|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519120|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153519121|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
153519122|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
153519123|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519124|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153519125|NCT01449357|Zalutumumab|zalutumumab|mesh-list
153519126|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519127|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519128|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
153519129|NCT01449435|Miotics|miotics|mesh-ancestor
153519130|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
153519131|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519132|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519133|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153519174|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519175|NCT01449578|Protective Agents|protective agents|mesh-ancestor
153519176|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519177|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
153519178|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519179|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153519180|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153519181|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
153519182|NCT01449617|Aspirin|aspirin|mesh-list
153519183|NCT01449617|Clopidogrel|clopidogrel|mesh-list
153519184|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153519185|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153519186|NCT01449617|Analgesics|analgesics|mesh-ancestor
153519187|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
153519188|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519191|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519256|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153519257|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153519258|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153519259|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153519261|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153519262|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153519263|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153519264|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
153519265|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519266|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519267|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513213|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153519269|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153519270|NCT01451320|Streptokinase|streptokinase|mesh-list
153519271|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153519272|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153519273|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519274|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
153519275|NCT01451489|Tacrolimus|tacrolimus|mesh-list
153519276|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153519277|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
153519278|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519279|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519280|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153519281|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
153519282|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519283|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519284|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153519285|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153519286|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519287|NCT01451853|Ebselen|ebselen|mesh-list
153519288|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153519289|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153519290|NCT01451853|Analgesics|analgesics|mesh-ancestor
153519291|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
153519295|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519296|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153519297|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519298|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
153519299|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519300|NCT01451853|Protective Agents|protective agents|mesh-ancestor
153519301|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153519302|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519303|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153519304|NCT01452243|Vitamin D|vitamin d|mesh-list
153519305|NCT01452243|Calcium|calcium|mesh-list
153519306|NCT01452243|Vitamins|vitamins|mesh-ancestor
153519307|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
153519308|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519309|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153519310|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153519311|NCT01452256|Propofol|propofol|mesh-list
153519312|NCT01452256|Desflurane|desflurane|mesh-list
153519313|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153519314|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153519315|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519316|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153513312|NCT01419405|Pregabalin|pregabalin|mesh-list
153519366|NCT05964387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153519367|NCT05964387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153519368|NCT05964387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153519369|NCT05964387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519370|NCT05964387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153519371|NCT05964387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153519372|NCT05964387|Adrenergic Agents|adrenergic agents|mesh-ancestor
153519373|NCT05964387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519374|NCT05964387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153519384|NCT05964257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153519385|NCT05964257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153519386|NCT05964257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153519387|NCT05964257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519388|NCT05964257|Cholinergic Agents|cholinergic agents|mesh-ancestor
153519389|NCT05964257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519390|NCT05964257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519391|NCT05964257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153519392|NCT05964257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519393|NCT05964114|Vancomycin|vancomycin|mesh-list
153519394|NCT05964114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153519395|NCT05964114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519396|NCT05964101|Paclitaxel|paclitaxel|mesh-list
153519397|NCT05964101|Carboplatin|carboplatin|mesh-list
153519398|NCT05964101|Nivolumab|nivolumab|mesh-list
153519399|NCT05964101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153519400|NCT05964101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519401|NCT05964101|Tubulin Modulators|tubulin modulators|mesh-ancestor
153519402|NCT05964101|Antimitotic Agents|antimitotic agents|mesh-ancestor
153519403|NCT05964101|Mitosis Modulators|mitosis modulators|mesh-ancestor
153519415|NCT05963711|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153519416|NCT05963711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519417|NCT05963711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519418|NCT05963334|Paclitaxel|paclitaxel|mesh-list
153519419|NCT05963334|Carboplatin|carboplatin|mesh-list
153519420|NCT05963334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153519421|NCT05963334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519422|NCT05963334|Tubulin Modulators|tubulin modulators|mesh-ancestor
153731717|NCT04705584|Prednisolone|prednisolone|mesh-list
153731718|NCT04705584|Cyclosporins|cyclosporins|mesh-list
153519423|NCT05963334|Antimitotic Agents|antimitotic agents|mesh-ancestor
153519424|NCT05963334|Mitosis Modulators|mitosis modulators|mesh-ancestor
153519425|NCT05963334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519426|NCT05963087|Cetuximab|cetuximab|mesh-list
153519427|NCT05963087|Tislelizumab|tislelizumab|mesh-list
153519428|NCT05963087|Dabrafenib|dabrafenib|mesh-list
153519429|NCT05963087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519430|NCT05963087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519431|NCT05963087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153519432|NCT05963087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519433|NCT05963087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519434|NCT05962775|Ethanol|ethanol|mesh-list
153519435|NCT05962775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153519436|NCT05962775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519437|NCT05962775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153519438|NCT05962775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519439|NCT05962671|Analgesics, Opioid|analgesics, opioid|mesh-list
153519457|NCT05962619|Immunologic Factors|immunologic factors|mesh-ancestor
153519458|NCT05962619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519476|NCT05961761|Pembrolizumab|pembrolizumab|mesh-list
153519477|NCT05961761|Propranolol|propranolol|mesh-list
153519478|NCT05961761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519479|NCT05961761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519480|NCT05961761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153519481|NCT05961761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519482|NCT05961761|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153519483|NCT05961761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153519484|NCT05961761|Adrenergic Agents|adrenergic agents|mesh-ancestor
153519485|NCT05961761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519486|NCT05961761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519487|NCT05961761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153519488|NCT05961761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153519489|NCT05961761|Vasodilator Agents|vasodilator agents|mesh-ancestor
153519493|NCT05961501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153519494|NCT05961202|Hydroxychloroquine|hydroxychloroquine|mesh-list
153519495|NCT05961202|Prednisolone|prednisolone|mesh-list
153519506|NCT05961202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519507|NCT05961202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519508|NCT05961202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519509|NCT05961202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519510|NCT05961007|Aflibercept|aflibercept|mesh-list
153519511|NCT05961007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153519512|NCT05961007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153519513|NCT05961007|Growth Substances|growth substances|mesh-ancestor
153519514|NCT05961007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519515|NCT05961007|Growth Inhibitors|growth inhibitors|mesh-ancestor
153519516|NCT05961007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519518|NCT05960721|Rivaroxaban|rivaroxaban|mesh-list
153519519|NCT05960721|Clopidogrel|clopidogrel|mesh-list
153519520|NCT05960721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153519521|NCT05960721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153519522|NCT05960721|Analgesics|analgesics|mesh-ancestor
153519526|NCT05960721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519527|NCT05960721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519528|NCT05960721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153519529|NCT05960721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153519530|NCT05960721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519531|NCT05960721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153519532|NCT05960721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153519533|NCT05960721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519534|NCT05960721|Antipyretics|antipyretics|mesh-ancestor
153519535|NCT05960721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153519536|NCT05960721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153462674|NCT04124094|Hormones|hormones|mesh-ancestor
153519537|NCT05960721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153519538|NCT05960721|Purinergic Agents|purinergic agents|mesh-ancestor
153519539|NCT05960721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519540|NCT05960721|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153519541|NCT05960721|Antithrombins|antithrombins|mesh-ancestor
153519542|NCT05960721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153519543|NCT05960721|Protease Inhibitors|protease inhibitors|mesh-ancestor
153519544|NCT05960721|Anticoagulants|anticoagulants|mesh-ancestor
153519545|NCT05960617|Empagliflozin|empagliflozin|mesh-list
153519546|NCT05960617|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153519547|NCT05960617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519548|NCT05960617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519549|NCT05960617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519550|NCT05928611|Dexamethasone|dexamethasone|mesh-list
153519551|NCT05928611|Dexamethasone acetate|dexamethasone acetate|mesh-list
153519552|NCT05928611|BB 1101|bb 1101|mesh-list
153519553|NCT05928611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519554|NCT05928611|Antiemetics|antiemetics|mesh-ancestor
153519555|NCT05928611|Autonomic Agents|autonomic agents|mesh-ancestor
153519556|NCT05928611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519557|NCT05928611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519558|NCT05928611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519559|NCT05928611|Glucocorticoids|glucocorticoids|mesh-ancestor
153519566|NCT05928611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539920|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
153646717|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
153646718|NCT02752815|Rituximab|rituximab|mesh-list
153519568|NCT05917912|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153519569|NCT05917912|Antidepressive Agents|antidepressive agents|mesh-ancestor
153519570|NCT05917912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153519571|NCT05917912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153519572|NCT05917912|Analgesics|analgesics|mesh-ancestor
153519573|NCT05917912|Sensory System Agents|sensory system agents|mesh-ancestor
153519574|NCT05917912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519575|NCT05917912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519576|NCT05917912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153519577|NCT05917912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153519578|NCT05917912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153519579|NCT05917912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519580|NCT05917912|Adrenergic Agents|adrenergic agents|mesh-ancestor
153519581|NCT05917912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519582|NCT05887726|Prednisone|prednisone|mesh-list
153519583|NCT05887726|Cyclophosphamide|cyclophosphamide|mesh-list
153519584|NCT05887726|Rituximab|rituximab|mesh-list
153519585|NCT05887726|Vincristine|vincristine|mesh-list
153519586|NCT05887726|Epirubicin|epirubicin|mesh-list
153519587|NCT05887726|Zanubrutinib|zanubrutinib|mesh-list
153519588|NCT05887726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153519589|NCT05887726|Immunologic Factors|immunologic factors|mesh-ancestor
153519590|NCT05887726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519591|NCT05887726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519592|NCT05887726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153519593|NCT05887726|Alkylating Agents|alkylating agents|mesh-ancestor
153519594|NCT05887726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519595|NCT05887726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519596|NCT05887726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153519597|NCT05887726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519598|NCT05887726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519599|NCT05887726|Glucocorticoids|glucocorticoids|mesh-ancestor
153519600|NCT05887726|Hormones|hormones|mesh-ancestor
153519607|NCT05887726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153519608|NCT05887726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153519609|NCT05887726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153618905|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153462738|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
153519610|NCT05887726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519611|NCT05887726|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153519612|NCT05887726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153519614|NCT05867550|Amitriptyline|amitriptyline|mesh-list
153519615|NCT05867550|Mebeverine|mebeverine|mesh-list
153519616|NCT05867550|Psyllium|psyllium|mesh-list
153519617|NCT05867550|Calcium polycarbophil|calcium polycarbophil|mesh-list
153519618|NCT05867550|Alverine|alverine|mesh-list
153519619|NCT05867550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153519620|NCT05867550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519621|NCT05867550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519622|NCT05867550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153519623|NCT05867550|Antidepressive Agents|antidepressive agents|mesh-ancestor
153519624|NCT05867550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153519625|NCT05867550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153519626|NCT05867550|Analgesics|analgesics|mesh-ancestor
153519640|NCT05867550|Autonomic Agents|autonomic agents|mesh-ancestor
153519641|NCT05854251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153519642|NCT05854251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519643|NCT05849753|Pancrelipase|pancrelipase|mesh-list
153519644|NCT05849753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519645|NCT05848947|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
153519646|NCT05848947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153519647|NCT05848947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519648|NCT05841420|Paclitaxel|paclitaxel|mesh-list
153519649|NCT05841420|Gemcitabine|gemcitabine|mesh-list
153519650|NCT05841420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153519651|NCT05841420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519658|NCT05801315|Glycine|glycine|mesh-list
153519661|NCT05801315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519662|NCT05801315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519663|NCT05798403|Solifenacin Succinate|solifenacin succinate|mesh-list
153519664|NCT05798403|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153519665|NCT05798403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153519666|NCT05798403|Cholinergic Agents|cholinergic agents|mesh-ancestor
153519667|NCT05798403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519668|NCT05798403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519669|NCT05798403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519670|NCT05798403|Urological Agents|urological agents|mesh-ancestor
153519671|NCT05783596|Obinutuzumab|obinutuzumab|mesh-list
153519672|NCT05783596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519673|NCT05783596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519674|NCT05712096|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
153519675|NCT05712096|Antiviral Agents|antiviral agents|mesh-ancestor
153519676|NCT05712096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519677|NCT05671172|Bupivacaine|bupivacaine|mesh-list
153519679|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
153519680|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153519681|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519682|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
153519683|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618906|NCT01980745|Analgesics|analgesics|mesh-ancestor
153519684|NCT05645913|Anticoagulants|anticoagulants|mesh-list
153519685|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
153519686|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153519696|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731719|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519698|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
153519699|NCT05620901|Hormones|hormones|mesh-ancestor
153519700|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519701|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153519702|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513545|NCT01421173|Rituximab|rituximab|mesh-list
153519703|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153519705|NCT05586789|Tryptophan|tryptophan|mesh-list
153519706|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153519707|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
153519708|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153519709|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
153519710|NCT05568550|Olaparib|olaparib|mesh-list
153519711|NCT05568550|Androgens|androgens|mesh-list
153519712|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519713|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519714|NCT05568550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153519715|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519716|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153519717|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519718|NCT05568550|Hormones|hormones|mesh-ancestor
153519719|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519720|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519721|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153519722|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153519723|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519724|NCT05542849|Acarbose|acarbose|mesh-list
153519725|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153519726|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519727|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519728|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519729|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519730|NCT05523934|Capsaicin|capsaicin|mesh-list
153519731|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
153519732|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
153519733|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
153519734|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519750|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519751|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519752|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153519761|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519762|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153519763|NCT05433480|Fulvestrant|fulvestrant|mesh-list
153519764|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153519765|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519766|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153519767|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153519768|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
153519769|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519770|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519771|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153519772|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153519773|NCT05428215|Estradiol|estradiol|mesh-list
153519774|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153519775|NCT05428215|Estrogens|estrogens|mesh-ancestor
153519776|NCT05428215|Hormones|hormones|mesh-ancestor
153519777|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519778|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519779|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153519780|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
153519781|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153519782|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153519783|NCT05417646|Empagliflozin|empagliflozin|mesh-list
153519784|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153519785|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519786|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519798|NCT05289323|Neostigmine|neostigmine|mesh-list
153519799|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153519800|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519801|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519802|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
153519803|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519804|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519805|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153519806|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
153519807|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519808|NCT05275738|Niacinamide|niacinamide|mesh-list
153519809|NCT05275738|Niacin|niacin|mesh-list
153519810|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
153519811|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
153519812|NCT05275738|Vitamins|vitamins|mesh-ancestor
153519813|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
153519814|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519815|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153519816|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
153519817|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519827|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519828|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
153519829|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
153519830|NCT05256797|Apixaban|apixaban|mesh-list
153519831|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153519832|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
153519833|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153519834|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
153519835|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519836|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519837|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
153519838|NCT05213650|Methamphetamine|methamphetamine|mesh-list
153519841|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
153519850|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153519851|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153519852|NCT05179512|Fluticasone|fluticasone|mesh-list
153519853|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
153519854|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153519855|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153519856|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519857|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153519858|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
153519859|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519860|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519861|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153519862|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
153519863|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
153519864|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153519865|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
153513588|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
153519910|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519911|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153519912|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153519913|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
153519914|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
153519915|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
153519916|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519917|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519918|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519919|NCT05086081|Ticagrelor|ticagrelor|mesh-list
153519920|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153519921|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153519922|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153519923|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153519924|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153519925|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
153519926|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519927|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519928|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519929|NCT05083949|Metformin|metformin|mesh-list
153519930|NCT05083949|Empagliflozin|empagliflozin|mesh-list
153519931|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519932|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519933|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153731720|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519934|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519935|NCT05083455|Enoxaparin|enoxaparin|mesh-list
153519936|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
153519937|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153519938|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
153519939|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153519940|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
153519941|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519947|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153519948|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153519949|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
153519950|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513602|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153519958|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519960|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153519961|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153519962|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
153519963|NCT05078879|Empagliflozin|empagliflozin|mesh-list
153519964|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153519965|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519966|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153519967|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519968|NCT05063201|Cariprazine|cariprazine|mesh-list
153519969|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153519970|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153519971|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153519972|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519973|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153519974|NCT05062304|Fluticasone|fluticasone|mesh-list
153519975|NCT05062304|Xhance|xhance|mesh-list
153519976|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153618907|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
153519977|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153519978|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
153519979|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519980|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519981|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153519982|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
153519983|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
153519984|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153519985|NCT05029466|Psilocybin|psilocybin|mesh-list
153519986|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
153519987|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519994|NCT05018481|Protective Agents|protective agents|mesh-ancestor
153519995|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153519996|NCT05001750|Doxycycline|doxycycline|mesh-list
153519997|NCT05001750|Nafcillin|nafcillin|mesh-list
153519998|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153519999|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520000|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
153520001|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
153520002|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153520003|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153520004|NCT04982575|Semaglutide|semaglutide|mesh-list
153520005|NCT04982575|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153520006|NCT04982575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153520007|NCT04982575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520008|NCT04979884|Cyclosporine|cyclosporine|mesh-list
153520009|NCT04979884|Interleukin-2|interleukin-2|mesh-list
153520010|NCT04979884|Cyclosporins|cyclosporins|mesh-list
153520011|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520012|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520013|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153520014|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
153731721|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153731722|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
153520015|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520016|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
153520017|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520036|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153520037|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520038|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520039|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520040|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
153520041|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520042|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520043|NCT04938466|Hormones|hormones|mesh-list
153520046|NCT06257017|Gemcitabine|gemcitabine|mesh-list
153520049|NCT06257017|Antimetabolites|antimetabolites|mesh-ancestor
153520050|NCT06257017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520051|NCT06256926|Turmeric extract|turmeric extract|mesh-list
153520052|NCT06256926|Antioxidants|antioxidants|mesh-ancestor
153520053|NCT06256926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520054|NCT06256926|Protective Agents|protective agents|mesh-ancestor
153520055|NCT06256926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520056|NCT06256627|Thalidomide|thalidomide|mesh-list
153520057|NCT06256627|Azacitidine|azacitidine|mesh-list
153520058|NCT06256627|Interleukin-2|interleukin-2|mesh-list
153520059|NCT06256627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520060|NCT06256627|Antimetabolites|antimetabolites|mesh-ancestor
153520061|NCT06256627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520062|NCT06256627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520063|NCT06256627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520064|NCT06256627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520127|NCT06256211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520128|NCT06256211|Analgesics|analgesics|mesh-ancestor
153520129|NCT06256211|Sensory System Agents|sensory system agents|mesh-ancestor
153520130|NCT06256211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520131|NCT06256211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520132|NCT06256211|Antipyretics|antipyretics|mesh-ancestor
153520133|NCT06256042|Salicylic Acid|salicylic acid|mesh-list
153520134|NCT06256042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520135|NCT06256042|Antifungal Agents|antifungal agents|mesh-ancestor
153520136|NCT06256042|Keratolytic Agents|keratolytic agents|mesh-ancestor
153520137|NCT06256042|Dermatologic Agents|dermatologic agents|mesh-ancestor
153520138|NCT06255886|Omeprazole|omeprazole|mesh-list
153520174|NCT06255704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520175|NCT06255704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520176|NCT06255652|Cephradine|cephradine|mesh-list
153520177|NCT06255652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153520178|NCT06255652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520179|NCT06255496|Hemostatics|hemostatics|mesh-list
153520210|NCT06255210|Immunologic Factors|immunologic factors|mesh-ancestor
153520211|NCT06255210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520212|NCT06255210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520213|NCT06255210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153520214|NCT06255210|Alkylating Agents|alkylating agents|mesh-ancestor
153520215|NCT06255210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520216|NCT06255210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520217|NCT06255210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153520218|NCT06255210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520219|NCT06255210|Antimetabolites|antimetabolites|mesh-ancestor
153520220|NCT06255210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153520221|NCT06255210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153520222|NCT06255210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153520223|NCT06255210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520224|NCT06254131|Ondansetron|ondansetron|mesh-list
153520225|NCT06254131|Antiemetics|antiemetics|mesh-ancestor
153520243|NCT06253546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153520244|NCT06253546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153520245|NCT06253546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520246|NCT06253546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153520247|NCT06253546|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153520248|NCT06253546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153520249|NCT06253546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153520250|NCT06253546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520251|NCT06253546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520252|NCT06253546|Serotonin Agents|serotonin agents|mesh-ancestor
153520253|NCT06249854|Pembrolizumab|pembrolizumab|mesh-list
153520254|NCT06249854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520255|NCT06249854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520256|NCT06249854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520257|NCT06249854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520258|NCT06248593|Phenylephrine|phenylephrine|mesh-list
153520259|NCT06248593|Oxymetazoline|oxymetazoline|mesh-list
153520260|NCT06248593|Norepinephrine|norepinephrine|mesh-list
153520261|NCT06248593|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153520262|NCT06248593|Mydriatics|mydriatics|mesh-ancestor
153731723|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731724|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
153520263|NCT06248593|Autonomic Agents|autonomic agents|mesh-ancestor
153520264|NCT06248593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520265|NCT06248593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520266|NCT06248593|Sympathomimetics|sympathomimetics|mesh-ancestor
153520277|NCT06245564|Ketamine|ketamine|mesh-list
153520289|NCT06245564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153520290|NCT06245564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153520291|NCT06245564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520292|NCT06245564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520317|NCT06225427|Gilteritinib|gilteritinib|mesh-list
153520318|NCT06225427|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153520319|NCT06225427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153520320|NCT06225427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520321|NCT06225427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520322|NCT06225024|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153520323|NCT06225024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153520324|NCT06225024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520325|NCT06225024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520326|NCT06225024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153520327|NCT06225024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153520328|NCT06225024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520329|NCT06225024|Cholinergic Agents|cholinergic agents|mesh-ancestor
153520330|NCT06225024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520331|NCT06223958|Aflibercept|aflibercept|mesh-list
153520332|NCT06223958|Axitinib|axitinib|mesh-list
153520333|NCT06223958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153520334|NCT06223958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153520335|NCT06223958|Growth Substances|growth substances|mesh-ancestor
153520336|NCT06223958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520337|NCT06223958|Growth Inhibitors|growth inhibitors|mesh-ancestor
153520353|NCT06185933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520354|NCT06185933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153520362|NCT06162949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153520363|NCT06162949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520365|NCT06162949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153520366|NCT06162949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153520367|NCT06162949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520368|NCT06162949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520369|NCT06162949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153520370|NCT06162949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153520371|NCT06162949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153520372|NCT06159647|Liver Extracts|liver extracts|mesh-list
153520373|NCT06159647|Hematinics|hematinics|mesh-ancestor
153520374|NCT06131437|Semaglutide|semaglutide|mesh-list
153520375|NCT06131437|Tirzepatide|tirzepatide|mesh-list
153520376|NCT06131437|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153520377|NCT06131437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153520378|NCT06131437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520379|NCT06131437|Incretins|incretins|mesh-ancestor
153520380|NCT06131437|Hormones|hormones|mesh-ancestor
153520381|NCT06131437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520382|NCT06079047|Dexamethasone|dexamethasone|mesh-list
153520383|NCT06079047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153520384|NCT06079047|Antiemetics|antiemetics|mesh-ancestor
153520410|NCT06063486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520411|NCT06063486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153520412|NCT06057831|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153520413|NCT06057831|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153520414|NCT06057831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520416|NCT06057519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153520417|NCT06057519|Antitubercular Agents|antitubercular agents|mesh-ancestor
153520418|NCT06057519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153520419|NCT06057519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520420|NCT06057519|Leprostatic Agents|leprostatic agents|mesh-ancestor
153513796|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153520421|NCT06057519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153520422|NCT06057519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520428|NCT06057519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153520429|NCT06057519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153520430|NCT06042153|Semaglutide|semaglutide|mesh-list
153520431|NCT06042153|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153520432|NCT06042153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153520433|NCT06042153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520434|NCT05989828|Aldesleukin|aldesleukin|mesh-list
153520435|NCT05989828|Cyclophosphamide|cyclophosphamide|mesh-list
153520436|NCT05989828|Fludarabine|fludarabine|mesh-list
153520437|NCT05989828|Interleukin-2|interleukin-2|mesh-list
153520462|NCT05982093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153520464|NCT05977907|Pembrolizumab|pembrolizumab|mesh-list
153520465|NCT05977907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520466|NCT05977907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520467|NCT05977907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520468|NCT05977907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520469|NCT05964868|Epinephrine|epinephrine|mesh-list
153520470|NCT05964868|Bupivacaine|bupivacaine|mesh-list
153520471|NCT05964868|Anesthetics, Local|anesthetics, local|mesh-ancestor
153520472|NCT05964868|Anesthetics|anesthetics|mesh-ancestor
153520473|NCT05964868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520474|NCT05964868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520475|NCT05964868|Sensory System Agents|sensory system agents|mesh-ancestor
153520476|NCT05964868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520477|NCT05964868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153520478|NCT05964868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153520479|NCT05964868|Adrenergic Agents|adrenergic agents|mesh-ancestor
153520480|NCT05964868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520481|NCT05964868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520482|NCT05964868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153520484|NCT05964868|Autonomic Agents|autonomic agents|mesh-ancestor
153520523|NCT05904743|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153520524|NCT05904743|Insulin, Short-Acting|insulin, short-acting|mesh-list
153520525|NCT05904743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153520526|NCT05904743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520527|NCT05902780|Dexmedetomidine|dexmedetomidine|mesh-list
153520528|NCT05902780|Bupivacaine|bupivacaine|mesh-list
153520529|NCT05902780|Anesthetics, Local|anesthetics, local|mesh-ancestor
153520530|NCT05902780|Anesthetics|anesthetics|mesh-ancestor
153520531|NCT05902780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520532|NCT05902780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520533|NCT05902780|Sensory System Agents|sensory system agents|mesh-ancestor
153520534|NCT05902780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520535|NCT05902780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153520536|NCT05902780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520537|NCT05902780|Analgesics|analgesics|mesh-ancestor
153520538|NCT05902780|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153520539|NCT05902780|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153520540|NCT05902780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153520541|NCT05902780|Adrenergic Agents|adrenergic agents|mesh-ancestor
153520542|NCT05902780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520543|NCT05902780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520544|NCT05888831|Nivolumab|nivolumab|mesh-list
153520545|NCT05888831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520546|NCT05888831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520547|NCT05888831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520548|NCT05888831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520583|NCT05842174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153520584|NCT05842174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520585|NCT05842174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520586|NCT05842174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520587|NCT05842174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520588|NCT05842174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520589|NCT05840471|Tranexamic Acid|tranexamic acid|mesh-list
153520590|NCT05840471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153520591|NCT05840471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153520592|NCT05840471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520593|NCT05840471|Hemostatics|hemostatics|mesh-ancestor
153520594|NCT05840471|Coagulants|coagulants|mesh-ancestor
153520595|NCT05827978|Vaccines|vaccines|mesh-list
153520596|NCT05827978|Immunologic Factors|immunologic factors|mesh-ancestor
153520597|NCT05827978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520598|NCT05818085|Allopurinol|allopurinol|mesh-list
153520599|NCT05818085|Antimetabolites|antimetabolites|mesh-ancestor
153520600|NCT05818085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520601|NCT05818085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520602|NCT05818085|Gout Suppressants|gout suppressants|mesh-ancestor
153520603|NCT05818085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520604|NCT05818085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153520605|NCT05818085|Antioxidants|antioxidants|mesh-ancestor
153520606|NCT05818085|Protective Agents|protective agents|mesh-ancestor
153520607|NCT05818085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731726|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
153520608|NCT05813288|Pramipexole|pramipexole|mesh-list
153520609|NCT05813288|Dexpramipexole|dexpramipexole|mesh-list
153520610|NCT05813288|Antioxidants|antioxidants|mesh-ancestor
153520612|NCT05813288|Protective Agents|protective agents|mesh-ancestor
153520637|NCT05763329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520638|NCT05763329|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153520639|NCT05763329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153520640|NCT05763329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520641|NCT05763329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520642|NCT05763121|Pramipexole|pramipexole|mesh-list
153520643|NCT05763121|Dexpramipexole|dexpramipexole|mesh-list
153520644|NCT05763121|Antioxidants|antioxidants|mesh-ancestor
153520645|NCT05763121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520646|NCT05763121|Protective Agents|protective agents|mesh-ancestor
153520647|NCT05763121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618909|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520648|NCT05763121|Dopamine Agents|dopamine agents|mesh-ancestor
153520649|NCT05763121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520650|NCT05763121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153520651|NCT05763121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153520652|NCT05763121|Dopamine Agonists|dopamine agonists|mesh-ancestor
153520653|NCT05757219|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153520654|NCT05757219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520655|NCT05757219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520656|NCT05753436|Curcumin|curcumin|mesh-list
153520657|NCT05753436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153520658|NCT05753436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520659|NCT05753436|Analgesics|analgesics|mesh-ancestor
153520660|NCT05753436|Sensory System Agents|sensory system agents|mesh-ancestor
153520661|NCT05753436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520662|NCT05753436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520663|NCT05753436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153520664|NCT05753436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520702|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153520704|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
153520705|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520706|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520707|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153520708|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
153520709|NCT05697809|Hormones|hormones|mesh-ancestor
153520710|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520711|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153520712|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520713|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153520714|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
153520715|NCT05666206|Coagulants|coagulants|mesh-ancestor
153520716|NCT05663580|Rilpivirine|rilpivirine|mesh-list
153520717|NCT05663580|Cabotegravir|cabotegravir|mesh-list
153520718|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153520719|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153520720|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520721|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520722|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
153520723|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153520724|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153520725|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153520726|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153520727|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153520761|NCT05629585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520762|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520763|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520764|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
153520765|NCT05626101|Gemcitabine|gemcitabine|mesh-list
153520766|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520767|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
153646719|NCT02752815|Vincristine|vincristine|mesh-list
153646720|NCT02752815|Epirubicin|epirubicin|mesh-list
153646721|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646722|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
153513876|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
153520768|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520769|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520775|NCT05583188|Paclitaxel|paclitaxel|mesh-list
153520776|NCT05583188|Vinorelbine|vinorelbine|mesh-list
153520777|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153520778|NCT05583188|Gemcitabine|gemcitabine|mesh-list
153520779|NCT05583188|Nivolumab|nivolumab|mesh-list
153520817|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520846|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153520847|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153520849|NCT05512962|Hormones|hormones|mesh-ancestor
153520850|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520851|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520852|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153520853|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
153520854|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520855|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520856|NCT05504291|Carboplatin|carboplatin|mesh-list
153520857|NCT05504291|Etoposide|etoposide|mesh-list
153520944|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520945|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520946|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
153520947|NCT05389995|Methamphetamine|methamphetamine|mesh-list
153464085|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153520948|NCT05389995|Citric Acid|citric acid|mesh-list
153520977|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520978|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520979|NCT05369351|Urological Agents|urological agents|mesh-ancestor
153520980|NCT05362955|Fluorouracil|fluorouracil|mesh-list
153520981|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
153520982|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520983|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520984|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520985|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153520986|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
153520987|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520988|NCT05359861|Bevacizumab|bevacizumab|mesh-list
153520989|NCT05359861|Atezolizumab|atezolizumab|mesh-list
153520990|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520991|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520992|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153520993|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153520994|NCT05359861|Growth Substances|growth substances|mesh-ancestor
153520995|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520996|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
153618910|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153618911|NCT01980745|Filaricides|filaricides|mesh-ancestor
153464161|NCT01490502|Vitamin D|vitamin d|mesh-list
153521020|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521021|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521022|NCT05288348|Sufentanil|sufentanil|mesh-list
153521030|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153513915|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
153521031|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153521032|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
153521033|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
153521034|NCT05280743|Oxycodone|oxycodone|mesh-list
153521035|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153521036|NCT05280743|Narcotics|narcotics|mesh-ancestor
153521037|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521038|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521039|NCT05280743|Analgesics|analgesics|mesh-ancestor
153521040|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
153521041|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521042|NCT05247788|Ethanol|ethanol|mesh-list
153521043|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153521044|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521045|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521069|NCT05183854|Vaccines|vaccines|mesh-list
153521070|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153521071|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
153521072|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521073|NCT05174884|Etonogestrel|etonogestrel|mesh-list
153521074|NCT05174884|Desogestrel|desogestrel|mesh-list
153521075|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153521076|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
153521077|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153521078|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521079|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153521081|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153521121|NCT04871269|Dronabinol|dronabinol|mesh-list
153521122|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
153521123|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521124|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153521125|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153521126|NCT04871269|Analgesics|analgesics|mesh-ancestor
153521127|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
153521128|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521129|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153521130|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153521131|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521132|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521133|NCT04871269|Hormones|hormones|mesh-ancestor
153521134|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521135|NCT04863885|Nivolumab|nivolumab|mesh-list
153521136|NCT04863885|Ipilimumab|ipilimumab|mesh-list
153521137|NCT04863885|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153521138|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521139|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521140|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521142|NCT04863885|Immunoconjugates|immunoconjugates|mesh-ancestor
153521264|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
153521265|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521266|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521267|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153521268|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153521269|NCT04486118|Protective Agents|protective agents|mesh-ancestor
153521270|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521271|NCT04476277|Biotin|biotin|mesh-list
153521272|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
153521273|NCT04476277|Vitamins|vitamins|mesh-ancestor
153521274|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
153521275|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521276|NCT04439357|Trametinib|trametinib|mesh-list
153521277|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153521278|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521303|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
153521304|NCT04340882|Docetaxel|docetaxel|mesh-list
153521305|NCT04340882|Ramucirumab|ramucirumab|mesh-list
153521306|NCT04340882|Antibodies|antibodies|mesh-list
153521307|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
153521308|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153521309|NCT04340882|Lexatumumab|lexatumumab|mesh-list
153521310|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
153521311|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521312|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521313|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
153521314|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
153521315|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
153521316|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521367|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153521403|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153521405|NCT04162873|Analgesics|analgesics|mesh-ancestor
153521436|NCT04143217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153521437|NCT04143217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153521438|NCT04143217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521439|NCT04143217|Adrenergic Agents|adrenergic agents|mesh-ancestor
153521440|NCT04143217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521441|NCT04143217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521442|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153521443|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153521444|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
153521445|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521446|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521472|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153521473|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521474|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521475|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
153521476|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731734|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731735|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
153521477|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153521478|NCT03896321|Anticoagulants|anticoagulants|mesh-list
153521479|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153521480|NCT03891446|Bimatoprost|bimatoprost|mesh-list
153521481|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153521482|NCT03869437|Cefiderocol|cefiderocol|mesh-list
153521483|NCT03869437|Siderophores|siderophores|mesh-ancestor
153521525|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521526|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521527|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
153521528|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521529|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521530|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
153521531|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521532|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153521533|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153521565|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153521566|NCT03646058|Narcotics|narcotics|mesh-ancestor
153521567|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521568|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521569|NCT03646058|Analgesics|analgesics|mesh-ancestor
153521570|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
153521571|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521572|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153521573|NCT03641560|Androgens|androgens|mesh-list
153521574|NCT03641560|Hormones|hormones|mesh-ancestor
153521575|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521576|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521601|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521602|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
153521603|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153521604|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
153521605|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153521606|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
153521607|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521623|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521624|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153521625|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521626|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521657|NCT03310957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521658|NCT03310957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521659|NCT03310957|Immunoconjugates|immunoconjugates|mesh-ancestor
153521660|NCT03310957|Immunologic Factors|immunologic factors|mesh-ancestor
153731736|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153521661|NCT03310957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521662|NCT03289039|Fulvestrant|fulvestrant|mesh-list
153521663|NCT03289039|Neratinib|neratinib|mesh-list
153521664|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153521665|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521666|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153521667|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153521668|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
153521669|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521695|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521696|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153521697|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153521699|NCT03057106|Tremelimumab|tremelimumab|mesh-list
153521700|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521701|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521746|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153521747|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153521748|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521749|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521750|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153521751|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
153521752|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521753|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521754|NCT02542852|Ritonavir|ritonavir|mesh-list
153521755|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153521756|NCT02542852|Dolutegravir|dolutegravir|mesh-list
153521757|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153521758|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153521759|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
153521760|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521761|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521762|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153521763|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153521764|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
153521765|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521766|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153521795|NCT02456857|Bevacizumab|bevacizumab|mesh-list
153521796|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153521851|NCT02152631|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153521852|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521853|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521854|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521855|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521856|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
153521890|NCT02106572|Mitomycin|mitomycin|mesh-list
153521891|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153521892|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521893|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
153521894|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521895|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153521896|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521897|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153521898|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153521928|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521929|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153521930|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521931|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
153521932|NCT02048813|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153521933|NCT02048813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521934|NCT02048813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521935|NCT02030860|Gemcitabine|gemcitabine|mesh-list
153521936|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153521937|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521938|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
153522051|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153522052|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153522053|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153522054|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153618917|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465216|NCT00195624|Cyclosporine|cyclosporine|mesh-list
153731739|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522055|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522056|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522057|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153522058|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153522059|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
153522060|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522061|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153522062|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153522063|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153522064|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522065|NCT04909333|Exenatide|exenatide|mesh-list
153522066|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153522067|NCT04909333|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153522068|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153522069|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522142|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522143|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522144|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153522145|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153522146|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
153522149|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153522150|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522151|NCT04793529|Vitamins|vitamins|mesh-ancestor
153522152|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
153522153|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153522154|NCT06040684|Antibodies|antibodies|mesh-list
153522155|NCT06040684|Immunologic Factors|immunologic factors|mesh-ancestor
153522156|NCT06040684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522157|NCT06040489|Amphotericin B|amphotericin b|mesh-list
153522158|NCT06040489|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153522159|NCT06040489|Miltefosine|miltefosine|mesh-list
153522160|NCT06040489|Pentoxifylline|pentoxifylline|mesh-list
153514079|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153522161|NCT06040489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153522162|NCT06040489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522216|NCT06039592|Natriuretic Agents|natriuretic agents|mesh-ancestor
153522217|NCT06039592|Expectorants|expectorants|mesh-ancestor
153522218|NCT06039592|Respiratory System Agents|respiratory system agents|mesh-ancestor
153522219|NCT06039592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153522220|NCT06039592|Protease Inhibitors|protease inhibitors|mesh-ancestor
153522221|NCT06039592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522222|NCT06039592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153522247|NCT06039540|Expectorants|expectorants|mesh-ancestor
153522248|NCT06039540|Respiratory System Agents|respiratory system agents|mesh-ancestor
153522249|NCT06039540|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153522250|NCT06039540|Protease Inhibitors|protease inhibitors|mesh-ancestor
153522251|NCT06039540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522252|NCT06039540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153522253|NCT06039540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153522254|NCT06039423|Ketorolac|ketorolac|mesh-list
153522255|NCT06039423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153522256|NCT06039423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153522257|NCT06039423|Analgesics|analgesics|mesh-ancestor
153522258|NCT06039423|Sensory System Agents|sensory system agents|mesh-ancestor
153522259|NCT06039423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522260|NCT06039423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522261|NCT06039423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153522262|NCT06039423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153522263|NCT06039423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153522264|NCT06039423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522265|NCT06039423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522266|NCT06039280|Acetylcysteine|acetylcysteine|mesh-list
153522267|NCT06039280|Dexamethasone|dexamethasone|mesh-list
153522268|NCT06039280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153522269|NCT06039280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153522270|NCT06039280|Antiemetics|antiemetics|mesh-ancestor
153522271|NCT06039280|Autonomic Agents|autonomic agents|mesh-ancestor
153522301|NCT06039202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522302|NCT06039150|Anesthetics|anesthetics|mesh-list
153522303|NCT06039150|Anesthetics, Local|anesthetics, local|mesh-list
153522304|NCT06039150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153522305|NCT06039150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522306|NCT06039150|Sensory System Agents|sensory system agents|mesh-ancestor
153522307|NCT06039150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522308|NCT06039124|Bevacizumab|bevacizumab|mesh-list
153522309|NCT06039124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522310|NCT06039124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522311|NCT06039124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153522312|NCT06039124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153522313|NCT06039124|Growth Substances|growth substances|mesh-ancestor
153731740|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153731741|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
153731742|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153522314|NCT06039124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522315|NCT06039124|Growth Inhibitors|growth inhibitors|mesh-ancestor
153522350|NCT06037434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153522351|NCT06037434|Hormone Antagonists|hormone antagonists|mesh-ancestor
153522442|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522476|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522477|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522478|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522479|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
153522481|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522482|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522513|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522515|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
153522516|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
153522517|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522518|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522519|NCT05284214|Ipilimumab|ipilimumab|mesh-list
153522520|NCT05284214|Sargramostim|sargramostim|mesh-list
153522521|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522522|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522523|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522524|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522525|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
153522553|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522554|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153522555|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522556|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522557|NCT05086627|Capecitabine|capecitabine|mesh-list
153522558|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
153522559|NCT05086627|Tislelizumab|tislelizumab|mesh-list
153522560|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153522570|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
153522571|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522572|NCT04917861|Vaccines|vaccines|mesh-list
153522573|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
153522641|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522642|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
153522643|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522644|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153522645|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153522646|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522647|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153522648|NCT04561206|Nivolumab|nivolumab|mesh-list
153522649|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153522650|NCT04561206|Antibodies|antibodies|mesh-list
153522651|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
153522652|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153522653|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
153522654|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
153522655|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522656|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522657|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522681|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522683|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522684|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522685|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153522686|NCT04328714|Interferons|interferons|mesh-list
153522687|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
153522688|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522689|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
153522690|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522691|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153522695|NCT04237649|Spartalizumab|spartalizumab|mesh-list
153522698|NCT04237649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522699|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522700|NCT04225988|Tacrolimus|tacrolimus|mesh-list
153522701|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522702|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
153522703|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522777|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
153522778|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
153522808|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
153522809|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522810|NCT03498716|Paclitaxel|paclitaxel|mesh-list
153522811|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
153522812|NCT03498716|Doxorubicin|doxorubicin|mesh-list
153522813|NCT03498716|Atezolizumab|atezolizumab|mesh-list
153522814|NCT03498716|Epirubicin|epirubicin|mesh-list
153522815|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153522816|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522817|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
153522818|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
153522854|NCT03390686|Carboplatin|carboplatin|mesh-list
153522855|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153522889|NCT03233347|Daunorubicin|daunorubicin|mesh-list
153522890|NCT03233347|Dacarbazine|dacarbazine|mesh-list
153522891|NCT03233347|Vinblastine|vinblastine|mesh-list
153522892|NCT03233347|Antibodies|antibodies|mesh-list
153522893|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
153522894|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153731744|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522927|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153522928|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153522929|NCT02940496|Ribavirin|ribavirin|mesh-list
153522930|NCT02940496|Grazoprevir|grazoprevir|mesh-list
153522931|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153522932|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
153522933|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522962|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153522963|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
153522964|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153522965|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522966|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
153522967|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153522968|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522969|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522970|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153522971|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153522972|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153522973|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153522974|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153522975|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153522977|NCT02265770|Cisplatin|cisplatin|mesh-list
153522978|NCT02265770|Carboplatin|carboplatin|mesh-list
153523013|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523014|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153523015|NCT02140242|Daunorubicin|daunorubicin|mesh-list
153523016|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153523017|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523018|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153523056|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
153523057|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523085|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
153523086|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153523087|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153523088|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153523095|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153523096|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
153523097|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523098|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523099|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153523100|NCT04787289|Bevacizumab|bevacizumab|mesh-list
153523101|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523136|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
153523137|NCT04705727|Hormones|hormones|mesh-ancestor
153523138|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523139|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153523140|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153523141|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153523213|NCT04518410|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
153523215|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
153523216|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153523217|NCT04518410|Antibodies|antibodies|mesh-list
153523299|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523300|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523301|NCT04228289|Oxytocin|oxytocin|mesh-list
153523302|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
153523303|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153523304|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523305|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153523306|NCT04215536|Empagliflozin|empagliflozin|mesh-list
153523307|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153523308|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153523309|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523310|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153523311|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523312|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523313|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523314|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
153523315|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153523316|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153466492|NCT00362466|Dasatinib|dasatinib|mesh-list
153523317|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523318|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153523355|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153523356|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
153523357|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153523358|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153523359|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618925|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153523392|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523438|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153523454|NCT03877354|Anesthetics|anesthetics|mesh-list
153523455|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523456|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523457|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153523458|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523459|NCT03821272|Vaccines|vaccines|mesh-list
153523460|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
153523461|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523462|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
153523463|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153523464|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523465|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
153523466|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
153523467|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523468|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523469|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153523470|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
153523471|NCT03818737|Hormones|hormones|mesh-ancestor
153523472|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523473|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153523474|NCT03818737|Protective Agents|protective agents|mesh-ancestor
153523475|NCT03777982|Prednisone|prednisone|mesh-list
153523476|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
153523477|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523478|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
153523479|NCT03777982|Hormones|hormones|mesh-ancestor
153514324|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523480|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523481|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523482|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153523483|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523484|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153523494|NCT03769025|Analgesics|analgesics|mesh-ancestor
153523495|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
153523528|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523530|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153523531|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153523532|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153523533|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153523534|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
153523535|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
153523536|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153523537|NCT03613792|Narcotics|narcotics|mesh-ancestor
153523538|NCT03575598|Nivolumab|nivolumab|mesh-list
153523539|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466707|NCT00393978|Topiramate|topiramate|mesh-list
153523576|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
153523577|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523578|NCT03423667|Protective Agents|protective agents|mesh-ancestor
153523579|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523580|NCT03423667|Antidotes|antidotes|mesh-ancestor
153523581|NCT03419897|Tislelizumab|tislelizumab|mesh-list
153523599|NCT03335488|Glycerol|glycerol|mesh-list
153523600|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153523601|NCT03335488|Protective Agents|protective agents|mesh-ancestor
153523602|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523603|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523604|NCT03323437|Risperidone|risperidone|mesh-list
153523605|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153523606|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
153523607|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523608|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523609|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523610|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153523611|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153523617|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153523618|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523619|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153523620|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153523621|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523622|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523623|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523625|NCT03219047|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153523626|NCT03219047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153523627|NCT03219047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523628|NCT03219047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523629|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
153523630|NCT03215277|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153523631|NCT03215277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523632|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153523633|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
153523634|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523635|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523636|NCT03182907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153523637|NCT03182907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523647|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523648|NCT02911701|Acetaminophen|acetaminophen|mesh-list
153523649|NCT02911701|Ibuprofen|ibuprofen|mesh-list
153523650|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153523651|NCT02911701|Analgesics|analgesics|mesh-ancestor
153523652|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
153523653|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523654|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523655|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
153523656|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153523657|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523658|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523659|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153523660|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523664|NCT02874742|Bortezomib|bortezomib|mesh-list
153523665|NCT02874742|Daratumumab|daratumumab|mesh-list
153523666|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523667|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
153523668|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
153523669|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523670|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523671|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153523672|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
153523673|NCT02874742|Hormones|hormones|mesh-ancestor
153523674|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523675|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153523676|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523677|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
153523678|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523679|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153523680|NCT02874742|Growth Substances|growth substances|mesh-ancestor
153523681|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
153523682|NCT02749292|Rituximab|rituximab|mesh-list
153523683|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523684|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523685|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
153523686|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523687|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523689|NCT02715609|Temozolomide|temozolomide|mesh-list
153523690|NCT02715609|Disulfiram|disulfiram|mesh-list
153523691|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153523692|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
153523693|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523694|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514412|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523695|NCT02715609|Trace Elements|trace elements|mesh-ancestor
153523696|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
153523697|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523698|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153523725|NCT02494882|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153523726|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153523727|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523728|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523729|NCT02481830|Nivolumab|nivolumab|mesh-list
153523730|NCT02481830|Topotecan|topotecan|mesh-list
153523731|NCT02481830|Amrubicin|amrubicin|mesh-list
153523732|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523733|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523734|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523735|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523736|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153523737|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153523738|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523739|NCT02425943|Mannitol|mannitol|mesh-list
153523740|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153523741|NCT02425943|Diuretics|diuretics|mesh-ancestor
153523742|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
153523743|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523744|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153523745|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
153523746|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523747|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
153523748|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523749|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523750|NCT02362997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523751|NCT02362997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523753|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153523754|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
153523797|NCT01772420|Lenalidomide|lenalidomide|mesh-list
153523798|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
153523799|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523800|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523801|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153523802|NCT01772420|Growth Substances|growth substances|mesh-ancestor
153523803|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
153523804|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514447|NCT01425775|Vitamin D|vitamin d|mesh-list
153523805|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153523806|NCT01728363|Rifampin|rifampin|mesh-list
153523807|NCT01728363|Clindamycin|clindamycin|mesh-list
153523828|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153523829|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153523830|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153523831|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
153523832|NCT01614197|Methotrexate|methotrexate|mesh-list
153523833|NCT01614197|Etoposide|etoposide|mesh-list
153523834|NCT01614197|Temsirolimus|temsirolimus|mesh-list
153523835|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153523836|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
153523837|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523838|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523839|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153523840|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
153523841|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523842|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523843|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153523845|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
153523894|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153523895|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153523896|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153523897|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
153523909|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523911|NCT01042379|Paclitaxel|paclitaxel|mesh-list
153523912|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153523913|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153523914|NCT01042379|Carboplatin|carboplatin|mesh-list
153523915|NCT01042379|Doxorubicin|doxorubicin|mesh-list
153523916|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
153523917|NCT01042379|Trastuzumab|trastuzumab|mesh-list
153523918|NCT01042379|Irinotecan|irinotecan|mesh-list
153523919|NCT01042379|Durvalumab|durvalumab|mesh-list
153523920|NCT01042379|Letrozole|letrozole|mesh-list
153523921|NCT01042379|Olaparib|olaparib|mesh-list
153523922|NCT01042379|Pertuzumab|pertuzumab|mesh-list
153523923|NCT01042379|Cemiplimab|cemiplimab|mesh-list
153523924|NCT01042379|Veliparib|veliparib|mesh-list
153523925|NCT01042379|Talazoparib|talazoparib|mesh-list
153523926|NCT01042379|Dostarlimab|dostarlimab|mesh-list
153523927|NCT01042379|Trebananib|trebananib|mesh-list
153523928|NCT01042379|Tucatinib|tucatinib|mesh-list
153523929|NCT01042379|Neratinib|neratinib|mesh-list
153523930|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153523931|NCT01042379|SGN-LIV1A|sgn-liv1a|mesh-list
153523932|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153523933|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523934|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
153523935|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
153523936|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
153523937|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523938|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153523939|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523940|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153523941|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153523942|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153523943|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523944|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523948|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153523949|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153523950|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153523951|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
153514490|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523952|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523953|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153523954|NCT01042379|Immunotoxins|immunotoxins|mesh-ancestor
153523955|NCT01042379|Immunoconjugates|immunoconjugates|mesh-ancestor
153523956|NCT01042379|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153523957|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153523958|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523959|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153523960|NCT01042379|Growth Substances|growth substances|mesh-ancestor
153523961|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
153523962|NCT00544115|Cyclosporine|cyclosporine|mesh-list
153523963|NCT00544115|Sirolimus|sirolimus|mesh-list
153523964|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
153523965|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
153523966|NCT00544115|Melphalan|melphalan|mesh-list
153523988|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
153523989|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523990|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153523991|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153523992|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153523993|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153523994|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153523995|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153524016|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
153524017|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524018|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153524019|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524032|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524034|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153524035|NCT01456585|Gemcitabine|gemcitabine|mesh-list
153524036|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153524037|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
153524038|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524039|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524040|NCT01456650|Glyburide|glyburide|mesh-list
153524041|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524042|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524043|NCT01457040|Etoposide|etoposide|mesh-list
153524044|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
153524045|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153524046|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524047|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153524048|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153524049|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514508|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
153524050|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524051|NCT01457508|Edetic Acid|edetic acid|mesh-list
153524052|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
153524053|NCT01457508|Antidotes|antidotes|mesh-ancestor
153524054|NCT01457508|Protective Agents|protective agents|mesh-ancestor
153524055|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524056|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
153524057|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
153524058|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524059|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153524060|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
153524061|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153524062|NCT01458431|Anesthetics|anesthetics|mesh-list
153524067|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
153524068|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524069|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
153524070|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153524071|NCT01459445|Metformin|metformin|mesh-list
153524072|NCT01459445|Drospirenone|drospirenone|mesh-list
153467243|NCT00478218|Hormones|hormones|mesh-ancestor
153524073|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153524074|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524075|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524076|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153524077|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
153524078|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524079|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153524080|NCT01459445|Diuretics|diuretics|mesh-ancestor
153524081|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
153524098|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524099|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524100|NCT01460069|Incretins|incretins|mesh-ancestor
153524101|NCT01460069|Hormones|hormones|mesh-ancestor
153524102|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524103|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153524104|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
153524105|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524106|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
153524107|NCT01460212|Citalopram|citalopram|mesh-list
153524127|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524128|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153524129|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153524130|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
153524131|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153524132|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153514556|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
153524133|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153524134|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524135|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524136|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
153524165|NCT01460563|Analgesics|analgesics|mesh-ancestor
153524166|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
153524167|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524168|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524169|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
153524170|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524171|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153524172|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
153524173|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153524174|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524175|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524176|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153524177|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
153524178|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153524179|NCT01460602|Rituximab|rituximab|mesh-list
153524180|NCT01460602|Bortezomib|bortezomib|mesh-list
153524201|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524219|NCT01460979|MTOR Inhibitors|mtor inhibitors|mesh-list
153524220|NCT01460979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524221|NCT01460979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524222|NCT01460979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524223|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153524224|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
153524225|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524226|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524227|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524228|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524229|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153524230|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
153524231|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
153524232|NCT01461018|Antibodies|antibodies|mesh-list
153524233|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
153524234|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153524235|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153524251|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524252|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524253|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
153524254|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153524255|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153524256|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
153524257|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153524265|NCT01461460|Tedizolid|tedizolid|mesh-list
153524280|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
153524281|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
153524282|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524283|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524284|NCT01461746|Docetaxel|docetaxel|mesh-list
153524285|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514601|NCT04850378|Tinzaparin|tinzaparin|mesh-list
153524286|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
153524287|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
153524288|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
153524289|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524290|NCT01461759|Cisplatin|cisplatin|mesh-list
153524291|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524292|NCT01461772|Carboplatin|carboplatin|mesh-list
153524293|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524294|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153524295|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
153524296|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524307|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
153524309|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
153524310|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524311|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153524312|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153524313|NCT01462149|Carboplatin|carboplatin|mesh-list
153524314|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524315|NCT01462214|Everolimus|everolimus|mesh-list
153524316|NCT01462214|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153524317|NCT01462214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524318|NCT01462214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524319|NCT01462214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524320|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153524321|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
153524322|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524331|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
153524332|NCT01462474|Cisplatin|cisplatin|mesh-list
153524333|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524334|NCT01462487|Zanamivir|zanamivir|mesh-list
153524335|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
153524336|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524337|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524338|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524339|NCT01462500|Miltefosine|miltefosine|mesh-list
153524340|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
153524341|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524342|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524343|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153524344|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153524345|NCT01462617|Nemiralisib|nemiralisib|mesh-list
153514618|NCT04765371|Dexamethasone|dexamethasone|mesh-list
153524346|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524347|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524348|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524349|NCT01462669|Ezogabine|ezogabine|mesh-list
153524350|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
153524351|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524352|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524353|NCT01462903|Immunomodulating Agents|immunomodulating agents|mesh-list
153524354|NCT01462903|Immunologic Factors|immunologic factors|mesh-ancestor
153524355|NCT01462903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524356|NCT01462968|Heparin|heparin|mesh-list
153524357|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
153524358|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153524359|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153524457|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524458|NCT01463735|Protective Agents|protective agents|mesh-ancestor
153524459|NCT01463774|Metformin|metformin|mesh-list
153524460|NCT01463774|Canagliflozin|canagliflozin|mesh-list
153524461|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524462|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524463|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153524464|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524465|NCT01463813|Vitamin D|vitamin d|mesh-list
153524466|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
153524467|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
153524468|NCT01463813|Vitamins|vitamins|mesh-list
153524469|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
153524470|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524471|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153524472|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153524473|NCT01463852|Vincristine|vincristine|mesh-list
153524474|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153524475|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524476|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
153524477|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
153524478|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
153524479|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524480|NCT01463865|Ropivacaine|ropivacaine|mesh-list
153524481|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
153524482|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
153524483|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524484|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524485|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
153524486|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524487|NCT01463956|Interferons|interferons|mesh-list
153524488|NCT01463956|Ribavirin|ribavirin|mesh-list
153524496|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
153524497|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
153524498|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153514692|NCT03945084|Niraparib|niraparib|mesh-list
153524499|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524500|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
153524501|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524502|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
153524503|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524504|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
153524505|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524516|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153524517|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153524518|NCT01464099|Insulin|insulin|mesh-list
153524519|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153524520|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
153524521|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
153524522|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153524523|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524524|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524525|NCT01464112|Dexamethasone|dexamethasone|mesh-list
153524526|NCT01464112|Bortezomib|bortezomib|mesh-list
153524527|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153524528|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
153524529|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
153524530|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524531|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524532|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153524533|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
153524550|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524551|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153524552|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
153524553|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153524554|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524555|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524556|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153524557|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153524558|NCT01464242|Protective Agents|protective agents|mesh-ancestor
153524559|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524560|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
153524561|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153524562|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
153524563|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153524564|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153524565|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524566|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153524567|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
153524568|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524569|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
153524570|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153524571|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
153524572|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153524585|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153524586|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153524587|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153524588|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
153524589|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524593|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
153524608|NCT01466712|Beclomethasone|beclomethasone|mesh-list
153524609|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
153524610|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
153524611|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153524612|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
153524613|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524614|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524615|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153524616|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
153524617|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153524618|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153524619|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153524620|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
153524621|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524622|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524623|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
153524624|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153524625|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
153524626|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153524627|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
153524628|NCT01466712|Hormones|hormones|mesh-ancestor
153524669|NCT01467115|Docetaxel|docetaxel|mesh-list
153524670|NCT01467115|Fluorouracil|fluorouracil|mesh-list
153524671|NCT01467115|Cetuximab|cetuximab|mesh-list
153524672|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
153524673|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
153524674|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524675|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
153524676|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
153524677|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
153524678|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524679|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
153524680|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153524681|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153524682|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
153524683|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524684|NCT01467115|Antidotes|antidotes|mesh-ancestor
153524685|NCT01467115|Protective Agents|protective agents|mesh-ancestor
153524686|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
153524687|NCT01467115|Vitamins|vitamins|mesh-ancestor
153524688|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
153524689|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153524690|NCT01467115|Hematinics|hematinics|mesh-ancestor
153524691|NCT01467141|Insulin|insulin|mesh-list
153524692|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153524693|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
153524694|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
153524729|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524731|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524732|NCT01467323|Insulin|insulin|mesh-list
153524750|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
153524751|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524752|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524753|NCT01467414|Insulin|insulin|mesh-list
153524754|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524755|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524766|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
153524767|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153524768|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153524769|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524770|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524771|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153524772|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153524773|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
153524774|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524777|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153524778|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153524779|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524780|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524781|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153524782|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153524783|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
153524784|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524785|NCT01467596|Lidocaine|lidocaine|mesh-list
153524786|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
153524787|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
153524788|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
153524789|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524790|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524791|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
153524792|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524793|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153524794|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153524795|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153524796|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524816|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524828|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524829|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524830|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153524831|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
153524832|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524833|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524834|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153524835|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
153524836|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153524837|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
153524838|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524839|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524840|NCT01467986|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153524842|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153524843|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153524845|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
153524846|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524847|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524848|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153524849|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153524850|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
153524851|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153524861|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153524862|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524863|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524865|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
153524866|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153524867|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
153524868|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153524869|NCT01468051|Vaccines|vaccines|mesh-list
153524870|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
153524876|NCT01468155|Dabigatran|dabigatran|mesh-list
153524877|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
153524878|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153524879|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
153524880|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524881|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524882|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
153524883|NCT01468259|Droxidopa|droxidopa|mesh-list
153524884|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153524885|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153524886|NCT01468272|Beclomethasone|beclomethasone|mesh-list
153524887|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
153524888|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153524889|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
153524890|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524891|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524892|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153524893|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
153524894|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153524895|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153524896|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153524897|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
153524898|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524899|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524900|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153524901|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
153524902|NCT01468272|Hormones|hormones|mesh-ancestor
153524903|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524904|NCT01468285|Betahistine|betahistine|mesh-list
153524905|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
153524906|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
153524907|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
153524908|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524909|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524910|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524914|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514816|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
153524937|NCT01468467|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153524938|NCT01468467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524940|NCT01468467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524941|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
153524942|NCT01468480|Calcium|calcium|mesh-list
153524943|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153524944|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524945|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153524946|NCT01468519|Insulin|insulin|mesh-list
153524947|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153524948|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524949|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524950|NCT01468545|Iloprost|iloprost|mesh-list
153524951|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153524952|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
153524953|NCT01468571|Spironolactone|spironolactone|mesh-list
153524954|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153524955|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
153524956|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524957|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524958|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153524959|NCT01468571|Diuretics|diuretics|mesh-ancestor
153524960|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
153524961|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153524962|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153524963|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153524985|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524986|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524987|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153524989|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
153524990|NCT01468740|Dacarbazine|dacarbazine|mesh-list
153524991|NCT01468740|Doxorubicin|doxorubicin|mesh-list
153524992|NCT01468740|Etoposide|etoposide|mesh-list
153524993|NCT01468740|Vincristine|vincristine|mesh-list
153524994|NCT01468740|Bleomycin|bleomycin|mesh-list
153524995|NCT01468740|Vinblastine|vinblastine|mesh-list
153524996|NCT01468740|Procarbazine|procarbazine|mesh-list
153524997|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153524998|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
153524999|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525000|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153525001|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153525002|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
153525003|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525009|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525051|NCT06077708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153525052|NCT06077682|Tropicamide|tropicamide|mesh-list
153525053|NCT06077682|Cyclopentolate|cyclopentolate|mesh-list
153525054|NCT06077682|Mydriatics|mydriatics|mesh-ancestor
153525055|NCT06077682|Autonomic Agents|autonomic agents|mesh-ancestor
153525056|NCT06077682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525057|NCT06077682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525058|NCT06077682|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153525059|NCT06077682|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153525060|NCT06077682|Cholinergic Agents|cholinergic agents|mesh-ancestor
153525061|NCT06077682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525062|NCT06077682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525063|NCT06077682|Parasympatholytics|parasympatholytics|mesh-ancestor
153525064|NCT06077539|Dexmedetomidine|dexmedetomidine|mesh-list
153525065|NCT06077539|Ketamine|ketamine|mesh-list
153525066|NCT06077539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153525067|NCT06077539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525068|NCT06077539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525069|NCT06077539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525070|NCT06077539|Analgesics|analgesics|mesh-ancestor
153525071|NCT06077539|Sensory System Agents|sensory system agents|mesh-ancestor
153525072|NCT06077539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525073|NCT06077539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153525074|NCT06077539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153525075|NCT06077539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153525076|NCT06077539|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525077|NCT06077539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525118|NCT06077019|Respiratory System Agents|respiratory system agents|mesh-ancestor
153525120|NCT06077019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153525121|NCT06076837|Chloroquine|chloroquine|mesh-list
153525122|NCT06076837|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153525123|NCT06076837|Celecoxib|celecoxib|mesh-list
153525124|NCT06076837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153525125|NCT06076837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525126|NCT06076837|Analgesics|analgesics|mesh-ancestor
153525127|NCT06076837|Sensory System Agents|sensory system agents|mesh-ancestor
153525128|NCT06076837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525129|NCT06076837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525130|NCT06076837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525131|NCT06076837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153525132|NCT06076837|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153525133|NCT06076837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153525134|NCT06076837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525135|NCT06076837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525136|NCT06076837|Amebicides|amebicides|mesh-ancestor
153525137|NCT06076837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153525138|NCT06076837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153525139|NCT06076837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525140|NCT06076837|Antimalarials|antimalarials|mesh-ancestor
153525141|NCT06076837|Filaricides|filaricides|mesh-ancestor
153525142|NCT06076837|Antinematodal Agents|antinematodal agents|mesh-ancestor
153525143|NCT06076837|Anthelmintics|anthelmintics|mesh-ancestor
153514892|NCT01426165|Analgesics|analgesics|mesh-ancestor
153525144|NCT06076824|Methylprednisolone|methylprednisolone|mesh-list
153525145|NCT06076824|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153525146|NCT06076824|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153525147|NCT06076824|Prednisolone|prednisolone|mesh-list
153525168|NCT06076772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525169|NCT06076772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525170|NCT06076772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153525177|NCT06076759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525178|NCT06076759|Analgesics|analgesics|mesh-ancestor
153525179|NCT06076759|Sensory System Agents|sensory system agents|mesh-ancestor
153525180|NCT06076759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525181|NCT06076759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153525182|NCT06076759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153525183|NCT06076759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153525184|NCT06076759|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525185|NCT06076759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525186|NCT06076759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525187|NCT06076759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153525188|NCT06076759|Narcotics|narcotics|mesh-ancestor
153525189|NCT06076642|Immunoglobulins|immunoglobulins|mesh-list
153525190|NCT06076642|gamma-Globulins|gamma-globulins|mesh-list
153525191|NCT06076642|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153525192|NCT06076642|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153525193|NCT06076642|Immunologic Factors|immunologic factors|mesh-ancestor
153525194|NCT06076642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525195|NCT06076603|Polymyxins|polymyxins|mesh-list
153525196|NCT06076603|Polymyxin B|polymyxin b|mesh-list
153525197|NCT06076603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153468368|NCT06297915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153525198|NCT06076603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525199|NCT06074367|Vitamins|vitamins|mesh-list
153525200|NCT06074367|Ascorbic Acid|ascorbic acid|mesh-list
153525201|NCT06074367|Micronutrients|micronutrients|mesh-ancestor
153525202|NCT06074367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525227|NCT06073730|Antimetabolites|antimetabolites|mesh-ancestor
153525228|NCT06073730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525229|NCT06073730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525230|NCT06073730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525231|NCT06073730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153525232|NCT06073015|Esketamine|esketamine|mesh-list
153525233|NCT06073015|Antidepressive Agents|antidepressive agents|mesh-ancestor
153525234|NCT06073015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153525236|NCT06072898|Psilocybin|psilocybin|mesh-list
153525237|NCT06072898|Vitamins|vitamins|mesh-ancestor
153525244|NCT06072898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153525245|NCT06072898|Vasodilator Agents|vasodilator agents|mesh-ancestor
153525246|NCT06072898|Hallucinogens|hallucinogens|mesh-ancestor
153525247|NCT06072898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153525248|NCT06072729|Magnesium Sulfate|magnesium sulfate|mesh-list
153525249|NCT06072729|Analgesics|analgesics|mesh-ancestor
153525250|NCT06072729|Sensory System Agents|sensory system agents|mesh-ancestor
153525251|NCT06072729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525252|NCT06072729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525253|NCT06072729|Anesthetics|anesthetics|mesh-ancestor
153525282|NCT06072547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525283|NCT06072352|Chlorhexidine|chlorhexidine|mesh-list
153514925|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153525284|NCT06072352|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153525285|NCT06072352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153525286|NCT06072352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525287|NCT06072352|Disinfectants|disinfectants|mesh-ancestor
153525288|NCT06072352|Dermatologic Agents|dermatologic agents|mesh-ancestor
153525289|NCT06072248|Meropenem|meropenem|mesh-list
153525290|NCT06072248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153525291|NCT06072248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525292|NCT06072222|Meropenem|meropenem|mesh-list
153525293|NCT06072222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153525294|NCT06072222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525295|NCT06072118|Adrenomedullin|adrenomedullin|mesh-list
153525296|NCT06072118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153525297|NCT06072118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153525298|NCT06072118|Autonomic Agents|autonomic agents|mesh-ancestor
153525313|NCT06071871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525315|NCT06071871|Immunologic Factors|immunologic factors|mesh-ancestor
153525325|NCT06071208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153525326|NCT06071208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525327|NCT06071208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153525328|NCT06071208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525329|NCT06067698|Thioctic Acid|thioctic acid|mesh-list
153525330|NCT06067698|Mesalamine|mesalamine|mesh-list
153525331|NCT06067698|Antioxidants|antioxidants|mesh-ancestor
153525332|NCT06067698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525333|NCT06067698|Protective Agents|protective agents|mesh-ancestor
153525334|NCT06067698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525335|NCT06067698|Vitamin B Complex|vitamin b complex|mesh-ancestor
153525336|NCT06067698|Vitamins|vitamins|mesh-ancestor
153525337|NCT06067698|Micronutrients|micronutrients|mesh-ancestor
153525338|NCT06067698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153525339|NCT06067698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525340|NCT06067698|Analgesics|analgesics|mesh-ancestor
153525341|NCT06067698|Sensory System Agents|sensory system agents|mesh-ancestor
153525342|NCT06067698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525343|NCT06067698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525344|NCT06067698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153525345|NCT06066827|Minoxidil|minoxidil|mesh-list
153525346|NCT06066827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153525347|NCT06066827|Vasodilator Agents|vasodilator agents|mesh-ancestor
153525348|NCT06064864|Infliximab|infliximab|mesh-list
153525349|NCT06064864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153525350|NCT06064864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525351|NCT06064864|Dermatologic Agents|dermatologic agents|mesh-ancestor
153525352|NCT06064864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153525353|NCT06064864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153525354|NCT06060704|Trifluridine|trifluridine|mesh-list
153525380|NCT06048588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153525381|NCT06048588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525382|NCT06020781|Dexmedetomidine|dexmedetomidine|mesh-list
153525383|NCT06020781|Bupivacaine|bupivacaine|mesh-list
153525384|NCT06020781|Anesthetics, Local|anesthetics, local|mesh-ancestor
153525385|NCT06020781|Anesthetics|anesthetics|mesh-ancestor
153525386|NCT06020781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525387|NCT06020781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525388|NCT06020781|Sensory System Agents|sensory system agents|mesh-ancestor
153525389|NCT06020781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525390|NCT06020781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153525391|NCT06020781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525392|NCT06020781|Analgesics|analgesics|mesh-ancestor
153525393|NCT06020781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153731745|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525394|NCT06020781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153525395|NCT06020781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153525396|NCT06020781|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525397|NCT06020781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525398|NCT06020781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525400|NCT06017583|Oxaliplatin|oxaliplatin|mesh-list
153525401|NCT06017583|Tislelizumab|tislelizumab|mesh-list
153525402|NCT06017583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525403|NCT06017583|Antimetabolites|antimetabolites|mesh-ancestor
153525405|NCT06017583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525455|NCT05939674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525456|NCT05939674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525457|NCT05900466|Metformin|metformin|mesh-list
153525458|NCT05900466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153525459|NCT05900466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525460|NCT05875961|MF59 oil emulsion|mf59 oil emulsion|mesh-list
153525461|NCT05875961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153525462|NCT05875961|Immunologic Factors|immunologic factors|mesh-ancestor
153525463|NCT05875961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525464|NCT05860881|Sirolimus|sirolimus|mesh-list
153525465|NCT05860881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153525466|NCT05860881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525467|NCT05860881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153525468|NCT05860881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525490|NCT05789303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153525491|NCT05789303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525492|NCT05789303|Immunologic Factors|immunologic factors|mesh-ancestor
153525493|NCT05789303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153525494|NCT05789303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153525495|NCT05789303|Growth Substances|growth substances|mesh-ancestor
153525560|NCT05746273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153525561|NCT05746273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153525562|NCT05746273|Cholinergic Agents|cholinergic agents|mesh-ancestor
153525563|NCT05746273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525564|NCT05746273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525566|NCT05742295|Vitamins|vitamins|mesh-ancestor
153525567|NCT05742295|Micronutrients|micronutrients|mesh-ancestor
153525581|NCT05728372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525582|NCT05728372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153514963|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153525583|NCT05728372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525584|NCT05728372|Trace Elements|trace elements|mesh-ancestor
153525585|NCT05728372|Micronutrients|micronutrients|mesh-ancestor
153525586|NCT05728372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525587|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
153525588|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153525589|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525590|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525591|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525592|NCT05700045|Analgesics|analgesics|mesh-ancestor
153525593|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
153525594|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525595|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153525596|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153525597|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153525598|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525599|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525600|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525601|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153525602|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153525603|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525604|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
153525612|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525613|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525614|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
153525615|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525616|NCT05658146|Sulconazole|sulconazole|mesh-list
153525617|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
153525618|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525619|NCT05646199|Metformin|metformin|mesh-list
153525620|NCT05646199|Semaglutide|semaglutide|mesh-list
153525621|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153525622|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525623|NCT05646199|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153525624|NCT05641649|Valproic Acid|valproic acid|mesh-list
153525625|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
153525626|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525627|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525628|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
153525629|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525655|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
153525656|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525658|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
153525659|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525660|NCT05569148|Faricimab|faricimab|mesh-list
153525661|NCT05569148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153525662|NCT05569148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153525663|NCT05569148|Growth Substances|growth substances|mesh-ancestor
153525664|NCT05569148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525665|NCT05569148|Growth Inhibitors|growth inhibitors|mesh-ancestor
153525666|NCT05569148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525667|NCT05558124|Cytarabine|cytarabine|mesh-list
153525668|NCT05558124|Daunorubicin|daunorubicin|mesh-list
153525669|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
153525670|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525676|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153525741|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525742|NCT05307198|Capecitabine|capecitabine|mesh-list
153525743|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
153525744|NCT05307198|Antibodies|antibodies|mesh-list
153525745|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153525746|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
153525747|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525748|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525749|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
153525750|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525751|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525752|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153525753|NCT05293938|Cathartics|cathartics|mesh-ancestor
153525754|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153525755|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
153525756|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
153525828|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
153745654|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153525829|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525830|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525831|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153525832|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
153525833|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
153525834|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
153525835|NCT05085574|Celecoxib|celecoxib|mesh-list
153525836|NCT05085574|Famotidine|famotidine|mesh-list
153525837|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153525838|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525839|NCT05085574|Analgesics|analgesics|mesh-ancestor
153525840|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
153525841|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525842|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525843|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525844|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153525845|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153525846|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153525847|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525848|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525849|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153525850|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153525851|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153525852|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
153525853|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
153525854|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525855|NCT05084248|Vitamin D|vitamin d|mesh-list
153525856|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
153525872|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153525874|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525881|NCT05077332|Celecoxib|celecoxib|mesh-list
153525882|NCT05077332|Famotidine|famotidine|mesh-list
153525883|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153525884|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525885|NCT05077332|Analgesics|analgesics|mesh-ancestor
153525886|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
153525887|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515121|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153525888|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525889|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525890|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153525891|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153525892|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153525893|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525894|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525896|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153525897|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153525898|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
153525899|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
153525900|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525901|NCT05076006|PF-06700841|pf-06700841|mesh-list
153525902|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153525903|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525904|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525905|NCT05073484|Antibodies|antibodies|mesh-list
153525923|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525924|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
153525925|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525926|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
153525927|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525928|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153525929|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
153525930|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153525931|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153525932|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525933|NCT05062317|Antidotes|antidotes|mesh-ancestor
153525934|NCT05062317|Protective Agents|protective agents|mesh-ancestor
153525935|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
153525936|NCT05062317|Vitamins|vitamins|mesh-ancestor
153525937|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
153525938|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
153525939|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153525940|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153525941|NCT04988282|Prednisolone|prednisolone|mesh-list
153525942|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
153525943|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153525944|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
153525945|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525946|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
153525951|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
153525952|NCT04988282|Hormones|hormones|mesh-ancestor
153525953|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525955|NCT04988282|Protective Agents|protective agents|mesh-ancestor
153525956|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153525957|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525958|NCT04962230|Ritonavir|ritonavir|mesh-list
153525959|NCT04962230|Nirmatrelvir|nirmatrelvir|mesh-list
153525960|NCT04962230|Carbamazepine|carbamazepine|mesh-list
153525961|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153525962|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153525970|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153525971|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153525972|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
153525973|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
153525974|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153525975|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525976|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525977|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153525978|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525979|NCT04962230|Analgesics|analgesics|mesh-ancestor
153525980|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
153525981|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525982|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153525983|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153525984|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153525985|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153525986|NCT04943445|Paclitaxel|paclitaxel|mesh-list
153525987|NCT04943445|Carboplatin|carboplatin|mesh-list
153525988|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
153525989|NCT04943445|Immunomodulating Agents|immunomodulating agents|mesh-list
153525990|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
153525991|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153525992|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525993|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
153525994|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
153525995|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
153525996|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525997|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525998|NCT04943445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153525999|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526000|NCT04939883|Carvedilol|carvedilol|mesh-list
153526002|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153526011|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153526012|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153526013|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
153526014|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153526015|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153526016|NCT04933695|Sotorasib|sotorasib|mesh-list
153526017|NCT04933695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526043|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526044|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526045|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
153526047|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153526048|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153526049|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526050|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
153526051|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526052|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526053|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
153526054|NCT04901494|Serotonin|serotonin|mesh-list
153526055|NCT04901494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153526056|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153526057|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
153526058|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526059|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526060|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526061|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153526096|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526097|NCT04700046|Mexiletine|mexiletine|mesh-list
153526098|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153526099|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153526100|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153526101|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153526102|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526103|NCT04664829|Capecitabine|capecitabine|mesh-list
153526104|NCT04664829|Bexarotene|bexarotene|mesh-list
153745656|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
153526105|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526106|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
153526107|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526108|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526109|NCT04651400|Antithrombins|antithrombins|mesh-list
153526110|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
153526111|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153526112|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
153526113|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526156|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153526157|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526158|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526159|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526160|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526161|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
153526162|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
153526163|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526164|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
153526165|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526166|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153526167|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153526169|NCT04527003|Norethindrone|norethindrone|mesh-list
153526170|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
153526171|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
153526172|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153526173|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153526174|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153526175|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
153469343|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526176|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153526177|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526178|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153526179|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153526180|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
153526181|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526182|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
153526183|NCT04510051|Fludarabine|fludarabine|mesh-list
153526184|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526185|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
153526186|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526187|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526188|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153526189|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
153526208|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526209|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526210|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
153526211|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153526212|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153526213|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526214|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526215|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526216|NCT04443010|Temozolomide|temozolomide|mesh-list
153526217|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153526218|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
153526219|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526220|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526221|NCT04423237|Deferasirox|deferasirox|mesh-list
153526222|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153526223|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
153526224|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
153526225|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526226|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
153526227|NCT04416750|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153526228|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526229|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526230|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526231|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526232|NCT04412538|Vaccines|vaccines|mesh-list
153526278|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526279|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526280|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153526281|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
153526282|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
153526283|NCT04314375|Hormones|hormones|mesh-ancestor
153526284|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153526285|NCT04303403|Trametinib|trametinib|mesh-list
153526286|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526287|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526288|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526289|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526290|NCT04285853|Oxycodone|oxycodone|mesh-list
153526291|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153526292|NCT04285853|Narcotics|narcotics|mesh-ancestor
153526293|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153526294|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526295|NCT04285853|Analgesics|analgesics|mesh-ancestor
153526296|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
153745657|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153526297|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526298|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
153526299|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526300|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
153526301|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153526302|NCT04199767|Insulin|insulin|mesh-list
153526303|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153526304|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
153526305|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153526306|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526332|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
153526333|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526334|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153526335|NCT04033029|Tazobactam|tazobactam|mesh-list
153526336|NCT04033029|Piperacillin|piperacillin|mesh-list
153526337|NCT04033029|Daptomycin|daptomycin|mesh-list
153526343|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153526344|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526345|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526346|NCT04033029|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153526347|NCT04033029|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153526348|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153526349|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526350|NCT04020185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526351|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526352|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153526354|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
153526355|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
153526370|NCT03844750|Vactosertib|vactosertib|mesh-list
153526371|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526372|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526373|NCT03844750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526374|NCT03844750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526375|NCT03844750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526376|NCT03844750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526377|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153526378|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526379|NCT03792867|Doxorubicin|doxorubicin|mesh-list
153526380|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153526409|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526410|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526411|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153526412|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526413|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526414|NCT03635892|Nivolumab|nivolumab|mesh-list
153515310|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526415|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526416|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526417|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526418|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526419|NCT03629223|Tepotinib|tepotinib|mesh-list
153526420|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526421|NCT03568383|Pyridoxine|pyridoxine|mesh-list
153526422|NCT03568383|Pyridoxal|pyridoxal|mesh-list
153526423|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
153526433|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153526434|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
153526475|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526476|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
153526477|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
153469641|NCT04663308|Volixibat|volixibat|mesh-list
153526478|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
153526479|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526480|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526481|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
153526482|NCT03425669|Methylphenidate|methylphenidate|mesh-list
153526483|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153526484|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526485|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153526486|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153526487|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153526488|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526489|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
153526510|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526511|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526512|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
153526513|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526514|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526515|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
153526516|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526517|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526518|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
153526519|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153526520|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153526521|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153526522|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153526523|NCT03233152|Nivolumab|nivolumab|mesh-list
153526524|NCT03233152|Ipilimumab|ipilimumab|mesh-list
153526525|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153526526|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526527|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526528|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526529|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526532|NCT03190967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526533|NCT03190967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526534|NCT03190967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153526535|NCT03190967|Alkylating Agents|alkylating agents|mesh-ancestor
153526536|NCT03190967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526537|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
153526538|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526539|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526540|NCT03184571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526541|NCT03184571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526542|NCT03097939|Nivolumab|nivolumab|mesh-list
153526543|NCT03097939|Ipilimumab|ipilimumab|mesh-list
153526544|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526545|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469720|NCT04548700|Hormones|hormones|mesh-ancestor
153526551|NCT03096782|Busulfan|busulfan|mesh-list
153526552|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
153526553|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153526554|NCT03096782|Rituximab|rituximab|mesh-list
153526555|NCT03096782|Fludarabine|fludarabine|mesh-list
153526556|NCT03096782|Clofarabine|clofarabine|mesh-list
153526557|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153526558|NCT03096782|Tacrolimus|tacrolimus|mesh-list
153526559|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
153526560|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153526561|NCT03096782|Antibodies|antibodies|mesh-list
153526562|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
153526563|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153526564|NCT03096782|Lenograstim|lenograstim|mesh-list
153526565|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526566|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
153526567|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526568|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526569|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153526570|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
153526571|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526573|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153526574|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526575|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
153526576|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153526577|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153526578|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526579|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153526580|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153526581|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
153526582|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153526583|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526584|NCT03093831|Ibrutinib|ibrutinib|mesh-list
153526585|NCT03093831|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153526586|NCT03093831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526587|NCT03093831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526588|NCT03093831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526589|NCT03055013|Nivolumab|nivolumab|mesh-list
153526590|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526594|NCT03033446|Nivolumab|nivolumab|mesh-list
153526634|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
153526635|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
153526636|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153526637|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153526638|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526639|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153515418|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
153526640|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153526641|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
153526642|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526643|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153526644|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
153526645|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153526646|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153526647|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153526648|NCT02945241|Vancomycin|vancomycin|mesh-list
153526649|NCT02945241|Cystatins|cystatins|mesh-list
153526712|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153526713|NCT02632708|Analgesics|analgesics|mesh-ancestor
153526714|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
153526715|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526716|NCT02617277|Durvalumab|durvalumab|mesh-list
153526717|NCT02617277|Adavosertib|adavosertib|mesh-list
153526718|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526719|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526720|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526721|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526722|NCT02471144|Etanercept|etanercept|mesh-list
153526723|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153526724|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153526725|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153526726|NCT02471144|Analgesics|analgesics|mesh-ancestor
153526727|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
153526728|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526729|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526730|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526731|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526732|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526733|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526734|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
153526735|NCT02448420|Trastuzumab|trastuzumab|mesh-list
153526736|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153526737|NCT02448420|Palbociclib|palbociclib|mesh-list
153526738|NCT02448420|Antibodies|antibodies|mesh-list
153526739|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
153526740|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
153526748|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
153526749|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153526751|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
153526752|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153526753|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
153526755|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153526756|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526757|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153526758|NCT02420002|Analgesics|analgesics|mesh-ancestor
153526759|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
153526760|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526761|NCT02403674|Tenofovir|tenofovir|mesh-list
153526762|NCT02403674|Lamivudine|lamivudine|mesh-list
153526763|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153526764|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
153526765|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526766|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153526767|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153526768|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526769|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526770|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153526771|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153526772|NCT02352948|Gemcitabine|gemcitabine|mesh-list
153526773|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153526774|NCT02352948|Durvalumab|durvalumab|mesh-list
153526775|NCT02352948|Vinorelbine|vinorelbine|mesh-list
153526776|NCT02352948|Tremelimumab|tremelimumab|mesh-list
153526777|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153526778|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526779|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
153781918|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153526780|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526799|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526801|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153526802|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
153526803|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153526804|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526805|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
153526815|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153526816|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
153526817|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153526818|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
153526819|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526820|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526821|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
153526822|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
153526823|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
153526824|NCT02248597|Busulfan|busulfan|mesh-list
153526825|NCT02248597|Fludarabine|fludarabine|mesh-list
153526826|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
153526827|NCT02248597|Tacrolimus|tacrolimus|mesh-list
153526828|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526829|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
153526830|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526831|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526832|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153526833|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
153526834|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526835|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526836|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153526837|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526838|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
153526839|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153526840|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526841|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153526842|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153526843|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
153526845|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526847|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153526848|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
153526849|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153526850|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526851|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526852|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
153526853|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781919|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
153526854|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526855|NCT02125461|Durvalumab|durvalumab|mesh-list
153526856|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526857|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526858|NCT02096042|Azacitidine|azacitidine|mesh-list
153526859|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153526860|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526861|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
153526862|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526863|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526864|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526865|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526866|NCT02096042|Immunotoxins|immunotoxins|mesh-ancestor
153526867|NCT02096042|Immunoconjugates|immunoconjugates|mesh-ancestor
153526868|NCT02096042|Immunologic Factors|immunologic factors|mesh-ancestor
153526869|NCT02096042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526870|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
153526885|NCT01765400|Clopidogrel|clopidogrel|mesh-list
153526886|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153526887|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153526888|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153526889|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153526890|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153526891|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
153526892|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526893|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526894|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526896|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526897|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526898|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526899|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526901|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153526902|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526903|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153526904|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153526905|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
153526906|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153526907|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526908|NCT01551823|Vaccines|vaccines|mesh-list
153526909|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
153526910|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526911|NCT01551810|Vaccines|vaccines|mesh-list
153526912|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
153526913|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526914|NCT01510366|Vaccines|vaccines|mesh-list
153515503|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
153526915|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
153526916|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526917|NCT01279850|Pregabalin|pregabalin|mesh-list
153526918|NCT01279850|Analgesics|analgesics|mesh-ancestor
153526919|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
153526920|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526921|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526922|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
153526954|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153526955|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153526956|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
153526957|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526958|NCT01035463|Cytarabine|cytarabine|mesh-list
153526959|NCT01035463|Rituximab|rituximab|mesh-list
153526960|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153526961|NCT01035463|Etoposide|etoposide|mesh-list
153526962|NCT01035463|Lenalidomide|lenalidomide|mesh-list
153526963|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
153526964|NCT01035463|Melphalan|melphalan|mesh-list
153526965|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
153526966|NCT01035463|Carmustine|carmustine|mesh-list
153526968|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153526969|NCT01035463|Antibodies|antibodies|mesh-list
153526970|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
153526971|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153526972|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
153526973|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526974|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526975|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526976|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153526977|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153526978|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153526979|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526980|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526981|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526982|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
153526983|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
153527018|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153527019|NCT00572234|Bupropion|bupropion|mesh-list
153527020|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153527021|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
153527022|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153515529|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
153527023|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153527024|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153527025|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153527026|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527027|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
153527028|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527029|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527030|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153527031|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153527032|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527034|NCT00411138|Carboplatin|carboplatin|mesh-list
153527035|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153527036|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527037|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
153527038|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
153527039|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
153527040|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527041|NCT00149149|Indomethacin|indomethacin|mesh-list
153527042|NCT00149149|Polaprezinc|polaprezinc|mesh-list
153527043|NCT00149149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153527044|NCT00149149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153527045|NCT00149149|Analgesics|analgesics|mesh-ancestor
153527046|NCT00149149|Sensory System Agents|sensory system agents|mesh-ancestor
153527076|NCT01469416|Clopidogrel|clopidogrel|mesh-list
153527077|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153527078|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153618931|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527079|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153527080|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153527081|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153527082|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
153527083|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527084|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527085|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527086|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153527087|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153527088|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
153527089|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153527090|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153527091|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527092|NCT01469468|Simvastatin|simvastatin|mesh-list
153527093|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153527094|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153527095|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
153527096|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527097|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153527098|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153527099|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527101|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527103|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
153527126|NCT01469572|Everolimus|everolimus|mesh-list
153527127|NCT01469572|Pasireotide|pasireotide|mesh-list
153527128|NCT01469572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153527129|NCT01469572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153527130|NCT01469572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515578|NCT01430065|Tacrolimus|tacrolimus|mesh-list
153527131|NCT01469572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527132|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153527133|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
153527134|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527135|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527136|NCT01469572|Hormones|hormones|mesh-ancestor
153527137|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527138|NCT01469598|Gemcitabine|gemcitabine|mesh-list
153527139|NCT01469598|Docetaxel|docetaxel|mesh-list
153527140|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527141|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
153527142|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527143|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527144|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
153527145|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
153527146|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
153527147|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
153730482|NCT00133796|Trastuzumab|trastuzumab|mesh-list
153527148|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153527149|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527150|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527151|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153527152|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153527153|NCT01469624|Protective Agents|protective agents|mesh-ancestor
153527154|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527155|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
153527156|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153527157|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
153527158|NCT01469702|Azithromycin|azithromycin|mesh-list
153527167|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527168|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153527169|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527170|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527171|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
153527172|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527173|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
153527174|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153527176|NCT01469884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153527177|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527178|NCT01469975|Edetic Acid|edetic acid|mesh-list
153527179|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
153527180|NCT01469975|Antidotes|antidotes|mesh-ancestor
153527181|NCT01469975|Protective Agents|protective agents|mesh-ancestor
153527182|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527183|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
153527201|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153527202|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153527203|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153527204|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153527205|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527206|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153527207|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153527208|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527209|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
153527210|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
153527211|NCT01470053|Azelastine|azelastine|mesh-list
153527232|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527233|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527234|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153527235|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153527236|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527237|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153527238|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
153527239|NCT01470092|Hormones|hormones|mesh-ancestor
153527250|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153527251|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153527252|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527253|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527255|NCT01470209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153527256|NCT01470209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153527257|NCT01470209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527258|NCT01470209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527259|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153527260|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
153527261|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527262|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527263|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
153527264|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153527265|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153527266|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
153527267|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527268|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527269|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153527280|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
153527281|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153527282|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
153527283|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153527284|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153527285|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153527286|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153527287|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527288|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527289|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527290|NCT01470352|Analgesics|analgesics|mesh-ancestor
153527291|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
153527292|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527293|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
153527294|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153527295|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
153527296|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
153527297|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527298|NCT01470456|Rituximab|rituximab|mesh-list
153527299|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470473|NCT01822314|Paclitaxel|paclitaxel|mesh-list
153527318|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527320|NCT01470794|Flucytosine|flucytosine|mesh-list
153527345|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
153527346|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527347|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153527348|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527349|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
153527350|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527351|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153527352|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527353|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153527354|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527355|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153527356|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153527392|NCT01471262|Liver Extracts|liver extracts|mesh-list
153527393|NCT01471262|Hematinics|hematinics|mesh-ancestor
153527394|NCT01471275|Metformin|metformin|mesh-list
153527395|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527423|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
153527424|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527425|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
153527426|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
153527427|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153527428|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527429|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527430|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
153527431|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153527432|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153527433|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527434|NCT01471678|Tamsulosin|tamsulosin|mesh-list
153527435|NCT01471678|Dutasteride|dutasteride|mesh-list
153527481|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527482|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527483|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153527484|NCT01471847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153527485|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153527486|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527487|NCT01471886|Ketorolac|ketorolac|mesh-list
153527488|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153527515|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527516|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
153527517|NCT01471925|Esomeprazole|esomeprazole|mesh-list
153527518|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153527519|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527520|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153527521|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527522|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527523|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153527524|NCT01471964|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153527525|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153527526|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527527|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527528|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527529|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
153515679|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
153527530|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
153527531|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527532|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
153527533|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153527534|NCT01471990|Protective Agents|protective agents|mesh-ancestor
153527535|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527552|NCT01472029|Docetaxel|docetaxel|mesh-list
153527553|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
153527554|NCT01472029|Trastuzumab|trastuzumab|mesh-list
153527555|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527556|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
153527557|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
153527558|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
153527560|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153527561|NCT01472029|Antidotes|antidotes|mesh-ancestor
153527562|NCT01472029|Protective Agents|protective agents|mesh-ancestor
153527563|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527564|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
153527565|NCT01472029|Vitamins|vitamins|mesh-ancestor
153527566|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
153527567|NCT01472055|Fludarabine|fludarabine|mesh-list
153527568|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527569|NCT01472146|Doxorubicin|doxorubicin|mesh-list
153527570|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527571|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153527572|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153527573|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153527574|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527575|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527576|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
153527577|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153527578|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527579|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527580|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153527581|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153527582|NCT01472263|Protective Agents|protective agents|mesh-ancestor
153527583|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527584|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
153527585|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153527586|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
153527587|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153527588|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
153527589|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153527590|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153527591|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153527592|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
153527593|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153527621|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153527623|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
153527624|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
153527625|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527626|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153527627|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
153527628|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527629|NCT01472770|Gemcitabine|gemcitabine|mesh-list
153527630|NCT01472770|Capecitabine|capecitabine|mesh-list
153527631|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527632|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
153527633|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527634|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527635|NCT01472783|Veliparib|veliparib|mesh-list
153527636|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153527637|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527638|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527639|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527640|NCT01472796|Vitamin D|vitamin d|mesh-list
153527641|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
153527642|NCT01472796|Aliskiren|aliskiren|mesh-list
153527643|NCT01472796|Vitamins|vitamins|mesh-ancestor
153527644|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
153527645|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527646|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153527647|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153527648|NCT01472796|Renin Inhibitors|renin inhibitors|mesh-ancestor
153527682|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527683|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527684|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153527686|NCT01473147|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153527687|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527700|NCT01473251|Ranibizumab|ranibizumab|mesh-list
153527701|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153527702|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527703|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153527704|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153527705|NCT01473251|Growth Substances|growth substances|mesh-ancestor
153527706|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527707|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
153527708|NCT01473277|Triamcinolone|triamcinolone|mesh-list
153527709|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153527710|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153527711|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153527712|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153527713|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153527714|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
153527715|NCT01473277|Hormones|hormones|mesh-ancestor
153527716|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527717|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527718|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153527719|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
153515732|NCT01431443|Theobromine|theobromine|mesh-list
153527720|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527721|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527722|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153527723|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153527724|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
153527725|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527726|NCT01473303|Leucovorin|leucovorin|mesh-list
153527727|NCT01473303|Fluorouracil|fluorouracil|mesh-list
153527728|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
153527729|NCT01473303|Irinotecan|irinotecan|mesh-list
153527730|NCT01473303|Calcium|calcium|mesh-list
153527731|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
153527732|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153527742|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527743|NCT01473303|Antidotes|antidotes|mesh-ancestor
153527744|NCT01473303|Protective Agents|protective agents|mesh-ancestor
153527745|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
153527746|NCT01473303|Vitamins|vitamins|mesh-ancestor
153527747|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
153527748|NCT01473316|Ketoconazole|ketoconazole|mesh-list
153527749|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
153527750|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470923|NCT02136498|Varenicline|varenicline|mesh-list
153527778|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527779|NCT01473810|Endocine|endocine|mesh-list
153527780|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153527781|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
153527782|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527783|NCT01473901|Temozolomide|temozolomide|mesh-list
153527784|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153527785|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
153527786|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527787|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527789|NCT01473914|Vitamin E|vitamin e|mesh-list
153527790|NCT01473914|Tocopherols|tocopherols|mesh-list
153527791|NCT01473914|Tocotrienols|tocotrienols|mesh-list
153527792|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
153527793|NCT01473914|Zinc|zinc|mesh-list
153527794|NCT01473914|Selenium|selenium|mesh-list
153527795|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
153527811|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153527836|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153527837|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153527838|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
153527839|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527840|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527841|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527842|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153527843|NCT01474460|Vitamin K|vitamin k|mesh-list
153527844|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
153527845|NCT01474460|Vitamins|vitamins|mesh-ancestor
153527846|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
153527847|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527848|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153527849|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153527850|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527851|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
153527852|NCT01474460|Coagulants|coagulants|mesh-ancestor
153527854|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153527888|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153527889|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153527890|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
153527891|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153527892|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
153527936|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153527937|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153527938|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527939|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
153527940|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153527941|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153527942|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153527943|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153527944|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
153527945|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153527946|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153527947|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
153527948|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153527949|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153527951|NCT01475552|Clopidogrel|clopidogrel|mesh-list
153527952|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527953|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527954|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153527985|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
153527986|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
153527987|NCT01475708|Doxycycline|doxycycline|mesh-list
153527988|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153527989|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527990|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
153527991|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153527992|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153527994|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153528026|NCT01476124|Morphine|morphine|mesh-list
153528032|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
153528033|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528034|NCT01476137|Trametinib|trametinib|mesh-list
153528035|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528036|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153528037|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528038|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528039|NCT01476176|Acetaminophen|acetaminophen|mesh-list
153528040|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528041|NCT01476176|Analgesics|analgesics|mesh-ancestor
153528042|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
153528043|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528044|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528045|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
153528046|NCT01476189|Acetaminophen|acetaminophen|mesh-list
153528047|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528048|NCT01476189|Analgesics|analgesics|mesh-ancestor
153528049|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
153528050|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618935|NCT01981005|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153528051|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528052|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
153528053|NCT01476215|Acetaminophen|acetaminophen|mesh-list
153471223|NCT05766436|Antioxidants|antioxidants|mesh-ancestor
153528054|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528055|NCT01476215|Analgesics|analgesics|mesh-ancestor
153528056|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
153528057|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528058|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528090|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
153528091|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153528092|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153528093|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
153528094|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
153528095|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528102|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153528103|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153528104|NCT01476410|Immunotoxins|immunotoxins|mesh-ancestor
153528141|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
153528142|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528174|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528175|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528176|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153528177|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
153528178|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528179|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528180|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153528182|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
153528183|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
153528213|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528214|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528215|NCT01477190|Analgesics|analgesics|mesh-ancestor
153528216|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
153528217|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528218|NCT01477203|Escitalopram|escitalopram|mesh-list
153528219|NCT01477203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153528220|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153528221|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153515866|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153528222|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528223|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528295|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153528296|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
153528297|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528298|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153528299|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153528300|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153528301|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528302|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153528303|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153528304|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153528306|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
153528307|NCT01477632|Estradiol|estradiol|mesh-list
153528308|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153528309|NCT01477632|Estrogens|estrogens|mesh-ancestor
153528310|NCT01477632|Hormones|hormones|mesh-ancestor
153528311|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153528312|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528313|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153528357|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153528358|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528359|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528361|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528362|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528363|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153528364|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153528365|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528366|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153528367|NCT01477983|Flecainide|flecainide|mesh-list
153528368|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153528369|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153528370|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528371|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528417|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153528418|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
153528419|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528420|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528421|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153528422|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153528423|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
153528424|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528425|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528426|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
153528427|NCT01478282|Dabigatran|dabigatran|mesh-list
153528428|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153528429|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
153528430|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153528431|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
153528432|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528433|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528434|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
153528435|NCT01478308|Metformin|metformin|mesh-list
153528436|NCT01478308|Prednisone|prednisone|mesh-list
153528437|NCT01478308|Docetaxel|docetaxel|mesh-list
153528438|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153528439|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528440|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528441|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
153528442|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
153528443|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
153528444|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528445|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153528447|NCT01478308|Hormones|hormones|mesh-ancestor
153528480|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528481|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528482|NCT01478503|Urological Agents|urological agents|mesh-ancestor
153528483|NCT01478529|Mirabegron|mirabegron|mesh-list
153528484|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153528485|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153528486|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153528487|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
153528488|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528489|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528490|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528491|NCT01478529|Urological Agents|urological agents|mesh-ancestor
153528492|NCT01478568|Desipramine|desipramine|mesh-list
153528493|NCT01478568|Mirabegron|mirabegron|mesh-list
153528494|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153528495|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153528496|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153528497|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
153528498|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153618936|NCT01981005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153528499|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528500|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528501|NCT01478568|Urological Agents|urological agents|mesh-ancestor
153528502|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153528503|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
153528531|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153528533|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
153528534|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
153528535|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
153528536|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528537|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153528538|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
153528539|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528540|NCT01478724|Caseins|caseins|mesh-list
153528541|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
153528542|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
153528543|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528544|NCT01478997|Acetaminophen|acetaminophen|mesh-list
153528545|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528546|NCT01478997|Analgesics|analgesics|mesh-ancestor
153528547|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
153528548|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528549|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528550|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
153528551|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153528552|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
153528553|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528554|NCT01479036|Docetaxel|docetaxel|mesh-list
153528555|NCT01479036|Epirubicin|epirubicin|mesh-list
153528556|NCT01479036|Endostatins|endostatins|mesh-list
153528557|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528558|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
153528559|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
153528560|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
153528561|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528562|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153528578|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153528579|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
153528580|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528581|NCT01479179|Trastuzumab|trastuzumab|mesh-list
153528614|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528615|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528617|NCT01479504|Docetaxel|docetaxel|mesh-list
153528618|NCT01479504|Nedaplatin|nedaplatin|mesh-list
153528619|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528620|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
153528621|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
153528622|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
153528623|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528624|NCT01479556|Pregabalin|pregabalin|mesh-list
153528625|NCT01479556|Analgesics|analgesics|mesh-ancestor
153528626|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
153528627|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528639|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153528641|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528670|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528671|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528672|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
153528673|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153528674|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153528675|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153528676|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153528678|NCT01479881|Simeprevir|simeprevir|mesh-list
153528679|NCT01479881|Tacrolimus|tacrolimus|mesh-list
153528680|NCT01479881|Cyclosporins|cyclosporins|mesh-list
153528681|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153528682|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
153528683|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528684|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153528685|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528686|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528687|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
153528697|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528699|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
153528700|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528701|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153528702|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
153528703|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153528704|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153528705|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153528706|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528707|NCT01479933|Vitamin D|vitamin d|mesh-list
153528708|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
153528709|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
153528710|NCT01479933|Vitamins|vitamins|mesh-list
153528716|NCT01480050|Mibefradil|mibefradil|mesh-list
153528718|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
153528719|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528720|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528721|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153528722|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153528723|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153618937|NCT01981005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528724|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528725|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528726|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
153528727|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153528728|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153528729|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528730|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
153528731|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153528732|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528733|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528735|NCT01480141|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153528780|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528781|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528782|NCT01480609|Ezogabine|ezogabine|mesh-list
153528783|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
153528784|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528785|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528786|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
153528787|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153528788|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
153528789|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528790|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153528791|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
153528792|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153528793|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153528794|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
153528795|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528796|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153528797|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153528798|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515992|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528799|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528800|NCT01480752|Lornoxicam|lornoxicam|mesh-list
153528801|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153528802|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528803|NCT01480752|Analgesics|analgesics|mesh-ancestor
153528804|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
153528805|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528806|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528807|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153528808|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528827|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528829|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153528830|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153528831|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153528832|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153528833|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153528834|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153528835|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
153528836|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153528837|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528838|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153528839|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153528840|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153528841|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153528842|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153528843|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153528844|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153528845|NCT01480791|Aliskiren|aliskiren|mesh-list
153528846|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153528847|NCT01480791|Diuretics|diuretics|mesh-ancestor
153528848|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
153528849|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528850|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153528851|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528852|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528853|NCT01480791|Renin Inhibitors|renin inhibitors|mesh-ancestor
153528854|NCT01480791|Protease Inhibitors|protease inhibitors|mesh-ancestor
153528855|NCT01480791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528856|NCT01480817|Sorafenib|sorafenib|mesh-list
153528857|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528858|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153528859|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528860|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516030|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
153528867|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153528868|NCT01480869|Vitamins|vitamins|mesh-ancestor
153528869|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
153472049|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528870|NCT01480986|Irinotecan|irinotecan|mesh-list
153528871|NCT01480986|Octreotide|octreotide|mesh-list
153528872|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528873|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153528874|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153528875|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528876|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528886|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528887|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528888|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153528889|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
153528890|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528891|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528892|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153528893|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153528894|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
153528895|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
153528897|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528919|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528920|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528921|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528922|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153528923|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153528925|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
153528926|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
153528927|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
153528928|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153528929|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153528930|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528931|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528932|NCT01481350|Urological Agents|urological agents|mesh-ancestor
153528933|NCT01481389|Theobromine|theobromine|mesh-list
153528934|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153528935|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
153528983|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153528984|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
153528985|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528986|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
153528987|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
153528988|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
153528989|NCT01481714|Citric Acid|citric acid|mesh-list
153528990|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
153528991|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153528992|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
153516098|NCT01434017|BB 1101|bb 1101|mesh-list
153528993|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
153528994|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528995|NCT01481714|Cathartics|cathartics|mesh-ancestor
153528996|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528997|NCT01481714|Antacids|antacids|mesh-ancestor
153528998|NCT01481831|Palonosetron|palonosetron|mesh-list
153528999|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
153529000|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
153529001|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529002|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529045|NCT01482052|Vaccines|vaccines|mesh-list
153529046|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
153529047|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529048|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153529049|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153529050|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153529051|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
153529052|NCT01482117|Cilostazol|cilostazol|mesh-list
153529053|NCT01482117|Clopidogrel|clopidogrel|mesh-list
153529054|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153529055|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153529056|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153529057|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153529058|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
153529059|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529060|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529061|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529062|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153529063|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
153529064|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529075|NCT01482156|Everolimus|everolimus|mesh-list
153529107|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153529108|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153529109|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153529110|NCT01482338|Progestins|progestins|mesh-ancestor
153529111|NCT01482338|Hormones|hormones|mesh-ancestor
153529112|NCT01482377|Cetuximab|cetuximab|mesh-list
153529113|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153529114|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153529115|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529116|NCT01482377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153529117|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529118|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529119|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529120|NCT01482416|Estrogens|estrogens|mesh-list
153529121|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153529122|NCT01482416|Hormones|hormones|mesh-ancestor
153529123|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153529124|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529125|NCT01482442|Sorafenib|sorafenib|mesh-list
153529126|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529128|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529129|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529130|NCT01482468|Palonosetron|palonosetron|mesh-list
153529131|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
153529132|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
153529133|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529134|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529135|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529136|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153529138|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
153529144|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
153529145|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529146|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529147|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
153529148|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529149|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529150|NCT01482559|Protective Agents|protective agents|mesh-ancestor
153529161|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529162|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529163|NCT01482754|Rituximab|rituximab|mesh-list
153529164|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153529165|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529166|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
153529167|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529168|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153529169|NCT01482897|Prednisolone|prednisolone|mesh-list
153472349|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153529170|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153529171|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
153529172|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153529173|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
153529174|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153529175|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
153529176|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153529177|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
153529178|NCT01482897|Hormones|hormones|mesh-ancestor
153529179|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153529180|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529181|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153529196|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529197|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
153529198|NCT01483014|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153529199|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529200|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529201|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529202|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529203|NCT01483053|Agomelatine|agomelatine|mesh-list
153529204|NCT01483053|Escitalopram|escitalopram|mesh-list
153529205|NCT01483053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153529206|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153529207|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153529208|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529209|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529210|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
153529211|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529212|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153529213|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529226|NCT01483365|Progesterone|progesterone|mesh-list
153529227|NCT01483365|Progestins|progestins|mesh-ancestor
153529228|NCT01483365|Hormones|hormones|mesh-ancestor
153529229|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153529230|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529231|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
153529232|NCT01483508|Procyanidin|procyanidin|mesh-list
153529233|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
153529234|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529235|NCT01483508|Protective Agents|protective agents|mesh-ancestor
153529236|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529237|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153529238|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153529239|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529240|NCT01483638|Axitinib|axitinib|mesh-list
153529245|NCT01483729|Ritonavir|ritonavir|mesh-list
153529246|NCT01483729|Lactams|lactams|mesh-list
153529247|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153529248|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153529249|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
153529250|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529251|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529252|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153529253|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153529254|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
153529255|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529256|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153529257|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153529258|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153529259|NCT01483781|Canagliflozin|canagliflozin|mesh-list
153529260|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153529261|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529262|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529263|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529264|NCT01483859|Liver Extracts|liver extracts|mesh-list
153529265|NCT01483859|Hematinics|hematinics|mesh-ancestor
153529266|NCT01483911|Gontivimab|gontivimab|mesh-list
153529267|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
153529268|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529269|NCT01484015|Cefepime|cefepime|mesh-list
153529270|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153529271|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529272|NCT01484080|Paclitaxel|paclitaxel|mesh-list
153529273|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153529274|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153529275|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529276|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
153529277|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
153529291|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529293|NCT01484184|Buspirone|buspirone|mesh-list
153529294|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153529295|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153529296|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
153529297|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529298|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529299|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529300|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153529301|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153529302|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529303|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153529304|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153529305|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
153529306|NCT01484262|Liraglutide|liraglutide|mesh-list
153529307|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529308|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529309|NCT01484262|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153529310|NCT01484262|Incretins|incretins|mesh-ancestor
153529311|NCT01484262|Hormones|hormones|mesh-ancestor
153529312|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153529313|NCT01484457|Pancrelipase|pancrelipase|mesh-list
153529314|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529315|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153529316|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
153529317|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529318|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153529319|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153529320|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
153529321|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153529322|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529333|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
153529334|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529335|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529336|NCT01484756|Micronutrients|micronutrients|mesh-list
153529337|NCT01484756|Trace Elements|trace elements|mesh-list
153529338|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529339|NCT01484847|Dacomitinib|dacomitinib|mesh-list
153529340|NCT01484847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153529341|NCT01484847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529342|NCT01484847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529346|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529348|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
153529349|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529350|NCT01484990|Levodopa|levodopa|mesh-list
153529351|NCT01484990|Carbidopa|carbidopa|mesh-list
153529352|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153529353|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153529354|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153529355|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
153529391|NCT01485185|Analgesics|analgesics|mesh-ancestor
153529392|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
153529393|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529394|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529395|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
153529396|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153529397|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153529398|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529399|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153529400|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153529401|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153529402|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529403|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529404|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
153529405|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153529406|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529407|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
153529408|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
153529409|NCT01485198|Acetaminophen|acetaminophen|mesh-list
153529410|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153529454|NCT01485445|Xhance|xhance|mesh-list
153529467|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153529468|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529482|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
153529483|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529484|NCT01485692|Promethazine|promethazine|mesh-list
153529485|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
153529487|NCT01485692|Haloperidol|haloperidol|mesh-list
153529488|NCT01485692|Olanzapine|olanzapine|mesh-list
153529489|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
153529490|NCT01485692|Ziprasidone|ziprasidone|mesh-list
153529491|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153529492|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153529493|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529494|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529495|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153529496|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153529497|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153529498|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153529499|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
153529500|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
153529501|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
153529502|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
153529547|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153529548|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529549|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529550|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
153529551|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516300|NCT01434901|Bethanechol|bethanechol|mesh-list
153529552|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153529553|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153529554|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529555|NCT01485744|Antidotes|antidotes|mesh-ancestor
153529556|NCT01485744|Protective Agents|protective agents|mesh-ancestor
153529557|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
153529558|NCT01485744|Vitamins|vitamins|mesh-ancestor
153529559|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
153529560|NCT01485822|Travoprost|travoprost|mesh-list
153472808|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
153529619|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529620|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529621|NCT01486017|Peficitinib|peficitinib|mesh-list
153529622|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529623|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529624|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529625|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
153529626|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529627|NCT01486082|Amoxicillin|amoxicillin|mesh-list
153529628|NCT01486082|Clarithromycin|clarithromycin|mesh-list
153529629|NCT01486082|Omeprazole|omeprazole|mesh-list
153529630|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153529631|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529632|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153529633|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529634|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153529635|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529636|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529637|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153529638|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153529639|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153529640|NCT01486251|Axitinib|axitinib|mesh-list
153529641|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529642|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529643|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529644|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529645|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
153529646|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
153529647|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153529672|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
153529673|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
153529674|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153529675|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529676|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529677|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
153529678|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153529679|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529680|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529681|NCT01486485|Nafamostat|nafamostat|mesh-list
153529682|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153529683|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153529684|NCT01486485|Analgesics|analgesics|mesh-ancestor
153529685|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
153529686|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529687|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529688|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153529689|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618941|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529690|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
153529691|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
153529692|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529693|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529694|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153529695|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153529696|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153529697|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529698|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
153529699|NCT01486511|Liver Extracts|liver extracts|mesh-list
153529700|NCT01486511|Hematinics|hematinics|mesh-ancestor
153529701|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153529713|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529714|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
153529720|NCT01486706|Analgesics|analgesics|mesh-ancestor
153529721|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
153529722|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529723|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529724|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
153529725|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153529726|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153529727|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529728|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153745659|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
153529729|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153529730|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153529731|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529732|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529733|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
153529734|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153529735|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153529736|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
153529737|NCT01486706|Urological Agents|urological agents|mesh-ancestor
153529772|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153529773|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
153529774|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
153529775|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529776|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529777|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153529778|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153529779|NCT01486979|Estradiol|estradiol|mesh-list
153529780|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153529781|NCT01486979|Estrogens|estrogens|mesh-ancestor
153529782|NCT01486979|Hormones|hormones|mesh-ancestor
153529783|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153529784|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529793|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153529795|NCT01487096|Analgesics|analgesics|mesh-ancestor
153529796|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
153516373|NCT01435343|Idarubicin|idarubicin|mesh-list
153529797|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529798|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529799|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153529800|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153529801|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529802|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
153529828|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153529830|NCT01487317|Rivastigmine|rivastigmine|mesh-list
153529831|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153529832|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529833|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529834|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
153529835|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529836|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529837|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153529838|NCT01487317|Protective Agents|protective agents|mesh-ancestor
153618942|NCT01981278|Tapentadol|tapentadol|mesh-list
153529839|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
153529840|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529841|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529842|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
153529843|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529844|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529845|NCT01487395|Donepezil|donepezil|mesh-list
153529846|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153529847|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529848|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529865|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529866|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529867|NCT01487512|Analgesics|analgesics|mesh-ancestor
153529890|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529891|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529893|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153529894|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
153529895|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
153529896|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153529897|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529898|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529899|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
153529900|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
153529901|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153529902|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529903|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529904|NCT01487993|Metformin|metformin|mesh-list
153529905|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516411|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
153529906|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529907|NCT01488136|Diazoxide|diazoxide|mesh-list
153529908|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153529909|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
153529921|NCT01488253|Temsirolimus|temsirolimus|mesh-list
153529922|NCT01488253|MTOR Inhibitors|mtor inhibitors|mesh-list
153529923|NCT01488253|Tacrolimus|tacrolimus|mesh-list
153529924|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529925|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
153529926|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529927|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153529928|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529929|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529930|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153529931|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529932|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153529933|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529934|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
153529935|NCT01488253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529936|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153529937|NCT01488266|Milnacipran|milnacipran|mesh-list
153529942|NCT01488266|Paroxetine|paroxetine|mesh-list
153529943|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153529944|NCT01488266|Sertraline|sertraline|mesh-list
153529945|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
153529946|NCT01488266|Escitalopram|escitalopram|mesh-list
153529947|NCT01488266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153529948|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153529949|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153529950|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529951|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529952|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
153529953|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529954|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529955|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153529956|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153529957|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153529958|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
153529959|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153529960|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153529961|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529962|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153529963|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153529964|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529965|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
153529966|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153529967|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153529968|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153529969|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153529992|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529994|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153529995|NCT01488396|Cyclosporins|cyclosporins|mesh-list
153529996|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529997|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529998|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516441|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529999|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
153530000|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530001|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
153530002|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530003|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
153530004|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530005|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153530006|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153530008|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
153530009|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530010|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153530011|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153530012|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530065|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530066|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530067|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153530068|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
153530069|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153530070|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153530071|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153530073|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530074|NCT01488955|Fosfomycin|fosfomycin|mesh-list
153530075|NCT01488955|Ibuprofen|ibuprofen|mesh-list
153530077|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153530139|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153530140|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153530141|NCT01489319|Analgesics|analgesics|mesh-ancestor
153530142|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
153530143|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530144|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530145|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530146|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530147|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153530148|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530149|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530150|NCT01489371|Doxorubicin|doxorubicin|mesh-list
153530151|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153530152|NCT01489371|Interleukin-12|interleukin-12|mesh-list
153530153|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153516488|NCT01435980|Incretins|incretins|mesh-ancestor
153530245|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153530246|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153530247|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153530248|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
153530249|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530250|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530251|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530252|NCT01489696|Urological Agents|urological agents|mesh-ancestor
153530253|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153530254|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153530255|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153530256|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
153530257|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153530258|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153530259|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
153530260|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530319|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
153530320|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
153530337|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530338|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153530339|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153530340|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
153530341|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153530342|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
153530343|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
153530344|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530345|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530346|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
153530347|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
153530348|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530349|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530350|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530352|NCT01490047|Doxorubicin|doxorubicin|mesh-list
153530401|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530402|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153530403|NCT01490255|Amlodipine|amlodipine|mesh-list
153530404|NCT01490255|Ranolazine|ranolazine|mesh-list
153530405|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153530406|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153530407|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153530408|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530409|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153530410|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530411|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
153730483|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153530412|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153530414|NCT01490268|Dsuvia|dsuvia|mesh-list
153530415|NCT01490268|Hydromorphone|hydromorphone|mesh-list
153530471|NCT01490476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153530472|NCT01490476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530473|NCT01490476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530474|NCT01490567|Donepezil|donepezil|mesh-list
153530475|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153530476|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530477|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530478|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
153530479|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530480|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530481|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
153530482|NCT01490658|Metformin|metformin|mesh-list
153530550|NCT01491009|Midazolam|midazolam|mesh-list
153530551|NCT01491009|Remifentanil|remifentanil|mesh-list
153530552|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153530553|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153530554|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530555|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530556|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153530557|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153530558|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153530559|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153530560|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
153530633|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153530634|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
153530635|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530636|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153530637|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153530638|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530639|NCT01491295|Tenofovir|tenofovir|mesh-list
153530640|NCT01491295|Lamivudine|lamivudine|mesh-list
153530641|NCT01491295|Adefovir|adefovir|mesh-list
153530642|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
153530702|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530703|NCT01492166|Insulin|insulin|mesh-list
153530704|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153530705|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530706|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530707|NCT01492179|Lidocaine|lidocaine|mesh-list
153530708|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
153530709|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
153530710|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516575|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
153530711|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530712|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
153530713|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530714|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153530715|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153530716|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153530719|NCT01492205|Insulin|insulin|mesh-list
153530759|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153530770|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153530771|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530772|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530773|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153530845|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
153530846|NCT01493102|Coagulants|coagulants|mesh-ancestor
153530847|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153530848|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
153530849|NCT01493115|Insulin|insulin|mesh-list
153530850|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153530851|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
153530852|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530853|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530854|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
153530855|NCT01493154|Vaccines|vaccines|mesh-list
153530856|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
153530857|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530858|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530859|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530860|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153530920|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530921|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153530922|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153530923|NCT01493674|Folic Acid|folic acid|mesh-list
153530924|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
153530925|NCT01493674|Hematinics|hematinics|mesh-ancestor
153530926|NCT01493674|Vitamins|vitamins|mesh-ancestor
153530927|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
153530928|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530929|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
153530930|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153530931|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
153530932|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153530933|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530934|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153530935|NCT01493843|Paclitaxel|paclitaxel|mesh-list
153530989|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530990|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530991|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
153530992|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153530993|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153530994|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530995|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530996|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530998|NCT01494259|Bupivacaine|bupivacaine|mesh-list
153530999|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
153531000|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
153531001|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531002|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531057|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153531058|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153531059|NCT01494402|Analgesics|analgesics|mesh-ancestor
153531060|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
153531061|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531062|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531063|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531064|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531065|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153531066|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153531067|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153531068|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153531069|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
153531070|NCT01494415|Paclitaxel|paclitaxel|mesh-list
153531071|NCT01494415|Carboplatin|carboplatin|mesh-list
153531072|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153531104|NCT01494688|Paclitaxel|paclitaxel|mesh-list
153531154|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153531156|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153531157|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531158|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
153531159|NCT01495039|Ionophores|ionophores|mesh-ancestor
153531160|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531161|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531163|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
153531164|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531165|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531166|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
153531167|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531168|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531169|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
153531170|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153531171|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531172|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153531173|NCT01495117|Iodine|iodine|mesh-list
153531174|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
153531175|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153531176|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
153531177|NCT01495117|Povidone|povidone|mesh-list
153531181|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
153531219|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531220|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
153531221|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531222|NCT01495260|Vitamin E|vitamin e|mesh-list
153531223|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
153531224|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
153531225|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153531226|NCT01495260|Vitamins|vitamins|mesh-ancestor
153531227|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
153531228|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531229|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
153531230|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531231|NCT01495260|Expectorants|expectorants|mesh-ancestor
153531232|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
153531233|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153531234|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
153531235|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531236|NCT01495260|Protective Agents|protective agents|mesh-ancestor
153531237|NCT01495260|Antidotes|antidotes|mesh-ancestor
153531238|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
153531239|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153531241|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153531243|NCT01495338|Analgesics|analgesics|mesh-ancestor
153531306|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153531307|NCT01495845|Clopidogrel|clopidogrel|mesh-list
153531308|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153531309|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153531310|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153531311|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153531312|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
153531313|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531314|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531411|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531412|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531413|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
153531414|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531415|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531416|NCT01496443|Glimepiride|glimepiride|mesh-list
153531417|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153531418|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531419|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531420|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531421|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
153531422|NCT01496521|Aspirin|aspirin|mesh-list
153531423|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153531424|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153531425|NCT01496521|Analgesics|analgesics|mesh-ancestor
153531426|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
153531427|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531428|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531429|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531430|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531431|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153531432|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153531433|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531434|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153531435|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153531436|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531437|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
153531438|NCT01496534|Carboplatin|carboplatin|mesh-list
153531439|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531440|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
153531441|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153531454|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153516749|NCT01437839|Apixaban|apixaban|mesh-list
153531455|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531456|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153531470|NCT01496742|Growth Substances|growth substances|mesh-ancestor
153531471|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531472|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
153531473|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531474|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153531475|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153531477|NCT01496911|Levocetirizine|levocetirizine|mesh-list
153531478|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153531479|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153531480|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
153531481|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
153531482|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531483|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531484|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531485|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
153531486|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
153531487|NCT01496989|Interleukin-12|interleukin-12|mesh-list
153531488|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153531489|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
153531490|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531491|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153531492|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153531493|NCT01496989|Growth Substances|growth substances|mesh-ancestor
153531506|NCT01497041|Docetaxel|docetaxel|mesh-list
153531517|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531518|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
153531519|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
153531526|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153531527|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531528|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
153531529|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153531530|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153531531|NCT01497093|Growth Substances|growth substances|mesh-ancestor
153531532|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
153531533|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531534|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
153531535|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153531536|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531537|NCT01497132|Vitamin D|vitamin d|mesh-list
153531538|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
153531539|NCT01497132|Vitamins|vitamins|mesh-ancestor
153531540|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
153531541|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531542|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153531544|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
153531575|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531576|NCT01497470|Paclitaxel|paclitaxel|mesh-list
153531577|NCT01497470|Carboplatin|carboplatin|mesh-list
153531578|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153531579|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531580|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
153531581|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
153531582|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
153531583|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531584|NCT01497483|Cyclosporine|cyclosporine|mesh-list
153531585|NCT01497483|Pravastatin|pravastatin|mesh-list
153531586|NCT01497483|Cyclosporins|cyclosporins|mesh-list
153531587|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531588|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531589|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531604|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531605|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153531606|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
153531607|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531649|NCT01497626|Bortezomib|bortezomib|mesh-list
153531650|NCT01497626|Lapatinib|lapatinib|mesh-list
153531651|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531652|NCT01497626|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153531661|NCT01497652|Protective Agents|protective agents|mesh-ancestor
153531662|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531663|NCT01497717|Adalimumab|adalimumab|mesh-list
153531664|NCT01497717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153531665|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531666|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531667|NCT01497873|Topotecan|topotecan|mesh-list
153531668|NCT01497873|Belotecan|belotecan|mesh-list
153531669|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153531670|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153531671|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531672|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531673|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531674|NCT01497912|Atorvastatin|atorvastatin|mesh-list
153531675|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153531709|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531710|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153531711|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
153531712|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
153531713|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153531714|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
153531715|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531716|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531736|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531737|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153531738|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153531739|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153531741|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
153531742|NCT01498562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153531743|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531744|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531745|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531746|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531747|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153531748|NCT01498718|Vaccines|vaccines|mesh-list
153531749|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
153531750|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531751|NCT01498783|Fluorouracil|fluorouracil|mesh-list
153531752|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
153531753|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531782|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531784|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531785|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153531786|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153531787|NCT01498835|Growth Substances|growth substances|mesh-ancestor
153531788|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531789|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
153531790|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531791|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531792|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531793|NCT01498861|Dolutegravir|dolutegravir|mesh-list
153531794|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
153531795|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153531796|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153531797|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153531798|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531799|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531800|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153531801|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153531802|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
153531803|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531804|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153516903|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153531805|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153531806|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153531807|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531808|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153531809|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
153531810|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153531811|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531812|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153531819|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531820|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531822|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153531823|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
153531824|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531825|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531826|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
153531827|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531828|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531829|NCT01499004|Tofacitinib|tofacitinib|mesh-list
153531830|NCT01499004|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153531831|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531832|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531833|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531834|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
153531835|NCT01499069|Fesoterodine|fesoterodine|mesh-list
153531836|NCT01499069|Propiverine|propiverine|mesh-list
153531837|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153531838|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153531839|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
153531853|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153531855|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531856|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153531857|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153531858|NCT01499121|Growth Substances|growth substances|mesh-ancestor
153531859|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531860|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
153531861|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531876|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153531877|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153531878|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153531880|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
153531881|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153531882|NCT01499433|Caspofungin|caspofungin|mesh-list
153531883|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
153531884|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531885|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531886|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531887|NCT01499446|Fluticasone|fluticasone|mesh-list
153531889|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531890|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153531891|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
153531892|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531893|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531894|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153531895|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
153531896|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
153531897|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153531898|NCT01499485|Acetazolamide|acetazolamide|mesh-list
153531899|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
153531900|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153531914|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531915|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153531937|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153531938|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531939|NCT01499693|Pantoprazole|pantoprazole|mesh-list
153531940|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153531941|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153531942|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153531943|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531944|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531945|NCT01499758|Atorvastatin|atorvastatin|mesh-list
153531946|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153531947|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153531948|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
153531949|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531950|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153531951|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153531952|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531953|NCT01499771|Atorvastatin|atorvastatin|mesh-list
153531954|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153531955|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153531956|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
153531957|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531958|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153531959|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153531960|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531961|NCT01499875|Penicillin V|penicillin v|mesh-list
153531980|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153531981|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153531982|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531983|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531984|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153531985|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
153531986|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153531987|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
153531994|NCT01500070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531995|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531996|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
153531997|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531998|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531999|NCT01500161|Cytarabine|cytarabine|mesh-list
153532000|NCT01500161|Fludarabine|fludarabine|mesh-list
153532001|NCT01500161|Etoposide|etoposide|mesh-list
153532002|NCT01500161|Melphalan|melphalan|mesh-list
153532003|NCT01500161|Busulfan|busulfan|mesh-list
153532004|NCT01500161|Carmustine|carmustine|mesh-list
153532005|NCT01500161|Clofarabine|clofarabine|mesh-list
153532006|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532007|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153532008|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
153532009|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532010|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153532011|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
153532012|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532013|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153532014|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153532015|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153532016|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532017|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
153532031|NCT01500538|Vorinostat|vorinostat|mesh-list
153532054|NCT01500590|Ramipril|ramipril|mesh-list
153532055|NCT01500590|Irbesartan|irbesartan|mesh-list
153532056|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153532057|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
153532058|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517013|NCT03980171|Growth Substances|growth substances|mesh-ancestor
153532059|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532060|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153532061|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153532062|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153532063|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
153532064|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
153532065|NCT01500785|Simendan|simendan|mesh-list
153532066|NCT01500785|Vitamins|vitamins|mesh-ancestor
153532067|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
153532068|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532069|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
153532070|NCT01500785|Hematinics|hematinics|mesh-ancestor
153532071|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153532072|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
153532073|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153532074|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153532075|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532076|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532077|NCT01500785|Protective Agents|protective agents|mesh-ancestor
153532078|NCT01500824|Crizotinib|crizotinib|mesh-list
153532079|NCT01500824|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153532081|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532114|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
153532115|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
153532116|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
153532117|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
153532118|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153532119|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532120|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153532121|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153532122|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153532123|NCT01500863|Estradiol|estradiol|mesh-list
153532124|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153532125|NCT01500863|Progesterone|progesterone|mesh-list
153532126|NCT01500863|Estrogens|estrogens|mesh-ancestor
153532127|NCT01500863|Hormones|hormones|mesh-ancestor
153532128|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532129|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532130|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153532131|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
153532132|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153532133|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153532134|NCT01500863|Progestins|progestins|mesh-ancestor
153532135|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
153532136|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153532137|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532138|NCT01500915|Ranibizumab|ranibizumab|mesh-list
153532139|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153532140|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153532141|NCT01500915|Growth Substances|growth substances|mesh-ancestor
153532142|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532143|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
153532144|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532155|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153532156|NCT01500993|Capecitabine|capecitabine|mesh-list
153532157|NCT01500993|Fluorouracil|fluorouracil|mesh-list
153517081|NCT02986334|Naproxen|naproxen|mesh-list
153532158|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153532159|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
153532160|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532161|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532162|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153532163|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
153532164|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618947|NCT01981278|Analgesics|analgesics|mesh-ancestor
153532165|NCT01501032|Pancrelipase|pancrelipase|mesh-list
153532166|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532168|NCT01501084|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153532169|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153532170|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532171|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153532172|NCT01501084|Incretins|incretins|mesh-ancestor
153532173|NCT01501084|Hormones|hormones|mesh-ancestor
153532174|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532175|NCT01501123|Midazolam|midazolam|mesh-list
153532176|NCT01501123|Haloperidol|haloperidol|mesh-list
153532177|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
153532178|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153532179|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153532180|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532181|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532182|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153532183|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153532184|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532185|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153532186|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
153532187|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
153532188|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
153532189|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
153532190|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532191|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532192|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
153532193|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
153532194|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532203|NCT01501136|Gemcitabine|gemcitabine|mesh-list
153532204|NCT01501136|Etoposide|etoposide|mesh-list
153532205|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
153532206|NCT01501136|Ifosfamide|ifosfamide|mesh-list
153532207|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
153532208|NCT01501136|Pegaspargase|pegaspargase|mesh-list
153532209|NCT01501136|Asparaginase|asparaginase|mesh-list
153532210|NCT01501136|BB 1101|bb 1101|mesh-list
153532211|NCT01501136|Mesna|mesna|mesh-list
153532212|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532213|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532214|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
153532222|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153532223|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
153532224|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532225|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532226|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153532227|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
153532228|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153532229|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153532230|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153532231|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153532232|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
153532233|NCT01501136|Protective Agents|protective agents|mesh-ancestor
153532234|NCT01501149|Dexamethasone|dexamethasone|mesh-list
153532235|NCT01501149|Gemcitabine|gemcitabine|mesh-list
153532236|NCT01501149|Etoposide|etoposide|mesh-list
153532237|NCT01501149|Pegaspargase|pegaspargase|mesh-list
153532238|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532239|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532240|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
153532241|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
153532242|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532252|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153532253|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153532254|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153532255|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532256|NCT01501214|Atosiban|atosiban|mesh-list
153532257|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
153532258|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532259|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532260|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
153532261|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153532262|NCT01501253|Amlodipine|amlodipine|mesh-list
153532263|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153532356|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153532357|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153532358|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153532359|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153532360|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153532361|NCT01501487|Paclitaxel|paclitaxel|mesh-list
153532362|NCT01501487|Docetaxel|docetaxel|mesh-list
153532363|NCT01501487|Trastuzumab|trastuzumab|mesh-list
153532364|NCT01501487|Pertuzumab|pertuzumab|mesh-list
153532365|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153532366|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532367|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
153532368|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
153532369|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
153532370|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532371|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153532372|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153532373|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153532374|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532375|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532376|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153532377|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153532378|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532379|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
153532380|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532394|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532396|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153532397|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153532398|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532399|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
153532400|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153517127|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532401|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153532402|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532408|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532410|NCT01501708|Amphotericin B|amphotericin b|mesh-list
153532411|NCT01501708|Caspofungin|caspofungin|mesh-list
153532412|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
153532413|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532414|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153532415|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153532416|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532417|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532418|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153532419|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
153532420|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532421|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532422|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153532423|NCT01501708|Amebicides|amebicides|mesh-ancestor
153532424|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153532425|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153532426|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153532427|NCT01501747|Acetaminophen|acetaminophen|mesh-list
153532429|NCT01501747|Ibuprofen|ibuprofen|mesh-list
153532430|NCT01501747|Caffeine|caffeine|mesh-list
153532431|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153532432|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153532433|NCT01501747|Analgesics|analgesics|mesh-ancestor
153532434|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
153532435|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532436|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532462|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532463|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532464|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153532465|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
153532466|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
153532467|NCT01501786|Analgesics|analgesics|mesh-ancestor
153532468|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
153532469|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532470|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153532471|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153532472|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153532473|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532474|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532475|NCT01501799|Adapalene|adapalene|mesh-list
153532476|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153532477|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
153532478|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153517169|NCT01877837|Fludarabine|fludarabine|mesh-list
153532479|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153532540|NCT01502046|Analgesics|analgesics|mesh-ancestor
153532541|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
153532542|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532543|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153532544|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153532545|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532546|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532547|NCT01502046|Hormones|hormones|mesh-ancestor
153532548|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532549|NCT01502202|Pemetrexed|pemetrexed|mesh-list
153532550|NCT01502202|Gefitinib|gefitinib|mesh-list
153532551|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532552|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532553|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532563|NCT01502267|Bortezomib|bortezomib|mesh-list
153532564|NCT01502267|Rituximab|rituximab|mesh-list
153532565|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153532566|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532571|NCT01502358|Vaccines|vaccines|mesh-list
153532601|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153532602|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153532603|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532604|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532605|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
153532606|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
153532607|NCT01502878|Cefpodoxime Proxetil|cefpodoxime proxetil|mesh-list
153532608|NCT01502878|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153618949|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532609|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153532610|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532611|NCT01502904|Sirolimus|sirolimus|mesh-list
153532612|NCT01502904|Pravastatin|pravastatin|mesh-list
153532613|NCT01502904|Pitavastatin|pitavastatin|mesh-list
153532614|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153532615|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532616|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153532617|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517194|NCT01375764|Ezetimibe|ezetimibe|mesh-list
153532618|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
153532644|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532645|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
153532647|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
153532648|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
153532690|NCT01503359|Glycine|glycine|mesh-list
153532691|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
153532692|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532693|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532694|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532695|NCT01503372|Leucovorin|leucovorin|mesh-list
153532696|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
153532697|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532698|NCT01503372|Antidotes|antidotes|mesh-ancestor
153532699|NCT01503372|Protective Agents|protective agents|mesh-ancestor
153532700|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532701|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
153532702|NCT01503372|Vitamins|vitamins|mesh-ancestor
153532703|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
153532704|NCT01503385|Celecoxib|celecoxib|mesh-list
153532705|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153532706|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153532707|NCT01503385|Analgesics|analgesics|mesh-ancestor
153532708|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
153532709|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532710|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532711|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532712|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153532715|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532747|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532748|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
153532749|NCT01503437|Olanzapine|olanzapine|mesh-list
153532750|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
153532751|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
153532752|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532753|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532754|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532755|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153532756|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153532757|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153618950|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153517273|NCT01438567|Analgesics|analgesics|mesh-ancestor
153532758|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532759|NCT01503437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153532760|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153532761|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153532762|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532763|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532764|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
153532765|NCT01503450|Olanzapine|olanzapine|mesh-list
153532766|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
153532767|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
153532768|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532769|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532770|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532806|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532807|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532809|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153532810|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153532811|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153532812|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532813|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153532814|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153532815|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532817|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153532818|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153532819|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153532820|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
153532821|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532822|NCT01503671|Atorvastatin|atorvastatin|mesh-list
153532823|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153532824|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153532825|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
153532826|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532827|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153532828|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153476041|NCT00879060|Spironolactone|spironolactone|mesh-list
153532853|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532854|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
153532859|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532860|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153532861|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
153532862|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153532864|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532865|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532866|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
153532867|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
153532868|NCT01503801|Protective Agents|protective agents|mesh-ancestor
153532869|NCT01503905|Tamoxifen|tamoxifen|mesh-list
153532870|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
153532871|NCT01503905|Docetaxel|docetaxel|mesh-list
153532872|NCT01503905|Trastuzumab|trastuzumab|mesh-list
153532873|NCT01503905|Epirubicin|epirubicin|mesh-list
153532874|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153532875|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
153532876|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532877|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153532878|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153532879|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
153532880|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532881|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532882|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153532883|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
153532884|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
153532885|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
153532886|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153532887|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153532890|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532901|NCT01503918|Ganciclovir|ganciclovir|mesh-list
153532902|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153532903|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
153618951|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153532904|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532905|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153532906|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532907|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532908|NCT01503983|Capecitabine|capecitabine|mesh-list
153532909|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
153532910|NCT01503983|Trastuzumab|trastuzumab|mesh-list
153532911|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153532912|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
153532913|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532914|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532915|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153532916|NCT01504074|Triamcinolone|triamcinolone|mesh-list
153532917|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153532918|NCT01504074|Levobunolol|levobunolol|mesh-list
153532919|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153532920|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153532921|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
153532923|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532945|NCT01504139|Progesterone|progesterone|mesh-list
153517386|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532946|NCT01504139|Estrogens|estrogens|mesh-ancestor
153532947|NCT01504139|Hormones|hormones|mesh-ancestor
153532948|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532949|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532950|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153532951|NCT01504139|Progestins|progestins|mesh-ancestor
153532962|NCT01504178|Analgesics|analgesics|mesh-ancestor
153532963|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
153532964|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532965|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
153532966|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532967|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
153532968|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153532969|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153532970|NCT01504178|Emetics|emetics|mesh-ancestor
153532971|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
153532972|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532973|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
153532974|NCT01504256|Leucovorin|leucovorin|mesh-list
153532975|NCT01504256|Docetaxel|docetaxel|mesh-list
153532976|NCT01504256|Fluorouracil|fluorouracil|mesh-list
153532987|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153533028|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533030|NCT01504490|Efatutazone|efatutazone|mesh-list
153533031|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533032|NCT01504503|Donepezil|donepezil|mesh-list
153533033|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153533034|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533035|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533036|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533037|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533038|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533039|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
153533040|NCT01504516|Donepezil|donepezil|mesh-list
153533041|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153533042|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533043|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533044|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533057|NCT01504646|Lyprinol|lyprinol|mesh-list
153533058|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153533059|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
153533060|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533061|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533063|NCT01504659|Analgesics|analgesics|mesh-ancestor
153533064|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
153533065|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533066|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533067|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153533068|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153533069|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
153533070|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
153533071|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533082|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533084|NCT01504776|Bortezomib|bortezomib|mesh-list
153533085|NCT01504776|Panobinostat|panobinostat|mesh-list
153533086|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533087|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153533088|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533089|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533090|NCT01504828|Ramipril|ramipril|mesh-list
153533091|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153533092|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
153533093|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533094|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533095|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153533096|NCT01504906|Cyclosporine|cyclosporine|mesh-list
153533097|NCT01504906|Ticagrelor|ticagrelor|mesh-list
153533098|NCT01504906|Cyclosporins|cyclosporins|mesh-list
153533099|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533100|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533101|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153533102|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
153533103|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533104|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
153533105|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533106|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
153533107|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153533108|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153533123|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533124|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
153533125|NCT01505088|Dexamethasone|dexamethasone|mesh-list
153533126|NCT01505088|Prednisolone|prednisolone|mesh-list
153533139|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
153533140|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
153533141|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533142|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533143|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533144|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
153517524|NCT01440582|Dexamethasone|dexamethasone|mesh-list
153533146|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533147|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153533148|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533149|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
153533150|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153533151|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
153533152|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
153533153|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533154|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153533155|NCT01505088|Protective Agents|protective agents|mesh-ancestor
153533156|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153533157|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533158|NCT01505127|Amoxicillin|amoxicillin|mesh-list
153533159|NCT01505127|Clarithromycin|clarithromycin|mesh-list
153533160|NCT01505127|Lansoprazole|lansoprazole|mesh-list
153533161|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
153533162|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153533193|NCT01505231|Coagulants|coagulants|mesh-ancestor
153533194|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153533195|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
153533196|NCT01505283|Lidocaine|lidocaine|mesh-list
153533197|NCT01505283|Sufentanil|sufentanil|mesh-list
153533198|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
153533199|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
153533200|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533201|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533202|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
153533203|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533204|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153533205|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153533206|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153533207|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153618952|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153533208|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533209|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153533210|NCT01505283|Narcotics|narcotics|mesh-ancestor
153533211|NCT01505283|Analgesics|analgesics|mesh-ancestor
153533212|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153533213|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153533214|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
153533215|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153533216|NCT01505413|Gemcitabine|gemcitabine|mesh-list
153533217|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
153533218|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153533219|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153533220|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
153533246|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533247|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533248|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533249|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153533250|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153533251|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533252|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153533253|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153533254|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153533255|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
153517579|NCT01440725|Mitogens|mitogens|mesh-list
153533256|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153533257|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153533259|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153533260|NCT01505777|Mosapride|mosapride|mesh-list
153533261|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533262|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153533263|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
153533264|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533265|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533266|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533267|NCT01505790|Clopidogrel|clopidogrel|mesh-list
153533268|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153533269|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153533270|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153533271|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153533284|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533285|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
153533286|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533287|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153533288|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153533289|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153533290|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153533291|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533292|NCT01505946|Thrombin|thrombin|mesh-list
153533293|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
153533294|NCT01505946|Coagulants|coagulants|mesh-ancestor
153533295|NCT01505998|Amlodipine|amlodipine|mesh-list
153533296|NCT01505998|Benazepril|benazepril|mesh-list
153533297|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153533298|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153533299|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153533300|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533301|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153533302|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533303|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
153533333|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533334|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533335|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533336|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153533337|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153533338|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
153533339|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
153533368|NCT01506115|Trioxsalen|trioxsalen|mesh-list
153533371|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153533372|NCT01506167|Leucovorin|leucovorin|mesh-list
153533373|NCT01506167|Folic Acid|folic acid|mesh-list
153533374|NCT01506167|Bevacizumab|bevacizumab|mesh-list
153533375|NCT01506167|Capecitabine|capecitabine|mesh-list
153533376|NCT01506167|Fluorouracil|fluorouracil|mesh-list
153533377|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
153533378|NCT01506167|Irinotecan|irinotecan|mesh-list
153533379|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
153533380|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153533381|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533382|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153533383|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153533384|NCT01506167|Growth Substances|growth substances|mesh-ancestor
153533385|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533386|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
153533387|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153533388|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
153533389|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533390|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153533391|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
153533392|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153533393|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153533394|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533395|NCT01506167|Antidotes|antidotes|mesh-ancestor
153533396|NCT01506167|Protective Agents|protective agents|mesh-ancestor
153533397|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
153533398|NCT01506167|Vitamins|vitamins|mesh-ancestor
153533399|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
153533400|NCT01506167|Hematinics|hematinics|mesh-ancestor
153533401|NCT01506336|Sunitinib|sunitinib|mesh-list
153533402|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533403|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153533404|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153533405|NCT01506336|Growth Substances|growth substances|mesh-ancestor
153533407|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
153533420|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153533421|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533422|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
153533423|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533424|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153533425|NCT01506505|Aspirin|aspirin|mesh-list
153533426|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153533427|NCT01506505|Lisinopril|lisinopril|mesh-list
153476642|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
153533428|NCT01506505|Simvastatin|simvastatin|mesh-list
153533429|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153533430|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153533431|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
153533432|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533433|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153533434|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153533435|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533436|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153533437|NCT01506505|Diuretics|diuretics|mesh-ancestor
153533438|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
153533439|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533440|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153533441|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153533442|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153533443|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153533444|NCT01506505|Analgesics|analgesics|mesh-ancestor
153533445|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
153533446|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533447|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153533448|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153533449|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153533450|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153533451|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153533452|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153533453|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
153646723|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646724|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646725|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153646726|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
153533454|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153533455|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
153533456|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153533457|NCT01506505|Protective Agents|protective agents|mesh-ancestor
153533458|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
153533459|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533460|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
153533461|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533462|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533463|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153533464|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
153533465|NCT01506557|Vitamin D|vitamin d|mesh-list
153533466|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153533467|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533468|NCT01506557|Vitamins|vitamins|mesh-ancestor
153533469|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
153533470|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153533471|NCT01506570|Vaccines|vaccines|mesh-list
153533472|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
153533473|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533474|NCT01506622|Fentanyl|fentanyl|mesh-list
153533475|NCT01506622|Propofol|propofol|mesh-list
153533476|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153533490|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153533491|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
153533492|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533493|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533494|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533495|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153533496|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153533497|NCT01506713|Clopidogrel|clopidogrel|mesh-list
153533498|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153533499|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153533500|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153533506|NCT01506739|Donepezil|donepezil|mesh-list
153533507|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153533508|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533509|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533510|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533511|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533512|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533513|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
153533514|NCT01506752|Donepezil|donepezil|mesh-list
153533515|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153533516|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533517|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533518|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533519|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533520|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533521|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
153533522|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
153533523|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153533524|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
153533525|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533526|NCT01506765|Expectorants|expectorants|mesh-ancestor
153533527|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
153533528|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153533529|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
153533565|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
153533566|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533567|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533568|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533569|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
153533570|NCT01506804|Hormones|hormones|mesh-ancestor
153533571|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533572|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153533573|NCT01506804|Protective Agents|protective agents|mesh-ancestor
153533574|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153533575|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533577|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153533578|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533579|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533580|NCT01506921|Ketamine|ketamine|mesh-list
153533581|NCT01506921|Esketamine|esketamine|mesh-list
153533582|NCT01506921|Analgesics|analgesics|mesh-ancestor
153533583|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
153533584|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533585|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533586|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153533587|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153533588|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
153533589|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
153533590|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533591|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153533592|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153533593|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533594|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533595|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
153533596|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153533597|NCT01507064|Sorafenib|sorafenib|mesh-list
153533598|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533599|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533600|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533601|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533631|NCT01507311|Liraglutide|liraglutide|mesh-list
153533632|NCT01507311|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153533633|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533634|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533635|NCT01507311|Incretins|incretins|mesh-ancestor
153533636|NCT01507311|Hormones|hormones|mesh-ancestor
153533637|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533638|NCT01507337|Liraglutide|liraglutide|mesh-list
153533639|NCT01507337|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153533640|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533641|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533642|NCT01507337|Incretins|incretins|mesh-ancestor
153533643|NCT01507337|Hormones|hormones|mesh-ancestor
153533644|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533645|NCT01507363|Gabapentin|gabapentin|mesh-list
153533646|NCT01507363|Analgesics|analgesics|mesh-ancestor
153533647|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
153533648|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533649|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533656|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153533657|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533658|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533659|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
153533660|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153533661|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153533685|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533686|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153533687|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153533688|NCT01507454|Estradiol|estradiol|mesh-list
153533689|NCT01507454|Estrogens|estrogens|mesh-ancestor
153533690|NCT01507454|Hormones|hormones|mesh-ancestor
153533691|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533692|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533693|NCT01507467|Nimorazole|nimorazole|mesh-list
153533694|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153533695|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153533696|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153533697|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533698|NCT01507480|Bevacizumab|bevacizumab|mesh-list
153533699|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153533700|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533701|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153533702|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153533703|NCT01507480|Growth Substances|growth substances|mesh-ancestor
153533704|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533705|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
153533706|NCT01507519|Sirolimus|sirolimus|mesh-list
153533707|NCT01507519|Temsirolimus|temsirolimus|mesh-list
153533708|NCT01507519|MTOR Inhibitors|mtor inhibitors|mesh-list
153533709|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153533710|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533750|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153533751|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
153533752|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
153533753|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153533754|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153533755|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153533756|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
153533757|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533758|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533759|NCT01507727|Tolvaptan|tolvaptan|mesh-list
153533760|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153533761|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533762|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
153533764|NCT01507740|Bevacizumab|bevacizumab|mesh-list
153533838|NCT01508104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533839|NCT01508104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533840|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153533841|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
153533842|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533843|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533844|NCT01507610|Sumatriptan|sumatriptan|mesh-list
153533845|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153533846|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153533847|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153533848|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
153533849|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533850|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533851|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533852|NCT01508143|Misoprostol|misoprostol|mesh-list
153533853|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153533854|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
153533855|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153533856|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533857|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153533858|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533859|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
153533860|NCT01508182|Metformin|metformin|mesh-list
153533861|NCT01508182|Canagliflozin|canagliflozin|mesh-list
153533862|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533863|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533864|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153533865|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533866|NCT01508195|Metformin|metformin|mesh-list
153533867|NCT01508195|Canagliflozin|canagliflozin|mesh-list
153533868|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533869|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533870|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153533871|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533872|NCT01508260|Furosemide|furosemide|mesh-list
153533873|NCT01508260|Diuretics|diuretics|mesh-ancestor
153646727|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533874|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
153533875|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533876|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153533877|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153533878|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533880|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
153533881|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533882|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
153533883|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533884|NCT01508364|Sorafenib|sorafenib|mesh-list
153533885|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517822|NCT01442025|Infliximab|infliximab|mesh-list
153533886|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533887|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533888|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533889|NCT01508429|Misoprostol|misoprostol|mesh-list
153533890|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153533891|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
153533892|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153533893|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533894|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153533895|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533896|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
153533897|NCT01508468|Rituximab|rituximab|mesh-list
153533922|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153533923|NCT01508494|Galantamine|galantamine|mesh-list
153533924|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153533925|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533926|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533927|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533928|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533929|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533930|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153533931|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
153533937|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153533938|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153533939|NCT01508572|Growth Substances|growth substances|mesh-ancestor
153533940|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533941|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
153533942|NCT01508611|Fluorides|fluorides|mesh-list
153533943|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
153533944|NCT01508611|Protective Agents|protective agents|mesh-ancestor
153533945|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533946|NCT01508637|Terazosin|terazosin|mesh-list
153533963|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533964|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533965|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
153533966|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153533967|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153533968|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
153533969|NCT01508806|Liraglutide|liraglutide|mesh-list
153534020|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534021|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534022|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153534023|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534024|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
153534025|NCT01509131|Bisacodyl|bisacodyl|mesh-list
153534026|NCT01509131|Cathartics|cathartics|mesh-ancestor
153534027|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534028|NCT01509131|Laxatives|laxatives|mesh-ancestor
153534029|NCT01509144|Vaccines|vaccines|mesh-list
153534030|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
153534031|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534032|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
153534033|NCT01509209|Ephedrine|ephedrine|mesh-list
153534034|NCT01509209|Levocetirizine|levocetirizine|mesh-list
153534035|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153534036|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153534037|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
153534038|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
153534039|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534040|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534041|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534083|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153534084|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153534085|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153534086|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153534088|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534089|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534090|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534091|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153534092|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153534093|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
153534094|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534095|NCT01509469|Caseins|caseins|mesh-list
153534096|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
153534097|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
153534098|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534100|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
153534101|NCT01509521|Ephedrine|ephedrine|mesh-list
153534102|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
153534103|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153534104|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
153534105|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
153534137|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534138|NCT01509755|Incretins|incretins|mesh-ancestor
153534139|NCT01509755|Hormones|hormones|mesh-ancestor
153534148|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534149|NCT01509976|Triclosan|triclosan|mesh-list
153534150|NCT01509976|Triclocarban|triclocarban|mesh-list
153517902|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
153534151|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153534152|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534153|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153534154|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153534155|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
153534156|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534157|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153534158|NCT01510015|Risperidone|risperidone|mesh-list
153534159|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153534160|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
153534161|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534162|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534163|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534164|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153534165|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153534166|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534167|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153534170|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
153534196|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153534197|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534198|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
153534199|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534200|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
153534201|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534202|NCT01510509|Everolimus|everolimus|mesh-list
153534203|NCT01510509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153534204|NCT01510509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153534238|NCT01510613|Pomalidomide|pomalidomide|mesh-list
153534239|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534240|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
153534241|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
153534242|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534243|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534244|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534245|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
153534254|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
153534255|NCT01510626|Omalizumab|omalizumab|mesh-list
153534256|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153534257|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153534258|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
153534259|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
153534260|NCT01510665|Cathartics|cathartics|mesh-ancestor
153534261|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534262|NCT01510795|Spironolactone|spironolactone|mesh-list
153534263|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153534264|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
153534265|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534266|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534267|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153534268|NCT01510795|Diuretics|diuretics|mesh-ancestor
153534269|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
153534270|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
153534271|NCT01510847|Androgens|androgens|mesh-ancestor
153534272|NCT01510847|Hormones|hormones|mesh-ancestor
153517953|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
153534273|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534274|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534275|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153534276|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153534277|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534278|NCT01510977|Bisacodyl|bisacodyl|mesh-list
153534279|NCT01510977|Cathartics|cathartics|mesh-ancestor
153534280|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534281|NCT01510977|Laxatives|laxatives|mesh-ancestor
153534282|NCT01510990|Gefitinib|gefitinib|mesh-list
153534283|NCT01510990|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153534284|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153534285|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534286|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534287|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534288|NCT01511003|Tacrolimus|tacrolimus|mesh-list
153534289|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534290|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
153534291|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534292|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153534293|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534294|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534295|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
153534296|NCT01511029|Pramipexole|pramipexole|mesh-list
153534297|NCT01511029|Dexpramipexole|dexpramipexole|mesh-list
153534298|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153534299|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534300|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153534301|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153534302|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534303|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534304|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534305|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534306|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
153534307|NCT01511029|Protective Agents|protective agents|mesh-ancestor
153534329|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534330|NCT01511159|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153534331|NCT01511159|Incretins|incretins|mesh-ancestor
153534332|NCT01511159|Hormones|hormones|mesh-ancestor
153534333|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534334|NCT01511172|Metformin|metformin|mesh-list
153534335|NCT01511172|Liraglutide|liraglutide|mesh-list
153534336|NCT01511172|Glimepiride|glimepiride|mesh-list
153534337|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534338|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534339|NCT01511172|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153534340|NCT01511172|Incretins|incretins|mesh-ancestor
153534341|NCT01511172|Hormones|hormones|mesh-ancestor
153534342|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534343|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153534344|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534345|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
153534346|NCT01511185|Liraglutide|liraglutide|mesh-list
153534347|NCT01511185|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153534348|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534349|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534350|NCT01511185|Incretins|incretins|mesh-ancestor
153534351|NCT01511185|Hormones|hormones|mesh-ancestor
153534353|NCT01511198|Metformin|metformin|mesh-list
153534354|NCT01511198|Liraglutide|liraglutide|mesh-list
153534393|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153534394|NCT01511263|Diuretics|diuretics|mesh-list
153534395|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
153534396|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534397|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
153534398|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153534399|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153534400|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534401|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153534402|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153534403|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153534404|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534405|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153534406|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153534407|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153534408|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
153534409|NCT01511289|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153534410|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153534411|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534412|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534413|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534414|NCT01511302|Budesonide|budesonide|mesh-list
153534415|NCT01511302|RNS60|rns60|mesh-list
153534416|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534417|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153534418|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
153534419|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534420|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534421|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153534442|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534444|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534445|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
153534446|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153534447|NCT01511471|Ticagrelor|ticagrelor|mesh-list
153534448|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153534449|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153534450|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153534451|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153534452|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
153534453|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534454|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534455|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534456|NCT01511562|Cytarabine|cytarabine|mesh-list
153534457|NCT01511562|Etoposide|etoposide|mesh-list
153534458|NCT01511562|Thiotepa|thiotepa|mesh-list
153534459|NCT01511562|Carmustine|carmustine|mesh-list
153534497|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
153534498|NCT01511705|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153534499|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153534500|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
153534501|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534502|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534534|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534536|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153534537|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153534539|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
153534540|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534541|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153534550|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153534553|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153534597|NCT01511887|Ibuprofen|ibuprofen|mesh-list
153534598|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153534599|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153534600|NCT01511887|Analgesics|analgesics|mesh-ancestor
153534601|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
153534602|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534603|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534604|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534605|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153534606|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153534615|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534616|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153534617|NCT01512004|Propiverine|propiverine|mesh-list
153534618|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153534619|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153534620|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
153534621|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534622|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534623|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534624|NCT01512004|Urological Agents|urological agents|mesh-ancestor
153534625|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
153534626|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
153534627|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534628|NCT01512017|Petrolatum|petrolatum|mesh-list
153534629|NCT01512017|Emollients|emollients|mesh-ancestor
153534630|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
153534655|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534656|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534657|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534658|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153534659|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153534660|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
153534661|NCT01512199|Paclitaxel|paclitaxel|mesh-list
153534662|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153534663|NCT01512199|Trastuzumab|trastuzumab|mesh-list
153534664|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153534665|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153534666|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534667|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
153534668|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
153534722|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534723|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153534724|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153534725|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153534726|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
153534727|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
153534728|NCT01512680|Insulin|insulin|mesh-list
153534729|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153518041|NCT01443065|Vitamins|vitamins|mesh-ancestor
153534730|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534731|NCT01512784|Vaccines|vaccines|mesh-list
153534732|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
153534733|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534734|NCT01512862|Calcitriol|calcitriol|mesh-list
153534735|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153534810|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153534811|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153534813|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
153534814|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153534815|NCT01513070|Diuretics|diuretics|mesh-ancestor
153534816|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
153534817|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
153534818|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153534819|NCT01513083|Trastuzumab|trastuzumab|mesh-list
153534820|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153534821|NCT01513083|Maytansine|maytansine|mesh-list
153534822|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153534823|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534824|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153534825|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
153534826|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
153534827|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
153534828|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534830|NCT01513083|Immunoconjugates|immunoconjugates|mesh-ancestor
153534831|NCT01513083|Immunologic Factors|immunologic factors|mesh-ancestor
153534832|NCT01513083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534833|NCT01513174|Olaparib|olaparib|mesh-list
153534834|NCT01513174|Gefitinib|gefitinib|mesh-list
153534835|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153534836|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534837|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534838|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534839|NCT01513174|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153534840|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153534869|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153534871|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534872|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534873|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
153534874|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534875|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534876|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
153534878|NCT01513603|Analgesics|analgesics|mesh-ancestor
153534946|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
153534947|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
153534948|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153534949|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534950|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
153534951|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534952|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
153534953|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534954|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
153534955|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534956|NCT01514019|Acebutolol|acebutolol|mesh-list
153534957|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153534958|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153534959|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
153534960|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
153534961|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534962|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534963|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153534964|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153534965|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153534966|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534967|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534968|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535000|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153535001|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153535002|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153535003|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535004|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535006|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153535007|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535008|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153535009|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535010|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535011|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535013|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153535014|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153535015|NCT01514227|Analgesics|analgesics|mesh-ancestor
153535016|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
153535017|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535018|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535019|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153535020|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153535021|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153535022|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153535023|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535024|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153535025|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153535026|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535027|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
153535028|NCT01514266|Curcumin|curcumin|mesh-list
153518123|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
153535029|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153535030|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153535031|NCT01514266|Analgesics|analgesics|mesh-ancestor
153535032|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
153535033|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535045|NCT01514487|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535047|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535049|NCT01514487|Hormones|hormones|mesh-ancestor
153535050|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535051|NCT01514695|Midazolam|midazolam|mesh-list
153535052|NCT01514695|Fentanyl|fentanyl|mesh-list
153535053|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153535054|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153535055|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153535056|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535057|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153535058|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153535059|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153535060|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153535061|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
153535062|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
153535063|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
153535064|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
153535065|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535102|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
153535103|NCT01514838|Acarbose|acarbose|mesh-list
153535104|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
153535105|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153535106|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535107|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535141|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535142|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153535143|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
153535144|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535266|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153535267|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153535268|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153535269|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153535270|NCT01515826|BB 1101|bb 1101|mesh-list
153535271|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153535272|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
153535273|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
153535274|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535275|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535276|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153535277|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
153535278|NCT01515826|Hormones|hormones|mesh-ancestor
153535279|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535280|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153535281|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535282|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518152|NCT01443624|Hematinics|hematinics|mesh-ancestor
153535283|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535284|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535341|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153535342|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153535343|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153535344|NCT01516138|Insulin|insulin|mesh-list
153535345|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535346|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535347|NCT01516255|Liraglutide|liraglutide|mesh-list
153535348|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
153535349|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535350|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535351|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153535352|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535353|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535354|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535355|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535356|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535366|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535408|NCT01516567|Etoposide|etoposide|mesh-list
153535409|NCT01516567|Vincristine|vincristine|mesh-list
153535410|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153535411|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
153535412|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535413|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153535414|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153535415|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
153535416|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535417|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535418|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153535419|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153535420|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153535441|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535442|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535443|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153535444|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153535445|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153535446|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153535488|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153535489|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535490|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153535491|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
153535492|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153535493|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535494|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535495|NCT01516840|Heparin|heparin|mesh-list
153535496|NCT01516840|Calcium heparin|calcium heparin|mesh-list
153535497|NCT01516840|Warfarin|warfarin|mesh-list
153535498|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
153535499|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
153535500|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153535501|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153535502|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535503|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153535504|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
153535542|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535544|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535545|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535546|NCT01517308|Interferons|interferons|mesh-list
153535547|NCT01517308|Ribavirin|ribavirin|mesh-list
153535574|NCT01517347|Analgesics|analgesics|mesh-ancestor
153535575|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
153535576|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535577|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535578|NCT01517360|Oxytocin|oxytocin|mesh-list
153535579|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
153535580|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153535581|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535582|NCT01517399|Vitamin K|vitamin k|mesh-list
153535583|NCT01517399|Digoxin|digoxin|mesh-list
153535637|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535639|NCT01517568|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535640|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535641|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535642|NCT01517568|Incretins|incretins|mesh-ancestor
153535644|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535645|NCT01517607|Mesalamine|mesalamine|mesh-list
153535646|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153535647|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153535648|NCT01517607|Analgesics|analgesics|mesh-ancestor
153535649|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
153535650|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535651|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535652|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153535653|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153535654|NCT01517724|Bortezomib|bortezomib|mesh-list
153535655|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535656|NCT01517815|Tazobactam|tazobactam|mesh-list
153535659|NCT01517815|Doripenem|doripenem|mesh-list
153535709|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153535710|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535711|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
153535712|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
153535713|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
153535714|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535715|NCT01518062|Estrogens|estrogens|mesh-list
153535716|NCT01518062|Hormones|hormones|mesh-ancestor
153535717|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535718|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535725|NCT01518101|Incretins|incretins|mesh-ancestor
153535726|NCT01518101|Hormones|hormones|mesh-ancestor
153535727|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535728|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153535729|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535730|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535731|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535732|NCT01516944|Capecitabine|capecitabine|mesh-list
153535733|NCT01516944|Tegafur|tegafur|mesh-list
153535734|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
153535735|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153535736|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
153535737|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535738|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535739|NCT01518166|Liraglutide|liraglutide|mesh-list
153478957|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
153535740|NCT01518166|Griseofulvin|griseofulvin|mesh-list
153535741|NCT01518166|Digoxin|digoxin|mesh-list
153535742|NCT01518166|Lisinopril|lisinopril|mesh-list
153535743|NCT01518166|Atorvastatin|atorvastatin|mesh-list
153535744|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153535745|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153535746|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
153535747|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535748|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153646728|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535749|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153535751|NCT01518166|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535752|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535753|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535754|NCT01518166|Incretins|incretins|mesh-ancestor
153535755|NCT01518166|Hormones|hormones|mesh-ancestor
153535756|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535757|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153535758|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153535759|NCT01518166|Protective Agents|protective agents|mesh-ancestor
153535760|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153535761|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535762|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153535763|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
153535764|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535765|NCT01518231|Aspirin|aspirin|mesh-list
153618956|NCT01981291|Anesthetics|anesthetics|mesh-list
153479039|NCT01231230|Fluticasone|fluticasone|mesh-list
153535815|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535816|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153535817|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535818|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
153535819|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153535820|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153535821|NCT01518465|Growth Substances|growth substances|mesh-ancestor
153535822|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
153535823|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
153535824|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153535825|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153535891|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153535892|NCT01518933|Silybin|silybin|mesh-list
153535893|NCT01518933|Silymarin|silymarin|mesh-list
153535894|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
153535895|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535896|NCT01518933|Protective Agents|protective agents|mesh-ancestor
153535897|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535898|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153535899|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535900|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
153535901|NCT01518959|Vitamin D|vitamin d|mesh-list
153535902|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153535930|NCT01519102|Hormones|hormones|mesh-list
153535931|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535932|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535933|NCT01519128|Rilpivirine|rilpivirine|mesh-list
153535934|NCT01519128|Digoxin|digoxin|mesh-list
153535935|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153535936|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153535937|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535938|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535939|NCT01519128|Protective Agents|protective agents|mesh-ancestor
153535940|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535941|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153535942|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153535943|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
153535944|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535945|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153535946|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153535947|NCT01519154|Ketamine|ketamine|mesh-list
153535948|NCT01519154|Propofol|propofol|mesh-list
153535962|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535968|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153535970|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
153535971|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535972|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153535973|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153535974|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153535975|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535976|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535977|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535978|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535979|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153535980|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153535981|NCT01519336|Ritonavir|ritonavir|mesh-list
153535982|NCT01519336|Darunavir|darunavir|mesh-list
153535983|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153535984|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153535985|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535986|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535987|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535988|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153535989|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153535990|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
153535991|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535992|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153535993|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153535994|NCT01519401|Drospirenone|drospirenone|mesh-list
153535995|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153535996|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153535997|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153535998|NCT01519401|Estradiol|estradiol|mesh-list
153535999|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153536000|NCT01519401|Estrogens|estrogens|mesh-ancestor
153536001|NCT01519401|Hormones|hormones|mesh-ancestor
153536002|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536003|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536004|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153536005|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
153536006|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153646729|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153536007|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153536018|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153536019|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536020|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536021|NCT01519544|Diuretics|diuretics|mesh-ancestor
153536022|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
153536023|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536024|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153536025|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536026|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153536027|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153536028|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153536029|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
153536030|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
153536031|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536033|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
153536034|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153536035|NCT01519726|Midazolam|midazolam|mesh-list
153536036|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153536037|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153536038|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536039|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536040|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153536041|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153536042|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153536043|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153536044|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
153536067|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153536068|NCT01520012|Esomeprazole|esomeprazole|mesh-list
153536069|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153536070|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536071|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153536072|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536073|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536074|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153536085|NCT01520103|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153536086|NCT01520103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153536087|NCT01520103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536088|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536089|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536090|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
153536091|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536092|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536093|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153536094|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
153536095|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
153536096|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
153536098|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153536099|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153536100|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
153518815|NCT01447862|Ibutilide|ibutilide|mesh-list
153536101|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536102|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536127|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
153536128|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153536129|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153536130|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153536131|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536132|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536133|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
153536134|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
153536135|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536136|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536155|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
153536156|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
153536157|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536158|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536159|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
153536160|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536161|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153536162|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153536163|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153536164|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536165|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536166|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153536167|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153536187|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
153536188|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536189|NCT01520753|Insulin|insulin|mesh-list
153536190|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153536206|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
153536207|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153536208|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153536209|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536210|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153536211|NCT01520792|Acetaminophen|acetaminophen|mesh-list
153536212|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536213|NCT01520792|Analgesics|analgesics|mesh-ancestor
153536214|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
153536215|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536216|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536217|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
153536219|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153536220|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
153536221|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
153536222|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153536223|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
153536224|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536225|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536226|NCT01520831|Insulin|insulin|mesh-list
153536227|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153536228|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
153536235|NCT01520896|Ketoconazole|ketoconazole|mesh-list
153536295|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
153536296|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
153536298|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536299|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
153536300|NCT01521481|Anesthetics|anesthetics|mesh-list
153536301|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536302|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536303|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153536304|NCT01521520|Hematinics|hematinics|mesh-ancestor
153536305|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153536306|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153536307|NCT01521572|Albuterol|albuterol|mesh-list
153536308|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153536309|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
153536310|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536311|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536312|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153536313|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
153536314|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
153536315|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153536316|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153536317|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153536318|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153536319|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
153536320|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536321|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536322|NCT01521624|Metformin|metformin|mesh-list
153536323|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536324|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536326|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153536327|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536328|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
153536336|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536337|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536338|NCT01521767|Urological Agents|urological agents|mesh-ancestor
153536339|NCT01521793|Retinol acetate|retinol acetate|mesh-list
153536340|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153536341|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
153536342|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536343|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153536344|NCT01521793|Protective Agents|protective agents|mesh-ancestor
153536345|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536346|NCT01521819|Ranibizumab|ranibizumab|mesh-list
153536347|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153536348|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153536362|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536363|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536364|NCT01521962|Incretins|incretins|mesh-ancestor
153536365|NCT01521962|Hormones|hormones|mesh-ancestor
153519138|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
153536366|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536367|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153536368|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
153536369|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536370|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536371|NCT01521975|Adefovir|adefovir|mesh-list
153536372|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153536373|NCT01521975|Telbivudine|telbivudine|mesh-list
153536374|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
153536375|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536376|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153536377|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153536378|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536379|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536380|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
153536381|NCT01522040|Analgesics|analgesics|mesh-ancestor
153536382|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
153536383|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536384|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646730|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153536387|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153536388|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
153536389|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153536390|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536391|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536392|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153536393|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
153536394|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153536395|NCT01522092|Escitalopram|escitalopram|mesh-list
153536396|NCT01522092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153536397|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153536398|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536399|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536400|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536401|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
153536402|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536403|NCT01522105|Daptomycin|daptomycin|mesh-list
153536404|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153536405|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536406|NCT01522326|Ibuprofen|ibuprofen|mesh-list
153536407|NCT01522326|Metoclopramide|metoclopramide|mesh-list
153536408|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153536436|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536437|NCT01522534|Analgesics|analgesics|mesh-ancestor
153536438|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
153536439|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536440|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
153536441|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
153536442|NCT01522547|Pomalidomide|pomalidomide|mesh-list
153536443|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
153536444|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536445|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153536447|NCT01522547|Growth Substances|growth substances|mesh-ancestor
153536448|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
153536449|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536450|NCT01522612|Leucovorin|leucovorin|mesh-list
153536451|NCT01522612|Fluorouracil|fluorouracil|mesh-list
153536452|NCT01522612|Cetuximab|cetuximab|mesh-list
153536453|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
153536454|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536455|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153536456|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536457|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536480|NCT01522729|Narcotics|narcotics|mesh-ancestor
153536481|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536482|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536483|NCT01522729|Analgesics|analgesics|mesh-ancestor
153536484|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
153536485|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536486|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153536540|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536541|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153536542|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536543|NCT01523015|Docetaxel|docetaxel|mesh-list
153536544|NCT01523015|Fluorouracil|fluorouracil|mesh-list
153536545|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
153536546|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536547|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
153536548|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
153536549|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
153536550|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536551|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
153536553|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536554|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
153536555|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536556|NCT01523041|Insulin|insulin|mesh-list
153536557|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153536558|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
153536559|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
153536560|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153536561|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
153536564|NCT01523054|Metoprolol|metoprolol|mesh-list
153536606|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
153536607|NCT01523119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153536608|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153536609|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
153536610|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536611|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536612|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
153536613|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536614|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
153536615|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153536616|NCT01523314|Dexamethasone|dexamethasone|mesh-list
153536617|NCT01523314|Bevacizumab|bevacizumab|mesh-list
153536618|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153519326|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536619|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536620|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
153536621|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
153536622|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536623|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536682|NCT01523483|Hormones|hormones|mesh-ancestor
153536683|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536684|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536685|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
153536686|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
153536687|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536688|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
153536689|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536690|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536691|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
153536692|NCT01523574|Vitamin E|vitamin e|mesh-list
153536693|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
153536700|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153536701|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536702|NCT01523574|Analgesics|analgesics|mesh-ancestor
153536703|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
153536704|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536705|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
153536706|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536707|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153536708|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
153536709|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153536710|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536711|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536712|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
153536713|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153536714|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
153536715|NCT01523574|Protective Agents|protective agents|mesh-ancestor
153536717|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536718|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536719|NCT01523678|Paclitaxel|paclitaxel|mesh-list
153536720|NCT01523678|Carboplatin|carboplatin|mesh-list
153536727|NCT01523847|Doxorubicin|doxorubicin|mesh-list
153536731|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153536732|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536733|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536734|NCT01523860|Rituximab|rituximab|mesh-list
153536735|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153536736|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
153536737|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153536738|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536739|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
153536740|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536741|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153536742|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153536743|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
153536744|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536745|NCT01523860|Analgesics|analgesics|mesh-ancestor
153536746|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
153536747|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536748|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153536749|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153536750|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536751|NCT01524068|Rituximab|rituximab|mesh-list
153536752|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153536753|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519447|NCT05962671|Narcotics|narcotics|mesh-ancestor
153536754|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
153536755|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536756|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153536757|NCT01524081|Amoxicillin|amoxicillin|mesh-list
153536786|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536787|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153536788|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536789|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536791|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536792|NCT01524094|Antidotes|antidotes|mesh-ancestor
153536793|NCT01524094|Protective Agents|protective agents|mesh-ancestor
153536794|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
153536795|NCT01524094|Vitamins|vitamins|mesh-ancestor
153536796|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
153536797|NCT01524237|Ketamine|ketamine|mesh-list
153536798|NCT01524237|Analgesics|analgesics|mesh-ancestor
153536799|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
153536800|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536801|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536802|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153536803|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153536804|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
153536805|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
153536806|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536807|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153536808|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153536809|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536810|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536811|NCT01524315|Vitamins|vitamins|mesh-list
153536812|NCT01524315|Thiamine|thiamine|mesh-list
153536813|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
153536814|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
153536815|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536816|NCT01524354|Anesthetics|anesthetics|mesh-list
153536817|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536818|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536819|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
153536820|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153536821|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536822|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646731|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536824|NCT01524367|Analgesics|analgesics|mesh-ancestor
153536825|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
153536859|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536866|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153536868|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536869|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536870|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153536871|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153536872|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153536873|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
153536874|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536875|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153536876|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153536877|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536917|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536919|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153536920|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536921|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153536922|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536923|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536924|NCT01524809|Insulin|insulin|mesh-list
153536925|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153536926|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
153536927|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
153536952|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153536953|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536954|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536955|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153536956|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
153536957|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153536958|NCT01524939|Antibodies|antibodies|mesh-list
153536959|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
153536960|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
153536961|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536962|NCT01525004|Vaccines|vaccines|mesh-list
153536963|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
153536964|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536965|NCT06053528|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153536966|NCT06053528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536967|NCT06052995|Pimecrolimus|pimecrolimus|mesh-list
153536968|NCT06052995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153536969|NCT06052995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536970|NCT06052995|Analgesics|analgesics|mesh-ancestor
153536971|NCT06052995|Sensory System Agents|sensory system agents|mesh-ancestor
153536972|NCT06052995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536973|NCT06052995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536974|NCT06052995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536975|NCT06052995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153536994|NCT06052111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153536998|NCT06052111|Analgesics|analgesics|mesh-ancestor
153537083|NCT06051370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153537084|NCT06051370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153537085|NCT06051370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153537086|NCT06051370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537087|NCT06051370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519754|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
153537088|NCT06051370|Glucocorticoids|glucocorticoids|mesh-ancestor
153537089|NCT06051370|Hormones|hormones|mesh-ancestor
153537090|NCT06051370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537091|NCT06051370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537092|NCT06051370|Immunologic Factors|immunologic factors|mesh-ancestor
153537093|NCT06051370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537094|NCT06046248|Rituximab|rituximab|mesh-list
153537095|NCT06046248|Belumosudil|belumosudil|mesh-list
153537123|NCT05891262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153537125|NCT05891262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153537126|NCT05891262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153537127|NCT05891262|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
153537128|NCT05874570|Metronidazole|metronidazole|mesh-list
153537129|NCT05874570|Doxycycline|doxycycline|mesh-list
153537130|NCT05874570|Tetracycline|tetracycline|mesh-list
153537131|NCT05874570|Potassium Citrate|potassium citrate|mesh-list
153537132|NCT05874570|Esomeprazole|esomeprazole|mesh-list
153537133|NCT05874570|Bismuth|bismuth|mesh-list
153537134|NCT05874570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537176|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153537177|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153537178|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
153537179|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537180|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
153537181|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537182|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153537183|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537184|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153537191|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
153537192|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537193|NCT05415397|Celecoxib|celecoxib|mesh-list
153537194|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153537195|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153537196|NCT05415397|Analgesics|analgesics|mesh-ancestor
153537197|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
153537198|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537199|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537200|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153537201|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537250|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
153537251|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537252|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537253|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537254|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
153537255|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537256|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537257|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153537258|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153537259|NCT05296564|Analgesics|analgesics|mesh-ancestor
153537276|NCT05252429|Docetaxel|docetaxel|mesh-list
153537277|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
153537278|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537279|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537280|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537281|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537282|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537283|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537284|NCT05252429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153537285|NCT05249309|Ketamine|ketamine|mesh-list
153537286|NCT05249309|Analgesics|analgesics|mesh-ancestor
153537287|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
153537288|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537289|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537315|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537316|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537317|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
153537330|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
153537331|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537332|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153537334|NCT04888858|Analgesics|analgesics|mesh-ancestor
153537335|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153537336|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153537337|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
153537338|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
153537339|NCT04784247|Lenvatinib|lenvatinib|mesh-list
153537340|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537341|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537342|NCT04784247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153537343|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537344|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153537390|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537391|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153537392|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
153537393|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537394|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153537395|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
153537396|NCT04548648|Isavuconazole|isavuconazole|mesh-list
153537397|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
153537398|NCT04548648|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153537399|NCT04548648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153537400|NCT04548648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537401|NCT04548648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537402|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537403|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
153537404|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153537405|NCT04544111|Trametinib|trametinib|mesh-list
153537406|NCT04544111|Dabrafenib|dabrafenib|mesh-list
153537407|NCT04544111|Spartalizumab|spartalizumab|mesh-list
153730489|NCT00141414|Analgesics|analgesics|mesh-ancestor
153537408|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537409|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153537410|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537412|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153537441|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153537442|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153537443|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
153537444|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537445|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153618962|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520031|NCT04951115|Etoposide|etoposide|mesh-list
153537446|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153537447|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
153537448|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153537464|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537466|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537467|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
153537468|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537469|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537470|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153537471|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153537472|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
153537473|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
153537474|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153537475|NCT04038619|Loperamide|loperamide|mesh-list
153537476|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
153537477|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153537478|NCT03951831|Docetaxel|docetaxel|mesh-list
153537479|NCT03951831|Leuprolide|leuprolide|mesh-list
153537480|NCT03951831|Cemiplimab|cemiplimab|mesh-list
153537481|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537482|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537483|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537484|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537485|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537486|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153537487|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
153537488|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153537492|NCT03884972|Venetoclax|venetoclax|mesh-list
153537497|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537498|NCT03819517|Resveratrol|resveratrol|mesh-list
153537499|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
153537500|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537501|NCT03819517|Protective Agents|protective agents|mesh-ancestor
153537502|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537503|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537504|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153537505|NCT03803761|Fulvestrant|fulvestrant|mesh-list
153537506|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153537507|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537508|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153537509|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153537510|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
153537520|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
153537521|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537522|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153537523|NCT03735095|Trioxsalen|trioxsalen|mesh-list
153537524|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537525|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
153537526|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153537527|NCT03726879|Paclitaxel|paclitaxel|mesh-list
153537528|NCT03726879|Maytansine|maytansine|mesh-list
153537529|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153537530|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
153537531|NCT03726879|Doxorubicin|doxorubicin|mesh-list
153537532|NCT03726879|Trastuzumab|trastuzumab|mesh-list
153537533|NCT03726879|Atezolizumab|atezolizumab|mesh-list
153537534|NCT03726879|Pertuzumab|pertuzumab|mesh-list
153537535|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153537536|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537537|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537538|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537539|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537540|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537549|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153537550|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153537551|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537552|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537553|NCT03726879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153537554|NCT03726879|Immunotoxins|immunotoxins|mesh-ancestor
153537555|NCT03726879|Immunoconjugates|immunoconjugates|mesh-ancestor
153537556|NCT03723187|Heparin|heparin|mesh-list
153537557|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
153537558|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153537559|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153537560|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537561|NCT03691051|Capecitabine|capecitabine|mesh-list
153537562|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153537563|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
153537564|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537565|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537566|NCT03630042|Rituximab|rituximab|mesh-list
153537567|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
153537568|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537569|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537570|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
153537571|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537572|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520194|NCT06255392|Antimetabolites|antimetabolites|mesh-ancestor
153537573|NCT03630042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153537588|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537589|NCT03354897|Torsemide|torsemide|mesh-list
153537590|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153537591|NCT03354897|Diuretics|diuretics|mesh-ancestor
153537592|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
153537593|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537596|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537598|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153537599|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153537600|NCT03186638|Analgesics|analgesics|mesh-ancestor
153537601|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
153537602|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537603|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537604|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153537605|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537606|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153537607|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537608|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537609|NCT03165292|Topotecan|topotecan|mesh-list
153537610|NCT03165292|Thiotepa|thiotepa|mesh-list
153537611|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153537612|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153537613|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537614|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537615|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537616|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537617|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
153537618|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153537619|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537620|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
153537621|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537622|NCT02998385|Cisplatin|cisplatin|mesh-list
153537623|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537650|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537651|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537652|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
153537653|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537654|NCT02639065|Durvalumab|durvalumab|mesh-list
153537655|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537656|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537657|NCT02620072|Insulin|insulin|mesh-list
153520490|NCT05963139|Morphine|morphine|mesh-list
153537658|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153537659|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537660|NCT02532257|Rituximab|rituximab|mesh-list
153537661|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153537662|NCT02532257|Lenalidomide|lenalidomide|mesh-list
153537663|NCT02532257|Antibodies|antibodies|mesh-list
153537664|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
153537665|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153537666|NCT02532257|Ibrutinib|ibrutinib|mesh-list
153537667|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
153537668|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537669|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537721|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537723|NCT00667121|Gabapentin|gabapentin|mesh-list
153537724|NCT00667121|Dexetimide|dexetimide|mesh-list
153537725|NCT00667121|Citalopram|citalopram|mesh-list
153537726|NCT00667121|Sertraline|sertraline|mesh-list
153537727|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153537728|NCT00667121|Escitalopram|escitalopram|mesh-list
153537729|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537730|NCT00667121|Analgesics|analgesics|mesh-ancestor
153537731|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
153537732|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537733|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537791|NCT00336024|Cisplatin|cisplatin|mesh-list
153537792|NCT00336024|Carboplatin|carboplatin|mesh-list
153537793|NCT00336024|Methotrexate|methotrexate|mesh-list
153537794|NCT00336024|Etoposide|etoposide|mesh-list
153537795|NCT00336024|Vincristine|vincristine|mesh-list
153537796|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
153537797|NCT00336024|Podophyllotoxin|podophyllotoxin|mesh-list
153537798|NCT00336024|Lenograstim|lenograstim|mesh-list
153537799|NCT00336024|Calcium|calcium|mesh-list
153537800|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
153537801|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537802|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
153537803|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537804|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537869|NCT01525537|Dsuvia|dsuvia|mesh-list
153537870|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153537871|NCT01525537|Narcotics|narcotics|mesh-ancestor
153537872|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537873|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537874|NCT01525537|Analgesics|analgesics|mesh-ancestor
153537875|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
153537876|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537877|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153481123|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153537895|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537896|NCT01525719|Everolimus|everolimus|mesh-list
153537897|NCT01525719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153537898|NCT01525719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153537899|NCT01525719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745661|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730495|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153537961|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537962|NCT01526122|Aspirin|aspirin|mesh-list
153537963|NCT01526122|Clopidogrel|clopidogrel|mesh-list
153537964|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153538035|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153538036|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538037|NCT01526369|Paclitaxel|paclitaxel|mesh-list
153538038|NCT01526369|Trastuzumab|trastuzumab|mesh-list
153538039|NCT01526369|Lapatinib|lapatinib|mesh-list
153538040|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153538041|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730496|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538042|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
153538043|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
153538044|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
153538045|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538046|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153538047|NCT01526369|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153538048|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153538049|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538050|NCT01526395|Propofol|propofol|mesh-list
153538051|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153538052|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538053|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538062|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538063|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153538064|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153538065|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538066|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
153538067|NCT01526499|Docetaxel|docetaxel|mesh-list
153538089|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153538090|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153538092|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
153538093|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538094|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153538095|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153538096|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538097|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538098|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153538099|NCT01526525|Narcotics|narcotics|mesh-ancestor
153538100|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153538101|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
153538102|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153538103|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153538104|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538105|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153538106|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538107|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153538108|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
153538109|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
153538110|NCT01526564|Vitamins|vitamins|mesh-ancestor
153538152|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538153|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153538154|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153538155|NCT01526837|Growth Substances|growth substances|mesh-ancestor
153538156|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538157|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
153538158|NCT01526850|Cyclosporine|cyclosporine|mesh-list
153538159|NCT01526850|Cyclosporins|cyclosporins|mesh-list
153538160|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
153538161|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538162|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538163|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538164|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
153538165|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538166|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
153538167|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538168|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
153538169|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153538170|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153538171|NCT01526850|Hormones|hormones|mesh-ancestor
153538172|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538173|NCT01526876|Clevidipine|clevidipine|mesh-list
153538174|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153538175|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538179|NCT01526941|Insulin|insulin|mesh-list
153538206|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153538207|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153538208|NCT01527032|Thalidomide|thalidomide|mesh-list
153538209|NCT01527032|Dexamethasone|dexamethasone|mesh-list
153538210|NCT01527032|Melphalan|melphalan|mesh-list
153538211|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538212|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
153538213|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
153538214|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538215|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538216|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153538217|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
153538218|NCT01527032|Hormones|hormones|mesh-ancestor
153538219|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538220|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153538221|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538222|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153538223|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
153538224|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538235|NCT01527097|Atorvastatin|atorvastatin|mesh-list
153538269|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538270|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153538271|NCT01527422|Prednisone|prednisone|mesh-list
153538272|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
153538273|NCT01527422|Doxorubicin|doxorubicin|mesh-list
153538274|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153538275|NCT01527422|Vincristine|vincristine|mesh-list
153538276|NCT01527422|Sargramostim|sargramostim|mesh-list
153538277|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538278|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
153538279|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538280|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153538291|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
153538340|NCT01527669|L 647318|l 647318|mesh-list
153538341|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
153538342|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153538343|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153538344|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
153538345|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538346|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153538347|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153538348|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538349|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
153538350|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
153538351|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
153538352|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538353|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538354|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
153538355|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538356|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153538357|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538358|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538359|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153538360|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153538361|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153538362|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538363|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538364|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538365|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538366|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
153538367|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538382|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
153538383|NCT01527890|Fentanyl|fentanyl|mesh-list
153538384|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153538391|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153538392|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153538393|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
153538394|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
153538395|NCT01527903|Midazolam|midazolam|mesh-list
153538396|NCT01527903|Propofol|propofol|mesh-list
153538397|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153538398|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538399|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538400|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153538401|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
153538402|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
153520813|NCT05528718|Midazolam|midazolam|mesh-list
153538403|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153538404|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153538405|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538406|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538407|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
153538408|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
153538409|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153618970|NCT01981369|Propofol|propofol|mesh-list
153538410|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538412|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
153538413|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153538414|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153538415|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538416|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
153538417|NCT01527968|Coagulants|coagulants|mesh-ancestor
153538418|NCT01527994|Aprepitant|aprepitant|mesh-list
153538419|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
153538420|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
153538446|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538447|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153538448|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
153538449|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538450|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538451|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
153538452|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538453|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153538454|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538455|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
153538456|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153538457|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153538458|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
153538459|NCT01528176|Vitamin D|vitamin d|mesh-list
153538460|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153538461|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538462|NCT01528176|Vitamins|vitamins|mesh-ancestor
153538463|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
153538464|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153538465|NCT01528371|Midazolam|midazolam|mesh-list
153538466|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153538467|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153538468|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538469|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538470|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153538471|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538472|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730498|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153538473|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153538474|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
153538475|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
153538476|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
153538477|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
153538478|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538480|NCT01528501|Panobinostat|panobinostat|mesh-list
153538484|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538486|NCT01528540|Antioxidants|antioxidants|mesh-list
153538487|NCT01528540|Analgesics|analgesics|mesh-ancestor
153538488|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
153538489|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538490|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538491|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
153538492|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153538505|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153538506|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
153538507|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538508|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538509|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
153538510|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538511|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
153538513|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
153538514|NCT01528644|Calcium|calcium|mesh-list
153538515|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153538516|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538517|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153538518|NCT01528644|Trace Elements|trace elements|mesh-ancestor
153538519|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
153538520|NCT01528644|Hematinics|hematinics|mesh-ancestor
153538521|NCT01528722|Bupivacaine|bupivacaine|mesh-list
153538523|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
153538551|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
153538552|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538553|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153538554|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153538563|NCT01528943|Tezosentan|tezosentan|mesh-list
153538564|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153538565|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153538566|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
153538567|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
153538568|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153538569|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538570|NCT01529125|Lamivudine|lamivudine|mesh-list
153538571|NCT01529125|Zidovudine|zidovudine|mesh-list
153538573|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153538574|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153538575|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538576|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538577|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
153538578|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538579|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153538580|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153538610|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538611|NCT01529164|Antidotes|antidotes|mesh-ancestor
153538612|NCT01529164|Protective Agents|protective agents|mesh-ancestor
153538613|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
153538614|NCT01529164|Vitamins|vitamins|mesh-ancestor
153538615|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
153538616|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153538617|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153538618|NCT01529164|Growth Substances|growth substances|mesh-ancestor
153538619|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
153538620|NCT01529177|Metformin|metformin|mesh-list
153538621|NCT01529177|Citric Acid|citric acid|mesh-list
153538622|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
153538623|NCT01529177|Clomiphene|clomiphene|mesh-list
153538624|NCT01529177|Enclomiphene|enclomiphene|mesh-list
153538625|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
153538626|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538635|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538636|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153538637|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
153538638|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153538639|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153538640|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153538642|NCT01529190|Analgesics|analgesics|mesh-ancestor
153538643|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
153538644|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538645|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538646|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
153538647|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153538651|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153538663|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538664|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153538665|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538666|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153538667|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
153538668|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153538669|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
153538670|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538671|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538672|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153538673|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153538674|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
153538675|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
153538676|NCT01529242|Prednisolone|prednisolone|mesh-list
153538677|NCT01529242|Betamethasone|betamethasone|mesh-list
153538678|NCT01529242|Desloratadine|desloratadine|mesh-list
153538679|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
153538680|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538681|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
153538682|NCT01529242|Hormones|hormones|mesh-ancestor
153538684|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538721|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538722|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153538723|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
153538725|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538726|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153538727|NCT01529320|Protective Agents|protective agents|mesh-ancestor
153538728|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153730502|NCT00145002|Lenograstim|lenograstim|mesh-list
153730503|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153538729|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538730|NCT01529437|Immunomodulating Agents|immunomodulating agents|mesh-list
153538731|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
153538732|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538733|NCT01529476|Levofloxacin|levofloxacin|mesh-list
153538734|NCT01529476|Nemonoxacin|nemonoxacin|mesh-list
153538735|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153538736|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538737|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153538738|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153538739|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153538740|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538741|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538742|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538743|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153538744|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153538746|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153538747|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
153538748|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538753|NCT01529541|Anagliptin|anagliptin|mesh-list
153538779|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153538780|NCT01529619|Protective Agents|protective agents|mesh-ancestor
153538781|NCT01529710|Praziquantel|praziquantel|mesh-list
153538782|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
153538783|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153538784|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538785|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153538786|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153538787|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153538788|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538789|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538790|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153538791|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538792|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538793|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
153538794|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538795|NCT01529892|Methamphetamine|methamphetamine|mesh-list
153538796|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153538797|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538798|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
153538799|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
153538800|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538801|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
153538802|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538803|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538804|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
153538805|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153538806|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153538807|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538808|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153538809|NCT01529957|Nemonoxacin|nemonoxacin|mesh-list
153538810|NCT01529957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153538811|NCT01529957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538812|NCT01530022|Lacosamide|lacosamide|mesh-list
153538813|NCT01530022|Carbamazepine|carbamazepine|mesh-list
153538817|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538850|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538852|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153538853|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153538855|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
153538856|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538857|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538930|NCT01530542|Oxycodone|oxycodone|mesh-list
153538997|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153538998|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538999|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539000|NCT01530815|Bupivacaine|bupivacaine|mesh-list
153539001|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
153539002|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
153539003|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730504|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
153730505|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730506|NCT00141492|Testosterone|testosterone|mesh-list
153539020|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539021|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153539022|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153539023|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
153539024|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539025|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539038|NCT01531140|Sennosides|sennosides|mesh-list
153539085|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539087|NCT01531361|Vemurafenib|vemurafenib|mesh-list
153539088|NCT01531361|Crizotinib|crizotinib|mesh-list
153539089|NCT01531361|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153539090|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539091|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153539092|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539093|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539094|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
153539095|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539096|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
153539097|NCT01531517|Propolis|propolis|mesh-list
153539192|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
153539193|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
153539194|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539195|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539196|NCT01531920|Ethanol|ethanol|mesh-list
153539197|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153539198|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539199|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539201|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153539270|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539271|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
153539272|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153539273|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
153539274|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539275|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153539276|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539277|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153539278|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
153539279|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539280|NCT01532856|Thalidomide|thalidomide|mesh-list
153539281|NCT01532856|Dexamethasone|dexamethasone|mesh-list
153539282|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
153539283|NCT01532856|Prednisone|prednisone|mesh-list
153539284|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
153539285|NCT01532856|Melphalan|melphalan|mesh-list
153539293|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539334|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539335|NCT01533155|Quinidine|quinidine|mesh-list
153539336|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
153539337|NCT01533155|Morphine|morphine|mesh-list
153539338|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153539339|NCT01533155|Narcotics|narcotics|mesh-ancestor
153539340|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539341|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539342|NCT01533155|Analgesics|analgesics|mesh-ancestor
153539343|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
153539344|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539345|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153539346|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153539347|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539348|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539349|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539350|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153539351|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
153539438|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539440|NCT01533441|Coagulants|coagulants|mesh-ancestor
153521101|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539441|NCT01533506|Stiripentol|stiripentol|mesh-list
153539442|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
153539443|NCT01533545|Epinephrine|epinephrine|mesh-list
153539444|NCT01533545|Mepivacaine|mepivacaine|mesh-list
153539445|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153539446|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153539447|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539448|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539449|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539450|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539451|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153539452|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153539453|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
153539454|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539455|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153539473|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
153539474|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539475|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539476|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
153539477|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153539478|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
153539479|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
153539480|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153539481|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153539482|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153539483|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539484|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539485|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539499|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153539500|NCT01533740|Growth Substances|growth substances|mesh-ancestor
153539501|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539502|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
153539503|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
153539504|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539505|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153539506|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153539507|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
153539508|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153539509|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153539510|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539511|NCT01533740|Antidotes|antidotes|mesh-ancestor
153539512|NCT01533740|Protective Agents|protective agents|mesh-ancestor
153539513|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
153539514|NCT01533740|Vitamins|vitamins|mesh-ancestor
153539515|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
153539595|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
153539596|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539597|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539598|NCT01534455|Lapatinib|lapatinib|mesh-list
153539599|NCT01534455|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153539600|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153539601|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539602|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539603|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539604|NCT01534546|Capecitabine|capecitabine|mesh-list
153539605|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
153539607|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
153539697|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
153539698|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539699|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539700|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539701|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539702|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153539703|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539704|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539706|NCT01535092|Protective Agents|protective agents|mesh-ancestor
153539707|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539708|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153539709|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539710|NCT01535157|Ketoconazole|ketoconazole|mesh-list
153539711|NCT01535157|Fenretinide|fenretinide|mesh-list
153539712|NCT01535157|Retinamide|retinamide|mesh-list
153539727|NCT01535170|Lactoferrin|lactoferrin|mesh-list
153539768|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153539769|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
154182218|NCT05749393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182220|NCT05717738|Atezolizumab|atezolizumab|mesh-list
154182221|NCT05717738|Sorafenib|sorafenib|mesh-list
154182222|NCT05717738|Apatinib|apatinib|mesh-list
154182223|NCT05717738|Lenvatinib|lenvatinib|mesh-list
154182224|NCT05717738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154182225|NCT05717738|Antibodies|antibodies|mesh-list
154182226|NCT05717738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154182227|NCT05717738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182228|NCT05717738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182229|NCT05717738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182230|NCT05717738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182231|NCT05717738|Growth Substances|growth substances|mesh-ancestor
154182232|NCT05717738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182233|NCT05717738|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182234|NCT05717738|Immunologic Factors|immunologic factors|mesh-ancestor
154182235|NCT05717738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182236|NCT05717738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182237|NCT05717738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182238|NCT05713994|Bevacizumab|bevacizumab|mesh-list
153521209|NCT04626635|Cemiplimab|cemiplimab|mesh-list
154182239|NCT05713994|Atezolizumab|atezolizumab|mesh-list
154182240|NCT05713994|Sorafenib|sorafenib|mesh-list
154182241|NCT05713994|Apatinib|apatinib|mesh-list
154182242|NCT05713994|Lenvatinib|lenvatinib|mesh-list
154182243|NCT05713994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154182244|NCT05713994|Antibodies|antibodies|mesh-list
154182245|NCT05713994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154182246|NCT05713994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182247|NCT05713994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182248|NCT05713994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182249|NCT05713994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182250|NCT05713994|Growth Substances|growth substances|mesh-ancestor
154182251|NCT05713994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182252|NCT05713994|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182253|NCT05713994|Immunologic Factors|immunologic factors|mesh-ancestor
154182254|NCT05713994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182255|NCT05713994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182257|NCT05695573|Cystatins|cystatins|mesh-list
154182258|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154182259|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
154182260|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182261|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182262|NCT05674487|Misoprostol|misoprostol|mesh-list
154182263|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154182264|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
154182265|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154182266|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182267|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154182323|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154182324|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182325|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154182326|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154182327|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182328|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182329|NCT05597917|Trabectedin|trabectedin|mesh-list
154182330|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154182331|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
154182332|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182333|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182334|NCT05566756|Ofatumumab|ofatumumab|mesh-list
154182335|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182336|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
154182384|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182385|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153929381|NCT02885597|Methotrexate|methotrexate|mesh-list
154182386|NCT05462613|Growth Substances|growth substances|mesh-ancestor
154182387|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182388|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182389|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154182390|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154182392|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
153521232|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154182393|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182450|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182451|NCT05305794|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154182452|NCT05300152|Antibodies|antibodies|mesh-list
154182453|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
154182454|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
154182455|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182456|NCT05281601|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
154182459|NCT05151731|Ranibizumab|ranibizumab|mesh-list
154182518|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182519|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182520|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154182521|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154182522|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
154182523|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182524|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182525|NCT04975555|Siltuximab|siltuximab|mesh-list
154182526|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182527|NCT04925479|Niacinamide|niacinamide|mesh-list
154182528|NCT04925479|Asciminib|asciminib|mesh-list
154182529|NCT04925479|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154182530|NCT04925479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182531|NCT04925479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182533|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
154182577|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154182579|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
154182580|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
154182581|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154182582|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182583|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154182584|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154182585|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182586|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182587|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182588|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154182589|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154182590|NCT04762953|Leucovorin|leucovorin|mesh-list
154182591|NCT04762953|Paclitaxel|paclitaxel|mesh-list
154182592|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154182593|NCT04762953|Fluorouracil|fluorouracil|mesh-list
154182594|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154182595|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182633|NCT04550442|Azacitidine|azacitidine|mesh-list
153521246|NCT04540211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182634|NCT04550442|Venetoclax|venetoclax|mesh-list
154182635|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182636|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
154182637|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182638|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182639|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182640|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
154182641|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
154182642|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
154182643|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154182644|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182645|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
154182646|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
154182647|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182648|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182649|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182650|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
154182651|NCT04548999|Hormones|hormones|mesh-ancestor
154182652|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182653|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154182654|NCT04548999|Protective Agents|protective agents|mesh-ancestor
154182655|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
154182656|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
154182657|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182658|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182659|NCT04547907|Paclitaxel|paclitaxel|mesh-list
154182660|NCT04547907|Docetaxel|docetaxel|mesh-list
154182661|NCT04547907|Carboplatin|carboplatin|mesh-list
154182662|NCT04547907|Trastuzumab|trastuzumab|mesh-list
154182663|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154182664|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182665|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
154182666|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
154182667|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
154182675|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182676|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154182677|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154182678|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
154182679|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182680|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182681|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154182682|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182683|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
154182684|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153929670|NCT02830048|Glyburide|glyburide|mesh-list
154182685|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154182686|NCT04534218|Analgesics|analgesics|mesh-ancestor
154182687|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
154182688|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182689|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182690|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154182691|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154182692|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154182693|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154182694|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182695|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
154182696|NCT04511078|Panitumumab|panitumumab|mesh-list
154182697|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182698|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182699|NCT04495452|Fentanyl|fentanyl|mesh-list
154182701|NCT04495452|Narcotics|narcotics|mesh-ancestor
154182721|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182722|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
153521328|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
154182723|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182724|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182725|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154182726|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
154182727|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154182728|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154182729|NCT04476030|Analgesics|analgesics|mesh-ancestor
154182730|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
154182731|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
154182732|NCT04458831|Dexamethasone|dexamethasone|mesh-list
154182733|NCT04458831|Pomalidomide|pomalidomide|mesh-list
154182734|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182735|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
154182736|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
154182737|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182738|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182739|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182740|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
154182741|NCT04458831|Hormones|hormones|mesh-ancestor
154182742|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182743|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154182744|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182745|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
154182746|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154182747|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154182748|NCT04458831|Growth Substances|growth substances|mesh-ancestor
154182749|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
154182750|NCT04450316|Naltrexone|naltrexone|mesh-list
154182751|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154182763|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154182764|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182765|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154182766|NCT04438213|Diuretics|diuretics|mesh-ancestor
154182767|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
154182768|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154182769|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154182770|NCT04395989|Paclitaxel|paclitaxel|mesh-list
154182771|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154182772|NCT04395989|Capecitabine|capecitabine|mesh-list
154182773|NCT04395989|Everolimus|everolimus|mesh-list
154182774|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154182775|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182776|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
154182777|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
154182778|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
154182779|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182780|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182781|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154182782|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
154182783|NCT04395989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154182784|NCT04395989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182785|NCT04395989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521342|NCT04231968|Ziresovir|ziresovir|mesh-list
154182786|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154182787|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
154182788|NCT04360941|Palbociclib|palbociclib|mesh-list
154182789|NCT04360941|Avelumab|avelumab|mesh-list
154182790|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182791|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182809|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
154182810|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154182811|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154182812|NCT04200911|Sirolimus|sirolimus|mesh-list
154182813|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154182814|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182815|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154182816|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182817|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
154182818|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154182819|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
154182820|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182821|NCT04076059|Androgens|androgens|mesh-list
154182822|NCT04076059|Hormones|hormones|mesh-ancestor
154182823|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182824|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182825|NCT04006457|Vaccines|vaccines|mesh-list
154182826|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
154182827|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182828|NCT03958045|Nivolumab|nivolumab|mesh-list
154182829|NCT03958045|Rucaparib|rucaparib|mesh-list
154182830|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182831|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182832|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182833|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182834|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154182835|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182836|NCT03952065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154182837|NCT03952065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182838|NCT03952065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182839|NCT03952065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182840|NCT03911271|Atropine|atropine|mesh-list
154182841|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154182842|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154182843|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154182844|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
154182845|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154182846|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182847|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154182848|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
154182849|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
154182850|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
154182851|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154182852|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154182853|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
154182854|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182855|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182856|NCT03844048|Venetoclax|venetoclax|mesh-list
154182857|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182858|NCT03759587|Niraparib|niraparib|mesh-list
154182859|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154182860|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182861|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182862|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182863|NCT03752684|Calcium|calcium|mesh-list
154182865|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182902|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182903|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154182904|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154182905|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154182906|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154182907|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182908|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154182909|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154182910|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182911|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
154182912|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154182913|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154182914|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154182915|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
154182916|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154182917|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154182918|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
154182919|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154182920|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
154182921|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
154182922|NCT03559400|Gentamicins|gentamicins|mesh-list
154182923|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154182924|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154182953|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154182954|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154182955|NCT03483012|Atezolizumab|atezolizumab|mesh-list
154182956|NCT03483012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154182957|NCT03483012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154182958|NCT03483012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154182959|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182960|NCT03363893|Fulvestrant|fulvestrant|mesh-list
154182961|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154182962|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154182963|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153521402|NCT04162873|Celecoxib|celecoxib|mesh-list
154182964|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154182965|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
154182966|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154182967|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182968|NCT03339128|Eluxadoline|eluxadoline|mesh-list
154182969|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154182970|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
154182971|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
154182972|NCT03231709|Alogliptin|alogliptin|mesh-list
154182973|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154182974|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154182975|NCT03231709|Incretins|incretins|mesh-ancestor
154182976|NCT03231709|Hormones|hormones|mesh-ancestor
154182977|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183001|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154183002|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
154183003|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183004|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154183005|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
154183006|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154183007|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154183008|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183009|NCT03117972|Antidotes|antidotes|mesh-ancestor
154183010|NCT03117972|Protective Agents|protective agents|mesh-ancestor
154183011|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
154183012|NCT03117972|Vitamins|vitamins|mesh-ancestor
154183013|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
154183014|NCT03054896|Venetoclax|venetoclax|mesh-list
154183015|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183062|NCT02654990|Dexamethasone|dexamethasone|mesh-list
154183063|NCT02654990|Bortezomib|bortezomib|mesh-list
154183064|NCT02654990|Panobinostat|panobinostat|mesh-list
154183065|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183066|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
154183067|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
154183068|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183069|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183070|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154183071|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
154183072|NCT02654990|Hormones|hormones|mesh-ancestor
154183073|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183074|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154183075|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183076|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154183132|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154183133|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
154183134|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183135|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183137|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183138|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
154183139|NCT02162810|Hormones|hormones|mesh-ancestor
154183140|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183141|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183142|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154183143|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183145|NCT01358877|Docetaxel|docetaxel|mesh-list
154183146|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
154183147|NCT01358877|Carboplatin|carboplatin|mesh-list
154183148|NCT01358877|Doxorubicin|doxorubicin|mesh-list
154183149|NCT01358877|Fluorouracil|fluorouracil|mesh-list
154183150|NCT01358877|Trastuzumab|trastuzumab|mesh-list
154183151|NCT01358877|Epirubicin|epirubicin|mesh-list
154183152|NCT01358877|Pertuzumab|pertuzumab|mesh-list
154183153|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154183189|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183190|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154183191|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154183192|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154183193|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183194|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183195|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
154183196|NCT00670358|Hormones|hormones|mesh-ancestor
154183197|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154183198|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154183199|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154183200|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
154183201|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
154183202|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
154183203|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154183204|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154183205|NCT00670358|Growth Substances|growth substances|mesh-ancestor
154183206|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
154183207|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
154183208|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
154183209|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183210|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
154183211|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183212|NCT00176631|Docetaxel|docetaxel|mesh-list
154183213|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183214|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
154183239|NCT06050044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183240|NCT06050031|Antioxidants|antioxidants|mesh-list
154183241|NCT06050031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183242|NCT06050031|Protective Agents|protective agents|mesh-ancestor
154183243|NCT06050031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183244|NCT06049966|Carboplatin|carboplatin|mesh-list
154183246|NCT06049966|Atezolizumab|atezolizumab|mesh-list
154183306|NCT06045884|Anesthetics, Local|anesthetics, local|mesh-ancestor
154183307|NCT06045884|Anesthetics|anesthetics|mesh-ancestor
154183308|NCT06045884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183309|NCT06045884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183310|NCT06045884|Sensory System Agents|sensory system agents|mesh-ancestor
154183311|NCT06045884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183312|NCT06044805|Chloroquine|chloroquine|mesh-list
154183313|NCT06044805|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153521466|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154183314|NCT06044805|Primaquine|primaquine|mesh-list
154183315|NCT06044805|Amebicides|amebicides|mesh-ancestor
154183316|NCT06044805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154183317|NCT06044805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154183318|NCT06044805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183319|NCT06044805|Antimalarials|antimalarials|mesh-ancestor
154183320|NCT06044805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154183321|NCT06044805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154183322|NCT06044805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154183323|NCT06044805|Analgesics|analgesics|mesh-ancestor
154183324|NCT06044805|Sensory System Agents|sensory system agents|mesh-ancestor
154183325|NCT06044805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183326|NCT06044805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183327|NCT06044805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183328|NCT06044805|Filaricides|filaricides|mesh-ancestor
154183358|NCT06040034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183359|NCT06040034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154183360|NCT06040034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154183361|NCT06040034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154183362|NCT06040034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154183363|NCT06040034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183364|NCT06038981|Tranexamic Acid|tranexamic acid|mesh-list
154183365|NCT06038981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154183366|NCT06038981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154183367|NCT06038981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183419|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
154183420|NCT05628883|Fludarabine|fludarabine|mesh-list
154183421|NCT05628883|Interleukin-2|interleukin-2|mesh-list
154183422|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154183423|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
154183424|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183425|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154183426|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154183427|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
154183428|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183429|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183430|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154183431|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154183432|NCT05628883|Analgesics|analgesics|mesh-ancestor
154183433|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
154183434|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183480|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154183482|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183483|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154183484|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183485|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183486|NCT05492565|Tenofovir|tenofovir|mesh-list
154183487|NCT05492565|Emtricitabine|emtricitabine|mesh-list
154183488|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
154183489|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521503|NCT03845075|Adrenergic Agents|adrenergic agents|mesh-ancestor
154183490|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154183491|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154183492|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183493|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183494|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154183495|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154183496|NCT05486104|Hemay005|hemay005|mesh-list
154183497|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
154183498|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154183499|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154183500|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183501|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183502|NCT05452174|Mirtazapine|mirtazapine|mesh-list
154183529|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154183530|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154183531|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154183532|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
154183533|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183534|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183535|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183536|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154183537|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154183538|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
154183539|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183540|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154183541|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
154183542|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
154183543|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
154183544|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154183545|NCT05423197|Panitumumab|panitumumab|mesh-list
154183546|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183547|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183548|NCT05411471|Vaccines|vaccines|mesh-list
154183549|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
154183550|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183551|NCT05399498|Psilocybin|psilocybin|mesh-list
154183552|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
154183582|NCT05159245|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154183583|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
154183584|NCT05116995|Ticagrelor|ticagrelor|mesh-list
154183585|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154183586|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
154183587|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154183588|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
154183589|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183590|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183591|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
154183592|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154183593|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154183594|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154183595|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154183596|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
154183597|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154183598|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183599|NCT05095857|Ketamine|ketamine|mesh-list
154183600|NCT05095857|Esketamine|esketamine|mesh-list
154183601|NCT05095857|Analgesics|analgesics|mesh-ancestor
154183602|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
154183603|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183604|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183605|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154183606|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154183607|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
154183608|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
154183609|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154183610|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154183626|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183627|NCT04995835|Cefiderocol|cefiderocol|mesh-list
154183628|NCT04995835|Siderophores|siderophores|mesh-ancestor
154183629|NCT04995835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154183630|NCT04995835|Chelating Agents|chelating agents|mesh-ancestor
154183631|NCT04995835|Sequestering Agents|sequestering agents|mesh-ancestor
154183632|NCT04995835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183633|NCT04995835|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154183692|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154183693|NCT04525157|Afamelanotide|afamelanotide|mesh-list
154183694|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
154183695|NCT04503694|Nivolumab|nivolumab|mesh-list
154183696|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154183697|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154183698|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154183699|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154183700|NCT04493151|Imipenem|imipenem|mesh-list
154183701|NCT04493151|Relebactam|relebactam|mesh-list
154183702|NCT04493151|Cilastatin|cilastatin|mesh-list
154183703|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154183704|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183705|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
154183706|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154183708|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154183760|NCT04278404|Guanfacine|guanfacine|mesh-list
154183761|NCT04278404|Labetalol|labetalol|mesh-list
154183762|NCT04278404|Nicardipine|nicardipine|mesh-list
154183763|NCT04278404|Nifedipine|nifedipine|mesh-list
154183764|NCT04278404|Milrinone|milrinone|mesh-list
154183765|NCT04278404|Furosemide|furosemide|mesh-list
154183766|NCT04278404|Spironolactone|spironolactone|mesh-list
154183767|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
154183768|NCT04278404|Oxycodone|oxycodone|mesh-list
154183769|NCT04278404|Gabapentin|gabapentin|mesh-list
154183770|NCT04278404|Nalbuphine|nalbuphine|mesh-list
154183771|NCT04278404|Clobazam|clobazam|mesh-list
154183772|NCT04278404|Zolpidem|zolpidem|mesh-list
154183773|NCT04278404|Risperidone|risperidone|mesh-list
154183774|NCT04278404|Amphetamine|amphetamine|mesh-list
154183775|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
154183776|NCT04278404|Sertraline|sertraline|mesh-list
154183777|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
154183778|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
154183826|NCT04278404|Narcotics|narcotics|mesh-ancestor
154183827|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
154183828|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154183829|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154183830|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154183831|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154183832|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154183833|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
154183834|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154183835|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
154183836|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154183837|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154183838|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
154183839|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
154183840|NCT04278404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154183885|NCT04278404|Protective Agents|protective agents|mesh-ancestor
154183886|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154183887|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154183888|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154183889|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154183890|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154183891|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154183892|NCT04275999|Ivermectin|ivermectin|mesh-list
154183893|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154183894|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154183950|NCT06082388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154183951|NCT06082388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154183952|NCT06082388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154183953|NCT06082388|Autonomic Agents|autonomic agents|mesh-ancestor
154183954|NCT06082388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154183955|NCT06082388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154183956|NCT06082388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154183957|NCT06082388|Respiratory System Agents|respiratory system agents|mesh-ancestor
154184015|NCT06082063|Aspirin|aspirin|mesh-list
154184016|NCT06082063|Semaglutide|semaglutide|mesh-list
154184017|NCT06082063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154184018|NCT06082063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154184019|NCT06082063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184020|NCT06082063|Analgesics|analgesics|mesh-ancestor
154184021|NCT06082063|Sensory System Agents|sensory system agents|mesh-ancestor
154184022|NCT06082063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184023|NCT06082063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184024|NCT06082063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184025|NCT06082063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184026|NCT06082063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154184027|NCT06082063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154184074|NCT06081803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184075|NCT06081803|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154184076|NCT06081803|Protease Inhibitors|protease inhibitors|mesh-ancestor
154184077|NCT06081803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184078|NCT06081803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154184079|NCT06081738|Neostigmine|neostigmine|mesh-list
154184089|NCT06081673|Paclitaxel|paclitaxel|mesh-list
154184144|NCT06063941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154184145|NCT06063941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154184146|NCT06063941|Trace Elements|trace elements|mesh-ancestor
154184147|NCT06063941|Micronutrients|micronutrients|mesh-ancestor
154184148|NCT06063941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184149|NCT06063941|Hemostatics|hemostatics|mesh-ancestor
154184150|NCT06063941|Coagulants|coagulants|mesh-ancestor
154184151|NCT06045104|Micronutrients|micronutrients|mesh-list
154184152|NCT06045104|Trace Elements|trace elements|mesh-list
154184153|NCT06045104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184154|NCT06034288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154184155|NCT06034288|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154184156|NCT06034288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154184157|NCT06034288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184207|NCT05943795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184208|NCT05938959|Ropivacaine|ropivacaine|mesh-list
154184209|NCT05938959|Anesthetics, Local|anesthetics, local|mesh-ancestor
154184210|NCT05938959|Anesthetics|anesthetics|mesh-ancestor
154184211|NCT05938959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184212|NCT05938959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184213|NCT05938959|Sensory System Agents|sensory system agents|mesh-ancestor
154184214|NCT05938959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184215|NCT05880849|Choline|choline|mesh-list
154184216|NCT05880849|Lipotropic Agents|lipotropic agents|mesh-ancestor
154184217|NCT05880849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154184218|NCT05880849|Antimetabolites|antimetabolites|mesh-ancestor
154184219|NCT05880849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184269|NCT05742698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154184270|NCT05742698|Hallucinogens|hallucinogens|mesh-ancestor
154184271|NCT05742698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184272|NCT05742698|Analgesics|analgesics|mesh-ancestor
154184273|NCT05742698|Sensory System Agents|sensory system agents|mesh-ancestor
154184274|NCT05742698|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154184275|NCT05742698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154184278|NCT05742698|Hormones|hormones|mesh-ancestor
154184338|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184339|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184340|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154184341|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
154184342|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
154184343|NCT05533372|Methotrexate|methotrexate|mesh-list
154184344|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154184345|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
154184346|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154184347|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184348|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154184349|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
154184350|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184351|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184352|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
154184353|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184354|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153931320|NCT00685009|Progestins|progestins|mesh-ancestor
154184355|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154184359|NCT05525078|Nicotine|nicotine|mesh-list
154184390|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184391|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
154184393|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
154184394|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184395|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154184396|NCT05439902|Tamsulosin|tamsulosin|mesh-list
154184397|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154184398|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154184399|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154184400|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
154184401|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184402|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184403|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184404|NCT05439902|Urological Agents|urological agents|mesh-ancestor
154184405|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154184406|NCT05424757|Laxatives|laxatives|mesh-ancestor
154184407|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154184408|NCT05419427|Denosumab|denosumab|mesh-list
154184409|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154184410|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184411|NCT05414305|Lidocaine|lidocaine|mesh-list
154184412|NCT05414305|Heparin|heparin|mesh-list
154184413|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
154184414|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
154184415|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154184416|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184417|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
154184418|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184419|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153521597|NCT03601923|Niraparib|niraparib|mesh-list
154184420|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154184421|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154184422|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154184423|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184424|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
154184425|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153646732|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
153646733|NCT02752815|Hormones|hormones|mesh-ancestor
154184426|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154184427|NCT05356897|Trifluridine|trifluridine|mesh-list
154184428|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154184429|NCT05356897|Trastuzumab|trastuzumab|mesh-list
154184430|NCT05356897|Tucatinib|tucatinib|mesh-list
154184431|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154184432|NCT05356897|Antibodies|antibodies|mesh-list
154184433|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
154184434|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154184435|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
154184436|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184437|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184438|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
154184439|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184440|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
154184441|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154184442|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184443|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184444|NCT05320887|Nicotine|nicotine|mesh-list
154184445|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154184446|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
154184447|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184448|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184449|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154184450|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154184451|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184452|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184475|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
154184476|NCT05275907|Diuretics|diuretics|mesh-ancestor
154184477|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
154184478|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154184479|NCT05274048|Trastuzumab|trastuzumab|mesh-list
154184480|NCT05274048|Neratinib|neratinib|mesh-list
154184481|NCT05274048|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154184482|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184483|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184484|NCT05274048|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154184485|NCT05274048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184486|NCT05274048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184487|NCT05274048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184488|NCT05274048|Immunoconjugates|immunoconjugates|mesh-ancestor
154184489|NCT05274048|Immunologic Factors|immunologic factors|mesh-ancestor
154184490|NCT05274048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184491|NCT05250843|Lenvatinib|lenvatinib|mesh-list
154184492|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184493|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521639|NCT03400332|Nivolumab|nivolumab|mesh-list
154184494|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184495|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184496|NCT05197842|Prednisone|prednisone|mesh-list
154184497|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
154184498|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
154184499|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154184500|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
154184522|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154184523|NCT05091372|Lenalidomide|lenalidomide|mesh-list
154184524|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
154184525|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184526|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154184527|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154184528|NCT05091372|Growth Substances|growth substances|mesh-ancestor
154184529|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
154184530|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184531|NCT05081219|Insulin|insulin|mesh-list
154184532|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154184533|NCT05081219|Empagliflozin|empagliflozin|mesh-list
154184534|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154184535|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184536|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154184537|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184538|NCT05071313|Vaccines|vaccines|mesh-list
154184539|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
154184540|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184541|NCT05048797|Carboplatin|carboplatin|mesh-list
154184542|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
154184543|NCT05048797|Trastuzumab|trastuzumab|mesh-list
154184544|NCT05048797|Pemetrexed|pemetrexed|mesh-list
154184545|NCT05048797|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154184546|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184547|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184572|NCT04643574|Interleukin-2|interleukin-2|mesh-list
154184573|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154184574|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
154184575|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184576|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184577|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154184578|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
153931552|NCT00680329|Timolol|timolol|mesh-list
154184639|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184640|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184641|NCT04330690|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154184642|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
154184643|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184644|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
154184645|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153521675|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
154184646|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154184647|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154184648|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
154184649|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
154184650|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154184651|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
154184652|NCT04268199|Bortezomib|bortezomib|mesh-list
153931619|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154184654|NCT04198116|Guanfacine|guanfacine|mesh-list
154184699|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184700|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184701|NCT04045613|Atezolizumab|atezolizumab|mesh-list
154184702|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154184703|NCT04045613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154184704|NCT04045613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184705|NCT04045613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154184709|NCT04042831|Olaparib|olaparib|mesh-list
154184765|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154184766|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154184767|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184768|NCT03503058|Analgesics|analgesics|mesh-ancestor
154184769|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
154184770|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184771|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184772|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184773|NCT03503058|Filaricides|filaricides|mesh-ancestor
154184831|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184832|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
154184833|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
154184834|NCT03074513|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154184835|NCT03074513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184836|NCT02756897|Venetoclax|venetoclax|mesh-list
154184837|NCT02756897|Ibrutinib|ibrutinib|mesh-list
154184838|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184839|NCT02756897|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154184840|NCT02756897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184841|NCT02756897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154184842|NCT02756897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184843|NCT02683239|Fasinumab|fasinumab|mesh-list
154184844|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154184845|NCT02683239|Analgesics|analgesics|mesh-ancestor
154184846|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
154184847|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184848|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184849|NCT02551237|Capecitabine|capecitabine|mesh-list
154184850|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154184851|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
154184852|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184853|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184854|NCT02097134|Melphalan|melphalan|mesh-list
154184855|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
154184856|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154184857|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154184858|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
154184859|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184860|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184861|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154184862|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154184865|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
154184871|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154184872|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154184873|NCT01954992|Fluorouracil|fluorouracil|mesh-list
154184874|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
154184875|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184876|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154184877|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184878|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154184879|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
154184880|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184881|NCT01927744|Docetaxel|docetaxel|mesh-list
154184882|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154184883|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154184884|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154184885|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154184886|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154184887|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184888|NCT01927744|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154184889|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154184925|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184926|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184927|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154184928|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154184929|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
154184930|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154184931|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154184932|NCT00488072|Mirtazapine|mirtazapine|mesh-list
154184933|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
154184934|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154184937|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
154184986|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154184988|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
154184989|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154184990|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154184991|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154184992|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
154184993|NCT00253318|Hormones|hormones|mesh-ancestor
154184994|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154184995|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185050|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154185052|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185053|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154185054|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
154185055|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185056|NCT03905265|Moxidectin|moxidectin|mesh-list
154185057|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
154185058|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154185059|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185060|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
154185061|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
154185062|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154185063|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185064|NCT03848845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154185065|NCT03848845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185066|NCT03781440|Lidocaine|lidocaine|mesh-list
154185067|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
154185068|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
154185069|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154185070|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185100|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185101|NCT03625388|Dasatinib|dasatinib|mesh-list
154185102|NCT03625388|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154185103|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154185104|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185105|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185106|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185107|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
154185108|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
154185109|NCT03570827|Androgens|androgens|mesh-list
154185165|NCT03079011|Palbociclib|palbociclib|mesh-list
154185166|NCT03079011|Anastrozole|anastrozole|mesh-list
154185167|NCT03079011|Exemestane|exemestane|mesh-list
154185168|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154185169|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185170|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154185171|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185172|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185173|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154185174|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
154185175|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185176|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185177|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185226|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154185227|NCT02285140|Vancomycin|vancomycin|mesh-list
154185228|NCT02285140|Cefazolin|cefazolin|mesh-list
154185229|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154185230|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185231|NCT02254278|Cisplatin|cisplatin|mesh-list
154185232|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185233|NCT02174549|Tirapazamine|tirapazamine|mesh-list
154185234|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185235|NCT02059499|Fluorouracil|fluorouracil|mesh-list
154185236|NCT02059499|Imiquimod|imiquimod|mesh-list
154185237|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
154185238|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185289|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
154185290|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154185291|NCT00352027|Doxorubicin|doxorubicin|mesh-list
154185292|NCT00352027|Etoposide|etoposide|mesh-list
154185293|NCT00352027|Vincristine|vincristine|mesh-list
154185294|NCT00352027|Bleomycin|bleomycin|mesh-list
154185295|NCT00352027|Vinblastine|vinblastine|mesh-list
154185296|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185297|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
154185298|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185299|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185300|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154185301|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
154185302|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185303|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185304|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154185311|NCT00352027|Hormones|hormones|mesh-ancestor
154185352|NCT00262470|Analgesics|analgesics|mesh-ancestor
154185353|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
154185354|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185355|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
154185356|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
154185357|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154185358|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154185359|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154185360|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154185361|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154185362|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
154185363|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154185364|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154185365|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154185366|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154185367|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185368|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154185369|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154185384|NCT00262470|Diuretics|diuretics|mesh-ancestor
154185408|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154185410|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185411|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154185412|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154185413|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154185414|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154185415|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154185416|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154185420|NCT00346216|Celecoxib|celecoxib|mesh-list
154185472|NCT01324960|Histamine|histamine|mesh-list
154185473|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154185474|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
154185475|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185476|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185477|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185478|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521845|NCT02168140|Vitamins|vitamins|mesh-ancestor
154185479|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154185486|NCT00417885|Sunitinib|sunitinib|mesh-list
154185539|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185540|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185541|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185542|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185543|NCT03989830|Endostatins|endostatins|mesh-list
154185544|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154185545|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154185546|NCT03989830|Growth Substances|growth substances|mesh-ancestor
154185547|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185548|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
154185549|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185550|NCT02533648|Allopurinol|allopurinol|mesh-list
154185551|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
154185601|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185603|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
154185604|NCT01057264|Paclitaxel|paclitaxel|mesh-list
154185605|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154185606|NCT01057264|Bevacizumab|bevacizumab|mesh-list
154185607|NCT01057264|Gemcitabine|gemcitabine|mesh-list
154185608|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154185609|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185610|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
154185611|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
154185612|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
154185613|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185614|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154185615|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154185616|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154185617|NCT01057264|Growth Substances|growth substances|mesh-ancestor
154185618|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185619|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
154185655|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
154185656|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185657|NCT01057498|RNS60|rns60|mesh-list
154185658|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154185659|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154185660|NCT01057498|Analgesics|analgesics|mesh-ancestor
154185661|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
154185725|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185726|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154185727|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154185728|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
154185729|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154185730|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185731|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
153521873|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
154185732|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185733|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154185734|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154185735|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154185789|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154185790|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185791|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154185792|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185793|NCT00512252|Cytarabine|cytarabine|mesh-list
154185794|NCT00512252|Plerixafor|plerixafor|mesh-list
154185795|NCT00512252|Etoposide|etoposide|mesh-list
154185796|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
154185797|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154185798|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185799|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154185854|NCT00523718|Protective Agents|protective agents|mesh-ancestor
154185855|NCT00523640|Bevacizumab|bevacizumab|mesh-list
154185856|NCT00523640|Gemcitabine|gemcitabine|mesh-list
154185857|NCT00523640|Capecitabine|capecitabine|mesh-list
154185858|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154185859|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154185860|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154185861|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154185862|NCT00523640|Growth Substances|growth substances|mesh-ancestor
154185863|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185864|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
154185865|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154185866|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
154185867|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185868|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154185869|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
154185870|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185871|NCT00516074|Exenatide|exenatide|mesh-list
154185872|NCT00516074|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154185873|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154185874|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185875|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154185876|NCT00516074|Incretins|incretins|mesh-ancestor
154185877|NCT00516074|Hormones|hormones|mesh-ancestor
154185878|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154185879|NCT01057654|Pravastatin|pravastatin|mesh-list
154185880|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154185881|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154185882|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
154185883|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185884|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154185885|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154185886|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185888|NCT00515294|Caffeine|caffeine|mesh-list
154185893|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185894|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
153521913|NCT02048813|Rituximab|rituximab|mesh-list
154185895|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154185896|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185897|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
154185898|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154185899|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154185900|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154185901|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154185902|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154185903|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185904|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154185912|NCT00345046|Prednisone|prednisone|mesh-list
154185954|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
154185955|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154185956|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154185957|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
154185958|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154185959|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185960|NCT01033305|Cyclosporine|cyclosporine|mesh-list
154185961|NCT01033305|Cyclosporins|cyclosporins|mesh-list
154185962|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154185963|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154185964|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154185965|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
154185966|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185967|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
154185968|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154185969|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
154185970|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154185971|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154185972|NCT00514904|Vaccines|vaccines|mesh-list
154185973|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
154185974|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185975|NCT00440115|Bupropion|bupropion|mesh-list
154185976|NCT00440115|Nicotine|nicotine|mesh-list
154185977|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154185978|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
154185979|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154185980|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154185981|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154186002|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186003|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
154186004|NCT00416715|Vitamin D|vitamin d|mesh-list
154186005|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
154186006|NCT00416715|Letrozole|letrozole|mesh-list
154186007|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
154186008|NCT00416715|Citric Acid|citric acid|mesh-list
154186009|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
154186010|NCT00416715|Calcium|calcium|mesh-list
154186011|NCT00416715|Vitamins|vitamins|mesh-ancestor
153521959|NCT01615731|Digoxin|digoxin|mesh-list
154186012|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
154186013|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186014|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154186015|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154186066|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186067|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
154186068|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154186069|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
154186070|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154186071|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
154186072|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186073|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186074|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
154186075|NCT00521586|Vaccines|vaccines|mesh-list
154186076|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154186077|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
154186078|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186128|NCT01324089|Protective Agents|protective agents|mesh-ancestor
154186129|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186130|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186131|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154186132|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154186133|NCT00404547|Ciclesonide|ciclesonide|mesh-list
154186134|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
154186194|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
154186195|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
154186196|NCT00509028|Hormones|hormones|mesh-ancestor
154186197|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186198|NCT00352846|Vitamin D|vitamin d|mesh-list
154186199|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
154186200|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
154186201|NCT00352846|Calcium|calcium|mesh-list
154186202|NCT00352846|Vitamins|vitamins|mesh-ancestor
154186203|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
154186204|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186205|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154186206|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154186207|NCT00352846|Antacids|antacids|mesh-ancestor
154186208|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186209|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186210|NCT00508872|Leucovorin|leucovorin|mesh-list
154186211|NCT00508872|Bevacizumab|bevacizumab|mesh-list
154186212|NCT00508872|Fluorouracil|fluorouracil|mesh-list
154186213|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
154186252|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
153521989|NCT01589302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186253|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186254|NCT00895505|Warfarin|warfarin|mesh-list
154186255|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
154186256|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
154186257|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
154186258|NCT03249012|Calcitriol|calcitriol|mesh-list
154186259|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
154186260|NCT03249012|Calcium|calcium|mesh-list
154186261|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154186262|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186263|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154186264|NCT03249012|Antacids|antacids|mesh-ancestor
154186265|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186266|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186267|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154186311|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186312|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154186313|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
154186314|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
154186315|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154186316|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154186317|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154186318|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
154186321|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
154186377|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
154186378|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186379|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186380|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
154186381|NCT00609167|Hormones|hormones|mesh-ancestor
154186382|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186383|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154186384|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
153933345|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154186385|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
154186386|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
154186440|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154186441|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186442|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186443|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
154186444|NCT00514020|Antidotes|antidotes|mesh-ancestor
154186445|NCT00514020|Protective Agents|protective agents|mesh-ancestor
154186446|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
154186447|NCT00514020|Vitamins|vitamins|mesh-ancestor
154186448|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
154186449|NCT03560531|Palbociclib|palbociclib|mesh-list
154186450|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186451|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154186452|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186453|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186454|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154186455|NCT00896285|Analgesics|analgesics|mesh-list
154186456|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
154186457|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
154186458|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186459|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186460|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153522028|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154186461|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186462|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186463|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154186465|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186466|NCT00891761|Dexamethasone|dexamethasone|mesh-list
154186467|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
154186468|NCT00891761|Ondansetron|ondansetron|mesh-list
154186469|NCT00891761|Casopitant|casopitant|mesh-list
154186470|NCT00891761|BB 1101|bb 1101|mesh-list
154186471|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186472|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
154186473|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
154186474|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186475|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186476|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154186482|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
154186483|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186484|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186485|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
154186486|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
154186487|NCT00891761|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154186488|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154186489|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
154186490|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186491|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154186492|NCT01012830|Huperzine A|huperzine a|mesh-list
154186493|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154186494|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186495|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186496|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
154186497|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186498|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186499|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154186500|NCT01012830|Protective Agents|protective agents|mesh-ancestor
154186501|NCT00513474|Cyclosporine|cyclosporine|mesh-list
154186502|NCT00513474|Sirolimus|sirolimus|mesh-list
154186503|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
154186504|NCT00513474|Busulfan|busulfan|mesh-list
154186505|NCT00513474|Methotrexate|methotrexate|mesh-list
154186506|NCT00513474|Fludarabine|fludarabine|mesh-list
154186507|NCT00513474|Etoposide|etoposide|mesh-list
154186508|NCT00513474|Allopurinol|allopurinol|mesh-list
153522047|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
153522048|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154186509|NCT00513474|Rasburicase|rasburicase|mesh-list
154186510|NCT00513474|Tacrolimus|tacrolimus|mesh-list
154186511|NCT00513474|Cyclosporins|cyclosporins|mesh-list
154186512|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154186528|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154186529|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154186530|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154186531|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154186532|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154186533|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154186534|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
154186535|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154186536|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153933494|NCT03071926|Doxorubicin|doxorubicin|mesh-list
154186537|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154186538|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
154186539|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154186540|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
154186541|NCT00513474|Protective Agents|protective agents|mesh-ancestor
154186542|NCT01010958|Valproic Acid|valproic acid|mesh-list
154186543|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
154186586|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186588|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154186589|NCT01011036|Clonazepam|clonazepam|mesh-list
154186590|NCT01011036|Clobazam|clobazam|mesh-list
154186591|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154186592|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154186593|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154186594|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
154186595|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186596|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186597|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186598|NCT01011036|Urological Agents|urological agents|mesh-ancestor
154186599|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
154186600|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
154186601|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
154186602|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154186603|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154186604|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186605|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186606|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154186607|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
154186608|NCT03601637|Ivacaftor|ivacaftor|mesh-list
154186609|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154186610|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154186611|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186612|NCT00894023|Abciximab|abciximab|mesh-list
154186613|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
154186614|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154186615|NCT00892073|Metformin|metformin|mesh-list
154186616|NCT00892073|Diazoxide|diazoxide|mesh-list
154186617|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154186628|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154186629|NCT02541227|Protective Agents|protective agents|mesh-ancestor
154186630|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186631|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
154186632|NCT00896987|Lamotrigine|lamotrigine|mesh-list
154186633|NCT00896987|Carbamazepine|carbamazepine|mesh-list
154186634|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
154186635|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154186636|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154186637|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186638|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154186639|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186640|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154186641|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154186642|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186643|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186644|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154186645|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
154186646|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154186647|NCT00896987|Analgesics|analgesics|mesh-ancestor
154186648|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
154186649|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186650|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154186651|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154186652|NCT00897065|Antibodies|antibodies|mesh-list
154186653|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
154186676|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
154186677|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186679|NCT00892307|Analgesics|analgesics|mesh-ancestor
154186680|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
154186681|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186682|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186683|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154186684|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
154186685|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154186686|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
154186687|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
154186688|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186689|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186690|NCT00342628|Vaccines|vaccines|mesh-list
154186691|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
154186692|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186693|NCT00897377|Temozolomide|temozolomide|mesh-list
154186694|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154186695|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
154186697|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186728|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154186729|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186730|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186731|NCT01011114|Cinacalcet|cinacalcet|mesh-list
154186732|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154186733|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186734|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154186735|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
154186736|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186737|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
154186738|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
154186739|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154186740|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154186741|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
154186742|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186743|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
154186744|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
154186745|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154186746|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186747|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186748|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
154186749|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154186750|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154186751|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186752|NCT03063762|Bevacizumab|bevacizumab|mesh-list
154186753|NCT03063762|Atezolizumab|atezolizumab|mesh-list
154186754|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154186755|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186756|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154186757|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154186758|NCT03063762|Growth Substances|growth substances|mesh-ancestor
154186759|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186760|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
154186761|NCT03063762|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154186764|NCT05278637|Ticagrelor|ticagrelor|mesh-list
154186766|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154186767|NCT05278637|Analgesics|analgesics|mesh-ancestor
154186768|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
154186769|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186770|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186771|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186772|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186773|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154186774|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154186775|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186776|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154186777|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154186778|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186779|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
154186780|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153522228|NCT06039540|Potassium Citrate|potassium citrate|mesh-list
154186781|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154186782|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154186783|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
154186784|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186785|NCT04017377|Paclitaxel|paclitaxel|mesh-list
154186786|NCT04017377|Cisplatin|cisplatin|mesh-list
154186787|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154186788|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186817|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186818|NCT00895115|Protective Agents|protective agents|mesh-ancestor
154186819|NCT00901745|Norepinephrine|norepinephrine|mesh-list
154186820|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
154186821|NCT00901745|Giapreza|giapreza|mesh-list
154186822|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
154186823|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154186824|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154186825|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
154186826|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186827|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186828|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186829|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
154186830|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
154186831|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186832|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153933792|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
154186833|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154186834|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
154186835|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186873|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186874|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
154186875|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186876|NCT00605267|Tamoxifen|tamoxifen|mesh-list
154186877|NCT00605267|Goserelin|goserelin|mesh-list
154186878|NCT00605267|Anastrozole|anastrozole|mesh-list
154186879|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154186880|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
154186881|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154186882|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186883|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154186884|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154186885|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154186886|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154186887|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154186888|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154186889|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154186890|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186892|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154186928|NCT00605813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153522289|NCT06039202|Trifluridine|trifluridine|mesh-list
154186929|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154186930|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154186931|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186932|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186933|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
154186934|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186935|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
154186936|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
154186937|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154186938|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154186939|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186940|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154186941|NCT00906269|Urological Agents|urological agents|mesh-ancestor
154186942|NCT00902915|Dexamethasone|dexamethasone|mesh-list
154186943|NCT00902915|Lenalidomide|lenalidomide|mesh-list
154186944|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186945|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
154186946|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
154186983|NCT00903227|Xhance|xhance|mesh-list
154186984|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154186985|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154186986|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
154186987|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154186988|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154186989|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154186990|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
154186991|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
154186992|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154186993|NCT00605657|Valproic Acid|valproic acid|mesh-list
154186994|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
154186995|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154186996|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522332|NCT06037811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154186997|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
154186998|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154186999|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187000|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
154187001|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154187040|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187042|NCT00900887|Nepafenac|nepafenac|mesh-list
154187043|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154187044|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154187045|NCT00900887|Analgesics|analgesics|mesh-ancestor
154187046|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
154187047|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187048|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187049|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154187050|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187051|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154187052|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187053|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187054|NCT00904085|Oxymorphone|oxymorphone|mesh-list
154187055|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154187056|NCT00904085|Narcotics|narcotics|mesh-ancestor
154187057|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187058|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934037|NCT04132063|Levetiracetam|levetiracetam|mesh-list
154187059|NCT00904085|Analgesics|analgesics|mesh-ancestor
154187060|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
154187061|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187062|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154187063|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
154187064|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
154187065|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154187066|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187067|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187069|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187070|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154187078|NCT00904397|Celecoxib|celecoxib|mesh-list
154187082|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187083|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187084|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
154187085|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187086|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154187087|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154187088|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154187089|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187090|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187091|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154187092|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154187093|NCT00904397|Analgesics|analgesics|mesh-ancestor
154187094|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154187095|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187096|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154187097|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154187098|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187137|NCT00909077|BB 1101|bb 1101|mesh-list
153522377|NCT06010927|Anesthetics|anesthetics|mesh-ancestor
154187138|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154187139|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
154187140|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
154187141|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187142|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187143|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154187144|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
154187145|NCT00909077|Hormones|hormones|mesh-ancestor
154187146|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187147|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154187148|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187149|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
154187150|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187151|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187152|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187153|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
154187154|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187155|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
154187156|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154187157|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154187158|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187159|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
154187160|NCT00904709|Coagulants|coagulants|mesh-ancestor
154187161|NCT00340834|Interferons|interferons|mesh-list
154187162|NCT00340834|Interferon-beta|interferon-beta|mesh-list
154187163|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
154187164|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154187165|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187166|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
154187167|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187170|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187179|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154187180|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187181|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
154187182|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
154187183|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
154187184|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187185|NCT00340678|Losartan|losartan|mesh-list
154187186|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154187187|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154187188|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154187189|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154187190|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187191|NCT01055470|Diclofenac|diclofenac|mesh-list
154187192|NCT01055470|Lornoxicam|lornoxicam|mesh-list
154187193|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154187194|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154187195|NCT01055470|Analgesics|analgesics|mesh-ancestor
154187196|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
154187197|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187198|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187199|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154187229|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154187230|NCT00907751|Rituximab|rituximab|mesh-list
154187231|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154187232|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187233|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
154187234|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187235|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187236|NCT00905333|Felodipine|felodipine|mesh-list
154187237|NCT00905333|Candesartan|candesartan|mesh-list
154187238|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
154187239|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154187240|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154187241|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154187242|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187243|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154187244|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154187245|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187246|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154187247|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187248|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
154187249|NCT00907829|Lidocaine|lidocaine|mesh-list
154187250|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
154187251|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
154187252|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187253|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187254|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
154187255|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187261|NCT00336544|Clarithromycin|clarithromycin|mesh-list
154187273|NCT01059058|Protective Agents|protective agents|mesh-ancestor
154187274|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187275|NCT00605033|Buprenorphine|buprenorphine|mesh-list
154187276|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154187277|NCT00605033|Naloxone|naloxone|mesh-list
154187278|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154187279|NCT00605033|Narcotics|narcotics|mesh-ancestor
154187280|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187281|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153934234|NCT02779348|Warfarin|warfarin|mesh-list
154187337|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
154187338|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
154187339|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187340|NCT00908297|Vitamins|vitamins|mesh-ancestor
154187341|NCT00927407|Malathion|malathion|mesh-list
154187342|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154187343|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187344|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187345|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
154187346|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187347|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187348|NCT00931697|Mefloquine|mefloquine|mesh-list
154187401|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
154187402|NCT00927875|Carboplatin|carboplatin|mesh-list
154187403|NCT00927875|Etoposide|etoposide|mesh-list
154187404|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187405|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154187406|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154187407|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154187408|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187409|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187410|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
154187411|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154187467|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187468|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154187469|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154187470|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187471|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187472|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154187473|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
154187474|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187475|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187476|NCT00338728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154187530|NCT00928655|Acetazolamide|acetazolamide|mesh-list
154187531|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
154187532|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154187533|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187534|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187535|NCT00928655|Diuretics|diuretics|mesh-ancestor
154187536|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
154187537|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187538|NCT01011426|Bisacodyl|bisacodyl|mesh-list
154187597|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187598|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187599|NCT00925457|Domperidone|domperidone|mesh-list
154187600|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154187601|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187603|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
154187666|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154187667|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154187668|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522510|NCT05353361|Paclitaxel|paclitaxel|mesh-list
154187669|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187670|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187671|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154187672|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
154187673|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154187674|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187675|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154187676|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154187677|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154187678|NCT00309946|Cediranib|cediranib|mesh-list
154187679|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187680|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187681|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187682|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154187683|NCT00929591|Tamoxifen|tamoxifen|mesh-list
154187684|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
154187685|NCT00929591|Doxorubicin|doxorubicin|mesh-list
154187686|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154187687|NCT00929591|Fluorouracil|fluorouracil|mesh-list
154187688|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187689|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
154187690|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187691|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187712|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154187713|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
154187714|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187715|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187716|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187717|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
154187718|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
154187719|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187720|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154187721|NCT01011660|Amlodipine|amlodipine|mesh-list
154187722|NCT01011660|Telmisartan|telmisartan|mesh-list
154187723|NCT01011660|Amiloride|amiloride|mesh-list
154187724|NCT01011660|Simvastatin|simvastatin|mesh-list
154187725|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154187726|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154187727|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154187728|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187729|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154187730|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187766|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187767|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
154187768|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187769|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154187770|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187771|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
153522541|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153522542|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154187772|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187773|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154187774|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154187775|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154187776|NCT00934193|Gabapentin|gabapentin|mesh-list
154187777|NCT00934193|Analgesics|analgesics|mesh-ancestor
154187778|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
154187779|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187780|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187781|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
154187782|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154187783|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154187821|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154187822|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
154187823|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187824|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187825|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187826|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154187827|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
154187828|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154187829|NCT00926627|Bosentan|bosentan|mesh-list
154187830|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154187831|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154187832|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187833|NCT00934739|Thalidomide|thalidomide|mesh-list
154187834|NCT00934739|Dexamethasone|dexamethasone|mesh-list
154187835|NCT00934739|Celecoxib|celecoxib|mesh-list
154187836|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
154187837|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154187838|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
154187839|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187840|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154187841|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154187842|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
154187843|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187844|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187845|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154187846|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154187847|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
154187848|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
154187849|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154187850|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154187851|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
154187852|NCT00934739|Hormones|hormones|mesh-ancestor
154187853|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154187854|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154187855|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
154187856|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153522594|NCT04809766|Fludarabine|fludarabine|mesh-list
154187858|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154187859|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154187860|NCT00934739|Growth Substances|growth substances|mesh-ancestor
154187861|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
154187862|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154187863|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154187864|NCT00934739|Analgesics|analgesics|mesh-ancestor
154187865|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
154187866|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154187867|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154187868|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154187869|NCT01015482|Midazolam|midazolam|mesh-list
154187870|NCT01015482|Remifentanil|remifentanil|mesh-list
154187871|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154187872|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154187921|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154187922|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
154187923|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
154187924|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154187925|NCT01013532|Protective Agents|protective agents|mesh-ancestor
154187926|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154187927|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154187928|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154187929|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154187930|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
154187931|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154187932|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
154187933|NCT00926705|Fentanyl|fentanyl|mesh-list
154187934|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
154187935|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154187936|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154187937|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187939|NCT00926705|Analgesics|analgesics|mesh-ancestor
154187980|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154187981|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154187982|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187983|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154187984|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154187985|NCT01018836|Protective Agents|protective agents|mesh-ancestor
154187987|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154187988|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154187989|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154187990|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
154187991|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
154187992|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
154187993|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154187994|NCT00491400|Atorvastatin|atorvastatin|mesh-list
154187995|NCT00491400|Fenofibrate|fenofibrate|mesh-list
154187996|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154187997|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154187998|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
153522659|NCT04561206|Immunotoxins|immunotoxins|mesh-ancestor
153522675|NCT04421222|Hormone Antagonists|hormone antagonists|mesh-ancestor
154187999|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188000|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154188001|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154188002|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188003|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
154188004|NCT00491322|Vitamin D|vitamin d|mesh-list
154188005|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154188006|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188007|NCT00491322|Vitamins|vitamins|mesh-ancestor
154188008|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
154188025|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154188026|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188027|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154188028|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154188029|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188030|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
154188031|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154188032|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
154188033|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154188034|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
154188035|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
154188036|NCT00930839|Vitamins|vitamins|mesh-ancestor
154188037|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
154188038|NCT01015794|Ephedrine|ephedrine|mesh-list
154188039|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
154188040|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154188041|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188042|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
154188043|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
154188053|NCT00935363|Glyburide|glyburide|mesh-list
154188079|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154188080|NCT00930995|Candesartan|candesartan|mesh-list
154188081|NCT00930995|Candesartan cilexetil|candesartan cilexetil|mesh-list
154188082|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154188083|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154188084|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154188085|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188086|NCT00931073|Ketoconazole|ketoconazole|mesh-list
154188087|NCT00931073|Omeprazole|omeprazole|mesh-list
154188088|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154188089|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154188090|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154188091|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188092|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188138|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154188139|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188140|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188141|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
154188142|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
154188143|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154188144|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
154188146|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
154188147|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188148|NCT00936923|Furosemide|furosemide|mesh-list
154188202|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188203|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188204|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154188205|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
154188272|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154188273|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188274|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
154188275|NCT04013243|Analgesics|analgesics|mesh-ancestor
154188276|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
154188277|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188278|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188279|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
154188280|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188281|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154188282|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
154188283|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154188284|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154188289|NCT00938171|Anesthetics|anesthetics|mesh-list
154188332|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154188333|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
154188334|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154188335|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188336|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
154188337|NCT00490698|Atorvastatin|atorvastatin|mesh-list
154188338|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154188339|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154188340|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
154188341|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188342|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154188343|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154188344|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153935392|NCT02774512|Nilotinib|nilotinib|mesh-list
154188392|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
154188393|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154188394|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154188395|NCT00511004|Albendazole|albendazole|mesh-list
154188396|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
154188397|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
154188412|NCT02550197|Vaccines|vaccines|mesh-list
154188461|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154188463|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
154188464|NCT00941057|Dienogest|dienogest|mesh-list
154188465|NCT00941057|Calcium|calcium|mesh-list
154188466|NCT00941057|Nandrolone|nandrolone|mesh-list
154188467|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153935438|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
154188471|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
154188526|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188527|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188528|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
154188529|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154188530|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188531|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154188532|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
154188533|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188534|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188535|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188537|NCT00522392|Dexamethasone|dexamethasone|mesh-list
154188589|NCT00309244|Insulin|insulin|mesh-list
154188590|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153522735|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
154188591|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
154188592|NCT00309244|Protamines|protamines|mesh-list
154188593|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154188594|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188595|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
154188596|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188597|NCT00309244|Coagulants|coagulants|mesh-ancestor
154188598|NCT00483756|Cyclosporine|cyclosporine|mesh-list
154188599|NCT00483756|Cyclosporins|cyclosporins|mesh-list
154188600|NCT00483756|Tofacitinib|tofacitinib|mesh-list
154188601|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188602|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188651|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188652|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154188653|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154188654|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188655|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154188656|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154188657|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
154188658|NCT01059604|Naproxen|naproxen|mesh-list
154188659|NCT01059604|Sumatriptan|sumatriptan|mesh-list
154188660|NCT01059604|Naratriptan|naratriptan|mesh-list
154188661|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154188662|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154188663|NCT01059604|Analgesics|analgesics|mesh-ancestor
154188664|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
154188665|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188666|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188667|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188668|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188669|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
154188670|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154188671|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188672|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188673|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154188674|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154188702|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154188703|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
154188704|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
154188705|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
154188706|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154188707|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188708|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188709|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
154188710|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154188711|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154188712|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188713|NCT01014156|Epoprostenol|epoprostenol|mesh-list
154188714|NCT01014156|Tezosentan|tezosentan|mesh-list
154188715|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154188716|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154188717|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
154188718|NCT00322348|Goserelin|goserelin|mesh-list
154188719|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188721|NCT01014234|Cyclosporine|cyclosporine|mesh-list
154188760|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188761|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154188762|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188763|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188764|NCT00308308|Insulin|insulin|mesh-list
154188765|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154188766|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188828|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188829|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154188830|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154188831|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154188832|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
154188833|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154188834|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188835|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154188836|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188837|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188838|NCT01015196|Daunorubicin|daunorubicin|mesh-list
154188839|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154188886|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188887|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154188888|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
154188889|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188890|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
154188891|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154188892|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154188893|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154188894|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154188895|NCT00307294|Growth Substances|growth substances|mesh-ancestor
154188896|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
154188897|NCT03981094|Pirfenidone|pirfenidone|mesh-list
154188898|NCT03981094|Analgesics|analgesics|mesh-ancestor
154188899|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
154188900|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154188901|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154188902|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154188903|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154188904|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154188905|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154188906|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154188940|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154188941|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154188942|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154188943|NCT01060228|Valproic Acid|valproic acid|mesh-list
154188944|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154188945|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154188946|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154188947|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189008|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
154189009|NCT00492284|Hormones|hormones|mesh-ancestor
154189010|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189011|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154189012|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522757|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
154189013|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189014|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189015|NCT00492284|Growth Substances|growth substances|mesh-ancestor
154189016|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189017|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154189018|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
154189019|NCT01013012|Dexamethasone|dexamethasone|mesh-list
154189020|NCT01013012|Ramosetron|ramosetron|mesh-list
154189021|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189022|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
154189023|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
154189068|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189069|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189070|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189071|NCT01015352|Hematinics|hematinics|mesh-ancestor
154189072|NCT03563157|Leucovorin|leucovorin|mesh-list
154189073|NCT03563157|Paclitaxel|paclitaxel|mesh-list
153522775|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189074|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
154189075|NCT03563157|Capecitabine|capecitabine|mesh-list
154189076|NCT03563157|Fluorouracil|fluorouracil|mesh-list
154189077|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
154189078|NCT03563157|Cetuximab|cetuximab|mesh-list
154189079|NCT03563157|Avelumab|avelumab|mesh-list
154189080|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189081|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189082|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189083|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189084|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189086|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189129|NCT00414765|Aldesleukin|aldesleukin|mesh-list
154189130|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189131|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154189132|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154189133|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
154189134|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154189135|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154189136|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154189137|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154189138|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189139|NCT01013402|Insulin|insulin|mesh-list
154189140|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154189193|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189194|NCT00503984|Prednisone|prednisone|mesh-list
154189195|NCT00503984|Docetaxel|docetaxel|mesh-list
154189196|NCT00503984|Azacitidine|azacitidine|mesh-list
154189197|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189198|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189199|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189200|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189201|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189202|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189203|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
154189204|NCT00503984|Hormones|hormones|mesh-ancestor
154189205|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189206|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189207|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154189208|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618920|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189254|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154189255|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189256|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189258|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189259|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189260|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
154189261|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154189262|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154189263|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189264|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
154189265|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154189266|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154189267|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154189268|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154189269|NCT00565409|Analgesics|analgesics|mesh-ancestor
154189270|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
154189271|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189274|NCT00394251|Paclitaxel|paclitaxel|mesh-list
154189309|NCT00503906|Paclitaxel|paclitaxel|mesh-list
154189310|NCT00503906|Bevacizumab|bevacizumab|mesh-list
154189311|NCT00503906|Gemcitabine|gemcitabine|mesh-list
154189312|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154189313|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189314|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189315|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189316|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189317|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189318|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189319|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189320|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154189321|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154189322|NCT00503906|Growth Substances|growth substances|mesh-ancestor
154189323|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189324|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189325|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189326|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
154189327|NCT00305110|Hydromorphone|hydromorphone|mesh-list
154189328|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154189329|NCT00305110|Narcotics|narcotics|mesh-ancestor
154189330|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189331|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189332|NCT00305110|Analgesics|analgesics|mesh-ancestor
154189359|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154189360|NCT00500292|Leucovorin|leucovorin|mesh-list
154189361|NCT00500292|Folic Acid|folic acid|mesh-list
154189362|NCT00500292|Fluorouracil|fluorouracil|mesh-list
154189363|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
154189364|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
154189365|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
154189366|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189367|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189368|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465975|NCT05201430|Irinotecan|irinotecan|mesh-list
154189369|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189370|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
154189371|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189372|NCT00500292|Antidotes|antidotes|mesh-ancestor
154189424|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
154189425|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154189426|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154189427|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154189428|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154189429|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154189430|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154189431|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189432|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189433|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
154189434|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154189435|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
154189436|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154189484|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154189485|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154189486|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189487|NCT01017198|Antacids|antacids|mesh-list
154189488|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189489|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154189490|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
154189491|NCT00499122|Docetaxel|docetaxel|mesh-list
154189492|NCT00499122|Doxorubicin|doxorubicin|mesh-list
154189493|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189494|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
154189495|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189496|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154189497|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154189545|NCT06314113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189546|NCT06314113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154189547|NCT06313996|Prednisone|prednisone|mesh-list
154189548|NCT06313996|Cyclophosphamide|cyclophosphamide|mesh-list
154189549|NCT06313996|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154189550|NCT06313996|Rituximab|rituximab|mesh-list
154189551|NCT06313996|Doxorubicin|doxorubicin|mesh-list
154189552|NCT06313996|Fludarabine|fludarabine|mesh-list
154189553|NCT06313996|Vincristine|vincristine|mesh-list
154189554|NCT06313996|Lenalidomide|lenalidomide|mesh-list
154189555|NCT06313996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154189556|NCT06313996|Immunologic Factors|immunologic factors|mesh-ancestor
154189557|NCT06313996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189609|NCT06313801|Docetaxel|docetaxel|mesh-list
154189610|NCT06313801|Fluorouracil|fluorouracil|mesh-list
154189611|NCT06313801|Oxaliplatin|oxaliplatin|mesh-list
154189612|NCT06313801|Calcium|calcium|mesh-list
154189613|NCT06313801|Levoleucovorin|levoleucovorin|mesh-list
154189614|NCT06313801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189615|NCT06313801|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189616|NCT06313801|Antimitotic Agents|antimitotic agents|mesh-ancestor
154189680|NCT06313268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153936647|NCT01074216|Vitamin D|vitamin d|mesh-list
154189681|NCT06313268|Growth Inhibitors|growth inhibitors|mesh-ancestor
154189682|NCT06313203|Floxuridine|floxuridine|mesh-list
154189683|NCT06313203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189684|NCT06313203|Antimetabolites|antimetabolites|mesh-ancestor
154189685|NCT06313203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189686|NCT06313203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522844|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154189687|NCT06313086|Trastuzumab|trastuzumab|mesh-list
154189733|NCT06312761|Methyltestosterone|methyltestosterone|mesh-list
154189734|NCT06312761|Testosterone|testosterone|mesh-list
154189735|NCT06312761|Testosterone undecanoate|testosterone undecanoate|mesh-list
154189736|NCT06312761|Testosterone enanthate|testosterone enanthate|mesh-list
154189737|NCT06312761|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154189738|NCT06312761|Relugolix|relugolix|mesh-list
154189739|NCT06312761|Androgens|androgens|mesh-ancestor
154189740|NCT06312761|Hormones|hormones|mesh-ancestor
154189741|NCT06312761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154189742|NCT06312761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189743|NCT06312761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154189744|NCT06312761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189745|NCT06312761|Anabolic Agents|anabolic agents|mesh-ancestor
154189746|NCT06312761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154189747|NCT06312761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154189748|NCT06312761|Analgesics|analgesics|mesh-ancestor
154189749|NCT06312761|Sensory System Agents|sensory system agents|mesh-ancestor
154189750|NCT06312761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189751|NCT06312761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154189752|NCT06312761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154189753|NCT06312761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153936704|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
154189784|NCT06312618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154189785|NCT06312618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154189786|NCT06312618|Adrenergic Agents|adrenergic agents|mesh-ancestor
154189787|NCT06312618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189788|NCT06312618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189789|NCT06312618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154189790|NCT06312618|Anesthetics, General|anesthetics, general|mesh-ancestor
154189791|NCT06312618|Anesthetics|anesthetics|mesh-ancestor
154189792|NCT06312605|Vitamins|vitamins|mesh-list
154189793|NCT06312605|Ascorbic Acid|ascorbic acid|mesh-list
154189794|NCT06312605|Micronutrients|micronutrients|mesh-ancestor
154189795|NCT06312605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189796|NCT06312605|Antioxidants|antioxidants|mesh-ancestor
154189797|NCT06312605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189798|NCT06312605|Protective Agents|protective agents|mesh-ancestor
154189799|NCT06312566|Brivaracetam|brivaracetam|mesh-list
153522845|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154189800|NCT06312566|Anticonvulsants|anticonvulsants|mesh-ancestor
154189801|NCT06312254|Pyrilamine|pyrilamine|mesh-list
153522852|NCT03390686|Paclitaxel|paclitaxel|mesh-list
154189841|NCT06312176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189842|NCT06312176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154189843|NCT06312176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154189844|NCT06312176|Antimetabolites|antimetabolites|mesh-ancestor
154189845|NCT06312137|Paclitaxel|paclitaxel|mesh-list
154189846|NCT06312137|Carboplatin|carboplatin|mesh-list
154189847|NCT06312137|Gemcitabine|gemcitabine|mesh-list
154189848|NCT06312137|Pembrolizumab|pembrolizumab|mesh-list
154189849|NCT06312137|Pemetrexed|pemetrexed|mesh-list
154189850|NCT06312137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189851|NCT06312137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189852|NCT06312137|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189904|NCT06311903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154189905|NCT06311903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189906|NCT06311903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189907|NCT06311903|Sympathomimetics|sympathomimetics|mesh-ancestor
154189908|NCT06311903|Autonomic Agents|autonomic agents|mesh-ancestor
154189909|NCT06311903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154189910|NCT06311903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154189911|NCT06311851|Bevacizumab|bevacizumab|mesh-list
154189912|NCT06311851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189919|NCT06311721|Pembrolizumab|pembrolizumab|mesh-list
154189970|NCT06310915|Pembrolizumab|pembrolizumab|mesh-list
154189971|NCT06310915|Vinorelbine|vinorelbine|mesh-list
154189972|NCT06310915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154189973|NCT06310915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154189974|NCT06310915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154189975|NCT06310915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154189976|NCT06310915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154189977|NCT06310915|Tubulin Modulators|tubulin modulators|mesh-ancestor
154189978|NCT06310915|Antimitotic Agents|antimitotic agents|mesh-ancestor
153936936|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
154189979|NCT06310915|Mitosis Modulators|mitosis modulators|mesh-ancestor
154189988|NCT06310863|Hyaluronic Acid|hyaluronic acid|mesh-list
154189989|NCT06310863|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154189990|NCT06310863|Immunologic Factors|immunologic factors|mesh-ancestor
154189991|NCT06310863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154189992|NCT06310863|Viscosupplements|viscosupplements|mesh-ancestor
154190028|NCT06310785|Antidepressive Agents|antidepressive agents|mesh-ancestor
154190029|NCT06310785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154190030|NCT06310746|Antibodies|antibodies|mesh-list
154190031|NCT06310746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154190032|NCT06310746|Immunologic Factors|immunologic factors|mesh-ancestor
154190033|NCT06310746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190034|NCT06310642|Diphenhydramine|diphenhydramine|mesh-list
154190035|NCT06310642|Promethazine|promethazine|mesh-list
154190036|NCT06310642|Prochlorperazine|prochlorperazine|mesh-list
154190037|NCT06310642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154190038|NCT06310642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154190039|NCT06310642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190040|NCT06310642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190041|NCT06310642|Anesthetics, Local|anesthetics, local|mesh-ancestor
154190042|NCT06310642|Anesthetics|anesthetics|mesh-ancestor
154190043|NCT06310642|Sensory System Agents|sensory system agents|mesh-ancestor
154190044|NCT06310642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190045|NCT06310642|Antiemetics|antiemetics|mesh-ancestor
154190046|NCT06310642|Autonomic Agents|autonomic agents|mesh-ancestor
154190047|NCT06310642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190048|NCT06310642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154190049|NCT06310642|Histamine Antagonists|histamine antagonists|mesh-ancestor
154190050|NCT06310642|Histamine Agents|histamine agents|mesh-ancestor
154190051|NCT06310642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190072|NCT06310473|Capecitabine|capecitabine|mesh-list
154190079|NCT06310343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522879|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190080|NCT06310343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190081|NCT06310200|Lidocaine|lidocaine|mesh-list
154190082|NCT06310200|Anesthetics, Local|anesthetics, local|mesh-ancestor
154190083|NCT06310200|Anesthetics|anesthetics|mesh-ancestor
154190084|NCT06310200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190085|NCT06310200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190086|NCT06310200|Sensory System Agents|sensory system agents|mesh-ancestor
154190087|NCT06310200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190088|NCT06310200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154190089|NCT06310200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154190090|NCT06310200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154190091|NCT06310200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190092|NCT06310200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190093|NCT06308419|Sirolimus|sirolimus|mesh-list
154190094|NCT06308419|Gemcitabine|gemcitabine|mesh-list
154190095|NCT06308419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154190134|NCT06304909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154190135|NCT06304909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190136|NCT06304909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190137|NCT06304909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154190138|NCT06304909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190139|NCT06304909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154190140|NCT06304909|Analgesics|analgesics|mesh-ancestor
154190141|NCT06304909|Sensory System Agents|sensory system agents|mesh-ancestor
154190142|NCT06304909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154190143|NCT06304909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154190144|NCT06304909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154190145|NCT06304909|Adrenergic Agents|adrenergic agents|mesh-ancestor
154190146|NCT06304909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190148|NCT06304870|Anesthetics, Local|anesthetics, local|mesh-ancestor
154190149|NCT06304870|Anesthetics|anesthetics|mesh-ancestor
154190150|NCT06304870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190151|NCT06304870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190152|NCT06304870|Sensory System Agents|sensory system agents|mesh-ancestor
154190153|NCT06304870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190154|NCT06304870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154190155|NCT06304870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154190156|NCT06304870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154190157|NCT06304870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190158|NCT06304870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190159|NCT06304142|Lidocaine|lidocaine|mesh-list
154190179|NCT06304116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154190180|NCT06304116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154190181|NCT06304116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190182|NCT06304116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190183|NCT06304090|Lidocaine|lidocaine|mesh-list
154190184|NCT06304090|Anesthetics, Local|anesthetics, local|mesh-ancestor
154190185|NCT06304090|Anesthetics|anesthetics|mesh-ancestor
154190186|NCT06304090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153937149|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153937150|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
153937151|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153937152|NCT02738632|Amlodipine|amlodipine|mesh-list
153937153|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153937154|NCT02738632|Telmisartan|telmisartan|mesh-list
153937155|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153522899|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522906|NCT03233347|Immunotoxins|immunotoxins|mesh-ancestor
153937156|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153937157|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153937158|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190219|NCT06290934|Ustekinumab|ustekinumab|mesh-list
154190220|NCT06290934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154190221|NCT06289673|Cytarabine|cytarabine|mesh-list
154190222|NCT06289673|Dexamethasone|dexamethasone|mesh-list
154190223|NCT06289673|Hydrocortisone|hydrocortisone|mesh-list
154190224|NCT06289673|Methotrexate|methotrexate|mesh-list
154190225|NCT06289673|Vincristine|vincristine|mesh-list
154190226|NCT06289673|Daunorubicin|daunorubicin|mesh-list
154190227|NCT06289673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190228|NCT06289673|Antiemetics|antiemetics|mesh-ancestor
154190229|NCT06289673|Autonomic Agents|autonomic agents|mesh-ancestor
154190230|NCT06289673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190231|NCT06289673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190232|NCT06289673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190233|NCT06289673|Glucocorticoids|glucocorticoids|mesh-ancestor
154190234|NCT06289673|Hormones|hormones|mesh-ancestor
154190235|NCT06289673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190237|NCT06289673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190277|NCT06288386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190278|NCT06284473|Ketamine|ketamine|mesh-list
154190279|NCT06284473|Analgesics|analgesics|mesh-ancestor
154190280|NCT06284473|Sensory System Agents|sensory system agents|mesh-ancestor
154190281|NCT06284473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190282|NCT06284473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190283|NCT06284473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154190284|NCT06284473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154190285|NCT06284473|Anesthetics, General|anesthetics, general|mesh-ancestor
154190286|NCT06284473|Anesthetics|anesthetics|mesh-ancestor
154190287|NCT06284473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190288|NCT06284473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154190289|NCT06284473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154190290|NCT06284473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190291|NCT06284473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190292|NCT06284122|Prednisone|prednisone|mesh-list
154190293|NCT06284122|Cyclophosphamide|cyclophosphamide|mesh-list
154190294|NCT06284122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154190295|NCT06284122|Rituximab|rituximab|mesh-list
154190296|NCT06284122|Doxorubicin|doxorubicin|mesh-list
154190297|NCT06284122|Lenalidomide|lenalidomide|mesh-list
154190298|NCT06284122|Obinutuzumab|obinutuzumab|mesh-list
154190299|NCT06284122|Vincristine|vincristine|mesh-list
154190300|NCT06284122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154190301|NCT06284122|Immunologic Factors|immunologic factors|mesh-ancestor
154190302|NCT06284122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190325|NCT06284122|Antimitotic Agents|antimitotic agents|mesh-ancestor
153522945|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
153522950|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190326|NCT06284122|Mitosis Modulators|mitosis modulators|mesh-ancestor
154190327|NCT06274333|Acetaminophen|acetaminophen|mesh-list
154190328|NCT06274333|Dexmedetomidine|dexmedetomidine|mesh-list
154190329|NCT06274333|Tramadol|tramadol|mesh-list
154190330|NCT06274333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154190331|NCT06274333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190332|NCT06274333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153937305|NCT00625469|Bosentan|bosentan|mesh-list
154190333|NCT06274333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154190334|NCT06274333|Analgesics|analgesics|mesh-ancestor
154190335|NCT06274333|Sensory System Agents|sensory system agents|mesh-ancestor
154190341|NCT06274333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190342|NCT06274333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190344|NCT06274333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154190398|NCT06255366|Coagulants|coagulants|mesh-ancestor
154190399|NCT06255366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154190400|NCT06255366|Natriuretic Agents|natriuretic agents|mesh-ancestor
154190401|NCT06255366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190402|NCT06254053|Methamphetamine|methamphetamine|mesh-list
154190403|NCT06254053|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154190404|NCT06254053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190405|NCT06254053|Sympathomimetics|sympathomimetics|mesh-ancestor
154190406|NCT06254053|Autonomic Agents|autonomic agents|mesh-ancestor
154190407|NCT06254053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154190416|NCT06252623|Exenatide|exenatide|mesh-list
154190461|NCT06224348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190462|NCT06224348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190463|NCT06223685|Rifaximin|rifaximin|mesh-list
154190464|NCT06223685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154190465|NCT06223685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190466|NCT06223685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154190467|NCT06221475|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154190468|NCT06219174|Eflornithine|eflornithine|mesh-list
154190469|NCT06219174|Pembrolizumab|pembrolizumab|mesh-list
154190470|NCT06219174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190471|NCT06219174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190472|NCT06219174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190473|NCT06219174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190474|NCT06219174|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154190475|NCT06219174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154190476|NCT06219174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154190477|NCT06219174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190478|NCT06219174|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154190479|NCT06219174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190480|NCT06218797|Dexmedetomidine|dexmedetomidine|mesh-list
153937445|NCT00704275|Cyclosporine|cyclosporine|mesh-list
154190513|NCT06202066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154190514|NCT06197776|Cisplatin|cisplatin|mesh-list
154190515|NCT06197776|Immunomodulating Agents|immunomodulating agents|mesh-list
154190516|NCT06197776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190517|NCT06197776|Immunologic Factors|immunologic factors|mesh-ancestor
154190518|NCT06197776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190519|NCT06194448|Paclitaxel|paclitaxel|mesh-list
154190520|NCT06194448|Carboplatin|carboplatin|mesh-list
154190521|NCT06194448|Pemetrexed|pemetrexed|mesh-list
154190522|NCT06194448|Osimertinib|osimertinib|mesh-list
154190581|NCT06176339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190582|NCT06176339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190583|NCT06176339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154190584|NCT06176339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154190585|NCT06176339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154190586|NCT06176339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190587|NCT06176339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190588|NCT06176339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154190589|NCT06176339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154190590|NCT06176339|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154190591|NCT06176339|Protective Agents|protective agents|mesh-ancestor
154190592|NCT06176339|Vasodilator Agents|vasodilator agents|mesh-ancestor
154190593|NCT06176339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154190595|NCT06169215|Dexamethasone|dexamethasone|mesh-list
154190643|NCT06157827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154190644|NCT06157827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153523005|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
153523009|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
153523058|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190645|NCT06157827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154190646|NCT06157827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190647|NCT06157827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190648|NCT06153004|Antidepressive Agents|antidepressive agents|mesh-list
154190649|NCT06153004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154190651|NCT06151236|Relatlimab|relatlimab|mesh-list
154190652|NCT06151236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154190653|NCT06151236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190654|NCT06151236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190655|NCT06151236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190656|NCT06149104|Valsartan|valsartan|mesh-list
154190657|NCT06149104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154190658|NCT06149104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154190659|NCT06149104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154190660|NCT06149104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154190661|NCT06149104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190662|NCT06143891|Prednisone|prednisone|mesh-list
154190663|NCT06143891|Prednisolone|prednisolone|mesh-list
154190664|NCT06143891|Belumosudil|belumosudil|mesh-list
154190693|NCT06136650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190694|NCT06136650|Hormone Antagonists|hormone antagonists|mesh-ancestor
154190695|NCT06136650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154190696|NCT06136624|Dexamethasone|dexamethasone|mesh-list
154190697|NCT06136624|Prednisone|prednisone|mesh-list
154190698|NCT06136624|Hydrocortisone|hydrocortisone|mesh-list
154190699|NCT06136624|Fludrocortisone|fludrocortisone|mesh-list
154190700|NCT06136624|Abiraterone Acetate|abiraterone acetate|mesh-list
154190761|NCT06123468|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154190762|NCT06123468|Immunoconjugates|immunoconjugates|mesh-ancestor
154190763|NCT06123468|Immunologic Factors|immunologic factors|mesh-ancestor
154190764|NCT06123468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190765|NCT06123351|Salicylic Acid|salicylic acid|mesh-list
154190766|NCT06123351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154190767|NCT06123351|Antifungal Agents|antifungal agents|mesh-ancestor
154190768|NCT06123351|Keratolytic Agents|keratolytic agents|mesh-ancestor
154190769|NCT06123351|Dermatologic Agents|dermatologic agents|mesh-ancestor
154190770|NCT06122610|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154190771|NCT06122610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154190772|NCT06122610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190773|NCT06119685|Cyclophosphamide|cyclophosphamide|mesh-list
154190774|NCT06119685|Rituximab|rituximab|mesh-list
154190775|NCT06119685|Fludarabine|fludarabine|mesh-list
154190776|NCT06119685|Interleukin-2|interleukin-2|mesh-list
154190777|NCT06119685|Daratumumab|daratumumab|mesh-list
154190778|NCT06119685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154190789|NCT06119685|Analgesics|analgesics|mesh-ancestor
154190820|NCT06111872|Anesthetics, General|anesthetics, general|mesh-ancestor
154190822|NCT06111872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154190823|NCT06111872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154190824|NCT06111872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154190825|NCT06111872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190826|NCT06111872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190827|NCT06111872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154190828|NCT06111872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154190886|NCT06088199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154190887|NCT06088199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154190888|NCT06088199|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154190889|NCT06088199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154190890|NCT06088199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190891|NCT06088199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190893|NCT06086340|Palbociclib|palbociclib|mesh-list
154190894|NCT06086340|Anastrozole|anastrozole|mesh-list
154190895|NCT06086340|Exemestane|exemestane|mesh-list
154190896|NCT06086340|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154190897|NCT06086340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190898|NCT06086340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154190899|NCT06086340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190900|NCT06086340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190901|NCT06086340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154190902|NCT06086340|Hormone Antagonists|hormone antagonists|mesh-ancestor
154190903|NCT06086340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154190904|NCT06086340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190942|NCT06077760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190943|NCT06077760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154190944|NCT06077760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190945|NCT06077669|Methylphenidate|methylphenidate|mesh-list
154190946|NCT06077669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154190947|NCT06077669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154190948|NCT06077669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154190949|NCT06077669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154190950|NCT06077669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154190951|NCT06077669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154190952|NCT06077669|Dopamine Agents|dopamine agents|mesh-ancestor
154190953|NCT06077669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154190954|NCT06066957|Letermovir|letermovir|mesh-list
154190955|NCT06066957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154190956|NCT06066957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154190958|NCT06066957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154190997|NCT06057675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154190998|NCT06057675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154190999|NCT06057675|Adrenergic Agents|adrenergic agents|mesh-ancestor
154191000|NCT06057675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191001|NCT06057675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154191002|NCT06057675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154191003|NCT06057675|Autonomic Agents|autonomic agents|mesh-ancestor
154191004|NCT06057675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154191005|NCT06057675|Respiratory System Agents|respiratory system agents|mesh-ancestor
154191006|NCT06057675|Mydriatics|mydriatics|mesh-ancestor
154191007|NCT06057675|Sympathomimetics|sympathomimetics|mesh-ancestor
154191008|NCT06057675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154191010|NCT06053580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154191011|NCT06053580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153937972|NCT01227616|Hematinics|hematinics|mesh-ancestor
154191012|NCT06053580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153523068|NCT01179009|Clonidine|clonidine|mesh-list
153523118|NCT04724239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191013|NCT06053580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191015|NCT06046859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154191016|NCT06046859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154191017|NCT06046859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154191018|NCT06046859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191028|NCT06041204|Letrozole|letrozole|mesh-list
154191047|NCT06034860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191051|NCT06033092|Tamoxifen|tamoxifen|mesh-list
154191052|NCT06033092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154191053|NCT06033092|Hormone Antagonists|hormone antagonists|mesh-ancestor
154191054|NCT06033092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154191055|NCT06033092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191056|NCT06033092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154191057|NCT06033092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191112|NCT06001372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191113|NCT06001372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154191114|NCT06001372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154191115|NCT06001372|Anesthetics, General|anesthetics, general|mesh-ancestor
154191117|NCT06001372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191118|NCT06001372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154191119|NCT06001372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154191120|NCT06001372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191121|NCT06001372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191122|NCT05976828|Vaccines|vaccines|mesh-list
154191123|NCT05976828|Immunologic Factors|immunologic factors|mesh-ancestor
154191124|NCT05976828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191125|NCT05962151|Nalbuphine|nalbuphine|mesh-list
154191126|NCT05962151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154191127|NCT05962151|Narcotics|narcotics|mesh-ancestor
154191128|NCT05962151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191129|NCT05962151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191130|NCT05962151|Analgesics|analgesics|mesh-ancestor
154191131|NCT05962151|Sensory System Agents|sensory system agents|mesh-ancestor
154191132|NCT05962151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191133|NCT05956821|Bevacizumab|bevacizumab|mesh-list
154191134|NCT05956821|Cetuximab|cetuximab|mesh-list
154191136|NCT05956821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191163|NCT05945615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154191165|NCT05945615|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154191166|NCT05945615|Protective Agents|protective agents|mesh-ancestor
154191167|NCT05943522|Asciminib|asciminib|mesh-list
154191168|NCT05943522|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154191169|NCT05943522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154191170|NCT05943522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191171|NCT05943522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191172|NCT05943106|Durvalumab|durvalumab|mesh-list
154191173|NCT05943106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191174|NCT05943106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191175|NCT05941741|Cisplatin|cisplatin|mesh-list
154191225|NCT05935280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191226|NCT05935280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154191227|NCT05935280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154191228|NCT05935280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154191229|NCT05935280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191230|NCT05924256|Leuprolide|leuprolide|mesh-list
154191231|NCT05924256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154191232|NCT05924256|Fertility Agents|fertility agents|mesh-ancestor
154191233|NCT05924256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154191234|NCT05924256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191235|NCT05924256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154191236|NCT05924256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191237|NCT05924126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154191238|NCT05924126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191239|NCT05915182|Budesonide|budesonide|mesh-list
154191240|NCT05915182|Glycopyrrolate|glycopyrrolate|mesh-list
154191241|NCT05915182|Bromides|bromides|mesh-list
154191242|NCT05915182|Formoterol Fumarate|formoterol fumarate|mesh-list
154191243|NCT05915182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154191244|NCT05915182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154191245|NCT05915182|Autonomic Agents|autonomic agents|mesh-ancestor
154191278|NCT05891561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191279|NCT05891119|Vitamin K|vitamin k|mesh-list
154191280|NCT05891119|Metoprolol|metoprolol|mesh-list
154191281|NCT05891119|Midazolam|midazolam|mesh-list
154191282|NCT05891119|Caffeine|caffeine|mesh-list
154191283|NCT05891119|Caffeine citrate|caffeine citrate|mesh-list
154191284|NCT05891119|Omeprazole|omeprazole|mesh-list
154191285|NCT05891119|Warfarin|warfarin|mesh-list
154191286|NCT05891119|Vitamins|vitamins|mesh-ancestor
154191287|NCT05891119|Micronutrients|micronutrients|mesh-ancestor
154191288|NCT05891119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191289|NCT05891119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153523156|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153523157|NCT04662944|Growth Substances|growth substances|mesh-ancestor
154191290|NCT05891119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154191291|NCT05891119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191343|NCT05873712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191344|NCT05873712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154191345|NCT05873712|Alkylating Agents|alkylating agents|mesh-ancestor
154191346|NCT05873712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191347|NCT05873712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191348|NCT05873712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154191349|NCT05873712|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154191350|NCT05873712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154191351|NCT05873712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191352|NCT05873244|Sorafenib|sorafenib|mesh-list
154191353|NCT05873244|Lenvatinib|lenvatinib|mesh-list
154191354|NCT05873244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191355|NCT05873244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154191356|NCT05873244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191357|NCT05873244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191402|NCT05850546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191403|NCT05850546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154191404|NCT05850546|Glucocorticoids|glucocorticoids|mesh-ancestor
154191405|NCT05850546|Hormones|hormones|mesh-ancestor
154191406|NCT05850546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154191407|NCT05850546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154191408|NCT05845645|Esomeprazole|esomeprazole|mesh-list
154191409|NCT05845645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154191410|NCT05845645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154191411|NCT05845645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154191414|NCT05844995|Acetaminophen|acetaminophen|mesh-list
154191464|NCT05837936|Sevoflurane|sevoflurane|mesh-list
154191465|NCT05837936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191466|NCT05837936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191467|NCT05837936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154191468|NCT05837936|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154191469|NCT05837936|Anesthetics, General|anesthetics, general|mesh-ancestor
154191470|NCT05813327|Ifosfamide|ifosfamide|mesh-list
154191471|NCT05813327|Mesna|mesna|mesh-list
154191472|NCT05813327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154191473|NCT05813327|Alkylating Agents|alkylating agents|mesh-ancestor
154191474|NCT05813327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191475|NCT05813327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191476|NCT05813327|Protective Agents|protective agents|mesh-ancestor
154191526|NCT05766670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154191527|NCT05766670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191528|NCT05766670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154191529|NCT05766670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153938493|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154191530|NCT05766670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191531|NCT05742607|Paclitaxel|paclitaxel|mesh-list
154191532|NCT05742607|Cisplatin|cisplatin|mesh-list
154191541|NCT05742607|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191542|NCT05742607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523191|NCT04593043|Warfarin|warfarin|mesh-list
154191543|NCT05742607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191544|NCT05742607|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154191545|NCT05742607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154191602|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
154191603|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191604|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154191605|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154191606|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
154191607|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
154191608|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
154191609|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
154191611|NCT05691010|Carboplatin|carboplatin|mesh-list
154191612|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154191613|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191614|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
154191615|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191616|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191617|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191618|NCT05685004|Temozolomide|temozolomide|mesh-list
154191619|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154191620|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
154191621|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191622|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191627|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
154191628|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191629|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191630|NCT05669846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191631|NCT05669846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191636|NCT05668741|Ivacaftor|ivacaftor|mesh-list
154191637|NCT05668741|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154191638|NCT05668741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153646734|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646735|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153646736|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153646737|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646738|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
153646739|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
153646757|NCT00388388|Diuretics|diuretics|mesh-ancestor
153646758|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
153646759|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191639|NCT05668741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191640|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
154191641|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191642|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191643|NCT05665595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523276|NCT04237935|Ticagrelor|ticagrelor|mesh-list
154191644|NCT05665595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191645|NCT05663515|Insulin|insulin|mesh-list
154191646|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154191647|NCT05663515|Exenatide|exenatide|mesh-list
154191648|NCT05663515|Biguanides|biguanides|mesh-list
154191649|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153523282|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191650|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154191651|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191652|NCT05663515|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154191653|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154191654|NCT05663515|Incretins|incretins|mesh-ancestor
154191655|NCT05663515|Hormones|hormones|mesh-ancestor
154191656|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154191657|NCT05661643|Temozolomide|temozolomide|mesh-list
154191658|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154191659|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
154191662|NCT05661578|Atezolizumab|atezolizumab|mesh-list
154191690|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154191691|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154191692|NCT05652205|Linaclotide|linaclotide|mesh-list
154191693|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154191694|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
154191695|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191696|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154191697|NCT05626803|Vaccines|vaccines|mesh-list
154191698|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
154191699|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191700|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
154191701|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191702|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
154191703|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191704|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191705|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154191706|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
154191707|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191747|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191748|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191749|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
154191750|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191751|NCT05567835|Antidotes|antidotes|mesh-ancestor
154191752|NCT05567835|Protective Agents|protective agents|mesh-ancestor
153938712|NCT00934791|Sirolimus|sirolimus|mesh-list
154191753|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
154191754|NCT05567835|Vitamins|vitamins|mesh-ancestor
154191755|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
154191756|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
154191757|NCT05554939|Fludarabine|fludarabine|mesh-list
154191758|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
154191759|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191760|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
154191761|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191762|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191763|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154191764|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
154191765|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191766|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191767|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154191768|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191797|NCT05492578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191799|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154191800|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154191801|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154191802|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191803|NCT05475483|Bevantolol|bevantolol|mesh-list
154191804|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154191805|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154191806|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154191807|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
154191808|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191809|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191810|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191811|NCT05472506|Nivolumab|nivolumab|mesh-list
154191812|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191813|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191814|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191815|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191816|NCT05469737|Azacitidine|azacitidine|mesh-list
154191817|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191818|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
154191820|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191847|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191848|NCT05458401|Immunoconjugates|immunoconjugates|mesh-ancestor
154191849|NCT05458401|Immunologic Factors|immunologic factors|mesh-ancestor
154191850|NCT05458401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191851|NCT05457972|Estradiol|estradiol|mesh-list
154191852|NCT05457972|Estrogens|estrogens|mesh-ancestor
154191853|NCT05457972|Hormones|hormones|mesh-ancestor
153523361|NCT04126070|Nivolumab|nivolumab|mesh-list
154191854|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154191855|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191856|NCT05454891|Insulin|insulin|mesh-list
154191857|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154191858|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154191859|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191860|NCT05450692|Docetaxel|docetaxel|mesh-list
154191861|NCT05450692|Durvalumab|durvalumab|mesh-list
154191862|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191863|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
154191864|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191865|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191866|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191867|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191868|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
154191869|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191870|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191871|NCT05425576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191873|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
154191896|NCT05407675|Paclitaxel|paclitaxel|mesh-list
154191897|NCT05407675|Cisplatin|cisplatin|mesh-list
154191898|NCT05407675|Nivolumab|nivolumab|mesh-list
154191899|NCT05407675|Pemetrexed|pemetrexed|mesh-list
154191900|NCT05407675|Ipilimumab|ipilimumab|mesh-list
154191901|NCT05407675|Rabeprazole|rabeprazole|mesh-list
154191902|NCT05407675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154191903|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191904|NCT05407675|Tubulin Modulators|tubulin modulators|mesh-ancestor
154191905|NCT05407675|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191906|NCT05407675|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191907|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191908|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191909|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191910|NCT05407675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191911|NCT05407675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154191912|NCT05407675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154191913|NCT05407675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154191914|NCT05407675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154191951|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191952|NCT05357482|Sirolimus|sirolimus|mesh-list
154191953|NCT05357482|Plerixafor|plerixafor|mesh-list
154191954|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
154191955|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
154191956|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
154191957|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191958|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154191959|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191960|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154191961|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523377|NCT04126070|Hormones|hormones|mesh-ancestor
154191962|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
154191963|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191964|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192014|NCT05336812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192015|NCT05336812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192016|NCT05335317|Hormones|hormones|mesh-list
154192017|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192018|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192019|NCT05330429|Leucovorin|leucovorin|mesh-list
154192020|NCT05330429|Bevacizumab|bevacizumab|mesh-list
154192021|NCT05330429|Magrolimab|magrolimab|mesh-list
154192022|NCT05330429|Fluorouracil|fluorouracil|mesh-list
154192023|NCT05330429|Irinotecan|irinotecan|mesh-list
154192024|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192025|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192026|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154192027|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154192028|NCT05330429|Growth Substances|growth substances|mesh-ancestor
154192029|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192030|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
154192031|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
154192032|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192033|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154192034|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192035|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
154192036|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154192037|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154192038|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192039|NCT05330429|Antidotes|antidotes|mesh-ancestor
154192040|NCT05330429|Protective Agents|protective agents|mesh-ancestor
154192041|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
154192042|NCT05330429|Vitamins|vitamins|mesh-ancestor
154192043|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
154192044|NCT05329428|Vitamin D|vitamin d|mesh-list
154192045|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
154192046|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
154192047|NCT05329428|Vitamins|vitamins|mesh-list
154192048|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
154192052|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
154192056|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154192057|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154192058|NCT05320926|Analgesics|analgesics|mesh-ancestor
154192059|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
153523410|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192060|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192061|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192062|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154192063|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154192064|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154192065|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154192066|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192067|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154192068|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154192069|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192070|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
154192071|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154192072|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154192073|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154192074|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
154192075|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154192077|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154192078|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
154192079|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154192080|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
154192081|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192082|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192083|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
154192084|NCT05318105|Diuretics|diuretics|mesh-list
154192085|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154192086|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
154192087|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192088|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154192089|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192090|NCT05301608|Psilocybin|psilocybin|mesh-list
154192093|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192094|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154192095|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154192096|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
154192097|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154192098|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192099|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154192100|NCT05298202|Capsaicin|capsaicin|mesh-list
154192101|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
154192102|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
154192103|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
154192162|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
154192163|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192164|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192165|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154192166|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
154192167|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154192168|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
154192169|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
154192170|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523451|NCT03893045|Hematinics|hematinics|mesh-ancestor
154192171|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154192172|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154192173|NCT05221840|Durvalumab|durvalumab|mesh-list
154192174|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192175|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192176|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
154192177|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192178|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192179|NCT05215340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192180|NCT05215340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192184|NCT05193370|Vasopressins|vasopressins|mesh-list
154192185|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
154192186|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
154192218|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154192219|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154192220|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
154192221|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192222|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192223|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154192224|NCT05175105|Mitapivat|mitapivat|mesh-list
154192225|NCT05175105|Enzyme Activators|enzyme activators|mesh-ancestor
154192226|NCT05175105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192227|NCT05158140|Vaccines|vaccines|mesh-list
154192228|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154192229|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
154192230|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192231|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
154192232|NCT05156268|Olaparib|olaparib|mesh-list
154192233|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192234|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192235|NCT05156268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192237|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154192272|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
154192273|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192274|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192275|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154192276|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154192277|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154192278|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154192283|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
154192336|NCT05041036|Nirogacestat|nirogacestat|mesh-list
154192337|NCT05041036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192338|NCT05041036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192339|NCT05035095|Semaglutide|semaglutide|mesh-list
154192340|NCT05035095|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153523592|NCT03355976|Nivolumab|nivolumab|mesh-list
153523708|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192341|NCT05035095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154192342|NCT05035095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192343|NCT05032157|Remibrutinib|remibrutinib|mesh-list
154192344|NCT05032157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192345|NCT05032157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192346|NCT05032157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192347|NCT05026203|Midazolam|midazolam|mesh-list
154192348|NCT05026203|Ketamine|ketamine|mesh-list
154192349|NCT05026203|Analgesics|analgesics|mesh-ancestor
154192350|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
154192351|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153939299|NCT03522064|Testosterone|testosterone|mesh-list
154192352|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192353|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154192354|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154192355|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
154192356|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
154192357|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154192387|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154192388|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154192389|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154192390|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154192391|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154192392|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
154192393|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154192394|NCT05020184|Cimetidine|cimetidine|mesh-list
154192395|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154192396|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154192397|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154192398|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
154192399|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
154192405|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192449|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192450|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192451|NCT04999202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192452|NCT04999202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192453|NCT04990869|Niacinamide|niacinamide|mesh-list
154192454|NCT04990869|Niacin|niacin|mesh-list
154192455|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
154192456|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
154192518|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192519|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192520|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154192521|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154192522|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154192523|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154192524|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192525|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192526|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192527|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192528|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192530|NCT04936230|Pembrolizumab|pembrolizumab|mesh-list
154192578|NCT04895748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192579|NCT04895748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192580|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192581|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192582|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
154192583|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192584|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192585|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192586|NCT04895748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192613|NCT04873453|Cannabidiol|cannabidiol|mesh-list
154192614|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
154192615|NCT04861064|Sirolimus|sirolimus|mesh-list
154192624|NCT04839198|Nicotine|nicotine|mesh-list
154192642|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192643|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192644|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192645|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154192646|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
154192647|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192648|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154192649|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154192650|NCT04832854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192651|NCT04832854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192653|NCT04793958|Adagrasib|adagrasib|mesh-list
154192654|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192655|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192657|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154192658|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154192659|NCT04793100|Growth Substances|growth substances|mesh-ancestor
154192698|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154192699|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192700|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154192701|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154192702|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192703|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
154192704|NCT04736173|Paclitaxel|paclitaxel|mesh-list
154192705|NCT04736173|Carboplatin|carboplatin|mesh-list
154192706|NCT04736173|Pembrolizumab|pembrolizumab|mesh-list
154192707|NCT04736173|Pemetrexed|pemetrexed|mesh-list
153523766|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192708|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192761|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192762|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192763|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154192764|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
154192765|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154192766|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192767|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
154192768|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192769|NCT04686305|Carboplatin|carboplatin|mesh-list
154192770|NCT04686305|Trastuzumab|trastuzumab|mesh-list
154192771|NCT04686305|Pemetrexed|pemetrexed|mesh-list
154192772|NCT04686305|Durvalumab|durvalumab|mesh-list
154192773|NCT04686305|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154192774|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192822|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154192823|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154192824|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154192825|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154192826|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154192827|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192828|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192829|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154192830|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
154192833|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
154192885|NCT04571619|Buprenorphine|buprenorphine|mesh-list
154192886|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154192887|NCT04571619|Narcotics|narcotics|mesh-ancestor
154192888|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154192889|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192890|NCT04571619|Analgesics|analgesics|mesh-ancestor
154192891|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
154192892|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192893|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154192894|NCT04567615|Nivolumab|nivolumab|mesh-list
154192895|NCT04567615|Relatlimab|relatlimab|mesh-list
154192896|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192897|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192901|NCT04560972|Etoposide|etoposide|mesh-list
154192946|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192947|NCT04533750|Antimetabolites|antimetabolites|mesh-ancestor
154192948|NCT04533750|Antiviral Agents|antiviral agents|mesh-ancestor
154192949|NCT04533750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192950|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192951|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192952|NCT04498468|Dexamethasone|dexamethasone|mesh-list
154192953|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153939891|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
154192954|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
154192955|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
154192956|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192960|NCT04498468|Hormones|hormones|mesh-ancestor
154193010|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154193011|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154193012|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154193013|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
154193014|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154193015|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193016|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193017|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154193018|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193019|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154193020|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
154193021|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
154193022|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
154193023|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154193024|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154193025|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154193026|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
154193027|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193028|NCT04440280|Expectorants|expectorants|mesh-ancestor
154193029|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
154193030|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154193033|NCT04440280|Protective Agents|protective agents|mesh-ancestor
154193065|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
154193066|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193067|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193068|NCT04332653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193069|NCT04332653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193070|NCT04321330|Atezolizumab|atezolizumab|mesh-list
154193071|NCT04321330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193072|NCT04321330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193073|NCT04321330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193074|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193075|NCT04311671|Ivermectin|ivermectin|mesh-list
154193076|NCT04311671|Albendazole|albendazole|mesh-list
154193077|NCT04311671|Moxidectin|moxidectin|mesh-list
154193078|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154193079|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193080|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
154193081|NCT04311671|Anticestodal Agents|anticestodal agents|mesh-ancestor
154193082|NCT04311671|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154193083|NCT04311671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154193084|NCT04311671|Tubulin Modulators|tubulin modulators|mesh-ancestor
154193085|NCT04311671|Antimitotic Agents|antimitotic agents|mesh-ancestor
154193086|NCT04311671|Mitosis Modulators|mitosis modulators|mesh-ancestor
154193087|NCT04311671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193088|NCT04311671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193089|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
154193090|NCT04310020|Atezolizumab|atezolizumab|mesh-list
154193091|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154193092|NCT04310020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193093|NCT04310020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193094|NCT04310020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193095|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193096|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
154193097|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193098|NCT04305145|Prednisone|prednisone|mesh-list
154193099|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
153646760|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154193100|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154193101|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154193102|NCT04305145|Prednisolone|prednisolone|mesh-list
154193103|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
154193104|NCT04305145|Infliximab|infliximab|mesh-list
154193105|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154193106|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
153940044|NCT01112267|Tramadol|tramadol|mesh-list
154193107|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154193109|NCT04305145|Hormones|hormones|mesh-ancestor
154193110|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193111|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193112|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193113|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193114|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
154193115|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
154193116|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193117|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154193118|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154193119|NCT04305145|Protective Agents|protective agents|mesh-ancestor
154193120|NCT04305145|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154193121|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
154193122|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193123|NCT04304820|Cyclosporine|cyclosporine|mesh-list
154193124|NCT04304820|Cyclosporins|cyclosporins|mesh-list
154193125|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154193126|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193127|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193128|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193129|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
154193130|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193131|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
154193143|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193144|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154193145|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193146|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
154193147|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
154193148|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193149|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193150|NCT04260126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193151|NCT04260126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193152|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
154193153|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154193154|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154193155|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193156|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
154193157|NCT04251247|Coagulants|coagulants|mesh-ancestor
153523898|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154193158|NCT04241185|Gemcitabine|gemcitabine|mesh-list
154193159|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
154193160|NCT04241185|Fluorouracil|fluorouracil|mesh-list
154193161|NCT04241185|Mitomycins|mitomycins|mesh-list
154193162|NCT04241185|Mitomycin|mitomycin|mesh-list
154193163|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193164|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193165|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
154193166|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193167|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193192|NCT04210115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193193|NCT04210115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193194|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154193195|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193196|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154193198|NCT04210115|Protective Agents|protective agents|mesh-ancestor
154193199|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
154193200|NCT04210115|Vitamins|vitamins|mesh-ancestor
154193201|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
154193256|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193257|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193258|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154193259|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
154193260|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154193261|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193262|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193263|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154193264|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
154193265|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
154193266|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154193267|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154193268|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154193269|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
154193270|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193271|NCT03978052|Protective Agents|protective agents|mesh-ancestor
154193272|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193273|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154193274|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154193293|NCT03944772|Carboplatin|carboplatin|mesh-list
154193309|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193310|NCT03944772|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154193311|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524020|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
153524021|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154193312|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154193313|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154193315|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154193316|NCT03941730|Estrogens|estrogens|mesh-ancestor
154193317|NCT03941730|Hormones|hormones|mesh-ancestor
154193318|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193319|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193320|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154193321|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
154193322|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154193323|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154193324|NCT03932201|Factor VIII|factor viii|mesh-list
154193325|NCT03932201|Coagulants|coagulants|mesh-ancestor
154193326|NCT03929601|Rituximab|rituximab|mesh-list
154193327|NCT03929601|Abatacept|abatacept|mesh-list
154193328|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193329|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193330|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
153940269|NCT02700022|Prednisone|prednisone|mesh-list
154193331|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193332|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193333|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193334|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193335|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193337|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193341|NCT03915964|Adalimumab|adalimumab|mesh-list
154193353|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193354|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
154193356|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
154193357|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
154193358|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193359|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
154193360|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154193361|NCT03875573|Durvalumab|durvalumab|mesh-list
154193362|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193363|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193364|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
154193365|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193366|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193367|NCT03867175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193368|NCT03867175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193369|NCT03866239|Atezolizumab|atezolizumab|mesh-list
154193370|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
154193371|NCT03866239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193372|NCT03866239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524141|NCT01460420|Lenalidomide|lenalidomide|mesh-list
154193373|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193374|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193375|NCT03853798|Mitapivat|mitapivat|mesh-list
154193376|NCT03853798|Enzyme Activators|enzyme activators|mesh-ancestor
154193377|NCT03853798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193378|NCT03851614|Durvalumab|durvalumab|mesh-list
154193379|NCT03851614|Olaparib|olaparib|mesh-list
154193380|NCT03851614|Cediranib|cediranib|mesh-list
154193381|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193382|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193387|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
154193396|NCT03829332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193397|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193398|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193399|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193401|NCT03807778|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154193402|NCT03807778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193403|NCT03807778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193404|NCT03807778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193405|NCT03789240|Rituximab|rituximab|mesh-list
154193406|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193407|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193408|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
154193409|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193410|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193411|NCT03782415|Temozolomide|temozolomide|mesh-list
154193412|NCT03782415|Ibudilast|ibudilast|mesh-list
154193413|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193450|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154193451|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154193452|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154193453|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154193454|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154193455|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154193456|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154193457|NCT03738397|Upadacitinib|upadacitinib|mesh-list
154193458|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154193459|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
154193460|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193461|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154193462|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193511|NCT03591575|Deferiprone|deferiprone|mesh-list
154193512|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154193513|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
154193514|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
153524188|NCT01460667|Acetaminophen|acetaminophen|mesh-list
154193515|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193516|NCT03582722|Orlistat|orlistat|mesh-list
154193517|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193518|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193519|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154193520|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154193521|NCT03537690|Paclitaxel|paclitaxel|mesh-list
154193522|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154193523|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154193524|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193525|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
154193526|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
154193527|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
154193528|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193529|NCT03522298|GDC-0084|gdc-0084|mesh-list
154193530|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193531|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193532|NCT03519308|Paclitaxel|paclitaxel|mesh-list
154193533|NCT03519308|Gemcitabine|gemcitabine|mesh-list
154193534|NCT03519308|Nivolumab|nivolumab|mesh-list
154193535|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154193536|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193537|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
154193538|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
154193539|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
154193540|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193541|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193542|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
154193543|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193544|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193545|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154193546|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154193547|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154193548|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193549|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153940505|NCT04939467|Pirfenidone|pirfenidone|mesh-list
154193550|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
154193551|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193552|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154193553|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154193554|NCT03505762|Prednisone|prednisone|mesh-list
154193555|NCT03505762|Cortisone|cortisone|mesh-list
154193556|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
154193557|NCT03505762|Rituximab|rituximab|mesh-list
154193558|NCT03505762|Doxorubicin|doxorubicin|mesh-list
154193559|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154193560|NCT03505762|Vincristine|vincristine|mesh-list
154193561|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154193562|NCT03505762|Antibodies|antibodies|mesh-list
154193563|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
154193564|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153524299|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524306|NCT01462058|Vitamin D|vitamin d|mesh-list
154193565|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193566|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
154193567|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193599|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193600|NCT03490513|Anastrozole|anastrozole|mesh-list
154193601|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193602|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193603|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154193604|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154193605|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193606|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193607|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154193608|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
154193609|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193610|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193611|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
154193612|NCT03463460|Sunitinib|sunitinib|mesh-list
154193613|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193614|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193615|NCT03463460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193616|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193617|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154193619|NCT03463460|Growth Substances|growth substances|mesh-ancestor
154193652|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154193653|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
154193654|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154193655|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193656|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193657|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193658|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
154193659|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154193660|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154193661|NCT03267030|Eryaspase|eryaspase|mesh-list
154193662|NCT03267030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193663|NCT03260881|Liraglutide|liraglutide|mesh-list
154193664|NCT03260881|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154193665|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154193666|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193667|NCT03260881|Incretins|incretins|mesh-ancestor
154193668|NCT03260881|Hormones|hormones|mesh-ancestor
154193669|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193670|NCT03245437|Oxytocin|oxytocin|mesh-list
154193671|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
154193672|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154193673|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193674|NCT03229057|Metformin|metformin|mesh-list
154193675|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154193676|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193677|NCT03214562|Cytarabine|cytarabine|mesh-list
154193678|NCT03214562|Fludarabine|fludarabine|mesh-list
154193679|NCT03214562|Venetoclax|venetoclax|mesh-list
154193680|NCT03214562|Idarubicin|idarubicin|mesh-list
154193700|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524378|NCT01463150|Clopidogrel|clopidogrel|mesh-list
153524388|NCT01463163|Ticagrelor|ticagrelor|mesh-list
154193701|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193702|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193703|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
154193704|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193705|NCT03131219|Ravulizumab|ravulizumab|mesh-list
154193706|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154193707|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193708|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
154193709|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193710|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154193711|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154193712|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
154193713|NCT03072238|Prednisone|prednisone|mesh-list
154193714|NCT03072238|Prednisolone|prednisolone|mesh-list
154193715|NCT03072238|Ipatasertib|ipatasertib|mesh-list
154193716|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154193717|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
154193718|NCT03072238|Hormones|hormones|mesh-ancestor
154193719|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193720|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193721|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193753|NCT03031730|Hormones|hormones|mesh-ancestor
154193754|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193755|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193756|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193757|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
154193758|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193759|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193760|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
154193761|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154193762|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154193763|NCT03031730|Growth Substances|growth substances|mesh-ancestor
154193764|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
154193765|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
154193766|NCT03029442|Denosumab|denosumab|mesh-list
154193815|NCT02936102|Spartalizumab|spartalizumab|mesh-list
154193816|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193817|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193818|NCT02936102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193819|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193820|NCT02927262|Gilteritinib|gilteritinib|mesh-list
154193821|NCT02927262|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154193822|NCT02927262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193823|NCT02927262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193824|NCT02927262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193825|NCT02896582|Cytarabine|cytarabine|mesh-list
154193826|NCT02896582|Dexamethasone|dexamethasone|mesh-list
154193827|NCT02896582|Etoposide|etoposide|mesh-list
154193828|NCT02896582|Melphalan|melphalan|mesh-list
154193829|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
154193830|NCT02896582|Cisplatin|cisplatin|mesh-list
154193831|NCT02896582|Carmustine|carmustine|mesh-list
154193871|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193872|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154193873|NCT02837237|Diuretics|diuretics|mesh-ancestor
154193874|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
154193875|NCT02837237|Hormones|hormones|mesh-ancestor
154193876|NCT02823002|Lidocaine|lidocaine|mesh-list
154193877|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
154193878|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
154193879|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154193880|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193881|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
154193882|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193883|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154193884|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154193885|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154193886|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154193887|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193888|NCT02810548|Mitogens|mitogens|mesh-list
154193928|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193929|NCT02476916|Mitapivat|mitapivat|mesh-list
154193930|NCT02476916|Enzyme Activators|enzyme activators|mesh-ancestor
154193931|NCT02476916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193932|NCT02427724|Lidocaine|lidocaine|mesh-list
154193933|NCT02427724|Tetracaine|tetracaine|mesh-list
154193934|NCT02427724|Prilocaine|prilocaine|mesh-list
154193935|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
154193936|NCT02427724|Anesthetics|anesthetics|mesh-list
154193937|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154193938|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193939|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
154193940|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193941|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154193942|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154193943|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154193944|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154193945|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193946|NCT02312102|Lenalidomide|lenalidomide|mesh-list
154193947|NCT02312102|Bortezomib|bortezomib|mesh-list
154193948|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
154193949|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193950|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154193951|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154193952|NCT02312102|Growth Substances|growth substances|mesh-ancestor
154193953|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
154193954|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193961|NCT02068586|Sunitinib|sunitinib|mesh-list
154193962|NCT02068586|Valproic Acid|valproic acid|mesh-list
154193963|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193964|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154193965|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154193966|NCT02068586|Growth Substances|growth substances|mesh-ancestor
153646761|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153646763|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153646764|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154193967|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193968|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
154193969|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193970|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193971|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193972|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
154193973|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
154193974|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154193975|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
154193976|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153524421|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154193977|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154193978|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154193979|NCT02055183|Antitoxins|antitoxins|mesh-list
154193980|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
154193981|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
154193982|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193983|NCT02008786|Ramipril|ramipril|mesh-list
154193984|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154193985|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154193986|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154193987|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
154193988|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193989|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154193990|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154193991|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193992|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154193993|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
154194015|NCT01885689|Clofarabine|clofarabine|mesh-list
154194016|NCT01885689|Tacrolimus|tacrolimus|mesh-list
154194017|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194018|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
154194019|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194020|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154194021|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194022|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194023|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194024|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194025|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154194026|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194027|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
154194028|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154194033|NCT01730833|Paclitaxel|paclitaxel|mesh-list
154194075|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194076|NCT01450306|Cycloserine|cycloserine|mesh-list
154194077|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154194078|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194079|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154194080|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
154194081|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194082|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
153524442|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
154194083|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194084|NCT01351103|Spartalizumab|spartalizumab|mesh-list
154194085|NCT01351103|LGK974|lgk974|mesh-list
154194086|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154194090|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194140|NCT00295646|Tamoxifen|tamoxifen|mesh-list
154194141|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
154194142|NCT00295646|Anastrozole|anastrozole|mesh-list
154194143|NCT00295646|Goserelin|goserelin|mesh-list
153524633|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194144|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154194145|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
154194146|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154194147|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194148|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154194149|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153941096|NCT01024920|Sunitinib|sunitinib|mesh-list
154194150|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154194151|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154194152|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154194153|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154194154|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154194155|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194156|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194190|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194191|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194192|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154194193|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154194194|NCT00488592|Molgramostim|molgramostim|mesh-list
154194195|NCT00488592|Sargramostim|sargramostim|mesh-list
154194196|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154194197|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
154194198|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194199|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194200|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154194201|NCT00488514|Naproxen|naproxen|mesh-list
154194202|NCT00488514|Sumatriptan|sumatriptan|mesh-list
154194203|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154194204|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154194205|NCT00488514|Analgesics|analgesics|mesh-ancestor
154194251|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
154194252|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154194253|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154194254|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
154194255|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194256|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194257|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154194258|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
154194259|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154194260|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
154194261|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
154194262|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154194263|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154194264|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154194265|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
154194266|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194267|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194268|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194270|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154194271|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194272|NCT00477594|Mipomersen|mipomersen|mesh-list
154194273|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154194274|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154194297|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194298|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
154194299|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194302|NCT00414609|Protease Inhibitors|protease inhibitors|mesh-ancestor
154194303|NCT00414609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194304|NCT00414609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194305|NCT00393705|Insulin|insulin|mesh-list
154194306|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154194307|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
154194308|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154194309|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194310|NCT00303628|Leucovorin|leucovorin|mesh-list
154194363|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154194364|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154194365|NCT00332332|Analgesics|analgesics|mesh-ancestor
154194366|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
154194367|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194368|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194369|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194370|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194371|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154194372|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194373|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
153941326|NCT05525611|Cabergoline|cabergoline|mesh-list
154194374|NCT00392925|Pramlintide|pramlintide|mesh-list
154194375|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
154194376|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154194377|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194378|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
154194379|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154194380|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
154194381|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194417|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154194418|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194419|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
154194420|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194421|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154194422|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
154194423|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154194424|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154194425|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154194426|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154194427|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194429|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194433|NCT01064752|Minocycline|minocycline|mesh-list
154194475|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154194476|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153524702|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154194477|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154194478|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194479|NCT00318370|Farletuzumab|farletuzumab|mesh-list
154194480|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194481|NCT00510068|Everolimus|everolimus|mesh-list
154194482|NCT00510068|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154194483|NCT00510068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154194484|NCT00510068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194485|NCT00510068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194486|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194487|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
154194488|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194489|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194490|NCT00509600|Etanercept|etanercept|mesh-list
154194491|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154194492|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154194493|NCT00509600|Analgesics|analgesics|mesh-ancestor
154194494|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
154194495|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194496|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194497|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194498|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194499|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154194500|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194501|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
154194502|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
154194503|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154194504|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154194505|NCT01014104|Prednisolone|prednisolone|mesh-list
154194506|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
154194507|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154194508|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
154194515|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
154194516|NCT01014104|Hormones|hormones|mesh-ancestor
154194517|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154194518|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154194519|NCT01014104|Protective Agents|protective agents|mesh-ancestor
154194520|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154194521|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194522|NCT00402987|Celecoxib|celecoxib|mesh-list
154194523|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154194524|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154194525|NCT00402987|Analgesics|analgesics|mesh-ancestor
154194526|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
154194527|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194528|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194529|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194530|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194531|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154194532|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154194533|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194534|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194535|NCT01015664|Sirolimus|sirolimus|mesh-list
154194536|NCT01015664|Cetuximab|cetuximab|mesh-list
154194537|NCT01015664|Temsirolimus|temsirolimus|mesh-list
154194538|NCT01015664|MTOR Inhibitors|mtor inhibitors|mesh-list
154194566|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154194567|NCT01010672|Sirolimus|sirolimus|mesh-list
154194568|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194569|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194570|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154194571|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194572|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
154194573|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194574|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
154194575|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194576|NCT01014338|Fosinopril|fosinopril|mesh-list
154194577|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154194578|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
154194579|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194580|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194581|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154194582|NCT01014416|Tolvaptan|tolvaptan|mesh-list
154194623|NCT01020708|Protective Agents|protective agents|mesh-ancestor
154194624|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194625|NCT01020708|Antidotes|antidotes|mesh-ancestor
154194626|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154194627|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154194694|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
154194695|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
154194696|NCT00496470|Hormones|hormones|mesh-ancestor
154194697|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154194698|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154194699|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154194700|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154194701|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
154194702|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194703|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194704|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
154194705|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154194706|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
154194707|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
154194708|NCT01021176|Diltiazem|diltiazem|mesh-list
154194750|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154194751|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194752|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
154194753|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154194754|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154194755|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154194757|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
154194758|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194759|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154194760|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154194761|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194762|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154194763|NCT00509366|Cisplatin|cisplatin|mesh-list
154194764|NCT00509366|Gemcitabine|gemcitabine|mesh-list
153524733|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154194765|NCT00509366|Docetaxel|docetaxel|mesh-list
154194766|NCT00509366|Pemetrexed|pemetrexed|mesh-list
154194767|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194768|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154194769|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
154194770|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194771|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
154194772|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
154194773|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
154194774|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194775|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154194776|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154194777|NCT01016054|Carboplatin|carboplatin|mesh-list
154194778|NCT01016054|Gemcitabine|gemcitabine|mesh-list
154194779|NCT01016054|Doxorubicin|doxorubicin|mesh-list
154194797|NCT00499694|Growth Substances|growth substances|mesh-ancestor
154194798|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194799|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
154194800|NCT00486954|Paclitaxel|paclitaxel|mesh-list
154194801|NCT00486954|Lapatinib|lapatinib|mesh-list
154194802|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154194803|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194804|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
154194805|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
154194806|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
154194807|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194808|NCT00486954|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154194809|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154194810|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194811|NCT00494676|Methamphetamine|methamphetamine|mesh-list
154194812|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154194813|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194814|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
154194815|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
154194816|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194817|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
154194850|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194851|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154194852|NCT01021566|Methadone|methadone|mesh-list
154194853|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154194854|NCT01021566|Narcotics|narcotics|mesh-ancestor
154194855|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154194856|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194857|NCT01021566|Analgesics|analgesics|mesh-ancestor
154194858|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
154194859|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194860|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
154194913|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
154194914|NCT00469092|Glimepiride|glimepiride|mesh-list
154194915|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
154194916|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154194917|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194918|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154194919|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194920|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
154194921|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
154194922|NCT00499616|Carboplatin|carboplatin|mesh-list
154194923|NCT00499616|Doxorubicin|doxorubicin|mesh-list
154194924|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154194925|NCT00499616|Etoposide|etoposide|mesh-list
154194978|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194979|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194980|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154194981|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154194982|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194983|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194984|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194985|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154194986|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
154194987|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154194988|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194989|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154194990|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154194991|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154194992|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154194993|NCT00392223|Azithromycin|azithromycin|mesh-list
154194994|NCT00392223|Minocycline|minocycline|mesh-list
154194995|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194996|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194997|NCT00402285|Lycopene|lycopene|mesh-list
154195032|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154195033|NCT00401973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154195034|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154195035|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195036|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195037|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195038|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
154195039|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154195040|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154195041|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
154195042|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195043|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
154195044|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154195045|NCT00401973|Analgesics|analgesics|mesh-ancestor
154195091|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195092|NCT01041729|Atorvastatin|atorvastatin|mesh-list
154195093|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154195094|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154195095|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
154195096|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195097|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154195098|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154195099|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195100|NCT01324245|Fenoldopam|fenoldopam|mesh-list
154195101|NCT01324245|Enalaprilat|enalaprilat|mesh-list
154195154|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154195155|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
154195156|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
154195157|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
154195158|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154195159|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195160|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
154195161|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195162|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
154195163|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154195164|NCT03980002|Thalidomide|thalidomide|mesh-list
154195165|NCT03980002|Ibrutinib|ibrutinib|mesh-list
154195166|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195167|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
154195168|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195169|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
154195170|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154195171|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195172|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154195173|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154195174|NCT03980002|Growth Substances|growth substances|mesh-ancestor
154195175|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
154195176|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195177|NCT03980002|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154195178|NCT03980002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195206|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
154195207|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154195208|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195209|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
154195210|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195211|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195212|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154195213|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
154195214|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195215|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195216|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154195217|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154195218|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154195219|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154195220|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195221|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154195222|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195223|NCT00331006|Rituximab|rituximab|mesh-list
154195224|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195225|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195226|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
154195227|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195228|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195229|NCT00302458|Methylphenidate|methylphenidate|mesh-list
154195230|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154195231|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195232|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154195233|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154195234|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195235|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195236|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
154195237|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195238|NCT00391053|Vaccines|vaccines|mesh-list
154195239|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
154195240|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195244|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154195245|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195246|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195247|NCT00301834|Cyclosporine|cyclosporine|mesh-list
154195248|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
154195249|NCT00301834|Methotrexate|methotrexate|mesh-list
154195250|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
154195251|NCT00301834|Fludarabine|fludarabine|mesh-list
154195252|NCT00301834|Busulfan|busulfan|mesh-list
154195253|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
154195254|NCT00301834|Cyclosporins|cyclosporins|mesh-list
154195255|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154195256|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
154195257|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154195258|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195259|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195260|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
154195261|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195262|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195263|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
154195264|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195265|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154195266|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195298|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
154195299|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195300|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195301|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
154195302|NCT00466440|Hormones|hormones|mesh-ancestor
154195303|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195304|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195305|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154195306|NCT00465972|Doxepin|doxepin|mesh-list
154195307|NCT00465972|Temazepam|temazepam|mesh-list
154195323|NCT03926754|Mirabegron|mirabegron|mesh-list
154195360|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
154195361|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195362|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195363|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154195364|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195365|NCT00400179|Cisplatin|cisplatin|mesh-list
154195366|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157459|NCT05782712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157460|NCT05763875|Ezetimibe|ezetimibe|mesh-list
154195367|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
154195368|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154195404|NCT00508742|Vaccines|vaccines|mesh-list
154195420|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195421|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195423|NCT00508274|Lapatinib|lapatinib|mesh-list
154195424|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195425|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
154195426|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195427|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195428|NCT00508274|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154195429|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195430|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195431|NCT01042041|Doxorubicin|doxorubicin|mesh-list
154195432|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154195482|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
154195483|NCT01039155|Azacitidine|azacitidine|mesh-list
154195484|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195485|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195486|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
154195487|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195488|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195489|NCT01039233|Bicalutamide|bicalutamide|mesh-list
154195490|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
154195491|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
154195492|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195493|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195494|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195496|NCT00490646|Trastuzumab|trastuzumab|mesh-list
154195497|NCT00490646|Epothilones|epothilones|mesh-list
154195498|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195499|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
154195500|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
154195504|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
154195537|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154195538|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195539|NCT00561353|Ribavirin|ribavirin|mesh-list
154195540|NCT00561353|Simeprevir|simeprevir|mesh-list
154195541|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
154195542|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195543|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
153525210|NCT06073873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195544|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195545|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
154195546|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195547|NCT00944957|Efavirenz|efavirenz|mesh-list
154195548|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
154195553|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
154195598|NCT00387465|Azacitidine|azacitidine|mesh-list
154195599|NCT00387465|Entinostat|entinostat|mesh-list
154195600|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154195601|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195602|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
154195603|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195604|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195605|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195606|NCT01042665|Latanoprost|latanoprost|mesh-list
154195607|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154195608|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154195609|NCT00949949|Gemcitabine|gemcitabine|mesh-list
154195610|NCT00949949|Everolimus|everolimus|mesh-list
154195611|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195612|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195613|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
154195614|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195615|NCT00949949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154195616|NCT00949949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195617|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195618|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195655|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154195657|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154195658|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154195659|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154195660|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195661|NCT00386607|Diuretics|diuretics|mesh-ancestor
154195662|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
154195663|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195664|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154195665|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195666|NCT00386607|Renin Inhibitors|renin inhibitors|mesh-ancestor
154195667|NCT00386607|Protease Inhibitors|protease inhibitors|mesh-ancestor
154195668|NCT00386607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195669|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
154195670|NCT00410163|Fludarabine|fludarabine|mesh-list
154195671|NCT00410163|Ofatumumab|ofatumumab|mesh-list
154195672|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154195673|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195674|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
154195675|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195676|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153525269|NCT06072716|Chelating Agents|chelating agents|mesh-ancestor
153618927|NCT01980966|Oseltamivir|oseltamivir|mesh-list
154195677|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154195707|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154195709|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154195710|NCT01043211|Lidocaine|lidocaine|mesh-list
154195711|NCT01043211|Epinephrine|epinephrine|mesh-list
154195712|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
154195713|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
154195714|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154195715|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195716|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
154195717|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195718|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154195719|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154195720|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154195721|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195722|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195723|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154195765|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195766|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
154195767|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154195768|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
154195769|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195770|NCT00507728|Bupropion|bupropion|mesh-list
154195771|NCT00507728|Varenicline|varenicline|mesh-list
154195772|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154195773|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
154195774|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154195828|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154195829|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
154195831|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
154195832|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154195833|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
154195834|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154195835|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154195836|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154195837|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195838|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195839|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
154195840|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195841|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195842|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154195843|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195844|NCT01011062|Losartan|losartan|mesh-list
154195845|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154195846|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154195847|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154195850|NCT00490490|Iodine|iodine|mesh-list
154195880|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154195882|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195883|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195884|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153525360|NCT06060704|Growth Substances|growth substances|mesh-ancestor
154195885|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
154195886|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
154195887|NCT00385593|Hormones|hormones|mesh-ancestor
154195888|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195889|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154195890|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154195891|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154195941|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154195942|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195943|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154195944|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154195945|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154195946|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195947|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195948|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195949|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195950|NCT00408993|Analgesics|analgesics|mesh-ancestor
154195951|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
154195952|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195953|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
154195954|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154195955|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
154195957|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154195999|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
154196000|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196001|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196002|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154196003|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154196004|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
154196005|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196006|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154196007|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154196008|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154196009|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154196010|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154196011|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154196012|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153525432|NCT05974839|Ocrelizumab|ocrelizumab|mesh-list
153525473|NCT05847244|Metformin|metformin|mesh-list
154196013|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154196014|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154196015|NCT00494780|Prednisone|prednisone|mesh-list
154196053|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
154196055|NCT00490022|Hormones|hormones|mesh-ancestor
154196056|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196057|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196058|NCT01011530|Pevonedistat|pevonedistat|mesh-list
154196059|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196060|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196061|NCT00493454|Rituximab|rituximab|mesh-list
154196062|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154196063|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196064|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196065|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
154196066|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196067|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196068|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
154196069|NCT00493220|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154196111|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
154196112|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196113|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196114|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196115|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
154196116|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154196117|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196119|NCT00560417|Insulin|insulin|mesh-list
154196178|NCT00947063|Promethazine|promethazine|mesh-list
154196179|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
154196180|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
154196181|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
154196182|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154196183|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
154196184|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
154196185|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196186|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196187|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196188|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154196189|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154196190|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154196191|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196192|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
154196193|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
154196194|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
154196195|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196196|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
154196197|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
154196198|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196199|NCT00942617|Aspirin|aspirin|mesh-list
154196200|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154196201|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154196202|NCT00942617|Analgesics|analgesics|mesh-ancestor
154196203|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
154196204|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196226|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154196227|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154196228|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
154196229|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196230|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196231|NCT00947141|Valganciclovir|valganciclovir|mesh-list
154196232|NCT00947141|Ganciclovir|ganciclovir|mesh-list
154196233|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154196234|NCT00947141|Foscarnet|foscarnet|mesh-list
154196235|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
154196236|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
154196289|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154196290|NCT00947453|Montelukast|montelukast|mesh-list
154196291|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154196292|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
154196293|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154196294|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
154196295|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196296|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196297|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154196298|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154196350|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196351|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154196352|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154196353|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196354|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
154196355|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154196356|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154196357|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154196358|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
154196359|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196360|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
154196361|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
154196362|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154196363|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196364|NCT00407745|Pregabalin|pregabalin|mesh-list
154196365|NCT00407745|Analgesics|analgesics|mesh-ancestor
154196366|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
154196367|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196368|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196369|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
154196370|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154196371|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154196372|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196373|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154196374|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154196375|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154196393|NCT00299494|Immunoconjugates|immunoconjugates|mesh-ancestor
154196394|NCT00943553|Decitabine|decitabine|mesh-list
154196395|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154196396|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
154196397|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196398|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196399|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196400|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
154196401|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154196402|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
154196403|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196459|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
154196460|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196462|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154196463|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
154196464|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196465|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154196466|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154196467|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196468|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
154196469|NCT00453102|Rituximab|rituximab|mesh-list
154196470|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196471|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196472|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
154196473|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196474|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196475|NCT00299182|Cytarabine|cytarabine|mesh-list
154196476|NCT00299182|Dexamethasone|dexamethasone|mesh-list
154196477|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
154196478|NCT00299182|Rituximab|rituximab|mesh-list
154196479|NCT00299182|Doxorubicin|doxorubicin|mesh-list
154196480|NCT00299182|Methotrexate|methotrexate|mesh-list
154196481|NCT00299182|Vincristine|vincristine|mesh-list
154196482|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154196483|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
154196513|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
154196514|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196515|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154196516|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
154196517|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
154196518|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
154196519|NCT00467142|Leucovorin|leucovorin|mesh-list
154196520|NCT00467142|Bevacizumab|bevacizumab|mesh-list
154196521|NCT00467142|Fluorouracil|fluorouracil|mesh-list
154196522|NCT00467142|Irinotecan|irinotecan|mesh-list
154196523|NCT00467142|Calcium|calcium|mesh-list
154196524|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
154196525|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196526|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196527|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154196576|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196577|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196578|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196579|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
154196580|NCT01060696|Scopolamine|scopolamine|mesh-list
154196581|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154196582|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154196583|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
154196588|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
154196643|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196644|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
154196645|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
154196646|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
154196647|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
154196648|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196650|NCT00551135|Analgesics|analgesics|mesh-ancestor
154196651|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
154196652|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196706|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196707|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
154196708|NCT00313612|Topotecan|topotecan|mesh-list
154196709|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196710|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154196711|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154196712|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196713|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196714|NCT00507416|Thalidomide|thalidomide|mesh-list
154196715|NCT00507416|Dexamethasone|dexamethasone|mesh-list
154196716|NCT00507416|Prednisone|prednisone|mesh-list
154196717|NCT00507416|Bortezomib|bortezomib|mesh-list
154196718|NCT00507416|Melphalan|melphalan|mesh-list
154196769|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154196770|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196771|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154196772|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153525695|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
154196773|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154196774|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196775|NCT00957203|Istradefylline|istradefylline|mesh-list
154196776|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154196777|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154196778|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154196779|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
154196780|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196831|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154196832|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154196833|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154196834|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
154196835|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196836|NCT00953303|Protective Agents|protective agents|mesh-ancestor
154196837|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
154196902|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196903|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196904|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196905|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154196906|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154196907|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154196908|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196966|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196967|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154196968|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
154196970|NCT01566474|Omeprazole|omeprazole|mesh-list
154197036|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197037|NCT00443430|Analgesics|analgesics|mesh-ancestor
154197038|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
154197039|NCT01022658|Insulin|insulin|mesh-list
154197040|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
154197041|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
154197042|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154197043|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197044|NCT01022736|Gabapentin|gabapentin|mesh-list
154197045|NCT01022736|Analgesics|analgesics|mesh-ancestor
154197046|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
154197047|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197048|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197049|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
154197050|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154197051|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154197052|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154197053|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154197054|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154197055|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154197056|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197092|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197093|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197094|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154197095|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154197096|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154197097|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154197098|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154197099|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154197100|NCT00373425|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154197101|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197102|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197103|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197104|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197105|NCT00459342|Dasatinib|dasatinib|mesh-list
154197106|NCT00459342|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154197148|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
154197149|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197150|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197151|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
154197152|NCT00459186|Prednisone|prednisone|mesh-list
153525766|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154197153|NCT00459186|Docetaxel|docetaxel|mesh-list
154197154|NCT00459186|Everolimus|everolimus|mesh-list
154197215|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
154197216|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154197217|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154197218|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197219|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154197221|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
154197222|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154197223|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
154197224|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154197225|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197226|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197227|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154197229|NCT00459108|Dasatinib|dasatinib|mesh-list
154197277|NCT01023360|Rabeprazole|rabeprazole|mesh-list
154197278|NCT01023360|Pantoprazole|pantoprazole|mesh-list
154197279|NCT01023360|Clopidogrel|clopidogrel|mesh-list
154197280|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154197281|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154197282|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154197283|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154197284|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154197285|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
153944242|NCT02663284|Ropivacaine|ropivacaine|mesh-list
154197286|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197287|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197288|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197289|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154197290|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154197291|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197292|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
154197293|NCT00442416|Hematinics|hematinics|mesh-ancestor
154197294|NCT00441792|Midazolam|midazolam|mesh-list
154197334|NCT00297778|Protective Agents|protective agents|mesh-ancestor
154197335|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197336|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154197337|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154197338|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
154197339|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
154197340|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197341|NCT03848832|Cannabidiol|cannabidiol|mesh-list
154197342|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
153525771|NCT05275426|Gemcitabine|gemcitabine|mesh-list
154197401|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154197402|NCT05352191|Beclomethasone|beclomethasone|mesh-list
154197403|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197404|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
154197405|NCT05352191|Hormones|hormones|mesh-ancestor
154197406|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154197407|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197408|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154197409|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
154197410|NCT00954005|Rituximab|rituximab|mesh-list
154197463|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
154197464|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197466|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154197467|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154197468|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
154197469|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197470|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154197471|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154197472|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197473|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
154197525|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197526|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197527|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197528|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197529|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154197530|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197531|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197532|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154197591|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197592|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197593|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197594|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
154197595|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197596|NCT00457626|Valsartan|valsartan|mesh-list
154197597|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154197598|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154197599|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154197600|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197601|NCT02748707|Celecoxib|celecoxib|mesh-list
154197602|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154197618|NCT05014061|Adenosine|adenosine|mesh-list
154197651|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197652|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197653|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
154197654|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154197655|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197656|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525811|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
154197657|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154197658|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154197659|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154197660|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154197661|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154197710|NCT01063192|Protective Agents|protective agents|mesh-ancestor
154197711|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
154197712|NCT01063192|Vitamins|vitamins|mesh-ancestor
154197713|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
154197714|NCT01063426|Enoxaparin|enoxaparin|mesh-list
154197715|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
154197716|NCT01063426|Atorvastatin|atorvastatin|mesh-list
154197717|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154197718|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154197719|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
154197720|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197721|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154197723|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197775|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154197776|NCT03948581|Vedolizumab|vedolizumab|mesh-list
154197777|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154197778|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154197779|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154197780|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154197781|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197782|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197783|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
154197784|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197785|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197786|NCT04720547|Zolpidem|zolpidem|mesh-list
154197787|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154197788|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154197789|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154197833|NCT00959777|Lenograstim|lenograstim|mesh-list
154197834|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154197835|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
154197836|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197837|NCT00959933|Ribavirin|ribavirin|mesh-list
154197838|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
154197839|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197840|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
154197841|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197842|NCT00960245|Nadolol|nadolol|mesh-list
154197843|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154197844|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154197845|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
154197846|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197847|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197848|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197851|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
154197889|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197890|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197891|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154197892|NCT00960713|Rituximab|rituximab|mesh-list
154197893|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526029|NCT04919317|Hormones|hormones|mesh-ancestor
154197894|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197895|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
154197896|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197897|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197898|NCT04009889|Silicon|silicon|mesh-list
154197899|NCT04009889|Trace Elements|trace elements|mesh-ancestor
154197900|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
154197901|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197902|NCT00962507|Everolimus|everolimus|mesh-list
154197903|NCT00962507|Panobinostat|panobinostat|mesh-list
154197904|NCT00962507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154197905|NCT00962507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197906|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197946|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
154197947|NCT00075387|Antidotes|antidotes|mesh-list
154197948|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197949|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
154197950|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197951|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197952|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154197953|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
154197954|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197955|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198009|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198010|NCT00963833|Interferons|interferons|mesh-list
154198011|NCT00963833|Interferon-beta|interferon-beta|mesh-list
154198012|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
154198013|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198014|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
154198015|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198016|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
154198017|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198018|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154198019|NCT00967655|Capecitabine|capecitabine|mesh-list
154198020|NCT00967655|Irinotecan|irinotecan|mesh-list
154198074|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
154198075|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198076|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198077|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154198078|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
154198079|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
154198080|NCT00964535|Hormones|hormones|mesh-ancestor
154198081|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198082|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154198083|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154198084|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154198085|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
154198086|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198087|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198088|NCT00964691|Chloroquine|chloroquine|mesh-list
154198089|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
154198131|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154198132|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
154198133|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198134|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
154198135|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
154198136|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526067|NCT04871594|Nivolumab|nivolumab|mesh-list
154198137|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198138|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154198139|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
154198140|NCT00968903|Hormones|hormones|mesh-ancestor
154198141|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198146|NCT00969137|Nicotine|nicotine|mesh-list
154198194|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198195|NCT00965549|Insulin|insulin|mesh-list
154198196|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154198197|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
154198198|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
154198199|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
154198200|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154198201|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198202|NCT00966251|Pidilizumab|pidilizumab|mesh-list
154198203|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198204|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198205|NCT00966329|Maraviroc|maraviroc|mesh-list
154198206|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154198207|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154198209|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153945211|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
154198254|NCT00406419|Methotrexate|methotrexate|mesh-list
154198255|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
154198256|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154198257|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
154198258|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154198259|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198260|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198261|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
154198262|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198263|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198264|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
154198265|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198266|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154198267|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154198268|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
154198269|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198310|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154198311|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198312|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198313|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154198314|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
154198315|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198316|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526193|NCT04480463|Aflibercept|aflibercept|mesh-list
154198317|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154198318|NCT00973583|Vitamin D|vitamin d|mesh-list
154198319|NCT00973583|Vitamins|vitamins|mesh-ancestor
154198320|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
154198321|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198322|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154198323|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
154198324|NCT00972101|Rituximab|rituximab|mesh-list
154198370|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154198371|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154198372|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198374|NCT00311584|Temozolomide|temozolomide|mesh-list
154198375|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154198376|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154198377|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198378|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198379|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198380|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154198381|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
154198382|NCT00383331|Gemcitabine|gemcitabine|mesh-list
154198383|NCT00383331|Pemetrexed|pemetrexed|mesh-list
154198384|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198385|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
154198386|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198387|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198388|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198389|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154198390|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154198391|NCT03934541|Vaccines|vaccines|mesh-list
154198392|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
154198421|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
154198422|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
154198423|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154198424|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198425|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
154198426|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198427|NCT00383019|Latanoprost|latanoprost|mesh-list
154198428|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154198429|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154198430|NCT00310804|Vaccines|vaccines|mesh-list
154198431|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
153526268|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154198433|NCT00590187|Sapacitabine|sapacitabine|mesh-list
154198484|NCT03933449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154198485|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154198486|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154198487|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198489|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
154198490|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198491|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198492|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
154198493|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198494|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198495|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
154198496|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154198497|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154198498|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154198499|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
154198500|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154198501|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154198502|NCT01049451|Prednisolone|prednisolone|mesh-list
154198503|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
154198504|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154198505|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
154198506|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198507|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
154198508|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
154198509|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198510|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198511|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154198531|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198532|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154198533|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198534|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198535|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
154198536|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154198537|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198538|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
154198539|NCT02908269|Vaccines|vaccines|mesh-list
154198540|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
154198541|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198593|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154198594|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
154198595|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198596|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154198597|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154198599|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
154198661|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198662|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154198663|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154198664|NCT00365547|Growth Substances|growth substances|mesh-ancestor
154198665|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198666|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
154198667|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154198668|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154198669|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198670|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198671|NCT00979589|Aspirin|aspirin|mesh-list
154198672|NCT00979589|Clopidogrel|clopidogrel|mesh-list
154198673|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154198683|NCT00979589|Analgesics|analgesics|mesh-ancestor
154198720|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198721|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198722|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198723|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198724|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
154198725|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198726|NCT00980213|Sunitinib|sunitinib|mesh-list
154198730|NCT00980213|Growth Substances|growth substances|mesh-ancestor
154198788|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198789|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198791|NCT00273052|Carvedilol|carvedilol|mesh-list
154198792|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154198793|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154198794|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
154198795|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
154198796|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198797|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198798|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154198799|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154198851|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198852|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154198853|NCT00272038|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154198854|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198855|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198856|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198857|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198859|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154198860|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154198917|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198918|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198919|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154198920|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
154198921|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198922|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
154198923|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
154198924|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
154198983|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154198984|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198985|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154198986|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198987|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154198988|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198989|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154198990|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154198991|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
154198992|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198993|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154198994|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154198995|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154198996|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154198997|NCT00981929|Narcotics|narcotics|mesh-ancestor
154198998|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154198999|NCT00981929|Analgesics|analgesics|mesh-ancestor
154199000|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
154199001|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199002|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
154199003|NCT00364845|Hematinics|hematinics|mesh-ancestor
154199004|NCT00978653|Allopurinol|allopurinol|mesh-list
154199005|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
154199006|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199007|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199008|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
154199009|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199030|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
154199031|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199032|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199034|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154199035|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
154199036|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199037|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154199038|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154199039|NCT00364689|Rifaximin|rifaximin|mesh-list
154199040|NCT00364689|Lactulose|lactulose|mesh-list
154199041|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199042|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199043|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154199044|NCT00545129|Tanezumab|tanezumab|mesh-list
154199045|NCT00545129|Analgesics|analgesics|mesh-ancestor
154199046|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
154199047|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199048|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199049|NCT00956111|Vaccines|vaccines|mesh-list
154199050|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
154199052|NCT00982631|Sirolimus|sirolimus|mesh-list
154199085|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154199086|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199087|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199088|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
154199089|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
154199090|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199091|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199092|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154199093|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154199094|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
154199095|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154199096|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154199097|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154199098|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154199099|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154199100|NCT00956267|Letrozole|letrozole|mesh-list
154199101|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199102|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154199103|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154199104|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199105|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199106|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154199107|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
153526500|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154199108|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199109|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199110|NCT04007003|Insulin|insulin|mesh-list
154199111|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154199112|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199113|NCT00364533|Oxycodone|oxycodone|mesh-list
154199114|NCT00364533|Tapentadol|tapentadol|mesh-list
154199115|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154199116|NCT00364533|Narcotics|narcotics|mesh-ancestor
154199124|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154199125|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199126|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154199127|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199128|NCT01047423|Simvastatin|simvastatin|mesh-list
154199129|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154199130|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154199131|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
154199132|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199133|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154199135|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199187|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199188|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154199189|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154199190|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199191|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199256|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
154199257|NCT00988715|Fludarabine|fludarabine|mesh-list
154199258|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
154199259|NCT00988715|Cyclosporins|cyclosporins|mesh-list
154199260|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199261|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154199262|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
154199263|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199264|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199265|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
154199266|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199267|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526693|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199268|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
154199269|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199270|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
154199271|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199272|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154199273|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154199274|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154199275|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
154199276|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199277|NCT03975166|Fluticasone|fluticasone|mesh-list
154199278|NCT03975166|Xhance|xhance|mesh-list
154199279|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154199280|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154199281|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154199305|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199306|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154199307|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154199309|NCT00379899|Vitamin D|vitamin d|mesh-list
154199310|NCT00379899|Cinacalcet|cinacalcet|mesh-list
154199311|NCT00379899|Vitamins|vitamins|mesh-ancestor
154199312|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
154199313|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199314|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154199315|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154199316|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154199317|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
154199318|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199319|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
154199320|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154199321|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154199322|NCT02535039|Prednisolone|prednisolone|mesh-list
154199323|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
154199324|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154199325|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
154199358|NCT00363051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154199359|NCT00363051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154199360|NCT00363051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199361|NCT00363051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199362|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199363|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
154199364|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199365|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199366|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154199367|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154199368|NCT00379353|Thalidomide|thalidomide|mesh-list
154199369|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199370|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
154199380|NCT01047657|Orlistat|orlistat|mesh-list
154199418|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154199419|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154199420|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
154199421|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199422|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154199423|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
154199424|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
154199425|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
154199426|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154199427|NCT02534571|Coagulants|coagulants|mesh-ancestor
154199428|NCT00457002|Enoxaparin|enoxaparin|mesh-list
154199429|NCT00457002|Apixaban|apixaban|mesh-list
154199430|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
154199431|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154199432|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154199433|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199434|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154199435|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
154199436|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154199437|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
154199438|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199439|NCT00362115|Olmesartan|olmesartan|mesh-list
154199440|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154199441|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154199442|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154199443|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154199444|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199445|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
154199446|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154199447|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154199448|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
154199463|NCT03975010|Naltrexone|naltrexone|mesh-list
154199464|NCT03975010|Buprenorphine|buprenorphine|mesh-list
154199465|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154199466|NCT03975010|Narcotics|narcotics|mesh-ancestor
154199467|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199468|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199469|NCT03975010|Analgesics|analgesics|mesh-ancestor
154199470|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
154199471|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199472|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154199473|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154199474|NCT01016990|Valproic Acid|valproic acid|mesh-list
154199527|NCT01029522|Atorvastatin|atorvastatin|mesh-list
154199528|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154199529|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154199530|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
154199531|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199532|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154199533|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154199534|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199535|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
154199536|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154199537|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154199538|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154199539|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154199540|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199541|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
154199542|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199543|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199544|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154199545|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199546|NCT01565772|Etoposide|etoposide|mesh-list
154199547|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199548|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154199549|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154199550|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154199551|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199552|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199553|NCT00456300|Exenatide|exenatide|mesh-list
154199572|NCT00267202|Immunomodulating Agents|immunomodulating agents|mesh-list
154199573|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
154199574|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199575|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154199576|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154199577|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
154199578|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
154199579|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154199580|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154199581|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199582|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
154199583|NCT01067638|Coagulants|coagulants|mesh-ancestor
154199584|NCT00267046|Doxorubicin|doxorubicin|mesh-list
154199585|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154199586|NCT00267046|Vincristine|vincristine|mesh-list
154199587|NCT00267046|Ifosfamide|ifosfamide|mesh-list
154199588|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199589|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154199590|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153527191|NCT01469988|Hormones|hormones|mesh-ancestor
154199591|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154199592|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199607|NCT00286468|Alogliptin|alogliptin|mesh-list
154199627|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199628|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154199629|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199630|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199631|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
154199632|NCT01019174|Lenalidomide|lenalidomide|mesh-list
154199633|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199634|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
154199635|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199636|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199637|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154199638|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
154199640|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199689|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199690|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199691|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199692|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199693|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
154199694|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199695|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
154199696|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199697|NCT00286234|Niacin|niacin|mesh-list
154199698|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
154199699|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154199700|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
154199701|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199702|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154199703|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
154199704|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
154199705|NCT00286234|Vitamins|vitamins|mesh-ancestor
154199706|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
154199707|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199708|NCT01019408|Chloroquine|chloroquine|mesh-list
154199709|NCT01019408|Amebicides|amebicides|mesh-ancestor
154199710|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154199711|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154199712|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199713|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
154199714|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199715|NCT01067950|Pancrelipase|pancrelipase|mesh-list
154199716|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154199717|NCT00445848|Bevacizumab|bevacizumab|mesh-list
154199718|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154199719|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154199720|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199721|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154199722|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154199723|NCT00445848|Growth Substances|growth substances|mesh-ancestor
154199724|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199725|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
153527312|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153463004|NCT03828474|Diuretics|diuretics|mesh-ancestor
154199727|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154199728|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199729|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199730|NCT00286156|Sirolimus|sirolimus|mesh-list
154199731|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199732|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199733|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154199734|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199735|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
154199736|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199737|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
154199738|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199739|NCT00455520|Tapentadol|tapentadol|mesh-list
154199740|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154199741|NCT00455520|Narcotics|narcotics|mesh-ancestor
154199742|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199743|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199744|NCT00455520|Analgesics|analgesics|mesh-ancestor
154199745|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
154199746|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199747|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154199748|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154199749|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154199751|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
154199778|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199779|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154199780|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
154199781|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199782|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199783|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154199784|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154199785|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154199845|NCT00292942|Diuretics|diuretics|mesh-ancestor
154199846|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
154199847|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199848|NCT00483938|Interferons|interferons|mesh-list
154199849|NCT00483938|Ribavirin|ribavirin|mesh-list
154199850|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
154199851|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
154199852|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154199853|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199854|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
154199855|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199856|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
154199857|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199858|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
154199907|NCT00369681|Doxorubicin|doxorubicin|mesh-list
154199908|NCT00369681|Dacarbazine|dacarbazine|mesh-list
153527374|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
154199909|NCT00369681|Bleomycin|bleomycin|mesh-list
154199910|NCT00369681|Vinblastine|vinblastine|mesh-list
154199911|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154199912|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199913|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
154199914|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199915|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199916|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154199932|NCT00488774|Golimumab|golimumab|mesh-list
154199973|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154199974|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
154199975|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527402|NCT01471470|Capecitabine|capecitabine|mesh-list
154199976|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
154199977|NCT02534415|Protective Agents|protective agents|mesh-ancestor
154199978|NCT00488618|Cariprazine|cariprazine|mesh-list
154199979|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154199980|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154199981|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199982|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199983|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154199984|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
154199985|NCT01019642|Vitamin D|vitamin d|mesh-list
154199986|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154199987|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199988|NCT01019642|Vitamins|vitamins|mesh-ancestor
154199989|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
154200029|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200031|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154200032|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
154200033|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200034|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200035|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154200036|NCT00266032|Diuretics|diuretics|mesh-ancestor
154200037|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
154200038|NCT01019798|Docetaxel|docetaxel|mesh-list
154200039|NCT01019798|Sunitinib|sunitinib|mesh-list
154200040|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200041|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
154200042|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
154200043|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
154200088|NCT02532322|Analgesics|analgesics|mesh-ancestor
154200089|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
154200090|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200091|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200092|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
154200093|NCT00445692|Clarithromycin|clarithromycin|mesh-list
154200094|NCT00445692|Dexamethasone|dexamethasone|mesh-list
154200095|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
154200096|NCT00445692|Lenalidomide|lenalidomide|mesh-list
154200097|NCT00445692|Ichthammol|ichthammol|mesh-list
154200098|NCT00445692|BB 1101|bb 1101|mesh-list
154200099|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200100|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
154200101|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
154200102|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200104|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200151|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
154200152|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527407|NCT01471470|Growth Substances|growth substances|mesh-ancestor
154200153|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154200154|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200155|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200157|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154200158|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
154200159|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200160|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200161|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200169|NCT00543569|Alefacept|alefacept|mesh-list
154200213|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154200214|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200215|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
154200217|NCT05586113|Antacids|antacids|mesh-ancestor
154200218|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200219|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200220|NCT00541385|Artesunate|artesunate|mesh-list
154200221|NCT00541385|Lumefantrine|lumefantrine|mesh-list
154200222|NCT00541385|Pyronaridine|pyronaridine|mesh-list
154200223|NCT00541385|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154200224|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
154200225|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154200226|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154200227|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200228|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200229|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
154200230|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
154200231|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154200232|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
154200233|NCT00988949|Spiradoline|spiradoline|mesh-list
154200234|NCT00988949|Analgesics|analgesics|mesh-ancestor
154200235|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
154200236|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200237|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200238|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154200239|NCT00988949|Diuretics|diuretics|mesh-ancestor
154200240|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
154200241|NCT00989027|Oxytocin|oxytocin|mesh-list
154200242|NCT00989027|Carboprost|carboprost|mesh-list
154200243|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
154200244|NCT00989027|Ergonovine|ergonovine|mesh-list
154200245|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
154200260|NCT00986609|Poly ICLC|poly iclc|mesh-list
154200261|NCT00986609|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
154200262|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
154200263|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200264|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
154200265|NCT00986609|Laxatives|laxatives|mesh-ancestor
154200266|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200267|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
154200268|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200269|NCT00986609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154200270|NCT00281320|Asenapine|asenapine|mesh-list
154200271|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154200272|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200273|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200274|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200275|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154200276|NCT00541307|Heparin|heparin|mesh-list
153947236|NCT02877173|Alprostadil|alprostadil|mesh-list
154200277|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
154200278|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154200279|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154200280|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200314|NCT00986765|Enoxaparin|enoxaparin|mesh-list
154200315|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154200316|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154200317|NCT00986765|Analgesics|analgesics|mesh-ancestor
154200318|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
153527465|NCT01471808|Incretins|incretins|mesh-ancestor
154200319|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200320|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200321|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200322|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154200323|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154200324|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154200325|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200326|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154200327|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154200328|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200329|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
154200330|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
154200331|NCT00986843|Irinotecan|irinotecan|mesh-list
154200332|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154200333|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154200334|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200335|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200367|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200368|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154200370|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
154200371|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200372|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200373|NCT00481832|Cyclosporine|cyclosporine|mesh-list
154200374|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
154200375|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
154200376|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154200377|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154200378|NCT00481832|Prednisolone|prednisolone|mesh-list
154200379|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
154200380|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
154200381|NCT00481832|Carmustine|carmustine|mesh-list
154200382|NCT00481832|Rituximab|rituximab|mesh-list
154200383|NCT00481832|Etoposide|etoposide|mesh-list
154200384|NCT00481832|Cyclosporins|cyclosporins|mesh-list
154200385|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154200386|NCT00481832|Lenograstim|lenograstim|mesh-list
154200387|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154200388|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
154200389|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200390|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
154200391|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200392|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154200393|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154200394|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
154200396|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200415|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200416|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200417|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
154200418|NCT00481832|Hormones|hormones|mesh-ancestor
154200419|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527466|NCT01471808|Hormones|hormones|mesh-ancestor
154200420|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154200421|NCT00481832|Protective Agents|protective agents|mesh-ancestor
154200422|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154200423|NCT00481676|Omalizumab|omalizumab|mesh-list
154200424|NCT00481676|Loratadine|loratadine|mesh-list
154200425|NCT00481676|Clemastine|clemastine|mesh-list
154200426|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154200427|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154200428|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154200432|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
154200477|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200478|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200480|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
154200481|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200482|NCT03996434|Cetrorelix|cetrorelix|mesh-list
154200483|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154200484|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
154200487|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
154200544|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154200545|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
154200546|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200547|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154200549|NCT00540449|Rilpivirine|rilpivirine|mesh-list
154200550|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154200551|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154200552|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200610|NCT01070290|Irinotecan|irinotecan|mesh-list
154200611|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154200612|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
154200613|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200614|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200615|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154200616|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154200617|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200618|NCT01070446|Choline|choline|mesh-list
154200619|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
154200620|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154200621|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
154200622|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200623|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200624|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154200625|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
154200626|NCT01050387|Vitamin D|vitamin d|mesh-list
154200627|NCT01050387|Vitamins|vitamins|mesh-ancestor
154200628|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
154200629|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200630|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154200631|NCT01070524|Budesonide|budesonide|mesh-list
154200632|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154200633|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200634|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154200635|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
154200636|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200660|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154200661|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
154200662|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200663|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200664|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154200665|NCT00368979|Dutasteride|dutasteride|mesh-list
154200666|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154200667|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154200668|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200669|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200670|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
154200671|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200672|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200673|NCT00264238|Memantine|memantine|mesh-list
154200674|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154200675|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154200676|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
154200677|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200678|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200679|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200680|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154200681|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154200682|NCT00540293|Atorvastatin|atorvastatin|mesh-list
154200683|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154200684|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154200685|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
154200686|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200687|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154200688|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154200689|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200690|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
154200691|NCT01050621|Vitamins|vitamins|mesh-ancestor
154200692|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
154200697|NCT00359073|Montelukast|montelukast|mesh-list
154200698|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154200699|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
154200700|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154200701|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
154200702|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200703|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200704|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154200705|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154200706|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200707|NCT00368745|Pregabalin|pregabalin|mesh-list
154200708|NCT00368745|Analgesics|analgesics|mesh-ancestor
154200709|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
154200755|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154200756|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
154200757|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200758|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200759|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154200760|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200761|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
154200762|NCT05711693|Bepridil|bepridil|mesh-list
154200763|NCT05711693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154200764|NCT05711693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154200765|NCT05711693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154200766|NCT05711693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154200817|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154200818|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200819|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154200820|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154200821|NCT00264004|Cediranib|cediranib|mesh-list
154200822|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200823|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154200824|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200825|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200826|NCT01069198|Vitamin A|vitamin a|mesh-list
154200827|NCT01069198|Albendazole|albendazole|mesh-list
154200828|NCT01069198|Vitamins|vitamins|mesh-ancestor
154200829|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
154200830|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200831|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200832|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200833|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
154200834|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154200835|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200836|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
154200837|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154200838|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154200839|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
154200840|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
154200841|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
154200842|NCT00368355|Cytarabine|cytarabine|mesh-list
154200843|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
154200844|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
154200845|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200865|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
154200866|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200867|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154200868|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154200869|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154200870|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
154200934|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
154200935|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200936|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200938|NCT02534337|Gemcitabine|gemcitabine|mesh-list
154200939|NCT02534337|Fluorouracil|fluorouracil|mesh-list
154200940|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
154200941|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154200942|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
154200943|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200944|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200945|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200946|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
153527606|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154200996|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
154200997|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200998|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200999|NCT04004117|Fentanyl|fentanyl|mesh-list
154201000|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154201001|NCT04004117|Narcotics|narcotics|mesh-ancestor
154201002|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201003|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201004|NCT04004117|Analgesics|analgesics|mesh-ancestor
154201005|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
154201010|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
154201062|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201063|NCT02404337|Betaine|betaine|mesh-list
154201064|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201065|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
154201066|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154201067|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
154201068|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201069|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154201070|NCT05360147|Metformin|metformin|mesh-list
154201129|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
154201130|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
154201131|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201132|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
154201133|NCT00539981|Coagulants|coagulants|mesh-ancestor
154201134|NCT00990197|Nicotine|nicotine|mesh-list
154201135|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154201136|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
154201137|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201138|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201139|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154201189|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
154201190|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201191|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201192|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201193|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201258|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
154201259|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201260|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
154201261|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154201262|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154201263|NCT00989729|Prednisolone|prednisolone|mesh-list
154201264|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
154201265|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154201266|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
154201267|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201268|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
154201269|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
154201270|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201321|NCT00357903|Etanercept|etanercept|mesh-list
154201322|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154201323|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154201324|NCT00357903|Analgesics|analgesics|mesh-ancestor
154201325|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
154201326|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201327|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201328|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201329|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201330|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201331|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201332|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
154201334|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154201335|NCT01053039|Narcotics|narcotics|mesh-ancestor
154201336|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201338|NCT01053039|Analgesics|analgesics|mesh-ancestor
154201382|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154201383|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154201384|NCT00444600|Ranibizumab|ranibizumab|mesh-list
154201385|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154201386|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154201387|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154201388|NCT00444600|Growth Substances|growth substances|mesh-ancestor
154201389|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201390|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
154201391|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201392|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201393|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
154201394|NCT00444600|Hormones|hormones|mesh-ancestor
154201395|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201396|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201397|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
154201398|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201399|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201400|NCT00443898|Terbinafine|terbinafine|mesh-list
154201401|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
154201402|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201403|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201434|NCT05493683|Immunologic Factors|immunologic factors|mesh-ancestor
154201435|NCT05493683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201436|NCT05440487|Chelating Agents|chelating agents|mesh-list
154201437|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
154201438|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201439|NCT00440310|Talaporfin|talaporfin|mesh-list
154201440|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201441|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154201442|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
154201443|NCT01055847|Aztreonam|aztreonam|mesh-list
154201444|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154201445|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201446|NCT02533791|Vaccines|vaccines|mesh-list
154201447|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
154201448|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201495|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154201496|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201497|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154201498|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154201499|NCT00356889|Growth Substances|growth substances|mesh-ancestor
154201500|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201501|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154201502|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
154201503|NCT00356889|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154201504|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154201505|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201507|NCT03742323|Idelalisib|idelalisib|mesh-list
154201560|NCT04994561|Resveratrol|resveratrol|mesh-list
154201561|NCT04994561|Quercetin|quercetin|mesh-list
154201562|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527674|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
153527685|NCT01473147|Exenatide|exenatide|mesh-list
154201563|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201564|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201565|NCT04994561|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154201566|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154201567|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201568|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201569|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
154201570|NCT04994561|Protective Agents|protective agents|mesh-ancestor
154201571|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154201623|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201624|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
154201625|NCT00347919|Lapatinib|lapatinib|mesh-list
154201626|NCT00347919|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154201627|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154201628|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201629|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201630|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201631|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
154201632|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154201633|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154201642|NCT00356421|Insulin|insulin|mesh-list
154201686|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201687|NCT00443820|Terbinafine|terbinafine|mesh-list
154201688|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
154201689|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201690|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201691|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201692|NCT00438672|Dexamethasone|dexamethasone|mesh-list
154201693|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201694|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
154201695|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
154201696|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201697|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201698|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201699|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
154201744|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154201745|NCT04002635|Estradiol|estradiol|mesh-list
154201746|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154201747|NCT04002635|Progesterone|progesterone|mesh-list
154201748|NCT04002635|Estrogens|estrogens|mesh-ancestor
154201749|NCT04002635|Hormones|hormones|mesh-ancestor
154201750|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201751|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201752|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154201753|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
154201754|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154201755|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154201756|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201757|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153527752|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154201758|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154201804|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154201805|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154201806|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
154201807|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201808|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154201809|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154201810|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
154201811|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154201812|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
154201813|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
154201814|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
154201815|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154201816|NCT00356265|Phenylephrine|phenylephrine|mesh-list
154201817|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
154201818|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154201819|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
154201862|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
154201863|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201864|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201865|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154201866|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154201867|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
154201868|NCT01056627|Valproic Acid|valproic acid|mesh-list
154201869|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
154201870|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201871|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201872|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
154201873|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201874|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201875|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
154201876|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154201877|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201878|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154201879|NCT01053585|Baclofen|baclofen|mesh-list
154201919|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154201920|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201921|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
154201922|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201923|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201924|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154201925|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201926|NCT05355467|Tenofovir|tenofovir|mesh-list
154201927|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
154201984|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201985|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201986|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154201987|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154201988|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201989|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153527775|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527797|NCT01473914|Trace Elements|trace elements|mesh-ancestor
154201990|NCT01057329|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154201991|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154201992|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154201993|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201994|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201995|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
154201996|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
154201997|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
154201998|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
154202040|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154202041|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154202042|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154202043|NCT04001855|Acetic Acid|acetic acid|mesh-list
154202044|NCT04001855|Retinol acetate|retinol acetate|mesh-list
154202045|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154202046|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202047|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154202048|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
154202049|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202050|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154202051|NCT04001855|Protective Agents|protective agents|mesh-ancestor
154202052|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202053|NCT00335829|Bevacizumab|bevacizumab|mesh-list
154202054|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202055|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202056|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202057|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202058|NCT00335829|Growth Substances|growth substances|mesh-ancestor
154202059|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202060|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202061|NCT02533011|Heparin|heparin|mesh-list
154202062|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
154202063|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154202064|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154202065|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202066|NCT05262257|Metformin|metformin|mesh-list
154202083|NCT03986385|Apatinib|apatinib|mesh-list
154202088|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202089|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202090|NCT00344019|Atorvastatin|atorvastatin|mesh-list
154202091|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154202092|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154202093|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
153527863|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202094|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202095|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154202096|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154202097|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202098|NCT00535847|Interferons|interferons|mesh-list
154202099|NCT00535847|Ribavirin|ribavirin|mesh-list
154202100|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
154202101|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
154202102|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154202103|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202104|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
154202105|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202106|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
154202107|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202108|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
154202109|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202110|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
154202111|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154202139|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202140|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154202141|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
154202142|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202143|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202144|NCT01060137|Fentanyl|fentanyl|mesh-list
154202145|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154202146|NCT01060137|Narcotics|narcotics|mesh-ancestor
154202147|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202148|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202149|NCT01060137|Analgesics|analgesics|mesh-ancestor
154202150|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
154202151|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949122|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
154202152|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154202153|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154202154|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
154202155|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
154202156|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
154202157|NCT01058109|Calcium|calcium|mesh-list
154202158|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154202189|NCT05343767|Metformin|metformin|mesh-list
154202190|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154202191|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202192|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154202193|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202262|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154202263|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154202264|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202265|NCT00992693|Ribavirin|ribavirin|mesh-list
154202266|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
154202267|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202268|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
154202269|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202270|NCT00992771|Varenicline|varenicline|mesh-list
154202271|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154202272|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154202273|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
154202274|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202275|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202276|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202277|NCT00992849|Bevacizumab|bevacizumab|mesh-list
154202278|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202279|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202280|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202316|NCT00993707|Protective Agents|protective agents|mesh-ancestor
154202317|NCT00473330|Ranibizumab|ranibizumab|mesh-list
154202318|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202319|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202320|NCT00473330|Growth Substances|growth substances|mesh-ancestor
154202321|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202322|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202323|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202324|NCT00416520|Sevelamer|sevelamer|mesh-list
154202325|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
154202326|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
154202327|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202328|NCT00533429|Bevacizumab|bevacizumab|mesh-list
154202329|NCT00533429|Carboplatin|carboplatin|mesh-list
154202330|NCT00533429|Pemetrexed|pemetrexed|mesh-list
154202331|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202332|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202333|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202334|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202335|NCT00533429|Growth Substances|growth substances|mesh-ancestor
154202373|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202374|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
154202375|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154202376|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
154202377|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202378|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
154202379|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202381|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202382|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202383|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154202438|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154202439|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154202440|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202441|NCT00994253|Renin Inhibitors|renin inhibitors|mesh-ancestor
154202442|NCT00994253|Protease Inhibitors|protease inhibitors|mesh-ancestor
154202443|NCT00994253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202444|NCT00338949|Olanzapine|olanzapine|mesh-list
154202445|NCT00338949|Risperidone|risperidone|mesh-list
154202446|NCT00338949|Ziprasidone|ziprasidone|mesh-list
154202448|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
154202502|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153527973|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
154202503|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154202504|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154202505|NCT01058577|Somatostatin|somatostatin|mesh-list
154202507|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202508|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202509|NCT03983889|Midazolam|midazolam|mesh-list
154202510|NCT03983889|Fentanyl|fentanyl|mesh-list
154202511|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
154202512|NCT03983889|Remifentanil|remifentanil|mesh-list
154202513|NCT03983889|Propofol|propofol|mesh-list
154202514|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154202515|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202516|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202564|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202565|NCT00533897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202566|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202567|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154202568|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
154202569|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202570|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154202571|NCT00426660|Maraviroc|maraviroc|mesh-list
154202572|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154202573|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154202574|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202575|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154202576|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154202577|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
154202624|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202625|NCT00324987|Growth Substances|growth substances|mesh-ancestor
154202626|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202627|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202628|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
154202629|NCT00324987|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154202630|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202631|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202632|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202633|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
154202634|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154202636|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
154202686|NCT01055301|Melphalan|melphalan|mesh-list
154202687|NCT01055301|Doxorubicin|doxorubicin|mesh-list
154202688|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154202689|NCT01055301|Etoposide|etoposide|mesh-list
154202690|NCT01055301|Lenalidomide|lenalidomide|mesh-list
154202691|NCT01055301|Bortezomib|bortezomib|mesh-list
154202692|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154202693|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
154202694|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202695|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528006|NCT01475877|Analgesics|analgesics|mesh-ancestor
153528007|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
154202696|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154202697|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
154202698|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202699|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202748|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202749|NCT03987867|Paclitaxel|paclitaxel|mesh-list
154202750|NCT03987867|Carboplatin|carboplatin|mesh-list
154202751|NCT03987867|Pemetrexed|pemetrexed|mesh-list
154202752|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154202753|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154202754|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202755|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
154202756|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
154202757|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
154202758|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202759|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202760|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154202761|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154202763|NCT00532493|Prazosin|prazosin|mesh-list
154202806|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202807|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202808|NCT00997061|Topotecan|topotecan|mesh-list
154202809|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154202810|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154202811|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202812|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202813|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202814|NCT00351819|Testosterone|testosterone|mesh-list
154202815|NCT00351819|Androgens|androgens|mesh-ancestor
154202816|NCT00351819|Hormones|hormones|mesh-ancestor
154202817|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202818|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202819|NCT00998933|Testosterone|testosterone|mesh-list
154202864|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
154202865|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154202866|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202867|NCT00997607|Vaccines|vaccines|mesh-list
154202868|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
154202869|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202870|NCT00997685|Capecitabine|capecitabine|mesh-list
154202871|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
154202872|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154202873|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
154202919|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154202920|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154202921|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154202922|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202924|NCT01004237|Pravastatin|pravastatin|mesh-list
154202925|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153528075|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
153528076|NCT01476358|Vitamins|vitamins|mesh-ancestor
153528079|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
154202926|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154202927|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154202928|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202929|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154202930|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154202931|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
154202932|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154202933|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154202934|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202935|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154202973|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202974|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202975|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202976|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154202977|NCT01006031|Interferons|interferons|mesh-list
154202978|NCT01006031|Ribavirin|ribavirin|mesh-list
154202979|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
154202980|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
154202981|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154202982|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202983|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
154202984|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202985|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
154202986|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202987|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
154202988|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202989|NCT01006187|Lidocaine|lidocaine|mesh-list
154202990|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
154202991|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
154202992|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202993|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202994|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
154202995|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202996|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154202997|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154202998|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153539934|NCT01536301|Oxycodone|oxycodone|mesh-list
154203021|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203022|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203024|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154203025|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
154203026|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154203027|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154203028|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154203029|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154203030|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
154203084|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154203085|NCT00999791|Growth Substances|growth substances|mesh-ancestor
154203086|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203087|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
154203088|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154203089|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154203090|NCT00999791|Analgesics|analgesics|mesh-ancestor
154203091|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
153528118|NCT01476592|Resveratrol|resveratrol|mesh-list
154203092|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203093|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203094|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154203095|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154203096|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203097|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203098|NCT00999869|Triamcinolone|triamcinolone|mesh-list
154203099|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154203142|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154203143|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203144|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154203145|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
153528136|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153528137|NCT01476774|Narcotics|narcotics|mesh-ancestor
154203147|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154203148|NCT01009073|Navitoclax|navitoclax|mesh-list
154203149|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154203150|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154203151|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203210|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154203211|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203212|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203213|NCT01003613|Tranilast|tranilast|mesh-list
154203214|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154203215|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154203216|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154203217|NCT01003613|Analgesics|analgesics|mesh-ancestor
154203218|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
154203219|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203220|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203273|NCT00486902|Ketamine|ketamine|mesh-list
154203274|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
154203275|NCT00486902|Analgesics|analgesics|mesh-ancestor
154203276|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
154203277|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203278|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203279|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154203280|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154203281|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
154203282|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
154203283|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154203285|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154203336|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203337|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154203338|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
153950320|NCT01717586|Pravastatin|pravastatin|mesh-list
154203339|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
154203341|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154203342|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203343|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203344|NCT00321711|Azacitidine|azacitidine|mesh-list
154203345|NCT00321711|Decitabine|decitabine|mesh-list
154203346|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154203347|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
154203348|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203349|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203350|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203351|NCT00486044|Simvastatin|simvastatin|mesh-list
154203352|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154203353|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154203354|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
154203355|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203356|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154203357|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154203387|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154203388|NCT01022528|Dexamethasone|dexamethasone|mesh-list
154203389|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
154203390|NCT01022528|BB 1101|bb 1101|mesh-list
154203391|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203392|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
154203393|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
154203394|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203395|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203396|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154203397|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
154203398|NCT01022528|Hormones|hormones|mesh-ancestor
154203399|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203400|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154203401|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203402|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
154203403|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203447|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203448|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154203449|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154203450|NCT01021592|Bortezomib|bortezomib|mesh-list
154203451|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203452|NCT00435162|Valsartan|valsartan|mesh-list
154203453|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154203454|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154203455|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154203456|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203457|NCT03836664|Timolol|timolol|mesh-list
154203458|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154203459|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154203460|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154203461|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154203462|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
154203463|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203502|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528200|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203503|NCT00424008|Fluticasone|fluticasone|mesh-list
154203504|NCT00424008|Xhance|xhance|mesh-list
154203505|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
154203506|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
154203507|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154203508|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154203509|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203510|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154203511|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
154203512|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203513|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203514|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154203515|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
154203516|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
154203517|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154203560|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203561|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
154203562|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203563|NCT01038024|Antioxidants|antioxidants|mesh-list
154203564|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203565|NCT01038024|Protective Agents|protective agents|mesh-ancestor
154203566|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203628|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154203629|NCT01025570|Gemcitabine|gemcitabine|mesh-list
154203630|NCT01025570|Bosutinib|bosutinib|mesh-list
154203631|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154203632|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
154203633|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203634|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203635|NCT01025570|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203636|NCT01025570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203637|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203638|NCT03983876|Adalimumab|adalimumab|mesh-list
154203639|NCT03983876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154203640|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203641|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154203642|NCT00327015|Metformin|metformin|mesh-list
154203643|NCT00327015|Pioglitazone|pioglitazone|mesh-list
154203644|NCT00327015|Saxagliptin|saxagliptin|mesh-list
154203645|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154203646|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203647|NCT00327015|Incretins|incretins|mesh-ancestor
154203648|NCT00327015|Hormones|hormones|mesh-ancestor
154203649|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203682|NCT00433836|Enalapril|enalapril|mesh-list
154203683|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154203684|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154203685|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154203686|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203687|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154203688|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
154203689|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203690|NCT01022918|Bevacizumab|bevacizumab|mesh-list
154203691|NCT01022918|Temozolomide|temozolomide|mesh-list
154203692|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154203693|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203741|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154203742|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154203743|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203744|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
154203745|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203747|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
154203748|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203749|NCT00452348|Fluticasone|fluticasone|mesh-list
154203750|NCT00452348|Xhance|xhance|mesh-list
154203751|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154203752|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154203753|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203754|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154203755|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
154203756|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203757|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203758|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154203759|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
154203760|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
154203761|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154203762|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154203763|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154203764|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154203791|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
154203793|NCT00320385|Lapatinib|lapatinib|mesh-list
154203794|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154203795|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203796|NCT00320385|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203797|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203798|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528248|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528249|NCT01477294|Caffeine|caffeine|mesh-list
154203799|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203800|NCT00309777|Simvastatin|simvastatin|mesh-list
154203801|NCT00309777|Pitavastatin|pitavastatin|mesh-list
154203802|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154203803|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154203804|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
154203805|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203806|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154203807|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154203808|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203809|NCT00325143|Edetic Acid|edetic acid|mesh-list
154203810|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
154203811|NCT00325143|Antidotes|antidotes|mesh-ancestor
154203812|NCT00325143|Protective Agents|protective agents|mesh-ancestor
154203813|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203820|NCT00319839|Paclitaxel|paclitaxel|mesh-list
154203843|NCT00319449|Atorvastatin|atorvastatin|mesh-list
154203844|NCT00319449|Ezetimibe|ezetimibe|mesh-list
154203845|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154203846|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154203847|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
154203848|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203849|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154203850|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154203851|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203852|NCT00308685|Albuterol|albuterol|mesh-list
154203853|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154203854|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
154203855|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203856|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203857|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154203858|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
154203859|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
154203860|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154203861|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154203862|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154203863|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154203864|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
154203865|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203866|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203867|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154203868|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203869|NCT03981081|Prednisone|prednisone|mesh-list
154203870|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203871|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
154203872|NCT03981081|Hormones|hormones|mesh-ancestor
154203873|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203874|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203875|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154203876|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203882|NCT00316719|Adefovir|adefovir|mesh-list
154203883|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154203884|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154203885|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154203886|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203887|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203888|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
154203889|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203890|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154203891|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154203892|NCT01065987|Tizanidine|tizanidine|mesh-list
154203893|NCT01065987|Analgesics|analgesics|mesh-ancestor
154203894|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
154203895|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203896|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203897|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
154203898|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154203899|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154203900|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
154203901|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
154203902|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154203903|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154203904|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154203905|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
154203906|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203907|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203908|NCT01064115|Cetirizine|cetirizine|mesh-list
154203909|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154203910|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154203926|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203927|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154203928|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154203929|NCT01032798|Mepivacaine|mepivacaine|mesh-list
154203930|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
154203931|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
154203932|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154203933|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203934|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
154203935|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203936|NCT00413244|Testosterone|testosterone|mesh-list
154203937|NCT00413244|Androgens|androgens|mesh-ancestor
154203938|NCT00413244|Hormones|hormones|mesh-ancestor
154203939|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203940|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203941|NCT01033032|Amrubicin|amrubicin|mesh-list
154203942|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203943|NCT01038570|Oxytocin|oxytocin|mesh-list
154203944|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
154203945|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154203980|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203981|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154203982|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
154203983|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203984|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203985|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154203986|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154203987|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203988|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203989|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154203990|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154203991|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203992|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
154203993|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203995|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154203996|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
154203997|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154203998|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203999|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154204000|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204001|NCT01025882|Gemcitabine|gemcitabine|mesh-list
154204002|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204003|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
154204005|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204025|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204026|NCT00432276|Metformin|metformin|mesh-list
154204027|NCT00432276|Pioglitazone|pioglitazone|mesh-list
154204028|NCT00432276|Alogliptin|alogliptin|mesh-list
154204029|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154204030|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204031|NCT00432276|Incretins|incretins|mesh-ancestor
154204032|NCT00432276|Hormones|hormones|mesh-ancestor
154204033|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204034|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154204035|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
154204036|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204037|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204038|NCT01027520|Monensin|monensin|mesh-list
154204039|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
154204040|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204084|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
154204085|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154204086|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154204087|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
154204088|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204089|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
154204090|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154204091|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154204093|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204094|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154204095|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154204096|NCT00443534|Growth Substances|growth substances|mesh-ancestor
154204097|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204098|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
154204099|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154204100|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204139|NCT01026350|Antibodies|antibodies|mesh-list
154204140|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
154204141|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204142|NCT01026428|Levodopa|levodopa|mesh-list
154204143|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154204144|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154204145|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
154204146|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204147|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204148|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204149|NCT00308139|Exenatide|exenatide|mesh-list
154204150|NCT00308139|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154204151|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154204152|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153951126|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
154204153|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154204154|NCT00308139|Incretins|incretins|mesh-ancestor
154204155|NCT00308139|Hormones|hormones|mesh-ancestor
154204156|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204157|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154204158|NCT00459056|Carvedilol|carvedilol|mesh-list
154204159|NCT00459056|Lisinopril|lisinopril|mesh-list
154204160|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154204161|NCT00459056|Diuretics|diuretics|mesh-ancestor
154204162|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
154204163|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204164|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154204165|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204166|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204167|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154204168|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154204169|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
154204170|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204171|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
154204172|NCT00459056|Protective Agents|protective agents|mesh-ancestor
154204177|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154204178|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154204179|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
154204180|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204181|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154204182|NCT01062477|Vaccines|vaccines|mesh-list
154204183|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
154204184|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204185|NCT00431964|Azithromycin|azithromycin|mesh-list
154204186|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154204187|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204188|NCT00431496|Cinacalcet|cinacalcet|mesh-list
154204189|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154204239|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154204240|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204241|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154204242|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
154204244|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204245|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154204246|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154204247|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
154204248|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204249|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
154204250|NCT00450866|Epothilones|epothilones|mesh-list
154204251|NCT00450866|Epothilone B|epothilone b|mesh-list
154204252|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
154204300|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154204301|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204302|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154204303|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204305|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154204306|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
154204307|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204308|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154204309|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154204310|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204311|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204312|NCT00441584|Ribavirin|ribavirin|mesh-list
154204313|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154204314|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
154204315|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
154204316|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204317|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
154204318|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528881|NCT01481194|Doxorubicin|doxorubicin|mesh-list
154204319|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
154204320|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204321|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
154204322|NCT00430716|Citric Acid|citric acid|mesh-list
154204323|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
154204324|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
154204351|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204352|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154204353|NCT00430638|Olmesartan|olmesartan|mesh-list
154204354|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154204355|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154204356|NCT00430638|Diuretics|diuretics|mesh-ancestor
154204357|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
154204358|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204359|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154204360|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204361|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204362|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154204363|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154204364|NCT01038882|Midazolam|midazolam|mesh-list
154204409|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
154204410|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204411|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204412|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154204413|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204414|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154204415|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204416|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204418|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
154204419|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154204420|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
154204421|NCT01024322|Hormones|hormones|mesh-ancestor
154204422|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204423|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154204466|NCT00428844|Vancomycin|vancomycin|mesh-list
154204467|NCT00428844|Daptomycin|daptomycin|mesh-list
154204468|NCT00428844|Teicoplanin|teicoplanin|mesh-list
154204469|NCT00428844|Floxacillin|floxacillin|mesh-list
154204470|NCT00428844|Oxacillin|oxacillin|mesh-list
154204471|NCT00428844|Nafcillin|nafcillin|mesh-list
154204472|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154204473|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204474|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154204475|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
154204476|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529097|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
154204477|NCT01039194|Galantamine|galantamine|mesh-list
154204478|NCT01039194|BMS 708163|bms 708163|mesh-list
154204479|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154204480|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204481|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204482|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
154204528|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204529|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
154204530|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
154204531|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204532|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204533|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204534|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
154204535|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154204536|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154204537|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204539|NCT00418938|Protective Agents|protective agents|mesh-ancestor
154204540|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
154204541|NCT00418938|Vitamins|vitamins|mesh-ancestor
154204542|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
154204543|NCT00448760|Leucovorin|leucovorin|mesh-list
154204544|NCT00448760|Docetaxel|docetaxel|mesh-list
154204545|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
154204546|NCT00448760|Floxuridine|floxuridine|mesh-list
154204547|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204548|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
154204549|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204550|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
154204551|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204552|NCT00448760|Antidotes|antidotes|mesh-ancestor
154204553|NCT00448760|Protective Agents|protective agents|mesh-ancestor
154204582|NCT01035450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204583|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204584|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
154204585|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204586|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204587|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154204588|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204589|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154204590|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
154204591|NCT01035528|Metformin|metformin|mesh-list
154204592|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
154204593|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154204594|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204595|NCT01033656|Methotrexate|methotrexate|mesh-list
154204596|NCT01033656|Azathioprine|azathioprine|mesh-list
154204597|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154204598|NCT01033656|Leflunomide|leflunomide|mesh-list
154204639|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154204640|NCT00448136|Growth Substances|growth substances|mesh-ancestor
154204641|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204642|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
154204643|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154204644|NCT00447902|Ritonavir|ritonavir|mesh-list
154204645|NCT00447902|Tipranavir|tipranavir|mesh-list
154204646|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154204647|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154204648|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
154204649|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204650|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204651|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154204652|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154204701|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154204702|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154204703|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154204704|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204705|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204706|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204707|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154204708|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154204709|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
154204713|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
154204766|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204767|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154204768|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154204770|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
154204771|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204772|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204773|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154204774|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154204775|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204776|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154204777|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154204778|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204779|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
154204780|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
154204781|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154204782|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154204783|NCT00405756|Growth Substances|growth substances|mesh-ancestor
154204784|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
154204785|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154204786|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
154204819|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
154204820|NCT00446030|Bevacizumab|bevacizumab|mesh-list
154204821|NCT00446030|Carboplatin|carboplatin|mesh-list
154204822|NCT00446030|Docetaxel|docetaxel|mesh-list
154204823|NCT00446030|Doxorubicin|doxorubicin|mesh-list
154204824|NCT00446030|Trastuzumab|trastuzumab|mesh-list
154204825|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204826|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
154204827|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204828|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204829|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154204830|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
154204831|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204855|NCT01036854|Ondansetron|ondansetron|mesh-list
154204882|NCT00439556|Etoposide|etoposide|mesh-list
154204883|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
154204884|NCT00439556|Bortezomib|bortezomib|mesh-list
154204885|NCT00439556|Melphalan|melphalan|mesh-list
154204886|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
154204887|NCT00439556|Carmustine|carmustine|mesh-list
154204888|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
154204889|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154204890|NCT00439556|Antibodies|antibodies|mesh-list
154204891|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
154204892|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154204893|NCT00439556|Lenograstim|lenograstim|mesh-list
154204894|NCT00439556|Tacrolimus|tacrolimus|mesh-list
154204895|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
154204896|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154204897|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
154204898|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204899|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204900|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204901|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154204902|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
154204903|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154204940|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154204941|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204943|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204944|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
154204945|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204946|NCT00445328|Heparin|heparin|mesh-list
154204947|NCT00445328|Calcium heparin|calcium heparin|mesh-list
154204948|NCT00445328|Dalteparin|dalteparin|mesh-list
154204949|NCT00445328|Tinzaparin|tinzaparin|mesh-list
154204950|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154204951|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
154204952|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154204953|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154204954|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204955|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
154204956|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
154204957|NCT00455312|Fludarabine|fludarabine|mesh-list
154204958|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
154204959|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
154204960|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154204961|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204962|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
154204963|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204964|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204965|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154204966|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
154204967|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204968|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204986|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
154204987|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204988|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204989|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154204990|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
154204991|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204992|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204993|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154204994|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
154204995|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204996|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154204997|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
154204998|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154204999|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
154205000|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205001|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154205002|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154205003|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154205004|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154205005|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154205006|NCT01024712|Paclitaxel|paclitaxel|mesh-list
153529486|NCT01485692|Midazolam|midazolam|mesh-list
154205007|NCT01024712|Carboplatin|carboplatin|mesh-list
154205008|NCT01024712|Gefitinib|gefitinib|mesh-list
154205009|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154205010|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205018|NCT01323452|Entecavir|entecavir|mesh-list
154205034|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154205035|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205036|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154205037|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
154205038|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
154205039|NCT00444626|Protective Agents|protective agents|mesh-ancestor
154205040|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154205041|NCT01024868|Ropivacaine|ropivacaine|mesh-list
154205042|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
154205043|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
154205044|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154205045|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205046|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
154205047|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205048|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
154205050|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
154205094|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
154205095|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205096|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205097|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154205098|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154205099|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
154205100|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205101|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154205102|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154205103|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154205104|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154205106|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154205157|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154205158|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205159|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154205160|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205161|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
154205162|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
154205163|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
154205164|NCT00416624|Hematinics|hematinics|mesh-ancestor
154205165|NCT00262600|Warfarin|warfarin|mesh-list
154205166|NCT00262600|Dabigatran|dabigatran|mesh-list
154205167|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
154205168|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
154205169|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154205170|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
154205171|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205172|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205173|NCT00409578|Valsartan|valsartan|mesh-list
154205174|NCT00409578|Aliskiren|aliskiren|mesh-list
154205175|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154205217|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
154205218|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205219|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205220|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
154205221|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205222|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153529596|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205223|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154205224|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
154205225|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205280|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
154205281|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205282|NCT01722812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154205283|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154205284|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154205285|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
154205286|NCT00250432|Caspofungin|caspofungin|mesh-list
154205287|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
154205288|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205289|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205290|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205291|NCT00249808|Antibodies|antibodies|mesh-list
154205292|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154205293|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
154205294|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205295|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
154205296|NCT00278512|Fludarabine|fludarabine|mesh-list
154205297|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
154205298|NCT00278512|Tacrolimus|tacrolimus|mesh-list
154205299|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
154205300|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205301|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
154205302|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205303|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205304|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154205305|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
154205306|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205307|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205308|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154205309|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154205310|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205311|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205312|NCT01072240|Rituximab|rituximab|mesh-list
154205313|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205319|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154205320|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154205321|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205322|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154205323|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154205324|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
154205325|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205326|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154205327|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154205328|NCT00427700|Clomiphene|clomiphene|mesh-list
154205329|NCT00427700|Enclomiphene|enclomiphene|mesh-list
154205330|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
154205331|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154205332|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
154205333|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205334|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205335|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154205336|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
154205337|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154205338|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154205339|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154205340|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154205341|NCT01324076|Doxorubicin|doxorubicin|mesh-list
154205342|NCT01324076|Sorafenib|sorafenib|mesh-list
154205343|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154205344|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205345|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154205346|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154205347|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205348|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205350|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
154205362|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154205363|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205364|NCT00434954|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154205365|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154205366|NCT00434954|Incretins|incretins|mesh-ancestor
154205367|NCT00434954|Hormones|hormones|mesh-ancestor
154205368|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205369|NCT00276484|Atorvastatin|atorvastatin|mesh-list
154205370|NCT00276484|Ezetimibe|ezetimibe|mesh-list
154205371|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154205372|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154205373|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
154205423|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205425|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
154205426|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
154205427|NCT00276016|Ephedrine|ephedrine|mesh-list
154205428|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154205429|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
154205430|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
154205431|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205432|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205433|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
154205434|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154205435|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
154205436|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
154205437|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154205438|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154205439|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154205440|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154205441|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205479|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154205480|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154205481|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
154205482|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205483|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205484|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205485|NCT00434252|Paclitaxel|paclitaxel|mesh-list
154205486|NCT00434252|Bevacizumab|bevacizumab|mesh-list
154205487|NCT00434252|Carboplatin|carboplatin|mesh-list
154205488|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154205489|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205490|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
154205491|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
154205492|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
154205493|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205494|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205495|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153529792|NCT01487096|Teriflunomide|teriflunomide|mesh-list
154205496|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154205497|NCT00434252|Growth Substances|growth substances|mesh-ancestor
154205498|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205499|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
154205500|NCT00425750|Docetaxel|docetaxel|mesh-list
154205501|NCT00425750|Bortezomib|bortezomib|mesh-list
154205502|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205503|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
154205504|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
154205505|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
154205506|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205523|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154205524|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529915|NCT01488227|Vitamins|vitamins|mesh-list
154205525|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205526|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205527|NCT00408876|Analgesics|analgesics|mesh-ancestor
154205528|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
154205529|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205530|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
154205531|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154205532|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
154205534|NCT00240994|Sirolimus|sirolimus|mesh-list
154205586|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154205587|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154205588|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
154205589|NCT00425438|Prednisolone|prednisolone|mesh-list
154205590|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
154205591|NCT00425438|Azathioprine|azathioprine|mesh-list
154205592|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205593|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
154205594|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205595|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205596|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154205597|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
154205598|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205599|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205600|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154205601|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154205602|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154205603|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
154205604|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154205605|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205606|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205607|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154205608|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
154205609|NCT00425438|Hormones|hormones|mesh-ancestor
154205610|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205612|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
154205634|NCT01323608|Vitamins|vitamins|mesh-ancestor
154205635|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
154205636|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205637|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154205638|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154205639|NCT00275002|Temozolomide|temozolomide|mesh-list
154205640|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
154205641|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154205642|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
154205643|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205644|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205645|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205646|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
154205647|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154205648|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
154205649|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154205650|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205651|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153530051|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154205652|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154205653|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154205655|NCT00393042|Adderall|adderall|mesh-list
154205656|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
154205657|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154205658|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205659|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
154205660|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
154205661|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205662|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
154205663|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205664|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205665|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
154205666|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154205667|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154205668|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154205672|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154205673|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205674|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
154205675|NCT01040286|Analgesics|analgesics|mesh-ancestor
154205676|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
154205677|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205678|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205679|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154205680|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154205681|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154205682|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205683|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154205684|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205685|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205686|NCT01041378|Dexamethasone|dexamethasone|mesh-list
154205687|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154205688|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
154205689|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
154205690|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205691|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205692|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154205693|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
154205694|NCT01041378|Hormones|hormones|mesh-ancestor
154205695|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205696|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154205697|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205698|NCT03546192|Vaccines|vaccines|mesh-list
154205699|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
154205700|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205701|NCT01043952|Remifentanil|remifentanil|mesh-list
154205702|NCT01043952|Propofol|propofol|mesh-list
154205703|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154205704|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154205705|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205712|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
154205713|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205714|NCT00274846|Aldesleukin|aldesleukin|mesh-list
154205715|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
154205716|NCT00274846|Fludarabine|fludarabine|mesh-list
154205717|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
154205718|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205719|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
154205720|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205721|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205722|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154205723|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
154205729|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154205776|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205777|NCT01073800|Atorvastatin|atorvastatin|mesh-list
154205778|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154205779|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154205780|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
154205781|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205782|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154205783|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154205784|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205785|NCT01037660|Metformin|metformin|mesh-list
154205786|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154205787|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205788|NCT00236080|Modafinil|modafinil|mesh-list
154205837|NCT00408408|Docetaxel|docetaxel|mesh-list
154205838|NCT00408408|Doxorubicin|doxorubicin|mesh-list
154205839|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154205840|NCT00408408|Capecitabine|capecitabine|mesh-list
154205841|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205842|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
154205843|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205844|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205845|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154205846|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
154205847|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205848|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205849|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154205850|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205851|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154205852|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154205853|NCT00408408|Growth Substances|growth substances|mesh-ancestor
154205854|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
154205855|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154205856|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
154205857|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
154205858|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
154205859|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
154205860|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154205861|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154205862|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154205863|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205864|NCT00414050|Vaccines|vaccines|mesh-list
154205865|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
154205866|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205867|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
154205868|NCT03973840|Testosterone|testosterone|mesh-list
154205869|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
154205879|NCT00413972|Simvastatin|simvastatin|mesh-list
154205880|NCT00413972|Ezetimibe|ezetimibe|mesh-list
154205881|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154205882|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154205883|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
154205884|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205885|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154205886|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154205887|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205888|NCT00259012|Pantoprazole|pantoprazole|mesh-list
154205889|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154205890|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154205891|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154205892|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205893|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205894|NCT01044186|Deferasirox|deferasirox|mesh-list
154205895|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154205899|NCT00209170|Escitalopram|escitalopram|mesh-list
154205934|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205935|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154205936|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154205937|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154205938|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154205939|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
154205940|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154205941|NCT01581814|Estrogens|estrogens|mesh-ancestor
154205943|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205944|NCT00407550|Gemcitabine|gemcitabine|mesh-list
154205945|NCT00407550|Pemetrexed|pemetrexed|mesh-list
154205946|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154205996|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
154205997|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154205998|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
154205999|NCT00406692|Zonisamide|zonisamide|mesh-list
154206000|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
154206001|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154206002|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206003|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206004|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154206005|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206006|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
154206007|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206008|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
154206009|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154206010|NCT00004494|Protective Agents|protective agents|mesh-ancestor
154206011|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206012|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
154206013|NCT00315705|Etoposide|etoposide|mesh-list
154206014|NCT00315705|Clofarabine|clofarabine|mesh-list
154206015|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153952996|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
154206052|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154206054|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
154206055|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
154206056|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
154206057|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206058|NCT00307047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154206059|NCT00307047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154206060|NCT00307047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206061|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206062|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
154206063|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206064|NCT01066377|Sulfalene|sulfalene|mesh-list
154206065|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206066|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154206067|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
154206068|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154206069|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154206070|NCT00306891|Cediranib|cediranib|mesh-list
154206071|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206072|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154206073|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206074|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206075|NCT03980847|Alendronate|alendronate|mesh-list
154206076|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154206077|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206079|NCT00391872|Ticagrelor|ticagrelor|mesh-list
154206099|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206100|NCT00402324|Valproic Acid|valproic acid|mesh-list
154206101|NCT00402324|Olanzapine|olanzapine|mesh-list
154206102|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
154206103|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
154206104|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206105|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206106|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206107|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154206108|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154206109|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206110|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154206116|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
154206163|NCT00312195|Narcotics|narcotics|mesh-ancestor
154206164|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206165|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206166|NCT00312195|Analgesics|analgesics|mesh-ancestor
154206167|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
154206168|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206169|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154206170|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
154206171|NCT02532777|Prednisone|prednisone|mesh-list
154206172|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
154206228|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206229|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206230|NCT01063101|Fucoidan|fucoidan|mesh-list
154206231|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154206232|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206233|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
154206234|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206235|NCT01066689|Rituximab|rituximab|mesh-list
154206236|NCT01066689|Citric Acid|citric acid|mesh-list
154206237|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
154206238|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206239|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206240|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
154206241|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206242|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206243|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
154206244|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154206245|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
154206246|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
154206247|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206248|NCT00293709|Etanercept|etanercept|mesh-list
154206249|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154206281|NCT03980379|Rituximab|rituximab|mesh-list
154206282|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206283|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206284|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
154206285|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206286|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206287|NCT01064271|Risperidone|risperidone|mesh-list
154206288|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154206289|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
154206290|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206291|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206292|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206293|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154206294|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154206295|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206296|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154206297|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154206298|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
154206299|NCT01066845|Tadalafil|tadalafil|mesh-list
154206300|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
154206301|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154206302|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154206306|NCT01064349|Trastuzumab|trastuzumab|mesh-list
154206332|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154206333|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206334|NCT00290745|Tamoxifen|tamoxifen|mesh-list
154206335|NCT00290745|Letrozole|letrozole|mesh-list
154206336|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206337|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206338|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154206339|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154206340|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206341|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154206342|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
154206343|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206344|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206345|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206346|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154206347|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154206348|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154206349|NCT03980223|Doxycycline|doxycycline|mesh-list
154206350|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154206351|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206352|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
154206385|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
154206386|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154206387|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
154206388|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
154206389|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206390|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206391|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206392|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
154206393|NCT00290589|Hormones|hormones|mesh-ancestor
154206394|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206395|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154206396|NCT00290589|Protective Agents|protective agents|mesh-ancestor
154206397|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206398|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206399|NCT01067547|Iron|iron|mesh-list
154206400|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154206401|NCT01067547|Trace Elements|trace elements|mesh-ancestor
154206402|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
154206403|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206404|NCT01067547|Hematinics|hematinics|mesh-ancestor
154206405|NCT00290511|Dexamethasone|dexamethasone|mesh-list
154206406|NCT00290511|Rituximab|rituximab|mesh-list
154206407|NCT00290511|Fludarabine|fludarabine|mesh-list
154206408|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
154206409|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
154206410|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154206411|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
154206412|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
154206413|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206414|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206415|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206416|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
154206417|NCT00290511|Hormones|hormones|mesh-ancestor
154206418|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206419|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206420|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206421|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206422|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
154206423|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206424|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154206425|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
154206426|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206427|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206428|NCT00290511|Analgesics|analgesics|mesh-ancestor
154206429|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
154206430|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206431|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206432|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206433|NCT00290433|Cytarabine|cytarabine|mesh-list
154206434|NCT00290433|Dexamethasone|dexamethasone|mesh-list
154206435|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
154206436|NCT00290433|Doxorubicin|doxorubicin|mesh-list
154206437|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154206438|NCT00290433|Methotrexate|methotrexate|mesh-list
154206439|NCT00290433|Vincristine|vincristine|mesh-list
154206440|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206441|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
154206442|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206443|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206444|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206445|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
154206446|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206447|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206473|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
154206474|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
154206475|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
154206476|NCT00304083|Doxorubicin|doxorubicin|mesh-list
154206477|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154206478|NCT00304083|Etoposide|etoposide|mesh-list
154206479|NCT00304083|Ifosfamide|ifosfamide|mesh-list
154206480|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154206481|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206482|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206483|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206484|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206485|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206486|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154206487|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206488|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
154206489|NCT01069965|BGP 15|bgp 15|mesh-list
154206494|NCT00391092|Docetaxel|docetaxel|mesh-list
154206532|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206533|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206534|NCT00374322|Lapatinib|lapatinib|mesh-list
154206535|NCT00374322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154206536|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154206537|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206538|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206539|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206540|NCT00303459|Bosentan|bosentan|mesh-list
154206541|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154206542|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154206543|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206544|NCT00289887|Losartan|losartan|mesh-list
154206545|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154206546|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154206547|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154206587|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154206588|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206589|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154206590|NCT00390858|Deferasirox|deferasirox|mesh-list
154206591|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154206592|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
154206593|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
154206594|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206595|NCT00390780|Clotrimazole|clotrimazole|mesh-list
154206596|NCT00390780|Miconazole|miconazole|mesh-list
154206597|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154206598|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206599|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
154206600|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154206601|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154206646|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154206647|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206648|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206649|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206650|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206651|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206652|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206653|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154206654|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
154206655|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154206656|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206658|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154206708|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206709|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
154206710|NCT01046058|Simeprevir|simeprevir|mesh-list
154206711|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
154206712|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206713|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
154206714|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206716|NCT01046214|Bupropion|bupropion|mesh-list
154206740|NCT00387426|Sunitinib|sunitinib|mesh-list
154206773|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
154206774|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206775|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206776|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
154206777|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206778|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154206779|NCT00413660|Tofacitinib|tofacitinib|mesh-list
154206780|NCT00413660|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154206781|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154206782|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206783|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206784|NCT01234532|Anastrozole|anastrozole|mesh-list
154206833|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
154206834|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953812|NCT00652431|Ezetimibe|ezetimibe|mesh-list
154206835|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206837|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154206838|NCT00429494|Leuprolide|leuprolide|mesh-list
154206839|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154206840|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
154206841|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154206842|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206843|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153530902|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154206844|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206845|NCT00429416|Cytarabine|cytarabine|mesh-list
154206846|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
154206847|NCT00429416|Fludarabine|fludarabine|mesh-list
154206848|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
154206849|NCT00429416|Molgramostim|molgramostim|mesh-list
154206850|NCT00429416|Tacrolimus|tacrolimus|mesh-list
154206851|NCT00429416|Sargramostim|sargramostim|mesh-list
154206852|NCT00429416|Mesna|mesna|mesh-list
154206853|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206854|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
154206855|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206870|NCT00429182|Thiotepa|thiotepa|mesh-list
154206889|NCT00429026|Fludarabine|fludarabine|mesh-list
154206890|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206891|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
154206892|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206893|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206894|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206895|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
154206896|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206897|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206898|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154206899|NCT00301821|Prednisone|prednisone|mesh-list
154206900|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
154206901|NCT00301821|Rituximab|rituximab|mesh-list
154206902|NCT00301821|Doxorubicin|doxorubicin|mesh-list
154206903|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154206904|NCT00301821|Vincristine|vincristine|mesh-list
154206905|NCT00301821|Epratuzumab|epratuzumab|mesh-list
154206906|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206907|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
154206908|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153953887|NCT02842125|Nivolumab|nivolumab|mesh-list
154206909|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206910|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206940|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206941|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206942|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
154206943|NCT00372996|Fulvestrant|fulvestrant|mesh-list
154206944|NCT00372996|Exemestane|exemestane|mesh-list
154206945|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206946|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206947|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154206948|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154206949|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
154206950|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206951|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206952|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154206953|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153531191|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206954|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206955|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206956|NCT00399360|Metformin|metformin|mesh-list
154206957|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154206958|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206959|NCT00428948|Tolvaptan|tolvaptan|mesh-list
154206960|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154206961|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206962|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
154206963|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206964|NCT00428792|Methylphenidate|methylphenidate|mesh-list
154206965|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154206966|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206967|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154206968|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154206973|NCT00300885|Paclitaxel|paclitaxel|mesh-list
154206981|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
154206982|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206983|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154206984|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206985|NCT00386334|Eszopiclone|eszopiclone|mesh-list
154206986|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154206987|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206988|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206989|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
154206990|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154206991|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206992|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
154206993|NCT00292227|Rotigotine|rotigotine|mesh-list
154206994|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154206995|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206996|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206997|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206998|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206999|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207000|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207005|NCT00386100|Metformin|metformin|mesh-list
154207034|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207035|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154207036|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154207037|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207038|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
154207039|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207041|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207042|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
154207043|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207044|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153531192|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618946|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207045|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207046|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207093|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154207094|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154207095|NCT00398112|Growth Substances|growth substances|mesh-ancestor
154207096|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207097|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
154207098|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207099|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207100|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207101|NCT01065129|Plerixafor|plerixafor|mesh-list
154207102|NCT01065129|Azacitidine|azacitidine|mesh-list
154207103|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154207104|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
154207105|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207106|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207107|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207108|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154207109|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154207110|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
154207111|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207112|NCT01042314|Donepezil|donepezil|mesh-list
154207113|NCT01042314|BMS 708163|bms 708163|mesh-list
154207114|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154207145|NCT00283803|Protective Agents|protective agents|mesh-ancestor
154207146|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154207147|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207148|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207149|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154207150|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154207151|NCT00283803|Analgesics|analgesics|mesh-ancestor
154207152|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
154207153|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207154|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154207155|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207157|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154207169|NCT01033370|Clevidipine|clevidipine|mesh-list
154207204|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154207205|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154207206|NCT01033526|Analgesics|analgesics|mesh-ancestor
154207207|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
154207208|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207209|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207210|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154207211|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207212|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154207213|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154207214|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207215|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154207216|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154207217|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207218|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
154207219|NCT00397488|Sunitinib|sunitinib|mesh-list
154207220|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207221|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154207222|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154207229|NCT01581411|Plasminogen|plasminogen|mesh-list
154207259|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207260|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154207261|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
154207262|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207263|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207264|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154207265|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207266|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154207267|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154207268|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154207269|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207270|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154207271|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
154207272|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
154207273|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
154207274|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154207275|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
154207276|NCT01324596|Hormones|hormones|mesh-ancestor
154207277|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207278|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154207315|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154207316|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207317|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
154207318|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207319|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
154207320|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207321|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
154207322|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207323|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154207324|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
154207325|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207326|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
154207327|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154207328|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207330|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207331|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
154207332|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207333|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154207334|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207335|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207336|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
154207340|NCT00282087|Gemcitabine|gemcitabine|mesh-list
154207363|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154207364|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
154207365|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207366|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207367|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154207368|NCT00232180|Diuretics|diuretics|mesh-ancestor
154207369|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
154207370|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154207371|NCT01070277|Albendazole|albendazole|mesh-list
154207372|NCT01070277|Tinidazole|tinidazole|mesh-list
154207373|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
154207421|NCT00268983|Iodine|iodine|mesh-list
154207427|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
154207428|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207429|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153954401|NCT00684190|Esomeprazole|esomeprazole|mesh-list
154207430|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154207431|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207432|NCT00268983|Trace Elements|trace elements|mesh-ancestor
154207433|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
154207435|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
154207436|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154207492|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154207493|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154207494|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207495|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207496|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
154207497|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207498|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207499|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154207560|NCT00423332|Cediranib|cediranib|mesh-list
154207561|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207562|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207563|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207564|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207565|NCT00413036|Lenalidomide|lenalidomide|mesh-list
154207566|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
154207567|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207568|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154207569|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154207570|NCT00413036|Growth Substances|growth substances|mesh-ancestor
154207571|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
154207572|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207573|NCT00412958|Plasminogen|plasminogen|mesh-list
154207574|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
154207575|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154207619|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154207620|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207621|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207622|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207623|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
154207624|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
154207625|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207626|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207627|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153531367|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
154207628|NCT00423098|Protective Agents|protective agents|mesh-ancestor
154207629|NCT01042704|Aspirin|aspirin|mesh-list
154207630|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154207631|NCT01042704|Dexamethasone|dexamethasone|mesh-list
154207682|NCT01042782|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154207683|NCT01042782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207684|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207685|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207686|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207687|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
154207688|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207689|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207690|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
154207693|NCT00411788|Sirolimus|sirolimus|mesh-list
154207745|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154207746|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154207747|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
154207748|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207749|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
154207750|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207751|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154207752|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207753|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154207754|NCT01039142|Acitretin|acitretin|mesh-list
154207755|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
154207756|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
154207757|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154207758|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154207759|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154207760|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207761|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207771|NCT00411632|Bexarotene|bexarotene|mesh-list
154207800|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207801|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154207802|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154207803|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207804|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207805|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
154207806|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207807|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
154207808|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
154207809|NCT01047072|Rituximab|rituximab|mesh-list
154207810|NCT01047072|Fludarabine|fludarabine|mesh-list
154207811|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
154207812|NCT01047072|Tacrolimus|tacrolimus|mesh-list
154207813|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207814|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
154207815|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207857|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207858|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154207859|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154207860|NCT01043484|Growth Substances|growth substances|mesh-ancestor
153531463|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
154207861|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207862|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
154207863|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154207864|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
154207865|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207866|NCT00396318|Tenecteplase|tenecteplase|mesh-list
154207867|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154207868|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154207869|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207871|NCT00381888|Fondaparinux|fondaparinux|mesh-list
154207872|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154207873|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
154207878|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
154207915|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207916|NCT00280059|Pregabalin|pregabalin|mesh-list
154207917|NCT00280059|Lamotrigine|lamotrigine|mesh-list
154207918|NCT00280059|Analgesics|analgesics|mesh-ancestor
154207919|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
154207920|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207921|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207922|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
154207923|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154207933|NCT00403130|Paclitaxel|paclitaxel|mesh-list
154207981|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
154207982|NCT00402116|Temozolomide|temozolomide|mesh-list
154207983|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154207984|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
154207985|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207986|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207987|NCT00401960|Daptomycin|daptomycin|mesh-list
154207988|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154207989|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207990|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154207991|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154207992|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154207993|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207994|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207995|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207996|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207997|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154207998|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
154207999|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208000|NCT00371826|Cyclosporine|cyclosporine|mesh-list
154208001|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
154208002|NCT00371826|Prednisone|prednisone|mesh-list
154208003|NCT00371826|Everolimus|everolimus|mesh-list
154208004|NCT00371826|Cyclosporins|cyclosporins|mesh-list
154208008|NCT00371826|Hormones|hormones|mesh-ancestor
154208030|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208032|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154208033|NCT02457702|Protective Agents|protective agents|mesh-ancestor
154208034|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208035|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
154208036|NCT00396084|Levofloxacin|levofloxacin|mesh-list
154208037|NCT00396084|Isoniazid|isoniazid|mesh-list
154208038|NCT00396084|Linezolid|linezolid|mesh-list
154208039|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
154208040|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154208041|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208042|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154208043|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154208044|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208045|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208046|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531598|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153531657|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154208047|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154208048|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154208049|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154208052|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154208085|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208086|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
154208087|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154208088|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208089|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208090|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154208091|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154208092|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154208093|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208094|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208095|NCT00420056|Palbociclib|palbociclib|mesh-list
154208100|NCT00411554|Inositol|inositol|mesh-list
154208145|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208146|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154208147|NCT00419744|Budesonide|budesonide|mesh-list
154208148|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
154208149|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154208150|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154208151|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154208152|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
154208153|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208154|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208155|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154208156|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
154208157|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
154208158|NCT00419744|Hormones|hormones|mesh-ancestor
154208159|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154208160|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154208161|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154208162|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154208163|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
154208164|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208165|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208166|NCT01047774|Caseins|caseins|mesh-list
154208167|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
153955195|NCT00674752|Gabapentin|gabapentin|mesh-list
154208169|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208170|NCT00395304|Fluticasone|fluticasone|mesh-list
154208171|NCT00395304|Xhance|xhance|mesh-list
154208172|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154208173|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154208174|NCT00395304|Montelukast|montelukast|mesh-list
154208175|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154208176|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154208177|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
154208178|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208179|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208183|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154208184|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154208185|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154208186|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154208187|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
154208188|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208189|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208190|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154208191|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
154208192|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154208193|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154208194|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154208195|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
154208197|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
154208198|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
154208199|NCT00395226|Astringents|astringents|mesh-ancestor
154208200|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208201|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208202|NCT00394914|Pleconaril|pleconaril|mesh-list
154208203|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
154208204|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208205|NCT00366444|Diclofenac|diclofenac|mesh-list
154208206|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154208207|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154208208|NCT00366444|Analgesics|analgesics|mesh-ancestor
154208209|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
154208210|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208211|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208212|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154208213|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208214|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154208215|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208216|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208217|NCT00365976|Eszopiclone|eszopiclone|mesh-list
154208218|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153646765|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208221|NCT00378534|Cyclosporine|cyclosporine|mesh-list
154208222|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
154208223|NCT00378534|Fludarabine|fludarabine|mesh-list
154208224|NCT00378534|Cyclosporins|cyclosporins|mesh-list
154208225|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208226|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
154208227|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208228|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208229|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154208230|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
154208231|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208285|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208286|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
154208287|NCT00410384|Belimumab|belimumab|mesh-list
154208288|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208289|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
154208290|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208291|NCT00370032|Alosetron|alosetron|mesh-list
154208292|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154208293|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153531731|NCT01498406|Vitamin D|vitamin d|mesh-list
154208294|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
154208295|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208296|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208297|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208298|NCT00410072|Tenofovir|tenofovir|mesh-list
154208344|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154208345|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208346|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208347|NCT01039766|Oxytocin|oxytocin|mesh-list
154208348|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
154208349|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154208350|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208351|NCT00409682|Adalimumab|adalimumab|mesh-list
154208352|NCT00409682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154208353|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154208354|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208355|NCT01039844|Paclitaxel|paclitaxel|mesh-list
154208356|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154208357|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208358|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
154208359|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
154208360|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
154208403|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
154208404|NCT00397982|Antibodies|antibodies|mesh-list
154208405|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
154208406|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154208407|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
154208408|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208409|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154208410|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154208411|NCT00397982|Growth Substances|growth substances|mesh-ancestor
154208412|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208413|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
154208414|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
154208415|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154208416|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208417|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154208418|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
154208419|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208420|NCT00397982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154208421|NCT00397982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208422|NCT00397982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208423|NCT03715166|Bumetanide|bumetanide|mesh-list
154208424|NCT03715166|Diuretics|diuretics|mesh-ancestor
154208425|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
154208426|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208427|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154208428|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208450|NCT01040078|Vaccines|vaccines|mesh-list
154208451|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
154208452|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208453|NCT01035320|Simvastatin|simvastatin|mesh-list
154208454|NCT01035320|Ezetimibe|ezetimibe|mesh-list
154208455|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154208456|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154208457|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
154208458|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208459|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154208515|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154208516|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208517|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208518|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154208519|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208520|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208521|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
154208522|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208523|NCT01043510|Insulin|insulin|mesh-list
154208524|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154208525|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
154208526|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154208527|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208528|NCT01043666|Mirabegron|mirabegron|mesh-list
154208573|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208575|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154208576|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154208577|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
154208578|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208579|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154208580|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154208581|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208582|NCT01045772|Rilonacept|rilonacept|mesh-list
154208583|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154208584|NCT01045928|Rituximab|rituximab|mesh-list
154208585|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154208586|NCT01045928|Lenalidomide|lenalidomide|mesh-list
154208587|NCT01045928|Antibodies|antibodies|mesh-list
154208588|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
154208589|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154208590|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
154208591|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208592|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208593|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208594|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154208595|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154208596|NCT01045928|Growth Substances|growth substances|mesh-ancestor
154208597|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
154208598|NCT00256750|Cyclosporine|cyclosporine|mesh-list
154208599|NCT00256750|Abatacept|abatacept|mesh-list
153532154|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
153955617|NCT04133506|Aspirin|aspirin|mesh-list
154208622|NCT00203476|Ezetimibe|ezetimibe|mesh-list
154208623|NCT00203476|Colestipol|colestipol|mesh-list
154208624|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154208625|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154208626|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
154208627|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208628|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154208629|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
154208630|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
154208631|NCT00203476|Vitamins|vitamins|mesh-ancestor
154208632|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
154208633|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208634|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
154208635|NCT00203242|Valproic Acid|valproic acid|mesh-list
154208636|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
154208637|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208638|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208639|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
154208640|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208641|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208642|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
154208643|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154208644|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208645|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208646|NCT00200356|Ozagrel|ozagrel|mesh-list
154208647|NCT00200356|Edaravone|edaravone|mesh-list
154208648|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154208649|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
154208650|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208651|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154208652|NCT00200356|Protective Agents|protective agents|mesh-ancestor
154208653|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208654|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208655|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154208656|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154208657|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
154208658|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
153631545|NCT00005857|Docetaxel|docetaxel|mesh-list
154208661|NCT00227266|Valproic Acid|valproic acid|mesh-list
154208662|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
154208663|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208664|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208665|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
154208666|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208667|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208668|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
154208669|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154208670|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208671|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208672|NCT00256282|Docetaxel|docetaxel|mesh-list
154208673|NCT00256282|Vinorelbine|vinorelbine|mesh-list
154208722|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154208723|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208724|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154208725|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208726|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208727|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154208728|NCT01071772|Insulin|insulin|mesh-list
154208729|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154208730|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208731|NCT01074346|Interferons|interferons|mesh-list
154208789|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154208790|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
154208791|NCT00278109|Doxorubicin|doxorubicin|mesh-list
154208792|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208793|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
154208794|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208795|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208796|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154208797|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
154208798|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208799|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208800|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154208801|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154208802|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154208803|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154208804|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208805|NCT00296517|Bupropion|bupropion|mesh-list
154208845|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154208846|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154208847|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
154208849|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208850|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154208851|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154208852|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208853|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208854|NCT00265395|Interferons|interferons|mesh-list
154208855|NCT00265395|Ribavirin|ribavirin|mesh-list
154208856|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
154208857|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
154208858|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154208859|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208860|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
154208861|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208862|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
154208863|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208864|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
154208865|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208866|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154208867|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
154208868|NCT00195442|Factor VIII|factor viii|mesh-list
154208869|NCT00195442|Coagulants|coagulants|mesh-ancestor
154208870|NCT01070823|Natalizumab|natalizumab|mesh-list
154208871|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
154208872|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208873|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154208874|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
154208875|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208876|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154208877|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154208878|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208879|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208880|NCT00275301|Olanzapine|olanzapine|mesh-list
154208884|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208885|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154208886|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154208887|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154208888|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208889|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208890|NCT00275301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154208891|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154208892|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208893|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208894|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208895|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
154208947|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154208948|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
154208949|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
154208950|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208951|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
154208952|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208953|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
154208954|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208955|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
154208956|NCT00254566|Azithromycin|azithromycin|mesh-list
154208957|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154208958|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154208959|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208960|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154208961|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154208962|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208963|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208972|NCT01048086|Tretinoin|tretinoin|mesh-list
154209004|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154209005|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
154209006|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209007|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209008|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209009|NCT01048320|Gemcitabine|gemcitabine|mesh-list
154209010|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
154209011|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
154209012|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154209013|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
154209014|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209015|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209016|NCT01048320|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154209017|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154209018|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209019|NCT03990480|Amlodipine|amlodipine|mesh-list
154209061|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
154209062|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154209063|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154209064|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154209065|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
154209066|NCT01048398|Acetaminophen|acetaminophen|mesh-list
154209067|NCT01048398|Remifentanil|remifentanil|mesh-list
154209068|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153956057|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
154209070|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
154209071|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209072|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209073|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
154209074|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154209075|NCT01048398|Narcotics|narcotics|mesh-ancestor
154209076|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154209077|NCT01073644|Sunitinib|sunitinib|mesh-list
154209120|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209122|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
154209123|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
154209124|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209125|NCT00187486|Temozolomide|temozolomide|mesh-list
154209126|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154209127|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154209128|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
154209129|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209130|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209133|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209181|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
154209182|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154209183|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209184|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209185|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154209186|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154209187|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154209189|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154209249|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154209250|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154209251|NCT00186628|Prednisolone|prednisolone|mesh-list
154209252|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
154209253|NCT00186628|Rituximab|rituximab|mesh-list
154209254|NCT00186628|Granisetron|granisetron|mesh-list
154209255|NCT00186628|Lenograstim|lenograstim|mesh-list
154209256|NCT00186628|Cyclosporins|cyclosporins|mesh-list
154209257|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
154209258|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154209259|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154209260|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
154209261|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154209262|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209263|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
154209264|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209265|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154209266|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154209267|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209268|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209269|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209270|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
154209271|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209272|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
154209273|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154209274|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154209275|NCT00186628|Analgesics|analgesics|mesh-ancestor
154209276|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
154209298|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154209299|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
154209300|NCT00186628|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154209301|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154209302|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
154209303|NCT00368550|Sertraline|sertraline|mesh-list
154209304|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
154209305|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154209306|NCT00368550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154209307|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154209308|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209309|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209359|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209360|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209361|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
154209362|NCT01050270|Ondansetron|ondansetron|mesh-list
154209363|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154209364|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
154209365|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
154209366|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209367|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209368|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154209369|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
154209370|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
154209371|NCT01050270|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154209372|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154209373|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
154209374|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209375|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209376|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
154209377|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532511|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209378|NCT01050270|Expectorants|expectorants|mesh-ancestor
154209415|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
154209416|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209418|NCT00361842|Floxuridine|floxuridine|mesh-list
154209419|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154209420|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154209421|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209422|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209423|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209424|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154209425|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
154209426|NCT01324752|Losartan|losartan|mesh-list
154209427|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154209428|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154209477|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154209478|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209479|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209480|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209481|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
154209482|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209483|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154209484|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
154209485|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154209486|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154209487|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
154209488|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154209489|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154209490|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209491|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154209492|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154209493|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209494|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209495|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209496|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154209497|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
154209498|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154209499|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209500|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154209501|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154209502|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154209503|NCT02534610|Etoricoxib|etoricoxib|mesh-list
154209521|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209522|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
154209523|NCT01050426|Vitamins|vitamins|mesh-ancestor
154209524|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
154209525|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154209526|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209527|NCT00367458|Atorvastatin|atorvastatin|mesh-list
154209528|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153532624|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154209529|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154209530|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
154209531|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209532|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154209533|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154209534|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209535|NCT00252694|Candesartan|candesartan|mesh-list
154209536|NCT00252694|Candesartan cilexetil|candesartan cilexetil|mesh-list
154209537|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154209538|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154209539|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154209540|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209541|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
154209542|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154209555|NCT01582672|Sunitinib|sunitinib|mesh-list
154209571|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209572|NCT01049178|Protective Agents|protective agents|mesh-ancestor
154209573|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209574|NCT02534454|Nicotine|nicotine|mesh-list
154209575|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154209576|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
154209577|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209578|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209579|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154209580|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154209581|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
154209582|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209583|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209584|NCT00355368|Rocuronium|rocuronium|mesh-list
154209585|NCT00355368|Succinylcholine|succinylcholine|mesh-list
154209603|NCT00373958|Vaccines|vaccines|mesh-list
154209629|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209630|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154209631|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154209632|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154209633|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209634|NCT00184600|Insulin|insulin|mesh-list
154209635|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154209636|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
154209637|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
154209638|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154209639|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
154209692|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209693|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
154209694|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209695|NCT00184054|Protective Agents|protective agents|mesh-ancestor
154209696|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209697|NCT02533908|Fentanyl|fentanyl|mesh-list
154209698|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154209699|NCT02533908|Narcotics|narcotics|mesh-ancestor
154209700|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154209701|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209702|NCT02533908|Analgesics|analgesics|mesh-ancestor
154209703|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
154209704|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532669|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
154209705|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154209706|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154209707|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
154209708|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
154209709|NCT00183430|Prazosin|prazosin|mesh-list
154209748|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154209749|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154209750|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154209751|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154209752|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209753|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209754|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
154209755|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154209756|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154209757|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
154209758|NCT00349752|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154209759|NCT00349752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154209810|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
154209811|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209812|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209813|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154209814|NCT03989700|Thiamine|thiamine|mesh-list
154209815|NCT03989700|Vitamins|vitamins|mesh-ancestor
153956794|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209816|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
154209817|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209818|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
154209819|NCT01051284|Gemcitabine|gemcitabine|mesh-list
154209820|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154209821|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
154209822|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209823|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209824|NCT01051362|Carboplatin|carboplatin|mesh-list
154209825|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209826|NCT01055808|Insulin|insulin|mesh-list
154209827|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154209828|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209829|NCT00265083|Golimumab|golimumab|mesh-list
154209836|NCT00264849|Omalizumab|omalizumab|mesh-list
154209863|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
154209864|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
154209865|NCT01071291|Vitamins|vitamins|mesh-ancestor
154209866|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
154209867|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209868|NCT00129766|Palivizumab|palivizumab|mesh-list
154209869|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
154209870|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209871|NCT00150592|Guanfacine|guanfacine|mesh-list
154209872|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154209873|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154209874|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154209875|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154209876|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
154209877|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209878|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209879|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209880|NCT00149890|Cyclosporine|cyclosporine|mesh-list
153956885|NCT00588445|Gefitinib|gefitinib|mesh-list
154209917|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209918|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209919|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209920|NCT00354744|Dactinomycin|dactinomycin|mesh-list
154209921|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
154209922|NCT00354744|Ifosfamide|ifosfamide|mesh-list
154209923|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
154209924|NCT00354744|Doxorubicin|doxorubicin|mesh-list
154209925|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154209926|NCT00354744|Irinotecan|irinotecan|mesh-list
154209927|NCT00354744|Etoposide|etoposide|mesh-list
154209928|NCT00354744|Vincristine|vincristine|mesh-list
154209929|NCT00354744|Camptothecin|camptothecin|mesh-list
154209930|NCT00354744|Lenograstim|lenograstim|mesh-list
154209931|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209932|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
154209933|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209934|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154209935|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154209936|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
154209937|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209938|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209973|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154209974|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154209975|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154209976|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154209977|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154209978|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154209979|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209980|NCT01056042|Progestins|progestins|mesh-ancestor
154209981|NCT00373256|Paclitaxel|paclitaxel|mesh-list
154209982|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154209983|NCT00373256|Bevacizumab|bevacizumab|mesh-list
154209984|NCT00373256|Sunitinib|sunitinib|mesh-list
154209985|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154209986|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209987|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210008|NCT00394082|Paclitaxel|paclitaxel|mesh-list
154210032|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210033|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210034|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154210035|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
154210036|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154210037|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
154210038|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210039|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210040|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154210041|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
154210042|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154210043|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153533309|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154210044|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153533356|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210045|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
154210046|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210047|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210048|NCT01046006|Dexamethasone|dexamethasone|mesh-list
154210050|NCT01046006|Bortezomib|bortezomib|mesh-list
154210051|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210052|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
154210053|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
154210054|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210055|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210056|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210057|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
154210058|NCT01046006|Hormones|hormones|mesh-ancestor
154210059|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210060|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154210061|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210062|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154210063|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
154210064|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210065|NCT01046162|Alprazolam|alprazolam|mesh-list
154210066|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154210069|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154210070|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154210071|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154210072|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
154210073|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
154210074|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210075|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210076|NCT00417482|Risperidone|risperidone|mesh-list
154210077|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154210078|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
154210079|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210080|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210081|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210082|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154210083|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154210084|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533357|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210085|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154210126|NCT00392990|Cytarabine|cytarabine|mesh-list
154210127|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
154210128|NCT00392990|Ifosfamide|ifosfamide|mesh-list
154210129|NCT00392990|Rituximab|rituximab|mesh-list
154210130|NCT00392990|Doxorubicin|doxorubicin|mesh-list
154210131|NCT00392990|Methotrexate|methotrexate|mesh-list
154210132|NCT00392990|Etoposide|etoposide|mesh-list
154210133|NCT00392990|Vincristine|vincristine|mesh-list
154210134|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
154210135|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154210136|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
154210137|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154210138|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
154210139|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210140|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210141|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154210188|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210189|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210190|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210191|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154210192|NCT01046630|Ketamine|ketamine|mesh-list
154210193|NCT01046630|Analgesics|analgesics|mesh-ancestor
154210194|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
154210195|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210196|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210197|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154210198|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154210199|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
154210200|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
154210201|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210202|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154210203|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154210204|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210205|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210206|NCT01046708|Progesterone|progesterone|mesh-list
154210207|NCT01046708|Progestins|progestins|mesh-ancestor
154210208|NCT01046708|Hormones|hormones|mesh-ancestor
154210209|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210210|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210211|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
154210212|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154210213|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154210214|NCT01046786|Prednisolone|prednisolone|mesh-list
154210215|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
154210233|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533606|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210234|NCT00762554|Fentanyl|fentanyl|mesh-list
154210235|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154210236|NCT00762554|Narcotics|narcotics|mesh-ancestor
154210237|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210238|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210239|NCT00762554|Analgesics|analgesics|mesh-ancestor
154210240|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
154210241|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210242|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154210243|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154210244|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
154210245|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
154210246|NCT00391898|Levodopa|levodopa|mesh-list
154210247|NCT00391898|Carbidopa|carbidopa|mesh-list
154210248|NCT00391898|Entacapone|entacapone|mesh-list
154210249|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154210250|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154210251|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
154210258|NCT01046864|Leucovorin|leucovorin|mesh-list
154210292|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
154210293|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154210294|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154210295|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154210296|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
154210297|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210298|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154210299|NCT01049438|Doxycycline|doxycycline|mesh-list
154210300|NCT01049438|Minocycline|minocycline|mesh-list
154210301|NCT01049438|Mupirocin|mupirocin|mesh-list
154210302|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154210303|NCT01049438|Trimethoprim|trimethoprim|mesh-list
154210304|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
154210305|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
154210306|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210307|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
154210308|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154210309|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154210351|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154210352|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210353|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210354|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210355|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
154210356|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210357|NCT00391274|Docetaxel|docetaxel|mesh-list
154210358|NCT00391274|Pemetrexed|pemetrexed|mesh-list
154210359|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210360|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210361|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210362|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210363|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210367|NCT00391118|Paclitaxel|paclitaxel|mesh-list
153533779|NCT01507792|Histamine|histamine|mesh-list
154210412|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
154210413|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210414|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210415|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
154210416|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154210417|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210418|NCT00264537|Golimumab|golimumab|mesh-list
154210419|NCT00264537|Methotrexate|methotrexate|mesh-list
154210420|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154210421|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154210422|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
154210423|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154210424|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210425|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154210426|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
154210469|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210470|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
154210471|NCT01071369|Hormones|hormones|mesh-ancestor
154210472|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210473|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154210474|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
154210475|NCT00370682|Vaccines|vaccines|mesh-list
154210476|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
154210477|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210478|NCT00264147|Diclofenac|diclofenac|mesh-list
154210479|NCT00264147|Etoricoxib|etoricoxib|mesh-list
154210480|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154210481|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154210482|NCT00264147|Analgesics|analgesics|mesh-ancestor
154210532|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210533|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154210534|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154210535|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210536|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153533780|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154210537|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154210538|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533781|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210539|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
154210540|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153533915|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533916|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210541|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154210542|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154210543|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
154210544|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210545|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
154210546|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154210547|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
154210548|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210549|NCT00248625|Expectorants|expectorants|mesh-ancestor
154210550|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
154210551|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154210552|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
154210586|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210588|NCT00170950|Diuretics|diuretics|mesh-ancestor
154210589|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
154210590|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154210591|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154210592|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
154210593|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210594|NCT00262041|Vaccines|vaccines|mesh-list
154210595|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
154210596|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210597|NCT00208767|Valsartan|valsartan|mesh-list
154210598|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154210602|NCT02531529|Fentanyl|fentanyl|mesh-list
154210647|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210648|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154210649|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154210650|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210651|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
154210652|NCT00390416|Leucovorin|leucovorin|mesh-list
154210653|NCT00390416|Bevacizumab|bevacizumab|mesh-list
154210654|NCT00390416|Docetaxel|docetaxel|mesh-list
154210655|NCT00390416|Fluorouracil|fluorouracil|mesh-list
154210656|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154210657|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210658|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154210659|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154210660|NCT00390416|Growth Substances|growth substances|mesh-ancestor
154210661|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210662|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
154210663|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210664|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210665|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210666|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210667|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
154210668|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154210669|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154210670|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
154210671|NCT00390416|Antidotes|antidotes|mesh-ancestor
154210672|NCT00390416|Protective Agents|protective agents|mesh-ancestor
154210698|NCT00365456|Hormones|hormones|mesh-list
154210699|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
154210700|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210701|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210702|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154210703|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210704|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210705|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154210706|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154210707|NCT01047956|Methadone|methadone|mesh-list
154210708|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154210709|NCT01047956|Narcotics|narcotics|mesh-ancestor
154210710|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210711|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210712|NCT01047956|Analgesics|analgesics|mesh-ancestor
154210713|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
154210714|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210715|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
154210716|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
154210717|NCT00206427|Lapatinib|lapatinib|mesh-list
154210718|NCT00206427|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154210719|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154210748|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210749|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153534074|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153534075|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153534076|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534077|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153534078|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154210750|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153534221|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154210752|NCT01049672|Heroin|heroin|mesh-list
154210753|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154210754|NCT01049672|Narcotics|narcotics|mesh-ancestor
154210755|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210756|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210757|NCT01049672|Analgesics|analgesics|mesh-ancestor
154210758|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
154210759|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210760|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154210761|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
154210762|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
154210763|NCT01048190|Vaccines|vaccines|mesh-list
154210764|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
154210765|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210766|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154210767|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210768|NCT01048268|Incretins|incretins|mesh-ancestor
154210769|NCT01048268|Hormones|hormones|mesh-ancestor
154210770|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210771|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210772|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154210773|NCT03993236|Ezetimibe|ezetimibe|mesh-list
154210774|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154210775|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154210776|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
154210794|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210795|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210796|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154210797|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210798|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154210799|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
154210800|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154210801|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210802|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154210803|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
154210804|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154210805|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210806|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210807|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210808|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
154210809|NCT00529373|Vitamin D|vitamin d|mesh-list
154210810|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
154210811|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
154210812|NCT00529373|Calcium|calcium|mesh-list
154210813|NCT00529373|Vitamins|vitamins|mesh-ancestor
154210814|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
153534222|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
153534223|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534224|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534225|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
154210815|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210816|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153534252|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154210846|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210847|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210848|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154210849|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154210850|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154210851|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154210852|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154210853|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154210854|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154210855|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154210856|NCT03872843|Ibuprofen|ibuprofen|mesh-list
154210857|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154210858|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154210859|NCT03872843|Analgesics|analgesics|mesh-ancestor
154210860|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
154210861|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210862|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210863|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210864|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210865|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154210866|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210867|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210868|NCT03966040|Vaccines|vaccines|mesh-list
154210869|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
154210870|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210871|NCT03999125|Dexamethasone|dexamethasone|mesh-list
154210872|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
154210873|NCT03999125|Ranibizumab|ranibizumab|mesh-list
154210874|NCT03999125|Aflibercept|aflibercept|mesh-list
154210889|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210891|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154210892|NCT03999125|Growth Substances|growth substances|mesh-ancestor
154210893|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
154210894|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
154210895|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154210896|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
154210897|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210898|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154210899|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210900|NCT00166114|Desipramine|desipramine|mesh-list
154210901|NCT00166114|Escitalopram|escitalopram|mesh-list
154210902|NCT00166114|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154210907|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
153534253|NCT01510613|Growth Substances|growth substances|mesh-ancestor
153534313|NCT01511146|Gemcitabine|gemcitabine|mesh-list
153534314|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
153534315|NCT01511146|Mitomycins|mitomycins|mesh-list
154210949|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154210950|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210951|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210953|NCT00129220|Olanzapine|olanzapine|mesh-list
154210954|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
154210955|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
154210956|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
154210957|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210958|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210959|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210960|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154210961|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154210962|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210963|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154210964|NCT00129220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154210965|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154210966|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210967|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210968|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210969|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
154210970|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154210971|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
154210972|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154210973|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
154210997|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
154210999|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154211000|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
154211001|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154211002|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211003|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154211004|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154211005|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154211006|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154211007|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154211008|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154211009|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211010|NCT01074892|Hormones|hormones|mesh-ancestor
154211011|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154211012|NCT00128206|Rifampin|rifampin|mesh-list
154211013|NCT00128206|Isoniazid|isoniazid|mesh-list
154211014|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153534435|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
154211015|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
154211016|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153534527|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534528|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154211017|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211018|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
154211019|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154211021|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211022|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154211029|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154211045|NCT03968146|Morphine|morphine|mesh-list
154211046|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154211047|NCT03968146|Narcotics|narcotics|mesh-ancestor
154211048|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154211049|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211050|NCT03968146|Analgesics|analgesics|mesh-ancestor
154211051|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
154211053|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154211113|NCT00141778|Diuretics|diuretics|mesh-ancestor
154211114|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
154211115|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
154211116|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211117|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154211118|NCT00141778|Hormones|hormones|mesh-ancestor
154211119|NCT01079884|Esomeprazole|esomeprazole|mesh-list
154211120|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154211121|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154211122|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154211123|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211124|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211125|NCT01075906|Colchicine|colchicine|mesh-list
154211126|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
154211175|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154211176|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154211177|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211178|NCT00127192|Incretins|incretins|mesh-ancestor
154211179|NCT00127192|Hormones|hormones|mesh-ancestor
154211180|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154211181|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154211182|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
154211183|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211184|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211238|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
153534529|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153534530|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211239|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534678|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154211240|NCT00126490|Aldesleukin|aldesleukin|mesh-list
154211241|NCT00126490|Bevacizumab|bevacizumab|mesh-list
154211242|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154211244|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
154211245|NCT00126490|Antibodies|antibodies|mesh-list
154211246|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
154211247|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154211248|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
154211249|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211250|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154211302|NCT00140140|Vinorelbine|vinorelbine|mesh-list
154211303|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154211304|NCT00140140|Trastuzumab|trastuzumab|mesh-list
154211305|NCT00140140|Lenograstim|lenograstim|mesh-list
154211306|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211307|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211308|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211309|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211369|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154211370|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154211372|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
154211373|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211374|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211375|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211376|NCT00368966|Vaccines|vaccines|mesh-list
154211437|NCT00136318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154211438|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154211439|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154211440|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211441|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
154211442|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211443|NCT01058850|Rindopepimut|rindopepimut|mesh-list
154211444|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211445|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211446|NCT00136084|Cytarabine|cytarabine|mesh-list
154211447|NCT00136084|Dexamethasone|dexamethasone|mesh-list
154211448|NCT00136084|Prednisone|prednisone|mesh-list
154211449|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
154211450|NCT00136084|Methotrexate|methotrexate|mesh-list
153534679|NCT01512355|Analgesics|analgesics|mesh-ancestor
154211451|NCT00136084|Etoposide|etoposide|mesh-list
154211452|NCT00136084|Vincristine|vincristine|mesh-list
153534852|NCT01513525|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153534853|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154211453|NCT00136084|Daunorubicin|daunorubicin|mesh-list
154211454|NCT00136084|Asparaginase|asparaginase|mesh-list
154211455|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
154211456|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
154211457|NCT00136084|Cladribine|cladribine|mesh-list
154211458|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
154211459|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154211460|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
154211462|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211490|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211491|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211492|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211493|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211494|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154211495|NCT00136084|Analgesics|analgesics|mesh-ancestor
154211496|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
153534854|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211497|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211498|NCT00136084|Immunotoxins|immunotoxins|mesh-ancestor
154211499|NCT00136084|Immunoconjugates|immunoconjugates|mesh-ancestor
154211500|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
154211501|NCT00364832|Hematinics|hematinics|mesh-ancestor
154211502|NCT00235755|Ezogabine|ezogabine|mesh-list
154211503|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
154211504|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154211505|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211506|NCT01581879|Ziprasidone|ziprasidone|mesh-list
154211507|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154211508|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
154211509|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211510|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211511|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211512|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154211513|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154211514|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154211515|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154211516|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154211517|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
154211518|NCT00337194|Gemcitabine|gemcitabine|mesh-list
154211538|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211539|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211540|NCT00337194|Immunotoxins|immunotoxins|mesh-ancestor
154211541|NCT00337194|Immunoconjugates|immunoconjugates|mesh-ancestor
154211542|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
154211543|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211544|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534856|NCT01513525|Hormones|hormones|mesh-ancestor
154211545|NCT01074333|Cetuximab|cetuximab|mesh-list
153534918|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211546|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211547|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211548|NCT00385736|Adalimumab|adalimumab|mesh-list
154211549|NCT00385736|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154211550|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211551|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211552|NCT01057212|Bevacizumab|bevacizumab|mesh-list
154211599|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211600|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211601|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154211602|NCT00336492|Infliximab|infliximab|mesh-list
154211603|NCT00336492|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154211604|NCT00336492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211605|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
154211606|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154211607|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211608|NCT00194025|Valproic Acid|valproic acid|mesh-list
154211609|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
154211610|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211611|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211612|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
154211657|NCT04090697|Oxandrolone|oxandrolone|mesh-list
154211658|NCT04090697|Androgens|androgens|mesh-ancestor
154211659|NCT04090697|Hormones|hormones|mesh-ancestor
154211660|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154211661|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211662|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
154211663|NCT00367640|Immunomodulating Agents|immunomodulating agents|mesh-list
154211664|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
154211665|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211666|NCT01325220|Baclofen|baclofen|mesh-list
154211667|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154211668|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211669|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154211685|NCT00526799|Sorafenib|sorafenib|mesh-list
154211720|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211721|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211722|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154211723|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
154211724|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211725|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211726|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154211728|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154211729|NCT01259648|Narcotics|narcotics|mesh-ancestor
154211730|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154211731|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211732|NCT01259648|Analgesics|analgesics|mesh-ancestor
154211733|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
154211734|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211735|NCT01049048|Vitamin D|vitamin d|mesh-list
154211736|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
154211737|NCT01049048|Vitamins|vitamins|mesh-ancestor
154211738|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
154211739|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211740|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154211741|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154211742|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154211743|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
154211744|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211745|NCT01044992|Levodopa|levodopa|mesh-list
154211746|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154211768|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211769|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211770|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211771|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211772|NCT00520013|Paclitaxel|paclitaxel|mesh-list
154211773|NCT00520013|Bevacizumab|bevacizumab|mesh-list
154211774|NCT00520013|Carboplatin|carboplatin|mesh-list
154211775|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154211776|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211777|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211778|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211779|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211780|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211781|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211782|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153535130|NCT01514942|Inositol|inositol|mesh-list
153535131|NCT01514942|Manganese|manganese|mesh-list
153535132|NCT01514942|Hematinics|hematinics|mesh-ancestor
154211783|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154211784|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154211785|NCT00520013|Growth Substances|growth substances|mesh-ancestor
154211786|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211787|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
154211788|NCT00520013|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154211789|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154211790|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211791|NCT00526097|Bisacodyl|bisacodyl|mesh-list
154211792|NCT00526097|Cathartics|cathartics|mesh-ancestor
154211793|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154211794|NCT00526097|Laxatives|laxatives|mesh-ancestor
154211795|NCT00525785|Leucovorin|leucovorin|mesh-list
154211796|NCT00525785|Folic Acid|folic acid|mesh-list
154211797|NCT00525785|Fluorouracil|fluorouracil|mesh-list
154211798|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
154211799|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
154211800|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
154211803|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211812|NCT00525785|Hematinics|hematinics|mesh-ancestor
154211814|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211815|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154211816|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211817|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211818|NCT00135694|Prednisone|prednisone|mesh-list
154211819|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154211820|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211821|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
154211822|NCT00135694|Hormones|hormones|mesh-ancestor
154211823|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154211824|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211825|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154211826|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211827|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211828|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211829|NCT00524459|Docetaxel|docetaxel|mesh-list
154211830|NCT00524459|Doxorubicin|doxorubicin|mesh-list
154211831|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154211832|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211833|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
153535202|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
154211834|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
153535263|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
154211835|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211836|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211841|NCT00519623|Insulin|insulin|mesh-list
154211860|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211862|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
154211863|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
154211864|NCT00124072|Simvastatin|simvastatin|mesh-list
154211865|NCT00124072|Vitamins|vitamins|mesh-ancestor
154211866|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
154211867|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211868|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154211869|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154211870|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
154211871|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211872|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154211873|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154211874|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211875|NCT00124072|Hematinics|hematinics|mesh-ancestor
154211876|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
154211877|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
154211878|NCT01080352|Vitamins|vitamins|mesh-ancestor
154211879|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
154211880|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211881|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
154211882|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211883|NCT01080352|Protective Agents|protective agents|mesh-ancestor
154211884|NCT00524303|Paclitaxel|paclitaxel|mesh-list
154211885|NCT00524303|Trastuzumab|trastuzumab|mesh-list
154211886|NCT00524303|Lapatinib|lapatinib|mesh-list
154211887|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211888|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211889|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211890|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211891|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211892|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211904|NCT00335556|Carboplatin|carboplatin|mesh-list
154211905|NCT00335556|Doxorubicin|doxorubicin|mesh-list
154211906|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154211907|NCT00335556|Irinotecan|irinotecan|mesh-list
154211908|NCT00335556|Etoposide|etoposide|mesh-list
154211909|NCT00335556|Vincristine|vincristine|mesh-list
154211910|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154211911|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
154211912|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211913|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211914|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154211915|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
154211916|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211917|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211918|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154211919|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154211920|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154211921|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211932|NCT00518687|Vaccines|vaccines|mesh-list
154211963|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211964|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211965|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154211966|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
154211967|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
154211968|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154211972|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
154212031|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154212032|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212033|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
154212034|NCT03755765|Amoxicillin|amoxicillin|mesh-list
154212035|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
154212036|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
154212037|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154212038|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154212039|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212040|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154212041|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212043|NCT01061112|Tolbutamide|tolbutamide|mesh-list
154212091|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
154212092|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
154212093|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
154212094|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212095|NCT00334542|Simvastatin|simvastatin|mesh-list
154212096|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153535564|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154212097|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154212098|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
154212099|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212100|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154212155|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
154212156|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154212157|NCT00323622|Amodiaquine|amodiaquine|mesh-list
154212158|NCT00323622|Vaccines|vaccines|mesh-list
154212159|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
154212160|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212161|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
154212162|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154212163|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154212164|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212165|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154212166|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212167|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212169|NCT01326039|Bupivacaine|bupivacaine|mesh-list
154212217|NCT01060176|Coagulants|coagulants|mesh-ancestor
154212218|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
154212219|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154212220|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212221|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154212222|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
154212223|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154212224|NCT00517361|Bevacizumab|bevacizumab|mesh-list
154212225|NCT00517361|Carboplatin|carboplatin|mesh-list
154212226|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212227|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212228|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154212229|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154212230|NCT00517361|Growth Substances|growth substances|mesh-ancestor
154212280|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212281|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212282|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212283|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
154212284|NCT02531841|Hormones|hormones|mesh-ancestor
154212285|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212286|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154212287|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212288|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
154212289|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212290|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212291|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154212292|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154212293|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154212295|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
154212336|NCT06169475|Dexmedetomidine|dexmedetomidine|mesh-list
154212337|NCT06169475|Esmolol|esmolol|mesh-list
154212338|NCT06169475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154212339|NCT06169475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212340|NCT06169475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212341|NCT06169475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154212342|NCT06169475|Analgesics|analgesics|mesh-ancestor
154212343|NCT06169475|Sensory System Agents|sensory system agents|mesh-ancestor
154212344|NCT06169475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212345|NCT06169475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154212346|NCT06169475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154212347|NCT06169475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154212348|NCT06169475|Adrenergic Agents|adrenergic agents|mesh-ancestor
154212349|NCT06169475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212350|NCT06169475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212352|NCT06169475|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154212393|NCT06168773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154212394|NCT06168773|Anticonvulsants|anticonvulsants|mesh-ancestor
154212395|NCT06168773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154212396|NCT06168773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154212397|NCT06168773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212398|NCT06168773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154212399|NCT06168773|Tocolytic Agents|tocolytic agents|mesh-ancestor
154212400|NCT06168773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154212401|NCT06168773|Antiemetics|antiemetics|mesh-ancestor
154212402|NCT06168773|Autonomic Agents|autonomic agents|mesh-ancestor
154212403|NCT06168773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212404|NCT06168773|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154212405|NCT06168773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154212406|NCT06168773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154212407|NCT06168773|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154212408|NCT06168773|Dopamine Agents|dopamine agents|mesh-ancestor
154212409|NCT06168773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212410|NCT06168773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154212411|NCT06168734|Meropenem|meropenem|mesh-list
154212412|NCT06168734|Cefepime|cefepime|mesh-list
154212413|NCT06168734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154212414|NCT06168734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212446|NCT06168279|Dermatologic Agents|dermatologic agents|mesh-ancestor
154212447|NCT06168084|Amoxicillin|amoxicillin|mesh-list
154212448|NCT06168084|Tetracycline|tetracycline|mesh-list
154212449|NCT06168084|Furazolidone|furazolidone|mesh-list
154212450|NCT06168084|Esomeprazole|esomeprazole|mesh-list
154212451|NCT06168084|Bismuth|bismuth|mesh-list
154212452|NCT06168084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154212453|NCT06168084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212454|NCT06168084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154212455|NCT06168084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212456|NCT06168084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154212457|NCT06168084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212458|NCT06168084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212459|NCT06168084|Antacids|antacids|mesh-ancestor
154212460|NCT06168084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154212461|NCT06168084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154212462|NCT06168084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154212463|NCT06168084|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154212464|NCT06168084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154212465|NCT06168084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154212466|NCT06168084|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154212467|NCT06167837|Metoclopramide|metoclopramide|mesh-list
154212468|NCT06167837|Antiemetics|antiemetics|mesh-ancestor
154212469|NCT06167837|Autonomic Agents|autonomic agents|mesh-ancestor
154212470|NCT06167837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212471|NCT06167837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212472|NCT06167837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212473|NCT06167837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154212474|NCT06167837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154212475|NCT06167837|Dopamine Agents|dopamine agents|mesh-ancestor
154212492|NCT06152497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212493|NCT06152497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212495|NCT06142396|Cyclophosphamide|cyclophosphamide|mesh-list
154212496|NCT06142396|Bortezomib|bortezomib|mesh-list
154212497|NCT06142396|Daratumumab|daratumumab|mesh-list
154212498|NCT06142396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154212499|NCT06142396|Immunologic Factors|immunologic factors|mesh-ancestor
154212500|NCT06142396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212501|NCT06142396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212502|NCT06142396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154212503|NCT06142396|Alkylating Agents|alkylating agents|mesh-ancestor
154212504|NCT06142396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212505|NCT06142396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212506|NCT06142396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154212550|NCT06084663|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154212551|NCT06084663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154212552|NCT06084663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212553|NCT06084663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212555|NCT06083844|Bevacizumab|bevacizumab|mesh-list
154212556|NCT06083844|Pembrolizumab|pembrolizumab|mesh-list
154212557|NCT06083844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154212558|NCT06083844|Immunologic Factors|immunologic factors|mesh-ancestor
154212559|NCT06083844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212560|NCT06083844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212561|NCT06083844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154212562|NCT06083844|Alkylating Agents|alkylating agents|mesh-ancestor
154212563|NCT06083844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212564|NCT06083844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212565|NCT06083844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154212566|NCT06083844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212567|NCT06083844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154212568|NCT06083844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154212569|NCT06083844|Growth Substances|growth substances|mesh-ancestor
154212570|NCT06083844|Growth Inhibitors|growth inhibitors|mesh-ancestor
154212571|NCT06083844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154212572|NCT06045650|Oxytocin|oxytocin|mesh-list
153535795|NCT01518413|Sorafenib|sorafenib|mesh-list
153535854|NCT01518634|Imipramine|imipramine|mesh-list
153535855|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154212573|NCT06045650|Oxytocics|oxytocics|mesh-ancestor
154212574|NCT06045650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154212575|NCT06045650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212576|NCT06043297|Apixaban|apixaban|mesh-list
154212577|NCT06043297|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154212578|NCT06043297|Antithrombins|antithrombins|mesh-ancestor
154212579|NCT06043297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154212593|NCT05984381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212594|NCT05984381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212595|NCT05984381|Dermatologic Agents|dermatologic agents|mesh-ancestor
154212596|NCT05984381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212597|NCT05984381|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154212598|NCT05984381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154212600|NCT05984381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212601|NCT05984381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154212602|NCT05984381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212603|NCT05984381|Glucocorticoids|glucocorticoids|mesh-ancestor
154212604|NCT05984381|Hormones|hormones|mesh-ancestor
154212605|NCT05984381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212606|NCT05984381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154212607|NCT05984381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212608|NCT05984381|Antimalarials|antimalarials|mesh-ancestor
154212652|NCT05820685|Dronabinol|dronabinol|mesh-list
154212653|NCT05820685|Hallucinogens|hallucinogens|mesh-ancestor
154212654|NCT05820685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212655|NCT05820685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154212656|NCT05820685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154212657|NCT05820685|Analgesics|analgesics|mesh-ancestor
154212658|NCT05820685|Sensory System Agents|sensory system agents|mesh-ancestor
154212659|NCT05820685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212660|NCT05820685|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154212661|NCT05820685|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154212662|NCT05820685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212664|NCT05820685|Hormones|hormones|mesh-ancestor
154212713|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
154212714|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212715|NCT05664789|Expectorants|expectorants|mesh-ancestor
153535874|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
153535903|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535904|NCT01518959|Vitamins|vitamins|mesh-ancestor
153535905|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
153535906|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153535907|NCT01518998|Amlodipine|amlodipine|mesh-list
154212716|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
154212717|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154212718|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
154212719|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212720|NCT05664789|Protective Agents|protective agents|mesh-ancestor
154212721|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212722|NCT05664789|Antidotes|antidotes|mesh-ancestor
154212723|NCT05659576|Sucralfate|sucralfate|mesh-list
154212724|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154212725|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212726|NCT05611307|Hormones|hormones|mesh-list
154212727|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212728|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212729|NCT05579626|Ezetimibe|ezetimibe|mesh-list
154212730|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154212731|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154212732|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154212733|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
154212734|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212735|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154212736|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212737|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
154212738|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154212739|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
154212740|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212758|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154212759|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
154212760|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212761|NCT05494398|Protective Agents|protective agents|mesh-ancestor
154212762|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212763|NCT05494398|Antidotes|antidotes|mesh-ancestor
154212764|NCT05424016|Propranolol|propranolol|mesh-list
153535953|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
153535954|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
153535955|NCT01519154|Analgesics|analgesics|mesh-ancestor
153535956|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
153535957|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618959|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536013|NCT01519401|Diuretics|diuretics|mesh-ancestor
154212765|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154212766|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154212767|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154212768|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212769|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212770|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212774|NCT05395117|Digoxin|digoxin|mesh-list
154212820|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536143|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154212821|NCT05261269|Niraparib|niraparib|mesh-list
154212822|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154212823|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212824|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212825|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212826|NCT05260320|Anesthetics|anesthetics|mesh-list
154212827|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212828|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212829|NCT05239091|Lidocaine|lidocaine|mesh-list
154212830|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
154212831|NCT05239091|Anesthetics|anesthetics|mesh-list
154212832|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212833|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212834|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
154212877|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
154212878|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212879|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212880|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154212881|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
154212882|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212883|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212884|NCT05117476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154212885|NCT05117476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212886|NCT05112549|Nivolumab|nivolumab|mesh-list
154212887|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212888|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212889|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154212890|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212891|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
154212892|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154212893|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154212894|NCT05097976|Prednisolone|prednisolone|mesh-list
154212895|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
154212896|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154212897|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
154212899|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
154212928|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153536144|NCT01520389|Irinotecan|irinotecan|mesh-list
154212929|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212930|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
154212931|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212932|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154212933|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212934|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154212935|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
154212936|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154212937|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154212938|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212939|NCT05015621|Antidotes|antidotes|mesh-ancestor
154212940|NCT05015621|Protective Agents|protective agents|mesh-ancestor
154212941|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
154212942|NCT05015621|Vitamins|vitamins|mesh-ancestor
154212943|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
154212944|NCT04977830|Xenon|xenon|mesh-list
154212945|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154212946|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
154212986|NCT04745832|Vincristine|vincristine|mesh-list
154212987|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154212988|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
154212989|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212990|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212991|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154212992|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
154212993|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212994|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212995|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154212996|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212999|NCT04745832|Hormones|hormones|mesh-ancestor
154213051|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154213052|NCT04561375|Narcotics|narcotics|mesh-ancestor
154213053|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154213054|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213055|NCT04561375|Analgesics|analgesics|mesh-ancestor
154213056|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
154213057|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213058|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154213059|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153960055|NCT06214910|Rifapentine|rifapentine|mesh-list
153536218|NCT01520818|Insulin|insulin|mesh-list
153960056|NCT06214910|Antitubercular Agents|antitubercular agents|mesh-ancestor
153960057|NCT06214910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153960058|NCT06214910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153960059|NCT06214910|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153960060|NCT06214910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154213115|NCT04439799|Androgens|androgens|mesh-ancestor
154213116|NCT04439799|Hormones|hormones|mesh-ancestor
154213117|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213118|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213119|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213120|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213121|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
154213122|NCT04435782|Selexipag|selexipag|mesh-list
154213123|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154213124|NCT04415944|Carboplatin|carboplatin|mesh-list
154213125|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213169|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154213170|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
154213171|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154213172|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
154213173|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154213174|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213175|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154213176|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213177|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213178|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154213179|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154213180|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
154213181|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213182|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213183|NCT04194216|Clindamycin|clindamycin|mesh-list
154213184|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
154213185|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
154213186|NCT04194216|Cephalexin|cephalexin|mesh-list
154213226|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154213228|NCT03971409|Camptothecin|camptothecin|mesh-list
154213229|NCT03971409|Antibodies|antibodies|mesh-list
154213230|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154213231|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
154213232|NCT03971409|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154213233|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
154213234|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
154213235|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213236|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153536356|NCT01521936|Vitamins|vitamins|mesh-list
154213237|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213240|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213289|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154213290|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213291|NCT03721341|Hormones|hormones|mesh-list
154213292|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213293|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213294|NCT03692910|Zuranolone|zuranolone|mesh-list
154213295|NCT03692910|Antidepressive Agents|antidepressive agents|mesh-ancestor
154213296|NCT03692910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154213297|NCT03682289|Durvalumab|durvalumab|mesh-list
154213298|NCT03682289|Olaparib|olaparib|mesh-list
154213299|NCT03682289|Adenosine|adenosine|mesh-list
154213300|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154213301|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213302|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213303|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
154213304|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213305|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154213306|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213307|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213308|NCT03682289|Analgesics|analgesics|mesh-ancestor
154213309|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
154213310|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213311|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154213312|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
154213313|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154213314|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
154213315|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
154213316|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213317|NCT03675256|Vaccines|vaccines|mesh-list
154213318|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
154213319|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213320|NCT03645863|Iron|iron|mesh-list
154213321|NCT03645863|Trace Elements|trace elements|mesh-ancestor
154213322|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
154213323|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213324|NCT03643367|Propofol|propofol|mesh-list
154213328|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213329|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154213330|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
154213331|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
154213332|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154213333|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154213334|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154213335|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154213336|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213337|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213338|NCT03587844|Immunotoxins|immunotoxins|mesh-ancestor
154213339|NCT03587844|Immunoconjugates|immunoconjugates|mesh-ancestor
154213340|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
154213341|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213342|NCT03584152|Acetaminophen|acetaminophen|mesh-list
153960282|NCT05903131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154213343|NCT03584152|Ibuprofen|ibuprofen|mesh-list
154213344|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154213345|NCT03584152|Analgesics|analgesics|mesh-ancestor
154213346|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
153536416|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154213347|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213348|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213349|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
154213356|NCT03545464|Prednisone|prednisone|mesh-list
154213379|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154213380|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154213381|NCT03326791|Analgesics|analgesics|mesh-ancestor
154213382|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
154213383|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213384|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213385|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213386|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213387|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154213388|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154213389|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213390|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154213391|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154213392|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213393|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
154213394|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
154213395|NCT03220776|Gabapentin|gabapentin|mesh-list
154213396|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154213397|NCT03220776|Analgesics|analgesics|mesh-ancestor
154213398|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
154213399|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213400|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213401|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
154213402|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154213403|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154213404|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154213405|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154213410|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
154213425|NCT03122197|Alkylating Agents|alkylating agents|mesh-ancestor
154213426|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213427|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213428|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154213429|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154213430|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213431|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154213432|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
154213433|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213434|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213435|NCT03029702|Metformin|metformin|mesh-list
154213436|NCT03029702|Glyburide|glyburide|mesh-list
154213437|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536434|NCT01522534|Narcotics|narcotics|mesh-ancestor
154213438|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536463|NCT01522612|Vitamins|vitamins|mesh-ancestor
154213439|NCT03014648|Atezolizumab|atezolizumab|mesh-list
154213440|NCT03014648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154213443|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536579|NCT01523080|Acetaminophen|acetaminophen|mesh-list
154213483|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154213484|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154213485|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
154213486|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154213487|NCT02760498|Cemiplimab|cemiplimab|mesh-list
154213488|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213489|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213490|NCT02684058|Carboplatin|carboplatin|mesh-list
154213491|NCT02684058|Vincristine|vincristine|mesh-list
154213492|NCT02684058|Trametinib|trametinib|mesh-list
154213493|NCT02684058|Dabrafenib|dabrafenib|mesh-list
154213494|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213495|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154213496|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213497|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213498|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213499|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213500|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154213542|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
154213543|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
154213544|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
154213546|NCT02506959|Melphalan|melphalan|mesh-list
154213547|NCT02506959|Busulfan|busulfan|mesh-list
154213548|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
154213549|NCT02506959|Panobinostat|panobinostat|mesh-list
154213550|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154213551|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154213552|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
154213553|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213554|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213555|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154213556|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
154213557|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154213558|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213559|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
154213560|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213561|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154213562|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213563|NCT02502006|Celecoxib|celecoxib|mesh-list
154213564|NCT02502006|Naproxen|naproxen|mesh-list
154213565|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154213566|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154213567|NCT02502006|Analgesics|analgesics|mesh-ancestor
154213568|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
154213571|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213590|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154213591|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154213592|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154213593|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
154213594|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213595|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213596|NCT02327455|Protective Agents|protective agents|mesh-ancestor
154213597|NCT02323698|Caffeine|caffeine|mesh-list
154213598|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154213599|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213600|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154213601|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213603|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154213650|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213651|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213652|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213653|NCT01651403|Tenofovir|tenofovir|mesh-list
154213654|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
154213655|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213656|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154213657|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154213658|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213659|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213660|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154213661|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154213662|NCT01515748|Docetaxel|docetaxel|mesh-list
154213663|NCT01515748|Fluorouracil|fluorouracil|mesh-list
154213664|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
154213665|NCT01515748|Tegafur|tegafur|mesh-list
154213666|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213667|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213706|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213707|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213708|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154213709|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213710|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
154213711|NCT01088750|Hormones|hormones|mesh-ancestor
153618960|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536838|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153536839|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154213712|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213713|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213714|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154213715|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213716|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213717|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213768|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
154213769|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213770|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213771|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154213772|NCT01076842|Insulin|insulin|mesh-list
154213773|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154213774|NCT01076842|Exenatide|exenatide|mesh-list
154213775|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
154213776|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154213777|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213778|NCT01076842|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154213779|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154213780|NCT01076842|Incretins|incretins|mesh-ancestor
154213781|NCT01076842|Hormones|hormones|mesh-ancestor
154213782|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213783|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
154213793|NCT00231465|Docetaxel|docetaxel|mesh-list
154213827|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154213828|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213829|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154213830|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
154213831|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213832|NCT00182637|Bortezomib|bortezomib|mesh-list
154213833|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213834|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154213835|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
154213836|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154213837|NCT00122278|Dexamethasone|dexamethasone|mesh-list
154213838|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213839|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
154213840|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
154213841|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213885|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
154213886|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213887|NCT00516269|Methylphenidate|methylphenidate|mesh-list
154213888|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154213889|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213890|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154213891|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154213892|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154213893|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213894|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
154213895|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213896|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154213897|NCT00228813|Lenograstim|lenograstim|mesh-list
154213898|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154213899|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
154213900|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213902|NCT00322374|Epothilones|epothilones|mesh-list
154213903|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154213904|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213938|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213939|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
154213940|NCT02533284|Analgesics|analgesics|mesh-ancestor
154213941|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
154213942|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213943|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213944|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
154213945|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154213946|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154213947|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
154213948|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154213949|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154213950|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213951|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154213952|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
154213953|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154213954|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
153536931|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154213955|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154213956|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
154213957|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213958|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213989|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154213990|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213991|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154213992|NCT01080742|Bisoprolol|bisoprolol|mesh-list
154213993|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154213994|NCT01080742|Diuretics|diuretics|mesh-ancestor
154213995|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
154213996|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213997|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154213998|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154213999|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214000|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
154214001|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
154214002|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214003|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154214004|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154214005|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154214006|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
154214007|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214008|NCT00131248|Metoclopramide|metoclopramide|mesh-list
154214009|NCT00131248|Ranitidine|ranitidine|mesh-list
154214010|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154214011|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
154214012|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
154214013|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214014|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214015|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214016|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154214017|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153960956|NCT04077736|Aldesleukin|aldesleukin|mesh-list
154214018|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
154214019|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214020|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214021|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154214022|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154214023|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
154214026|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
154214027|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214028|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
154214029|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
153537042|NCT06051786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214030|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214031|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154214032|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154214033|NCT01049204|Maraviroc|maraviroc|mesh-list
154214034|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154214037|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154214090|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214091|NCT01078714|Bumetanide|bumetanide|mesh-list
154214092|NCT01078714|Diuretics|diuretics|mesh-ancestor
154214093|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
154214094|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214095|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154214096|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154214097|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214098|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
154214099|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154214100|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
154214101|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214102|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214149|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214150|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
154214151|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214152|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214153|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
154214154|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154214155|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154214156|NCT01078870|Analgesics|analgesics|mesh-ancestor
154214157|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
154214158|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
154214159|NCT00105196|Aripiprazole|aripiprazole|mesh-list
154214160|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
154214161|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154214162|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154214163|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154214164|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214165|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214166|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
154214167|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
154214168|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214169|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214203|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537112|NCT05891262|Norethindrone|norethindrone|mesh-list
153537114|NCT05891262|Estradiol|estradiol|mesh-list
154214204|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214205|NCT00103402|Alfuzosin|alfuzosin|mesh-list
154214206|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154214207|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154214208|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154214209|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
154214210|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214211|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214212|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214214|NCT00095836|Gefitinib|gefitinib|mesh-list
154214265|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154214266|NCT04580147|Growth Substances|growth substances|mesh-ancestor
154214267|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214268|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
154214269|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214270|NCT00228423|Clopidogrel|clopidogrel|mesh-list
154214271|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154214272|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154214273|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154214274|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154214275|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
154214328|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154214329|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214330|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154214331|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
154214332|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
154214333|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154214334|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
154214335|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154214336|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154214337|NCT00511355|Estradiol|estradiol|mesh-list
154214338|NCT00511355|Estrogens|estrogens|mesh-ancestor
154214339|NCT00511355|Hormones|hormones|mesh-ancestor
154214340|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154214341|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214350|NCT01083784|Valproic Acid|valproic acid|mesh-list
154214386|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214387|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154214389|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214390|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154214391|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154214392|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
154214393|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537217|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153537319|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
154214394|NCT00384176|Leucovorin|leucovorin|mesh-list
154214395|NCT00384176|Bevacizumab|bevacizumab|mesh-list
154214454|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
154214455|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154214456|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154214457|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214458|NCT01012349|Aspirin|aspirin|mesh-list
154214459|NCT01012349|Citric Acid|citric acid|mesh-list
154214460|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
154214461|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154214462|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154214463|NCT01012349|Analgesics|analgesics|mesh-ancestor
153961401|NCT02396979|Analgesics|analgesics|mesh-ancestor
154214464|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
154214465|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214466|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214467|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214468|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214469|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154214470|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154214471|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214472|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154214473|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154214474|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214475|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
154214476|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
154214477|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154214478|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
154214479|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
154214480|NCT00358826|Atreleuton|atreleuton|mesh-list
154214481|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154214482|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214483|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214484|NCT01009541|Pregabalin|pregabalin|mesh-list
154214485|NCT01009541|Analgesics|analgesics|mesh-ancestor
154214493|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154214494|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154214495|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154214496|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214497|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154214498|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
153537325|NCT04888858|Bupivacaine|bupivacaine|mesh-list
154214499|NCT00510653|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153537326|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
154214500|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154214501|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214502|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214503|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214556|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214557|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214558|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214559|NCT00505661|Letrozole|letrozole|mesh-list
154214560|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214561|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154214562|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154214563|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214564|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214565|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154214566|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
154214567|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154214568|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214569|NCT00383786|Vofopitant|vofopitant|mesh-list
154214570|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
154214571|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
154214572|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214573|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214574|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214575|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154214576|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214577|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214578|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154214579|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
154214580|NCT05358977|Coagulants|coagulants|mesh-ancestor
154214581|NCT01010243|Pioglitazone|pioglitazone|mesh-list
154214582|NCT01010243|Dexamethasone|dexamethasone|mesh-list
154214583|NCT01010243|Lenalidomide|lenalidomide|mesh-list
154214602|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154214603|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
154214604|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214606|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214607|NCT00504881|Brivaracetam|brivaracetam|mesh-list
154214608|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
154214609|NCT00504725|Ketamine|ketamine|mesh-list
154214610|NCT00504725|Analgesics|analgesics|mesh-ancestor
154214611|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
154214612|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214613|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153961559|NCT01327781|Tamoxifen|tamoxifen|mesh-list
154214615|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154214616|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
154214617|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
154214618|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214619|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154214620|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154214621|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214622|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214623|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
154214624|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
154214625|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154214626|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
154214627|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214628|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214649|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154214650|NCT00383162|Analgesics|analgesics|mesh-ancestor
154214651|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
154214652|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214653|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214654|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214655|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214656|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
154214657|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154214658|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214659|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214660|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154214661|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154214662|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154214663|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
154214664|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214665|NCT01052792|Naproxen|naproxen|mesh-list
154214666|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154214667|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154214668|NCT01052792|Analgesics|analgesics|mesh-ancestor
154214669|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
154214670|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214678|NCT01052870|Finasteride|finasteride|mesh-list
154214698|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
154214699|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214700|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154214701|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214702|NCT00361634|Etanercept|etanercept|mesh-list
154214703|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154214704|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154214705|NCT00361634|Analgesics|analgesics|mesh-ancestor
154214706|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
154214707|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214708|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214709|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214710|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214711|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214712|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214713|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
154214714|NCT00357968|Clopidogrel|clopidogrel|mesh-list
154214715|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154214716|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154214717|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154214718|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154214750|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154214751|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154214752|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
154214753|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154214754|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214755|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153537711|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214756|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154214757|NCT00357500|Growth Substances|growth substances|mesh-ancestor
154214758|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
154214759|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154214761|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154214762|NCT00357110|Fulvestrant|fulvestrant|mesh-list
154214763|NCT00357110|Anastrozole|anastrozole|mesh-list
154214764|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154214765|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214766|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154214767|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154214768|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
154214769|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154214770|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214771|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154214772|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154214773|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214774|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214775|NCT00098722|Maraviroc|maraviroc|mesh-list
154214776|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154214777|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154214778|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214795|NCT00098254|Sorafenib|sorafenib|mesh-list
154214796|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214797|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154214798|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214799|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214800|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154214801|NCT00095056|Glipizide|glipizide|mesh-list
154214802|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154214803|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214804|NCT00095056|Incretins|incretins|mesh-ancestor
154214805|NCT00095056|Hormones|hormones|mesh-ancestor
154214806|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154214807|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154214808|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
154214809|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214810|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214811|NCT00098020|Isotretinoin|isotretinoin|mesh-list
154214812|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
154214813|NCT03292250|Durvalumab|durvalumab|mesh-list
154214814|NCT03292250|Tremelimumab|tremelimumab|mesh-list
154214815|NCT03292250|Nintedanib|nintedanib|mesh-list
154214816|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154214817|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214818|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154214819|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537757|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
154214820|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214844|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
154214845|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
154214846|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214847|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154214848|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
154214849|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
154214850|NCT01050374|Albendazole|albendazole|mesh-list
154214851|NCT01050374|Praziquantel|praziquantel|mesh-list
154214852|NCT01050374|Mebendazole|mebendazole|mesh-list
154214853|NCT01050374|Piperazine|piperazine|mesh-list
154214854|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
154214855|NCT01050374|DMP 777|dmp 777|mesh-list
154214856|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
154214857|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154214858|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214859|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
154214860|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154214907|NCT01074723|Carotenoids|carotenoids|mesh-list
154214908|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
154214909|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214910|NCT01074723|Protective Agents|protective agents|mesh-ancestor
154214911|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214912|NCT01074801|Insulin|insulin|mesh-list
154214913|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154214914|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154214915|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214916|NCT01074879|Caseins|caseins|mesh-list
154214917|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
154214918|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
154214919|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214920|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
154214921|NCT00226941|Promethazine|promethazine|mesh-list
154214922|NCT00226941|Capecitabine|capecitabine|mesh-list
154214923|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
154214924|NCT00226941|Cetuximab|cetuximab|mesh-list
154214925|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154214926|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
153537835|NCT00133705|Mifepristone|mifepristone|mesh-list
154214927|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214928|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537836|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154214929|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154214930|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154214931|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154214932|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537991|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537992|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537993|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153537994|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
154214933|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214934|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
154214935|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
154214936|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
154214937|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214951|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214952|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214953|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
154214954|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214955|NCT01075581|Epinephrine|epinephrine|mesh-list
154214956|NCT01075581|Racepinephrine|racepinephrine|mesh-list
154214957|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
154214958|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154214959|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154214960|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
154214961|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214962|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214963|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214964|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154214965|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154214966|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
154214967|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214968|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154214969|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
154214970|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
153537995|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
154214971|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
154214972|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154214973|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
153538247|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538248|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214974|NCT00356408|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154214975|NCT00356408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214976|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214977|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
154214978|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214979|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214980|NCT00509795|Ranibizumab|ranibizumab|mesh-list
154214981|NCT00509795|Aflibercept|aflibercept|mesh-list
154214982|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154214983|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154214984|NCT00509795|Growth Substances|growth substances|mesh-ancestor
154214985|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214986|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
154214988|NCT00504257|Bevacizumab|bevacizumab|mesh-list
154214989|NCT00504257|Docetaxel|docetaxel|mesh-list
154214990|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154214991|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214992|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154214993|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154214994|NCT00504257|Growth Substances|growth substances|mesh-ancestor
154214995|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214996|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
154214997|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
154214998|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
154214999|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
154215000|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215001|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
154215002|NCT00509093|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215003|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215004|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215005|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215006|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215007|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
154215008|NCT00160641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154215009|NCT00160641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538312|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
154215010|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215011|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
154215012|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215038|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
154215039|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215040|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215041|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154215042|NCT01073319|Protective Agents|protective agents|mesh-ancestor
154215043|NCT00160563|Levocetirizine|levocetirizine|mesh-list
154215044|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154215045|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154215046|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
154215047|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
154215048|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215049|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215050|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215051|NCT01050452|Ivermectin|ivermectin|mesh-list
154215052|NCT01050452|Albendazole|albendazole|mesh-list
154215053|NCT01050452|Mebendazole|mebendazole|mesh-list
154215054|NCT01050452|Piperazine|piperazine|mesh-list
154215055|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
154215056|NCT01050452|DMP 777|dmp 777|mesh-list
154215057|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154215058|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215059|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
154215060|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
154215061|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154215062|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154215063|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
154215064|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
154215065|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
154215066|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215067|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215068|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
154215069|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215073|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
154215082|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154215083|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154215084|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215085|NCT03990038|Ropivacaine|ropivacaine|mesh-list
154215086|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
154215087|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
154215088|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154215089|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215090|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
154215091|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215092|NCT00355784|Hormones|hormones|mesh-list
154215093|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153538429|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154215094|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215095|NCT02534636|Interferons|interferons|mesh-list
154215096|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
154215097|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
154215098|NCT02534636|Deucravacitinib|deucravacitinib|mesh-list
154215099|NCT02534636|Famotidine|famotidine|mesh-list
154215100|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215101|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
154215102|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215103|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
154215104|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215105|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154215106|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154215125|NCT01050608|Ethanol|ethanol|mesh-list
154215132|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
154215133|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215134|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154215135|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154215136|NCT01053806|Growth Substances|growth substances|mesh-ancestor
154215137|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
154215138|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215139|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215140|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
154215141|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215142|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215144|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215145|NCT01053884|Anidulafungin|anidulafungin|mesh-list
154215146|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
154215147|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215148|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154215149|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
154215150|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215151|NCT01010789|Modafinil|modafinil|mesh-list
154215152|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154215153|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215154|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154215155|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154215156|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154215157|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215158|NCT01015235|Ketorolac|ketorolac|mesh-list
154215159|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154215160|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154215161|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154215162|NCT01015235|Analgesics|analgesics|mesh-ancestor
154215163|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
154215164|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215170|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215171|NCT00508157|Olanzapine|olanzapine|mesh-list
153538771|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215172|NCT00508157|Risperidone|risperidone|mesh-list
154215173|NCT00508157|Aripiprazole|aripiprazole|mesh-list
154215174|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154215175|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
154215176|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154215177|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
154215178|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215179|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215180|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215181|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154215182|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154215183|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154215184|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154215185|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
154215186|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
154215187|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
154215188|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215189|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154215190|NCT00508157|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154215191|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154215192|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154215193|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
154215194|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
154215195|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154215196|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154215197|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154215198|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154215199|NCT04331717|Leuprolide|leuprolide|mesh-list
154215200|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154215201|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
154215202|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154215203|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215204|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638114|NCT00005876|Rubitecan|rubitecan|mesh-list
154215206|NCT01015391|Azathioprine|azathioprine|mesh-list
154215207|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
154157461|NCT05763875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153538772|NCT01529619|Rivastigmine|rivastigmine|mesh-list
154215208|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538847|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154215209|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215210|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215211|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215212|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
154215213|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215214|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215215|NCT01010945|Paclitaxel|paclitaxel|mesh-list
154215216|NCT01010945|Gemcitabine|gemcitabine|mesh-list
154215217|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154215218|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154215219|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215220|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
154215221|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
154215222|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
154215223|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215224|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215225|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
154215226|NCT01010945|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215227|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215228|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215229|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
154215230|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154215231|NCT00507689|Antibodies|antibodies|mesh-list
154215232|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
154215233|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215234|NCT00491387|Metoprolol|metoprolol|mesh-list
154215251|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154215252|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
154215253|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215254|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215255|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215256|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
154215257|NCT01015547|Infliximab|infliximab|mesh-list
154215258|NCT01015547|Methotrexate|methotrexate|mesh-list
154215259|NCT01015547|Naltrexone|naltrexone|mesh-list
154215260|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154215261|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
154215262|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154215263|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215264|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215265|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
154215266|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215267|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215268|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
154215269|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215270|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154215271|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215272|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
154215273|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215274|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154215275|NCT01015547|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154215276|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215277|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154215278|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215279|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154215280|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154215294|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154215297|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154215298|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154215299|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154215300|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
154215301|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215302|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215303|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215304|NCT00507455|Urological Agents|urological agents|mesh-ancestor
154215305|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154215306|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154215307|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
154215308|NCT04275713|Metformin|metformin|mesh-list
154215309|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215310|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215311|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
154215312|NCT00506831|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215313|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215314|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215315|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215316|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215317|NCT00490919|Buprenorphine|buprenorphine|mesh-list
154215318|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154215319|NCT00490919|Narcotics|narcotics|mesh-ancestor
154215320|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154215321|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215322|NCT00490919|Analgesics|analgesics|mesh-ancestor
154215323|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
154215324|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215325|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154215326|NCT01015937|Losartan|losartan|mesh-list
154215327|NCT01015937|Enalapril|enalapril|mesh-list
154215328|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
154215329|NCT01015937|Giapreza|giapreza|mesh-list
153538885|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154215335|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153538919|NCT01530503|Capecitabine|capecitabine|mesh-list
154215336|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154215337|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215338|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
154215339|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215340|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
154215341|NCT01015937|Protective Agents|protective agents|mesh-ancestor
154215342|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215343|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154215344|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154215345|NCT01012193|Cilostazol|cilostazol|mesh-list
154215346|NCT01012193|Clopidogrel|clopidogrel|mesh-list
154215347|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154215348|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154215349|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154215350|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154215351|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
154215352|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215355|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154215389|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215390|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215391|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154215392|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
154215393|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
154215394|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154215401|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
154215454|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154215455|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154215456|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
154157462|NCT05763875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153539065|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
154215457|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215458|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154215459|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
154215460|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
154215461|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
154215462|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154215464|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154215465|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
154215466|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
154215467|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215468|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215469|NCT00502775|Fluticasone|fluticasone|mesh-list
154215470|NCT00502775|Xhance|xhance|mesh-list
154215471|NCT00502775|Fexofenadine|fexofenadine|mesh-list
154215472|NCT00502775|Terfenadine|terfenadine|mesh-list
154215473|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215474|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154215475|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
154215476|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215477|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215478|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154215479|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
154215480|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
154215481|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154215482|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154215502|NCT01050842|Bicalutamide|bicalutamide|mesh-list
154215503|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
154215504|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
154215505|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215506|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215507|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215508|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154215509|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154215510|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154215511|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154215512|NCT00485069|Levodopa|levodopa|mesh-list
154215513|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154215514|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154215515|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
154215516|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215517|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215557|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215558|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154215559|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215560|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154215562|NCT00376688|Temsirolimus|temsirolimus|mesh-list
154215563|NCT00376688|MTOR Inhibitors|mtor inhibitors|mesh-list
154215564|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154215565|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215566|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154215567|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215568|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
154215569|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215570|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
154215571|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215572|NCT00376688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215573|NCT00376688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215574|NCT00376688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215575|NCT00376220|Riluzole|riluzole|mesh-list
154215576|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
154215577|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154215578|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154215579|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215580|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215581|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215582|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154215584|NCT00375752|Letrozole|letrozole|mesh-list
154215601|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215602|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215603|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154215604|NCT01013831|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215605|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215606|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215607|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215608|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215609|NCT01013909|Terbinafine|terbinafine|mesh-list
154215610|NCT01013909|Bifonazole|bifonazole|mesh-list
154215611|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
154215612|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215613|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215614|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215615|NCT01013987|Ritonavir|ritonavir|mesh-list
154215616|NCT01013987|Darunavir|darunavir|mesh-list
154215617|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
154215618|NCT01013987|Maraviroc|maraviroc|mesh-list
154215619|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154215620|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154215621|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
154215622|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539136|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154215623|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539225|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154215624|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154215625|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154215626|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
154215627|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215628|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154215648|NCT00490529|Rituximab|rituximab|mesh-list
154215649|NCT00490529|Vaccines|vaccines|mesh-list
154215650|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
154215651|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215652|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215653|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215654|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154215655|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
154215656|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215657|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215658|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154215659|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154215660|NCT00333840|Interferons|interferons|mesh-list
154215661|NCT00333840|Cytarabine|cytarabine|mesh-list
154215662|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
154215663|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
154215664|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
154215709|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
154215710|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154215711|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215712|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154215713|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154215714|NCT00321828|Growth Substances|growth substances|mesh-ancestor
154215715|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215716|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
154215717|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
154215718|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215719|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215720|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215721|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
154215722|NCT00321828|Antidotes|antidotes|mesh-ancestor
154215768|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215769|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154157463|NCT05763875|Antimetabolites|antimetabolites|mesh-ancestor
153539228|NCT01532232|Varenicline|varenicline|mesh-list
154215770|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153539371|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539372|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
154215771|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215772|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215773|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
154215774|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
154215775|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
154215776|NCT00321672|Capsaicin|capsaicin|mesh-list
154215777|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
154215778|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
154215779|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
154215780|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215781|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215782|NCT00330174|Acamprosate|acamprosate|mesh-list
154215783|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154215784|NCT00320424|PENTA|penta|mesh-list
154215785|NCT00320424|Fondaparinux|fondaparinux|mesh-list
154215786|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154215787|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
154215788|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154215789|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
154215790|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215821|NCT00320190|Dasatinib|dasatinib|mesh-list
154215822|NCT00320190|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215823|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215824|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215825|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215826|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215827|NCT02534402|Prednisone|prednisone|mesh-list
154215828|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215829|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
154215830|NCT02534402|Hormones|hormones|mesh-ancestor
154215831|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215832|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215833|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154215834|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215835|NCT00319956|Azithromycin|azithromycin|mesh-list
154215836|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154215837|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215838|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154215839|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215840|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215841|NCT01062048|Incretins|incretins|mesh-ancestor
154215842|NCT01062048|Hormones|hormones|mesh-ancestor
154215843|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215844|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154215845|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
154215846|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215847|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215848|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
154215849|NCT00349622|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154215850|NCT00349622|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154215851|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154215852|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215853|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154215854|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215855|NCT03987698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154215856|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460007|NCT05041127|Cetuximab|cetuximab|mesh-list
154215857|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
154215858|NCT01054508|Niacin|niacin|mesh-list
154215859|NCT01054508|Niacinamide|niacinamide|mesh-list
154215860|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
154215861|NCT01054508|Vitamins|vitamins|mesh-ancestor
154215862|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
154215863|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215864|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154215865|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
154215866|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215867|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154215868|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
154215869|NCT00348686|Felodipine|felodipine|mesh-list
154215870|NCT00348686|Candesartan|candesartan|mesh-list
154215871|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
154215872|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154215873|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154215874|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154215875|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215876|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154215877|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154215878|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154215879|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154215880|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215881|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
154215882|NCT00360230|Vaccines|vaccines|mesh-list
154215884|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215885|NCT03989024|Clomiphene|clomiphene|mesh-list
154215886|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154215887|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154215888|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
154215889|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215890|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215891|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154215892|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
154215893|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153539528|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215897|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
154215898|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215899|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215900|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
154215901|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215902|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215903|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154215904|NCT03742232|Laxatives|laxatives|mesh-ancestor
154215905|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154215906|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
154215907|NCT00352664|Donepezil|donepezil|mesh-list
154215908|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154215909|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215910|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215911|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
154215912|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215913|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215914|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
154215915|NCT03991442|Amlodipine|amlodipine|mesh-list
154215916|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154215917|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154215918|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154215919|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215920|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154215921|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215922|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
154215923|NCT03742310|Vitamin D|vitamin d|mesh-list
154215924|NCT03742310|Calcitriol|calcitriol|mesh-list
154215925|NCT03742310|Vitamins|vitamins|mesh-ancestor
154215926|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
154215941|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215942|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
154215943|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215944|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215945|NCT01051388|Rabeprazole|rabeprazole|mesh-list
154215946|NCT01051388|Gefarnate|gefarnate|mesh-list
154215947|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154215948|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154215949|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154215950|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157500|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
153539530|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154215951|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215952|NCT00490061|Lapatinib|lapatinib|mesh-list
154215953|NCT00490061|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215954|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215955|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153962914|NCT05438264|Donepezil|donepezil|mesh-list
154215956|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215957|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215958|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
154215959|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
154215960|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154215961|NCT00483119|Antibodies|antibodies|mesh-list
154215992|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215993|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215994|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154215995|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215996|NCT00482729|Metformin|metformin|mesh-list
154215997|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154215998|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215999|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216000|NCT00482729|Incretins|incretins|mesh-ancestor
154216001|NCT00482729|Hormones|hormones|mesh-ancestor
154216002|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154216003|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154216004|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
154216005|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216006|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216007|NCT00359762|Exenatide|exenatide|mesh-list
154216008|NCT00359762|Glimepiride|glimepiride|mesh-list
154216009|NCT00359762|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154216010|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154216011|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216012|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154216013|NCT00359762|Incretins|incretins|mesh-ancestor
154216014|NCT00359762|Hormones|hormones|mesh-ancestor
154216015|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154216016|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154216040|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154216041|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
154216042|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216043|NCT03987152|Sirolimus|sirolimus|mesh-list
154216044|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154216045|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539630|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154216046|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154216047|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216048|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
154216049|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153539685|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154216050|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
154216051|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216052|NCT00347438|Capecitabine|capecitabine|mesh-list
154216053|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154216054|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
154216055|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216056|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216057|NCT00329238|Warfarin|warfarin|mesh-list
154216058|NCT00329238|Dabigatran|dabigatran|mesh-list
154216059|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
154216060|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
154216061|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154216062|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
154216063|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216064|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216065|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154216066|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154216067|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154216068|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
154216069|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216082|NCT00319254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216083|NCT00319254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216084|NCT00347360|Carvedilol|carvedilol|mesh-list
154216085|NCT00347360|Lisinopril|lisinopril|mesh-list
154216086|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154216087|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154216088|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
154216089|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216090|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216091|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216092|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154216093|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
154216094|NCT00347360|Protective Agents|protective agents|mesh-ancestor
154216095|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154216096|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154216097|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154216098|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
154216099|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154216100|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154216101|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154216102|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
154216103|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216104|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154216105|NCT00319020|Bosentan|bosentan|mesh-list
154216106|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154216107|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154216108|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216109|NCT01056224|Remifentanil|remifentanil|mesh-list
154216110|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154216111|NCT01056224|Narcotics|narcotics|mesh-ancestor
154216112|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539686|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539741|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154216113|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216114|NCT01056224|Analgesics|analgesics|mesh-ancestor
154216115|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
154216116|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216117|NCT03982680|Gemcitabine|gemcitabine|mesh-list
153639028|NCT00005993|Aldesleukin|aldesleukin|mesh-list
154216118|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154216119|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
154216120|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216121|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216122|NCT00352118|Docetaxel|docetaxel|mesh-list
154216123|NCT00352118|Fluorouracil|fluorouracil|mesh-list
154216124|NCT00352118|Lenograstim|lenograstim|mesh-list
154216125|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216126|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154216127|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216128|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216129|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216130|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
154216131|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154216132|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216133|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
154216134|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216135|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154216136|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
154216137|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154216138|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154216139|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154216140|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216141|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154216142|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
154216143|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154216144|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216145|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216146|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
154216147|NCT00350870|Disulfiram|disulfiram|mesh-list
154216148|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154216149|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154216150|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216151|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216152|NCT00350792|Carboplatin|carboplatin|mesh-list
154216153|NCT00350792|Pemetrexed|pemetrexed|mesh-list
154216154|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216155|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216156|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216157|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154216158|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154216159|NCT00317772|Topotecan|topotecan|mesh-list
154216160|NCT00317772|Gefitinib|gefitinib|mesh-list
154216161|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154216162|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154216163|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216164|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216165|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216166|NCT00317772|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154216167|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153539789|NCT01535677|Metformin|metformin|mesh-list
154216168|NCT01325298|Riboflavin|riboflavin|mesh-list
154216169|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
154216170|NCT01325298|Vitamins|vitamins|mesh-ancestor
154216171|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
154216175|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
154216213|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216214|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216215|NCT00327444|Aflibercept|aflibercept|mesh-list
154216216|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154216217|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154216218|NCT00327444|Growth Substances|growth substances|mesh-ancestor
154216219|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216220|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
154216221|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216222|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
154216223|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154216224|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216225|NCT03982134|Panobinostat|panobinostat|mesh-list
154216226|NCT03982134|Spartalizumab|spartalizumab|mesh-list
154216227|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216228|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154216229|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216230|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216231|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154216232|NCT03982134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154216233|NCT00337610|Metformin|metformin|mesh-list
154216234|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154216235|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154216236|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216237|NCT00337610|Incretins|incretins|mesh-ancestor
154216238|NCT00337610|Hormones|hormones|mesh-ancestor
154216239|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154216240|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154216241|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
154216242|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216243|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216244|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154216245|NCT01062204|Laxatives|laxatives|mesh-ancestor
154216246|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154216247|NCT01062282|Iloprost|iloprost|mesh-list
154216248|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154216249|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
154216250|NCT03985280|Anesthetics|anesthetics|mesh-list
154216251|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
153963202|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216252|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216253|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216254|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
154216255|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216257|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154216258|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
154216259|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216260|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216261|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154216262|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154216263|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
154216264|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216265|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216266|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
154216267|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
154216268|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539830|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153539831|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
153539832|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539833|NCT01535989|Sirolimus|sirolimus|mesh-list
153539834|NCT01535989|Temsirolimus|temsirolimus|mesh-list
153539836|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153539837|NCT01535989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153539838|NCT01535989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539839|NCT01535989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539840|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216269|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216270|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216271|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216272|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154216273|NCT01051934|Paclitaxel|paclitaxel|mesh-list
154216274|NCT01051934|Bevacizumab|bevacizumab|mesh-list
154216275|NCT01051934|Carboplatin|carboplatin|mesh-list
154216276|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154216277|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216278|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
154216279|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216293|NCT00316914|Calcium|calcium|mesh-list
154216294|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154216295|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216296|NCT00316914|Analgesics|analgesics|mesh-ancestor
154216297|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
154216298|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216299|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
154216300|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216301|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154216302|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
154216303|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154216304|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154216305|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216306|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
154216307|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154216308|NCT00316602|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154216309|NCT00316602|Antiviral Agents|antiviral agents|mesh-ancestor
154216310|NCT00316602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216311|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
154216312|NCT00335972|Remifentanil|remifentanil|mesh-list
154216345|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
154216346|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154216347|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
153539893|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216348|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154216349|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216350|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154216351|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
154216352|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216353|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216354|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
154216355|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216356|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154216357|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216358|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
154216359|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216360|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154216361|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154216362|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
154216363|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154216364|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154216366|NCT00346034|Analgesics|analgesics|mesh-ancestor
153539901|NCT01536223|Docetaxel|docetaxel|mesh-list
153539902|NCT01536223|Fluorouracil|fluorouracil|mesh-list
153539903|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539904|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
153539905|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
153539906|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216367|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
153539907|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539908|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
153539909|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153539911|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
153539950|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153539951|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153539952|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153539953|NCT01536431|Insulin|insulin|mesh-list
153539954|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153539955|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154216368|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216369|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216370|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
154216371|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154216372|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154216373|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216375|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154216387|NCT01059110|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154216388|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
154216389|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216390|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153539956|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539957|NCT01536470|Norepinephrine|norepinephrine|mesh-list
154216391|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216392|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
154216393|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
154216394|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154216395|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216396|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154216397|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216398|NCT01059110|Analgesics|analgesics|mesh-ancestor
154216399|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
154216400|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153963349|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154216401|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216444|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216445|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154216446|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154216447|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
154216448|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216449|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216450|NCT01059422|Lamivudine|lamivudine|mesh-list
154216451|NCT01059422|Abacavir|abacavir|mesh-list
154216452|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
154216453|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154216454|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154216455|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216456|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216457|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
154216504|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154216505|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154216506|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216507|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
154216508|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154216509|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
154216510|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154216511|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
154216512|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
154216513|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154216514|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154216515|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
154216516|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539966|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539968|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
154216517|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216518|NCT01063842|Acetaminophen|acetaminophen|mesh-list
154216519|NCT01063842|Tramadol|tramadol|mesh-list
154216520|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216521|NCT01063842|Analgesics|analgesics|mesh-ancestor
154216522|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
154216523|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216524|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216525|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
154216526|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153540047|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153540048|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216527|NCT01063842|Narcotics|narcotics|mesh-ancestor
154216528|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216529|NCT01063920|Naproxen|naproxen|mesh-list
154216530|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154216531|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216532|NCT01063920|Analgesics|analgesics|mesh-ancestor
154216533|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
154216534|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216542|NCT01062516|Esomeprazole|esomeprazole|mesh-list
154216548|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216549|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154216550|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
153963500|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
154216551|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
154216552|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216553|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216554|NCT00334802|Paclitaxel|paclitaxel|mesh-list
154216555|NCT00334802|Gemcitabine|gemcitabine|mesh-list
154216556|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154216557|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216558|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
154216559|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216581|NCT01059890|Cefotaxime|cefotaxime|mesh-list
154216609|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216610|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
154216611|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216612|NCT02533544|Tenofovir|tenofovir|mesh-list
154216613|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
154216614|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157501|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216615|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154216616|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154216617|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216618|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216619|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154216620|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154216621|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154216622|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
154216623|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154216624|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154216625|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216626|NCT00325416|Melphalan|melphalan|mesh-list
154216662|NCT06252584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216663|NCT06252506|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154216664|NCT06252506|Harmine|harmine|mesh-list
154216665|NCT06252506|Hallucinogens|hallucinogens|mesh-ancestor
154216666|NCT06252506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216667|NCT06252506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154216668|NCT06252506|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154216669|NCT06252506|Serotonin Agents|serotonin agents|mesh-ancestor
154216670|NCT06252506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216671|NCT06252506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216672|NCT06252506|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154216673|NCT06252506|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154216674|NCT06252506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216675|NCT06252454|Furosemide|furosemide|mesh-list
154216724|NCT06252116|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154216725|NCT06252116|Analgesics|analgesics|mesh-ancestor
154216726|NCT06252116|Sensory System Agents|sensory system agents|mesh-ancestor
154216727|NCT06252116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216728|NCT06252116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216729|NCT06252116|Anticonvulsants|anticonvulsants|mesh-ancestor
154216730|NCT06252116|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154216731|NCT06252116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154216732|NCT06252116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216733|NCT06252116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154216734|NCT06252116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154216735|NCT06252116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154216736|NCT06252116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216737|NCT06252116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153540128|NCT01537744|Romidepsin|romidepsin|mesh-list
154216738|NCT06252116|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154216739|NCT06252116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154216740|NCT06252116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216741|NCT06252116|Antidepressive Agents|antidepressive agents|mesh-ancestor
154216742|NCT06252116|Dopamine Agents|dopamine agents|mesh-ancestor
154216743|NCT06252103|Lactoferrin|lactoferrin|mesh-list
154216744|NCT06252103|Ferrous gluconate|ferrous gluconate|mesh-list
154216745|NCT06252103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216746|NCT06252103|Hematinics|hematinics|mesh-ancestor
154216747|NCT06251999|Propofol|propofol|mesh-list
154216748|NCT06251999|Fospropofol|fospropofol|mesh-list
154216749|NCT06251999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154216750|NCT06251999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216751|NCT06251999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216752|NCT06251999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154216753|NCT06251999|Anesthetics, General|anesthetics, general|mesh-ancestor
154216754|NCT06251999|Anesthetics|anesthetics|mesh-ancestor
154216755|NCT06251739|Ivermectin|ivermectin|mesh-list
154216756|NCT06251739|Miltefosine|miltefosine|mesh-list
154216757|NCT06251739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154216758|NCT06251739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216763|NCT06251648|Immunologic Factors|immunologic factors|mesh-ancestor
154216764|NCT06251648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216765|NCT06251648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154216766|NCT06251648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154216767|NCT06251648|Growth Substances|growth substances|mesh-ancestor
154216768|NCT06251648|Growth Inhibitors|growth inhibitors|mesh-ancestor
154216769|NCT06251648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216770|NCT06251635|Insulin|insulin|mesh-list
154216771|NCT06251635|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154216772|NCT06251635|Insulin Lispro|insulin lispro|mesh-list
154216773|NCT06251635|Olanzapine|olanzapine|mesh-list
154216774|NCT06251635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154216775|NCT06251635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216776|NCT06251635|Antiemetics|antiemetics|mesh-ancestor
154216826|NCT06251180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216827|NCT06251180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216828|NCT06251180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154216829|NCT06251180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154216830|NCT06251180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154216831|NCT06251180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154216832|NCT06251180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154216833|NCT06251180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216834|NCT06251180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216836|NCT06251180|Hormones|hormones|mesh-ancestor
154216837|NCT06251180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154216895|NCT06250504|Tenofovir|tenofovir|mesh-list
154216896|NCT06250504|Emtricitabine|emtricitabine|mesh-list
154216897|NCT06250504|Dolutegravir|dolutegravir|mesh-list
154216898|NCT06250504|Cabotegravir|cabotegravir|mesh-list
153540176|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540177|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
154216899|NCT06250504|Dapivirine|dapivirine|mesh-list
154216900|NCT06250504|Antiviral Agents|antiviral agents|mesh-ancestor
154216901|NCT06250504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216902|NCT06250504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154216903|NCT06250504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154216904|NCT06250504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216905|NCT06250504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216906|NCT06250504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154216907|NCT06250504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154216908|NCT06250504|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154216909|NCT06250504|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154216910|NCT06250400|Loratadine|loratadine|mesh-list
154216911|NCT06250400|Antipruritics|antipruritics|mesh-ancestor
154216912|NCT06250400|Dermatologic Agents|dermatologic agents|mesh-ancestor
154216913|NCT06250400|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154216914|NCT06250400|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154216915|NCT06250400|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154216916|NCT06250400|Histamine Antagonists|histamine antagonists|mesh-ancestor
154216917|NCT06250400|Histamine Agents|histamine agents|mesh-ancestor
154216918|NCT06250400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216919|NCT06250400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216920|NCT06250400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216921|NCT06250348|Nitric Oxide|nitric oxide|mesh-list
154216922|NCT06250348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154216923|NCT06250348|Autonomic Agents|autonomic agents|mesh-ancestor
154216924|NCT06250348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216925|NCT06250348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216926|NCT06250348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154216927|NCT06250348|Respiratory System Agents|respiratory system agents|mesh-ancestor
153639833|NCT00018343|Estrogens|estrogens|mesh-list
154216930|NCT06250348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216931|NCT06250348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216932|NCT06250348|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154216933|NCT06250348|Vasodilator Agents|vasodilator agents|mesh-ancestor
154216934|NCT06250348|Gasotransmitters|gasotransmitters|mesh-ancestor
154216935|NCT06250348|Protective Agents|protective agents|mesh-ancestor
154216936|NCT06245356|Bevacizumab|bevacizumab|mesh-list
154216937|NCT06245356|Nivolumab|nivolumab|mesh-list
154216938|NCT06245356|Trastuzumab|trastuzumab|mesh-list
154216939|NCT06245356|Panitumumab|panitumumab|mesh-list
154216940|NCT06245356|Oxaliplatin|oxaliplatin|mesh-list
154216941|NCT06245356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154216942|NCT06245356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216943|NCT06245356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153540269|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540272|NCT01538459|Hormones|hormones|mesh-ancestor
154216944|NCT06245356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154216945|NCT06245356|Growth Substances|growth substances|mesh-ancestor
154216946|NCT06245356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216947|NCT06245356|Growth Inhibitors|growth inhibitors|mesh-ancestor
154216948|NCT06245356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154216949|NCT06245356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216950|NCT06236113|Ketamine|ketamine|mesh-list
154216951|NCT06236113|Analgesics|analgesics|mesh-ancestor
154216952|NCT06236113|Sensory System Agents|sensory system agents|mesh-ancestor
154216953|NCT06236113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216954|NCT06236113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216955|NCT06236113|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154216956|NCT06236113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154216978|NCT06220032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216979|NCT06220032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154216980|NCT06220032|Alkylating Agents|alkylating agents|mesh-ancestor
154216981|NCT06220032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216982|NCT06220032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216983|NCT06220032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154216984|NCT06220032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154216985|NCT06220032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154216986|NCT06220032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154216987|NCT06220032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154216988|NCT06220032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216989|NCT06220032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154216990|NCT06220032|Tubulin Modulators|tubulin modulators|mesh-ancestor
154216991|NCT06220032|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216992|NCT06220032|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216993|NCT06220032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154216994|NCT06220032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154216995|NCT06220032|Growth Substances|growth substances|mesh-ancestor
154216996|NCT06220032|Growth Inhibitors|growth inhibitors|mesh-ancestor
154216997|NCT06220032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216998|NCT06220032|Glucocorticoids|glucocorticoids|mesh-ancestor
154216999|NCT06220032|Hormones|hormones|mesh-ancestor
154217000|NCT06220032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154217004|NCT06219824|Pemetrexed|pemetrexed|mesh-list
154217027|NCT06216639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154217028|NCT06216639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154217029|NCT06216639|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154217030|NCT06216639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154217031|NCT06216639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154217032|NCT06216639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217033|NCT06216639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154217034|NCT06216639|Antacids|antacids|mesh-ancestor
154217035|NCT06210594|Chlorhexidine|chlorhexidine|mesh-list
153540412|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
154217036|NCT06210594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153540455|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154217037|NCT06210594|Mupirocin|mupirocin|mesh-list
154217038|NCT06210594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154217039|NCT06210594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217040|NCT06210594|Disinfectants|disinfectants|mesh-ancestor
153540468|NCT01539174|Hormones|hormones|mesh-ancestor
154217041|NCT06210594|Dermatologic Agents|dermatologic agents|mesh-ancestor
154217042|NCT06210594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154217043|NCT06210594|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154217044|NCT06210594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217045|NCT06210594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217046|NCT06144606|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154217047|NCT06144606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217048|NCT06144606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217049|NCT06132165|Deoxycholic Acid|deoxycholic acid|mesh-list
154217050|NCT06132165|Polidocanol|polidocanol|mesh-list
154217051|NCT06132165|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154217052|NCT06132165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154217053|NCT06132165|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154217054|NCT06132165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217055|NCT06130384|Bromfenac|bromfenac|mesh-list
154217056|NCT06130384|Lubricant Eye Drops|lubricant eye drops|mesh-list
154217057|NCT06130384|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154217058|NCT06130384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154217059|NCT06130384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154217060|NCT06130384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154217067|NCT06108232|Obinutuzumab|obinutuzumab|mesh-list
154217068|NCT06108232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217069|NCT06108232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217070|NCT06105554|Belumosudil|belumosudil|mesh-list
154217071|NCT06105554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154217072|NCT06105554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217073|NCT06105554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217088|NCT06050122|Veratrum Alkaloids|veratrum alkaloids|mesh-list
154217089|NCT06050122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154217090|NCT06041802|Pembrolizumab|pembrolizumab|mesh-list
154217091|NCT06041802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217092|NCT06041802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217093|NCT06041802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217094|NCT06041802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217095|NCT06041152|Psilocybin|psilocybin|mesh-list
154217096|NCT06041152|Hallucinogens|hallucinogens|mesh-ancestor
154217097|NCT06041152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217098|NCT06041152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154217099|NCT06031688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154217100|NCT06031688|Ramucirumab|ramucirumab|mesh-list
154217101|NCT06031688|Tepotinib|tepotinib|mesh-list
154217102|NCT06031688|Antibodies|antibodies|mesh-list
154217103|NCT06031688|Immunoglobulins|immunoglobulins|mesh-list
154217104|NCT06031688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154217105|NCT06031688|Lexatumumab|lexatumumab|mesh-list
154217106|NCT06031688|Immunologic Factors|immunologic factors|mesh-ancestor
154217107|NCT06031688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217108|NCT06031688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217109|NCT06031688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154217110|NCT06031688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154217111|NCT06031688|Growth Substances|growth substances|mesh-ancestor
154217112|NCT06031688|Growth Inhibitors|growth inhibitors|mesh-ancestor
153646766|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217113|NCT06027086|Durvalumab|durvalumab|mesh-list
154217114|NCT06027086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217115|NCT06027086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217116|NCT06026657|Gemcitabine|gemcitabine|mesh-list
154217117|NCT06026657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154217118|NCT06026657|Antibodies|antibodies|mesh-list
154217119|NCT06026657|Immunoglobulins|immunoglobulins|mesh-list
154217120|NCT06026657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154217121|NCT06026657|Immunologic Factors|immunologic factors|mesh-ancestor
154217122|NCT06026657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217123|NCT06026657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217124|NCT06026657|Antimetabolites|antimetabolites|mesh-ancestor
154217125|NCT06026657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217126|NCT06026657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217130|NCT05986838|Metformin|metformin|mesh-list
154217131|NCT05986838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154217132|NCT05986838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217133|NCT05902208|Antiviral Agents|antiviral agents|mesh-list
154217134|NCT05902208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217135|NCT05872386|Buprenorphine|buprenorphine|mesh-list
154217136|NCT05872386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154217137|NCT05872386|Narcotics|narcotics|mesh-ancestor
154217138|NCT05872386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154217139|NCT05872386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217140|NCT05872386|Analgesics|analgesics|mesh-ancestor
154217141|NCT05872386|Sensory System Agents|sensory system agents|mesh-ancestor
154217142|NCT05872386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217144|NCT05859126|Choline|choline|mesh-list
154217165|NCT05843188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217166|NCT05843188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217167|NCT05843188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154217168|NCT05843188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154217169|NCT05843188|Growth Substances|growth substances|mesh-ancestor
154217170|NCT05843188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217171|NCT05843188|Growth Inhibitors|growth inhibitors|mesh-ancestor
154217172|NCT05843188|Antimetabolites|antimetabolites|mesh-ancestor
154217173|NCT05843188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217174|NCT05843188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217175|NCT05843188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154217176|NCT05843188|Immunologic Factors|immunologic factors|mesh-ancestor
154217177|NCT05843188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154217178|NCT05843188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154217179|NCT05843188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217180|NCT05843188|Antidotes|antidotes|mesh-ancestor
154217181|NCT05843188|Protective Agents|protective agents|mesh-ancestor
154217182|NCT05843188|Vitamin B Complex|vitamin b complex|mesh-ancestor
154217183|NCT05843188|Vitamins|vitamins|mesh-ancestor
154217184|NCT05843188|Micronutrients|micronutrients|mesh-ancestor
154217220|NCT05690204|Colchicine|colchicine|mesh-list
154217221|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
154217222|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154217223|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
154217224|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
154217225|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
154217226|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217227|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217228|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
154217229|NCT05666310|Denosumab|denosumab|mesh-list
154217230|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154217231|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217232|NCT05663944|Sirolimus|sirolimus|mesh-list
154217285|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154217286|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154217287|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154217288|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
154217289|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217290|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217291|NCT05602259|Dimercaprol|dimercaprol|mesh-list
153540857|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
154217292|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
154217293|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
154217294|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217295|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
154217296|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154217297|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217298|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217299|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217300|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154217302|NCT05563220|Palbociclib|palbociclib|mesh-list
154217303|NCT05563220|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153964265|NCT02848950|Metformin|metformin|mesh-list
154217340|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217341|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154217342|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154217343|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217344|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217345|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154217346|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154217347|NCT05376202|Cetuximab|cetuximab|mesh-list
154217348|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217349|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217350|NCT05358249|Cetuximab|cetuximab|mesh-list
154217351|NCT05358249|Trametinib|trametinib|mesh-list
154217352|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217353|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217354|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154217355|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217356|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217357|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
154217358|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153540858|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
154217359|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154217360|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217361|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154217362|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154217389|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
154217390|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217391|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217392|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217393|NCT05163249|Osimertinib|osimertinib|mesh-list
154217394|NCT05163249|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154217395|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154217396|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217397|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217398|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217399|NCT05154747|Rilpivirine|rilpivirine|mesh-list
154217400|NCT05154747|Cabotegravir|cabotegravir|mesh-list
154217401|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
154217402|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154217403|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154217404|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217405|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540967|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217406|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
154217407|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217408|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154217409|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154217410|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154217411|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154217412|NCT05149131|Leuprolide|leuprolide|mesh-list
154217419|NCT05116189|Paclitaxel|paclitaxel|mesh-list
154217437|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217438|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
154217439|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217440|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217441|NCT05073315|Adalimumab|adalimumab|mesh-list
154217442|NCT05073315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154217443|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217444|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154217445|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
154217446|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217447|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217448|NCT05064059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217449|NCT05064059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217450|NCT05042791|Capecitabine|capecitabine|mesh-list
154217451|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217452|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
154217455|NCT04999644|Nicotine|nicotine|mesh-list
154217493|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
154217494|NCT04912427|Hormones|hormones|mesh-ancestor
154217495|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154217496|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217497|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217498|NCT04911166|Atezolizumab|atezolizumab|mesh-list
154217499|NCT04911166|Interleukin-12|interleukin-12|mesh-list
154217500|NCT04911166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217501|NCT04911166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217502|NCT04911166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217503|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217504|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153541029|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
154217505|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
154217506|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541181|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
153541182|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217507|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154217508|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154217509|NCT04911166|Growth Substances|growth substances|mesh-ancestor
154217550|NCT04731467|Fluorouracil|fluorouracil|mesh-list
154217551|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154217552|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217553|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
154217554|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
154217555|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
154217556|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217557|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217558|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
154217559|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217560|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217561|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154217562|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
154217563|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217564|NCT04727229|Bupivacaine|bupivacaine|mesh-list
154217565|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
154217566|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
154217567|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154217568|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217569|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
154217570|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217602|NCT04645602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217603|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217604|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154217605|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217606|NCT04610671|Nivolumab|nivolumab|mesh-list
154217607|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153964559|NCT00757783|Ritonavir|ritonavir|mesh-list
154217608|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217609|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217610|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217611|NCT04579757|Tislelizumab|tislelizumab|mesh-list
154217612|NCT04579757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217613|NCT04579757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217614|NCT04577963|Tislelizumab|tislelizumab|mesh-list
154217615|NCT04577963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217616|NCT04577963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217617|NCT04501861|Vasopressins|vasopressins|mesh-list
154217618|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
154217619|NCT04501861|Norepinephrine|norepinephrine|mesh-list
154217620|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154217630|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
154217655|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217656|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
154217657|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153541184|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217658|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217659|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217660|NCT04373317|Pimavanserin|pimavanserin|mesh-list
154217661|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154217662|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
154217721|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154217722|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154217723|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154217724|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
154217725|NCT04171284|Docetaxel|docetaxel|mesh-list
154217726|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217727|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
154217728|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
154217729|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
154217730|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217731|NCT04151667|Dexamethasone|dexamethasone|mesh-list
154217732|NCT04151667|Lenalidomide|lenalidomide|mesh-list
154217733|NCT04151667|Bortezomib|bortezomib|mesh-list
154217734|NCT04151667|Daratumumab|daratumumab|mesh-list
154217735|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217736|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
154217737|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
154217738|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217739|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217740|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217777|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217778|NCT03893695|Nivolumab|nivolumab|mesh-list
154217779|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217780|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217781|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217782|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217783|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
154217784|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154217785|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
154217786|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
154217787|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154217788|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541274|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541329|NCT01544283|Hormones|hormones|mesh-ancestor
154217789|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154217790|NCT03879538|Analgesics|analgesics|mesh-ancestor
154217791|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
154217792|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217793|NCT03843359|Dostarlimab|dostarlimab|mesh-list
154217794|NCT03843359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217795|NCT03828799|Folfirinox|folfirinox|mesh-list
154217796|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217797|NCT03742895|Olaparib|olaparib|mesh-list
154217798|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154217831|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217832|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217833|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217834|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
154217835|NCT03539744|Hormones|hormones|mesh-ancestor
154217836|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154217837|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217838|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217839|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
154217840|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154217841|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154217842|NCT03539744|Growth Substances|growth substances|mesh-ancestor
154217843|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
154217844|NCT03493568|Dolutegravir|dolutegravir|mesh-list
154217845|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154217846|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154217847|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154217848|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217849|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217850|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154217851|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154217852|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
154217853|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217854|NCT03488719|Metoprolol|metoprolol|mesh-list
154217855|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154217856|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154217857|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
154217858|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
154217859|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217860|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217861|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154217862|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154217863|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153541349|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154217864|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
154217869|NCT03488225|Folic Acid|folic acid|mesh-list
154217870|NCT03488225|Cytarabine|cytarabine|mesh-list
154217871|NCT03488225|Dexamethasone|dexamethasone|mesh-list
154217872|NCT03488225|Prednisone|prednisone|mesh-list
154217873|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
154217874|NCT03488225|Cortisone|cortisone|mesh-list
154217875|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
154217876|NCT03488225|Rituximab|rituximab|mesh-list
154217877|NCT03488225|Doxorubicin|doxorubicin|mesh-list
154217878|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154217879|NCT03488225|Methotrexate|methotrexate|mesh-list
154217880|NCT03488225|Vincristine|vincristine|mesh-list
154217881|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
154217882|NCT03488225|Ofatumumab|ofatumumab|mesh-list
154217883|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154217884|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154217885|NCT03488225|Antibodies|antibodies|mesh-list
154217886|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
154217887|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154217888|NCT03488225|BB 1101|bb 1101|mesh-list
154217889|NCT03488225|Calcium|calcium|mesh-list
154217890|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
154217891|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154217892|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
154217927|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
154217928|NCT03488225|Vitamins|vitamins|mesh-ancestor
154217929|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
154217930|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154217931|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
154217932|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
154217933|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
154217934|NCT03488225|Hematinics|hematinics|mesh-ancestor
154217935|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
154217936|NCT03488225|Immunotoxins|immunotoxins|mesh-ancestor
154217994|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
153541428|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
154217995|NCT03107988|Topotecan|topotecan|mesh-list
154217996|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154217997|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
154217998|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217999|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541432|NCT01544842|Tacrolimus|tacrolimus|mesh-list
154218000|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154218001|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
154218002|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218003|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218004|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154218005|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154218006|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154218057|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218058|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218059|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218060|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154218062|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218063|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218064|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154218065|NCT02438722|Cetuximab|cetuximab|mesh-list
154218066|NCT02438722|Afatinib|afatinib|mesh-list
154218067|NCT02438722|Antibodies|antibodies|mesh-list
154218068|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
154218069|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154218070|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
154218071|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218072|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218073|NCT02438722|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154218074|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154218077|NCT02422498|Cisplatin|cisplatin|mesh-list
154218114|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154218115|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218116|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218117|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218118|NCT02030964|Eflornithine|eflornithine|mesh-list
154218119|NCT02030964|Celecoxib|celecoxib|mesh-list
154218120|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
154218121|NCT02030964|Topotecan|topotecan|mesh-list
154218122|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218123|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
154218124|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218125|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218126|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154218127|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
154218128|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218129|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218130|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154218131|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154218132|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154218133|NCT02030964|Analgesics|analgesics|mesh-ancestor
154218134|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
154218135|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218136|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218137|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154218138|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154218139|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218140|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154218147|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
154218160|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218161|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154218162|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
154218163|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
154218164|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218165|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218166|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154218167|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
154218168|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
154218169|NCT02023164|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154218170|NCT01959139|Leucovorin|leucovorin|mesh-list
154218171|NCT01959139|Fluorouracil|fluorouracil|mesh-list
154218172|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
154218173|NCT01959139|Irinotecan|irinotecan|mesh-list
154218174|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
154218175|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218176|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
154218177|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218178|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154218179|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218180|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218181|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
154218185|NCT01959139|Antidotes|antidotes|mesh-ancestor
154218213|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154218215|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154218216|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154218217|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
154218218|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218219|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218220|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154218221|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154218222|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218223|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218224|NCT01511809|Ritonavir|ritonavir|mesh-list
154218225|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154218226|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154218227|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154218228|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
154218229|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218230|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218231|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154218232|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154218233|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
154218234|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218235|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154218236|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154218237|NCT01134575|Rituximab|rituximab|mesh-list
153541858|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154218238|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154218239|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218240|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218259|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154218260|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
154218261|NCT01064154|Carvedilol|carvedilol|mesh-list
154218262|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154218263|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154218264|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
154218265|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218266|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218267|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218268|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154218269|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
154218270|NCT01064154|Protective Agents|protective agents|mesh-ancestor
154218271|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154218272|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154218273|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154218274|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
154218275|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154218276|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154218277|NCT00314340|Acetaminophen|acetaminophen|mesh-list
154218278|NCT00314340|Morphine|morphine|mesh-list
154218279|NCT00314340|Hydrocodone|hydrocodone|mesh-list
154218280|NCT00314340|Phenobarbital|phenobarbital|mesh-list
154218281|NCT00314340|Amphetamine|amphetamine|mesh-list
154218310|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154218311|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154218312|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154218313|NCT00306852|Mitomycins|mitomycins|mesh-list
154218314|NCT00306852|Mitomycin|mitomycin|mesh-list
153541860|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218315|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154218316|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542047|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542048|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218317|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
154218318|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218319|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154218320|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218321|NCT00314262|Celecoxib|celecoxib|mesh-list
154218322|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154218323|NCT00314262|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154218324|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154218325|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218326|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218327|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218328|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154218329|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154218330|NCT00314262|Analgesics|analgesics|mesh-ancestor
154218331|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
154218332|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218333|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218334|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218335|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218336|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154218337|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154218338|NCT00333866|Pregabalin|pregabalin|mesh-list
154218339|NCT00333866|Analgesics|analgesics|mesh-ancestor
154218340|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
154218341|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218342|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218348|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154218349|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154218350|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218351|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154218352|NCT00324740|Vorinostat|vorinostat|mesh-list
154218353|NCT00324740|Isotretinoin|isotretinoin|mesh-list
154218354|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218355|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154218356|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218357|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218358|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
154218359|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
154218360|NCT00333788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154218361|NCT00333788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218362|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218363|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
154218364|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218365|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218366|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
154218404|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
154218405|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218406|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
154218407|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218408|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154218409|NCT00324038|Acetaminophen|acetaminophen|mesh-list
154218410|NCT00324038|Buprenorphine|buprenorphine|mesh-list
154218411|NCT00324038|Codeine|codeine|mesh-list
154218412|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154218413|NCT00324038|Analgesics|analgesics|mesh-ancestor
154218414|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
154218415|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218416|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218417|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
154218418|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154218419|NCT00324038|Narcotics|narcotics|mesh-ancestor
154218420|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218421|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154218422|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
154218423|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
154218424|NCT03984110|Dexamethasone|dexamethasone|mesh-list
154218425|NCT03984110|Aflibercept|aflibercept|mesh-list
154218426|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218427|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
154218428|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
154218429|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218430|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218431|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218432|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
154218453|NCT00331760|Cisplatin|cisplatin|mesh-list
154218454|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218455|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154218456|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154218457|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218458|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
154218459|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218460|NCT00313014|Oxycodone|oxycodone|mesh-list
154218461|NCT00313014|Buprenorphine|buprenorphine|mesh-list
154218462|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154218463|NCT00313014|Narcotics|narcotics|mesh-ancestor
154218464|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218466|NCT00313014|Analgesics|analgesics|mesh-ancestor
154218515|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
154218516|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154218517|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154218518|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153542252|NCT01550354|Alfentanil|alfentanil|mesh-list
154218519|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154218520|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
154218521|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218522|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218523|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154218524|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
154218525|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218526|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154218527|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154218529|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154218530|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154218531|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154218532|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
154218536|NCT00224133|Urological Agents|urological agents|mesh-ancestor
154218570|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218571|NCT00148317|Dexamethasone|dexamethasone|mesh-list
154218572|NCT00148317|Doxorubicin|doxorubicin|mesh-list
154218573|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154218574|NCT00148317|Bortezomib|bortezomib|mesh-list
154218575|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218576|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
154218577|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
154218578|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218579|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218580|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218581|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
154218582|NCT00148317|Hormones|hormones|mesh-ancestor
154218583|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218584|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154218585|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218586|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154218587|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154218588|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154218589|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153965527|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154218622|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154218623|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218624|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542253|NCT01550354|Propofol|propofol|mesh-list
153542254|NCT01550354|Rocuronium|rocuronium|mesh-list
154218625|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
154218626|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
154218627|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154218628|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
154218629|NCT00330668|Mecasermin|mecasermin|mesh-list
154218630|NCT00330668|Growth Substances|growth substances|mesh-ancestor
154218631|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218632|NCT00306384|Alogliptin|alogliptin|mesh-list
154218633|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154218634|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218635|NCT00306384|Incretins|incretins|mesh-ancestor
154218636|NCT00306384|Hormones|hormones|mesh-ancestor
154218637|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218638|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154218639|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
154218640|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218641|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218642|NCT01062906|Lidocaine|lidocaine|mesh-list
154218643|NCT01062906|Fentanyl|fentanyl|mesh-list
154218644|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
154218645|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
154218646|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218647|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218670|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218672|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154218673|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
154218674|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218675|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218676|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218677|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154218678|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154218679|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218680|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154218681|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154218682|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
154218683|NCT00501059|Aspirin|aspirin|mesh-list
154218684|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154218685|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154218686|NCT00501059|Analgesics|analgesics|mesh-ancestor
154218687|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
154218688|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218689|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218690|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542345|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
153542390|NCT01551394|Meropenem|meropenem|mesh-list
154218691|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218692|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154218693|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154218694|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218695|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154218696|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154218697|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218698|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
154218699|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154218700|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
154218701|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218702|NCT00322868|Pioglitazone|pioglitazone|mesh-list
154218703|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154218705|NCT01016717|Omeprazole|omeprazole|mesh-list
154218708|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218709|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154218710|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218711|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218713|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154218714|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
154218715|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218716|NCT00343382|Pilocarpine|pilocarpine|mesh-list
154218717|NCT00343382|Miotics|miotics|mesh-ancestor
154218718|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
154218719|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218720|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218721|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154218722|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154218723|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
154218768|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
154218769|NCT00329030|Rituximab|rituximab|mesh-list
154218770|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
154218771|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218772|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218773|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
154218774|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218775|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218776|NCT00328562|Gefitinib|gefitinib|mesh-list
154218777|NCT00328562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154218778|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154218779|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218780|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218782|NCT00328172|Metformin|metformin|mesh-list
154218828|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218829|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154218830|NCT01063140|Vaccines|vaccines|mesh-list
154218831|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
154218832|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218833|NCT00305448|Fulvestrant|fulvestrant|mesh-list
154218834|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154218841|NCT01063218|Emollients|emollients|mesh-list
154218897|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
154218898|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
154218899|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542517|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218900|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218901|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
154218902|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
154218903|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
154218904|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153965899|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154218964|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154218965|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
154218966|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154218967|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154218968|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
154218969|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
154218970|NCT01058174|Fluconazole|fluconazole|mesh-list
154218971|NCT01058174|Amphotericin B|amphotericin b|mesh-list
154218972|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154218973|NCT01058174|Caspofungin|caspofungin|mesh-list
154218974|NCT01058174|Micafungin|micafungin|mesh-list
154218975|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
154218976|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218977|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154218978|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154218979|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219020|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219021|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
154219022|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219023|NCT01061060|Epoprostenol|epoprostenol|mesh-list
154219024|NCT01061060|Beraprost|beraprost|mesh-list
154219025|NCT01061060|Tezosentan|tezosentan|mesh-list
154219026|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154219027|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
154219028|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154219029|NCT00310388|Ezogabine|ezogabine|mesh-list
154219030|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
154219031|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219032|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219033|NCT03981770|Anesthetics|anesthetics|mesh-list
154219034|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154219035|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219036|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153542567|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153542568|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
154219037|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
154219038|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219039|NCT01063556|Donepezil|donepezil|mesh-list
154219040|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154219041|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219074|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154219075|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154219076|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154219077|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
154219078|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154219079|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
154219080|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154219081|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154219082|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154219083|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219084|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219085|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
154219086|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219087|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219088|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154219089|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219090|NCT00499889|Vidarabine|vidarabine|mesh-list
154219091|NCT00499889|Methotrexate|methotrexate|mesh-list
154219092|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
154219093|NCT00499889|Fludarabine|fludarabine|mesh-list
154219094|NCT00499889|Busulfan|busulfan|mesh-list
154219127|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219128|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
154219129|NCT00309608|Incretins|incretins|mesh-ancestor
154219130|NCT00309608|Hormones|hormones|mesh-ancestor
154219131|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219132|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154219133|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
154219134|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219135|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219136|NCT00308750|Carboplatin|carboplatin|mesh-list
154219137|NCT00308750|Docetaxel|docetaxel|mesh-list
154219138|NCT00308750|Pemetrexed|pemetrexed|mesh-list
154219139|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219140|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
154219141|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153542684|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
154219142|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
154219143|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219144|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542833|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
154219145|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154219146|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154219147|NCT00489359|Carboplatin|carboplatin|mesh-list
154219148|NCT00489359|Pemetrexed|pemetrexed|mesh-list
154219149|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219150|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219151|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219177|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219178|NCT03997019|Analgesics|analgesics|mesh-ancestor
154219179|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
154219180|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219181|NCT00480857|Docetaxel|docetaxel|mesh-list
154219182|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219183|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
154219184|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
154219185|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
154219186|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219187|NCT00499031|Cetuximab|cetuximab|mesh-list
154219188|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154219189|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219190|NCT00498797|Prednisolone|prednisolone|mesh-list
154219191|NCT00498797|Docetaxel|docetaxel|mesh-list
154219192|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219193|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
154219194|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
154219195|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
154219196|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219197|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219198|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
154219199|NCT00498797|Hormones|hormones|mesh-ancestor
154219200|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219201|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542834|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542837|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
153542902|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219225|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154219226|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
154219227|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219228|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219229|NCT03980496|Omeprazole|omeprazole|mesh-list
154219230|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154219231|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219232|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154219233|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219234|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219235|NCT01063530|Fluorides|fluorides|mesh-list
154219236|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
154219237|NCT01063530|Protective Agents|protective agents|mesh-ancestor
154219238|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219239|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
154219240|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154219241|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219242|NCT01069302|Clopidogrel|clopidogrel|mesh-list
154219243|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154219244|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154219245|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154219246|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154219247|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
154219276|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219277|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219279|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
154219280|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154219281|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
154219282|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154219283|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219284|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
154219285|NCT00307736|Bevacizumab|bevacizumab|mesh-list
154219286|NCT00307736|Fluorouracil|fluorouracil|mesh-list
154219287|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154219288|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543088|NCT05847257|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154219289|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219290|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154219291|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154219292|NCT00307736|Growth Substances|growth substances|mesh-ancestor
154219293|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219294|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
154219295|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
154219296|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219297|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219298|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219326|NCT00294762|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154219327|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219329|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
154219330|NCT00294684|Prednisolone|prednisolone|mesh-list
154219331|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219332|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
154219333|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
154219334|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219335|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219336|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219337|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
154219338|NCT00294684|Hormones|hormones|mesh-ancestor
154219339|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219340|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154219342|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154219385|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219387|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
154219388|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219389|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154219390|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154219391|NCT03978156|Analgesics|analgesics|mesh-ancestor
154219392|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
154219393|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219394|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154219395|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154219396|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219397|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219398|NCT03978156|Hormones|hormones|mesh-ancestor
154219399|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219400|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154219401|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154219410|NCT01066494|Cytarabine|cytarabine|mesh-list
154219441|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219442|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154219443|NCT00302952|Lovastatin|lovastatin|mesh-list
154219444|NCT00302952|L 647318|l 647318|mesh-list
154219445|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
154219446|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154219447|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154219448|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
154219449|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219450|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154219451|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154219452|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219453|NCT01066572|Lisinopril|lisinopril|mesh-list
154219454|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154219455|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
154219456|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219457|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219458|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154219459|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154219460|NCT01066572|Protective Agents|protective agents|mesh-ancestor
154219461|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219462|NCT01066650|Everolimus|everolimus|mesh-list
154219463|NCT01066650|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154219464|NCT01066650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219465|NCT01066650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219466|NCT01066650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219467|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219468|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
154219469|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219470|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219471|NCT01066728|Theophylline|theophylline|mesh-list
154219472|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154219473|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
154219476|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154219480|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219481|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
154219482|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154219483|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153543113|NCT05847088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153543114|NCT05847088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543173|NCT05840692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543175|NCT05840692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219484|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
154219485|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153966424|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
154219488|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154219489|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219490|NCT01325610|Vitamins|vitamins|mesh-ancestor
154219491|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
154219492|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154219493|NCT00301080|Cycloserine|cycloserine|mesh-list
154219494|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154219495|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219496|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154219497|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
154219498|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154219499|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
154219501|NCT01066806|Calcium|calcium|mesh-list
154219532|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154219533|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
154219534|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
154219535|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154219536|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219537|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154219538|NCT01581450|Analgesics|analgesics|mesh-ancestor
154219539|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
154219540|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219541|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154219542|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154219543|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219544|NCT00289848|Incretins|incretins|mesh-ancestor
154219545|NCT00289848|Hormones|hormones|mesh-ancestor
154219546|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219547|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154219548|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
154219549|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219550|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219588|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
154219589|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219590|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219591|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
154219592|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219593|NCT01065246|Catumaxomab|catumaxomab|mesh-list
154219594|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219595|NCT01325844|Anesthetics|anesthetics|mesh-list
154219596|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154219597|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219599|NCT01067430|Etoricoxib|etoricoxib|mesh-list
154219600|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154219601|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154219648|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219649|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153543246|NCT05840172|Sensory System Agents|sensory system agents|mesh-ancestor
154219650|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219651|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
154219652|NCT00319592|Vaccines|vaccines|mesh-list
154219653|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
154219654|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219655|NCT03980990|Metformin|metformin|mesh-list
154219656|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154219657|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219658|NCT03980756|Esomeprazole|esomeprazole|mesh-list
154219659|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154219660|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219661|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154219662|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219663|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219705|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154219706|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154219707|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
154219708|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219709|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154219711|NCT00299130|Rituximab|rituximab|mesh-list
154219712|NCT00299130|Methotrexate|methotrexate|mesh-list
154219713|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154219714|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219715|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
154219716|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219717|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219718|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154219719|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
154219720|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154219721|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219722|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
154219723|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219724|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219725|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219726|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154219727|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219728|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154219729|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219730|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
154219731|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
154219732|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219733|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219734|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
154219735|NCT00299130|Hormones|hormones|mesh-ancestor
154219736|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219737|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154219738|NCT00299130|Protective Agents|protective agents|mesh-ancestor
154219745|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219746|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154219747|NCT00287586|Testosterone|testosterone|mesh-list
154219748|NCT00287586|Androgens|androgens|mesh-ancestor
154219749|NCT00287586|Hormones|hormones|mesh-ancestor
154219750|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219751|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219752|NCT01070160|Metformin|metformin|mesh-list
154219753|NCT01070160|Progesterone|progesterone|mesh-list
154219754|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154219755|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219756|NCT01070160|Progestins|progestins|mesh-ancestor
154219757|NCT01070160|Hormones|hormones|mesh-ancestor
154219758|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219759|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
154219760|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154219761|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219762|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
154219763|NCT03977220|Paclitaxel|paclitaxel|mesh-list
154219764|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154219765|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219766|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
154219767|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
154219768|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
154219769|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219770|NCT00293202|Etanercept|etanercept|mesh-list
154219771|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154219772|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154219773|NCT00293202|Analgesics|analgesics|mesh-ancestor
154219774|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
154219782|NCT00286494|Pioglitazone|pioglitazone|mesh-list
154219789|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154219790|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
154219791|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543314|NCT05838846|Protective Agents|protective agents|mesh-ancestor
153543340|NCT05805683|Calcitonin|calcitonin|mesh-list
154219792|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219794|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153543343|NCT05805683|Katacalcin|katacalcin|mesh-list
154219795|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219796|NCT01067898|Vitamin D|vitamin d|mesh-list
154219797|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
154219798|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
154219799|NCT01067898|Vitamins|vitamins|mesh-list
154219800|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
154219801|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
154219802|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219803|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154219804|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154219805|NCT01067898|Antacids|antacids|mesh-ancestor
154219806|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219807|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219808|NCT03979248|Deucravacitinib|deucravacitinib|mesh-list
154219809|NCT03979248|Rabeprazole|rabeprazole|mesh-list
154219843|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219845|NCT00284856|Montelukast|montelukast|mesh-list
154219846|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219847|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154219848|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
154219849|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219850|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219851|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154219852|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
154219853|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219854|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154219855|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154219856|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
154219857|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219858|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154219859|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154219861|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
154219899|NCT01068054|Cyclosporins|cyclosporins|mesh-list
154219900|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219901|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
154219902|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219903|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154219904|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219905|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219906|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
154219907|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219908|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219909|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219910|NCT00298038|Rifaximin|rifaximin|mesh-list
154219914|NCT00283686|Telmisartan|telmisartan|mesh-list
153543391|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219963|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219964|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219965|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154219966|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154219967|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
154219968|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219969|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219970|NCT00496769|Aspirin|aspirin|mesh-list
154219971|NCT00496769|Apixaban|apixaban|mesh-list
154219972|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154219973|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154219974|NCT00496769|Analgesics|analgesics|mesh-ancestor
154219975|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
154219976|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219977|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219978|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219979|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219980|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154219981|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154219982|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219983|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154219984|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154219985|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219986|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
154219987|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154219988|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
154219989|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154219990|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
154219991|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
154219992|NCT01014845|Vaccines|vaccines|mesh-list
154219993|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
154219994|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219995|NCT00488345|Tigecycline|tigecycline|mesh-list
154219996|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154219997|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220001|NCT00283062|Docetaxel|docetaxel|mesh-list
154220002|NCT00283062|Leuprolide|leuprolide|mesh-list
154220003|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220004|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220005|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220006|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220007|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220008|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154220009|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
154220010|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153543507|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220011|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543609|NCT04305444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220012|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154220014|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154220015|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154220016|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
154220017|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220018|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220019|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220020|NCT00296400|Atorvastatin|atorvastatin|mesh-list
154220059|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154220060|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220061|NCT00282048|Axitinib|axitinib|mesh-list
154220062|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220063|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220064|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220065|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220066|NCT00474539|Vaccines|vaccines|mesh-list
154220067|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154220068|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
154220069|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220070|NCT01017809|Aprepitant|aprepitant|mesh-list
154220071|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
154220072|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
154220073|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220074|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220075|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154220076|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154220077|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220078|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220079|NCT01020539|Fludarabine|fludarabine|mesh-list
154220080|NCT01020539|Busulfan|busulfan|mesh-list
154220081|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
154220082|NCT01020539|Isotretinoin|isotretinoin|mesh-list
154220083|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
154220084|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154220085|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220088|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
154220104|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220105|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
154220106|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154220107|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154220108|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
154220109|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220110|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220111|NCT01070862|Thalidomide|thalidomide|mesh-list
154220112|NCT01070862|Dexamethasone|dexamethasone|mesh-list
154220113|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
154220114|NCT01070862|Doxorubicin|doxorubicin|mesh-list
154220115|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154220116|NCT01070862|Melphalan|melphalan|mesh-list
154220117|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
154220118|NCT01070862|Vincristine|vincristine|mesh-list
154220119|NCT01070862|BB 1101|bb 1101|mesh-list
154220120|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220121|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
154220122|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
154220123|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220124|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220125|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154220126|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
154220127|NCT01070862|Hormones|hormones|mesh-ancestor
154220128|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220129|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154220130|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220131|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
154220132|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220133|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220134|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220135|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154220136|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154220137|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154220138|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
154220139|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154220140|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220141|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
154220142|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
154220143|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220144|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220145|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154220146|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154220147|NCT01070862|Growth Substances|growth substances|mesh-ancestor
154220148|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
154220149|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154220150|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154220151|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220152|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
153543758|NCT03664180|Enoxaparin|enoxaparin|mesh-list
153543759|NCT03664180|Hirudins|hirudins|mesh-list
154220153|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220154|NCT00495677|PF 232798|pf 232798|mesh-list
154220155|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154220156|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220157|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154220158|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153543854|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153543855|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
153543856|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543857|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220159|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
154220160|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220161|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154220162|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
154220163|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220164|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220165|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
154220166|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154220167|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220168|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220169|NCT00292188|Pregabalin|pregabalin|mesh-list
154220170|NCT00292188|Analgesics|analgesics|mesh-ancestor
154220171|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
154220185|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154220186|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154220187|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220188|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220190|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220191|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154220192|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
154220193|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154220194|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
154220195|NCT01068756|Rifampin|rifampin|mesh-list
154220196|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154220197|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220198|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154220199|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220200|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154220201|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
154220202|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220203|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543858|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153543905|NCT03321526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153543906|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
154220204|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
154220205|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154220206|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220207|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154220208|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154220209|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154220210|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154220211|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154220213|NCT00291642|Cetirizine|cetirizine|mesh-list
154220226|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154220227|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220228|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154220229|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154220230|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
154220231|NCT00280566|Ziprasidone|ziprasidone|mesh-list
154220232|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154220233|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
154220234|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220235|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220236|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220237|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154220238|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154220239|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220240|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154220241|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154220242|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
154220243|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
154220244|NCT00270894|Docetaxel|docetaxel|mesh-list
154220245|NCT00270894|Trastuzumab|trastuzumab|mesh-list
154220246|NCT00270894|Epirubicin|epirubicin|mesh-list
154220247|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220248|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
154220249|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220250|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153543968|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543969|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220251|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154220252|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
153544034|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
153544035|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220253|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220254|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220255|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154220256|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220257|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220258|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220259|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220260|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220261|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154220263|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220264|NCT01070628|Levodopa|levodopa|mesh-list
153544036|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220265|NCT01070628|Carbidopa|carbidopa|mesh-list
154220266|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154220267|NCT01070628|Entacapone|entacapone|mesh-list
154220268|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154220269|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154220270|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
154220271|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220272|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220273|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220274|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154220275|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220276|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154220277|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
154220278|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
154220279|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154220323|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154220324|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220325|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154220326|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154220327|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
154220328|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
154220329|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220330|NCT01062152|Lenalidomide|lenalidomide|mesh-list
154220331|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
154220332|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220333|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154220334|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154220335|NCT01062152|Growth Substances|growth substances|mesh-ancestor
154220336|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
154220337|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220338|NCT00303446|Dutasteride|dutasteride|mesh-list
154220339|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154220340|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154220341|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220342|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220343|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
154220344|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220345|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220346|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
154220371|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154220372|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154220373|NCT00301964|Growth Substances|growth substances|mesh-ancestor
154220374|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220375|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
154220376|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
154220377|NCT01070706|Paclitaxel|paclitaxel|mesh-list
154220378|NCT01070706|Gemcitabine|gemcitabine|mesh-list
154220379|NCT01070706|Sunitinib|sunitinib|mesh-list
154220380|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154220395|NCT00268242|Gemcitabine|gemcitabine|mesh-list
154220436|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220437|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154220438|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154220439|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220440|NCT00299702|Aripiprazole|aripiprazole|mesh-list
154220441|NCT00299702|Risperidone|risperidone|mesh-list
154220442|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
154220443|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154220444|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154220445|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154220446|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220447|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220448|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
154220449|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
154220450|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220451|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220452|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154220453|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154220454|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
154220455|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154220456|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154220457|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153544060|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
153544063|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154220458|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154220459|NCT00291330|Warfarin|warfarin|mesh-list
154220460|NCT00291330|Dabigatran|dabigatran|mesh-list
154220484|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220485|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220486|NCT00278148|Paclitaxel|paclitaxel|mesh-list
154220487|NCT00278148|Carboplatin|carboplatin|mesh-list
154220488|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154220489|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154220490|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220491|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220492|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220493|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220494|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220495|NCT00278148|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154220496|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220497|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220498|NCT00299546|Golimumab|golimumab|mesh-list
154220542|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154220543|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220544|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220545|NCT01065194|Protective Agents|protective agents|mesh-ancestor
154220546|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220547|NCT01065272|Dexamethasone|dexamethasone|mesh-list
154220548|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220549|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
154220550|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
154220551|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220552|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220553|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154220554|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
154220555|NCT01065272|Hormones|hormones|mesh-ancestor
153544159|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544160|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544161|NCT00713193|Cyclosporine|cyclosporine|mesh-list
153544162|NCT00713193|Prednisone|prednisone|mesh-list
153544163|NCT00713193|Cyclosporins|cyclosporins|mesh-list
153544164|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544165|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
153544166|NCT00713193|Hormones|hormones|mesh-ancestor
153544167|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544168|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544169|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153544170|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544171|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544172|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544173|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153544174|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
153544175|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
153544176|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544177|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
154220556|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220557|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154220559|NCT00299156|Clofarabine|clofarabine|mesh-list
154220598|NCT00276744|Gemcitabine|gemcitabine|mesh-list
154220599|NCT00276744|Capecitabine|capecitabine|mesh-list
154220600|NCT00276744|Docetaxel|docetaxel|mesh-list
154220601|NCT00276744|Irinotecan|irinotecan|mesh-list
154220602|NCT00276744|Cetuximab|cetuximab|mesh-list
154220603|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154220604|NCT00276744|Mitomycins|mitomycins|mesh-list
154220605|NCT00276744|Mitomycin|mitomycin|mesh-list
153967560|NCT04070287|Antibodies|antibodies|mesh-list
154220606|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220607|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
154220608|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220609|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220610|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220611|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220612|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220613|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154220614|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154220615|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220616|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220617|NCT00276744|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154220618|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220619|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220622|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
154220653|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220654|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154220655|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220656|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
154220657|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154220658|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220659|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
154220660|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220661|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
154220662|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220663|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220664|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220665|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154220666|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154220667|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220668|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154220669|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154220670|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
154220671|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154220673|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
154220705|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220706|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
154220707|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
154220708|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544185|NCT00710424|Nabiximols|nabiximols|mesh-list
154220709|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220710|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154220711|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
153544222|NCT01556737|Daidzein|daidzein|mesh-list
154220712|NCT03979664|Hormones|hormones|mesh-ancestor
154220713|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220714|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154220715|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220716|NCT01325558|Gemcitabine|gemcitabine|mesh-list
154220717|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220718|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
154220719|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220720|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220765|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154220767|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220768|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
154220769|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220770|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154220771|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154220772|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
154220773|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220774|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220775|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154220776|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220777|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
154220778|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
154220780|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154220824|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220826|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220827|NCT01084486|Metformin|metformin|mesh-list
154220828|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154220829|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220830|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154220831|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154220832|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154220833|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220834|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220835|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154220886|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
154220887|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220888|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
154220889|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154220890|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154220891|NCT00251004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154220892|NCT00251004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220893|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220894|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220895|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154220896|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
154220897|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220898|NCT00275262|Leuprolide|leuprolide|mesh-list
154220899|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154220900|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
154220901|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154220902|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220903|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154220904|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220905|NCT00275028|Cediranib|cediranib|mesh-list
154220906|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220907|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220908|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220909|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220910|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
154220911|NCT00471497|Nilotinib|nilotinib|mesh-list
154220912|NCT00471497|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154220913|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220914|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220915|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220916|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220917|NCT04357457|Almitrine|almitrine|mesh-list
154220928|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220929|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220930|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154220931|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220932|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220933|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220934|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220935|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
154220936|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154220937|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
153544263|NCT01557127|Sorafenib|sorafenib|mesh-list
154220938|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220939|NCT01021163|Expectorants|expectorants|mesh-ancestor
154220940|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
154220941|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154220942|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
154220943|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220944|NCT01021163|Protective Agents|protective agents|mesh-ancestor
154220945|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220946|NCT01021163|Antidotes|antidotes|mesh-ancestor
154220947|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
154220948|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154220949|NCT01022333|Protective Agents|protective agents|mesh-ancestor
154220950|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220951|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220952|NCT00117598|Sirolimus|sirolimus|mesh-list
154220953|NCT00117598|Temsirolimus|temsirolimus|mesh-list
154220954|NCT00117598|MTOR Inhibitors|mtor inhibitors|mesh-list
154220956|NCT00117598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220975|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154220976|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154220977|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154220978|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220979|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154220980|NCT01082458|Narcotics|narcotics|mesh-ancestor
153967933|NCT00798135|Itraconazole|itraconazole|mesh-list
154220981|NCT01082458|Analgesics|analgesics|mesh-ancestor
154220982|NCT00469859|Cytarabine|cytarabine|mesh-list
154220983|NCT00469859|Idarubicin|idarubicin|mesh-list
154220984|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220986|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220987|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220988|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
154220989|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220990|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220991|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
154220992|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220993|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220994|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154220995|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154220996|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220997|NCT01021475|Domperidone|domperidone|mesh-list
154220998|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
154220999|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
154221000|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221001|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221002|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221003|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154221004|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
154221005|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221006|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221007|NCT01085032|Nicotine|nicotine|mesh-list
154221009|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
154221015|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221016|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221017|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
154221018|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
154221019|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154221020|NCT01021787|Protective Agents|protective agents|mesh-ancestor
154221021|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221022|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
154221023|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154221025|NCT00093808|Trastuzumab|trastuzumab|mesh-list
154221026|NCT00093808|Vinorelbine|vinorelbine|mesh-list
154221036|NCT00469079|Nicotine|nicotine|mesh-list
154221079|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154221080|NCT01073748|Analgesics|analgesics|mesh-ancestor
154221081|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
154221082|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221083|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221084|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
154221085|NCT00468845|Pregabalin|pregabalin|mesh-list
154221086|NCT00468845|Analgesics|analgesics|mesh-ancestor
154221087|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
154221088|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221089|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221090|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
154221091|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154221092|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154221093|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544366|NCT01557634|Insulin|insulin|mesh-list
154221136|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221137|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
154221138|NCT00467831|Erythromycin|erythromycin|mesh-list
154221139|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
154221140|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154221141|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
154221142|NCT00467831|Zileuton|zileuton|mesh-list
154221143|NCT00467831|Losartan|losartan|mesh-list
154221144|NCT00467831|Pravastatin|pravastatin|mesh-list
154221145|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154221146|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154221147|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154221199|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221200|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
154221201|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221202|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154221203|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154221204|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
154221205|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221206|NCT00467597|Levodopa|levodopa|mesh-list
154221207|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154221208|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154221209|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
154221210|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221211|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221212|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221214|NCT00115804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154221215|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154221216|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154221217|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221218|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221219|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
154221220|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221221|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154221222|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
154221227|NCT00467363|Aspirin|aspirin|mesh-list
154221247|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
154221248|NCT01071174|Dapivirine|dapivirine|mesh-list
154221249|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154221250|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154221251|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
154221252|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221253|NCT00466505|Celecoxib|celecoxib|mesh-list
154221254|NCT00466505|Cetuximab|cetuximab|mesh-list
154221255|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154221256|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221257|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154221258|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153544409|NCT01557816|Analgesics|analgesics|mesh-ancestor
154221259|NCT00466505|Analgesics|analgesics|mesh-ancestor
154221260|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
154221261|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221262|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221263|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154221264|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154221265|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154221266|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154221267|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221268|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221269|NCT02531568|Warfarin|warfarin|mesh-list
154221270|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
154221271|NCT00467051|Paclitaxel|paclitaxel|mesh-list
154221272|NCT00467051|Carboplatin|carboplatin|mesh-list
154221273|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154221274|NCT00467051|Ifosfamide|ifosfamide|mesh-list
154221275|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
154221276|NCT00467051|Lenograstim|lenograstim|mesh-list
154221290|NCT00264498|Gefitinib|gefitinib|mesh-list
154221294|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221295|NCT00264498|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154221296|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221297|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221298|NCT00466193|Zolpidem|zolpidem|mesh-list
154221299|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154221300|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154221301|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221302|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221303|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154221304|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
154221305|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
154221356|NCT00237042|Hormones|hormones|mesh-ancestor
154221357|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154221358|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221359|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154221360|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
154221361|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154221362|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153544443|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
154221363|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154221364|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154221365|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154221366|NCT00465647|Hydromorphone|hydromorphone|mesh-list
154221367|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154221417|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154221418|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
154221419|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
154221420|NCT03812380|Cathartics|cathartics|mesh-ancestor
154221421|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221422|NCT01085422|Temozolomide|temozolomide|mesh-list
154221423|NCT01085422|Veliparib|veliparib|mesh-list
154221424|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154221425|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
154221426|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221427|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221428|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154221429|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221430|NCT01085656|Combretastatin|combretastatin|mesh-list
153968391|NCT05430243|Diuretics|diuretics|mesh-list
154221431|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154221432|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221433|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
154221434|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
154221435|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
154221436|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221437|NCT01087138|Calcium|calcium|mesh-list
154221438|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154221439|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221440|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154221466|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
154221467|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
154221468|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154221469|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154221470|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154221471|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154221472|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
154221473|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221474|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221475|NCT00069784|Insulin|insulin|mesh-list
154221476|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154221477|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
154221478|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154221479|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221480|NCT00090610|Carboplatin|carboplatin|mesh-list
154221481|NCT00090610|Docetaxel|docetaxel|mesh-list
154221526|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544479|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153544480|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221528|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154221529|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221530|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
154221531|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154221532|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154221533|NCT00463385|Growth Substances|growth substances|mesh-ancestor
154221534|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
154221535|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154221536|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
154221537|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154221538|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221587|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221588|NCT00067990|Losartan|losartan|mesh-list
154221589|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154221590|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154221591|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154221592|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154221593|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221594|NCT00263328|Tacrolimus|tacrolimus|mesh-list
154221595|NCT00263328|Tofacitinib|tofacitinib|mesh-list
154221596|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154221597|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
154221598|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221599|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154221600|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221601|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221602|NCT00263328|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154221603|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221604|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154221605|NCT03741660|Cathartics|cathartics|mesh-ancestor
154221606|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221640|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221641|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154221642|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154221643|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154221644|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221645|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154221646|NCT00462761|Quizartinib|quizartinib|mesh-list
154221647|NCT00462761|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154221648|NCT00462761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221649|NCT00462761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221650|NCT00462761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221651|NCT00235872|Adalimumab|adalimumab|mesh-list
154221652|NCT00235872|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154221653|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154221654|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154221655|NCT00461981|Vaccines|vaccines|mesh-list
154221656|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
154221657|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544507|NCT01558622|Analgesics|analgesics|mesh-ancestor
154221696|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221697|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221698|NCT00313586|Azacitidine|azacitidine|mesh-list
154221699|NCT00313586|Entinostat|entinostat|mesh-list
154221700|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154221701|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154221702|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
154221703|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221704|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221705|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221706|NCT01069328|Paclitaxel|paclitaxel|mesh-list
154221707|NCT01069328|Bevacizumab|bevacizumab|mesh-list
154221708|NCT01069328|Carboplatin|carboplatin|mesh-list
154221709|NCT01069328|Sorafenib|sorafenib|mesh-list
154221710|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154221711|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221712|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
154221713|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
154221714|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
154221715|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221716|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154221717|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154221718|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154221719|NCT01069328|Growth Substances|growth substances|mesh-ancestor
154221720|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221721|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
154221722|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221723|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221724|NCT01067222|Modafinil|modafinil|mesh-list
154221725|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154221739|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154221740|NCT00290732|Doxorubicin|doxorubicin|mesh-list
154221741|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154221742|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154221743|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221744|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154221745|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154221746|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221747|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221748|NCT00312494|Ziprasidone|ziprasidone|mesh-list
154221749|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154221750|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
154221751|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221752|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221753|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221754|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154221755|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154221756|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221757|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154221758|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153544552|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154221759|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
154221760|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
154221761|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154221762|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154221763|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221776|NCT00290498|Cytarabine|cytarabine|mesh-list
154221788|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154221789|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154221790|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
154221791|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221792|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221793|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154221794|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154221795|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
154221796|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
154221797|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221798|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221799|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
154221800|NCT00290498|Hormones|hormones|mesh-ancestor
154221801|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154221802|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154221803|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154221845|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
154221846|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
154221847|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154221848|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154221849|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154221850|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154221851|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
154221852|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221853|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221854|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
154221855|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154221907|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221908|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154221909|NCT01062776|Furosemide|furosemide|mesh-list
154221910|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154221911|NCT01062776|Diuretics|diuretics|mesh-ancestor
154221912|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
154221913|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221914|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154221915|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154221916|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221917|NCT01070030|Amlodipine|amlodipine|mesh-list
154221918|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154221919|NCT01070030|Aliskiren|aliskiren|mesh-list
154221920|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153544597|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
154221921|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154221922|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154221923|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221924|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154221925|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221926|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
154221927|NCT01070030|Diuretics|diuretics|mesh-ancestor
154221928|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
154221929|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154221930|NCT01070030|Renin Inhibitors|renin inhibitors|mesh-ancestor
154221931|NCT01070030|Protease Inhibitors|protease inhibitors|mesh-ancestor
154221932|NCT01070030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221954|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221955|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221956|NCT01070108|Ketamine|ketamine|mesh-list
154221957|NCT01070108|Analgesics|analgesics|mesh-ancestor
154221958|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
154221959|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221960|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221961|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154221962|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154221963|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
154221964|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
154221965|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221966|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154221967|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154221968|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221969|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221970|NCT01067690|Indinavir|indinavir|mesh-list
154221971|NCT01067690|Bleomycin|bleomycin|mesh-list
154221972|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154221973|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154221974|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
154221975|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221976|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221977|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154221978|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154221979|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
154221980|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221981|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154221982|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221997|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221998|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154221999|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222000|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222001|NCT01026233|Immunotoxins|immunotoxins|mesh-ancestor
154222002|NCT01026233|Immunoconjugates|immunoconjugates|mesh-ancestor
154222003|NCT01026233|Immunologic Factors|immunologic factors|mesh-ancestor
154222004|NCT01026233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222005|NCT01062932|Cycloserine|cycloserine|mesh-list
154222006|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154222066|NCT00288626|Lenograstim|lenograstim|mesh-list
154222067|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222068|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
154222069|NCT00288626|Hormones|hormones|mesh-ancestor
154222070|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222071|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222072|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154222073|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222074|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154222075|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154222076|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222077|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222078|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222079|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154222080|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
154222081|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
154222082|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222083|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154222084|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
154222085|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154222086|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
154222087|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154222115|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154222116|NCT00288080|Dexamethasone|dexamethasone|mesh-list
154222117|NCT00288080|Prednisone|prednisone|mesh-list
154222118|NCT00288080|Docetaxel|docetaxel|mesh-list
154222119|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
154222120|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222121|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
154222122|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
154222123|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222124|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222125|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222126|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
154222127|NCT00288080|Hormones|hormones|mesh-ancestor
153544746|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222128|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222129|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154222130|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222131|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
154222132|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
154222133|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
154222134|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222135|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
154222136|NCT01068392|Prednisolone|prednisolone|mesh-list
154222137|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
154222168|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
154222169|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154222170|NCT00287690|Estrogens|estrogens|mesh-ancestor
154222171|NCT00287690|Hormones|hormones|mesh-ancestor
154222172|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222173|NCT01070186|Sunitinib|sunitinib|mesh-list
154222174|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222175|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154222176|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154222177|NCT01070186|Growth Substances|growth substances|mesh-ancestor
154222178|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222179|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
154222180|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154222181|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222182|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222183|NCT00066742|Etoposide|etoposide|mesh-list
154222227|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154222228|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154222229|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
154222231|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
154222232|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
154222233|NCT01091896|Bevacizumab|bevacizumab|mesh-list
154222234|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222235|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222236|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154222237|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154222238|NCT01091896|Growth Substances|growth substances|mesh-ancestor
154222239|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222240|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
154222241|NCT00065260|Cyclosporine|cyclosporine|mesh-list
154222288|NCT00460031|Ketoconazole|ketoconazole|mesh-list
154222289|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
154222290|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154222291|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154222292|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154222293|NCT00460031|Lenalidomide|lenalidomide|mesh-list
154222294|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
154222295|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222296|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154222297|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154222298|NCT00460031|Growth Substances|growth substances|mesh-ancestor
154222299|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
154222300|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222301|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222302|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
154222303|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222304|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154222305|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154222306|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222307|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222308|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154222309|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
154222311|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154222338|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154222339|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153969281|NCT00805792|Donepezil|donepezil|mesh-list
154222341|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222342|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
154222343|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154222344|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222345|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222346|NCT00311402|Aspirin|aspirin|mesh-list
154222347|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
154222350|NCT00311402|Analgesics|analgesics|mesh-ancestor
154222401|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222402|NCT01092130|Vitamin D|vitamin d|mesh-list
154222403|NCT01092130|Vitamins|vitamins|mesh-ancestor
154222404|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
154222405|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222406|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154222407|NCT00064792|Simvastatin|simvastatin|mesh-list
154222408|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154222468|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154222469|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
154222470|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222471|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222473|NCT00063934|Doxorubicin|doxorubicin|mesh-list
154222474|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154222475|NCT00063934|Oblimersen|oblimersen|mesh-list
154222476|NCT00063934|Lenograstim|lenograstim|mesh-list
154222477|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222478|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
154222532|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222533|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154222534|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154222536|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
154222537|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
154222538|NCT00062374|Alovudine|alovudine|mesh-list
154222539|NCT00062374|Cisplatin|cisplatin|mesh-list
154222540|NCT00062374|Irinotecan|irinotecan|mesh-list
154222541|NCT00062374|Camptothecin|camptothecin|mesh-list
154222542|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154222543|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222544|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154222545|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222546|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222547|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222548|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154222549|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154222550|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
154222551|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
154222552|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222553|NCT00285818|Mifepristone|mifepristone|mesh-list
154222554|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154222555|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
154222556|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154222557|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222558|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154222559|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154222560|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154222561|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
154222562|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154222563|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154222565|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222566|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
154222567|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154222568|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153646767|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646768|NCT00117052|Cinacalcet|cinacalcet|mesh-list
153646769|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154222569|NCT01023347|Paclitaxel|paclitaxel|mesh-list
154222570|NCT01023347|genexol-PM|genexol-pm|mesh-list
154222571|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154222572|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154222573|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222574|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
154222575|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
154222576|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
154222577|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222578|NCT06202755|Cilostazol|cilostazol|mesh-list
154222579|NCT06202755|Ticagrelor|ticagrelor|mesh-list
154222580|NCT06202755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154222581|NCT06202755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154222582|NCT06202755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154222583|NCT06202755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154222584|NCT06202755|Purinergic Agents|purinergic agents|mesh-ancestor
154222585|NCT06202755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222586|NCT06202755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222625|NCT06202001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222626|NCT06202001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222627|NCT06202001|Antimetabolites|antimetabolites|mesh-ancestor
154222628|NCT06202001|Antiviral Agents|antiviral agents|mesh-ancestor
154222629|NCT06202001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222630|NCT06201949|Carticaine|carticaine|mesh-list
154222631|NCT06201949|Anesthetics, Local|anesthetics, local|mesh-ancestor
154222632|NCT06201949|Anesthetics|anesthetics|mesh-ancestor
154222633|NCT06201949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222634|NCT06201949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222635|NCT06201949|Sensory System Agents|sensory system agents|mesh-ancestor
154222636|NCT06201949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222637|NCT06201676|Ketorolac|ketorolac|mesh-list
154222638|NCT06201676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154222639|NCT06201676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154222640|NCT06201676|Analgesics|analgesics|mesh-ancestor
154222641|NCT06201676|Sensory System Agents|sensory system agents|mesh-ancestor
154222642|NCT06201676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222643|NCT06201676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222644|NCT06201676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222645|NCT06201676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154222646|NCT06201676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154222678|NCT06201559|Mitosis Modulators|mitosis modulators|mesh-ancestor
154222679|NCT06201559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222680|NCT06201559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222681|NCT06201234|Niraparib|niraparib|mesh-list
154222682|NCT06201234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154222683|NCT06201234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222684|NCT06201234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222685|NCT06201234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222686|NCT06201195|Iodine|iodine|mesh-list
154222687|NCT06201195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154222688|NCT06201195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222689|NCT06201195|Trace Elements|trace elements|mesh-ancestor
154222690|NCT06201195|Micronutrients|micronutrients|mesh-ancestor
154222741|NCT06200883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222742|NCT06200883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222743|NCT06200883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154222744|NCT06200883|Nootropic Agents|nootropic agents|mesh-ancestor
154222745|NCT06200779|Amoxicillin|amoxicillin|mesh-list
154222746|NCT06200779|Clarithromycin|clarithromycin|mesh-list
154222747|NCT06200779|Levofloxacin|levofloxacin|mesh-list
154222748|NCT06200779|Ofloxacin|ofloxacin|mesh-list
154222749|NCT06200779|Metronidazole|metronidazole|mesh-list
153545333|NCT06309485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222750|NCT06200779|Tetracycline|tetracycline|mesh-list
154222751|NCT06200779|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154222752|NCT06200779|Bismuth|bismuth|mesh-list
154222808|NCT06200584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154222809|NCT06200584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154222810|NCT06200584|Antidepressive Agents|antidepressive agents|mesh-ancestor
154222812|NCT06200584|Protective Agents|protective agents|mesh-ancestor
154222813|NCT06200402|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154222814|NCT06200402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222815|NCT06200298|Ropivacaine|ropivacaine|mesh-list
154222816|NCT06200298|Anesthetics, Local|anesthetics, local|mesh-ancestor
154222817|NCT06200298|Anesthetics|anesthetics|mesh-ancestor
154222818|NCT06200298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222819|NCT06200298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222820|NCT06200298|Sensory System Agents|sensory system agents|mesh-ancestor
154222871|NCT06092931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154222872|NCT06092931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154222873|NCT06092931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222874|NCT06092931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222875|NCT06092931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154222876|NCT06092931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154222877|NCT06092931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154222878|NCT06092931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154222879|NCT06092931|Anesthetics, General|anesthetics, general|mesh-ancestor
154222880|NCT06092931|Anesthetics|anesthetics|mesh-ancestor
154222881|NCT06092931|GABA Modulators|gaba modulators|mesh-ancestor
154222882|NCT06092931|GABA Agents|gaba agents|mesh-ancestor
154222883|NCT06092931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222884|NCT06092931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222885|NCT06092931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154222886|NCT06092931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154222887|NCT06092931|Antimetabolites|antimetabolites|mesh-ancestor
154222888|NCT06092931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153545622|NCT06304350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153545623|NCT06304350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545624|NCT06304324|Dexamethasone|dexamethasone|mesh-list
153545625|NCT06304324|Dexmedetomidine|dexmedetomidine|mesh-list
153545626|NCT06304324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545627|NCT06304324|Antiemetics|antiemetics|mesh-ancestor
153545628|NCT06304324|Autonomic Agents|autonomic agents|mesh-ancestor
154222889|NCT06092931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154222890|NCT06092931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222891|NCT06092931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154222892|NCT06092931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154222893|NCT06092931|Protective Agents|protective agents|mesh-ancestor
154222894|NCT06092931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154222895|NCT06034470|Cytarabine|cytarabine|mesh-list
154222896|NCT06034470|Fludarabine|fludarabine|mesh-list
154222921|NCT06027606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222922|NCT06027606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154222923|NCT06027606|Autonomic Agents|autonomic agents|mesh-ancestor
154222924|NCT06027606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222925|NCT06027606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222926|NCT06027606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154222927|NCT06027606|Respiratory System Agents|respiratory system agents|mesh-ancestor
154222928|NCT06027606|Glucocorticoids|glucocorticoids|mesh-ancestor
154222929|NCT06027606|Hormones|hormones|mesh-ancestor
154222930|NCT06027606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222931|NCT06027606|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154222932|NCT06027606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154222933|NCT06027606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154222934|NCT06027606|Adrenergic Agents|adrenergic agents|mesh-ancestor
154222935|NCT06027606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222936|NCT06027606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222972|NCT05882214|Niacin|niacin|mesh-list
154222980|NCT05882214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222981|NCT05882214|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154222982|NCT05882214|Vasodilator Agents|vasodilator agents|mesh-ancestor
154222983|NCT05848128|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154222984|NCT05848128|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154222985|NCT05829226|Azacitidine|azacitidine|mesh-list
154222987|NCT05829226|Venetoclax|venetoclax|mesh-list
154222988|NCT05829226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154222989|NCT05829226|Antimetabolites|antimetabolites|mesh-ancestor
154222990|NCT05829226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223004|NCT05806021|Hormones|hormones|mesh-ancestor
154223043|NCT05713006|Alectinib|alectinib|mesh-list
154223044|NCT05713006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154223045|NCT05713006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223046|NCT05713006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223047|NCT05713006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223048|NCT05709028|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154223049|NCT05709028|Fosfomycin|fosfomycin|mesh-list
154223050|NCT05709028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223051|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
154223052|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223053|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223054|NCT05691829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153619104|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
154223056|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
154223103|NCT05589792|Acetazolamide|acetazolamide|mesh-list
154223104|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
154223105|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154223106|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223107|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223108|NCT05589792|Diuretics|diuretics|mesh-ancestor
154223109|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
154223110|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223111|NCT05577676|Triamcinolone|triamcinolone|mesh-list
154223112|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154223113|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154223114|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154223115|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223116|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
154223117|NCT05577676|Hormones|hormones|mesh-ancestor
154223118|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223119|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223120|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223121|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
154223133|NCT05445128|Plerixafor|plerixafor|mesh-list
154223158|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
154223159|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154223160|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
154223161|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
154223162|NCT05378113|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154223163|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154223164|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
154223165|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223166|NCT05346393|Terlipressin|terlipressin|mesh-list
154223167|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154223168|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154223169|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154223170|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223171|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223172|NCT05321810|Warfarin|warfarin|mesh-list
154223173|NCT05321810|Apixaban|apixaban|mesh-list
154223174|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
154223175|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154223176|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
154223177|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154223178|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
154223179|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223180|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223181|NCT05317364|Estradiol|estradiol|mesh-list
154223182|NCT05317364|Estrogens|estrogens|mesh-ancestor
153619243|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
154223183|NCT05317364|Hormones|hormones|mesh-ancestor
154223185|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223209|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154223210|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154223211|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
154223212|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154223213|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154223214|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
154223215|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223216|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
154223217|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154223218|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154223219|NCT05096884|Metoprolol|metoprolol|mesh-list
154223272|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223273|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223274|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154223275|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
154223276|NCT04996160|Hormones|hormones|mesh-ancestor
154223277|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223278|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154223279|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223280|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
154223281|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223282|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223283|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154223284|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154223285|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154223286|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223287|NCT04995484|Belzutifan|belzutifan|mesh-list
154223288|NCT04995484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223327|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223329|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154223330|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
154223331|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154223332|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223333|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154223334|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154223335|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154223336|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154223337|NCT04762875|Plerixafor|plerixafor|mesh-list
154223338|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154223390|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154223391|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
154223392|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223393|NCT04632069|Protective Agents|protective agents|mesh-ancestor
153619338|NCT01984008|Antacids|antacids|mesh-ancestor
154223394|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223395|NCT04632069|Antidotes|antidotes|mesh-ancestor
154223397|NCT04627064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223398|NCT04625946|Metformin|metformin|mesh-list
154223399|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154223400|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223402|NCT04624217|Gemcitabine|gemcitabine|mesh-list
154223456|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223457|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154223458|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223459|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
154223460|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
154223461|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154223462|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154223463|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154223464|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
154223465|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154223522|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154223523|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154223524|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223525|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
154223526|NCT04149210|Hormones|hormones|mesh-ancestor
154223527|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223528|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223529|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154223530|NCT04065009|Ropivacaine|ropivacaine|mesh-list
154223588|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154223589|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223590|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223591|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223592|NCT03776071|Temozolomide|temozolomide|mesh-list
154223593|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154223594|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
154223595|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223596|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223597|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
154223598|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154223599|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
154223600|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619410|NCT01984463|Analgesics|analgesics|mesh-ancestor
154223601|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223605|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
154223648|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
154223649|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223650|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223651|NCT03147287|Fulvestrant|fulvestrant|mesh-list
154223652|NCT03147287|Palbociclib|palbociclib|mesh-list
154223653|NCT03147287|Avelumab|avelumab|mesh-list
154223654|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154223655|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223656|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154223657|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154223658|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
154223659|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223660|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223661|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223662|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223663|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223664|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223665|NCT03068442|Flutemetamol|flutemetamol|mesh-list
154223666|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154223667|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223668|NCT03049462|Mirabegron|mirabegron|mesh-list
154223669|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223670|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223671|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154223672|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154223673|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154223674|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
154223675|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223676|NCT03049462|Urological Agents|urological agents|mesh-ancestor
154223677|NCT02990546|Midodrine|midodrine|mesh-list
154223678|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
154223679|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
154223687|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223688|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223689|NCT02965963|Dopamine|dopamine|mesh-list
154223690|NCT02965963|Metoclopramide|metoclopramide|mesh-list
154223691|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
154223692|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
154223693|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223694|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223695|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154223696|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154223697|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154223698|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
154223699|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223700|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223702|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
154223703|NCT02965963|Protective Agents|protective agents|mesh-ancestor
154223704|NCT02865135|Cyclophosphamide|cyclophosphamide|mesh-list
154223705|NCT02865135|Vaccines|vaccines|mesh-list
154223706|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
154223707|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223708|NCT02865135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223709|NCT02865135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223710|NCT02865135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154223711|NCT02865135|Alkylating Agents|alkylating agents|mesh-ancestor
154223712|NCT02865135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223713|NCT02865135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223714|NCT02865135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154223715|NCT02709720|Cisplatin|cisplatin|mesh-list
154223716|NCT02709720|Vinorelbine|vinorelbine|mesh-list
154223717|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223732|NCT02571725|Olaparib|olaparib|mesh-list
154223733|NCT02571725|Tremelimumab|tremelimumab|mesh-list
154223734|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154223735|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223736|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223737|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223738|NCT02501941|Ketamine|ketamine|mesh-list
154223739|NCT02501941|Analgesics|analgesics|mesh-ancestor
154223740|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
154223797|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
154223798|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
154223799|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223800|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223801|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154223802|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154223803|NCT01763645|Growth Substances|growth substances|mesh-ancestor
154223804|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223805|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
154223806|NCT00754260|Caffeine|caffeine|mesh-list
154223807|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154223808|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223809|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154223810|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223811|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223812|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154223813|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154223850|NCT00291668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154223851|NCT00291668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223852|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223853|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
154223854|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223855|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223856|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154223857|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154223858|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154223859|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223860|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223861|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
154223862|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223863|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154223908|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154223909|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154223910|NCT02532062|Vitamin D|vitamin d|mesh-list
154223911|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
154223912|NCT02532062|Vitamins|vitamins|mesh-ancestor
154223913|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
154223914|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223915|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154223916|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154223917|NCT00283712|Infliximab|infliximab|mesh-list
154223918|NCT00283712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154223927|NCT00449033|Sorafenib|sorafenib|mesh-list
154223973|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223974|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223975|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
154223976|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223977|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154223978|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154223979|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223980|NCT00457691|Antidotes|antidotes|mesh-ancestor
154223981|NCT00457691|Protective Agents|protective agents|mesh-ancestor
154223982|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
154223983|NCT00457691|Vitamins|vitamins|mesh-ancestor
154223984|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
154223985|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154223986|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154223987|NCT00457691|Growth Substances|growth substances|mesh-ancestor
154223988|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
154223989|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153620033|NCT01988896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223990|NCT00447005|Axitinib|axitinib|mesh-list
154223991|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223992|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223993|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223994|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223995|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
154223996|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
154223997|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154223998|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223999|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224004|NCT00446849|Mesalamine|mesalamine|mesh-list
154224020|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224021|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154224022|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
154224023|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154224024|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224025|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224026|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224028|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
154224029|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154224030|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
154224031|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224032|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224079|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154224080|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154224081|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224082|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224084|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224085|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154224086|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
154224087|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154224088|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154224089|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154224090|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224091|NCT00445601|Gemcitabine|gemcitabine|mesh-list
154224092|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154224093|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
154224094|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224095|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224096|NCT00444587|Trastuzumab|trastuzumab|mesh-list
154224097|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224098|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224099|NCT00235716|Vitamins|vitamins|mesh-list
154224100|NCT00235716|Vitamin E|vitamin e|mesh-list
154224101|NCT00235716|Tocopherols|tocopherols|mesh-list
154224102|NCT00235716|Tocotrienols|tocotrienols|mesh-list
154224103|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
154224104|NCT00235716|Memantine|memantine|mesh-list
154224105|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
154224126|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224127|NCT03970044|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154224128|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154224129|NCT03970044|Incretins|incretins|mesh-ancestor
154224130|NCT03970044|Hormones|hormones|mesh-ancestor
154224131|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224132|NCT00444275|Esomeprazole|esomeprazole|mesh-list
154224133|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154224134|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154224135|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154224136|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224188|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
154224189|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154224190|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224191|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154224192|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154224193|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154224194|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154224195|NCT00282308|Rituximab|rituximab|mesh-list
154224196|NCT00282308|Methotrexate|methotrexate|mesh-list
154224197|NCT00282308|Vaccines|vaccines|mesh-list
154224198|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154224199|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154224200|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
154224201|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224202|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224203|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224204|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224205|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154224206|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
154224207|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154224208|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154224237|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
154224238|NCT01069094|Leuprolide|leuprolide|mesh-list
154224239|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154224240|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
154224241|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154224242|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224243|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154224244|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224245|NCT00048568|Methotrexate|methotrexate|mesh-list
154224246|NCT00048568|Abatacept|abatacept|mesh-list
154224247|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154224248|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
154224300|NCT01095640|Analgesics|analgesics|mesh-ancestor
154224301|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
154224302|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224303|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224304|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224305|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224306|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
154224307|NCT00280748|Pemetrexed|pemetrexed|mesh-list
154224308|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224309|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224310|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224311|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154224312|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154224313|NCT03975374|Tobramycin|tobramycin|mesh-list
154224363|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224364|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154224365|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
154224366|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224367|NCT00207090|Rifampin|rifampin|mesh-list
154224430|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154224431|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224432|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154224433|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
154224434|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154224435|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224436|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224438|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
154224495|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224496|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154224497|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
153620432|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154224499|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224500|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154224501|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224502|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224503|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
154224504|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224518|NCT00276614|Bortezomib|bortezomib|mesh-list
154224558|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
154224559|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224560|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224561|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154224562|NCT01073696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154224563|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154224564|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
154224565|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224566|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224567|NCT00058552|Pertuzumab|pertuzumab|mesh-list
154224568|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224569|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224621|NCT06185621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154224622|NCT06185621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154224624|NCT06185621|Antipyretics|antipyretics|mesh-ancestor
154224625|NCT06185608|Ropivacaine|ropivacaine|mesh-list
154224626|NCT06185608|Anesthetics, Local|anesthetics, local|mesh-ancestor
154224627|NCT06185608|Anesthetics|anesthetics|mesh-ancestor
154224628|NCT06185608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224629|NCT06185608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224630|NCT06185608|Sensory System Agents|sensory system agents|mesh-ancestor
154224631|NCT06185608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224632|NCT06185400|Osimertinib|osimertinib|mesh-list
154224633|NCT06185400|Aflutinib|aflutinib|mesh-list
154224634|NCT06185400|Disitamab vedotin|disitamab vedotin|mesh-list
154224635|NCT06185400|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154224636|NCT06185400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224637|NCT06185400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620531|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224638|NCT06185400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224639|NCT06185400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224640|NCT06185400|Immunoconjugates|immunoconjugates|mesh-ancestor
154224641|NCT06185400|Immunologic Factors|immunologic factors|mesh-ancestor
154224644|NCT06185361|Fluoxetine|fluoxetine|mesh-list
154224674|NCT06185127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154224675|NCT06185127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154224676|NCT06185127|Adrenergic Agents|adrenergic agents|mesh-ancestor
154224677|NCT06185127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224678|NCT06185127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224679|NCT06185127|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154224680|NCT06185127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154224681|NCT06185127|Anesthetics, General|anesthetics, general|mesh-ancestor
154224682|NCT06185127|Anesthetics|anesthetics|mesh-ancestor
154224683|NCT06185127|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154224684|NCT06185127|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154224685|NCT06185127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154224686|NCT06185127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154224687|NCT06185127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154224688|NCT06185127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154224689|NCT06185127|GABA Modulators|gaba modulators|mesh-ancestor
154224733|NCT06162819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154224734|NCT06162819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224735|NCT06162819|Analgesics|analgesics|mesh-ancestor
154224736|NCT06162819|Sensory System Agents|sensory system agents|mesh-ancestor
154224737|NCT06162819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224746|NCT06162819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154224747|NCT06162819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154224748|NCT06162819|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154224749|NCT06162819|Histamine Antagonists|histamine antagonists|mesh-ancestor
154224750|NCT06162819|Histamine Agents|histamine agents|mesh-ancestor
154224751|NCT06162819|Vasodilator Agents|vasodilator agents|mesh-ancestor
154224752|NCT06124235|Chlorhexidine|chlorhexidine|mesh-list
154224753|NCT06124235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154224754|NCT06124235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154224755|NCT06124235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224756|NCT06124235|Disinfectants|disinfectants|mesh-ancestor
154224757|NCT06124235|Dermatologic Agents|dermatologic agents|mesh-ancestor
154224758|NCT06120725|Clopidogrel|clopidogrel|mesh-list
154224759|NCT06120725|Ticagrelor|ticagrelor|mesh-list
154224760|NCT06120725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154224761|NCT06120725|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154224762|NCT06120725|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154224763|NCT06120725|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154224764|NCT06120725|Purinergic Agents|purinergic agents|mesh-ancestor
154224765|NCT06120725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224766|NCT06120725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224767|NCT06120725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224768|NCT06094387|Thrombin|thrombin|mesh-list
154224769|NCT06094387|Hemostatics|hemostatics|mesh-ancestor
154224770|NCT06094387|Coagulants|coagulants|mesh-ancestor
154224780|NCT06074471|Bupivacaine|bupivacaine|mesh-list
154224781|NCT06074471|Anesthetics, Local|anesthetics, local|mesh-ancestor
154224782|NCT06074471|Anesthetics|anesthetics|mesh-ancestor
154224785|NCT06074471|Sensory System Agents|sensory system agents|mesh-ancestor
154224791|NCT06030804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224793|NCT06030804|Sensory System Agents|sensory system agents|mesh-ancestor
154224794|NCT06030804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224795|NCT06030804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154224796|NCT06030804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154224797|NCT06030804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154224798|NCT06030804|Adrenergic Agents|adrenergic agents|mesh-ancestor
154224799|NCT06030804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224800|NCT06030804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224801|NCT06005818|Pembrolizumab|pembrolizumab|mesh-list
154224802|NCT06005818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224803|NCT06005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224806|NCT05996627|Belumosudil|belumosudil|mesh-list
154224849|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224850|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224851|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154224852|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154224853|NCT05611879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224854|NCT05604170|Ganaxolone|ganaxolone|mesh-list
154224855|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
154224856|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224857|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224858|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224859|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
154224860|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
154224910|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154224911|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224912|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154224913|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154224914|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
154224915|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620904|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
153620976|NCT01996085|Lisinopril|lisinopril|mesh-list
154224916|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224917|NCT05351801|Dronabinol|dronabinol|mesh-list
154224977|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
154224978|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224979|NCT05062889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224980|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154224981|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154224982|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224983|NCT05062889|Antidotes|antidotes|mesh-ancestor
154224984|NCT05062889|Protective Agents|protective agents|mesh-ancestor
154224985|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
154224986|NCT05062889|Vitamins|vitamins|mesh-ancestor
154224987|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
154224988|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
154224989|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224990|NCT05062889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224991|NCT05037045|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154224992|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154224993|NCT05037045|Incretins|incretins|mesh-ancestor
154224994|NCT05037045|Hormones|hormones|mesh-ancestor
154224995|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224996|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224997|NCT05037045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154224998|NCT04997993|Leflunomide|leflunomide|mesh-list
154224999|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225000|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225001|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154225002|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
154225003|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225004|NCT04975269|Acetazolamide|acetazolamide|mesh-list
154225005|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
154225006|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154225007|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154225008|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225009|NCT04975269|Diuretics|diuretics|mesh-ancestor
154225010|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
154225011|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225012|NCT04931511|Betamethasone|betamethasone|mesh-list
154225013|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
153646479|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154225014|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154225015|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
154225016|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154225017|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225018|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
154225019|NCT04931511|Hormones|hormones|mesh-ancestor
154225020|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153621041|NCT01996384|Lidocaine|lidocaine|mesh-list
154225021|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225022|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154225023|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
154225024|NCT04738318|Dexamethasone|dexamethasone|mesh-list
154225025|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
154225026|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
154225027|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154225028|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
154225029|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
154225030|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154225031|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154225032|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154225033|NCT04738318|Hormones|hormones|mesh-ancestor
153971954|NCT00915382|Cisplatin|cisplatin|mesh-list
154225034|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154225035|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154138169|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138170|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154138171|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154138172|NCT04205357|Analgesics|analgesics|mesh-ancestor
154138173|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
154138174|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138175|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138176|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154138177|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138178|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154138180|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
154138184|NCT01008813|Vaccines|vaccines|mesh-list
154138186|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138188|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154138189|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154138190|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138191|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
154138192|NCT01005147|Coagulants|coagulants|mesh-ancestor
154138193|NCT01001871|Vitamins|vitamins|mesh-list
154138194|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
154138195|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138196|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
154138197|NCT01005381|Vitamin D|vitamin d|mesh-list
154138198|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
154138199|NCT01005381|Calcium|calcium|mesh-list
154138200|NCT01005381|Vitamins|vitamins|mesh-ancestor
154138201|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
154138202|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138203|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154138204|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154138205|NCT01005381|Antacids|antacids|mesh-ancestor
154138206|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138207|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154138208|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
154138209|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138210|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138211|NCT05154279|Terlipressin|terlipressin|mesh-list
154138214|NCT01005537|Aldesleukin|aldesleukin|mesh-list
154138237|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138238|NCT01002729|Oseltamivir|oseltamivir|mesh-list
154138239|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
154138240|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138241|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138242|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138243|NCT01002807|Metformin|metformin|mesh-list
154138244|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
154138245|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154138247|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154138248|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138249|NCT05733117|Vitamin D|vitamin d|mesh-list
154138250|NCT05733117|Vitamins|vitamins|mesh-ancestor
154138251|NCT05733117|Micronutrients|micronutrients|mesh-ancestor
154138252|NCT05733117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138253|NCT05733117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154138254|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
154138255|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154138256|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138257|NCT00615056|Leucovorin|leucovorin|mesh-list
154138258|NCT00615056|Bevacizumab|bevacizumab|mesh-list
154138259|NCT00615056|Fluorouracil|fluorouracil|mesh-list
154138261|NCT00615056|Irinotecan|irinotecan|mesh-list
154138291|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154138292|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154138293|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154138294|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154138295|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154138297|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
154138298|NCT00873626|Levofloxacin|levofloxacin|mesh-list
154138299|NCT00873626|Ofloxacin|ofloxacin|mesh-list
154138300|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
154138301|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138302|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138303|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154138312|NCT00879242|Deferasirox|deferasirox|mesh-list
154138354|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154138356|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138357|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138358|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138359|NCT00868946|Ribavirin|ribavirin|mesh-list
154138360|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
154138361|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138362|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
154138363|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138364|NCT00482014|Carboplatin|carboplatin|mesh-list
154138365|NCT00482014|Pemetrexed|pemetrexed|mesh-list
154138366|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138367|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621490|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138368|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138369|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154138370|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154138371|NCT00879788|Ramipril|ramipril|mesh-list
154138372|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154138373|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
154138374|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138375|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138376|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138377|NCT03595553|Vancomycin|vancomycin|mesh-list
154138378|NCT03595553|Ridinilazole|ridinilazole|mesh-list
154138379|NCT03595553|Benzimidazole|benzimidazole|mesh-list
154138380|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138381|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138382|NCT03595553|Anthelmintics|anthelmintics|mesh-ancestor
154138383|NCT03595553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154138384|NCT00874172|Analgesics|analgesics|mesh-list
154138398|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138399|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138400|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154138401|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154138402|NCT04861298|Quercetin|quercetin|mesh-list
154138403|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
154138404|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138405|NCT04861298|Protective Agents|protective agents|mesh-ancestor
154138406|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138452|NCT00880178|Niacin|niacin|mesh-list
154138463|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
154138464|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
154138465|NCT00880178|Vitamins|vitamins|mesh-ancestor
154138466|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
154138467|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138468|NCT04077125|Rifaximin|rifaximin|mesh-list
154138469|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138470|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138471|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154138472|NCT05172401|Triamcinolone|triamcinolone|mesh-list
154138473|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154138474|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154138475|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154138476|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154138478|NCT05172401|Hormones|hormones|mesh-ancestor
154138479|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154138480|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138481|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138482|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
154138483|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138484|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138485|NCT00143455|Cisplatin|cisplatin|mesh-list
154138486|NCT00143455|Irinotecan|irinotecan|mesh-list
154138518|NCT03529955|Analgesics|analgesics|mesh-ancestor
154138519|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
154138520|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138521|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138522|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154138523|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138524|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154138525|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154138526|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138527|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138528|NCT00142909|Lofexidine|lofexidine|mesh-list
154138529|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138530|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154138531|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138532|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
154138533|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138534|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154138535|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154138536|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154138537|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
154138538|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138539|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138540|NCT01007019|Esomeprazole|esomeprazole|mesh-list
154138568|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138569|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154138570|NCT00205699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153462067|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
154138571|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154138572|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154138573|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
154138574|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
154138575|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154138576|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154138577|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154138578|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154138579|NCT03503513|Gentamicins|gentamicins|mesh-list
154138580|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138581|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138582|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154138583|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138584|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138585|NCT02580149|Clopidogrel|clopidogrel|mesh-list
154138586|NCT02580149|Ticagrelor|ticagrelor|mesh-list
154138587|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154138588|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154138589|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154138590|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154138591|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
154138592|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138593|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138594|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138595|NCT04996017|Atezolizumab|atezolizumab|mesh-list
154138596|NCT04996017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154138597|NCT04996017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138598|NCT04996017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138599|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138603|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154138604|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
154138605|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138606|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138607|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
154138608|NCT01007565|Anesthetics|anesthetics|mesh-list
154138609|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154138610|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138611|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
154138612|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154138613|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138614|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154138615|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
154138616|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138617|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138618|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138619|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621873|NCT02001896|Carboplatin|carboplatin|mesh-list
154138620|NCT02798471|Heparin|heparin|mesh-list
154138621|NCT02798471|Enoxaparin|enoxaparin|mesh-list
154138622|NCT02798471|Warfarin|warfarin|mesh-list
154138623|NCT02798471|Edoxaban|edoxaban|mesh-list
154138624|NCT02798471|Fondaparinux|fondaparinux|mesh-list
154138625|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
154138626|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154138627|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154138628|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138629|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154138630|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
154138631|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154138634|NCT03443765|Vitamin D|vitamin d|mesh-list
154138650|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138651|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154138652|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138653|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154138654|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138655|NCT03440177|Ramipril|ramipril|mesh-list
154138656|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154138657|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
154138658|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138659|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138660|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138661|NCT00489736|Amiodarone|amiodarone|mesh-list
154138662|NCT00489736|Dronedarone|dronedarone|mesh-list
154138663|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154138664|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
154138665|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154138666|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154138667|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138668|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154138669|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154138670|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154138671|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138672|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154138673|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154138674|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154138675|NCT00617084|Everolimus|everolimus|mesh-list
154138696|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138697|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138699|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
154138700|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154138701|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154138702|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138703|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154138704|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
154138705|NCT00489424|Acetaminophen|acetaminophen|mesh-list
154138706|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154138707|NCT00489424|Analgesics|analgesics|mesh-ancestor
154138708|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
154138709|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138710|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138711|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
154138712|NCT00869570|Capecitabine|capecitabine|mesh-list
154138713|NCT00869570|Sorafenib|sorafenib|mesh-list
154138714|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138715|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
154138716|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138717|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138718|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153519097|NCT01449344|Cytarabine|cytarabine|mesh-list
154138748|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138749|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154138750|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
154138751|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154138752|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154138753|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154138754|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154138755|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138756|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138757|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154138758|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154138759|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138760|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154138761|NCT01020214|Olmesartan|olmesartan|mesh-list
154138809|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154138810|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138811|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153622177|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138812|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
154138813|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154138814|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154138815|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138816|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138817|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
154138818|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154138819|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154138820|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154138821|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154138822|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154138823|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154138824|NCT04013880|Decitabine|decitabine|mesh-list
154138825|NCT04013880|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154138826|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138827|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
154138828|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138829|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138830|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138831|NCT00934518|Cetuximab|cetuximab|mesh-list
154138832|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138833|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138834|NCT00496366|Capecitabine|capecitabine|mesh-list
154138835|NCT00496366|Lapatinib|lapatinib|mesh-list
154138836|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138837|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
154138838|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138839|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138840|NCT00496366|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154138843|NCT00934674|Bosutinib|bosutinib|mesh-list
154138847|NCT00934674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138848|NCT00934752|Paclitaxel|paclitaxel|mesh-list
154138849|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138850|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138851|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138852|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138853|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138854|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138855|NCT01020292|Nelfinavir|nelfinavir|mesh-list
154138856|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154138857|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154138858|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
154138859|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138860|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138861|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154138862|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154138863|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
154138864|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138865|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154138866|NCT00934830|Amoxicillin|amoxicillin|mesh-list
153462361|NCT04275258|Analgesics|analgesics|mesh-ancestor
154138867|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138868|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
154138869|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138870|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138871|NCT02575404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154138872|NCT02575404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138873|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
154138891|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138893|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138894|NCT00935610|Caseins|caseins|mesh-list
154138895|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
154138896|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
154138897|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138898|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
154138899|NCT04013646|Hematinics|hematinics|mesh-ancestor
154138900|NCT04074473|Propranolol|propranolol|mesh-list
154138901|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154138902|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154138903|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
154138904|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138905|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138906|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622459|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
153622460|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154138907|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154138908|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138909|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
154138910|NCT03093480|Factor VIII|factor viii|mesh-list
154138911|NCT03093480|Coagulants|coagulants|mesh-ancestor
154138912|NCT02578511|Ixazomib|ixazomib|mesh-list
154138913|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138914|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
154138915|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138916|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138917|NCT00563784|Paclitaxel|paclitaxel|mesh-list
154138918|NCT00563784|Carboplatin|carboplatin|mesh-list
154138919|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154138920|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138921|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138922|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138923|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138934|NCT00203047|Hormones|hormones|mesh-ancestor
154138935|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154138936|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138937|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154138938|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138939|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154138940|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
154138941|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153462450|NCT01926132|Vitamins|vitamins|mesh-ancestor
154138942|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138943|NCT00870038|Paclitaxel|paclitaxel|mesh-list
154138944|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138945|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138946|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138947|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138948|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138949|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138950|NCT04074551|Losartan|losartan|mesh-list
154138951|NCT04074551|Amlodipine|amlodipine|mesh-list
154138952|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154138953|NCT04074551|Ezetimibe|ezetimibe|mesh-list
154138954|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138985|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
154138986|NCT00141817|Pantoprazole|pantoprazole|mesh-list
154138987|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154138988|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154138989|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154138990|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138991|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138992|NCT03967171|Oxytocin|oxytocin|mesh-list
154138993|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
154138994|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154138995|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138997|NCT03967327|Buprenorphine|buprenorphine|mesh-list
154138998|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154138999|NCT03967327|Narcotics|narcotics|mesh-ancestor
154139000|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139001|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139002|NCT03967327|Analgesics|analgesics|mesh-ancestor
154139003|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
154139004|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139005|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154139006|NCT01075945|Lumefantrine|lumefantrine|mesh-list
154139007|NCT01075945|Artemether|artemether|mesh-list
154139008|NCT01075945|Piperaquine|piperaquine|mesh-list
154139010|NCT01075945|Artenimol|artenimol|mesh-list
154139041|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139042|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139043|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154139044|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139045|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
154139046|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139047|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154139048|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139049|NCT03798314|Growth Substances|growth substances|mesh-ancestor
154139050|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
154139051|NCT01077427|Gemcitabine|gemcitabine|mesh-list
154139052|NCT01077427|Capecitabine|capecitabine|mesh-list
154139053|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139054|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154139055|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
154139056|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139057|NCT00883064|Lisinopril|lisinopril|mesh-list
154139058|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154139059|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
154139060|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139061|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139062|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154139063|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154139064|NCT00883064|Protective Agents|protective agents|mesh-ancestor
154139065|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139066|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
154139067|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
154157502|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622590|NCT05970705|Antimetabolites|antimetabolites|mesh-ancestor
154139068|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
154139069|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
154139070|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154139071|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139072|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154139073|NCT01077505|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154139074|NCT01077505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153646480|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
153646481|NCT00115492|Hormones|hormones|mesh-ancestor
153646770|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139075|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154139076|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154139077|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154139078|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
154139079|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154139080|NCT01073995|Triamcinolone|triamcinolone|mesh-list
154139081|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154139082|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154139083|NCT01073995|Bupivacaine|bupivacaine|mesh-list
154139084|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154139085|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
154139086|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
154139087|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139088|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139089|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
154139090|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139131|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154139132|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154139133|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154139134|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154139135|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
154139136|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139137|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139138|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139139|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154139140|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
154139141|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139195|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154139196|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139197|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
154139198|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139199|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154139200|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139201|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154139202|NCT00614120|Metformin|metformin|mesh-list
154139203|NCT00614120|Liraglutide|liraglutide|mesh-list
154139204|NCT00614120|Glimepiride|glimepiride|mesh-list
154139205|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154139257|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139258|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157504|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154139259|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154139260|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
154139261|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
154139262|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154139263|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
154139264|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139265|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139266|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
154139267|NCT00881426|Cefprozil|cefprozil|mesh-list
154139268|NCT00881426|Cephalosporins|cephalosporins|mesh-list
154139269|NCT00881426|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154139270|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139271|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139272|NCT00883532|Budesonide|budesonide|mesh-list
154139273|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154139274|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139275|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154139276|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
154139277|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139278|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139279|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154139280|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
154139281|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
154139307|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139308|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139309|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139310|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154139311|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139312|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139313|NCT00881816|Paclitaxel|paclitaxel|mesh-list
154139314|NCT00881816|Capecitabine|capecitabine|mesh-list
154139315|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154139317|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
154139318|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
154139319|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
154139320|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139321|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154139322|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
154139323|NCT03712904|Aflibercept|aflibercept|mesh-list
154139324|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
154139325|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154139340|NCT00141037|Prednisone|prednisone|mesh-list
154139365|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154139366|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154139367|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154139368|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
154139369|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154139370|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
154139371|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154139372|NCT01582555|Antidotes|antidotes|mesh-ancestor
154139373|NCT01582555|Protective Agents|protective agents|mesh-ancestor
154139374|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139375|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
154139376|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139377|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
154139378|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139379|NCT01582555|Expectorants|expectorants|mesh-ancestor
154139380|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
154139381|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154139382|NCT00923390|Aldesleukin|aldesleukin|mesh-list
154139383|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
154139384|NCT00923390|Fludarabine|fludarabine|mesh-list
154139385|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154139420|NCT00888758|Everolimus|everolimus|mesh-list
154139421|NCT00888758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154139422|NCT00888758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154139423|NCT00888758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139424|NCT00888758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139425|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154139426|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
154139427|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139428|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139429|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139430|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139431|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139432|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154139481|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154139482|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139483|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139484|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
154139485|NCT00936156|Carboplatin|carboplatin|mesh-list
154139486|NCT00936156|Etoposide|etoposide|mesh-list
153622924|NCT05783544|Antiviral Agents|antiviral agents|mesh-ancestor
154139487|NCT00936156|Thiotepa|thiotepa|mesh-list
154139488|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139489|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154139490|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154139491|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154139492|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139493|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139494|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154139495|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
154139496|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154139497|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154139498|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
154139499|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139500|NCT00129961|Cyclosporine|cyclosporine|mesh-list
154139501|NCT00129961|Sirolimus|sirolimus|mesh-list
154139502|NCT00129961|Tacrolimus|tacrolimus|mesh-list
154139503|NCT00129961|Cyclosporins|cyclosporins|mesh-list
154139504|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154139505|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
154139506|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139507|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154139508|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139509|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139510|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
154139511|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139512|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
154139513|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139514|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139515|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154139516|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139517|NCT00528567|Bevacizumab|bevacizumab|mesh-list
153646482|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646483|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
154139518|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139519|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139520|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154139521|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139522|NCT00528567|Growth Substances|growth substances|mesh-ancestor
154139523|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139524|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
154139525|NCT00936234|Vildagliptin|vildagliptin|mesh-list
154139526|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154139527|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139528|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154139529|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
154139530|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139531|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139532|NCT00886028|Doxorubicin|doxorubicin|mesh-list
154139533|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154139534|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139535|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154139536|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154139537|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154139538|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139539|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139541|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139542|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139543|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
154139544|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139559|NCT00138151|Paclitaxel|paclitaxel|mesh-list
154139564|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
154139565|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
154139566|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139567|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
154139568|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139569|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
154139570|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139571|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154139572|NCT02543060|Fluorides|fluorides|mesh-list
154139573|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
154139574|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
154139575|NCT02543060|Protective Agents|protective agents|mesh-ancestor
154139576|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139577|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154139578|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154139579|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
154157505|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154139580|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139581|NCT00889616|Antacids|antacids|mesh-ancestor
154139582|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139583|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139584|NCT02581631|Nivolumab|nivolumab|mesh-list
154139585|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154139586|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139587|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139596|NCT00884546|Bortezomib|bortezomib|mesh-list
154139615|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154139616|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154139617|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139618|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139619|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154139620|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154139621|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154139622|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154139623|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
154139624|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
154139625|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
154139626|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
154139627|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139628|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139629|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154139630|NCT00886106|Narcotics|narcotics|mesh-ancestor
154139631|NCT00886106|Analgesics|analgesics|mesh-ancestor
154139675|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139677|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154139678|NCT04074317|Pramlintide|pramlintide|mesh-list
154139679|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154139680|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139681|NCT00941148|Insulin|insulin|mesh-list
154139682|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154139683|NCT00941148|Metformin|metformin|mesh-list
154139704|NCT00609674|Xhance|xhance|mesh-list
154139742|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139743|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785348|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154139744|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154139745|NCT00563316|Irinotecan|irinotecan|mesh-list
154139746|NCT00563316|Panitumumab|panitumumab|mesh-list
154139747|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154139748|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154139749|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139750|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139751|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139752|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139753|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
154139754|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154139755|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139756|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139757|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154139758|NCT04037774|Analgesics|analgesics|mesh-ancestor
154139759|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
154139760|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139761|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154139762|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154139792|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139793|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139794|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139795|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
154139796|NCT02542592|Hormones|hormones|mesh-ancestor
154139797|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139798|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154139799|NCT02542592|Protective Agents|protective agents|mesh-ancestor
154139800|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154139801|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139802|NCT03178487|Upadacitinib|upadacitinib|mesh-list
154139803|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154139804|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154139805|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139806|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139807|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139808|NCT04430036|Cisplatin|cisplatin|mesh-list
154139809|NCT04430036|Gemcitabine|gemcitabine|mesh-list
154139810|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139811|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154139812|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
154139842|NCT00890786|Bevacizumab|bevacizumab|mesh-list
154139843|NCT00890786|Irinotecan|irinotecan|mesh-list
154139844|NCT00890786|Temozolomide|temozolomide|mesh-list
154139845|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139846|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139847|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154139848|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139849|NCT00890786|Growth Substances|growth substances|mesh-ancestor
154139850|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139851|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
154139852|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154139853|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154139854|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139855|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139856|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154139857|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
154139858|NCT00560508|Pramipexole|pramipexole|mesh-list
154139859|NCT00560508|Dexpramipexole|dexpramipexole|mesh-list
154139860|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
154139861|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139862|NCT00560508|Protective Agents|protective agents|mesh-ancestor
154139863|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139864|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154139865|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154139866|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
154139867|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
154139869|NCT00890942|Naloxone|naloxone|mesh-list
154139891|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139892|NCT00942318|Insulin|insulin|mesh-list
154139893|NCT00942318|Metformin|metformin|mesh-list
154139894|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
154139895|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154139896|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139897|NCT05280054|Probenecid|probenecid|mesh-list
154139898|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
154139899|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
154139900|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139901|NCT03999099|Suvorexant|suvorexant|mesh-list
154139902|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154139903|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154139904|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139905|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139906|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154139907|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139908|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139909|NCT01007799|Vitamin D|vitamin d|mesh-list
154139910|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
154139911|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
154139912|NCT01007799|Vitamins|vitamins|mesh-list
154139913|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
154139914|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139915|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154139916|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154139917|NCT00609518|Folic Acid|folic acid|mesh-list
154139918|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
154139919|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
154139920|NCT00609518|Dexamethasone|dexamethasone|mesh-list
154139922|NCT00609518|Pemetrexed|pemetrexed|mesh-list
154139939|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139940|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154139941|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154139942|NCT00609518|Hematinics|hematinics|mesh-ancestor
154139943|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154139944|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154139945|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139946|NCT00886496|Lectins|lectins|mesh-list
154139947|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
154139948|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
154139949|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139950|NCT00886496|Coagulants|coagulants|mesh-ancestor
154139951|NCT00884858|Maraviroc|maraviroc|mesh-list
154139952|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154139953|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154139954|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139955|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154139956|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154139957|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
154139958|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153623374|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
154139959|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154139994|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154139996|NCT00611858|Fluorouracil|fluorouracil|mesh-list
154139997|NCT00611858|Cetuximab|cetuximab|mesh-list
153463490|NCT05020782|Belimumab|belimumab|mesh-list
154139998|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
154139999|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140000|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154140002|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154140003|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
154140004|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140005|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154140006|NCT00137449|Sunitinib|sunitinib|mesh-list
154140007|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140008|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154140009|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154140010|NCT00137449|Growth Substances|growth substances|mesh-ancestor
154140011|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140012|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
154140013|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154140014|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140015|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140016|NCT00886886|Reboxetine|reboxetine|mesh-list
154140017|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
154140018|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140019|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154140020|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154140021|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154140022|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140023|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
154140026|NCT00887042|Fludarabine|fludarabine|mesh-list
154140035|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154140036|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154140037|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
154140038|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
154140039|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154140040|NCT00892112|Antibodies|antibodies|mesh-list
154140041|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
154140042|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154140043|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
154140044|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140045|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
154140046|NCT00887120|Ritonavir|ritonavir|mesh-list
154140047|NCT00887120|Lopinavir|lopinavir|mesh-list
154140048|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154140049|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154140050|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
154140051|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140052|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140053|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154140054|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154140055|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
154140056|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140057|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154140058|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154140059|NCT00892190|Dasatinib|dasatinib|mesh-list
154140060|NCT00892190|Tretinoin|tretinoin|mesh-list
154140061|NCT00892190|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154140062|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154140063|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140064|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140065|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140066|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
154140067|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
154140068|NCT00887276|Amoxicillin|amoxicillin|mesh-list
154140069|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
154140070|NCT00887276|Ampicillin|ampicillin|mesh-list
154140076|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140079|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
154140080|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154140081|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140082|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154140083|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140084|NCT00608894|Prednisone|prednisone|mesh-list
154140085|NCT00608894|Azathioprine|azathioprine|mesh-list
154140086|NCT00608894|Tacrolimus|tacrolimus|mesh-list
154140087|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140088|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
154140140|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140141|NCT00191113|Estrogens|estrogens|mesh-ancestor
154140142|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154140143|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
154140144|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154140145|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154140146|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154140147|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154140148|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154140149|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154140150|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140151|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140152|NCT03965052|Travoprost|travoprost|mesh-list
154140153|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154140154|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154140155|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154140156|NCT00892658|Sorafenib|sorafenib|mesh-list
154140157|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140158|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154140159|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140160|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140161|NCT00892736|Veliparib|veliparib|mesh-list
154140162|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154140163|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140164|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140165|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140166|NCT03966235|Melatonin|melatonin|mesh-list
154140186|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154140187|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140188|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140189|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
154140190|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
154140191|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140192|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140193|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154140194|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154140195|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
154140196|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154140197|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154140199|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154140247|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140248|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140249|NCT00187135|Fentanyl|fentanyl|mesh-list
154140250|NCT00187135|Propofol|propofol|mesh-list
154140251|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154140252|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140253|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140254|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154140255|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
154140256|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
154140257|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154140258|NCT00187135|Narcotics|narcotics|mesh-ancestor
154140259|NCT00187135|Analgesics|analgesics|mesh-ancestor
154140260|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
154140261|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140262|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154140263|NCT00896402|Iodine|iodine|mesh-list
154140264|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
154140265|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154140266|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
154140267|NCT00896402|Povidone|povidone|mesh-list
154140268|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154140303|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
154140304|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
154140305|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
154140306|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140307|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154140308|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154140309|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154140310|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
154140311|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140312|NCT00944814|Zinc|zinc|mesh-list
154140313|NCT00944814|Trace Elements|trace elements|mesh-ancestor
154140314|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
154140315|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140316|NCT00527787|Naproxen|naproxen|mesh-list
154140317|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154140318|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154140319|NCT00527787|Analgesics|analgesics|mesh-ancestor
154140320|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
154140321|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140322|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140323|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140324|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140325|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
154140326|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154140327|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140328|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140329|NCT00893048|Prednisone|prednisone|mesh-list
154140330|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140331|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
154140332|NCT00893048|Hormones|hormones|mesh-ancestor
154140345|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154140346|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154140347|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140348|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140349|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154140350|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154140351|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140352|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154140353|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
154140354|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
154140355|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
154140356|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
154140357|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140358|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140359|NCT00943176|Modafinil|modafinil|mesh-list
154140360|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154140361|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140362|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154140363|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154140364|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154140365|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140366|NCT00129259|Iron|iron|mesh-list
154140367|NCT00129259|Trace Elements|trace elements|mesh-ancestor
154140368|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
153729701|NCT00139815|PENTA|penta|mesh-list
153463886|NCT02549898|Cilostazol|cilostazol|mesh-list
154140369|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140390|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154140391|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
154140392|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154140393|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154140394|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
154140395|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
154140396|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140397|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154140398|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154140399|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154140400|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154140401|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154140402|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
154140403|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140404|NCT00940524|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154140405|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154140406|NCT00940524|Analgesics|analgesics|mesh-ancestor
154140407|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
154140408|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140447|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140448|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154140449|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
154140450|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140451|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140452|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154140453|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
154140454|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154140455|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154140456|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153623973|NCT03830866|Durvalumab|durvalumab|mesh-list
154140457|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154140508|NCT06089733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140509|NCT06089733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154140510|NCT06089733|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154140511|NCT06089733|Antitubercular Agents|antitubercular agents|mesh-ancestor
154140512|NCT06089733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154140513|NCT06089733|Leprostatic Agents|leprostatic agents|mesh-ancestor
154140514|NCT06089733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154140515|NCT06089733|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154140516|NCT06089733|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153729702|NCT00139815|Fondaparinux|fondaparinux|mesh-list
154140517|NCT06089733|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154140518|NCT06089733|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154140519|NCT06089733|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154140520|NCT06089733|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154140566|NCT06089044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140567|NCT06088771|Cemiplimab|cemiplimab|mesh-list
154140568|NCT06088771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154140569|NCT06088771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140570|NCT06088745|Vaccines|vaccines|mesh-list
154140571|NCT06088745|Immunologic Factors|immunologic factors|mesh-ancestor
154140572|NCT06088745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140573|NCT06088433|Aspirin|aspirin|mesh-list
154140574|NCT06088433|Clopidogrel|clopidogrel|mesh-list
154140575|NCT06088433|Ticagrelor|ticagrelor|mesh-list
154140576|NCT06088433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154140577|NCT06088433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154140578|NCT06088433|Analgesics|analgesics|mesh-ancestor
154140579|NCT06088433|Sensory System Agents|sensory system agents|mesh-ancestor
154140583|NCT06088433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140630|NCT06088082|Anesthetics, Local|anesthetics, local|mesh-ancestor
154140631|NCT06088082|Anesthetics|anesthetics|mesh-ancestor
154140632|NCT06088082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140633|NCT06088082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140634|NCT06088082|Sensory System Agents|sensory system agents|mesh-ancestor
154140635|NCT06088082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140636|NCT06087965|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153624092|NCT03095235|Riboflavin|riboflavin|mesh-list
154140637|NCT06087965|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154140638|NCT06087965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140639|NCT06087965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154140640|NCT06087965|Immunologic Factors|immunologic factors|mesh-ancestor
154140641|NCT06087965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140642|NCT06087952|Anticoagulants|anticoagulants|mesh-list
154140689|NCT06087653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154140690|NCT06087653|Growth Substances|growth substances|mesh-ancestor
154140691|NCT06087653|Growth Inhibitors|growth inhibitors|mesh-ancestor
154140692|NCT06087562|Ropivacaine|ropivacaine|mesh-list
154140693|NCT06087562|Anesthetics, Local|anesthetics, local|mesh-ancestor
154140694|NCT06087562|Anesthetics|anesthetics|mesh-ancestor
154140695|NCT06087562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140696|NCT06087562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140697|NCT06087562|Sensory System Agents|sensory system agents|mesh-ancestor
154140698|NCT06087562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140699|NCT06083922|Dexamethasone|dexamethasone|mesh-list
154140700|NCT06083922|Cyclophosphamide|cyclophosphamide|mesh-list
154140701|NCT06083922|Bortezomib|bortezomib|mesh-list
154140702|NCT06083922|Daratumumab|daratumumab|mesh-list
154140703|NCT06083922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154140704|NCT06083922|Immunologic Factors|immunologic factors|mesh-ancestor
154140750|NCT06053021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154140751|NCT06053021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154140752|NCT06053021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154140753|NCT06053021|Analgesics|analgesics|mesh-ancestor
154140754|NCT06053021|Sensory System Agents|sensory system agents|mesh-ancestor
154140755|NCT06053021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140756|NCT06053021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140757|NCT06053021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140758|NCT06053021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140759|NCT06053021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154140760|NCT06053021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154140761|NCT06053021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140762|NCT06053021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154140763|NCT06053021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140764|NCT06053021|Antipyretics|antipyretics|mesh-ancestor
154140765|NCT06053021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154140766|NCT06053021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154140767|NCT06053021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153624285|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140768|NCT06053021|Purinergic Agents|purinergic agents|mesh-ancestor
154140769|NCT06053021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140770|NCT06053021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154140771|NCT06053021|Autonomic Agents|autonomic agents|mesh-ancestor
154140772|NCT06053021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154140773|NCT06053021|Respiratory System Agents|respiratory system agents|mesh-ancestor
154140801|NCT05941494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140802|NCT05941494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154140803|NCT05941494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154140804|NCT05941494|Anesthetics, General|anesthetics, general|mesh-ancestor
154140805|NCT05941494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154140806|NCT05941494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154140807|NCT05941494|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154140808|NCT05941494|Mydriatics|mydriatics|mesh-ancestor
154140809|NCT05941494|Autonomic Agents|autonomic agents|mesh-ancestor
154140810|NCT05941494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140811|NCT05941494|Sympathomimetics|sympathomimetics|mesh-ancestor
154140812|NCT05941494|Nasal Decongestants|nasal decongestants|mesh-ancestor
154140813|NCT05941494|Respiratory System Agents|respiratory system agents|mesh-ancestor
154140814|NCT05941494|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154140815|NCT05941494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154140816|NCT05941494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154140817|NCT05941494|Adrenergic Agents|adrenergic agents|mesh-ancestor
154140818|NCT05941494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140819|NCT05941494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140820|NCT05941494|Protective Agents|protective agents|mesh-ancestor
154140821|NCT05941494|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154140822|NCT05941494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154140823|NCT05941494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154140824|NCT05932238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154140825|NCT05860439|Polidocanol|polidocanol|mesh-list
154140826|NCT05860439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154140827|NCT05860439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154140828|NCT05858710|Doxorubicin|doxorubicin|mesh-list
154140829|NCT05858710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154140833|NCT05858710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140845|NCT05852873|Antiviral Agents|antiviral agents|mesh-ancestor
154140846|NCT05852873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140847|NCT05852873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154140848|NCT05852873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154140849|NCT05845359|Methadone|methadone|mesh-list
154140850|NCT05845359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154140851|NCT05845359|Narcotics|narcotics|mesh-ancestor
154140854|NCT05845359|Analgesics|analgesics|mesh-ancestor
154140923|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
153624423|NCT02007174|Bevacizumab|bevacizumab|mesh-list
154140924|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154140925|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
154140926|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140927|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140928|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154140929|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
154140930|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154140931|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
154140932|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140933|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140934|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154140935|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
154140972|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154140973|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154140974|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
154140975|NCT05550246|Urological Agents|urological agents|mesh-ancestor
154140976|NCT05531591|Aripiprazole|aripiprazole|mesh-list
154140977|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
154140978|NCT05531591|Bupropion|bupropion|mesh-list
154140979|NCT05531591|Nortriptyline|nortriptyline|mesh-list
154140980|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154140981|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
154140982|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140983|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154140984|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154140985|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154140986|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140987|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
154141030|NCT05505630|Dexmedetomidine|dexmedetomidine|mesh-list
154141031|NCT05505630|Ketamine|ketamine|mesh-list
154141032|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
154141033|NCT05505630|Anesthetics|anesthetics|mesh-list
154141034|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154141035|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141036|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141038|NCT05505630|Analgesics|analgesics|mesh-ancestor
154141099|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
154141100|NCT05156606|Testosterone|testosterone|mesh-list
154141101|NCT05156606|Androgens|androgens|mesh-ancestor
154141102|NCT05156606|Hormones|hormones|mesh-ancestor
154141103|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154141104|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141105|NCT05132439|Metformin|metformin|mesh-list
154141106|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153624542|NCT02008006|Cytarabine|cytarabine|mesh-list
154141107|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141108|NCT05086250|Ketamine|ketamine|mesh-list
154141109|NCT05086250|Analgesics|analgesics|mesh-ancestor
154141110|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
154141111|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141112|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141113|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154141114|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154141115|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
154141116|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
154141157|NCT04982367|MTOR Inhibitors|mtor inhibitors|mesh-list
154141158|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154141159|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141160|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
154141161|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
154141162|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
154141163|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141164|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154141165|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141166|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154141167|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
154141168|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141169|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
154141170|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141171|NCT04982367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141172|NCT04982367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141173|NCT04979442|Trabectedin|trabectedin|mesh-list
154141174|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154141175|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
154141176|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141177|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141178|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
154141179|NCT04968132|Narcotics|narcotics|mesh-ancestor
154141180|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141181|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141182|NCT04968132|Analgesics|analgesics|mesh-ancestor
154141183|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
154141184|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141185|NCT04968054|Propofol|propofol|mesh-list
154141186|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154141187|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141191|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
154141198|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141201|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
154141202|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
154141203|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141204|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141205|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154141206|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141207|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
154141208|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141209|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
154141210|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154141211|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
154141212|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141213|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
154141214|NCT04936204|Protective Agents|protective agents|mesh-ancestor
154141215|NCT04868565|Caffeine|caffeine|mesh-list
154141216|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
154141217|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141234|NCT04858776|Hormones|hormones|mesh-ancestor
154141252|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141253|NCT04763577|Bradykinin|bradykinin|mesh-list
154141254|NCT04763577|Kininogens|kininogens|mesh-list
154141255|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
154141256|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154141257|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
154141258|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141259|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141260|NCT04739358|Tepotinib|tepotinib|mesh-list
154141261|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141262|NCT04713735|Lactoferrin|lactoferrin|mesh-list
154141263|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141264|NCT04591808|Perindopril|perindopril|mesh-list
154141265|NCT04591808|Atorvastatin|atorvastatin|mesh-list
154141314|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154141315|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141316|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154141317|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154141318|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154141319|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141320|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141321|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
154141323|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154141324|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154141325|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
154141326|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141327|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141328|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141329|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154141330|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
154141331|NCT04218968|Protective Agents|protective agents|mesh-ancestor
154141332|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154141333|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154141335|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
154141367|NCT03792841|Etanercept|etanercept|mesh-list
154141368|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
154141369|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154141370|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141371|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141372|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141373|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154141374|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154141375|NCT03792841|Analgesics|analgesics|mesh-ancestor
154141376|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
154141377|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141378|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141379|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154141380|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154141381|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154141426|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154141427|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
154141428|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154141429|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141430|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141431|NCT03635983|Nivolumab|nivolumab|mesh-list
154141432|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141433|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141434|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154141435|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141436|NCT03610971|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154141437|NCT03610971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141438|NCT03610971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141439|NCT03610971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141484|NCT03517449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154141485|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141488|NCT03480360|Fludarabine|fludarabine|mesh-list
154141489|NCT03480360|Tacrolimus|tacrolimus|mesh-list
154141490|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141491|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
154141492|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141493|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154141494|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154141496|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141497|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141498|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154141499|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154141500|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141501|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154141502|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154141503|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
154141504|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154141505|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141506|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154141507|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154141508|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141509|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
154141510|NCT03410836|Lidocaine|lidocaine|mesh-list
154141511|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
154141512|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
154141513|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141514|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141515|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
154141516|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141517|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154141519|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154141526|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154141527|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
154141528|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141529|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141530|NCT03387761|Nivolumab|nivolumab|mesh-list
154141531|NCT03387761|Ipilimumab|ipilimumab|mesh-list
154141532|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141533|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141534|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154141535|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141536|NCT03367312|Xenon|xenon|mesh-list
154141537|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154141538|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
154141539|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
154141540|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141541|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141542|NCT03288545|Carboplatin|carboplatin|mesh-list
154141543|NCT03288545|Gemcitabine|gemcitabine|mesh-list
154141544|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
154141545|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141546|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154141547|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
153624955|NCT04278833|Dexamethasone|dexamethasone|mesh-list
154141548|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141549|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141550|NCT03288545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154141551|NCT03274414|Cisplatin|cisplatin|mesh-list
154141573|NCT03267316|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154141574|NCT03257631|Thalidomide|thalidomide|mesh-list
154141575|NCT03257631|Pomalidomide|pomalidomide|mesh-list
154141576|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
154141577|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141578|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154141579|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154141580|NCT03257631|Growth Substances|growth substances|mesh-ancestor
154141581|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
154141582|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141583|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141584|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
154141585|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154141586|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141587|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
154141588|NCT03152058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154141589|NCT03152058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154141590|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141628|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141629|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154141630|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
154141631|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141632|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141633|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
154141634|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141635|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154141636|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141637|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
154141638|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154141639|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154141655|NCT02491632|Ichthammol|ichthammol|mesh-list
154141689|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154141690|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154141691|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154141692|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154141693|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141694|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154141695|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154141696|NCT01361399|Analgesics|analgesics|mesh-ancestor
154141697|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154141698|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154141699|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154141700|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154141701|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154141702|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154141703|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141704|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
154141705|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154141706|NCT01116622|Bexarotene|bexarotene|mesh-list
154141707|NCT01116622|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154141708|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141709|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141741|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
154141742|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141743|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141745|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154141746|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154141747|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154141748|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141749|NCT00171015|Valsartan|valsartan|mesh-list
154141750|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154141751|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154141752|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154141753|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154141754|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141755|NCT00171015|Diuretics|diuretics|mesh-ancestor
154141756|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
154141757|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141758|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154141759|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154141760|NCT00556998|Voriconazole|voriconazole|mesh-list
154141761|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
154141762|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141763|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154141764|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154141765|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141766|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141767|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154141768|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
154141769|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154141770|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141771|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154141772|NCT00945360|Letrozole|letrozole|mesh-list
154141773|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154141776|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141777|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141778|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154141779|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
154141780|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154141781|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141782|NCT00943566|Sufentanil|sufentanil|mesh-list
154141783|NCT00943566|Morphine|morphine|mesh-list
154141784|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154141785|NCT00943566|Narcotics|narcotics|mesh-ancestor
154141786|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141787|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141788|NCT00943566|Analgesics|analgesics|mesh-ancestor
153522132|NCT04848519|Nivolumab|nivolumab|mesh-list
154141794|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
154141835|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
154141836|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141838|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
154141839|NCT00940836|Phenylephrine|phenylephrine|mesh-list
154141840|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154141841|NCT00940836|Analgesics|analgesics|mesh-ancestor
154141842|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
154141843|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141844|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141845|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
154141846|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154141847|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
154141848|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
154141849|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
154141850|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154141851|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
154141852|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
154141853|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154141854|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154141855|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154141856|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
154141857|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141858|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141859|NCT00940836|Protective Agents|protective agents|mesh-ancestor
154141860|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
154141861|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
154141862|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154141863|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
154141882|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154141884|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154141885|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
154141886|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
154141887|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141888|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141889|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154141890|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
154141891|NCT00944502|Hormones|hormones|mesh-ancestor
154141892|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154141893|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154141894|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141895|NCT00949962|Leuprolide|leuprolide|mesh-list
154141943|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625228|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141944|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154141945|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141946|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141947|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
154141948|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141950|NCT00521001|Temozolomide|temozolomide|mesh-list
154141951|NCT00521001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154141952|NCT00521001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141953|NCT00521001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141954|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141955|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141956|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
154141957|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141958|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142001|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142002|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
154142003|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
154142004|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
154142005|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142006|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142007|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154142008|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154142009|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154142010|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142011|NCT00520845|Analgesics|analgesics|mesh-ancestor
154142012|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
154142013|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142014|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142015|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142016|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142017|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154142057|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154142059|NCT03873987|Oritavancin|oritavancin|mesh-list
154142060|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154142061|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142062|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154142063|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
154142064|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154142065|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
154142066|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142068|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142069|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142070|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142071|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
154142072|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
154142073|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154142074|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
154142075|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142076|NCT01017796|Expectorants|expectorants|mesh-ancestor
154142077|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
154142078|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154142079|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
154142114|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154142115|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142117|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
154142118|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
154142119|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142120|NCT01020994|Octenidine|octenidine|mesh-list
154142121|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142122|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154142123|NCT00494026|Carboplatin|carboplatin|mesh-list
154142124|NCT00494026|Pemetrexed|pemetrexed|mesh-list
154142125|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142126|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142127|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142128|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154142129|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154142130|NCT00524589|Calcitriol|calcitriol|mesh-list
154142131|NCT00524589|Dexamethasone|dexamethasone|mesh-list
154142132|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142133|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
154142134|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
154142135|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142138|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
153465663|NCT00237666|Ziprasidone|ziprasidone|mesh-list
154142168|NCT00472030|Hormones|hormones|mesh-ancestor
154142169|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142170|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142171|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154142172|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142173|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154142174|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154142175|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
154142176|NCT00127855|Vaccines|vaccines|mesh-list
154142177|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154142178|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
154142179|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142180|NCT00493636|Gemcitabine|gemcitabine|mesh-list
154142181|NCT00493636|Capecitabine|capecitabine|mesh-list
154142182|NCT00493636|Sorafenib|sorafenib|mesh-list
154142230|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142231|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142232|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154142233|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142234|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142235|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154142236|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154142237|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
154142238|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154142239|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154142240|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
154142241|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
154142242|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142243|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154142244|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154142245|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154142246|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
154142247|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142248|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154142249|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154142250|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
154142251|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154142277|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154142278|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
154142279|NCT01076803|Lanreotide|lanreotide|mesh-list
154142280|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142281|NCT00523419|Pemetrexed|pemetrexed|mesh-list
154142282|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142283|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142284|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142285|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154142286|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154142287|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
154142288|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154142289|NCT03868059|Testosterone|testosterone|mesh-list
154142290|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
154142291|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
154142292|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154142293|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142294|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
154142295|NCT03868059|Hormones|hormones|mesh-ancestor
154142296|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142297|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142298|NCT03868059|Androgens|androgens|mesh-ancestor
154142299|NCT04028115|Ixazomib|ixazomib|mesh-list
154142300|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142301|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
154142328|NCT06026787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142330|NCT06026553|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154142331|NCT06026553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154142332|NCT06026553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142333|NCT06026553|Analgesics|analgesics|mesh-ancestor
154142334|NCT06026553|Sensory System Agents|sensory system agents|mesh-ancestor
154142335|NCT06026553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142336|NCT06026553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142337|NCT06026553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142338|NCT06026553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142339|NCT06026553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154142340|NCT06026553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142341|NCT06026553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142342|NCT06026527|Magnesium Sulfate|magnesium sulfate|mesh-list
154142343|NCT06026527|Analgesics|analgesics|mesh-ancestor
154142344|NCT06026527|Sensory System Agents|sensory system agents|mesh-ancestor
154142345|NCT06026527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142347|NCT06026527|Anesthetics|anesthetics|mesh-ancestor
154142384|NCT05959850|Expectorants|expectorants|mesh-ancestor
154142385|NCT05959850|Respiratory System Agents|respiratory system agents|mesh-ancestor
154142386|NCT05955768|Lidocaine|lidocaine|mesh-list
154142387|NCT05955768|Anesthetics, Local|anesthetics, local|mesh-ancestor
154142388|NCT05955768|Anesthetics|anesthetics|mesh-ancestor
154142389|NCT05955768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142390|NCT05955768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625479|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154142391|NCT05955768|Sensory System Agents|sensory system agents|mesh-ancestor
154142392|NCT05955768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142393|NCT05955768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154142394|NCT05955768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154142395|NCT05955768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154142396|NCT05955768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154142397|NCT05955768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142398|NCT05938699|Bimatoprost|bimatoprost|mesh-list
154142399|NCT05938699|Nitric Oxide|nitric oxide|mesh-list
154142443|NCT05796089|Etoposide phosphate|etoposide phosphate|mesh-list
154142444|NCT05796089|Durvalumab|durvalumab|mesh-list
154142445|NCT05796089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142446|NCT05796089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154142447|NCT05796089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154142448|NCT05796089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154142449|NCT05796089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142450|NCT05796089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142451|NCT05796089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142452|NCT05774366|Desflurane|desflurane|mesh-list
154142453|NCT05774366|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154142454|NCT05774366|Anesthetics, General|anesthetics, general|mesh-ancestor
154142455|NCT05774366|Anesthetics|anesthetics|mesh-ancestor
154142456|NCT05774366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142457|NCT05774366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142458|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
154142459|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154142499|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142501|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
154142502|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154142503|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
154142504|NCT05598619|Vitamins|vitamins|mesh-ancestor
154142505|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
154142506|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142507|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
154142508|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142509|NCT05598619|Protective Agents|protective agents|mesh-ancestor
154142510|NCT05546554|Suvorexant|suvorexant|mesh-list
154142511|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154142512|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154142513|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142514|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142515|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154142516|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142517|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142518|NCT05540574|Zolpidem|zolpidem|mesh-list
154142519|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154142520|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154142524|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
154142552|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
154142553|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
154142554|NCT05497596|Vitamin D|vitamin d|mesh-list
154142555|NCT05497596|Vitamins|vitamins|mesh-ancestor
154142556|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
154142557|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142558|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154142559|NCT05495204|Ibalizumab|ibalizumab|mesh-list
154142560|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154142561|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154142562|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154142621|NCT05228574|Diuretics|diuretics|mesh-ancestor
154142622|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
154142623|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142624|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154142625|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154142626|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154142627|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142628|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154142629|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154142631|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142632|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142633|NCT05176509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154142634|NCT05176509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142680|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154142681|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154142682|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142683|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142684|NCT05002270|Cetuximab|cetuximab|mesh-list
154142685|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142686|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142687|NCT04965064|Capecitabine|capecitabine|mesh-list
154142688|NCT04965064|Neratinib|neratinib|mesh-list
154142689|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154142690|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
154142691|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142692|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142693|NCT04965064|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153523022|NCT01990196|Dasatinib|dasatinib|mesh-list
154142694|NCT04965064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154142695|NCT04965064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142696|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
154142697|NCT04938024|Vitamins|vitamins|mesh-ancestor
154142698|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
154142699|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142700|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
154142701|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142702|NCT04938024|Protective Agents|protective agents|mesh-ancestor
154142703|NCT04899778|Iron|iron|mesh-list
154142704|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154142705|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154142706|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
154142707|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
154142726|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142727|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142728|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142729|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
154142730|NCT04843982|Esketamine|esketamine|mesh-list
154142731|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
154142732|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154142733|NCT04824599|Ropivacaine|ropivacaine|mesh-list
154142734|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
154142735|NCT04824599|Anesthetics|anesthetics|mesh-list
154142736|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142737|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142738|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
154142739|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142740|NCT04817800|Azelastine|azelastine|mesh-list
154142741|NCT04817800|Beclomethasone|beclomethasone|mesh-list
154142742|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142743|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
154142744|NCT04817800|Hormones|hormones|mesh-ancestor
154142750|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
154142780|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154142781|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154142782|NCT04675151|Phentolamine|phentolamine|mesh-list
154142783|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154142784|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154142785|NCT04675151|Pilocarpine|pilocarpine|mesh-list
154142787|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
154142788|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142789|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142790|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154142791|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154142792|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
154142793|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142794|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142795|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153625655|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154142796|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154142797|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
154142798|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154142799|NCT04674670|Bromocriptine|bromocriptine|mesh-list
154142800|NCT04674670|Amisulpride|amisulpride|mesh-list
154142817|NCT04666259|Asciminib|asciminib|mesh-list
154142832|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142833|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142834|NCT04598074|Analgesics|analgesics|mesh-ancestor
154142835|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
154142836|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142837|NCT04585750|Pembrolizumab|pembrolizumab|mesh-list
154142838|NCT04585750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142839|NCT04585750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142840|NCT04585750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154142841|NCT04585750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523173|NCT04608474|Evolocumab|evolocumab|mesh-list
154142842|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
154142843|NCT04520451|Hormones|hormones|mesh-ancestor
154142844|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142845|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142846|NCT04507412|Dexamethasone|dexamethasone|mesh-list
154142847|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142848|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
154142849|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
154142850|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142851|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142852|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142853|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
154142854|NCT04507412|Hormones|hormones|mesh-ancestor
154142855|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142856|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154142857|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142858|NCT04488926|Palmidrol|palmidrol|mesh-list
154142859|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142860|NCT04488926|Analgesics|analgesics|mesh-ancestor
154142861|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
154142862|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142863|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142864|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154142866|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142868|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142869|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154142870|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154142871|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142872|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142873|NCT04488926|Hormones|hormones|mesh-ancestor
154142874|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142875|NCT04483739|Dexamethasone|dexamethasone|mesh-list
154142876|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
154142877|NCT04483739|Lenalidomide|lenalidomide|mesh-list
154142878|NCT04483739|BB 1101|bb 1101|mesh-list
154142879|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142880|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
154142881|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
154142882|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142883|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142884|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142885|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
154142886|NCT04483739|Hormones|hormones|mesh-ancestor
154142887|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142888|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154142889|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142890|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
154142891|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788409|NCT00286689|Hormones|hormones|mesh-list
154142892|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142893|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
154142894|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154142895|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154142896|NCT04483739|Growth Substances|growth substances|mesh-ancestor
154142897|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
154142899|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154142900|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154142901|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
154142906|NCT04432012|Dexamethasone|dexamethasone|mesh-list
154142907|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
154142908|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154142909|NCT04432012|BB 1101|bb 1101|mesh-list
154142910|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142911|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
154142912|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
154142913|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142914|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142915|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142916|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
154142917|NCT04432012|Hormones|hormones|mesh-ancestor
154142918|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142919|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154142920|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142921|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
154142922|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142964|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142965|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154142966|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142967|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154142968|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142969|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154142970|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142971|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153625884|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
154142972|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154142973|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154142975|NCT04198363|Diuretics|diuretics|mesh-ancestor
154142976|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
154142977|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142978|NCT04198363|Expectorants|expectorants|mesh-ancestor
154143026|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143027|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143028|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
154143029|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143030|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
154143031|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154143032|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154143033|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154143034|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154143035|NCT03896737|Growth Substances|growth substances|mesh-ancestor
154143036|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
154143037|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154143038|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154143040|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154143041|NCT03815929|Estrogens|estrogens|mesh-ancestor
154143042|NCT03815929|Hormones|hormones|mesh-ancestor
154143043|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143044|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143045|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154143047|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154143048|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154143049|NCT03809988|Letrozole|letrozole|mesh-list
154143050|NCT03809988|Fulvestrant|fulvestrant|mesh-list
154143051|NCT03809988|Palbociclib|palbociclib|mesh-list
154143052|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143053|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154143054|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154143055|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143056|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143057|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154143058|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
154143060|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143067|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
154143068|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143069|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143070|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143071|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
154143072|NCT03773107|Hormones|hormones|mesh-ancestor
154143073|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143074|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143075|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143076|NCT03743766|Nivolumab|nivolumab|mesh-list
154143132|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143133|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143134|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154143135|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143136|NCT03389750|Oxymorphone|oxymorphone|mesh-list
154143137|NCT03389750|Oxycodone|oxycodone|mesh-list
154143138|NCT03389750|Hydromorphone|hydromorphone|mesh-list
154143139|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154143140|NCT03389750|Narcotics|narcotics|mesh-ancestor
154143141|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729704|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154143142|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143195|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
154143196|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154143197|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
154143198|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143199|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143200|NCT02777385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154143201|NCT02777385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143202|NCT02725567|Ivacaftor|ivacaftor|mesh-list
154143203|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154143204|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154143205|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143206|NCT02639702|Clozapine|clozapine|mesh-list
154143207|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154143208|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
154143209|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143210|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143211|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143253|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154143254|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143255|NCT01797523|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154143256|NCT01797523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154143257|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143258|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143259|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143260|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
154143261|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143262|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154143263|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154143316|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
154143317|NCT00956007|Cetuximab|cetuximab|mesh-list
154143318|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143319|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143320|NCT00905515|Cyclosporine|cyclosporine|mesh-list
154143321|NCT00905515|Tacrolimus|tacrolimus|mesh-list
154143322|NCT00905515|Cyclosporins|cyclosporins|mesh-list
154143323|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143324|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
154143325|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143326|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154143327|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143328|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143329|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
154143330|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154143331|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
154143332|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143333|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154143334|NCT00659126|Hematinics|hematinics|mesh-ancestor
154143335|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154143336|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154143337|NCT00581139|Midazolam|midazolam|mesh-list
154143338|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
154143339|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143340|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143341|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154143342|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154143343|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154143344|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154143345|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154143346|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154143347|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
154143362|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143363|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154143364|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154143365|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
154143366|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143367|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143368|NCT00482690|Nicotine|nicotine|mesh-list
154143369|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154143370|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
154143371|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143372|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143373|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154143374|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154143375|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
154143376|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143377|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143379|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
154143380|NCT00004197|Doxorubicin|doxorubicin|mesh-list
154143381|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154143382|NCT00004197|Vincristine|vincristine|mesh-list
154143383|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
154143384|NCT00004197|Sargramostim|sargramostim|mesh-list
154143416|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143417|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
154143418|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143419|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154143420|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
154143421|NCT03865407|Protective Agents|protective agents|mesh-ancestor
154143422|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143423|NCT00487942|Modafinil|modafinil|mesh-list
154143424|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154143425|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143426|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154143430|NCT00132301|Prednisone|prednisone|mesh-list
154143477|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143478|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143479|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154143480|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154143481|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143482|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154143483|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154143484|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
154143485|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
154143486|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
154143487|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143540|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143542|NCT01021150|Cisplatin|cisplatin|mesh-list
154143543|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143544|NCT03997006|Atropine|atropine|mesh-list
154143545|NCT03997006|Aminophylline|aminophylline|mesh-list
154143546|NCT03997006|Neostigmine|neostigmine|mesh-list
154143547|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154143548|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154143549|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154143550|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
154143551|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143552|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143553|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154143554|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
154143555|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
154143556|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
154143557|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154143558|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154143559|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
154143560|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143597|NCT02577965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154143598|NCT02577965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143599|NCT02577965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143600|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143601|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
154143602|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143603|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143666|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143668|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154143669|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
154143670|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143671|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143672|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154143673|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154143674|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
154143675|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143676|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143677|NCT00487162|Insulin|insulin|mesh-list
154143678|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154143680|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
154143725|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
154143726|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143727|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143728|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
154143729|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143730|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154143731|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154143732|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154143733|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154143734|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143735|NCT02199665|Dexamethasone|dexamethasone|mesh-list
154143736|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143737|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
154143773|NCT00485758|Niacin|niacin|mesh-list
154143787|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143789|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
154143790|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
154143791|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143792|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143793|NCT02577497|Fluticasone|fluticasone|mesh-list
154143794|NCT02577497|Beclomethasone|beclomethasone|mesh-list
154143795|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143796|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154143797|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
154143798|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143799|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143800|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154143801|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
154143802|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
154143803|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154143804|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
154143843|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143844|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
154143845|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154143846|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154143847|NCT03987022|Acetaminophen|acetaminophen|mesh-list
154143848|NCT03987022|Ketorolac|ketorolac|mesh-list
154143849|NCT03987022|Oxycodone|oxycodone|mesh-list
154143850|NCT03987022|Hydromorphone|hydromorphone|mesh-list
154143851|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154143852|NCT03987022|Narcotics|narcotics|mesh-ancestor
154143853|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143854|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143855|NCT03987022|Analgesics|analgesics|mesh-ancestor
154143856|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
154143857|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143858|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154143859|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154143860|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143861|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143862|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154143863|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143864|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143865|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
154143866|NCT01025128|Vitamin D|vitamin d|mesh-list
154143867|NCT01025128|Vitamins|vitamins|mesh-ancestor
154143893|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
154143894|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143895|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143896|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154143897|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143899|NCT00519285|Prednisolone|prednisolone|mesh-list
154143901|NCT00519285|Aflibercept|aflibercept|mesh-list
154143902|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143903|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
154143904|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
154143905|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
154143906|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143907|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143908|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
154143954|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154143955|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154143956|NCT02578823|Antipyretics|antipyretics|mesh-list
154143957|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143958|NCT01969643|Trastuzumab|trastuzumab|mesh-list
154143959|NCT01969643|SGN-LIV1A|sgn-liv1a|mesh-list
154143960|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143961|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143962|NCT01969643|Immunoconjugates|immunoconjugates|mesh-ancestor
154143963|NCT01969643|Immunologic Factors|immunologic factors|mesh-ancestor
154143964|NCT01969643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144019|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154144020|NCT00468052|Narcotics|narcotics|mesh-ancestor
154144021|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154144022|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154144023|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
154144024|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
154144026|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144027|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154144028|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154144029|NCT00453310|Growth Substances|growth substances|mesh-ancestor
154144030|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144031|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
154144032|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144033|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144034|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144035|NCT00128843|Anastrozole|anastrozole|mesh-list
154144036|NCT00128843|Exemestane|exemestane|mesh-list
154144037|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154144038|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144039|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154144040|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154144041|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144042|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144043|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154144044|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
154144045|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154144046|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144047|NCT04073927|Butyric Acid|butyric acid|mesh-list
154144048|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
154144049|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
154144050|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144051|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144052|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144053|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154144054|NCT00124657|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154144055|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144057|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144058|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144060|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154144061|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154144062|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
154144063|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144064|NCT00555906|Dexamethasone|dexamethasone|mesh-list
154144065|NCT00555906|Bortezomib|bortezomib|mesh-list
154144066|NCT00555906|Palbociclib|palbociclib|mesh-list
154144067|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154144122|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144123|NCT00709553|Midazolam|midazolam|mesh-list
154144124|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154144125|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154144126|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154144127|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144128|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154144129|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154144130|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154144131|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154144132|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
154144133|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
154144134|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
154144182|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
154144183|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
154144184|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144185|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144186|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144187|NCT00463684|Vaccines|vaccines|mesh-list
154144188|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
154144189|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144190|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
154144193|NCT00463606|Calcium|calcium|mesh-list
154144247|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
154144248|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
154144249|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144250|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144251|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144252|NCT01326559|Docetaxel|docetaxel|mesh-list
154144253|NCT01326559|Cetuximab|cetuximab|mesh-list
154144254|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144255|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
154144256|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
154144257|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
154144258|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144259|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154144260|NCT04069949|Sorafenib|sorafenib|mesh-list
154144261|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144262|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144263|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144306|NCT00553254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144307|NCT00553254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144308|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
154144309|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154144310|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154144311|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
154144312|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144313|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154144314|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154144315|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144316|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626418|NCT02016391|Analgesics|analgesics|mesh-ancestor
154144317|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
154144318|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154144319|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154144320|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154144321|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154144364|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
154144365|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144366|NCT00168805|Enoxaparin|enoxaparin|mesh-list
154144367|NCT00168805|Dabigatran|dabigatran|mesh-list
154144368|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
154144369|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154144370|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154144372|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
154144431|NCT00463060|Growth Substances|growth substances|mesh-ancestor
154144432|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144433|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
154144434|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144435|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144436|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144437|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
154144438|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
154144439|NCT00956748|Dexamethasone|dexamethasone|mesh-list
154144440|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154144441|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
154144442|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
154144443|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524841|NCT01468025|Naproxen|naproxen|mesh-list
154144493|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
154144494|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144495|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144496|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144497|NCT02573597|Sufentanil|sufentanil|mesh-list
154144498|NCT02573597|Bupivacaine|bupivacaine|mesh-list
154144499|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
154144500|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
154144501|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154144502|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144503|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
154144504|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144505|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154144554|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154144555|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144556|NCT00957060|Incretins|incretins|mesh-ancestor
154144557|NCT00957060|Hormones|hormones|mesh-ancestor
154144558|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154144559|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154144560|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
154144561|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144562|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144563|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154144564|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144565|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
154144616|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154144617|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154144618|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154144619|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144620|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154144621|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154144622|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
154144623|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154144624|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
154144625|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144626|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144627|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154144628|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
154144629|NCT00957216|Ubiquinone|ubiquinone|mesh-list
154144630|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
154144674|NCT00715013|Epothilone B|epothilone b|mesh-list
154144675|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144676|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
154144677|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
154144678|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
154144679|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144680|NCT00715091|Diclofenac|diclofenac|mesh-list
154144681|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154144682|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154144683|NCT00715091|Analgesics|analgesics|mesh-ancestor
154144684|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
154144685|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144686|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144687|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154144688|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154144689|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154144690|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144691|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144692|NCT00718913|Docetaxel|docetaxel|mesh-list
154144693|NCT00718913|Capecitabine|capecitabine|mesh-list
154144694|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144695|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
154144696|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
154144697|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
154144698|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144699|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144700|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
154144701|NCT04011930|Vitamin D|vitamin d|mesh-list
154144702|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
154144703|NCT04011930|Calcitriol|calcitriol|mesh-list
154144704|NCT04011930|Vitamins|vitamins|mesh-ancestor
154144705|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
154144717|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144718|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154144719|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154144721|NCT02574221|Fluorides|fluorides|mesh-list
154144722|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
154144723|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
154144724|NCT02574221|Protective Agents|protective agents|mesh-ancestor
153626559|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
154144725|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144726|NCT00452530|Enoxaparin|enoxaparin|mesh-list
154144727|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
154144728|NCT00452530|Apixaban|apixaban|mesh-list
154144729|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
154144781|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144782|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154144783|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154144784|NCT00719381|Pioglitazone|pioglitazone|mesh-list
154144785|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154144786|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144787|NCT00510783|Phenytoin|phenytoin|mesh-list
154144788|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
154144789|NCT00510783|Levetiracetam|levetiracetam|mesh-list
154144790|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
154144791|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
154144845|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144847|NCT02541734|Incretins|incretins|mesh-ancestor
154144848|NCT02541734|Hormones|hormones|mesh-ancestor
154144849|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154144850|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
154144851|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
154144852|NCT00462670|Tolvaptan|tolvaptan|mesh-list
154144853|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154144854|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144855|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
154144856|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144857|NCT01009593|Sorafenib|sorafenib|mesh-list
154144858|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144859|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144860|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144861|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144862|NCT00719459|Iron|iron|mesh-list
154144863|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154144864|NCT00719459|Trace Elements|trace elements|mesh-ancestor
154144865|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
154144866|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144867|NCT00719459|Hematinics|hematinics|mesh-ancestor
154144868|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153525235|NCT06072898|Niacin|niacin|mesh-list
154144869|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153626566|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
154144870|NCT00948168|Exenatide|exenatide|mesh-list
154144871|NCT00948168|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154144872|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154144889|NCT00719693|Fenofibrate|fenofibrate|mesh-list
154144891|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154144892|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144893|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154144894|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154144895|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154144896|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
154144897|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144898|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154144899|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154144900|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144901|NCT00948402|Metformin|metformin|mesh-list
154144902|NCT00948402|Biguanides|biguanides|mesh-list
154144903|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
154144904|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
154144905|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154144949|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
154144950|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144951|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144952|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
154144953|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144954|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154144955|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154144956|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154144957|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144958|NCT00893594|Naproxen|naproxen|mesh-list
154144959|NCT00893594|Sumatriptan|sumatriptan|mesh-list
154144960|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154144962|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154145011|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154145012|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
154145013|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145014|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145015|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154145016|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154145017|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
154145018|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145019|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145020|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
154145021|NCT00712049|Niacin|niacin|mesh-list
154145023|NCT00712049|Simvastatin|simvastatin|mesh-list
154145024|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154145025|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154145026|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
154145027|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145028|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154145029|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154145030|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145066|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154145067|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154145068|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154145069|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154145070|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154145071|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154145072|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154145073|NCT00712439|Gabapentin|gabapentin|mesh-list
154145074|NCT00712439|Analgesics|analgesics|mesh-ancestor
154145075|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
154145076|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145077|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145078|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
154145079|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154145080|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154145081|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145082|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154145083|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154145121|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
154145122|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145123|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
154145124|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154145125|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154145126|NCT00115765|Bevacizumab|bevacizumab|mesh-list
154145127|NCT00115765|Panitumumab|panitumumab|mesh-list
154145128|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
154145187|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145189|NCT01027546|Coagulants|coagulants|mesh-ancestor
154145190|NCT00115063|Orlistat|orlistat|mesh-list
154145191|NCT00115063|Sibutramine|sibutramine|mesh-list
154145192|NCT00115063|Diethylpropion|diethylpropion|mesh-list
154145193|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145194|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145195|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154145196|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154145197|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
154145198|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154145199|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
154145200|NCT01026064|Azithromycin|azithromycin|mesh-list
154145201|NCT01026064|Cantharidin|cantharidin|mesh-list
154145202|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154145203|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145204|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910780|NCT04228315|Primaquine|primaquine|mesh-list
154145205|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145206|NCT02571959|Amoxicillin|amoxicillin|mesh-list
154145207|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
154145208|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
154145209|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154145210|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145211|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145212|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145213|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154145214|NCT00461500|Fluticasone|fluticasone|mesh-list
154145215|NCT00461500|Xhance|xhance|mesh-list
154145216|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154145217|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145218|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154145219|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
154145231|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145232|NCT00893906|Vaccines|vaccines|mesh-list
154145233|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
154145234|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145235|NCT00721487|Fluconazole|fluconazole|mesh-list
154145236|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
154145237|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145238|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154145239|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154145240|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145241|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145242|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154145243|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
154145291|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145292|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
154145293|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154145294|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
154145295|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154145296|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154145297|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154145298|NCT01026376|Decitabine|decitabine|mesh-list
154145299|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154145300|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
154157506|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145301|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145302|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145303|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145304|NCT00716573|Everolimus|everolimus|mesh-list
154145305|NCT00716573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154145306|NCT00716573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145307|NCT00716573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145308|NCT00716573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145313|NCT02539706|Rocuronium|rocuronium|mesh-list
154145347|NCT03537586|Analgesics|analgesics|mesh-ancestor
154145348|NCT03537586|Sensory System Agents|sensory system agents|mesh-ancestor
154145349|NCT03537586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145350|NCT03537586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145351|NCT03537586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154145352|NCT03537586|Vasodilator Agents|vasodilator agents|mesh-ancestor
154145353|NCT03537586|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154145417|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154145418|NCT02573051|Isosorbide|isosorbide|mesh-list
154145419|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154145420|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154145421|NCT02573051|Misoprostol|misoprostol|mesh-list
154145422|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154145423|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
154145424|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154145425|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145426|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154145427|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154145428|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
154145429|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154145430|NCT02573051|Diuretics|diuretics|mesh-ancestor
154145431|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
154145432|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
154145433|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154145435|NCT02539940|Paclitaxel|paclitaxel|mesh-list
154145477|NCT00905918|Protective Agents|protective agents|mesh-ancestor
154145479|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145480|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154145481|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154145482|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145483|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145484|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154145485|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
154145486|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145487|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145488|NCT00901784|Topiramate|topiramate|mesh-list
154145489|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
154145490|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154145491|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145492|NCT00905996|Propranolol|propranolol|mesh-list
154145493|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154145494|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154145495|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154145496|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145497|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145498|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145499|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154145500|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154145501|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
154145502|NCT02539628|Ropivacaine|ropivacaine|mesh-list
154145503|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
154145504|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
154145509|NCT02573987|Lidocaine|lidocaine|mesh-list
154145521|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145522|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154145523|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
154145524|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154145526|NCT00906386|Varenicline|varenicline|mesh-list
154145527|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154145528|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154145529|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
154145530|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145531|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145532|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145533|NCT00722579|Cobalt|cobalt|mesh-list
154145584|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145585|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154145586|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154145587|NCT00717587|Growth Substances|growth substances|mesh-ancestor
154145588|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145589|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
154145590|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145591|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145592|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145593|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154145594|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145595|NCT00894998|Heparin|heparin|mesh-list
154145596|NCT00894998|Calcium heparin|calcium heparin|mesh-list
154145597|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
154145598|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154145599|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154145600|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145601|NCT00713921|Fesoterodine|fesoterodine|mesh-list
154145602|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154145603|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154145604|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
154145605|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145606|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145607|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145608|NCT00713921|Urological Agents|urological agents|mesh-ancestor
154145609|NCT00713999|Praziquantel|praziquantel|mesh-list
154145610|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
154145611|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154145612|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145613|NCT04072601|Atorvastatin|atorvastatin|mesh-list
154145614|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154145627|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145628|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145629|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145630|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145631|NCT04069325|Febuxostat|febuxostat|mesh-list
154145632|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
154145633|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145634|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154145635|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
154145636|NCT00723047|Coagulants|coagulants|mesh-ancestor
154145637|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
154145638|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154145639|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
154145640|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145641|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145642|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154145643|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
154145644|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145645|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145646|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154145647|NCT02571491|Ketamine|ketamine|mesh-list
154145648|NCT02571491|Morphine|morphine|mesh-list
154145649|NCT02571491|Remifentanil|remifentanil|mesh-list
154145650|NCT02571491|Analgesics|analgesics|mesh-ancestor
154145680|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
154145681|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145682|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154145683|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154145684|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145685|NCT00518115|Exenatide|exenatide|mesh-list
154145686|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
154145687|NCT00518115|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154145688|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910826|NCT05266417|Insulin|insulin|mesh-list
154145689|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145690|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154145691|NCT00518115|Incretins|incretins|mesh-ancestor
154145692|NCT00518115|Hormones|hormones|mesh-ancestor
154145693|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145694|NCT00723983|Sumatriptan|sumatriptan|mesh-list
154145695|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154145736|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
154145737|NCT00724295|Ribavirin|ribavirin|mesh-list
154145738|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154145739|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
154145740|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145741|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
154145742|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145743|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
154145744|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154145745|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
154145746|NCT00517413|Hematinics|hematinics|mesh-ancestor
154145747|NCT00724529|Infliximab|infliximab|mesh-list
154145748|NCT00724529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154145749|NCT00724529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145750|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145751|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154145752|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145753|NCT01012869|Everolimus|everolimus|mesh-list
154145794|NCT02570789|Growth Substances|growth substances|mesh-ancestor
154145795|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145796|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
154145797|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145798|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145799|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145800|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
154145801|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145802|NCT00450580|Ritonavir|ritonavir|mesh-list
154145803|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
154145804|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154145805|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154145806|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
154145807|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145808|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145809|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154145810|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154145811|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
154145852|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145853|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
154145854|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145855|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145856|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154145857|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
154145858|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910852|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154145859|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154145860|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
154145861|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145862|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145863|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145864|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154145865|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154145866|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154145867|NCT03968263|Hydrocodone|hydrocodone|mesh-list
154145911|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
154145912|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145913|NCT00509769|Immunotoxins|immunotoxins|mesh-ancestor
154145914|NCT00509769|Immunoconjugates|immunoconjugates|mesh-ancestor
154145915|NCT00509769|Immunologic Factors|immunologic factors|mesh-ancestor
154145916|NCT00509769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145917|NCT02977715|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154145918|NCT02977715|Antiviral Agents|antiviral agents|mesh-ancestor
154145919|NCT02977715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145920|NCT01074697|Dexamethasone|dexamethasone|mesh-list
154145921|NCT01074697|Palonosetron|palonosetron|mesh-list
154145922|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
154145923|NCT01074697|Aprepitant|aprepitant|mesh-list
154145924|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145925|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
154145926|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
154145927|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145928|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145929|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154145930|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
154145931|NCT01074697|Hormones|hormones|mesh-ancestor
154145932|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145933|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154145934|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145935|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145936|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154145937|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154145938|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
154145939|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145940|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154145941|NCT01080079|Terbinafine|terbinafine|mesh-list
154145942|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
153452606|NCT01840410|Ranibizumab|ranibizumab|mesh-list
154145943|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145944|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655743|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153646484|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153646485|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154145945|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145946|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
154145947|NCT00725231|Doxorubicin|doxorubicin|mesh-list
154145948|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154145949|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154145950|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145951|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154145952|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154145953|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154145954|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145955|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145956|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154145957|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154145996|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145997|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
154145998|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
154145999|NCT02540642|Vitamins|vitamins|mesh-ancestor
154146000|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
154146001|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146002|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
154146003|NCT00122317|Eculizumab|eculizumab|mesh-list
154146004|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154146005|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154146006|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
154146007|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146008|NCT00908336|Docetaxel|docetaxel|mesh-list
154146009|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154146010|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146011|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154146012|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154146013|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154146014|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146053|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154146054|NCT00460798|Growth Substances|growth substances|mesh-ancestor
154146055|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146056|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
153910889|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
154146057|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154146058|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146059|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146060|NCT00726869|Elotuzumab|elotuzumab|mesh-list
154146061|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146062|NCT01028248|Ranibizumab|ranibizumab|mesh-list
154146063|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154146064|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154146065|NCT01028248|Growth Substances|growth substances|mesh-ancestor
154146066|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146067|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
154146068|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146069|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
154146070|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
154146071|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
154146072|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154146073|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146074|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
154146075|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146076|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154146077|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146078|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146100|NCT01028482|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154146101|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154146102|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146103|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146104|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146105|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
154146106|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146107|NCT00903188|Cyclosporine|cyclosporine|mesh-list
154146108|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
154146109|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
154146110|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154146111|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154146112|NCT00903188|Prednisolone|prednisolone|mesh-list
154146113|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
154146114|NCT00903188|Everolimus|everolimus|mesh-list
154146115|NCT00903188|Cyclosporins|cyclosporins|mesh-list
154146116|NCT00903188|Basiliximab|basiliximab|mesh-list
154146117|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154146118|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
154146119|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146120|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146121|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154146122|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
154146123|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146124|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
154146125|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146126|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
154146127|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154146129|NCT00903188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154146146|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154146147|NCT00908726|Propofol|propofol|mesh-list
154146148|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154146149|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154146150|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146151|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154146152|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
154146153|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
154146154|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
154146155|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146156|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154146157|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154146158|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
154146159|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146160|NCT00449956|Timolol|timolol|mesh-list
154146161|NCT00449956|Dorzolamide|dorzolamide|mesh-list
154146162|NCT00449956|Maleic acid|maleic acid|mesh-list
154146163|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146164|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146165|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154146166|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154146167|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
154146168|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146169|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146170|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154146171|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154146172|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154146173|NCT00907400|Naproxen|naproxen|mesh-list
154146175|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146194|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146195|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146196|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146197|NCT00903656|Lapatinib|lapatinib|mesh-list
154146198|NCT00903656|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154146199|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154146200|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146201|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146202|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146203|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
154146204|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
154146205|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154146206|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154146207|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146208|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146209|NCT00730067|Urological Agents|urological agents|mesh-ancestor
154146210|NCT02538224|Doxycycline|doxycycline|mesh-list
154146211|NCT02538224|Ketoprofen|ketoprofen|mesh-list
154146212|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154146248|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146249|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146251|NCT00509067|Risperidone|risperidone|mesh-list
154146252|NCT00509067|Aripiprazole|aripiprazole|mesh-list
154146253|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154146254|NCT00509067|Ziprasidone|ziprasidone|mesh-list
154146255|NCT00509067|Choline|choline|mesh-list
154146256|NCT00509067|Galantamine|galantamine|mesh-list
154146257|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154146258|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154146260|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146261|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146262|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146263|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154146264|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154146265|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154146266|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154146267|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154146268|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
154146269|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
154146270|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
154146271|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146272|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154146273|NCT00509067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154146274|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154146275|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146276|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
154146295|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146296|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
154146297|NCT00908024|Cetuximab|cetuximab|mesh-list
154146298|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154146299|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146300|NCT00730223|Efavirenz|efavirenz|mesh-list
154146301|NCT00730223|Nevirapine|nevirapine|mesh-list
154146302|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154146303|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154146304|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146305|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146306|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
154146307|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146308|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154146309|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154146310|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154146353|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146355|NCT02570243|Calcium heparin|calcium heparin|mesh-list
154146356|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
154146357|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154146358|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154146359|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146360|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
154146361|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154146362|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
154146363|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146364|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146365|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154146366|NCT00927212|Protective Agents|protective agents|mesh-ancestor
154146367|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154146368|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154146369|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146370|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146371|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
154146372|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146373|NCT00927290|Pioglitazone|pioglitazone|mesh-list
154146374|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154146375|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146378|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
154146402|NCT00728273|Trace Elements|trace elements|mesh-list
154146403|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146405|NCT00927602|Fondaparinux|fondaparinux|mesh-list
154146406|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154146407|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
154146408|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154146409|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
154146410|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146411|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146467|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146468|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146469|NCT00728585|Mitogens|mitogens|mesh-list
154146470|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
154146471|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146472|NCT00730769|Valganciclovir|valganciclovir|mesh-list
154146473|NCT00730769|Ganciclovir|ganciclovir|mesh-list
153910961|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
154146474|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154146534|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154146535|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154146537|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146538|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154146539|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154146540|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146541|NCT00568178|Losartan|losartan|mesh-list
154146542|NCT00568178|Amlodipine|amlodipine|mesh-list
154146543|NCT00568178|Enalapril|enalapril|mesh-list
154146544|NCT00568178|Enalaprilat|enalaprilat|mesh-list
154146545|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154146546|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154146547|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146595|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154146596|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
154146598|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154146599|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154146600|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154146601|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
154146602|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
154146603|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
154146604|NCT02538926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154146605|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154146606|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
154146607|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
154146608|NCT00904904|Ketorolac|ketorolac|mesh-list
154146658|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146659|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146660|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154146661|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154146662|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154146663|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146664|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154146665|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154146666|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154146667|NCT04018703|Midazolam|midazolam|mesh-list
154146668|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
154146669|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154146670|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154146671|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146672|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146673|NCT04018703|Analgesics|analgesics|mesh-ancestor
154146674|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
154146675|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146676|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154146677|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154146678|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154146679|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
154146680|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146681|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146682|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154146683|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154146684|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154146685|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154146686|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154146699|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154146700|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146701|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154146702|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146703|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146704|NCT00733889|Docetaxel|docetaxel|mesh-list
154146705|NCT00733889|Fluorouracil|fluorouracil|mesh-list
154146706|NCT00733889|Cetuximab|cetuximab|mesh-list
154146707|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146708|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
154146709|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
154146711|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146712|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
154146713|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154146714|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154146715|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
154146716|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146717|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154146718|NCT00733967|Varenicline|varenicline|mesh-list
154146719|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154146720|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154146721|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
154146722|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146723|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146724|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146725|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154146726|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154146727|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154146728|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
154146729|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154146730|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154146742|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146745|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154146746|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154146747|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154146748|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154146749|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146750|NCT00732407|Renin Inhibitors|renin inhibitors|mesh-ancestor
154146751|NCT00732407|Protease Inhibitors|protease inhibitors|mesh-ancestor
154146752|NCT00732407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146753|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
154146754|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
154146755|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154146756|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154146757|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146758|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146759|NCT00507819|Urological Agents|urological agents|mesh-ancestor
154146760|NCT02569307|Minocycline|minocycline|mesh-list
154146761|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154146762|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146763|NCT01013103|Atorvastatin|atorvastatin|mesh-list
154146764|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154146765|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154146792|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146793|NCT00734123|Aspirin|aspirin|mesh-list
154146794|NCT00734123|Rimonabant|rimonabant|mesh-list
154146795|NCT00734123|Enalapril|enalapril|mesh-list
154146796|NCT00734123|Clopidogrel|clopidogrel|mesh-list
154146797|NCT00734123|Atorvastatin|atorvastatin|mesh-list
154146798|NCT00734123|Simvastatin|simvastatin|mesh-list
154146799|NCT00734123|Diuretics|diuretics|mesh-list
154146800|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154146801|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154146802|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146803|NCT00734123|Analgesics|analgesics|mesh-ancestor
154146804|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
154146854|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146855|NCT00732953|Paclitaxel|paclitaxel|mesh-list
154146856|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154146857|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146858|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154146859|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154146860|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154146861|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146862|NCT00577655|Albuterol|albuterol|mesh-list
154146863|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154146864|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
154146918|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146919|NCT00449644|Bedaquiline|bedaquiline|mesh-list
154146920|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
154146921|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154146922|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146923|NCT00733265|Ticagrelor|ticagrelor|mesh-list
154146924|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154146925|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154146926|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154146927|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154146981|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154146982|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
154146983|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
154146984|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146985|NCT00733811|Siderophores|siderophores|mesh-ancestor
154146986|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
154146987|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
154146988|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146989|NCT00507507|Tenofovir|tenofovir|mesh-list
154146990|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
154146991|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146992|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154146993|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154146994|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146995|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146996|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154147041|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154147042|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147044|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
154147045|NCT00507429|Combretastatin|combretastatin|mesh-list
154147046|NCT00507429|Carboplatin|carboplatin|mesh-list
154147047|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147048|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147049|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147050|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147051|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147052|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147053|NCT01011621|Prednisolone|prednisolone|mesh-list
154147054|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154147103|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147104|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147105|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147106|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147107|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
154147108|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
154147109|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147110|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147111|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154147112|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
154147113|NCT00515073|Hormones|hormones|mesh-ancestor
154147114|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147115|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154147116|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154147117|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154147118|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147119|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
154147120|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
154147124|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
154147157|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147159|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154147160|NCT04065035|Protective Agents|protective agents|mesh-ancestor
154147161|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147162|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
154147163|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
154147164|NCT00442702|Hematinics|hematinics|mesh-ancestor
154147165|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
154147166|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154147167|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147225|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154147226|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154147227|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
154147228|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147229|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154147230|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154147231|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147232|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
154147233|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154147235|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
154147236|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147237|NCT00736541|Expectorants|expectorants|mesh-ancestor
154147238|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
154147239|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154147240|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
154147241|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147257|NCT01082809|Sunitinib|sunitinib|mesh-list
154147283|NCT00711191|Antibodies|antibodies|mesh-list
154147284|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154147285|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
154147286|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147287|NCT00741221|Bevacizumab|bevacizumab|mesh-list
154147288|NCT00741221|Pemetrexed|pemetrexed|mesh-list
154147289|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147290|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147291|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154147292|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154147293|NCT00741221|Growth Substances|growth substances|mesh-ancestor
154147294|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147295|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
154147296|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147297|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147298|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154147299|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154147300|NCT00736619|Paclitaxel|paclitaxel|mesh-list
154147301|NCT00736619|Cetuximab|cetuximab|mesh-list
154147302|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154147303|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147304|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147305|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147306|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147310|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
154147333|NCT00925028|Warfarin|warfarin|mesh-list
154147334|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
154147335|NCT00905216|Heparin|heparin|mesh-list
154147336|NCT00905216|Calcium heparin|calcium heparin|mesh-list
154147338|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154147339|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154147340|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147341|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154147342|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
154147343|NCT00929630|Coagulants|coagulants|mesh-ancestor
154147344|NCT00925106|Celecoxib|celecoxib|mesh-list
154147345|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154147346|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154147347|NCT00925106|Analgesics|analgesics|mesh-ancestor
154147348|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
154147349|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147350|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147351|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147352|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147353|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154147354|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154147355|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147356|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147357|NCT00905528|Telmisartan|telmisartan|mesh-list
154147358|NCT00905528|Ramipril|ramipril|mesh-list
154147359|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154147360|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154147361|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154147362|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147363|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154147364|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
154147365|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147366|NCT00736697|Moxidectin|moxidectin|mesh-list
154147371|NCT02568995|Ketorolac|ketorolac|mesh-list
154147377|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
154147378|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147379|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147380|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
154147381|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147382|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154147383|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154147384|NCT02568995|Analgesics|analgesics|mesh-ancestor
154147386|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147387|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154147388|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147389|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147390|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154147391|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154147392|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
154147393|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147394|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154147395|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154147396|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
154147397|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154147398|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
154147399|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
154147400|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
154147401|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154147402|NCT00930020|Minocycline|minocycline|mesh-list
154147403|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154147404|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147423|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154147424|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154147425|NCT02568839|Docetaxel|docetaxel|mesh-list
154147426|NCT02568839|Trastuzumab|trastuzumab|mesh-list
154147427|NCT02568839|Pertuzumab|pertuzumab|mesh-list
154147428|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147429|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147430|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147431|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147432|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147433|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147434|NCT06140771|Fluorides|fluorides|mesh-list
154147435|NCT06140771|Tin Fluorides|tin fluorides|mesh-list
154147436|NCT06140771|Fluorophosphate|fluorophosphate|mesh-list
154147437|NCT06140771|Cariostatic Agents|cariostatic agents|mesh-ancestor
154147438|NCT06140771|Protective Agents|protective agents|mesh-ancestor
154147439|NCT06140771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147440|NCT06140745|Fluorides|fluorides|mesh-list
154147441|NCT06140745|Cariostatic Agents|cariostatic agents|mesh-ancestor
154147442|NCT06140745|Protective Agents|protective agents|mesh-ancestor
154147443|NCT06140745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147444|NCT06140732|Apatinib|apatinib|mesh-list
154147445|NCT06140732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147446|NCT06140732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154147447|NCT06140732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147448|NCT06140732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147473|NCT06138028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147474|NCT06138028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147475|NCT06138028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147476|NCT06137950|Interferons|interferons|mesh-list
154147477|NCT06137950|Interferon-alpha|interferon-alpha|mesh-list
154147478|NCT06137950|Interferon alpha-2|interferon alpha-2|mesh-list
154147479|NCT06137950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147480|NCT06137950|Antiviral Agents|antiviral agents|mesh-ancestor
154147481|NCT06137950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147482|NCT06137950|Immunologic Factors|immunologic factors|mesh-ancestor
154147483|NCT06137950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147484|NCT06137924|Dexamethasone|dexamethasone|mesh-list
154147485|NCT06137924|Dexamethasone acetate|dexamethasone acetate|mesh-list
154147487|NCT06137924|Bupivacaine|bupivacaine|mesh-list
154147488|NCT06137924|Anesthetics, Local|anesthetics, local|mesh-list
154147490|NCT06137924|BB 1101|bb 1101|mesh-list
154147491|NCT06137924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911139|NCT02771587|Ethanol|ethanol|mesh-list
154147492|NCT06137924|Antiemetics|antiemetics|mesh-ancestor
154147493|NCT06137924|Autonomic Agents|autonomic agents|mesh-ancestor
154147494|NCT06137924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147495|NCT06137924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147528|NCT06137430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147529|NCT06137092|Factor VIII|factor viii|mesh-list
154147530|NCT06137092|Coagulants|coagulants|mesh-ancestor
154147531|NCT06137027|Cannabidiol|cannabidiol|mesh-list
154147532|NCT06137027|Anticonvulsants|anticonvulsants|mesh-ancestor
154147533|NCT06136988|Paclitaxel|paclitaxel|mesh-list
154147534|NCT06136988|Docetaxel|docetaxel|mesh-list
154147535|NCT06136988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147536|NCT06136988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147537|NCT06136988|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147538|NCT06136988|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147539|NCT06136988|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147540|NCT06136988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147541|NCT06136806|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154147542|NCT06136806|Hematinics|hematinics|mesh-ancestor
154147543|NCT06136806|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154147544|NCT06136806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154147545|NCT06136676|Complement Factor H|complement factor h|mesh-list
154147546|NCT06136676|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154147547|NCT06136676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154147548|NCT06136676|Immunologic Factors|immunologic factors|mesh-ancestor
154147585|NCT06135402|Hormones|hormones|mesh-ancestor
154147586|NCT06135402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147587|NCT06135402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147588|NCT06135194|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154147589|NCT06135194|Immunoconjugates|immunoconjugates|mesh-ancestor
154147590|NCT06135194|Immunologic Factors|immunologic factors|mesh-ancestor
154147591|NCT06135194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147592|NCT06134895|Ketamine|ketamine|mesh-list
154147593|NCT06134895|Tramadol|tramadol|mesh-list
154147594|NCT06134895|Analgesics|analgesics|mesh-ancestor
154147595|NCT06134895|Sensory System Agents|sensory system agents|mesh-ancestor
154147596|NCT06134895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147597|NCT06134895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147598|NCT06134895|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154147599|NCT06134895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154147600|NCT06134895|Anesthetics, General|anesthetics, general|mesh-ancestor
154147601|NCT06134895|Anesthetics|anesthetics|mesh-ancestor
154147602|NCT06134895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147603|NCT06134895|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154147604|NCT06134895|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154147605|NCT06134895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911141|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147606|NCT06134895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147607|NCT06134895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154147608|NCT06134895|Narcotics|narcotics|mesh-ancestor
154147609|NCT06134635|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154147610|NCT06134635|Evolocumab|evolocumab|mesh-list
154147633|NCT06134388|Sensory System Agents|sensory system agents|mesh-ancestor
154147634|NCT06134388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147635|NCT06134388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147636|NCT06134388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147637|NCT06134388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147638|NCT06134388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154147639|NCT06134193|Tislelizumab|tislelizumab|mesh-list
154147640|NCT06134193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147641|NCT06134193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147642|NCT06133803|Aspirin|aspirin|mesh-list
154147643|NCT06133803|Enoxaparin|enoxaparin|mesh-list
154147644|NCT06133803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154147645|NCT06133803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154147646|NCT06133803|Analgesics|analgesics|mesh-ancestor
154147647|NCT06133803|Sensory System Agents|sensory system agents|mesh-ancestor
154147648|NCT06133803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147649|NCT06133803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147650|NCT06133803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147651|NCT06133803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147652|NCT06133803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154147653|NCT06133803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154147657|NCT06133803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147685|NCT06133465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147686|NCT06133465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147687|NCT06132178|Psilocybin|psilocybin|mesh-list
154147688|NCT06132178|Hallucinogens|hallucinogens|mesh-ancestor
154147689|NCT06132178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147690|NCT06132178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154147691|NCT06128616|Botulinum Toxins|botulinum toxins|mesh-list
154147692|NCT06128616|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154147693|NCT06128616|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154147694|NCT06128616|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154147695|NCT06128616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154147696|NCT06128616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147697|NCT06128616|Cholinergic Agents|cholinergic agents|mesh-ancestor
154147698|NCT06128616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147699|NCT06128616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147744|NCT06095492|Incretins|incretins|mesh-ancestor
154147745|NCT06095492|Hormones|hormones|mesh-ancestor
154147746|NCT06095492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147747|NCT06095492|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154147748|NCT06095492|Protease Inhibitors|protease inhibitors|mesh-ancestor
153452892|NCT01607346|Ezogabine|ezogabine|mesh-list
154147749|NCT06095492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147750|NCT06091995|Abatacept|abatacept|mesh-list
154147751|NCT06091995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154147752|NCT06091995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147753|NCT06091995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147754|NCT06091995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147755|NCT06091995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154147756|NCT06091995|Immunologic Factors|immunologic factors|mesh-ancestor
154147757|NCT06091995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147758|NCT06091995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147759|NCT06091124|Cisplatin|cisplatin|mesh-list
154147760|NCT06091124|Etoposide|etoposide|mesh-list
154147761|NCT06091124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147762|NCT06091124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147763|NCT06091124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154147764|NCT06091124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154147765|NCT06091124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147766|NCT06091124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147767|NCT06085755|Trastuzumab|trastuzumab|mesh-list
154147768|NCT06085755|Afatinib|afatinib|mesh-list
154147769|NCT06085755|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154147770|NCT06085755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147771|NCT06085755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147772|NCT06085755|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154147773|NCT06085755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154147774|NCT06085755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147775|NCT06085755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147776|NCT06085755|Immunoconjugates|immunoconjugates|mesh-ancestor
154147777|NCT06085755|Immunologic Factors|immunologic factors|mesh-ancestor
154147782|NCT06078241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147783|NCT06078241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147784|NCT06078241|Sensory System Agents|sensory system agents|mesh-ancestor
154147785|NCT06078241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147786|NCT06078241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154147787|NCT06078241|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154147789|NCT06078241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154147790|NCT06078241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147791|NCT06069180|Busulfan|busulfan|mesh-list
154147792|NCT06069180|Alkylating Agents|alkylating agents|mesh-ancestor
154147793|NCT06069180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147794|NCT06069180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154147795|NCT06069180|Immunologic Factors|immunologic factors|mesh-ancestor
154147796|NCT06069180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147797|NCT06069180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154147798|NCT06069180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147799|NCT06069180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154147800|NCT06067217|Tranexamic Acid|tranexamic acid|mesh-list
154147801|NCT06067217|Estradiol|estradiol|mesh-list
154147802|NCT06067217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154147803|NCT06067217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154147804|NCT06067217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147805|NCT06067217|Hemostatics|hemostatics|mesh-ancestor
154147828|NCT06056804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154147829|NCT06056804|Immunologic Factors|immunologic factors|mesh-ancestor
154147830|NCT06056804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147831|NCT06042647|Clobetasol|clobetasol|mesh-list
154147832|NCT06042647|Halobetasol|halobetasol|mesh-list
154147833|NCT06042647|Tazarotene|tazarotene|mesh-list
154147834|NCT06042647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147835|NCT06042647|Glucocorticoids|glucocorticoids|mesh-ancestor
154147836|NCT06042647|Hormones|hormones|mesh-ancestor
154147838|NCT06042647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147893|NCT05961527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154147894|NCT05961527|Adrenergic Agents|adrenergic agents|mesh-ancestor
154147895|NCT05960955|Docetaxel|docetaxel|mesh-list
154147896|NCT05960955|Fluorouracil|fluorouracil|mesh-list
154147897|NCT05960955|Oxaliplatin|oxaliplatin|mesh-list
154147898|NCT05960955|Tegafur|tegafur|mesh-list
154147899|NCT05960955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147900|NCT05960955|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147901|NCT05960955|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147902|NCT05960955|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147903|NCT05960955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147904|NCT05960955|Antimetabolites|antimetabolites|mesh-ancestor
154147905|NCT05960955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154147906|NCT05960955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154147907|NCT05960955|Immunologic Factors|immunologic factors|mesh-ancestor
154147908|NCT05960955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147909|NCT05953038|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154147910|NCT05953038|Hallucinogens|hallucinogens|mesh-ancestor
154147952|NCT05946655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154147953|NCT05946655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154147954|NCT05946655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154147955|NCT05946655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154147956|NCT05946655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154147957|NCT05946655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154147958|NCT05946655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147959|NCT05946655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147960|NCT05946655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147961|NCT05946655|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154147962|NCT05946655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154147963|NCT05939726|Vitamins|vitamins|mesh-list
154147964|NCT05939726|Vitamin E|vitamin e|mesh-list
154147965|NCT05939726|Tocopherols|tocopherols|mesh-list
154147966|NCT05939726|Tocotrienols|tocotrienols|mesh-list
154147967|NCT05939726|alpha-Tocopherol|alpha-tocopherol|mesh-list
154147968|NCT05939726|Micronutrients|micronutrients|mesh-ancestor
154147969|NCT05939726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147970|NCT05939726|Antioxidants|antioxidants|mesh-ancestor
154147971|NCT05939726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147972|NCT05939726|Protective Agents|protective agents|mesh-ancestor
154147973|NCT05939193|Furosemide|furosemide|mesh-list
154147974|NCT05939193|Diuretics|diuretics|mesh-ancestor
154147975|NCT05939193|Natriuretic Agents|natriuretic agents|mesh-ancestor
154147976|NCT05939193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147977|NCT05939193|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154147978|NCT05939193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154147979|NCT05939193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147980|NCT05926466|Moxifloxacin|moxifloxacin|mesh-list
154147981|NCT05926466|Bedaquiline|bedaquiline|mesh-list
154147982|NCT05926466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154147983|NCT05926466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147984|NCT05926466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154147985|NCT05926466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154147986|NCT05926466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646486|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
154147991|NCT05925127|Immunologic Factors|immunologic factors|mesh-ancestor
154147992|NCT05925127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147993|NCT05919888|Povidone-Iodine|povidone-iodine|mesh-list
154147994|NCT05919888|Povidone|povidone|mesh-list
154147995|NCT05919888|Plasma Substitutes|plasma substitutes|mesh-ancestor
154147996|NCT05919888|Blood Substitutes|blood substitutes|mesh-ancestor
154147997|NCT05919888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154147998|NCT05919888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147999|NCT05914779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154148000|NCT05914779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154148001|NCT05914779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148002|NCT05914779|Antitubercular Agents|antitubercular agents|mesh-ancestor
154148003|NCT05888597|Menthol|menthol|mesh-list
154148004|NCT05888597|Antipruritics|antipruritics|mesh-ancestor
154148005|NCT05888597|Dermatologic Agents|dermatologic agents|mesh-ancestor
154148006|NCT05885542|Cannabidiol|cannabidiol|mesh-list
154148007|NCT05885542|Anticonvulsants|anticonvulsants|mesh-ancestor
154148008|NCT05872256|Halobetasol|halobetasol|mesh-list
154148009|NCT05872256|Tazarotene|tazarotene|mesh-list
154148010|NCT05872256|Dermatologic Agents|dermatologic agents|mesh-ancestor
154148011|NCT05872256|Keratolytic Agents|keratolytic agents|mesh-ancestor
154148012|NCT05872256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154148014|NCT05868226|Tucatinib|tucatinib|mesh-list
154148015|NCT05868226|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154148016|NCT05868226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148017|NCT05868226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148018|NCT05868226|Immunoconjugates|immunoconjugates|mesh-ancestor
154148019|NCT05868226|Immunologic Factors|immunologic factors|mesh-ancestor
154148020|NCT05868226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148021|NCT05868226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148022|NCT05868226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148023|NCT05868226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148024|NCT05851976|Naproxen|naproxen|mesh-list
154148036|NCT05851976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154148037|NCT05851976|Dopamine Agents|dopamine agents|mesh-ancestor
154148038|NCT05851976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154148039|NCT05851976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154148040|NCT05851976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148041|NCT05851976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148042|NCT05851976|Gout Suppressants|gout suppressants|mesh-ancestor
154148043|NCT05851976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154148044|NCT05851976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148045|NCT05839574|Letrozole|letrozole|mesh-list
154148046|NCT05839574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148047|NCT05839574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154148099|NCT05807932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154148100|NCT05807932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148101|NCT05807932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148102|NCT05807932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154148103|NCT05807932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148104|NCT05807932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154148105|NCT05807932|Antitubercular Agents|antitubercular agents|mesh-ancestor
154148106|NCT05807932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148107|NCT05807932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148108|NCT05803941|Pluvicto|pluvicto|mesh-list
154148109|NCT05803941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154148110|NCT05803941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148111|NCT05797376|Rivaroxaban|rivaroxaban|mesh-list
154148112|NCT05797376|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154148113|NCT05797376|Antithrombins|antithrombins|mesh-ancestor
154148114|NCT05797376|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154148115|NCT05797376|Protease Inhibitors|protease inhibitors|mesh-ancestor
154148116|NCT05797376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148118|NCT05797376|Anticoagulants|anticoagulants|mesh-ancestor
154148155|NCT05733598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154148156|NCT05733598|Growth Substances|growth substances|mesh-ancestor
153911213|NCT02765815|Bupivacaine|bupivacaine|mesh-list
154148157|NCT05733598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148158|NCT05733598|Growth Inhibitors|growth inhibitors|mesh-ancestor
154148159|NCT05733598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148160|NCT05733598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148162|NCT05719714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154148163|NCT05719714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148164|NCT05719714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154148165|NCT05719714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148220|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148221|NCT05659563|Tamoxifen|tamoxifen|mesh-list
154148222|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154148223|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148224|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148225|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148226|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154148227|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148228|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154148229|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154148230|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154148231|NCT05647512|Dexamethasone|dexamethasone|mesh-list
154148232|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148233|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
154148234|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
154148235|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148278|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148279|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148280|NCT05609682|Gabapentin|gabapentin|mesh-list
154148281|NCT05609682|Analgesics|analgesics|mesh-ancestor
154148282|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
154148283|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148284|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148285|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
153340342|NCT00002524|Antidotes|antidotes|mesh-ancestor
154148286|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154148287|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154148338|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148339|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
154148340|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148341|NCT05536349|Valacyclovir|valacyclovir|mesh-list
154148342|NCT05536349|Venetoclax|venetoclax|mesh-list
154148343|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
154148344|NCT05536349|Allopurinol|allopurinol|mesh-list
154148345|NCT05536349|Pirtobrutinib|pirtobrutinib|mesh-list
154148346|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148347|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148348|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
154148349|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148350|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148351|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
154148352|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148400|NCT05527444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154148401|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148402|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148403|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154148404|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
154148471|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148472|NCT05463133|Sirolimus|sirolimus|mesh-list
154148473|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
154148474|NCT05463133|Busulfan|busulfan|mesh-list
154148475|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
154148476|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154148477|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
154148478|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148479|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148480|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154148481|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
154148482|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148483|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148484|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154148485|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148532|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
154148533|NCT05409872|Pyridoxal|pyridoxal|mesh-list
154148534|NCT05409872|Pyridoxine|pyridoxine|mesh-list
154148535|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153729717|NCT00131027|Methotrexate|methotrexate|mesh-list
154148536|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
154148537|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148538|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154148539|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
154148540|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
154148541|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148542|NCT05409872|Protective Agents|protective agents|mesh-ancestor
154148543|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154148544|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154148545|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148546|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154148547|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154148548|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
154148549|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148550|NCT05351229|Morphine|morphine|mesh-list
154148551|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154148588|NCT05261672|Bupivacaine|bupivacaine|mesh-list
154148589|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
154148590|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
154148591|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154148659|NCT05138549|Vitamins|vitamins|mesh-ancestor
154148660|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
154148661|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154148662|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
154148663|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
154148664|NCT05084378|Povidone|povidone|mesh-list
154148665|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154148666|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148729|NCT05003453|Palmidrol|palmidrol|mesh-list
154148730|NCT05003453|Analgesics|analgesics|mesh-ancestor
154148731|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
153911243|NCT02765347|Metformin|metformin|mesh-list
154148732|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148733|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148734|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154148735|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154148736|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148737|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148738|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
153794227|NCT00259376|Dronedarone|dronedarone|mesh-list
154148739|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148740|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154148741|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154148742|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148743|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148745|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148746|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
154148747|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148748|NCT04991493|Tramadol|tramadol|mesh-list
154148749|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154148750|NCT04991493|Narcotics|narcotics|mesh-ancestor
154148751|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154148752|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148753|NCT04991493|Analgesics|analgesics|mesh-ancestor
154148754|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
154148755|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148756|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
154148757|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148758|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148759|NCT04986852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148760|NCT04986852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148769|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154148770|NCT04928586|Pirfenidone|pirfenidone|mesh-list
154148771|NCT04928586|Analgesics|analgesics|mesh-ancestor
154148772|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
154148773|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148774|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148775|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154148776|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154148777|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148778|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148779|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148780|NCT04928066|Prednisone|prednisone|mesh-list
154148781|NCT04928066|Tofacitinib|tofacitinib|mesh-list
154148782|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148783|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
154148830|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148831|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148832|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154148833|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154148834|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
154148835|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
154148836|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729719|NCT00131027|Vincristine|vincristine|mesh-list
153911264|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154148837|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154148847|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
154148893|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
154148894|NCT04783415|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154148895|NCT04783415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148896|NCT04783415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148897|NCT04783415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148898|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148899|NCT04716933|Carboplatin|carboplatin|mesh-list
154148900|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
154148901|NCT04716933|Pemetrexed|pemetrexed|mesh-list
154148902|NCT04716933|Lenvatinib|lenvatinib|mesh-list
154148903|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148904|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148905|NCT04716933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148906|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148907|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148908|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154148912|NCT04715230|Haloperidol|haloperidol|mesh-list
154148955|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
154148956|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
154148957|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
154148958|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148959|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154148960|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
154148961|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154148962|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154148963|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148964|NCT04672005|Antidotes|antidotes|mesh-ancestor
154148965|NCT04672005|Protective Agents|protective agents|mesh-ancestor
154148966|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148968|NCT04672005|Vitamins|vitamins|mesh-ancestor
154148969|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
154148970|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154148971|NCT04643379|Carboplatin|carboplatin|mesh-list
154148972|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
154148973|NCT04643379|Olaparib|olaparib|mesh-list
154148974|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148975|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148976|NCT04643379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148977|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148978|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154148979|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148980|NCT04638751|Immunomodulating Agents|immunomodulating agents|mesh-list
154149005|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149006|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149007|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149008|NCT04590963|Cetuximab|cetuximab|mesh-list
154149009|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149010|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149011|NCT04583488|Docetaxel|docetaxel|mesh-list
154149012|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149013|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
153453027|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
154149014|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149015|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149016|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149017|NCT04559646|Hemostatics|hemostatics|mesh-list
154149018|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154149019|NCT04559646|Coagulants|coagulants|mesh-ancestor
154149020|NCT04545151|Verapamil|verapamil|mesh-list
154149021|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154149022|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154149023|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154149025|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154149059|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149060|NCT04462328|Durvalumab|durvalumab|mesh-list
154149061|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
154149062|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149063|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149064|NCT04462328|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154149065|NCT04462328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154149066|NCT04462328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149067|NCT04462328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149068|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
154149069|NCT04409873|Listerine|listerine|mesh-list
154149070|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
154149071|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
154149072|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154149073|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149074|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
154149075|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
154149076|NCT04392297|Antibodies|antibodies|mesh-list
154149077|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
154149118|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149120|NCT04290624|Fluorides|fluorides|mesh-list
154149121|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
154149122|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
154149123|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
154149124|NCT04290624|Protective Agents|protective agents|mesh-ancestor
154149125|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149126|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154149127|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149128|NCT04262193|Suvorexant|suvorexant|mesh-list
154149129|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154149130|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154149131|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911295|NCT02769325|Ketorolac|ketorolac|mesh-list
154149132|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149133|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154149134|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149135|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149136|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154149176|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149177|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149178|NCT04191096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149179|NCT04191096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149181|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149182|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149183|NCT04187833|Nivolumab|nivolumab|mesh-list
154149184|NCT04187833|Talazoparib|talazoparib|mesh-list
154149185|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149186|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149187|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149188|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149189|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154149190|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149191|NCT04157335|Benralizumab|benralizumab|mesh-list
154149206|NCT04092894|Suvorexant|suvorexant|mesh-list
154149230|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154149232|NCT04039750|Gentamicins|gentamicins|mesh-list
154149233|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149234|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154149235|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149236|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149237|NCT04028596|Acetaminophen|acetaminophen|mesh-list
154149238|NCT04028596|Nimodipine|nimodipine|mesh-list
154149239|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154149240|NCT04028596|Analgesics|analgesics|mesh-ancestor
154149241|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
154149242|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149243|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149244|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
154149245|NCT04028596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154149246|NCT04028596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154149247|NCT04028596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154149248|NCT04028596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149250|NCT04028596|Vasodilator Agents|vasodilator agents|mesh-ancestor
154149286|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149288|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149289|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
154149290|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149291|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149292|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154149293|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154149294|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
154149295|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154149296|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154149297|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
154149298|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
154149299|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149300|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154149301|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154149302|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154149303|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
154149304|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149305|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154149306|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154149307|NCT03944954|Dronabinol|dronabinol|mesh-list
154149337|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149338|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149339|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
154149340|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149341|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154149342|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154149343|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154149344|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149345|NCT03895203|Adalimumab|adalimumab|mesh-list
154149346|NCT03895203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154149347|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154149348|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149349|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
154149350|NCT03855007|Prednisone|prednisone|mesh-list
154149351|NCT03855007|Methotrexate|methotrexate|mesh-list
154149352|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154149353|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
154149354|NCT03855007|Hormones|hormones|mesh-ancestor
154149355|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149356|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149357|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154149358|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149359|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154149360|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
154149361|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153626673|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
154149362|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154149363|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
154149364|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149365|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
154149366|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149367|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154149379|NCT03828019|Azathioprine|azathioprine|mesh-list
154149380|NCT03828019|Tacrolimus|tacrolimus|mesh-list
154149381|NCT03828019|Cyclosporins|cyclosporins|mesh-list
154149382|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154149383|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
154149384|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154149385|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149386|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154149387|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
154149388|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149389|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149390|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
154149391|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149392|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154149393|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149394|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
154149395|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149396|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154149397|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154149398|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
154149399|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149400|NCT03828019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154149401|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154149402|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
154149403|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154149404|NCT03819322|Velpatasvir|velpatasvir|mesh-list
154149405|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
154149406|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149407|NCT03817970|Ondansetron|ondansetron|mesh-list
154149408|NCT03817970|Palonosetron|palonosetron|mesh-list
154149409|NCT03817970|Granisetron|granisetron|mesh-list
154149410|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
154149423|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149424|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149425|NCT03815058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149426|NCT03815058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149428|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154149429|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154149430|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149431|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149432|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149433|NCT03790670|Sargramostim|sargramostim|mesh-list
154149434|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
154149435|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149436|NCT03783494|Propofol|propofol|mesh-list
154149437|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154149438|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154149479|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149480|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154149481|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154149482|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154149483|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
154149484|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149485|NCT03641209|Acetaminophen|acetaminophen|mesh-list
154149486|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154149487|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154149488|NCT03641209|Analgesics|analgesics|mesh-ancestor
154149489|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
154149490|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149543|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154149544|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
154149545|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154149546|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154149547|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149548|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154149549|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153911373|NCT02769013|Praziquantel|praziquantel|mesh-list
154149550|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154149551|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154149552|NCT03498521|Bevacizumab|bevacizumab|mesh-list
154149553|NCT03498521|Carboplatin|carboplatin|mesh-list
154149554|NCT03498521|Gemcitabine|gemcitabine|mesh-list
154149555|NCT03498521|Trastuzumab|trastuzumab|mesh-list
154149556|NCT03498521|Atezolizumab|atezolizumab|mesh-list
154149557|NCT03498521|Olaparib|olaparib|mesh-list
154149558|NCT03498521|Pertuzumab|pertuzumab|mesh-list
154149559|NCT03498521|Vemurafenib|vemurafenib|mesh-list
154149604|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
154149605|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149606|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149607|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149608|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
154149609|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149610|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149611|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154149612|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154149613|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154149614|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154149615|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149616|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
154149617|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
154149618|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
154149619|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149620|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149621|NCT03409458|Avelumab|avelumab|mesh-list
154149622|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149623|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149624|NCT03406897|Vitamin D|vitamin d|mesh-list
154149625|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
154149626|NCT03406897|Vitamins|vitamins|mesh-ancestor
154149627|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
154149628|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149629|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154149630|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154149650|NCT03243058|Interleukin-2|interleukin-2|mesh-list
154149651|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149652|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154149653|NCT03243058|Analgesics|analgesics|mesh-ancestor
154149654|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
154149655|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149656|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149657|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154149658|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154149716|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154149717|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
154149718|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149719|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149720|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154149721|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
154149722|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
154149723|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
154149724|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154149725|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154149726|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
154149727|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149728|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149729|NCT03094052|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154149730|NCT03094052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154149731|NCT03094052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149732|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154149733|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154149734|NCT03094052|Narcotics|narcotics|mesh-ancestor
154149735|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154149736|NCT03094052|Analgesics|analgesics|mesh-ancestor
154149765|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149766|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149767|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154149768|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
154149769|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
154149770|NCT03023449|Protective Agents|protective agents|mesh-ancestor
154149771|NCT02998918|Curcumin|curcumin|mesh-list
154149772|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154149773|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154149774|NCT02998918|Analgesics|analgesics|mesh-ancestor
154149775|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
154149776|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149777|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149778|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154149779|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149780|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149781|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149782|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149820|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149821|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
154149822|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149823|NCT02877303|Cytarabine|cytarabine|mesh-list
154149824|NCT02877303|Dexamethasone|dexamethasone|mesh-list
154149825|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
154149826|NCT02877303|Prednisone|prednisone|mesh-list
154149827|NCT02877303|Cortisone|cortisone|mesh-list
154149828|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
154149829|NCT02877303|Rituximab|rituximab|mesh-list
154149830|NCT02877303|Doxorubicin|doxorubicin|mesh-list
154149831|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154149832|NCT02877303|Methotrexate|methotrexate|mesh-list
154149833|NCT02877303|Vincristine|vincristine|mesh-list
154149834|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
154149835|NCT02877303|Ofatumumab|ofatumumab|mesh-list
154149836|NCT02877303|Blinatumomab|blinatumomab|mesh-list
154149837|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154149838|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154149839|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
154149840|NCT02877303|Antibodies|antibodies|mesh-list
154149841|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
154149842|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154149843|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154149844|NCT02877303|BB 1101|bb 1101|mesh-list
154149845|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149846|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
154149847|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149848|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149872|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
154149873|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
154149874|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154149875|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154149876|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
154149877|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149878|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154149879|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
154149880|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149940|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149941|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
154149942|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149943|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149944|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149945|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
154149946|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149947|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149948|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154149949|NCT02614066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149950|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
154149951|NCT02600949|Imiquimod|imiquimod|mesh-list
154149952|NCT02600949|Vaccines|vaccines|mesh-list
154149953|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149954|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149955|NCT02600949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149956|NCT02600949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149957|NCT02600949|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154149958|NCT02600949|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154149959|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
154149960|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149961|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154149962|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
154149992|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149993|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149994|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154149995|NCT02586831|Analgesics|analgesics|mesh-ancestor
154149996|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
154149997|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149998|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149999|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154150000|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154150001|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
154150002|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150003|NCT02586831|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154150004|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154150005|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154150006|NCT02586831|Incretins|incretins|mesh-ancestor
154150007|NCT02586831|Hormones|hormones|mesh-ancestor
154150008|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150009|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
154150010|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150011|NCT02434744|Metformin|metformin|mesh-list
154150012|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154150013|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150014|NCT02432417|Chloroquine|chloroquine|mesh-list
154150015|NCT02432417|Amebicides|amebicides|mesh-ancestor
154150016|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154150017|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154150021|NCT02231723|Leucovorin|leucovorin|mesh-list
154150044|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
154150045|NCT02231723|Vitamins|vitamins|mesh-ancestor
154150046|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
154150047|NCT02198404|Propofol|propofol|mesh-list
154150048|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154150049|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150050|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150051|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154150052|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
154150053|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
154150054|NCT02131597|Guadecitabine|guadecitabine|mesh-list
154150055|NCT02131597|Azacitidine|azacitidine|mesh-list
154150056|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150058|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
154150107|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154150108|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154150109|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150179|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
154150180|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
154150181|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150182|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154150183|NCT00931580|Vitamin D|vitamin d|mesh-list
154150185|NCT00931580|Vitamins|vitamins|mesh-ancestor
154150247|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150248|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
154150249|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150250|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
154150251|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154150252|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150253|NCT00737789|Mesalamine|mesalamine|mesh-list
154150254|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154150255|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154150256|NCT00737789|Analgesics|analgesics|mesh-ancestor
154150257|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
154150258|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150260|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154150308|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
154150309|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150310|NCT00514683|Nintedanib|nintedanib|mesh-list
154150311|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150312|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150313|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150315|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
154150376|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154150377|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
154150378|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154150379|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
154150380|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150381|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150382|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
154150383|NCT00506883|Colchicine|colchicine|mesh-list
154150384|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
154150385|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150386|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
154150387|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
154150388|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
154150389|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150390|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150391|NCT01028638|Bevacizumab|bevacizumab|mesh-list
154150392|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
154150393|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154150394|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150395|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154150396|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154150398|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150399|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
154150400|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154150401|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150402|NCT00938132|Warfarin|warfarin|mesh-list
154150403|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
154150404|NCT01023334|Lidocaine|lidocaine|mesh-list
154150405|NCT01023334|Anesthetics|anesthetics|mesh-list
154150406|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
154150416|NCT00938522|Cilostazol|cilostazol|mesh-list
153729720|NCT00131027|Daunorubicin|daunorubicin|mesh-list
154150421|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154150422|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
154150423|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154150424|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154150425|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150426|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154150427|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
154150428|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154150429|NCT00938522|Protective Agents|protective agents|mesh-ancestor
154150430|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154150431|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154150432|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150433|NCT00938600|Vitamin D|vitamin d|mesh-list
154150434|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
154150435|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
154150436|NCT00938600|Vitamins|vitamins|mesh-list
154150437|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
154150438|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150439|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154150440|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154150441|NCT00503685|Cetuximab|cetuximab|mesh-list
154150442|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154150444|NCT00712673|Metformin|metformin|mesh-list
154150473|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154150474|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154150475|NCT03976466|Calcium|calcium|mesh-list
154150476|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154150477|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150478|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150479|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
154150480|NCT02536755|Eliglustat|eliglustat|mesh-list
154150481|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150482|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150483|NCT02567279|Denosumab|denosumab|mesh-list
154150484|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154150485|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150486|NCT00933374|Paclitaxel|paclitaxel|mesh-list
154150487|NCT00933374|Everolimus|everolimus|mesh-list
153453218|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154150488|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154150489|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150490|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
154150491|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
154150492|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
154150493|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150494|NCT00933374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154150495|NCT00933374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150496|NCT00933374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150497|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150521|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
154150522|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150524|NCT00933920|Renin Inhibitors|renin inhibitors|mesh-ancestor
154150525|NCT00933920|Protease Inhibitors|protease inhibitors|mesh-ancestor
154150526|NCT00933920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150527|NCT00933920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150528|NCT00938990|Midazolam|midazolam|mesh-list
154150529|NCT00938990|Etomidate|etomidate|mesh-list
154150530|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154150531|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154150587|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154150588|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150589|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154150590|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154150591|NCT00577031|Growth Substances|growth substances|mesh-ancestor
154150592|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150593|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
154150594|NCT00565448|Docetaxel|docetaxel|mesh-list
154150595|NCT00565448|Fluorouracil|fluorouracil|mesh-list
154150596|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150597|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
154150598|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
154150599|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
154150600|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150601|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
154150602|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150603|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150604|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
154150642|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150643|NCT05078255|Semaglutide|semaglutide|mesh-list
154150644|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154150645|NCT05078255|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154150646|NCT05078255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154150647|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150648|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154150649|NCT05078255|Incretins|incretins|mesh-ancestor
154150650|NCT05078255|Hormones|hormones|mesh-ancestor
154150651|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150652|NCT00939458|Lamotrigine|lamotrigine|mesh-list
154150653|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
154150654|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154150655|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150656|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150657|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154150658|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150659|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154150697|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150698|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154150699|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
154150700|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150701|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150702|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154150704|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154150705|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150706|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154150707|NCT00738335|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154150708|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150709|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150710|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150711|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150713|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150714|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
154150715|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150716|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150717|NCT00738413|Deferasirox|deferasirox|mesh-list
154150718|NCT00738413|Deferoxamine|deferoxamine|mesh-list
153531045|NCT01494363|Antidotes|antidotes|mesh-ancestor
154150719|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154150720|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
154150721|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
154150722|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150723|NCT00738413|Siderophores|siderophores|mesh-ancestor
154150724|NCT00697463|Teriparatide|teriparatide|mesh-list
154150725|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154150726|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150727|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154150728|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
154150729|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
154150730|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
154150734|NCT00492531|Urological Agents|urological agents|mesh-ancestor
154150735|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
154150736|NCT01015209|Chitosan|chitosan|mesh-list
154150737|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154150738|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154150739|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154150740|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
154150741|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150742|NCT01015209|Expectorants|expectorants|mesh-ancestor
154150743|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
154150744|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154150745|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
154150746|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150747|NCT01015209|Protective Agents|protective agents|mesh-ancestor
154150748|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150749|NCT01015209|Antidotes|antidotes|mesh-ancestor
154150750|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154150751|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154150752|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
154150753|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154150754|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
154150755|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
154150792|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150793|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150794|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154150795|NCT00492297|Sorafenib|sorafenib|mesh-list
154150796|NCT00492297|Dacarbazine|dacarbazine|mesh-list
154150797|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150798|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150860|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150861|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150862|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154150863|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
154150864|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154150865|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154150866|NCT04013438|Urological Agents|urological agents|mesh-ancestor
154150867|NCT02565719|Interferons|interferons|mesh-list
154150868|NCT02565719|Tenofovir|tenofovir|mesh-list
154150869|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
154150870|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
154150871|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154150923|NCT00935246|Citalopram|citalopram|mesh-list
154150924|NCT00935246|Escitalopram|escitalopram|mesh-list
154150925|NCT00935246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154150926|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154150927|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150928|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150929|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150930|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
154150931|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150932|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154150989|NCT05280236|Propofol|propofol|mesh-list
154150990|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154150991|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150992|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150993|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154150994|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
154150995|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
154150997|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154150998|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150999|NCT00939926|Risperidone|risperidone|mesh-list
154151000|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154151001|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
154151002|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151003|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151004|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151005|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154151006|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154151007|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151008|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154151009|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154151010|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
154151011|NCT00940550|Melatonin|melatonin|mesh-list
154151012|NCT00940550|Zolpidem|zolpidem|mesh-list
154151013|NCT00940550|Temazepam|temazepam|mesh-list
154151014|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
154151015|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151016|NCT00940550|Protective Agents|protective agents|mesh-ancestor
154151017|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151018|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474596|NCT00706446|Xhance|xhance|mesh-list
154151033|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154151035|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
154151036|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151037|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154151038|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154151039|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151040|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151041|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154151042|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
154151043|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154151044|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151045|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154151046|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154151047|NCT00936260|Alendronate|alendronate|mesh-list
154151048|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154151049|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151050|NCT00445978|Verapamil|verapamil|mesh-list
154151051|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154151052|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154151053|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154151054|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151055|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154151056|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151057|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
154151058|NCT02566733|Remifentanil|remifentanil|mesh-list
154151059|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154151060|NCT02566733|Narcotics|narcotics|mesh-ancestor
154151061|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151062|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151074|NCT00940784|Aspirin|aspirin|mesh-list
154151075|NCT00940784|Clopidogrel|clopidogrel|mesh-list
154151076|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154151077|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151078|NCT00940784|Analgesics|analgesics|mesh-ancestor
154151079|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
154151080|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151081|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151090|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
153796608|NCT03051282|Enalapril|enalapril|mesh-list
153453301|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151141|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151142|NCT00921167|Bevacizumab|bevacizumab|mesh-list
154151143|NCT00921167|Irinotecan|irinotecan|mesh-list
154151144|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151145|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151146|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154151147|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154151148|NCT00921167|Growth Substances|growth substances|mesh-ancestor
154151149|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151150|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
154151201|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151202|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151203|NCT05324891|Analgesics|analgesics|mesh-ancestor
154151204|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
154151205|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151206|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154151269|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151270|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151271|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154151272|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
154151273|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
154151274|NCT04060979|Protective Agents|protective agents|mesh-ancestor
154151275|NCT00458302|Darunavir|darunavir|mesh-list
154151276|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154151277|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154151278|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
154151279|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151280|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151281|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154151282|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154151283|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
154151284|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151285|NCT00444106|Artesunate|artesunate|mesh-list
154151286|NCT00444106|Lumefantrine|lumefantrine|mesh-list
154151287|NCT00444106|Artemether|artemether|mesh-list
154151288|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154151289|NCT00444106|Mefloquine|mefloquine|mesh-list
154151290|NCT00444106|Atovaquone|atovaquone|mesh-list
154151291|NCT00444106|Proguanil|proguanil|mesh-list
154151292|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
154151293|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
154151294|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154151295|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154151296|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151297|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151298|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
154151299|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
154151300|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154151301|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
154151302|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151303|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151305|NCT00561470|Leucovorin|leucovorin|mesh-list
154151311|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151312|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154151313|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151314|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151315|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
154151316|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151317|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154151318|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154151319|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151320|NCT00561470|Antidotes|antidotes|mesh-ancestor
153531643|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
154151321|NCT00561470|Protective Agents|protective agents|mesh-ancestor
154151322|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
154151323|NCT00561470|Vitamins|vitamins|mesh-ancestor
154151324|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
154151325|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154151326|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154151327|NCT00561470|Growth Substances|growth substances|mesh-ancestor
154151328|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
154151329|NCT00443872|Selegiline|selegiline|mesh-list
154151330|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
154151331|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154151332|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154151333|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154151334|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154151335|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151336|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151340|NCT01323244|Simeprevir|simeprevir|mesh-list
154151358|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151359|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151360|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151361|NCT00561392|Rivastigmine|rivastigmine|mesh-list
154151362|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154151363|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151364|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151365|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
154151370|NCT00694109|Mipomersen|mipomersen|mesh-list
154151422|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151423|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
154151424|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151425|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151426|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154151427|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
154151428|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151429|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151430|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154151431|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154151437|NCT03817853|Hormones|hormones|mesh-ancestor
154151486|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151487|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151489|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154151490|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154151491|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151492|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154151493|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154151494|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151495|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
154151550|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154151551|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151552|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151553|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
154151554|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151555|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154151556|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
154151557|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154151558|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154151559|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154151560|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151561|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154151562|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154151563|NCT00950066|Amlodipine|amlodipine|mesh-list
154151564|NCT00950066|Irbesartan|irbesartan|mesh-list
154151565|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154151566|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154151567|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154151568|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151569|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154151570|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151571|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
154151572|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154151573|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154151574|NCT01031212|Acetic Acid|acetic acid|mesh-list
154151575|NCT01031212|Paclitaxel|paclitaxel|mesh-list
154151576|NCT01031212|Carboplatin|carboplatin|mesh-list
154151577|NCT01031212|Cetuximab|cetuximab|mesh-list
154151578|NCT01031212|Vadimezan|vadimezan|mesh-list
154151579|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154151580|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151581|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
154151582|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
154151583|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
154151584|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646771|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154151585|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151586|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154151587|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151588|NCT01024348|Acetaminophen|acetaminophen|mesh-list
154151589|NCT01024348|Tramadol|tramadol|mesh-list
154151590|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151591|NCT01024348|Analgesics|analgesics|mesh-ancestor
154151592|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
154151593|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151594|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151595|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
154151596|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154151597|NCT01024348|Narcotics|narcotics|mesh-ancestor
154151598|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151599|NCT03994744|Metformin|metformin|mesh-list
154151600|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154151601|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154151602|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151603|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151604|NCT03994744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151605|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151606|NCT00950222|Imipenem|imipenem|mesh-list
154151607|NCT00950222|Amikacin|amikacin|mesh-list
154151608|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154151609|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151610|NCT05301530|Docetaxel|docetaxel|mesh-list
154151611|NCT05301530|Trastuzumab|trastuzumab|mesh-list
154151612|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151618|NCT00941174|Leucovorin|leucovorin|mesh-list
154151633|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151634|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
154151635|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154151636|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151637|NCT00941252|Imiquimod|imiquimod|mesh-list
154151638|NCT00941252|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154151639|NCT00941252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151640|NCT00941252|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154151641|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
154151642|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151643|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154151644|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151645|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
154151646|NCT01031368|Cytarabine|cytarabine|mesh-list
154151647|NCT01031368|Clofarabine|clofarabine|mesh-list
154151648|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154151649|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
154151650|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151651|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151652|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
154151653|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151654|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151655|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
154151656|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151657|NCT00945308|Eptifibatide|eptifibatide|mesh-list
154151683|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151684|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151685|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154151686|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154151687|NCT01024504|Growth Substances|growth substances|mesh-ancestor
154151688|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151689|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
154151690|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154151691|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
153911677|NCT00942994|Diuretics|diuretics|mesh-ancestor
154151692|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151693|NCT01030120|Etanercept|etanercept|mesh-list
154151694|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154151695|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151696|NCT01030120|Analgesics|analgesics|mesh-ancestor
154151697|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
154151698|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151699|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151700|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151701|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151702|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154151703|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151704|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
154151705|NCT00951236|Cortisone|cortisone|mesh-list
154151706|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151707|NCT00945542|Hemostatics|hemostatics|mesh-list
154151708|NCT00945542|Coagulants|coagulants|mesh-ancestor
154151709|NCT00438256|Capecitabine|capecitabine|mesh-list
154151710|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154151711|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
154151712|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151713|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151714|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154151715|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154151716|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
154151717|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151721|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151722|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151723|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
154151724|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151725|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154151726|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151728|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154151729|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154151730|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154151733|NCT04813822|Miconazole|miconazole|mesh-list
154151783|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
154151784|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154151785|NCT00942344|Losartan|losartan|mesh-list
154151786|NCT00942344|Amlodipine|amlodipine|mesh-list
154151787|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154151852|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
154151853|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154151854|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151855|NCT00943358|Vaccines|vaccines|mesh-list
154151856|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
154151857|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151858|NCT00120289|Niacin|niacin|mesh-list
154151859|NCT00120289|Simvastatin|simvastatin|mesh-list
154151860|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154151861|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154151862|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
154151863|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151917|NCT00953550|Rocuronium|rocuronium|mesh-list
154151918|NCT00953550|Succinylcholine|succinylcholine|mesh-list
154151919|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154151920|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154151921|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153729722|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
154151922|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151923|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151924|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154151925|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154151926|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154151927|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151928|NCT00949026|Sirolimus|sirolimus|mesh-list
154151929|NCT00949026|Temsirolimus|temsirolimus|mesh-list
154151930|NCT00949026|MTOR Inhibitors|mtor inhibitors|mesh-list
154151931|NCT00949026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154151932|NCT00949026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151933|NCT00949026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151934|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151935|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
154151970|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154151971|NCT00943982|Interferons|interferons|mesh-list
154151972|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
154151973|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151974|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
154151975|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151976|NCT00548808|Insulin|insulin|mesh-list
154151977|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154151978|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
154151979|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
154151980|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154151981|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151982|NCT04011878|Mitomycins|mitomycins|mesh-list
154151983|NCT04011878|Mitomycin|mitomycin|mesh-list
154151984|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154151985|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151986|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
154151987|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151988|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154151989|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151990|NCT00954096|Nicotine|nicotine|mesh-list
154151991|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154151992|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
154151995|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154152024|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154152025|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152026|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152027|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154152028|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154152029|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154152030|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
154152031|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152032|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152033|NCT00946946|Mesalamine|mesalamine|mesh-list
154152034|NCT00946946|Azathioprine|azathioprine|mesh-list
154152035|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
154152036|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152037|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154152038|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152039|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154152040|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
154152041|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152042|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154152043|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154152044|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154152076|NCT00954902|Protective Agents|protective agents|mesh-ancestor
154152077|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152078|NCT01034020|Nicotine|nicotine|mesh-list
154152079|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154152080|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
154152081|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152082|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152083|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154152084|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154152085|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
154152086|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152087|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152088|NCT01032148|Panobinostat|panobinostat|mesh-list
154152089|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152090|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154152091|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152134|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152135|NCT00435994|Epinephrine|epinephrine|mesh-list
154152136|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154152137|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154152138|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
154152139|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152140|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152141|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152202|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
154152203|NCT01079455|Protective Agents|protective agents|mesh-ancestor
154152204|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154152205|NCT00549848|Cytarabine|cytarabine|mesh-list
154152206|NCT00549848|Dexamethasone|dexamethasone|mesh-list
154152207|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
154152208|NCT00549848|Prednisone|prednisone|mesh-list
154152209|NCT00549848|Prednisolone|prednisolone|mesh-list
154152210|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
154152211|NCT00549848|Doxorubicin|doxorubicin|mesh-list
154152212|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154152213|NCT00549848|Methotrexate|methotrexate|mesh-list
154152214|NCT00549848|Etoposide|etoposide|mesh-list
154152215|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
154152216|NCT00549848|Vincristine|vincristine|mesh-list
154152217|NCT00549848|Daunorubicin|daunorubicin|mesh-list
154152218|NCT00549848|Asparaginase|asparaginase|mesh-list
154152219|NCT00549848|Dasatinib|dasatinib|mesh-list
154152220|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
154152221|NCT00549848|Clofarabine|clofarabine|mesh-list
154152222|NCT00549848|Pegaspargase|pegaspargase|mesh-list
154152223|NCT00549848|Thioguanine|thioguanine|mesh-list
154152224|NCT00549848|BB 1101|bb 1101|mesh-list
154152225|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154152226|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
154152227|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152228|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154152229|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154152230|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
154152231|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152232|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152233|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154152234|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154152251|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154152252|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
154152253|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
154152254|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154152255|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154152256|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154152257|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
154152258|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152259|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
154152264|NCT01083589|Docetaxel|docetaxel|mesh-list
154152317|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152318|NCT00427960|Atorvastatin|atorvastatin|mesh-list
154152319|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154152320|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154152321|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154152322|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
154152323|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152324|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154152325|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154152326|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152327|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
154152328|NCT00955890|Razoxane|razoxane|mesh-list
154152329|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152330|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154152331|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154152332|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154152377|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154152378|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
153911794|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
154152379|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152380|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152381|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152382|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154152383|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154152384|NCT02565173|Analgesics|analgesics|mesh-ancestor
154152385|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
154152386|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152387|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
154152388|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154152389|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
154152390|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
154152391|NCT04619082|Tenofovir|tenofovir|mesh-list
154152392|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
154152393|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152394|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154152395|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154152396|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152397|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152398|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154152399|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154152400|NCT03717623|Posaconazole|posaconazole|mesh-list
154152414|NCT00095173|Abatacept|abatacept|mesh-list
154152424|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
154152425|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
154152426|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152427|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152428|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
154152429|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152430|NCT00690443|Atorvastatin|atorvastatin|mesh-list
154152431|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154152432|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154152433|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
154152434|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152435|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154152436|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154152437|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152438|NCT03954834|Tirzepatide|tirzepatide|mesh-list
154152439|NCT03954834|Incretins|incretins|mesh-ancestor
154152480|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152482|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
154152483|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152484|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
154152485|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154152486|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
154152487|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154152488|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
154152489|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154152546|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154152547|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154152548|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
154152549|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152550|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152551|NCT02564237|Vaccines|vaccines|mesh-list
154152552|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
154152553|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152554|NCT00427648|Lidocaine|lidocaine|mesh-list
154152555|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
154152556|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
154152557|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152558|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152559|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
154152560|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152561|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154152562|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154152563|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154152564|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154152602|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152603|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154152604|NCT00555620|Capecitabine|capecitabine|mesh-list
154152605|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
154152606|NCT00555620|Sunitinib|sunitinib|mesh-list
154152607|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152608|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154152609|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
154152610|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152611|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154152618|NCT00433966|Paclitaxel|paclitaxel|mesh-list
154152665|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152666|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154152668|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
154152669|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154152670|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154152671|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152672|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152673|NCT05300360|Adenosine|adenosine|mesh-list
154152674|NCT05300360|Analgesics|analgesics|mesh-ancestor
154152675|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
154152679|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
154152728|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154152729|NCT00955604|Protective Agents|protective agents|mesh-ancestor
154152730|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152731|NCT03623646|Immunomodulating Agents|immunomodulating agents|mesh-list
154152732|NCT03623646|Immunologic Factors|immunologic factors|mesh-ancestor
154152733|NCT03623646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152734|NCT00962286|Furosemide|furosemide|mesh-list
154152735|NCT00962286|Diuretics|diuretics|mesh-ancestor
154152736|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
154152737|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152738|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154152739|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154152790|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154152791|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154152792|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
154152793|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
154152795|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154152796|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154152797|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154152798|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152799|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152800|NCT00956306|Udenafil|udenafil|mesh-list
154152801|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154152802|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154152803|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152804|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152805|NCT00775229|Naltrexone|naltrexone|mesh-list
154152806|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154152807|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154152850|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
154152851|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152852|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153453599|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
154152853|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154152854|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154152855|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154152856|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152857|NCT00948272|Vaccines|vaccines|mesh-list
154152858|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
154152859|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152860|NCT00957554|Amlodipine|amlodipine|mesh-list
154152861|NCT00957554|Irbesartan|irbesartan|mesh-list
154152862|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154152863|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154152864|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154152865|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152905|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152907|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
154152908|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152909|NCT00741767|Fluticasone|fluticasone|mesh-list
154152910|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154152911|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154152912|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154152913|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154152914|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
154152915|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152916|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152917|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154152918|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
154152919|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
154152920|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154152921|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154152922|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154152923|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154152924|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
154152925|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152926|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152927|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
154152928|NCT00741767|Hormones|hormones|mesh-ancestor
154152929|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154152930|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
154152931|NCT00741845|Metronidazole|metronidazole|mesh-list
154152932|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152950|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152951|NCT00549302|Tadalafil|tadalafil|mesh-list
154152952|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
154152953|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154152954|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154152955|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152956|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152957|NCT00549302|Urological Agents|urological agents|mesh-ancestor
154152958|NCT00957866|Interferons|interferons|mesh-list
154152959|NCT00957866|Ribavirin|ribavirin|mesh-list
154152960|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152961|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
154152962|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152963|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
154152964|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152965|NCT00958022|Carboplatin|carboplatin|mesh-list
154152966|NCT00958022|Etoposide|etoposide|mesh-list
154152967|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
154152968|NCT00958022|Panobinostat|panobinostat|mesh-list
154152969|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
154152970|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152971|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154152972|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154152973|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154152974|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152975|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152976|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154152977|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
154152978|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
154152979|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
154152980|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152981|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152982|NCT00958100|Tenofovir|tenofovir|mesh-list
154152983|NCT00958100|Lamivudine|lamivudine|mesh-list
154152984|NCT00958100|Emtricitabine|emtricitabine|mesh-list
154152991|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154152992|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152993|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152994|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154152995|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154152996|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154152997|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154152998|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
154152999|NCT00948584|Insulin|insulin|mesh-list
154153000|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154153001|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
154153002|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154153003|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153004|NCT00948662|Ketoconazole|ketoconazole|mesh-list
154153052|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153053|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154153054|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153055|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153057|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154153058|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153059|NCT00108355|Octreotide|octreotide|mesh-list
154153060|NCT00108355|Midodrine|midodrine|mesh-list
154153116|NCT00963534|Rituximab|rituximab|mesh-list
154153117|NCT00963534|Lenalidomide|lenalidomide|mesh-list
154153118|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154153119|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153120|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153121|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
154153122|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153123|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154153124|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154153125|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154153126|NCT00963534|Growth Substances|growth substances|mesh-ancestor
154153127|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
154153128|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154153129|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
154153130|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153133|NCT01079767|Sirolimus|sirolimus|mesh-list
154153174|NCT00963846|Protective Agents|protective agents|mesh-ancestor
154153175|NCT00969696|Galantamine|galantamine|mesh-list
154153176|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154153177|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153178|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153179|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
154153180|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153181|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153182|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154153183|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
154153184|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153185|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
154153237|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153238|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153239|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153240|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
153533576|NCT01506895|Darapladib|darapladib|mesh-list
154153241|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153242|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153243|NCT00426556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154153244|NCT00426556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154153245|NCT00426556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153300|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154153302|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154153303|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154153304|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
154153305|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153306|NCT00746681|Urological Agents|urological agents|mesh-ancestor
154153307|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
154153308|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154153309|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153310|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154153311|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154153312|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
154153313|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153314|NCT00749099|Pancrelipase|pancrelipase|mesh-list
154153315|NCT00749099|Pancreatin|pancreatin|mesh-list
154153316|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154153317|NCT00959400|Fentanyl|fentanyl|mesh-list
154153318|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154153354|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154153355|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154153356|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154153357|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
154153358|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
154153359|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
154153360|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153361|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154153362|NCT02562287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154153363|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154153417|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154153418|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
154153419|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154153420|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154153421|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154153422|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154153423|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154153424|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154153425|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154153427|NCT00744887|Darunavir|darunavir|mesh-list
154153480|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153481|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153482|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153483|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
154153484|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
154153485|NCT00949442|Insulin|insulin|mesh-list
154153486|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154153487|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
154153488|NCT00949442|Glimepiride|glimepiride|mesh-list
154153489|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154153490|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153491|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154153492|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153493|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
154153494|NCT00749723|Carboplatin|carboplatin|mesh-list
154153495|NCT00749723|Etoposide|etoposide|mesh-list
154153496|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
154153497|NCT00749723|Temozolomide|temozolomide|mesh-list
154153498|NCT00749723|Thiotepa|thiotepa|mesh-list
154153499|NCT00749723|Trofosfamide|trofosfamide|mesh-list
154153500|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
154153501|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153502|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154153514|NCT00547248|Vaccines|vaccines|mesh-list
154153534|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154153535|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154153536|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153533879|NCT01508286|Ribavirin|ribavirin|mesh-list
154153537|NCT00688103|Analgesics|analgesics|mesh-ancestor
154153538|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
154153539|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153540|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154153541|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154153543|NCT00949598|Letrozole|letrozole|mesh-list
154153544|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153545|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153546|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154153547|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154153548|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153549|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154153550|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
154153551|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153552|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153553|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154153554|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154153555|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154153556|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154153557|NCT00964704|Bevacizumab|bevacizumab|mesh-list
154153558|NCT00964704|Trastuzumab|trastuzumab|mesh-list
154153559|NCT00964704|Docetaxel|docetaxel|mesh-list
154153560|NCT00964704|Capecitabine|capecitabine|mesh-list
154153561|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153562|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153563|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154153564|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154153565|NCT00964704|Growth Substances|growth substances|mesh-ancestor
154153566|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153567|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
154153568|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153571|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153572|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154153573|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
154153574|NCT00686855|Dexamethasone|dexamethasone|mesh-list
154153575|NCT00686855|Tacrolimus|tacrolimus|mesh-list
154153576|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154153577|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
154153578|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
154153579|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153580|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153581|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154153582|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
154153583|NCT00686855|Hormones|hormones|mesh-ancestor
154153584|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153585|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154153586|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153587|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153588|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
154153589|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154153590|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153591|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153624|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
154153625|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154153626|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153627|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
154153628|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153629|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
154153630|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153631|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
154153632|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153633|NCT04009772|Metronidazole|metronidazole|mesh-list
154153634|NCT04009772|Cefepime|cefepime|mesh-list
154153635|NCT04009772|Cefuroxime|cefuroxime|mesh-list
154153636|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
154153637|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153638|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153639|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154153640|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154153641|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154153642|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154153643|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153644|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154153645|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
154153646|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
154153647|NCT01563068|Calcipotriene|calcipotriene|mesh-list
154153649|NCT00747305|Sunitinib|sunitinib|mesh-list
154153674|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
154153675|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153676|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153677|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154153678|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153679|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
154153680|NCT00106639|Tacrolimus|tacrolimus|mesh-list
154153682|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153683|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
154153684|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153685|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154153686|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153687|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153688|NCT00106639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154153689|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154153690|NCT00747539|Interferons|interferons|mesh-list
154153691|NCT00747539|Ribavirin|ribavirin|mesh-list
154153692|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
154153693|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153694|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
154153695|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153696|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
154153697|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153698|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
154153699|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153700|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
154153701|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153702|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154153703|NCT00962234|Protective Agents|protective agents|mesh-ancestor
154153704|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153705|NCT00747695|Rabeprazole|rabeprazole|mesh-list
154153706|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154153711|NCT00959972|Nicotine|nicotine|mesh-list
154153717|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154153718|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154153719|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
154153720|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153721|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153722|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
154153723|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154153724|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153725|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
154153726|NCT00960284|Gemcitabine|gemcitabine|mesh-list
154153727|NCT00960284|Capecitabine|capecitabine|mesh-list
154153728|NCT00960284|Fluorouracil|fluorouracil|mesh-list
154153729|NCT00960284|Epirubicin|epirubicin|mesh-list
154153730|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153731|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154153732|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
154153733|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153734|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153735|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
154153736|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153737|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154153738|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154153739|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154153740|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153741|NCT00105469|Tobramycin|tobramycin|mesh-list
154153742|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153743|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153744|NCT00962312|Capecitabine|capecitabine|mesh-list
154153745|NCT00962312|Lapatinib|lapatinib|mesh-list
154153746|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154153747|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
154153748|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153749|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153750|NCT00962312|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154153751|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154153752|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153753|NCT00960518|Adefovir|adefovir|mesh-list
154153754|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
154153755|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153756|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154153757|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154153758|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153759|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153761|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
154153762|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154153763|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153534099|NCT01509521|Phenylephrine|phenylephrine|mesh-list
154153819|NCT01087099|Albendazole|albendazole|mesh-list
154153820|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
154153821|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154153822|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153823|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
154153824|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154153825|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154153826|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153827|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153828|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
154153829|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153830|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153831|NCT00686543|Posaconazole|posaconazole|mesh-list
154153832|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
154153833|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153834|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154153835|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154153836|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154153837|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154153838|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154153839|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153846|NCT00750113|Nifedipine|nifedipine|mesh-list
154153872|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
154153873|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153874|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153876|NCT00502203|Carboplatin|carboplatin|mesh-list
154153877|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154153878|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153879|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153880|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153881|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
154153882|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153883|NCT00546078|Vaccines|vaccines|mesh-list
154153884|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
154153885|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153934|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153935|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153936|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154153937|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154153938|NCT00968240|Growth Substances|growth substances|mesh-ancestor
154153939|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153940|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
154153941|NCT00501969|Rotigotine|rotigotine|mesh-list
154153942|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
154153943|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
154153944|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153945|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153946|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153995|NCT00104299|Hormones|hormones|mesh-ancestor
154153996|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153997|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154153998|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
154153999|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
154154000|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154001|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154002|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154154003|NCT00104299|Protective Agents|protective agents|mesh-ancestor
154154004|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
154154007|NCT00082381|Exenatide|exenatide|mesh-list
154154061|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154154062|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153477616|NCT04955678|Sorbitol|sorbitol|mesh-list
154154063|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154154064|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154154065|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154154066|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
154154067|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154154068|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154154069|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154154070|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154071|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154072|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154154073|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154154074|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154154075|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154154076|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
154154077|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
153912048|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154078|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154154079|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154154080|NCT00964106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154154081|NCT00964106|Narcotics|narcotics|mesh-ancestor
154154082|NCT00964106|Analgesics|analgesics|mesh-ancestor
154154083|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
154154084|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154085|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154154090|NCT00960336|Doxorubicin|doxorubicin|mesh-list
154154103|NCT00545844|Montelukast|montelukast|mesh-list
154154104|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154154105|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
154154106|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154154107|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154108|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154109|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154110|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154154111|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154154112|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154113|NCT01084993|Heparin|heparin|mesh-list
154154114|NCT01084993|Bivalirudin|bivalirudin|mesh-list
154154115|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
154154116|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154154117|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154154118|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154119|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
154154120|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154154121|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
154154122|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154123|NCT00492063|Vaccines|vaccines|mesh-list
154154124|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
154154125|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154126|NCT00960492|Temozolomide|temozolomide|mesh-list
154154127|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154154128|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
154154129|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154130|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154131|NCT00971724|Prednisolone|prednisolone|mesh-list
154154132|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154133|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
154154134|NCT00971724|Hormones|hormones|mesh-ancestor
154154135|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154136|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154137|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153663973|NCT00010322|Toremifene|toremifene|mesh-list
153646487|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154138|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154140|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154154142|NCT02976909|Fluorouracil|fluorouracil|mesh-list
154154143|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154154144|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154145|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
154154146|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
154154147|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
154154148|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154149|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
154154150|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154154151|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154152|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
154154153|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154154|NCT02878083|Adalimumab|adalimumab|mesh-list
154154155|NCT02878083|Vedolizumab|vedolizumab|mesh-list
154154156|NCT02878083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154154157|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154158|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154159|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154160|NCT00093145|Paclitaxel|paclitaxel|mesh-list
154154161|NCT00093145|Carboplatin|carboplatin|mesh-list
154154162|NCT00093145|Trastuzumab|trastuzumab|mesh-list
154154163|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154154164|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154154165|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154166|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
154154167|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
154154168|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
154154169|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154170|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154154183|NCT00960960|Letrozole|letrozole|mesh-list
154154184|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154154185|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154186|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
154154187|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
154154188|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
154154189|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154190|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154154191|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153453826|NCT01720602|Anastrozole|anastrozole|mesh-list
154154192|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154154193|NCT00960960|Growth Substances|growth substances|mesh-ancestor
154154194|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154195|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
154154196|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154154197|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154154198|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154199|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154154200|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154201|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154202|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
154154203|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154154204|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154154205|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154206|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
154154207|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154208|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154209|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
154154210|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154154211|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154212|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154154213|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154154214|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154215|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154219|NCT00961194|Ketamine|ketamine|mesh-list
154154221|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
154154222|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154223|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154224|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154154225|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154154226|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
154154227|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
154154228|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154154229|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154154230|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154154231|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154232|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154233|NCT05279586|Colistin|colistin|mesh-list
154154234|NCT05279586|Lactulose|lactulose|mesh-list
154154235|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154236|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154154237|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154238|NCT00965796|Lidocaine|lidocaine|mesh-list
154154239|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
154154240|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
154154241|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154154242|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154243|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
154154244|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154245|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154154246|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154154247|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154154248|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154154249|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154250|NCT00415636|Pemetrexed|pemetrexed|mesh-list
154154251|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154252|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154253|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154254|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154154255|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154154256|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
154154257|NCT00965874|Analgesics|analgesics|mesh-ancestor
154154258|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
154154259|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154260|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154261|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
154154262|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154154263|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154154264|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
154154265|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154154266|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154154267|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154268|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154154269|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
154154270|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154154271|NCT00972426|Timolol|timolol|mesh-list
154154272|NCT00972426|Carteolol|carteolol|mesh-list
154154273|NCT00972426|Latanoprost|latanoprost|mesh-list
154154274|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154154275|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154154276|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
154154277|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154278|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154279|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477846|NCT04033419|Memantine|memantine|mesh-list
154154307|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154154308|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154154309|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154154310|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
154154311|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154154312|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154154313|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154154314|NCT04008966|Cetrorelix|cetrorelix|mesh-list
154154315|NCT04008966|Progesterone|progesterone|mesh-list
154154316|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154154317|NCT04008966|Progestins|progestins|mesh-ancestor
154154318|NCT04008966|Hormones|hormones|mesh-ancestor
154154319|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154320|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154321|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
154154322|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154154323|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
154154324|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154154325|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154154326|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154327|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154328|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154154329|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
154154330|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154331|NCT00425854|Afatinib|afatinib|mesh-list
154154332|NCT00425854|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154154333|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154154334|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154336|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154353|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
154154354|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154355|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154154356|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154154357|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154358|NCT00973986|Atorvastatin|atorvastatin|mesh-list
153534698|NCT01512485|Clopidogrel|clopidogrel|mesh-list
154154359|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154154360|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154154361|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
154154362|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154363|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154154364|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154154365|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154366|NCT00966576|Timolol|timolol|mesh-list
154154367|NCT00966576|Brinzolamide|brinzolamide|mesh-list
154154368|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154369|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154370|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154154371|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154154372|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
154154373|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154374|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154375|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154154376|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154154377|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154154402|NCT04008888|Melphalan|melphalan|mesh-list
154154403|NCT04008888|BB 1101|bb 1101|mesh-list
154154404|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154405|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
154154406|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
154154407|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154408|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154409|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154410|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
154154411|NCT04008888|Hormones|hormones|mesh-ancestor
154154412|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154413|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154414|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154415|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154154416|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154417|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154418|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154419|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
154154455|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154154457|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
154154458|NCT00979836|Coagulants|coagulants|mesh-ancestor
154154459|NCT01588912|Tenofovir|tenofovir|mesh-list
154154460|NCT01588912|Entecavir|entecavir|mesh-list
154154461|NCT01588912|Telbivudine|telbivudine|mesh-list
154154462|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
154154463|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154464|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154154465|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154154466|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154467|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154468|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153912142|NCT05381038|Docetaxel|docetaxel|mesh-list
154154469|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154154470|NCT00432562|Vinorelbine|vinorelbine|mesh-list
154154471|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154154472|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154473|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
154154474|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154154475|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
154154477|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
153729726|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154508|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154154509|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154154510|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154154511|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154512|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154154513|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154154514|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154154515|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154516|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154517|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154518|NCT01034410|Cytarabine|cytarabine|mesh-list
154154519|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154154520|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
154154521|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154522|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154523|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
154154524|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154525|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154526|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
154154527|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154528|NCT00415168|Pemetrexed|pemetrexed|mesh-list
154154529|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154530|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154534|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
154154555|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154154556|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
154154557|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154558|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154154559|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154154560|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154561|NCT00967512|Cytarabine|cytarabine|mesh-list
154154562|NCT00967512|Idarubicin|idarubicin|mesh-list
154154563|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154154564|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
154157507|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154565|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154566|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154567|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
154154568|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154569|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154570|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
154154571|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154572|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154154573|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154154575|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154576|NCT04082910|Infliximab|infliximab|mesh-list
154154577|NCT04082910|Etanercept|etanercept|mesh-list
154154578|NCT04082910|Metoprolol|metoprolol|mesh-list
154154579|NCT04082910|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154154580|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154581|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
154154582|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154583|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154584|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154154585|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154154586|NCT04082910|Analgesics|analgesics|mesh-ancestor
154154587|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
154154588|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154598|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154154599|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
154154600|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154601|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154603|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154604|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
154154605|NCT00975078|Hormones|hormones|mesh-ancestor
154154606|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154607|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154608|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154609|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154610|NCT00980616|Ropivacaine|ropivacaine|mesh-list
154154611|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
154154612|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
154154613|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729727|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154154656|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
154154657|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912190|NCT01183104|Glimepiride|glimepiride|mesh-list
154154658|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154659|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154154660|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
154154661|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
154154662|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154154663|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
154154664|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154665|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154666|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154154667|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154154668|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154154669|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
154154671|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
154154672|NCT04974996|Rituximab|rituximab|mesh-list
154154673|NCT04974996|Doxorubicin|doxorubicin|mesh-list
154154674|NCT04974996|Vincristine|vincristine|mesh-list
154154675|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154154676|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154677|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
154154678|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154679|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154680|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154154681|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
154154682|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154683|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154684|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154154685|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154154686|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154154687|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154154688|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154154689|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154690|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154692|NCT04974996|Hormones|hormones|mesh-ancestor
154154693|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154694|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154695|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154154696|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
153912203|NCT02885688|Insulin|insulin|mesh-list
154154697|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
154154698|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
154154699|NCT00981006|Mitogens|mitogens|mesh-list
154154700|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
154154701|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154702|NCT00975390|Caffeine|caffeine|mesh-list
154154703|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154154704|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154705|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154154706|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154707|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154708|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154154709|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154154710|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
154154711|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154712|NCT00981318|Ritonavir|ritonavir|mesh-list
154154713|NCT00981318|Lopinavir|lopinavir|mesh-list
154154714|NCT00981318|Maraviroc|maraviroc|mesh-list
154154715|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154154716|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154154717|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
154154718|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154720|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154154738|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
154154739|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154740|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154741|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154742|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
154154743|NCT00984984|Hormones|hormones|mesh-ancestor
154154744|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154745|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154154746|NCT00984984|Protective Agents|protective agents|mesh-ancestor
154154747|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154748|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154749|NCT00545532|Oseltamivir|oseltamivir|mesh-list
154154750|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
154154751|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154752|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154753|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154754|NCT00544440|Prednisone|prednisone|mesh-list
154154755|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
154154756|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154757|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
154154758|NCT00544440|Hormones|hormones|mesh-ancestor
154154759|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154760|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154761|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154762|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154763|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154154764|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154765|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154766|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154782|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154783|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
154154784|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
154154785|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154786|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154787|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
154154788|NCT00981708|Hormones|hormones|mesh-ancestor
154154789|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154790|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154791|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
154154792|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154793|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154154794|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154154795|NCT00981708|Growth Substances|growth substances|mesh-ancestor
154154796|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
154154797|NCT00981786|Timolol|timolol|mesh-list
154154798|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154154800|NCT00981786|Brinzolamide|brinzolamide|mesh-list
154154801|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154154802|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154154803|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
154154804|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729728|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
154154805|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154806|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154807|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154154808|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154154809|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154154810|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154154811|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154154812|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154154813|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154814|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
154154815|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
154154816|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154154817|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154154819|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154820|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154821|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154822|NCT00985374|Everolimus|everolimus|mesh-list
154154823|NCT00985374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154154824|NCT00985374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154154825|NCT00985374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154826|NCT00985374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154827|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154828|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
154154829|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154830|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154831|NCT00975936|Ketoconazole|ketoconazole|mesh-list
154154832|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
154154833|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154834|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154154835|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154154836|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154837|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154838|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154154839|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154840|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154841|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154842|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154154843|NCT00976092|Heparin|heparin|mesh-list
154154844|NCT00976092|Calcium heparin|calcium heparin|mesh-list
154154845|NCT00976092|Bivalirudin|bivalirudin|mesh-list
154154846|NCT00976092|Clopidogrel|clopidogrel|mesh-list
154154847|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154154856|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
154154863|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
154154864|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154865|NCT04006470|Fluorides|fluorides|mesh-list
154154866|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
154154867|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
154154868|NCT04006470|Protective Agents|protective agents|mesh-ancestor
154154869|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154870|NCT01323712|Vitamin D|vitamin d|mesh-list
154154871|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
154154872|NCT01323712|Vitamins|vitamins|mesh-ancestor
154154873|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
154154874|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154875|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154154876|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153535215|NCT01515579|Incretins|incretins|mesh-ancestor
154154877|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
154154878|NCT00981942|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154154879|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154154880|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154881|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154882|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154883|NCT00976170|Sorafenib|sorafenib|mesh-list
154154884|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154885|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154154886|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154887|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154888|NCT00982254|Insulin|insulin|mesh-list
154154889|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154154890|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154154891|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154892|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154154893|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154154894|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154895|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
154154896|NCT00976326|Insulin|insulin|mesh-list
154154903|NCT00982332|Hormones|hormones|mesh-ancestor
154154904|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154905|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154906|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154154907|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
154154908|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
154154909|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154154910|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154154911|NCT04007328|Prednisolone|prednisolone|mesh-list
154154912|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
154154913|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154154914|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
154154915|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154916|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
154154917|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
154154918|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154919|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154920|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154921|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
154154922|NCT04007328|Hormones|hormones|mesh-ancestor
154154923|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154924|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154154925|NCT04007328|Protective Agents|protective agents|mesh-ancestor
154154926|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154927|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154928|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
154154929|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154154930|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154154931|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154932|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
154154933|NCT00985920|Coagulants|coagulants|mesh-ancestor
154154947|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154948|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154154949|NCT00976794|Analgesics|analgesics|mesh-ancestor
154154950|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
154154951|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154952|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154154953|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154154954|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154154955|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154154956|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
154154957|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154154958|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154959|NCT00982566|Navitoclax|navitoclax|mesh-list
154154960|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154961|NCT00977028|Lidocaine|lidocaine|mesh-list
154154962|NCT00977028|Epinephrine|epinephrine|mesh-list
154154963|NCT00977028|Racepinephrine|racepinephrine|mesh-list
154154964|NCT00977028|Anesthetics|anesthetics|mesh-list
154154965|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
154154966|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
154154967|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154154968|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154969|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
154154970|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154971|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154154972|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154154973|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154154974|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154154975|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154976|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154154977|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154154978|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
154154979|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154980|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154154981|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154154982|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
154154984|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
154154985|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
154154986|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
154154987|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154154988|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
154154989|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
154154990|NCT00982722|Vitamin D|vitamin d|mesh-list
154154991|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
154154992|NCT00982722|Calcium|calcium|mesh-list
154154993|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154154994|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154995|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154154996|NCT00982722|Vitamins|vitamins|mesh-ancestor
154154997|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
154154998|NCT00982722|Antacids|antacids|mesh-ancestor
154154999|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155000|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154155001|NCT00982800|Gabapentin|gabapentin|mesh-list
154155002|NCT00982800|Analgesics|analgesics|mesh-ancestor
154155003|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
154155004|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155005|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155006|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
154155007|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154155008|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155009|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155010|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155011|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154155012|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154155013|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155014|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155015|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
154155016|NCT00986076|Enoxaparin|enoxaparin|mesh-list
154155017|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
154155018|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154155019|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154155026|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
154155027|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155028|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454031|NCT01691508|Prednisone|prednisone|mesh-list
154155029|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154155030|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155031|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155032|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154155033|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154155034|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154155035|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154155036|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154155037|NCT00983112|Thrombin|thrombin|mesh-list
154155038|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
154155039|NCT00983112|Coagulants|coagulants|mesh-ancestor
154155040|NCT00986466|Vitamin D|vitamin d|mesh-list
154155041|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
154155042|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
154155043|NCT00986466|Vitamins|vitamins|mesh-list
154155044|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
154155045|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155046|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154155047|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154155048|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
154155049|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154155050|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
154155051|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155052|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155053|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154155054|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
154155055|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154155056|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
154155057|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155067|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155068|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155069|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154155070|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155072|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
154155073|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
154155074|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155075|NCT00983424|Cyclosporine|cyclosporine|mesh-list
154155076|NCT00983424|Paclitaxel|paclitaxel|mesh-list
154155077|NCT00983424|Cyclosporins|cyclosporins|mesh-list
154155078|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154155079|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155080|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
154155081|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
154155082|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
154155083|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155084|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155085|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154155086|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
154155087|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155088|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
154155089|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155090|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
154155091|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155092|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154155093|NCT00983736|Tramadol|tramadol|mesh-list
154155094|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154155095|NCT00983736|Narcotics|narcotics|mesh-ancestor
154155096|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155097|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155098|NCT00983736|Analgesics|analgesics|mesh-ancestor
154155100|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155101|NCT00986778|Lamivudine|lamivudine|mesh-list
154155102|NCT00986778|Adefovir|adefovir|mesh-list
154155103|NCT00986778|Entecavir|entecavir|mesh-list
154155104|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154155105|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154155106|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155107|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155108|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
154155109|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155110|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154155111|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154155112|NCT00429364|Losartan|losartan|mesh-list
154155113|NCT00429364|Atenolol|atenolol|mesh-list
154155114|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154155115|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154155116|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154155117|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154155118|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155119|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
154155120|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
154155121|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155122|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155123|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154155124|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154155125|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154155126|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
154155127|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155128|NCT00978354|Furosemide|furosemide|mesh-list
154155129|NCT00978354|Diuretics|diuretics|mesh-ancestor
154155130|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
154155131|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155132|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154155133|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154155134|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155135|NCT00984360|Naltrexone|naltrexone|mesh-list
154155136|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154155137|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154155138|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155145|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155146|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154155147|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
154155148|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
154155149|NCT01037608|Nabiximols|nabiximols|mesh-list
154155150|NCT01037608|Analgesics|analgesics|mesh-ancestor
154155151|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
154155152|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155153|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155154|NCT04006080|Vedolizumab|vedolizumab|mesh-list
154155155|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154155156|NCT00984438|Bevacizumab|bevacizumab|mesh-list
154155157|NCT00984438|Irinotecan|irinotecan|mesh-list
154155158|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154155159|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155160|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154155161|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154155162|NCT00984438|Growth Substances|growth substances|mesh-ancestor
154155163|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155164|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
154155165|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154155166|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154155167|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155168|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155169|NCT00424372|Pregabalin|pregabalin|mesh-list
154155170|NCT00424372|Analgesics|analgesics|mesh-ancestor
154155171|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
154155172|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155173|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155174|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
154155175|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154155189|NCT00978978|Propofol|propofol|mesh-list
154155190|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154155191|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155192|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155193|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154155194|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
154155195|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
154155196|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154155197|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154155198|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155199|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155200|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
154155201|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
154155202|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155203|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155204|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154155205|NCT00978978|Narcotics|narcotics|mesh-ancestor
154155206|NCT00978978|Analgesics|analgesics|mesh-ancestor
154155207|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
154155208|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155209|NCT00414310|Decitabine|decitabine|mesh-list
154155210|NCT00414310|Valproic Acid|valproic acid|mesh-list
154155217|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
154155243|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154155244|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154155245|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
154155246|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155247|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155248|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
154155249|NCT00414076|Letrozole|letrozole|mesh-list
154155250|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155251|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154155252|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154155253|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155254|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155255|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154155256|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
154155257|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154155258|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155260|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154155261|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154155262|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154155263|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154155296|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154155297|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155298|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155299|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
154155300|NCT00987636|Diphosphonates|diphosphonates|mesh-list
154155302|NCT00987636|Treosulfan|treosulfan|mesh-list
154155303|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
154155304|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155305|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154155306|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
154155307|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155308|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154155309|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155310|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154155311|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154155312|NCT00424294|Celecoxib|celecoxib|mesh-list
154155313|NCT00424294|Methotrexate|methotrexate|mesh-list
154155314|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154155315|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
154155316|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154155317|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155318|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154155319|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
154155320|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155321|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155322|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
154155323|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155342|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154155343|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154155344|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155345|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155346|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155347|NCT00988728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154155348|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154155349|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154155350|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155351|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155352|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
154155353|NCT00988806|Simendan|simendan|mesh-list
154155354|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154155355|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
154155356|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154155357|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154155358|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155359|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155360|NCT00988806|Protective Agents|protective agents|mesh-ancestor
154155361|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155362|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
154155363|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
154155364|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154155365|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154155366|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155367|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155368|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155369|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155370|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
154155371|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154155372|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155382|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155383|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154155384|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154155385|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154155386|NCT00987870|Betamethasone|betamethasone|mesh-list
154155387|NCT00987870|Calcipotriene|calcipotriene|mesh-list
154155388|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155389|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
154155390|NCT00987870|Hormones|hormones|mesh-ancestor
154155391|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154155392|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155393|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154155394|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
154155395|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
153800811|NCT00283985|Hormones|hormones|mesh-ancestor
154155396|NCT00988026|Minocycline|minocycline|mesh-list
154155397|NCT00988026|Lymecycline|lymecycline|mesh-list
154155398|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155399|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155400|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
154155401|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154155402|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155403|NCT05578170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154155404|NCT05578170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155406|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
154155407|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155408|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154155409|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154155424|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
154155425|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155426|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154157508|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155427|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154155428|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155429|NCT04005612|Vitamin D|vitamin d|mesh-list
154155430|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
154155431|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
154155432|NCT04005612|Vitamins|vitamins|mesh-list
154155433|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
154155434|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155435|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154155436|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154155437|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
154155438|NCT00413920|Prednisone|prednisone|mesh-list
154155439|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155440|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
154155441|NCT00413920|Hormones|hormones|mesh-ancestor
154155442|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154155443|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155444|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154155445|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155446|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154155447|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154155448|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
154155451|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155473|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154155474|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154155475|NCT05919797|Naltrexone|naltrexone|mesh-list
154155476|NCT05919797|Bupropion|bupropion|mesh-list
154155477|NCT05919797|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154155478|NCT05919797|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154155479|NCT05919797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155480|NCT05919797|Sensory System Agents|sensory system agents|mesh-ancestor
154155481|NCT05919797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155482|NCT05919797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154155483|NCT05919797|Antidepressive Agents|antidepressive agents|mesh-ancestor
154155484|NCT05919797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155485|NCT05919797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154155486|NCT05919797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154155487|NCT05919797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154155488|NCT05919797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155489|NCT05919797|Dopamine Agents|dopamine agents|mesh-ancestor
154155490|NCT05919797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155491|NCT05919797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154155492|NCT05919797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154155493|NCT05919797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155494|NCT05919732|Epinephrine|epinephrine|mesh-list
154155495|NCT05919732|Bupivacaine|bupivacaine|mesh-list
154155496|NCT05919732|Anesthetics, Local|anesthetics, local|mesh-ancestor
154155497|NCT05919732|Anesthetics|anesthetics|mesh-ancestor
154155498|NCT05919732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155499|NCT05919732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155500|NCT05919732|Sensory System Agents|sensory system agents|mesh-ancestor
154155501|NCT05919732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155502|NCT05919732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154155503|NCT05919732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154155504|NCT05919732|Adrenergic Agents|adrenergic agents|mesh-ancestor
154155514|NCT05919732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154155516|NCT05919615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154155517|NCT05919615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154155518|NCT05919615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155519|NCT05919615|Hemostatics|hemostatics|mesh-ancestor
154155520|NCT05919615|Coagulants|coagulants|mesh-ancestor
154155521|NCT05919550|Clozapine|clozapine|mesh-list
154155522|NCT05919550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154155523|NCT05919550|Serotonin Agents|serotonin agents|mesh-ancestor
154155524|NCT05919550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155525|NCT05919550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155526|NCT05919550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155527|NCT05919550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154155528|NCT05919550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155529|NCT05919550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155530|NCT05919550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155531|NCT05919550|GABA Antagonists|gaba antagonists|mesh-ancestor
154155532|NCT05919550|GABA Agents|gaba agents|mesh-ancestor
154155533|NCT05919407|Amifampridine|amifampridine|mesh-list
154155534|NCT05919407|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154155535|NCT05919407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154155536|NCT05919407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155537|NCT05919407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155538|NCT05919407|Cholinergic Agents|cholinergic agents|mesh-ancestor
154155550|NCT05919017|Naltrexone|naltrexone|mesh-list
154155563|NCT05918614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155565|NCT05918588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154155566|NCT05918588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155567|NCT05918588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155568|NCT05918341|Piracetam|piracetam|mesh-list
154155569|NCT05918341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154155570|NCT05918341|Protective Agents|protective agents|mesh-ancestor
154155571|NCT05918341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155572|NCT05918341|Nootropic Agents|nootropic agents|mesh-ancestor
154155573|NCT05918068|Vitamin B 6|vitamin b 6|mesh-list
154155574|NCT05918068|Pyridoxal|pyridoxal|mesh-list
154155575|NCT05918068|Pyridoxine|pyridoxine|mesh-list
154155576|NCT05918068|Metformin|metformin|mesh-list
154155577|NCT05918068|Vitamins|vitamins|mesh-ancestor
154155578|NCT05918068|Micronutrients|micronutrients|mesh-ancestor
154155579|NCT05918068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155580|NCT05918068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154155581|NCT05918068|Vitamin B Complex|vitamin b complex|mesh-ancestor
154155582|NCT05917691|Anesthetics|anesthetics|mesh-list
154155583|NCT05917691|Anesthetics, General|anesthetics, general|mesh-list
154155584|NCT05917691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155585|NCT05917691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155586|NCT05914506|Xenon|xenon|mesh-list
154155587|NCT05914506|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154155588|NCT05914506|Anesthetics, General|anesthetics, general|mesh-ancestor
154155615|NCT05874245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154155616|NCT05874245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155617|NCT05874245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155618|NCT05874245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154155619|NCT05874245|Analgesics|analgesics|mesh-ancestor
154155620|NCT05874245|Sensory System Agents|sensory system agents|mesh-ancestor
154155621|NCT05874245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155622|NCT05874245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154155623|NCT05874245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154155624|NCT05874245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154155625|NCT05874245|Adrenergic Agents|adrenergic agents|mesh-ancestor
153535969|NCT01519310|Metronidazole|metronidazole|mesh-list
154155626|NCT05874245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155627|NCT05874245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155629|NCT05874245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154155630|NCT05874245|Anesthetics, General|anesthetics, general|mesh-ancestor
154155631|NCT05874245|Anesthetics|anesthetics|mesh-ancestor
154155632|NCT05874245|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154155633|NCT05874245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154155634|NCT05874245|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154155635|NCT05874245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154155636|NCT05874245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155637|NCT05874245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155638|NCT05874245|GABA Modulators|gaba modulators|mesh-ancestor
154155639|NCT05874245|GABA Agents|gaba agents|mesh-ancestor
154155664|NCT05789199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155665|NCT05788965|Semaglutide|semaglutide|mesh-list
154155666|NCT05788965|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154155667|NCT05788965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154155668|NCT05788965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155669|NCT05664568|Amoxicillin|amoxicillin|mesh-list
154155670|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
153465586|NCT00290472|Sirolimus|sirolimus|mesh-list
154155671|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
154155672|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154155673|NCT05664568|Cephalexin|cephalexin|mesh-list
154155674|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155675|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155676|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154155677|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155678|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155679|NCT05524584|Fulvestrant|fulvestrant|mesh-list
154155680|NCT05524584|Anastrozole|anastrozole|mesh-list
154155681|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154155682|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155683|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154155684|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154155685|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
154155686|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154155687|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155688|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154155689|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154155690|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155691|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155692|NCT05494437|Gabapentin|gabapentin|mesh-list
154155693|NCT05494437|Nabilone|nabilone|mesh-list
154155706|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155707|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
154155708|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
154155709|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
154155710|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154155711|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
154155712|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154155713|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155714|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155715|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154155716|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154155717|NCT05387187|Protective Agents|protective agents|mesh-ancestor
154155718|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155719|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
154155720|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154155721|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
154155722|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
154155723|NCT05365893|Losartan|losartan|mesh-list
154155724|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
154155725|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154155726|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154155727|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155728|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155729|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155730|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155731|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154155732|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154155733|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154155734|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154155735|NCT05312671|Cisplatin|cisplatin|mesh-list
154155736|NCT05312671|Carboplatin|carboplatin|mesh-list
154155737|NCT05312671|Etoposide|etoposide|mesh-list
154155738|NCT05312671|Atezolizumab|atezolizumab|mesh-list
154155739|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
154155740|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155741|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154155742|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154155743|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153646488|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154155744|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155745|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155746|NCT05312671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154155747|NCT05312671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154155748|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
154155749|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
154155750|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
154155751|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
154155752|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
154155753|NCT05254574|Diclofenac|diclofenac|mesh-list
154155754|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154155755|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154155756|NCT05254574|Analgesics|analgesics|mesh-ancestor
154155757|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
154155758|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155759|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155760|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155761|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155762|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154155763|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155764|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155765|NCT05219929|Tetracycline|tetracycline|mesh-list
154155766|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155767|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155768|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154155769|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155770|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155790|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155791|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155792|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155793|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155794|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
154155795|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
154155796|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154155797|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154155798|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155799|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155800|NCT05117450|Heparin|heparin|mesh-list
154155801|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
154155802|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154155803|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154155804|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155805|NCT05102669|Antibodies|antibodies|mesh-list
154155806|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
154155807|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155808|NCT05050448|Diclofenac|diclofenac|mesh-list
154155809|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154155810|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154155811|NCT05050448|Analgesics|analgesics|mesh-ancestor
154155812|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
154157510|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
154155813|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155814|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155815|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155816|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155817|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154155818|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155819|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155820|NCT04899388|Fentanyl|fentanyl|mesh-list
154155821|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154155822|NCT04899388|Narcotics|narcotics|mesh-ancestor
154155823|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155824|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155828|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154155829|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154155830|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
154155831|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
154155833|NCT04880785|Dolutegravir|dolutegravir|mesh-list
154155834|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154155835|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154155836|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155837|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155838|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
154155839|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155840|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154155841|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154155842|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154155843|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154155844|NCT04874246|Vasopressins|vasopressins|mesh-list
154155845|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
154155846|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
154155847|NCT04874246|Coagulants|coagulants|mesh-ancestor
154155849|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154155850|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
154155851|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155853|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154155882|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155883|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
154155884|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154155885|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155886|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154155887|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155889|NCT04678102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154155890|NCT04678102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155891|NCT04678102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154155892|NCT04678102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155893|NCT04643106|Hemostatics|hemostatics|mesh-list
154155894|NCT04643106|Coagulants|coagulants|mesh-ancestor
154155895|NCT04636437|Tenofovir|tenofovir|mesh-list
154155896|NCT04636437|Lamivudine|lamivudine|mesh-list
154155897|NCT04636437|Emtricitabine|emtricitabine|mesh-list
154155898|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
154155899|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
154155900|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155901|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154155902|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154155903|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155904|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155905|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154155906|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154155907|NCT04600648|Insulin|insulin|mesh-list
154155908|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154155909|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155910|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154155911|NCT04469595|Aflibercept|aflibercept|mesh-list
154155912|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154155913|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154155914|NCT04469595|Growth Substances|growth substances|mesh-ancestor
154155915|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155916|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
154155917|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155921|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536254|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
154155922|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154155923|NCT04250636|Antibodies|antibodies|mesh-list
154155924|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
154155925|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154155926|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
154155927|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155928|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155929|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
154155930|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154155931|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154155932|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155933|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
153454222|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
154155934|NCT04233749|Coagulants|coagulants|mesh-ancestor
154155935|NCT04201561|Selenious Acid|selenious acid|mesh-list
154155936|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
154155937|NCT04201561|Paclitaxel|paclitaxel|mesh-list
154155938|NCT04201561|Carboplatin|carboplatin|mesh-list
154155939|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154155940|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155941|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
154155942|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
154155943|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
154155944|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155945|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155946|NCT04201561|Trace Elements|trace elements|mesh-ancestor
154155947|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
154155948|NCT04061421|Decitabine|decitabine|mesh-list
154155949|NCT04061421|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154155950|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154155951|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
154155952|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155962|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154155963|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155964|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155965|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155966|NCT03937843|Carboplatin|carboplatin|mesh-list
154155967|NCT03937843|Etoposide|etoposide|mesh-list
154155968|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155969|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154155970|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154155971|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154155972|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155973|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155974|NCT03839823|Paclitaxel|paclitaxel|mesh-list
154155975|NCT03839823|Vinorelbine|vinorelbine|mesh-list
154155976|NCT03839823|Docetaxel|docetaxel|mesh-list
154155977|NCT03839823|Gemcitabine|gemcitabine|mesh-list
154155978|NCT03839823|Capecitabine|capecitabine|mesh-list
154155979|NCT03839823|Letrozole|letrozole|mesh-list
154155980|NCT03839823|Anastrozole|anastrozole|mesh-list
154155981|NCT03839823|Goserelin|goserelin|mesh-list
154155982|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154155983|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155984|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
154155985|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
154155986|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
154155987|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155988|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154155989|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
154155990|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154155991|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154155992|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155993|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154155994|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
153479558|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
154156003|NCT03743636|Niacinamide|niacinamide|mesh-list
154156005|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
154156006|NCT03743636|Resveratrol|resveratrol|mesh-list
154156007|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
154156008|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156009|NCT03743636|Protective Agents|protective agents|mesh-ancestor
154156010|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156011|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156012|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154156013|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
154156014|NCT03743636|Vitamins|vitamins|mesh-ancestor
154156015|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
154156016|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154156017|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
154156018|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154156019|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
154156020|NCT03726775|Durvalumab|durvalumab|mesh-list
154156021|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156022|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156023|NCT03718039|Aprepitant|aprepitant|mesh-list
154156024|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
154156025|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
154156026|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156027|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156028|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156032|NCT03602014|Droxidopa|droxidopa|mesh-list
154156056|NCT03523585|Lapatinib|lapatinib|mesh-list
154156057|NCT03523585|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154156058|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154156059|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
154156060|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156061|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156062|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156063|NCT03523585|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154156064|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154156065|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156066|NCT03523585|Immunoconjugates|immunoconjugates|mesh-ancestor
154156067|NCT03523585|Immunologic Factors|immunologic factors|mesh-ancestor
154156068|NCT03523585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156069|NCT03485911|Berotralstat|berotralstat|mesh-list
154156070|NCT03485911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154156071|NCT03485911|Protease Inhibitors|protease inhibitors|mesh-ancestor
154156072|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156073|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156074|NCT03395314|Midazolam|midazolam|mesh-list
154156075|NCT03395314|Ketamine|ketamine|mesh-list
154156076|NCT03395314|Analgesics|analgesics|mesh-ancestor
154156078|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156079|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156080|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154156081|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154156082|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
154156083|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
154156084|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156085|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154156086|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154156087|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156100|NCT03293680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156101|NCT03172975|Albendazole|albendazole|mesh-list
154156102|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154156103|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
154156104|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154156105|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156106|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
154156107|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154156108|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154156109|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
154156110|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
154156111|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
154156112|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156113|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156114|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154156115|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
154156116|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156117|NCT03172975|Antacids|antacids|mesh-ancestor
154156118|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156119|NCT03028103|Repaglinide|repaglinide|mesh-list
154156120|NCT03028103|Fluconazole|fluconazole|mesh-list
154156121|NCT03028103|Omeprazole|omeprazole|mesh-list
154156122|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154156123|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156138|NCT03020589|Tacrolimus|tacrolimus|mesh-list
154156151|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156152|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156154|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154156155|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154156156|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154156157|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
154156158|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156159|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156160|NCT02893553|Midodrine|midodrine|mesh-list
154156161|NCT02893553|Bromides|bromides|mesh-list
154156162|NCT02893553|Mirabegron|mirabegron|mesh-list
154156163|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154156164|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
154156165|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154156166|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154156167|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154156168|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
154156169|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156170|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156171|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156172|NCT02893553|Urological Agents|urological agents|mesh-ancestor
154156173|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
154156174|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
154156175|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156176|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154156199|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156200|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156201|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153912522|NCT02753803|Pioglitazone|pioglitazone|mesh-list
154156202|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154156203|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
154156204|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154156205|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
154156206|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154156207|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154156208|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156209|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
154156210|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
154156211|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156212|NCT06271551|Estrogens|estrogens|mesh-list
154156213|NCT06271551|Androgens|androgens|mesh-list
154156214|NCT06271551|Hormones|hormones|mesh-ancestor
154156215|NCT06271551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156216|NCT06271551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156217|NCT06271486|Pregabalin|pregabalin|mesh-list
154156218|NCT06271486|Analgesics|analgesics|mesh-ancestor
154156219|NCT06271486|Sensory System Agents|sensory system agents|mesh-ancestor
154156222|NCT06271486|Anticonvulsants|anticonvulsants|mesh-ancestor
154156250|NCT06271330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156251|NCT06271330|Growth Inhibitors|growth inhibitors|mesh-ancestor
154156252|NCT06271330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156253|NCT06271265|Bupivacaine|bupivacaine|mesh-list
154156254|NCT06271265|Anesthetics, Local|anesthetics, local|mesh-ancestor
154156255|NCT06271265|Anesthetics|anesthetics|mesh-ancestor
154156256|NCT06271265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156257|NCT06271265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156258|NCT06271265|Sensory System Agents|sensory system agents|mesh-ancestor
154156259|NCT06271265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156260|NCT06271174|Anesthetics|anesthetics|mesh-list
154156261|NCT06271174|Sevoflurane|sevoflurane|mesh-list
154156262|NCT06271174|Mepivacaine|mepivacaine|mesh-list
154156263|NCT06271174|Anesthetics, General|anesthetics, general|mesh-list
154156264|NCT06271174|Succinylcholine|succinylcholine|mesh-list
154156265|NCT06271174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156266|NCT06271174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156267|NCT06271174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154156268|NCT06271174|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154156269|NCT06271174|Anesthetics, Local|anesthetics, local|mesh-ancestor
154156270|NCT06271174|Sensory System Agents|sensory system agents|mesh-ancestor
154156271|NCT06271174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156272|NCT06271174|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154156273|NCT06271174|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154156274|NCT06271174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154156275|NCT06271109|Liver Extracts|liver extracts|mesh-list
154156276|NCT06271109|Hematinics|hematinics|mesh-ancestor
154156277|NCT06270797|Anesthetics|anesthetics|mesh-list
154156278|NCT06270797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156280|NCT06270706|Pembrolizumab|pembrolizumab|mesh-list
154156293|NCT06270433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154156294|NCT06270407|Tranexamic Acid|tranexamic acid|mesh-list
154156295|NCT06270407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154156296|NCT06270407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154156297|NCT06270407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156299|NCT06270407|Coagulants|coagulants|mesh-ancestor
154156300|NCT06270225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154156301|NCT06270225|Colchicine|colchicine|mesh-list
154156302|NCT06270225|Antibodies|antibodies|mesh-list
154156303|NCT06270225|Immunoglobulins|immunoglobulins|mesh-list
154156304|NCT06270225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154156305|NCT06270225|Immunologic Factors|immunologic factors|mesh-ancestor
154156306|NCT06270225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156307|NCT06270225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156308|NCT06270225|Gout Suppressants|gout suppressants|mesh-ancestor
154156309|NCT06270225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154156310|NCT06270225|Tubulin Modulators|tubulin modulators|mesh-ancestor
154156311|NCT06270225|Antimitotic Agents|antimitotic agents|mesh-ancestor
154156312|NCT06270225|Mitosis Modulators|mitosis modulators|mesh-ancestor
154156313|NCT06270225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156314|NCT06270147|Epinephrine|epinephrine|mesh-list
154156315|NCT06270147|Bupivacaine|bupivacaine|mesh-list
154156316|NCT06270147|Anesthetics, Local|anesthetics, local|mesh-ancestor
154156347|NCT06269978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154156348|NCT06269978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156349|NCT06269978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156350|NCT06269978|Immunologic Factors|immunologic factors|mesh-ancestor
154156351|NCT06269978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156352|NCT06269900|Dexamethasone|dexamethasone|mesh-list
154156353|NCT06269900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156354|NCT06269900|Antiemetics|antiemetics|mesh-ancestor
154156355|NCT06269900|Autonomic Agents|autonomic agents|mesh-ancestor
154156356|NCT06269900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156357|NCT06269900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156358|NCT06269900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156359|NCT06269900|Glucocorticoids|glucocorticoids|mesh-ancestor
154156360|NCT06269900|Hormones|hormones|mesh-ancestor
154156361|NCT06269900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156362|NCT06269900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154156363|NCT06269900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156364|NCT06269705|Triamcinolone|triamcinolone|mesh-list
154156365|NCT06269705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154156366|NCT06269705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154156367|NCT06269705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154156368|NCT06269705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156369|NCT06269705|Glucocorticoids|glucocorticoids|mesh-ancestor
154156370|NCT06269705|Hormones|hormones|mesh-ancestor
154156371|NCT06269705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156372|NCT06269705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156373|NCT06269705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156376|NCT06269705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156377|NCT06269445|Bevacizumab|bevacizumab|mesh-list
154156378|NCT06269445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156379|NCT06269445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156380|NCT06269445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154156381|NCT06269445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154156382|NCT06269445|Growth Substances|growth substances|mesh-ancestor
154156387|NCT06269406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154156388|NCT06269406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154156390|NCT06269406|Sensory System Agents|sensory system agents|mesh-ancestor
154156391|NCT06269406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156392|NCT06269406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156393|NCT06269406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156394|NCT06269406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154156395|NCT06269406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154156396|NCT06269406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156397|NCT06269406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156398|NCT06269406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156399|NCT06269146|Pramipexole|pramipexole|mesh-list
154156400|NCT06269146|Dexpramipexole|dexpramipexole|mesh-list
154156401|NCT06269146|Antioxidants|antioxidants|mesh-ancestor
154156402|NCT06269146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156403|NCT06269146|Protective Agents|protective agents|mesh-ancestor
154156404|NCT06269146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156405|NCT06269146|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154156406|NCT06269146|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154156407|NCT06269146|Dopamine Agonists|dopamine agonists|mesh-ancestor
154156408|NCT06269146|Dopamine Agents|dopamine agents|mesh-ancestor
154156409|NCT06269146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156410|NCT06269120|Semaglutide|semaglutide|mesh-list
154156411|NCT06269120|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154156412|NCT06269120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154156413|NCT06269120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156414|NCT06268977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154156415|NCT06268977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156416|NCT06268977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154156417|NCT06268977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156418|NCT06268964|Trimebutine|trimebutine|mesh-list
154156428|NCT06268470|Histamine Antagonists|histamine antagonists|mesh-list
154156429|NCT06268470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154156430|NCT06268470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154156431|NCT06268470|Autonomic Agents|autonomic agents|mesh-ancestor
154156432|NCT06268470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156433|NCT06268470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156434|NCT06268470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154156435|NCT06268470|Respiratory System Agents|respiratory system agents|mesh-ancestor
154156436|NCT06268470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154156437|NCT06268470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154156438|NCT06268470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156439|NCT06268470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154156440|NCT06268470|Vasodilator Agents|vasodilator agents|mesh-ancestor
154156441|NCT06268470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154156442|NCT06268470|Protective Agents|protective agents|mesh-ancestor
154156443|NCT06268470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154156444|NCT06268470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153454381|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153454382|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454383|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454384|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454385|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454386|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
154156445|NCT06268470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912622|NCT02753647|Hormones|hormones|mesh-ancestor
153912623|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912624|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154156446|NCT06268470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154156447|NCT06268470|Cholinergic Agents|cholinergic agents|mesh-ancestor
154156448|NCT06268470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156449|NCT06268470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154156450|NCT06268470|Histamine Agents|histamine agents|mesh-ancestor
154156451|NCT06268470|Antipruritics|antipruritics|mesh-ancestor
154156452|NCT06268470|Dermatologic Agents|dermatologic agents|mesh-ancestor
154156453|NCT06268470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154156454|NCT06267664|Lasmiditan|lasmiditan|mesh-list
154156455|NCT06267664|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154156475|NCT06266481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156476|NCT06266481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154156477|NCT06266481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156478|NCT06266481|Anesthetics, Local|anesthetics, local|mesh-ancestor
154156479|NCT06266481|Anesthetics|anesthetics|mesh-ancestor
154156480|NCT06266481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156481|NCT06266481|Sensory System Agents|sensory system agents|mesh-ancestor
154156482|NCT06266481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154156483|NCT06266481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154156484|NCT06266481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154156485|NCT06266481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912625|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153912626|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
153912627|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
153912628|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
153912629|NCT02872389|Sevoflurane|sevoflurane|mesh-list
153912630|NCT02872389|Desflurane|desflurane|mesh-list
153912631|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153912632|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153912633|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
153912634|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
153912635|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912636|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912638|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
153454404|NCT01585272|Rivastigmine|rivastigmine|mesh-list
154156486|NCT06266481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156487|NCT06266299|Docetaxel|docetaxel|mesh-list
154156488|NCT06266299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156489|NCT06266299|Tubulin Modulators|tubulin modulators|mesh-ancestor
154156490|NCT06266299|Antimitotic Agents|antimitotic agents|mesh-ancestor
154156491|NCT06266299|Mitosis Modulators|mitosis modulators|mesh-ancestor
154156492|NCT06266299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156493|NCT06266221|Prednisone|prednisone|mesh-list
154156494|NCT06266221|Methylprednisolone|methylprednisolone|mesh-list
154156495|NCT06266221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154156496|NCT06266221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154156497|NCT06266221|Prednisolone|prednisolone|mesh-list
154156498|NCT06266221|Prednisolone acetate|prednisolone acetate|mesh-list
154156499|NCT06266221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154156500|NCT06266221|Prednisolone phosphate|prednisolone phosphate|mesh-list
154156521|NCT06265883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156522|NCT06265883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154156523|NCT06265883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156525|NCT06265675|Betamethasone|betamethasone|mesh-list
154156526|NCT06265675|Lidocaine|lidocaine|mesh-list
154156527|NCT06265675|Anesthetics, Local|anesthetics, local|mesh-ancestor
154156528|NCT06265675|Anesthetics|anesthetics|mesh-ancestor
154156529|NCT06265675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156530|NCT06265675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156531|NCT06265675|Sensory System Agents|sensory system agents|mesh-ancestor
154156532|NCT06265675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156533|NCT06265675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154156534|NCT06265675|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154156535|NCT06265675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154156536|NCT06265675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154156537|NCT06265675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156538|NCT06265675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154156539|NCT06265675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156540|NCT06265675|Disinfectants|disinfectants|mesh-ancestor
154156541|NCT06265675|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154156542|NCT06265675|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154156543|NCT06265675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156544|NCT06265675|Glucocorticoids|glucocorticoids|mesh-ancestor
154156545|NCT06265675|Hormones|hormones|mesh-ancestor
154156546|NCT06265675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156547|NCT06265675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154156548|NCT06265675|Respiratory System Agents|respiratory system agents|mesh-ancestor
154156549|NCT06265545|Venetoclax|venetoclax|mesh-list
154156550|NCT06265545|Ivosidenib|ivosidenib|mesh-list
154156565|NCT06265532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154156566|NCT06265454|Atropine|atropine|mesh-list
154156567|NCT06265454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154156568|NCT06265454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154156569|NCT06265454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154156570|NCT06265454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154156571|NCT06265454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154156572|NCT06265454|Autonomic Agents|autonomic agents|mesh-ancestor
154156573|NCT06265454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156574|NCT06265454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156575|NCT06265454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154156576|NCT06265454|Respiratory System Agents|respiratory system agents|mesh-ancestor
154156577|NCT06265454|Mydriatics|mydriatics|mesh-ancestor
154156578|NCT06265454|Parasympatholytics|parasympatholytics|mesh-ancestor
154156579|NCT06265454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154156580|NCT06265454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154156581|NCT06265454|Cholinergic Agents|cholinergic agents|mesh-ancestor
154156582|NCT06265454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156584|NCT06265415|Labetalol|labetalol|mesh-list
154156622|NCT06265350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156623|NCT06265350|Growth Inhibitors|growth inhibitors|mesh-ancestor
154156624|NCT06265220|Cyclophosphamide|cyclophosphamide|mesh-list
154156625|NCT06265220|Rituximab|rituximab|mesh-list
154156626|NCT06265220|Fludarabine|fludarabine|mesh-list
154156627|NCT06265220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156628|NCT06265220|Immunologic Factors|immunologic factors|mesh-ancestor
154156629|NCT06265220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156630|NCT06265220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154156631|NCT06265220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154156632|NCT06265220|Alkylating Agents|alkylating agents|mesh-ancestor
154156633|NCT06265220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156634|NCT06265220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156635|NCT06265220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154156636|NCT06265220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156637|NCT06265077|Loratadine|loratadine|mesh-list
154156638|NCT06265077|Famotidine|famotidine|mesh-list
154156639|NCT06265077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154156640|NCT06265077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156641|NCT06265077|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154156642|NCT06265077|Histamine Antagonists|histamine antagonists|mesh-ancestor
154156643|NCT06265077|Histamine Agents|histamine agents|mesh-ancestor
154156644|NCT06265077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156645|NCT06265077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156646|NCT06265077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156647|NCT06265077|Antipruritics|antipruritics|mesh-ancestor
154156648|NCT06265077|Dermatologic Agents|dermatologic agents|mesh-ancestor
154156649|NCT06265077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154156650|NCT06265077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154156651|NCT06265077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154156665|NCT06264882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156666|NCT06264882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156668|NCT06264778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156669|NCT06264778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154156670|NCT06264778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156671|NCT06264778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156672|NCT06264739|Dexmedetomidine|dexmedetomidine|mesh-list
153480236|NCT05842096|Antibodies|antibodies|mesh-list
154156673|NCT06264739|Remifentanil|remifentanil|mesh-list
154156674|NCT06264739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154156675|NCT06264739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156676|NCT06264739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156677|NCT06264739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154156678|NCT06264739|Analgesics|analgesics|mesh-ancestor
154156679|NCT06264739|Sensory System Agents|sensory system agents|mesh-ancestor
154156680|NCT06264739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156681|NCT06264739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154156682|NCT06264739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154156683|NCT06264739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154156684|NCT06264739|Adrenergic Agents|adrenergic agents|mesh-ancestor
154156685|NCT06264739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156686|NCT06264739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156687|NCT06264739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154156688|NCT06264739|Narcotics|narcotics|mesh-ancestor
154156689|NCT06264674|Norflurane|norflurane|mesh-list
154156690|NCT06264674|Anesthetics|anesthetics|mesh-ancestor
154156710|NCT06264544|Protective Agents|protective agents|mesh-ancestor
154156711|NCT06264544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156712|NCT06264544|Trace Elements|trace elements|mesh-ancestor
154156713|NCT06264544|Micronutrients|micronutrients|mesh-ancestor
154156714|NCT06264401|Alendronate|alendronate|mesh-list
154156715|NCT06264401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154156716|NCT06264401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156717|NCT06264388|Flucytosine|flucytosine|mesh-list
154156718|NCT06264388|Antifungal Agents|antifungal agents|mesh-ancestor
154156719|NCT06264388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156720|NCT06264388|Antimetabolites|antimetabolites|mesh-ancestor
154156721|NCT06264388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156722|NCT06263582|Artesunate|artesunate|mesh-list
154156723|NCT06263582|Antimalarials|antimalarials|mesh-ancestor
154156724|NCT06263582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154156725|NCT06263582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154156726|NCT06263582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156727|NCT06263582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156728|NCT06263582|Antiviral Agents|antiviral agents|mesh-ancestor
154156729|NCT06263582|Schistosomicides|schistosomicides|mesh-ancestor
154156730|NCT06263582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154156731|NCT06263582|Anthelmintics|anthelmintics|mesh-ancestor
154156767|NCT06253611|Fluorouracil|fluorouracil|mesh-list
154156768|NCT06253611|Nivolumab|nivolumab|mesh-list
154156769|NCT06253611|Oxaliplatin|oxaliplatin|mesh-list
154156770|NCT06253611|Antimetabolites|antimetabolites|mesh-ancestor
154156771|NCT06253611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156772|NCT06253611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154156773|NCT06253611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156774|NCT06253611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156775|NCT06253611|Immunologic Factors|immunologic factors|mesh-ancestor
154156776|NCT06253611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156777|NCT06253611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156778|NCT06253611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154156779|NCT06253611|Antidotes|antidotes|mesh-ancestor
154156780|NCT06253611|Protective Agents|protective agents|mesh-ancestor
154156781|NCT06253611|Vitamin B Complex|vitamin b complex|mesh-ancestor
154156782|NCT06253611|Vitamins|vitamins|mesh-ancestor
154156783|NCT06253611|Micronutrients|micronutrients|mesh-ancestor
154156784|NCT06253260|Dexmedetomidine|dexmedetomidine|mesh-list
154156785|NCT06253260|Analgesics|analgesics|mesh-list
154156786|NCT06253260|Bupivacaine|bupivacaine|mesh-list
154156787|NCT06253260|Anesthetics, Local|anesthetics, local|mesh-ancestor
154156788|NCT06253260|Anesthetics|anesthetics|mesh-ancestor
154156789|NCT06253260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156790|NCT06253260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156791|NCT06253260|Sensory System Agents|sensory system agents|mesh-ancestor
154156792|NCT06253260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156793|NCT06253260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154156794|NCT06253260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154156795|NCT06253260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154156796|NCT06253260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154156797|NCT06253260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154156798|NCT06253260|Adrenergic Agents|adrenergic agents|mesh-ancestor
154156799|NCT06253260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156800|NCT06253260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156801|NCT06251232|Prednisone|prednisone|mesh-list
154156802|NCT06251232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156803|NCT06251232|Glucocorticoids|glucocorticoids|mesh-ancestor
154156804|NCT06251232|Hormones|hormones|mesh-ancestor
154156805|NCT06251232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156806|NCT06251232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156807|NCT06251232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154156808|NCT06251232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156809|NCT06251050|Lithium Carbonate|lithium carbonate|mesh-list
154156810|NCT06251050|Antidepressive Agents|antidepressive agents|mesh-ancestor
154156811|NCT06251050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154156812|NCT06251050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156813|NCT06251050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156814|NCT06251050|Antimanic Agents|antimanic agents|mesh-ancestor
154156815|NCT06251050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154156816|NCT06251050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156817|NCT06251050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156818|NCT06237231|Dipyrone|dipyrone|mesh-list
154156819|NCT06237231|Tramadol|tramadol|mesh-list
154156820|NCT06237231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154156821|NCT06237231|Narcotics|narcotics|mesh-ancestor
154156822|NCT06237231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156823|NCT06237231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156824|NCT06237231|Analgesics|analgesics|mesh-ancestor
154156825|NCT06237231|Sensory System Agents|sensory system agents|mesh-ancestor
154156826|NCT06237231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156828|NCT06237231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154156856|NCT06217796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156858|NCT06217796|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154156859|NCT06217796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154156860|NCT06217796|Cholinergic Agents|cholinergic agents|mesh-ancestor
154156861|NCT06216522|Mineral Oil|mineral oil|mesh-list
154156862|NCT06216522|Emollients|emollients|mesh-ancestor
154156863|NCT06216522|Dermatologic Agents|dermatologic agents|mesh-ancestor
154156864|NCT06210776|Trastuzumab|trastuzumab|mesh-list
154156865|NCT06210776|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154156866|NCT06210776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156867|NCT06210776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156868|NCT06210776|Immunoconjugates|immunoconjugates|mesh-ancestor
154156869|NCT06210776|Immunologic Factors|immunologic factors|mesh-ancestor
154156870|NCT06210776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156871|NCT06200545|Antibodies|antibodies|mesh-list
154156872|NCT06200545|HIV Antibodies|hiv antibodies|mesh-list
154156873|NCT06200545|Immunologic Factors|immunologic factors|mesh-ancestor
154156874|NCT06200545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156875|NCT06199999|Anesthetics|anesthetics|mesh-list
154156876|NCT06199999|Anesthetics, Local|anesthetics, local|mesh-list
154156877|NCT06199999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156878|NCT06199999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156879|NCT06199999|Sensory System Agents|sensory system agents|mesh-ancestor
154156880|NCT06199999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156881|NCT06190249|Aldesleukin|aldesleukin|mesh-list
154156882|NCT06190249|Cyclophosphamide|cyclophosphamide|mesh-list
154156883|NCT06190249|Pembrolizumab|pembrolizumab|mesh-list
154156884|NCT06190249|Fludarabine|fludarabine|mesh-list
154156885|NCT06190249|Interleukin-2|interleukin-2|mesh-list
154156886|NCT06190249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156887|NCT06190249|Immunologic Factors|immunologic factors|mesh-ancestor
154156888|NCT06190249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156889|NCT06190249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154156890|NCT06190249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154156897|NCT06190249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154156899|NCT06190249|Sensory System Agents|sensory system agents|mesh-ancestor
154156900|NCT06190249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156901|NCT06190249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154156902|NCT06190249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154156903|NCT06190249|Antiviral Agents|antiviral agents|mesh-ancestor
154156904|NCT06190249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156905|NCT06186063|Pramlintide|pramlintide|mesh-list
154156906|NCT06186063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154156907|NCT06186063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156908|NCT06180356|Niraparib|niraparib|mesh-list
154156909|NCT06180356|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154156910|NCT06180356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156911|NCT06180356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156912|NCT06180356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156913|NCT06179004|Bupivacaine|bupivacaine|mesh-list
154156914|NCT06179004|Anesthetics, Local|anesthetics, local|mesh-ancestor
154156915|NCT06179004|Anesthetics|anesthetics|mesh-ancestor
154156916|NCT06179004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156917|NCT06179004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156918|NCT06179004|Sensory System Agents|sensory system agents|mesh-ancestor
154156919|NCT06179004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156920|NCT06168851|Antibodies|antibodies|mesh-list
154156948|NCT06113809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154156949|NCT06113809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156950|NCT06111781|Relugolix|relugolix|mesh-list
154156951|NCT06111781|Androgen Antagonists|androgen antagonists|mesh-ancestor
154156952|NCT06111781|Hormone Antagonists|hormone antagonists|mesh-ancestor
154156953|NCT06111781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156954|NCT06111781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156955|NCT06111313|Androgens|androgens|mesh-list
154156956|NCT06111313|Relugolix|relugolix|mesh-list
154156957|NCT06111313|Hormones|hormones|mesh-ancestor
154156958|NCT06111313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156959|NCT06111313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156960|NCT06111313|Androgen Antagonists|androgen antagonists|mesh-ancestor
154156961|NCT06111313|Hormone Antagonists|hormone antagonists|mesh-ancestor
154156962|NCT06109155|Tranexamic Acid|tranexamic acid|mesh-list
154156963|NCT06109155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154156964|NCT06109155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154156966|NCT06109155|Hemostatics|hemostatics|mesh-ancestor
154157022|NCT06070597|Moxifloxacin|moxifloxacin|mesh-list
154157023|NCT06070597|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154157024|NCT06070597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154157025|NCT06070597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157026|NCT06070597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154157027|NCT06070597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153912812|NCT02758873|Montelukast|montelukast|mesh-list
154157028|NCT06070597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157029|NCT06070597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157030|NCT06070597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157031|NCT06070597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154157032|NCT06070597|Contraceptive Agents|contraceptive agents|mesh-ancestor
154157033|NCT06070597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154157034|NCT06070597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157035|NCT06070597|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154157036|NCT06070597|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154157037|NCT06070597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154157038|NCT06069726|Atezolizumab|atezolizumab|mesh-list
154157039|NCT06069726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154157040|NCT06069726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157041|NCT06069726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157042|NCT06069726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157043|NCT06067737|Buprenorphine|buprenorphine|mesh-list
154157044|NCT06067737|Psilocybin|psilocybin|mesh-list
154157045|NCT06067737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154157046|NCT06067737|Narcotics|narcotics|mesh-ancestor
154157047|NCT06067737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157048|NCT06067737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157049|NCT06067737|Analgesics|analgesics|mesh-ancestor
153646489|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157051|NCT06067737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157052|NCT06067737|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154157054|NCT06067737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154157055|NCT06066424|Cyclophosphamide|cyclophosphamide|mesh-list
154157056|NCT06066424|Fludarabine|fludarabine|mesh-list
154157057|NCT06066424|Fludarabine phosphate|fludarabine phosphate|mesh-list
154157058|NCT06066424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154157059|NCT06066424|Immunologic Factors|immunologic factors|mesh-ancestor
154157060|NCT06066424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157061|NCT06066424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154157062|NCT06066424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154157063|NCT06066424|Alkylating Agents|alkylating agents|mesh-ancestor
153454626|NCT01554618|Incretins|incretins|mesh-ancestor
154157064|NCT06066424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157065|NCT06066424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157066|NCT06066424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154157067|NCT06066424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154157068|NCT06066424|Antimetabolites|antimetabolites|mesh-ancestor
154157069|NCT06066255|Thymoglobulin|thymoglobulin|mesh-list
154157070|NCT06066255|Immunologic Factors|immunologic factors|mesh-ancestor
154157071|NCT06066255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157072|NCT06066255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154157074|NCT06062966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154157103|NCT06055608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157104|NCT06055608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154157105|NCT06049680|SMOFlipid|smoflipid|mesh-list
154157106|NCT06049680|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154157107|NCT06049680|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154157108|NCT06049680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154157109|NCT06042257|Guanfacine|guanfacine|mesh-list
154157110|NCT06042257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154157111|NCT06042257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154157112|NCT06042257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154157113|NCT06042257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154157114|NCT06042257|Adrenergic Agents|adrenergic agents|mesh-ancestor
154157115|NCT06042257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157116|NCT06042257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157117|NCT06042257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157118|NCT06039371|Carboplatin|carboplatin|mesh-list
154157119|NCT06039371|Etoposide|etoposide|mesh-list
154157120|NCT06039371|Etoposide phosphate|etoposide phosphate|mesh-list
154157121|NCT06039371|Methyltestosterone|methyltestosterone|mesh-list
154157122|NCT06039371|Podophyllotoxin|podophyllotoxin|mesh-list
154157123|NCT06039371|Testosterone|testosterone|mesh-list
154157157|NCT06020898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157158|NCT06020898|GABA Agents|gaba agents|mesh-ancestor
154157159|NCT06020898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157160|NCT06020898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157161|NCT06020898|Antimanic Agents|antimanic agents|mesh-ancestor
154157162|NCT06020898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154157163|NCT06020898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157164|NCT06020898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154157165|NCT06014827|Osimertinib|osimertinib|mesh-list
154157166|NCT06014827|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154157167|NCT06014827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154157168|NCT06014827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157169|NCT06014827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157170|NCT06014827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157171|NCT06013423|Cyclosporine|cyclosporine|mesh-list
154157172|NCT06013423|Mycophenolic Acid|mycophenolic acid|mesh-list
154157173|NCT06013423|Cyclophosphamide|cyclophosphamide|mesh-list
154157174|NCT06013423|Thiotepa|thiotepa|mesh-list
154157175|NCT06013423|Fludarabine|fludarabine|mesh-list
154157176|NCT06013423|Fludarabine phosphate|fludarabine phosphate|mesh-list
154157177|NCT06013423|Cyclosporins|cyclosporins|mesh-list
154157178|NCT06013423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154157179|NCT06013423|Immunologic Factors|immunologic factors|mesh-ancestor
154157180|NCT06013423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157181|NCT06013423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154157182|NCT06013423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154157183|NCT06013423|Alkylating Agents|alkylating agents|mesh-ancestor
154157184|NCT06013423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157185|NCT06013423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157186|NCT06013423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154157187|NCT06013423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154157188|NCT06013423|Antimetabolites|antimetabolites|mesh-ancestor
154157189|NCT06013423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157190|NCT06013423|Antifungal Agents|antifungal agents|mesh-ancestor
154157197|NCT06013423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154157198|NCT06013111|Cyclophosphamide|cyclophosphamide|mesh-list
154157199|NCT06013111|Fludarabine|fludarabine|mesh-list
154157200|NCT06013111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154157201|NCT06013111|Immunologic Factors|immunologic factors|mesh-ancestor
154157202|NCT06013111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157203|NCT06013111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154157204|NCT06013111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154157205|NCT06013111|Alkylating Agents|alkylating agents|mesh-ancestor
154157206|NCT06013111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157207|NCT06013111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157208|NCT06013111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154157209|NCT06007547|Poractant alfa|poractant alfa|mesh-list
154157210|NCT06007547|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154157211|NCT06007547|Respiratory System Agents|respiratory system agents|mesh-ancestor
154157212|NCT05998135|Atovaquone|atovaquone|mesh-list
154157213|NCT05998135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157214|NCT05998135|Antimalarials|antimalarials|mesh-ancestor
154157215|NCT05998135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154157216|NCT05998135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154157217|NCT05998135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157218|NCT05998135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157219|NCT05983770|Tacrolimus|tacrolimus|mesh-list
154157226|NCT05979389|Bicalutamide|bicalutamide|mesh-list
154157249|NCT05965544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154157250|NCT05965544|Narcotics|narcotics|mesh-ancestor
154157251|NCT05965544|Analgesics|analgesics|mesh-ancestor
154157252|NCT05965544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154157253|NCT05965544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154157254|NCT05965544|Anesthetics, General|anesthetics, general|mesh-ancestor
154157255|NCT05953584|Hydroxyurea|hydroxyurea|mesh-list
154157256|NCT05953584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157257|NCT05953584|Antisickling Agents|antisickling agents|mesh-ancestor
154157258|NCT05953584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157259|NCT05953584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157260|NCT05953584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154157261|NCT05953428|Analgesics, Opioid|analgesics, opioid|mesh-list
154157262|NCT05953428|Anesthetics|anesthetics|mesh-list
154157263|NCT05953428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157264|NCT05953428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157265|NCT05953428|Narcotics|narcotics|mesh-ancestor
154157266|NCT05953428|Analgesics|analgesics|mesh-ancestor
154157267|NCT05953428|Sensory System Agents|sensory system agents|mesh-ancestor
154157268|NCT05953428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157269|NCT05941507|Antibodies|antibodies|mesh-list
154157270|NCT05941507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154157271|NCT05941507|Immunologic Factors|immunologic factors|mesh-ancestor
154157272|NCT05941507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157273|NCT05935930|Propofol|propofol|mesh-list
154157274|NCT05935930|Sevoflurane|sevoflurane|mesh-list
154157275|NCT05935930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154157297|NCT05930665|Growth Inhibitors|growth inhibitors|mesh-ancestor
154157298|NCT05930665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912897|NCT00635557|Carboplatin|carboplatin|mesh-list
154157299|NCT05930665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157300|NCT05930665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153912905|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154157301|NCT05930665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154157302|NCT05924997|Apatinib|apatinib|mesh-list
154157303|NCT05924997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157304|NCT05924997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154157305|NCT05924997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157306|NCT05924997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157307|NCT05918861|Dalcetrapib|dalcetrapib|mesh-list
154157308|NCT05918861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154157309|NCT05918861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154157310|NCT05918861|Antimetabolites|antimetabolites|mesh-ancestor
154157311|NCT05918861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157312|NCT05918861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154157313|NCT05918055|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154157314|NCT05918055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154157315|NCT05918055|Antimetabolites|antimetabolites|mesh-ancestor
154157316|NCT05918055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157317|NCT05918055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157318|NCT05884372|Vitamin D|vitamin d|mesh-list
154157319|NCT05884372|Denosumab|denosumab|mesh-list
154157320|NCT05884372|Eldecalcitol|eldecalcitol|mesh-list
154157321|NCT05884372|Calcium|calcium|mesh-list
154157322|NCT05884372|Vitamins|vitamins|mesh-ancestor
154157323|NCT05884372|Micronutrients|micronutrients|mesh-ancestor
154157324|NCT05884372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157327|NCT05878769|Astegolimab|astegolimab|mesh-list
154157344|NCT05867121|Atezolizumab|atezolizumab|mesh-list
154157345|NCT05867121|Tegafur|tegafur|mesh-list
154157346|NCT05867121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154157347|NCT05867121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157348|NCT05867121|Tubulin Modulators|tubulin modulators|mesh-ancestor
154157349|NCT05867121|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191215|NCT05940324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191216|NCT05940324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154191217|NCT05940324|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154191218|NCT05935280|Lidocaine|lidocaine|mesh-list
154191219|NCT05935280|Sodium Channel Blockers|sodium channel blockers|mesh-list
154191220|NCT05935280|Anesthetics, Local|anesthetics, local|mesh-ancestor
154191221|NCT05935280|Anesthetics|anesthetics|mesh-ancestor
154191222|NCT05935280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191223|NCT05935280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191224|NCT05935280|Sensory System Agents|sensory system agents|mesh-ancestor
154191246|NCT05915182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191247|NCT05915182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191248|NCT05915182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154191249|NCT05915182|Respiratory System Agents|respiratory system agents|mesh-ancestor
154191250|NCT05915182|Glucocorticoids|glucocorticoids|mesh-ancestor
154191251|NCT05915182|Hormones|hormones|mesh-ancestor
154191252|NCT05915182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154191253|NCT05915182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154191254|NCT05915182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154191255|NCT05915182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154191256|NCT05915182|Adrenergic Agents|adrenergic agents|mesh-ancestor
154191257|NCT05915182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191258|NCT05915182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191259|NCT05915182|Anticonvulsants|anticonvulsants|mesh-ancestor
154191260|NCT05915182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154191261|NCT05915182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154191262|NCT05915182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154191263|NCT05915182|Cholinergic Agents|cholinergic agents|mesh-ancestor
154191264|NCT05910476|Ezetimibe|ezetimibe|mesh-list
154191265|NCT05910476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154191266|NCT05910476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154191267|NCT05910476|Antimetabolites|antimetabolites|mesh-ancestor
154191268|NCT05910476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191269|NCT05910476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154191270|NCT05907304|Trametinib|trametinib|mesh-list
154191271|NCT05907304|Naporafenib|naporafenib|mesh-list
154191272|NCT05907304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191273|NCT05907304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154191274|NCT05907304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191275|NCT05907304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191276|NCT05891561|Pertuzumab|pertuzumab|mesh-list
153454717|NCT01528254|Metformin|metformin|mesh-list
154191277|NCT05891561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191292|NCT05891119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154191293|NCT05891119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154191294|NCT05891119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154191295|NCT05891119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154191296|NCT05891119|Anesthetics, General|anesthetics, general|mesh-ancestor
154191297|NCT05891119|Anesthetics|anesthetics|mesh-ancestor
154191298|NCT05891119|GABA Modulators|gaba modulators|mesh-ancestor
154191299|NCT05891119|GABA Agents|gaba agents|mesh-ancestor
154191300|NCT05891119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191301|NCT05891119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191302|NCT05891119|Anticoagulants|anticoagulants|mesh-ancestor
154191303|NCT05891119|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154191304|NCT05891119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154191305|NCT05891119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191306|NCT05891119|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154191307|NCT05891119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153938266|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
154191308|NCT05891119|Purinergic Agents|purinergic agents|mesh-ancestor
154191309|NCT05891119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154191310|NCT05891119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154191311|NCT05891119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154191312|NCT05891119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154191313|NCT05891119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154191314|NCT05891119|Sympatholytics|sympatholytics|mesh-ancestor
154191315|NCT05891119|Autonomic Agents|autonomic agents|mesh-ancestor
154191316|NCT05891119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191317|NCT05891119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154191318|NCT05891119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154191319|NCT05891119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154191320|NCT05891119|Adrenergic Agents|adrenergic agents|mesh-ancestor
154191321|NCT05891119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154191322|NCT05891119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154191323|NCT05891119|Hemostatics|hemostatics|mesh-ancestor
154191324|NCT05891119|Coagulants|coagulants|mesh-ancestor
154191325|NCT05883956|Azacitidine|azacitidine|mesh-list
154191326|NCT05883956|Decitabine|decitabine|mesh-list
154191327|NCT05883956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191328|NCT05883956|Antimetabolites|antimetabolites|mesh-ancestor
154191329|NCT05883956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191330|NCT05883956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191331|NCT05883956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191332|NCT05874414|Trametinib|trametinib|mesh-list
154191333|NCT05874414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191334|NCT05874414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154191335|NCT05874414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191336|NCT05874414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191337|NCT05873712|Cyclophosphamide|cyclophosphamide|mesh-list
154191338|NCT05873712|Fludarabine|fludarabine|mesh-list
154191339|NCT05873712|Zanubrutinib|zanubrutinib|mesh-list
154191340|NCT05873712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191341|NCT05873712|Immunologic Factors|immunologic factors|mesh-ancestor
154191342|NCT05873712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191358|NCT05868122|Acetaminophen|acetaminophen|mesh-list
154191359|NCT05868122|Naproxen|naproxen|mesh-list
154191360|NCT05868122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154191361|NCT05868122|Analgesics|analgesics|mesh-ancestor
154191362|NCT05868122|Sensory System Agents|sensory system agents|mesh-ancestor
154191363|NCT05868122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191364|NCT05868122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191365|NCT05868122|Antipyretics|antipyretics|mesh-ancestor
154191366|NCT05868122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154191367|NCT05868122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154191368|NCT05868122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191369|NCT05868122|Gout Suppressants|gout suppressants|mesh-ancestor
154191370|NCT05868122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154191371|NCT05868122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191372|NCT05868122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191373|NCT05862272|Relugolix|relugolix|mesh-list
154191374|NCT05862272|Androgen Antagonists|androgen antagonists|mesh-ancestor
154191375|NCT05862272|Hormone Antagonists|hormone antagonists|mesh-ancestor
154191376|NCT05862272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154191377|NCT05862272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191378|NCT05861999|Risdiplam|risdiplam|mesh-list
154191379|NCT05861999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154191380|NCT05861999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191381|NCT05861999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191382|NCT05853575|Adagrasib|adagrasib|mesh-list
154191383|NCT05853575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153938348|NCT05378919|Hematinics|hematinics|mesh-ancestor
154191384|NCT05852132|Temazepam|temazepam|mesh-list
154191385|NCT05852132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154191386|NCT05852132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191387|NCT05852132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191388|NCT05852132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154191389|NCT05852132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154191390|NCT05852132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154191391|NCT05852132|GABA Modulators|gaba modulators|mesh-ancestor
154191392|NCT05852132|GABA Agents|gaba agents|mesh-ancestor
154191393|NCT05852132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191394|NCT05852132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191395|NCT05850546|Prednisone|prednisone|mesh-list
154191396|NCT05850546|Prednisolone|prednisolone|mesh-list
154191397|NCT05850546|Rituximab|rituximab|mesh-list
154191398|NCT05850546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191399|NCT05850546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191400|NCT05850546|Immunologic Factors|immunologic factors|mesh-ancestor
153454735|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
154191401|NCT05850546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191412|NCT05845645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191413|NCT05845645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191415|NCT05844995|Naproxen|naproxen|mesh-list
154191416|NCT05844995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154191417|NCT05844995|Analgesics|analgesics|mesh-ancestor
154191418|NCT05844995|Sensory System Agents|sensory system agents|mesh-ancestor
154191419|NCT05844995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191420|NCT05844995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191421|NCT05844995|Antipyretics|antipyretics|mesh-ancestor
154191422|NCT05844995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154191423|NCT05844995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154191424|NCT05844995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191425|NCT05844995|Gout Suppressants|gout suppressants|mesh-ancestor
154191426|NCT05844995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154191427|NCT05844995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191428|NCT05844995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191429|NCT05844332|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154191430|NCT05844332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154191431|NCT05844332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191432|NCT05842954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154191433|NCT05842954|Antimalarials|antimalarials|mesh-ancestor
154191434|NCT05842954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154191435|NCT05842954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154191436|NCT05842954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191437|NCT05841056|Amiodarone|amiodarone|mesh-list
154191438|NCT05841056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154191439|NCT05841056|Vasodilator Agents|vasodilator agents|mesh-ancestor
154191440|NCT05841056|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154191441|NCT05841056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154191442|NCT05841056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191443|NCT05841056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154191444|NCT05841056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154191445|NCT05841056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154191446|NCT05841056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191447|NCT05841056|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154191448|NCT05841056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154191449|NCT05841056|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154191450|NCT05839951|Trifluridine|trifluridine|mesh-list
154191451|NCT05839951|Bevacizumab|bevacizumab|mesh-list
154191452|NCT05839951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191453|NCT05839951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191454|NCT05839951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154191455|NCT05839951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154191456|NCT05839951|Growth Substances|growth substances|mesh-ancestor
154191457|NCT05839951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153938417|NCT00936975|Listerine|listerine|mesh-list
154191458|NCT05839951|Growth Inhibitors|growth inhibitors|mesh-ancestor
154191459|NCT05839951|Antimetabolites|antimetabolites|mesh-ancestor
154191460|NCT05839951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191461|NCT05839951|Antiviral Agents|antiviral agents|mesh-ancestor
154191462|NCT05839951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191463|NCT05837936|Anesthetics|anesthetics|mesh-list
154191477|NCT05813327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191478|NCT05801133|Pirfenidone|pirfenidone|mesh-list
154191479|NCT05801133|Analgesics|analgesics|mesh-ancestor
154191480|NCT05801133|Sensory System Agents|sensory system agents|mesh-ancestor
154191481|NCT05801133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256355|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
154191482|NCT05801133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191483|NCT05801133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154191484|NCT05801133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154191485|NCT05801133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154191486|NCT05801133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191487|NCT05801133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191488|NCT05782777|Ezetimibe|ezetimibe|mesh-list
154191489|NCT05782777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
154191490|NCT05782777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154191491|NCT05782777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154191492|NCT05782777|Antimetabolites|antimetabolites|mesh-ancestor
154191493|NCT05782777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191494|NCT05782777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154191495|NCT05782777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191496|NCT05779423|Nivolumab|nivolumab|mesh-list
154191497|NCT05779423|Ipilimumab|ipilimumab|mesh-list
154191498|NCT05779423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191499|NCT05779423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191500|NCT05779423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191501|NCT05779423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191502|NCT05777993|Mitapivat|mitapivat|mesh-list
154191503|NCT05777993|Enzyme Activators|enzyme activators|mesh-ancestor
154191504|NCT05777993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191505|NCT05776134|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154191506|NCT05776134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191507|NCT05776134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191508|NCT05771480|Paclitaxel|paclitaxel|mesh-list
154191509|NCT05771480|Cisplatin|cisplatin|mesh-list
154191510|NCT05771480|Carboplatin|carboplatin|mesh-list
154191511|NCT05771480|Gemcitabine|gemcitabine|mesh-list
154191512|NCT05771480|Oxaliplatin|oxaliplatin|mesh-list
154191513|NCT05771480|Durvalumab|durvalumab|mesh-list
154191514|NCT05771480|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154191515|NCT05771480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154191516|NCT05771480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191517|NCT05771480|Tubulin Modulators|tubulin modulators|mesh-ancestor
154191518|NCT05771480|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191519|NCT05771480|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191520|NCT05771480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191521|NCT05771480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191522|NCT05771480|Antimetabolites|antimetabolites|mesh-ancestor
154191523|NCT05771480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191524|NCT05766670|Vancomycin|vancomycin|mesh-list
154191525|NCT05766670|Gentamicins|gentamicins|mesh-list
154191546|NCT05742607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191547|NCT05742607|Immunologic Factors|immunologic factors|mesh-ancestor
154191548|NCT05742607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191558|NCT05712278|Fludarabine|fludarabine|mesh-list
154191559|NCT05712278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191560|NCT05712278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191561|NCT05712278|Antimetabolites|antimetabolites|mesh-ancestor
154191562|NCT05712278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191563|NCT05712278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191564|NCT05712278|Immunologic Factors|immunologic factors|mesh-ancestor
154191565|NCT05712278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191566|NCT05712278|Antiviral Agents|antiviral agents|mesh-ancestor
154191567|NCT05712278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191568|NCT05709977|Histamine Antagonists|histamine antagonists|mesh-list
154191569|NCT05709977|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154191570|NCT05709977|Histamine Agents|histamine agents|mesh-ancestor
154191571|NCT05709977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191572|NCT05709977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191573|NCT05709977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191574|NCT05705258|Aflibercept|aflibercept|mesh-list
154191575|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154191576|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154191577|NCT05705258|Growth Substances|growth substances|mesh-ancestor
154191578|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191579|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
154191580|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157350|NCT05867121|Mitosis Modulators|mitosis modulators|mesh-ancestor
153454800|NCT01524978|Cetuximab|cetuximab|mesh-list
154191581|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154191582|NCT05700565|Immunomodulating Agents|immunomodulating agents|mesh-list
154191583|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
154191585|NCT05699603|Fluorouracil|fluorouracil|mesh-list
154191586|NCT05699603|Calcipotriene|calcipotriene|mesh-list
154191587|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
154191588|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191589|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191590|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191591|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191592|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
154191593|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191594|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154191595|NCT05697783|Fentanyl|fentanyl|mesh-list
154191596|NCT05697783|Methadone|methadone|mesh-list
154191597|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154191598|NCT05697783|Narcotics|narcotics|mesh-ancestor
154191599|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191600|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191601|NCT05697783|Analgesics|analgesics|mesh-ancestor
154191660|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191661|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191663|NCT05661578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191664|NCT05661578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191665|NCT05661578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191666|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191667|NCT05656248|Cytarabine|cytarabine|mesh-list
154191668|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
154191669|NCT05656248|Methotrexate|methotrexate|mesh-list
154191670|NCT05656248|Daunorubicin|daunorubicin|mesh-list
154191671|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154191672|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
154191673|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154191674|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191675|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191676|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
154191677|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191678|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191679|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
154191680|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191681|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154191682|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154191683|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
154191684|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154191685|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154191686|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
154191687|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191688|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913056|NCT04216771|Cytarabine|cytarabine|mesh-list
154191689|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154191708|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191709|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154191710|NCT05615220|Ecopipam|ecopipam|mesh-list
154191711|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154191712|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154191713|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191714|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191715|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154191716|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154191717|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
154191718|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191719|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191720|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154191721|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
154191722|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191723|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191724|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154191725|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154191726|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154191727|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
154191728|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191729|NCT05604560|Tislelizumab|tislelizumab|mesh-list
154191730|NCT05604560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191731|NCT05604560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191732|NCT05571059|Ifetroban|ifetroban|mesh-list
154191733|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154191734|NCT05568797|Vaccines|vaccines|mesh-list
154256357|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154191735|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
154191736|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191737|NCT05567835|Leucovorin|leucovorin|mesh-list
154191738|NCT05567835|Docetaxel|docetaxel|mesh-list
154191739|NCT05567835|Fluorouracil|fluorouracil|mesh-list
154191740|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
154191741|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191742|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
153454840|NCT01571232|Dexamethasone|dexamethasone|mesh-list
154191743|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191744|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191745|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191746|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
154191769|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
154191770|NCT05554367|Palbociclib|palbociclib|mesh-list
154191771|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191772|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154191773|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191774|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191775|NCT05554094|Psilocybin|psilocybin|mesh-list
154191776|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
154191777|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191778|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154191779|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
154191780|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191781|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
154191782|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191783|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191784|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154191785|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
154191786|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191787|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191788|NCT05539365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191789|NCT05539365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191790|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
154191791|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191792|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191793|NCT05514444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191794|NCT05514444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191795|NCT05492578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154191796|NCT05492578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191819|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191821|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191822|NCT05468320|Prednisone|prednisone|mesh-list
154191823|NCT05468320|Prednisolone|prednisolone|mesh-list
154191824|NCT05468320|Antibodies|antibodies|mesh-list
154191825|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
154191826|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191827|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191828|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154191829|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
153938785|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191831|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154191832|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154191833|NCT05459129|Paclitaxel|paclitaxel|mesh-list
154191834|NCT05459129|Carboplatin|carboplatin|mesh-list
154191835|NCT05459129|Atezolizumab|atezolizumab|mesh-list
154191836|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154191837|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191838|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
154191839|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191840|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
154191841|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191842|NCT05459129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191843|NCT05459129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191844|NCT05458401|Trastuzumab|trastuzumab|mesh-list
154191845|NCT05458401|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154191846|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191872|NCT05425576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191874|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
154191875|NCT05424263|Calcium|calcium|mesh-list
154191876|NCT05424263|Calcium acetate|calcium acetate|mesh-list
154191878|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191879|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154191880|NCT05424263|Antacids|antacids|mesh-ancestor
154191881|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191882|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154191883|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
154191884|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
154191885|NCT05415267|Vaccines|vaccines|mesh-list
154191886|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
154191887|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191888|NCT05411081|Atezolizumab|atezolizumab|mesh-list
154191889|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154191890|NCT05411081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191891|NCT05411081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913149|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154191892|NCT05411081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191893|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191894|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
154191895|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191915|NCT05407675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154191916|NCT05396859|Decitabine|decitabine|mesh-list
154191917|NCT05396859|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154191918|NCT05396859|Entrectinib|entrectinib|mesh-list
154191919|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154191920|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
154191921|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191922|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191923|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191924|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154191925|NCT05394519|Semaglutide|semaglutide|mesh-list
154191926|NCT05394519|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154191927|NCT05394519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154191928|NCT05394519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191929|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154191930|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154191931|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154191932|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154191933|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191934|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191935|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
154191936|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191937|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154191938|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154191939|NCT05371015|Ropivacaine|ropivacaine|mesh-list
154191940|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
154191941|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
154191942|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191943|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191944|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
154191945|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191946|NCT05369052|Linezolid|linezolid|mesh-list
154191947|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154191948|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154191949|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154191950|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154191965|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191966|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191967|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
154191968|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154191969|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154191970|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154191971|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
154191972|NCT05350501|Nivolumab|nivolumab|mesh-list
154191973|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154191974|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191975|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154191976|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191977|NCT05348577|Docetaxel|docetaxel|mesh-list
154191978|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154191980|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
154191981|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
154256358|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
154191982|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191983|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
154191984|NCT05347173|Nalbuphine|nalbuphine|mesh-list
154191985|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154191986|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154191987|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154191988|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154191989|NCT05347173|Analgesics|analgesics|mesh-ancestor
154191990|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
154191991|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154191992|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154191993|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154191994|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154191995|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
154191996|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154191997|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154191998|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154191999|NCT05347173|Narcotics|narcotics|mesh-ancestor
154192000|NCT05345457|Amoxicillin|amoxicillin|mesh-list
154192001|NCT05345457|Azithromycin|azithromycin|mesh-list
154192002|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154192003|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192004|NCT05339087|Riociguat|riociguat|mesh-list
154192005|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
154192006|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192007|NCT05336812|Venetoclax|venetoclax|mesh-list
154192008|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
154192009|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
154192010|NCT05336812|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154192011|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192012|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192013|NCT05336812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192049|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192050|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154192051|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154192053|NCT05325073|Hematinics|hematinics|mesh-ancestor
154192054|NCT05320926|Aspirin|aspirin|mesh-list
154192055|NCT05320926|Clopidogrel|clopidogrel|mesh-list
154192091|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154192092|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
154192104|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192105|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192106|NCT05294406|Piperaquine|piperaquine|mesh-list
154192107|NCT05294406|Artenimol|artenimol|mesh-list
154192108|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
154192109|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154192110|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154192111|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192112|NCT05288166|Prednisone|prednisone|mesh-list
154192113|NCT05288166|Prednisolone|prednisolone|mesh-list
154192114|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154192115|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
154192116|NCT05288166|Hormones|hormones|mesh-ancestor
154192117|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192118|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192119|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154192120|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192121|NCT05267626|Aldesleukin|aldesleukin|mesh-list
154192122|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192123|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154192124|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154192125|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
154192126|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192127|NCT05267613|Esomeprazole|esomeprazole|mesh-list
153939081|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
154192128|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154192129|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154192130|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154192135|NCT05254171|Paclitaxel|paclitaxel|mesh-list
154192136|NCT05254171|Gemcitabine|gemcitabine|mesh-list
154192137|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192138|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192139|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192140|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192141|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801748|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
154192142|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192143|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154192145|NCT05253768|Glycerol|glycerol|mesh-list
154192146|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154192147|NCT05253768|Protective Agents|protective agents|mesh-ancestor
154192148|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192149|NCT05249634|Testosterone|testosterone|mesh-list
154192150|NCT05249634|Androgens|androgens|mesh-ancestor
154192151|NCT05249634|Hormones|hormones|mesh-ancestor
154192152|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192153|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192154|NCT05234307|Nivolumab|nivolumab|mesh-list
154192155|NCT05234307|Adenosine|adenosine|mesh-list
154192156|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
154192157|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192158|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192159|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192160|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192161|NCT05234307|Analgesics|analgesics|mesh-ancestor
154192187|NCT05193370|Giapreza|giapreza|mesh-list
154192188|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
154192189|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
154192190|NCT05193370|Coagulants|coagulants|mesh-ancestor
154192191|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154192192|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154192193|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
154192194|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192195|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154192196|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
154192197|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192198|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192199|NCT05185947|Paclitaxel|paclitaxel|mesh-list
154192200|NCT05185947|Nilotinib|nilotinib|mesh-list
154192201|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192202|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192203|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192204|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192205|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192206|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192207|NCT05185947|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154192208|NCT05185947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192209|NCT05185947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192210|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
154192211|NCT05182073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154192212|NCT05182073|Fludarabine|fludarabine|mesh-list
154192213|NCT05182073|Daratumumab|daratumumab|mesh-list
154192214|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154192215|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192216|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
154192217|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192236|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192238|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192239|NCT05144256|Mitapivat|mitapivat|mesh-list
154192240|NCT05144256|Enzyme Activators|enzyme activators|mesh-ancestor
154192241|NCT05144256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192242|NCT05140278|Artesunate|artesunate|mesh-list
154192243|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
154192244|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153454980|NCT01514370|Curcumin|curcumin|mesh-list
154192245|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154192246|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192247|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192248|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
154192249|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
154192250|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154192251|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
154192252|NCT05138575|Empagliflozin|empagliflozin|mesh-list
154192253|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154192254|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192255|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154192256|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192257|NCT05124080|Deucravacitinib|deucravacitinib|mesh-list
154192258|NCT05124080|Dermatologic Agents|dermatologic agents|mesh-ancestor
154192259|NCT05124080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192260|NCT05124080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192261|NCT05124080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192262|NCT05120349|Osimertinib|osimertinib|mesh-list
154192263|NCT05120349|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154192264|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192265|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192266|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192267|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192268|NCT05105919|Aspirin|aspirin|mesh-list
154192269|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154192270|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154192271|NCT05105919|Analgesics|analgesics|mesh-ancestor
154192279|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192280|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154192281|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154192282|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192284|NCT05086224|Lidocaine|lidocaine|mesh-list
154192285|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
154192286|NCT05086224|Anesthetics|anesthetics|mesh-list
154192287|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154192288|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192289|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
154192290|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192291|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154192292|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154192293|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154192294|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154192295|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192296|NCT05077800|Losartan|losartan|mesh-list
154192297|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154192298|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154192299|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154192300|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154192301|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192302|NCT05065658|Posaconazole|posaconazole|mesh-list
154192303|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
154192304|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192305|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154192306|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154192307|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154192308|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154192309|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154192310|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192311|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192312|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154192313|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
154192314|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192315|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192320|NCT05057494|Venetoclax|venetoclax|mesh-list
154192321|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
154192322|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
154192323|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192324|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192325|NCT05057494|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154192326|NCT05057494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192327|NCT05057494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913251|NCT02733679|Metformin|metformin|mesh-list
154192328|NCT05057494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192329|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
154192330|NCT05054348|Cemiplimab|cemiplimab|mesh-list
154192331|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192332|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192333|NCT05054348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192334|NCT05054348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192335|NCT05041036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154192358|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154192359|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154192360|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154192361|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192362|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154192363|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154256359|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256360|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
154192364|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154192365|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154192366|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154192367|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
154192368|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
154192369|NCT05025488|Poly ICLC|poly iclc|mesh-list
154192370|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
154192371|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
154192372|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192373|NCT05021731|Rifampin|rifampin|mesh-list
154192374|NCT05021731|Rifapentine|rifapentine|mesh-list
154192375|NCT05021731|Isoniazid|isoniazid|mesh-list
154192376|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154192377|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
154192378|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154192379|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192380|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
154192381|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154192382|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192383|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192384|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154192385|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154192386|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154192400|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154192401|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192402|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192403|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154192404|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154192406|NCT05018091|Dexamethasone|dexamethasone|mesh-list
154192407|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
154192408|NCT05018091|BB 1101|bb 1101|mesh-list
154192409|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154192410|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
154192411|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
154192412|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192413|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192414|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154192415|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
154192416|NCT05018091|Hormones|hormones|mesh-ancestor
154192417|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192418|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154192419|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192420|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
154192421|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192422|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192423|NCT05006079|Morphine|morphine|mesh-list
154192424|NCT05006079|Alprazolam|alprazolam|mesh-list
154192425|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154192426|NCT05006079|Narcotics|narcotics|mesh-ancestor
154192427|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154192428|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192429|NCT05006079|Analgesics|analgesics|mesh-ancestor
154192430|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
154192431|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192432|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154192433|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154192434|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154192435|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154192436|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
154192437|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
154192438|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154192439|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192440|NCT05000294|Atezolizumab|atezolizumab|mesh-list
154192441|NCT05000294|Tivozanib|tivozanib|mesh-list
154192442|NCT05000294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192443|NCT05000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192444|NCT05000294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192445|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192446|NCT05000294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192447|NCT05000294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192457|NCT04990869|Vitamins|vitamins|mesh-ancestor
154192458|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
153802150|NCT05969795|Hormones|hormones|mesh-ancestor
154192459|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192460|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154192461|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
154192462|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192463|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154192464|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
154192465|NCT04958785|Paclitaxel|paclitaxel|mesh-list
154192466|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154192467|NCT04958785|Magrolimab|magrolimab|mesh-list
154192468|NCT04958785|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154192469|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192470|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192471|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192472|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192473|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192474|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192475|NCT04958785|Immunoconjugates|immunoconjugates|mesh-ancestor
154192476|NCT04958785|Immunologic Factors|immunologic factors|mesh-ancestor
154192477|NCT04958785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192478|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192479|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
154192480|NCT04949256|Leucovorin|leucovorin|mesh-list
154192481|NCT04949256|Paclitaxel|paclitaxel|mesh-list
154192482|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
154192483|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
154192484|NCT04949256|Lenvatinib|lenvatinib|mesh-list
154192485|NCT04949256|Calcium|calcium|mesh-list
154192486|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
154192487|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192488|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192489|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192490|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192491|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192492|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192493|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192494|NCT04949256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192495|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154192496|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192497|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154192498|NCT04949256|Antidotes|antidotes|mesh-ancestor
154192499|NCT04949256|Protective Agents|protective agents|mesh-ancestor
154192500|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
154192501|NCT04949256|Vitamins|vitamins|mesh-ancestor
154192502|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
154192503|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192504|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192505|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
154192506|NCT04947501|Ifosfamide|ifosfamide|mesh-list
154192507|NCT04947501|Carboplatin|carboplatin|mesh-list
154192508|NCT04947501|Doxorubicin|doxorubicin|mesh-list
154192509|NCT04947501|Etoposide|etoposide|mesh-list
154192510|NCT04947501|Vincristine|vincristine|mesh-list
154192511|NCT04947501|Topotecan|topotecan|mesh-list
154192512|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192513|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
154192514|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192515|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154192516|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154192517|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
154192529|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154192531|NCT04936230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192532|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455116|NCT01462266|Incretins|incretins|mesh-ancestor
154192533|NCT04936230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192534|NCT04936230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192535|NCT04925375|Abatacept|abatacept|mesh-list
154192536|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192537|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192538|NCT04925375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192539|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192540|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192541|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
154192542|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192543|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154192544|NCT04921722|Sirolimus|sirolimus|mesh-list
154192545|NCT04921722|Temsirolimus|temsirolimus|mesh-list
154192546|NCT04921722|MTOR Inhibitors|mtor inhibitors|mesh-list
154192548|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192549|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154192550|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192551|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
154192552|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192553|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
154192554|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192555|NCT04921722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192556|NCT04921722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192557|NCT04921722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192558|NCT04916470|Semaglutide|semaglutide|mesh-list
154192559|NCT04916470|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154192560|NCT04916470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154192561|NCT04916470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192562|NCT04910022|Temozolomide|temozolomide|mesh-list
154192563|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154192564|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
154192565|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192566|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192567|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154192568|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154192569|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154192570|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
154192571|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192572|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154192573|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154192574|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192575|NCT04895748|Everolimus|everolimus|mesh-list
154192576|NCT04895748|Spartalizumab|spartalizumab|mesh-list
154192577|NCT04895748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154192616|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154192617|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192618|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154192619|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192620|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
154192621|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192622|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
154192623|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192625|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154192626|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
154192627|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192628|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192629|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154192630|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154192631|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
154192632|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154192633|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192634|NCT04832854|Paclitaxel|paclitaxel|mesh-list
154192635|NCT04832854|Carboplatin|carboplatin|mesh-list
154192636|NCT04832854|Gemcitabine|gemcitabine|mesh-list
154192637|NCT04832854|Pemetrexed|pemetrexed|mesh-list
154192638|NCT04832854|Atezolizumab|atezolizumab|mesh-list
154192639|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192640|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192641|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192660|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192661|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
154192662|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192663|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
154192664|NCT04789408|Fludarabine|fludarabine|mesh-list
154192665|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192666|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
154192667|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192668|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154192669|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154192670|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
154192671|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192672|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192673|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154192674|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
154192675|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154192676|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192677|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154192680|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192681|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192682|NCT04770779|Mitapivat|mitapivat|mesh-list
154192683|NCT04770779|Enzyme Activators|enzyme activators|mesh-ancestor
154192684|NCT04770779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192685|NCT04770753|Mitapivat|mitapivat|mesh-list
154192686|NCT04770753|Enzyme Activators|enzyme activators|mesh-ancestor
154192687|NCT04770753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192688|NCT04753749|Aspirin|aspirin|mesh-list
154192689|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154192690|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154192691|NCT04753749|Analgesics|analgesics|mesh-ancestor
154192692|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
154192693|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192694|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192695|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154192696|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154192697|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154192709|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192710|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192711|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192712|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192713|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192714|NCT04736173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192715|NCT04736173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192716|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192717|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154192718|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154192719|NCT04735549|Hormones|hormones|mesh-list
154192720|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192721|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192722|NCT04734652|Tenofovir|tenofovir|mesh-list
154192723|NCT04734652|Lamivudine|lamivudine|mesh-list
154192724|NCT04734652|Dolutegravir|dolutegravir|mesh-list
154192725|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
154192726|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192727|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153939670|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154192728|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154192729|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192730|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192731|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154192732|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154192733|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154192734|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154192735|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
154192736|NCT04729348|Lenvatinib|lenvatinib|mesh-list
154192737|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192738|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192739|NCT04729348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192740|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192741|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192742|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192743|NCT04722523|Carboplatin|carboplatin|mesh-list
154192744|NCT04722523|Docetaxel|docetaxel|mesh-list
154192745|NCT04722523|Cetuximab|cetuximab|mesh-list
154192746|NCT04722523|Cemiplimab|cemiplimab|mesh-list
154192747|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192748|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192749|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192750|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192751|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192752|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192753|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154192754|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154192755|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192756|NCT04690192|Gemcitabine|gemcitabine|mesh-list
154192757|NCT04690192|Melphalan|melphalan|mesh-list
154192758|NCT04690192|Busulfan|busulfan|mesh-list
154192759|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154192760|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
154192775|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192776|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192777|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192778|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154192779|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154192780|NCT04686305|Immunoconjugates|immunoconjugates|mesh-ancestor
154192781|NCT04686305|Immunologic Factors|immunologic factors|mesh-ancestor
154192782|NCT04686305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455224|NCT01460628|Modafinil|modafinil|mesh-list
154192783|NCT04680442|Trastuzumab|trastuzumab|mesh-list
154192784|NCT04680442|Pertuzumab|pertuzumab|mesh-list
154192785|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154192786|NCT04680442|Maytansine|maytansine|mesh-list
154192787|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192788|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192789|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192790|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192791|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192792|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192793|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192794|NCT04680442|Immunotoxins|immunotoxins|mesh-ancestor
154192795|NCT04680442|Immunoconjugates|immunoconjugates|mesh-ancestor
154192796|NCT04680442|Immunologic Factors|immunologic factors|mesh-ancestor
154192797|NCT04680442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192798|NCT04669171|Rituximab|rituximab|mesh-list
154192799|NCT04669171|Lenalidomide|lenalidomide|mesh-list
154192800|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192801|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192802|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
154192803|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153939753|NCT04261023|Abatacept|abatacept|mesh-list
154192804|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154192805|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154192806|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154192807|NCT04669171|Growth Substances|growth substances|mesh-ancestor
154192808|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
154192809|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
154192810|NCT04666740|Olaparib|olaparib|mesh-list
154192811|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192812|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192813|NCT04666740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192814|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192815|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154192816|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192819|NCT04665037|Posaconazole|posaconazole|mesh-list
154192820|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
154192821|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192831|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192832|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192834|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154192835|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192836|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154192837|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
153455252|NCT03026946|Cyclosporine|cyclosporine|mesh-list
154192838|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154192839|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192840|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192841|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192842|NCT04642469|Durvalumab|durvalumab|mesh-list
154192843|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192844|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192845|NCT04632927|Ustekinumab|ustekinumab|mesh-list
154192846|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
154192847|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
154192848|NCT04630756|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154192849|NCT04630756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192850|NCT04630756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192851|NCT04630756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192852|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192853|NCT04623216|Azacitidine|azacitidine|mesh-list
154192854|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154192855|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
154192856|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192857|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192858|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192859|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
154256361|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192860|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154192861|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154192863|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
154192864|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154192865|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
154192866|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154192867|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
154192868|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
154192869|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154192870|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192871|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154192872|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
154192873|NCT04622917|Hormones|hormones|mesh-ancestor
154192874|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192875|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154192876|NCT04622917|Protective Agents|protective agents|mesh-ancestor
154192877|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153939822|NCT00609063|Atorvastatin|atorvastatin|mesh-list
154192878|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192879|NCT04617002|TIC10 compound|tic10 compound|mesh-list
154192880|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192881|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
154192882|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154192883|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192898|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192899|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192900|NCT04560972|Carboplatin|carboplatin|mesh-list
154192902|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
154192903|NCT04560972|Atezolizumab|atezolizumab|mesh-list
154192904|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
154192905|NCT04560972|LB100|lb100|mesh-list
154192906|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154192907|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192908|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154192909|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154192910|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154192911|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192912|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192913|NCT04560972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192914|NCT04560972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192915|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
154192916|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192917|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
154192918|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
154192919|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
154192920|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
154192921|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
154192922|NCT04544189|Fulvestrant|fulvestrant|mesh-list
154192923|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154192924|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192925|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154192926|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154192927|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
153913494|NCT02720575|Vitamin D|vitamin d|mesh-list
154192928|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192929|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192930|NCT04544007|Poly ICLC|poly iclc|mesh-list
154192931|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
154192932|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
154192933|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192934|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154192935|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
154192936|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192937|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
154192938|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154192939|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192940|NCT04534205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154192941|NCT04534205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192942|NCT04533750|Deoxyglucose|deoxyglucose|mesh-list
154192943|NCT04533750|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154192944|NCT04533750|Peposertib|peposertib|mesh-list
154192945|NCT04533750|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154192957|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192958|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154192959|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
154192961|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154192962|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154192963|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192964|NCT04496960|Tofacitinib|tofacitinib|mesh-list
154192965|NCT04496960|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154192966|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154192967|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192968|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192969|NCT04493164|Cytarabine|cytarabine|mesh-list
154192970|NCT04493164|Daunorubicin|daunorubicin|mesh-list
154192971|NCT04493164|Ivosidenib|ivosidenib|mesh-list
154192972|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154192973|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
154192974|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192975|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192976|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
154192977|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154192978|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192979|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
154192980|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192981|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154192982|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154192983|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154192984|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154192985|NCT04488159|Leucovorin|leucovorin|mesh-list
154192986|NCT04488159|Capecitabine|capecitabine|mesh-list
154192987|NCT04488159|Fluorouracil|fluorouracil|mesh-list
154192988|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
153455310|NCT06175117|Cortisone|cortisone|mesh-list
153455318|NCT06174935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154192989|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154192990|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
154192991|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154192992|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154192993|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154192994|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
154192995|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154192996|NCT04488159|Antidotes|antidotes|mesh-ancestor
154192997|NCT04488159|Protective Agents|protective agents|mesh-ancestor
154192998|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
154192999|NCT04488159|Vitamins|vitamins|mesh-ancestor
154193000|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
154193001|NCT04477486|Venetoclax|venetoclax|mesh-list
154193002|NCT04477486|Ibrutinib|ibrutinib|mesh-list
154193003|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193004|NCT04477486|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154193005|NCT04477486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193006|NCT04477486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193007|NCT04477486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193008|NCT04469959|Levodopa|levodopa|mesh-list
154193009|NCT04469959|Carbidopa|carbidopa|mesh-list
154193032|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193034|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193035|NCT04440280|Antidotes|antidotes|mesh-ancestor
154193036|NCT04435600|Ustekinumab|ustekinumab|mesh-list
154193037|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
154193038|NCT04411836|Primaquine|primaquine|mesh-list
154193039|NCT04411836|Tafenoquine|tafenoquine|mesh-list
154193040|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
154193041|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154193042|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154193043|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193044|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
154193045|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154193046|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154193047|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193048|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
154193049|NCT04410042|Coagulants|coagulants|mesh-ancestor
154193050|NCT04401748|Azacitidine|azacitidine|mesh-list
154193051|NCT04401748|Venetoclax|venetoclax|mesh-list
154193052|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193053|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
154193054|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193055|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193056|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193057|NCT04394546|Anticoagulants|anticoagulants|mesh-list
154193058|NCT04372433|Azacitidine|azacitidine|mesh-list
154256363|NCT01265576|Sorafenib|sorafenib|mesh-list
154256364|NCT01265576|Propranolol|propranolol|mesh-list
153349406|NCT05266274|Antibodies|antibodies|mesh-list
154193059|NCT04372433|Venetoclax|venetoclax|mesh-list
154193060|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193061|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
154193062|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193063|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193132|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193133|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
154193134|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193135|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154193136|NCT04303702|Oxytocin|oxytocin|mesh-list
154193137|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
154193138|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154193139|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193140|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
154193141|NCT04298229|Diuretics|diuretics|mesh-list
154193142|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154193168|NCT04241185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193169|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193170|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
154193171|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193172|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154193173|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
154193174|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154193175|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193176|NCT04230148|Triclabendazole|triclabendazole|mesh-list
154193177|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154193178|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
154193179|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154193180|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153940116|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193181|NCT04212052|Immunomodulating Agents|immunomodulating agents|mesh-list
154193182|NCT04212052|Immunologic Factors|immunologic factors|mesh-ancestor
154193183|NCT04212052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193184|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
154193185|NCT04210115|Leucovorin|leucovorin|mesh-list
154193186|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
154193187|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
154193188|NCT04210115|Calcium|calcium|mesh-list
154193189|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
154193190|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193191|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193202|NCT04200963|Nivolumab|nivolumab|mesh-list
154193203|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193204|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193205|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193206|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193207|NCT04174196|Lenalidomide|lenalidomide|mesh-list
154193208|NCT04174196|Cc-486|cc-486|mesh-list
154193209|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
154193210|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193211|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154193212|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154193213|NCT04174196|Growth Substances|growth substances|mesh-ancestor
154193214|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
154193215|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193216|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
154193217|NCT04173988|Fludarabine|fludarabine|mesh-list
154193218|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193219|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
154193220|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193221|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913538|NCT02719795|Ropivacaine|ropivacaine|mesh-list
154193222|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193223|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
154193224|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193225|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193226|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154193227|NCT04140487|Azacitidine|azacitidine|mesh-list
154193228|NCT04140487|Venetoclax|venetoclax|mesh-list
154193229|NCT04140487|Gilteritinib|gilteritinib|mesh-list
154193230|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193231|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
153802923|NCT03661723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153802924|NCT03661723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802925|NCT03629340|Metformin|metformin|mesh-list
153802926|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153802927|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802928|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
153802929|NCT03598595|Gemcitabine|gemcitabine|mesh-list
153802930|NCT03598595|Docetaxel|docetaxel|mesh-list
153802931|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802932|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
153802933|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193232|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193233|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193234|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193235|NCT04140487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154193236|NCT04140487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193237|NCT04130542|Pembrolizumab|pembrolizumab|mesh-list
154193238|NCT04130542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193239|NCT04130542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193240|NCT04130542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193241|NCT04130542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193242|NCT04062448|Rituximab|rituximab|mesh-list
154193243|NCT04062448|Ibrutinib|ibrutinib|mesh-list
154193244|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193245|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193246|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
154193247|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193248|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193249|NCT04062448|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154193250|NCT04062448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193251|NCT04062448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193252|NCT04062448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193253|NCT04057898|Ibudilast|ibudilast|mesh-list
154193254|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154193255|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
154193275|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193276|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154193277|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154193278|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154193279|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193280|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193281|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154193282|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154193283|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193284|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
154193285|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154193287|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154193288|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154193289|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193290|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193291|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154193292|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193294|NCT03944772|Etoposide|etoposide|mesh-list
154193295|NCT03944772|Pemetrexed|pemetrexed|mesh-list
154193296|NCT03944772|Durvalumab|durvalumab|mesh-list
154193297|NCT03944772|Gefitinib|gefitinib|mesh-list
154193298|NCT03944772|Osimertinib|osimertinib|mesh-list
154193299|NCT03944772|Necitumumab|necitumumab|mesh-list
154193300|NCT03944772|Alectinib|alectinib|mesh-list
154193301|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193302|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154193303|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154193304|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153803043|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193305|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193306|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193307|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154193308|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154193338|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193339|NCT03924895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193340|NCT03924895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193342|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
154193343|NCT03915964|Etanercept|etanercept|mesh-list
154193344|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154193345|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193346|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154193347|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154193348|NCT03915964|Analgesics|analgesics|mesh-ancestor
154193349|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
154193350|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193351|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193352|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154193383|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154193384|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193385|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193386|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193388|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193389|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193390|NCT03833167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193391|NCT03833167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193392|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
154193393|NCT03829332|Lenvatinib|lenvatinib|mesh-list
154193394|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193395|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193414|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
154193415|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193416|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193417|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154193418|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
154193419|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193420|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193421|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154193422|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
154193423|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154193424|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193425|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154193426|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
154193427|NCT03779334|Risdiplam|risdiplam|mesh-list
154193428|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154193429|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193430|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193431|NCT03771157|Vaccines|vaccines|mesh-list
154193432|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
154193433|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193434|NCT03761095|Dacarbazine|dacarbazine|mesh-list
154193435|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193436|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
154193437|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193438|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193439|NCT03745144|Cladribine|cladribine|mesh-list
154193440|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154193441|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154193442|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193443|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193444|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
154193445|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193446|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154193447|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
154193448|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154193449|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154193463|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193464|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193465|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193466|NCT03692052|Mitapivat|mitapivat|mesh-list
154193467|NCT03692052|Enzyme Activators|enzyme activators|mesh-ancestor
154193468|NCT03692052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193469|NCT03656536|Gemcitabine|gemcitabine|mesh-list
154193470|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455384|NCT06173986|Antimitotic Agents|antimitotic agents|mesh-ancestor
154193471|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193472|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
154193473|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193474|NCT03617718|Glycine|glycine|mesh-list
154193475|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
154193476|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154193477|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193478|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193479|NCT03613116|Vitamin D|vitamin d|mesh-list
154193480|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
154193481|NCT03613116|Vitamins|vitamins|mesh-ancestor
154193482|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
154193483|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193484|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154193485|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154193486|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
154193487|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154193488|NCT03604315|Fluorides|fluorides|mesh-list
154193489|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154193490|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193491|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
154193492|NCT03604315|Protective Agents|protective agents|mesh-ancestor
154193493|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193494|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
154193495|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
154193496|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193497|NCT03593018|Gemcitabine|gemcitabine|mesh-list
154193498|NCT03593018|Azacitidine|azacitidine|mesh-list
154193499|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154193500|NCT03593018|Romidepsin|romidepsin|mesh-list
154193501|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193502|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
154193503|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193504|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193505|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193506|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193507|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
154193508|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154193509|NCT03593018|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154193568|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193569|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193570|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
154193571|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193572|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193573|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154193574|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154193575|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154193576|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154193577|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193578|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154193579|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
154193580|NCT03505762|Hormones|hormones|mesh-ancestor
154193581|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193582|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193583|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154193584|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
154193585|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
154193586|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
154193587|NCT03504956|Metoprolol|metoprolol|mesh-list
154193588|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154193589|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154193590|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154193591|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
154193592|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
154193593|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193594|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193595|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154193596|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154193597|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
154193598|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154193618|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154193620|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193621|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
154193622|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193623|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193624|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154193625|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193626|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455419|NCT06155331|Doxorubicin|doxorubicin|mesh-list
154193627|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154193629|NCT03441061|Immunoconjugates|immunoconjugates|mesh-ancestor
154193630|NCT03441061|Immunologic Factors|immunologic factors|mesh-ancestor
154193631|NCT03441061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193632|NCT03382977|Carmustine|carmustine|mesh-list
154193633|NCT03382977|Lomustine|lomustine|mesh-list
154193634|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193635|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
154193636|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193637|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193638|NCT03382717|Amorolfine|amorolfine|mesh-list
154193639|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
154193640|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193641|NCT03321656|Tacrolimus|tacrolimus|mesh-list
154193642|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193643|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
154193644|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193645|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154193646|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193647|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193648|NCT03299426|Vaccines|vaccines|mesh-list
154193649|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
154193650|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193651|NCT03298087|Leuprolide|leuprolide|mesh-list
154193681|NCT03214562|Lenograstim|lenograstim|mesh-list
154193682|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193683|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193684|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
154193685|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193686|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193687|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
154193688|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193689|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
154193690|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193691|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154193692|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154193693|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154193694|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154193695|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193696|NCT03161522|Capecitabine|capecitabine|mesh-list
154193697|NCT03161522|Fluorouracil|fluorouracil|mesh-list
154193698|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193699|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
153940640|NCT01097057|Plerixafor|plerixafor|mesh-list
154193722|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193723|NCT03072238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193724|NCT03072238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193725|NCT03072238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193726|NCT03065335|Ketamine|ketamine|mesh-list
154193727|NCT03065335|Analgesics|analgesics|mesh-ancestor
154193728|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
154193729|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913666|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
154193730|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193731|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154193732|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154193733|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
154193734|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
154193735|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154193736|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154193737|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154193738|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154193739|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193740|NCT03031730|Dexamethasone|dexamethasone|mesh-list
154193741|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
154193742|NCT03031730|Lenalidomide|lenalidomide|mesh-list
154193743|NCT03031730|Ichthammol|ichthammol|mesh-list
154193744|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154193745|NCT03031730|BB 1101|bb 1101|mesh-list
154193746|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154193747|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
154193748|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
154193749|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193750|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193751|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154193752|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
154193767|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154193768|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193769|NCT03024489|Cetuximab|cetuximab|mesh-list
154193770|NCT03024489|Palbociclib|palbociclib|mesh-list
154193771|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193772|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193773|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193774|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193775|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193777|NCT03012529|Rifampin|rifampin|mesh-list
154193778|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154193779|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
153913707|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154193780|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154193781|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193782|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
154193783|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154193784|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193785|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193786|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154193787|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154193788|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154193789|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154193790|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154193791|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154193792|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
154193793|NCT03012529|Vitamins|vitamins|mesh-ancestor
154193794|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
154193795|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193796|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154193797|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
154193798|NCT02997202|Gilteritinib|gilteritinib|mesh-list
154193799|NCT02997202|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154193800|NCT02997202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193801|NCT02997202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193802|NCT02997202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193803|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154193804|NCT02981446|Latanoprost|latanoprost|mesh-list
154193805|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154193832|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154193833|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
154193834|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
154193835|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154193836|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193837|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154193838|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
154193839|NCT02896582|Hormones|hormones|mesh-ancestor
154193840|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193841|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193842|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193843|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154193844|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154193845|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154193846|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193847|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193848|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154193849|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
154193850|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
154193851|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193852|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193853|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
154193854|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193855|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
154193856|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154193857|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193859|NCT02842749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154193860|NCT02842749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154193861|NCT02842749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154193862|NCT02842749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193863|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193864|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
154193865|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193866|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193867|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154193868|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
154193869|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
154193870|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154193889|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
154193890|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193891|NCT02791334|Ramucirumab|ramucirumab|mesh-list
154193892|NCT02791334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154193893|NCT02791334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154193894|NCT02791334|Growth Substances|growth substances|mesh-ancestor
154193895|NCT02791334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193896|NCT02791334|Growth Inhibitors|growth inhibitors|mesh-ancestor
154193897|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193898|NCT02772588|Leuprolide|leuprolide|mesh-list
154193899|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154193900|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
154193901|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154193902|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193903|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154193904|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193905|NCT02621021|Aldesleukin|aldesleukin|mesh-list
154193906|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
154193907|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
154193908|NCT02621021|Fludarabine|fludarabine|mesh-list
154193909|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154193910|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
154193911|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154193912|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154193913|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154193914|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
154193915|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154193916|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193917|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154193918|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154193919|NCT02621021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154193920|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154193921|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154193922|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
154193923|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193924|NCT02567422|Cisplatin|cisplatin|mesh-list
154193925|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154193926|NCT02506933|Vaccines|vaccines|mesh-list
154193927|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
154193994|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154193995|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
154193996|NCT01976286|Salicylates|salicylates|mesh-list
154193997|NCT01976286|Glycolic acid|glycolic acid|mesh-list
154193998|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154193999|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
154194000|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
154194001|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
154194002|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154194003|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154194005|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
154194006|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194007|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194008|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194009|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194010|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154194011|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194012|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194014|NCT01885689|Melphalan|melphalan|mesh-list
153913767|NCT01015131|Alovudine|alovudine|mesh-list
154194029|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
154194030|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154194031|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154194032|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
154194034|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154194035|NCT01730833|Trastuzumab|trastuzumab|mesh-list
154194036|NCT01730833|Pertuzumab|pertuzumab|mesh-list
154194037|NCT01730833|Antibodies|antibodies|mesh-list
154194038|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
154194039|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154194040|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194041|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
154194042|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
154194043|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
154194044|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194045|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
154194046|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194047|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194048|NCT01703507|Ipilimumab|ipilimumab|mesh-list
154194049|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194050|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194051|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154194052|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194053|NCT01653678|Vitamin D|vitamin d|mesh-list
154194054|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
154194055|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
154194056|NCT01653678|Vitamins|vitamins|mesh-list
154194057|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
154194058|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194059|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154194060|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154194061|NCT01650701|Rituximab|rituximab|mesh-list
154194062|NCT01650701|Lenalidomide|lenalidomide|mesh-list
154194063|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154194064|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194065|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194066|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
154194067|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194068|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455573|NCT05773846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194069|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154194070|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154194071|NCT01650701|Growth Substances|growth substances|mesh-ancestor
154194072|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
154194073|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154194074|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
154194087|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194088|NCT01351103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194089|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194091|NCT01329614|Nicotine|nicotine|mesh-list
154194092|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154194093|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
154194094|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194095|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194096|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154194097|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154194098|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
154194099|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194100|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194101|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154194102|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154194103|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194104|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194105|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
154194106|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194107|NCT01135394|Pioglitazone|pioglitazone|mesh-list
154194108|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154194109|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194110|NCT00967785|Plerixafor|plerixafor|mesh-list
154194111|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154194112|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154194113|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
154194115|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
154194116|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
153455587|NCT05757063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153455588|NCT05757063|Analgesics|analgesics|mesh-ancestor
153455589|NCT05757063|Sensory System Agents|sensory system agents|mesh-ancestor
153913811|NCT01222715|MTOR Inhibitors|mtor inhibitors|mesh-list
154194117|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194118|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
154194119|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194120|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
154194121|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
154194122|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194157|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
154194158|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194159|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
154194160|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194161|NCT00024622|Levodopa|levodopa|mesh-list
154194162|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154194163|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154194164|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
154194165|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194166|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194167|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194168|NCT01017354|Calcifediol|calcifediol|mesh-list
154194169|NCT01017354|Vitamins|vitamins|mesh-ancestor
154194170|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
154194171|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194172|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154194173|NCT00393861|Bevacizumab|bevacizumab|mesh-list
154194174|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
154194175|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194176|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194177|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154194178|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154194179|NCT00393861|Growth Substances|growth substances|mesh-ancestor
154194180|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194181|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
154194182|NCT01040559|Idarubicin|idarubicin|mesh-list
154194183|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154194184|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194185|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154194186|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154194187|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194188|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194189|NCT01020396|Metronidazole|metronidazole|mesh-list
153455628|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
154194206|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
154194207|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194208|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194209|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194210|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194211|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
154194212|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154194213|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194214|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194215|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154194216|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154194217|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154194218|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
154194219|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194220|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
154194221|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154194222|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194223|NCT00320398|PENTA|penta|mesh-list
154194224|NCT00320398|Fondaparinux|fondaparinux|mesh-list
154194225|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154194226|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
154194227|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154194228|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
154194229|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194230|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194231|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
154194232|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154194233|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154194234|NCT00498186|Rotigotine|rotigotine|mesh-list
154194235|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
154194236|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
154194237|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194238|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804018|NCT00292526|Enalapril|enalapril|mesh-list
154194239|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194240|NCT03984526|Atropine|atropine|mesh-list
154194241|NCT03984526|Ephedrine|ephedrine|mesh-list
154194242|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154194243|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154194244|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154194245|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
154194246|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194247|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194248|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154194249|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
154194250|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
154194275|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
154194276|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194277|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154194278|NCT00304954|Sirolimus|sirolimus|mesh-list
154194279|NCT00304954|Infliximab|infliximab|mesh-list
154194280|NCT00304954|Daclizumab|daclizumab|mesh-list
154194281|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194282|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194283|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154194284|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194285|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
154194286|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194287|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
154194288|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194289|NCT00304954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154194290|NCT00304954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194291|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
154194292|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154194293|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194294|NCT00475176|Ribavirin|ribavirin|mesh-list
154194295|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154194296|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
153539925|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154194311|NCT00303628|Bevacizumab|bevacizumab|mesh-list
154194312|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154194313|NCT00303628|Fluorouracil|fluorouracil|mesh-list
154194314|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
154194315|NCT00303628|Antibodies|antibodies|mesh-list
154194316|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
154194317|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154194318|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
154194319|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194320|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154194321|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154194322|NCT00303628|Growth Substances|growth substances|mesh-ancestor
153455694|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455697|NCT05150938|Heparin|heparin|mesh-list
154194323|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194324|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
154194325|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
154194326|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
154194327|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194328|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154194329|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194330|NCT00303628|Antidotes|antidotes|mesh-ancestor
154194331|NCT00303628|Protective Agents|protective agents|mesh-ancestor
154194332|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
154194333|NCT00303628|Vitamins|vitamins|mesh-ancestor
154194334|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
154194335|NCT00414453|Lidocaine|lidocaine|mesh-list
154194336|NCT00414453|Oxycodone|oxycodone|mesh-list
154194337|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
154194338|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
154194339|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154194340|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194341|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
154194342|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194343|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154194344|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154194345|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154194346|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154194347|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194348|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154194349|NCT00414453|Narcotics|narcotics|mesh-ancestor
154194350|NCT00414453|Analgesics|analgesics|mesh-ancestor
154256366|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154256367|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194351|NCT01037595|Turmeric extract|turmeric extract|mesh-list
154194353|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194354|NCT01037595|Protective Agents|protective agents|mesh-ancestor
154194355|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194356|NCT00332488|Insulin|insulin|mesh-list
154194357|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154194358|NCT00332488|Metformin|metformin|mesh-list
154194359|NCT00332488|Secretagogues|secretagogues|mesh-list
154194360|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154194361|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194362|NCT00332332|Etanercept|etanercept|mesh-list
154194382|NCT00474786|Sirolimus|sirolimus|mesh-list
154194383|NCT00474786|Sorafenib|sorafenib|mesh-list
154194384|NCT00474786|Temsirolimus|temsirolimus|mesh-list
154194385|NCT00474786|MTOR Inhibitors|mtor inhibitors|mesh-list
154194386|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194387|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154194388|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194389|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194390|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194391|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
154194392|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194393|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194394|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455699|NCT05150938|Tinzaparin|tinzaparin|mesh-list
153455700|NCT05150938|Dalteparin|dalteparin|mesh-list
154194395|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154194396|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
154194397|NCT00392769|Cetuximab|cetuximab|mesh-list
154194398|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194399|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194400|NCT01041183|Ramosetron|ramosetron|mesh-list
154194401|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
154194402|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
154194403|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194404|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194405|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154194406|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154194407|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
154194408|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194409|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194410|NCT00319696|Bosentan|bosentan|mesh-list
154194411|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154194412|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154194413|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194414|NCT00474630|Naltrexone|naltrexone|mesh-list
154194415|NCT00474630|Bupropion|bupropion|mesh-list
154194416|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154194430|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154194431|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154194432|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194434|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194435|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913945|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
154194436|NCT00392379|Nicotine|nicotine|mesh-list
154194437|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154194438|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
154194439|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194440|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194441|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154194442|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154194443|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
154194444|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194445|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194446|NCT01038063|Lumefantrine|lumefantrine|mesh-list
154194447|NCT01038063|Artemether|artemether|mesh-list
154194448|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154194449|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
154194450|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154194451|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154194452|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194454|NCT01043991|Hematinics|hematinics|mesh-ancestor
154194455|NCT01020630|Sunitinib|sunitinib|mesh-list
154194456|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194457|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154194458|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154194462|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154194463|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194464|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194465|NCT00403455|Paroxetine|paroxetine|mesh-list
154194466|NCT00403455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154194467|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154194468|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154194469|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194470|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194471|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
154194472|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194473|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154194474|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
154194509|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194510|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
154194511|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
154194512|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194513|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194514|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154194539|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194540|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194541|NCT01015664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154194542|NCT01015664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194543|NCT01015664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194544|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194545|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
154194546|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194547|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194548|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194549|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154194550|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
154194551|NCT00501644|Interferons|interferons|mesh-list
154194552|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
154194553|NCT00501644|Carboplatin|carboplatin|mesh-list
154194554|NCT00501644|Molgramostim|molgramostim|mesh-list
154194555|NCT00501644|Sargramostim|sargramostim|mesh-list
153913969|NCT02722603|Gabapentin|gabapentin|mesh-list
154194556|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455784|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154194557|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
154194558|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194559|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
154194560|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194561|NCT01014260|Doxycycline|doxycycline|mesh-list
154194562|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194563|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194564|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
154194565|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154194583|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154194584|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194585|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
154194586|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194587|NCT00497796|Ganciclovir|ganciclovir|mesh-list
154194588|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154194589|NCT00497796|Maribavir|maribavir|mesh-list
154194590|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
154194591|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194592|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154194593|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194594|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194595|NCT01017822|Gemcitabine|gemcitabine|mesh-list
154194596|NCT01017822|Capecitabine|capecitabine|mesh-list
154194597|NCT01017822|Conatumumab|conatumumab|mesh-list
154194598|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154194599|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
153941536|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194600|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194601|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194602|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194604|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154256368|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194605|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154194606|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194607|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154194608|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154194609|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
154194610|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913996|NCT01220297|Sirolimus|sirolimus|mesh-list
154194611|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154194612|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
154194613|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154194614|NCT01020708|Mesalamine|mesalamine|mesh-list
154194615|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154194616|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
154194617|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194618|NCT01020708|Expectorants|expectorants|mesh-ancestor
154194619|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
154194620|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154194621|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
154194622|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194628|NCT01020708|Analgesics|analgesics|mesh-ancestor
154194629|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
154194630|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194631|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194632|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194633|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
154194634|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194635|NCT01020864|Carboplatin|carboplatin|mesh-list
154194636|NCT01020864|Cetuximab|cetuximab|mesh-list
154194637|NCT01020864|Vinorelbine|vinorelbine|mesh-list
154194638|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194639|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194640|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154194641|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
154194642|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
154194643|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
154194644|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194645|NCT01014858|Donepezil|donepezil|mesh-list
154194646|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154194647|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194648|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194649|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
154194650|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194651|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194652|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
154194653|NCT00471276|Sunitinib|sunitinib|mesh-list
154194654|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194655|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154194656|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154194657|NCT00471276|Growth Substances|growth substances|mesh-ancestor
154194658|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194659|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
154194660|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153914009|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154194661|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194662|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194663|NCT00470262|Pioglitazone|pioglitazone|mesh-list
154194664|NCT00470262|Fenofibrate|fenofibrate|mesh-list
154194665|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154194666|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194667|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154194668|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
154194669|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194670|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154194671|NCT04034862|Lamivudine|lamivudine|mesh-list
154194672|NCT04034862|Dolutegravir|dolutegravir|mesh-list
154194673|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154194674|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154194675|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194676|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194677|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
154194678|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194679|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154194680|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154194681|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154194684|NCT00496470|Bromides|bromides|mesh-list
154194685|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
154194686|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
154194687|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154194688|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194689|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154194690|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
154194691|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194692|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194693|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154194709|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154194710|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154194711|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154194712|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194713|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154194714|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194715|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
154194716|NCT01018368|Rifampin|rifampin|mesh-list
154194717|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154194718|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
154194719|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154194720|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154194721|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
154194722|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154194723|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194724|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194725|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154194726|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154194727|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154194728|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154194729|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154194730|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154194731|NCT00487578|Naratriptan|naratriptan|mesh-list
154194732|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154194733|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154194734|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154194735|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
154194736|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194737|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194738|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194739|NCT00495612|Omalizumab|omalizumab|mesh-list
154194740|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154194741|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154194742|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
154194743|NCT01021488|Enoxaparin|enoxaparin|mesh-list
154194744|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154194745|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154194746|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154194747|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
154194748|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194749|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154194780|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154194781|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194782|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154194783|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
154194784|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914057|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153914058|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455838|NCT04642391|Hormones|hormones|mesh-ancestor
154194785|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154194786|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154194787|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154194788|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194789|NCT00500318|Bromides|bromides|mesh-list
154194790|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
154194791|NCT00499694|Bevacizumab|bevacizumab|mesh-list
154194792|NCT00499694|Satraplatin|satraplatin|mesh-list
154194793|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154194794|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194795|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154194796|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154194818|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194819|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194820|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
154194821|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154194822|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154194823|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154194824|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154194825|NCT00486720|Vorinostat|vorinostat|mesh-list
154194826|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194827|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154194828|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194829|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194830|NCT00486330|Ritonavir|ritonavir|mesh-list
154194831|NCT00486330|Tipranavir|tipranavir|mesh-list
154194832|NCT00486330|Buprenorphine|buprenorphine|mesh-list
154194833|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154194834|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154194835|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
154194836|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194837|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194838|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154194839|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154194840|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
154194841|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914072|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914073|NCT00612625|Incretins|incretins|mesh-ancestor
153914074|NCT02711917|Propofol|propofol|mesh-list
153914075|NCT02711917|Etomidate|etomidate|mesh-list
153914076|NCT02711917|Rocuronium|rocuronium|mesh-list
153914077|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153914078|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914079|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914080|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153914081|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
153914082|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
153914083|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153455868|NCT04564547|Islatravir|islatravir|mesh-list
154194842|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154194843|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154194844|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154194845|NCT00486330|Narcotics|narcotics|mesh-ancestor
154194846|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154194847|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194848|NCT00486330|Analgesics|analgesics|mesh-ancestor
154194849|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
154194861|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
154194862|NCT00494442|Olaparib|olaparib|mesh-list
154194863|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154194864|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194865|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194866|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194867|NCT00493974|Zileuton|zileuton|mesh-list
154194868|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154194869|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154194870|NCT00493974|Analgesics|analgesics|mesh-ancestor
154194871|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
154194872|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194873|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194874|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194875|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194876|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154194877|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194878|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194879|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154194880|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
154194881|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154194882|NCT01018446|Busulfan|busulfan|mesh-list
154194883|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
154194884|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194885|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194886|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
154194887|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194888|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154194889|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194890|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154194891|NCT01018602|Vildagliptin|vildagliptin|mesh-list
154194892|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154194893|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194894|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154194895|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
154194896|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914101|NCT02711449|Hormones|hormones|mesh-ancestor
154194897|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194898|NCT01018758|Palonosetron|palonosetron|mesh-list
154194899|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
154194900|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
154194901|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154194902|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194903|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154256369|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154194904|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154194905|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154194906|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
154194907|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154194908|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194909|NCT00469092|Insulin|insulin|mesh-list
154194910|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154194911|NCT00469092|Metformin|metformin|mesh-list
154194912|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
154194926|NCT00499616|Topotecan|topotecan|mesh-list
154194927|NCT00499616|Isotretinoin|isotretinoin|mesh-list
154194928|NCT00499616|Lenograstim|lenograstim|mesh-list
154194929|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194930|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
154194931|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194932|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154194933|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154194934|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
154194935|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194936|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194937|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154194938|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154194939|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154194940|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154194941|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194942|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154194943|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154194944|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154194945|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
154194946|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
154194947|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154194948|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
154194949|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154194950|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
154194951|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154194952|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194953|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
154194954|NCT00469014|Fludarabine|fludarabine|mesh-list
154194955|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
154194956|NCT00469014|Busulfan|busulfan|mesh-list
154194957|NCT00469014|Clofarabine|clofarabine|mesh-list
154194958|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
154194959|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154194960|NCT00469014|Lenograstim|lenograstim|mesh-list
154194961|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154194962|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154194963|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
154194964|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154194965|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154194966|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
154194967|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154194968|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154194969|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
154194970|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154194971|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154194972|NCT00493038|Amoxicillin|amoxicillin|mesh-list
154194973|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
154194974|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
153941913|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
154194975|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
154194976|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154194977|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154194998|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154194999|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
154195000|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195001|NCT00402285|Protective Agents|protective agents|mesh-ancestor
154195002|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195003|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154195004|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154195005|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195006|NCT00413283|Carboplatin|carboplatin|mesh-list
154195007|NCT00413283|Gemcitabine|gemcitabine|mesh-list
154195008|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195009|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195011|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195012|NCT00402051|Carboplatin|carboplatin|mesh-list
154195013|NCT00402051|Pemetrexed|pemetrexed|mesh-list
154195014|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195015|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195016|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195017|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154195018|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154195019|NCT00401973|Metformin|metformin|mesh-list
154195020|NCT00401973|Amantadine|amantadine|mesh-list
154195021|NCT00401973|Zonisamide|zonisamide|mesh-list
154195022|NCT00401973|Olanzapine|olanzapine|mesh-list
154195023|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154195024|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195025|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
153455942|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195026|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
154195027|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195028|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154195029|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154195030|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154195031|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154195046|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
154195047|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
154195048|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154195049|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154195050|NCT01038453|Vitamin D|vitamin d|mesh-list
154195051|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
154195052|NCT01038453|Vitamins|vitamins|mesh-ancestor
154195054|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195055|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154195056|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154195057|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
154195058|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154195059|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154195060|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195061|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
154195062|NCT00401193|Coagulants|coagulants|mesh-ancestor
154195063|NCT00400569|Sunitinib|sunitinib|mesh-list
154195064|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195065|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154195066|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154195067|NCT00400569|Growth Substances|growth substances|mesh-ancestor
154195068|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195069|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
154195070|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195071|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195072|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195073|NCT00413049|Amlodipine|amlodipine|mesh-list
154195074|NCT00413049|Valsartan|valsartan|mesh-list
154195075|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154195076|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154195077|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195078|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195079|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154195080|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195081|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
154195082|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154195083|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154195084|NCT03732495|Denosumab|denosumab|mesh-list
154195085|NCT03732495|Lenvatinib|lenvatinib|mesh-list
154195086|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195087|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195088|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195089|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195090|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153539926|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195102|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154195103|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
154195104|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
154195105|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
154195106|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195107|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195108|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195109|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154195110|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
154195111|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195113|NCT00454194|Sorafenib|sorafenib|mesh-list
154195114|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195115|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195116|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195117|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154195118|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154195119|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195120|NCT00468546|Methotrexate|methotrexate|mesh-list
154195121|NCT00468546|Rituximab|rituximab|mesh-list
154195122|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154195123|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
154195124|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154195125|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195126|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195127|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
154195128|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195129|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195130|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
154195131|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195132|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154195133|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195134|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
154195135|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195136|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153914673|NCT04188691|Vaccines|vaccines|mesh-list
154195137|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195138|NCT00303316|Vaccines|vaccines|mesh-list
154195139|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
154195140|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195141|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
154195142|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154195143|NCT01064986|Epinephrine|epinephrine|mesh-list
154195144|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154195145|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154195146|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
154195147|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195148|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195149|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195150|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154195151|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154195152|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
154195153|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195179|NCT03980002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195180|NCT03980002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195181|NCT00331864|Ranibizumab|ranibizumab|mesh-list
154195182|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154195183|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154195184|NCT00331864|Growth Substances|growth substances|mesh-ancestor
154195185|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195186|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
154195187|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195188|NCT00331630|Paclitaxel|paclitaxel|mesh-list
154195189|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154195190|NCT00331630|Lapatinib|lapatinib|mesh-list
154195191|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154195192|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195193|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
154195194|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
154195195|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
154195196|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195197|NCT00331630|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154195198|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195199|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195200|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
154195201|NCT00331552|Doxorubicin|doxorubicin|mesh-list
154195203|NCT00331552|Trastuzumab|trastuzumab|mesh-list
154195204|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154195205|NCT00331552|Antibodies|antibodies|mesh-list
154195241|NCT00317044|Esomeprazole|esomeprazole|mesh-list
154195242|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153805061|NCT00299390|Sagopilone|sagopilone|mesh-list
154195243|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154195267|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
154195268|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195269|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154195270|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
154195271|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195272|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154195273|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195274|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
154195275|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
154195276|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195278|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
154195279|NCT00301834|Hormones|hormones|mesh-ancestor
154195280|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195281|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154195282|NCT00301834|Protective Agents|protective agents|mesh-ancestor
154195283|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
154195284|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154195285|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154195286|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195287|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
154195288|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154195289|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195290|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195291|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154195292|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154195293|NCT00466440|Prednisone|prednisone|mesh-list
154195294|NCT00466440|Docetaxel|docetaxel|mesh-list
154195295|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195296|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
154195297|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
154195308|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154195309|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154195310|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154195311|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195312|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154195313|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
154195314|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154195315|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
154195316|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
154195317|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195318|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195319|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154195320|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154195321|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
154195322|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
154195324|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154195325|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154195326|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154195327|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
154195328|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195329|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195330|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195331|NCT03926754|Urological Agents|urological agents|mesh-ancestor
154195332|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154195333|NCT00465894|Estradiol|estradiol|mesh-list
154195334|NCT00465894|Estrogens|estrogens|mesh-ancestor
154195335|NCT00465894|Hormones|hormones|mesh-ancestor
154195336|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195337|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195338|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154195339|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154195340|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
154195341|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195342|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195343|NCT00465894|Urological Agents|urological agents|mesh-ancestor
154195344|NCT00330460|Denosumab|denosumab|mesh-list
154195345|NCT00330460|Alendronate|alendronate|mesh-list
154195346|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154195347|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195348|NCT01062490|Treosulfan|treosulfan|mesh-list
154195349|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154195350|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
154195351|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195353|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
154195354|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154195355|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154195356|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154195357|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154195358|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195359|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195369|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154195370|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195371|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195372|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
154195373|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154195374|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154195375|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195376|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154195377|NCT00464490|Analgesics|analgesics|mesh-ancestor
154195378|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
154195379|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195380|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153456077|NCT03812393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195381|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154195382|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154195383|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
154195384|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195385|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195386|NCT00412893|Voriconazole|voriconazole|mesh-list
154195387|NCT00412893|Isavuconazole|isavuconazole|mesh-list
154195388|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
154195389|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195390|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154195391|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154195392|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195393|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195394|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154195395|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
154195396|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195397|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195398|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154195399|NCT00412737|Oseltamivir|oseltamivir|mesh-list
154195400|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
154195401|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195402|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195403|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195405|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154195406|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
154195407|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195408|NCT01041963|Losartan|losartan|mesh-list
154195409|NCT01041963|Enalapril|enalapril|mesh-list
154195410|NCT01041963|Enalaprilat|enalaprilat|mesh-list
154195411|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154195412|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154195413|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154195414|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154195415|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195416|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154195417|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
154195418|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195419|NCT01044225|Cetuximab|cetuximab|mesh-list
154195433|NCT01042041|Sorafenib|sorafenib|mesh-list
154195434|NCT01042041|Mitomycins|mitomycins|mesh-list
154195435|NCT01042041|Mitomycin|mitomycin|mesh-list
154195436|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195437|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154195438|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154195439|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154195440|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195441|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195442|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195443|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
154195444|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154256371|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
154195445|NCT00499460|Oxycodone|oxycodone|mesh-list
154195446|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154195447|NCT00499460|Narcotics|narcotics|mesh-ancestor
154195448|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914295|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195449|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195450|NCT00499460|Analgesics|analgesics|mesh-ancestor
154195451|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
154195452|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195453|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
154195454|NCT00412113|Amlodipine|amlodipine|mesh-list
154195455|NCT00412113|Atorvastatin|atorvastatin|mesh-list
154195456|NCT00412113|Calcium|calcium|mesh-list
154195457|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154195458|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195459|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154195460|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154195461|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154195462|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
154195463|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195464|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154195465|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154195466|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195467|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154195468|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154195469|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195470|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
154195471|NCT01014650|Glycine|glycine|mesh-list
154195472|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
154195473|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195474|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195475|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195476|NCT00411645|Maribavir|maribavir|mesh-list
154195477|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
154195478|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195479|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154195480|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
154195481|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195501|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
154195502|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195503|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195505|NCT03992937|Progesterone|progesterone|mesh-list
154195506|NCT03992937|Progestins|progestins|mesh-ancestor
154195507|NCT03992937|Hormones|hormones|mesh-ancestor
154195508|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195509|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195510|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154195511|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
154195512|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154195513|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154195514|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154195515|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154195516|NCT01039545|Norfloxacin|norfloxacin|mesh-list
154195517|NCT01039545|Diclofenac|diclofenac|mesh-list
154195518|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154195519|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154195520|NCT01039545|Analgesics|analgesics|mesh-ancestor
154195521|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
154195522|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195523|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195524|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195525|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195526|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154195527|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195528|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195529|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154195530|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195531|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154195532|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154195533|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195534|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154195535|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154195536|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
154195549|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154195550|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154195551|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195552|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195554|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195555|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154195556|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154195557|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154195558|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154195559|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154195560|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154195561|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154195562|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154195563|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154195564|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154195565|NCT00945347|Miglustat|miglustat|mesh-list
154195566|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195567|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456123|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154195568|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154195569|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153942514|NCT00639262|Sorafenib|sorafenib|mesh-list
154195570|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
154195571|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195572|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154195573|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154195574|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195575|NCT00941135|Docetaxel|docetaxel|mesh-list
154195576|NCT00941135|Cetuximab|cetuximab|mesh-list
154195577|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195578|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
154195579|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
154195580|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
154195581|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195582|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195583|NCT00556439|Abatacept|abatacept|mesh-list
154195584|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154195585|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195586|NCT00556439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195587|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195588|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195589|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
154195590|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195591|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195592|NCT04012307|Candesartan|candesartan|mesh-list
154195593|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
154195594|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154195595|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154195596|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154195597|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195619|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
154195620|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195621|NCT00941369|Insulin|insulin|mesh-list
154195622|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
154195623|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
154195624|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
154195625|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
154195626|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154195627|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195628|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
154195629|NCT00950027|Povidone|povidone|mesh-list
154195630|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
154195631|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
154195632|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154195633|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195634|NCT00941525|Latanoprost|latanoprost|mesh-list
154195635|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154195636|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153456140|NCT03607656|Capecitabine|capecitabine|mesh-list
154195637|NCT00456261|Bevacizumab|bevacizumab|mesh-list
154195638|NCT00456261|Carboplatin|carboplatin|mesh-list
154195639|NCT00456261|Gemcitabine|gemcitabine|mesh-list
154195640|NCT00456261|Pemetrexed|pemetrexed|mesh-list
154195641|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195642|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195643|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154195644|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153805583|NCT00419718|Insulin|insulin|mesh-list
154195645|NCT00456261|Growth Substances|growth substances|mesh-ancestor
154195646|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195648|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195649|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
154195650|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195651|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195652|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154195653|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154195654|NCT00386607|Valsartan|valsartan|mesh-list
154195678|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
154195679|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195680|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195681|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154195682|NCT03617523|Vaccines|vaccines|mesh-list
154195683|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
154195684|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195685|NCT00409617|Adalimumab|adalimumab|mesh-list
154195686|NCT00409617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154195687|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195688|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195689|NCT00300274|Cyclosporine|cyclosporine|mesh-list
154195690|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
154195691|NCT00300274|Everolimus|everolimus|mesh-list
154195692|NCT00300274|Cyclosporins|cyclosporins|mesh-list
154195693|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195694|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195695|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195696|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
154195697|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195698|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
154195699|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195700|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
154195701|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195702|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154195703|NCT00300274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153456181|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154195704|NCT00300274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195705|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195706|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154195724|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154195725|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
154195726|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195727|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154195728|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154195729|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
154195730|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154195731|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
154195732|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
154195733|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
154195734|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154195735|NCT01043445|Glycerol|glycerol|mesh-list
154195736|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154195737|NCT01043445|Protective Agents|protective agents|mesh-ancestor
154195738|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195739|NCT00396591|Aflibercept|aflibercept|mesh-list
154195740|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154195741|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154195742|NCT00396591|Growth Substances|growth substances|mesh-ancestor
154195743|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195744|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
154195745|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195746|NCT00316264|Palivizumab|palivizumab|mesh-list
154195747|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
154195748|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195749|NCT00385827|Prednisone|prednisone|mesh-list
154195750|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
154195751|NCT00385827|Siltuximab|siltuximab|mesh-list
154195752|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195753|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
154195754|NCT00385827|Hormones|hormones|mesh-ancestor
154195755|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195756|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195757|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154195758|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195759|NCT00385827|Analgesics|analgesics|mesh-ancestor
154195760|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
154195761|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805734|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154195762|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154195763|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154195764|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195775|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154195776|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153914408|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154195777|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195778|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195779|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
154195780|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195781|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195782|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154195783|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154195784|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195785|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154195786|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154195787|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
154195788|NCT00498368|Rituximab|rituximab|mesh-list
154195789|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
154195790|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154195791|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195792|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
154195793|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195794|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195795|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154195796|NCT04460066|Paclitaxel|paclitaxel|mesh-list
154195797|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154195798|NCT04460066|Antibodies|antibodies|mesh-list
154195799|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154195800|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195801|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
154195802|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
154195803|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
154195804|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195805|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
154195806|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195807|NCT00385671|Pregabalin|pregabalin|mesh-list
154195808|NCT00385671|Gabapentin|gabapentin|mesh-list
154195809|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154195810|NCT00385671|Analgesics|analgesics|mesh-ancestor
154195811|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
154195812|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195813|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195814|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
154195815|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154195816|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154195817|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195818|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154195819|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154195820|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154195821|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154195822|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154195823|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154195824|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154195825|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195826|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
154195827|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154195848|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154195849|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195851|NCT00490490|Lugol's solution|lugol's solution|mesh-list
154195852|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154195853|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154195854|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195855|NCT00490490|Trace Elements|trace elements|mesh-ancestor
154195856|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
154195857|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195858|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
154195859|NCT00490490|Coagulants|coagulants|mesh-ancestor
154195860|NCT05049980|Mifepristone|mifepristone|mesh-list
154195861|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154195862|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
154195863|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154195864|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195865|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154195866|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154195867|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154195868|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
154195869|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154195870|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153942815|NCT02928406|Atezolizumab|atezolizumab|mesh-list
154195871|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
154195872|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195873|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
154195874|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154195875|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154195877|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
154195878|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154195879|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195892|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
154195893|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195894|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195895|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
154195896|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154195897|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154195898|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
154195899|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195900|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195901|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195902|NCT01015040|Urological Agents|urological agents|mesh-ancestor
154195903|NCT00495170|Paclitaxel|paclitaxel|mesh-list
153469766|NCT04439292|Trametinib|trametinib|mesh-list
154195904|NCT00495170|Carboplatin|carboplatin|mesh-list
154195905|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154195906|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195907|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
154195908|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
154195909|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
154195910|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195911|NCT01011374|Ranibizumab|ranibizumab|mesh-list
154195912|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154195913|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154195914|NCT01011374|Growth Substances|growth substances|mesh-ancestor
154195915|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195916|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
154195917|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195918|NCT00385203|Cediranib|cediranib|mesh-list
154195919|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195920|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154195921|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195922|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195923|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
154195924|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154195925|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
154195926|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195927|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195928|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154195929|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
154195930|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154195931|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154195932|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154195933|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
154195934|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154195935|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195936|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154195937|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
154195938|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154195939|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154195940|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154195958|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154195959|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
154195960|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154195961|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154195962|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154195963|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195964|NCT00395343|Incretins|incretins|mesh-ancestor
154195965|NCT00395343|Hormones|hormones|mesh-ancestor
154195966|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154195967|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154195969|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195970|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195971|NCT00560573|Gemcitabine|gemcitabine|mesh-list
154195972|NCT00560573|Pemetrexed|pemetrexed|mesh-list
154195973|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195974|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154195975|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
154195976|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154195977|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154195978|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154195979|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154195980|NCT00950105|Semapimod|semapimod|mesh-list
154195981|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154195982|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154195983|NCT00950105|Analgesics|analgesics|mesh-ancestor
154195984|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
154195985|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154195986|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154195987|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154195988|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154195989|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154195990|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
154195991|NCT00950261|Cisplatin|cisplatin|mesh-list
154195992|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154195993|NCT00946595|Ritonavir|ritonavir|mesh-list
154195994|NCT00946595|Lopinavir|lopinavir|mesh-list
154195995|NCT00946595|Tenofovir|tenofovir|mesh-list
154195996|NCT00946595|Efavirenz|efavirenz|mesh-list
154195997|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154195998|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154196016|NCT00494780|Prednisolone|prednisolone|mesh-list
154196018|NCT00494780|Doxorubicin|doxorubicin|mesh-list
154196019|NCT00494780|Vincristine|vincristine|mesh-list
154196020|NCT00494780|Ofatumumab|ofatumumab|mesh-list
154196021|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154196022|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
154196023|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196024|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196025|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154196026|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
154196027|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196028|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196029|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154196030|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154196031|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154196032|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154196033|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196034|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196035|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
154196036|NCT00494780|Hormones|hormones|mesh-ancestor
154196037|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196038|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154196039|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154196040|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
154196041|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
154196042|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
154196043|NCT01011452|Montelukast|montelukast|mesh-list
154196044|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154196045|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
154196046|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154196047|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
154196048|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196049|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914523|NCT00935818|Bupropion|bupropion|mesh-list
154196050|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154196051|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154196052|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196070|NCT00493220|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154196071|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154196072|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196073|NCT00950339|Omeprazole|omeprazole|mesh-list
154196074|NCT00950339|Pantoprazole|pantoprazole|mesh-list
154196075|NCT00950339|Famotidine|famotidine|mesh-list
154196076|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154196077|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196078|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154196079|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196080|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196081|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154196082|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
154196083|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
154196084|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196085|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196086|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
154196087|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196088|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196089|NCT00946673|Vorinostat|vorinostat|mesh-list
154196090|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196091|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154196092|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196093|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196094|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
154196095|NCT00394953|Hematinics|hematinics|mesh-ancestor
154196096|NCT00946751|Levetiracetam|levetiracetam|mesh-list
154196097|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
154196098|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
154196099|NCT00485732|Vaccines|vaccines|mesh-list
154196100|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
154196101|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196102|NCT00946829|Telmisartan|telmisartan|mesh-list
154196103|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154196104|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154196105|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154196106|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196107|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154196108|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
154196109|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196110|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
154196118|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914524|NCT00935818|Varenicline|varenicline|mesh-list
154196120|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154196121|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
154196122|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
154196123|NCT00560417|Protamines|protamines|mesh-list
154196124|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154196125|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196126|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
154196127|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196128|NCT00560417|Coagulants|coagulants|mesh-ancestor
154196129|NCT01040091|Tenofovir|tenofovir|mesh-list
154196130|NCT01040091|Emtricitabine|emtricitabine|mesh-list
154196131|NCT01040091|Efavirenz|efavirenz|mesh-list
154196132|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154196133|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
154196134|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196135|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154196136|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154196137|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196138|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196139|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154196140|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154196141|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154196142|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154196143|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154196144|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154196145|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154196146|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154196147|NCT00946907|Aspirin|aspirin|mesh-list
154196148|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154196149|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154196150|NCT00946907|Analgesics|analgesics|mesh-ancestor
154196151|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
154196152|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196153|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196154|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196155|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196156|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154196157|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154256372|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456337|NCT02400255|Crenolanib|crenolanib|mesh-list
154196158|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196159|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154196160|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154196161|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196163|NCT00942539|Midazolam|midazolam|mesh-list
154196164|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154196166|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196167|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196168|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154196169|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154196170|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196171|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154196172|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
154196173|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
154196174|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
154196175|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
154196176|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196177|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196205|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196206|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196207|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196208|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154196209|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154196210|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196211|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153456382|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
154196212|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154196213|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196214|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
154196215|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
154196216|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196217|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196218|NCT03968159|Pimavanserin|pimavanserin|mesh-list
154196219|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154196220|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153914567|NCT05260255|Vitamin D|vitamin d|mesh-list
154196221|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154196222|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154196223|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196224|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196225|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196237|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196238|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154196239|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196240|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196241|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154196242|NCT03966365|Timolol|timolol|mesh-list
154196243|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154196244|NCT03966365|Dorzolamide|dorzolamide|mesh-list
154196245|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154196246|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154196247|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
154196248|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196249|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196250|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196251|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154196252|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154196253|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154196254|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154196255|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154196256|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154196257|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196258|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
154196259|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154196260|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196261|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154196262|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196263|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196264|NCT03965351|Probenecid|probenecid|mesh-list
154196265|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
154196266|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
154196267|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196268|NCT00947375|Lamotrigine|lamotrigine|mesh-list
154196269|NCT00947375|Haloperidol|haloperidol|mesh-list
154196270|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
154196271|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
154196272|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
154196273|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196274|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196275|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196276|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154196277|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154196278|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196279|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196280|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154196281|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
154196282|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196283|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196284|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154196285|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
154196286|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154196287|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154196288|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153539927|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
154196299|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196300|NCT00942773|Voriconazole|voriconazole|mesh-list
154196301|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
154196302|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196303|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154196304|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154196305|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196306|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196307|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154196308|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
154196309|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196310|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153943269|NCT02677246|Denosumab|denosumab|mesh-list
154196311|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154196312|NCT00374907|Metformin|metformin|mesh-list
154196313|NCT00374907|Saxagliptin|saxagliptin|mesh-list
154196314|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154196315|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196316|NCT00374907|Incretins|incretins|mesh-ancestor
154196317|NCT00374907|Hormones|hormones|mesh-ancestor
154196318|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196319|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154196320|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
154196321|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196322|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196323|NCT01045083|Methylphenidate|methylphenidate|mesh-list
154196324|NCT01045083|Escitalopram|escitalopram|mesh-list
154196325|NCT01045083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154196326|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154196327|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154196328|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196329|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196330|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
154196331|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196332|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154196333|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154196334|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
154196335|NCT01040325|Vaccines|vaccines|mesh-list
154196336|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
154196337|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196338|NCT00947843|Aspirin|aspirin|mesh-list
154196339|NCT00947843|Clopidogrel|clopidogrel|mesh-list
154196340|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154196341|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154196342|NCT00947843|Analgesics|analgesics|mesh-ancestor
154196343|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
154196344|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196345|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196346|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196347|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196348|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154196376|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806544|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
154196377|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196379|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153815178|NCT00448383|Adalimumab|adalimumab|mesh-list
154196380|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196381|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154196382|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196383|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196384|NCT00299494|Rituximab|rituximab|mesh-list
154196385|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154196386|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196387|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196388|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
154196389|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196390|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196391|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154196392|NCT00299494|Immunotoxins|immunotoxins|mesh-ancestor
154196404|NCT00453180|Expectorants|expectorants|mesh-ancestor
154196405|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
154196406|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154196407|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
154196408|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196409|NCT00453180|Protective Agents|protective agents|mesh-ancestor
154196410|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196411|NCT00453180|Antidotes|antidotes|mesh-ancestor
154196412|NCT00943709|Insulin|insulin|mesh-list
154196413|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154196414|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
154196415|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154196416|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196417|NCT00464178|Bortezomib|bortezomib|mesh-list
153815226|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626727|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196418|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196419|NCT00316186|Carboplatin|carboplatin|mesh-list
154196420|NCT00316186|Topotecan|topotecan|mesh-list
154196421|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196422|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154196423|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154196424|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196425|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196426|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
154196427|NCT01065220|Testolactone|testolactone|mesh-list
154196428|NCT01065220|Lynestrenol|lynestrenol|mesh-list
154196429|NCT01065220|Estradiol|estradiol|mesh-list
154196430|NCT01065220|Cyproterone|cyproterone|mesh-list
154196431|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
154196432|NCT01065220|Estrogens|estrogens|mesh-ancestor
154196433|NCT01065220|Hormones|hormones|mesh-ancestor
154196434|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196435|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196436|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154196437|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
154196438|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154196439|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154196440|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
154196441|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
154196442|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196443|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154196444|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154196445|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196446|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196447|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154196448|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154196449|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154196450|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154196451|NCT00943943|Plerixafor|plerixafor|mesh-list
154196452|NCT00943943|Sorafenib|sorafenib|mesh-list
154196453|NCT00943943|Lenograstim|lenograstim|mesh-list
154196454|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196455|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154196456|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456546|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
154196457|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196458|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154196484|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196485|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196486|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154196487|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
154196488|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196489|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196490|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154196491|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196493|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
154196494|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196495|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196496|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
154196497|NCT00299182|Hormones|hormones|mesh-ancestor
154196498|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196499|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154196500|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196501|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154196502|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154196503|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154196504|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196505|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154196506|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
154196507|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154196508|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154196509|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
154196510|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
154196511|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154196512|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153815263|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154196528|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154196529|NCT00467142|Growth Substances|growth substances|mesh-ancestor
154196530|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196531|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
154196532|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154196533|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
154196534|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196535|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154196536|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154196537|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
154196538|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154196539|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154196540|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196541|NCT00467142|Antidotes|antidotes|mesh-ancestor
154196542|NCT00467142|Protective Agents|protective agents|mesh-ancestor
154196543|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
154196544|NCT00467142|Vitamins|vitamins|mesh-ancestor
154196545|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
154196546|NCT01065376|Cabergoline|cabergoline|mesh-list
154196547|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154196548|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154196549|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
154196550|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
154196551|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196552|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196553|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196554|NCT00944177|Metformin|metformin|mesh-list
154196555|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154196556|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196557|NCT00553475|Pregabalin|pregabalin|mesh-list
154196558|NCT00553475|Analgesics|analgesics|mesh-ancestor
154196559|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
154196560|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196561|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196562|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
154196563|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154196564|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154196565|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196566|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154196567|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154196568|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154196569|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196570|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196571|NCT00329602|Ropinirole|ropinirole|mesh-list
154196572|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154196573|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154196574|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
154196575|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
154196584|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
154256373|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256374|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154256375|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154256376|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
154256377|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153806864|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
154196585|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196586|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196587|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196589|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154196590|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
154196591|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196592|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196593|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154196594|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
154196595|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154196596|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154196597|NCT01060696|Analgesics|analgesics|mesh-ancestor
154196598|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
154196599|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196600|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196601|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154196602|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196603|NCT01065610|Oxytocin|oxytocin|mesh-list
154196604|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
154196605|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154196606|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196607|NCT00463866|Budesonide|budesonide|mesh-list
154196608|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
154196609|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196610|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154196611|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
154196612|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196613|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196614|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154196615|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
154196616|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
154196617|NCT00463866|Hormones|hormones|mesh-ancestor
154196618|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196619|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154196620|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154196621|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154196622|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
154196623|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196624|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196625|NCT00313846|Buprenorphine|buprenorphine|mesh-list
154196626|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154196627|NCT00313846|Narcotics|narcotics|mesh-ancestor
154196628|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196629|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196630|NCT00313846|Analgesics|analgesics|mesh-ancestor
154196631|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
154196632|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196633|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154196634|NCT00949247|Bevacizumab|bevacizumab|mesh-list
154196635|NCT00949247|Trastuzumab|trastuzumab|mesh-list
154196636|NCT00949247|Carboplatin|carboplatin|mesh-list
154196637|NCT00949247|Docetaxel|docetaxel|mesh-list
154196638|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196639|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196640|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154196641|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154196642|NCT00949247|Growth Substances|growth substances|mesh-ancestor
154196653|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196654|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
154196655|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154196656|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154196657|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196658|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154196659|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154196660|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154196661|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196662|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196663|NCT00944333|Clopidogrel|clopidogrel|mesh-list
154196664|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154196665|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154196666|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154196667|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154196668|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
154196669|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196670|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196671|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196672|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
154196673|NCT00299104|Rituximab|rituximab|mesh-list
154196674|NCT00299104|Methotrexate|methotrexate|mesh-list
154196675|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196676|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196677|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
154196678|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196679|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196680|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154196681|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
154196682|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154196683|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154196684|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
154196685|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196686|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
154196687|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196688|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154196689|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154196690|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154196691|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196692|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
154196693|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
154196694|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196695|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196696|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
154196697|NCT00299104|Hormones|hormones|mesh-ancestor
154196698|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196699|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154196700|NCT00299104|Protective Agents|protective agents|mesh-ancestor
154196701|NCT03979456|Rituximab|rituximab|mesh-list
154196702|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196703|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196704|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
154196705|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196719|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196720|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
154196721|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
154196722|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196723|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196724|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196725|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
154196726|NCT00507416|Hormones|hormones|mesh-ancestor
154196727|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196728|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154196729|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196730|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154196731|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
154196732|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196733|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154196734|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154196735|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
154196736|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
154196737|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154196738|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196739|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154196740|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154196741|NCT00507416|Growth Substances|growth substances|mesh-ancestor
154196742|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
154196743|NCT00489476|Loxapine|loxapine|mesh-list
154196744|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154256378|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153807080|NCT00337389|Vitamins|vitamins|mesh-ancestor
154196745|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154196746|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196747|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196748|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154196749|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154196750|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
154196751|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154196752|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196753|NCT04216043|Caseins|caseins|mesh-list
154196754|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
154196755|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
154196756|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196757|NCT00957125|Bevacizumab|bevacizumab|mesh-list
154196758|NCT00957125|Docetaxel|docetaxel|mesh-list
154196759|NCT00957125|Epirubicin|epirubicin|mesh-list
154196760|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196761|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153943729|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
154196762|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154196763|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154196764|NCT00957125|Growth Substances|growth substances|mesh-ancestor
154196765|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196766|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
154196767|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
154196768|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154196781|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196782|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196783|NCT00952913|Lansoprazole|lansoprazole|mesh-list
154196784|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
154196785|NCT00952913|Bosutinib|bosutinib|mesh-list
154196786|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154196787|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196788|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154196789|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196790|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196791|NCT00952913|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154196792|NCT00952913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154196793|NCT00952991|Vildagliptin|vildagliptin|mesh-list
154196794|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154196795|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196796|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154196797|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154196798|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196799|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196800|NCT00953303|Dexamethasone|dexamethasone|mesh-list
154196801|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
154196802|NCT00953303|Prednisone|prednisone|mesh-list
154196803|NCT00953303|Torsemide|torsemide|mesh-list
154196804|NCT00953303|Dobutamine|dobutamine|mesh-list
154196805|NCT00953303|Dopamine|dopamine|mesh-list
154196806|NCT00953303|Furosemide|furosemide|mesh-list
154196807|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
154196808|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
154196809|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154196810|NCT00953303|BB 1101|bb 1101|mesh-list
154196811|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196812|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
154196813|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
154196814|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196815|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456767|NCT04073316|Warfarin|warfarin|mesh-list
154196816|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196817|NCT00953303|Hormones|hormones|mesh-ancestor
154196818|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196819|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154196820|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196821|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
154196822|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196823|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196824|NCT00953303|Diuretics|diuretics|mesh-ancestor
154196825|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
154196826|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154196827|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431456|NCT06285357|Folic Acid|folic acid|mesh-list
154196828|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
154196829|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154196830|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
153539928|NCT01536249|Protective Agents|protective agents|mesh-ancestor
154196838|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154196839|NCT05300555|Warfarin|warfarin|mesh-list
154196840|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
154196841|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
154196842|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154196843|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
154196844|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154196845|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
154196846|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196847|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196848|NCT04010669|Somatostatin|somatostatin|mesh-list
154196849|NCT04010669|Hormones|hormones|mesh-ancestor
154196850|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196851|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196852|NCT00452790|Vaccines|vaccines|mesh-list
154196853|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154196854|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
154196855|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196856|NCT00953381|Omeprazole|omeprazole|mesh-list
154196857|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154196858|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196859|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154196860|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196861|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196862|NCT05300477|Acetazolamide|acetazolamide|mesh-list
154196863|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
154196864|NCT05300477|Hematinics|hematinics|mesh-ancestor
154196865|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
154196866|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154196867|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196868|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196869|NCT05300477|Diuretics|diuretics|mesh-ancestor
154196870|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
154196871|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196872|NCT00953459|Sunitinib|sunitinib|mesh-list
154196873|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154196874|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196875|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154196876|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154196877|NCT00953459|Growth Substances|growth substances|mesh-ancestor
154196878|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196879|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
154196880|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154196881|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196882|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196883|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154196884|NCT00953537|Capecitabine|capecitabine|mesh-list
154196885|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154196886|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
154196887|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196888|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196889|NCT00463788|Cisplatin|cisplatin|mesh-list
154196890|NCT00463788|Cetuximab|cetuximab|mesh-list
154196891|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196892|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154196893|NCT00548249|Iron|iron|mesh-list
154196894|NCT00548249|Trace Elements|trace elements|mesh-ancestor
154196895|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
154196896|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196897|NCT01025466|Memantine|memantine|mesh-list
154196898|NCT01025466|Rivastigmine|rivastigmine|mesh-list
154196899|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154196900|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154196909|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
154196910|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154196911|NCT01025466|Protective Agents|protective agents|mesh-ancestor
154196912|NCT01025544|Vaccines|vaccines|mesh-list
153943877|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
154196913|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
154196914|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196915|NCT03839940|Dexamethasone|dexamethasone|mesh-list
154196916|NCT03839940|Everolimus|everolimus|mesh-list
154256379|NCT01265576|Analgesics|analgesics|mesh-ancestor
154196917|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196918|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
154196919|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
154196920|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196921|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196922|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196923|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
154196924|NCT03839940|Hormones|hormones|mesh-ancestor
154196925|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196926|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154196927|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196928|NCT03839940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154196929|NCT03839940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154196930|NCT03839940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196931|NCT03839940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196932|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154196933|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
154196934|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
154196935|NCT01027494|Dexamethasone|dexamethasone|mesh-list
154196936|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154196937|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
153815570|NCT00348023|Timolol|timolol|mesh-list
154196938|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
154196939|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196940|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196941|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196942|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
154196943|NCT01027494|Hormones|hormones|mesh-ancestor
154196944|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154196945|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154196946|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196947|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154196948|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196949|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154196950|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154196951|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196952|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196953|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154196954|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154196955|NCT00462462|Ethanol|ethanol|mesh-list
154196956|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154196957|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154196958|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196959|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196960|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
154196961|NCT00462384|Hematinics|hematinics|mesh-ancestor
154196962|NCT00452400|Olodaterol|olodaterol|mesh-list
154196963|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154196964|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
154196965|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154196971|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
154196972|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196973|NCT01566474|Protective Agents|protective agents|mesh-ancestor
154196974|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815592|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154196975|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154196976|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154196977|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154196978|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154196979|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196980|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
154196981|NCT01025778|Thiotepa|thiotepa|mesh-list
154196982|NCT01025778|Etoposide|etoposide|mesh-list
154196983|NCT01025778|Clofarabine|clofarabine|mesh-list
154196984|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154196985|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
154196986|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154196987|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154196988|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153943961|NCT02669368|Rocuronium|rocuronium|mesh-list
154196989|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
154196990|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154196991|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154196992|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154196993|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153807488|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
154196994|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154196995|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154196996|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154196997|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154196998|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
154196999|NCT00443430|Prednisone|prednisone|mesh-list
154197000|NCT00443430|Prednisolone|prednisolone|mesh-list
154197001|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154197002|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
154197003|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154197004|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
154197005|NCT00443430|Etanercept|etanercept|mesh-list
154197006|NCT00443430|Methotrexate|methotrexate|mesh-list
154197007|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154197008|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
154197009|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197010|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
154197011|NCT00443430|Hormones|hormones|mesh-ancestor
154197012|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154197013|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197014|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154197015|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197016|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154197017|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
154197018|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154197019|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197020|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
154197021|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197022|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
154197023|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197024|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154197025|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197026|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
154197027|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197028|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154197029|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
154197030|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
154197031|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197032|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154197033|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154197034|NCT00443430|Protective Agents|protective agents|mesh-ancestor
154197035|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154197057|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197058|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
154197059|NCT01025934|Bevacizumab|bevacizumab|mesh-list
154197060|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154197061|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197062|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154197063|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154197064|NCT01025934|Growth Substances|growth substances|mesh-ancestor
154197065|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153944022|NCT00646516|Budesonide|budesonide|mesh-list
154197067|NCT01026090|Dronedarone|dronedarone|mesh-list
154197068|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154197069|NCT00460746|Ritonavir|ritonavir|mesh-list
154197070|NCT00460746|Darunavir|darunavir|mesh-list
154197071|NCT00460746|Etravirine|etravirine|mesh-list
154197072|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154197073|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154197074|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
154197075|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197076|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197077|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154197078|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154197079|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
154197080|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197081|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154197082|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154197083|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154197084|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154197085|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
154197086|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154197087|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154197088|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197089|NCT01025700|Nabilone|nabilone|mesh-list
154197090|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
154197091|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
154197107|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197108|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197109|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197110|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197111|NCT00442962|Tenofovir|tenofovir|mesh-list
154197112|NCT00442962|Emtricitabine|emtricitabine|mesh-list
154197113|NCT00442962|Efavirenz|efavirenz|mesh-list
154197114|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154197115|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
154197116|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197117|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154197118|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154197119|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197120|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197121|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154197122|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154197123|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154197124|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154197125|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154197126|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154197127|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154197128|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154197129|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154197130|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
154197131|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154197132|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197133|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157511|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197134|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154197135|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154197136|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197137|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197138|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154197139|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
154197140|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154197141|NCT01026636|Cephalosporins|cephalosporins|mesh-list
154197142|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154197143|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197144|NCT00313300|Apixaban|apixaban|mesh-list
154197145|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154197146|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
154197147|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154197155|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197156|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154197157|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154197158|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154197159|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197160|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197161|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
154197162|NCT00459186|Hormones|hormones|mesh-ancestor
154197163|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154197164|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197165|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154197166|NCT00459186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154197167|NCT00459186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197168|NCT00459186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197169|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197170|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
154197171|NCT01026714|Rifampin|rifampin|mesh-list
154197172|NCT01026714|Fluconazole|fluconazole|mesh-list
154197173|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
154197174|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154197175|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
154197176|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154197177|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197178|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
154197179|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154197180|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197181|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197182|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154197183|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153807713|NCT00310934|Analgesics|analgesics|mesh-ancestor
154197184|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154197185|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154197186|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154197187|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154197188|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
154197189|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154197190|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154197191|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154197192|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
154197193|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154197194|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197195|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154197196|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154197197|NCT01026714|Analgesics|analgesics|mesh-ancestor
154197198|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
154197199|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197200|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154197201|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197202|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197203|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197204|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154197205|NCT03996252|Calcitriol|calcitriol|mesh-list
154197206|NCT03996252|Fluorouracil|fluorouracil|mesh-list
154197207|NCT03996252|Calcipotriene|calcipotriene|mesh-list
154197208|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
154197209|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197210|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197211|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197212|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197213|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
154197214|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197228|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154197230|NCT00459108|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154197231|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197232|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197233|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197234|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197235|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
154197236|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154197237|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197238|NCT00450450|Lenograstim|lenograstim|mesh-list
154197239|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154197240|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
154197241|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197242|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
154197243|NCT03440892|Methotrexate|methotrexate|mesh-list
154197244|NCT03440892|Abatacept|abatacept|mesh-list
154197245|NCT03440892|Tofacitinib|tofacitinib|mesh-list
154197246|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154197247|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
154197248|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154197249|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197250|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197251|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
154197252|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197253|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197254|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
154197255|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197256|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154197257|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197258|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
154197259|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197260|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154197261|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154197262|NCT03440892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154197263|NCT03440892|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154197264|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197265|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197266|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154256380|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
154256381|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256382|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197267|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197268|NCT03440892|Analgesics|analgesics|mesh-ancestor
154197269|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
154197270|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197271|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197272|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154197273|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153815803|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
154197274|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
154197275|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197276|NCT01023360|Esomeprazole|esomeprazole|mesh-list
154197295|NCT00441792|Etomidate|etomidate|mesh-list
154197296|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154197297|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154197298|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154197299|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197300|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154197301|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154197302|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154197303|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154197304|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
154197305|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
154197306|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
154197307|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
154197308|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197309|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197310|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
154197311|NCT00312208|Docetaxel|docetaxel|mesh-list
154197312|NCT00312208|Doxorubicin|doxorubicin|mesh-list
154197313|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154197314|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197315|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
154197316|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197317|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197318|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154197319|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
154197320|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197321|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197322|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154197323|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
154197324|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
154197325|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
154197326|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154197327|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154197328|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154197329|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197330|NCT00297778|Pramipexole|pramipexole|mesh-list
154197331|NCT00297778|Dexpramipexole|dexpramipexole|mesh-list
154197332|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
154197333|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197343|NCT00327340|Docetaxel|docetaxel|mesh-list
153815832|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154197344|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
154197345|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197346|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
154197347|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
154197348|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
154197349|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197350|NCT00327340|Analgesics|analgesics|mesh-ancestor
154197351|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
154197352|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197353|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197354|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154197355|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154197356|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197357|NCT00548093|Dacomitinib|dacomitinib|mesh-list
154197358|NCT00548093|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154197359|NCT00548093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197360|NCT00548093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197361|NCT00548093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197362|NCT00958139|Permethrin|permethrin|mesh-list
154197363|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256383|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197364|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197366|NCT00450216|Famotidine|famotidine|mesh-list
153457245|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154197367|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154197368|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197369|NCT00450216|Analgesics|analgesics|mesh-ancestor
154197370|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
154197371|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197372|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197373|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197374|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197375|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154197376|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197377|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197378|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154197379|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154197380|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154197381|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
154197382|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
154197383|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197384|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
154197385|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
154197386|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154197387|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197388|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154197389|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
154197390|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154197391|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197392|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197393|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197394|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154197395|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
154197396|NCT00958451|Vitamin D|vitamin d|mesh-list
154197397|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154197398|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197399|NCT00958451|Vitamins|vitamins|mesh-ancestor
154197400|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
154197411|NCT00954005|Gemcitabine|gemcitabine|mesh-list
154197412|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
154197413|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154197414|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197415|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
154197416|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197417|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197418|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197419|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
154197420|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197421|NCT01023750|Fenofibrate|fenofibrate|mesh-list
154197422|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154197423|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
154197424|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815949|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197425|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154197426|NCT05300009|Methotrexate|methotrexate|mesh-list
154197427|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154197428|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
154197429|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154197430|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197431|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197432|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
154197433|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197434|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197435|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
153944404|NCT00994110|Hormones|hormones|mesh-ancestor
154197436|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197437|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154197438|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197439|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
154197440|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197441|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154197442|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
154197443|NCT05352113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154197444|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154197445|NCT05352113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154197446|NCT05352113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197447|NCT05352113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197448|NCT05352113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197449|NCT05352113|Serotonin Agents|serotonin agents|mesh-ancestor
154197450|NCT05352113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197452|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154197453|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
154197454|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154197455|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154197456|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154197457|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197458|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197459|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
154197460|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197461|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197462|NCT00297232|Natalizumab|natalizumab|mesh-list
154197474|NCT03867383|Calcium|calcium|mesh-list
154197475|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154197476|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197477|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154197478|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
154197479|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
154197480|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154197481|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154197482|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197483|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
154197484|NCT00954395|Coagulants|coagulants|mesh-ancestor
154197485|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
154197486|NCT03741101|Trametinib|trametinib|mesh-list
154197487|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197488|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197489|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197490|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197491|NCT00449670|Vaccines|vaccines|mesh-list
154197492|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
154197493|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197494|NCT04010903|Insulin|insulin|mesh-list
154197495|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154197496|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197497|NCT00296374|Atorvastatin|atorvastatin|mesh-list
154197498|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154197499|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153457396|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
154197500|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154197501|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
154197502|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197503|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154197504|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154197505|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197506|NCT01060774|Lidocaine|lidocaine|mesh-list
154197507|NCT01060774|Bupivacaine|bupivacaine|mesh-list
154197508|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
154197509|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
154197510|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154197511|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197512|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
154197513|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197514|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154197515|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154197516|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154197517|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197518|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197519|NCT00954785|Diclofenac|diclofenac|mesh-list
154197520|NCT00954785|Etoricoxib|etoricoxib|mesh-list
154197521|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154197522|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197523|NCT00954785|Analgesics|analgesics|mesh-ancestor
154197524|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
154197533|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
154197535|NCT00548717|Bortezomib|bortezomib|mesh-list
154197536|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153816079|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197537|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197538|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154197539|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
154197540|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154197541|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197542|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197543|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197544|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
154197545|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197546|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
154197547|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197548|NCT00441168|Dexamethasone|dexamethasone|mesh-list
154197549|NCT00441168|Vincristine|vincristine|mesh-list
154197550|NCT00441168|Doxorubicin|doxorubicin|mesh-list
154197551|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154197552|NCT00441168|Bortezomib|bortezomib|mesh-list
154197553|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197554|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
154197555|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
154197556|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197557|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197558|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154197559|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
154197560|NCT00441168|Hormones|hormones|mesh-ancestor
154197561|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154197562|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154197563|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197564|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154197565|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
154197566|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
154197567|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
154197568|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816112|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154197569|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154197570|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154197571|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154197572|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197573|NCT01062958|Vitamins|vitamins|mesh-list
154197574|NCT01062958|Folic Acid|folic acid|mesh-list
154197575|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
154197576|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
154197577|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
154197578|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197579|NCT01062958|Hematinics|hematinics|mesh-ancestor
154197580|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
154197581|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
153944537|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
154197582|NCT01028976|Vitamins|vitamins|mesh-ancestor
154197583|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
154197584|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197585|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
154197586|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197587|NCT01028976|Protective Agents|protective agents|mesh-ancestor
154197588|NCT01024140|Escitalopram|escitalopram|mesh-list
154197589|NCT01024140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154197590|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154197603|NCT02748707|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154197604|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197605|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197606|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197607|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197608|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154197609|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197610|NCT02748707|Analgesics|analgesics|mesh-ancestor
154197611|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
154197612|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197613|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197614|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197615|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197616|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154197617|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154197619|NCT05014061|Analgesics|analgesics|mesh-ancestor
154197620|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
154157512|NCT05639751|Docetaxel|docetaxel|mesh-list
154197621|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197622|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197623|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154197624|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
153431724|NCT05981209|Hormones|hormones|mesh-ancestor
154197625|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154197626|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
154197627|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
154197628|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197629|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197630|NCT00373113|Capecitabine|capecitabine|mesh-list
154197631|NCT00373113|Sunitinib|sunitinib|mesh-list
154197632|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197633|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
154197634|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197635|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197636|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154197637|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154197638|NCT00373113|Growth Substances|growth substances|mesh-ancestor
154197639|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197640|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
154197641|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154197642|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197643|NCT01045941|Gemcitabine|gemcitabine|mesh-list
154197644|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197645|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
154197646|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197647|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197648|NCT00407511|Pregabalin|pregabalin|mesh-list
154197649|NCT00407511|Analgesics|analgesics|mesh-ancestor
154197663|NCT00384189|Albuterol|albuterol|mesh-list
153736789|NCT06182098|Autonomic Agents|autonomic agents|mesh-ancestor
154197664|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154197665|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
154197666|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197667|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197668|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154197669|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
154197670|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
154197671|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154197672|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154197673|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154197674|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154197675|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
154197676|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197677|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197678|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
154197679|NCT00384189|Hormones|hormones|mesh-ancestor
154197680|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154197681|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154197682|NCT00326716|Ritonavir|ritonavir|mesh-list
154197683|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154197684|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154197685|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154197686|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154197687|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
154197688|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197689|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197690|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154197691|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154197692|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
154197693|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197694|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154197695|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154197696|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154197697|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154197698|NCT01063192|Leucovorin|leucovorin|mesh-list
154197699|NCT01063192|Gemcitabine|gemcitabine|mesh-list
154197700|NCT01063192|Fluorouracil|fluorouracil|mesh-list
154197701|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
154197702|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197703|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
154197704|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197705|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197706|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197707|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
154197708|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197709|NCT01063192|Antidotes|antidotes|mesh-ancestor
154197722|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154197724|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
154197725|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154197726|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154197727|NCT00548405|Interferons|interferons|mesh-list
154197728|NCT00548405|Interferon-beta|interferon-beta|mesh-list
154197729|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
154197730|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
154197731|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197732|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
153737240|NCT05701917|Heparin|heparin|mesh-list
154197733|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197734|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154197735|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
154197736|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197737|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154197738|NCT00959075|Thiamine|thiamine|mesh-list
154197739|NCT00959075|Vitamins|vitamins|mesh-ancestor
154197740|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
154197741|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197742|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
154197743|NCT00295750|Leuprolide|leuprolide|mesh-list
154197744|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154197745|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
154197746|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154197747|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197748|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154197749|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197750|NCT00959231|Cyclosporine|cyclosporine|mesh-list
154197751|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
154197752|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
154197753|NCT00959231|Fludarabine|fludarabine|mesh-list
154197754|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
154197755|NCT00959231|Cyclosporins|cyclosporins|mesh-list
154197756|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197757|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
154197758|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197759|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153737421|NCT05318443|Growth Substances|growth substances|mesh-ancestor
154197760|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154197761|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
154197762|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197763|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197764|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154197765|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154197766|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
154197767|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197768|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
154197769|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197770|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
154197771|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154197772|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154197773|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154197774|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
154197790|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197791|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154197792|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
154197793|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
154197794|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197795|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197796|NCT00959387|Paclitaxel|paclitaxel|mesh-list
154197797|NCT00959387|Cisplatin|cisplatin|mesh-list
154197798|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154197799|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197800|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154197801|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154197802|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154197803|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197804|NCT04718285|Favipiravir|favipiravir|mesh-list
154197805|NCT04718285|Montelukast|montelukast|mesh-list
154197806|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153944761|NCT01169636|Etoposide|etoposide|mesh-list
154197807|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
154197808|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154197809|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
154197810|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256384|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153737686|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
154256385|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154256387|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154256388|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154256389|NCT01159652|Zaleplon|zaleplon|mesh-list
154197811|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197812|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154197813|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154197814|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197815|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
154197816|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197818|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154197819|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197820|NCT00959621|Analgesics|analgesics|mesh-ancestor
154197821|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
154197822|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197823|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197824|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197825|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197826|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154197827|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154197828|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197829|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154197830|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154197831|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197849|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154197850|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154197852|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
154197853|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197854|NCT00406653|Abatacept|abatacept|mesh-list
154197855|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154197856|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197857|NCT00406653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154197858|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197859|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154197860|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
154197861|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197862|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197863|NCT00547157|Cisplatin|cisplatin|mesh-list
154197864|NCT00547157|Panitumumab|panitumumab|mesh-list
154197865|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197866|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154197867|NCT00960479|Ribavirin|ribavirin|mesh-list
154197868|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
154197869|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197870|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
154197871|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197872|NCT00960557|Combretastatin|combretastatin|mesh-list
154197873|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154197874|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197875|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
154197876|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
154197877|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
154197878|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197879|NCT00960635|Vitamin D|vitamin d|mesh-list
154197880|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
154197881|NCT00960635|Calcitriol|calcitriol|mesh-list
154197882|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154197883|NCT00960635|Vitamins|vitamins|mesh-ancestor
154197884|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
154197885|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197886|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154197887|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154197888|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154197907|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197908|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256391|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154256392|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154256393|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256394|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197909|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
153738163|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197910|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197911|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197912|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154197913|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154197914|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154197915|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154197916|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154197917|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154197918|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197919|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154197920|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197921|NCT00384033|Analgesics|analgesics|mesh-ancestor
154197922|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
154197923|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197924|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
154197925|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154197926|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
154197927|NCT00962663|Ibuprofen|ibuprofen|mesh-list
154197928|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154197929|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197930|NCT00962663|Analgesics|analgesics|mesh-ancestor
154197931|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
154197932|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197933|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197934|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197935|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197936|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154197937|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197938|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197939|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154197940|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
154197941|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738431|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197942|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
154197943|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
154197944|NCT00075387|Carboplatin|carboplatin|mesh-list
154197945|NCT00075387|Etoposide|etoposide|mesh-list
154197956|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154197957|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154197958|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154197959|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154197960|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197961|NCT00075387|Protective Agents|protective agents|mesh-ancestor
154197962|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
154197963|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
154197964|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154197965|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154197966|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
154197967|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
154197968|NCT00963131|Antioxidants|antioxidants|mesh-list
154197969|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197970|NCT00963131|Protective Agents|protective agents|mesh-ancestor
154197971|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197972|NCT00963209|Tamoxifen|tamoxifen|mesh-list
154197973|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154197974|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
154197975|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154197976|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197977|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154197978|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154197979|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154197980|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154197981|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154197984|NCT00963443|Ephedrine|ephedrine|mesh-list
154197985|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154197986|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154197987|NCT00963443|Analgesics|analgesics|mesh-ancestor
154197988|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
154197989|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154197990|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154197991|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154197992|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154197993|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154197994|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154197995|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154197996|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154197997|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154197998|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154197999|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
154198000|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154198001|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
154198002|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154198003|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
154198004|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
154198005|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154198006|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154198007|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
154198008|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
154198021|NCT00967655|Panitumumab|panitumumab|mesh-list
154198022|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198023|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
154198024|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198025|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198026|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154198027|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154198028|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198029|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738695|NCT00469924|Caffeine|caffeine|mesh-list
153738725|NCT00157716|Vitamins|vitamins|mesh-ancestor
154198030|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
154198031|NCT00546377|Rituximab|rituximab|mesh-list
154198032|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
154198033|NCT00546377|Pentostatin|pentostatin|mesh-list
154198034|NCT00546377|Sargramostim|sargramostim|mesh-list
154198035|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154198036|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
154198037|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198038|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198039|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154198040|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
154198041|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198042|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198043|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154198044|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198045|NCT00546377|Analgesics|analgesics|mesh-ancestor
154198046|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
154198047|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198048|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154198049|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154198050|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198051|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154198052|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
154198053|NCT00967967|Desloratadine|desloratadine|mesh-list
154198054|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198055|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
154198056|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154198057|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154198058|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
154198059|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738726|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
153738727|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198060|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198061|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198062|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154198063|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154198064|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
154198065|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
154198066|NCT00964457|Cetuximab|cetuximab|mesh-list
154198067|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198068|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198069|NCT00964535|Budesonide|budesonide|mesh-list
154198070|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
154198071|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154198072|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198073|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154198090|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
154198091|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154198092|NCT00964691|Amebicides|amebicides|mesh-ancestor
154198093|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154198094|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154198095|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198096|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
154198097|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198098|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154198099|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198100|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198101|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154198102|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154198103|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
154198104|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198105|NCT00968435|Bevacizumab|bevacizumab|mesh-list
154198107|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198108|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198109|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154198110|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154198111|NCT00968435|Growth Substances|growth substances|mesh-ancestor
154198112|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198113|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
154198114|NCT05253287|Hormones|hormones|mesh-list
154198115|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198116|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198117|NCT00968591|Everolimus|everolimus|mesh-list
154198118|NCT00968591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154198119|NCT00968591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198120|NCT00968591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198121|NCT00968591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198122|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154198123|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
154198124|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198125|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198126|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
154198127|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154198128|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154198129|NCT00968903|Prednisolone|prednisolone|mesh-list
154198130|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
153539929|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
154198142|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154198143|NCT00968903|Protective Agents|protective agents|mesh-ancestor
154198144|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154198145|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738945|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
153738985|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154198147|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154198148|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
154198149|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198150|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198151|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154198152|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154198153|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
154198154|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198155|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198156|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154198157|NCT00965315|Fenofibrate|fenofibrate|mesh-list
154198158|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154198159|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154198160|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
154198161|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198162|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154198163|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154198164|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198165|NCT00969293|Ecallantide|ecallantide|mesh-list
154198166|NCT00969293|Analgesics|analgesics|mesh-ancestor
154198167|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
154198168|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198169|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198170|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154198171|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154198172|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198173|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198174|NCT00969449|Naproxen|naproxen|mesh-list
154198175|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154198176|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154198177|NCT00969449|Analgesics|analgesics|mesh-ancestor
154198178|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
154198179|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198180|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198181|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198182|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198183|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
154198184|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154198185|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198186|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198187|NCT00965393|Bradykinin|bradykinin|mesh-list
154198188|NCT00965393|Kininogens|kininogens|mesh-list
154198189|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
154198190|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
154198191|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154198192|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
154198193|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198208|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198210|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154198211|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
154198212|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198213|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154198214|NCT00970697|Becaplermin|becaplermin|mesh-list
154198215|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
154198216|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154198217|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154198218|NCT00970697|Growth Substances|growth substances|mesh-ancestor
154198219|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198220|NCT00967031|Capecitabine|capecitabine|mesh-list
154198221|NCT00967031|Lapatinib|lapatinib|mesh-list
154198222|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198223|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
154198224|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198225|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198226|NCT00967031|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154198227|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198228|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198229|NCT00967109|Chrysarobin|chrysarobin|mesh-list
154198230|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154198231|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154198232|NCT00967109|Analgesics|analgesics|mesh-ancestor
154198233|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
154198234|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198235|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198236|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198237|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198238|NCT00545753|Permethrin|permethrin|mesh-list
154198239|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198240|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198241|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
154198242|NCT00970931|Amiloride|amiloride|mesh-list
154198243|NCT00970931|Diuretics|diuretics|mesh-list
154198244|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
154198245|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198246|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153739196|NCT00405080|Casopitant|casopitant|mesh-list
154198247|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154198248|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154198249|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198250|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154198251|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154198252|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154198253|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154198270|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154198272|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154198273|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198274|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154198275|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198276|NCT00971165|Losartan|losartan|mesh-list
154198277|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
154198278|NCT00971165|Amiloride|amiloride|mesh-list
154198279|NCT00971165|Diuretics|diuretics|mesh-list
154198280|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154198281|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154198282|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154198283|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154198284|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198285|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
154198286|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198287|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154198288|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154198289|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154198290|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154198291|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154198292|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154198293|NCT00971399|Ondansetron|ondansetron|mesh-list
154198294|NCT00971399|Ramosetron|ramosetron|mesh-list
154198295|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
154198296|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
154198297|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198298|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198299|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154198300|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
154198301|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
154198302|NCT00971399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154198303|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154198304|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
154198305|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198306|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739315|NCT00405158|Cefadroxil|cefadroxil|mesh-list
154198307|NCT00973505|Anastrozole|anastrozole|mesh-list
154198308|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154198309|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198325|NCT00972101|Fludarabine|fludarabine|mesh-list
154198326|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
154198327|NCT00972101|Etoposide|etoposide|mesh-list
154198328|NCT00972101|Melphalan|melphalan|mesh-list
154198330|NCT00972101|Tacrolimus|tacrolimus|mesh-list
154198331|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154198332|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198333|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198334|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
154198335|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198336|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198337|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198338|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
154198339|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198340|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154198341|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198342|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154198343|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154198344|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154198345|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198346|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154198347|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154198348|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154198349|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
154198350|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154198351|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154198352|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
154198353|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154198354|NCT00325468|Denosumab|denosumab|mesh-list
154198355|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154198356|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198357|NCT00972257|Timolol|timolol|mesh-list
154198358|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154198359|NCT00972257|Dorzolamide|dorzolamide|mesh-list
154198360|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154198361|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154198362|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
154198363|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198364|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198365|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809253|NCT04523207|Relugolix|relugolix|mesh-list
154198366|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154198367|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154198368|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154198369|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154198393|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198394|NCT00325234|Carboplatin|carboplatin|mesh-list
154198395|NCT00325234|Gemcitabine|gemcitabine|mesh-list
154198396|NCT00325234|Pemetrexed|pemetrexed|mesh-list
154198397|NCT00325234|Vinorelbine|vinorelbine|mesh-list
154198398|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198399|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198400|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
154198401|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198402|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153945367|NCT02649478|Hormones|hormones|mesh-ancestor
154198403|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154198404|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154198405|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154198406|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
154198407|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
154198408|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
154198409|NCT01063504|Teriparatide|teriparatide|mesh-list
154198410|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154198411|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198412|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154198413|NCT00366249|Ertapenem|ertapenem|mesh-list
154198414|NCT00366249|Tigecycline|tigecycline|mesh-list
154198415|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154198416|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198417|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154198418|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198419|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198420|NCT03927911|Bupivacaine|bupivacaine|mesh-list
154198432|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198434|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198435|NCT03978364|Azacitidine|azacitidine|mesh-list
154198436|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198437|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
154198438|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198439|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198440|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198441|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
154198442|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
154198443|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154198444|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
154198445|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198446|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198447|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154198448|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
154198449|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198450|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198451|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154198452|NCT01046487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154198453|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198454|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198455|NCT03978286|Vortioxetine|vortioxetine|mesh-list
154198456|NCT03978286|Sertraline|sertraline|mesh-list
154198457|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
154198458|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154198459|NCT03978286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154198460|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154198461|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154198462|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198463|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739478|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
153739479|NCT00338221|Glycine|glycine|mesh-list
154198464|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
154198465|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198466|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154198467|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154198468|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154198469|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154198470|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154198471|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154198472|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154198474|NCT03933449|Docetaxel|docetaxel|mesh-list
154198475|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
154198476|NCT03933449|Irinotecan|irinotecan|mesh-list
154198477|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154198478|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198479|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
154198480|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
154198481|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
154198482|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198483|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198512|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
154198513|NCT01049451|Hormones|hormones|mesh-ancestor
154198514|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198515|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154198516|NCT01049451|Protective Agents|protective agents|mesh-ancestor
154198517|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154198518|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198519|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154198520|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
154198521|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198522|NCT00974753|Ketorolac|ketorolac|mesh-list
154198523|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154198524|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154198525|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154198526|NCT00974753|Analgesics|analgesics|mesh-ancestor
154198527|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
154198528|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198529|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198530|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198542|NCT00974987|Temozolomide|temozolomide|mesh-list
154198543|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154198544|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
154198545|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198546|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198547|NCT00975065|Metformin|metformin|mesh-list
154198548|NCT00975065|Vildagliptin|vildagliptin|mesh-list
154198549|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154198550|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198551|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153945521|NCT02644486|Irbesartan|irbesartan|mesh-list
154198552|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
154198553|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198554|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198555|NCT00972881|Capecitabine|capecitabine|mesh-list
154198556|NCT00972881|Irinotecan|irinotecan|mesh-list
154198557|NCT00972881|Cetuximab|cetuximab|mesh-list
154198558|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198559|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
154198560|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198561|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198562|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154198563|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154198564|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198565|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198566|NCT00290758|Genistein|genistein|mesh-list
154198567|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154198568|NCT00290758|Protective Agents|protective agents|mesh-ancestor
154198569|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198570|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198571|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198572|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198573|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198574|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
154198575|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154198576|NCT00290758|Estrogens|estrogens|mesh-ancestor
154198577|NCT00290758|Hormones|hormones|mesh-ancestor
154198578|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198579|NCT00975299|Bombesin|bombesin|mesh-list
154198580|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198581|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198582|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198583|NCT01060930|Epinephrine|epinephrine|mesh-list
154198584|NCT01060930|Norepinephrine|norepinephrine|mesh-list
154198586|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154198587|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154198588|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
154198589|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198590|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198591|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198592|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154198600|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154198601|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198602|NCT00973037|Tamoxifen|tamoxifen|mesh-list
154198603|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154198604|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
154198605|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198606|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198607|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154198608|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198609|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154198610|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154198611|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154198612|NCT00973115|Simvastatin|simvastatin|mesh-list
154198613|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154198614|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154198615|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
154198616|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198617|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154198618|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154198619|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198620|NCT00973193|Panitumumab|panitumumab|mesh-list
154198621|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198622|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198623|NCT00975533|Insulin|insulin|mesh-list
154198624|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154198625|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198627|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
154198628|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198629|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154198630|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154198631|NCT00372567|Growth Substances|growth substances|mesh-ancestor
154198632|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198633|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
154198634|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198635|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198636|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198637|NCT00372567|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154198638|NCT00973271|Atorvastatin|atorvastatin|mesh-list
154198639|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
154198640|NCT00973271|Fenofibrate|fenofibrate|mesh-list
154198641|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154198642|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154198643|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
154157513|NCT05639751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198644|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198645|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154198646|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154198647|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198648|NCT00975767|Docetaxel|docetaxel|mesh-list
154198649|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154198650|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198651|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
154198652|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
154198653|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
154198654|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198655|NCT00975767|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154198656|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198657|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198658|NCT00365547|Bevacizumab|bevacizumab|mesh-list
154198659|NCT00365547|Topotecan|topotecan|mesh-list
154198660|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154198674|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154198675|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154198676|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154198677|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
154198678|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198679|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198680|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198681|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154198682|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154198684|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
154198685|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198686|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198687|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154198688|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154198689|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154198690|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154198691|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198692|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
154198693|NCT00294658|Prednisone|prednisone|mesh-list
154198694|NCT00294658|Prednisolone|prednisolone|mesh-list
154198695|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154198696|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
154198697|NCT00294658|Hormones|hormones|mesh-ancestor
154198698|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198699|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198700|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154198701|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198702|NCT00979667|Oseltamivir|oseltamivir|mesh-list
154198703|NCT00979667|Zanamivir|zanamivir|mesh-list
154198704|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
154198705|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198706|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198707|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198708|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
154198709|NCT03923933|Bumetanide|bumetanide|mesh-list
154198710|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154198711|NCT03923933|Diuretics|diuretics|mesh-ancestor
154198712|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
154198713|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198714|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154198715|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154198716|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198717|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154198718|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
154198719|NCT01066468|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153813617|NCT00334685|Analgesics|analgesics|mesh-ancestor
154198727|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198728|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154198729|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154198731|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198732|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
154198733|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198734|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198735|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198736|NCT00976469|Vaccines|vaccines|mesh-list
154198737|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
154198738|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198739|NCT00980603|Docetaxel|docetaxel|mesh-list
154157514|NCT05639751|Tubulin Modulators|tubulin modulators|mesh-ancestor
154198740|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198741|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
154198742|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
154198743|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
154198744|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198745|NCT00274456|Paclitaxel|paclitaxel|mesh-list
154198746|NCT00274456|Docetaxel|docetaxel|mesh-list
154198747|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154198748|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154198749|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198750|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
154198751|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
154198752|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
154198753|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198754|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
154198755|NCT00977093|Antidotes|antidotes|mesh-ancestor
154198756|NCT00977093|Protective Agents|protective agents|mesh-ancestor
154198757|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198758|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
154198759|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
154198760|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198761|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154198762|NCT00977249|Varenicline|varenicline|mesh-list
154198763|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154198764|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154198765|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
154198766|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198767|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198768|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198769|NCT01069822|Midazolam|midazolam|mesh-list
154198770|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154198771|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154198772|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154198773|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198774|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154198775|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154198776|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154198777|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154198778|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
154198780|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
154198781|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
154198782|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198783|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198784|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
154198785|NCT00364923|Aminopterin|aminopterin|mesh-list
154198786|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154198787|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539930|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154198800|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154198801|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
154198802|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198803|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198804|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
154198805|NCT00273052|Protective Agents|protective agents|mesh-ancestor
154198806|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154198807|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154198808|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154198809|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
154198810|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154198811|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154198812|NCT01046721|Exenatide|exenatide|mesh-list
154198813|NCT01046721|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154198814|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154198815|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198816|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154198817|NCT01046721|Incretins|incretins|mesh-ancestor
154198818|NCT01046721|Hormones|hormones|mesh-ancestor
154198819|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154198820|NCT01046799|Entecavir|entecavir|mesh-list
154198821|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
154198822|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198823|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
154198824|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
154198825|NCT00290290|Povidone|povidone|mesh-list
154198826|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154198827|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198828|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
154198829|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
154198830|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
154198831|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154198832|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
154157515|NCT05639751|Antimitotic Agents|antimitotic agents|mesh-ancestor
154198833|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198834|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
154198835|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154198836|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154198837|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198838|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
154198839|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
154198840|NCT02534961|Cefazolin|cefazolin|mesh-list
154198841|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154198842|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198843|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
154198844|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
154198845|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154198846|NCT01046955|Daclizumab|daclizumab|mesh-list
154198847|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
154198848|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198849|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154198850|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153945810|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154198861|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198862|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
154198863|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198864|NCT00381693|Azacitidine|azacitidine|mesh-list
154198865|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154198866|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
154198867|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198868|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198869|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198870|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
154198871|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154198872|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198873|NCT00977405|Gentamicins|gentamicins|mesh-list
154198874|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154198875|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198876|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154198877|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739906|NCT00165828|Zonisamide|zonisamide|mesh-list
154198878|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198879|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154198880|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154198881|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
154198882|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
154198883|NCT00977873|Vitamin D|vitamin d|mesh-list
154198884|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154198885|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198886|NCT00977873|Vitamins|vitamins|mesh-ancestor
154198887|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
154198888|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154198889|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154198890|NCT00457392|Sunitinib|sunitinib|mesh-list
154198891|NCT00457392|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154198892|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198893|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198894|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198895|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198896|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154198897|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154198898|NCT00457392|Growth Substances|growth substances|mesh-ancestor
154198899|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198900|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
154198901|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
154198902|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154198903|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198904|NCT00381615|Vaccines|vaccines|mesh-list
154198905|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
154198906|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198907|NCT00978107|Flucytosine|flucytosine|mesh-list
154198908|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
154198909|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198910|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
154198911|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198912|NCT01029132|Galantamine|galantamine|mesh-list
154198913|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154198914|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198915|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198925|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198927|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
154198928|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198929|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198930|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198931|NCT00981773|Maraviroc|maraviroc|mesh-list
154198932|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154198933|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154198934|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198935|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154198936|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154198937|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
154198938|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198939|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154198940|NCT01049841|Sirolimus|sirolimus|mesh-list
154198941|NCT01049841|Temsirolimus|temsirolimus|mesh-list
154198942|NCT01049841|MTOR Inhibitors|mtor inhibitors|mesh-list
154198943|NCT01049841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154198944|NCT01049841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154198945|NCT01049841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198946|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154198947|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
154198948|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198949|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154198950|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154198951|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154198952|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154198953|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
154198954|NCT00978263|Metformin|metformin|mesh-list
154198955|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154198956|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198957|NCT00981851|Albuterol|albuterol|mesh-list
154198958|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
154198959|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154198960|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
154198961|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154198962|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154198963|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154198964|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
154198965|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
154198966|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154198967|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
154198968|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154198969|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154198970|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
154198971|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154198972|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154198973|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154198974|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154198975|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
154198976|NCT00981929|Losartan|losartan|mesh-list
154198977|NCT00981929|Tramadol|tramadol|mesh-list
154198978|NCT00981929|Caffeine|caffeine|mesh-list
154198979|NCT00981929|Omeprazole|omeprazole|mesh-list
154198980|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154198981|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154198982|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153461926|NCT05241132|Tislelizumab|tislelizumab|mesh-list
154199010|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154199011|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
154199012|NCT00978653|Protective Agents|protective agents|mesh-ancestor
154199013|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199014|NCT00293722|Etanercept|etanercept|mesh-list
154199015|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154199016|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154199017|NCT00293722|Analgesics|analgesics|mesh-ancestor
154199018|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
154157516|NCT05639751|Mitosis Modulators|mitosis modulators|mesh-ancestor
154199019|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199020|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199021|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154199022|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199023|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154199024|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199025|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
154199026|NCT00381303|Ritonavir|ritonavir|mesh-list
154199027|NCT00381303|Darunavir|darunavir|mesh-list
154199028|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154199029|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154199051|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199053|NCT00982631|Temsirolimus|temsirolimus|mesh-list
154199054|NCT00982631|MTOR Inhibitors|mtor inhibitors|mesh-list
154199055|NCT00982631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154199056|NCT00982631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199057|NCT00982631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199058|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199059|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
154199060|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199061|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199062|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199063|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199064|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154199065|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
154199066|NCT00364611|Bevacizumab|bevacizumab|mesh-list
154199067|NCT00364611|Trastuzumab|trastuzumab|mesh-list
154199068|NCT00364611|Docetaxel|docetaxel|mesh-list
154199069|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154199070|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199071|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154199072|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154199073|NCT00364611|Growth Substances|growth substances|mesh-ancestor
154199074|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199075|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
154199076|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
154199077|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
154199078|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
154199079|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199080|NCT00956189|Aripiprazole|aripiprazole|mesh-list
154199081|NCT00956189|Amisulpride|amisulpride|mesh-list
154199082|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
154199083|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154199084|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154199117|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199118|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740147|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
154199119|NCT00364533|Analgesics|analgesics|mesh-ancestor
154199120|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
154199121|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199122|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154199123|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153462191|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
154199134|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154199136|NCT00984737|Insulin|insulin|mesh-list
154199137|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154199138|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199139|NCT01047579|Rivastigmine|rivastigmine|mesh-list
154199140|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154199141|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199142|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199143|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
154199144|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199145|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199146|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154199147|NCT01047579|Protective Agents|protective agents|mesh-ancestor
154199148|NCT04006847|Dasatinib|dasatinib|mesh-list
154199149|NCT04006847|Nilotinib|nilotinib|mesh-list
154199150|NCT04006847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154199151|NCT04006847|Bosutinib|bosutinib|mesh-list
154199152|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154199153|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199154|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199155|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199156|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
154199157|NCT00984893|Diphosphonates|diphosphonates|mesh-list
153740262|NCT04620200|Nivolumab|nivolumab|mesh-list
154199158|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154199159|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199160|NCT00983021|Insulin|insulin|mesh-list
154199161|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154199162|NCT00983021|Liraglutide|liraglutide|mesh-list
154199163|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
154199164|NCT00983021|Xultophy|xultophy|mesh-list
154199165|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154199166|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199167|NCT00983021|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154199168|NCT00983021|Incretins|incretins|mesh-ancestor
154199169|NCT00983021|Hormones|hormones|mesh-ancestor
154199170|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199171|NCT00984971|Tenofovir|tenofovir|mesh-list
154199172|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
154199173|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199174|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154199175|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154199176|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740414|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154199177|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199178|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154199179|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154199180|NCT00544817|Temozolomide|temozolomide|mesh-list
154199181|NCT00544817|Sorafenib|sorafenib|mesh-list
154199182|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154199183|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
154199184|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199185|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199186|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154199192|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
154199193|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199194|NCT00983177|Colchicine|colchicine|mesh-list
154199195|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
154199196|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199197|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
154199198|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
154199199|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
154199200|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199201|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199202|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
154199203|NCT00983255|Tedizolid|tedizolid|mesh-list
154199204|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
154199205|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199206|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199207|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154199208|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199209|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199210|NCT00988403|Levan|levan|mesh-list
154199211|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199212|NCT00988481|Topiramate|topiramate|mesh-list
154199213|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
154199214|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154199215|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199216|NCT00289900|Atorvastatin|atorvastatin|mesh-list
154199217|NCT00289900|Simvastatin|simvastatin|mesh-list
154199218|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154199219|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154199220|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
154199221|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199222|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154199223|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154199224|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199225|NCT00543725|Efavirenz|efavirenz|mesh-list
153946183|NCT00984126|Coagulants|coagulants|mesh-ancestor
154199226|NCT00543725|Rilpivirine|rilpivirine|mesh-list
154199227|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154199228|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154199229|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199230|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199231|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
154199232|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199233|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154199234|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153740548|NCT05860062|Vitamin D|vitamin d|mesh-list
154199235|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154199236|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154199237|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154199238|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154199239|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154199240|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154199242|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
154199243|NCT00985361|Vitamins|vitamins|mesh-list
154199244|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
154199245|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199246|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154199247|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154199248|NCT00269152|Carboplatin|carboplatin|mesh-list
154199249|NCT00269152|Pemetrexed|pemetrexed|mesh-list
154199250|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199251|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199252|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199253|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154199254|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154199255|NCT00988715|Cyclosporine|cyclosporine|mesh-list
154199282|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154199283|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
154199284|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199285|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199286|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154199287|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
154199288|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
154199289|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154199290|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154199291|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154199292|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154199293|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
154199294|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199295|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199296|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
154199297|NCT03975166|Hormones|hormones|mesh-ancestor
153946258|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
154199298|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199299|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
154199300|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154199301|NCT01325818|Pravastatin|pravastatin|mesh-list
154199302|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154199303|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154199304|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
154199326|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154199327|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
154199328|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
154199329|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199330|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199331|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154199332|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
154199333|NCT02535039|Hormones|hormones|mesh-ancestor
154157351|NCT05867121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740798|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
154199334|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199335|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154199336|NCT02535039|Protective Agents|protective agents|mesh-ancestor
154199337|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154199338|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199339|NCT00363129|Vitamin E|vitamin e|mesh-list
154199340|NCT00363129|Vitamins|vitamins|mesh-ancestor
154199341|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
154199342|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199343|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
154199344|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199345|NCT00363129|Protective Agents|protective agents|mesh-ancestor
154199346|NCT00268996|Darapladib|darapladib|mesh-list
154199347|NCT00268996|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154199348|NCT00268996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199349|NCT00268996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199350|NCT00379587|Rituximab|rituximab|mesh-list
154199351|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154199352|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199353|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
154199354|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199355|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199356|NCT00363051|Everolimus|everolimus|mesh-list
154199357|NCT00363051|Octreotide|octreotide|mesh-list
154199371|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199372|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
154199373|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199374|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153946330|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199375|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154199376|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154199377|NCT00379353|Growth Substances|growth substances|mesh-ancestor
154199378|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
154199379|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199381|NCT01047657|Sibutramine|sibutramine|mesh-list
154199382|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199383|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199384|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154199385|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154199386|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
154199387|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154199388|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
154199389|NCT00378573|Bevacizumab|bevacizumab|mesh-list
154199390|NCT00378573|Gemcitabine|gemcitabine|mesh-list
154199391|NCT00378573|Docetaxel|docetaxel|mesh-list
154199392|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154199393|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199394|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154256396|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
154199395|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154199396|NCT00378573|Growth Substances|growth substances|mesh-ancestor
154199397|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199398|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
154199399|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154199400|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
154199401|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199402|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
154199403|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
154199404|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
154199405|NCT01047891|Sorafenib|sorafenib|mesh-list
154199406|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199407|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154199408|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199409|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199410|NCT02534571|Epinephrine|epinephrine|mesh-list
154199411|NCT02534571|Hemostatics|hemostatics|mesh-list
154199412|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154199413|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154199414|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
154199415|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199416|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199417|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199449|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199450|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154199451|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154199452|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199453|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199454|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
154199455|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154199456|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154199457|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
154199458|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199459|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154199460|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154199461|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199462|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199475|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
154199476|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199477|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199478|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
154199479|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199480|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199481|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
154199482|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154199483|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199484|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154199485|NCT01048047|Amlodipine|amlodipine|mesh-list
154199486|NCT01048047|Aliskiren|aliskiren|mesh-list
154199487|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154199488|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154199489|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154199490|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199491|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154199492|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199493|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
154199494|NCT01048047|Renin Inhibitors|renin inhibitors|mesh-ancestor
154199495|NCT01048047|Protease Inhibitors|protease inhibitors|mesh-ancestor
154199496|NCT01048047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199497|NCT01324635|Panobinostat|panobinostat|mesh-list
154199498|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154199499|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199500|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199501|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199502|NCT00456846|Paclitaxel|paclitaxel|mesh-list
154199503|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154199504|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154199505|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199506|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
154199507|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
154199508|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
154199509|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810574|NCT00320294|Irinotecan|irinotecan|mesh-list
154199510|NCT03324282|Avelumab|avelumab|mesh-list
154199511|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154199512|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199513|NCT00484094|Sirolimus|sirolimus|mesh-list
154199514|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199515|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199516|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154199517|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199518|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
154199519|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199520|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
154199521|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199522|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154199523|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199524|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
154199525|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154199526|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153946485|NCT01133678|Paclitaxel|paclitaxel|mesh-list
154199554|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154199555|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199556|NCT00456300|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154199557|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154199558|NCT00456300|Incretins|incretins|mesh-ancestor
154199559|NCT00456300|Hormones|hormones|mesh-ancestor
154199560|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199561|NCT00267748|Sunitinib|sunitinib|mesh-list
154199562|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199563|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154199564|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154199565|NCT00267748|Growth Substances|growth substances|mesh-ancestor
154199566|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199567|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
154199568|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154199569|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199570|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199571|NCT00267202|Omalizumab|omalizumab|mesh-list
154199593|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199594|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154199595|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
154199596|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
154199597|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
154199598|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154199599|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
154199600|NCT01029678|Vinorelbine|vinorelbine|mesh-list
154199601|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199602|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154199604|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
154199605|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
154199606|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199608|NCT00286468|Glyburide|glyburide|mesh-list
154199609|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154199610|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199611|NCT00286468|Incretins|incretins|mesh-ancestor
154199612|NCT00286468|Hormones|hormones|mesh-ancestor
154199613|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199614|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154199615|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
154199616|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199617|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199618|NCT00507026|Diclofenac|diclofenac|mesh-list
154199619|NCT00507026|Ketorolac|ketorolac|mesh-list
154199620|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154199621|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154199622|NCT00507026|Analgesics|analgesics|mesh-ancestor
154199623|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
154199624|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199625|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199626|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154199639|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199641|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154199642|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154199643|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154199644|NCT01019174|Growth Substances|growth substances|mesh-ancestor
154199645|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
154199646|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154199647|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154199648|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199649|NCT01011920|Cytarabine|cytarabine|mesh-list
154199650|NCT01011920|Rituximab|rituximab|mesh-list
154199651|NCT01011920|Methotrexate|methotrexate|mesh-list
154199652|NCT01011920|Thiotepa|thiotepa|mesh-list
154199653|NCT01011920|Carmustine|carmustine|mesh-list
154199654|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154199655|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199656|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
154199657|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199658|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199659|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154199660|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
154199661|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154199662|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154199663|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
153741576|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
154199664|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199665|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
154199666|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199667|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154199668|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199669|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154199670|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
154199671|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199672|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154199673|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
153946638|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
154199675|NCT03976102|Rituximab|rituximab|mesh-list
154199676|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154199677|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199678|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
154199679|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199680|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154199681|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
154199682|NCT00506948|Sirolimus|sirolimus|mesh-list
154199683|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
154199684|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154199685|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154199686|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199687|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154199688|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
154199726|NCT00445848|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154199750|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199752|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199753|NCT00284050|Ranibizumab|ranibizumab|mesh-list
154199754|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154199755|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154199756|NCT00284050|Growth Substances|growth substances|mesh-ancestor
154199757|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199758|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
154199759|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199761|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153741741|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199762|NCT00293020|Narcotics|narcotics|mesh-ancestor
154199763|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199764|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199765|NCT00293020|Analgesics|analgesics|mesh-ancestor
154199766|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
154199767|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199768|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154199769|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154199770|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
154199771|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
154199772|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
154199773|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
154199774|NCT00377637|Azathioprine|azathioprine|mesh-list
154199775|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199776|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
154199777|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256398|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432341|NCT05039619|Hormones|hormones|mesh-ancestor
154199786|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
154199787|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199788|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199789|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199790|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
154199791|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154199793|NCT00377403|Amoxicillin|amoxicillin|mesh-list
154199794|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
154199795|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
154199796|NCT00377403|Ephedrine|ephedrine|mesh-list
154199797|NCT00377403|Levomethorphan|levomethorphan|mesh-list
154199798|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
154199799|NCT00377403|Guaifenesin|guaifenesin|mesh-list
154199800|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153741925|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
154199801|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154199802|NCT00377403|Analgesics|analgesics|mesh-ancestor
154199803|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
154199804|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154199805|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199806|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
154199807|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154199808|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199809|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
154199810|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
154199811|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154199812|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154199813|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199814|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199815|NCT00377403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154199816|NCT00377403|Narcotics|narcotics|mesh-ancestor
154199817|NCT00377403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199818|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154199819|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
154199820|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154199821|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
154199822|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153946789|NCT00656110|Hormones|hormones|mesh-ancestor
154199823|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154199824|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
154199825|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
154199826|NCT00377403|Expectorants|expectorants|mesh-ancestor
154199827|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154199828|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154199829|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
154199830|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154199831|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154199832|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199833|NCT00292942|Artesunate|artesunate|mesh-list
154199834|NCT00292942|Mannitol|mannitol|mesh-list
154199835|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
154199836|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154199837|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154199838|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199839|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199840|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
154199841|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
154199842|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154199843|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
154199844|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154199859|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199860|NCT00370071|Interferons|interferons|mesh-list
154199861|NCT00370071|Interferon-beta|interferon-beta|mesh-list
154199862|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
154199863|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199864|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
154199865|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154199866|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
154199867|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199868|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154199869|NCT00369915|Scopolamine|scopolamine|mesh-list
154199870|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154199871|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154199872|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
154199873|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
154199874|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256399|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256400|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
154256401|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
154256402|NCT01261832|Cilostazol|cilostazol|mesh-list
154256403|NCT01261832|Clopidogrel|clopidogrel|mesh-list
154256404|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154256405|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154256406|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154256407|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154256408|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
153742369|NCT00524836|Levocetirizine|levocetirizine|mesh-list
154256409|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256410|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256411|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199875|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199876|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154199877|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
154199878|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154199879|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
154199880|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199881|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199882|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154199883|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
154199884|NCT03991845|Levocetirizine|levocetirizine|mesh-list
154199885|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154199886|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154199887|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
154199888|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
154199889|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199890|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199891|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199892|NCT01017380|Celecoxib|celecoxib|mesh-list
154199893|NCT01017380|Etoricoxib|etoricoxib|mesh-list
154199894|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154199895|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154199896|NCT01017380|Analgesics|analgesics|mesh-ancestor
154199897|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
154199898|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153946864|NCT00884650|Analgesics|analgesics|mesh-list
154199899|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199900|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154199901|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742546|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154199902|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154199903|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154199904|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199905|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199906|NCT00369681|Rituximab|rituximab|mesh-list
154199917|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154199918|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154199919|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199920|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199921|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154199922|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
154199923|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154199924|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
154199925|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
154199926|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
154199927|NCT00266812|Temozolomide|temozolomide|mesh-list
154199928|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154199929|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
154199930|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199931|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199933|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154199934|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154199935|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154199936|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154199937|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
154199938|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199939|NCT00361569|Estrogens|estrogens|mesh-list
154199940|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154199941|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
154199942|NCT00361569|Hormones|hormones|mesh-ancestor
154199943|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199944|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199945|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
154199946|NCT01011998|Valproic Acid|valproic acid|mesh-list
154199947|NCT01011998|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154199948|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154199949|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154199950|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199951|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199952|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
154199953|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
154199954|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199955|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199956|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
154199957|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154199958|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154199959|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154199960|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
154199961|NCT01017458|Testosterone|testosterone|mesh-list
154199962|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
154199963|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
154199964|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154199965|NCT01017458|Androgens|androgens|mesh-ancestor
154199966|NCT01017458|Hormones|hormones|mesh-ancestor
154199967|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199968|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199969|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154199970|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154199971|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
154199990|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154199991|NCT00266656|Hormones|hormones|mesh-list
154199992|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154199993|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154199994|NCT00483548|Ziprasidone|ziprasidone|mesh-list
154199995|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153742921|NCT00527761|Cisplatin|cisplatin|mesh-list
154199996|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
154199997|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154199998|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154199999|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200000|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154200001|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200002|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200003|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154200004|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154200005|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
154200006|NCT00445770|Etanercept|etanercept|mesh-list
154200007|NCT00445770|Methotrexate|methotrexate|mesh-list
154200008|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154200009|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
154200010|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200011|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200012|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154200013|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
154200014|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200015|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200016|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200017|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200018|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154200019|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200020|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
154200021|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154200022|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153743024|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154200023|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154200024|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154200025|NCT00445770|Analgesics|analgesics|mesh-ancestor
154200026|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
154200027|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200028|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200044|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200045|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154200046|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154200047|NCT01019798|Growth Substances|growth substances|mesh-ancestor
154200048|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200049|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
154200050|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153947007|NCT00657982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154200051|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200053|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154200054|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154200055|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
154200056|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200057|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200058|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200059|NCT00482612|Mirtazapine|mirtazapine|mesh-list
154200060|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
154200061|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154200062|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154200063|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
154200064|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
154200065|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200066|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200067|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200068|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154200069|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200070|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200071|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154200072|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154200073|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154200074|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154200075|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154200076|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154200077|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
154200078|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154200079|NCT00282568|Tacrolimus|tacrolimus|mesh-list
154200080|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200081|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
154200082|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200083|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154200084|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200085|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200086|NCT02532322|Acetaminophen|acetaminophen|mesh-list
154200087|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154200103|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200105|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
154200106|NCT00445692|Hormones|hormones|mesh-ancestor
154200107|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200108|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154200109|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200110|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
154200111|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154200112|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154200113|NCT00445692|Growth Substances|growth substances|mesh-ancestor
154200114|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
154200115|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154200116|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200117|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154200118|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200119|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200120|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154200121|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154200122|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
154200124|NCT00282412|Cyclosporine|cyclosporine|mesh-list
154200125|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
154200127|NCT00282412|Fludarabine|fludarabine|mesh-list
154200128|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
154200129|NCT00282412|Cyclosporins|cyclosporins|mesh-list
154200130|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200131|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
154200132|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200133|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743517|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743518|NCT02276911|Ibuprofen|ibuprofen|mesh-list
154200134|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154200135|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
154200136|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200137|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200138|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154200139|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200140|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
154200141|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200142|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200143|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154200144|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154200145|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154200146|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
154200147|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154200148|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154200149|NCT00282256|Tacrolimus|tacrolimus|mesh-list
154200150|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200162|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154200163|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200164|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200165|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154200166|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154200167|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
154200168|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
154200170|NCT00543569|Tacrolimus|tacrolimus|mesh-list
154200171|NCT00543569|Basiliximab|basiliximab|mesh-list
154200172|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200173|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
154200174|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200175|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154200176|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200177|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200178|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154200179|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200180|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154200181|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
154200182|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154200183|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200184|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200185|NCT00984347|Oxytocin|oxytocin|mesh-list
154200186|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
154200187|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200188|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200189|NCT00984425|Sorafenib|sorafenib|mesh-list
154200190|NCT00984425|Lapatinib|lapatinib|mesh-list
154200191|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200192|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154200193|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200194|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200195|NCT00984425|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154200196|NCT00445458|Paclitaxel|paclitaxel|mesh-list
154200197|NCT00445458|Neratinib|neratinib|mesh-list
154200198|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154200199|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200200|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
154200201|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
154200202|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
154200203|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200204|NCT00445458|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154200205|NCT00445458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154200206|NCT00445458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200207|NCT03914417|Imiquimod|imiquimod|mesh-list
154200208|NCT03914417|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154200209|NCT03914417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200210|NCT03914417|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154200211|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
154200212|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464051|NCT02086500|Coagulants|coagulants|mesh-ancestor
154200246|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200247|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200248|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154200249|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
154200250|NCT00265096|Golimumab|golimumab|mesh-list
154200251|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154200252|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154200253|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200254|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200255|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
154200256|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200257|NCT00986609|Poly I-C|poly i-c|mesh-list
154200258|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154200259|NCT00986609|Vaccines|vaccines|mesh-list
154200281|NCT05499689|Bupivacaine|bupivacaine|mesh-list
154200282|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
154200283|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
154200284|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200285|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200286|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
154200287|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200288|NCT01012232|Ropivacaine|ropivacaine|mesh-list
154200289|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
154200290|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
154200291|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200292|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200293|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
154200294|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200295|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154200296|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154200297|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200298|NCT00541229|Incretins|incretins|mesh-ancestor
154200299|NCT00541229|Hormones|hormones|mesh-ancestor
154200300|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200301|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154200302|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
154200303|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200304|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200305|NCT04006691|Mitomycins|mitomycins|mesh-list
154200306|NCT04006691|Mitomycin|mitomycin|mesh-list
154200307|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154200308|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200309|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
154200310|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200311|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154200312|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200313|NCT00986765|Aspirin|aspirin|mesh-list
154200336|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200337|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
154200338|NCT01019876|Fludarabine|fludarabine|mesh-list
154200339|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200340|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
154200341|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200342|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154200343|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154200344|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
154200345|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200346|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200347|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154200348|NCT01017770|Artesunate|artesunate|mesh-list
154200349|NCT01017770|Lumefantrine|lumefantrine|mesh-list
154200350|NCT01017770|Artemether|artemether|mesh-list
154200351|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154200352|NCT01017770|Amodiaquine|amodiaquine|mesh-list
153743872|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
154200353|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
154200354|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154200355|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154200356|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200357|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200358|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
154200359|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
154200360|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154200361|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
154200362|NCT01017926|Triazolam|triazolam|mesh-list
154200363|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154200364|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154200365|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200366|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200395|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200397|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154200398|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154200399|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154200400|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154200401|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154200402|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200403|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154200404|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
154200405|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200406|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200407|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154200408|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153744049|NCT02943655|Hormones|hormones|mesh-ancestor
154200409|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154200410|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
154200411|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154200412|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200413|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
154200414|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
153464430|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
153744220|NCT00147680|Paclitaxel|paclitaxel|mesh-list
153744407|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744410|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
154200429|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
154200430|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
154200431|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200433|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200434|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154200435|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154200436|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
154200438|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200439|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200440|NCT00987233|Triamcinolone|triamcinolone|mesh-list
154200441|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154200442|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154200443|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154200444|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200445|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
154200446|NCT00987233|Hormones|hormones|mesh-ancestor
154200447|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200448|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200449|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200450|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
154200451|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200452|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200453|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
154200454|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154200455|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154200456|NCT04377503|Prednisolone|prednisolone|mesh-list
154200457|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
154200458|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154200459|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
154200460|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200461|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
154200462|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
154200463|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200464|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200465|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200466|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
154200467|NCT04377503|Hormones|hormones|mesh-ancestor
154200468|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200469|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154200470|NCT04377503|Protective Agents|protective agents|mesh-ancestor
154200471|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154200472|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200473|NCT00542789|Esomeprazole|esomeprazole|mesh-list
154200474|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154200475|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200476|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154200485|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200486|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200488|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200489|NCT00987779|Gabapentin|gabapentin|mesh-list
154200490|NCT00987779|Analgesics|analgesics|mesh-ancestor
154200491|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
154200492|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200493|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200494|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
154200495|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154200496|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200497|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200498|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153744709|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200499|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154200500|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154200501|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200502|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200503|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
154200504|NCT01018160|Rabeprazole|rabeprazole|mesh-list
154200505|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154200506|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200507|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154200508|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200509|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200511|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154200512|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200513|NCT00463580|Infliximab|infliximab|mesh-list
154200514|NCT00463580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154200515|NCT00463580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200516|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200517|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200518|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154200519|NCT01020734|Cyclosporine|cyclosporine|mesh-list
154200520|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
154200521|NCT01020734|Busulfan|busulfan|mesh-list
154200522|NCT01020734|Methotrexate|methotrexate|mesh-list
154200523|NCT01020734|Fludarabine|fludarabine|mesh-list
154200524|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
154200525|NCT01020734|Cyclosporins|cyclosporins|mesh-list
154200526|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154200527|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200528|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
153744840|NCT00170742|Octreotide|octreotide|mesh-list
154200529|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200530|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154200531|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154200532|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
154200533|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200534|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200535|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154200536|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154200537|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
154200538|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200539|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154200540|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
154200541|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200542|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200543|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153464576|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
154200553|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200554|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
154200555|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200556|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154200557|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154200558|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154200559|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154200560|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154200561|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154200562|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153745027|NCT05786677|Serotonin|serotonin|mesh-list
153745112|NCT05784467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153745159|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200563|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154200564|NCT03911843|Vitamin D|vitamin d|mesh-list
154200565|NCT03911843|Vitamins|vitamins|mesh-ancestor
154200566|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
154200567|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200568|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154200569|NCT00361335|Golimumab|golimumab|mesh-list
154200570|NCT00361335|Methotrexate|methotrexate|mesh-list
154200571|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154256412|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154256413|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
154200572|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
154200573|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200574|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200575|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154200576|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
154200577|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200578|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200579|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200580|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200581|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154200582|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200583|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
154200584|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153745160|NCT05634577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154200585|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154200586|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154200587|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200589|NCT00264550|Methotrexate|methotrexate|mesh-list
154200590|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154200591|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154200592|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
154200593|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154200594|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200595|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154200596|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
154200597|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200598|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200599|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200600|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200601|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154200602|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200603|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
154200604|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154200605|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154200606|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154200607|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200608|NCT01070290|Capecitabine|capecitabine|mesh-list
154200609|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
154200637|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200638|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154200639|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
154200640|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
154200641|NCT01070524|Hormones|hormones|mesh-ancestor
154200642|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200643|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
154200644|NCT01071304|Midazolam|midazolam|mesh-list
154200645|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154200646|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154200647|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200648|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200649|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154200650|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200651|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154200652|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154200653|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
154200654|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
154200655|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
154200656|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
154200657|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200658|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200693|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200694|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
154200695|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200710|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200711|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200712|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
154200713|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154200714|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154200715|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200716|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154200717|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154200718|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200719|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200720|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154200722|NCT04573673|Cathartics|cathartics|mesh-ancestor
154200723|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200724|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154200725|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200726|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200727|NCT01050699|Midazolam|midazolam|mesh-list
154200728|NCT01050699|Fentanyl|fentanyl|mesh-list
153947694|NCT06040840|Lidocaine|lidocaine|mesh-list
154200729|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
154200730|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154200731|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200732|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200733|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154200734|NCT01050699|Analgesics|analgesics|mesh-ancestor
154200735|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
154200736|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200737|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154200738|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154200739|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154200740|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
154200741|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200742|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200743|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154200744|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154200745|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154200746|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154200747|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154200748|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
154200749|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
154200750|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
154200751|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
154200752|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154200753|NCT01050699|Narcotics|narcotics|mesh-ancestor
154200754|NCT02408315|Misoprostol|misoprostol|mesh-list
153464905|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200767|NCT05711693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200768|NCT05711693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154200769|NCT05711693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200770|NCT05711693|Vasodilator Agents|vasodilator agents|mesh-ancestor
154200771|NCT04005365|Propranolol|propranolol|mesh-list
154200772|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154200773|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154200774|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
154200775|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200776|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200777|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200778|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153745806|NCT00326456|Paclitaxel|paclitaxel|mesh-list
154200779|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154200780|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
154200781|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
154200782|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153745971|NCT00150137|Methimazole|methimazole|mesh-list
154200783|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154200784|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
154200785|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200786|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154200787|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154200788|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200789|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200790|NCT00358917|Ritonavir|ritonavir|mesh-list
154200791|NCT00358917|Lopinavir|lopinavir|mesh-list
154200792|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154200793|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154200794|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154200795|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
154200796|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200797|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200798|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154200799|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154200800|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
154200801|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200802|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154200803|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154200804|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154200806|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154200807|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200808|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154200809|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200810|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200811|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154200812|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154200813|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
154200814|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200816|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154200846|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
154200847|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200848|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154200849|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154200850|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
154200851|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200852|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200853|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154200854|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154200855|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
154200856|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
154200857|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200858|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154200859|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
154200860|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154200861|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154200862|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200863|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154200864|NCT01070680|Analgesics|analgesics|mesh-ancestor
154200871|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200872|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200873|NCT00445146|Elvitegravir|elvitegravir|mesh-list
154200874|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154200875|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154200876|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
154200877|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200878|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154200879|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200880|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200881|NCT01581736|Insulin|insulin|mesh-list
154200882|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154200883|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154200884|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200885|NCT01030302|Bortezomib|bortezomib|mesh-list
154200886|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200887|NCT00368277|Amlodipine|amlodipine|mesh-list
154200888|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154200889|NCT00368277|Ramipril|ramipril|mesh-list
154200890|NCT00368277|Aliskiren|aliskiren|mesh-list
154200891|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154200892|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154200893|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154200894|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200895|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154200896|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200897|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
154200898|NCT00368277|Diuretics|diuretics|mesh-ancestor
154200899|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
154200900|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154200901|NCT00368277|Renin Inhibitors|renin inhibitors|mesh-ancestor
154200902|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
154200903|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200904|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154200905|NCT00280150|Paclitaxel|paclitaxel|mesh-list
154200906|NCT00280150|Bevacizumab|bevacizumab|mesh-list
154200907|NCT00280150|Carboplatin|carboplatin|mesh-list
154200908|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154200909|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154200911|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
154200912|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
154200913|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
154200914|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746011|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746013|NCT02913469|Morphine|morphine|mesh-list
153746127|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154200915|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154200916|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154200917|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154200918|NCT00280150|Growth Substances|growth substances|mesh-ancestor
154200919|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200920|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
154200921|NCT00280150|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154200922|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154200923|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200924|NCT00279916|Triamcinolone|triamcinolone|mesh-list
154200925|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154200926|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154200927|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154200928|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200929|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
154200930|NCT00279916|Hormones|hormones|mesh-ancestor
154200931|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200932|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200933|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154200947|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200948|NCT02534337|Antidotes|antidotes|mesh-ancestor
154200949|NCT02534337|Protective Agents|protective agents|mesh-ancestor
154200950|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
154200951|NCT02534337|Vitamins|vitamins|mesh-ancestor
154200952|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
154200953|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154200954|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
153947913|NCT05446571|Letermovir|letermovir|mesh-list
154200955|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200956|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
154200957|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
154200958|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200959|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
154200960|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154200961|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200962|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
154200963|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154200964|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
154200965|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154200966|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
154200967|NCT00251758|Lansoprazole|lansoprazole|mesh-list
154200968|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154200969|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154200970|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154200971|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200972|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200973|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
154200974|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154200975|NCT00262834|Vorinostat|vorinostat|mesh-list
154200976|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154200977|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154200978|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154200979|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200980|NCT04417361|Erenumab|erenumab|mesh-list
154200981|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154200982|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154200983|NCT04417361|Analgesics|analgesics|mesh-ancestor
154200984|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
154200985|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154200986|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200987|NCT00541775|Metformin|metformin|mesh-list
154200988|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154200989|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
154200990|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154200991|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154200992|NCT00541775|Incretins|incretins|mesh-ancestor
154200993|NCT00541775|Hormones|hormones|mesh-ancestor
154200994|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154200995|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154201006|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201007|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154201008|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154201009|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
154201011|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
154201012|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154201013|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
154201014|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201015|NCT00539513|Expectorants|expectorants|mesh-ancestor
154201016|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
154201017|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154201018|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
154201019|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201020|NCT00539513|Protective Agents|protective agents|mesh-ancestor
154201021|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201022|NCT00539513|Antidotes|antidotes|mesh-ancestor
154201023|NCT00454584|Etanercept|etanercept|mesh-list
154201024|NCT00454584|Ustekinumab|ustekinumab|mesh-list
154201025|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154201026|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154201027|NCT00454584|Analgesics|analgesics|mesh-ancestor
154201028|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
154201029|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201030|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201031|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201032|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201033|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201034|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201035|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
154201036|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
154201037|NCT04204343|Bupivacaine|bupivacaine|mesh-list
154201038|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
154201039|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
154201040|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201041|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201042|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
154201043|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201044|NCT02845271|Acetaminophen|acetaminophen|mesh-list
154201045|NCT02845271|Tramadol|tramadol|mesh-list
154201046|NCT02845271|Codeine|codeine|mesh-list
154201047|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154201048|NCT02845271|Analgesics|analgesics|mesh-ancestor
154201049|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
154201050|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201051|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201052|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
154201053|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154201054|NCT02845271|Narcotics|narcotics|mesh-ancestor
154201055|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201056|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
154201057|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
154201058|NCT00445068|Panobinostat|panobinostat|mesh-list
154201059|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201060|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154201061|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539931|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154201071|NCT05360147|Liraglutide|liraglutide|mesh-list
154201072|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154201073|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154201074|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201075|NCT05360147|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154201076|NCT05360147|Incretins|incretins|mesh-ancestor
154201077|NCT05360147|Hormones|hormones|mesh-ancestor
154201078|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201079|NCT00444912|Plerixafor|plerixafor|mesh-list
154201080|NCT00444912|Rituximab|rituximab|mesh-list
154201081|NCT00444912|Lenograstim|lenograstim|mesh-list
154201082|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154201083|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201084|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
154201085|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201086|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201087|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154201088|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154201089|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154201090|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
154201091|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201092|NCT00538733|Clarithromycin|clarithromycin|mesh-list
154256414|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256415|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154256416|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
154256417|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154256418|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154256419|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
154201093|NCT00538733|Thalidomide|thalidomide|mesh-list
154201094|NCT00538733|Dexamethasone|dexamethasone|mesh-list
154201095|NCT00538733|Lenalidomide|lenalidomide|mesh-list
154201096|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201097|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
154201098|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
154201099|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201100|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201101|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201102|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
154201103|NCT00538733|Hormones|hormones|mesh-ancestor
154201104|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201105|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154201106|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746322|NCT03782740|Protective Agents|protective agents|mesh-ancestor
154201107|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
154201108|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154201109|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154201110|NCT00538733|Growth Substances|growth substances|mesh-ancestor
154201111|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
154201112|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154201113|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201114|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154201115|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201116|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201117|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154201118|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154201119|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201120|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
154201122|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
154201123|NCT00444678|Cetuximab|cetuximab|mesh-list
154201124|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154201125|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
154201126|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201127|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201128|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465375|NCT00282828|Clonazepam|clonazepam|mesh-list
154201140|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154201141|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
154201142|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201143|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201144|NCT01051011|Metformin|metformin|mesh-list
154201145|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
154201146|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154201147|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201148|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201149|NCT01051011|Incretins|incretins|mesh-ancestor
154201150|NCT01051011|Hormones|hormones|mesh-ancestor
154201151|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201152|NCT01048827|Busulfan|busulfan|mesh-list
154201153|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
154201154|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201155|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201156|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
154201157|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201158|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154201159|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201160|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154201161|NCT01302327|Exenatide|exenatide|mesh-list
154201162|NCT01302327|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154201163|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201164|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201165|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154201166|NCT01302327|Incretins|incretins|mesh-ancestor
154201167|NCT01302327|Hormones|hormones|mesh-ancestor
154201168|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201169|NCT01048983|Minocycline|minocycline|mesh-list
154201170|NCT01048983|Curcumin|curcumin|mesh-list
154201171|NCT01048983|Modafinil|modafinil|mesh-list
154201172|NCT01048983|Bupropion|bupropion|mesh-list
154201173|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154201174|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
154201175|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154201176|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154201177|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153746465|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153948137|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153948138|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153948139|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153948140|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
153948141|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201178|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154201179|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201180|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
154201181|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201182|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201183|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154201184|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154201185|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201186|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153746517|NCT05466019|Leucovorin|leucovorin|mesh-list
154201187|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154201194|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154201195|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201196|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154201197|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154201198|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154201199|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154201201|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
154201202|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201203|NCT01340417|Protective Agents|protective agents|mesh-ancestor
154201204|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201205|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201206|NCT01049061|Farletuzumab|farletuzumab|mesh-list
154201207|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201208|NCT00367341|Escitalopram|escitalopram|mesh-list
154201209|NCT00367341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154201210|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154201211|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154201212|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201213|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201214|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
154201215|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201216|NCT01052961|Oseltamivir|oseltamivir|mesh-list
154201217|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
154201218|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201219|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201220|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201221|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
154201222|NCT00440466|Hematinics|hematinics|mesh-ancestor
154201223|NCT01051167|Cetuximab|cetuximab|mesh-list
154201224|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154201225|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201226|NCT00989651|Paclitaxel|paclitaxel|mesh-list
154201227|NCT00989651|Bevacizumab|bevacizumab|mesh-list
154201228|NCT00989651|Cisplatin|cisplatin|mesh-list
154201229|NCT00989651|Carboplatin|carboplatin|mesh-list
154201230|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154201231|NCT00989651|Veliparib|veliparib|mesh-list
154201232|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154201233|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
154201234|NCT00989651|Antibodies|antibodies|mesh-list
154201235|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
154201236|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154201237|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
154201238|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154201239|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201240|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
154201241|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
154201242|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
154201243|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201244|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154201245|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154201246|NCT00989651|Growth Substances|growth substances|mesh-ancestor
154201247|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201248|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
154201249|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
154201250|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154201251|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201252|NCT05590559|Morphine|morphine|mesh-list
154201253|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154201254|NCT05590559|Narcotics|narcotics|mesh-ancestor
154201255|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201256|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201257|NCT05590559|Analgesics|analgesics|mesh-ancestor
154201271|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201272|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201273|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
154201274|NCT00989729|Hormones|hormones|mesh-ancestor
154201275|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201276|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154201277|NCT00989729|Protective Agents|protective agents|mesh-ancestor
154201278|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154201279|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201280|NCT00989807|Aztreonam|aztreonam|mesh-list
154201281|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154201282|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201283|NCT00990587|Ciclopirox|ciclopirox|mesh-list
154201284|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
154201285|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201286|NCT00537329|Anidulafungin|anidulafungin|mesh-list
154201287|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
154201288|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201289|NCT03905135|Avelumab|avelumab|mesh-list
154201290|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154201291|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201292|NCT00991055|Pioglitazone|pioglitazone|mesh-list
154201293|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201294|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201295|NCT00991133|Clofarabine|clofarabine|mesh-list
153746733|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153746734|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154201296|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201297|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201298|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154201299|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
154201300|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
154201301|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154201302|NCT00991211|Doxorubicin|doxorubicin|mesh-list
154201303|NCT00991211|Vincristine|vincristine|mesh-list
154201304|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201305|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
154201306|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746735|NCT05293600|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154201307|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201308|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154201309|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
154201310|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201311|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201312|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154201313|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154201314|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154201315|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154201316|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201317|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154201318|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
154201319|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
154201320|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
154201337|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201339|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
154201340|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201341|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154201342|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154201343|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154201344|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
154201345|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201346|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154201347|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154201348|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201350|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
154201351|NCT00348933|Betaine|betaine|mesh-list
154201352|NCT00348933|Vitamins|vitamins|mesh-ancestor
154201353|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
154201354|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201355|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
154201356|NCT00348933|Hematinics|hematinics|mesh-ancestor
154201357|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201358|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
154201359|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154201360|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
153746785|NCT00164736|Ritonavir|ritonavir|mesh-list
154201361|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201362|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154201363|NCT01051479|Choline|choline|mesh-list
154201364|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
154201365|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154201366|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
154201367|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201368|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201369|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154201370|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
154201371|NCT01055691|Metformin|metformin|mesh-list
154201372|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
154201373|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201374|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201375|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154201376|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201377|NCT03896477|Vaccines|vaccines|mesh-list
154201378|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154201379|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
154201380|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201381|NCT00444600|Triamcinolone|triamcinolone|mesh-list
154201404|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201405|NCT00537017|Levodopa|levodopa|mesh-list
154201406|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153746859|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
154201407|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154201408|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
154201409|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201410|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201411|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201412|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
154201413|NCT00348309|Donepezil|donepezil|mesh-list
154201414|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154201415|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201416|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201417|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
153746974|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
154201418|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201419|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201420|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
154201421|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201422|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
154201423|NCT04451837|Semaglutide|semaglutide|mesh-list
154201424|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154201425|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201426|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201427|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201428|NCT04451837|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154201429|NCT05493683|Tislelizumab|tislelizumab|mesh-list
154201430|NCT05493683|Disitamab vedotin|disitamab vedotin|mesh-list
154201431|NCT05493683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154201432|NCT05493683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201433|NCT05493683|Immunoconjugates|immunoconjugates|mesh-ancestor
154201449|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154201450|NCT01055925|Laxatives|laxatives|mesh-ancestor
154201451|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201452|NCT00440232|Frovatriptan|frovatriptan|mesh-list
154201453|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154201454|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
154256420|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154201455|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201456|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201457|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201459|NCT01564199|Xhance|xhance|mesh-list
154201460|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154201461|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201462|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154201463|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
154201464|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201465|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201466|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154201467|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
154201468|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
154201469|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154201470|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154201471|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154201472|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154201473|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
154201474|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201475|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201476|NCT02533323|Gemcitabine|gemcitabine|mesh-list
154201477|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
154201478|NCT02533323|Pegaspargase|pegaspargase|mesh-list
153948445|NCT03668041|Trazodone|trazodone|mesh-list
154201479|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154201480|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
154201481|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201482|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201483|NCT05357885|Antibodies|antibodies|mesh-list
154201484|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
154201485|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201486|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154201487|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
154201488|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201489|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201490|NCT00356889|Bevacizumab|bevacizumab|mesh-list
154201491|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154201492|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154201493|NCT00356889|Antibodies|antibodies|mesh-list
154201494|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
154201506|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201508|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201509|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201510|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201511|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
154201512|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
154201513|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201514|NCT04715022|Protective Agents|protective agents|mesh-ancestor
154201515|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201516|NCT04715022|Vitamins|vitamins|mesh-ancestor
154201517|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
154201518|NCT00356811|Paclitaxel|paclitaxel|mesh-list
154201519|NCT00356811|Lapatinib|lapatinib|mesh-list
154201520|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154201521|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201522|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
154201523|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
154201524|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
154201525|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201526|NCT00356811|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154201527|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154201528|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201529|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154201530|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201531|NCT01030614|Dexamethasone|dexamethasone|mesh-list
154201532|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201533|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
154201534|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
154201535|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201536|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201537|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154201538|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
154201539|NCT01030614|Hormones|hormones|mesh-ancestor
154201540|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201541|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154201542|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201543|NCT01030692|Rivastigmine|rivastigmine|mesh-list
153747180|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154201544|NCT01030692|Huperzine A|huperzine a|mesh-list
154201545|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154201546|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201547|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201548|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
154201549|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201550|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201551|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154201552|NCT01030692|Protective Agents|protective agents|mesh-ancestor
154201553|NCT03138252|Oxytocin|oxytocin|mesh-list
154201554|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
154201555|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154201556|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201557|NCT04994561|Niacinamide|niacinamide|mesh-list
154201558|NCT04994561|Metformin|metformin|mesh-list
154201572|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
154201573|NCT04994561|Vitamins|vitamins|mesh-ancestor
154201574|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
154201575|NCT01030770|Ranibizumab|ranibizumab|mesh-list
154201576|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154201577|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154201578|NCT01030770|Growth Substances|growth substances|mesh-ancestor
154201579|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201580|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
154201581|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201582|NCT04941443|Ibuprofen|ibuprofen|mesh-list
154201583|NCT04941443|Methadone|methadone|mesh-list
154201584|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154201585|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154201586|NCT04941443|Analgesics|analgesics|mesh-ancestor
154201587|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
154201588|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201589|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201590|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201591|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747279|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154201592|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154201593|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201594|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201595|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154201596|NCT04941443|Narcotics|narcotics|mesh-ancestor
154201597|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201598|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
154201599|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
154201600|NCT03994692|Ether|ether|mesh-list
154201601|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154201602|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
154201603|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
154201604|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201605|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201606|NCT01030926|Insulin|insulin|mesh-list
154201607|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154201608|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
154201609|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201610|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201611|NCT00536939|Paclitaxel|paclitaxel|mesh-list
154201612|NCT00536939|Bevacizumab|bevacizumab|mesh-list
154201613|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154201614|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201615|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
154201616|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
154201617|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
154201618|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201619|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154201620|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154201621|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154201622|NCT00536939|Growth Substances|growth substances|mesh-ancestor
154201634|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154201635|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154201636|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201637|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
154201638|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201639|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201640|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154201641|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201643|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154201645|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201646|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201647|NCT03990129|Dipyrone|dipyrone|mesh-list
154201648|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154201649|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154201650|NCT03990129|Analgesics|analgesics|mesh-ancestor
154201651|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
154201652|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201653|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201654|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201655|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201656|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
154201657|NCT01051947|Metoprolol|metoprolol|mesh-list
154201658|NCT01051947|Nebivolol|nebivolol|mesh-list
154201659|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154201660|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154201661|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
154201662|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
154201663|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201664|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201665|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154201666|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154201667|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154201668|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
154201669|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201670|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201671|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
154201672|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154201673|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154201674|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154201675|NCT01052025|Curcumin|curcumin|mesh-list
154201676|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154201677|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154201678|NCT01052025|Analgesics|analgesics|mesh-ancestor
154201679|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
154201680|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201681|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201682|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201683|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201684|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201685|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201701|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201702|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154201703|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201704|NCT00438360|Cyclosporine|cyclosporine|mesh-list
154201705|NCT00438360|Cyclosporins|cyclosporins|mesh-list
154201706|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201707|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201708|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201709|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
154201710|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201711|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
154201712|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201713|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
154201714|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201715|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154201716|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154201717|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154201718|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154201719|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154201720|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747462|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201721|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201722|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201723|NCT00536471|Analgesics|analgesics|mesh-ancestor
154201724|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
154201725|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201726|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
154256421|NCT01261832|Protective Agents|protective agents|mesh-ancestor
154201727|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154201728|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
154201729|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154201730|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
154201731|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154201732|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154201733|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154201734|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
154201735|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154201736|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201737|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154201738|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154201739|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154201740|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154201741|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201742|NCT04002635|Letrozole|letrozole|mesh-list
154201743|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154201759|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201760|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201761|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154201762|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
154201763|NCT04002635|Progestins|progestins|mesh-ancestor
154201764|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
154201765|NCT01052181|Vitamin D|vitamin d|mesh-list
154201766|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154201767|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201768|NCT01052181|Vitamins|vitamins|mesh-ancestor
154201769|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
154201770|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154201771|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
154201772|NCT01056237|Azathioprine|azathioprine|mesh-list
154201773|NCT01056237|Tacrolimus|tacrolimus|mesh-list
154201774|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201775|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
154201776|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201777|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154201778|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201779|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201780|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154201781|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201782|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154201783|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
154201784|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154201785|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201786|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
154201787|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154201788|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154201789|NCT02533557|Lidocaine|lidocaine|mesh-list
154201790|NCT02533557|Epinephrine|epinephrine|mesh-list
154201791|NCT02533557|Racepinephrine|racepinephrine|mesh-list
154201792|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
154201793|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
154201794|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
154201795|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201796|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201797|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
154201798|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201799|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154201800|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154201801|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153747675|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154201802|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154201803|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201820|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
154201821|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201822|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201823|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
154201824|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154201825|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
154201826|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
154201827|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154201828|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154201829|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154201830|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
154201831|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201832|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201833|NCT00356265|Protective Agents|protective agents|mesh-ancestor
154201835|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154201836|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201837|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201838|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201839|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154201840|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
154201841|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154201842|NCT01052259|Protective Agents|protective agents|mesh-ancestor
154201843|NCT01056549|Exenatide|exenatide|mesh-list
154201844|NCT01056549|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154201845|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154201846|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201847|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154201848|NCT01056549|Incretins|incretins|mesh-ancestor
154201849|NCT01056549|Hormones|hormones|mesh-ancestor
154201850|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201851|NCT01052337|Anesthetics|anesthetics|mesh-list
154201852|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201853|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201854|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153948818|NCT02299999|Cisplatin|cisplatin|mesh-list
153948825|NCT02299999|Durvalumab|durvalumab|mesh-list
154201855|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154201856|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154201857|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201858|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201859|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154201860|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154201861|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153466449|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
154201880|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154201881|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201882|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154201883|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201884|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154201885|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
154201886|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
154201887|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154201888|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201889|NCT01564355|Triamcinolone|triamcinolone|mesh-list
154201890|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154201891|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
154201892|NCT01564355|Hormones|hormones|mesh-ancestor
154201893|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154201894|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201895|NCT01056705|Vaccines|vaccines|mesh-list
154201896|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
154201897|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201898|NCT00437268|Irinotecan|irinotecan|mesh-list
154201899|NCT00437268|Cetuximab|cetuximab|mesh-list
154201900|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154201901|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154201902|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201903|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201904|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201905|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154201906|NCT04002089|Bupivacaine|bupivacaine|mesh-list
154201907|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
154201908|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
154201909|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154201910|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201911|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
154201912|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201913|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154201914|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201915|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
154201916|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154201917|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154201918|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154201928|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153948906|NCT02117167|Pemetrexed|pemetrexed|mesh-list
154201929|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154201930|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154201931|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201932|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201933|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154201934|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154201935|NCT04139525|Heparin|heparin|mesh-list
154201936|NCT04139525|Calcium heparin|calcium heparin|mesh-list
154201937|NCT04139525|Citric Acid|citric acid|mesh-list
154201938|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
154201939|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
154201940|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154201941|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
154201942|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
154201943|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201944|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154201945|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154201946|NCT00437034|Aflibercept|aflibercept|mesh-list
154201947|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
154201948|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154201949|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154201950|NCT00437034|Growth Substances|growth substances|mesh-ancestor
154201951|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201952|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
154201953|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201954|NCT00337467|Ritonavir|ritonavir|mesh-list
154201955|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154201956|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154201957|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154201958|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
154201959|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201960|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201961|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154201962|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154201963|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
154201964|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154201965|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154201966|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154201967|NCT00428220|Sunitinib|sunitinib|mesh-list
154201968|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154201969|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154201970|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154201971|NCT00428220|Growth Substances|growth substances|mesh-ancestor
154201972|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154201973|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
154201974|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154201975|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154201976|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154201977|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154201978|NCT01057329|Olanzapine|olanzapine|mesh-list
154201979|NCT01057329|Aripiprazole|aripiprazole|mesh-list
154201980|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154201981|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
154201982|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
154201983|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154201999|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154202000|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154202001|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154202002|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153948979|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
154202003|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154202004|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154202005|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154202006|NCT01057329|Analgesics|analgesics|mesh-ancestor
154202007|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
154202008|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154202009|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
154202010|NCT01057407|Sevelamer|sevelamer|mesh-list
154202011|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
154202012|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
154202013|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202014|NCT02873975|Prexasertib|prexasertib|mesh-list
154202015|NCT02873975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202016|NCT02873975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202017|NCT02873975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202018|NCT01057563|Paclitaxel|paclitaxel|mesh-list
154202019|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154202020|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154202021|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202022|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
154202023|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
154202024|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
154202025|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202026|NCT00345579|PENTA|penta|mesh-list
154202027|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
154202028|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154202029|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154202030|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202031|NCT04002323|Lamivudine|lamivudine|mesh-list
154202032|NCT04002323|Dolutegravir|dolutegravir|mesh-list
154202033|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154202034|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154202035|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202036|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202037|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
154202038|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202039|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154202067|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
154202068|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154202069|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202070|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154202071|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202072|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
154202073|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154202074|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
154202075|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154202076|NCT03989817|Protective Agents|protective agents|mesh-ancestor
154202077|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202078|NCT01059123|Amoxicillin|amoxicillin|mesh-list
154202079|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154202080|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202081|NCT03986385|Capecitabine|capecitabine|mesh-list
154202082|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
154202084|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154202085|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
154202086|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202087|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202112|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154202113|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202114|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
154202115|NCT03606785|Coagulants|coagulants|mesh-ancestor
154202116|NCT05356169|Venetoclax|venetoclax|mesh-list
154202117|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202118|NCT01057875|Caffeine|caffeine|mesh-list
154202119|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154202120|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202121|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154202122|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202123|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202124|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154202125|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154202126|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
154202127|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202128|NCT04001387|Anesthetics|anesthetics|mesh-list
154202129|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202130|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202131|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
154202132|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
154202133|NCT00334737|Hematinics|hematinics|mesh-ancestor
154202134|NCT03986073|Linagliptin|linagliptin|mesh-list
154202135|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154202136|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202137|NCT03986073|Incretins|incretins|mesh-ancestor
154202138|NCT03986073|Hormones|hormones|mesh-ancestor
153539932|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
154202159|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202160|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154202174|NCT01060293|Dopamine|dopamine|mesh-list
154202175|NCT01060293|Furosemide|furosemide|mesh-list
154202176|NCT01060293|Diuretics|diuretics|mesh-ancestor
154202177|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
154202178|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202179|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154202180|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154202181|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202182|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154202183|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
154202184|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
154202185|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202186|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
154202187|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202188|NCT01060293|Protective Agents|protective agents|mesh-ancestor
154202194|NCT00416598|Cytarabine|cytarabine|mesh-list
154202195|NCT00416598|Etoposide|etoposide|mesh-list
154202196|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
154202197|NCT00416598|Daunorubicin|daunorubicin|mesh-list
154202198|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
154202199|NCT00416598|Busulfan|busulfan|mesh-list
154202200|NCT00416598|Decitabine|decitabine|mesh-list
154202201|NCT00416598|Lenograstim|lenograstim|mesh-list
154202202|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154202203|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202204|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154202205|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154202206|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202207|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202208|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154202209|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
154202210|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
154202211|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202214|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202215|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154202216|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
154202217|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154202218|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154202219|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154202220|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
154202221|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
154202222|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
154202223|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
154202224|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
154202225|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154202226|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
154202227|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154202228|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154202230|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202231|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202232|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
154202233|NCT04001465|Miotics|miotics|mesh-ancestor
154202234|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
154202235|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202236|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202237|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154202238|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154202239|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
154202240|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154202241|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154202242|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
154202243|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202244|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202245|NCT00992381|Naproxen|naproxen|mesh-list
154202246|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154202247|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154202248|NCT00992381|Analgesics|analgesics|mesh-ancestor
154202249|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
154202250|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202251|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202252|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154202253|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154202254|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
154202255|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154202256|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202257|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202258|NCT00992537|Insulin|insulin|mesh-list
154202259|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154202260|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
154202261|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
154202281|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202282|NCT00992849|Growth Substances|growth substances|mesh-ancestor
154202283|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202284|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202285|NCT04001231|Exenatide|exenatide|mesh-list
154202286|NCT04001231|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154202287|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154202288|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202289|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154202290|NCT04001231|Incretins|incretins|mesh-ancestor
154202291|NCT04001231|Hormones|hormones|mesh-ancestor
154202292|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202293|NCT03892889|Aripiprazole|aripiprazole|mesh-list
154202294|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
154202295|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154202296|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154202297|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154202298|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202299|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202300|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
154202301|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
154202302|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202303|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202304|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154202305|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154202306|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
154202307|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154202308|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154202309|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154202310|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154202311|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
154202312|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154202313|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
154202314|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202315|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
154202336|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202337|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202338|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202339|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202340|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154202341|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154202342|NCT01034124|Vitamin K|vitamin k|mesh-list
154202343|NCT01034124|Midazolam|midazolam|mesh-list
154202344|NCT01034124|Warfarin|warfarin|mesh-list
154202345|NCT01034124|Vitamins|vitamins|mesh-ancestor
154202346|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
154202347|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202348|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154202349|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154202350|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202351|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154202352|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154202353|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154202354|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154202355|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
154202356|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
154202357|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
154202358|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
154202359|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202360|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202361|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
154202362|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154202363|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154202364|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
154202365|NCT01034124|Coagulants|coagulants|mesh-ancestor
154202366|NCT00339183|Panitumumab|panitumumab|mesh-list
154202367|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202368|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202369|NCT01060605|Sirolimus|sirolimus|mesh-list
154202370|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154202371|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202372|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153467064|NCT00412074|Vitamin D|vitamin d|mesh-list
154202384|NCT00993863|Ibuprofen|ibuprofen|mesh-list
154202385|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154202386|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154202387|NCT00993863|Analgesics|analgesics|mesh-ancestor
154202388|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
154202389|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202390|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202391|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154202392|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154202393|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154202394|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202395|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202396|NCT00995423|Paclitaxel|paclitaxel|mesh-list
154202397|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154202398|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202399|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
154202400|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
154202401|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
154202402|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202403|NCT00995657|Fluticasone|fluticasone|mesh-list
154202404|NCT00995657|Xhance|xhance|mesh-list
154202405|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154202406|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154202407|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
154202408|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202409|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202410|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154202411|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
154202412|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
154202413|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154202414|NCT00994097|Gemcitabine|gemcitabine|mesh-list
154202415|NCT00994097|Pemetrexed|pemetrexed|mesh-list
154202416|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202417|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154202418|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
154202419|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202420|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202421|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154202422|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154202423|NCT04000919|Carbidopa|carbidopa|mesh-list
154202424|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154202425|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154202426|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
154202427|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202428|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202429|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202430|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154202431|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202432|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154202433|NCT00994253|Aliskiren|aliskiren|mesh-list
154202434|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154202435|NCT00994253|Diuretics|diuretics|mesh-ancestor
154202436|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
154202437|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202447|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154202449|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202450|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202451|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202452|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154202453|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154202454|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202455|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154202456|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154202457|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
154202458|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
154202459|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
154202460|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202461|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154202462|NCT00338949|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154202463|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154202464|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154202465|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154202466|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154202467|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202468|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
154202469|NCT00332709|Letrozole|letrozole|mesh-list
154202470|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202471|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154202472|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154202473|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202474|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202475|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154202476|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
154202477|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202478|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202479|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154202480|NCT03988725|Vitamin E|vitamin e|mesh-list
154202481|NCT03988725|Vitamins|vitamins|mesh-ancestor
154202482|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
154202483|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202484|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
154202485|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202486|NCT03988725|Protective Agents|protective agents|mesh-ancestor
154202487|NCT00332241|Aripiprazole|aripiprazole|mesh-list
154202488|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
154202489|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154202490|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154202491|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154202492|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154202493|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202494|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
154202495|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
154202496|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202497|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202498|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154202499|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154202500|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
154202501|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154202517|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154202518|NCT03983889|Analgesics|analgesics|mesh-ancestor
154202519|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
154202520|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202521|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154202522|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154202523|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154202524|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
154202525|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202526|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153949505|NCT02864628|Antiviral Agents|antiviral agents|mesh-ancestor
154202527|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154202528|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
154202529|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
154202530|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154202531|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154202532|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154202533|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154202534|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
154202535|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
154202536|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154202537|NCT03983889|Narcotics|narcotics|mesh-ancestor
154202538|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
154202539|NCT00337935|Hematinics|hematinics|mesh-ancestor
154202540|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
154202541|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
154202542|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154202543|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
154202544|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202545|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154202546|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154202547|NCT00352755|Leucovorin|leucovorin|mesh-list
154202548|NCT00352755|Fluorouracil|fluorouracil|mesh-list
154202549|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
154202550|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
154202551|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202552|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154202553|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202554|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154202555|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
154202556|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202557|NCT00352755|Antidotes|antidotes|mesh-ancestor
154202558|NCT00352755|Protective Agents|protective agents|mesh-ancestor
154202559|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
154202560|NCT00352755|Vitamins|vitamins|mesh-ancestor
154202561|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
154202562|NCT00533897|Abatacept|abatacept|mesh-list
154202563|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153467369|NCT00533910|Rifaximin|rifaximin|mesh-list
154202578|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202579|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154202580|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
154202581|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
154202582|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202583|NCT00330681|Edaravone|edaravone|mesh-list
154202584|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154202585|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
154202586|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202587|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154202588|NCT00330681|Protective Agents|protective agents|mesh-ancestor
154202589|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202590|NCT00329901|Vaccines|vaccines|mesh-list
154202591|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
154202592|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202593|NCT00436956|Prednisone|prednisone|mesh-list
154202594|NCT00436956|Cediranib|cediranib|mesh-list
154202595|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154202596|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
154202597|NCT00436956|Hormones|hormones|mesh-ancestor
154202598|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202599|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202600|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154202601|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202602|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202603|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202604|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202606|NCT00436644|Lapatinib|lapatinib|mesh-list
154202607|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154202608|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154202609|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202610|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202611|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202612|NCT00436644|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154202613|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202614|NCT00324987|Bevacizumab|bevacizumab|mesh-list
154202615|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154202616|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
154202617|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
154202618|NCT00324987|Antibodies|antibodies|mesh-list
154202619|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
154202620|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154202621|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
154202622|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202623|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202635|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202637|NCT01055145|Levofloxacin|levofloxacin|mesh-list
154202638|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154202639|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202640|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154202641|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154202642|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202643|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202644|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202645|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154202646|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154202647|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154202648|NCT00436566|Paclitaxel|paclitaxel|mesh-list
154202649|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
154202650|NCT00436566|Doxorubicin|doxorubicin|mesh-list
154202651|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154202652|NCT00436566|Trastuzumab|trastuzumab|mesh-list
154202653|NCT00436566|Lapatinib|lapatinib|mesh-list
154202654|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154202655|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202656|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
154202657|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
154202658|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
154202659|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202660|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154202661|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
154202662|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202663|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154202664|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154202665|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
154202666|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154202667|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154202668|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154202669|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154202670|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202671|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202672|NCT00436566|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154202673|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202674|NCT01060683|Chrysarobin|chrysarobin|mesh-list
154202675|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154202676|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154202677|NCT01060683|Analgesics|analgesics|mesh-ancestor
153949650|NCT00972504|Cetirizine|cetirizine|mesh-list
154202678|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
154202679|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202680|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202681|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154202682|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154202684|NCT01055301|Dexamethasone|dexamethasone|mesh-list
154202685|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
154202700|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154202701|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154202702|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
154202703|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
154202704|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154202705|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154202706|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
154202707|NCT01055301|Hormones|hormones|mesh-ancestor
154202708|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202709|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154202710|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154202711|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154202712|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154202713|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202714|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154202715|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202716|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202717|NCT01055301|Growth Substances|growth substances|mesh-ancestor
154202718|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202719|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
154202720|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154202721|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202722|NCT01055379|Rasagiline|rasagiline|mesh-list
154202723|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154202724|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202725|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202726|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154202727|NCT01055379|Protective Agents|protective agents|mesh-ancestor
154202728|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202729|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154202730|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154202731|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154202732|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
154202733|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202734|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154202735|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154202736|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202737|NCT00352365|Lenalidomide|lenalidomide|mesh-list
154202738|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
154202739|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202740|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202741|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202742|NCT00352365|Growth Substances|growth substances|mesh-ancestor
154202743|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202744|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202745|NCT01055535|Plasminogen|plasminogen|mesh-list
154202746|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154202747|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154202762|NCT03987867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202764|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154202765|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154202766|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154202767|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154202768|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
154202769|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202770|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202771|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202772|NCT00996515|Azacitidine|azacitidine|mesh-list
154202773|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154202774|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154202775|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
154202776|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202777|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202778|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202779|NCT00996515|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154202780|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202781|NCT00994799|Ranibizumab|ranibizumab|mesh-list
154202782|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202783|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202784|NCT00994799|Growth Substances|growth substances|mesh-ancestor
154202785|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202786|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202787|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202788|NCT00533507|Vaccines|vaccines|mesh-list
154202789|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154202790|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
154202791|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202792|NCT00352053|Tenofovir|tenofovir|mesh-list
154202793|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
154202794|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202795|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154202796|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154202797|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202798|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202799|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154202800|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154202801|NCT00995033|Varenicline|varenicline|mesh-list
154202802|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154202803|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154202804|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
154202805|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467693|NCT00504660|Capecitabine|capecitabine|mesh-list
154202820|NCT00998933|Androgens|androgens|mesh-ancestor
154202821|NCT00998933|Hormones|hormones|mesh-ancestor
154202822|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202823|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202824|NCT00323115|Temozolomide|temozolomide|mesh-list
154202825|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154202826|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
154202827|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202828|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202829|NCT00322881|Paclitaxel|paclitaxel|mesh-list
154202830|NCT00322881|Carboplatin|carboplatin|mesh-list
154202831|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154202832|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202833|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
154202834|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
154202835|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
154202836|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202837|NCT00415194|Pemetrexed|pemetrexed|mesh-list
154202838|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202839|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202840|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202841|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154202842|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154202843|NCT00436332|Bevacizumab|bevacizumab|mesh-list
154202844|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154202845|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202846|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202847|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154202848|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154202849|NCT00436332|Growth Substances|growth substances|mesh-ancestor
154202850|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202851|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
154202852|NCT00436332|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154202853|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202854|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202855|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202856|NCT00532259|Pidilizumab|pidilizumab|mesh-list
154202857|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154202858|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202859|NCT00322491|Plerixafor|plerixafor|mesh-list
154202860|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154202861|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154202862|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
154202863|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539933|NCT01536301|Morphine|morphine|mesh-list
154202874|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202875|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202876|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154202877|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
154202878|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202879|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
154202880|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154202881|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154202882|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154202883|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154202884|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154202885|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202886|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202887|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202888|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154202889|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
154202890|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154202891|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202892|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153949869|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
153949870|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153949871|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153949872|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153949873|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
153949874|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
153949875|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
153949876|NCT05561062|Atorvastatin|atorvastatin|mesh-list
154202893|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154202894|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154202895|NCT00998075|Esomeprazole|esomeprazole|mesh-list
154202896|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202897|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202898|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154202899|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154202900|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154202901|NCT00531947|Selegiline|selegiline|mesh-list
154202902|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
154202903|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154202904|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154202905|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154202906|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154202907|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202908|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202909|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154202910|NCT00531947|Protective Agents|protective agents|mesh-ancestor
154202911|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202912|NCT01003847|Fenofibrate|fenofibrate|mesh-list
154202913|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154202914|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
154202915|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202916|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154202917|NCT00530855|Lacosamide|lacosamide|mesh-list
154202918|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
153467907|NCT00553098|Cyclosporine|cyclosporine|mesh-list
154202936|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154202937|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154202938|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
154202939|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154202940|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202941|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202942|NCT01004315|Urological Agents|urological agents|mesh-ancestor
154202943|NCT05239637|Heparin|heparin|mesh-list
154202944|NCT05239637|Calcium heparin|calcium heparin|mesh-list
154202945|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
154202946|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154202947|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154202948|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202949|NCT01005095|Vitamin D|vitamin d|mesh-list
154202950|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
154202951|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
154202952|NCT01005095|Vitamins|vitamins|mesh-list
154202953|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
154202954|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202955|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154202956|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154202957|NCT01005641|Lapatinib|lapatinib|mesh-list
154202958|NCT01005641|Exemestane|exemestane|mesh-list
154202960|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154202961|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154202962|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154202963|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202964|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154202965|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154202966|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153949955|NCT05023070|Cannabidiol|cannabidiol|mesh-list
154202967|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
154202968|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154202969|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154202970|NCT01005797|Sorafenib|sorafenib|mesh-list
154202971|NCT01005797|Panobinostat|panobinostat|mesh-list
154202972|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154202999|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154203000|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203001|NCT00530777|Valacyclovir|valacyclovir|mesh-list
154203002|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
154203003|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203004|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
154203005|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154203006|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203007|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203008|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154203009|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154203010|NCT01006499|Protective Agents|protective agents|mesh-ancestor
154203011|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203012|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
154203013|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154203014|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
154203015|NCT03882047|Fluticasone|fluticasone|mesh-list
154203017|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
154203018|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203019|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154203020|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
154203031|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203032|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154203033|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154203034|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203035|NCT00530621|Pemetrexed|pemetrexed|mesh-list
154203036|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203037|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203038|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203039|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153950022|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154203040|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154203041|NCT00531479|Voriconazole|voriconazole|mesh-list
154203042|NCT00531479|Anidulafungin|anidulafungin|mesh-list
154203043|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
154203044|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203045|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154203046|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154203047|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203048|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203049|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154203050|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
154203051|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203052|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203053|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154203054|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
154203055|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154203056|NCT00999479|Norethindrone|norethindrone|mesh-list
154203057|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
154203058|NCT00999479|Estradiol|estradiol|mesh-list
154203059|NCT00999479|Estrogens|estrogens|mesh-ancestor
154203060|NCT00999479|Hormones|hormones|mesh-ancestor
154203061|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203062|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203065|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154203066|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154203067|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154203068|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154203069|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154203070|NCT00999479|Trace Elements|trace elements|mesh-ancestor
154203071|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
154203072|NCT00999557|Bimatoprost|bimatoprost|mesh-list
154203073|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154203074|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154203075|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154203076|NCT01008137|Vaccines|vaccines|mesh-list
154203077|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
154203078|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203079|NCT00999791|Diclofenac|diclofenac|mesh-list
154203080|NCT00999791|Bevacizumab|bevacizumab|mesh-list
154203081|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154203082|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203083|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154203100|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154203101|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
154203102|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154203103|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154203104|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154203105|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154203106|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154203107|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203108|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
154203109|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203110|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203111|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203112|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
154203113|NCT00999869|Hormones|hormones|mesh-ancestor
153950097|NCT04084171|Insulin|insulin|mesh-list
154203114|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203115|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154203116|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
154203117|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203118|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154203119|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203120|NCT01008293|Lactulose|lactulose|mesh-list
154203121|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154203122|NCT01008527|Poly ICLC|poly iclc|mesh-list
154203123|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
154203124|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
154203125|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203126|NCT01000415|Cisplatin|cisplatin|mesh-list
154203127|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203128|NCT01008761|Azithromycin|azithromycin|mesh-list
154203129|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154203130|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203131|NCT01008917|Sirolimus|sirolimus|mesh-list
154203132|NCT01008917|Sorafenib|sorafenib|mesh-list
154203133|NCT01008917|Temsirolimus|temsirolimus|mesh-list
154203134|NCT01008917|MTOR Inhibitors|mtor inhibitors|mesh-list
154203135|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203136|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203137|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203138|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203139|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154203140|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
154203141|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203152|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203153|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203154|NCT01009073|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203155|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203156|NCT00530075|Gusperimus|gusperimus|mesh-list
154203157|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154203158|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203159|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154203160|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203161|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154203162|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
154203163|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154203164|NCT00530075|Protective Agents|protective agents|mesh-ancestor
154203165|NCT01001585|Sevoflurane|sevoflurane|mesh-list
154203166|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154203167|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154203168|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
154203169|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
154203170|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154203171|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203172|NCT01001897|Misoprostol|misoprostol|mesh-list
154203173|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154203174|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
154203175|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154203176|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203177|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154203178|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154203179|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
154203180|NCT01002911|Cefazolin|cefazolin|mesh-list
154203181|NCT01002911|Cephalexin|cephalexin|mesh-list
154203182|NCT01002911|Bacitracin|bacitracin|mesh-list
154203183|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154203184|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203185|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154203186|NCT00531011|Paclitaxel|paclitaxel|mesh-list
154203187|NCT00531011|Everolimus|everolimus|mesh-list
154203188|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154203189|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203190|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
154203191|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
154203192|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
154203193|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203194|NCT00531011|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154203195|NCT00531011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203196|NCT00531011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203197|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154203198|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
154203199|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203201|NCT04000295|Etoposide|etoposide|mesh-list
154203202|NCT04000295|Apatinib|apatinib|mesh-list
154203203|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154203204|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203205|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
154203206|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
154203207|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
154203208|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203209|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154203221|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203222|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154203223|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154203224|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154203225|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748085|NCT02918812|Diclofenac|diclofenac|mesh-list
154203226|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154203227|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154203228|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
154203229|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
154203230|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203231|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154203232|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154203233|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
154203234|NCT01003613|Coagulants|coagulants|mesh-ancestor
154203235|NCT00471146|Gemcitabine|gemcitabine|mesh-list
154203236|NCT00471146|Axitinib|axitinib|mesh-list
154203237|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154203238|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
154203239|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203240|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203241|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203242|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203243|NCT01021358|Ketoconazole|ketoconazole|mesh-list
154203244|NCT01021358|Navitoclax|navitoclax|mesh-list
154203245|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
154203246|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203247|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154203248|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154203249|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203250|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203251|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154203252|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
154203253|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203254|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203255|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154203256|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203257|NCT00469898|Carboplatin|carboplatin|mesh-list
154203259|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203260|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154203261|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154203262|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203263|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203264|NCT01021436|Amikacin|amikacin|mesh-list
154203265|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154203266|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203267|NCT00529763|Dasatinib|dasatinib|mesh-list
154203268|NCT00529763|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203269|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203270|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203271|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203272|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203284|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154203286|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203287|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203288|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154203289|NCT03687827|Insulin|insulin|mesh-list
154203290|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154203291|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
154203292|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154203293|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203294|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154203295|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154203296|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
154203297|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203298|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203299|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154203300|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
154203301|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154203302|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154203303|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154203304|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
154203305|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203306|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203307|NCT00486434|Calcitonin|calcitonin|mesh-list
154203308|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
154203309|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154203310|NCT00486434|Katacalcin|katacalcin|mesh-list
154203311|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154203312|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203313|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154203314|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
154203315|NCT00529451|Ramipril|ramipril|mesh-list
154203316|NCT00529451|Aliskiren|aliskiren|mesh-list
154203317|NCT00529451|Renin Inhibitors|renin inhibitors|mesh-ancestor
154203318|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
154203319|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203320|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203321|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154203322|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154203323|NCT03999437|Terbinafine|terbinafine|mesh-list
154203324|NCT03999437|Butenafine|butenafine|mesh-list
154203325|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
154203326|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203327|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203328|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203329|NCT05637281|Indomethacin|indomethacin|mesh-list
154203330|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154203331|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154203332|NCT05637281|Analgesics|analgesics|mesh-ancestor
154203333|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
154203334|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203335|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203358|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203359|NCT00351273|Azithromycin|azithromycin|mesh-list
154203360|NCT00351273|Doxycycline|doxycycline|mesh-list
154203361|NCT00351273|Rifampin|rifampin|mesh-list
154203362|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154203363|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203364|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
154203365|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154203366|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154203367|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154203368|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
154203369|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
154203370|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154203371|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203372|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203373|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154203374|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154203375|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154203376|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154203377|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154203378|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154203379|NCT00327717|Zonisamide|zonisamide|mesh-list
154203380|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
154203381|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154203382|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154203383|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203384|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154203385|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203386|NCT00463346|Acamprosate|acamprosate|mesh-list
154203404|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203405|NCT01025102|Sufentanil|sufentanil|mesh-list
154203406|NCT01025102|Ropivacaine|ropivacaine|mesh-list
154203407|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154203408|NCT01025102|Narcotics|narcotics|mesh-ancestor
154203409|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154203410|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203411|NCT01025102|Analgesics|analgesics|mesh-ancestor
154203412|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
153950390|NCT01131182|Metformin|metformin|mesh-list
154203413|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203414|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154203415|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154203416|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
154203418|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
154203419|NCT00424476|Belimumab|belimumab|mesh-list
154203420|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154203421|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
154203422|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203423|NCT01037634|Oseltamivir|oseltamivir|mesh-list
154203424|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
154203425|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203426|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203427|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203428|NCT01034748|Dacomitinib|dacomitinib|mesh-list
154203429|NCT01034748|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203430|NCT01034748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203431|NCT01034748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203432|NCT01034748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203433|NCT01037712|Valacyclovir|valacyclovir|mesh-list
154203434|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
154203435|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203436|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154203437|NCT00453362|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203438|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203439|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203440|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203441|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203442|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
154203443|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154203444|NCT00461786|Pemetrexed|pemetrexed|mesh-list
154203445|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203446|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203464|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203465|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203466|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154203467|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154203468|NCT00350727|Lapatinib|lapatinib|mesh-list
154203469|NCT00350727|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203470|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203471|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203472|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203473|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203474|NCT01032486|Rasagiline|rasagiline|mesh-list
154203475|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154203476|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203477|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203478|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154203479|NCT01032486|Protective Agents|protective agents|mesh-ancestor
154203480|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203481|NCT01061697|Pregabalin|pregabalin|mesh-list
154203482|NCT01061697|Analgesics|analgesics|mesh-ancestor
154203483|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
154203484|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203485|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203486|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
154203487|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154203488|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154203489|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203490|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154203492|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154203493|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154203494|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154203495|NCT00434304|Ropinirole|ropinirole|mesh-list
154203496|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154203497|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154203498|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
154203499|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
154203500|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203501|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539935|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154203518|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154203519|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154203520|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154203521|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
154203522|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203523|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203524|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
154203525|NCT00424008|Hormones|hormones|mesh-ancestor
154203526|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203527|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
154203528|NCT00423930|Bevacizumab|bevacizumab|mesh-list
154203529|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154203530|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203531|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154203532|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154203533|NCT00423930|Growth Substances|growth substances|mesh-ancestor
154203534|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203535|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
154203536|NCT00423852|Paclitaxel|paclitaxel|mesh-list
154203537|NCT00423852|Carboplatin|carboplatin|mesh-list
154203538|NCT00423852|Ifosfamide|ifosfamide|mesh-list
154203539|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154203540|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203541|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
154203542|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
154203543|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
154203544|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203545|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154203546|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
154203547|NCT00461708|Gemcitabine|gemcitabine|mesh-list
154203548|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154203551|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203552|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203553|NCT00461708|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154203554|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154203555|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203556|NCT00327171|Aflibercept|aflibercept|mesh-list
154203557|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154203558|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154203559|NCT00327171|Growth Substances|growth substances|mesh-ancestor
153950537|NCT01129622|Letrozole|letrozole|mesh-list
154203568|NCT00461630|Simvastatin|simvastatin|mesh-list
154203569|NCT00461630|Ezetimibe|ezetimibe|mesh-list
154203570|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154203571|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154203572|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154203573|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
154203574|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203575|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154203576|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154203577|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203578|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
154203579|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
154203580|NCT00461630|Vitamins|vitamins|mesh-ancestor
154203581|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
154203582|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203583|NCT01061853|Sirolimus|sirolimus|mesh-list
154203584|NCT01061853|Betamethasone|betamethasone|mesh-list
154203585|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154203586|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203587|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154203588|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203589|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
154203590|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154203591|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
154203592|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203593|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203594|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
154203595|NCT01061853|Hormones|hormones|mesh-ancestor
154203596|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203597|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154203598|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
154203599|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
154203600|NCT01325415|Naloxegol|naloxegol|mesh-list
154203601|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154203602|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203603|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154203604|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154203605|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203606|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203607|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203608|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203609|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154203610|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
154203611|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203612|NCT01022840|Ketamine|ketamine|mesh-list
154203613|NCT01022840|Esketamine|esketamine|mesh-list
154203614|NCT01022840|Analgesics|analgesics|mesh-ancestor
154203615|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
154203616|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203617|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203618|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154203619|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154203620|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
154203621|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
154203622|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154203623|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154203624|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154203625|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203626|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203627|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
154203650|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154203651|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
154203652|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203653|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203654|NCT00434148|Pasireotide|pasireotide|mesh-list
154203656|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203657|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203658|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
154203659|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154203660|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154203661|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154203662|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203663|NCT00468728|Vancomycin|vancomycin|mesh-list
154203664|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154203665|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154203666|NCT00433914|Vaccines|vaccines|mesh-list
154203667|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
154203668|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203669|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
154203670|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203671|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
154203672|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154203673|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154203674|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154203675|NCT00468650|Urological Agents|urological agents|mesh-ancestor
154203676|NCT00423150|Temozolomide|temozolomide|mesh-list
154203677|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154203678|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
154203679|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203680|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203694|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154203695|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154203696|NCT01022918|Growth Substances|growth substances|mesh-ancestor
154203697|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203698|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
154203699|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154203700|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
154203701|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203702|NCT00433446|Siltuximab|siltuximab|mesh-list
154203703|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203704|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154203705|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154203706|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154203707|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203708|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
154203709|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
154203710|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154203711|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
154203712|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203713|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154203714|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154203715|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154203716|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154203717|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154203718|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154203719|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203720|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203721|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203722|NCT00433290|Analgesics|analgesics|mesh-ancestor
154203723|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
154203724|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203725|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
154203726|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154203727|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
154203728|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
154203729|NCT00467870|Testosterone|testosterone|mesh-list
154203730|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
154203731|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
154203732|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154203733|NCT00467870|Androgens|androgens|mesh-ancestor
154203734|NCT00467870|Hormones|hormones|mesh-ancestor
154203735|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203736|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203737|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154203738|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203739|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
154203740|NCT00467558|Naltrexone|naltrexone|mesh-list
154203765|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
154203766|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203767|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203768|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
154203769|NCT00452348|Hormones|hormones|mesh-ancestor
154203770|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203771|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
154203772|NCT01323062|Bavituximab|bavituximab|mesh-list
154203773|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154203774|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203775|NCT00320541|Paclitaxel|paclitaxel|mesh-list
154203776|NCT00320541|Bevacizumab|bevacizumab|mesh-list
154203777|NCT00320541|Gemcitabine|gemcitabine|mesh-list
154203778|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154203779|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203780|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
154203781|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
154203782|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
154203783|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203784|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154203785|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154203786|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154203787|NCT00320541|Growth Substances|growth substances|mesh-ancestor
154203788|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203789|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
154203790|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154203814|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
154203815|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
154203816|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203817|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154203818|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
154203819|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154203821|NCT00319839|Cetuximab|cetuximab|mesh-list
154203822|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154203823|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154203824|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203825|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
154203826|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
154203827|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154203828|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203829|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154203830|NCT01062087|Lidocaine|lidocaine|mesh-list
154203831|NCT01062087|Bupivacaine|bupivacaine|mesh-list
154203832|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
154203833|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
154203834|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154203835|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203836|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
154203837|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154203838|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154203839|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154203840|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154203841|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154203842|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469053|NCT05627245|Belinostat|belinostat|mesh-list
154203877|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
154203878|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154203879|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
154203880|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154203881|NCT00316719|Lamivudine|lamivudine|mesh-list
154203911|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154203912|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
154203913|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
154203914|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154203915|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154203916|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203917|NCT00422058|Liraglutide|liraglutide|mesh-list
154203918|NCT00422058|Orlistat|orlistat|mesh-list
154203919|NCT00422058|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154203920|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154203921|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203922|NCT00422058|Incretins|incretins|mesh-ancestor
154203923|NCT00422058|Hormones|hormones|mesh-ancestor
154203924|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203925|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539936|NCT01536301|Narcotics|narcotics|mesh-ancestor
154203946|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203947|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154203948|NCT00420342|Drospirenone|drospirenone|mesh-list
154203949|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154203950|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154203951|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
154203952|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154203953|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154203954|NCT00420342|Estradiol|estradiol|mesh-list
154203955|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154203956|NCT00420342|Estrogens|estrogens|mesh-ancestor
154203957|NCT00420342|Hormones|hormones|mesh-ancestor
154203958|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154203959|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203960|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154203961|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
154203962|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154203963|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154203964|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154203965|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154203966|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154203967|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154203968|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154203969|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154203970|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154203971|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
154203972|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154203973|NCT00420342|Diuretics|diuretics|mesh-ancestor
154203974|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
154203975|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154203976|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154203977|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154203978|NCT01038648|Incretins|incretins|mesh-ancestor
154203979|NCT01038648|Hormones|hormones|mesh-ancestor
153539937|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154204004|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204006|NCT01026116|Paclitaxel|paclitaxel|mesh-list
154204007|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
154204008|NCT01026116|Epirubicin|epirubicin|mesh-list
154204009|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154204010|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204011|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
154204012|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204013|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
154204014|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204015|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204016|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
154204017|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204018|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204019|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153748091|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
154204020|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
154204021|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154204022|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154204023|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154204024|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153626890|NCT02019485|Tapentadol|tapentadol|mesh-list
154204041|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154204042|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154204043|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
154204044|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
154204045|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
154204046|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204047|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204048|NCT01027520|Ionophores|ionophores|mesh-ancestor
154204049|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204050|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
154204051|NCT01023230|Entecavir|entecavir|mesh-list
154204052|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
154204053|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204054|NCT01027832|Tazobactam|tazobactam|mesh-list
154204055|NCT01027832|Piperacillin|piperacillin|mesh-list
154204056|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154204057|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154204058|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204059|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154204060|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204061|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204062|NCT00413010|Pregabalin|pregabalin|mesh-list
154204063|NCT00413010|Analgesics|analgesics|mesh-ancestor
154204064|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
154204065|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204066|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204067|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
154204068|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154204069|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204070|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204071|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154204072|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154204073|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154204074|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154204075|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154204076|NCT00459290|Mifepristone|mifepristone|mesh-list
154204077|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154204078|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
154204079|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154204080|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204081|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154204082|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154204083|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153626941|NCT02019836|Vitamin D|vitamin d|mesh-list
154204101|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204103|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
154204104|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154204105|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154204106|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154204107|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
154204108|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204109|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204110|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154204111|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
154204112|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
154204113|NCT00419952|Hormones|hormones|mesh-ancestor
154204114|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204115|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154204116|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154204117|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154204118|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
154204119|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204120|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204121|NCT00443456|Amlodipine|amlodipine|mesh-list
154204122|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154204123|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154204124|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204125|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204126|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154204127|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204128|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
154204129|NCT00419562|Insulin|insulin|mesh-list
154204130|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154204131|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204132|NCT03557294|Varenicline|varenicline|mesh-list
154204133|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154204134|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154204135|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
154204136|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204137|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204138|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204173|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154204174|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154204175|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
154204176|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154204190|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204191|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154204192|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
154204193|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204194|NCT00316173|Carboplatin|carboplatin|mesh-list
154204195|NCT00316173|Topotecan|topotecan|mesh-list
154204196|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204197|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154204198|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154204199|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204200|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204201|NCT00412542|Thalidomide|thalidomide|mesh-list
154204202|NCT00412542|Irinotecan|irinotecan|mesh-list
154204203|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154204204|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154204205|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204206|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204207|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204208|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204209|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
154204210|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204211|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
154204212|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154204213|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204214|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154204215|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154204216|NCT00412542|Growth Substances|growth substances|mesh-ancestor
154204217|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
154204218|NCT00316017|Dextrans|dextrans|mesh-list
154204219|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
154204220|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
154204221|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
154204222|NCT00451178|Prednisone|prednisone|mesh-list
154204223|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
154204224|NCT00451178|Rituximab|rituximab|mesh-list
153951200|NCT00660244|Anastrozole|anastrozole|mesh-list
154204225|NCT00451178|Doxorubicin|doxorubicin|mesh-list
154204226|NCT00451178|Vincristine|vincristine|mesh-list
154204227|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204228|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
154204229|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204231|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154204232|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
154204233|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204234|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204235|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154204236|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154204237|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154204238|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153627105|NCT02021123|Anidulafungin|anidulafungin|mesh-list
154204253|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204254|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
154204255|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204256|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204257|NCT01026584|Aripiprazole|aripiprazole|mesh-list
154204258|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
154204259|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154204260|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154204261|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154256422|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154204262|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154204263|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204264|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
154204265|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
154204266|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204267|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204268|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154204269|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154204270|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
154204271|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154204272|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154204273|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154204274|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154204275|NCT01023464|Emollients|emollients|mesh-list
154204276|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154204277|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154204278|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
154204279|NCT01023542|Everolimus|everolimus|mesh-list
154204280|NCT01023542|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154204281|NCT01023542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154204282|NCT01023542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204283|NCT01023542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204284|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204285|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
154204286|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204287|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204288|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
154204289|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154204290|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154204291|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204292|NCT01028534|Olmesartan|olmesartan|mesh-list
154204293|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154204294|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
154204295|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
154204296|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154204297|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154204298|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204299|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154204325|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154204326|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
154204327|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
154204328|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204329|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
154204330|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154204331|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154204332|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204333|NCT00430716|Urological Agents|urological agents|mesh-ancestor
154204334|NCT01028768|Teduglutide|teduglutide|mesh-list
154204335|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154204336|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154204337|NCT01028768|Protective Agents|protective agents|mesh-ancestor
154204338|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204339|NCT00441272|Pioglitazone|pioglitazone|mesh-list
154204340|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154204341|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204342|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154204343|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
154204344|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204345|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154204346|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154204347|NCT01028924|Teduglutide|teduglutide|mesh-list
154204348|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154204349|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154204350|NCT01028924|Protective Agents|protective agents|mesh-ancestor
154204365|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154204366|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154204367|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154204368|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204369|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154204370|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154204371|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154204372|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154204373|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
154204374|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
154204375|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
154204376|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
153951344|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204377|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204378|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204379|NCT00449930|Metformin|metformin|mesh-list
154204380|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154204381|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154204382|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204383|NCT00449930|Incretins|incretins|mesh-ancestor
154204384|NCT00449930|Hormones|hormones|mesh-ancestor
154204385|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204386|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154204387|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
154204388|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204389|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204390|NCT00441116|Dutasteride|dutasteride|mesh-list
154204391|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154204392|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154204393|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204394|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204395|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
154204396|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204397|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204398|NCT01024322|Diclofenac|diclofenac|mesh-list
154204399|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
154204400|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154204401|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
154204402|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154204403|NCT01024322|Prednisolone|prednisolone|mesh-list
154204404|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154204405|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
154204406|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154204407|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154204408|NCT01024322|Analgesics|analgesics|mesh-ancestor
154204424|NCT01024322|Protective Agents|protective agents|mesh-ancestor
154204425|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154204426|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204427|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154204428|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204429|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204430|NCT01566266|Amoxicillin|amoxicillin|mesh-list
154204431|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154204432|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204433|NCT00430248|Allopurinol|allopurinol|mesh-list
154204434|NCT00430248|Febuxostat|febuxostat|mesh-list
154204435|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
154204436|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204437|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204438|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
154204439|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204440|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154204441|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
154204442|NCT00430248|Protective Agents|protective agents|mesh-ancestor
154204443|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204444|NCT00411762|Capecitabine|capecitabine|mesh-list
154204445|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204446|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
154204447|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204448|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204449|NCT00429858|Gemcitabine|gemcitabine|mesh-list
153951419|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204450|NCT00429858|Tegafur|tegafur|mesh-list
154204451|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204452|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
154204453|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204454|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204455|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
154204456|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154204457|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
154204458|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204461|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
154204462|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154204463|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204464|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
154204465|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204483|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204484|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204485|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154204486|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
154204487|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204488|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
154204489|NCT01039194|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154204490|NCT00449072|Loratadine|loratadine|mesh-list
154204491|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
154204492|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
154204493|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154204494|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154204495|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154204496|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
154204497|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
154204498|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204499|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204500|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204501|NCT00419094|Levetiracetam|levetiracetam|mesh-list
154204502|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
154204503|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
154204504|NCT00448916|Pregabalin|pregabalin|mesh-list
154204505|NCT00448916|Analgesics|analgesics|mesh-ancestor
154204506|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
154204507|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204508|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204509|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
154204510|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154204511|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204512|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204513|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154204514|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154204515|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154204516|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154204517|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154204518|NCT00418938|Leucovorin|leucovorin|mesh-list
154204519|NCT00418938|Bevacizumab|bevacizumab|mesh-list
154204520|NCT00418938|Panitumumab|panitumumab|mesh-list
154204521|NCT00418938|Fluorouracil|fluorouracil|mesh-list
154204522|NCT00418938|Irinotecan|irinotecan|mesh-list
154204523|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154204524|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204525|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154204526|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154204527|NCT00418938|Growth Substances|growth substances|mesh-ancestor
154204554|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204555|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
154204556|NCT00448760|Vitamins|vitamins|mesh-ancestor
154204557|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
154204558|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204559|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
154204560|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
154204561|NCT01039350|Hematinics|hematinics|mesh-ancestor
154204562|NCT01039506|Irinotecan|irinotecan|mesh-list
154204563|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154204564|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154204565|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204566|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204567|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204568|NCT01033500|Abatacept|abatacept|mesh-list
154204569|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154204570|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204571|NCT01033500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154204572|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204573|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204574|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
154204575|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204576|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204577|NCT01035450|Sirolimus|sirolimus|mesh-list
154204578|NCT01035450|Everolimus|everolimus|mesh-list
154204579|NCT01035450|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154204580|NCT01035450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154204581|NCT01035450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204599|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154204600|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
154204601|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154204602|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204603|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204604|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
154204605|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204606|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204607|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
154204608|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204609|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154204610|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204611|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
154204612|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204613|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154204614|NCT01039740|Mirtazapine|mirtazapine|mesh-list
154204615|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
154204616|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154204617|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154204618|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
154204619|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
154204620|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204621|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204622|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204623|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154204624|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154204625|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154204626|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154204627|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154204628|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154204629|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
154204630|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154204631|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154204632|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
154204633|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154204634|NCT00448136|Bevacizumab|bevacizumab|mesh-list
154204635|NCT00448136|Streptozocin|streptozocin|mesh-list
154204636|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154204637|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204638|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154204653|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
154204654|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204655|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154204656|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154204657|NCT00307437|Ustekinumab|ustekinumab|mesh-list
154204658|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
154204659|NCT00440726|Cytarabine|cytarabine|mesh-list
154204660|NCT00440726|Dexamethasone|dexamethasone|mesh-list
154204661|NCT00440726|Doxorubicin|doxorubicin|mesh-list
154204662|NCT00440726|Methotrexate|methotrexate|mesh-list
154204663|NCT00440726|Vincristine|vincristine|mesh-list
154204664|NCT00440726|Bortezomib|bortezomib|mesh-list
154204665|NCT00440726|Asparaginase|asparaginase|mesh-list
154204666|NCT00440726|Pegaspargase|pegaspargase|mesh-list
154204667|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154204668|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
154204669|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
154204670|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204671|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204672|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154204673|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
154204674|NCT00440726|Hormones|hormones|mesh-ancestor
154204675|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204676|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154204677|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204678|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154204679|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154204680|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154204681|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204682|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204683|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154204684|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
154204685|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154204686|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204687|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
154204688|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
154204689|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154204690|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204691|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
154204692|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204693|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154204694|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
154204695|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204696|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154204697|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
154204698|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204699|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
154204700|NCT01030016|Atenolol|atenolol|mesh-list
153627555|NCT02024009|Nelfinavir|nelfinavir|mesh-list
154204710|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
154204711|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204712|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154204714|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
154204715|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204716|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204717|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154204718|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154204719|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154204720|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204721|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204722|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
154204723|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204724|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204725|NCT01030094|Topiramate|topiramate|mesh-list
154204726|NCT01030094|Carbamazepine|carbamazepine|mesh-list
154204727|NCT01030094|Valproic Acid|valproic acid|mesh-list
154204728|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
154204729|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154204730|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204731|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204732|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204733|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
154204734|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204735|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
154204736|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154204737|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154204738|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154204739|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154204740|NCT01030094|Analgesics|analgesics|mesh-ancestor
154204741|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
154204742|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204743|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154204744|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154204745|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154204746|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154204747|NCT01565798|Copper|copper|mesh-list
154204748|NCT01565798|Trace Elements|trace elements|mesh-ancestor
154204749|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
154204750|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204751|NCT01030328|Fenofibrate|fenofibrate|mesh-list
154204752|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154204753|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
153951734|NCT00879970|Vitamin D|vitamin d|mesh-list
154204754|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204755|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154204757|NCT00405756|Prednisone|prednisone|mesh-list
154204758|NCT00405756|Lenalidomide|lenalidomide|mesh-list
154204759|NCT00405756|Melphalan|melphalan|mesh-list
154204760|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154204761|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
154204762|NCT00405756|Hormones|hormones|mesh-ancestor
154204763|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204764|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204765|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154204787|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154204788|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204789|NCT00456092|Apremilast|apremilast|mesh-list
154204790|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154204791|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154204792|NCT00456092|Analgesics|analgesics|mesh-ancestor
154204793|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
154204794|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204795|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204796|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154204797|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154204798|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154204799|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154204800|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204801|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204802|NCT01030640|Tanezumab|tanezumab|mesh-list
154204803|NCT01030640|Analgesics|analgesics|mesh-ancestor
154204804|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
154204805|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204806|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204807|NCT00411450|Panitumumab|panitumumab|mesh-list
154204808|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154204809|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204810|NCT00404820|Vitamin D|vitamin d|mesh-list
154204811|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
154204812|NCT00404820|Alendronate|alendronate|mesh-list
154204813|NCT00404820|Calcium|calcium|mesh-list
154204814|NCT00404820|Vitamins|vitamins|mesh-ancestor
154204815|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
154204816|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204817|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154204818|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154204832|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154204833|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154204834|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154204835|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154204836|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154204837|NCT00446030|Growth Substances|growth substances|mesh-ancestor
154204838|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
154204839|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154204840|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204841|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154204842|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154204843|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154204844|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154204845|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204847|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154204848|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154204849|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154204850|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
154204851|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204852|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204853|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204854|NCT00410514|Urological Agents|urological agents|mesh-ancestor
154204856|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
154204857|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
154204858|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204859|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204860|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154204861|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
154204862|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
154204863|NCT01036854|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154204864|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154204865|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
154204866|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204867|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204868|NCT01030796|Caffeine|caffeine|mesh-list
154204869|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154204870|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154204871|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154204872|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204873|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204874|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154204875|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154204876|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
154204877|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154204878|NCT00439556|Cytarabine|cytarabine|mesh-list
154204879|NCT00439556|Rituximab|rituximab|mesh-list
154204880|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154204881|NCT00439556|Methotrexate|methotrexate|mesh-list
154204904|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154204905|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
153951872|NCT00676702|Vitamin K|vitamin k|mesh-list
154204906|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204907|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
154204908|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204909|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154204910|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154204911|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154204912|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154204913|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154204914|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154204915|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
154204916|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204917|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154204918|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154204919|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154204920|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
154204921|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154204922|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
154204923|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154204924|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154204925|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154204926|NCT00410202|Tenofovir|tenofovir|mesh-list
154204927|NCT00410202|Lamivudine|lamivudine|mesh-list
154204928|NCT00410202|Entecavir|entecavir|mesh-list
154204929|NCT00410202|Adefovir|adefovir|mesh-list
154204930|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
154204931|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154204932|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154204933|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154204934|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154204935|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154204936|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154204937|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154204938|NCT03802058|Paclitaxel|paclitaxel|mesh-list
154204939|NCT03802058|Carboplatin|carboplatin|mesh-list
154204969|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154204970|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154204971|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
154204972|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
154204973|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154204974|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154204975|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
154204976|NCT00455312|Hormones|hormones|mesh-ancestor
154204977|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154204978|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154204979|NCT00455312|Protective Agents|protective agents|mesh-ancestor
153951944|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
154204980|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154204981|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
154204982|NCT01031030|Fluorouracil|fluorouracil|mesh-list
154204983|NCT01031030|Methotrexate|methotrexate|mesh-list
154204984|NCT01031030|Epirubicin|epirubicin|mesh-list
154204985|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627860|NCT02025712|Everolimus|everolimus|mesh-list
154205011|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
154205012|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
154205013|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
154205014|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205015|NCT01024712|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154205016|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154205017|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205019|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
154205020|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205021|NCT00444626|Lidocaine|lidocaine|mesh-list
154205022|NCT00444626|Prilocaine|prilocaine|mesh-list
154205023|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154205025|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
154205026|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
154205027|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154205028|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205029|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
154205030|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205031|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154205032|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154205033|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154205049|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154205051|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205052|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205053|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
154205054|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205055|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
154205056|NCT00439244|Teriparatide|teriparatide|mesh-list
154205057|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154205058|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205059|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154205060|NCT04844762|Menthol|menthol|mesh-list
154205061|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
154205062|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
154205063|NCT01323218|Vitamin D|vitamin d|mesh-list
154205064|NCT01323218|Vitamins|vitamins|mesh-ancestor
154205065|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
154205066|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205067|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154205068|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154205069|NCT01323296|Hematinics|hematinics|mesh-ancestor
154205070|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154205071|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154205072|NCT00438464|Finasteride|finasteride|mesh-list
154205073|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154205074|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154205075|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205076|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205077|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
154205078|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205079|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205080|NCT00438464|Urological Agents|urological agents|mesh-ancestor
154205081|NCT00437294|Capecitabine|capecitabine|mesh-list
154205082|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154205083|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
154205084|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205085|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205086|NCT01033760|Ritonavir|ritonavir|mesh-list
154205087|NCT01033760|Darunavir|darunavir|mesh-list
154205088|NCT01033760|Tenofovir|tenofovir|mesh-list
154205089|NCT01033760|Emtricitabine|emtricitabine|mesh-list
154205090|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
154205091|NCT01033760|Maraviroc|maraviroc|mesh-list
154205092|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154205093|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154205105|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154205107|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154205108|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154205109|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154205110|NCT01031732|Tacrine|tacrine|mesh-list
154205111|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154205112|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205113|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205114|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
154205115|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205116|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205117|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154205118|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
154205119|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205120|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
154205121|NCT01033994|Mitogens|mitogens|mesh-list
154205122|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
154205123|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205124|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154205125|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154205127|NCT00436826|Interferon-beta|interferon-beta|mesh-list
154205128|NCT00436826|Cladribine|cladribine|mesh-list
154205129|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
154205130|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205131|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
154205132|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205133|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
154205134|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205135|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205136|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154205138|NCT00410124|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154205139|NCT00410124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154205140|NCT00410124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205141|NCT00410124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205142|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205143|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
154205144|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205145|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205146|NCT01036932|Lenograstim|lenograstim|mesh-list
154205147|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154205148|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
154205149|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205150|NCT00410046|Etanercept|etanercept|mesh-list
154205151|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154205152|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154205153|NCT00410046|Analgesics|analgesics|mesh-ancestor
154205154|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
154205155|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205156|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205176|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154205177|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154205178|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205179|NCT00409578|Renin Inhibitors|renin inhibitors|mesh-ancestor
154205180|NCT00409578|Protease Inhibitors|protease inhibitors|mesh-ancestor
154205181|NCT00409578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205182|NCT01037322|Cannabidiol|cannabidiol|mesh-list
154205183|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
154205184|NCT01070758|Lanreotide|lanreotide|mesh-list
154205185|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205186|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
154205187|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154205188|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205189|NCT01031966|Thymalfasin|thymalfasin|mesh-list
154205190|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154205191|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
154205192|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205193|NCT00436436|Temozolomide|temozolomide|mesh-list
154205194|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
154205195|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154205196|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
154205197|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205198|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205199|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205200|NCT00262522|Ritonavir|ritonavir|mesh-list
154205201|NCT00262522|Lopinavir|lopinavir|mesh-list
154205202|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154205203|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154205204|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154205205|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
154205206|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205207|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205208|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154205209|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154205210|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
154205211|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205212|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154205213|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154205214|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154205215|NCT00436280|Rituximab|rituximab|mesh-list
154205216|NCT00436280|Gemcitabine|gemcitabine|mesh-list
154205226|NCT00394836|Ofatumumab|ofatumumab|mesh-list
154205227|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154205228|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205229|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
154205230|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205231|NCT01040598|Omalizumab|omalizumab|mesh-list
154205232|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154205233|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154205234|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
154205235|NCT01039974|Ketoconazole|ketoconazole|mesh-list
154205236|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
154205237|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205238|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154205239|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154205240|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205241|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205242|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154205243|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
154205244|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205245|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205246|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154205247|NCT01032122|Rituximab|rituximab|mesh-list
154205248|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205249|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205250|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
154205251|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205252|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205253|NCT00394524|Insulin|insulin|mesh-list
154205254|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154205255|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205256|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
154205257|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154205258|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154205259|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205260|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154205261|NCT00409344|Analgesics|analgesics|mesh-ancestor
154205262|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
154205263|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205264|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154205265|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154205266|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154205267|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
154205268|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205269|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205270|NCT00415610|Nicardipine|nicardipine|mesh-list
154205271|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154205272|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154205273|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154205274|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205275|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154205276|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205277|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
154205278|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
154205279|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154205314|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205315|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
154205316|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205317|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205318|NCT00427934|Maraviroc|maraviroc|mesh-list
153628180|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
154205349|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154205351|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205352|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
154205353|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205354|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205355|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154205356|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
154205357|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205358|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205359|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154205361|NCT00434954|Exenatide|exenatide|mesh-list
154205374|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205375|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154205376|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154205377|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205378|NCT00426842|Midodrine|midodrine|mesh-list
154205379|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
154205380|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
154205381|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205382|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205383|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154205384|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154205385|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154205386|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154205387|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
154205388|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205389|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205390|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154205391|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
154205392|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154205393|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154205394|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154205395|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154205396|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205397|NCT01072318|Letrozole|letrozole|mesh-list
154205398|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205399|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154205400|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154205401|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205402|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205403|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154205404|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
154205405|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205406|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205407|NCT00276094|Tamoxifen|tamoxifen|mesh-list
154205408|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154205409|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
154205410|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205411|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205412|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154205413|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205414|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154205415|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154205416|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154205417|NCT03975088|Ranibizumab|ranibizumab|mesh-list
154205418|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154205419|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154205420|NCT03975088|Growth Substances|growth substances|mesh-ancestor
154205421|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205422|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
154205442|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205443|NCT00276016|Protective Agents|protective agents|mesh-ancestor
154205444|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154205445|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154205446|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154205447|NCT00434642|Bevacizumab|bevacizumab|mesh-list
154205448|NCT00434642|Carboplatin|carboplatin|mesh-list
154205449|NCT00434642|Gemcitabine|gemcitabine|mesh-list
154205450|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205451|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205452|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154205453|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154205454|NCT00434642|Growth Substances|growth substances|mesh-ancestor
154205455|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205456|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
154205457|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154205458|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
154205459|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205460|NCT01032434|Sertraline|sertraline|mesh-list
154205461|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
154205462|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154205463|NCT01032434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154205464|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154205465|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154205466|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205467|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205468|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
154205469|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205470|NCT00426764|Romidepsin|romidepsin|mesh-list
154205471|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154205472|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205473|NCT00426764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154205474|NCT00426764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205475|NCT00426764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205476|NCT01032668|Clopidogrel|clopidogrel|mesh-list
154205477|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154205478|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154205507|NCT00414908|Pancrelipase|pancrelipase|mesh-list
154205508|NCT00414908|Pancreatin|pancreatin|mesh-list
154205509|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154205510|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
154205511|NCT00242710|Estrogens|estrogens|mesh-list
154205512|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154205513|NCT00242710|Hormones|hormones|mesh-ancestor
154205514|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205515|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205516|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154205517|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154205518|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
154205519|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154205520|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154205521|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154205522|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153628390|NCT02028923|Morphine|morphine|mesh-list
154205533|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
154205535|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
154205536|NCT00240994|Tacrolimus|tacrolimus|mesh-list
154205537|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205538|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
154205539|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205540|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154205541|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205542|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205543|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154205544|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205545|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154205546|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
154205547|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154205548|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205549|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
154205550|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205551|NCT01070836|Natalizumab|natalizumab|mesh-list
154205552|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
154205553|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205554|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
154205555|NCT00239590|Testosterone|testosterone|mesh-list
154205556|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
154205557|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
154205558|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154205559|NCT00239590|Androgens|androgens|mesh-ancestor
154205560|NCT00239590|Hormones|hormones|mesh-ancestor
154205561|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205562|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205563|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154205564|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205565|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
154205566|NCT00433160|Teriparatide|teriparatide|mesh-list
154205567|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154205568|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205569|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154205570|NCT00239356|Aripiprazole|aripiprazole|mesh-list
154205571|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
154205572|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154205573|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154205574|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154205575|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154205576|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205577|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
154205578|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
154205579|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205580|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205581|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154205582|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154205584|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154205585|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153628427|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154205611|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154205613|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154205614|NCT01041066|Labetalol|labetalol|mesh-list
154205615|NCT01041066|Nicardipine|nicardipine|mesh-list
154205616|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154205617|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154205618|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
154205619|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205620|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205621|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205622|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154205623|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
154205624|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
154205625|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154205626|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154205627|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154205628|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154205629|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154205630|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154205631|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
154205632|NCT01323608|Vitamin D|vitamin d|mesh-list
154205633|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
154205669|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154205670|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
154205671|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
153628563|NCT02029950|Cytarabine|cytarabine|mesh-list
154205706|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154205707|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
154205708|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
154205709|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154205710|NCT01043952|Narcotics|narcotics|mesh-ancestor
154205711|NCT01043952|Analgesics|analgesics|mesh-ancestor
154205724|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205725|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205726|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154205727|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154205730|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154205731|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
154205732|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205733|NCT01072786|Vaccines|vaccines|mesh-list
154205734|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
154205735|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205736|NCT03970798|Midazolam|midazolam|mesh-list
154205737|NCT03970798|Caffeine|caffeine|mesh-list
154205738|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154205739|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154205740|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153748102|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154205741|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154205742|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205743|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154205744|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154205745|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154205746|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154205747|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
154205748|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
154205749|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
154205750|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
154205751|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205752|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205753|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154205754|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154205755|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
154205756|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154205757|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154205758|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205759|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154205760|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154205761|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154205762|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154205763|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
154205765|NCT00414440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154205766|NCT00414440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154205767|NCT00414440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205768|NCT00414440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205769|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154205770|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
154205771|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205772|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205773|NCT00209560|Fospropofol|fospropofol|mesh-list
154205774|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154205775|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154205789|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154205790|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205791|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154205792|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154205793|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154205794|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205795|NCT01033058|Atorvastatin|atorvastatin|mesh-list
154205796|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154205797|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154205798|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
154205799|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205800|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154205801|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154205802|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748132|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
154205804|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153748259|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
154205805|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154205806|NCT03973138|Growth Substances|growth substances|mesh-ancestor
154205807|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205808|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
154205809|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205810|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
154205811|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154205812|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205813|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154205814|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154205815|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205816|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205817|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205818|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154205819|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154205820|NCT00234052|Bevacizumab|bevacizumab|mesh-list
154205821|NCT00234052|Carboplatin|carboplatin|mesh-list
154205822|NCT00234052|Pemetrexed|pemetrexed|mesh-list
154205823|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154205824|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205825|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154205826|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154205827|NCT00234052|Growth Substances|growth substances|mesh-ancestor
154205828|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205829|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
154205830|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205831|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205833|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154205835|NCT00408408|Bevacizumab|bevacizumab|mesh-list
154205836|NCT00408408|Gemcitabine|gemcitabine|mesh-list
154205870|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
154205871|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154205872|NCT03973840|Androgens|androgens|mesh-ancestor
153952845|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
154205873|NCT03973840|Hormones|hormones|mesh-ancestor
154205874|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205876|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154205877|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205878|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
153628754|NCT02039869|Omeprazole|omeprazole|mesh-list
154205896|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
154205897|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
154205898|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205900|NCT00209170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154205901|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153748301|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
154205902|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154205903|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205904|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205905|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
154205906|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205907|NCT01071694|Interferons|interferons|mesh-list
154205908|NCT01071694|Interferon-beta|interferon-beta|mesh-list
154205909|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
154205910|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205911|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
154205912|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205913|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
154205914|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205915|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154205916|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
154205917|NCT00413894|Hematinics|hematinics|mesh-ancestor
154205918|NCT03972748|Itraconazole|itraconazole|mesh-list
154205919|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
154205920|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205921|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154205922|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154205923|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205924|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205925|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154205926|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
154205927|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154205928|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205929|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154205930|NCT01581814|Metformin|metformin|mesh-list
154205931|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154205932|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154205933|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628781|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
154205947|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
154205948|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205950|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154205951|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154205952|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154205953|NCT00209092|Docetaxel|docetaxel|mesh-list
154205954|NCT00209092|Capecitabine|capecitabine|mesh-list
154205955|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205956|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
154205957|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
154205958|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
154205959|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205960|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154205961|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
154205962|NCT03972982|Insulin|insulin|mesh-list
154205963|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154205964|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154205965|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205966|NCT00403494|Verapamil|verapamil|mesh-list
154205967|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154205970|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205971|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154205972|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205973|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
154205974|NCT00403260|Artesunate|artesunate|mesh-list
154205975|NCT00403260|Mefloquine|mefloquine|mesh-list
154205976|NCT00403260|Pyronaridine|pyronaridine|mesh-list
154205977|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
154205978|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154205979|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154205980|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154205981|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154205982|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
154205983|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
154205984|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154205985|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
154205986|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154205987|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154205988|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154205989|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154205990|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154205991|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154205992|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154205993|NCT00406848|Analgesics|analgesics|mesh-ancestor
154205994|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
154205995|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206016|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
154206017|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206018|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206019|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206020|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
154206021|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206023|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153748328|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154206024|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154206025|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206026|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206027|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206028|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154206029|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
154206030|NCT03982173|Durvalumab|durvalumab|mesh-list
154206031|NCT03982173|Tremelimumab|tremelimumab|mesh-list
154206032|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206033|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206034|NCT01062633|Erythritol|erythritol|mesh-list
154206035|NCT01062633|Sorbitol|sorbitol|mesh-list
154206036|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
154206037|NCT01062633|Cathartics|cathartics|mesh-ancestor
154206038|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206039|NCT00307125|Rituximab|rituximab|mesh-list
154206040|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206041|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206042|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
154206043|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206044|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206045|NCT01066299|Oxytocin|oxytocin|mesh-list
154206046|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
154206047|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154206048|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206049|NCT00307047|Paclitaxel|paclitaxel|mesh-list
154206050|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154206051|NCT00307047|Everolimus|everolimus|mesh-list
154206078|NCT00391872|Clopidogrel|clopidogrel|mesh-list
154206080|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154206081|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154206082|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154206083|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154206084|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
154206085|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206086|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206087|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206088|NCT00391170|Dexamethasone|dexamethasone|mesh-list
154206091|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
154206092|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206093|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206094|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206095|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
154206096|NCT00391170|Hormones|hormones|mesh-ancestor
154206097|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585458|NCT01766960|Analgesics|analgesics|mesh-ancestor
154206098|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206111|NCT00402324|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154206112|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154206113|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206114|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206115|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206117|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
154206118|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206119|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
154206120|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
154206121|NCT00294723|Liraglutide|liraglutide|mesh-list
154206122|NCT00294723|Glimepiride|glimepiride|mesh-list
154206123|NCT00294723|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154206124|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154206125|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206126|NCT00294723|Incretins|incretins|mesh-ancestor
154206127|NCT00294723|Hormones|hormones|mesh-ancestor
154206128|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206129|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154206130|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206131|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
154206132|NCT00375492|Exenatide|exenatide|mesh-list
154206133|NCT00375492|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154206134|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154206135|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206136|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154206137|NCT00375492|Incretins|incretins|mesh-ancestor
154206138|NCT00375492|Hormones|hormones|mesh-ancestor
154206139|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206140|NCT00306189|Denosumab|denosumab|mesh-list
154206141|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154206142|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206143|NCT00305877|Bevacizumab|bevacizumab|mesh-list
154206144|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154206145|NCT00305877|Cetuximab|cetuximab|mesh-list
154206146|NCT00305877|Gemcitabine|gemcitabine|mesh-list
154206147|NCT00305877|Capecitabine|capecitabine|mesh-list
154206148|NCT00305877|Antibodies|antibodies|mesh-list
154206149|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
154206150|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154206151|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206152|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154206153|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154206154|NCT00305877|Growth Substances|growth substances|mesh-ancestor
154206155|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206156|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
154206157|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
154206158|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154206159|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
154206160|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206161|NCT00312195|Buprenorphine|buprenorphine|mesh-list
154206162|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154206174|NCT02532777|Leflunomide|leflunomide|mesh-list
154206175|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154206176|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154206177|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206178|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
154206179|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206180|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206181|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206182|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
154206183|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206184|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206185|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154206186|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154206188|NCT02532777|Hormones|hormones|mesh-ancestor
154206189|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206190|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206191|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154206192|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154206193|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
154206194|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154206195|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206196|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
154206197|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
154206198|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206199|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206200|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154206201|NCT02532777|Protective Agents|protective agents|mesh-ancestor
154206202|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
154206203|NCT01062945|Doxazosin|doxazosin|mesh-list
154206204|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154206205|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154206206|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154206207|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154206208|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154206209|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206210|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206211|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206212|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
153748523|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154206213|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154206214|NCT01063023|Asunaprevir|asunaprevir|mesh-list
154206215|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
154206216|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206217|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206218|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154206219|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
154206220|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154206221|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206222|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154206223|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154206224|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154206225|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154206226|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206227|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206250|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154206251|NCT00293709|Analgesics|analgesics|mesh-ancestor
154206252|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
154206253|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206254|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206255|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154206256|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206257|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206258|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206259|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
154206260|NCT01063257|Clofarabine|clofarabine|mesh-list
154206261|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154206262|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
154206263|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206264|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206265|NCT03977649|Erenumab|erenumab|mesh-list
154206266|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154206267|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206268|NCT03977649|Analgesics|analgesics|mesh-ancestor
154206269|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
154206270|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206271|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748747|NCT00536614|Cetuximab|cetuximab|mesh-list
154206272|NCT01066767|Fexofenadine|fexofenadine|mesh-list
154206273|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154206274|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154206275|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154206276|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
154206277|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
154206278|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206279|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206304|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206305|NCT01066845|Urological Agents|urological agents|mesh-ancestor
154206307|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206308|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206309|NCT00293397|Doxorubicin|doxorubicin|mesh-list
154206310|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154206311|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154206312|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206313|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206314|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206315|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206316|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206317|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
154206318|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153953287|NCT05317689|Psilocybin|psilocybin|mesh-list
154206319|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206321|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154206322|NCT01069263|Protective Agents|protective agents|mesh-ancestor
154206323|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206324|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154206325|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
154206326|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206327|NCT01067235|Modafinil|modafinil|mesh-list
154206328|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154206329|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206330|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154206331|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153629183|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
154206353|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154206354|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154206355|NCT01067391|Tadalafil|tadalafil|mesh-list
154206356|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
154206357|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154206358|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154206359|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206360|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206361|NCT01067391|Urological Agents|urological agents|mesh-ancestor
154206362|NCT00402168|Cyclosporine|cyclosporine|mesh-list
154206363|NCT00402168|Abatacept|abatacept|mesh-list
154206364|NCT00402168|Tacrolimus|tacrolimus|mesh-list
154206365|NCT00402168|Cyclosporins|cyclosporins|mesh-list
154206366|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206367|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
153748912|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154206368|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206369|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154206370|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206371|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206372|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
154206373|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206374|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
154206375|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206376|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154206377|NCT00402168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206378|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206379|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
154206380|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154206381|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154206382|NCT00290589|Prednisolone|prednisolone|mesh-list
154206383|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
154206448|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154206449|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154206450|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
154206451|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
154206452|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206453|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154206454|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
154206455|NCT00290433|Hormones|hormones|mesh-ancestor
154206456|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206457|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206458|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154206459|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206462|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154206463|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
154206464|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154206465|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154206466|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
154206467|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
154206468|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154206469|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154206470|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
154206471|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206472|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154206490|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206491|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206492|NCT00391092|Bevacizumab|bevacizumab|mesh-list
154206493|NCT00391092|Trastuzumab|trastuzumab|mesh-list
154206495|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206496|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206497|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154206498|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154206499|NCT00391092|Growth Substances|growth substances|mesh-ancestor
154206500|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206501|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
154206502|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
153748933|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
154206503|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
154206504|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
154206505|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206506|NCT00374868|Pemetrexed|pemetrexed|mesh-list
154206507|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206508|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206509|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206510|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154206511|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153748983|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154206512|NCT01044342|Donepezil|donepezil|mesh-list
154206513|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154206514|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206515|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206516|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
154206517|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206518|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206519|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
154206520|NCT00374556|Eszopiclone|eszopiclone|mesh-list
154206521|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154206522|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206523|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206524|NCT01064973|Baclofen|baclofen|mesh-list
154206525|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154206526|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206527|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154206528|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206529|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154206530|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
154206548|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154206549|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206550|NCT01068093|Ezetimibe|ezetimibe|mesh-list
154206551|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154206552|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154206553|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
154206554|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206555|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154206556|NCT00401544|Dextrans|dextrans|mesh-list
154206557|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
154206558|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
154206559|NCT00401544|Hematinics|hematinics|mesh-ancestor
154206560|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
154206561|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
154206562|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
154206563|NCT00292461|Lamotrigine|lamotrigine|mesh-list
154206564|NCT00292461|Zonisamide|zonisamide|mesh-list
154206565|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
153748988|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
154206566|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154206567|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206568|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206569|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154206570|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206571|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154206572|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154206573|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206574|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154206575|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154206577|NCT00288639|Analgesics|analgesics|mesh-ancestor
154206578|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
154206579|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206580|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206581|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
154206582|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154206583|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206584|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206585|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154206586|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154206602|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206603|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206604|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154206605|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
154206606|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206607|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206608|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154206609|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154206610|NCT00390546|Propranolol|propranolol|mesh-list
154206611|NCT00390546|Digoxin|digoxin|mesh-list
154206612|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154206613|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154206614|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154206615|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206616|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153953583|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
154206617|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206618|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154206619|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154206620|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
154206621|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154206622|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206623|NCT00390546|Protective Agents|protective agents|mesh-ancestor
154206625|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206626|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206627|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
154206628|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206629|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206630|NCT00302211|Bosentan|bosentan|mesh-list
154206631|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
154206632|NCT00302211|Iloprost|iloprost|mesh-list
154206633|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
154206634|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154206635|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154206636|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206637|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206638|NCT00302211|Urological Agents|urological agents|mesh-ancestor
154206639|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154206640|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154206641|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154206642|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
154206643|NCT01045902|Ampicillin|ampicillin|mesh-list
154206644|NCT01045902|Sulbactam|sulbactam|mesh-list
154206645|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154206657|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154206659|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154206660|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154206661|NCT01041690|Bevacizumab|bevacizumab|mesh-list
154206662|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206663|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206664|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154206665|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154206666|NCT01041690|Growth Substances|growth substances|mesh-ancestor
154206667|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206668|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
154206669|NCT00288015|Bevacizumab|bevacizumab|mesh-list
154206670|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206671|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206672|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154206673|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154206674|NCT00288015|Growth Substances|growth substances|mesh-ancestor
154206675|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206676|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
154206677|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154206678|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
154206679|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154206680|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154206681|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154206682|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154206683|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206684|NCT01045980|Vitamin D|vitamin d|mesh-list
154206685|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
154206686|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
154206687|NCT01045980|Vitamins|vitamins|mesh-list
154206688|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
154206689|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206690|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153953668|NCT02848443|Trifluridine|trifluridine|mesh-list
154206691|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154206693|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
154206694|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206695|NCT00388362|Sirolimus|sirolimus|mesh-list
154206696|NCT00388362|Prednisone|prednisone|mesh-list
154206697|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154206698|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
154206699|NCT00388362|Hormones|hormones|mesh-ancestor
154206700|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206701|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206702|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206703|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206704|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154206705|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206706|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154206707|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
154206715|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206717|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154206718|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
154206719|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154206720|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154206721|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154206722|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206723|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206724|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
154206725|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206726|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206727|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154206728|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154206729|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206730|NCT01324284|Lubiprostone|lubiprostone|mesh-list
154206731|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154206732|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206733|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206734|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154206735|NCT00387894|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154206736|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154206737|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206738|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206739|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434824|NCT00002197|Abacavir|abacavir|mesh-list
154206741|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206742|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154206743|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154206744|NCT00387426|Growth Substances|growth substances|mesh-ancestor
154206745|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206746|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
154206747|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154206748|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206749|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206750|NCT00387348|Dexetimide|dexetimide|mesh-list
154206751|NCT00387348|Citalopram|citalopram|mesh-list
154206752|NCT00387348|Escitalopram|escitalopram|mesh-list
154206753|NCT00387348|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154206754|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154206755|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206756|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206757|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206758|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
154206759|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206760|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154206761|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154206762|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
154206763|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
154206764|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206765|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154206766|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154206767|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
154206768|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154206769|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
154206770|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154206771|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154206772|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
154206786|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206787|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206788|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154206789|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154206790|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206791|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206792|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154206793|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
154206794|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206795|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206796|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154206797|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
154206798|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154206799|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154206800|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206801|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154206802|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
154206803|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206804|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154206805|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154206806|NCT00430352|Rituximab|rituximab|mesh-list
154206807|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206808|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206809|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
154206810|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206811|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206812|NCT01068405|Methotrexate|methotrexate|mesh-list
154206813|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154206814|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
154206815|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154206816|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206817|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154206818|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
154206819|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206820|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206821|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
154206822|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206823|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154206824|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206825|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
154206826|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206827|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154206829|NCT00429572|Melphalan|melphalan|mesh-list
154206830|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206831|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206832|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629678|NCT02046668|Diuretics|diuretics|mesh-ancestor
154206856|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206857|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206858|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
154206859|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206860|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206861|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154206862|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154206863|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
154206864|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
154206865|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154206866|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154206867|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206868|NCT00429416|Protective Agents|protective agents|mesh-ancestor
154206869|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
154206871|NCT00429182|Carboplatin|carboplatin|mesh-list
154206872|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154206873|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
154206874|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206875|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154206876|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154206877|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
154206878|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206879|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206880|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154206881|NCT00429104|Trastuzumab|trastuzumab|mesh-list
154206882|NCT00429104|Sargramostim|sargramostim|mesh-list
154206883|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206884|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206885|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
154206886|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206887|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
154206911|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
154206912|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206913|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206914|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154206915|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154206916|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154206917|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154206918|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154206919|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154206920|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154206922|NCT00301821|Hormones|hormones|mesh-ancestor
154206923|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154206924|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154206925|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154206926|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
154206927|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
154206928|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
154206929|NCT03976713|Bromides|bromides|mesh-list
154206930|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
154206931|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154206932|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
153749338|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
154206933|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154206934|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154206935|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154206936|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
154206937|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
154206938|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154206939|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
153629790|NCT02047175|Niacin|niacin|mesh-list
154206969|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154206970|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154206971|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
154206972|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154206974|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154206975|NCT00300885|Carboplatin|carboplatin|mesh-list
154206976|NCT00300885|Sorafenib|sorafenib|mesh-list
154206977|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154206978|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154206979|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
154206980|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
154207001|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207002|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
154207003|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
154207004|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207006|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154207007|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207008|NCT00300495|Amiodarone|amiodarone|mesh-list
154207009|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154207010|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
154207011|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154207012|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207013|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207014|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154207015|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154207016|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154207017|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207018|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154207019|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154207020|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154207021|NCT03979989|Tapentadol|tapentadol|mesh-list
154207022|NCT03979989|Omeprazole|omeprazole|mesh-list
154207023|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154207024|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207025|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154207026|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207027|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207028|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154207029|NCT03979989|Narcotics|narcotics|mesh-ancestor
154207030|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154207031|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207032|NCT03979989|Analgesics|analgesics|mesh-ancestor
154207033|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
154207047|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154207048|NCT00386022|Estrogens|estrogens|mesh-list
154207049|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
154207050|NCT00386022|Hormones|hormones|mesh-ancestor
154207051|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207052|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207053|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
154207054|NCT01068795|Enoxaparin|enoxaparin|mesh-list
154207055|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
154207056|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154207057|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154207058|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207059|NCT00286455|Alogliptin|alogliptin|mesh-list
154207060|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154207061|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207062|NCT00286455|Incretins|incretins|mesh-ancestor
154207063|NCT00286455|Hormones|hormones|mesh-ancestor
154207064|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207065|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154207066|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
154207067|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207068|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207069|NCT00385944|Clopidogrel|clopidogrel|mesh-list
154207070|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154207071|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154207072|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154207073|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154207074|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154207075|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
154207076|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207077|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207078|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207079|NCT00286221|Fentanyl|fentanyl|mesh-list
154207080|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154207081|NCT00286221|Narcotics|narcotics|mesh-ancestor
154207082|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154207083|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207084|NCT00286221|Analgesics|analgesics|mesh-ancestor
154207085|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
154207086|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207087|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154207088|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154207089|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
154207090|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
154207091|NCT00398112|Sunitinib|sunitinib|mesh-list
154207092|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207115|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207116|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207117|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
154207118|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207119|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207120|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
154207121|NCT01042314|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154207122|NCT00372528|Pregabalin|pregabalin|mesh-list
154207123|NCT00372528|Analgesics|analgesics|mesh-ancestor
154207124|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
154207125|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207126|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207127|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
154207128|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154207129|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207130|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207131|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154207132|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154207133|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153749454|NCT00538018|Telithromycin|telithromycin|mesh-list
153749455|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154207134|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154207135|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154207136|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
154207137|NCT00283803|Hormones|hormones|mesh-list
154207138|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154207139|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
154207140|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207141|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207142|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207143|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
154207144|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154207158|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154207159|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207160|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207161|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
154207162|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207163|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154207164|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154207165|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154207166|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154207167|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154207168|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154207170|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154207171|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207172|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207173|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154207174|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207175|NCT01044888|Heparin|heparin|mesh-list
154207176|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
154207177|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154207178|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154207179|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207180|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
154207181|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154207182|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154207183|NCT03742466|Prednisolone|prednisolone|mesh-list
154207184|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
154207185|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154207186|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
154207187|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154207188|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
154207189|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
154207190|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207191|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207192|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207193|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
154207194|NCT03742466|Hormones|hormones|mesh-ancestor
154207195|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207196|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154207197|NCT03742466|Protective Agents|protective agents|mesh-ancestor
154207198|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154207199|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207200|NCT01065285|Vaccines|vaccines|mesh-list
154207201|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
154207202|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207203|NCT01033526|Aspirin|aspirin|mesh-list
154207223|NCT00397488|Growth Substances|growth substances|mesh-ancestor
154207224|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207225|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
154207226|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207227|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749595|NCT00537121|Vorinostat|vorinostat|mesh-list
154207228|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207230|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154207231|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154207232|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154207233|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207234|NCT02900664|Trametinib|trametinib|mesh-list
154207235|NCT02900664|Spartalizumab|spartalizumab|mesh-list
154207236|NCT02900664|Nazartinib|nazartinib|mesh-list
154207237|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207238|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207239|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207240|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207241|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154207242|NCT02900664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207243|NCT01324596|Prednisolone|prednisolone|mesh-list
154207244|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154207245|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
154207246|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154207247|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
154207248|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
154207249|NCT01324596|Rituximab|rituximab|mesh-list
154207250|NCT01324596|Doxorubicin|doxorubicin|mesh-list
154207251|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154207252|NCT01324596|Vincristine|vincristine|mesh-list
154207253|NCT01324596|Bortezomib|bortezomib|mesh-list
154207254|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154207255|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
154207256|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207257|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
154207258|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207279|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
154207281|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207282|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207283|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154207284|NCT01324596|Protective Agents|protective agents|mesh-ancestor
154207285|NCT00424190|Vancomycin|vancomycin|mesh-list
154207286|NCT00424190|Ceftaroline|ceftaroline|mesh-list
154207287|NCT00424190|Aztreonam|aztreonam|mesh-list
154207288|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154207289|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207290|NCT00424190|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154207291|NCT02859012|Axitinib|axitinib|mesh-list
154207292|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207293|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207294|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207295|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207296|NCT00274287|Sargramostim|sargramostim|mesh-list
154207297|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
154207298|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207299|NCT01045278|Interferons|interferons|mesh-list
154207300|NCT01045278|Ribavirin|ribavirin|mesh-list
154207301|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
154207302|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
154207303|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153749672|NCT00537472|Bupivacaine|bupivacaine|mesh-list
154207304|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207305|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
154207306|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207307|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
154207308|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207309|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
154207310|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207311|NCT00423800|Interferons|interferons|mesh-list
154207312|NCT00423800|Ribavirin|ribavirin|mesh-list
154207313|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
154207314|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
154207337|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154207338|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154207339|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207341|NCT00282087|Docetaxel|docetaxel|mesh-list
154207342|NCT00282087|Doxorubicin|doxorubicin|mesh-list
154207343|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154207344|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
154207345|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207346|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207347|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
154207348|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
154207349|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
154207350|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154207351|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154207352|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154207353|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207354|NCT00281697|Bevacizumab|bevacizumab|mesh-list
154207355|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207356|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207357|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154207358|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154207359|NCT00281697|Growth Substances|growth substances|mesh-ancestor
154207360|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207361|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
154207362|NCT00232180|Eplerenone|eplerenone|mesh-list
154207374|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154207375|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207376|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
154207377|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154207378|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154207379|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
154207380|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
154207381|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
154207382|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207383|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207384|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
154207385|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154207386|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154207387|NCT00270231|Naltrexone|naltrexone|mesh-list
154207388|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154207389|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154207390|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207391|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
154207392|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207393|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154207394|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154207395|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154207396|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
154207397|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207398|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154207399|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154207400|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207401|NCT00258856|Vaccines|vaccines|mesh-list
154207402|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
154207403|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207404|NCT00269919|Risperidone|risperidone|mesh-list
154207405|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154207406|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
154207407|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207408|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207409|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207410|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154207411|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154207412|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154207413|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154207414|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154207415|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
154207416|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
154207417|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207418|NCT00257920|Vitamins|vitamins|mesh-ancestor
154207419|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
154207420|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154207422|NCT00268983|Rituximab|rituximab|mesh-list
154207423|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
154207424|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154207425|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207426|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207437|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154207438|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207439|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207440|NCT01070511|Urological Agents|urological agents|mesh-ancestor
154207441|NCT01070667|Dronedarone|dronedarone|mesh-list
154207442|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154207443|NCT00257608|Bevacizumab|bevacizumab|mesh-list
154207444|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154207445|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207446|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207447|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154207448|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154207449|NCT00257608|Growth Substances|growth substances|mesh-ancestor
154207450|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207451|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
154207452|NCT00257608|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154207453|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207454|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207455|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207456|NCT00231478|Granisetron|granisetron|mesh-list
154207457|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
154207458|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
154207459|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207460|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207461|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207462|NCT00231478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154207463|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153749982|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
154207464|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
154207465|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207466|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207467|NCT00207142|Ritonavir|ritonavir|mesh-list
154207468|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154207469|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154207470|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154207471|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
154207472|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207473|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207474|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154207475|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154207476|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
154207477|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207478|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154207479|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154207480|NCT00268905|Carboplatin|carboplatin|mesh-list
154207481|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256423|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154207482|NCT00206518|Docetaxel|docetaxel|mesh-list
154207483|NCT00206518|Doxorubicin|doxorubicin|mesh-list
154207484|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154207485|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
154207486|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207487|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
154207488|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
154207489|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
154207490|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207491|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154207500|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
154207501|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154207502|NCT00206440|Esomeprazole|esomeprazole|mesh-list
154207503|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154207504|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207505|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154207507|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207508|NCT00268437|Carboplatin|carboplatin|mesh-list
154207509|NCT00268437|Pemetrexed|pemetrexed|mesh-list
154207510|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207511|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207512|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207513|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154207514|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154207515|NCT00423488|Simvastatin|simvastatin|mesh-list
154207516|NCT00423488|Ezetimibe|ezetimibe|mesh-list
154207517|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154207518|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154207519|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
154207520|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207521|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154207522|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154207523|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207524|NCT00404066|Dexamethasone|dexamethasone|mesh-list
154207525|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
154207526|NCT00404066|Docetaxel|docetaxel|mesh-list
154207527|NCT00404066|Doxorubicin|doxorubicin|mesh-list
154207528|NCT00404066|Trastuzumab|trastuzumab|mesh-list
154207529|NCT00404066|Lapatinib|lapatinib|mesh-list
154207530|NCT00404066|Lenograstim|lenograstim|mesh-list
154207531|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207532|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
154207533|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207534|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207535|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154207536|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
154207537|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207538|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207539|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154207540|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154207541|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
154207542|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
154207543|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207544|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207545|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
154207546|NCT00404066|Hormones|hormones|mesh-ancestor
154207547|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207548|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154207549|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
154207550|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
154207551|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
154207552|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154207553|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154207554|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154207555|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207556|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207557|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154207558|NCT00404066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154207559|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207576|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153750064|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207577|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207578|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154207579|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154207580|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207583|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154207584|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207585|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154207586|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154207587|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207588|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207589|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
154207590|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207591|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
154207592|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207593|NCT00384930|Tadalafil|tadalafil|mesh-list
154207594|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
154207595|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154207596|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154207597|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207598|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207599|NCT00384930|Urological Agents|urological agents|mesh-ancestor
154207600|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
154207601|NCT00423098|Prednisone|prednisone|mesh-list
154207602|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
154207603|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154207604|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154207605|NCT00423098|Prednisolone|prednisolone|mesh-list
154207606|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
154207607|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154207608|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
154207609|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154207610|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
154207611|NCT00423098|Hormones|hormones|mesh-ancestor
154207612|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207613|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207614|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154207615|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207616|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154207617|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154207618|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
153630467|NCT00006018|Paclitaxel|paclitaxel|mesh-list
154207632|NCT01042704|Lenalidomide|lenalidomide|mesh-list
154207633|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153750199|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207634|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154207635|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
154207636|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
154207637|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207638|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207639|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207640|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
154207641|NCT01042704|Hormones|hormones|mesh-ancestor
154207642|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207643|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154207644|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207645|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154207646|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154207647|NCT01042704|Analgesics|analgesics|mesh-ancestor
154207648|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
154207649|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207650|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154207651|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154207652|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207653|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154207654|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154207655|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207657|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
154207658|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154207659|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154207660|NCT01042704|Growth Substances|growth substances|mesh-ancestor
154207661|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
154207662|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207663|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154207664|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
154207665|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154207666|NCT00750698|Entinostat|entinostat|mesh-list
154207667|NCT00750698|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154207668|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207669|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207670|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207671|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207672|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154207673|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
154207674|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
154207675|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154207676|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154207677|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207678|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207679|NCT01046838|Urological Agents|urological agents|mesh-ancestor
154207680|NCT01042782|Everolimus|everolimus|mesh-list
154207681|NCT01042782|Mitomycin|mitomycin|mesh-list
154207691|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154207692|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154207694|NCT00411788|Trastuzumab|trastuzumab|mesh-list
154207695|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207696|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207697|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154207698|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207699|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154207700|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
154207701|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207702|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
154207703|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750289|NCT00190632|Analgesics|analgesics|mesh-ancestor
154207704|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154207705|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207706|NCT01040936|Atorvastatin|atorvastatin|mesh-list
154207707|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154207708|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154207709|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
154207710|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207711|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154207712|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154207713|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207714|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154207715|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154207716|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
154207717|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207718|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207719|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154207720|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154207721|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154207722|NCT01041170|Rimonabant|rimonabant|mesh-list
154207723|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154207724|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154207725|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154207726|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207727|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207729|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207730|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207731|NCT01041482|Sorafenib|sorafenib|mesh-list
154207732|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207733|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207734|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207735|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207736|NCT00422942|Rituximab|rituximab|mesh-list
154207737|NCT00422942|Methotrexate|methotrexate|mesh-list
154207738|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207739|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207740|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
154207741|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207742|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207743|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154207744|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
154207762|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207763|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207764|NCT00422162|Analgesics|analgesics|mesh-ancestor
154207765|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
154256425|NCT01265810|Calcium|calcium|mesh-list
154207766|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207767|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750410|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
154207768|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154207769|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
154207770|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154207772|NCT00411632|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154207773|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207774|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207775|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207776|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207777|NCT00422084|Artesunate|artesunate|mesh-list
154207778|NCT00422084|Lumefantrine|lumefantrine|mesh-list
154207779|NCT00422084|Artemether|artemether|mesh-list
154207780|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154207781|NCT00422084|Pyronaridine|pyronaridine|mesh-list
154207782|NCT00422084|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154207783|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
154207784|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154207785|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154207786|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207787|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207788|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
154207789|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
154207790|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154207791|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
154207792|NCT00421928|Oxycodone|oxycodone|mesh-list
154207793|NCT00421928|Tapentadol|tapentadol|mesh-list
154207794|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154207795|NCT00421928|Narcotics|narcotics|mesh-ancestor
154207796|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154207797|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207798|NCT00421928|Analgesics|analgesics|mesh-ancestor
154207799|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
153954778|NCT00691912|Doxorubicin|doxorubicin|mesh-list
154207816|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207817|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154207818|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
154207819|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207820|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207821|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154207822|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207823|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154207824|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
154207825|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154207826|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207827|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154207828|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154207829|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
154207830|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154207831|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207832|NCT00372060|Pioglitazone|pioglitazone|mesh-list
154207833|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154207834|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154207835|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207836|NCT00372060|Incretins|incretins|mesh-ancestor
154207837|NCT00372060|Hormones|hormones|mesh-ancestor
154207838|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154207839|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154207840|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
154207841|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207842|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207843|NCT01043172|Gemcitabine|gemcitabine|mesh-list
154207844|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154207845|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
154207846|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207847|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207848|NCT01045434|Omeprazole|omeprazole|mesh-list
154207849|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154207850|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154207851|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154207852|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207853|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435265|NCT00002798|Analgesics|analgesics|mesh-ancestor
154207854|NCT01043484|Bevacizumab|bevacizumab|mesh-list
154207855|NCT01043484|Capecitabine|capecitabine|mesh-list
154207856|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207874|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154207875|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
154207876|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207877|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207879|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154207880|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154207881|NCT00267969|Ustekinumab|ustekinumab|mesh-list
154207882|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
154207883|NCT00280293|Lamotrigine|lamotrigine|mesh-list
154207884|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
154207885|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154207886|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207887|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207888|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154207889|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207890|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154207891|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154207892|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154207893|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154207894|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154207895|NCT00421148|Bromides|bromides|mesh-list
154207896|NCT00421148|Rocuronium|rocuronium|mesh-list
154207897|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
154207898|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154207899|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154207900|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154207901|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207902|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207903|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154207904|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154207905|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
154207906|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154207907|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207908|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154207909|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
154207910|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154207911|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154207912|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154207913|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
154207914|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154207924|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154207925|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207926|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154207927|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154207928|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154207929|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154207930|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154207931|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154207932|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154207934|NCT00403130|Bevacizumab|bevacizumab|mesh-list
154207935|NCT00403130|Gemcitabine|gemcitabine|mesh-list
154207936|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154207937|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207938|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
154207939|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
154207940|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
154207941|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207942|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154207943|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154207944|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154207945|NCT00403130|Growth Substances|growth substances|mesh-ancestor
154207946|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153954933|NCT02624830|Glyburide|glyburide|mesh-list
154207947|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
154207948|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154207950|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
154207951|NCT01039610|Linezolid|linezolid|mesh-list
154207952|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154207953|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750558|NCT00544999|Everolimus|everolimus|mesh-list
154207954|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154207955|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154207956|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207957|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207958|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207959|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154207960|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154207961|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207962|NCT00267189|Cyclosporine|cyclosporine|mesh-list
154207963|NCT00267189|Everolimus|everolimus|mesh-list
154207964|NCT00267189|Azathioprine|azathioprine|mesh-list
154207965|NCT00267189|Tacrolimus|tacrolimus|mesh-list
154207966|NCT00267189|Cyclosporins|cyclosporins|mesh-list
154207967|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154207968|NCT00267189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154207969|NCT00267189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154207970|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154207971|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154207972|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154207973|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
154207974|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154207975|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154207976|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154207977|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
154207978|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154207979|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154207980|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
154208005|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
154208006|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154208007|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
154208009|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154208010|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208011|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154208012|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208013|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208014|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208015|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208016|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
154208017|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
154208018|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208019|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208020|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208021|NCT00371826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154208022|NCT00371826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154208023|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154208024|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154208025|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
154208026|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154208027|NCT03993366|Pramlintide|pramlintide|mesh-list
154208028|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
154208029|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154208050|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
154208051|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154208053|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
154208054|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154208055|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154208056|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154208057|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154208058|NCT00395850|Disulfiram|disulfiram|mesh-list
154208059|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154208060|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154208061|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208062|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208063|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154208064|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208065|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208066|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
154208067|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208068|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154208069|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154208070|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154208071|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208072|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208073|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208074|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208075|NCT00401258|Analgesics|analgesics|mesh-ancestor
154208076|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
154208077|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208078|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
154208079|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208080|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
154208081|NCT00380874|Pregabalin|pregabalin|mesh-list
154208082|NCT00380874|Analgesics|analgesics|mesh-ancestor
154208083|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
154208084|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208096|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208097|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154208098|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208099|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208101|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154208102|NCT00411554|Voglibose|voglibose|mesh-list
154208103|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154208104|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208105|NCT00411554|Incretins|incretins|mesh-ancestor
154208106|NCT00411554|Hormones|hormones|mesh-ancestor
154208107|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154208108|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154208109|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
154208110|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208111|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208112|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154208113|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
154208114|NCT00411554|Vitamins|vitamins|mesh-ancestor
154208115|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
154208116|NCT00380718|Pemetrexed|pemetrexed|mesh-list
154208117|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208118|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208119|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208120|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154208121|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154208122|NCT00380250|Lubiprostone|lubiprostone|mesh-list
154208123|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154208124|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208125|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208126|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
154208127|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154208128|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208129|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154208130|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
154208131|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154208132|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208133|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208134|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208135|NCT00395694|Lamotrigine|lamotrigine|mesh-list
154208136|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
154208137|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154208138|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208139|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208140|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154208141|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208142|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154208143|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154208144|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208180|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154208181|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
154208182|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208219|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208220|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208232|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208233|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154256426|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153750728|NCT00191178|Protamines|protamines|mesh-list
154256427|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256428|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
154208234|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208235|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
154208236|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208237|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208238|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154208239|NCT00377676|Bromocriptine|bromocriptine|mesh-list
154208240|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154208241|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154208242|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
154208243|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154208244|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208245|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
154208246|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
154208247|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208248|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208249|NCT00377520|Pemetrexed|pemetrexed|mesh-list
154208250|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208251|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208252|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208253|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154208254|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154208255|NCT00377364|Acetaminophen|acetaminophen|mesh-list
154208256|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154208257|NCT00377364|Analgesics|analgesics|mesh-ancestor
154208258|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
154208259|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208260|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208261|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
154208262|NCT00365508|Nicotine|nicotine|mesh-list
154208263|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154208264|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
154208265|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208266|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208267|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154208268|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154208269|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
154208270|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208271|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208272|NCT00365352|Gabapentin|gabapentin|mesh-list
154208273|NCT00365352|Analgesics|analgesics|mesh-ancestor
154208274|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
154208275|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208276|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208277|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
154208278|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154208279|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154208280|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208281|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208282|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154208283|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154208284|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208299|NCT00410072|Entecavir|entecavir|mesh-list
154208300|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
154208301|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208302|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154208303|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154208304|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208305|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208306|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154208307|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154208308|NCT00409838|Methotrexate|methotrexate|mesh-list
154208309|NCT00409838|Abatacept|abatacept|mesh-list
154208310|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154208311|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
154208312|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154208313|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208314|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154208315|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
154208317|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208318|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208319|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208320|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154208321|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208322|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
154208323|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208324|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154208325|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154208326|NCT00409838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154208327|NCT01041872|Lidocaine|lidocaine|mesh-list
154208328|NCT01041872|Propofol|propofol|mesh-list
154208329|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
154208330|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
154208331|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208332|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208333|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
154208334|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208335|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154208336|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154208337|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154208338|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208339|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208340|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154208341|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154208342|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
154208343|NCT00399542|Lubiprostone|lubiprostone|mesh-list
153631197|NCT00006216|Ganciclovir|ganciclovir|mesh-list
154208361|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208362|NCT01042028|Capecitabine|capecitabine|mesh-list
154208363|NCT01042028|Irinotecan|irinotecan|mesh-list
153751016|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154208364|NCT01042028|Cetuximab|cetuximab|mesh-list
154208365|NCT01042028|Everolimus|everolimus|mesh-list
154208366|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
154208367|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154208368|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
154208369|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208370|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208371|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154208372|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154208373|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208374|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154208375|NCT01042028|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154208376|NCT01042028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154208377|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208378|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
154208379|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208380|NCT03993626|Nivolumab|nivolumab|mesh-list
154208381|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154208382|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208383|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154208384|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208385|NCT00398216|Edoxaban|edoxaban|mesh-list
154208386|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
154208387|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
154208388|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154208389|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
154208390|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208391|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208392|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
154208393|NCT00398138|Sargramostim|sargramostim|mesh-list
154208394|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
154208395|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
154208396|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208397|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154208398|NCT00397982|Sirolimus|sirolimus|mesh-list
154208399|NCT00397982|Bevacizumab|bevacizumab|mesh-list
154208400|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154208401|NCT00397982|Temsirolimus|temsirolimus|mesh-list
154208402|NCT00397982|MTOR Inhibitors|mtor inhibitors|mesh-list
154208429|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208430|NCT00397046|Neratinib|neratinib|mesh-list
154208431|NCT00397046|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154208432|NCT00397046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154208433|NCT00397046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208434|NCT00397046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208435|NCT01042574|Clevidipine|clevidipine|mesh-list
154208436|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154208437|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208438|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208439|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154208440|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208441|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
154208442|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154208443|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154208444|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
154208445|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208446|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154208447|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154208448|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208449|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208460|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154208461|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208462|NCT01042730|Pitavastatin|pitavastatin|mesh-list
154208463|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154208464|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154208465|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153955454|NCT02622334|Latanoprost|latanoprost|mesh-list
154208466|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
154208467|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208468|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208469|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154208470|NCT00396812|Rituximab|rituximab|mesh-list
154208471|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154208472|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208473|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
154208474|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208475|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208476|NCT01566578|Mitogens|mitogens|mesh-list
154208477|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
154208478|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208479|NCT01040234|Bupivacaine|bupivacaine|mesh-list
154208480|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
154208481|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
154208482|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208483|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208484|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
154208485|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208486|NCT00396656|Atenolol|atenolol|mesh-list
154208487|NCT00396656|Valsartan|valsartan|mesh-list
154208488|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154208489|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154208490|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154208491|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154208492|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208493|NCT00396656|Diuretics|diuretics|mesh-ancestor
154208494|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
154208495|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208496|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154208497|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208498|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154208499|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
154208500|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
154208501|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208502|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154208503|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154208504|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154208505|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
154208506|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208507|NCT00408434|Efatutazone|efatutazone|mesh-list
154208508|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208509|NCT01040312|Cisplatin|cisplatin|mesh-list
154208510|NCT01040312|Carboplatin|carboplatin|mesh-list
154208511|NCT01040312|Nedaplatin|nedaplatin|mesh-list
154208512|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208513|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153631366|NCT00006276|Paclitaxel|paclitaxel|mesh-list
154208529|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154208530|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154208531|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154208532|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154208533|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
154208534|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208535|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208536|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208537|NCT01043666|Urological Agents|urological agents|mesh-ancestor
154208538|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154208539|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153955544|NCT00864682|Lidocaine|lidocaine|mesh-list
154208540|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
154208541|NCT00394472|Lesogaberan|lesogaberan|mesh-list
154208542|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154208543|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154208544|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
154208545|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
154208546|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208547|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208548|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208549|NCT00395486|Atorvastatin|atorvastatin|mesh-list
154208550|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154208551|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154208552|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154208553|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
154208554|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208555|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154208556|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154208557|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208558|NCT01043744|Lumefantrine|lumefantrine|mesh-list
154208559|NCT01043744|Artemether|artemether|mesh-list
154208560|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154208561|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
154208562|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154208563|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153751454|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154208564|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208565|NCT00395018|Entecavir|entecavir|mesh-list
154208566|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
154208567|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208568|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
154208569|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154208570|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154208571|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208572|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
154208600|NCT00256750|Cyclosporins|cyclosporins|mesh-list
154208601|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208602|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208603|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208604|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
154208605|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208606|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
154208607|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208608|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208609|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208610|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154208611|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154208612|NCT00256750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154208613|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208614|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
154208615|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
154208616|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
154208617|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
154208618|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
154208619|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154208620|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208621|NCT00203476|Niacin|niacin|mesh-list
154208659|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208660|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154208674|NCT00256282|Sargramostim|sargramostim|mesh-list
154208675|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208676|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
154208677|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
154208678|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
154208679|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208680|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154208681|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
154208682|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208684|NCT00266877|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154208685|NCT00266877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154208686|NCT00266877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208687|NCT00266877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208688|NCT00256204|Rasagiline|rasagiline|mesh-list
154208689|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154208690|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208691|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208692|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153955676|NCT00593554|Fludarabine|fludarabine|mesh-list
154208693|NCT00256204|Protective Agents|protective agents|mesh-ancestor
153751456|NCT00551590|Incretins|incretins|mesh-ancestor
154208694|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208696|NCT03972358|Mifepristone|mifepristone|mesh-list
154208697|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154208698|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
154208699|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154208700|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208701|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154208702|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154208703|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
154208704|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154208705|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154208706|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154208707|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154208708|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
154208709|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154208710|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154208711|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
154208712|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154208713|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
154208714|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154208715|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154208716|NCT01073332|Antioxidants|antioxidants|mesh-list
154208717|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208718|NCT01073332|Protective Agents|protective agents|mesh-ancestor
154208719|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208720|NCT03972046|Trametinib|trametinib|mesh-list
154208721|NCT03972046|Dabrafenib|dabrafenib|mesh-list
153631580|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
154208732|NCT01074346|Interferon-beta|interferon-beta|mesh-list
154208733|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
154208734|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208735|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
154208736|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154208737|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
154208738|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208739|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154208740|NCT00278889|Leucovorin|leucovorin|mesh-list
154208741|NCT00278889|Bevacizumab|bevacizumab|mesh-list
154208742|NCT00278889|Fluorouracil|fluorouracil|mesh-list
154208743|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
154208744|NCT00278889|Cediranib|cediranib|mesh-list
153751584|NCT00552682|Analgesics|analgesics|mesh-ancestor
154208745|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154208746|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208747|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154208748|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154208749|NCT00278889|Growth Substances|growth substances|mesh-ancestor
154208750|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208751|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
154208752|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
154208753|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208754|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154208755|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154208756|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
154208757|NCT00278889|Antidotes|antidotes|mesh-ancestor
154208758|NCT00278889|Protective Agents|protective agents|mesh-ancestor
154208760|NCT00278889|Vitamins|vitamins|mesh-ancestor
154208761|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
154208762|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154208763|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208764|NCT01070745|Ibuprofen|ibuprofen|mesh-list
154208765|NCT01070745|Indomethacin|indomethacin|mesh-list
154208766|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154208767|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154208768|NCT01070745|Analgesics|analgesics|mesh-ancestor
154208769|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
154208770|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208771|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208772|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154208773|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154208774|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154208775|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208776|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208777|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
154208778|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
154208779|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154208780|NCT01071057|Morphine|morphine|mesh-list
154208781|NCT01071057|Naloxone|naloxone|mesh-list
154208782|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154208783|NCT01071057|Narcotics|narcotics|mesh-ancestor
154208784|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208785|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208786|NCT01071057|Analgesics|analgesics|mesh-ancestor
154208787|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
154208788|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208806|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154208807|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
154208808|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208809|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154208810|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154208811|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154208812|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208813|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
154208814|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208815|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208816|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154208817|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154208818|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751710|NCT00162695|Etoposide|etoposide|mesh-list
154208819|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154208820|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154208821|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154208822|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208823|NCT00266409|Alprazolam|alprazolam|mesh-list
154208824|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154208825|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208826|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208827|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154208828|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154208829|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154208830|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
154208831|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
154208832|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208833|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208834|NCT00265785|Pemetrexed|pemetrexed|mesh-list
154208835|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208836|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208837|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208838|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154208839|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154208840|NCT02532153|Ketamine|ketamine|mesh-list
154208841|NCT02532153|Analgesics|analgesics|mesh-ancestor
154208842|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
154208843|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208844|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208881|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
154208882|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
154208883|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153631765|NCT00006348|Ondansetron|ondansetron|mesh-list
154208896|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154208897|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154208898|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208899|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
154208900|NCT00251745|Lansoprazole|lansoprazole|mesh-list
154208901|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154208902|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154208903|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154208904|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208905|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208906|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
154208907|NCT00255190|Lansoprazole|lansoprazole|mesh-list
154208908|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154208909|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154208910|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154208911|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208912|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208913|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154208914|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154208915|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154208916|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208918|NCT01049646|Giapreza|giapreza|mesh-list
154208919|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
154208920|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154208921|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154208922|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
154208923|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208924|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208925|NCT02286414|Vitamins|vitamins|mesh-list
154208926|NCT02286414|Vitamin K|vitamin k|mesh-list
154208927|NCT02286414|Warfarin|warfarin|mesh-list
154208928|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
154208929|NCT02286414|Dabigatran|dabigatran|mesh-list
154208930|NCT02286414|Apixaban|apixaban|mesh-list
154208931|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
154208932|NCT02286414|Fluindione|fluindione|mesh-list
154208933|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
154208934|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208935|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
154208936|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154208937|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
154208938|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154208939|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
154208940|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154208941|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208942|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154208943|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154208944|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
154208945|NCT02286414|Coagulants|coagulants|mesh-ancestor
154208946|NCT00255034|Ribavirin|ribavirin|mesh-list
153631806|NCT00005944|Leucovorin|leucovorin|mesh-list
154208964|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208965|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154208966|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
154208967|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154208968|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208969|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154208970|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154208971|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154208973|NCT01048086|Isotretinoin|isotretinoin|mesh-list
154208974|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208975|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
154208976|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
154208977|NCT03830892|Nicotine|nicotine|mesh-list
154208978|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154208979|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
154208980|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154208981|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208982|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154208983|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154208984|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
154208985|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154208986|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208987|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
154208988|NCT01049880|Gemcitabine|gemcitabine|mesh-list
154208989|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154208990|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
154208991|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154208992|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154208993|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
154208994|NCT01049880|Protective Agents|protective agents|mesh-ancestor
154208995|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154208996|NCT01049880|Vitamins|vitamins|mesh-ancestor
154208997|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
154208998|NCT00253630|Vorinostat|vorinostat|mesh-list
154208999|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209000|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154209001|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209002|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209003|NCT00358644|Decitabine|decitabine|mesh-list
154209020|NCT03990480|Valsartan|valsartan|mesh-list
154209021|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154209022|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154209023|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209024|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209025|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154209026|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209027|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
154209028|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154209029|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154209030|NCT00369486|Triamcinolone|triamcinolone|mesh-list
154209031|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154209032|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154209033|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154209034|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154209035|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
154209036|NCT00369486|Hormones|hormones|mesh-ancestor
154209037|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209038|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209039|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209040|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
154209041|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209042|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209043|NCT00363480|Fluticasone|fluticasone|mesh-list
154209044|NCT00363480|Albuterol|albuterol|mesh-list
154209045|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154209046|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154209047|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154209048|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
154209049|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209050|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209051|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154209052|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
154209053|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
154209054|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154209055|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154209056|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154209057|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154209058|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
154209059|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209060|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209078|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209079|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154209080|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154209081|NCT01073644|Growth Substances|growth substances|mesh-ancestor
154209082|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209083|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
154209084|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154209085|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209086|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209087|NCT03992586|Methamphetamine|methamphetamine|mesh-list
154209088|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154209089|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209090|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
154209091|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
154209092|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209094|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209095|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209096|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
154209097|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154209098|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154209099|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209100|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154209101|NCT00221104|Pravastatin|pravastatin|mesh-list
154209102|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154209103|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154209104|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
154209105|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209106|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153752201|NCT05781698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154209107|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154209108|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209110|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154209111|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209112|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154209113|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209114|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
154209115|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209116|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
154209117|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209118|NCT01071928|Docetaxel|docetaxel|mesh-list
154209119|NCT01071928|Vadimezan|vadimezan|mesh-list
154209131|NCT00187486|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154209132|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154209134|NCT00220636|Aripiprazole|aripiprazole|mesh-list
154209135|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
154209136|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154209137|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154209138|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154209139|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154209140|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209141|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
153956133|NCT00866788|Omalizumab|omalizumab|mesh-list
154209142|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
154209143|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209144|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209145|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154209146|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154209147|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
154209148|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154209149|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154209150|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154209151|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154209152|NCT00362232|Enoxaparin|enoxaparin|mesh-list
154209153|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
154209154|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
154209155|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154209156|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
154209157|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154209158|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
154209159|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209160|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209161|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
154209162|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154209163|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154209164|NCT01048554|Bevacizumab|bevacizumab|mesh-list
154209165|NCT01048554|Temozolomide|temozolomide|mesh-list
154209166|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154209167|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209168|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154209169|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154209170|NCT01048554|Growth Substances|growth substances|mesh-ancestor
154209171|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209172|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
154209173|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154209174|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
154209175|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209176|NCT00219544|Pregabalin|pregabalin|mesh-list
154209177|NCT00219544|Analgesics|analgesics|mesh-ancestor
153435796|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
154209178|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
154209179|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209180|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209188|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154209190|NCT00357552|Ritonavir|ritonavir|mesh-list
154209191|NCT00357552|Lopinavir|lopinavir|mesh-list
154209192|NCT00357552|Tenofovir|tenofovir|mesh-list
154209193|NCT00357552|Emtricitabine|emtricitabine|mesh-list
154209194|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154209195|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154209196|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154209197|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
154209198|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209199|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209200|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154209201|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154209202|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
154209203|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209204|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154209205|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154209206|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154209207|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154209208|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
154209209|NCT00187096|Fludarabine|fludarabine|mesh-list
154209210|NCT00187096|Etoposide|etoposide|mesh-list
154209211|NCT00187096|Interleukin-2|interleukin-2|mesh-list
154209212|NCT00187096|Clofarabine|clofarabine|mesh-list
154209213|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209214|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
154209215|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209216|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154209217|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154209218|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
154209219|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209220|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209221|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154209222|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154209223|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
154209224|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154209225|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154209226|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154209227|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209228|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154209230|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
154209231|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209232|NCT00357396|Melphalan|melphalan|mesh-list
154209233|NCT00357396|Busulfan|busulfan|mesh-list
154209234|NCT00357396|Thiotepa|thiotepa|mesh-list
154209235|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154209236|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
154209237|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209238|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752517|NCT03557918|Tremelimumab|tremelimumab|mesh-list
154209239|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154209240|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209241|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
154209242|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209243|NCT00186628|Acetaminophen|acetaminophen|mesh-list
154209244|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
154209245|NCT00186628|Promethazine|promethazine|mesh-list
154209246|NCT00186628|Cyclosporine|cyclosporine|mesh-list
154209247|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
154209248|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
154209277|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209278|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
154209279|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154209280|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
154209281|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
154209282|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154209283|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
154209284|NCT00186628|Hormones|hormones|mesh-ancestor
154209285|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209286|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154209287|NCT00186628|Protective Agents|protective agents|mesh-ancestor
154256429|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154209288|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154209289|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154209290|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154209291|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154209292|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
154209293|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
154209294|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154209295|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
154209296|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
154209297|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209310|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209311|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
154209312|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209313|NCT01050036|Busulfan|busulfan|mesh-list
154209314|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
154209315|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209316|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209317|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
154209318|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209319|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154209320|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209321|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154209322|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154209323|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154209324|NCT00357006|Estradiol|estradiol|mesh-list
154209325|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154209326|NCT00357006|Estrogens|estrogens|mesh-ancestor
154209327|NCT00357006|Hormones|hormones|mesh-ancestor
154209328|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209329|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209330|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154209331|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
154209332|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154209333|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154209334|NCT01050114|Oxybutynin|oxybutynin|mesh-list
154209335|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154209336|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154209337|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209338|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209339|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154209340|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209341|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209342|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
154209343|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209344|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
154209345|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
154209346|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154209347|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154209348|NCT01050114|Urological Agents|urological agents|mesh-ancestor
154209349|NCT01048632|Oxandrolone|oxandrolone|mesh-list
154209350|NCT01048632|Androgens|androgens|mesh-ancestor
154209351|NCT01048632|Hormones|hormones|mesh-ancestor
154209352|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209353|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209354|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
154209355|NCT00165646|Rabeprazole|rabeprazole|mesh-list
154209356|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154209357|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154209358|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154209379|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
154209380|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154209381|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
154209382|NCT01050270|Protective Agents|protective agents|mesh-ancestor
154209383|NCT01050270|Antidotes|antidotes|mesh-ancestor
154209384|NCT00367770|Bosentan|bosentan|mesh-list
154209385|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154209386|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154209387|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209388|NCT00185614|Cyclosporine|cyclosporine|mesh-list
154209389|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
154209390|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
154209391|NCT00185614|Melphalan|melphalan|mesh-list
154209392|NCT00185614|Cyclosporins|cyclosporins|mesh-list
154209393|NCT00185614|Lenograstim|lenograstim|mesh-list
153752741|NCT01075971|Analgesics|analgesics|mesh-ancestor
154209394|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209395|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
154209396|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209397|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154209398|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154209399|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
154209400|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209401|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209402|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154209403|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154209404|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209405|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
154209406|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209407|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
154209408|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154209409|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154209410|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154209411|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
154209412|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154209413|NCT01075438|Vaccines|vaccines|mesh-list
154209414|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154209429|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154209430|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154209431|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209432|NCT01050348|Atorvastatin|atorvastatin|mesh-list
154209433|NCT01050348|Calcium|calcium|mesh-list
154209434|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154209435|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209436|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154209437|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154209438|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
154209439|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209440|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154209441|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154209442|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209443|NCT01053390|Leucovorin|leucovorin|mesh-list
154209444|NCT01053390|Fluorouracil|fluorouracil|mesh-list
154209445|NCT01053390|Epirubicin|epirubicin|mesh-list
154209446|NCT01053390|Somatostatin|somatostatin|mesh-list
154209447|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209448|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
154209449|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209450|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154209451|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209452|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
154209453|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209454|NCT01053390|Antidotes|antidotes|mesh-ancestor
154209455|NCT01053390|Protective Agents|protective agents|mesh-ancestor
154209456|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
154209457|NCT01053390|Vitamins|vitamins|mesh-ancestor
154209458|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
154209459|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154209460|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153752877|NCT00193323|Docetaxel|docetaxel|mesh-list
154209461|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154209462|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209463|NCT01053390|Hormones|hormones|mesh-ancestor
154209464|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209465|NCT00356148|Ampicillin|ampicillin|mesh-list
154209466|NCT00356148|Sulbactam|sulbactam|mesh-list
154209467|NCT00356148|Sultamicillin|sultamicillin|mesh-list
154209468|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154209469|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209470|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154209471|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209472|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209473|NCT00361218|Citalopram|citalopram|mesh-list
154209474|NCT00361218|Escitalopram|escitalopram|mesh-list
154209475|NCT00361218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154209476|NCT00361218|Serotonin|serotonin|mesh-list
154209504|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154209505|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154209506|NCT02534610|Analgesics|analgesics|mesh-ancestor
154256430|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
154209507|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
154209508|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209509|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209510|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154209511|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154209512|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154209513|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154209514|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209515|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209516|NCT01050426|Leucovorin|leucovorin|mesh-list
154209517|NCT01050426|Cetuximab|cetuximab|mesh-list
154209518|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
154209519|NCT01050426|Antidotes|antidotes|mesh-ancestor
154209520|NCT01050426|Protective Agents|protective agents|mesh-ancestor
154209543|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
154209544|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154209545|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209546|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154209547|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154209548|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154209549|NCT01077466|Natalizumab|natalizumab|mesh-list
154209550|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
154209551|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209552|NCT00160654|Levetiracetam|levetiracetam|mesh-list
154209553|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
154209554|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
154209556|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209557|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154209558|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154209559|NCT01582672|Growth Substances|growth substances|mesh-ancestor
154209560|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209561|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
154209562|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154209563|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209564|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209565|NCT00366678|Vaccines|vaccines|mesh-list
154209566|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154209567|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
154209568|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209569|NCT01049178|Silymarin|silymarin|mesh-list
154209570|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
153539938|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209586|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154209587|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154209588|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154209589|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209590|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209591|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154209592|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
154209593|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154209594|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209595|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154209596|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209598|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154209599|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
154209600|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209601|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209602|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209604|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154209605|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
154209606|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209607|NCT00373880|Cocaine|cocaine|mesh-list
154209608|NCT00373880|Aripiprazole|aripiprazole|mesh-list
154209609|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
154209610|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154209611|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154209612|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154209613|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154209614|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209615|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
154209616|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
154209617|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209619|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154209620|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154209621|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
154209622|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154209623|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154209624|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154209625|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154209626|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
154209627|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
154209628|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
154209640|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
154209641|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154209642|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209643|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154209644|NCT00265317|Sunitinib|sunitinib|mesh-list
154209645|NCT00265317|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154209646|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154209647|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209648|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209649|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209650|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154209651|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154209652|NCT00265317|Growth Substances|growth substances|mesh-ancestor
154209653|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209654|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
154209655|NCT00373490|Vorinostat|vorinostat|mesh-list
154209656|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209657|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154209658|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209659|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209660|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154209661|NCT00251589|Vorinostat|vorinostat|mesh-list
154209662|NCT00251589|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154209663|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154209664|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209665|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209666|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209667|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154209668|NCT00265239|Edaravone|edaravone|mesh-list
154209669|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154209670|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
154209671|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209672|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154209673|NCT00265239|Protective Agents|protective agents|mesh-ancestor
154209674|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209675|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
154209676|NCT00159874|Citric Acid|citric acid|mesh-list
154209677|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
154209678|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
154209679|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154209680|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
154209681|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
154209682|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209683|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
154209684|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154209685|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154209686|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209687|NCT00159874|Urological Agents|urological agents|mesh-ancestor
154209688|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
154209689|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
154209690|NCT00184054|Vitamins|vitamins|mesh-ancestor
154209691|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
153539939|NCT01536301|Analgesics|analgesics|mesh-ancestor
154209710|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154209711|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154209712|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154209713|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154209714|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
154209715|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209716|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209717|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209718|NCT00183274|Norepinephrine|norepinephrine|mesh-list
153436076|NCT00003944|Paclitaxel|paclitaxel|mesh-list
154209719|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154209720|NCT00183274|Serotonin|serotonin|mesh-list
154209721|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
154209722|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154209723|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154209724|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
154209725|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209726|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209727|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209728|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
154209729|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
154209730|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209731|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154209732|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154209733|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209734|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154209735|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
154209736|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154209737|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154209738|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
154209739|NCT00183196|Naltrexone|naltrexone|mesh-list
154209740|NCT00183196|Gabapentin|gabapentin|mesh-list
154209741|NCT00183196|Analgesics|analgesics|mesh-ancestor
154209742|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
154209743|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209744|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209745|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
154209746|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154209747|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153632610|NCT00006471|Protective Agents|protective agents|mesh-ancestor
154209760|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209761|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
154209762|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209763|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154209764|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
154209765|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154209766|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209767|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154209768|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209769|NCT00348816|Prednisone|prednisone|mesh-list
154209770|NCT00348816|Docetaxel|docetaxel|mesh-list
154209771|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209772|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
154209773|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
154209774|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
154209775|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209776|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154209777|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
154209778|NCT00348816|Hormones|hormones|mesh-ancestor
154209779|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209780|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209781|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154209782|NCT03989310|Manganese|manganese|mesh-list
154209783|NCT03989310|Paclitaxel|paclitaxel|mesh-list
154209784|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154209785|NCT03989310|Gemcitabine|gemcitabine|mesh-list
154209786|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154209787|NCT03989310|Antibodies|antibodies|mesh-list
154209788|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
154209789|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154209790|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209791|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
154209792|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
154209793|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
154209794|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209795|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
154209796|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209797|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154209798|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
154209799|NCT03989310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154209800|NCT03989310|Trace Elements|trace elements|mesh-ancestor
154209801|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
154209802|NCT03966898|Letrozole|letrozole|mesh-list
154209803|NCT03966898|Anastrozole|anastrozole|mesh-list
154209804|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154209805|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154209806|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154209807|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209808|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209809|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154209830|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154209831|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154209832|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154209833|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209834|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
154209835|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209837|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154209838|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154209839|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
154209840|NCT01073709|Acetaminophen|acetaminophen|mesh-list
154209841|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154209842|NCT01073709|Analgesics|analgesics|mesh-ancestor
154209843|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
154209844|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154209845|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209846|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
154209847|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154209848|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154209849|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154209850|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154209851|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209852|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209853|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209854|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154209855|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
154209856|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154209857|NCT01071291|Niacin|niacin|mesh-list
154209858|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
154209859|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154209860|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
154209861|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209881|NCT00149890|Cyclosporins|cyclosporins|mesh-list
154209882|NCT00149890|Basiliximab|basiliximab|mesh-list
154209883|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209884|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209885|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209886|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
154209887|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209888|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
154209889|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209890|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
154209891|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154209892|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154209894|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154209895|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209896|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209897|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
154209898|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154209899|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209900|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
154209901|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154209902|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154209903|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209904|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209905|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
153753261|NCT00176943|Imiquimod|imiquimod|mesh-list
154209906|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209907|NCT00171730|Pasireotide|pasireotide|mesh-list
154209908|NCT00171730|Hormones|hormones|mesh-ancestor
154209909|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209910|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209911|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
154209912|NCT00348348|Besifloxacin|besifloxacin|mesh-list
154256431|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256432|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209913|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154209914|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209915|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154209916|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632793|NCT00006747|Cytarabine|cytarabine|mesh-list
154209939|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154209940|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154209941|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154209942|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154209943|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209944|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154209945|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154209946|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154209947|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
154209948|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
154209949|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
154209950|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154209951|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154209952|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154209953|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154209954|NCT01055964|Tacrolimus|tacrolimus|mesh-list
154209955|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154209956|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
154209957|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209958|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154209959|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209960|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209961|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154209962|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154209963|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
154209964|NCT01056042|Gestodene|gestodene|mesh-list
154209965|NCT01056042|Estradiol|estradiol|mesh-list
154209966|NCT01056042|Estrogens|estrogens|mesh-ancestor
154209967|NCT01056042|Hormones|hormones|mesh-ancestor
154209968|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154209969|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209970|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154209972|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154209988|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
154209989|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
154209990|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154209991|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154209992|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154209993|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154209994|NCT00373256|Growth Substances|growth substances|mesh-ancestor
154209995|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154209996|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
154209997|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154209998|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154209999|NCT01324544|Buprenorphine|buprenorphine|mesh-list
154210000|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154210001|NCT01324544|Narcotics|narcotics|mesh-ancestor
154210002|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210003|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210004|NCT01324544|Analgesics|analgesics|mesh-ancestor
154210005|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
154210006|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210007|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154210009|NCT00394082|Bevacizumab|bevacizumab|mesh-list
154210010|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154210011|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154210012|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210013|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210014|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210015|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210016|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210017|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154210018|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154210019|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154210020|NCT00394082|Growth Substances|growth substances|mesh-ancestor
154210023|NCT00393848|Ketoconazole|ketoconazole|mesh-list
154210024|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
154210025|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210026|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154210027|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154210028|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210029|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210030|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154210031|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
154210067|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210068|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210086|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154210087|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
154210088|NCT00417248|Etoposide|etoposide|mesh-list
154210089|NCT00417248|Sorafenib|sorafenib|mesh-list
154210090|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210091|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154210092|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154210093|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154210094|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210095|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210096|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154210097|NCT01046240|Palonosetron|palonosetron|mesh-list
154210098|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
154210099|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
154210100|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210101|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210102|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210103|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154210104|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154210105|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
154210106|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210107|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210108|NCT00392288|Ciclesonide|ciclesonide|mesh-list
154210109|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
154210110|NCT00392288|Hormones|hormones|mesh-ancestor
154210111|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210112|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210113|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154210114|NCT00417170|Amlodipine|amlodipine|mesh-list
154210115|NCT00417170|Aliskiren|aliskiren|mesh-list
154210116|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154210117|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154210118|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210119|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210120|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154210121|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210122|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
154210123|NCT00417170|Renin Inhibitors|renin inhibitors|mesh-ancestor
154210124|NCT00417170|Protease Inhibitors|protease inhibitors|mesh-ancestor
154210125|NCT00417170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210142|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
154210143|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210144|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210145|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154210146|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154210147|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154210148|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154210149|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154210150|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210151|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154210152|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
154210153|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154210154|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154210155|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
154210156|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
154210157|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154210158|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154210159|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154210161|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210163|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210164|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210165|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
154210166|NCT00249873|Clopidogrel|clopidogrel|mesh-list
154210167|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154210168|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154210169|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154210170|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154210171|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
154210172|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210173|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210174|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210175|NCT01037348|Ranibizumab|ranibizumab|mesh-list
154210176|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154210177|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154210178|NCT01037348|Growth Substances|growth substances|mesh-ancestor
154210179|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210180|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
154210181|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210182|NCT03490292|Paclitaxel|paclitaxel|mesh-list
154210183|NCT03490292|Carboplatin|carboplatin|mesh-list
154210184|NCT03490292|Avelumab|avelumab|mesh-list
154210185|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154210186|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210187|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210216|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154210217|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
154210218|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210219|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
154210220|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
154210221|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210222|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210223|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210224|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
154210225|NCT01046786|Hormones|hormones|mesh-ancestor
154210226|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210227|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154210228|NCT01046786|Protective Agents|protective agents|mesh-ancestor
154210229|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154210230|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210231|NCT00391976|Tobramycin|tobramycin|mesh-list
154210232|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154210252|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210253|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210254|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210255|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154210256|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210257|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154210259|NCT01046864|Fluorouracil|fluorouracil|mesh-list
154210260|NCT01046864|Irinotecan|irinotecan|mesh-list
154210261|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
154210262|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210263|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154210264|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210265|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154210266|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
154210267|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210268|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154210269|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154210270|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210272|NCT01046864|Protective Agents|protective agents|mesh-ancestor
154210273|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
154210274|NCT01046864|Vitamins|vitamins|mesh-ancestor
154210275|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
154210276|NCT01046942|Aspirin|aspirin|mesh-list
154210277|NCT01046942|Clopidogrel|clopidogrel|mesh-list
154210278|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154210279|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154210280|NCT01046942|Analgesics|analgesics|mesh-ancestor
154210281|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
154210282|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210283|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210284|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210285|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210286|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154210287|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154210288|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210289|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154210290|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154210291|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210310|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154210311|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154210312|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210313|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210314|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154210315|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154210316|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154210317|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154210318|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154210319|NCT01047098|Iron|iron|mesh-list
154210320|NCT01047098|Trace Elements|trace elements|mesh-ancestor
154210321|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
154210322|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210323|NCT00391586|Paclitaxel|paclitaxel|mesh-list
154210324|NCT00391586|Etoposide|etoposide|mesh-list
154210325|NCT00391586|Vinorelbine|vinorelbine|mesh-list
154210326|NCT00391586|Docetaxel|docetaxel|mesh-list
154210327|NCT00391586|Gemcitabine|gemcitabine|mesh-list
154210328|NCT00391586|Irinotecan|irinotecan|mesh-list
154210329|NCT00391586|Pemetrexed|pemetrexed|mesh-list
154210330|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154210331|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154210332|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210333|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210334|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210335|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210336|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210337|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154210338|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
154210339|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154210340|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154210341|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210342|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154210343|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154210344|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154210345|NCT00391586|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154210346|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154210347|NCT00391430|Sertraline|sertraline|mesh-list
154210348|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
154210349|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753532|NCT00166556|Tacrolimus|tacrolimus|mesh-list
154210350|NCT00391430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154210364|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210365|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154210366|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154210368|NCT00391118|Carboplatin|carboplatin|mesh-list
154210369|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154210370|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210371|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210372|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210373|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210374|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210375|NCT00390884|Vaccines|vaccines|mesh-list
154210376|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
154210377|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210378|NCT01047488|Pregabalin|pregabalin|mesh-list
154210379|NCT01047488|Imipramine|imipramine|mesh-list
154210380|NCT01047488|Analgesics|analgesics|mesh-ancestor
154210381|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
154210382|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210383|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210384|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
154210385|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154210386|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210387|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210388|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154210389|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154210390|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154210391|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210392|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154210393|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154210394|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
154210395|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154210396|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154210397|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
154210398|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210399|NCT01047566|Digoxin|digoxin|mesh-list
154210400|NCT01047566|Dronedarone|dronedarone|mesh-list
154210401|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
154210402|NCT01047566|Calcium|calcium|mesh-list
154210403|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154210404|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154210405|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210406|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154210407|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154210408|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210409|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210410|NCT01047566|Protective Agents|protective agents|mesh-ancestor
154210427|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210428|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210429|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
154210430|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210431|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154210432|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154210433|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
154210434|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210435|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154210436|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154210437|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210438|NCT00371150|Entecavir|entecavir|mesh-list
154210439|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
154210440|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210441|NCT00264303|Levocetirizine|levocetirizine|mesh-list
154210442|NCT00264303|Desloratadine|desloratadine|mesh-list
154210443|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154210444|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154210445|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
154210446|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
154210447|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210448|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210449|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210450|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154210451|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
154210452|NCT01071369|Betamethasone|betamethasone|mesh-list
154210453|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
154210454|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154210455|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
154210456|NCT01071369|Lidocaine|lidocaine|mesh-list
154210457|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154210458|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
154210459|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
154210460|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210461|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210462|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
154210463|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210464|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154210465|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154210466|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154210467|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210468|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210483|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
154210484|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210485|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256433|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154256434|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
154210486|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210487|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210488|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154210489|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210490|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210491|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154210492|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
154210494|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154210495|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
154210496|NCT03971019|Atorvastatin|atorvastatin|mesh-list
154210497|NCT03971019|Simvastatin|simvastatin|mesh-list
154210498|NCT03971019|Calcium|calcium|mesh-list
154210499|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154210500|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210501|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154210502|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154210503|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154210504|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
154210505|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210506|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154210507|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154210508|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210509|NCT03974685|Niacinamide|niacinamide|mesh-list
154210510|NCT03974685|Niacin|niacin|mesh-list
154210511|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
154210512|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
154210513|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
154210514|NCT03974685|Vitamins|vitamins|mesh-ancestor
154210515|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
154210516|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210517|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154210518|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
154210519|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210520|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154210521|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
154210522|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210523|NCT00263211|Aspirin|aspirin|mesh-list
154210524|NCT00263211|Clopidogrel|clopidogrel|mesh-list
154210525|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154210526|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154210527|NCT00263211|Analgesics|analgesics|mesh-ancestor
154210528|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
154210529|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210530|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210531|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210553|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210554|NCT00248625|Protective Agents|protective agents|mesh-ancestor
154210555|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210556|NCT00248625|Antidotes|antidotes|mesh-ancestor
154210557|NCT00262821|Tirapazamine|tirapazamine|mesh-list
154210558|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210559|NCT01326117|Tadalafil|tadalafil|mesh-list
154210560|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
154210561|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154210562|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154210563|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210564|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210565|NCT01326117|Urological Agents|urological agents|mesh-ancestor
154210566|NCT03970239|Ketanserin|ketanserin|mesh-list
154210567|NCT03970239|Fluorides|fluorides|mesh-list
154210568|NCT03970239|Altanserin|altanserin|mesh-list
154210569|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
154210570|NCT03970239|Protective Agents|protective agents|mesh-ancestor
154210571|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210572|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154210573|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
154210574|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210575|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210576|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154210577|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154210578|NCT00170950|Amlodipine|amlodipine|mesh-list
154210579|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154210581|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154210582|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154210583|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210584|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210585|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154210599|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154210600|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154210601|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210603|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154210604|NCT02531529|Narcotics|narcotics|mesh-ancestor
154210605|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210606|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210607|NCT02531529|Analgesics|analgesics|mesh-ancestor
154210608|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
154210609|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210610|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154210611|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154210612|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
154210613|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
154210615|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154210616|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
154210617|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210618|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154210619|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
154210620|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
154210621|NCT01071525|Vitamins|vitamins|mesh-ancestor
154210622|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
154210623|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210624|NCT01072695|Ribavirin|ribavirin|mesh-list
154210625|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154210626|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
154210627|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210628|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
154210629|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210630|NCT00390806|Topotecan|topotecan|mesh-list
154210631|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154210632|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154210633|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210634|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210635|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210636|NCT01047722|Aspirin|aspirin|mesh-list
154210637|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154210638|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154210639|NCT01047722|Analgesics|analgesics|mesh-ancestor
154210640|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
153957593|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154210641|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210642|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210643|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210644|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210645|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154210646|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153539940|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
154210673|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
154210674|NCT00390416|Vitamins|vitamins|mesh-ancestor
154210675|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
154210676|NCT00261495|Oxycodone|oxycodone|mesh-list
154210677|NCT00261495|Hydromorphone|hydromorphone|mesh-list
154210678|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154210679|NCT00261495|Narcotics|narcotics|mesh-ancestor
154210680|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154210681|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210682|NCT00261495|Analgesics|analgesics|mesh-ancestor
154210683|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
154210684|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210685|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
154210686|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154210687|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
154210688|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210689|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210690|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154210691|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
154210692|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
154210693|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154210694|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
154210695|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210696|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210720|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210721|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210722|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210723|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
154210724|NCT00389324|Antibodies|antibodies|mesh-list
154210725|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
154210726|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154210727|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154210728|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
154210729|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
154210730|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210731|NCT00365300|Pantoprazole|pantoprazole|mesh-list
154210732|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154210733|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210734|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154210735|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210736|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210737|NCT01048034|Azacitidine|azacitidine|mesh-list
154210738|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
154210739|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154210740|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
154210741|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210742|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210743|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210744|NCT01048034|Hematinics|hematinics|mesh-ancestor
154210745|NCT00370292|Pemetrexed|pemetrexed|mesh-list
154210746|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210747|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210777|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210778|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154210779|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154210780|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210781|NCT00388154|Cisplatin|cisplatin|mesh-list
154210782|NCT00388154|Gemcitabine|gemcitabine|mesh-list
154210783|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210784|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154210785|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
154210786|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210787|NCT02535104|Ranpirnase|ranpirnase|mesh-list
154210788|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210789|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154210790|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210791|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683702|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154210792|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
154210793|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154210817|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154210818|NCT00529373|Antacids|antacids|mesh-ancestor
154210819|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210820|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210821|NCT00369122|Bevacizumab|bevacizumab|mesh-list
154210822|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154210823|NCT00369122|Cisplatin|cisplatin|mesh-list
154210824|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
154210825|NCT00369122|Antibodies|antibodies|mesh-list
154210826|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
154210827|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154210828|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
154210829|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210830|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154210831|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154210832|NCT00369122|Growth Substances|growth substances|mesh-ancestor
154210833|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210834|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
154210835|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
154210836|NCT05173493|Amoxicillin|amoxicillin|mesh-list
154210837|NCT05173493|Levofloxacin|levofloxacin|mesh-list
154210838|NCT05173493|Tetracycline|tetracycline|mesh-list
154210839|NCT05173493|Furazolidone|furazolidone|mesh-list
154210841|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210842|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154210843|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154210844|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154210845|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210875|NCT03999125|BB 1101|bb 1101|mesh-list
154210876|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154210877|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
154210878|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
154210879|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154210880|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210881|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210882|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
154210883|NCT03999125|Hormones|hormones|mesh-ancestor
154210884|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154210885|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154210886|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210887|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
154210888|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633764|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210903|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154210904|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154210905|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210906|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154210908|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210909|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
154210910|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154210911|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154210912|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210913|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154210914|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
154210915|NCT05032781|Minocycline|minocycline|mesh-list
154210916|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154210917|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210918|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
154210919|NCT00129376|Docetaxel|docetaxel|mesh-list
154210920|NCT00129376|Doxorubicin|doxorubicin|mesh-list
154210921|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154210922|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
154210923|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154210924|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154210925|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154210926|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
154210927|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210928|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210929|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154210930|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210931|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210932|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210933|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154210934|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154210935|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154210936|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210937|NCT04878107|Docetaxel|docetaxel|mesh-list
154210938|NCT04878107|Apatinib|apatinib|mesh-list
154210939|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154210940|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154210941|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
154210942|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
154210943|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210944|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154210946|NCT03998969|Pantoprazole|pantoprazole|mesh-list
154210947|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154210948|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154210974|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210975|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
154210976|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154210977|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154210978|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210979|NCT03686813|Urological Agents|urological agents|mesh-ancestor
154210983|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154210984|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
154210985|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154210986|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154210987|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154210988|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
154210989|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154210990|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154210991|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154210992|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154210993|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154210994|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154210995|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154210996|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
154211023|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154211024|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154211025|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154211026|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154211027|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154211028|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154211030|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
154211031|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154211032|NCT01075828|Cetuximab|cetuximab|mesh-list
154211033|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211034|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211035|NCT01074970|Cisplatin|cisplatin|mesh-list
154211036|NCT01074970|Rucaparib|rucaparib|mesh-list
154211037|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211038|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154211039|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211040|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211041|NCT03968146|Acetaminophen|acetaminophen|mesh-list
154211042|NCT03968146|Ketorolac|ketorolac|mesh-list
154211043|NCT03968146|Fentanyl|fentanyl|mesh-list
154211044|NCT03968146|Meperidine|meperidine|mesh-list
154211052|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211054|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154211055|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
154211056|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
154211057|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154211058|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
154211059|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154211060|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211061|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211062|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154211063|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211064|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211065|NCT03966118|Paclitaxel|paclitaxel|mesh-list
154211066|NCT03966118|Avelumab|avelumab|mesh-list
154211067|NCT03966118|Ramucirumab|ramucirumab|mesh-list
154211068|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211069|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211070|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211071|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211072|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211073|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211074|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211075|NCT03966118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154211076|NCT03966118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154211077|NCT03966118|Growth Substances|growth substances|mesh-ancestor
154211078|NCT03966118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211079|NCT03966118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154211080|NCT03968224|Metformin|metformin|mesh-list
154211081|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
154211082|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154211083|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211084|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154211085|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211086|NCT01075126|Valproic Acid|valproic acid|mesh-list
154211087|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154256435|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154256436|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
154211088|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211089|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211090|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
154211091|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154211092|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154211093|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211094|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
154211096|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211097|NCT03823378|Upadacitinib|upadacitinib|mesh-list
154211098|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154211099|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154211100|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211101|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211102|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211103|NCT00141778|Ramipril|ramipril|mesh-list
154211104|NCT00141778|Spironolactone|spironolactone|mesh-list
154211105|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154211106|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154211107|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154211108|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
154211109|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
154211110|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154211111|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211112|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154211127|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211128|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211129|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211130|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211131|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211132|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211133|NCT01076062|Misoprostol|misoprostol|mesh-list
154211134|NCT01076062|Oxytocin|oxytocin|mesh-list
154211135|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
154211136|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154211137|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211138|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154211139|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
154211140|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154211141|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154211142|NCT00115336|Ibuprofen|ibuprofen|mesh-list
154211143|NCT00115336|Ketorolac|ketorolac|mesh-list
154211144|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154211145|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154211146|NCT00115336|Analgesics|analgesics|mesh-ancestor
154211147|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
154211148|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211149|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211150|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211151|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211152|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153683970|NCT00145093|Chromium|chromium|mesh-list
154211153|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211154|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211155|NCT01076140|Lisinopril|lisinopril|mesh-list
154211156|NCT01076140|Nebivolol|nebivolol|mesh-list
154211157|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154211158|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
154211159|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211160|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211161|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154211162|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154211163|NCT01076140|Protective Agents|protective agents|mesh-ancestor
154211164|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211165|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
154211166|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154211167|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154211168|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154211169|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
154211170|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211171|NCT00205803|Vaccines|vaccines|mesh-list
154211172|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154211173|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
154211174|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211185|NCT00127036|Bevacizumab|bevacizumab|mesh-list
154211186|NCT00127036|Capecitabine|capecitabine|mesh-list
154211187|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
154211188|NCT00127036|Irinotecan|irinotecan|mesh-list
154211189|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211190|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211191|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154211192|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154211193|NCT00127036|Growth Substances|growth substances|mesh-ancestor
154211194|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211195|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
154211196|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211197|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
154211198|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211199|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154211200|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211201|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211202|NCT00259857|Alendronate|alendronate|mesh-list
154211203|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154211204|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211205|NCT01071681|Telmisartan|telmisartan|mesh-list
154211206|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154211207|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154211208|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154211209|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211210|NCT00203307|Olanzapine|olanzapine|mesh-list
154211211|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
154211212|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
154211213|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211214|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211215|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154211216|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154211217|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154211218|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154211219|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154211220|NCT00203307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154211221|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154211222|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154211223|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211224|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211225|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
154211226|NCT00126568|Sorafenib|sorafenib|mesh-list
154211227|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211228|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154211229|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211230|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211231|NCT00202839|Ribavirin|ribavirin|mesh-list
154211232|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154211233|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
154211234|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
154211235|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211236|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
154211237|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211251|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154211252|NCT00126490|Growth Substances|growth substances|mesh-ancestor
154211253|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211254|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
154211255|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
154211256|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154211257|NCT00126490|Analgesics|analgesics|mesh-ancestor
154211258|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
154211259|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211260|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154211261|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154211262|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
154211263|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211264|NCT00200967|Beclomethasone|beclomethasone|mesh-list
154211265|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154211266|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154211267|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
154211268|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211269|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211270|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154211271|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
154211272|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154211273|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154211274|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154211275|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
154211276|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211277|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211278|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211279|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
154211280|NCT00200967|Hormones|hormones|mesh-ancestor
154211281|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154211282|NCT02533440|Anesthetics|anesthetics|mesh-list
154211283|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
154211284|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154211285|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211286|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
154211287|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684083|NCT00145639|Ifosfamide|ifosfamide|mesh-list
154211288|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154211289|NCT00354432|Caseins|caseins|mesh-list
154211290|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154211291|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154211292|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154211293|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211294|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211295|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211296|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154211297|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
154211298|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154211299|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
154211300|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
154211301|NCT00140140|Paclitaxel|paclitaxel|mesh-list
154211310|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211311|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211312|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211313|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154211314|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
154211315|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211316|NCT00346398|Immunomodulating Agents|immunomodulating agents|mesh-list
154211317|NCT00346398|Immunologic Factors|immunologic factors|mesh-ancestor
154211318|NCT00346398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211319|NCT00346164|Doxorubicin|doxorubicin|mesh-list
154211320|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154211321|NCT00346164|Ifosfamide|ifosfamide|mesh-list
154211322|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154211323|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211324|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154211325|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211326|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211327|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211328|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154211329|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
154211330|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
154211331|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154211332|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211333|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154211334|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211335|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211336|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211337|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211338|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154211339|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154211340|NCT00114244|Gemcitabine|gemcitabine|mesh-list
154211341|NCT00114244|Sorafenib|sorafenib|mesh-list
154211342|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211343|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
154211344|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211345|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211346|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153684103|NCT00145990|Miotics|miotics|mesh-ancestor
154211347|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211348|NCT01054872|Vaccines|vaccines|mesh-list
154211349|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
154211350|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211351|NCT00337662|Olanzapine|olanzapine|mesh-list
154211352|NCT00337662|Risperidone|risperidone|mesh-list
154211353|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154211354|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
154211355|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211356|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211357|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211358|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154211359|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154211360|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154211361|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154211362|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154211363|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
154211364|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
154211365|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
154211366|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211367|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154211368|NCT00337662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154211377|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154211378|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
154211379|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211380|NCT00114166|Topotecan|topotecan|mesh-list
154211381|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154211382|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211383|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211384|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211385|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211386|NCT00337428|Vaccines|vaccines|mesh-list
154211387|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
154211388|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211389|NCT00235989|Interferons|interferons|mesh-list
154211390|NCT00235989|Interferon-beta|interferon-beta|mesh-list
154211391|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
154211392|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211393|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
154211394|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211395|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
154211396|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211397|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154211398|NCT00113386|Docetaxel|docetaxel|mesh-list
154211399|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211400|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211401|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211402|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211403|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211404|NCT00353262|Capecitabine|capecitabine|mesh-list
154211405|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
154211406|NCT00353262|Bevacizumab|bevacizumab|mesh-list
154211407|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211408|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
154211409|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211410|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211411|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211412|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154211413|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154211414|NCT00353262|Growth Substances|growth substances|mesh-ancestor
154211415|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211416|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
154211417|NCT00125164|Mecasermin|mecasermin|mesh-list
154211418|NCT00125164|Growth Substances|growth substances|mesh-ancestor
154211419|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211420|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
154211421|NCT03985410|Durlobactam|durlobactam|mesh-list
154211422|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154211423|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211424|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154211425|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211426|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211427|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211428|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211429|NCT03985410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154211430|NCT00136318|Ribavirin|ribavirin|mesh-list
154211431|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154211432|NCT00136318|Escitalopram|escitalopram|mesh-list
154211433|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
154211434|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211435|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
154211436|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211461|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211463|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154211464|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
154211465|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211466|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211467|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154211468|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211469|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
154211470|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
154211471|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684398|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
154211472|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154211473|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
154211474|NCT00136084|Hormones|hormones|mesh-ancestor
154211475|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154211476|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154211477|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154211478|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
154211479|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154211480|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211481|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
154211482|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
154211483|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211484|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154211485|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154211486|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211487|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154211488|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211489|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
153634372|NCT00008281|Leucovorin|leucovorin|mesh-list
154211519|NCT00337194|Doxorubicin|doxorubicin|mesh-list
154211520|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154211521|NCT00337194|Vinorelbine|vinorelbine|mesh-list
154211522|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154211523|NCT00337194|Antibodies|antibodies|mesh-list
154211524|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154211525|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
154211526|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211527|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211528|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
154211529|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211530|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211531|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154211532|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154211533|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211534|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211535|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211536|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634412|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
154211553|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211554|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211555|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154211556|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154211557|NCT01057212|Growth Substances|growth substances|mesh-ancestor
154211558|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211559|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
154211560|NCT03988452|Ritonavir|ritonavir|mesh-list
154211561|NCT03988452|Darunavir|darunavir|mesh-list
154211562|NCT03988452|Tenofovir|tenofovir|mesh-list
154211563|NCT03988452|Lamivudine|lamivudine|mesh-list
154211564|NCT03988452|Zidovudine|zidovudine|mesh-list
154211565|NCT03988452|Dolutegravir|dolutegravir|mesh-list
154211566|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154211567|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154211568|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
154211569|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211570|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211571|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154211572|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154211573|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
154211574|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211575|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154211576|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154211577|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154211578|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154211579|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
154211580|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154211581|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154211582|NCT01048580|Capecitabine|capecitabine|mesh-list
154211583|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211584|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
154211585|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211586|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211587|NCT00195819|Adalimumab|adalimumab|mesh-list
154211588|NCT00195819|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154211589|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211590|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211591|NCT00527735|Paclitaxel|paclitaxel|mesh-list
154211592|NCT00527735|Carboplatin|carboplatin|mesh-list
154211593|NCT00527735|Ipilimumab|ipilimumab|mesh-list
154211594|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211595|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211596|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211597|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634468|NCT05637268|Paclitaxel|paclitaxel|mesh-list
154211613|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211614|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211615|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
154211616|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154211617|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154211618|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154211619|NCT00521339|Apremilast|apremilast|mesh-list
154211620|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154211621|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154211622|NCT00521339|Analgesics|analgesics|mesh-ancestor
154211623|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
154211624|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211625|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211626|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211627|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154211628|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154211629|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154211630|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211631|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211632|NCT00363896|Bromides|bromides|mesh-list
154211633|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
154211634|NCT00527423|Aflibercept|aflibercept|mesh-list
154211635|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154211636|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154211637|NCT00527423|Growth Substances|growth substances|mesh-ancestor
154211638|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211639|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
154211640|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211641|NCT00527111|Fluorouracil|fluorouracil|mesh-list
154211642|NCT00527111|Cetuximab|cetuximab|mesh-list
154211643|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
154211644|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211645|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211646|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211647|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154211648|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
154211649|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211650|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211651|NCT00384956|Azacitidine|azacitidine|mesh-list
154211652|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211653|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
154211654|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211655|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211656|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211670|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154211671|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154211672|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
154211673|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
154211674|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211675|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211676|NCT00367484|Interferons|interferons|mesh-list
154211677|NCT00367484|Interferon-beta|interferon-beta|mesh-list
154211678|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
154211679|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211680|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
154211681|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211682|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
154211683|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211684|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154211686|NCT00526799|Topotecan|topotecan|mesh-list
154211687|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211688|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154211689|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211690|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211691|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154211692|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211693|NCT01059084|Valacyclovir|valacyclovir|mesh-list
154211694|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
154211695|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153958638|NCT00707824|Analgesics|analgesics|mesh-ancestor
154211696|NCT03992144|Amoxicillin|amoxicillin|mesh-list
154211697|NCT03992144|Metronidazole|metronidazole|mesh-list
154211698|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154211699|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211700|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154211701|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154211702|NCT02534870|Ritonavir|ritonavir|mesh-list
154211703|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154211704|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154211705|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
154211706|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211707|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211708|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154211709|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154211710|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
154211711|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211712|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154211713|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154211714|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
154211715|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
154211716|NCT03992066|Hematinics|hematinics|mesh-ancestor
154211717|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
154211718|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154211719|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
154211747|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154211748|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
154211749|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211750|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211751|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211752|NCT00520403|Interferons|interferons|mesh-list
154211753|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
154211754|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
154211755|NCT00520403|Bevacizumab|bevacizumab|mesh-list
154211756|NCT00520403|Vinblastine|vinblastine|mesh-list
154211757|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211758|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211759|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154211760|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154211761|NCT00520403|Growth Substances|growth substances|mesh-ancestor
154211762|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211763|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
154211764|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
154211765|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211766|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
154211767|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211801|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211802|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154211804|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154211805|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
154211806|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211807|NCT00525785|Antidotes|antidotes|mesh-ancestor
154211808|NCT00525785|Protective Agents|protective agents|mesh-ancestor
154211809|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
154211810|NCT00525785|Vitamins|vitamins|mesh-ancestor
154211811|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
154211837|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154211838|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154211839|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154211840|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211842|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154211843|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211844|NCT01076530|Temozolomide|temozolomide|mesh-list
154211845|NCT01076530|Vorinostat|vorinostat|mesh-list
154211846|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153958792|NCT00913692|Glycine|glycine|mesh-list
154211847|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
154211848|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211849|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211850|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154211851|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211852|NCT00519077|Gefitinib|gefitinib|mesh-list
154211853|NCT00519077|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154211854|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154211855|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211856|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211857|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211858|NCT00124618|Cetuximab|cetuximab|mesh-list
154211859|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211893|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154211894|NCT00524303|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154211895|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154211896|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211897|NCT04461041|Empagliflozin|empagliflozin|mesh-list
154211898|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154211899|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211900|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154211901|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211902|NCT00335556|Dactinomycin|dactinomycin|mesh-list
154211903|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
154211922|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211923|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154211924|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154211925|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211926|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211928|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154211929|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211930|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154211931|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154211933|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
154211934|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211935|NCT00134056|Prednisone|prednisone|mesh-list
154211936|NCT00134056|Docetaxel|docetaxel|mesh-list
154211937|NCT00134056|Atrasentan|atrasentan|mesh-list
154211938|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211939|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
154211940|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
154211941|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
154211942|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211943|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154211944|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
154211945|NCT00134056|Hormones|hormones|mesh-ancestor
154211946|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154211947|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211948|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154211949|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154211950|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154211951|NCT00518531|Denosumab|denosumab|mesh-list
154211952|NCT00518531|Alendronate|alendronate|mesh-list
154211953|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154211954|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211955|NCT01326442|Vitamin D|vitamin d|mesh-list
154211956|NCT01326442|Vitamins|vitamins|mesh-ancestor
154211957|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
154211958|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154211959|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154211960|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
154211961|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154211962|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
154211969|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
154211970|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154211971|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211973|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211974|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
154211975|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211976|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211977|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154211978|NCT00345540|Carboplatin|carboplatin|mesh-list
154211979|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154211980|NCT00335322|Ritonavir|ritonavir|mesh-list
154211981|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154211982|NCT00335322|Tenofovir|tenofovir|mesh-list
154211983|NCT00335322|Emtricitabine|emtricitabine|mesh-list
154211984|NCT00335322|Zidovudine|zidovudine|mesh-list
154211985|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154211986|NCT00335322|Abacavir|abacavir|mesh-list
154211987|NCT00335322|Efavirenz|efavirenz|mesh-list
154211988|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154211989|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154211990|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
154211991|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154211992|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154211993|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154211994|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154211995|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
154211996|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154211997|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154211998|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154211999|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154212000|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154212001|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
154212002|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154212003|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154212004|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154212005|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154212006|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154212008|NCT01059396|Carvedilol|carvedilol|mesh-list
154212009|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154212010|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154212011|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
154212012|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212013|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212014|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212015|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154212016|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154212017|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
154212018|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
154212019|NCT01059396|Protective Agents|protective agents|mesh-ancestor
154212020|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154212021|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154212022|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154212023|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154212024|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154212025|NCT01059552|Vorinostat|vorinostat|mesh-list
154212026|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212027|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154212028|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212029|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212042|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212044|NCT01061112|Fluconazole|fluconazole|mesh-list
154212045|NCT01061112|Ketoprofen|ketoprofen|mesh-list
154212046|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
154212047|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
154212048|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212049|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154212050|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153437014|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
154212051|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212052|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212053|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154212054|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
154212055|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153685096|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
154212056|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212057|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154212058|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154212059|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154212060|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154212061|NCT01061112|Analgesics|analgesics|mesh-ancestor
154212062|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
154212063|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212064|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212065|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212066|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154212067|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154212068|NCT01061190|Propranolol|propranolol|mesh-list
154212069|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154212070|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154212071|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
154212072|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153959009|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212073|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212074|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212075|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154212076|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154212077|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
154212078|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154212079|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212080|NCT00517829|Docetaxel|docetaxel|mesh-list
154212081|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
154212082|NCT00517829|Cetuximab|cetuximab|mesh-list
154212083|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212084|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
154212085|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
154212086|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
154212087|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212088|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212089|NCT00343512|Docetaxel|docetaxel|mesh-list
154212090|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212101|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154212102|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212103|NCT00112294|Paclitaxel|paclitaxel|mesh-list
154212104|NCT00112294|Docetaxel|docetaxel|mesh-list
154212105|NCT00112294|Carboplatin|carboplatin|mesh-list
154212106|NCT00112294|Cetuximab|cetuximab|mesh-list
154212107|NCT00112294|Taxane|taxane|mesh-list
154212108|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154212109|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212110|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
154212111|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
154212112|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
154212113|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212114|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212115|NCT00235443|Lacosamide|lacosamide|mesh-list
154212116|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
154212117|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154212118|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154212119|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154212120|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212121|NCT00234039|Gemcitabine|gemcitabine|mesh-list
154212122|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154212123|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
154212124|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212125|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212126|NCT02531451|Aspirin|aspirin|mesh-list
154212127|NCT02531451|Ibuprofen|ibuprofen|mesh-list
154212128|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154212129|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153437056|NCT00002755|Trace Elements|trace elements|mesh-ancestor
154212131|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
154212132|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212133|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212134|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212135|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212136|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154212137|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212138|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212139|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154212140|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154212141|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154212142|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
154212143|NCT01073007|Simvastatin|simvastatin|mesh-list
154212144|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154212145|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154212146|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
154212147|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212148|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154212149|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154212150|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212151|NCT03741621|Psyllium|psyllium|mesh-list
154212152|NCT03741621|Cathartics|cathartics|mesh-ancestor
154212153|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212154|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
154212168|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154212170|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
154212171|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
154212172|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212173|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212174|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
154212175|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212176|NCT01057758|Simvastatin|simvastatin|mesh-list
154212177|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154212178|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154212179|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
154212180|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212181|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154212182|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154212183|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212184|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
154212185|NCT00186537|Fenofibrate|fenofibrate|mesh-list
154212186|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154212187|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212188|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154212189|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
154212190|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212191|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154212192|NCT03968835|Bacitracin|bacitracin|mesh-list
154212193|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154212194|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212195|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154212196|NCT00322842|Plerixafor|plerixafor|mesh-list
154212197|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154212198|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154212199|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
154212200|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212201|NCT00255723|Carboplatin|carboplatin|mesh-list
154212202|NCT00255723|Etoposide|etoposide|mesh-list
154212203|NCT00255723|Ifosfamide|ifosfamide|mesh-list
154212204|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212205|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154212206|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154212207|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154212208|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212209|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212210|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154212211|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
154212212|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
154212213|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154212214|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154212215|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212216|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
154212231|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212232|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
154212233|NCT00516893|Natalizumab|natalizumab|mesh-list
154212234|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
154212235|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212236|NCT00522431|Testosterone|testosterone|mesh-list
154212237|NCT00522431|Androgens|androgens|mesh-ancestor
154212238|NCT00522431|Hormones|hormones|mesh-ancestor
154212239|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212240|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212241|NCT00185211|Interferons|interferons|mesh-list
154212242|NCT00185211|Interferon-beta|interferon-beta|mesh-list
154212243|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
154212244|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212245|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
154212246|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212247|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
154212248|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212249|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154212250|NCT00516737|Rizatriptan|rizatriptan|mesh-list
154212251|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154212252|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
154212253|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212254|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212255|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212256|NCT03540485|Melatonin|melatonin|mesh-list
154212257|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
154212258|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212259|NCT03540485|Protective Agents|protective agents|mesh-ancestor
154212260|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212261|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212262|NCT00132730|MK 0873|mk 0873|mesh-list
154212263|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154212264|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154212265|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212266|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212267|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
154212268|NCT02531841|Dexamethasone|dexamethasone|mesh-list
154212269|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
154212270|NCT02531841|Etoposide|etoposide|mesh-list
154212271|NCT02531841|Thiotepa|thiotepa|mesh-list
154212272|NCT02531841|Ifosfamide|ifosfamide|mesh-list
154212273|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
154212274|NCT02531841|Carmustine|carmustine|mesh-list
154212275|NCT02531841|Busulfan|busulfan|mesh-list
154212276|NCT02531841|BB 1101|bb 1101|mesh-list
154212277|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212278|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
154212279|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
153635128|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154212294|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154212296|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154212297|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153959234|NCT00845182|Incretins|incretins|mesh-ancestor
154212298|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
154212299|NCT01074411|Carboplatin|carboplatin|mesh-list
154212300|NCT01074411|Bortezomib|bortezomib|mesh-list
154212301|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212302|NCT03973047|Ondansetron|ondansetron|mesh-list
154212303|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
154212304|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
154212305|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212306|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212307|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212308|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
154212309|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
154212310|NCT03973047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154212311|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154212312|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
154212313|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212314|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212315|NCT00522275|Lacosamide|lacosamide|mesh-list
154212316|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
154212317|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154212318|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154212319|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154212320|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212321|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
154212322|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154212323|NCT01074567|Protective Agents|protective agents|mesh-ancestor
154212324|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212325|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154212326|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
154212327|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212328|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
154212329|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
154212330|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
154212331|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212332|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
154212333|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212334|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212335|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635197|NCT00000760|Zidovudine|zidovudine|mesh-list
154212351|NCT06169475|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154212353|NCT06169475|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154212354|NCT06169202|Capecitabine|capecitabine|mesh-list
154212355|NCT06169202|Irinotecan|irinotecan|mesh-list
154212356|NCT06169202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154212357|NCT06169202|Antimetabolites|antimetabolites|mesh-ancestor
154212358|NCT06169202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212359|NCT06169202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212360|NCT06169202|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154212361|NCT06169202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154212362|NCT06169202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212363|NCT06168994|Eplerenone|eplerenone|mesh-list
154212364|NCT06168994|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154212365|NCT06168994|Hormone Antagonists|hormone antagonists|mesh-ancestor
154212366|NCT06168994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212367|NCT06168994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212368|NCT06168994|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154212369|NCT06168994|Diuretics|diuretics|mesh-ancestor
154212370|NCT06168994|Natriuretic Agents|natriuretic agents|mesh-ancestor
154212371|NCT06168994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154212372|NCT06168890|Choline|choline|mesh-list
154212373|NCT06168890|Lipotropic Agents|lipotropic agents|mesh-ancestor
154212374|NCT06168890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154212375|NCT06168890|Antimetabolites|antimetabolites|mesh-ancestor
154212376|NCT06168890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212377|NCT06168890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212378|NCT06168890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154212379|NCT06168890|Nootropic Agents|nootropic agents|mesh-ancestor
154212380|NCT06168877|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154212381|NCT06168877|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154212382|NCT06168877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212383|NCT06168838|Anticoagulants|anticoagulants|mesh-list
154212384|NCT06168773|Magnesium Sulfate|magnesium sulfate|mesh-list
154212385|NCT06168773|Haloperidol|haloperidol|mesh-list
154212386|NCT06168773|Haloperidol decanoate|haloperidol decanoate|mesh-list
154212387|NCT06168773|Analgesics|analgesics|mesh-ancestor
154212388|NCT06168773|Sensory System Agents|sensory system agents|mesh-ancestor
154212389|NCT06168773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212390|NCT06168773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212391|NCT06168773|Anesthetics|anesthetics|mesh-ancestor
154212392|NCT06168773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153635250|NCT00000799|Probenecid|probenecid|mesh-list
154212415|NCT06168708|Gentamicins|gentamicins|mesh-list
154212416|NCT06168708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154212417|NCT06168708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212418|NCT06168708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154212419|NCT06168708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685661|NCT00152815|Vitamin E|vitamin e|mesh-list
154212420|NCT06168708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212421|NCT06168487|Telmisartan|telmisartan|mesh-list
154212422|NCT06168487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154212423|NCT06168487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154212424|NCT06168487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154212425|NCT06168487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212426|NCT06168461|Aspirin|aspirin|mesh-list
154212427|NCT06168461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154212428|NCT06168461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154212429|NCT06168461|Analgesics|analgesics|mesh-ancestor
154212430|NCT06168461|Sensory System Agents|sensory system agents|mesh-ancestor
154212431|NCT06168461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212432|NCT06168461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212433|NCT06168461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212434|NCT06168461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212435|NCT06168461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154212436|NCT06168461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154212437|NCT06168461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212438|NCT06168461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154212439|NCT06168461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154212440|NCT06168461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212441|NCT06168461|Antipyretics|antipyretics|mesh-ancestor
154212442|NCT06168279|Salicylic Acid|salicylic acid|mesh-list
154212443|NCT06168279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212444|NCT06168279|Antifungal Agents|antifungal agents|mesh-ancestor
154212445|NCT06168279|Keratolytic Agents|keratolytic agents|mesh-ancestor
154212476|NCT06167837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212477|NCT06167837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212478|NCT06156215|Vaccines|vaccines|mesh-list
154212479|NCT06156215|Immunologic Factors|immunologic factors|mesh-ancestor
154212480|NCT06156215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212481|NCT06154083|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154212482|NCT06154083|Hormones|hormones|mesh-ancestor
154212483|NCT06154083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212484|NCT06154083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212485|NCT06152497|Fexofenadine|fexofenadine|mesh-list
154212486|NCT06152497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154212487|NCT06152497|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154212488|NCT06152497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154212489|NCT06152497|Histamine Antagonists|histamine antagonists|mesh-ancestor
154212490|NCT06152497|Histamine Agents|histamine agents|mesh-ancestor
154212491|NCT06152497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153635361|NCT00000895|Azithromycin|azithromycin|mesh-list
154212507|NCT06142396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212508|NCT06142396|Antiemetics|antiemetics|mesh-ancestor
154212509|NCT06142396|Autonomic Agents|autonomic agents|mesh-ancestor
154212510|NCT06142396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212511|NCT06142396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212512|NCT06142396|Glucocorticoids|glucocorticoids|mesh-ancestor
154212513|NCT06142396|Hormones|hormones|mesh-ancestor
154212514|NCT06142396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212515|NCT06142396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154212516|NCT06111339|Ketamine|ketamine|mesh-list
154212517|NCT06111339|Analgesics|analgesics|mesh-ancestor
154212518|NCT06111339|Sensory System Agents|sensory system agents|mesh-ancestor
154212519|NCT06111339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212520|NCT06111339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212521|NCT06111339|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154212522|NCT06111339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154212523|NCT06111339|Anesthetics, General|anesthetics, general|mesh-ancestor
154212524|NCT06111339|Anesthetics|anesthetics|mesh-ancestor
153959460|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212525|NCT06111339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212526|NCT06111339|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154212527|NCT06111339|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154212528|NCT06111339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212529|NCT06111339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212530|NCT06099171|Caryophyllene|caryophyllene|mesh-list
154212531|NCT06099171|Cannabidiol|cannabidiol|mesh-list
154212532|NCT06099171|Anticonvulsants|anticonvulsants|mesh-ancestor
154212533|NCT06099171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154212534|NCT06099171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154212535|NCT06099171|Analgesics|analgesics|mesh-ancestor
154212536|NCT06099171|Sensory System Agents|sensory system agents|mesh-ancestor
154212537|NCT06099171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212538|NCT06099171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212539|NCT06099171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212540|NCT06099171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212542|NCT06084663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154212543|NCT06084663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154212544|NCT06084663|Analgesics|analgesics|mesh-ancestor
154212545|NCT06084663|Sensory System Agents|sensory system agents|mesh-ancestor
154212546|NCT06084663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212547|NCT06084663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212548|NCT06084663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212549|NCT06084663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212580|NCT06043297|Protease Inhibitors|protease inhibitors|mesh-ancestor
154212581|NCT06043297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212582|NCT06043297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212583|NCT06043297|Anticoagulants|anticoagulants|mesh-ancestor
154212584|NCT05984381|Dapsone|dapsone|mesh-list
154212585|NCT05984381|Prednisolone|prednisolone|mesh-list
154212586|NCT05984381|Methotrexate|methotrexate|mesh-list
153685768|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212587|NCT05984381|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154212588|NCT05984381|Abortifacient Agents|abortifacient agents|mesh-ancestor
154212589|NCT05984381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154212590|NCT05984381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212591|NCT05984381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154212592|NCT05984381|Antimetabolites|antimetabolites|mesh-ancestor
153539941|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212609|NCT05984381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154212610|NCT05984381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154212611|NCT05984381|Leprostatic Agents|leprostatic agents|mesh-ancestor
154212612|NCT05984381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154212613|NCT05957211|Cyclosporine|cyclosporine|mesh-list
154212614|NCT05957211|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154212615|NCT05957211|Cyclosporins|cyclosporins|mesh-list
154212616|NCT05957211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212617|NCT05957211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212618|NCT05957211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154212619|NCT05957211|Immunologic Factors|immunologic factors|mesh-ancestor
154212620|NCT05957211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212621|NCT05957211|Antifungal Agents|antifungal agents|mesh-ancestor
154212622|NCT05957211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212623|NCT05957211|Dermatologic Agents|dermatologic agents|mesh-ancestor
154212624|NCT05957211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212625|NCT05957211|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154212626|NCT05957211|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154212627|NCT05948462|Cisplatin|cisplatin|mesh-list
154212628|NCT05948462|Carboplatin|carboplatin|mesh-list
154212629|NCT05948462|Pemetrexed|pemetrexed|mesh-list
154212630|NCT05948462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212631|NCT05948462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212632|NCT05948462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212633|NCT05948462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154212634|NCT05948462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154212635|NCT05886244|Eculizumab|eculizumab|mesh-list
154212636|NCT05886244|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154212637|NCT05886244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154212638|NCT05886244|Immunologic Factors|immunologic factors|mesh-ancestor
154212639|NCT05886244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212640|NCT05854667|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154212641|NCT05854667|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154212642|NCT05854667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212643|NCT05854667|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154212644|NCT05854667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154212645|NCT05854667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154212646|NCT05854667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212647|NCT05854667|Dopamine Agents|dopamine agents|mesh-ancestor
154212648|NCT05854667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212649|NCT05829356|Vaccines|vaccines|mesh-list
154212650|NCT05829356|Immunologic Factors|immunologic factors|mesh-ancestor
154212651|NCT05829356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212663|NCT05820685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212665|NCT05820685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212666|NCT05776862|Ursolic Acid|ursolic acid|mesh-list
154212667|NCT05776862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212668|NCT05776862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154212669|NCT05776862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212670|NCT05776862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154212671|NCT05776862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212672|NCT05776862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212673|NCT05776862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154212674|NCT05776862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154212675|NCT05776862|Analgesics|analgesics|mesh-ancestor
154212676|NCT05776862|Sensory System Agents|sensory system agents|mesh-ancestor
154212677|NCT05776862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212678|NCT05776862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212679|NCT05776862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212680|NCT05776862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212681|NCT05776108|Cabotegravir|cabotegravir|mesh-list
154212682|NCT05776108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154212683|NCT05776108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154212684|NCT05776108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212685|NCT05776108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212686|NCT05776108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154212687|NCT05776108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154212688|NCT05776108|Antiviral Agents|antiviral agents|mesh-ancestor
154212689|NCT05776108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212690|NCT05768334|Lubiprostone|lubiprostone|mesh-list
154212691|NCT05768334|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154212692|NCT05768334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154212693|NCT05768334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212694|NCT05732701|Oxymetazoline|oxymetazoline|mesh-list
154212695|NCT05732701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154212696|NCT05732701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154212697|NCT05732701|Adrenergic Agents|adrenergic agents|mesh-ancestor
154212698|NCT05732701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212699|NCT05732701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212700|NCT05732701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212701|NCT05732701|Sympathomimetics|sympathomimetics|mesh-ancestor
154212702|NCT05732701|Autonomic Agents|autonomic agents|mesh-ancestor
154212703|NCT05732701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212704|NCT05732701|Nasal Decongestants|nasal decongestants|mesh-ancestor
154212705|NCT05732701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154212706|NCT05732701|Respiratory System Agents|respiratory system agents|mesh-ancestor
154212707|NCT05716724|Semaglutide|semaglutide|mesh-list
154212708|NCT05716724|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154212709|NCT05716724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154212710|NCT05716724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212711|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
154212712|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154212741|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212742|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153685864|NCT00153634|Azithromycin|azithromycin|mesh-list
154212743|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
154212744|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153959686|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
154212745|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
154212746|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212747|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212748|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154212749|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
154212750|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
154212751|NCT05564546|Protective Agents|protective agents|mesh-ancestor
154212752|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
154212753|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154212754|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
154212755|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212756|NCT05494398|Expectorants|expectorants|mesh-ancestor
154212757|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
153635647|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
154212771|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154212772|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154212773|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
154212775|NCT05395117|Midazolam|midazolam|mesh-list
154212776|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154212777|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154212778|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154212779|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212782|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154212783|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154212784|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154212785|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
154212786|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
154212787|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
154212788|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
154212789|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212790|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212791|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154212792|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154212793|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
154212794|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154212795|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154212796|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212797|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154212798|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154212799|NCT05395117|Protective Agents|protective agents|mesh-ancestor
154212800|NCT05371600|Midazolam|midazolam|mesh-list
154212801|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154212802|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154212803|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212804|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212805|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154212806|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154212807|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154212808|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154212809|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
154212810|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
154212811|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
154212812|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
154212813|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212814|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212815|NCT05358691|Durvalumab|durvalumab|mesh-list
154212816|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212817|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212818|NCT05288153|Metformin|metformin|mesh-list
154212819|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154212835|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212836|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154212837|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154212838|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154212839|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154212840|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212841|NCT05229653|Ketamine|ketamine|mesh-list
154212842|NCT05229653|Analgesics|analgesics|mesh-ancestor
154212843|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
154212844|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212845|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212846|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154212847|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154212848|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
154212849|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
154212850|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212851|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154212852|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154212853|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154212854|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212855|NCT05226598|Paclitaxel|paclitaxel|mesh-list
154212856|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154212857|NCT05226598|Carboplatin|carboplatin|mesh-list
154212858|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
154212859|NCT05226598|Pemetrexed|pemetrexed|mesh-list
154212860|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154212861|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212862|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
154212863|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
154212864|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
154212865|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212866|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212867|NCT05226598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154212869|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154212870|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154212871|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154212873|NCT05169684|Nivolumab|nivolumab|mesh-list
154212874|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212875|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
154212876|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
153635750|NCT00001087|Ritonavir|ritonavir|mesh-list
154212898|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212900|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
154212901|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212902|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212903|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154212904|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
154212905|NCT05097976|Hormones|hormones|mesh-ancestor
154212906|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212907|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154212908|NCT05097976|Protective Agents|protective agents|mesh-ancestor
154212909|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154212910|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212911|NCT05082662|Diclofenac|diclofenac|mesh-list
154212912|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154212913|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154212914|NCT05082662|Analgesics|analgesics|mesh-ancestor
154212915|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
154212916|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154212917|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212918|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212919|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212920|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154212921|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212922|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212923|NCT05015621|Leucovorin|leucovorin|mesh-list
154212924|NCT05015621|Fluorouracil|fluorouracil|mesh-list
154212925|NCT05015621|Irinotecan|irinotecan|mesh-list
154212926|NCT05015621|Calcium|calcium|mesh-list
154212927|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
154212947|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
154212948|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154212949|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212950|NCT04966507|Listerine|listerine|mesh-list
154212951|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154212952|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154212953|NCT04933617|Prednisone|prednisone|mesh-list
154212954|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
154212955|NCT04933617|Rituximab|rituximab|mesh-list
154212956|NCT04933617|Doxorubicin|doxorubicin|mesh-list
154212957|NCT04933617|Etoposide|etoposide|mesh-list
154212958|NCT04933617|Vincristine|vincristine|mesh-list
154212959|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154212960|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
154212961|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154212962|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154212963|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154212964|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
154212965|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154212966|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154212967|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154212968|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154212969|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154212970|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154212971|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154212972|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154212973|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212974|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
154212975|NCT04933617|Hormones|hormones|mesh-ancestor
154212976|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154212977|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154212978|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154212979|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
154212980|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
154212981|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
154212982|NCT04745832|Prednisone|prednisone|mesh-list
154212983|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
154212984|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154212985|NCT04745832|Rituximab|rituximab|mesh-list
154212997|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154212998|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
154213000|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213001|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213002|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154213003|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213004|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213005|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213006|NCT04726592|Ketoprofen|ketoprofen|mesh-list
154213007|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
154213008|NCT04726592|Metoclopramide|metoclopramide|mesh-list
154213009|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
154213010|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
154213011|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213012|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213013|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213014|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154213015|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154213016|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
154213017|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213018|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213019|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153686132|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
154213020|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154213021|NCT04726592|Analgesics|analgesics|mesh-ancestor
154213022|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
154213023|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213024|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213025|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154213026|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213027|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
154213028|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154213029|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154213030|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154213031|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154213032|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
154213033|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
154213034|NCT04686799|Doxycycline|doxycycline|mesh-list
154213035|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154213036|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213037|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
154213038|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154213039|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154213040|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
154213041|NCT04626024|Dasatinib|dasatinib|mesh-list
154213042|NCT04626024|Nilotinib|nilotinib|mesh-list
154213043|NCT04626024|Bosutinib|bosutinib|mesh-list
154213044|NCT04626024|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154213045|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154213046|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213047|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213048|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213049|NCT04561375|Fentanyl|fentanyl|mesh-list
154213060|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
154213061|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
154213062|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154213063|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154213064|NCT04535362|Nicotine|nicotine|mesh-list
154213065|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154213066|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
154213067|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213068|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213069|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154213070|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154213071|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
154213072|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213073|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213074|NCT04518293|Amlodipine|amlodipine|mesh-list
154213075|NCT04518293|Telmisartan|telmisartan|mesh-list
154213076|NCT04518293|Indapamide|indapamide|mesh-list
154213077|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154213078|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154213079|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154213080|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213081|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154213082|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437479|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
154213083|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
154213084|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154213085|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154213086|NCT04518293|Diuretics|diuretics|mesh-ancestor
154213087|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
154213088|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154213089|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
154213090|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
154213091|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213092|NCT04475276|Protective Agents|protective agents|mesh-ancestor
154213093|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213094|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
154213095|NCT04475276|Vitamins|vitamins|mesh-ancestor
154213096|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
154213097|NCT04472429|Paclitaxel|paclitaxel|mesh-list
154213098|NCT04472429|Carboplatin|carboplatin|mesh-list
154213099|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154213100|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213101|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213102|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213103|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213104|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213105|NCT04456387|Factor VIII|factor viii|mesh-list
154213106|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154213107|NCT04456387|Coagulants|coagulants|mesh-ancestor
154213108|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
154213109|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213110|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
154213111|NCT04439799|Testosterone|testosterone|mesh-list
154213112|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
154213113|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
154213114|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153960053|NCT06220162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153960054|NCT06214910|Isoniazid|isoniazid|mesh-list
154213126|NCT04405596|Ambroxol|ambroxol|mesh-list
154213127|NCT04405596|Expectorants|expectorants|mesh-ancestor
154213128|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
154213129|NCT04396821|Paclitaxel|paclitaxel|mesh-list
154213130|NCT04396821|Gemcitabine|gemcitabine|mesh-list
154213131|NCT04396821|Nivolumab|nivolumab|mesh-list
154213132|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154213133|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154213134|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213135|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213136|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213137|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213138|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213139|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154213140|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
154213141|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213142|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154213143|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
154213144|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154213145|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
154213146|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213147|NCT04278898|Expectorants|expectorants|mesh-ancestor
154213148|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
154213149|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154213150|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
154213151|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213152|NCT04278898|Protective Agents|protective agents|mesh-ancestor
154213153|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213154|NCT04278898|Antidotes|antidotes|mesh-ancestor
154213155|NCT04246047|Dexamethasone|dexamethasone|mesh-list
154213156|NCT04246047|Bortezomib|bortezomib|mesh-list
154213157|NCT04246047|Daratumumab|daratumumab|mesh-list
154213158|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213159|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
154213160|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
154213161|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213162|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213163|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213164|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
154213165|NCT04246047|Hormones|hormones|mesh-ancestor
154213166|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213167|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213168|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213187|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154213188|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213189|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154213190|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213191|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213192|NCT04150939|Immunomodulating Agents|immunomodulating agents|mesh-list
154213193|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
153960136|NCT06087328|Nicotine|nicotine|mesh-list
154213195|NCT04080804|Nivolumab|nivolumab|mesh-list
154213196|NCT04080804|Ipilimumab|ipilimumab|mesh-list
154213197|NCT04080804|Relatlimab|relatlimab|mesh-list
154213198|NCT04080804|Antibodies|antibodies|mesh-list
154213199|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
154213200|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
154213201|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213202|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213203|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213204|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154213205|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213206|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
154213207|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154213208|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213209|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154213210|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213211|NCT04070768|Venetoclax|venetoclax|mesh-list
154213212|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
154213213|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213214|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213215|NCT04070768|Immunotoxins|immunotoxins|mesh-ancestor
154213216|NCT04070768|Immunoconjugates|immunoconjugates|mesh-ancestor
154213217|NCT04070768|Immunologic Factors|immunologic factors|mesh-ancestor
154213218|NCT04070768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213219|NCT04058743|Cobalt|cobalt|mesh-list
154213220|NCT04058743|Chromium|chromium|mesh-list
154213221|NCT04058743|Nickel|nickel|mesh-list
154213222|NCT04058743|Trace Elements|trace elements|mesh-ancestor
154213223|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
154213224|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213225|NCT03971409|Doxorubicin|doxorubicin|mesh-list
153636105|NCT00001729|Ribavirin|ribavirin|mesh-list
154213238|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154213239|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154213241|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213242|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213243|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154213244|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154213245|NCT03962647|Letrozole|letrozole|mesh-list
154213246|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213247|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154213248|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154213249|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213250|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213251|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154213252|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
154213253|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213254|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213255|NCT03933215|Cladribine|cladribine|mesh-list
154213256|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213257|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213258|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
154213259|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213260|NCT03928210|Digoxin|digoxin|mesh-list
154213261|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154213262|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154213263|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213264|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213265|NCT03928210|Protective Agents|protective agents|mesh-ancestor
154213266|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213267|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154213268|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213269|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
154213270|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213271|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686407|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
154213272|NCT03897881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154213273|NCT03897881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213274|NCT03857321|Insulin|insulin|mesh-list
154213275|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154213276|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
154213277|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154213278|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213279|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
154213280|NCT03831711|Bombesin|bombesin|mesh-list
154213281|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213282|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213283|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213284|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213285|NCT03789110|Nivolumab|nivolumab|mesh-list
154213286|NCT03789110|Ipilimumab|ipilimumab|mesh-list
154213287|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213288|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213325|NCT03643367|Sevoflurane|sevoflurane|mesh-list
154213326|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154213327|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154213350|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154213351|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213352|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213353|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154213354|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213355|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213357|NCT03545464|Levocetirizine|levocetirizine|mesh-list
154213358|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213359|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
154213360|NCT03545464|Hormones|hormones|mesh-ancestor
154213361|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213362|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213363|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213364|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213365|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154213366|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154213367|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
154213368|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
154213369|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213370|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213371|NCT03351348|Bupivacaine|bupivacaine|mesh-list
154213372|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
154213373|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
154213374|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154213375|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213376|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
154213377|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213378|NCT03326791|Aspirin|aspirin|mesh-list
154213406|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154213407|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154213408|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213409|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213411|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
154213412|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213413|NCT03220776|Expectorants|expectorants|mesh-ancestor
154213414|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
154213415|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154213416|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
154213417|NCT03220776|Protective Agents|protective agents|mesh-ancestor
154213418|NCT03220776|Antidotes|antidotes|mesh-ancestor
153960353|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
154213419|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154213420|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154213421|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213422|NCT03122197|Temozolomide|temozolomide|mesh-list
154213424|NCT03122197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153636310|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
154213441|NCT03014648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213442|NCT03014648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213444|NCT03009045|Tedizolid|tedizolid|mesh-list
154213445|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
154213446|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
154213447|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154213448|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213449|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154213450|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213451|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213452|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
154213453|NCT03006926|Lenvatinib|lenvatinib|mesh-list
154213454|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213455|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213456|NCT03006926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154213457|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213458|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154213459|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213460|NCT02861417|Vidarabine|vidarabine|mesh-list
154213461|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
154213462|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
154213463|NCT02861417|Busulfan|busulfan|mesh-list
154213464|NCT02861417|Thiotepa|thiotepa|mesh-list
154213465|NCT02861417|Fludarabine|fludarabine|mesh-list
154213466|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
154213467|NCT02861417|Tacrolimus|tacrolimus|mesh-list
154213468|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213469|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
154213470|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213471|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213472|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154213473|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
154213474|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213475|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213476|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154213477|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154213478|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
154213479|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
154213480|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213481|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154213482|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213501|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213502|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
154213503|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213504|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213505|NCT02644369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154213506|NCT02644369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213508|NCT02561273|Cortisone|cortisone|mesh-list
154213509|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
154213510|NCT02561273|Doxorubicin|doxorubicin|mesh-list
154213511|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154213512|NCT02561273|Etoposide|etoposide|mesh-list
154213513|NCT02561273|Vincristine|vincristine|mesh-list
154213514|NCT02561273|Lenalidomide|lenalidomide|mesh-list
154213515|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
154213516|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
154213517|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213518|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
154213519|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213520|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213521|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154213522|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
154213523|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213524|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213525|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154213526|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154213527|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154213528|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154213529|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213530|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213531|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
154213532|NCT02561273|Hormones|hormones|mesh-ancestor
153686677|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154213533|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213534|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213535|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154213536|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213537|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213538|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213539|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154213540|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154213541|NCT02561273|Growth Substances|growth substances|mesh-ancestor
154213569|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213570|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213572|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213573|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154213574|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154213575|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213576|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213577|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
154213578|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
154213579|NCT02457598|Idelalisib|idelalisib|mesh-list
154213580|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213581|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213582|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213583|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213584|NCT02327455|Dobutamine|dobutamine|mesh-list
154213585|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154213586|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
154213587|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
154213588|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213589|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539942|NCT01536314|Memantine|memantine|mesh-list
154213602|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213604|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154213605|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
154213606|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213607|NCT02308072|Olaparib|olaparib|mesh-list
154213608|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213609|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154213610|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213611|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213612|NCT02304809|Vemurafenib|vemurafenib|mesh-list
154213613|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213614|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154213615|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686766|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213616|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213617|NCT02246270|Heparin|heparin|mesh-list
154213618|NCT02246270|Calcium heparin|calcium heparin|mesh-list
154213619|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
154213620|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154213621|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154213622|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213623|NCT02101008|Disulfiram|disulfiram|mesh-list
154213624|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154213625|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154213626|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213627|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213628|NCT02006576|Ibuprofen|ibuprofen|mesh-list
154213629|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154213630|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154213631|NCT02006576|Analgesics|analgesics|mesh-ancestor
154213632|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
154213633|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213634|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213635|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213636|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213637|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154213638|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213639|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213640|NCT01913730|Dexamethasone|dexamethasone|mesh-list
154213641|NCT01913730|Bortezomib|bortezomib|mesh-list
154213642|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213643|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
154213644|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
154213645|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213646|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213647|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213649|NCT01913730|Hormones|hormones|mesh-ancestor
153539943|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154213668|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213669|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213670|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213671|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
154213672|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154213673|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213674|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
154263452|NCT05549037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213675|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213676|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154213677|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213678|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213679|NCT01352520|Immunotoxins|immunotoxins|mesh-ancestor
154213680|NCT01352520|Immunoconjugates|immunoconjugates|mesh-ancestor
154213681|NCT01352520|Immunologic Factors|immunologic factors|mesh-ancestor
154213682|NCT01352520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213683|NCT01309672|Prednisone|prednisone|mesh-list
154213684|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
154213685|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213686|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
154213687|NCT01309672|Hormones|hormones|mesh-ancestor
154213688|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213689|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213690|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213691|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213692|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154213693|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213694|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213695|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
154213696|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154213697|NCT01088750|Prednisolone|prednisolone|mesh-list
154213698|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
154213699|NCT01088750|Vinblastine|vinblastine|mesh-list
154213700|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213701|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
154213702|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213703|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213704|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154213705|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
153636573|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
154213718|NCT00393471|Etanercept|etanercept|mesh-list
154213719|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154213720|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154213722|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
154213723|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213724|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213725|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154213726|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213727|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213728|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213729|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
154213730|NCT00340704|Tamsulosin|tamsulosin|mesh-list
154213731|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154213732|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154213733|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154213734|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
154213735|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213736|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213737|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213738|NCT00340704|Urological Agents|urological agents|mesh-ancestor
154213739|NCT00132496|Rabeprazole|rabeprazole|mesh-list
154213740|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154213741|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213742|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154213743|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213744|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213745|NCT01080586|Cyclosporine|cyclosporine|mesh-list
154213746|NCT01080586|Cyclosporins|cyclosporins|mesh-list
154213747|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213748|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213749|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213750|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
154213751|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213752|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
154213753|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213754|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
154213755|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213756|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154213757|NCT00231777|Ondansetron|ondansetron|mesh-list
154213758|NCT00231777|Aprepitant|aprepitant|mesh-list
154213759|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
154213760|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
154213761|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154213762|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213763|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213764|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
154213765|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
154213766|NCT00231777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154213767|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153636629|NCT00000555|Vitamins|vitamins|mesh-ancestor
154213784|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213785|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
154213786|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213787|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213788|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154213789|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
154213790|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213791|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213792|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154213794|NCT00231465|Gefitinib|gefitinib|mesh-list
154213795|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213796|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213797|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213798|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213799|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213800|NCT00231465|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154213801|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154213802|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213803|NCT00254397|Leuprolide|leuprolide|mesh-list
154213804|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154213805|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
154213806|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153523861|NCT01422148|Minocycline|minocycline|mesh-list
154213807|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213808|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213809|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213810|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
154213811|NCT00254163|Rituximab|rituximab|mesh-list
154213812|NCT00254163|Fludarabine|fludarabine|mesh-list
154213813|NCT00254163|Pentostatin|pentostatin|mesh-list
154213814|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154213815|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
154213816|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213817|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213818|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154213819|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
154213820|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213821|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213822|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154213823|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154213824|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154213825|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213842|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213843|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213844|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
154213845|NCT00122278|Hormones|hormones|mesh-ancestor
154213846|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213847|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154213848|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213849|NCT00182091|Hormones|hormones|mesh-list
154213850|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213851|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213852|NCT01072071|Furosemide|furosemide|mesh-list
154213853|NCT01072071|Diuretics|diuretics|mesh-ancestor
154213854|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
154213855|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213856|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154213857|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154213858|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213859|NCT00181155|Allopurinol|allopurinol|mesh-list
154213860|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
154213861|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437804|NCT00003788|Carmustine|carmustine|mesh-list
154213862|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213863|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
154213864|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154213865|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154213866|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
154213867|NCT00181155|Protective Agents|protective agents|mesh-ancestor
154213868|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213869|NCT00322452|Paclitaxel|paclitaxel|mesh-list
154213870|NCT00322452|Carboplatin|carboplatin|mesh-list
154213871|NCT00322452|Gefitinib|gefitinib|mesh-list
154213872|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154213873|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213874|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213875|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213876|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213877|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213878|NCT00322452|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154213879|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154213880|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213881|NCT00110812|Aldesleukin|aldesleukin|mesh-list
154213882|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213883|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154213884|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154213905|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154213906|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154213907|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213908|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213909|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
154213910|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
154213911|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
154213912|NCT00174447|Ziprasidone|ziprasidone|mesh-list
154213913|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154213914|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
154213915|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154213916|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213917|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213918|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154213919|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154213920|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154213921|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154213922|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154213923|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
154213924|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
154213925|NCT00321984|Lansoprazole|lansoprazole|mesh-list
154213926|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154213927|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154213928|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154213929|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213930|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213931|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154213932|NCT01060488|Hormones|hormones|mesh-ancestor
154213933|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154213934|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213935|NCT01060566|Ivacaftor|ivacaftor|mesh-list
154213936|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154213937|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636812|NCT00389025|Analgesics|analgesics|mesh-ancestor
154213959|NCT00110266|Deferasirox|deferasirox|mesh-list
154213960|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154213961|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
154213962|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
154213963|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213964|NCT00366548|Vaccines|vaccines|mesh-list
154213965|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154213966|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
154213967|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154213968|NCT01074645|Tenofovir|tenofovir|mesh-list
154213969|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
154213970|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154213971|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154213972|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154213974|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213975|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154213976|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154213977|NCT00132028|Vorinostat|vorinostat|mesh-list
154213978|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213979|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154213980|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154213981|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154213982|NCT01045304|Carboplatin|carboplatin|mesh-list
154213983|NCT01045304|Gemcitabine|gemcitabine|mesh-list
154213984|NCT01045304|Iniparib|iniparib|mesh-list
154213985|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154213986|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154213987|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
153687188|NCT00162214|Ketoconazole|ketoconazole|mesh-list
154213988|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636861|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214024|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
153636913|NCT00000681|Sargramostim|sargramostim|mesh-list
154214035|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154214036|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214038|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154214039|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
154214040|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214041|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154214042|NCT00096382|Aldesleukin|aldesleukin|mesh-list
154214043|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
154214044|NCT00096382|Fludarabine|fludarabine|mesh-list
154214045|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
154214046|NCT00096382|Interleukin-2|interleukin-2|mesh-list
154214047|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214048|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
154214049|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214050|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214051|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154214052|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
154214053|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214054|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214055|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154214056|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154214057|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
154214058|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154214059|NCT00096382|Analgesics|analgesics|mesh-ancestor
154214060|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
154214061|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214062|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154214063|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154214064|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
154214065|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214066|NCT00384332|Olanzapine|olanzapine|mesh-list
154214067|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
154214068|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
154214069|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214070|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214071|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214072|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154214073|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154214074|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214075|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154214076|NCT00384332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154214077|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154214078|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154214079|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214080|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214081|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
154214082|NCT00096226|Paclitaxel|paclitaxel|mesh-list
154214083|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154214084|NCT00096226|Carboplatin|carboplatin|mesh-list
153687271|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154214085|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154214086|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214087|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
154214088|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
154214089|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
153636953|NCT00000690|Dextrans|dextrans|mesh-list
154214103|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154214104|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
154214105|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154214106|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
154214107|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214108|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214109|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154214110|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
154214111|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
154214112|NCT03964324|Protective Agents|protective agents|mesh-ancestor
154214113|NCT01082848|Aripiprazole|aripiprazole|mesh-list
154214114|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
154214115|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154214116|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154214117|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154214118|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214119|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214120|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
154214121|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
154214122|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214123|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214124|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154214125|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154214126|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
154214127|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154214128|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154214129|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154214130|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154214131|NCT01082926|Aldesleukin|aldesleukin|mesh-list
154214132|NCT01082926|Interleukin-2|interleukin-2|mesh-list
154214133|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214134|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154214135|NCT01082926|Analgesics|analgesics|mesh-ancestor
154214136|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
154214137|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214138|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214139|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154214140|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154214141|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
154214142|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214143|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154214144|NCT01078870|Escitalopram|escitalopram|mesh-list
154214145|NCT01078870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154214146|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154214147|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154214148|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214170|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154214171|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154214172|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
154214173|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154214174|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154214175|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154214176|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154214178|NCT00104572|Anastrozole|anastrozole|mesh-list
154214179|NCT00104572|Calcium|calcium|mesh-list
154214180|NCT00104572|Testosterone|testosterone|mesh-list
154214181|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154214182|NCT00104572|Vitamins|vitamins|mesh-ancestor
154214183|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
154214184|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214185|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154214186|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154214187|NCT00104572|Androgens|androgens|mesh-ancestor
154214188|NCT00104572|Hormones|hormones|mesh-ancestor
154214189|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154214190|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154214191|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214192|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154214194|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214196|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
154214197|NCT00514943|Cetuximab|cetuximab|mesh-list
154214198|NCT00514943|Afatinib|afatinib|mesh-list
154214199|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154214200|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214201|NCT00514943|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154214202|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154214213|NCT00103402|Urological Agents|urological agents|mesh-ancestor
154214215|NCT00095836|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154214216|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154214217|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214218|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214219|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214220|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
154214221|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154214222|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
154214223|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214224|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214225|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154214226|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
154214227|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
154214228|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154214229|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
154214230|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214231|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214232|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
154214233|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154214234|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154214235|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154214236|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154214237|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154214238|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214239|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
154214240|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214241|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214242|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154214243|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214245|NCT03235505|Varenicline|varenicline|mesh-list
154214246|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154214247|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
154214248|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214249|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214250|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154214251|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154214252|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
154214253|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214254|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214255|NCT00251979|Esomeprazole|esomeprazole|mesh-list
154214256|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154214257|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214258|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154214259|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214260|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214261|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
154214262|NCT00511901|Hematinics|hematinics|mesh-ancestor
154214263|NCT04580147|Aflibercept|aflibercept|mesh-list
154214264|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153637131|NCT00000768|Ganciclovir|ganciclovir|mesh-list
154214276|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214277|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214278|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214279|NCT00513695|Paclitaxel|paclitaxel|mesh-list
154214280|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
154214281|NCT00513695|Doxorubicin|doxorubicin|mesh-list
154214282|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154214283|NCT00513695|Sunitinib|sunitinib|mesh-list
154214284|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154214285|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214286|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
154214287|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
154214289|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214290|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214291|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
154214292|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214293|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214294|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154214295|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
154214296|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154214297|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154214298|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154214299|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154214300|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214301|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154214302|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154214303|NCT00513695|Growth Substances|growth substances|mesh-ancestor
154214304|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
154214305|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154214306|NCT00162981|Clobazam|clobazam|mesh-list
154214307|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
154214308|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154214309|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154214310|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214311|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214312|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154214313|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154214314|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
154214315|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
154214316|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214317|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214319|NCT00099268|Carbidopa|carbidopa|mesh-list
154214320|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154214321|NCT00099268|Entacapone|entacapone|mesh-list
154214322|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154214323|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154214324|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
154214325|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214326|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214327|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637192|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214342|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154214343|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
154214344|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154214345|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154214346|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154214347|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154214348|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154214349|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154214351|NCT01083784|Clonazepam|clonazepam|mesh-list
154214352|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
154214353|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214354|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214355|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
154214356|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214357|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214358|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
154214359|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154214360|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214361|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154214362|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
154214363|NCT00095212|Testosterone|testosterone|mesh-list
154214364|NCT00095212|Androgens|androgens|mesh-ancestor
154214365|NCT00095212|Hormones|hormones|mesh-ancestor
154214366|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154214367|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214368|NCT00120874|Memantine|memantine|mesh-list
154214369|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154214370|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154214371|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
154214372|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214373|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214374|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214375|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154214376|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154214377|NCT00120250|Eszopiclone|eszopiclone|mesh-list
154214378|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154214379|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214380|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214381|NCT01081600|Trastuzumab|trastuzumab|mesh-list
154214382|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154214383|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214384|NCT01079338|Caffeine|caffeine|mesh-list
154214385|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153637257|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
154214396|NCT00384176|Fluorouracil|fluorouracil|mesh-list
154214397|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
154214398|NCT00384176|Cediranib|cediranib|mesh-list
154214399|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154214400|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214401|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154214402|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154214403|NCT00384176|Growth Substances|growth substances|mesh-ancestor
154214404|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214405|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
154214406|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
154214407|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214408|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154214409|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214410|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
154214411|NCT00384176|Antidotes|antidotes|mesh-ancestor
154214412|NCT00384176|Protective Agents|protective agents|mesh-ancestor
154214413|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
154214414|NCT00384176|Vitamins|vitamins|mesh-ancestor
154214415|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
154214416|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154214417|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214418|NCT00513305|Cytarabine|cytarabine|mesh-list
154214419|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
154214420|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154214421|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
154214422|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214423|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214424|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
154214425|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214426|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214427|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
154214428|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214429|NCT00513071|Saracatinib|saracatinib|mesh-list
154214430|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214431|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214432|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214433|NCT00510887|Dexamethasone|dexamethasone|mesh-list
154214434|NCT00510887|Rituximab|rituximab|mesh-list
154214435|NCT00510887|Fludarabine|fludarabine|mesh-list
154214436|NCT00510887|Bortezomib|bortezomib|mesh-list
154214437|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
154214438|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214439|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
154214440|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
154214441|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214442|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214443|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214444|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
154214445|NCT00510887|Hormones|hormones|mesh-ancestor
154214446|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154214447|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154214448|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214449|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154214450|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
154214451|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214452|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637317|NCT00000870|Stavudine|stavudine|mesh-list
154214486|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
154214487|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214488|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214489|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
154214490|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154214491|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154214492|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637386|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214504|NCT01009697|Codeine|codeine|mesh-list
154214505|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154214506|NCT01009697|Narcotics|narcotics|mesh-ancestor
154214507|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214508|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214509|NCT01009697|Analgesics|analgesics|mesh-ancestor
154214510|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
154214511|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214512|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
154214513|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
154214514|NCT01009853|Codeine|codeine|mesh-list
154214515|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154214516|NCT01009853|Narcotics|narcotics|mesh-ancestor
154214517|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214518|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214519|NCT01009853|Analgesics|analgesics|mesh-ancestor
154214520|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
154214521|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214522|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
154214523|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
154214524|NCT00506285|Methylphenidate|methylphenidate|mesh-list
154214525|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154214526|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214527|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154214528|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154214529|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154214530|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214531|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
154214532|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214533|NCT00506129|Fludarabine|fludarabine|mesh-list
154214534|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
154214535|NCT00506129|Melphalan|melphalan|mesh-list
154214536|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
154214537|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154214538|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214539|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154214540|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
154214541|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214542|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214543|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
154214544|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214545|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154214546|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
154214547|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154214548|NCT00358670|Infliximab|infliximab|mesh-list
154214549|NCT00358670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154214550|NCT00358670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214551|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
154214552|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214553|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214554|NCT01010087|Oseltamivir|oseltamivir|mesh-list
154214555|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
154214584|NCT01010243|Treosulfan|treosulfan|mesh-list
154214585|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214586|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
154214587|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
154214588|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214589|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214590|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214591|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
154214592|NCT01010243|Hormones|hormones|mesh-ancestor
154214593|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154214594|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154214595|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214596|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
154214597|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154214598|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154214599|NCT01010243|Growth Substances|growth substances|mesh-ancestor
154214600|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
154214601|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154214629|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154214630|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
154214631|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154214632|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154214633|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154214634|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
154214635|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214636|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214637|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214638|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
154214639|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154214640|NCT00362180|Mipomersen|mipomersen|mesh-list
154214641|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154214642|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154214643|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
154214644|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214645|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154214646|NCT00383162|Naproxen|naproxen|mesh-list
154214647|NCT00383162|Sumatriptan|sumatriptan|mesh-list
154214648|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154214671|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214672|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214673|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214674|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
154214675|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154214676|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214677|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214679|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154214680|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154214681|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214682|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214683|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
154214684|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153961633|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
154214685|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214686|NCT01052870|Urological Agents|urological agents|mesh-ancestor
154214687|NCT00358436|Bromides|bromides|mesh-list
154214688|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
154214689|NCT01053026|Olmesartan|olmesartan|mesh-list
154214690|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154214691|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154214692|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154214693|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214694|NCT01045538|Capecitabine|capecitabine|mesh-list
154214695|NCT01045538|Vorinostat|vorinostat|mesh-list
154214696|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214697|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154214719|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154214720|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
154214721|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688107|NCT00167401|Docetaxel|docetaxel|mesh-list
154214722|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214723|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214724|NCT00357656|Factor VIII|factor viii|mesh-list
154214725|NCT00357656|Coagulants|coagulants|mesh-ancestor
154214726|NCT00357500|Thalidomide|thalidomide|mesh-list
154214727|NCT00357500|Celecoxib|celecoxib|mesh-list
154214728|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
154214729|NCT00357500|Etoposide|etoposide|mesh-list
154214730|NCT00357500|Fenofibrate|fenofibrate|mesh-list
154214731|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214732|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
154214733|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214734|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214735|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154214736|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
154214737|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214738|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214739|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154214740|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154214741|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154214742|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154214743|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214744|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154214745|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154214746|NCT00357500|Analgesics|analgesics|mesh-ancestor
154214747|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
154214748|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214749|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214779|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154214780|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154214781|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
154214782|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154214783|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154214784|NCT02531152|Latanoprost|latanoprost|mesh-list
154214785|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154214786|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154214787|NCT01084408|Paclitaxel|paclitaxel|mesh-list
154214788|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154214789|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154214790|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214791|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
154214792|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
154214793|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
154214794|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214821|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
154214822|NCT01053338|Promethazine|promethazine|mesh-list
154214823|NCT01053338|Ibuprofen|ibuprofen|mesh-list
154214824|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214825|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154214826|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154214827|NCT01053338|Analgesics|analgesics|mesh-ancestor
154214828|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
154214829|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214830|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214831|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154214832|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154214833|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154214834|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214835|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154214836|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154214837|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214838|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
154214839|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
154214840|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
154214841|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
154214842|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214843|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154214861|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154214862|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
154214863|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
154214864|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
154214865|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214866|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214867|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
154214868|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154214869|NCT00360698|Insulin|insulin|mesh-list
154214870|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154214871|NCT00360698|Metformin|metformin|mesh-list
154214872|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
154214873|NCT00360698|Glimepiride|glimepiride|mesh-list
154214874|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
154214875|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154214876|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214877|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154214878|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154214879|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
154214880|NCT03990194|Leuprolide|leuprolide|mesh-list
154214881|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154214882|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
154214883|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154214884|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214885|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154214886|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214887|NCT00380978|Narcotics|narcotics|mesh-list
154214888|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154214889|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154214890|NCT00380978|Analgesics|analgesics|mesh-ancestor
154214891|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
154214892|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154214893|NCT00162123|Ipilimumab|ipilimumab|mesh-list
154214894|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154214895|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688318|NCT00168610|Vitamin A|vitamin a|mesh-list
154214896|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154214897|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214898|NCT00227721|Gemcitabine|gemcitabine|mesh-list
154214899|NCT00227721|Docetaxel|docetaxel|mesh-list
154214900|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154214901|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
154214902|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154214903|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154214904|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
154214905|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
154214906|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
154214938|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
154214939|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
154214940|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154214941|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154214942|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
154214943|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
154214944|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154214945|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154214946|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
154214947|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
154214948|NCT01075503|Ropivacaine|ropivacaine|mesh-list
154214949|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
154214950|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
154214987|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215013|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215014|NCT00493025|Paclitaxel|paclitaxel|mesh-list
154215015|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154215016|NCT00493025|Cisplatin|cisplatin|mesh-list
154215017|NCT00493025|Gefitinib|gefitinib|mesh-list
154215018|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154215019|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215020|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
154215021|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
154215022|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
154215023|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215024|NCT00493025|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215025|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215026|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215027|NCT01075113|Sorafenib|sorafenib|mesh-list
154215028|NCT01075113|Vorinostat|vorinostat|mesh-list
154215029|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215030|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215031|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215032|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215033|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154215034|NCT01073319|Rivastigmine|rivastigmine|mesh-list
154215035|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154215036|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215037|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215071|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215072|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215074|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215075|NCT00379808|Montelukast|montelukast|mesh-list
153688446|NCT00054977|Fluorouracil|fluorouracil|mesh-list
154215076|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154215077|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
154215078|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154215079|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
154215080|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215081|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215107|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154215108|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
154215109|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
154215110|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438220|NCT00003908|Carboplatin|carboplatin|mesh-list
154215111|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215112|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
154215113|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215114|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215115|NCT01053650|Acetaminophen|acetaminophen|mesh-list
154215116|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154215117|NCT01053650|Analgesics|analgesics|mesh-ancestor
154215118|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
154215119|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215120|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215121|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
154215122|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
154215123|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215124|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215126|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154215127|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215128|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154215129|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215130|NCT01053806|Lenalidomide|lenalidomide|mesh-list
154215165|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215166|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215167|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215168|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154215169|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638067|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
154215205|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215235|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154215236|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154215237|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
154215238|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
154215239|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215240|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215241|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154215242|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154215243|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154215244|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
154215245|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215246|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215247|NCT01011257|Clopidogrel|clopidogrel|mesh-list
154215248|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154215249|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154215250|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154215281|NCT01015547|Analgesics|analgesics|mesh-ancestor
154215282|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
154215283|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215284|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154215285|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154215286|NCT00491075|Gemcitabine|gemcitabine|mesh-list
154215287|NCT00491075|Pemetrexed|pemetrexed|mesh-list
154215288|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215289|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
154215290|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215291|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215292|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215293|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154215330|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154215331|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
154215332|NCT01015937|Turmeric extract|turmeric extract|mesh-list
154215333|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154215334|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154215353|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215354|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215356|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
154215357|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154215358|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154215359|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
153688683|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154215360|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153962312|NCT05549115|Amoxicillin|amoxicillin|mesh-list
154215362|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
154215363|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154215364|NCT01012193|Protective Agents|protective agents|mesh-ancestor
154215365|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154215366|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154215367|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215368|NCT00503399|Teriparatide|teriparatide|mesh-list
154215369|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
154215370|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154215371|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215372|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154215373|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154215374|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154215375|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215376|NCT00506519|Antithrombins|antithrombins|mesh-list
154215377|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
154215378|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154215379|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
154215380|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215381|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215382|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
154215383|NCT00503009|Fluticasone|fluticasone|mesh-list
154215384|NCT00503009|Xhance|xhance|mesh-list
154215385|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154215386|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215387|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154215395|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154215396|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154215397|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154215398|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
154215399|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215400|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215402|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154215403|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215404|NCT00160251|Ribavirin|ribavirin|mesh-list
154215405|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154215406|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
154215407|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215408|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
154215409|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215410|NCT01075425|Bortezomib|bortezomib|mesh-list
154215411|NCT01075425|Belinostat|belinostat|mesh-list
154215412|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215413|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154215414|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215415|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215416|NCT00378014|Everolimus|everolimus|mesh-list
154215417|NCT00378014|Basiliximab|basiliximab|mesh-list
154215418|NCT00378014|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154215419|NCT00378014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215420|NCT00378014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215421|NCT00378014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215422|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215423|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
154215424|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215425|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215426|NCT00485303|Prednisone|prednisone|mesh-list
154215427|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
154215428|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215429|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
154215430|NCT00485303|Hormones|hormones|mesh-ancestor
154215431|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215432|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153962379|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215433|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154215434|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215436|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215437|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215438|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
154215439|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154215441|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154215442|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215443|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215444|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215445|NCT01016249|Epinephrine|epinephrine|mesh-list
154215446|NCT01016249|Racepinephrine|racepinephrine|mesh-list
154215447|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
154215448|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154215449|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154215450|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
154215451|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215452|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215453|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215483|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154215484|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
154215485|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
154215486|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215487|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215488|NCT01013675|Vaccines|vaccines|mesh-list
154215489|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
154215490|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215491|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154215492|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154215493|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215494|NCT01054118|Incretins|incretins|mesh-ancestor
154215495|NCT01054118|Hormones|hormones|mesh-ancestor
154215496|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215497|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154215498|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
154215499|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215500|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215501|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154215518|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215519|NCT00355082|Lamotrigine|lamotrigine|mesh-list
154215520|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
154215521|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154215522|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154215523|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215524|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154215525|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215526|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154215527|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154215528|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154215529|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154215530|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154215531|NCT00502307|Tivozanib|tivozanib|mesh-list
154215532|NCT00502307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215533|NCT00502307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215534|NCT00502307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215535|NCT00484679|Triamcinolone|triamcinolone|mesh-list
154215536|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154215537|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154215538|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154215539|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215540|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
154215541|NCT00484679|Hormones|hormones|mesh-ancestor
154215542|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215543|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215544|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215545|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
154215546|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215547|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215548|NCT00377312|Hormones|hormones|mesh-list
154215549|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
154215550|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215551|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215552|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154215553|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
154215554|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
154215555|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154215556|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154215583|NCT00376220|Protective Agents|protective agents|mesh-ancestor
154215585|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215586|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154215587|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154215588|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215589|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215590|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154215591|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
154215592|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215593|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215594|NCT00484289|Abatacept|abatacept|mesh-list
154215595|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154215596|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215597|NCT00484289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154215598|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215599|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215600|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
154215629|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154215630|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154215631|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154215632|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154215633|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154215634|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154215635|NCT01019291|Formaldehyde|formaldehyde|mesh-list
154215636|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
154215637|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215638|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
154215639|NCT01019447|Triclosan|triclosan|mesh-list
154215640|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154215641|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154215642|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154215643|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154215644|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
154215645|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215646|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154215647|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
154215665|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215666|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
154215667|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215668|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215669|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
154215670|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215671|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215672|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
154215673|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215674|NCT00333840|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215675|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215676|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215677|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
154215678|NCT01019603|Tazarotene|tazarotene|mesh-list
154215679|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
154215680|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
154215681|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
154215682|NCT01019603|Vitamins|vitamins|mesh-ancestor
154215683|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
154215684|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215685|NCT00321906|Sirolimus|sirolimus|mesh-list
154215686|NCT00321906|Azathioprine|azathioprine|mesh-list
154215687|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154215688|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154215689|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154215690|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215691|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
154215692|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215693|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
154215694|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215695|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215696|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
154215697|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215698|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215699|NCT00339144|Dasatinib|dasatinib|mesh-list
154215700|NCT00339144|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215701|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215702|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215703|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215704|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215706|NCT00321828|Bevacizumab|bevacizumab|mesh-list
154215707|NCT00321828|Fluorouracil|fluorouracil|mesh-list
154215723|NCT00321828|Protective Agents|protective agents|mesh-ancestor
154215724|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
154215725|NCT00321828|Vitamins|vitamins|mesh-ancestor
154215726|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
154215727|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154215728|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154215729|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215730|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153962677|NCT05804305|Misoprostol|misoprostol|mesh-list
154215731|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
154215732|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215734|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
154215735|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215736|NCT01058382|Progesterone|progesterone|mesh-list
154215737|NCT01058382|Progestins|progestins|mesh-ancestor
154215738|NCT01058382|Hormones|hormones|mesh-ancestor
154215739|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215740|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215741|NCT01061814|Mipomersen|mipomersen|mesh-list
154215742|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154215743|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154215744|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
154215745|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215746|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154215747|NCT00331422|Paclitaxel|paclitaxel|mesh-list
154215748|NCT00331422|Carboplatin|carboplatin|mesh-list
154215749|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154215750|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215751|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
154215752|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
154215753|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
154215754|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215755|NCT00331344|Prednisone|prednisone|mesh-list
154215756|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
154215757|NCT00331344|Epothilone B|epothilone b|mesh-list
154215758|NCT00331344|Epothilones|epothilones|mesh-list
154215759|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215760|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
154215761|NCT00331344|Hormones|hormones|mesh-ancestor
154215762|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154215763|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215764|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154215765|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215766|NCT00331344|Analgesics|analgesics|mesh-ancestor
154215767|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
154215791|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215792|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
154215793|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154215794|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154215795|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
154215796|NCT00338286|Hematinics|hematinics|mesh-ancestor
154215797|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
154215798|NCT00329550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154215799|NCT00329550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215800|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215801|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
154215802|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215803|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215804|NCT00375674|Sunitinib|sunitinib|mesh-list
154215805|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215806|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154215807|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154215808|NCT00375674|Growth Substances|growth substances|mesh-ancestor
154215809|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215810|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
154215811|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215812|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215813|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215814|NCT03991910|Ramipril|ramipril|mesh-list
154215815|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154215816|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
154215817|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215818|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215819|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154215820|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
154215894|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154215895|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154215927|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215928|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154215929|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154215930|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154215931|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154215932|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215933|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154215934|NCT00490139|Trastuzumab|trastuzumab|mesh-list
154215935|NCT00490139|Lapatinib|lapatinib|mesh-list
154215936|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154215937|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215938|NCT00490139|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154215939|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154215940|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154215962|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
154215963|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154215964|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154215965|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
154215966|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215967|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154215968|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154215969|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
154215970|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215971|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215972|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154215973|NCT01016639|Capecitabine|capecitabine|mesh-list
154215974|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
154215975|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154215976|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
154215977|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215978|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154215979|NCT00501293|Methylphenidate|methylphenidate|mesh-list
154215980|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154215981|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154215982|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154215983|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154215984|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154215985|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154215986|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
154215987|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154215988|NCT01014221|Prednisolone|prednisolone|mesh-list
154215989|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154215990|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
154215991|NCT01014221|Hormones|hormones|mesh-ancestor
153638884|NCT00014638|Letrozole|letrozole|mesh-list
154216017|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216018|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
154216019|NCT03988010|Amantadine|amantadine|mesh-list
154216020|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154216021|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154216022|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
154216023|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216024|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
154216025|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216026|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216027|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216028|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216029|NCT03988010|Analgesics|analgesics|mesh-ancestor
154216030|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
154216031|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216033|NCT01055522|Dacarbazine|dacarbazine|mesh-list
154216034|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216035|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216036|NCT01055522|Analgesics|analgesics|mesh-ancestor
154216037|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
154216038|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216039|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216070|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154216071|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154216072|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216073|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154216074|NCT00328926|Hormones|hormones|mesh-list
154216075|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154216076|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154216077|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216078|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154216079|NCT00319254|Bosutinib|bosutinib|mesh-list
154216080|NCT00319254|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154216081|NCT00319254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153638988|NCT00014755|Hormones|hormones|mesh-ancestor
154216172|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216173|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154216174|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
154216176|NCT00350636|Oxybutynin|oxybutynin|mesh-list
154216177|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
154216178|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
154216179|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216180|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216181|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154216182|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154216183|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
154216184|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216185|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216186|NCT00350636|Urological Agents|urological agents|mesh-ancestor
154216187|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154216188|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216189|NCT01051544|Factor VIII|factor viii|mesh-list
154216190|NCT01051544|Coagulants|coagulants|mesh-ancestor
154216191|NCT01058720|Vitamin D|vitamin d|mesh-list
154216192|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
154216193|NCT01058720|Vitamins|vitamins|mesh-ancestor
154216194|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
154216195|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216196|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154216197|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154216198|NCT00346268|Parecoxib|parecoxib|mesh-list
154216199|NCT00346268|Morphine|morphine|mesh-list
154216200|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154216201|NCT00346268|Narcotics|narcotics|mesh-ancestor
154216202|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216203|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216204|NCT00346268|Analgesics|analgesics|mesh-ancestor
154216205|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
154216206|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216207|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154216208|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154216209|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216210|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216211|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154216212|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153639151|NCT00001365|Levomethorphan|levomethorphan|mesh-list
154216280|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216281|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216282|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154216283|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154216284|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154216285|NCT01051934|Growth Substances|growth substances|mesh-ancestor
154216286|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216287|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
154216288|NCT01325168|Oxytocin|oxytocin|mesh-list
154216289|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
154216290|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154216291|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216313|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154216314|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216315|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216316|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216318|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
154216319|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216320|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154216321|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154216322|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154216323|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
154216324|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216325|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216326|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154216327|NCT00335972|Narcotics|narcotics|mesh-ancestor
154216328|NCT03983460|Betamethasone|betamethasone|mesh-list
154216329|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
154216330|NCT03983460|Clobetasol|clobetasol|mesh-list
154216331|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216332|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
154216333|NCT03983460|Hormones|hormones|mesh-ancestor
154216334|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154216335|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216336|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154216337|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
154216338|NCT01056614|Methotrexate|methotrexate|mesh-list
154216339|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
154216340|NCT01056614|Fludarabine|fludarabine|mesh-list
154216341|NCT01056614|Busulfan|busulfan|mesh-list
154216342|NCT01056614|Tacrolimus|tacrolimus|mesh-list
154216343|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
154216344|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154216374|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154216376|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154216377|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216378|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154216379|NCT00345878|Vaccines|vaccines|mesh-list
154216380|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
154216381|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216382|NCT01059110|Salicylates|salicylates|mesh-list
154216383|NCT01059110|Imiquimod|imiquimod|mesh-list
154216384|NCT01059110|Fluorouracil|fluorouracil|mesh-list
154216385|NCT01059110|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154216386|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639283|NCT00016315|Paclitaxel|paclitaxel|mesh-list
154216402|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216403|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154216404|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216405|NCT03991364|Methamphetamine|methamphetamine|mesh-list
154216406|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153689665|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
154216407|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216408|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
154216409|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
154216410|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216411|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
154216412|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216413|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216414|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
154216415|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154216416|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154216417|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154216418|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154216420|NCT00335738|Etoposide|etoposide|mesh-list
154216421|NCT00335738|Vincristine|vincristine|mesh-list
154216422|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
154216423|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216424|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154216425|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154216426|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154216427|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216428|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216429|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154216430|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216431|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216432|NCT02533076|Capsaicin|capsaicin|mesh-list
154216433|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
154216434|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
154216435|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
154216436|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216437|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216438|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154216439|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216440|NCT01056926|Nicotine|nicotine|mesh-list
154216441|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154216442|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
154216443|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639327|NCT00006023|Capecitabine|capecitabine|mesh-list
154216458|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216459|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154216460|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154216461|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154216462|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154216463|NCT01052246|Clindamycin|clindamycin|mesh-list
154216464|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
154216465|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
154216466|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154216467|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154216468|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216469|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154216470|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216471|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216472|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
154216473|NCT00334958|Rufinamide|rufinamide|mesh-list
154216474|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
154216475|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154216476|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154216477|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154216478|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216479|NCT00326898|Sorafenib|sorafenib|mesh-list
154216480|NCT00326898|Sunitinib|sunitinib|mesh-list
154216481|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216482|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154216483|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216484|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216485|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154216486|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154216487|NCT00326898|Growth Substances|growth substances|mesh-ancestor
154216488|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216489|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
154216490|NCT01062360|Aspirin|aspirin|mesh-list
154216491|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
154216492|NCT01062360|Ephedrine|ephedrine|mesh-list
154216493|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154216494|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216495|NCT01062360|Analgesics|analgesics|mesh-ancestor
154216496|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
154216497|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216498|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216499|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216500|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216501|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154216502|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154216503|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216535|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216536|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216537|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216538|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
154216539|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154216540|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216541|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216543|NCT01062516|Famotidine|famotidine|mesh-list
154216544|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154216545|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154216546|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154216547|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639442|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216560|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216561|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438666|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
154216562|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154216563|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
154216564|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
154216565|NCT03985358|Narcotics|narcotics|mesh-ancestor
154216566|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216567|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216568|NCT03985358|Analgesics|analgesics|mesh-ancestor
154216569|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
154216570|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216571|NCT01052324|Remifentanil|remifentanil|mesh-list
154216572|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154216573|NCT01052324|Narcotics|narcotics|mesh-ancestor
154216574|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216575|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216576|NCT01052324|Analgesics|analgesics|mesh-ancestor
154216577|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
154216578|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216579|NCT01059890|Metronidazole|metronidazole|mesh-list
154216580|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
154216582|NCT01059890|Cefoxitin|cefoxitin|mesh-list
154216583|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216584|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154216585|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154216586|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154216587|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154216588|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154216589|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216590|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216591|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216592|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154216593|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154216594|NCT01057160|Rizatriptan|rizatriptan|mesh-list
154216595|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154216596|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
154216597|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216598|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216599|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216600|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
154216601|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154216602|NCT00307086|Bortezomib|bortezomib|mesh-list
154216603|NCT00307086|Melphalan|melphalan|mesh-list
154216604|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216605|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154216606|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
154216607|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639490|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
154216627|NCT00325416|Topotecan|topotecan|mesh-list
154216628|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154216629|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
154216630|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216631|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216632|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154216633|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216634|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
154216635|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216636|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154216637|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154216638|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216639|NCT00314808|Dronabinol|dronabinol|mesh-list
153690062|NCT00182104|Warfarin|warfarin|mesh-list
154216640|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
154216641|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216642|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154216643|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216644|NCT00314808|Analgesics|analgesics|mesh-ancestor
154216645|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
154216646|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216647|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154216648|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154216649|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216650|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216651|NCT00314808|Hormones|hormones|mesh-ancestor
154216652|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154216653|NCT01060514|Vinorelbine|vinorelbine|mesh-list
154216654|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154216655|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216656|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
154216657|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216658|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216659|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216660|NCT06252584|Vaccines|vaccines|mesh-list
154216661|NCT06252584|Immunologic Factors|immunologic factors|mesh-ancestor
153639548|NCT00017251|Oblimersen|oblimersen|mesh-list
154216676|NCT06252454|Dipropizine|dipropizine|mesh-list
154216677|NCT06252454|Diuretics|diuretics|mesh-ancestor
154216678|NCT06252454|Natriuretic Agents|natriuretic agents|mesh-ancestor
154216679|NCT06252454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216680|NCT06252454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154216681|NCT06252454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154216682|NCT06252454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216683|NCT06252454|Antitussive Agents|antitussive agents|mesh-ancestor
154216684|NCT06252454|Respiratory System Agents|respiratory system agents|mesh-ancestor
154216685|NCT06252441|Acetylcysteine|acetylcysteine|mesh-list
154216686|NCT06252441|Diclofenac|diclofenac|mesh-list
154216687|NCT06252441|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154216688|NCT06252441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154216689|NCT06252441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216690|NCT06252441|Analgesics|analgesics|mesh-ancestor
154216691|NCT06252441|Sensory System Agents|sensory system agents|mesh-ancestor
154216692|NCT06252441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216693|NCT06252441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216694|NCT06252441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216695|NCT06252441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216696|NCT06252441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154216697|NCT06252441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216698|NCT06252441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216699|NCT06252441|Antiviral Agents|antiviral agents|mesh-ancestor
154216700|NCT06252441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216701|NCT06252441|Expectorants|expectorants|mesh-ancestor
154216702|NCT06252441|Respiratory System Agents|respiratory system agents|mesh-ancestor
154216703|NCT06252441|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154216704|NCT06252441|Antioxidants|antioxidants|mesh-ancestor
154216705|NCT06252441|Protective Agents|protective agents|mesh-ancestor
154216706|NCT06252441|Antidotes|antidotes|mesh-ancestor
154216707|NCT06252207|Desflurane|desflurane|mesh-list
154216708|NCT06252207|Isoflurane|isoflurane|mesh-list
154216709|NCT06252207|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154216710|NCT06252207|Anesthetics, General|anesthetics, general|mesh-ancestor
154216711|NCT06252207|Anesthetics|anesthetics|mesh-ancestor
154216712|NCT06252207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216713|NCT06252207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216714|NCT06252194|Metformin|metformin|mesh-list
154216715|NCT06252194|Doxycycline|doxycycline|mesh-list
154216716|NCT06252194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154216717|NCT06252194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216718|NCT06252194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154216719|NCT06252194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154216720|NCT06252194|Antimalarials|antimalarials|mesh-ancestor
154216721|NCT06252194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154216722|NCT06252194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154216723|NCT06252116|Pregabalin|pregabalin|mesh-list
153639605|NCT00017329|Bortezomib|bortezomib|mesh-list
154216759|NCT06251739|Antifungal Agents|antifungal agents|mesh-ancestor
154216760|NCT06251739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216761|NCT06251739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154216762|NCT06251648|Lenalidomide|lenalidomide|mesh-list
153639690|NCT00017680|Melphalan|melphalan|mesh-list
154216777|NCT06251635|Autonomic Agents|autonomic agents|mesh-ancestor
154216778|NCT06251635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216779|NCT06251635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154216781|NCT06251635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154216782|NCT06251635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216783|NCT06251635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154216784|NCT06251635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154216785|NCT06251635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154216786|NCT06251635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154216787|NCT06251635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216788|NCT06251635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216789|NCT06251635|Serotonin Agents|serotonin agents|mesh-ancestor
154216790|NCT06251609|Naloxone|naloxone|mesh-list
154216791|NCT06251609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154216792|NCT06251609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216793|NCT06251609|Sensory System Agents|sensory system agents|mesh-ancestor
154216794|NCT06251609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216795|NCT06251453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154216796|NCT06251453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216797|NCT06251453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154216798|NCT06251453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216799|NCT06251427|Micronutrients|micronutrients|mesh-list
154216800|NCT06251427|Trace Elements|trace elements|mesh-list
154216801|NCT06251427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216802|NCT06251349|Diclofenac|diclofenac|mesh-list
154216803|NCT06251349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154216804|NCT06251349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154216805|NCT06251349|Analgesics|analgesics|mesh-ancestor
154216806|NCT06251349|Sensory System Agents|sensory system agents|mesh-ancestor
154216807|NCT06251349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154216808|NCT06251349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216809|NCT06251349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154216810|NCT06251349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216811|NCT06251349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154216812|NCT06251349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216813|NCT06251349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216814|NCT06251180|Prednisone|prednisone|mesh-list
154216815|NCT06251180|Cortisone|cortisone|mesh-list
154216816|NCT06251180|Cyclophosphamide|cyclophosphamide|mesh-list
154216817|NCT06251180|Rituximab|rituximab|mesh-list
154216818|NCT06251180|Doxorubicin|doxorubicin|mesh-list
154216819|NCT06251180|Vincristine|vincristine|mesh-list
154216820|NCT06251180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216821|NCT06251180|Immunologic Factors|immunologic factors|mesh-ancestor
154216822|NCT06251180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216823|NCT06251180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154216824|NCT06251180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154216825|NCT06251180|Alkylating Agents|alkylating agents|mesh-ancestor
154216838|NCT06251180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154216839|NCT06251180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154216840|NCT06251180|Tubulin Modulators|tubulin modulators|mesh-ancestor
154216841|NCT06251180|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216842|NCT06251180|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216843|NCT06251141|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154216844|NCT06251141|Hemostatics|hemostatics|mesh-ancestor
154216845|NCT06251141|Coagulants|coagulants|mesh-ancestor
154216846|NCT06250972|Paclitaxel|paclitaxel|mesh-list
154216847|NCT06250972|Gemcitabine|gemcitabine|mesh-list
154216848|NCT06250972|Irinotecan|irinotecan|mesh-list
154216849|NCT06250972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154216850|NCT06250972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216851|NCT06250972|Tubulin Modulators|tubulin modulators|mesh-ancestor
154216852|NCT06250972|Antimitotic Agents|antimitotic agents|mesh-ancestor
154216853|NCT06250972|Mitosis Modulators|mitosis modulators|mesh-ancestor
154216854|NCT06250972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216855|NCT06250972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154216856|NCT06250972|Antimetabolites|antimetabolites|mesh-ancestor
154216857|NCT06250972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154216858|NCT06250972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154216859|NCT06250972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154216860|NCT06250894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154216861|NCT06250894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216862|NCT06250894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154216863|NCT06250894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216864|NCT06250777|Trastuzumab|trastuzumab|mesh-list
154216865|NCT06250777|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154216866|NCT06250777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154216867|NCT06250777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154216868|NCT06250777|Immunoconjugates|immunoconjugates|mesh-ancestor
154263454|NCT05546866|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153438792|NCT00385970|Vitamins|vitamins|mesh-ancestor
154216869|NCT06250777|Immunologic Factors|immunologic factors|mesh-ancestor
154216870|NCT06250777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216871|NCT06250647|Vitamin K|vitamin k|mesh-list
154216872|NCT06250647|Vitamins|vitamins|mesh-ancestor
154216873|NCT06250647|Micronutrients|micronutrients|mesh-ancestor
154216874|NCT06250647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154216875|NCT06250647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154216876|NCT06250647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154216877|NCT06250647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216878|NCT06250647|Hemostatics|hemostatics|mesh-ancestor
154216879|NCT06250647|Coagulants|coagulants|mesh-ancestor
154216928|NCT06250348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154216929|NCT06250348|Antioxidants|antioxidants|mesh-ancestor
154216957|NCT06236113|Anesthetics, General|anesthetics, general|mesh-ancestor
154216958|NCT06236113|Anesthetics|anesthetics|mesh-ancestor
154216959|NCT06236113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154216960|NCT06236113|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154216961|NCT06236113|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154216962|NCT06236113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154216963|NCT06236113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216964|NCT06224309|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154216965|NCT06224309|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154216966|NCT06224309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154216967|NCT06220032|Prednisolone|prednisolone|mesh-list
154216968|NCT06220032|Cyclophosphamide|cyclophosphamide|mesh-list
154216969|NCT06220032|Rituximab|rituximab|mesh-list
154216970|NCT06220032|Doxorubicin|doxorubicin|mesh-list
154216971|NCT06220032|Vincristine|vincristine|mesh-list
154216972|NCT06220032|Lenalidomide|lenalidomide|mesh-list
154216973|NCT06220032|Dexrazoxane|dexrazoxane|mesh-list
154216974|NCT06220032|Razoxane|razoxane|mesh-list
154216975|NCT06220032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154216976|NCT06220032|Immunologic Factors|immunologic factors|mesh-ancestor
154216977|NCT06220032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217001|NCT06220032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217002|NCT06220032|Protective Agents|protective agents|mesh-ancestor
154217003|NCT06220032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153963963|NCT00703144|Tazobactam|tazobactam|mesh-list
154217005|NCT06219824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217006|NCT06219824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690451|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154217007|NCT06219824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217008|NCT06219824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154217009|NCT06219824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154217010|NCT06216639|Amoxicillin|amoxicillin|mesh-list
154217011|NCT06216639|Metronidazole|metronidazole|mesh-list
154217012|NCT06216639|Clarithromycin|clarithromycin|mesh-list
154217013|NCT06216639|Levofloxacin|levofloxacin|mesh-list
154217014|NCT06216639|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154217015|NCT06216639|Esomeprazole|esomeprazole|mesh-list
154217016|NCT06216639|Bismuth|bismuth|mesh-list
154217017|NCT06216639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154217018|NCT06216639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217019|NCT06216639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154217020|NCT06216639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154217021|NCT06216639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154217022|NCT06216639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217023|NCT06216639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154217024|NCT06216639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217025|NCT06216639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217026|NCT06216639|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154217061|NCT06130384|Analgesics|analgesics|mesh-ancestor
154217062|NCT06130384|Sensory System Agents|sensory system agents|mesh-ancestor
154217063|NCT06130384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217064|NCT06130384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217065|NCT06130384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217066|NCT06130384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154217143|NCT05872386|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154217145|NCT05859126|Lipotropic Agents|lipotropic agents|mesh-ancestor
154217146|NCT05859126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154217147|NCT05859126|Antimetabolites|antimetabolites|mesh-ancestor
154217148|NCT05859126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217149|NCT05859126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438839|NCT00423163|Micafungin|micafungin|mesh-list
154217150|NCT05859126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154217151|NCT05859126|Nootropic Agents|nootropic agents|mesh-ancestor
154217152|NCT05845567|Clarithromycin|clarithromycin|mesh-list
154217153|NCT05845567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154217154|NCT05845567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217155|NCT05845567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154217156|NCT05845567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217157|NCT05845567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217158|NCT05845567|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154217159|NCT05845567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154217160|NCT05843188|Leucovorin|leucovorin|mesh-list
154217161|NCT05843188|Hydroxychloroquine|hydroxychloroquine|mesh-list
154217162|NCT05843188|Bevacizumab|bevacizumab|mesh-list
154217163|NCT05843188|Fluorouracil|fluorouracil|mesh-list
154217164|NCT05843188|Irinotecan|irinotecan|mesh-list
154217185|NCT05843188|Antimalarials|antimalarials|mesh-ancestor
154217186|NCT05843188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154217187|NCT05843188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154217188|NCT05843188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217189|NCT05843188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154217190|NCT05842317|Lenvatinib|lenvatinib|mesh-list
154217191|NCT05842317|Tislelizumab|tislelizumab|mesh-list
154217192|NCT05842317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217193|NCT05842317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154217194|NCT05842317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217195|NCT05842317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217196|NCT05842317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217197|NCT05834257|Plasma-lyte 148|plasma-lyte 148|mesh-list
154217198|NCT05834257|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154217199|NCT05834257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154217200|NCT05780541|Remdesivir|remdesivir|mesh-list
154217201|NCT05780541|Antimetabolites|antimetabolites|mesh-ancestor
154217202|NCT05780541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217203|NCT05780541|Antiviral Agents|antiviral agents|mesh-ancestor
154217204|NCT05780541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217205|NCT05698680|Prednisolone|prednisolone|mesh-list
154217206|NCT05698680|Colchicine|colchicine|mesh-list
154217207|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217208|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
154217209|NCT05698680|Hormones|hormones|mesh-ancestor
154217210|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154217211|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217212|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217213|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217214|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
154217215|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154217216|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
154217217|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
154217218|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690703|NCT00187057|Cytarabine|cytarabine|mesh-list
154217219|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217233|NCT05663944|Liver Extracts|liver extracts|mesh-list
154217234|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154217235|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217236|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154217237|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217238|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
154217239|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154217240|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
154217241|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217242|NCT05663944|Hematinics|hematinics|mesh-ancestor
154217243|NCT05661708|Chitosan|chitosan|mesh-list
154217244|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154217245|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154217246|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
154217247|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217248|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154217249|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
154217250|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
154217251|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
154217252|NCT05661708|Coagulants|coagulants|mesh-ancestor
154217253|NCT05625555|Midazolam|midazolam|mesh-list
154217254|NCT05625555|Ketamine|ketamine|mesh-list
154217255|NCT05625555|Analgesics|analgesics|mesh-ancestor
154217256|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
154217257|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217258|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217259|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154217260|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154217261|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
154217262|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
154217263|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154217264|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154217265|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154217266|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217267|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217268|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154217269|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154217270|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154217271|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154217272|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154217273|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
154217274|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
154217275|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
154217276|NCT05619627|Anesthetics|anesthetics|mesh-list
154217277|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
154217278|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154217279|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154217280|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217281|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154217282|NCT05619627|Analgesics|analgesics|mesh-ancestor
154217283|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
154217284|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217304|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154217305|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217306|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217307|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154217308|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
154217309|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217310|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217311|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154217312|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217313|NCT05540522|Vaccines|vaccines|mesh-list
154217314|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
154217315|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217316|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
154217317|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
154217318|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217319|NCT05511428|Daratumumab|daratumumab|mesh-list
154217320|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154217321|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217322|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
154217323|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217324|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154217325|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154217326|NCT05460533|Tisagenlecleucel|tisagenlecleucel|mesh-list
154217327|NCT05460533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217328|NCT05460533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217329|NCT05426395|Vitamins|vitamins|mesh-list
154217330|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
154217331|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
154217332|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
154217333|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
154217334|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217335|NCT05426395|Hematinics|hematinics|mesh-ancestor
154217336|NCT05405751|Tenofovir|tenofovir|mesh-list
154217337|NCT05405751|Emtricitabine|emtricitabine|mesh-list
154217338|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153640215|NCT04733326|Ketorolac|ketorolac|mesh-list
154217363|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
154217364|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154217365|NCT05325632|Paclitaxel|paclitaxel|mesh-list
154217366|NCT05325632|Trastuzumab|trastuzumab|mesh-list
154217367|NCT05325632|Pertuzumab|pertuzumab|mesh-list
154217368|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154217369|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217370|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
154217371|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
154217372|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
154217373|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217374|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217376|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
154217377|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217378|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154217379|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
154217380|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217381|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
154217382|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
153964330|NCT00913666|Interferons|interferons|mesh-list
154217383|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217384|NCT05220228|Prucalopride|prucalopride|mesh-list
154217385|NCT05220228|Laxatives|laxatives|mesh-ancestor
153690929|NCT00188227|Analgesics|analgesics|mesh-ancestor
154217386|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217387|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154217388|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154217413|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154217414|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
154217415|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154217416|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217417|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217418|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217420|NCT05116189|Docetaxel|docetaxel|mesh-list
154217421|NCT05116189|Bevacizumab|bevacizumab|mesh-list
154217422|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
154217423|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154217424|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217425|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
154217426|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
154217427|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
154217428|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217429|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217430|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154217431|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154217432|NCT05116189|Growth Substances|growth substances|mesh-ancestor
154217433|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217434|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
154217435|NCT05116189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217436|NCT05093322|Gemcitabine|gemcitabine|mesh-list
153640336|NCT03933865|Ketamine|ketamine|mesh-list
154217453|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217454|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217456|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154217457|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
154217458|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217459|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217460|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154217461|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154217462|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
154217463|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217464|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217465|NCT04968366|Temozolomide|temozolomide|mesh-list
154217466|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154217467|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
154217468|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217469|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217470|NCT04957615|Nivolumab|nivolumab|mesh-list
154217471|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217472|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217473|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217474|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217475|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
154217476|NCT04921878|Analgesics|analgesics|mesh-ancestor
154217477|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
154217478|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217479|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217480|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217481|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154217482|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154217483|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217484|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217485|NCT04912427|Dexamethasone|dexamethasone|mesh-list
154217486|NCT04912427|Bortezomib|bortezomib|mesh-list
154217487|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217488|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
154217489|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
154217490|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217491|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217492|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217510|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
154217511|NCT04911127|Cannabidiol|cannabidiol|mesh-list
154217512|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
154217513|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
154217514|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154217515|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154217516|NCT04844385|Paclitaxel|paclitaxel|mesh-list
154217517|NCT04844385|Capecitabine|capecitabine|mesh-list
154217518|NCT04844385|Nedaplatin|nedaplatin|mesh-list
154217519|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154217520|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217521|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
154217522|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
154217523|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
154217524|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217525|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217526|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
154217527|NCT04804644|Memantine|memantine|mesh-list
154217528|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154217529|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154217530|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
154217531|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217532|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217533|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153964481|NCT00916669|Etoposide|etoposide|mesh-list
154217534|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154217535|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154217536|NCT04752566|Eculizumab|eculizumab|mesh-list
154217537|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154217538|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154217539|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
154217540|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217541|NCT04741074|Semaglutide|semaglutide|mesh-list
154217542|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154217543|NCT04741074|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154217544|NCT04741074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154217545|NCT04741074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217546|NCT04731467|Paclitaxel|paclitaxel|mesh-list
154217547|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154217548|NCT04731467|Gemcitabine|gemcitabine|mesh-list
154217549|NCT04731467|Nivolumab|nivolumab|mesh-list
154217571|NCT04727151|Pembrolizumab|pembrolizumab|mesh-list
154217572|NCT04727151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217573|NCT04727151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217574|NCT04727151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217575|NCT04727151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217576|NCT04710498|Atezolizumab|atezolizumab|mesh-list
154217577|NCT04710498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217578|NCT04710498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217579|NCT04710498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217580|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217581|NCT04708054|Fludarabine|fludarabine|mesh-list
154217582|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
154217583|NCT04708054|Busulfan|busulfan|mesh-list
154217584|NCT04708054|Venetoclax|venetoclax|mesh-list
154217585|NCT04708054|Thiotepa|thiotepa|mesh-list
154217586|NCT04708054|Cladribine|cladribine|mesh-list
154217587|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154217588|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217589|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217590|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
154217591|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217592|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154217593|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
154217594|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217595|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
154217596|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154217597|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154217598|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
154217599|NCT04645602|Lenvatinib|lenvatinib|mesh-list
154217600|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217601|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217621|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154217622|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
154217623|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217624|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217625|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217626|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
154217627|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
154217628|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217629|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154217631|NCT04501861|Coagulants|coagulants|mesh-ancestor
154217632|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154217633|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
154217634|NCT04474470|Cetuximab|cetuximab|mesh-list
154217635|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217636|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217637|NCT04436107|Lenalidomide|lenalidomide|mesh-list
154217638|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
154217639|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
154217640|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217641|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154217642|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154217643|NCT04436107|Growth Substances|growth substances|mesh-ancestor
154217644|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
154217645|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217646|NCT04436107|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154217647|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154217648|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217649|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217650|NCT04409223|Sunitinib|sunitinib|mesh-list
154217651|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217652|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154217653|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154217654|NCT04409223|Growth Substances|growth substances|mesh-ancestor
154217663|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154217664|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154217665|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154217666|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154217667|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217668|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154217669|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154217670|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154217671|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154217672|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
154217673|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217674|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217675|NCT04300309|Lumefantrine|lumefantrine|mesh-list
154217676|NCT04300309|Artemether|artemether|mesh-list
154217677|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
153691347|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217678|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154217679|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153964631|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
154217680|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217681|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
154217682|NCT04262492|Apixaban|apixaban|mesh-list
154217684|NCT04262492|Dabigatran|dabigatran|mesh-list
154217685|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154217686|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
154217687|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154217688|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
154217689|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217690|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217691|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
154217693|NCT04262154|Atezolizumab|atezolizumab|mesh-list
154217694|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217695|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
154217696|NCT04262154|Hormones|hormones|mesh-ancestor
154217697|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154217698|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217699|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217700|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217701|NCT04262154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217702|NCT04262154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217703|NCT04262154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217704|NCT04221503|Niraparib|niraparib|mesh-list
154217705|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154217706|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217707|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217708|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217709|NCT04218539|Psilocybin|psilocybin|mesh-list
154217710|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
154217711|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217712|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154217713|NCT04201834|Risperidone|risperidone|mesh-list
154217714|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154217715|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
154217716|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217717|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217718|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691452|NCT00191347|Pemetrexed|pemetrexed|mesh-list
154217719|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154217720|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153640590|NCT03150316|CKD-581|ckd-581|mesh-list
154217741|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
154217742|NCT04151667|Hormones|hormones|mesh-ancestor
154217743|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154217744|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217745|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217746|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
154217747|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154217748|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154217749|NCT04151667|Growth Substances|growth substances|mesh-ancestor
154217750|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
154217751|NCT04127786|Vaccines|vaccines|mesh-list
154217752|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
154217753|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217754|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154217755|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
154217756|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217757|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153964709|NCT00757237|Tobramycin|tobramycin|mesh-list
154217758|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
154217759|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217760|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217761|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154217762|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154217763|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154217764|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
154217765|NCT03915366|Valganciclovir|valganciclovir|mesh-list
154217766|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
154217767|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
154217768|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217769|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154217770|NCT03914742|Temozolomide|temozolomide|mesh-list
154217772|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154217773|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154217774|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
154217811|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217813|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154217814|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217815|NCT03601078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
154217816|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691553|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
153691554|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217817|NCT03601078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217818|NCT03590171|Bortezomib|bortezomib|mesh-list
154217819|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217820|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
154217821|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154217822|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217823|NCT03553836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154217824|NCT03553836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217825|NCT03539744|Dexamethasone|dexamethasone|mesh-list
154217826|NCT03539744|Venetoclax|venetoclax|mesh-list
154217827|NCT03539744|Pomalidomide|pomalidomide|mesh-list
154217828|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217829|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
154217830|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
154217865|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154217866|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217867|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
154217868|NCT03488225|Leucovorin|leucovorin|mesh-list
154217893|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217894|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154217895|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154217896|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
154217897|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217898|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217899|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154217900|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217901|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
154217902|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
154217903|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217904|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217905|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
154217906|NCT03488225|Hormones|hormones|mesh-ancestor
154217907|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154217908|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217909|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154217910|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154217911|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154217912|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217913|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154217914|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154217915|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154217916|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
154217917|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154217918|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217919|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
154217920|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
154217921|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154217922|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154217923|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
154217924|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217925|NCT03488225|Antidotes|antidotes|mesh-ancestor
154217926|NCT03488225|Protective Agents|protective agents|mesh-ancestor
153640798|NCT05517291|Paclitaxel|paclitaxel|mesh-list
154217937|NCT03488225|Immunoconjugates|immunoconjugates|mesh-ancestor
154217938|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154217939|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154217940|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217941|NCT03413995|Rucaparib|rucaparib|mesh-list
154217942|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154217943|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217944|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217945|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217946|NCT03347760|Octreotide|octreotide|mesh-list
154217947|NCT03347760|Edotreotide|edotreotide|mesh-list
154217948|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154217949|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217950|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217951|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217952|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217953|NCT03250923|Acemannan|acemannan|mesh-list
154217954|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154217955|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
154217956|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217957|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217958|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
154217959|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154217960|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154217961|NCT03198559|Vorinostat|vorinostat|mesh-list
154217962|NCT03198559|Disulfiram|disulfiram|mesh-list
154217963|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217964|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154217965|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217966|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217967|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154217968|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154217969|NCT03132454|Dexamethasone|dexamethasone|mesh-list
154217970|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
154217971|NCT03132454|Sorafenib|sorafenib|mesh-list
154217972|NCT03132454|Decitabine|decitabine|mesh-list
153691823|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
153691825|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217973|NCT03132454|Palbociclib|palbociclib|mesh-list
154217974|NCT03132454|Ichthammol|ichthammol|mesh-list
154217975|NCT03132454|BB 1101|bb 1101|mesh-list
154217976|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154217977|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
154217978|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
154217979|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154217980|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154217981|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439196|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
154217982|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
154217983|NCT03132454|Hormones|hormones|mesh-ancestor
154217984|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154217985|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154217986|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154217987|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
154217988|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154217989|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154217990|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154217991|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154217992|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
154217993|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
153640852|NCT01805908|Pertuzumab|pertuzumab|mesh-list
154218007|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218008|NCT03026517|Phenformin|phenformin|mesh-list
154218009|NCT03026517|Trametinib|trametinib|mesh-list
154218010|NCT03026517|Dabrafenib|dabrafenib|mesh-list
154218011|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218012|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154218013|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218014|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218015|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154218016|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218017|NCT03019003|Durvalumab|durvalumab|mesh-list
154218018|NCT03019003|Decitabine|decitabine|mesh-list
154218019|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218020|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218021|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154218022|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
154218023|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218024|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218025|NCT02790853|Proflavine|proflavine|mesh-list
154218026|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154218027|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218028|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
154218029|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154218030|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154218031|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218032|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
154218033|NCT02606045|Coagulants|coagulants|mesh-ancestor
154218034|NCT02577406|Cytarabine|cytarabine|mesh-list
154218035|NCT02577406|Azacitidine|azacitidine|mesh-list
154218036|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154218037|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
154218038|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218039|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218040|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
154218041|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218042|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218043|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
154218044|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218045|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218046|NCT02570984|Omalizumab|omalizumab|mesh-list
154218047|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154218048|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154218049|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
154218050|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154218051|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154218052|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154218053|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154218054|NCT02500108|Domperidone|domperidone|mesh-list
154218055|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
154218056|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
154218075|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218076|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218078|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218079|NCT02347891|Belimumab|belimumab|mesh-list
154218080|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218081|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
154218082|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218083|NCT02304783|Acetaminophen|acetaminophen|mesh-list
154218084|NCT02304783|Piroxicam|piroxicam|mesh-list
154218085|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154218086|NCT02304783|Analgesics|analgesics|mesh-ancestor
154218087|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
154218088|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218089|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218090|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
154218091|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154218092|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218093|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218094|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154218095|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218096|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218097|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
154218098|NCT02298348|Sorafenib|sorafenib|mesh-list
154218099|NCT02298348|Topotecan|topotecan|mesh-list
154218100|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218101|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
154218102|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218103|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218104|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154218105|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
154218106|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218107|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218108|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154218109|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154218110|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218111|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154218112|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154218113|NCT02208375|Olaparib|olaparib|mesh-list
154218141|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154218142|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154218143|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154218144|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154218145|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218146|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154218148|NCT02023164|Promethazine|promethazine|mesh-list
154218149|NCT02023164|Cetirizine|cetirizine|mesh-list
154218150|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154218151|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154218152|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218153|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218154|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
154218155|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
154218156|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
154218157|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218158|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
154218159|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
154218182|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154218183|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154218184|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218186|NCT01959139|Protective Agents|protective agents|mesh-ancestor
154218187|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
154218188|NCT01959139|Vitamins|vitamins|mesh-ancestor
154218189|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
154218190|NCT01884623|Methotrexate|methotrexate|mesh-list
154218191|NCT01884623|Cetuximab|cetuximab|mesh-list
154218192|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154218193|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
154218194|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154218195|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218196|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154218197|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
154218198|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218199|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218200|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
154218201|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218202|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154218203|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218204|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
154218205|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218206|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154218207|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218208|NCT01802814|Epratuzumab|epratuzumab|mesh-list
154218209|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218210|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218211|NCT01602380|Fulvestrant|fulvestrant|mesh-list
154218212|NCT01602380|Anastrozole|anastrozole|mesh-list
153641085|NCT00847678|Amphotericin B|amphotericin b|mesh-list
154218241|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
154218242|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218243|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218244|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154218245|NCT01134575|Immunotoxins|immunotoxins|mesh-ancestor
154218246|NCT01134575|Immunoconjugates|immunoconjugates|mesh-ancestor
154218247|NCT01132326|Droxidopa|droxidopa|mesh-list
154218248|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154218249|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154218250|NCT00150709|Levetiracetam|levetiracetam|mesh-list
154218251|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
154218252|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
154218253|NCT01061216|Insulin|insulin|mesh-list
154218254|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154218255|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154218256|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218257|NCT00314574|Omalizumab|omalizumab|mesh-list
154218258|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154218282|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154218283|NCT00314340|Narcotics|narcotics|mesh-ancestor
154218284|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218285|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218286|NCT00314340|Analgesics|analgesics|mesh-ancestor
154218287|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
154218288|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218289|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153965237|NCT00634959|Maraviroc|maraviroc|mesh-list
154218290|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
154218291|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
154218292|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
154218293|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154218294|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
154218295|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
154218296|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
154218297|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218298|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218299|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
154218300|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154218301|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154218302|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154218303|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154218304|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
154218305|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154218306|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154218307|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154218308|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
154218309|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
153692080|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
154218343|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
154218344|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154218345|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154218346|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218347|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154218367|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154218368|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154218369|NCT00332696|Prednisolone|prednisolone|mesh-list
154218370|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
154218371|NCT00332696|Octreotide|octreotide|mesh-list
154218372|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154218373|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
154218374|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218375|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
154218376|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
154218377|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218378|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218379|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218380|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
154218381|NCT00332696|Hormones|hormones|mesh-ancestor
154218382|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154263455|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154263456|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154263457|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218383|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154218384|NCT00332696|Protective Agents|protective agents|mesh-ancestor
154218385|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154218386|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218387|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
154218388|NCT00313716|Hematinics|hematinics|mesh-ancestor
154218389|NCT00313170|Fulvestrant|fulvestrant|mesh-list
154218390|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154218391|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218392|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154218393|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154218394|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
154218395|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218396|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218397|NCT00332462|Cyclosporine|cyclosporine|mesh-list
154218398|NCT00332462|Cyclosporins|cyclosporins|mesh-list
154218399|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218400|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218401|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218402|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
154218403|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218433|NCT03984110|Hormones|hormones|mesh-ancestor
154218434|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218435|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154218436|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218437|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154218438|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154218439|NCT03984110|Growth Substances|growth substances|mesh-ancestor
154218440|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
154218441|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
153692266|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154218442|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218444|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154218445|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154218446|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218447|NCT00159861|Urological Agents|urological agents|mesh-ancestor
154218448|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
154218449|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154218450|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218451|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154218452|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218465|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218467|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
154218468|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218469|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154218470|NCT01075659|Nicotine|nicotine|mesh-list
154218471|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154218472|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
154218473|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218474|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218475|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154218476|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154218477|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
154218478|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218479|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218480|NCT01077453|Letrozole|letrozole|mesh-list
154218481|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218482|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154218483|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154218484|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218485|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218486|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154218487|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
154218488|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218489|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218490|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
154218491|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218492|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
154218493|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218494|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218495|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154218496|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
154218497|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218498|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218499|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154218500|NCT00312858|Vaccines|vaccines|mesh-list
154218501|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154218502|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
154218503|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218504|NCT00156819|Fluticasone|fluticasone|mesh-list
154218505|NCT00156819|Xhance|xhance|mesh-list
154218506|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154218507|NCT00156819|Montelukast|montelukast|mesh-list
154218508|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218509|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154218510|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
154218511|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218512|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218513|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154218514|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
153641391|NCT00276757|Leucovorin|leucovorin|mesh-list
154218533|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218534|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218535|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218537|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
154218538|NCT00224055|Hematinics|hematinics|mesh-ancestor
154218539|NCT00150345|Voriconazole|voriconazole|mesh-list
154218540|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
154218541|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218542|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154218543|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154218544|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218545|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218546|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154218547|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
154218548|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218549|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218550|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154218551|NCT01077609|Fluticasone|fluticasone|mesh-list
154218552|NCT01077609|Xhance|xhance|mesh-list
154218553|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218554|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154218555|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
154218556|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218557|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218558|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154218559|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
154218560|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
154218561|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154218562|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
154218563|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
154218564|NCT00223977|Hematinics|hematinics|mesh-ancestor
154218565|NCT00148941|Vaccines|vaccines|mesh-list
154218566|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
154218567|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218568|NCT01073553|Cephalexin|cephalexin|mesh-list
154218569|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154218590|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218591|NCT00323882|Ipilimumab|ipilimumab|mesh-list
154218592|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218593|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218594|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154218595|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218596|NCT00331682|Docetaxel|docetaxel|mesh-list
154218597|NCT00331682|Alvocidib|alvocidib|mesh-list
154218598|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218599|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
154218600|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
154218601|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
154218602|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218603|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
154218604|NCT00331682|Growth Substances|growth substances|mesh-ancestor
154218605|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218606|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154218607|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218608|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154218609|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154218610|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154218611|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218612|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218613|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
154218614|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154218615|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154218616|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154218617|NCT00331136|Artesunate|artesunate|mesh-list
154218618|NCT00331136|Pyronaridine|pyronaridine|mesh-list
154218619|NCT00331136|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154218620|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
154218621|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154218648|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
154218649|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218650|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154218651|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154218652|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154218653|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154218654|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218655|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154218656|NCT01062906|Narcotics|narcotics|mesh-ancestor
154218657|NCT01062906|Analgesics|analgesics|mesh-ancestor
154218658|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154218659|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154218660|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
153692545|NCT00198445|Bromfenac|bromfenac|mesh-list
154218661|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154218662|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154218663|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218664|NCT00305604|Incretins|incretins|mesh-ancestor
154218665|NCT00305604|Hormones|hormones|mesh-ancestor
154218666|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218667|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154218668|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
154218669|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539944|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154218704|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218706|NCT01016717|Pantoprazole|pantoprazole|mesh-list
154218707|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154218724|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218725|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218726|NCT00481871|Vitamins|vitamins|mesh-list
154218727|NCT00481871|Folic Acid|folic acid|mesh-list
154218728|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
154218729|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
154218730|NCT00481871|Gemcitabine|gemcitabine|mesh-list
154218731|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
154218732|NCT00481871|Aminopterin|aminopterin|mesh-list
154218733|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
154218734|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218735|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154218736|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
154218737|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153965678|NCT02767635|Triamcinolone|triamcinolone|mesh-list
154218738|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218739|NCT00481871|Hematinics|hematinics|mesh-ancestor
154218740|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154218741|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218742|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
154218743|NCT00329420|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154218744|NCT00329420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218745|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218746|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
154218747|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218748|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218749|NCT00329108|Olanzapine|olanzapine|mesh-list
154218750|NCT00329108|Ziprasidone|ziprasidone|mesh-list
154263458|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263459|NCT05480306|Bevacizumab|bevacizumab|mesh-list
154263460|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218751|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
154218752|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
153692565|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
154218753|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218754|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218755|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218756|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154218757|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154218758|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218759|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154218760|NCT00329108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154218761|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154218762|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154218763|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218764|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218765|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
154218766|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154218781|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218783|NCT00328172|Linagliptin|linagliptin|mesh-list
154218784|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154218785|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218786|NCT00328172|Incretins|incretins|mesh-ancestor
154218787|NCT00328172|Hormones|hormones|mesh-ancestor
154218788|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218789|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154218790|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
154218791|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218792|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218793|NCT01061372|Pregabalin|pregabalin|mesh-list
154218794|NCT01061372|Analgesics|analgesics|mesh-ancestor
154218795|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
154218796|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218797|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218798|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
154218799|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154218800|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154218801|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218802|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154218803|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154218804|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154218805|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218806|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154218807|NCT00328094|Insulin|insulin|mesh-list
154218808|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154218809|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154218810|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218811|NCT00295932|Prednisone|prednisone|mesh-list
153965764|NCT04532463|Amebicides|amebicides|mesh-ancestor
154218812|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
154218813|NCT00295932|Rituximab|rituximab|mesh-list
154218815|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154218816|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
154218817|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218818|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154218819|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154218820|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
154218821|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218822|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218823|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154218824|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218825|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218826|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
154218827|NCT00295932|Hormones|hormones|mesh-ancestor
154218835|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218836|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154218837|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154218838|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
154218839|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218840|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218842|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
154218843|NCT00305058|Morphine|morphine|mesh-list
154218844|NCT00305058|Hydromorphone|hydromorphone|mesh-list
154218845|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154218846|NCT00305058|Narcotics|narcotics|mesh-ancestor
154218847|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218848|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218849|NCT00305058|Analgesics|analgesics|mesh-ancestor
154218850|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
154218851|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218852|NCT01061450|Simvastatin|simvastatin|mesh-list
154218853|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154218854|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154218855|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
154218856|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218857|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154218858|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154218859|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218860|NCT03986294|Leucovorin|leucovorin|mesh-list
154218861|NCT03986294|Antidotes|antidotes|mesh-ancestor
154218862|NCT03986294|Protective Agents|protective agents|mesh-ancestor
154218863|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218864|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
154218865|NCT03986294|Vitamins|vitamins|mesh-ancestor
154218866|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
154218867|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
154218868|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154218869|NCT00322556|Antibodies|antibodies|mesh-list
154218870|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
154218871|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218872|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
154218873|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
154218874|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
154218875|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
154218876|NCT00321932|Calcium|calcium|mesh-list
154218877|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154218878|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218879|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154218880|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218881|NCT00321932|Vitamins|vitamins|mesh-ancestor
154218882|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
154218883|NCT00321932|Antacids|antacids|mesh-ancestor
154218884|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218885|NCT00326612|Midazolam|midazolam|mesh-list
154218886|NCT00326612|Diazepam|diazepam|mesh-list
154218887|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154218888|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154218889|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218890|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218891|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154218892|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154218893|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154218894|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154218895|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
154218896|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
154218905|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154218906|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154218907|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154218908|NCT01060826|Somatostatin|somatostatin|mesh-list
154218909|NCT01060826|Hormones|hormones|mesh-ancestor
154218910|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218911|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218912|NCT00321854|Pramipexole|pramipexole|mesh-list
154218913|NCT00321854|Dexpramipexole|dexpramipexole|mesh-list
154218914|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
154218915|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218916|NCT00321854|Protective Agents|protective agents|mesh-ancestor
154218917|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218918|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154218919|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154218920|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
154218921|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
154218922|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153439547|NCT00003493|Dexamethasone|dexamethasone|mesh-list
154218923|NCT03982862|Triamcinolone|triamcinolone|mesh-list
154218924|NCT03982862|Lidocaine|lidocaine|mesh-list
154218925|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
154218926|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154218927|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154218928|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
154218929|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
154218930|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154218931|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218932|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
154218933|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154218934|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154218935|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154218936|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154218937|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154218938|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218939|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154218940|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
154218941|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154218942|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154218943|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
154218944|NCT03982862|Hormones|hormones|mesh-ancestor
154218945|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218946|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154218947|NCT01060904|Doxorubicin|doxorubicin|mesh-list
154218948|NCT01060904|Bleomycin|bleomycin|mesh-list
154218949|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154218950|NCT01060904|Dacarbazine|dacarbazine|mesh-list
154218951|NCT01060904|Vinblastine|vinblastine|mesh-list
154218952|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154218953|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154218954|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218955|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154218956|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154218957|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218958|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218959|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154218960|NCT01060904|Immunotoxins|immunotoxins|mesh-ancestor
154218961|NCT01060904|Immunoconjugates|immunoconjugates|mesh-ancestor
154218962|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
154218963|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641842|NCT00006050|Antidotes|antidotes|mesh-ancestor
154218980|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218981|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154218982|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
154218983|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154218984|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154218985|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154218986|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154218987|NCT01058174|Amebicides|amebicides|mesh-ancestor
154218988|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154218989|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154218990|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154218991|NCT01058252|Indomethacin|indomethacin|mesh-list
154218992|NCT01058252|Letrozole|letrozole|mesh-list
154218993|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154218994|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154218995|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154218996|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154218997|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154218998|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154218999|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
154219000|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219001|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219002|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153692870|NCT02962804|Nivolumab|nivolumab|mesh-list
154219003|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154219004|NCT01058252|Analgesics|analgesics|mesh-ancestor
154219005|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
154219006|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219007|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219008|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219009|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
154219010|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
154219011|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154219012|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154219013|NCT01058408|Cisplatin|cisplatin|mesh-list
154219014|NCT01058408|Everolimus|everolimus|mesh-list
154219015|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219016|NCT01058408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154219017|NCT01058408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219018|NCT01058408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219019|NCT01058408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219042|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219043|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
154219044|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219045|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219046|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
154219047|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
154219048|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154219049|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
154219050|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219051|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
154219052|NCT03981458|Protective Agents|protective agents|mesh-ancestor
154219053|NCT00309842|Cyclosporine|cyclosporine|mesh-list
154219054|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
154219055|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
154219056|NCT00309842|Fludarabine|fludarabine|mesh-list
154219057|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
154219058|NCT00309842|Cyclosporins|cyclosporins|mesh-list
154219059|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219060|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
154219061|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219062|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219063|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154219064|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
154219065|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219066|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219067|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154219068|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219069|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
154219070|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219071|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
154219072|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219073|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219095|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
154219096|NCT00499889|Tacrolimus|tacrolimus|mesh-list
154219097|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
154219098|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154219099|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154219100|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
154219101|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154219102|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219103|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219104|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
154219105|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219106|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219107|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219108|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219109|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154219110|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219111|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
154219112|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219113|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154219114|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
154219115|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219116|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154219117|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
154219118|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154219119|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154219120|NCT00499889|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154219121|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219122|NCT00309608|Glimepiride|glimepiride|mesh-list
154219123|NCT00309608|Linagliptin|linagliptin|mesh-list
154219124|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154219125|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154219126|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642013|NCT00084721|Analgesics|analgesics|mesh-ancestor
154219152|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154219153|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154219154|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
154219155|NCT00481247|Dasatinib|dasatinib|mesh-list
154219156|NCT00481247|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154219157|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219158|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219159|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219160|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219161|NCT04101461|Iron|iron|mesh-list
154219162|NCT04101461|Hepcidins|hepcidins|mesh-list
154219163|NCT04101461|Trace Elements|trace elements|mesh-ancestor
154219164|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
154219165|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219166|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219167|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
154219168|NCT01017107|Protein C|protein c|mesh-list
154219169|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
154219170|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154219171|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154219172|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219173|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219174|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
154219175|NCT03997019|Narcotics|narcotics|mesh-ancestor
154219176|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154219202|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154219203|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
154219204|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154219205|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154219206|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
154219207|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
154219208|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154219209|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219210|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153692909|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
154219211|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154219212|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154219213|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219214|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219215|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
154219216|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219217|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219218|NCT00295620|Anastrozole|anastrozole|mesh-list
154219219|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154219220|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219221|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154219222|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154219223|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219224|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219248|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219249|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219250|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219251|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
154219252|NCT00321620|Denosumab|denosumab|mesh-list
154219253|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154219254|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219255|NCT00304278|Cisplatin|cisplatin|mesh-list
154219256|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154219257|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219258|NCT00304278|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154219259|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219260|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219261|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219262|NCT03981068|Nimorazole|nimorazole|mesh-list
154219263|NCT03981068|Cisplatin|cisplatin|mesh-list
154219264|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219265|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154219266|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154219267|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154219268|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219269|NCT01064102|Cetirizine|cetirizine|mesh-list
154219270|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154219271|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154219272|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154219273|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
154219274|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
154219275|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219299|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
154219300|NCT00307736|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154219301|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219302|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219303|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154219304|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154219305|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154219306|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219307|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219308|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
154219309|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219310|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219311|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
154219312|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154219313|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
154219314|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219315|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
154219316|NCT03979586|Protective Agents|protective agents|mesh-ancestor
154219317|NCT00294762|Paclitaxel|paclitaxel|mesh-list
154219318|NCT00294762|Carboplatin|carboplatin|mesh-list
154219319|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154219320|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154219321|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219322|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
154219323|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
154219324|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
154219325|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219343|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219344|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154219345|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
154219346|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219347|NCT01061996|Basiliximab|basiliximab|mesh-list
154219348|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219349|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
154219350|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219351|NCT01064180|Carvedilol|carvedilol|mesh-list
154219352|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154219353|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154219354|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
154219355|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219356|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219357|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219358|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154219359|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
154219360|NCT01064180|Protective Agents|protective agents|mesh-ancestor
154219361|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154219362|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219363|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154219364|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
154219365|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154219366|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154219367|NCT01069536|Metoclopramide|metoclopramide|mesh-list
154219368|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
154219369|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
154219370|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219371|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219372|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219373|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153439701|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
154219374|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154219375|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
154219376|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219377|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219378|NCT00320216|Ustekinumab|ustekinumab|mesh-list
154219379|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219380|NCT00290706|Gemcitabine|gemcitabine|mesh-list
154219381|NCT00290706|Bortezomib|bortezomib|mesh-list
154219382|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219383|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
154219384|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219402|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154219403|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219404|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219405|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
154219406|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219407|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219408|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154219409|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219411|NCT01066494|Amonafide|amonafide|mesh-list
154219412|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219413|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
154219414|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219415|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219416|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
154219417|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219418|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219419|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
154219420|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219421|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219422|NCT01069770|Sunitinib|sunitinib|mesh-list
154219423|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219424|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154219425|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154219426|NCT01069770|Growth Substances|growth substances|mesh-ancestor
154219427|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219428|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
154219429|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219430|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219431|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219432|NCT00303108|Carboplatin|carboplatin|mesh-list
154219433|NCT00303108|Doxorubicin|doxorubicin|mesh-list
154219434|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154219435|NCT00303108|Trastuzumab|trastuzumab|mesh-list
154219436|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219437|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154219438|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154219439|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154219440|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219474|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219475|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219477|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
154219478|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154219479|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219500|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219502|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154219503|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219504|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154219505|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154219506|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219507|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154219508|NCT01066884|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154219509|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219510|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219511|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219512|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219513|NCT02532270|Phenylephrine|phenylephrine|mesh-list
154219514|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
154219515|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154219516|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
154219517|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
154219518|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219519|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219520|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
154219521|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154219522|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
154219523|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
154219524|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154219525|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154219526|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154219527|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
154219528|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157352|NCT05867121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219529|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219530|NCT02532270|Protective Agents|protective agents|mesh-ancestor
154219531|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
154219551|NCT00289536|Factor VIII|factor viii|mesh-list
154219552|NCT00289536|Coagulants|coagulants|mesh-ancestor
154219554|NCT01066962|Darunavir|darunavir|mesh-list
154219555|NCT01066962|Tenofovir|tenofovir|mesh-list
154219556|NCT01066962|Emtricitabine|emtricitabine|mesh-list
154219557|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
154219558|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154219559|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154219560|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
154219561|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219562|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219563|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154219564|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154219565|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
154219566|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219567|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154219568|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154219569|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154219570|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154219571|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154219572|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154219574|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154219575|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
154219576|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154219577|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219578|NCT01067274|Cytarabine|cytarabine|mesh-list
154219579|NCT01067274|Azacitidine|azacitidine|mesh-list
154219580|NCT01067274|Tretinoin|tretinoin|mesh-list
154219581|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219582|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
154219583|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219584|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219585|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
154219586|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219587|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642488|NCT00006125|Topotecan|topotecan|mesh-list
154219602|NCT01067430|Analgesics|analgesics|mesh-ancestor
154219603|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
154219604|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219605|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219606|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219607|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219608|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154219609|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219610|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219611|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154219612|NCT00305864|Temozolomide|temozolomide|mesh-list
154219613|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
154219614|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154219615|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
154219616|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219617|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219618|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154219619|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219620|NCT03982784|Morphine|morphine|mesh-list
154219621|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154219622|NCT03982784|Narcotics|narcotics|mesh-ancestor
154219623|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154219624|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219625|NCT03982784|Analgesics|analgesics|mesh-ancestor
154219626|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
154157353|NCT05867121|Antimetabolites|antimetabolites|mesh-ancestor
154219627|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219628|NCT03978884|Losartan|losartan|mesh-list
154219629|NCT03978884|Amlodipine|amlodipine|mesh-list
154219630|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154219631|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154219632|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154219633|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219634|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219635|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153966573|NCT04217733|Ethosuximide|ethosuximide|mesh-list
154219636|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219637|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
154219638|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154219639|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154219640|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154219641|NCT03978884|Diuretics|diuretics|mesh-ancestor
154219642|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
154219643|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154219644|NCT00319982|Diltiazem|diltiazem|mesh-list
154219645|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154219646|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154219647|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219664|NCT03978494|Tacrolimus|tacrolimus|mesh-list
154219665|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219666|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
154219667|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219668|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154219669|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219670|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219671|NCT01064570|Tretinoin|tretinoin|mesh-list
154219672|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219673|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
154219674|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219675|NCT01581164|Vaccines|vaccines|mesh-list
154219676|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
154219677|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219678|NCT00319046|Miglustat|miglustat|mesh-list
154219679|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219680|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219681|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154219682|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154219683|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
154219684|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219685|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154219686|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154219687|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219688|NCT00303602|Olanzapine|olanzapine|mesh-list
154219689|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
154219690|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
154219691|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219692|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219693|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219694|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154219695|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154219696|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154219697|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154219698|NCT00303602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154219699|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154219700|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154219701|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219702|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219703|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
154219704|NCT03979976|Ramipril|ramipril|mesh-list
153539945|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
154219739|NCT00288054|Docetaxel|docetaxel|mesh-list
154219740|NCT00288054|Cetuximab|cetuximab|mesh-list
154219741|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219742|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
154219743|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
154219744|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642652|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154219775|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219776|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219777|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219778|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219779|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219780|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219781|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
154219783|NCT00286494|Alogliptin|alogliptin|mesh-list
153966730|NCT03737253|Hormones|hormones|mesh-ancestor
154219784|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154219785|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219787|NCT00286494|Hormones|hormones|mesh-ancestor
154219788|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219810|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154219811|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219812|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154219813|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219814|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219815|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219816|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154219817|NCT00285012|Varenicline|varenicline|mesh-list
154219818|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154219819|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154219820|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
154219821|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154219822|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219823|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219824|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
154219825|NCT00284934|Prednisone|prednisone|mesh-list
154219826|NCT00284934|Tacrolimus|tacrolimus|mesh-list
154219827|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219828|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
154219829|NCT00284934|Hormones|hormones|mesh-ancestor
154219830|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219831|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219832|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154219833|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219834|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219835|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
154219836|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154219837|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219838|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219839|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154219840|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154219841|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
154219842|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154219860|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219862|NCT00298272|Adalimumab|adalimumab|mesh-list
154219863|NCT00298272|Etanercept|etanercept|mesh-list
154219864|NCT00298272|Rituximab|rituximab|mesh-list
153693064|NCT00221611|Baclofen|baclofen|mesh-list
154219865|NCT00298272|Methotrexate|methotrexate|mesh-list
154219866|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154219867|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219868|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
154219869|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219870|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219871|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154219872|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
154219873|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154219874|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219875|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
154219876|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219877|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
154219878|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219879|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154219880|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219881|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154219882|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219883|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
154219884|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
154219885|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154219886|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219887|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
154219888|NCT00298272|Hormones|hormones|mesh-ancestor
154219889|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154219890|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154219891|NCT00298272|Protective Agents|protective agents|mesh-ancestor
154219892|NCT00298272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154219893|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154219894|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154219895|NCT00298272|Analgesics|analgesics|mesh-ancestor
154219896|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
154219897|NCT01068054|Cyclosporine|cyclosporine|mesh-list
154219898|NCT01068054|Tacrolimus|tacrolimus|mesh-list
154219911|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154219912|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219913|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154219915|NCT00283686|Lisinopril|lisinopril|mesh-list
154219916|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154219917|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154219918|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154219919|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154219920|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219921|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
154219922|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154219923|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154219924|NCT00283686|Protective Agents|protective agents|mesh-ancestor
154219925|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219926|NCT00297882|Artesunate|artesunate|mesh-list
154219927|NCT00297882|Lumefantrine|lumefantrine|mesh-list
154219928|NCT00297882|Artemether|artemether|mesh-list
154219929|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154219930|NCT00297882|Amodiaquine|amodiaquine|mesh-list
154219931|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
154219932|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154219933|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154219934|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154219935|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219936|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
154219937|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
154219938|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154219939|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
154219940|NCT01065870|Gemcitabine|gemcitabine|mesh-list
154219941|NCT01065870|Capecitabine|capecitabine|mesh-list
154219942|NCT01065870|Docetaxel|docetaxel|mesh-list
154219943|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154219944|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
154219945|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154219946|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219947|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
154219948|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
154219949|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
154219950|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
154219951|NCT00297648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154219952|NCT00297648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154219953|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154219954|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
154219955|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154219956|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154219957|NCT01068132|Cetuximab|cetuximab|mesh-list
154219958|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154219959|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154219960|NCT00297492|Nicotine|nicotine|mesh-list
154219961|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154219962|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
153642844|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
154219998|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154219999|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220000|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220021|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154220022|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154220023|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154220024|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
154220025|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220026|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154220027|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153898637|NCT04321850|Zinc|zinc|mesh-list
154220028|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220029|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
154220030|NCT00296244|Prednisone|prednisone|mesh-list
154220031|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
154220032|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154220033|NCT00296244|Tacrolimus|tacrolimus|mesh-list
154220034|NCT00296244|Basiliximab|basiliximab|mesh-list
154220035|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220036|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
154220037|NCT00296244|Hormones|hormones|mesh-ancestor
154220038|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220039|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220040|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154220041|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220042|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220043|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
154220044|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154220045|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220046|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220047|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
154220048|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
154220049|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220050|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154220051|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154220052|NCT00296244|Protective Agents|protective agents|mesh-ancestor
154220053|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220054|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154220055|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
154220056|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220057|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642952|NCT00090727|AQ4N|aq4n|mesh-list
154220086|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220087|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220089|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220090|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
154220091|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154220092|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154220093|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
154220094|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220095|NCT01020539|Immunotoxins|immunotoxins|mesh-ancestor
154220096|NCT01020539|Immunoconjugates|immunoconjugates|mesh-ancestor
154220097|NCT00281580|Amlodipine|amlodipine|mesh-list
154220098|NCT00281580|Telmisartan|telmisartan|mesh-list
154220099|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154220100|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154220101|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154220102|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220103|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153643003|NCT00091312|Leucovorin|leucovorin|mesh-list
154220172|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220173|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220174|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
154220175|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154220176|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154220177|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220178|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154220179|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154220180|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154220181|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220182|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154220183|NCT00271596|Citalopram|citalopram|mesh-list
154220184|NCT00271596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153643091|NCT00006206|Naltrexone|naltrexone|mesh-list
154220212|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154220214|NCT00291642|Levocetirizine|levocetirizine|mesh-list
154220215|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154220216|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154220217|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154220218|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
153439989|NCT00002881|Suramin|suramin|mesh-list
154220219|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
154220220|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220221|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220222|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220223|NCT01070472|Misoprostol|misoprostol|mesh-list
154220224|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154220225|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
153643137|NCT00091936|Lamivudine|lamivudine|mesh-list
154220262|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154220280|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154220281|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220282|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220283|NCT00317642|Cytarabine|cytarabine|mesh-list
154220284|NCT00317642|Clofarabine|clofarabine|mesh-list
154220285|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220286|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
154220287|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220288|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220289|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
154220290|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220291|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220292|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
154220293|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220294|NCT01064726|Fluticasone|fluticasone|mesh-list
154220296|NCT01064726|Ibuprofen|ibuprofen|mesh-list
154220297|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154220298|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154220299|NCT01064726|Analgesics|analgesics|mesh-ancestor
154220300|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
154220301|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220302|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220303|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220304|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154220305|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154220306|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220307|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220308|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154220309|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
154220310|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154220311|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
154220312|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
154220313|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154220315|NCT00295022|Levocetirizine|levocetirizine|mesh-list
154220316|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154220317|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
154220318|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154220319|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
154220320|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220321|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220322|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154220347|NCT01065038|Anagrelide|anagrelide|mesh-list
154220348|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220349|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
154220350|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220351|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220352|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154220353|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154220354|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154220355|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154220356|NCT00291486|Capecitabine|capecitabine|mesh-list
154220357|NCT00291486|Antibodies|antibodies|mesh-list
154220358|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154220359|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
154220360|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220361|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220362|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
154220363|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220364|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220365|NCT00301964|Bevacizumab|bevacizumab|mesh-list
154220366|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154220368|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
154220369|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154220370|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220381|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220382|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220383|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220384|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220385|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220386|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220387|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
154220388|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154220389|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154220390|NCT01070706|Growth Substances|growth substances|mesh-ancestor
154220391|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220392|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
154220393|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220394|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220396|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
154220397|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220398|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
154220399|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220400|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220401|NCT00268242|Analgesics|analgesics|mesh-ancestor
154220402|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
154220403|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220404|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220405|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154220406|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154220407|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220408|NCT00294554|Memantine|memantine|mesh-list
154220409|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154220410|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154220411|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
154220412|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220413|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220414|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220415|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154220416|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154220417|NCT00294398|Fluticasone|fluticasone|mesh-list
154220418|NCT00294398|Xhance|xhance|mesh-list
154220419|NCT00294398|Budesonide|budesonide|mesh-list
154220420|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220421|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154220422|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
154220423|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220424|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220425|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154220426|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
154220427|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
154220428|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154220429|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
154220430|NCT00294398|Hormones|hormones|mesh-ancestor
154220431|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220432|NCT00279708|Atorvastatin|atorvastatin|mesh-list
154220433|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154220434|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154220435|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
153643324|NCT00006233|Cyclosporine|cyclosporine|mesh-list
154220461|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
154220462|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
154220463|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154220464|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
154220465|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220466|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220467|NCT03975036|Antibodies|antibodies|mesh-list
154220468|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
154220469|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220470|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
154220471|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220472|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263461|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154263462|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154220473|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154220474|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
154220475|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220476|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220477|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220478|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220479|NCT01582230|Vildagliptin|vildagliptin|mesh-list
154220480|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154220481|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220482|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154220483|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
154220499|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154220500|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154220501|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220502|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220503|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
154220504|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220505|NCT03975270|Paclitaxel|paclitaxel|mesh-list
154220506|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154220507|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220508|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220509|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220510|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220511|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220512|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154220513|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
154220514|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154220515|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154220516|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220517|NCT03977792|Docosanol|docosanol|mesh-list
154220518|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
154220519|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220520|NCT01066598|Rituximab|rituximab|mesh-list
154220521|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220522|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220523|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
154220524|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220525|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154220526|NCT01066676|Ibuprofen|ibuprofen|mesh-list
154220527|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154220528|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154220529|NCT01066676|Analgesics|analgesics|mesh-ancestor
154220530|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
154220531|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220532|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153967490|NCT04425629|Antiviral Agents|antiviral agents|mesh-ancestor
154220533|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220534|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154220535|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154220536|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220537|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220538|NCT01065194|Simendan|simendan|mesh-list
154220539|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154220540|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
154220541|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153643434|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154220558|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220560|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154220561|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
154220562|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220563|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220564|NCT00277212|Lamotrigine|lamotrigine|mesh-list
154220565|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
154220566|NCT00277212|Aripiprazole|aripiprazole|mesh-list
154220567|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
154220568|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154220569|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154220570|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154220571|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220572|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220573|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
154220574|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
154220575|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220576|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220577|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154220578|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154220579|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
154220580|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154220581|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154220582|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154220583|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154220584|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154220585|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154220586|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154220587|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154220588|NCT01066754|Fexofenadine|fexofenadine|mesh-list
154220589|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154220590|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154220591|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154220592|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
154220593|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
154220594|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220595|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220596|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220597|NCT00276744|Sirolimus|sirolimus|mesh-list
154220620|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220621|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220623|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220624|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
154220625|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220626|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
154220627|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154220628|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
154220629|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
154220630|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154220631|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220632|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220633|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
154220634|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154220635|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220636|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220637|NCT02532192|Cytarabine|cytarabine|mesh-list
154220638|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
154220639|NCT02532192|Fluconazole|fluconazole|mesh-list
154220640|NCT02532192|Dexamethasone|dexamethasone|mesh-list
154220641|NCT02532192|Cisplatin|cisplatin|mesh-list
154220642|NCT02532192|Rituximab|rituximab|mesh-list
154220643|NCT02532192|Belinostat|belinostat|mesh-list
154220644|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220645|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154220646|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
154220647|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
154220648|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220649|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220650|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154220651|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
154220652|NCT02532192|Hormones|hormones|mesh-ancestor
154220672|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154220674|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154220675|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154220676|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154220677|NCT00293462|Sargramostim|sargramostim|mesh-list
154220678|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
154220679|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220680|NCT00316082|Metformin|metformin|mesh-list
154220681|NCT00316082|Saxagliptin|saxagliptin|mesh-list
154220682|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154220683|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220684|NCT00316082|Incretins|incretins|mesh-ancestor
154220685|NCT00316082|Hormones|hormones|mesh-ancestor
154220686|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220687|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154220688|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
154220689|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220690|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220691|NCT00316004|Dextrans|dextrans|mesh-list
154220692|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
154220693|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
154220694|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
154220695|NCT01066832|Paclitaxel|paclitaxel|mesh-list
154220696|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154220697|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220698|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220699|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220700|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220701|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220702|NCT00298766|Bortezomib|bortezomib|mesh-list
154220703|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220704|NCT03979664|Dexamethasone|dexamethasone|mesh-list
154220721|NCT00315458|Buprenorphine|buprenorphine|mesh-list
154220722|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154220723|NCT00315458|Narcotics|narcotics|mesh-ancestor
154220724|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220725|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220726|NCT00315458|Analgesics|analgesics|mesh-ancestor
154220727|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
154220728|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220729|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154220730|NCT01065662|Sirolimus|sirolimus|mesh-list
154220731|NCT01065662|Temsirolimus|temsirolimus|mesh-list
154220732|NCT01065662|MTOR Inhibitors|mtor inhibitors|mesh-list
154220733|NCT01065662|Cediranib|cediranib|mesh-list
154220734|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220735|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220736|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220737|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220738|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
154220739|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220740|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220741|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220742|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220743|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220744|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
154220745|NCT01581242|Adefovir|adefovir|mesh-list
154220746|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154220747|NCT01581242|Clevudine|clevudine|mesh-list
154220748|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
154220749|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220750|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154220751|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154220752|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220753|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220754|NCT03982238|Metformin|metformin|mesh-list
154220755|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
154220756|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154220757|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157354|NCT05867121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220758|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154220759|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220761|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
154220762|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
154220763|NCT00293384|Aprepitant|aprepitant|mesh-list
154220764|NCT00293384|Granisetron|granisetron|mesh-list
154220779|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220781|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
154220782|NCT00293384|Hormones|hormones|mesh-ancestor
154220783|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154220784|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154220785|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
154220786|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220787|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154220788|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220789|NCT00293384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154220790|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154220791|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
154220792|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
154220793|NCT00297830|Alendronate|alendronate|mesh-list
154220794|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154220795|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220796|NCT00296816|Bevacizumab|bevacizumab|mesh-list
154220797|NCT00296816|Docetaxel|docetaxel|mesh-list
154220798|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
154220799|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220800|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220801|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154220802|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154220803|NCT00296816|Growth Substances|growth substances|mesh-ancestor
154220804|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220805|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
154220806|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220807|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220808|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220809|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220810|NCT01066988|Emollients|emollients|mesh-list
154220811|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154220812|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154220813|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
154220814|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154220815|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154220816|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220817|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
154220818|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154220819|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
154220820|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154220821|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154220822|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220823|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153643712|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154220836|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154220837|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154220838|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154220839|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
154220840|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154220841|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220842|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154220843|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154220844|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
154220845|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154220846|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154220847|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
154220848|NCT01084720|V0034CR|v0034cr|mesh-list
154220849|NCT01084720|Emollients|emollients|mesh-ancestor
154220850|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
154220851|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
154220852|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154220853|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154220854|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220855|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
154220856|NCT03963466|Coagulants|coagulants|mesh-ancestor
154220857|NCT01084876|Paclitaxel|paclitaxel|mesh-list
154220858|NCT01084876|Trastuzumab|trastuzumab|mesh-list
154220859|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154220860|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220861|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
154220862|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
154220863|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
154220864|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220865|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154220866|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154220867|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154220868|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154220869|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154220870|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220871|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220872|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
154220873|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220874|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154220875|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154220876|NCT00251004|Cyclosporine|cyclosporine|mesh-list
154220877|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
154220878|NCT00251004|Everolimus|everolimus|mesh-list
154220879|NCT00251004|Cyclosporins|cyclosporins|mesh-list
154220880|NCT00251004|Basiliximab|basiliximab|mesh-list
154220881|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154220882|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220883|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220884|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
154220885|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220918|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
154220919|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
154220921|NCT00493649|Trastuzumab|trastuzumab|mesh-list
154220922|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220923|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
154220924|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220925|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154220926|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154220927|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
153643835|NCT00096967|Bevacizumab|bevacizumab|mesh-list
154220955|NCT00117598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154220957|NCT00117598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154220958|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154220959|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
154220960|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220961|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154220962|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154220963|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154220964|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154220965|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
154220966|NCT01082458|Lidocaine|lidocaine|mesh-list
154220967|NCT01082458|Remifentanil|remifentanil|mesh-list
154220968|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
154220969|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
154220970|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154220971|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154220972|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
154220973|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154220974|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153643875|NCT00097279|Metformin|metformin|mesh-list
154221008|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154221010|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221011|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221012|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154221013|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154221014|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
153643926|NCT00400387|Folic Acid|folic acid|mesh-list
154221027|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154221028|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
154221029|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221030|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221031|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154221032|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154221033|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
154221034|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
154221035|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
154221037|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154221038|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
154221039|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221040|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221041|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154221042|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154221043|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
154221044|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221045|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221046|NCT01326754|Artesunate|artesunate|mesh-list
154221047|NCT01326754|Lumefantrine|lumefantrine|mesh-list
154221048|NCT01326754|Artemether|artemether|mesh-list
154221049|NCT01326754|Piperaquine|piperaquine|mesh-list
154221050|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154221051|NCT01326754|Amodiaquine|amodiaquine|mesh-list
154221052|NCT01326754|Artenimol|artenimol|mesh-list
154221053|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
154221054|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
154221055|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154221056|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154221057|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221058|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256437|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221059|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
154221060|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
154221061|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154221062|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
154221063|NCT00093496|Gemcitabine|gemcitabine|mesh-list
154221064|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154221065|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
154221066|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221067|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221068|NCT00265122|Ustekinumab|ustekinumab|mesh-list
154221069|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
154221070|NCT00096538|Valganciclovir|valganciclovir|mesh-list
154221071|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
154221072|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221073|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154221074|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154221075|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221076|NCT03971214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154221077|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221078|NCT01073748|Acetaminophen|acetaminophen|mesh-list
154221094|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154221095|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154221096|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154221097|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221098|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154221099|NCT00468299|Misoprostol|misoprostol|mesh-list
154221100|NCT00468299|Mifepristone|mifepristone|mesh-list
154221101|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154221102|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
154221103|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154221104|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221105|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154221106|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221107|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
154221108|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154221109|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154221110|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154221111|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154221112|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
154221113|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154221114|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154221115|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
154221116|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154221117|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
154221118|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154221119|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154221121|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154221122|NCT01021865|Regadenoson|regadenoson|mesh-list
153693550|NCT00062075|Romidepsin|romidepsin|mesh-list
154221123|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221124|NCT01021865|Hormones|hormones|mesh-ancestor
154221125|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154221126|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221127|NCT01021865|Incretins|incretins|mesh-ancestor
154221128|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154221129|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154221130|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
154221131|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
154221132|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221133|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153968080|NCT02609230|TIC10 compound|tic10 compound|mesh-list
154221134|NCT00468143|Adderall|adderall|mesh-list
154221135|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154221148|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154221149|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154221150|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221151|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
154221152|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221153|NCT00467831|Expectorants|expectorants|mesh-ancestor
154221154|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
154221155|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154221156|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
154221157|NCT00467831|Protective Agents|protective agents|mesh-ancestor
154221158|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221159|NCT00467831|Antidotes|antidotes|mesh-ancestor
154221160|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154221161|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154221162|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
154221163|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154221164|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154221165|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221166|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154221167|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221168|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154221169|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154221170|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154221171|NCT00467831|Analgesics|analgesics|mesh-ancestor
154221172|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
154221173|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221174|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154221175|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154221176|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154221177|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154221178|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
154221179|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154221180|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
154221181|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
154221182|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154221183|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154221184|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154221185|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221186|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154221187|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154221188|NCT01021943|Spironolactone|spironolactone|mesh-list
154221189|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154221190|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
154221191|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154221192|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221193|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154221194|NCT01021943|Diuretics|diuretics|mesh-ancestor
154221195|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
154221196|NCT01022021|Rituximab|rituximab|mesh-list
154221197|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154221198|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154221223|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154221224|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154221225|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154221226|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221228|NCT00467363|Folic Acid|folic acid|mesh-list
154221229|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154221230|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154221231|NCT00467363|Analgesics|analgesics|mesh-ancestor
154221232|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
154221233|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221234|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221235|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154221236|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154221237|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154221238|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154221239|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221240|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154221241|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154221242|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221243|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
154221244|NCT00467363|Hematinics|hematinics|mesh-ancestor
154221245|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
154221246|NCT00467363|Vitamins|vitamins|mesh-ancestor
154221277|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154221278|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221279|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
154221280|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
154221281|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
154221282|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221283|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154221284|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
154221285|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221286|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154221287|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
154221288|NCT00264498|Carboplatin|carboplatin|mesh-list
154221289|NCT00264498|Gemcitabine|gemcitabine|mesh-list
154221291|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221292|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154221293|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
153644201|NCT00100126|Amoxicillin|amoxicillin|mesh-list
154221306|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221307|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221308|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
154221309|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154221310|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221311|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154221312|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221313|NCT01072734|Vaccines|vaccines|mesh-list
154221314|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
154221315|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221316|NCT03970668|Insulin|insulin|mesh-list
154221317|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154221318|NCT03970668|Linagliptin|linagliptin|mesh-list
154221319|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154221320|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221321|NCT03970668|Incretins|incretins|mesh-ancestor
154221322|NCT03970668|Hormones|hormones|mesh-ancestor
154221323|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154221324|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154221325|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
154221326|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221327|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221328|NCT00454181|Interferons|interferons|mesh-list
154221329|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
154221330|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221331|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
154221332|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221333|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
154221334|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221335|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154221336|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154221337|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221338|NCT01073826|Incretins|incretins|mesh-ancestor
154221339|NCT01073826|Hormones|hormones|mesh-ancestor
154221340|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154221341|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154221342|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
154221343|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221344|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221345|NCT01072812|Phenserine|phenserine|mesh-list
154221346|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154221347|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221348|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221349|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
154221350|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221351|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221352|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
154221353|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154221354|NCT00237042|Estradiol|estradiol|mesh-list
154221355|NCT00237042|Estrogens|estrogens|mesh-ancestor
154221368|NCT00465647|Narcotics|narcotics|mesh-ancestor
154221369|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221370|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221371|NCT00465647|Analgesics|analgesics|mesh-ancestor
154221372|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
154221373|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221374|NCT00090766|Valganciclovir|valganciclovir|mesh-list
154221376|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221377|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
154221378|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154221379|NCT03961828|Ledipasvir|ledipasvir|mesh-list
154221380|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
154221381|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221382|NCT00465179|Sunitinib|sunitinib|mesh-list
154221383|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221384|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154221385|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154221386|NCT00465179|Growth Substances|growth substances|mesh-ancestor
154221387|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221388|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
154221389|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221390|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221391|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221392|NCT00084136|Tenofovir|tenofovir|mesh-list
154221393|NCT00084136|Lamivudine|lamivudine|mesh-list
154221394|NCT00084136|Emtricitabine|emtricitabine|mesh-list
154221395|NCT00084136|Zidovudine|zidovudine|mesh-list
154221396|NCT00084136|Efavirenz|efavirenz|mesh-list
154221397|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154221398|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154221399|NCT00084136|Didanosine|didanosine|mesh-list
154221400|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
154221401|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
154221402|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221403|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154221404|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154221405|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221406|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221407|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154221408|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154221409|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
154221410|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154221411|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154221412|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154221413|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154221414|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154221415|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154221416|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154221441|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
154221442|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221443|NCT00464087|Heparin|heparin|mesh-list
154221444|NCT00464087|Calcium heparin|calcium heparin|mesh-list
154221445|NCT00464087|PENTA|penta|mesh-list
154221446|NCT00464087|Bivalirudin|bivalirudin|mesh-list
154221447|NCT00464087|Fondaparinux|fondaparinux|mesh-list
154221448|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
154221449|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154221450|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154221451|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221452|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
154221453|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154221454|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
154221455|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221456|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154221457|NCT00452699|Fluticasone|fluticasone|mesh-list
154221458|NCT00452699|Xhance|xhance|mesh-list
154221459|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154221460|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154221461|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154221462|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
154221463|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221464|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221465|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153644378|NCT00006386|Carmustine|carmustine|mesh-list
154221482|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221483|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
154221484|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
154221485|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
154221486|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440430|NCT00003145|Fludarabine|fludarabine|mesh-list
154221487|NCT01326988|Anesthetics|anesthetics|mesh-list
154221488|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221489|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221490|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
154221492|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154221493|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221494|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
154221495|NCT03962296|Coagulants|coagulants|mesh-ancestor
154221496|NCT01086046|Heparin|heparin|mesh-list
154221497|NCT01086046|Enoxaparin|enoxaparin|mesh-list
154221498|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154221499|NCT01086046|Tinzaparin|tinzaparin|mesh-list
154221500|NCT01086046|Dalteparin|dalteparin|mesh-list
154221501|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
154221502|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154221503|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154221504|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221505|NCT01090648|Etravirine|etravirine|mesh-list
154221506|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153968450|NCT02729961|Ceritinib|ceritinib|mesh-list
154221507|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154221508|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221509|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221510|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
154221511|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221512|NCT03741244|Temozolomide|temozolomide|mesh-list
154221513|NCT03741244|Apatinib|apatinib|mesh-list
154221514|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154221515|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
154221516|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221517|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221518|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221519|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221520|NCT00463385|Thalidomide|thalidomide|mesh-list
154221521|NCT00463385|Prednisone|prednisone|mesh-list
154221522|NCT00463385|Pomalidomide|pomalidomide|mesh-list
154221523|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154221524|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
154221525|NCT00463385|Hormones|hormones|mesh-ancestor
153644417|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154221539|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
154221540|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154221541|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154221542|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154221543|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154221544|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221545|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
154221546|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154221547|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221548|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154221549|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221550|NCT00068692|Leucovorin|leucovorin|mesh-list
154221551|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
154221552|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
154221553|NCT00068692|Fluorouracil|fluorouracil|mesh-list
154221554|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
154221555|NCT00068692|Irinotecan|irinotecan|mesh-list
154221556|NCT00068692|Camptothecin|camptothecin|mesh-list
154221557|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
154221558|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221559|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
154221560|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221561|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154221562|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221563|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154221564|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
154221565|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154221566|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154221567|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221568|NCT00068692|Antidotes|antidotes|mesh-ancestor
154221569|NCT00068692|Protective Agents|protective agents|mesh-ancestor
154221570|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
154221571|NCT00068692|Vitamins|vitamins|mesh-ancestor
154221572|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
154221573|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154221574|NCT00463151|Rebamipide|rebamipide|mesh-list
154221575|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154221576|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221577|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
154221578|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221579|NCT00463151|Protective Agents|protective agents|mesh-ancestor
154221580|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221581|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221582|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
154221583|NCT00068380|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154221584|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221585|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221586|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221607|NCT00262860|Gemcitabine|gemcitabine|mesh-list
154221608|NCT00262860|Bortezomib|bortezomib|mesh-list
154221609|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154221610|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
154221611|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221612|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221613|NCT00236184|Rabeprazole|rabeprazole|mesh-list
154221614|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154221615|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154221616|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154221617|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221618|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221619|NCT00296504|Ritonavir|ritonavir|mesh-list
154221620|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
154221621|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154221622|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154221623|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
154221624|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221625|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221626|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154221627|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154221628|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
154221629|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221630|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154221631|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154221632|NCT00313820|Pregabalin|pregabalin|mesh-list
154221633|NCT00313820|Analgesics|analgesics|mesh-ancestor
154221634|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
154221635|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221636|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221637|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
154221638|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154221639|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153644544|NCT00102271|Oxypurinol|oxypurinol|mesh-list
154221658|NCT00296036|Pyridoxine|pyridoxine|mesh-list
154221659|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
154221660|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
154221661|NCT00296036|Vitamins|vitamins|mesh-ancestor
154221662|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
154221663|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221664|NCT01072890|Sirolimus|sirolimus|mesh-list
154221665|NCT01072890|Temsirolimus|temsirolimus|mesh-list
153693762|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
154221666|NCT01072890|MTOR Inhibitors|mtor inhibitors|mesh-list
154221667|NCT01072890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221668|NCT01072890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221669|NCT01072890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221670|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154221671|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
154221672|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221673|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221674|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154221675|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221676|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154221677|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
154221678|NCT00089674|Denosumab|denosumab|mesh-list
154221679|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154221680|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221681|NCT01090882|Bupivacaine|bupivacaine|mesh-list
154221682|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
154221683|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
154256438|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256439|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154221684|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221685|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221686|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
154221687|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221689|NCT01090960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221690|NCT01090960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154221691|NCT01090960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221692|NCT01090960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221693|NCT01067066|Temozolomide|temozolomide|mesh-list
154221694|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154221695|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
154221726|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221727|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154221728|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154221729|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154221730|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221731|NCT00312572|Buprenorphine|buprenorphine|mesh-list
154221732|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154221733|NCT00312572|Narcotics|narcotics|mesh-ancestor
154221734|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154221735|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221736|NCT00312572|Analgesics|analgesics|mesh-ancestor
154221737|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
154221738|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221764|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154221765|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154221766|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221767|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221768|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221769|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154221770|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
154221771|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154221772|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221773|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154221774|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154221775|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154221777|NCT00290498|Dexamethasone|dexamethasone|mesh-list
154221778|NCT00290498|Prednisone|prednisone|mesh-list
154221779|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
154221780|NCT00290498|Rituximab|rituximab|mesh-list
154221781|NCT00290498|Doxorubicin|doxorubicin|mesh-list
154221782|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154221783|NCT00290498|Methotrexate|methotrexate|mesh-list
154221784|NCT00290498|Vincristine|vincristine|mesh-list
154221785|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154221786|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
154221787|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221804|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154221805|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154221806|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154221807|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221808|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154221809|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
154221810|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154221811|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154221812|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
154221813|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
154221814|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154221815|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154221816|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
154221817|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221818|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154221819|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
154221820|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
154221821|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
154221822|NCT01069796|Paclitaxel|paclitaxel|mesh-list
154221823|NCT01069796|Bevacizumab|bevacizumab|mesh-list
154221824|NCT01069796|Capecitabine|capecitabine|mesh-list
154221825|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154221826|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221827|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
154221828|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
154221829|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
154221830|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221831|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154221832|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154221833|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154221834|NCT01069796|Growth Substances|growth substances|mesh-ancestor
154221835|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221836|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
154221837|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154221838|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
154221839|NCT01067534|Albuterol|albuterol|mesh-list
154221840|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154221841|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
154221842|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154221843|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221844|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154221857|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
154221858|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154221859|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
154221860|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221861|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154221862|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154221863|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154221864|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154221865|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154221866|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221867|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
154221868|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154221869|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221870|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
154221871|NCT01069874|Vitamin D|vitamin d|mesh-list
154221872|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
154221873|NCT01069874|Vitamins|vitamins|mesh-ancestor
154221874|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
154221875|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221876|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154221877|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154221878|NCT01022645|Copper|copper|mesh-list
154221879|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
154221880|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154221881|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
154221882|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154221883|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221884|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154221885|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154221886|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154221887|NCT01022645|Trace Elements|trace elements|mesh-ancestor
154221888|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
154221889|NCT01025765|Metformin|metformin|mesh-list
154221890|NCT01025765|Pioglitazone|pioglitazone|mesh-list
154221891|NCT01025765|Acarbose|acarbose|mesh-list
154221892|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154221893|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221894|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154221895|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221896|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221897|NCT03824912|Ketoconazole|ketoconazole|mesh-list
154221898|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
154221899|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154221900|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154221901|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154221902|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154221903|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221904|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154221905|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
154221906|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644799|NCT03879408|Narcotics|narcotics|mesh-ancestor
154221933|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154221934|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
154221935|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154221936|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154221937|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256440|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
153440562|NCT00004057|Paclitaxel|paclitaxel|mesh-list
154221938|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221939|NCT00461123|Urological Agents|urological agents|mesh-ancestor
154221940|NCT00290342|Edetic Acid|edetic acid|mesh-list
154221941|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
154221942|NCT00290342|Antidotes|antidotes|mesh-ancestor
154221943|NCT00290342|Protective Agents|protective agents|mesh-ancestor
154221944|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221945|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
154221946|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
154221947|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221948|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154221949|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
154221950|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154221951|NCT00460811|Linaclotide|linaclotide|mesh-list
154221952|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154221953|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
154221983|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
154221984|NCT03982004|Imiquimod|imiquimod|mesh-list
154221985|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154221986|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154221987|NCT03982004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154221988|NCT03982004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154221989|NCT03982004|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154221990|NCT03982004|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154221991|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
154221992|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154221993|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154221994|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
154221995|NCT01025921|Colistin|colistin|mesh-list
154221996|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153644906|NCT00104845|Vaccines|vaccines|mesh-list
154222007|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222008|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154222009|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
154222010|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154222011|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
154222012|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222013|NCT01026311|Ubiquinone|ubiquinone|mesh-list
154222014|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
154222015|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
154222016|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222017|NCT01026311|Vitamins|vitamins|mesh-ancestor
154222018|NCT01063010|Bevacizumab|bevacizumab|mesh-list
154222019|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222020|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222021|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154222022|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154222023|NCT01063010|Growth Substances|growth substances|mesh-ancestor
154222024|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222025|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
154222026|NCT00460577|Bromides|bromides|mesh-list
154222027|NCT00460577|Fenoterol|fenoterol|mesh-list
154222028|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
154222029|NCT00460577|Ipratropium|ipratropium|mesh-list
154222030|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154222031|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
154222032|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222033|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222034|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154222035|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
154222036|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154222037|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154222038|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154222039|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
154222040|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222041|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222042|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
154222043|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154222044|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
154222045|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
154222046|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
154222047|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154222048|NCT01581320|Vitamin D|vitamin d|mesh-list
153693978|NCT00226096|Analgesics|analgesics|mesh-ancestor
154222049|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
154222050|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
154222051|NCT01581320|Vitamins|vitamins|mesh-ancestor
154222052|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
154222053|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222054|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154222055|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154222056|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154222057|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222058|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222059|NCT00288704|Rilonacept|rilonacept|mesh-list
154222060|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222061|NCT00288626|Cytarabine|cytarabine|mesh-list
154222062|NCT00288626|Prednisone|prednisone|mesh-list
154222063|NCT00288626|Etoposide|etoposide|mesh-list
154222064|NCT00288626|Melphalan|melphalan|mesh-list
154222088|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154222089|NCT00087490|Vancomycin|vancomycin|mesh-list
154222090|NCT00087490|Linezolid|linezolid|mesh-list
154222091|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154222092|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222093|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154222094|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222095|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222096|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
154222097|NCT00087178|Doxorubicin|doxorubicin|mesh-list
154222098|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154222099|NCT00087178|Fluorouracil|fluorouracil|mesh-list
154222100|NCT00087178|Epirubicin|epirubicin|mesh-list
154222101|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154222102|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
154222103|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222104|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154222105|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154222106|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
154222107|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222108|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222109|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154222110|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154222111|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154222112|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222113|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222114|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
153645018|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
154222138|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222139|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222140|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
154222141|NCT01068392|Hormones|hormones|mesh-ancestor
154222142|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222143|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222144|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154222145|NCT01086826|Cisplatin|cisplatin|mesh-list
154222146|NCT01086826|Docetaxel|docetaxel|mesh-list
154222147|NCT01086826|Fluorouracil|fluorouracil|mesh-list
154222148|NCT01086826|Cetuximab|cetuximab|mesh-list
154222149|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222150|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
154222151|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
154222152|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
154222153|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222154|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
153694106|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154222155|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154222156|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154222157|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
154222158|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222159|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222160|NCT00287690|Genistein|genistein|mesh-list
154222161|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154222162|NCT00287690|Protective Agents|protective agents|mesh-ancestor
154222163|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222164|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222165|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154222166|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222167|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222184|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
154222186|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222187|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154222188|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154222189|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222190|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222191|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222192|NCT01026467|Carboplatin|carboplatin|mesh-list
154222193|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222194|NCT01094158|Cholic Acids|cholic acids|mesh-list
154222195|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222196|NCT00460109|Rituximab|rituximab|mesh-list
154222197|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
154222198|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222199|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222200|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
154222201|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222202|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154222203|NCT03956212|Doxycycline|doxycycline|mesh-list
154222204|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154222205|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222206|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
154222207|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154222208|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154222209|NCT01091818|Midazolam|midazolam|mesh-list
154222210|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
154222211|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154222212|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222213|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222214|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154222215|NCT01091818|Analgesics|analgesics|mesh-ancestor
154222216|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
154222217|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222218|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154222219|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154222220|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154222221|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
154222222|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222223|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222224|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154222225|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154222226|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154222242|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
154222243|NCT00065260|Cyclosporins|cyclosporins|mesh-list
154222244|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
154222245|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154222246|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222247|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222248|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154222249|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
154222250|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222251|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
154222252|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222253|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
154222254|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154222255|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154222256|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222257|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222258|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
154222259|NCT01327066|Droxidopa|droxidopa|mesh-list
154222260|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154222261|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222262|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154222263|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222264|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222265|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222266|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222267|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154222268|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154222269|NCT01094626|Secretin|secretin|mesh-list
154222270|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222271|NCT01094626|Hormones|hormones|mesh-ancestor
154222272|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154256441|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
154222273|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222274|NCT03956134|Tapentadol|tapentadol|mesh-list
154222275|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154222276|NCT03956134|Narcotics|narcotics|mesh-ancestor
154222277|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222278|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222279|NCT03956134|Analgesics|analgesics|mesh-ancestor
154222280|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
154222281|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222282|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154222283|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154222284|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154222285|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222286|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154222287|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694142|NCT00095862|Interferons|interferons|mesh-list
154222310|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222312|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
154222313|NCT00451217|Neostigmine|neostigmine|mesh-list
154222314|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154222315|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222316|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222317|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
154222318|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222319|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222320|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154222321|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
154222322|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222323|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154222324|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154222325|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154222326|NCT00459953|Nicotine|nicotine|mesh-list
154222327|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154222328|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
154222329|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222330|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222331|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154222332|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154222333|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
154222334|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222335|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222336|NCT00459875|Sunitinib|sunitinib|mesh-list
154222337|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222348|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154222349|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154222351|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
154222352|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222353|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222354|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222355|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154222356|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154222357|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154222358|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222359|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154222360|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154222361|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222362|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
154222363|NCT00450749|Lycopene|lycopene|mesh-list
154222364|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
154222365|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222366|NCT00450749|Protective Agents|protective agents|mesh-ancestor
154222367|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222368|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222369|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154222370|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154222371|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222372|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154222373|NCT00292370|Paroxetine|paroxetine|mesh-list
154222374|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
154222375|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154222376|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154222377|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154222378|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222379|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222380|NCT00292370|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154222381|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154222382|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154222383|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222384|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222385|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
154222386|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154222387|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154222388|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154222389|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222391|NCT00065182|Topotecan|topotecan|mesh-list
154222392|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222393|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
154222394|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
154222395|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
154222396|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222397|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154222398|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222399|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222409|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154222410|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
154222411|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222412|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154222413|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154222414|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222415|NCT01095016|Fenoterol|fenoterol|mesh-list
154222416|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154222417|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
154222418|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222419|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222420|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154222421|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
154222422|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
154222423|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
154222424|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154222425|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154222426|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154222427|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154222428|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
154222429|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222430|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222431|NCT01095172|Prednisolone|prednisolone|mesh-list
154222432|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154222433|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
154222434|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154222435|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
154222436|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
154222437|NCT01095172|Rituximab|rituximab|mesh-list
154222438|NCT01095172|Tacrolimus|tacrolimus|mesh-list
154222439|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154222440|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
154222441|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153694207|NCT04721899|Vitamin D|vitamin d|mesh-list
154222442|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222443|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
154222444|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222445|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154222446|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154222447|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154222448|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222449|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222450|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222451|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
154222452|NCT01095172|Hormones|hormones|mesh-ancestor
154222453|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222454|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154222455|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
154222456|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
154222457|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222458|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222459|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154222460|NCT01095172|Protective Agents|protective agents|mesh-ancestor
154222462|NCT00286442|Alogliptin|alogliptin|mesh-list
154222463|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154222464|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222465|NCT00286442|Incretins|incretins|mesh-ancestor
154222466|NCT00286442|Hormones|hormones|mesh-ancestor
154222467|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222479|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
154222480|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
154222481|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222482|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154222483|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154222484|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222485|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222486|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154222487|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
153969416|NCT05754736|Growth Substances|growth substances|mesh-ancestor
154222488|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222489|NCT00063154|Pertuzumab|pertuzumab|mesh-list
154222490|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222491|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222492|NCT01092520|Gabapentin|gabapentin|mesh-list
154222493|NCT01092520|Analgesics|analgesics|mesh-ancestor
154222494|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
154222495|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222496|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222497|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
154222498|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154222499|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154222500|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222501|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154222502|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154222503|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154222504|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222505|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222506|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
154222507|NCT00458705|Thalidomide|thalidomide|mesh-list
154222508|NCT00458705|Dexamethasone|dexamethasone|mesh-list
154222509|NCT00458705|Doxorubicin|doxorubicin|mesh-list
154222510|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154222511|NCT00458705|Bortezomib|bortezomib|mesh-list
154222512|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694212|NCT00062972|Donepezil|donepezil|mesh-list
154222513|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
154222514|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
154222515|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222516|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222517|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222518|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
154222519|NCT00458705|Hormones|hormones|mesh-ancestor
154222520|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222521|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154222522|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222523|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154222524|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154222525|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222526|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222527|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222528|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154222529|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
154222530|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
154222531|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154222587|NCT06202755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222588|NCT06202755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154222589|NCT06202755|Autonomic Agents|autonomic agents|mesh-ancestor
154222590|NCT06202755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222591|NCT06202755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154222592|NCT06202755|Respiratory System Agents|respiratory system agents|mesh-ancestor
154222593|NCT06202755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154222594|NCT06202755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154222595|NCT06202755|Vasodilator Agents|vasodilator agents|mesh-ancestor
154222596|NCT06202755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154222597|NCT06202755|Protective Agents|protective agents|mesh-ancestor
154222598|NCT06202755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154222599|NCT06202755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154222600|NCT06202755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222601|NCT06202703|Vaccines|vaccines|mesh-list
154222602|NCT06202703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154222603|NCT06202703|Immunologic Factors|immunologic factors|mesh-ancestor
154222604|NCT06202703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222605|NCT06202560|Tofacitinib|tofacitinib|mesh-list
154222606|NCT06202560|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154222607|NCT06202560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154222608|NCT06202560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222609|NCT06202560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222610|NCT06202079|Insulin|insulin|mesh-list
154222611|NCT06202079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154222612|NCT06202079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222613|NCT06202001|Trifluridine|trifluridine|mesh-list
154222614|NCT06202001|Bevacizumab|bevacizumab|mesh-list
154222615|NCT06202001|Irinotecan|irinotecan|mesh-list
154222616|NCT06202001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222617|NCT06202001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222618|NCT06202001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154222619|NCT06202001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154222620|NCT06202001|Growth Substances|growth substances|mesh-ancestor
153694239|NCT00227734|Capecitabine|capecitabine|mesh-list
154222621|NCT06202001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222622|NCT06202001|Growth Inhibitors|growth inhibitors|mesh-ancestor
154222623|NCT06202001|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154222624|NCT06202001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222647|NCT06201676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222648|NCT06201676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222649|NCT06201624|Isotretinoin|isotretinoin|mesh-list
154222650|NCT06201624|Dermatologic Agents|dermatologic agents|mesh-ancestor
154222651|NCT06201611|Thioctic Acid|thioctic acid|mesh-list
154222652|NCT06201611|Nebivolol|nebivolol|mesh-list
154222653|NCT06201611|Epalrestat|epalrestat|mesh-list
154222654|NCT06201611|Antioxidants|antioxidants|mesh-ancestor
154222655|NCT06201611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222656|NCT06201611|Protective Agents|protective agents|mesh-ancestor
154222657|NCT06201611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222658|NCT06201611|Vitamin B Complex|vitamin b complex|mesh-ancestor
154222659|NCT06201611|Vitamins|vitamins|mesh-ancestor
154222660|NCT06201611|Micronutrients|micronutrients|mesh-ancestor
154222661|NCT06201611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154222662|NCT06201611|Vasodilator Agents|vasodilator agents|mesh-ancestor
154222663|NCT06201611|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154222664|NCT06201611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154222665|NCT06201611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154222666|NCT06201611|Adrenergic Agents|adrenergic agents|mesh-ancestor
154222667|NCT06201611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222668|NCT06201611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222669|NCT06201559|Albendazole|albendazole|mesh-list
154222670|NCT06201559|Anthelmintics|anthelmintics|mesh-ancestor
154222671|NCT06201559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154222672|NCT06201559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222673|NCT06201559|Anticestodal Agents|anticestodal agents|mesh-ancestor
154222674|NCT06201559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154222675|NCT06201559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154222676|NCT06201559|Tubulin Modulators|tubulin modulators|mesh-ancestor
154222677|NCT06201559|Antimitotic Agents|antimitotic agents|mesh-ancestor
153645572|NCT00110071|Trace Elements|trace elements|mesh-ancestor
154222691|NCT06201195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222692|NCT06201065|Leucovorin|leucovorin|mesh-list
154222693|NCT06201065|Fluorouracil|fluorouracil|mesh-list
154222694|NCT06201065|Oxaliplatin|oxaliplatin|mesh-list
154222695|NCT06201065|Lenvatinib|lenvatinib|mesh-list
154222696|NCT06201065|Antimetabolites|antimetabolites|mesh-ancestor
154222697|NCT06201065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222698|NCT06201065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154222699|NCT06201065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222700|NCT06201065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154222701|NCT06201065|Immunologic Factors|immunologic factors|mesh-ancestor
154222702|NCT06201065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222703|NCT06201065|Antidotes|antidotes|mesh-ancestor
154222704|NCT06201065|Protective Agents|protective agents|mesh-ancestor
154222705|NCT06201065|Vitamin B Complex|vitamin b complex|mesh-ancestor
154222706|NCT06201065|Vitamins|vitamins|mesh-ancestor
154222707|NCT06201065|Micronutrients|micronutrients|mesh-ancestor
154222708|NCT06201065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154222709|NCT06201065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222710|NCT06201039|Lidocaine|lidocaine|mesh-list
154222711|NCT06201039|Anesthetics, Local|anesthetics, local|mesh-ancestor
154222712|NCT06201039|Anesthetics|anesthetics|mesh-ancestor
154222713|NCT06201039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222714|NCT06201039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694349|NCT00063089|Antibodies|antibodies|mesh-list
154222715|NCT06201039|Sensory System Agents|sensory system agents|mesh-ancestor
154222716|NCT06201039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222717|NCT06201039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154222718|NCT06201039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154222719|NCT06201039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154222720|NCT06201039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154222721|NCT06201039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222722|NCT06201013|Vitamin D|vitamin d|mesh-list
154222723|NCT06201013|Ergocalciferols|ergocalciferols|mesh-list
154222724|NCT06201013|Cholecalciferol|cholecalciferol|mesh-list
154222725|NCT06201013|Vitamins|vitamins|mesh-list
154222726|NCT06201013|Solifenacin Succinate|solifenacin succinate|mesh-list
154222727|NCT06201013|Micronutrients|micronutrients|mesh-ancestor
154222728|NCT06201013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222729|NCT06201013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154222730|NCT06201013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154222731|NCT06201013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154222732|NCT06201013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154222733|NCT06201013|Cholinergic Agents|cholinergic agents|mesh-ancestor
154222734|NCT06201013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222735|NCT06201013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222736|NCT06201013|Urological Agents|urological agents|mesh-ancestor
154222737|NCT06200883|Choline|choline|mesh-list
154222738|NCT06200883|Lipotropic Agents|lipotropic agents|mesh-ancestor
154222739|NCT06200883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154222740|NCT06200883|Antimetabolites|antimetabolites|mesh-ancestor
154222753|NCT06200779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154222754|NCT06200779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222755|NCT06200779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154222756|NCT06200779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222757|NCT06200779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222758|NCT06200779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154222759|NCT06200779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154222760|NCT06200779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154222761|NCT06200779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154222762|NCT06200779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222763|NCT06200779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222764|NCT06200779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154222765|NCT06200779|Antacids|antacids|mesh-ancestor
154222766|NCT06200779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222767|NCT06200779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154222768|NCT06200779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154222769|NCT06200779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154222770|NCT06200766|Mometasone Furoate|mometasone furoate|mesh-list
154222771|NCT06200766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222772|NCT06200766|Dermatologic Agents|dermatologic agents|mesh-ancestor
154222773|NCT06200766|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154222774|NCT06200662|Analgesics|analgesics|mesh-list
154222775|NCT06200662|Sensory System Agents|sensory system agents|mesh-ancestor
154222776|NCT06200662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222777|NCT06200662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222778|NCT06200584|Vitamin D|vitamin d|mesh-list
154222779|NCT06200584|Ergocalciferols|ergocalciferols|mesh-list
154222780|NCT06200584|Cholecalciferol|cholecalciferol|mesh-list
154222781|NCT06200584|Vitamins|vitamins|mesh-list
154222782|NCT06200584|Vitamin E|vitamin e|mesh-list
154222783|NCT06200584|Tocopherols|tocopherols|mesh-list
154222784|NCT06200584|Tocotrienols|tocotrienols|mesh-list
154222785|NCT06200584|alpha-Tocopherol|alpha-tocopherol|mesh-list
154222786|NCT06200584|Olanzapine|olanzapine|mesh-list
154222787|NCT06200584|Risperidone|risperidone|mesh-list
154222788|NCT06200584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154222789|NCT06200584|Antipsychotic Agents|antipsychotic agents|mesh-list
154222790|NCT06200584|Micronutrients|micronutrients|mesh-ancestor
154222792|NCT06200584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154222793|NCT06200584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154222794|NCT06200584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154222795|NCT06200584|Serotonin Agents|serotonin agents|mesh-ancestor
154222796|NCT06200584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154222797|NCT06200584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222798|NCT06200584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154222799|NCT06200584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222800|NCT06200584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154222801|NCT06200584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154222802|NCT06200584|Dopamine Agents|dopamine agents|mesh-ancestor
154222803|NCT06200584|Antiemetics|antiemetics|mesh-ancestor
154222804|NCT06200584|Autonomic Agents|autonomic agents|mesh-ancestor
154222805|NCT06200584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222806|NCT06200584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222807|NCT06200584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154222821|NCT06200298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222822|NCT06198322|Vitamin D|vitamin d|mesh-list
154222823|NCT06198322|Cholecalciferol|cholecalciferol|mesh-list
154222824|NCT06198322|Vitamins|vitamins|mesh-ancestor
154222825|NCT06198322|Micronutrients|micronutrients|mesh-ancestor
154222826|NCT06198322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222827|NCT06198322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154222828|NCT06198322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154222829|NCT06184659|Meropenem|meropenem|mesh-list
154222830|NCT06184659|Tazobactam|tazobactam|mesh-list
154222831|NCT06184659|Piperacillin|piperacillin|mesh-list
154222832|NCT06184659|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154222833|NCT06184659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154222834|NCT06184659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222835|NCT06184659|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154222836|NCT06184659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222837|NCT06184659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222838|NCT06162559|Trastuzumab|trastuzumab|mesh-list
154222839|NCT06162559|Pertuzumab|pertuzumab|mesh-list
154222840|NCT06162559|Tucatinib|tucatinib|mesh-list
154222841|NCT06162559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222842|NCT06162559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222843|NCT06162559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154222844|NCT06162559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222845|NCT06162559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222846|NCT06144255|Insulin|insulin|mesh-list
154222847|NCT06144255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154222848|NCT06144255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222849|NCT06128369|Dexamethasone|dexamethasone|mesh-list
154222850|NCT06128369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154222851|NCT06128369|Antiemetics|antiemetics|mesh-ancestor
154222852|NCT06128369|Autonomic Agents|autonomic agents|mesh-ancestor
154222853|NCT06128369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222854|NCT06128369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222855|NCT06128369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222856|NCT06128369|Glucocorticoids|glucocorticoids|mesh-ancestor
154222857|NCT06128369|Hormones|hormones|mesh-ancestor
154222858|NCT06128369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154222859|NCT06128369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154222860|NCT06128369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222861|NCT06113211|Narcotics|narcotics|mesh-list
154222862|NCT06113211|Analgesics|analgesics|mesh-list
154222863|NCT06113211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222864|NCT06113211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222865|NCT06113211|Sensory System Agents|sensory system agents|mesh-ancestor
154222866|NCT06113211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222867|NCT06092931|Repaglinide|repaglinide|mesh-list
154222868|NCT06092931|Digoxin|digoxin|mesh-list
153969798|NCT02716857|Oxycodone|oxycodone|mesh-list
154222869|NCT06092931|Midazolam|midazolam|mesh-list
154222870|NCT06092931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154222897|NCT06034470|Idarubicin|idarubicin|mesh-list
154222898|NCT06034470|Lenograstim|lenograstim|mesh-list
154222899|NCT06034470|Immunoconjugates|immunoconjugates|mesh-list
154222900|NCT06034470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222901|NCT06034470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154222902|NCT06034470|Antimetabolites|antimetabolites|mesh-ancestor
154222903|NCT06034470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256442|NCT01265888|Protective Agents|protective agents|mesh-ancestor
154222904|NCT06034470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154222905|NCT06034470|Immunologic Factors|immunologic factors|mesh-ancestor
154222906|NCT06034470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222907|NCT06034470|Antiviral Agents|antiviral agents|mesh-ancestor
154222908|NCT06034470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222909|NCT06034470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154222910|NCT06034470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154222911|NCT06034470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154222912|NCT06034470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154222913|NCT06034470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222914|NCT06028932|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154222915|NCT06028932|Immunoconjugates|immunoconjugates|mesh-ancestor
154222916|NCT06028932|Immunologic Factors|immunologic factors|mesh-ancestor
154222917|NCT06028932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222918|NCT06027606|Budesonide|budesonide|mesh-list
154222919|NCT06027606|Albuterol|albuterol|mesh-list
154222920|NCT06027606|Formoterol Fumarate|formoterol fumarate|mesh-list
153645816|NCT00401596|Omalizumab|omalizumab|mesh-list
154222937|NCT06027606|Tocolytic Agents|tocolytic agents|mesh-ancestor
154222938|NCT06027606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154222939|NCT06006013|Atezolizumab|atezolizumab|mesh-list
154222940|NCT06006013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154222941|NCT06006013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154222942|NCT06006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222943|NCT06006013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154222944|NCT06006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694518|NCT02967653|Atorvastatin|atorvastatin|mesh-list
154222945|NCT06006013|Immunologic Factors|immunologic factors|mesh-ancestor
154222946|NCT06006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222947|NCT05999734|Bupivacaine|bupivacaine|mesh-list
154222948|NCT05999734|Anesthetics, Local|anesthetics, local|mesh-ancestor
154222949|NCT05999734|Anesthetics|anesthetics|mesh-ancestor
154222950|NCT05999734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154222951|NCT05999734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222952|NCT05999734|Sensory System Agents|sensory system agents|mesh-ancestor
154222953|NCT05999734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154222954|NCT05997433|Amoxicillin|amoxicillin|mesh-list
154222955|NCT05997433|Tetracycline|tetracycline|mesh-list
154222956|NCT05997433|Bismuth|bismuth|mesh-list
154222957|NCT05997433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154222958|NCT05997433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154222959|NCT05997433|Antacids|antacids|mesh-ancestor
154222960|NCT05997433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222961|NCT05997433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154222962|NCT05997433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154222963|NCT05997433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222964|NCT05973422|Insulin|insulin|mesh-list
154222965|NCT05973422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154222966|NCT05973422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222967|NCT05890118|Ustekinumab|ustekinumab|mesh-list
154222968|NCT05890118|Dermatologic Agents|dermatologic agents|mesh-ancestor
154222969|NCT05885646|Sulthiame|sulthiame|mesh-list
154222970|NCT05885646|Anticonvulsants|anticonvulsants|mesh-ancestor
154222971|NCT05882214|Niacinamide|niacinamide|mesh-list
154222973|NCT05882214|Nicotinic Acids|nicotinic acids|mesh-list
154222974|NCT05882214|Vitamin B Complex|vitamin b complex|mesh-ancestor
154222975|NCT05882214|Vitamins|vitamins|mesh-ancestor
154222976|NCT05882214|Micronutrients|micronutrients|mesh-ancestor
154222977|NCT05882214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154222978|NCT05882214|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154222979|NCT05882214|Antimetabolites|antimetabolites|mesh-ancestor
154222991|NCT05829226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154222992|NCT05829226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222993|NCT05821374|Deucravacitinib|deucravacitinib|mesh-list
154222994|NCT05821374|Dermatologic Agents|dermatologic agents|mesh-ancestor
154222995|NCT05821374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154222996|NCT05821374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154222997|NCT05821374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154222998|NCT05806021|Triamcinolone|triamcinolone|mesh-list
154222999|NCT05806021|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154223000|NCT05806021|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154223001|NCT05806021|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154223002|NCT05806021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223003|NCT05806021|Glucocorticoids|glucocorticoids|mesh-ancestor
154223005|NCT05806021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223006|NCT05806021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223007|NCT05806021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256443|NCT01155206|Glucagon|glucagon|mesh-list
154223008|NCT05806021|Immunologic Factors|immunologic factors|mesh-ancestor
154223009|NCT05806021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223010|NCT05806021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223011|NCT05795062|Warfarin|warfarin|mesh-list
154223012|NCT05795062|Apixaban|apixaban|mesh-list
154223013|NCT05795062|Anticoagulants|anticoagulants|mesh-ancestor
154223014|NCT05795062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154223015|NCT05795062|Antithrombins|antithrombins|mesh-ancestor
154223016|NCT05795062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154223017|NCT05795062|Protease Inhibitors|protease inhibitors|mesh-ancestor
154223018|NCT05795062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223019|NCT05795062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223020|NCT05765487|Sildenafil Citrate|sildenafil citrate|mesh-list
154223021|NCT05765487|Vasodilator Agents|vasodilator agents|mesh-ancestor
154223022|NCT05765487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154223023|NCT05765487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154223024|NCT05765487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223025|NCT05765487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223026|NCT05765487|Urological Agents|urological agents|mesh-ancestor
154223027|NCT05762328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154223028|NCT05762328|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154223029|NCT05762328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223030|NCT05762328|Antitubercular Agents|antitubercular agents|mesh-ancestor
154223031|NCT05752526|Diclofenac|diclofenac|mesh-list
154223032|NCT05752526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154223033|NCT05752526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154223034|NCT05752526|Analgesics|analgesics|mesh-ancestor
154223035|NCT05752526|Sensory System Agents|sensory system agents|mesh-ancestor
154223036|NCT05752526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223037|NCT05752526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223038|NCT05752526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223039|NCT05752526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223040|NCT05752526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154223041|NCT05752526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223042|NCT05752526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223055|NCT05691829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223057|NCT05669001|Abatacept|abatacept|mesh-list
154223058|NCT05669001|Tacrolimus|tacrolimus|mesh-list
154223059|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154223060|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223061|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
154223062|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223063|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154223064|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223065|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223066|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154223067|NCT05669001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223068|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223069|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223070|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154223071|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154223072|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
154223073|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154223074|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223075|NCT05656534|Suvorexant|suvorexant|mesh-list
154223076|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154223077|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154223078|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154223079|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694633|NCT00229918|Hormones|hormones|mesh-ancestor
154223080|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154223081|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223082|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223083|NCT05650164|Avelumab|avelumab|mesh-list
154223084|NCT05650164|Axitinib|axitinib|mesh-list
154223085|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223086|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223087|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223088|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223089|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223090|NCT05642845|Atorvastatin|atorvastatin|mesh-list
154223091|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154223092|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154223093|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
154223094|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223095|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154223096|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154223097|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223098|NCT05608369|Vorinostat|vorinostat|mesh-list
154223099|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223100|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154223101|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223102|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223122|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223123|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223124|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
154223125|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154223126|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223127|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154223128|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
154223129|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154223130|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223131|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223132|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223134|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154223135|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154223136|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
154223137|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223138|NCT05411484|Doxycycline|doxycycline|mesh-list
154223139|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154223140|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223141|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
154223142|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154223143|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154223144|NCT05378113|Lidocaine|lidocaine|mesh-list
154223145|NCT05378113|Ondansetron|ondansetron|mesh-list
154223146|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
154223147|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
154223148|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154223149|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223150|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
154223151|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223152|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154223153|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154223154|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154223155|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154223156|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223157|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
154223184|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223186|NCT05277051|Dostarlimab|dostarlimab|mesh-list
154223187|NCT05277051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223188|NCT05188170|Niclosamide|niclosamide|mesh-list
154223189|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
154223190|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154223191|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
154223192|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154223193|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223194|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
154223195|NCT05178472|Immunomodulating Agents|immunomodulating agents|mesh-list
154223196|NCT05178472|Immunologic Factors|immunologic factors|mesh-ancestor
154223197|NCT05178472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223198|NCT05097326|Misoprostol|misoprostol|mesh-list
154223199|NCT05097326|Mifepristone|mifepristone|mesh-list
154223200|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154223201|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
154223202|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154223203|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223204|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154223205|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154223206|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
154223207|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154223208|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154223220|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154223221|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154223222|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
154223223|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
154223224|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223225|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223226|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154223227|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154223228|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154223229|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
154223230|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223231|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223232|NCT05069831|Abrocitinib|abrocitinib|mesh-list
154223233|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223234|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223235|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223236|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
154223237|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223238|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
154223239|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154223240|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154223241|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223242|NCT05061368|Urological Agents|urological agents|mesh-ancestor
154223243|NCT05050253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154223244|NCT05024552|Cytarabine|cytarabine|mesh-list
154223245|NCT05024552|Daunorubicin|daunorubicin|mesh-list
154223246|NCT05024552|Gilteritinib|gilteritinib|mesh-list
154223247|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154223248|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
154223249|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223250|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223251|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
154223252|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223253|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223254|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
154223255|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223256|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154223257|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154223258|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154223259|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223260|NCT05024552|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154223261|NCT05024552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223262|NCT04996160|Dexamethasone|dexamethasone|mesh-list
154223263|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
154223264|NCT04996160|Doxorubicin|doxorubicin|mesh-list
154223265|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154223266|NCT04996160|Bortezomib|bortezomib|mesh-list
154223267|NCT04996160|Palbociclib|palbociclib|mesh-list
154223268|NCT04996160|BB 1101|bb 1101|mesh-list
154223269|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223270|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
154223271|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
154223289|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
154223290|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
154223291|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154223292|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154223293|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223294|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223295|NCT04985929|Urological Agents|urological agents|mesh-ancestor
154223296|NCT04925960|Epalrestat|epalrestat|mesh-list
154223297|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223298|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223299|NCT04922723|Daratumumab|daratumumab|mesh-list
154223300|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223301|NCT04840199|Letermovir|letermovir|mesh-list
154223302|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154223303|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223304|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223305|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223306|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
154223307|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223308|NCT04829383|Bevacizumab|bevacizumab|mesh-list
154223309|NCT04829383|Atezolizumab|atezolizumab|mesh-list
154223310|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223311|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223312|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154223313|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154223314|NCT04829383|Growth Substances|growth substances|mesh-ancestor
153810934|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154223315|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223316|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
154223317|NCT04829383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154223318|NCT04829383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223319|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
154223320|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154223321|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
154223322|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154223323|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223324|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154223325|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154223326|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223339|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154223340|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
154223341|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223342|NCT04761627|Ustekinumab|ustekinumab|mesh-list
154223343|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
154223344|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
154223345|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223346|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223347|NCT04754321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154223348|NCT04754321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223349|NCT04739800|Paclitaxel|paclitaxel|mesh-list
154223350|NCT04739800|Doxorubicin|doxorubicin|mesh-list
154223351|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154223352|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154223353|NCT04739800|Durvalumab|durvalumab|mesh-list
154223354|NCT04739800|Topotecan|topotecan|mesh-list
154223355|NCT04739800|Olaparib|olaparib|mesh-list
154223356|NCT04739800|Cediranib|cediranib|mesh-list
154223357|NCT04739800|Maleic acid|maleic acid|mesh-list
154223358|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
154223359|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154223360|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
154223361|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154223362|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223363|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
154223364|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
154223365|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
154223366|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223367|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154223368|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154223369|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154223370|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223371|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223372|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
154223373|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223374|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154223375|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154223376|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223377|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
154223378|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
154223379|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154223380|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223381|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
154223382|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
154223383|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223384|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
154223385|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154223386|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
154223387|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223388|NCT04632069|Expectorants|expectorants|mesh-ancestor
154223389|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
154223403|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154223404|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223405|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
154223406|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
154223407|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
154223408|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223409|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154223410|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
154223411|NCT04601740|Semaglutide|semaglutide|mesh-list
154223413|NCT04601740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154223414|NCT04601740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223415|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
154223416|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223417|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223418|NCT04555837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154223419|NCT04555837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223420|NCT04493203|Nivolumab|nivolumab|mesh-list
154223421|NCT04493203|Axitinib|axitinib|mesh-list
154223422|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223423|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223424|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154223425|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223426|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223427|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223428|NCT04452344|Analgesics|analgesics|mesh-list
154223429|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223430|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
154223431|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223432|NCT04375631|Cytarabine|cytarabine|mesh-list
154223433|NCT04375631|Cyclosporine|cyclosporine|mesh-list
154223434|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
154223435|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
154223436|NCT04375631|Fludarabine|fludarabine|mesh-list
154223437|NCT04375631|Fludarabine phosphate|fludarabine phosphate|mesh-list
154223438|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
154223439|NCT04375631|Idarubicin|idarubicin|mesh-list
154223440|NCT04375631|Cladribine|cladribine|mesh-list
154223441|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154223442|NCT04375631|Cyclosporins|cyclosporins|mesh-list
154223443|NCT04375631|Lenograstim|lenograstim|mesh-list
154223444|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223445|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
154223446|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223447|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223448|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154223449|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
154223450|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223451|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223452|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154223453|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154223454|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
154223455|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
154223467|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
154223468|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223469|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154223470|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154223471|NCT04340193|Nivolumab|nivolumab|mesh-list
154223472|NCT04340193|Ipilimumab|ipilimumab|mesh-list
154223473|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223474|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223475|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154223476|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223477|NCT04324463|Aspirin|aspirin|mesh-list
154223478|NCT04324463|Interferons|interferons|mesh-list
154223479|NCT04324463|Interferon-beta|interferon-beta|mesh-list
154223480|NCT04324463|Colchicine|colchicine|mesh-list
154223481|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
154223482|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223483|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
154223484|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223485|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154223486|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154223487|NCT04324463|Analgesics|analgesics|mesh-ancestor
154223488|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
154223489|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223490|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223491|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223492|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223493|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154223494|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154223495|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223496|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154223497|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154223498|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223499|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
154223500|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154223501|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
154223502|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154223503|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
154223504|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
154223505|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
154223506|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
154223507|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
154223508|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
154223509|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
154223510|NCT04291079|Antibodies|antibodies|mesh-list
154223511|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
154223512|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223513|NCT04168710|Bupivacaine|bupivacaine|mesh-list
154223514|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
154223515|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
154223516|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154223517|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223518|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
154223519|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223520|NCT04149210|Fluorometholone|fluorometholone|mesh-list
154223521|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
154223531|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
154223532|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
154223533|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154223534|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223535|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
154223536|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223537|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154223538|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154223539|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223540|NCT04002297|Rituximab|rituximab|mesh-list
154223541|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154223542|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
153970463|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
154223543|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223544|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223545|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
154223546|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223547|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223548|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154223549|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
154223550|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223551|NCT04002297|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154223552|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223553|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223554|NCT03967054|Ivermectin|ivermectin|mesh-list
154223555|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154223556|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223557|NCT03962894|Prednisolone|prednisolone|mesh-list
154223558|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223559|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
154223560|NCT03962894|Hormones|hormones|mesh-ancestor
154223561|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223562|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223563|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154223564|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223565|NCT03962855|Ifetroban|ifetroban|mesh-list
154223566|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154223567|NCT03943173|Olaparib|olaparib|mesh-list
154223568|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154223569|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223570|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223571|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223572|NCT03933904|Sirolimus|sirolimus|mesh-list
154223573|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154223574|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223575|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154223576|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223577|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
154223578|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223579|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
154223580|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223581|NCT03932864|Plerixafor|plerixafor|mesh-list
154223582|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154223583|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154223584|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
154223585|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223586|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154223587|NCT03809078|Bombesin|bombesin|mesh-list
154223602|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154223603|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
154223604|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154223606|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223607|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223608|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154223609|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
154223610|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
154223611|NCT03679312|Protective Agents|protective agents|mesh-ancestor
154223612|NCT03501979|Capecitabine|capecitabine|mesh-list
154223613|NCT03501979|Trastuzumab|trastuzumab|mesh-list
154223614|NCT03501979|Tucatinib|tucatinib|mesh-list
154223615|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154223616|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
154223617|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223618|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223619|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223620|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223621|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223622|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
154223623|NCT03456843|Docetaxel|docetaxel|mesh-list
154223624|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
154223625|NCT03456843|Hormones|hormones|mesh-list
154223626|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154223628|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
154223629|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223630|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
154223631|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
154223632|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
154223633|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223634|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154223635|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223636|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
154223637|NCT03456843|Protective Agents|protective agents|mesh-ancestor
154223638|NCT03456843|Vitamins|vitamins|mesh-ancestor
154223639|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
154223640|NCT03456843|Estrogens|estrogens|mesh-ancestor
154223641|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154223642|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
154223643|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
154223644|NCT03395184|PF-06700841|pf-06700841|mesh-list
154223645|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223646|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223647|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223680|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223681|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223682|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154223683|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154223684|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154223685|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154223686|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154223718|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154223719|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
154223720|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
154223721|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
154223722|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223723|NCT02593526|Bumetanide|bumetanide|mesh-list
154223724|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
154223725|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154223726|NCT02593526|Diuretics|diuretics|mesh-ancestor
154223727|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
154223728|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223729|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154223730|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154223731|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223741|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223742|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223743|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154223744|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154223745|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
154223746|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
154223747|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154223748|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154223749|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154223750|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223751|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223753|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154223754|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154223755|NCT02470299|Analgesics|analgesics|mesh-ancestor
154223756|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
154223757|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154223758|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223759|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223760|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223761|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154223762|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223763|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223764|NCT02179086|Temozolomide|temozolomide|mesh-list
154223765|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154223766|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
154223767|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223768|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223769|NCT01996865|Rituximab|rituximab|mesh-list
154223770|NCT01996865|Lenalidomide|lenalidomide|mesh-list
154223771|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153970685|NCT00715429|Vitamin D|vitamin d|mesh-list
154223772|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223773|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
154223774|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223775|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223776|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154223777|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154223778|NCT01996865|Growth Substances|growth substances|mesh-ancestor
153695287|NCT00064181|Vitamins|vitamins|mesh-ancestor
154223779|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
154223780|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
154223781|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154223782|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223783|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223784|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154223785|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154223786|NCT01774487|Protective Agents|protective agents|mesh-ancestor
154223787|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223788|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
154223789|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154223790|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
154223791|NCT01763645|Paclitaxel|paclitaxel|mesh-list
154223792|NCT01763645|Bevacizumab|bevacizumab|mesh-list
154223793|NCT01763645|Carboplatin|carboplatin|mesh-list
154223794|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154223795|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223796|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
154223814|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
154223815|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223816|NCT00237263|Entacapone|entacapone|mesh-list
154223817|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154223818|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154223819|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154223820|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223821|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223822|NCT01023425|Donepezil|donepezil|mesh-list
154223823|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154223824|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223825|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223826|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
154223827|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223828|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223829|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
154223830|NCT00285584|Bupropion|bupropion|mesh-list
154223831|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154223832|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
154223833|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154223834|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154223835|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154223836|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154223837|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223838|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
154223839|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223840|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223841|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154223842|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154223843|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223844|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154223845|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223846|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223847|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223848|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154223849|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
154223864|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154223865|NCT03955354|Apatinib|apatinib|mesh-list
154223866|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223867|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223868|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223869|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223870|NCT01095484|Rotigotine|rotigotine|mesh-list
154223871|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
154223872|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
154223873|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154223874|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223875|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223876|NCT01063478|Everolimus|everolimus|mesh-list
154223877|NCT01063478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154223878|NCT01063478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223879|NCT01063478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223880|NCT01063478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223881|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223882|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
154223883|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223884|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223885|NCT01327144|Acyclovir|acyclovir|mesh-list
154223886|NCT01327144|Famciclovir|famciclovir|mesh-list
154223887|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
154223888|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223889|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154223890|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223891|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223892|NCT01323101|Doxycycline|doxycycline|mesh-list
154223893|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154223894|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223895|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
154223896|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154223897|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154223898|NCT00310856|Vaccines|vaccines|mesh-list
154223899|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
154223900|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223901|NCT03670355|Tenofovir|tenofovir|mesh-list
154223902|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
154223903|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223904|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154223905|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154223906|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223907|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153970835|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154223919|NCT00283712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154223920|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
154223921|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154223922|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223923|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154223924|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
154223925|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154223926|NCT00449033|Gemcitabine|gemcitabine|mesh-list
154223928|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223929|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154223930|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
154223931|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223932|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223933|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223935|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223936|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154223937|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154223938|NCT01024205|Growth Substances|growth substances|mesh-ancestor
154223939|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223940|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
154223941|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154223942|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154223943|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223944|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
154223945|NCT00448019|Bevacizumab|bevacizumab|mesh-list
154223946|NCT00448019|Rituximab|rituximab|mesh-list
154223947|NCT00448019|Fludarabine|fludarabine|mesh-list
154223948|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
154223949|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154223950|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
154223951|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154223952|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154223953|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154223954|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
154223955|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223956|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154223957|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154223958|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154223959|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154223960|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154223961|NCT00448019|Growth Substances|growth substances|mesh-ancestor
154223962|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
154223963|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154223964|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
154223965|NCT00457691|Leucovorin|leucovorin|mesh-list
154223966|NCT00457691|Fluorouracil|fluorouracil|mesh-list
154223967|NCT00457691|Irinotecan|irinotecan|mesh-list
154223968|NCT00457691|Sunitinib|sunitinib|mesh-list
154223969|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
154223970|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
154223971|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154223972|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154224000|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
154224001|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154224002|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224003|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224005|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154224006|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224007|NCT00446849|Analgesics|analgesics|mesh-ancestor
154224008|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
154224009|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224010|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224011|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224012|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224013|NCT01565837|Ipilimumab|ipilimumab|mesh-list
154224014|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224015|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224016|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154224017|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224018|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
154224019|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154224033|NCT00456521|Naltrexone|naltrexone|mesh-list
154224034|NCT00456521|Bupropion|bupropion|mesh-list
154224035|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154224036|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154224037|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224038|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
154224039|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224040|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154224041|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
154224042|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154224043|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154224044|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154224045|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154224046|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224047|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
154224048|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224049|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154224050|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154224051|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224052|NCT00456365|Pravastatin|pravastatin|mesh-list
154224053|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154224054|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154224055|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
154224056|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224057|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154224058|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154224059|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224060|NCT03843047|Nicotine|nicotine|mesh-list
154224061|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154224062|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
154224063|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224064|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224065|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154224066|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154224067|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
154224068|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224069|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224070|NCT00455741|Estradiol|estradiol|mesh-list
154224071|NCT00455741|Progesterone|progesterone|mesh-list
154224072|NCT00455741|Estrogens|estrogens|mesh-ancestor
154224073|NCT00455741|Hormones|hormones|mesh-ancestor
154224074|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224075|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224076|NCT00455741|Progestins|progestins|mesh-ancestor
154224077|NCT00445679|Paroxetine|paroxetine|mesh-list
154224078|NCT00445679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153646967|NCT00118300|Capecitabine|capecitabine|mesh-list
154224106|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224107|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
154224108|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224109|NCT00235716|Protective Agents|protective agents|mesh-ancestor
154224110|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154224111|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154224112|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
154224113|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224114|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154224115|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154224116|NCT00274742|Blinatumomab|blinatumomab|mesh-list
154224117|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154224118|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224119|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
154224120|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224121|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
154224122|NCT03970044|Exenatide|exenatide|mesh-list
154224123|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154224124|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224125|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154224137|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224138|NCT00454805|Fulvestrant|fulvestrant|mesh-list
154224139|NCT00454805|Cediranib|cediranib|mesh-list
154224140|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154224141|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224142|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153971073|NCT02604784|Cisplatin|cisplatin|mesh-list
154224143|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154224144|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
154224145|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224146|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224147|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224148|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224149|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224150|NCT00283244|Gemcitabine|gemcitabine|mesh-list
154224151|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154224152|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154224153|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
154224155|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224156|NCT00283244|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154224157|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224158|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224159|NCT00282464|Ziprasidone|ziprasidone|mesh-list
154224160|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154224161|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
154224162|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224163|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224164|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224165|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154224166|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154224167|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224168|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154224169|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154224170|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
154224171|NCT03841331|Serlopitant|serlopitant|mesh-list
154224172|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154224173|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224174|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224175|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224176|NCT00262080|Ecallantide|ecallantide|mesh-list
154224177|NCT00262080|Analgesics|analgesics|mesh-ancestor
154224178|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
154224179|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224180|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224181|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154224182|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224183|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224184|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224185|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
154224209|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
154224210|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224211|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
154224212|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224213|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154224214|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153971157|NCT05175235|Nivolumab|nivolumab|mesh-list
154224215|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154224216|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154224218|NCT00281840|Docetaxel|docetaxel|mesh-list
154224219|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224220|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224221|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154224222|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154224223|NCT00281840|Growth Substances|growth substances|mesh-ancestor
154224224|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224225|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
154224226|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
154224227|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
154224228|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
154224229|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224230|NCT00272792|Verapamil|verapamil|mesh-list
154224231|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154224232|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154224233|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154224234|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224235|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154224236|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224249|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154224250|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224251|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154224252|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
154224253|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224254|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224255|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
154224256|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224257|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154224258|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154224260|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224261|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154224262|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154224263|NCT00048568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224264|NCT00262002|Vaccines|vaccines|mesh-list
154224265|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
154224266|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224267|NCT01584076|Donepezil|donepezil|mesh-list
154224268|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154224269|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224270|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224271|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
154224272|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224273|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224274|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
154224275|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
154224276|NCT03954964|Narcotics|narcotics|mesh-ancestor
154224277|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224278|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224279|NCT03954964|Analgesics|analgesics|mesh-ancestor
154224280|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
154224281|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224282|NCT00281528|Paclitaxel|paclitaxel|mesh-list
154224283|NCT00281528|Bevacizumab|bevacizumab|mesh-list
154224284|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154224285|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154224286|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224287|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
154224288|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
154224289|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
154224290|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224291|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224292|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154224293|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154224294|NCT00281528|Growth Substances|growth substances|mesh-ancestor
154224295|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224296|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
154224297|NCT01095640|Adapalene|adapalene|mesh-list
154224298|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154224299|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224314|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154224315|NCT03975374|Dexamethasone|dexamethasone|mesh-list
154224316|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154224317|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224318|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
154224319|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
154224320|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224321|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224322|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154224323|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
154224324|NCT03975374|Hormones|hormones|mesh-ancestor
154224325|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224326|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154224327|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224328|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154224329|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224330|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154224331|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
154224332|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224333|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224334|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154224335|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
154224336|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
154224337|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224338|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
154224339|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224340|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154224341|NCT03741686|Cathartics|cathartics|mesh-ancestor
154224342|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154224343|NCT00279812|Selenium|selenium|mesh-list
154224344|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
154224345|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224346|NCT00279812|Protective Agents|protective agents|mesh-ancestor
154224347|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224348|NCT00279812|Trace Elements|trace elements|mesh-ancestor
154224349|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
154224351|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224352|NCT01070732|Analgesics|analgesics|mesh-ancestor
154224353|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
154224354|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224355|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224356|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
154224357|NCT00207714|Infliximab|infliximab|mesh-list
154224358|NCT00207714|Golimumab|golimumab|mesh-list
154224359|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154224360|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224361|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
154224368|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154224369|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
154224370|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154224371|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224372|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
154224373|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154224374|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224375|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224376|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154224377|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154224378|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154224379|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154224380|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154224381|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154224382|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
154224383|NCT00059332|Analgesics|analgesics|mesh-ancestor
154224384|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
154224385|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224386|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224387|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
154224388|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224389|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154224390|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
154224391|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154224392|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154224393|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224394|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154224395|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
154224396|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154224397|NCT00233454|Midostaurin|midostaurin|mesh-list
154224398|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224399|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224400|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224401|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224402|NCT00047320|Carboplatin|carboplatin|mesh-list
154224403|NCT00047320|Etoposide|etoposide|mesh-list
154224404|NCT00047320|Ifosfamide|ifosfamide|mesh-list
154224405|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
154224406|NCT00047320|Thiotepa|thiotepa|mesh-list
154224407|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224408|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154224409|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154224410|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154224411|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224412|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224413|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154224414|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
154224415|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154224416|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154224417|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
154224418|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224419|NCT00233064|Palivizumab|palivizumab|mesh-list
154224420|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
154224421|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224422|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
154224423|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154224424|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154224425|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224426|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224428|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027385|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224437|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224439|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154224440|NCT00278954|Antibodies|antibodies|mesh-list
154224441|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
154224442|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154224443|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
154224444|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224445|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
154224446|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154224447|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154224448|NCT00278564|Prednisolone|prednisolone|mesh-list
154224449|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
154224450|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
154224451|NCT00278564|Rituximab|rituximab|mesh-list
154224452|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154224453|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
154224454|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154224455|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
154224456|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224457|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224458|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154224459|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
154224460|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224461|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224462|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154224463|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224464|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
154224465|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
154224466|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224467|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154224468|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
154224469|NCT00278564|Hormones|hormones|mesh-ancestor
154224470|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224471|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154224472|NCT00278564|Protective Agents|protective agents|mesh-ancestor
154224473|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154224474|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224475|NCT01071564|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
154224476|NCT01071564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
154224477|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224478|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224479|NCT00268346|Gefitinib|gefitinib|mesh-list
154224480|NCT00268346|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154224481|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224482|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224483|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224484|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224485|NCT00250718|Levofloxacin|levofloxacin|mesh-list
154224486|NCT00250718|Ofloxacin|ofloxacin|mesh-list
154224487|NCT00250718|Dexamethasone|dexamethasone|mesh-list
154224488|NCT00250718|Rituximab|rituximab|mesh-list
154224489|NCT00250718|Etoposide|etoposide|mesh-list
154224490|NCT00250718|Vincristine|vincristine|mesh-list
154224491|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224492|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
154224493|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
154224494|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224505|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154224506|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154224507|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154224508|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157355|NCT05867121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154224509|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224510|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
154224511|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
154224512|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
154224513|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154224514|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224515|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154224516|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154224517|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154224519|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224520|NCT00276458|Atorvastatin|atorvastatin|mesh-list
154224521|NCT00276458|Ezetimibe|ezetimibe|mesh-list
154224522|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154224523|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154224524|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
154224525|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224526|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154224527|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154224528|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224529|NCT00276380|Aspirin|aspirin|mesh-list
154224530|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154224531|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224532|NCT00276380|Analgesics|analgesics|mesh-ancestor
154224533|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
154224534|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224535|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224536|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224537|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224538|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154224539|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154224540|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224541|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154224542|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154224543|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224544|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
154224545|NCT02531984|Azithromycin|azithromycin|mesh-list
154224546|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154224547|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695523|NCT00234910|Tenofovir|tenofovir|mesh-list
154224548|NCT00267956|Ustekinumab|ustekinumab|mesh-list
154224549|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
154224550|NCT00267488|Topotecan|topotecan|mesh-list
154224551|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154224552|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154224553|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224554|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224555|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224556|NCT01073696|Granisetron|granisetron|mesh-list
154224557|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
154224570|NCT01093768|Vasopressins|vasopressins|mesh-list
154224571|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
154224572|NCT01093768|Oxytocin|oxytocin|mesh-list
154224573|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
154224574|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154224575|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224576|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
154224577|NCT01093768|Coagulants|coagulants|mesh-ancestor
154224578|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154224579|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154224580|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
154224581|NCT00044512|Sorafenib|sorafenib|mesh-list
154224582|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153971508|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154224583|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224584|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224585|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224586|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
154224587|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
154224588|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
154224589|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224590|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224591|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
154224592|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224593|NCT01096420|Topiramate|topiramate|mesh-list
154224594|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
154224595|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154224596|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224597|NCT06186154|Leucovorin|leucovorin|mesh-list
154224598|NCT06186154|Folic Acid|folic acid|mesh-list
154224599|NCT06186154|Vitamin B 12|vitamin b 12|mesh-list
154224600|NCT06186154|Hydroxocobalamin|hydroxocobalamin|mesh-list
154224601|NCT06186154|Levoleucovorin|levoleucovorin|mesh-list
154224602|NCT06186154|Antidotes|antidotes|mesh-ancestor
154224603|NCT06186154|Protective Agents|protective agents|mesh-ancestor
154224606|NCT06186154|Vitamins|vitamins|mesh-ancestor
154224607|NCT06186154|Micronutrients|micronutrients|mesh-ancestor
154224608|NCT06186154|Hematinics|hematinics|mesh-ancestor
154224609|NCT06185621|Aspirin|aspirin|mesh-list
154224610|NCT06185621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154224611|NCT06185621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224612|NCT06185621|Analgesics|analgesics|mesh-ancestor
154224613|NCT06185621|Sensory System Agents|sensory system agents|mesh-ancestor
154224614|NCT06185621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224615|NCT06185621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224616|NCT06185621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154224617|NCT06185621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154224618|NCT06185621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154224619|NCT06185621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154224620|NCT06185621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647519|NCT00129142|Toremifene|toremifene|mesh-list
154224642|NCT06185400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224643|NCT06185361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154224645|NCT06185361|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154224646|NCT06185361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154224647|NCT06185361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154224648|NCT06185361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224649|NCT06185361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224650|NCT06185361|Serotonin Agents|serotonin agents|mesh-ancestor
154224651|NCT06185361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224652|NCT06185361|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154224653|NCT06185361|Antidepressive Agents|antidepressive agents|mesh-ancestor
154224654|NCT06185361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154224655|NCT06185361|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154224656|NCT06185361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153971582|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154224657|NCT06185361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224658|NCT06185361|Hemostatics|hemostatics|mesh-ancestor
154224659|NCT06185361|Coagulants|coagulants|mesh-ancestor
154224660|NCT06185361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154224661|NCT06185361|Natriuretic Agents|natriuretic agents|mesh-ancestor
154224663|NCT06185127|Fentanyl|fentanyl|mesh-list
154224664|NCT06185127|Dexmedetomidine|dexmedetomidine|mesh-list
154224665|NCT06185127|Ketamine|ketamine|mesh-list
154224666|NCT06185127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154224667|NCT06185127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224668|NCT06185127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224669|NCT06185127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224670|NCT06185127|Analgesics|analgesics|mesh-ancestor
154224671|NCT06185127|Sensory System Agents|sensory system agents|mesh-ancestor
154224672|NCT06185127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224673|NCT06185127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154224690|NCT06185127|GABA Agents|gaba agents|mesh-ancestor
154224691|NCT06185127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154224692|NCT06185127|Narcotics|narcotics|mesh-ancestor
154224693|NCT06184958|Lidocaine|lidocaine|mesh-list
154224694|NCT06184958|Ketamine|ketamine|mesh-list
154224695|NCT06184958|Anesthetics, Local|anesthetics, local|mesh-ancestor
154224696|NCT06184958|Anesthetics|anesthetics|mesh-ancestor
154224697|NCT06184958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224698|NCT06184958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224699|NCT06184958|Sensory System Agents|sensory system agents|mesh-ancestor
154224700|NCT06184958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224701|NCT06184958|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154224702|NCT06184958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154224703|NCT06184958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154224704|NCT06184958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154224705|NCT06184958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224706|NCT06184958|Analgesics|analgesics|mesh-ancestor
154224707|NCT06184958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154224708|NCT06184958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154224709|NCT06184958|Anesthetics, General|anesthetics, general|mesh-ancestor
154224710|NCT06184958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154224711|NCT06184958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154224712|NCT06184958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224713|NCT06181838|Tretinoin|tretinoin|mesh-list
154224714|NCT06181838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224715|NCT06181838|Keratolytic Agents|keratolytic agents|mesh-ancestor
154224716|NCT06181838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154224717|NCT06180889|Enoxaparin|enoxaparin|mesh-list
154224718|NCT06180889|Anticoagulants|anticoagulants|mesh-ancestor
154224719|NCT06180889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154224720|NCT06180889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154224721|NCT06180889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224722|NCT06165991|Bupivacaine|bupivacaine|mesh-list
154224723|NCT06165991|Anesthetics, Local|anesthetics, local|mesh-ancestor
154224724|NCT06165991|Anesthetics|anesthetics|mesh-ancestor
154224725|NCT06165991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224726|NCT06165991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224727|NCT06165991|Sensory System Agents|sensory system agents|mesh-ancestor
154224728|NCT06165991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224729|NCT06162819|Flunarizine|flunarizine|mesh-list
154224730|NCT06162819|Amitriptyline|amitriptyline|mesh-list
154224731|NCT06162819|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154224732|NCT06162819|Antidepressive Agents|antidepressive agents|mesh-ancestor
154224783|NCT06074471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224784|NCT06074471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224786|NCT06074471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224787|NCT06030804|Dexmedetomidine|dexmedetomidine|mesh-list
154224788|NCT06030804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154224789|NCT06030804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224790|NCT06030804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647687|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
154224804|NCT06005818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154224805|NCT06005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224807|NCT05996627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224808|NCT05996627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224809|NCT05996627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224810|NCT05972473|Aflibercept|aflibercept|mesh-list
153971726|NCT02587741|Gliclazide|gliclazide|mesh-list
154224811|NCT05972473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154224812|NCT05972473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154224813|NCT05972473|Growth Substances|growth substances|mesh-ancestor
154224814|NCT05972473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224815|NCT05972473|Growth Inhibitors|growth inhibitors|mesh-ancestor
154224816|NCT05972473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224817|NCT05971251|Acalabrutinib|acalabrutinib|mesh-list
154224818|NCT05971251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
154224819|NCT05971251|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154224820|NCT05971251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224821|NCT05971251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224822|NCT05971251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224823|NCT05971251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224824|NCT05971251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224825|NCT05759754|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154224826|NCT05759754|Protease Inhibitors|protease inhibitors|mesh-ancestor
154224827|NCT05759754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224828|NCT05759754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224829|NCT05743270|Paclitaxel|paclitaxel|mesh-list
154224830|NCT05743270|Carboplatin|carboplatin|mesh-list
154224831|NCT05743270|Nivolumab|nivolumab|mesh-list
154224832|NCT05743270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154224833|NCT05743270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224834|NCT05743270|Tubulin Modulators|tubulin modulators|mesh-ancestor
154224835|NCT05743270|Antimitotic Agents|antimitotic agents|mesh-ancestor
154224836|NCT05743270|Mitosis Modulators|mitosis modulators|mesh-ancestor
154224837|NCT05743270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224838|NCT05743270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224839|NCT05743270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154224840|NCT05611879|Paclitaxel|paclitaxel|mesh-list
154224841|NCT05611879|Carboplatin|carboplatin|mesh-list
154224842|NCT05611879|Pemetrexed|pemetrexed|mesh-list
154224843|NCT05611879|Tislelizumab|tislelizumab|mesh-list
154224844|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154224845|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224846|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
154224847|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
154224848|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
153539946|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224861|NCT05571670|Sirolimus|sirolimus|mesh-list
154224862|NCT05571670|MTOR Inhibitors|mtor inhibitors|mesh-list
154256445|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154256446|NCT01155206|Hormones|hormones|mesh-ancestor
154224863|NCT05571670|Temsirolimus|temsirolimus|mesh-list
154224864|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224865|NCT05571670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224866|NCT05571670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224867|NCT05571670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224868|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154224869|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
154224870|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224871|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154224872|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224873|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154224874|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
154224875|NCT05517330|Tislelizumab|tislelizumab|mesh-list
154224876|NCT05517330|Afatinib|afatinib|mesh-list
154224877|NCT05517330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224878|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224879|NCT05517330|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154224880|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224881|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224882|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224883|NCT05516589|Paclitaxel|paclitaxel|mesh-list
154224884|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154224885|NCT05516589|Tislelizumab|tislelizumab|mesh-list
154224886|NCT05516589|Afatinib|afatinib|mesh-list
154224887|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154224888|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224889|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
154224890|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
154224891|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
154224892|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224893|NCT05516589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224894|NCT05516589|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154224895|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154224896|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154224897|NCT05492591|Valacyclovir|valacyclovir|mesh-list
154224898|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
153695812|NCT00097968|Everolimus|everolimus|mesh-list
154224899|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224900|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
154224901|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154224902|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224903|NCT05446129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154224904|NCT05446129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224905|NCT05381363|Interferons|interferons|mesh-list
154224906|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224907|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
154224908|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154224909|NCT05365178|Fulvestrant|fulvestrant|mesh-list
153647788|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154224918|NCT05351801|Nabiximols|nabiximols|mesh-list
154224919|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
154224920|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224921|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154224922|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154224923|NCT05351801|Analgesics|analgesics|mesh-ancestor
154224924|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
154224925|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224926|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154224927|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154224928|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224929|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224930|NCT05351801|Hormones|hormones|mesh-ancestor
154224931|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154224932|NCT05294640|Lidocaine|lidocaine|mesh-list
154224933|NCT05294640|Epinephrine|epinephrine|mesh-list
154224934|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
154224935|NCT05294640|Anesthetics|anesthetics|mesh-list
154224936|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154224937|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224938|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
154224939|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154224940|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154224941|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154224942|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154224943|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154224944|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224945|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154224946|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154224947|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
154224948|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154224949|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154224950|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154224951|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
154224952|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154224953|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
154224954|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
154224955|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
154224956|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154224957|NCT05158777|Vaccines|vaccines|mesh-list
154224958|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
154224959|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224961|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154224962|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154224963|NCT05062889|Leucovorin|leucovorin|mesh-list
154224964|NCT05062889|Trifluridine|trifluridine|mesh-list
154224965|NCT05062889|Capecitabine|capecitabine|mesh-list
154224966|NCT05062889|Fluorouracil|fluorouracil|mesh-list
154224967|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
154224968|NCT05062889|Trastuzumab|trastuzumab|mesh-list
154224969|NCT05062889|Irinotecan|irinotecan|mesh-list
154224970|NCT05062889|Tucatinib|tucatinib|mesh-list
154224971|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
154224972|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154224973|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
154224974|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154224975|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154224976|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647854|NCT00009828|Vitamins|vitamins|mesh-ancestor
154138181|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154138182|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154138183|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138185|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
154138212|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138213|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154138215|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
154138216|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138217|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
154138218|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138219|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138220|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154138221|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
154138222|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138223|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138224|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154138225|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154138226|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154138227|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
154138228|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138229|NCT01005927|Calcium|calcium|mesh-list
154138230|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154138231|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138232|NCT03742713|Docetaxel|docetaxel|mesh-list
154138233|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138234|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138235|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138236|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138260|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
154138262|NCT00615056|Axitinib|axitinib|mesh-list
154138263|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
154138264|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138265|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138266|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154138267|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154138268|NCT00615056|Growth Substances|growth substances|mesh-ancestor
154138269|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138270|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
153518642|NCT01446497|Timolol|timolol|mesh-list
154256447|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441567|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
154138271|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
154138272|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138273|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138274|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138275|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
154138276|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154138277|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154138278|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138279|NCT00615056|Antidotes|antidotes|mesh-ancestor
154138280|NCT00615056|Protective Agents|protective agents|mesh-ancestor
154138281|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
154138282|NCT00615056|Vitamins|vitamins|mesh-ancestor
154138283|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
154138284|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154138285|NCT01006551|Ziprasidone|ziprasidone|mesh-list
154138286|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154138287|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
154138288|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138289|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138290|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138304|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154138305|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138306|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138307|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138308|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154138309|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154138310|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154138311|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154138313|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154138314|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
154138315|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
154138316|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138317|NCT05732493|Capecitabine|capecitabine|mesh-list
154138318|NCT05732493|Oxaliplatin|oxaliplatin|mesh-list
154138319|NCT05732493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138320|NCT05732493|Antimetabolites|antimetabolites|mesh-ancestor
154138321|NCT05732493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138322|NCT05732493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138323|NCT00868634|Bevacizumab|bevacizumab|mesh-list
154138324|NCT00868634|Capecitabine|capecitabine|mesh-list
154138325|NCT00868634|Vinorelbine|vinorelbine|mesh-list
154138326|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138327|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138328|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154138329|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154138330|NCT00868634|Growth Substances|growth substances|mesh-ancestor
154138331|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138332|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
154138333|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138334|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
154138335|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138336|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138337|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138338|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138339|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138340|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
154138341|NCT05232357|Methylene Blue|methylene blue|mesh-list
154138342|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138343|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138344|NCT05232357|Antidotes|antidotes|mesh-ancestor
154138345|NCT05232357|Protective Agents|protective agents|mesh-ancestor
154138346|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138347|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
154138348|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
154138349|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154138350|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138351|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
154138352|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
154138353|NCT00879476|Ramipril|ramipril|mesh-list
154138385|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
154138386|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138387|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138388|NCT00614822|Bevacizumab|bevacizumab|mesh-list
154138389|NCT00614822|Carboplatin|carboplatin|mesh-list
153695867|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
154138390|NCT00614822|Pemetrexed|pemetrexed|mesh-list
154138391|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138392|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138393|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154138394|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154138395|NCT00614822|Growth Substances|growth substances|mesh-ancestor
154138396|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138397|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
154138407|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
154138408|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154138409|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154138410|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138411|NCT03582917|Vitamins|vitamins|mesh-ancestor
154138412|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
154138413|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
154138414|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138415|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138416|NCT05226728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154138417|NCT05226728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138418|NCT00869180|Diclofenac|diclofenac|mesh-list
154138419|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154138420|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154138421|NCT00869180|Analgesics|analgesics|mesh-ancestor
154138422|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
154138423|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138424|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138425|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154138426|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138427|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154138428|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138429|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138431|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138432|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154138433|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154138434|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138435|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138436|NCT00874406|Leucovorin|leucovorin|mesh-list
154138437|NCT00874406|Fluorouracil|fluorouracil|mesh-list
154138438|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
154138439|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
154138440|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138441|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154138442|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138443|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138444|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
154138445|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138446|NCT00874406|Antidotes|antidotes|mesh-ancestor
154138447|NCT00874406|Protective Agents|protective agents|mesh-ancestor
154138448|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
154138449|NCT00874406|Vitamins|vitamins|mesh-ancestor
154138450|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
154138451|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
154138453|NCT00880178|Niacinamide|niacinamide|mesh-list
154138454|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
154138455|NCT00880178|Simvastatin|simvastatin|mesh-list
154157356|NCT05858671|Fenugreek seed meal|fenugreek seed meal|mesh-list
154138456|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154138457|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154138458|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
154138459|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138460|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154138461|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154138462|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648215|NCT00020917|Antidotes|antidotes|mesh-ancestor
154138487|NCT00143455|Etoposide|etoposide|mesh-list
154138488|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138489|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154138490|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154138491|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138492|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138493|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138494|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154138495|NCT01006863|Phenylephrine|phenylephrine|mesh-list
154138496|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
154138497|NCT01006863|Ephedrine|ephedrine|mesh-list
154138498|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154138499|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
154138501|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138502|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138503|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
154138504|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154138505|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
154138506|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
154138507|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154138508|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154138509|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154138510|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
154138511|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138512|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138513|NCT01006863|Protective Agents|protective agents|mesh-ancestor
154138514|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154138515|NCT03529955|Apremilast|apremilast|mesh-list
154138516|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154138517|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154138541|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154138542|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154138543|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154138544|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138545|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138546|NCT03508739|Valsartan|valsartan|mesh-list
154138547|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154138549|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154138550|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154138551|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138552|NCT00205699|Olanzapine|olanzapine|mesh-list
154138553|NCT00205699|Risperidone|risperidone|mesh-list
154138554|NCT00205699|Aripiprazole|aripiprazole|mesh-list
154138555|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154138556|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
154138557|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138558|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138559|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138560|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154138561|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154138562|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154138563|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154138564|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154138565|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
154138566|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
154138567|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
154138600|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
154138601|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154138602|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
154138632|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
154138633|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138635|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
154138636|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154138637|NCT03443765|Antibodies|antibodies|mesh-list
154138638|NCT03443765|Vitamins|vitamins|mesh-ancestor
154138639|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
154138640|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138641|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154138642|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
154138643|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
154138644|NCT03441893|Mesalamine|mesalamine|mesh-list
154138645|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154138646|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154138648|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
154138649|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648420|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
154138676|NCT00617084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154138677|NCT00617084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154138678|NCT00617084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138679|NCT00617084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138680|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138681|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
154138682|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138683|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138684|NCT02758847|Paclitaxel|paclitaxel|mesh-list
154138685|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154138686|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138687|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138688|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138689|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138690|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138691|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138692|NCT01016860|Irinotecan|irinotecan|mesh-list
154138693|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154138694|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154138695|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138719|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138720|NCT00880412|Etazolate|etazolate|mesh-list
154138721|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154138722|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138723|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138724|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154138725|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154138726|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154138727|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138728|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154138729|NCT01020136|Axitinib|axitinib|mesh-list
154138730|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138731|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154138732|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138733|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138734|NCT03412643|Paclitaxel|paclitaxel|mesh-list
154138735|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
154138736|NCT03412643|Doxorubicin|doxorubicin|mesh-list
154138737|NCT03412643|Trastuzumab|trastuzumab|mesh-list
154138738|NCT03412643|Pertuzumab|pertuzumab|mesh-list
154138739|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138740|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138741|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138742|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138743|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138744|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138745|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138746|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
154138747|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138762|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154138763|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138764|NCT01020214|Diuretics|diuretics|mesh-ancestor
154138765|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
154138766|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138767|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154138768|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154138769|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138770|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154138771|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154138773|NCT03970824|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154138774|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154138775|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154138776|NCT00933894|Escitalopram|escitalopram|mesh-list
154138777|NCT00933894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154138778|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154138779|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154138780|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138781|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138782|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
154138783|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138784|NCT00564486|Acetaminophen|acetaminophen|mesh-list
154138785|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154138786|NCT00564486|Analgesics|analgesics|mesh-ancestor
154138787|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
154138788|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138789|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138790|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
154138791|NCT00481078|Paclitaxel|paclitaxel|mesh-list
154138792|NCT00481078|Carboplatin|carboplatin|mesh-list
154138793|NCT00481078|Vorinostat|vorinostat|mesh-list
154138794|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154138795|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138797|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138798|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138799|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138800|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154138801|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138802|NCT00480532|Doxycycline|doxycycline|mesh-list
154138803|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
154138804|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154138805|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154138807|NCT00480532|Estrogens|estrogens|mesh-ancestor
154138808|NCT00480532|Hormones|hormones|mesh-ancestor
153539883|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138841|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154138842|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138844|NCT00934674|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154138845|NCT00934674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154138846|NCT00934674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539884|NCT01536132|Protective Agents|protective agents|mesh-ancestor
154138874|NCT00564018|Protamines|protamines|mesh-list
154138875|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154138876|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138877|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
154138878|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138879|NCT00564018|Coagulants|coagulants|mesh-ancestor
154138880|NCT00935298|Tacrolimus|tacrolimus|mesh-list
154138881|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138882|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
154138883|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138884|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154138885|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138886|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138887|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
154138888|NCT04014192|Empagliflozin|empagliflozin|mesh-list
154138889|NCT04014192|Canagliflozin|canagliflozin|mesh-list
154138890|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153539885|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138924|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138925|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138926|NCT00563784|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154138927|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154138928|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138929|NCT00203047|Prednisone|prednisone|mesh-list
154138930|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
154138931|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
154138932|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154138933|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
154138955|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154138956|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154138957|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138958|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154138959|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138960|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
154138961|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154138962|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154138963|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
153696007|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138964|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154138965|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154138966|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138967|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154138968|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154138969|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154138970|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
154138971|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154138972|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138973|NCT02608385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154138974|NCT02608385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138975|NCT00142519|Morphine|morphine|mesh-list
154138976|NCT00142519|Methadone|methadone|mesh-list
154138977|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154138978|NCT00142519|Narcotics|narcotics|mesh-ancestor
154138979|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154138980|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138981|NCT00142519|Analgesics|analgesics|mesh-ancestor
154138982|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
154138983|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138984|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
154139009|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154139011|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
154139012|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154139013|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154139014|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139015|NCT00874562|Sirolimus|sirolimus|mesh-list
154139016|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139017|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139018|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154139019|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139020|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
154139021|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154139022|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
154139023|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139024|NCT00201643|Dexamethasone|dexamethasone|mesh-list
154139025|NCT00201643|Betamethasone|betamethasone|mesh-list
154139026|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139027|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
154139028|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
154139029|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139030|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139031|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139032|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
154139034|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139035|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154139036|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139037|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154139038|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
154139039|NCT03798314|Nivolumab|nivolumab|mesh-list
154139040|NCT03798314|Pomalidomide|pomalidomide|mesh-list
153462594|NCT04550520|Glucagon|glucagon|mesh-list
154139091|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139092|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
154139093|NCT01073995|Hormones|hormones|mesh-ancestor
154139094|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139095|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154139096|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
154139097|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139098|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139099|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154139100|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154139101|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154139102|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139103|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139104|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154139105|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154139106|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154139107|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154139108|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
154139109|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139110|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139111|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154139112|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154139113|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
154139114|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154139115|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154139116|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
154139117|NCT00874874|Sorafenib|sorafenib|mesh-list
154139118|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139119|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154139120|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139121|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139122|NCT04489628|Vitamin D|vitamin d|mesh-list
154139123|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
154139124|NCT04489628|Vitamins|vitamins|mesh-ancestor
154139125|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
154139126|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139127|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154139128|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154139129|NCT00130039|Cilostazol|cilostazol|mesh-list
154139130|NCT00130039|Clopidogrel|clopidogrel|mesh-list
154139142|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154139143|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154139144|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154139145|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154139146|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
154139147|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154139148|NCT00130039|Protective Agents|protective agents|mesh-ancestor
154139149|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154139150|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154139151|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139153|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
154139154|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154139155|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154139156|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139157|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139158|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
154139159|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
154139160|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154139161|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
154139162|NCT00883298|Bevacizumab|bevacizumab|mesh-list
154139163|NCT00883298|Temozolomide|temozolomide|mesh-list
154139164|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139165|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139166|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154139167|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139168|NCT00883298|Growth Substances|growth substances|mesh-ancestor
154139169|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139170|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
154139171|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154139172|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
154139173|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139174|NCT00881114|Cetuximab|cetuximab|mesh-list
154139175|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139176|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139177|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154139178|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
154139179|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139180|NCT00141271|Ziprasidone|ziprasidone|mesh-list
154139181|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154139182|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
154139183|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139184|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139185|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139186|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154139187|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154139188|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139189|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154139190|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154139191|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
154139192|NCT01017640|Mitomycins|mitomycins|mesh-list
154139193|NCT01017640|Mitomycin|mitomycin|mesh-list
154139206|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139207|NCT00614120|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154139208|NCT00614120|Incretins|incretins|mesh-ancestor
154139209|NCT00614120|Hormones|hormones|mesh-ancestor
154139210|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139211|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154139212|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154139213|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
154139214|NCT00496054|Vaccines|vaccines|mesh-list
154139215|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
154139216|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139217|NCT00495820|Methylphenidate|methylphenidate|mesh-list
153696076|NCT00098241|Everolimus|everolimus|mesh-list
154139218|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154139219|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139220|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154139221|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154139222|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154139223|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139224|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
154139225|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139226|NCT04387240|Artesunate|artesunate|mesh-list
154139227|NCT04387240|Artemisinins|artemisinins|mesh-list
154139228|NCT04387240|Artemisinin|artemisinin|mesh-list
154139229|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
154139230|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154139231|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154139232|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139233|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139234|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
154139235|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
154139236|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154139237|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
154139238|NCT00495586|Amoxicillin|amoxicillin|mesh-list
154139239|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
154139240|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
153519613|NCT05867550|Rifaximin|rifaximin|mesh-list
154139241|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139242|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139243|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139244|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139245|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154139246|NCT00613730|Gemcitabine|gemcitabine|mesh-list
154139247|NCT00613730|Panitumumab|panitumumab|mesh-list
154139248|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154139249|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
154139250|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139251|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139252|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139253|NCT00613574|Bromides|bromides|mesh-list
154139254|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
154139255|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154139256|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
154139282|NCT00883532|Hormones|hormones|mesh-ancestor
154139283|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139284|NCT00881582|Interferons|interferons|mesh-list
154139285|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
154139286|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
154139287|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154139288|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139289|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
154139290|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139291|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
154139292|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139293|NCT00881738|Clarithromycin|clarithromycin|mesh-list
154139294|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153696093|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
154139295|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139296|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154139297|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139298|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139299|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154139300|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154139301|NCT00613106|Ibuprofen|ibuprofen|mesh-list
154139302|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154139303|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154139304|NCT00613106|Analgesics|analgesics|mesh-ancestor
154139305|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
154139306|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139326|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139327|NCT03712904|Growth Substances|growth substances|mesh-ancestor
154139328|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139329|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
154139330|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139331|NCT00875966|Azithromycin|azithromycin|mesh-list
154139332|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139333|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139334|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
154139335|NCT00141037|Trimethoprim|trimethoprim|mesh-list
154139336|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
154139337|NCT00141037|Valganciclovir|valganciclovir|mesh-list
154139338|NCT00141037|Ganciclovir|ganciclovir|mesh-list
154139339|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154139341|NCT00141037|Tacrolimus|tacrolimus|mesh-list
154139342|NCT00141037|Daclizumab|daclizumab|mesh-list
154139343|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139344|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
154139345|NCT00141037|Hormones|hormones|mesh-ancestor
154139346|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139347|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139348|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154139349|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139350|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154139351|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
154139352|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154139353|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139354|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139355|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154139356|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154139357|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
154139358|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139359|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139360|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154139361|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
154139362|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154139363|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154139364|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154139386|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
154139387|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139388|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139389|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153462887|NCT03012360|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154139390|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
154139391|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139392|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139393|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154139394|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154139395|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154139396|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
154139397|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139398|NCT00885794|Ranibizumab|ranibizumab|mesh-list
154139399|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154139400|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139401|NCT00885794|Growth Substances|growth substances|mesh-ancestor
154139402|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139403|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
154139404|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139405|NCT00888602|Psyllium|psyllium|mesh-list
154139406|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
154139407|NCT00888602|Cathartics|cathartics|mesh-ancestor
154139408|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139409|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
154139410|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154139411|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154139412|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154139413|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
154139414|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139415|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154139416|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154139417|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139418|NCT00888758|Sirolimus|sirolimus|mesh-list
154139433|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
154139434|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154139435|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139436|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
154139437|NCT04038320|Ledipasvir|ledipasvir|mesh-list
154139438|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
154139439|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139440|NCT00563706|Risperidone|risperidone|mesh-list
154139441|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154139442|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
154139443|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139444|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139445|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139446|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154139447|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153696186|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139448|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139449|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154139450|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154139452|NCT02543606|Esomeprazole|esomeprazole|mesh-list
154139453|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154139454|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139455|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154139456|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139457|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139458|NCT00939588|Valsartan|valsartan|mesh-list
154139460|NCT00939588|Ramipril|ramipril|mesh-list
154139461|NCT00939588|Aliskiren|aliskiren|mesh-list
154139462|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154139463|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154139464|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154139465|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139466|NCT00939588|Renin Inhibitors|renin inhibitors|mesh-ancestor
154139467|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
154139468|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139469|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154139470|NCT00889148|Gabapentin|gabapentin|mesh-list
154139471|NCT00889148|Analgesics|analgesics|mesh-ancestor
154139472|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
154139473|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139474|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139475|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
154139476|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154139477|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154139478|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154139479|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154139480|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154139545|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139546|NCT00936624|Montelukast|montelukast|mesh-list
154139547|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154139548|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
154139549|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154139550|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
154139551|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139552|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139553|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154139554|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154139555|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139556|NCT00138151|Interferons|interferons|mesh-list
154139557|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
154139558|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
154139560|NCT00138151|Isotretinoin|isotretinoin|mesh-list
154139561|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154139562|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139563|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
154139588|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154139589|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139590|NCT02581631|Immunotoxins|immunotoxins|mesh-ancestor
154139591|NCT02581631|Immunoconjugates|immunoconjugates|mesh-ancestor
154139592|NCT02581631|Immunologic Factors|immunologic factors|mesh-ancestor
154139593|NCT02581631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139594|NCT00884546|Dexamethasone|dexamethasone|mesh-list
154139595|NCT00884546|Lenalidomide|lenalidomide|mesh-list
154139597|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139598|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
154139599|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
154139600|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139601|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139602|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139603|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
154139604|NCT00884546|Hormones|hormones|mesh-ancestor
154139605|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139606|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154139607|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139608|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
154139609|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154139610|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139611|NCT00884546|Growth Substances|growth substances|mesh-ancestor
154139612|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
154139613|NCT00886106|Midazolam|midazolam|mesh-list
154139614|NCT00886106|Remifentanil|remifentanil|mesh-list
153649385|NCT00000395|Vitamins|vitamins|mesh-ancestor
154139632|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
154139633|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139634|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
154139635|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139636|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154139637|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154139638|NCT00889694|Analgesics|analgesics|mesh-ancestor
154256448|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256449|NCT01155206|Incretins|incretins|mesh-ancestor
154139639|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
154139640|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139641|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139642|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139643|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139644|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139645|NCT00529035|Interleukin-2|interleukin-2|mesh-list
154139646|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139647|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154139648|NCT00529035|Analgesics|analgesics|mesh-ancestor
154139649|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
154139650|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139651|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139652|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
154139653|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
154139654|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154139655|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154139656|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139657|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139658|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139659|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139660|NCT02578043|Clindamycin|clindamycin|mesh-list
153696249|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139661|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
154139662|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
154139663|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154139664|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139665|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139666|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154139667|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139668|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139669|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
154139671|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154139672|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139673|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154139674|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139684|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
154139685|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
154139686|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
154139687|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
154139688|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154139689|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139690|NCT02541500|Minocycline|minocycline|mesh-list
154139691|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139692|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139693|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
154139694|NCT04073849|Hematinics|hematinics|mesh-ancestor
154139695|NCT03263429|Irinotecan|irinotecan|mesh-list
154139696|NCT03263429|Panitumumab|panitumumab|mesh-list
154139697|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154139698|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154139699|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139700|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139701|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139702|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154139703|NCT00609674|Fluticasone|fluticasone|mesh-list
154139705|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139706|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154139707|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
154139708|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139709|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139710|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154139711|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
154139712|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
154139713|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154139714|NCT00941382|Metformin|metformin|mesh-list
154139715|NCT00941382|Sibutramine|sibutramine|mesh-list
154139716|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154139717|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139718|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
154139719|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154139720|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
154139721|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154139722|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154139723|NCT00137839|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154139724|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154139725|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696272|NCT02961829|Maraviroc|maraviroc|mesh-list
154139726|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139727|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139728|NCT00941460|Temozolomide|temozolomide|mesh-list
154139729|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154139730|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
154139731|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139732|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139733|NCT00890318|Ketoconazole|ketoconazole|mesh-list
154139734|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
154139735|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139736|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154139737|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154139738|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139739|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139740|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154139741|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
153539886|NCT01536158|Acetaminophen|acetaminophen|mesh-list
154139763|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154139764|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
154139765|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139766|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139767|NCT02542748|Norepinephrine|norepinephrine|mesh-list
154139768|NCT02542748|Ephedrine|ephedrine|mesh-list
154139769|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154139770|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154139771|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
154139772|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139773|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139774|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139775|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
154139776|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
154139777|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139778|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154139779|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154139780|NCT00941616|Factor VIII|factor viii|mesh-list
154139781|NCT00941616|Coagulants|coagulants|mesh-ancestor
154139782|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
154139783|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154139784|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154139785|NCT02542592|Prednisolone|prednisolone|mesh-list
154139786|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
154139787|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154139788|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
154139789|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139790|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
154139813|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139814|NCT00528957|Tenofovir|tenofovir|mesh-list
154139815|NCT00528957|Zidovudine|zidovudine|mesh-list
154139816|NCT00528957|Stavudine|stavudine|mesh-list
154139817|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
154139818|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157357|NCT05858671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154139819|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154139820|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154139821|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139822|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139823|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154139824|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154139825|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
154139827|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
154139828|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154139829|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139830|NCT00890708|Voriconazole|voriconazole|mesh-list
154139831|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
154139832|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139833|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154139834|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154139835|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139836|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139837|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154139838|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
154139839|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139840|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139841|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154139868|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154139870|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154139871|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139872|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
154139873|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139874|NCT00942006|Doxycycline|doxycycline|mesh-list
154139875|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
154139876|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154139877|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154139878|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
154139879|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154139880|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154139881|NCT00942006|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154139882|NCT00942006|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154139883|NCT02542124|Interleukin-12|interleukin-12|mesh-list
154139884|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154139885|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
154139886|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139887|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154139888|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154139889|NCT02542124|Growth Substances|growth substances|mesh-ancestor
154139890|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
154139921|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
154139923|NCT00609518|BB 1101|bb 1101|mesh-list
154139924|NCT00609518|Vitamins|vitamins|mesh-ancestor
154139925|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
154139926|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139927|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139928|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
154139929|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
154139930|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139931|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154139932|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
154139933|NCT00609518|Hormones|hormones|mesh-ancestor
154139934|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154139935|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154139936|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154139937|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
154139938|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539887|NCT01536158|Ibuprofen|ibuprofen|mesh-list
154139960|NCT00891332|Leucovorin|leucovorin|mesh-list
154139961|NCT00891332|Antidotes|antidotes|mesh-ancestor
154139962|NCT00891332|Protective Agents|protective agents|mesh-ancestor
154139963|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139964|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
154139965|NCT00891332|Vitamins|vitamins|mesh-ancestor
154139966|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
154139967|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
154139968|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154139969|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139970|NCT00886574|Aspirin|aspirin|mesh-list
154139971|NCT00886574|Cilostazol|cilostazol|mesh-list
154139972|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154139973|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154139975|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
154139976|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154139977|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154139978|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154139979|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154139980|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154139981|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154139982|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154139983|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154139984|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154139985|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154139986|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
154139987|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154139988|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
154139989|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154139990|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
154139991|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
154139992|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154139993|NCT00886574|Protective Agents|protective agents|mesh-ancestor
153649778|NCT00011895|Lamivudine|lamivudine|mesh-list
154140024|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140025|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140027|NCT00887042|Busulfan|busulfan|mesh-list
154140028|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
154140029|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140030|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140031|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154140032|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
154140033|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140034|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
153649815|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154140071|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154140072|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140073|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154140074|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154140075|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140089|NCT00608894|Hormones|hormones|mesh-ancestor
154140090|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140091|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140092|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140093|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140094|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154140095|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
154140096|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154140097|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140098|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140099|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
154140100|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154140101|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140102|NCT00892346|Thalidomide|thalidomide|mesh-list
154140103|NCT00892346|Melphalan|melphalan|mesh-list
154140104|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154140105|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
154140106|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140107|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140108|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154140109|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154140110|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
154140111|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140112|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
154140113|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154140114|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140115|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154140116|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154140117|NCT00892346|Growth Substances|growth substances|mesh-ancestor
154140118|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
154140119|NCT00892424|Sorafenib|sorafenib|mesh-list
154140120|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140121|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154140122|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140123|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140124|NCT02541032|Minocycline|minocycline|mesh-list
154140125|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154140126|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140127|NCT00892502|Bismuth|bismuth|mesh-list
154140128|NCT00892502|Antacids|antacids|mesh-ancestor
154140129|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140130|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154140131|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154140132|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
154140133|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154140134|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154140135|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154140136|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
154140137|NCT00191113|Estradiol|estradiol|mesh-list
154140138|NCT00191113|Hormones|hormones|mesh-ancestor
154140139|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140167|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
154140168|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140169|NCT03966235|Protective Agents|protective agents|mesh-ancestor
154140170|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140171|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140172|NCT01077661|Nebivolol|nebivolol|mesh-list
154140173|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154140174|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
154140175|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154140176|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154140177|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154140178|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
154140179|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140180|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140181|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140182|NCT00606320|Aripiprazole|aripiprazole|mesh-list
154140183|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
154140184|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140185|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154140198|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154140200|NCT03966079|Plasminogen|plasminogen|mesh-list
154140201|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154140202|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154140203|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154140204|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140205|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
154140206|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
154140207|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154140208|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140209|NCT03966859|Atorvastatin|atorvastatin|mesh-list
154140210|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154140211|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154140212|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
154140213|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140214|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154140215|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154140216|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140217|NCT00528411|Aspirin|aspirin|mesh-list
154140218|NCT00528411|Clopidogrel|clopidogrel|mesh-list
154140219|NCT00528411|Ticagrelor|ticagrelor|mesh-list
154140220|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154140221|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154140222|NCT00528411|Analgesics|analgesics|mesh-ancestor
154140223|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
154140225|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140226|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140227|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140228|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154140229|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154140230|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140231|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154140232|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154140233|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140234|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
154140235|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154140236|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154140237|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154140238|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
154140239|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140240|NCT00895544|Vaccines|vaccines|mesh-list
154140241|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
154140242|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140243|NCT00895778|Rocuronium|rocuronium|mesh-list
154140244|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154140245|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154140246|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154140269|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140270|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
154140271|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
154140272|NCT00896402|Trace Elements|trace elements|mesh-ancestor
154140273|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
154140274|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140275|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
154140276|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
154140277|NCT00560352|Dexamethasone|dexamethasone|mesh-list
154140278|NCT00560352|Bortezomib|bortezomib|mesh-list
154140279|NCT00560352|Dasatinib|dasatinib|mesh-list
154140280|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140281|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
154140282|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
154140283|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140284|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140285|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154140286|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
154140288|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140289|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140290|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140291|NCT00560352|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154140292|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154140293|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140294|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140295|NCT00892892|Nitrendipine|nitrendipine|mesh-list
154140296|NCT00892892|Rilmenidine|rilmenidine|mesh-list
154140297|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154140298|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154140299|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154140300|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140301|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154140302|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140333|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140334|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140335|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140336|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140337|NCT00942864|Ranibizumab|ranibizumab|mesh-list
154140338|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154140339|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154140340|NCT00942864|Growth Substances|growth substances|mesh-ancestor
154140341|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140342|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729696|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729697|NCT03226821|Tesamorelin|tesamorelin|mesh-list
153729698|NCT03226821|Growth Substances|growth substances|mesh-ancestor
153729699|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729700|NCT00139815|Enoxaparin|enoxaparin|mesh-list
154140343|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140370|NCT00896714|Anesthetics|anesthetics|mesh-list
154140371|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140372|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140373|NCT00940524|Cytarabine|cytarabine|mesh-list
154140374|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
154140375|NCT00940524|Methotrexate|methotrexate|mesh-list
154140376|NCT00940524|Etoposide|etoposide|mesh-list
154140377|NCT00940524|Asparaginase|asparaginase|mesh-list
154140378|NCT00940524|Dasatinib|dasatinib|mesh-list
154140379|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
154140380|NCT00940524|Pegaspargase|pegaspargase|mesh-list
154140381|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154140382|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
154140383|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140384|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140385|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154140386|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
154140387|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140388|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140389|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153650171|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
154140409|NCT00186901|Vitamin D|vitamin d|mesh-list
154140410|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
154140411|NCT00186901|Calcium|calcium|mesh-list
154140412|NCT00186901|Vitamins|vitamins|mesh-ancestor
154140413|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
154140414|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140415|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154140416|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154140417|NCT00186901|Antacids|antacids|mesh-ancestor
154140418|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140419|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154140420|NCT00943410|Trastuzumab|trastuzumab|mesh-list
154140421|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154140422|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140424|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
154140425|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140426|NCT00186121|Anastrozole|anastrozole|mesh-list
154140427|NCT00186121|Goserelin|goserelin|mesh-list
154256451|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
154140428|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140429|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140430|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154140431|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154140432|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140433|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140434|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154140435|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
154140436|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140437|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140438|NCT00897026|Paclitaxel|paclitaxel|mesh-list
154140439|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
154140440|NCT00897026|Doxorubicin|doxorubicin|mesh-list
154140441|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154140442|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154140443|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140444|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
153463939|NCT04390152|Ritonavir|ritonavir|mesh-list
154140458|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140459|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154140460|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
154140461|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140462|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154140463|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154140464|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140465|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140466|NCT01076491|Mannitol|mannitol|mesh-list
154140467|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154140468|NCT01076491|Diuretics|diuretics|mesh-ancestor
154140469|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
154140470|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140471|NCT00127933|Capecitabine|capecitabine|mesh-list
154140472|NCT00127933|Docetaxel|docetaxel|mesh-list
154140473|NCT00127933|Trastuzumab|trastuzumab|mesh-list
154140474|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154140475|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
154140476|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140477|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140478|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
154140479|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
154140480|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
154140481|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154140482|NCT03875313|Talazoparib|talazoparib|mesh-list
154140483|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154140484|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140485|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140486|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140487|NCT01008345|Ezetimibe|ezetimibe|mesh-list
154140488|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154140489|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154140490|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
154140491|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696848|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154140492|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154140493|NCT06089811|Tryptophan|tryptophan|mesh-list
154140494|NCT06089811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154140495|NCT06089811|Antidepressive Agents|antidepressive agents|mesh-ancestor
154140496|NCT06089811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140497|NCT06089733|Itraconazole|itraconazole|mesh-list
154140499|NCT06089733|Antifungal Agents|antifungal agents|mesh-ancestor
154140500|NCT06089733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140501|NCT06089733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154140502|NCT06089733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154140503|NCT06089733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140504|NCT06089733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140505|NCT06089733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154140506|NCT06089733|Hormone Antagonists|hormone antagonists|mesh-ancestor
154140507|NCT06089733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140521|NCT06089720|Zinc Oxide|zinc oxide|mesh-list
154140522|NCT06089720|Dermatologic Agents|dermatologic agents|mesh-ancestor
154140523|NCT06089720|Sunscreening Agents|sunscreening agents|mesh-ancestor
154140524|NCT06089720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154140525|NCT06089720|Protective Agents|protective agents|mesh-ancestor
154140526|NCT06089720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140527|NCT06089707|Naloxone|naloxone|mesh-list
154140528|NCT06089707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154140529|NCT06089707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140530|NCT06089707|Sensory System Agents|sensory system agents|mesh-ancestor
154140531|NCT06089707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140532|NCT06089382|Lenvatinib|lenvatinib|mesh-list
154140533|NCT06089382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140534|NCT06089382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154140535|NCT06089382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140536|NCT06089382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140537|NCT06089356|Topiramate|topiramate|mesh-list
154140538|NCT06089356|Valproic Acid|valproic acid|mesh-list
154140539|NCT06089356|Anticonvulsants|anticonvulsants|mesh-ancestor
154140540|NCT06089356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154140541|NCT06089356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140542|NCT06089356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140543|NCT06089356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140544|NCT06089356|GABA Agents|gaba agents|mesh-ancestor
154140545|NCT06089356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140546|NCT06089356|Antimanic Agents|antimanic agents|mesh-ancestor
154140547|NCT06089356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154140548|NCT06089356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140549|NCT06089356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140550|NCT06089330|Irinotecan|irinotecan|mesh-list
154140551|NCT06089330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154140552|NCT06089330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154140553|NCT06089330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140554|NCT06089330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140555|NCT06089330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140556|NCT06089200|Morphine|morphine|mesh-list
154140557|NCT06089200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154140558|NCT06089200|Narcotics|narcotics|mesh-ancestor
154140559|NCT06089200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140560|NCT06089200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140561|NCT06089200|Analgesics|analgesics|mesh-ancestor
154140562|NCT06089200|Sensory System Agents|sensory system agents|mesh-ancestor
154140563|NCT06089200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140564|NCT06089044|Dalbavancin|dalbavancin|mesh-list
154140565|NCT06089044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154140580|NCT06088433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140581|NCT06088433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140582|NCT06088433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140584|NCT06088433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154140585|NCT06088433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154140586|NCT06088433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140587|NCT06088433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154140588|NCT06088433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154140589|NCT06088433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140590|NCT06088433|Antipyretics|antipyretics|mesh-ancestor
154140591|NCT06088433|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154140592|NCT06088433|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154140593|NCT06088433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154140595|NCT06088433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140596|NCT06088420|Morphine|morphine|mesh-list
154140597|NCT06088420|Bupivacaine|bupivacaine|mesh-list
154140598|NCT06088420|Anesthetics, Local|anesthetics, local|mesh-ancestor
154140599|NCT06088420|Anesthetics|anesthetics|mesh-ancestor
154140600|NCT06088420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140601|NCT06088420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140602|NCT06088420|Sensory System Agents|sensory system agents|mesh-ancestor
154140603|NCT06088420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140604|NCT06088420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154140605|NCT06088420|Narcotics|narcotics|mesh-ancestor
154140606|NCT06088420|Analgesics|analgesics|mesh-ancestor
154140607|NCT06088407|Tranexamic Acid|tranexamic acid|mesh-list
154140608|NCT06088407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154140609|NCT06088407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154140610|NCT06088407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140611|NCT06088407|Hemostatics|hemostatics|mesh-ancestor
154140612|NCT06088407|Coagulants|coagulants|mesh-ancestor
154140613|NCT06088316|Amoxicillin|amoxicillin|mesh-list
154140614|NCT06088316|Levofloxacin|levofloxacin|mesh-list
154140615|NCT06088316|Esomeprazole|esomeprazole|mesh-list
154140616|NCT06088316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154140617|NCT06088316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140618|NCT06088316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154140619|NCT06088316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154140620|NCT06088316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154140621|NCT06088316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140622|NCT06088316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140623|NCT06088316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154140624|NCT06088316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154140625|NCT06088316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154140626|NCT06088316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140627|NCT06088316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154140628|NCT06088316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154140643|NCT06087796|Metformin|metformin|mesh-list
154140644|NCT06087796|Betamethasone|betamethasone|mesh-list
154140645|NCT06087796|Betamethasone Valerate|betamethasone valerate|mesh-list
154140646|NCT06087796|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154140647|NCT06087796|Betamethasone benzoate|betamethasone benzoate|mesh-list
154140648|NCT06087796|Pentoxifylline|pentoxifylline|mesh-list
154140649|NCT06087796|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154140650|NCT06087796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154140651|NCT06087796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140652|NCT06087796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140653|NCT06087796|Glucocorticoids|glucocorticoids|mesh-ancestor
154140654|NCT06087796|Hormones|hormones|mesh-ancestor
154140655|NCT06087796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140656|NCT06087796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154140657|NCT06087796|Respiratory System Agents|respiratory system agents|mesh-ancestor
154140658|NCT06087796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154140659|NCT06087796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140660|NCT06087796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140661|NCT06087796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154140662|NCT06087796|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154140663|NCT06087796|Protective Agents|protective agents|mesh-ancestor
154140664|NCT06087796|Vasodilator Agents|vasodilator agents|mesh-ancestor
154140665|NCT06087796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154140666|NCT06087796|Antioxidants|antioxidants|mesh-ancestor
154140667|NCT06087705|Hyaluronic Acid|hyaluronic acid|mesh-list
154140668|NCT06087705|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154140669|NCT06087705|Immunologic Factors|immunologic factors|mesh-ancestor
154140670|NCT06087705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140671|NCT06087705|Viscosupplements|viscosupplements|mesh-ancestor
154140672|NCT06087705|Protective Agents|protective agents|mesh-ancestor
154140673|NCT06087653|Dexamethasone|dexamethasone|mesh-list
154140674|NCT06087653|Lenalidomide|lenalidomide|mesh-list
154140675|NCT06087653|Bortezomib|bortezomib|mesh-list
154140676|NCT06087653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140677|NCT06087653|Antiemetics|antiemetics|mesh-ancestor
154140678|NCT06087653|Autonomic Agents|autonomic agents|mesh-ancestor
154140679|NCT06087653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140680|NCT06087653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140681|NCT06087653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154140682|NCT06087653|Glucocorticoids|glucocorticoids|mesh-ancestor
154140683|NCT06087653|Hormones|hormones|mesh-ancestor
154140684|NCT06087653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140685|NCT06087653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140686|NCT06087653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140687|NCT06087653|Immunologic Factors|immunologic factors|mesh-ancestor
154140688|NCT06087653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153650458|NCT00012519|Ritonavir|ritonavir|mesh-list
154140705|NCT06083922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140706|NCT06083922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140707|NCT06083922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154140708|NCT06083922|Alkylating Agents|alkylating agents|mesh-ancestor
154140709|NCT06083922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140710|NCT06083922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140711|NCT06083922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154140712|NCT06083922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140713|NCT06083922|Antiemetics|antiemetics|mesh-ancestor
154140714|NCT06083922|Autonomic Agents|autonomic agents|mesh-ancestor
153697171|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154140715|NCT06083922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140716|NCT06083922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154140717|NCT06083922|Glucocorticoids|glucocorticoids|mesh-ancestor
154140718|NCT06083922|Hormones|hormones|mesh-ancestor
154140719|NCT06083922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140720|NCT06083922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140721|NCT06080204|Octreotide|octreotide|mesh-list
154140722|NCT06080204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154140723|NCT06080204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140724|NCT06080204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140725|NCT06072768|Prednisone|prednisone|mesh-list
154140726|NCT06072768|Prednisolone|prednisolone|mesh-list
154140727|NCT06072768|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154140728|NCT06072768|Methylprednisolone|methylprednisolone|mesh-list
154140729|NCT06072768|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154140730|NCT06072768|Prednisolone acetate|prednisolone acetate|mesh-list
154140731|NCT06072768|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154140732|NCT06072768|Prednisolone phosphate|prednisolone phosphate|mesh-list
154140733|NCT06072768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154140734|NCT06072768|Glucocorticoids|glucocorticoids|mesh-ancestor
154140735|NCT06072768|Hormones|hormones|mesh-ancestor
154140736|NCT06072768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154140737|NCT06072768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140738|NCT06072768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154140739|NCT06072768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140740|NCT06072768|Antiemetics|antiemetics|mesh-ancestor
154140741|NCT06072768|Autonomic Agents|autonomic agents|mesh-ancestor
154140742|NCT06072768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140743|NCT06072768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154140744|NCT06072768|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154140745|NCT06072768|Protective Agents|protective agents|mesh-ancestor
154140746|NCT06053021|Aspirin|aspirin|mesh-list
154140747|NCT06053021|Cilostazol|cilostazol|mesh-list
154140748|NCT06053021|Dipyridamole|dipyridamole|mesh-list
154140749|NCT06053021|Clopidogrel|clopidogrel|mesh-list
153650521|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
154140774|NCT06053021|Vasodilator Agents|vasodilator agents|mesh-ancestor
154140775|NCT06053021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154140776|NCT06053021|Protective Agents|protective agents|mesh-ancestor
154140777|NCT06053021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154140778|NCT06053021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154140779|NCT06049940|Vaccines|vaccines|mesh-list
154140780|NCT06049940|Immunologic Factors|immunologic factors|mesh-ancestor
154140781|NCT06049940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140782|NCT06045819|Venetoclax|venetoclax|mesh-list
154140783|NCT06045819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140784|NCT06014775|Antibodies|antibodies|mesh-list
154140785|NCT06014775|Immunologic Factors|immunologic factors|mesh-ancestor
154140786|NCT06014775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140787|NCT05966688|Azithromycin|azithromycin|mesh-list
154140788|NCT05966688|Ethambutol|ethambutol|mesh-list
154140789|NCT05966688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154140790|NCT05966688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140791|NCT05966688|Antitubercular Agents|antitubercular agents|mesh-ancestor
154140792|NCT05941494|Phenylephrine|phenylephrine|mesh-list
154140793|NCT05941494|Oxymetazoline|oxymetazoline|mesh-list
154140794|NCT05941494|Ephedrine|ephedrine|mesh-list
154140795|NCT05941494|Pseudoephedrine|pseudoephedrine|mesh-list
154140796|NCT05941494|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154140797|NCT05941494|Anesthetics|anesthetics|mesh-list
154140798|NCT05941494|Propofol|propofol|mesh-list
154140799|NCT05941494|Sevoflurane|sevoflurane|mesh-list
154140800|NCT05941494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140830|NCT05858710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140831|NCT05858710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154140832|NCT05858710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154140834|NCT05858710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140835|NCT05852873|Ritonavir|ritonavir|mesh-list
154140836|NCT05852873|Nirmatrelvir|nirmatrelvir|mesh-list
154140837|NCT05852873|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
154140838|NCT05852873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154140839|NCT05852873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154140840|NCT05852873|Protease Inhibitors|protease inhibitors|mesh-ancestor
154140841|NCT05852873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140842|NCT05852873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140843|NCT05852873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154140844|NCT05852873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154140852|NCT05845359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140853|NCT05845359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140855|NCT05845359|Sensory System Agents|sensory system agents|mesh-ancestor
154140856|NCT05845359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140857|NCT05845359|Antitussive Agents|antitussive agents|mesh-ancestor
154140858|NCT05845359|Respiratory System Agents|respiratory system agents|mesh-ancestor
154140859|NCT05816070|Ofloxacin|ofloxacin|mesh-list
154140860|NCT05816070|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154140861|NCT05816070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154140862|NCT05816070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154140863|NCT05816070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140864|NCT05816070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154140865|NCT05816070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154140866|NCT05816070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154140867|NCT05816070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140868|NCT05816070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140869|NCT05816070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140870|NCT05816070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154140871|NCT05816070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154140872|NCT05795413|Bupivacaine|bupivacaine|mesh-list
154140873|NCT05795413|Anesthetics, Local|anesthetics, local|mesh-ancestor
154140875|NCT05795413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140876|NCT05795413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140877|NCT05795413|Sensory System Agents|sensory system agents|mesh-ancestor
154140878|NCT05795413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140879|NCT05788081|Rituximab|rituximab|mesh-list
154140880|NCT05788081|Nivolumab|nivolumab|mesh-list
154140881|NCT05788081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154140882|NCT05788081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140883|NCT05788081|Immunologic Factors|immunologic factors|mesh-ancestor
154140884|NCT05788081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140885|NCT05788081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140886|NCT05788081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153697349|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
154140887|NCT05788081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140888|NCT05762536|Docetaxel|docetaxel|mesh-list
154140889|NCT05762536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140890|NCT05762536|Tubulin Modulators|tubulin modulators|mesh-ancestor
154140891|NCT05762536|Antimitotic Agents|antimitotic agents|mesh-ancestor
154140892|NCT05762536|Mitosis Modulators|mitosis modulators|mesh-ancestor
154140893|NCT05762536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140894|NCT05754073|Oxytocin|oxytocin|mesh-list
154140895|NCT05754073|Oxytocics|oxytocics|mesh-ancestor
154140896|NCT05754073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153464443|NCT04775238|Copper|copper|mesh-list
154140897|NCT05754073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140898|NCT05693766|Capecitabine|capecitabine|mesh-list
154140899|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154140900|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
154140901|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140902|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140903|NCT05945160|Thioctic Acid|thioctic acid|mesh-list
154140904|NCT05945160|Ubiquinone|ubiquinone|mesh-list
154140905|NCT05945160|Coenzyme Q10|coenzyme q10|mesh-list
154140906|NCT05945160|Antioxidants|antioxidants|mesh-ancestor
154140907|NCT05945160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140908|NCT05945160|Protective Agents|protective agents|mesh-ancestor
154140909|NCT05945160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140910|NCT05945160|Vitamin B Complex|vitamin b complex|mesh-ancestor
154140911|NCT05945160|Vitamins|vitamins|mesh-ancestor
154140912|NCT05945160|Micronutrients|micronutrients|mesh-ancestor
154140936|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
154140937|NCT05612074|Protective Agents|protective agents|mesh-ancestor
154140938|NCT05586971|Allopurinol|allopurinol|mesh-list
154140939|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
154140940|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140941|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140942|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
154140943|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154140944|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154140945|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
154140946|NCT05586971|Protective Agents|protective agents|mesh-ancestor
154140947|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140948|NCT05578820|Ganciclovir|ganciclovir|mesh-list
154140949|NCT05578820|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154140950|NCT05578820|Antiviral Agents|antiviral agents|mesh-ancestor
154140951|NCT05578820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154140952|NCT05578820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154140953|NCT05578820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140954|NCT05578820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140955|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
154140956|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154140957|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
154140958|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140959|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154140960|NCT05550246|Oxybutynin|oxybutynin|mesh-list
154140961|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154140962|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154140963|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154140964|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154140965|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154140966|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
154140967|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140968|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140969|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
153729703|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
154140970|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
154140971|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154140988|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154140989|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154140990|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154140991|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154140992|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154140993|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154140994|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154140995|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154140996|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
154140997|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154140998|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154140999|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
154141000|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154141001|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154141002|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154141003|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154141004|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
154141005|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154141006|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154141007|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
154141008|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154141009|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154141010|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
154141011|NCT05508594|Sufentanil|sufentanil|mesh-list
154141012|NCT05508594|Ketamine|ketamine|mesh-list
154141013|NCT05508594|Analgesics|analgesics|mesh-ancestor
154141014|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
154141015|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141016|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141017|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154141018|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154141019|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
154141020|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
154141021|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141022|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154141023|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154141024|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141025|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141026|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154141027|NCT05508594|Narcotics|narcotics|mesh-ancestor
154141028|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154141029|NCT05505630|Midazolam|midazolam|mesh-list
153697538|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141037|NCT05505630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154141039|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
154141040|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141041|NCT05505630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154141042|NCT05505630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154141043|NCT05505630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154141044|NCT05505630|Adrenergic Agents|adrenergic agents|mesh-ancestor
154141045|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141046|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141047|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154141048|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
154141049|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154141050|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154141051|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154141052|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154141053|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154141054|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154141056|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
154141057|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-list
154141058|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154141059|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141060|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141061|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154141062|NCT05483062|Fluorides|fluorides|mesh-list
154141063|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
154141064|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
154141065|NCT05483062|Protective Agents|protective agents|mesh-ancestor
154141066|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141067|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154141068|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141069|NCT05260671|Cetuximab|cetuximab|mesh-list
154141070|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141071|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141072|NCT05180422|Sotorasib|sotorasib|mesh-list
154141073|NCT05180422|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154141074|NCT05180422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141075|NCT05180422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141076|NCT05180422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141077|NCT05161533|Cisplatin|cisplatin|mesh-list
154141078|NCT05161533|Carboplatin|carboplatin|mesh-list
154141079|NCT05161533|Etoposide|etoposide|mesh-list
154141080|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
154141081|NCT05161533|Durvalumab|durvalumab|mesh-list
154141082|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
154141083|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
154141084|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154141085|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
154141086|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141087|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154141088|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154141089|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154141090|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141091|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141092|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141093|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
154141094|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141095|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
154141096|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
154141097|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
154141098|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650862|NCT00000563|Dexamethasone|dexamethasone|mesh-list
154141117|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141118|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154141119|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154141120|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141121|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141122|NCT05030493|Bevacizumab|bevacizumab|mesh-list
154141123|NCT05030493|Panitumumab|panitumumab|mesh-list
154141124|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141125|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141126|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154141127|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154141128|NCT05030493|Growth Substances|growth substances|mesh-ancestor
154141129|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141130|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
154141131|NCT05023382|Teduglutide|teduglutide|mesh-list
154141132|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154141133|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154141134|NCT05023382|Protective Agents|protective agents|mesh-ancestor
154141135|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141136|NCT05014438|Branebrutinib|branebrutinib|mesh-list
154141137|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141138|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141139|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141140|NCT05014048|Vitamin D|vitamin d|mesh-list
154141141|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
154141142|NCT05014048|Vitamins|vitamins|mesh-ancestor
154141143|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
154141144|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141145|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154141146|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154141147|NCT05008783|Capecitabine|capecitabine|mesh-list
154141148|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
154141149|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154141150|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
154141151|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141152|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141153|NCT04982367|Sirolimus|sirolimus|mesh-list
154141154|NCT04982367|Paclitaxel|paclitaxel|mesh-list
154141155|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154141156|NCT04982367|Temsirolimus|temsirolimus|mesh-list
154141188|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141189|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154141190|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
154141192|NCT04951804|Bupivacaine|bupivacaine|mesh-list
154141193|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
154141194|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
154141195|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521536|NCT03689946|Listerine|listerine|mesh-list
154141196|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141197|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
154141218|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154141219|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141220|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154141221|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141222|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154141223|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154141224|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
154141225|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141226|NCT04858776|Dexamethasone|dexamethasone|mesh-list
154141227|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154141228|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
154141229|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
154141230|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141231|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141232|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154141233|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
154141235|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154141236|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154141237|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141238|NCT04849416|Pirtobrutinib|pirtobrutinib|mesh-list
154141239|NCT04849416|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154141240|NCT04849416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141241|NCT04849416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141242|NCT04849416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141243|NCT04786340|Pirenzepine|pirenzepine|mesh-list
154141244|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154141245|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154141246|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154141247|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154141248|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154141249|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
154141250|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141251|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651023|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141266|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154141267|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154141268|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
154141269|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521610|NCT03485547|Venetoclax|venetoclax|mesh-list
154141270|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154141271|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154141272|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141273|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154141274|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
154141275|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154141276|NCT04588545|Trastuzumab|trastuzumab|mesh-list
154141277|NCT04588545|Pertuzumab|pertuzumab|mesh-list
154141278|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141279|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141280|NCT04544202|Trametinib|trametinib|mesh-list
154141281|NCT04544202|Dabrafenib|dabrafenib|mesh-list
154141282|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141283|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141284|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141285|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141286|NCT04415333|Butyric Acid|butyric acid|mesh-list
154141287|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
154141288|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
154141289|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141290|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141291|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141292|NCT04249622|Rifaximin|rifaximin|mesh-list
154141293|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154141294|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141295|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154141296|NCT04249544|Pramipexole|pramipexole|mesh-list
154141297|NCT04249544|Dexpramipexole|dexpramipexole|mesh-list
154141298|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
154141299|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141300|NCT04249544|Protective Agents|protective agents|mesh-ancestor
154141301|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141302|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154141303|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154141304|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
154141305|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
154141306|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141307|NCT04230980|Gabapentin|gabapentin|mesh-list
154141308|NCT04230980|Analgesics|analgesics|mesh-ancestor
154141309|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
154141310|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141311|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141312|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
154141313|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153651090|NCT00000596|Hormones|hormones|mesh-ancestor
154141334|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154141336|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154141337|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154141338|NCT04140448|Ranibizumab|ranibizumab|mesh-list
154141339|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154141340|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154141341|NCT04140448|Growth Substances|growth substances|mesh-ancestor
154141342|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141343|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
154141344|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141345|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
154141346|NCT04087096|Denosumab|denosumab|mesh-list
154141347|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154141348|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141349|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154141350|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
154141351|NCT04006769|Entacapone|entacapone|mesh-list
154141352|NCT04006769|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154141353|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141354|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141355|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141356|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141357|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154141358|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154141359|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154141360|NCT03936998|Vancomycin|vancomycin|mesh-list
154141361|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154141362|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141364|NCT03897673|Trace Elements|trace elements|mesh-ancestor
154141365|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
154141366|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141382|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141383|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
154141384|NCT03727724|Cetuximab|cetuximab|mesh-list
154141385|NCT03727724|Afatinib|afatinib|mesh-list
154141386|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141387|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141388|NCT03727724|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154141389|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141390|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141391|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141393|NCT03714555|Paclitaxel|paclitaxel|mesh-list
154141394|NCT03714555|Gemcitabine|gemcitabine|mesh-list
154141395|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154141396|NCT03714555|Folfirinox|folfirinox|mesh-list
154141397|NCT03714555|Disulfiram|disulfiram|mesh-list
154141398|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154141399|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141400|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
154141401|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
154141402|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
154141404|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154141405|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
154141406|NCT03714555|Trace Elements|trace elements|mesh-ancestor
154141407|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
154141408|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141409|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154141410|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154141411|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141412|NCT03701295|Azacitidine|azacitidine|mesh-list
154141413|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154141414|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
154141415|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141416|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141417|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141418|NCT03697720|Naproxen|naproxen|mesh-list
154141419|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154141420|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154141421|NCT03697720|Analgesics|analgesics|mesh-ancestor
154141422|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
154141423|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141424|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141425|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154141440|NCT03596385|Metoprolol|metoprolol|mesh-list
154141441|NCT03596385|Atenolol|atenolol|mesh-list
154141442|NCT03596385|Carvedilol|carvedilol|mesh-list
154141443|NCT03596385|Bisoprolol|bisoprolol|mesh-list
154141444|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154141445|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154141446|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154141447|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
154141448|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
154141449|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141450|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141451|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154141452|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154141453|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
154141454|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141455|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141456|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
154141457|NCT03596385|Protective Agents|protective agents|mesh-ancestor
154141458|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154141459|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154141460|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154141461|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
154141462|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154141463|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154141464|NCT03549000|Spartalizumab|spartalizumab|mesh-list
154141465|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154141466|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141467|NCT03549000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141468|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141469|NCT03517449|Paclitaxel|paclitaxel|mesh-list
154141470|NCT03517449|Doxorubicin|doxorubicin|mesh-list
154141471|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
154141472|NCT03517449|Lenvatinib|lenvatinib|mesh-list
154141473|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154141474|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141475|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
154141476|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
154141477|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
154141478|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141479|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154141480|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154141481|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154141482|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697770|NCT00099918|Vildagliptin|vildagliptin|mesh-list
153697775|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141483|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141518|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154141520|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154141521|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141522|NCT03390595|Carboplatin|carboplatin|mesh-list
154141523|NCT03390595|Gemcitabine|gemcitabine|mesh-list
154141524|NCT03390595|Avelumab|avelumab|mesh-list
153651336|NCT00033358|Estradiol|estradiol|mesh-list
154141552|NCT03274414|Etoposide|etoposide|mesh-list
154141553|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141554|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154141555|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154141556|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154141557|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141558|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141559|NCT03267316|Paclitaxel|paclitaxel|mesh-list
154141560|NCT03267316|Carboplatin|carboplatin|mesh-list
154141561|NCT03267316|Gemcitabine|gemcitabine|mesh-list
154141562|NCT03267316|Pemetrexed|pemetrexed|mesh-list
154141563|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154141564|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141565|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
154141566|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
154141567|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
154141568|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141569|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154141570|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
154141571|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141572|NCT03267316|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651357|NCT00033436|Niacin|niacin|mesh-list
154141591|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
154141592|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141593|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154141594|NCT03122639|Atorvastatin|atorvastatin|mesh-list
154141595|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154141596|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154141597|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
154141598|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141599|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154141600|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154141601|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141602|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
154141603|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154141604|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
154141605|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141606|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141607|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154141608|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154141609|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154141610|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141611|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141612|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154141613|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154141614|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141615|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
154141616|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141617|NCT02918864|Oxytocin|oxytocin|mesh-list
154141618|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
154141619|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154141620|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141621|NCT02916979|Methotrexate|methotrexate|mesh-list
154141622|NCT02916979|Fludarabine|fludarabine|mesh-list
154141623|NCT02916979|Busulfan|busulfan|mesh-list
154141624|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
154141625|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154141626|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
154141627|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153651406|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
154141640|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
154141641|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154141642|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154141643|NCT02716116|Mobocertinib|mobocertinib|mesh-list
154141644|NCT02716116|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154141645|NCT02716116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141646|NCT02716116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141647|NCT02716116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141648|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
154141649|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154141650|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141651|NCT02702414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154141652|NCT02702414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141653|NCT02491632|Dexamethasone|dexamethasone|mesh-list
154141654|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
154141656|NCT02491632|BB 1101|bb 1101|mesh-list
154141657|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154141658|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
154141659|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
154141660|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141661|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141662|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154141663|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
154141664|NCT02491632|Hormones|hormones|mesh-ancestor
154141665|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154141666|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154141667|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141668|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
154141669|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141670|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141671|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154141672|NCT02086188|Mirabegron|mirabegron|mesh-list
154141673|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154141674|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154141675|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154141676|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
154141677|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141678|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141679|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141680|NCT02086188|Urological Agents|urological agents|mesh-ancestor
154141681|NCT01361399|Aspirin|aspirin|mesh-list
154141682|NCT01361399|Lidocaine|lidocaine|mesh-list
154141683|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
154141684|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
154141685|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141686|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141687|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
154141688|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141710|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141711|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141712|NCT01064479|Cisplatin|cisplatin|mesh-list
154141713|NCT01064479|Carboplatin|carboplatin|mesh-list
154141714|NCT01064479|Docetaxel|docetaxel|mesh-list
154141715|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154141716|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141717|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
154141718|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
154141719|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
154141720|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141721|NCT01064479|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154141722|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141723|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141724|NCT00640978|Everolimus|everolimus|mesh-list
154141725|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154141726|NCT00640978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154141727|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141728|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141729|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141730|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141731|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
154141732|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141733|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141734|NCT00640978|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154141735|NCT00449748|Everolimus|everolimus|mesh-list
154141736|NCT00449748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154141737|NCT00449748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141738|NCT00449748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141739|NCT00449748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141740|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141774|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141775|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154141789|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
154141790|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141791|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154141792|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154141793|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
154141796|NCT00940680|Amlodipine|amlodipine|mesh-list
154141797|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154141798|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154141799|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154141800|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141801|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154141802|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141803|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
154141804|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154141805|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154141806|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154141807|NCT00945438|Vaccines|vaccines|mesh-list
154141808|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
154141809|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141810|NCT00527397|Insulin|insulin|mesh-list
154141811|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154141812|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141813|NCT00943956|Everolimus|everolimus|mesh-list
154141814|NCT00943956|Leuprolide|leuprolide|mesh-list
154141815|NCT00943956|Bicalutamide|bicalutamide|mesh-list
154141816|NCT00943956|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154141817|NCT00943956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154141818|NCT00943956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141819|NCT00943956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141820|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141821|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
154141822|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141823|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141824|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154141825|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
154141826|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154141827|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154141828|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
154141829|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
154141830|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154141831|NCT00944346|Metformin|metformin|mesh-list
154141832|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154141833|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141834|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154141864|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
154141865|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154141866|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
154141867|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154141868|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141869|NCT00944424|Vitamin D|vitamin d|mesh-list
154141870|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
154141871|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
154141872|NCT00944424|Vitamins|vitamins|mesh-list
154141873|NCT00944424|Docetaxel|docetaxel|mesh-list
154141874|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
154141875|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141876|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141877|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
154141878|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
154141879|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
154141880|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141881|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153651683|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
154141896|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
154141897|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154141898|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
154141899|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154141900|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141901|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154141902|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141903|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
154141904|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154141905|NCT00946374|Cyclosporine|cyclosporine|mesh-list
154141906|NCT00946374|Doxorubicin|doxorubicin|mesh-list
154141907|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154141908|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141909|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154141910|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154141911|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154141912|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141913|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
154141914|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141915|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154141916|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141917|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
154141918|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141919|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
154141920|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154141922|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154141923|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154141924|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
154141925|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154141926|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
154141927|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141928|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141929|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141930|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154141931|NCT00950196|Analgesics|analgesics|mesh-ancestor
154141932|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
154141933|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141934|NCT01565109|Docetaxel|docetaxel|mesh-list
154141935|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154141936|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
154141937|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
154141938|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
154141939|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141940|NCT00525915|Fluorouracil|fluorouracil|mesh-list
154141941|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
154141942|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
154141959|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154141960|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
154141961|NCT00134563|Teriflunomide|teriflunomide|mesh-list
154141962|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154141963|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154141964|NCT00134563|Analgesics|analgesics|mesh-ancestor
154141965|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
154141966|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141967|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141968|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154141969|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154141970|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154141971|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
154141972|NCT03966547|Anesthetics|anesthetics|mesh-list
154141973|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
154141974|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141975|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141976|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
154141977|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141978|NCT01326325|Ketamine|ketamine|mesh-list
154141979|NCT01326325|Analgesics|analgesics|mesh-ancestor
154141980|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
154141981|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154141982|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154141983|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154141984|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154141985|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
154141986|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
154141987|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154141988|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154141989|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154141990|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154141991|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141992|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
154141993|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154141994|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154141995|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154141996|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
154141997|NCT01326403|Coagulants|coagulants|mesh-ancestor
154141998|NCT00520845|Celecoxib|celecoxib|mesh-list
154141999|NCT00520845|Docetaxel|docetaxel|mesh-list
154142000|NCT00520845|Pemetrexed|pemetrexed|mesh-list
154142018|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154142019|NCT00185731|Atorvastatin|atorvastatin|mesh-list
154142020|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154142021|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154142022|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
154142023|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142024|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154142025|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154142026|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142028|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154142029|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142030|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154142031|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154142032|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153697916|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142033|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142034|NCT00520767|Dexamethasone|dexamethasone|mesh-list
154142035|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
154142036|NCT00520767|Bortezomib|bortezomib|mesh-list
154142037|NCT00520767|Melphalan|melphalan|mesh-list
154142038|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154142039|NCT00520767|BB 1101|bb 1101|mesh-list
154142040|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142041|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
154142042|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
154142043|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142044|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142045|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142046|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
154142047|NCT00520767|Hormones|hormones|mesh-ancestor
154142048|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142049|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154142050|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142051|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
154142052|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142053|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142054|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154142055|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
154142056|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154142080|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142081|NCT01017796|Protective Agents|protective agents|mesh-ancestor
154142082|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142083|NCT01017796|Antidotes|antidotes|mesh-ancestor
154142084|NCT01017796|Vitamins|vitamins|mesh-ancestor
154142085|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
154142086|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
154142087|NCT01783535|Carboplatin|carboplatin|mesh-list
154142088|NCT01783535|Doxorubicin|doxorubicin|mesh-list
154142089|NCT01783535|Etoposide|etoposide|mesh-list
154142090|NCT01783535|Vincristine|vincristine|mesh-list
154142091|NCT01783535|Topotecan|topotecan|mesh-list
154142092|NCT01783535|Lenograstim|lenograstim|mesh-list
154142093|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154142094|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
154142095|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142096|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142097|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154142098|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
154142099|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142100|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142101|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154142102|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154142103|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154142104|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154142105|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142106|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154142107|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154142108|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
154142109|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
154142110|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
154142111|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154142112|NCT04073537|Paclitaxel|paclitaxel|mesh-list
154142113|NCT04073537|Carboplatin|carboplatin|mesh-list
154142136|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142137|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142139|NCT00524589|Hormones|hormones|mesh-ancestor
154142140|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142141|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154142142|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142143|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154142144|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154142145|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154142146|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142147|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154142148|NCT00524589|Vitamins|vitamins|mesh-ancestor
154142149|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
154142150|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154142151|NCT01015066|Naltrexone|naltrexone|mesh-list
154142152|NCT01015066|Buprenorphine|buprenorphine|mesh-list
154142153|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154142154|NCT01015066|Naloxone|naloxone|mesh-list
154142155|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154142156|NCT01015066|Narcotics|narcotics|mesh-ancestor
154142157|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142158|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142159|NCT01015066|Analgesics|analgesics|mesh-ancestor
154142160|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
154142161|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142162|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154142163|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154142164|NCT00472030|Omalizumab|omalizumab|mesh-list
154142165|NCT00472030|Prednisone|prednisone|mesh-list
154142166|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142183|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154142184|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
154142185|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142186|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142187|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154142188|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142189|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154142190|NCT00524121|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154142191|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154142192|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142193|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142194|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142195|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
154142196|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154142197|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142198|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154142199|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
154142200|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154142201|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154142202|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142203|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
154142204|NCT03965767|Coagulants|coagulants|mesh-ancestor
154142205|NCT00132769|MK 0873|mk 0873|mesh-list
154142206|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154142207|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154142208|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142209|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142210|NCT02478255|Xenon|xenon|mesh-list
154142211|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154142212|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
154142213|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
154142214|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142215|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142216|NCT00132691|Cyclosporine|cyclosporine|mesh-list
154142217|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
154142218|NCT00132691|Infliximab|infliximab|mesh-list
154142219|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154142220|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
154142222|NCT00132691|Methotrexate|methotrexate|mesh-list
154142223|NCT00132691|Azathioprine|azathioprine|mesh-list
154142224|NCT00132691|Tacrolimus|tacrolimus|mesh-list
154142225|NCT00132691|Cyclosporins|cyclosporins|mesh-list
154142226|NCT00132691|Daclizumab|daclizumab|mesh-list
154142227|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154142228|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
154142252|NCT00132691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154142253|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142254|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142255|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
154142256|NCT00132691|Hormones|hormones|mesh-ancestor
154142257|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142258|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154142259|NCT00125359|Bexarotene|bexarotene|mesh-list
154142260|NCT00125359|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154142261|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154142262|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142263|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142264|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142265|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154142266|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154142267|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154142268|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142269|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142270|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154142271|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154142272|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154142273|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
154142274|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142275|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142276|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154142302|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142303|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142304|NCT06027970|Terlipressin|terlipressin|mesh-list
154142305|NCT06027970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154142306|NCT06027970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154142307|NCT06027151|Metronidazole|metronidazole|mesh-list
154142308|NCT06027151|Minocycline|minocycline|mesh-list
154142309|NCT06027151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142310|NCT06027151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154142311|NCT06027151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154142312|NCT06027151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154142313|NCT06027073|Omalizumab|omalizumab|mesh-list
154142314|NCT06027073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154142315|NCT06027073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154142316|NCT06027073|Respiratory System Agents|respiratory system agents|mesh-ancestor
154142317|NCT06026878|Gemcitabine|gemcitabine|mesh-list
154142318|NCT06026878|Nimotuzumab|nimotuzumab|mesh-list
154142319|NCT06026878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142320|NCT06026878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154142321|NCT06026878|Antimetabolites|antimetabolites|mesh-ancestor
154142322|NCT06026878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142323|NCT06026878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142324|NCT06026787|Dapagliflozin|dapagliflozin|mesh-list
154142325|NCT06026787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154142326|NCT06026787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142327|NCT06026787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154142346|NCT06026527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142348|NCT06026527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142349|NCT06026527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154142350|NCT06026527|Anticonvulsants|anticonvulsants|mesh-ancestor
153698031|NCT04720183|Analgesics|analgesics|mesh-ancestor
154142351|NCT06026527|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154142352|NCT06026527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154142353|NCT06026527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142354|NCT06026527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154142355|NCT06026527|Tocolytic Agents|tocolytic agents|mesh-ancestor
154142356|NCT06026527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154142357|NCT06005012|Semaglutide|semaglutide|mesh-list
154142358|NCT06005012|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154142359|NCT06005012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154142360|NCT06005012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142361|NCT05997199|Vitamin D|vitamin d|mesh-list
154142362|NCT05997199|Vitamins|vitamins|mesh-ancestor
154142363|NCT05997199|Micronutrients|micronutrients|mesh-ancestor
154142364|NCT05997199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142365|NCT05997199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154142366|NCT05980702|Paclitaxel|paclitaxel|mesh-list
154142367|NCT05980702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154142368|NCT05980702|Carboplatin|carboplatin|mesh-list
154142369|NCT05980702|Pembrolizumab|pembrolizumab|mesh-list
154142370|NCT05980702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154142371|NCT05980702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142372|NCT05980702|Tubulin Modulators|tubulin modulators|mesh-ancestor
154142373|NCT05980702|Antimitotic Agents|antimitotic agents|mesh-ancestor
154142374|NCT05980702|Mitosis Modulators|mitosis modulators|mesh-ancestor
154142375|NCT05980702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142376|NCT05980702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142377|NCT05980702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154142378|NCT05974748|Propolis|propolis|mesh-list
154142379|NCT05974748|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154142380|NCT05974748|Eusol|eusol|mesh-list
154142381|NCT05974748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142382|NCT05974748|Disinfectants|disinfectants|mesh-ancestor
154142383|NCT05959850|Ambroxol|ambroxol|mesh-list
154142400|NCT05938699|Lubricant Eye Drops|lubricant eye drops|mesh-list
154142401|NCT05938699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154142402|NCT05938699|Autonomic Agents|autonomic agents|mesh-ancestor
154142403|NCT05938699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142404|NCT05938699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142405|NCT05938699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154142406|NCT05938699|Respiratory System Agents|respiratory system agents|mesh-ancestor
154142407|NCT05938699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154142408|NCT05938699|Antioxidants|antioxidants|mesh-ancestor
154142409|NCT05938699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142410|NCT05938699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142411|NCT05938699|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154142412|NCT05938699|Vasodilator Agents|vasodilator agents|mesh-ancestor
154142413|NCT05938699|Gasotransmitters|gasotransmitters|mesh-ancestor
154142414|NCT05938699|Protective Agents|protective agents|mesh-ancestor
154142415|NCT05938699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154142416|NCT05938699|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154142417|NCT05938699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154142418|NCT05828095|MEDI9197|medi9197|mesh-list
154142419|NCT05828095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154142420|NCT05828095|Immunologic Factors|immunologic factors|mesh-ancestor
154142421|NCT05828095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142422|NCT05816356|Decitabine|decitabine|mesh-list
154142423|NCT05816356|Tetrahydrouridine|tetrahydrouridine|mesh-list
154142424|NCT05816356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154142425|NCT05816356|Antimetabolites|antimetabolites|mesh-ancestor
154142426|NCT05816356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142427|NCT05816356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142428|NCT05816356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142429|NCT05801757|Propofol|propofol|mesh-list
154142430|NCT05801757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153698091|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
154142431|NCT05801757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142432|NCT05801757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142433|NCT05801757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154142434|NCT05801757|Anesthetics, General|anesthetics, general|mesh-ancestor
154142435|NCT05801757|Anesthetics|anesthetics|mesh-ancestor
154142436|NCT05799755|Nintedanib|nintedanib|mesh-list
154142437|NCT05799755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142438|NCT05799755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154142439|NCT05799755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142440|NCT05799755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142441|NCT05796089|Carboplatin|carboplatin|mesh-list
154142442|NCT05796089|Etoposide|etoposide|mesh-list
154142460|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142461|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142462|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142463|NCT05692167|Analgesics|analgesics|mesh-ancestor
154142464|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
154142465|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142466|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154142467|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154142468|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154142469|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
154142470|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142471|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142472|NCT05650775|Methylphenidate|methylphenidate|mesh-list
154142473|NCT05650775|Adderall|adderall|mesh-list
154142474|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154142475|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142476|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154142477|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154142478|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154142479|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142480|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
154142481|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142482|NCT05630222|Acetaminophen|acetaminophen|mesh-list
154142483|NCT05630222|Ibuprofen|ibuprofen|mesh-list
154142484|NCT05630222|Morphine|morphine|mesh-list
154142485|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154142486|NCT05630222|Narcotics|narcotics|mesh-ancestor
154142487|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142488|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142489|NCT05630222|Analgesics|analgesics|mesh-ancestor
154142490|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
154142491|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142492|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142493|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
154142494|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154142495|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142496|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142497|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154142498|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652279|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
154142521|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142522|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142523|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154142526|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142527|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142528|NCT05523986|Vitamin D|vitamin d|mesh-list
154142529|NCT05523986|Vitamins|vitamins|mesh-ancestor
154142530|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
154142531|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142532|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154142533|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
154142534|NCT05501678|Promethazine|promethazine|mesh-list
154142535|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154142536|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154142537|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142538|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142539|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
154142540|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
154142541|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
154142542|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142543|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
154142545|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142546|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154142547|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
154142548|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
154142549|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142550|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142551|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154142563|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
154142564|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142565|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
154142566|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142567|NCT05488405|Mesalamine|mesalamine|mesh-list
154142568|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154142569|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142570|NCT05488405|Analgesics|analgesics|mesh-ancestor
154142571|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
154142572|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142573|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142574|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142575|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142576|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
154142577|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154142578|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154142579|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154142580|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154142581|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142582|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142583|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154142584|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154142585|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142586|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
154142587|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154256452|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
154142588|NCT05283980|Bupivacaine|bupivacaine|mesh-list
154142589|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
154142590|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
154142591|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142592|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142593|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
154142594|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142595|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
154142596|NCT05272254|Povidone|povidone|mesh-list
154142597|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
154142598|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
154142599|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154142600|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142602|NCT05264896|Docetaxel|docetaxel|mesh-list
154142603|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
154142604|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142605|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
154142606|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
154142607|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
154142608|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142609|NCT05264896|Antidotes|antidotes|mesh-ancestor
154142610|NCT05264896|Protective Agents|protective agents|mesh-ancestor
154142611|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142612|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
154142613|NCT05264896|Vitamins|vitamins|mesh-ancestor
154142614|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
154142615|NCT05248919|Sofosbuvir|sofosbuvir|mesh-list
154142616|NCT05248919|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154142617|NCT05248919|Velpatasvir|velpatasvir|mesh-list
154142618|NCT05248919|Antiviral Agents|antiviral agents|mesh-ancestor
154142619|NCT05248919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142620|NCT05228574|Amiloride|amiloride|mesh-list
154142635|NCT05176288|Palbociclib|palbociclib|mesh-list
154142636|NCT05176288|Avelumab|avelumab|mesh-list
154142637|NCT05176288|Axitinib|axitinib|mesh-list
154142638|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142639|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154142640|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142641|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142642|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142643|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
154142644|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
154142645|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142646|NCT05098028|Rifaximin|rifaximin|mesh-list
154142647|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154142648|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142649|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154142650|NCT05082753|Ivermectin|ivermectin|mesh-list
154142651|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154142652|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142653|NCT05081986|Cycloserine|cycloserine|mesh-list
154142654|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154142655|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142656|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154142657|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
154142658|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154142659|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
154142660|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142661|NCT05053737|Atezolizumab|atezolizumab|mesh-list
154142662|NCT05053737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154142663|NCT05053737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142664|NCT05053737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142665|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142666|NCT05021484|Felzartamab|felzartamab|mesh-list
154142667|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142668|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
154142669|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142670|NCT05019885|Ketamine|ketamine|mesh-list
154142671|NCT05019885|Analgesics|analgesics|mesh-ancestor
154142672|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
153788229|NCT00286143|Fentanyl|fentanyl|mesh-list
154142673|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142674|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142675|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154142676|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154142677|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
154142678|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
154142679|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142708|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154142709|NCT04899778|Estradiol|estradiol|mesh-list
154142710|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154142711|NCT04899778|Trace Elements|trace elements|mesh-ancestor
154142712|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
154142713|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142714|NCT04899778|Estrogens|estrogens|mesh-ancestor
154142715|NCT04899778|Hormones|hormones|mesh-ancestor
154142716|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142717|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154142718|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154142719|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154142720|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154142721|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154142722|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142723|NCT04892706|Analgesics|analgesics|mesh-ancestor
153698203|NCT02961166|Antibodies|antibodies|mesh-list
154142724|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
154142745|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142746|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142747|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154142748|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
154142749|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154142751|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142752|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154142753|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142754|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142755|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154142756|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154142757|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154142758|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
154142759|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
154142760|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142762|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
154142763|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154142764|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142765|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
154142766|NCT04802408|Protective Agents|protective agents|mesh-ancestor
154142767|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142768|NCT04740593|Methamphetamine|methamphetamine|mesh-list
154142769|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154142770|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142771|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
154142772|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
154142773|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142774|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
154142775|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142776|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142777|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
154142778|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154142779|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154142801|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154142802|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154142803|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142804|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142805|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154142806|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154142807|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
154142808|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142809|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142810|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154142811|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
154142812|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154142813|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154142814|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
154142815|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142816|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
153442754|NCT02109744|Decitabine|decitabine|mesh-list
154142818|NCT04666259|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154142819|NCT04666259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154142820|NCT04666259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142821|NCT04666259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142822|NCT04629547|Suvorexant|suvorexant|mesh-list
154142823|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154142824|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154142825|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154142826|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142827|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154142828|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142829|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142830|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
154142831|NCT04598074|Narcotics|narcotics|mesh-ancestor
153652623|NCT00037570|Pantoprazole|pantoprazole|mesh-list
154142865|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142867|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
153652673|NCT00037804|Irinotecan|irinotecan|mesh-list
154142902|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154142903|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142904|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154142905|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142923|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142924|NCT04420598|Trastuzumab|trastuzumab|mesh-list
154142925|NCT04420598|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154142926|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142927|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142928|NCT04420598|Immunoconjugates|immunoconjugates|mesh-ancestor
154142929|NCT04420598|Immunologic Factors|immunologic factors|mesh-ancestor
154142930|NCT04420598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142931|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
154142932|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142933|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154142934|NCT04369937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154142935|NCT04369937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142936|NCT04312360|Metronidazole|metronidazole|mesh-list
154142937|NCT04312360|Fosfomycin|fosfomycin|mesh-list
154142938|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154142939|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154142940|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154142941|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154142942|NCT04272372|Ketoprofen|ketoprofen|mesh-list
154142943|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154142944|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142945|NCT04272372|Analgesics|analgesics|mesh-ancestor
154142946|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
154142947|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142948|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142949|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154142950|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154142951|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154142952|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142953|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142954|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154142955|NCT04256473|Saruplase|saruplase|mesh-list
154142956|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154142957|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154142958|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142959|NCT04198363|Amoxicillin|amoxicillin|mesh-list
154142960|NCT04198363|Clarithromycin|clarithromycin|mesh-list
154142961|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
154142962|NCT04198363|Esomeprazole|esomeprazole|mesh-list
154142963|NCT04198363|Bismuth|bismuth|mesh-list
153652747|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154142979|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
154142980|NCT04195828|Paclitaxel|paclitaxel|mesh-list
154142981|NCT04195828|Apatinib|apatinib|mesh-list
154142982|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154142983|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154142984|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
154142985|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
154142986|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
154142987|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154142988|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154142989|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154142990|NCT04173247|Mineral Oil|mineral oil|mesh-list
154142991|NCT04173247|Emollients|emollients|mesh-ancestor
154142993|NCT04093219|Acetaminophen|acetaminophen|mesh-list
154142994|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154142995|NCT04093219|Analgesics|analgesics|mesh-ancestor
154142996|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
154142997|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154142998|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154142999|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
154143000|NCT04046107|Cemiplimab|cemiplimab|mesh-list
154143001|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143002|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143003|NCT03896737|Thalidomide|thalidomide|mesh-list
154143004|NCT03896737|Dexamethasone|dexamethasone|mesh-list
154143005|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
154143006|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
154143007|NCT03896737|Bortezomib|bortezomib|mesh-list
154143008|NCT03896737|Daratumumab|daratumumab|mesh-list
154143009|NCT03896737|BB 1101|bb 1101|mesh-list
154143010|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143011|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
154143012|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143013|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143014|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154143015|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
154143016|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143017|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143018|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154143019|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143020|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
154143021|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
154143022|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143023|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143024|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
154143025|NCT03896737|Hormones|hormones|mesh-ancestor
153652805|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154143059|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143061|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143062|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154143063|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154143064|NCT03773107|Dexamethasone|dexamethasone|mesh-list
154143065|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143066|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
154143077|NCT03743766|Relatlimab|relatlimab|mesh-list
154143078|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143079|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143080|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154143081|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143082|NCT03716180|Paclitaxel|paclitaxel|mesh-list
154143083|NCT03716180|Trastuzumab|trastuzumab|mesh-list
154143084|NCT03716180|Pertuzumab|pertuzumab|mesh-list
154143085|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154143086|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143087|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
154143088|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
154143089|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
154143090|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143091|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143092|NCT03696199|Anesthetics|anesthetics|mesh-list
153698329|NCT00252655|Sirolimus|sirolimus|mesh-list
154143093|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143094|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143095|NCT03566667|Metoprolol|metoprolol|mesh-list
154143096|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154143097|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154143098|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
154143099|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
154143100|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143101|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143102|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154143103|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154143104|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154143105|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
154143106|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143107|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143108|NCT03514589|Cosyntropin|cosyntropin|mesh-list
154143109|NCT03514589|Hormones|hormones|mesh-ancestor
154143110|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143111|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143112|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154143113|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154143114|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143115|NCT03475810|Midazolam|midazolam|mesh-list
154143116|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154143117|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154143118|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143119|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143120|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154143121|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154143122|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154143123|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154143124|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
154143126|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
154143127|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
154143128|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143129|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143130|NCT03443856|Nivolumab|nivolumab|mesh-list
154143131|NCT03443856|Ipilimumab|ipilimumab|mesh-list
154143143|NCT03389750|Analgesics|analgesics|mesh-ancestor
154143144|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
154143145|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143146|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154143147|NCT03328884|Irinotecan|irinotecan|mesh-list
154143148|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154143149|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154143150|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143151|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143152|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143153|NCT03156036|Capecitabine|capecitabine|mesh-list
154143154|NCT03156036|Temozolomide|temozolomide|mesh-list
154143155|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154143156|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
154143157|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143158|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143159|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154143160|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
154143161|NCT02873338|Cytarabine|cytarabine|mesh-list
154143162|NCT02873338|Idarubicin|idarubicin|mesh-list
154143163|NCT02873338|Heparin|heparin|mesh-list
154143164|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154143165|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
154143166|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143167|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143168|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
154143169|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154143170|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143171|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
154143172|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143173|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
154143174|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154143175|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154143176|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154143177|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154143178|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154143179|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143180|NCT02864147|Imiquimod|imiquimod|mesh-list
154143181|NCT02864147|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154143182|NCT02864147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143183|NCT02864147|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154143184|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
154143185|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143187|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143188|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
154143189|NCT02863055|Nintedanib|nintedanib|mesh-list
154143190|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143191|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154143192|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143193|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143212|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154143213|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154143214|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143215|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154143216|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
154143217|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
154143218|NCT02209545|Pyridoxine|pyridoxine|mesh-list
154143219|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
154143220|NCT02209545|Misoprostol|misoprostol|mesh-list
154143221|NCT02209545|Vitamins|vitamins|mesh-ancestor
154143222|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
154143223|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143224|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154143225|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
154143226|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154143227|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154143228|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143229|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
154143230|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
154143231|NCT02108964|Nazartinib|nazartinib|mesh-list
154143232|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143233|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154143234|NCT01976065|Metronidazole|metronidazole|mesh-list
154143235|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
154143236|NCT01976065|Minocycline|minocycline|mesh-list
154143237|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154143238|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154143239|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154143240|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154143241|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154143242|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698486|NCT00253903|SR 46349B|sr 46349b|mesh-list
154143243|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143244|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143245|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154143246|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154143247|NCT01921335|Trastuzumab|trastuzumab|mesh-list
154143248|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143249|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143250|NCT01797523|Metformin|metformin|mesh-list
154143251|NCT01797523|Everolimus|everolimus|mesh-list
154143264|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154143265|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
154143266|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143267|NCT01669824|Aspirin|aspirin|mesh-list
154143268|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154143269|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154143271|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
154143272|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143273|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143274|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143275|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143276|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154143277|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154143278|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143279|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154143280|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154143281|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143282|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
154143283|NCT01472562|Rituximab|rituximab|mesh-list
154143284|NCT01472562|Lenalidomide|lenalidomide|mesh-list
154143285|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143286|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143287|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
154143288|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143289|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143290|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154143291|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154143293|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
154143294|NCT01196390|Paclitaxel|paclitaxel|mesh-list
154143295|NCT01196390|Carboplatin|carboplatin|mesh-list
154143296|NCT01196390|Trastuzumab|trastuzumab|mesh-list
154143297|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154143298|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154143299|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154143300|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143301|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
154143302|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
154143303|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
154143304|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143305|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143306|NCT01164995|Carboplatin|carboplatin|mesh-list
154143307|NCT01164995|Adavosertib|adavosertib|mesh-list
153698564|NCT00254800|Exenatide|exenatide|mesh-list
154143308|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143309|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143310|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143311|NCT01156129|Bisacodyl|bisacodyl|mesh-list
154143312|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154143313|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143314|NCT01156129|Cathartics|cathartics|mesh-ancestor
154143315|NCT01156129|Laxatives|laxatives|mesh-ancestor
154143348|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
154143349|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
154143350|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143351|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143353|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153698624|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143354|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143355|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
154143356|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143357|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143358|NCT00493831|Nicotine|nicotine|mesh-list
154143359|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154143360|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
154143361|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143385|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154143386|NCT00004197|Vaccines|vaccines|mesh-list
154143387|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143388|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
154143389|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143390|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143391|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154143392|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
154143393|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143394|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143395|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154143396|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154143397|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154143398|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154143399|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143400|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143401|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
154143402|NCT00004197|Hormones|hormones|mesh-ancestor
154143403|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143404|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143405|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153698625|NCT00254917|Vaccines|vaccines|mesh-list
154143406|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
154143407|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
154143408|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
154143409|NCT00004197|Analgesics|analgesics|mesh-ancestor
154143410|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
154143411|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143412|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153698628|NCT00254956|Ciclesonide|ciclesonide|mesh-list
154143413|NCT03865407|Allopurinol|allopurinol|mesh-list
154143414|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
154143415|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143427|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154143428|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154143429|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143431|NCT00132301|Docetaxel|docetaxel|mesh-list
154143432|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143433|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
154143447|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154143448|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143450|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
154143451|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143452|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143453|NCT00131911|Sorafenib|sorafenib|mesh-list
154143454|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143455|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154143456|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143457|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143458|NCT00184093|Gemcitabine|gemcitabine|mesh-list
154143459|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154143460|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
154143461|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143462|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143463|NCT01074619|Memantine|memantine|mesh-list
154143464|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154143465|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154143466|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
154143467|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143468|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143469|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143470|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154143471|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154143472|NCT00183625|Olanzapine|olanzapine|mesh-list
154143473|NCT00183625|Risperidone|risperidone|mesh-list
154143474|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154143475|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
154143476|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153653252|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
154143488|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143489|NCT00183625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154143490|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154143491|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154143492|NCT00511875|Doxycycline|doxycycline|mesh-list
154143493|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154143494|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154143495|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
154143496|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154143497|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154143498|NCT02576327|Dexamethasone|dexamethasone|mesh-list
154143499|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
154143500|NCT02576327|Aprepitant|aprepitant|mesh-list
154143501|NCT02576327|Tropisetron|tropisetron|mesh-list
154143502|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154143503|NCT02576327|BB 1101|bb 1101|mesh-list
154143504|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143505|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
154143506|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
154143507|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143508|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143509|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143510|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
154143511|NCT02576327|Hormones|hormones|mesh-ancestor
154143512|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143513|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143514|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143515|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
154143516|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143517|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143518|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154143519|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143520|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154143521|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154143522|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
154143523|NCT00183391|Methylphenidate|methylphenidate|mesh-list
154143524|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154143525|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154143526|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143527|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154143528|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154143529|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154143530|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143531|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
154143532|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143533|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154143534|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
154143535|NCT00493246|Acetaminophen|acetaminophen|mesh-list
154143536|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154143537|NCT00493246|Analgesics|analgesics|mesh-ancestor
154143538|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
154143539|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143561|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143562|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154143563|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143564|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154143565|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154143566|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154143567|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154143568|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154143569|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
154143570|NCT03997006|Protective Agents|protective agents|mesh-ancestor
154143572|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154143573|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
154143574|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
154143575|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143576|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143577|NCT03996538|Metformin|metformin|mesh-list
154143578|NCT03996538|Vaccines|vaccines|mesh-list
154143579|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
154143580|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143581|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154143582|NCT02576015|Lidocaine|lidocaine|mesh-list
154143583|NCT02576015|Ropivacaine|ropivacaine|mesh-list
154143584|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
154143585|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
154143586|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143587|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143588|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
154143589|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143590|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154143591|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154143592|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154143593|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154143594|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143595|NCT02577965|Everolimus|everolimus|mesh-list
154143596|NCT02577965|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154143604|NCT00182689|Sorafenib|sorafenib|mesh-list
154143605|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143606|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154143607|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143608|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143609|NCT02578121|Dexamethasone|dexamethasone|mesh-list
154143610|NCT02578121|Pomalidomide|pomalidomide|mesh-list
154143611|NCT02578121|Ixazomib|ixazomib|mesh-list
154143612|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143613|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
154143614|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
154143615|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143616|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143617|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143618|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
154143619|NCT02578121|Hormones|hormones|mesh-ancestor
154143620|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143621|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143622|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143623|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
154143624|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154143625|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154143626|NCT02578121|Growth Substances|growth substances|mesh-ancestor
154143627|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
154143628|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
154143629|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143630|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143631|NCT00487240|Insulin|insulin|mesh-list
154143632|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154143633|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
154143634|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
154143635|NCT00487240|Protamines|protamines|mesh-list
154143636|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154143637|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143638|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
154143639|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143640|NCT00487240|Coagulants|coagulants|mesh-ancestor
154143641|NCT02577809|Indomethacin|indomethacin|mesh-list
154143642|NCT02577809|Fentanyl|fentanyl|mesh-list
154143643|NCT02577809|Morphine|morphine|mesh-list
154143644|NCT02577809|Bupivacaine|bupivacaine|mesh-list
154143645|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
154143646|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
154143647|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143648|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143649|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
154143650|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143651|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154143653|NCT02577809|Analgesics|analgesics|mesh-ancestor
154143654|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154143655|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154143656|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
154143657|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154143658|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154143659|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143660|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143661|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
154143663|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154143664|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154143665|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653437|NCT00016341|Tamoxifen|tamoxifen|mesh-list
154143679|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143681|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154143682|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143683|NCT03871959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154143684|NCT03871959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143685|NCT00487084|Lidocaine|lidocaine|mesh-list
154143686|NCT00487084|Morphine|morphine|mesh-list
154143687|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
154143688|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
154143689|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143690|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143691|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
154143692|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143693|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154143694|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154143695|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154143696|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154143697|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143698|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154143699|NCT00487084|Narcotics|narcotics|mesh-ancestor
154143700|NCT00487084|Analgesics|analgesics|mesh-ancestor
154143701|NCT00466726|Sargramostim|sargramostim|mesh-list
154143702|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
154143703|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143704|NCT01721291|Albuterol|albuterol|mesh-list
154143705|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154143706|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
154143707|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143708|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143709|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154143710|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
154143711|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
154143712|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154143713|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154143714|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154143715|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154143716|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
154143717|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143718|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143719|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154143720|NCT01021540|Hormones|hormones|mesh-ancestor
154143721|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789228|NCT01683175|Cisplatin|cisplatin|mesh-list
154143722|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143723|NCT04840511|Lidocaine|lidocaine|mesh-list
154143724|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
154143738|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
154143739|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143740|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143741|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143742|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
154143743|NCT02199665|Hormones|hormones|mesh-ancestor
154143744|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143745|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143746|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143747|NCT01021696|Acetaminophen|acetaminophen|mesh-list
154143748|NCT01021696|Pregabalin|pregabalin|mesh-list
154143749|NCT01021696|Morphine|morphine|mesh-list
154143750|NCT01021696|Buprenorphine|buprenorphine|mesh-list
154143751|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154143752|NCT01021696|Narcotics|narcotics|mesh-ancestor
154143753|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154143754|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143755|NCT01021696|Analgesics|analgesics|mesh-ancestor
154143756|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
154143757|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143758|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
154143759|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154256453|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143760|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154143761|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143762|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154143763|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154143764|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154143765|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154143766|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154143767|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
154143768|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154143769|NCT02577575|Oxytocin|oxytocin|mesh-list
154143770|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
154143771|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154143772|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143774|NCT00485758|Niacinamide|niacinamide|mesh-list
154143775|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
154143776|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154143777|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
154143778|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143779|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154143780|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
154143781|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
154143782|NCT00485758|Vitamins|vitamins|mesh-ancestor
154143783|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
154143784|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143785|NCT02577341|Docetaxel|docetaxel|mesh-list
154143786|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
154143805|NCT02577497|Hormones|hormones|mesh-ancestor
154143806|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143807|NCT02575859|Cisplatin|cisplatin|mesh-list
154143808|NCT02575859|Mitomycins|mitomycins|mesh-list
154143809|NCT02575859|Mitomycin|mitomycin|mesh-list
154143810|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143811|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154143812|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
154143813|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143814|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154143815|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143816|NCT00469456|Memantine|memantine|mesh-list
154143817|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154143818|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154143819|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
154143820|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154143821|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143822|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467341|NCT00428922|Docetaxel|docetaxel|mesh-list
154143823|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154143824|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154143825|NCT00581555|Etanercept|etanercept|mesh-list
154143826|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154143827|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154143828|NCT00581555|Analgesics|analgesics|mesh-ancestor
154143829|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
154143830|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143831|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143832|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143833|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143834|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143835|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143836|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
154143837|NCT00469144|Fludarabine|fludarabine|mesh-list
154143838|NCT00469144|Busulfan|busulfan|mesh-list
154143839|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143840|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143841|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143842|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
154143868|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
154143869|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143870|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154143871|NCT00468910|Aspirin|aspirin|mesh-list
154143872|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154143873|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154143874|NCT00468910|Analgesics|analgesics|mesh-ancestor
154143875|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
154256455|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
154143876|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154143877|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143878|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154143879|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143880|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154143881|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154143882|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143883|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154143884|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154143885|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143886|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
154143887|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
154143888|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154143889|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154143890|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154143891|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154143892|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143909|NCT00519285|Hormones|hormones|mesh-ancestor
154143910|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143911|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143912|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143913|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154143914|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154143915|NCT00519285|Growth Substances|growth substances|mesh-ancestor
154143916|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
154143917|NCT00464620|Dasatinib|dasatinib|mesh-list
154143918|NCT00464620|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154143919|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154143920|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143921|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143922|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143923|NCT05212857|Leuprolide|leuprolide|mesh-list
154143924|NCT05212857|Goserelin|goserelin|mesh-list
154143925|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154143926|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
154143927|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154143928|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
154143929|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154143930|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143931|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154143932|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143933|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154143934|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143935|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143936|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
154157358|NCT05858671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143937|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154143938|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154143939|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
154143940|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154143941|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
154143942|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154143943|NCT02099123|Atorvastatin|atorvastatin|mesh-list
154143944|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154143945|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154143946|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
154143947|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143948|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154143949|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154143950|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143952|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154143953|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154143965|NCT00464308|Esomeprazole|esomeprazole|mesh-list
154143966|NCT00464308|Rabeprazole|rabeprazole|mesh-list
154143967|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154143968|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154143969|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154143970|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154143971|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143972|NCT00463840|Fluorouracil|fluorouracil|mesh-list
154143973|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
153524297|NCT01462006|Sirolimus|sirolimus|mesh-list
154143974|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
154143975|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143976|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154143977|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143978|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143979|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
154143980|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143982|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
154143983|NCT00129389|Doxorubicin|doxorubicin|mesh-list
154143984|NCT00129389|Fluorouracil|fluorouracil|mesh-list
154143985|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154143986|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154143987|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
154143988|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
154143989|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
154143990|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154143991|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154143992|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
154143993|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154143994|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154143995|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154143996|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
154143997|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154143998|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154143999|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154144000|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154144001|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144002|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
154144003|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144004|NCT00468052|Fentanyl|fentanyl|mesh-list
154144005|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
154144006|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154144007|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154144008|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144009|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154144010|NCT00468052|Analgesics|analgesics|mesh-ancestor
154144011|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
154144012|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144013|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154144014|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154144015|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154144016|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
154144017|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144018|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144068|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
154144069|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
154144070|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144071|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144072|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154144073|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
154144074|NCT00555906|Hormones|hormones|mesh-ancestor
154144075|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154144076|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154144077|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144078|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144079|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144080|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144081|NCT04071353|Interferons|interferons|mesh-list
154144082|NCT04071353|Ribavirin|ribavirin|mesh-list
154144083|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144084|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
154144085|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144086|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
154144087|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144088|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
154144089|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154144090|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144091|NCT00555672|Fluorouracil|fluorouracil|mesh-list
154144092|NCT00555672|Sunitinib|sunitinib|mesh-list
154144093|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144094|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
154144095|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144096|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144097|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256456|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
153901775|NCT05816616|Xenon|xenon|mesh-list
154144098|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
154144099|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144100|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154144101|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154144102|NCT00555672|Growth Substances|growth substances|mesh-ancestor
154144103|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
154144104|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144105|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144106|NCT02575547|Docetaxel|docetaxel|mesh-list
154144107|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144108|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
154144109|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
154144110|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
154144111|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144112|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
154144113|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
154144114|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144115|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144116|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154144117|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
154144118|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
154144119|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154144120|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154144121|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144135|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
154144136|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144137|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144138|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
154144139|NCT03958656|Fludarabine|fludarabine|mesh-list
154144140|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144141|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
154144142|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144143|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154144144|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154144145|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
154144146|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144147|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144148|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154144149|NCT00561912|Interferons|interferons|mesh-list
154144150|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
154144151|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
154144152|NCT00561912|Decitabine|decitabine|mesh-list
154144153|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144154|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
154144155|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144156|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
154144157|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144158|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144159|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
154144160|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144161|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144162|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
154144163|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154144164|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154144165|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144166|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154144167|NCT00561678|Analgesics|analgesics|mesh-ancestor
154144168|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
154144169|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144170|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154144171|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154144172|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154144173|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
154144174|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144175|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144177|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
154144178|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
154144179|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154144180|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154144181|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153653974|NCT00040690|Leucovorin|leucovorin|mesh-list
153443208|NCT02036502|Hormones|hormones|mesh-ancestor
154144191|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154144192|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
154144194|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154144195|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144196|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154144197|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154144198|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154144199|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
154144200|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144201|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154144202|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154144203|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144204|NCT03961308|Vedolizumab|vedolizumab|mesh-list
154144205|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154144206|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154144207|NCT00956436|Sorafenib|sorafenib|mesh-list
154144208|NCT00956436|Liver Extracts|liver extracts|mesh-list
154144209|NCT00956436|Antibodies|antibodies|mesh-list
154144210|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
154144211|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154144212|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
154144213|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144214|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144215|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144216|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144217|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144218|NCT00956436|Hematinics|hematinics|mesh-ancestor
154144219|NCT00950586|Levomethorphan|levomethorphan|mesh-list
154144220|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
154144221|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
154144222|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
154144223|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154144224|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154144225|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144226|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144227|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144228|NCT00950586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154144229|NCT00950586|Narcotics|narcotics|mesh-ancestor
154144230|NCT00950586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154144231|NCT00950586|Analgesics|analgesics|mesh-ancestor
154144232|NCT00950586|Sensory System Agents|sensory system agents|mesh-ancestor
154144233|NCT00950586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144234|NCT00467896|Iloprost|iloprost|mesh-list
154144235|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154144236|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
154144237|NCT00946686|Leflunomide|leflunomide|mesh-list
154144238|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144239|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144240|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144241|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
154144242|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144243|NCT02531737|Docetaxel|docetaxel|mesh-list
154144244|NCT02531737|Nintedanib|nintedanib|mesh-list
154144245|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144246|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654024|NCT00040885|Docetaxel|docetaxel|mesh-list
154144264|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144265|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
154144266|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154144267|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144268|NCT00467740|Olodaterol|olodaterol|mesh-list
154144269|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154144270|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
154144271|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144272|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144273|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154144274|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
154144276|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
154144277|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154144278|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154144279|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144280|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144281|NCT00710099|Urological Agents|urological agents|mesh-ancestor
154144282|NCT03944044|Acetaminophen|acetaminophen|mesh-list
154144283|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154144284|NCT03944044|Analgesics|analgesics|mesh-ancestor
154144285|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
154144286|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144287|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144288|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
154144289|NCT00714623|Sirolimus|sirolimus|mesh-list
154144290|NCT00714623|Temsirolimus|temsirolimus|mesh-list
154144291|NCT00714623|MTOR Inhibitors|mtor inhibitors|mesh-list
154144292|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154144293|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144294|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154144295|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144296|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
154144297|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144298|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
154144299|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144300|NCT00714623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144301|NCT00714623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144302|NCT00714623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144303|NCT00553254|Dacomitinib|dacomitinib|mesh-list
154144304|NCT00553254|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154144305|NCT00553254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144323|NCT01021930|Paclitaxel|paclitaxel|mesh-list
154144324|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154144325|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144326|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
154144327|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
154144328|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
154144329|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144330|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154144331|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144332|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154144333|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
154144334|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144335|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
154144336|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144337|NCT00946764|Imipramine|imipramine|mesh-list
154144338|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154144339|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
154144340|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154144341|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154144342|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154144343|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154144344|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144345|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
154144346|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144347|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144348|NCT00950820|Capecitabine|capecitabine|mesh-list
154144349|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
154144350|NCT00950820|Panitumumab|panitumumab|mesh-list
154144351|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144352|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
154144353|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144354|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144355|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154144357|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154144358|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144359|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154144360|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144361|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144362|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154144363|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154144371|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144373|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154144374|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
154144375|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144377|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154144378|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154144379|NCT00467584|Analgesics|analgesics|mesh-ancestor
154144380|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
154144381|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144382|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144383|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154144384|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154144385|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154144386|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154144387|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144388|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154144389|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154144390|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144391|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
154144392|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
154144393|NCT02574611|Neostigmine|neostigmine|mesh-list
154144394|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154144395|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789898|NCT01600807|Gemcitabine|gemcitabine|mesh-list
154144396|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144398|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144399|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144400|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154144401|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
154144402|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144403|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154144404|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154144405|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154144406|NCT00714779|Fluoxetine|fluoxetine|mesh-list
154144407|NCT00714779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154144408|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154144409|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154144410|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144411|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144412|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
154144413|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144414|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154144415|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
154144416|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154144417|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154144418|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154144419|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144420|NCT00168103|Complement C1s|complement c1s|mesh-list
154144421|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154144422|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154144423|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
154144424|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144425|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154144426|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144427|NCT00463060|Sunitinib|sunitinib|mesh-list
154144428|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144429|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154144430|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154144444|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144445|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154144446|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
154144447|NCT00956748|Hormones|hormones|mesh-ancestor
154144448|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154144449|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154144450|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144451|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144452|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144453|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
154144454|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144455|NCT00956748|Expectorants|expectorants|mesh-ancestor
154144456|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
154144457|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154144458|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
154144459|NCT00956748|Protective Agents|protective agents|mesh-ancestor
154144460|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154144461|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154144462|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154144463|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154144464|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154144465|NCT01079923|Vitamin D|vitamin d|mesh-list
154144466|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
154144467|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
154144468|NCT01079923|Vitamins|vitamins|mesh-list
154144470|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144471|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154144472|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154144473|NCT00947076|Fluoxetine|fluoxetine|mesh-list
154144474|NCT00947076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154144475|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154144476|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154144477|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144478|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144479|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
154144480|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144481|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154144482|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
154144483|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154144484|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154144485|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154144486|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144487|NCT00462982|Sunitinib|sunitinib|mesh-list
154144488|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144489|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154144490|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154144491|NCT00462982|Growth Substances|growth substances|mesh-ancestor
154144492|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144506|NCT02573597|Narcotics|narcotics|mesh-ancestor
154144507|NCT02573597|Analgesics|analgesics|mesh-ancestor
154144508|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154144509|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154144510|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
154144511|NCT05300958|Deferoxamine|deferoxamine|mesh-list
154144512|NCT05300958|Siderophores|siderophores|mesh-ancestor
154144513|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154144514|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
154144515|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
154144516|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144517|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
154144518|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154144519|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
154144520|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144521|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
154144522|NCT04070729|Protective Agents|protective agents|mesh-ancestor
154144523|NCT00467272|Daptomycin|daptomycin|mesh-list
154144524|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154144525|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144526|NCT00956982|Interferons|interferons|mesh-list
154144527|NCT00956982|Ribavirin|ribavirin|mesh-list
154144528|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
154144529|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
154144530|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154144531|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144532|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
154144533|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144534|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
154144535|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144536|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
154144537|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144538|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
154144539|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154144540|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154144541|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790045|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
154144542|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154144543|NCT00714857|Analgesics|analgesics|mesh-ancestor
154144544|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
154144545|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144546|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154144547|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154144548|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154144549|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
154144550|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144551|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144552|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154144553|NCT00957060|Glimepiride|glimepiride|mesh-list
154144566|NCT02573519|Acetylcholine|acetylcholine|mesh-list
154144567|NCT02573519|Donepezil|donepezil|mesh-list
154144568|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154144569|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154144571|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144572|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
154144573|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144574|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144575|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
154144576|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
154144577|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154144578|NCT02572583|Oseltamivir|oseltamivir|mesh-list
154144579|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
154144580|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144581|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144582|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144583|NCT00951444|Carboplatin|carboplatin|mesh-list
154144584|NCT00951444|Gemcitabine|gemcitabine|mesh-list
154144585|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144586|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144587|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
154144588|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144589|NCT00462826|Aflibercept|aflibercept|mesh-list
154144590|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
154144591|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154144592|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154144593|NCT00462826|Growth Substances|growth substances|mesh-ancestor
154144594|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144595|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
154144596|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144597|NCT00718601|Imetelstat|imetelstat|mesh-list
154144598|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
154144599|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144600|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144601|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154144602|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154144603|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
154144604|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154144605|NCT00947388|Antibodies|antibodies|mesh-list
154144606|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
154144607|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154144608|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
154144609|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144610|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144611|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154144612|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
154144613|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144614|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
154144615|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
153654396|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144631|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
154144632|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144633|NCT00957216|Vitamins|vitamins|mesh-ancestor
154144634|NCT00718757|Dexamethasone|dexamethasone|mesh-list
154144635|NCT00718757|Irinotecan|irinotecan|mesh-list
154144636|NCT00718757|Vincristine|vincristine|mesh-list
154144637|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154144638|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
154144639|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
154144640|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144641|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144642|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154144643|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
154144645|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154144646|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154144647|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144648|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154144649|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154144650|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144651|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144652|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154144653|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
154144654|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
154144655|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
154144656|NCT00947466|Buprenorphine|buprenorphine|mesh-list
154144657|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154144658|NCT00947466|Narcotics|narcotics|mesh-ancestor
154144659|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154144660|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144661|NCT00947466|Analgesics|analgesics|mesh-ancestor
154144662|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
154144663|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144664|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154144665|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154144666|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
154144667|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144668|NCT00951834|Protective Agents|protective agents|mesh-ancestor
153700146|NCT00102141|Diuretics|diuretics|mesh-ancestor
154144669|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144670|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154144671|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154144672|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144673|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154144706|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144707|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154144708|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154144709|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154144710|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154144711|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144712|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154144713|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
154144714|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154144715|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
154144716|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154144730|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154144731|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154144732|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144733|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154144734|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
154144735|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154144736|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
154144737|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144738|NCT00549198|Tenofovir|tenofovir|mesh-list
154144739|NCT00549198|Lamivudine|lamivudine|mesh-list
154144740|NCT00549198|Emtricitabine|emtricitabine|mesh-list
154144741|NCT00549198|Efavirenz|efavirenz|mesh-list
154144742|NCT00549198|Abacavir|abacavir|mesh-list
154144743|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
154144744|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144745|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154144746|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154144747|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144748|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144749|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154144750|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154144751|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154144752|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154144753|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154144754|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154144755|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154144756|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154144757|NCT00506415|Rivastigmine|rivastigmine|mesh-list
154144758|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154144759|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144760|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144761|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
154144762|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144763|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144764|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154144765|NCT00506415|Protective Agents|protective agents|mesh-ancestor
154144766|NCT04036526|Vaccines|vaccines|mesh-list
154144767|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
154144768|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144769|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154144770|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
154144771|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144772|NCT01009437|Ritonavir|ritonavir|mesh-list
154144773|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154144774|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154144775|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
154144776|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144777|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144778|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154144779|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154144780|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
154144792|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153468293|NCT06298383|Analgesics|analgesics|mesh-ancestor
154144793|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154144794|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154144795|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144796|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154144797|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154144798|NCT00952302|Iron|iron|mesh-list
154144799|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154144800|NCT00952302|Trace Elements|trace elements|mesh-ancestor
154144801|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
154144802|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144803|NCT00952302|Hematinics|hematinics|mesh-ancestor
154144804|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154144805|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
154144806|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154144807|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154144808|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154144809|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154144810|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144811|NCT05300334|Adenosine|adenosine|mesh-list
154144812|NCT05300334|Analgesics|analgesics|mesh-ancestor
154144813|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
154144814|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144815|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144816|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154144817|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
154144818|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154144819|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
154144820|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
154144821|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144822|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144823|NCT00897884|Metformin|metformin|mesh-list
154144824|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154144825|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144826|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154144827|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
154144828|NCT01022164|Coagulants|coagulants|mesh-ancestor
154144829|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154144830|NCT01012479|Candesartan|candesartan|mesh-list
154144831|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
154144832|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154144833|NCT01012479|Diuretics|diuretics|mesh-ancestor
154144834|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
154144835|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144836|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154144837|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154144838|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144839|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154144840|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154144841|NCT02541734|Exenatide|exenatide|mesh-list
154144842|NCT02541734|Polygeline|polygeline|mesh-list
154144843|NCT02541734|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153443347|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
154144844|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154144873|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144874|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154144875|NCT00948168|Incretins|incretins|mesh-ancestor
154144876|NCT00948168|Hormones|hormones|mesh-ancestor
154144877|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154144878|NCT00958386|Irinotecan|irinotecan|mesh-list
154144879|NCT00958386|Panitumumab|panitumumab|mesh-list
154144880|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154144881|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154144882|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144883|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144884|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144885|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154144886|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
154144887|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154144888|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
153654691|NCT00044551|Taxane|taxane|mesh-list
154144906|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144907|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154144908|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154144909|NCT05352126|Disinfectants|disinfectants|mesh-list
154144910|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144911|NCT00948480|Sargramostim|sargramostim|mesh-list
154144912|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
154144913|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144914|NCT00606086|Interferons|interferons|mesh-list
154144915|NCT00606086|Ribavirin|ribavirin|mesh-list
154144916|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154144917|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
154144918|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144919|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
154144920|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144921|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
154144922|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144923|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
154144924|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144925|NCT02573363|Cytarabine|cytarabine|mesh-list
154144926|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
154144927|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144928|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
154144929|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144930|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144931|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
154144932|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154144933|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144934|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
154144935|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144936|NCT02573363|Analgesics|analgesics|mesh-ancestor
154144937|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
154144938|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144939|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154144940|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154144941|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144942|NCT00715637|Cytarabine|cytarabine|mesh-list
154144943|NCT00715637|Amonafide|amonafide|mesh-list
154144944|NCT00715637|Daunorubicin|daunorubicin|mesh-list
154144945|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144946|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
154144947|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144961|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154144963|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
154144964|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154144965|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144966|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144967|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154144968|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154144969|NCT00893594|Analgesics|analgesics|mesh-ancestor
154144970|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
154144971|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154144972|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154144973|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154144974|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
154144975|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154144976|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154144978|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154144979|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
154144980|NCT00715715|Hormones|hormones|mesh-ancestor
154144981|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154144982|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144983|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154144984|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144985|NCT00953394|Octreotide|octreotide|mesh-list
154144986|NCT00953394|Fluorouracil|fluorouracil|mesh-list
154144987|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154144988|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154144989|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154144990|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
154144991|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154144992|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154144993|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154144994|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
154144995|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144997|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154144998|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154144999|NCT00898508|Antibodies|antibodies|mesh-list
154145000|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
154145001|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145002|NCT00609986|Insulin|insulin|mesh-list
154145003|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154145004|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
154145005|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
154145006|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
154145007|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
154145008|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154145009|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145010|NCT00715871|Nicotine|nicotine|mesh-list
154145031|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
154145032|NCT00712049|Vitamins|vitamins|mesh-ancestor
154145033|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
154145034|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145035|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
154145036|NCT00712205|Calcitriol|calcitriol|mesh-list
154145037|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154145038|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145039|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154145040|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154145041|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145042|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154145043|NCT00712205|Vitamins|vitamins|mesh-ancestor
154145044|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
154145045|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154145046|NCT00451906|Bevacizumab|bevacizumab|mesh-list
154145047|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154145048|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145049|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154145050|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154145051|NCT00451906|Growth Substances|growth substances|mesh-ancestor
154145052|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145053|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
154145054|NCT04070495|Clarithromycin|clarithromycin|mesh-list
154145055|NCT04070495|Rifampin|rifampin|mesh-list
154145056|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154145057|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145058|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154145059|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145060|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145061|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154145062|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154145063|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154145064|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
154145065|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
153654854|NCT00018291|Gabapentin|gabapentin|mesh-list
154145084|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154145085|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145086|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902008|NCT04941573|Xenon|xenon|mesh-list
154145087|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
154145088|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154145089|NCT00716183|Amoxicillin|amoxicillin|mesh-list
154145090|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
154145091|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
154145092|NCT00716183|Lactams|lactams|mesh-list
154145093|NCT00716183|beta-Lactams|beta-lactams|mesh-list
154145094|NCT00716183|Cloxacillin|cloxacillin|mesh-list
154145095|NCT00716183|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
154145096|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145097|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145098|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145099|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154145100|NCT00712517|Propofol|propofol|mesh-list
154145101|NCT00712517|Sevoflurane|sevoflurane|mesh-list
154145102|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154145103|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145104|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145105|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154145106|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
154145107|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
154145108|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154145109|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154145110|NCT00712595|Mifepristone|mifepristone|mesh-list
154145111|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154145112|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
154145113|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154145114|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145115|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154145116|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154145117|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154145118|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
154145119|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154145120|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154145129|NCT00115765|Irinotecan|irinotecan|mesh-list
154145130|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154145131|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145132|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154145133|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154145134|NCT00115765|Growth Substances|growth substances|mesh-ancestor
154145135|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145136|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
154145137|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154145138|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154145139|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145140|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145141|NCT00606008|Sunitinib|sunitinib|mesh-list
154145142|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145143|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154145144|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154145145|NCT00606008|Growth Substances|growth substances|mesh-ancestor
154145146|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145147|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
154145148|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145149|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145150|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145151|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
154145152|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145153|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145154|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154145155|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
154145156|NCT00721331|Loratadine|loratadine|mesh-list
154145157|NCT00721331|Nortriptyline|nortriptyline|mesh-list
154145158|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145159|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145160|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154145161|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
154145162|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154145163|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154145164|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
154145165|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
154145166|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145167|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145168|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145169|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154145170|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
154145171|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154145172|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154145173|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154145174|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154145175|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
154145177|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154145178|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
154145179|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145180|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145181|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154145182|NCT00123955|Diuretics|diuretics|mesh-ancestor
154145183|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
154145184|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
154145185|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154145186|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154145220|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145221|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145223|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
154145224|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145225|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154145226|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154145227|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154145228|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154145229|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
154145230|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655027|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145244|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145245|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145246|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154145247|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154145248|NCT00167245|Topiramate|topiramate|mesh-list
154145249|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
154145250|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154145251|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145252|NCT00894062|Everolimus|everolimus|mesh-list
154145253|NCT00894062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154145254|NCT00894062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145255|NCT00894062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145256|NCT00894062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145257|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154145258|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
154145259|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145260|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145261|NCT00443560|Fentanyl|fentanyl|mesh-list
154145262|NCT00443560|Bupivacaine|bupivacaine|mesh-list
154145263|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
154145264|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
154145265|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145266|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145267|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
154145268|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145269|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154145270|NCT00443560|Narcotics|narcotics|mesh-ancestor
154145271|NCT00443560|Analgesics|analgesics|mesh-ancestor
154145272|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154145273|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154145274|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
154145275|NCT01022632|Curcumin|curcumin|mesh-list
154145276|NCT01022632|Fluoxetine|fluoxetine|mesh-list
154145277|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154145278|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154145279|NCT01022632|Analgesics|analgesics|mesh-ancestor
154145280|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
154145281|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145282|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145283|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145284|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443467|NCT01994226|Naproxen|naproxen|mesh-list
154145285|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145286|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145287|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145288|NCT01022632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154145289|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154145290|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154145309|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154145310|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
154145311|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145312|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145314|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154145315|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154145316|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154145317|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145318|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145320|NCT00451204|Estrogens|estrogens|mesh-list
154145321|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
154145322|NCT00451204|Hormones|hormones|mesh-ancestor
154145323|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145324|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145325|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154145326|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
154145327|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154145328|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145329|NCT04067999|Semaglutide|semaglutide|mesh-list
154145330|NCT04067999|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154145331|NCT04067999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154145332|NCT04067999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145333|NCT00721877|Resveratrol|resveratrol|mesh-list
154145334|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
154145335|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145336|NCT00721877|Protective Agents|protective agents|mesh-ancestor
154145337|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145338|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145339|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154145340|NCT03537586|Adenosine|adenosine|mesh-list
154145341|NCT03537586|Heparin|heparin|mesh-list
154145342|NCT03537586|Bivalirudin|bivalirudin|mesh-list
154145343|NCT03537586|Anticoagulants|anticoagulants|mesh-ancestor
154145344|NCT03537586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154145345|NCT03537586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154145346|NCT03537586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145354|NCT03537586|Purinergic Agonists|purinergic agonists|mesh-ancestor
154145355|NCT03537586|Purinergic Agents|purinergic agents|mesh-ancestor
154145356|NCT03537586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145357|NCT03537586|Antithrombins|antithrombins|mesh-ancestor
154145358|NCT03537586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154145359|NCT03537586|Protease Inhibitors|protease inhibitors|mesh-ancestor
154145360|NCT03537586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145361|NCT00722033|Indomethacin|indomethacin|mesh-list
153537749|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
154145362|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154145363|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154145364|NCT00722033|Analgesics|analgesics|mesh-ancestor
154145365|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
154145366|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145367|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145368|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145369|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145370|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
154145371|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
154145372|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154145373|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154145374|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145375|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145377|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
154145378|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154145379|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154145380|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145381|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145382|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
154145383|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
154145384|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154145385|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
154145386|NCT04920149|Mesalamine|mesalamine|mesh-list
154145387|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154145388|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154145389|NCT04920149|Analgesics|analgesics|mesh-ancestor
154145390|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
154145391|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145392|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145393|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145394|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145396|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
154145397|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145398|NCT00901550|Infliximab|infliximab|mesh-list
154145399|NCT00901550|Methotrexate|methotrexate|mesh-list
154145400|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154145401|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
154145402|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154145403|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145404|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154145405|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
154145406|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145407|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145408|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145409|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145410|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154145411|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154145412|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
154145413|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145414|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154145415|NCT00901550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154145416|NCT00901550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145434|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145436|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154145437|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145438|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
154145439|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
154145440|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
154145441|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145442|NCT01028092|Cyclosporine|cyclosporine|mesh-list
154145443|NCT01028092|Everolimus|everolimus|mesh-list
154145444|NCT01028092|Interleukin-2|interleukin-2|mesh-list
154145445|NCT01028092|Cyclosporins|cyclosporins|mesh-list
154145446|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
154145447|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145448|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145449|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154145450|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
154145451|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145452|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
154145453|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145454|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145455|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145456|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154145457|NCT01028092|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154145458|NCT01028092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145459|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145460|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154145461|NCT01028092|Analgesics|analgesics|mesh-ancestor
154145462|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
154145463|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145464|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
154145465|NCT00605306|Maleic acid|maleic acid|mesh-list
154145466|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145467|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145468|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145469|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145470|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154145471|NCT00905918|Vitamin E|vitamin e|mesh-list
154145472|NCT00905918|Vitamins|vitamins|mesh-ancestor
154145473|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
154145474|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145475|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
154145476|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145505|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145506|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145507|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
154145508|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145510|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
154145511|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
154145512|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
154145513|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145514|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145515|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
154145516|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145517|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154145518|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154145519|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154145520|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655313|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145534|NCT00722579|Chromium|chromium|mesh-list
154145535|NCT00722579|Trace Elements|trace elements|mesh-ancestor
154145536|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
154145537|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145538|NCT00713687|Gemcitabine|gemcitabine|mesh-list
154145539|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
154145540|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154145541|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
154145542|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145543|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145544|NCT02540876|Ilorasertib|ilorasertib|mesh-list
153525880|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145545|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145546|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145547|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145548|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145549|NCT00894920|Biotin|biotin|mesh-list
154145550|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
154145551|NCT00894920|Vitamins|vitamins|mesh-ancestor
154145552|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
154145553|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145554|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
154145555|NCT00722735|Finafloxacin|finafloxacin|mesh-list
154145556|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154145557|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145558|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154145559|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154145560|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145561|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145562|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145563|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154145564|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154145565|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154145566|NCT04067531|Clindamycin|clindamycin|mesh-list
154145567|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
154145568|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
154145569|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154145570|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145571|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154145572|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145573|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145574|NCT00713765|Donepezil|donepezil|mesh-list
154145575|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154145576|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145577|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145578|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
154145579|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145580|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145581|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
154145582|NCT00717587|Sunitinib|sunitinib|mesh-list
154145583|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
154145615|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154145616|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
154145617|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525954|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154145618|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154145619|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154145620|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145621|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
154145622|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
154145623|NCT00717821|Hematinics|hematinics|mesh-ancestor
154145624|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154145625|NCT00722969|Sorafenib|sorafenib|mesh-list
154145626|NCT00722969|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154145651|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
154145652|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145653|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145654|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154145655|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154145656|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
154145657|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
154145658|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145659|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154145660|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154145661|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145662|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145663|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154145664|NCT02571491|Narcotics|narcotics|mesh-ancestor
154145665|NCT00723437|Acitretin|acitretin|mesh-list
154145666|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
154145667|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
154145668|NCT00723515|Listerine|listerine|mesh-list
154145669|NCT00723515|Calcium|calcium|mesh-list
154145670|NCT00723515|Fluorides|fluorides|mesh-list
154145671|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
154145672|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154145673|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145674|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
154145675|NCT00723515|Protective Agents|protective agents|mesh-ancestor
154145676|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154145677|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145678|NCT01028170|Furosemide|furosemide|mesh-list
154145679|NCT01028170|Diuretics|diuretics|mesh-ancestor
153655462|NCT00048334|Romidepsin|romidepsin|mesh-list
154145696|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154145697|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154145698|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
154145699|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145700|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145701|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145702|NCT00450658|Ibuprofen|ibuprofen|mesh-list
154145703|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154145704|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154145705|NCT00450658|Analgesics|analgesics|mesh-ancestor
154145706|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
154145707|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145708|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145709|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145710|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154145711|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154145712|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145713|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145714|NCT02572505|Tenofovir|tenofovir|mesh-list
154145715|NCT02572505|Emtricitabine|emtricitabine|mesh-list
154145716|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154145717|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
154145718|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145719|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154145720|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154145721|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145722|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145723|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154145724|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154145725|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
154145726|NCT00517881|Hematinics|hematinics|mesh-ancestor
154145727|NCT01010139|Codeine|codeine|mesh-list
154145728|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154145729|NCT01010139|Narcotics|narcotics|mesh-ancestor
154145730|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145731|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145732|NCT01010139|Analgesics|analgesics|mesh-ancestor
154145733|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
154145734|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145735|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
154145754|NCT01012869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154145755|NCT01012869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145756|NCT01012869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145757|NCT01012869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145758|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154145759|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
154145760|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145761|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145762|NCT01010295|Doxycycline|doxycycline|mesh-list
154145763|NCT01010295|Tetracycline|tetracycline|mesh-list
154145764|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154145765|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701341|NCT00274495|Ribavirin|ribavirin|mesh-list
154145766|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
154145767|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154145768|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154145769|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154145770|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145771|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145772|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
154145773|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154145774|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
154145775|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145776|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145777|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154145778|NCT01010373|Protective Agents|protective agents|mesh-ancestor
154145779|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154145780|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154145781|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145782|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145783|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
154145784|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145785|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
154145786|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154145788|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154145789|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145790|NCT02570789|Sunitinib|sunitinib|mesh-list
154145791|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145792|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154145793|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154145812|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154145813|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154145814|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154145815|NCT00724685|Ropivacaine|ropivacaine|mesh-list
154145816|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
154145817|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
154145818|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145819|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145820|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
154145821|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145823|NCT00123487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154145824|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154145825|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145826|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145827|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145828|NCT00509925|Insulin|insulin|mesh-list
154145829|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154145830|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
154145831|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
154145832|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
154145833|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
154145834|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
154145835|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154145836|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145837|NCT05277974|Dexamethasone|dexamethasone|mesh-list
154145838|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145839|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
154145840|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
154145841|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145842|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145843|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154145844|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
154145845|NCT05277974|Hormones|hormones|mesh-ancestor
154145846|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145847|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154145848|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145849|NCT00504777|Rituximab|rituximab|mesh-list
154145850|NCT00504777|Methotrexate|methotrexate|mesh-list
154145851|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154145868|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154145869|NCT03968263|Narcotics|narcotics|mesh-ancestor
154145870|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145871|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145872|NCT03968263|Analgesics|analgesics|mesh-ancestor
154145873|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
154145874|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145875|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
154145876|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
154145877|NCT00895076|Dexamethasone|dexamethasone|mesh-list
154145878|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145879|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
154145880|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
154145881|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145882|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145883|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154145884|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
154145885|NCT00895076|Hormones|hormones|mesh-ancestor
154145886|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145887|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154145888|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145889|NCT01078519|Anesthetics|anesthetics|mesh-list
154145890|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
154145891|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154145892|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145893|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
154145894|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145895|NCT02539316|SMOFlipid|smoflipid|mesh-list
154145896|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154145897|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154145898|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154145899|NCT03968185|Analgesics|analgesics|mesh-list
153701560|NCT00108615|Metformin|metformin|mesh-list
154145900|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
154145901|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145902|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145903|NCT00509769|Trastuzumab|trastuzumab|mesh-list
154145904|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154145905|NCT00509769|Maytansine|maytansine|mesh-list
154145906|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154145907|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145908|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154145909|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
154145958|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154145959|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154145960|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145961|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154145962|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145963|NCT00114127|Analgesics|analgesics|mesh-ancestor
154145964|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
154145965|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145966|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
154145968|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
154145969|NCT00902954|Letrozole|letrozole|mesh-list
154145970|NCT00902954|Anastrozole|anastrozole|mesh-list
154145971|NCT00902954|Exemestane|exemestane|mesh-list
154145972|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154145973|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154145974|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154145975|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154145976|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154145977|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154145978|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
154145979|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145980|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256457|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154256458|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256459|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
154256460|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154256461|NCT03882710|Metoprolol|metoprolol|mesh-list
154256462|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154256463|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154145981|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154145982|NCT02540720|Dexamethasone|dexamethasone|mesh-list
154145983|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
154145984|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153729705|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153701605|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
153729706|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729707|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153729708|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
153729709|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153729710|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
153729711|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729712|NCT00131027|Cytarabine|cytarabine|mesh-list
153729713|NCT00131027|Dexamethasone|dexamethasone|mesh-list
154145985|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154145986|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154145987|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
154145988|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
154145989|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154145990|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154145991|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154145992|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
154145993|NCT02540720|Hormones|hormones|mesh-ancestor
154145994|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154145995|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154146015|NCT00908336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154146016|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154146017|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146018|NCT00908414|TMC-310911|tmc-310911|mesh-list
154146019|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
154146020|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146021|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146022|NCT01074853|Propranolol|propranolol|mesh-list
154146023|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154146024|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154146025|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
154146026|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146027|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146028|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146029|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154146030|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154146031|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
154146032|NCT00725777|Lumefantrine|lumefantrine|mesh-list
154146033|NCT00725777|Artemether|artemether|mesh-list
154146034|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154146035|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
154146036|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154146037|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154146038|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146039|NCT00165841|Rabeprazole|rabeprazole|mesh-list
154146040|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154146041|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154146042|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154146043|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146044|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146045|NCT00907166|Gemcitabine|gemcitabine|mesh-list
154146046|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154146047|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
154146048|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146049|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146050|NCT00460798|Sunitinib|sunitinib|mesh-list
154146051|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146052|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153655839|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
154146079|NCT00603980|Alprazolam|alprazolam|mesh-list
154146080|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154146081|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154146082|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146083|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154146084|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154146085|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154146086|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
154146087|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
154146088|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146089|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146090|NCT01028404|Insulin|insulin|mesh-list
154146091|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154146092|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
154146093|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
154146094|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154146095|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154146096|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146097|NCT01028482|Sertraline|sertraline|mesh-list
154146098|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
154146099|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154146128|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154146130|NCT00903188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154146131|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146132|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154146133|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
154146134|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
154146135|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146136|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154146137|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
154146138|NCT00903188|Hormones|hormones|mesh-ancestor
154146139|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154146140|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154146141|NCT00903188|Protective Agents|protective agents|mesh-ancestor
154146142|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154146143|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154146144|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154146145|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
154146174|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154146176|NCT00907400|Analgesics|analgesics|mesh-ancestor
154146177|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
154146178|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146179|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146180|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154146181|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154146182|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
154146183|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154146184|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146185|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146187|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154146188|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146189|NCT00727727|Piribedil|piribedil|mesh-list
154146190|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154146191|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154146192|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
154146193|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
154146213|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146214|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
154146215|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154146216|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154146217|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154146218|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146220|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
154146221|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146222|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146223|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154146224|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154146225|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154146226|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146227|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146228|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154146229|NCT02538302|Oxybutynin|oxybutynin|mesh-list
154256464|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
154256465|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
154146230|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
154146231|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
154146232|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146233|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146234|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154146235|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154146236|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
154146237|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701810|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154146238|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146239|NCT02538302|Urological Agents|urological agents|mesh-ancestor
154146240|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
154146241|NCT02538302|Coagulants|coagulants|mesh-ancestor
154146242|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154146243|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
154146244|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154146245|NCT00903734|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154146246|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154146247|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656048|NCT00052390|Bevacizumab|bevacizumab|mesh-list
154146277|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
154146278|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154146279|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154146280|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154146281|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154146282|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
154146283|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154146284|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
154146285|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154146286|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
154146287|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154146288|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146289|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
154146290|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154146291|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
154146292|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
154146293|NCT02538146|Vitamins|vitamins|mesh-ancestor
154146294|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
153656090|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
154146311|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154146312|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154146313|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154146314|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154146315|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154146316|NCT00908180|Cytarabine|cytarabine|mesh-list
154146317|NCT00908180|Cyclosporine|cyclosporine|mesh-list
154146318|NCT00908180|Etoposide|etoposide|mesh-list
154146319|NCT00908180|Melphalan|melphalan|mesh-list
154146320|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
154146321|NCT00908180|Carmustine|carmustine|mesh-list
154146322|NCT00908180|Cyclosporins|cyclosporins|mesh-list
154146323|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154146324|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146325|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154146326|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154146327|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146328|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146329|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154146330|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
154146331|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
154146332|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146333|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154146334|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
154146335|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146336|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
154146337|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
154146338|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154146339|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154146340|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154146341|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
154146342|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154146343|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154146344|NCT00909506|Metformin|metformin|mesh-list
154146345|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154146346|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146347|NCT03997539|Vinorelbine|vinorelbine|mesh-list
154146348|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154146349|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146350|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
154146351|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
154146352|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656137|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
154146377|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
154146379|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
154146380|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146381|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146382|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154146383|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154146384|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154146385|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154146386|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154146387|NCT00728195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154146388|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154146389|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146390|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146391|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146392|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
154146393|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154146394|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154146395|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
154146396|NCT00927524|Insulin|insulin|mesh-list
154146397|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154146398|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
154146399|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154146400|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146412|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
154146413|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154146414|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154146415|NCT04286867|Ethanol|ethanol|mesh-list
154146416|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154146417|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701919|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
154146418|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154146419|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146420|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154146421|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154146422|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154146423|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
154146424|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146425|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146426|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146427|NCT00730535|Urological Agents|urological agents|mesh-ancestor
154146428|NCT00927836|Lenograstim|lenograstim|mesh-list
154146429|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154146430|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
154146431|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146432|NCT00904280|Oxymorphone|oxymorphone|mesh-list
154146433|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154146434|NCT00904280|Narcotics|narcotics|mesh-ancestor
154146435|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154146436|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146437|NCT00904280|Analgesics|analgesics|mesh-ancestor
154146438|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
154146439|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146440|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154146441|NCT00928148|Amphetamine|amphetamine|mesh-list
154146442|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154146443|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146444|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
154146445|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
154146446|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146447|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
154146448|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146449|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146450|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
154146451|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154146452|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154146454|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154146455|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
154146456|NCT02430077|Cathartics|cathartics|mesh-ancestor
154146457|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154146458|NCT00904436|Ipratropium|ipratropium|mesh-list
154146459|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154146460|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
154146461|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146462|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146463|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154146464|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
154146465|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154146475|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
154146476|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146477|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154146478|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146479|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146480|NCT00728663|Docetaxel|docetaxel|mesh-list
154146481|NCT00728663|Cetuximab|cetuximab|mesh-list
154146482|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146483|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
154146485|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
154146486|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146487|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154146488|NCT00731003|Tryptophan|tryptophan|mesh-list
154146489|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
154146490|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154146491|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
154146492|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154146493|NCT00729131|Etanercept|etanercept|mesh-list
154146494|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154146495|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146496|NCT00729131|Analgesics|analgesics|mesh-ancestor
154146497|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
154146498|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146499|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146500|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154146501|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154146502|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154146503|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154146504|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
154146505|NCT00729287|Selenium|selenium|mesh-list
154146506|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
154146507|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146508|NCT00729287|Protective Agents|protective agents|mesh-ancestor
154146509|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146510|NCT00729287|Trace Elements|trace elements|mesh-ancestor
154146511|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
154146512|NCT00731393|Vaccines|vaccines|mesh-list
154146513|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
154146514|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146515|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
154146516|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154146517|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154146518|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146519|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
154146520|NCT04390217|Coagulants|coagulants|mesh-ancestor
154146521|NCT02569463|Aldesleukin|aldesleukin|mesh-list
154146522|NCT02569463|Interleukin-2|interleukin-2|mesh-list
154146523|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146524|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146525|NCT02569463|Analgesics|analgesics|mesh-ancestor
154146526|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
154146527|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146528|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146529|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154146530|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154146531|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
154146532|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146533|NCT00731627|Simvastatin|simvastatin|mesh-list
154146548|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146549|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154146550|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146551|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
154146552|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154146553|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154146554|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154146555|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146556|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154146557|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
154146558|NCT00577889|Gemcitabine|gemcitabine|mesh-list
154146559|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154146560|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
154146561|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146562|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146563|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
154146564|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154146565|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146566|NCT02538926|Prednisone|prednisone|mesh-list
154146567|NCT02538926|Cortisone|cortisone|mesh-list
154146568|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
154146569|NCT02538926|Rituximab|rituximab|mesh-list
154146570|NCT02538926|Doxorubicin|doxorubicin|mesh-list
154146571|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154146572|NCT02538926|Etoposide|etoposide|mesh-list
154146573|NCT02538926|Vincristine|vincristine|mesh-list
154146574|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
154146575|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
154146576|NCT02538926|Asparaginase|asparaginase|mesh-list
154146577|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
154146578|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154146579|NCT02538926|Antibodies|antibodies|mesh-list
154146580|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
154146581|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154146582|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154146583|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
154146584|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146585|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154146586|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154146587|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
154146588|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146589|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146590|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154146591|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154146592|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154146593|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154146594|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656380|NCT00054886|Sunitinib|sunitinib|mesh-list
154146609|NCT00904904|Indomethacin|indomethacin|mesh-list
154146610|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154146611|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154146612|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154146613|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146614|NCT00904904|Analgesics|analgesics|mesh-ancestor
154146615|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
154146616|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146617|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146618|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154146619|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154146620|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154146621|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146622|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146623|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
154146624|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
154146625|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154146626|NCT00731861|Paclitaxel|paclitaxel|mesh-list
154146627|NCT00731861|Vatalanib|vatalanib|mesh-list
154146628|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154146629|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146630|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
153820261|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
153820262|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820263|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820264|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153820265|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153820266|NCT00463203|Bevacizumab|bevacizumab|mesh-list
154146631|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
154146632|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
154146633|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146634|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154146635|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146637|NCT00567476|Terbutaline|terbutaline|mesh-list
154146638|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
154146639|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
154146640|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154256466|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146641|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
154146642|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146643|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146644|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154146645|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
154146646|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
154146647|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154146648|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154146649|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154146650|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146651|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146652|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154146653|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
154146654|NCT00729911|Amiodarone|amiodarone|mesh-list
154146655|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154146656|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
154146657|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154146687|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
154146688|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
154146689|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
154146690|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
154146691|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154146692|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154146693|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146694|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154146695|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
154146696|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146697|NCT04065581|Metformin|metformin|mesh-list
154146698|NCT04065581|Acarbose|acarbose|mesh-list
153656507|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
154146731|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
154146732|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146733|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154146734|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154146735|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146736|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146737|NCT04644627|Gentamicins|gentamicins|mesh-list
154146738|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154146739|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146740|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154146741|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820268|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153820269|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820270|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153820271|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153820272|NCT00463203|Growth Substances|growth substances|mesh-ancestor
153406263|NCT05090384|Prednisone|prednisone|mesh-list
153663491|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153656547|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
154146766|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
154146767|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146768|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154146769|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154146770|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146771|NCT00732485|Fenofibrate|fenofibrate|mesh-list
154146772|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154146773|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
154146774|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146775|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154146776|NCT02569073|Dronabinol|dronabinol|mesh-list
154146777|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
154146778|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146779|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154146780|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146781|NCT02569073|Analgesics|analgesics|mesh-ancestor
154146782|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
154146783|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146784|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154146785|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154146786|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146787|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146789|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154146790|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154146791|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153656590|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146805|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146806|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146807|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154146808|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443883|NCT01999218|Metformin|metformin|mesh-list
154146809|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154146810|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154146811|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146812|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154146813|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154146814|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146815|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
154146816|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154146817|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154146818|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
154146819|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154146820|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154146821|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154146822|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154146823|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153820273|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820274|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
153820275|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153820276|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153461698|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
153461699|NCT05158062|Olaparib|olaparib|mesh-list
153461700|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153461701|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461702|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
153461703|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
154146824|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
154146825|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146826|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
154146827|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
154146828|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154146829|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154146830|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154146831|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154146832|NCT00734123|Hormones|hormones|mesh-ancestor
154146833|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154146834|NCT00734279|Leuprolide|leuprolide|mesh-list
154146835|NCT00734279|Ganirelix|ganirelix|mesh-list
154146836|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154146837|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
154146838|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154146839|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146840|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154146841|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146842|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
154146843|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154146844|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
154146845|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
154146846|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154146847|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154146848|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
154146849|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146850|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146851|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146852|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146853|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154146865|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154146866|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146867|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154146868|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
154146869|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
154146870|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154146871|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154146872|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154146873|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154146874|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
154146875|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146876|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146877|NCT00733031|Gemcitabine|gemcitabine|mesh-list
154146878|NCT00733031|Pemetrexed|pemetrexed|mesh-list
154146879|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154146880|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
154146881|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146882|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146883|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146884|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154146885|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154146886|NCT00734669|Glyburide|glyburide|mesh-list
154146887|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154146888|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146889|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
154146890|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
154146891|NCT00113269|Tacrolimus|tacrolimus|mesh-list
154146892|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
154146893|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154146894|NCT00113269|Basiliximab|basiliximab|mesh-list
154146895|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154146896|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
154146897|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146898|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154146899|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146900|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146901|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154146902|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146903|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154146904|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
154146905|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154146906|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146907|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154146908|NCT04065269|Olaparib|olaparib|mesh-list
154146909|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154146910|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146911|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146912|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146913|NCT00515619|Lacosamide|lacosamide|mesh-list
154146914|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
154146915|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154146916|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154146917|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146928|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
154146929|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154146930|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146931|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146932|NCT00112489|Paclitaxel|paclitaxel|mesh-list
154146933|NCT00112489|Carboplatin|carboplatin|mesh-list
154146934|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154146935|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146936|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154146937|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154146938|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154146939|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146940|NCT01023100|Tofacitinib|tofacitinib|mesh-list
154146941|NCT01023100|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154146942|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154146943|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146944|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146945|NCT00515463|Denosumab|denosumab|mesh-list
153820280|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153820281|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153820282|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
153820283|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820284|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153820285|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153820286|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820287|NCT00432575|Surinabant|surinabant|mesh-list
153820288|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153360257|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360258|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153360259|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360260|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
153360261|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360262|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360263|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153360264|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154146946|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154146947|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154146948|NCT01082731|Artesunate|artesunate|mesh-list
154146949|NCT01082731|Lumefantrine|lumefantrine|mesh-list
154146950|NCT01082731|Artemether|artemether|mesh-list
154146951|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154146952|NCT01082731|Mefloquine|mefloquine|mesh-list
154146953|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
154146954|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154146955|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154146956|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154146957|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154146958|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
154146959|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
153729714|NCT00131027|Prednisolone|prednisolone|mesh-list
154146960|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154146961|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
154146962|NCT00739193|Amiodarone|amiodarone|mesh-list
154146963|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154146964|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
154146965|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154146966|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154146967|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146968|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154146969|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154146970|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154146971|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154146972|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154146973|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154146974|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154146975|NCT01011543|Dimercaprol|dimercaprol|mesh-list
154146976|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
154146977|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
154146978|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154146979|NCT00733811|Deferiprone|deferiprone|mesh-list
154146980|NCT00733811|Deferoxamine|deferoxamine|mesh-list
154146997|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154146998|NCT00459706|Etanercept|etanercept|mesh-list
154146999|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154147000|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154147001|NCT00459706|Analgesics|analgesics|mesh-ancestor
154147002|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
154147003|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147004|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147005|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147006|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147007|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154147008|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154147009|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
154147010|NCT00735527|Lorazepam|lorazepam|mesh-list
153781779|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153406339|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
154147011|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
154147012|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
154147013|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
154147014|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147015|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147016|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154147017|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154147018|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147019|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154147020|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154147021|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154147022|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
154147023|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
154147024|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147025|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147026|NCT00735761|Acyclovir|acyclovir|mesh-list
154147027|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
154147028|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
154147029|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147030|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147031|NCT00740285|Lidocaine|lidocaine|mesh-list
154147032|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
154147033|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
154147034|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729715|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
154147035|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147037|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147038|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154147039|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154147040|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154147055|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
154147056|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154147057|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
154147058|NCT01011621|Betamethasone|betamethasone|mesh-list
154147059|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
154147060|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154147061|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
154147062|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154147063|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
154147064|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154147065|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147066|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
154147067|NCT01011621|Hormones|hormones|mesh-ancestor
154147068|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147069|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147070|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153664038|NCT01464606|Dactinomycin|dactinomycin|mesh-list
154147071|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147072|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
154147073|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
154147074|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147075|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154147076|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154147077|NCT01011621|Protective Agents|protective agents|mesh-ancestor
154147078|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154147079|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
154147080|NCT00449176|Oxycodone|oxycodone|mesh-list
154147081|NCT00449176|Tapentadol|tapentadol|mesh-list
154147082|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154147083|NCT00449176|Narcotics|narcotics|mesh-ancestor
154147084|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147085|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147086|NCT00449176|Analgesics|analgesics|mesh-ancestor
154147087|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
154147088|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147089|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154147090|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154147091|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154147092|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147093|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
154147094|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147095|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
154147096|NCT00515073|Promethazine|promethazine|mesh-list
154147097|NCT00515073|Dexamethasone|dexamethasone|mesh-list
154147098|NCT00515073|Paclitaxel|paclitaxel|mesh-list
154147099|NCT00515073|Cimetidine|cimetidine|mesh-list
154147100|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147101|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147102|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147121|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
154147122|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154147123|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
154147125|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147126|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154147127|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
154147128|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
154147129|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154147130|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154147131|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154147132|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154147133|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147134|NCT00710021|Vitamin D|vitamin d|mesh-list
153781780|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153664094|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
154147135|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
154147136|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
154147137|NCT00710021|Vitamins|vitamins|mesh-list
154147138|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
154147139|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147140|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154147141|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154147142|NCT00504153|Dasatinib|dasatinib|mesh-list
154147143|NCT00504153|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154147144|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154147145|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147146|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147147|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147148|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154147149|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154147150|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147151|NCT00740363|Incretins|incretins|mesh-ancestor
154147152|NCT00740363|Hormones|hormones|mesh-ancestor
154147153|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147154|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154147155|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
154147156|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656950|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147168|NCT00514917|Docetaxel|docetaxel|mesh-list
154147169|NCT00514917|Leuprolide|leuprolide|mesh-list
154147170|NCT00514917|Bicalutamide|bicalutamide|mesh-list
154147171|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147172|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147173|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147174|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147175|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256467|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811103|NCT00331851|Hormones|hormones|mesh-ancestor
154147176|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154147177|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
154147178|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154147179|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147180|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154147181|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
154147182|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
153820302|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820303|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
153820304|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820305|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153820306|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153820307|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
153820308|NCT00432614|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153360278|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
153360279|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360280|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
153360283|NCT00802880|Dacarbazine|dacarbazine|mesh-list
153360284|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153360285|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
154147183|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147184|NCT01011699|Niacinamide|niacinamide|mesh-list
154147186|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
154147187|NCT01011699|Sevelamer|sevelamer|mesh-list
154147188|NCT01011699|Cinacalcet|cinacalcet|mesh-list
154147189|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
154147190|NCT01011699|Vitamins|vitamins|mesh-ancestor
154147191|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
154147192|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147193|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154147194|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
154147195|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147196|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154147197|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
154147198|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
154147199|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
154147200|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154147201|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154147202|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
154147203|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147204|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
154147205|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154147206|NCT00504075|Antibodies|antibodies|mesh-list
154147207|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
154147208|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154147209|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
154147210|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147211|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
154147212|NCT00503997|Pemetrexed|pemetrexed|mesh-list
154147213|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147214|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147215|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147216|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154147217|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154147218|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
154147219|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154147220|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
154147221|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
154147222|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147223|NCT00736463|Atorvastatin|atorvastatin|mesh-list
154147224|NCT00736463|Simvastatin|simvastatin|mesh-list
154147242|NCT00736541|Protective Agents|protective agents|mesh-ancestor
154147243|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147244|NCT00736541|Antidotes|antidotes|mesh-ancestor
154147245|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154147246|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
154147247|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147248|NCT00096265|Temozolomide|temozolomide|mesh-list
154147249|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154147250|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154147251|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
154147252|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147253|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147254|NCT00096265|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154147255|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154147256|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664220|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
154147258|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147259|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154147260|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154147261|NCT01082809|Growth Substances|growth substances|mesh-ancestor
154147262|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147263|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
154147264|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154147265|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147266|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147268|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154147269|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
154147270|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147271|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154147272|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147273|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147275|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154147276|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154147277|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154147278|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
154147279|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
154147280|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147281|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147282|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147307|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147308|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147309|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147311|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154147312|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147313|NCT00448864|Ecallantide|ecallantide|mesh-list
154147314|NCT00448864|Analgesics|analgesics|mesh-ancestor
154147315|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
154147316|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147317|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147318|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154147319|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154147320|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360286|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360287|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360288|NCT03839888|Atropine|atropine|mesh-list
153360289|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153360290|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153360291|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153360293|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360294|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360295|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153360296|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
153360297|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
154147321|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147322|NCT00567398|Icodextrin|icodextrin|mesh-list
154147323|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
154147324|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154147325|NCT00448708|Paclitaxel|paclitaxel|mesh-list
154147326|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154147327|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147328|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147329|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147330|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147331|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147332|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147367|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
154147368|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154147369|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147370|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
154147372|NCT02568995|Epinephrine|epinephrine|mesh-list
154147373|NCT02568995|Racepinephrine|racepinephrine|mesh-list
154147374|NCT02568995|Ropivacaine|ropivacaine|mesh-list
154147375|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
153494146|NCT03861000|BPN14770|bpn14770|mesh-list
154147405|NCT00930098|Clofarabine|clofarabine|mesh-list
154147406|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154147407|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
154147408|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147409|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147410|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154147411|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154147412|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147413|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
154147414|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
154147415|NCT00905762|Besifloxacin|besifloxacin|mesh-list
154147416|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154147417|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147418|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154147419|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154147420|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147421|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360298|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
153360299|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154147422|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147449|NCT06140576|Paclitaxel|paclitaxel|mesh-list
154147450|NCT06140576|Lenvatinib|lenvatinib|mesh-list
154147451|NCT06140576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147452|NCT06140576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147453|NCT06140576|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147455|NCT06140576|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147456|NCT06140576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147457|NCT06140576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154147458|NCT06140576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147459|NCT06138041|Lidocaine|lidocaine|mesh-list
154147460|NCT06138041|Anesthetics, Local|anesthetics, local|mesh-ancestor
154147461|NCT06138041|Anesthetics|anesthetics|mesh-ancestor
154147462|NCT06138041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147463|NCT06138041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147464|NCT06138041|Sensory System Agents|sensory system agents|mesh-ancestor
154147465|NCT06138041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147466|NCT06138041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154147467|NCT06138041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154147468|NCT06138041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154147469|NCT06138041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154147470|NCT06138041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147471|NCT06138028|Cisplatin|cisplatin|mesh-list
154147472|NCT06138028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153657264|NCT06197438|Irinotecan|irinotecan|mesh-list
154147496|NCT06137924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154147497|NCT06137924|Glucocorticoids|glucocorticoids|mesh-ancestor
154147498|NCT06137924|Hormones|hormones|mesh-ancestor
154147499|NCT06137924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147500|NCT06137924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154147501|NCT06137924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147502|NCT06137924|Protease Inhibitors|protease inhibitors|mesh-ancestor
154147503|NCT06137924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147504|NCT06137924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147505|NCT06137924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147506|NCT06137924|Sensory System Agents|sensory system agents|mesh-ancestor
154147507|NCT06137924|Analgesics|analgesics|mesh-ancestor
154147508|NCT06137924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154147509|NCT06137924|Sympatholytics|sympatholytics|mesh-ancestor
154147510|NCT06137924|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154147511|NCT06137924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154147512|NCT06137924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154147513|NCT06137924|Adrenergic Agents|adrenergic agents|mesh-ancestor
154147514|NCT06137924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147515|NCT06137664|Vaccines|vaccines|mesh-list
154147516|NCT06137664|Immunologic Factors|immunologic factors|mesh-ancestor
154147517|NCT06137664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147518|NCT06137651|Vinorelbine|vinorelbine|mesh-list
154147519|NCT06137651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147520|NCT06137651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147521|NCT06137651|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147522|NCT06137651|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147523|NCT06137651|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147524|NCT06137651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147525|NCT06137430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154147526|NCT06137430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147527|NCT06137430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154147549|NCT06136676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147550|NCT06136377|Pluvicto|pluvicto|mesh-list
154147551|NCT06136377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154147552|NCT06136377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147553|NCT06135974|Metronidazole|metronidazole|mesh-list
154147554|NCT06135974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147555|NCT06135974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154147556|NCT06135974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154147557|NCT06135974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154147558|NCT06135844|Hand Sanitizers|hand sanitizers|mesh-list
154147559|NCT06135844|Mineral Oil|mineral oil|mesh-list
154147560|NCT06135844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154147561|NCT06135844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147562|NCT06135844|Disinfectants|disinfectants|mesh-ancestor
154147563|NCT06135844|Emollients|emollients|mesh-ancestor
153471075|NCT00618540|Fludarabine|fludarabine|mesh-list
154147564|NCT06135844|Dermatologic Agents|dermatologic agents|mesh-ancestor
154147565|NCT06135805|Fluocinonide|fluocinonide|mesh-list
154147566|NCT06135805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147567|NCT06135805|Glucocorticoids|glucocorticoids|mesh-ancestor
154147568|NCT06135805|Hormones|hormones|mesh-ancestor
154147569|NCT06135805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147570|NCT06135805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147571|NCT06135805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154147572|NCT06135675|Rifamycins|rifamycins|mesh-list
154147573|NCT06135675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154147574|NCT06135675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147575|NCT06135584|Metformin|metformin|mesh-list
154147576|NCT06135584|Pioglitazone|pioglitazone|mesh-list
154147577|NCT06135584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154147578|NCT06135584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147579|NCT06135415|Tirbanibulin|tirbanibulin|mesh-list
154147580|NCT06135415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147581|NCT06135415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147582|NCT06135402|Clobetasol|clobetasol|mesh-list
154147583|NCT06135402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147584|NCT06135402|Glucocorticoids|glucocorticoids|mesh-ancestor
154147611|NCT06134635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154147612|NCT06134635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154147613|NCT06134635|Antimetabolites|antimetabolites|mesh-ancestor
154147614|NCT06134635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147615|NCT06134635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147616|NCT06134635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154147617|NCT06134635|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154147618|NCT06134635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154147619|NCT06134635|Protease Inhibitors|protease inhibitors|mesh-ancestor
154147621|NCT06134622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154147622|NCT06134622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154147623|NCT06134622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147624|NCT06134622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153820309|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153820310|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153820311|NCT00432653|Rituximab|rituximab|mesh-list
153820312|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153820313|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820314|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
153820315|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820327|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
153820328|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820329|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153360300|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153360301|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
153360302|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360303|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147625|NCT06134531|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154147626|NCT06134531|Immunologic Factors|immunologic factors|mesh-ancestor
154147627|NCT06134531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147628|NCT06134388|Sulfasalazine|sulfasalazine|mesh-list
154147629|NCT06134388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147630|NCT06134388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154147631|NCT06134388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154147632|NCT06134388|Analgesics|analgesics|mesh-ancestor
153657434|NCT06192784|Lenvatinib|lenvatinib|mesh-list
154147654|NCT06133803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147655|NCT06133803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154147656|NCT06133803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154147658|NCT06133803|Antipyretics|antipyretics|mesh-ancestor
154147659|NCT06133803|Anticoagulants|anticoagulants|mesh-ancestor
154147660|NCT06133712|Dexamethasone|dexamethasone|mesh-list
154147661|NCT06133712|Dexmedetomidine|dexmedetomidine|mesh-list
154147662|NCT06133712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147663|NCT06133712|Antiemetics|antiemetics|mesh-ancestor
154147664|NCT06133712|Autonomic Agents|autonomic agents|mesh-ancestor
154147665|NCT06133712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147666|NCT06133712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147667|NCT06133712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154147668|NCT06133712|Glucocorticoids|glucocorticoids|mesh-ancestor
154147669|NCT06133712|Hormones|hormones|mesh-ancestor
154147670|NCT06133712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147671|NCT06133712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154147672|NCT06133712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147673|NCT06133712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154147674|NCT06133712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147675|NCT06133712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154147676|NCT06133712|Analgesics|analgesics|mesh-ancestor
154147677|NCT06133712|Sensory System Agents|sensory system agents|mesh-ancestor
154147678|NCT06133712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154147679|NCT06133712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154147680|NCT06133712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154147681|NCT06133712|Adrenergic Agents|adrenergic agents|mesh-ancestor
154147682|NCT06133712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147683|NCT06133712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147684|NCT06133465|Hormones|hormones|mesh-list
153657475|NCT06170346|Antioxidants|antioxidants|mesh-list
154147700|NCT06128616|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154147701|NCT06128616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147702|NCT06127069|Chitosan|chitosan|mesh-list
154147703|NCT06127069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154147704|NCT06127069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154147705|NCT06127069|Antimetabolites|antimetabolites|mesh-ancestor
154147706|NCT06127069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147707|NCT06127069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154147708|NCT06127069|Chelating Agents|chelating agents|mesh-ancestor
154147709|NCT06127069|Sequestering Agents|sequestering agents|mesh-ancestor
154147710|NCT06127069|Hemostatics|hemostatics|mesh-ancestor
154147711|NCT06127069|Coagulants|coagulants|mesh-ancestor
154147712|NCT06126614|Chlorhexidine|chlorhexidine|mesh-list
154147713|NCT06126614|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153729716|NCT00131027|Doxorubicin|doxorubicin|mesh-list
154147714|NCT06126614|Povidone-Iodine|povidone-iodine|mesh-list
154147715|NCT06126614|Vancomycin|vancomycin|mesh-list
154147716|NCT06126614|Povidone|povidone|mesh-list
153360306|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
153360307|NCT05089526|Ketamine|ketamine|mesh-list
153360308|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
153360309|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
153360310|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360311|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360312|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
154147717|NCT06126614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154147718|NCT06126614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147719|NCT06126614|Disinfectants|disinfectants|mesh-ancestor
154147720|NCT06126614|Dermatologic Agents|dermatologic agents|mesh-ancestor
154147721|NCT06126614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154147722|NCT06126614|Plasma Substitutes|plasma substitutes|mesh-ancestor
154147723|NCT06126614|Blood Substitutes|blood substitutes|mesh-ancestor
154147724|NCT06110572|Carboplatin|carboplatin|mesh-list
154147725|NCT06110572|Etoposide|etoposide|mesh-list
154147726|NCT06110572|Atezolizumab|atezolizumab|mesh-list
154147727|NCT06110572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147728|NCT06110572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154147729|NCT06110572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154147730|NCT06110572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154147731|NCT06110572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147732|NCT06110572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147733|NCT06110572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154147734|NCT06110572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147735|NCT06107725|Minocycline|minocycline|mesh-list
154147736|NCT06107725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154147737|NCT06107725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147738|NCT06095492|Empagliflozin|empagliflozin|mesh-list
154147739|NCT06095492|Linagliptin|linagliptin|mesh-list
154147740|NCT06095492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154147741|NCT06095492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147742|NCT06095492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154147743|NCT06095492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147778|NCT06085755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147779|NCT06078241|Lidocaine|lidocaine|mesh-list
154147780|NCT06078241|Anesthetics, Local|anesthetics, local|mesh-ancestor
154147781|NCT06078241|Anesthetics|anesthetics|mesh-ancestor
153657586|NCT06039358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147806|NCT06067217|Coagulants|coagulants|mesh-ancestor
154147807|NCT06067217|Estrogens|estrogens|mesh-ancestor
154147808|NCT06067217|Hormones|hormones|mesh-ancestor
154147809|NCT06067217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147810|NCT06067217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147811|NCT06061523|Sotorasib|sotorasib|mesh-list
154147812|NCT06061523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154147813|NCT06061523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147814|NCT06061523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154147815|NCT06061523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147816|NCT06060392|Semaglutide|semaglutide|mesh-list
154147817|NCT06060392|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154147818|NCT06060392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154147819|NCT06060392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147820|NCT06056804|Capecitabine|capecitabine|mesh-list
154147821|NCT06056804|Tislelizumab|tislelizumab|mesh-list
154147822|NCT06056804|Thymalfasin|thymalfasin|mesh-list
154147823|NCT06056804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153406641|NCT04179396|Rucaparib|rucaparib|mesh-list
153664708|NCT00014183|Gefitinib|gefitinib|mesh-list
154147824|NCT06056804|Antimetabolites|antimetabolites|mesh-ancestor
154147825|NCT06056804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147826|NCT06056804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147827|NCT06056804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657629|NCT05820763|Glucocorticoids|glucocorticoids|mesh-ancestor
154147837|NCT06042647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154147839|NCT06042647|Dermatologic Agents|dermatologic agents|mesh-ancestor
154147840|NCT06042647|Keratolytic Agents|keratolytic agents|mesh-ancestor
154147841|NCT06042647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154147842|NCT06037889|Aspirin|aspirin|mesh-list
154147843|NCT06037889|Tirofiban|tirofiban|mesh-list
154147844|NCT06037889|Clopidogrel|clopidogrel|mesh-list
154147845|NCT06037889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154147846|NCT06037889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154147847|NCT06037889|Analgesics|analgesics|mesh-ancestor
154147848|NCT06037889|Sensory System Agents|sensory system agents|mesh-ancestor
154147849|NCT06037889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147850|NCT06037889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147851|NCT06037889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154147852|NCT06037889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147853|NCT06037889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154147854|NCT06037889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154147855|NCT06037889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147856|NCT06037889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154147857|NCT06037889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154147858|NCT06037889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147859|NCT06037889|Antipyretics|antipyretics|mesh-ancestor
154147860|NCT06037889|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153528205|NCT01477112|Vitamins|vitamins|mesh-ancestor
154147861|NCT06037889|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154147862|NCT06037889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154147863|NCT06037889|Purinergic Agents|purinergic agents|mesh-ancestor
154147864|NCT06037889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147865|NCT06034340|Lidocaine|lidocaine|mesh-list
154147866|NCT06034340|Anesthetics, Local|anesthetics, local|mesh-ancestor
154147867|NCT06034340|Anesthetics|anesthetics|mesh-ancestor
154147868|NCT06034340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664783|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154147869|NCT06034340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147870|NCT06034340|Sensory System Agents|sensory system agents|mesh-ancestor
154147871|NCT06034340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147872|NCT06034340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154147873|NCT06034340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154147874|NCT06034340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154147875|NCT06034340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154147876|NCT06034340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147877|NCT05974969|Daratumumab|daratumumab|mesh-list
154147878|NCT05974969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147879|NCT05974293|Nabiximols|nabiximols|mesh-list
154147880|NCT05974293|Analgesics|analgesics|mesh-ancestor
154147881|NCT05974293|Sensory System Agents|sensory system agents|mesh-ancestor
154147882|NCT05974293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154147883|NCT05974293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147884|NCT05961527|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154147885|NCT05961527|Hallucinogens|hallucinogens|mesh-ancestor
154147886|NCT05961527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147887|NCT05961527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154147888|NCT05961527|Serotonin Agents|serotonin agents|mesh-ancestor
154147889|NCT05961527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147890|NCT05961527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147891|NCT05961527|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154147892|NCT05961527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154147911|NCT05953038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147912|NCT05953038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154147913|NCT05953038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154147914|NCT05953038|Serotonin Agents|serotonin agents|mesh-ancestor
154147915|NCT05953038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147916|NCT05953038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147917|NCT05953038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154147918|NCT05952089|Midazolam|midazolam|mesh-list
154147919|NCT05952089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154147920|NCT05952089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154147921|NCT05952089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154147922|NCT05952089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154147923|NCT05952089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154147924|NCT05952089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154147925|NCT05952089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154147926|NCT05952089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154147927|NCT05952089|Anesthetics, General|anesthetics, general|mesh-ancestor
154147928|NCT05952089|Anesthetics|anesthetics|mesh-ancestor
154147929|NCT05952089|GABA Modulators|gaba modulators|mesh-ancestor
154147930|NCT05952089|GABA Agents|gaba agents|mesh-ancestor
154147931|NCT05952089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154147932|NCT05952089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147933|NCT05949281|Colchicine|colchicine|mesh-list
153360327|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153360328|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153360329|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
153360330|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153360331|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153360332|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153820330|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153820331|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820332|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153820336|NCT00463359|Imiquimod|imiquimod|mesh-list
154147934|NCT05949281|Gout Suppressants|gout suppressants|mesh-ancestor
154147935|NCT05949281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154147936|NCT05949281|Tubulin Modulators|tubulin modulators|mesh-ancestor
154147937|NCT05949281|Antimitotic Agents|antimitotic agents|mesh-ancestor
154147938|NCT05949281|Mitosis Modulators|mitosis modulators|mesh-ancestor
154147939|NCT05949281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147940|NCT05949281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147941|NCT05949021|Doxorubicin|doxorubicin|mesh-list
154147942|NCT05949021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154147943|NCT05949021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154147944|NCT05949021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147945|NCT05949021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154147946|NCT05949021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154147947|NCT05949021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154147948|NCT05949021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147949|NCT05946655|Metronidazole|metronidazole|mesh-list
154147950|NCT05946655|Ofloxacin|ofloxacin|mesh-list
154147951|NCT05946655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154147987|NCT05926466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154147988|NCT05926466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154147989|NCT05926466|Antitubercular Agents|antitubercular agents|mesh-ancestor
154148025|NCT05851976|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154148026|NCT05851976|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154148027|NCT05851976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154148028|NCT05851976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148029|NCT05851976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148030|NCT05851976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148031|NCT05851976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148032|NCT05851976|Analgesics|analgesics|mesh-ancestor
154148033|NCT05851976|Sensory System Agents|sensory system agents|mesh-ancestor
154148034|NCT05851976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148035|NCT05851976|Antidepressive Agents|antidepressive agents|mesh-ancestor
154148048|NCT05839574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154148049|NCT05839574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148050|NCT05839574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148051|NCT05839574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154148052|NCT05839574|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148053|NCT05839574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148054|NCT05839574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148055|NCT05839561|Letrozole|letrozole|mesh-list
154148056|NCT05839561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148057|NCT05839561|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154148058|NCT05839561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154148059|NCT05839561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148060|NCT05839561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148061|NCT05839561|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154148062|NCT05839561|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148063|NCT05839561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148064|NCT05839561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148065|NCT05829317|Magnesium Sulfate|magnesium sulfate|mesh-list
154148066|NCT05829317|Analgesics|analgesics|mesh-ancestor
154148067|NCT05829317|Sensory System Agents|sensory system agents|mesh-ancestor
154148068|NCT05829317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148069|NCT05829317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148070|NCT05829317|Anesthetics|anesthetics|mesh-ancestor
154148071|NCT05829317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154148072|NCT05829317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154148073|NCT05829317|Anticonvulsants|anticonvulsants|mesh-ancestor
154148074|NCT05829317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154148075|NCT05829317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148076|NCT05829317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148077|NCT05829317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154148078|NCT05829317|Tocolytic Agents|tocolytic agents|mesh-ancestor
154148079|NCT05829317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154148080|NCT05825391|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154148082|NCT05823311|Gemcitabine|gemcitabine|mesh-list
154148083|NCT05823311|Lenvatinib|lenvatinib|mesh-list
154148084|NCT05823311|Tislelizumab|tislelizumab|mesh-list
153471614|NCT04151706|Busulfan|busulfan|mesh-list
154148085|NCT05823311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148086|NCT05823311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154148087|NCT05823311|Antimetabolites|antimetabolites|mesh-ancestor
154148088|NCT05823311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148089|NCT05823311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148090|NCT05823311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256468|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154148091|NCT05823311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148092|NCT05807932|Mycophenolic Acid|mycophenolic acid|mesh-list
154148094|NCT05807932|Amsacrine|amsacrine|mesh-list
154148095|NCT05807932|Tacrolimus|tacrolimus|mesh-list
154148096|NCT05807932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154148097|NCT05807932|Immunologic Factors|immunologic factors|mesh-ancestor
154148098|NCT05807932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148117|NCT05797376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148119|NCT05776758|Cisplatin|cisplatin|mesh-list
154148120|NCT05776758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148121|NCT05757310|Vidarabine|vidarabine|mesh-list
154148122|NCT05757310|Cyclophosphamide|cyclophosphamide|mesh-list
154148123|NCT05757310|Pentostatin|pentostatin|mesh-list
154148124|NCT05757310|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154148125|NCT05757310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154148126|NCT05757310|Immunologic Factors|immunologic factors|mesh-ancestor
154148127|NCT05757310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148128|NCT05757310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148129|NCT05757310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154148130|NCT05757310|Alkylating Agents|alkylating agents|mesh-ancestor
154148131|NCT05757310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820341|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820342|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153820343|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820344|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
153820345|NCT00471627|Pancrelipase|pancrelipase|mesh-list
153820346|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153820347|NCT00432887|Caffeine|caffeine|mesh-list
153820348|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153820349|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820350|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153820351|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820352|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820353|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153820363|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148132|NCT05757310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148133|NCT05757310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154148134|NCT05757310|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154148135|NCT05757310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148136|NCT05757310|Antimetabolites|antimetabolites|mesh-ancestor
154148137|NCT05757310|Antiviral Agents|antiviral agents|mesh-ancestor
154148138|NCT05757310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148139|NCT05733611|Bevacizumab|bevacizumab|mesh-list
154148140|NCT05733611|Atezolizumab|atezolizumab|mesh-list
154148141|NCT05733611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148142|NCT05733611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148143|NCT05733611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154148144|NCT05733611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154148145|NCT05733611|Growth Substances|growth substances|mesh-ancestor
154148146|NCT05733611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148147|NCT05733611|Growth Inhibitors|growth inhibitors|mesh-ancestor
154148148|NCT05733611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148149|NCT05733611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148150|NCT05733598|Bevacizumab|bevacizumab|mesh-list
154148151|NCT05733598|Atezolizumab|atezolizumab|mesh-list
154148152|NCT05733598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148153|NCT05733598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148154|NCT05733598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154148166|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
154148167|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154148168|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
154148169|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148170|NCT05706402|Expectorants|expectorants|mesh-ancestor
154148171|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
154148172|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154148173|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
154148174|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148175|NCT05706402|Protective Agents|protective agents|mesh-ancestor
153820364|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
153820365|NCT00463515|Carboplatin|carboplatin|mesh-list
153820366|NCT00463515|Gemcitabine|gemcitabine|mesh-list
153820367|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820368|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153360341|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
153360342|NCT02323217|Idazoxan|idazoxan|mesh-list
153360343|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153360344|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153360345|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153360346|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
153360347|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360348|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360349|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360350|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
153360351|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153360352|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153360353|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360354|NCT04382768|Ibuprofen|ibuprofen|mesh-list
153360355|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154148176|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148177|NCT05706402|Antidotes|antidotes|mesh-ancestor
154148178|NCT05704725|Aflibercept|aflibercept|mesh-list
154148179|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154148180|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154148181|NCT05704725|Growth Substances|growth substances|mesh-ancestor
154148182|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148183|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
154148184|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148185|NCT05700903|Leuprolide|leuprolide|mesh-list
154148186|NCT05700903|Goserelin|goserelin|mesh-list
154148187|NCT05700903|Flutamide|flutamide|mesh-list
154148188|NCT05700903|Bicalutamide|bicalutamide|mesh-list
154148189|NCT05700903|Hormones|hormones|mesh-list
154148190|NCT05700903|Androgens|androgens|mesh-list
154148191|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
154148192|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148193|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148194|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154148195|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
154148196|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154148197|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154148198|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148199|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
154148200|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148201|NCT05697029|Tetrandrine|tetrandrine|mesh-list
154148202|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
154148203|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154148204|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154148205|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148206|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154148207|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626801|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360356|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153360357|NCT04382768|Analgesics|analgesics|mesh-ancestor
153360358|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
153360359|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360360|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665028|NCT00275418|Vitamins|vitamins|mesh-ancestor
154148208|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
154148209|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154148210|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148211|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148212|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154148213|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148214|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154148215|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
154148217|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
154148218|NCT05689710|Vitamins|vitamins|mesh-ancestor
154148219|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
154148236|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148237|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154148238|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
154148239|NCT05647512|Hormones|hormones|mesh-ancestor
154148240|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148241|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154148242|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148243|NCT05640245|Adalimumab|adalimumab|mesh-list
154148244|NCT05640245|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154148245|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148246|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148247|NCT05631093|Islatravir|islatravir|mesh-list
154148248|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
154148249|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148250|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148251|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148252|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154148253|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154148254|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154148255|NCT05615974|Rituximab|rituximab|mesh-list
154148256|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148257|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148258|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
154148259|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148260|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148261|NCT05615818|Gemcitabine|gemcitabine|mesh-list
154148262|NCT05615818|Trastuzumab|trastuzumab|mesh-list
154148263|NCT05615818|Niraparib|niraparib|mesh-list
154148264|NCT05615818|Ivosidenib|ivosidenib|mesh-list
154148265|NCT05615818|Futibatinib|futibatinib|mesh-list
154148266|NCT05615818|Neratinib|neratinib|mesh-list
154148267|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148268|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154148269|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
154148270|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148271|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148272|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154148273|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148274|NCT05615818|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154148275|NCT05615818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148276|NCT05612880|Androgens|androgens|mesh-list
154148277|NCT05612880|Hormones|hormones|mesh-ancestor
154148288|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153665106|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
154148289|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154148290|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154148291|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154148292|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148293|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148294|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
154148295|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154148296|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154148297|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
154148298|NCT05600062|Racecadotril|racecadotril|mesh-list
154148299|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
154148300|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154148301|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
154148302|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148303|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148304|NCT05593055|Eplerenone|eplerenone|mesh-list
154148305|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
154148306|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154148307|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148308|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471821|NCT02099188|Antidotes|antidotes|mesh-ancestor
154148309|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148310|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154148311|NCT05593055|Diuretics|diuretics|mesh-ancestor
154148312|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
154148313|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154148314|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154148315|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148316|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148317|NCT05589688|Acyclovir|acyclovir|mesh-list
154148318|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
154148319|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148320|NCT05584735|Vaccines|vaccines|mesh-list
154148321|NCT05584735|Immunologic Factors|immunologic factors|mesh-ancestor
154148322|NCT05584735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148323|NCT05565729|Levocetirizine|levocetirizine|mesh-list
154148324|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154148325|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154148326|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
154148327|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
154148328|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148329|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148330|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148331|NCT05558280|Dinutuximab|dinutuximab|mesh-list
154148332|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148333|NCT05536414|Escitalopram|escitalopram|mesh-list
154148334|NCT05536414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154148335|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154148336|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148337|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148353|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154148354|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
154148355|NCT05536349|Protective Agents|protective agents|mesh-ancestor
154148356|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148357|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
154148358|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148359|NCT05536349|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154148360|NCT05536349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148361|NCT05535309|Sulbactam|sulbactam|mesh-list
154148362|NCT05535309|Cefoperazone|cefoperazone|mesh-list
154148363|NCT05535309|Sulperazone|sulperazone|mesh-list
154148364|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148365|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148366|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154148367|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148368|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148369|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154148370|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154148371|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148372|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148373|NCT05533606|Lactams|lactams|mesh-list
154148374|NCT05533606|beta-Lactams|beta-lactams|mesh-list
154148375|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148376|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148377|NCT05532059|Cisplatin|cisplatin|mesh-list
154148378|NCT05532059|Gemcitabine|gemcitabine|mesh-list
154148379|NCT05532059|Lenvatinib|lenvatinib|mesh-list
154148380|NCT05532059|Tislelizumab|tislelizumab|mesh-list
154148381|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148382|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154148383|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
154148384|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148385|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148386|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148387|NCT05532059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148388|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
154148389|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154148390|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148391|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154148392|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154148393|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148394|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148395|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
154148396|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148397|NCT05527444|Thalidomide|thalidomide|mesh-list
154148399|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153658200|NCT04508400|Ondansetron|ondansetron|mesh-list
154148405|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148406|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
154148407|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148408|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148409|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154148410|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154148411|NCT05527444|Growth Substances|growth substances|mesh-ancestor
154148412|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
154148413|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148415|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
154148416|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148417|NCT05520619|Paclitaxel|paclitaxel|mesh-list
154148418|NCT05520619|Tislelizumab|tislelizumab|mesh-list
154148419|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154148420|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148421|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
154148422|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
154148423|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
154148424|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148425|NCT05520619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148426|NCT05514990|Dexamethasone|dexamethasone|mesh-list
154148427|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
154148428|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
154148429|NCT05514990|Bortezomib|bortezomib|mesh-list
154148430|NCT05514990|Ichthammol|ichthammol|mesh-list
154148431|NCT05514990|BB 1101|bb 1101|mesh-list
154148432|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148433|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
154148434|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
154148435|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148436|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148437|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154148438|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
154148439|NCT05514990|Hormones|hormones|mesh-ancestor
154148440|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148441|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154148442|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148443|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
154148444|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148445|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148446|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148447|NCT05514990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148448|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
154148449|NCT05512520|Capecitabine|capecitabine|mesh-list
154148450|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154148451|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
154148452|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148453|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148454|NCT05505279|Nicotine|nicotine|mesh-list
154148455|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154148456|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
154148457|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148458|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148459|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154148460|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154148461|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
154148462|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148463|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148464|NCT05472337|Colchicine|colchicine|mesh-list
154148465|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
154148466|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148467|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
154148468|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
154148469|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
154148470|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148486|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148487|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154148488|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
154148489|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148490|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154148492|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
154148493|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154148494|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
154148495|NCT05462496|Folfirinox|folfirinox|mesh-list
154148496|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148497|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148498|NCT05462496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148499|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148500|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148501|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
154148502|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154148503|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154148504|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154148505|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153360361|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360362|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360363|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153360364|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360365|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148506|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148507|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154148508|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154148509|NCT05447910|Letrozole|letrozole|mesh-list
154148510|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148511|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154148512|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154148513|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148514|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148515|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154148516|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148517|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148518|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148519|NCT05415709|Paclitaxel|paclitaxel|mesh-list
154148520|NCT05415709|Cisplatin|cisplatin|mesh-list
154148521|NCT05415709|Carboplatin|carboplatin|mesh-list
154148522|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154148523|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154148524|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148525|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
154148526|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
154148527|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
154148528|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148529|NCT05409872|Vitamin D|vitamin d|mesh-list
154148530|NCT05409872|Vitamins|vitamins|mesh-list
154148531|NCT05409872|Inositol|inositol|mesh-list
154148552|NCT05351229|Narcotics|narcotics|mesh-ancestor
154148553|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154148554|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148555|NCT05351229|Analgesics|analgesics|mesh-ancestor
154148556|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
154148557|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148558|NCT05319587|Cytarabine|cytarabine|mesh-list
154148559|NCT05319587|Annamycin|annamycin|mesh-list
154148560|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153360368|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360369|NCT00806078|Quinine|quinine|mesh-list
153820369|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
153820370|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820372|NCT00433043|Carvedilol|carvedilol|mesh-list
153820373|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153820374|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153820375|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153820376|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
153820377|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
153820378|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820379|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820380|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153820381|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153820382|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
153820383|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820384|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820385|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
153820386|NCT00433043|Protective Agents|protective agents|mesh-ancestor
154148561|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
154148562|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148563|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148564|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
154148565|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148566|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154148567|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
154148568|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148569|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154148570|NCT05318755|Testosterone|testosterone|mesh-list
154148571|NCT05318755|Androgens|androgens|mesh-ancestor
154148572|NCT05318755|Hormones|hormones|mesh-ancestor
154148573|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148574|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148575|NCT05291403|Erythromycin|erythromycin|mesh-list
154148576|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
154148577|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154148578|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
154148579|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148580|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148581|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154148582|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154148583|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148584|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148585|NCT05269459|Cannabidiol|cannabidiol|mesh-list
154148586|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
154148587|NCT05261672|Midazolam|midazolam|mesh-list
154148592|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148593|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
154148594|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148595|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154148596|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154148597|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154148598|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154148599|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154148600|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154148601|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
154148602|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
154148603|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
154148604|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148605|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148606|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
153820388|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820389|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153820390|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
153820391|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153820392|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153820393|NCT03273075|Ticagrelor|ticagrelor|mesh-list
153820394|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153820395|NCT03273075|Cangrelor|cangrelor|mesh-list
153820396|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153360370|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
153360371|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153360372|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153360373|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148608|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
154148609|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148610|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148611|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148612|NCT05232851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148613|NCT05232851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148614|NCT05226871|Cetuximab|cetuximab|mesh-list
154148615|NCT05226871|Letrozole|letrozole|mesh-list
154148616|NCT05226871|Fulvestrant|fulvestrant|mesh-list
154148617|NCT05226871|Palbociclib|palbociclib|mesh-list
154148618|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148619|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148620|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154148621|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154148622|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148623|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148624|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154148625|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148626|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148627|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148628|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154148629|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154148630|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148631|NCT05205486|Cefazolin|cefazolin|mesh-list
154148632|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148633|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148634|NCT05178862|Fluconazole|fluconazole|mesh-list
154148635|NCT05178862|Caspofungin|caspofungin|mesh-list
154148636|NCT05178862|Micafungin|micafungin|mesh-list
154148637|NCT05178862|Anidulafungin|anidulafungin|mesh-list
154148638|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
153360385|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153360386|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153360387|NCT00806234|Ziprasidone|ziprasidone|mesh-list
153360388|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153360389|NCT00806234|Asenapine|asenapine|mesh-list
153360390|NCT00806234|Iloperidone|iloperidone|mesh-list
153360391|NCT00806234|Perphenazine|perphenazine|mesh-list
153360392|NCT00806234|Fluoxetine|fluoxetine|mesh-list
153360393|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153360394|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360395|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153665603|NCT00129246|Bupropion|bupropion|mesh-list
154148639|NCT05178862|Echinocandins|echinocandins|mesh-list
154148640|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
154148641|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148642|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154148643|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154148644|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148645|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148646|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154148647|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148648|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148649|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148650|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154148651|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154148652|NCT05139563|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154148653|NCT05139563|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154148654|NCT05139563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154148655|NCT05139563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154148656|NCT05138549|Beta Carotene|beta carotene|mesh-list
154148657|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148658|NCT05138549|Provitamins|provitamins|mesh-ancestor
154148667|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154148669|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
154148670|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
154148671|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
154148672|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154148673|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154148674|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154148675|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148676|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148677|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
154148678|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148679|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148680|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154148681|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148682|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
153360396|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
153360397|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360398|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360399|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153360400|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153360401|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360402|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153820400|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
153820401|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820402|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820403|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820404|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153820405|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153820417|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820418|NCT01051466|Analgesics|analgesics|mesh-ancestor
153820419|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
154148683|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148684|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148685|NCT05067166|Ansuvimab|ansuvimab|mesh-list
154148686|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
154148687|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148688|NCT05059535|Acetaminophen|acetaminophen|mesh-list
154148689|NCT05059535|Analgesics|analgesics|mesh-list
154148690|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154148691|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
154148692|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148693|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148694|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
154148695|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
154148696|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154148697|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154148698|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148699|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
154148700|NCT05053867|Coagulants|coagulants|mesh-ancestor
154148701|NCT05020574|Cephalexin|cephalexin|mesh-list
154148702|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148703|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148704|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
154148705|NCT05013632|Remdesivir|remdesivir|mesh-list
154148706|NCT05013632|Sotrovimab|sotrovimab|mesh-list
154148707|NCT05013632|Molnupiravir|molnupiravir|mesh-list
154148708|NCT05013632|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154148709|NCT05013632|Antibodies|antibodies|mesh-list
154148710|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154148711|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
154148712|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148713|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148714|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
154148715|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148716|NCT05004077|Amiodarone|amiodarone|mesh-list
154148717|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154148718|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
154148719|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154148720|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148721|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148722|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154148723|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154148724|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154148725|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820420|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820421|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
153820422|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153820423|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
153820424|NCT01051349|Daclizumab|daclizumab|mesh-list
153360403|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153360404|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
153360405|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
153360406|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
153360407|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360408|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153360409|NCT00806234|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153360410|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153360411|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153360412|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
153360413|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
154148726|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154148727|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154148728|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154148761|NCT04957329|Latanoprost|latanoprost|mesh-list
153729718|NCT00131027|Etoposide|etoposide|mesh-list
154148763|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154148764|NCT04932096|Melatonin|melatonin|mesh-list
154148765|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
154148766|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148767|NCT04932096|Protective Agents|protective agents|mesh-ancestor
154148768|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148784|NCT04928066|Hormones|hormones|mesh-ancestor
154148785|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148786|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148787|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154148788|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148789|NCT04928066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154148790|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148791|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148792|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148793|NCT04918524|Aspirin|aspirin|mesh-list
154148794|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
154148795|NCT04918524|Prednisone|prednisone|mesh-list
154148796|NCT04918524|Heparin|heparin|mesh-list
154148797|NCT04918524|Enoxaparin|enoxaparin|mesh-list
154148798|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154148799|NCT04918524|Tinzaparin|tinzaparin|mesh-list
154148800|NCT04918524|Dalteparin|dalteparin|mesh-list
154148801|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154148802|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
154148803|NCT04918524|Hormones|hormones|mesh-ancestor
154148804|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148805|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148806|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154148807|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148808|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154148809|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154148810|NCT04918524|Analgesics|analgesics|mesh-ancestor
154148811|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
154148812|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794303|NCT00259883|Paroxetine|paroxetine|mesh-list
153820425|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153360419|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153360420|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153360421|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360422|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153360423|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153360424|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153360425|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
153360426|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
153360427|NCT01275365|Testosterone|testosterone|mesh-list
153360428|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
153360429|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
153360430|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153360431|NCT01275365|Androgens|androgens|mesh-ancestor
153665802|NCT00017576|Calcitriol|calcitriol|mesh-list
154148813|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154148814|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154148815|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154148816|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148817|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154148818|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154148819|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148820|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
154148821|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
154148822|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
154148823|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154148824|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154148825|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148826|NCT04912115|Midazolam|midazolam|mesh-list
154148827|NCT04912115|Ketamine|ketamine|mesh-list
154148828|NCT04912115|Analgesics|analgesics|mesh-ancestor
154148829|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
154148838|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154148839|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148840|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148841|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154148842|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154148843|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154148844|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154148845|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154148846|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
154148848|NCT04896645|Albuterol|albuterol|mesh-list
154148849|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154148850|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
154148851|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148852|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148853|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154148854|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
154148855|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
154148856|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154148857|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153626802|NCT02019095|Dimercaprol|dimercaprol|mesh-list
153820447|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820448|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153820449|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
153820450|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
154148858|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154148859|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154148860|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
154148861|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148862|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148863|NCT04854395|Bupivacaine|bupivacaine|mesh-list
154148864|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
154148865|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
154148866|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154148867|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148868|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
154148869|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148870|NCT04827537|Metronidazole|metronidazole|mesh-list
154148871|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148872|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154148873|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154148874|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154148875|NCT04820179|Atezolizumab|atezolizumab|mesh-list
154148876|NCT04820179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154148877|NCT04820179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148878|NCT04820179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154148879|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148880|NCT04820036|Insulin|insulin|mesh-list
154148881|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154148882|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148883|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154148884|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154148885|NCT04800692|Verapamil|verapamil|mesh-list
154148886|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154148887|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154148888|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154148889|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148890|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154148891|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148892|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
154148909|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154148910|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148913|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
154148914|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
154148915|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
154148916|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154148917|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148918|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154148919|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154148920|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154148921|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154148922|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154148923|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154148924|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
154148925|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154148926|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148927|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154148928|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
154148929|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154148930|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154148931|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
154148932|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
154148933|NCT04710368|Evolocumab|evolocumab|mesh-list
154148934|NCT04710368|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153820454|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
153360432|NCT01275365|Hormones|hormones|mesh-ancestor
153360433|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665856|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
154148935|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154148936|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154148937|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
154148938|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148939|NCT04710368|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154148940|NCT04710368|Protease Inhibitors|protease inhibitors|mesh-ancestor
154148941|NCT04710368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148942|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154148943|NCT04695340|Psyllium|psyllium|mesh-list
154148944|NCT04695340|Cathartics|cathartics|mesh-ancestor
154148945|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154148946|NCT04672005|Leucovorin|leucovorin|mesh-list
154148947|NCT04672005|Paclitaxel|paclitaxel|mesh-list
154148948|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154148949|NCT04672005|Gemcitabine|gemcitabine|mesh-list
154148950|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
154148951|NCT04672005|Irinotecan|irinotecan|mesh-list
154148952|NCT04672005|Folfirinox|folfirinox|mesh-list
154148953|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154148954|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148981|NCT04638751|Immunologic Factors|immunologic factors|mesh-ancestor
154148982|NCT04638751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148983|NCT04606446|Letrozole|letrozole|mesh-list
154148984|NCT04606446|Fulvestrant|fulvestrant|mesh-list
153444422|NCT03822377|Ticagrelor|ticagrelor|mesh-list
154148985|NCT04606446|Palbociclib|palbociclib|mesh-list
154148986|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154148987|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154148988|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154148989|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154148990|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154148991|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154148992|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
154148993|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154148994|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154148995|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154148996|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154148997|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154148998|NCT04602117|Paclitaxel|paclitaxel|mesh-list
154148999|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154149000|NCT04602117|Trastuzumab|trastuzumab|mesh-list
153360434|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360435|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153360436|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360437|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
153360438|NCT00811850|Timolol|timolol|mesh-list
153360439|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153360440|NCT00811850|Dorzolamide|dorzolamide|mesh-list
153360441|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153360442|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153360443|NCT00811850|Maleic acid|maleic acid|mesh-list
153360444|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360445|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360446|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153360447|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153360448|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
153360449|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149001|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154149002|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149003|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
154149004|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149024|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149026|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149027|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
154149028|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154149029|NCT04538092|Analgesics|analgesics|mesh-list
154149030|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149031|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
154149032|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149033|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149034|NCT04502849|Vitamin E|vitamin e|mesh-list
154149035|NCT04502849|Tocopherols|tocopherols|mesh-list
154149036|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
154149037|NCT04502849|Vitamins|vitamins|mesh-ancestor
154149038|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
154149039|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149040|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
154149041|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149042|NCT04502849|Protective Agents|protective agents|mesh-ancestor
154149043|NCT04502602|Niraparib|niraparib|mesh-list
154149044|NCT04502602|Neratinib|neratinib|mesh-list
154149045|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154149046|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149047|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149048|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149049|NCT04502602|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154149050|NCT04502602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154149051|NCT04493216|Dolutegravir|dolutegravir|mesh-list
154149052|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154149053|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154149054|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149055|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149056|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154149057|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154149058|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
153658869|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
153820455|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820456|NCT00463671|Expectorants|expectorants|mesh-ancestor
153820457|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
153820458|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153820459|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
153820460|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820461|NCT00463671|Protective Agents|protective agents|mesh-ancestor
153820462|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820463|NCT00463671|Antidotes|antidotes|mesh-ancestor
153360452|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153360453|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153360454|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153360455|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153360456|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154149078|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
154149079|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149080|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154149081|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154149082|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149083|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
154149084|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
154149085|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149086|NCT04345341|Bupivacaine|bupivacaine|mesh-list
154149087|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
154149088|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
154149089|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154149090|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149091|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
154149092|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149093|NCT04329949|Paclitaxel|paclitaxel|mesh-list
154149094|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153444481|NCT01094561|Secretin|secretin|mesh-list
154149095|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149096|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
154149097|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149098|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149099|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149100|NCT04329065|Paclitaxel|paclitaxel|mesh-list
154149101|NCT04329065|Trastuzumab|trastuzumab|mesh-list
154149102|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154149103|NCT04329065|Pertuzumab|pertuzumab|mesh-list
154149104|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154149105|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154149106|NCT04329065|Vaccines|vaccines|mesh-list
154149107|NCT04329065|Antibodies|antibodies|mesh-list
154149108|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
154149109|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154149110|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
154149111|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
154149112|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149113|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154149114|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149115|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
154149116|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149117|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149137|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
154149138|NCT04248452|Leucovorin|leucovorin|mesh-list
154149139|NCT04248452|Folic Acid|folic acid|mesh-list
154149140|NCT04248452|Capecitabine|capecitabine|mesh-list
154149141|NCT04248452|Fluorouracil|fluorouracil|mesh-list
154149142|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
154149144|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
153820473|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820474|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
153820475|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153820476|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
153820477|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820478|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820479|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
153820480|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820481|NCT00433277|Cyclosporine|cyclosporine|mesh-list
153820482|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153915297|NCT02703571|Trametinib|trametinib|mesh-list
154149145|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154149146|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149147|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154149148|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154149149|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
154149150|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149151|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149152|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149153|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
154149154|NCT04248452|Antidotes|antidotes|mesh-ancestor
154149155|NCT04248452|Protective Agents|protective agents|mesh-ancestor
154149156|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
154149157|NCT04248452|Vitamins|vitamins|mesh-ancestor
154149158|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
154149159|NCT04248452|Hematinics|hematinics|mesh-ancestor
154149160|NCT04238637|Durvalumab|durvalumab|mesh-list
154149161|NCT04238637|Tremelimumab|tremelimumab|mesh-list
154149162|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149163|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149164|NCT04198623|Montelukast|montelukast|mesh-list
154149165|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154149166|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
154149167|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154149168|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
154149169|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149170|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149171|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154149172|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154149173|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149174|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
154149175|NCT04191096|Androgens|androgens|mesh-list
153658982|NCT04917900|Paclitaxel|paclitaxel|mesh-list
154149192|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154149193|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
154149195|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
154149196|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154149197|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154149198|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149207|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154149208|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154149209|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154149210|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149211|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154149212|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149213|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820487|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
153820488|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360467|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153360468|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
153360469|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360470|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360471|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
153360472|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360473|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153360474|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
153360475|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360476|NCT00844298|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153360477|NCT00844298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154149214|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154149215|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154149216|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154149217|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149218|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
154149219|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154149220|NCT04083495|Fludarabine|fludarabine|mesh-list
154149221|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149222|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
154149223|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149224|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149225|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149226|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
154149227|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149228|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149229|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153659039|NCT00392340|Topotecan|topotecan|mesh-list
154149249|NCT04028596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154149251|NCT04006483|Fluorides|fluorides|mesh-list
154149252|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
154149253|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
154149254|NCT04006483|Protective Agents|protective agents|mesh-ancestor
154149255|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149256|NCT04003649|Nivolumab|nivolumab|mesh-list
154149257|NCT04003649|Ipilimumab|ipilimumab|mesh-list
154149258|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149259|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149260|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149261|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149262|NCT04002141|Letrozole|letrozole|mesh-list
154149263|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149264|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154149265|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154149266|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149267|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149268|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154149269|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
154149270|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149271|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149272|NCT03999710|Durvalumab|durvalumab|mesh-list
154149273|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149274|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149275|NCT03970096|Cyclosporine|cyclosporine|mesh-list
154149276|NCT03970096|Sirolimus|sirolimus|mesh-list
154149277|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
154149278|NCT03970096|Busulfan|busulfan|mesh-list
154149279|NCT03970096|Thiotepa|thiotepa|mesh-list
154149280|NCT03970096|Methotrexate|methotrexate|mesh-list
154149281|NCT03970096|Fludarabine|fludarabine|mesh-list
154149282|NCT03970096|Tacrolimus|tacrolimus|mesh-list
154149283|NCT03970096|Cyclosporins|cyclosporins|mesh-list
154149284|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149285|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
153659088|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154149308|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
154149309|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149310|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154149311|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154149312|NCT03944954|Analgesics|analgesics|mesh-ancestor
154149313|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
154149314|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149315|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154149316|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153666255|NCT00020943|Leucovorin|leucovorin|mesh-list
154149317|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149318|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149319|NCT03944954|Hormones|hormones|mesh-ancestor
154149320|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149321|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
154149322|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
154149323|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149324|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149325|NCT03899805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149326|NCT03899805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149327|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154149328|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154149329|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
154149330|NCT03897127|Cytarabine|cytarabine|mesh-list
154149331|NCT03897127|Daunorubicin|daunorubicin|mesh-list
154149332|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154149333|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
154149334|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149335|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149368|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149369|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
154149370|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149371|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154149372|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
154149373|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154149374|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154149375|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149376|NCT03828019|Cyclosporine|cyclosporine|mesh-list
154149377|NCT03828019|Adalimumab|adalimumab|mesh-list
154149378|NCT03828019|Methotrexate|methotrexate|mesh-list
154149411|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
154149412|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149413|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149414|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154149415|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
154149416|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
154149417|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154149418|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154149419|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
154149420|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149421|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149422|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
154149439|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529769|NCT01486953|Sevoflurane|sevoflurane|mesh-list
154149440|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154149441|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
154149442|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
154149443|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
154149444|NCT03774472|Letrozole|letrozole|mesh-list
154149445|NCT03774472|Palbociclib|palbociclib|mesh-list
154149446|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149447|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154149448|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154149449|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149450|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149451|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154149452|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
154149453|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149454|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149455|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
154149456|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154149457|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154149458|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149459|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360478|NCT00844298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360479|NCT01329185|Valganciclovir|valganciclovir|mesh-list
154149460|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154149461|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
154149462|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149463|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149464|NCT03753659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149465|NCT03753659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149466|NCT03679676|Omalizumab|omalizumab|mesh-list
154149467|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154149468|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154149469|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
154149470|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
154149471|NCT03666000|Fludarabine|fludarabine|mesh-list
154149472|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149473|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
154149474|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149475|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149476|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149477|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
154149478|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149491|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149492|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
154149494|NCT03637062|Progestins|progestins|mesh-ancestor
154149495|NCT03637062|Hormones|hormones|mesh-ancestor
153444560|NCT03792191|Fentanyl|fentanyl|mesh-list
154149496|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149497|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149498|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
154149499|NCT03624036|Fludarabine|fludarabine|mesh-list
154149500|NCT03624036|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154149501|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149502|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
154149503|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149504|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149505|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149506|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
154149507|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149508|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149509|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154149510|NCT03624036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149511|NCT03618134|Durvalumab|durvalumab|mesh-list
154149512|NCT03618134|Ipilimumab|ipilimumab|mesh-list
154149513|NCT03618134|Tremelimumab|tremelimumab|mesh-list
154149514|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
154149515|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154149516|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
154149517|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149518|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149519|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
154149520|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149521|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149522|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149523|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
154149524|NCT03602612|Fludarabine|fludarabine|mesh-list
154149525|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149526|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
154149527|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149528|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149529|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149530|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
154149531|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149532|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360480|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
153360481|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360482|NCT01276301|Empagliflozin|empagliflozin|mesh-list
153360483|NCT01276301|Verapamil|verapamil|mesh-list
154149533|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154149534|NCT03557619|Venetoclax|venetoclax|mesh-list
154149535|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
154149536|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154149537|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154149538|NCT03557619|Estradiol|estradiol|mesh-list
154149539|NCT03557619|Estrogens|estrogens|mesh-ancestor
154149540|NCT03557619|Hormones|hormones|mesh-ancestor
154149541|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149542|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149560|NCT03498521|Ipatasertib|ipatasertib|mesh-list
154149561|NCT03498521|Ivosidenib|ivosidenib|mesh-list
154149562|NCT03498521|Alectinib|alectinib|mesh-list
154149563|NCT03498521|Entrectinib|entrectinib|mesh-list
154149564|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149565|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149566|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149567|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154149568|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154149569|NCT03498521|Growth Substances|growth substances|mesh-ancestor
154149570|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149571|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
154149572|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154149573|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
154149574|NCT03498521|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154149575|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154149576|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149577|NCT03498521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149578|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154149580|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154149581|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154149582|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149583|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149584|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149585|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
154256469|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154149586|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153360500|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360501|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153666579|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154149587|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149588|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149589|NCT03457948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149590|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149591|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154149593|NCT03442569|Ipilimumab|ipilimumab|mesh-list
154149594|NCT03442569|Panitumumab|panitumumab|mesh-list
154149595|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149596|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149597|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149598|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149599|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
154149600|NCT03420963|Etoposide|etoposide|mesh-list
154149601|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
154149602|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
154149603|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149631|NCT03383458|Nivolumab|nivolumab|mesh-list
154149632|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149633|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149634|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149635|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149636|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
154149637|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149638|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149639|NCT03319745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149640|NCT03319745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149641|NCT03309150|Paclitaxel|paclitaxel|mesh-list
154149642|NCT03309150|Carboplatin|carboplatin|mesh-list
154149643|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154149644|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149645|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
154149646|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149647|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149648|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149649|NCT03243058|Aldesleukin|aldesleukin|mesh-list
154149659|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
154149660|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149661|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154149662|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154149663|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149664|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154149665|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154149666|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154149667|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149668|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
154149669|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149670|NCT03187080|Bupivacaine|bupivacaine|mesh-list
154149671|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
154149672|NCT03187080|Anesthetics|anesthetics|mesh-list
154149673|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154149674|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149675|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
154149676|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149677|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
154149678|NCT03179384|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153820489|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
153820490|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820491|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
153820492|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153820493|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153820495|NCT00463827|Atorvastatin|atorvastatin|mesh-list
153820496|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153820497|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154149679|NCT03179384|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154149680|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154149681|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149682|NCT03176693|Doxazosin|doxazosin|mesh-list
154149683|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
154149684|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154149685|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154149686|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154149687|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154149688|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154149689|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154149690|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149691|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149692|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
154149693|NCT03141034|Irinotecan|irinotecan|mesh-list
154149694|NCT03141034|Ramucirumab|ramucirumab|mesh-list
154149695|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154149696|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154149697|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149698|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149699|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149700|NCT03141034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154149701|NCT03141034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154149702|NCT03141034|Growth Substances|growth substances|mesh-ancestor
154149703|NCT03141034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149704|NCT03141034|Growth Inhibitors|growth inhibitors|mesh-ancestor
154149705|NCT03094052|Trastuzumab|trastuzumab|mesh-list
154149706|NCT03094052|Atropine|atropine|mesh-list
154149707|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
154149708|NCT03094052|Loperamide|loperamide|mesh-list
154149709|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
154149710|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
154149711|NCT03094052|Neratinib|neratinib|mesh-list
154149712|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149713|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149714|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153659515|NCT00399022|Analgesics|analgesics|mesh-ancestor
154149737|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
154149738|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
154149739|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149740|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149741|NCT03092323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153530072|NCT01488838|Cisplatin|cisplatin|mesh-list
154149742|NCT03092323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149743|NCT03083821|Entecavir|entecavir|mesh-list
154149744|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
154149745|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154149746|NCT03056001|Doxorubicin|doxorubicin|mesh-list
154149747|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
154149748|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154149749|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149750|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154149751|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154149752|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149753|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149754|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149755|NCT03056001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149756|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
154149757|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153820498|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
153820499|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820500|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154149758|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
154149759|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149760|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149761|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154149762|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
154149763|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154149764|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
153659571|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154149783|NCT02990338|Dexamethasone|dexamethasone|mesh-list
154149784|NCT02990338|Pomalidomide|pomalidomide|mesh-list
154149785|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154149786|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
154149787|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
154149788|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149789|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149790|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154149791|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
154149793|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149794|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154149795|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149796|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
154149797|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154149798|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154149799|NCT02990338|Growth Substances|growth substances|mesh-ancestor
154149800|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
154149811|NCT02950766|Ipilimumab|ipilimumab|mesh-list
154149812|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149813|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149814|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149815|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149816|NCT02907983|Bupivacaine|bupivacaine|mesh-list
154149817|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
154149818|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
154149819|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153659626|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149849|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149850|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
154149851|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149852|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149853|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154149854|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154149855|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
154149856|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
154149857|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154149858|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154149859|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
154149860|NCT02877303|Hormones|hormones|mesh-ancestor
154149861|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149862|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154149863|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
154149864|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149865|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154149866|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154149867|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154149868|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154149869|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
154149870|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154149871|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154149881|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149882|NCT02877303|Immunotoxins|immunotoxins|mesh-ancestor
154149883|NCT02877303|Immunoconjugates|immunoconjugates|mesh-ancestor
154149884|NCT02822378|Vitamin D|vitamin d|mesh-list
154149885|NCT02822378|Calcium|calcium|mesh-list
154149886|NCT02822378|Vitamins|vitamins|mesh-ancestor
154149887|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
154149888|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149889|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154149890|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154149891|NCT02813655|Cosyntropin|cosyntropin|mesh-list
154149892|NCT02813655|Hormones|hormones|mesh-ancestor
154149893|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149894|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149896|NCT02733042|Durvalumab|durvalumab|mesh-list
154149897|NCT02733042|Lenalidomide|lenalidomide|mesh-list
154149898|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154149899|NCT02733042|Ibrutinib|ibrutinib|mesh-list
154149900|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149901|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149902|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
154149903|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149904|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154149905|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154149906|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154149907|NCT02733042|Growth Substances|growth substances|mesh-ancestor
154149908|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
154149909|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154149910|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
154149911|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149912|NCT02733042|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154149913|NCT02733042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154149914|NCT02733042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149915|NCT02689427|Paclitaxel|paclitaxel|mesh-list
154149916|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154149917|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154149918|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149919|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
154149920|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149921|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149922|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149923|NCT02673931|Exenatide|exenatide|mesh-list
154149924|NCT02673931|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154149925|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154149926|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149927|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154149928|NCT02673931|Incretins|incretins|mesh-ancestor
154149929|NCT02673931|Hormones|hormones|mesh-ancestor
154149930|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154149931|NCT02654561|Heparin|heparin|mesh-list
154149932|NCT02654561|Calcium heparin|calcium heparin|mesh-list
154149933|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
154149934|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154149935|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154149936|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149937|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
154149938|NCT02614066|Fludarabine|fludarabine|mesh-list
154149939|NCT02614066|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
154149963|NCT02599324|Paclitaxel|paclitaxel|mesh-list
154149964|NCT02599324|Docetaxel|docetaxel|mesh-list
154149965|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
154149966|NCT02599324|Cetuximab|cetuximab|mesh-list
154149967|NCT02599324|Everolimus|everolimus|mesh-list
154149968|NCT02599324|Ibrutinib|ibrutinib|mesh-list
154149969|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154149970|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154149971|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
154149972|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
154149973|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
154149974|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154149975|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154149976|NCT02599324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154149977|NCT02599324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154149978|NCT02599324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154149979|NCT02599324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154149980|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154149981|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
154149982|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154149983|NCT02599324|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154149984|NCT02586831|Exenatide|exenatide|mesh-list
154149985|NCT02586831|Aldesleukin|aldesleukin|mesh-list
154149986|NCT02586831|Adalimumab|adalimumab|mesh-list
154149987|NCT02586831|Interleukin-2|interleukin-2|mesh-list
154149988|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
154149989|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154149990|NCT02586831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154149991|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154150018|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150019|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
154150020|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150022|NCT02231723|Paclitaxel|paclitaxel|mesh-list
154150023|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154150024|NCT02231723|Gemcitabine|gemcitabine|mesh-list
154150025|NCT02231723|Fluorouracil|fluorouracil|mesh-list
154150026|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
154150028|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154150029|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150030|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
154150031|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
154150032|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
154150033|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150034|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150035|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
154150036|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153820507|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820508|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
153820509|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820510|NCT00472134|Bupivacaine|bupivacaine|mesh-list
153820511|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
153820512|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
153820513|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820514|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820515|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
153820516|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820517|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154150037|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
154150038|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150039|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154150040|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154150041|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150042|NCT02231723|Antidotes|antidotes|mesh-ancestor
154150043|NCT02231723|Protective Agents|protective agents|mesh-ancestor
154150057|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150059|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150060|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150061|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154150062|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154150063|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150064|NCT01765218|Topiramate|topiramate|mesh-list
154150065|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
154150066|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154150067|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150068|NCT01756040|Lactulose|lactulose|mesh-list
154256471|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
154150069|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154150070|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154150071|NCT01500473|Desogestrel|desogestrel|mesh-list
154150072|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154150073|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154150074|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154150075|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
154150076|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154150077|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150078|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154150079|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154150080|NCT01500473|Progestins|progestins|mesh-ancestor
154150081|NCT01500473|Hormones|hormones|mesh-ancestor
154150082|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150083|NCT01306357|Hormones|hormones|mesh-list
154150084|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820518|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153820519|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820520|NCT00463983|Octreotide|octreotide|mesh-list
153820521|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153820522|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153360502|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360503|NCT01330043|Bupropion|bupropion|mesh-list
153360504|NCT01330043|Nicotine|nicotine|mesh-list
153360505|NCT01330043|Varenicline|varenicline|mesh-list
153667169|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154150085|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150086|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
154150087|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154150088|NCT01219075|Estrogens|estrogens|mesh-ancestor
154150089|NCT01219075|Hormones|hormones|mesh-ancestor
154150090|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150091|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150092|NCT00871936|Metformin|metformin|mesh-list
154150093|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154150094|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150095|NCT00741910|Semapimod|semapimod|mesh-list
154150096|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154150097|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154150098|NCT00741910|Analgesics|analgesics|mesh-ancestor
154150099|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
154150100|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150101|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150102|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154150103|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150104|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150105|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
154150106|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
154150110|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154150111|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154150112|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150113|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150114|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150115|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154150116|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
154150117|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154150118|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150119|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154150120|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154150121|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154150122|NCT00736931|Levetiracetam|levetiracetam|mesh-list
154150123|NCT00736931|Lorazepam|lorazepam|mesh-list
153473639|NCT02973204|Lanreotide|lanreotide|mesh-list
154150124|NCT00736931|Brivaracetam|brivaracetam|mesh-list
154150125|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
154150126|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
154150127|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
154150128|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
154150129|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150130|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150131|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154150132|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154150133|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150134|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154150135|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153360508|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360509|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360510|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153360511|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153360512|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
153360513|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360514|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360515|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153360516|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
154150136|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150137|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
154150138|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
154150139|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150140|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150141|NCT00567164|Drospirenone|drospirenone|mesh-list
154150142|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154150143|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
154256472|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150144|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150145|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150146|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154150147|NCT00567164|Diuretics|diuretics|mesh-ancestor
154150148|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
154150149|NCT00920933|Prednisolone|prednisolone|mesh-list
154150150|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154150151|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
154150152|NCT00920933|Hormones|hormones|mesh-ancestor
154150153|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150154|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150155|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154150156|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150157|NCT00930566|Methoxsalen|methoxsalen|mesh-list
154150158|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154150159|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
154150160|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
154150161|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154150162|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154150163|NCT00925730|Analgesics|analgesics|mesh-ancestor
154150164|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
154150165|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150166|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150167|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154150168|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150169|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
154150170|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150171|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
154150172|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154150173|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150174|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150177|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150178|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
154150184|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
154150186|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
154150187|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150188|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154150189|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154150190|NCT00931736|Rifampin|rifampin|mesh-list
154150191|NCT00931736|Isoniazid|isoniazid|mesh-list
154150192|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154150193|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
154150194|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154150195|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150196|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
154150197|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154150198|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150199|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150200|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154150201|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154150202|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153820523|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820524|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
153820525|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154150203|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154150204|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154150205|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154150206|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154150207|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154150208|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
154150209|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154150210|NCT02567981|Vitamin A|vitamin a|mesh-list
154150211|NCT02567981|Micronutrients|micronutrients|mesh-list
154150212|NCT02567981|Trace Elements|trace elements|mesh-list
154150213|NCT02567981|Vitamins|vitamins|mesh-ancestor
154150214|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150215|NCT00737555|Tosedostat|tosedostat|mesh-list
154150216|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150217|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150218|NCT00932048|Atorvastatin|atorvastatin|mesh-list
154150219|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154150220|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154150221|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
154150222|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150223|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154256473|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256474|NCT01161836|Iniparib|iniparib|mesh-list
154256475|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154256476|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256477|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256478|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256479|NCT01266434|Simvastatin|simvastatin|mesh-list
154256480|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154256481|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154256482|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
154256483|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150224|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153820526|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153820527|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
153820528|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820529|NCT00472173|Calcium|calcium|mesh-list
153820530|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153820531|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820532|NCT00472329|Fludarabine|fludarabine|mesh-list
153820533|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820534|NCT00464217|Idarubicin|idarubicin|mesh-list
153820535|NCT00464217|Molgramostim|molgramostim|mesh-list
153820536|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153820537|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820538|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153360517|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153360518|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153360519|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153360520|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153360522|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153360523|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154150225|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150226|NCT04015778|Paclitaxel|paclitaxel|mesh-list
154150227|NCT04015778|Carboplatin|carboplatin|mesh-list
154150228|NCT04015778|Nivolumab|nivolumab|mesh-list
154150229|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154150230|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150231|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
154150232|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154150233|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154150234|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150235|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154150236|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154150237|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
154150238|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154150239|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
154150240|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150241|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150242|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154150243|NCT00926354|Protective Agents|protective agents|mesh-ancestor
154150244|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154150245|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154150246|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150259|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150261|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150262|NCT00700115|Ritonavir|ritonavir|mesh-list
154150263|NCT00700115|Lopinavir|lopinavir|mesh-list
154150264|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
154150265|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154150266|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154150267|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154150268|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
154150269|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150270|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150271|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154150272|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
154150273|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150274|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153820539|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153820540|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820541|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820542|NCT00433784|Clopidogrel|clopidogrel|mesh-list
153820543|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153820544|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154150275|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154150276|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154150277|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154150278|NCT00566852|Memantine|memantine|mesh-list
154150279|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154150280|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154150281|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
154150282|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150283|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150284|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150285|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154150286|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153736400|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150287|NCT00936650|Cinacalcet|cinacalcet|mesh-list
154150288|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154150289|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150290|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154150291|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
154150292|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150293|NCT00442546|Pregabalin|pregabalin|mesh-list
154150294|NCT00442546|Analgesics|analgesics|mesh-ancestor
154150295|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
154150296|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150297|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150298|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
154150299|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154150300|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150301|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150302|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154150303|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154150304|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154150305|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150306|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150314|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820545|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153820546|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153820547|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
153820548|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360537|NCT02193815|Calcipotriene|calcipotriene|mesh-list
153360538|NCT02193815|Tofacitinib|tofacitinib|mesh-list
153360539|NCT02193815|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153360540|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153360541|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360542|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360543|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
154150316|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
154150317|NCT00566696|Melphalan|melphalan|mesh-list
154150318|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
154150319|NCT00566696|Thiotepa|thiotepa|mesh-list
154150320|NCT00566696|Rituximab|rituximab|mesh-list
154150321|NCT00566696|Fludarabine|fludarabine|mesh-list
154150322|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
154150323|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
154150325|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
154150326|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150327|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
154150328|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150329|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150330|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154150331|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
154150332|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150333|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150334|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154150335|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154150336|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154150337|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154150338|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
154150339|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154150340|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150341|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150342|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
154150343|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
154150344|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
154150345|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150346|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150347|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
154150348|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150349|NCT00926900|Cycloserine|cycloserine|mesh-list
154150350|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154150351|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150352|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154150353|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
154150354|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154150355|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
154150356|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150357|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154150358|NCT00503841|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154150359|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150360|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150361|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150362|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150363|NCT00937508|Varenicline|varenicline|mesh-list
154150364|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154150365|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154150366|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
153820550|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820551|NCT00464256|Rimonabant|rimonabant|mesh-list
153820552|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153820553|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154150367|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150368|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150369|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150371|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150372|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
154150373|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150374|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150375|NCT00937820|Darexaban|darexaban|mesh-list
154150407|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150408|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150409|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
154150410|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150411|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154150412|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154150413|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154150414|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150415|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150417|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154150418|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
154150419|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150420|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150443|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150445|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154150446|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150447|NCT01562990|Rituximab|rituximab|mesh-list
154150448|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154150449|NCT01562990|Gemcitabine|gemcitabine|mesh-list
154150450|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
154150451|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154150452|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150453|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
154150454|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150455|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150456|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150457|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
154150458|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150459|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154150460|NCT01562990|Immunotoxins|immunotoxins|mesh-ancestor
154150461|NCT01562990|Immunoconjugates|immunoconjugates|mesh-ancestor
154150462|NCT00737867|Carboplatin|carboplatin|mesh-list
154150463|NCT00737867|Gemcitabine|gemcitabine|mesh-list
154150464|NCT00737867|Vinorelbine|vinorelbine|mesh-list
154150465|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150466|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150467|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
154150468|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150469|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154150470|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
154150472|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
154150498|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
154150499|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150500|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154150501|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
154150502|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150503|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154150504|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153820554|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153820563|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153820564|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
153360544|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153360545|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360546|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153360547|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150505|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154150506|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150507|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150508|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150509|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150510|NCT00933452|Analgesics|analgesics|mesh-ancestor
154150511|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
154150512|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150513|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
154150514|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150515|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
154150516|NCT00447694|Deferasirox|deferasirox|mesh-list
154150517|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154150518|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
154150519|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
154150520|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150532|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150533|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150534|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154150535|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154150536|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150537|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154150538|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
154150539|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
154150540|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
154150541|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
154150542|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150543|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150544|NCT00933998|Pyridoxal|pyridoxal|mesh-list
154150545|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
154150546|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
154150547|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
154150549|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
154150550|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150551|NCT00447226|Lapatinib|lapatinib|mesh-list
154150552|NCT00447226|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154150553|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150554|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150555|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150556|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150557|NCT00446992|Olanzapine|olanzapine|mesh-list
154150558|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
154150559|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
154150560|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360550|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
153360551|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153360552|NCT01277081|Acetaminophen|acetaminophen|mesh-list
153360553|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153360554|NCT01277081|Analgesics|analgesics|mesh-ancestor
153360555|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
153360556|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360557|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360558|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
153360559|NCT01361633|Cycloserine|cycloserine|mesh-list
153360560|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153360561|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360562|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153360563|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
153360564|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153360565|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
154150561|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150562|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154150563|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154150564|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154150565|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150566|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150567|NCT00446992|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154150568|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154150569|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150570|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729721|NCT00131027|Asparaginase|asparaginase|mesh-list
154150571|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150572|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
154150573|NCT00503139|Etanercept|etanercept|mesh-list
154150574|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154150575|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154150576|NCT00503139|Analgesics|analgesics|mesh-ancestor
154150577|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
154150578|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150579|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150580|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154150581|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154150582|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154150583|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150584|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
154150585|NCT00577031|Bevacizumab|bevacizumab|mesh-list
154150586|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
153660377|NCT00392691|Melphalan|melphalan|mesh-list
154150605|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150606|NCT01012011|Sorafenib|sorafenib|mesh-list
154150607|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150608|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150609|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150610|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150611|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154150612|NCT00934076|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154150613|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150614|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626803|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
153820570|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153820571|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
153820572|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820573|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820574|NCT03273036|Triamcinolone|triamcinolone|mesh-list
153820575|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153820576|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
153820577|NCT03273036|Hormones|hormones|mesh-ancestor
153820578|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820579|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820580|NCT03270735|Thrombin|thrombin|mesh-list
153820581|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
153820582|NCT03270735|Coagulants|coagulants|mesh-ancestor
153820583|NCT04702685|Ropivacaine|ropivacaine|mesh-list
153820584|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
153820585|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
154150615|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150616|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150617|NCT00934154|Thalidomide|thalidomide|mesh-list
154150618|NCT00934154|Prednisolone|prednisolone|mesh-list
154150619|NCT00934154|Melphalan|melphalan|mesh-list
154150620|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154150621|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
154150622|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150623|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150624|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154150625|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150626|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
154150627|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150628|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154150629|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
154150630|NCT00934154|Hormones|hormones|mesh-ancestor
154150631|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360577|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153360578|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153360579|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360580|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153360581|NCT01332071|Metformin|metformin|mesh-list
153360582|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
153360583|NCT01332071|Maleic acid|maleic acid|mesh-list
153360584|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153820587|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820588|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
153820589|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820590|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
153820591|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153820592|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153820593|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153820594|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820595|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820596|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
153820597|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820598|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820599|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153820600|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820602|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820603|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153820604|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360585|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360586|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150632|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154150633|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
154150634|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154150635|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150636|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154150637|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154150638|NCT00934154|Growth Substances|growth substances|mesh-ancestor
154150639|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
154150640|NCT00446446|Panitumumab|panitumumab|mesh-list
154150641|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660443|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150660|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154150661|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150662|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150663|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154150664|NCT02566967|Tofacitinib|tofacitinib|mesh-list
154150665|NCT02566967|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154150666|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150667|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150668|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150669|NCT00939068|Telbivudine|telbivudine|mesh-list
154150670|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
154150671|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150672|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154150673|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150674|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150675|NCT00934232|Busulfan|busulfan|mesh-list
154150676|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
154150677|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150678|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150679|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
154150680|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150681|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154150682|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150683|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154150684|NCT01013571|Insulin|insulin|mesh-list
154150685|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154150686|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
154150687|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
154150688|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154150689|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150690|NCT00514449|Valacyclovir|valacyclovir|mesh-list
154150691|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
154150692|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150693|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
154150694|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154150695|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
154150696|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150731|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154150732|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150733|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150756|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
154150757|NCT01015209|Coagulants|coagulants|mesh-ancestor
154150758|NCT04948463|Vancomycin|vancomycin|mesh-list
154150759|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
154150760|NCT04948463|Tazobactam|tazobactam|mesh-list
154150761|NCT04948463|Piperacillin|piperacillin|mesh-list
154150762|NCT04948463|Amikacin|amikacin|mesh-list
154150763|NCT04948463|Ceftazidime|ceftazidime|mesh-list
154150764|NCT04948463|Cefepime|cefepime|mesh-list
154150765|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154150766|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150767|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154150768|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154150769|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150770|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150772|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153360589|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
153360590|NCT01277159|Buprenorphine|buprenorphine|mesh-list
153360591|NCT01277159|BB 1101|bb 1101|mesh-list
153360592|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360593|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
154150773|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154150774|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154150775|NCT04948463|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154150776|NCT04948463|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154150777|NCT01080547|Capecitabine|capecitabine|mesh-list
154150778|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
154150779|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150780|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
154150781|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150782|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150783|NCT00111241|Letrozole|letrozole|mesh-list
154150784|NCT00111241|Anastrozole|anastrozole|mesh-list
154150785|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154150786|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150787|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154150788|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150789|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150790|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154150791|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
154150799|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150800|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150801|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154150802|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
154150803|NCT00446134|Ribavirin|ribavirin|mesh-list
154150804|NCT00446134|Taribavirin|taribavirin|mesh-list
154150805|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
154150806|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150807|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
154150808|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150809|NCT00934466|Levomethorphan|levomethorphan|mesh-list
154150810|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
154150811|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
154150812|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
154150813|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154150814|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154150815|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150816|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150817|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150818|NCT00934466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154150819|NCT00934466|Narcotics|narcotics|mesh-ancestor
154150820|NCT00934466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150821|NCT00934466|Analgesics|analgesics|mesh-ancestor
154150822|NCT00934466|Sensory System Agents|sensory system agents|mesh-ancestor
154150823|NCT00934466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150824|NCT00921245|Darifenacin|darifenacin|mesh-list
154150825|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154150826|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154150827|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
154150828|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150829|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150830|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150831|NCT00921245|Urological Agents|urological agents|mesh-ancestor
154150832|NCT00940238|Dexetimide|dexetimide|mesh-list
154150833|NCT00940238|Citalopram|citalopram|mesh-list
154150834|NCT00940238|Escitalopram|escitalopram|mesh-list
154150835|NCT00940238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154150836|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154150837|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150838|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150839|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154150840|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
154150841|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150842|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154150843|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
154150844|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150845|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154150846|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154150847|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
154150848|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
154150849|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150850|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154150851|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154150852|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
154150854|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154150855|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
154150856|NCT04013438|Estradiol|estradiol|mesh-list
154150857|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154150858|NCT04013438|Estrogens|estrogens|mesh-ancestor
154150872|NCT02565719|REP 2139|rep 2139|mesh-list
154150873|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150874|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
154150875|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150876|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154150877|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154150878|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150879|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150880|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154150881|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154150882|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
154150883|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150884|NCT00111007|Paclitaxel|paclitaxel|mesh-list
154150885|NCT00111007|Carboplatin|carboplatin|mesh-list
154150886|NCT00111007|Sorafenib|sorafenib|mesh-list
154150887|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154150888|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150889|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
154150890|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
154150891|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
154150892|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150893|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150894|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150895|NCT00699335|Fentanyl|fentanyl|mesh-list
154150896|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154150897|NCT00699335|Narcotics|narcotics|mesh-ancestor
154150898|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150899|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150900|NCT00699335|Analgesics|analgesics|mesh-ancestor
154150901|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
154150902|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150903|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154150904|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154150905|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
154150906|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
154150907|NCT00939614|Lamotrigine|lamotrigine|mesh-list
154150908|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
154150909|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154150910|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154150911|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150912|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154150913|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150914|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154150915|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154150916|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154150917|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150919|NCT03962881|Vaccines|vaccines|mesh-list
154150920|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
154150921|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150922|NCT00935246|Dexetimide|dexetimide|mesh-list
154150933|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154150934|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
154150935|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
154150936|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150937|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154150938|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153360595|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360596|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150939|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
154150940|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154150941|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
153360597|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154150942|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154150943|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
154150944|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154150945|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154150946|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
154150947|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154150948|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154150949|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154150950|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150951|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150952|NCT00939848|Cisplatin|cisplatin|mesh-list
154150953|NCT00939848|Gemcitabine|gemcitabine|mesh-list
154150954|NCT00939848|Cediranib|cediranib|mesh-list
154150955|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150956|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154150957|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
154150958|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150959|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154150960|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150961|NCT04013048|Fluzoparib|fluzoparib|mesh-list
154150962|NCT04013048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154150963|NCT04013048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150964|NCT04013048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150965|NCT04013048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150966|NCT00935558|Interleukin-2|interleukin-2|mesh-list
154150967|NCT00935558|Exemestane|exemestane|mesh-list
154150968|NCT00935558|Anastrozole|anastrozole|mesh-list
154150969|NCT00935558|Letrozole|letrozole|mesh-list
154150970|NCT00935558|Lactitol|lactitol|mesh-list
154150971|NCT00935558|Vaccines|vaccines|mesh-list
154150972|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154150973|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
154150974|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154150975|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154150976|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154150977|NCT00935558|Analgesics|analgesics|mesh-ancestor
154150978|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
154150979|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154150980|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154150981|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154150982|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154150983|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154150984|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
154150985|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154150986|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154150987|NCT00935558|Cathartics|cathartics|mesh-ancestor
154151019|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154151020|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154151021|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154151022|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
154151023|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
154151024|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151025|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154151026|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154151027|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154151028|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
154151029|NCT00940628|Orlistat|orlistat|mesh-list
154151030|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151031|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151032|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153660854|NCT00078442|Interferons|interferons|mesh-list
154151063|NCT02566733|Analgesics|analgesics|mesh-ancestor
154151064|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
154151065|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151066|NCT01028950|Darexaban|darexaban|mesh-list
154151068|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
153360598|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
153360599|NCT01277159|Hormones|hormones|mesh-ancestor
154151069|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154151070|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
154151071|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151072|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151073|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
154151082|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151083|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151084|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154151085|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154151086|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151087|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154151088|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154151089|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151091|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154151092|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154151093|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154151094|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
154151095|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151096|NCT01023490|Vitamin D|vitamin d|mesh-list
154151097|NCT01023490|Vitamins|vitamins|mesh-ancestor
154151098|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
154151099|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151100|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154151101|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
154151102|NCT00698009|Fludarabine|fludarabine|mesh-list
154151103|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
154151104|NCT00698009|Interleukin-2|interleukin-2|mesh-list
154151105|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151106|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
154151107|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151108|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151109|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154151110|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
154151111|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151112|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151113|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154151114|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154151115|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
154151116|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151117|NCT00698009|Analgesics|analgesics|mesh-ancestor
154151118|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
154151119|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151120|NCT00944606|Vitamin D|vitamin d|mesh-list
154151121|NCT00944606|Vitamins|vitamins|mesh-ancestor
154151122|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
154151123|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151124|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154151125|NCT00944684|Ribavirin|ribavirin|mesh-list
154151126|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
154151127|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151128|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
154151129|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151130|NCT04061057|Lidocaine|lidocaine|mesh-list
154151131|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
154151132|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
154151133|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151134|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151135|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
154151136|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151137|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154151138|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154151139|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154151140|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154151151|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154151152|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154151153|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151154|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151155|NCT04061447|Clarithromycin|clarithromycin|mesh-list
154151156|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154151157|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151158|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154151159|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151160|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151161|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154151162|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154151163|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154151164|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
154151165|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151166|NCT02565953|Paclitaxel|paclitaxel|mesh-list
154151167|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154151168|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151169|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154151170|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
153531496|NCT01497002|Cytarabine|cytarabine|mesh-list
154151171|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
154151172|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151173|NCT00562718|Capecitabine|capecitabine|mesh-list
154151174|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154151175|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
154151176|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151177|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151178|NCT05222165|Infigratinib|infigratinib|mesh-list
154151179|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151180|NCT04555811|Rituximab|rituximab|mesh-list
154151181|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151182|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151183|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
154151184|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151185|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151186|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
154151187|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154151188|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151189|NCT02566187|Atorvastatin|atorvastatin|mesh-list
154151190|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154151191|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154151192|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
154151193|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151194|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154151195|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154151196|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151197|NCT05324891|Fentanyl|fentanyl|mesh-list
154151198|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
154151199|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154151200|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153660996|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
154151207|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154151208|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154151209|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
154151210|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151211|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151212|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154151213|NCT05324891|Narcotics|narcotics|mesh-ancestor
154151214|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154151215|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154151216|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
154151217|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
154151218|NCT00445432|Adalimumab|adalimumab|mesh-list
154151219|NCT00445432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154151220|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151221|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151222|NCT00696137|Fentanyl|fentanyl|mesh-list
154151223|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154151224|NCT00696137|Narcotics|narcotics|mesh-ancestor
154151225|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151226|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151227|NCT00696137|Analgesics|analgesics|mesh-ancestor
154151228|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
154151229|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151230|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154151231|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154151232|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
154151233|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
154151234|NCT02565641|Gemcitabine|gemcitabine|mesh-list
154151235|NCT02565641|Capecitabine|capecitabine|mesh-list
154151236|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154151237|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
154151238|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151239|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151240|NCT04036721|Prednisone|prednisone|mesh-list
154151241|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151242|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
154151243|NCT04036721|Hormones|hormones|mesh-ancestor
154151244|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154151245|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531571|NCT01497444|Sorafenib|sorafenib|mesh-list
154151246|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154151247|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151248|NCT00441142|Temozolomide|temozolomide|mesh-list
154151249|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154151250|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
154151251|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151252|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151253|NCT03848416|Ixekizumab|ixekizumab|mesh-list
154151254|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
154151255|NCT01029418|Sorafenib|sorafenib|mesh-list
154151256|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151257|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154151258|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151259|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151260|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
154151261|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154151262|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
154151263|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151264|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151265|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154151266|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
154151267|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153661059|NCT00079300|Imiquimod|imiquimod|mesh-list
154151304|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
154151306|NCT00561470|Fluorouracil|fluorouracil|mesh-list
154151307|NCT00561470|Irinotecan|irinotecan|mesh-list
154151308|NCT00561470|Aflibercept|aflibercept|mesh-list
154151309|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
154151310|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
153661130|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
154151337|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154151338|NCT00443872|Protective Agents|protective agents|mesh-ancestor
154151339|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151341|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
154151342|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151343|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
154151344|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151345|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151346|NCT03034642|Dimercaprol|dimercaprol|mesh-list
154151347|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
154151348|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
154151349|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151350|NCT00441064|Aliskiren|aliskiren|mesh-list
154151351|NCT00441064|Renin Inhibitors|renin inhibitors|mesh-ancestor
154151352|NCT00441064|Protease Inhibitors|protease inhibitors|mesh-ancestor
154151353|NCT00441064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151354|NCT00441064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151355|NCT03962738|Lasmiditan|lasmiditan|mesh-list
154151356|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154151357|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
154151366|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151367|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151368|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154151369|NCT00561392|Protective Agents|protective agents|mesh-ancestor
154151371|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154151372|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154151373|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
154151374|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151375|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154151376|NCT00940862|Adalimumab|adalimumab|mesh-list
154151377|NCT00940862|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154151378|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151379|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151380|NCT00561080|Vaccines|vaccines|mesh-list
154151381|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
154151382|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151383|NCT01307306|Metformin|metformin|mesh-list
154151384|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154151385|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151386|NCT00941096|Timolol|timolol|mesh-list
154151387|NCT00941096|Bimatoprost|bimatoprost|mesh-list
154151388|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154151389|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154151390|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
154151391|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151392|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151393|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151394|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154151395|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153531722|NCT01498380|Analgesics|analgesics|mesh-ancestor
154151396|NCT04012424|Curcumin|curcumin|mesh-list
154151397|NCT04012424|Analgesics|analgesics|mesh-list
154151398|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154151399|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151400|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
154151401|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151402|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151403|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151404|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151405|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151406|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151407|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151408|NCT00562094|Pantoprazole|pantoprazole|mesh-list
154151409|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154151410|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154151411|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154151412|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151413|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151414|NCT03817853|Prednisone|prednisone|mesh-list
154151415|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
154151416|NCT03817853|Prednisolone|prednisolone|mesh-list
154151417|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
154151418|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154151419|NCT03817853|Doxorubicin|doxorubicin|mesh-list
154151420|NCT03817853|Vincristine|vincristine|mesh-list
154151421|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
153661217|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
154151432|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154151433|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154151434|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151435|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151436|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
154151438|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154151439|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154151440|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154151441|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
154151442|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
154151443|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
153702328|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154151444|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
154151445|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
154151446|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151447|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154151448|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154151449|NCT03817853|Protective Agents|protective agents|mesh-ancestor
154151450|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151451|NCT00944840|Amodiaquine|amodiaquine|mesh-list
154151452|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
154151453|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154151454|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154151455|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151457|NCT00439270|Dasatinib|dasatinib|mesh-list
154151458|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151459|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
154151460|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
154151461|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
154151462|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151463|NCT00439270|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154151464|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154151465|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151466|NCT00944918|Fulvestrant|fulvestrant|mesh-list
154151467|NCT00944918|Anastrozole|anastrozole|mesh-list
154151468|NCT00944918|Exemestane|exemestane|mesh-list
154151469|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154151470|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151471|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154151472|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154151473|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
154151474|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154151475|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151476|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154151477|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154151478|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151479|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151480|NCT04012268|Aspirin|aspirin|mesh-list
154151481|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154151482|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151483|NCT04012268|Analgesics|analgesics|mesh-ancestor
154151484|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
154151485|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151496|NCT03995134|Remifentanil|remifentanil|mesh-list
153820605|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820606|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
153820607|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153820608|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820609|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820610|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153360602|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360603|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
153360604|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360605|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360606|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153915531|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
154151497|NCT03995134|Propofol|propofol|mesh-list
154151498|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154151499|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151500|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151501|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154151502|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
154151503|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
154151504|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154151505|NCT03995134|Narcotics|narcotics|mesh-ancestor
154151506|NCT03995134|Analgesics|analgesics|mesh-ancestor
154151507|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
154151508|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151509|NCT00553280|Pregabalin|pregabalin|mesh-list
154151510|NCT00553280|Analgesics|analgesics|mesh-ancestor
154151511|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
154151512|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151513|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151514|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
154151515|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154151516|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154151517|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151518|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154151519|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154151520|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154151521|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151522|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154151523|NCT01024192|Zolpidem|zolpidem|mesh-list
154151524|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154151525|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154151526|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151527|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151528|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154151529|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
154151530|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
154151531|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151532|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151533|NCT01024270|Misoprostol|misoprostol|mesh-list
154151534|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154151535|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
154151536|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154151537|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151538|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154151539|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154151540|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
154151541|NCT00944996|Citalopram|citalopram|mesh-list
154151542|NCT00944996|Fluoxetine|fluoxetine|mesh-list
154151543|NCT00944996|Paroxetine|paroxetine|mesh-list
154151544|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154151545|NCT00944996|Sertraline|sertraline|mesh-list
154151546|NCT00944996|Clomipramine|clomipramine|mesh-list
154151547|NCT00944996|Escitalopram|escitalopram|mesh-list
154151548|NCT00944996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154151549|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153475064|NCT00759642|Lapatinib|lapatinib|mesh-list
153661346|NCT00080782|Celecoxib|celecoxib|mesh-list
153661406|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154151613|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
154151614|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
154151615|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
154151616|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151617|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151619|NCT00941174|Calcium|calcium|mesh-list
154151620|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
154151621|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154151622|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151623|NCT00941174|Antidotes|antidotes|mesh-ancestor
154151624|NCT00941174|Protective Agents|protective agents|mesh-ancestor
154151625|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
154151626|NCT00941174|Vitamins|vitamins|mesh-ancestor
154151627|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
154151628|NCT00440518|Lacosamide|lacosamide|mesh-list
154151629|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
154151630|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154151631|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154151632|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153661446|NCT00081757|Growth Substances|growth substances|mesh-ancestor
154151658|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154151659|NCT03172936|Spartalizumab|spartalizumab|mesh-list
154151660|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154151661|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151662|NCT03172936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151663|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151664|NCT01030042|Leucovorin|leucovorin|mesh-list
154151665|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
154151666|NCT01030042|Irinotecan|irinotecan|mesh-list
154151667|NCT01030042|Cetuximab|cetuximab|mesh-list
154151668|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151669|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154151670|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154151671|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151672|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151673|NCT01030042|Antidotes|antidotes|mesh-ancestor
154151674|NCT01030042|Protective Agents|protective agents|mesh-ancestor
154151675|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151676|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
154151677|NCT01030042|Vitamins|vitamins|mesh-ancestor
154151678|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
154151679|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154151680|NCT01024504|Bevacizumab|bevacizumab|mesh-list
154151681|NCT01024504|Capecitabine|capecitabine|mesh-list
154151682|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
154151718|NCT00945620|Ropivacaine|ropivacaine|mesh-list
154151719|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154151720|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
153661540|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151731|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151732|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151734|NCT04813822|Clotrimazole|clotrimazole|mesh-list
154151735|NCT04813822|Bromides|bromides|mesh-list
154151736|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
154151737|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
154151738|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151739|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154151740|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154151741|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151742|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151743|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154151744|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
154151745|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154151746|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151747|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154151748|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154151749|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154151751|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154151752|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154151753|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154151754|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151755|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
154151756|NCT02917564|Hormones|hormones|mesh-ancestor
154151757|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154151758|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151759|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151760|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
154151761|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360608|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151762|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151763|NCT00952016|Methotrexate|methotrexate|mesh-list
154151764|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154151765|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
154151766|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154151767|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151768|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154151769|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
154151770|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151771|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151772|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
154151773|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151774|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154151775|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151776|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
154151777|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151778|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154151779|NCT00952094|Cinacalcet|cinacalcet|mesh-list
154151780|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154151781|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151782|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154151788|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154151789|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154151790|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151791|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154151792|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151793|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
154151794|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154151795|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154151796|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154151797|NCT00946166|Simvastatin|simvastatin|mesh-list
154151798|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154151799|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154151800|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
154151801|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151802|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154151803|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154151804|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151805|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
154151806|NCT00952562|Vitamin D|vitamin d|mesh-list
154151807|NCT00952562|Vitamins|vitamins|mesh-ancestor
154151808|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
154151809|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151810|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154151811|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154151812|NCT00952640|Vitamin A|vitamin a|mesh-list
154151813|NCT00952640|Vitamins|vitamins|mesh-ancestor
154151814|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
154151815|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151816|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
154151817|NCT00952796|Ampicillin|ampicillin|mesh-list
154151818|NCT00952796|Sulbactam|sulbactam|mesh-list
154151819|NCT00952796|Sultamicillin|sultamicillin|mesh-list
154151820|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154151821|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151822|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154151823|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154151824|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151825|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151826|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151827|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154151828|NCT00952952|Mesalamine|mesalamine|mesh-list
154151829|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153360609|NCT01277159|Analgesics|analgesics|mesh-ancestor
154151830|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151831|NCT00952952|Analgesics|analgesics|mesh-ancestor
154151832|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
154151833|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151834|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151835|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151836|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151837|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154151838|NCT00953108|Escitalopram|escitalopram|mesh-list
154151839|NCT00953108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154151840|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154151841|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154151842|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151843|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151844|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
154151845|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151846|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
154151847|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154151848|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154151849|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154151850|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154151851|NCT00953498|Pioglitazone|pioglitazone|mesh-list
154151864|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154151865|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154151866|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151867|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
154151868|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
154151869|NCT00120289|Vitamins|vitamins|mesh-ancestor
154151870|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
154151871|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151872|NCT00946556|Valacyclovir|valacyclovir|mesh-list
154151873|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
154151874|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151875|NCT00943748|Deferiprone|deferiprone|mesh-list
154151876|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154151877|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
154151878|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
154151879|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151880|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
154151881|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
154151882|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154151883|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154151884|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151885|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151886|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151887|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151889|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154151890|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154151891|NCT00954200|Analgesics|analgesics|mesh-ancestor
154151892|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
154151893|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151894|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151895|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154151896|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151897|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154151898|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151899|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151901|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151902|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154151903|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151904|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151905|NCT00550446|Adalimumab|adalimumab|mesh-list
154151906|NCT00550446|Tofacitinib|tofacitinib|mesh-list
154151907|NCT00550446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154151908|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360620|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464298|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151909|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154151910|NCT00550446|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154151911|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154151912|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151913|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151914|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154151915|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
154151916|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151936|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151937|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151938|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154151939|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151940|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154151941|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
154151942|NCT00436618|Everolimus|everolimus|mesh-list
154151943|NCT00436618|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154151944|NCT00436618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154151945|NCT00436618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151946|NCT00436618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151947|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151948|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
154151949|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151950|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154151951|NCT01024660|Donepezil|donepezil|mesh-list
154151952|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154151953|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151954|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151955|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
154151956|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151957|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151958|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
154151959|NCT01751126|Cyclosporine|cyclosporine|mesh-list
154151960|NCT01751126|Cyclosporins|cyclosporins|mesh-list
154151961|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154151962|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154151963|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154151964|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
154151965|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154151966|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
154151967|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154151968|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
154151969|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661779|NCT00135811|Hormones|hormones|mesh-ancestor
154151993|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154151994|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811173|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811174|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154151996|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154151997|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
154151998|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154151999|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152000|NCT00954252|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
154152001|NCT00954252|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154152002|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152003|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152004|NCT00110617|Deferasirox|deferasirox|mesh-list
154152005|NCT00110617|Deferoxamine|deferoxamine|mesh-list
154152006|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154152007|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
154152008|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
154152009|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152010|NCT00110617|Siderophores|siderophores|mesh-ancestor
154152012|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
154152013|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
154152014|NCT00949494|Protective Agents|protective agents|mesh-ancestor
154152015|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152016|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154152017|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
154152018|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
154152019|NCT00954486|Hematinics|hematinics|mesh-ancestor
154152020|NCT00550238|Pimavanserin|pimavanserin|mesh-list
154152021|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154152022|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154152023|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154152046|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
154152047|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152048|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154152049|NCT00947024|Glipizide|glipizide|mesh-list
154152050|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154152051|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152052|NCT00949572|Vaccines|vaccines|mesh-list
154152053|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
154152054|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
154152055|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152056|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154152057|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
154152058|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154152059|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154152060|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152061|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
154152062|NCT01031992|Coagulants|coagulants|mesh-ancestor
154152063|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154152064|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154152065|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152066|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152067|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154152068|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
154152069|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154152070|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152071|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154152072|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
154152073|NCT00949728|Coagulants|coagulants|mesh-ancestor
153532390|NCT01501669|Capecitabine|capecitabine|mesh-list
154152074|NCT00954902|Antioxidants|antioxidants|mesh-list
154152075|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445252|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
154152092|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152093|NCT01032304|Erdosteine|erdosteine|mesh-list
154152094|NCT01032304|Expectorants|expectorants|mesh-ancestor
154152095|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
154152096|NCT00954642|Paclitaxel|paclitaxel|mesh-list
154152097|NCT00954642|Bevacizumab|bevacizumab|mesh-list
154152098|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154152099|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152100|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
154152101|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152102|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152103|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152104|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154152105|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154152106|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154152107|NCT00954642|Growth Substances|growth substances|mesh-ancestor
154152108|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152109|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
154152110|NCT00954798|Vaccines|vaccines|mesh-list
154152111|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
154152112|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152113|NCT00110305|Efavirenz|efavirenz|mesh-list
154152114|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
154152115|NCT00110305|Rilpivirine|rilpivirine|mesh-list
154152116|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153820619|NCT00464451|Analgesics|analgesics|mesh-ancestor
154152117|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152118|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152119|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
154152120|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152121|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154152122|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154152123|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154152124|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154152125|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154152126|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154152127|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154152128|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154152129|NCT00560066|Vaccines|vaccines|mesh-list
154152130|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
154152131|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152132|NCT00549900|Vaccines|vaccines|mesh-list
154152133|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
154152142|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154152143|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154152144|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
154152145|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152146|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154152147|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
154152149|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
154152150|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154152151|NCT01563120|Metformin|metformin|mesh-list
154152152|NCT01563120|Glyburide|glyburide|mesh-list
154152153|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154152154|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152155|NCT00435370|Tropisetron|tropisetron|mesh-list
154152156|NCT00435370|Risperidone|risperidone|mesh-list
154152157|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154152158|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
154152159|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152160|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152161|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152162|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154152163|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154152164|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152165|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154152166|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154152167|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
154152168|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
154152169|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
154152170|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152171|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154152172|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154152173|NCT00096031|Cetuximab|cetuximab|mesh-list
154152174|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154152176|NCT00118417|Clonazepam|clonazepam|mesh-list
154152177|NCT00118417|Sertraline|sertraline|mesh-list
154152178|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
154152179|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154152180|NCT00118417|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154152181|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154152182|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154152183|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152184|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152185|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
154152186|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152187|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
154152188|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
154152189|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
154152190|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154152191|NCT01079455|Corticosterone|corticosterone|mesh-list
154152192|NCT01079455|Bupivacaine|bupivacaine|mesh-list
154152193|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
154152194|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
154152195|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
154152196|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152197|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152198|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
154152199|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152200|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154152201|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
153661996|NCT00137410|Celecoxib|celecoxib|mesh-list
154152235|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
154152236|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
154152237|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152238|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154152239|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
154152240|NCT00549848|Hormones|hormones|mesh-ancestor
154152241|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154152242|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154152243|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
154152244|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152245|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154152246|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154152247|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154152248|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154152249|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
154152250|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154152260|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152261|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152262|NCT00549848|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154152263|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154152265|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
154152266|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152267|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
154152268|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152269|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152270|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152271|NCT01083589|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154152272|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154152273|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152275|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154152276|NCT00949182|Mitomycins|mitomycins|mesh-list
154152277|NCT00949182|Mitomycin|mitomycin|mesh-list
154152278|NCT00949182|Sorafenib|sorafenib|mesh-list
154152279|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154152280|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152281|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154152282|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154152283|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152284|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152285|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154152286|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
154152287|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154152288|NCT00549770|Valsartan|valsartan|mesh-list
154152289|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154152290|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154152291|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154152292|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154152293|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152294|NCT00548184|Trastuzumab|trastuzumab|mesh-list
154152295|NCT00548184|Lapatinib|lapatinib|mesh-list
154152296|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154152297|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152298|NCT00548184|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154152299|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154152300|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152301|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152302|NCT00454636|Cisplatin|cisplatin|mesh-list
154152303|NCT00454636|Docetaxel|docetaxel|mesh-list
153820632|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820637|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
154152304|NCT00454636|Capecitabine|capecitabine|mesh-list
154152305|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
154152306|NCT00454636|Epirubicin|epirubicin|mesh-list
154152307|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152308|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
154152309|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152310|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152311|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152312|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154152313|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
154152314|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154152315|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154152316|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154152333|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152334|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152335|NCT00955890|Protective Agents|protective agents|mesh-ancestor
154152336|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152337|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152338|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152339|NCT00956046|Vaccines|vaccines|mesh-list
153797772|NCT00301587|Hematinics|hematinics|mesh-ancestor
154152340|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
154152341|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152342|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
154152343|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
154152344|NCT00454246|Hematinics|hematinics|mesh-ancestor
154152346|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154152347|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152348|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154152349|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
154152350|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154152351|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152352|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152353|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152354|NCT00956202|Vaccines|vaccines|mesh-list
154152355|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
154152356|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152357|NCT00695903|Vancomycin|vancomycin|mesh-list
154152358|NCT00695903|Daptomycin|daptomycin|mesh-list
154152359|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154152360|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152361|NCT00548262|Voriconazole|voriconazole|mesh-list
154152362|NCT00548262|Anidulafungin|anidulafungin|mesh-list
154152363|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
154152364|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152365|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154152366|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154152367|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152368|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152369|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154152370|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
154152371|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154152372|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152373|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154152374|NCT02565173|Timolol|timolol|mesh-list
154152375|NCT02565173|Adenosine|adenosine|mesh-list
154152376|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154152401|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
154152402|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152403|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154152404|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154152405|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154152406|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154152407|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154152408|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152409|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152410|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154152411|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
154152412|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154152413|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152415|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154152416|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475974|NCT00869622|Vitamin D|vitamin d|mesh-list
154152417|NCT00095173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154152418|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152419|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154152420|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
154152421|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152422|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154152423|NCT03704753|Ropivacaine|ropivacaine|mesh-list
154152441|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154152442|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152443|NCT00693017|Zonisamide|zonisamide|mesh-list
154152444|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
154152445|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154152446|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154152447|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152448|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154152449|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152450|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
154152451|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
154152452|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154152453|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154152454|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152455|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152456|NCT00692237|Urological Agents|urological agents|mesh-ancestor
154152457|NCT00110149|Rituximab|rituximab|mesh-list
154152458|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154152459|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152460|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
154152461|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152462|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154152463|NCT01084057|Vorinostat|vorinostat|mesh-list
154152464|NCT01084057|Epothilone B|epothilone b|mesh-list
154152465|NCT01084057|Epothilones|epothilones|mesh-list
154152466|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152467|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154152468|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152469|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152470|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
154152471|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152472|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152473|NCT03954444|Phenylephrine|phenylephrine|mesh-list
154152474|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
154152475|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154152476|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154152477|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
154152478|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152479|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662276|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154152490|NCT03954444|Protective Agents|protective agents|mesh-ancestor
154152491|NCT03953820|Diazepam|diazepam|mesh-list
154152492|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154152493|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
154152494|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
154152495|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
154152496|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152497|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152498|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154152499|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154152500|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360630|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153360631|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
154152501|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154152502|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154152503|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154152504|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154152505|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154152506|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154152507|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
154152508|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
154152509|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
154152510|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
154152511|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152512|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152513|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
154152514|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154152515|NCT04492956|Ecopipam|ecopipam|mesh-list
154152516|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154152517|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154152518|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152519|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152520|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154152521|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154152522|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
154152523|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152524|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152525|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154152526|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
154152527|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154152528|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154152529|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152530|NCT00742937|Vitamin A|vitamin a|mesh-list
154152531|NCT00742937|Vitamins|vitamins|mesh-ancestor
154152532|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
154152533|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152534|NCT00692003|Zonisamide|zonisamide|mesh-list
154152535|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
154152536|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154152537|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154152538|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152539|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154152540|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152541|NCT02564315|Nicotine|nicotine|mesh-list
154152542|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154152543|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
154152544|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152545|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152565|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152566|NCT02153177|Acetaminophen|acetaminophen|mesh-list
154152567|NCT02153177|Ibuprofen|ibuprofen|mesh-list
154152568|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154152569|NCT02153177|Hydrocodone|hydrocodone|mesh-list
154152570|NCT02153177|Oxycodone|oxycodone|mesh-list
154152571|NCT02153177|Omeprazole|omeprazole|mesh-list
154152572|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154152573|NCT02153177|Analgesics|analgesics|mesh-ancestor
154152574|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
154152575|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152576|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152577|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
154152578|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154152579|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154152580|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154152581|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154152582|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152583|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152584|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154152585|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153407920|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
154152586|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154152587|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154152588|NCT02153177|Narcotics|narcotics|mesh-ancestor
154152589|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152590|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
154152591|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
154152592|NCT00743327|Pioglitazone|pioglitazone|mesh-list
154152593|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154152594|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152595|NCT02564861|DS-1971a|ds-1971a|mesh-list
154152596|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154152597|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154152598|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154152599|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152600|NCT00416884|Fludarabine|fludarabine|mesh-list
154152612|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154152613|NCT00555620|Growth Substances|growth substances|mesh-ancestor
154152614|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152615|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
154152616|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154152617|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152619|NCT00433966|Heparin|heparin|mesh-list
154152620|NCT00433966|Calcium heparin|calcium heparin|mesh-list
154152621|NCT00433966|Bivalirudin|bivalirudin|mesh-list
154152622|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154152623|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152624|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
154152625|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152626|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152627|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152628|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
154152629|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154152630|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154152631|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
154152632|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154152633|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
154152634|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152635|NCT00947336|Norfloxacin|norfloxacin|mesh-list
154152636|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154152637|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152638|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154152639|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154152640|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152641|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152642|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152643|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154152644|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154152645|NCT00955214|Paclitaxel|paclitaxel|mesh-list
154152646|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154152647|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152648|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
154152649|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
154152650|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152651|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152652|NCT00956462|Dexamethasone|dexamethasone|mesh-list
154152653|NCT00956462|Ketorolac|ketorolac|mesh-list
154152654|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154152655|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154152656|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
154152657|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
154152658|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152659|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152660|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154152661|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
154152662|NCT00956462|Hormones|hormones|mesh-ancestor
154152663|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154152664|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154152676|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152677|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152678|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154152680|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154152681|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
154152682|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
154152683|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152684|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152685|NCT00956696|Topiramate|topiramate|mesh-list
154152686|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
154152687|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154152688|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152689|NCT03952650|Chloroquine|chloroquine|mesh-list
154152690|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154152691|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
154152692|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154152693|NCT03952650|Ibuprofen|ibuprofen|mesh-list
154152694|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154152695|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154152696|NCT03952650|Analgesics|analgesics|mesh-ancestor
154152697|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
154152698|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152699|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152700|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154152701|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154152702|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154152703|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152704|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152705|NCT03952650|Amebicides|amebicides|mesh-ancestor
154152706|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154152707|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154152708|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152709|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
154152710|NCT03952650|Filaricides|filaricides|mesh-ancestor
154152711|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
154152712|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
154152713|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154152714|NCT00955526|Istradefylline|istradefylline|mesh-list
154152715|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
154152716|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154152717|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153533062|NCT01504659|Ketamine|ketamine|mesh-list
154152718|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
154152719|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152720|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152721|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152722|NCT00955604|Rasagiline|rasagiline|mesh-list
154152723|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
154152724|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154152725|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154152726|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152727|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152740|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152741|NCT00691301|Pemetrexed|pemetrexed|mesh-list
154152742|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152743|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152744|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152745|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153360634|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153360635|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153360636|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153360637|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
154152746|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154152747|NCT05277480|Apatinib|apatinib|mesh-list
154152748|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152749|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154152750|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152751|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152752|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
154152753|NCT00956072|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154152754|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154152755|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152756|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152757|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152758|NCT02564003|Oxycodone|oxycodone|mesh-list
154152759|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154152760|NCT02564003|Narcotics|narcotics|mesh-ancestor
154152761|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152762|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152763|NCT02564003|Analgesics|analgesics|mesh-ancestor
154152764|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
154152765|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152766|NCT00956150|Rifaximin|rifaximin|mesh-list
154152767|NCT00956150|Lactulose|lactulose|mesh-list
154152768|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154152769|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152770|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154152771|NCT00923663|Lenalidomide|lenalidomide|mesh-list
154152772|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
154152773|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152774|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154152775|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154152776|NCT00923663|Growth Substances|growth substances|mesh-ancestor
154152777|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
154152778|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152779|NCT00743873|Mitogens|mitogens|mesh-list
154152780|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
154152781|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152782|NCT04011098|Fentanyl|fentanyl|mesh-list
154152783|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154152785|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152786|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152787|NCT04011098|Analgesics|analgesics|mesh-ancestor
154152788|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
154152789|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152808|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152809|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
154152810|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152811|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
154152812|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154152813|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
154152814|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152815|NCT00962442|Expectorants|expectorants|mesh-ancestor
154152816|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
154152817|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154152818|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
154152819|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152820|NCT00962442|Protective Agents|protective agents|mesh-ancestor
154152821|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152822|NCT00962442|Antidotes|antidotes|mesh-ancestor
154152823|NCT00957320|Sirolimus|sirolimus|mesh-list
154152824|NCT00957320|Asparaginase|asparaginase|mesh-list
154152825|NCT00957320|Pegaspargase|pegaspargase|mesh-list
154152826|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154152827|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152828|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154152829|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152830|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
154152831|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154152832|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
154152833|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152834|NCT00653159|Copper|copper|mesh-list
154152835|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
154152836|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154152837|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
154152838|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154152839|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152840|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154152841|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154152842|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154152843|NCT00653159|Trace Elements|trace elements|mesh-ancestor
154152844|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
154152845|NCT03047070|Lidocaine|lidocaine|mesh-list
154152846|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
154152847|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
154152848|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154152849|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476413|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
154152866|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154152867|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152868|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
154152869|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154152870|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154152871|NCT03024684|Atorvastatin|atorvastatin|mesh-list
154152872|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154152873|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154152874|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
154152875|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152876|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154152877|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154152878|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152879|NCT00744107|Cobalt|cobalt|mesh-list
154152880|NCT00744107|Trace Elements|trace elements|mesh-ancestor
154152881|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
154152882|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152883|NCT00117637|Interferons|interferons|mesh-list
154152884|NCT00117637|Sorafenib|sorafenib|mesh-list
154152885|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152886|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
154152887|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152888|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154152889|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154152890|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152891|NCT00744185|Propranolol|propranolol|mesh-list
154152892|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154152893|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154152894|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
154152895|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154152896|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154152897|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152898|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154152899|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154152900|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
154152901|NCT02897778|Entinostat|entinostat|mesh-list
154152902|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154152903|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154152904|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662702|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154152933|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154152934|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154152935|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154152936|NCT00746447|Mesalamine|mesalamine|mesh-list
153360639|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360640|NCT01279187|Teriparatide|teriparatide|mesh-list
153360641|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153360642|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461711|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
154152937|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154152938|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154152940|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
153533280|NCT01505920|Lidocaine|lidocaine|mesh-list
154152941|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154152942|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154152943|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154152944|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154152945|NCT00744419|Pantoprazole|pantoprazole|mesh-list
154152946|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154152947|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154152948|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154152949|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662758|NCT00142948|Naltrexone|naltrexone|mesh-list
154152985|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
154152986|NCT00958100|Abacavir|abacavir|mesh-list
154152987|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
154152988|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
154152989|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154152990|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153662803|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153005|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
154153006|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153007|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154153008|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154153009|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153010|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153011|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154153012|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
154153013|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153014|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153015|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154153016|NCT00948740|Vitamin D|vitamin d|mesh-list
154153017|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
154153018|NCT00948740|Vitamins|vitamins|mesh-ancestor
154153019|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
154153020|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153021|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154153022|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154153023|NCT00108433|Vancomycin|vancomycin|mesh-list
154153024|NCT00108433|Cefazolin|cefazolin|mesh-list
154153025|NCT00108433|Linezolid|linezolid|mesh-list
154153026|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153027|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153028|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154153029|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153030|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153031|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
154153032|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154153033|NCT01084369|Testosterone|testosterone|mesh-list
154153034|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
154153035|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
154153036|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154153037|NCT01084369|Androgens|androgens|mesh-ancestor
154153038|NCT01084369|Hormones|hormones|mesh-ancestor
154153039|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153040|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153041|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154153042|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153044|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
154153045|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154153046|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154153047|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153048|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153049|NCT01084369|Urological Agents|urological agents|mesh-ancestor
154153050|NCT00949130|Linezolid|linezolid|mesh-list
154153051|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153061|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154153062|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154153063|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153064|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
154153065|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
154153066|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153067|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153068|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154153069|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154153070|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154153071|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154153072|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
154153073|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153074|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153075|NCT00963222|Vitamin A|vitamin a|mesh-list
154153076|NCT00963222|Vitamins|vitamins|mesh-ancestor
154153077|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
154153078|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153079|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154153080|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154153081|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153082|NCT00968682|Trastuzumab|trastuzumab|mesh-list
154153083|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153084|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153085|NCT02465138|Ketorolac|ketorolac|mesh-list
154153086|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154153087|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154153088|NCT02465138|Analgesics|analgesics|mesh-ancestor
154153089|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
154153090|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153091|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153092|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729723|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153093|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154153094|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154153095|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153096|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153097|NCT00968994|Petrolatum|petrolatum|mesh-list
154153098|NCT00968994|Emollients|emollients|mesh-ancestor
154153099|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
154153100|NCT00969072|Dutasteride|dutasteride|mesh-list
154153101|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154153102|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154153103|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153104|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153105|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
154153106|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153107|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153108|NCT00094861|Paclitaxel|paclitaxel|mesh-list
154153109|NCT00094861|Carboplatin|carboplatin|mesh-list
154153110|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154153111|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153112|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153113|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153114|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
154153115|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153131|NCT00963690|Hemostatics|hemostatics|mesh-list
154153132|NCT00963690|Coagulants|coagulants|mesh-ancestor
154153134|NCT01079767|Temsirolimus|temsirolimus|mesh-list
154153135|NCT01079767|MTOR Inhibitors|mtor inhibitors|mesh-list
154153136|NCT01079767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154153137|NCT01079767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153138|NCT01079767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153139|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153140|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
154153141|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153142|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153143|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153144|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153145|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154153146|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
154153147|NCT00969306|Chloroquine|chloroquine|mesh-list
154153148|NCT00969306|Amebicides|amebicides|mesh-ancestor
154153149|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154153150|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154153151|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153152|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
154153153|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154153154|NCT00963768|Canagliflozin|canagliflozin|mesh-list
154153155|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154153156|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153157|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154153158|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153159|NCT00969462|Doxorubicin|doxorubicin|mesh-list
154153160|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154153161|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153162|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154153163|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154153164|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153165|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153166|NCT00963846|Huperzine A|huperzine a|mesh-list
153729724|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
154153167|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154153168|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153169|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153170|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
154153171|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153172|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153173|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154153186|NCT00958854|Thalidomide|thalidomide|mesh-list
154153187|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
154153188|NCT00958854|Fludarabine|fludarabine|mesh-list
154153189|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
154153190|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153191|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
154153192|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153193|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153820650|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153820651|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
153820652|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820653|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
154153194|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154153195|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
154153196|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153197|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153198|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154153199|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154153200|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
154153201|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
154153202|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153203|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153204|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154153205|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154153206|NCT00958854|Growth Substances|growth substances|mesh-ancestor
154153207|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
154153208|NCT00964080|Leucovorin|leucovorin|mesh-list
154153209|NCT00964080|Fluorouracil|fluorouracil|mesh-list
154153210|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
154153211|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
154153212|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153213|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154153214|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153215|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153216|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
154153217|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153218|NCT00964080|Antidotes|antidotes|mesh-ancestor
154153219|NCT00964080|Protective Agents|protective agents|mesh-ancestor
154153220|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
154153221|NCT00964080|Vitamins|vitamins|mesh-ancestor
154153222|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
154153223|NCT00969852|Sertraline|sertraline|mesh-list
154153224|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
154153225|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154153226|NCT00969852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154153227|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154153228|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154153229|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153230|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153231|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
154153232|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153233|NCT00426556|Paclitaxel|paclitaxel|mesh-list
154153234|NCT00426556|Trastuzumab|trastuzumab|mesh-list
154153235|NCT00426556|Everolimus|everolimus|mesh-list
154153236|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153663028|NCT00404794|Prednisolone|prednisolone|mesh-list
154153246|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153247|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
154153248|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153249|NCT00107653|Ribavirin|ribavirin|mesh-list
154153250|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154153251|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
154153252|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
154153253|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153254|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
154153255|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153256|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
154153257|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153258|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154153259|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
154153260|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153261|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
154153262|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154153263|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153264|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
154153265|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153266|NCT00970086|Bupivacaine|bupivacaine|mesh-list
154153267|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
154153268|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
154153269|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
154153270|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154153271|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153272|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
154153273|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153274|NCT00689351|Vaccines|vaccines|mesh-list
154153275|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154153276|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
154153277|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153278|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154153279|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
154153280|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153281|NCT02563847|Erythritol|erythritol|mesh-list
154153282|NCT02563847|Tryptophan|tryptophan|mesh-list
154153283|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154153284|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
154153285|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154153286|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
154153287|NCT00746681|Pregabalin|pregabalin|mesh-list
154153288|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154153289|NCT00746681|Analgesics|analgesics|mesh-ancestor
154153290|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
154153291|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153292|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153293|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
154153294|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154153295|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154153296|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153297|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154153298|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154153299|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153663091|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
154153319|NCT00959400|Narcotics|narcotics|mesh-ancestor
154153320|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154153321|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153322|NCT00959400|Analgesics|analgesics|mesh-ancestor
154153323|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
154153324|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153325|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154153326|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154153327|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
154153328|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
154153329|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
154256484|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154153330|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
154153331|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153332|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
154153333|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153334|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153335|NCT00964626|Paclitaxel|paclitaxel|mesh-list
154153336|NCT00964626|Cisplatin|cisplatin|mesh-list
154153337|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154153338|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153339|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153340|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153341|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
154153342|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153343|NCT02562287|Olanzapine|olanzapine|mesh-list
154153344|NCT02562287|Risperidone|risperidone|mesh-list
154153345|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154153346|NCT02562287|Clozapine|clozapine|mesh-list
154153347|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154153348|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
154153349|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153350|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153351|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153352|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154153353|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154153364|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154153365|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
154153366|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
154153367|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
154153368|NCT02562053|Fluoxetine|fluoxetine|mesh-list
154153369|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
154153370|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
154153371|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154153372|NCT02562053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154153373|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154153374|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154153375|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153376|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153377|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
154153378|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153379|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154153380|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
154153381|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154153382|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154153383|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154153384|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153385|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154153386|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154153387|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
154153388|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154153389|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153390|NCT04060043|Goserelin|goserelin|mesh-list
154153391|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154153392|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153393|NCT00553358|Paclitaxel|paclitaxel|mesh-list
154153394|NCT00553358|Trastuzumab|trastuzumab|mesh-list
154153395|NCT00553358|Lapatinib|lapatinib|mesh-list
154153396|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154153397|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153398|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153399|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153400|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
154153401|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153402|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153403|NCT00553358|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154153404|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154153405|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153406|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
154153407|NCT00744809|Efavirenz|efavirenz|mesh-list
154153408|NCT00744809|Rilpivirine|rilpivirine|mesh-list
154153409|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153410|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153411|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154153412|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154263463|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154263464|NCT05480306|Growth Substances|growth substances|mesh-ancestor
154153413|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153414|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360644|NCT01280123|Pioglitazone|pioglitazone|mesh-list
153360645|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153360646|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360647|NCT03608696|Buprenorphine|buprenorphine|mesh-list
153360648|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154153415|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153416|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154153426|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154153428|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154153429|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154153430|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
154153431|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153432|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153433|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154153434|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154153435|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
154153436|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153437|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
154153438|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154153439|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153440|NCT00749567|Bevacizumab|bevacizumab|mesh-list
154153441|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154153442|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153443|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153444|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154153445|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154153446|NCT00749567|Growth Substances|growth substances|mesh-ancestor
154153447|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153448|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
154153449|NCT00749567|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154153450|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154153451|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153452|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153453|NCT04010942|Metformin|metformin|mesh-list
154153454|NCT04010942|Clomiphene|clomiphene|mesh-list
154153455|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154153456|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153457|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154153458|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
154153459|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153460|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154153461|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
154153462|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153477016|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
154153463|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154153464|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154153465|NCT00949364|Pomalidomide|pomalidomide|mesh-list
154153466|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
154153467|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153468|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154153469|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154153470|NCT00949364|Growth Substances|growth substances|mesh-ancestor
154153471|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
154153472|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153473|NCT00689117|Clindamycin|clindamycin|mesh-list
154153474|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
154153475|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
154153477|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153478|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153479|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154153503|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154153504|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154153505|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153506|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153507|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154153508|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
154153509|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154153510|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153511|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
154153512|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153513|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154153515|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154153517|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153518|NCT00688103|Etanercept|etanercept|mesh-list
154153519|NCT00688103|Methotrexate|methotrexate|mesh-list
154153520|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154153521|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
154153522|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154153523|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153524|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154153525|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
154153526|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153527|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153528|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
154153529|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153530|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154153531|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153532|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
154153533|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154153569|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153570|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
154153592|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
154153593|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
154153594|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153595|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153596|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154153597|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
154153598|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
154153599|NCT00949832|Vitamin D|vitamin d|mesh-list
154153600|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
154153601|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
154153602|NCT00949832|Vitamins|vitamins|mesh-list
154153603|NCT00949832|Calcium|calcium|mesh-list
154153604|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
154153605|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799050|NCT00272909|Piclozotan|piclozotan|mesh-list
154153606|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154153607|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154153608|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
154153609|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154153610|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
154153611|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153612|NCT00745199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153533950|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
154153613|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154153614|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154153615|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
154153616|NCT00961844|Temozolomide|temozolomide|mesh-list
154153617|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154153618|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
154153619|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153620|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153621|NCT00686777|Interferons|interferons|mesh-list
154153622|NCT00686777|Ribavirin|ribavirin|mesh-list
154153648|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
154153650|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153651|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154153652|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154153653|NCT00747305|Growth Substances|growth substances|mesh-ancestor
154153654|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153655|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
154153656|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154153657|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153658|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153659|NCT05254106|Paclitaxel|paclitaxel|mesh-list
154153660|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153360651|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360652|NCT03608696|Analgesics|analgesics|mesh-ancestor
153360653|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
154153661|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153662|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153663|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153664|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
154153665|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153666|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154153667|NCT00747383|Glimepiride|glimepiride|mesh-list
154153668|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154153669|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153670|NCT00747383|Incretins|incretins|mesh-ancestor
154153671|NCT00747383|Hormones|hormones|mesh-ancestor
154153672|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153673|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154153707|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154153708|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154153709|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153710|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153712|NCT00959972|Varenicline|varenicline|mesh-list
154153713|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154153714|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
154153715|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153716|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153764|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
154153765|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
154153766|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153767|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153768|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153769|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154153770|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154153771|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154153772|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154153773|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154153774|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154153775|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
154153776|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154153777|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154153778|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
154153779|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154153780|NCT00962624|Vaccines|vaccines|mesh-list
154153781|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
154153782|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153783|NCT00105235|Cyclosporine|cyclosporine|mesh-list
154153784|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
154153785|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
154153786|NCT00105235|Tacrolimus|tacrolimus|mesh-list
154153787|NCT00105235|Cyclosporins|cyclosporins|mesh-list
154153788|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153789|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
154153790|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153791|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154153792|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153793|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153794|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
154153795|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154153796|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
154153797|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154153798|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154153799|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153800|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154153801|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
154153802|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154153803|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153804|NCT03962803|Vaccines|vaccines|mesh-list
154153805|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
153820662|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820663|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820664|NCT00434096|Hormones|hormones|mesh-ancestor
154153806|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153807|NCT00547118|Rimonabant|rimonabant|mesh-list
154153808|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154153809|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154153810|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154153811|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153812|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153813|NCT00547118|Hormones|hormones|mesh-ancestor
154153814|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153815|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153816|NCT00962936|Pidilizumab|pidilizumab|mesh-list
154153817|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153818|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153840|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153841|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154153842|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
154153843|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153844|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153845|NCT00750113|Telmisartan|telmisartan|mesh-list
154153847|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154153848|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154153849|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154153850|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153851|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154153852|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154153853|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154153854|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153855|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
154153856|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
154153857|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154153858|NCT00745511|Bevacizumab|bevacizumab|mesh-list
154153859|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153860|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153861|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154153862|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154153863|NCT00745511|Growth Substances|growth substances|mesh-ancestor
154153864|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153865|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
154153866|NCT00545688|Docetaxel|docetaxel|mesh-list
154153867|NCT00545688|Trastuzumab|trastuzumab|mesh-list
154153868|NCT00545688|Pertuzumab|pertuzumab|mesh-list
154153869|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153870|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
154153871|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
154153886|NCT00967772|Naftopidil|naftopidil|mesh-list
154153887|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154153888|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154153889|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
154153890|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154153891|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153892|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153893|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154153894|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154153895|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154153896|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154153897|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154153898|NCT00967850|Verteporfin|verteporfin|mesh-list
154153899|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154153900|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
154153901|NCT00967928|Everolimus|everolimus|mesh-list
154153902|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153903|NCT00967928|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154153905|NCT00967928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153906|NCT00967928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153907|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153908|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
154153909|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153910|NCT00546000|Fluticasone|fluticasone|mesh-list
154153911|NCT00546000|Xhance|xhance|mesh-list
154153912|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154153913|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154153914|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
154153915|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154153916|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153917|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154153918|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
154153919|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
154153920|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154153921|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154153922|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154153923|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153924|NCT00968006|Incretins|incretins|mesh-ancestor
154153925|NCT00968006|Hormones|hormones|mesh-ancestor
154153926|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154153927|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154153928|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
154153929|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154153930|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153931|NCT00968162|Fludarabine|fludarabine|mesh-list
154153932|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153947|NCT03942042|Ixekizumab|ixekizumab|mesh-list
154153948|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
154153949|NCT00968396|Melphalan|melphalan|mesh-list
154256485|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154153950|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154153951|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
154153952|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153953|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153954|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154153955|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153956|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
154153957|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153958|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
154153959|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
154153960|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
154153961|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154153962|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153963|NCT01013805|Leucovorin|leucovorin|mesh-list
154153964|NCT01013805|Fluorouracil|fluorouracil|mesh-list
154153965|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
154153966|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
154153967|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153968|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154153969|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153970|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153971|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
154153972|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153973|NCT01013805|Antidotes|antidotes|mesh-ancestor
154153974|NCT01013805|Protective Agents|protective agents|mesh-ancestor
154153975|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
154153976|NCT01013805|Vitamins|vitamins|mesh-ancestor
154153977|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
154153978|NCT00104299|Prednisone|prednisone|mesh-list
154153979|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
154153980|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
154153981|NCT00104299|Rituximab|rituximab|mesh-list
154153982|NCT00104299|Azathioprine|azathioprine|mesh-list
154153983|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
154153984|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154153985|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
154153986|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154153987|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154153988|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154153989|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
154153990|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154153991|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154153992|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154153993|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154153994|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154005|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154154006|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
154154008|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154154009|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154010|NCT00082381|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154154011|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154154012|NCT00082381|Incretins|incretins|mesh-ancestor
154154013|NCT00082381|Hormones|hormones|mesh-ancestor
154154014|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154015|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
154154016|NCT00964106|Rifampin|rifampin|mesh-list
154154017|NCT00964106|Fluconazole|fluconazole|mesh-list
154154018|NCT00964106|Ketoconazole|ketoconazole|mesh-list
154154019|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
154154020|NCT00964106|Midazolam|midazolam|mesh-list
154154021|NCT00964106|Levomethorphan|levomethorphan|mesh-list
154154022|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
154154023|NCT00964106|Caffeine|caffeine|mesh-list
154154024|NCT00964106|Omeprazole|omeprazole|mesh-list
154154025|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154154026|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154154027|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154154028|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154154029|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154030|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154154031|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154154032|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154154033|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154154034|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
154154035|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
154154036|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
154154037|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
154154038|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154039|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154040|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154154041|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154154042|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
154154043|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154154044|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154154045|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154046|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154154047|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154154048|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154154049|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154154050|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
154154051|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154154052|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154154053|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154154054|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154154055|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
154154056|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154154057|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154058|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
154154059|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154154060|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154154086|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154154087|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154088|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154089|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154154091|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154154092|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154154093|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154094|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154154095|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154154096|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154097|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154099|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154154100|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154101|NCT01084837|Bortezomib|bortezomib|mesh-list
154154102|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663935|NCT01465152|Metformin|metformin|mesh-list
154154171|NCT00965406|Insulin|insulin|mesh-list
154154172|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154154173|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154174|NCT00513357|Melatonin|melatonin|mesh-list
154154175|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
154154176|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154177|NCT00513357|Protective Agents|protective agents|mesh-ancestor
154154178|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154179|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154154180|NCT00960960|Paclitaxel|paclitaxel|mesh-list
154154181|NCT00960960|Bevacizumab|bevacizumab|mesh-list
154154182|NCT00960960|Trastuzumab|trastuzumab|mesh-list
154154216|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154217|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154154218|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154154220|NCT00961194|Analgesics|analgesics|mesh-ancestor
154154280|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154154281|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154154282|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154154283|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154154284|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
154154285|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
154154286|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154288|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
154154289|NCT00972660|Prednisone|prednisone|mesh-list
154154290|NCT00972660|Cyclosporins|cyclosporins|mesh-list
154154291|NCT00972660|Tacrolimus|tacrolimus|mesh-list
154154292|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154293|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
154154294|NCT00972660|Hormones|hormones|mesh-ancestor
154154295|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154296|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154297|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154154298|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256486|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256487|NCT01266512|Docetaxel|docetaxel|mesh-list
154154299|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154300|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154301|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154302|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
154154303|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
154154304|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154305|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
154154306|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664126|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154335|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154337|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
154154338|NCT00425698|Hematinics|hematinics|mesh-ancestor
154154339|NCT01037530|Ramipril|ramipril|mesh-list
154154340|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154154341|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
154154342|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154343|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360657|NCT01334723|Dutasteride|dutasteride|mesh-list
153360658|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
153360659|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153360660|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154344|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154154345|NCT00973050|Bicalutamide|bicalutamide|mesh-list
154154346|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
154154347|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154348|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154349|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154350|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154351|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154154378|NCT00425308|Cyclosporine|cyclosporine|mesh-list
154154379|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
154154380|NCT00425308|Everolimus|everolimus|mesh-list
154154381|NCT00425308|Cyclosporins|cyclosporins|mesh-list
154154382|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154383|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154384|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154385|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
154154386|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154387|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
154154388|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154389|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
154154390|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154391|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154154392|NCT00425308|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154154393|NCT00425308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154154394|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154395|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154154396|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154154397|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
154154398|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154154399|NCT04008888|Dexamethasone|dexamethasone|mesh-list
154154400|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
154154420|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154154421|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
154154422|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154154423|NCT01033084|Sertraline|sertraline|mesh-list
154154424|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
154154425|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154154426|NCT01033084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154154427|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154154428|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154154429|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154430|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154431|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
154154432|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729725|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154433|NCT00979758|Atorvastatin|atorvastatin|mesh-list
154154434|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154154435|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154154436|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
154154437|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154438|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154154439|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153360661|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360662|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
154154440|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154442|NCT00545064|Dorzolamide|dorzolamide|mesh-list
154154443|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154444|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154445|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154154446|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154154447|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
154154448|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154449|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154450|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154154451|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154154452|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154154453|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
154154454|NCT00979836|Calcium|calcium|mesh-list
154154476|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154478|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154154479|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
154154480|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154481|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154154482|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154154483|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154154484|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154485|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
154154486|NCT00974532|Calcium|calcium|mesh-list
154154487|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154154488|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154489|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154154490|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
154154491|NCT00432172|Carboplatin|carboplatin|mesh-list
154154492|NCT00432172|Docetaxel|docetaxel|mesh-list
154154493|NCT00432172|Epirubicin|epirubicin|mesh-list
154154494|NCT00432172|Exemestane|exemestane|mesh-list
154154495|NCT00432172|Goserelin|goserelin|mesh-list
154154496|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154497|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
154154498|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154499|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154500|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154154501|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
154154502|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154503|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154504|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154154505|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
154154506|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
154154507|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664323|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
154154531|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154532|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154154533|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154154535|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154154536|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154537|NCT00980304|Rituximab|rituximab|mesh-list
154154538|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154154539|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154540|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
154154541|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154542|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154154543|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
154154544|NCT00974766|Hormones|hormones|mesh-ancestor
154154545|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154154546|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154547|NCT00980382|Docetaxel|docetaxel|mesh-list
154154548|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154549|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
154154550|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
154154551|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
154154552|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154553|NCT00967434|Atorvastatin|atorvastatin|mesh-list
154154554|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153664377|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
154154589|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154590|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154591|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
154154592|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154154593|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154154594|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
154154595|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
154154596|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154154614|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154615|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
154154616|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154617|NCT00980850|Vaccines|vaccines|mesh-list
154154618|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
154154619|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154620|NCT00414466|Gabapentin|gabapentin|mesh-list
154154621|NCT00414466|Analgesics|analgesics|mesh-ancestor
154154622|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
154154623|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154154624|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154625|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
154154626|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154154627|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154154628|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154154629|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154154630|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154154631|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154154632|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154633|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154634|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
154154635|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
154154636|NCT00984750|Simvastatin|simvastatin|mesh-list
154154637|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154154638|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154154639|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
154154640|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154641|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154154642|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154154643|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154644|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
154154645|NCT00984750|Vitamins|vitamins|mesh-ancestor
154154646|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
154154647|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154648|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
154154649|NCT00975312|Tretinoin|tretinoin|mesh-list
154154650|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154651|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
154154652|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
154154653|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
154154654|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
154154655|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154154691|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
154154719|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154721|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154154722|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
154154723|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154724|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154154725|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154154726|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154154727|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154154728|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154154729|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
154154730|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154154731|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154154732|NCT00984984|Prednisolone|prednisolone|mesh-list
154154733|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
154154734|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154154735|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
154154736|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154737|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
154154767|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154154768|NCT00981708|Dexamethasone|dexamethasone|mesh-list
154154769|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
154154770|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
154154771|NCT00981708|Lenalidomide|lenalidomide|mesh-list
154154772|NCT00981708|BB 1101|bb 1101|mesh-list
154154773|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154154774|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
154154775|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154776|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153445905|NCT00001193|Melphalan|melphalan|mesh-list
154154777|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154154778|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
154154779|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154780|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154154781|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154154818|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154154848|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154154849|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154154850|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154154851|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154154852|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
154154853|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154154854|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154855|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154857|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154154858|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154154859|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
154154860|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154154861|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
154154862|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154897|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154154898|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154899|NCT00982332|Betamethasone|betamethasone|mesh-list
154154900|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154154901|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154154902|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
154154934|NCT00976794|Carbamazepine|carbamazepine|mesh-list
154154935|NCT00976794|Valproic Acid|valproic acid|mesh-list
154154936|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
154154937|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
154154938|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154154939|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154154940|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154154941|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
154154942|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154154943|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154154944|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154154945|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
154154983|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153664818|NCT00276198|Vitamin D|vitamin d|mesh-list
154155020|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155021|NCT00984828|Bortezomib|bortezomib|mesh-list
154155022|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155023|NCT00983034|Amoxicillin|amoxicillin|mesh-list
154155024|NCT00983034|Clarithromycin|clarithromycin|mesh-list
154155058|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155059|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154155060|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
154155061|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
154155062|NCT00545298|Protective Agents|protective agents|mesh-ancestor
154155063|NCT00983268|Capecitabine|capecitabine|mesh-list
154155064|NCT00983268|Vorinostat|vorinostat|mesh-list
154155065|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154155066|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
153664891|NCT00015236|Analgesics|analgesics|mesh-ancestor
154155139|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
154155140|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155141|NCT00414388|Sorafenib|sorafenib|mesh-list
154155142|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155143|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154155144|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155176|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154155177|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155178|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154155179|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154155180|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155181|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155182|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155184|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154155185|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154155186|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155187|NCT00978978|Midazolam|midazolam|mesh-list
154155188|NCT00978978|Fentanyl|fentanyl|mesh-list
154155211|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154155212|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
154155213|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155214|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155215|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155216|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
154155218|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155219|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155220|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
154155221|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155222|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155223|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155224|NCT00542880|Fluticasone|fluticasone|mesh-list
154155225|NCT00542880|Budesonide|budesonide|mesh-list
154155226|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
154155227|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154155228|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154155229|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154155230|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155231|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154155232|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
154155233|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155234|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155235|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154155236|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
154155237|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
154155238|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154155239|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
154155240|NCT00542880|Hormones|hormones|mesh-ancestor
154155241|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154155242|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154155264|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155265|NCT01033396|Fexofenadine|fexofenadine|mesh-list
154155266|NCT01033396|Terfenadine|terfenadine|mesh-list
154155267|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154155268|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154155269|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154155270|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
154155271|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
154155272|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155273|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155274|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155275|NCT00979056|Rifaximin|rifaximin|mesh-list
154155276|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155277|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155278|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154155279|NCT00092677|Simvastatin|simvastatin|mesh-list
154155280|NCT00092677|Ezetimibe|ezetimibe|mesh-list
154155281|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154155282|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154155283|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
154155284|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155285|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154155286|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154155287|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155288|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154155289|NCT00542178|Simvastatin|simvastatin|mesh-list
154155290|NCT00542178|Fenofibrate|fenofibrate|mesh-list
154155291|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154155292|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154155293|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
154155294|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155295|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154155324|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154155325|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154155326|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
154155327|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155328|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154155329|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154155330|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154155331|NCT00424294|Analgesics|analgesics|mesh-ancestor
154155332|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
154155333|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155334|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155335|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154155336|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154155338|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
154155339|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
154155340|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155341|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155373|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155374|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154155375|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154155376|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155377|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155378|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155379|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154155380|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
154155381|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154155410|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155411|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154155412|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820678|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153820679|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360663|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360664|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360665|NCT01334723|Urological Agents|urological agents|mesh-ancestor
154155413|NCT05712642|Bevacizumab|bevacizumab|mesh-list
154155414|NCT05712642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154155415|NCT05712642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155416|NCT05712642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154155417|NCT05712642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154155418|NCT05712642|Growth Substances|growth substances|mesh-ancestor
154155419|NCT05712642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155420|NCT05712642|Growth Inhibitors|growth inhibitors|mesh-ancestor
154155421|NCT01085149|Simvastatin|simvastatin|mesh-list
154155422|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154155423|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154155449|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155450|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155452|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155453|NCT00091819|Vancomycin|vancomycin|mesh-list
154155454|NCT00091819|Telavancin|telavancin|mesh-list
154155455|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155456|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155457|NCT01326871|Gemcitabine|gemcitabine|mesh-list
154155458|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155459|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154155460|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
154155461|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155462|NCT01081561|Riboflavin|riboflavin|mesh-list
154155463|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
154155464|NCT01081561|Vitamins|vitamins|mesh-ancestor
154155465|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
154155466|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155467|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154155468|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
154155469|NCT04004754|Miltefosine|miltefosine|mesh-list
154155470|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
154155471|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155472|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155505|NCT05919732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155506|NCT05919732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155507|NCT05919732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154155508|NCT05919732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154155509|NCT05919732|Autonomic Agents|autonomic agents|mesh-ancestor
154155510|NCT05919732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154155511|NCT05919732|Respiratory System Agents|respiratory system agents|mesh-ancestor
154155512|NCT05919732|Mydriatics|mydriatics|mesh-ancestor
154155513|NCT05919732|Sympathomimetics|sympathomimetics|mesh-ancestor
154155539|NCT05919407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155540|NCT05919407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155541|NCT05919407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154155542|NCT05919407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155543|NCT05919407|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154155544|NCT05919407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154155545|NCT05919121|Hydrocortisone|hydrocortisone|mesh-list
154155546|NCT05919121|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154155548|NCT05919121|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154256488|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155549|NCT05919121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155551|NCT05919017|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154155552|NCT05919017|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154155553|NCT05919017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155554|NCT05919017|Sensory System Agents|sensory system agents|mesh-ancestor
154155555|NCT05919017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155556|NCT05918627|Belumosudil|belumosudil|mesh-list
154155557|NCT05918627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154155558|NCT05918627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155559|NCT05918627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155560|NCT05918614|Belumosudil|belumosudil|mesh-list
154155561|NCT05918614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154155562|NCT05918614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665381|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154155589|NCT05914506|Anesthetics|anesthetics|mesh-ancestor
154155590|NCT05914506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155591|NCT05914506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155592|NCT05913817|Adalimumab|adalimumab|mesh-list
154155593|NCT05913817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154155594|NCT05913817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155595|NCT05913817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155596|NCT05890976|Semaglutide|semaglutide|mesh-list
154155597|NCT05890976|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154155598|NCT05890976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154155599|NCT05890976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155600|NCT05883241|Diclofenac|diclofenac|mesh-list
154155601|NCT05883241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154155602|NCT05883241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154155603|NCT05883241|Analgesics|analgesics|mesh-ancestor
154155604|NCT05883241|Sensory System Agents|sensory system agents|mesh-ancestor
154155605|NCT05883241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155606|NCT05883241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155607|NCT05883241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155608|NCT05883241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154155609|NCT05883241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154155610|NCT05883241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155611|NCT05883241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155612|NCT05874245|Midazolam|midazolam|mesh-list
154155613|NCT05874245|Dexmedetomidine|dexmedetomidine|mesh-list
154155614|NCT05874245|Ketamine|ketamine|mesh-list
154155640|NCT05824143|Carbamazepine|carbamazepine|mesh-list
154155641|NCT05824143|Anticonvulsants|anticonvulsants|mesh-ancestor
154155642|NCT05824143|Antimanic Agents|antimanic agents|mesh-ancestor
154155643|NCT05824143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155644|NCT05824143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155645|NCT05824143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155646|NCT05824143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155647|NCT05824143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154155648|NCT05824143|Analgesics|analgesics|mesh-ancestor
154155649|NCT05824143|Sensory System Agents|sensory system agents|mesh-ancestor
154155650|NCT05824143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155651|NCT05824143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154155652|NCT05824143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154155653|NCT05824143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155654|NCT05824143|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154155655|NCT05824143|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154155656|NCT05789199|Cefiderocol|cefiderocol|mesh-list
154155657|NCT05789199|Siderophores|siderophores|mesh-ancestor
154155658|NCT05789199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154155659|NCT05789199|Chelating Agents|chelating agents|mesh-ancestor
154155660|NCT05789199|Sequestering Agents|sequestering agents|mesh-ancestor
154155661|NCT05789199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155662|NCT05789199|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154155663|NCT05789199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155694|NCT05494437|Analgesics|analgesics|mesh-ancestor
154155695|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
154155696|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155697|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155698|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
154155699|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154155700|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154155701|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154155702|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155703|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154155704|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154155705|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665531|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
154155771|NCT05205382|Nicotine|nicotine|mesh-list
154155772|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153479331|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154155773|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
154155774|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155775|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155776|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154155777|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154155778|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
154155779|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155780|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155782|NCT05132829|Cefazolin|cefazolin|mesh-list
154155783|NCT05132829|Indomethacin|indomethacin|mesh-list
154155784|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155785|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155786|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154155787|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154155788|NCT05132829|Analgesics|analgesics|mesh-ancestor
154155789|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
154155825|NCT04899388|Analgesics|analgesics|mesh-ancestor
154155826|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
154155827|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155854|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154155855|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154155856|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155857|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155858|NCT04777006|Amitriptyline|amitriptyline|mesh-list
154155859|NCT04777006|Fluoxetine|fluoxetine|mesh-list
154155860|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
154155861|NCT04777006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154155862|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154155863|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154155864|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154155865|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154155866|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
154155867|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155868|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154155869|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154155870|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154155871|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154155872|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155873|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154155874|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154155875|NCT04777006|Analgesics|analgesics|mesh-ancestor
154155876|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
154155877|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154155878|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154155879|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
154155880|NCT04766086|Vaccines|vaccines|mesh-list
154155881|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
154155918|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154155919|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
154155920|NCT04469595|Hormones|hormones|mesh-ancestor
153665746|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154155953|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154155954|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154155955|NCT04046900|Metronidazole|metronidazole|mesh-list
154155956|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154155957|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154155958|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154155959|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154155960|NCT03989115|Osimertinib|osimertinib|mesh-list
154155961|NCT03989115|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154155995|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154155996|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154155997|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154155998|NCT03787680|Olaparib|olaparib|mesh-list
154155999|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154156000|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156001|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256489|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
153446003|NCT00000437|Naltrexone|naltrexone|mesh-list
154156002|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156029|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154156030|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156031|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156033|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154156034|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154156035|NCT03559192|Aticaprant|aticaprant|mesh-list
154156036|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154156037|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156038|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
154156039|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156040|NCT03552471|Rucaparib|rucaparib|mesh-list
154156041|NCT03552471|Maytansine|maytansine|mesh-list
154156042|NCT03552471|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
154156043|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154156044|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156045|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156046|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156047|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154156048|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
154156049|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
154156050|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
154156051|NCT03552471|Immunoconjugates|immunoconjugates|mesh-ancestor
154156052|NCT03552471|Immunologic Factors|immunologic factors|mesh-ancestor
154156053|NCT03552471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156054|NCT03523585|Capecitabine|capecitabine|mesh-list
154156055|NCT03523585|Trastuzumab|trastuzumab|mesh-list
154156088|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156089|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154156090|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154156091|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154156092|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154156093|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154156094|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
154156095|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
154156096|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
154156097|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156098|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156099|NCT03293680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154156124|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154156125|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156126|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156127|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
154156128|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156129|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154156130|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154156131|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154156132|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
154156133|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156134|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156135|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154156136|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154156137|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154156139|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156140|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
154156141|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156142|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154156143|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156144|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156145|NCT02932475|Metformin|metformin|mesh-list
154156146|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154156147|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156148|NCT02919917|Midodrine|midodrine|mesh-list
154156149|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
154156150|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
154156177|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154156178|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154156179|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154156180|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446030|NCT00000449|Naltrexone|naltrexone|mesh-list
154156181|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
154156182|NCT02507687|Bimatoprost|bimatoprost|mesh-list
154156183|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154156184|NCT02321501|Everolimus|everolimus|mesh-list
154156185|NCT02321501|Ceritinib|ceritinib|mesh-list
154156186|NCT02321501|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154156187|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154156188|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156189|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156190|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156191|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
154156192|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156193|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156194|NCT02321501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154156195|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
154156196|NCT02237079|Estrogens|estrogens|mesh-list
154156197|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154156198|NCT02237079|Hormones|hormones|mesh-ancestor
153666011|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
154156220|NCT06271486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156221|NCT06271486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156223|NCT06271486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154156224|NCT06271486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154156225|NCT06271486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156226|NCT06271486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154156228|NCT06271486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154156229|NCT06271486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156230|NCT06271486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154156231|NCT06271408|Albuterol|albuterol|mesh-list
154156232|NCT06271408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154156233|NCT06271408|Autonomic Agents|autonomic agents|mesh-ancestor
154156234|NCT06271408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156235|NCT06271408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156236|NCT06271408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154156237|NCT06271408|Respiratory System Agents|respiratory system agents|mesh-ancestor
154156238|NCT06271408|Tocolytic Agents|tocolytic agents|mesh-ancestor
154156239|NCT06271408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154156240|NCT06271408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154156241|NCT06271408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154156242|NCT06271408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154156243|NCT06271408|Adrenergic Agents|adrenergic agents|mesh-ancestor
154156244|NCT06271408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156245|NCT06271408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156246|NCT06271330|Faricimab|faricimab|mesh-list
154156247|NCT06271330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154156248|NCT06271330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154156249|NCT06271330|Growth Substances|growth substances|mesh-ancestor
153666061|NCT00019227|Antidotes|antidotes|mesh-ancestor
154156279|NCT06270797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156281|NCT06270706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156282|NCT06270706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156283|NCT06270706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154156284|NCT06270706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156285|NCT06270433|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154156286|NCT06270433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154156287|NCT06270433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154156288|NCT06270433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154156289|NCT06270433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156290|NCT06270433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156291|NCT06270433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156292|NCT06270433|Antidepressive Agents|antidepressive agents|mesh-ancestor
154156317|NCT06270147|Anesthetics|anesthetics|mesh-ancestor
154156318|NCT06270147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156319|NCT06270147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156320|NCT06270147|Sensory System Agents|sensory system agents|mesh-ancestor
154156321|NCT06270147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156322|NCT06270147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154156323|NCT06270147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154156324|NCT06270147|Adrenergic Agents|adrenergic agents|mesh-ancestor
154256490|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
154156325|NCT06270147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156326|NCT06270147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156327|NCT06270147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154156328|NCT06270147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154156329|NCT06270147|Autonomic Agents|autonomic agents|mesh-ancestor
154156330|NCT06270147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154156331|NCT06270147|Respiratory System Agents|respiratory system agents|mesh-ancestor
154156332|NCT06270147|Mydriatics|mydriatics|mesh-ancestor
154156333|NCT06270147|Sympathomimetics|sympathomimetics|mesh-ancestor
154156334|NCT06270147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154156335|NCT06270056|Misoprostol|misoprostol|mesh-list
154156336|NCT06270056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154156337|NCT06270056|Abortifacient Agents|abortifacient agents|mesh-ancestor
154156338|NCT06270056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154156339|NCT06270056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156340|NCT06270056|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154156341|NCT06270056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156342|NCT06270056|Oxytocics|oxytocics|mesh-ancestor
154156343|NCT06269978|Fluorouracil|fluorouracil|mesh-list
154156344|NCT06269978|Oxaliplatin|oxaliplatin|mesh-list
154156345|NCT06269978|Antimetabolites|antimetabolites|mesh-ancestor
154156346|NCT06269978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156383|NCT06269445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156384|NCT06269445|Growth Inhibitors|growth inhibitors|mesh-ancestor
154156385|NCT06269406|Ibuprofen|ibuprofen|mesh-list
154156386|NCT06269406|Curcumin|curcumin|mesh-list
153666210|NCT00020709|Docetaxel|docetaxel|mesh-list
154156419|NCT06268964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156420|NCT06268964|Parasympatholytics|parasympatholytics|mesh-ancestor
154156421|NCT06268964|Autonomic Agents|autonomic agents|mesh-ancestor
154156422|NCT06268964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156423|NCT06268964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156424|NCT06268470|Loratadine|loratadine|mesh-list
154156425|NCT06268470|Cilostazol|cilostazol|mesh-list
154156426|NCT06268470|Dipyridamole|dipyridamole|mesh-list
154156427|NCT06268470|Desloratadine|desloratadine|mesh-list
154156456|NCT06267664|Serotonin Agents|serotonin agents|mesh-ancestor
154156457|NCT06267664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156458|NCT06267664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156459|NCT06267664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156460|NCT06266611|Cannabidiol|cannabidiol|mesh-list
154156461|NCT06266611|Anticonvulsants|anticonvulsants|mesh-ancestor
154156462|NCT06266494|Dalbavancin|dalbavancin|mesh-list
154156463|NCT06266494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154156464|NCT06266494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156465|NCT06266481|Dexamethasone|dexamethasone|mesh-list
154156466|NCT06266481|Lidocaine|lidocaine|mesh-list
154156467|NCT06266481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156468|NCT06266481|Antiemetics|antiemetics|mesh-ancestor
154156469|NCT06266481|Autonomic Agents|autonomic agents|mesh-ancestor
154156470|NCT06266481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156471|NCT06266481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156472|NCT06266481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156473|NCT06266481|Glucocorticoids|glucocorticoids|mesh-ancestor
154156474|NCT06266481|Hormones|hormones|mesh-ancestor
154156501|NCT06266221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156502|NCT06266221|Glucocorticoids|glucocorticoids|mesh-ancestor
154156503|NCT06266221|Hormones|hormones|mesh-ancestor
154156504|NCT06266221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156505|NCT06266221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156506|NCT06266221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154156507|NCT06266221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156508|NCT06266221|Antiemetics|antiemetics|mesh-ancestor
154156509|NCT06266221|Autonomic Agents|autonomic agents|mesh-ancestor
154156510|NCT06266221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156511|NCT06266221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154156512|NCT06266221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154156513|NCT06266221|Protective Agents|protective agents|mesh-ancestor
154156514|NCT06266000|Saw palmetto extract|saw palmetto extract|mesh-list
154156515|NCT06266000|Urological Agents|urological agents|mesh-ancestor
154156516|NCT06265883|Chlorotrianisene|chlorotrianisene|mesh-list
154156517|NCT06265883|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154156518|NCT06265883|Estrogens|estrogens|mesh-ancestor
154156519|NCT06265883|Hormones|hormones|mesh-ancestor
154156520|NCT06265883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666338|NCT05574218|Glycine|glycine|mesh-list
154156551|NCT06265545|Gilteritinib|gilteritinib|mesh-list
154156553|NCT06265545|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154156554|NCT06265545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154156555|NCT06265545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156556|NCT06265545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156557|NCT06265532|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154156558|NCT06265532|Antioxidants|antioxidants|mesh-ancestor
154156559|NCT06265532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156560|NCT06265532|Protective Agents|protective agents|mesh-ancestor
154156561|NCT06265532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156562|NCT06265532|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154156563|NCT06265532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154156564|NCT06265532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156583|NCT06265454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156585|NCT06265415|Nifedipine|nifedipine|mesh-list
154156586|NCT06265415|Nitroglycerin|nitroglycerin|mesh-list
154156587|NCT06265415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154156588|NCT06265415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154156589|NCT06265415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156590|NCT06265415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154156591|NCT06265415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156592|NCT06265415|Vasodilator Agents|vasodilator agents|mesh-ancestor
154156593|NCT06265415|Tocolytic Agents|tocolytic agents|mesh-ancestor
154156594|NCT06265415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154156595|NCT06265415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154156596|NCT06265415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154156597|NCT06265415|Adrenergic Agents|adrenergic agents|mesh-ancestor
154156598|NCT06265415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156599|NCT06265415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154156601|NCT06265415|Autonomic Agents|autonomic agents|mesh-ancestor
154156602|NCT06265415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156603|NCT06265415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154156604|NCT06265415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154156605|NCT06265389|Pentoxifylline|pentoxifylline|mesh-list
154156606|NCT06265389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154156607|NCT06265389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156608|NCT06265389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156609|NCT06265389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154156610|NCT06265389|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154156611|NCT06265389|Protective Agents|protective agents|mesh-ancestor
154156612|NCT06265389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156613|NCT06265389|Vasodilator Agents|vasodilator agents|mesh-ancestor
154156614|NCT06265389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154156615|NCT06265389|Antioxidants|antioxidants|mesh-ancestor
154156616|NCT06265350|Bevacizumab|bevacizumab|mesh-list
154156617|NCT06265350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156618|NCT06265350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156619|NCT06265350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154156620|NCT06265350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154156621|NCT06265350|Growth Substances|growth substances|mesh-ancestor
154156652|NCT06265051|Tirofiban|tirofiban|mesh-list
154156653|NCT06265051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154156654|NCT06265051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154156655|NCT06265051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156656|NCT06265051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154156657|NCT06265025|Pembrolizumab|pembrolizumab|mesh-list
154156658|NCT06265025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156659|NCT06265025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156660|NCT06265025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154156661|NCT06265025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156662|NCT06264882|Estradiol|estradiol|mesh-list
154156663|NCT06264882|Estrogens|estrogens|mesh-ancestor
154156664|NCT06264882|Hormones|hormones|mesh-ancestor
153666483|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154156691|NCT06264674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156692|NCT06264674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156693|NCT06264661|Chrysarobin|chrysarobin|mesh-list
154156694|NCT06264661|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154156695|NCT06264661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154156696|NCT06264661|Analgesics|analgesics|mesh-ancestor
154156697|NCT06264661|Sensory System Agents|sensory system agents|mesh-ancestor
154156698|NCT06264661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156699|NCT06264661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156700|NCT06264661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156701|NCT06264661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154156702|NCT06264609|Alendronate|alendronate|mesh-list
154156703|NCT06264609|Teriparatide|teriparatide|mesh-list
154156704|NCT06264609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154156705|NCT06264609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156706|NCT06264609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154156707|NCT06264544|Selenium|selenium|mesh-list
154156708|NCT06264544|Antioxidants|antioxidants|mesh-ancestor
154156709|NCT06264544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156732|NCT06263010|Pregnanolone|pregnanolone|mesh-list
154156733|NCT06263010|Anesthetics|anesthetics|mesh-ancestor
154156734|NCT06263010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156735|NCT06263010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156736|NCT06262360|Anesthetics|anesthetics|mesh-list
154156737|NCT06262360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156738|NCT06262360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156739|NCT06262347|Analgesics, Opioid|analgesics, opioid|mesh-list
154156740|NCT06262347|Narcotics|narcotics|mesh-ancestor
154156741|NCT06262347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156742|NCT06262347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156743|NCT06262347|Analgesics|analgesics|mesh-ancestor
154156744|NCT06262347|Sensory System Agents|sensory system agents|mesh-ancestor
154156745|NCT06262347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156746|NCT06260618|Dextrans|dextrans|mesh-list
154156747|NCT06260618|Chitosan|chitosan|mesh-list
154156748|NCT06260618|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154156750|NCT06260618|Plasma Substitutes|plasma substitutes|mesh-ancestor
154156751|NCT06260618|Blood Substitutes|blood substitutes|mesh-ancestor
154156752|NCT06260618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154156753|NCT06260618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154156754|NCT06260618|Antimetabolites|antimetabolites|mesh-ancestor
154156755|NCT06260618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156756|NCT06260618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154156757|NCT06260618|Chelating Agents|chelating agents|mesh-ancestor
154156758|NCT06260618|Sequestering Agents|sequestering agents|mesh-ancestor
154156759|NCT06260618|Hemostatics|hemostatics|mesh-ancestor
154156760|NCT06260618|Coagulants|coagulants|mesh-ancestor
154156761|NCT06257771|Ethanol|ethanol|mesh-list
154156762|NCT06257771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154156763|NCT06257771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156764|NCT06257771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154156765|NCT06257771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156766|NCT06253611|Leucovorin|leucovorin|mesh-list
153666630|NCT00022620|Paclitaxel|paclitaxel|mesh-list
154156827|NCT06237231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154156829|NCT06237231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156830|NCT06237231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154156831|NCT06237231|Antipyretics|antipyretics|mesh-ancestor
154156832|NCT06235892|Tacrolimus|tacrolimus|mesh-list
154156833|NCT06235892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154156834|NCT06235892|Immunologic Factors|immunologic factors|mesh-ancestor
154156835|NCT06235892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156836|NCT06235892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154156837|NCT06235892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154156838|NCT06235892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156839|NCT06217796|Phenylephrine|phenylephrine|mesh-list
154156840|NCT06217796|Oxymetazoline|oxymetazoline|mesh-list
154156841|NCT06217796|Tropicamide|tropicamide|mesh-list
154156842|NCT06217796|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154156843|NCT06217796|Mydriatics|mydriatics|mesh-ancestor
154156844|NCT06217796|Autonomic Agents|autonomic agents|mesh-ancestor
154156845|NCT06217796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154156846|NCT06217796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156847|NCT06217796|Sympathomimetics|sympathomimetics|mesh-ancestor
154156848|NCT06217796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154156849|NCT06217796|Nasal Decongestants|nasal decongestants|mesh-ancestor
154156850|NCT06217796|Respiratory System Agents|respiratory system agents|mesh-ancestor
154156851|NCT06217796|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154156852|NCT06217796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154156853|NCT06217796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154156854|NCT06217796|Adrenergic Agents|adrenergic agents|mesh-ancestor
154156855|NCT06217796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154156891|NCT06190249|Alkylating Agents|alkylating agents|mesh-ancestor
154156892|NCT06190249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156893|NCT06190249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154256491|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
154156894|NCT06190249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154156895|NCT06190249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156896|NCT06190249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153666725|NCT02971878|Vitamins|vitamins|mesh-ancestor
154156921|NCT06168851|Immunologic Factors|immunologic factors|mesh-ancestor
154156922|NCT06168851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156923|NCT06148090|Clobetasol|clobetasol|mesh-list
154156924|NCT06148090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154156925|NCT06148090|Glucocorticoids|glucocorticoids|mesh-ancestor
154156926|NCT06148090|Hormones|hormones|mesh-ancestor
154156927|NCT06148090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154156928|NCT06148090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156929|NCT06140537|Dapagliflozin|dapagliflozin|mesh-list
154156930|NCT06140537|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154156931|NCT06140537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156932|NCT06140537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154156933|NCT06140537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156934|NCT06131957|Fluorides|fluorides|mesh-list
154156935|NCT06131957|Fluorides, Topical|fluorides, topical|mesh-list
154156936|NCT06131957|Cariostatic Agents|cariostatic agents|mesh-ancestor
154156937|NCT06131957|Protective Agents|protective agents|mesh-ancestor
154156938|NCT06131957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156939|NCT06128733|Vaccines|vaccines|mesh-list
154156940|NCT06128733|Immunologic Factors|immunologic factors|mesh-ancestor
154156941|NCT06128733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156942|NCT06113809|Pembrolizumab|pembrolizumab|mesh-list
154156943|NCT06113809|Palbociclib|palbociclib|mesh-list
154156944|NCT06113809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156945|NCT06113809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156946|NCT06113809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154156947|NCT06113809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156965|NCT06109155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156967|NCT06109155|Coagulants|coagulants|mesh-ancestor
154156968|NCT06108050|Pembrolizumab|pembrolizumab|mesh-list
154156969|NCT06108050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156970|NCT06108050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156971|NCT06108050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154156972|NCT06108050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156973|NCT06105008|Disitamab vedotin|disitamab vedotin|mesh-list
154156974|NCT06105008|Immunoconjugates|immunoconjugates|mesh-ancestor
154156975|NCT06105008|Immunologic Factors|immunologic factors|mesh-ancestor
154156976|NCT06105008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154156977|NCT06082167|Pembrolizumab|pembrolizumab|mesh-list
154156978|NCT06082167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154156979|NCT06082167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156980|NCT06082167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154156981|NCT06082167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154156983|NCT06075264|Artenimol|artenimol|mesh-list
154156984|NCT06075264|Artemisinins|artemisinins|mesh-list
154156985|NCT06075264|Artemisinin|artemisinin|mesh-list
154156986|NCT06075264|Antimalarials|antimalarials|mesh-ancestor
154156987|NCT06075264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154156988|NCT06075264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154156989|NCT06075264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154156990|NCT06075264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154156991|NCT06075264|Antiviral Agents|antiviral agents|mesh-ancestor
154156992|NCT06075264|Schistosomicides|schistosomicides|mesh-ancestor
154156993|NCT06075264|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154156994|NCT06075264|Anthelmintics|anthelmintics|mesh-ancestor
154157050|NCT06067737|Sensory System Agents|sensory system agents|mesh-ancestor
154157073|NCT06062966|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154157075|NCT06056687|Thioctic Acid|thioctic acid|mesh-list
154157076|NCT06056687|Antioxidants|antioxidants|mesh-ancestor
154157077|NCT06056687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157078|NCT06056687|Protective Agents|protective agents|mesh-ancestor
154157079|NCT06056687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157080|NCT06056687|Vitamin B Complex|vitamin b complex|mesh-ancestor
154157081|NCT06056687|Vitamins|vitamins|mesh-ancestor
154157082|NCT06056687|Micronutrients|micronutrients|mesh-ancestor
154157083|NCT06055920|Anticoagulants|anticoagulants|mesh-list
154157084|NCT06055608|Mycophenolic Acid|mycophenolic acid|mesh-list
154157085|NCT06055608|Sirolimus|sirolimus|mesh-list
154157086|NCT06055608|Abatacept|abatacept|mesh-list
154157087|NCT06055608|Tacrolimus|tacrolimus|mesh-list
154157088|NCT06055608|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154263465|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157089|NCT06055608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154157090|NCT06055608|Immunologic Factors|immunologic factors|mesh-ancestor
154157091|NCT06055608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157092|NCT06055608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154157093|NCT06055608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157094|NCT06055608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157095|NCT06055608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154157096|NCT06055608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157097|NCT06055608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154157098|NCT06055608|Antitubercular Agents|antitubercular agents|mesh-ancestor
154157099|NCT06055608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154157100|NCT06055608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157101|NCT06055608|Antifungal Agents|antifungal agents|mesh-ancestor
154157102|NCT06055608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153666921|NCT00023868|Mitomycins|mitomycins|mesh-list
154157124|NCT06039371|Testosterone undecanoate|testosterone undecanoate|mesh-list
154157125|NCT06039371|Testosterone enanthate|testosterone enanthate|mesh-list
154157126|NCT06039371|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154157127|NCT06039371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157128|NCT06039371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154157129|NCT06039371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154157130|NCT06039371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154157131|NCT06039371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157132|NCT06039371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157133|NCT06039371|Androgens|androgens|mesh-ancestor
154157134|NCT06039371|Hormones|hormones|mesh-ancestor
154157135|NCT06039371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157136|NCT06039371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157137|NCT06039371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154157138|NCT06039371|Anabolic Agents|anabolic agents|mesh-ancestor
154157139|NCT06039371|Keratolytic Agents|keratolytic agents|mesh-ancestor
154157140|NCT06039371|Dermatologic Agents|dermatologic agents|mesh-ancestor
154157141|NCT06039371|Tubulin Modulators|tubulin modulators|mesh-ancestor
154157142|NCT06039371|Antimitotic Agents|antimitotic agents|mesh-ancestor
154157143|NCT06039371|Mitosis Modulators|mitosis modulators|mesh-ancestor
154157144|NCT06038903|Caffeine|caffeine|mesh-list
154157145|NCT06038903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154157146|NCT06038903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157147|NCT06038903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154157148|NCT06038903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157149|NCT06038903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157150|NCT06038903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154157151|NCT06038903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154157152|NCT06038903|Purinergic Agents|purinergic agents|mesh-ancestor
154157153|NCT06038903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157154|NCT06020898|Valproic Acid|valproic acid|mesh-list
154157155|NCT06020898|Anticonvulsants|anticonvulsants|mesh-ancestor
154157156|NCT06020898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157191|NCT06013423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157192|NCT06013423|Dermatologic Agents|dermatologic agents|mesh-ancestor
154157193|NCT06013423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154157194|NCT06013423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154157195|NCT06013423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154157196|NCT06013423|Antitubercular Agents|antitubercular agents|mesh-ancestor
154157220|NCT05983770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154157221|NCT05983770|Immunologic Factors|immunologic factors|mesh-ancestor
154157222|NCT05983770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157223|NCT05983770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154157224|NCT05983770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157225|NCT05983770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157227|NCT05979389|Androgen Antagonists|androgen antagonists|mesh-ancestor
154157228|NCT05979389|Hormone Antagonists|hormone antagonists|mesh-ancestor
154157229|NCT05979389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157230|NCT05979389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157231|NCT05979389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157232|NCT05976698|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
154157233|NCT05976698|Hallucinogens|hallucinogens|mesh-ancestor
154157234|NCT05976698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157235|NCT05976698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154157236|NCT05976698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154157237|NCT05976698|Serotonin Agents|serotonin agents|mesh-ancestor
154157238|NCT05976698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157239|NCT05976698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157240|NCT05976698|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154157241|NCT05965544|Fentanyl|fentanyl|mesh-list
154157242|NCT05965544|Bupivacaine|bupivacaine|mesh-list
154157243|NCT05965544|Anesthetics, Local|anesthetics, local|mesh-ancestor
154157244|NCT05965544|Anesthetics|anesthetics|mesh-ancestor
154157245|NCT05965544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157246|NCT05965544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157247|NCT05965544|Sensory System Agents|sensory system agents|mesh-ancestor
154157276|NCT05935930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157277|NCT05935930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157278|NCT05935930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154157279|NCT05935930|Anesthetics, General|anesthetics, general|mesh-ancestor
154157280|NCT05935930|Anesthetics|anesthetics|mesh-ancestor
154157281|NCT05935930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154157282|NCT05935930|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154157283|NCT05934110|Orlistat|orlistat|mesh-list
154157284|NCT05934110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157285|NCT05934110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157286|NCT05934110|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154157287|NCT05934110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154157288|NCT05930665|Bevacizumab|bevacizumab|mesh-list
154157289|NCT05930665|Carboplatin|carboplatin|mesh-list
154157290|NCT05930665|Pemetrexed|pemetrexed|mesh-list
154157291|NCT05930665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157292|NCT05930665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157293|NCT05930665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154157294|NCT05930665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154157295|NCT05930665|Growth Substances|growth substances|mesh-ancestor
154157296|NCT05930665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157325|NCT05884372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154157326|NCT05884372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154157328|NCT05878769|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154157329|NCT05878769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154157330|NCT05878769|Antiviral Agents|antiviral agents|mesh-ancestor
154157331|NCT05878769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157332|NCT05876351|Eculizumab|eculizumab|mesh-list
154157333|NCT05876351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154157334|NCT05876351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154157335|NCT05876351|Immunologic Factors|immunologic factors|mesh-ancestor
154157336|NCT05876351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157337|NCT05875272|Hemostatics|hemostatics|mesh-list
154157338|NCT05875272|Coagulants|coagulants|mesh-ancestor
154157339|NCT05867121|Paclitaxel|paclitaxel|mesh-list
154157340|NCT05867121|Gemcitabine|gemcitabine|mesh-list
154157341|NCT05867121|Capecitabine|capecitabine|mesh-list
154157342|NCT05867121|Nivolumab|nivolumab|mesh-list
154157343|NCT05867121|Oxaliplatin|oxaliplatin|mesh-list
154157373|NCT05823532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154157374|NCT05823532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154157375|NCT05823532|Dermatologic Agents|dermatologic agents|mesh-ancestor
154157376|NCT05823532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154157377|NCT05823532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154157378|NCT05808764|Risdiplam|risdiplam|mesh-list
154157379|NCT05808764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154157380|NCT05808764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157381|NCT05808764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157382|NCT05807139|Spironolactone|spironolactone|mesh-list
154157383|NCT05807139|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154157384|NCT05807139|Hormone Antagonists|hormone antagonists|mesh-ancestor
154157385|NCT05807139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157386|NCT05807139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157387|NCT05807139|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154157388|NCT05807139|Diuretics|diuretics|mesh-ancestor
153667214|NCT00025584|Bortezomib|bortezomib|mesh-list
154157408|NCT05797233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154157409|NCT05797233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154157410|NCT05797233|Alkylating Agents|alkylating agents|mesh-ancestor
154157411|NCT05797233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157412|NCT05797233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157413|NCT05797233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154157414|NCT05793060|Dexamethasone|dexamethasone|mesh-list
154157415|NCT05793060|Dexamethasone acetate|dexamethasone acetate|mesh-list
154157416|NCT05793060|Dexmedetomidine|dexmedetomidine|mesh-list
154157417|NCT05793060|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154157418|NCT05793060|BB 1101|bb 1101|mesh-list
154157419|NCT05793060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154157420|NCT05793060|Antiemetics|antiemetics|mesh-ancestor
154157421|NCT05793060|Autonomic Agents|autonomic agents|mesh-ancestor
154157422|NCT05793060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157423|NCT05793060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157424|NCT05793060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154157425|NCT05793060|Glucocorticoids|glucocorticoids|mesh-ancestor
154157426|NCT05793060|Hormones|hormones|mesh-ancestor
154157427|NCT05793060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157428|NCT05793060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154157429|NCT05793060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157430|NCT05793060|Protease Inhibitors|protease inhibitors|mesh-ancestor
154157431|NCT05793060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157432|NCT05793060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157433|NCT05793060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154157434|NCT05793060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157435|NCT05793060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154157436|NCT05793060|Analgesics|analgesics|mesh-ancestor
154157437|NCT05793060|Sensory System Agents|sensory system agents|mesh-ancestor
154157438|NCT05793060|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154157439|NCT05793060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154157440|NCT05793060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154157441|NCT05793060|Adrenergic Agents|adrenergic agents|mesh-ancestor
154157442|NCT05793060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157443|NCT05784844|Meropenem|meropenem|mesh-list
154157464|NCT05763875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157465|NCT05763875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154157466|NCT05759156|Tranexamic Acid|tranexamic acid|mesh-list
154157467|NCT05759156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154157468|NCT05759156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154157469|NCT05759156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157470|NCT05759156|Hemostatics|hemostatics|mesh-ancestor
154157471|NCT05759156|Coagulants|coagulants|mesh-ancestor
154157472|NCT05696678|Morphine|morphine|mesh-list
153360677|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153408373|NCT00361010|Levetiracetam|levetiracetam|mesh-list
153811009|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815052|NCT00454272|Teicoplanin|teicoplanin|mesh-list
153357559|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915924|NCT04213495|Anesthetics|anesthetics|mesh-list
154157473|NCT05696678|Ropivacaine|ropivacaine|mesh-list
154157474|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154157475|NCT05696678|Narcotics|narcotics|mesh-ancestor
154157476|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157477|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157478|NCT05696678|Analgesics|analgesics|mesh-ancestor
154157479|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
154157480|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157481|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
154157482|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
154157483|NCT05689450|Amikacin|amikacin|mesh-list
154157484|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154157485|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157486|NCT05686044|Phenserine|phenserine|mesh-list
154157487|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154157488|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157489|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157490|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
154157491|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157492|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157493|NCT05665283|Ensartinib|ensartinib|mesh-list
154157494|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157495|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154157496|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157497|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157498|NCT05650996|Calpastatin|calpastatin|mesh-list
154157499|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153667321|NCT00026364|Antidotes|antidotes|mesh-ancestor
154157531|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
154157532|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154157533|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154157534|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154157535|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157536|NCT05633667|Paclitaxel|paclitaxel|mesh-list
154157537|NCT05633667|Docetaxel|docetaxel|mesh-list
154157538|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154157539|NCT05633667|Carboplatin|carboplatin|mesh-list
154157540|NCT05633667|Nivolumab|nivolumab|mesh-list
154157541|NCT05633667|Pemetrexed|pemetrexed|mesh-list
154157542|NCT05633667|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154157543|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154157575|NCT05560009|Levodopa|levodopa|mesh-list
154157576|NCT05560009|Fluorides|fluorides|mesh-list
154157577|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
154157578|NCT05560009|Protective Agents|protective agents|mesh-ancestor
154157579|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157580|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
154157581|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802976|NCT03484299|Gemcitabine|gemcitabine|mesh-list
154157582|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157583|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154157584|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154157585|NCT05555862|Artesunate|artesunate|mesh-list
154157614|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
154157615|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
154157616|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154157617|NCT05517668|Fomepizole|fomepizole|mesh-list
154157618|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
154157619|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157620|NCT05517668|Expectorants|expectorants|mesh-ancestor
154157621|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
154157622|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154157623|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
154157624|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702331|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157625|NCT05517668|Protective Agents|protective agents|mesh-ancestor
154157626|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157627|NCT05517668|Antidotes|antidotes|mesh-ancestor
154157628|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915935|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
154157629|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
154157630|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
154157631|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157632|NCT05498480|Nivolumab|nivolumab|mesh-list
154157633|NCT05498480|Relatlimab|relatlimab|mesh-list
154157634|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157651|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154157652|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157653|NCT05481970|Dexamethasone|dexamethasone|mesh-list
154157654|NCT05481970|Lidocaine|lidocaine|mesh-list
154157655|NCT05481970|Fentanyl|fentanyl|mesh-list
154157656|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
153537985|NCT01526161|Xhance|xhance|mesh-list
154157657|NCT05481970|Ketamine|ketamine|mesh-list
154157658|NCT05481970|Propofol|propofol|mesh-list
154157659|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154157660|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
154157661|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
154157662|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157663|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157664|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154157665|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
154157666|NCT05481970|Hormones|hormones|mesh-ancestor
154157667|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157668|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154157669|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157670|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157671|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
154157672|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
154157673|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157674|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
154157675|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154157676|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154157677|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154157678|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154157679|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154157680|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154157681|NCT05481970|Analgesics|analgesics|mesh-ancestor
154157682|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154157683|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154157684|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154157685|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
154157686|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157687|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154157688|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
154157689|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154157690|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154157691|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154157692|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154157718|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154157719|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157720|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154157721|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157722|NCT05458765|Tenofovir|tenofovir|mesh-list
154157723|NCT05458765|Emtricitabine|emtricitabine|mesh-list
154157724|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154157725|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154157726|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
154157727|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157728|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153811014|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357564|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154157729|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153443109|NCT02058108|Telbivudine|telbivudine|mesh-list
153811015|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153915944|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
154157730|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157731|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157732|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154157733|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154157734|NCT05440734|Melatonin|melatonin|mesh-list
154157735|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
154157736|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157737|NCT05440734|Protective Agents|protective agents|mesh-ancestor
154157738|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157739|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157740|NCT05377905|Doxorubicin|doxorubicin|mesh-list
154157741|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154157774|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154157775|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154157776|NCT05288062|Dexamethasone|dexamethasone|mesh-list
154157777|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
154157778|NCT05288062|Lenalidomide|lenalidomide|mesh-list
154157779|NCT05288062|Pomalidomide|pomalidomide|mesh-list
154157780|NCT05288062|Ichthammol|ichthammol|mesh-list
154157781|NCT05288062|BB 1101|bb 1101|mesh-list
154157782|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154157804|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157805|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
154157806|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
154157807|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
154157808|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157809|NCT05265728|Natalizumab|natalizumab|mesh-list
154157810|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
154157811|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157812|NCT05259033|Semaglutide|semaglutide|mesh-list
154157813|NCT05259033|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154157814|NCT05259033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154157815|NCT05259033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157816|NCT05256069|Propranolol|propranolol|mesh-list
154157817|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154157818|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154157819|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
154157820|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157821|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157822|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157823|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154157824|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154157825|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
154157826|NCT05255900|Metyrapone|metyrapone|mesh-list
154157827|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
154157828|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157829|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157830|NCT05238142|Insulin|insulin|mesh-list
154157831|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154157832|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157833|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
154157834|NCT05232825|Promethazine|promethazine|mesh-list
154157835|NCT05232825|Dexamethasone|dexamethasone|mesh-list
154157869|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154157870|NCT05223335|Clopidogrel|clopidogrel|mesh-list
154157871|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153360678|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360679|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
153915951|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
153915952|NCT04213573|Fluorides|fluorides|mesh-list
153915953|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
154157872|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154157873|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154157874|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154157875|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154157876|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
153504667|NCT04677959|Xhance|xhance|mesh-list
154263466|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
154157908|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157909|NCT05209984|Topiramate|topiramate|mesh-list
154157910|NCT05209984|Sibutramine|sibutramine|mesh-list
154157911|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
154157912|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154157913|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157914|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
154157915|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154157916|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
154157917|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154157918|NCT05203822|Itraconazole|itraconazole|mesh-list
154157919|NCT05203822|Tepotinib|tepotinib|mesh-list
154157920|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
153667761|NCT03959501|Hormones|hormones|mesh-ancestor
154157952|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157953|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
154157954|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157955|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157956|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157957|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154157984|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
154157985|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157986|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154157987|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158059|NCT04975997|Bortezomib|bortezomib|mesh-list
154158060|NCT04975997|Daratumumab|daratumumab|mesh-list
154158061|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158062|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
154158063|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
154158064|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158065|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158066|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154158067|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
154158068|NCT04975997|Hormones|hormones|mesh-ancestor
154158069|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158070|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154158071|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158072|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
154158073|NCT04955743|Lenvatinib|lenvatinib|mesh-list
154158074|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158075|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158076|NCT04955743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158077|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158078|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154158079|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158080|NCT04940078|Semaglutide|semaglutide|mesh-list
154158081|NCT04940078|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154158082|NCT04940078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154158083|NCT04940078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158084|NCT04925427|Naloxone|naloxone|mesh-list
154158085|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154158086|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158087|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
154158088|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158089|NCT04916002|Cemiplimab|cemiplimab|mesh-list
154158090|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158091|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443129|NCT04678050|Analgesics|analgesics|mesh-ancestor
154158092|NCT04914234|Metoprolol|metoprolol|mesh-list
154158093|NCT04914234|Atenolol|atenolol|mesh-list
154158094|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154158095|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154158096|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
154158097|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
154158098|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158099|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158100|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154158101|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154158102|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154158103|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
154158114|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158115|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158116|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
154158117|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
154158120|NCT04904588|Fludarabine|fludarabine|mesh-list
154158121|NCT04904588|Tacrolimus|tacrolimus|mesh-list
154158122|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158123|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
154158124|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158125|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158126|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158127|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
154158128|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158129|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158130|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154158131|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154158132|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158133|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154158134|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154158135|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
154158136|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154158137|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158138|NCT04895709|Docetaxel|docetaxel|mesh-list
154158139|NCT04895709|Nivolumab|nivolumab|mesh-list
154158140|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158141|NCT04895709|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158142|NCT04895709|Antimitotic Agents|antimitotic agents|mesh-ancestor
154158143|NCT04895709|Mitosis Modulators|mitosis modulators|mesh-ancestor
154158144|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158145|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158146|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158147|NCT04892186|Inositol|inositol|mesh-list
154158148|NCT04892186|Metformin|metformin|mesh-list
154158149|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154158150|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158151|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
154158152|NCT04892186|Vitamins|vitamins|mesh-ancestor
154158153|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
154158154|NCT04884035|Prednisone|prednisone|mesh-list
154158155|NCT04884035|Prednisolone|prednisolone|mesh-list
154158156|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
154158157|NCT04884035|Rituximab|rituximab|mesh-list
153357565|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153464694|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158158|NCT04884035|Doxorubicin|doxorubicin|mesh-list
154158159|NCT04884035|Vincristine|vincristine|mesh-list
154158160|NCT04884035|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154158161|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158162|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
154158163|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158164|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158165|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158166|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
154158167|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158168|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158202|NCT04792502|Lenalidomide|lenalidomide|mesh-list
154158203|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
154158204|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158205|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153668010|NCT03873857|Venetoclax|venetoclax|mesh-list
154158242|NCT04756063|Protective Agents|protective agents|mesh-ancestor
154158243|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154158275|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154158276|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154158277|NCT04747314|Analgesics|analgesics|mesh-ancestor
154158278|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
154158279|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154158280|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
154158281|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
154158282|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154158283|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154158284|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154158285|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154158286|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
154158287|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154158288|NCT04745026|Cannabidiol|cannabidiol|mesh-list
154158289|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
154158291|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154158292|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158293|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
154158294|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158295|NCT04725656|Nicotine|nicotine|mesh-list
154158333|NCT04704934|Immunologic Factors|immunologic factors|mesh-ancestor
154158397|NCT04585035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158399|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153446369|NCT00002057|Nystatin|nystatin|mesh-list
154158434|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158435|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154158436|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158437|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154158438|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154158439|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668193|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158472|NCT04447027|Lenalidomide|lenalidomide|mesh-list
154158473|NCT04447027|Azacitidine|azacitidine|mesh-list
154158474|NCT04447027|Romidepsin|romidepsin|mesh-list
154158475|NCT04447027|Cc-486|cc-486|mesh-list
154158476|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158477|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
154158478|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
153668234|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
154158495|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158496|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154158497|NCT04447027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154158499|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
154158500|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158501|NCT04432584|Eculizumab|eculizumab|mesh-list
154158502|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154158503|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158504|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
154158505|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158506|NCT04392622|Cisplatin|cisplatin|mesh-list
154158507|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158508|NCT04388839|Dactinomycin|dactinomycin|mesh-list
154158509|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
154158510|NCT04388839|Vincristine|vincristine|mesh-list
154158511|NCT04388839|Vinorelbine|vinorelbine|mesh-list
154158512|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158513|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
154158514|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158515|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158516|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158517|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
154158518|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158519|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158520|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154158521|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154158522|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158523|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
154158524|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154158525|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154158526|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158527|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154158528|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154158529|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158530|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154158531|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
154158532|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
154158533|NCT04384692|Melphalan|melphalan|mesh-list
154158534|NCT04384692|Busulfan|busulfan|mesh-list
154158535|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
154158536|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154158537|NCT04384692|Methotrexate|methotrexate|mesh-list
154158538|NCT04384692|Fludarabine|fludarabine|mesh-list
154158559|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154158560|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153811019|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158561|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
154158562|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154158563|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158566|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154158567|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154158568|NCT04384367|Analgesics|analgesics|mesh-ancestor
154158569|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
154158570|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158571|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158572|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158573|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158574|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
154158575|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154158576|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158578|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154158579|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
154158580|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154158581|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
154158582|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
154158583|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158584|NCT04350463|Nivolumab|nivolumab|mesh-list
154158585|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
154158586|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158587|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158588|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158589|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158590|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158591|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
154158592|NCT04311632|Tacrolimus|tacrolimus|mesh-list
154158593|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158668|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154158669|NCT04047797|Ixazomib|ixazomib|mesh-list
154158670|NCT04047797|Antibodies|antibodies|mesh-list
154158698|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158699|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158700|NCT03997448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158701|NCT03997448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158702|NCT03993717|Vaccines|vaccines|mesh-list
154158703|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
154158704|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158705|NCT03986034|Venetoclax|venetoclax|mesh-list
154158706|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158707|NCT03964090|Cytarabine|cytarabine|mesh-list
154158708|NCT03964090|Isavuconazole|isavuconazole|mesh-list
154158709|NCT03964090|Methotrexate|methotrexate|mesh-list
154158710|NCT03964090|Ibrutinib|ibrutinib|mesh-list
154158711|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154158712|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
154158713|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154158714|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158715|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154158716|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
154158717|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668462|NCT00031941|Lenalidomide|lenalidomide|mesh-list
154158753|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154158754|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154158755|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158756|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158757|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
154158758|NCT03920007|Trimethoprim|trimethoprim|mesh-list
154158759|NCT03920007|Polymyxins|polymyxins|mesh-list
154158760|NCT03920007|Polymyxin B|polymyxin b|mesh-list
154158761|NCT03920007|Prednisone|prednisone|mesh-list
154158762|NCT03920007|Prednisolone|prednisolone|mesh-list
154158778|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154158779|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154158780|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154158781|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154158782|NCT03878979|Nivolumab|nivolumab|mesh-list
153357568|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153916001|NCT00620347|Sunitinib|sunitinib|mesh-list
154158783|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158784|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158785|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158786|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158787|NCT03872401|Evolocumab|evolocumab|mesh-list
154158788|NCT03872401|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154158789|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154158790|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154158791|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
154158792|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158793|NCT03872401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154158794|NCT03872401|Protease Inhibitors|protease inhibitors|mesh-ancestor
154158795|NCT03872401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158796|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154158797|NCT03853707|Paclitaxel|paclitaxel|mesh-list
154158798|NCT03853707|Carboplatin|carboplatin|mesh-list
154158799|NCT03853707|Capecitabine|capecitabine|mesh-list
154158800|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154158801|NCT03853707|Atezolizumab|atezolizumab|mesh-list
154158802|NCT03853707|Ipatasertib|ipatasertib|mesh-list
154158803|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154158804|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154158805|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158806|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158807|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
154158808|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
154158809|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158810|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154158811|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
154158812|NCT03853707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158813|NCT03853707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158814|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
154158815|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158816|NCT03853707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154158817|NCT03853707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158818|NCT03845166|Atezolizumab|atezolizumab|mesh-list
154158819|NCT03845166|Avelumab|avelumab|mesh-list
154158820|NCT03845166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153668553|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154158830|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
154158831|NCT03825757|Salicylates|salicylates|mesh-list
154158832|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158833|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
154158834|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
154158835|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
154158836|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154158837|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154158838|NCT03825757|Analgesics|analgesics|mesh-ancestor
154158839|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
154158840|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158841|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158842|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158843|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158844|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154158845|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158846|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158847|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154158848|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154158849|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154158850|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
154158851|NCT03812562|Nivolumab|nivolumab|mesh-list
153811023|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153916004|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154158852|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158853|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158854|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158855|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158856|NCT03812224|Erenumab|erenumab|mesh-list
154158857|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154158858|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158859|NCT03812224|Analgesics|analgesics|mesh-ancestor
154158860|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
154158861|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158862|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158863|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
154158864|NCT03809624|Antibodies|antibodies|mesh-list
154158865|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
154158866|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158867|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158868|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158869|NCT03809624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158870|NCT03809624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158871|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
154158872|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158873|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158874|NCT03799003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158875|NCT03799003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158876|NCT03778229|Osimertinib|osimertinib|mesh-list
154158877|NCT03778229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154158878|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154158879|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158880|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158881|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158882|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154158900|NCT03646123|Vinblastine|vinblastine|mesh-list
154158901|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154158902|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158903|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154158904|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154158905|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158906|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158907|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158908|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158909|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158910|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
154158912|NCT03646123|Immunoconjugates|immunoconjugates|mesh-ancestor
154158913|NCT03646123|Immunologic Factors|immunologic factors|mesh-ancestor
154158914|NCT03646123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158915|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154158916|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158917|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
154158918|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
154158919|NCT03622775|Daratumumab|daratumumab|mesh-list
154158920|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158921|NCT03598309|Curcumin|curcumin|mesh-list
154158922|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154158923|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154158924|NCT03598309|Analgesics|analgesics|mesh-ancestor
154158925|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
154158926|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158927|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158928|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158929|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357570|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
154158930|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158931|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158932|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158933|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
154158934|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
154158935|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482476|NCT01504854|Resveratrol|resveratrol|mesh-list
154158936|NCT03589547|Durvalumab|durvalumab|mesh-list
154158937|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158938|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158939|NCT03568630|Chrysarobin|chrysarobin|mesh-list
154158940|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154158953|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154158954|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158955|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158956|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158957|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158958|NCT03554317|Androgens|androgens|mesh-ancestor
154158959|NCT03554317|Hormones|hormones|mesh-ancestor
154158960|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158961|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158962|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154158963|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
154158964|NCT03511196|Prednisone|prednisone|mesh-list
154158965|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
154158966|NCT03511196|Androgens|androgens|mesh-list
154158967|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158968|NCT03511196|Hormones|hormones|mesh-ancestor
154158969|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158970|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158971|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154158972|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158973|NCT03477396|Estrogens|estrogens|mesh-list
154158974|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154158975|NCT03477396|Hormones|hormones|mesh-ancestor
154158976|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158977|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158978|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154158979|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158980|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158981|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154158982|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
154158983|NCT03475186|Ramipril|ramipril|mesh-list
154158984|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154256492|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256494|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154158985|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
154158986|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158987|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158988|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154158989|NCT03439891|Nivolumab|nivolumab|mesh-list
154158990|NCT03439891|Sorafenib|sorafenib|mesh-list
154158991|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158992|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811024|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357571|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154158993|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158994|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158995|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154158996|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158997|NCT03439345|Fenofibrate|fenofibrate|mesh-list
154158998|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154158999|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
154159000|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159001|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154159002|NCT03374670|Aflibercept|aflibercept|mesh-list
153668733|NCT00033423|Rituximab|rituximab|mesh-list
154159075|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154159076|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159077|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154159078|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154159079|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154159080|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159081|NCT03179904|Paclitaxel|paclitaxel|mesh-list
154159082|NCT03179904|Trastuzumab|trastuzumab|mesh-list
153482625|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159083|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154159084|NCT03179904|Letrozole|letrozole|mesh-list
154159085|NCT03179904|Fulvestrant|fulvestrant|mesh-list
154159087|NCT03179904|Exemestane|exemestane|mesh-list
154159088|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
154159089|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
154159090|NCT03179904|Immunoglobulin G|immunoglobulin g|mesh-list
153668832|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154159117|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
154159118|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159119|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159120|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154159121|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154159122|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
154159123|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
154159124|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154159125|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154159126|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154159127|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159128|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159129|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154159130|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154159131|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154159132|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154159133|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154159134|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
154159135|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
154159136|NCT03113500|Prednisone|prednisone|mesh-list
154159137|NCT03113500|Cortisone|cortisone|mesh-list
154159169|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159171|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
154159172|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
154159173|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159174|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159175|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159176|NCT03071406|Nivolumab|nivolumab|mesh-list
154159177|NCT03071406|Ipilimumab|ipilimumab|mesh-list
154159178|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159179|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159180|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153668927|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
154159216|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154159217|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
153811025|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
154159219|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668974|NCT01806857|Quinidine|quinidine|mesh-list
154159251|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
153811026|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357572|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154159252|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
153781787|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154159253|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159254|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159256|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
154159257|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154159258|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159259|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
154159260|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154159261|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154159291|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159292|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154159293|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154159294|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154159295|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154159296|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154159297|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
154159298|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
154159299|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
154159300|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154159301|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154159302|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154159303|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154159304|NCT02806882|Ceftaroline|ceftaroline|mesh-list
154159305|NCT02806882|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154159306|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154159307|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159308|NCT02782104|Esketamine|esketamine|mesh-list
154159309|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669055|NCT01806311|Amlodipine|amlodipine|mesh-list
154159342|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159344|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154159345|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
154159346|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159347|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159348|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154159349|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159350|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159351|NCT02588651|Immunotoxins|immunotoxins|mesh-ancestor
154159352|NCT02588651|Immunoconjugates|immunoconjugates|mesh-ancestor
154159353|NCT02588651|Immunologic Factors|immunologic factors|mesh-ancestor
154159373|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159374|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159375|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
154159376|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159377|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408666|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811027|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153811028|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153357573|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153916051|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
154159378|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154159379|NCT02397083|Everolimus|everolimus|mesh-list
154159380|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
154159381|NCT02397083|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154159382|NCT02397083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154159383|NCT02397083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482932|NCT05891548|Aflibercept|aflibercept|mesh-list
154159384|NCT02397083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159385|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159386|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
154159387|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159388|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159389|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154159390|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
154159391|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154159392|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154159393|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154159394|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154159395|NCT02393859|Dexamethasone|dexamethasone|mesh-list
154159396|NCT02393859|Methotrexate|methotrexate|mesh-list
154159397|NCT02393859|Daunorubicin|daunorubicin|mesh-list
154159398|NCT02393859|Asparaginase|asparaginase|mesh-list
154159399|NCT02393859|Ifosfamide|ifosfamide|mesh-list
154159400|NCT02393859|Blinatumomab|blinatumomab|mesh-list
154159401|NCT02393859|Pegaspargase|pegaspargase|mesh-list
154159402|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154159403|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
154159404|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
154159405|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159406|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159407|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154159433|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159434|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154159435|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
154159436|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159437|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159438|NCT02365766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154159439|NCT02205034|Oxytocin|oxytocin|mesh-list
154159440|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
154159441|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154159442|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159443|NCT02192021|Doxorubicin|doxorubicin|mesh-list
154159444|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154159445|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154159446|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159447|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159448|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159449|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159450|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159485|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159486|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154159487|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154159488|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
154159489|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159490|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154159491|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154159492|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154159493|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154159494|NCT01911195|Isoflurane|isoflurane|mesh-list
154159495|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154159496|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
154159497|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
153811029|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153357574|NCT00249002|Paclitaxel|paclitaxel|mesh-list
154159498|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154159499|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159500|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154159501|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
154159502|NCT01785641|Gentamicins|gentamicins|mesh-list
154159503|NCT01785641|Cefazolin|cefazolin|mesh-list
154159504|NCT01785641|Ceftazidime|ceftazidime|mesh-list
154159505|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154159506|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159507|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
154159508|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159509|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159510|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159511|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159512|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669237|NCT01805726|Analgesics|analgesics|mesh-ancestor
154159544|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154159545|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
154159546|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154159547|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154159548|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
154159549|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
154159550|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154159551|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154159552|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159553|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159554|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159590|NCT01563731|Diuretics|diuretics|mesh-list
154159591|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154159592|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154159593|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
154159594|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
154159595|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154159596|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159621|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159622|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159623|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159624|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159625|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159626|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
154159627|NCT01176006|Busulfan|busulfan|mesh-list
154159628|NCT01176006|Fludarabine|fludarabine|mesh-list
154159629|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
154159630|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159631|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
154159632|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159633|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159634|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154159635|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
154159636|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159637|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159638|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154159639|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154159640|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
154159641|NCT01154920|Paclitaxel|paclitaxel|mesh-list
153811030|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
153357575|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153357576|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153357577|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357579|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
153357580|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
153357581|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357582|NCT00748826|Infliximab|infliximab|mesh-list
153811031|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159642|NCT01154920|Docetaxel|docetaxel|mesh-list
154159643|NCT01154920|Cisplatin|cisplatin|mesh-list
154159644|NCT01154920|Carboplatin|carboplatin|mesh-list
154159645|NCT01154920|Fluorouracil|fluorouracil|mesh-list
154159646|NCT01154920|Cetuximab|cetuximab|mesh-list
154159670|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159671|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
154159672|NCT00782093|Volociximab|volociximab|mesh-list
154159673|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154159674|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154159675|NCT00782093|Growth Substances|growth substances|mesh-ancestor
154159676|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159677|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
154159678|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159679|NCT00673335|Letrozole|letrozole|mesh-list
154159680|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159681|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154159682|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154159683|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159684|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159686|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
154159687|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159688|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159689|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
154159690|NCT00630032|Docetaxel|docetaxel|mesh-list
154159691|NCT00630032|Fluorouracil|fluorouracil|mesh-list
154159692|NCT00630032|Epirubicin|epirubicin|mesh-list
154159693|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159694|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
154159695|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159696|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159717|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159718|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159720|NCT00544830|Goserelin|goserelin|mesh-list
154159721|NCT00544830|Bicalutamide|bicalutamide|mesh-list
154159722|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154159723|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
154159724|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154159725|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159726|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154159727|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159728|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
154159729|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
154159730|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811032|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159731|NCT00534430|Cyclosporine|cyclosporine|mesh-list
153811033|NCT00331695|Progestins|progestins|mesh-ancestor
153811034|NCT00331695|Hormones|hormones|mesh-ancestor
153811035|NCT00353145|Gemcitabine|gemcitabine|mesh-list
153811036|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
153811037|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153811038|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
153811039|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357588|NCT00246740|Doxycycline|doxycycline|mesh-list
153357589|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153357590|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357591|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
153357592|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154159732|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
154159733|NCT00534430|Etoposide|etoposide|mesh-list
154159734|NCT00534430|Busulfan|busulfan|mesh-list
154159735|NCT00534430|Cyclosporins|cyclosporins|mesh-list
154159736|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159737|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159738|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159739|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159740|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159741|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159742|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159743|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
154159744|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159745|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
154159746|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159747|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
154159748|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159749|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154159750|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154159823|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159824|NCT04005222|Protective Agents|protective agents|mesh-ancestor
154159825|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159826|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154159828|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
154159852|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159853|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154159854|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
154159855|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159856|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159857|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154159858|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154159859|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159860|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159861|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159862|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154159863|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
154159864|NCT00098839|Hormones|hormones|mesh-ancestor
154159865|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159866|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153811041|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153811042|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811043|NCT00353184|Montelukast|montelukast|mesh-list
153811044|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153811045|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
153811046|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153811047|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
153357593|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153357595|NCT01274624|Bevacizumab|bevacizumab|mesh-list
153357597|NCT01274624|Irinotecan|irinotecan|mesh-list
153357598|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153357599|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159867|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154159868|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
154159869|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154159870|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154159871|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
154159872|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
154159873|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154159874|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154159875|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159876|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
154159877|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159878|NCT00098839|Antidotes|antidotes|mesh-ancestor
154159879|NCT00098839|Protective Agents|protective agents|mesh-ancestor
154159880|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
154159881|NCT00098839|Vitamins|vitamins|mesh-ancestor
154159882|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
154159883|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159884|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159885|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159886|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159887|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154159888|NCT02531191|Peficitinib|peficitinib|mesh-list
154159910|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540212|NCT01538316|Protective Agents|protective agents|mesh-ancestor
154159912|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
154159913|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159914|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159915|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154159916|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154159917|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
154159918|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154159919|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154159920|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154159921|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154159923|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
154159924|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154159925|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
154159926|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154159927|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159928|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154159929|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
154159930|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159931|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159932|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
154159933|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811048|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811049|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811050|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153811051|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153811052|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916111|NCT04211545|Rabeprazole|rabeprazole|mesh-list
154159934|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154159935|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159936|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
154159937|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159938|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154159955|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
154159956|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154159957|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154159958|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154159959|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154159960|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
154159961|NCT00750347|Acetaminophen|acetaminophen|mesh-list
154159962|NCT00750347|Rimonabant|rimonabant|mesh-list
154159963|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154159964|NCT00750347|Analgesics|analgesics|mesh-ancestor
154159965|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
154159966|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159967|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159968|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
154159969|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154159970|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
154159971|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154159972|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159973|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159974|NCT00750347|Hormones|hormones|mesh-ancestor
154159975|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159976|NCT00750425|Cediranib|cediranib|mesh-list
154159977|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159978|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154159979|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159980|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159981|NCT00745589|Sevelamer|sevelamer|mesh-list
154159982|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
154159983|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
154159984|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159985|NCT00750581|Indomethacin|indomethacin|mesh-list
153540287|NCT01538511|Insulin|insulin|mesh-list
154159986|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154159987|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154159988|NCT00750581|Analgesics|analgesics|mesh-ancestor
154159989|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
154159990|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159991|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159992|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154159993|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159994|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
154160015|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154160016|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154160017|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160018|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160019|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
154160020|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160021|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154160022|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154160023|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
154160024|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154160025|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154160026|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154160027|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154160028|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154160029|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154160030|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153916127|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153916130|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160031|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154160032|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154160033|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
154160034|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160035|NCT00685685|Lovastatin|lovastatin|mesh-list
154160036|NCT00685685|L 647318|l 647318|mesh-list
154160037|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
154160038|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154160039|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154160040|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
154160041|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160042|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154160043|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154160044|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160045|NCT01087567|Insulin|insulin|mesh-list
154160046|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154160047|NCT01087567|Metformin|metformin|mesh-list
154160048|NCT01087567|Pioglitazone|pioglitazone|mesh-list
154160049|NCT01087567|Glimepiride|glimepiride|mesh-list
153669770|NCT00846989|Latanoprost|latanoprost|mesh-list
154160063|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154160064|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154160065|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154160066|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154160068|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154160069|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160071|NCT01019109|Trace Elements|trace elements|mesh-ancestor
154160072|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
154160073|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160074|NCT00499863|Methylphenidate|methylphenidate|mesh-list
154160075|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154160076|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160077|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154160078|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154160079|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154160080|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160081|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
154160082|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160083|NCT04475835|Heparin|heparin|mesh-list
154160084|NCT04475835|Bivalirudin|bivalirudin|mesh-list
154160085|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
154160086|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154160087|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154160088|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160089|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
154160090|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154160091|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
154160092|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160093|NCT01014507|Goserelin|goserelin|mesh-list
154160094|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
154160095|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
154160096|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154160097|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160098|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154160099|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160100|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154160101|NCT00097981|Thalidomide|thalidomide|mesh-list
154160102|NCT00097981|Dexamethasone|dexamethasone|mesh-list
154160103|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160104|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
154160105|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
154160106|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160107|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160108|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154160109|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
154160110|NCT00097981|Hormones|hormones|mesh-ancestor
153669821|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154160146|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
154160147|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160148|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154160149|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154160170|NCT01019421|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
154160172|NCT01019421|Serotonin Agents|serotonin agents|mesh-ancestor
154160173|NCT01019421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160174|NCT01019421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160175|NCT01019421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160176|NCT01085695|Rabeprazole|rabeprazole|mesh-list
154160177|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154160178|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154160179|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154160180|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160181|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160182|NCT01088035|Carboplatin|carboplatin|mesh-list
154160183|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160184|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
154160185|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154160186|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154160187|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
154160189|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160190|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160191|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160192|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
154160193|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
154160194|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154160196|NCT00751127|Latanoprost|latanoprost|mesh-list
154160197|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154160198|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154160199|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
154160200|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160201|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160202|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669921|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154160229|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154160230|NCT00751205|Protective Agents|protective agents|mesh-ancestor
154160231|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
154160232|NCT00751205|Vitamins|vitamins|mesh-ancestor
154160233|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
154160234|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
154160235|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
154160236|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
154160237|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
154160238|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160239|NCT00752063|Capecitabine|capecitabine|mesh-list
154160240|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
154160241|NCT00752063|Sorafenib|sorafenib|mesh-list
154160242|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154160243|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
154160244|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160245|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160246|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154160247|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160248|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
154160249|NCT00752141|Oxybutynin|oxybutynin|mesh-list
154160250|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
154160251|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
154160252|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160253|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160254|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154160255|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154160256|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
154160271|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357610|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154160272|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160273|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154160274|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154160275|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154160276|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154160277|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
154160278|NCT00751517|Methotrexate|methotrexate|mesh-list
154160279|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154160280|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
154160281|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160282|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160283|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154160284|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
154160285|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160286|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160287|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154160288|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154160289|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
154160290|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154160291|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154160292|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
154160293|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
154160294|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160295|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154160296|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154160297|NCT02561117|Metronidazole|metronidazole|mesh-list
154160298|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160299|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154160300|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154160301|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154160303|NCT00684515|Vorapaxar|vorapaxar|mesh-list
154160304|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154160305|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160306|NCT00684515|Analgesics|analgesics|mesh-ancestor
154160307|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
154160308|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160309|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160310|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153357611|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153357612|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357613|NCT01274624|Antidotes|antidotes|mesh-ancestor
153357614|NCT01274624|Protective Agents|protective agents|mesh-ancestor
153357615|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
153357616|NCT01274624|Vitamins|vitamins|mesh-ancestor
153357617|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
153357618|NCT00761930|Listerine|listerine|mesh-list
153916135|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154160311|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160312|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154160313|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154160314|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160315|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154160329|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
154160330|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160331|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154160332|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154160333|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154160334|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160335|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
154160337|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160338|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160339|NCT04453137|Adalimumab|adalimumab|mesh-list
154160340|NCT04453137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154160341|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160342|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160343|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
154160344|NCT03855189|Beclomethasone|beclomethasone|mesh-list
154160345|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160346|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
154160347|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154160348|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
154160349|NCT03855189|Hormones|hormones|mesh-ancestor
154160350|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160351|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160352|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154160353|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
154160354|NCT03853551|Osimertinib|osimertinib|mesh-list
154160355|NCT03853551|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154160356|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154160357|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160358|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160359|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160360|NCT00423670|Ribavirin|ribavirin|mesh-list
154160361|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154160362|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
154160363|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160364|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
154160365|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160366|NCT01019655|Nadroparin|nadroparin|mesh-list
154160367|NCT01019655|Calcium|calcium|mesh-list
154160368|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153811053|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153811054|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153811055|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153811056|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811057|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811058|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
153811059|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811060|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153811061|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153811062|NCT00323804|Ribavirin|ribavirin|mesh-list
153811063|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153811064|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
153811066|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
154160369|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160370|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
154160371|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154160372|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154160373|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160374|NCT00483717|Ketorolac|ketorolac|mesh-list
154160375|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154160376|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154160377|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160393|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160394|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160395|NCT01037842|Mitiglinide|mitiglinide|mesh-list
154160396|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154160397|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160398|NCT00483405|Capecitabine|capecitabine|mesh-list
154160399|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
154160400|NCT00483405|Cetuximab|cetuximab|mesh-list
154160401|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154160402|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
154160403|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160404|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160405|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154160406|NCT00483327|Megestrol|megestrol|mesh-list
154160407|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
154160408|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154160409|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154160410|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154160411|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
154160412|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154160413|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160414|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154160415|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154160416|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154160417|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160418|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
154160419|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154160420|NCT00684203|Aspirin|aspirin|mesh-list
154160421|NCT00684203|Clopidogrel|clopidogrel|mesh-list
154160422|NCT00684203|Vorapaxar|vorapaxar|mesh-list
154160423|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154160424|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160425|NCT00684203|Analgesics|analgesics|mesh-ancestor
154160426|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
154160427|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357619|NCT00761930|Triclosan|triclosan|mesh-list
154160428|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160429|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160430|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160431|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154160432|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154160433|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670152|NCT00276068|Lidocaine|lidocaine|mesh-list
154160460|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154160461|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
154160462|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154160463|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160464|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154160465|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154160466|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154160467|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
154160468|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154160469|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154160470|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
154160471|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160472|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
154160473|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154160474|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154160475|NCT00752921|Etoricoxib|etoricoxib|mesh-list
154160476|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154160477|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160478|NCT00752921|Analgesics|analgesics|mesh-ancestor
154160479|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
153670213|NCT00275834|Zonisamide|zonisamide|mesh-list
154160500|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154160502|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160503|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
154160504|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160505|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160506|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154160507|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154160508|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154160510|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154160511|NCT00755963|Progesterone|progesterone|mesh-list
154160512|NCT00755963|Estrogens|estrogens|mesh-ancestor
154160513|NCT00755963|Hormones|hormones|mesh-ancestor
154160514|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160515|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160516|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154160517|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
154160518|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154160519|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154160520|NCT00755963|Progestins|progestins|mesh-ancestor
154160521|NCT00753311|Rizatriptan|rizatriptan|mesh-list
154160522|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154160523|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
154160524|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160525|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160526|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160527|NCT00753389|Anesthetics|anesthetics|mesh-list
154160528|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154160529|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160530|NCT00753467|Interferons|interferons|mesh-list
154160555|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154160556|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154160557|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154160558|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160559|NCT00482391|Paclitaxel|paclitaxel|mesh-list
154160560|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
154160561|NCT00482391|Doxorubicin|doxorubicin|mesh-list
154160562|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154160563|NCT00482391|Trastuzumab|trastuzumab|mesh-list
154160564|NCT00482391|Lapatinib|lapatinib|mesh-list
154160565|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153916181|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
154160566|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160567|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
154160568|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
154160569|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
154160570|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160571|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154160572|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
154160573|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160574|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160575|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154160576|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
154160577|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154160578|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154160579|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153670304|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
154160611|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160612|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160613|NCT00757679|Analgesics|analgesics|mesh-ancestor
154160614|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
154160615|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160616|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
154160649|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154160651|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
154160652|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154160653|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160654|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154160655|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
154160656|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154160657|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160691|NCT02560649|Entecavir|entecavir|mesh-list
154160692|NCT02560649|Adefovir|adefovir|mesh-list
154160693|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154160694|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
154160695|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160696|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154160697|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154160698|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160699|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160700|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154160701|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154160702|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
154160738|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
154160740|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154160741|NCT00758381|Sorafenib|sorafenib|mesh-list
154160742|NCT00758381|Cisplatin|cisplatin|mesh-list
154160743|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160744|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670478|NCT00394394|Enalapril|enalapril|mesh-list
154160771|NCT01038388|Dexamethasone|dexamethasone|mesh-list
154160772|NCT01038388|Lenalidomide|lenalidomide|mesh-list
154160773|NCT01038388|Bortezomib|bortezomib|mesh-list
154160774|NCT01038388|Vorinostat|vorinostat|mesh-list
154160775|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160776|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
154160777|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
154160778|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160779|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160780|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154160781|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
154160782|NCT01038388|Hormones|hormones|mesh-ancestor
154160783|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160784|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154160785|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160786|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
154160787|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154160788|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154160789|NCT01038388|Growth Substances|growth substances|mesh-ancestor
154160790|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
154160791|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153670523|NCT00129818|Famciclovir|famciclovir|mesh-list
154160818|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
154160820|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811070|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
153811071|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357622|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
153357623|NCT00761930|Protective Agents|protective agents|mesh-ancestor
153357624|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357625|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153464918|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160821|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
154160822|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
154160823|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160824|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160825|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154160826|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
154160827|NCT00421174|Hormones|hormones|mesh-ancestor
154160828|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160829|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154160830|NCT00421174|Protective Agents|protective agents|mesh-ancestor
154160831|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154160832|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160833|NCT00421174|Analgesics|analgesics|mesh-ancestor
154160834|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
154160835|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160836|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154160837|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
154160838|NCT00496197|Fluconazole|fluconazole|mesh-list
154160839|NCT00496197|Voriconazole|voriconazole|mesh-list
154160867|NCT00404092|Caspofungin|caspofungin|mesh-list
154160868|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
154160869|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160870|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160871|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160872|NCT00481767|Vaccines|vaccines|mesh-list
154160873|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
154160874|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160875|NCT00489489|Interferons|interferons|mesh-list
154160876|NCT00489489|Interferon-beta|interferon-beta|mesh-list
154160877|NCT00489489|Teriflunomide|teriflunomide|mesh-list
154160878|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
154160879|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160880|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
153806235|NCT00306254|Enoxaparin|enoxaparin|mesh-list
154160881|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670611|NCT00128804|Vitamins|vitamins|mesh-ancestor
154160897|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160899|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160901|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
154160902|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160903|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
154160904|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154160905|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
154160906|NCT00420784|Interferons|interferons|mesh-list
154160907|NCT00420784|Ribavirin|ribavirin|mesh-list
154160908|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
154160909|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
154160910|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154160911|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160912|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
154160913|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160914|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
154160915|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160916|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
154160917|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160918|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154160919|NCT00420628|Tobramycin|tobramycin|mesh-list
154160920|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154160921|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160922|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154160923|NCT00413218|Voriconazole|voriconazole|mesh-list
154160924|NCT00413218|Caspofungin|caspofungin|mesh-list
154160925|NCT00413218|Isavuconazole|isavuconazole|mesh-list
153736381|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736382|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736383|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153736384|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153736385|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736386|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160926|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
154160927|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160928|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154160929|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154160930|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160931|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160932|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154160933|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
154160934|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160935|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160936|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154160937|NCT02303392|Ibrutinib|ibrutinib|mesh-list
154160938|NCT02303392|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154160939|NCT02303392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670661|NCT00038493|Temozolomide|temozolomide|mesh-list
154160957|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160958|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160959|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160960|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154160961|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154160962|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
154160963|NCT00420004|Escitalopram|escitalopram|mesh-list
154160964|NCT00420004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154160965|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154160966|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154160967|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160968|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160969|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
154160970|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160971|NCT00494481|Docetaxel|docetaxel|mesh-list
154160972|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160973|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
154160974|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
154160975|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
154160976|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160977|NCT01040494|Aliskiren|aliskiren|mesh-list
154160978|NCT01040494|Renin Inhibitors|renin inhibitors|mesh-ancestor
154160979|NCT01040494|Protease Inhibitors|protease inhibitors|mesh-ancestor
154160980|NCT01040494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160981|NCT01040494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160982|NCT00097591|Clopidogrel|clopidogrel|mesh-list
154160983|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154160984|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154160985|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154160986|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154160987|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154160988|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
154160989|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160990|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160991|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160992|NCT01082029|Lansoprazole|lansoprazole|mesh-list
154160993|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
154160994|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153670715|NCT05769725|Docetaxel|docetaxel|mesh-list
154161025|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
154161026|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
154161027|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161028|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464930|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154161029|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154161030|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154161031|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
154161032|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161033|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154161034|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154161035|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
154161036|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154161037|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153670772|NCT05736978|Azacitidine|azacitidine|mesh-list
154161052|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161053|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154161054|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154161055|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154161056|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161057|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161058|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154161059|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154161060|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154161061|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154161062|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
154161063|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161064|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161065|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154161066|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154161067|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
154161068|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154161069|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154161070|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
154161071|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154161072|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154161073|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161074|NCT00494091|Sirolimus|sirolimus|mesh-list
154161075|NCT00494091|Temsirolimus|temsirolimus|mesh-list
154161076|NCT00494091|MTOR Inhibitors|mtor inhibitors|mesh-list
154161077|NCT00494091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154161078|NCT00494091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161079|NCT00494091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161080|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161081|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
154161082|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161083|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161084|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161085|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161086|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154161087|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
154161088|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
154161089|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154161090|NCT01017159|Antibodies|antibodies|mesh-list
154161091|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
154161092|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161093|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
154161094|NCT00494013|Protamines|protamines|mesh-list
154161095|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161096|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161097|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
153781789|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
153781790|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153409038|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
153357630|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443729|NCT01960842|Levodopa|levodopa|mesh-list
153811081|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153670812|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154161120|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161122|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154161123|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161124|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
154161125|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161126|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161127|NCT00090493|Immunomodulating Agents|immunomodulating agents|mesh-list
154161128|NCT00090493|Immunologic Factors|immunologic factors|mesh-ancestor
154161129|NCT00090493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161130|NCT01088347|Mapatumumab|mapatumumab|mesh-list
154161131|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161132|NCT04221828|Paclitaxel|paclitaxel|mesh-list
154161133|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154161134|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154161135|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161136|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
154161137|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
154161138|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
154161139|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161140|NCT04221750|Metformin|metformin|mesh-list
154161141|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161142|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161143|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154161144|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154161145|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
154161146|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161147|NCT01017393|Ketamine|ketamine|mesh-list
154161148|NCT01017393|Analgesics|analgesics|mesh-ancestor
154161149|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
154161150|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670885|NCT05287425|Povidone|povidone|mesh-list
154161171|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154161172|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
154161173|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154161174|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
154161175|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161176|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161177|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
153541482|NCT01544972|Acetaminophen|acetaminophen|mesh-list
154161178|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154161179|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154161180|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154161181|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
154161182|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161183|NCT03917472|Aflibercept|aflibercept|mesh-list
154161184|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154161185|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154161186|NCT03917472|Growth Substances|growth substances|mesh-ancestor
154161187|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161188|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
154161189|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161190|NCT00681863|Pramipexole|pramipexole|mesh-list
154161191|NCT00681863|Dexpramipexole|dexpramipexole|mesh-list
154161192|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
154161193|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161194|NCT00681863|Protective Agents|protective agents|mesh-ancestor
154161195|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161196|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153357632|NCT00245102|Sorafenib|sorafenib|mesh-list
154161197|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154161198|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
154161199|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
154161200|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161201|NCT02559791|Reslizumab|reslizumab|mesh-list
154161202|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154161203|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
154161204|NCT05677620|Propofol|propofol|mesh-list
154161205|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154161234|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161235|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161237|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
154161238|NCT00679367|Hormones|hormones|mesh-ancestor
154161239|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161240|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154161241|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161242|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
154161243|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154161244|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154161245|NCT00679367|Growth Substances|growth substances|mesh-ancestor
154161246|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
154161247|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154161248|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
154161249|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161250|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154161251|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161252|NCT00969566|Metformin|metformin|mesh-list
154161253|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154161271|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
154161272|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
154161273|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161274|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161276|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161277|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161278|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
154161279|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
154161280|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
154161281|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161282|NCT00964262|Exenatide|exenatide|mesh-list
154161283|NCT00964262|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154161284|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161285|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161286|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154161287|NCT00964262|Incretins|incretins|mesh-ancestor
154161288|NCT00964262|Hormones|hormones|mesh-ancestor
154161289|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161290|NCT00973778|Capecitabine|capecitabine|mesh-list
154161291|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154161292|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
154161293|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161294|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357633|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357634|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153357635|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811082|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153811083|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
153811084|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811085|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916230|NCT04293549|Mitogens|mitogens|mesh-list
154161295|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154256495|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256496|NCT03882788|Fentanyl|fentanyl|mesh-list
154161296|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154161297|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161298|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161299|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154161300|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154161301|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161302|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
154161303|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161304|NCT00964418|Insulin|insulin|mesh-list
154161305|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154161306|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
154161307|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161308|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161346|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
154161347|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161358|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154161359|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154161360|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161361|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161362|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161363|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
154161364|NCT00539838|Prednisone|prednisone|mesh-list
154161365|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
154161366|NCT00539838|Methotrexate|methotrexate|mesh-list
154161367|NCT00539838|Azathioprine|azathioprine|mesh-list
154161368|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154161369|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
154161370|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161371|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
154161372|NCT00539838|Hormones|hormones|mesh-ancestor
154161373|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161374|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161375|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154161376|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161377|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154161378|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
154161379|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154161380|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154161381|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
154161382|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161383|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
154161384|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161385|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154161386|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
154161387|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161388|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154161389|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154161390|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154161391|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
154161392|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161393|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161394|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
154161395|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
154161396|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161397|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154161398|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154161399|NCT00539838|Protective Agents|protective agents|mesh-ancestor
154161400|NCT00970892|Warfarin|warfarin|mesh-list
154161401|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
154161402|NCT00964808|Oxycodone|oxycodone|mesh-list
153702332|NCT00282607|Udenafil|udenafil|mesh-list
153357636|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464965|NCT00256776|Thalidomide|thalidomide|mesh-list
154161403|NCT00964808|Buprenorphine|buprenorphine|mesh-list
154161404|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154161405|NCT00964808|Narcotics|narcotics|mesh-ancestor
154161406|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161407|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161408|NCT00964808|Analgesics|analgesics|mesh-ancestor
154161409|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
154161410|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161411|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154161412|NCT00970970|Bevacizumab|bevacizumab|mesh-list
154161450|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
154161451|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154161470|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154161471|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
154161472|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161473|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161474|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154161475|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154161476|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154161477|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154161478|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154161479|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161480|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154161481|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
154161482|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154161483|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154161484|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
154161485|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
154161486|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154161487|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154161488|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154161489|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
154161490|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161492|NCT00974792|Protective Agents|protective agents|mesh-ancestor
154161493|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
154161494|NCT00974792|Vitamins|vitamins|mesh-ancestor
154161495|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
154161496|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
154161497|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
154161498|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
154161499|NCT00965120|Bradykinin|bradykinin|mesh-list
154161500|NCT00965120|Kininogens|kininogens|mesh-list
154161501|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
154161502|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
154161503|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154161504|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
154161505|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161506|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161507|NCT00679289|Interferons|interferons|mesh-list
154161508|NCT00679289|Ecromeximab|ecromeximab|mesh-list
154161509|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161510|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
154161511|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161512|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154161513|NCT00679211|Trastuzumab|trastuzumab|mesh-list
154161530|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161531|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161532|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161533|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153781791|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
154161534|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154161535|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154161536|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
154161537|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
154161538|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
154161539|NCT00755573|Pregabalin|pregabalin|mesh-list
154161540|NCT00755573|Analgesics|analgesics|mesh-ancestor
154161541|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
154161542|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161543|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161544|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
154161545|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154161546|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154161547|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161548|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154161549|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154161550|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154161551|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161552|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154161553|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
154161554|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
154161555|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161556|NCT04008290|Liraglutide|liraglutide|mesh-list
154161557|NCT04008290|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154161558|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161559|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161560|NCT04008290|Incretins|incretins|mesh-ancestor
154161562|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161563|NCT02559167|Cannabidiol|cannabidiol|mesh-list
154161564|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
154161565|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154161566|NCT00975182|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154161567|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154161568|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161569|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161570|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161571|NCT05271071|Lidocaine|lidocaine|mesh-list
154161572|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
154161602|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154161603|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
154161604|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161605|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161606|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154161607|NCT05230901|Diuretics|diuretics|mesh-ancestor
154161608|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
154161609|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154161610|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
154161611|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154161612|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161613|NCT03927950|Bupropion|bupropion|mesh-list
154161614|NCT03927950|Escitalopram|escitalopram|mesh-list
153671350|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161634|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154161635|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154161636|NCT00972842|Growth Substances|growth substances|mesh-ancestor
154161637|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
154161638|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161639|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154161640|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161641|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161642|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
154161643|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
153443858|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
153357637|NCT01275014|Dexamethasone|dexamethasone|mesh-list
153916242|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
154161644|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154161645|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154161646|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161647|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161648|NCT00975494|Urological Agents|urological agents|mesh-ancestor
154161650|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
154161651|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161652|NCT00965666|Etanercept|etanercept|mesh-list
154161653|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154161654|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154161655|NCT00965666|Analgesics|analgesics|mesh-ancestor
154161656|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
154161657|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161658|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161659|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161660|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161661|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154161662|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161663|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
154161664|NCT00975728|Antioxidants|antioxidants|mesh-list
154161665|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161666|NCT00975728|Protective Agents|protective agents|mesh-ancestor
154161699|NCT00973232|Tramadol|tramadol|mesh-list
154161700|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154161701|NCT00973232|Analgesics|analgesics|mesh-ancestor
154161702|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
154161703|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161704|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161705|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
154161706|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154161707|NCT00973232|Narcotics|narcotics|mesh-ancestor
154161725|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154161726|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161727|NCT00966056|Mitomycins|mitomycins|mesh-list
154161728|NCT00966056|Mitomycin|mitomycin|mesh-list
154161729|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154161730|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161731|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
154161732|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161733|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154161735|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154161736|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
154161737|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161738|NCT03523728|Venglustat|venglustat|mesh-list
154161739|NCT03523728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161740|NCT03523728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161741|NCT00979706|Cyclosporine|cyclosporine|mesh-list
154161742|NCT00979706|Interleukin-2|interleukin-2|mesh-list
154161743|NCT00979706|Cyclosporins|cyclosporins|mesh-list
154161744|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161745|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161746|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161747|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
154161748|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161749|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
154161750|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161751|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
154161752|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161753|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154161754|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161755|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153811088|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
154161756|NCT00979706|Analgesics|analgesics|mesh-ancestor
154161757|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
153357638|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153357639|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
153357640|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
153357641|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161758|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161759|NCT00979862|Cediranib|cediranib|mesh-list
154161760|NCT00979862|Maleic acid|maleic acid|mesh-list
154161761|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161762|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161763|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161794|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161795|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161796|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154161797|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154161798|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161799|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161800|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161801|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154161802|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154161804|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161805|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161806|NCT00990054|Plerixafor|plerixafor|mesh-list
154161807|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154161808|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154161809|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
154161838|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154161839|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154161840|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161841|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161842|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154161843|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154161844|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154161845|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154161846|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154161847|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154161848|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154161849|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154161850|NCT02897076|Betamethasone|betamethasone|mesh-list
154161851|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
154161852|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154161853|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
154161854|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154161855|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161856|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
154161857|NCT02897076|Hormones|hormones|mesh-ancestor
154161873|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154161874|NCT00538590|Mitomycins|mitomycins|mesh-list
154161875|NCT00538590|Mitomycin|mitomycin|mesh-list
154161876|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154161877|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161878|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
154161879|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161880|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154161881|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161882|NCT00990834|Simvastatin|simvastatin|mesh-list
154161883|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154161884|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154161885|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
154161886|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161887|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154161888|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154161889|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161890|NCT00990990|Linezolid|linezolid|mesh-list
154161891|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
154161892|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161893|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161894|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154161895|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161896|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161897|NCT00466947|Vaccines|vaccines|mesh-list
154161898|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154161899|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
154161900|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161901|NCT00537810|Sibutramine|sibutramine|mesh-list
154161902|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
154161903|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154161904|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
154161905|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154161906|NCT00989352|Rituximab|rituximab|mesh-list
154161907|NCT00989352|Methotrexate|methotrexate|mesh-list
154161908|NCT00989352|Lomustine|lomustine|mesh-list
154161909|NCT00989352|Procarbazine|procarbazine|mesh-list
154161910|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154161911|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161912|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
154161913|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161914|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161915|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154161916|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
154161927|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
154161928|NCT05566626|Tropicamide|tropicamide|mesh-list
154161929|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
154161930|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
154161931|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161932|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161934|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154161935|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
154161936|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161937|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161939|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154161940|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154161941|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161942|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154161943|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161944|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
154161945|NCT05360394|Paclitaxel|paclitaxel|mesh-list
154161946|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154161947|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154161948|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161949|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
154161950|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
154161951|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
154161952|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161953|NCT00090259|Losartan|losartan|mesh-list
154161954|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154161955|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154161956|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154161957|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154161958|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161959|NCT00079183|Sirolimus|sirolimus|mesh-list
154161960|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161961|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161962|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154161963|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161964|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
154256497|NCT03882788|Isoflurane|isoflurane|mesh-list
154256498|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154161965|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161966|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
154161967|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161968|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154161969|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
154161970|NCT01086085|Adefovir|adefovir|mesh-list
154161971|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
154161972|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161973|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
154161974|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161975|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154161976|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154161977|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161978|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161979|NCT01589419|Capecitabine|capecitabine|mesh-list
154161980|NCT01589419|Veliparib|veliparib|mesh-list
154162014|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162015|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162016|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154162017|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154162018|NCT03961867|Docetaxel|docetaxel|mesh-list
154162019|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
154162020|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162048|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162049|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162050|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
154162051|NCT00545402|Hormones|hormones|mesh-ancestor
154162052|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162053|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154162054|NCT00545402|Protective Agents|protective agents|mesh-ancestor
154162055|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153811093|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
153357642|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162056|NCT03963115|Epinephrine|epinephrine|mesh-list
154162057|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154162058|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154162059|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
154162060|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162061|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162062|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162063|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154162064|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154162065|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
154162066|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162083|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154162084|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154162085|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162086|NCT00976976|Cisplatin|cisplatin|mesh-list
154162087|NCT00976976|Docetaxel|docetaxel|mesh-list
154162088|NCT00976976|Capecitabine|capecitabine|mesh-list
154162089|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162090|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
154162091|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
154162092|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
154162093|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162094|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154162095|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
154162096|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154162097|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
154162098|NCT00977054|Ribavirin|ribavirin|mesh-list
154162099|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
154162100|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154162101|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
154162102|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162103|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
154162104|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162105|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
154162106|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162107|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162108|NCT00977132|Lenalidomide|lenalidomide|mesh-list
154162109|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
154162110|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162111|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154162112|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154162113|NCT00977132|Growth Substances|growth substances|mesh-ancestor
154162114|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
154162115|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162116|NCT00545792|Bevacizumab|bevacizumab|mesh-list
154162117|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154162118|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162119|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154162120|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154162121|NCT00545792|Growth Substances|growth substances|mesh-ancestor
154162122|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162123|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
154162138|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162139|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162140|NCT00977444|Prednisolone|prednisolone|mesh-list
154162141|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154162142|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
154162143|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154162144|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
154162145|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153916312|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
153916313|NCT00622141|Saquinavir|saquinavir|mesh-list
154162146|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
154162147|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162148|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
154162150|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162151|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162152|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154162153|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162154|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
154162155|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
154162156|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162157|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162158|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154162159|NCT00977444|Protective Agents|protective agents|mesh-ancestor
154162160|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154162161|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162162|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
154162163|NCT00966836|Valganciclovir|valganciclovir|mesh-list
154162165|NCT00966836|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154162166|NCT00966836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154162167|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162168|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162169|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162170|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
154162171|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162172|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162173|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154162174|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154162175|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
154162176|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162177|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162178|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
154162179|NCT00967070|Nicotine|nicotine|mesh-list
154162180|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154162181|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
154162182|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162183|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162184|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154162206|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154162207|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154162208|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154162209|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154162210|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154162211|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154162212|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154162213|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153811097|NCT00331851|Liraglutide|liraglutide|mesh-list
153811098|NCT00331851|Glimepiride|glimepiride|mesh-list
153811099|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153357645|NCT01275014|Hormones|hormones|mesh-ancestor
153357646|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357647|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153736387|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
153811100|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811101|NCT00331851|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153811104|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811105|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153811106|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162214|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154162215|NCT00967148|Tinzaparin|tinzaparin|mesh-list
154162216|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154162217|NCT00967148|Dalteparin|dalteparin|mesh-list
154162218|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
154162219|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154162220|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154162221|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162222|NCT04007588|Nivolumab|nivolumab|mesh-list
154162223|NCT04007588|Ipilimumab|ipilimumab|mesh-list
154162225|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154162226|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162227|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154162228|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162229|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162230|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
154162231|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162232|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
154162233|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162234|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162235|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154162236|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
154162237|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154162238|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162239|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154162260|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162261|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162262|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162263|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162264|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
154162265|NCT00982358|Valsartan|valsartan|mesh-list
154162266|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154162267|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154162268|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154162269|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162270|NCT00982436|Carboplatin|carboplatin|mesh-list
154162271|NCT00982436|Docetaxel|docetaxel|mesh-list
154162272|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162273|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
154162274|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
154162275|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
154162276|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162277|NCT00545168|Permethrin|permethrin|mesh-list
154162278|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162279|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162280|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154162281|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154162282|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154162283|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
154162284|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162285|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154162286|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154162287|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162288|NCT00983138|Asparaginase|asparaginase|mesh-list
154162289|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162290|NCT00544544|Riluzole|riluzole|mesh-list
154162291|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
154162292|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154162293|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153672022|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
154162350|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154162351|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154162353|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154162354|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154162355|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154162356|NCT00985322|Ramipril|ramipril|mesh-list
153916336|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154162357|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
154162358|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154162359|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
154162360|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162361|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162362|NCT00984230|Lactoferrin|lactoferrin|mesh-list
154162363|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162364|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154162365|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154162366|NCT00984386|Estradiol|estradiol|mesh-list
154162367|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154162368|NCT00984386|Estrogens|estrogens|mesh-ancestor
154162369|NCT00984386|Hormones|hormones|mesh-ancestor
154162370|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162371|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162372|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154162373|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
154162374|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154162375|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154162376|NCT00984464|Paclitaxel|paclitaxel|mesh-list
154162377|NCT00984464|Carboplatin|carboplatin|mesh-list
154162378|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154162403|NCT00988520|Bromides|bromides|mesh-list
154162404|NCT00988520|Propofol|propofol|mesh-list
154162405|NCT00988520|Sevoflurane|sevoflurane|mesh-list
154162406|NCT00988520|Rocuronium|rocuronium|mesh-list
154162407|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154162408|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162409|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162410|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154162411|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
154162412|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
154162413|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154162414|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154162415|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
154162416|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154162417|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154162418|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154162419|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162420|NCT05498090|Fenofibrate|fenofibrate|mesh-list
154162421|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154162422|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
154162423|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162424|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154162425|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
154162426|NCT00077623|Hematinics|hematinics|mesh-ancestor
154162427|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
154162428|NCT00541034|Rituximab|rituximab|mesh-list
154162429|NCT00541034|Pentostatin|pentostatin|mesh-list
154162460|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154162462|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
154162463|NCT05450900|Biotin|biotin|mesh-list
154162464|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154162465|NCT05450900|Vitamins|vitamins|mesh-ancestor
154162466|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
154162467|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162468|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
154162469|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153811111|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154162470|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
154162471|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
153811112|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
153811113|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811114|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162472|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154162473|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154162509|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154162510|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
154162511|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154162512|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162548|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162549|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154162550|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
154162551|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162585|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154162586|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162587|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162588|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
154162589|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154162590|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162591|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154162592|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162593|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154162594|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
154162595|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153672344|NCT00039234|Histamine|histamine|mesh-list
154162618|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162619|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154162620|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154162621|NCT00748163|Growth Substances|growth substances|mesh-ancestor
154162622|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162623|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
154162624|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154162625|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162626|NCT00687401|Infliximab|infliximab|mesh-list
154162627|NCT00687401|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154162628|NCT00687401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162629|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
154162630|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162631|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162632|NCT00485693|Epinephrine|epinephrine|mesh-list
154162633|NCT00485693|Bupivacaine|bupivacaine|mesh-list
154162634|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
154162635|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
154162636|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162637|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162638|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
154162639|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162640|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154162641|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154162642|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
154162643|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162644|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162645|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154162646|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154162647|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
153672385|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
154162675|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154162676|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162677|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154162678|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
154162679|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162680|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162681|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
154162682|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162683|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154162684|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162685|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
154162686|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162687|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154162688|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162689|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
154162690|NCT05408208|Hormones|hormones|mesh-ancestor
154162691|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162692|NCT00758693|Rituximab|rituximab|mesh-list
154162693|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154162694|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154162695|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162696|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
154162709|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154162710|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154162711|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162712|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162713|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154162714|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
154162715|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162716|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162717|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154162718|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154162719|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
154162720|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162721|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
154162722|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154162723|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154162724|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154162725|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154162726|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154162727|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154162728|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154162729|NCT00748787|Psyllium|psyllium|mesh-list
154162730|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
154162731|NCT00748787|Cathartics|cathartics|mesh-ancestor
154162732|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162733|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
154162734|NCT05712044|Folic Acid|folic acid|mesh-list
154162735|NCT05712044|Vitamin B Complex|vitamin b complex|mesh-list
154162736|NCT05712044|Hematinics|hematinics|mesh-ancestor
154162737|NCT05712044|Vitamins|vitamins|mesh-ancestor
154162738|NCT05712044|Micronutrients|micronutrients|mesh-ancestor
154162739|NCT05712044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162740|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154162741|NCT00986960|Hormones|hormones|mesh-ancestor
153916380|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154162742|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162743|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162744|NCT05711966|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154162745|NCT05711966|Respiratory System Agents|respiratory system agents|mesh-ancestor
154162746|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
154162747|NCT00759005|Propranolol|propranolol|mesh-list
154162748|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154162749|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154162750|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
154162751|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162752|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162753|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162754|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154162755|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154162757|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162759|NCT04360070|Analgesics|analgesics|mesh-ancestor
154162760|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
154162794|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162795|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162796|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154162797|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154162798|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154162799|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154162800|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
154162801|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
154162832|NCT05711810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154162833|NCT05711810|Sympatholytics|sympatholytics|mesh-ancestor
154162834|NCT05711810|Autonomic Agents|autonomic agents|mesh-ancestor
154162835|NCT05711810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154162836|NCT05711810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154162837|NCT05711810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154162838|NCT05711810|Adrenergic Agents|adrenergic agents|mesh-ancestor
154162839|NCT05711810|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154162840|NCT05711810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162841|NCT05711810|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154162842|NCT05711810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154162843|NCT05711810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154162844|NCT05711810|Vasodilator Agents|vasodilator agents|mesh-ancestor
154162845|NCT05711810|Tocolytic Agents|tocolytic agents|mesh-ancestor
154162846|NCT05711810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153672592|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
153916390|NCT05368675|Methadone|methadone|mesh-list
154162881|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162882|NCT05357196|Gemcitabine|gemcitabine|mesh-list
154162883|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154162884|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
154162885|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162886|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162887|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
154162888|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
154162889|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162912|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162913|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
154162915|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162916|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162917|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154162918|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162919|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
154162920|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162921|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154162922|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162923|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
154162924|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162925|NCT05711732|Busulfan|busulfan|mesh-list
154162926|NCT05711732|Alkylating Agents|alkylating agents|mesh-ancestor
154162927|NCT05711732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162928|NCT05711732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162929|NCT05711732|Immunologic Factors|immunologic factors|mesh-ancestor
154162930|NCT05711732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162931|NCT05711732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154162932|NCT05711732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162933|NCT05711732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154162934|NCT04004702|Levetiracetam|levetiracetam|mesh-list
154162935|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
154162936|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
154162937|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
154162938|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
154162939|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154162940|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
153672679|NCT00020579|Entinostat|entinostat|mesh-list
154162974|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154162975|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162976|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163006|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
154163007|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
154163008|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163009|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154163010|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
154163011|NCT00086515|Metformin|metformin|mesh-list
154163012|NCT00086515|Pioglitazone|pioglitazone|mesh-list
154163013|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154163014|NCT00086515|Glipizide|glipizide|mesh-list
154163015|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154163016|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163017|NCT00086515|Incretins|incretins|mesh-ancestor
154163018|NCT00086515|Hormones|hormones|mesh-ancestor
153916427|NCT02641873|Antidotes|antidotes|mesh-ancestor
154163019|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154163020|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154163021|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
154163022|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163023|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163024|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
154163025|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
153672765|NCT00020774|Lonafarnib|lonafarnib|mesh-list
154163050|NCT03905642|Amikacin|amikacin|mesh-list
154163051|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154163052|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163053|NCT04126538|Pirfenidone|pirfenidone|mesh-list
154163054|NCT04126538|Analgesics|analgesics|mesh-ancestor
154163055|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
154163056|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163057|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163058|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154163059|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163060|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163061|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163062|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163063|NCT04004234|Manganese|manganese|mesh-list
154163064|NCT04004234|Paclitaxel|paclitaxel|mesh-list
154163065|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154163066|NCT04004234|Gemcitabine|gemcitabine|mesh-list
154163067|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154163068|NCT04004234|Antibodies|antibodies|mesh-list
154163069|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
154163070|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154163071|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163072|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
154163073|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
154163074|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672815|NCT00040872|Thiotepa|thiotepa|mesh-list
154163095|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
154163096|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154163097|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
154163098|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154163099|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
154163100|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163101|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163102|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
154163103|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
154163104|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
154163105|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163106|NCT00539864|Coagulants|coagulants|mesh-ancestor
154163107|NCT04003376|Vitamin D|vitamin d|mesh-list
154163108|NCT04003376|Triamcinolone|triamcinolone|mesh-list
154163109|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154163110|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154163111|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154163112|NCT04003376|Vitamins|vitamins|mesh-ancestor
154163114|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163115|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154163116|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163117|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
154163118|NCT04003376|Hormones|hormones|mesh-ancestor
154163119|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154163120|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154163121|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
154163122|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811116|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
153811117|NCT01059773|Methotrexate|methotrexate|mesh-list
153916433|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
154163123|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163124|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154163125|NCT04086212|Icodextrin|icodextrin|mesh-list
154163126|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
154163127|NCT05404490|Bupivacaine|bupivacaine|mesh-list
154163128|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
154163129|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
154163130|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163131|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163132|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
154163164|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154163165|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154163166|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154163167|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163168|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163169|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154163170|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
154163171|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154163172|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163173|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154163174|NCT00673049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154163175|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154163176|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163177|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163178|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486750|NCT01846728|Estrogens|estrogens|mesh-list
154163204|NCT05589584|Expectorants|expectorants|mesh-ancestor
154163205|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
154163206|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154163207|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
154163208|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163209|NCT05589584|Protective Agents|protective agents|mesh-ancestor
154163210|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163211|NCT05589584|Antidotes|antidotes|mesh-ancestor
154163212|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154163213|NCT00412750|Telbivudine|telbivudine|mesh-list
154163214|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
154163215|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163216|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154163217|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163218|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163219|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
154163220|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154163221|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154163223|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154163224|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154163225|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163226|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
154163227|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
154163228|NCT00764855|Propofol|propofol|mesh-list
154163229|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154163230|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163231|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163256|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
154163257|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154163258|NCT00765167|Triclosan|triclosan|mesh-list
154163259|NCT00765167|Fluorides|fluorides|mesh-list
154163260|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
154163261|NCT00765167|Protective Agents|protective agents|mesh-ancestor
154163262|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163263|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154163264|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163265|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
154163266|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
154163267|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153811118|NCT01059773|Ustekinumab|ustekinumab|mesh-list
154163268|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154163269|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
154163270|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163271|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154163272|NCT00759551|Olmesartan|olmesartan|mesh-list
154163273|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154163274|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154163275|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154163276|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154163277|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163278|NCT03905096|Donepezil|donepezil|mesh-list
154163279|NCT03905096|BI 425809|bi 425809|mesh-list
154163280|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154163299|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163300|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154163301|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163302|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
154163303|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163304|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
154163305|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154163306|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154163307|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154163308|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
154163309|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154163311|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154163312|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163313|NCT00761501|Analgesics|analgesics|mesh-ancestor
154163314|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
154163315|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163316|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163317|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163318|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163319|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
154163320|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154163321|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163322|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163323|NCT01088893|Everolimus|everolimus|mesh-list
154163324|NCT01088893|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154163325|NCT01088893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154163326|NCT01088893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163327|NCT01088893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163328|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154163329|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
154163330|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163331|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163332|NCT03026036|Raclopride|raclopride|mesh-list
154163333|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154163334|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154163335|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163336|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163355|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154163356|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
154163357|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
154163359|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154163360|NCT00571103|Acamprosate|acamprosate|mesh-list
154163361|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154163362|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154163363|NCT00765557|Laxatives|laxatives|mesh-ancestor
154163364|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154163366|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163367|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154163368|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
154163369|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444172|NCT02936999|Vitamins|vitamins|mesh-ancestor
153811119|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154163370|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163371|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154163372|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
154163373|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
154163374|NCT01086553|Hormones|hormones|mesh-ancestor
154163375|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154163376|NCT02810990|Bosutinib|bosutinib|mesh-list
154163377|NCT02810990|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154163378|NCT02810990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154163379|NCT02810990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163380|NCT02810990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163381|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154163383|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154163384|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163385|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154163386|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154163387|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
154163388|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163389|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154163390|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154163391|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163392|NCT00766181|Lidocaine|lidocaine|mesh-list
154163414|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154163415|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
154163416|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154163417|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163418|NCT00760175|Vaccines|vaccines|mesh-list
154163419|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
154163420|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163421|NCT00766337|Sirolimus|sirolimus|mesh-list
154163422|NCT00766337|Temsirolimus|temsirolimus|mesh-list
154163423|NCT00766337|Ranibizumab|ranibizumab|mesh-list
154163424|NCT00766337|MTOR Inhibitors|mtor inhibitors|mesh-list
154163425|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154163426|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163427|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154163428|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163429|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
154163430|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154163431|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
154163432|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163433|NCT00766337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154163434|NCT00766337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163435|NCT00766337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163436|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154163437|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154163438|NCT00766337|Growth Substances|growth substances|mesh-ancestor
154163439|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
154163440|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
154163441|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154163442|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163443|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163444|NCT00991562|Immunotoxins|immunotoxins|mesh-ancestor
154163445|NCT00991562|Immunoconjugates|immunoconjugates|mesh-ancestor
154163477|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154163478|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154163479|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154163480|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154163481|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
153409635|NCT04500613|Bupivacaine|bupivacaine|mesh-list
154163482|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163483|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163484|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163485|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154163486|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154163487|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
154163488|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154163489|NCT00766805|Diuretics|diuretics|mesh-ancestor
154163517|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163518|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163520|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154163521|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163522|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154163523|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154163524|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
154163525|NCT00767117|Ritonavir|ritonavir|mesh-list
154163526|NCT00767117|Lopinavir|lopinavir|mesh-list
154163527|NCT00767117|Etravirine|etravirine|mesh-list
154163528|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154163529|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154163530|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
154163531|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256499|NCT03882788|Narcotics|narcotics|mesh-ancestor
154163532|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163533|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154163534|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154163535|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
154163536|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163537|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154163538|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154163539|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154163575|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163576|NCT00767663|Dipyridamole|dipyridamole|mesh-list
154163577|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154163578|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163579|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163612|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163613|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163614|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163615|NCT00671879|Carisoprodol|carisoprodol|mesh-list
154163616|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154163617|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163618|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154163619|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163620|NCT00767975|Rifampin|rifampin|mesh-list
154163655|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163658|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
154163680|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
154163681|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163682|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163683|NCT00770471|Temozolomide|temozolomide|mesh-list
153916478|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154163684|NCT00770471|Veliparib|veliparib|mesh-list
154163685|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154163686|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
154163687|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163688|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163689|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154163690|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163691|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
154163692|NCT00539240|Nortriptyline|nortriptyline|mesh-list
154163693|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
154163694|NCT00539240|Rabeprazole|rabeprazole|mesh-list
154163695|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154163696|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154163697|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154163698|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163699|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163700|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154163701|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154163702|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154163703|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154163704|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
154163705|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163706|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163707|NCT00417976|Bevacizumab|bevacizumab|mesh-list
154163708|NCT00417976|Gemcitabine|gemcitabine|mesh-list
154163709|NCT00417976|Fluorouracil|fluorouracil|mesh-list
154163710|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673456|NCT00023348|Isoniazid|isoniazid|mesh-list
154163770|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
154163771|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163772|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163773|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154163774|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
154163775|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163777|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
154163778|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154163779|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163780|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154163781|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154163782|NCT02557451|Growth Substances|growth substances|mesh-ancestor
154163783|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163784|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
154163785|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163786|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154163787|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163788|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153811120|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
154163789|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163790|NCT02558153|Paclitaxel|paclitaxel|mesh-list
154163791|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154163792|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163793|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
154163794|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
154163795|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
154163796|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163809|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
154163810|NCT00763763|Hormones|hormones|mesh-ancestor
154163811|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154163812|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154163813|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163814|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
154163815|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163816|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154163817|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
154163818|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
154163819|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
154163820|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163821|NCT00763763|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154163822|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154163823|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163824|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
154163825|NCT01037140|Vitamin D|vitamin d|mesh-list
154163826|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
154163827|NCT01037140|Vitamins|vitamins|mesh-ancestor
154163828|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
154163829|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163830|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154163831|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154163832|NCT05357456|Epinephrine|epinephrine|mesh-list
154163833|NCT05357456|Racepinephrine|racepinephrine|mesh-list
154163834|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
154163835|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154163836|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154163837|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
154163838|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163839|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163840|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163841|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154163842|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154163843|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
154163844|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163845|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154163846|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
154163847|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
154163848|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
154163849|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154163850|NCT00069121|Leucovorin|leucovorin|mesh-list
154163851|NCT00069121|Capecitabine|capecitabine|mesh-list
154163852|NCT00069121|Fluorouracil|fluorouracil|mesh-list
154163853|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
154163854|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153781792|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811121|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153811122|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357663|NCT00756236|Esmolol|esmolol|mesh-list
153357664|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154163855|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
154163856|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163857|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163858|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154163859|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
154163860|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163891|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163892|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154163893|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811123|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154163894|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163895|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154163896|NCT00771251|Golimumab|golimumab|mesh-list
154163897|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154163898|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163899|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154163900|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
154163901|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163902|NCT00399568|Acetaminophen|acetaminophen|mesh-list
154163903|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163904|NCT00399568|Analgesics|analgesics|mesh-ancestor
154163905|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
154163906|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163943|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154163981|NCT00399490|Analgesics|analgesics|mesh-ancestor
154163982|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
154163983|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163984|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163985|NCT00398866|Triamcinolone|triamcinolone|mesh-list
154164022|NCT00775073|Growth Substances|growth substances|mesh-ancestor
154164023|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164024|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
153487573|NCT03551730|Enoxaparin|enoxaparin|mesh-list
154164025|NCT00775073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154164026|NCT00775073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154164045|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154164046|NCT01589146|Tinzaparin|tinzaparin|mesh-list
154164047|NCT01589146|Dalteparin|dalteparin|mesh-list
154164048|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
154164049|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154164050|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154164051|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164052|NCT00775151|Amlodipine|amlodipine|mesh-list
154164053|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154164054|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154164055|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154164056|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164057|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154164058|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164059|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
154164060|NCT04694300|Acetaminophen|acetaminophen|mesh-list
154164061|NCT04694300|Naproxen|naproxen|mesh-list
154164062|NCT04694300|Tramadol|tramadol|mesh-list
154164063|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154164064|NCT04694300|Analgesics|analgesics|mesh-ancestor
154164065|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
154164066|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164067|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164068|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
154164069|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154164070|NCT04694300|Narcotics|narcotics|mesh-ancestor
154164071|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164072|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154164073|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164074|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164075|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
154164076|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154164077|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164078|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164079|NCT00771641|Cobalt|cobalt|mesh-list
154164080|NCT00771641|Trace Elements|trace elements|mesh-ancestor
154164081|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
154164103|NCT00393718|Glyburide|glyburide|mesh-list
154164104|NCT00393718|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154164105|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154164106|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164107|NCT00393718|Incretins|incretins|mesh-ancestor
154164108|NCT00393718|Hormones|hormones|mesh-ancestor
153809433|NCT03405155|Nivolumab|nivolumab|mesh-list
154164109|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154164111|NCT00669071|Tretinoin|tretinoin|mesh-list
154164112|NCT00669071|Hydroquinone|hydroquinone|mesh-list
154164113|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164114|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
154164115|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
154164116|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164117|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
154164118|NCT00669071|Hormones|hormones|mesh-ancestor
154164119|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154164120|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164121|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
154164122|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164123|NCT00669071|Protective Agents|protective agents|mesh-ancestor
154164124|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154164125|NCT00398320|Bevacizumab|bevacizumab|mesh-list
154164126|NCT00398320|Capecitabine|capecitabine|mesh-list
154164127|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
154164128|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154164129|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164130|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154164131|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154164132|NCT00398320|Growth Substances|growth substances|mesh-ancestor
154164133|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164134|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
154164135|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154164136|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
154164167|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164169|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154164170|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154164171|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154164172|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154164173|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164174|NCT00772187|Fentanyl|fentanyl|mesh-list
154164175|NCT00772187|Morphine|morphine|mesh-list
154164176|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
154164177|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164200|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164202|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154164203|NCT02556437|Antibodies|antibodies|mesh-list
154164204|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
154164205|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465291|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164206|NCT04946006|Oxytocin|oxytocin|mesh-list
154164207|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
154164208|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154164209|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811126|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164210|NCT00775619|Carvedilol|carvedilol|mesh-list
154164211|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154164212|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154164213|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
154164214|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164215|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164216|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164217|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154164218|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
154164219|NCT00775619|Protective Agents|protective agents|mesh-ancestor
154164220|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154164221|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154164222|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154164223|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
154164224|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154164225|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154164226|NCT00775697|Montelukast|montelukast|mesh-list
154164227|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
154164228|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154164229|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
154164230|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
154164251|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164252|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544551|NCT01558934|Lofexidine|lofexidine|mesh-list
154164254|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
154164255|NCT02556905|Hormones|hormones|mesh-ancestor
154164256|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154164258|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164259|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
154164260|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154164261|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154164262|NCT02556905|Growth Substances|growth substances|mesh-ancestor
154164263|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
154164264|NCT00539006|Fluticasone|fluticasone|mesh-list
154164265|NCT00539006|Xhance|xhance|mesh-list
154164266|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164267|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154164268|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
154164269|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164270|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164271|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154164272|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
154164273|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
154164274|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154164275|NCT04047329|Anesthetics|anesthetics|mesh-list
154164276|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164277|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164278|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
154164279|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154164280|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154164281|NCT00537056|Sunitinib|sunitinib|mesh-list
154164282|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154164283|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164319|NCT00772499|Atenolol|atenolol|mesh-list
154164320|NCT00772499|Amlodipine|amlodipine|mesh-list
154164321|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154164386|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154164387|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153357669|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916568|NCT00622375|Mesalamine|mesalamine|mesh-list
154164388|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154164390|NCT00776477|Clopidogrel|clopidogrel|mesh-list
154164391|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154164392|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154164393|NCT00776477|Analgesics|analgesics|mesh-ancestor
154164394|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
154164395|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164396|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164397|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164398|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164399|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154164400|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154164401|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164402|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154164403|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154164404|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164405|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
153809734|NCT00679029|Bevacizumab|bevacizumab|mesh-list
154164406|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154164407|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154164430|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154164431|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154164432|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164433|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
154164434|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154164435|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154164436|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154164437|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
154164438|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164439|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154164440|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154164441|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164442|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154164443|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154164444|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154164445|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164446|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
154164447|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164449|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
154164450|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
154164451|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
154164452|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164453|NCT03961087|Vitamins|vitamins|mesh-ancestor
154164454|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154164455|NCT03961087|Protective Agents|protective agents|mesh-ancestor
154164456|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
154164457|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
154164458|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154164459|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164460|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164491|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811127|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
153357670|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154164492|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154164493|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
154164494|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154164495|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154164496|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
154164497|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
154164498|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164499|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154164500|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154164502|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164503|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154164504|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154164505|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154164506|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154164508|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
154164542|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154164543|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
154164544|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
154164545|NCT00536510|Vitamins|vitamins|mesh-ancestor
154164546|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
154164547|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164548|NCT04424264|Tenofovir|tenofovir|mesh-list
154164549|NCT04424264|Lamivudine|lamivudine|mesh-list
154164550|NCT04424264|Emtricitabine|emtricitabine|mesh-list
154164551|NCT04424264|Efavirenz|efavirenz|mesh-list
154164567|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154164568|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154164569|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154164570|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
154164571|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154164572|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
154164573|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154164574|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154164575|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154164576|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154164577|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154164578|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
154164579|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154164581|NCT00398086|Gemcitabine|gemcitabine|mesh-list
154164582|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154164583|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154164584|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164585|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
154164586|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
154164587|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
154164588|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164589|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154164590|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
154164591|NCT04364360|Sulforaphane|sulforaphane|mesh-list
154164592|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154164593|NCT04364360|Protective Agents|protective agents|mesh-ancestor
154164594|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164595|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164596|NCT00536198|Sertraline|sertraline|mesh-list
154164597|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
154164598|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154164599|NCT00536198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154164600|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154164601|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154164602|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164603|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164604|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
154164605|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164635|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154164636|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154164637|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153409864|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
154164638|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
154164639|NCT00057811|Rituximab|rituximab|mesh-list
154164640|NCT00057811|Doxorubicin|doxorubicin|mesh-list
154164641|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154164642|NCT00057811|Methotrexate|methotrexate|mesh-list
154164643|NCT00057811|Etoposide|etoposide|mesh-list
154164644|NCT00057811|Vincristine|vincristine|mesh-list
154164645|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
154164646|NCT00057811|Rasburicase|rasburicase|mesh-list
154164647|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154164648|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
154164649|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
154164650|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164651|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
154164652|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164653|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164654|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154164655|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
154164656|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164657|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674398|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
154164678|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
154164679|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164681|NCT00057811|Protective Agents|protective agents|mesh-ancestor
154164682|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
154164683|NCT00057811|Vitamins|vitamins|mesh-ancestor
154164684|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
154164685|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
154164686|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
154164687|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
154164688|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
154164689|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
154164690|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164691|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154164692|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154164693|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
154164694|NCT03502148|Cisplatin|cisplatin|mesh-list
154164695|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164696|NCT02530801|Bevacizumab|bevacizumab|mesh-list
154164697|NCT02530801|Fluorouracil|fluorouracil|mesh-list
154164698|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154164699|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164700|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154164701|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154164702|NCT02530801|Growth Substances|growth substances|mesh-ancestor
153544985|NCT03205423|Analgesics|analgesics|mesh-ancestor
154164703|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164704|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
154164705|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
153810027|NCT00317330|Rifampin|rifampin|mesh-list
154164706|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164707|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154164708|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164709|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
154164740|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164741|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
154164742|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154164743|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
154164744|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164745|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164746|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154164747|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
154164748|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154164749|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
154164750|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164751|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153674501|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
154164785|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
154164786|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164787|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164788|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154164789|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164790|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154164791|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
154164793|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154164821|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164822|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154164823|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
154164824|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
154164825|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154164826|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154164827|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154164828|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154164829|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
154164830|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164831|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164832|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
154164833|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154164834|NCT03979352|Empagliflozin|empagliflozin|mesh-list
154164835|NCT03979352|Pancrelipase|pancrelipase|mesh-list
154164836|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154164837|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447398|NCT00002567|Etoposide|etoposide|mesh-list
154164838|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154164839|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164840|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153674637|NCT00398385|Gemcitabine|gemcitabine|mesh-list
154164910|NCT00995306|Capsaicin|capsaicin|mesh-list
154164911|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
154164912|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
154164913|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
154164914|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164915|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164916|NCT00666965|Rotigotine|rotigotine|mesh-list
154164917|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
154164918|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
154164919|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164920|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164921|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164943|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154164945|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
154164946|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164947|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
154164948|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164949|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
154164950|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154164951|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
154164952|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154164953|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154164954|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164955|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154164956|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164957|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154164958|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164959|NCT00778115|Simethicone|simethicone|mesh-list
154164960|NCT00778115|Loperamide|loperamide|mesh-list
154164961|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
153357671|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154164962|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154164963|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
154164964|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164965|NCT00778115|Emollients|emollients|mesh-ancestor
154164966|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
154164967|NCT00993122|Ribavirin|ribavirin|mesh-list
154164968|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
154164969|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164970|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
154164971|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164972|NCT00778193|Aspirin|aspirin|mesh-list
154164973|NCT00778193|Celecoxib|celecoxib|mesh-list
154164974|NCT00778193|Naproxen|naproxen|mesh-list
154164975|NCT00778193|Clopidogrel|clopidogrel|mesh-list
154164976|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154165000|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
154165001|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165002|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165003|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
154165004|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154165005|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154165006|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165008|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154165009|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154165010|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165011|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165012|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
154165013|NCT00778349|Metformin|metformin|mesh-list
154165014|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154165015|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165016|NCT00995618|Tranilast|tranilast|mesh-list
154165017|NCT00995618|Febuxostat|febuxostat|mesh-list
154165018|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
154165019|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165020|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154165021|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154165022|NCT00995618|Analgesics|analgesics|mesh-ancestor
154165023|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
154165024|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165025|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165026|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154165027|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153674772|NCT00055653|Hormones|hormones|mesh-ancestor
154165062|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
154165063|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165065|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165066|NCT00532844|Protective Agents|protective agents|mesh-ancestor
154165067|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154165068|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154165069|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165090|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
154165091|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154165092|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165093|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165094|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
154165095|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165096|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165097|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154165098|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
154165099|NCT00666263|Antibodies|antibodies|mesh-list
154165100|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
154165101|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153811131|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
153811132|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357672|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153811133|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153357673|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
154165102|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154165103|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
154165104|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165105|NCT00667277|Bevacizumab|bevacizumab|mesh-list
154165106|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165107|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165108|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154165109|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154165110|NCT00667277|Growth Substances|growth substances|mesh-ancestor
154165111|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165112|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
154165113|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
154165114|NCT00774527|Fludarabine|fludarabine|mesh-list
154165115|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154165116|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165117|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
154165118|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165119|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165120|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154165121|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
154165122|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165153|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154165154|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154165155|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
154165156|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165157|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154165158|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154165159|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165160|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165161|NCT00784511|Vitamin D|vitamin d|mesh-list
154165162|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
154165163|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
154165164|NCT00784511|Vitamins|vitamins|mesh-list
154165183|NCT00784745|Dexamethasone|dexamethasone|mesh-list
154165184|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154165185|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
154165186|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
154165187|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165188|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165189|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165190|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
154165191|NCT00784745|Hormones|hormones|mesh-ancestor
154165192|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165193|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154165194|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165195|NCT00993512|Bleomycin|bleomycin|mesh-list
154165196|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154165197|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165198|NCT00662129|Paclitaxel|paclitaxel|mesh-list
154165199|NCT00662129|Bevacizumab|bevacizumab|mesh-list
154165200|NCT00662129|Gemcitabine|gemcitabine|mesh-list
154165201|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154256500|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165202|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154165203|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165204|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
154165205|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
154165206|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
154165207|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165208|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165209|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154165210|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154165211|NCT00662129|Growth Substances|growth substances|mesh-ancestor
153811134|NCT00353379|Guanfacine|guanfacine|mesh-list
154165212|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165213|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
154165214|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154165215|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
154165216|NCT00993746|Lidocaine|lidocaine|mesh-list
154165217|NCT00993746|Bupivacaine|bupivacaine|mesh-list
154165218|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
154165219|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
153674971|NCT00028496|Vaccines|vaccines|mesh-list
154165249|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165250|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154165251|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
154165252|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
154165253|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165254|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165255|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154165256|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154165257|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154165258|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154165259|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
154165260|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154165280|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154165281|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154165282|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165283|NCT00996788|Rebamipide|rebamipide|mesh-list
154165284|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154165285|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165286|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
154165287|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165288|NCT00996788|Protective Agents|protective agents|mesh-ancestor
154165289|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165290|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165291|NCT01564550|Insulin|insulin|mesh-list
154165292|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154165293|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154165294|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165295|NCT00790439|Cyclosporine|cyclosporine|mesh-list
154165296|NCT00790439|Sirolimus|sirolimus|mesh-list
154165297|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
154165298|NCT00790439|Heparin|heparin|mesh-list
154165299|NCT00790439|Calcium heparin|calcium heparin|mesh-list
154165300|NCT00790439|Dextrans|dextrans|mesh-list
154165301|NCT00790439|Tacrolimus|tacrolimus|mesh-list
154165302|NCT00790439|Cyclosporins|cyclosporins|mesh-list
154165303|NCT00790439|Basiliximab|basiliximab|mesh-list
154165304|NCT00790439|Daclizumab|daclizumab|mesh-list
154165305|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165306|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
154165307|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165308|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154165309|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165310|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165311|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
154165312|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165313|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
154165314|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165315|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154165316|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165317|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154165318|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
154165319|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165354|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165356|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165357|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153675112|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154165388|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165390|NCT02555813|Gemcitabine|gemcitabine|mesh-list
154165391|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154165392|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154165393|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165394|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
154165395|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
154165396|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
154165397|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165398|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154165399|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
154165425|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165426|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154165427|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154165428|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
154165429|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165430|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165431|NCT00393094|Bevacizumab|bevacizumab|mesh-list
154165432|NCT00393094|Irinotecan|irinotecan|mesh-list
154165433|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165434|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165435|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154165436|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154165437|NCT00393094|Growth Substances|growth substances|mesh-ancestor
154165438|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165439|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
154165440|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154165441|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154165442|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165443|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165444|NCT00783653|Sunitinib|sunitinib|mesh-list
154165445|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165446|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154165447|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154165448|NCT00783653|Growth Substances|growth substances|mesh-ancestor
154165475|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165476|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154165477|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154165478|NCT00790595|Growth Substances|growth substances|mesh-ancestor
154165479|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165480|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
154165481|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165482|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165483|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165485|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154165486|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154165487|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165488|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165489|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153916635|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916636|NCT00994461|Analgesics|analgesics|mesh-ancestor
153916637|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
153811136|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153811137|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153357675|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357676|NCT00762320|Ritonavir|ritonavir|mesh-list
153916638|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165490|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154165491|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154165492|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154165493|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
154165494|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
154165495|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
154165496|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
154165509|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154165510|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154165511|NCT00790985|Analgesics|analgesics|mesh-ancestor
154165512|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
154165513|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165514|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165515|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154165516|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165517|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
154165518|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154165519|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165520|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165521|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
154165522|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
154165523|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154256501|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165524|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154165525|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165526|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165527|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
154165528|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165529|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154165530|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165531|NCT01324492|Everolimus|everolimus|mesh-list
154165532|NCT01324492|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154165533|NCT01324492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165534|NCT01324492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165535|NCT01324492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165536|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165537|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
154165538|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165539|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165540|NCT01039948|Gefitinib|gefitinib|mesh-list
154165541|NCT01039948|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154165542|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165543|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165544|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165545|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165546|NCT00391846|Metoprolol|metoprolol|mesh-list
154165547|NCT00391846|Valsartan|valsartan|mesh-list
154165548|NCT00391846|Carvedilol|carvedilol|mesh-list
154165549|NCT00391846|Candesartan|candesartan|mesh-list
154165550|NCT00391846|Ramipril|ramipril|mesh-list
154165551|NCT00391846|Enalapril|enalapril|mesh-list
154165552|NCT00391846|Lisinopril|lisinopril|mesh-list
154165553|NCT00391846|Eplerenone|eplerenone|mesh-list
154165554|NCT00391846|Bisoprolol|bisoprolol|mesh-list
154165555|NCT00391846|Captopril|captopril|mesh-list
154165556|NCT00391846|Trandolapril|trandolapril|mesh-list
154165557|NCT00391846|Spironolactone|spironolactone|mesh-list
154165558|NCT00391846|Diuretics|diuretics|mesh-list
153675292|NCT00395915|Aripiprazole|aripiprazole|mesh-list
154165584|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154165585|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154165586|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154165587|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
154165588|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165589|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153811140|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916646|NCT00993915|Atorvastatin|atorvastatin|mesh-list
154165590|NCT00391768|Oseltamivir|oseltamivir|mesh-list
154165591|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
154165592|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165593|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165594|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165595|NCT00391222|Olanzapine|olanzapine|mesh-list
154165596|NCT00391222|Risperidone|risperidone|mesh-list
154165597|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154165598|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
154165599|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165600|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165601|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165602|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153675369|NCT00057564|BB 1101|bb 1101|mesh-list
154165635|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154165637|NCT00408928|Bortezomib|bortezomib|mesh-list
154165638|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165639|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
154165640|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154165641|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165642|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154165643|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
154165665|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
154165666|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165667|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165668|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154165669|NCT02275286|Trabectedin|trabectedin|mesh-list
154165670|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154165671|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
154165672|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165673|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165674|NCT00998192|Paclitaxel|paclitaxel|mesh-list
154165675|NCT00998192|Carboplatin|carboplatin|mesh-list
154165676|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154165677|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165678|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
154165679|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
154165680|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
154165681|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165682|NCT00994526|Vitamin E|vitamin e|mesh-list
154165683|NCT00994526|Calcium|calcium|mesh-list
154165684|NCT00994526|Vitamins|vitamins|mesh-ancestor
154165685|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
154165686|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165687|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154165688|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
154165689|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165690|NCT00994526|Protective Agents|protective agents|mesh-ancestor
154165691|NCT00998504|Resveratrol|resveratrol|mesh-list
154165692|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
154165693|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165694|NCT00998504|Protective Agents|protective agents|mesh-ancestor
154165695|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165696|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165697|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154165715|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165716|NCT00998972|Antidotes|antidotes|mesh-ancestor
154165717|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153444591|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
153815055|NCT00344825|Fludarabine|fludarabine|mesh-list
153357679|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154165718|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
154165719|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465404|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
154165720|NCT00998816|Pregabalin|pregabalin|mesh-list
154165721|NCT00998816|Analgesics|analgesics|mesh-ancestor
154165722|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
154165723|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165724|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165725|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
154165726|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154165727|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165728|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165729|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154165730|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154165731|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154165732|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165733|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154165734|NCT00533702|Dacarbazine|dacarbazine|mesh-list
154165735|NCT00533702|Ramucirumab|ramucirumab|mesh-list
154165736|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154165737|NCT00533702|Imidazole|imidazole|mesh-list
154165738|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154165739|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
154165740|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165741|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165742|NCT00533702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154165743|NCT00533702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154165744|NCT00533702|Growth Substances|growth substances|mesh-ancestor
154165745|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165746|NCT00533702|Growth Inhibitors|growth inhibitors|mesh-ancestor
154165747|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
154165748|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165749|NCT00408694|Bevacizumab|bevacizumab|mesh-list
154165750|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154165751|NCT00408694|Cisplatin|cisplatin|mesh-list
154165752|NCT00408694|Fluorouracil|fluorouracil|mesh-list
154165754|NCT00408694|Antibodies|antibodies|mesh-list
154165755|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
154165756|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154165757|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
153675495|NCT02969733|Lidocaine|lidocaine|mesh-list
154165779|NCT01043224|Calcipotriene|calcipotriene|mesh-list
154165780|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154165781|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
154165782|NCT01043224|Hormones|hormones|mesh-ancestor
154165783|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165784|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165785|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
154165786|NCT01044238|Methylphenidate|methylphenidate|mesh-list
154165787|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154165788|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165789|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154165790|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154165791|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165792|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165794|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165795|NCT01043380|Atorvastatin|atorvastatin|mesh-list
154165796|NCT01043380|Ezetimibe|ezetimibe|mesh-list
154165797|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154165798|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154165799|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
154165800|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165801|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154165802|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154165803|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165804|NCT01044394|Bisacodyl|bisacodyl|mesh-list
154165805|NCT01044394|Cathartics|cathartics|mesh-ancestor
154165806|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165807|NCT01044394|Laxatives|laxatives|mesh-ancestor
154165808|NCT03474094|Atezolizumab|atezolizumab|mesh-list
154165809|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154165810|NCT03474094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154165824|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154165825|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165826|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165828|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165829|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165830|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
154165831|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165832|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154165833|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
154165835|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154165836|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154165837|NCT00073021|Analgesics|analgesics|mesh-ancestor
154165838|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
154165839|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165840|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165841|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154165842|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165843|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
154165844|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154165845|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
154165846|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165847|NCT00395746|Liraglutide|liraglutide|mesh-list
154165848|NCT00395746|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154165849|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154165850|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165851|NCT00395746|Incretins|incretins|mesh-ancestor
154165852|NCT00395746|Hormones|hormones|mesh-ancestor
154165853|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165854|NCT01004900|Timolol|timolol|mesh-list
154165855|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154165856|NCT01004900|Travoprost|travoprost|mesh-list
154165857|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154165858|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154165859|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
154165860|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165861|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165862|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165863|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153444699|NCT01978535|Iron|iron|mesh-list
154165864|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154165865|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154165866|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154165867|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154165868|NCT04001348|Diazepam|diazepam|mesh-list
154165869|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154165904|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165905|NCT03956017|Vitamins|vitamins|mesh-ancestor
154165906|NCT00994916|Amifampridine|amifampridine|mesh-list
154165907|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154165908|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165909|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165910|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154165911|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165912|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165949|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165950|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154165951|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165952|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
154165953|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
154165954|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165986|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
154165987|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
154165988|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165989|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165991|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154165992|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154165993|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
154165994|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165995|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165996|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166032|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154166033|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154166034|NCT00066469|Protective Agents|protective agents|mesh-ancestor
154166035|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
154166036|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154166073|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166074|NCT00387010|Fentanyl|fentanyl|mesh-list
154166136|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166138|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154166139|NCT00786851|Growth Substances|growth substances|mesh-ancestor
154166140|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
154166141|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166142|NCT00787007|Equol|equol|mesh-list
154166143|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
154166144|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154166145|NCT00787007|Estrogens|estrogens|mesh-ancestor
154166146|NCT00787007|Hormones|hormones|mesh-ancestor
154166147|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166148|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166149|NCT00791141|Cetuximab|cetuximab|mesh-list
154166150|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166151|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166152|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
154166153|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
154166154|NCT00386152|Hematinics|hematinics|mesh-ancestor
154166155|NCT00787553|Cefazolin|cefazolin|mesh-list
154166156|NCT00787553|Tinidazole|tinidazole|mesh-list
154166157|NCT00787553|Imidazole|imidazole|mesh-list
154166158|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154166159|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166160|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357680|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
153811142|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166161|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166190|NCT00385762|Serotonin|serotonin|mesh-list
154166191|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154166192|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154166193|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166194|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166195|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
154166196|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166197|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154166198|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
154166199|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154166200|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154166201|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154166202|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166203|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154166204|NCT00385684|Acetaminophen|acetaminophen|mesh-list
154166205|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154166207|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154166208|NCT00385684|Narcotics|narcotics|mesh-ancestor
154166230|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166231|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166232|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154166233|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166234|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154166235|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154256502|NCT03882788|Analgesics|analgesics|mesh-ancestor
154256503|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
154166236|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154166237|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154166238|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154166239|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166240|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166241|NCT01095445|Ribavirin|ribavirin|mesh-list
154166242|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154166243|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
154166244|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166245|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
154166246|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166247|NCT00660179|Macitentan|macitentan|mesh-list
154166248|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154166249|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154166250|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166251|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154166252|NCT00050167|Paclitaxel|paclitaxel|mesh-list
154166253|NCT00050167|Docetaxel|docetaxel|mesh-list
154166254|NCT00050167|Capecitabine|capecitabine|mesh-list
154166255|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154166256|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166257|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
154166258|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
154166259|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
154166260|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166274|NCT02554955|Daclizumab|daclizumab|mesh-list
154166275|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154166276|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166277|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154166278|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
154166279|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154166280|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166281|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157360|NCT05852262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153811143|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
154166282|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166283|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154166284|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
154166285|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166286|NCT00062647|Vancomycin|vancomycin|mesh-list
154166287|NCT00062647|Cloxacillin|cloxacillin|mesh-list
154166288|NCT00062647|Oxacillin|oxacillin|mesh-list
154166289|NCT00062647|Telavancin|telavancin|mesh-list
154166290|NCT00062647|Nafcillin|nafcillin|mesh-list
154166291|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154166292|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166293|NCT00570323|Fulvestrant|fulvestrant|mesh-list
154166294|NCT00570323|Anastrozole|anastrozole|mesh-list
154166295|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154166296|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166297|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154166298|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154166299|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
154166300|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166301|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166302|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154166303|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154166304|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166305|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166306|NCT00791531|Methotrexate|methotrexate|mesh-list
154166307|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154166308|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
154166309|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154166310|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166311|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154166312|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
154166313|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166314|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166315|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
154166316|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166317|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154166318|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154166319|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
154166320|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154166321|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154166322|NCT00788099|Gemcitabine|gemcitabine|mesh-list
154166323|NCT00788099|Sorafenib|sorafenib|mesh-list
153676052|NCT00060411|Leucovorin|leucovorin|mesh-list
154166396|NCT00050011|Letrozole|letrozole|mesh-list
154166397|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166398|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154166399|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154166400|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166401|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166414|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166415|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166416|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154166418|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166419|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
154166420|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166421|NCT00035815|Mitogens|mitogens|mesh-list
154166422|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
154166423|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166424|NCT00662831|Dalteparin|dalteparin|mesh-list
154166425|NCT00662831|Tinzaparin|tinzaparin|mesh-list
153444752|NCT00795665|Bevacizumab|bevacizumab|mesh-list
154166426|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154166428|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153811144|NCT00324077|Dasatinib|dasatinib|mesh-list
154166429|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154166430|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166431|NCT02555423|Anesthetics|anesthetics|mesh-list
154166432|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
154166433|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
154166434|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166435|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166436|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
154166437|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166438|NCT00792779|Propofol|propofol|mesh-list
154166439|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154166440|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166441|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166442|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154166443|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
154166444|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
154166445|NCT00662363|Lubiprostone|lubiprostone|mesh-list
154166446|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154166447|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154166448|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166449|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154166450|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154166451|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154166452|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166453|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166454|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154166455|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154166456|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154166457|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
154166458|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166459|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166460|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154166461|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154166462|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
154166498|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
154166499|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
154166500|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
154166501|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166503|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154166504|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166570|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154166571|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154166572|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
154166573|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
153620016|NCT01988649|Oxytocin|oxytocin|mesh-list
154166574|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154166575|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154166576|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166577|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166578|NCT00798083|Lidocaine|lidocaine|mesh-list
154166579|NCT00798083|Ketamine|ketamine|mesh-list
154166580|NCT00798083|Amitriptyline|amitriptyline|mesh-list
154166581|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
154166582|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
154166583|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166584|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166585|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
153444779|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153815056|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
153916713|NCT02687425|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154166586|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166587|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154166588|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154166589|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153676322|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
154166621|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154166622|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154166623|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
154166624|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154166625|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154166626|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
154166627|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154166628|NCT00801905|Nepafenac|nepafenac|mesh-list
154166629|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154166630|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154166631|NCT00801905|Analgesics|analgesics|mesh-ancestor
154166663|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
154166664|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
154166665|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166666|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166667|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
154166668|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154166669|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154166670|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154166671|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
154166672|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166673|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166674|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166675|NCT00802373|Urological Agents|urological agents|mesh-ancestor
154166677|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166706|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166707|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154166708|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
154166709|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
154166710|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
154166711|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166713|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154166714|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166715|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154166716|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166717|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154166718|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
154166719|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
154166720|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166721|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166722|NCT00794261|Lenograstim|lenograstim|mesh-list
153736388|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153736389|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153736390|NCT02879695|Nivolumab|nivolumab|mesh-list
153736391|NCT02879695|Ipilimumab|ipilimumab|mesh-list
153736392|NCT02879695|Blinatumomab|blinatumomab|mesh-list
153736393|NCT02879695|Antibodies|antibodies|mesh-list
153736394|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
153736395|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153736396|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
153736397|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153736398|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
153736399|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444810|NCT00716807|Nalbuphine|nalbuphine|mesh-list
154166757|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
154166758|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
154166759|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154166760|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166761|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
154166762|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166763|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
154166764|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166765|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
154166766|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166767|NCT03953209|Spironolactone|spironolactone|mesh-list
154166768|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154166788|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166789|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154166790|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
154166791|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166792|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166793|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154166794|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
154166795|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
154166796|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154166797|NCT00803699|Selenium|selenium|mesh-list
154166798|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
154166799|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166800|NCT00803699|Protective Agents|protective agents|mesh-ancestor
154166801|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166802|NCT00803699|Trace Elements|trace elements|mesh-ancestor
154166803|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
154166804|NCT00798785|Rituximab|rituximab|mesh-list
154166805|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166806|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166807|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
154166808|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166809|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154166810|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154166811|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154166812|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166813|NCT01095991|Incretins|incretins|mesh-ancestor
154166814|NCT01095991|Hormones|hormones|mesh-ancestor
154166815|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166816|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154166817|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
154166818|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166819|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166820|NCT00794807|Alefacept|alefacept|mesh-list
154166821|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
154166822|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
154166823|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166824|NCT00794885|Folic Acid|folic acid|mesh-list
154166825|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
154166826|NCT00794885|Enalapril|enalapril|mesh-list
154166827|NCT00794885|Enalaprilat|enalaprilat|mesh-list
154166828|NCT00794885|Maleic acid|maleic acid|mesh-list
154166858|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154166859|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
154166860|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166861|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166862|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154166863|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154166864|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
154166865|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153811145|NCT00324077|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154166866|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
154166867|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
154166868|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
154166869|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154166870|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154166871|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154166872|NCT00799175|Analgesics|analgesics|mesh-ancestor
154166873|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166874|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154166875|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154166897|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166899|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154166900|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
154166901|NCT00804401|Naproxen|naproxen|mesh-list
154166902|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154166903|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154166904|NCT00804401|Analgesics|analgesics|mesh-ancestor
154166905|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
154166906|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166907|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166908|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166909|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154166910|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
154166911|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154166912|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166913|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166914|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154166915|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
154166916|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154166917|NCT02553083|Amoxicillin|amoxicillin|mesh-list
154166918|NCT02553083|Doxycycline|doxycycline|mesh-list
154166919|NCT02553083|Esomeprazole|esomeprazole|mesh-list
154166920|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154166921|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166922|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
154166923|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154166924|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154166925|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154166926|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154166927|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154166928|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166929|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166930|NCT00804947|Melphalan|melphalan|mesh-list
154166931|NCT00804947|Busulfan|busulfan|mesh-list
154166963|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154166964|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154166965|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
154166966|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166967|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166968|NCT00806741|Protective Agents|protective agents|mesh-ancestor
154166969|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166970|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
154166971|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154166972|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166991|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154166993|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916740|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
153916741|NCT05392127|Vitamin K|vitamin k|mesh-list
154166994|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154166995|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154166996|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154166997|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
154166998|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
154166999|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167000|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167001|NCT00807053|Ciclesonide|ciclesonide|mesh-list
154167002|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
154167003|NCT00807053|Hormones|hormones|mesh-ancestor
154167004|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167005|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167006|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154167007|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
154167008|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154167009|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154167010|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167011|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
154167012|NCT00809393|Coagulants|coagulants|mesh-ancestor
154167013|NCT00658775|Esomeprazole|esomeprazole|mesh-list
154167014|NCT00658775|Rabeprazole|rabeprazole|mesh-list
154167015|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154167016|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154167017|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154167018|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167019|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167020|NCT00488631|Golimumab|golimumab|mesh-list
154167021|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154167022|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154167023|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167024|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167025|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
154167026|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167027|NCT00809549|Lenograstim|lenograstim|mesh-list
154167028|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154167029|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
154167030|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167031|NCT00809627|Caffeine|caffeine|mesh-list
154167065|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167067|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154167068|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154167069|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154167099|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154167101|NCT00800423|Timolol|timolol|mesh-list
154167102|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154167103|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167104|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153620535|NCT01992588|Insulin|insulin|mesh-list
154167105|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154167106|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
154167107|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167108|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167109|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154167111|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154167113|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154167114|NCT00651755|Prednisone|prednisone|mesh-list
154167142|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
153357682|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357683|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153357684|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153357685|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
153357686|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167143|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
154167144|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
154167145|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
154167146|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
154167147|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167148|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154167149|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
154167150|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
154167151|NCT00651755|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154167152|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154167153|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
154167154|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167155|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154167156|NCT00807755|Carboplatin|carboplatin|mesh-list
154167158|NCT00807755|Everolimus|everolimus|mesh-list
154167159|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167160|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154167161|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154167162|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154167196|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167198|NCT02552459|Analgesics|analgesics|mesh-ancestor
154167199|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
154167200|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167201|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154167202|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154167203|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154167204|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
154167205|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167244|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
154167281|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
154167282|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167283|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
154167320|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
154167321|NCT00812123|Hormones|hormones|mesh-ancestor
153677045|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167346|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154167347|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167348|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154167349|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154167350|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154167351|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154167352|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154167353|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
154167355|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
154167356|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154167357|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154167358|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167359|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167360|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167361|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167362|NCT00809237|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154167363|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167364|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167365|NCT00817583|Docetaxel|docetaxel|mesh-list
154167366|NCT00817583|Fluorouracil|fluorouracil|mesh-list
153811146|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811147|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811148|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811149|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811150|NCT00324194|Mocetinostat|mocetinostat|mesh-list
153811151|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153357687|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153916775|NCT02685163|Protective Agents|protective agents|mesh-ancestor
154167367|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167388|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167389|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154167390|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154167391|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
154167392|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167394|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154167395|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154167396|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154167397|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167398|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167399|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154167400|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
154167401|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167402|NCT00817739|Leuprolide|leuprolide|mesh-list
154167403|NCT00817739|Flutamide|flutamide|mesh-list
154167404|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154167405|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
154167406|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154167407|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167408|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153620837|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
154167409|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167410|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
154167412|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167414|NCT00817895|Fluorouracil|fluorouracil|mesh-list
154167415|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167416|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
154167417|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167418|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154167419|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167420|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
154167421|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167422|NCT00814229|Vaccines|vaccines|mesh-list
154167423|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
154167424|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
154167459|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167460|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154167461|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167462|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
154167463|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
154167464|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167465|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154167466|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
154167467|NCT00061945|Hormones|hormones|mesh-ancestor
153677188|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
154167490|NCT00061945|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154167491|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167492|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154167493|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154167494|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154167495|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154167496|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
154167497|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154167498|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
154167499|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153781797|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154167500|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
153410393|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
153811152|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167501|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154167502|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154167503|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154167504|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154167505|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154167506|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154167507|NCT00817973|Caseins|caseins|mesh-list
154167508|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
154167509|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
154167510|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167511|NCT01097941|Vaccines|vaccines|mesh-list
154167512|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
154167513|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167514|NCT00642473|Metronidazole|metronidazole|mesh-list
154167515|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154167516|NCT00642473|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154167517|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167518|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167519|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167520|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167521|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167522|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153677228|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
154167541|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167542|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154167543|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154167544|NCT03992326|Analgesics|analgesics|mesh-ancestor
154167545|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
154167546|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167547|NCT01045954|Insulin|insulin|mesh-list
154167548|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
154167549|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
154167550|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154167551|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167552|NCT01046032|Metformin|metformin|mesh-list
154167553|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154167554|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167555|NCT00061633|Vancomycin|vancomycin|mesh-list
154167556|NCT00061633|Penicillins|penicillins|mesh-list
154167557|NCT00061633|Telavancin|telavancin|mesh-list
154167558|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154167559|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167560|NCT00645593|Gemcitabine|gemcitabine|mesh-list
154167561|NCT00645593|Cetuximab|cetuximab|mesh-list
153621002|NCT01996150|Eusol|eusol|mesh-list
154167562|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167563|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154167564|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
154167565|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167566|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154167568|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
153811154|NCT00324389|Interferons|interferons|mesh-list
153811155|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
154167569|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811156|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811157|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
153357693|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
153811158|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357694|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167570|NCT02550977|Gestodene|gestodene|mesh-list
154167571|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154167572|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154167573|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154167574|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
154167575|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154167576|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167577|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154167578|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154167579|NCT02550977|Progestins|progestins|mesh-ancestor
154167580|NCT02550977|Hormones|hormones|mesh-ancestor
154167581|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167612|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167613|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167615|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154167616|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154167617|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154167618|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154167619|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167620|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
154167621|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167622|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167623|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153677344|NCT00398658|Clindamycin|clindamycin|mesh-list
154167653|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167654|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154167655|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154167656|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167657|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167658|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167660|NCT00059839|Hormones|hormones|mesh-ancestor
154167661|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167662|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167663|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154167664|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154167665|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
154167666|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154167667|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154167668|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
154167669|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
154167670|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154167671|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167695|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167696|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167697|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
154167698|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167699|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154167700|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811159|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
153357695|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153916799|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
153916801|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167701|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
154167702|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167703|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
154167704|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167705|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154256504|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167706|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154167707|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
154167708|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167709|NCT03953989|Ranolazine|ranolazine|mesh-list
153621136|NCT01996618|Ranolazine|ranolazine|mesh-list
154167710|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154167711|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154167712|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167713|NCT01096225|Vaccines|vaccines|mesh-list
154167714|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
154167715|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167716|NCT02535130|Amikacin|amikacin|mesh-list
154167717|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154167718|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167719|NCT01046500|Inositol|inositol|mesh-list
154167720|NCT01046500|Metformin|metformin|mesh-list
154167721|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153677437|NCT00069888|Docetaxel|docetaxel|mesh-list
154167745|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154167746|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154167747|NCT00372424|Growth Substances|growth substances|mesh-ancestor
154167748|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167749|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
154167750|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167751|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167752|NCT02530411|Fulvestrant|fulvestrant|mesh-list
154167753|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154167754|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167755|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154167756|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154167757|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
154167758|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167759|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167760|NCT01327027|Vasopressins|vasopressins|mesh-list
154167761|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
154167762|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
154167763|NCT01327027|Coagulants|coagulants|mesh-ancestor
154167764|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154167765|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154167766|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
154167767|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167768|NCT01093807|Enalapril|enalapril|mesh-list
154167769|NCT01093807|Enalaprilat|enalaprilat|mesh-list
154167770|NCT01093807|Lercanidipine|lercanidipine|mesh-list
154167771|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154167772|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
154167773|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167793|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167794|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
154167795|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
154167796|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
154167797|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167798|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154167799|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
153811160|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357696|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154167801|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167802|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
154167803|NCT00021229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154167804|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167805|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167806|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167807|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167808|NCT02688790|Dalbavancin|dalbavancin|mesh-list
154167809|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154167810|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167811|NCT00488475|Etanercept|etanercept|mesh-list
154167812|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154167813|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154167814|NCT00488475|Analgesics|analgesics|mesh-ancestor
154167815|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
154167816|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167817|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167818|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167819|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167820|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154167821|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167822|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
154167823|NCT01020279|Celecoxib|celecoxib|mesh-list
154167824|NCT01020279|Ketoprofen|ketoprofen|mesh-list
154167825|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154167826|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154167851|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167852|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167853|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167854|NCT00466167|Pramipexole|pramipexole|mesh-list
154167855|NCT00466167|Dexpramipexole|dexpramipexole|mesh-list
154167856|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
154167857|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167858|NCT00466167|Protective Agents|protective agents|mesh-ancestor
154167859|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167860|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154167861|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154167862|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
154167863|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
154167864|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167865|NCT01017939|Prednisone|prednisone|mesh-list
154167866|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
154167867|NCT01017939|Theophylline|theophylline|mesh-list
154167868|NCT01017939|Levomethorphan|levomethorphan|mesh-list
154167869|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
154167870|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167871|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
154167872|NCT01017939|Hormones|hormones|mesh-ancestor
154167873|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167874|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167875|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154167901|NCT00480441|Dronabinol|dronabinol|mesh-list
154167902|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
154167903|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167904|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154167905|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154167906|NCT00480441|Analgesics|analgesics|mesh-ancestor
153360680|NCT01365611|Fluticasone|fluticasone|mesh-list
153811161|NCT00353691|Metformin|metformin|mesh-list
154167907|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
154167908|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167909|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154167910|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154167911|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167912|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167913|NCT00480441|Hormones|hormones|mesh-ancestor
154167914|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167915|NCT01022463|Atenolol|atenolol|mesh-list
154167916|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154167917|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154167918|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
154167919|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
154167920|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167921|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167922|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154167938|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167939|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154167940|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154167941|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
154167943|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
154167944|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167945|NCT00463047|Fentanyl|fentanyl|mesh-list
154167946|NCT00463047|Oxycodone|oxycodone|mesh-list
154167947|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154167948|NCT00463047|Narcotics|narcotics|mesh-ancestor
154167949|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154167950|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167951|NCT00463047|Analgesics|analgesics|mesh-ancestor
154167952|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
154167953|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167954|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154167955|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154167956|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
154167957|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
154167958|NCT00487539|Golimumab|golimumab|mesh-list
154167959|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154167960|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154167961|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167962|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167963|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
154167964|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167965|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
154167966|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154167967|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167968|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167969|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154167970|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153811163|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153465597|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167971|NCT00486759|Bevacizumab|bevacizumab|mesh-list
154167972|NCT00486759|Rituximab|rituximab|mesh-list
154167973|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154167974|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167975|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154167976|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154167977|NCT00486759|Growth Substances|growth substances|mesh-ancestor
154167978|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167979|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
154167980|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
154167981|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167982|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
154167983|NCT00486603|Temozolomide|temozolomide|mesh-list
154168000|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
154168001|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154168002|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168003|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154168004|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
154168005|NCT01020825|Coagulants|coagulants|mesh-ancestor
154168006|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
154168007|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154168008|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153621437|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
154168009|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154168010|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154168011|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168012|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
154168013|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168014|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168015|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154168016|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168017|NCT00462501|Leucovorin|leucovorin|mesh-list
154168018|NCT00462501|Bevacizumab|bevacizumab|mesh-list
154168019|NCT00462501|Fluorouracil|fluorouracil|mesh-list
154168020|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
154168021|NCT00462501|Calcium|calcium|mesh-list
154168022|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
154168023|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168024|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168025|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154168026|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154168027|NCT00462501|Growth Substances|growth substances|mesh-ancestor
154168028|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168029|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
154168030|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154168031|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
154168032|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168033|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168034|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154168035|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
154168036|NCT00462501|Antidotes|antidotes|mesh-ancestor
154168037|NCT00462501|Protective Agents|protective agents|mesh-ancestor
154168038|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
154168039|NCT00462501|Vitamins|vitamins|mesh-ancestor
154168040|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
154168041|NCT03996603|Estrogens|estrogens|mesh-list
154168042|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154168043|NCT03996603|Hormones|hormones|mesh-ancestor
153677751|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168079|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168080|NCT01049854|Vidarabine|vidarabine|mesh-list
154168117|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
153677856|NCT00066885|Vitamins|vitamins|mesh-ancestor
154168149|NCT00371254|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154168150|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154168151|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168152|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168153|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168154|NCT00452673|Capecitabine|capecitabine|mesh-list
154168155|NCT00452673|Dasatinib|dasatinib|mesh-list
154168156|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168157|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
154168158|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621585|NCT01999933|Cisplatin|cisplatin|mesh-list
154168160|NCT00452673|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154168189|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168191|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
154168192|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168193|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168194|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154168195|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
154168196|NCT00814541|Hormones|hormones|mesh-ancestor
154168197|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168198|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154168199|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168200|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154168201|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154168202|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154168203|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168204|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168205|NCT00814619|Capecitabine|capecitabine|mesh-list
154168206|NCT00814619|Panitumumab|panitumumab|mesh-list
154168207|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168208|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
154168209|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168248|NCT06334094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168251|NCT06334094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168252|NCT06334042|Chromium|chromium|mesh-list
154168253|NCT06334042|Trace Elements|trace elements|mesh-ancestor
154168254|NCT06334042|Micronutrients|micronutrients|mesh-ancestor
154168255|NCT06334042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168256|NCT06334016|Nicotine|nicotine|mesh-list
154168257|NCT06334016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154168258|NCT06334016|Autonomic Agents|autonomic agents|mesh-ancestor
154168259|NCT06334016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168260|NCT06334016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168261|NCT06334016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154168262|NCT06334016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154168263|NCT06334016|Cholinergic Agents|cholinergic agents|mesh-ancestor
154168264|NCT06334016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168265|NCT06334016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168266|NCT06333990|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154168267|NCT06333990|Antidepressive Agents|antidepressive agents|mesh-ancestor
154168268|NCT06333990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154168269|NCT06333990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154168270|NCT06333990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154168271|NCT06333990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154168272|NCT06333990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168273|NCT06333951|Paclitaxel|paclitaxel|mesh-list
153677981|NCT00067509|Estrogens|estrogens|mesh-list
154168311|NCT06333691|Cabergoline|cabergoline|mesh-list
154168346|NCT06333561|Tislelizumab|tislelizumab|mesh-list
154168347|NCT06333561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811165|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153811166|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154168348|NCT06333561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154168349|NCT06333561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168350|NCT06333561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168351|NCT06333561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168353|NCT06333522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154168367|NCT06333418|Adrenergic Agents|adrenergic agents|mesh-ancestor
154168368|NCT06333418|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154168369|NCT06333418|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154168370|NCT06333418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154168371|NCT06333418|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154168372|NCT06333340|Oxytocin|oxytocin|mesh-list
154168373|NCT06333340|Carbetocin|carbetocin|mesh-list
154168374|NCT06333340|Oxytocics|oxytocics|mesh-ancestor
154168375|NCT06333340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154168376|NCT06333340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168379|NCT06333262|Obinutuzumab|obinutuzumab|mesh-list
154168380|NCT06333262|Pirtobrutinib|pirtobrutinib|mesh-list
154168382|NCT06333262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168383|NCT06333262|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154168384|NCT06333262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154168408|NCT06332950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154168409|NCT06332950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154168410|NCT06332950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168411|NCT06332950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168412|NCT06332950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168413|NCT06332872|Ivermectin|ivermectin|mesh-list
154168414|NCT06332872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154168415|NCT06332872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154168424|NCT06332690|Dexamethasone|dexamethasone|mesh-list
154168425|NCT06332690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168426|NCT06332690|Antiemetics|antiemetics|mesh-ancestor
154168427|NCT06332690|Autonomic Agents|autonomic agents|mesh-ancestor
154168428|NCT06332690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168429|NCT06332690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168430|NCT06332690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154168431|NCT06332690|Glucocorticoids|glucocorticoids|mesh-ancestor
154168432|NCT06332690|Hormones|hormones|mesh-ancestor
154168433|NCT06332690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168434|NCT06332690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154168435|NCT06332690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168436|NCT06332638|Famotidine|famotidine|mesh-list
154168437|NCT06332638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154168438|NCT06332638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154168439|NCT06332638|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154168440|NCT06332638|Histamine Antagonists|histamine antagonists|mesh-ancestor
153811167|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
153811168|NCT00332046|Casopitant|casopitant|mesh-list
154168441|NCT06332638|Histamine Agents|histamine agents|mesh-ancestor
154168442|NCT06332638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678107|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154168473|NCT06332534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168474|NCT06332534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168475|NCT06332534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154168477|NCT06332443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154168478|NCT06332443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168479|NCT06332365|Triamcinolone|triamcinolone|mesh-list
154168480|NCT06332365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154168481|NCT06332365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154168482|NCT06332365|Hyaluronic Acid|hyaluronic acid|mesh-list
154168483|NCT06332365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154168484|NCT06332365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168514|NCT06332170|Carboplatin|carboplatin|mesh-list
154168516|NCT06332170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168517|NCT06332170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168518|NCT06332157|Propofol|propofol|mesh-list
154168519|NCT06332157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154168520|NCT06332157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154168521|NCT06332157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168522|NCT06332157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154168523|NCT06332157|Anesthetics, General|anesthetics, general|mesh-ancestor
154168524|NCT06332157|Anesthetics|anesthetics|mesh-ancestor
154168525|NCT06332092|Paclitaxel|paclitaxel|mesh-list
154168526|NCT06332092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154168527|NCT06332092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168547|NCT06332079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154168548|NCT06332079|Immunologic Factors|immunologic factors|mesh-ancestor
154168550|NCT06332066|Oxytocics|oxytocics|mesh-ancestor
154168551|NCT06332066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154168552|NCT06332066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168553|NCT06332053|Itraconazole|itraconazole|mesh-list
154168554|NCT06332053|Rifampin|rifampin|mesh-list
154168555|NCT06332053|Antifungal Agents|antifungal agents|mesh-ancestor
154168556|NCT06332053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154168557|NCT06332053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154168558|NCT06332053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154168559|NCT06332053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168560|NCT06332053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168561|NCT06332053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154168562|NCT06332053|Hormone Antagonists|hormone antagonists|mesh-ancestor
154168563|NCT06332053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168564|NCT06332053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168565|NCT06332053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154168566|NCT06332053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154168567|NCT06332053|Antitubercular Agents|antitubercular agents|mesh-ancestor
154168568|NCT06332053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154168569|NCT06332053|Leprostatic Agents|leprostatic agents|mesh-ancestor
154168570|NCT06332053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154168571|NCT06332053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154168572|NCT06332053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154168573|NCT06332053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154168574|NCT06332053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154168575|NCT06332053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154168576|NCT06332053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153360681|NCT01365611|Xhance|xhance|mesh-list
154168577|NCT06331182|Dexmedetomidine|dexmedetomidine|mesh-list
154168579|NCT06331182|Bupivacaine|bupivacaine|mesh-list
154168580|NCT06331182|Anesthetics, Local|anesthetics, local|mesh-ancestor
154168581|NCT06331182|Anesthetics|anesthetics|mesh-ancestor
154168582|NCT06331182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678252|NCT00202852|Infliximab|infliximab|mesh-list
154168629|NCT06326684|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154168630|NCT06326684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154168631|NCT06326684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154168632|NCT06326684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168633|NCT06326684|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154168634|NCT06326684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168673|NCT06321185|Anesthetics|anesthetics|mesh-list
154168674|NCT06321185|Anesthetics, Local|anesthetics, local|mesh-list
154168675|NCT06321185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154168676|NCT06321185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168677|NCT06321185|Sensory System Agents|sensory system agents|mesh-ancestor
154168678|NCT06321185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168679|NCT06316219|Estradiol|estradiol|mesh-list
154168680|NCT06316219|Estrogens|estrogens|mesh-ancestor
154168681|NCT06316219|Hormones|hormones|mesh-ancestor
154168682|NCT06316219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168683|NCT06316219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168684|NCT06316206|Dienogest|dienogest|mesh-list
154168685|NCT06316206|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154168686|NCT06316206|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154168687|NCT06316206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154168688|NCT06316206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154168689|NCT06316206|Contraceptive Agents|contraceptive agents|mesh-ancestor
154168690|NCT06316206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154168691|NCT06316206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168692|NCT06316206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154168693|NCT06316206|Estrogens|estrogens|mesh-ancestor
154168694|NCT06316206|Hormones|hormones|mesh-ancestor
154168695|NCT06316206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168696|NCT06316206|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154168697|NCT06316206|Hormone Antagonists|hormone antagonists|mesh-ancestor
154168698|NCT06316206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154168699|NCT06316206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168732|NCT06287073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154168733|NCT06287073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168735|NCT06284486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168736|NCT06260163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154168737|NCT06260163|Immunologic Factors|immunologic factors|mesh-ancestor
154168738|NCT06260163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168739|NCT06257355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154168740|NCT06257355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154168773|NCT06237062|Sensory System Agents|sensory system agents|mesh-ancestor
154168774|NCT06237062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168775|NCT06237062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168777|NCT06236815|Hallucinogens|hallucinogens|mesh-ancestor
153811170|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
154168778|NCT06236815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168779|NCT06236815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154168780|NCT06236815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154168781|NCT06236815|Analgesics|analgesics|mesh-ancestor
154168818|NCT06227832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168819|NCT06227832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154168820|NCT06227832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154168821|NCT06227832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154168823|NCT06227832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154168824|NCT06227832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154168825|NCT06227377|Cetuximab|cetuximab|mesh-list
153678445|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168917|NCT06136832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168918|NCT06130254|Olaparib|olaparib|mesh-list
154168919|NCT06130254|Adagrasib|adagrasib|mesh-list
154168920|NCT06130254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154168921|NCT06130254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168976|NCT06084936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154168977|NCT06084936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168979|NCT06084936|Immunologic Factors|immunologic factors|mesh-ancestor
154168980|NCT06084936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168981|NCT06084936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154168982|NCT06084936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154168983|NCT06084936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154168984|NCT06084936|Growth Substances|growth substances|mesh-ancestor
154168985|NCT06084936|Growth Inhibitors|growth inhibitors|mesh-ancestor
154168986|NCT06084936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154169011|NCT06075953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154169012|NCT06075953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154169013|NCT06067269|Edetic Acid|edetic acid|mesh-list
154169014|NCT06067269|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154169015|NCT06067269|Chelating Agents|chelating agents|mesh-ancestor
154169016|NCT06067269|Sequestering Agents|sequestering agents|mesh-ancestor
154169017|NCT06067269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169018|NCT06067269|Anticoagulants|anticoagulants|mesh-ancestor
153678580|NCT00072267|Topotecan|topotecan|mesh-list
154169078|NCT06047080|Alkylating Agents|alkylating agents|mesh-ancestor
154169079|NCT06047080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169080|NCT06047080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169081|NCT06047080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154169082|NCT06047080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169083|NCT06047080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154169084|NCT06047080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154169085|NCT06047080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154169086|NCT06047080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169087|NCT06047080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169088|NCT06047080|Glucocorticoids|glucocorticoids|mesh-ancestor
154169089|NCT06047080|Hormones|hormones|mesh-ancestor
154169090|NCT06047080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169091|NCT06047080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169092|NCT06047080|Immunoconjugates|immunoconjugates|mesh-ancestor
154169104|NCT06042725|Venetoclax|venetoclax|mesh-list
154169105|NCT06042725|Daratumumab|daratumumab|mesh-list
154169106|NCT06042725|Ichthammol|ichthammol|mesh-list
154169107|NCT06042725|BB 1101|bb 1101|mesh-list
154169108|NCT06042725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154169109|NCT06042725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169110|NCT06042725|Antiemetics|antiemetics|mesh-ancestor
153678633|NCT00072462|Tamoxifen|tamoxifen|mesh-list
154169154|NCT05987332|Nivolumab|nivolumab|mesh-list
154169155|NCT05987332|Ipilimumab|ipilimumab|mesh-list
154169156|NCT05987332|Dacarbazine|dacarbazine|mesh-list
154169157|NCT05987332|Crizotinib|crizotinib|mesh-list
154169158|NCT05987332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153668011|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678680|NCT00205816|Tigecycline|tigecycline|mesh-list
154169197|NCT05911321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169198|NCT05911321|Immunologic Factors|immunologic factors|mesh-ancestor
154169199|NCT05911321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169200|NCT05911321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169201|NCT05911321|Growth Substances|growth substances|mesh-ancestor
154169202|NCT05911321|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169203|NCT05908734|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154169204|NCT05908734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169205|NCT05908734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169207|NCT05908331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154169208|NCT05908331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154169209|NCT05908331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154169210|NCT05908331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169211|NCT05908331|Antifungal Agents|antifungal agents|mesh-ancestor
154169212|NCT05908331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169213|NCT05908331|Immunologic Factors|immunologic factors|mesh-ancestor
154169214|NCT05908331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169217|NCT05904028|Faricimab|faricimab|mesh-list
154169218|NCT05904028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153811428|NCT00426582|Epothilone B|epothilone b|mesh-list
154169219|NCT05904028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169220|NCT05904028|Growth Substances|growth substances|mesh-ancestor
154169221|NCT05904028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169222|NCT05904028|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169223|NCT05904028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169225|NCT05901961|Zinc Oxide|zinc oxide|mesh-list
154169226|NCT05901961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154169227|NCT05901961|Trace Elements|trace elements|mesh-ancestor
154169228|NCT05901961|Micronutrients|micronutrients|mesh-ancestor
154169229|NCT05901961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169298|NCT05823961|Hyaluronic Acid|hyaluronic acid|mesh-list
154169299|NCT05823961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154169300|NCT05823961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154169301|NCT05823961|Immunologic Factors|immunologic factors|mesh-ancestor
154169302|NCT05823961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169303|NCT05823961|Viscosupplements|viscosupplements|mesh-ancestor
154169304|NCT05823961|Protective Agents|protective agents|mesh-ancestor
154169305|NCT05811351|Prednisone|prednisone|mesh-list
154169306|NCT05811351|Triamcinolone|triamcinolone|mesh-list
154169307|NCT05811351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169308|NCT05811351|Glucocorticoids|glucocorticoids|mesh-ancestor
154169309|NCT05811351|Hormones|hormones|mesh-ancestor
154169310|NCT05811351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169311|NCT05811351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169312|NCT05811351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169313|NCT05811351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169314|NCT05807360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154169315|NCT05807360|Hyaluronic Acid|hyaluronic acid|mesh-list
153678770|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
154169333|NCT05779943|Cariostatic Agents|cariostatic agents|mesh-ancestor
154169334|NCT05779943|Protective Agents|protective agents|mesh-ancestor
154169344|NCT05770531|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154169345|NCT05770531|Immunoconjugates|immunoconjugates|mesh-ancestor
154169346|NCT05770531|Immunologic Factors|immunologic factors|mesh-ancestor
154169347|NCT05770531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169349|NCT05757869|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154169350|NCT05757869|Antithrombins|antithrombins|mesh-ancestor
154169351|NCT05757869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154169352|NCT05757869|Protease Inhibitors|protease inhibitors|mesh-ancestor
154169353|NCT05757869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169354|NCT05757869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702333|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154169355|NCT05757869|Anticoagulants|anticoagulants|mesh-ancestor
154169356|NCT05730036|Dexamethasone|dexamethasone|mesh-list
154169357|NCT05730036|Pomalidomide|pomalidomide|mesh-list
154169358|NCT05730036|Elotuzumab|elotuzumab|mesh-list
154169359|NCT05730036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169360|NCT05730036|Antiemetics|antiemetics|mesh-ancestor
154169361|NCT05730036|Autonomic Agents|autonomic agents|mesh-ancestor
154169362|NCT05730036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169363|NCT05730036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169364|NCT05730036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169365|NCT05730036|Glucocorticoids|glucocorticoids|mesh-ancestor
154169366|NCT05730036|Hormones|hormones|mesh-ancestor
154169367|NCT05730036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169368|NCT05730036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169369|NCT05730036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169370|NCT05730036|Immunologic Factors|immunologic factors|mesh-ancestor
154169371|NCT05730036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169372|NCT05730036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169373|NCT05730036|Growth Substances|growth substances|mesh-ancestor
154169374|NCT05730036|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169380|NCT05726227|Semaglutide|semaglutide|mesh-list
154169381|NCT05726227|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154169382|NCT05726227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154169383|NCT05726227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169403|NCT05712356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169404|NCT05712356|Tubulin Modulators|tubulin modulators|mesh-ancestor
154169405|NCT05712356|Antimitotic Agents|antimitotic agents|mesh-ancestor
154169406|NCT05712356|Mitosis Modulators|mitosis modulators|mesh-ancestor
154169407|NCT05712356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169408|NCT05712356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169409|NCT05712356|Antimetabolites|antimetabolites|mesh-ancestor
154169410|NCT05712356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169411|NCT05704543|Buprenorphine|buprenorphine|mesh-list
154169412|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154169413|NCT05704543|Narcotics|narcotics|mesh-ancestor
154169414|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154169415|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169416|NCT05704543|Analgesics|analgesics|mesh-ancestor
154169417|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
154169418|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169419|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153678820|NCT00411190|Analgesics|analgesics|mesh-ancestor
154169448|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169449|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
154169450|NCT05663866|Hormones|hormones|mesh-ancestor
154169451|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169452|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169453|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169454|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154169455|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
154169456|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154169457|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169458|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
154169459|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169460|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
154169461|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169462|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154169463|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169464|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
154169465|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154169466|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154169467|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154169468|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
153811171|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169469|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154169470|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
154169510|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169511|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
154169512|NCT05623020|Hormones|hormones|mesh-ancestor
153678885|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
154169541|NCT05615012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154169542|NCT05615012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169543|NCT05615012|Immunologic Factors|immunologic factors|mesh-ancestor
154169544|NCT05615012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154169545|NCT05615012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154169546|NCT05615012|Antidotes|antidotes|mesh-ancestor
154169548|NCT05615012|Vitamin B Complex|vitamin b complex|mesh-ancestor
154169549|NCT05615012|Vitamins|vitamins|mesh-ancestor
154169550|NCT05615012|Micronutrients|micronutrients|mesh-ancestor
154169551|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154169552|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154169553|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154169554|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154169555|NCT05595642|Astegolimab|astegolimab|mesh-list
154169556|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154169557|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169558|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
154169559|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154169593|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154169594|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154169595|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154169596|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169597|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169599|NCT05564117|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154169600|NCT05564117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154169601|NCT05564117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169602|NCT05564052|Rituximab|rituximab|mesh-list
154169603|NCT05564052|Lenalidomide|lenalidomide|mesh-list
154169604|NCT05564052|Bortezomib|bortezomib|mesh-list
153679028|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169702|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
154169703|NCT05520567|Azacitidine|azacitidine|mesh-list
154169704|NCT05520567|Venetoclax|venetoclax|mesh-list
154169705|NCT05520567|Gilteritinib|gilteritinib|mesh-list
154169706|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169707|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
154169708|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169709|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169710|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169711|NCT05520567|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154169712|NCT05520567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154169713|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
154169714|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154169715|NCT05519072|Cephalexin|cephalexin|mesh-list
154169716|NCT05519072|Fosfomycin|fosfomycin|mesh-list
154169717|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
154169718|NCT05519072|Trimethoprim|trimethoprim|mesh-list
154169719|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
154169720|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154169721|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154169722|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154169723|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154169724|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169725|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169726|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169727|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154169728|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153916963|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
154169729|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154169730|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
154169731|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154169732|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154169733|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154169734|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154169735|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154169736|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154169737|NCT05518149|Aticaprant|aticaprant|mesh-list
154169738|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154169739|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169740|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
154169741|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169742|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154169743|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
154169744|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154169745|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154169746|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154169747|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
154169748|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154169749|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169750|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154169751|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154169752|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153679066|NCT00207844|Selenium|selenium|mesh-list
154169797|NCT05455684|Aticaprant|aticaprant|mesh-list
154169798|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154169799|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169800|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
154169801|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169802|NCT05455320|Dexamethasone|dexamethasone|mesh-list
154169803|NCT05455320|Daratumumab|daratumumab|mesh-list
154169804|NCT05455320|Pomalidomide|pomalidomide|mesh-list
154169805|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169806|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
154169807|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
154169808|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169809|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169810|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169811|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
154169812|NCT05455320|Hormones|hormones|mesh-ancestor
153623239|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
154169813|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169814|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169815|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169816|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
154169817|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169818|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169819|NCT05455320|Growth Substances|growth substances|mesh-ancestor
154169820|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169821|NCT05453903|Cytarabine|cytarabine|mesh-list
154169822|NCT05453903|Azacitidine|azacitidine|mesh-list
154169823|NCT05453903|Daunorubicin|daunorubicin|mesh-list
154169824|NCT05453903|Venetoclax|venetoclax|mesh-list
154169825|NCT05453903|Idarubicin|idarubicin|mesh-list
154169826|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169827|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
154169828|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169829|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169830|NCT05453903|Antiviral Agents|antiviral agents|mesh-ancestor
154169831|NCT05453903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154169832|NCT05453903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169891|NCT05379634|Hormones|hormones|mesh-ancestor
154169892|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169893|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169894|NCT05379595|Leucovorin|leucovorin|mesh-list
154169895|NCT05379595|Fluorouracil|fluorouracil|mesh-list
154169896|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
154169897|NCT05379595|Irinotecan|irinotecan|mesh-list
154169898|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154169899|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
154169900|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169901|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169902|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169903|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169904|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
154169905|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731371|NCT00137774|Growth Substances|growth substances|mesh-ancestor
154169906|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154169907|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154169908|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169910|NCT05379595|Protective Agents|protective agents|mesh-ancestor
154169911|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
154169912|NCT05379595|Vitamins|vitamins|mesh-ancestor
154169913|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
154169914|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169915|NCT05371886|Midazolam|midazolam|mesh-list
154169916|NCT05371886|Morphine|morphine|mesh-list
154169917|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154169918|NCT05371886|Narcotics|narcotics|mesh-ancestor
154169919|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154169920|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169921|NCT05371886|Analgesics|analgesics|mesh-ancestor
154169922|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
154169923|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169924|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154169925|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154169926|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154169927|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153679225|NCT00040781|Gefitinib|gefitinib|mesh-list
154169958|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
154169959|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154169960|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169961|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154169962|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154169963|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169964|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169965|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154169966|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169967|NCT05338775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169968|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169969|NCT05332795|Metformin|metformin|mesh-list
154169970|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154169971|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169995|NCT05250973|Bortezomib|bortezomib|mesh-list
154169996|NCT05250973|Daratumumab|daratumumab|mesh-list
154169997|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169998|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
154169999|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170000|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154170001|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154170002|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
154170003|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170004|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170005|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154170006|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170007|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
154170008|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
154170009|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170010|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170011|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
154170012|NCT05250973|Hormones|hormones|mesh-ancestor
154170013|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170014|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154170016|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170017|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170018|NCT05242484|Golimumab|golimumab|mesh-list
154170019|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154170020|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170021|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170040|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154170041|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
154170042|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170043|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170044|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170045|NCT05231122|Growth Substances|growth substances|mesh-ancestor
154170046|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170047|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170048|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
154170049|NCT05231122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154170050|NCT05231122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170051|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154170052|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
154170053|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170054|NCT05179876|Selexipag|selexipag|mesh-list
154170055|NCT05179876|Tadalafil|tadalafil|mesh-list
154170056|NCT05179876|Macitentan|macitentan|mesh-list
154170057|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
154170058|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154170059|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154170060|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170061|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170062|NCT05179876|Urological Agents|urological agents|mesh-ancestor
154170063|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154170064|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154170065|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154170066|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154170067|NCT05171647|Rituximab|rituximab|mesh-list
154170068|NCT05171647|Gemcitabine|gemcitabine|mesh-list
154170069|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
154170070|NCT05171647|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154170071|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170072|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170073|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
154170074|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170075|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154170076|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170077|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
154170078|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170079|NCT05171647|Immunoconjugates|immunoconjugates|mesh-ancestor
154170096|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
154170097|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
154170098|NCT05152147|Capecitabine|capecitabine|mesh-list
154170099|NCT05152147|Fluorouracil|fluorouracil|mesh-list
154170100|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
154170101|NCT05152147|Trastuzumab|trastuzumab|mesh-list
154170102|NCT05152147|Tislelizumab|tislelizumab|mesh-list
154170103|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170104|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170105|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
154170106|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170107|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170108|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
154170109|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170110|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170111|NCT05143424|Morphine|morphine|mesh-list
154170112|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154170113|NCT05143424|Narcotics|narcotics|mesh-ancestor
154170114|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154170115|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170116|NCT05143424|Analgesics|analgesics|mesh-ancestor
154170117|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
154170118|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170119|NCT05123599|Tenofovir|tenofovir|mesh-list
154170120|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
154170121|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170122|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154170123|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154170124|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170125|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170126|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154170127|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154170128|NCT05112939|Cabotegravir|cabotegravir|mesh-list
154170129|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154170130|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154170131|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170132|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170133|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154170134|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154170135|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
154170136|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170137|NCT05092269|Ustekinumab|ustekinumab|mesh-list
154170163|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170164|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170165|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
154170166|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170167|NCT05053750|Paclitaxel|paclitaxel|mesh-list
154170168|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154170169|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154170170|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170171|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
154170172|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153465777|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
153917015|NCT02686177|Incretins|incretins|mesh-ancestor
154170173|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
154170174|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170175|NCT05050097|Lenalidomide|lenalidomide|mesh-list
154170176|NCT05050097|Pomalidomide|pomalidomide|mesh-list
154170177|NCT05050097|Daratumumab|daratumumab|mesh-list
154170178|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
154170179|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170180|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170181|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170182|NCT05050097|Growth Substances|growth substances|mesh-ancestor
154170183|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170184|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170185|NCT05048524|Leucovorin|leucovorin|mesh-list
154170186|NCT05048524|Gemcitabine|gemcitabine|mesh-list
154170187|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
154170188|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170189|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
154170190|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170225|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170226|NCT04990167|Bromides|bromides|mesh-list
154170227|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
154170228|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154170229|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
154170230|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170263|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154170264|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154170265|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154170267|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154170268|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154170269|NCT04930783|Pembrolizumab|pembrolizumab|mesh-list
154170271|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170272|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170360|NCT04822181|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154170362|NCT04822181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170363|NCT04821310|Pantoprazole|pantoprazole|mesh-list
154170364|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154170365|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170366|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154170367|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170368|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170369|NCT04804540|Vedolizumab|vedolizumab|mesh-list
154170370|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170371|NCT04790812|Acetaminophen|acetaminophen|mesh-list
154170372|NCT04790812|Celecoxib|celecoxib|mesh-list
154170373|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154170374|NCT04790812|Analgesics|analgesics|mesh-ancestor
154170375|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
154170376|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170377|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170379|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154170380|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170381|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154170382|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153679664|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
154170505|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154170506|NCT04658862|Gemcitabine|gemcitabine|mesh-list
154170507|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170508|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170509|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
154170510|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170512|NCT04644237|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154170513|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811175|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154170536|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
154170537|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
154170538|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154170539|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154170540|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154170541|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154170542|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154170543|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154170544|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154170546|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
154170547|NCT04628767|Cisplatin|cisplatin|mesh-list
154170548|NCT04628767|Gemcitabine|gemcitabine|mesh-list
154170549|NCT04628767|Doxorubicin|doxorubicin|mesh-list
154170550|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154170551|NCT04628767|Methotrexate|methotrexate|mesh-list
154170552|NCT04628767|Durvalumab|durvalumab|mesh-list
154170553|NCT04628767|Vinblastine|vinblastine|mesh-list
154170554|NCT04628767|Lenograstim|lenograstim|mesh-list
154170555|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
154170556|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154170557|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
154170558|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170559|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170560|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
154170561|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170562|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154170563|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154170564|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154170565|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170566|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154170591|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170593|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154170594|NCT04606381|Lazertinib|lazertinib|mesh-list
154170595|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170596|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170597|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170598|NCT04586426|Daratumumab|daratumumab|mesh-list
154170599|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170600|NCT04577833|Prednisone|prednisone|mesh-list
154170601|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
154170602|NCT04577833|Niraparib|niraparib|mesh-list
154170603|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170604|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
154170605|NCT04577833|Hormones|hormones|mesh-ancestor
154170606|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170607|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170608|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154170609|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679889|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154170735|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170736|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170737|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170739|NCT04313634|Protective Agents|protective agents|mesh-ancestor
154170740|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170741|NCT04298541|Edotreotide|edotreotide|mesh-list
154170742|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154170743|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170744|NCT04276493|Docetaxel|docetaxel|mesh-list
154170745|NCT04276493|Capecitabine|capecitabine|mesh-list
153357703|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
154170747|NCT04276493|Tislelizumab|tislelizumab|mesh-list
154170748|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170749|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
154170750|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
154170751|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
154170752|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170753|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170754|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
154170755|NCT04276493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170756|NCT04273945|Macitentan|macitentan|mesh-list
154170757|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154170758|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154170759|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170760|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154170785|NCT04229979|Cytarabine|cytarabine|mesh-list
154170786|NCT04229979|Azacitidine|azacitidine|mesh-list
154170787|NCT04229979|Decitabine|decitabine|mesh-list
154170788|NCT04229979|Venetoclax|venetoclax|mesh-list
154170789|NCT04229979|Sargramostim|sargramostim|mesh-list
154170790|NCT04229979|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154170824|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
154170825|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
154170826|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170827|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170828|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170829|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
154170830|NCT04182997|Hormones|hormones|mesh-ancestor
154170831|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170832|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154170833|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170834|NCT04181827|Dexamethasone|dexamethasone|mesh-list
154170835|NCT04181827|Bortezomib|bortezomib|mesh-list
154170836|NCT04181827|Daratumumab|daratumumab|mesh-list
154170837|NCT04181827|Pomalidomide|pomalidomide|mesh-list
154170838|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170839|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
154170840|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
154170841|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170842|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170843|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170844|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
154170845|NCT04181827|Hormones|hormones|mesh-ancestor
154170846|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170847|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154170848|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170849|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
154170850|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170851|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170852|NCT04181827|Growth Substances|growth substances|mesh-ancestor
154170853|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170854|NCT04181060|Bevacizumab|bevacizumab|mesh-list
154170855|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154170856|NCT04181060|Osimertinib|osimertinib|mesh-list
154170857|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
154170858|NCT04181060|Antibodies|antibodies|mesh-list
154170895|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
154170973|NCT04108208|Androgens|androgens|mesh-list
154170992|NCT04097561|Belimumab|belimumab|mesh-list
154170993|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170994|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
154170995|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170996|NCT04093765|Antimalarials|antimalarials|mesh-list
154170997|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154170998|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154170999|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811177|NCT00324467|Acetaminophen|acetaminophen|mesh-list
153357704|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153917031|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
154171000|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
154171001|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171002|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171003|NCT04077463|Carboplatin|carboplatin|mesh-list
154171004|NCT04077463|Pemetrexed|pemetrexed|mesh-list
154171005|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154171006|NCT04077463|Lazertinib|lazertinib|mesh-list
154171007|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171008|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171009|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171010|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154171011|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153812217|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154171012|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171013|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171014|NCT04068194|Avelumab|avelumab|mesh-list
154171015|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154171016|NCT04068194|Peposertib|peposertib|mesh-list
154171017|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171018|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171019|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
154171020|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171021|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171022|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171023|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171025|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154171026|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154171027|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680187|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154171079|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171080|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171081|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
154171082|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171083|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171106|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
154171107|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171108|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171109|NCT03983668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171110|NCT03983668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171111|NCT03980483|Tofacitinib|tofacitinib|mesh-list
154171144|NCT03923725|Amodiaquine|amodiaquine|mesh-list
154171183|NCT03866382|Ipilimumab|ipilimumab|mesh-list
154171184|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171185|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171186|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171187|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171188|NCT03847610|Penicillins|penicillins|mesh-list
154171201|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171202|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
154171203|NCT03737955|Calicheamicins|calicheamicins|mesh-list
153680285|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154171242|NCT03652753|Protective Agents|protective agents|mesh-ancestor
154171243|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171261|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154171262|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154171263|NCT03652064|Growth Substances|growth substances|mesh-ancestor
154171264|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
154171265|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
154171266|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171267|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
153811178|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
154171268|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171269|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171270|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154171271|NCT03633058|Ketamine|ketamine|mesh-list
154171272|NCT03633058|Analgesics|analgesics|mesh-ancestor
154171273|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
154171274|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171275|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171276|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154171277|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154171278|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
154171279|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
154171280|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154171281|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154171282|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154171283|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154171284|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171285|NCT03598257|Olaparib|olaparib|mesh-list
154171286|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154171287|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171288|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171289|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171290|NCT03596645|Infliximab|infliximab|mesh-list
154171291|NCT03596645|Golimumab|golimumab|mesh-list
154171292|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154171293|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171294|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
154171295|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154171296|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154171297|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171298|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
154171299|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171300|NCT03573648|Palbociclib|palbociclib|mesh-list
154171301|NCT03573648|Avelumab|avelumab|mesh-list
154171302|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680369|NCT00216190|Midazolam|midazolam|mesh-list
154171319|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171320|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171321|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171322|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171323|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
154171324|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171325|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171327|NCT03505320|Folic Acid|folic acid|mesh-list
154171328|NCT03505320|Docetaxel|docetaxel|mesh-list
154171329|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
154171330|NCT03505320|Fluorouracil|fluorouracil|mesh-list
154171331|NCT03505320|Nivolumab|nivolumab|mesh-list
154171332|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
154171333|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
154171334|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171335|NCT03505320|Tubulin Modulators|tubulin modulators|mesh-ancestor
154171336|NCT03505320|Antimitotic Agents|antimitotic agents|mesh-ancestor
154171337|NCT03505320|Mitosis Modulators|mitosis modulators|mesh-ancestor
154157361|NCT05852262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811179|NCT00324467|Promethazine|promethazine|mesh-list
153357706|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153465793|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
154171338|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171339|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171340|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171341|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
154171342|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154171343|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171344|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
154171345|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171346|NCT03505320|Antidotes|antidotes|mesh-ancestor
154171347|NCT03505320|Protective Agents|protective agents|mesh-ancestor
154171348|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
154171349|NCT03505320|Vitamins|vitamins|mesh-ancestor
154171350|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
154171351|NCT03505320|Hematinics|hematinics|mesh-ancestor
154171352|NCT03472586|Nivolumab|nivolumab|mesh-list
154171353|NCT03472586|Ipilimumab|ipilimumab|mesh-list
154171354|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171355|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171356|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171357|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171358|NCT03466411|Ustekinumab|ustekinumab|mesh-list
154171359|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154171360|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
154171361|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
154171362|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171383|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154171384|NCT03446612|Hematinics|hematinics|mesh-ancestor
154171385|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154171386|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
154171387|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154171388|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171389|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154171390|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
154171391|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154171392|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171393|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171394|NCT03433781|Ascorbic Acid|ascorbic acid|mesh-list
154171395|NCT03433781|Vitamins|vitamins|mesh-ancestor
154171396|NCT03433781|Micronutrients|micronutrients|mesh-ancestor
154171397|NCT03433781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624808|NCT05777369|Analgesics|analgesics|mesh-ancestor
154171398|NCT03433781|Antioxidants|antioxidants|mesh-ancestor
154171399|NCT03433781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171400|NCT03433781|Protective Agents|protective agents|mesh-ancestor
154171401|NCT03390504|Docetaxel|docetaxel|mesh-list
154171402|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
154171403|NCT03390504|Mitogens|mitogens|mesh-list
154171404|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171405|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
153812446|NCT00429468|Acetaminophen|acetaminophen|mesh-list
154171406|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
154171407|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
154171408|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171409|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171410|NCT03390504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171411|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
154171412|NCT03321630|Lenvatinib|lenvatinib|mesh-list
154171413|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171414|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171415|NCT03321630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171416|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171417|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171418|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171419|NCT03301220|Daratumumab|daratumumab|mesh-list
154171420|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811180|NCT00324467|Dexamethasone|dexamethasone|mesh-list
153357707|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153465798|NCT00242502|Bevacizumab|bevacizumab|mesh-list
153729755|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729756|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
154171423|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
154171424|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154171425|NCT03269669|Doxorubicin|doxorubicin|mesh-list
154171426|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154171427|NCT03269669|Vincristine|vincristine|mesh-list
154171428|NCT03269669|Lenalidomide|lenalidomide|mesh-list
154171429|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
154171430|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171431|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
154171432|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171433|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154171434|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154171435|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
154171436|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171437|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171438|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154171470|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171503|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171504|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171505|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171506|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154171507|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
154171508|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171509|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154171510|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171511|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
154171512|NCT03178643|Piperaquine|piperaquine|mesh-list
154171513|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
154171514|NCT03178643|Amodiaquine|amodiaquine|mesh-list
154171516|NCT03178643|Proguanil|proguanil|mesh-list
154171517|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
154171518|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154171519|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154171520|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171521|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154171522|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
154171523|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171524|NCT03176173|Immunomodulating Agents|immunomodulating agents|mesh-list
154171525|NCT03176173|Immunologic Factors|immunologic factors|mesh-ancestor
154171526|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171527|NCT03158805|Liraglutide|liraglutide|mesh-list
154171528|NCT03158805|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154171529|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154171530|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171531|NCT03158805|Incretins|incretins|mesh-ancestor
154171532|NCT03158805|Hormones|hormones|mesh-ancestor
154171533|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171534|NCT03147612|Cytarabine|cytarabine|mesh-list
154171535|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
154171536|NCT03147612|Rituximab|rituximab|mesh-list
154171537|NCT03147612|Methotrexate|methotrexate|mesh-list
154171538|NCT03147612|Vincristine|vincristine|mesh-list
154171539|NCT03147612|Blinatumomab|blinatumomab|mesh-list
154171540|NCT03147612|Ponatinib|ponatinib|mesh-list
154171541|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154171542|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
154171543|NCT03147612|Antibodies|antibodies|mesh-list
154171544|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
153812594|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
153811181|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
154171545|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154171546|NCT03147612|Lenograstim|lenograstim|mesh-list
154171547|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154171548|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171549|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
154171550|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171551|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680632|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
154171580|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171581|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171582|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171584|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
154171585|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
154171586|NCT03118986|Olanzapine|olanzapine|mesh-list
154171587|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
154171588|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
154171589|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171590|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171591|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154171592|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154171593|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154171594|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154171595|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154171596|NCT03118986|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154171685|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171686|NCT02938923|Testosterone|testosterone|mesh-list
154171687|NCT02938923|Androgens|androgens|mesh-ancestor
154171688|NCT02938923|Hormones|hormones|mesh-ancestor
154171689|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171690|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171691|NCT02919683|Nivolumab|nivolumab|mesh-list
154171692|NCT02919683|Ipilimumab|ipilimumab|mesh-list
154171693|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171694|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171695|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171696|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171697|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
154171698|NCT02816021|Azacitidine|azacitidine|mesh-list
154171699|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171700|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171701|NCT02816021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171702|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171703|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154171734|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171735|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171736|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
154171737|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171738|NCT02592317|Pioglitazone|pioglitazone|mesh-list
154171739|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154171740|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154171741|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154171742|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
154171743|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171744|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154171745|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154171746|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171747|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154171787|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171810|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171811|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171812|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
154171813|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171814|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154171815|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154171816|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154171817|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171818|NCT02310321|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154171819|NCT02310321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171820|NCT02303678|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
154171821|NCT02303678|Immunoconjugates|immunoconjugates|mesh-ancestor
154171822|NCT02303678|Immunologic Factors|immunologic factors|mesh-ancestor
154171823|NCT02303678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171824|NCT02233829|Dopamine|dopamine|mesh-list
154171825|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154171826|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
154171827|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
154171828|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171829|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171830|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
154171831|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154171832|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171833|NCT02233829|Protective Agents|protective agents|mesh-ancestor
154171835|NCT02203526|Isavuconazole|isavuconazole|mesh-list
154171836|NCT02203526|Rituximab|rituximab|mesh-list
154171837|NCT02203526|Methotrexate|methotrexate|mesh-list
154171838|NCT02203526|Ibrutinib|ibrutinib|mesh-list
154171839|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171840|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171841|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
154171842|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680885|NCT00219895|Ibuprofen|ibuprofen|mesh-list
154171911|NCT02078648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171912|NCT02078648|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154171913|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
154171914|NCT02078648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154171915|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
154171916|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
154171917|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171918|NCT02078648|Laxatives|laxatives|mesh-ancestor
154171919|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154171920|NCT02052648|Bevacizumab|bevacizumab|mesh-list
154171921|NCT02052648|Temozolomide|temozolomide|mesh-list
154171923|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171924|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171925|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154171926|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154171927|NCT02052648|Growth Substances|growth substances|mesh-ancestor
154171928|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171929|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
154171930|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154171931|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
154171932|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171933|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154171934|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
154171935|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154172069|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172071|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154172112|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154172113|NCT01174121|Aldesleukin|aldesleukin|mesh-list
154172114|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
154172115|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
154172116|NCT01174121|Fludarabine|fludarabine|mesh-list
154172117|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172118|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
154172119|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632371|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153633352|NCT00006247|Growth Substances|growth substances|mesh-ancestor
153633727|NCT00006388|Tamoxifen|tamoxifen|mesh-list
153917074|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153634631|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
153635690|NCT00001048|Zalcitabine|zalcitabine|mesh-list
153636269|NCT03575208|Antibodies|antibodies|mesh-list
153636290|NCT00000378|Sertraline|sertraline|mesh-list
153636659|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
153636735|NCT04547530|Vitamin D|vitamin d|mesh-list
153636837|NCT00000651|Zidovudine|zidovudine|mesh-list
153637031|NCT00000720|Antibodies|antibodies|mesh-list
153637105|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
153637863|NCT00005858|Immunotoxins|immunotoxins|mesh-list
153638014|NCT00008866|Didanosine|didanosine|mesh-list
153729762|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638173|NCT00009802|Vitamins|vitamins|mesh-ancestor
153729763|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153729764|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153729765|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153729766|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
153639994|NCT05419921|Lidocaine|lidocaine|mesh-list
153729767|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
153640187|NCT03960151|Dexamethasone|dexamethasone|mesh-list
153640635|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153729768|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729769|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448329|NCT00003065|Paclitaxel|paclitaxel|mesh-list
153729770|NCT00131144|Octreotide|octreotide|mesh-list
153729771|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729772|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153729773|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729774|NCT00139893|Metoclopramide|metoclopramide|mesh-list
153729775|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
153729776|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
153729777|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729778|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729779|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729780|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153729781|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153729782|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
153729783|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730474|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
153649063|NCT00024232|Antibodies|antibodies|mesh-list
153649140|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
153649208|NCT00000368|Paroxetine|paroxetine|mesh-list
153730475|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153649661|NCT00027079|Naltrexone|naltrexone|mesh-list
153649845|NCT00027625|Gefitinib|gefitinib|mesh-list
153650354|NCT00028873|Paclitaxel|paclitaxel|mesh-list
153730476|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153651471|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153651849|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652074|NCT00000752|Beclomethasone|beclomethasone|mesh-list
153652241|NCT02971345|Iodine|iodine|mesh-list
153730477|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153730479|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
153654261|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655016|NCT00045799|Omeprazole|omeprazole|mesh-list
153655161|NCT00397657|Niacin|niacin|mesh-list
153655454|NCT00048139|Irinotecan|irinotecan|mesh-list
153655684|NCT05640713|Fludarabine|fludarabine|mesh-list
153656448|NCT00055159|Plasminogen|plasminogen|mesh-list
153656588|NCT00056056|Bexarotene|bexarotene|mesh-list
153729788|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729789|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729790|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
153659589|NCT00068029|Octreotide|octreotide|mesh-list
153659892|NCT00071227|Hormones|hormones|mesh-ancestor
153729820|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
153660128|NCT03959397|Paclitaxel|paclitaxel|mesh-list
153729821|NCT00131300|Protective Agents|protective agents|mesh-ancestor
153662146|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153662601|NCT00141427|Pregabalin|pregabalin|mesh-list
153662704|NCT00142324|Donepezil|donepezil|mesh-list
153663651|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663877|NCT00009971|Fenretinide|fenretinide|mesh-list
153664399|NCT00846690|Lidocaine|lidocaine|mesh-list
153664482|NCT00846339|Bupropion|bupropion|mesh-list
153360682|NCT01365611|Ketorolac|ketorolac|mesh-list
153664846|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
153665004|NCT00275457|Pramipexole|pramipexole|mesh-list
153672298|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
153672978|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
153673507|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673595|NCT00051285|Enoximone|enoximone|mesh-list
153673656|NCT00023855|Bortezomib|bortezomib|mesh-list
153673886|NCT00052377|Analgesics|analgesics|mesh-ancestor
153674033|NCT00052923|Carmustine|carmustine|mesh-list
153674573|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
153675641|NCT00058305|Vincristine|vincristine|mesh-list
153675773|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153676675|NCT00062127|Growth Substances|growth substances|mesh-ancestor
153676973|NCT00063453|Vitamins|vitamins|mesh-list
153729824|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153729825|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729826|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153729827|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
153677805|NCT00066768|Suramin|suramin|mesh-list
153677883|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
153679177|NCT00040625|Pemetrexed|pemetrexed|mesh-list
153679242|NCT00208546|Capecitabine|capecitabine|mesh-list
153679399|NCT00209209|Prednisone|prednisone|mesh-list
153679469|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679549|NCT00041210|Hormones|hormones|mesh-ancestor
153679631|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
153679849|NCT00211354|Anecortave|anecortave|mesh-list
153729828|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153729829|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
153680514|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
153680741|NCT00042146|Zolpidem|zolpidem|mesh-list
153923703|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153923704|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923705|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153923706|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153923707|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153923708|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153923709|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923710|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153923711|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153923712|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153923713|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
153923714|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681343|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923741|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
153923743|NCT00968253|Methotrexate|methotrexate|mesh-list
153923744|NCT00968253|Vincristine|vincristine|mesh-list
153923745|NCT00968253|Everolimus|everolimus|mesh-list
153923746|NCT00968253|Lenograstim|lenograstim|mesh-list
153923747|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153923748|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
153923749|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923750|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
153923751|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923752|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923753|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153923754|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
153923755|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923756|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923757|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153923758|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811184|NCT00324467|Ifosfamide|ifosfamide|mesh-list
153923759|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
153923760|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
153923761|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923762|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923763|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
153923764|NCT00968253|Hormones|hormones|mesh-ancestor
153923765|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157362|NCT05848713|Heparin|heparin|mesh-list
153923766|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923767|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153923785|NCT00968253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153923786|NCT00968253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923787|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153923788|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153923789|NCT00968253|Protective Agents|protective agents|mesh-ancestor
153923790|NCT00646009|Fluticasone|fluticasone|mesh-list
153923791|NCT00646009|Budesonide|budesonide|mesh-list
153923792|NCT00646009|Albuterol|albuterol|mesh-list
153923793|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
153923794|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153923795|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153923796|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923797|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153923798|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
153923799|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923800|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923801|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153923802|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
153923803|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
153923804|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153923805|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
153923806|NCT00646009|Hormones|hormones|mesh-ancestor
153923807|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923808|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153923809|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153923810|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153923811|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
153923812|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923813|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923814|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
153923815|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153923816|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
153923817|NCT00646087|Ketamine|ketamine|mesh-list
153923818|NCT00646087|Analgesics|analgesics|mesh-ancestor
153923819|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
153923820|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923821|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923822|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153923823|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153923824|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
153923825|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
153681451|NCT00124267|Analgesics|analgesics|mesh-ancestor
153923856|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153923857|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
153923858|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153923859|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153923860|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
153923861|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923862|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
153923863|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153923864|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153923865|NCT02666209|Dexamethasone|dexamethasone|mesh-list
153923866|NCT02666209|Lenalidomide|lenalidomide|mesh-list
153923867|NCT02666209|Bortezomib|bortezomib|mesh-list
153681509|NCT00124306|Analgesics|analgesics|mesh-ancestor
153923883|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
153923885|NCT00964743|Sorafenib|sorafenib|mesh-list
153923886|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923887|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
153923888|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923889|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923890|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
153923891|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736401|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153811186|NCT00324467|Carboplatin|carboplatin|mesh-list
153811187|NCT00324467|Doxorubicin|doxorubicin|mesh-list
153923892|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923893|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
153923894|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923895|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923896|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923897|NCT02862327|Dexamethasone|dexamethasone|mesh-list
153923898|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
153923899|NCT02862327|Ropivacaine|ropivacaine|mesh-list
153923900|NCT02862327|BB 1101|bb 1101|mesh-list
153923901|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923902|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
153923903|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
153923904|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923905|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923906|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923907|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
153923908|NCT02862327|Hormones|hormones|mesh-ancestor
153923909|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923910|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923911|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923912|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
153923913|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923914|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923915|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
153923916|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
153923917|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153923918|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
153923919|NCT04945720|Durvalumab|durvalumab|mesh-list
153923920|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153923921|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923922|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923923|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
153923924|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923925|NCT02666365|Cefazolin|cefazolin|mesh-list
153923926|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153681553|NCT00074022|Docetaxel|docetaxel|mesh-list
153923955|NCT04258306|Protective Agents|protective agents|mesh-ancestor
153923956|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923957|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923958|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153923960|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
153923961|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923962|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923963|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
153923964|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923965|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923966|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
153923967|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153923968|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153923969|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153923970|NCT00972777|Besifloxacin|besifloxacin|mesh-list
153923971|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153681606|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
153924003|NCT04257838|Tazobactam|tazobactam|mesh-list
153924004|NCT04257838|Piperacillin|piperacillin|mesh-list
153924005|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153924006|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153924007|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924008|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153924009|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157363|NCT05848713|Anticoagulants|anticoagulants|mesh-ancestor
153445647|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153917105|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
153924010|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924011|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
153924012|NCT01172639|Prednisone|prednisone|mesh-list
153924013|NCT01172639|Methotrexate|methotrexate|mesh-list
153924014|NCT01172639|Leflunomide|leflunomide|mesh-list
153924015|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924016|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
153924031|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153924032|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
153924033|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153924034|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153924035|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924036|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153924037|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153924039|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
153924040|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924041|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153924042|NCT01225562|Ticagrelor|ticagrelor|mesh-list
153924043|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153924044|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153924045|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153924046|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153924047|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
153924048|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924049|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924050|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924051|NCT00925288|Vaccines|vaccines|mesh-list
153924052|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
153924053|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924054|NCT01143714|Petrolatum|petrolatum|mesh-list
153924055|NCT01143714|Emollients|emollients|mesh-ancestor
153924056|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
153924058|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153924059|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924060|NCT04920682|Trace Elements|trace elements|mesh-ancestor
153924061|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
153924062|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924063|NCT04174339|Apatinib|apatinib|mesh-list
153924064|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924065|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153924066|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924067|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924068|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153924069|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
153924070|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924071|NCT00925132|Temozolomide|temozolomide|mesh-list
153924072|NCT00925132|Decitabine|decitabine|mesh-list
153924073|NCT00925132|Panobinostat|panobinostat|mesh-list
153924074|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153924075|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
153681694|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
153924109|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
153924110|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924111|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924113|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153924114|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924115|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924140|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924141|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924142|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924143|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
153924144|NCT00647023|Metformin|metformin|mesh-list
153924145|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153924146|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811188|NCT00324467|Etoposide|etoposide|mesh-list
153924147|NCT00924898|Tenofovir|tenofovir|mesh-list
153924148|NCT00924898|Emtricitabine|emtricitabine|mesh-list
153924149|NCT00924898|Efavirenz|efavirenz|mesh-list
153924150|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
153924151|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924152|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153924153|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153924154|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924155|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924156|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153924157|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153924158|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153924159|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153924160|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153924161|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153924162|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153924163|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153681801|NCT00126061|Tedisamil|tedisamil|mesh-list
153924192|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153924193|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153924194|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
153924195|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924196|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153924197|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153924199|NCT01170221|Tedizolid|tedizolid|mesh-list
153924200|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
153924201|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153924202|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924203|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153924204|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924205|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924206|NCT04254640|Cytarabine|cytarabine|mesh-list
153924207|NCT04254640|Cladribine|cladribine|mesh-list
153924233|NCT01129284|Hormones|hormones|mesh-ancestor
153924234|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924235|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924236|NCT00647257|Losartan|losartan|mesh-list
153924237|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153924238|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153924239|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153924240|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153924241|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924242|NCT01166178|Vitamin D|vitamin d|mesh-list
153924243|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
153924244|NCT01166178|Calcium|calcium|mesh-list
153924245|NCT01166178|Vitamins|vitamins|mesh-ancestor
153924246|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
153924247|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924248|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153924249|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153924250|NCT00924820|Bevacizumab|bevacizumab|mesh-list
153924251|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153924252|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924253|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153924254|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153924255|NCT00924820|Growth Substances|growth substances|mesh-ancestor
153924256|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924287|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153924289|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924290|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153924291|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153811189|NCT00324467|Vincristine|vincristine|mesh-list
153811190|NCT00324467|Ondansetron|ondansetron|mesh-list
153465869|NCT00250926|Hormones|hormones|mesh-ancestor
153924292|NCT04252456|Growth Substances|growth substances|mesh-ancestor
153924293|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
153924294|NCT04252456|Antidotes|antidotes|mesh-ancestor
153924295|NCT04252456|Protective Agents|protective agents|mesh-ancestor
153924296|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
153924297|NCT04252456|Vitamins|vitamins|mesh-ancestor
153924298|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
153924299|NCT04252456|Hematinics|hematinics|mesh-ancestor
153924300|NCT02665351|Peramivir|peramivir|mesh-list
153924301|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
153681940|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
153924321|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924322|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
153924323|NCT01221350|Vitamins|vitamins|mesh-ancestor
153924324|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
153924325|NCT00647647|Terbinafine|terbinafine|mesh-list
153924327|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924328|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924329|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924331|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153924332|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924333|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924334|NCT01220414|Naltrexone|naltrexone|mesh-list
153924335|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153924336|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153924337|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924338|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
153924339|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924340|NCT01128894|Liraglutide|liraglutide|mesh-list
153924341|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
153924342|NCT01128894|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153924343|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153924344|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924345|NCT01128894|Incretins|incretins|mesh-ancestor
153924346|NCT01128894|Hormones|hormones|mesh-ancestor
153924347|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924348|NCT01220180|Pregabalin|pregabalin|mesh-list
153924349|NCT01220180|Analgesics|analgesics|mesh-ancestor
153924350|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
153924351|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924352|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924353|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
153924354|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153924387|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153924388|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
153924390|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153924391|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153924392|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924393|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924426|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153924427|NCT02887976|Protective Agents|protective agents|mesh-ancestor
153924428|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153924429|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924430|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153924431|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924432|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924433|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
153924434|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153924459|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153924460|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153924461|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924462|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924463|NCT01217060|Dexamethasone|dexamethasone|mesh-list
153924464|NCT01217060|Docetaxel|docetaxel|mesh-list
153924465|NCT01217060|Fluorouracil|fluorouracil|mesh-list
153811191|NCT00324467|BB 1101|bb 1101|mesh-list
153924466|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924467|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
153924468|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
153924469|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924470|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924471|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153924472|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
153924473|NCT01217060|Hormones|hormones|mesh-ancestor
153924474|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924475|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153924476|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924477|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
153924478|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
153924479|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
153924480|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924481|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
153924482|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924483|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153924484|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
153924498|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924500|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
153924501|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924502|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924503|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153924504|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
153924505|NCT00966693|Hormones|hormones|mesh-ancestor
153924506|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924507|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153924508|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924509|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
153924510|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153924511|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153924512|NCT00966693|Growth Substances|growth substances|mesh-ancestor
153924513|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
153924514|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153924515|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
153924516|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153924517|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924518|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
153924519|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924520|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682081|NCT00127504|Rifampin|rifampin|mesh-list
153924521|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
153924522|NCT01215968|Dulaglutide|dulaglutide|mesh-list
153924523|NCT01215968|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153924524|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153924525|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924527|NCT02663713|Ticagrelor|ticagrelor|mesh-list
153924528|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153924529|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153924530|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153924531|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153924532|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
153924533|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924534|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924535|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924536|NCT02664649|Apixaban|apixaban|mesh-list
153924537|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
153924538|NCT02664649|Anticoagulants|anticoagulants|mesh-list
153924539|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
153924540|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153924541|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
153924542|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924543|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924544|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
153924545|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153811192|NCT00324467|Mesna|mesna|mesh-list
153445775|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
153924546|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153924548|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
153924575|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153924576|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
153924577|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
153924578|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924579|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153924580|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153924581|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924582|NCT01142466|Interferons|interferons|mesh-list
153924583|NCT01142466|Interferon-beta|interferon-beta|mesh-list
153924584|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
153924585|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924586|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
153924587|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924588|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
153924589|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924590|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153924591|NCT00648505|Metformin|metformin|mesh-list
153924592|NCT00648505|Glipizide|glipizide|mesh-list
153924593|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153924594|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924595|NCT01215734|Vaccines|vaccines|mesh-list
153924596|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
153924597|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924598|NCT04172311|Levetiracetam|levetiracetam|mesh-list
153924599|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
153924600|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
153924601|NCT02863185|Atorvastatin|atorvastatin|mesh-list
153924618|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153924619|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
153924621|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153924622|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153924623|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924624|NCT04174261|Clopidogrel|clopidogrel|mesh-list
153924625|NCT04174261|Ticagrelor|ticagrelor|mesh-list
153924626|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153924627|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153924628|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153924629|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153924630|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
153924631|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924632|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924633|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924634|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
153924635|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153924636|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924637|NCT00910741|Gemcitabine|gemcitabine|mesh-list
153924638|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924639|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
153924640|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924641|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924642|NCT00647959|Doxycycline|doxycycline|mesh-list
153924643|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153924644|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924645|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
153924646|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153924647|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153924648|NCT00648583|Ondansetron|ondansetron|mesh-list
153924649|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
153924650|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
153924651|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924652|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924653|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153682286|NCT00078390|S 3304|s 3304|mesh-list
153924681|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924682|NCT00649129|Urological Agents|urological agents|mesh-ancestor
153924683|NCT01127646|Methylphenidate|methylphenidate|mesh-list
153924684|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153924685|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153924686|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924687|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153924688|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153924689|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924690|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924692|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924693|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153924694|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
153924695|NCT02660047|Liraglutide|liraglutide|mesh-list
153924696|NCT02660047|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153924697|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153924698|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924699|NCT02660047|Incretins|incretins|mesh-ancestor
153924700|NCT02660047|Hormones|hormones|mesh-ancestor
153924729|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153924730|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153924731|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
153924732|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924733|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924734|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924736|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
153924737|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924738|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153924739|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153924740|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924741|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924742|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153924743|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153924766|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153924767|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153924768|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924769|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924770|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
153924771|NCT02659657|Interleukin-2|interleukin-2|mesh-list
153924772|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924773|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153924775|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
153924776|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924777|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924778|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153924779|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
153924780|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924781|NCT00648193|Paroxetine|paroxetine|mesh-list
153924782|NCT00648193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153924783|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153924784|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924785|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924786|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924787|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
153924788|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924789|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153924790|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
153924791|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154157364|NCT05848713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153924792|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153924793|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153702334|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153924794|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924817|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153924818|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
153924819|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
153924820|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924821|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924822|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153924823|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153924824|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153924825|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
153924826|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924827|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924829|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153924830|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153924831|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153924832|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924833|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924834|NCT00649207|Veliparib|veliparib|mesh-list
153924835|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153924836|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924837|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924838|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924839|NCT00920686|Sumatriptan|sumatriptan|mesh-list
153924840|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153924841|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153924842|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153924843|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
153924844|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924845|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682480|NCT04457557|Anesthetics|anesthetics|mesh-list
153924875|NCT04170751|Coagulants|coagulants|mesh-ancestor
153924876|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153924877|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
153924878|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
153924879|NCT02659033|Third Generation Cephalosporins|third generation cephalosporins|mesh-list
153924880|NCT02659033|Cephalosporins|cephalosporins|mesh-list
153924881|NCT02659033|Cefotaxime|cefotaxime|mesh-list
153924882|NCT02659033|Cefoxitin|cefoxitin|mesh-list
153924883|NCT02659033|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153924884|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153924885|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924886|NCT04170595|Trastuzumab|trastuzumab|mesh-list
153924887|NCT04170595|Capecitabine|capecitabine|mesh-list
153924888|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153924889|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924915|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
153924916|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924917|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924918|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153924919|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
153924920|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
153924921|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153924922|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153924923|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
153924924|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
153811194|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
153917160|NCT02683291|Tacrolimus|tacrolimus|mesh-list
153924925|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153924926|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153924928|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
153924930|NCT02662309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153924931|NCT02662309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924932|NCT02662309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153924933|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924935|NCT04032691|Analgesics|analgesics|mesh-ancestor
153924936|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
153924937|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924938|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682576|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153924962|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924963|NCT02655757|Incretins|incretins|mesh-ancestor
153924964|NCT02655757|Hormones|hormones|mesh-ancestor
153924965|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924966|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153924967|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
153682525|NCT00044954|Cyclosporine|cyclosporine|mesh-list
153924968|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924969|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924970|NCT01214720|Bevacizumab|bevacizumab|mesh-list
153924971|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153924972|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924973|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153924974|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153924975|NCT01214720|Growth Substances|growth substances|mesh-ancestor
153924976|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924977|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
153924978|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
153924979|NCT02655913|Vitamins|vitamins|mesh-ancestor
153924980|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
153924981|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924982|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
153924983|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924984|NCT02655913|Protective Agents|protective agents|mesh-ancestor
153924985|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
153924986|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153924987|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925011|NCT00649051|Diuretics|diuretics|mesh-ancestor
153925012|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
153925013|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925014|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153925015|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925016|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925017|NCT00649987|Albuterol|albuterol|mesh-list
153925018|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153925019|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
153925020|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925021|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925022|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153925023|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
153925024|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
153925025|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153925026|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153925027|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153925028|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153925029|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
153925030|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811195|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357711|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153811196|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357712|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
153465921|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
153925031|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925032|NCT01142232|Lenalidomide|lenalidomide|mesh-list
153925033|NCT01142232|Melphalan|melphalan|mesh-list
153925034|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
153925035|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925036|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153925037|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153925038|NCT01142232|Growth Substances|growth substances|mesh-ancestor
153925039|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
153925065|NCT01140906|Vortioxetine|vortioxetine|mesh-list
153925066|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153925067|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153925068|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925069|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925070|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925071|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925072|NCT01140906|Analgesics|analgesics|mesh-ancestor
153925073|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
153925074|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925075|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
153925076|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153925077|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
153925078|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153925079|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153925080|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925081|NCT01140906|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153925082|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
153925083|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153925084|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153925085|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153925086|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153925104|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925105|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
153925106|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153925107|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
153925108|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
153925109|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925110|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153925111|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
153925112|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925113|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153925114|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
153925115|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153925116|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153925117|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153925118|NCT04170439|Trace Elements|trace elements|mesh-ancestor
153925119|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
153925121|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
153925122|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
153925123|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925124|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925125|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153925126|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
153925127|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
153925128|NCT00649363|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153925129|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153925130|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
153925131|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925132|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925133|NCT02654743|Sulforaphane|sulforaphane|mesh-list
153925134|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153811197|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153925135|NCT02654743|Protective Agents|protective agents|mesh-ancestor
153925136|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925137|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925138|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
153925139|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153925140|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925141|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925142|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153925143|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153925144|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925145|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925169|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925171|NCT02654665|Hormones|hormones|mesh-ancestor
153925172|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925173|NCT02658721|Diclofenac|diclofenac|mesh-list
153925174|NCT02658721|Lidocaine|lidocaine|mesh-list
153925175|NCT02658721|Atropine|atropine|mesh-list
153925176|NCT02658721|Ephedrine|ephedrine|mesh-list
153925177|NCT02658721|Midazolam|midazolam|mesh-list
153925178|NCT02658721|Fentanyl|fentanyl|mesh-list
153925179|NCT02658721|Tramadol|tramadol|mesh-list
153925180|NCT02658721|Ondansetron|ondansetron|mesh-list
153925181|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
153925182|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
153925183|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925184|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925185|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
153925186|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925187|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153925188|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153925189|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153925190|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925191|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925192|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153925193|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153925194|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153925195|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153925209|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153925210|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925211|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
153925212|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
153925213|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153925214|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
153925215|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
153925216|NCT02658721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153925217|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153925218|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
153925219|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153925220|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153925221|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
153925222|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
153925223|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
153925224|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153925225|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153925226|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
153925227|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153925228|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
153925229|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153925230|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
153925231|NCT00629967|Interferons|interferons|mesh-list
153925233|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
153925234|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
153925235|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153925236|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925237|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
153925238|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925239|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
153925240|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925241|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
153925242|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925243|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
153925244|NCT01122264|Tadalafil|tadalafil|mesh-list
153925245|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925246|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
153925247|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153925248|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153925249|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925250|NCT01122264|Urological Agents|urological agents|mesh-ancestor
153925251|NCT00920218|Vaccines|vaccines|mesh-list
153925252|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
153925253|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925254|NCT00649519|Amlodipine|amlodipine|mesh-list
153925255|NCT00649519|Benazepril|benazepril|mesh-list
153925256|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153925257|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153925258|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925259|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925260|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153682891|NCT00403429|Capecitabine|capecitabine|mesh-list
153925291|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153925293|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
153925294|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925295|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925296|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153925297|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153925298|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
153925299|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154256509|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154256510|NCT01156688|Misoprostol|misoprostol|mesh-list
154256511|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154256512|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
154256513|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154256514|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925300|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925301|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925302|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153925303|NCT02654041|Methimazole|methimazole|mesh-list
153925304|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
153925305|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
153925306|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925325|NCT02658253|Antacids|antacids|mesh-ancestor
153925326|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925327|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153925328|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
153925329|NCT02651623|Sertraline|sertraline|mesh-list
153925330|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925331|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925332|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153925333|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153925334|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925335|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925336|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925337|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925338|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
153925339|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153925340|NCT02651623|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153925341|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153925342|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925343|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925345|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153925346|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153925347|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153925348|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925349|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925350|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925351|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925352|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
153925353|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153925354|NCT00650221|Pravastatin|pravastatin|mesh-list
153925355|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153925356|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153925357|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
153925358|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925359|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153925360|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153925361|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925397|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153925398|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153925399|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153925400|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925419|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153925420|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
153925421|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
153925422|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153925423|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153925424|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153925425|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153925426|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153925427|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925428|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925429|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
153917227|NCT02680717|Clobetasol|clobetasol|mesh-list
153925430|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153925440|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153925441|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
153925442|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
153925443|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925444|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925445|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925446|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153925448|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153925449|NCT00649597|Diuretics|diuretics|mesh-ancestor
153925450|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
153925451|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925452|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153925453|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925454|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925455|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153925456|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
153925457|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925458|NCT02653027|Ivacaftor|ivacaftor|mesh-list
153925459|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153925495|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
153925496|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
153925497|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683150|NCT00131482|Thrombin|thrombin|mesh-list
153925526|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925527|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
153925528|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925529|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153925530|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
153925531|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925532|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153925533|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153925534|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153925535|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925536|NCT00650299|Alprazolam|alprazolam|mesh-list
153925537|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153925538|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925539|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925540|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153925541|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153925542|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153925543|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
153925544|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
153925545|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683187|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
153782203|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782204|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
153731898|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153731899|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153731913|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731917|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545968|NCT06276361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545969|NCT06276361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545970|NCT06276361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545971|NCT06276361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153545972|NCT06276361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153811199|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545973|NCT06276361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545974|NCT06276361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545975|NCT06276361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153545976|NCT06276361|Dopamine Agents|dopamine agents|mesh-ancestor
153545978|NCT06275087|Sevoflurane|sevoflurane|mesh-list
153545979|NCT06275087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153545980|NCT06275087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545981|NCT06275087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545982|NCT06275087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153545983|NCT06275087|Anesthetics, General|anesthetics, general|mesh-ancestor
153545985|NCT06275087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153545986|NCT06275087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153545995|NCT06270719|Glucocorticoids|glucocorticoids|mesh-list
153545996|NCT06270719|Hormones|hormones|mesh-ancestor
153546030|NCT06263153|Immunoglobulin G|immunoglobulin g|mesh-list
153546031|NCT06263153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546032|NCT06263153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546038|NCT06262932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153546039|NCT06262932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546040|NCT06262932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546077|NCT06252857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546078|NCT06252857|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153546079|NCT06252857|Immunologic Factors|immunologic factors|mesh-ancestor
153546115|NCT06233071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546116|NCT06233071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153546117|NCT06233071|Contraceptive Agents|contraceptive agents|mesh-ancestor
153546118|NCT06233071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153546119|NCT06233071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153546120|NCT06233071|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153546121|NCT06233071|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153546122|NCT06233071|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153546123|NCT06233071|Hormone Antagonists|hormone antagonists|mesh-ancestor
153546124|NCT06233071|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153546154|NCT06207344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153546155|NCT06207344|Adrenergic Agents|adrenergic agents|mesh-ancestor
153546156|NCT06207344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546157|NCT06207344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546158|NCT06207344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153546159|NCT06207344|Anesthetics, General|anesthetics, general|mesh-ancestor
153546160|NCT06207344|Anesthetics|anesthetics|mesh-ancestor
153546161|NCT06207344|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153546162|NCT06207331|Dexmedetomidine|dexmedetomidine|mesh-list
153546163|NCT06207331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153546164|NCT06207331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546165|NCT06207331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546166|NCT06207331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153546167|NCT06207331|Analgesics|analgesics|mesh-ancestor
153546168|NCT06207331|Sensory System Agents|sensory system agents|mesh-ancestor
153445958|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
153546169|NCT06207331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546208|NCT06196814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153546235|NCT06172478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546237|NCT06172296|Cyclophosphamide|cyclophosphamide|mesh-list
153546238|NCT06172296|Temozolomide|temozolomide|mesh-list
153546239|NCT06172296|Melphalan|melphalan|mesh-list
153546240|NCT06172296|Mechlorethamine|mechlorethamine|mesh-list
153546241|NCT06172296|Thiotepa|thiotepa|mesh-list
153546242|NCT06172296|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153546243|NCT06172296|Cisplatin|cisplatin|mesh-list
153546244|NCT06172296|Carboplatin|carboplatin|mesh-list
153546245|NCT06172296|Doxorubicin|doxorubicin|mesh-list
153546246|NCT06172296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153546247|NCT06172296|Irinotecan|irinotecan|mesh-list
153546250|NCT06172296|Etoposide phosphate|etoposide phosphate|mesh-list
153546251|NCT06172296|Daunorubicin|daunorubicin|mesh-list
153546252|NCT06172296|Topotecan|topotecan|mesh-list
153546253|NCT06172296|Tretinoin|tretinoin|mesh-list
153546254|NCT06172296|Podophyllotoxin|podophyllotoxin|mesh-list
153546255|NCT06172296|Dinutuximab|dinutuximab|mesh-list
153546256|NCT06172296|Dexrazoxane|dexrazoxane|mesh-list
153546257|NCT06172296|Razoxane|razoxane|mesh-list
153546258|NCT06172296|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
153546259|NCT06172296|Isotretinoin|isotretinoin|mesh-list
153546260|NCT06172296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153546261|NCT06172296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546321|NCT06158620|Sensory System Agents|sensory system agents|mesh-ancestor
153546322|NCT06158620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546324|NCT06158620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153546325|NCT06158620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546326|NCT06158620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153546327|NCT06158620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546328|NCT06158620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546329|NCT06157892|Tucatinib|tucatinib|mesh-list
153546330|NCT06157892|Disitamab vedotin|disitamab vedotin|mesh-list
153546331|NCT06157892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546332|NCT06157892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546333|NCT06157892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546334|NCT06157892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546335|NCT06157892|Immunoconjugates|immunoconjugates|mesh-ancestor
153546336|NCT06157892|Immunologic Factors|immunologic factors|mesh-ancestor
153546337|NCT06157892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731920|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153546338|NCT06140836|Crizotinib|crizotinib|mesh-list
153546339|NCT06140836|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153546340|NCT06140836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546341|NCT06140836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546342|NCT06140836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546343|NCT06140836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546344|NCT06140134|Liver Extracts|liver extracts|mesh-list
153546345|NCT06140134|Hematinics|hematinics|mesh-ancestor
153702335|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815060|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
153357713|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546346|NCT06139536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153546347|NCT06139536|Antibodies|antibodies|mesh-list
153546348|NCT06139536|Immunoglobulins|immunoglobulins|mesh-list
153546349|NCT06139536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153546375|NCT06126315|Acetylcarnitine|acetylcarnitine|mesh-list
153546376|NCT06126315|Vitamin B Complex|vitamin b complex|mesh-ancestor
153546377|NCT06126315|Vitamins|vitamins|mesh-ancestor
153546378|NCT06126315|Micronutrients|micronutrients|mesh-ancestor
153546379|NCT06126315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546380|NCT06126315|Nootropic Agents|nootropic agents|mesh-ancestor
153546381|NCT06118255|Fenfluramine|fenfluramine|mesh-list
153546382|NCT06118255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153546383|NCT06118255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153546384|NCT06118255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546385|NCT06118255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546386|NCT06118255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546387|NCT06118255|Serotonin Agents|serotonin agents|mesh-ancestor
153546388|NCT06118255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546389|NCT06117423|Adalimumab|adalimumab|mesh-list
153546390|NCT06117423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153546391|NCT06117423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153546392|NCT06117423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546393|NCT06116526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153546394|NCT06116526|Immunologic Factors|immunologic factors|mesh-ancestor
153546395|NCT06116526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546398|NCT06108297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153546400|NCT06108297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546402|NCT06108297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153546403|NCT06108297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546404|NCT06108297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546406|NCT06108063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153546407|NCT06108063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153546408|NCT06108063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153546409|NCT06108063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153546507|NCT06071442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153546508|NCT06071442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153546509|NCT06071442|Analgesics|analgesics|mesh-ancestor
153546510|NCT06071442|Sensory System Agents|sensory system agents|mesh-ancestor
153546511|NCT06071442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546512|NCT06071442|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153546513|NCT06071442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546514|NCT06071442|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153546515|NCT06071442|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153546528|NCT06065735|Paroxetine|paroxetine|mesh-list
153546529|NCT06065735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153546530|NCT06065735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153546531|NCT06065735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546532|NCT06065735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546533|NCT06065735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546534|NCT06065735|Serotonin Agents|serotonin agents|mesh-ancestor
153546565|NCT06044025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153546566|NCT06044025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546567|NCT06042270|Betaine|betaine|mesh-list
153546568|NCT06042270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153546569|NCT06042270|Lipotropic Agents|lipotropic agents|mesh-ancestor
153917283|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
153782498|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782499|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
153546570|NCT06042270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153546571|NCT06042270|Antimetabolites|antimetabolites|mesh-ancestor
153546572|NCT06042270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546573|NCT06042270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153546574|NCT06040970|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153546605|NCT06015477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153546606|NCT06015477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153546607|NCT06015477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153546608|NCT06015477|Purinergic Agents|purinergic agents|mesh-ancestor
153546609|NCT06015477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546636|NCT06003231|Immunoconjugates|immunoconjugates|mesh-ancestor
153546637|NCT06003231|Immunologic Factors|immunologic factors|mesh-ancestor
153546638|NCT06003231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546639|NCT06003179|Cyclophosphamide|cyclophosphamide|mesh-list
153546641|NCT06003179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546642|NCT06003179|Immunologic Factors|immunologic factors|mesh-ancestor
153546643|NCT06003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546644|NCT06003179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546645|NCT06003179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153546646|NCT06003179|Alkylating Agents|alkylating agents|mesh-ancestor
153546647|NCT06003179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546648|NCT06003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547564|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153547565|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547566|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
153547567|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
153547568|NCT05405114|Decitabine|decitabine|mesh-list
153547569|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
153547570|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
153547571|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153547572|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
153547573|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547574|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547575|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547576|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
153547577|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153547616|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547617|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547618|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547620|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153547655|NCT05323955|Pertuzumab|pertuzumab|mesh-list
153547656|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153547657|NCT05323955|Maytansine|maytansine|mesh-list
153547658|NCT05323955|Tucatinib|tucatinib|mesh-list
153547659|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547660|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547661|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547662|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
153547663|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
153917286|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153357714|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
153547664|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547665|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547666|NCT05323955|Immunotoxins|immunotoxins|mesh-ancestor
153547667|NCT05323955|Immunoconjugates|immunoconjugates|mesh-ancestor
153547668|NCT05323955|Immunologic Factors|immunologic factors|mesh-ancestor
153547669|NCT05323955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547670|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547671|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547672|NCT05319730|Acetaminophen|acetaminophen|mesh-list
153547673|NCT05319730|Dexamethasone|dexamethasone|mesh-list
153547674|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
153547675|NCT05319730|Irinotecan|irinotecan|mesh-list
153547676|NCT05319730|Lenvatinib|lenvatinib|mesh-list
153547677|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
153547678|NCT05319730|Histamine Antagonists|histamine antagonists|mesh-list
153547679|NCT05319730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153547680|NCT05319730|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
153547681|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547725|NCT05306340|Everolimus|everolimus|mesh-list
153547726|NCT05306340|Exemestane|exemestane|mesh-list
153547727|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547746|NCT05306340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153547747|NCT05306340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153547748|NCT05306340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153547749|NCT05306340|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153547750|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153547751|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153547752|NCT05296798|Paclitaxel|paclitaxel|mesh-list
153547753|NCT05296798|Docetaxel|docetaxel|mesh-list
153547754|NCT05296798|Trastuzumab|trastuzumab|mesh-list
153782517|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547755|NCT05296798|Pertuzumab|pertuzumab|mesh-list
153547756|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547766|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547767|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547768|NCT05287906|Protective Agents|protective agents|mesh-ancestor
153547769|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547770|NCT05286814|Leucovorin|leucovorin|mesh-list
153547771|NCT05286814|Dexamethasone|dexamethasone|mesh-list
153547772|NCT05286814|Gemcitabine|gemcitabine|mesh-list
153547773|NCT05286814|Fluorouracil|fluorouracil|mesh-list
153547774|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
153547776|NCT05286814|Floxuridine|floxuridine|mesh-list
153547777|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547778|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
153547779|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
153547780|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547781|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547782|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153547783|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
153547784|NCT05286814|Hormones|hormones|mesh-ancestor
153547785|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547786|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547787|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547788|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153547789|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
153547790|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547791|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153547792|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
153547824|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547831|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547832|NCT05268003|Venetoclax|venetoclax|mesh-list
153547833|NCT05268003|Ponatinib|ponatinib|mesh-list
153547834|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782518|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
153547835|NCT05268003|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153547836|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547837|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547838|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547839|NCT05265546|Psilocybin|psilocybin|mesh-list
153547840|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
153547841|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547875|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
153547876|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
153547877|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547878|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153547879|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153547880|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
153547881|NCT05253651|Antidotes|antidotes|mesh-ancestor
153547906|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
153547907|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547908|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547909|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782519|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547910|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547911|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547912|NCT05224102|Faricimab|faricimab|mesh-list
153547913|NCT05224102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153547914|NCT05224102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153547915|NCT05224102|Growth Substances|growth substances|mesh-ancestor
153547916|NCT05224102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547917|NCT05224102|Growth Inhibitors|growth inhibitors|mesh-ancestor
153547918|NCT05224102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547919|NCT05222932|Avelumab|avelumab|mesh-list
153547920|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547921|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547922|NCT05201066|Azacitidine|azacitidine|mesh-list
153547923|NCT05201066|Decitabine|decitabine|mesh-list
153547924|NCT05201066|Venetoclax|venetoclax|mesh-list
153547925|NCT05201066|Spartalizumab|spartalizumab|mesh-list
153547926|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153547927|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
153547928|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547929|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547930|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547931|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547932|NCT05201066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547933|NCT05199311|Dexamethasone|dexamethasone|mesh-list
153547934|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547935|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
153547936|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
153547937|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547938|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547939|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154157365|NCT05848713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153811203|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
153357715|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153446071|NCT04331327|Mitogens|mitogens|mesh-list
153917325|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153547984|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153547985|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547986|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153547987|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548008|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153548009|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153548010|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548012|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153548013|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548014|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153548015|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548016|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
153548017|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548018|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
153548019|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548020|NCT05100862|Rituximab|rituximab|mesh-list
153548021|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
153548022|NCT05100862|Lenalidomide|lenalidomide|mesh-list
153548023|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
153548024|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548025|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548026|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
153548028|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153548029|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153548030|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153548031|NCT05100862|Growth Substances|growth substances|mesh-ancestor
153548032|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
153548033|NCT05100862|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153548034|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548035|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548036|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548053|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153548054|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548056|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782521|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
153548057|NCT05092360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548089|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548090|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548091|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153548092|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153548093|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153548104|NCT05041309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548105|NCT05041309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548106|NCT05037929|Astegolimab|astegolimab|mesh-list
153548107|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153548108|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548109|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
153548110|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548111|NCT05030311|Remibrutinib|remibrutinib|mesh-list
153548112|NCT05030311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548140|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
153548142|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
153548143|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466090|NCT00151320|Bortezomib|bortezomib|mesh-list
153548144|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548145|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548146|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548147|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548148|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548154|NCT05010122|Decitabine|decitabine|mesh-list
153548155|NCT05010122|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153548156|NCT05010122|Gilteritinib|gilteritinib|mesh-list
153548157|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548158|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548159|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
153548160|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548161|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548162|NCT05010122|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153548163|NCT05010122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548216|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548217|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548218|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153548219|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
153548220|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548249|NCT04907253|Quercetin|quercetin|mesh-list
153548250|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
153548251|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548252|NCT04907253|Protective Agents|protective agents|mesh-ancestor
153548253|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548254|NCT04907084|Fenofibrate|fenofibrate|mesh-list
153548255|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153548256|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
153548257|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548258|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153548259|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153548260|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153548261|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548262|NCT04892446|Dexamethasone|dexamethasone|mesh-list
153548263|NCT04892446|Bortezomib|bortezomib|mesh-list
153548264|NCT04892446|Daratumumab|daratumumab|mesh-list
153548265|NCT04892446|Pomalidomide|pomalidomide|mesh-list
153548266|NCT04892446|Magrolimab|magrolimab|mesh-list
153548267|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548268|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
153548269|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
153548270|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548271|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548272|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153548273|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
153548274|NCT04892446|Hormones|hormones|mesh-ancestor
153548275|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548276|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548277|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548278|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
153548304|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
153548305|NCT04875702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153548306|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548307|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548308|NCT04875702|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548309|NCT04875702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153731923|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153548310|NCT04875702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548311|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
153357716|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153548312|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153548331|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548332|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548333|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548334|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548335|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548336|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548337|NCT04854499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548353|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
153548354|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548355|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548360|NCT04821284|Calcium, Dietary|calcium, dietary|mesh-list
153548361|NCT04821284|Leucovorin|leucovorin|mesh-list
153548362|NCT04821284|Folic Acid|folic acid|mesh-list
153548363|NCT04821284|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153548402|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548403|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548404|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153548405|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153548406|NCT04809285|Insulin|insulin|mesh-list
153548407|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153548408|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548409|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153548410|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153548411|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153548412|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548413|NCT04802759|Trastuzumab|trastuzumab|mesh-list
153548414|NCT04802759|Atezolizumab|atezolizumab|mesh-list
153548415|NCT04802759|Pertuzumab|pertuzumab|mesh-list
153548416|NCT04802759|Everolimus|everolimus|mesh-list
153548417|NCT04802759|Palbociclib|palbociclib|mesh-list
153548418|NCT04802759|Ipatasertib|ipatasertib|mesh-list
153548452|NCT04793399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548453|NCT04793399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548454|NCT04772300|Sirolimus|sirolimus|mesh-list
153548455|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153548456|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548499|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
153548500|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153548501|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153548502|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153548503|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
153548504|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
153548505|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548506|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548507|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153548508|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153811206|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153548509|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
153548510|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548511|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548512|NCT04749628|Cannabidiol|cannabidiol|mesh-list
153811207|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
153548513|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
153548514|NCT04746235|Venetoclax|venetoclax|mesh-list
153548515|NCT04746235|Decitabine|decitabine|mesh-list
153548558|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548560|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153548561|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
153548562|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153548563|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
153548564|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153548565|NCT04717193|Epinephrine|epinephrine|mesh-list
153548566|NCT04717193|Racepinephrine|racepinephrine|mesh-list
153548567|NCT04717193|Bupivacaine|bupivacaine|mesh-list
153548568|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
153548569|NCT04717193|Anesthetics|anesthetics|mesh-list
153548570|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
153548571|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153548597|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153548598|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548599|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548600|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
153548601|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
153548602|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153548603|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
153548604|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
153548605|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548606|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731924|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153731925|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153548607|NCT04694781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548608|NCT04694781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548611|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
153548612|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548613|NCT04663997|Docetaxel|docetaxel|mesh-list
153548614|NCT04663997|Pluvicto|pluvicto|mesh-list
153548615|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548616|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548617|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548618|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548619|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548620|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153548621|NCT04663347|Cytarabine|cytarabine|mesh-list
153548622|NCT04663347|Dexamethasone|dexamethasone|mesh-list
153548623|NCT04663347|Prednisone|prednisone|mesh-list
153548624|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
153548625|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153548626|NCT04663347|Ifosfamide|ifosfamide|mesh-list
153548627|NCT04663347|Rituximab|rituximab|mesh-list
153548628|NCT04663347|Carboplatin|carboplatin|mesh-list
153548629|NCT04663347|Gemcitabine|gemcitabine|mesh-list
153548630|NCT04663347|Doxorubicin|doxorubicin|mesh-list
153548631|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153548668|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153548669|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153548670|NCT04663347|Growth Substances|growth substances|mesh-ancestor
153548671|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
153548672|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
153548673|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548674|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548675|NCT04659629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548676|NCT04659629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548677|NCT04655755|Venetoclax|venetoclax|mesh-list
153548678|NCT04655755|Decitabine|decitabine|mesh-list
153548698|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548700|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548701|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548702|NCT04630171|Anesthetics|anesthetics|mesh-list
153446172|NCT00002009|Sargramostim|sargramostim|mesh-list
153811208|NCT00324467|Hormones|hormones|mesh-ancestor
153548703|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153548704|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548705|NCT04626791|Cytarabine|cytarabine|mesh-list
153548706|NCT04626791|Prednisone|prednisone|mesh-list
153548707|NCT04626791|Cortisone|cortisone|mesh-list
153548708|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
153548709|NCT04626791|Rituximab|rituximab|mesh-list
153548710|NCT04626791|Doxorubicin|doxorubicin|mesh-list
153548711|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153548712|NCT04626791|Bortezomib|bortezomib|mesh-list
153548713|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
153548714|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153548715|NCT04626791|Antibodies|antibodies|mesh-list
153548716|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
153548717|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153548718|NCT04626791|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153548719|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548720|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
153548721|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548722|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153548723|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153548724|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
153548736|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548737|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548738|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
153548769|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153548770|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153548771|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153548772|NCT04602221|Lamotrigine|lamotrigine|mesh-list
153548774|NCT04602221|BI 409306|bi 409306|mesh-list
153548775|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
153548776|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153548777|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153548778|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548779|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153548780|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548781|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153548782|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153548783|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153548891|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153548892|NCT04544436|Protective Agents|protective agents|mesh-ancestor
153548893|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
153548894|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
153548895|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548896|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548898|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153548899|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548900|NCT04531462|Empagliflozin|empagliflozin|mesh-list
153548901|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153548902|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548943|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548945|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548946|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153916812|NCT01201265|Growth Substances|growth substances|mesh-ancestor
153446222|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917404|NCT00983385|Analgesics|analgesics|mesh-ancestor
153548947|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153548948|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548949|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153548950|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
153548951|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153548952|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548953|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
153548954|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
153548955|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153548956|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153548957|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
153548958|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548959|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548960|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548961|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548962|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548996|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153548997|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548998|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548999|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549000|NCT04504812|Analgesics|analgesics|mesh-ancestor
153549001|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
153549002|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549003|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
153549004|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153549005|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
153549006|NCT04461028|Dexamethasone|dexamethasone|mesh-list
153549007|NCT04461028|Bupivacaine|bupivacaine|mesh-list
153549008|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549009|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
153549010|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
153549011|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549012|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549013|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549014|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
153549015|NCT04461028|Hormones|hormones|mesh-ancestor
153549017|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549018|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549019|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
153549020|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
153549021|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153549022|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
153549065|NCT04430699|Cisplatin|cisplatin|mesh-list
153549066|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
153549067|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549068|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549069|NCT04430699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153917432|NCT04290819|Caffeine|caffeine|mesh-list
153549070|NCT04430699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549071|NCT04423211|Leuprolide|leuprolide|mesh-list
153549072|NCT04423211|Goserelin|goserelin|mesh-list
153549073|NCT04423211|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153549074|NCT04423211|Tryptophan|tryptophan|mesh-list
153549075|NCT04423211|Relugolix|relugolix|mesh-list
153549076|NCT04423211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549077|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549078|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153549079|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
153549080|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153549081|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549082|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549083|NCT04423211|Luteolytic Agents|luteolytic agents|mesh-ancestor
153549084|NCT04423211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153549085|NCT04423211|Contraceptive Agents|contraceptive agents|mesh-ancestor
153549086|NCT04423211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153549087|NCT04423211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153549088|NCT04423211|Antidepressive Agents|antidepressive agents|mesh-ancestor
153549089|NCT04423211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153549090|NCT04423211|Androgen Antagonists|androgen antagonists|mesh-ancestor
153549091|NCT04423211|Hormone Antagonists|hormone antagonists|mesh-ancestor
153549092|NCT04408638|Gemcitabine|gemcitabine|mesh-list
153549128|NCT04368559|Posaconazole|posaconazole|mesh-list
153549129|NCT04368559|Rezafungin|rezafungin|mesh-list
153549130|NCT04368559|Trimethoprim|trimethoprim|mesh-list
153549131|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
153549132|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153549133|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
153549134|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549135|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153549136|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153549137|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549138|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549139|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153549140|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
153549141|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549142|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549176|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
153549177|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549186|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549187|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549190|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
153549191|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153549192|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153549193|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153549194|NCT04293562|Methotrexate|methotrexate|mesh-list
153549195|NCT04293562|Etoposide|etoposide|mesh-list
153549234|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
153549235|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549274|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153549275|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
153549277|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549278|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
153549279|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
153549280|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357720|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549281|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549282|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153549283|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153549284|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153549330|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
153549331|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153549332|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549333|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
153549335|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153549336|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
153549337|NCT04187703|Azacitidine|azacitidine|mesh-list
153782532|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
153549338|NCT04187703|Decitabine|decitabine|mesh-list
153549339|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549340|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
153549341|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549342|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549343|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549344|NCT04182204|Rituximab|rituximab|mesh-list
153549345|NCT04182204|Gemcitabine|gemcitabine|mesh-list
153549387|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
153549388|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549389|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549391|NCT04161248|Rituximab|rituximab|mesh-list
153549392|NCT04161248|Gemcitabine|gemcitabine|mesh-list
153549393|NCT04161248|Venetoclax|venetoclax|mesh-list
153549394|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549395|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549420|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
153549421|NCT04137978|Diuretics|diuretics|mesh-ancestor
153549422|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
153549423|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549424|NCT04137978|Expectorants|expectorants|mesh-ancestor
153549425|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
153549426|NCT04127578|Sirolimus|sirolimus|mesh-list
153549427|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
153549428|NCT04127578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153549429|NCT04127578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153549430|NCT04127578|Prednisolone|prednisolone|mesh-list
153549431|NCT04127578|Prednisolone acetate|prednisolone acetate|mesh-list
153549432|NCT04127578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153549433|NCT04127578|Prednisolone phosphate|prednisolone phosphate|mesh-list
153549434|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153549435|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549436|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153549437|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549438|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
153549439|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549440|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
153549441|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549450|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153549451|NCT04127578|Protective Agents|protective agents|mesh-ancestor
153549452|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549453|NCT04102436|Aldesleukin|aldesleukin|mesh-list
153549454|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
153549455|NCT04102436|Fludarabine|fludarabine|mesh-list
153549471|NCT04094961|Pomalidomide|pomalidomide|mesh-list
153549473|NCT04094961|BB 1101|bb 1101|mesh-list
153549474|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549475|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
153549476|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
153549477|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549478|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549479|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549480|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
153782533|NCT00556387|Ketamine|ketamine|mesh-list
153782534|NCT00556387|Analgesics|analgesics|mesh-ancestor
153782535|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
153782536|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782537|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782538|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153782539|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153782540|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
153782541|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
153549481|NCT04094961|Hormones|hormones|mesh-ancestor
153731928|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
153549482|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782542|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153549484|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549485|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
153549486|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549487|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549488|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
153549489|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153549490|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153549491|NCT04094961|Growth Substances|growth substances|mesh-ancestor
153811209|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357721|NCT00243932|Vitamins|vitamins|mesh-ancestor
153357722|NCT00243386|Factor VIII|factor viii|mesh-list
153357723|NCT00243386|Coagulants|coagulants|mesh-ancestor
153357724|NCT03807362|CC-11050|cc-11050|mesh-list
153357725|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153357726|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153357727|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357728|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357729|NCT01275560|Metronidazole|metronidazole|mesh-list
153357730|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811210|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153811211|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
153811212|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811213|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811214|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153811215|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153357731|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153549492|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
153549493|NCT04091386|Factor VIII|factor viii|mesh-list
153549494|NCT04091386|Coagulants|coagulants|mesh-ancestor
153549743|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
153549744|NCT03914625|BB 1101|bb 1101|mesh-list
153549797|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549798|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
153549799|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549800|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549801|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549802|NCT03902782|Dexamethasone|dexamethasone|mesh-list
153549803|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
153549804|NCT03902782|Epinephrine|epinephrine|mesh-list
153549805|NCT03902782|Bupivacaine|bupivacaine|mesh-list
153549844|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153549845|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
153549846|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153549847|NCT03856216|Antibodies|antibodies|mesh-list
153549848|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
153549849|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153549850|NCT03856216|Lenograstim|lenograstim|mesh-list
153549851|NCT03856216|Tacrolimus|tacrolimus|mesh-list
153549852|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
153549853|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549854|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549855|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549856|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549857|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549858|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153549906|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
153549907|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549908|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153372295|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
153549912|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153549913|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153549914|NCT03739814|Blinatumomab|blinatumomab|mesh-list
153549915|NCT03739814|Antibodies|antibodies|mesh-list
153549916|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
153549917|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153549918|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
153549919|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153549920|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
153549921|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549922|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549923|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549924|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153549925|NCT03739814|Immunotoxins|immunotoxins|mesh-ancestor
153549926|NCT03739814|Immunoconjugates|immunoconjugates|mesh-ancestor
153549927|NCT03728361|Nivolumab|nivolumab|mesh-list
153549928|NCT03728361|Temozolomide|temozolomide|mesh-list
153549929|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549930|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549931|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549942|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
153549969|NCT03678883|Carboplatin|carboplatin|mesh-list
153549970|NCT03678883|Gemcitabine|gemcitabine|mesh-list
153549971|NCT03678883|Doxorubicin|doxorubicin|mesh-list
153549972|NCT03678883|Irinotecan|irinotecan|mesh-list
153549973|NCT03678883|Lomustine|lomustine|mesh-list
153549974|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153549975|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549976|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549977|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
153549978|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549979|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549980|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549981|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
153549982|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154256524|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153549983|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153549984|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153549985|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549986|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153549987|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549988|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
153549990|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153549991|NCT03677830|Analgesics|analgesics|mesh-ancestor
153549992|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
153549993|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550026|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550027|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153550028|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153550029|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
153550030|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550031|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550032|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153550033|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550034|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153550035|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
153550036|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153550037|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153550039|NCT03604991|Carboplatin|carboplatin|mesh-list
153550040|NCT03604991|Nivolumab|nivolumab|mesh-list
153550041|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153550042|NCT03604991|Ipilimumab|ipilimumab|mesh-list
153550043|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153550044|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550045|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550046|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550047|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550048|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550049|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550050|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550051|NCT03600155|Nivolumab|nivolumab|mesh-list
153550052|NCT03600155|Ipilimumab|ipilimumab|mesh-list
153550053|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550054|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550055|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550056|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550069|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550070|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550071|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
153550072|NCT03565445|Nivolumab|nivolumab|mesh-list
153550073|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550074|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550094|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153550095|NCT03535363|Osimertinib|osimertinib|mesh-list
153550096|NCT03535363|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153550097|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550098|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550099|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550100|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811219|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
153811220|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550101|NCT03533946|Rucaparib|rucaparib|mesh-list
153550102|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153550103|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550104|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550105|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550106|NCT03530397|Paclitaxel|paclitaxel|mesh-list
153550107|NCT03530397|Carboplatin|carboplatin|mesh-list
153550108|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
153550109|NCT03530397|Pemetrexed|pemetrexed|mesh-list
153550110|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153550111|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550112|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550113|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550114|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550115|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550116|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550118|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550119|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153550120|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153550121|NCT03528369|Capsaicin|capsaicin|mesh-list
153550122|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
153550123|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
153550166|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
153550167|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550168|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550169|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550170|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153550194|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550205|NCT03452137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550206|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550208|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153550209|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153550210|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153550211|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550212|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153550213|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
153550214|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
153550215|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550216|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550217|NCT03432065|Buspirone|buspirone|mesh-list
153550218|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153550219|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153550220|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153550221|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550222|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153550223|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153550224|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
153550225|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550226|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550227|NCT03424005|Bevacizumab|bevacizumab|mesh-list
153550228|NCT03424005|Carboplatin|carboplatin|mesh-list
153550229|NCT03424005|Gemcitabine|gemcitabine|mesh-list
153550230|NCT03424005|Capecitabine|capecitabine|mesh-list
153550231|NCT03424005|Trastuzumab|trastuzumab|mesh-list
153550232|NCT03424005|Atezolizumab|atezolizumab|mesh-list
153446330|NCT00000731|Acetaminophen|acetaminophen|mesh-list
153357732|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153357733|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153550233|NCT03424005|Fulvestrant|fulvestrant|mesh-list
153811221|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153550234|NCT03424005|Ipatasertib|ipatasertib|mesh-list
153550235|NCT03424005|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153550283|NCT03376477|Molgramostim|molgramostim|mesh-list
153550315|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550316|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153550317|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550318|NCT03337698|Growth Substances|growth substances|mesh-ancestor
153550319|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550320|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
153550321|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153550346|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550347|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550348|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550349|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550350|NCT03311828|Daratumumab|daratumumab|mesh-list
153550351|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550432|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550433|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550442|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153550444|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153550477|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
153550478|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
153550479|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550480|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550481|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
153550482|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550483|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550484|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
153550485|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153550486|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153550542|NCT02879318|Durvalumab|durvalumab|mesh-list
153550543|NCT02879318|Tremelimumab|tremelimumab|mesh-list
153550680|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550682|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153550683|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550684|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550685|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550686|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153550687|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550688|NCT02636322|Growth Substances|growth substances|mesh-ancestor
153550689|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
153550690|NCT02636322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153782556|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550776|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153550777|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550778|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550780|NCT02451111|Ibrutinib|ibrutinib|mesh-list
153550781|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550782|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550783|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
153550784|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550785|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153550786|NCT02451111|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153550787|NCT02451111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550788|NCT02451111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550843|NCT02359565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550844|NCT02299141|Nintedanib|nintedanib|mesh-list
153550845|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811222|NCT00324467|Analgesics|analgesics|mesh-ancestor
153550846|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550847|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372507|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
153550848|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550850|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153550851|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153550852|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153550853|NCT02230930|Apomorphine|apomorphine|mesh-list
153550854|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153550907|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550937|NCT01904162|Finafloxacin|finafloxacin|mesh-list
153550938|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153550939|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550940|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153550941|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153550942|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153550943|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550944|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550945|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550946|NCT01892722|Interferons|interferons|mesh-list
153550947|NCT01892722|Interferon-beta|interferon-beta|mesh-list
153550948|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
153550949|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153550950|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550976|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550977|NCT01861314|Bortezomib|bortezomib|mesh-list
153550978|NCT01861314|Sorafenib|sorafenib|mesh-list
153550979|NCT01861314|Decitabine|decitabine|mesh-list
153550980|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550981|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550982|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550983|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782558|NCT00234299|Aspirin|aspirin|mesh-list
153551044|NCT01375829|MTOR Inhibitors|mtor inhibitors|mesh-list
153551046|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153551047|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551048|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153551049|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551105|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153551106|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551108|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551109|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551192|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551193|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
153551194|NCT01570504|Ivermectin|ivermectin|mesh-list
153551195|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153551196|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551197|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153551198|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551199|NCT01570569|Losartan|losartan|mesh-list
153551200|NCT01570569|Midazolam|midazolam|mesh-list
153811224|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
153357735|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153917527|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
153551201|NCT01570569|Levomethorphan|levomethorphan|mesh-list
153551202|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
153551203|NCT01570569|Caffeine|caffeine|mesh-list
153551204|NCT01570569|Omeprazole|omeprazole|mesh-list
153551205|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153551301|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153782572|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782573|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
153782574|NCT04556032|Ergothioneine|ergothioneine|mesh-list
153782575|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
153782576|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551433|NCT01571687|Antioxidants|antioxidants|mesh-list
153551434|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551435|NCT01571687|Protective Agents|protective agents|mesh-ancestor
153551436|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551438|NCT01571791|Lidocaine|lidocaine|mesh-list
153551524|NCT01572116|Sufentanil|sufentanil|mesh-list
153551525|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
153551526|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
153551527|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
153551528|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551529|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551530|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
153551531|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551532|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153551559|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153551560|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
153551561|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551562|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551563|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551564|NCT01572181|Fludarabine|fludarabine|mesh-list
153551565|NCT01572181|Busulfan|busulfan|mesh-list
153551622|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
153551623|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153551624|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
153551625|NCT01572350|Hormones|hormones|mesh-ancestor
153551626|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551627|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551628|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
153551629|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551644|NCT01572454|Analgesics|analgesics|mesh-ancestor
153551645|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
153551646|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551647|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153551648|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153551649|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153551663|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153551664|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153551665|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551666|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551667|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551668|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153551669|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153811225|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
153811226|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
153811227|NCT00324467|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153551670|NCT01572597|Metronidazole|metronidazole|mesh-list
153551671|NCT01572597|Clarithromycin|clarithromycin|mesh-list
153551672|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
153551673|NCT01572597|Rabeprazole|rabeprazole|mesh-list
153551674|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551675|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153551676|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153551677|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153551678|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153551679|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551680|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153551681|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551682|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551683|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153551684|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153551704|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153551705|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153551706|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
153551707|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551708|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551710|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153551711|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
153551712|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551713|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551714|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153551715|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551716|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
153551717|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551719|NCT01572753|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153551720|NCT01572753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551721|NCT01572753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551722|NCT01572805|Melatonin|melatonin|mesh-list
153551723|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
153551724|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551725|NCT01572805|Protective Agents|protective agents|mesh-ancestor
153551726|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551728|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
153551729|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
153551730|NCT01572831|Protective Agents|protective agents|mesh-ancestor
153551731|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551732|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
153551733|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153551785|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551786|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153551787|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153551788|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153551789|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
153551790|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153551791|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153551822|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153551823|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153551826|NCT01573663|Expectorants|expectorants|mesh-ancestor
153551827|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
153551828|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
153551829|NCT01573715|Cisatracurium|cisatracurium|mesh-list
153551830|NCT01573715|Atracurium|atracurium|mesh-list
153551854|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551856|NCT01573806|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153551857|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551916|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
153551917|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
153551918|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
153551919|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551920|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551921|NCT01574508|Insulin|insulin|mesh-list
153551922|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153551923|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551924|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551925|NCT01574638|Rifapentine|rifapentine|mesh-list
153551926|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153551927|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
153551928|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153551929|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551930|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
153551979|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551980|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153551981|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153551982|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551983|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552008|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153552009|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153552010|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
153552011|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
153782582|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552012|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552013|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552014|NCT01575639|Prednisolone|prednisolone|mesh-list
153552015|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552016|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
153552018|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552071|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
153552072|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153552073|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153552074|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552075|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552076|NCT01576094|Protective Agents|protective agents|mesh-ancestor
153552077|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552078|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153552079|NCT01576185|Sorafenib|sorafenib|mesh-list
153552080|NCT01576185|Quizartinib|quizartinib|mesh-list
153552081|NCT01576185|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153552082|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552083|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153552084|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552114|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
153552115|NCT01576627|Trace Elements|trace elements|mesh-ancestor
153552116|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
153552190|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552191|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153552193|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552194|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153811228|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153552195|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
153552196|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552230|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
153552231|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153552259|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552261|NCT01577524|Povidone|povidone|mesh-list
153552262|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
153552263|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
153552264|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153552265|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552318|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153552319|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153552320|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552321|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
153552322|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153552407|NCT01578265|Ondansetron|ondansetron|mesh-list
153552408|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
153552409|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
153552410|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552411|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552412|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552413|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
153552414|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
153552415|NCT01578265|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153552416|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153552417|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
153552418|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552419|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552420|NCT01578304|Fesoterodine|fesoterodine|mesh-list
153552507|NCT01578564|SOR-C13|sor-c13|mesh-list
153552508|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552509|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153552510|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153552511|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552512|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552513|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552514|NCT01578603|Calcium|calcium|mesh-list
153552515|NCT01578603|Caseins|caseins|mesh-list
153552516|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552517|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552518|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
153552519|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
153552535|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153552536|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153552574|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
153552575|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811231|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153811232|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153357739|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
153668012|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153552644|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153552646|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552647|NCT01579227|Protective Agents|protective agents|mesh-ancestor
153552648|NCT01579227|Vitamins|vitamins|mesh-ancestor
153552649|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
153552650|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153552651|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153552652|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153552653|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153552654|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552655|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552656|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552657|NCT01579279|Analgesics|analgesics|mesh-ancestor
153552700|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153552702|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552703|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
153552704|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
153552705|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552706|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552707|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552738|NCT01579786|Acetaminophen|acetaminophen|mesh-list
153552739|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552740|NCT01579786|Analgesics|analgesics|mesh-ancestor
153552741|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
153552742|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552743|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552744|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
153552745|NCT01579838|Eculizumab|eculizumab|mesh-list
153552746|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153552747|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153552781|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153552782|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552834|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552835|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153552836|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153552837|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
153552838|NCT01583062|Amoxicillin|amoxicillin|mesh-list
153552839|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
153552840|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
153552841|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153552842|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552886|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
153552887|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552888|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
153552889|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552890|NCT01587339|Pregabalin|pregabalin|mesh-list
153552891|NCT01587339|Zonisamide|zonisamide|mesh-list
153552892|NCT01587339|Lacosamide|lacosamide|mesh-list
153552893|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153552894|NCT01587339|Ezogabine|ezogabine|mesh-list
153552895|NCT01587339|Analgesics|analgesics|mesh-ancestor
153552896|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
153782590|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782591|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153782592|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
153782593|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153782594|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153782595|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153552908|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153552909|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153552910|NCT01587378|Metformin|metformin|mesh-list
153360683|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153360684|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552911|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153552912|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552913|NCT01587482|Paclitaxel|paclitaxel|mesh-list
153552914|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153552943|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552950|NCT01589367|Letrozole|letrozole|mesh-list
153552951|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153552952|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552953|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552954|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153552955|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153552956|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552957|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782603|NCT02211118|Analgesics|analgesics|mesh-ancestor
153552958|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153552959|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
153552960|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552962|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
153552963|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
153552964|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552965|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552966|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
153552967|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552968|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153553004|NCT01590199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153553005|NCT01590199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153553056|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153553057|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553059|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553060|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553105|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153782605|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153731933|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
153731934|NCT00161733|Coagulants|coagulants|mesh-ancestor
153553107|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153553108|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153553109|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
153553110|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553111|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153553112|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
153553113|NCT01590901|Protective Agents|protective agents|mesh-ancestor
153553114|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553115|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
153553116|NCT01590966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153553165|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
153553166|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
153553167|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
153553168|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553169|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
153553170|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153553171|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553172|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
153553173|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553174|NCT01591148|Propofol|propofol|mesh-list
153553228|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
153553229|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153553230|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
153446442|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
153811234|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
153553231|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153553232|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153553233|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153553234|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153553235|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153553236|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153553337|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153553338|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
153553339|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
153553340|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153553341|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153553342|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153553343|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153553344|NCT01592214|Benzocaine|benzocaine|mesh-list
153553345|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
153553346|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
153553347|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553348|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553349|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
153553480|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153553481|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
153553482|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553483|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553485|NCT01593163|Ibuprofen|ibuprofen|mesh-list
153553575|NCT01593514|Lactitol|lactitol|mesh-list
153553576|NCT01593514|Vaccines|vaccines|mesh-list
153553577|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
153553578|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553595|NCT01593644|Adenosine|adenosine|mesh-list
153553596|NCT01593644|Dipyridamole|dipyridamole|mesh-list
153553597|NCT01593644|Analgesics|analgesics|mesh-ancestor
153553598|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
153553599|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553600|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553601|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153553631|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153553632|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153553633|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153553634|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
153553635|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553657|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
153553658|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
153553659|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153731938|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553660|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553661|NCT01594099|Paclitaxel|paclitaxel|mesh-list
153553717|NCT01594268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153553718|NCT01594268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553719|NCT01594268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553720|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553721|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
153553722|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553723|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553724|NCT01594346|Vitamin E|vitamin e|mesh-list
153553725|NCT01594346|Tocopherols|tocopherols|mesh-list
153553726|NCT01594346|Tocotrienols|tocotrienols|mesh-list
153553727|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
153553728|NCT01594346|Vitamins|vitamins|mesh-ancestor
153553729|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
153553730|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553731|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
153553732|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357740|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553733|NCT01594346|Protective Agents|protective agents|mesh-ancestor
153540025|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540026|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153540027|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540028|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540029|NCT01536873|Dolutegravir|dolutegravir|mesh-list
153540030|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153540031|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153540032|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540079|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540080|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
153540081|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540082|NCT01537250|Levofloxacin|levofloxacin|mesh-list
153540083|NCT01537250|Ofloxacin|ofloxacin|mesh-list
153540084|NCT01537250|Nemonoxacin|nemonoxacin|mesh-list
153540085|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153540086|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540087|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540088|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153540089|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153540090|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540091|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540092|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540093|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153540094|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153540095|NCT01537354|Poractant alfa|poractant alfa|mesh-list
153540096|NCT01537354|Beractant|beractant|mesh-list
153540097|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153540206|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540241|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540242|NCT01538394|Nicotine|nicotine|mesh-list
153540243|NCT01538394|Varenicline|varenicline|mesh-list
153540244|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153540245|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
153540246|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540247|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540248|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153540249|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153540331|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153540332|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153540333|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
153540334|NCT01538693|Dexetimide|dexetimide|mesh-list
153540335|NCT01538693|Citalopram|citalopram|mesh-list
153540336|NCT01538693|Escitalopram|escitalopram|mesh-list
153540337|NCT01538693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153540338|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153540339|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540340|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540341|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540342|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
153540343|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540344|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153540345|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153540374|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
153540375|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540376|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540377|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540378|NCT01538849|Esomeprazole|esomeprazole|mesh-list
153540379|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153540380|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540381|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153540382|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540383|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540384|NCT01538875|Labetalol|labetalol|mesh-list
153540385|NCT01538875|Hydralazine|hydralazine|mesh-list
153540386|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153540387|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153540388|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
153540389|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540390|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540424|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153540425|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
153540493|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540494|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540495|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153540496|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
153540497|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153540498|NCT01539408|Misoprostol|misoprostol|mesh-list
153540499|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153540500|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
153540501|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153540502|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540503|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153540504|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540505|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
153540506|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
153483768|NCT01541358|Listerine|listerine|mesh-list
153540508|NCT01539473|Tyramine|tyramine|mesh-list
153540509|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540539|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153540554|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540555|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153540556|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540557|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540558|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153540559|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
153540560|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
153540561|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540562|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540564|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540565|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153540566|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540586|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540587|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153811238|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
153357741|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466416|NCT00360360|Growth Substances|growth substances|mesh-ancestor
153540588|NCT01539733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153540589|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153540590|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540591|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540592|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540593|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
153540594|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153540595|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
153540596|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153540597|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153540598|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
153540610|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153540611|NCT01540032|Analgesics|analgesics|mesh-ancestor
153540612|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
153540613|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540614|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540615|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153540616|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153540617|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153540618|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540619|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540620|NCT01540084|Propofol|propofol|mesh-list
153540621|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153540622|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540623|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540624|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153540625|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
153540626|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
153540627|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
153540675|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153540697|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
153540698|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
153540699|NCT01540708|Hormones|hormones|mesh-ancestor
153540700|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540701|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
153540702|NCT01540721|Acetaminophen|acetaminophen|mesh-list
153540703|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153540704|NCT01540721|Analgesics|analgesics|mesh-ancestor
153540705|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
153540706|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540707|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540708|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
153540709|NCT01540734|Acetaminophen|acetaminophen|mesh-list
153540710|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153540711|NCT01540734|Analgesics|analgesics|mesh-ancestor
153540712|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
153540713|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540714|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540715|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
153540716|NCT01540747|Folic Acid|folic acid|mesh-list
153540717|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
153540718|NCT01540747|Inositol|inositol|mesh-list
153540719|NCT01540747|Melatonin|melatonin|mesh-list
153540720|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
153540721|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540722|NCT01540747|Protective Agents|protective agents|mesh-ancestor
153540731|NCT01540812|Prednisone|prednisone|mesh-list
153540732|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
153540733|NCT01540812|Fludarabine|fludarabine|mesh-list
153540734|NCT01540812|Vincristine|vincristine|mesh-list
153540735|NCT01540812|Daunorubicin|daunorubicin|mesh-list
153540736|NCT01540812|Idarubicin|idarubicin|mesh-list
153540737|NCT01540812|Methotrexate|methotrexate|mesh-list
153540738|NCT01540812|Pegaspargase|pegaspargase|mesh-list
153540739|NCT01540812|Asparaginase|asparaginase|mesh-list
153811239|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153540770|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153540772|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153540773|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153540774|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153540775|NCT01540877|Anesthetics|anesthetics|mesh-list
153540776|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153540824|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540826|NCT01541267|Aliskiren|aliskiren|mesh-list
153540827|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153540828|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153540829|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153540830|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540831|NCT01541267|Renin Inhibitors|renin inhibitors|mesh-ancestor
153540832|NCT01541267|Protease Inhibitors|protease inhibitors|mesh-ancestor
153540833|NCT01541267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540834|NCT01541280|Azacitidine|azacitidine|mesh-list
153540835|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153540836|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
153540837|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540838|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540839|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540840|NCT01541293|Lidocaine|lidocaine|mesh-list
153540841|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
153540842|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
153540843|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540864|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540865|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153540890|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540891|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540893|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540894|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153540895|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153540896|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
153540897|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
153540907|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153540908|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153540909|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540910|NCT01541605|Methylphenidate|methylphenidate|mesh-list
153540911|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153540912|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540913|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153540914|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153540915|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540916|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540917|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
153540918|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540919|NCT01541631|Albendazole|albendazole|mesh-list
153540920|NCT01541631|Praziquantel|praziquantel|mesh-list
153540921|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
153540922|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153540956|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153540957|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153540958|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153540960|NCT01541943|Atorvastatin|atorvastatin|mesh-list
153540961|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153540994|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540995|NCT01542138|Niacinamide|niacinamide|mesh-list
153540997|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
153540998|NCT01542138|Desonide|desonide|mesh-list
153540999|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
153541000|NCT01542138|Vitamins|vitamins|mesh-ancestor
153541001|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
153541002|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811240|NCT00324467|Protective Agents|protective agents|mesh-ancestor
153811241|NCT00332085|Chromium|chromium|mesh-list
153541003|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153541004|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
153541005|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541006|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153541007|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
153541008|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153541009|NCT01542190|Ketorolac|ketorolac|mesh-list
153541010|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153541011|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153541012|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153541013|NCT01542190|Analgesics|analgesics|mesh-ancestor
153541014|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
153541056|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541057|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541058|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
153541059|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541060|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541061|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
153541062|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541063|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541064|NCT01542489|Insulin|insulin|mesh-list
153541065|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153541066|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
153541067|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
153541068|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541069|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541070|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
153541071|NCT01542697|Analgesics|analgesics|mesh-ancestor
153541072|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
153541104|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153618978|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153541105|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541107|NCT01542801|Norfloxacin|norfloxacin|mesh-list
153541108|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153541109|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541110|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153541111|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153541112|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541113|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541114|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541115|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153541116|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153541119|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541120|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541121|NCT01542918|Rituximab|rituximab|mesh-list
153541122|NCT01542918|Lenalidomide|lenalidomide|mesh-list
153541123|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153541124|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541125|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
153541126|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541159|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153541160|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153541161|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153541162|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541186|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541187|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541188|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541190|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
153541191|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
153412661|NCT04744753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357743|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153357744|NCT00756548|Laxatives|laxatives|mesh-ancestor
153917672|NCT04290195|Aflibercept|aflibercept|mesh-list
153541192|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541193|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541231|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541232|NCT01543906|Retinol acetate|retinol acetate|mesh-list
153541233|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153541234|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
153541235|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541236|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153541237|NCT01543906|Protective Agents|protective agents|mesh-ancestor
153541238|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541239|NCT01543932|Clopidogrel|clopidogrel|mesh-list
153541241|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153541242|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153541243|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153541244|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153541245|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153541246|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
153541247|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541268|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541290|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153541291|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153541292|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153541293|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153541294|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
153541295|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
153541296|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
153541297|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
153541298|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541299|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541300|NCT01544192|Tocopherols|tocopherols|mesh-list
153541301|NCT01544192|Vitamin E|vitamin e|mesh-list
153541302|NCT01544192|Tocotrienols|tocotrienols|mesh-list
153541303|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
153541304|NCT01544192|Antioxidants|antioxidants|mesh-list
153541305|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541306|NCT01544192|Protective Agents|protective agents|mesh-ancestor
153541307|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541308|NCT01544192|Vitamins|vitamins|mesh-ancestor
153541309|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
153541310|NCT01544283|Triamcinolone|triamcinolone|mesh-list
153541311|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153541312|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153541313|NCT01544283|Lidocaine|lidocaine|mesh-list
153541314|NCT01544283|Tetracaine|tetracaine|mesh-list
153541315|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153541316|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
153541317|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
153541318|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541319|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541398|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541399|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153541401|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
153541402|NCT01544725|Analgesics|analgesics|mesh-ancestor
153541403|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
153541407|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153541408|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541409|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541410|NCT01544751|Metformin|metformin|mesh-list
153541411|NCT01544751|Atorvastatin|atorvastatin|mesh-list
153541412|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541455|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153541457|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153541458|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541459|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
153811245|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541460|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
153541461|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
153541462|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541464|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153541465|NCT01544959|Esmolol|esmolol|mesh-list
153541466|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153541513|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541515|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153541516|NCT01545297|Analgesics|analgesics|mesh-ancestor
153541517|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
153541518|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541519|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153541520|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153541521|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153541522|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541523|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541524|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541525|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153541526|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
153541527|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
153541528|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153541529|NCT01545297|Narcotics|narcotics|mesh-ancestor
153541530|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
153541531|NCT01545427|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153541532|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153541533|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541586|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541588|NCT01545947|Azacitidine|azacitidine|mesh-list
153541589|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153541590|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153541591|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
153541592|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541593|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541639|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541640|NCT01546558|Metformin|metformin|mesh-list
153541641|NCT01546558|Ranolazine|ranolazine|mesh-list
153541642|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541643|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541644|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153541684|NCT01546961|Amebicides|amebicides|mesh-ancestor
153541685|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153541686|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153811246|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153541687|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541688|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
153541689|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541718|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541719|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153541720|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541721|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541722|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541723|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153541724|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153541725|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153541726|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153541727|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
153541728|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
153541743|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153541746|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541747|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153541748|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
153541779|NCT01547377|Trace Elements|trace elements|mesh-ancestor
153541780|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
153618981|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541781|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541782|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
153541783|NCT01547377|Protective Agents|protective agents|mesh-ancestor
153541784|NCT01547416|Fentanyl|fentanyl|mesh-list
153541785|NCT01547416|Ropivacaine|ropivacaine|mesh-list
153541786|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
153541787|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
153541788|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541789|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541790|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
153541791|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541792|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153541810|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153541834|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
153541835|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541836|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153541837|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153541838|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
153541839|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541840|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153541841|NCT01548027|Anesthetics|anesthetics|mesh-list
153541842|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
153541843|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541844|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541845|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
153917700|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
153917701|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153541846|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541847|NCT01548066|Valproic Acid|valproic acid|mesh-list
153541848|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
153541849|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541850|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541851|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
153541862|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
153541863|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541864|NCT01548144|Pemetrexed|pemetrexed|mesh-list
153541865|NCT01548144|Crizotinib|crizotinib|mesh-list
153541866|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541867|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541890|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541891|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541892|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
153541893|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541894|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153541895|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153541896|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153541897|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
153541898|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541899|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153541901|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153541902|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541903|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541904|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153541905|NCT01548209|Analgesics|analgesics|mesh-ancestor
153541906|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
153541907|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541908|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153541909|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153541910|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153541911|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541912|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541913|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541914|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
153541964|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541966|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153541967|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153542008|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153542009|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153542012|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153542094|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542095|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542106|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542107|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
153542108|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
153542109|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542110|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542111|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542112|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
153542113|NCT01549431|Hormones|hormones|mesh-ancestor
153542114|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542115|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153542139|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153542140|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542141|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542142|NCT01549574|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153542143|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811247|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
153542144|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542145|NCT01549600|Psyllium|psyllium|mesh-list
153542146|NCT01549600|Cathartics|cathartics|mesh-ancestor
153542147|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542148|NCT01549691|Alprazolam|alprazolam|mesh-list
153542149|NCT01549691|Zopiclone|zopiclone|mesh-list
153542150|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153542151|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542152|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542153|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153542154|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153542155|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153542156|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
153542157|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
153542158|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542159|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542160|NCT01549704|Ropivacaine|ropivacaine|mesh-list
153542161|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
153542162|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
153542163|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542174|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542175|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542205|NCT01549990|Desflurane|desflurane|mesh-list
153542206|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153542207|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153542208|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
153542209|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
153542210|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542211|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542212|NCT01550055|Irinotecan|irinotecan|mesh-list
153542213|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153542214|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153542215|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542216|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542217|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542218|NCT01550107|Allopurinol|allopurinol|mesh-list
153542219|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
153542220|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542221|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542222|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
153542296|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542297|NCT01550653|Incretins|incretins|mesh-ancestor
153542298|NCT01550653|Hormones|hormones|mesh-ancestor
153542299|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542300|NCT01550770|Propofol|propofol|mesh-list
153542301|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153542302|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542303|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542304|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153542305|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
153542306|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
153542307|NCT01550848|Gemcitabine|gemcitabine|mesh-list
153542308|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154256527|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668013|NCT00030537|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153542354|NCT01551225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153542355|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153542356|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153542357|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542385|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542396|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153542397|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542398|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542400|NCT01551459|Dacarbazine|dacarbazine|mesh-list
153730535|NCT00141570|Hormones|hormones|mesh-ancestor
153542401|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542402|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153542403|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153542404|NCT01551459|Growth Substances|growth substances|mesh-ancestor
153542405|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542406|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
153542407|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153542408|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542432|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542433|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542435|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542436|NCT01551589|Docetaxel|docetaxel|mesh-list
153542437|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542438|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
153542439|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
153542440|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
153542441|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542442|NCT01551615|Metformin|metformin|mesh-list
153542443|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153542444|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542445|NCT01551628|BCT-100|bct-100|mesh-list
153542446|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542447|NCT01551641|Thalidomide|thalidomide|mesh-list
153542448|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153542449|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
153542450|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542451|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
153542467|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153542469|NCT01551719|Linezolid|linezolid|mesh-list
153542470|NCT01551719|Penicillins|penicillins|mesh-list
153542471|NCT01551719|Daptomycin|daptomycin|mesh-list
153542472|NCT01551719|Tigecycline|tigecycline|mesh-list
153542473|NCT01551719|Cephalosporins|cephalosporins|mesh-list
153542474|NCT01551719|Teicoplanin|teicoplanin|mesh-list
153542509|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
153542510|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542565|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542580|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153542582|NCT01552798|Analgesics|analgesics|mesh-ancestor
153542583|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
153542584|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542585|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542586|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542587|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542588|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153811248|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
153542589|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153542590|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542591|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153542592|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153542593|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542594|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
153542595|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153542596|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
153542597|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153542609|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542610|NCT01552863|Oxycodone|oxycodone|mesh-list
153542611|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153542612|NCT01552863|Narcotics|narcotics|mesh-ancestor
153542613|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542614|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542615|NCT01552863|Analgesics|analgesics|mesh-ancestor
153542617|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542619|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153542620|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
153542621|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542623|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
153542624|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542625|NCT01552993|Acetaminophen|acetaminophen|mesh-list
153542626|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153542648|NCT01553357|Lenalidomide|lenalidomide|mesh-list
153542649|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542650|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
153542651|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
153542652|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542653|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542654|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542655|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
153542656|NCT01553357|Hormones|hormones|mesh-ancestor
153542657|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542658|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153542659|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542660|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
153542661|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153542662|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153542663|NCT01553357|Growth Substances|growth substances|mesh-ancestor
153542664|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
153542665|NCT01553435|Levomethorphan|levomethorphan|mesh-list
153542666|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
153542667|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
153542668|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
153542669|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153542670|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153542671|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542672|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542673|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542674|NCT01553435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153668014|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153542675|NCT01553435|Narcotics|narcotics|mesh-ancestor
153466520|NCT00305760|Cetuximab|cetuximab|mesh-list
153542676|NCT01553435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542677|NCT01553435|Analgesics|analgesics|mesh-ancestor
153542678|NCT01553435|Sensory System Agents|sensory system agents|mesh-ancestor
153542679|NCT01553435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542717|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153542718|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153542719|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153542720|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153542722|NCT01553942|Afatinib|afatinib|mesh-list
153542723|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542724|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542725|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542726|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153542727|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153542728|NCT01553942|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153542729|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153542772|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542773|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542774|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153542775|NCT01554631|Acarbose|acarbose|mesh-list
153542776|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153542777|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542778|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542779|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153542808|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153542809|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542810|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
153542811|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
153542812|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542869|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542870|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542872|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
153542873|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
153542874|NCT01555099|Hormones|hormones|mesh-ancestor
153542875|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542876|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
153542877|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153542878|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
153542879|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542880|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542930|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153542931|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542932|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
153542933|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153542934|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
153542935|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542936|NCT01555710|Carboplatin|carboplatin|mesh-list
153542937|NCT01555710|Etoposide|etoposide|mesh-list
153542938|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
153542939|NCT01555710|Ifosfamide|ifosfamide|mesh-list
153542971|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542972|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153542974|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542975|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542976|NCT01555918|Isavuconazole|isavuconazole|mesh-list
153542977|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
153542978|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542979|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
153542980|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153542981|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
153542982|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542983|NCT01555970|Expectorants|expectorants|mesh-ancestor
153542984|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
153542985|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153542986|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
153542987|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542988|NCT01555970|Protective Agents|protective agents|mesh-ancestor
153542989|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542990|NCT01555970|Antidotes|antidotes|mesh-ancestor
153542991|NCT01556035|Lenalidomide|lenalidomide|mesh-list
153542992|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
153542993|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542994|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153542995|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153542996|NCT01556035|Growth Substances|growth substances|mesh-ancestor
153542997|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
153542998|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543041|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
153543042|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543043|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153543044|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
153543045|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543046|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543048|NCT01556529|Antidotes|antidotes|mesh-ancestor
153543049|NCT01556529|Protective Agents|protective agents|mesh-ancestor
153618985|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
153486309|NCT02339168|Metformin|metformin|mesh-list
153543050|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543051|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
153543052|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
153543062|NCT05847660|Progesterone|progesterone|mesh-list
153543063|NCT05847660|Dydrogesterone|dydrogesterone|mesh-list
153543064|NCT05847660|Progestins|progestins|mesh-ancestor
153543065|NCT05847660|Hormones|hormones|mesh-ancestor
153543066|NCT05847660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543067|NCT05847660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543068|NCT05847660|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153543070|NCT05847660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153543071|NCT05847660|Hormone Antagonists|hormone antagonists|mesh-ancestor
153543072|NCT05847413|Verapamil|verapamil|mesh-list
153543073|NCT05847413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153543074|NCT05847413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153543075|NCT05847413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543076|NCT05847413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543077|NCT05847413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153543078|NCT05847413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543079|NCT05847413|Vasodilator Agents|vasodilator agents|mesh-ancestor
153543080|NCT05847257|Ubiquinone|ubiquinone|mesh-list
153543081|NCT05847257|Coenzyme Q10|coenzyme q10|mesh-list
154256529|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153543082|NCT05847257|Letrozole|letrozole|mesh-list
153543083|NCT05847257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543084|NCT05847257|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153543085|NCT05847257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153543086|NCT05847257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543121|NCT05847049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543122|NCT05847049|Growth Inhibitors|growth inhibitors|mesh-ancestor
153543123|NCT05847049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543124|NCT05847049|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153618986|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
153543125|NCT05847049|Hormone Antagonists|hormone antagonists|mesh-ancestor
153543160|NCT05845736|Antihypertensive Agents|antihypertensive agents|mesh-list
153543161|NCT05840744|Antithrombins|antithrombins|mesh-list
153543162|NCT05840744|Thrombin|thrombin|mesh-list
153543163|NCT05840744|Hemostatics|hemostatics|mesh-ancestor
153543164|NCT05840744|Coagulants|coagulants|mesh-ancestor
153543165|NCT05840744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153543166|NCT05840744|Protease Inhibitors|protease inhibitors|mesh-ancestor
153543167|NCT05840744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543168|NCT05840744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543169|NCT05840744|Anticoagulants|anticoagulants|mesh-ancestor
153543170|NCT05840692|Escitalopram|escitalopram|mesh-list
153543182|NCT05840640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543183|NCT05840588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153543184|NCT05840588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543185|NCT05840536|Chlorothiazide|chlorothiazide|mesh-list
153543187|NCT05840536|Diuretics|diuretics|mesh-ancestor
153543188|NCT05840536|Natriuretic Agents|natriuretic agents|mesh-ancestor
153543189|NCT05840536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543190|NCT05840536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153543191|NCT05840536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543192|NCT05840536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543193|NCT05840536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153543194|NCT05840536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153543195|NCT05840406|Acetaminophen|acetaminophen|mesh-list
153543196|NCT05840406|Ibuprofen|ibuprofen|mesh-list
153543197|NCT05840406|Ketoprofen|ketoprofen|mesh-list
153543198|NCT05840406|Dexmedetomidine|dexmedetomidine|mesh-list
153543230|NCT05840328|Sensory System Agents|sensory system agents|mesh-ancestor
153543231|NCT05840328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543232|NCT05840328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153543250|NCT05840094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543252|NCT05839548|Racepinephrine|racepinephrine|mesh-list
153543253|NCT05839548|Mepivacaine|mepivacaine|mesh-list
153543254|NCT05839548|Carticaine|carticaine|mesh-list
153543255|NCT05839548|Epinephryl borate|epinephryl borate|mesh-list
153543256|NCT05839548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153543257|NCT05839548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153543258|NCT05839548|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543259|NCT05839548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543287|NCT05839509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543288|NCT05839509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543289|NCT05839509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153543313|NCT05838846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543315|NCT05838846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543317|NCT05837403|Vasodilator Agents|vasodilator agents|mesh-ancestor
153543318|NCT05836610|Hydrocortisone|hydrocortisone|mesh-list
153543319|NCT05836610|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153543320|NCT05836610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153543321|NCT05830630|Bupivacaine|bupivacaine|mesh-list
153543322|NCT05830630|Methylene Blue|methylene blue|mesh-list
153543323|NCT05830630|Anesthetics, Local|anesthetics, local|mesh-ancestor
153543324|NCT05830630|Anesthetics|anesthetics|mesh-ancestor
153543325|NCT05830630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543378|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
153543379|NCT05527483|Protective Agents|protective agents|mesh-ancestor
153543380|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543381|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153543382|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543408|NCT05254418|Dulaglutide|dulaglutide|mesh-list
153543409|NCT05254418|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153543410|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153543411|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543412|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153543413|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153543414|NCT05095259|Insulin|insulin|mesh-list
153543415|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153543416|NCT05095259|Epinephrine|epinephrine|mesh-list
153543417|NCT05095259|Glucagon|glucagon|mesh-list
153543418|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153543419|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543420|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153543421|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153543422|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543423|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543424|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543425|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153543426|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153543427|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
153543428|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543429|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153543466|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
153543467|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153543468|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153543469|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543470|NCT04932382|Misoprostol|misoprostol|mesh-list
153543471|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153543472|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
153543473|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153543474|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543475|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153543476|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543477|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
153543478|NCT04901715|Albuterol|albuterol|mesh-list
153543479|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153543480|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
153543481|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543482|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543483|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153543484|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
153543544|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
153543545|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543595|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
153543596|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
153543597|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153543599|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153543643|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153543644|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
153543681|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543683|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153543685|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543686|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543687|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543688|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543689|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153543690|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153543691|NCT04137536|Antibodies|antibodies|mesh-list
153543692|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153730549|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
153730550|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
153811252|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543723|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543724|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543725|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153543726|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
153543727|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153543728|NCT03778424|Rufinamide|rufinamide|mesh-list
153543729|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
153543730|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153543731|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153543732|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543733|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543734|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
153543735|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
153543736|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
153543807|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543808|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543809|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
153543810|NCT03634852|Hormones|hormones|mesh-ancestor
153543811|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543812|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153543813|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543844|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
153543846|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153543847|NCT03552575|Valsartan|valsartan|mesh-list
153543859|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543860|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153543861|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153543862|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153543863|NCT03463408|Nivolumab|nivolumab|mesh-list
153543864|NCT03463408|Ipilimumab|ipilimumab|mesh-list
153543865|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543866|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543895|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
153543897|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543898|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153543899|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153543900|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543955|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
153543956|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543957|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544049|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153544050|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544081|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153544082|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
153544083|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
153544084|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544085|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153544086|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153544087|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544088|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544089|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153544131|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544132|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153544133|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544134|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544135|NCT01734694|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153544137|NCT01599234|Analgesics|analgesics|mesh-ancestor
153544138|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
153544139|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544140|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446910|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917809|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544141|NCT00716625|Sunitinib|sunitinib|mesh-list
153544142|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544143|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153544144|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153544145|NCT00716625|Growth Substances|growth substances|mesh-ancestor
153544146|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544147|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
153544148|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544149|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544150|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544151|NCT00713817|Nabiximols|nabiximols|mesh-list
153544202|NCT01556672|Adalimumab|adalimumab|mesh-list
153544203|NCT01556672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153544265|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544266|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544267|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544268|NCT01557140|Carvedilol|carvedilol|mesh-list
153544269|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153544270|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153544271|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
153544272|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544273|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544274|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544275|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153544276|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
153544277|NCT01557140|Protective Agents|protective agents|mesh-ancestor
153544278|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153544279|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544280|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153544281|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
153544283|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153544284|NCT01557153|Amlodipine|amlodipine|mesh-list
153544285|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153544286|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153544287|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544313|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153544314|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
153544315|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544316|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544318|NCT01557335|Omeprazole|omeprazole|mesh-list
153544319|NCT01557335|Clopidogrel|clopidogrel|mesh-list
153544320|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153544321|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153544322|NCT01557335|Analgesics|analgesics|mesh-ancestor
153544413|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544452|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153544518|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
153544519|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544520|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544521|NCT01558713|Fentanyl|fentanyl|mesh-list
153544522|NCT01558713|Bupivacaine|bupivacaine|mesh-list
153544523|NCT01558713|Ropivacaine|ropivacaine|mesh-list
153544524|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
153544525|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
153544526|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
153544527|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544528|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544529|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
153544530|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811254|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
153811255|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153668015|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544531|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153544532|NCT01558713|Narcotics|narcotics|mesh-ancestor
153544618|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
153487871|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
153544619|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544620|NCT01559298|Aspirin|aspirin|mesh-list
153544621|NCT01559298|Clopidogrel|clopidogrel|mesh-list
153544622|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153544623|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153544624|NCT01559298|Analgesics|analgesics|mesh-ancestor
153544625|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
153544664|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
153544665|NCT01559584|Hormones|hormones|mesh-ancestor
153544666|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544667|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544668|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153544669|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
153544670|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544671|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544672|NCT01559727|Prednisone|prednisone|mesh-list
153544673|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544674|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
153544675|NCT01559727|Hormones|hormones|mesh-ancestor
153544676|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544677|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544678|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153544679|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544680|NCT01559740|Bupivacaine|bupivacaine|mesh-list
153544681|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
153544724|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153544725|NCT05570383|Antacids|antacids|mesh-list
153544726|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730558|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
153567592|NCT05261139|Ritonavir|ritonavir|mesh-list
153544727|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153544728|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
153544729|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544730|NCT05570084|Tamsulosin|tamsulosin|mesh-list
153544731|NCT05570084|Silodosin|silodosin|mesh-list
153544732|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153544733|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153544734|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153544735|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
153544736|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544737|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544738|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544740|NCT05569668|Paclitaxel|paclitaxel|mesh-list
153544741|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153544742|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544778|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544779|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153544810|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153544843|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544845|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
153544846|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544847|NCT05137080|Dexamethasone|dexamethasone|mesh-list
153544848|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544849|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
153544850|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
153544851|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544852|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544853|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153544854|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
153544855|NCT05137080|Hormones|hormones|mesh-ancestor
153544856|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544857|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153544858|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544859|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
153544860|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153544861|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544862|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153544863|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544864|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544865|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544866|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544867|NCT04713358|Nalmefene|nalmefene|mesh-list
153544868|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153544869|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544870|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
153544871|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544872|NCT04705051|Venglustat|venglustat|mesh-list
153544873|NCT04705051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730560|NCT00141648|Vincristine|vincristine|mesh-list
153544913|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544915|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544916|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153544917|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153544918|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544919|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544920|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544921|NCT03893435|Valsartan|valsartan|mesh-list
153544922|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153544923|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153544924|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153544967|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153544969|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544970|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544971|NCT03468335|Irinotecan|irinotecan|mesh-list
153544972|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153544973|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544974|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544975|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544976|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545001|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545002|NCT02917772|Nivolumab|nivolumab|mesh-list
153545003|NCT02917772|Ipilimumab|ipilimumab|mesh-list
153545004|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545005|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545019|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
153545020|NCT02686593|Clofarabine|clofarabine|mesh-list
153545021|NCT02686593|Analgesics|analgesics|mesh-ancestor
153545022|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
153545023|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545024|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545025|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545026|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153811256|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811257|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154256530|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
153545027|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153545028|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545029|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545030|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153545031|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
153545033|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153545034|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545035|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
153545036|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153545037|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153545038|NCT02553941|Azacitidine|azacitidine|mesh-list
153545039|NCT02553941|Ibrutinib|ibrutinib|mesh-list
153545040|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153545041|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
153545081|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545115|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153545116|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545117|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545118|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153545119|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
153545120|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545121|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
153545122|NCT01564238|Calcium|calcium|mesh-list
153545123|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153545124|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545166|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153545167|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153545168|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545169|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545170|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
153545171|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545172|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545173|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153545174|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545175|NCT01566422|Vancomycin|vancomycin|mesh-list
153545176|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153545177|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545178|NCT01566760|Fesoterodine|fesoterodine|mesh-list
153545210|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545211|NCT01568632|Imetelstat|imetelstat|mesh-list
153545212|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
153545213|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745662|NCT03249792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153730566|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
153730567|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545214|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545215|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545216|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
153545217|NCT01568645|Carvedilol|carvedilol|mesh-list
153545218|NCT01568645|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153545219|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545220|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545221|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545222|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545223|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153545224|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153545225|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
153545226|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545347|NCT06309472|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153545348|NCT06309472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153545349|NCT06309472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153545350|NCT06309472|Adrenergic Agents|adrenergic agents|mesh-ancestor
153782002|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357750|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153357751|NCT00241358|Plerixafor|plerixafor|mesh-list
153917847|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153545351|NCT06309472|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153545352|NCT06309472|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153545353|NCT06309472|Serotonin Agents|serotonin agents|mesh-ancestor
153545354|NCT06309472|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153545355|NCT06309043|Antibodies|antibodies|mesh-list
153545356|NCT06309043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153545357|NCT06309043|Immunologic Factors|immunologic factors|mesh-ancestor
153545358|NCT06309043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545359|NCT06308978|Cyclophosphamide|cyclophosphamide|mesh-list
153545361|NCT06308978|Fludarabine|fludarabine|mesh-list
153545362|NCT06308978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153545363|NCT06308978|Immunologic Factors|immunologic factors|mesh-ancestor
153545364|NCT06308978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545382|NCT06308887|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153545399|NCT06308731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153545400|NCT06308731|Purinergic Agents|purinergic agents|mesh-ancestor
153545401|NCT06308731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545403|NCT06308679|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153545404|NCT06308679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545405|NCT06308679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153545406|NCT06308679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545409|NCT06308588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545410|NCT06308588|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153545411|NCT06308588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545412|NCT06308588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545413|NCT06308588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545414|NCT06308575|Apatinib|apatinib|mesh-list
153545415|NCT06308575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545416|NCT06308575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545417|NCT06308575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545418|NCT06308575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545419|NCT06308445|Sirolimus|sirolimus|mesh-list
153545420|NCT06308445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153545421|NCT06308445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545422|NCT06308445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153545423|NCT06308445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545424|NCT06308445|Antifungal Agents|antifungal agents|mesh-ancestor
153545425|NCT06308445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153545426|NCT06308445|Immunologic Factors|immunologic factors|mesh-ancestor
153545427|NCT06308445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545428|NCT06308406|Bevacizumab|bevacizumab|mesh-list
153545429|NCT06308406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545430|NCT06308406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545431|NCT06308406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153545432|NCT06308406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153545433|NCT06308406|Growth Substances|growth substances|mesh-ancestor
153545434|NCT06308406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545491|NCT06305416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153545492|NCT06305416|Growth Substances|growth substances|mesh-ancestor
153545493|NCT06305416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545494|NCT06305416|Growth Inhibitors|growth inhibitors|mesh-ancestor
153545495|NCT06305416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545497|NCT06305299|Fludarabine|fludarabine|mesh-list
153545498|NCT06305299|Fludarabine phosphate|fludarabine phosphate|mesh-list
153545499|NCT06305299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153545500|NCT06305299|Immunologic Factors|immunologic factors|mesh-ancestor
153618993|NCT01981460|Methylene Blue|methylene blue|mesh-list
153545541|NCT06304987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153811258|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917853|NCT04261270|Oseltamivir|oseltamivir|mesh-list
153545542|NCT06304987|Antimetabolites|antimetabolites|mesh-ancestor
153545543|NCT06304987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153545544|NCT06304987|Protease Inhibitors|protease inhibitors|mesh-ancestor
153545545|NCT06304987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545546|NCT06304987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153545559|NCT06304896|Colchicine|colchicine|mesh-list
153545560|NCT06304896|Carvedilol|carvedilol|mesh-list
153545561|NCT06304896|Ramipril|ramipril|mesh-list
153545562|NCT06304896|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153545563|NCT06304896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153545564|NCT06304896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153545565|NCT06304896|Antimetabolites|antimetabolites|mesh-ancestor
153545611|NCT06304441|Osimertinib|osimertinib|mesh-list
153545612|NCT06304441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545613|NCT06304441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545614|NCT06304441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545615|NCT06304441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153545616|NCT06304441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153545617|NCT06304441|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153545618|NCT06304441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545619|NCT06304350|Pembrolizumab|pembrolizumab|mesh-list
153545620|NCT06304350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545621|NCT06304350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545629|NCT06304324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545715|NCT06303167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545717|NCT06303076|Zolpidem|zolpidem|mesh-list
153545718|NCT06303076|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153545719|NCT06303076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153545720|NCT06303076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545721|NCT06303076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545722|NCT06303076|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153545723|NCT06303076|GABA Agonists|gaba agonists|mesh-ancestor
153545724|NCT06303076|GABA Agents|gaba agents|mesh-ancestor
153545725|NCT06303076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545726|NCT06303076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545727|NCT06303076|Analgesics|analgesics|mesh-ancestor
153545728|NCT06303076|Sensory System Agents|sensory system agents|mesh-ancestor
153619006|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153619007|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619008|NCT01981707|Choline|choline|mesh-list
153619009|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
153619010|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153619011|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
153619012|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619013|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619014|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153619015|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
153619016|NCT01981746|Ropivacaine|ropivacaine|mesh-list
153619017|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
153619018|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
153619019|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619020|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619061|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619062|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619063|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
153447033|NCT00002159|Amebicides|amebicides|mesh-ancestor
153811260|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
153917883|NCT00624936|Bortezomib|bortezomib|mesh-list
153619064|NCT01982019|Hormones|hormones|mesh-list
153619065|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619066|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619067|NCT01982071|Micafungin|micafungin|mesh-list
153619068|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
153619069|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619070|NCT01982097|Sorafenib|sorafenib|mesh-list
153619147|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619148|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
153619149|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
153619150|NCT01982864|Gentamicins|gentamicins|mesh-list
153619151|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153619198|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619199|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619201|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
153619202|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153619203|NCT01983449|BB 1101|bb 1101|mesh-list
153619204|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619274|NCT01983735|Vitamins|vitamins|mesh-ancestor
153619275|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
153619293|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153619294|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619325|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619326|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153619328|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
153619329|NCT01984008|Citric Acid|citric acid|mesh-list
153619330|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
153619331|NCT01984008|Cathartics|cathartics|mesh-ancestor
153619332|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619333|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
153619334|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153619335|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
153619336|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
153619337|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619351|NCT01984086|Albuterol|albuterol|mesh-list
153619352|NCT01984086|Charcoal|charcoal|mesh-list
153619353|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153619385|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153619386|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
153619387|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619388|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153619389|NCT01984099|Hematinics|hematinics|mesh-ancestor
153619390|NCT01984177|Hormones|hormones|mesh-list
153619391|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153619392|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
153619393|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619394|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619395|NCT01984255|Ipilimumab|ipilimumab|mesh-list
153619396|NCT01984255|Bavituximab|bavituximab|mesh-list
153619397|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153619398|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619399|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153619437|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153619438|NCT01984749|Febuxostat|febuxostat|mesh-list
153619439|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
153619440|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619441|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
153619442|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153619443|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619444|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153619445|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153619446|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619447|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619448|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619449|NCT01984931|Medazepam|medazepam|mesh-list
153619450|NCT01984931|Metoclopramide|metoclopramide|mesh-list
153619451|NCT01984931|Bromazepam|bromazepam|mesh-list
153619452|NCT01984931|Simethicone|simethicone|mesh-list
153619453|NCT01984931|Trimebutine|trimebutine|mesh-list
153619454|NCT01984931|Mosapride|mosapride|mesh-list
153619455|NCT01984931|Maleic acid|maleic acid|mesh-list
153619456|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619457|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619458|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
153730574|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153619459|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
153619460|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619461|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619498|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153619499|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153619500|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153619501|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619502|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
153619503|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153619504|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
153619505|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619506|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153619510|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619511|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
153619512|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619513|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
153619514|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153619515|NCT01985373|Antibodies|antibodies|mesh-list
153619516|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
153619517|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153619518|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
153619519|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619520|NCT01985451|Temozolomide|temozolomide|mesh-list
153619521|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153619522|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
153619523|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619524|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619525|NCT01985477|Dexamethasone|dexamethasone|mesh-list
153619526|NCT01985477|Lenalidomide|lenalidomide|mesh-list
153619527|NCT01985477|Tretinoin|tretinoin|mesh-list
153619528|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619529|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
153619576|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
153619577|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153619578|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153619579|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153619580|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619581|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
153619582|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153619583|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153619584|NCT01985750|Cycloserine|cycloserine|mesh-list
153619585|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153619586|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619603|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619604|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
153811265|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153357757|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153917894|NCT00979953|Analgesics|analgesics|mesh-ancestor
153619605|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
153619606|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619638|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
153619639|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153619640|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153619641|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153619642|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153619643|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619644|NCT01985854|Propofol|propofol|mesh-list
153619645|NCT01985854|Desflurane|desflurane|mesh-list
153619646|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153619660|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619662|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153619699|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153619700|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153619745|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619746|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619747|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619749|NCT01986465|Hormones|hormones|mesh-ancestor
153619750|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619751|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153619752|NCT01986465|Protective Agents|protective agents|mesh-ancestor
153481617|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
153619753|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153619754|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619755|NCT01986556|Lesinurad|lesinurad|mesh-list
153619756|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
153619806|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619840|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153619841|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
153619842|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
153619843|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153619844|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153619846|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
153619847|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153619848|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
153619849|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619852|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619853|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619854|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619855|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
153619856|NCT01986998|Hormones|hormones|mesh-ancestor
153619857|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619942|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153619943|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619944|NCT01988077|Ipilimumab|ipilimumab|mesh-list
153619987|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619988|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619989|NCT01988545|Exenatide|exenatide|mesh-list
153619990|NCT01988545|Glucagon|glucagon|mesh-list
153619991|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153619992|NCT01988545|Incretins|incretins|mesh-ancestor
153619993|NCT01988545|Hormones|hormones|mesh-ancestor
153620019|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620021|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153620022|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153620023|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
153620024|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620038|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153620039|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
153620040|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620041|NCT01989000|Gemcitabine|gemcitabine|mesh-list
153620042|NCT01989000|Imidazole|imidazole|mesh-list
153620043|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153620044|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
153620045|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620046|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620047|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620048|NCT01989052|Lomustine|lomustine|mesh-list
153620049|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
153620050|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153620051|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
153620074|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
153620075|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620076|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620077|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
153620078|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620079|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153620080|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153620081|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153620082|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620089|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153620090|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
153620091|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
153620092|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
153620093|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620094|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153620095|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153620096|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
153620097|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153620098|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153620099|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
153620100|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153620101|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
153620102|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
153620103|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
153620104|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153620105|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
153620106|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153620107|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153620109|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
153620140|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620142|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153620143|NCT01989676|Paclitaxel|paclitaxel|mesh-list
153620144|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153620145|NCT01989676|Trastuzumab|trastuzumab|mesh-list
153620146|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153620147|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620148|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
153620149|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
153620151|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620152|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153620161|NCT01989884|IDN 5109|idn 5109|mesh-list
153620162|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811277|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620164|NCT01989897|Histamine|histamine|mesh-list
153620189|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620190|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730578|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620191|NCT01990079|Bupropion|bupropion|mesh-list
153620192|NCT01990079|Nicotine|nicotine|mesh-list
153620193|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153620194|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
153620195|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620196|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620197|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153620198|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153620199|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
153620200|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620201|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620202|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153620203|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
153620204|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153620205|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153620206|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153620207|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620208|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
153620209|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153620210|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153620211|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620212|NCT01990118|Cyclosporine|cyclosporine|mesh-list
153620233|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620235|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153620236|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620237|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153620238|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620239|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620240|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
153620241|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153620242|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
153620243|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
153620244|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620245|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620246|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153620247|NCT01990404|Analgesics|analgesics|mesh-ancestor
153620248|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
153620249|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620250|NCT01990443|Reslizumab|reslizumab|mesh-list
153620251|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153620252|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
153620253|NCT01990586|Rabeprazole|rabeprazole|mesh-list
153620254|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153620255|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620256|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153620257|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620258|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620259|NCT01990690|Antioxidants|antioxidants|mesh-list
153620260|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620261|NCT01990690|Protective Agents|protective agents|mesh-ancestor
153620262|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620263|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
153620264|NCT01990755|Olanzapine|olanzapine|mesh-list
153730579|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
153620265|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
153620266|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
153620267|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620268|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620269|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620270|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153620271|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153620305|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153620306|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620308|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153620309|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620310|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153620311|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153620312|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620313|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620314|NCT01990872|Vitamin D|vitamin d|mesh-list
153620315|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
153620316|NCT01990872|Vitamins|vitamins|mesh-ancestor
153620317|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
153620318|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620319|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153620320|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620321|NCT01990937|Midazolam|midazolam|mesh-list
153620322|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153620350|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620352|NCT01991145|Hematinics|hematinics|mesh-ancestor
153620353|NCT01991158|Dexamethasone|dexamethasone|mesh-list
153620354|NCT01991158|Gemcitabine|gemcitabine|mesh-list
153620355|NCT01991158|Methotrexate|methotrexate|mesh-list
153620367|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620368|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153620370|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620371|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153620372|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
153620373|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153620374|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
153620375|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620376|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153620377|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153620378|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
153620379|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153620380|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153620381|NCT01991275|Morphine|morphine|mesh-list
153620382|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153620409|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
153620410|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
153620411|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
153620412|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153620413|NCT01991327|Enclomiphene|enclomiphene|mesh-list
153620414|NCT01991327|Clomiphene|clomiphene|mesh-list
153620415|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
153620416|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153620417|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
153620418|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620419|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620452|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620453|NCT01991834|Cefazolin|cefazolin|mesh-list
153620454|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153620455|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620456|NCT01991951|Warfarin|warfarin|mesh-list
153620457|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
153620458|NCT01992133|Vitamin D|vitamin d|mesh-list
153620459|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
153620460|NCT01992133|Vitamins|vitamins|mesh-ancestor
153730581|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153730582|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153620461|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
153620507|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153620508|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
153620509|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620511|NCT01992341|Trebananib|trebananib|mesh-list
153620554|NCT01992705|Fluorouracil|fluorouracil|mesh-list
153620555|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
153620556|NCT01992705|Irinotecan|irinotecan|mesh-list
153620557|NCT01992705|Folfirinox|folfirinox|mesh-list
153620558|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
153620559|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620560|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153620561|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620562|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153620563|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
153620564|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620617|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620618|NCT01993251|Protective Agents|protective agents|mesh-ancestor
153620666|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620667|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153620670|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153620671|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
153620701|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153620702|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620703|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
153620704|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
153620705|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
153620706|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620707|NCT01994070|Procainamide|procainamide|mesh-list
153620708|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153620709|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153620710|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153620711|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620719|NCT01994265|Dabigatran|dabigatran|mesh-list
153620720|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
153620721|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
153620722|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153620723|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
153620724|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620725|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620747|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620748|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
153620749|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
153620750|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620751|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620752|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620753|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
153620788|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153620790|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620791|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620792|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
153620793|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153811281|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811282|NCT00419471|Escitalopram|escitalopram|mesh-list
153620794|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620795|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
153620796|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
153620797|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620798|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620799|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620800|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
153620801|NCT01994759|Hormones|hormones|mesh-ancestor
153620802|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620803|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153620804|NCT01994759|Protective Agents|protective agents|mesh-ancestor
153620805|NCT01994941|Clopidogrel|clopidogrel|mesh-list
153620806|NCT01994941|Ticagrelor|ticagrelor|mesh-list
153620807|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153620844|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
153620845|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620864|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
153620891|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620892|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153620894|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
153620895|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153620896|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153620897|NCT01995292|Anesthetics|anesthetics|mesh-list
153620898|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
153620899|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620900|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620901|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
153620910|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153620911|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
153620912|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620913|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620944|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
153620945|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153620946|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
153620947|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
153620948|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153620949|NCT01995370|Protective Agents|protective agents|mesh-ancestor
153620950|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153620951|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153620952|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153620953|NCT01995695|Vaccines|vaccines|mesh-list
153620954|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
153620955|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620956|NCT01995734|Pasireotide|pasireotide|mesh-list
153620957|NCT01995734|Hormones|hormones|mesh-ancestor
153621003|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
153621004|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621006|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153621007|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621008|NCT01996306|Leucovorin|leucovorin|mesh-list
153621009|NCT01996306|Bevacizumab|bevacizumab|mesh-list
153621010|NCT01996306|Capecitabine|capecitabine|mesh-list
153621011|NCT01996306|Fluorouracil|fluorouracil|mesh-list
153621012|NCT01996306|Irinotecan|irinotecan|mesh-list
153621013|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153621014|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621015|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153621052|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621055|NCT01996423|Vitamins|vitamins|mesh-ancestor
153621056|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
153811283|NCT00419471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153621057|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811284|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153621058|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153621059|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153621060|NCT01996462|Dexetimide|dexetimide|mesh-list
153621061|NCT01996462|Citalopram|citalopram|mesh-list
153621062|NCT01996462|Escitalopram|escitalopram|mesh-list
153621063|NCT01996462|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153621064|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153621065|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621066|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730601|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621067|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621068|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
153621069|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621070|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153621071|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153621072|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
153621073|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
153621074|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621075|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153621076|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153621077|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
153621078|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153621079|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
153621115|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621116|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621117|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
153621118|NCT01996501|Olanzapine|olanzapine|mesh-list
153621119|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
153621120|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
153621121|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621122|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621123|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153621124|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153621125|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153621126|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621127|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153621128|NCT01996501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153621129|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153621130|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621131|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621175|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153621176|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153621177|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153621178|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153621179|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153621180|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153621181|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
153621182|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
153621183|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
153621184|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
153621185|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621186|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621187|NCT01997112|Acetaminophen|acetaminophen|mesh-list
153811285|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621230|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153621232|NCT01997580|Escitalopram|escitalopram|mesh-list
153621233|NCT01997580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153621234|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153621266|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153621267|NCT01997658|Protective Agents|protective agents|mesh-ancestor
153621268|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153621269|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621270|NCT01997762|Resveratrol|resveratrol|mesh-list
153621271|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
153621272|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621273|NCT01997762|Protective Agents|protective agents|mesh-ancestor
153621274|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621275|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621276|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153621277|NCT01997775|Metformin|metformin|mesh-list
153621278|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153621279|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621280|NCT01997788|Morphine|morphine|mesh-list
153621281|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153621321|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730604|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
153730605|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153621322|NCT01998061|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153621323|NCT01998061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153621324|NCT01998061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621325|NCT01998061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621327|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153621328|NCT01998113|Metformin|metformin|mesh-list
153621329|NCT01998113|Glyburide|glyburide|mesh-list
153621330|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153621331|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621332|NCT01998126|Nivolumab|nivolumab|mesh-list
153621333|NCT01998126|Ipilimumab|ipilimumab|mesh-list
153621377|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621378|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
153621379|NCT01998308|Protective Agents|protective agents|mesh-ancestor
153621381|NCT01998347|Fluorouracil|fluorouracil|mesh-list
153621382|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153621383|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621413|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153621420|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153357771|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357773|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621422|NCT01998685|Fentanyl|fentanyl|mesh-list
153621423|NCT01998685|Remifentanil|remifentanil|mesh-list
153621424|NCT01998685|Propofol|propofol|mesh-list
153621425|NCT01998685|Sevoflurane|sevoflurane|mesh-list
153621426|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153621427|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621428|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621429|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153621430|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
153621431|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
153621432|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153621433|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153621434|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153621435|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153621436|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
153621468|NCT01998763|Vitamin D|vitamin d|mesh-list
153621469|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
153621470|NCT01998763|Vitamins|vitamins|mesh-ancestor
153621471|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
153621472|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621473|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153621474|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153621475|NCT01998776|Misoprostol|misoprostol|mesh-list
153621476|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153621477|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
153621478|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153621479|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621480|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153621481|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153621506|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153621507|NCT01999270|Growth Substances|growth substances|mesh-ancestor
153621508|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621509|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
153621510|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153621511|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153621512|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621513|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621515|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153621516|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153621517|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
153621518|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621519|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153621520|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153621521|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621522|NCT01999413|Cytarabine|cytarabine|mesh-list
153621523|NCT01999413|Daunorubicin|daunorubicin|mesh-list
153621524|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153621525|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
153621526|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621527|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621528|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
153621529|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621530|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153621531|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
153621532|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621533|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153621534|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153621535|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153621536|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621537|NCT01999647|Ropivacaine|ropivacaine|mesh-list
153621538|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
153621539|NCT01999647|Anesthetics|anesthetics|mesh-list
153621540|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621541|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621542|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
153621543|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621544|NCT01999673|Docetaxel|docetaxel|mesh-list
153621545|NCT01999673|Bavituximab|bavituximab|mesh-list
153621546|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153621547|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621548|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
153621642|NCT02000388|Analgesics|analgesics|mesh-ancestor
153621643|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
153621644|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621645|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621646|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621647|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153621648|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153621649|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621650|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621651|NCT02000401|Ketorolac|ketorolac|mesh-list
153621652|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153621653|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153621654|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153621655|NCT02000401|Analgesics|analgesics|mesh-ancestor
153621656|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
153621657|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621658|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621659|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621660|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153621661|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153621662|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621706|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153621707|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621708|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
153621757|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153621787|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621788|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153621789|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
153621790|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153621791|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621792|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
153782004|NCT04566211|Metronidazole|metronidazole|mesh-list
153621793|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153621794|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153621795|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621796|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
153621804|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153621805|NCT02001428|Piperaquine|piperaquine|mesh-list
153621806|NCT02001428|Artenimol|artenimol|mesh-list
153621808|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153621809|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153621810|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621841|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153730610|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153730611|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153730612|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
153621842|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153621843|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621844|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153621845|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
153621846|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
153621847|NCT02001740|Lidocaine|lidocaine|mesh-list
153621848|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
153621849|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
153621850|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621894|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153621895|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
153621896|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153621898|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621899|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
153621900|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153621901|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153621902|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
153621903|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621904|NCT02001948|Morphine|morphine|mesh-list
153621905|NCT02001948|Bupivacaine|bupivacaine|mesh-list
153621906|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
153621907|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
153621908|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621909|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621910|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
153621911|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621912|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153621913|NCT02001948|Narcotics|narcotics|mesh-ancestor
153621914|NCT02001948|Analgesics|analgesics|mesh-ancestor
153621915|NCT02001974|Paclitaxel|paclitaxel|mesh-list
153621916|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153621917|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621918|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
153621961|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153621962|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621963|NCT02002156|Vaccines|vaccines|mesh-list
153621964|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153621965|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
153621966|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
153621967|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621968|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153621969|NCT02002195|Leucovorin|leucovorin|mesh-list
153621970|NCT02002195|Capecitabine|capecitabine|mesh-list
153621971|NCT02002195|Fluorouracil|fluorouracil|mesh-list
153621972|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
153622019|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622021|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153622022|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
153622023|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
153622024|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622025|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153622026|NCT02002325|Plasminogen|plasminogen|mesh-list
153622027|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153622028|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153622029|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622075|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
153622076|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153622077|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153622078|NCT02002663|Prednisolone|prednisolone|mesh-list
153622079|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
153622080|NCT02002663|Morphine|morphine|mesh-list
153622081|NCT02002663|Ropivacaine|ropivacaine|mesh-list
153622082|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153622083|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
153622084|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153622085|NCT02002663|Narcotics|narcotics|mesh-ancestor
153622127|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153622128|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
153622130|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153622131|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622132|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622133|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622134|NCT02002858|Nicotine|nicotine|mesh-list
153622135|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153622136|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
153622137|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622165|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622166|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622167|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622168|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622169|NCT02001818|Interferons|interferons|mesh-list
153622170|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
153622171|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
153622179|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622180|NCT02001818|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153622181|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153622183|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622185|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
153622186|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622187|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153622188|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153622217|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
153622218|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153622219|NCT02003885|Desflurane|desflurane|mesh-list
153622220|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153622221|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
153622222|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
153622223|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622224|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622225|NCT02004067|Cyclosporine|cyclosporine|mesh-list
153622226|NCT02004067|Castor Oil|castor oil|mesh-list
153622227|NCT02004067|Cyclosporins|cyclosporins|mesh-list
153622228|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622229|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622230|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153622231|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
153622232|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622233|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
153622234|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622235|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
153622236|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622237|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153622266|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153622267|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153622268|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
153622269|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
153622270|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622271|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622272|NCT02004301|Diclofenac|diclofenac|mesh-list
153622273|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153622274|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153622275|NCT02004301|Analgesics|analgesics|mesh-ancestor
153622276|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
153622277|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622278|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622279|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153622280|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622281|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153622282|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622283|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622284|NCT02004314|Chloroquine|chloroquine|mesh-list
153622285|NCT02004314|Amebicides|amebicides|mesh-ancestor
153622286|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153622287|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153622288|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622289|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
153622290|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622291|NCT02004418|Choline|choline|mesh-list
153622292|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
153622293|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153622295|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622296|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153622297|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153622298|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
153622299|NCT02004509|Anticoagulants|anticoagulants|mesh-list
153622300|NCT02004574|Betamethasone|betamethasone|mesh-list
153622301|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
153622302|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153622303|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
153622352|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153622353|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153622354|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
153622355|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
153622356|NCT02005068|Ceftaroline|ceftaroline|mesh-list
153622357|NCT02005068|Cephalosporins|cephalosporins|mesh-list
153622358|NCT02005068|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153622359|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153622360|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622361|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153622362|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153622363|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153622364|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153622365|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622397|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
153622398|NCT02005419|Metformin|metformin|mesh-list
153622399|NCT02005419|Gemcitabine|gemcitabine|mesh-list
153622400|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622401|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
153622402|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622403|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622404|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153622405|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622406|NCT02005523|RNS60|rns60|mesh-list
153622407|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153622408|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153622409|NCT02005523|Analgesics|analgesics|mesh-ancestor
153622410|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
153622411|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622412|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622413|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153622493|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622494|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153622495|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
153622497|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153622498|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153622499|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
153622500|NCT02005783|Docetaxel|docetaxel|mesh-list
153622501|NCT02005783|Epirubicin|epirubicin|mesh-list
153622502|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153622503|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
153622504|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622505|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622506|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153622507|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
153622508|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811292|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153918091|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
153622509|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622510|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153622511|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
153622512|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
153622513|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
153622514|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153622515|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153622516|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153622517|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622518|NCT02005822|Valganciclovir|valganciclovir|mesh-list
153622567|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153622568|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153622569|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
153622570|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622571|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622572|NCT02006485|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153622573|NCT02006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153622574|NCT02006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622576|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622578|NCT05970900|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153622601|NCT05970679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153622603|NCT05970627|Oxaliplatin|oxaliplatin|mesh-list
153622626|NCT05970250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622627|NCT05970250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153622628|NCT05970250|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153622629|NCT05969990|Tryptophan|tryptophan|mesh-list
153622630|NCT05969990|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153622646|NCT05969847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622647|NCT05969834|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153622648|NCT05969834|Luteolytic Agents|luteolytic agents|mesh-ancestor
153622649|NCT05969834|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153622650|NCT05969834|Contraceptive Agents|contraceptive agents|mesh-ancestor
153622651|NCT05969834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153622652|NCT05969834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622653|NCT05969834|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153622654|NCT05969834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153622655|NCT05969834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622656|NCT05969743|Letermovir|letermovir|mesh-list
153622657|NCT05969743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153413869|NCT00300768|Ivermectin|ivermectin|mesh-list
153622658|NCT05969743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622659|NCT05969743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622660|NCT05969743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622661|NCT05969743|Antiviral Agents|antiviral agents|mesh-ancestor
153622662|NCT05969743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622663|NCT05969561|Analgesics|analgesics|mesh-list
153622664|NCT05969561|Sensory System Agents|sensory system agents|mesh-ancestor
153622665|NCT05969561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622666|NCT05969561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622667|NCT05969522|Cyclophosphamide|cyclophosphamide|mesh-list
153622668|NCT05969522|Glucocorticoids|glucocorticoids|mesh-list
153622669|NCT05969522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153622670|NCT05969522|Immunologic Factors|immunologic factors|mesh-ancestor
153622671|NCT05969522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622672|NCT05969522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622727|NCT05968885|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153622728|NCT05968885|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153622729|NCT05968885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622730|NCT05968885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622782|NCT05967442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622783|NCT05967442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153622836|NCT05966792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153730624|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730625|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730626|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153622838|NCT05966792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622839|NCT05966792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622840|NCT05965908|Metformin|metformin|mesh-list
153622841|NCT05965908|Liraglutide|liraglutide|mesh-list
153622842|NCT05965908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153622843|NCT05965908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622844|NCT05965908|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153622845|NCT05965908|Incretins|incretins|mesh-ancestor
153622846|NCT05965908|Hormones|hormones|mesh-ancestor
153622847|NCT05965908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622848|NCT05951387|Dexmedetomidine|dexmedetomidine|mesh-list
153622849|NCT05951387|Ketamine|ketamine|mesh-list
153622885|NCT05928858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622886|NCT05923476|Lithium Carbonate|lithium carbonate|mesh-list
153622887|NCT05923476|Antidepressive Agents|antidepressive agents|mesh-ancestor
153622888|NCT05923476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153622889|NCT05923476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622890|NCT05923476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622891|NCT05923476|Antimanic Agents|antimanic agents|mesh-ancestor
153622892|NCT05923476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153622893|NCT05923476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622894|NCT05923476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622897|NCT05876858|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153622898|NCT05876858|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153622899|NCT05876858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622900|NCT05871684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153622914|NCT05835258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622915|NCT05835258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622916|NCT05835258|Antipruritics|antipruritics|mesh-ancestor
153622917|NCT05835258|Dermatologic Agents|dermatologic agents|mesh-ancestor
153622918|NCT05835258|Sensory System Agents|sensory system agents|mesh-ancestor
153622919|NCT05835258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622920|NCT05783544|Interferons|interferons|mesh-list
153622921|NCT05783544|Interferon-gamma|interferon-gamma|mesh-list
153622922|NCT05783544|Interleukin-4|interleukin-4|mesh-list
153622923|NCT05783544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622934|NCT05760677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622936|NCT05760677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622937|NCT05760677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153622938|NCT05760677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153622939|NCT05725031|Ephedrine|ephedrine|mesh-list
153622940|NCT05725031|Rocuronium|rocuronium|mesh-list
153622941|NCT05725031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153622942|NCT05725031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153622943|NCT05725031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153622944|NCT05725031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622945|NCT05725031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622946|NCT05725031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153622947|NCT05725031|Sympathomimetics|sympathomimetics|mesh-ancestor
153622948|NCT05725031|Autonomic Agents|autonomic agents|mesh-ancestor
153622949|NCT05725031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153622950|NCT05725031|Adrenergic Agents|adrenergic agents|mesh-ancestor
153622951|NCT05725031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622952|NCT05725031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622953|NCT05707754|Bupivacaine|bupivacaine|mesh-list
153622954|NCT05707754|Anesthetics, Local|anesthetics, local|mesh-ancestor
153622955|NCT05707754|Anesthetics|anesthetics|mesh-ancestor
153622956|NCT05707754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622957|NCT05707754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622958|NCT05707754|Sensory System Agents|sensory system agents|mesh-ancestor
153622959|NCT05707754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622960|NCT05699824|Carvedilol|carvedilol|mesh-list
153622961|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153622962|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153622963|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
153622964|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622965|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622966|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622967|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153622968|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
153622969|NCT05699824|Protective Agents|protective agents|mesh-ancestor
153622970|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153622971|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153622972|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153622973|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
153622974|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153623066|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
153623082|NCT05444751|Anesthetics|anesthetics|mesh-list
153623083|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
153623084|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623085|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357777|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
153357778|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153623086|NCT05422534|Ubiquinone|ubiquinone|mesh-list
153623087|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
153623088|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623089|NCT05422066|Prednisone|prednisone|mesh-list
153623090|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
153623091|NCT05422066|Rituximab|rituximab|mesh-list
153623092|NCT05422066|Doxorubicin|doxorubicin|mesh-list
153623093|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153623094|NCT05422066|Vincristine|vincristine|mesh-list
153623095|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153623096|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
153623097|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623098|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623099|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153623100|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
153623101|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623102|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623103|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153623104|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623105|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153623124|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
153623126|NCT05413343|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153623145|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
153623146|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153623148|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153623149|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
153623150|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
153623151|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
153623152|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153623153|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153623154|NCT05319899|Growth Substances|growth substances|mesh-ancestor
153623155|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623156|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
153623157|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623158|NCT05291364|Ethanol|ethanol|mesh-list
153623159|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
153623160|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153623161|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623162|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623163|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623164|NCT05291364|Analgesics|analgesics|mesh-ancestor
153623165|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
153623166|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623167|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153730627|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153623168|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153623169|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153623170|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
153623171|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623172|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623173|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153623174|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153623175|NCT05291221|Lidocaine|lidocaine|mesh-list
153623176|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
153623177|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
153623178|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
153623179|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623214|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
153623215|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623216|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357779|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153623217|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153623218|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153623219|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153623220|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623222|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153623223|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623224|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153623225|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623226|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
153623227|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623228|NCT05190562|Astringents|astringents|mesh-ancestor
153623229|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
153623230|NCT05152472|Atezolizumab|atezolizumab|mesh-list
153623231|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
153623232|NCT05152472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153623233|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623234|NCT05152472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623276|NCT04999449|Scopolamine|scopolamine|mesh-list
153623277|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153623280|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
153623281|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623282|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623283|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153623284|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
153623303|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153623304|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153623305|NCT04929080|Antibodies|antibodies|mesh-list
153623306|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
153623307|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153623308|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
153623309|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
153623310|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623328|NCT04901299|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153623329|NCT04901299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623331|NCT04901299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623332|NCT04898075|Nicotine|nicotine|mesh-list
153623333|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153623334|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
153623335|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623336|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623337|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153623338|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153623339|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
153623340|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730633|NCT00152373|Levetiracetam|levetiracetam|mesh-list
153730634|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
153623341|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623342|NCT04893655|Dobutamine|dobutamine|mesh-list
153623343|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153623344|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
153623345|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
153623346|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623347|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623348|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153623349|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153623350|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153623351|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
153623352|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623353|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782008|NCT04566211|Bismuth|bismuth|mesh-list
153811297|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153811298|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
153466921|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623388|NCT04816162|Propofol|propofol|mesh-list
153623389|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153623390|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623391|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623392|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623393|NCT04816162|Analgesics|analgesics|mesh-ancestor
153623394|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
153623395|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623396|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153623397|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153623398|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153623399|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
153623400|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623401|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623402|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153623403|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
153623404|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
153623405|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153623406|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153623407|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153623408|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
153623409|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623410|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
153623411|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623412|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623413|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153623458|NCT04734730|Hormones|hormones|mesh-ancestor
153623459|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623460|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623462|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623463|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153623464|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
153623465|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153623561|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623562|NCT04487236|Capecitabine|capecitabine|mesh-list
153623563|NCT04487236|Trastuzumab|trastuzumab|mesh-list
153623564|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153623565|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
153623566|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623567|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623568|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623569|NCT04473664|Quizartinib|quizartinib|mesh-list
153623600|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153623601|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153623602|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153623603|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153623604|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153623605|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730637|NCT00134654|Estrogens|estrogens|mesh-ancestor
153623606|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
153623607|NCT04400838|Vaccines|vaccines|mesh-list
153623608|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
153623609|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623610|NCT04396990|Prednisolone|prednisolone|mesh-list
153623611|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623612|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
153623613|NCT04396990|Hormones|hormones|mesh-ancestor
153623651|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623652|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153623653|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153623654|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
153811299|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153811300|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
153918184|NCT01134042|Fluticasone|fluticasone|mesh-list
153623655|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153623656|NCT04254081|Lidocaine|lidocaine|mesh-list
153623657|NCT04254081|Buprenorphine|buprenorphine|mesh-list
153623658|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
153623659|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
153623660|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623661|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623662|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
153623663|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623664|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153623665|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153623666|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153623667|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153623668|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623669|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153623670|NCT04254081|Narcotics|narcotics|mesh-ancestor
153623671|NCT04254081|Analgesics|analgesics|mesh-ancestor
153623672|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153623673|NCT04250948|Capecitabine|capecitabine|mesh-list
153623674|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
153623720|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153623721|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153623722|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
153623723|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
153623724|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623725|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153623726|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153623727|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623728|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623729|NCT04122196|Pregabalin|pregabalin|mesh-list
153623730|NCT04122196|Analgesics|analgesics|mesh-ancestor
153623731|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
153623741|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623742|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153623743|NCT04106115|Durvalumab|durvalumab|mesh-list
153623744|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153623745|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623778|NCT04042558|Bevacizumab|bevacizumab|mesh-list
153623779|NCT04042558|Atezolizumab|atezolizumab|mesh-list
153623780|NCT04042558|Carboplatin|carboplatin|mesh-list
153623781|NCT04042558|Pemetrexed|pemetrexed|mesh-list
153623782|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153623783|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623785|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153623786|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153623787|NCT04042558|Growth Substances|growth substances|mesh-ancestor
153623788|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623789|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
153623829|NCT03994172|Citric Acid|citric acid|mesh-list
153623830|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
153623831|NCT03994172|Calcium|calcium|mesh-list
153623832|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
153623833|NCT03994172|Cinacalcet|cinacalcet|mesh-list
153623834|NCT03994172|Hormones|hormones|mesh-list
153623835|NCT03994172|Vitamins|vitamins|mesh-ancestor
153623836|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
153623837|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623838|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153623839|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153623840|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
153623841|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153623842|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
153623843|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
153623844|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811304|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
153918189|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623845|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623957|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623958|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153623959|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623960|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623961|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153623962|NCT03859024|Narcotics|narcotics|mesh-ancestor
153623963|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153623985|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624007|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624008|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624009|NCT03607175|Triamcinolone|triamcinolone|mesh-list
153624010|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153624011|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624012|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
153624014|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624015|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624016|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624017|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
153624018|NCT03573024|Azacitidine|azacitidine|mesh-list
153624022|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624023|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624024|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624025|NCT03560960|Pramlintide|pramlintide|mesh-list
153624026|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153624027|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624028|NCT03534323|Venetoclax|venetoclax|mesh-list
153624029|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624030|NCT03520842|Methotrexate|methotrexate|mesh-list
153624031|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153624032|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
153624033|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153624034|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624035|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153624036|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
153624037|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624038|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624039|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
153447437|NCT00002609|Idarubicin|idarubicin|mesh-list
153918200|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153624040|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624041|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153624042|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624069|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624071|NCT03277482|Durvalumab|durvalumab|mesh-list
153624072|NCT03277482|Tremelimumab|tremelimumab|mesh-list
153624073|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624074|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624075|NCT03267186|Ibrutinib|ibrutinib|mesh-list
153624076|NCT03267186|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153624077|NCT03267186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153624078|NCT03267186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624079|NCT03267186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624080|NCT03249142|Durvalumab|durvalumab|mesh-list
153624081|NCT03249142|Tremelimumab|tremelimumab|mesh-list
153624082|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153624083|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624084|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624085|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
153731746|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153624086|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624134|NCT02916771|Ixazomib|ixazomib|mesh-list
153624135|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624136|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
153624137|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
153624154|NCT02913196|Prednisone|prednisone|mesh-list
153624155|NCT02913196|Docetaxel|docetaxel|mesh-list
153624156|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
153624157|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624158|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
153624166|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624167|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153624168|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153624169|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624170|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
153624171|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153624172|NCT02890082|Tamoxifen|tamoxifen|mesh-list
153624173|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153624174|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
153624175|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624176|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624178|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624179|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153624180|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153624181|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153624182|NCT02844933|Cannabidiol|cannabidiol|mesh-list
153624183|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
153624184|NCT02797470|Cytarabine|cytarabine|mesh-list
153624185|NCT02797470|Etoposide|etoposide|mesh-list
153624186|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
153624187|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
153624188|NCT02797470|Melphalan|melphalan|mesh-list
153811308|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624189|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
153624190|NCT02797470|Carmustine|carmustine|mesh-list
153624191|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153624192|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153624193|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624194|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153624195|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153624196|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624197|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624198|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153624199|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
153624200|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
153811310|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
153624201|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624202|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624246|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153624247|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624248|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153624249|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153624250|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
153624251|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153624252|NCT02506517|Afatinib|afatinib|mesh-list
153624253|NCT02506517|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153624254|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153624255|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624256|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624257|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624258|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
153624259|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
153624260|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
153624261|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624262|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624263|NCT02499835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153624264|NCT02499835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624265|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
153624266|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624267|NCT02460497|Minoxidil|minoxidil|mesh-list
153624268|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153624269|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
153624311|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153624312|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
153624313|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624314|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624315|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153624317|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
153624318|NCT02130453|Regadenoson|regadenoson|mesh-list
153624319|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153624320|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153624321|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
153624322|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
153624323|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624324|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624325|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624326|NCT02059265|Dasatinib|dasatinib|mesh-list
153624327|NCT02059265|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153624328|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153624329|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624330|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624331|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624332|NCT01661647|Anesthetics|anesthetics|mesh-list
153624333|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624334|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624335|NCT00655967|Acamprosate|acamprosate|mesh-list
153624336|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153624337|NCT00601198|Leucovorin|leucovorin|mesh-list
153624372|NCT02006849|Hormones|hormones|mesh-ancestor
153624373|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624374|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624375|NCT02006914|Chromium|chromium|mesh-list
153624376|NCT02006914|Picolinic acid|picolinic acid|mesh-list
153624377|NCT02006914|Trace Elements|trace elements|mesh-ancestor
153624378|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
153624379|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624380|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153624381|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
153624382|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
153624383|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624384|NCT02006966|Lidocaine|lidocaine|mesh-list
153624385|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
153624386|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
153624387|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624388|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624389|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
153624406|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
153624407|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
153624408|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624409|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153624411|NCT02007161|Diclofenac|diclofenac|mesh-list
153624424|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624425|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624426|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153624427|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153624428|NCT02007174|Growth Substances|growth substances|mesh-ancestor
153624429|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624430|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
153624432|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
153624433|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
153624434|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624435|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624436|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
153624437|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624438|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153624439|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153624440|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153624441|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624442|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624443|NCT02007408|Lidocaine|lidocaine|mesh-list
153624444|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
153624445|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
153624446|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624447|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624449|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624450|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153624451|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153624452|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153624453|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624454|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624455|NCT02007447|Oxytocin|oxytocin|mesh-list
153624456|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
153624457|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153624458|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624495|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624496|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624497|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447490|NCT00002633|Leuprolide|leuprolide|mesh-list
153918237|NCT01145898|Timolol|timolol|mesh-list
153624498|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153624499|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153624500|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624501|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153624502|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153624503|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624505|NCT02007850|Ropivacaine|ropivacaine|mesh-list
153624506|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
153624507|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
153624508|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624509|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624510|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
153624511|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624512|NCT02007915|Pamidronate|pamidronate|mesh-list
153624513|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153624514|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624515|NCT02007928|Olanzapine|olanzapine|mesh-list
153624516|NCT02007928|Risperidone|risperidone|mesh-list
153624517|NCT02007928|Aripiprazole|aripiprazole|mesh-list
153624518|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153624519|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
153624520|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624521|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624522|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624523|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153624524|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153624560|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
153624561|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153624566|NCT02008019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624568|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
153624569|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624570|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624571|NCT02008123|Primidone|primidone|mesh-list
153624572|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
153624573|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
153624574|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
153624597|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624598|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624600|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
153624601|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153624602|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153624603|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153624604|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153624605|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
153624606|NCT02008201|Vitamin D|vitamin d|mesh-list
153624607|NCT02008201|Vitamins|vitamins|mesh-ancestor
153624608|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
153624609|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624610|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153624611|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
153624612|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153624613|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624614|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624615|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153624616|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153624617|NCT02008214|Protective Agents|protective agents|mesh-ancestor
153624618|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256532|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153624619|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
153624620|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153624621|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
153624622|NCT02008383|Panitumumab|panitumumab|mesh-list
153624623|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624624|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624625|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
153624626|NCT02008422|Tegafur|tegafur|mesh-list
153814599|NCT00341432|Nicotine|nicotine|mesh-list
153624667|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153624669|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153624670|NCT02008968|Allopurinol|allopurinol|mesh-list
153624671|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
153624672|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624673|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624674|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
153624675|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624676|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153730640|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624677|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
153624678|NCT02008968|Protective Agents|protective agents|mesh-ancestor
153624679|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624681|NCT02008981|Turmeric extract|turmeric extract|mesh-list
153624682|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153624683|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153624684|NCT02008981|Analgesics|analgesics|mesh-ancestor
153624685|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
153624686|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624687|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624688|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624715|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624716|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624717|NCT02009007|Protective Agents|protective agents|mesh-ancestor
153624718|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
153624719|NCT02009098|Cefuroxime|cefuroxime|mesh-list
153624720|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
153624721|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153624722|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624746|NCT05778305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153624748|NCT05778305|Sensory System Agents|sensory system agents|mesh-ancestor
153624749|NCT05778305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624750|NCT05778305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153624751|NCT05778305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153624752|NCT05778305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153624753|NCT05778305|Adrenergic Agents|adrenergic agents|mesh-ancestor
153624754|NCT05778305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624755|NCT05778305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624756|NCT05778097|Androgens|androgens|mesh-list
153624757|NCT05778097|Hormones|hormones|mesh-ancestor
153624758|NCT05778097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624759|NCT05778097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624760|NCT05778084|Empagliflozin|empagliflozin|mesh-list
153624761|NCT05778084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153624762|NCT05778084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624763|NCT05778084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153624764|NCT05778084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624765|NCT05777902|Ozanimod|ozanimod|mesh-list
153624766|NCT05777902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153624767|NCT05777902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624768|NCT05777902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624769|NCT05777902|Immunologic Factors|immunologic factors|mesh-ancestor
153624770|NCT05777902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624771|NCT05777707|Paclitaxel|paclitaxel|mesh-list
153624772|NCT05777707|Carboplatin|carboplatin|mesh-list
153624773|NCT05777707|Nedaplatin|nedaplatin|mesh-list
153624774|NCT05777707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153624775|NCT05777707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624776|NCT05777707|Tubulin Modulators|tubulin modulators|mesh-ancestor
153811311|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624777|NCT05777707|Antimitotic Agents|antimitotic agents|mesh-ancestor
153624778|NCT05777707|Mitosis Modulators|mitosis modulators|mesh-ancestor
153624779|NCT05777707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624780|NCT05777694|Anesthetics|anesthetics|mesh-list
153624781|NCT05777694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624782|NCT05777694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624783|NCT05777369|Prednisone|prednisone|mesh-list
153624784|NCT05777369|Cyclophosphamide|cyclophosphamide|mesh-list
153624785|NCT05777369|Rituximab|rituximab|mesh-list
153624822|NCT05777122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153624823|NCT05777122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153624824|NCT05777122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624825|NCT05777122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624826|NCT05616390|Bevacizumab|bevacizumab|mesh-list
153624827|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624828|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624829|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153624830|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153624831|NCT05616390|Growth Substances|growth substances|mesh-ancestor
153624832|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624833|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
153624834|NCT05548270|Scopolamine|scopolamine|mesh-list
153624835|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153624836|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
153624837|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
153624838|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624839|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624840|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153624841|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
153624842|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153624843|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
153624844|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624845|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624846|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153624847|NCT05410158|Ketamine|ketamine|mesh-list
153624848|NCT05410158|Analgesics|analgesics|mesh-ancestor
153624849|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
153624850|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624851|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624888|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153624889|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153624890|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624892|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624893|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624910|NCT04771000|Ambrisentan|ambrisentan|mesh-list
153624911|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153624924|NCT04567420|Fulvestrant|fulvestrant|mesh-list
153624925|NCT04567420|Palbociclib|palbociclib|mesh-list
153624926|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153624927|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624928|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153624929|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153624930|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
153624931|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624932|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624933|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153624934|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624935|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811316|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624936|NCT04461587|Pirfenidone|pirfenidone|mesh-list
153624937|NCT04461587|Analgesics|analgesics|mesh-ancestor
153624938|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
153624939|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624940|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624941|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153624942|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153624943|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624944|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624982|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153624983|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
153624985|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624986|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153624987|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624988|NCT04062591|Piroxicam|piroxicam|mesh-list
153624989|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153624990|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153624991|NCT04062591|Analgesics|analgesics|mesh-ancestor
153624992|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
153624993|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624994|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624996|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624997|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153624998|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624999|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625000|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153625001|NCT04059770|Amphotericin B|amphotericin b|mesh-list
153625002|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
153625003|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730642|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153731747|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625004|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153625005|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153625006|NCT04059770|Amebicides|amebicides|mesh-ancestor
153625007|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153625008|NCT04050280|Cytarabine|cytarabine|mesh-list
153625009|NCT04050280|Cladribine|cladribine|mesh-list
153625010|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
153625011|NCT04050280|Lenograstim|lenograstim|mesh-list
153625056|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153625057|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153625081|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625082|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
153730643|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153730644|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153625108|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625109|NCT03463876|Apatinib|apatinib|mesh-list
153625110|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625111|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153625112|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625113|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625114|NCT03461120|Anesthetics|anesthetics|mesh-list
153625115|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
153625116|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625117|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447653|NCT00002735|Cobalt|cobalt|mesh-list
153625118|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
153625119|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625120|NCT03396588|Clonidine|clonidine|mesh-list
153625121|NCT03396588|Morphine|morphine|mesh-list
153625122|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153625123|NCT03396588|Narcotics|narcotics|mesh-ancestor
153625124|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625125|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625126|NCT03396588|Analgesics|analgesics|mesh-ancestor
153625127|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
153625128|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625129|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153625130|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
153625131|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
153625132|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153625133|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153625177|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625178|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153625179|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153625180|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
153625181|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625182|NCT02649998|Furosemide|furosemide|mesh-list
153625183|NCT02649998|Isosorbide|isosorbide|mesh-list
153625184|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153625185|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153625186|NCT02649998|Diuretics|diuretics|mesh-ancestor
153625187|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
153625188|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625189|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153625190|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153625191|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625192|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153625193|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625194|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153625195|NCT02503358|Paclitaxel|paclitaxel|mesh-list
153730645|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
153730646|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
153625236|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625237|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
153625240|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153625242|NCT02332980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153625243|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625244|NCT02332980|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153625245|NCT02332980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153625246|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625247|NCT02087826|Metformin|metformin|mesh-list
153625248|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153625249|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625250|NCT02048150|Antibodies|antibodies|mesh-list
153625251|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153625252|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
153461967|NCT00638508|Ketorolac|ketorolac|mesh-list
153625269|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153625271|NCT02038452|Protective Agents|protective agents|mesh-ancestor
153625272|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153625273|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625274|NCT01748448|Vitamin D|vitamin d|mesh-list
153625275|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
153625276|NCT01748448|Vitamins|vitamins|mesh-ancestor
153625277|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
153625278|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625279|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153625280|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153625281|NCT01476839|Cytarabine|cytarabine|mesh-list
153625282|NCT01476839|Etoposide|etoposide|mesh-list
153625283|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
153625284|NCT01476839|Melphalan|melphalan|mesh-list
153625285|NCT01476839|Carmustine|carmustine|mesh-list
153625286|NCT01476839|Basiliximab|basiliximab|mesh-list
153625287|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153625288|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625289|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153625290|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153625291|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625292|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625293|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153625294|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
153625295|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
153625296|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625379|NCT02009280|Propofol|propofol|mesh-list
153625380|NCT02009280|Sevoflurane|sevoflurane|mesh-list
153625381|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625382|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625383|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153625384|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153625385|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
153625386|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153625387|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153625388|NCT02009306|Midazolam|midazolam|mesh-list
153625389|NCT02009306|Fentanyl|fentanyl|mesh-list
153625390|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153625391|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153625392|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625393|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625433|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
153625434|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153625435|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
153625436|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153625437|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153625438|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153625439|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153625440|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625441|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
153625442|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625443|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625444|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153625445|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625446|NCT02009592|Rifaximin|rifaximin|mesh-list
153625447|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153625448|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730647|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731748|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
153625449|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625451|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153625497|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153625498|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153625499|NCT02010762|Vitamin D|vitamin d|mesh-list
153625500|NCT02010762|Vitamins|vitamins|mesh-ancestor
153625501|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
153625502|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625503|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153625504|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
153625505|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153625506|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153625507|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153625508|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153625509|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625510|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
153625511|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625512|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625513|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153625514|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625515|NCT02010827|Glucagon|glucagon|mesh-list
153625516|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625517|NCT02010827|Hormones|hormones|mesh-ancestor
153625518|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153625519|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625520|NCT02010905|Losartan|losartan|mesh-list
153625521|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153625522|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153625523|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153625524|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153730654|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
153730655|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153730656|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
153730657|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730658|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
153730659|NCT00134693|Hormones|hormones|mesh-ancestor
153625570|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153625571|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
153462284|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
153625578|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
153625579|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625580|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625581|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153625583|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
153625584|NCT02011191|Vitamins|vitamins|mesh-ancestor
153625585|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
153625586|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625587|NCT02011347|Ketamine|ketamine|mesh-list
153625588|NCT02011347|Analgesics|analgesics|mesh-ancestor
153625589|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
153625590|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625591|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625592|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153625593|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153625594|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
153625595|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
153625596|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625597|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153625598|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153625599|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731749|NCT00139217|Protective Agents|protective agents|mesh-ancestor
153625627|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
153625628|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811320|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153357788|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625629|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625630|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625631|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153625632|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
153625633|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625634|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625635|NCT02011737|Naftopidil|naftopidil|mesh-list
153625636|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153625637|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153462333|NCT00630786|Panitumumab|panitumumab|mesh-list
153625660|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153625664|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153625665|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
153625666|NCT02011841|Rifaximin|rifaximin|mesh-list
153625667|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153625688|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153625689|NCT02011958|Miltefosine|miltefosine|mesh-list
153625698|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153625699|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
153625700|NCT02012049|Risperidone|risperidone|mesh-list
153625701|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153625702|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
153625703|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625704|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625705|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625706|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153625707|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153625708|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625709|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153625710|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153625711|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
153625712|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
153625713|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625714|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153625715|NCT02012075|Metoprolol|metoprolol|mesh-list
153625716|NCT02012075|Carvedilol|carvedilol|mesh-list
153625717|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153625718|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153625719|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
153625720|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
153625721|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625722|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625723|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153625724|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153625725|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153625726|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
153625727|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625728|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625729|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
153625730|NCT02012075|Protective Agents|protective agents|mesh-ancestor
153625731|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153625770|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153625771|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
153625772|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625774|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
153625775|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
153625776|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625778|NCT02012335|Ketamine|ketamine|mesh-list
153625779|NCT02012335|Analgesics|analgesics|mesh-ancestor
153625780|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
153625781|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625782|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625783|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153625784|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153625785|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
153625786|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
153625809|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
153625810|NCT02012556|Tesamorelin|tesamorelin|mesh-list
153625811|NCT02012556|Growth Substances|growth substances|mesh-ancestor
153625812|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625813|NCT02012569|Hemostatics|hemostatics|mesh-list
153625815|NCT02012595|Donepezil|donepezil|mesh-list
153625816|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153625817|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625818|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625819|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
153625820|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625821|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625822|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
153625843|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153625844|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625845|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625846|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154256533|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451652|NCT02211443|Antibodies|antibodies|mesh-list
153625847|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153625848|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625850|NCT02012946|Dobutamine|dobutamine|mesh-list
153625851|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153625852|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625853|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153625854|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153625855|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625856|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625857|NCT02012946|Protective Agents|protective agents|mesh-ancestor
153625858|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625859|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
153625860|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
153625861|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625919|NCT02013271|Paclitaxel|paclitaxel|mesh-list
153625920|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153625921|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625942|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
153625943|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
153625944|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625945|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
153625946|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153625996|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153625997|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782009|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153357803|NCT01301183|Mecasermin|mecasermin|mesh-list
153918357|NCT00641329|Clonidine|clonidine|mesh-list
153625998|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625999|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153626000|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
153626002|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153626027|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626028|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626029|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
153626030|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626031|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626032|NCT02013089|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153626033|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153626066|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
153626067|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626068|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
153626069|NCT02014428|Protective Agents|protective agents|mesh-ancestor
153626070|NCT02014454|Propranolol|propranolol|mesh-list
153626071|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153626072|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153462821|NCT04120350|Rituximab|rituximab|mesh-list
153731751|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153626086|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
153626087|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626088|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153626089|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153626090|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
153626091|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626092|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626093|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153626094|NCT02014532|Montelukast|montelukast|mesh-list
153626095|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
153626096|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153626122|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
153626123|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
153626124|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
153626125|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
153626126|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626127|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626128|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
153626129|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626130|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153626131|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153626132|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626133|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153626143|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626144|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
153626145|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626146|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626147|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
153626148|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153626149|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626150|NCT02014636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153626151|NCT02014636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626152|NCT02014714|Fentanyl|fentanyl|mesh-list
153626153|NCT02014714|Morphine|morphine|mesh-list
153626154|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153626173|NCT02014753|Chromium|chromium|mesh-list
153626174|NCT02014753|Everolimus|everolimus|mesh-list
153626175|NCT02014753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153626176|NCT02014753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153626177|NCT02014753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626178|NCT02014753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626179|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626180|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
153626181|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626182|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626183|NCT02014753|Trace Elements|trace elements|mesh-ancestor
153626184|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
153626185|NCT02014831|Cetuximab|cetuximab|mesh-list
153626186|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153626187|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626188|NCT02014922|Vitamin E|vitamin e|mesh-list
153626189|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
153626190|NCT02014922|Tocopherols|tocopherols|mesh-list
153626191|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153626192|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153626193|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
153626194|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153626195|NCT02014922|Laxatives|laxatives|mesh-ancestor
153626196|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153626197|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
153626198|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626199|NCT02014922|Protective Agents|protective agents|mesh-ancestor
153626219|NCT02015260|Citric Acid|citric acid|mesh-list
153626220|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
153626221|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153626222|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
153626223|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
153626224|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626225|NCT02015299|Linagliptin|linagliptin|mesh-list
153626226|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153626227|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153626228|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626229|NCT02015299|Incretins|incretins|mesh-ancestor
153626230|NCT02015299|Hormones|hormones|mesh-ancestor
153811341|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153357808|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153357809|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
153918363|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
153918364|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
153626231|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153626254|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626255|NCT02015403|Expectorants|expectorants|mesh-ancestor
153462970|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153626290|NCT02015650|Mitomycins|mitomycins|mesh-list
153626291|NCT02015650|Mitomycin|mitomycin|mesh-list
153626292|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
153626293|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626294|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626295|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626296|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626323|NCT02015728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153626324|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153626325|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626327|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153626328|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626329|NCT02015949|Methylphenidate|methylphenidate|mesh-list
153626330|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153626331|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626332|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153626333|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153626334|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626335|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626336|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
153626337|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626338|NCT02015988|Simvastatin|simvastatin|mesh-list
153626339|NCT02015988|Fenofibrate|fenofibrate|mesh-list
153451693|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153626340|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153626341|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153626343|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626344|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153626345|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153626392|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626393|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
153626394|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
153626395|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
153782010|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626396|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626397|NCT02016287|Paclitaxel|paclitaxel|mesh-list
153626398|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153626399|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626400|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
153463127|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
153626429|NCT02016417|Docetaxel|docetaxel|mesh-list
153626430|NCT02016417|Fluorouracil|fluorouracil|mesh-list
153626431|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626432|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626433|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
153626434|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626544|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626545|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153626546|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626548|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
153626549|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
153626550|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626551|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626552|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
153626553|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730661|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626554|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153463275|NCT03823638|Mannitol|mannitol|mesh-list
153626583|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626584|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736495|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153736497|NCT01814397|Letrozole|letrozole|mesh-list
153736498|NCT01814397|Anastrozole|anastrozole|mesh-list
153736499|NCT01814397|Exemestane|exemestane|mesh-list
153736500|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736501|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153736502|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153736503|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736504|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736505|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153736506|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
153736507|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736508|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736509|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153736510|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
153736511|NCT01701986|Rituximab|rituximab|mesh-list
153736512|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153736513|NCT01701986|Gemcitabine|gemcitabine|mesh-list
153736514|NCT01701986|Busulfan|busulfan|mesh-list
153736515|NCT01701986|Clofarabine|clofarabine|mesh-list
153736516|NCT01701986|Antibodies|antibodies|mesh-list
153736517|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
153736562|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736563|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153736564|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153736565|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153736566|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736567|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736568|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153736569|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
153736570|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
153736571|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
153736572|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736573|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451733|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
153736574|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736576|NCT01527149|Dexamethasone|dexamethasone|mesh-list
153736577|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
153736578|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
153736579|NCT01527149|Doxorubicin|doxorubicin|mesh-list
153736580|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153736581|NCT01527149|Methotrexate|methotrexate|mesh-list
153736582|NCT01527149|Vincristine|vincristine|mesh-list
153736584|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153736585|NCT01527149|BB 1101|bb 1101|mesh-list
153736586|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736587|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
153736588|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736589|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736590|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153736602|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736603|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153736604|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153573678|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
153736636|NCT00502463|Cetuximab|cetuximab|mesh-list
153736637|NCT00502463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736638|NCT00502463|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736639|NCT00502463|Antimitotic Agents|antimitotic agents|mesh-ancestor
153736640|NCT00502463|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736641|NCT00502463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736642|NCT00502463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736643|NCT00390793|Cytarabine|cytarabine|mesh-list
153736644|NCT00390793|Dexamethasone|dexamethasone|mesh-list
153736645|NCT00390793|Prednisone|prednisone|mesh-list
153730662|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153730663|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736646|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
153736692|NCT00390793|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153736693|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153736694|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
153736695|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
153736696|NCT00338377|Fludarabine|fludarabine|mesh-list
153736697|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
153736714|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736715|NCT00338377|Protective Agents|protective agents|mesh-ancestor
153736716|NCT06182891|Dulaglutide|dulaglutide|mesh-list
153736717|NCT06182891|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153736718|NCT06182891|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153472683|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736725|NCT06182800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153736726|NCT06182800|Growth Substances|growth substances|mesh-ancestor
153736727|NCT06182800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736728|NCT06182800|Growth Inhibitors|growth inhibitors|mesh-ancestor
153736729|NCT06182800|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736730|NCT06182800|Antimitotic Agents|antimitotic agents|mesh-ancestor
153736731|NCT06182800|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736732|NCT06182800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736733|NCT06182735|Cyclophosphamide|cyclophosphamide|mesh-list
153736734|NCT06182735|Fludarabine|fludarabine|mesh-list
153736735|NCT06182735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736736|NCT06182735|Immunologic Factors|immunologic factors|mesh-ancestor
153736737|NCT06182735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736738|NCT06182735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736739|NCT06182735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153736740|NCT06182735|Alkylating Agents|alkylating agents|mesh-ancestor
153736741|NCT06182735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736742|NCT06182735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736743|NCT06182735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153736744|NCT06182618|Metformin|metformin|mesh-list
153736745|NCT06182618|Semaglutide|semaglutide|mesh-list
153736746|NCT06182618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153736747|NCT06182618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736748|NCT06182618|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153736749|NCT06182397|Sirolimus|sirolimus|mesh-list
153736750|NCT06182397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153736751|NCT06182397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736752|NCT06182397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153736753|NCT06182397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736754|NCT06182397|Antifungal Agents|antifungal agents|mesh-ancestor
153736755|NCT06182397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736756|NCT06182397|Immunologic Factors|immunologic factors|mesh-ancestor
153736757|NCT06182397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736758|NCT06182358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153736759|NCT06182358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153736760|NCT06182111|Morphine|morphine|mesh-list
153736761|NCT06182111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153736782|NCT06182098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736783|NCT06182098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153736785|NCT06182098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736786|NCT06182098|Anesthetics, Local|anesthetics, local|mesh-ancestor
153736787|NCT06182098|Anesthetics|anesthetics|mesh-ancestor
153736788|NCT06182098|Antiemetics|antiemetics|mesh-ancestor
153736802|NCT06182098|Dopamine Agents|dopamine agents|mesh-ancestor
153736803|NCT06182072|Paclitaxel|paclitaxel|mesh-list
153736804|NCT06182072|Gemcitabine|gemcitabine|mesh-list
153736805|NCT06182072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153736806|NCT06182072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736807|NCT06182072|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736808|NCT06182072|Antimitotic Agents|antimitotic agents|mesh-ancestor
153736809|NCT06182072|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736810|NCT06182072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736811|NCT06182072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736812|NCT06182072|Antimetabolites|antimetabolites|mesh-ancestor
153736813|NCT06182020|Calcium|calcium|mesh-list
153736814|NCT06182020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153736815|NCT06182020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736816|NCT06181695|Sufentanil|sufentanil|mesh-list
153736817|NCT06181695|Morphine|morphine|mesh-list
153736818|NCT06181695|Dsuvia|dsuvia|mesh-list
153736819|NCT06181695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153736820|NCT06181695|Narcotics|narcotics|mesh-ancestor
153736821|NCT06181695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736822|NCT06181695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736823|NCT06181695|Analgesics|analgesics|mesh-ancestor
153736824|NCT06181695|Sensory System Agents|sensory system agents|mesh-ancestor
153736825|NCT06181695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736826|NCT06181695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153736827|NCT06181695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153736828|NCT06181695|Anesthetics, General|anesthetics, general|mesh-ancestor
153736829|NCT06181695|Anesthetics|anesthetics|mesh-ancestor
153736853|NCT06181682|GABA Agents|gaba agents|mesh-ancestor
153736876|NCT06181188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153736877|NCT06181188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736878|NCT06181188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736879|NCT06181188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153736880|NCT06181188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153736882|NCT06181188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153736883|NCT06181188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153736884|NCT06181188|GABA Modulators|gaba modulators|mesh-ancestor
153736885|NCT06181188|GABA Agents|gaba agents|mesh-ancestor
153736886|NCT06181188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153736887|NCT06181188|Narcotics|narcotics|mesh-ancestor
153736888|NCT06181175|Tamsulosin|tamsulosin|mesh-list
153736889|NCT06181175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153736890|NCT06181175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153736891|NCT06181175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153736892|NCT06181175|Adrenergic Agents|adrenergic agents|mesh-ancestor
153736893|NCT06181175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736894|NCT06181175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736895|NCT06181175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736896|NCT06181175|Urological Agents|urological agents|mesh-ancestor
153736897|NCT06181084|Esomeprazole|esomeprazole|mesh-list
153736898|NCT06181084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153736899|NCT06181084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153736900|NCT06181084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153736901|NCT06181084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736902|NCT06181084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736903|NCT06181019|Mirabegron|mirabegron|mesh-list
153736950|NCT06180941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736951|NCT06180941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736952|NCT06180941|Anesthetics|anesthetics|mesh-ancestor
153736953|NCT06180941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736954|NCT06180941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153736955|NCT06180941|Anticonvulsants|anticonvulsants|mesh-ancestor
153736987|NCT06176963|Growth Substances|growth substances|mesh-ancestor
153736988|NCT06176963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736989|NCT06176963|Growth Inhibitors|growth inhibitors|mesh-ancestor
153736990|NCT06176963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736992|NCT06176235|Teriflunomide|teriflunomide|mesh-list
153736993|NCT06176235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153736994|NCT06176235|Antiemetics|antiemetics|mesh-ancestor
153736995|NCT06176235|Autonomic Agents|autonomic agents|mesh-ancestor
153736996|NCT06176235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736997|NCT06176235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736998|NCT06176235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153736999|NCT06176235|Glucocorticoids|glucocorticoids|mesh-ancestor
153737000|NCT06176235|Hormones|hormones|mesh-ancestor
153737001|NCT06176235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737002|NCT06176235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153737003|NCT06176235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737004|NCT06176235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153737005|NCT06176235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153737006|NCT06176235|Analgesics|analgesics|mesh-ancestor
153737007|NCT06176235|Sensory System Agents|sensory system agents|mesh-ancestor
153737008|NCT06176235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153737009|NCT06176235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153737010|NCT06176235|Immunologic Factors|immunologic factors|mesh-ancestor
153737011|NCT06174155|Botulinum Toxins|botulinum toxins|mesh-list
153737012|NCT06174155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153737013|NCT06174155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153737053|NCT06163820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153737054|NCT06163820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153782012|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153737056|NCT06163820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737057|NCT06163820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153737058|NCT06163820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737059|NCT06163820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737060|NCT06161454|Baloxavir|baloxavir|mesh-list
153737061|NCT06161454|Antiviral Agents|antiviral agents|mesh-ancestor
153737062|NCT06161454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737063|NCT06161454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737064|NCT06161454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737065|NCT06157242|Ceftibuten|ceftibuten|mesh-list
153737066|NCT06157242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153737067|NCT06157242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737068|NCT06145191|Epinephrine|epinephrine|mesh-list
153737069|NCT06145191|Racepinephrine|racepinephrine|mesh-list
153737091|NCT06104618|Immunoconjugates|immunoconjugates|mesh-list
153737092|NCT06104618|Immunologic Factors|immunologic factors|mesh-ancestor
153737093|NCT06104618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737094|NCT06099886|N-Methylaspartate|n-methylaspartate|mesh-list
153737095|NCT06099886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574128|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
153737096|NCT06099886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737097|NCT06099886|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153737098|NCT06099886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153737099|NCT06099886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737100|NCT06061146|Tislelizumab|tislelizumab|mesh-list
153737114|NCT05979311|Antiviral Agents|antiviral agents|mesh-ancestor
153737115|NCT05979311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737116|NCT05979311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153737117|NCT05979311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153737118|NCT05979311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737119|NCT05979311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737120|NCT05979311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153737121|NCT05979311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153737122|NCT05979311|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153737123|NCT05979311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153737124|NCT05969431|Hydrocortisone|hydrocortisone|mesh-list
153737125|NCT05969431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153737126|NCT05968612|Ivacaftor|ivacaftor|mesh-list
153737127|NCT05968612|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153737128|NCT05968612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153737129|NCT05968612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737130|NCT05938530|Sirolimus|sirolimus|mesh-list
153737131|NCT05938530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153737132|NCT05938530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737133|NCT05938530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153737134|NCT05938530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737162|NCT05839314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153737163|NCT05839314|Immunologic Factors|immunologic factors|mesh-ancestor
154256534|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737173|NCT05822765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153737174|NCT05822765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153737175|NCT05822765|Adrenergic Agents|adrenergic agents|mesh-ancestor
153737176|NCT05822765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737177|NCT05822765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737178|NCT05822765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737179|NCT05822765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153737180|NCT05822765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153737182|NCT05822765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737183|NCT05822765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153737184|NCT05822765|Respiratory System Agents|respiratory system agents|mesh-ancestor
153737185|NCT05822765|Mydriatics|mydriatics|mesh-ancestor
153737186|NCT05822765|Sympathomimetics|sympathomimetics|mesh-ancestor
153737187|NCT05822765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153737221|NCT05722704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737222|NCT05722704|Antifungal Agents|antifungal agents|mesh-ancestor
153737223|NCT05722704|Keratolytic Agents|keratolytic agents|mesh-ancestor
153737265|NCT05661357|Immunoconjugates|immunoconjugates|mesh-ancestor
153737266|NCT05661357|Immunologic Factors|immunologic factors|mesh-ancestor
153737267|NCT05661357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737268|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153737269|NCT05581706|Calcium|calcium|mesh-list
153737270|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153737271|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737272|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737273|NCT05553938|Empagliflozin|empagliflozin|mesh-list
153737274|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153737275|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737276|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153730670|NCT00152412|Levocetirizine|levocetirizine|mesh-list
153731752|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
153737277|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737278|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
153737279|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153737280|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737281|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
153737282|NCT05514912|Paclitaxel|paclitaxel|mesh-list
153737283|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153737284|NCT05514912|Cisplatin|cisplatin|mesh-list
153737285|NCT05514912|Gemcitabine|gemcitabine|mesh-list
153737286|NCT05514912|Infigratinib|infigratinib|mesh-list
153737287|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153737330|NCT05443334|Semaglutide|semaglutide|mesh-list
153737331|NCT05443334|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153737332|NCT05443334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737333|NCT05443334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737334|NCT05443191|Semaglutide|semaglutide|mesh-list
153737335|NCT05443191|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153737336|NCT05443191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737337|NCT05443191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737338|NCT05375305|Morphine|morphine|mesh-list
153737339|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153737340|NCT05375305|Narcotics|narcotics|mesh-ancestor
153737341|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153737342|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737343|NCT05375305|Analgesics|analgesics|mesh-ancestor
153737344|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
153737345|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737346|NCT05374525|Cabotegravir|cabotegravir|mesh-list
153737347|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153737348|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153737349|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473328|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153737360|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737361|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153737362|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
153737363|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153737364|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153737365|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
153737366|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737367|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737370|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153737371|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153737372|NCT05329740|Prednisolone|prednisolone|mesh-list
153737373|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
153737374|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153737375|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
153737376|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153737377|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
153737401|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153737402|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
153737403|NCT05324748|Hormones|hormones|mesh-ancestor
153737404|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737405|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153737406|NCT05324748|Protective Agents|protective agents|mesh-ancestor
153737407|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153737408|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737409|NCT05318443|Paclitaxel|paclitaxel|mesh-list
153737410|NCT05318443|Carboplatin|carboplatin|mesh-list
153737411|NCT05318443|Bevacizumab|bevacizumab|mesh-list
153737412|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153737413|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737414|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
153473382|NCT03004014|Propofol|propofol|mesh-list
153737436|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153737437|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
153737438|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153737439|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
153737440|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
153737441|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737442|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737443|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153737444|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
153737445|NCT05302388|Hormones|hormones|mesh-ancestor
153737446|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737447|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153737448|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737504|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737505|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153737507|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153737508|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153737509|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737510|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
153737511|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
153737512|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737550|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737551|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737552|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153737553|NCT05108974|Choline|choline|mesh-list
153737554|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
153737555|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153737556|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
153737557|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737558|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153737559|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153737560|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
153737561|NCT05089916|Osimertinib|osimertinib|mesh-list
153737562|NCT05089916|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153737563|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153737624|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153737625|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153737674|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737675|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153737676|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153737677|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737678|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737679|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
153737680|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737681|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737694|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
153737695|NCT04818216|Vitamins|vitamins|mesh-ancestor
153737696|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
153737697|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737699|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
153737700|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737701|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153737702|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
153737703|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
153737735|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737736|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153737737|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153737738|NCT04737187|Growth Substances|growth substances|mesh-ancestor
153737739|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737740|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
153737742|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737784|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153737785|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153737786|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737787|NCT04535401|Antidotes|antidotes|mesh-ancestor
153737788|NCT04535401|Protective Agents|protective agents|mesh-ancestor
153737789|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
153737790|NCT04535401|Vitamins|vitamins|mesh-ancestor
153737791|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
153737792|NCT04535401|Hematinics|hematinics|mesh-ancestor
153737793|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153737794|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
153737795|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153737796|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737797|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737798|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737799|NCT04486352|Bevacizumab|bevacizumab|mesh-list
153737800|NCT04486352|Trastuzumab|trastuzumab|mesh-list
153415001|NCT05730907|Simendan|simendan|mesh-list
153737801|NCT04486352|Atezolizumab|atezolizumab|mesh-list
153473786|NCT04739202|Bevacizumab|bevacizumab|mesh-list
153737828|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
153737830|NCT04486352|Immunoconjugates|immunoconjugates|mesh-ancestor
153737831|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153737832|NCT04486352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153737833|NCT04486352|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153737834|NCT04468360|Pregnanolone|pregnanolone|mesh-list
153737835|NCT04468360|Brexanolone|brexanolone|mesh-list
153737836|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
153737837|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153737838|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737877|NCT04439006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737878|NCT04439006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737880|NCT04401059|Osimertinib|osimertinib|mesh-list
153737881|NCT04401059|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153737882|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153737883|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737884|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737885|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737886|NCT04382664|Nivolumab|nivolumab|mesh-list
153737887|NCT04382664|Ipilimumab|ipilimumab|mesh-list
153737888|NCT04382664|Sargramostim|sargramostim|mesh-list
153737889|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737890|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737891|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737892|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737893|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
153737894|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737895|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
153737896|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153737897|NCT04382404|Velpatasvir|velpatasvir|mesh-list
153737898|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
153737899|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737911|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153737912|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737914|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153737915|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153737916|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
153737917|NCT04375605|Antidotes|antidotes|mesh-ancestor
153737918|NCT04375605|Protective Agents|protective agents|mesh-ancestor
153737919|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
153737920|NCT04375605|Vitamins|vitamins|mesh-ancestor
153737921|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
153737922|NCT04363359|Vaccines|vaccines|mesh-list
153737923|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
153737924|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737925|NCT04361279|Rituximab|rituximab|mesh-list
153737926|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737927|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737928|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
153737929|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737930|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153737931|NCT04338191|Leucovorin|leucovorin|mesh-list
153737932|NCT04338191|Fluorouracil|fluorouracil|mesh-list
153737933|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
153737934|NCT04338191|Irinotecan|irinotecan|mesh-list
153737935|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
153737936|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
153737937|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737963|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737964|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153737965|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737966|NCT04271735|Niacinamide|niacinamide|mesh-list
153737967|NCT04271735|Niacin|niacin|mesh-list
153737968|NCT04271735|Nicotinic Acids|nicotinic acids|mesh-list
153737979|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737981|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737982|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737983|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
153737984|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737985|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737986|NCT04187872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737987|NCT04187872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738000|NCT04161066|Psilocybin|psilocybin|mesh-list
153738001|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
153738002|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738003|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153738004|NCT04110028|Niacinamide|niacinamide|mesh-list
153738005|NCT04110028|Niacin|niacin|mesh-list
153738006|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
153738007|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
153738008|NCT04110028|Vitamins|vitamins|mesh-ancestor
153738009|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
153738010|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738011|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153738012|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
153738031|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738032|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153738033|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153474002|NCT00166530|Atorvastatin|atorvastatin|mesh-list
153738046|NCT04068207|Minocycline|minocycline|mesh-list
153738047|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153730674|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
153730675|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738048|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738049|NCT04065841|Licogliflozin|licogliflozin|mesh-list
153738050|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153738051|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738052|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153738053|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738054|NCT03989037|Carboplatin|carboplatin|mesh-list
153738055|NCT03989037|Docetaxel|docetaxel|mesh-list
153738056|NCT03989037|Trastuzumab|trastuzumab|mesh-list
153738057|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738058|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738059|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738060|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738061|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738062|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738063|NCT03976375|Docetaxel|docetaxel|mesh-list
153738064|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
153738065|NCT03976375|Lenvatinib|lenvatinib|mesh-list
153738066|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738067|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738068|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738069|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738070|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738071|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738072|NCT03976375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153738073|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738074|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738075|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
153738076|NCT03939923|Rocuronium|rocuronium|mesh-list
153738077|NCT03939923|Neostigmine|neostigmine|mesh-list
153738113|NCT03912831|Sensory System Agents|sensory system agents|mesh-ancestor
153738114|NCT03912831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738116|NCT03873883|Carboplatin|carboplatin|mesh-list
153738117|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
153738118|NCT03873883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153738119|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738120|NCT03873883|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738121|NCT03873883|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738122|NCT03873883|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738123|NCT03873883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738124|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415154|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
153738125|NCT03873883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153738126|NCT03790800|Urapidil|urapidil|mesh-list
153738127|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153738128|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
153738129|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153738130|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
153738131|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738132|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738177|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738178|NCT03601806|Thalidomide|thalidomide|mesh-list
153738179|NCT03601806|Pomalidomide|pomalidomide|mesh-list
153738180|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738181|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
153738182|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738183|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
153738184|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153738185|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738186|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153738187|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153738188|NCT03601806|Growth Substances|growth substances|mesh-ancestor
153738189|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
153738190|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738191|NCT03433183|Sirolimus|sirolimus|mesh-list
153738192|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153738218|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738219|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738220|NCT03300557|Exemestane|exemestane|mesh-list
153738221|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738222|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153738223|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153474193|NCT00628134|Calfactant|calfactant|mesh-list
153738236|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
153738237|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
153738238|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738240|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738241|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738242|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153738243|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738244|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
153738245|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153738246|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
153738247|NCT03118232|Povidone|povidone|mesh-list
153738248|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153738249|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738271|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738272|NCT02968810|Simvastatin|simvastatin|mesh-list
153738273|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153738274|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153738275|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
153738276|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738277|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153738278|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153738279|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738280|NCT02913274|Paclitaxel|paclitaxel|mesh-list
153738281|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153738282|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738283|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
153474256|NCT00641862|Vitamins|vitamins|mesh-ancestor
153738289|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738290|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
153738291|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738293|NCT02774421|Molgramostim|molgramostim|mesh-list
153738294|NCT02774421|Sargramostim|sargramostim|mesh-list
153738295|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738296|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738297|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
153738298|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738299|NCT02728102|Lenalidomide|lenalidomide|mesh-list
153738300|NCT02728102|Melphalan|melphalan|mesh-list
153738301|NCT02728102|Molgramostim|molgramostim|mesh-list
153738302|NCT02728102|Vaccines|vaccines|mesh-list
153738303|NCT02728102|Sargramostim|sargramostim|mesh-list
153738304|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
153738305|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738306|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153730678|NCT00142038|Docetaxel|docetaxel|mesh-list
153730679|NCT00142038|Capecitabine|capecitabine|mesh-list
153738307|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153738308|NCT02728102|Growth Substances|growth substances|mesh-ancestor
153738309|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
153738344|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738345|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782014|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738346|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
153738347|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738348|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738349|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153738350|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153738351|NCT02600897|Growth Substances|growth substances|mesh-ancestor
153738395|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738396|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
153738397|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738398|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738399|NCT02098954|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153738400|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738417|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738418|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738419|NCT01955460|Aldesleukin|aldesleukin|mesh-list
153738420|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
153738421|NCT01955460|Fludarabine|fludarabine|mesh-list
153738422|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
153738468|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738469|NCT01734512|Everolimus|everolimus|mesh-list
153738470|NCT01734512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153738471|NCT01734512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738472|NCT01734512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738473|NCT01734512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738474|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738475|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
153738476|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738477|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738478|NCT01477333|Treprostinil|treprostinil|mesh-list
153738479|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153738480|NCT01371630|Cytarabine|cytarabine|mesh-list
153738481|NCT01371630|Dexamethasone|dexamethasone|mesh-list
153738482|NCT01371630|Prednisone|prednisone|mesh-list
153738483|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
153738484|NCT01371630|Rituximab|rituximab|mesh-list
153738485|NCT01371630|Methotrexate|methotrexate|mesh-list
153738486|NCT01371630|Vincristine|vincristine|mesh-list
153738487|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
153738488|NCT01371630|Blinatumomab|blinatumomab|mesh-list
153738489|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153738490|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738491|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
153738492|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738493|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738494|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153738495|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
153738496|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738497|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738498|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153738499|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738500|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
153738501|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
153738502|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738503|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153738504|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
153738505|NCT01371630|Hormones|hormones|mesh-ancestor
153738554|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738555|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738556|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
153738557|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738558|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
153738559|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738560|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153738561|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738562|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153738563|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153738564|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153738643|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738644|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738645|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
153738646|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
153738647|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738677|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
153738678|NCT00004112|Hormones|hormones|mesh-ancestor
153738679|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153738680|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153738681|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153738682|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738683|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738684|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738685|NCT00469885|Nicotine|nicotine|mesh-list
153738686|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153738687|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
153738688|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738689|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738690|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153738691|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153738692|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
153738774|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738775|NCT05378906|Darunavir|darunavir|mesh-list
153738776|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153738777|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153738778|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
153738779|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738780|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738781|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153738782|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153738783|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
153738829|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738831|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153738832|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153738833|NCT00470977|Growth Substances|growth substances|mesh-ancestor
153738834|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738835|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
153738836|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738837|NCT05350592|Dobutamine|dobutamine|mesh-list
153738838|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153738839|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
153738840|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
153738841|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738842|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738843|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153738878|NCT03271255|Bevacizumab|bevacizumab|mesh-list
153738880|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738881|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738882|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474894|NCT00737178|Copper|copper|mesh-list
153738897|NCT00336154|Tetracycline|tetracycline|mesh-list
153738898|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153738899|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738900|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153738901|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738902|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738903|NCT00158028|Risperidone|risperidone|mesh-list
153738904|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153738939|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738941|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738942|NCT00471523|Metformin|metformin|mesh-list
153738992|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738993|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739018|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153739020|NCT00336310|Repaglinide|repaglinide|mesh-list
153739021|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153739022|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739023|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
153739024|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153739025|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153739026|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153739027|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739028|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739029|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
153739030|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739031|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739032|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153739033|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739035|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153739036|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739037|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
153739038|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739039|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739066|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153739067|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576080|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739069|NCT00337051|Sevoflurane|sevoflurane|mesh-list
153739113|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739114|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153739115|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153739116|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739117|NCT00158301|Fluoxetine|fluoxetine|mesh-list
153739118|NCT00158301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153739119|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153739120|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739121|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739122|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739123|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
153739124|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739125|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153739126|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
153739127|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153739128|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153739129|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153739130|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739131|NCT00149877|Tegaserod|tegaserod|mesh-list
153739132|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153739133|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
153739134|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739135|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739136|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739137|NCT00473239|Vitamin D|vitamin d|mesh-list
153739138|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
153739139|NCT00473239|Vitamins|vitamins|mesh-ancestor
153739140|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
153739141|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811629|NCT00326768|Telmisartan|telmisartan|mesh-list
153739183|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153739185|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153739186|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153739187|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153739188|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153739189|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153739190|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
153739191|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739192|NCT00509158|Antacids|antacids|mesh-ancestor
153739222|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153739223|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739224|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
153739225|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739226|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
153739227|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739228|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
153739229|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739231|NCT00337792|Fentanyl|fentanyl|mesh-list
153739232|NCT00337792|Oxycodone|oxycodone|mesh-list
153739233|NCT00337792|Lorazepam|lorazepam|mesh-list
153739234|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153475234|NCT00787332|Desirudin|desirudin|mesh-list
153739264|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739265|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739266|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153739267|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
153739268|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
153739269|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739270|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739271|NCT04715737|Vasopressins|vasopressins|mesh-list
153739272|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
153739273|NCT04715737|Oxytocin|oxytocin|mesh-list
153739274|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
153739275|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153739276|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739277|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
153739278|NCT04715737|Coagulants|coagulants|mesh-ancestor
153739279|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153739280|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153739281|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
153739432|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739434|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153739435|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153739436|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739437|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739438|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739439|NCT00509938|Lactoferrin|lactoferrin|mesh-list
153739440|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739494|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153739496|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153739497|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
153739498|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739499|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739500|NCT00150228|Varenicline|varenicline|mesh-list
153739501|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153739502|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153739503|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
153739504|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739563|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153739564|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
153739565|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153739566|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153739567|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153739568|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739594|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153739596|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153739597|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153739598|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
153739599|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739600|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153739601|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153739602|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739665|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153739698|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
153739699|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739700|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739701|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153739702|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
153739703|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739828|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153739856|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739857|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153739858|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739859|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153739860|NCT00510913|Tacrolimus|tacrolimus|mesh-list
153739861|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153739862|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
153739863|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739864|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154256536|NCT01160276|Colchicine|colchicine|mesh-list
154256537|NCT01160276|Tacrolimus|tacrolimus|mesh-list
153739865|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739866|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739867|NCT00150735|Levetiracetam|levetiracetam|mesh-list
153739868|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
153739956|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739957|NCT02951806|Fentanyl|fentanyl|mesh-list
153739986|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153739987|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153739988|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
153739989|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
153739990|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
153739991|NCT00150891|Cyclosporine|cyclosporine|mesh-list
153739992|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
153739993|NCT00150891|Azathioprine|azathioprine|mesh-list
153739994|NCT00150891|Tacrolimus|tacrolimus|mesh-list
153739995|NCT00150891|Cyclosporins|cyclosporins|mesh-list
153739996|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153739997|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
153739998|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739999|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153740001|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740002|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
153740003|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740004|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
153740005|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153740037|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
153740038|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153577054|NCT01715363|Hematinics|hematinics|mesh-ancestor
153740039|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153740040|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740041|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153740042|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153740043|NCT00513253|Lapatinib|lapatinib|mesh-list
153740044|NCT00513253|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153740045|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153740046|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740061|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153740087|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740089|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740090|NCT00513877|Bortezomib|bortezomib|mesh-list
153740091|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740092|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
153740093|NCT04695613|Analgesics|analgesics|mesh-ancestor
153740094|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
153740095|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740096|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740097|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
153740098|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740099|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153740100|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
153740101|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153740102|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153740103|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740104|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153740105|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
153740106|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153740107|NCT00151047|Docetaxel|docetaxel|mesh-list
153740144|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
153740165|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811850|NCT00427362|Adalimumab|adalimumab|mesh-list
153740166|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153740167|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
153740196|NCT02951299|Protective Agents|protective agents|mesh-ancestor
153740197|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740198|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
153740199|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153740200|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
153740215|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740216|NCT00515320|Fluoxetine|fluoxetine|mesh-list
153740217|NCT00515320|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153740218|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153740219|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154256538|NCT01160276|Cyclosporins|cyclosporins|mesh-list
153740220|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740221|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740222|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
153740223|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740224|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153740225|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
153740226|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153740227|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153740228|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153740229|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740230|NCT00515554|Rituximab|rituximab|mesh-list
153740674|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740675|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
153740676|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740677|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740678|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153740679|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740680|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153740681|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153740682|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
153740683|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153740684|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153740686|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
153740687|NCT05678114|Vitamins|vitamins|mesh-ancestor
153740688|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
153741349|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741350|NCT00517582|Analgesics|analgesics|mesh-ancestor
153741351|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
153741352|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741353|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741394|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
153741825|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741826|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
153741827|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741829|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153741830|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741831|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153741832|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153741833|NCT00521482|Growth Substances|growth substances|mesh-ancestor
153741834|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
153741835|NCT00521521|Docetaxel|docetaxel|mesh-list
153741836|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741837|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
153741838|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
153741839|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
153741876|NCT04186013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153741877|NCT04186013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741878|NCT04186013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153741879|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741881|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
153741882|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741883|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153741884|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153741885|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741886|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
153741887|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153741888|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153741889|NCT00167232|Naltrexone|naltrexone|mesh-list
153741890|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153741891|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153741892|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741893|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
153741894|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741895|NCT00522886|Cetuximab|cetuximab|mesh-list
153741896|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153741897|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741898|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
153741972|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741973|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153741974|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153741975|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
154256539|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154256540|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
154256541|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154256542|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154256543|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736414|NCT02750540|Tenofovir|tenofovir|mesh-list
153742478|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153742479|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742480|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153742481|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
153742482|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
153742483|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
153742484|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153742502|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742504|NCT04693312|Protective Agents|protective agents|mesh-ancestor
153742505|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153742506|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742507|NCT00168090|Factor VIII|factor viii|mesh-list
153742508|NCT00168090|Coagulants|coagulants|mesh-ancestor
153742509|NCT00525382|Levocetirizine|levocetirizine|mesh-list
153742510|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153742511|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153742512|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
153742513|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
153742514|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742515|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742516|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742564|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742565|NCT00525694|Cocaine|cocaine|mesh-list
153742566|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
153742567|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
153742568|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742569|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742570|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
153742571|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742572|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153742573|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153742574|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153742575|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742576|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742577|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
153742578|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742673|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742674|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742675|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742676|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742677|NCT00407394|Amoxicillin|amoxicillin|mesh-list
153742692|NCT00516412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742693|NCT00516412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742694|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742695|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
153742696|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742697|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742698|NCT03058835|Tenofovir|tenofovir|mesh-list
153742699|NCT03058835|Emtricitabine|emtricitabine|mesh-list
153742700|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
153742701|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742702|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153742703|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153742704|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742705|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742706|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153742707|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153731754|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742708|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153742713|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742714|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154256544|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742715|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153742717|NCT00516607|Temozolomide|temozolomide|mesh-list
153742718|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153742719|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
153742720|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742721|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742722|NCT00173667|Nifedipine|nifedipine|mesh-list
153742723|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153742724|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742725|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742726|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153742727|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742736|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
153742737|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742738|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742739|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
153742740|NCT00527215|Hematinics|hematinics|mesh-ancestor
153742741|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
153742771|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742772|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742773|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153742774|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
153742775|NCT02945527|Hormones|hormones|mesh-ancestor
153742815|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
153742816|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742817|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742818|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742819|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742820|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153742821|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153742822|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742823|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742824|NCT00173862|Gemcitabine|gemcitabine|mesh-list
153742825|NCT00173862|Ifosfamide|ifosfamide|mesh-list
153742826|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153742827|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
153742828|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742829|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742830|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153742831|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
153742832|NCT00529750|Atenolol|atenolol|mesh-list
153742869|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153742870|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742871|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742872|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742873|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742874|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742875|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153742876|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742877|NCT00527449|Carboplatin|carboplatin|mesh-list
153742880|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742881|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
153742882|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
153742883|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
153812106|NCT01051791|Everolimus|everolimus|mesh-list
153742884|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742885|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153742886|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153742887|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153742888|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742889|NCT00168519|Nitroprusside|nitroprusside|mesh-list
153742890|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153742891|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
153730721|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153742892|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153742893|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742894|NCT04692376|Cyclosporine|cyclosporine|mesh-list
153742895|NCT04692376|Cyclosporins|cyclosporins|mesh-list
153742896|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
154256545|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
153452260|NCT01894152|Everolimus|everolimus|mesh-list
153478831|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153742918|NCT00173901|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153742919|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742920|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742922|NCT00527761|Docetaxel|docetaxel|mesh-list
153742923|NCT00527761|Temozolomide|temozolomide|mesh-list
153742924|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742925|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
153742926|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
153742927|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
153742928|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742929|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153742930|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
153742931|NCT00527800|Lumefantrine|lumefantrine|mesh-list
153742932|NCT00527800|Artemether|artemether|mesh-list
153742933|NCT00527800|Piperaquine|piperaquine|mesh-list
153742934|NCT00527800|Trimethoprim|trimethoprim|mesh-list
153742935|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153742936|NCT00527800|Artenimol|artenimol|mesh-list
153742962|NCT02945215|Rituximab|rituximab|mesh-list
153742963|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742964|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742965|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
153742966|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742967|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742968|NCT00144677|Sirolimus|sirolimus|mesh-list
153742969|NCT00144677|Tacrolimus|tacrolimus|mesh-list
153743048|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153743049|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153743050|NCT02944942|Anesthetics|anesthetics|mesh-list
153743051|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743071|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743072|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743073|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
153743074|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
153743086|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730730|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153730732|NCT00134966|Carbidopa|carbidopa|mesh-list
153730733|NCT00134966|Entacapone|entacapone|mesh-list
153730734|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153730735|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153730736|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
153730737|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731755|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153743101|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
153743102|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
153743103|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153580131|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743104|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153743105|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153743106|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153743107|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
153743128|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153743129|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153743130|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743131|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153743132|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153743133|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153743134|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743135|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743136|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
153743137|NCT00168636|Vitamin A|vitamin a|mesh-list
153743151|NCT00528502|Lidocaine|lidocaine|mesh-list
153743152|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
153743168|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743169|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153743170|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153743171|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153743172|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153743173|NCT00528619|Growth Substances|growth substances|mesh-ancestor
153743174|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743175|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
153743189|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153743190|NCT00528658|Analgesics|analgesics|mesh-ancestor
153743191|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
153743192|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743193|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743194|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743195|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743196|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153743197|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743198|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743199|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
153743216|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153743217|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743218|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743219|NCT00531349|Propofol|propofol|mesh-list
153743224|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153743225|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153743226|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
153743227|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153743228|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153743229|NCT00531466|Tolperisone|tolperisone|mesh-list
153743230|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153743231|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743232|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153743233|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743234|NCT00168792|Tenecteplase|tenecteplase|mesh-list
153743235|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153743236|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153743237|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743238|NCT00531544|Sunitinib|sunitinib|mesh-list
153743239|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743240|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153743241|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153743242|NCT00531544|Growth Substances|growth substances|mesh-ancestor
153743285|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153743286|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743287|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153743288|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153743289|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153743290|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743291|NCT00530101|Doxorubicin|doxorubicin|mesh-list
153743310|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743311|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153743312|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153743313|NCT00145301|Analgesics|analgesics|mesh-ancestor
153743314|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
153743315|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743316|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743317|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743318|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743319|NCT00168870|Gemcitabine|gemcitabine|mesh-list
153743320|NCT00168870|Treosulfan|treosulfan|mesh-list
153743342|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153743343|NCT00145340|Pioglitazone|pioglitazone|mesh-list
153743344|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743345|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743346|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
153743347|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153743348|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153743349|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743350|NCT00168909|Vitamins|vitamins|mesh-ancestor
153743351|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
153743367|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743368|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153743369|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153743370|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743371|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743373|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
153743374|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153743375|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153743376|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153743377|NCT00174330|Amlodipine|amlodipine|mesh-list
153743378|NCT00174330|Atorvastatin|atorvastatin|mesh-list
153743379|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153743380|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153743381|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
153743382|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743389|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153743390|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479316|NCT01285050|Tenofovir|tenofovir|mesh-list
153743400|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153743401|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743402|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743403|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743404|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743406|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
153743407|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743408|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
153743409|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153743410|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
153743411|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
153743412|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743445|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743446|NCT00174486|Urological Agents|urological agents|mesh-ancestor
153743447|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
153743448|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
153743449|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153743450|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153743451|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743452|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743453|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153743481|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
153743482|NCT00145730|Ibuprofen|ibuprofen|mesh-list
153743483|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153743484|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153743485|NCT00145730|Analgesics|analgesics|mesh-ancestor
153743486|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
153743487|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743488|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743489|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743490|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743491|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153743492|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743493|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743494|NCT00169143|Rituximab|rituximab|mesh-list
153743495|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153743496|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743537|NCT00169182|Niacin|niacin|mesh-list
153743538|NCT00169182|Docetaxel|docetaxel|mesh-list
153743539|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743540|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
153743541|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
153743542|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
153743543|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743544|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
153743545|NCT00169182|Vitamins|vitamins|mesh-ancestor
153743546|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
153736415|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
153743596|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153743597|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
153743598|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743599|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743600|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153743601|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153743628|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153743629|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
153743630|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743631|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743633|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153743634|NCT00174642|Metformin|metformin|mesh-list
153743635|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
153743653|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743676|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743678|NCT02942602|Ezetimibe|ezetimibe|mesh-list
153743679|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
153743680|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153743681|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153743682|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
153743683|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743684|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153743685|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153743710|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153743711|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743712|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153812485|NCT02957643|Iron|iron|mesh-list
153743713|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153743715|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743716|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153743717|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
153743718|NCT00146159|Analgesics|analgesics|mesh-ancestor
153743719|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
153743720|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743721|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743722|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743723|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153743724|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153743725|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743726|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743727|NCT02276989|Riboflavin|riboflavin|mesh-list
153743728|NCT02276989|Quinine|quinine|mesh-list
153743731|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
153743732|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743733|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
153743734|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153743735|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
153743736|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
153743737|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153743738|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743739|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743740|NCT02276989|Diuretics|diuretics|mesh-ancestor
153743741|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
153743742|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
153743743|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153743744|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153743745|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743746|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153743747|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153743748|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743749|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153743750|NCT02276989|Analgesics|analgesics|mesh-ancestor
153743751|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
153743752|NCT00174759|Clopidogrel|clopidogrel|mesh-list
153743753|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153743755|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153743756|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153743757|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
153743758|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479694|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
153743783|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153743793|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743794|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153743795|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743796|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743797|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153731757|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153743798|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153743799|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
153743800|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743830|NCT02940379|Midazolam|midazolam|mesh-list
153743831|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153743832|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153743833|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743834|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743835|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153743836|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153743837|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153743838|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153743839|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
153743840|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
153743841|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
153743842|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
153743843|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743844|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743845|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153743846|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153743862|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
153743863|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
153359018|NCT06212830|Antimanic Agents|antimanic agents|mesh-ancestor
153479807|NCT06243822|Ketamine|ketamine|mesh-list
153743876|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153743877|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743878|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153743879|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
153743880|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
153743881|NCT00146588|Capecitabine|capecitabine|mesh-list
153743882|NCT00146588|Epirubicin|epirubicin|mesh-list
153743883|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153743884|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
153743885|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744029|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744030|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153744031|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153744032|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153814672|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744162|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153744163|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153744164|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153744165|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
153744166|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744167|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744168|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744210|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744211|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153744212|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
153744213|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744214|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744215|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153744216|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
153744217|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
153744218|NCT02941510|Hormones|hormones|mesh-ancestor
153744219|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744241|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
153814676|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814677|NCT03277209|Plerixafor|plerixafor|mesh-list
153814678|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153814679|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153814680|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
153814681|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814682|NCT00453141|Betamethasone|betamethasone|mesh-list
153744443|NCT00175695|Protein C|protein c|mesh-list
153744449|NCT02930317|Factor VIII|factor viii|mesh-list
153744450|NCT02930317|Coagulants|coagulants|mesh-ancestor
153744451|NCT00148148|Amphotericin B|amphotericin b|mesh-list
153744483|NCT00175734|Analgesics|analgesics|mesh-ancestor
153812646|NCT00429936|Fenretinide|fenretinide|mesh-list
153744484|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
153744600|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744602|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153744603|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744604|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153814688|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153814689|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
153814690|NCT00421109|Levocetirizine|levocetirizine|mesh-list
153814691|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153814692|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153744803|NCT00170547|Vaccines|vaccines|mesh-list
153744804|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
153744805|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744806|NCT00149201|Fluorouracil|fluorouracil|mesh-list
153744807|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
153744808|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744809|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153744810|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814703|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814704|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153814705|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
153814706|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814707|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814708|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153744862|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
153744863|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744864|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744937|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153744938|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744940|NCT02916238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153744941|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153744942|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744943|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744944|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745009|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745010|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745011|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
153745012|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153745013|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745014|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745015|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153745016|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153745048|NCT05786339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153745119|NCT05781516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745120|NCT05781516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745121|NCT05781516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153745122|NCT05781516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745123|NCT05780437|Remdesivir|remdesivir|mesh-list
153745124|NCT05780437|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
153745125|NCT05780437|Antimetabolites|antimetabolites|mesh-ancestor
153745126|NCT05780437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745127|NCT05780437|Antiviral Agents|antiviral agents|mesh-ancestor
153745128|NCT05780437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745129|NCT05778266|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153745130|NCT05778266|Laxatives|laxatives|mesh-ancestor
153745131|NCT05778266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153745132|NCT05774405|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153745133|NCT05774405|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153745134|NCT05774405|Estradiol|estradiol|mesh-list
153745135|NCT05774405|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153745136|NCT05774405|Estrogens|estrogens|mesh-ancestor
153745197|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745198|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153745250|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745251|NCT05266027|Nalbuphine|nalbuphine|mesh-list
153745252|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153745253|NCT05266027|Narcotics|narcotics|mesh-ancestor
153745254|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745255|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745256|NCT05266027|Analgesics|analgesics|mesh-ancestor
153745257|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
153745258|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745259|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
153745260|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153745383|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153745384|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
153745385|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745386|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745387|NCT04532918|Cyclosporine|cyclosporine|mesh-list
153745388|NCT04532918|Rifampin|rifampin|mesh-list
153745389|NCT04532918|Allopurinol|allopurinol|mesh-list
153745390|NCT04532918|Verinurad|verinurad|mesh-list
153745391|NCT04532918|Cyclosporins|cyclosporins|mesh-list
153745392|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745393|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745394|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745395|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
153745396|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745397|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
153745405|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
153745455|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153745456|NCT04347798|Amebicides|amebicides|mesh-ancestor
153745457|NCT04335669|Paclitaxel|paclitaxel|mesh-list
153745543|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153745544|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745545|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745546|NCT03985722|Trabectedin|trabectedin|mesh-list
153745547|NCT03985722|Olaratumab|olaratumab|mesh-list
153745548|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153745549|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
153745550|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745582|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745583|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745584|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
153745585|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745586|NCT03460327|Candesartan|candesartan|mesh-list
153745587|NCT03460327|Candesartan cilexetil|candesartan cilexetil|mesh-list
153745588|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153745589|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153745590|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153745591|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027539|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027540|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027541|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027542|NCT02647632|Ribavirin|ribavirin|mesh-list
154027543|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
154027544|NCT02647632|Grazoprevir|grazoprevir|mesh-list
154027545|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154027546|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
154027564|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
154027565|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027566|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154027567|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154027568|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
154027569|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027570|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
154027571|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
154027572|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154027573|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154027574|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027575|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027577|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027578|NCT00651612|Timolol|timolol|mesh-list
154027579|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154027580|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154027581|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154027582|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154027583|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154027584|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
154027585|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027586|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027587|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027588|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153814725|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153814726|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814727|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
153814728|NCT00446901|Selenium|selenium|mesh-list
153814729|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
153360216|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154027613|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154027614|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
154027615|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027616|NCT00889421|Apremilast|apremilast|mesh-list
154027617|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154027618|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154027619|NCT00889421|Analgesics|analgesics|mesh-ancestor
154027620|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
154027621|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027622|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027623|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027624|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027625|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154027626|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154027627|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027628|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027629|NCT02827643|Vitamin D|vitamin d|mesh-list
154027630|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
154027631|NCT02827643|Lamivudine|lamivudine|mesh-list
154027632|NCT02827643|Calcium|calcium|mesh-list
154027633|NCT02827643|Vitamins|vitamins|mesh-ancestor
154027669|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154027670|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154027671|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027672|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154027673|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154027674|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
154027675|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153359542|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027710|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027866|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154027867|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
154027868|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027869|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027871|NCT02646540|Furosemide|furosemide|mesh-list
154027872|NCT02646540|Tolvaptan|tolvaptan|mesh-list
154027873|NCT02646540|Diuretics|diuretics|mesh-list
154027877|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154027977|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
154027978|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027979|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027980|NCT00887549|Pemetrexed|pemetrexed|mesh-list
154027981|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027982|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027983|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028054|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028055|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154028056|NCT02645370|Topiramate|topiramate|mesh-list
153814736|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
154028119|NCT00652782|Diuretics|diuretics|mesh-ancestor
154028120|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
154028121|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028122|NCT00653562|Zolpidem|zolpidem|mesh-list
154028123|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154028124|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154028125|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028126|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028127|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154028128|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
154028129|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
154028130|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028131|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028151|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154028152|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028153|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153417096|NCT00370760|Colchicine|colchicine|mesh-list
153782015|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417205|NCT02740543|Xhance|xhance|mesh-list
154055040|NCT00912392|Growth Substances|growth substances|mesh-ancestor
154055041|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055042|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
154055043|NCT00690170|Ketamine|ketamine|mesh-list
154055044|NCT00690170|Nicotine|nicotine|mesh-list
154055045|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154055046|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
154055047|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055048|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055049|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154055050|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154055051|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
154055052|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055071|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055072|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055073|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
154055074|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055075|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154055076|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154055077|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055079|NCT00689624|Protective Agents|protective agents|mesh-ancestor
154055080|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
154055081|NCT00689624|Vitamins|vitamins|mesh-ancestor
154055082|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
154055083|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154055084|NCT00696098|Butyric Acid|butyric acid|mesh-list
154055085|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
154055086|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
154055087|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055088|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055089|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055090|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
154055091|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154055092|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055093|NCT00684164|Conivaptan|conivaptan|mesh-list
154055094|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154055095|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055096|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
154055098|NCT04135508|Adalimumab|adalimumab|mesh-list
154055121|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
154055122|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055123|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154055124|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055125|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154055126|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154055127|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055128|NCT00499369|Antidotes|antidotes|mesh-ancestor
154055129|NCT00499369|Protective Agents|protective agents|mesh-ancestor
154055130|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
154055132|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
154055133|NCT02616692|Sorafenib|sorafenib|mesh-list
154055134|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055135|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154055136|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702376|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702380|NCT00283114|Lintuzumab|lintuzumab|mesh-list
154055137|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055138|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
154055139|NCT01014637|Clotrimazole|clotrimazole|mesh-list
154055140|NCT01014637|Miconazole|miconazole|mesh-list
154055141|NCT01014637|Amorolfine|amorolfine|mesh-list
154055142|NCT01014637|Ciclopirox|ciclopirox|mesh-list
154055143|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
154055144|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055145|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153574038|NCT01697410|Terlipressin|terlipressin|mesh-list
153574039|NCT01697410|Norepinephrine|norepinephrine|mesh-list
153574040|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153574041|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153574042|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
153574043|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574044|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574045|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458323|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458324|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153458325|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153458326|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153458327|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153458328|NCT04020588|Minocycline|minocycline|mesh-list
153458330|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153458331|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153458332|NCT04020588|Analgesics|analgesics|mesh-ancestor
153458333|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
153816965|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816966|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
153816967|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153816968|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816969|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055146|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154055147|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154055148|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055149|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055150|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154055151|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
154055152|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055153|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702418|NCT00283465|Hematinics|hematinics|mesh-ancestor
154055154|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154055155|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154055156|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
154055158|NCT00696566|Clopidogrel|clopidogrel|mesh-list
154055159|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154055160|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154055161|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154055162|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154055163|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
154055164|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055165|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055166|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055167|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154055168|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
154055169|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154055170|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055171|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
154055172|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154055173|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816970|NCT00427310|Fluorouracil|fluorouracil|mesh-list
153816971|NCT00427310|Heparin|heparin|mesh-list
153816972|NCT00427310|Calcium heparin|calcium heparin|mesh-list
153816973|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
153816974|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574046|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
153574047|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
153574048|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574049|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153574050|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153574052|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
153574053|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574054|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
153574055|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574056|NCT01697605|Infigratinib|infigratinib|mesh-list
154055174|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154055175|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154055176|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154055177|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154055178|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154055179|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154055180|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
154055181|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154055182|NCT01017133|Fluorides|fluorides|mesh-list
154055183|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154055184|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055185|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
154055186|NCT01017133|Protective Agents|protective agents|mesh-ancestor
154055187|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055188|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
154055189|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
154055190|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055191|NCT00869258|Gemcitabine|gemcitabine|mesh-list
154055192|NCT00869258|Capecitabine|capecitabine|mesh-list
154055193|NCT00869258|Docetaxel|docetaxel|mesh-list
154055194|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154055195|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
154055196|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055197|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055198|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
154055199|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
154055200|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
154055201|NCT00696644|Teriparatide|teriparatide|mesh-list
154055202|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154055203|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055204|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154055205|NCT01017367|Antibodies|antibodies|mesh-list
154055208|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154055212|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055213|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055214|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154055215|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154055216|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
154055217|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055219|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154055220|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055221|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
154055222|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
154055223|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
154055224|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055225|NCT02616848|Everolimus|everolimus|mesh-list
153702533|NCT00110604|Vitamins|vitamins|mesh-ancestor
154055226|NCT02616848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154055227|NCT02616848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154055228|NCT02616848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055229|NCT02616848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055230|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055231|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
154055232|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702534|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
154055233|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055234|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154055265|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154055266|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055267|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055268|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154055270|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
154055271|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055272|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154055273|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055274|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055275|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154055276|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154055277|NCT00711269|Risperidone|risperidone|mesh-list
154055278|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154055279|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154055280|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
154055281|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055282|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055283|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055284|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154055286|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055287|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154055288|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154055289|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
154055290|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154055291|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154055292|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154055293|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
154055294|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154055296|NCT01014793|Cabergoline|cabergoline|mesh-list
154055306|NCT00693472|Propranolol|propranolol|mesh-list
154055307|NCT00693472|Haloperidol|haloperidol|mesh-list
154055308|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
154055309|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154055310|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
154055311|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
154055312|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055313|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055314|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154055315|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154055316|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154055317|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702694|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055318|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154055319|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154055320|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
154055321|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055322|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055323|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154055324|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
154055325|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154055326|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154055327|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
154055328|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154055329|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154055330|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
154055332|NCT00498433|Aliskiren|aliskiren|mesh-list
154055333|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154055334|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154055335|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154055336|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055337|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154055339|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
154055350|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154055351|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055352|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
154055353|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055354|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
154055355|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055356|NCT00498355|Ranibizumab|ranibizumab|mesh-list
154055357|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154055358|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154055359|NCT00498355|Growth Substances|growth substances|mesh-ancestor
154055360|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055361|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
154055362|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055364|NCT04539223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154055365|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154055366|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154055367|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
154055368|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055369|NCT04539223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154055407|NCT02686619|Cyclosporins|cyclosporins|mesh-list
154055408|NCT02686619|Daclizumab|daclizumab|mesh-list
154055409|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055410|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055411|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055412|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
154055413|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055414|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
154055415|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055416|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
154055417|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055418|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154055419|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154055420|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154055421|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055422|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055423|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
154055424|NCT02686619|Hormones|hormones|mesh-ancestor
154055425|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055426|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154055427|NCT00688636|Infliximab|infliximab|mesh-list
154055428|NCT00688636|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154055429|NCT00688636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055430|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
154055431|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154055432|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055433|NCT00870740|Daclizumab|daclizumab|mesh-list
154055434|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055436|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055437|NCT02686853|Amphotericin B|amphotericin b|mesh-list
154055438|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154055439|NCT02686853|Amebicides|amebicides|mesh-ancestor
153574057|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574058|NCT01697618|Insulin|insulin|mesh-list
153574059|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153574060|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
153574061|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
153574062|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154055440|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154055441|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154055442|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055443|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154055444|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
154055446|NCT01017679|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154055447|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154055448|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055449|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055450|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055451|NCT04130672|Hemostatics|hemostatics|mesh-list
154055452|NCT04130672|Coagulants|coagulants|mesh-ancestor
154055453|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
154055454|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154055455|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055456|NCT02685449|Insulin|insulin|mesh-list
154055457|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154055458|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
154055459|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
154055460|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
154055461|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154055462|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055463|NCT00697034|Capsaicin|capsaicin|mesh-list
154055464|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
154055465|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
154055466|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
154055467|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055468|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574063|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153574064|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574065|NCT01697631|Insulin|insulin|mesh-list
153816982|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153816983|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
153816984|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153458356|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458357|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153458358|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574068|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
153574069|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153574070|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
153574071|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153574072|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153574073|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574074|NCT01697657|Insulin|insulin|mesh-list
153574075|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153703028|NCT00287443|Hormones|hormones|mesh-list
153574076|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
153574077|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
154055469|NCT00506779|Paclitaxel|paclitaxel|mesh-list
154055470|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
154055471|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154055472|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055473|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
154055474|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
154055475|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
153598145|NCT01872858|Analgesics|analgesics|mesh-ancestor
154055476|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055477|NCT00506779|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154055478|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154055479|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055480|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
154055481|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154055482|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
154055483|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
154055486|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154055531|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154055532|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
154055533|NCT02686151|Hormones|hormones|mesh-ancestor
154055534|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055535|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154055536|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055537|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154055538|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154055539|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055540|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055541|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154055542|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
154055543|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
154055544|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
154055545|NCT00868790|Metformin|metformin|mesh-list
154055546|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154055547|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055548|NCT00496483|Tacrolimus|tacrolimus|mesh-list
154055549|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055550|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
154055551|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055552|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154055553|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055554|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055555|NCT02614352|Candesartan|candesartan|mesh-list
154055556|NCT02614352|Candesartan cilexetil|candesartan cilexetil|mesh-list
154055557|NCT02614352|Atorvastatin|atorvastatin|mesh-list
154055558|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154055559|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154055560|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
153574078|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
153574079|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
153574080|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
153574081|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153574082|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574083|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153574084|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153574085|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
153574086|NCT01697722|Beclomethasone|beclomethasone|mesh-list
153574087|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574088|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
153574089|NCT01697722|Hormones|hormones|mesh-ancestor
154055561|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055562|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154055563|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154055564|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055565|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154055566|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154055567|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154055568|NCT01018225|Darifenacin|darifenacin|mesh-list
154055569|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154055570|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154055571|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
154055572|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055573|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055574|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055622|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
154055623|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055624|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055625|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
154055626|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154055627|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055628|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055629|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154055630|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055631|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055632|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154055633|NCT00699114|Narcotics|narcotics|mesh-ancestor
154055634|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055635|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
154055636|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
154055638|NCT00639587|Ketotifen|ketotifen|mesh-list
154055639|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154055640|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154055641|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154055642|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
154055643|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
154055644|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055645|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055646|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055647|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
154055648|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154055649|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
154055650|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
154055668|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154055669|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
154055670|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055671|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055672|NCT00860574|Methotrexate|methotrexate|mesh-list
154055673|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
154055674|NCT00860574|Fludarabine|fludarabine|mesh-list
154055675|NCT00860574|Treosulfan|treosulfan|mesh-list
154055676|NCT00860574|Tacrolimus|tacrolimus|mesh-list
154055677|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154055678|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
154055679|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154055680|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055681|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154055682|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
154055683|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055684|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055685|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
154055686|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055687|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154055688|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154055689|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
154055690|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055691|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154055692|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154055693|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154055694|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
154055695|NCT00496015|Acetaminophen|acetaminophen|mesh-list
154055696|NCT00496015|Vaccines|vaccines|mesh-list
154055697|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154055698|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
154055699|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055700|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154055701|NCT00496015|Analgesics|analgesics|mesh-ancestor
154055702|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
154055703|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574090|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574091|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574092|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154055704|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
154055705|NCT01018381|Ethanol|ethanol|mesh-list
153598367|NCT05852730|Diphenhydramine|diphenhydramine|mesh-list
154055706|NCT01018381|Entecavir|entecavir|mesh-list
154055707|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154055708|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055709|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055710|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055711|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
154055712|NCT00487825|Methotrexate|methotrexate|mesh-list
154055713|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154055714|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
154055715|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154055716|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055717|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154055718|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
154055719|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055720|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055721|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
154055722|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055723|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154055756|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055757|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
154055758|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154055759|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055760|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055761|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
154055762|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154055763|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154055764|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154055765|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703145|NCT00288379|Budesonide|budesonide|mesh-list
154055766|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154055767|NCT00847626|Diuretics|diuretics|mesh-ancestor
154055768|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
154055769|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055770|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154055771|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154055772|NCT04115904|Ibuprofen|ibuprofen|mesh-list
154055773|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154055774|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154055775|NCT04115904|Analgesics|analgesics|mesh-ancestor
154055776|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
154055777|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055778|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055779|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154055780|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055781|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154055782|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055783|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055784|NCT05297994|Vaccines|vaccines|mesh-list
154055798|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055799|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
154055800|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154055801|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154055802|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
154055803|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154055804|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055805|NCT00860028|Varenicline|varenicline|mesh-list
154055806|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154055807|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154055808|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
154055809|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055810|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055811|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055813|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154055814|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055815|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154055816|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154055817|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154055818|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055819|NCT00846768|Olodaterol|olodaterol|mesh-list
154055820|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154055821|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
154055822|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055823|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055824|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154055825|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
153574093|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
153574094|NCT01697735|Atorvastatin|atorvastatin|mesh-list
153574095|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153574096|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153574097|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153574098|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
153574099|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574100|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153574101|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153458359|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458360|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153703185|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458361|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153574103|NCT01697787|Artesunate|artesunate|mesh-list
153574113|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
153574114|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
153574115|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153574116|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
153574117|NCT01697826|Clindamycin|clindamycin|mesh-list
154055826|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154055827|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154055828|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154055829|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154055830|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055831|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055832|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055833|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
154055834|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154055835|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154055836|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154055837|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154055838|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055839|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055840|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154055841|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154055842|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154055843|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
154055844|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055845|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055846|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154055847|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154055848|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
154055875|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055876|NCT04134416|Donepezil|donepezil|mesh-list
154055877|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154055878|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055879|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055880|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
154055881|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055882|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055883|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
154055884|NCT04134182|Nivolumab|nivolumab|mesh-list
154055885|NCT04134182|Ipilimumab|ipilimumab|mesh-list
154055886|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154055887|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055888|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154055889|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055890|NCT00870584|Omalizumab|omalizumab|mesh-list
154055891|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154055892|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154055893|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
154055894|NCT02614508|Ofatumumab|ofatumumab|mesh-list
154055895|NCT02614508|Ibrutinib|ibrutinib|mesh-list
154055896|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154055897|NCT02614508|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154055898|NCT02614508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154055899|NCT02614508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055900|NCT02614508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055901|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055902|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
154055903|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055904|NCT02616068|Loxoprofen|loxoprofen|mesh-list
154055905|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154055906|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154055907|NCT02616068|Analgesics|analgesics|mesh-ancestor
154055908|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
154055912|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055913|NCT04127084|Empagliflozin|empagliflozin|mesh-list
154055914|NCT04127084|Canagliflozin|canagliflozin|mesh-list
154055915|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154055916|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055917|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154055918|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055919|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154055920|NCT00870194|Exenatide|exenatide|mesh-list
154055921|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154055922|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055923|NCT00870194|Incretins|incretins|mesh-ancestor
153598591|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055924|NCT00870194|Hormones|hormones|mesh-ancestor
154055925|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055926|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154055927|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
154055928|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055929|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055930|NCT00870194|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154055931|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154055932|NCT00690430|Octreotide|octreotide|mesh-list
154055933|NCT00690430|Pasireotide|pasireotide|mesh-list
154055934|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154055935|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154055936|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055937|NCT00690430|Hormones|hormones|mesh-ancestor
154055938|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154055939|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055940|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154055941|NCT04126304|Azithromycin|azithromycin|mesh-list
154055942|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055943|NCT02563054|Capecitabine|capecitabine|mesh-list
154055953|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154055954|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154055957|NCT00743470|Rifabutin|rifabutin|mesh-list
154055958|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154055959|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154055960|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
154055961|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055962|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055963|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154055964|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154055965|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
154055966|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055967|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154055968|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154055969|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154055970|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154055971|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
153574118|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
153574119|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
153574120|NCT01697826|Clotrimazole|clotrimazole|mesh-list
153574121|NCT01697826|Miconazole|miconazole|mesh-list
153574122|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153574123|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574124|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153574125|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574126|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574127|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153574129|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153574130|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153574131|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153574132|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
153458363|NCT04022226|Methohexital|methohexital|mesh-list
153458364|NCT04022226|Analgesics|analgesics|mesh-ancestor
153458365|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
153458366|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703364|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153458367|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458368|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153458369|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153574133|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574134|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574135|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153574136|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153574137|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153574138|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153574139|NCT01698164|Estradiol|estradiol|mesh-list
153574140|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153574141|NCT01698164|Progesterone|progesterone|mesh-list
153574142|NCT01698164|Estrogens|estrogens|mesh-ancestor
153574143|NCT01698164|Hormones|hormones|mesh-ancestor
154055973|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154055974|NCT02619578|Remifentanil|remifentanil|mesh-list
154055975|NCT02619578|Propofol|propofol|mesh-list
154055976|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
154055977|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154055978|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055979|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055980|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154055981|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
154055982|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
154055983|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154055984|NCT02619578|Narcotics|narcotics|mesh-ancestor
154055985|NCT02619578|Analgesics|analgesics|mesh-ancestor
154055986|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
154055987|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154055988|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154055989|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154055990|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154055991|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154055992|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154055993|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
154055994|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055995|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055996|NCT02615912|Castor Oil|castor oil|mesh-list
154055997|NCT02615912|Cathartics|cathartics|mesh-ancestor
154055998|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154055999|NCT04123652|Lidocaine|lidocaine|mesh-list
154056000|NCT04123652|Ketamine|ketamine|mesh-list
154056001|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
154056002|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
154056003|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056004|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056013|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154056014|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154056015|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
154056016|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154056017|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154056018|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056019|NCT00862940|Memantine|memantine|mesh-list
154056020|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154056021|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154056022|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
154056023|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056024|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056025|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056026|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154056027|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154056028|NCT04122716|Liraglutide|liraglutide|mesh-list
154056029|NCT04122716|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154056030|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154056031|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056033|NCT04122716|Hormones|hormones|mesh-ancestor
154056034|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154056035|NCT00868166|Riluzole|riluzole|mesh-list
154056036|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
154056037|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154056038|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154056039|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056040|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056041|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056042|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154056043|NCT00868166|Protective Agents|protective agents|mesh-ancestor
154056044|NCT00858780|Etanercept|etanercept|mesh-list
154056045|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056046|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056047|NCT00858780|Analgesics|analgesics|mesh-ancestor
154056048|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
154056051|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056052|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703395|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
154056053|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154056054|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154056055|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
154056056|NCT02619266|Megestrol|megestrol|mesh-list
154056057|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
154056058|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154056059|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154056060|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154056061|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
154056062|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154056063|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056064|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154056065|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154056066|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154056067|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056068|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
154056069|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154056070|NCT00699062|Montelukast|montelukast|mesh-list
154056071|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154056072|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
153598739|NCT04757584|Carvedilol|carvedilol|mesh-list
154056073|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154056075|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154056076|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056077|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154056078|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154056079|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056080|NCT02619032|Fentanyl|fentanyl|mesh-list
154056081|NCT02619032|Remifentanil|remifentanil|mesh-list
154056082|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154056083|NCT02619032|Narcotics|narcotics|mesh-ancestor
154056084|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056085|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056086|NCT02619032|Analgesics|analgesics|mesh-ancestor
153574144|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154056088|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056089|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154056090|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154056091|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
154056092|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
154056093|NCT00858234|Bortezomib|bortezomib|mesh-list
154056094|NCT00858234|Vorinostat|vorinostat|mesh-list
154056095|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056096|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154056097|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056098|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056099|NCT00697814|Clomiphene|clomiphene|mesh-list
154056100|NCT00697814|Enclomiphene|enclomiphene|mesh-list
154056101|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
154056102|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154056103|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
153360244|NCT01355705|Dexamethasone|dexamethasone|mesh-list
153745623|NCT03433755|Evolocumab|evolocumab|mesh-list
154056104|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154056105|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056106|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154056107|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
154056108|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154056109|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154056110|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154056111|NCT00862082|Sorafenib|sorafenib|mesh-list
153703456|NCT00291148|Pregabalin|pregabalin|mesh-list
153703458|NCT00291148|Analgesics|analgesics|mesh-ancestor
154056112|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154056113|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056119|NCT00692770|Sorafenib|sorafenib|mesh-list
154056129|NCT00867308|Growth Substances|growth substances|mesh-ancestor
154056130|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
154056131|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056133|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056134|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154056135|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154056136|NCT00849186|Growth Substances|growth substances|mesh-ancestor
154056137|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056138|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
154056139|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056140|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056141|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056142|NCT02618876|Nalbuphine|nalbuphine|mesh-list
154056143|NCT02618876|Bupivacaine|bupivacaine|mesh-list
154056144|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
154056145|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
154056146|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056147|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056148|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
154056149|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056150|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154056151|NCT02618876|Narcotics|narcotics|mesh-ancestor
154056152|NCT02618876|Analgesics|analgesics|mesh-ancestor
153574145|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574146|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153574147|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
153574148|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153574149|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153574150|NCT01698164|Progestins|progestins|mesh-ancestor
153574151|NCT01698177|Vaccines|vaccines|mesh-list
153574152|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
153574153|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574154|NCT01698203|Ropivacaine|ropivacaine|mesh-list
153574155|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
153574156|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
153574157|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574158|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574159|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
153574160|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574161|NCT01698476|Vitamin D|vitamin d|mesh-list
153574162|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
153574171|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153574172|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
153574173|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574174|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153574175|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577516|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154056156|NCT04119752|Analgesics|analgesics|mesh-ancestor
154056157|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
154056158|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056159|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056160|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056161|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056162|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056163|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056164|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703459|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
154056165|NCT00866918|Vitamins|vitamins|mesh-list
154056166|NCT00866918|Vitamin A|vitamin a|mesh-list
154056167|NCT00866918|Cytarabine|cytarabine|mesh-list
154056168|NCT00866918|Methotrexate|methotrexate|mesh-list
154056169|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
154056170|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
154056171|NCT00866918|Idarubicin|idarubicin|mesh-list
154056172|NCT00866918|Tretinoin|tretinoin|mesh-list
154056173|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
153703512|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
154056174|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
154056175|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
154056176|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056177|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153574176|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574177|NCT01698567|Antithrombins|antithrombins|mesh-list
153574178|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
153574179|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153574180|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
153574181|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574182|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574183|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
153574184|NCT01698593|Epinephrine|epinephrine|mesh-list
153574185|NCT01698593|Bupivacaine|bupivacaine|mesh-list
153574186|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
153574187|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
153574188|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574189|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574190|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
153574191|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574192|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153574193|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153574194|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
153574195|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574196|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574197|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153574198|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153574199|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
153574200|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153574201|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
154056178|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
154056179|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154056180|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154056181|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
154056182|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056183|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056184|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
154056185|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056186|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154056187|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154056188|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
154056189|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056190|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154056191|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
154056192|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056193|NCT00866918|Analgesics|analgesics|mesh-ancestor
154056194|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
154056195|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056196|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153703513|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154056197|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154056198|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154056199|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
154056200|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
154056201|NCT00866918|Protective Agents|protective agents|mesh-ancestor
153574202|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
153574203|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
153574204|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153574206|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153574207|NCT01698645|Narcotics|narcotics|mesh-ancestor
153574208|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574209|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574210|NCT01698645|Analgesics|analgesics|mesh-ancestor
153574211|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
153574212|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574213|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153574214|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153574215|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
153574216|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
153574217|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
153574234|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574235|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153574236|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574237|NCT01698788|Dexamethasone|dexamethasone|mesh-list
153574238|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
153574239|NCT01698788|BB 1101|bb 1101|mesh-list
153574240|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574241|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
153574242|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
153574243|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574244|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574245|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574246|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
154056202|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154056203|NCT00861692|Argatroban|argatroban|mesh-list
154056204|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
154056205|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154056206|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
154056207|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056208|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056209|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
154056210|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154056211|NCT02689037|Aspirin|aspirin|mesh-list
154056212|NCT02689037|Clopidogrel|clopidogrel|mesh-list
154056213|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056214|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056215|NCT02689037|Analgesics|analgesics|mesh-ancestor
154056216|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
154056217|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056218|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056219|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056220|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056221|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154056222|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154056223|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056224|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154056225|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154056226|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056250|NCT04184921|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154056251|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056253|NCT00602927|Varenicline|varenicline|mesh-list
154056254|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154056255|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154056256|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
154056257|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056258|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056259|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056260|NCT00639743|Tenecteplase|tenecteplase|mesh-list
154056261|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154056262|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154056263|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056264|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
154056265|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154056266|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
154056267|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154056268|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056269|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056270|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
154056271|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154056272|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056273|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056274|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154056275|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154056276|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154056277|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056278|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154056279|NCT02688803|Paclitaxel|paclitaxel|mesh-list
154056280|NCT02688803|Docetaxel|docetaxel|mesh-list
154056281|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154056290|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056292|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
154056293|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056294|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056295|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154056296|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
153598969|NCT03147859|Vedolizumab|vedolizumab|mesh-list
154056297|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154056298|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154056299|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154056300|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154056301|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056302|NCT02976935|Xenon|xenon|mesh-list
154056303|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154056304|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
154056305|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
154056307|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056347|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056349|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154056350|NCT00869960|Tenofovir|tenofovir|mesh-list
154056351|NCT00869960|Emtricitabine|emtricitabine|mesh-list
154056352|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154056353|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154056354|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
153540679|NCT01540526|Axitinib|axitinib|mesh-list
153703692|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154056355|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056356|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056357|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154056358|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154056359|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
154056360|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056361|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154056362|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154056363|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154056364|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154056365|NCT02618564|Sennosides|sennosides|mesh-list
154056366|NCT02618564|Laxatives|laxatives|mesh-ancestor
154056367|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154056368|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
154056369|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154056370|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153703707|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056371|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056372|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
153574247|NCT01698788|Hormones|hormones|mesh-ancestor
153574248|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574249|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817011|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153817012|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
153817013|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817014|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817015|NCT00427466|Pemetrexed|pemetrexed|mesh-list
153817016|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817017|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817018|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817019|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153458370|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
153458371|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
153458372|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458373|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153458374|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153458375|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458376|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056373|NCT02615366|Coagulants|coagulants|mesh-ancestor
154056375|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056376|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154056377|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056378|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056379|NCT00494299|Sorafenib|sorafenib|mesh-list
154056380|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056381|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056382|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056383|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056384|NCT05298176|Carboplatin|carboplatin|mesh-list
154056385|NCT05298176|Pemetrexed|pemetrexed|mesh-list
154056386|NCT05298176|Osimertinib|osimertinib|mesh-list
154056387|NCT05298176|Afatinib|afatinib|mesh-list
154056388|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056389|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703708|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154056390|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056391|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154056392|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154056393|NCT05298176|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154056394|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056395|NCT02615288|Vitamin D|vitamin d|mesh-list
154056396|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
154056397|NCT02615288|Vitamins|vitamins|mesh-ancestor
154056398|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
154056399|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056400|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154056401|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154056402|NCT02618096|Oxytocin|oxytocin|mesh-list
154056403|NCT02618096|Dinoprostone|dinoprostone|mesh-list
154056420|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154056421|NCT00859898|Metformin|metformin|mesh-list
154056422|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
154056423|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154056424|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056425|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154056426|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056427|NCT00638729|Clonidine|clonidine|mesh-list
154056428|NCT00638729|Midazolam|midazolam|mesh-list
154056429|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154056430|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154056431|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056432|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056433|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154056434|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154056435|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154056436|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154056437|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
154056438|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
154056439|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
154056440|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
154056441|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056442|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056443|NCT00638729|Analgesics|analgesics|mesh-ancestor
154056444|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
154056445|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056446|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154056447|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
154056448|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
154056449|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154056450|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154056451|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154056452|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
154056465|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154056466|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
154056467|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056468|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154056469|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154056470|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154056471|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154056472|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153703734|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154056473|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154056474|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154056475|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154056476|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154056477|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
154056478|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154056479|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154056480|NCT00699452|Candesartan|candesartan|mesh-list
154056481|NCT00699452|Candesartan cilexetil|candesartan cilexetil|mesh-list
154056482|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154056483|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154056484|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154056485|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056486|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
154056487|NCT02683733|Curcumin|curcumin|mesh-list
154056488|NCT02683733|Mesalamine|mesalamine|mesh-list
153574250|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574259|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153574260|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574261|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153574262|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574263|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574264|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153574265|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153574266|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153574267|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
153574268|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574269|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153574270|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153574271|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056489|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056491|NCT02683733|Analgesics|analgesics|mesh-ancestor
154056492|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
154056493|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056494|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056495|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056496|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056497|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056498|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056499|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056500|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
154056501|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154056502|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056503|NCT02683655|Apatinib|apatinib|mesh-list
154056504|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056505|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056506|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056507|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056508|NCT00494221|Leucovorin|leucovorin|mesh-list
154056509|NCT00494221|Fluorouracil|fluorouracil|mesh-list
154056510|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
154056511|NCT00494221|Cediranib|cediranib|mesh-list
154056512|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
154056513|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
154056514|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056515|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154056516|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056517|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154056518|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
154056519|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056520|NCT00494221|Antidotes|antidotes|mesh-ancestor
154056521|NCT00494221|Protective Agents|protective agents|mesh-ancestor
153574272|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
153458377|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
153458378|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153458379|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
153458380|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
153458381|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458382|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458383|NCT04025658|Oxytocin|oxytocin|mesh-list
153458384|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
153458385|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154056524|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
154056525|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056526|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056527|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
154056528|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154056529|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056530|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056531|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056532|NCT00909935|Analgesics|analgesics|mesh-ancestor
154056533|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
154056534|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056535|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154056536|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154056537|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154056538|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
154056539|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056540|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056541|NCT00857948|Ivermectin|ivermectin|mesh-list
154056542|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154056543|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056544|NCT02688491|Sunitinib|sunitinib|mesh-list
154056545|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056546|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154056547|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154056548|NCT02688491|Growth Substances|growth substances|mesh-ancestor
153458386|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458387|NCT05586438|Colistin|colistin|mesh-list
153458388|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703850|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
153458389|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458390|NCT04145232|Nivolumab|nivolumab|mesh-list
153458391|NCT04145232|Ipilimumab|ipilimumab|mesh-list
153458392|NCT04145232|Atezolizumab|atezolizumab|mesh-list
153458393|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458394|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458395|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153458396|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574273|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153574274|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
153574275|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574276|NCT01699204|Expectorants|expectorants|mesh-ancestor
153781613|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574277|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
154056549|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056550|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
154056551|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056552|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056553|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056555|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154056556|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154056557|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
154056558|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
154056559|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056560|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056561|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056562|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
154056563|NCT02613494|Scopolamine|scopolamine|mesh-list
154056564|NCT02613494|Bromides|bromides|mesh-list
154056565|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154056566|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
154056567|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154056568|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154056569|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154056570|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
154056571|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056572|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056573|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056574|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
154056575|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
154056576|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056577|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154056578|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
154056579|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
154056580|NCT00699530|Cabergoline|cabergoline|mesh-list
154056581|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154056582|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153703962|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056583|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
154056584|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
154056585|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056586|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056587|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056588|NCT02617862|Anesthetics|anesthetics|mesh-list
154056589|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056590|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056591|NCT00601835|Vaccines|vaccines|mesh-list
154056592|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
154056593|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056594|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154056595|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154056596|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154056597|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056598|NCT00697502|Capecitabine|capecitabine|mesh-list
154056599|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153599331|NCT01874574|Hylan|hylan|mesh-list
154056600|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
154056601|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056602|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056603|NCT00857246|Irinotecan|irinotecan|mesh-list
154056604|NCT00857246|Cetuximab|cetuximab|mesh-list
154056605|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056606|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154056607|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154056608|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056609|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056610|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154056624|NCT02682953|Plerixafor|plerixafor|mesh-list
154056631|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056632|NCT04184141|Alprazolam|alprazolam|mesh-list
154056633|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
154056634|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154056635|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056636|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056637|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154056638|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154056639|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154056640|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
154056641|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
154056644|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
154056696|NCT00603473|Gabapentin|gabapentin|mesh-list
154056697|NCT00603473|Analgesics|analgesics|mesh-ancestor
154056698|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
154056699|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056700|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056701|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
154056702|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154056703|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154056704|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056705|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703989|NCT00079430|Growth Substances|growth substances|mesh-ancestor
154056706|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154056707|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154056708|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056709|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056710|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
154056711|NCT02688023|Leucovorin|leucovorin|mesh-list
154056712|NCT02688023|Capecitabine|capecitabine|mesh-list
154056713|NCT02688023|Fluorouracil|fluorouracil|mesh-list
154056714|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
154056715|NCT02688023|Irinotecan|irinotecan|mesh-list
154056716|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154056717|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
154056718|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056719|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056720|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154056721|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
154056722|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056724|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154056740|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056742|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
154056743|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056744|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056745|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056746|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056747|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154056748|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056749|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056750|NCT02680379|Minocycline|minocycline|mesh-list
154056751|NCT02680379|Lovastatin|lovastatin|mesh-list
154056752|NCT02680379|L 647318|l 647318|mesh-list
154056753|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
154056754|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154056755|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056756|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154056757|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154056758|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
154056759|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056760|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154056761|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154056762|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056763|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
153704013|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154056764|NCT03996421|Trace Elements|trace elements|mesh-ancestor
154056791|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154056792|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154056793|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
154056794|NCT02687867|Coagulants|coagulants|mesh-ancestor
154056795|NCT02681783|Aflibercept|aflibercept|mesh-list
154056796|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154056797|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154056798|NCT02681783|Growth Substances|growth substances|mesh-ancestor
154056799|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056800|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
154056801|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056802|NCT00486811|Oxycodone|oxycodone|mesh-list
154056803|NCT00486811|Tapentadol|tapentadol|mesh-list
154056804|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154056805|NCT00486811|Narcotics|narcotics|mesh-ancestor
153704014|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154056806|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056807|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056808|NCT00486811|Analgesics|analgesics|mesh-ancestor
154056809|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
154056810|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056811|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154056812|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154056813|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154056814|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056815|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
154056816|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154056817|NCT00921700|Acetaminophen|acetaminophen|mesh-list
154056818|NCT00921700|Ibuprofen|ibuprofen|mesh-list
154056819|NCT00921700|Codeine|codeine|mesh-list
154056820|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154056821|NCT00921700|Analgesics|analgesics|mesh-ancestor
154056822|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
154056823|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056824|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056825|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
154056826|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154056827|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154056828|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154056829|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154056830|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056831|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056832|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154056834|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056835|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
154056836|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
154056837|NCT02678195|Amoxicillin|amoxicillin|mesh-list
154056838|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154056839|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056840|NCT03996577|Lidocaine|lidocaine|mesh-list
154056841|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
154056842|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
154056843|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056844|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056845|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
154056846|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056847|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154056848|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154056849|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154056850|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154056851|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056852|NCT02681705|Temozolomide|temozolomide|mesh-list
154056853|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154056854|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
154056855|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056856|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056857|NCT00921622|Vitamin D|vitamin d|mesh-list
154056858|NCT00921622|Vitamins|vitamins|mesh-list
153574278|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153574280|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574281|NCT01699204|Protective Agents|protective agents|mesh-ancestor
153704060|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
153574282|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574283|NCT01699204|Antidotes|antidotes|mesh-ancestor
153574284|NCT01699282|Antivitamins K|antivitamins k|mesh-list
153574285|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
153574287|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574288|NCT01699360|Cyclosporine|cyclosporine|mesh-list
153574289|NCT01699360|Sirolimus|sirolimus|mesh-list
153574290|NCT01699360|Tacrolimus|tacrolimus|mesh-list
153574291|NCT01699360|Cyclosporins|cyclosporins|mesh-list
153574292|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153574293|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
153574294|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574295|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154056859|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
154056860|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056861|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154056862|NCT02681471|Mannitol|mannitol|mesh-list
154056863|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154056864|NCT02681471|Diuretics|diuretics|mesh-ancestor
154056865|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
154056866|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056867|NCT00642395|Bortezomib|bortezomib|mesh-list
154056868|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056869|NCT01018615|Silymarin|silymarin|mesh-list
154056870|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
154056871|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056872|NCT01018615|Protective Agents|protective agents|mesh-ancestor
154056873|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056874|NCT00743782|Hormones|hormones|mesh-list
154056875|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
154056876|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154056877|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056878|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154056879|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
154056880|NCT02678117|Pregabalin|pregabalin|mesh-list
154056881|NCT02678117|Analgesics|analgesics|mesh-ancestor
154056882|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
154056883|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056884|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056885|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
154056886|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154056887|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154056888|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056889|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154056890|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154056891|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154056892|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056893|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154056894|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
154056899|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
154056900|NCT01018849|Vitamins|vitamins|mesh-ancestor
154056901|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
153599561|NCT01876290|Hormones|hormones|mesh-ancestor
154056902|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056903|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154056904|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154056905|NCT04102319|Hepcidins|hepcidins|mesh-list
154056906|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154056907|NCT00743860|Darapladib|darapladib|mesh-list
154056908|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
154056909|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056910|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056911|NCT00747526|Rabeprazole|rabeprazole|mesh-list
154056912|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154056913|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154056914|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154056915|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056916|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056917|NCT00747604|Mecasermin|mecasermin|mesh-list
154056918|NCT00747604|Growth Substances|growth substances|mesh-ancestor
154056919|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056920|NCT02151604|Xenon|xenon|mesh-list
154056921|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154056922|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
154056923|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
154056924|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056925|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056945|NCT00466687|Bevacizumab|bevacizumab|mesh-list
154056946|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154056947|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154056948|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056949|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154056950|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154056951|NCT00466687|Growth Substances|growth substances|mesh-ancestor
154056952|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056953|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
154056954|NCT00466687|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154056955|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154056956|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154056957|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056958|NCT01759459|Lidocaine|lidocaine|mesh-list
154056959|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
154056960|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
154056961|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154056962|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056963|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
154056964|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154056965|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154056966|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154056967|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154056968|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154056969|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056970|NCT02562742|Ribavirin|ribavirin|mesh-list
154056971|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
154056972|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056973|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
154056989|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
154056990|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154056991|NCT04181645|Paclitaxel|paclitaxel|mesh-list
154056992|NCT04181645|Gemcitabine|gemcitabine|mesh-list
154056993|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154056994|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154056995|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
154056996|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
154056997|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
154056998|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154056999|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154057000|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
154057001|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
154057002|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
154057003|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
154057004|NCT02679833|Vitamins|vitamins|mesh-ancestor
154057005|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
154057006|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057007|NCT02679833|Hematinics|hematinics|mesh-ancestor
154057008|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
154057009|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154057010|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
154057011|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154057012|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057013|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057038|NCT02676011|Atropine|atropine|mesh-list
154057039|NCT02676011|Succinylcholine|succinylcholine|mesh-list
154057040|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154057041|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154057042|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154057043|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
154057044|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057045|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057046|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154057047|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
154057048|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
154057049|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
154057050|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154057051|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153599707|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
154057052|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
154057053|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057054|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057055|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154057056|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154057057|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154057058|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154057059|NCT05663255|Azithromycin|azithromycin|mesh-list
154057060|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057061|NCT02678975|Copper|copper|mesh-list
154057062|NCT02678975|Temozolomide|temozolomide|mesh-list
153574296|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704159|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704161|NCT04727853|Irinotecan|irinotecan|mesh-list
153574297|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574298|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
153574299|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574312|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574313|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
153574314|NCT01699412|Hormones|hormones|mesh-ancestor
153574315|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574316|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153574317|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574318|NCT01699438|Mesalamine|mesalamine|mesh-list
153574319|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153574320|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153574321|NCT01699438|Analgesics|analgesics|mesh-ancestor
153574322|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
153574323|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574324|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574325|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817023|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
154057063|NCT02678975|Lomustine|lomustine|mesh-list
154057064|NCT02678975|Disulfiram|disulfiram|mesh-list
154057065|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
154057066|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154057067|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057068|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057069|NCT02678975|Trace Elements|trace elements|mesh-ancestor
154057070|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
154057071|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057072|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154057073|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154057074|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057075|NCT02677415|Anesthetics|anesthetics|mesh-list
153704244|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057076|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
154057077|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057078|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057079|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
154057080|NCT00454051|Omalizumab|omalizumab|mesh-list
154057081|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154057082|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154057083|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
154057085|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
154057086|NCT04181489|Rituximab|rituximab|mesh-list
154057087|NCT04181489|Doxorubicin|doxorubicin|mesh-list
154057088|NCT04181489|Vincristine|vincristine|mesh-list
154057089|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154057090|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
154057091|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057092|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154057093|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154057094|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
154057095|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057096|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057097|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154057098|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154057099|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154057100|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154057103|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154057104|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
154057105|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154057106|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154057107|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057108|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
154057109|NCT04181489|Hormones|hormones|mesh-ancestor
154057110|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057111|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154057112|NCT02537561|Cisplatin|cisplatin|mesh-list
154057113|NCT02537561|Gemcitabine|gemcitabine|mesh-list
154057114|NCT02537561|Talazoparib|talazoparib|mesh-list
154057115|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057116|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154057117|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
154057118|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057119|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154057120|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057121|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
154057122|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154057123|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
154057124|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057125|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057126|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154057127|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
154057128|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
153599789|NCT01878357|Primaquine|primaquine|mesh-list
154057129|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154057130|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
154057131|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817024|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
153817025|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817026|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
153817027|NCT00427583|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153817028|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153817029|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817030|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817031|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817032|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
153817033|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154057132|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057133|NCT02679131|Belinostat|belinostat|mesh-list
154057134|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057135|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154057136|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057137|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057138|NCT00484939|Bevacizumab|bevacizumab|mesh-list
154057139|NCT00484939|Capecitabine|capecitabine|mesh-list
154057140|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154057141|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057142|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154057143|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154057144|NCT00484939|Growth Substances|growth substances|mesh-ancestor
154057145|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057146|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
154057147|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154057148|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
154057149|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057150|NCT00642161|Budesonide|budesonide|mesh-list
154057169|NCT00642551|Vitamin K|vitamin k|mesh-list
154057185|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057186|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
154057187|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057188|NCT00643409|Azithromycin|azithromycin|mesh-list
154057189|NCT00643409|Levofloxacin|levofloxacin|mesh-list
154057190|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057191|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057192|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154057193|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154057194|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154057195|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057196|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057197|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057198|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154057199|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154057200|NCT04180007|Apatinib|apatinib|mesh-list
154057201|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599859|NCT01878708|Dexamethasone|dexamethasone|mesh-list
154057202|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153704306|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153704307|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704308|NCT00119769|Hormones|hormones|mesh-list
153704309|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704310|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704311|NCT00300313|Escitalopram|escitalopram|mesh-list
153704312|NCT00300313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153466152|NCT00343044|Topotecan|topotecan|mesh-list
153704313|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153704317|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
153704325|NCT00300352|Folic Acid|folic acid|mesh-list
153704326|NCT00300352|Hematinics|hematinics|mesh-ancestor
154057203|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057204|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057205|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154057206|NCT02675309|Simvastatin|simvastatin|mesh-list
154057207|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154057208|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154057209|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
154057210|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057211|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154057212|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154057214|NCT01025245|Remifentanil|remifentanil|mesh-list
154057228|NCT02677259|Hormones|hormones|mesh-ancestor
154057229|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057230|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057231|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154057232|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
154057233|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154057234|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154057235|NCT02677259|Progestins|progestins|mesh-ancestor
154057236|NCT02675387|Lidocaine|lidocaine|mesh-list
154057237|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
154057238|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
154057239|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057240|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057241|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
154057242|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057243|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154057244|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154057245|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154057246|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057247|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057248|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
154057249|NCT02678507|Narcotics|narcotics|mesh-ancestor
154057250|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057251|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057252|NCT02678507|Analgesics|analgesics|mesh-ancestor
153704408|NCT00300937|Ubiquinone|ubiquinone|mesh-list
154057253|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
154057254|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057255|NCT00464737|Rotigotine|rotigotine|mesh-list
154057261|NCT02678585|Lidocaine|lidocaine|mesh-list
154057269|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154057270|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154057271|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154057272|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057273|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057274|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154057275|NCT02678585|Narcotics|narcotics|mesh-ancestor
154057276|NCT02678585|Analgesics|analgesics|mesh-ancestor
154057277|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
154057278|NCT00453349|Metronidazole|metronidazole|mesh-list
154057279|NCT00453349|Levofloxacin|levofloxacin|mesh-list
154057280|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154057281|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057282|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057283|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154057284|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154057285|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057286|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057287|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057288|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154057289|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
154057290|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154057291|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057292|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154057293|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154057294|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154057295|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154057296|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154057297|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154057298|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154057299|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154057300|NCT02675153|Sirolimus|sirolimus|mesh-list
154057301|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057308|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057309|NCT04179617|Nicotine|nicotine|mesh-list
154057310|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154057311|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
154057312|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057313|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057314|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154057315|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154057316|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
154057317|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057318|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057319|NCT00464269|Brivaracetam|brivaracetam|mesh-list
154057320|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
154057321|NCT00642863|Vitamin D|vitamin d|mesh-list
154057322|NCT00642863|Vitamins|vitamins|mesh-list
154057323|NCT00642863|Vitamin A|vitamin a|mesh-list
154057324|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
153704453|NCT00301210|Tramadol|tramadol|mesh-list
154057325|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
154057326|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057327|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
154057328|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057329|NCT00642863|Protective Agents|protective agents|mesh-ancestor
154057330|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154057331|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057332|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154057333|NCT02674997|Factor VIII|factor viii|mesh-list
154057334|NCT02674997|Coagulants|coagulants|mesh-ancestor
154057335|NCT04178291|Erythritol|erythritol|mesh-list
154057336|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
154057337|NCT00643643|Maraviroc|maraviroc|mesh-list
154057338|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154057339|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154057340|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057341|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154057342|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154057343|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
154057346|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
154057349|NCT02676869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154057350|NCT02676869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057351|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
154057352|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154057353|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154057354|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154057355|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057356|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057357|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
154057358|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057359|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057360|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154057361|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057362|NCT05584319|Empagliflozin|empagliflozin|mesh-list
154057363|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154057364|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057365|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154057367|NCT02676323|Leucovorin|leucovorin|mesh-list
154057405|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057406|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057407|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057408|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154057409|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154057410|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154057411|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057412|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057413|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
154057414|NCT05348213|Decitabine|decitabine|mesh-list
154057415|NCT05348213|Pomalidomide|pomalidomide|mesh-list
154057416|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
154057417|NCT05348213|Tofacitinib|tofacitinib|mesh-list
154057418|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154057419|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
154057420|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057421|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057422|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057423|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
154057424|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057425|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154057426|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154057427|NCT05348213|Growth Substances|growth substances|mesh-ancestor
154057428|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
154057429|NCT05348213|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154057430|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154057431|NCT05348213|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154057432|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
154057433|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057434|NCT02674295|Esketamine|esketamine|mesh-list
154057435|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
154057436|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154057437|NCT04179071|Famotidine|famotidine|mesh-list
154057438|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154057439|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154057440|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154057441|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
154057442|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
154057443|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057444|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057445|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057447|NCT02674139|Trace Elements|trace elements|mesh-ancestor
154057448|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
154057449|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057450|NCT00484315|Paclitaxel|paclitaxel|mesh-list
154057451|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154057452|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154057453|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057454|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
154057455|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
154057456|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
154057457|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057458|NCT01019083|Zinc|zinc|mesh-list
154057459|NCT01019083|Albendazole|albendazole|mesh-list
154057460|NCT01019083|Secnidazole|secnidazole|mesh-list
154057461|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
154057462|NCT01019083|Trace Elements|trace elements|mesh-ancestor
154057463|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
154057499|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
154057500|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057501|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057502|NCT00644111|Hydromorphone|hydromorphone|mesh-list
154057503|NCT00644111|Bupivacaine|bupivacaine|mesh-list
154057504|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
154057505|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
154057506|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057507|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057508|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
154057509|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057510|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154057511|NCT00644111|Narcotics|narcotics|mesh-ancestor
154057512|NCT00644111|Analgesics|analgesics|mesh-ancestor
154057513|NCT00644891|Amoxicillin|amoxicillin|mesh-list
154057514|NCT00644891|Cefdinir|cefdinir|mesh-list
154057515|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057516|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057517|NCT00644891|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154057518|NCT00644891|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154057519|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153704613|NCT00086892|Carboplatin|carboplatin|mesh-list
154057520|NCT04178057|Antibodies|antibodies|mesh-list
154057521|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
154057522|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154057523|NCT04178057|Mitogens|mitogens|mesh-list
154057524|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
154057525|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
154057526|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057527|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057528|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
154057529|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057530|NCT04178057|Growth Substances|growth substances|mesh-ancestor
154057547|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
154057548|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057549|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154057550|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154057551|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
154057552|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057553|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057554|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154057555|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154057556|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154057557|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154057558|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057559|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057560|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
154057562|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057563|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154057564|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154057565|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
154057566|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
154057567|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
154057568|NCT02670317|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153817034|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817035|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153817036|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
153817037|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153817038|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817039|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817040|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817041|NCT00469053|Buprenorphine|buprenorphine|mesh-list
153817042|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153817043|NCT00469053|Narcotics|narcotics|mesh-ancestor
153817044|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817045|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458397|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
153574326|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153574328|NCT01699490|Fluoxetine|fluoxetine|mesh-list
153574329|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153574330|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153820139|NCT00431990|Hormones|hormones|mesh-ancestor
153574334|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153574335|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153574336|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574337|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
153574338|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057569|NCT02670317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154057570|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154057571|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
154057572|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154057573|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
154057574|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057575|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
154057576|NCT02671565|Protective Agents|protective agents|mesh-ancestor
154057577|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
154057578|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154057579|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
154057580|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154057581|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
154057582|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057583|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057584|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
154057585|NCT04175171|Trastuzumab|trastuzumab|mesh-list
154057586|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154057587|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057588|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
154057589|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057590|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057591|NCT00645125|Amoxicillin|amoxicillin|mesh-list
154057592|NCT00645125|Cefdinir|cefdinir|mesh-list
154057593|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057594|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057595|NCT00645125|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154057596|NCT00645125|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154057597|NCT02669459|Imiquimod|imiquimod|mesh-list
154057598|NCT02669459|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154057599|NCT02669459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057613|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057614|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154057615|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154057616|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154057617|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057618|NCT00645203|Cefdinir|cefdinir|mesh-list
154057619|NCT00645203|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154057620|NCT00645203|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154057621|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057622|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057623|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
154057624|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154057625|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154057626|NCT02669303|Prednisolone|prednisolone|mesh-list
154057627|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
153704732|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704733|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153704734|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
154057628|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154057629|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
154057630|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057631|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
154057632|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
154057633|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057634|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057635|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154057636|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
154057637|NCT02669303|Hormones|hormones|mesh-ancestor
154057638|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057639|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154057640|NCT02669303|Protective Agents|protective agents|mesh-ancestor
154057641|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154057642|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057643|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154057644|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154057645|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154057646|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
153574339|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153574340|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
153574341|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153574342|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153574343|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154057648|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057649|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057650|NCT00645281|Urological Agents|urological agents|mesh-ancestor
154057651|NCT02668679|Hormones|hormones|mesh-list
154057652|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057653|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057654|NCT00645437|Levofloxacin|levofloxacin|mesh-list
154057655|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154057656|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057657|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154057658|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154057659|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154057660|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057661|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057662|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057663|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154057664|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154057665|NCT02537171|Apatinib|apatinib|mesh-list
154057666|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057667|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154057668|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057669|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057670|NCT00645515|Risperidone|risperidone|mesh-list
154057671|NCT00645515|Ziprasidone|ziprasidone|mesh-list
154057672|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154057673|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
154057674|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057675|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057676|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057677|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154057678|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153574344|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574345|NCT01699594|Mannitol|mannitol|mesh-list
153574346|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
153574347|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153574348|NCT01699594|Diuretics|diuretics|mesh-ancestor
153574349|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
153574350|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057680|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154057681|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154057684|NCT00644735|Lansoprazole|lansoprazole|mesh-list
154057685|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
154057686|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154057687|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154057688|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154057689|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057690|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057691|NCT02667743|Paclitaxel|paclitaxel|mesh-list
154057692|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154057693|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154057694|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057695|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
154057696|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
154057697|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
153574351|NCT01699594|Miotics|miotics|mesh-ancestor
153781614|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
153458398|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153458399|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153458400|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
153458401|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458402|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458403|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458404|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
153458405|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
153458406|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458407|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
153458408|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153458409|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
153458410|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153458412|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574353|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574355|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153574356|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
153574357|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153574358|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153574359|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
153574360|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574361|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574362|NCT01699659|Immunomodulating Agents|immunomodulating agents|mesh-list
153574363|NCT01699659|Immunologic Factors|immunologic factors|mesh-ancestor
153574364|NCT01699659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574365|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153574366|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
153574367|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574368|NCT01699711|Protective Agents|protective agents|mesh-ancestor
153574369|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574370|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153574371|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153574372|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574373|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153574374|NCT01699724|Sertraline|sertraline|mesh-list
154057698|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057699|NCT02666651|Tolvaptan|tolvaptan|mesh-list
154057700|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154057701|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057702|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
154057703|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057704|NCT02671175|Piperaquine|piperaquine|mesh-list
154057705|NCT02671175|Artenimol|artenimol|mesh-list
154057706|NCT02671175|Artemisinins|artemisinins|mesh-list
154057707|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
154057708|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154057709|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154057710|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154057711|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154057712|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154057713|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153704894|NCT00301951|Fludarabine|fludarabine|mesh-list
153704895|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
153704896|NCT00301951|Busulfan|busulfan|mesh-list
153704897|NCT00301951|Tacrolimus|tacrolimus|mesh-list
153704898|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153704899|NCT00301951|Sargramostim|sargramostim|mesh-list
153704900|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704901|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153704902|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
153704904|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704942|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704944|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
153704945|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546778|NCT05948891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153546779|NCT05948891|Glucocorticoids|glucocorticoids|mesh-ancestor
154057714|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
154057715|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057716|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154057717|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154057718|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057719|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
154057720|NCT02667197|Narcotics|narcotics|mesh-ancestor
154057721|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057722|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057723|NCT02667197|Analgesics|analgesics|mesh-ancestor
154057724|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
154057725|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057726|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
154057727|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
154057728|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154057729|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
154057730|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057731|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057738|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057739|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057740|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
154057741|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154057742|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
154057743|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154057744|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
154057746|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057747|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057748|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154057749|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154057750|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
154057751|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057752|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057753|NCT00646841|Doxazosin|doxazosin|mesh-list
154057754|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154057755|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154057756|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154057757|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154057758|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
153704946|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704947|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153704948|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
153704949|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704950|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704951|NCT00087165|Prednisone|prednisone|mesh-list
153704952|NCT00087165|Docetaxel|docetaxel|mesh-list
153704953|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704954|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
153704955|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
153704956|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
153704957|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704958|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057759|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057760|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057761|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057762|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
154057763|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057764|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057765|NCT00484159|Lidocaine|lidocaine|mesh-list
154057766|NCT00484159|Bupivacaine|bupivacaine|mesh-list
154057767|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
154057768|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
154057779|NCT02666417|Trace Elements|trace elements|mesh-ancestor
153704961|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057780|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
154057781|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057782|NCT00910637|Gestodene|gestodene|mesh-list
154057783|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154057784|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154057785|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154057786|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
154057787|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154057788|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057789|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154057790|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154057791|NCT00910637|Progestins|progestins|mesh-ancestor
154057792|NCT00910637|Hormones|hormones|mesh-ancestor
154057793|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057794|NCT00462865|Bevacizumab|bevacizumab|mesh-list
154057795|NCT00462865|Gemcitabine|gemcitabine|mesh-list
154057796|NCT00462865|Capecitabine|capecitabine|mesh-list
154057797|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154057798|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057799|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154057800|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154057801|NCT00462865|Growth Substances|growth substances|mesh-ancestor
154057802|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057803|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
153600465|NCT01884402|Ribavirin|ribavirin|mesh-list
154057804|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154057806|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057807|NCT02667353|Anesthetics|anesthetics|mesh-list
153574375|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
153574376|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153574377|NCT01699724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153574378|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153574379|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153574380|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704962|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704963|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153704964|NCT00302341|Trimethoprim|trimethoprim|mesh-list
153704965|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153704966|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
153541945|NCT01548482|MTOR Inhibitors|mtor inhibitors|mesh-list
153704967|NCT00302341|Pafuramidine|pafuramidine|mesh-list
153458413|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458416|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153574404|NCT01699854|Capsaicin|capsaicin|mesh-list
153574405|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
153574406|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
154057808|NCT02667353|Etomidate|etomidate|mesh-list
154057809|NCT02667353|Succinylcholine|succinylcholine|mesh-list
154057810|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057811|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057812|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154057813|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154057814|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
154057815|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154057816|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154057817|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154057818|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057819|NCT00462709|Complement C1s|complement c1s|mesh-list
154057820|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154057821|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154057822|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
154057823|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057824|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154057825|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154057826|NCT02664857|Vitamin D|vitamin d|mesh-list
154057827|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
154057828|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
154057829|NCT02664857|Vitamins|vitamins|mesh-list
154057830|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
154057831|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057832|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154057833|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154057834|NCT02665871|Vaccines|vaccines|mesh-list
154057835|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
153704991|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
153704992|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
153704993|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
153704994|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704995|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704996|NCT00302536|Tacrolimus|tacrolimus|mesh-list
153704997|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704998|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
153704999|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705000|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153705001|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705002|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705003|NCT00081224|Celecoxib|celecoxib|mesh-list
153705034|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705035|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
153705037|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154057836|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057837|NCT00647543|Atorvastatin|atorvastatin|mesh-list
154057838|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154057839|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154057840|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
154057841|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057842|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154057843|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154057846|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
154057847|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153705045|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705047|NCT00418288|Incretins|incretins|mesh-ancestor
154057848|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154057849|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057850|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057851|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154057852|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154057853|NCT00461305|Drospirenone|drospirenone|mesh-list
154057854|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154057855|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
154057856|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057857|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057858|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154057859|NCT00461305|Diuretics|diuretics|mesh-ancestor
154057860|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
154057861|NCT01022671|Belotecan|belotecan|mesh-list
154057862|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154057863|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154057864|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057865|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057866|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057867|NCT01022749|Vaccines|vaccines|mesh-list
154057868|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
154057869|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057870|NCT00645905|Adalimumab|adalimumab|mesh-list
154057871|NCT00645905|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154057872|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057873|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154057874|NCT00647777|Olanzapine|olanzapine|mesh-list
154057875|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
154057876|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
153600551|NCT01884857|Metoprolol|metoprolol|mesh-list
154057877|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574407|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
153574408|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574409|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574410|NCT01699919|Lidocaine|lidocaine|mesh-list
153574411|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
153574412|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
154057878|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057879|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154057880|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154057881|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154057882|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057883|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154057884|NCT00647777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154057885|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154057886|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153705131|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705132|NCT00303004|Urological Agents|urological agents|mesh-ancestor
154057887|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057888|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057889|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
154057890|NCT04173611|Bupivacaine|bupivacaine|mesh-list
154057891|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
154057892|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
154057893|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057894|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057895|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
154057896|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057897|NCT02665637|Trastuzumab|trastuzumab|mesh-list
154057898|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154057899|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057900|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153574413|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574414|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574415|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
153574416|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574417|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153574418|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153574419|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153574420|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153574421|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574422|NCT01699932|Metformin|metformin|mesh-list
153574423|NCT01699932|Glimepiride|glimepiride|mesh-list
153574424|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153705133|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153705134|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153705135|NCT00081575|Levofloxacin|levofloxacin|mesh-list
153705136|NCT00081575|Tigecycline|tigecycline|mesh-list
153705137|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153705138|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705139|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153574425|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574427|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153574428|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
153574429|NCT01699997|Oxytocin|oxytocin|mesh-list
153574430|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
153574431|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153574457|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
153574458|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153574459|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153574460|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574461|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153574462|NCT01700322|Clopidogrel|clopidogrel|mesh-list
153574463|NCT01700322|Ticagrelor|ticagrelor|mesh-list
153574464|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153577517|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154057901|NCT00648011|Quinapril|quinapril|mesh-list
153705140|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153705141|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153705142|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705143|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705144|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057902|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153705145|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153705147|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154057903|NCT00648011|Diuretics|diuretics|mesh-ancestor
154057904|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
154057905|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057906|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154057907|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057908|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057909|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154057910|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
154057911|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057913|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
154057914|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154057915|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154057916|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154057917|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
154057918|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057919|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057920|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154057921|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
154057922|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
154057923|NCT00646529|Hormones|hormones|mesh-ancestor
154057924|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154057925|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154057927|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154057950|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154057951|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057953|NCT00648323|Doxazosin|doxazosin|mesh-list
154057954|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154057955|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154057956|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154057957|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154057958|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
154057959|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154057960|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057961|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057962|NCT00856388|Fludarabine|fludarabine|mesh-list
154057963|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
154057964|NCT00856388|Melphalan|melphalan|mesh-list
154057965|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
154057966|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154057967|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
154057968|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154057969|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154057970|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
154057971|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057972|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154057973|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
154057974|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705292|NCT00303940|Carboplatin|carboplatin|mesh-list
153705293|NCT00303940|Temozolomide|temozolomide|mesh-list
153705294|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705295|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153705296|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
153705297|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057975|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154057976|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
154057977|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154057978|NCT00648401|Verapamil|verapamil|mesh-list
154057979|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154057980|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154057981|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154057982|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154057983|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154057984|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574465|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154057985|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
154057986|NCT02663999|Diazepam|diazepam|mesh-list
154057987|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154057988|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
154057989|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
154057990|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
154057991|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154057992|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154057993|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154057994|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154057995|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154057996|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154057997|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154057998|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154057999|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705309|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058000|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154058001|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154058002|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
154058003|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
154058004|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
154058005|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
154058006|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058007|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058008|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
154058009|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
154058010|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154058011|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058012|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058013|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
154058014|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705344|NCT00304252|Interferon-beta|interferon-beta|mesh-list
153705352|NCT00120471|Tenofovir|tenofovir|mesh-list
154058015|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058016|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058017|NCT04171739|Itraconazole|itraconazole|mesh-list
154058018|NCT04171739|Olorofim|olorofim|mesh-list
154058027|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
154058028|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058029|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058030|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154058031|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154058032|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
154058033|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154058034|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
154058035|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154058036|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154058037|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154058038|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154058039|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154058040|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154058041|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154058043|NCT02656121|Clomiphene|clomiphene|mesh-list
154058044|NCT02656121|Vitamins|vitamins|mesh-ancestor
154058045|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
154058046|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058047|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154058048|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154058049|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
154058050|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058051|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154058052|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
154058053|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153574466|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153574467|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153574468|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153574469|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
153574470|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574471|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574472|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574473|NCT01700400|Bevacizumab|bevacizumab|mesh-list
153574474|NCT01700400|Carboplatin|carboplatin|mesh-list
153574475|NCT01700400|Pemetrexed|pemetrexed|mesh-list
153574476|NCT01700400|Everolimus|everolimus|mesh-list
153574477|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153574478|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574479|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153574480|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153705373|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705374|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705375|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153705376|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153705384|NCT00082082|Thymalfasin|thymalfasin|mesh-list
153705385|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153705402|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153574481|NCT01700400|Growth Substances|growth substances|mesh-ancestor
154058054|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154058055|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154058057|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
154058058|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058059|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058060|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058061|NCT00649883|Vaccines|vaccines|mesh-list
154058062|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
154058063|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058064|NCT00648791|Finasteride|finasteride|mesh-list
154058065|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154058066|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154058067|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058068|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058069|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
154058070|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058071|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058072|NCT00648791|Urological Agents|urological agents|mesh-ancestor
154058073|NCT00649181|Metolazone|metolazone|mesh-list
154058074|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154058075|NCT00649181|Diuretics|diuretics|mesh-ancestor
154058076|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
154058077|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058078|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153574482|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705403|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153705404|NCT00304642|Dapivirine|dapivirine|mesh-list
153705405|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153705406|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153705407|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
153705408|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705409|NCT00304681|Methylphenidate|methylphenidate|mesh-list
153705410|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153705411|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705418|NCT00304720|Tacrolimus|tacrolimus|mesh-list
153705431|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705432|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
153705433|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
153574483|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
153574484|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574485|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574486|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153574487|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153574498|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574501|NCT01700426|Tocopherols|tocopherols|mesh-list
153574502|NCT01700426|Tocotrienols|tocotrienols|mesh-list
153574503|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
153574504|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
153574505|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574506|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
153574507|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574508|NCT01700426|Protective Agents|protective agents|mesh-ancestor
153574509|NCT01700478|Vasopressins|vasopressins|mesh-list
153574510|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
153705454|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153574511|NCT01700478|Misoprostol|misoprostol|mesh-list
153574512|NCT01700478|Diuretics|diuretics|mesh-list
153574513|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574514|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153574515|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
153574516|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153705455|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
153705456|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153705457|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153705469|NCT00304993|Niacin|niacin|mesh-list
153705476|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705477|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153705479|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
153705480|NCT00304993|Vitamins|vitamins|mesh-ancestor
153705481|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
153705482|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
153705483|NCT00082277|Anastrozole|anastrozole|mesh-list
153705498|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
153574517|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153574518|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154058090|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154058091|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
154058092|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
154058093|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154058094|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154058095|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154058096|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
154058098|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058099|NCT04170179|Lenvatinib|lenvatinib|mesh-list
154058100|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058101|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154058102|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058103|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058104|NCT02659085|Ketamine|ketamine|mesh-list
154058105|NCT02659085|Analgesics|analgesics|mesh-ancestor
153574519|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
154058106|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
154058107|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058108|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058109|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154058110|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154058111|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
154058112|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
154058113|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058114|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154058115|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154058116|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058117|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058118|NCT04171193|Isoflurane|isoflurane|mesh-list
154058119|NCT04171193|Sertraline|sertraline|mesh-list
154058120|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
154058121|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705524|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
153705525|NCT00305461|Ciclesonide|ciclesonide|mesh-list
153705526|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
153705527|NCT00305461|Hormones|hormones|mesh-ancestor
154058122|NCT04171193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154058123|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154058124|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058125|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058126|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058127|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
154058128|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058129|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154058130|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
154058131|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
154058132|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542546|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705561|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058133|NCT02663141|Bevacizumab|bevacizumab|mesh-list
154058134|NCT02663141|Losartan|losartan|mesh-list
154058135|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058136|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058137|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154058138|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154058139|NCT02663141|Growth Substances|growth substances|mesh-ancestor
154058140|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058145|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154058146|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058147|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
154058148|NCT04171349|Carticaine|carticaine|mesh-list
154058149|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154058150|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058151|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058152|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154058153|NCT04171349|Analgesics|analgesics|mesh-ancestor
154058154|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
154058155|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058156|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154058157|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154058158|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154058159|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
154058160|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058161|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058162|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
153705562|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705563|NCT00082472|Docetaxel|docetaxel|mesh-list
153705564|NCT00082472|Doxorubicin|doxorubicin|mesh-list
153705565|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153705566|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705567|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153705568|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705569|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153705571|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153705621|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153705622|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705623|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705624|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546867|NCT05889624|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153546868|NCT05889624|Antidepressive Agents|antidepressive agents|mesh-ancestor
154058163|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
154058164|NCT00650039|Valdecoxib|valdecoxib|mesh-list
154058165|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153574520|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
153574521|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
153817046|NCT00469053|Analgesics|analgesics|mesh-ancestor
153817047|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
153817048|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817049|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153461673|NCT03818802|Niacin|niacin|mesh-list
153817058|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153817059|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817060|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153817061|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
153817062|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153817063|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817064|NCT00428129|Plasminogen|plasminogen|mesh-list
153817065|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153458417|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154058166|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154058167|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058168|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058169|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154058170|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154058171|NCT00650039|Analgesics|analgesics|mesh-ancestor
154058172|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
154058173|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058174|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058175|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058176|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058177|NCT00649259|Oxybutynin|oxybutynin|mesh-list
154058178|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
154058179|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
154058180|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058181|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058182|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154058183|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154058184|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
154058185|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058186|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058187|NCT00649259|Urological Agents|urological agents|mesh-ancestor
154058188|NCT02658773|Lidocaine|lidocaine|mesh-list
154058189|NCT02658773|Prilocaine|prilocaine|mesh-list
154058190|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154058191|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
154058192|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
154058193|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058194|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058195|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
154058196|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058197|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153458418|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153574523|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153574524|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153574525|NCT01700491|Ropivacaine|ropivacaine|mesh-list
153574526|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
153574527|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
153574528|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574529|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574530|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
153574531|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058198|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154058199|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154058200|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058201|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058202|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154058204|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154058205|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058206|NCT04169945|Erythritol|erythritol|mesh-list
154058207|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
154058208|NCT04169867|Nivolumab|nivolumab|mesh-list
154058209|NCT04169867|Ipilimumab|ipilimumab|mesh-list
154058210|NCT04169867|Atezolizumab|atezolizumab|mesh-list
154058211|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058212|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058213|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154058214|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058215|NCT02655029|Amlodipine|amlodipine|mesh-list
154058216|NCT02655029|Perindopril|perindopril|mesh-list
154058217|NCT02655029|Indapamide|indapamide|mesh-list
154058218|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154058219|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154058220|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058221|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058222|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154058223|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058224|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
154058225|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154058226|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
154058227|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058228|NCT02655029|Diuretics|diuretics|mesh-ancestor
154058229|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
154058230|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154058231|NCT02536859|Insulin|insulin|mesh-list
153574532|NCT01700504|Gentamicins|gentamicins|mesh-list
153574533|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153574534|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574535|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153574536|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574537|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058233|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
154058234|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154058235|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058236|NCT02536937|Eliglustat|eliglustat|mesh-list
153705662|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153705663|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705664|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705670|NCT00082862|Interferons|interferons|mesh-list
154058237|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058238|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058239|NCT02654405|Butyric Acid|butyric acid|mesh-list
154058240|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
154058241|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
154058242|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058243|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058244|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058245|NCT00649415|Valdecoxib|valdecoxib|mesh-list
154058246|NCT00649415|Piroxicam|piroxicam|mesh-list
154058247|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154058248|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153574538|NCT01700608|Plerixafor|plerixafor|mesh-list
153574539|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153574540|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153574541|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
153574542|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574543|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153458419|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458420|NCT05580822|Tenecteplase|tenecteplase|mesh-list
153458421|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153458422|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153458423|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458424|NCT05580354|Tislelizumab|tislelizumab|mesh-list
153458425|NCT05580354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458426|NCT05580354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458427|NCT04143906|Carboplatin|carboplatin|mesh-list
153458428|NCT04143906|Gemcitabine|gemcitabine|mesh-list
153458429|NCT04143906|Vinorelbine|vinorelbine|mesh-list
153458430|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458431|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153458432|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
153458433|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458435|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
153458436|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
153458437|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
153458438|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
153705730|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705731|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
153705732|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705733|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
153705734|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705735|NCT00083057|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153705736|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153705737|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705738|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
153705739|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153705740|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153705741|NCT00307606|Prednisolone|prednisolone|mesh-list
153458439|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153458440|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
153458441|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458442|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
153458443|NCT02708706|Protective Agents|protective agents|mesh-ancestor
153458444|NCT05587608|Anesthetics|anesthetics|mesh-list
153574544|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153574545|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574546|NCT01700751|Immunotoxins|immunotoxins|mesh-ancestor
153574547|NCT01700751|Immunoconjugates|immunoconjugates|mesh-ancestor
153574560|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574561|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153574562|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153574563|NCT01700803|Iodine|iodine|mesh-list
153574564|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
153574565|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
154058249|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058250|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058251|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154058252|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154058253|NCT00649415|Analgesics|analgesics|mesh-ancestor
154058254|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
154058255|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058256|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058257|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058258|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058259|NCT00650117|Fentanyl|fentanyl|mesh-list
154058260|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154058261|NCT00650117|Narcotics|narcotics|mesh-ancestor
154058262|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058263|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058264|NCT00650117|Analgesics|analgesics|mesh-ancestor
154058265|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
154058266|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058267|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154058268|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154058269|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
154058270|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
154058271|NCT00648947|Clopidogrel|clopidogrel|mesh-list
154058272|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154058273|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154058274|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153705758|NCT00083096|Temozolomide|temozolomide|mesh-list
153705765|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
153705766|NCT00307645|Prednisone|prednisone|mesh-list
153705767|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
153705768|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
153705769|NCT00307645|Azathioprine|azathioprine|mesh-list
153705770|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153705771|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
153705772|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705773|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153705774|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153705775|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
153705776|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705777|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705778|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154058275|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154058276|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
154058277|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058278|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058279|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058280|NCT00649493|Rabeprazole|rabeprazole|mesh-list
154058281|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154058282|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154058283|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154058284|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574566|NCT01700803|Povidone|povidone|mesh-list
153574567|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154058285|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058286|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
154058287|NCT02654093|Vitamin D|vitamin d|mesh-list
154058288|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154058289|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154058290|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058291|NCT02654093|Vitamins|vitamins|mesh-ancestor
154058292|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
154058293|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154058294|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154058295|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
154058296|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058297|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154058298|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154058299|NCT04168619|Methotrexate|methotrexate|mesh-list
154058300|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154058301|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
154058302|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154058303|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058304|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154058305|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
154058306|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058307|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058333|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
154058334|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058335|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058336|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
154058337|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058338|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154058339|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154058340|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
154058341|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058342|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154058343|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154058344|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153705782|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705783|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153705784|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153705785|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153705786|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
153705787|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153705788|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705789|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705790|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
154058345|NCT00848354|Analgesics|analgesics|mesh-ancestor
154058346|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
154058347|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058348|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058349|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154058351|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154058352|NCT00600821|Bevacizumab|bevacizumab|mesh-list
154058353|NCT00600821|Carboplatin|carboplatin|mesh-list
154058354|NCT00600821|Axitinib|axitinib|mesh-list
154058355|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153574568|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574569|NCT01700803|Trace Elements|trace elements|mesh-ancestor
153574570|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
153574571|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574572|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
153574573|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
153574574|NCT01700881|Vitamin E|vitamin e|mesh-list
153574575|NCT01700881|Vitamins|vitamins|mesh-ancestor
153574576|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
153574577|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574579|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574580|NCT01700881|Protective Agents|protective agents|mesh-ancestor
153574581|NCT01701076|Dexamethasone|dexamethasone|mesh-list
153574582|NCT01701076|Lenalidomide|lenalidomide|mesh-list
153574583|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153574584|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574585|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
153574586|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
153574587|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705820|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153705821|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153705822|NCT00307723|Growth Substances|growth substances|mesh-ancestor
153705823|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705824|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
153705825|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705826|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
153705827|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705828|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153705829|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
153705830|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153705831|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705832|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705833|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705834|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153705835|NCT00120822|Folic Acid|folic acid|mesh-list
153705836|NCT00120822|Hematinics|hematinics|mesh-ancestor
153574588|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574589|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574590|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
153574591|NCT01701076|Hormones|hormones|mesh-ancestor
153574592|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574593|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153574594|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577518|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154058356|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058357|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
154058358|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
154058359|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
154058360|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058361|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058362|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154058363|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154058364|NCT00600821|Growth Substances|growth substances|mesh-ancestor
154058365|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058366|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
154058367|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154058368|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058370|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
154058371|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058372|NCT02653703|Ethanol|ethanol|mesh-list
154058373|NCT02653703|Menthol|menthol|mesh-list
154058374|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154058375|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058376|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058377|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058378|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
154058379|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
154058380|NCT00649571|Doxycycline|doxycycline|mesh-list
154058381|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154058382|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058383|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
154058384|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154058385|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154058386|NCT02662283|Acteoside|acteoside|mesh-list
154058387|NCT02662283|Prednisolone|prednisolone|mesh-list
154058388|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058389|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
153601061|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
154058390|NCT02662283|Hormones|hormones|mesh-ancestor
154058391|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058392|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058393|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154058394|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058396|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058397|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154058398|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
154058399|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058400|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
154058401|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
154058402|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154058403|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
154058404|NCT02657603|Lidocaine|lidocaine|mesh-list
154058405|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
154058406|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
154058407|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058408|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058409|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
154058410|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058411|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154058412|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154058413|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154058414|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058415|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058416|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154058417|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
154058418|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
153705991|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
153705992|NCT00083486|Hematinics|hematinics|mesh-ancestor
153705993|NCT00120978|Fluticasone|fluticasone|mesh-list
153705994|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153705995|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
153917978|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
153705996|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705997|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058419|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058420|NCT00649649|Quinapril|quinapril|mesh-list
154058421|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154058422|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
154058423|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058424|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058425|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154058426|NCT02657291|Ropivacaine|ropivacaine|mesh-list
154058428|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
154058429|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058430|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058431|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
154058432|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058433|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154058434|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
154058435|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154058436|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154058437|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058438|NCT02661893|Rifampin|rifampin|mesh-list
154058439|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154058440|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
154058441|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154058442|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058443|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
154058444|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154058445|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058446|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058447|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154058448|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154058449|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154058450|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154058451|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154058452|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154058453|NCT00855920|Indomethacin|indomethacin|mesh-list
154058454|NCT00855920|Rilonacept|rilonacept|mesh-list
154058455|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154058456|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154058457|NCT00855920|Analgesics|analgesics|mesh-ancestor
153706053|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153706054|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153706055|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153706056|NCT00088491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153706057|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153706058|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153706072|NCT00121017|Ritonavir|ritonavir|mesh-list
154058458|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
154058459|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058465|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154058466|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154058467|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058468|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058469|NCT02657213|Insulin|insulin|mesh-list
154058470|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154058471|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154058472|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058473|NCT00649727|Oxybutynin|oxybutynin|mesh-list
154058474|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
154058475|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
154058476|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058477|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058478|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154058479|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154058480|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
154058481|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058482|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058483|NCT00649727|Urological Agents|urological agents|mesh-ancestor
154058484|NCT00650273|Azithromycin|azithromycin|mesh-list
154058485|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154058519|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154058520|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
154058521|NCT00847808|Lansoprazole|lansoprazole|mesh-list
154058522|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154058523|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154058524|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154058525|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058526|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058527|NCT02656979|Latanoprost|latanoprost|mesh-list
154058528|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154058529|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154058530|NCT04017455|Bevacizumab|bevacizumab|mesh-list
154058531|NCT04017455|Atezolizumab|atezolizumab|mesh-list
154058532|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058533|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058534|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154058535|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153601210|NCT01888744|Progesterone|progesterone|mesh-list
154058536|NCT04017455|Growth Substances|growth substances|mesh-ancestor
154058537|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058538|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
154058539|NCT04017455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154058540|NCT04017455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058541|NCT05298020|Paclitaxel|paclitaxel|mesh-list
154058542|NCT05298020|Gemcitabine|gemcitabine|mesh-list
154058543|NCT05298020|Endostar protein|endostar protein|mesh-list
154058544|NCT05298020|Endostatins|endostatins|mesh-list
153706086|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058545|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154058546|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058547|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
154058548|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
154058549|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
154058550|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574595|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574596|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
153574597|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153574598|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153574599|NCT01701076|Growth Substances|growth substances|mesh-ancestor
153574600|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
153574601|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153574602|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
153817066|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154058551|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154058553|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058554|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154058555|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154058556|NCT05298020|Growth Substances|growth substances|mesh-ancestor
154058557|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
154058558|NCT04170647|Plasminogen|plasminogen|mesh-list
154058559|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154058560|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154058561|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058562|NCT02661347|Risperidone|risperidone|mesh-list
154058563|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154058564|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
154058565|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058566|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058567|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058568|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154058569|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154058570|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058571|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154058572|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154058573|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
154058575|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154058576|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153706180|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153706181|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
153706182|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706183|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706184|NCT00088686|Capsaicin|capsaicin|mesh-list
153706185|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
153706186|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
153706187|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
153706188|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706189|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706190|NCT00083681|Thalidomide|thalidomide|mesh-list
153706191|NCT00083681|Dexamethasone|dexamethasone|mesh-list
153706192|NCT00083681|Etoposide|etoposide|mesh-list
153706202|NCT00083681|Hormones|hormones|mesh-ancestor
154058577|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058578|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058579|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154058580|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058581|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
154058582|NCT02656589|Capecitabine|capecitabine|mesh-list
154058594|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
154058595|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058596|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058597|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154058598|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
154058599|NCT00600353|Hormones|hormones|mesh-ancestor
154058600|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058601|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154058602|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058603|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154058604|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058605|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058606|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153706203|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058607|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154058608|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
154058609|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
154058610|NCT02661191|Vitamin D|vitamin d|mesh-list
153817067|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817068|NCT00428168|Betahistine|betahistine|mesh-list
153817069|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
153817070|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
153817071|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
153817072|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817073|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817075|NCT00428480|Methamphetamine|methamphetamine|mesh-list
153706204|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153706205|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153706206|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153706207|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153706227|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
153706228|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
153706229|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706230|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153706231|NCT00121095|Analgesics|analgesics|mesh-ancestor
153706232|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
153706233|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706234|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706235|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
153706236|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153706293|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153706295|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153817076|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153817077|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817078|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
153817079|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
153817080|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817081|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
153817082|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817083|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574603|NCT01701089|Selegiline|selegiline|mesh-list
153574604|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
153574605|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153574606|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153574607|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153574608|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153574609|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574610|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574611|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153574612|NCT01701089|Protective Agents|protective agents|mesh-ancestor
153574613|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574614|NCT01701180|Oxytocin|oxytocin|mesh-list
153574615|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
153574616|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153574617|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574618|NCT01701219|Ceftaroline|ceftaroline|mesh-list
153574619|NCT01701219|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153574620|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153574621|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574622|NCT01701232|Rituximab|rituximab|mesh-list
154058612|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058613|NCT02661191|Vitamins|vitamins|mesh-ancestor
154058614|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
153706300|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706301|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
154058615|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154058616|NCT00691210|Niacinamide|niacinamide|mesh-list
154058617|NCT00691210|Niacin|niacin|mesh-list
154058618|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
154058619|NCT00691210|Etoposide|etoposide|mesh-list
154058620|NCT00691210|Vorinostat|vorinostat|mesh-list
154058621|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154058622|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058623|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154058624|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154058625|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058626|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058627|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154058628|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
154058629|NCT00691210|Vitamins|vitamins|mesh-ancestor
154058630|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
154058631|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058632|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154058633|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
153706302|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706355|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153706356|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706357|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706358|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706359|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153706360|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154058634|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154058635|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
154058636|NCT02652065|Acetylcholine|acetylcholine|mesh-list
154058637|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
154058638|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154058639|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
154058640|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058641|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058642|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058643|NCT00650429|Ziprasidone|ziprasidone|mesh-list
154058644|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154058645|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
154058646|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574623|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058648|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058649|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154058650|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154058651|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058652|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154058653|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154058654|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
154058655|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
154058656|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058657|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058658|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154058659|NCT00691132|Protective Agents|protective agents|mesh-ancestor
154058660|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058661|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058662|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
154058663|NCT02651753|Atorvastatin|atorvastatin|mesh-list
154058664|NCT02651753|Fenofibrate|fenofibrate|mesh-list
154058665|NCT02651753|Calcium|calcium|mesh-list
154058666|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154058667|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058668|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154058669|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154058670|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154058671|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
154058672|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058673|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154058674|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154058675|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058676|NCT00855218|Sorafenib|sorafenib|mesh-list
154058677|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058678|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154058679|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058680|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058681|NCT00748150|Vaccines|vaccines|mesh-list
154058689|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
154058690|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058691|NCT02651441|Gemcitabine|gemcitabine|mesh-list
154058692|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058693|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154058694|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
154058695|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058696|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
153706367|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154058697|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154058698|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
154058699|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058700|NCT01063348|Expectorants|expectorants|mesh-ancestor
154058701|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
154058702|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154058703|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
154058704|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058705|NCT01063348|Protective Agents|protective agents|mesh-ancestor
154058706|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058707|NCT01063348|Antidotes|antidotes|mesh-ancestor
154058708|NCT00855062|Minocycline|minocycline|mesh-list
154058709|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154058710|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058711|NCT00744250|Pancrelipase|pancrelipase|mesh-list
154058712|NCT00744250|Pancreatin|pancreatin|mesh-list
154058713|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154058715|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
154058716|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
154058717|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
154058718|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
154058719|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058720|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058721|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
154058722|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058723|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154058724|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154058725|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154058726|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058727|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058728|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154058729|NCT02564536|Decitabine|decitabine|mesh-list
154058730|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154058731|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
154058732|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058733|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058734|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058735|NCT00600119|Naloxegol|naloxegol|mesh-list
154058736|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154058737|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058738|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
154058739|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058740|NCT00866294|Paroxetine|paroxetine|mesh-list
154058741|NCT00866294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154058742|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154058743|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058753|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058754|NCT00649103|Quinapril|quinapril|mesh-list
154058755|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154058756|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
154058757|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058758|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058759|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154058760|NCT02660177|Dipyrone|dipyrone|mesh-list
154058761|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154058762|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154058763|NCT02660177|Analgesics|analgesics|mesh-ancestor
154058764|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
154058765|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058766|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058767|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058768|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058769|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
154058770|NCT00701246|Folic Acid|folic acid|mesh-list
154058771|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
153574624|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574625|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
153817084|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
153817085|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153817086|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153817087|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153817088|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153817089|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
153817090|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153817091|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458445|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458446|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458447|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
153458448|NCT02703714|Sargramostim|sargramostim|mesh-list
153458449|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458450|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458451|NCT02703714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153706541|NCT05567471|Vaccines|vaccines|mesh-list
153458452|NCT02703714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458453|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
153458454|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458455|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
153458456|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153458457|NCT03904446|Methylergonovine|methylergonovine|mesh-list
153458458|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
153458459|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153458460|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458462|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153458464|NCT04149678|Cyclosporine|cyclosporine|mesh-list
153458465|NCT04149678|Cyclosporins|cyclosporins|mesh-list
153458466|NCT04149678|Ozanimod|ozanimod|mesh-list
153574626|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574627|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153574628|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154058772|NCT00701246|Hematinics|hematinics|mesh-ancestor
154058773|NCT00701246|Vitamins|vitamins|mesh-ancestor
154058774|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
154058775|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058776|NCT02648711|Leucovorin|leucovorin|mesh-list
154058777|NCT02648711|Bevacizumab|bevacizumab|mesh-list
154058778|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
153706653|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
154058779|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058780|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058781|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154058782|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154058783|NCT02648711|Growth Substances|growth substances|mesh-ancestor
154058784|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058785|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
154058786|NCT02648711|Antidotes|antidotes|mesh-ancestor
154058787|NCT02648711|Protective Agents|protective agents|mesh-ancestor
154058788|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
154058789|NCT02648711|Vitamins|vitamins|mesh-ancestor
154058790|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
154058791|NCT00854360|Beclomethasone|beclomethasone|mesh-list
154058792|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058794|NCT00854360|Hormones|hormones|mesh-ancestor
154058795|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058796|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058797|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154058798|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
154058799|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
154058825|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154058826|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154058827|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154058828|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154058829|NCT00853970|Analgesics|analgesics|mesh-ancestor
153706658|NCT00293371|Prednisone|prednisone|mesh-list
154058830|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
154058831|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058832|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058833|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058834|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058835|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153601510|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
154058836|NCT00651287|Quinapril|quinapril|mesh-list
154058837|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154058838|NCT00651287|Diuretics|diuretics|mesh-ancestor
154058839|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
154058840|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058841|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154058842|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058843|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058844|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154058845|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
154058846|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058847|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154058848|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154058849|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058851|NCT02650427|Hormones|hormones|mesh-ancestor
154058852|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058853|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154058854|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
153574629|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153574630|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574631|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153574632|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
153574633|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153574634|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153574635|NCT01701323|Cytarabine|cytarabine|mesh-list
153574636|NCT01701323|Fludarabine|fludarabine|mesh-list
154058856|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058858|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058859|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058860|NCT00651443|Galiximab|galiximab|mesh-list
154058861|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058862|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058863|NCT00650897|Escitalopram|escitalopram|mesh-list
154058864|NCT00650897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154058865|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154058866|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154058867|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058868|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058870|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058871|NCT02644499|Folic Acid|folic acid|mesh-list
154058872|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
154058873|NCT02644499|Prednisolone|prednisolone|mesh-list
154058874|NCT02644499|Methotrexate|methotrexate|mesh-list
154058875|NCT02644499|Leflunomide|leflunomide|mesh-list
154058876|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
154058877|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154058878|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
154058879|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154058880|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058881|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154058882|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
154058883|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058893|NCT02644499|Hormones|hormones|mesh-ancestor
154058898|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154058899|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058900|NCT02644499|Hematinics|hematinics|mesh-ancestor
154058901|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
154058902|NCT02644499|Vitamins|vitamins|mesh-ancestor
154058903|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
154058904|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
154058905|NCT00652691|Carboplatin|carboplatin|mesh-list
154058906|NCT00652691|Topotecan|topotecan|mesh-list
154058907|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154058908|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
154058909|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058910|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154058911|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154058912|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
154058913|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058914|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058915|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154058916|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154058917|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154058918|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058919|NCT02649179|Ropivacaine|ropivacaine|mesh-list
154058920|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
154058921|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
154058922|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058923|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058924|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
154058925|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058926|NCT02644577|Metformin|metformin|mesh-list
154058927|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154058928|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058929|NCT02644421|Lidocaine|lidocaine|mesh-list
154058940|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058941|NCT00651599|Drospirenone|drospirenone|mesh-list
154058942|NCT00651599|Estradiol|estradiol|mesh-list
154058943|NCT00651599|Estrogens|estrogens|mesh-ancestor
154058944|NCT00651599|Hormones|hormones|mesh-ancestor
154058945|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154058946|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058947|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154058948|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
154058949|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154058950|NCT00651599|Diuretics|diuretics|mesh-ancestor
154058951|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
154058952|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154058953|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
154058954|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154058955|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154058956|NCT02536391|Ipatasertib|ipatasertib|mesh-list
154058957|NCT02536391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058958|NCT02536391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154058959|NCT02536391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154058960|NCT02536391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058961|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154058962|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154058963|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
154058964|NCT00651131|Daptomycin|daptomycin|mesh-list
154058965|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154058966|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154058967|NCT04167137|Atezolizumab|atezolizumab|mesh-list
154058968|NCT04167137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154058969|NCT04167137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058970|NCT04167137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154058971|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058972|NCT02649413|Prednisone|prednisone|mesh-list
154058973|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154058974|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
154058975|NCT02649413|Hormones|hormones|mesh-ancestor
154058978|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154058979|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154058980|NCT02643563|Epinephrine|epinephrine|mesh-list
154058981|NCT02643563|Bupivacaine|bupivacaine|mesh-list
154058982|NCT02643563|Ropivacaine|ropivacaine|mesh-list
154058983|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
154058984|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
154058985|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154058986|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154058987|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
154058988|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154058989|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154058990|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154058991|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
154058992|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154058993|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154058994|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154058995|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154058996|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
154058997|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154058998|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
154058999|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
154059000|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
154059001|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154059002|NCT00651209|Tenofovir|tenofovir|mesh-list
154059003|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
154059004|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059005|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154059006|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154059007|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059008|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059009|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154059010|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154059021|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154059022|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154059023|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059024|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059025|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
154059026|NCT00653003|Leflunomide|leflunomide|mesh-list
154059027|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059028|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059029|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154059030|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
154059031|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059032|NCT02643719|Topiramate|topiramate|mesh-list
154059033|NCT02643719|Naproxen|naproxen|mesh-list
154059034|NCT02643719|Sumatriptan|sumatriptan|mesh-list
154059035|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153706802|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
154059036|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154059037|NCT02643719|Analgesics|analgesics|mesh-ancestor
154059038|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
154059039|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059040|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059041|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059042|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059043|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
154059044|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154059045|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574637|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
153574639|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153574640|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
153574641|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574642|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153574643|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
153574644|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574645|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
153574646|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574648|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153574649|NCT01701349|Paclitaxel|paclitaxel|mesh-list
153574650|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
153574651|NCT01701349|Combretastatin|combretastatin|mesh-list
153574652|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153574653|NCT01701349|Carboplatin|carboplatin|mesh-list
153574654|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153574655|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574656|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
153574657|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
153574658|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
153574668|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059046|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059047|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
154059048|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154059049|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154059050|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154059051|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154059052|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
154059053|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059054|NCT02649101|Thalidomide|thalidomide|mesh-list
154059055|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154059056|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
154059057|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059058|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
154059059|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154059060|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059061|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059062|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153706811|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154059063|NCT02649101|Growth Substances|growth substances|mesh-ancestor
154059064|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059065|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059067|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154059068|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
154059069|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154059100|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059101|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059102|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
154059103|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
154059104|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154059105|NCT02646137|Estrogens|estrogens|mesh-ancestor
154059106|NCT02646137|Hormones|hormones|mesh-ancestor
154059107|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059108|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059109|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154059110|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059111|NCT00653549|Torsemide|torsemide|mesh-list
154059112|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154059113|NCT00653549|Diuretics|diuretics|mesh-ancestor
154059114|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
154059115|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059116|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154059117|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154059118|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059119|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
154059120|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
154059121|NCT02642861|Calcium|calcium|mesh-list
154059122|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154059123|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059124|NCT02642861|Antacids|antacids|mesh-ancestor
154059125|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574669|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574670|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574671|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153574672|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153574673|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574674|NCT01701479|Aldesleukin|aldesleukin|mesh-list
153574675|NCT01701479|Interleukin-2|interleukin-2|mesh-list
153574676|NCT01701479|Dinutuximab|dinutuximab|mesh-list
153574677|NCT01701479|Isotretinoin|isotretinoin|mesh-list
153574678|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574679|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153574680|NCT01701479|Analgesics|analgesics|mesh-ancestor
153706909|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543896|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
153706910|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153574681|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
153574682|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574683|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574684|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153574685|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153574686|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
154059127|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154059128|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
154059129|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154059130|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154059131|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154059132|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059133|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154059134|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059135|NCT02641457|Ranibizumab|ranibizumab|mesh-list
154059136|NCT02641457|Aflibercept|aflibercept|mesh-list
154059137|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059138|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154059139|NCT02641457|Growth Substances|growth substances|mesh-ancestor
154059140|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059141|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059142|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059144|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154059145|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
154059146|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154059147|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059148|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154059149|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154059150|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153574687|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574688|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
153574689|NCT01701518|Dexamethasone|dexamethasone|mesh-list
153574690|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574691|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
153574692|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
153574693|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574694|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574695|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574696|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
153574715|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153574716|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574717|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574718|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153574719|NCT01701778|Analgesics|analgesics|mesh-ancestor
153574720|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
153574721|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574722|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153574723|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153574724|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153574725|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
153574726|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574727|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574728|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154059151|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
154059152|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154059153|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154059154|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
154059155|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059156|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
154059157|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154059158|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154059160|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154059161|NCT02641301|Narcotics|narcotics|mesh-ancestor
154059162|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059163|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059164|NCT02641301|Analgesics|analgesics|mesh-ancestor
154059165|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
154059166|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059167|NCT02640989|Vaccines|vaccines|mesh-list
154059168|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
154059169|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059170|NCT02645747|Aflibercept|aflibercept|mesh-list
154059171|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059172|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154059173|NCT02645747|Growth Substances|growth substances|mesh-ancestor
154059174|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059175|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059176|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059177|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
154059178|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154059179|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059180|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
154059181|NCT00653315|Tramadol|tramadol|mesh-list
154059182|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154059183|NCT00653315|Narcotics|narcotics|mesh-ancestor
154059184|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574729|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153574730|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
153574731|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
153574732|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
153574733|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
153574734|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
153574735|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
153574736|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059187|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
154059188|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059189|NCT02640833|Venetoclax|venetoclax|mesh-list
154059190|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059191|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
154059192|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
154059193|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154059194|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154059195|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059196|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059197|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154059198|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154059199|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059200|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059201|NCT02645903|Morphine|morphine|mesh-list
154059202|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059203|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059204|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154059205|NCT02645903|Narcotics|narcotics|mesh-ancestor
154059206|NCT02645903|Analgesics|analgesics|mesh-ancestor
154059207|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
154059208|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059209|NCT02645981|Sorafenib|sorafenib|mesh-list
154059210|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059211|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153707095|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153601886|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154059213|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059214|NCT02535767|Primaquine|primaquine|mesh-list
154059215|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
154059216|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154059217|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154059218|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059219|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
153574737|NCT01701843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153574738|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059220|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059221|NCT02640365|Leucovorin|leucovorin|mesh-list
154059222|NCT02640365|Bevacizumab|bevacizumab|mesh-list
154059223|NCT02640365|Irinotecan|irinotecan|mesh-list
154059224|NCT02640365|Camptothecin|camptothecin|mesh-list
154059225|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154059226|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059227|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059228|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154059229|NCT02640365|Growth Substances|growth substances|mesh-ancestor
154059230|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059231|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059232|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154059233|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154059234|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059235|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059236|NCT02640365|Antidotes|antidotes|mesh-ancestor
154059237|NCT02640365|Protective Agents|protective agents|mesh-ancestor
154059238|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
154059239|NCT02640365|Vitamins|vitamins|mesh-ancestor
154059240|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
154059241|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154059242|NCT02642003|Lenograstim|lenograstim|mesh-list
154059243|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154059244|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
154059245|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059246|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
154059247|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059248|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
153574739|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153574758|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574759|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153574760|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153574761|NCT01701921|Pregabalin|pregabalin|mesh-list
153574762|NCT01701921|Analgesics|analgesics|mesh-ancestor
153574763|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
153574764|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574765|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574766|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
153574767|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153574768|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153574769|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574770|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153574771|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153574772|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153574773|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059249|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154059250|NCT00652379|Octreotide|octreotide|mesh-list
154059251|NCT00652379|Lanreotide|lanreotide|mesh-list
154059252|NCT00652379|Somatostatin|somatostatin|mesh-list
154059253|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059254|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154059255|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059256|NCT00652379|Hormones|hormones|mesh-ancestor
154059257|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059258|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059259|NCT04164797|Endostar protein|endostar protein|mesh-list
154059260|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059261|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154059262|NCT04164797|Growth Substances|growth substances|mesh-ancestor
154059263|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059264|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059265|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059266|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
154059267|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
154059268|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154059269|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154059270|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059271|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059272|NCT00654017|Urological Agents|urological agents|mesh-ancestor
154059273|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
154059274|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154059275|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154059276|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059277|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
154059278|NCT02639819|Coagulants|coagulants|mesh-ancestor
154059279|NCT02639741|Vitamins|vitamins|mesh-list
154059280|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
153574774|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153574775|NCT01702038|Rituximab|rituximab|mesh-list
153574776|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153574777|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574778|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
153574779|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574780|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153574781|NCT01702064|Nilotinib|nilotinib|mesh-list
153574782|NCT01702064|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153574783|NCT01702064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153574784|NCT01702064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577519|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
154059282|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
154059283|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059284|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
154059285|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059286|NCT02639741|Protective Agents|protective agents|mesh-ancestor
154059287|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059288|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
154059289|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154059290|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
154059291|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154059292|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154059293|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059294|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154059295|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059296|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154059297|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059299|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154059300|NCT00654173|Simvastatin|simvastatin|mesh-list
154059301|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154059302|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154059303|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
153574785|NCT01702064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458467|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458468|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458469|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153458470|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
153458471|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458472|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
153574786|NCT01702090|Ritonavir|ritonavir|mesh-list
153574787|NCT01702090|Darunavir|darunavir|mesh-list
153574788|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153574789|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153574790|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
153574791|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574792|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574793|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153574794|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153574795|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
153574796|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574797|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153574798|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153574799|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
153574800|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574801|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
153574802|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153574803|NCT01702129|Doxorubicin|doxorubicin|mesh-list
153574805|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153574806|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574807|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153574808|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153574809|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059305|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154059306|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154059307|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059308|NCT02645279|Midazolam|midazolam|mesh-list
154059309|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154059310|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154059311|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059312|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059313|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154059314|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154059315|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154059316|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154059317|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
154059318|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
154059319|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
154059320|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
154059321|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059322|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059323|NCT04164329|Anesthetics|anesthetics|mesh-list
154059324|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
154059325|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059326|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059327|NCT02639039|Cortisone|cortisone|mesh-list
154059328|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059329|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154059330|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153817098|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153817100|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
153817101|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574813|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153574814|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
153574815|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574816|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153574817|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574818|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574820|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153574821|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
153574822|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574823|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153574824|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574825|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574826|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
153574827|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154059331|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154059332|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
154059333|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059334|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154059336|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154059337|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059338|NCT00654407|Atorvastatin|atorvastatin|mesh-list
154059339|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154059340|NCT00654407|Simvastatin|simvastatin|mesh-list
154059341|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154059342|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154059343|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
154059344|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059345|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154059346|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154059347|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059348|NCT00691054|Paclitaxel|paclitaxel|mesh-list
154059349|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154059350|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154059351|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059352|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
154059353|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
154059354|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
154059355|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059356|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154059357|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154059358|NCT00744406|Sertraline|sertraline|mesh-list
154059359|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154059360|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
154059361|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707304|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059362|NCT00744406|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153602042|NCT01902186|Ritonavir|ritonavir|mesh-list
154059363|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154059364|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154059367|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
154059369|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154059370|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154059371|NCT00690820|Pancrelipase|pancrelipase|mesh-list
154059372|NCT00690820|Pancreatin|pancreatin|mesh-list
154059373|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059374|NCT02562508|Vaccines|vaccines|mesh-list
154059375|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
154059376|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059377|NCT00689338|Fluconazole|fluconazole|mesh-list
154059378|NCT00689338|Voriconazole|voriconazole|mesh-list
154059379|NCT00689338|Anidulafungin|anidulafungin|mesh-list
154059380|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
154059381|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059382|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154059383|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154059384|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059385|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059386|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154059387|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
154059388|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059389|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059390|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154059391|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154059392|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154059393|NCT00686998|Olanzapine|olanzapine|mesh-list
153574828|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574829|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153574830|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153574831|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574832|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574833|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574834|NCT01702389|Remifentanil|remifentanil|mesh-list
153574835|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153574836|NCT01702389|Narcotics|narcotics|mesh-ancestor
153574837|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574838|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574839|NCT01702389|Analgesics|analgesics|mesh-ancestor
153574840|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
153574841|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574842|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
153574843|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153574844|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574845|NCT01702506|Antacids|antacids|mesh-list
153574846|NCT01702506|Dacomitinib|dacomitinib|mesh-list
154059394|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
154059395|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
154059396|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059397|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059398|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059399|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154059400|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154059401|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059402|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154059403|NCT00686998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154059404|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153707355|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154059405|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154059406|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059407|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059408|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
154059409|NCT00744640|Gemcitabine|gemcitabine|mesh-list
154059410|NCT00744640|Capecitabine|capecitabine|mesh-list
154059411|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
154059412|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154059413|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
154059414|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059415|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059416|NCT00848718|Paclitaxel|paclitaxel|mesh-list
154059417|NCT00848718|Docetaxel|docetaxel|mesh-list
154059418|NCT00848718|Carboplatin|carboplatin|mesh-list
153707368|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
154059419|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154059420|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154059421|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059422|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
154059423|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
154059424|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
154059425|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059426|NCT00848718|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154059427|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153602111|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059436|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059437|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
154059438|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059439|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154059440|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154059441|NCT00883337|Analgesics|analgesics|mesh-ancestor
154059442|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
154059443|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059444|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059445|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059446|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059447|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154059448|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
154059449|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154059450|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
154059451|NCT04163783|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154059452|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153574847|NCT01702506|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153574848|NCT01702506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153574850|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574851|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574852|NCT01702610|Temozolomide|temozolomide|mesh-list
153574853|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153574854|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
153574855|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574856|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574857|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
153574858|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
153574859|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153574860|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153574861|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153574864|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153574865|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
153574866|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153574867|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153574868|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574870|NCT01702636|Coagulants|coagulants|mesh-ancestor
153574871|NCT01702649|Biapenem|biapenem|mesh-list
153574872|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574873|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
153574874|NCT01702688|Giapreza|giapreza|mesh-list
153574875|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
153574876|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153354762|NCT04856228|Lidocaine|lidocaine|mesh-list
153574877|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153574878|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
153574879|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574880|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817102|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817103|NCT00428519|Aprepitant|aprepitant|mesh-list
154059453|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059454|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059455|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059456|NCT00654485|Atorvastatin|atorvastatin|mesh-list
154059457|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154059458|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154059459|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154059460|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
154059461|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059462|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154059463|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154059464|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059465|NCT00837876|Sorafenib|sorafenib|mesh-list
154059466|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059467|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154059468|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707420|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
154059469|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059470|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
154059471|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
154059472|NCT00655421|Coagulants|coagulants|mesh-ancestor
154059473|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
154059474|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059475|NCT00707070|Acitretin|acitretin|mesh-list
154059476|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154059477|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
154059478|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059479|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
154059480|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
154059481|NCT00686920|Rifaximin|rifaximin|mesh-list
154059482|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154059483|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059484|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059485|NCT02562118|Letrozole|letrozole|mesh-list
154059486|NCT02562118|Lenvatinib|lenvatinib|mesh-list
154059487|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059488|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154059492|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154059493|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
154059494|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059495|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059496|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154059497|NCT00744718|Bevacizumab|bevacizumab|mesh-list
154059498|NCT00744718|Carboplatin|carboplatin|mesh-list
153707421|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707422|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707423|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
154059499|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154059500|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059501|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059502|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154059503|NCT00744718|Growth Substances|growth substances|mesh-ancestor
154059504|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059505|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059506|NCT00845832|Rituximab|rituximab|mesh-list
154059507|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154059508|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059509|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
154059510|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059511|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059512|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
154059513|NCT00703482|Ubiquinone|ubiquinone|mesh-list
154059514|NCT00703482|Fenofibrate|fenofibrate|mesh-list
154059515|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154059516|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
154059517|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059518|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153707466|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153707467|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154059519|NCT00703482|Vitamins|vitamins|mesh-ancestor
154059520|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
154059521|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059522|NCT00885755|Capecitabine|capecitabine|mesh-list
154059523|NCT00885755|Trastuzumab|trastuzumab|mesh-list
153817104|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
153817105|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
153817106|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
153574882|NCT01702701|Montelukast|montelukast|mesh-list
153574883|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574884|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153574885|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
153574886|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574887|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574888|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153574889|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
153574890|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
154059526|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
154059527|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059528|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059529|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154059530|NCT00749710|Clopidogrel|clopidogrel|mesh-list
154059531|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154059532|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154059533|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154059534|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154059535|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
153707468|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707469|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707470|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707471|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707472|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154059536|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059537|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059538|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059539|NCT00749866|Gentamicins|gentamicins|mesh-list
154059540|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154059541|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059542|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154059543|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574891|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153574892|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153574893|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
153574894|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153574895|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153574896|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153574897|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574898|NCT01702714|Paclitaxel|paclitaxel|mesh-list
153574899|NCT01702714|Carboplatin|carboplatin|mesh-list
153574900|NCT01702714|Gemcitabine|gemcitabine|mesh-list
153574901|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153574902|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574903|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
153817107|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817108|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817109|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817110|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153817111|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817112|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817113|NCT00428558|Cytarabine|cytarabine|mesh-list
153817114|NCT00428558|Daunorubicin|daunorubicin|mesh-list
153817115|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153817116|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
153817117|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458473|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458474|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
153458475|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458476|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154059544|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059546|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
154059547|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
154059548|NCT00742066|Felodipine|felodipine|mesh-list
154059549|NCT00742066|Irbesartan|irbesartan|mesh-list
154059550|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154059551|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154059552|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154059553|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059554|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154059555|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154059556|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154059557|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154059558|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059559|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
154059560|NCT00742144|Ofatumumab|ofatumumab|mesh-list
153458477|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153458478|NCT05581992|Sotorasib|sotorasib|mesh-list
153458479|NCT05581992|Omeprazole|omeprazole|mesh-list
153458480|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153458481|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153458482|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153458483|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820399|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153574912|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574913|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153574915|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
153574916|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
153574917|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574918|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153574919|NCT01702857|Antacids|antacids|mesh-ancestor
153574920|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574921|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574922|NCT01702974|Vitamin D|vitamin d|mesh-list
153574923|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
153574924|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153574925|NCT01702974|Vitamins|vitamins|mesh-ancestor
153574926|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
153574927|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574928|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153574929|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153574930|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574931|NCT01703104|Folic Acid|folic acid|mesh-list
153574932|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
153574933|NCT01703104|Proguanil|proguanil|mesh-list
153574934|NCT01703104|Hematinics|hematinics|mesh-ancestor
153574935|NCT01703104|Vitamins|vitamins|mesh-ancestor
153574936|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
153574937|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574939|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153574940|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153574941|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574942|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
153574943|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574944|NCT01703130|Ropivacaine|ropivacaine|mesh-list
153574945|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
153574946|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
153577520|NCT01718327|Sunitinib|sunitinib|mesh-list
154059561|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059563|NCT00845676|Ribavirin|ribavirin|mesh-list
154059564|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
154059565|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
154059566|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154059567|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059568|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
154059569|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059570|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
154059571|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059572|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
154059573|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059574|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
154059575|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154059576|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
154059577|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059578|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059579|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154059580|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
154059581|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059582|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059583|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154059584|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
154059585|NCT02611908|Ibrutinib|ibrutinib|mesh-list
154059586|NCT02611908|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154059587|NCT02611908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154059588|NCT02611908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059589|NCT02611908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059590|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154059591|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059592|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153574947|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574948|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707586|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574949|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
153574950|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781615|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153574951|NCT01703234|Ramipril|ramipril|mesh-list
153574952|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153574953|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
154059594|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154059595|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154059596|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
154059597|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059598|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154059599|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154059600|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059601|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154059602|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154059603|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154059604|NCT00655655|Everolimus|everolimus|mesh-list
154059605|NCT00655655|Vatalanib|vatalanib|mesh-list
154059606|NCT00655655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154059607|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154059608|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059609|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059610|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154059611|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
154059612|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059613|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059614|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
154059615|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059616|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059617|NCT00837330|Ranibizumab|ranibizumab|mesh-list
154059618|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059619|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154059620|NCT00837330|Growth Substances|growth substances|mesh-ancestor
154059621|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059622|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059623|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059624|NCT00703638|Pemetrexed|pemetrexed|mesh-list
154059625|NCT00703638|Sorafenib|sorafenib|mesh-list
154059626|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059627|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059628|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059642|NCT00827112|Ritonavir|ritonavir|mesh-list
154059643|NCT00827112|Lopinavir|lopinavir|mesh-list
154059644|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153707595|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059645|NCT00827112|Darunavir|darunavir|mesh-list
154059646|NCT00827112|Tenofovir|tenofovir|mesh-list
154059647|NCT00827112|Emtricitabine|emtricitabine|mesh-list
154059648|NCT00827112|Maraviroc|maraviroc|mesh-list
154059649|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154059650|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154059651|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
154059652|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782177|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782178|NCT00267384|Expectorants|expectorants|mesh-ancestor
154059653|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059654|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154059655|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154059656|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
154059657|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059658|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154059659|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154059660|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154059661|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154059662|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154059663|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154059664|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154059665|NCT00689104|Mirabegron|mirabegron|mesh-list
154059666|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154059667|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154059668|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154059669|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154059670|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
154059671|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059672|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059673|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059674|NCT00689104|Urological Agents|urological agents|mesh-ancestor
154059675|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154059676|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154059677|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
154059678|NCT00702156|Bisoprolol|bisoprolol|mesh-list
154059679|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154059680|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
154059681|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
154059682|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574954|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574955|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574956|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153574957|NCT01703312|Omalizumab|omalizumab|mesh-list
153574958|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153574959|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153574960|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
153574961|NCT01703325|Triamcinolone|triamcinolone|mesh-list
153574962|NCT01703325|Clobetasol|clobetasol|mesh-list
153574985|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153574994|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
153574995|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154059683|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059684|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154059685|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154059686|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154059687|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707620|NCT00090675|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153707626|NCT00312988|Topotecan|topotecan|mesh-list
154059688|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059689|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707645|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153707646|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153707647|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154059691|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154059692|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154059693|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
154059694|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059695|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059696|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059697|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154059698|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
154059699|NCT02638415|Protective Agents|protective agents|mesh-ancestor
154059700|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154059701|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154059702|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154059703|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
154059704|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154059705|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154059706|NCT00703872|Interferons|interferons|mesh-list
154059707|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059708|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
154059709|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059710|NCT00689026|Lubiprostone|lubiprostone|mesh-list
154059711|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154059712|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154059713|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059714|NCT00598559|Acetaminophen|acetaminophen|mesh-list
154059715|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154059716|NCT00598559|Analgesics|analgesics|mesh-ancestor
154059717|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
154059720|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
154059721|NCT00686686|Infliximab|infliximab|mesh-list
154059722|NCT00686686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154059723|NCT00686686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059724|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
154059725|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059726|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059727|NCT02637167|Rifaximin|rifaximin|mesh-list
154059728|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154059729|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059730|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059731|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154059732|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154059733|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059734|NCT00655109|Fluticasone|fluticasone|mesh-list
154059735|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154059736|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
154059737|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059738|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154059739|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
154059740|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059741|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059742|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154059743|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
154059744|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
154059745|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153574996|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153574997|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153574998|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574999|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153575000|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153575001|NCT01703559|Phentolamine|phentolamine|mesh-list
153575002|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153575003|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153575004|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153575005|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153575006|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
153575007|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575008|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575009|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575010|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153575011|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
153575012|NCT01703624|Bromides|bromides|mesh-list
153575013|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
153707721|NCT06001593|Vasodilator Agents|vasodilator agents|mesh-ancestor
153707722|NCT06001593|Histamine Agonists|histamine agonists|mesh-ancestor
153707723|NCT06001593|Histamine Agents|histamine agents|mesh-ancestor
153707724|NCT06001593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707725|NCT06001593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707726|NCT06001593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707727|NCT06001151|Carboplatin|carboplatin|mesh-list
153707728|NCT06001151|Pemetrexed|pemetrexed|mesh-list
153707729|NCT06001151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707730|NCT06001151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707734|NCT06000917|Paclitaxel|paclitaxel|mesh-list
154059748|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154059749|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154059750|NCT00655109|Analgesics|analgesics|mesh-ancestor
154059751|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
154059752|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059753|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154059754|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154059755|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
154059756|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
154059757|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059758|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059759|NCT02632877|Pirfenidone|pirfenidone|mesh-list
154059760|NCT02632877|Ketanserin|ketanserin|mesh-list
153707793|NCT05999890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707794|NCT05999890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153707795|NCT05999890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154059761|NCT02632877|Analgesics|analgesics|mesh-ancestor
154059762|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
154059763|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059764|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575014|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153575015|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153575016|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153575017|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
153575018|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575019|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575020|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575021|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153575022|NCT01703637|Vildagliptin|vildagliptin|mesh-list
153575023|NCT01703637|Saxagliptin|saxagliptin|mesh-list
153575024|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575025|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575026|NCT01703637|Incretins|incretins|mesh-ancestor
153575027|NCT01703637|Hormones|hormones|mesh-ancestor
153575028|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575029|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153575030|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
153575031|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575032|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575033|NCT01703728|Menotropins|menotropins|mesh-list
153575034|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153575035|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
153575036|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153575037|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575038|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
153575039|NCT01703754|Ifosfamide|ifosfamide|mesh-list
153575040|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153575041|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
153707796|NCT05999890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153707830|NCT05999383|Nicotine|nicotine|mesh-list
153707831|NCT05999383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153707832|NCT05999383|Autonomic Agents|autonomic agents|mesh-ancestor
153707833|NCT05999383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707834|NCT05999383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707835|NCT05999383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153707836|NCT05999383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153707837|NCT05999383|Cholinergic Agents|cholinergic agents|mesh-ancestor
153575042|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575043|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575044|NCT01703910|Paclitaxel|paclitaxel|mesh-list
153575045|NCT01703910|Etoposide|etoposide|mesh-list
153575046|NCT01703910|Vinorelbine|vinorelbine|mesh-list
153575047|NCT01703910|Docetaxel|docetaxel|mesh-list
154059766|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154059767|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059768|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059769|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059770|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154059771|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154059772|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154059773|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
154059774|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059775|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059776|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
154059777|NCT00656123|Molgramostim|molgramostim|mesh-list
154059778|NCT00656123|Sargramostim|sargramostim|mesh-list
154059779|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
154059780|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059781|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154059782|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575048|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153575049|NCT01703910|Cisplatin|cisplatin|mesh-list
153575050|NCT01703910|Gemcitabine|gemcitabine|mesh-list
153575064|NCT01703910|Mitomycins|mitomycins|mesh-list
153575065|NCT01703910|Mitomycin|mitomycin|mesh-list
153575066|NCT01703910|Raltitrexed|raltitrexed|mesh-list
153575075|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153575076|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153707842|NCT05999331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153575077|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153575078|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575079|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153575080|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
153575081|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575082|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153575083|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153575084|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153575085|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153575087|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153575088|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
153575090|NCT01704027|Hormones|hormones|mesh-ancestor
153575091|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575092|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575093|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
153707843|NCT05999331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575094|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153575095|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575096|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575097|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575098|NCT01704092|Analgesics|analgesics|mesh-ancestor
153575099|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
153575100|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575101|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153781616|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575102|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153575103|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153575105|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575106|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059783|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154059784|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
154059785|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059786|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059787|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154059788|NCT04163471|Hemostatics|hemostatics|mesh-list
154059789|NCT04163471|Coagulants|coagulants|mesh-ancestor
154059790|NCT00657449|Valdecoxib|valdecoxib|mesh-list
154059791|NCT00657449|Rofecoxib|rofecoxib|mesh-list
154059792|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154059793|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154059794|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059795|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059796|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154059797|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154059798|NCT00657449|Analgesics|analgesics|mesh-ancestor
154059799|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
154059800|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059801|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059802|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059803|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059804|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
154059805|NCT04160195|Fludarabine|fludarabine|mesh-list
154059806|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154059807|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
154059808|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708045|NCT05996406|Dexamethasone|dexamethasone|mesh-list
154059809|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059810|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154059811|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
154059812|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059813|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059814|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154059826|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154059827|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154059828|NCT00750178|Vorinostat|vorinostat|mesh-list
154059829|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059830|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154059831|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059832|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059833|NCT00750334|Clofarabine|clofarabine|mesh-list
154059834|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154059835|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
154059836|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059837|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059838|NCT00745186|Glucagon|glucagon|mesh-list
154059839|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059840|NCT00745186|Hormones|hormones|mesh-ancestor
154059841|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059842|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059844|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154059845|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
154059846|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059847|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
154059848|NCT00750724|Protective Agents|protective agents|mesh-ancestor
154059849|NCT00752518|Bortezomib|bortezomib|mesh-list
154059850|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059851|NCT00752596|Azimilide|azimilide|mesh-list
154059852|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154059853|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153575107|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153575108|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153575110|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
153575111|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
153817121|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817122|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
153817123|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817124|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153817125|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153817126|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153817127|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817128|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153817129|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153817130|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153817131|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458486|NCT05581992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458487|NCT05581992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059855|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059857|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059858|NCT00750802|Lorazepam|lorazepam|mesh-list
154059859|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
154059860|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
154059861|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
154059862|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059863|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059864|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059865|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154059866|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059867|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154059868|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154059869|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154059870|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
154059871|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
153458489|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
153458490|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153458491|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458492|NCT03645408|Exenatide|exenatide|mesh-list
153575112|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
153575113|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575114|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575115|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
153575116|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
153575117|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575118|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575119|NCT01704417|Insulin|insulin|mesh-list
153575120|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153575121|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
153575122|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575123|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575124|NCT01704469|Anesthetics|anesthetics|mesh-list
153575125|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
153575126|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575127|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575128|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
153575129|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575130|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
153575131|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153575132|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
153575133|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575134|NCT01704482|Expectorants|expectorants|mesh-ancestor
153575135|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
153575136|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153575137|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
153708188|NCT05952713|Amitriptyline|amitriptyline|mesh-list
153575138|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575139|NCT01704482|Protective Agents|protective agents|mesh-ancestor
153575140|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575141|NCT01704482|Antidotes|antidotes|mesh-ancestor
153575142|NCT01704508|Lumefantrine|lumefantrine|mesh-list
153575143|NCT01704508|Artemether|artemether|mesh-list
154059872|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154059873|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059874|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154059875|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
154059876|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154059877|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154059878|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154059879|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059880|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059881|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
154059882|NCT00576628|Hematinics|hematinics|mesh-ancestor
154059883|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
154059884|NCT00683878|Pioglitazone|pioglitazone|mesh-list
154059885|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
154059886|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154059887|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059888|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154059889|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059890|NCT00884741|Bevacizumab|bevacizumab|mesh-list
154059891|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154059892|NCT00884741|Temozolomide|temozolomide|mesh-list
153575157|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575158|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
153575159|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575160|NCT01704638|Digoxin|digoxin|mesh-list
153575161|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
153575162|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153575163|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153575164|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575165|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708311|NCT05826964|Hormone Antagonists|hormone antagonists|mesh-ancestor
153708312|NCT05826964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708313|NCT05826964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153708314|NCT05826964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708315|NCT05826964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153708366|NCT05733351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708367|NCT05722340|Anesthetics|anesthetics|mesh-list
153708368|NCT05722340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708369|NCT05722340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708370|NCT05721027|Dexamethasone|dexamethasone|mesh-list
153708372|NCT05721027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708373|NCT05721027|Antiemetics|antiemetics|mesh-ancestor
153708374|NCT05721027|Autonomic Agents|autonomic agents|mesh-ancestor
153708375|NCT05721027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575166|NCT01704638|Protective Agents|protective agents|mesh-ancestor
153575167|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575168|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153575169|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153575170|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575171|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153575172|NCT01704638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153575173|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153575174|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575175|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575176|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
153575178|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
153575179|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153575180|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153575181|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153458493|NCT03645408|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153458494|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153458495|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458496|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153458498|NCT03645408|Hormones|hormones|mesh-ancestor
153458499|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059894|NCT00884741|Antibodies|antibodies|mesh-list
154059895|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
154059896|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154059897|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
154059898|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708433|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154059899|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154059900|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154059901|NCT00884741|Growth Substances|growth substances|mesh-ancestor
154059902|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059903|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
154059904|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
154059905|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154059906|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
154059907|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059908|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154059909|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154059910|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154059911|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
154059912|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059913|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154059914|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153708434|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154059915|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059916|NCT04159649|Letrozole|letrozole|mesh-list
154059917|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059918|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154059919|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154059920|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059921|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059926|NCT00880763|Interferons|interferons|mesh-list
154059935|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154059936|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059937|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
154059938|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
154059939|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154059940|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059941|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
154059942|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154059943|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154059944|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059945|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154059946|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154059947|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
154059948|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059949|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154059950|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
154059951|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154059952|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154059953|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059954|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059955|NCT00657839|Urological Agents|urological agents|mesh-ancestor
154059956|NCT00884117|Oseltamivir|oseltamivir|mesh-list
154059957|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
154059958|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154059959|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059960|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059961|NCT04159181|Lactulose|lactulose|mesh-list
154059962|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
154059963|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154059964|NCT04159181|Cathartics|cathartics|mesh-ancestor
154059965|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
154059979|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154059980|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154059981|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
154059982|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154059983|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154059984|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154059985|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154059986|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708547|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154059987|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059988|NCT04158947|Trastuzumab|trastuzumab|mesh-list
154059989|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154059990|NCT04158947|Afatinib|afatinib|mesh-list
154059991|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154059992|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154059993|NCT04158947|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154059994|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154059995|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154059996|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154059997|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
154059998|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
154059999|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
154060000|NCT04158947|Immunotoxins|immunotoxins|mesh-ancestor
154060001|NCT04158947|Immunoconjugates|immunoconjugates|mesh-ancestor
154060002|NCT04158947|Immunologic Factors|immunologic factors|mesh-ancestor
154060003|NCT04158947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060004|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154060005|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
154060006|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154060007|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
154060008|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060009|NCT04163237|Sorafenib|sorafenib|mesh-list
154060010|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708660|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154060011|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154060012|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060016|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154060017|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
154060018|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060019|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060020|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060021|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154060022|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154060023|NCT02612298|Metoprolol|metoprolol|mesh-list
154060024|NCT02612298|Arotinolol|arotinolol|mesh-list
154060025|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154060026|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154060027|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
154060028|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
154060029|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060030|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060031|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154060032|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154060033|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154060034|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154060035|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060036|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060037|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154060039|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153708661|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
153708663|NCT05342519|Sirolimus|sirolimus|mesh-list
154060040|NCT00880607|Narcotics|narcotics|mesh-ancestor
154060041|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060042|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060043|NCT00880607|Analgesics|analgesics|mesh-ancestor
154060044|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
154060045|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060046|NCT00656435|Bevacizumab|bevacizumab|mesh-list
154060047|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060048|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060049|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154060050|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154060051|NCT00656435|Growth Substances|growth substances|mesh-ancestor
153458500|NCT04141410|Simendan|simendan|mesh-list
154060053|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
154060054|NCT02636231|Endostatins|endostatins|mesh-list
154060055|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154060056|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154060057|NCT02636231|Growth Substances|growth substances|mesh-ancestor
154060058|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060059|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
154060060|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060061|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154060062|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154060063|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154060064|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
154060065|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060067|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154060068|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060069|NCT00656591|Methotrexate|methotrexate|mesh-list
154060070|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154060071|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
154060072|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154060073|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060074|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153458501|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153458502|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
153458503|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153458505|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458506|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458507|NCT04141410|Protective Agents|protective agents|mesh-ancestor
153458508|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458510|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
153458511|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458512|NCT04149444|Trifluridine|trifluridine|mesh-list
153458513|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
153575182|NCT01704690|Paclitaxel|paclitaxel|mesh-list
153575183|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153575184|NCT01704690|Cisplatin|cisplatin|mesh-list
153575185|NCT01704690|Fluorouracil|fluorouracil|mesh-list
153575186|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153575187|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575188|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
153575189|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
153575190|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
153575191|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575192|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
153575193|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153575194|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153575195|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
153575196|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575197|NCT01704703|Panitumumab|panitumumab|mesh-list
153575198|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153575199|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060075|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
154060076|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060077|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060078|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
154060079|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060080|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154060081|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154060082|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
154060083|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154060084|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154060085|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154060086|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154060087|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154060088|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154060089|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060090|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060091|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060092|NCT00658931|Analgesics|analgesics|mesh-ancestor
154060093|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
154060094|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060095|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
154060096|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154060097|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
154060099|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154060100|NCT00834912|Narcotics|narcotics|mesh-ancestor
154060101|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060102|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708841|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153708842|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153708844|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708898|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154060103|NCT00834912|Analgesics|analgesics|mesh-ancestor
154060104|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
154060105|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060106|NCT02535689|Tofacitinib|tofacitinib|mesh-list
154060107|NCT02535689|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154060108|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154060114|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060115|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060117|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154060118|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154060119|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060120|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154060121|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154060122|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154060123|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060124|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060125|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
154060126|NCT04162535|Lidocaine|lidocaine|mesh-list
154060127|NCT04162535|Propofol|propofol|mesh-list
154060128|NCT04162535|Anesthetics|anesthetics|mesh-list
154060129|NCT04162535|Sevoflurane|sevoflurane|mesh-list
154060130|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
153708976|NCT04872790|Hormones|hormones|mesh-ancestor
154060131|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
154060132|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060133|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060134|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
154060135|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060136|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154060137|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154060138|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154060139|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575200|NCT01704716|Aldesleukin|aldesleukin|mesh-list
153575201|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
153575202|NCT01704716|Melphalan|melphalan|mesh-list
153575203|NCT01704716|Busulfan|busulfan|mesh-list
153575204|NCT01704716|Carboplatin|carboplatin|mesh-list
153575205|NCT01704716|Doxorubicin|doxorubicin|mesh-list
153575206|NCT01704716|Etoposide|etoposide|mesh-list
153575207|NCT01704716|Vincristine|vincristine|mesh-list
153575208|NCT01704716|Interleukin-2|interleukin-2|mesh-list
153575209|NCT01704716|Dinutuximab|dinutuximab|mesh-list
153575210|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153575211|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
153575212|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575230|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575231|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153575232|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153575233|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
153575234|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575235|NCT01704794|Folic Acid|folic acid|mesh-list
153575236|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
153575237|NCT01704794|Proguanil|proguanil|mesh-list
153575238|NCT01704794|Hematinics|hematinics|mesh-ancestor
153575239|NCT01704794|Vitamins|vitamins|mesh-ancestor
153575240|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
153575241|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709093|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154060140|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060142|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
154060143|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154060144|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154060145|NCT02632019|Gemcitabine|gemcitabine|mesh-list
154060146|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154060147|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
154060148|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060149|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060150|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154060151|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
154060152|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
154060153|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154060154|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154060155|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154060156|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060157|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060158|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060159|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060160|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
154060161|NCT00659321|Nicotine|nicotine|mesh-list
154060162|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154060163|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
154060164|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060165|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060166|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154060167|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154060168|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
154060169|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060170|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060171|NCT00659399|PENTA|penta|mesh-list
154060172|NCT00659399|Fondaparinux|fondaparinux|mesh-list
153575242|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
153575243|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153575244|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153575245|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575246|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
153575247|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060175|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154060176|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
154060177|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060178|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060179|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
154060180|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154060181|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154060183|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154060184|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060185|NCT00911339|Atorvastatin|atorvastatin|mesh-list
154060186|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154060187|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154060188|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
154060189|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060190|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154060191|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154060192|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060193|NCT05863195|Leucovorin|leucovorin|mesh-list
154060194|NCT05863195|Bevacizumab|bevacizumab|mesh-list
154060195|NCT05863195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154060196|NCT05863195|Cetuximab|cetuximab|mesh-list
154060197|NCT05863195|Panitumumab|panitumumab|mesh-list
154060198|NCT05863195|Fluorouracil|fluorouracil|mesh-list
154060199|NCT05863195|Oxaliplatin|oxaliplatin|mesh-list
154060200|NCT05863195|Irinotecan|irinotecan|mesh-list
154060201|NCT05863195|Floxuridine|floxuridine|mesh-list
154060202|NCT05863195|Endothelial Growth Factors|endothelial growth factors|mesh-list
154060203|NCT05863195|Antibodies|antibodies|mesh-list
153575248|NCT01704872|Dinutuximab|dinutuximab|mesh-list
153575249|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575250|NCT01704898|Efavirenz|efavirenz|mesh-list
153575284|NCT01705249|Hormones|hormones|mesh-ancestor
153575285|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575286|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575287|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153575288|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
153575289|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153575290|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153575291|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153575292|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153575293|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153575294|NCT01704963|Ibrutinib|ibrutinib|mesh-list
153575295|NCT01704963|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153575296|NCT01704963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154060204|NCT05863195|Immunoglobulins|immunoglobulins|mesh-list
154060205|NCT05863195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154060206|NCT05863195|Immunoglobulin G|immunoglobulin g|mesh-list
154060207|NCT05863195|Deoxyuridine|deoxyuridine|mesh-list
154060208|NCT05863195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060209|NCT05863195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154060210|NCT05863195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154060211|NCT05863195|Growth Substances|growth substances|mesh-ancestor
154060212|NCT05863195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060213|NCT05863195|Growth Inhibitors|growth inhibitors|mesh-ancestor
154060214|NCT05863195|Immunologic Factors|immunologic factors|mesh-ancestor
154060215|NCT05863195|Antimetabolites|antimetabolites|mesh-ancestor
154060216|NCT05863195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060217|NCT05863195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154060218|NCT05863195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154060219|NCT05863195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154060220|NCT05863195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154060221|NCT05863195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060223|NCT05863195|Protective Agents|protective agents|mesh-ancestor
154060224|NCT05863195|Vitamin B Complex|vitamin b complex|mesh-ancestor
154060225|NCT05863195|Vitamins|vitamins|mesh-ancestor
154060226|NCT05863195|Micronutrients|micronutrients|mesh-ancestor
154060227|NCT05862753|Etomidate|etomidate|mesh-list
154060228|NCT05862753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154060229|NCT05862753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060230|NCT05862753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060231|NCT05862753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154060232|NCT05862753|Anesthetics, General|anesthetics, general|mesh-ancestor
154060233|NCT05862753|Anesthetics|anesthetics|mesh-ancestor
154060234|NCT05862714|Itraconazole|itraconazole|mesh-list
154060235|NCT05862714|Fluconazole|fluconazole|mesh-list
154060236|NCT05862714|Antifungal Agents|antifungal agents|mesh-ancestor
154060237|NCT05862714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060238|NCT05862714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154060239|NCT05862714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154060240|NCT05862714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575297|NCT01704963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575298|NCT01704963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575299|NCT01705314|Vitamin D|vitamin d|mesh-list
153575300|NCT01705314|Vitamins|vitamins|mesh-ancestor
153575301|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
154060241|NCT05862714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060242|NCT05862714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154060243|NCT05862714|Hormone Antagonists|hormone antagonists|mesh-ancestor
154060244|NCT05862714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060245|NCT05862714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060246|NCT05862714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154060247|NCT05862714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154060248|NCT05862714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153709723|NCT03216967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060249|NCT05862701|Permethrin|permethrin|mesh-list
154060250|NCT05862701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060251|NCT05862701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060252|NCT05862519|Testosterone|testosterone|mesh-list
154060253|NCT05862519|Androgens|androgens|mesh-ancestor
154060254|NCT05862519|Hormones|hormones|mesh-ancestor
154060255|NCT05862519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060256|NCT05862519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060257|NCT05862428|Misoprostol|misoprostol|mesh-list
154060258|NCT05862428|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154060259|NCT05862428|Abortifacient Agents|abortifacient agents|mesh-ancestor
154060260|NCT05862428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154060261|NCT05862428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060262|NCT05862428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154060263|NCT05862428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060264|NCT05862428|Oxytocics|oxytocics|mesh-ancestor
154060265|NCT05862402|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154060266|NCT05862402|Gentamicins|gentamicins|mesh-list
154060267|NCT05862402|Meropenem|meropenem|mesh-list
154060268|NCT05862402|Imipenem|imipenem|mesh-list
153575302|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575303|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153575304|NCT01705340|Trastuzumab|trastuzumab|mesh-list
153575305|NCT01705340|Lapatinib|lapatinib|mesh-list
153458514|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458515|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
153817132|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817133|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153575306|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153575307|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575308|NCT01705340|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153575309|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153575310|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575311|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575312|NCT01705379|Lactitol|lactitol|mesh-list
153575313|NCT01705379|Cathartics|cathartics|mesh-ancestor
153709909|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153709910|NCT02157974|Incretins|incretins|mesh-ancestor
153709911|NCT02157974|Hormones|hormones|mesh-ancestor
153709912|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709913|NCT02140255|Ritonavir|ritonavir|mesh-list
153575314|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060270|NCT05862402|Colistin|colistin|mesh-list
154060271|NCT05862402|Ceftazidime|ceftazidime|mesh-list
154060272|NCT05862402|Tigecycline|tigecycline|mesh-list
154060273|NCT05862402|Avibactam|avibactam|mesh-list
154060274|NCT05862402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154060275|NCT05862402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060276|NCT05862402|Antitubercular Agents|antitubercular agents|mesh-ancestor
154060277|NCT05862402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154060278|NCT05862402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709914|NCT02140255|Lopinavir|lopinavir|mesh-list
154060279|NCT05862402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060280|NCT05862402|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154060281|NCT05862402|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154060282|NCT05862402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154060283|NCT05862220|Fibrin fragment D|fibrin fragment d|mesh-list
154060284|NCT05862220|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154060285|NCT05862220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154060286|NCT05862220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060287|NCT05862220|Hemostatics|hemostatics|mesh-ancestor
154060288|NCT05862220|Coagulants|coagulants|mesh-ancestor
154060289|NCT05861791|Ketorolac|ketorolac|mesh-list
154060291|NCT05861791|Fentanyl|fentanyl|mesh-list
154060325|NCT05861687|Lansoprazole|lansoprazole|mesh-list
154060326|NCT05861687|Dexlansoprazole|dexlansoprazole|mesh-list
154060327|NCT05861687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154060328|NCT05861687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060329|NCT05861687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154060330|NCT05861687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060331|NCT05861687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154060332|NCT05861687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060333|NCT05861687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060334|NCT05861687|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154060335|NCT05861687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154060336|NCT05861687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154060338|NCT05861648|Hematinics|hematinics|mesh-ancestor
154060339|NCT05861648|Vitamin B Complex|vitamin b complex|mesh-ancestor
154060340|NCT05861648|Vitamins|vitamins|mesh-ancestor
154060341|NCT05861648|Micronutrients|micronutrients|mesh-ancestor
154060342|NCT05861648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060343|NCT05861635|Tislelizumab|tislelizumab|mesh-list
154060344|NCT05861635|Disitamab vedotin|disitamab vedotin|mesh-list
154060345|NCT05861635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060346|NCT05861635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060347|NCT05861635|Immunoconjugates|immunoconjugates|mesh-ancestor
154060348|NCT05861635|Immunologic Factors|immunologic factors|mesh-ancestor
154060349|NCT05861635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060350|NCT05861609|Analgesics|analgesics|mesh-list
154060351|NCT05861609|Sensory System Agents|sensory system agents|mesh-ancestor
154060352|NCT05861609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060353|NCT05861609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060354|NCT05773326|Sirolimus|sirolimus|mesh-list
154060355|NCT05773326|Temsirolimus|temsirolimus|mesh-list
154060356|NCT05773326|MTOR Inhibitors|mtor inhibitors|mesh-list
154060369|NCT05765071|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154060370|NCT05765071|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154060371|NCT05765071|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154060372|NCT05765071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154060373|NCT05765071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060374|NCT05765071|Cholinergic Agents|cholinergic agents|mesh-ancestor
154060375|NCT05765071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060376|NCT05765071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060377|NCT05765071|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154060378|NCT05765071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060380|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
154060381|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154060382|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
154060383|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710144|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
154060384|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060385|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154060386|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
154060387|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
154060388|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154060389|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154060390|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060391|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
154060392|NCT05489185|Coagulants|coagulants|mesh-ancestor
154060393|NCT05465304|Azithromycin|azithromycin|mesh-list
154060394|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154060395|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060396|NCT05370313|Nicotine|nicotine|mesh-list
154060397|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154060398|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
153710147|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154060399|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060400|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060401|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154060402|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153575315|NCT01705392|Bevacizumab|bevacizumab|mesh-list
153575316|NCT01705392|Dacarbazine|dacarbazine|mesh-list
153575317|NCT01705392|Propranolol|propranolol|mesh-list
153575318|NCT01705392|Enalapril|enalapril|mesh-list
153575319|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153575320|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575321|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153575322|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154060404|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060405|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060406|NCT05357768|Formaldehyde|formaldehyde|mesh-list
154060407|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
154060408|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060409|NCT05324449|Cannabidiol|cannabidiol|mesh-list
154060410|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
154060411|NCT05304871|Cefazolin|cefazolin|mesh-list
154060412|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154060413|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060414|NCT05281406|Carboplatin|carboplatin|mesh-list
154060415|NCT05281406|Pemetrexed|pemetrexed|mesh-list
154060416|NCT05281406|Osimertinib|osimertinib|mesh-list
154060417|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060418|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060419|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060420|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154060421|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154060422|NCT05281406|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154060423|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154060424|NCT05233722|Sirolimus|sirolimus|mesh-list
154060425|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060426|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154060427|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060428|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154060429|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060430|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
154060431|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710367|NCT00314782|Docetaxel|docetaxel|mesh-list
154060432|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
154060433|NCT05221892|Thiamine|thiamine|mesh-list
154060434|NCT05221892|Pyridoxine|pyridoxine|mesh-list
154060435|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
154060436|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
153575323|NCT01705392|Growth Substances|growth substances|mesh-ancestor
153575324|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575325|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
153575327|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153575328|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
153575329|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575330|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817134|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154060437|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
154060438|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060439|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
154060440|NCT05221892|Vitamins|vitamins|mesh-ancestor
154060441|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
154060442|NCT05221892|Hematinics|hematinics|mesh-ancestor
154060443|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
154060445|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060446|NCT05045794|Liver Extracts|liver extracts|mesh-list
154060447|NCT05045794|Hematinics|hematinics|mesh-ancestor
154060448|NCT05044936|Cannabidiol|cannabidiol|mesh-list
154060449|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
154060450|NCT05021900|Tenalisib|tenalisib|mesh-list
154060451|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
154060452|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060453|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060454|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
154060455|NCT05014646|Leflunomide|leflunomide|mesh-list
154060456|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060457|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060458|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154060459|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
154060460|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060461|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154060462|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154060463|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
154060464|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154060465|NCT04971954|Nicotine|nicotine|mesh-list
154060466|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154060467|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
153710495|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060468|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060469|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060470|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154060471|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154060472|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
154060473|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060474|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060476|NCT04942340|Caffeine|caffeine|mesh-list
154060477|NCT04942340|Atipamezole|atipamezole|mesh-list
154060478|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154060479|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060480|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060481|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154060482|NCT04942340|Analgesics|analgesics|mesh-ancestor
154060483|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
154060484|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060485|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154060486|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154060487|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153603237|NCT01910285|Dsuvia|dsuvia|mesh-list
154060488|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
154060489|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060490|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060491|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154060492|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154060493|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060494|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154060495|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154060496|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
154060497|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154060498|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154060499|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154060500|NCT04905654|Cromakalim|cromakalim|mesh-list
154060501|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154060502|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154060510|NCT04878406|Semaglutide|semaglutide|mesh-list
154060522|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060523|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060524|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154060525|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154060526|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060527|NCT04698525|Valproic Acid|valproic acid|mesh-list
154060528|NCT04698525|Memantine|memantine|mesh-list
154060529|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154060530|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154060531|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
154060532|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060533|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060534|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060535|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154060536|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154060537|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
154060538|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060539|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
154060540|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
154060541|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154060542|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060543|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154060544|NCT04667104|Tenofovir|tenofovir|mesh-list
154060545|NCT04667104|Entecavir|entecavir|mesh-list
154060546|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154060547|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
154060548|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060549|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154060550|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154060551|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060552|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060553|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154060554|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154060555|NCT04659369|Nivolumab|nivolumab|mesh-list
154060556|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060559|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060560|NCT04651439|Lenograstim|lenograstim|mesh-list
154060561|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154060562|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
154060563|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060564|NCT04635774|Insulin|insulin|mesh-list
154060565|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154060566|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060567|NCT04634799|Plasminogen|plasminogen|mesh-list
154060568|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
154060569|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
154060570|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154060571|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154060572|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060573|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154060574|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
154060575|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060576|NCT04603365|Temozolomide|temozolomide|mesh-list
154060577|NCT04603365|Pamiparib|pamiparib|mesh-list
154060578|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154060612|NCT04556526|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154060614|NCT04556526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060615|NCT04478617|Metronidazole|metronidazole|mesh-list
154060616|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060617|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154060618|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154060619|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154060620|NCT04424966|Infigratinib|infigratinib|mesh-list
153710975|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060621|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060627|NCT04301271|Simvastatin|simvastatin|mesh-list
154060628|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154060629|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154060630|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
154060631|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711028|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153711029|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060632|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154060633|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154060634|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060635|NCT04228783|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154060636|NCT04228783|Antiviral Agents|antiviral agents|mesh-ancestor
154060637|NCT04228783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060638|NCT04188119|Aspirin|aspirin|mesh-list
154060639|NCT04188119|Avelumab|avelumab|mesh-list
154060640|NCT04188119|Lansoprazole|lansoprazole|mesh-list
154060641|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
154060642|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154060643|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154060644|NCT04188119|Analgesics|analgesics|mesh-ancestor
154060652|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060654|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154060655|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060656|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
154060657|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060658|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060659|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154060660|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060661|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154060662|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
154060663|NCT04138394|Vitamins|vitamins|mesh-ancestor
154060664|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
154060665|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711030|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711031|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711032|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
153711033|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711034|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711037|NCT00316420|Capecitabine|capecitabine|mesh-list
153711069|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060670|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
154060671|NCT04129931|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154060672|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154060673|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060674|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060675|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060676|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154060677|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
154060678|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060679|NCT03977363|Anticoagulants|anticoagulants|mesh-list
154060680|NCT03950674|Folic Acid|folic acid|mesh-list
153817135|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153817136|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
153817137|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817138|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817139|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153711143|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711144|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153711145|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153711150|NCT02960035|Etanercept|etanercept|mesh-list
153711192|NCT00328549|Interferons|interferons|mesh-list
153711193|NCT00328549|Ribavirin|ribavirin|mesh-list
153817140|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153817141|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
153817142|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
153817143|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153817144|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817145|NCT01055834|Eszopiclone|eszopiclone|mesh-list
153817146|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153817147|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817148|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817149|NCT00469326|Atorvastatin|atorvastatin|mesh-list
153711194|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711195|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
153711196|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711197|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
153711198|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711199|NCT00092508|Mesalamine|mesalamine|mesh-list
153711202|NCT00092508|Analgesics|analgesics|mesh-ancestor
153817150|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153817151|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153817152|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
153817153|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817154|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153817155|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153817156|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575331|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153575333|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
154060682|NCT03950674|Dexamethasone|dexamethasone|mesh-list
154060683|NCT03950674|Carboplatin|carboplatin|mesh-list
154060684|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
154060685|NCT03950674|Pemetrexed|pemetrexed|mesh-list
154060686|NCT03950674|Vitamins|vitamins|mesh-ancestor
154060687|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
153711329|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153711330|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153711331|NCT00329446|Escitalopram|escitalopram|mesh-list
153711332|NCT00329446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153711333|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153711381|NCT00123903|Protective Agents|protective agents|mesh-ancestor
153711382|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154060688|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060689|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060690|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154060691|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
154060692|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
153711383|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154060693|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060694|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060695|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
154060696|NCT03950674|Hormones|hormones|mesh-ancestor
154060697|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060698|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154060699|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060700|NCT03950674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154060701|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060702|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060703|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153711571|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153711572|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
153711573|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153711574|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
153711635|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711636|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060704|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154060705|NCT03950674|Hematinics|hematinics|mesh-ancestor
154060706|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
154060707|NCT03911661|Warfarin|warfarin|mesh-list
154060708|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
154060709|NCT03909477|Xenon|xenon|mesh-list
154060710|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154060711|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
154060731|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
154060732|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060733|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154060734|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154060735|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060736|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
154060737|NCT03684876|Diuretics|diuretics|mesh-list
154060738|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
154060739|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060740|NCT03655665|Ofloxacin|ofloxacin|mesh-list
154060741|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153711643|NCT00317785|Sirolimus|sirolimus|mesh-list
154060742|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060743|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154060744|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154060745|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154060746|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060747|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060748|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060749|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154060750|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154060751|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
154060752|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154060753|NCT03604627|Calcium|calcium|mesh-list
154060754|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154060755|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060756|NCT03516656|Heparin|heparin|mesh-list
154060757|NCT03516656|Calcium heparin|calcium heparin|mesh-list
154060758|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
154060759|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154060760|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154060761|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060762|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
154060763|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154060765|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154060771|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060772|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060773|NCT03203473|Nivolumab|nivolumab|mesh-list
154060774|NCT03203473|Ipilimumab|ipilimumab|mesh-list
154060775|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060776|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060777|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154060778|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060779|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
154060780|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
154060781|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154060782|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060783|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060784|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
154060785|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154060786|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060787|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060788|NCT03115567|Triamcinolone|triamcinolone|mesh-list
154060789|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154060790|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
154060791|NCT03115567|Hormones|hormones|mesh-ancestor
154060792|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060793|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060794|NCT02982902|Immunomodulating Agents|immunomodulating agents|mesh-list
154060795|NCT02982902|Immunologic Factors|immunologic factors|mesh-ancestor
154060796|NCT02982902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060797|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
153575334|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153575335|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
153575336|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153712084|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
153575337|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
153575338|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575339|NCT01705457|Vitamin A|vitamin a|mesh-list
153575340|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
153575341|NCT01705457|Vitamins|vitamins|mesh-ancestor
153575342|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
153575343|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575344|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
153575345|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575346|NCT01705457|Protective Agents|protective agents|mesh-ancestor
153575347|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153575348|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575349|NCT01705470|Furosemide|furosemide|mesh-list
154060798|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060799|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060800|NCT02964559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154060801|NCT02964559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060802|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154060803|NCT02893293|Hematinics|hematinics|mesh-ancestor
154060804|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154060805|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154060806|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154060807|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154060808|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
154060810|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
154060811|NCT02578680|Dexamethasone|dexamethasone|mesh-list
154060812|NCT02578680|Carboplatin|carboplatin|mesh-list
154060813|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
154060814|NCT02578680|Pemetrexed|pemetrexed|mesh-list
154060815|NCT02578680|Vitamins|vitamins|mesh-ancestor
154060816|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
154060817|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060818|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060819|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154060820|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
154060821|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
154060822|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060823|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154060824|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
154060825|NCT02578680|Hormones|hormones|mesh-ancestor
154060826|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060827|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154060828|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154060829|NCT02578680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154060830|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060831|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060832|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154060833|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153575350|NCT01705470|Diuretics|diuretics|mesh-ancestor
154060834|NCT02578680|Hematinics|hematinics|mesh-ancestor
154060835|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
154060836|NCT02385266|Cycloserine|cycloserine|mesh-list
154060837|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154060838|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060839|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154060840|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
154060841|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154060842|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
154060843|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060844|NCT02351765|Cisplatin|cisplatin|mesh-list
154060845|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060846|NCT02251431|Exenatide|exenatide|mesh-list
154060847|NCT02251431|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154060848|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154060849|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060850|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154060851|NCT02251431|Incretins|incretins|mesh-ancestor
154060852|NCT02251431|Hormones|hormones|mesh-ancestor
154060853|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154060854|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153712429|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
154060855|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154060856|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
154060857|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
154060858|NCT01494441|Calcium|calcium|mesh-list
154060859|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154060860|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060861|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154060862|NCT01367002|Paclitaxel|paclitaxel|mesh-list
154060863|NCT01367002|Carboplatin|carboplatin|mesh-list
154060880|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
154060881|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154060882|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060883|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154060884|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154060885|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154060886|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154060887|NCT02635607|Ganirelix|ganirelix|mesh-list
154060888|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
154060889|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154060890|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
154060891|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154060892|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060893|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154060894|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154060895|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154060896|NCT02635607|Hormones|hormones|mesh-ancestor
154060933|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154060934|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154060935|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060936|NCT00834366|Tramadol|tramadol|mesh-list
154060937|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154060938|NCT00834366|Narcotics|narcotics|mesh-ancestor
154060939|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154060940|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154060941|NCT00834366|Analgesics|analgesics|mesh-ancestor
153712525|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712526|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712532|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153712533|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
153712534|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154060942|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
154060943|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154060944|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
154060947|NCT00660647|Adalimumab|adalimumab|mesh-list
154060993|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
154060994|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154060995|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154060996|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154060997|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154060998|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154060999|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154061000|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154061001|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
154061002|NCT00665717|Pravastatin|pravastatin|mesh-list
154061003|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154061004|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154061005|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
154061006|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061007|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154061008|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154061009|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061016|NCT02611596|Ranolazine|ranolazine|mesh-list
154061050|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
153712623|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
153712646|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153712647|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061051|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
154061052|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061053|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
154061054|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061055|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
154061056|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061057|NCT00665951|Ritonavir|ritonavir|mesh-list
154061058|NCT00665951|Lopinavir|lopinavir|mesh-list
154061059|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154061060|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154061061|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
154061062|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061063|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061064|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154061065|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153712837|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154061066|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
154061067|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061068|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154061069|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154061070|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154061071|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154061072|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
154061073|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061099|NCT00666185|Fluconazole|fluconazole|mesh-list
154061100|NCT00666185|Micafungin|micafungin|mesh-list
154061101|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
154061102|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061103|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154061104|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154061105|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061106|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061107|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154061108|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
154061109|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154061110|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061111|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154061112|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154061114|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154061115|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154061116|NCT00913224|Analgesics|analgesics|mesh-ancestor
154061117|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
154061118|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061119|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061120|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154061149|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154061150|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154061151|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061152|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061153|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
154061154|NCT00666653|Pramipexole|pramipexole|mesh-list
154061155|NCT00666653|Dexpramipexole|dexpramipexole|mesh-list
154061156|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
154061157|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061158|NCT00666653|Protective Agents|protective agents|mesh-ancestor
154061159|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061160|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154061161|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154061162|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
153781735|NCT04560049|Phenol|phenol|mesh-list
154061163|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
154061164|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061165|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
154061166|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
153713108|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061167|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154061168|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
154061169|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154061170|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154061171|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061172|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061173|NCT00666809|Urological Agents|urological agents|mesh-ancestor
154061196|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154061197|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154061198|NCT00825162|Vaccines|vaccines|mesh-list
154061199|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
154061200|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061201|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154061202|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
154061203|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154061204|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154061205|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061206|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061207|NCT00662441|Urological Agents|urological agents|mesh-ancestor
154061208|NCT00911573|Vancomycin|vancomycin|mesh-list
154061209|NCT00911573|Clindamycin|clindamycin|mesh-list
154061210|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
154061211|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
154061212|NCT00911573|Tigecycline|tigecycline|mesh-list
154061213|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154061214|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061218|NCT00667433|Tenofovir|tenofovir|mesh-list
154061251|NCT00667979|Urological Agents|urological agents|mesh-ancestor
154061252|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154061253|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
154061254|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154061255|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154061256|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713240|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061257|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061258|NCT00668057|Urological Agents|urological agents|mesh-ancestor
154061259|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154061260|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
154061261|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154061262|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154061263|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061264|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061265|NCT00668135|Urological Agents|urological agents|mesh-ancestor
154061266|NCT02630303|Coal Tar|coal tar|mesh-list
154061267|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
154061268|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
154061269|NCT04155983|Ropivacaine|ropivacaine|mesh-list
154061270|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
154061271|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
154061272|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061273|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061274|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
154061275|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061276|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154061277|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154061278|NCT00668603|Estradiol|estradiol|mesh-list
154061279|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154061280|NCT00668603|Estrogens|estrogens|mesh-ancestor
154061292|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154061293|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
154061294|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154061295|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061296|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061297|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153713241|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713273|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713274|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153713275|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153713277|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
154061298|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154061299|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154061300|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061301|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154061302|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154061303|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154061304|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154061305|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154061306|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154061307|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061308|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061309|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154061310|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154061311|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154061312|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
154061313|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061314|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061339|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154061340|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
154061341|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
154061342|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061343|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061344|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154061345|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
154061346|NCT02631239|Hormones|hormones|mesh-ancestor
154061347|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154061348|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154061349|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061350|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154061351|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
154061352|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154061353|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154061354|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
154061355|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061356|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
154061357|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061358|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154061359|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154061360|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
154061366|NCT00663377|Losartan|losartan|mesh-list
154061389|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154061390|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061392|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154061393|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154061394|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154061395|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
154061396|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061397|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
154061398|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
154061399|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154061400|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
154061401|NCT00663455|Cyclosporine|cyclosporine|mesh-list
154061402|NCT00663455|Cyclosporins|cyclosporins|mesh-list
154061403|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061404|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061405|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154061406|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
154061407|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061408|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
154061409|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061410|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
154061411|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061412|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154061413|NCT00669695|Atorvastatin|atorvastatin|mesh-list
154061414|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154061415|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154061416|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
154061417|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061418|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154061419|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154061427|NCT00669773|Docetaxel|docetaxel|mesh-list
154061431|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
154061432|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
154061433|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
154061434|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061435|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154061436|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154061437|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154061438|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061439|NCT00824616|Insulin|insulin|mesh-list
154061440|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154061441|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061442|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154061443|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
153713895|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154061444|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154061445|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154061446|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061447|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061448|NCT00663845|Urological Agents|urological agents|mesh-ancestor
154061449|NCT00708240|Escitalopram|escitalopram|mesh-list
154061450|NCT00708240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154061451|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154061452|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061453|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061476|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
154061477|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154061478|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061479|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154061480|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154061481|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154061483|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154061484|NCT00708318|Narcotics|narcotics|mesh-ancestor
154061485|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061486|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061487|NCT00708318|Analgesics|analgesics|mesh-ancestor
154061488|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
154061489|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061490|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154061491|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154061492|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
154061493|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
154061494|NCT00670475|Piroxicam|piroxicam|mesh-list
154061495|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154061496|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154061497|NCT00670475|Analgesics|analgesics|mesh-ancestor
154061498|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
154061499|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061500|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061501|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154061502|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061523|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061524|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154061525|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061526|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061527|NCT00833040|Sufentanil|sufentanil|mesh-list
154061528|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154061529|NCT00833040|Narcotics|narcotics|mesh-ancestor
154061530|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154061531|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061532|NCT00833040|Analgesics|analgesics|mesh-ancestor
154061533|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
154061534|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061535|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154061536|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154061538|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
154061539|NCT02629835|Dexamethasone|dexamethasone|mesh-list
154061540|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
154061541|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154061542|NCT02629835|BB 1101|bb 1101|mesh-list
154061543|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154061544|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
154061578|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
154061579|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154061580|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061581|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061582|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154061583|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154061584|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154061585|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
154061586|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061588|NCT04154813|Fluoxetine|fluoxetine|mesh-list
154061589|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
154061590|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575351|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
153575352|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575353|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153575354|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575355|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575356|NCT01705483|Paclitaxel|paclitaxel|mesh-list
153575357|NCT01705483|Docetaxel|docetaxel|mesh-list
153575358|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153575359|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575360|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
153817157|NCT04704713|Afamelanotide|afamelanotide|mesh-list
153714419|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153714420|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153714421|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153714422|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817158|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
153817159|NCT00460707|Ketoconazole|ketoconazole|mesh-list
153817160|NCT00460707|Casopitant|casopitant|mesh-list
153817161|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
153458516|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458518|NCT03020706|Analgesics|analgesics|mesh-ancestor
153458519|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
153458520|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458521|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458522|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
153458523|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458524|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153458525|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
153458526|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153458527|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575370|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
153575371|NCT01705743|Sevoflurane|sevoflurane|mesh-list
153575372|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153575373|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153575374|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
153575375|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
153458528|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458529|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153458530|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
153458531|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153458532|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
153458533|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153458534|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
153458536|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458537|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153458538|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
153458539|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153458540|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
153458541|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458542|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061591|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061592|NCT04154813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154061593|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154061594|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061595|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061596|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061597|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
154061598|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154061599|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
154061600|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154061601|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154061602|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154061603|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061604|NCT00664703|Methylphenidate|methylphenidate|mesh-list
154061606|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154061607|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061608|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154061609|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154061610|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061611|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061612|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
154061613|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061614|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154061636|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061637|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061638|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
154061639|NCT00832650|Fesoterodine|fesoterodine|mesh-list
154061640|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154061641|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154061642|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
154061643|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061644|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061645|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061646|NCT00832650|Urological Agents|urological agents|mesh-ancestor
154061647|NCT00708396|Escitalopram|escitalopram|mesh-list
153714627|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
153714628|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154061648|NCT00708396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154061649|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154061650|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153714653|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
154061651|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061652|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061653|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
154061654|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061655|NCT00665093|Insulin|insulin|mesh-list
154061656|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154061686|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061687|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154061688|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
154061689|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
154061690|NCT00665327|Levofloxacin|levofloxacin|mesh-list
154061691|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154061692|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154061693|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154061694|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154061695|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154061696|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061697|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061698|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061699|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154061700|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
154061743|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061744|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154061745|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061746|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154061747|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154061748|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
154061749|NCT00879437|Bevacizumab|bevacizumab|mesh-list
154061750|NCT00879437|Valproic Acid|valproic acid|mesh-list
154061751|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154061752|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604439|NCT01917708|Abatacept|abatacept|mesh-list
154061753|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154061754|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154061755|NCT00879437|Growth Substances|growth substances|mesh-ancestor
154061803|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061804|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061805|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
154061806|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061807|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154061808|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154061809|NCT00671801|Growth Substances|growth substances|mesh-ancestor
154061810|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
154061811|NCT00676559|Ranibizumab|ranibizumab|mesh-list
154061812|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154061813|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154061814|NCT00676559|Growth Substances|growth substances|mesh-ancestor
153714927|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154061815|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061816|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
154061817|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061818|NCT00672113|Nifedipine|nifedipine|mesh-list
154061819|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154061820|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061824|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
154061859|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061860|NCT00676871|Blinatumomab|blinatumomab|mesh-list
154061861|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061862|NCT00677027|Lentinan|lentinan|mesh-list
154061863|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154061864|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
154061865|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061866|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061867|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
154061868|NCT00595127|Fludarabine|fludarabine|mesh-list
154061869|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154061870|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
154061871|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061872|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154061873|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154061874|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
154061875|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061876|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061877|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153458543|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153458544|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
153714928|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714929|NCT00856947|Vitamin D|vitamin d|mesh-list
153714930|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
153714931|NCT00856947|Vitamins|vitamins|mesh-ancestor
153714932|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
153714933|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714934|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153714957|NCT00087815|Hormones|hormones|mesh-ancestor
153458545|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
153458546|NCT04149132|Protective Agents|protective agents|mesh-ancestor
153458547|NCT03908892|Tetracycline|tetracycline|mesh-list
153817162|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817163|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153817164|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153817165|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817166|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817167|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153817168|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
153817169|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817170|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817171|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153817172|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
153817173|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
153817174|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575376|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575377|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575378|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575380|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
153575381|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575382|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153575383|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575384|NCT01705769|Micronutrients|micronutrients|mesh-list
153575385|NCT01705769|Trace Elements|trace elements|mesh-list
153575386|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575387|NCT01705795|Antibodies|antibodies|mesh-list
153575388|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
153714972|NCT00125229|Mannitol|mannitol|mesh-list
153575389|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575390|NCT01705808|Protein C|protein c|mesh-list
153575391|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
154061879|NCT00672659|Pipamperone|pipamperone|mesh-list
154061880|NCT00672659|Citalopram|citalopram|mesh-list
154061881|NCT00672659|Escitalopram|escitalopram|mesh-list
153715021|NCT00125307|Tacrolimus|tacrolimus|mesh-list
154061882|NCT00672659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154061883|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154061884|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154061885|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154061886|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154061887|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
154061888|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061889|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154061890|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
154061891|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154061892|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154061936|NCT00673205|Bicalutamide|bicalutamide|mesh-list
154061937|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
154061938|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
154061939|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154061940|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061941|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154061942|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154061943|NCT00677729|Albuterol|albuterol|mesh-list
154061944|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154061945|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
154061946|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154061947|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061948|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154061949|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
154061950|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
154061996|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154061997|NCT00674141|Dexamethasone|dexamethasone|mesh-list
154061998|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715045|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154061999|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
154062001|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062002|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062003|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154062004|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
154062005|NCT00674141|Hormones|hormones|mesh-ancestor
154062006|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154062007|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154062008|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062009|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154062010|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
154062011|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062013|NCT02627807|Cisplatin|cisplatin|mesh-list
154062056|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062057|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154062058|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154062059|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062060|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062061|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062062|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154062063|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
154062064|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154062065|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062066|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154062067|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154062068|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154062069|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154062070|NCT00678743|Simvastatin|simvastatin|mesh-list
154062071|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154062113|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
154062114|NCT00882713|Hematinics|hematinics|mesh-ancestor
154062115|NCT04151381|Aminophylline|aminophylline|mesh-list
154062116|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154062117|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
154062118|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062119|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062120|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153715267|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
154062121|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
154062122|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154062123|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154062124|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604822|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
154062125|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062126|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154062127|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154062128|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
154062129|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062130|NCT04151381|Protective Agents|protective agents|mesh-ancestor
154062131|NCT00809133|Paclitaxel|paclitaxel|mesh-list
154062132|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154062133|NCT00809133|Bevacizumab|bevacizumab|mesh-list
154062134|NCT00809133|Carboplatin|carboplatin|mesh-list
154062135|NCT00809133|Afatinib|afatinib|mesh-list
154062136|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062137|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062138|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062139|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062140|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062141|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062142|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062143|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154062144|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154062145|NCT00809133|Growth Substances|growth substances|mesh-ancestor
154062151|NCT00912275|Vinorelbine|vinorelbine|mesh-list
154062153|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062154|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062155|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062156|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062157|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062158|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062159|NCT00912275|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154062160|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154062161|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062162|NCT00882557|Daptomycin|daptomycin|mesh-list
154062221|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154062222|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
154062223|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062224|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062225|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154062226|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154062227|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154062228|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154062229|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062230|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154062231|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062232|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
154062233|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062234|NCT00808899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154062235|NCT00808899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154062236|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
154062237|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154062238|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062239|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062240|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154062242|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
154062243|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062244|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154062245|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154062246|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154062247|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
154062248|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062249|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715556|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
153715560|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
153715611|NCT00343369|Hormones|hormones|mesh-ancestor
154062250|NCT00808509|Adalimumab|adalimumab|mesh-list
154062251|NCT00808509|Methotrexate|methotrexate|mesh-list
154062252|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154062262|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154062263|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154062264|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
154062265|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154062266|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154062267|NCT00808509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154062268|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154062269|NCT00807573|Paclitaxel|paclitaxel|mesh-list
154062270|NCT00807573|Bevacizumab|bevacizumab|mesh-list
154062271|NCT00807573|Pemetrexed|pemetrexed|mesh-list
154062272|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062273|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062274|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
153604970|NCT01927679|Vitamins|vitamins|mesh-ancestor
154062275|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062276|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062277|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062321|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062322|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
154062323|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062324|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154062325|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062326|NCT00832416|Tramadol|tramadol|mesh-list
154062327|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154062328|NCT00832416|Narcotics|narcotics|mesh-ancestor
154062329|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062330|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062331|NCT00832416|Analgesics|analgesics|mesh-ancestor
154062332|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
154062333|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062334|NCT00705198|Temozolomide|temozolomide|mesh-list
154062335|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154062336|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
154062337|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062338|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062339|NCT00702936|Telmisartan|telmisartan|mesh-list
154062340|NCT00702936|Ramipril|ramipril|mesh-list
154062358|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
154062374|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154062375|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154062376|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154062377|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062378|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154062379|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062380|NCT04060264|Eculizumab|eculizumab|mesh-list
154062381|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154062382|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154062383|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
154062384|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062385|NCT00684814|Zolpidem|zolpidem|mesh-list
154062386|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154062387|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154062388|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062389|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062390|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154062391|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
154062392|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
154062395|NCT00576472|Methylphenidate|methylphenidate|mesh-list
154062430|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154062431|NCT02561494|Analgesics|analgesics|mesh-ancestor
154062432|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
154062433|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062434|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062435|NCT05958693|Lumefantrine|lumefantrine|mesh-list
154062436|NCT05958693|Artemether|artemether|mesh-list
154062437|NCT05958693|Primaquine|primaquine|mesh-list
154062438|NCT05958693|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154062439|NCT05958693|Antimalarials|antimalarials|mesh-ancestor
154062440|NCT05958693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154062441|NCT05958693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154062442|NCT05958693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062443|NCT05958589|Levobupivacaine|levobupivacaine|mesh-list
154062444|NCT05958589|Anesthetics|anesthetics|mesh-ancestor
154062445|NCT05958589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062447|NCT05958589|Anesthetics, Local|anesthetics, local|mesh-ancestor
153715978|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
153715980|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154062448|NCT05958589|Sensory System Agents|sensory system agents|mesh-ancestor
154062449|NCT05958589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062463|NCT05958173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154062464|NCT05958173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062465|NCT05958173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062466|NCT05958160|Topiramate|topiramate|mesh-list
154062467|NCT05958160|Anticonvulsants|anticonvulsants|mesh-ancestor
154062468|NCT05958160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154062469|NCT05958160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062470|NCT05958069|Minocycline|minocycline|mesh-list
154062471|NCT05958069|Anticonvulsants|anticonvulsants|mesh-list
154062472|NCT05958069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154062473|NCT05958069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062474|NCT05957991|Metformin|metformin|mesh-list
154062475|NCT05957991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154062476|NCT05957991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062477|NCT05957913|Tenofovir|tenofovir|mesh-list
154062478|NCT05957913|Emtricitabine|emtricitabine|mesh-list
154062479|NCT05957913|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154062480|NCT05957913|Antiviral Agents|antiviral agents|mesh-ancestor
154062481|NCT05957913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062482|NCT05957913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154062483|NCT05957913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154062484|NCT05957913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716027|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153716028|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154062485|NCT05957913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062486|NCT05957913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154062487|NCT05957913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154062488|NCT05957887|Dapagliflozin|dapagliflozin|mesh-list
154062491|NCT05957887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154062505|NCT05957653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154062506|NCT05957653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062507|NCT05957653|Sensory System Agents|sensory system agents|mesh-ancestor
154062508|NCT05957653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062509|NCT05957653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154062510|NCT05957653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154062511|NCT05957653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154062512|NCT05957653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154062513|NCT05957653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062514|NCT05957653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154062515|NCT05957653|Narcotics|narcotics|mesh-ancestor
154062516|NCT05957653|Analgesics|analgesics|mesh-ancestor
154062517|NCT05957653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154062518|NCT05957653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153716136|NCT00346489|Mitomycins|mitomycins|mesh-list
154062519|NCT05957653|Anesthetics, General|anesthetics, general|mesh-ancestor
154062521|NCT05957328|Antioxidants|antioxidants|mesh-ancestor
154062522|NCT05957328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062562|NCT05951712|Antiviral Agents|antiviral agents|mesh-ancestor
154062563|NCT05951712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062564|NCT05951712|Expectorants|expectorants|mesh-ancestor
154062565|NCT05951712|Respiratory System Agents|respiratory system agents|mesh-ancestor
154062566|NCT05951712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154062567|NCT05951712|Antioxidants|antioxidants|mesh-ancestor
154062568|NCT05951712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062569|NCT05951712|Protective Agents|protective agents|mesh-ancestor
154062570|NCT05951712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062571|NCT05951712|Antidotes|antidotes|mesh-ancestor
154062572|NCT05951712|Antifoaming Agents|antifoaming agents|mesh-ancestor
154062573|NCT05951712|Emollients|emollients|mesh-ancestor
154062574|NCT05951712|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062575|NCT05951595|Artesunate|artesunate|mesh-list
154062576|NCT05951595|Lumefantrine|lumefantrine|mesh-list
154062577|NCT05951595|Artemether|artemether|mesh-list
154062626|NCT05809895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062627|NCT05809895|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062628|NCT05809895|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062629|NCT05809895|Mitosis Modulators|mitosis modulators|mesh-ancestor
154062630|NCT05809895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716364|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
153716366|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154062631|NCT05809895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154062633|NCT05809895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062634|NCT05809895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154062635|NCT05791097|Paclitaxel|paclitaxel|mesh-list
154062636|NCT05791097|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154062637|NCT05791097|Carboplatin|carboplatin|mesh-list
154062638|NCT05791097|Pembrolizumab|pembrolizumab|mesh-list
154062639|NCT05791097|Pemetrexed|pemetrexed|mesh-list
154062640|NCT05791097|Tislelizumab|tislelizumab|mesh-list
154062641|NCT05791097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062642|NCT05791097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062643|NCT05791097|Tubulin Modulators|tubulin modulators|mesh-ancestor
154062644|NCT05791097|Antimitotic Agents|antimitotic agents|mesh-ancestor
154062645|NCT05791097|Mitosis Modulators|mitosis modulators|mesh-ancestor
153605347|NCT01932203|Aspirin|aspirin|mesh-list
154062646|NCT05791097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062647|NCT05791097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062649|NCT05791097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062679|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154062680|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154062681|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062682|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154062683|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153716495|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153716496|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153716505|NCT00426478|Diuretics|diuretics|mesh-ancestor
153716533|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716534|NCT04705129|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153716535|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153716536|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716538|NCT00126321|Cladribine|cladribine|mesh-list
154062684|NCT05626478|Protective Agents|protective agents|mesh-ancestor
154062685|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
154062686|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062687|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062688|NCT05600309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153716650|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062689|NCT05600309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062690|NCT05481645|Paclitaxel|paclitaxel|mesh-list
154062691|NCT05481645|Docetaxel|docetaxel|mesh-list
154062741|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062742|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154062743|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154062744|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154062745|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062747|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154062748|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
154062808|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062809|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062810|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062811|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153716651|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
153716652|NCT00426946|Reboxetine|reboxetine|mesh-list
154062812|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154062813|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
154062814|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062815|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154062816|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
154062817|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
154062818|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
154062819|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154062820|NCT05074433|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
154062821|NCT05074433|Antiviral Agents|antiviral agents|mesh-ancestor
153545909|NCT06294704|Insulin|insulin|mesh-list
154062822|NCT05074433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062823|NCT05064319|Gabapentin|gabapentin|mesh-list
154062824|NCT05064319|Analgesics|analgesics|mesh-ancestor
154062825|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
154062826|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062827|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062860|NCT04939142|Dexamethasone|dexamethasone|mesh-list
154062861|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
154062862|NCT04939142|Bortezomib|bortezomib|mesh-list
154062863|NCT04939142|BB 1101|bb 1101|mesh-list
154062864|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154062865|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
154062866|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
154062867|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062868|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062869|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154062870|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
154062871|NCT04939142|Hormones|hormones|mesh-ancestor
154062872|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154062873|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154062874|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062875|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
154062876|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062877|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062878|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
153605563|NCT01933412|Vaccines|vaccines|mesh-list
154062880|NCT04722354|Growth Substances|growth substances|mesh-ancestor
154062881|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062882|NCT04607954|Durvalumab|durvalumab|mesh-list
154062883|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
153716832|NCT00428428|Isoproterenol|isoproterenol|mesh-list
154062884|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154062885|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
154062886|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062887|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062888|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
154062889|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062890|NCT04585841|Cannabidiol|cannabidiol|mesh-list
154062891|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
154062892|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154062893|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
154062957|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154062958|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154062960|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
154062961|NCT04201197|Dronabinol|dronabinol|mesh-list
154062962|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
154062963|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154062964|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154062965|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154062966|NCT04201197|Analgesics|analgesics|mesh-ancestor
154062967|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
154062968|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154062969|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154062970|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153575392|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153575393|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153575394|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575395|NCT01705938|Dolcanatide|dolcanatide|mesh-list
153575396|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153575397|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
153575398|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575399|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153575400|NCT01705951|Nicotine|nicotine|mesh-list
153575401|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153575402|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
153575403|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575404|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716894|NCT00092924|Mapatumumab|mapatumumab|mesh-list
153575405|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153575406|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153575407|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
153575408|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575417|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575418|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153575419|NCT01706172|Lidocaine|lidocaine|mesh-list
153575420|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
153575421|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
153575422|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575423|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575424|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
153575425|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575426|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153575427|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153575428|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153575429|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575430|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575431|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
153575432|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575433|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575434|NCT01706315|Gepotidacin|gepotidacin|mesh-list
153575435|NCT01706315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153575436|NCT01706315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575437|NCT01706315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575438|NCT01706315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817175|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817176|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153817177|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817178|NCT00469404|Buprenorphine|buprenorphine|mesh-list
153817179|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153817180|NCT00469404|Narcotics|narcotics|mesh-ancestor
154062971|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154062972|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062973|NCT04201197|Hormones|hormones|mesh-ancestor
154062974|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154062975|NCT04107740|TA 0910|ta 0910|mesh-list
154062976|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
154062977|NCT04085315|Osimertinib|osimertinib|mesh-list
154062978|NCT04085315|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154062979|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154062980|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062981|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062982|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062983|NCT04028050|Carboplatin|carboplatin|mesh-list
154062984|NCT04028050|Etoposide|etoposide|mesh-list
154062985|NCT04028050|Atezolizumab|atezolizumab|mesh-list
154062986|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154062987|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154062988|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154062989|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154062990|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154062991|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154062992|NCT04028050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154062993|NCT04028050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154062994|NCT04016805|Venetoclax|venetoclax|mesh-list
154062995|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
154063020|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063022|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154063023|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154063024|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063025|NCT03554083|Atezolizumab|atezolizumab|mesh-list
154063026|NCT03554083|Vemurafenib|vemurafenib|mesh-list
154063027|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154063028|NCT03554083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153605723|NCT01934712|Insulin|insulin|mesh-list
154063029|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063030|NCT03554083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063031|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063032|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
154063033|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063034|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154063035|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063036|NCT03479476|Metformin|metformin|mesh-list
154063037|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153717032|NCT05543109|Fentanyl|fentanyl|mesh-list
153717033|NCT05543109|Narcotics|narcotics|mesh-list
153717034|NCT05543109|Propofol|propofol|mesh-list
153717035|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
153717036|NCT05543109|Ropivacaine|ropivacaine|mesh-list
154063038|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063039|NCT03358706|Vitamin K|vitamin k|mesh-list
154063040|NCT03358706|Midazolam|midazolam|mesh-list
154063041|NCT03358706|Levomethorphan|levomethorphan|mesh-list
154063042|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
154063043|NCT03358706|Caffeine|caffeine|mesh-list
154063044|NCT03358706|Ustekinumab|ustekinumab|mesh-list
154063045|NCT03358706|Omeprazole|omeprazole|mesh-list
154063072|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154063073|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
154063074|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154063075|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154063076|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
154063077|NCT03358706|Coagulants|coagulants|mesh-ancestor
154063078|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
154063079|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063080|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154063081|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154063082|NCT03358706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154063083|NCT03358706|Narcotics|narcotics|mesh-ancestor
154063084|NCT03358706|Analgesics|analgesics|mesh-ancestor
154063085|NCT03358706|Sensory System Agents|sensory system agents|mesh-ancestor
154063086|NCT03358706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063087|NCT03338920|Sumatriptan|sumatriptan|mesh-list
154063088|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154063089|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154063090|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154063091|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
154063092|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063126|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063127|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063128|NCT02977468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154063129|NCT02977468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063130|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
154063131|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
154063132|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063133|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154063134|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
154063135|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063136|NCT02891538|Protective Agents|protective agents|mesh-ancestor
154063137|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063138|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154063139|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154063140|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063141|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154063182|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063183|NCT01251718|Donepezil|donepezil|mesh-list
154063184|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154063185|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063186|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063187|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
154063188|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063189|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063190|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
154063191|NCT00581828|Vitamin D|vitamin d|mesh-list
154063192|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
154063193|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
154063194|NCT00581828|Vitamins|vitamins|mesh-list
154063195|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
154063196|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063197|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154063198|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154063199|NCT00220337|Lacosamide|lacosamide|mesh-list
154063200|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
154063201|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154063235|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154063236|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154063237|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063238|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063239|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063240|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154063241|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
154063242|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154063243|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063244|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154063245|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154063246|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154063247|NCT00840996|Lidocaine|lidocaine|mesh-list
154063248|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
153717423|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153717424|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
153717425|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717426|NCT00095927|Paclitaxel|paclitaxel|mesh-list
153717427|NCT00095927|Carboplatin|carboplatin|mesh-list
154063249|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
154063250|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063251|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063252|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
154063253|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063254|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154063255|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154063256|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154063257|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153717428|NCT00095927|Amifostine|amifostine|mesh-list
154063258|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063260|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154063283|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063284|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
154063285|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063286|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
154063287|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063288|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154063289|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154063290|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154063291|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
154063292|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063293|NCT00680836|Rifaximin|rifaximin|mesh-list
154063294|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063295|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063296|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154063297|NCT05428306|Acetaminophen|acetaminophen|mesh-list
154063298|NCT05428306|Ibuprofen|ibuprofen|mesh-list
154063299|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154063300|NCT05428306|Analgesics|analgesics|mesh-ancestor
154063301|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
154063302|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063303|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063304|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
154063305|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153717615|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153717616|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153717617|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153717618|NCT00095186|Lactoferrin|lactoferrin|mesh-list
154063306|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063307|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063321|NCT00679432|Budesonide|budesonide|mesh-list
154063334|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154063335|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063336|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
154063337|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
154063338|NCT04050826|Lidocaine|lidocaine|mesh-list
154063339|NCT04050826|Prilocaine|prilocaine|mesh-list
154063340|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
154063341|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
154063342|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063343|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063344|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
154063345|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063346|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154063347|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154063348|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154063349|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154063350|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063351|NCT00757978|Memantine|memantine|mesh-list
154063352|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154063353|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154063354|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
154063355|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063356|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063357|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063358|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154063359|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154063360|NCT00754702|Vinorelbine|vinorelbine|mesh-list
154063361|NCT00754702|Lapatinib|lapatinib|mesh-list
154063362|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154063363|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063364|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
154063365|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
154063366|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
154063367|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063368|NCT00754702|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154063369|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154063370|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063371|NCT00754780|Pirfenidone|pirfenidone|mesh-list
154063372|NCT00754780|Analgesics|analgesics|mesh-ancestor
154063373|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
154063374|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063375|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063376|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154063377|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154063378|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063379|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063380|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063381|NCT00822900|Progesterone|progesterone|mesh-list
154063382|NCT00822900|Progestins|progestins|mesh-ancestor
154063383|NCT00822900|Hormones|hormones|mesh-ancestor
154063384|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063385|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063386|NCT00682786|Fluorouracil|fluorouracil|mesh-list
154063387|NCT00682786|Irinotecan|irinotecan|mesh-list
154063388|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
153817181|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817182|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817183|NCT00469404|Analgesics|analgesics|mesh-ancestor
153817184|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
153717845|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153817185|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817186|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153817187|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
153817188|NCT00460785|Narcotics|narcotics|mesh-ancestor
153817189|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817190|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817191|NCT00460785|Analgesics|analgesics|mesh-ancestor
153817192|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
153458548|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153458549|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458550|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153458551|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458552|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458553|NCT04140318|Paclitaxel|paclitaxel|mesh-list
153458554|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153458555|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458556|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
153458557|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
153575439|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153575440|NCT01706354|Anesthetics|anesthetics|mesh-list
153575441|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
153575442|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575443|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575444|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
153575448|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575449|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
153575450|NCT01706471|Everolimus|everolimus|mesh-list
153575451|NCT01706471|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153575452|NCT01706471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153575453|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063389|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063390|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154063391|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063392|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063393|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
154063394|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063395|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154063396|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154063397|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063398|NCT00840450|Paclitaxel|paclitaxel|mesh-list
154063399|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154063400|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
154063401|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154063402|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063403|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
154063404|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
154063405|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
154063406|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063407|NCT00840450|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154063408|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154063409|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063440|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
154063441|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
154063442|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063443|NCT00705822|Prednisone|prednisone|mesh-list
154063444|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
154063445|NCT00705822|Docetaxel|docetaxel|mesh-list
154063446|NCT00705822|Estramustine|estramustine|mesh-list
154063447|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063448|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
154063449|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
154063450|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
154063451|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063452|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063453|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
154063454|NCT00705822|Hormones|hormones|mesh-ancestor
154063455|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063456|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063457|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154063458|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154063459|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
154063460|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
154063461|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063462|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063463|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154063464|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154063465|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063466|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063467|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063484|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
154063485|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063486|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063487|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063488|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
154063490|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063491|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063492|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
154063493|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063494|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063495|NCT02560636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154063496|NCT02560636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063497|NCT00758212|Vaccines|vaccines|mesh-list
154063498|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
154063499|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063500|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
154063501|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
154063502|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154063503|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
154063504|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717940|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717941|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717942|NCT00400478|Rituximab|rituximab|mesh-list
153717958|NCT01052038|Hormones|hormones|mesh-ancestor
153717959|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717960|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154063505|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063506|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154063507|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063518|NCT00758368|Emetics|emetics|mesh-ancestor
154063534|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063535|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153729920|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729921|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153729922|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729923|NCT00140361|Artesunate|artesunate|mesh-list
153729924|NCT00140361|Lumefantrine|lumefantrine|mesh-list
153729925|NCT00140361|Artemether|artemether|mesh-list
153729926|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
153729927|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
153729928|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153729929|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
153729930|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153729931|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153729932|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729933|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729934|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
153729935|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
153729936|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153729937|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
154063536|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154063537|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154063538|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
154063539|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063540|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063542|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
154063543|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
154063544|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
154063565|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154063567|NCT02559154|Hormones|hormones|mesh-ancestor
154063568|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063569|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154063570|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154063571|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154063572|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154063573|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063574|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
154063575|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063576|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063577|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154063578|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154063579|NCT02559154|Growth Substances|growth substances|mesh-ancestor
154063580|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
154063581|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
154063582|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
154063583|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063584|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063585|NCT00804843|Niacin|niacin|mesh-list
154063586|NCT00804843|Atorvastatin|atorvastatin|mesh-list
154063587|NCT00804843|Simvastatin|simvastatin|mesh-list
154063588|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154063589|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154063590|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
154063591|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063592|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154063593|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154063594|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063595|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
154063596|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
154063597|NCT00804843|Vitamins|vitamins|mesh-ancestor
154063598|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
153729938|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154063609|NCT00822120|Procarbazine|procarbazine|mesh-list
154063610|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063611|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
154063612|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063613|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063614|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154063624|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
154063674|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
154063675|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154063676|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154063677|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063678|NCT00804141|Bromides|bromides|mesh-list
154063679|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
154063680|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
153718059|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718060|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063681|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154063682|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063683|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
153718061|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063684|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063685|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
154063686|NCT00677092|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154063687|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154063688|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063689|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063690|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063691|NCT02607579|Ropivacaine|ropivacaine|mesh-list
154063692|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
154063693|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
154063694|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063695|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063696|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
154063697|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063698|NCT03539367|Acetazolamide|acetazolamide|mesh-list
154063699|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
154063700|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154063701|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063702|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063703|NCT03539367|Diuretics|diuretics|mesh-ancestor
154063704|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
154063705|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063706|NCT03416361|Vitamin D|vitamin d|mesh-list
154063707|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
154063708|NCT03416361|Vitamins|vitamins|mesh-ancestor
154063709|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
154063710|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575454|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063711|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154063712|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154063713|NCT00761254|Domperidone|domperidone|mesh-list
154063714|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
154063715|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
154063716|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063717|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063718|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154063719|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154063720|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
154063721|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063722|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063723|NCT00761332|Teriparatide|teriparatide|mesh-list
154063724|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
154063725|NCT00761332|Diphosphonates|diphosphonates|mesh-list
154063726|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154063727|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718141|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718142|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153718143|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718144|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718145|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
153718147|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718159|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718160|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153718161|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153718162|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
153718163|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154063728|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154063729|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154063730|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
154063731|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063732|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154063733|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154063760|NCT00761644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154063761|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063762|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
154063763|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154063764|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154063765|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
154063766|NCT02559388|Montelukast|montelukast|mesh-list
154063767|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154063768|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063769|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154063770|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
154063771|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063772|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063773|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154063774|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154063775|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063776|NCT03168256|Apremilast|apremilast|mesh-list
154063777|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154063778|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154063779|NCT03168256|Analgesics|analgesics|mesh-ancestor
154063780|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
154063781|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063789|NCT00761722|Azacitidine|azacitidine|mesh-list
154063810|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718164|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718165|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153718166|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
153718167|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718168|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718169|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718170|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718171|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
153718172|NCT00433225|Prednisolone|prednisolone|mesh-list
153718173|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153547374|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547375|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063811|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
154063812|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063813|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154063814|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063815|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063816|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063817|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
154063818|NCT00762658|Hormones|hormones|mesh-ancestor
154063819|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063820|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154063821|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
154063822|NCT02558452|Tacrolimus|tacrolimus|mesh-list
154063823|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154063824|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
154063825|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063826|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154063827|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063828|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063829|NCT00762736|Pioglitazone|pioglitazone|mesh-list
154063830|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154063831|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154063832|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729939|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063833|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154063834|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154063835|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063836|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
154063837|NCT02915224|Chlorambucil|chlorambucil|mesh-list
154063838|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154063839|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154063848|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
154063849|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154063850|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063851|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063852|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154063853|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154063854|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154063855|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063856|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154063857|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154063858|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063859|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
154063860|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154063861|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154063862|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063863|NCT00673894|Incretins|incretins|mesh-ancestor
154063864|NCT00673894|Hormones|hormones|mesh-ancestor
154063865|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063866|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154063867|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
154063868|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154063869|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063870|NCT00763204|Betamethasone|betamethasone|mesh-list
154063871|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154063872|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154063873|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
154063874|NCT00763204|Hormones|hormones|mesh-ancestor
154063875|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154063876|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063884|NCT02558218|Hormones|hormones|mesh-ancestor
154063888|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154063889|NCT00763438|Sertindole|sertindole|mesh-list
154063890|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154063891|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154063892|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063893|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063894|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154063895|NCT02559232|Anticoagulants|anticoagulants|mesh-list
154063896|NCT00763906|Norepinephrine|norepinephrine|mesh-list
154063897|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154063898|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154063899|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
154063900|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063901|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063902|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063903|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
154063904|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
154063946|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154063947|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154063948|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154063949|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154063950|NCT00672958|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154063951|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154063952|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154063953|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154063954|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154063955|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
154063956|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154063957|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154063958|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154063959|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154063960|NCT00764374|Z 338|z 338|mesh-list
154063961|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154063968|NCT00759226|Leucovorin|leucovorin|mesh-list
154064003|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154064004|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154064005|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154064006|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064007|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154064008|NCT00759460|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153718174|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
153718175|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153718177|NCT00433225|Ketorolac|ketorolac|mesh-list
153718178|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153718179|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
153718180|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718210|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
153782508|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782509|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782510|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
153782511|NCT00234143|Hematinics|hematinics|mesh-ancestor
153782512|NCT00234182|Interferons|interferons|mesh-list
153782513|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
153782514|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
154064009|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154064010|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154064011|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064012|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064013|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
154064014|NCT00765154|Ritonavir|ritonavir|mesh-list
154064015|NCT00765154|Darunavir|darunavir|mesh-list
154064016|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154064017|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154064061|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154064062|NCT00759928|Sorafenib|sorafenib|mesh-list
154064063|NCT00759928|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154064064|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154064065|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064066|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064067|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064068|NCT00670930|Omalizumab|omalizumab|mesh-list
154064069|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154064070|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154064071|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
154064072|NCT00770536|Doxorubicin|doxorubicin|mesh-list
154064073|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154064074|NCT00770536|Topotecan|topotecan|mesh-list
154064075|NCT00770536|Trebananib|trebananib|mesh-list
154064076|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154064077|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064078|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154064079|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154064080|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064081|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064082|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154064083|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154064084|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154064085|NCT00770536|Growth Substances|growth substances|mesh-ancestor
154064086|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064087|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
154064088|NCT00771004|Pioglitazone|pioglitazone|mesh-list
154064089|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064091|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
154064104|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064105|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
154064106|NCT00820950|Hormones|hormones|mesh-ancestor
154064107|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154064108|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064109|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154064110|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
154064111|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
154064112|NCT00765934|Lidocaine|lidocaine|mesh-list
154064113|NCT00765934|Tetracaine|tetracaine|mesh-list
154064114|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
154064115|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
154064116|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064117|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064118|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
154064119|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064120|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154064121|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154064122|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154064123|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154064125|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
154064158|NCT00591630|Carmustine|carmustine|mesh-list
154064159|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154064160|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064161|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
154064162|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064163|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064164|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154064165|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154064166|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154064167|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064168|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064169|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154064170|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
154064171|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
154064172|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064173|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064174|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154064175|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
154064176|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154064177|NCT00771394|Tamsulosin|tamsulosin|mesh-list
154064178|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
154064179|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154064180|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154064181|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154064182|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
154064183|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064184|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064185|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064186|NCT00771394|Urological Agents|urological agents|mesh-ancestor
154064187|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154064188|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154064189|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
154064190|NCT00670228|Insulin|insulin|mesh-list
154064198|NCT00766246|Docetaxel|docetaxel|mesh-list
154064199|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154064200|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064201|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154064202|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153606924|NCT04460352|Leucovorin|leucovorin|mesh-list
154064203|NCT00766246|Growth Substances|growth substances|mesh-ancestor
154064204|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064205|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
154064206|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
154064207|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
154064208|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
154064209|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064210|NCT00766402|Acetaminophen|acetaminophen|mesh-list
154064211|NCT00766402|Diclofenac|diclofenac|mesh-list
154064212|NCT00766402|Tramadol|tramadol|mesh-list
154064213|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154064214|NCT00766402|Analgesics|analgesics|mesh-ancestor
154064215|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
154064216|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064217|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064218|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
154064219|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154064220|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064221|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064222|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154064223|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064224|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064225|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154064226|NCT00766402|Narcotics|narcotics|mesh-ancestor
154064227|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154064228|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154064229|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064230|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064231|NCT00760864|Methotrexate|methotrexate|mesh-list
154064232|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154064234|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064235|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064236|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154064237|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
154064238|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064239|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064240|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
154064241|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064242|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154064243|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064244|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
154064245|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064246|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154064247|NCT00766480|Fluorouracil|fluorouracil|mesh-list
154064248|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064249|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
154064250|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064251|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154064252|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064253|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
154064254|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064255|NCT00772174|Metformin|metformin|mesh-list
154064256|NCT00772174|Pioglitazone|pioglitazone|mesh-list
154064283|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154064284|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064285|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064287|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154064288|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154064289|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064290|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154064291|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154064292|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
154064293|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064294|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154064295|NCT00772798|Paclitaxel|paclitaxel|mesh-list
154064296|NCT00772798|Carboplatin|carboplatin|mesh-list
154064297|NCT00772798|Vorinostat|vorinostat|mesh-list
154064298|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154064299|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064300|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
154064301|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
154064302|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
153575455|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153575456|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
153575457|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575458|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575459|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153575460|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153575461|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
153575462|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153575463|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575464|NCT01706510|Clopidogrel|clopidogrel|mesh-list
153458558|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
153458559|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458560|NCT04140006|Alendronate|alendronate|mesh-list
153458561|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153458562|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458563|NCT04146324|Nivolumab|nivolumab|mesh-list
153458564|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458565|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458566|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153718224|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153718225|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718226|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
153718228|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153817215|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817216|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
153817217|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153817218|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
153817219|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817220|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817221|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
153817222|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153817223|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153817224|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817225|NCT00469443|Antidotes|antidotes|mesh-ancestor
153817226|NCT00469443|Protective Agents|protective agents|mesh-ancestor
153817227|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
153575466|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153575467|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154064304|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154064305|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064306|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
154064307|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154064308|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154064309|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154064310|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
154064311|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064312|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064313|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064314|NCT00775372|Clarithromycin|clarithromycin|mesh-list
154064315|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064316|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575468|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153575469|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153575470|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
153575471|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575472|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575473|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575474|NCT01706562|Itraconazole|itraconazole|mesh-list
153575475|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
153575476|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575477|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153575478|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153575479|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575480|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575481|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153575482|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
153575483|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575484|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575486|NCT01706627|Melatonin|melatonin|mesh-list
153575511|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153575512|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153575513|NCT01707082|Midazolam|midazolam|mesh-list
153575514|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153575515|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153575516|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575517|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575518|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153575519|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153575520|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153575521|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153575522|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
153575524|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
153575525|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
153575526|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575527|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575528|NCT01707134|Insulin|insulin|mesh-list
153575529|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153575530|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
153575531|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
153575532|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
153575533|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
153575534|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575535|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064318|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064319|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064320|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154064321|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154064322|NCT00668746|Minocycline|minocycline|mesh-list
154064323|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064324|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064325|NCT04047940|Metformin|metformin|mesh-list
154064326|NCT04047940|Valsartan|valsartan|mesh-list
154064327|NCT04047940|Atorvastatin|atorvastatin|mesh-list
154064328|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064380|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154064381|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154064382|NCT00775762|Analgesics|analgesics|mesh-ancestor
154064383|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
154064384|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064385|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064386|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064387|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064388|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154064389|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154064390|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064391|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154064392|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154064393|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064394|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
154064395|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154064396|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154064397|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154064398|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
154064399|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064432|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064433|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154064434|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154064435|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
154064436|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064437|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064438|NCT00767728|Mesalamine|mesalamine|mesh-list
154064439|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154064440|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154064441|NCT00767728|Analgesics|analgesics|mesh-ancestor
154064442|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
154064443|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064444|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064445|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064446|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064447|NCT00776074|Leuprolide|leuprolide|mesh-list
154064448|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154064449|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
154064450|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064453|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064487|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064488|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154064489|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154064490|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064491|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064492|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064493|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154064494|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154064495|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154064496|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154064497|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064498|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
154064499|NCT00774280|Busulfan|busulfan|mesh-list
154064500|NCT00774280|Fludarabine|fludarabine|mesh-list
154064501|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064502|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
154064503|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064504|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064505|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154064506|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
154064507|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575536|NCT01707160|Insulin|insulin|mesh-list
153575537|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153575538|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
153575539|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
153575540|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153817228|NCT00469443|Vitamins|vitamins|mesh-ancestor
153817229|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
153817230|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
153817231|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153817232|NCT00428909|Acetaminophen|acetaminophen|mesh-list
153817233|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
153817234|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817235|NCT00428909|Analgesics|analgesics|mesh-ancestor
153817236|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
153817237|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817243|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458597|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458598|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458600|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458601|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153458602|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153575541|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575542|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575543|NCT01707199|Artesunate|artesunate|mesh-list
153575544|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
153575545|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
153575546|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153575547|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
153575548|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153575549|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154064508|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064509|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154064510|NCT04151147|Mitogens|mitogens|mesh-list
154064511|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
154064512|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064513|NCT00774358|Aldesleukin|aldesleukin|mesh-list
154064514|NCT00774358|Interleukin-2|interleukin-2|mesh-list
154064515|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064516|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154064517|NCT00774358|Analgesics|analgesics|mesh-ancestor
154064518|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
154064519|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064520|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064521|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154064522|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154064523|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
154064524|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064525|NCT02627417|Dapsone|dapsone|mesh-list
154064526|NCT02627417|Prednisone|prednisone|mesh-list
154064527|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064565|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064566|NCT00774904|Losartan|losartan|mesh-list
154064567|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154064568|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154064569|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154064570|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154064571|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607292|NCT03454646|Donepezil|donepezil|mesh-list
154064573|NCT00829296|Nebivolol|nebivolol|mesh-list
154064574|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154064575|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154064576|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
154064577|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
154064578|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154064579|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064580|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154064581|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154064582|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154064583|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
154064619|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064620|NCT00779350|Sertraline|sertraline|mesh-list
154064621|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
154064622|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154064623|NCT00779350|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154064624|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154064625|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154064626|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064627|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154064628|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
154064629|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064630|NCT00705978|Pancreatin|pancreatin|mesh-list
154064631|NCT00705978|Pancrelipase|pancrelipase|mesh-list
154064632|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154064681|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
154064682|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
154064683|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
154064684|NCT00776542|Minocycline|minocycline|mesh-list
154064685|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064686|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064687|NCT00776620|Glimepiride|glimepiride|mesh-list
154064688|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154064689|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064690|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064691|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064745|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064746|NCT00681005|Rabeprazole|rabeprazole|mesh-list
154064747|NCT00681005|Pantoprazole|pantoprazole|mesh-list
154064748|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154064749|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154064750|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154064751|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064752|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547437|NCT05507983|Coagulants|coagulants|mesh-ancestor
153547438|NCT05506943|Paclitaxel|paclitaxel|mesh-list
153547439|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547440|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547441|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
153547442|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547443|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
154064753|NCT02633969|Indomethacin|indomethacin|mesh-list
154064754|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154064755|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154064756|NCT02633969|Analgesics|analgesics|mesh-ancestor
154064807|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064808|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154064809|NCT00709332|Hematinics|hematinics|mesh-ancestor
154064810|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
154064811|NCT00709332|Vitamins|vitamins|mesh-ancestor
154064812|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
154064813|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154064814|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154064815|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154064816|NCT00684905|Leuprolide|leuprolide|mesh-list
154064817|NCT00684905|Bicalutamide|bicalutamide|mesh-list
154064818|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154064819|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
154064820|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154064821|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064822|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154064823|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064824|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
154064825|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
154064826|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154064827|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
154064828|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
154064829|NCT00685061|Daclizumab|daclizumab|mesh-list
154064830|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
154064831|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064832|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154064858|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
154064859|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154064860|NCT00819390|Chloroquine|chloroquine|mesh-list
154064861|NCT00819390|Amebicides|amebicides|mesh-ancestor
154064862|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154064863|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154064864|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064865|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
154064866|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154064867|NCT00876395|Paclitaxel|paclitaxel|mesh-list
154064868|NCT00876395|Trastuzumab|trastuzumab|mesh-list
154064869|NCT00876395|Everolimus|everolimus|mesh-list
154064870|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154064871|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064872|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
154064873|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
154064874|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607593|NCT01446133|Rituximab|rituximab|mesh-list
154064876|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154064918|NCT04148183|Metformin|metformin|mesh-list
154064919|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
154064920|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154064921|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064922|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154064923|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154064924|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154064925|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
154064926|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154064927|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154064928|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154064929|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154064930|NCT02633579|Erythromycin|erythromycin|mesh-list
154064931|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
154064932|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154064977|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
154064979|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
153547444|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547446|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153547447|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154064980|NCT00657059|Irbesartan|irbesartan|mesh-list
154064981|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154064982|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
154064983|NCT00657059|Hormones|hormones|mesh-ancestor
154064984|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154064985|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154064986|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154064987|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154064988|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154064989|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154064990|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
154064991|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154064992|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154064993|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065034|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065035|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065036|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154065037|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
154065038|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154065039|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154065040|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154065041|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
154065042|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065043|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065045|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154065046|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
154065047|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154065048|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154065049|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065050|NCT00671788|Dasatinib|dasatinib|mesh-list
154065051|NCT00671788|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154065052|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154065053|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065054|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065055|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065056|NCT02626481|Dexamethasone|dexamethasone|mesh-list
154065057|NCT02626481|Daratumumab|daratumumab|mesh-list
154065058|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065059|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
154065060|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
154065061|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065062|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065063|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065064|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
154065065|NCT02626481|Hormones|hormones|mesh-ancestor
153575550|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575551|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781618|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153575552|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
153575553|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
153575554|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153575555|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
153575556|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153575557|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575558|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065066|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065067|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154065068|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065070|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
154065071|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154065072|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065073|NCT00681941|Sevelamer|sevelamer|mesh-list
154065074|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
154065075|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
154065076|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065077|NCT00657137|Capecitabine|capecitabine|mesh-list
154065078|NCT00657137|Lapatinib|lapatinib|mesh-list
154065079|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154065124|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
154065125|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
154065126|NCT02556268|Riociguat|riociguat|mesh-list
154065127|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
154065128|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
154065129|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065130|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
154065131|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065132|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154065133|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154065134|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065135|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154065136|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154065137|NCT00875615|Carboplatin|carboplatin|mesh-list
154065138|NCT00875615|Sorafenib|sorafenib|mesh-list
154065139|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065140|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154065141|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065142|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065143|NCT02626559|Bupivacaine|bupivacaine|mesh-list
154065178|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
154065179|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154065180|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065181|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065182|NCT00780598|Tosedostat|tosedostat|mesh-list
154065183|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065184|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065185|NCT00780754|Dutasteride|dutasteride|mesh-list
154065186|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154065187|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154065188|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065189|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065190|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
154065191|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065192|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065193|NCT00780832|Caffeine|caffeine|mesh-list
154065194|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154065195|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154065196|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065197|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154065198|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065199|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065200|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154065201|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154065202|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
154065203|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065204|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
154065205|NCT00597701|Lorazepam|lorazepam|mesh-list
154065206|NCT00597701|Baclofen|baclofen|mesh-list
153718234|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718255|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153718256|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
153718257|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153718258|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153718259|NCT00433576|Resveratrol|resveratrol|mesh-list
154065221|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065222|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154065223|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154065224|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154065225|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
154065227|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065228|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065229|NCT00682721|Valacyclovir|valacyclovir|mesh-list
154065230|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
154065231|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065232|NCT02556814|Dexamethasone|dexamethasone|mesh-list
154065233|NCT02556814|Caffeic acid|caffeic acid|mesh-list
154065234|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065235|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
154065236|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
154065237|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065238|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065239|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065240|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
154065241|NCT02556814|Hormones|hormones|mesh-ancestor
154065242|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065243|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154065244|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065245|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
153575559|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153575560|NCT01707251|Ibuprofen|ibuprofen|mesh-list
153575561|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153575563|NCT01707251|Analgesics|analgesics|mesh-ancestor
153575564|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
153575565|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575566|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575567|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153575568|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458603|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458604|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153718306|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153458605|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153458606|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458608|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153458609|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153458610|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
153458611|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153458612|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153458618|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
153458619|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458620|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065246|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065247|NCT02556814|Protective Agents|protective agents|mesh-ancestor
154065249|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
153718314|NCT00433927|Leucovorin|leucovorin|mesh-list
153607968|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153608045|NCT01938508|Minocycline|minocycline|mesh-list
154065250|NCT00682955|Trace Elements|trace elements|mesh-ancestor
154065251|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
154065252|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065253|NCT00682955|Astringents|astringents|mesh-ancestor
154065254|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
154065255|NCT00686621|Posaconazole|posaconazole|mesh-list
154065256|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
154065257|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065258|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154065259|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154065260|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154065261|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154065262|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154065263|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065264|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065265|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154065266|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
154065267|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065268|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065269|NCT00683111|Esomeprazole|esomeprazole|mesh-list
154065270|NCT00683111|Famotidine|famotidine|mesh-list
154065271|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154065272|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065273|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154065274|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065275|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065276|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154065277|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
154065284|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065285|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065286|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
154065287|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718368|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718369|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718370|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718371|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718372|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153718373|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
153718374|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
153718375|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153718376|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
153718377|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718418|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718419|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718420|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718421|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718422|NCT00098579|Doxorubicin|doxorubicin|mesh-list
153718423|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153718424|NCT00098579|Alvocidib|alvocidib|mesh-list
153718425|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153718426|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718435|NCT00098618|Interferons|interferons|mesh-list
154065288|NCT00922649|Insulin|insulin|mesh-list
154065289|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154065290|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065291|NCT04142411|Insulin|insulin|mesh-list
154065292|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154065293|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
154065294|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154065295|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065296|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154065297|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
154065298|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
154065299|NCT04142411|Protective Agents|protective agents|mesh-ancestor
154065300|NCT00683189|Warfarin|warfarin|mesh-list
154065301|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
154065302|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
154065303|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065304|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
154065305|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154065306|NCT00667576|Protective Agents|protective agents|mesh-ancestor
153458621|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575569|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153575570|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575571|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575572|NCT01707316|Canagliflozin|canagliflozin|mesh-list
153575573|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153575574|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575575|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575576|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575577|NCT01707342|Simeprevir|simeprevir|mesh-list
153575578|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
153575579|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575580|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
153575581|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575582|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575583|NCT01707394|Apixaban|apixaban|mesh-list
153718482|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718483|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718484|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
153718485|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153718486|NCT00099008|Estrogens|estrogens|mesh-ancestor
153718487|NCT00099008|Hormones|hormones|mesh-ancestor
153718488|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718489|NCT00434239|Lenalidomide|lenalidomide|mesh-list
153718490|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
153718491|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468382|NCT06297681|Dexamethasone|dexamethasone|mesh-list
153919706|NCT00927394|Protease Inhibitors|protease inhibitors|mesh-ancestor
153919707|NCT00927394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575584|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153575585|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
153575586|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153575587|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
153575588|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575589|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575590|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
153575591|NCT01707407|Ketoconazole|ketoconazole|mesh-list
153575592|NCT01707407|Pomalidomide|pomalidomide|mesh-list
153575593|NCT01707407|Carbamazepine|carbamazepine|mesh-list
153458622|NCT03580980|Acetaminophen|acetaminophen|mesh-list
153458623|NCT03580980|Ketamine|ketamine|mesh-list
153458624|NCT03580980|Morphine|morphine|mesh-list
153458625|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
153458626|NCT03580980|Analgesics|analgesics|mesh-ancestor
153458627|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
154065308|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154065310|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
154065311|NCT04141787|Daptomycin|daptomycin|mesh-list
154065312|NCT04141787|Cloxacillin|cloxacillin|mesh-list
154065313|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065314|NCT04141787|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154065315|NCT04141787|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154065317|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
153718498|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154065318|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065319|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154065320|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154065321|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065322|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065323|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153718499|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153718500|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153718502|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
154065324|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154065325|NCT00687011|Dexamethasone|dexamethasone|mesh-list
154065326|NCT00687011|Palonosetron|palonosetron|mesh-list
154065327|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065328|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
154065329|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
154065330|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065331|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065332|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065333|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
154065334|NCT00687011|Hormones|hormones|mesh-ancestor
153458628|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458629|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458630|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153458631|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153458632|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
153817244|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817245|NCT00429065|Rituximab|rituximab|mesh-list
153817246|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817247|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817248|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
153817249|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817250|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153817251|NCT06189638|Anti-Infective Agents|anti-infective agents|mesh-list
153817252|NCT06189638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153817253|NCT06189586|Glucocorticoids|glucocorticoids|mesh-list
153817254|NCT06189586|Hormones|hormones|mesh-ancestor
153817255|NCT06189586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575595|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
153575596|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575597|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153575598|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154065335|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065337|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065338|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154065339|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154065340|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
154065341|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065342|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718690|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065343|NCT00683267|Capsaicin|capsaicin|mesh-list
154065344|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
154065345|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
154065346|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
154065347|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065348|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065349|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154065350|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065351|NCT00687245|Esomeprazole|esomeprazole|mesh-list
154065352|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154065353|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065354|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154065355|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065356|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065357|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154065358|NCT00690521|Metolazone|metolazone|mesh-list
154065359|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154065360|NCT00690521|Diuretics|diuretics|mesh-ancestor
154065361|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
154065362|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575599|NCT01707407|Growth Substances|growth substances|mesh-ancestor
153575600|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
153575601|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575602|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
153575603|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575604|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153575605|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153575606|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575607|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575611|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153575612|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
153575613|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
153575614|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153575615|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575616|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154065363|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154065364|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154065365|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065366|NCT00666718|Insulin|insulin|mesh-list
154065367|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154065368|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
154065369|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
154065370|NCT00666718|Protamines|protamines|mesh-list
154065371|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154065372|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065373|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
154065374|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065375|NCT00666718|Coagulants|coagulants|mesh-ancestor
154065376|NCT00683735|Metformin|metformin|mesh-list
154065377|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154065378|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153718724|NCT00100139|Paclitaxel|paclitaxel|mesh-list
153718725|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153718726|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154065379|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065380|NCT00683735|Incretins|incretins|mesh-ancestor
154065381|NCT00683735|Hormones|hormones|mesh-ancestor
154065382|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065383|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154065384|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
154065385|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065386|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065387|NCT04139681|Menthol|menthol|mesh-list
154065388|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
154065389|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
154065391|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
154065392|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065393|NCT02625779|Valproic Acid|valproic acid|mesh-list
154065394|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
154065395|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065409|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154065410|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154065411|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154065412|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065413|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154065414|NCT04141319|Ketorolac|ketorolac|mesh-list
154065415|NCT04141319|Epinephrine|epinephrine|mesh-list
154065416|NCT04141319|Ropivacaine|ropivacaine|mesh-list
154065417|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
154065418|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
154065419|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065420|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065421|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
154065422|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065423|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154065424|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154065425|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
154065426|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065427|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065428|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154065429|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154065430|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
154065431|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154065432|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
154065433|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
154065434|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
154065435|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154065436|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154065437|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154065438|NCT04141319|Analgesics|analgesics|mesh-ancestor
154065439|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065440|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065441|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153718825|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
153718826|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
153718827|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
153718831|NCT04728386|Curcumin|curcumin|mesh-list
153718886|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718887|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
153718888|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153718889|NCT00100958|Protective Agents|protective agents|mesh-ancestor
153718891|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575617|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575618|NCT01707407|Analgesics|analgesics|mesh-ancestor
153575619|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
153575620|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575621|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154065443|NCT00683891|Clozapine|clozapine|mesh-list
154065444|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154065445|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
154065446|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065447|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065448|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065449|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154065450|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154065451|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065452|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154065453|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
154065454|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
154065455|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
154065456|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154065457|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065458|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154065459|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
154065460|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154065461|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817256|NCT06189586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817257|NCT06189521|Dexamethasone|dexamethasone|mesh-list
153817258|NCT06189521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817259|NCT06189521|Antiemetics|antiemetics|mesh-ancestor
153817260|NCT06189521|Autonomic Agents|autonomic agents|mesh-ancestor
153817261|NCT06189521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817262|NCT06189521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817263|NCT06189521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817264|NCT06189521|Glucocorticoids|glucocorticoids|mesh-ancestor
153817265|NCT06189521|Hormones|hormones|mesh-ancestor
153817266|NCT06189521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817267|NCT06189521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817268|NCT06189521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817270|NCT06189404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153817271|NCT06189404|Autonomic Agents|autonomic agents|mesh-ancestor
153817272|NCT06189404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575622|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575623|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153575624|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153718954|NCT00135408|Ipilimumab|ipilimumab|mesh-list
153718955|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153718956|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718957|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153718958|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718959|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718960|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153718961|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
153719016|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153719018|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719019|NCT00133185|Diuretics|diuretics|mesh-ancestor
153575625|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153781619|NCT00231140|Growth Substances|growth substances|mesh-ancestor
153575626|NCT01707407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153575627|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153575628|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575630|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153575631|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
153575632|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153575633|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153575635|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
153575636|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575637|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
153575638|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
154065463|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065464|NCT00778024|Fluoxetine|fluoxetine|mesh-list
154065465|NCT00778024|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154065466|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154065467|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154065468|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065469|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065470|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
154065471|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065472|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154065473|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
154065474|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154065475|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154065476|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154065477|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065478|NCT00853658|Enalapril|enalapril|mesh-list
154065479|NCT00853658|Aliskiren|aliskiren|mesh-list
154065480|NCT00853658|Renin Inhibitors|renin inhibitors|mesh-ancestor
154065481|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
154065482|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065483|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065484|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154065485|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154065486|NCT00690677|Panobinostat|panobinostat|mesh-list
154065487|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065488|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154065489|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065490|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065491|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153575639|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575640|NCT01707615|Protective Agents|protective agents|mesh-ancestor
153575641|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575642|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153575643|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153575644|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575645|NCT01707732|Enoxaparin|enoxaparin|mesh-list
153575646|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
153575647|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153575648|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154065492|NCT00781300|Dexamethasone|dexamethasone|mesh-list
154065493|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065494|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
154065495|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
154065496|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065497|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065498|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154065499|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
154065500|NCT00781300|Hormones|hormones|mesh-ancestor
153719024|NCT00135603|Amoxicillin|amoxicillin|mesh-list
154065501|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065502|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154065503|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065504|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154065505|NCT00781378|Plasminogen|plasminogen|mesh-list
154065506|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154065507|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154065508|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154065509|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065510|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
154065511|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065512|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154065513|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
154065514|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065515|NCT00666562|Protective Agents|protective agents|mesh-ancestor
154065516|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065517|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154065518|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154065519|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065521|NCT00769054|Ropivacaine|ropivacaine|mesh-list
154065536|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065537|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154065538|NCT00666328|Clevidipine|clevidipine|mesh-list
154065539|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154065540|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154065541|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065542|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154065543|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065544|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154065546|NCT00778180|Diuretics|diuretics|mesh-ancestor
154065547|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
154065548|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608272|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
154065549|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154065550|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154065551|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065553|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154065554|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154065555|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
154065556|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065557|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154065558|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154065559|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065560|NCT00690911|Adalimumab|adalimumab|mesh-list
154065561|NCT00690911|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154065562|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065563|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065564|NCT00781846|Sirolimus|sirolimus|mesh-list
154065565|NCT00781846|Bevacizumab|bevacizumab|mesh-list
154065580|NCT00853580|L 647318|l 647318|mesh-list
154065581|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
154065582|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154065583|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154065584|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
153719084|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153719085|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719086|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153719087|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719088|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719089|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
153719090|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719091|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065585|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065586|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154065587|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154065588|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065589|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
154065590|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
154065591|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154065592|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154065593|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065594|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154065595|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154065596|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065597|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065598|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065599|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154065600|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
154065601|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154065602|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065603|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154065604|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154065605|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154065606|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154065607|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154065608|NCT00778414|Amoxicillin|amoxicillin|mesh-list
154065609|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
154065610|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
154065611|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154065612|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153817273|NCT06189404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817274|NCT06189404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153817275|NCT06189404|Respiratory System Agents|respiratory system agents|mesh-ancestor
153817276|NCT06189404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153817277|NCT06189404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065613|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065614|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065615|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065616|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154065617|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
154065618|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
154065619|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
154065620|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065621|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
154065622|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065623|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
154065624|NCT00769288|Growth Substances|growth substances|mesh-ancestor
154065625|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065626|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
153719092|NCT00135759|Naltrexone|naltrexone|mesh-list
153719093|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153719094|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153719095|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719096|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
153719097|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719099|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153719100|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153547520|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547521|NCT05421858|Fluconazole|fluconazole|mesh-list
153547522|NCT05421858|Caspofungin|caspofungin|mesh-list
154065627|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154065628|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065629|NCT00688805|Propranolol|propranolol|mesh-list
154065630|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154065631|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154065632|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
154065633|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065634|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065635|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065636|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154065637|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154065638|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
154065639|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
154065640|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
154065642|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
154065643|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
154065644|NCT04136639|Protective Agents|protective agents|mesh-ancestor
154065646|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065656|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154065657|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
154065658|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065659|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065660|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154065661|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
154065662|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065663|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065664|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154065665|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
154065666|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
154065667|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
154065668|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154065669|NCT00778726|Benazepril|benazepril|mesh-list
154065670|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154065671|NCT00778726|Diuretics|diuretics|mesh-ancestor
154065672|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
154065673|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065674|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154065675|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154065676|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065677|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154065678|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
154065679|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065680|NCT00688883|Fludarabine|fludarabine|mesh-list
154065681|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
154065682|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065683|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154065684|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
154065686|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154065699|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065700|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065701|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154065702|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154065704|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154065705|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154065706|NCT00688961|Analgesics|analgesics|mesh-ancestor
154065707|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
154065708|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065709|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065710|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065711|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065712|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154065713|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154065714|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065715|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154065716|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154065717|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065718|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
154065719|NCT00782470|Factor VIII|factor viii|mesh-list
154065720|NCT00782470|Coagulants|coagulants|mesh-ancestor
154065721|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
154065722|NCT00865280|Linezolid|linezolid|mesh-list
154065723|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154065724|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065725|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154065726|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154065727|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065728|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065729|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065730|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154065731|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154065732|NCT00782548|Morphine|morphine|mesh-list
154065740|NCT00689195|Curcumin|curcumin|mesh-list
154065741|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154065742|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154065743|NCT00689195|Analgesics|analgesics|mesh-ancestor
154065744|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
154065745|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065746|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065747|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065748|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154065749|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065750|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065751|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065752|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154065753|NCT00865124|Spironolactone|spironolactone|mesh-list
154065754|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154065755|NCT00865124|Diuretics|diuretics|mesh-ancestor
154065756|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
154065757|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548897|NCT04536805|Metformin|metformin|mesh-list
154065758|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154065759|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154065760|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065761|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154065763|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065764|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154065765|NCT00691067|Mifepristone|mifepristone|mesh-list
154065766|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154065767|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
154065768|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153458634|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458635|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153458636|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153458637|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458638|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458639|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153458640|NCT03580980|Narcotics|narcotics|mesh-ancestor
153575655|NCT01707745|Growth Substances|growth substances|mesh-ancestor
153575656|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575657|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
154065769|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065770|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154065771|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154065772|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154065773|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
154065774|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154065775|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154065776|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
154065777|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065778|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
154065779|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154065780|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154065781|NCT00691145|Tacrolimus|tacrolimus|mesh-list
154065782|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154065783|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
154065784|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065785|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154065786|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065787|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065788|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154065789|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154065790|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154065791|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
154065792|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065793|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065794|NCT00694967|Progestins|progestins|mesh-ancestor
154065795|NCT00694967|Hormones|hormones|mesh-ancestor
154065796|NCT00695045|Morphine|morphine|mesh-list
154065797|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154065798|NCT00695045|Narcotics|narcotics|mesh-ancestor
154065799|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065800|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065801|NCT00695045|Analgesics|analgesics|mesh-ancestor
154065802|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
154065803|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575658|NCT01707823|Aspirin|aspirin|mesh-list
153575659|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154065804|NCT02624453|Fluconazole|fluconazole|mesh-list
154065805|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154065806|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
154065807|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065808|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154065809|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154065810|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065811|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065812|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154065813|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
154065814|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065815|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065816|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154065817|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154065818|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
154065819|NCT00819234|Pramlintide|pramlintide|mesh-list
154065861|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154065862|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065863|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065864|NCT02555800|Cidofovir|cidofovir|mesh-list
154065865|NCT02555800|Bevacizumab|bevacizumab|mesh-list
154065866|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154065867|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065868|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154065869|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154065870|NCT02555800|Growth Substances|growth substances|mesh-ancestor
154065871|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065872|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
154065873|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
154065874|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065875|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065876|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065877|NCT00783172|Gemcitabine|gemcitabine|mesh-list
154065878|NCT00783172|Mitogens|mitogens|mesh-list
154065879|NCT00783172|Enkephalins|enkephalins|mesh-list
154065880|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154065881|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
154065882|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065883|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065884|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719189|NCT00403962|Paroxetine|paroxetine|mesh-list
154065885|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
154065886|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065887|NCT00783250|Albuterol|albuterol|mesh-list
154065906|NCT00783328|Dacomitinib|dacomitinib|mesh-list
154065908|NCT00783328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154065909|NCT00783328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065910|NCT00783328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065912|NCT02555644|Prexasertib|prexasertib|mesh-list
154065913|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065914|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154065915|NCT02555644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154065916|NCT02555644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065917|NCT02555644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065918|NCT00871403|Pemetrexed|pemetrexed|mesh-list
154065919|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065920|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065921|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065922|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154065923|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154065924|NCT00691379|Paclitaxel|paclitaxel|mesh-list
154065925|NCT00691379|Bevacizumab|bevacizumab|mesh-list
154065926|NCT00691379|Carboplatin|carboplatin|mesh-list
154065927|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154065928|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065929|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
154065930|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
154065931|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
154065932|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065933|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153575660|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575661|NCT01707823|Analgesics|analgesics|mesh-ancestor
153575662|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
153575663|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575664|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575665|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153575666|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575667|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153458645|NCT03587220|Capsaicin|capsaicin|mesh-list
153458646|NCT03587220|Histamine|histamine|mesh-list
153575668|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153575669|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575670|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153575671|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153575672|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575673|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
153575674|NCT01707849|Everolimus|everolimus|mesh-list
153575675|NCT01707849|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153575676|NCT01707849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153575677|NCT01707849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575678|NCT01707849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575679|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154065935|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154065936|NCT00691379|Growth Substances|growth substances|mesh-ancestor
154065937|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065938|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
154065939|NCT02624531|Cisplatin|cisplatin|mesh-list
154065941|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065942|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
154065943|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154065944|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
154065945|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065946|NCT04136015|Dasatinib|dasatinib|mesh-list
154065947|NCT04136015|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154065948|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154065949|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065950|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065951|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065952|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
154065953|NCT02624063|Simeprevir|simeprevir|mesh-list
154065954|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
154065955|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154065956|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
154065957|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154065958|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065959|NCT05298683|Acetaminophen|acetaminophen|mesh-list
154065960|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
154065961|NCT05298683|Promethazine|promethazine|mesh-list
154065962|NCT05298683|Dexamethasone|dexamethasone|mesh-list
154065963|NCT05298683|Pomalidomide|pomalidomide|mesh-list
154065964|NCT05298683|Ranitidine|ranitidine|mesh-list
154065965|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154065966|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154065967|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
154065968|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
154065969|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154065970|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065971|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153575680|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
153575681|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154065972|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
154065973|NCT05298683|Hormones|hormones|mesh-ancestor
154065974|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154065975|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154065976|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154065977|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154065978|NCT05298683|Analgesics|analgesics|mesh-ancestor
154065979|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
154065980|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
154065981|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
154065982|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154065983|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154065984|NCT05298683|Growth Substances|growth substances|mesh-ancestor
154065985|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
154065986|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154065987|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154065988|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154065989|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
154065991|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154065992|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
154065993|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
154065994|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154065995|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154065996|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154065997|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
154065998|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
154065999|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154066000|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154066001|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
154066002|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
153575682|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817279|NCT06189404|Vasodilator Agents|vasodilator agents|mesh-ancestor
153817280|NCT06189404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153817281|NCT06189404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153817283|NCT06189404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817284|NCT06189144|Emollients|emollients|mesh-list
153817285|NCT06189144|Dermatologic Agents|dermatologic agents|mesh-ancestor
153817286|NCT06189092|Bleomycin|bleomycin|mesh-list
153575692|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575693|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575694|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153575695|NCT01707953|Midodrine|midodrine|mesh-list
153575696|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
153719205|NCT00102479|Aripiprazole|aripiprazole|mesh-list
153575697|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
153575698|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066004|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154066005|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066006|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066007|NCT00853112|Urological Agents|urological agents|mesh-ancestor
154066008|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
154066009|NCT02624141|Hematinics|hematinics|mesh-ancestor
154066010|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
154066011|NCT00691613|Hematinics|hematinics|mesh-ancestor
154066012|NCT00460603|Bevacizumab|bevacizumab|mesh-list
154066013|NCT00460603|Axitinib|axitinib|mesh-list
154066014|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066015|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066016|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154066017|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154066018|NCT00460603|Growth Substances|growth substances|mesh-ancestor
154066019|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066020|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
154066021|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154066022|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066023|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066024|NCT00696059|Adalimumab|adalimumab|mesh-list
154066025|NCT00696059|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154066026|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066027|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066028|NCT00700466|Metoprolol|metoprolol|mesh-list
154066029|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154066030|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154066031|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154066032|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
154066033|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
154066034|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781620|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
153575699|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575700|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153575701|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153575702|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153575703|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153575704|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
153575705|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575706|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066035|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066036|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154066037|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154066038|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
154066039|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066040|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066041|NCT00700544|Norethandrolone|norethandrolone|mesh-list
154066042|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
154066043|NCT00700544|Hormones|hormones|mesh-ancestor
154066044|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154066045|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066046|NCT02612792|Atorvastatin|atorvastatin|mesh-list
154066047|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154066048|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154066049|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
154066050|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066051|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154066052|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154066053|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066054|NCT00662038|Pirfenidone|pirfenidone|mesh-list
154066055|NCT00662038|Analgesics|analgesics|mesh-ancestor
154066056|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
154066057|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066058|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066059|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154066060|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154066061|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066062|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066063|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066064|NCT00701792|Liver Extracts|liver extracts|mesh-list
154066065|NCT00701792|Hematinics|hematinics|mesh-ancestor
154066066|NCT00784498|Midazolam|midazolam|mesh-list
153575707|NCT01708005|Vitamin D|vitamin d|mesh-list
153575708|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
153575709|NCT01708005|Vitamins|vitamins|mesh-ancestor
153575710|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
153575711|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575712|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153575713|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153575714|NCT01708044|Pramlintide|pramlintide|mesh-list
153575715|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575716|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066067|NCT00784498|Ketamine|ketamine|mesh-list
154066068|NCT00784498|Propofol|propofol|mesh-list
154066069|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153608807|NCT01942681|Propiverine|propiverine|mesh-list
154066070|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066071|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066072|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154066073|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
154066075|NCT00784498|Analgesics|analgesics|mesh-ancestor
154066076|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
154066077|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066078|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154066079|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154066080|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154066081|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066082|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066083|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154066084|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154066085|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154066086|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066087|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
154066088|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
154066089|NCT01022983|Simendan|simendan|mesh-list
154066090|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154066091|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
154066092|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154066093|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154066094|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066095|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066096|NCT01022983|Protective Agents|protective agents|mesh-ancestor
154066097|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066098|NCT00912860|Interferons|interferons|mesh-list
154066099|NCT00912860|Interferon-beta|interferon-beta|mesh-list
154066100|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
154066101|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066102|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
154066103|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154066104|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
154066105|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066106|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154066107|NCT02623673|Dexamethasone|dexamethasone|mesh-list
154066108|NCT02623673|Bevacizumab|bevacizumab|mesh-list
154066109|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066110|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066111|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154066112|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154066113|NCT02623673|Growth Substances|growth substances|mesh-ancestor
154066114|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066115|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
154066116|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066117|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
154066118|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
154066119|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066120|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154066121|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
154066122|NCT02623673|Hormones|hormones|mesh-ancestor
154066123|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154066124|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154066125|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
154066126|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066127|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
154066128|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154066129|NCT00459979|Sunitinib|sunitinib|mesh-list
154066130|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066131|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154066132|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154066133|NCT00459979|Growth Substances|growth substances|mesh-ancestor
154066134|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066135|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
154066136|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154066137|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066138|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817287|NCT06189092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153817288|NCT06189092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817289|NCT06189001|Oxytocin|oxytocin|mesh-list
153817290|NCT06189001|Oxytocics|oxytocics|mesh-ancestor
153458647|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
153458648|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
154066139|NCT00783484|Maraviroc|maraviroc|mesh-list
154066140|NCT00783484|Darunavir|darunavir|mesh-list
154066141|NCT00783484|Midazolam|midazolam|mesh-list
154066142|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154066143|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154066144|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066145|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066146|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154066147|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154066148|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066149|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154066150|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
154066151|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
154066152|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
154066153|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
154066154|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066155|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066156|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154066157|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154066158|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154066159|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154066160|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
154066161|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154066162|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154066192|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154066193|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066194|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
154066195|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
154066196|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
154066197|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066198|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154066199|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066200|NCT00661726|Decitabine|decitabine|mesh-list
154066201|NCT00661726|Azacitidine|azacitidine|mesh-list
154066202|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154066203|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
154066204|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066205|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066206|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066207|NCT00706680|Cyclosporine|cyclosporine|mesh-list
154066208|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
154066209|NCT00706680|Prednisone|prednisone|mesh-list
154066210|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154066211|NCT00706680|Cyclosporins|cyclosporins|mesh-list
154066212|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
154066213|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066214|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
154066215|NCT00706680|Hormones|hormones|mesh-ancestor
153458649|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458650|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458651|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
153458652|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458653|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153458654|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153458655|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153575718|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153575719|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153575720|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575721|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
153575722|NCT01708239|Coagulants|coagulants|mesh-ancestor
153575723|NCT01708330|Lidocaine|lidocaine|mesh-list
153575724|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
153575725|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
153575726|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575727|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575728|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
153575729|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575730|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153575731|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153575732|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153575733|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154066216|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154066217|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066218|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154066219|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066220|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066221|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066222|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154066223|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
154066224|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
154066225|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154066226|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
154066227|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066228|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154066229|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154066230|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154066231|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
154066232|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154066233|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154066234|NCT00706680|Protective Agents|protective agents|mesh-ancestor
154066235|NCT02624999|Cisplatin|cisplatin|mesh-list
154066236|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066237|NCT02612480|Aspirin|aspirin|mesh-list
154066238|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
154066239|NCT02612480|Clopidogrel|clopidogrel|mesh-list
154066240|NCT02612480|Ticagrelor|ticagrelor|mesh-list
154066241|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154066242|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575734|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575735|NCT01708369|Aspirin|aspirin|mesh-list
153575736|NCT01708369|Ethanol|ethanol|mesh-list
153575737|NCT01708369|Oseltamivir|oseltamivir|mesh-list
153575738|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153575739|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575740|NCT01708369|Analgesics|analgesics|mesh-ancestor
153575741|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
153575742|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575743|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575744|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458664|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153458665|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
153575745|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575746|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153575747|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153575748|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575749|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153550569|NCT02829268|Dantrolene|dantrolene|mesh-list
153575750|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153575751|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066243|NCT02612480|Analgesics|analgesics|mesh-ancestor
154066244|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
154066245|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066246|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066247|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066248|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066249|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154066250|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154066251|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066252|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154066253|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154066254|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066255|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
154066256|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154066257|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154066258|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154066259|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
154066260|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066261|NCT00784966|Etanercept|etanercept|mesh-list
154066262|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154066263|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154066264|NCT00784966|Analgesics|analgesics|mesh-ancestor
154066265|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
154066266|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066267|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066268|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066269|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066270|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154066271|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154066272|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
154066273|NCT02623595|Molgramostim|molgramostim|mesh-list
154066274|NCT02623595|Sargramostim|sargramostim|mesh-list
153575752|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
153575753|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153575754|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575755|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575756|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
153575758|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
153575759|NCT01708447|Anesthetics|anesthetics|mesh-list
153575760|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575761|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575762|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
154066275|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
154066276|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066277|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066278|NCT00665392|Docetaxel|docetaxel|mesh-list
154066279|NCT00665392|Fluorouracil|fluorouracil|mesh-list
154066280|NCT00665392|Cetuximab|cetuximab|mesh-list
154066281|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066282|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
154066283|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
154066284|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
154066285|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066286|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
154066287|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154066288|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154066289|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
154066290|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066291|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066292|NCT00851630|Lamivudine|lamivudine|mesh-list
154066293|NCT00851630|Zidovudine|zidovudine|mesh-list
154066294|NCT00851630|Abacavir|abacavir|mesh-list
154066295|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154066296|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154066297|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066298|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609030|NCT01944410|Mitogens|mitogens|mesh-list
154066299|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
154066300|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154066301|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154066302|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153575763|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575764|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153575765|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153575780|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
153575781|NCT01708642|Epinephrine|epinephrine|mesh-list
153575782|NCT01708642|Racepinephrine|racepinephrine|mesh-list
153575783|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
153575784|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153575785|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153575786|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
153575787|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575788|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575789|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575790|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153575791|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153575792|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
153575793|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066303|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
154066304|NCT00459667|Interferons|interferons|mesh-list
154066305|NCT00459667|Interferon-beta|interferon-beta|mesh-list
154066306|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
154066307|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066308|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
154066309|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154066310|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
154066311|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066312|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154066313|NCT02621255|Bupivacaine|bupivacaine|mesh-list
154066314|NCT02621255|Anesthetics|anesthetics|mesh-list
154066315|NCT02621255|Sevoflurane|sevoflurane|mesh-list
154066316|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
154066317|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066318|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066319|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
154066320|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066321|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154066322|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154066323|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
154066324|NCT00828204|Interferons|interferons|mesh-list
154066325|NCT00828204|Interferon-beta|interferon-beta|mesh-list
154066326|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
154066327|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066328|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
154066329|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154066330|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
154066331|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066332|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154066333|NCT00696215|Rasagiline|rasagiline|mesh-list
154066334|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154066335|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066336|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066337|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154066338|NCT00696215|Protective Agents|protective agents|mesh-ancestor
154066344|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154066345|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066346|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154066347|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154066348|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
154066349|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154066350|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154066351|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154066352|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154066353|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
154066354|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154066355|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154066356|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
154066357|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154066358|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
154066359|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154066360|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154066362|NCT00851552|Doxorubicin|doxorubicin|mesh-list
154066363|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154066364|NCT00851552|Bortezomib|bortezomib|mesh-list
154066365|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066366|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066367|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
154066368|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066369|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575794|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153575795|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
153575796|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
153817291|NCT06189001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153817292|NCT06189001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817293|NCT06188767|Methyltestosterone|methyltestosterone|mesh-list
153817294|NCT06188767|Testosterone|testosterone|mesh-list
153817295|NCT06188767|Testosterone undecanoate|testosterone undecanoate|mesh-list
153817296|NCT06188767|Testosterone enanthate|testosterone enanthate|mesh-list
153817297|NCT06188767|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153817298|NCT06188767|Androgens|androgens|mesh-ancestor
153817299|NCT06188767|Hormones|hormones|mesh-ancestor
153817300|NCT06188767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817301|NCT06188767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817302|NCT06188767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817305|NCT06188676|Prednisolone|prednisolone|mesh-list
153817306|NCT06188676|Cyclophosphamide|cyclophosphamide|mesh-list
153817307|NCT06188676|Rituximab|rituximab|mesh-list
153817308|NCT06188676|Doxorubicin|doxorubicin|mesh-list
153817309|NCT06188676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153817310|NCT06188676|Nivolumab|nivolumab|mesh-list
153817311|NCT06188676|Etoposide|etoposide|mesh-list
153458666|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153458668|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066371|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154066372|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154066373|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066374|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066375|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
154066376|NCT00785122|Molgramostim|molgramostim|mesh-list
154066377|NCT00785122|Imiquimod|imiquimod|mesh-list
154066378|NCT00785122|Sargramostim|sargramostim|mesh-list
154066379|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154066380|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
154066381|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066382|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066383|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154066384|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
154066385|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066386|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066387|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154066388|NCT00785122|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154066389|NCT00785122|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154066390|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154066391|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
154066392|NCT04116554|Bupivacaine|bupivacaine|mesh-list
154066393|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
154066394|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
154066395|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066396|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066397|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
154066398|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066399|NCT00700856|Pioglitazone|pioglitazone|mesh-list
154066400|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154066401|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066402|NCT00790114|Midazolam|midazolam|mesh-list
154066403|NCT00790114|Caffeine|caffeine|mesh-list
154066404|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154066405|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154066406|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066407|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066408|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154066409|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154066410|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066411|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154066412|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
154066413|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
154066414|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
154066415|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
154066416|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066417|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066418|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154066419|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154066420|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066421|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154066422|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154066423|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
154066424|NCT01023139|Sibutramine|sibutramine|mesh-list
154066425|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
154066426|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066427|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
154066428|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154066429|NCT00459043|Docetaxel|docetaxel|mesh-list
154066430|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066431|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
154066432|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
154066433|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
154066434|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066435|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
154066436|NCT00795262|Quinapril|quinapril|mesh-list
154066437|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
154066438|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066439|NCT00795262|Protective Agents|protective agents|mesh-ancestor
154066440|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458669|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458670|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153458671|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
153458672|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
153575797|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
153575798|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153575799|NCT01708707|Morphine|morphine|mesh-list
153575800|NCT01708707|Buprenorphine|buprenorphine|mesh-list
153575801|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154066443|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
154066444|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154066445|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
154066446|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066447|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153609182|NCT01945736|Methadone|methadone|mesh-list
154066448|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
154066449|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154066450|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154066452|NCT00817206|Tacrolimus|tacrolimus|mesh-list
154066453|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154066454|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
154066455|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066456|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154066457|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066458|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066459|NCT02611518|Metformin|metformin|mesh-list
154066460|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154066461|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154066462|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066463|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154066464|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154066465|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
154066466|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066467|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154066468|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154066469|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066470|NCT01023607|Atorvastatin|atorvastatin|mesh-list
154066471|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154066472|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154066473|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154066474|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
153575802|NCT01708707|Narcotics|narcotics|mesh-ancestor
153575803|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575804|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575805|NCT01708707|Analgesics|analgesics|mesh-ancestor
153719276|NCT00135993|Rotigotine|rotigotine|mesh-list
153575806|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
153575807|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575808|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154066475|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066476|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154066477|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154066478|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066479|NCT00665002|Sargramostim|sargramostim|mesh-list
154066480|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154066481|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
154066482|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066483|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154066484|NCT00660010|Leuprolide|leuprolide|mesh-list
154066485|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154066486|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
154066487|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154066488|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066489|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154066490|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066491|NCT04015908|Acetaminophen|acetaminophen|mesh-list
154066492|NCT04015908|Celecoxib|celecoxib|mesh-list
154066493|NCT04015908|Pregabalin|pregabalin|mesh-list
154066494|NCT04015908|Oxycodone|oxycodone|mesh-list
154066495|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154066496|NCT04015908|Analgesics|analgesics|mesh-ancestor
154066497|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
154066498|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066499|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066500|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
154066501|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
154066502|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154066503|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154066504|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066505|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154066506|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154066517|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066519|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
154066520|NCT00790816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154066521|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154066522|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066523|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066525|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154066526|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
154066527|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
154066528|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066529|NCT00795496|Histamine|histamine|mesh-list
154066530|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
154066531|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
154066532|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066533|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066534|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066535|NCT00795574|Infliximab|infliximab|mesh-list
154066536|NCT00795574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154066537|NCT00795574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066538|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
154066539|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154066540|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066541|NCT00785434|Escitalopram|escitalopram|mesh-list
154066542|NCT00785434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154066543|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154066544|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154066545|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066546|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066547|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
154066548|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066549|NCT00790894|Epothilones|epothilones|mesh-list
154066550|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
154066551|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
154066552|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
154066556|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066557|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154066558|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154066559|NCT02623127|Growth Substances|growth substances|mesh-ancestor
154066560|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066561|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
154066562|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154066563|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066564|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066565|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
154066566|NCT05263492|Lenvatinib|lenvatinib|mesh-list
154066567|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066568|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066569|NCT05263492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154066570|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066571|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154066572|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066573|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
153549710|NCT03914625|Folic Acid|folic acid|mesh-list
154066574|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154066575|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
154066576|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066577|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
154066578|NCT04134611|Protective Agents|protective agents|mesh-ancestor
154066579|NCT02620631|Morphine|morphine|mesh-list
154066580|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154066581|NCT02620631|Narcotics|narcotics|mesh-ancestor
154066582|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575809|NCT01708720|Vaccines|vaccines|mesh-list
153575810|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
153575811|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575812|NCT01708798|Eplerenone|eplerenone|mesh-list
153575813|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153575814|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
153575815|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575816|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575817|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153575818|NCT01708798|Diuretics|diuretics|mesh-ancestor
153575819|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
153575820|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153575821|NCT01708837|Propofol|propofol|mesh-list
153575822|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153575823|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575824|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575825|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153575826|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
154066583|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066584|NCT02620631|Analgesics|analgesics|mesh-ancestor
154066585|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
154066586|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066588|NCT04030572|Analgesics|analgesics|mesh-ancestor
154066589|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
154066590|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066591|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066592|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154066593|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
154066594|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
154066595|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154066596|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154066597|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154066598|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
154066599|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066600|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066601|NCT00795808|Metformin|metformin|mesh-list
154066602|NCT00795808|Clomiphene|clomiphene|mesh-list
154066603|NCT00795808|Enclomiphene|enclomiphene|mesh-list
154066604|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
154066605|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154066606|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066607|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154066608|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
154066609|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154066610|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154066611|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
154066612|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154066613|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154066614|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154066615|NCT04135781|Paclitaxel|paclitaxel|mesh-list
154066616|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154066617|NCT04135781|Capecitabine|capecitabine|mesh-list
154066618|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
154066619|NCT04135781|Tegafur|tegafur|mesh-list
154066622|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
154066623|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
154066624|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
154066625|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066626|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154066627|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
154066628|NCT04135313|Capecitabine|capecitabine|mesh-list
154066629|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
154066630|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154066631|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
154066632|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066633|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066635|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066636|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066637|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066638|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154066639|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154066640|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
154066641|NCT00692315|Vitamins|vitamins|mesh-ancestor
154066642|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
154066643|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066644|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
154066645|NCT02623049|Anticoagulants|anticoagulants|mesh-list
154066646|NCT02608944|Adenosine|adenosine|mesh-list
154066647|NCT02608944|Regadenoson|regadenoson|mesh-list
154066648|NCT02608944|Analgesics|analgesics|mesh-ancestor
154066649|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
154066650|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066651|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575827|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
153458673|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153458674|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
153458675|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458676|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458677|NCT03580590|Diltiazem|diltiazem|mesh-list
153458678|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
153458679|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153458680|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153458681|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458682|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
153458683|NCT03580590|Coagulants|coagulants|mesh-ancestor
153458684|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153458685|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153575828|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
153575829|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154066652|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154066653|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
154066654|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154066655|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
154066656|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
154066657|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066658|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066659|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154066661|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154066662|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154066663|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066664|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154066665|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154066666|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
154066667|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066668|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066669|NCT00664534|Insulin|insulin|mesh-list
154066670|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154066671|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
154066672|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
154066673|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154066674|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066675|NCT00913848|Valproic Acid|valproic acid|mesh-list
154066676|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
154066677|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066678|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066679|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
154066680|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066681|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066697|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154066698|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154066700|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
154066701|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154066702|NCT05758116|Tislelizumab|tislelizumab|mesh-list
154066703|NCT05758116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066704|NCT05758116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066705|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
154066706|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154066707|NCT00570310|Pregabalin|pregabalin|mesh-list
154066708|NCT00570310|Analgesics|analgesics|mesh-ancestor
154066709|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
154066710|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066711|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066712|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
153575830|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
153575831|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153575832|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
153575833|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575834|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575835|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
153575836|NCT01708876|Artesunate|artesunate|mesh-list
153575837|NCT01708876|Chloroquine|chloroquine|mesh-list
153575838|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153575839|NCT01708876|Primaquine|primaquine|mesh-list
153575840|NCT01708876|Mefloquine|mefloquine|mesh-list
153575841|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
153575842|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153575843|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153575844|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575845|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575846|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
153575847|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
153575848|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153575849|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
153575850|NCT01708876|Amebicides|amebicides|mesh-ancestor
153575852|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153575853|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575854|NCT01708876|Analgesics|analgesics|mesh-ancestor
153575855|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
153575856|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575857|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575858|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153575859|NCT01708876|Filaricides|filaricides|mesh-ancestor
153575860|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
153575861|NCT01709019|Vaccines|vaccines|mesh-list
153575862|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
153575884|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
153575885|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817312|NCT06188676|Vincristine|vincristine|mesh-list
153817313|NCT06188676|Etoposide phosphate|etoposide phosphate|mesh-list
153817314|NCT06188676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817315|NCT06188676|Immunologic Factors|immunologic factors|mesh-ancestor
153817316|NCT06188676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575886|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153575887|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
153575888|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153575889|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575890|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066714|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154066715|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066716|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154066718|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153731231|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154066719|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066720|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066721|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
154066722|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
154066723|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154066724|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154066725|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066726|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
154066727|NCT00664066|Hematinics|hematinics|mesh-ancestor
154066728|NCT02619929|Vinorelbine|vinorelbine|mesh-list
154066729|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154066730|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066731|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
154066732|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
154066733|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
154066734|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066735|NCT00796198|Latanoprost|latanoprost|mesh-list
154066736|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154066737|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154066738|NCT02622503|Rituximab|rituximab|mesh-list
154066739|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066740|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066741|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
153575891|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153575892|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
153575893|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153575899|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575900|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575901|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153575902|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575903|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153575904|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154066742|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066743|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066744|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154066745|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
154066746|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066747|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154066748|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154066749|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154066750|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066751|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066752|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066753|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154066754|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154066755|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
154066756|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066757|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066758|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154066759|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154066760|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
154066761|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154066762|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154066763|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154066764|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066765|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066766|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066767|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153575905|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575906|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817317|NCT06188676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153817318|NCT06188676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153817319|NCT06188676|Alkylating Agents|alkylating agents|mesh-ancestor
153817320|NCT06188676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817321|NCT06188676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817322|NCT06188676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153817323|NCT06188676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817324|NCT06188676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153817325|NCT06188676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153817326|NCT06188676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153817327|NCT06188676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817328|NCT06188676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153817329|NCT06188676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153458686|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153458687|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153458688|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458689|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
154066768|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154066769|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
154066770|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066771|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066772|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154066773|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154066774|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
154066775|NCT00786058|Fluorouracil|fluorouracil|mesh-list
154066776|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
154066777|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066778|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154066779|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066780|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154066781|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
154066782|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066783|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
154066785|NCT00871169|Cetuximab|cetuximab|mesh-list
154066786|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066787|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154066788|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154066789|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458691|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153458692|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458693|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458694|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458695|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153458697|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153458698|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
153458699|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458700|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153575908|NCT01709682|Sotalol|sotalol|mesh-list
153575909|NCT01709682|Flecainide|flecainide|mesh-list
153575910|NCT01709682|Propafenone|propafenone|mesh-list
153575911|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153575912|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
153575913|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153575914|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575915|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575916|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153575917|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153575918|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153575919|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575920|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153575921|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153575922|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153575923|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153575924|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153575925|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
153575926|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066790|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066791|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154066792|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154066793|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154066794|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154066795|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066796|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066797|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154066798|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154066799|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154066800|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
154066801|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066802|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066803|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154066804|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154066805|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
154066806|NCT00814632|Apremilast|apremilast|mesh-list
154066807|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154066808|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154066809|NCT00814632|Analgesics|analgesics|mesh-ancestor
154066810|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
154066811|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066812|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066813|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066814|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066815|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154066816|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154066817|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066818|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066819|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154066820|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154066821|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154066828|NCT02554942|Hematinics|hematinics|mesh-ancestor
154066829|NCT02619773|Mupirocin|mupirocin|mesh-list
154066830|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154066831|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154066832|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154066833|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066834|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066835|NCT02555488|Methylene Blue|methylene blue|mesh-list
154066836|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066837|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066838|NCT02554864|Lidocaine|lidocaine|mesh-list
154066839|NCT02554864|Ropivacaine|ropivacaine|mesh-list
154066840|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
154066841|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
154066842|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066843|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066844|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
154066845|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066846|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154066847|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154066848|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154066849|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154066850|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066851|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
154066852|NCT00851318|Methotrexate|methotrexate|mesh-list
154066853|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154066854|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
154066855|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153719467|NCT00103298|Calcium|calcium|mesh-list
154066856|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066857|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154066872|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154066873|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066874|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066875|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154066876|NCT00786370|Analgesics|analgesics|mesh-ancestor
154066877|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
154066878|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066879|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154066880|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154066881|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154066882|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
154066883|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066884|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066885|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154066886|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
154066887|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
154066888|NCT00796900|Dantrolene|dantrolene|mesh-list
154066889|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154066890|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066891|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154066892|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066893|NCT00791830|Irbesartan|irbesartan|mesh-list
154066894|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154066895|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154066896|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153575927|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575928|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
153575929|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
153575930|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575931|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153458701|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153458702|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153575941|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
153575942|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575943|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153575944|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153575945|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
153575946|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575947|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153575948|NCT01709825|Sulfalene|sulfalene|mesh-list
153575949|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575950|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153575951|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
153609621|NCT04721821|Tofacitinib|tofacitinib|mesh-list
154066897|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066898|NCT00786448|Darifenacin|darifenacin|mesh-list
154066899|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154066900|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154066901|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
154066902|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066903|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066904|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066905|NCT00786448|Urological Agents|urological agents|mesh-ancestor
154066906|NCT04137653|Paclitaxel|paclitaxel|mesh-list
154066907|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154066908|NCT04137653|Carboplatin|carboplatin|mesh-list
154066909|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154066910|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066911|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
154066912|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
154066913|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
154066914|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066915|NCT00797056|Aspirin|aspirin|mesh-list
154066916|NCT00797056|Clopidogrel|clopidogrel|mesh-list
153719470|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066917|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154066918|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154066919|NCT00797056|Analgesics|analgesics|mesh-ancestor
154066920|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
154066921|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066922|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066923|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066924|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066925|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154066926|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153575952|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153575953|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153575954|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
153575955|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153575956|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575957|NCT01709942|Cetrorelix|cetrorelix|mesh-list
153575958|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153817330|NCT06188676|Tubulin Modulators|tubulin modulators|mesh-ancestor
153817331|NCT06188676|Antimitotic Agents|antimitotic agents|mesh-ancestor
153817332|NCT06188676|Mitosis Modulators|mitosis modulators|mesh-ancestor
153817333|NCT06188676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817334|NCT06188676|Glucocorticoids|glucocorticoids|mesh-ancestor
153817335|NCT06188676|Hormones|hormones|mesh-ancestor
153575959|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
154066927|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066928|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154066929|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154066930|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066931|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
154066932|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154066933|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154066934|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154066935|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
154066936|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066937|NCT00593957|Levomethorphan|levomethorphan|mesh-list
154066938|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
154066939|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
154066940|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
154066941|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154066942|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154066943|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154066944|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066945|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066946|NCT00593957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154066947|NCT00593957|Narcotics|narcotics|mesh-ancestor
154066948|NCT00593957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154066949|NCT00593957|Analgesics|analgesics|mesh-ancestor
154066950|NCT00593957|Sensory System Agents|sensory system agents|mesh-ancestor
153719477|NCT00103298|Antidotes|antidotes|mesh-ancestor
153575960|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153575961|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575962|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
153575963|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575964|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
153575965|NCT01709955|Cathartics|cathartics|mesh-ancestor
153575966|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153575967|NCT01709994|Aspirin|aspirin|mesh-list
153575979|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153575980|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153575981|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575983|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
153575984|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
153575985|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575986|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575987|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817336|NCT06188676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817337|NCT06188676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817338|NCT06188637|Ozanimod|ozanimod|mesh-list
153817339|NCT06188637|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153817340|NCT06188637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817341|NCT06188637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817342|NCT06188637|Immunologic Factors|immunologic factors|mesh-ancestor
154066952|NCT00697151|Aspirin|aspirin|mesh-list
154066953|NCT00697151|Warfarin|warfarin|mesh-list
154066954|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154066955|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154066956|NCT00697151|Analgesics|analgesics|mesh-ancestor
154066957|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
154066958|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154066959|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066960|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154066961|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154066962|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154066963|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154066964|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066965|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154066966|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154066967|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066968|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
154066969|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
154066970|NCT02621957|Pravastatin|pravastatin|mesh-list
154066972|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154066973|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
154066974|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154066975|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153817343|NCT06188637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817344|NCT06188546|Propofol|propofol|mesh-list
153817345|NCT06188546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153817346|NCT06188546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817348|NCT06188546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153817349|NCT06188546|Anesthetics, General|anesthetics, general|mesh-ancestor
153575989|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153575990|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575991|NCT01710072|Analgesics|analgesics|mesh-ancestor
153575992|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
153575993|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575994|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575995|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153575996|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781621|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575997|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153575998|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153575999|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719601|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153576000|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153576001|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153576002|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576003|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
153576004|NCT01710163|Aripiprazole|aripiprazole|mesh-list
153576005|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
154066976|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154066977|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154066978|NCT00851084|Leucovorin|leucovorin|mesh-list
154066979|NCT00851084|Folic Acid|folic acid|mesh-list
154066980|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
154066981|NCT00851084|Aflibercept|aflibercept|mesh-list
154066982|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
154066983|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154066984|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154066985|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154066986|NCT00851084|Growth Substances|growth substances|mesh-ancestor
154066987|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154066988|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
154066989|NCT00851084|Antidotes|antidotes|mesh-ancestor
154066990|NCT00851084|Protective Agents|protective agents|mesh-ancestor
154066991|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
154066992|NCT00851084|Vitamins|vitamins|mesh-ancestor
154066993|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
154066994|NCT00851084|Hematinics|hematinics|mesh-ancestor
154066995|NCT02617199|Fentanyl|fentanyl|mesh-list
154066996|NCT02617199|Analgesics|analgesics|mesh-list
154066997|NCT02617199|Ropivacaine|ropivacaine|mesh-list
154066998|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
154066999|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067000|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067001|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
154067002|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
154067003|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067004|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154067005|NCT02617199|Narcotics|narcotics|mesh-ancestor
154067006|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153576006|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153576007|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153817350|NCT06188546|Anesthetics|anesthetics|mesh-ancestor
153817351|NCT06188468|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153458719|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
153458720|NCT03585738|Inositol|inositol|mesh-list
153458721|NCT03585738|Hematinics|hematinics|mesh-ancestor
153458722|NCT03585738|Vitamins|vitamins|mesh-ancestor
153458723|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
153458724|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458725|NCT03583164|Olorofim|olorofim|mesh-list
153576019|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153576020|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153576021|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153576022|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
153576023|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576024|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
153576025|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153576026|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153576027|NCT01710228|Prednisolone|prednisolone|mesh-list
154067007|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154067008|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
154067009|NCT00845858|Metoclopramide|metoclopramide|mesh-list
154067010|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
154067011|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
154067012|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067013|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067014|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067015|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154067016|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154067017|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
154067018|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067019|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067021|NCT02619149|Piperacillin|piperacillin|mesh-list
154067022|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154067023|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154067024|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067025|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154067026|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067027|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067028|NCT04134065|Vitamin D|vitamin d|mesh-list
154067029|NCT04134065|Vitamins|vitamins|mesh-ancestor
154067030|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
154067031|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067032|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154067033|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
154067034|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154067035|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154067036|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067037|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
154067038|NCT02616731|Coagulants|coagulants|mesh-ancestor
154067039|NCT00850460|Atorvastatin|atorvastatin|mesh-list
154067040|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154067041|NCT00850460|Simvastatin|simvastatin|mesh-list
154067042|NCT00850460|Pravastatin|pravastatin|mesh-list
154067043|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154067044|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153609780|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
154067046|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067047|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154067048|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154067049|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067050|NCT00661492|Cetuximab|cetuximab|mesh-list
154067051|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
154067052|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154067053|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067054|NCT00661492|Analgesics|analgesics|mesh-ancestor
154067055|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
154067056|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067057|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067058|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154067059|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154067060|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067061|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067062|NCT00693251|Sirolimus|sirolimus|mesh-list
154067063|NCT00693251|Paclitaxel|paclitaxel|mesh-list
154067064|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154067065|NCT00693251|Everolimus|everolimus|mesh-list
154067066|NCT00693251|Temsirolimus|temsirolimus|mesh-list
154067067|NCT00693251|MTOR Inhibitors|mtor inhibitors|mesh-list
154067068|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154067070|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
154067095|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067096|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154067097|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154067098|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154067099|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154067100|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067101|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067102|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154067103|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154067104|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154067105|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
154067106|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067107|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719793|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
154067108|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154067109|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154067110|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
154067111|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
154067112|NCT00814320|Antibodies|antibodies|mesh-list
154067113|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
154067114|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154067115|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154067119|NCT00869999|Rituximab|rituximab|mesh-list
154067146|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067147|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067148|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154067149|NCT00703352|Diuretics|diuretics|mesh-ancestor
154067150|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
154067151|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154067153|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154067154|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154067155|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
154067156|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067157|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067158|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067159|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154067160|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154067161|NCT00797836|Interferons|interferons|mesh-list
154067162|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067163|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
154067164|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067165|NCT00693407|Capsaicin|capsaicin|mesh-list
154067166|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
154067167|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
154067168|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
154067169|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067170|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067171|NCT02618603|Triamcinolone|triamcinolone|mesh-list
154067172|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154067173|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154067174|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
154067175|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154067176|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154067177|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154067178|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154067179|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154067185|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
154067186|NCT02618603|Hormones|hormones|mesh-ancestor
154067187|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067188|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067189|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
154067190|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067191|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154067192|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067193|NCT02616497|Aspirin|aspirin|mesh-list
154067194|NCT02616497|Triflusal|triflusal|mesh-list
154067195|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154067196|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154067197|NCT02616497|Analgesics|analgesics|mesh-ancestor
154067198|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
154067199|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067200|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067201|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067202|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067203|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154067204|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154067205|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067206|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154067207|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154067208|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067209|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
154067210|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154067213|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067232|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067233|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067234|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719839|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067235|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067236|NCT02616419|Lidocaine|lidocaine|mesh-list
154067237|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
154067238|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
154067239|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067240|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067241|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
154067242|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067243|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154067244|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154067245|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154067246|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154067247|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067248|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
154067249|NCT00798070|Fluorouracil|fluorouracil|mesh-list
154067250|NCT00798070|Docetaxel|docetaxel|mesh-list
154067251|NCT00798070|Epirubicin|epirubicin|mesh-list
154067252|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067253|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
154067254|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067255|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067256|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154067257|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
154067258|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067259|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067260|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154067261|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
154067262|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154067263|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
154067264|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
154067265|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
153576028|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
153576029|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153576030|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
153576031|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576032|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
154067267|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154067268|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154067269|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067270|NCT00809328|Azithromycin|azithromycin|mesh-list
154067271|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154067272|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067273|NCT00798148|Carboplatin|carboplatin|mesh-list
154067274|NCT00798148|Etoposide|etoposide|mesh-list
154067275|NCT00798148|Melphalan|melphalan|mesh-list
154067276|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067277|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154067278|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154067279|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154067280|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067281|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067282|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154067283|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
154067284|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154067285|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067286|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
154067287|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576033|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
153576034|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576035|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576036|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576037|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
153576038|NCT01710228|Hormones|hormones|mesh-ancestor
153576039|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153576040|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153576041|NCT01710228|Protective Agents|protective agents|mesh-ancestor
153576042|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153576043|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576044|NCT01710384|Betamethasone|betamethasone|mesh-list
153576045|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576046|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
153576047|NCT01710384|Hormones|hormones|mesh-ancestor
153576048|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817353|NCT06188468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817354|NCT06188455|Apatinib|apatinib|mesh-list
153817355|NCT06188455|Fluzoparib|fluzoparib|mesh-list
153817356|NCT06188455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817357|NCT06188455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153817358|NCT06188455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817359|NCT06188455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817360|NCT06188455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153817361|NCT06188442|Doxycycline|doxycycline|mesh-list
153817362|NCT06188442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153817363|NCT06188442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817367|NCT06188390|Hyaluronic Acid|hyaluronic acid|mesh-list
153458726|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
153458727|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067290|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
154067291|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067292|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067293|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
154067294|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154067295|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154067296|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067297|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154067298|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154067299|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154067300|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067301|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154067302|NCT00792766|Everolimus|everolimus|mesh-list
154067303|NCT00792766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154067304|NCT00792766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067305|NCT00792766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067306|NCT00792766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067307|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067308|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
154067309|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067310|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067311|NCT00798460|Lamivudine|lamivudine|mesh-list
154067312|NCT00798460|Adefovir|adefovir|mesh-list
153458730|NCT03589326|Prednisone|prednisone|mesh-list
153458731|NCT03589326|Methotrexate|methotrexate|mesh-list
153458732|NCT03589326|Vincristine|vincristine|mesh-list
153458733|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
153458734|NCT03589326|Ponatinib|ponatinib|mesh-list
153458735|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458736|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
153458737|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
153458738|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458739|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576058|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576059|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
153576060|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
153576061|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576062|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576063|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153576064|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
153576065|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576066|NCT01710488|Levofloxacin|levofloxacin|mesh-list
153576067|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
153576068|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153576069|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576070|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153781622|NCT00231218|Propolis|propolis|mesh-list
154067313|NCT00798460|Clevudine|clevudine|mesh-list
154067314|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154067316|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067317|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067318|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
154067319|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067320|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154067321|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154067322|NCT02615873|Levodopa|levodopa|mesh-list
154067323|NCT02615873|Carbidopa|carbidopa|mesh-list
154067324|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154067325|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154067326|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154067327|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
154067328|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067329|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067330|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067331|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154067332|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067333|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154067334|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
154067335|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
154067336|NCT00814164|Daunorubicin|daunorubicin|mesh-list
154067337|NCT00814164|Clofarabine|clofarabine|mesh-list
154067338|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154067339|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067340|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154067341|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154067342|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067343|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576071|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153576072|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153576073|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576074|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576075|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576076|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153576077|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153576078|NCT01710540|Metformin|metformin|mesh-list
153576079|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153576081|NCT01710553|Metformin|metformin|mesh-list
153576082|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153576083|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576084|NCT01710566|Misoprostol|misoprostol|mesh-list
153576085|NCT01710566|Oxytocin|oxytocin|mesh-list
153576086|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
154067344|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154067346|NCT02609334|Pemirolast|pemirolast|mesh-list
154067347|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
154067348|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
154067349|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067350|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067351|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067353|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154067354|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
154067355|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
154067356|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067357|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067358|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
154067359|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067360|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067361|NCT00659230|Protective Agents|protective agents|mesh-ancestor
154067362|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
154067363|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154067403|NCT00798616|Hormones|hormones|mesh-ancestor
154067404|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067405|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154067406|NCT00798616|Protective Agents|protective agents|mesh-ancestor
154067407|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154067408|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067409|NCT02618057|Levofloxacin|levofloxacin|mesh-list
154067410|NCT02618057|Prednisolone|prednisolone|mesh-list
154067411|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067412|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
154067413|NCT02618057|Hormones|hormones|mesh-ancestor
154067414|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067415|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067416|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154067417|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067418|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154067419|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067420|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154067421|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154067422|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154067423|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067427|NCT04137029|Bromides|bromides|mesh-list
154067451|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154067452|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154067453|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067454|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067455|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154067456|NCT00452413|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154067457|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067458|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067459|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067460|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067461|NCT00798772|Micronutrients|micronutrients|mesh-list
154067462|NCT00798772|Trace Elements|trace elements|mesh-list
154067463|NCT00798772|Antioxidants|antioxidants|mesh-list
154067464|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067465|NCT00798772|Protective Agents|protective agents|mesh-ancestor
154067466|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067467|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154067468|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154067469|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
154067470|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067471|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067472|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
154067473|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
154067474|NCT02615561|Vitamins|vitamins|mesh-ancestor
154067475|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
154067476|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067477|NCT00793234|Enoxaparin|enoxaparin|mesh-list
154067478|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
154067479|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154067480|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154067481|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067482|NCT00697775|Vaccines|vaccines|mesh-list
154067483|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
154067484|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067485|NCT04133051|Bupivacaine|bupivacaine|mesh-list
153576087|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154067486|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
154067487|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
154067488|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067489|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067490|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
154067491|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067492|NCT00788242|Insulin|insulin|mesh-list
154067493|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154067494|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067495|NCT02609802|Sevoflurane|sevoflurane|mesh-list
154067496|NCT02609802|Desflurane|desflurane|mesh-list
154067497|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153610224|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067498|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154067499|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
154067501|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067502|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067503|NCT02609646|Vancomycin|vancomycin|mesh-list
154067504|NCT02609646|Meropenem|meropenem|mesh-list
154067505|NCT02609646|Tazobactam|tazobactam|mesh-list
154067506|NCT02609646|Linezolid|linezolid|mesh-list
154067507|NCT02609646|Piperacillin|piperacillin|mesh-list
154067508|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154067509|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154067510|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067511|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154067512|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067513|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067514|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154067515|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
154067516|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154067517|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
154067518|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067519|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
154067520|NCT02610504|Protective Agents|protective agents|mesh-ancestor
154067528|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067529|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067530|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154067531|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067532|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067533|NCT05754762|Remifentanil|remifentanil|mesh-list
154067534|NCT05754762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154067535|NCT05754762|Narcotics|narcotics|mesh-ancestor
154067536|NCT05754762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067537|NCT05754762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067538|NCT05754762|Analgesics|analgesics|mesh-ancestor
154067539|NCT05754762|Sensory System Agents|sensory system agents|mesh-ancestor
154067540|NCT05754762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067541|NCT05326152|Immunomodulating Agents|immunomodulating agents|mesh-list
154067542|NCT05326152|Immunologic Factors|immunologic factors|mesh-ancestor
154067543|NCT05326152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067544|NCT00914004|Desipramine|desipramine|mesh-list
154067545|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154067546|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
154067547|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154067548|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067549|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067550|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154067551|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154067552|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154067553|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
154067554|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067555|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067556|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
154067557|NCT00867113|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154067558|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153576088|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576089|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153458740|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153458741|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
153576100|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
153576101|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576102|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154067560|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067562|NCT02608710|Verinurad|verinurad|mesh-list
154067563|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
154067564|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067565|NCT04030260|Antibodies|antibodies|mesh-list
154067566|NCT04030260|Immunoglobulins|immunoglobulins|mesh-list
154067567|NCT04030260|Immunologic Factors|immunologic factors|mesh-ancestor
154067568|NCT04030260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067569|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
154067570|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154067571|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153610299|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154067572|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067573|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
154067574|NCT00697385|Coagulants|coagulants|mesh-ancestor
154067575|NCT00451555|Fulvestrant|fulvestrant|mesh-list
154067576|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154067577|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067578|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154067579|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154067580|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
154067581|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067582|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067583|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
154067584|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154067585|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
154067586|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154067587|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067588|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
154067589|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
154067590|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
154067591|NCT00694187|Zaleplon|zaleplon|mesh-list
154067592|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
154067593|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153576103|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
153576104|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154067594|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067595|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067596|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
154067597|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
154067598|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067599|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067600|NCT02617121|Gabapentin|gabapentin|mesh-list
154067601|NCT02617121|Ramosetron|ramosetron|mesh-list
154067602|NCT02617121|Analgesics|analgesics|mesh-ancestor
154067603|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
154067604|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067605|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067606|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
154067607|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154067608|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154067609|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067610|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154067611|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154067612|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154067613|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067614|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067615|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
154067617|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
154067618|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067619|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154067620|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
154067621|NCT02609490|Olmesartan|olmesartan|mesh-list
154067622|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154067623|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154067624|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154067625|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154067626|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154067628|NCT02610348|Vaccines|vaccines|mesh-list
154067637|NCT05757336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154067638|NCT05757336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154067639|NCT05757336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154067640|NCT05757336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067641|NCT05757336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154067642|NCT05757336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154067643|NCT05757336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154067644|NCT05757336|Growth Substances|growth substances|mesh-ancestor
154067645|NCT05757336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067646|NCT05757336|Growth Inhibitors|growth inhibitors|mesh-ancestor
154067647|NCT05757336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154067648|NCT05757336|Antimetabolites|antimetabolites|mesh-ancestor
154067649|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154067651|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154067652|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154067653|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154067654|NCT00871871|Diuretics|diuretics|mesh-ancestor
154067655|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
154067656|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067657|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154067658|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576105|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153576106|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153576107|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576108|NCT01710631|Eszopiclone|eszopiclone|mesh-list
153576109|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153576110|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576111|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576112|NCT01710670|Ethanol|ethanol|mesh-list
153576113|NCT01710670|Brivaracetam|brivaracetam|mesh-list
153576114|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153576115|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576116|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576117|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576118|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
153576119|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153576120|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153576121|NCT01710696|Estradiol|estradiol|mesh-list
153576122|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153576134|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153576135|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576136|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153576137|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576138|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576139|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154067659|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067660|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154067661|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
154067662|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154067663|NCT02608788|Ketorolac|ketorolac|mesh-list
154067664|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154067665|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154067666|NCT02608788|Analgesics|analgesics|mesh-ancestor
154067667|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
154067668|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067669|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067670|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067671|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067672|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154067673|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067674|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067675|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
154067676|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154067677|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
154067678|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154067679|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067680|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153576140|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153576141|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
153576142|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576143|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
153576144|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
153576145|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576146|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153781623|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576147|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
153576148|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153576149|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153576150|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
153576151|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
153576153|NCT01710748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153576154|NCT01710748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153576155|NCT01710748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576156|NCT01710748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576157|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153576158|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
153576159|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576160|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576161|NCT01710826|Venglustat|venglustat|mesh-list
153576162|NCT01710826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576163|NCT01710826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576164|NCT01710904|Oxycodone|oxycodone|mesh-list
153576165|NCT01710904|Naloxone|naloxone|mesh-list
153576166|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153576168|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576177|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067681|NCT00849680|Vaccines|vaccines|mesh-list
154067682|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
154067683|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067684|NCT00866723|Bevacizumab|bevacizumab|mesh-list
154067685|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154067686|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067687|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154067688|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154067689|NCT00866723|Growth Substances|growth substances|mesh-ancestor
154067690|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067691|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
154067692|NCT02613455|Triamcinolone|triamcinolone|mesh-list
154067693|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154067694|NCT02613455|Lidocaine|lidocaine|mesh-list
154067695|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
154067696|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
154067697|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067698|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067699|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
153720064|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067700|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067701|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154067702|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154067703|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154067704|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154067705|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067706|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067707|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
154067708|NCT02613455|Hormones|hormones|mesh-ancestor
154067709|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067710|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067711|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
154067712|NCT00703586|Maraviroc|maraviroc|mesh-list
153576178|NCT01711060|Oxytocin|oxytocin|mesh-list
153576179|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
153576180|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576181|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576182|NCT01711073|Plerixafor|plerixafor|mesh-list
153576183|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153576184|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153576185|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
153576186|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576187|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
153576188|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153576189|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
154067713|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154067714|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154067715|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067716|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154067717|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154067718|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
154067719|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067720|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154067721|NCT04130399|Folfirinox|folfirinox|mesh-list
154067722|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067723|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
154067724|NCT00849056|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154067725|NCT00849056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154067726|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067727|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154067728|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
154067729|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154067730|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154067731|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154067732|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067733|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067734|NCT00706862|Lactoferrin|lactoferrin|mesh-list
154067735|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
154067736|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067737|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067738|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154067739|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154067740|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154067741|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
154067742|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067743|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154067744|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153576190|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576191|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576192|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153576193|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
153576194|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153576195|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153576196|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153576197|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
153576198|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067747|NCT00837434|Etanercept|etanercept|mesh-list
154067748|NCT00837434|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154067749|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067750|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067751|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154067752|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154067753|NCT00837434|Analgesics|analgesics|mesh-ancestor
154067754|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
154067755|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067756|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067757|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067758|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067759|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
154067760|NCT00703742|Escitalopram|escitalopram|mesh-list
154067761|NCT00703742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154067762|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154067763|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576199|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576201|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576202|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
153576203|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
153576204|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
153576205|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576206|NCT01711125|Baclofen|baclofen|mesh-list
153576207|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153576208|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576209|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153576210|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576211|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153576212|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
153576213|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
153576214|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576215|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576216|NCT01711229|Acetaminophen|acetaminophen|mesh-list
153576217|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153576218|NCT01711229|Analgesics|analgesics|mesh-ancestor
153817379|NCT06188221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817381|NCT06188221|Sensory System Agents|sensory system agents|mesh-ancestor
153576219|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
153576220|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576221|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576224|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153576225|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576226|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153576227|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576228|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576229|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
153576230|NCT01711437|Simethicone|simethicone|mesh-list
153576231|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
154067765|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154067766|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
154067767|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067768|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154067770|NCT00702182|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154067771|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067772|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067773|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067774|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067775|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154067776|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
154067777|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
154067778|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
154067780|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154067781|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
154067782|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067783|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067784|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154067785|NCT00702416|Acetaminophen|acetaminophen|mesh-list
154067786|NCT00702416|Fentanyl|fentanyl|mesh-list
154067787|NCT00702416|Morphine|morphine|mesh-list
154067788|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
153576232|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
153576233|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153576234|NCT01711437|Citric Acid|citric acid|mesh-list
153576235|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
153576236|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153576237|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
153576238|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153576239|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
153576240|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
153817382|NCT06188221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458743|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153458744|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153458745|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458746|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153458747|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
153458748|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153458749|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153458750|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
153458751|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458752|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
153458753|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458754|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153458755|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067789|NCT00702416|Narcotics|narcotics|mesh-list
154067790|NCT00702416|Analgesics|analgesics|mesh-list
154067791|NCT00702416|Anesthetics|anesthetics|mesh-list
154067792|NCT00702416|Ropivacaine|ropivacaine|mesh-list
154067793|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
154067794|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610529|NCT01947660|Anesthetics|anesthetics|mesh-list
154067795|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067796|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
154067797|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067798|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154067799|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154067800|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
154067801|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154067802|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
154067803|NCT00827918|Olanzapine|olanzapine|mesh-list
154067804|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
154067805|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
154067806|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067807|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067808|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067809|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154067810|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153720202|NCT00435448|Lonidamine|lonidamine|mesh-list
154067811|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067818|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
154067840|NCT00807846|Celecoxib|celecoxib|mesh-list
154067841|NCT00807846|Naproxen|naproxen|mesh-list
154067842|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154067843|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154067844|NCT00807846|Analgesics|analgesics|mesh-ancestor
154067845|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
154067846|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067847|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067848|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067849|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067850|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154067851|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154067852|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067853|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067854|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
154067855|NCT00810108|Ritonavir|ritonavir|mesh-list
154067856|NCT00810108|Lopinavir|lopinavir|mesh-list
154067857|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154067858|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154067859|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
154067860|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067861|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067862|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154067863|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154067891|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
154067892|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154067893|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067894|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067895|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154067896|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154067897|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067898|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
154067899|NCT05599880|Bortezomib|bortezomib|mesh-list
154067900|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067901|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154067902|NCT00707252|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154067903|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067904|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067905|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067906|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067907|NCT00826748|Beclomethasone|beclomethasone|mesh-list
154067908|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067909|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
154067910|NCT00826748|Hormones|hormones|mesh-ancestor
154067911|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154067912|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067913|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154067914|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
154067915|NCT00922844|Sevoflurane|sevoflurane|mesh-list
154067916|NCT00922844|Isoflurane|isoflurane|mesh-list
154067917|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154067918|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153458756|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
153576241|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576253|NCT01711437|Laxatives|laxatives|mesh-ancestor
153576254|NCT01711463|Fluticasone|fluticasone|mesh-list
153576256|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576257|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153576258|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
153576259|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576260|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576261|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153576262|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
153576263|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
153576264|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153576265|NCT01711476|Complement Factor H|complement factor h|mesh-list
153576266|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154067919|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
154067921|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154067922|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067923|NCT00707330|Clarithromycin|clarithromycin|mesh-list
154067924|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154067925|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067926|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154067927|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067928|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067929|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154067930|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154067931|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
154067932|NCT00707408|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154067933|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154067934|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067935|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067936|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067937|NCT00788320|Vitamin D|vitamin d|mesh-list
154067938|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
154067939|NCT00788320|Vitamins|vitamins|mesh-ancestor
154067940|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
154067941|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067942|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154067943|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154067944|NCT00807144|Tacrolimus|tacrolimus|mesh-list
153576267|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153576268|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
153576269|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576270|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
153576271|NCT01711489|Isavuconazole|isavuconazole|mesh-list
153576272|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153576273|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576274|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153576275|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
153576276|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153576277|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576278|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576279|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576280|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
153576281|NCT01711515|Cisplatin|cisplatin|mesh-list
153576282|NCT01711515|Ipilimumab|ipilimumab|mesh-list
153576283|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576284|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153576285|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153576286|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576287|NCT01711528|Dexamethasone|dexamethasone|mesh-list
154067945|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067946|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
154067947|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067948|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154067949|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067950|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067951|NCT00799240|Cisplatin|cisplatin|mesh-list
154067952|NCT00799240|Pemetrexed|pemetrexed|mesh-list
154067953|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154067954|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067955|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154067956|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067957|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154067958|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154067959|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
154067960|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067961|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
154067962|NCT00591006|Phenytoin|phenytoin|mesh-list
154067963|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154067964|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
154067965|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154067966|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154067967|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154067968|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067969|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154067970|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154067971|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154067972|NCT00844844|Eculizumab|eculizumab|mesh-list
154067973|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154067974|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154067975|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
153576288|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
153817390|NCT06188208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817391|NCT06188208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153817392|NCT06188208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817393|NCT06188195|Dexamethasone|dexamethasone|mesh-list
153817395|NCT06188195|Antiemetics|antiemetics|mesh-ancestor
153817396|NCT06188195|Autonomic Agents|autonomic agents|mesh-ancestor
153458758|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153458759|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
153458760|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154067976|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067977|NCT05748054|Fluorides|fluorides|mesh-list
154067978|NCT05748054|Cariostatic Agents|cariostatic agents|mesh-ancestor
154067979|NCT05748054|Protective Agents|protective agents|mesh-ancestor
154067980|NCT05748054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067981|NCT00702572|Paclitaxel|paclitaxel|mesh-list
154067982|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154067983|NCT00702572|Bevacizumab|bevacizumab|mesh-list
154067984|NCT00702572|Carboplatin|carboplatin|mesh-list
154067985|NCT00702572|Vorinostat|vorinostat|mesh-list
154067986|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154067987|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154067988|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
154067989|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
154067990|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
154067991|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154067992|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154067993|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154067994|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154067995|NCT00702572|Growth Substances|growth substances|mesh-ancestor
154067996|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154067997|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
154067998|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154067999|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068000|NCT00793468|Nicotine|nicotine|mesh-list
154068001|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154068002|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
154068003|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068004|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068005|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154068006|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154068007|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
154068008|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068009|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068010|NCT00836810|Prednisone|prednisone|mesh-list
154068011|NCT00836810|Prednisolone|prednisolone|mesh-list
153458761|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153458762|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
153458763|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
154068014|NCT00836810|Hormones|hormones|mesh-ancestor
154068015|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154068016|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068017|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154068018|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610758|NCT01949038|Alprazolam|alprazolam|mesh-list
154068019|NCT00658684|Fesoterodine|fesoterodine|mesh-list
154068020|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154068021|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154068022|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
154068023|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068024|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068025|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068026|NCT00658684|Urological Agents|urological agents|mesh-ancestor
154068027|NCT00660400|Azacitidine|azacitidine|mesh-list
154068028|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154068029|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
154068030|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068033|NCT00826514|Tanezumab|tanezumab|mesh-list
154068064|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068065|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154068066|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154068067|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
154068068|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068069|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154068070|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154068071|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
154068072|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154068073|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154068074|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154068075|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
154068076|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068077|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154068078|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154068079|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068080|NCT00703898|Nevirapine|nevirapine|mesh-list
154068081|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154068082|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154068083|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068084|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068085|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
154068086|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068087|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154068088|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154068089|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154068090|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154068091|NCT00801034|Calcium|calcium|mesh-list
153610828|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154068092|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154068093|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458764|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
153458765|NCT03589326|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153458766|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153458767|NCT03585426|Vancomycin|vancomycin|mesh-list
153458768|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153458769|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068094|NCT04130477|Nickel|nickel|mesh-list
154068095|NCT04130477|Trace Elements|trace elements|mesh-ancestor
154068096|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
154068097|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068098|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
154068099|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154068100|NCT00702728|Furosemide|furosemide|mesh-list
154068101|NCT00702728|Diuretics|diuretics|mesh-ancestor
154068102|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
154068103|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068104|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154068105|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068106|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068107|NCT04132115|Vancomycin|vancomycin|mesh-list
154068108|NCT04132115|Gentamicins|gentamicins|mesh-list
154068109|NCT04132115|Meropenem|meropenem|mesh-list
154068110|NCT04132115|Tazobactam|tazobactam|mesh-list
154068111|NCT04132115|Linezolid|linezolid|mesh-list
154068112|NCT04132115|Piperacillin|piperacillin|mesh-list
154068113|NCT04132115|Daptomycin|daptomycin|mesh-list
154068114|NCT04132115|Amikacin|amikacin|mesh-list
154068115|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154068116|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
154068117|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154068118|NCT04132115|Acyclovir|acyclovir|mesh-list
154068119|NCT04132115|Ganciclovir|ganciclovir|mesh-list
154068120|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068121|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068122|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154068123|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068124|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068125|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154068126|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
154068127|NCT00801268|Emodin|emodin|mesh-list
154068128|NCT00801268|Cathartics|cathartics|mesh-ancestor
154068129|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068139|NCT02614937|Growth Substances|growth substances|mesh-ancestor
154068140|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068141|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
154068142|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068143|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068144|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068145|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154068146|NCT02614937|Protective Agents|protective agents|mesh-ancestor
154068148|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
154068149|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068150|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
154068151|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154068152|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068153|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068154|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154068155|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154068156|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068157|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068158|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068159|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154068160|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
154068161|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154068162|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068163|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154068186|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
154068187|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068188|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068189|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154068190|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
154068191|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068193|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154068194|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154068195|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068196|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154068197|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154068198|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068199|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068200|NCT00805194|Docetaxel|docetaxel|mesh-list
154068201|NCT00805194|Nintedanib|nintedanib|mesh-list
154068202|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068203|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
154068204|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
154068205|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
154068206|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068207|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154068208|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068209|NCT00657046|Droxidopa|droxidopa|mesh-list
154068210|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154068211|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153458770|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153458771|NCT03585036|Tramadol|tramadol|mesh-list
153458772|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153576289|NCT01711528|Bortezomib|bortezomib|mesh-list
153576290|NCT01711528|Ichthammol|ichthammol|mesh-list
153576291|NCT01711528|BB 1101|bb 1101|mesh-list
153576292|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576293|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
153576294|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
153576295|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576296|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576297|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576298|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
153576299|NCT01711528|Hormones|hormones|mesh-ancestor
153576300|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153576301|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153576302|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576303|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
153576304|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068212|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154068213|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
154068214|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068215|NCT00801736|Paclitaxel|paclitaxel|mesh-list
154068216|NCT00801736|Cisplatin|cisplatin|mesh-list
154068217|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154068218|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068219|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
154068220|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
154068221|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
154068222|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068223|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
154068224|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154068225|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154068226|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068227|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
154068228|NCT02606994|Lidocaine|lidocaine|mesh-list
154068229|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
154068230|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
154068231|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068232|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068233|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
154068234|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068235|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154068236|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154068237|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154068238|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068239|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068240|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154068241|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154068243|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
154068244|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068245|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154068246|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
154068253|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
154068254|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068255|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154068256|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154068257|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068258|NCT04046302|Dinoprostone|dinoprostone|mesh-list
154068259|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
154068260|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154068261|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068262|NCT00914394|Phenylephrine|phenylephrine|mesh-list
154068263|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
154068264|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154068265|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154068266|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
154068267|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
154068268|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068269|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068270|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
154068271|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154068272|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
154068273|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
154068274|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154068275|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154068276|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154068278|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576305|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576306|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
153576307|NCT01711567|Tenofovir|tenofovir|mesh-list
153576308|NCT01711567|Entecavir|entecavir|mesh-list
153576309|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
153576310|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576311|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153576312|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153576322|NCT01711671|Lenalidomide|lenalidomide|mesh-list
153576323|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576324|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
153576325|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
153576326|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576327|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576328|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576329|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
153576330|NCT01711671|Hormones|hormones|mesh-ancestor
153817706|NCT06140966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068280|NCT00914394|Protective Agents|protective agents|mesh-ancestor
154068281|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068283|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
154068284|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
154068285|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068286|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068287|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068288|NCT00658606|Alefacept|alefacept|mesh-list
154068289|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
154068290|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
154068291|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068292|NCT00795106|Capsaicin|capsaicin|mesh-list
154068293|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
154068294|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
154068295|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
154068296|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068297|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068298|NCT00589290|Belinostat|belinostat|mesh-list
154068299|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576331|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153576332|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153576333|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817397|NCT06188195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817398|NCT06188195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817399|NCT06188195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817400|NCT06188195|Glucocorticoids|glucocorticoids|mesh-ancestor
153817401|NCT06188195|Hormones|hormones|mesh-ancestor
153817402|NCT06188195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817403|NCT06188195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817404|NCT06188195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817405|NCT06188143|Acetaminophen|acetaminophen|mesh-list
153817406|NCT06188143|Ibuprofen|ibuprofen|mesh-list
153817407|NCT06188143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153817408|NCT06188143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817409|NCT06188143|Analgesics|analgesics|mesh-ancestor
153817410|NCT06188143|Sensory System Agents|sensory system agents|mesh-ancestor
153576334|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
153576335|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153576336|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153576337|NCT01711671|Growth Substances|growth substances|mesh-ancestor
153576338|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
153576339|NCT01711697|Paclitaxel|paclitaxel|mesh-list
153576340|NCT01711697|Carboplatin|carboplatin|mesh-list
153576341|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153576342|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576343|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
153576344|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
153576345|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
153576346|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576347|NCT01711723|Darapladib|darapladib|mesh-list
154068300|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154068301|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068302|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068303|NCT00802048|Ropivacaine|ropivacaine|mesh-list
154068304|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
154068305|NCT00802048|Anesthetics|anesthetics|mesh-list
154068306|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068307|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068308|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
154068309|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068310|NCT00809536|Metformin|metformin|mesh-list
154068311|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154068312|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068313|NCT00809692|Histamine|histamine|mesh-list
154068314|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
153611053|NCT01951053|Citalopram|citalopram|mesh-list
154068315|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
154068316|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
154068317|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068318|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068319|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068320|NCT00843284|Pregabalin|pregabalin|mesh-list
154068321|NCT00843284|Analgesics|analgesics|mesh-ancestor
154068322|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
154068323|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068324|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068325|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
154068326|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154068327|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068328|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068329|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154068330|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154068331|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153576355|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153576356|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153817411|NCT06188143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817412|NCT06188143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817413|NCT06188143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817414|NCT06188143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153817415|NCT06188143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154068332|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068334|NCT00802282|Psilocybin|psilocybin|mesh-list
154068335|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
154068336|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068337|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154068338|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
154068339|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154068340|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068341|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154068342|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
154068343|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068344|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068345|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068346|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068347|NCT00825812|Atropine|atropine|mesh-list
154068348|NCT00825812|Neostigmine|neostigmine|mesh-list
154068349|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154068350|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154068351|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154068352|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
154068353|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068354|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068355|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154068356|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
154068357|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
154068358|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
154068359|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154068360|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153817416|NCT06188143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817417|NCT06188143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817418|NCT06188143|Antipyretics|antipyretics|mesh-ancestor
153576357|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
153576358|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576359|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153576360|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153576361|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576362|NCT01711814|Peficitinib|peficitinib|mesh-list
153576363|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576364|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576365|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153576366|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
153576367|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576368|NCT01711827|Isavuconazole|isavuconazole|mesh-list
153576370|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154068363|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068364|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154068365|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068366|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154068367|NCT00802594|Pafuramidine|pafuramidine|mesh-list
154068368|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154068369|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154068370|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154068371|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068372|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
154068373|NCT00707876|Hematinics|hematinics|mesh-ancestor
154068374|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154068375|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154068376|NCT00802828|Famotidine|famotidine|mesh-list
154068377|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154068378|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068379|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154068380|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
154068381|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
154068382|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068383|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068384|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068385|NCT00802906|Bevacizumab|bevacizumab|mesh-list
154068386|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154068387|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068388|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154068389|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154068390|NCT00802906|Growth Substances|growth substances|mesh-ancestor
154068391|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068392|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
154068393|NCT00803218|Fluticasone|fluticasone|mesh-list
154068394|NCT00803218|Xhance|xhance|mesh-list
154068395|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576371|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
153576372|NCT01711827|Hormones|hormones|mesh-ancestor
153576373|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154068397|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
154068398|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068399|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068400|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154068401|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
154068402|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
154068403|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154068404|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
154068405|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154068406|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154068407|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068408|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
154068409|NCT00824564|Coagulants|coagulants|mesh-ancestor
154068410|NCT00803374|Ipilimumab|ipilimumab|mesh-list
154068411|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154068412|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154068413|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068414|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154068415|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068416|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
154068417|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068418|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
154068419|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
153576374|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576375|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153576376|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576377|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
153576378|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576379|NCT01711905|Vitamin D|vitamin d|mesh-list
153576380|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
153576381|NCT01711905|Vitamins|vitamins|mesh-ancestor
153576382|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
153576383|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817419|NCT06188104|Acetic Acid|acetic acid|mesh-list
153817420|NCT06188104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153817421|NCT06188104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817422|NCT06188052|Tranexamic Acid|tranexamic acid|mesh-list
153817423|NCT06188052|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153817424|NCT06188052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153817425|NCT06188052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458799|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458800|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153458801|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153576384|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153576385|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153576387|NCT01711931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153720609|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153576388|NCT01711931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153576389|NCT01711931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817707|NCT06140966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068421|NCT00803530|Protective Agents|protective agents|mesh-ancestor
154068422|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068424|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
154068425|NCT00803764|Naproxen|naproxen|mesh-list
154068426|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154068427|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154068428|NCT00803764|Analgesics|analgesics|mesh-ancestor
154068429|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
154068430|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068431|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068432|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154068433|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068434|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
154068435|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154068436|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068437|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068438|NCT00704366|Saracatinib|saracatinib|mesh-list
154068439|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068440|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576390|NCT01711931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576391|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153576392|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
153576393|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576394|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576395|NCT01711957|Liver Extracts|liver extracts|mesh-list
153576396|NCT01711957|Hematinics|hematinics|mesh-ancestor
153576397|NCT01711970|Paclitaxel|paclitaxel|mesh-list
153576398|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153576399|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576400|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
153576401|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
153576402|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
153576403|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576404|NCT01712100|Irbesartan|irbesartan|mesh-list
153576405|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576406|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153458802|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153458803|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
153576407|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153576408|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576410|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576411|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153576412|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153576413|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576414|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153576415|NCT01712126|Irbesartan|irbesartan|mesh-list
153576416|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154068441|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068442|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154068443|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154068444|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154068445|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154068446|NCT00803842|Doxycycline|doxycycline|mesh-list
154068447|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068448|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068449|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
154068450|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154068451|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154068452|NCT00658528|Esomeprazole|esomeprazole|mesh-list
154068453|NCT00658528|Rabeprazole|rabeprazole|mesh-list
154068454|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154068455|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068456|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154068457|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068458|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068459|NCT00856583|Risperidone|risperidone|mesh-list
154068461|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154068462|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
153611199|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068463|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068464|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068465|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068466|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154068467|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154068468|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068469|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154068470|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153576417|NCT01712126|Diuretics|diuretics|mesh-ancestor
153576418|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
153576419|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576420|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153817430|NCT06187987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153817431|NCT06187987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817432|NCT06187961|Lenvatinib|lenvatinib|mesh-list
153576431|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153576432|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576433|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576434|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153576435|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153576437|NCT01712295|Salicylates|salicylates|mesh-list
154068471|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
154068472|NCT00803244|Immunomodulating Agents|immunomodulating agents|mesh-list
154068473|NCT00803244|Immunologic Factors|immunologic factors|mesh-ancestor
154068474|NCT00803244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068475|NCT05753280|Vitamin D|vitamin d|mesh-list
154068476|NCT05753280|Vitamins|vitamins|mesh-ancestor
154068477|NCT05753280|Micronutrients|micronutrients|mesh-ancestor
154068478|NCT05753280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068479|NCT05753280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154068480|NCT00824408|Pemetrexed|pemetrexed|mesh-list
154068481|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068482|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068483|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068484|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154068485|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154068486|NCT02611700|Paclitaxel|paclitaxel|mesh-list
154068487|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154068488|NCT02611700|Cisplatin|cisplatin|mesh-list
154068489|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
154068490|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154068491|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068492|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
154068493|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
154068494|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
154068495|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068496|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154068497|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154068498|NCT00708344|Irbesartan|irbesartan|mesh-list
154068499|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576438|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153576439|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153576440|NCT01712295|Analgesics|analgesics|mesh-ancestor
153576441|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
153576442|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576443|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576444|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576445|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153576446|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153576447|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576448|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781624|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
153576449|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576450|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
153576451|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
153576452|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
153576453|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153782579|NCT04556071|Bevacizumab|bevacizumab|mesh-list
154068501|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
154068502|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068503|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154068504|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068505|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068506|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154068507|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154068508|NCT00866333|Entinostat|entinostat|mesh-list
154068509|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068510|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154068511|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068512|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068513|NCT00834080|Naltrexone|naltrexone|mesh-list
154068514|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154068515|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154068516|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068517|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
154068518|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068519|NCT00823472|Ganirelix|ganirelix|mesh-list
154068520|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
154068521|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154068522|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068523|NCT04118699|Rifaximin|rifaximin|mesh-list
154068524|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068525|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576454|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
153576455|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153576456|NCT01712321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153576457|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153626785|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153817433|NCT06187961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817434|NCT06187961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153817435|NCT06187961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817436|NCT06187961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817437|NCT06187922|Pregabalin|pregabalin|mesh-list
153817438|NCT06187922|Analgesics|analgesics|mesh-ancestor
153817439|NCT06187922|Sensory System Agents|sensory system agents|mesh-ancestor
153817440|NCT06187922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576462|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576463|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153576464|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153576466|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154068526|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068527|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
154068528|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154068529|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154068530|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154068531|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
154068532|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068533|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068534|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068535|NCT04130087|Selegiline|selegiline|mesh-list
154068536|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
154068537|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154068538|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154068539|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154068540|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153611272|NCT01952652|Naproxen|naproxen|mesh-list
154068541|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068542|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068543|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154068544|NCT04130087|Protective Agents|protective agents|mesh-ancestor
154068545|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068546|NCT00652366|Gemcitabine|gemcitabine|mesh-list
154068547|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154068548|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154068549|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
154068550|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068551|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068552|NCT00652366|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154068553|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154068554|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068555|NCT00841568|Tolvaptan|tolvaptan|mesh-list
154068556|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154068557|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068558|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
154068559|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068562|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154068563|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
154068564|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068565|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068566|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154068567|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
154068568|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
154068569|NCT00855959|Hormones|hormones|mesh-ancestor
154068570|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154068571|NCT00704600|Nelfinavir|nelfinavir|mesh-list
154068572|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154068573|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154068574|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
154068575|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068576|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068577|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154068578|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154068579|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
154068580|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068581|NCT00699881|Cetuximab|cetuximab|mesh-list
154068582|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154068583|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068584|NCT00708578|Metformin|metformin|mesh-list
154068585|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
153576467|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576468|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153576469|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153576470|NCT01712347|Growth Substances|growth substances|mesh-ancestor
153576471|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576472|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
153576473|NCT01712464|Oxytocin|oxytocin|mesh-list
153576474|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
153576475|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576476|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576477|NCT01712477|Midazolam|midazolam|mesh-list
153576478|NCT01712477|Propofol|propofol|mesh-list
153576479|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153576480|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576481|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576482|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153576483|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
153576484|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
153576485|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153576486|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153576487|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153576488|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153576504|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153576505|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153576506|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
153576507|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
153576508|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576509|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068587|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154068588|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068589|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154068590|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154068591|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
154068592|NCT00704678|Sevelamer|sevelamer|mesh-list
154068593|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
154068594|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
154068595|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068596|NCT00708656|Mesalamine|mesalamine|mesh-list
154068597|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154068598|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154068599|NCT00708656|Analgesics|analgesics|mesh-ancestor
154068600|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
154068601|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068602|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068603|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154068604|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068605|NCT00913328|Montelukast|montelukast|mesh-list
154068606|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154068607|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
154068608|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154068609|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
154068610|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154068611|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611347|NCT05876169|Keratolytic Agents|keratolytic agents|mesh-ancestor
154068612|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154068613|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154068614|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068615|NCT00804310|Lapatinib|lapatinib|mesh-list
154068616|NCT00804310|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153576510|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576511|NCT01712646|Oxytocin|oxytocin|mesh-list
153576512|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
153576513|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576514|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576515|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
153576516|NCT01712828|Promethazine|promethazine|mesh-list
153576517|NCT01712828|Sirolimus|sirolimus|mesh-list
154068617|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154068618|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068619|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068620|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068621|NCT04118777|Ropivacaine|ropivacaine|mesh-list
154068622|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
154068623|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
154068624|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068625|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068626|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
154068627|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068628|NCT00708812|Paclitaxel|paclitaxel|mesh-list
154068629|NCT00708812|Carboplatin|carboplatin|mesh-list
154068630|NCT00708812|Endostar protein|endostar protein|mesh-list
154068631|NCT00708812|Endostatins|endostatins|mesh-list
154068632|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154068633|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068634|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154068635|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
154068636|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
154068637|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068638|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154068639|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154068640|NCT00708812|Growth Substances|growth substances|mesh-ancestor
154068641|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068642|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
154068643|NCT04127747|Rituximab|rituximab|mesh-list
154068644|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154068645|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068647|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068648|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068649|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
153576518|NCT01712828|Quinidine|quinidine|mesh-list
154068660|NCT00822770|Plerixafor|plerixafor|mesh-list
154068661|NCT00822770|Fludarabine|fludarabine|mesh-list
154068662|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
154068663|NCT00822770|Busulfan|busulfan|mesh-list
154068664|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
154068665|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154068666|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068667|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154068668|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
154068669|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068670|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154068671|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
154068672|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068673|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
154068674|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068675|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
154068676|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154068677|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154068678|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154068679|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154068680|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154068681|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154068682|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068683|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068684|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
154068685|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154068686|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154068687|NCT02607111|Dalteparin|dalteparin|mesh-list
153611420|NCT05875285|Keratolytic Agents|keratolytic agents|mesh-ancestor
154068688|NCT02607111|Tinzaparin|tinzaparin|mesh-list
154068689|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154068690|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
154068691|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154068692|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154068693|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068694|NCT00703196|Folic Acid|folic acid|mesh-list
154068696|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
154068697|NCT00703196|Vitamins|vitamins|mesh-ancestor
154068698|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
154068699|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068700|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
154068701|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154068702|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
154068703|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068704|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068705|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
154068706|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068707|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
154068708|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
154068709|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154068710|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154068711|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068712|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068713|NCT00914277|Urological Agents|urological agents|mesh-ancestor
154068714|NCT00704756|Ribavirin|ribavirin|mesh-list
154068715|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154068716|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
154068717|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
154068718|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068719|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
154068720|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068721|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
154068722|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068744|NCT02607696|Zolpidem|zolpidem|mesh-list
154068745|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154068746|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154068747|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068748|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068749|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154068750|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
154068751|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
154068752|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068753|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068754|NCT00839852|Cariprazine|cariprazine|mesh-list
154068755|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154068756|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154068757|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068758|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068759|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154068760|NCT02604849|Gentamicins|gentamicins|mesh-list
154068761|NCT02604849|Neomycin|neomycin|mesh-list
154068762|NCT02604849|Streptomycin|streptomycin|mesh-list
154068763|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154068764|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154068765|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154068766|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068767|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068768|NCT00709046|Pantoprazole|pantoprazole|mesh-list
154068769|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154068770|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068771|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154068772|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068773|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068774|NCT00820898|Gemcitabine|gemcitabine|mesh-list
154068775|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154068776|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
154068786|NCT00865709|Protective Agents|protective agents|mesh-ancestor
154068787|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068788|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
154068789|NCT00865709|Vitamins|vitamins|mesh-ancestor
154068790|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
154068791|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
154068792|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068793|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154068794|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154068795|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
154068796|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154068797|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068799|NCT00839306|Ranitidine|ranitidine|mesh-list
154068800|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154068801|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154068802|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068803|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154068804|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068805|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068806|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154068807|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
154068808|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
154068809|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068810|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068811|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154068812|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154068813|NCT00839072|Trazodone|trazodone|mesh-list
154068814|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154068815|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154068816|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068817|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068830|NCT00704990|Pyridoxal|pyridoxal|mesh-list
154068831|NCT00704990|Pyridoxine|pyridoxine|mesh-list
154068832|NCT00704990|Zinc|zinc|mesh-list
154068833|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
154068834|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
153611573|NCT05790161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068835|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068836|NCT00704990|Trace Elements|trace elements|mesh-ancestor
154068837|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
154068838|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068839|NCT00704990|Protective Agents|protective agents|mesh-ancestor
154068840|NCT02607774|Midazolam|midazolam|mesh-list
154068841|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154068842|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154068843|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154068844|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068845|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154068846|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154068847|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154068848|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154068849|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
154068850|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
154068851|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
154068852|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
154068853|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068854|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068855|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
154068856|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
154068857|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154068858|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068859|NCT00838916|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154068877|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
154068878|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068879|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154068880|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154068881|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154068882|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
154068883|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154068884|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
154068885|NCT00803634|Diltiazem|diltiazem|mesh-list
154068886|NCT00803634|Nitroprusside|nitroprusside|mesh-list
154068887|NCT00803634|Nicardipine|nicardipine|mesh-list
154068888|NCT00803634|Clevidipine|clevidipine|mesh-list
154068889|NCT00803634|Isosorbide|isosorbide|mesh-list
154068890|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154068891|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
154068892|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
154068893|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154068894|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154068895|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068896|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154068897|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068898|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154068899|NCT00803634|Diuretics|diuretics|mesh-ancestor
154068900|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
154068901|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154068902|NCT00838526|Rabeprazole|rabeprazole|mesh-list
154068903|NCT00838526|Ranitidine|ranitidine|mesh-list
154068904|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154068905|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154068906|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068907|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154068908|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576519|NCT01712828|Lenalidomide|lenalidomide|mesh-list
153576520|NCT01712828|Temsirolimus|temsirolimus|mesh-list
153576521|NCT01712828|MTOR Inhibitors|mtor inhibitors|mesh-list
153458808|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
153458809|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
153458810|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
153458811|NCT03584178|Budesonide|budesonide|mesh-list
153458812|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458813|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154068909|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068910|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154068911|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
154068912|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
154068913|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068914|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068915|NCT00914472|Heparin|heparin|mesh-list
154068916|NCT00914472|Calcium heparin|calcium heparin|mesh-list
154068917|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
154068918|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154068919|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154068920|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068921|NCT02611466|Naproxen|naproxen|mesh-list
154068922|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154068923|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154068924|NCT02611466|Analgesics|analgesics|mesh-ancestor
154068925|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
154068926|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154068927|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068928|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154068929|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068930|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
154068931|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154068932|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068933|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068934|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
154068935|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
154068937|NCT02610920|Trace Elements|trace elements|mesh-ancestor
154068938|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
154068939|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458814|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
153458815|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458816|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458817|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153458818|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
153458819|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
153458820|NCT03584178|Hormones|hormones|mesh-ancestor
153458821|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153576531|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576532|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153576533|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153576534|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576535|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154068940|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154068941|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154068942|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154068943|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
154068944|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068945|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154068946|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154068947|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154068948|NCT00818168|Infliximab|infliximab|mesh-list
154068949|NCT00818168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154068950|NCT00818168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154068951|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
154068952|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154068953|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154068954|NCT02607540|Cisplatin|cisplatin|mesh-list
154068955|NCT02607540|Fluorouracil|fluorouracil|mesh-list
154068956|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154068957|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
154068958|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068959|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154068960|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154068961|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
154068962|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068963|NCT00705692|Levamisole|levamisole|mesh-list
154068964|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154068965|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
154068966|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154068990|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154068991|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154068992|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
154068993|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154068994|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154068995|NCT00806286|Paclitaxel|paclitaxel|mesh-list
154068996|NCT00806286|Carboplatin|carboplatin|mesh-list
154068997|NCT00806286|Efatutazone|efatutazone|mesh-list
154068998|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154068999|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069000|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069001|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
154069002|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
154069003|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069004|NCT03537924|Acetazolamide|acetazolamide|mesh-list
154069005|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
154069006|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154069007|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069008|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069009|NCT03537924|Diuretics|diuretics|mesh-ancestor
154069010|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
154069011|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069012|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
154069013|NCT00590538|Genistein|genistein|mesh-list
154069014|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069015|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153576536|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
153576537|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153576538|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153576539|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576540|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
153576542|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
153576543|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576544|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
153576545|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
153817442|NCT06187922|Anticonvulsants|anticonvulsants|mesh-ancestor
153817443|NCT06187922|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153817444|NCT06187922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153817445|NCT06187922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817446|NCT06187922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153817447|NCT06187922|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153817448|NCT06187922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154069017|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069018|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154069019|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069020|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069021|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
154069022|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154069023|NCT00590538|Estrogens|estrogens|mesh-ancestor
154069025|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069026|NCT02608320|Fentanyl|fentanyl|mesh-list
154069027|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154069028|NCT02608320|Narcotics|narcotics|mesh-ancestor
154069029|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069030|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069031|NCT02608320|Analgesics|analgesics|mesh-ancestor
154069032|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
154069033|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069034|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154069035|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154069036|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
154069037|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
154069038|NCT05728788|Antineoplastic Agents|antineoplastic agents|mesh-list
154069039|NCT02608164|Vitamin D|vitamin d|mesh-list
154069040|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
154069041|NCT02608164|Vitamins|vitamins|mesh-ancestor
154069042|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
153817449|NCT06187922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576546|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576547|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153576548|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
153576549|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
153576550|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576551|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153576552|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
153576553|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
153576554|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153576555|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153576556|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
153576557|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153576563|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
153576564|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153576565|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153576566|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576567|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153576568|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154069043|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069044|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154069045|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154069046|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154069047|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
154069048|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
154069050|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
154069051|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069052|NCT02604615|Capecitabine|capecitabine|mesh-list
154069053|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
154069054|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154069055|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
154069056|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069057|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069058|NCT00796107|Letrozole|letrozole|mesh-list
154069059|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069060|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154069061|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154069097|NCT01227876|Protective Agents|protective agents|mesh-ancestor
154069098|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154069099|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069101|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154069102|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069103|NCT05297292|Ranibizumab|ranibizumab|mesh-list
154069104|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154069105|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154069106|NCT05297292|Growth Substances|growth substances|mesh-ancestor
154069107|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069108|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
154069109|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069110|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
154069111|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154069112|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
154069113|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
154069114|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069115|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069117|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154069118|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069119|NCT02607072|Analgesics|analgesics|mesh-ancestor
154069120|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
154069121|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069122|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069123|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069124|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069125|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154069126|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154069127|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069128|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154069138|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154069139|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069140|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069141|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
154069142|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
154069143|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069144|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069145|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154069146|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154069147|NCT00588237|Growth Substances|growth substances|mesh-ancestor
154069148|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069149|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
154069151|NCT02605746|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154069152|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154069153|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069154|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069155|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069156|NCT04109859|Methylene Blue|methylene blue|mesh-list
154069157|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069158|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069159|NCT00790023|Ciclesonide|ciclesonide|mesh-list
154069160|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
154069161|NCT00790023|Hormones|hormones|mesh-ancestor
154069162|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069163|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069164|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154069165|NCT00588822|Rituximab|rituximab|mesh-list
154069166|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069167|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069168|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
154069169|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069170|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153576569|NCT01712893|Goserelin|goserelin|mesh-list
153576570|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153576571|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576572|NCT01712919|Paclitaxel|paclitaxel|mesh-list
153576573|NCT01712919|Cetuximab|cetuximab|mesh-list
153576574|NCT01712919|Nedaplatin|nedaplatin|mesh-list
153576575|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153576576|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069171|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
154069172|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069173|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069174|NCT05563467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154069175|NCT05563467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069176|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154069177|NCT00589914|Risperidone|risperidone|mesh-list
154069178|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154069179|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154069180|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069181|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069182|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154069183|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154069184|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154069185|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
154069186|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069187|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069188|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154069189|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154069190|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
154069191|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
154069192|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154069193|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069194|NCT00789555|Analgesics|analgesics|mesh-ancestor
154069195|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
154069196|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069197|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069198|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069199|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069200|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154069201|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154069202|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154069203|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
154069204|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
154069212|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154069213|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153611945|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069214|NCT01026337|Growth Substances|growth substances|mesh-ancestor
154069215|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069216|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
154069217|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154069218|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069219|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069220|NCT03746275|Aspirin|aspirin|mesh-list
154069221|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
154069222|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154069223|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069224|NCT03746275|Analgesics|analgesics|mesh-ancestor
154069225|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
154069226|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069227|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069228|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069229|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069230|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154069231|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154069232|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069233|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153576577|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
153817450|NCT06187922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153817451|NCT06187896|Propofol|propofol|mesh-list
153817452|NCT06187896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153817453|NCT06187896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817454|NCT06187896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817455|NCT06187896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153817456|NCT06187896|Anesthetics, General|anesthetics, general|mesh-ancestor
153817457|NCT06187896|Anesthetics|anesthetics|mesh-ancestor
153817458|NCT06187584|Acetaminophen|acetaminophen|mesh-list
153817459|NCT06187584|Ibuprofen|ibuprofen|mesh-list
153458822|NCT04405206|Capecitabine|capecitabine|mesh-list
153576578|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
153576579|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
153576580|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576581|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153576582|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
153576583|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153576584|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069234|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154069235|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069236|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
154069237|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154069238|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
154069239|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154069240|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
154069241|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
154069242|NCT01026415|Rifampin|rifampin|mesh-list
154069243|NCT01026415|Ketoconazole|ketoconazole|mesh-list
154069244|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154069245|NCT01026415|Midazolam|midazolam|mesh-list
154069246|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154069247|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154069248|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154069249|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069250|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069251|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154069252|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154069253|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154069254|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154069255|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
154069256|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
154069257|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
154069258|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
154069259|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069260|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576586|NCT01712997|Iloprost|iloprost|mesh-list
153576587|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576588|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153576589|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576590|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153576591|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
153576592|NCT01713049|Alovudine|alovudine|mesh-list
153576593|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
153576594|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576595|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
153576596|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
153576597|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
153576598|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153576599|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576600|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
153576602|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
153458823|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
153458824|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153458825|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
153458826|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458827|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458828|NCT03101046|Docetaxel|docetaxel|mesh-list
153458829|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458830|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
153558449|NCT01626443|Folic Acid|folic acid|mesh-list
154069262|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
154069263|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154069264|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069265|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
154069266|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154069267|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069268|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154069269|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154069270|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154069271|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154069272|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154069273|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154069274|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069275|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069276|NCT01026415|Immunotoxins|immunotoxins|mesh-ancestor
154069277|NCT01026415|Immunoconjugates|immunoconjugates|mesh-ancestor
154069278|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
154069279|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
154069280|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154069281|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154069282|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154069283|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
154069284|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069285|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154069286|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153612022|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154069287|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
154069288|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069290|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
154069291|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154069292|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154069293|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069294|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069295|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
154069296|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
154069297|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154069298|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
154069299|NCT00914160|Diclofenac|diclofenac|mesh-list
154069300|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154069301|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069302|NCT00914160|Analgesics|analgesics|mesh-ancestor
154069303|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
154069304|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069305|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069306|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069307|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069308|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154069309|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069310|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069311|NCT00450619|Metronidazole|metronidazole|mesh-list
154069312|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
154069313|NCT00450619|Vaccines|vaccines|mesh-list
154069314|NCT00450619|Sargramostim|sargramostim|mesh-list
154069315|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
154069317|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069318|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154069319|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154069320|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154069321|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069322|NCT00450619|Analgesics|analgesics|mesh-ancestor
154069323|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
153458831|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
153458832|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
153458833|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458834|NCT03159936|Tofacitinib|tofacitinib|mesh-list
153458835|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458836|NCT03159936|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153458837|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153458838|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458839|NCT03156816|Colchicine|colchicine|mesh-list
153576613|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576614|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576615|NCT01713127|Analgesics|analgesics|mesh-ancestor
153576616|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
153576617|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576618|NCT01713153|Misoprostol|misoprostol|mesh-list
153576619|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153576620|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
153576621|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576622|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576623|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153576624|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154069327|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
154069328|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154069329|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154069330|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
154069331|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069332|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069333|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154069334|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154069335|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
154069336|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069337|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154069338|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154069339|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154069340|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154069341|NCT04112394|Anesthetics|anesthetics|mesh-list
154069342|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
154069343|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069344|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069345|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
154069346|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069348|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
154069349|NCT00450385|Rituximab|rituximab|mesh-list
154069350|NCT00450385|Doxorubicin|doxorubicin|mesh-list
154069351|NCT00450385|Vincristine|vincristine|mesh-list
154069352|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154069353|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
154069354|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069355|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069356|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154069357|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
153820695|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576626|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
153576627|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153576628|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154069358|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069359|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069360|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154069361|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153612109|NCT01719237|Ropivacaine|ropivacaine|mesh-list
154069362|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154069363|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154069364|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154069365|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069366|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069367|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
154069368|NCT00450385|Hormones|hormones|mesh-ancestor
154069369|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069370|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154069371|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154069372|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069373|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
154069374|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
154069375|NCT00588354|Triamcinolone|triamcinolone|mesh-list
154069376|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154069377|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154069378|NCT00588354|Lidocaine|lidocaine|mesh-list
154069379|NCT00588354|Clonidine|clonidine|mesh-list
154069380|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154069381|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
153576629|NCT01713179|Ambroxol|ambroxol|mesh-list
154069405|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154069406|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
154069407|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069409|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069410|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154069411|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069412|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069413|NCT00800982|Etanercept|etanercept|mesh-list
154069414|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154069415|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069416|NCT00800982|Analgesics|analgesics|mesh-ancestor
154069417|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
154069418|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069419|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069420|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069421|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069422|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154069423|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154069461|NCT01026961|Protective Agents|protective agents|mesh-ancestor
154069462|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
154069463|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
154069464|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154069465|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
154069467|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154069468|NCT01566253|Acetaminophen|acetaminophen|mesh-list
154069470|NCT01566253|Morphine|morphine|mesh-list
154069471|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154069472|NCT01566253|Narcotics|narcotics|mesh-ancestor
154069473|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069474|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069475|NCT01566253|Analgesics|analgesics|mesh-ancestor
154069476|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
154069477|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069478|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069479|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
154069480|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154069481|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069482|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069483|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154069484|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069485|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069486|NCT03849313|Adalimumab|adalimumab|mesh-list
154069487|NCT03849313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154069488|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069489|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069490|NCT04111614|Tofacitinib|tofacitinib|mesh-list
154069491|NCT04111614|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154069492|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154069508|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
154069509|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069510|NCT04028622|Anesthetics|anesthetics|mesh-list
154069511|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069512|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069514|NCT00830804|Darunavir|darunavir|mesh-list
154069515|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
154069516|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154069517|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154069518|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
154069519|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069520|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069521|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154069522|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154069523|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
154069524|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069525|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154069526|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154069527|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154069528|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154069529|NCT00789477|Aflibercept|aflibercept|mesh-list
154069536|NCT01024075|Dexamethasone|dexamethasone|mesh-list
154069559|NCT00796614|Tamsulosin|tamsulosin|mesh-list
154069560|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154069561|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154069562|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154069563|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
154069564|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069565|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069566|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069567|NCT00796614|Urological Agents|urological agents|mesh-ancestor
154069568|NCT02603445|Idelalisib|idelalisib|mesh-list
154069569|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069570|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069571|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069572|NCT02603679|Tamoxifen|tamoxifen|mesh-list
154069573|NCT02603679|Paclitaxel|paclitaxel|mesh-list
154069574|NCT02603679|Letrozole|letrozole|mesh-list
154069575|NCT02603679|Palbociclib|palbociclib|mesh-list
154069576|NCT02603679|Anastrozole|anastrozole|mesh-list
154069577|NCT02603679|Exemestane|exemestane|mesh-list
154069578|NCT02603679|Goserelin|goserelin|mesh-list
154069579|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154069580|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154069581|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069582|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069597|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
154069610|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069611|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154069612|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
154069613|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
154069614|NCT05758298|Nicotine|nicotine|mesh-list
154069615|NCT05758298|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154069616|NCT05758298|Autonomic Agents|autonomic agents|mesh-ancestor
154069617|NCT05758298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069618|NCT05758298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069619|NCT05758298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154069620|NCT05758298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154069621|NCT05758298|Cholinergic Agents|cholinergic agents|mesh-ancestor
154069622|NCT05758298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069623|NCT05758298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069625|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154069626|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154069627|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154069628|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069629|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154069630|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069631|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
154069632|NCT00811928|Fluconazole|fluconazole|mesh-list
154069633|NCT00811928|Posaconazole|posaconazole|mesh-list
154069634|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
154069635|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069636|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154069637|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154069638|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069639|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069640|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154069641|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
154069649|NCT00788775|Nilotinib|nilotinib|mesh-list
154069650|NCT00788775|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154069651|NCT00788775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154069652|NCT00788775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069653|NCT00788775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069655|NCT00448669|Emtricitabine|emtricitabine|mesh-list
154069656|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
154069657|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069658|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154069659|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154069660|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069661|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069662|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154069663|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154069664|NCT00591734|Bevacizumab|bevacizumab|mesh-list
154069665|NCT00591734|Everolimus|everolimus|mesh-list
154069666|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069667|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069668|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154069669|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154069670|NCT00591734|Growth Substances|growth substances|mesh-ancestor
154069671|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069672|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
154069673|NCT00591734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154069674|NCT00591734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154069675|NCT00591734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069676|NCT00591734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069677|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154069678|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
154069679|NCT00848549|Carbamazepine|carbamazepine|mesh-list
154069680|NCT00848549|Zonisamide|zonisamide|mesh-list
154069681|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
154069682|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
154069683|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153576630|NCT01713179|Expectorants|expectorants|mesh-ancestor
153576631|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
153576632|NCT01713218|Gemcitabine|gemcitabine|mesh-list
153576633|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153576634|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
153576635|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576636|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576637|NCT01713231|Vitamin D|vitamin d|mesh-list
154069684|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069685|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069686|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154069687|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069688|NCT00848549|Analgesics|analgesics|mesh-ancestor
154069689|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
154069690|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069691|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154069692|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154069693|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069694|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154069695|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154069696|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154069697|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154069698|NCT00788151|Vaccines|vaccines|mesh-list
154069699|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154069700|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
154069701|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069702|NCT04116359|Cisplatin|cisplatin|mesh-list
154069703|NCT04116359|Etoposide|etoposide|mesh-list
154069704|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
154069705|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
154069735|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
154069736|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069737|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154069738|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154069739|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154069740|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
154069741|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069742|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069743|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154069744|NCT00848393|Narcotics|narcotics|mesh-ancestor
154069745|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154069746|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154069747|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
154069748|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
154069749|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
154069750|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154069751|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
154069752|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
154069753|NCT00815516|Amphotericin B|amphotericin b|mesh-list
154069754|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154069755|NCT00815516|Micafungin|micafungin|mesh-list
154069756|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
154069757|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
154069758|NCT00815516|Amebicides|amebicides|mesh-ancestor
154069759|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154069760|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154069761|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069762|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154069763|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
154069764|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154069765|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154069766|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154069768|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069769|NCT00787917|Omalizumab|omalizumab|mesh-list
154069770|NCT00787917|Itraconazole|itraconazole|mesh-list
154069771|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
154069775|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069776|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069777|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154069778|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
154069779|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069780|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069781|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154069782|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154069783|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154069784|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
154069785|NCT05758064|Dydrogesterone|dydrogesterone|mesh-list
154069786|NCT05758064|Progestins|progestins|mesh-ancestor
154069787|NCT05758064|Hormones|hormones|mesh-ancestor
154069788|NCT05758064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069789|NCT05758064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069790|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154069791|NCT00829244|Hormones|hormones|mesh-ancestor
154069792|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069793|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069794|NCT00787605|Amlodipine|amlodipine|mesh-list
154069795|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154069796|NCT00787605|Aliskiren|aliskiren|mesh-list
154069797|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154069798|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154069799|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154069800|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069801|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154069802|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576638|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
153576639|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
153576640|NCT01713231|Vitamins|vitamins|mesh-list
153576641|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
153576642|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576643|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153576644|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153576645|NCT01713309|Lenograstim|lenograstim|mesh-list
153817464|NCT06187584|Sensory System Agents|sensory system agents|mesh-ancestor
153817465|NCT06187584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817466|NCT06187584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817467|NCT06187584|Antipyretics|antipyretics|mesh-ancestor
153817468|NCT06187584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153817469|NCT06187584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817470|NCT06187584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069803|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
154069804|NCT00787605|Diuretics|diuretics|mesh-ancestor
154069805|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
154069806|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154069807|NCT00787605|Renin Inhibitors|renin inhibitors|mesh-ancestor
154069808|NCT00787605|Protease Inhibitors|protease inhibitors|mesh-ancestor
154069809|NCT00787605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069812|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069813|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069814|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154069815|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154069816|NCT00448591|Growth Substances|growth substances|mesh-ancestor
154069817|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069818|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
154069819|NCT00787527|Prednisone|prednisone|mesh-list
154069820|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
154069821|NCT00787527|Doxorubicin|doxorubicin|mesh-list
154069822|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154069823|NCT00787527|Vincristine|vincristine|mesh-list
154069824|NCT00787527|Vorinostat|vorinostat|mesh-list
154069825|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154069826|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
154069827|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069828|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069829|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154069830|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
154069831|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069832|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069851|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069852|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
154069853|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069854|NCT00804388|Protective Agents|protective agents|mesh-ancestor
154069855|NCT00806962|Vaccines|vaccines|mesh-list
154069856|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
154069857|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069858|NCT02553226|Oxytocin|oxytocin|mesh-list
154069859|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
154069860|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154069861|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069862|NCT00810316|Clonazepam|clonazepam|mesh-list
154069863|NCT00810316|Alprazolam|alprazolam|mesh-list
154069864|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154069865|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069866|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069867|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154069868|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154069869|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154069870|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
154069871|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
154069872|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069873|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069874|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
154069875|NCT00448435|Fluticasone|fluticasone|mesh-list
154069876|NCT00448435|Xhance|xhance|mesh-list
154069877|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154069878|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154069879|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817471|NCT06187584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153817472|NCT06187584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817473|NCT06187584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817474|NCT06187584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153817475|NCT06187584|Narcotics|narcotics|mesh-ancestor
153817476|NCT06187584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458840|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
153458841|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458842|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
153458843|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
153458844|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
153458845|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576652|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153576653|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576654|NCT01713387|Gemcitabine|gemcitabine|mesh-list
153576655|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153576656|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
153817708|NCT06140966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154069880|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154069881|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
154069882|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069883|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069884|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154069885|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
154069886|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
154069887|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154069888|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154069889|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154069890|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154069891|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
154069892|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069893|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069894|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
154069895|NCT00448435|Hormones|hormones|mesh-ancestor
154069896|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154069897|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
154069898|NCT00804622|Tenofovir|tenofovir|mesh-list
154069899|NCT00804622|Telbivudine|telbivudine|mesh-list
154069900|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
154069901|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154069902|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154069903|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154069904|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154069905|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069906|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154069907|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154069908|NCT02603055|Vaccines|vaccines|mesh-list
154069909|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
154069910|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069911|NCT02602743|Ketamine|ketamine|mesh-list
154069912|NCT02602743|Remifentanil|remifentanil|mesh-list
154069913|NCT02602743|Propofol|propofol|mesh-list
154069914|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154069915|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154069916|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069917|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154069918|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
154069919|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
154069920|NCT02602743|Analgesics|analgesics|mesh-ancestor
154069921|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
154069922|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069923|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154069924|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154069925|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154069926|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069927|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069928|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154069929|NCT02602743|Narcotics|narcotics|mesh-ancestor
154069930|NCT00807118|Fesoterodine|fesoterodine|mesh-list
154069931|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154069932|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154069933|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
154069934|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069935|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069936|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069937|NCT00807118|Urological Agents|urological agents|mesh-ancestor
154069938|NCT00448279|Trastuzumab|trastuzumab|mesh-list
154069939|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154069940|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069941|NCT00810706|Exemestane|exemestane|mesh-list
154069942|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069964|NCT00448123|Tamsulosin|tamsulosin|mesh-list
154069965|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154069966|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154069967|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154069968|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
154069969|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154069970|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069971|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069972|NCT00448123|Urological Agents|urological agents|mesh-ancestor
154069973|NCT00804934|Ranibizumab|ranibizumab|mesh-list
154069974|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154069975|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154069976|NCT00804934|Growth Substances|growth substances|mesh-ancestor
154069977|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154069978|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
154069979|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069980|NCT00805012|Docetaxel|docetaxel|mesh-list
154069981|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560035|NCT01636557|Coagulants|coagulants|mesh-ancestor
154069982|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
154069983|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
154069984|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
154069985|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154069986|NCT00447499|Lanreotide|lanreotide|mesh-list
154069987|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154069988|NCT00805090|Itraconazole|itraconazole|mesh-list
154069989|NCT00805090|Diclofenac|diclofenac|mesh-list
154069990|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154069991|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154069992|NCT00805090|Analgesics|analgesics|mesh-ancestor
154069993|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
154069994|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154069995|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576657|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576658|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576659|NCT01713426|Pregabalin|pregabalin|mesh-list
153576660|NCT01713426|Capsaicin|capsaicin|mesh-list
153576661|NCT01713426|Analgesics|analgesics|mesh-ancestor
153576662|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
153576663|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576664|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576665|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
153576666|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154069996|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154069997|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154069998|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154069999|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070000|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070001|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
154070002|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070003|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154070004|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154070005|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154070006|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
154070007|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070008|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154070009|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
154070010|NCT00810862|Lactitol|lactitol|mesh-list
154070011|NCT00810862|Cathartics|cathartics|mesh-ancestor
154070012|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154070013|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154070014|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154070015|NCT00810862|Analgesics|analgesics|mesh-ancestor
154070016|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
154070017|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070018|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070019|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070020|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070021|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070022|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070041|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
154070042|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070044|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070045|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070046|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070047|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154070048|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154070049|NCT00651118|Fluticasone|fluticasone|mesh-list
154070050|NCT00651118|Xhance|xhance|mesh-list
154070051|NCT00651118|Azelastine|azelastine|mesh-list
154070052|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070053|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154070054|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
154070055|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070056|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070057|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154070058|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153720933|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
154070059|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070060|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154070061|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154070062|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070063|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070064|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154070065|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154070066|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
154070067|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
154070068|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070069|NCT00447265|Etanercept|etanercept|mesh-list
154070070|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154070071|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154070072|NCT00447265|Analgesics|analgesics|mesh-ancestor
154070073|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
154070074|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070075|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070076|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070078|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154070079|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070080|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
154070081|NCT00657358|Lidocaine|lidocaine|mesh-list
154070082|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
154070083|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
154070084|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070085|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070086|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
154070087|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070088|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154070089|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154070090|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154070091|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070092|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070093|NCT00457639|Cholic Acids|cholic acids|mesh-list
154070094|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154070095|NCT00800202|Paclitaxel|paclitaxel|mesh-list
154070135|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070136|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070137|NCT04111302|Dezocine|dezocine|mesh-list
154070138|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154070139|NCT04111302|Narcotics|narcotics|mesh-ancestor
154070140|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070141|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070142|NCT04111302|Analgesics|analgesics|mesh-ancestor
154070143|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
154070144|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070146|NCT04111848|Analgesics|analgesics|mesh-ancestor
154070147|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
154070148|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070149|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070150|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154070151|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154070152|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
154070153|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
154070154|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070155|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154070156|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154070157|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070158|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070159|NCT00457015|Ecallantide|ecallantide|mesh-list
154070160|NCT00457015|Analgesics|analgesics|mesh-ancestor
154070161|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
154070162|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070163|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070164|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154070165|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154070166|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070167|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070176|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070177|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154070178|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154070179|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154070180|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070181|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154070182|NCT00588666|Bevacizumab|bevacizumab|mesh-list
154070183|NCT00588666|Carboplatin|carboplatin|mesh-list
154070184|NCT00588666|Gemcitabine|gemcitabine|mesh-list
154070185|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154070186|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070187|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154070188|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154070189|NCT00588666|Growth Substances|growth substances|mesh-ancestor
154070190|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070191|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
154070192|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154070193|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
154070194|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070195|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
154070196|NCT00805558|Metronidazole|metronidazole|mesh-list
154070197|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
154070198|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154070199|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154070200|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070201|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154070202|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154070203|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070204|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070205|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070216|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154070217|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
154070218|NCT01019785|Vitamin D|vitamin d|mesh-list
154070219|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154070220|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070221|NCT01019785|Vitamins|vitamins|mesh-ancestor
154070222|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
154070223|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154070224|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
154070225|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154070226|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070227|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070228|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
154070229|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070230|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070231|NCT01024543|Phenylephrine|phenylephrine|mesh-list
154070232|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
154070233|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
154070234|NCT01024543|Giapreza|giapreza|mesh-list
154070235|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
154070236|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154070237|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
154070238|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
154070239|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070240|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070241|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
154070242|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154070243|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
154070255|NCT00811330|Atorvastatin|atorvastatin|mesh-list
154070262|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070265|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070266|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
154070267|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070268|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070269|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070270|NCT00446797|Celecoxib|celecoxib|mesh-list
154070271|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154070272|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154070273|NCT00446797|Analgesics|analgesics|mesh-ancestor
154070274|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
154070275|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070276|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070277|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070278|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070279|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154070280|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154070281|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070282|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070283|NCT00855335|Ritonavir|ritonavir|mesh-list
154070284|NCT00855335|Darunavir|darunavir|mesh-list
154070285|NCT00855335|Cobicistat|cobicistat|mesh-list
154070287|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154070288|NCT00855335|Etravirine|etravirine|mesh-list
154070289|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154070290|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154070291|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
154070292|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070293|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070294|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153576667|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576668|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576669|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153458846|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458847|NCT03583476|Amoxicillin|amoxicillin|mesh-list
153458848|NCT03583476|Metronidazole|metronidazole|mesh-list
153458849|NCT03583476|Clarithromycin|clarithromycin|mesh-list
153458850|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153458851|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153458852|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458853|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153458854|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153817709|NCT06140966|Alkylating Agents|alkylating agents|mesh-ancestor
154070295|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154070296|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
154070297|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070298|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154070299|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154070300|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154070301|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154070302|NCT00811486|Spironolactone|spironolactone|mesh-list
154070303|NCT00811486|Conivaptan|conivaptan|mesh-list
154070304|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154070305|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
154070306|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070307|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721057|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070308|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154070309|NCT00811486|Diuretics|diuretics|mesh-ancestor
154070310|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
154070311|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154070312|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070313|NCT04114188|Prednisolone|prednisolone|mesh-list
154070314|NCT04114188|Infliximab|infliximab|mesh-list
154070315|NCT04114188|Tacrolimus|tacrolimus|mesh-list
154070316|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
154070317|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154070318|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
154070319|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154070320|NCT04114188|Antibodies|antibodies|mesh-list
154070321|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070322|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
154070323|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070324|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154070325|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070326|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070327|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070328|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
154070329|NCT04114188|Hormones|hormones|mesh-ancestor
154070330|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070334|NCT04114188|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154070335|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070336|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070337|NCT00811876|Leuprolide|leuprolide|mesh-list
154070338|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154070339|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
154070340|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154070341|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070342|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154070343|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070344|NCT00915252|Cytarabine|cytarabine|mesh-list
154070345|NCT00915252|Azacitidine|azacitidine|mesh-list
154070346|NCT00915252|Daunorubicin|daunorubicin|mesh-list
154070347|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154070348|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
154070349|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070350|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070351|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
154070352|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070353|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070354|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
154070355|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070356|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458855|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153458856|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458857|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458858|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153458859|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153458860|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
153458861|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153458862|NCT03583242|Growth Substances|growth substances|mesh-ancestor
153458863|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576678|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153576679|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
153576680|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576681|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576682|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576683|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153576684|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576685|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
153576686|NCT01713647|Losartan|losartan|mesh-list
153576687|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153576688|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576689|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154070357|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154070358|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154070359|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154070361|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154070362|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070363|NCT00446641|Cilostazol|cilostazol|mesh-list
154070364|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154070365|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
154070366|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070367|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070368|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154070369|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
154070370|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154070371|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154070372|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070373|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154070374|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
154070375|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154070376|NCT00446641|Protective Agents|protective agents|mesh-ancestor
154070377|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154070378|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154070379|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070380|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
154070381|NCT00646282|Vitamins|vitamins|mesh-ancestor
154070382|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
154070383|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070384|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154070385|NCT00814060|Neratinib|neratinib|mesh-list
154070386|NCT00814060|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154070387|NCT00814060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154070388|NCT00814060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070389|NCT00814060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070390|NCT00792636|Naproxen|naproxen|mesh-list
154070391|NCT00792636|Sumatriptan|sumatriptan|mesh-list
154070392|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153576690|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153576691|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576692|NCT01713725|Omalizumab|omalizumab|mesh-list
153576693|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154070398|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070399|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070400|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
154070401|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154070445|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154070446|NCT00863057|Narcotics|narcotics|mesh-ancestor
154070447|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070448|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
154070449|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
154070450|NCT00814216|Fluticasone|fluticasone|mesh-list
154070452|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070453|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154070454|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
154070455|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070456|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070457|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154070458|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
154070459|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070460|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154070461|NCT00829166|Capecitabine|capecitabine|mesh-list
154070462|NCT00829166|Trastuzumab|trastuzumab|mesh-list
154070463|NCT00829166|Lapatinib|lapatinib|mesh-list
154070464|NCT00829166|Maytansine|maytansine|mesh-list
154070465|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154070466|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154070467|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
154070468|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070469|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070470|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154070471|NCT00829166|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154070472|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154070473|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070491|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070492|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070493|NCT00808054|Lidocaine|lidocaine|mesh-list
154070494|NCT00808054|Prilocaine|prilocaine|mesh-list
154070495|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
154070496|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
154070497|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070498|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070499|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
154070500|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070501|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154070502|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154070503|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154070504|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070505|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070507|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
154070508|NCT00814528|Imiquimod|imiquimod|mesh-list
154070509|NCT00814528|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154070510|NCT00814528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070511|NCT00814528|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154070512|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
154070513|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070514|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154070515|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070516|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
154070517|NCT00814606|Ribavirin|ribavirin|mesh-list
154070518|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154070519|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
154070520|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070521|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
154070522|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070523|NCT00814762|Vaccines|vaccines|mesh-list
154070524|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
154070525|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070526|NCT00654238|Sorafenib|sorafenib|mesh-list
153576694|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153576695|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
153576696|NCT01713738|Rituximab|rituximab|mesh-list
153817477|NCT06187584|Antitussive Agents|antitussive agents|mesh-ancestor
154070527|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070528|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154070530|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070531|NCT00862979|Cyclosporine|cyclosporine|mesh-list
154070532|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
154070533|NCT00862979|Everolimus|everolimus|mesh-list
154070534|NCT00862979|Tacrolimus|tacrolimus|mesh-list
154070535|NCT00862979|Cyclosporins|cyclosporins|mesh-list
154070536|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070537|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
154070538|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070539|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154070540|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070541|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070542|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
154070543|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070544|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070545|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070546|NCT00862979|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154070547|NCT00862979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154070548|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070549|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154070550|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154070551|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
154070552|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154070553|NCT02605356|Dexamethasone|dexamethasone|mesh-list
154070554|NCT02605356|Bortezomib|bortezomib|mesh-list
154070555|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154070556|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070557|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
154070558|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
154070559|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070561|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154070570|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070571|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154070572|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154070573|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154070574|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070575|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070576|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154070577|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154070578|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154070579|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070580|NCT04113954|Prilocaine|prilocaine|mesh-list
154070581|NCT04113954|Mepivacaine|mepivacaine|mesh-list
154070582|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
154070583|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
154070584|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070585|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070586|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
154070587|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070588|NCT00812344|Ketoconazole|ketoconazole|mesh-list
154070589|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
154070590|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070591|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154070592|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154070593|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070594|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070595|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154070615|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154070616|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154070617|NCT00812422|Analgesics|analgesics|mesh-ancestor
154070618|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
154070619|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070620|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070621|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070622|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070623|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154070624|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070625|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070626|NCT04110834|Itraconazole|itraconazole|mesh-list
154070627|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
154070628|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
154070629|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070630|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154070631|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154070632|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070668|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070669|NCT02551276|Albuterol|albuterol|mesh-list
154070670|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154070671|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
154070672|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070673|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070674|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154070675|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
154070676|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
154070677|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154070678|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154070679|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154070680|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154070681|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
154070682|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070683|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070684|NCT00848081|Tadalafil|tadalafil|mesh-list
154070685|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
154070686|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154070687|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154070688|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070689|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070693|NCT04111380|Paclitaxel|paclitaxel|mesh-list
154070717|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070719|NCT00701285|Pitavastatin|pitavastatin|mesh-list
154070720|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154070721|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154070722|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
154070723|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070724|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154070725|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154070726|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070727|NCT02604498|Nemonoxacin|nemonoxacin|mesh-list
154070728|NCT02604498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154070729|NCT02604498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070730|NCT00700037|Atorvastatin|atorvastatin|mesh-list
154070731|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154070732|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154070733|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
154070734|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070735|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154070736|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154070737|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070738|NCT00815542|Dinoprostone|dinoprostone|mesh-list
154070739|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
154070740|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154070741|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070742|NCT00791778|Sorafenib|sorafenib|mesh-list
154070743|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070744|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154070745|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070746|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817478|NCT06187584|Respiratory System Agents|respiratory system agents|mesh-ancestor
153817479|NCT06187519|Uric Acid|uric acid|mesh-list
153817480|NCT06187519|Antioxidants|antioxidants|mesh-ancestor
153817481|NCT06187519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817482|NCT06187519|Protective Agents|protective agents|mesh-ancestor
153817483|NCT06187519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817484|NCT06187506|Disitamab vedotin|disitamab vedotin|mesh-list
153817485|NCT06187506|BCG Vaccine|bcg vaccine|mesh-list
153817486|NCT06187506|Immunoconjugates|immunoconjugates|mesh-ancestor
153817487|NCT06187506|Immunologic Factors|immunologic factors|mesh-ancestor
153817488|NCT06187506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576697|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154070747|NCT02604576|Bromopride|bromopride|mesh-list
154070748|NCT02604576|Metoclopramide|metoclopramide|mesh-list
154070749|NCT02604576|Simethicone|simethicone|mesh-list
154070750|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
154070751|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070752|NCT02604576|Emollients|emollients|mesh-ancestor
154070753|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070754|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
154070755|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
154070756|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070757|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070758|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154070759|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154070760|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
154070761|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070762|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154070763|NCT00795600|Insulin|insulin|mesh-list
154070764|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154070765|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
154070766|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
154070767|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
154070768|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
154070769|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154070770|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070771|NCT00795132|Cyclosporine|cyclosporine|mesh-list
154070772|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
154070773|NCT00795132|Fludarabine|fludarabine|mesh-list
154070774|NCT00795132|Busulfan|busulfan|mesh-list
154070775|NCT00795132|Cyclosporins|cyclosporins|mesh-list
154070776|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
154070777|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154070778|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070779|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070780|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070781|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
154070791|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
154070792|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154070793|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
154070794|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154070795|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154070796|NCT02604420|Eculizumab|eculizumab|mesh-list
154070797|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154070798|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070799|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
154070800|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070801|NCT04110210|Morphine|morphine|mesh-list
154070802|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154070803|NCT04110210|Narcotics|narcotics|mesh-ancestor
154070804|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070805|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070807|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
154070808|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070809|NCT00647296|Pramipexole|pramipexole|mesh-list
154070810|NCT00647296|Dexpramipexole|dexpramipexole|mesh-list
154070811|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
154070848|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154070849|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070850|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154070851|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154070852|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154070853|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
153613588|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
154070854|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070855|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154070856|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154070857|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070858|NCT00815854|Folic Acid|folic acid|mesh-list
154070859|NCT00815854|Hematinics|hematinics|mesh-ancestor
154070860|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
154070861|NCT00815854|Vitamins|vitamins|mesh-ancestor
154070862|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
154070863|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070864|NCT00817648|Risperidone|risperidone|mesh-list
154070865|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154070866|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154070867|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
154070868|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070869|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070870|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070871|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154070872|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154070873|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154070874|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154070875|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154070876|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
154070877|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
154070878|NCT00829010|Vaccines|vaccines|mesh-list
153576698|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576699|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
153576700|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576701|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153576702|NCT01713777|Lamotrigine|lamotrigine|mesh-list
153576703|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
153576704|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153576705|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576706|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576707|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153576708|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070879|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154070880|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
154070881|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070882|NCT00644332|Ranolazine|ranolazine|mesh-list
154070883|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154070884|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070885|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070886|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
154070887|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
154070888|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154070889|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154070890|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070891|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070892|NCT00808912|Urological Agents|urological agents|mesh-ancestor
154070893|NCT02551042|Factor VIII|factor viii|mesh-list
154070894|NCT02551042|Coagulants|coagulants|mesh-ancestor
154070895|NCT00445939|Adalimumab|adalimumab|mesh-list
154070896|NCT00445939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154070897|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070898|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070899|NCT00816244|Atorvastatin|atorvastatin|mesh-list
154070900|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154070901|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153576709|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153576710|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153576711|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576712|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153576713|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153576714|NCT01713803|Buprenorphine|buprenorphine|mesh-list
153817496|NCT06187493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153817497|NCT06187493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817498|NCT06187493|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153817499|NCT06187493|Protease Inhibitors|protease inhibitors|mesh-ancestor
153817500|NCT06187493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817501|NCT06187493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153458864|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153458865|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458866|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
153458867|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458868|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458869|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
153458870|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153458871|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
153458872|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458873|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458874|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
153458875|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153458876|NCT03582306|Protective Agents|protective agents|mesh-ancestor
153458877|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458878|NCT03159234|Epinephrine|epinephrine|mesh-list
153458879|NCT03159234|Racepinephrine|racepinephrine|mesh-list
153458880|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
154070902|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
154070903|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070904|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154070905|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154070906|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070907|NCT00817960|Methylphenidate|methylphenidate|mesh-list
154070908|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154070909|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070910|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154070911|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154070912|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154070913|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070914|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
154070915|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070916|NCT00818038|Natalizumab|natalizumab|mesh-list
154070917|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
154070918|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070919|NCT00482053|Acetaminophen|acetaminophen|mesh-list
154070920|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
154070921|NCT00482053|Promethazine|promethazine|mesh-list
154070922|NCT00482053|Cyclosporine|cyclosporine|mesh-list
154070923|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
154070924|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
154070925|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154070926|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
154070927|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
154070928|NCT00482053|Carmustine|carmustine|mesh-list
153613674|NCT01963910|Mannitol|mannitol|mesh-list
154070929|NCT00482053|Rituximab|rituximab|mesh-list
154070930|NCT00482053|Etoposide|etoposide|mesh-list
153458881|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153458882|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153458883|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
153458884|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576717|NCT01713803|Narcotics|narcotics|mesh-ancestor
153576718|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576719|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576720|NCT01713803|Analgesics|analgesics|mesh-ancestor
153576721|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
153576722|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576723|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153576724|NCT01713920|Amlodipine|amlodipine|mesh-list
153576725|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576726|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153576727|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576728|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070931|NCT00482053|Cyclosporins|cyclosporins|mesh-list
154070932|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154070933|NCT00482053|Lenograstim|lenograstim|mesh-list
154070934|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154070935|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
154070936|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070937|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154070938|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154070939|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
154070940|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154070941|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154070942|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154070943|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154070944|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154070945|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154070946|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154070947|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154070948|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154070949|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
154070950|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154070951|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070952|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154070953|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154070954|NCT00482053|Analgesics|analgesics|mesh-ancestor
154070955|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
154070956|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070957|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
154070958|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154070959|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154070975|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
154070977|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154070978|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
154070979|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
154070980|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154070981|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154070982|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
154070983|NCT00455923|Fluticasone|fluticasone|mesh-list
154070984|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154070985|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154070986|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
154070987|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154070988|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154070989|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154070990|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
154070991|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
154070992|NCT00455923|Hormones|hormones|mesh-ancestor
154070993|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154070994|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
153576729|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153576730|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576731|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
153576732|NCT01713972|Dabrafenib|dabrafenib|mesh-list
153576733|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576734|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153576735|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576736|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576737|NCT01714011|Aripiprazole|aripiprazole|mesh-list
153576738|NCT01714011|Ziprasidone|ziprasidone|mesh-list
153458885|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458886|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458887|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153458888|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153458889|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
153458890|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458891|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153458892|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
153458893|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
153458894|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
153576740|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153576741|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153576742|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153576743|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576744|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576745|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
153576746|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
153576747|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781626|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576748|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781627|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
153576749|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153576750|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153576751|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
154070995|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154070996|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
154070997|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154070998|NCT00642616|Insulin|insulin|mesh-list
154070999|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154071000|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071001|NCT00809068|Tibolone|tibolone|mesh-list
154071002|NCT00809068|Fenofibrate|fenofibrate|mesh-list
154071003|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154071004|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
154071005|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071006|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154071007|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
154071008|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
154071009|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071010|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071011|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071012|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154071013|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071014|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154071015|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
154071016|NCT00809068|Hormones|hormones|mesh-ancestor
154071017|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154071018|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154071019|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
154071020|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
154071021|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154071022|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154071023|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071024|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071025|NCT01027117|Urological Agents|urological agents|mesh-ancestor
154071026|NCT03995563|Dexamethasone|dexamethasone|mesh-list
153576752|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153576753|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153576754|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153576755|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153576757|NCT01714037|Docetaxel|docetaxel|mesh-list
153576758|NCT01714037|Pemetrexed|pemetrexed|mesh-list
153576759|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817509|NCT06187441|Autonomic Agents|autonomic agents|mesh-ancestor
153817510|NCT06187441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817511|NCT06187441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817512|NCT06187441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817513|NCT06187441|Glucocorticoids|glucocorticoids|mesh-ancestor
154071027|NCT03995563|Ropivacaine|ropivacaine|mesh-list
154071028|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071029|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
154071030|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
154071031|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071032|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071033|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071034|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
154071035|NCT03995563|Hormones|hormones|mesh-ancestor
154071036|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071037|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154071038|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071039|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
154071040|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
154071041|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071042|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
154071043|NCT00445003|Triamcinolone|triamcinolone|mesh-list
154071044|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154071045|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154071046|NCT00445003|Ranibizumab|ranibizumab|mesh-list
154071047|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154071048|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154071049|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154071050|NCT00445003|Growth Substances|growth substances|mesh-ancestor
154071051|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071052|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
154071053|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071054|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071055|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
154071072|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154071073|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071074|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154071075|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
154071076|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071077|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071078|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
154071079|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071080|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154071081|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071082|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
154071083|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071084|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154071085|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154071086|NCT00642460|Analgesics|analgesics|mesh-ancestor
154071087|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
154071088|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071089|NCT00814658|Nimodipine|nimodipine|mesh-list
154071090|NCT00814658|Galantamine|galantamine|mesh-list
154071091|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154071092|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071093|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071124|NCT00814580|Analgesics|analgesics|mesh-ancestor
154071125|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
154071126|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071127|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154071128|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154071129|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071130|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071131|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
154071132|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071133|NCT00643162|Escitalopram|escitalopram|mesh-list
154071134|NCT00643162|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154071135|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154071136|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071137|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071138|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071139|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
154071141|NCT00814502|Zolpidem|zolpidem|mesh-list
154071178|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154071179|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071180|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154071181|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154071182|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154071183|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071184|NCT00828464|Clobetasol|clobetasol|mesh-list
154071185|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071186|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
154071187|NCT00828464|Hormones|hormones|mesh-ancestor
154071188|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071189|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071190|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
154071191|NCT00816712|Testosterone|testosterone|mesh-list
154071192|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
154071193|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
154071194|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154071195|NCT00816712|Androgens|androgens|mesh-ancestor
154071196|NCT00816712|Hormones|hormones|mesh-ancestor
154071197|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071198|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071199|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154071200|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071201|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
154071202|NCT00818194|Cyclosporine|cyclosporine|mesh-list
154071203|NCT00818194|Tacrolimus|tacrolimus|mesh-list
154071204|NCT00818194|Cyclosporins|cyclosporins|mesh-list
154071215|NCT02610686|Chloroquine|chloroquine|mesh-list
153613988|NCT01965353|Bortezomib|bortezomib|mesh-list
154071226|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071227|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154071228|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071229|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071231|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071232|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154071233|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154071234|NCT00818350|Growth Substances|growth substances|mesh-ancestor
154071235|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071236|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
154071237|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154071238|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071239|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071240|NCT00810602|Vorinostat|vorinostat|mesh-list
154071241|NCT00810602|Tacrolimus|tacrolimus|mesh-list
154071242|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071243|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
154071244|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071245|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154071246|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071247|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071248|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071249|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154071250|NCT00816868|Capecitabine|capecitabine|mesh-list
154071251|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154071252|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154071253|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
154071254|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071255|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071264|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154071265|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
154071266|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071267|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154071268|NCT00628108|Levocetirizine|levocetirizine|mesh-list
154071269|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154071270|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154071271|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
154071272|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
154071273|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071274|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071275|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071276|NCT00821392|Febuxostat|febuxostat|mesh-list
154071277|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
154071278|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071279|NCT00591578|Valsartan|valsartan|mesh-list
154071280|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154071281|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071282|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154071283|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154071284|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071316|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154071317|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154071318|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
154071319|NCT00455533|Paclitaxel|paclitaxel|mesh-list
154071320|NCT00455533|Epothilones|epothilones|mesh-list
154071321|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
154071322|NCT00455533|Doxorubicin|doxorubicin|mesh-list
154071323|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154071324|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071325|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
154071326|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
154071327|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
154071328|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071329|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071330|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
154071331|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071332|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071333|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154071334|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
154071335|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154071336|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154071337|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154071338|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154071339|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071340|NCT00818584|Micafungin|micafungin|mesh-list
153721484|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154071341|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
154071342|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071364|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154071365|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071366|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071367|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071368|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
154071369|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071370|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
154071371|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154071372|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154071373|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071374|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
154071375|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
154071376|NCT03840811|Cefixime|cefixime|mesh-list
154071377|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154071378|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071379|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154071380|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154071381|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071382|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071383|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071384|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154071385|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154071386|NCT03840811|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154071387|NCT03840811|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154071388|NCT00640510|Olanzapine|olanzapine|mesh-list
154071412|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154071413|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
154071414|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154071415|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154071416|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154071417|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071418|NCT00813800|Varenicline|varenicline|mesh-list
154071419|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154071420|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154071421|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
154071422|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071423|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071424|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071425|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
154071426|NCT00627016|Lansoprazole|lansoprazole|mesh-list
154071427|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154071428|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071429|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154071430|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071431|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071432|NCT00794664|Mipomersen|mipomersen|mesh-list
154071433|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154071434|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154071435|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
154071436|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071437|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153817514|NCT06187441|Hormones|hormones|mesh-ancestor
153817515|NCT06187441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817516|NCT06187441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817517|NCT06187441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817518|NCT06187441|Immunologic Factors|immunologic factors|mesh-ancestor
153817519|NCT06187441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153817520|NCT06187441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153817521|NCT06187441|Growth Substances|growth substances|mesh-ancestor
153817522|NCT06187441|Growth Inhibitors|growth inhibitors|mesh-ancestor
153817523|NCT06187090|Palmidrol|palmidrol|mesh-list
153817524|NCT06187090|Analgesics|analgesics|mesh-ancestor
153817525|NCT06187090|Sensory System Agents|sensory system agents|mesh-ancestor
153817526|NCT06187090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817527|NCT06187090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817528|NCT06187090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153817529|NCT06187090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817530|NCT06187090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817531|NCT06187090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458895|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154071439|NCT00444535|Lapatinib|lapatinib|mesh-list
154071440|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154071441|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071442|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154071443|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154071444|NCT00444535|Growth Substances|growth substances|mesh-ancestor
154071445|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071446|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
153458896|NCT05701332|Gemcitabine|gemcitabine|mesh-list
153458897|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
153458898|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153458899|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
153820696|NCT00434135|Paclitaxel|paclitaxel|mesh-list
153576760|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153576761|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
153576762|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576763|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
153576764|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
153576765|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
153576766|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576767|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153576768|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153576769|NCT01714089|Interferons|interferons|mesh-list
153576778|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153576779|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153576780|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153576781|NCT01714089|Analgesics|analgesics|mesh-ancestor
153576782|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
153576783|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576784|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576785|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153576786|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153576787|NCT01714102|Resveratrol|resveratrol|mesh-list
153576788|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
153576789|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576790|NCT01714102|Protective Agents|protective agents|mesh-ancestor
153458900|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458901|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458902|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153458903|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
153458904|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458905|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
153458906|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153458907|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458908|NCT03158142|Atropine|atropine|mesh-list
153458909|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153458910|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153458911|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153458912|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
153576791|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576792|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576793|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153576794|NCT01714115|Aflibercept|aflibercept|mesh-list
153576795|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153576796|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153576797|NCT01714115|Growth Substances|growth substances|mesh-ancestor
153576798|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576799|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
153576800|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576801|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153576802|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153576803|NCT01714128|Estradiol|estradiol|mesh-list
153576804|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153576805|NCT01714128|Estrogens|estrogens|mesh-ancestor
153576806|NCT01714128|Hormones|hormones|mesh-ancestor
154071447|NCT00444535|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153614189|NCT01966783|Mesalamine|mesalamine|mesh-list
154071448|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154071449|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071450|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071452|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154071453|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071454|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
154071455|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
154071456|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
154071457|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071458|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
154071459|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154071460|NCT00826306|Protective Agents|protective agents|mesh-ancestor
154071461|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071462|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
154071463|NCT05753852|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
154071464|NCT05753852|Antiviral Agents|antiviral agents|mesh-ancestor
154071465|NCT05753852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071466|NCT05753852|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154071467|NCT05753852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071468|NCT00821782|Azithromycin|azithromycin|mesh-list
154071469|NCT00821782|Levofloxacin|levofloxacin|mesh-list
154071470|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154071471|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071472|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154071473|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154071487|NCT00807092|Insulin|insulin|mesh-list
154071494|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071495|NCT04112550|Acetaminophen|acetaminophen|mesh-list
154071496|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154071497|NCT04112550|Oxycodone|oxycodone|mesh-list
154071498|NCT04112550|Methadone|methadone|mesh-list
154071499|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154071500|NCT04112550|Analgesics|analgesics|mesh-ancestor
154071501|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
154071502|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071503|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071504|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
154071505|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154071506|NCT04112550|Narcotics|narcotics|mesh-ancestor
154071507|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071508|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
154071509|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
154071510|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154071511|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071512|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071513|NCT00640042|Morphine|morphine|mesh-list
154071514|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154071515|NCT00640042|Narcotics|narcotics|mesh-ancestor
154071516|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071517|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071518|NCT00640042|Analgesics|analgesics|mesh-ancestor
154071519|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
154071520|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614262|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154071521|NCT00807014|Adapalene|adapalene|mesh-list
154071522|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154071523|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154071524|NCT00807014|Analgesics|analgesics|mesh-ancestor
154071525|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
154071533|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154071534|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071535|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154071536|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154071537|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071538|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071540|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071541|NCT00794040|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154071542|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
154071543|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154071544|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
154071545|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154071546|NCT04109742|Curcumin|curcumin|mesh-list
154071547|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154071548|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154071549|NCT04109742|Analgesics|analgesics|mesh-ancestor
154071550|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
154071551|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071552|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071553|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071554|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071555|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071556|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071557|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576807|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153576808|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576809|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153576810|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
153576811|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576812|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153576813|NCT01714154|Ritonavir|ritonavir|mesh-list
153576814|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153576815|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153576816|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
153576817|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576818|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576819|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153576820|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153458913|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458914|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458915|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154071559|NCT00813488|Oxycodone|oxycodone|mesh-list
154071560|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154071561|NCT00813488|Narcotics|narcotics|mesh-ancestor
154071562|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071563|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071564|NCT00813488|Analgesics|analgesics|mesh-ancestor
154071565|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
154071566|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071567|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154071568|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154071569|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
154071570|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
154071571|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154071572|NCT00797316|Aliskiren|aliskiren|mesh-list
154071573|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071574|NCT00797316|Diuretics|diuretics|mesh-ancestor
154071575|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
154071576|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071577|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154071578|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071579|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071580|NCT00797316|Renin Inhibitors|renin inhibitors|mesh-ancestor
154071581|NCT00797316|Protease Inhibitors|protease inhibitors|mesh-ancestor
154071583|NCT05753696|Losartan|losartan|mesh-list
154071610|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071611|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071612|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154071613|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071614|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
154071615|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
154071616|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071617|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071618|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
154071619|NCT00915408|Hormones|hormones|mesh-ancestor
154071620|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071621|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154071622|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154071623|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154071624|NCT00915408|Growth Substances|growth substances|mesh-ancestor
154071625|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
154071626|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
154071627|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071628|NCT00791076|Hormones|hormones|mesh-ancestor
154071629|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071630|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071631|NCT02610062|AGS67E|ags67e|mesh-list
154071632|NCT02610062|Immunoconjugates|immunoconjugates|mesh-ancestor
154071633|NCT02610062|Immunologic Factors|immunologic factors|mesh-ancestor
154071634|NCT02610062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071635|NCT00625378|Sorafenib|sorafenib|mesh-list
154071636|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071637|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154071638|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071639|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071640|NCT00806624|Warfarin|warfarin|mesh-list
154071641|NCT00806624|Edoxaban|edoxaban|mesh-list
154071642|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
154071651|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154071652|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
154071653|NCT00826852|Carboplatin|carboplatin|mesh-list
154071654|NCT00826852|Docetaxel|docetaxel|mesh-list
154071655|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071656|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
154071657|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
154071658|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
154071659|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071660|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
154071661|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
154071662|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071663|NCT00826930|Protective Agents|protective agents|mesh-ancestor
154071664|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071665|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154071666|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071667|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
154071668|NCT00913796|Diuretics|diuretics|mesh-ancestor
154071669|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
154071670|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071671|NCT00913796|Expectorants|expectorants|mesh-ancestor
154071672|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
154071673|NCT00633880|Droxidopa|droxidopa|mesh-list
154071674|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154071675|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154071676|NCT04029428|Octreotide|octreotide|mesh-list
154071677|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154071678|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154071679|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071680|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071681|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154071682|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071683|NCT00819520|Ivermectin|ivermectin|mesh-list
154071694|NCT00631696|Analgesics|analgesics|mesh-ancestor
154071695|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
154071696|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071697|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071699|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154071700|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071701|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071702|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154071703|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154071704|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154071705|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071706|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154071707|NCT02608112|Methotrexate|methotrexate|mesh-list
153721524|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153721525|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
154071708|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154071709|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
154071710|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154071711|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071712|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154071713|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
154071714|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071715|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071716|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
154071744|NCT00819676|Protective Agents|protective agents|mesh-ancestor
154071746|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
154071748|NCT00819754|Bevacizumab|bevacizumab|mesh-list
154071749|NCT00819754|Capecitabine|capecitabine|mesh-list
154071750|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
154071751|NCT00819754|Irinotecan|irinotecan|mesh-list
154071752|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154071753|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071754|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154071755|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154071756|NCT00819754|Growth Substances|growth substances|mesh-ancestor
154071757|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071758|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
154071759|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154071760|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
154071761|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071762|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154071763|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154071764|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071765|NCT00819988|Pregabalin|pregabalin|mesh-list
154071766|NCT00819988|Analgesics|analgesics|mesh-ancestor
154071767|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
154071768|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071769|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071770|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
154071771|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154071772|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071779|NCT00827554|Nadroparin|nadroparin|mesh-list
154071792|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
154071793|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071795|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154071796|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071797|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071798|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154071799|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071800|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154071801|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154071802|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154071803|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154071804|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154071805|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154071806|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154071807|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071808|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071809|NCT00862823|Tenofovir|tenofovir|mesh-list
154071810|NCT00862823|Emtricitabine|emtricitabine|mesh-list
154071811|NCT00862823|Efavirenz|efavirenz|mesh-list
154071812|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
154071813|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071814|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154071815|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154071816|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071818|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154071838|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071839|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154071840|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
154071841|NCT00790842|Hormones|hormones|mesh-ancestor
154071842|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154071843|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154071844|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071845|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154071846|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154071847|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071848|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
153563120|NCT01660997|Hormones|hormones|mesh-ancestor
154071849|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154071850|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154071851|NCT00790842|Growth Substances|growth substances|mesh-ancestor
154071852|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
154071853|NCT04104204|Morphine|morphine|mesh-list
154071854|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154071855|NCT04104204|Narcotics|narcotics|mesh-ancestor
154071856|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071857|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071858|NCT04104204|Analgesics|analgesics|mesh-ancestor
154071859|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
154071860|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071861|NCT00574288|Dexamethasone|dexamethasone|mesh-list
154071862|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
154071863|NCT00574288|Daratumumab|daratumumab|mesh-list
154071864|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154071865|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071866|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
154071884|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071885|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071886|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071887|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154071888|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154071889|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154071890|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071891|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154071892|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154071893|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071894|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
154071895|NCT00823030|Lidocaine|lidocaine|mesh-list
154071897|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
154071898|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154071899|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071900|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
154071901|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071902|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154071903|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154071904|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154071905|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576834|NCT01714206|Canagliflozin|canagliflozin|mesh-list
153576835|NCT01714206|Digoxin|digoxin|mesh-list
153576836|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153576837|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153576838|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576839|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576840|NCT01714206|Protective Agents|protective agents|mesh-ancestor
153576841|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576842|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153576843|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153576844|NCT01714297|Dalteparin|dalteparin|mesh-list
153576845|NCT01714297|Tinzaparin|tinzaparin|mesh-list
153576846|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153576847|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
153576848|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153576849|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153626786|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153576850|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576851|NCT01714388|Remifentanil|remifentanil|mesh-list
153576852|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153576853|NCT01714388|Narcotics|narcotics|mesh-ancestor
153576854|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576855|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576856|NCT01714388|Analgesics|analgesics|mesh-ancestor
153576857|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
153576858|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576859|NCT01714401|Albuterol|albuterol|mesh-list
153576860|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153576861|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
153576862|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576863|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071906|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071908|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154071909|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071910|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
154071911|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
154071912|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
154071913|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071914|NCT00626392|Aspirin|aspirin|mesh-list
154071915|NCT00626392|Niacin|niacin|mesh-list
154071916|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154071917|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153576864|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153576865|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
153576866|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
153576867|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576868|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153576869|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153576870|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153576871|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
153576872|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817535|NCT06187090|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153817537|NCT06187090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817538|NCT06187090|Hormones|hormones|mesh-ancestor
153817539|NCT06187090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153576878|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153576879|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576880|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576881|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
153576882|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576883|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153576884|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153576885|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
153576886|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153576887|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153576888|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153576889|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153576890|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153576891|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153576892|NCT01714427|Dexamethasone|dexamethasone|mesh-list
153576893|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576894|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
153576895|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
153576896|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781628|NCT00231335|Escitalopram|escitalopram|mesh-list
153576897|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576898|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576899|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
153576900|NCT01714427|Hormones|hormones|mesh-ancestor
153576901|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153576902|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153576903|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576904|NCT01714557|Tazobactam|tazobactam|mesh-list
153576905|NCT01714557|Piperacillin|piperacillin|mesh-list
153576906|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153576907|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153576908|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817540|NCT06186986|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153817541|NCT06186986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817542|NCT06186986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071918|NCT00626392|Analgesics|analgesics|mesh-ancestor
154071919|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
154071920|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154071921|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071922|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154071924|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154071925|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154071926|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071927|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154071928|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154071929|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154071930|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
154071931|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154071932|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
154071933|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154071934|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
154071935|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
154071936|NCT00626392|Vitamins|vitamins|mesh-ancestor
154071937|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
154071938|NCT00820690|Paclitaxel|paclitaxel|mesh-list
154071939|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
154071940|NCT00820690|Doxorubicin|doxorubicin|mesh-list
154071941|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154071942|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071943|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
154071944|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
154071945|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
154071946|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071947|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071948|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
154071949|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071963|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154071964|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154071965|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154071966|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154071967|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071968|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
153614709|NCT01969903|Analgesics|analgesics|mesh-ancestor
154071969|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154071970|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154071971|NCT00821080|Sirolimus|sirolimus|mesh-list
154071972|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154071973|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154071974|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154071975|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071976|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
154071977|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154071978|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
154071979|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154071980|NCT04044430|Nivolumab|nivolumab|mesh-list
154071981|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154071982|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154071983|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154071984|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072010|NCT00828802|Growth Substances|growth substances|mesh-ancestor
154072011|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
154072012|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072013|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154072014|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
154072015|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072016|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072017|NCT00785577|Pregabalin|pregabalin|mesh-list
154072018|NCT00785577|Analgesics|analgesics|mesh-ancestor
154072019|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
154072020|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072021|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072022|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
154072023|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154072024|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721541|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154072025|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072026|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154072027|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154072028|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154072029|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072030|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154072031|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
154072032|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154072033|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
154072034|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072035|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
154072036|NCT00830830|Protective Agents|protective agents|mesh-ancestor
154072037|NCT00828958|Risperidone|risperidone|mesh-list
154072038|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154072039|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
154072040|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817543|NCT06186986|Immunotoxins|immunotoxins|mesh-ancestor
153817544|NCT06186986|Immunoconjugates|immunoconjugates|mesh-ancestor
153817545|NCT06186986|Immunologic Factors|immunologic factors|mesh-ancestor
153817546|NCT06186986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817547|NCT06186921|Dexamethasone|dexamethasone|mesh-list
153817548|NCT06186921|Diclofenac|diclofenac|mesh-list
153576909|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153576910|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576911|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576913|NCT01714570|Piperacillin|piperacillin|mesh-list
153576914|NCT01714570|Imipenem|imipenem|mesh-list
153576915|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154072041|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072042|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072043|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154072044|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154072045|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072046|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154072047|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154072049|NCT02548780|Doxorubicin|doxorubicin|mesh-list
154072050|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154072051|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072052|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154072053|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154072054|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072055|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072056|NCT04105023|Genistein|genistein|mesh-list
154072057|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154072058|NCT04105023|Protective Agents|protective agents|mesh-ancestor
154072059|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072060|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576916|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153576917|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576918|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153576919|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458916|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
153458917|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
153458918|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
153458919|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153458920|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153458921|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
153458922|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458923|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458924|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
153458925|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153458926|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458927|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153458928|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153458929|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
153458930|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458931|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
153458932|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153458933|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
153458934|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576928|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576929|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153576930|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153576931|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576933|NCT01714765|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153576934|NCT01714765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153576935|NCT01714765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576936|NCT01714765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576937|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153576938|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
154072061|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154072062|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072063|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072064|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
154072065|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154072066|NCT04105023|Estrogens|estrogens|mesh-ancestor
154072068|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072069|NCT04104867|Domperidone|domperidone|mesh-list
154072070|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
154072071|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
154072072|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072073|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072074|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072075|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154072076|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
154072077|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072078|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072079|NCT00789828|Everolimus|everolimus|mesh-list
154072080|NCT00789828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154072081|NCT00789828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154072082|NCT00789828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072083|NCT00789828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072084|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072085|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
154072086|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072087|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072088|NCT02550262|Fentanyl|fentanyl|mesh-list
154072089|NCT02550262|Bupivacaine|bupivacaine|mesh-list
154072090|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
154072091|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
154072092|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576939|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576940|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576941|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
153576942|NCT01714817|Prednisone|prednisone|mesh-list
153576943|NCT01714817|Abatacept|abatacept|mesh-list
153576944|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153576945|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
153576946|NCT01714817|Hormones|hormones|mesh-ancestor
153576947|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072094|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
154072095|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072096|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154072097|NCT02550262|Narcotics|narcotics|mesh-ancestor
154072098|NCT02550262|Analgesics|analgesics|mesh-ancestor
154072099|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154072100|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154072101|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
154072102|NCT02550418|Budesonide|budesonide|mesh-list
154072103|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072104|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154072105|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
154072106|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072107|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072108|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154072109|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
154072110|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
154072111|NCT02550418|Hormones|hormones|mesh-ancestor
154072112|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072113|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154072114|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154072115|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153614856|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
154072116|NCT00829114|Estradiol|estradiol|mesh-list
154072117|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154072119|NCT00829114|Hormones|hormones|mesh-ancestor
154072120|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072121|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576948|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576949|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153576950|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576951|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153576952|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153576953|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
153576954|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153576961|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
153576962|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153576963|NCT01714843|Linaclotide|linaclotide|mesh-list
153576964|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153576965|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
153576966|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576967|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072122|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154072123|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
154072124|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154072125|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154072126|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154072127|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154072128|NCT00790296|Hormones|hormones|mesh-list
154072129|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
154072130|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072131|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072132|NCT00829192|Afamelanotide|afamelanotide|mesh-list
154072133|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
154072134|NCT00623194|Insulin|insulin|mesh-list
154072135|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154072136|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
154072137|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
154072138|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072139|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072140|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154072141|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
154072142|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
154072143|NCT02548468|Fludarabine|fludarabine|mesh-list
154072144|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
154072145|NCT02548468|Tacrolimus|tacrolimus|mesh-list
154072146|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072147|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
154072148|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072149|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072150|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154072151|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
154072153|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072167|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072168|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072169|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072171|NCT00915564|Methadone|methadone|mesh-list
154072172|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154072173|NCT00915564|Narcotics|narcotics|mesh-ancestor
154072174|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072175|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072176|NCT00915564|Analgesics|analgesics|mesh-ancestor
154072177|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
154072178|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072179|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
154072180|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
154072181|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
154072182|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072183|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
154072184|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072185|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072186|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
154072187|NCT02603406|Hematinics|hematinics|mesh-ancestor
154072188|NCT04106700|Apixaban|apixaban|mesh-list
154072190|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
154072222|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
154072223|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072224|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072225|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072226|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072227|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
154072228|NCT00824200|Tamsulosin|tamsulosin|mesh-list
154072229|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
154072230|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
154072231|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
154072232|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154072233|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072234|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072235|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072236|NCT00824200|Urological Agents|urological agents|mesh-ancestor
154072237|NCT00829894|Risperidone|risperidone|mesh-list
154072238|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154072239|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
154072240|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072241|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072242|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072243|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154072244|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154072245|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072246|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154072247|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154072248|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
154072249|NCT00622726|Bevacizumab|bevacizumab|mesh-list
154072250|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154072251|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072252|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154072254|NCT00622726|Growth Substances|growth substances|mesh-ancestor
154072261|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
154072262|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072263|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072264|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072265|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153615007|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
154072266|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
154072267|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154072268|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072269|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072270|NCT00623428|Ribavirin|ribavirin|mesh-list
154072271|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154072272|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
154072273|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072274|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
154072275|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072276|NCT00824668|Insulin|insulin|mesh-list
154072277|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154072278|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
154072279|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
154072280|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
154072281|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154072282|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
154072283|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072284|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072285|NCT00832234|Dexamethasone|dexamethasone|mesh-list
154072286|NCT00832234|Rituximab|rituximab|mesh-list
154072287|NCT00832234|Bortezomib|bortezomib|mesh-list
154072288|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072289|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
154072290|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
154072291|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072292|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072304|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072305|NCT05036980|Protective Agents|protective agents|mesh-ancestor
154072306|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072307|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154072308|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072309|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
154072310|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
154072311|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154072312|NCT00837850|Protective Agents|protective agents|mesh-ancestor
154072313|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072314|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154072315|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154072316|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154072317|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072318|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154072319|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154072320|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
154072321|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072322|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072323|NCT04102566|Ibuprofen|ibuprofen|mesh-list
154072324|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154072325|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154072326|NCT04102566|Analgesics|analgesics|mesh-ancestor
154072327|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
154072328|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072329|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072330|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072331|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072332|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154072346|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154072347|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072348|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072349|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154072350|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154072351|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154072352|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
154072353|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
154072354|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072355|NCT00789360|Loxapine|loxapine|mesh-list
154072356|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154072357|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154072358|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072359|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072360|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154072361|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154072362|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
154072363|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072364|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072365|NCT00782418|Exenatide|exenatide|mesh-list
154072366|NCT00782418|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154072367|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072368|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072370|NCT00782418|Incretins|incretins|mesh-ancestor
154072371|NCT00782418|Hormones|hormones|mesh-ancestor
154072372|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072373|NCT00782340|Droxidopa|droxidopa|mesh-list
154072374|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154072375|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154072376|NCT00774852|Prednisone|prednisone|mesh-list
154072377|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
154072378|NCT00774852|Abatacept|abatacept|mesh-list
154072390|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
154072391|NCT00774852|Hormones|hormones|mesh-ancestor
154072392|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072393|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154072394|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154072395|NCT00774852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154072396|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
154072397|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154072398|NCT00774306|Phenytoin|phenytoin|mesh-list
154072399|NCT00774306|Levetiracetam|levetiracetam|mesh-list
154072400|NCT00774306|Valproic Acid|valproic acid|mesh-list
154072401|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
154072402|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
154072403|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072404|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072405|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
154072406|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072407|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072408|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
154072409|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154072410|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072411|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154072412|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154072413|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154072414|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615157|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154072415|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154072416|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154072417|NCT04105764|Bromides|bromides|mesh-list
154072418|NCT04105764|Rocuronium|rocuronium|mesh-list
154072419|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154072420|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
154072421|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154072422|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153576968|NCT01714856|Ropinirole|ropinirole|mesh-list
153576969|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153576970|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154072423|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072424|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072425|NCT00781326|Nimodipine|nimodipine|mesh-list
154072426|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154072427|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154072428|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154072429|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072430|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154072431|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072432|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
154072433|NCT00773838|Dexamethasone|dexamethasone|mesh-list
154072434|NCT00773838|Bortezomib|bortezomib|mesh-list
154072435|NCT00773838|Vorinostat|vorinostat|mesh-list
154072436|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072437|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
154072438|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
154072439|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072440|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072441|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072443|NCT00773838|Hormones|hormones|mesh-ancestor
154072444|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072445|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154072446|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072447|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154072448|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072449|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072450|NCT00787644|Pioglitazone|pioglitazone|mesh-list
154072451|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072452|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072453|NCT02602002|Remifentanil|remifentanil|mesh-list
154072454|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154072455|NCT02602002|Narcotics|narcotics|mesh-ancestor
154072458|NCT02602002|Analgesics|analgesics|mesh-ancestor
154072465|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072466|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072467|NCT00787566|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154072468|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154072469|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
154072470|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072471|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072473|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154072474|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154072475|NCT02602938|Analgesics|analgesics|mesh-ancestor
154072476|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
154072477|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072478|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072479|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072480|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072481|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154072482|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154072483|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072484|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154072485|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154072486|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072487|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
154072488|NCT00787254|Lansoprazole|lansoprazole|mesh-list
154072489|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
154072490|NCT00787254|Gefarnate|gefarnate|mesh-list
154072491|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154072492|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072493|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154072494|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072495|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072496|NCT00922402|Insulin|insulin|mesh-list
154072497|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072498|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072499|NCT04105374|Flucytosine|flucytosine|mesh-list
154072500|NCT04105374|Temozolomide|temozolomide|mesh-list
154072501|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153576972|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
154072502|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
154072503|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072504|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072505|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
154072506|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072507|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
154072508|NCT04102878|Anesthetics|anesthetics|mesh-list
154072509|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
154072510|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072511|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072512|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
154072513|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072514|NCT00838240|Cytarabine|cytarabine|mesh-list
154072515|NCT00838240|Clofarabine|clofarabine|mesh-list
154072516|NCT00838240|Idarubicin|idarubicin|mesh-list
154072517|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154072518|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
154072561|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072562|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
153615309|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
154072563|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
154072564|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072565|NCT00833404|Nicotine|nicotine|mesh-list
154072566|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154072567|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
154072568|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072569|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072570|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154072571|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154072572|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
154072573|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072574|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072575|NCT00833716|Semaglutide|semaglutide|mesh-list
154072576|NCT00833716|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154072577|NCT00833716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072578|NCT00833716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072579|NCT00621322|Vaccines|vaccines|mesh-list
154072580|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
154072581|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072582|NCT00839488|Pantoprazole|pantoprazole|mesh-list
154072583|NCT00839488|Famotidine|famotidine|mesh-list
154072584|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154072585|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072586|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154072587|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072588|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072589|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154072590|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
153564135|NCT01668446|Estradiol|estradiol|mesh-list
154072591|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
154072592|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072594|NCT00834184|Nikkomycin|nikkomycin|mesh-list
154072601|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
154072602|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
154072603|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154072604|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
154072605|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154072606|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072607|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072608|NCT00853385|Adalimumab|adalimumab|mesh-list
154072609|NCT00853385|Tofacitinib|tofacitinib|mesh-list
154072610|NCT00853385|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154072611|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072612|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072613|NCT00853385|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154072614|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154072615|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072616|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072617|NCT00622336|Lenalidomide|lenalidomide|mesh-list
154072618|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
154072619|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072620|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154072621|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154072622|NCT00622336|Growth Substances|growth substances|mesh-ancestor
154072623|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
154072624|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072625|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154072626|NCT00846365|Olmesartan|olmesartan|mesh-list
154072627|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154072628|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
154072629|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154072630|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154072631|NCT00846365|Diuretics|diuretics|mesh-ancestor
154072632|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
154072633|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072634|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154072635|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154072636|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576973|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072637|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154072638|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154072639|NCT00834730|Ketamine|ketamine|mesh-list
154072640|NCT00834730|Analgesics|analgesics|mesh-ancestor
154072641|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
154072642|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072643|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072644|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154072645|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154072646|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
154072647|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
154072648|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072649|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154072650|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154072651|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072652|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072653|NCT02601924|Anesthetics|anesthetics|mesh-list
154072654|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
154072655|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072656|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072657|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
154072658|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072660|NCT00840112|Tocopherols|tocopherols|mesh-list
154072661|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
154072662|NCT00840112|Vitamins|vitamins|mesh-ancestor
154072663|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
154072664|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072665|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
154072666|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072667|NCT00840112|Protective Agents|protective agents|mesh-ancestor
154072668|NCT04101474|Ketamine|ketamine|mesh-list
154072680|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072681|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072682|NCT04101708|Amoxicillin|amoxicillin|mesh-list
154072683|NCT04101708|Clarithromycin|clarithromycin|mesh-list
154072684|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154072685|NCT04101708|Lansoprazole|lansoprazole|mesh-list
154072686|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
154072687|NCT04101708|Bismuth|bismuth|mesh-list
154072688|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154072689|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072690|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154072691|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072692|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072693|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154072694|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154072695|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154072696|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072697|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154072698|NCT04101708|Antacids|antacids|mesh-ancestor
154072699|NCT00779142|Methotrexate|methotrexate|mesh-list
154072700|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154072701|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
154072702|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154072703|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072704|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154072705|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
154072706|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072707|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072728|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154072729|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154072730|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072731|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154072732|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154072733|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072734|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072735|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072736|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154072737|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
154072738|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154072739|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072740|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154072741|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154072742|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154072743|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154072744|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154072745|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154072746|NCT00773136|Bimatoprost|bimatoprost|mesh-list
153576974|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576975|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576976|NCT01714895|Insulin|insulin|mesh-list
153576977|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153576978|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153576979|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576980|NCT01714908|Etoposide|etoposide|mesh-list
153576981|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153576982|NCT01714908|Cisplatin|cisplatin|mesh-list
153817553|NCT06186921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817554|NCT06186921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817555|NCT06186921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817556|NCT06186921|Glucocorticoids|glucocorticoids|mesh-ancestor
153817557|NCT06186921|Hormones|hormones|mesh-ancestor
153817558|NCT06186921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817559|NCT06186921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817560|NCT06186921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817561|NCT06186921|Anesthetics, Local|anesthetics, local|mesh-ancestor
153817562|NCT06186921|Anesthetics|anesthetics|mesh-ancestor
153817563|NCT06186921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817564|NCT06186921|Sensory System Agents|sensory system agents|mesh-ancestor
153817565|NCT06186921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153817566|NCT06186921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817567|NCT06186921|Analgesics|analgesics|mesh-ancestor
153817568|NCT06186921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153817569|NCT06186921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153817570|NCT06186921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072747|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154072748|NCT02602860|Levetiracetam|levetiracetam|mesh-list
154072749|NCT02602860|Brivaracetam|brivaracetam|mesh-list
154072750|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
154072751|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
154072752|NCT00825058|Paroxetine|paroxetine|mesh-list
154072753|NCT00825058|Amibegron|amibegron|mesh-list
154072754|NCT00825058|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
154072755|NCT00825058|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154072756|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154072757|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154072758|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072759|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072760|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
154072761|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072762|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154072763|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
154072764|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154072765|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154072766|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154072767|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072768|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154072769|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154072770|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
154072771|NCT00825058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154072772|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
154072773|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072774|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072775|NCT00835744|Clomiphene|clomiphene|mesh-list
154072776|NCT00835744|Enclomiphene|enclomiphene|mesh-list
154072777|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
154072778|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154072779|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
154072780|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072781|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072783|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
154072785|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154072786|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154072787|NCT00778830|Cetuximab|cetuximab|mesh-list
153615533|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
154072788|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154072789|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072790|NCT00772668|Prednisone|prednisone|mesh-list
154072791|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
154072792|NCT00772668|Rituximab|rituximab|mesh-list
154072793|NCT00772668|Bortezomib|bortezomib|mesh-list
154072794|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072795|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
154072796|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072797|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072798|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154072799|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
154072800|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072843|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072844|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154072845|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154072846|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154072847|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072848|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154072849|NCT00853073|Bevacizumab|bevacizumab|mesh-list
154072850|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154072851|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072852|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154072853|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154072854|NCT00853073|Growth Substances|growth substances|mesh-ancestor
154072855|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072856|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
154072857|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
154072858|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154072859|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154072860|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072861|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
154072862|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154072863|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576983|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153576984|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576985|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153576986|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153576987|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576988|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576989|NCT01714908|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153576990|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153576999|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153577000|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577001|NCT01715142|Paclitaxel|paclitaxel|mesh-list
153577002|NCT01715142|Gemcitabine|gemcitabine|mesh-list
153577003|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153577004|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153577005|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577006|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
153577007|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
153577008|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
153577009|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458935|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458936|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153458937|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153458938|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153458939|NCT01671384|Valproic Acid|valproic acid|mesh-list
153458940|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
153458941|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072864|NCT04120337|Lidocaine|lidocaine|mesh-list
154072865|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
154072866|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
154072867|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072868|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072869|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
154072870|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072871|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154072872|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154072873|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154072874|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154072875|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072876|NCT00592319|Celecoxib|celecoxib|mesh-list
154072877|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154072878|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154072879|NCT00592319|Analgesics|analgesics|mesh-ancestor
154072880|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
154072881|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072882|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072883|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072884|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072885|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154072886|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154072887|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072888|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072889|NCT00862121|Mesalamine|mesalamine|mesh-list
154072890|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154072891|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154072892|NCT00862121|Analgesics|analgesics|mesh-ancestor
154072893|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
154072894|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072895|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072896|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154072902|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072903|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072904|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
154072905|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072906|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
154072907|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154072908|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154072909|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072910|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154072911|NCT00784719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154072912|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154072913|NCT00852917|Tramadol|tramadol|mesh-list
154072914|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154072915|NCT00852917|Narcotics|narcotics|mesh-ancestor
154072916|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154072917|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072918|NCT00852917|Analgesics|analgesics|mesh-ancestor
154072919|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
154072920|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154072921|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154072922|NCT00700583|Terazosin|terazosin|mesh-list
154072923|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154072924|NCT00700583|Diuretics|diuretics|mesh-ancestor
154072925|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
154072926|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072927|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154072928|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154072929|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072930|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154072931|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154072932|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154072933|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
153615688|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
154072934|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458942|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458943|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
153458944|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458945|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458946|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
154072935|NCT00700583|Urological Agents|urological agents|mesh-ancestor
154072937|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072938|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154072939|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072940|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154072941|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154072942|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072943|NCT00845429|Vaccines|vaccines|mesh-list
154072944|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
154072945|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072946|NCT00844883|Sorafenib|sorafenib|mesh-list
154072947|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072948|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154072949|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072950|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072951|NCT00851903|Metformin|metformin|mesh-list
154072952|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
154072953|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154072954|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154072955|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072956|NCT00851903|Incretins|incretins|mesh-ancestor
154072957|NCT00851903|Hormones|hormones|mesh-ancestor
153745625|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154072958|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154072959|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154072960|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
154072961|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072962|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072963|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
154072964|NCT00587457|Immunotoxins|immunotoxins|mesh-ancestor
154072965|NCT00587457|Immunoconjugates|immunoconjugates|mesh-ancestor
154072978|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154072979|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
154072980|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154072981|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154072982|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154072983|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
154072984|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154072985|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154072986|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
154072987|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154072988|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154072989|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154072990|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
154072991|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154072992|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154072993|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154072994|NCT00767325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154072995|NCT00851591|Psyllium|psyllium|mesh-list
154072996|NCT00851591|Cathartics|cathartics|mesh-ancestor
154072997|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154072998|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
154072999|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154073000|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073001|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073002|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154073003|NCT02612363|Analgesics|analgesics|mesh-ancestor
154073004|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
154073005|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073006|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154073007|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154073008|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153458947|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153458948|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577010|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153577012|NCT01715168|Doxorubicin|doxorubicin|mesh-list
153577013|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153577014|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153577015|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073009|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
154073010|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073011|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073012|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154073013|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154073014|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154073015|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154073017|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
154073018|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
154073019|NCT00700895|Warfarin|warfarin|mesh-list
154073020|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
154073021|NCT00861341|Aspirin|aspirin|mesh-list
154073022|NCT00861341|Pioglitazone|pioglitazone|mesh-list
154073023|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154073024|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154073025|NCT00861341|Analgesics|analgesics|mesh-ancestor
154073026|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
154073027|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073028|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073029|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073030|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073031|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154073032|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154073033|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073034|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154073035|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154073036|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073037|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
154073038|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154073039|NCT00766467|Modafinil|modafinil|mesh-list
154073040|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154073041|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073046|NCT00850499|Rituximab|rituximab|mesh-list
154073050|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073051|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
154073052|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073053|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073054|NCT00844805|Infliximab|infliximab|mesh-list
154073055|NCT00844805|Naproxen|naproxen|mesh-list
154073056|NCT00844805|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154073057|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073058|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
154073059|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073060|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073061|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154073062|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154073063|NCT00844805|Analgesics|analgesics|mesh-ancestor
154073064|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
154073065|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073066|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073067|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
154073068|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154073069|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073070|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073071|NCT00765999|Linaclotide|linaclotide|mesh-list
154073072|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154073073|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
154073074|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073075|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073076|NCT04099407|Pirfenidone|pirfenidone|mesh-list
154073077|NCT04099407|Analgesics|analgesics|mesh-ancestor
154073078|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
153721931|NCT00454519|Mitomycins|mitomycins|mesh-list
154073079|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073080|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073081|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154073082|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154073083|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073084|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577016|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153577017|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153577018|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073087|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
154073088|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154073089|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154073090|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073091|NCT00764751|Calcipotriene|calcipotriene|mesh-list
154073092|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
154073093|NCT00764517|Rituximab|rituximab|mesh-list
154073094|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154073095|NCT00764517|Vorinostat|vorinostat|mesh-list
154073096|NCT00764517|Cladribine|cladribine|mesh-list
154073097|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
154073098|NCT00764517|Antibodies|antibodies|mesh-list
154073099|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
154073100|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154073101|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
154073102|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073103|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073104|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073105|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154073106|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073107|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073108|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154073110|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
154073111|NCT00764361|Doxycycline|doxycycline|mesh-list
154073112|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073113|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073114|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
154073115|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154073116|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154073117|NCT00763971|Methylphenidate|methylphenidate|mesh-list
154073118|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154073119|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154073120|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073121|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154073122|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154073123|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154073124|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073125|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
154073126|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073127|NCT00763815|Metformin|metformin|mesh-list
154073128|NCT00763815|Pioglitazone|pioglitazone|mesh-list
154073129|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154073130|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073131|NCT00763269|Silicon|silicon|mesh-list
154073132|NCT00763269|Triclosan|triclosan|mesh-list
154073133|NCT00763269|Fluorides|fluorides|mesh-list
154073134|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
154073135|NCT00763269|Protective Agents|protective agents|mesh-ancestor
154073136|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073137|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154073138|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073139|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154073140|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154073141|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
154073142|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073143|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154073144|NCT00763269|Trace Elements|trace elements|mesh-ancestor
154073145|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
154073146|NCT00763035|Dobutamine|dobutamine|mesh-list
154073147|NCT00763035|Regadenoson|regadenoson|mesh-list
154073148|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154073149|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
154073150|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
154073151|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073152|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073153|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154073154|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154073155|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153577019|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577020|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
153577021|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
153577022|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
153577023|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577024|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153577025|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577026|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577027|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
153577028|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153577029|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073156|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
154073157|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073158|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073159|NCT00763035|Protective Agents|protective agents|mesh-ancestor
154073160|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154073161|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154073162|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
154073163|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
154073164|NCT00844649|Paclitaxel|paclitaxel|mesh-list
154073165|NCT00844649|Gemcitabine|gemcitabine|mesh-list
154073166|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154073167|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154073168|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073169|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
154073170|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
154073171|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
154073172|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073173|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154073174|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
154073175|NCT04098861|Timolol|timolol|mesh-list
154073176|NCT04098861|Latanoprost|latanoprost|mesh-list
154073177|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154073178|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154073207|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
154073208|NCT00843635|Tadalafil|tadalafil|mesh-list
154073209|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
154073210|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154073211|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154073212|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073213|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073214|NCT00843635|Urological Agents|urological agents|mesh-ancestor
154073215|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
154073216|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
154073217|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154073218|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154073219|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073220|NCT04116827|Tamoxifen|tamoxifen|mesh-list
154073221|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154073222|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
154073223|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073224|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721974|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
154073225|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154073226|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073227|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154073228|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154073229|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154073230|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
154073231|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154073232|NCT00849017|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154073233|NCT00849017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154073235|NCT00849017|Incretins|incretins|mesh-ancestor
154073236|NCT00849017|Hormones|hormones|mesh-ancestor
154073237|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073250|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073251|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073252|NCT00762411|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
154073253|NCT00762411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154073255|NCT00762411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073256|NCT00841763|Vaccines|vaccines|mesh-list
154073257|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
154073258|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073259|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154073260|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
154073261|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073262|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
154073263|NCT02602704|Calcium|calcium|mesh-list
154073264|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154073265|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073266|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154073267|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154073268|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
154073269|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073270|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154073271|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154073272|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
154073273|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
154073274|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
154073275|NCT00703313|Levofloxacin|levofloxacin|mesh-list
154073276|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
154073277|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154073278|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153577030|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153577031|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
153577032|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153577033|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
153577034|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577035|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577036|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153577049|NCT01715363|Protective Agents|protective agents|mesh-ancestor
153577050|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577051|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
153577052|NCT01715363|Vitamins|vitamins|mesh-ancestor
154073279|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154073280|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073281|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073282|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154073283|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154073284|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073285|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073286|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073287|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154073288|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
154073289|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154073290|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073291|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153729940|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729941|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153729943|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
153729944|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
153729945|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729946|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153729947|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729948|NCT00131963|Paclitaxel|paclitaxel|mesh-list
153729949|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
153729950|NCT00131963|Doxorubicin|doxorubicin|mesh-list
153729951|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153729952|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729953|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
153729954|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
153729955|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
153729956|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577053|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
153577055|NCT01715441|Irinotecan|irinotecan|mesh-list
153577056|NCT01715441|Sorafenib|sorafenib|mesh-list
153577057|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153577058|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153577059|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577060|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577061|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577062|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153577063|NCT01715493|Muramidase|muramidase|mesh-list
153577064|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729957|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153729958|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
153729959|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729960|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073292|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154073293|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154073294|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154073295|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154073296|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154073297|NCT00703079|Octreotide|octreotide|mesh-list
154073298|NCT00703079|Lanreotide|lanreotide|mesh-list
154073299|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073300|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154073301|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073302|NCT00840827|Cyclosporine|cyclosporine|mesh-list
154073303|NCT00840827|Lenalidomide|lenalidomide|mesh-list
154073304|NCT00840827|Cyclosporins|cyclosporins|mesh-list
154073305|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073306|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073307|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154073308|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
154073309|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073310|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
154073311|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073312|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
154073313|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073314|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154073315|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154073316|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154073317|NCT00840827|Growth Substances|growth substances|mesh-ancestor
154073318|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
154073319|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073320|NCT00703469|Nivolumab|nivolumab|mesh-list
154073321|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073322|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073323|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154073325|NCT02612207|Bilirubin|bilirubin|mesh-list
154073327|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073328|NCT02612207|Protective Agents|protective agents|mesh-ancestor
154073329|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073330|NCT00859937|Dasatinib|dasatinib|mesh-list
154073331|NCT00859937|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154073332|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073333|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073334|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073335|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073336|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154073337|NCT04030715|Bismuth|bismuth|mesh-list
154073338|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073339|NCT04030715|Antacids|antacids|mesh-ancestor
154073340|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073341|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073342|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154073343|NCT00592007|Fulvestrant|fulvestrant|mesh-list
154073344|NCT00592007|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154073345|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073346|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073347|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073348|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073374|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154073375|NCT00859469|Gemcitabine|gemcitabine|mesh-list
154073376|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
154073377|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154073378|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
154073379|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073380|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073381|NCT00703625|Sirolimus|sirolimus|mesh-list
154073382|NCT00703625|Docetaxel|docetaxel|mesh-list
154073383|NCT00703625|Temsirolimus|temsirolimus|mesh-list
154073384|NCT00703625|MTOR Inhibitors|mtor inhibitors|mesh-list
154073385|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073386|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
154073387|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
154073388|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
154073389|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073390|NCT00703625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073391|NCT00703625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073392|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154073393|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
154073394|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073395|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073396|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073397|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154073398|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
154073399|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154073400|NCT00703703|Darifenacin|darifenacin|mesh-list
154073401|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154073402|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154073403|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
154073404|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073405|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073406|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073407|NCT00703703|Urological Agents|urological agents|mesh-ancestor
154073408|NCT00859313|Sufentanil|sufentanil|mesh-list
154073409|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154073410|NCT00859313|Narcotics|narcotics|mesh-ancestor
154073413|NCT00859313|Analgesics|analgesics|mesh-ancestor
154073414|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
154073415|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073416|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154073417|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154073418|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
154073419|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
154073420|NCT02611973|Aspirin|aspirin|mesh-list
154073421|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
154073422|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154073423|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154073424|NCT02611973|Analgesics|analgesics|mesh-ancestor
154073425|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
154073426|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073427|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073428|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073429|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073430|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154073431|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154073432|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073433|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154073434|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154073435|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073436|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
154073437|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073438|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
154073439|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154073440|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
154073441|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154073442|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
154073443|NCT00836927|Sirolimus|sirolimus|mesh-list
153729961|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153729962|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
154073447|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073448|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
154073449|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154073450|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
154073451|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073453|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073454|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073455|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154073456|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154073457|NCT00703235|Growth Substances|growth substances|mesh-ancestor
154073458|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073459|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
154073460|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154073461|NCT00771030|Brodalumab|brodalumab|mesh-list
154073462|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
154073463|NCT00768300|Ambrisentan|ambrisentan|mesh-list
154073464|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154073465|NCT00768222|Triclosan|triclosan|mesh-list
154073466|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154073467|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073468|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154073469|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154073470|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
154073471|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073472|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154073473|NCT00768144|Sunitinib|sunitinib|mesh-list
154073474|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073475|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154073476|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154073477|NCT00768144|Growth Substances|growth substances|mesh-ancestor
154073478|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073479|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
154073480|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073481|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073489|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
154073490|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073491|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154073493|NCT04104984|Progesterone|progesterone|mesh-list
154073494|NCT04104984|Progestins|progestins|mesh-ancestor
154073495|NCT04104984|Hormones|hormones|mesh-ancestor
154073496|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073497|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073498|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154073499|NCT00767520|Dasatinib|dasatinib|mesh-list
154073501|NCT00767520|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154073502|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073503|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073504|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073505|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073506|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154073507|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154073508|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154073509|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
154073510|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073511|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073512|NCT00858845|Clonidine|clonidine|mesh-list
154073513|NCT00858845|Analgesics|analgesics|mesh-ancestor
154073514|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
154073515|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073516|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073517|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154073518|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
154073519|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
154073520|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154073521|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154073522|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154073523|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
154073524|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577065|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153577066|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
154073525|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073526|NCT00770562|Dexamethasone|dexamethasone|mesh-list
154073527|NCT00770562|Rituximab|rituximab|mesh-list
154073528|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073529|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
154073530|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
154073531|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073532|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073533|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729967|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729968|NCT00140400|Immunomodulating Agents|immunomodulating agents|mesh-list
153729969|NCT00140400|Immunologic Factors|immunologic factors|mesh-ancestor
153729970|NCT00140400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729972|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153729973|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729974|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
153729975|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729976|NCT00132158|Irinotecan|irinotecan|mesh-list
153729977|NCT00132158|Gefitinib|gefitinib|mesh-list
154073534|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
154073535|NCT00770562|Hormones|hormones|mesh-ancestor
154073536|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073537|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154073538|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073539|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073540|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
154073541|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729978|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153616373|NCT06327269|Lenvatinib|lenvatinib|mesh-list
154073563|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
154073564|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153729979|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153729980|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729981|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729982|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729983|NCT00132158|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153729984|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153729985|NCT00140478|Mifepristone|mifepristone|mesh-list
153729986|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153729987|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
153729988|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153729989|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729990|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153729991|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154073601|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073603|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
154073604|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
154073605|NCT02600988|Vitamins|vitamins|mesh-list
154073606|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
154073607|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073608|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153722036|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154073609|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154073610|NCT04097574|Menthol|menthol|mesh-list
154073611|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
154073612|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
154073613|NCT00766038|Hormones|hormones|mesh-list
154073614|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073615|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073616|NCT00765882|Linaclotide|linaclotide|mesh-list
154073617|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154073618|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
154073619|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073620|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073621|NCT00913367|Insulin|insulin|mesh-list
154073622|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154073623|NCT00913367|Metformin|metformin|mesh-list
154073624|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
154073625|NCT00913367|Glimepiride|glimepiride|mesh-list
154073626|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154073627|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073628|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154073629|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154073630|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
154073631|NCT00828113|Varenicline|varenicline|mesh-list
154073632|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154073633|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154073634|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
154073644|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154073645|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
154073646|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073647|NCT00769704|Molgramostim|molgramostim|mesh-list
154073648|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154073649|NCT00769704|Sargramostim|sargramostim|mesh-list
154073650|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
154073651|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073652|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073653|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073654|NCT00818753|Heparin|heparin|mesh-list
154073655|NCT00818753|Calcium heparin|calcium heparin|mesh-list
154073656|NCT00818753|Dabigatran|dabigatran|mesh-list
154073657|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
154073658|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154073659|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154073660|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073661|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
154073662|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154073663|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
154073664|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073665|NCT00704249|Nevirapine|nevirapine|mesh-list
154073666|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154073667|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154073668|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073669|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073670|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
154073671|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073672|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154073673|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154073674|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154073675|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154073676|NCT00765726|Factor VIII|factor viii|mesh-list
154073677|NCT00765726|Coagulants|coagulants|mesh-ancestor
154073678|NCT04100226|Vitamin D|vitamin d|mesh-list
153577067|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153577068|NCT01715519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153577069|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153577082|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
153577083|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073679|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
154073680|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
154073682|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
154073683|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073684|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154073685|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154073686|NCT04100226|Antacids|antacids|mesh-ancestor
154073687|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073688|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073689|NCT00765336|Minocycline|minocycline|mesh-list
154073690|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073691|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073692|NCT00818519|Drospirenone|drospirenone|mesh-list
154073693|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154073694|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
154073695|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073696|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073697|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154073698|NCT00818519|Diuretics|diuretics|mesh-ancestor
154073708|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730020|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153730021|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153730022|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
153730023|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730024|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730025|NCT00132275|Amoxicillin|amoxicillin|mesh-list
153730026|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
153730027|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
153730028|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073709|NCT00765102|Bortezomib|bortezomib|mesh-list
154073710|NCT00765102|Romidepsin|romidepsin|mesh-list
154073711|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073712|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154073713|NCT00765102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154073714|NCT00765102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073715|NCT00765102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073716|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154073717|NCT00809354|Tanezumab|tanezumab|mesh-list
154073718|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154073719|NCT00809354|Analgesics|analgesics|mesh-ancestor
154073720|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
154073721|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073722|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073723|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073724|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073725|NCT00834899|Eptifibatide|eptifibatide|mesh-list
154073746|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073747|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073748|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154073749|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153730029|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730030|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153730031|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730032|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730033|NCT01246999|Vaccines|vaccines|mesh-list
153730034|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
153730035|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730036|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
153730037|NCT00140595|Rituximab|rituximab|mesh-list
154073750|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073751|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154073752|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154073753|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154073754|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073755|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
154073756|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073757|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
154073758|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073759|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154073760|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154073761|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073762|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073763|NCT00764478|Asenapine|asenapine|mesh-list
154073764|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154073765|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154073766|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073767|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073768|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154073769|NCT00805766|Infliximab|infliximab|mesh-list
154073770|NCT00805766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153577084|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577085|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153577086|NCT01715584|Analgesics|analgesics|mesh-ancestor
153577087|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
153577088|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073771|NCT00805766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073772|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
154073773|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073774|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073775|NCT00764322|Tamoxifen|tamoxifen|mesh-list
154073776|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154073777|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
154073778|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154073779|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073780|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154073781|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073782|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154073783|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154073784|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154073785|NCT03908060|Morphine|morphine|mesh-list
154073786|NCT03908060|Methadone|methadone|mesh-list
154073787|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154073788|NCT03908060|Narcotics|narcotics|mesh-ancestor
154073789|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073790|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730038|NCT00140595|Doxorubicin|doxorubicin|mesh-list
153730039|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730040|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
153730041|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730042|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730043|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153730044|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
153730045|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730046|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730047|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153730048|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153577089|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
153577090|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
153577091|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577092|NCT01715597|Protective Agents|protective agents|mesh-ancestor
153577093|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577094|NCT01715597|Vitamins|vitamins|mesh-ancestor
153577095|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
153577096|NCT01715610|Clindamycin|clindamycin|mesh-list
153577097|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
153577098|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
153577099|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153577100|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153730050|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153730051|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153730052|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730053|NCT04696783|Esomeprazole|esomeprazole|mesh-list
153730054|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153730055|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153730056|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153730057|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730058|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730059|NCT00132431|Cinacalcet|cinacalcet|mesh-list
154073791|NCT03908060|Analgesics|analgesics|mesh-ancestor
154073792|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
154073793|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073794|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
154073795|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
154073796|NCT00752856|Ritonavir|ritonavir|mesh-list
154073797|NCT00752856|Lopinavir|lopinavir|mesh-list
154073798|NCT00752856|Tenofovir|tenofovir|mesh-list
154073799|NCT00752856|Emtricitabine|emtricitabine|mesh-list
154073800|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
154073801|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154073802|NCT00752856|Efavirenz|efavirenz|mesh-list
154073803|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154073804|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153730060|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153730061|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730062|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153730063|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
153730064|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153730065|NCT00140712|Ropinirole|ropinirole|mesh-list
153730066|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153730067|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153730068|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
153817581|NCT06186895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153817582|NCT06186895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153817583|NCT06186895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153458949|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153458950|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
153458951|NCT01671774|Interleukin-2|interleukin-2|mesh-list
154073805|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
154073806|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073807|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073808|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154073809|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154073810|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
154073811|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073812|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154073813|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154073814|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154073815|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154073816|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154073817|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154073818|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154073819|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153730069|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
153730070|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730071|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730072|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730073|NCT00132548|Artesunate|artesunate|mesh-list
153730074|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
153730075|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
153730076|NCT00132548|Amodiaquine|amodiaquine|mesh-list
153730077|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153730078|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
153730079|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153730080|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153730081|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730082|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730083|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
153730084|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
153730085|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153730086|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
153730087|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153458952|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458962|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153458963|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
153458964|NCT01672086|Antacids|antacids|mesh-ancestor
153458965|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458966|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073820|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154073821|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154073822|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154073823|NCT00805142|Tapentadol|tapentadol|mesh-list
154073824|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154073825|NCT00805142|Narcotics|narcotics|mesh-ancestor
154073826|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073827|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073828|NCT00805142|Analgesics|analgesics|mesh-ancestor
153730088|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616739|NCT06158126|Lamivudine|lamivudine|mesh-list
154073830|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073831|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154073832|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154073833|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154073834|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073835|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
154073836|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154073837|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154073838|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
154073839|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073840|NCT00761319|Travoprost|travoprost|mesh-list
154073841|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154073842|NCT00761319|Latanoprost|latanoprost|mesh-list
154073843|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154073844|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154073845|NCT00818441|Dacomitinib|dacomitinib|mesh-list
153730089|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073862|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073863|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073864|NCT00707369|Amoxicillin|amoxicillin|mesh-list
154073865|NCT00707369|Metronidazole|metronidazole|mesh-list
153730093|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153730094|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154073866|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154073867|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073868|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154073869|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154073870|NCT00834041|Aliskiren|aliskiren|mesh-list
154073871|NCT00834041|Renin Inhibitors|renin inhibitors|mesh-ancestor
154073872|NCT00834041|Protease Inhibitors|protease inhibitors|mesh-ancestor
153730095|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
153730096|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730097|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730098|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153730099|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154073873|NCT00834041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073907|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154073908|NCT00759759|Narcotics|narcotics|mesh-ancestor
154073909|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073910|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073911|NCT00759759|Analgesics|analgesics|mesh-ancestor
154073912|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
154073913|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073914|NCT00759681|Thrombin|thrombin|mesh-list
154073915|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
154073916|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
154073917|NCT00759681|Coagulants|coagulants|mesh-ancestor
154073918|NCT00826241|Temozolomide|temozolomide|mesh-list
154073919|NCT00826241|Lapatinib|lapatinib|mesh-list
154073920|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154073921|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
154073922|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073923|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073924|NCT00826241|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154073925|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154073926|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073927|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
154073928|NCT04097847|Tocopherols|tocopherols|mesh-list
153730101|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730102|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153730103|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153730104|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153730105|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
153730106|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153730109|NCT00140790|Valsartan|valsartan|mesh-list
154073939|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073940|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
154073941|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154073942|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
154073943|NCT04097847|Vitamins|vitamins|mesh-ancestor
154073944|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
154073945|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154073946|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
154073947|NCT00762372|Sevoflurane|sevoflurane|mesh-list
154073948|NCT00762372|Desflurane|desflurane|mesh-list
154073949|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154073950|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154073951|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
154073952|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
154073953|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154073954|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073955|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154073956|NCT00762372|Analgesics|analgesics|mesh-ancestor
154073957|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
154073958|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154073960|NCT00833261|Cetuximab|cetuximab|mesh-list
154073961|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153730116|NCT01245673|Poly ICLC|poly iclc|mesh-list
153730117|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
154073963|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
154073974|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154073975|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
154073976|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154073977|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154073978|NCT00752622|Infliximab|infliximab|mesh-list
153730134|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730135|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730136|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153730137|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
154073979|NCT00752622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154073980|NCT00752622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154073981|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
154073982|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154073983|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154073984|NCT00754650|Bevacizumab|bevacizumab|mesh-list
154073985|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154073986|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154073987|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154073988|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154073989|NCT00754650|Growth Substances|growth substances|mesh-ancestor
154073990|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154073991|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
154073992|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154073993|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154073994|NCT00825305|Vaccines|vaccines|mesh-list
153730152|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074003|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
154074004|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074005|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074006|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
154074007|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074008|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154074009|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154074010|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
154074011|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154074012|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154074013|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
154074014|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074015|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154074016|NCT04095312|Pancrelipase|pancrelipase|mesh-list
154074017|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154074018|NCT04095390|Capecitabine|capecitabine|mesh-list
154074019|NCT04095390|Letrozole|letrozole|mesh-list
153730153|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730154|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153730175|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074034|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154074035|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154074036|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074037|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074038|NCT04016051|Clarithromycin|clarithromycin|mesh-list
153617044|NCT05890027|Phenylephrine|phenylephrine|mesh-list
154074039|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154074040|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074041|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154074042|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074043|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074044|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154074045|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154074046|NCT00761514|Adalimumab|adalimumab|mesh-list
154074047|NCT00761514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154074048|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074049|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154074050|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
154074051|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154074052|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074053|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154074054|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074081|NCT05425355|Acetaminophen|acetaminophen|mesh-list
154074082|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154074083|NCT05425355|Analgesics|analgesics|mesh-ancestor
154074084|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
154074085|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074086|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074087|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
154074088|NCT04093713|Nordefrin|nordefrin|mesh-list
154074089|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154074090|NCT00831311|Vaccines|vaccines|mesh-list
153730176|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730177|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730178|NCT00132899|Methotrexate|methotrexate|mesh-list
153730179|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153730180|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
153730181|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153730182|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730183|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154074091|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
154074092|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074093|NCT00831233|Goserelin|goserelin|mesh-list
154074094|NCT00831233|Bicalutamide|bicalutamide|mesh-list
154074126|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154074127|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
154074128|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074129|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074130|NCT00916890|Fentanyl|fentanyl|mesh-list
154074131|NCT00916890|Morphine|morphine|mesh-list
154074132|NCT00916890|Oxycodone|oxycodone|mesh-list
153730187|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
153730188|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730189|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153567219|NCT05782894|Remifentanil|remifentanil|mesh-list
153730190|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730191|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
153730192|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730193|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153730195|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
153730196|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153730197|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730198|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730199|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153730200|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154074133|NCT00916890|Buprenorphine|buprenorphine|mesh-list
154074134|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154074135|NCT00916890|Narcotics|narcotics|mesh-ancestor
154074136|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074137|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074138|NCT00916890|Analgesics|analgesics|mesh-ancestor
154074139|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
154074140|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074141|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154074142|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154074143|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
154074144|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
154074154|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074155|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154074156|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154074157|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154074158|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074159|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074160|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
154074161|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154074162|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154074163|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154074164|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154074165|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074166|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074167|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074168|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
154074169|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154074170|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
154074171|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154074172|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
154074173|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074174|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153730201|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730202|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730203|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
153730204|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
153730205|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153458967|NCT05547750|Vitamin K|vitamin k|mesh-list
153458968|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
153458969|NCT05547750|Vitamins|vitamins|mesh-ancestor
153458970|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
153458971|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458972|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153458973|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153820697|NCT00434135|Gemcitabine|gemcitabine|mesh-list
153577101|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577102|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153577104|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577105|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153577106|NCT01715636|Tenofovir|tenofovir|mesh-list
153577107|NCT01715636|Emtricitabine|emtricitabine|mesh-list
153577108|NCT01715636|Rilpivirine|rilpivirine|mesh-list
153577109|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
153730206|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153730207|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153557563|NCT01620307|Sirolimus|sirolimus|mesh-list
153730209|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153730210|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730211|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
153730212|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
154074176|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154074177|NCT00760266|Diuretics|diuretics|mesh-ancestor
154074178|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
154074179|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074180|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154074181|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730213|NCT02955706|Vitamins|vitamins|mesh-ancestor
153730214|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
153730215|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730216|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
154074182|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074183|NCT00760266|Renin Inhibitors|renin inhibitors|mesh-ancestor
154074184|NCT00760266|Protease Inhibitors|protease inhibitors|mesh-ancestor
154074185|NCT00760266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074186|NCT00753714|Gemcitabine|gemcitabine|mesh-list
154074187|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154074188|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
154074189|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074190|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074191|NCT00759954|Morphine|morphine|mesh-list
154074192|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154074193|NCT00759954|Narcotics|narcotics|mesh-ancestor
154074194|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074195|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074196|NCT00759954|Analgesics|analgesics|mesh-ancestor
154074197|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
154074198|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074200|NCT00804908|Veliparib|veliparib|mesh-list
154074205|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154074206|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074207|NCT02608034|Itraconazole|itraconazole|mesh-list
154074208|NCT02608034|Rifampin|rifampin|mesh-list
154074209|NCT02608034|Vemurafenib|vemurafenib|mesh-list
154074210|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
154074211|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074212|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154074213|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154074214|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074215|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730217|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153730218|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
153730219|NCT01244425|Coagulants|coagulants|mesh-ancestor
153730220|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153730221|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153730222|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617253|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
153730223|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153730224|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153730225|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730226|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730227|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
153730228|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730229|NCT01154439|Cytarabine|cytarabine|mesh-list
153730230|NCT01154439|Etoposide|etoposide|mesh-list
153730231|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
153730232|NCT01154439|Idarubicin|idarubicin|mesh-list
153730233|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
153730234|NCT01154439|Everolimus|everolimus|mesh-list
153730252|NCT01154439|Analgesics|analgesics|mesh-ancestor
153730253|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
153730254|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730255|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153730256|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153730257|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
153730258|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
153730259|NCT00133172|Prednisone|prednisone|mesh-list
154074216|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154074217|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
154074218|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074219|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074220|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154074221|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154074222|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
154074223|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154074224|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
154074225|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154074226|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154074227|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154074228|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154074229|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154074230|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154074231|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154074232|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074233|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074234|NCT00589784|Sunitinib|sunitinib|mesh-list
154074235|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
154074250|NCT05742854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074252|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154074253|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154074254|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074255|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074256|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
154074257|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074258|NCT04094766|Immunomodulating Agents|immunomodulating agents|mesh-list
154074259|NCT04094766|Immunologic Factors|immunologic factors|mesh-ancestor
154074260|NCT04094766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074261|NCT02606864|Nifurtimox|nifurtimox|mesh-list
154074262|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154074263|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154074264|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154074265|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074266|NCT00823901|Clindamycin|clindamycin|mesh-list
154074267|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
154074268|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
153730260|NCT00133172|Tacrolimus|tacrolimus|mesh-list
153730261|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730262|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
153730263|NCT00133172|Hormones|hormones|mesh-ancestor
153567291|NCT05725512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730264|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153730265|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722341|NCT00457678|Hormones|hormones|mesh-ancestor
153730266|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153730267|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074269|NCT00823901|Tretinoin|tretinoin|mesh-list
154074270|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154074271|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074284|NCT02926898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154074285|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154074286|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154074287|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074289|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
154074290|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074291|NCT00759564|Lactams|lactams|mesh-list
154074292|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154074293|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074294|NCT00816023|Ecallantide|ecallantide|mesh-list
154074295|NCT00816023|Analgesics|analgesics|mesh-ancestor
154074296|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
154074297|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074298|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074299|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154074300|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154074301|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074302|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154074303|NCT00815633|Alefacept|alefacept|mesh-list
154074307|NCT02610881|Iron|iron|mesh-list
154074339|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074340|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074341|NCT00914420|Trapidil|trapidil|mesh-list
154074342|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154074343|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074344|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074345|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154074346|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
154074347|NCT04094532|Bupivacaine|bupivacaine|mesh-list
154074348|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
154074349|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
154074350|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074351|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074352|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
154074353|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074354|NCT00708773|Irinotecan|irinotecan|mesh-list
154074355|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154074356|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154074357|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074358|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074359|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074360|NCT05758259|Vitamin D|vitamin d|mesh-list
154074361|NCT05758259|Ergocalciferols|ergocalciferols|mesh-list
154074362|NCT05758259|Cholecalciferol|cholecalciferol|mesh-list
154074363|NCT05758259|Vitamins|vitamins|mesh-list
154074364|NCT05758259|Micronutrients|micronutrients|mesh-ancestor
154074365|NCT05758259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074366|NCT05758259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154074367|NCT05758259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154074368|NCT00803738|Terconazole|terconazole|mesh-list
154074369|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
154074370|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074371|NCT00591266|Amlodipine|amlodipine|mesh-list
154074372|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153577110|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577111|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154074373|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154074374|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154074375|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154074376|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074377|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154074378|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074379|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
154074380|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154074381|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154074382|NCT04093050|Vasopressins|vasopressins|mesh-list
154074383|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
154074384|NCT04093050|Coagulants|coagulants|mesh-ancestor
154074385|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154074386|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154074387|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
154074388|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074389|NCT00758394|Listerine|listerine|mesh-list
154074390|NCT00758394|Triclosan|triclosan|mesh-list
154074391|NCT00758394|Fluorides|fluorides|mesh-list
154074392|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
154074393|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
154074394|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
154074395|NCT00758394|Protective Agents|protective agents|mesh-ancestor
154074401|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
154074424|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074425|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154074426|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154074427|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154074428|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074429|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154074430|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154074431|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074432|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
154074433|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154074434|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154074435|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154074436|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
153730268|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730269|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
153730270|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153730271|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730272|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730273|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153730274|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153730275|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
153730276|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153730277|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730278|NCT00141141|Atorvastatin|atorvastatin|mesh-list
153730279|NCT00141141|Simvastatin|simvastatin|mesh-list
153730280|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153730281|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153730282|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
153730283|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730284|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153730285|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153577112|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153577113|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577114|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577115|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153577116|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153577117|NCT01715688|Lidocaine|lidocaine|mesh-list
153577118|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
153577119|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
153357011|NCT01278290|Hormones|hormones|mesh-ancestor
153577120|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730286|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730287|NCT00133250|Heparin|heparin|mesh-list
153730288|NCT00133250|Calcium heparin|calcium heparin|mesh-list
153730289|NCT00133250|Abciximab|abciximab|mesh-list
153617557|NCT05139316|Hormones|hormones|mesh-ancestor
154074437|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074438|NCT02608736|Valproic Acid|valproic acid|mesh-list
154074439|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
154074440|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074441|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074442|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
154074443|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074444|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074445|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
154074446|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154074447|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074448|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154074449|NCT02607410|Insulin|insulin|mesh-list
154074450|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154074451|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154074452|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
154074453|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
154074454|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
154074455|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
154074456|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154074457|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154074458|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074459|NCT02607410|Incretins|incretins|mesh-ancestor
154074460|NCT02607410|Hormones|hormones|mesh-ancestor
154074461|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074462|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
154074463|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782647|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
154074464|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074475|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154074476|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154074477|NCT00751296|Growth Substances|growth substances|mesh-ancestor
154074478|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
154074479|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074481|NCT04093518|Estrogens|estrogens|mesh-ancestor
153730290|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
153730291|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153730292|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154074482|NCT04093518|Hormones|hormones|mesh-ancestor
154074483|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074484|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074485|NCT02606084|Esketamine|esketamine|mesh-list
154074486|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
153730293|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730294|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153730295|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
153730296|NCT00144495|Hematinics|hematinics|mesh-ancestor
153730297|NCT00133328|Valsartan|valsartan|mesh-list
153730298|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153730299|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153730300|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154074487|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154074488|NCT02607488|Lidocaine|lidocaine|mesh-list
154074489|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
154074490|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
154074491|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074492|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074493|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
154074494|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730301|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730302|NCT00133367|Sirolimus|sirolimus|mesh-list
153730303|NCT00133367|Fludarabine|fludarabine|mesh-list
153730304|NCT00133367|Melphalan|melphalan|mesh-list
153730305|NCT00133367|Tacrolimus|tacrolimus|mesh-list
153730306|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
153730310|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154074495|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154074496|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154074497|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154074498|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154074499|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074500|NCT00914498|Lidocaine|lidocaine|mesh-list
153730311|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
154074501|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
154074502|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
154074503|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074504|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074505|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
154074506|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074507|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154074508|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154074509|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154074510|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154074511|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074512|NCT00751881|Teriflunomide|teriflunomide|mesh-list
154074513|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154074514|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154074515|NCT00751881|Analgesics|analgesics|mesh-ancestor
154074516|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
154074517|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074518|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074519|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577121|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577122|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
153577123|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577124|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153626787|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153458974|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458975|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
153458976|NCT05547750|Coagulants|coagulants|mesh-ancestor
153458977|NCT01672476|Valsartan|valsartan|mesh-list
153458978|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153458979|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153817584|NCT06186895|Adrenergic Agents|adrenergic agents|mesh-ancestor
154074520|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154074521|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154074522|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
154074523|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
154074524|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154074525|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074526|NCT02599779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154074527|NCT02599779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074528|NCT02597556|Albendazole|albendazole|mesh-list
154074529|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
154074530|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154074531|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074532|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
154074533|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154074534|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154074535|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154074536|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154074537|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154074538|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074539|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074540|NCT02599857|Bisoprolol|bisoprolol|mesh-list
154074541|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154074542|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
154074543|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
154074544|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074545|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074546|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154074547|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153577125|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153577126|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153577127|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577128|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577130|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153577131|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577133|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
153577135|NCT01715909|Oseltamivir|oseltamivir|mesh-list
153577136|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
153577137|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577138|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577139|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577140|NCT01715922|Fluconazole|fluconazole|mesh-list
153577141|NCT01715922|Flucytosine|flucytosine|mesh-list
153577142|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
153577143|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577144|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154074548|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154074549|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
154074550|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074551|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074552|NCT02599623|Anesthetics|anesthetics|mesh-list
154074553|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074554|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074555|NCT02597400|Metformin|metformin|mesh-list
154074556|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154074557|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074558|NCT00830063|Naproxen|naproxen|mesh-list
153730312|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730313|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153730314|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730315|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153730316|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153730317|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153730318|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
154074559|NCT00830063|Tanezumab|tanezumab|mesh-list
153730319|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153730320|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
153730321|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153730322|NCT00141258|Pregabalin|pregabalin|mesh-list
153730323|NCT00141258|Analgesics|analgesics|mesh-ancestor
153730324|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
154074560|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154074561|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153730325|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074562|NCT00830063|Analgesics|analgesics|mesh-ancestor
154074563|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
154074564|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074565|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074566|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074572|NCT04092621|Amiodarone|amiodarone|mesh-list
154074576|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154074577|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074578|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154074579|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154074580|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154074581|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074582|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154074583|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154074584|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154074586|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154074587|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
154074588|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074589|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074590|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154074591|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154074592|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
154074593|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074594|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074595|NCT04092309|Valsartan|valsartan|mesh-list
154074596|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154074597|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154074598|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154074599|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154074608|NCT04020003|Simendan|simendan|mesh-list
154074616|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074618|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154074619|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154074620|NCT03977142|Analgesics|analgesics|mesh-ancestor
154074621|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
154074622|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074623|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074624|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074625|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154074626|NCT00751023|Modafinil|modafinil|mesh-list
154074627|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154074628|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074629|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154074630|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154074631|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154074632|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074633|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
154074634|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154074635|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154074636|NCT04091412|Protective Agents|protective agents|mesh-ancestor
154074637|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074638|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154074639|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154074640|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154074641|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
154074642|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074643|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074644|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577145|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153577146|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577147|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577148|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153577149|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
153577150|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153577151|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577152|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153577153|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153577154|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
153577155|NCT01715935|Everolimus|everolimus|mesh-list
154074646|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
154074647|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154074648|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154074649|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154074650|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074651|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154074652|NCT00591773|Diuretics|diuretics|mesh-ancestor
154074653|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
154074654|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074655|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154074656|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154074657|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
153730326|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730327|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
153730328|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153730329|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730330|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730331|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153730332|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153730333|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153730334|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730335|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730336|NCT00403910|Canrenone|canrenone|mesh-list
153730337|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153730338|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
153730339|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074658|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154074659|NCT00750867|Antibodies|antibodies|mesh-list
154074660|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
154074661|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154074662|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
154074663|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074664|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
154074665|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
153730340|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730342|NCT00403910|Diuretics|diuretics|mesh-ancestor
153730343|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
153730344|NCT00141336|Pregabalin|pregabalin|mesh-list
153730345|NCT00141336|Analgesics|analgesics|mesh-ancestor
154074668|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154074669|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154074670|NCT00829829|Rilonacept|rilonacept|mesh-list
154074671|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074672|NCT00829439|Levodopa|levodopa|mesh-list
154074673|NCT00829439|Carbidopa|carbidopa|mesh-list
154074674|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154074675|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154074676|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
154074677|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730346|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
153730347|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730348|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730349|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
153730350|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153730351|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730352|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730353|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154074678|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074679|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730354|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153730355|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153730356|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730357|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730358|NCT00133406|Vitamin A|vitamin a|mesh-list
154074680|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154074681|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074682|NCT02599077|Dienogest|dienogest|mesh-list
154074683|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
154074684|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154074685|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
154074687|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074688|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154074689|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154074690|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154074691|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154074692|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154074693|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
154074694|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074695|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154074696|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074697|NCT00829283|Orlistat|orlistat|mesh-list
154074698|NCT00829283|Sibutramine|sibutramine|mesh-list
154074699|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074700|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074701|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154074702|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154074703|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
154074704|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154074705|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
154074706|NCT05758025|Parathyroid Hormone|parathyroid hormone|mesh-list
154074707|NCT05758025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154074708|NCT05758025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074709|NCT00706277|Fentanyl|fentanyl|mesh-list
154074710|NCT00706277|Remifentanil|remifentanil|mesh-list
154074711|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
154074712|NCT00706277|Propofol|propofol|mesh-list
154074713|NCT00706277|Sevoflurane|sevoflurane|mesh-list
154074714|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154074715|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074716|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074717|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154074718|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
154074719|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
154074720|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154074721|NCT00706277|Narcotics|narcotics|mesh-ancestor
154074722|NCT00706277|Analgesics|analgesics|mesh-ancestor
153577156|NCT01715935|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153577157|NCT01715935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153577158|NCT01715935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577159|NCT01715935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074724|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074725|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154074726|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154074727|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154074728|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154074730|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154074731|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
154074732|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074733|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074734|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154074735|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154074736|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
154074737|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074738|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074739|NCT00821327|Gemcitabine|gemcitabine|mesh-list
154074740|NCT00821327|Sunitinib|sunitinib|mesh-list
154074741|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074742|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154074743|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
154074744|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074745|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154074746|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153817585|NCT06186895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577160|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153577161|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
153577162|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577163|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577164|NCT01715987|Tenofovir|tenofovir|mesh-list
153577165|NCT01715987|Entecavir|entecavir|mesh-list
153577166|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
153577167|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577168|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153577169|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153577170|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577171|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577172|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153577173|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153577174|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153577175|NCT01716273|Laxatives|laxatives|mesh-ancestor
153577176|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153577177|NCT01716338|Glyburide|glyburide|mesh-list
153577178|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153577179|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577180|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153577181|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153577182|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153577183|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154074748|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074749|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
154074750|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074751|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074752|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154074753|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
154074754|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074755|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154074756|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154074757|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
154074758|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074759|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730360|NCT00133406|Vitamins|vitamins|mesh-ancestor
153730361|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
153730362|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730363|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730364|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
153730365|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730366|NCT00133445|Vaccines|vaccines|mesh-list
153730367|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
153730368|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730369|NCT00141375|Pregabalin|pregabalin|mesh-list
153730370|NCT00141375|Analgesics|analgesics|mesh-ancestor
153730371|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
153730372|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730373|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730374|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
153730375|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153730376|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577184|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577185|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577186|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817586|NCT06186895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817587|NCT06186895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153817588|NCT06186895|Narcotics|narcotics|mesh-ancestor
153817589|NCT06186895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153817590|NCT06186895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153817591|NCT06186895|Anesthetics, General|anesthetics, general|mesh-ancestor
153817592|NCT06186895|Anesthetics|anesthetics|mesh-ancestor
153817593|NCT06186648|Obinutuzumab|obinutuzumab|mesh-list
153817594|NCT06186648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618016|NCT04183790|Ivacaftor|ivacaftor|mesh-list
154074760|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154074761|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
154074762|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154074763|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154074764|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154074765|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
154074766|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074767|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074768|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154074769|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
154074770|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074771|NCT02611505|Esketamine|esketamine|mesh-list
154074772|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
154074773|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154074774|NCT00743652|Vaccines|vaccines|mesh-list
154074775|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154074776|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
154074777|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074778|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
154074779|NCT00748215|Loperamide|loperamide|mesh-list
154074780|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
154074781|NCT00748215|Calcium|calcium|mesh-list
154074782|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154074783|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074784|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154074785|NCT00917163|Sirolimus|sirolimus|mesh-list
154074786|NCT00917163|Everolimus|everolimus|mesh-list
154074787|NCT00917163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154074788|NCT00917163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074789|NCT00917163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074790|NCT00917163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074791|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817595|NCT06186648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817596|NCT06186609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153817597|NCT06186609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817598|NCT06186609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154074792|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
154074793|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074794|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074795|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154074796|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074797|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154074798|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
154074799|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154074800|NCT00749892|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154074801|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074802|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074803|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074804|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074805|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
154074806|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154074852|NCT00748566|Ziprasidone|ziprasidone|mesh-list
154074853|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154074854|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
154074855|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074856|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074857|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074858|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154074859|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154074860|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074861|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154074862|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154074863|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
154074864|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
154074865|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154074866|NCT02597166|Ledipasvir|ledipasvir|mesh-list
154074867|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
154074868|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154074869|NCT00743106|Fenoldopam|fenoldopam|mesh-list
154074870|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154074871|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
154074872|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
154074873|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
154074874|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074875|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074876|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817599|NCT06186609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817600|NCT06186596|Triamcinolone|triamcinolone|mesh-list
153817601|NCT06186596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817602|NCT06186596|Glucocorticoids|glucocorticoids|mesh-ancestor
153577202|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
153577203|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153577204|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577205|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153577206|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153577207|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577208|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817604|NCT06186596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817605|NCT06186596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817606|NCT06186440|Temozolomide|temozolomide|mesh-list
153817607|NCT06186440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458992|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458993|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458994|NCT03153072|Amiodarone|amiodarone|mesh-list
153458995|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153458996|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
153577209|NCT01716611|Tolvaptan|tolvaptan|mesh-list
153577210|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153577211|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577212|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
154074879|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074880|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074881|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074882|NCT00738699|Paclitaxel|paclitaxel|mesh-list
154074883|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154074884|NCT00738699|Farletuzumab|farletuzumab|mesh-list
154074885|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154074886|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074887|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
154074888|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
154074889|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
154074890|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074891|NCT00814307|Tofacitinib|tofacitinib|mesh-list
154074892|NCT00814307|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154074893|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074894|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558451|NCT01626443|Inositol|inositol|mesh-list
154074895|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074897|NCT02596776|Propranolol|propranolol|mesh-list
154074898|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154074899|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154074900|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
154074901|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074902|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074903|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074904|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154074905|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154074906|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
154074907|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074908|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154074909|NCT02596776|Protective Agents|protective agents|mesh-ancestor
154074910|NCT00748098|Gabapentin|gabapentin|mesh-list
154074914|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074916|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154074917|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154074918|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074919|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154074920|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154074921|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154074922|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154074923|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074924|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
154074925|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154074926|NCT00813995|Metformin|metformin|mesh-list
154074927|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154074928|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074929|NCT00813995|Incretins|incretins|mesh-ancestor
154074930|NCT00813995|Hormones|hormones|mesh-ancestor
153722594|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
154074931|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074932|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154074933|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
154074934|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074935|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074936|NCT00737529|Lenalidomide|lenalidomide|mesh-list
154074937|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
154074938|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074941|NCT00737529|Growth Substances|growth substances|mesh-ancestor
154074962|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074963|NCT02610647|Anesthetics|anesthetics|mesh-list
154074964|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154074965|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074966|NCT02595918|Nivolumab|nivolumab|mesh-list
154074967|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154074968|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074969|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154074970|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074971|NCT02595840|Pemetrexed|pemetrexed|mesh-list
154074972|NCT02595840|Afatinib|afatinib|mesh-list
154074973|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074974|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154074975|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154074976|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154074977|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154074978|NCT02595840|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154074979|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154074980|NCT02594241|Prednisolone|prednisolone|mesh-list
154074981|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154074982|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
154074983|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154074984|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
153577213|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577214|NCT01716624|Oxybutynin|oxybutynin|mesh-list
153577215|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
153577216|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153577217|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153577218|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153577219|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577220|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577221|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
153577222|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577223|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577224|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153817623|NCT06185179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153817624|NCT06185179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817625|NCT06184282|Lidocaine|lidocaine|mesh-list
153817626|NCT06184282|Anesthetics, Local|anesthetics, local|mesh-ancestor
153817627|NCT06184282|Anesthetics|anesthetics|mesh-ancestor
153817628|NCT06184282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817629|NCT06184282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722622|NCT00348244|Ketorolac|ketorolac|mesh-list
153458997|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153458998|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153458999|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722654|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074986|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
154074987|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154074988|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
154074989|NCT02594241|Hormones|hormones|mesh-ancestor
154074990|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154074991|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154074992|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154074993|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154074994|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
154074995|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
154074996|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154074997|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154074998|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154074999|NCT02594241|Protective Agents|protective agents|mesh-ancestor
154075000|NCT00585975|Bromfenac|bromfenac|mesh-list
154075001|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154075002|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154075003|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154075004|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154075005|NCT00585975|Analgesics|analgesics|mesh-ancestor
154075006|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
154075007|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075008|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075009|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075010|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075011|NCT00918021|Olanzapine|olanzapine|mesh-list
154075012|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
154075013|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
154075014|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075015|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075016|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459000|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153459001|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153577225|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577226|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
153577227|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
153577228|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153577229|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153577230|NCT01716624|Urological Agents|urological agents|mesh-ancestor
153577231|NCT01716637|Etanercept|etanercept|mesh-list
154075017|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154075018|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154075019|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075020|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154075021|NCT00918021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154075022|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154075023|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154075024|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075025|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075026|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
154075027|NCT00585585|Betahistine|betahistine|mesh-list
154075028|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
154075029|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
154075030|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
154075031|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075032|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075033|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075034|NCT02593695|Fluoxetine|fluoxetine|mesh-list
153722656|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154075035|NCT02593695|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154075036|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154075037|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154075038|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075039|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075040|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
154075041|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075042|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154075043|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
154075044|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154075045|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154075046|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154075047|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075048|NCT00734097|Esomeprazole|esomeprazole|mesh-list
154075049|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154075050|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075053|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075055|NCT00819767|Aliskiren|aliskiren|mesh-list
154075056|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154075057|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154075058|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154075059|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075060|NCT00819767|Renin Inhibitors|renin inhibitors|mesh-ancestor
154075061|NCT00819767|Protease Inhibitors|protease inhibitors|mesh-ancestor
154075062|NCT00819767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075063|NCT04088175|Menthol|menthol|mesh-list
154075064|NCT04088175|Nicotine|nicotine|mesh-list
154075065|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154075066|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
154075067|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075068|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075069|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154075070|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154075071|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
154075072|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075073|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075074|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
154075075|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
154075076|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
154075077|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075078|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
154075079|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154075080|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
154075081|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075082|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
154075083|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154075084|NCT00732303|Pemetrexed|pemetrexed|mesh-list
154075085|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075086|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075087|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577232|NCT01716637|Curcumin|curcumin|mesh-list
153577233|NCT01716637|Resveratrol|resveratrol|mesh-list
154075088|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154075089|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154075090|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154075091|NCT00732069|Valsartan|valsartan|mesh-list
154075092|NCT00732069|Ramipril|ramipril|mesh-list
154075093|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154075094|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154075095|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154075096|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075097|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154075098|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
154075099|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075100|NCT02593383|Clindamycin|clindamycin|mesh-list
154075101|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
154075102|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
154075103|NCT02593383|Adapalene|adapalene|mesh-list
154075104|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154075105|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075106|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154075107|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075108|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075109|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154075110|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154075111|NCT02593383|Analgesics|analgesics|mesh-ancestor
154075112|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
154075113|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075114|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075115|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075117|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
154075118|NCT00731679|Rifaximin|rifaximin|mesh-list
154075119|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154075120|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577234|NCT01716637|Quercetin|quercetin|mesh-list
153577235|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153577236|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153577237|NCT01716637|Analgesics|analgesics|mesh-ancestor
153577238|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
153577239|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577240|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577241|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577242|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154075122|NCT02609087|Propofol|propofol|mesh-list
154075123|NCT02609087|Sevoflurane|sevoflurane|mesh-list
154075124|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154075125|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075126|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075127|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154075128|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
154075129|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
154075130|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154075131|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154075132|NCT00731133|Disulfiram|disulfiram|mesh-list
154075133|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154075134|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154075135|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075136|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075137|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154075138|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154075139|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075140|NCT00730275|Incretins|incretins|mesh-ancestor
154075141|NCT00730275|Hormones|hormones|mesh-ancestor
154075142|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075143|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154075144|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
154075145|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075146|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075147|NCT04793711|Decanoic acid|decanoic acid|mesh-list
154075148|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
154075149|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075150|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
154075151|NCT00729651|Vitamin D|vitamin d|mesh-list
154075152|NCT00729651|Alendronate|alendronate|mesh-list
154075153|NCT00729651|Calcium|calcium|mesh-list
153577243|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153577244|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153577245|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
153577246|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577247|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577248|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577249|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
153577250|NCT01716637|Protective Agents|protective agents|mesh-ancestor
154075154|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154075155|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075156|NCT00729651|Vitamins|vitamins|mesh-ancestor
154075157|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
154075158|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154075159|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
154075160|NCT00729183|Vitamin D|vitamin d|mesh-list
154075161|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
154075162|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
154075163|NCT00729183|Calcium|calcium|mesh-list
154075164|NCT00729183|Vitamins|vitamins|mesh-ancestor
154075165|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
154075166|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075167|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154075168|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154075169|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075170|NCT00729183|Antacids|antacids|mesh-ancestor
154075171|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075172|NCT00811733|Ofatumumab|ofatumumab|mesh-list
154075173|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075174|NCT00728949|Tamoxifen|tamoxifen|mesh-list
154075175|NCT00728949|Letrozole|letrozole|mesh-list
154075176|NCT00728949|Fulvestrant|fulvestrant|mesh-list
154075177|NCT00728949|Anastrozole|anastrozole|mesh-list
154075178|NCT00728949|Exemestane|exemestane|mesh-list
154075179|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154075180|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075181|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154075182|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154075183|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075184|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075185|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154075186|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
154075187|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075188|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075189|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154075190|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154075191|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154075193|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154075194|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
154075195|NCT00918177|Levodopa|levodopa|mesh-list
154075196|NCT00918177|Carbidopa|carbidopa|mesh-list
154075197|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154075198|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154075199|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154075200|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
154075201|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154075202|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075203|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075204|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154075205|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075206|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154075207|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
154075208|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
154075209|NCT00728481|Budesonide|budesonide|mesh-list
154075210|NCT00728481|Esomeprazole|esomeprazole|mesh-list
154075211|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154075212|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154075213|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
154075214|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154075215|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075216|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154075217|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
154075218|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
154075219|NCT00728481|Hormones|hormones|mesh-ancestor
154075220|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154075221|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154075222|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154075223|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154075224|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154075225|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075226|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
154075232|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154075233|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
154075234|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154075235|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154075236|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154075237|NCT04030481|Anesthetics|anesthetics|mesh-list
154075238|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075239|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075240|NCT02592915|Clonidine|clonidine|mesh-list
154075241|NCT02592915|Anesthetics|anesthetics|mesh-list
154075242|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154075243|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154075244|NCT02592915|Analgesics|analgesics|mesh-ancestor
154075294|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
154075295|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075364|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154075365|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154075366|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
154075367|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154075368|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
154075369|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154075370|NCT00807248|Analgesics|analgesics|mesh-ancestor
154075371|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
154075431|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154075506|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154075507|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
154075579|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154075580|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154075581|NCT00739596|Amlodipine|amlodipine|mesh-list
154075582|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154075583|NCT00739596|Aliskiren|aliskiren|mesh-list
154075647|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
154075648|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075649|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154075650|NCT00793598|Brincidofovir|brincidofovir|mesh-list
154075651|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
154075653|NCT04115072|Praziquantel|praziquantel|mesh-list
154075797|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075798|NCT00800540|Timolol|timolol|mesh-list
154075799|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154075800|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154075869|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154075870|NCT00915200|Expectorants|expectorants|mesh-ancestor
154075944|NCT04107896|Tamsulosin|tamsulosin|mesh-list
154075945|NCT04107896|Silodosin|silodosin|mesh-list
154075946|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154075947|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154075949|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
154076016|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
154076024|NCT00724893|Interferons|interferons|mesh-list
154076089|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154076090|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154076092|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
154076160|NCT02593734|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154076161|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154076233|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076234|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154076235|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153559786|NCT01635608|Talinolol|talinolol|mesh-list
154076243|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
154076302|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154076303|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154076304|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076376|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154076450|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154076461|NCT00719901|Bortezomib|bortezomib|mesh-list
154076521|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
154076522|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154076595|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154076597|NCT00733902|Analgesics|analgesics|mesh-ancestor
154076669|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154076674|NCT00786188|Paroxetine|paroxetine|mesh-list
154076747|NCT05728151|Carticaine|carticaine|mesh-list
154076819|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154076820|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154076829|NCT00590135|Atorvastatin|atorvastatin|mesh-list
154076890|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154076964|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
154076965|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
154076966|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
154077038|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154077039|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154077040|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154077107|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
154077108|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154077183|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154077184|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154077185|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154077254|NCT05684913|Hemostatics|hemostatics|mesh-list
154077255|NCT05684913|Coagulants|coagulants|mesh-ancestor
154077327|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154077328|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154077401|NCT00724932|Atropine|atropine|mesh-list
154077402|NCT00724932|Bromides|bromides|mesh-list
154077403|NCT00724932|Rocuronium|rocuronium|mesh-list
154077404|NCT00724932|Neostigmine|neostigmine|mesh-list
153400586|NCT02046200|Ivermectin|ivermectin|mesh-list
154077474|NCT00724854|Ribavirin|ribavirin|mesh-list
154077475|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154077550|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
154077551|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154077552|NCT02588547|Granisetron|granisetron|mesh-list
154077553|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
154077623|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154077624|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154077625|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154077626|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
154077627|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
154077695|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154077697|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
154077768|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154077769|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
154077840|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154077841|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
154077912|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154077913|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154077914|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154077988|NCT04101578|Bromides|bromides|mesh-list
154078065|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
154078066|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154078067|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154078068|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153722803|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154078135|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154078136|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078137|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078138|NCT00761306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154078203|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078204|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
154078205|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078211|NCT00437281|Pregabalin|pregabalin|mesh-list
154078273|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
154078274|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078275|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154078346|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078416|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
154078417|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154078418|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078489|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154078490|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154078560|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154078561|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
154078562|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154078566|NCT00779324|Analgesics|analgesics|mesh-ancestor
154078631|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
154078632|NCT02581683|Ropivacaine|ropivacaine|mesh-list
154078633|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
154078634|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
154078704|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154078778|NCT00797225|Leuprolide|leuprolide|mesh-list
154078779|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154078780|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
154078853|NCT04236141|Immunoconjugates|immunoconjugates|mesh-ancestor
154078930|NCT04209855|Immunologic Factors|immunologic factors|mesh-ancestor
154078931|NCT04209855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078933|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154078934|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154078935|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154078936|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154078937|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154078939|NCT04076865|Histamine|histamine|mesh-list
154078940|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
154078941|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
154078942|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154078943|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154078944|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
154078945|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154078946|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154078947|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154078988|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154078989|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079060|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079061|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079062|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154079063|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154079131|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079132|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154079133|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154079198|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154079199|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079201|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154079270|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154079272|NCT00717756|Growth Substances|growth substances|mesh-ancestor
154079346|NCT00791765|Analgesics|analgesics|mesh-ancestor
154079347|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
154079355|NCT00789191|Metformin|metformin|mesh-list
153722858|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154079417|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
154079418|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154079419|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153722869|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
154079490|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154079491|NCT02473263|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154079493|NCT03222609|Navitoclax|navitoclax|mesh-list
154079561|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154079562|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154079563|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
154079564|NCT02600780|Protective Agents|protective agents|mesh-ancestor
154079635|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
154079636|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154079638|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154079708|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154079709|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154079710|NCT00755846|Incretins|incretins|mesh-ancestor
154079782|NCT00770120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154079857|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154079928|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
154079929|NCT00723528|Ustekinumab|ustekinumab|mesh-list
154079930|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080075|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080076|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
154080149|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080150|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080151|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154080152|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080153|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
154080154|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080155|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154080156|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080158|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080159|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080160|NCT02598440|Alendronate|alendronate|mesh-list
154080161|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
154080162|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154080163|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080164|NCT00750308|Ramipril|ramipril|mesh-list
154080165|NCT00750308|Tadalafil|tadalafil|mesh-list
154080166|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
154080167|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154080168|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154080169|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080170|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080171|NCT00750308|Urological Agents|urological agents|mesh-ancestor
154080172|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154080173|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
154080174|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154080198|NCT06240039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080199|NCT06240039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080200|NCT06240039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154080201|NCT06240039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080202|NCT06239727|Cisplatin|cisplatin|mesh-list
154080203|NCT06239727|Gemcitabine|gemcitabine|mesh-list
154080204|NCT06239727|Capecitabine|capecitabine|mesh-list
154080205|NCT06239727|Antibodies|antibodies|mesh-list
154080206|NCT06239727|Antibodies, Blocking|antibodies, blocking|mesh-list
154080207|NCT06239727|Immunologic Factors|immunologic factors|mesh-ancestor
153577251|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153577252|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
153577253|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153577254|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
153577255|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577256|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577257|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153459002|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153459003|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577264|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
153577265|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357152|NCT00722072|Sorafenib|sorafenib|mesh-list
153577266|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577267|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
153577268|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
153577269|NCT01716858|Sulforaphane|sulforaphane|mesh-list
153577270|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153577271|NCT01716858|Protective Agents|protective agents|mesh-ancestor
153577272|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577273|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577274|NCT01716949|Capecitabine|capecitabine|mesh-list
153577275|NCT01716949|Fluorouracil|fluorouracil|mesh-list
153577276|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
153577277|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153577278|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
153577279|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577280|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459010|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
153459011|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459012|NCT01673724|Protective Agents|protective agents|mesh-ancestor
153459013|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459014|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153577281|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153577282|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
153577283|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577284|NCT01717027|Oxycodone|oxycodone|mesh-list
153577285|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153577286|NCT01717027|Narcotics|narcotics|mesh-ancestor
153577287|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577288|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577289|NCT01717027|Analgesics|analgesics|mesh-ancestor
153577290|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
153577291|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577292|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
153577293|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153577294|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577295|NCT01717118|Vaccines|vaccines|mesh-list
153817644|NCT06182267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817645|NCT06179030|Dexamethasone|dexamethasone|mesh-list
153817646|NCT06179030|Ranibizumab|ranibizumab|mesh-list
153817647|NCT06179030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817648|NCT06179030|Antiemetics|antiemetics|mesh-ancestor
154080209|NCT06239727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080210|NCT06239727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080211|NCT06239727|Antimetabolites|antimetabolites|mesh-ancestor
154080212|NCT06239727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080214|NCT06239714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154080215|NCT06239714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154080216|NCT06239714|Antimetabolites|antimetabolites|mesh-ancestor
154080217|NCT06239714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080218|NCT06239714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154080219|NCT06239714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153459015|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153459016|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
153459017|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
153459018|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459019|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
153722914|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459020|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459022|NCT04765098|Etoposide|etoposide|mesh-list
153577305|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577306|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153577307|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153577308|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
153577309|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
153577310|NCT01717222|Lidocaine|lidocaine|mesh-list
153577311|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
153577312|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
153577313|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577314|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577315|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
153577316|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577317|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153577318|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153459023|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459024|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459025|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153459026|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153459027|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459028|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459029|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153459030|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
153577327|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577328|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577329|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577331|NCT01717300|Anacetrapib|anacetrapib|mesh-list
153577332|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153577333|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153577334|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
153577335|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577336|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153577337|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817649|NCT06179030|Autonomic Agents|autonomic agents|mesh-ancestor
153817650|NCT06179030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817651|NCT06179030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817652|NCT06179030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817653|NCT06179030|Glucocorticoids|glucocorticoids|mesh-ancestor
153817654|NCT06179030|Hormones|hormones|mesh-ancestor
153817655|NCT06179030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817656|NCT06179030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154080220|NCT06239714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080221|NCT06239532|Tislelizumab|tislelizumab|mesh-list
154080222|NCT06239532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080223|NCT06239532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080224|NCT06239480|Sirolimus|sirolimus|mesh-list
154080225|NCT06239480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154080226|NCT06239480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080227|NCT06239480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154080228|NCT06239480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080229|NCT06239480|Antifungal Agents|antifungal agents|mesh-ancestor
154080230|NCT06239480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080231|NCT06239480|Immunologic Factors|immunologic factors|mesh-ancestor
154080232|NCT06239480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080233|NCT06239441|Benralizumab|benralizumab|mesh-list
154080234|NCT06239441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154080235|NCT06239441|Respiratory System Agents|respiratory system agents|mesh-ancestor
154080236|NCT06239324|Latanoprost|latanoprost|mesh-list
154080237|NCT06239324|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154080238|NCT06239324|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154080239|NCT06239311|Methotrexate|methotrexate|mesh-list
153817657|NCT06179030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723044|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817658|NCT06179030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153817659|NCT06179030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153817660|NCT06179030|Growth Substances|growth substances|mesh-ancestor
153817661|NCT06179030|Growth Inhibitors|growth inhibitors|mesh-ancestor
153817662|NCT06178367|Hyaluronic Acid|hyaluronic acid|mesh-list
153817663|NCT06178367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153459031|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459032|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459033|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153459034|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153459035|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153459036|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153459037|NCT01674036|Venglustat|venglustat|mesh-list
153459038|NCT01674036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459039|NCT01674036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459040|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
153459041|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
153577347|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153577348|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153577350|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
153577351|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577352|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577353|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577354|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577355|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153577356|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577357|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577358|NCT01717612|Thrombin|thrombin|mesh-list
153577359|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
153577360|NCT01717612|Coagulants|coagulants|mesh-ancestor
153577361|NCT01717625|Montelukast|montelukast|mesh-list
153577362|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153577363|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
153577364|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154080241|NCT06239311|Abortifacient Agents|abortifacient agents|mesh-ancestor
154080242|NCT06239311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154080243|NCT06239311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080244|NCT06239311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080245|NCT06239311|Antimetabolites|antimetabolites|mesh-ancestor
154080246|NCT06239311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080247|NCT06239311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080248|NCT06239311|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080249|NCT06239311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080250|NCT06239311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154080251|NCT06239311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080252|NCT06239311|Immunologic Factors|immunologic factors|mesh-ancestor
154080253|NCT06239311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080254|NCT06239311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154080255|NCT06238934|Hyaluronic Acid|hyaluronic acid|mesh-list
154080256|NCT06238934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154080257|NCT06238934|Immunologic Factors|immunologic factors|mesh-ancestor
154080258|NCT06238934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577365|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
153577366|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153577367|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577368|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153577369|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153577370|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577371|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
153577372|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153577373|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153577374|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577375|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
153577376|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
153577377|NCT01717729|Iodine|iodine|mesh-list
153577378|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153577379|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577380|NCT01717729|Trace Elements|trace elements|mesh-ancestor
153577381|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
153577382|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577383|NCT01716260|Chloroquine|chloroquine|mesh-list
153577384|NCT01716260|Primaquine|primaquine|mesh-list
153577385|NCT01716260|Amebicides|amebicides|mesh-ancestor
153577386|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153577387|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153577388|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577389|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
153577390|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577391|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153577392|NCT01717807|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153577393|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153577394|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577399|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577400|NCT01717846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153577401|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080261|NCT06238882|Nitroglycerin|nitroglycerin|mesh-list
154080262|NCT06238882|Vasodilator Agents|vasodilator agents|mesh-ancestor
154080263|NCT06238856|Amikacin|amikacin|mesh-list
154080264|NCT06238856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154080265|NCT06238856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080266|NCT06238843|Paclitaxel|paclitaxel|mesh-list
154080268|NCT06238843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154080269|NCT06238843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080270|NCT06238843|Tubulin Modulators|tubulin modulators|mesh-ancestor
154080271|NCT06238843|Antimitotic Agents|antimitotic agents|mesh-ancestor
154080272|NCT06238843|Mitosis Modulators|mitosis modulators|mesh-ancestor
154080273|NCT06238843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080274|NCT06238843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154080275|NCT06238843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153577402|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153577403|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
153577404|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577405|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577406|NCT01717911|Metformin|metformin|mesh-list
153577407|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153577408|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
153577409|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153577410|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577411|NCT01717911|Incretins|incretins|mesh-ancestor
153577412|NCT01717911|Hormones|hormones|mesh-ancestor
153577413|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459051|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153459052|NCT01674192|Prucalopride|prucalopride|mesh-list
153459053|NCT01674192|Laxatives|laxatives|mesh-ancestor
153459054|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459055|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153459056|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153459057|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
153577424|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153577425|NCT01717963|Naltrexone|naltrexone|mesh-list
153577426|NCT01717963|Buprenorphine|buprenorphine|mesh-list
153577427|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153577428|NCT01717963|Naloxone|naloxone|mesh-list
153577429|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153577430|NCT01717963|Narcotics|narcotics|mesh-ancestor
153577431|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577432|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577433|NCT01717963|Analgesics|analgesics|mesh-ancestor
153577434|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
153577435|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577436|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153817679|NCT06165900|Antimitotic Agents|antimitotic agents|mesh-ancestor
153817680|NCT06165900|Mitosis Modulators|mitosis modulators|mesh-ancestor
153817681|NCT06165900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817682|NCT06150144|Fluorouracil|fluorouracil|mesh-list
153817683|NCT06150144|Antimetabolites|antimetabolites|mesh-ancestor
153817684|NCT06150144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817685|NCT06150144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153817686|NCT06150144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817687|NCT06150144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817688|NCT06150144|Immunologic Factors|immunologic factors|mesh-ancestor
153817689|NCT06150144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817690|NCT06148337|Psyllium|psyllium|mesh-list
154080276|NCT06238843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080277|NCT06238752|Apatinib|apatinib|mesh-list
154080278|NCT06238752|Tislelizumab|tislelizumab|mesh-list
154080279|NCT06238752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080280|NCT06238752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080281|NCT06238752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553826|NCT01594918|Hormones|hormones|mesh-ancestor
153817691|NCT06148337|Cathartics|cathartics|mesh-ancestor
153459058|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577438|NCT01718054|Chloroquine|chloroquine|mesh-list
153577439|NCT01718054|Amebicides|amebicides|mesh-ancestor
153577440|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153577441|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153577442|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577443|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
153577444|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577445|NCT01718093|Metformin|metformin|mesh-list
153577446|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153577447|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153577448|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577449|NCT01718093|Incretins|incretins|mesh-ancestor
153577450|NCT01718093|Hormones|hormones|mesh-ancestor
153577451|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153577452|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153577453|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
153459059|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459060|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459062|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
153459063|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
153459064|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459065|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459066|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577465|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153577466|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577467|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577468|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153577469|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577470|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577471|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
153817692|NCT06148337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817693|NCT06144099|Thrombin|thrombin|mesh-list
153817694|NCT06144099|Hemostatics|hemostatics|mesh-ancestor
153817695|NCT06144099|Coagulants|coagulants|mesh-ancestor
153459067|NCT01674504|Montelukast|montelukast|mesh-list
153459068|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153459069|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
153459070|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153459071|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
153459072|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459073|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577473|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153577474|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
153577475|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153577476|NCT01718288|Aspirin|aspirin|mesh-list
153577477|NCT01718288|Iloprost|iloprost|mesh-list
153577478|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153577479|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153577480|NCT01718288|Analgesics|analgesics|mesh-ancestor
153577481|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
153577482|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577483|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577484|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577485|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577486|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153577487|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153577488|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577489|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153577490|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153577491|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080282|NCT06238752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080283|NCT06238752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080284|NCT06238648|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154080285|NCT06238648|Immunologic Factors|immunologic factors|mesh-ancestor
154080286|NCT06238648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080287|NCT06238219|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
154080288|NCT06238219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154080289|NCT06238219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080290|NCT06238219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080292|NCT06238167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080293|NCT06238167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080294|NCT06238154|Flurbiprofen|flurbiprofen|mesh-list
153646773|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646774|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153646775|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646776|NCT02972450|Vedolizumab|vedolizumab|mesh-list
153646777|NCT02972450|Vaccines|vaccines|mesh-list
153646778|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
153646779|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646780|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153646781|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
153646782|NCT00117130|Hematinics|hematinics|mesh-ancestor
153646783|NCT00117208|Mannitol|mannitol|mesh-list
153646784|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153646785|NCT00117208|Diuretics|diuretics|mesh-ancestor
153646787|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646788|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
153646789|NCT00117247|Hematinics|hematinics|mesh-ancestor
153646790|NCT00388427|Cetuximab|cetuximab|mesh-list
153646791|NCT00388427|Dasatinib|dasatinib|mesh-list
153646793|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646794|NCT00388427|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153646795|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153646812|NCT00117403|Protective Agents|protective agents|mesh-ancestor
153646813|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
153646814|NCT00117442|Paclitaxel|paclitaxel|mesh-list
153646815|NCT00117442|Carboplatin|carboplatin|mesh-list
153646816|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153646817|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646818|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646819|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
153646820|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723083|NCT00351169|Escitalopram|escitalopram|mesh-list
153646821|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646822|NCT00117520|Caffeine|caffeine|mesh-list
153646823|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153646824|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646825|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153646826|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646827|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646828|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153646829|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153646830|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
153646831|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646832|NCT04727515|Fentanyl|fentanyl|mesh-list
153646833|NCT04727515|Isoflurane|isoflurane|mesh-list
153646834|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153646835|NCT04727515|Narcotics|narcotics|mesh-ancestor
153646836|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153646837|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646838|NCT04727515|Analgesics|analgesics|mesh-ancestor
154080295|NCT06238154|Analgesics|analgesics|mesh-ancestor
154080296|NCT06238154|Sensory System Agents|sensory system agents|mesh-ancestor
154080297|NCT06238154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080298|NCT06238154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080299|NCT06238154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154080300|NCT06238154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154080301|NCT06238154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153646839|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
153646840|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646841|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153646842|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153646843|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
153646844|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
153646845|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153646846|NCT00117754|Terbinafine|terbinafine|mesh-list
153646847|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
153646848|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646849|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646850|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646851|NCT00117832|Azelastine|azelastine|mesh-list
153646852|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153646853|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
153646854|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646855|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646866|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646867|NCT00117871|Resiquimod|resiquimod|mesh-list
153646868|NCT00117871|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153646869|NCT00117871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646870|NCT00117871|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153646871|NCT00117871|Immunologic Factors|immunologic factors|mesh-ancestor
153646872|NCT00117871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646873|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
153646874|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
153646875|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153646876|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
153646877|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153646878|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153646879|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646880|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153646881|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646882|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646883|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153646884|NCT00118066|Calcitriol|calcitriol|mesh-list
153646885|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153646886|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646887|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153646888|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153646889|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646890|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153646893|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153646894|NCT00118105|Bevacizumab|bevacizumab|mesh-list
153646895|NCT00118105|Capecitabine|capecitabine|mesh-list
153646896|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
153646897|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646898|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646899|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153646900|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153646901|NCT00118105|Growth Substances|growth substances|mesh-ancestor
153646902|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646903|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
153646904|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646905|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
153646906|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646907|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153646908|NCT00118183|Cetuximab|cetuximab|mesh-list
153646909|NCT00118183|Docetaxel|docetaxel|mesh-list
153646910|NCT00118183|Bortezomib|bortezomib|mesh-list
154080302|NCT06238154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080303|NCT06238154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154080304|NCT06238154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080305|NCT06238154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080306|NCT06238128|Analgesics, Opioid|analgesics, opioid|mesh-list
154080307|NCT06238128|Narcotics|narcotics|mesh-ancestor
154080308|NCT06238128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153646911|NCT00118183|Antibodies|antibodies|mesh-list
153646912|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
153646913|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153646914|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
153646915|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646916|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646917|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646918|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
153646946|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646947|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646948|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153646949|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153646951|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646952|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
153646953|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153646954|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
153646955|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646956|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646957|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646958|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
153646959|NCT00118261|Antidotes|antidotes|mesh-ancestor
153646960|NCT00118261|Protective Agents|protective agents|mesh-ancestor
153646961|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
153646962|NCT00118261|Vitamins|vitamins|mesh-ancestor
153646963|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
153646964|NCT00118261|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153646965|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153646966|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646981|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
153646982|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
153646983|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153646984|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153646985|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153646986|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153646987|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
153646988|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646989|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646990|NCT00402142|Vaccines|vaccines|mesh-list
153646991|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
153646992|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646993|NCT00118768|Interferons|interferons|mesh-list
153646994|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
153646995|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646996|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
153646997|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646998|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
153646999|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647000|NCT00118807|Artesunate|artesunate|mesh-list
153647001|NCT00118807|Chloroquine|chloroquine|mesh-list
153647002|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
153647003|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
153647004|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153647005|NCT00118807|Amodiaquine|amodiaquine|mesh-list
153647006|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
153647007|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153647008|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153647009|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647010|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647011|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
153647012|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
153647013|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153647014|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
153647015|NCT00118807|Amebicides|amebicides|mesh-ancestor
154080309|NCT06238128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080310|NCT06238128|Analgesics|analgesics|mesh-ancestor
154080311|NCT06238128|Sensory System Agents|sensory system agents|mesh-ancestor
154080312|NCT06238128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080313|NCT06237556|Melatonin|melatonin|mesh-list
154080314|NCT06237556|Antioxidants|antioxidants|mesh-ancestor
154080315|NCT06237556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080316|NCT06237556|Protective Agents|protective agents|mesh-ancestor
153546770|NCT05948891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153647016|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153647017|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153647018|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647019|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647020|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153647021|NCT00118963|Metformin|metformin|mesh-list
153647022|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
153647023|NCT00118963|Repaglinide|repaglinide|mesh-list
153647024|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153647025|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647026|NCT00119002|Dexamethasone|dexamethasone|mesh-list
153647027|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153647028|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
153647029|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
153647030|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647058|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
153647059|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647060|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647061|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
153647062|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
153647063|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
153647064|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153647065|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153647066|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647067|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
153647068|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647069|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
153647071|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
153647072|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
153647073|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647074|NCT00119626|Protective Agents|protective agents|mesh-ancestor
153647075|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647076|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
153647077|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153647078|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153647079|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153647090|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
153647091|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647092|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153647093|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153647094|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647095|NCT00120133|Atorvastatin|atorvastatin|mesh-list
153460107|NCT04615013|Vitamins|vitamins|mesh-ancestor
153647096|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153647097|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153647098|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
153647099|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647100|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153647101|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153647102|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647103|NCT00120172|Bevacizumab|bevacizumab|mesh-list
153647104|NCT00120172|Capecitabine|capecitabine|mesh-list
153647105|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
153647106|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153647107|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647108|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153647109|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154080317|NCT06237556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080318|NCT06237556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080320|NCT06236724|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154080321|NCT06236724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080322|NCT06236724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546777|NCT05948891|Cholinergic Agents|cholinergic agents|mesh-ancestor
153647110|NCT00120172|Growth Substances|growth substances|mesh-ancestor
153647111|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647112|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
153647113|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647114|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
153647115|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647116|NCT00402181|Dexamethasone|dexamethasone|mesh-list
153647117|NCT00402181|Siltuximab|siltuximab|mesh-list
153647118|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153647119|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
153647120|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
153647121|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647124|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
153647125|NCT00402181|Hormones|hormones|mesh-ancestor
153647126|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153647127|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153647128|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647129|NCT04727437|Heparin|heparin|mesh-list
153647130|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153647131|NCT04727437|Tinzaparin|tinzaparin|mesh-list
153647132|NCT04727437|Dalteparin|dalteparin|mesh-list
153647133|NCT04727437|Warfarin|warfarin|mesh-list
153647134|NCT04727437|Anticoagulants|anticoagulants|mesh-list
153647135|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153647136|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153647137|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647138|NCT00120367|Tenofovir|tenofovir|mesh-list
153647139|NCT00120367|Emtricitabine|emtricitabine|mesh-list
153647140|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
153647141|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
153647142|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647166|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153647167|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153647168|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647169|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153332884|NCT03797872|Leflunomide|leflunomide|mesh-list
153647170|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
153647172|NCT00120601|Acamprosate|acamprosate|mesh-list
153647173|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153647174|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153647175|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647176|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
153647177|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647178|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153647179|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153647180|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153647181|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
153647182|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153647183|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647184|NCT00120640|Progestins|progestins|mesh-ancestor
153647185|NCT00120640|Hormones|hormones|mesh-ancestor
153647186|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
153647187|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
153647188|NCT00120679|Hematinics|hematinics|mesh-ancestor
153647189|NCT00120718|Fasudil|fasudil|mesh-list
153647190|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153647191|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647192|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647193|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153647194|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647195|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
153647206|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
153647207|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647208|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154080323|NCT06236724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080325|NCT06235801|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
154080326|NCT06235801|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154080327|NCT06235801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080328|NCT06235801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546784|NCT05946941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153647209|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153647211|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647212|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
153647213|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647214|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
153647215|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153647216|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153647217|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
153647218|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153647219|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647220|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
153647221|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
153647222|NCT00121030|Hematinics|hematinics|mesh-ancestor
153647223|NCT00121069|Escitalopram|escitalopram|mesh-list
153647224|NCT00121069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153647225|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153647226|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647227|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647228|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647229|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
153647230|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647231|NCT00121147|Travoprost|travoprost|mesh-list
153647232|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153647233|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153647234|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153647235|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153647236|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153647237|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
153723341|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647238|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647239|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647240|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647241|NCT00121264|Sorafenib|sorafenib|mesh-list
153647242|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647243|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153647244|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647245|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647247|NCT00121303|Daunorubicin|daunorubicin|mesh-list
153647248|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
153647249|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647250|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
153647251|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647252|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647253|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
153647254|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647255|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647256|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
153647257|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647258|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153647259|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153647275|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
153647276|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647277|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
153647278|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153647279|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647280|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647281|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
153647282|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080329|NCT06235801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080331|NCT06234072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080332|NCT06234072|Antimetabolites|antimetabolites|mesh-ancestor
154080333|NCT06234072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080334|NCT06234072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080335|NCT06231758|Metformin|metformin|mesh-list
154080336|NCT06231758|Celecoxib|celecoxib|mesh-list
154080337|NCT06231758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154080338|NCT06231758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080339|NCT06231758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153647283|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153647284|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
153647285|NCT00121459|Psyllium|psyllium|mesh-list
153647286|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
153647287|NCT00121459|Cathartics|cathartics|mesh-ancestor
153647288|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153647289|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
153647290|NCT00121498|Lidocaine|lidocaine|mesh-list
153647291|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
153647292|NCT00121498|Anesthetics|anesthetics|mesh-list
153647293|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153647294|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647295|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
153647296|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647297|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153647298|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153647299|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153647300|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647301|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647302|NCT00121615|Etanercept|etanercept|mesh-list
153647303|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153647304|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153647305|NCT00121615|Analgesics|analgesics|mesh-ancestor
153647306|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
153647307|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647308|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647309|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153647310|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153647311|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153647312|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647313|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
153647314|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153647315|NCT00391248|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153647316|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153647317|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647318|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647319|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647326|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647328|NCT04705948|Ketamine|ketamine|mesh-list
153647330|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
153647331|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647332|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647333|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153647334|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153647335|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
153647337|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153647338|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153647339|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153647340|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647341|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647342|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154080340|NCT06231758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154080341|NCT06231758|Analgesics|analgesics|mesh-ancestor
154080342|NCT06231758|Sensory System Agents|sensory system agents|mesh-ancestor
154080343|NCT06231758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080344|NCT06231758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154080345|NCT06231758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080346|NCT06231758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153647343|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
153647344|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153647345|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647346|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153647347|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
153647348|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153647349|NCT00121888|Paroxetine|paroxetine|mesh-list
153647350|NCT00121888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153647351|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153647352|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647353|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647354|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647355|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
153647356|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647357|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153647358|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
153647359|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153647360|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153647361|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153647362|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647363|NCT00121966|Insulin|insulin|mesh-list
153647364|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153647365|NCT00121966|Metformin|metformin|mesh-list
153647366|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
153647367|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
153647368|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
153647369|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
153723383|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
153647370|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
153647371|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153647372|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647373|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
153647374|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153647375|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153647377|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153647378|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
153647379|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647380|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647381|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647382|NCT02013492|Propranolol|propranolol|mesh-list
153647383|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153647384|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153647385|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
153647386|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647387|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647395|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
153647396|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153647397|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
153647398|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647399|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647400|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153647401|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
153647402|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
153647403|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153647404|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
153647405|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647406|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647407|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
153546818|NCT05900895|Olaparib|olaparib|mesh-list
153546819|NCT05900895|Estradiol|estradiol|mesh-list
153546820|NCT05900895|Estrogens|estrogens|mesh-ancestor
153546821|NCT05900895|Hormones|hormones|mesh-ancestor
154080347|NCT06231758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154080348|NCT06231758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080349|NCT06231758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080350|NCT06231745|Methotrexate|methotrexate|mesh-list
154080351|NCT06231745|Paroxetine|paroxetine|mesh-list
154080352|NCT06231745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154080353|NCT06231745|Abortifacient Agents|abortifacient agents|mesh-ancestor
154080354|NCT06231745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154080355|NCT06231745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647408|NCT00122473|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153647410|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647411|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647412|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647413|NCT00122512|Tenofovir|tenofovir|mesh-list
153647414|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
153647415|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647416|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153647417|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153647418|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647419|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647420|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153647421|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153647422|NCT01720407|Imiquimod|imiquimod|mesh-list
153723435|NCT00353002|Lidocaine|lidocaine|mesh-list
153647423|NCT01720407|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153647424|NCT01720407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647425|NCT01720407|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153647426|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
153647427|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647428|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153647429|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647430|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
153647431|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153647432|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
153647433|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647434|NCT00122590|Ritonavir|ritonavir|mesh-list
153647435|NCT00122590|Lopinavir|lopinavir|mesh-list
153647436|NCT00122590|Nelfinavir|nelfinavir|mesh-list
153647437|NCT00122590|Indinavir|indinavir|mesh-list
153647438|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153647439|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153647440|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
153647441|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647442|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647443|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153647444|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153647445|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
153647446|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647447|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153647448|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153647449|NCT00122629|Interferons|interferons|mesh-list
153647450|NCT00122629|Ribavirin|ribavirin|mesh-list
153647451|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
153647452|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
153647453|NCT00122629|Amantadine|amantadine|mesh-list
153647454|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153647466|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153647468|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
154080356|NCT06231745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080358|NCT06231745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080359|NCT06231745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080360|NCT06231745|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080361|NCT06231745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080362|NCT06231745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154080363|NCT06231745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546828|NCT05899049|Pembrolizumab|pembrolizumab|mesh-list
153460201|NCT04214990|Aspirin|aspirin|mesh-list
153647469|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647470|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153647471|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153647472|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
153647473|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153647474|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647475|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647476|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
153647477|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647478|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153647479|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153647480|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153647481|NCT05637164|Norepinephrine|norepinephrine|mesh-list
153647482|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153647483|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153647484|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
153647485|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647486|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647487|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647488|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
153647489|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
153647490|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647491|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153647492|NCT00129337|Bavituximab|bavituximab|mesh-list
153647493|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153647494|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647495|NCT00129298|Tiagabine|tiagabine|mesh-list
153647496|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
153647497|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153647498|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153647499|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647500|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647501|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
153647502|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647503|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647504|NCT00129181|Levodopa|levodopa|mesh-list
153647505|NCT00129181|Carbidopa|carbidopa|mesh-list
153647506|NCT00129181|Cabergoline|cabergoline|mesh-list
153647507|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153647508|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153647509|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153647510|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
153647511|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647512|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647513|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647514|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153647515|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647516|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
153647517|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153647518|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
153647530|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647531|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153647532|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
153647533|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153647534|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647535|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577492|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
154080364|NCT06231745|Immunologic Factors|immunologic factors|mesh-ancestor
154080365|NCT06231745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080366|NCT06231745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154080367|NCT06231745|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154080368|NCT06231745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154080369|NCT06231745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154080370|NCT06231745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080371|NCT06231745|Serotonin Agents|serotonin agents|mesh-ancestor
154080372|NCT06231745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153546829|NCT05899049|Lenvatinib|lenvatinib|mesh-list
153647536|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647537|NCT00819780|Bevacizumab|bevacizumab|mesh-list
153647538|NCT00819780|Panitumumab|panitumumab|mesh-list
153647539|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153647540|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647541|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153647542|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153647543|NCT00819780|Growth Substances|growth substances|mesh-ancestor
153647544|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647545|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
153647546|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153647547|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
153647548|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647549|NCT00128791|Nitroprusside|nitroprusside|mesh-list
153647550|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153647551|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
153647552|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153647553|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647554|NCT00128752|Beta Carotene|beta carotene|mesh-list
153647555|NCT00128752|Carotenoids|carotenoids|mesh-list
153647556|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
153647557|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647558|NCT00128752|Protective Agents|protective agents|mesh-ancestor
153647559|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647560|NCT00128752|Provitamins|provitamins|mesh-ancestor
153647562|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
153647563|NCT00063414|Alicaforsen|alicaforsen|mesh-list
153647564|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153647565|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647566|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
153647567|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647568|NCT05638451|Bevacizumab|bevacizumab|mesh-list
153647569|NCT05638451|Temozolomide|temozolomide|mesh-list
153647570|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153647571|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647572|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153647573|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153647574|NCT05638451|Growth Substances|growth substances|mesh-ancestor
153647575|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647576|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
153647577|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153647578|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
153647579|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647600|NCT00128635|Antibodies|antibodies|mesh-list
153647601|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153647603|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647604|NCT00009048|Levodopa|levodopa|mesh-list
153647605|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153647606|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153647607|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
153647608|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647609|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647610|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647611|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
154080373|NCT06231745|Antidepressive Agents|antidepressive agents|mesh-ancestor
154080374|NCT06231745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154080375|NCT06231745|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154080376|NCT06231745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153647612|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647613|NCT00128557|Vitamin A|vitamin a|mesh-list
153647614|NCT00128557|Vitamins|vitamins|mesh-ancestor
153647615|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
153647616|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647617|NCT00128518|Perindopril|perindopril|mesh-list
153647618|NCT00128518|Indapamide|indapamide|mesh-list
153647619|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153647620|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
153647621|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647622|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647623|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153647624|NCT00128518|Diuretics|diuretics|mesh-ancestor
153647625|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
153647626|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647627|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153647628|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647629|NCT00009204|Perphenazine|perphenazine|mesh-list
153647630|NCT00009204|Citalopram|citalopram|mesh-list
153647631|NCT00009204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153647647|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153647648|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647650|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153647651|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
153647652|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647653|NCT00394537|Labetalol|labetalol|mesh-list
153647654|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153647655|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153647656|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
153647657|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647658|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647659|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647660|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153647661|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
153647662|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
153647663|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647664|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153647665|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153647666|NCT00009555|Testosterone|testosterone|mesh-list
153647667|NCT00009555|Androgens|androgens|mesh-ancestor
153647668|NCT00009555|Hormones|hormones|mesh-ancestor
153647669|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153647670|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647671|NCT00128479|Mifepristone|mifepristone|mesh-list
153647672|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153647673|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
153647674|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153647675|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647676|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153647677|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153647678|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153647679|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
153647680|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153647681|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153647682|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
153647683|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153647684|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
153647685|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153647686|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153647720|NCT00009672|Narcotics|narcotics|mesh-ancestor
153723614|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
153647721|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153647722|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080380|NCT06229054|Dexmedetomidine|dexmedetomidine|mesh-list
154080381|NCT06229054|Bupivacaine|bupivacaine|mesh-list
154080382|NCT06229054|Anesthetics, Local|anesthetics, local|mesh-ancestor
154080383|NCT06229054|Anesthetics|anesthetics|mesh-ancestor
154080384|NCT06229054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080385|NCT06229054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080386|NCT06229054|Sensory System Agents|sensory system agents|mesh-ancestor
154080387|NCT06229054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080388|NCT06229054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154080389|NCT06229054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154080390|NCT06229054|Analgesics|analgesics|mesh-ancestor
154080391|NCT06229054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154080392|NCT06229054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154080393|NCT06229054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154080394|NCT06229054|Adrenergic Agents|adrenergic agents|mesh-ancestor
154080395|NCT06229054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080396|NCT06229054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080397|NCT06226753|Anesthetics|anesthetics|mesh-list
153647724|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
153647725|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647726|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153647740|NCT00018733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153647741|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153647742|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647743|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647746|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647747|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153647748|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
153647749|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153647750|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153647751|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153647752|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647753|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153647754|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153647755|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
153647756|NCT00018850|Haloperidol|haloperidol|mesh-list
153647757|NCT00018850|Ondansetron|ondansetron|mesh-list
153647758|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
153647759|NCT00018850|Nicotine|nicotine|mesh-list
153647760|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153647761|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
153647762|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647763|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647764|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153647765|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153647766|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
153647767|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647768|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647769|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
153647770|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153647771|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
153647772|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
153647773|NCT00018850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154080398|NCT06226753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080399|NCT06226753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080400|NCT06225752|Probucol|probucol|mesh-list
153546866|NCT05889624|Amitriptyline|amitriptyline|mesh-list
153647774|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153647775|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
153647776|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153647777|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153647778|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153647779|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153647780|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153647781|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
153647782|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153647783|NCT00009750|Cyclosporine|cyclosporine|mesh-list
153647784|NCT00009750|Paclitaxel|paclitaxel|mesh-list
153647785|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153647786|NCT00009750|Antibodies|antibodies|mesh-list
153647787|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
153647801|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647802|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
153647803|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153647804|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153647805|NCT00019084|Aldesleukin|aldesleukin|mesh-list
153647806|NCT00019084|Vaccines|vaccines|mesh-list
153647807|NCT00019084|Sargramostim|sargramostim|mesh-list
153647808|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
153647809|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647810|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647811|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153647812|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153647813|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
153647814|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647815|NCT00019123|Thalidomide|thalidomide|mesh-list
153647816|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647817|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
153647818|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647819|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
153647820|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153647821|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647822|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153647823|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153647824|NCT00019123|Growth Substances|growth substances|mesh-ancestor
153647826|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647827|NCT00019240|Cidofovir|cidofovir|mesh-list
153647828|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
153647829|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647830|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647831|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647832|NCT00019357|Aldesleukin|aldesleukin|mesh-list
153647833|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647834|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153647835|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153647836|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
153647837|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647839|NCT00009828|Paclitaxel|paclitaxel|mesh-list
153647840|NCT00009828|Tegafur|tegafur|mesh-list
153647841|NCT00009828|Calcium|calcium|mesh-list
153647842|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
153647843|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153647844|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647845|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
153647846|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
153647847|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
153647848|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647849|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153647850|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647851|NCT00009828|Antidotes|antidotes|mesh-ancestor
153647862|NCT00019474|Interferons|interferons|mesh-list
153647863|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
153647864|NCT00019474|Fluorouracil|fluorouracil|mesh-list
153647865|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
153647866|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
153647867|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647868|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647869|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080401|NCT06225752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154080402|NCT06225752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154080403|NCT06225752|Antimetabolites|antimetabolites|mesh-ancestor
154080404|NCT06225752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080405|NCT06225752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154080406|NCT06225752|Antioxidants|antioxidants|mesh-ancestor
154080407|NCT06225752|Protective Agents|protective agents|mesh-ancestor
153723638|NCT00115245|Adefovir|adefovir|mesh-list
153647870|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647871|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
153647872|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647873|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
153647874|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647875|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
153647876|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647877|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153647878|NCT00019513|Leucovorin|leucovorin|mesh-list
153647879|NCT00019513|Gemcitabine|gemcitabine|mesh-list
153647880|NCT00019513|Fluorouracil|fluorouracil|mesh-list
153647881|NCT00019513|Calcium|calcium|mesh-list
153647882|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
153647883|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647884|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
153647885|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647886|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647887|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153647888|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647889|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647890|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
153647891|NCT00019513|Antidotes|antidotes|mesh-ancestor
153647892|NCT00019513|Protective Agents|protective agents|mesh-ancestor
153647893|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
153647894|NCT00019513|Vitamins|vitamins|mesh-ancestor
153647895|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
153647896|NCT00019552|Irofulven|irofulven|mesh-list
153647897|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153647898|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
153647899|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647900|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647901|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
153647902|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647903|NCT00019591|Aldesleukin|aldesleukin|mesh-list
153647904|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647905|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153647906|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153647907|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
153647908|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647909|NCT00019669|Aldesleukin|aldesleukin|mesh-list
153647910|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647911|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153647912|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153647913|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
153647915|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
153647916|NCT00009906|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153647917|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153647918|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647919|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647920|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647996|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
153647997|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647998|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647999|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153648025|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648026|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648027|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648028|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648029|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080408|NCT06225752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080410|NCT06190288|Cholinergic Agents|cholinergic agents|mesh-ancestor
154080411|NCT06190288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080412|NCT06190288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080413|NCT06190288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648030|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648031|NCT00020332|Growth Substances|growth substances|mesh-ancestor
153648032|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648033|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153648034|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648036|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153648037|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
153648038|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648039|NCT00020449|Paclitaxel|paclitaxel|mesh-list
153648040|NCT00020449|Doxorubicin|doxorubicin|mesh-list
153648041|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153648042|NCT00020449|Interleukin-12|interleukin-12|mesh-list
153648043|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153648044|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648045|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648046|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648047|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648048|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648049|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648073|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648074|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648075|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648076|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648077|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
153648078|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153648079|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648080|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460264|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648081|NCT00020488|Antidotes|antidotes|mesh-ancestor
153648082|NCT00020488|Protective Agents|protective agents|mesh-ancestor
153648083|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
153648085|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
153648086|NCT00020527|Caspofungin|caspofungin|mesh-list
153648087|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
153648088|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648089|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648090|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648091|NCT00020566|Dactinomycin|dactinomycin|mesh-list
153648092|NCT00020566|Doxorubicin|doxorubicin|mesh-list
153648093|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153648094|NCT00020566|Etoposide|etoposide|mesh-list
153648095|NCT00020566|Vincristine|vincristine|mesh-list
153648096|NCT00020566|Melphalan|melphalan|mesh-list
153648097|NCT00020566|Busulfan|busulfan|mesh-list
153648098|NCT00020566|Ifosfamide|ifosfamide|mesh-list
153648099|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648100|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648101|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648102|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648103|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648116|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648117|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153648118|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648119|NCT00010062|Fluorouracil|fluorouracil|mesh-list
153648120|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
153648121|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648122|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648123|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648124|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648127|NCT00020605|Naloxone|naloxone|mesh-list
153648128|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153648129|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080414|NCT06170372|Nitric Oxide|nitric oxide|mesh-list
154080415|NCT06170372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154080416|NCT06170372|Autonomic Agents|autonomic agents|mesh-ancestor
154080417|NCT06170372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080418|NCT06170372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080419|NCT06170372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153730378|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153730379|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153730380|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153730381|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153648130|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
153648131|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648132|NCT00020644|Gemcitabine|gemcitabine|mesh-list
153648133|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648134|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
153648135|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648136|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648138|NCT00020761|Irinotecan|irinotecan|mesh-list
153648139|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153648140|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648141|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648142|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648143|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648144|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648145|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153648146|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648147|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648149|NCT00020800|Fludarabine|fludarabine|mesh-list
153648150|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
153648151|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153648152|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648153|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
153648154|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648155|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648156|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648157|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
153648158|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648159|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648160|NCT00020839|Temozolomide|temozolomide|mesh-list
153648161|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153648162|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
153648163|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648193|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648194|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153648195|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153648196|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648197|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648199|NCT00020917|Fluorouracil|fluorouracil|mesh-list
153648201|NCT00020917|Cetuximab|cetuximab|mesh-list
153648202|NCT00020917|Calcium|calcium|mesh-list
153648203|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
153648204|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153648205|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648206|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
153648217|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
153648218|NCT00020917|Vitamins|vitamins|mesh-ancestor
153648219|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
153648220|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153648221|NCT00021034|Taurolidine|taurolidine|mesh-list
153648222|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648223|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153648224|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648225|NCT00010179|Lurtotecan|lurtotecan|mesh-list
154080420|NCT06170372|Respiratory System Agents|respiratory system agents|mesh-ancestor
154080421|NCT06170372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154080422|NCT06170372|Antioxidants|antioxidants|mesh-ancestor
154080423|NCT06170372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080424|NCT06170372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080425|NCT06170372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154080426|NCT06170372|Vasodilator Agents|vasodilator agents|mesh-ancestor
153648226|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648227|NCT00021073|Leucovorin|leucovorin|mesh-list
153648228|NCT00021073|Fluorouracil|fluorouracil|mesh-list
153648229|NCT00021073|Irinotecan|irinotecan|mesh-list
153648230|NCT00021073|Alvocidib|alvocidib|mesh-list
153648231|NCT00021073|Calcium|calcium|mesh-list
153648232|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
153648233|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153648234|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648235|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
153648236|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648237|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648238|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648239|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648240|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
153648242|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648243|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648244|NCT00021073|Antidotes|antidotes|mesh-ancestor
153648245|NCT00021073|Protective Agents|protective agents|mesh-ancestor
153648246|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
153648247|NCT00021073|Vitamins|vitamins|mesh-ancestor
153648248|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
153648249|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648250|NCT00021073|Growth Substances|growth substances|mesh-ancestor
153648251|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153648252|NCT00021112|Etoposide|etoposide|mesh-list
153648253|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648254|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153648255|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648256|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648257|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648258|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648259|NCT00000122|Fluorouracil|fluorouracil|mesh-list
153648260|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
153648261|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648262|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648263|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648264|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648265|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
153648266|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648267|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
153648268|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153648269|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648270|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
153648271|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648272|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
153648295|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648296|NCT00021385|Growth Substances|growth substances|mesh-ancestor
153648297|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648298|NCT00021463|Lamivudine|lamivudine|mesh-list
153648300|NCT00021463|Efavirenz|efavirenz|mesh-list
153648301|NCT00021463|Nevirapine|nevirapine|mesh-list
153648302|NCT00021463|Abacavir|abacavir|mesh-list
153648303|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
153648304|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153648305|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153460306|NCT03710343|Metformin|metformin|mesh-list
153648306|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648307|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648308|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
153648309|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648310|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154080428|NCT06170372|Protective Agents|protective agents|mesh-ancestor
154080429|NCT06163729|Paclitaxel|paclitaxel|mesh-list
154080430|NCT06163729|Oxaliplatin|oxaliplatin|mesh-list
154080431|NCT06163729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154080432|NCT06163729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080433|NCT06163729|Tubulin Modulators|tubulin modulators|mesh-ancestor
154080434|NCT06163729|Antimitotic Agents|antimitotic agents|mesh-ancestor
154080435|NCT06163729|Mitosis Modulators|mitosis modulators|mesh-ancestor
154080436|NCT06163729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080437|NCT06143059|Ethanol|ethanol|mesh-list
154080438|NCT06143059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154080439|NCT06143059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080440|NCT06143059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546905|NCT05878964|Mitogens|mitogens|mesh-list
153648311|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153648312|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
153648313|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153648314|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153648315|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153648316|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153648317|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153648318|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153648319|NCT00021502|Chrysarobin|chrysarobin|mesh-list
153648320|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153648321|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153648322|NCT00021502|Analgesics|analgesics|mesh-ancestor
153648323|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
153648324|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648325|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648350|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
153648351|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648352|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
153648353|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648354|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
153648355|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648356|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648357|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648358|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648359|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648360|NCT00021814|Doxazosin|doxazosin|mesh-list
153648361|NCT00021814|Finasteride|finasteride|mesh-list
153648363|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153648364|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648365|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648366|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
153648367|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648368|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648369|NCT00021814|Urological Agents|urological agents|mesh-ancestor
153648370|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153648371|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153648372|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153648373|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153648374|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
153648375|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648412|NCT00388700|Fluorouracil|fluorouracil|mesh-list
153648413|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153648414|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648447|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080441|NCT06143059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080442|NCT06110598|Capecitabine|capecitabine|mesh-list
154080443|NCT06110598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080444|NCT06110598|Antimetabolites|antimetabolites|mesh-ancestor
154080445|NCT06110598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080446|NCT06110598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080447|NCT06109701|Erythritol|erythritol|mesh-list
154080448|NCT06109701|Vasodilator Agents|vasodilator agents|mesh-ancestor
154080449|NCT06049654|Fexofenadine|fexofenadine|mesh-list
154080450|NCT06049654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153648448|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648449|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153648450|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
153648451|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648452|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648453|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153648454|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648456|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
153648457|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648458|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153648459|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
153648460|NCT00022126|Hormones|hormones|mesh-ancestor
153648461|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648489|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648490|NCT00022165|Trace Elements|trace elements|mesh-ancestor
153648491|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
153648492|NCT00022204|Vitamin E|vitamin e|mesh-list
153648493|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
153648494|NCT00022204|Vitamins|vitamins|mesh-ancestor
153648495|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
153648496|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648497|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
153648498|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648499|NCT00022204|Protective Agents|protective agents|mesh-ancestor
153648500|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153648501|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648502|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153648503|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153648504|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
153648505|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153648506|NCT00388739|Prednisolone|prednisolone|mesh-list
153648507|NCT00388739|Budesonide|budesonide|mesh-list
153648508|NCT00388739|Albuterol|albuterol|mesh-list
153648509|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648532|NCT00022321|Immunotoxins|immunotoxins|mesh-ancestor
153648533|NCT00022321|Immunoconjugates|immunoconjugates|mesh-ancestor
153648534|NCT00022321|Immunologic Factors|immunologic factors|mesh-ancestor
153648535|NCT00022321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648536|NCT00022360|Taurolidine|taurolidine|mesh-list
153648537|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648538|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153648539|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648540|NCT00022399|Celecoxib|celecoxib|mesh-list
153648541|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153648542|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153648543|NCT00022399|Analgesics|analgesics|mesh-ancestor
153648544|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
153648545|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648546|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648547|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648548|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648549|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153648550|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153648551|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648552|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648554|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154080451|NCT06049654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154080453|NCT06049654|Histamine Antagonists|histamine antagonists|mesh-ancestor
154080454|NCT06049654|Histamine Agents|histamine agents|mesh-ancestor
154080455|NCT06049654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080456|NCT06049654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080457|NCT06049654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080458|NCT06039878|Oxytocin|oxytocin|mesh-list
154080459|NCT06039878|Oxytocics|oxytocics|mesh-ancestor
153648555|NCT00000143|Cidofovir|cidofovir|mesh-list
153648556|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
153648557|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648558|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648559|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469164|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648575|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648576|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648577|NCT00022555|Vincristine|vincristine|mesh-list
153648578|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
153648579|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153648580|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648581|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648582|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648583|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648584|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648585|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153648586|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
153648587|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648588|NCT00000146|Prednisone|prednisone|mesh-list
153648589|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
153648590|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153648591|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153648592|NCT00000146|Prednisolone|prednisolone|mesh-list
153648593|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
153648594|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153648595|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
153648596|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648597|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
153648598|NCT00000146|Hormones|hormones|mesh-ancestor
153648599|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648600|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648601|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153648602|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648603|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
153648604|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
153648605|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648606|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153648607|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153648608|NCT00000146|Protective Agents|protective agents|mesh-ancestor
153648609|NCT00010725|Vitamins|vitamins|mesh-list
153648610|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
153648611|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648612|NCT00022594|Lurtotecan|lurtotecan|mesh-list
153648613|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648614|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153648615|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153648616|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
153648617|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648618|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648619|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648620|NCT00022711|Temozolomide|temozolomide|mesh-list
153648655|NCT00000152|Protective Agents|protective agents|mesh-ancestor
153648657|NCT00000152|Vitamins|vitamins|mesh-ancestor
153648658|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
153648659|NCT00010881|Antioxidants|antioxidants|mesh-list
153648660|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080460|NCT06039878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154080461|NCT06039878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080463|NCT06022614|Bupivacaine|bupivacaine|mesh-list
154080464|NCT06022614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154080465|NCT06022614|Anesthetics, Local|anesthetics, local|mesh-ancestor
154080466|NCT06022614|Anesthetics|anesthetics|mesh-ancestor
154080467|NCT06022614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153648661|NCT00010881|Protective Agents|protective agents|mesh-ancestor
153648662|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648692|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153648693|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648694|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648695|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648696|NCT00023218|Ritonavir|ritonavir|mesh-list
153648697|NCT00023218|Lopinavir|lopinavir|mesh-list
153648698|NCT00023218|Efavirenz|efavirenz|mesh-list
153648699|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153648700|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153648701|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
153648702|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648703|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648704|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153648705|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153648706|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
153648708|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153648709|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153648741|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648742|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648743|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153648744|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
153648745|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153648746|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
153648747|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648748|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648772|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648773|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
153648774|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648775|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
153648776|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
153648777|NCT00000173|Protective Agents|protective agents|mesh-ancestor
153648778|NCT00023374|Rifampin|rifampin|mesh-list
153648779|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
153648780|NCT00023374|Ethambutol|ethambutol|mesh-list
153648781|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153648782|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
153648783|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153648784|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648785|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
153648786|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648787|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648788|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648789|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153648790|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153648791|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153648792|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153648793|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153648794|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153648795|NCT00023413|Efavirenz|efavirenz|mesh-list
153648796|NCT00023413|Rifabutin|rifabutin|mesh-list
153648797|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153648798|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648799|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648800|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648801|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
154080469|NCT06022614|Sensory System Agents|sensory system agents|mesh-ancestor
154080470|NCT06022614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080471|NCT06022614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154080472|NCT06022614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154080473|NCT06022614|Analgesics|analgesics|mesh-ancestor
154080474|NCT06022614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154080475|NCT06022614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154080476|NCT06022614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153648824|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648825|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153648826|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648827|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648828|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
153648829|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
153648830|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153648831|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648832|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648833|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648834|NCT00023530|Growth Substances|growth substances|mesh-ancestor
153648835|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648836|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
153648837|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153648838|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153648839|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648840|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648841|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153648842|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
153648843|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153648844|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153648845|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153648847|NCT00000176|Estrogens|estrogens|mesh-list
153648848|NCT00000176|Progestins|progestins|mesh-ancestor
153648849|NCT00000176|Hormones|hormones|mesh-ancestor
153648850|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648851|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648904|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153648905|NCT00023842|Mitomycins|mitomycins|mesh-list
153648906|NCT00023842|Mitomycin|mitomycin|mesh-list
153648907|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
153648908|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648909|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648910|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
153648911|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648912|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648913|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648914|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153648915|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
153648916|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648917|NCT00000221|Buprenorphine|buprenorphine|mesh-list
153648918|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153648919|NCT00000221|Narcotics|narcotics|mesh-ancestor
153648920|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153648921|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648922|NCT00000221|Analgesics|analgesics|mesh-ancestor
153648923|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
153648924|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648925|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153648926|NCT00023881|Bortezomib|bortezomib|mesh-list
153648927|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648928|NCT00023920|Cytarabine|cytarabine|mesh-list
153648929|NCT00023920|Bevacizumab|bevacizumab|mesh-list
154080477|NCT06022614|Adrenergic Agents|adrenergic agents|mesh-ancestor
154080478|NCT06022614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080479|NCT06022614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080480|NCT06021275|Insulin|insulin|mesh-list
154080481|NCT06021275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154080482|NCT06021275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153546950|NCT05836584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153648930|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153648931|NCT00023920|Idarubicin|idarubicin|mesh-list
153648932|NCT00023920|Antibodies|antibodies|mesh-list
153648933|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
153648934|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153648935|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648936|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648937|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648938|NCT00023920|Growth Substances|growth substances|mesh-ancestor
153648939|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648940|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648941|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
153648942|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648943|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
153648944|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648945|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
153648946|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460379|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
153648960|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648961|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648962|NCT00023959|Growth Substances|growth substances|mesh-ancestor
153648963|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648964|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648965|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
153648966|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
153648967|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648968|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648969|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648970|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
153648971|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648972|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648973|NCT00023998|Leucovorin|leucovorin|mesh-list
153648974|NCT00023998|Doxorubicin|doxorubicin|mesh-list
153648975|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153648976|NCT00023998|Methotrexate|methotrexate|mesh-list
153648977|NCT00023998|Trastuzumab|trastuzumab|mesh-list
153648978|NCT00023998|Etoposide|etoposide|mesh-list
153648979|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
153648980|NCT00023998|Ifosfamide|ifosfamide|mesh-list
153648981|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
153648982|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648983|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648984|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648985|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648986|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648987|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648988|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648989|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153648990|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
153648991|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153648992|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648993|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
153648994|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
153648997|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
153648998|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648999|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649000|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153649001|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649003|NCT00023998|Protective Agents|protective agents|mesh-ancestor
153649004|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
153649005|NCT00023998|Vitamins|vitamins|mesh-ancestor
153649006|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
154080483|NCT06021275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080484|NCT06010628|Tenecteplase|tenecteplase|mesh-list
154080485|NCT06010628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154080486|NCT06010628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154080487|NCT06010628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080488|NCT06001125|Methotrexate|methotrexate|mesh-list
153649007|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649008|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
153649009|NCT00024115|Antibodies|antibodies|mesh-list
153649010|NCT00024115|Immunotoxins|immunotoxins|mesh-list
153649011|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
153649024|NCT00011076|Analgesics|analgesics|mesh-ancestor
153649025|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
153649026|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649027|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649028|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153649029|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153649030|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153649031|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649032|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649033|NCT00000248|Pergolide|pergolide|mesh-list
153649034|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
153649035|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
153649036|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153649037|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649038|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649039|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
153649040|NCT00024193|Melphalan|melphalan|mesh-list
153649041|NCT00024193|Busulfan|busulfan|mesh-list
153649042|NCT00024193|Doxorubicin|doxorubicin|mesh-list
153649043|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153649044|NCT00024193|Etoposide|etoposide|mesh-list
153649045|NCT00024193|Vincristine|vincristine|mesh-list
153649046|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649047|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
153649048|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649049|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649050|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649051|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
153649052|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649053|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649054|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649055|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649056|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649057|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649058|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649059|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649060|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649061|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649062|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649064|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153649065|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
153649066|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649067|NCT00024271|Interferons|interferons|mesh-list
153649068|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
153649069|NCT00024271|Gemcitabine|gemcitabine|mesh-list
153649070|NCT00024271|Doxorubicin|doxorubicin|mesh-list
153649071|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153649072|NCT00024271|Mitomycins|mitomycins|mesh-list
153649073|NCT00024271|Mitomycin|mitomycin|mesh-list
153649074|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649075|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649076|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
153649102|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153649103|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649104|NCT00024349|Fluorouracil|fluorouracil|mesh-list
153649105|NCT00024349|Mitomycins|mitomycins|mesh-list
153649106|NCT00024349|Mitomycin|mitomycin|mesh-list
153649107|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
153649108|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649111|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649112|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
153546963|NCT05827055|Antimitotic Agents|antimitotic agents|mesh-ancestor
154080489|NCT06001125|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154080490|NCT06001125|Abortifacient Agents|abortifacient agents|mesh-ancestor
154080491|NCT06001125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154080492|NCT06001125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080493|NCT06001125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080494|NCT06001125|Antimetabolites|antimetabolites|mesh-ancestor
154080495|NCT06001125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080496|NCT06001125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080498|NCT06001125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080499|NCT06001125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153730382|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153730384|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
153546970|NCT05822583|Abatacept|abatacept|mesh-list
153649113|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649114|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649115|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
153649116|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649117|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649118|NCT00000251|Isoflurane|isoflurane|mesh-list
153649119|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153649120|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
153649121|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
153649122|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153649123|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649124|NCT00024388|Paclitaxel|paclitaxel|mesh-list
153649125|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649126|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649127|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649146|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153649147|NCT00000257|Analgesics|analgesics|mesh-ancestor
153649148|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
153649149|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649150|NCT00024466|Vaccines|vaccines|mesh-list
153649151|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
153649152|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649153|NCT04733131|Abatacept|abatacept|mesh-list
153649154|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153649155|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649156|NCT04733131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153649157|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649158|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649159|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
153649160|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649161|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649162|NCT00024544|Antibodies|antibodies|mesh-list
153649163|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153649164|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
153649165|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649166|NCT00395239|Budesonide|budesonide|mesh-list
153649167|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153649168|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153649169|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
153649170|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649171|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649172|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153649173|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
153649174|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
153649175|NCT00395239|Hormones|hormones|mesh-ancestor
153577493|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
153730386|NCT00133562|Glycine|glycine|mesh-list
153730387|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
153730388|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080500|NCT06001125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730389|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730390|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730391|NCT00404391|Acetaminophen|acetaminophen|mesh-list
153649176|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153649177|NCT00025012|Isotretinoin|isotretinoin|mesh-list
153649178|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
153649179|NCT00025051|Celecoxib|celecoxib|mesh-list
153649180|NCT00025051|Mitogens|mitogens|mesh-list
153649181|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153649182|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153649183|NCT00025051|Analgesics|analgesics|mesh-ancestor
153649184|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
153649205|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
153649206|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649207|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649209|NCT00000368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153649210|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153649211|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153649212|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649213|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153649214|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
153649215|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649216|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153649217|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
153649218|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153910733|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153649223|NCT00025168|Irinotecan|irinotecan|mesh-list
153649224|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649225|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
153649226|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649227|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649228|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153649229|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649230|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649231|NCT00025207|Gefitinib|gefitinib|mesh-list
153649232|NCT00025207|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153649233|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153649234|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649235|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649250|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649251|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649252|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
153649253|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649254|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
153649255|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153649256|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649257|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649258|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649259|NCT00025285|Growth Substances|growth substances|mesh-ancestor
153649260|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649261|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
153649262|NCT00025324|Thiotepa|thiotepa|mesh-list
153649263|NCT00025324|Carboplatin|carboplatin|mesh-list
153649264|NCT00025324|Etoposide|etoposide|mesh-list
153649265|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649266|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
153649267|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649268|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649269|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649270|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
153730392|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153730393|NCT00404391|Hydrocodone|hydrocodone|mesh-list
154080501|NCT06001125|Immunologic Factors|immunologic factors|mesh-ancestor
154080502|NCT06001125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080503|NCT06001125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154080504|NCT05981365|Metformin|metformin|mesh-list
154080505|NCT05981365|Repaglinide|repaglinide|mesh-list
154080506|NCT05981365|Flurbiprofen|flurbiprofen|mesh-list
154080507|NCT05981365|Furosemide|furosemide|mesh-list
154080508|NCT05981365|Midazolam|midazolam|mesh-list
154080509|NCT05981365|Bupropion|bupropion|mesh-list
153546982|NCT05819541|Respiratory System Agents|respiratory system agents|mesh-ancestor
153649271|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649272|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649273|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649274|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649275|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649276|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649277|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649278|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
153649279|NCT00025363|Ifosfamide|ifosfamide|mesh-list
153649280|NCT00025363|Doxorubicin|doxorubicin|mesh-list
153649281|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153649283|NCT00025363|Etoposide|etoposide|mesh-list
153649284|NCT00025363|Vincristine|vincristine|mesh-list
153649285|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
153649286|NCT00025363|Tirapazamine|tirapazamine|mesh-list
153649287|NCT00025363|Sargramostim|sargramostim|mesh-list
153649288|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649289|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
153649290|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649291|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649292|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649293|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
153649294|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649295|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649296|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649297|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649298|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649364|NCT00000395|Folic Acid|folic acid|mesh-list
153649365|NCT00000395|Leucovorin|leucovorin|mesh-list
153649366|NCT00000395|Methotrexate|methotrexate|mesh-list
153649367|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
153649368|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153649369|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
153649370|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153649371|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649372|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649374|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649375|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649376|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
153649377|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649378|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153649379|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649380|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
153649381|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649382|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649383|NCT00000395|Hematinics|hematinics|mesh-ancestor
153649409|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649411|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649412|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649413|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153649414|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
153649415|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153649416|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649417|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
154080510|NCT05981365|Omeprazole|omeprazole|mesh-list
154080511|NCT05981365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154080512|NCT05981365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154080513|NCT05981365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080514|NCT05981365|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154080515|NCT05981365|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153546990|NCT05819541|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153649418|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649419|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649420|NCT00025519|Growth Substances|growth substances|mesh-ancestor
153649421|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649422|NCT00025558|Carboplatin|carboplatin|mesh-list
153649423|NCT00025558|Temozolomide|temozolomide|mesh-list
153649424|NCT00025558|Thiotepa|thiotepa|mesh-list
153649425|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649426|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
153649427|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649428|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649429|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
153649430|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649431|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649432|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649433|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
153649434|NCT00025597|Carboplatin|carboplatin|mesh-list
153649452|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649453|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649454|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649455|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649456|NCT00025636|Cytarabine|cytarabine|mesh-list
153649457|NCT00025636|Dexamethasone|dexamethasone|mesh-list
153649458|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
153649459|NCT00025636|Melphalan|melphalan|mesh-list
153649460|NCT00025636|Carmustine|carmustine|mesh-list
153649461|NCT00025636|Methotrexate|methotrexate|mesh-list
153649462|NCT00025636|Etoposide|etoposide|mesh-list
153649463|NCT00025636|Vincristine|vincristine|mesh-list
153649464|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649465|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
153649466|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649467|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649468|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649469|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
153649470|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649471|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649472|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649473|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153649474|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
153649475|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
153649476|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649477|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153649478|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
153649479|NCT00025636|Hormones|hormones|mesh-ancestor
153649480|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153649481|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153649482|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153649483|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
153649484|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153649485|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649486|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
153649487|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
153649488|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649490|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649491|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649492|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649493|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649503|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649504|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649505|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
153649506|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154080516|NCT05981365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080518|NCT05981365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154080519|NCT05981365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154080520|NCT05981365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154080521|NCT05981365|Anesthetics, General|anesthetics, general|mesh-ancestor
154080522|NCT05981365|Anesthetics|anesthetics|mesh-ancestor
154080523|NCT05981365|GABA Modulators|gaba modulators|mesh-ancestor
154080524|NCT05981365|GABA Agents|gaba agents|mesh-ancestor
154080525|NCT05981365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080526|NCT05981365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080527|NCT05981365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153547001|NCT05816707|Antioxidants|antioxidants|mesh-ancestor
153649507|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649508|NCT00025792|Pramipexole|pramipexole|mesh-list
153649509|NCT00025792|Dexpramipexole|dexpramipexole|mesh-list
153649510|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
153649511|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649512|NCT00025792|Protective Agents|protective agents|mesh-ancestor
153649513|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649514|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153649515|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153649516|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
153649517|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
153649518|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153649519|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153649520|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153649521|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153649522|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
153649523|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153649524|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649525|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153649526|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153649527|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153649528|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649529|NCT00000419|Estrogens|estrogens|mesh-ancestor
153649530|NCT00000419|Hormones|hormones|mesh-ancestor
153649531|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153649532|NCT00026104|Paclitaxel|paclitaxel|mesh-list
153649533|NCT00026104|Gemcitabine|gemcitabine|mesh-list
153649534|NCT00026104|Tipifarnib|tipifarnib|mesh-list
153649535|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649536|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649537|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649538|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649539|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649540|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649541|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649542|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
153649543|NCT00026143|Interferons|interferons|mesh-list
153649544|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
153649545|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
153649546|NCT00026143|Interleukin-12|interleukin-12|mesh-list
153649547|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649548|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
153649549|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649550|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
153649551|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649552|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153649553|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649554|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649555|NCT00026143|Growth Substances|growth substances|mesh-ancestor
153649556|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
154080529|NCT05981365|Antimetabolites|antimetabolites|mesh-ancestor
154080530|NCT05981365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154080531|NCT05981365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154080532|NCT05981365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080533|NCT05981365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154080534|NCT05981365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154080535|NCT05981365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154080536|NCT05981365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153649557|NCT00026182|Rituximab|rituximab|mesh-list
153649558|NCT00026182|Interleukin-12|interleukin-12|mesh-list
153649559|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153649560|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649584|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649585|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649586|NCT00026338|Gemcitabine|gemcitabine|mesh-list
153649587|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153649588|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723946|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649589|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
153649590|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649591|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649592|NCT00026338|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153649594|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649596|NCT00026377|Goserelin|goserelin|mesh-list
153649597|NCT00026377|Flutamide|flutamide|mesh-list
153649598|NCT00026377|Bicalutamide|bicalutamide|mesh-list
153649599|NCT00026377|Semaxinib|semaxinib|mesh-list
153649600|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153649601|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
153649602|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153649603|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649604|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153649605|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649606|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
153649607|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
153649608|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153649609|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649610|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649634|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649635|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
153649636|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153649637|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649638|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649639|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649640|NCT00026533|Growth Substances|growth substances|mesh-ancestor
153649641|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649642|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649643|NCT00026962|Estradiol|estradiol|mesh-list
153649644|NCT00026962|Progesterone|progesterone|mesh-list
153649645|NCT00026962|Estrogens|estrogens|mesh-ancestor
153649646|NCT00026962|Hormones|hormones|mesh-ancestor
153649647|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153649648|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649649|NCT00026962|Progestins|progestins|mesh-ancestor
153649650|NCT00027040|Selegiline|selegiline|mesh-list
153649651|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
153649652|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153649653|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153649654|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153649655|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153649656|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649657|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649658|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153649659|NCT00027040|Protective Agents|protective agents|mesh-ancestor
153577494|NCT01718301|Ribavirin|ribavirin|mesh-list
154080538|NCT05981365|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154080539|NCT05981365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154080540|NCT05981365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154080541|NCT05981365|Dopamine Agents|dopamine agents|mesh-ancestor
154080542|NCT05981365|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154080543|NCT05981365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154080544|NCT05981365|Diuretics|diuretics|mesh-ancestor
153730394|NCT00404391|Oxycodone|oxycodone|mesh-list
154080545|NCT05981365|Natriuretic Agents|natriuretic agents|mesh-ancestor
154080546|NCT05981365|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154080547|NCT05981365|Analgesics|analgesics|mesh-ancestor
153649660|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649662|NCT00027079|Ondansetron|ondansetron|mesh-list
153649663|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153649664|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153649691|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153649693|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153649694|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153649695|NCT00000428|Analgesics|analgesics|mesh-ancestor
153649696|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
153649697|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649698|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649699|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153649700|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153649701|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153649702|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649703|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
153649704|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153649705|NCT00027391|Albuterol|albuterol|mesh-list
153649706|NCT00027391|Oxandrolone|oxandrolone|mesh-list
153649707|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153649708|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
153649709|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649710|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649711|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153649712|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
153649740|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649741|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153649742|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153649744|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649745|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
153452613|NCT01797432|Triamcinolone|triamcinolone|mesh-list
153649746|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649748|NCT00027547|Cytarabine|cytarabine|mesh-list
153649749|NCT00027547|Cyclosporine|cyclosporine|mesh-list
153649750|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
153649751|NCT00027547|Methotrexate|methotrexate|mesh-list
153649752|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
153649753|NCT00027547|Fludarabine|fludarabine|mesh-list
153649754|NCT00027547|Cyclosporins|cyclosporins|mesh-list
153649755|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153649756|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
153649757|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153649758|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649781|NCT00011895|Abacavir|abacavir|mesh-list
153649782|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153649783|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649784|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649785|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649786|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
153577495|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154080548|NCT05981365|Sensory System Agents|sensory system agents|mesh-ancestor
154080549|NCT05981365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080550|NCT05981365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154080551|NCT05981365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154080552|NCT05981365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154080553|NCT05981365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080554|NCT05981365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154080555|NCT05952947|Cyclophosphamide|cyclophosphamide|mesh-list
154080556|NCT05952947|Fludarabine|fludarabine|mesh-list
154080557|NCT05952947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649787|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649788|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153649789|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153649790|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
153649791|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153649792|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153649793|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153649794|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153649795|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153649796|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153649797|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
153649798|NCT00027586|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153649799|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153649800|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469405|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153649801|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649802|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649803|NCT00000464|Quinidine|quinidine|mesh-list
153649804|NCT00000464|Amiodarone|amiodarone|mesh-list
153649805|NCT00000464|Sotalol|sotalol|mesh-list
153649806|NCT00000464|Propafenone|propafenone|mesh-list
153649807|NCT00000464|Mexiletine|mexiletine|mesh-list
153649808|NCT00000464|Procainamide|procainamide|mesh-list
153649809|NCT00000464|Imipramine|imipramine|mesh-list
153649810|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153649811|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
153649812|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153649843|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153649844|NCT00027625|Temozolomide|temozolomide|mesh-list
153649846|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649847|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
153649848|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649849|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649850|NCT00027625|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153649851|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153649852|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649853|NCT00027664|Interferons|interferons|mesh-list
153649889|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649891|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649892|NCT00027742|Interferons|interferons|mesh-list
153649893|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
153649894|NCT00027742|Temozolomide|temozolomide|mesh-list
153649895|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649908|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649909|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649910|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
153649911|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649912|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649913|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
153649914|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649915|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649916|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
153649917|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649918|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
153649919|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649920|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154080559|NCT05952947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080560|NCT05952947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080561|NCT05952947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154080562|NCT05952947|Alkylating Agents|alkylating agents|mesh-ancestor
154080563|NCT05952947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080564|NCT05952947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080565|NCT05952947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154080566|NCT05939414|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153649921|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649922|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153649923|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
153649924|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153649926|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649927|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153649928|NCT00011973|Protective Agents|protective agents|mesh-ancestor
153649929|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649930|NCT00027898|Carboplatin|carboplatin|mesh-list
153649931|NCT00027898|Etoposide|etoposide|mesh-list
153649932|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
153649933|NCT00027898|Bortezomib|bortezomib|mesh-list
153649934|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649935|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649936|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649937|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649938|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649939|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649940|NCT00027937|Aldesleukin|aldesleukin|mesh-list
153649941|NCT00027937|Paclitaxel|paclitaxel|mesh-list
153649942|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
153649943|NCT00027937|Melphalan|melphalan|mesh-list
153649944|NCT00027937|Busulfan|busulfan|mesh-list
153649945|NCT00027937|Thiotepa|thiotepa|mesh-list
153649946|NCT00027937|Sargramostim|sargramostim|mesh-list
153649947|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649948|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649949|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649950|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649951|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649952|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649953|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649954|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
153649955|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649956|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649957|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649958|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
153649959|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649960|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153649990|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
153649991|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649992|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
153649993|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649994|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153649995|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649996|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649997|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649998|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649999|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650000|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
153650001|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650002|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153650003|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
153650004|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153650005|NCT00027976|Celecoxib|celecoxib|mesh-list
153577496|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154080567|NCT05939414|Chelating Agents|chelating agents|mesh-ancestor
154080568|NCT05939414|Sequestering Agents|sequestering agents|mesh-ancestor
154080569|NCT05939414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080570|NCT05922501|Dexamethasone|dexamethasone|mesh-list
154080571|NCT05922501|Pomalidomide|pomalidomide|mesh-list
154080572|NCT05922501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154080573|NCT05922501|Antiemetics|antiemetics|mesh-ancestor
154080574|NCT05922501|Autonomic Agents|autonomic agents|mesh-ancestor
154080575|NCT05922501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080576|NCT05922501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650006|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153650007|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650008|NCT00027976|Analgesics|analgesics|mesh-ancestor
153650022|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650023|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153650025|NCT00000479|Analgesics|analgesics|mesh-ancestor
153650026|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
153650027|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650028|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650029|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650030|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153650031|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153650032|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650033|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153650034|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153650035|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650036|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
153650037|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
153650038|NCT00000479|Protective Agents|protective agents|mesh-ancestor
153650039|NCT00028132|Tenofovir|tenofovir|mesh-list
153650040|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
153561013|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
153650042|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153650043|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153650045|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650046|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153650047|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153650048|NCT00028171|Tacrolimus|tacrolimus|mesh-list
153650049|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650050|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
153650051|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650052|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153650053|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650054|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650055|NCT00012090|Goserelin|goserelin|mesh-list
153650056|NCT00012090|Bicalutamide|bicalutamide|mesh-list
153650057|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153650058|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650059|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
153650060|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
153650061|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650062|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650063|NCT00395395|Calcitonin|calcitonin|mesh-list
153650064|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
153650065|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153650066|NCT00395395|Katacalcin|katacalcin|mesh-list
153650067|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153650068|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650088|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153650090|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650091|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
153650092|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650093|NCT00012129|Annamycin|annamycin|mesh-list
153650094|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153650095|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650096|NCT00028288|Daclizumab|daclizumab|mesh-list
154080577|NCT05922501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154080578|NCT05922501|Glucocorticoids|glucocorticoids|mesh-ancestor
154080580|NCT05922501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080581|NCT05922501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154080582|NCT05922501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080583|NCT05922501|Immunologic Factors|immunologic factors|mesh-ancestor
154080584|NCT05922501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154080585|NCT05922501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154080586|NCT05922501|Growth Substances|growth substances|mesh-ancestor
154080587|NCT05922501|Growth Inhibitors|growth inhibitors|mesh-ancestor
154080588|NCT05921942|Metformin|metformin|mesh-list
154080589|NCT05921942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154080590|NCT05921942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650097|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650098|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
153650099|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650100|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153650101|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153650102|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650103|NCT00000482|Niacin|niacin|mesh-list
153650104|NCT00000482|Clofibrate|clofibrate|mesh-list
153736425|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650105|NCT00000482|Estrogens|estrogens|mesh-list
153650106|NCT00000482|Hormones|hormones|mesh-ancestor
153650107|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650108|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650109|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153650110|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
153650111|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650112|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153920670|NCT06329921|Dalteparin|dalteparin|mesh-list
153650113|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
153650114|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
153650115|NCT00000482|Vitamins|vitamins|mesh-ancestor
153650116|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
153650117|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153650118|NCT00028327|Lamivudine|lamivudine|mesh-list
153650119|NCT00028327|Zidovudine|zidovudine|mesh-list
153650120|NCT00028327|Efavirenz|efavirenz|mesh-list
153650121|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153650122|NCT00028327|Nelfinavir|nelfinavir|mesh-list
153650123|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153650124|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153650153|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650154|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153650155|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153650156|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153650157|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153650159|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650160|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153650161|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
153650164|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
153650165|NCT00012207|Vincristine|vincristine|mesh-list
153650166|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650167|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
153650168|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650169|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650170|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153650197|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153650198|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650199|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650200|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
154080591|NCT05920967|Dexamethasone|dexamethasone|mesh-list
154080592|NCT05920967|Dexamethasone acetate|dexamethasone acetate|mesh-list
154080593|NCT05920967|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154080594|NCT05920967|BB 1101|bb 1101|mesh-list
154080595|NCT05920967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154080596|NCT05920967|Antiemetics|antiemetics|mesh-ancestor
154080597|NCT05920967|Autonomic Agents|autonomic agents|mesh-ancestor
154080598|NCT05920967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650201|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650202|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
153650204|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
153650205|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650206|NCT00028561|Carboplatin|carboplatin|mesh-list
153650207|NCT00028561|Epothilone B|epothilone b|mesh-list
153650208|NCT00028561|Epothilones|epothilones|mesh-list
153650209|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650210|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
153650211|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650212|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650213|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650214|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
153650215|NCT00028600|Melphalan|melphalan|mesh-list
153650216|NCT00028600|Methotrexate|methotrexate|mesh-list
153650217|NCT00028600|Fludarabine|fludarabine|mesh-list
153650218|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
153650238|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153650239|NCT00388778|Doxycycline|doxycycline|mesh-list
153650240|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153650241|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650242|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
153650243|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153650244|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153650245|NCT00012246|Sargramostim|sargramostim|mesh-list
153650246|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
153650247|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
153650248|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650249|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153650250|NCT00028717|Prednisone|prednisone|mesh-list
153650251|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
153650252|NCT00028717|Rituximab|rituximab|mesh-list
153650253|NCT00028717|Doxorubicin|doxorubicin|mesh-list
153650254|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153650255|NCT00028717|Vincristine|vincristine|mesh-list
153650256|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650257|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
153335968|NCT02317276|Hormones|hormones|mesh-ancestor
153650258|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650259|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650260|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153650261|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
153650262|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650263|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650264|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153650265|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153650266|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153650267|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153650268|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650269|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650270|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650271|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
153650273|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650287|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650288|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153650289|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153650290|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650291|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650292|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153650293|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
153650294|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153650295|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080599|NCT05920967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080600|NCT05920967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154080601|NCT05920967|Glucocorticoids|glucocorticoids|mesh-ancestor
154080603|NCT05920967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080604|NCT05920967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154080605|NCT05920967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080606|NCT05920967|Protease Inhibitors|protease inhibitors|mesh-ancestor
154080607|NCT05920967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080608|NCT05920967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080609|NCT05915728|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
154080610|NCT05915728|Chelating Agents|chelating agents|mesh-ancestor
154080611|NCT05915728|Sequestering Agents|sequestering agents|mesh-ancestor
153547078|NCT05775159|Antimetabolites|antimetabolites|mesh-ancestor
153650296|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
153650298|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650299|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
153650300|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650301|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153650302|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153650303|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
153650304|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650305|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650307|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153650308|NCT00012324|Nolatrexed|nolatrexed|mesh-list
153650309|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153650310|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650311|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153650312|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650313|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650314|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650315|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650316|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
153650317|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153650318|NCT00028795|Temozolomide|temozolomide|mesh-list
153650319|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153650320|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
153650321|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650322|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650323|NCT00012363|Gemcitabine|gemcitabine|mesh-list
153650324|NCT00012363|Irinotecan|irinotecan|mesh-list
153650325|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650326|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
153650327|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922574|NCT04673448|Niraparib|niraparib|mesh-list
153650328|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650329|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153650330|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650331|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650332|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
153650333|NCT00388895|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153650334|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153650335|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650350|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
153650351|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650352|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
153650353|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650356|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153650357|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080612|NCT05915728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080613|NCT05909904|Tislelizumab|tislelizumab|mesh-list
154080614|NCT05909904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080615|NCT05909904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080616|NCT05909644|Efavirenz|efavirenz|mesh-list
154080617|NCT05909644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154080618|NCT05909644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154080619|NCT05909644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080620|NCT05909644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080621|NCT05909644|Antiviral Agents|antiviral agents|mesh-ancestor
154080622|NCT05909644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080623|NCT05909644|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154080624|NCT05909644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153650358|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
153650359|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650360|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650361|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650362|NCT00028912|Carboplatin|carboplatin|mesh-list
153650363|NCT00028912|Bortezomib|bortezomib|mesh-list
153650364|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650365|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153650366|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
153650367|NCT00028951|Coagulants|coagulants|mesh-ancestor
153650368|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
153650369|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153650370|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153650371|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
153650372|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650373|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153650374|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
153650375|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153650376|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650377|NCT00000491|Aspirin|aspirin|mesh-list
153650378|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153650379|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650380|NCT00000491|Analgesics|analgesics|mesh-ancestor
153650381|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
153650382|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650383|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650384|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650385|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650386|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153650387|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153650388|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922619|NCT04620382|Midodrine|midodrine|mesh-list
153650389|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153650390|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153650391|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650392|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
153650393|NCT00029380|Cyclosporine|cyclosporine|mesh-list
153650394|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
153650395|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
153650396|NCT00029380|Busulfan|busulfan|mesh-list
153650410|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
153650411|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153650412|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153650413|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153650414|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
153650415|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153650416|NCT00029458|Clozapine|clozapine|mesh-list
153650417|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153650418|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
154080625|NCT05909644|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154080626|NCT05909644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154080627|NCT05909644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154080628|NCT05909644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154080629|NCT05883124|Rivastigmine|rivastigmine|mesh-list
154080630|NCT05883124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154080631|NCT05883124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650419|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650420|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650421|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650422|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153650423|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153650424|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153650425|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153650426|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
153650427|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
153650428|NCT00029497|Amitriptyline|amitriptyline|mesh-list
153650429|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153650430|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
153650431|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153650432|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650433|NCT00029497|Analgesics|analgesics|mesh-ancestor
153650434|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
153650435|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650436|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650437|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153650438|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153650439|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153650440|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650441|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
153650442|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650443|NCT00000494|Indomethacin|indomethacin|mesh-list
153650444|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153650445|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650446|NCT00000494|Analgesics|analgesics|mesh-ancestor
153650447|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
153650448|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650449|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650450|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650451|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650452|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
153650453|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
153650454|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153650455|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153650456|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469165|NCT05479812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153650471|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153650472|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153650473|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153650474|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153650475|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650476|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
153650477|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650478|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650479|NCT00029770|Acetaminophen|acetaminophen|mesh-list
153650480|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153650481|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153650482|NCT00029770|Codeine|codeine|mesh-list
153650483|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650484|NCT00029770|Analgesics|analgesics|mesh-ancestor
153650485|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
153650486|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650487|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650488|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
154080634|NCT05883124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080635|NCT05883124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080636|NCT05883124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154080637|NCT05883124|Protective Agents|protective agents|mesh-ancestor
154080638|NCT05849207|Cyclophosphamide|cyclophosphamide|mesh-list
154080639|NCT05849207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153547113|NCT05753189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650489|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153650490|NCT00029770|Narcotics|narcotics|mesh-ancestor
153650491|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153650492|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
153650493|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
153650494|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650495|NCT00012558|Inositol|inositol|mesh-list
153650496|NCT00012558|Lamotrigine|lamotrigine|mesh-list
153650497|NCT00012558|Valproic Acid|valproic acid|mesh-list
153650498|NCT00012558|Risperidone|risperidone|mesh-list
153650499|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
153650500|NCT00012558|Bupropion|bupropion|mesh-list
153650501|NCT00012558|Paroxetine|paroxetine|mesh-list
153650502|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153650503|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
153650504|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650505|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650506|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650507|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153650508|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153650509|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153650510|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153650511|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153650512|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
153650513|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153650514|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
153650515|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153650516|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153650532|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153650533|NCT00395707|Ranibizumab|ranibizumab|mesh-list
153650534|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153650535|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153650536|NCT00395707|Growth Substances|growth substances|mesh-ancestor
153650537|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650538|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
153650539|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650540|NCT00000500|Aspirin|aspirin|mesh-list
153650541|NCT00000500|Carotenoids|carotenoids|mesh-list
153650542|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153723986|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153650543|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650544|NCT00000500|Analgesics|analgesics|mesh-ancestor
153650545|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
153650546|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650547|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650548|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650549|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650550|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153650551|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153650552|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650553|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153650554|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153650555|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650556|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
153650557|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
153650558|NCT00000500|Protective Agents|protective agents|mesh-ancestor
153650559|NCT00395902|Cinacalcet|cinacalcet|mesh-list
153650560|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153650561|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080640|NCT05849207|Immunologic Factors|immunologic factors|mesh-ancestor
154080641|NCT05849207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080642|NCT05849207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080643|NCT05849207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154080644|NCT05849207|Alkylating Agents|alkylating agents|mesh-ancestor
154080645|NCT05849207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080646|NCT05849207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650562|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153650563|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
153650564|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650565|NCT00029848|Rimonabant|rimonabant|mesh-list
153650566|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153650567|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153650568|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153650569|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650570|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650571|NCT00029848|Hormones|hormones|mesh-ancestor
153650572|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650573|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650574|NCT00000503|Streptokinase|streptokinase|mesh-list
153650575|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
153650600|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153650601|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650603|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650605|NCT00000518|Sotalol|sotalol|mesh-list
153650606|NCT00000518|Mexiletine|mexiletine|mesh-list
153650607|NCT00000518|Procainamide|procainamide|mesh-list
153650608|NCT00000518|Imipramine|imipramine|mesh-list
153650609|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153650610|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153650611|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
153650612|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650613|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650614|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650615|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153650616|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
153650617|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
153650618|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650619|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153650620|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
153650621|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153650622|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153650623|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153650624|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153650653|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650655|NCT00395941|Pioglitazone|pioglitazone|mesh-list
153650656|NCT00395941|Acitretin|acitretin|mesh-list
153650657|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153650658|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650659|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
153650660|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
153650661|NCT00030433|Gemcitabine|gemcitabine|mesh-list
153650662|NCT00030433|Irinotecan|irinotecan|mesh-list
153650663|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650664|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
153650665|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650666|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650667|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153650668|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650676|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650677|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650678|NCT00000527|Aspirin|aspirin|mesh-list
153650679|NCT00000527|Dipyridamole|dipyridamole|mesh-list
153650680|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153650681|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650682|NCT00000527|Analgesics|analgesics|mesh-ancestor
154080647|NCT05849207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154080649|NCT05840159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154080650|NCT05840159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154080651|NCT05840159|Antimalarials|antimalarials|mesh-ancestor
154080652|NCT05840159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154080653|NCT05840159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154080654|NCT05834244|Azacitidine|azacitidine|mesh-list
154080655|NCT05834244|Venetoclax|venetoclax|mesh-list
154080656|NCT05834244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080657|NCT05834244|Antimetabolites|antimetabolites|mesh-ancestor
154080658|NCT05834244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080659|NCT05834244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080660|NCT05834244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080661|NCT05822609|Semaglutide|semaglutide|mesh-list
153650683|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
153650684|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650685|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650686|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650687|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650688|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153650689|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153650690|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650691|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153650692|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153650693|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650694|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
153650695|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153650696|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
153650697|NCT00030511|Fluorouracil|fluorouracil|mesh-list
153650698|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
153650699|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650700|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650701|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650702|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650703|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
153650704|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650705|NCT00030550|Thalidomide|thalidomide|mesh-list
153650706|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650707|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
153724023|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
153650708|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650709|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
153650710|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153650711|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650712|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153650713|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153650714|NCT00030550|Growth Substances|growth substances|mesh-ancestor
153650715|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
153650716|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650718|NCT00030589|Methoxsalen|methoxsalen|mesh-list
153650719|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650720|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153650721|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
153650722|NCT00000530|Nifedipine|nifedipine|mesh-list
153650723|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153650724|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153650725|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650726|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153650727|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650728|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
154080662|NCT05822609|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154080664|NCT05822609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080665|NCT05814159|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154080666|NCT05814159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080667|NCT05763667|Bupivacaine|bupivacaine|mesh-list
153650729|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
153650730|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153650731|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
153650732|NCT00030667|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153650733|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153650734|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650735|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650736|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650750|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650752|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
153650753|NCT00030862|Irinotecan|irinotecan|mesh-list
153650754|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650755|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153650756|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650757|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650758|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650759|NCT00000539|Vitamins|vitamins|mesh-list
153650760|NCT00000539|Vitamin E|vitamin e|mesh-list
153650761|NCT00000539|Beta Carotene|beta carotene|mesh-list
153650762|NCT00000539|Warfarin|warfarin|mesh-list
153650763|NCT00000539|Pravastatin|pravastatin|mesh-list
153650764|NCT00000539|Carotenoids|carotenoids|mesh-list
153650765|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
153650766|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650767|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
153650768|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
153650769|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650770|NCT00000539|Protective Agents|protective agents|mesh-ancestor
153650771|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153650772|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
153650773|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153650774|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153650775|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153650776|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650777|NCT00000539|Provitamins|provitamins|mesh-ancestor
153650778|NCT00030979|Donepezil|donepezil|mesh-list
153650779|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153650780|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650781|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650782|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
153650783|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650784|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650785|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
153650786|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
153650787|NCT00031018|Donepezil|donepezil|mesh-list
153650788|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153650789|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650790|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650791|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
153650792|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650793|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650794|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
153650795|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
153650796|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650797|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650798|NCT00031057|Riboflavin|riboflavin|mesh-list
153650799|NCT00031057|Thiamine|thiamine|mesh-list
153650816|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650817|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650818|NCT00000554|Protective Agents|protective agents|mesh-ancestor
153650821|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650822|NCT00031096|Azelaic acid|azelaic acid|mesh-list
153650823|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650824|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080668|NCT05763667|Anesthetics, Local|anesthetics, local|mesh-ancestor
154080669|NCT05763667|Anesthetics|anesthetics|mesh-ancestor
154080670|NCT05763667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080671|NCT05763667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080672|NCT05763667|Sensory System Agents|sensory system agents|mesh-ancestor
154080673|NCT05763667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080674|NCT05743504|Paclitaxel|paclitaxel|mesh-list
154080675|NCT05743504|Cisplatin|cisplatin|mesh-list
153650825|NCT00031135|Choline|choline|mesh-list
153650826|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
153650827|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153650828|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
153650829|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650830|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153650831|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153650832|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
153650833|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
153650834|NCT00031291|Antibodies|antibodies|mesh-list
153650835|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
153650836|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153650837|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153650838|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
153650839|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650840|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
153650841|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153650842|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650843|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650844|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650845|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153650846|NCT00396058|Methylphenidate|methylphenidate|mesh-list
153650847|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153650848|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650849|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153650850|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153650851|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153650852|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650853|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
153650854|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650855|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153650856|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
153650857|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153650866|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650867|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650868|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153650869|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
153650870|NCT00000563|Hormones|hormones|mesh-ancestor
153650871|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650872|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153724066|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
153650873|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650874|NCT00031564|Aldesleukin|aldesleukin|mesh-list
153650875|NCT00031564|Interleukin-2|interleukin-2|mesh-list
153650876|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650877|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650878|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650879|NCT00031564|Analgesics|analgesics|mesh-ancestor
153650880|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
153650881|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650882|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153650883|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153650884|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
153650885|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650886|NCT00031642|Rituximab|rituximab|mesh-list
153650887|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153650888|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650889|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
153650890|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650891|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080677|NCT05743504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154080678|NCT05743504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080679|NCT05743504|Tubulin Modulators|tubulin modulators|mesh-ancestor
154080680|NCT05743504|Antimitotic Agents|antimitotic agents|mesh-ancestor
154080681|NCT05743504|Mitosis Modulators|mitosis modulators|mesh-ancestor
154080682|NCT05743504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080683|NCT05743504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154080684|NCT05743504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080685|NCT05724329|Dasatinib|dasatinib|mesh-list
154080686|NCT05724329|Tislelizumab|tislelizumab|mesh-list
153650892|NCT00031681|Irinotecan|irinotecan|mesh-list
153650893|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153650894|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153650895|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650896|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650897|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650898|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650899|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153650900|NCT00031720|Tamoxifen|tamoxifen|mesh-list
153650902|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
153650903|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650904|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650905|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153650906|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650907|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153650908|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153650909|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153650910|NCT00000569|Triamcinolone|triamcinolone|mesh-list
153650911|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650912|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
153650913|NCT00000569|Hormones|hormones|mesh-ancestor
153650914|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650915|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650916|NCT00031759|Imiquimod|imiquimod|mesh-list
153650917|NCT00031759|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153650918|NCT00031759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650919|NCT00031759|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153650920|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
153650921|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650922|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153650923|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650942|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650943|NCT01791816|Protective Agents|protective agents|mesh-ancestor
153650944|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650945|NCT00031798|Methylphenidate|methylphenidate|mesh-list
153650946|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153650947|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650948|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153650949|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153650950|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153650951|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650952|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
153650953|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650954|NCT00031837|Gemcitabine|gemcitabine|mesh-list
153650955|NCT00031837|Dalteparin|dalteparin|mesh-list
153650956|NCT00031837|Tinzaparin|tinzaparin|mesh-list
153650957|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153650958|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650959|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
153650960|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080688|NCT05724329|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154080689|NCT05724329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080690|NCT05724329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080691|NCT05724329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080692|NCT05724329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080693|NCT05724329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080695|NCT05724329|Protective Agents|protective agents|mesh-ancestor
154080696|NCT05724329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080697|NCT05718258|Venglustat|venglustat|mesh-list
153547167|NCT05734625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650961|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650962|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
153650963|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153650964|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153650965|NCT00031876|Paclitaxel|paclitaxel|mesh-list
153650966|NCT00031876|Capecitabine|capecitabine|mesh-list
153650967|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153650968|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650969|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
153650970|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650971|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650972|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650973|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650974|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
153650975|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
153650976|NCT00031915|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153650977|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153650978|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650979|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650980|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651013|NCT00032032|Paclitaxel|paclitaxel|mesh-list
153651014|NCT00032032|Carboplatin|carboplatin|mesh-list
153651015|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153651016|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651017|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651018|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651019|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651020|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911377|NCT02768545|Ezetimibe|ezetimibe|mesh-list
153651022|NCT00032110|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153651043|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153651044|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153651045|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651046|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651047|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651048|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651049|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651050|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
153651051|NCT00032149|Hormones|hormones|mesh-ancestor
153651052|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651053|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153651054|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651055|NCT00032149|Analgesics|analgesics|mesh-ancestor
153651056|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
153651057|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153651058|NCT00032188|Aldesleukin|aldesleukin|mesh-list
153651059|NCT00032188|Interleukin-2|interleukin-2|mesh-list
153651060|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
153651061|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651062|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153651063|NCT00032188|Analgesics|analgesics|mesh-ancestor
153651064|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
153577497|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
154080698|NCT05718258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080699|NCT05718258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080700|NCT05712018|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154080701|NCT05712018|Plasma Substitutes|plasma substitutes|mesh-ancestor
154080702|NCT05712018|Blood Substitutes|blood substitutes|mesh-ancestor
154080703|NCT05691400|Palbociclib|palbociclib|mesh-list
153651065|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651066|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651067|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153651068|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153651069|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
153651070|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651071|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153651072|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
153651073|NCT00032305|Visilizumab|visilizumab|mesh-list
153651074|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
153651075|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651076|NCT00000596|Dapsone|dapsone|mesh-list
153651077|NCT00000596|Prednisone|prednisone|mesh-list
153651078|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
153651079|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651092|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153651093|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651094|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
153651095|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153651096|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153651097|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651098|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651099|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
153651100|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153651102|NCT00000599|Colestipol|colestipol|mesh-list
153651103|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153651104|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
153651105|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651106|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153651107|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
153651108|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
153651109|NCT00000599|Vitamins|vitamins|mesh-ancestor
153651110|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
153651111|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651112|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
153651113|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
153651114|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651115|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
153651116|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651117|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651118|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651119|NCT00032734|Satavaptan|satavaptan|mesh-list
153651120|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153651121|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651122|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
153651123|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651124|NCT00032773|Pentostatin|pentostatin|mesh-list
153651125|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651126|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153651127|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651128|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651129|NCT00032812|Raclopride|raclopride|mesh-list
153651130|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153651131|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153651132|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153651133|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651134|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153651135|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153651136|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
153651137|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651138|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651139|NCT00032890|Celecoxib|celecoxib|mesh-list
153651140|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154080705|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080706|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080707|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080708|NCT05672355|Vaccines|vaccines|mesh-list
154080709|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
154080710|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080711|NCT05670795|Clomiphene|clomiphene|mesh-list
154080712|NCT05670795|Enclomiphene|enclomiphene|mesh-list
154080713|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
153651162|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651163|NCT00000611|Vitamin D|vitamin d|mesh-list
153651164|NCT00000611|Calcium|calcium|mesh-list
153651165|NCT00000611|Hormones|hormones|mesh-list
153651166|NCT00000611|Estrogens|estrogens|mesh-list
153651167|NCT00000611|Progestins|progestins|mesh-list
153651168|NCT00000611|Vitamins|vitamins|mesh-ancestor
153651169|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
153651170|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651171|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153651172|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153651173|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651174|NCT00032968|Buprenorphine|buprenorphine|mesh-list
153651175|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153651176|NCT00032968|Naloxone|naloxone|mesh-list
153651177|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153651178|NCT00032968|Narcotics|narcotics|mesh-ancestor
153651179|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153651180|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651181|NCT00032968|Analgesics|analgesics|mesh-ancestor
153651182|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
153651183|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651184|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153651185|NCT00033046|Modafinil|modafinil|mesh-list
153651186|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153651187|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651188|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153651189|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153651190|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153651191|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651192|NCT00033085|Ondansetron|ondansetron|mesh-list
153651209|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651210|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153651211|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651212|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651213|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651214|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153651215|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153651217|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153651218|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651219|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
153651220|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651221|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651222|NCT00033241|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153651223|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153651224|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651225|NCT00000620|Insulin|insulin|mesh-list
153651226|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153651227|NCT00000620|Metformin|metformin|mesh-list
153651228|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
153651229|NCT00000620|Pioglitazone|pioglitazone|mesh-list
153651230|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
153651231|NCT00000620|Glimepiride|glimepiride|mesh-list
153651232|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
153651233|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
153651234|NCT00000620|Acarbose|acarbose|mesh-list
153651235|NCT00000620|Repaglinide|repaglinide|mesh-list
154080715|NCT05670795|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154080716|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080717|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080718|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154080719|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
154080720|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154080721|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
154080722|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154080723|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154080724|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154080725|NCT05646563|Eculizumab|eculizumab|mesh-list
154080726|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154080727|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651236|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153651237|NCT00000620|Metoprolol|metoprolol|mesh-list
153651238|NCT00000620|Felodipine|felodipine|mesh-list
153651239|NCT00000620|Amlodipine|amlodipine|mesh-list
153651240|NCT00000620|Valsartan|valsartan|mesh-list
153651241|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153651242|NCT00000620|Carvedilol|carvedilol|mesh-list
153651243|NCT00000620|Candesartan|candesartan|mesh-list
153651244|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
153651245|NCT00000620|Lisinopril|lisinopril|mesh-list
153651249|NCT00000620|Hydralazine|hydralazine|mesh-list
153651250|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
153651251|NCT00000620|Reserpine|reserpine|mesh-list
153651252|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
153651253|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
153651254|NCT00000620|Triamterene|triamterene|mesh-list
153651255|NCT00000620|Furosemide|furosemide|mesh-list
153651256|NCT00000620|Simvastatin|simvastatin|mesh-list
153651257|NCT00000620|Fenofibrate|fenofibrate|mesh-list
153651272|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153651273|NCT00000620|Diuretics|diuretics|mesh-ancestor
153651274|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
153651275|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153651276|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153651277|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153651278|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651279|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
153651280|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
153651281|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
153651282|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651283|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153651284|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153651285|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153651286|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
153651287|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651288|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
153651289|NCT00000620|Protective Agents|protective agents|mesh-ancestor
153651290|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153651291|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153651292|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153651293|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
153651294|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153651295|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153651296|NCT00000620|Urological Agents|urological agents|mesh-ancestor
153651297|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153651298|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153651299|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153651300|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154080729|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080730|NCT05641259|Azacitidine|azacitidine|mesh-list
154080731|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080732|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
154080733|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080734|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080735|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651301|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153651302|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153651303|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153651304|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153651305|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153651306|NCT00033280|Temozolomide|temozolomide|mesh-list
153651307|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153651308|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
153651309|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651310|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651311|NCT00033319|Aspirin|aspirin|mesh-list
153651312|NCT00033319|Folic Acid|folic acid|mesh-list
153651313|NCT00033319|Hematinics|hematinics|mesh-ancestor
153651314|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
153651315|NCT00033319|Vitamins|vitamins|mesh-ancestor
153651349|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153651350|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651352|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651353|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153651354|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651355|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651356|NCT00033436|Niacinamide|niacinamide|mesh-list
153651385|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651386|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651387|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651388|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
153651390|NCT00033592|Nicotine|nicotine|mesh-list
153651391|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153651392|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
153651393|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651394|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651395|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153651397|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
153651398|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651399|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651400|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153651401|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
153651402|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153651403|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153651404|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153651423|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153651424|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
153651425|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651426|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651427|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651428|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
153651429|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651430|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
153651431|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153651432|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651433|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153651434|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153651435|NCT00033709|Growth Substances|growth substances|mesh-ancestor
153651436|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
153651437|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153651438|NCT00033748|Antibodies|antibodies|mesh-list
154080736|NCT05633810|Aspirin|aspirin|mesh-list
154080737|NCT05633810|Colchicine|colchicine|mesh-list
154080738|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154080739|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153724140|NCT00447967|Vitamins|vitamins|mesh-ancestor
154080740|NCT05633810|Analgesics|analgesics|mesh-ancestor
154080741|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
154080742|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154080743|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080744|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651439|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
153651440|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153651441|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
153651442|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651443|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651444|NCT00000641|Azithromycin|azithromycin|mesh-list
153651445|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
153651446|NCT00000641|Rifampin|rifampin|mesh-list
153651447|NCT00000641|Amikacin|amikacin|mesh-list
153651448|NCT00000641|Ethambutol|ethambutol|mesh-list
153651449|NCT00000641|Clofazimine|clofazimine|mesh-list
153651450|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153651451|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651452|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153651453|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153651454|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651455|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651456|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651457|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153651458|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153651459|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153651460|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
153651461|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
153651475|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460974|NCT00084864|Dexamethasone|dexamethasone|mesh-list
153651476|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153651477|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153651478|NCT02971423|Imipenem|imipenem|mesh-list
153651479|NCT02971423|Sulbactam|sulbactam|mesh-list
153651480|NCT02971423|Durlobactam|durlobactam|mesh-list
153651481|NCT02971423|Cilastatin|cilastatin|mesh-list
153651482|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153651483|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651484|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
153651485|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651486|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651487|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153651488|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153651489|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153651490|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
153651491|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651492|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651493|NCT00389090|Temozolomide|temozolomide|mesh-list
153651494|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153651495|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153651496|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
153651497|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651498|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651499|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651500|NCT00033982|Posaconazole|posaconazole|mesh-list
153651501|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
153651502|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651503|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153651504|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153651505|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153651506|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153651507|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153651508|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080745|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080746|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154080747|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154080748|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080749|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154080750|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154080751|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080752|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
153651509|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651510|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153651511|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
153651512|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651513|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651514|NCT00034060|Etanercept|etanercept|mesh-list
153651515|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153651516|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153651517|NCT00034060|Analgesics|analgesics|mesh-ancestor
153651518|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
153651519|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651520|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651521|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651543|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651544|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651545|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651546|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153651547|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153651548|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651549|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153651550|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153651551|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651552|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
153651553|NCT00013962|Vitamin D|vitamin d|mesh-list
153651554|NCT00013962|Vitamins|vitamins|mesh-ancestor
153651555|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
153651556|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651557|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153651558|NCT00000665|Ganciclovir|ganciclovir|mesh-list
153651559|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153651560|NCT00000665|Foscarnet|foscarnet|mesh-list
153651561|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153651562|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
153651563|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651564|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651565|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651566|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651567|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153651568|NCT00034372|Oregovomab|oregovomab|mesh-list
153651569|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153651570|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651571|NCT00014001|Olanzapine|olanzapine|mesh-list
153651572|NCT00014001|Risperidone|risperidone|mesh-list
153651573|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153651574|NCT00014001|Ziprasidone|ziprasidone|mesh-list
153651575|NCT00014001|Clozapine|clozapine|mesh-list
153651611|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153651613|NCT02971540|Tramadol|tramadol|mesh-list
153651614|NCT02971540|Bupivacaine|bupivacaine|mesh-list
153651615|NCT02971540|Ropivacaine|ropivacaine|mesh-list
153651616|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
153651633|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
153651634|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651635|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651636|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651637|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651638|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651639|NCT00396487|Capecitabine|capecitabine|mesh-list
153651640|NCT00396487|Fluorouracil|fluorouracil|mesh-list
153651641|NCT00396487|Irinotecan|irinotecan|mesh-list
154080754|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
154080755|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
154080756|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
154080757|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080758|NCT05618314|Probenecid|probenecid|mesh-list
154080759|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
154080760|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
153651642|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651643|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
153651644|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651645|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651646|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651647|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
153651648|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651649|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153651651|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651652|NCT00000674|Leucovorin|leucovorin|mesh-list
153651653|NCT00000674|Clindamycin|clindamycin|mesh-list
153651654|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
153651655|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
153651656|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
153651657|NCT00000674|Calcium|calcium|mesh-list
153651658|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
153651659|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153651660|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651661|NCT00000674|Antidotes|antidotes|mesh-ancestor
153651662|NCT00000674|Protective Agents|protective agents|mesh-ancestor
153651663|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
153651664|NCT00000674|Vitamins|vitamins|mesh-ancestor
153651665|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
153651666|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153651667|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651668|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153651669|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651670|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651671|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
153651672|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153651673|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153651674|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651675|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
153651676|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153651677|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
153651678|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651679|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651708|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651709|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
153651710|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153651711|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
153651712|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651713|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
153651714|NCT04711642|Protective Agents|protective agents|mesh-ancestor
153651715|NCT00034606|Gemcitabine|gemcitabine|mesh-list
153651716|NCT00034606|Pemetrexed|pemetrexed|mesh-list
153651717|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651718|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
153651719|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651720|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651721|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651722|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651723|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651724|NCT00034645|Posaconazole|posaconazole|mesh-list
153651725|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
153651739|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153651740|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
153651741|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651742|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651743|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651744|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153651745|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154080761|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080765|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
154080766|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153651746|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153651747|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153651748|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153651749|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
153651750|NCT00000686|Stavudine|stavudine|mesh-list
153651751|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
153651752|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651753|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153651754|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651755|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651756|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
153651757|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651758|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153651759|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153651760|NCT00034801|Olanzapine|olanzapine|mesh-list
153651761|NCT00034801|Ziprasidone|ziprasidone|mesh-list
153651762|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
153651763|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
153651764|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651765|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651767|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153651768|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153651769|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153651770|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153651771|NCT00034801|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153651772|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153651773|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153651774|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651775|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651776|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
153651777|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153651778|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153651779|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
153651780|NCT00014196|Docetaxel|docetaxel|mesh-list
153651781|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651782|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651783|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651784|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651803|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651804|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
153651805|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651806|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651807|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153651808|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
153651809|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651810|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651811|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153651812|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651813|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
153651814|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
153651815|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651816|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153651817|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
153651818|NCT00000689|Hormones|hormones|mesh-ancestor
153651819|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651820|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153651821|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153651822|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153651823|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153651824|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651825|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153651826|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
153651827|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153651828|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651829|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
153651830|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
153547241|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
154080767|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
154080768|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080769|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
154080770|NCT05575063|Protective Agents|protective agents|mesh-ancestor
154080771|NCT05566639|Vaccines|vaccines|mesh-list
154080772|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
154080773|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080774|NCT05525858|Bevacizumab|bevacizumab|mesh-list
154080775|NCT05525858|Trastuzumab|trastuzumab|mesh-list
154080776|NCT05525858|Atezolizumab|atezolizumab|mesh-list
153651831|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651832|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651833|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
153651834|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651835|NCT00000689|Antidotes|antidotes|mesh-ancestor
153651836|NCT00000689|Protective Agents|protective agents|mesh-ancestor
153651837|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
153651838|NCT00000689|Vitamins|vitamins|mesh-ancestor
153651839|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
153651840|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153651841|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651842|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651843|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651844|NCT00034879|Gefitinib|gefitinib|mesh-list
153651864|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651865|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651866|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
153651867|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651868|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651869|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
153651870|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651871|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
153651872|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651873|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153651874|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153651875|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153651880|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651881|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153651882|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651884|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
153651885|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651886|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153651887|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153651888|NCT00000716|Zidovudine|zidovudine|mesh-list
153651889|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
153651890|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651891|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153651892|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651893|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651894|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
153651895|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651896|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153651897|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153651898|NCT00014274|Carboplatin|carboplatin|mesh-list
153651899|NCT00014274|Gemcitabine|gemcitabine|mesh-list
153651900|NCT00014274|Methotrexate|methotrexate|mesh-list
153651901|NCT00014274|Vinblastine|vinblastine|mesh-list
153651902|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651923|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651924|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
153651925|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651926|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651927|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651928|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651929|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651930|NCT00000719|Zidovudine|zidovudine|mesh-list
154080778|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154080779|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154080780|NCT05525858|Vemurafenib|vemurafenib|mesh-list
154080781|NCT05525858|Maytansine|maytansine|mesh-list
154080782|NCT05525858|Pralsetinib|pralsetinib|mesh-list
154080783|NCT05525858|Alectinib|alectinib|mesh-list
154080784|NCT05525858|Entrectinib|entrectinib|mesh-list
154080785|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080787|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154080788|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154080789|NCT05525858|Growth Substances|growth substances|mesh-ancestor
154080790|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080791|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
154080792|NCT05525858|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154080793|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080794|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080795|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080796|NCT05525858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547246|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651931|NCT00000719|Zalcitabine|zalcitabine|mesh-list
153651932|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
153651933|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651934|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153651935|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651936|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651937|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
153651938|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651939|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153651940|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153651941|NCT00014313|Etoposide|etoposide|mesh-list
153651942|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651943|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153651944|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153651945|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153651946|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651947|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651948|NCT00035074|Methotrexate|methotrexate|mesh-list
153651949|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153651950|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
153651951|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153651952|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651953|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651976|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153651978|NCT00035152|Carboplatin|carboplatin|mesh-list
153651979|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153651980|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651981|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651982|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651983|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651984|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651985|NCT00014352|Ketoconazole|ketoconazole|mesh-list
153651986|NCT00014352|Docetaxel|docetaxel|mesh-list
153651987|NCT00014352|Doxorubicin|doxorubicin|mesh-list
153651988|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153547265|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080797|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154080798|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
154080799|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
154080800|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
154080802|NCT05525858|Immunoconjugates|immunoconjugates|mesh-ancestor
154080803|NCT05525858|Immunologic Factors|immunologic factors|mesh-ancestor
154080804|NCT05503030|Nintedanib|nintedanib|mesh-list
154080805|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080806|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080807|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080808|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080809|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153547267|NCT05634057|Anisodamine|anisodamine|mesh-list
153651989|NCT00014352|Estramustine|estramustine|mesh-list
153651990|NCT00014352|Warfarin|warfarin|mesh-list
153651993|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651994|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651995|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651996|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153651997|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153651998|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153651999|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652000|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
153652001|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
153652002|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652003|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153652004|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153724250|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
153652005|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153652006|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
153652021|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
153652022|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652023|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
153652024|NCT00035230|Topiramate|topiramate|mesh-list
153652025|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
153652026|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153652027|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652028|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153652029|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652030|NCT00014391|Ribavirin|ribavirin|mesh-list
153652031|NCT00014391|Palivizumab|palivizumab|mesh-list
153652032|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
153652033|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652034|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
153652035|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652036|NCT00035308|Abetimus|abetimus|mesh-list
153652037|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652038|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
153652039|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652040|NCT00035347|Azithromycin|azithromycin|mesh-list
153652041|NCT00035347|Levofloxacin|levofloxacin|mesh-list
153652042|NCT00035347|Ofloxacin|ofloxacin|mesh-list
153652043|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
153652044|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652045|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652046|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153652047|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153652048|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153652049|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652050|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652051|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080810|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
154080811|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
154080812|NCT05468697|Palbociclib|palbociclib|mesh-list
154080813|NCT05468697|Belzutifan|belzutifan|mesh-list
154080814|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080815|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080816|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080817|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080818|NCT05442216|Azacitidine|azacitidine|mesh-list
154080819|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153652052|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153652053|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153652054|NCT00035347|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153652055|NCT00035347|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153652057|NCT00014430|Vinorelbine|vinorelbine|mesh-list
153652058|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153652059|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652060|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153652061|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
153652062|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
153652063|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
153652064|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652065|NCT00035425|Vancomycin|vancomycin|mesh-list
153652091|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153652092|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153652093|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
153652094|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
153652095|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652096|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652097|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652098|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652099|NCT00000752|Expectorants|expectorants|mesh-ancestor
153652100|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153652101|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153652102|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
153652103|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153652104|NCT00035464|Azimilide|azimilide|mesh-list
153652106|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153652107|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153652108|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652109|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153652110|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652111|NCT00014469|Methotrexate|methotrexate|mesh-list
153652112|NCT00014469|Melphalan|melphalan|mesh-list
153652113|NCT00014469|Busulfan|busulfan|mesh-list
153652114|NCT00014469|Tacrolimus|tacrolimus|mesh-list
153652115|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153652116|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
153652117|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153652141|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652142|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652143|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652144|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153652146|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
153652147|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489114|NCT04907682|Ribavirin|ribavirin|mesh-list
153652148|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
153652149|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
153652150|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652151|NCT00000758|Fluorouracil|fluorouracil|mesh-list
153652152|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
153652153|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652154|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153652155|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080820|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
154080821|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080822|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080823|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080824|NCT05436535|Triamcinolone|triamcinolone|mesh-list
153730395|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153730396|NCT00404391|Analgesics|analgesics|mesh-ancestor
153730397|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
153730398|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730399|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730400|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
153730401|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153730402|NCT00404391|Narcotics|narcotics|mesh-ancestor
153730403|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730404|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
153652156|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652157|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
153652158|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652159|NCT00035620|Lenograstim|lenograstim|mesh-list
153652160|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153652161|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
153652162|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652163|NCT00014547|BBR 3464|bbr 3464|mesh-list
153652164|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652165|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
153652166|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153652187|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
153652188|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652189|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652190|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
153652191|NCT04732390|Bupivacaine|bupivacaine|mesh-list
153652192|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
153652193|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
153652194|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652195|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652196|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
153652197|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652198|NCT04732390|Analgesics|analgesics|mesh-ancestor
153461091|NCT01678716|Micronutrients|micronutrients|mesh-list
153652199|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153652200|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
153652201|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153652202|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153652203|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652204|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153652205|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
153652206|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153652207|NCT00035854|Linezolid|linezolid|mesh-list
153652208|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652209|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652210|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153652211|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652212|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652213|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153652214|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153652215|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
153652216|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652217|NCT00000779|Antacids|antacids|mesh-ancestor
153652218|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652219|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153547301|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
153730405|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
153730406|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153730407|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730408|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730409|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
153730411|NCT00144807|Doxorubicin|doxorubicin|mesh-list
153730412|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730413|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
153730414|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730415|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730416|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153730417|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
153730418|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547302|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153652220|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153652237|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652238|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153652239|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652240|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652242|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
153652243|NCT02971345|Epirubicin|epirubicin|mesh-list
153652244|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
153652245|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153652246|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652247|NCT02971345|Trace Elements|trace elements|mesh-ancestor
153652248|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
153652249|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652250|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153652251|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652252|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153652253|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153652254|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652255|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652256|NCT00036088|Olanzapine|olanzapine|mesh-list
153652257|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
153652258|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
153652259|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652260|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652261|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153652262|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153652263|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153652264|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652265|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153652266|NCT00036088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153652267|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153652268|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153652269|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652270|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652271|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
153652272|NCT00036127|Aripiprazole|aripiprazole|mesh-list
153652273|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
153652274|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153652275|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153652276|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153652277|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652278|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080825|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154080826|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154080827|NCT05436535|Hydrocortisone|hydrocortisone|mesh-list
154080828|NCT05436535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154080829|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154080830|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154080831|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
154080832|NCT05436535|Hormones|hormones|mesh-ancestor
154080833|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080834|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080835|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080836|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
154080837|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080838|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080839|NCT05429268|Lenalidomide|lenalidomide|mesh-list
154080840|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
154080841|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080842|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153652295|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652297|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
153652298|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652299|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
153652300|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
153461115|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153652301|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
153652302|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652303|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153652304|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153652305|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724475|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
153652306|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652307|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153652308|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
153652309|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652310|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153652311|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153652312|NCT00036166|Micafungin|micafungin|mesh-list
153652313|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
153652314|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652315|NCT00000794|Leucovorin|leucovorin|mesh-list
153652316|NCT00000794|Clarithromycin|clarithromycin|mesh-list
153652317|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
153652318|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
153652319|NCT00000794|Atovaquone|atovaquone|mesh-list
153652320|NCT00000794|Calcium|calcium|mesh-list
153652321|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
153652322|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153652323|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652324|NCT00000794|Antidotes|antidotes|mesh-ancestor
153652326|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
153652327|NCT00000794|Vitamins|vitamins|mesh-ancestor
153652328|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
153652329|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652330|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652331|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153652332|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652333|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547332|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154080843|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154080844|NCT05429268|Growth Substances|growth substances|mesh-ancestor
154080845|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
154080846|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080849|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
154080850|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154080851|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154080852|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154080853|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
154080854|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
154080855|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154080856|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080857|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080858|NCT05413811|Fluorouracil|fluorouracil|mesh-list
153652334|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153652335|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153652336|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
153652360|NCT00391638|Tenofovir|tenofovir|mesh-list
153652361|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153652362|NCT00391638|Emtricitabine|emtricitabine|mesh-list
153652363|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153652364|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652365|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
153652366|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652367|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652368|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652369|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652370|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652371|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652372|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652373|NCT00036361|Aripiprazole|aripiprazole|mesh-list
153652374|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
153652375|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153652376|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153652377|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153652378|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652379|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652380|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
153652381|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
153652382|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652383|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652384|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153652385|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153652386|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
153652397|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153652398|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652399|NCT00000821|Aldesleukin|aldesleukin|mesh-list
153652400|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652401|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652402|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652403|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
153652404|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652405|NCT00036556|Atrasentan|atrasentan|mesh-list
153652406|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461124|NCT01679106|Fentanyl|fentanyl|mesh-list
153652407|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153547347|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080859|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
154080860|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080861|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154080862|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080863|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080864|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
154080865|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080866|NCT05396898|Tacrolimus|tacrolimus|mesh-list
154080867|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080868|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
153652408|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153652409|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652410|NCT00000827|Immune Sera|immune sera|mesh-list
153652411|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
153652412|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652413|NCT00036634|Tenofovir|tenofovir|mesh-list
153652414|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
153652415|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652416|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652417|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652418|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652419|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652420|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652421|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652422|NCT00000851|Stavudine|stavudine|mesh-list
153652423|NCT00000851|Didanosine|didanosine|mesh-list
153652424|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
153652425|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652426|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652427|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652428|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652429|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
153652430|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652432|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652433|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
153652434|NCT00036751|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153652435|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153652436|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652437|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652438|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652439|NCT00036790|Doxorubicin|doxorubicin|mesh-list
153652440|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153652441|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
153652442|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153652443|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652444|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153652445|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153652446|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652447|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652448|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153652449|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
153652450|NCT00000857|Interleukin-12|interleukin-12|mesh-list
153652451|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153652452|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
153652468|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
153652469|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652470|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652471|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153652472|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
153652473|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153652474|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154080869|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080870|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154080871|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080872|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080873|NCT05384587|Asciminib|asciminib|mesh-list
154080874|NCT05384587|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154080875|NCT05384587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080876|NCT05384587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547357|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153652475|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
153652476|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153652477|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
153652478|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652479|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153652480|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652481|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153652482|NCT00036946|Aflibercept|aflibercept|mesh-list
153652483|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153652484|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153652485|NCT00036946|Growth Substances|growth substances|mesh-ancestor
153652486|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652487|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
153652488|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652489|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
153652490|NCT00036985|Doxorubicin|doxorubicin|mesh-list
153652491|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153652492|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652493|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
153652495|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652496|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153652497|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
153652498|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652499|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652500|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153652501|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153652502|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153652503|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153652504|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652505|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
153652506|NCT00037063|Vitamin E|vitamin e|mesh-list
153652507|NCT00037063|Riboflavin|riboflavin|mesh-list
153652508|NCT00037063|Thiamine|thiamine|mesh-list
153652509|NCT00037063|Vitamins|vitamins|mesh-ancestor
153652510|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
153652511|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652512|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
153652513|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652542|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652543|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153652544|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652545|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
153652546|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652547|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652548|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
153652549|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652551|NCT00037141|Ethanol|ethanol|mesh-list
153652552|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153652553|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652554|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652555|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652556|NCT00037180|Leucovorin|leucovorin|mesh-list
153652557|NCT00037180|Celecoxib|celecoxib|mesh-list
153652558|NCT00037180|Fluorouracil|fluorouracil|mesh-list
153652559|NCT00037180|Irinotecan|irinotecan|mesh-list
153652560|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
153652580|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153652581|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080877|NCT05384587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080879|NCT05375825|Immunoconjugates|immunoconjugates|mesh-ancestor
154080880|NCT05375825|Immunologic Factors|immunologic factors|mesh-ancestor
154080881|NCT05375825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080882|NCT05351554|Prednisone|prednisone|mesh-list
154080883|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154080884|NCT05351554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153652582|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153652583|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153652584|NCT00037219|Anidulafungin|anidulafungin|mesh-list
153652585|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
153652586|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652587|NCT00000893|Efavirenz|efavirenz|mesh-list
153652588|NCT00000893|Nelfinavir|nelfinavir|mesh-list
153652589|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652590|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652591|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652592|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652593|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
153652594|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652595|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153652596|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153652597|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153652598|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153652599|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153652600|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153652601|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153652602|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153652603|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
153652604|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652605|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652606|NCT00396526|Amoxicillin|amoxicillin|mesh-list
153652607|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153652608|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652609|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652610|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153652611|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
153652612|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153652613|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153652614|NCT00037531|Sirolimus|sirolimus|mesh-list
153652637|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153652638|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
153652639|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652640|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652641|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153652642|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652643|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652644|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652645|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
153652646|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652647|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652648|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652649|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153652650|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153652651|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
153652652|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
153652653|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
153652654|NCT00037609|Capecitabine|capecitabine|mesh-list
153652655|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153652656|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
153652657|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652658|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652659|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153652660|NCT00037609|Protective Agents|protective agents|mesh-ancestor
153652661|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080885|NCT05351554|Glucocorticoids|glucocorticoids|mesh-ancestor
154080886|NCT05351554|Hormones|hormones|mesh-ancestor
154080887|NCT05351554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652662|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153652663|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652664|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153652667|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
153652704|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652705|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652741|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652742|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153652743|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
153652744|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153652745|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153652746|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
153652764|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153652765|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153652766|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
153652767|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652768|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153652769|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153652770|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652771|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153652772|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153652773|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
153652774|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652775|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652776|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
153652777|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652778|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153652779|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153652782|NCT00014937|Lamivudine|lamivudine|mesh-list
153652783|NCT00014937|Zidovudine|zidovudine|mesh-list
153652784|NCT00014937|Stavudine|stavudine|mesh-list
153652785|NCT00014937|Didanosine|didanosine|mesh-list
153652786|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153652787|NCT00014937|Efavirenz|efavirenz|mesh-list
153652788|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153652789|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153652790|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
153652791|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652792|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652793|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652794|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652795|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
153652796|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652797|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153652798|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153652799|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652800|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652802|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153652803|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153652804|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153652820|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
153652821|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652823|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652824|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652825|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652826|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652827|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
153652828|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652829|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652830|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652831|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153652832|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153652833|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
153652834|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652835|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
153652836|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080889|NCT05351554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154080890|NCT05351554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080891|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
154080892|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
154080893|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154080894|NCT05350774|Antibodies|antibodies|mesh-list
154080895|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
154080896|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153547376|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
153652837|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652838|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153652839|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
153652840|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652841|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652842|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153652844|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153652845|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153652846|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652847|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652848|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153652849|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652850|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
153652851|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652852|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
153652853|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652854|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652855|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652856|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153652857|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153652858|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
153652859|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153652860|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
153652862|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
153652863|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652896|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652897|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652898|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153652899|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153652900|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
153652901|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652902|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652914|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
153652915|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652916|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153652917|NCT00015210|Nefazodone|nefazodone|mesh-list
153652918|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153652919|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153652920|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153652921|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652922|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652923|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652924|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153652925|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
153652926|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153652927|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153461192|NCT01679652|Nebivolol|nebivolol|mesh-list
153652928|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153652929|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
153652930|NCT00000986|Zidovudine|zidovudine|mesh-list
153652931|NCT00000986|Aldesleukin|aldesleukin|mesh-list
154080897|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
154080898|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080899|NCT05350202|Empagliflozin|empagliflozin|mesh-list
154080900|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154080901|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080902|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153652932|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
153652933|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652934|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652935|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652936|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652937|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
153652938|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652939|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652940|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652941|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652942|NCT00015249|Amantadine|amantadine|mesh-list
153652943|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153652944|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153652945|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
153652946|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652947|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
153652948|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652949|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652950|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652951|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153652952|NCT00015249|Analgesics|analgesics|mesh-ancestor
153652953|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
153652954|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652955|NCT05195242|Dexamethasone|dexamethasone|mesh-list
153652956|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153652960|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652961|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153652962|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
153652963|NCT05195242|Hormones|hormones|mesh-ancestor
153652964|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652965|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153652966|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652978|NCT00000998|Leucovorin|leucovorin|mesh-list
153652979|NCT00000998|Trimetrexate|trimetrexate|mesh-list
153652980|NCT00000998|Calcium|calcium|mesh-list
153652981|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
153652982|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153652983|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652984|NCT00000998|Antidotes|antidotes|mesh-ancestor
153652985|NCT00000998|Protective Agents|protective agents|mesh-ancestor
153652986|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
153652987|NCT00000998|Vitamins|vitamins|mesh-ancestor
153652988|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
153652989|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
153652990|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652991|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153652992|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
153652993|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652994|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652995|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153652996|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652997|NCT00001001|Zidovudine|zidovudine|mesh-list
153652998|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
153652999|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653000|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153653001|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653002|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653003|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
153653004|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653005|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153653006|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153653007|NCT05076877|Metformin|metformin|mesh-list
153653008|NCT05076877|Midazolam|midazolam|mesh-list
153782515|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080903|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080904|NCT05306028|Metformin|metformin|mesh-list
154080905|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154080906|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080907|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154080908|NCT05286554|Hormones|hormones|mesh-list
154080910|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154080911|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080912|NCT05286554|Progestins|progestins|mesh-ancestor
154080913|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
154080914|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153653009|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153653010|NCT05076877|Lazertinib|lazertinib|mesh-list
153653011|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153653012|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653013|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153653014|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153653015|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153653016|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153653017|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153653018|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153653019|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153653020|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
153653021|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
153653022|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
153653023|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
153653024|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153653025|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653026|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153653027|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153653028|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
153653029|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153653030|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153653031|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653051|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153653052|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153653053|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
153653054|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653055|NCT00001007|Zidovudine|zidovudine|mesh-list
153653056|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
153653057|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653058|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153653059|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653060|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653063|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153653064|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153653065|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
153653066|NCT00396799|Estrogens|estrogens|mesh-list
153653067|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153653068|NCT00396799|Hormones|hormones|mesh-ancestor
153653069|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653070|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653071|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153653072|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153653073|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
153653074|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153653075|NCT01786434|Fentanyl|fentanyl|mesh-list
153653076|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153653077|NCT01786434|Narcotics|narcotics|mesh-ancestor
153653078|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153653079|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653080|NCT01786434|Analgesics|analgesics|mesh-ancestor
154080915|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
154080916|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154080917|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154080918|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154080919|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080920|NCT05280548|Venglustat|venglustat|mesh-list
154080921|NCT05280548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080922|NCT05280548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080923|NCT05277896|Ketamine|ketamine|mesh-list
154080924|NCT05277896|Etomidate|etomidate|mesh-list
154080925|NCT05277896|Analgesics|analgesics|mesh-ancestor
154080926|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
154080927|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547390|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653081|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
153653082|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653083|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153653084|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153653085|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
153653086|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
153653087|NCT00001010|Zidovudine|zidovudine|mesh-list
153653088|NCT00001010|Acyclovir|acyclovir|mesh-list
153653089|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
153653102|NCT00001013|Pentamidine|pentamidine|mesh-list
153653103|NCT00001013|Trimetrexate|trimetrexate|mesh-list
153653104|NCT00001013|Calcium|calcium|mesh-list
153653105|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
153653106|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153653107|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653108|NCT00001013|Antidotes|antidotes|mesh-ancestor
153653109|NCT00001013|Protective Agents|protective agents|mesh-ancestor
153653110|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
153653111|NCT00001013|Vitamins|vitamins|mesh-ancestor
153653112|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
153653113|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153653114|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653115|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
153653116|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153653117|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153653118|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153653119|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653120|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653121|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153653122|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153461223|NCT03080766|Decitabine|decitabine|mesh-list
153653123|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153653124|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
153653125|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153653126|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153653127|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653128|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
153653129|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653130|NCT00015834|Cytarabine|cytarabine|mesh-list
153653131|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
153653132|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653133|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
153653134|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653135|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653136|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
153653137|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653138|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653139|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
153653140|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080928|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080929|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154080930|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154080931|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
154080932|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
153653141|NCT00015834|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153653142|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653143|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653144|NCT00001040|Zidovudine|zidovudine|mesh-list
153653145|NCT00001040|Zalcitabine|zalcitabine|mesh-list
153653146|NCT00001040|Saquinavir|saquinavir|mesh-list
153653147|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
153912112|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653149|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153653150|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653151|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653152|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
153653184|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153653185|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
153653186|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
153653187|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
153653188|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153653189|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
153653190|NCT00015873|Hormones|hormones|mesh-ancestor
153653191|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653192|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653193|NCT00015912|Interferons|interferons|mesh-list
153653194|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
153653195|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
153653196|NCT00015912|Thalidomide|thalidomide|mesh-list
153653197|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653220|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
153653221|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
153653222|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153653223|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153653224|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153653225|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653226|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
153653227|NCT00015951|Cytarabine|cytarabine|mesh-list
153653228|NCT00015951|Bevacizumab|bevacizumab|mesh-list
153653229|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
153653230|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153653231|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653232|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153653233|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153653234|NCT00015951|Growth Substances|growth substances|mesh-ancestor
153724840|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
153653235|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653236|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
153653237|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653238|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
153653239|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653240|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
153653241|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653242|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653243|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
153653244|NCT00015951|Analgesics|analgesics|mesh-ancestor
153653245|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
153653246|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653247|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153653248|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653249|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653250|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
153653251|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153653264|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653265|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
153653266|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153653267|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653268|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153653269|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153653270|NCT00015990|Growth Substances|growth substances|mesh-ancestor
153653271|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
153653272|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080933|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154080934|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154080935|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154080936|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547408|NCT05537220|Antidotes|antidotes|mesh-ancestor
153653273|NCT00001085|Lamivudine|lamivudine|mesh-list
153653274|NCT00001085|Zidovudine|zidovudine|mesh-list
153653275|NCT00001085|Amprenavir|amprenavir|mesh-list
153653276|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153653277|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653278|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653279|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653280|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
153653281|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653282|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153653283|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153653284|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
153653285|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153653286|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
153912141|NCT05381038|Paclitaxel|paclitaxel|mesh-list
153653287|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153653288|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153653289|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153653290|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
153653292|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153653293|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153653294|NCT02970916|Growth Substances|growth substances|mesh-ancestor
153653295|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653296|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
153653297|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653298|NCT00016068|Valganciclovir|valganciclovir|mesh-list
153653299|NCT00016068|Ganciclovir|ganciclovir|mesh-list
153653300|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153653301|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
153653302|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653303|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653304|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653305|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653306|NCT00016107|Bevacizumab|bevacizumab|mesh-list
153653307|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153653308|NCT00016107|Docetaxel|docetaxel|mesh-list
153653309|NCT00016107|Estramustine|estramustine|mesh-list
153653310|NCT00016107|Antibodies|antibodies|mesh-list
153653311|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
153653312|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153653313|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653314|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153653315|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153653316|NCT00016107|Growth Substances|growth substances|mesh-ancestor
153653328|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153653329|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153653330|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653331|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153653332|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153653333|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
153653334|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653335|NCT00016185|Docetaxel|docetaxel|mesh-list
153653336|NCT00016185|Alvocidib|alvocidib|mesh-list
153653337|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653338|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
153653339|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
153653340|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
153653341|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653342|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
153653343|NCT00016185|Growth Substances|growth substances|mesh-ancestor
153653344|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653345|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653346|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653347|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153653348|NCT00001151|Calcitriol|calcitriol|mesh-list
153653349|NCT00001151|Vitamins|vitamins|mesh-ancestor
153653350|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
154080937|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080938|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154080939|NCT05242029|Psilocybin|psilocybin|mesh-list
154080940|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
154080941|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080942|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154080943|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
154080944|NCT05208047|Sunitinib|sunitinib|mesh-list
154080945|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547414|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547417|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
153653351|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653352|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153724911|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153653353|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153653354|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153653355|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153653356|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653357|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153653358|NCT00016224|Thalidomide|thalidomide|mesh-list
153653359|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653360|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
153653361|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653362|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
153653363|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153653364|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653365|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153653366|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153653367|NCT00016224|Growth Substances|growth substances|mesh-ancestor
153653368|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
153653369|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653370|NCT00016263|Dacarbazine|dacarbazine|mesh-list
153653371|NCT00016263|Oblimersen|oblimersen|mesh-list
153653372|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653373|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
153653374|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653376|NCT00016302|Leucovorin|leucovorin|mesh-list
153653377|NCT00016302|Cytarabine|cytarabine|mesh-list
153653378|NCT00016302|Dexamethasone|dexamethasone|mesh-list
153653379|NCT00016302|Prednisone|prednisone|mesh-list
153653380|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
153653402|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
153653403|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653404|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153653405|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
153653407|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653408|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653409|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153653410|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153653411|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653412|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653413|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153653414|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
153653415|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153653416|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653417|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
153653418|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
153653419|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153653420|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653421|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
153653422|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653423|NCT00016302|Antidotes|antidotes|mesh-ancestor
153653424|NCT00016302|Protective Agents|protective agents|mesh-ancestor
153653425|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
153653426|NCT00016302|Vitamins|vitamins|mesh-ancestor
153653427|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
154080947|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154080948|NCT05208047|Growth Substances|growth substances|mesh-ancestor
154080949|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080950|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
154080951|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154080952|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653428|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153653429|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
153653430|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
153653431|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
153490397|NCT02056236|Midazolam|midazolam|mesh-list
153653432|NCT00389285|Sorafenib|sorafenib|mesh-list
153653433|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653434|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653435|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653436|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653446|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
153653447|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
153653448|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653449|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153653450|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153653451|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653452|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653453|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653454|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153461268|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653455|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
153653456|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653457|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653458|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153653459|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153653460|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153653461|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153653462|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153653463|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153653464|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
153653465|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153653466|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153653467|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153653468|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
153653469|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153653470|NCT00001181|Testolactone|testolactone|mesh-list
153653471|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653472|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653473|NCT00016380|Dexamethasone|dexamethasone|mesh-list
153653474|NCT00016380|Ondansetron|ondansetron|mesh-list
153653475|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153653476|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
153653478|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653479|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653480|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153653481|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
153653482|NCT00016380|Hormones|hormones|mesh-ancestor
153653483|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653484|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653485|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653486|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
153653487|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
153653488|NCT00016380|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153653489|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153653490|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
153653491|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153653492|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653493|NCT00001190|Deslorelin|deslorelin|mesh-list
153653494|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080953|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080954|NCT05204550|Heparin|heparin|mesh-list
154080955|NCT05204550|Calcium heparin|calcium heparin|mesh-list
154080956|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
154080957|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154080958|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153653495|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653496|NCT00001202|Testolactone|testolactone|mesh-list
153653497|NCT00001202|Spironolactone|spironolactone|mesh-list
153653498|NCT00001202|Deslorelin|deslorelin|mesh-list
153653499|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153653500|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
153653501|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653502|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653517|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653518|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
153653519|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653520|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
153653521|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653522|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153653523|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
153653524|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153653525|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653526|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
153653527|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653528|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653529|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653530|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
153653531|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653532|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653533|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153653534|NCT01156545|Afatinib|afatinib|mesh-list
153653535|NCT01156545|Simvastatin|simvastatin|mesh-list
153653536|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153653537|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153653538|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
153653539|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653540|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153653541|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153653542|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653543|NCT01156545|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153653544|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653545|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653546|NCT00001262|Copper|copper|mesh-list
153653547|NCT00001262|Trace Elements|trace elements|mesh-ancestor
153653548|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
153653549|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653550|NCT00001280|Itraconazole|itraconazole|mesh-list
153653551|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
153653552|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653553|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153653554|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153653555|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653556|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653557|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153653558|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
153653559|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653560|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653561|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153653577|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653578|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153653579|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153653581|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
153653582|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653583|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153653584|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
153653585|NCT00016887|Hormones|hormones|mesh-ancestor
153547435|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080959|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080960|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154080961|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154080962|NCT05189145|Hormones|hormones|mesh-list
154080963|NCT05189145|Estradiol|estradiol|mesh-list
154080964|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154080965|NCT05189145|Progesterone|progesterone|mesh-list
154080966|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
154080967|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547436|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
153653586|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653587|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653588|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153653589|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153653590|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653591|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653592|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
153653593|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653594|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653595|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
153653596|NCT00038389|Rofecoxib|rofecoxib|mesh-list
153653597|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153653598|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153653599|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653600|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653601|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153653602|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153653603|NCT00038389|Analgesics|analgesics|mesh-ancestor
153653604|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
153653605|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653606|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653607|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153653608|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653609|NCT00038506|Tenofovir|tenofovir|mesh-list
153653610|NCT00038506|Lamivudine|lamivudine|mesh-list
153653611|NCT00038506|Zidovudine|zidovudine|mesh-list
153653612|NCT00038506|Abacavir|abacavir|mesh-list
153653613|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153653614|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
153653615|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653616|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153653617|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653618|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653619|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653620|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153653621|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153653622|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
153653623|NCT00016926|Capecitabine|capecitabine|mesh-list
153653641|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653643|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153653644|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653645|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
153653646|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653647|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653648|NCT00038662|Atrasentan|atrasentan|mesh-list
153653649|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653650|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153653651|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153653652|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653653|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
154080968|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080969|NCT05189145|Estrogens|estrogens|mesh-ancestor
154080970|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154080972|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154080973|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154080974|NCT05189145|Progestins|progestins|mesh-ancestor
154080975|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
154080976|NCT05159193|Carboplatin|carboplatin|mesh-list
154080977|NCT05159193|Docetaxel|docetaxel|mesh-list
154080978|NCT05159193|Doxorubicin|doxorubicin|mesh-list
154080979|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153547445|NCT05491616|Nivolumab|nivolumab|mesh-list
153653654|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153653655|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653656|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153653657|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153653658|NCT00038701|Growth Substances|growth substances|mesh-ancestor
153653659|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653660|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
153653661|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153653662|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153653663|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153653664|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153653665|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653666|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153653667|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653668|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153653669|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
153653670|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153653672|NCT00038935|Coagulants|coagulants|mesh-ancestor
153653673|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
153653674|NCT00017004|Hematinics|hematinics|mesh-ancestor
153653676|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153653677|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
153724967|NCT00462553|Sunitinib|sunitinib|mesh-list
153653678|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653679|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
153653705|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153653706|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653707|NCT00039169|IDN 5109|idn 5109|mesh-list
153653708|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653709|NCT00001304|Vitamin D|vitamin d|mesh-list
153653710|NCT00001304|Calcitriol|calcitriol|mesh-list
153653711|NCT00001304|Calcium|calcium|mesh-list
153653712|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
153653713|NCT00001304|Hormones|hormones|mesh-list
153653714|NCT00001304|Vitamins|vitamins|mesh-ancestor
153653715|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
153653716|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653717|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153653718|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153653719|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653720|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153653721|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153653722|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653723|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153653724|NCT00039208|Leucovorin|leucovorin|mesh-list
153653725|NCT00039208|Fluorouracil|fluorouracil|mesh-list
153653726|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
153653727|NCT00039208|Irinotecan|irinotecan|mesh-list
153653728|NCT00039208|Calcium|calcium|mesh-list
153653729|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
153653730|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153653731|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653747|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
153653748|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547463|NCT05467176|Relugolix|relugolix|mesh-list
154080980|NCT05159193|Trastuzumab|trastuzumab|mesh-list
154080981|NCT05159193|Pertuzumab|pertuzumab|mesh-list
154080982|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154080983|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
154080984|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080985|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154080986|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154080987|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
154080988|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154080989|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154080990|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154080991|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
154080992|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
154080993|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
153653749|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153653750|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153653751|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653752|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
153653753|NCT00039364|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153653754|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653755|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653756|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653757|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653758|NCT00039403|Gemcitabine|gemcitabine|mesh-list
153653759|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153653760|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653761|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
153653762|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653763|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653764|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653765|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653766|NCT00039442|Capecitabine|capecitabine|mesh-list
153653767|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653768|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
153653769|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653770|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653771|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
153653772|NCT00039481|Doxorubicin|doxorubicin|mesh-list
153653773|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153653774|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
153653775|NCT00039481|Razoxane|razoxane|mesh-list
153653776|NCT00039481|Oblimersen|oblimersen|mesh-list
153653777|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653778|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
153653779|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653780|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653781|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653782|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
153653783|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653784|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653785|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153653787|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153653788|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653789|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653790|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153653791|NCT00039481|Protective Agents|protective agents|mesh-ancestor
153653792|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
153653804|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
153653805|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547467|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154080994|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154080995|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154080996|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154080997|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154080998|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154080999|NCT05156710|Rituximab|rituximab|mesh-list
154081000|NCT05156710|Tacrolimus|tacrolimus|mesh-list
154081001|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
153653806|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653807|NCT00039520|Sulindac|sulindac|mesh-list
153653808|NCT00039520|Docetaxel|docetaxel|mesh-list
153653809|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653810|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
153653811|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
153653812|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
153653813|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653814|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153653815|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153653816|NCT00039520|Analgesics|analgesics|mesh-ancestor
153653817|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
153653818|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653819|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653820|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153653821|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653822|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153653823|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653824|NCT00001328|Ganciclovir|ganciclovir|mesh-list
153653825|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153653826|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
153653827|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653828|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653829|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653830|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653831|NCT00017160|Doxorubicin|doxorubicin|mesh-list
153653832|NCT00017160|Ifosfamide|ifosfamide|mesh-list
153653833|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
153724992|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
153653834|NCT00017160|Immunomodulating Agents|immunomodulating agents|mesh-list
153653835|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153653836|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653837|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153653838|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653839|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653840|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653841|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653842|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653843|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
153653844|NCT00039832|Reteplase|reteplase|mesh-list
153653845|NCT00039832|Abciximab|abciximab|mesh-list
153653846|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
153653847|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153653848|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153653849|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153653850|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653851|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
153653852|NCT00039988|Albuterol|albuterol|mesh-list
153653853|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
153653854|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153653855|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
153653856|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653857|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653858|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153653904|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653905|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653906|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653908|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154081002|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154081003|NCT05156710|Antibodies|antibodies|mesh-list
154081004|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154081005|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
154081006|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154081007|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154081008|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081009|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
153547474|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653909|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653910|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653911|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653912|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
153653913|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653914|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153653915|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153653916|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153653917|NCT00040183|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153653918|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653919|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653920|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653921|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653923|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153653924|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153653925|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
153653926|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153653927|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653928|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653929|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153653930|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153653931|NCT00040300|Racivir|racivir|mesh-list
153653932|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
153653933|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653934|NCT00040378|Vitamins|vitamins|mesh-list
153653935|NCT00040378|Vitamin E|vitamin e|mesh-list
153653936|NCT00040378|Tocopherols|tocopherols|mesh-list
153653937|NCT00040378|Tocotrienols|tocotrienols|mesh-list
153653938|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
153653939|NCT00040378|Selenium|selenium|mesh-list
153653940|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
153653941|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653942|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
153653943|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653944|NCT00040378|Protective Agents|protective agents|mesh-ancestor
153653945|NCT00040378|Trace Elements|trace elements|mesh-ancestor
153653946|NCT00017199|Bortezomib|bortezomib|mesh-list
153653947|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653948|NCT00040417|Fludarabine|fludarabine|mesh-list
153653949|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
153653950|NCT00040417|Lenograstim|lenograstim|mesh-list
153653951|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653952|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
153653953|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653954|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153653955|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153653956|NCT00040495|Pantoprazole|pantoprazole|mesh-list
153653957|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153653958|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153653959|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153653960|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653975|NCT00040690|Cytarabine|cytarabine|mesh-list
153653976|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
153653977|NCT00040690|Ifosfamide|ifosfamide|mesh-list
153653978|NCT00040690|Doxorubicin|doxorubicin|mesh-list
153653979|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153653980|NCT00040690|Methotrexate|methotrexate|mesh-list
153653981|NCT00040690|Etoposide|etoposide|mesh-list
153653982|NCT00040690|Vincristine|vincristine|mesh-list
153653983|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
154081011|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081012|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081013|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154081014|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081015|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081016|NCT05151640|Nintedanib|nintedanib|mesh-list
153547488|NCT05457959|Laxatives|laxatives|mesh-ancestor
153653984|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653985|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
153653986|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653987|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653988|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653989|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
153653990|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653991|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653992|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153653993|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153653994|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153653995|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653996|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653997|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153653998|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
153653999|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153654000|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654001|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
153654002|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
153654003|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153654004|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153725010|NCT00462787|Thiotepa|thiotepa|mesh-list
153654005|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153654006|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
153654007|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654008|NCT00040690|Antidotes|antidotes|mesh-ancestor
153654010|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
153654011|NCT00040690|Vitamins|vitamins|mesh-ancestor
153654012|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
153654013|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654014|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
153654015|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654016|NCT00040768|Bortezomib|bortezomib|mesh-list
153654017|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654018|NCT00017238|KRN 5500|krn 5500|mesh-list
153654019|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654020|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153654021|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654022|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654023|NCT00040885|Infliximab|infliximab|mesh-list
153654033|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153654034|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153654035|NCT00001421|Methimazole|methimazole|mesh-list
153654036|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
153654037|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
153654038|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654039|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654040|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
153654041|NCT00017277|Hematinics|hematinics|mesh-ancestor
153654042|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
153654043|NCT00041041|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153654044|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654045|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654046|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654047|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654048|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
153654049|NCT00041197|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153654050|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654051|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654052|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081017|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081018|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081019|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547489|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153654053|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654054|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
153654055|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654056|NCT00041236|Exatecan|exatecan|mesh-list
153654057|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153654058|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654059|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654060|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654061|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654062|NCT00017316|Thalidomide|thalidomide|mesh-list
153654063|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654064|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
153654065|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654066|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
153654067|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654068|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654069|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153654070|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153654071|NCT00017316|Growth Substances|growth substances|mesh-ancestor
153654072|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
153654073|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654074|NCT00041275|Megestrol|megestrol|mesh-list
153654075|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
153654076|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153654077|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153654078|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153654079|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
153654080|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153654081|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654082|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153654083|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153654084|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153654085|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654086|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
153654087|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153654106|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
153654107|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153654108|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654109|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
153654110|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654111|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654113|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654114|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654115|NCT00001436|Tamoxifen|tamoxifen|mesh-list
153654116|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153654117|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
153654118|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654119|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654120|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153654121|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654122|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153654123|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153654124|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153654125|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
153654126|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153654127|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
153654128|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654129|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654130|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153654131|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
153654132|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153654133|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
153654134|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654135|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081020|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081021|NCT05113368|Fulvestrant|fulvestrant|mesh-list
154081022|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081023|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081024|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154081025|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154081026|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
154081027|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547494|NCT05456191|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153547495|NCT05456191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547496|NCT05456191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547498|NCT05453968|Berotralstat|berotralstat|mesh-list
153725040|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
153654136|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153654137|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
153654138|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
153654139|NCT00041548|Protective Agents|protective agents|mesh-ancestor
153654140|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
153654141|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654142|NCT00041665|Mitogens|mitogens|mesh-list
153654143|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654144|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654162|NCT00017511|Cevimeline|cevimeline|mesh-list
153654163|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153654164|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
153654165|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654166|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654167|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153654168|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153654169|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
153654170|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654171|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654172|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
153654173|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153654174|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
153654175|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153654176|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654177|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153654178|NCT00041977|Doxycycline|doxycycline|mesh-list
153654179|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654180|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654181|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
153654182|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153654183|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153654184|NCT00042016|Decitabine|decitabine|mesh-list
153654185|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654186|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
153654187|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654188|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654189|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654190|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153654191|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
153654192|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654193|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654194|NCT00001457|Lamivudine|lamivudine|mesh-list
153654195|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153654196|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153654197|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654198|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654199|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
153912510|NCT01031979|Yohimbine|yohimbine|mesh-list
153654202|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153654203|NCT00042172|Donepezil|donepezil|mesh-list
154081028|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081029|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
154081030|NCT05110742|Fludarabine|fludarabine|mesh-list
154081031|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
154081032|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081033|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
154081034|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081035|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081036|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154081037|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
153547502|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654204|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153654212|NCT00017589|Oblimersen|oblimersen|mesh-list
153654213|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153654214|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654215|NCT00017589|Immunotoxins|immunotoxins|mesh-ancestor
153654216|NCT00017589|Immunoconjugates|immunoconjugates|mesh-ancestor
153654217|NCT00017589|Immunologic Factors|immunologic factors|mesh-ancestor
153654218|NCT00017589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654219|NCT00001475|Thalidomide|thalidomide|mesh-list
153654220|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654221|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
153654222|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654223|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
153654224|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654225|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654226|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153654227|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153654228|NCT00001475|Growth Substances|growth substances|mesh-ancestor
153654229|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
153654230|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654231|NCT00042328|Valacyclovir|valacyclovir|mesh-list
153654232|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
153654233|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654234|NCT00042367|Mafosfamide|mafosfamide|mesh-list
153654235|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
153654236|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153654237|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
153654238|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654239|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654240|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654241|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153654242|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153654243|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
153654244|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654245|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153654246|NCT02970643|Olanzapine|olanzapine|mesh-list
153654247|NCT02970643|Palonosetron|palonosetron|mesh-list
153654248|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
153654249|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
153654250|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654251|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654252|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153654253|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153654254|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153654255|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153654256|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153654257|NCT02970643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153654258|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153491210|NCT05447364|Analgesics|analgesics|mesh-ancestor
153654259|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654260|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654262|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
154081038|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725061|NCT00116324|Montelukast|montelukast|mesh-list
154081039|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081040|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154081041|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154081042|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
154081043|NCT05109728|Temozolomide|temozolomide|mesh-list
153547513|NCT05425979|Bupivacaine|bupivacaine|mesh-list
153654263|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153654264|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153654265|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
153654266|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153654267|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153654268|NCT00017628|Prednisolone|prednisolone|mesh-list
153654269|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
153654270|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
153654271|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153654272|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
153654285|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654286|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153654287|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
153654288|NCT00017628|Hormones|hormones|mesh-ancestor
153654289|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654290|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153654291|NCT00017628|Protective Agents|protective agents|mesh-ancestor
153654292|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153654294|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153654296|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654297|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654298|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654299|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654300|NCT00042562|Analgesics|analgesics|mesh-ancestor
153654301|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
153654302|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654303|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
153654304|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153654305|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
153654306|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153654307|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153654308|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
153654309|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654310|NCT00042601|Pramlintide|pramlintide|mesh-list
153654311|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153654312|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654313|NCT00042679|Carboplatin|carboplatin|mesh-list
153654314|NCT00042679|Gemcitabine|gemcitabine|mesh-list
153654315|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654316|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654317|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
153654318|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654319|NCT00042718|Amoxicillin|amoxicillin|mesh-list
153654320|NCT00042718|Azithromycin|azithromycin|mesh-list
153654321|NCT00042718|Levofloxacin|levofloxacin|mesh-list
153654322|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
153654323|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
153654324|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153654325|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654326|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654327|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153654328|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153654329|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654330|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654331|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654332|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654347|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
153654348|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153654349|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153654350|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081044|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154081045|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153654351|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654352|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
153654353|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654354|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654355|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153654356|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654357|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654358|NCT00042835|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153654359|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654360|NCT00017784|Valganciclovir|valganciclovir|mesh-list
153654361|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
153654362|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654364|NCT00042874|Fluorouracil|fluorouracil|mesh-list
153654365|NCT00042874|Irinotecan|irinotecan|mesh-list
153654366|NCT00042874|Alvocidib|alvocidib|mesh-list
153654367|NCT00042874|Calcium|calcium|mesh-list
153654368|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
153654369|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153654370|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654371|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
153654372|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654373|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654374|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654375|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654376|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
153654377|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153654378|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654379|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654380|NCT00042874|Antidotes|antidotes|mesh-ancestor
153654381|NCT00042874|Protective Agents|protective agents|mesh-ancestor
153654382|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
153654383|NCT00042874|Vitamins|vitamins|mesh-ancestor
153654384|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
153654385|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
153654386|NCT00042874|Growth Substances|growth substances|mesh-ancestor
153654387|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654388|NCT00042913|Epratuzumab|epratuzumab|mesh-list
153654389|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153654390|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654391|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
153654392|NCT00042952|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153654393|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654394|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654395|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654409|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654411|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654412|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153654413|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153654414|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654415|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
153654416|NCT00043147|Prednisone|prednisone|mesh-list
153654417|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
153654418|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153654419|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153654420|NCT00043147|Prednisolone|prednisolone|mesh-list
153654421|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
153654422|NCT00043147|Beclomethasone|beclomethasone|mesh-list
153654423|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153654424|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
153654425|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153654426|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
153654427|NCT00043147|Hormones|hormones|mesh-ancestor
153654428|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654429|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654430|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153654431|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654432|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
153654433|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
154081046|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154081047|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
154081048|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081049|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081050|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
154081051|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
154081052|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154081053|NCT05090371|Ofatumumab|ofatumumab|mesh-list
153654434|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654435|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153654436|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153654437|NCT00043147|Protective Agents|protective agents|mesh-ancestor
153654438|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153654439|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
153654440|NCT00017862|Reslizumab|reslizumab|mesh-list
153654441|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153654442|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
153654443|NCT00043264|Azithromycin|azithromycin|mesh-list
153654444|NCT00043264|Rifampin|rifampin|mesh-list
153654445|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654446|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654447|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153654448|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
153654449|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
153654450|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153461506|NCT04400136|Lansoprazole|lansoprazole|mesh-list
153654451|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654452|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654453|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153654454|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153654455|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153654456|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153654457|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153654474|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153654475|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153654476|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153654477|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153654478|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654479|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153654480|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153654481|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654482|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
153654483|NCT00043342|Interferons|interferons|mesh-list
153654484|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
153654486|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
153654487|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654488|NCT00043381|Decitabine|decitabine|mesh-list
153654489|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654490|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
153654491|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654492|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654493|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654494|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
153654495|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153654496|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
153654497|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654498|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
153654499|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654500|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153654501|NCT00043537|Fluoxetine|fluoxetine|mesh-list
153654502|NCT00043537|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153654503|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153654504|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654505|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654506|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654507|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
153547526|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154081054|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081055|NCT05084638|Ofatumumab|ofatumumab|mesh-list
154081056|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081057|NCT05035498|Phenylephrine|phenylephrine|mesh-list
154081058|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
154081059|NCT05035498|Norepinephrine|norepinephrine|mesh-list
154081060|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154081061|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154081063|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
154081064|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081065|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081066|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
154081067|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
153654508|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654509|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153654510|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
153654511|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153654512|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153654513|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153654514|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654515|NCT00043576|Calcitriol|calcitriol|mesh-list
153654545|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153654547|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153654548|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654549|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
153654550|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654551|NCT00043810|Fludarabine|fludarabine|mesh-list
153654552|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
153654553|NCT00043810|Busulfan|busulfan|mesh-list
153654554|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
153654555|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654556|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654568|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153654569|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
153654570|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153654571|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153654572|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153654573|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153654574|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654576|NCT00001586|Fludarabine|fludarabine|mesh-list
153654577|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
153654578|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153654579|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654580|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
153654581|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654582|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153654583|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654584|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
153654585|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654586|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654587|NCT00043888|Ritonavir|ritonavir|mesh-list
153654588|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
153654589|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153654590|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153654591|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153654592|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
153654593|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654594|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654595|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153654596|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154081068|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
154081069|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154081070|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154081071|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154081072|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
154081075|NCT05035498|Protective Agents|protective agents|mesh-ancestor
154081136|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154081137|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154081138|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154081139|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081211|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081212|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153564761|NCT05596071|Dsuvia|dsuvia|mesh-list
154081213|NCT04773353|Hormones|hormones|mesh-ancestor
154081214|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081215|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081216|NCT04767217|Lumefantrine|lumefantrine|mesh-list
154081278|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081279|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081280|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154081281|NCT04624854|Aspirin|aspirin|mesh-list
154081282|NCT04624854|Clopidogrel|clopidogrel|mesh-list
154081283|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154081284|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154081285|NCT04624854|Analgesics|analgesics|mesh-ancestor
154081286|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
154081344|NCT04380545|Fluorouracil|fluorouracil|mesh-list
154081345|NCT04380545|Nivolumab|nivolumab|mesh-list
154081346|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
154081347|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081412|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154081413|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081414|NCT04298203|Topiramate|topiramate|mesh-list
154081415|NCT04298203|Phentermine|phentermine|mesh-list
154081416|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
154081417|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154081418|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081419|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154081420|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
154081421|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154081422|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
154081423|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
154081424|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154081484|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154081485|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081486|NCT04035850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154081487|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154081488|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154081489|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081549|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
154081550|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
154081551|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
154081552|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
154081553|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154081554|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154081555|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081556|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081557|NCT03817931|Urological Agents|urological agents|mesh-ancestor
154081558|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154081559|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
154081560|NCT03810807|Osimertinib|osimertinib|mesh-list
154081561|NCT03810807|Dacomitinib|dacomitinib|mesh-list
154081562|NCT03810807|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154081563|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154081564|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081607|NCT03736889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081609|NCT03726268|Sufentanil|sufentanil|mesh-list
154081610|NCT03726268|Morphine|morphine|mesh-list
154081611|NCT03726268|Methadone|methadone|mesh-list
154081612|NCT03726268|Hydromorphone|hydromorphone|mesh-list
154081613|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154081614|NCT03726268|Narcotics|narcotics|mesh-ancestor
154081615|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154081616|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081617|NCT03726268|Analgesics|analgesics|mesh-ancestor
154081623|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
154081673|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081674|NCT03595371|Dapansutrile|dapansutrile|mesh-list
154081675|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154081676|NCT03580044|Aztreonam|aztreonam|mesh-list
154081677|NCT03580044|Avibactam|avibactam|mesh-list
154081678|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154081679|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154081680|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154081681|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081739|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154081740|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154081742|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154081743|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154081808|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081809|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081810|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154081811|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
154081812|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154081813|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081814|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154081822|NCT03232073|Ponesimod|ponesimod|mesh-list
154081823|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154081824|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081825|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081826|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
154081827|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081828|NCT03196934|Cannabidiol|cannabidiol|mesh-list
154081829|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
154081830|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
154081870|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081871|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081873|NCT03047005|Bupropion|bupropion|mesh-list
154081874|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154081875|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154081876|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081938|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081939|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154081940|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154081941|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154081942|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
154081943|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154081944|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
154081945|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154081946|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154081947|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154081948|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
154081949|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154081950|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154081998|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154081999|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154082000|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082002|NCT02259231|Ipilimumab|ipilimumab|mesh-list
154082003|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082004|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082005|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154082006|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082007|NCT02105766|Sirolimus|sirolimus|mesh-list
154082062|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154082063|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154082064|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154082065|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
154082067|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154082134|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154082135|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154082136|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
154082137|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
154082138|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082139|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154082204|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154082205|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154082206|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
154082207|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154082208|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154082209|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154082210|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154082211|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
154082212|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154082213|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154082214|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082215|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
154082267|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154082268|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154082269|NCT02590614|Vitamin D|vitamin d|mesh-list
154082270|NCT02590614|Vitamins|vitamins|mesh-ancestor
154082271|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
154082272|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082273|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154082274|NCT02575443|Rocuronium|rocuronium|mesh-list
154082275|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154082276|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154082277|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154082278|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082280|NCT02596334|Lamivudine|lamivudine|mesh-list
154082328|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082329|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082330|NCT00719472|Antipyretics|antipyretics|mesh-list
154082331|NCT00719472|Prednisone|prednisone|mesh-list
154082332|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
154082333|NCT00719472|Rituximab|rituximab|mesh-list
154082334|NCT00719472|Doxorubicin|doxorubicin|mesh-list
154082335|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154082336|NCT00719472|Vincristine|vincristine|mesh-list
154082337|NCT00719472|Analgesics|analgesics|mesh-list
154082338|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
154082339|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
154082340|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154082341|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
154082342|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082343|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154082388|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082389|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
154082390|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082391|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154082392|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
154082393|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082394|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154082395|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
154082396|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
154082397|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
154082398|NCT04086186|Bupivacaine|bupivacaine|mesh-list
154082453|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082454|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154082455|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
154082456|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154082457|NCT02590224|Glycine|glycine|mesh-list
154082458|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
154082459|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082460|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082461|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082463|NCT00709449|Moxaverine|moxaverine|mesh-list
154082464|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
154082517|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
154082518|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
154082519|NCT02574975|Miotics|miotics|mesh-ancestor
154082520|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154082521|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154082522|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154082523|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154082586|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082587|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154082588|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
154082589|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
154082590|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
154082591|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154082592|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154082593|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
154082594|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
154082652|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082653|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082654|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154082655|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154082656|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
154082657|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154082658|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154082717|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
154082718|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
154082719|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154082720|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154082721|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154082722|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154082723|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
154082724|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154082725|NCT05683626|Adalimumab|adalimumab|mesh-list
154082729|NCT02588196|Dexamethasone|dexamethasone|mesh-list
154082784|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154082785|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
154082786|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
154082787|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
154082788|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082789|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082790|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154082791|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154082792|NCT02574663|Growth Substances|growth substances|mesh-ancestor
154082793|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154082794|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
154082795|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154082796|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
154082846|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154082847|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082848|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082849|NCT00719199|Cetuximab|cetuximab|mesh-list
154082850|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154082882|NCT05192460|Vaccines|vaccines|mesh-list
154082912|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154082913|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154082914|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725146|NCT00464347|Triamcinolone|triamcinolone|mesh-list
154082915|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154082916|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154082917|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
154082918|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154082919|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154082920|NCT00919776|Cyclosporine|cyclosporine|mesh-list
154082980|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154082981|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154082982|NCT00716547|Celecoxib|celecoxib|mesh-list
154082983|NCT00716547|Ketoprofen|ketoprofen|mesh-list
154082984|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154082985|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154082986|NCT00716547|Analgesics|analgesics|mesh-ancestor
154082987|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
154083050|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154083051|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
154083052|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083053|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154083054|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
154083055|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154083056|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154083057|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
154083058|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154083059|NCT04828824|Norgestimate|norgestimate|mesh-list
154083060|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154083061|NCT04828824|Estradiol|estradiol|mesh-list
154083062|NCT04828824|Estrogens|estrogens|mesh-ancestor
154083063|NCT04828824|Hormones|hormones|mesh-ancestor
154083064|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083065|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083066|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154083108|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
154083109|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154083110|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
154083111|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154083112|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083113|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154083114|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083115|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
154083116|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154083117|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
154083118|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083119|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083120|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
154083121|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
154083122|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083123|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154083124|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
154083125|NCT04936854|Hormones|hormones|mesh-ancestor
154083126|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083127|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154083128|NCT04936854|Protective Agents|protective agents|mesh-ancestor
154083129|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154083130|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
154083159|NCT02596256|Apatinib|apatinib|mesh-list
154083160|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083161|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
154083162|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
154083163|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
154083164|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083165|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154083166|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083167|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
154083168|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154083169|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154083170|NCT00717561|Amoxicillin|amoxicillin|mesh-list
154083171|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
154083172|NCT00717561|Azithromycin|azithromycin|mesh-list
154083173|NCT00717561|Clarithromycin|clarithromycin|mesh-list
154083174|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
154083175|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
154083176|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
154083177|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154083178|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154083179|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154083213|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083214|NCT00740792|Fluticasone|fluticasone|mesh-list
154083215|NCT00740792|Xhance|xhance|mesh-list
154083217|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083218|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154083219|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
154083220|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083221|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083222|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154083223|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
154083224|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
154083225|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154083226|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154083228|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083229|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154083230|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154083231|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
154083232|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
154083272|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083273|NCT00712491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154083274|NCT00712491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083275|NCT00712491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083276|NCT04083066|Cytarabine|cytarabine|mesh-list
154083277|NCT04083066|Dexamethasone|dexamethasone|mesh-list
154083278|NCT04083066|Rituximab|rituximab|mesh-list
154083279|NCT04083066|Methotrexate|methotrexate|mesh-list
154083280|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154083281|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
154083287|NCT04083066|Hormones|hormones|mesh-ancestor
154083340|NCT04070469|Amoxicillin|amoxicillin|mesh-list
154083341|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154083342|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083343|NCT00712647|Beta Carotene|beta carotene|mesh-list
154083344|NCT00712647|Vitamin A|vitamin a|mesh-list
154083345|NCT00712647|Carotenoids|carotenoids|mesh-list
154083346|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
154083347|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083348|NCT00712647|Protective Agents|protective agents|mesh-ancestor
154083349|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083350|NCT00712647|Provitamins|provitamins|mesh-ancestor
154083351|NCT00712647|Vitamins|vitamins|mesh-ancestor
154083352|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
154083353|NCT00788957|Panitumumab|panitumumab|mesh-list
154083354|NCT00788957|Rilotumumab|rilotumumab|mesh-list
154083355|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154083356|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083357|NCT04067817|Phenylephrine|phenylephrine|mesh-list
154083358|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
154083359|NCT04067817|Norepinephrine|norepinephrine|mesh-list
154083360|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154083361|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154083396|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
154083397|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083398|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154083399|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083400|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083401|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
154083403|NCT04070391|Pyridoxine|pyridoxine|mesh-list
154083404|NCT04070391|Vitamins|vitamins|mesh-ancestor
154083405|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
154083406|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083407|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
154083461|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154083462|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154083463|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154083464|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083465|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083466|NCT00722631|Pioglitazone|pioglitazone|mesh-list
154083467|NCT00722631|Glimepiride|glimepiride|mesh-list
154083468|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154083469|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083470|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154083471|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154083526|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154083527|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154083528|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154083529|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083530|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154083531|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154083594|NCT00713739|Prazosin|prazosin|mesh-list
154083595|NCT00713739|Doxazosin|doxazosin|mesh-list
154083596|NCT00713739|Nifedipine|nifedipine|mesh-list
154083597|NCT00713739|Alfuzosin|alfuzosin|mesh-list
154083598|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154083599|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154083601|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154083660|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
154083661|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083662|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083663|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083664|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154083665|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154083666|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
154083667|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083668|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154083669|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
154083670|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
154083722|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
154083723|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083724|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154083725|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154083726|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154083727|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154083728|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154083729|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154083730|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
154083731|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
154083732|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
154083733|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154083785|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153725226|NCT00464932|Protective Agents|protective agents|mesh-ancestor
154083786|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154083787|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083788|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154083789|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154083790|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154083791|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083792|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154083793|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154083794|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154083795|NCT02570841|Capsaicin|capsaicin|mesh-list
154083796|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
154083797|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
154083798|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
154083799|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154083800|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083801|NCT00577863|Teriparatide|teriparatide|mesh-list
154083802|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154083803|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083804|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154083805|NCT04956627|Itraconazole|itraconazole|mesh-list
154083834|NCT00920088|Levomethorphan|levomethorphan|mesh-list
154083835|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
154083836|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154083837|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154083838|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154083839|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083840|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154083841|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154083842|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154083843|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154083844|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
154083845|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
154083898|NCT00725517|Icodextrin|icodextrin|mesh-list
154083899|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
154083900|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154083901|NCT04620291|UB-421|ub-421|mesh-list
154083902|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154083903|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
154083904|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083905|NCT00794417|Pemetrexed|pemetrexed|mesh-list
154083906|NCT00794417|Aflibercept|aflibercept|mesh-list
154083907|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154083917|NCT00725829|Simvastatin|simvastatin|mesh-list
154083964|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154083965|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154083966|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154083967|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154083969|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154083970|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154083971|NCT04250883|Trace Elements|trace elements|mesh-ancestor
154083972|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
154083973|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083974|NCT04469634|Antibodies|antibodies|mesh-list
154083975|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
154083976|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083977|NCT04465500|Androgens|androgens|mesh-list
154083978|NCT04465500|Hormones|hormones|mesh-ancestor
154083979|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154083980|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154083982|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154083983|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154083984|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154083985|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154083992|NCT00790907|Heparin|heparin|mesh-list
153550552|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154084019|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
154084020|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084021|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084022|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084023|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084024|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154084025|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084026|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084027|NCT00726687|Capecitabine|capecitabine|mesh-list
154084028|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154084029|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
154084030|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084031|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084032|NCT00727077|Interferons|interferons|mesh-list
154084033|NCT00727077|Ribavirin|ribavirin|mesh-list
154084034|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
154084035|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
154084036|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084037|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
154084038|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084039|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
154084040|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550593|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153550594|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153550595|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153550596|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153550597|NCT02720094|Cabotegravir|cabotegravir|mesh-list
153550598|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153550599|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153550602|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
154084061|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084062|NCT00727233|Sorafenib|sorafenib|mesh-list
154084063|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084064|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154084065|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084066|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084067|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
154084110|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084111|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154084112|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
154084113|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
154084114|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154084115|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154084116|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154084117|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154084118|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
154084119|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084120|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084178|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
154084179|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
154084180|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154084181|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154084182|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154084183|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154084184|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154084185|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
154084186|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
154084187|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154084188|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
153407388|NCT01013961|Rituximab|rituximab|mesh-list
154084189|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084190|NCT02582736|Analgesics|analgesics|mesh-ancestor
154084191|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
154084192|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154084193|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154084194|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154084195|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
154084196|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154084197|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154084198|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084199|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154084200|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154084201|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084202|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084203|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084204|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154084205|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
154084221|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084222|NCT00727935|Lidocaine|lidocaine|mesh-list
154084223|NCT00727935|Ropivacaine|ropivacaine|mesh-list
154084224|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
154084225|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
154084226|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084227|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084228|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
154084229|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084230|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154084231|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154084232|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154084233|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154084234|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084235|NCT00728013|Atorvastatin|atorvastatin|mesh-list
154084236|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154084237|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154084238|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
154084239|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084240|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154084243|NCT00577707|Pemetrexed|pemetrexed|mesh-list
154084274|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
154084275|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084276|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084277|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084278|NCT04064619|Urological Agents|urological agents|mesh-ancestor
154084279|NCT00730977|Mannitol|mannitol|mesh-list
154084280|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154084281|NCT00730977|Diuretics|diuretics|mesh-ancestor
154084282|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
154084283|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084284|NCT00728715|Budesonide|budesonide|mesh-list
154084285|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
154084286|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084287|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154084289|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084290|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084291|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154084292|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
154084293|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
154084294|NCT00728715|Hormones|hormones|mesh-ancestor
154084295|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084327|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084328|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154084329|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154084330|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084331|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084332|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
154084333|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084334|NCT02569125|Everolimus|everolimus|mesh-list
154084335|NCT02569125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154084336|NCT02569125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154084337|NCT02569125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084338|NCT02569125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084339|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084340|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
154084341|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084342|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084343|NCT00731601|Pantoprazole|pantoprazole|mesh-list
154084344|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154084345|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084346|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154084347|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084348|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084349|NCT00736905|Rilpivirine|rilpivirine|mesh-list
154084350|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154084351|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154084374|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154084376|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084377|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084378|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084379|NCT00737139|Epinephrine|epinephrine|mesh-list
154084380|NCT00737139|Bupivacaine|bupivacaine|mesh-list
154084381|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154084382|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154084383|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
154084384|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084385|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084386|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084387|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154084388|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154084389|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
154084390|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084391|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154084392|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
154084393|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
154084394|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
154084395|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154084396|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
154084397|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
154084398|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084399|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
154084400|NCT00732147|Pramlintide|pramlintide|mesh-list
154084401|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154084402|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084403|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
154084420|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084422|NCT00737373|Protective Agents|protective agents|mesh-ancestor
154084423|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
154084424|NCT00737373|Vitamins|vitamins|mesh-ancestor
154084425|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
154084426|NCT00737373|Hematinics|hematinics|mesh-ancestor
154084427|NCT00729495|Celecoxib|celecoxib|mesh-list
154084428|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154084429|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084430|NCT00729495|Analgesics|analgesics|mesh-ancestor
154084431|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
154084432|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084433|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084434|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084435|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084436|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154084437|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154084438|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725295|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084439|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084440|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
154084441|NCT00737685|Fludarabine|fludarabine|mesh-list
154084442|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
154084443|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084444|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
154084445|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084468|NCT00732693|Norethindrone|norethindrone|mesh-list
154084469|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
154084470|NCT00732693|Estradiol|estradiol|mesh-list
154084471|NCT00732693|Progesterone|progesterone|mesh-list
154084472|NCT00732693|Estrogens|estrogens|mesh-ancestor
154084473|NCT00732693|Hormones|hormones|mesh-ancestor
154084474|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084475|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084476|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154084477|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
154084478|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154084479|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154084480|NCT00732693|Progestins|progestins|mesh-ancestor
154084481|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154084482|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154084483|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154084484|NCT00729963|Sibutramine|sibutramine|mesh-list
154084485|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
154084486|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154084487|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
154084488|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154084489|NCT00737997|Morphine|morphine|mesh-list
154084490|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154084491|NCT00737997|Narcotics|narcotics|mesh-ancestor
154084494|NCT00737997|Analgesics|analgesics|mesh-ancestor
154084522|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084523|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084524|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
154084525|NCT00733083|Hormones|hormones|mesh-ancestor
154084526|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084527|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154084528|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084529|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154084530|NCT00733083|Narcotics|narcotics|mesh-ancestor
154084531|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084532|NCT00733083|Analgesics|analgesics|mesh-ancestor
154084533|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
154084534|NCT00712335|Fluticasone|fluticasone|mesh-list
154084535|NCT00712335|Xhance|xhance|mesh-list
154084536|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154084537|NCT00712335|Montelukast|montelukast|mesh-list
154084538|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
154084539|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084540|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154084541|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
154084542|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084576|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084577|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084578|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
154084579|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
154084580|NCT00738621|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154084581|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154084582|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
154084583|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084584|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154084586|NCT00733239|Verapamil|verapamil|mesh-list
154084587|NCT00733239|Diltiazem|diltiazem|mesh-list
154084588|NCT00733239|Isradipine|isradipine|mesh-list
154084589|NCT00733239|Nifedipine|nifedipine|mesh-list
154084590|NCT00733239|Gabapentin|gabapentin|mesh-list
154084591|NCT00733239|Naloxone|naloxone|mesh-list
154084592|NCT00733239|Analgesics|analgesics|mesh-ancestor
154084593|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
154084594|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084595|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084596|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
154084597|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154084598|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154084599|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084600|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154084630|NCT00577629|Etoposide|etoposide|mesh-list
154084631|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154084632|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
154084633|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084634|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084635|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154084636|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
154084637|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084638|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084639|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154084640|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154084641|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154084642|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154084643|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154084644|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084686|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154084687|NCT00710385|Buprenorphine|buprenorphine|mesh-list
154084689|NCT00710385|Naloxone|naloxone|mesh-list
154084690|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154084691|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084692|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
154084693|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084694|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154084695|NCT00710385|Narcotics|narcotics|mesh-ancestor
154084696|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084697|NCT00710385|Analgesics|analgesics|mesh-ancestor
154084698|NCT04063527|Paclitaxel|paclitaxel|mesh-list
154084699|NCT04063527|Carboplatin|carboplatin|mesh-list
154084700|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154084701|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084702|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
154084703|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
154084704|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
154084705|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084706|NCT00738777|Tamoxifen|tamoxifen|mesh-list
154084707|NCT00738777|Fulvestrant|fulvestrant|mesh-list
154084708|NCT00738777|Anastrozole|anastrozole|mesh-list
154084709|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154084710|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
154084711|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084712|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084713|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154084714|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084715|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154084716|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154084717|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154084719|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154084728|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084729|NCT04063449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154084730|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084731|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154084732|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154084733|NCT04063449|Growth Substances|growth substances|mesh-ancestor
154084734|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084735|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
154084737|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154084738|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
154084739|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084740|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084741|NCT05512767|Capecitabine|capecitabine|mesh-list
154084742|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154084743|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
154084744|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084745|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084747|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
154084748|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084749|NCT00921063|Alprazolam|alprazolam|mesh-list
154084750|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154084751|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084752|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084753|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154084760|NCT00707031|Metformin|metformin|mesh-list
154084775|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084776|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154084777|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
154084778|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154084779|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154084780|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154084781|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154084782|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084783|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
154084784|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084785|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154084786|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154084787|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084788|NCT00734474|Metformin|metformin|mesh-list
154084789|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154084790|NCT00734474|Dulaglutide|dulaglutide|mesh-list
154084791|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154084792|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084793|NCT00734474|Incretins|incretins|mesh-ancestor
154084794|NCT00734474|Hormones|hormones|mesh-ancestor
154084795|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084796|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154084801|NCT00583362|Belimumab|belimumab|mesh-list
154084824|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
154084826|NCT02568111|Interferon-beta|interferon-beta|mesh-list
154084827|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
154084828|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154084829|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084830|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
154084831|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084832|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
154084833|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084834|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154084835|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154084836|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154084837|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154084838|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
154084839|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084840|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084841|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154084842|NCT00785291|Paclitaxel|paclitaxel|mesh-list
154084843|NCT00785291|Epothilones|epothilones|mesh-list
154084844|NCT00785291|Epothilone B|epothilone b|mesh-list
154084845|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154084846|NCT00785291|Bevacizumab|bevacizumab|mesh-list
154084847|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154084848|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
154084873|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
154084874|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
154084875|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084876|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
154084877|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
154084878|NCT04063839|Grazoprevir|grazoprevir|mesh-list
154084879|NCT04063839|Ledipasvir|ledipasvir|mesh-list
154084880|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154084881|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
154084882|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084883|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
154084884|NCT00785213|Quinine|quinine|mesh-list
154084885|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154084886|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084887|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
154084888|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154084889|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154084890|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084891|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154084892|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154084893|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084894|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084896|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
154084897|NCT02583594|Loratadine|loratadine|mesh-list
154084898|NCT02583594|Acyclovir|acyclovir|mesh-list
154084899|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
154084900|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
154084901|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
154084902|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084924|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084925|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084927|NCT00740415|Rituximab|rituximab|mesh-list
154084928|NCT00740415|Bortezomib|bortezomib|mesh-list
154084929|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154084930|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154084931|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
154084932|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
154084933|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084934|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084935|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154084936|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
154084937|NCT00740415|Hormones|hormones|mesh-ancestor
154084938|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154084939|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154084940|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154084941|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154084942|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
154084943|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154084944|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154084945|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
154084946|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084947|NCT00734162|Tenofovir|tenofovir|mesh-list
154084948|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
154084949|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154084950|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154084951|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154084952|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154084953|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084954|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154084955|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154084956|NCT00740493|Warfarin|warfarin|mesh-list
154084957|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
154084962|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154084963|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154084965|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154084966|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154084967|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154084968|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154084969|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154084970|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154084971|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154084972|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154084973|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154084974|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
154084975|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154084976|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154084977|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154084978|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
154084979|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154084980|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
154085018|NCT02568033|Pemetrexed|pemetrexed|mesh-list
154085019|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154085020|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085021|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
154085022|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
153725427|NCT00117182|Budesonide|budesonide|mesh-list
154085023|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
154085024|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408222|NCT03984656|Lidocaine|lidocaine|mesh-list
154085025|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085026|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154085027|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154085028|NCT00582972|Omeprazole|omeprazole|mesh-list
154085029|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154085030|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154085031|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154085032|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085033|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085034|NCT05224401|Amoxicillin|amoxicillin|mesh-list
154085035|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
154085036|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154085037|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
154085038|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
154085039|NCT05224401|Ertapenem|ertapenem|mesh-list
154085040|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
154085041|NCT05224401|Trimethoprim|trimethoprim|mesh-list
154085042|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
154085043|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154085066|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085067|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
154085068|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085069|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085070|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
154085071|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085072|NCT04366908|Calcifediol|calcifediol|mesh-list
154085073|NCT04366908|Vitamins|vitamins|mesh-ancestor
154085074|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
154085075|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085076|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154085077|NCT00711243|Docetaxel|docetaxel|mesh-list
154085078|NCT00711243|Fluorouracil|fluorouracil|mesh-list
154085079|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
154085080|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085081|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
154085082|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
154085083|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154085084|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085085|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
154085086|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154085087|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154085088|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
154085089|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085090|NCT04366518|Scopolamine|scopolamine|mesh-list
154085091|NCT04366518|Rivastigmine|rivastigmine|mesh-list
154085118|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085119|NCT00741117|Bilirubin|bilirubin|mesh-list
154085120|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
154085121|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085122|NCT00741117|Protective Agents|protective agents|mesh-ancestor
154085123|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085124|NCT00732992|Pemetrexed|pemetrexed|mesh-list
154085125|NCT00732992|Sunitinib|sunitinib|mesh-list
154085126|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085127|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085128|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085129|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154085130|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154085131|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085132|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154085133|NCT00732992|Growth Substances|growth substances|mesh-ancestor
154085134|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085178|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154085179|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154085181|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
154085182|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154085183|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
154085184|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
154085185|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
154085186|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085187|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085188|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154085189|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154085190|NCT05742243|Insulin|insulin|mesh-list
154085191|NCT05742243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154085192|NCT05742243|Abatacept|abatacept|mesh-list
154085193|NCT05742243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154085194|NCT05742243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085195|NCT05742243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154085198|NCT05742243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085233|NCT00738530|Growth Substances|growth substances|mesh-ancestor
154085234|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085235|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
154085236|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
154085237|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085238|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
154085239|NCT00711009|Ritonavir|ritonavir|mesh-list
154085240|NCT00711009|Lopinavir|lopinavir|mesh-list
154085241|NCT00711009|Tenofovir|tenofovir|mesh-list
154085242|NCT00711009|Emtricitabine|emtricitabine|mesh-list
154085243|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154085244|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
154085245|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154085246|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154085247|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
154085248|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085249|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085250|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154085251|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154085252|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
154085253|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085254|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154085258|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154085286|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085287|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085289|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085290|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085291|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
154085292|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154085293|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085294|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085295|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154085296|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085297|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154085298|NCT04062357|Lidocaine|lidocaine|mesh-list
154085299|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085300|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
154085301|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085302|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085303|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
154085304|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085305|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154085306|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154085307|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154085308|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085309|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085310|NCT05190120|Ropivacaine|ropivacaine|mesh-list
154085311|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085312|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
154085313|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085314|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085315|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
154085316|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085325|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
154085326|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408537|NCT00361868|Metformin|metformin|mesh-list
154085327|NCT02581176|Apixaban|apixaban|mesh-list
154085328|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154085329|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
154085330|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154085331|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
154085332|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085333|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085334|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
154085335|NCT00697593|Antibodies|antibodies|mesh-list
154085336|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154085337|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
154085338|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085339|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154085340|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154085341|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154085342|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085343|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085344|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154085345|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085346|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085347|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
154085375|NCT04137354|Vitamin A|vitamin a|mesh-list
154085376|NCT04137354|Iron|iron|mesh-list
154085377|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
154085378|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
154085379|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085380|NCT04137354|Trace Elements|trace elements|mesh-ancestor
154085381|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
154085382|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085383|NCT04137354|Protective Agents|protective agents|mesh-ancestor
154085384|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154085385|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085386|NCT04902729|Oxytocin|oxytocin|mesh-list
154085387|NCT04902729|Carbetocin|carbetocin|mesh-list
154085388|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
154085389|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154085390|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085391|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
154085392|NCT00698685|Pentostatin|pentostatin|mesh-list
154085393|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085394|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085395|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154085396|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085397|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085398|NCT00737438|Bevacizumab|bevacizumab|mesh-list
154085399|NCT00737438|Docetaxel|docetaxel|mesh-list
154085400|NCT00737438|Capecitabine|capecitabine|mesh-list
153408610|NCT03674294|Aprepitant|aprepitant|mesh-list
154085401|NCT00737438|Irinotecan|irinotecan|mesh-list
154085427|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085428|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
154085429|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154085430|NCT00737048|Narcotics|narcotics|mesh-ancestor
154085431|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085432|NCT02593448|Anesthetics|anesthetics|mesh-list
154085433|NCT02593448|Propofol|propofol|mesh-list
154085434|NCT02593448|Sevoflurane|sevoflurane|mesh-list
154085435|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085436|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085437|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154085438|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154085439|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
154085440|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154085441|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154085442|NCT02592746|Capecitabine|capecitabine|mesh-list
154085443|NCT02592746|Palbociclib|palbociclib|mesh-list
154085444|NCT02592746|Leuprolide|leuprolide|mesh-list
154085445|NCT02592746|Exemestane|exemestane|mesh-list
154085446|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154085447|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
154085480|NCT02580006|Hematinics|hematinics|mesh-ancestor
154085481|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154085482|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154085483|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085484|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
154085485|NCT02787642|Olaparib|olaparib|mesh-list
154085486|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154085487|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085488|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085489|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085490|NCT04075188|Aflibercept|aflibercept|mesh-list
154085491|NCT04075188|Verteporfin|verteporfin|mesh-list
154085492|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085493|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154085494|NCT04075188|Growth Substances|growth substances|mesh-ancestor
154085495|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085496|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
154085497|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085498|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154085499|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
154085500|NCT00726986|Etoposide|etoposide|mesh-list
154085501|NCT00726986|Sorafenib|sorafenib|mesh-list
154085502|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085503|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154085531|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085532|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154085533|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085534|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154085535|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085536|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
154085537|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085538|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085539|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154085540|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154085541|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
154085542|NCT02566707|Lamivudine|lamivudine|mesh-list
154085543|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154085544|NCT02566707|Dolutegravir|dolutegravir|mesh-list
154085545|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154085546|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154085547|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085548|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085549|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
154085550|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085551|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154085552|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154085553|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154085555|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
154085582|NCT00730028|Clindamycin|clindamycin|mesh-list
154085583|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
154085584|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
154085585|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154085586|NCT00730028|Trimethoprim|trimethoprim|mesh-list
154085587|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
154085588|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154085589|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085590|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154085591|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085592|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085593|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154085594|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
154085595|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154085596|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154085597|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154085598|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154085599|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154085600|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154085601|NCT04088084|Palmidrol|palmidrol|mesh-list
154085602|NCT04088084|Analgesics|analgesics|mesh-ancestor
154085603|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
154085604|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085605|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085606|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154085607|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154085608|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154085609|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154085610|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
154085616|NCT04088084|Hormones|hormones|mesh-ancestor
154085624|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085625|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
154085626|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085627|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154085628|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154085629|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154085630|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085631|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085632|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154085633|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154085634|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
154085635|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085636|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154085637|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154085638|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
154085639|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154085640|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
154085641|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
154085642|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
154085643|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154085644|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
154085645|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
154085646|NCT00918320|Temozolomide|temozolomide|mesh-list
154085647|NCT00918320|Topotecan|topotecan|mesh-list
154085648|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154085649|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
154085650|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085651|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085652|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154085668|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085669|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154085670|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154085671|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154085672|NCT00729326|Exenatide|exenatide|mesh-list
154085673|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154085674|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085675|NCT00729326|Incretins|incretins|mesh-ancestor
154085676|NCT00729326|Hormones|hormones|mesh-ancestor
154085677|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154085678|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154085679|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
154085684|NCT02565303|Ropivacaine|ropivacaine|mesh-list
154085731|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154085732|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085733|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154085734|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154085735|NCT02565693|Analgesics|analgesics|mesh-ancestor
154085736|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
154085737|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085738|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154085739|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154085740|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154085741|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154085742|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085743|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154085744|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154085745|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085746|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
154085747|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154085748|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154085749|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154085750|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
154085751|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085752|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154085753|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
154085754|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154085755|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
154085756|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
154085757|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154085777|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
154085778|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085779|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154085780|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154085781|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154085782|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153343420|NCT00003202|Gemcitabine|gemcitabine|mesh-list
154085783|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085784|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154085785|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154085786|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
154085787|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085788|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154085789|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154085790|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
154085791|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154085792|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
154085793|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
154085794|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
154085795|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154085796|NCT02592980|Warfarin|warfarin|mesh-list
154085797|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
154085829|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
154085830|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
154085831|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085832|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085833|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
154085834|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085835|NCT00724958|Infliximab|infliximab|mesh-list
154085836|NCT00724958|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154085837|NCT00724958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154085838|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
154085839|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154085840|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154085841|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
154085842|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154085843|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
154085844|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085845|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
154085846|NCT04088006|Protective Agents|protective agents|mesh-ancestor
154085847|NCT00695565|Clonidine|clonidine|mesh-list
154085848|NCT00695565|Analgesics|analgesics|mesh-ancestor
154085849|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
154085850|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085851|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085852|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154085853|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
154085854|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
154085855|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154085856|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154085857|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154085875|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085876|NCT02592278|Listerine|listerine|mesh-list
154085877|NCT02592278|Fluorides|fluorides|mesh-list
154085878|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
154085879|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
154085880|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
154085881|NCT02592278|Protective Agents|protective agents|mesh-ancestor
154085882|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085883|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154085884|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085885|NCT00695019|Interferons|interferons|mesh-list
154085886|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
154085887|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
154085888|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154085889|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085890|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
154085891|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085892|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
154085893|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085894|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154085895|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
154085896|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085897|NCT00742911|Copper|copper|mesh-list
154085898|NCT00742911|Disulfiram|disulfiram|mesh-list
154085899|NCT00742911|Trace Elements|trace elements|mesh-ancestor
154085929|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154085930|NCT00694551|Vaccines|vaccines|mesh-list
154085931|NCT00694551|Poly ICLC|poly iclc|mesh-list
154085932|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
154085933|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085934|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
154085935|NCT00694551|Laxatives|laxatives|mesh-ancestor
154085936|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154085937|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
154085938|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154085939|NCT02603705|Oxycodone|oxycodone|mesh-list
154085940|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154085941|NCT02603705|Narcotics|narcotics|mesh-ancestor
154085942|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154085943|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085944|NCT02603705|Analgesics|analgesics|mesh-ancestor
154085945|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
154085946|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154085947|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154085948|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
154085949|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154085950|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085951|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154085952|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154085953|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085954|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085955|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
154085956|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085957|NCT00915785|Azacitidine|azacitidine|mesh-list
154085958|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154085959|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
154085960|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085961|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085969|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154085970|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085971|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
154085972|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154085973|NCT00720356|Bevacizumab|bevacizumab|mesh-list
154085974|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154085975|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154085976|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154085977|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154085978|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154085979|NCT00720356|Growth Substances|growth substances|mesh-ancestor
154085980|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154085981|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
154085982|NCT00720356|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154085983|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154085984|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154085985|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154085986|NCT00745953|Valsartan|valsartan|mesh-list
154085987|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154085988|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154085989|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154085992|NCT00745953|Diuretics|diuretics|mesh-ancestor
154086019|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154086020|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086021|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154086022|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
154086023|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154086024|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
154086025|NCT00720122|Insulin|insulin|mesh-list
154086026|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154086027|NCT00720122|Mitogens|mitogens|mesh-list
154086028|NCT00720122|Mecasermin|mecasermin|mesh-list
154086029|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154086030|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086031|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
154086032|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086033|NCT00720122|Growth Substances|growth substances|mesh-ancestor
154086034|NCT00743847|Varenicline|varenicline|mesh-list
154086035|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154086078|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154086079|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154086080|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
154086081|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154086082|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086083|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154086084|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
154086085|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154086086|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086087|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086088|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086089|NCT01090089|Dexamethasone|dexamethasone|mesh-list
154086090|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
154086091|NCT01090089|Lenalidomide|lenalidomide|mesh-list
154086093|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086094|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
154086095|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
154086096|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086097|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086098|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154086099|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
154086100|NCT01090089|Hormones|hormones|mesh-ancestor
154086101|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086102|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154086104|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
154086128|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154086129|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086130|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154086132|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
154086133|NCT00744549|Vitamins|vitamins|mesh-list
154086134|NCT00744549|Vitamin E|vitamin e|mesh-list
154086135|NCT00744549|Selenium|selenium|mesh-list
154086136|NCT00744549|Lycopene|lycopene|mesh-list
154086137|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
154086138|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086139|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154086140|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154086141|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
154086142|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086190|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086192|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
154086193|NCT00717236|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154086194|NCT00717236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086195|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154086196|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
154086197|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086198|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086199|NCT04085354|Vitamins|vitamins|mesh-list
154086200|NCT04085354|Folic Acid|folic acid|mesh-list
154086224|NCT00688545|Celecoxib|celecoxib|mesh-list
154086258|NCT00741585|Quinapril|quinapril|mesh-list
154086259|NCT00741585|Lercanidipine|lercanidipine|mesh-list
154086260|NCT00741585|Manidipine|manidipine|mesh-list
154086261|NCT00741585|Doxazosin|doxazosin|mesh-list
154086262|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154086263|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086264|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086265|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154086266|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086267|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
154086268|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154086269|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154086270|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154086271|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154086272|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
154086273|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086274|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
154086275|NCT00741585|Protective Agents|protective agents|mesh-ancestor
154086276|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154086277|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154086278|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154086279|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
154086280|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086281|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154086282|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154086283|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
154086284|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
154086285|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086286|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154086287|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
154086288|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
154086289|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154086290|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154086299|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154086300|NCT00741663|Furosemide|furosemide|mesh-list
154086301|NCT00741663|Spironolactone|spironolactone|mesh-list
153343827|NCT00086138|Sertraline|sertraline|mesh-list
154086302|NCT00741663|Diuretics|diuretics|mesh-ancestor
154086303|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
154086304|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086305|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154086306|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086307|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086308|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154086309|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
154086310|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086311|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154086312|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
154086313|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154086315|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154086348|NCT00747279|Insulin|insulin|mesh-list
154086354|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086355|NCT00742287|Protective Agents|protective agents|mesh-ancestor
154086356|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086357|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154086358|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154086359|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086360|NCT00747669|Lidocaine|lidocaine|mesh-list
154086361|NCT00747669|Tetracaine|tetracaine|mesh-list
154086362|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
154086363|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
154086364|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086365|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086366|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
154086367|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086368|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154086369|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154086414|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086415|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
154086416|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086417|NCT04085120|Dexamethasone|dexamethasone|mesh-list
154086418|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
154086419|NCT04085120|Lidocaine|lidocaine|mesh-list
154086420|NCT04085120|Ropivacaine|ropivacaine|mesh-list
154086421|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086422|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
154086423|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
154086424|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086425|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086426|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154086427|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
154086428|NCT04085120|Hormones|hormones|mesh-ancestor
154086429|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086430|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154086431|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086432|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
154086467|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154086468|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154086469|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086470|NCT00716456|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154086471|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154086535|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086536|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086537|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086538|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
154086539|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154086540|NCT00748059|Propranolol|propranolol|mesh-list
154086541|NCT00748059|Atropine|atropine|mesh-list
154086542|NCT00748059|Clonidine|clonidine|mesh-list
154086543|NCT00748059|Nitroprusside|nitroprusside|mesh-list
154086544|NCT00748059|Methyldopa|methyldopa|mesh-list
154086545|NCT00748059|Phenylephrine|phenylephrine|mesh-list
154086546|NCT00748059|Isoproterenol|isoproterenol|mesh-list
154086547|NCT00748059|Metoclopramide|metoclopramide|mesh-list
154086548|NCT00748059|Yohimbine|yohimbine|mesh-list
154086549|NCT00748059|Tyramine|tyramine|mesh-list
154086550|NCT00748059|Edrophonium|edrophonium|mesh-list
154086551|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154086552|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154086553|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
154086596|NCT00748059|Antidotes|antidotes|mesh-ancestor
154086597|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154086598|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086599|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
154086600|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154086601|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086602|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086603|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154086604|NCT00576381|Analgesics|analgesics|mesh-ancestor
154086605|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
154086606|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086607|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154086613|NCT02562417|Dexamethasone|dexamethasone|mesh-list
154086659|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154086660|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086661|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086662|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154086663|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
154086664|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154086665|NCT00684567|Temozolomide|temozolomide|mesh-list
154086666|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154086667|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
154086668|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086669|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086670|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154086671|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154086672|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154086673|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086674|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086678|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
154086714|NCT00687297|Carboplatin|carboplatin|mesh-list
154086715|NCT00687297|Docetaxel|docetaxel|mesh-list
154086716|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086717|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
154086718|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
154086719|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
154086720|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086721|NCT00684177|Retapamulin|retapamulin|mesh-list
154086722|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154086723|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086724|NCT00752661|Tramadol|tramadol|mesh-list
154086725|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154086726|NCT00752661|Narcotics|narcotics|mesh-ancestor
154086727|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154086728|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086729|NCT00752661|Analgesics|analgesics|mesh-ancestor
154086730|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
154086731|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086732|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
154086733|NCT00576303|Hematinics|hematinics|mesh-ancestor
154086734|NCT00752739|Selenium|selenium|mesh-list
154086735|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
154086739|NCT00752739|Trace Elements|trace elements|mesh-ancestor
154086770|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154086771|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
154086772|NCT00755859|Hormones|hormones|mesh-ancestor
154086773|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154086774|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154086775|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154086776|NCT00755859|Protective Agents|protective agents|mesh-ancestor
154086777|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
154086778|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
154086779|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086780|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154086781|NCT00686517|Interferons|interferons|mesh-list
154086782|NCT00686517|Ribavirin|ribavirin|mesh-list
154086783|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
154086784|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
154086785|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154086786|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086787|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
154086788|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154086825|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
154086826|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086827|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086828|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
154086829|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086830|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154086831|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154086832|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
154086833|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086834|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154086836|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086837|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
154086838|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
154086839|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
154086840|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086885|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154086886|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
154086887|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086888|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086889|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154086890|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154086891|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
154086892|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
154086893|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
154086894|NCT00753207|Epirubicin|epirubicin|mesh-list
154086895|NCT00753207|Lapatinib|lapatinib|mesh-list
154086896|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154086897|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086898|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154086899|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154086900|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086901|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086902|NCT00753207|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154086903|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154086904|NCT00715910|Vaccines|vaccines|mesh-list
154086905|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
154086906|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086907|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154086908|NCT00715676|Vitamins|vitamins|mesh-ancestor
154086909|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
154086935|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154086936|NCT00715520|Methylphenidate|methylphenidate|mesh-list
154086937|NCT00715520|Amphetamine|amphetamine|mesh-list
154086938|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154086939|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154086940|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154086941|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154086942|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154086943|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154086944|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
154086945|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154086946|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154086947|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154086948|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154086949|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086950|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
154086951|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
154086952|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154086989|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154086990|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
154086991|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154086992|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
154086993|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
154086994|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
154086995|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154086996|NCT00715208|Prednisone|prednisone|mesh-list
154086997|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
154086998|NCT00715208|Rituximab|rituximab|mesh-list
154086999|NCT00715208|Doxorubicin|doxorubicin|mesh-list
154087000|NCT00715208|Bortezomib|bortezomib|mesh-list
154087001|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087002|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
154087003|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087004|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087005|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154087049|NCT00918554|Methotrexate|methotrexate|mesh-list
154087050|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154087051|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
154087052|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154087053|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725457|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
154087054|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154087055|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
154087056|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087058|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
154087059|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087060|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154087061|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087062|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
154087063|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087064|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154087065|NCT02590016|Insulin|insulin|mesh-list
154087107|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154087108|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154087109|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
154087110|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087111|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087112|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154087113|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154087114|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
154087115|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087116|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154087117|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154087118|NCT00916253|Modafinil|modafinil|mesh-list
154087119|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154087120|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087121|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154087142|NCT04101929|Irinotecan|irinotecan|mesh-list
154087164|NCT00751257|Protective Agents|protective agents|mesh-ancestor
154087165|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087166|NCT00751257|Antidotes|antidotes|mesh-ancestor
154087167|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
154087168|NCT00757185|Testosterone|testosterone|mesh-list
154087169|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
154087170|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
154087171|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154087172|NCT00757185|Ganirelix|ganirelix|mesh-list
154087173|NCT00757185|Androgens|androgens|mesh-ancestor
154087174|NCT00757185|Hormones|hormones|mesh-ancestor
154087175|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087176|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087177|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154087178|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087179|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
154087180|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
154087181|NCT00751491|Clopidogrel|clopidogrel|mesh-list
154087182|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154087183|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154087184|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154087185|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154087217|NCT00757731|Milnacipran|milnacipran|mesh-list
154087218|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
154087219|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154087220|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154087221|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154087222|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087223|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087224|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087225|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087226|NCT00757731|Analgesics|analgesics|mesh-ancestor
154087227|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
154087228|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087229|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
154087230|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154087231|NCT00757809|Neratinib|neratinib|mesh-list
154087232|NCT00757809|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154087233|NCT00757809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087234|NCT00757809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087235|NCT00757809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087236|NCT00753909|Paclitaxel|paclitaxel|mesh-list
154087237|NCT00753909|Bevacizumab|bevacizumab|mesh-list
154087238|NCT00753909|Carboplatin|carboplatin|mesh-list
154087239|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154087240|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087241|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
154087265|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087267|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
154087268|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087269|NCT00773747|Bortezomib|bortezomib|mesh-list
154087270|NCT00773747|Vorinostat|vorinostat|mesh-list
154087271|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087272|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154087273|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087274|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087275|NCT00784277|Oxycodone|oxycodone|mesh-list
154087276|NCT00784277|Tapentadol|tapentadol|mesh-list
154087277|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154087278|NCT00784277|Narcotics|narcotics|mesh-ancestor
154087279|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153410477|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
154087281|NCT00784277|Analgesics|analgesics|mesh-ancestor
154087323|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154087324|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154087325|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
154087326|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087327|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
154087329|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087330|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087331|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154087332|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087333|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
154087334|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
154087335|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087336|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154087337|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154087338|NCT00758199|Protective Agents|protective agents|mesh-ancestor
154087339|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154087340|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154087341|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154087342|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154087343|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087344|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087345|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154087346|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
154087347|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154087348|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154087349|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154087370|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087371|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154087372|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087373|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154087374|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154087375|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
154087376|NCT05428293|Acetaminophen|acetaminophen|mesh-list
154087377|NCT05428293|Ibuprofen|ibuprofen|mesh-list
154087378|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087379|NCT05428293|Analgesics|analgesics|mesh-ancestor
154087380|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
154087381|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087382|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087383|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
154087384|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154087385|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087386|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087387|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153725464|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
154087388|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087389|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087390|NCT05427825|Anesthetics|anesthetics|mesh-list
154087393|NCT00680121|Benphothiamine|benphothiamine|mesh-list
154087421|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
154087422|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
154087423|NCT00584870|Naproxen|naproxen|mesh-list
154087424|NCT00584870|Tanezumab|tanezumab|mesh-list
154087425|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154087426|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087427|NCT00584870|Analgesics|analgesics|mesh-ancestor
154087428|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
154087429|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087430|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087431|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087432|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087433|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
154087434|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154087435|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087436|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087437|NCT00679341|Docetaxel|docetaxel|mesh-list
154087438|NCT00679341|Trastuzumab|trastuzumab|mesh-list
154087439|NCT00679341|Maytansine|maytansine|mesh-list
154087440|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154087441|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087442|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
154087443|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087444|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
154087445|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087446|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154087447|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154087448|NCT00679341|Immunotoxins|immunotoxins|mesh-ancestor
154087449|NCT00679341|Immunoconjugates|immunoconjugates|mesh-ancestor
154087450|NCT00679341|Immunologic Factors|immunologic factors|mesh-ancestor
154087451|NCT00679341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087452|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
154087453|NCT00680043|Hematinics|hematinics|mesh-ancestor
154087454|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154087455|NCT00682539|Triamcinolone|triamcinolone|mesh-list
154087456|NCT00682539|Bevacizumab|bevacizumab|mesh-list
154087462|NCT00682539|Growth Substances|growth substances|mesh-ancestor
154087463|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087464|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
154087465|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087466|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
154087467|NCT00682539|Hormones|hormones|mesh-ancestor
154087468|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154087469|NCT00682461|Nicotine|nicotine|mesh-list
154087470|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154087471|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
154087472|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087473|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087474|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154087475|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154087476|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
154087477|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087478|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087479|NCT00921765|Ketamine|ketamine|mesh-list
154087480|NCT00921765|Naloxone|naloxone|mesh-list
154087481|NCT00921765|Analgesics|analgesics|mesh-ancestor
154087482|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
154087483|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087484|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087514|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154087515|NCT00919880|Carboplatin|carboplatin|mesh-list
154087516|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154087517|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087518|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
154087519|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
154087520|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
154087521|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087522|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
154087523|NCT00755313|Carboplatin|carboplatin|mesh-list
154087524|NCT00755313|Docetaxel|docetaxel|mesh-list
154087525|NCT00755313|Doxorubicin|doxorubicin|mesh-list
154087526|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154087527|NCT00755313|Trastuzumab|trastuzumab|mesh-list
154087528|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154087529|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153730439|NCT00404508|Hydralazine|hydralazine|mesh-list
153730440|NCT00404508|Valproic Acid|valproic acid|mesh-list
153730441|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
154087563|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154087564|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154087565|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087566|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087567|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154087568|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154087569|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154087570|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154087571|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154087572|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
154087573|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
154087575|NCT00919022|Cyproterone|cyproterone|mesh-list
154087620|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154087621|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154087622|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087623|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087624|NCT02559141|Dobutamine|dobutamine|mesh-list
154087625|NCT02559141|Norepinephrine|norepinephrine|mesh-list
154087626|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154087627|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154087628|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
154087629|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087630|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087631|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087681|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
154087683|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
154087684|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154087685|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154087686|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154087687|NCT00678561|Tofacitinib|tofacitinib|mesh-list
154087688|NCT00678561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154087689|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087690|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087691|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087692|NCT04081376|Hydromorphone|hydromorphone|mesh-list
154087693|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154087694|NCT04081376|Narcotics|narcotics|mesh-ancestor
154087695|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154087696|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087697|NCT04081376|Analgesics|analgesics|mesh-ancestor
154087698|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
154087699|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087700|NCT02584400|Imidazole|imidazole|mesh-list
154087701|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087702|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087703|NCT04504071|Dacomitinib|dacomitinib|mesh-list
154087704|NCT04504071|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154087705|NCT04504071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154087706|NCT04504071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087729|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
154087730|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087731|NCT04585022|Cimetidine|cimetidine|mesh-list
154087732|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154087733|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154087734|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154087735|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
154087736|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
153725497|NCT00117260|Estrogens|estrogens|mesh-ancestor
154087737|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087738|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087792|NCT02677545|Aspirin|aspirin|mesh-list
154087793|NCT02677545|Clopidogrel|clopidogrel|mesh-list
154087794|NCT02677545|Ticagrelor|ticagrelor|mesh-list
154087795|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154087796|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087797|NCT02677545|Analgesics|analgesics|mesh-ancestor
154087798|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
154087799|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087800|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087801|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154087802|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154087803|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154087804|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154087805|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087828|NCT02559297|Desflurane|desflurane|mesh-list
154087854|NCT00673179|Ifosfamide|ifosfamide|mesh-list
154087855|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
154087856|NCT00673179|Razoxane|razoxane|mesh-list
154087857|NCT00673179|Sargramostim|sargramostim|mesh-list
154087858|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154087859|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154087860|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
154087861|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087862|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154087863|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154087864|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154087865|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154087916|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154087917|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
154087918|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154087919|NCT02585882|Fluorides|fluorides|mesh-list
154087920|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
154087921|NCT02585882|Protective Agents|protective agents|mesh-ancestor
154087922|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087923|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154087924|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154087925|NCT02584010|Silicon|silicon|mesh-list
154087926|NCT02584010|Trace Elements|trace elements|mesh-ancestor
154087927|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
154087928|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087929|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
154087930|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154087931|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154087932|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154087933|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154087934|NCT02582996|Acetaminophen|acetaminophen|mesh-list
154087935|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
154087936|NCT02582996|Metoclopramide|metoclopramide|mesh-list
154087937|NCT02582996|Caffeine|caffeine|mesh-list
154087938|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154087939|NCT02582996|Analgesics|analgesics|mesh-ancestor
154087940|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
154087941|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154087967|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
154087968|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154087969|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
154087970|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
154087971|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154087972|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154087973|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154087974|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
154087975|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154087976|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725509|NCT00474838|Metformin|metformin|mesh-list
154087977|NCT02585570|Protective Agents|protective agents|mesh-ancestor
154087979|NCT02583854|Coagulants|coagulants|mesh-ancestor
154087980|NCT00764907|Leucovorin|leucovorin|mesh-list
154087981|NCT00764907|Cytarabine|cytarabine|mesh-list
154087982|NCT00764907|Dexamethasone|dexamethasone|mesh-list
154087983|NCT00764907|Prednisone|prednisone|mesh-list
154087984|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
154088027|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154088028|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
154088029|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088030|NCT00764907|Antidotes|antidotes|mesh-ancestor
154088031|NCT00764907|Protective Agents|protective agents|mesh-ancestor
154088032|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
154088034|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
154088035|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
154088036|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
154088037|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
154088038|NCT02583698|Carvedilol|carvedilol|mesh-list
154088039|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154088040|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154088041|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
154088042|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088043|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088044|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088045|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154088046|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
154088047|NCT02583698|Protective Agents|protective agents|mesh-ancestor
154088048|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154088049|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088050|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154088051|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
154088052|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154088053|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154088054|NCT00762099|Pregabalin|pregabalin|mesh-list
154088055|NCT00762099|Analgesics|analgesics|mesh-ancestor
154088056|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
154088057|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088058|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088068|NCT00762255|Bevacizumab|bevacizumab|mesh-list
154088071|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154088072|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088073|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154088074|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154088075|NCT00762255|Growth Substances|growth substances|mesh-ancestor
154088076|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088077|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
154088078|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154088079|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154088080|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088081|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088082|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154088083|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154088084|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154088085|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088086|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
154088087|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154088088|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154088089|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154088090|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088091|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088092|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
154088093|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088094|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088117|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088118|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
154088119|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088120|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
154088121|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153725555|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154088122|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088123|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
154088124|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154088125|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088126|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
154088127|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088128|NCT00766155|Capecitabine|capecitabine|mesh-list
154088129|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
154088130|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154088131|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
154088132|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088133|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088134|NCT00762567|Phenylephrine|phenylephrine|mesh-list
154088135|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
154088136|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
154088137|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154088138|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
154088139|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
154088140|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088141|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088142|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
154088143|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154088144|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
154088145|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154088163|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088164|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154088165|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154088166|NCT00923234|Growth Substances|growth substances|mesh-ancestor
154088167|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
154088168|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088169|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154088171|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088172|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088174|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154088175|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154088176|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
154088177|NCT00674661|Vitamins|vitamins|mesh-ancestor
154088178|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
154088179|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088180|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154088181|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
154088183|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154088184|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
154088185|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088186|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088187|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154088188|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
154088189|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154088190|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154088199|NCT02558205|Liver Extracts|liver extracts|mesh-list
154088211|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088212|NCT00766857|Insulin|insulin|mesh-list
154088213|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154088214|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
154088215|NCT00766857|Exenatide|exenatide|mesh-list
154088216|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154088217|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088218|NCT00766857|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154088219|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154088220|NCT00766857|Incretins|incretins|mesh-ancestor
154088221|NCT00766857|Hormones|hormones|mesh-ancestor
154088222|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154088223|NCT02558283|Lidocaine|lidocaine|mesh-list
154088224|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
154088225|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
154088226|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088227|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088228|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
154088229|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088230|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154088231|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154088232|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154088233|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088234|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088235|NCT00759837|Bosutinib|bosutinib|mesh-list
154088236|NCT00759837|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154088259|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
154088261|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154088262|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088263|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088264|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154088265|NCT00671931|Analgesics|analgesics|mesh-ancestor
154088266|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
154088267|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088268|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154088269|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154088270|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154088271|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
154088272|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088273|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088274|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154088275|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
154088276|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
154088277|NCT00767559|PENTA|penta|mesh-list
154088278|NCT00767559|Warfarin|warfarin|mesh-list
154088279|NCT00767559|Fondaparinux|fondaparinux|mesh-list
154088280|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
154088281|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154088282|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
154088283|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154088284|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
154088311|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154088312|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088314|NCT00759993|Trace Elements|trace elements|mesh-ancestor
154088315|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
154088316|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088317|NCT00673881|Choline|choline|mesh-list
154088318|NCT00673881|Fenofibrate|fenofibrate|mesh-list
154088319|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154088320|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
154088321|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088322|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154088324|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154088325|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
154088326|NCT00763347|Alogliptin|alogliptin|mesh-list
154088327|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154088328|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088329|NCT00763347|Incretins|incretins|mesh-ancestor
154088330|NCT00763347|Hormones|hormones|mesh-ancestor
154088331|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154088332|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154088333|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
154088334|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088335|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088336|NCT00767871|Escitalopram|escitalopram|mesh-list
154088337|NCT00767871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154088338|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154088339|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088340|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088355|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154088356|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154088357|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154088358|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154088359|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154088360|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
154088361|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154088362|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154088363|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154088364|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088365|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088366|NCT00768183|Ethanol|ethanol|mesh-list
154088367|NCT00768183|Morphine|morphine|mesh-list
154088368|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154088369|NCT00768183|Narcotics|narcotics|mesh-ancestor
153725564|NCT00475189|Estrogens|estrogens|mesh-ancestor
154088370|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154088371|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088372|NCT00768183|Analgesics|analgesics|mesh-ancestor
154088373|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
154088374|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088406|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088407|NCT00768573|Urological Agents|urological agents|mesh-ancestor
154088409|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154088410|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154088411|NCT02558361|Analgesics|analgesics|mesh-ancestor
154088412|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
154088413|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088414|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088415|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154088416|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154088417|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154088418|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154088419|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088420|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088421|NCT02558595|Niacinamide|niacinamide|mesh-list
154088422|NCT02558595|Niacin|niacin|mesh-list
154088423|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
154088424|NCT02558595|Vitamins|vitamins|mesh-ancestor
154088425|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
154088426|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088427|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
154088460|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154088461|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154088462|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
154088463|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088464|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088465|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154088466|NCT02582372|Narcotics|narcotics|mesh-ancestor
154088467|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154088468|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154088469|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
154088470|NCT00768729|Sirolimus|sirolimus|mesh-list
154088471|NCT00768729|Azathioprine|azathioprine|mesh-list
154088472|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154088473|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088474|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154088475|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088476|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
154088477|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154088478|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
154088479|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088516|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154088517|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088519|NCT00770835|Pioglitazone|pioglitazone|mesh-list
154088520|NCT00770835|Glyburide|glyburide|mesh-list
154088521|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154088522|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088523|NCT00769587|Thalidomide|thalidomide|mesh-list
154088524|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154088525|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
154088526|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088527|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
154088528|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154088529|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088530|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154088531|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154088532|NCT00769587|Growth Substances|growth substances|mesh-ancestor
154088533|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
154088534|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088535|NCT00570921|Everolimus|everolimus|mesh-list
154088536|NCT00570921|Fulvestrant|fulvestrant|mesh-list
154088537|NCT00570921|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154088538|NCT00570921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154088539|NCT00570921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088540|NCT00570921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088541|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154088542|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
154088543|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088561|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154088562|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088563|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088564|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
154088565|NCT04353986|Ledipasvir|ledipasvir|mesh-list
154088566|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154088567|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
154088568|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088569|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154088570|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154088571|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088572|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154088573|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
154088574|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088575|NCT00771147|Sorafenib|sorafenib|mesh-list
154088576|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088577|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154088578|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088579|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088580|NCT04155710|Interleukin-2|interleukin-2|mesh-list
154088581|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088582|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154088583|NCT04155710|Analgesics|analgesics|mesh-ancestor
154088584|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
154088587|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154088609|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154088610|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
154088611|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154088612|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154088613|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154088614|NCT02557503|Fluorouracil|fluorouracil|mesh-list
154088615|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
154088616|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
154088617|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088618|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154088619|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088620|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154088621|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
154088622|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088624|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154088625|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
154088626|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088633|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
154088666|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088667|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
154088668|NCT02557269|Azelastine|azelastine|mesh-list
154088669|NCT02557269|Prednisolone|prednisolone|mesh-list
154088670|NCT02557269|Xylometazoline|xylometazoline|mesh-list
154088671|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154088672|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
154088673|NCT02557269|Hormones|hormones|mesh-ancestor
154088674|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154088675|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088676|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154088677|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088678|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
154088679|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088680|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
154088681|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154088682|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154088683|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154088684|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
154088685|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154088721|NCT00775905|Amlodipine|amlodipine|mesh-list
154088722|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154088723|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154088724|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088725|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088726|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154088727|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088728|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
154088729|NCT00772161|Methylphenidate|methylphenidate|mesh-list
154088730|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153725567|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
154088731|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088732|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154088733|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154088734|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088735|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088736|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
154088737|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088738|NCT00776139|Cetirizine|cetirizine|mesh-list
154088739|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154088740|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154088741|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154088742|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
154088743|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
154088744|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088745|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088746|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088765|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088766|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154088767|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154088768|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154088769|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088770|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088771|NCT00779649|Bisacodyl|bisacodyl|mesh-list
154088772|NCT00779649|Cathartics|cathartics|mesh-ancestor
154088773|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154088775|NCT00776217|Loratadine|loratadine|mesh-list
154088776|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
154088777|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
154088778|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154088779|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154088782|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
154088826|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
154088827|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154088828|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088829|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154088830|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
154088831|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
154088832|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154088833|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154088834|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
154088835|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
154088836|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154088837|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088838|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
154088839|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154088840|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154088841|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088842|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154088882|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154088883|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154088884|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154088885|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088886|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088887|NCT00776763|Bevacizumab|bevacizumab|mesh-list
154088888|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154088889|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088890|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154088891|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154088892|NCT00776763|Growth Substances|growth substances|mesh-ancestor
154088893|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088894|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
154088895|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
154088896|NCT00772551|Ezetimibe|ezetimibe|mesh-list
154088938|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
154088939|NCT00667719|Diuretics|diuretics|mesh-ancestor
154088940|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
154088941|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154088942|NCT00667719|Renin Inhibitors|renin inhibitors|mesh-ancestor
154088943|NCT00667719|Protease Inhibitors|protease inhibitors|mesh-ancestor
154088944|NCT00667719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154088945|NCT00669669|Plerixafor|plerixafor|mesh-list
154088946|NCT00669669|Temozolomide|temozolomide|mesh-list
154088947|NCT00669669|Carmustine|carmustine|mesh-list
154088948|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
154088949|NCT00669669|Lenograstim|lenograstim|mesh-list
154088950|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154088951|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
154088952|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154088953|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154088954|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
154088955|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154088956|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154088957|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154088959|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
154088995|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
154088996|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
154088997|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
154088998|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
154088999|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089000|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089001|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
154089002|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
154089003|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154089004|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154089005|NCT00467779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154089006|NCT00467779|Narcotics|narcotics|mesh-ancestor
154089007|NCT00467779|Analgesics|analgesics|mesh-ancestor
154089008|NCT00467779|Sensory System Agents|sensory system agents|mesh-ancestor
154089009|NCT00467779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089011|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154089012|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089013|NCT01021891|Insulin|insulin|mesh-list
154089051|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089052|NCT00777543|Protective Agents|protective agents|mesh-ancestor
154089053|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
154089054|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089055|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089056|NCT01022047|Budesonide|budesonide|mesh-list
154089057|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154089058|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154089059|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
154089060|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089061|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089062|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154089063|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
154089064|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
154089066|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089067|NCT01022125|Simeprevir|simeprevir|mesh-list
154089068|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
154089069|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089070|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
154089071|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089107|NCT01029613|Adalimumab|adalimumab|mesh-list
154089108|NCT01029613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154089109|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154089110|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089111|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
154089112|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
154089113|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089114|NCT03268057|Avelumab|avelumab|mesh-list
154089115|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154089116|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089117|NCT01033903|Misoprostol|misoprostol|mesh-list
154089118|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154089119|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
154089172|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154089173|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089174|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089175|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154089176|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154089177|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089178|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
154089179|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089180|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154089181|NCT00667095|Protective Agents|protective agents|mesh-ancestor
154089182|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154089183|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
154089184|NCT00777933|Cyclosporine|cyclosporine|mesh-list
154089185|NCT00777933|Tacrolimus|tacrolimus|mesh-list
154089186|NCT00777933|Cyclosporins|cyclosporins|mesh-list
154089187|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154089188|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
154089189|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089190|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154089191|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089192|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089228|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
154089229|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154089230|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
154089231|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089232|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154089233|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154089234|NCT00433381|Growth Substances|growth substances|mesh-ancestor
154089235|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089236|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
154089237|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
154089238|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154089239|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154089240|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089241|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089242|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154089243|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
154089244|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154089245|NCT00667017|Immunotoxins|immunotoxins|mesh-list
154089246|NCT00667017|Immunoconjugates|immunoconjugates|mesh-ancestor
154089247|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
154089248|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089249|NCT00781131|Pregabalin|pregabalin|mesh-list
154089250|NCT00781131|Analgesics|analgesics|mesh-ancestor
154089251|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
154089252|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154089253|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089254|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
154089255|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154089256|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154089273|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154089274|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154089275|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089276|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154089277|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154089278|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154089279|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089280|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089281|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
154089282|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
154089283|NCT00666705|Maraviroc|maraviroc|mesh-list
154089284|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154089285|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154089286|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
154089287|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089288|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154089289|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154089290|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089291|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089292|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154089295|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154089328|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089329|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154089330|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154089331|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
154089332|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089333|NCT00778791|Metformin|metformin|mesh-list
153345823|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
154089334|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154089335|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089336|NCT00774189|Clarithromycin|clarithromycin|mesh-list
154089337|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089338|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089339|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154089340|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089341|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089342|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154089343|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089344|NCT00774423|Riluzole|riluzole|mesh-list
154089345|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
154089346|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154089347|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154089348|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089349|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089350|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089351|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154089352|NCT00774423|Protective Agents|protective agents|mesh-ancestor
154089353|NCT00781521|Ofloxacin|ofloxacin|mesh-list
154089367|NCT00784485|Omalizumab|omalizumab|mesh-list
154089372|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154089373|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154089374|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
154089375|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089376|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089377|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089379|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154089380|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154089381|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089382|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089383|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154089384|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154089385|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
154089386|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089387|NCT00666237|Mitomycins|mitomycins|mesh-list
154089388|NCT00666237|Mitomycin|mitomycin|mesh-list
154089389|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154089390|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089391|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
154089392|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089393|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154089394|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089423|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154089424|NCT00774969|Metronidazole|metronidazole|mesh-list
154089425|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089426|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089427|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154089428|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154089430|NCT00785109|Vitamins|vitamins|mesh-ancestor
154089431|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
154089432|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089433|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154089434|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154089435|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089436|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
154089437|NCT00785109|Coagulants|coagulants|mesh-ancestor
154089438|NCT00662025|Capecitabine|capecitabine|mesh-list
154089439|NCT00662025|Sunitinib|sunitinib|mesh-list
154089440|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154089441|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
154089442|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089443|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089477|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154089478|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154089479|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154089480|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089481|NCT00785421|Leucovorin|leucovorin|mesh-list
154089482|NCT00785421|Folic Acid|folic acid|mesh-list
154089483|NCT00785421|Cisplatin|cisplatin|mesh-list
154089484|NCT00785421|Gemcitabine|gemcitabine|mesh-list
154089485|NCT00785421|Enoxaparin|enoxaparin|mesh-list
154089486|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
154089487|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
154089488|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089489|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154089490|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
154089491|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089492|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089493|NCT00785421|Antidotes|antidotes|mesh-ancestor
154089494|NCT00785421|Protective Agents|protective agents|mesh-ancestor
154089495|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
154089496|NCT00785421|Vitamins|vitamins|mesh-ancestor
154089497|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
154089498|NCT00785421|Hematinics|hematinics|mesh-ancestor
154089499|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
154089500|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154089501|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154089502|NCT00790179|Ropivacaine|ropivacaine|mesh-list
154089503|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
154089504|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
154089505|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089506|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089525|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
154089526|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154089527|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154089528|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089529|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089530|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089531|NCT00440947|Ritonavir|ritonavir|mesh-list
154089532|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154089533|NCT00440947|Lamivudine|lamivudine|mesh-list
154089534|NCT00440947|Abacavir|abacavir|mesh-list
154089535|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
154089536|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154089537|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154089587|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154089588|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154089589|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154089590|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089591|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089592|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
154089594|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154089595|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089596|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
154089597|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089598|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089599|NCT02581046|Dexamethasone|dexamethasone|mesh-list
154089600|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154089649|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089650|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089651|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154089652|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
154089653|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154089654|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154089655|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
154089656|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089657|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
154089658|NCT00440557|Hematinics|hematinics|mesh-ancestor
154089659|NCT01029847|Adalimumab|adalimumab|mesh-list
154089660|NCT01029847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154089661|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154089662|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089663|NCT02452268|Spartalizumab|spartalizumab|mesh-list
154089709|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154089710|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089711|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089712|NCT03087656|Levofloxacin|levofloxacin|mesh-list
154089713|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
154089714|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154089715|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089716|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089717|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154089718|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154089719|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089720|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089721|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089722|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154089723|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089724|NCT03087656|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154089725|NCT03087656|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154089726|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
154089727|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154089728|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089729|NCT04076228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154089731|NCT02580734|Melatonin|melatonin|mesh-list
154089759|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154089760|NCT00427999|Analgesics|analgesics|mesh-ancestor
154089761|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
154089762|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154089763|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154089764|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154089765|NCT04825652|Pluvicto|pluvicto|mesh-list
154089766|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154089767|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089768|NCT00661713|Vaccines|vaccines|mesh-list
154089769|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
154089770|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089771|NCT02578472|Zolpidem|zolpidem|mesh-list
154089772|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154089773|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154089774|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089775|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089776|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154089777|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
154089778|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
154089779|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089780|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089781|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154089782|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
154089783|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089806|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089807|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154089808|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154089809|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154089810|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
154089811|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154089812|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154089813|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154089814|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154089815|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089816|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154089817|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154089818|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089820|NCT02576288|Hormones|hormones|mesh-ancestor
154089821|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089822|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154089864|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154089866|NCT02576366|Voriconazole|voriconazole|mesh-list
154089867|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154089868|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
154089869|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154089870|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089871|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
154089872|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154089873|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154089874|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089875|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154089876|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154089877|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154089878|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154089879|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154089880|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154089881|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
154089882|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154089883|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089884|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154089885|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
154089886|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154089887|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154089888|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154089889|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154089890|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
154089907|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154089908|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
154089909|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154089910|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154089911|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154089912|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154089913|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
154089914|NCT00791271|Interferons|interferons|mesh-list
154089915|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
154089916|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
154089917|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154089918|NCT00791271|Decitabine|decitabine|mesh-list
154089919|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154089920|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
154089921|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154089943|NCT00440401|Thrombin|thrombin|mesh-list
154089967|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154089968|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154089969|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
154089970|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154089971|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154089972|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154089973|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154089974|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154089975|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154089984|NCT00665847|Etravirine|etravirine|mesh-list
154090035|NCT00786669|Camptothecin|camptothecin|mesh-list
154090036|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090037|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090038|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154090039|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154090040|NCT00786669|Growth Substances|growth substances|mesh-ancestor
154090041|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090042|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
154090043|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154090044|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154090045|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090046|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090047|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154090048|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
154090049|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
154090050|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
154090051|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154090052|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
154090053|NCT00786669|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154090054|NCT00786669|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154090055|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154090056|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090057|NCT00791739|Pregabalin|pregabalin|mesh-list
154090058|NCT00791739|Trazodone|trazodone|mesh-list
154090059|NCT00791739|Analgesics|analgesics|mesh-ancestor
154090060|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
154090061|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090062|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090063|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
154090064|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154090065|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154090066|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090067|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154090072|NCT00791739|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154090073|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154090074|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090075|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
154090076|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154090077|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
154090078|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
154090079|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
154090080|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154090081|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154090082|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090083|NCT00430573|Cycloserine|cycloserine|mesh-list
154090084|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154090085|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090086|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154090087|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
154090088|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154090089|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
154090090|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090091|NCT00783393|Temozolomide|temozolomide|mesh-list
154090092|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154090093|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
154090094|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090095|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090096|NCT00783471|Docetaxel|docetaxel|mesh-list
154090097|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154090098|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090099|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
154090100|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
154090113|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154090114|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
154090115|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
154090116|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090117|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
154090118|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090119|NCT02554695|Denosumab|denosumab|mesh-list
154090120|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154090121|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090122|NCT00792363|Irinotecan|irinotecan|mesh-list
154090123|NCT00792363|Panitumumab|panitumumab|mesh-list
154090124|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154090125|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154090126|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090127|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090128|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090129|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090130|NCT00425113|Metronidazole|metronidazole|mesh-list
154090131|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090132|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154090133|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154090134|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154090135|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
154090136|NCT03994783|Rituximab|rituximab|mesh-list
154090137|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
154090138|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154090139|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
154090140|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154090141|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090142|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090143|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
154090159|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154090160|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154090161|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154090162|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
154090163|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090164|NCT00663117|Naltrexone|naltrexone|mesh-list
154090165|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154090166|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154090167|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090168|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
154090169|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090170|NCT04072328|Midazolam|midazolam|mesh-list
154090171|NCT04072328|Propofol|propofol|mesh-list
154090172|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154090173|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090174|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090175|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154090176|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
154090177|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
154090178|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154090179|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154090180|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154090181|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154090182|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
154090183|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
154090213|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154090214|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
154090215|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
154090216|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154090217|NCT04074122|Protective Agents|protective agents|mesh-ancestor
154090218|NCT02578550|Tenofovir|tenofovir|mesh-list
154090219|NCT02578550|Emtricitabine|emtricitabine|mesh-list
154090220|NCT02578550|Darunavir|darunavir|mesh-list
154090221|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154090222|NCT02578550|Cobicistat|cobicistat|mesh-list
154090223|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154090224|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
154090225|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
154090226|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090227|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154090228|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154090229|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090230|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090231|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154090266|NCT00793221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090267|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154090268|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
154090269|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090270|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090271|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154090272|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090273|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154090274|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
154090275|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
154090276|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154090277|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154090278|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154090279|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154090280|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090281|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
154090282|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090283|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090284|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154090320|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090321|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154090322|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
154090323|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154090324|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154090325|NCT00709982|Hematinics|hematinics|mesh-ancestor
154090326|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
154090327|NCT00709982|Vitamins|vitamins|mesh-ancestor
154090328|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
154090329|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154090330|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154090331|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153413571|NCT02596022|Ketamine|ketamine|mesh-list
154090332|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
154090333|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154090334|NCT00710138|Vitamins|vitamins|mesh-list
154090335|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
154090336|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
154090337|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
154090338|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
154090339|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090340|NCT00710138|Hematinics|hematinics|mesh-ancestor
154090341|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
154090342|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090343|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090344|NCT00710216|Lamivudine|lamivudine|mesh-list
154090345|NCT00710216|Telbivudine|telbivudine|mesh-list
154090346|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154090350|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
154090367|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154090368|NCT00711308|Vitamin K|vitamin k|mesh-list
154090369|NCT00711308|Tinzaparin|tinzaparin|mesh-list
154090370|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154090371|NCT00711308|Dalteparin|dalteparin|mesh-list
154090372|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
154090373|NCT00711308|Vitamins|vitamins|mesh-ancestor
154090374|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
154090375|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090376|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154090377|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154090378|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090379|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
154090380|NCT00711308|Coagulants|coagulants|mesh-ancestor
154090381|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
154090382|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154090383|NCT02601911|Acetaminophen|acetaminophen|mesh-list
154090384|NCT02601911|Ketorolac|ketorolac|mesh-list
154090385|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154090386|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154090387|NCT02601911|Analgesics|analgesics|mesh-ancestor
154090388|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
154090389|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090390|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090391|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
154090392|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154090393|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154090394|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090395|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154090396|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090416|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
154090417|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154090418|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154090419|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090420|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154090422|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090423|NCT02577770|Caffeine|caffeine|mesh-list
154090424|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154090425|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090426|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154090427|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090428|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090429|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154090430|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154090431|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
154090432|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090433|NCT00129896|Docetaxel|docetaxel|mesh-list
154090434|NCT00129896|Doxorubicin|doxorubicin|mesh-list
154090435|NCT00129896|Trastuzumab|trastuzumab|mesh-list
154090436|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090437|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
154090438|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
154090439|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
154090440|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090441|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154090442|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154090443|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154090444|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090459|NCT00711698|Narcotics|narcotics|mesh-ancestor
154090460|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090461|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090462|NCT00711698|Analgesics|analgesics|mesh-ancestor
154090463|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
154090464|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090465|NCT00795171|Docetaxel|docetaxel|mesh-list
154090466|NCT00795171|Sunitinib|sunitinib|mesh-list
154090467|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090468|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
154090469|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
154090470|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
154090471|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090472|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154090473|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154090474|NCT00795171|Growth Substances|growth substances|mesh-ancestor
154090475|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090476|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
154090477|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154090478|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090479|NCT00711854|Rifampin|rifampin|mesh-list
154090480|NCT00711854|Linezolid|linezolid|mesh-list
154090481|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154090482|NCT00711854|Trimethoprim|trimethoprim|mesh-list
154090509|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090511|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154090512|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154090514|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
154090515|NCT03015792|Lenalidomide|lenalidomide|mesh-list
154090516|NCT03015792|Ichthammol|ichthammol|mesh-list
154090517|NCT03015792|BB 1101|bb 1101|mesh-list
154090518|NCT03015792|Ibrutinib|ibrutinib|mesh-list
154090519|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154090520|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
154090521|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
154090522|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090523|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090524|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154090525|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
154090526|NCT03015792|Hormones|hormones|mesh-ancestor
154090527|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154090528|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154090529|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090530|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
154090531|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090532|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090533|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
154090534|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154090560|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154090561|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154090562|NCT00712556|Fluorides|fluorides|mesh-list
154090563|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
154090564|NCT00712556|Protective Agents|protective agents|mesh-ancestor
154090565|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090566|NCT00772967|Naproxen|naproxen|mesh-list
154090567|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154090568|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154090569|NCT00772967|Analgesics|analgesics|mesh-ancestor
154090570|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
154090571|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090572|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090573|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154090574|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090575|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
154090576|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154090577|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090578|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090579|NCT00793377|Tamoxifen|tamoxifen|mesh-list
154090580|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
154090581|NCT00793377|Docetaxel|docetaxel|mesh-list
154090582|NCT00793377|Doxorubicin|doxorubicin|mesh-list
154090583|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154090584|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154090585|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
154090586|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090587|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090606|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154090607|NCT00662259|Alprazolam|alprazolam|mesh-list
154090608|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154090609|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090610|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090611|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154090612|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154090613|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154090614|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
154090615|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
154090616|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090617|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090618|NCT00712790|Sorafenib|sorafenib|mesh-list
154090619|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090620|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154090621|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090623|NCT00660699|Gemcitabine|gemcitabine|mesh-list
154090666|NCT00581360|Bortezomib|bortezomib|mesh-list
154090667|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154090668|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090669|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154090670|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154090671|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090672|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090673|NCT01650792|Aspirin|aspirin|mesh-list
154090674|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154090675|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154090676|NCT01650792|Analgesics|analgesics|mesh-ancestor
154090677|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
154090678|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090679|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090680|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154090681|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090682|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154090683|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154090688|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
154090720|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090721|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154090722|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
154090723|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154090725|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154090726|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154090727|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154090728|NCT00789711|Insulin|insulin|mesh-list
154090729|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154090730|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
154090731|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
154090732|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
154090733|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154090736|NCT00713726|Fentanyl|fentanyl|mesh-list
154090783|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
154090784|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090785|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090786|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154090787|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154090788|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154090789|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154090790|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090791|NCT00800709|Memantine|memantine|mesh-list
154090792|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154090793|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154090794|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
154090795|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090796|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090797|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090798|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154090799|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154090840|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154090841|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
154090842|NCT02345850|Methotrexate|methotrexate|mesh-list
154090843|NCT02345850|Tacrolimus|tacrolimus|mesh-list
154090844|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154090845|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
154090846|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090847|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090848|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154090849|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
154090850|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090851|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090852|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154090853|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154090854|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
154090855|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154090856|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154090857|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
154090858|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
154090859|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090860|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154090863|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
154090893|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154090894|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154090895|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
154090896|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090897|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090898|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154090899|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154090900|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
154090902|NCT00660309|Captopril|captopril|mesh-list
154090903|NCT00660309|Aliskiren|aliskiren|mesh-list
154090904|NCT00660309|Renin Inhibitors|renin inhibitors|mesh-ancestor
154090905|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
154090906|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090907|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090908|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154090909|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154090910|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154090911|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154090912|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
154090913|NCT04046133|Capecitabine|capecitabine|mesh-list
154090914|NCT04046133|Mitomycins|mitomycins|mesh-list
154090915|NCT04046133|Mitomycin|mitomycin|mesh-list
154090944|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090945|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090946|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154090947|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
154090948|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
154090949|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090950|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090951|NCT02575664|Buprenorphine|buprenorphine|mesh-list
154090952|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154090953|NCT02575664|Narcotics|narcotics|mesh-ancestor
154090954|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154090955|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090956|NCT02575664|Analgesics|analgesics|mesh-ancestor
154090957|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
154090958|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090959|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154090960|NCT00796497|Ondansetron|ondansetron|mesh-list
154090961|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
154090962|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
154090963|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090964|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090965|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154090966|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
154090967|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
154090968|NCT00796497|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154090969|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154090970|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
154090971|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154090972|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090973|NCT00801177|Necitumumab|necitumumab|mesh-list
154090974|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154090975|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154090976|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154090977|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
154090984|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154090985|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154090987|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154090988|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154090989|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154090990|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
154090991|NCT00579098|Atorvastatin|atorvastatin|mesh-list
154090992|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154090993|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154090994|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
154090995|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154090996|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154090997|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154090998|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154090999|NCT00772109|Vaccines|vaccines|mesh-list
154091000|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
154091001|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091002|NCT00801255|Lactams|lactams|mesh-list
153725670|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154091003|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154091004|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091005|NCT00794625|Valproic Acid|valproic acid|mesh-list
154091006|NCT00794625|Risperidone|risperidone|mesh-list
154091034|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091035|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154091036|NCT02577432|Narcotics|narcotics|mesh-ancestor
154091037|NCT02577432|Analgesics|analgesics|mesh-ancestor
154091038|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154091039|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154091040|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
154091041|NCT00794703|Itraconazole|itraconazole|mesh-list
154091042|NCT00794703|Micafungin|micafungin|mesh-list
154091043|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
154091044|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091045|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154091046|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154091047|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091048|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091049|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154091050|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
154091051|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091052|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091053|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154091054|NCT00772031|Topiramate|topiramate|mesh-list
154091055|NCT00772031|Propranolol|propranolol|mesh-list
154091086|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091088|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091089|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154091090|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091091|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091092|NCT00771953|Docetaxel|docetaxel|mesh-list
154091093|NCT00771953|Pemetrexed|pemetrexed|mesh-list
154091094|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091095|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
154091096|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
154091097|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
153783224|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
154091098|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091100|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154091101|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154091102|NCT00714584|Naltrexone|naltrexone|mesh-list
154091103|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154091144|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091145|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154091146|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154091147|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091148|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154091150|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154091151|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154091152|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091153|NCT00796887|Niacin|niacin|mesh-list
154091154|NCT00796887|Niacinamide|niacinamide|mesh-list
154091155|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
154091207|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154091208|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091209|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091210|NCT00718484|Doxorubicin|doxorubicin|mesh-list
154091211|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154091212|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
154091213|NCT00718484|Ifosfamide|ifosfamide|mesh-list
154091214|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154091215|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091216|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154091217|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154091218|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091219|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091220|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154091221|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
154091267|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
154091268|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091269|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154091270|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154091271|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154091272|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
154091273|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091274|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091275|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154091276|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
154091277|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
154091278|NCT00656799|Bromides|bromides|mesh-list
154091279|NCT00656799|Rocuronium|rocuronium|mesh-list
154091280|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
154091281|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154091282|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154091283|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154091284|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091285|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091286|NCT00764699|Mecasermin|mecasermin|mesh-list
154091287|NCT00764699|Growth Substances|growth substances|mesh-ancestor
154091288|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091289|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154091290|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154091291|NCT00844012|Estradiol|estradiol|mesh-list
154091292|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154091294|NCT00844012|Hormones|hormones|mesh-ancestor
154091314|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091316|NCT00836212|Lopinavir|lopinavir|mesh-list
154091317|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154091318|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154091319|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091320|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091321|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
153783227|NCT02213146|Insulin|insulin|mesh-list
154091322|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091323|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154091324|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154091325|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154091326|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154091327|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154091328|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154091329|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154091330|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154091331|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
154091332|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154091333|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154091365|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091366|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154091367|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154091368|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091369|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091370|NCT02601677|Fluoxetine|fluoxetine|mesh-list
154091371|NCT02601677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154091372|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154091373|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154091374|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091375|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091376|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
154091377|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091378|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154091379|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
154091380|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154091381|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154091382|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154091383|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091384|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154091393|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154091416|NCT00836368|Tocotrienols|tocotrienols|mesh-list
154091417|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
154091418|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
154091420|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
154091421|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091422|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
154091423|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091424|NCT00836368|Protective Agents|protective agents|mesh-ancestor
154091425|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
154091426|NCT00718796|Ubiquinone|ubiquinone|mesh-list
154091427|NCT00718796|Atorvastatin|atorvastatin|mesh-list
153347608|NCT01325311|Hormones|hormones|mesh-ancestor
154091428|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154091429|NCT00718796|Simvastatin|simvastatin|mesh-list
154091430|NCT00718796|Pravastatin|pravastatin|mesh-list
154091431|NCT00718796|Lovastatin|lovastatin|mesh-list
154091432|NCT00718796|L 647318|l 647318|mesh-list
154091433|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
154091434|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
154091435|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154091436|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
154091437|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091438|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154091439|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154091440|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091441|NCT00718796|Vitamins|vitamins|mesh-ancestor
154091442|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
154091443|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091444|NCT00844168|Sorafenib|sorafenib|mesh-list
154091445|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091446|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154091447|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091448|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091449|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
154091450|NCT00764465|Ritonavir|ritonavir|mesh-list
154091451|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
154091452|NCT00764465|Maraviroc|maraviroc|mesh-list
154091458|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154091459|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154091460|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
154091461|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091462|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154091463|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154091464|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154091465|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154091466|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154091467|NCT00655863|Pioglitazone|pioglitazone|mesh-list
154091468|NCT00655863|Alogliptin|alogliptin|mesh-list
154091469|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154091470|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091471|NCT00655863|Incretins|incretins|mesh-ancestor
154091472|NCT00655863|Hormones|hormones|mesh-ancestor
154091473|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091474|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154091475|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
154091476|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091477|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091478|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154091479|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
154091480|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154091481|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154091482|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091483|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091484|NCT00718952|Urological Agents|urological agents|mesh-ancestor
154091485|NCT00781937|Liraglutide|liraglutide|mesh-list
154091486|NCT00781937|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154091487|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154091488|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091489|NCT00781937|Incretins|incretins|mesh-ancestor
154091490|NCT00781937|Hormones|hormones|mesh-ancestor
154091491|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091495|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091496|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
154091497|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091499|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154091500|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154091501|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091502|NCT00842140|Metformin|metformin|mesh-list
154091503|NCT00842140|Spironolactone|spironolactone|mesh-list
154091504|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
154091505|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
154091506|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154091507|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091508|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154091509|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154091510|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
154091511|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091512|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154091513|NCT00842140|Diuretics|diuretics|mesh-ancestor
154091514|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
154091515|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154091516|NCT00806169|Triamcinolone|triamcinolone|mesh-list
154091517|NCT00806169|Bevacizumab|bevacizumab|mesh-list
154091518|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154091519|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091520|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154091521|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154091522|NCT00806169|Growth Substances|growth substances|mesh-ancestor
154091523|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091524|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
154091525|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091526|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
154091527|NCT00806169|Hormones|hormones|mesh-ancestor
154091528|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091534|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091535|NCT00802815|Etanercept|etanercept|mesh-list
154091536|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154091537|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154091538|NCT00802815|Analgesics|analgesics|mesh-ancestor
154091539|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
154091540|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091541|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091542|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091543|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154091544|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154091545|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091546|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
154091548|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
154091549|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154091550|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154091551|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091552|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091553|NCT04100759|Urological Agents|urological agents|mesh-ancestor
154091588|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154091589|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154091590|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
154091591|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091592|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154091593|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154091594|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
154091595|NCT00659373|Tamoxifen|tamoxifen|mesh-list
153725685|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
154091596|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154091597|NCT00659373|Exemestane|exemestane|mesh-list
154091598|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154091599|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
154091600|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154091601|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091602|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154091603|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091604|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154091605|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154091606|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154091642|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091643|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091644|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154091645|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154091646|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154091647|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154091648|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154091649|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154091650|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154091651|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154091652|NCT00439777|Enoxaparin|enoxaparin|mesh-list
154091653|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
154091654|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154091655|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
154091656|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154091657|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
154091658|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091659|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091660|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
154091661|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154091662|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154091663|NCT00842686|Bevacizumab|bevacizumab|mesh-list
154091664|NCT00842686|Capecitabine|capecitabine|mesh-list
154091665|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154091666|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091667|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154091668|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154091669|NCT00842686|Growth Substances|growth substances|mesh-ancestor
154091670|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091685|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091686|NCT00806481|Sevelamer|sevelamer|mesh-list
154091687|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
154091688|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
154091689|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091690|NCT00709436|Ketamine|ketamine|mesh-list
154091691|NCT00709436|Analgesics|analgesics|mesh-ancestor
154091692|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
154091693|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091694|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091695|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154091696|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154091697|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
154091698|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
154091699|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154091700|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154091701|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154091702|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091703|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091741|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
154091742|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154091743|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154091744|NCT00716612|Ubiquinone|ubiquinone|mesh-list
154091745|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
154091746|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
154091747|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091748|NCT00716612|Vitamins|vitamins|mesh-ancestor
154091749|NCT00842920|Simvastatin|simvastatin|mesh-list
154091750|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154091751|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154091752|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
154091753|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091754|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154091755|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154091756|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091757|NCT00842998|Trastuzumab|trastuzumab|mesh-list
154091758|NCT00842998|Lapatinib|lapatinib|mesh-list
154091759|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154091760|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091797|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091798|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091799|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154091800|NCT04766229|Gabapentin|gabapentin|mesh-list
154091801|NCT04766229|Citalopram|citalopram|mesh-list
154091802|NCT04766229|Analgesics|analgesics|mesh-ancestor
154091803|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
154091804|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091805|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091806|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
154091807|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154091808|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154091809|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154091810|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154091811|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154091812|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154091813|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154091814|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091815|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
154091816|NCT04766229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154091817|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154091818|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154091819|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
154091822|NCT04068506|Gabapentin|gabapentin|mesh-list
154091845|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
154091846|NCT00843154|Candesartan|candesartan|mesh-list
154091847|NCT00843154|Candesartan cilexetil|candesartan cilexetil|mesh-list
154091848|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154091849|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154091850|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154091851|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091853|NCT00429793|Temsirolimus|temsirolimus|mesh-list
154091854|NCT00429793|MTOR Inhibitors|mtor inhibitors|mesh-list
154091855|NCT00429793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154091856|NCT00429793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091857|NCT00429793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091858|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091859|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
154091860|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091861|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091862|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154091863|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091864|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154091865|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
154091866|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
154091867|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154091897|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091899|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
154091900|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154091901|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091902|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
154091903|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091904|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154091905|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154091906|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154091907|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154091908|NCT00845104|Bevacizumab|bevacizumab|mesh-list
154091909|NCT00845104|Rituximab|rituximab|mesh-list
154091910|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154091911|NCT00845104|Fludarabine|fludarabine|mesh-list
154091912|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
154091913|NCT00845104|Antibodies|antibodies|mesh-list
154091914|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
154091915|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154091916|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091917|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154091918|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154091919|NCT00845104|Growth Substances|growth substances|mesh-ancestor
154091920|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091949|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154091950|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
154091951|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154091952|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
154091953|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154091954|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154091955|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154091956|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
154091957|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154091958|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154091959|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154091960|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154091961|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
154091962|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
154091963|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154091964|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154091965|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
154091969|NCT00424489|Protective Agents|protective agents|mesh-ancestor
154092007|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092008|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154092009|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
154092010|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154092011|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092012|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092013|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154092014|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154092015|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
154092016|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154092017|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092019|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
154092020|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092021|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154092022|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154092023|NCT00717470|Protective Agents|protective agents|mesh-ancestor
154092024|NCT00631566|Mupirocin|mupirocin|mesh-list
154092025|NCT00631566|Triclosan|triclosan|mesh-list
154092026|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
154092027|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154092028|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092062|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092063|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092064|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
154092065|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092066|NCT00763139|Pioglitazone|pioglitazone|mesh-list
154092067|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154092068|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092069|NCT00781859|Plasminogen|plasminogen|mesh-list
154092070|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154092071|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154092072|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092073|NCT01344252|Lidocaine|lidocaine|mesh-list
154092074|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
154092075|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
154092076|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092077|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092078|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
154092079|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092080|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154092081|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154092082|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154092085|NCT04101383|Insulin|insulin|mesh-list
154092113|NCT00417079|Hormones|hormones|mesh-ancestor
154092114|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092115|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092116|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154092117|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092118|NCT00417079|Analgesics|analgesics|mesh-ancestor
154092119|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
154092120|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092121|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154092122|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092123|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092124|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092125|NCT00429169|Bupropion|bupropion|mesh-list
154092126|NCT00429169|Paroxetine|paroxetine|mesh-list
154092142|NCT01037491|Aspirin|aspirin|mesh-list
154092169|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
154092170|NCT02576340|Octylonium|octylonium|mesh-list
154092171|NCT02576340|Bromides|bromides|mesh-list
154092172|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
154092173|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154092174|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154092175|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092176|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154092177|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092178|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154092179|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
154092180|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
154092181|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092182|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154092183|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154092184|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
154092185|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092225|NCT00714246|Docetaxel|docetaxel|mesh-list
154092226|NCT00714246|Bortezomib|bortezomib|mesh-list
154092227|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092228|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
154092229|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
154092230|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
154092231|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092232|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154092233|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154092234|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092235|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
154092236|NCT00415909|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154092237|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154092238|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092239|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092240|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092241|NCT00709644|Folic Acid|folic acid|mesh-list
154092242|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154092243|NCT00709644|Norgestimate|norgestimate|mesh-list
154092244|NCT00709644|Estradiol|estradiol|mesh-list
154092245|NCT00709644|Estrogens|estrogens|mesh-ancestor
154092246|NCT00709644|Hormones|hormones|mesh-ancestor
154092250|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
154092282|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092283|NCT00714558|Analgesics|analgesics|mesh-ancestor
154092284|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
154092285|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092286|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154092287|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154092288|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
154092289|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
154092290|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154092291|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154092292|NCT02575638|Camptothecin|camptothecin|mesh-list
154092293|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154092294|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092295|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154092296|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092297|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092298|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092299|NCT02573610|Levofloxacin|levofloxacin|mesh-list
154092300|NCT02573610|Ofloxacin|ofloxacin|mesh-list
154092301|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154092302|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092303|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154092304|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154092305|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092306|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092307|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092308|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092311|NCT02574468|Dexamethasone|dexamethasone|mesh-list
154092326|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092327|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092328|NCT00710268|Bevacizumab|bevacizumab|mesh-list
154092329|NCT00710268|Olaparib|olaparib|mesh-list
154092330|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092331|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092332|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154092333|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154092334|NCT00710268|Growth Substances|growth substances|mesh-ancestor
154092335|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092336|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
154092337|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154092386|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154092387|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
154092388|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
154092389|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092390|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092391|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092392|NCT00711204|Donepezil|donepezil|mesh-list
154092393|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154092394|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092395|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092396|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
154092397|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092398|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092399|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
154092448|NCT05809336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154092449|NCT05809336|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154092450|NCT05809336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092451|NCT05809336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092452|NCT05809336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092453|NCT05809336|Immunologic Factors|immunologic factors|mesh-ancestor
154092454|NCT05809336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092455|NCT05809024|Letrozole|letrozole|mesh-list
154092456|NCT05809024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092457|NCT05809024|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154092458|NCT05809024|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154092459|NCT05809024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092460|NCT05809024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092461|NCT05809024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154092462|NCT05809024|Hormone Antagonists|hormone antagonists|mesh-ancestor
154092463|NCT05809024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092464|NCT05809024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092465|NCT05808985|Butyric Acid|butyric acid|mesh-list
154092466|NCT05808985|Histamine Antagonists|histamine antagonists|mesh-ancestor
154092467|NCT05808985|Histamine Agents|histamine agents|mesh-ancestor
154092468|NCT05808985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092469|NCT05808985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092470|NCT05808985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092471|NCT05808946|Thioctic Acid|thioctic acid|mesh-list
154092472|NCT05808946|Antioxidants|antioxidants|mesh-ancestor
154092473|NCT05808946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092474|NCT05808946|Protective Agents|protective agents|mesh-ancestor
154092475|NCT05808946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092476|NCT05808946|Vitamin B Complex|vitamin b complex|mesh-ancestor
154092477|NCT05808946|Vitamins|vitamins|mesh-ancestor
154092478|NCT05808946|Micronutrients|micronutrients|mesh-ancestor
154092479|NCT05764876|Azithromycin|azithromycin|mesh-list
154092480|NCT05764876|Linezolid|linezolid|mesh-list
154092481|NCT05764876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154092482|NCT05764876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092485|NCT05764876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092486|NCT05716763|Tramadol|tramadol|mesh-list
154092487|NCT05716763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154092488|NCT05716763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154092489|NCT05716763|Narcotics|narcotics|mesh-ancestor
154092490|NCT05716763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092491|NCT05716763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092492|NCT05716763|Analgesics|analgesics|mesh-ancestor
154092493|NCT05716763|Sensory System Agents|sensory system agents|mesh-ancestor
154092494|NCT05716763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092495|NCT05716503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154092496|NCT05716503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092497|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
154092498|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
154092499|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154092500|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092547|NCT05610800|Incretins|incretins|mesh-ancestor
154092548|NCT05610800|Hormones|hormones|mesh-ancestor
154092549|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092550|NCT05596383|Vitamin D|vitamin d|mesh-list
154092551|NCT05596383|Vitamins|vitamins|mesh-ancestor
154092552|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
154092553|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092554|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154092555|NCT05594745|Lifitegrast|lifitegrast|mesh-list
154092556|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154092557|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154092558|NCT05568953|Vaccines|vaccines|mesh-list
154092559|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
154092560|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092561|NCT05556200|Apatinib|apatinib|mesh-list
154092562|NCT05556200|Antibodies|antibodies|mesh-list
154092563|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154092564|NCT05556200|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154092565|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
154092566|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092567|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092568|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154092569|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092570|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092571|NCT05532215|Misoprostol|misoprostol|mesh-list
154092572|NCT05532215|Oxytocin|oxytocin|mesh-list
154092573|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
154092574|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154092575|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092576|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154092577|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
154092578|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154092579|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154092580|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154092581|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092582|NCT05471947|Glycolic acid|glycolic acid|mesh-list
154092590|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154092591|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154092592|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092593|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092594|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154092595|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
154092596|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154092597|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092598|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154092599|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154092600|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154092601|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154092602|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154092603|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154092605|NCT05391360|Entecavir|entecavir|mesh-list
154092647|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092648|NCT05093920|Doxorubicin|doxorubicin|mesh-list
154092649|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154092650|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154092651|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092652|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154092653|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154092654|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092655|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092656|NCT05052879|Tadalafil|tadalafil|mesh-list
154092657|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
154092658|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154092659|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154092660|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092661|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092662|NCT05052879|Urological Agents|urological agents|mesh-ancestor
154092663|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
154092664|NCT05049707|Analgesics|analgesics|mesh-ancestor
154092665|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
154092666|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092700|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092701|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092702|NCT04981899|Carboplatin|carboplatin|mesh-list
154092703|NCT04981899|Nivolumab|nivolumab|mesh-list
154092704|NCT04981899|Etoposide|etoposide|mesh-list
154092705|NCT04981899|Ifosfamide|ifosfamide|mesh-list
154092706|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092707|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092708|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154092709|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092710|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154092761|NCT04684238|Midazolam|midazolam|mesh-list
154092762|NCT04684238|Isoflurane|isoflurane|mesh-list
154092763|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154092764|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154092765|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092766|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092767|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154092768|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154092769|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154092770|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154092771|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
154092772|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
154092773|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
154092774|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
154092775|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154092776|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092777|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154092778|NCT04586348|Iodine|iodine|mesh-list
154092779|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
154092780|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154092782|NCT04586348|Trace Elements|trace elements|mesh-ancestor
154092816|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092818|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
154092819|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154092821|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154092822|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092823|NCT04480502|Ipilimumab|ipilimumab|mesh-list
154092824|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092825|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092826|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154092827|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092828|NCT04447092|Leucovorin|leucovorin|mesh-list
154092829|NCT04447092|Paclitaxel|paclitaxel|mesh-list
154092830|NCT04447092|Gemcitabine|gemcitabine|mesh-list
154092831|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
154092832|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
154092833|NCT04447092|Irinotecan|irinotecan|mesh-list
154092834|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154092835|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092877|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154092878|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092879|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
154092880|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
154092881|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
154092882|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092883|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154092884|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
154092885|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154092886|NCT04306900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154092887|NCT04288687|Niraparib|niraparib|mesh-list
154092888|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154092889|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092890|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092891|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154092892|NCT04218786|Colchicine|colchicine|mesh-list
154092893|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
154092901|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
154092934|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154092935|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154092936|NCT04003103|Islatravir|islatravir|mesh-list
154092937|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
154092938|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725815|NCT00117923|Resiquimod|resiquimod|mesh-list
154092939|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092940|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092941|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154092942|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154092943|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154092944|NCT03999216|Diuretics|diuretics|mesh-list
154092945|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
154092946|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
154092947|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
154092948|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092949|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154092950|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092951|NCT03945448|Fluconazole|fluconazole|mesh-list
154092952|NCT03945448|Amphotericin B|amphotericin b|mesh-list
154092953|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154092985|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154092986|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154092987|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154092988|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154092989|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154092990|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154092991|NCT03720119|Lidocaine|lidocaine|mesh-list
154092992|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
154092993|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
154092994|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154092995|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154092996|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
154092997|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154092998|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154092999|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154093000|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154093001|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154093002|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093003|NCT03713528|Vancomycin|vancomycin|mesh-list
154093004|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154093005|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093006|NCT03705845|Tocotrienols|tocotrienols|mesh-list
154093039|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093040|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
154093041|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
154093042|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
154093043|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093044|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093045|NCT03582475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154093046|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154093047|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154093048|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154093049|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093050|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
154093051|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
154093052|NCT03579784|Paclitaxel|paclitaxel|mesh-list
154093053|NCT03579784|Durvalumab|durvalumab|mesh-list
154093054|NCT03579784|Olaparib|olaparib|mesh-list
154093055|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154093056|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093057|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
154093058|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
154093059|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
154093089|NCT06063200|Methylphenidate|methylphenidate|mesh-list
154093090|NCT06063200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154093091|NCT06063200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093092|NCT06063200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154093093|NCT06063200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153725821|NCT00117351|Bortezomib|bortezomib|mesh-list
154093094|NCT06063200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154093095|NCT06063200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093096|NCT06063200|Dopamine Agents|dopamine agents|mesh-ancestor
154093097|NCT06063200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093098|NCT06063070|Bevacizumab|bevacizumab|mesh-list
154093100|NCT06063070|Fluzoparib|fluzoparib|mesh-list
154093152|NCT06062277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093153|NCT06062277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093154|NCT06060236|Ibuprofen|ibuprofen|mesh-list
154093155|NCT06060236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154093156|NCT06060236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154093157|NCT06060236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154093158|NCT06060236|Analgesics|analgesics|mesh-ancestor
154093159|NCT06060236|Sensory System Agents|sensory system agents|mesh-ancestor
154093160|NCT06060236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093161|NCT06060236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093162|NCT06060236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093163|NCT06060236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093164|NCT06060236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154093165|NCT06060236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093166|NCT06060236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093167|NCT06049927|Vaccines|vaccines|mesh-list
154093168|NCT06049927|Immunologic Factors|immunologic factors|mesh-ancestor
154093169|NCT06049927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093170|NCT06018467|Niacinamide|niacinamide|mesh-list
154093172|NCT06018467|Nicotinic Acids|nicotinic acids|mesh-list
154093173|NCT06018467|Dasatinib|dasatinib|mesh-list
154093174|NCT06018467|Quercetin|quercetin|mesh-list
154093175|NCT06018467|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154093176|NCT06018467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154093177|NCT06018467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093178|NCT06018467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093200|NCT05920798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093201|NCT05920798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093202|NCT05920798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093203|NCT05920798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154093204|NCT05920798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093205|NCT05907980|Atezolizumab|atezolizumab|mesh-list
154093206|NCT05907980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154093207|NCT05907980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093208|NCT05907980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093262|NCT05825092|Hormones|hormones|mesh-ancestor
154093263|NCT05825092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093264|NCT05825092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093265|NCT05825092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154093267|NCT05825092|Anabolic Agents|anabolic agents|mesh-ancestor
154093268|NCT05795101|Trastuzumab|trastuzumab|mesh-list
154093269|NCT05795101|Durvalumab|durvalumab|mesh-list
154093270|NCT05795101|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154093271|NCT05795101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093272|NCT05795101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093273|NCT05795101|Immunoconjugates|immunoconjugates|mesh-ancestor
154093274|NCT05795101|Immunologic Factors|immunologic factors|mesh-ancestor
154093275|NCT05795101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093276|NCT05765578|Vaccines|vaccines|mesh-list
154093277|NCT05765578|Immunologic Factors|immunologic factors|mesh-ancestor
154093278|NCT05765578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093279|NCT05714007|Ferrous succinate|ferrous succinate|mesh-list
154093280|NCT05714007|Hematinics|hematinics|mesh-ancestor
154093281|NCT05713838|Durvalumab|durvalumab|mesh-list
154093282|NCT05713838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093283|NCT05713838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093284|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
154093285|NCT05513560|Ibudilast|ibudilast|mesh-list
154093316|NCT05412082|Antidotes|antidotes|mesh-ancestor
154093317|NCT05412082|Protective Agents|protective agents|mesh-ancestor
154093318|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
154093319|NCT05412082|Vitamins|vitamins|mesh-ancestor
154093320|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
154093321|NCT05214664|Anesthetics|anesthetics|mesh-list
154093322|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154093323|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093324|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154093325|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154093326|NCT05214573|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154093327|NCT05214573|Glucagon|glucagon|mesh-list
154093328|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154093329|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416568|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154093377|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093378|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093379|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154093380|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154093381|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154093382|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154093383|NCT05027308|Teduglutide|teduglutide|mesh-list
154093384|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093385|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154093386|NCT05027308|Protective Agents|protective agents|mesh-ancestor
154093387|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093437|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154093438|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154093439|NCT04611152|Growth Substances|growth substances|mesh-ancestor
154093440|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093441|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
154093442|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093443|NCT04603937|Aflibercept|aflibercept|mesh-list
154093444|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154093445|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154093450|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
154093504|NCT04203901|Everolimus|everolimus|mesh-list
154093505|NCT04203901|Lenvatinib|lenvatinib|mesh-list
154093506|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093507|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093508|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154093509|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093510|NCT04203901|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154093511|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154093512|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093513|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093514|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
154093515|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093516|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
154093567|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
154093568|NCT03909165|Neostigmine|neostigmine|mesh-list
154093569|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154093570|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154093571|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154093572|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
154093573|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093574|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093575|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154093576|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
154093577|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
154093578|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
154093579|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154093580|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154093581|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
154093582|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093583|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093584|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154093585|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093586|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154093587|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154093588|NCT03784443|Ranibizumab|ranibizumab|mesh-list
154093589|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154093590|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154093591|NCT03784443|Growth Substances|growth substances|mesh-ancestor
154093592|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093593|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
154093594|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093595|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093596|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
154093597|NCT03784443|Hormones|hormones|mesh-ancestor
154093598|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093599|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
154093607|NCT03512223|Dexamethasone|dexamethasone|mesh-list
154093608|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154093609|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
154093610|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
154093611|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154093612|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093613|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154093614|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
154093615|NCT03512223|Hormones|hormones|mesh-ancestor
154093616|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154093617|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154093618|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093619|NCT03502668|Decitabine|decitabine|mesh-list
154093620|NCT03502668|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154093621|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093622|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
154093623|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093624|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093625|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093626|NCT03474458|Doxycycline|doxycycline|mesh-list
154093661|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093662|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093663|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
154093664|NCT03073785|Capecitabine|capecitabine|mesh-list
154093665|NCT03073785|Fluorouracil|fluorouracil|mesh-list
154093666|NCT03073785|Imidazole|imidazole|mesh-list
154093667|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093668|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
154093669|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093670|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093671|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093672|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
154093673|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093674|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154093675|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093676|NCT03066648|Azacitidine|azacitidine|mesh-list
154093677|NCT03066648|Decitabine|decitabine|mesh-list
154093678|NCT03066648|Spartalizumab|spartalizumab|mesh-list
154093720|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154093721|NCT02743455|Vaccines|vaccines|mesh-list
154093722|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
154093723|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093724|NCT02553447|Vitamin D|vitamin d|mesh-list
154093725|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
154093726|NCT02553447|Vitamins|vitamins|mesh-ancestor
154093727|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
154093728|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093729|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154093731|NCT02020707|Paclitaxel|paclitaxel|mesh-list
154093786|NCT01056523|Cytarabine|cytarabine|mesh-list
154093787|NCT01056523|Ribavirin|ribavirin|mesh-list
154093788|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093789|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
153725845|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093790|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093791|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093792|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
154093793|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093794|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093795|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
154093796|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093798|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
154093799|NCT00579878|Methotrexate|methotrexate|mesh-list
154093800|NCT00579878|Leflunomide|leflunomide|mesh-list
154093801|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154093802|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
154093803|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154093804|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093805|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154093806|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
154093807|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093808|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093809|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
154093828|NCT00554788|Thiotepa|thiotepa|mesh-list
154093836|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093837|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
154093838|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093839|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154093840|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154093841|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
154093842|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093843|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093844|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154093845|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154093846|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154093847|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154093848|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093849|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154093850|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
154093851|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
154093852|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
154093853|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
154093854|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
154093856|NCT00138216|Vincristine|vincristine|mesh-list
154093883|NCT03465540|Hormones|hormones|mesh-ancestor
154093889|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093890|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093891|NCT03368547|Edetic Acid|edetic acid|mesh-list
154093892|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154093893|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
154093894|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
154093895|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093896|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
154093897|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154093898|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154093899|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154093900|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154093901|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154093902|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154093903|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154093904|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
154093905|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154093906|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
154093907|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093908|NCT03152890|Insulin|insulin|mesh-list
154093946|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
154093947|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154093948|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154093949|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
154093950|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154093951|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
154093952|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154093953|NCT02891278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154093954|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154093955|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154093956|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154093957|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
154093958|NCT02807181|Cisplatin|cisplatin|mesh-list
154093959|NCT02807181|Gemcitabine|gemcitabine|mesh-list
154094006|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094008|NCT02078869|Progestins|progestins|mesh-ancestor
154094009|NCT02078869|Hormones|hormones|mesh-ancestor
154094010|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154094011|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094012|NCT01946815|Atorvastatin|atorvastatin|mesh-list
154094013|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154094014|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154094015|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
154094016|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094017|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154094018|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154094019|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094020|NCT01937156|Granisetron|granisetron|mesh-list
154094021|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
154094022|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
154094031|NCT01805804|Valsartan|valsartan|mesh-list
154094063|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
154094064|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094065|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094066|NCT01367561|Naloxone|naloxone|mesh-list
154094067|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
154094068|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154094069|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094070|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
154094071|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094072|NCT01361607|Nabiximols|nabiximols|mesh-list
154094073|NCT01361607|Analgesics|analgesics|mesh-ancestor
154094128|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094130|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
154094131|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
154094132|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154094133|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154094134|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094135|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
154094136|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094137|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094138|NCT00202774|Capecitabine|capecitabine|mesh-list
154094139|NCT00202774|Fluorouracil|fluorouracil|mesh-list
154094140|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
154094141|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154094142|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
154094143|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094144|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094145|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094146|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
154094147|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094148|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
154094149|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094150|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
154094151|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094152|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154094153|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154094154|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
154094156|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094173|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154094174|NCT00923962|Hormones|hormones|mesh-ancestor
154094175|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154094176|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094177|NCT00923962|Incretins|incretins|mesh-ancestor
154094178|NCT00923962|Analgesics|analgesics|mesh-ancestor
154094179|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
154094180|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094181|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154094182|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
154094184|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
154094238|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094239|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154094240|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154094241|NCT04018950|Durlobactam|durlobactam|mesh-list
154094242|NCT04018950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154094243|NCT04018950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094244|NCT04018950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094245|NCT04018950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154094246|NCT04018950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094248|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094249|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
154094250|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094251|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154094252|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094253|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094254|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
154094255|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154094256|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094257|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094258|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154094259|NCT00852046|Analgesics|analgesics|mesh-ancestor
154094268|NCT02573064|Vancomycin|vancomycin|mesh-list
154094290|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094291|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154094293|NCT00923806|Aldesleukin|aldesleukin|mesh-list
154094294|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094295|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154094296|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154094297|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
154094298|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094299|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154094300|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
154094301|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154094302|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
154094303|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154094304|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154094305|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
154094306|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094307|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154094308|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154094309|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094310|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094311|NCT00712062|Pemetrexed|pemetrexed|mesh-list
154094312|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094313|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094314|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094315|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154094316|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154094317|NCT00712140|Trastuzumab|trastuzumab|mesh-list
154094318|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154094319|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094320|NCT02545738|Liraglutide|liraglutide|mesh-list
154094334|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154094335|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
154094336|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094337|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094338|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154094339|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
154094340|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
154094341|NCT00848302|Protective Agents|protective agents|mesh-ancestor
154094342|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
154094343|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094344|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
154094345|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094397|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094398|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094399|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154094400|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154094401|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
154094402|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
154094403|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
153349733|NCT01184885|Sirolimus|sirolimus|mesh-list
154094405|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094406|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154094407|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094408|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094409|NCT02544880|Tadalafil|tadalafil|mesh-list
154094410|NCT02544880|Vaccines|vaccines|mesh-list
154094411|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
154094412|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094413|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
154094455|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
154094456|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
154094457|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094458|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094459|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154094460|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154094461|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154094462|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094463|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154094464|NCT00712686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154094465|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154094466|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154094467|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094468|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094469|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
154094470|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
154094471|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
154094472|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
154094473|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154094508|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094509|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
154094510|NCT00578786|Ambrisentan|ambrisentan|mesh-list
154094511|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154094512|NCT00424255|Lapatinib|lapatinib|mesh-list
154094513|NCT00424255|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154094514|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154094515|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094516|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094517|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094518|NCT02574156|Insulin|insulin|mesh-list
154094519|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154094520|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094521|NCT00848692|Rituximab|rituximab|mesh-list
154094522|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154094523|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094524|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
154094525|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094526|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154094527|NCT00848770|Norepinephrine|norepinephrine|mesh-list
154094528|NCT00848770|Esmolol|esmolol|mesh-list
154094529|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154094530|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154094531|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
154094532|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094533|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094534|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094555|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094556|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154094557|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
154094558|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154094559|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094560|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154094561|NCT02571296|Progesterone|progesterone|mesh-list
154094562|NCT02571296|Progestins|progestins|mesh-ancestor
154094563|NCT02571296|Hormones|hormones|mesh-ancestor
154094564|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154094565|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094566|NCT00857038|Doxycycline|doxycycline|mesh-list
154094567|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154094568|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094569|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
154094570|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154094571|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154094572|NCT00719316|Aliskiren|aliskiren|mesh-list
154094573|NCT00719316|Renin Inhibitors|renin inhibitors|mesh-ancestor
154094610|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154094611|NCT00857428|Oxymorphone|oxymorphone|mesh-list
154094612|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154094613|NCT00857428|Narcotics|narcotics|mesh-ancestor
154094614|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094615|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094616|NCT00857428|Analgesics|analgesics|mesh-ancestor
154094617|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
154094618|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094619|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154094620|NCT04018768|Acetaminophen|acetaminophen|mesh-list
154094621|NCT04018768|Ibuprofen|ibuprofen|mesh-list
154094674|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094675|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154094676|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154094677|NCT00720512|Growth Substances|growth substances|mesh-ancestor
154094678|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094679|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
154094680|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154094681|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
154094682|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094683|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154094684|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730466|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730467|NCT00144846|Albuterol|albuterol|mesh-list
153730468|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153730469|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
153730470|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417976|NCT04762381|Hormones|hormones|mesh-ancestor
154094713|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094714|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154094715|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154094716|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154094717|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154094718|NCT00718172|Ribavirin|ribavirin|mesh-list
154094719|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
154094720|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094768|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
154094769|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094770|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094771|NCT00849082|Goserelin|goserelin|mesh-list
154094772|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
154094773|NCT00849082|Cyproterone|cyproterone|mesh-list
154094774|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154094775|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094776|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
154094777|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
153725933|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154094778|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154094779|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094780|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154094781|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
154094782|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154094783|NCT00849160|Darunavir|darunavir|mesh-list
154094784|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154094785|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154094786|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
154094787|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094788|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094789|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154094790|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154094791|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
154094792|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094793|NCT00720590|Ritonavir|ritonavir|mesh-list
154094794|NCT00720590|Lopinavir|lopinavir|mesh-list
154094795|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154094796|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154094797|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154094798|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
154094799|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094800|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094810|NCT00718406|Narcotics|narcotics|mesh-ancestor
154094811|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094812|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094813|NCT00718406|Analgesics|analgesics|mesh-ancestor
154094814|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
154094815|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094816|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154094817|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154094818|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
154094819|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
154094820|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154094821|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154094822|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154094823|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
154094824|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094825|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094826|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
154094827|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154094828|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094829|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154094830|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
154094831|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154094832|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154094833|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094834|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094835|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
154094837|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094838|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
154094839|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094840|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154094841|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094852|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154094853|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
154094854|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094855|NCT00717210|Temozolomide|temozolomide|mesh-list
154094856|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154094857|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
154094858|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094859|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094860|NCT00723086|Docetaxel|docetaxel|mesh-list
154094861|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094862|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
154094863|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
154094864|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
154094865|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094866|NCT04018378|Varenicline|varenicline|mesh-list
154094867|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154094868|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154094869|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
154094870|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154094871|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094872|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094873|NCT00849550|Bevacizumab|bevacizumab|mesh-list
154094876|NCT00849550|Everolimus|everolimus|mesh-list
154094904|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154094906|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094907|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154094908|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094909|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
154094910|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154094911|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094912|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
154094913|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154094914|NCT00723164|Midazolam|midazolam|mesh-list
154094915|NCT00723164|Fentanyl|fentanyl|mesh-list
154094916|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154094917|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154094918|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154094919|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094920|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154094921|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154094922|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154094925|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
154094959|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154094960|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
154094961|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154094962|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
154094963|NCT00723320|Atorvastatin|atorvastatin|mesh-list
154094964|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154094965|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154094966|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
154094967|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094968|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154094969|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154094970|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154094971|NCT00578448|Abatacept|abatacept|mesh-list
154094972|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154094973|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154094974|NCT00578448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154094975|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154094976|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095011|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154095012|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095013|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095015|NCT04067102|Paclitaxel|paclitaxel|mesh-list
154095016|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154095017|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
154095018|NCT04067102|Carboplatin|carboplatin|mesh-list
154095019|NCT04067102|Epirubicin|epirubicin|mesh-list
154095020|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154095021|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095022|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
154095023|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
154095024|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
154095025|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095026|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725946|NCT00477997|Hormones|hormones|mesh-list
154095027|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
154095028|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095029|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095037|NCT05659290|Bevacizumab|bevacizumab|mesh-list
154095068|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154095069|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095070|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
154095071|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095072|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095073|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095074|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
154095075|NCT02571842|Hormones|hormones|mesh-ancestor
154095076|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095077|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095078|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154095079|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
154095080|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095081|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095082|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154095083|NCT02546284|Lenzilumab|lenzilumab|mesh-list
154095084|NCT02546284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095085|NCT00721448|Ticagrelor|ticagrelor|mesh-list
154095086|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154095087|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154095088|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154095089|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154095116|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095117|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154095118|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154095119|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154095121|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154095122|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154095123|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154095124|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154095125|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154095126|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154095127|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095128|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095129|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154095130|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154095131|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095132|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
154095133|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095134|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
154095135|NCT00853294|Hydrocodone|hydrocodone|mesh-list
154095136|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095137|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154095166|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
154095167|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095168|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154095169|NCT00658359|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153725953|NCT00478075|Analgesics|analgesics|mesh-ancestor
154095170|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154095171|NCT00853450|Clopidogrel|clopidogrel|mesh-list
154095172|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154095173|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154095174|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154095175|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154095176|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
154095177|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095178|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095179|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095181|NCT04066790|Trastuzumab|trastuzumab|mesh-list
154095182|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154095183|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418445|NCT00374023|Vitamin A|vitamin a|mesh-list
154095185|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
154095186|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
154095192|NCT02571192|Volixibat|volixibat|mesh-list
154095220|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154095221|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095222|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095223|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095224|NCT00717990|Bevacizumab|bevacizumab|mesh-list
154095225|NCT00717990|Capecitabine|capecitabine|mesh-list
154095226|NCT00717990|Irinotecan|irinotecan|mesh-list
154095227|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154095228|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095229|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154095230|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154095231|NCT00717990|Growth Substances|growth substances|mesh-ancestor
154095232|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095233|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
154095234|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154095235|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
154095236|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095237|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154095238|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154095239|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095240|NCT02572986|Permethrin|permethrin|mesh-list
154095241|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095242|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095243|NCT00853684|Capecitabine|capecitabine|mesh-list
154095244|NCT00853684|Endostar protein|endostar protein|mesh-list
154095245|NCT00853684|Endostatins|endostatins|mesh-list
154095255|NCT00723060|Escitalopram|escitalopram|mesh-list
154095267|NCT02571816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095269|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
154095270|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154095271|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095272|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154095274|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
154095275|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154095276|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154095277|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095278|NCT00724178|Vitamin D|vitamin d|mesh-list
154095279|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
154095280|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
154095281|NCT00724178|Calcium|calcium|mesh-list
154095282|NCT00724178|Vitamins|vitamins|mesh-ancestor
154095283|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
154095284|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095285|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154095286|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154095287|NCT00724178|Antacids|antacids|mesh-ancestor
154095288|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095324|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154095325|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
154095326|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095327|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095328|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154095329|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095331|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
154095332|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095333|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095334|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
154095335|NCT01005914|Hormones|hormones|mesh-ancestor
154095336|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095337|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095338|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154095339|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154095340|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154095341|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342143|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095342|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154095343|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
154095344|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154095345|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154095346|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
154095347|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
154095348|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154095349|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154095350|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
154095351|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095352|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154095353|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
154095354|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
154095355|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
154095356|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154095361|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154095362|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154095363|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095364|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
154095365|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095366|NCT00861016|Metoprolol|metoprolol|mesh-list
154095367|NCT00861016|Felodipine|felodipine|mesh-list
154095368|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154095369|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154095370|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
154095371|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
154095372|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095373|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095374|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154095425|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095426|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
154095427|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095428|NCT00861094|Antidotes|antidotes|mesh-ancestor
154095429|NCT00861094|Protective Agents|protective agents|mesh-ancestor
154095430|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
154095431|NCT00861094|Vitamins|vitamins|mesh-ancestor
154095432|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
154095433|NCT00861094|Hematinics|hematinics|mesh-ancestor
154095434|NCT00807261|Gemcitabine|gemcitabine|mesh-list
154095435|NCT00807261|Docetaxel|docetaxel|mesh-list
154095436|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154095437|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
154095438|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095439|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095440|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
154095441|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
154095442|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
154095443|NCT04019106|Budesonide|budesonide|mesh-list
154095444|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
154095445|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154095483|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154095484|NCT00861406|Vaccines|vaccines|mesh-list
154095485|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
154095486|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095487|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095488|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
154095489|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095490|NCT00865384|Mirtazapine|mirtazapine|mesh-list
154095491|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
154095492|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154095493|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154095494|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
154095495|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
154095496|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095543|NCT04130204|Colchicine|colchicine|mesh-list
154095544|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
154095545|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154095546|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
154095547|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
154095548|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
154095549|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095550|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095551|NCT00723918|Methadone|methadone|mesh-list
154095552|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154095553|NCT00723918|Narcotics|narcotics|mesh-ancestor
154095554|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095555|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095556|NCT00723918|Analgesics|analgesics|mesh-ancestor
154095557|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
154095558|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095559|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
154095560|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
154095561|NCT00865540|Prednisolone|prednisolone|mesh-list
154095562|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154095563|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
154095597|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154095598|NCT00865618|Diuretics|diuretics|mesh-ancestor
154095599|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
154095600|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154095601|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154095602|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
154095603|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154095604|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154095605|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095606|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095607|NCT00655629|Urological Agents|urological agents|mesh-ancestor
154095608|NCT00865696|Mirtazapine|mirtazapine|mesh-list
154095609|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
154095610|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154095611|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154095612|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
154095613|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
154095614|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095615|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095616|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095617|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154095648|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095649|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095650|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
154095651|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095653|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
154095654|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154095655|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154095656|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095657|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154095658|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095659|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095660|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154095661|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
154095662|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095664|NCT00798525|Lepirudin|lepirudin|mesh-list
154095665|NCT00798525|Argatroban|argatroban|mesh-list
154095666|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
154095667|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154095668|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
154095669|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095670|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095671|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
154095672|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154095673|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154095674|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154095675|NCT00861640|Omeprazole|omeprazole|mesh-list
154095676|NCT00861640|Rabeprazole|rabeprazole|mesh-list
153725987|NCT00117468|Hormones|hormones|mesh-ancestor
154095677|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154095678|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095679|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154095680|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095681|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095682|NCT00724230|Ribavirin|ribavirin|mesh-list
154095683|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154095688|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095689|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
154095690|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095692|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154095693|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
154095694|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
154095695|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
154095696|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
154095697|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154095698|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095699|NCT00724386|Paclitaxel|paclitaxel|mesh-list
154095700|NCT00724386|Vinorelbine|vinorelbine|mesh-list
154095701|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154095702|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095703|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
154095704|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
154095705|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
154095706|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095707|NCT00865852|Metformin|metformin|mesh-list
154095708|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154095709|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419011|NCT05748587|Iron|iron|mesh-list
154095710|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
154095711|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
154095712|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
154095713|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095714|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095715|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
154095716|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154095717|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154095718|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154095720|NCT00724542|Voglibose|voglibose|mesh-list
154095730|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
154095731|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095732|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154095733|NCT00866008|Ganirelix|ganirelix|mesh-list
154095734|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
154095735|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154095736|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
154095737|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154095738|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095739|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154095740|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154095741|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095742|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
154095743|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095744|NCT02571426|Propofol|propofol|mesh-list
154095745|NCT02571426|Sevoflurane|sevoflurane|mesh-list
154095746|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154095747|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154095748|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095749|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154095750|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
154095751|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
154095752|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154095753|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154095754|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154095755|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095756|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
154095757|NCT00578292|Busulfan|busulfan|mesh-list
154095758|NCT00578292|Fludarabine|fludarabine|mesh-list
154095759|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
154095760|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095770|NCT00861874|Sirolimus|sirolimus|mesh-list
154095774|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095775|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095776|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095777|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154095778|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095779|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154095780|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
154095781|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154095782|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
154095783|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095784|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
154095785|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095787|NCT04067856|Bevacizumab|bevacizumab|mesh-list
154095788|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154095789|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095834|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154095835|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095836|NCT00855088|Ritonavir|ritonavir|mesh-list
154095837|NCT00855088|Darunavir|darunavir|mesh-list
154095838|NCT00855088|Etravirine|etravirine|mesh-list
154095839|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154095840|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154095841|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
154095842|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095843|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095844|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154095845|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154095846|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
154095847|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095848|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154095849|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154095850|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154095851|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154095852|NCT00725426|Bosutinib|bosutinib|mesh-list
154095853|NCT00725426|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154095888|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
154095889|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154095890|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
154095891|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095892|NCT00866866|Protective Agents|protective agents|mesh-ancestor
154095893|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095894|NCT00866866|Antidotes|antidotes|mesh-ancestor
154095895|NCT00312728|Bevacizumab|bevacizumab|mesh-list
154095896|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154095897|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154095898|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154095899|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154095900|NCT00312728|Growth Substances|growth substances|mesh-ancestor
154095901|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095948|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154095949|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
154095950|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
154095951|NCT04046289|Calcium|calcium|mesh-list
154095952|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154095953|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095954|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154095955|NCT04046289|Antacids|antacids|mesh-ancestor
154095956|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095957|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154095958|NCT00807807|Folic Acid|folic acid|mesh-list
154095959|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
154095960|NCT00807807|Hematinics|hematinics|mesh-ancestor
154095961|NCT00807807|Vitamins|vitamins|mesh-ancestor
154095962|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
154095963|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095964|NCT00870298|Trimethoprim|trimethoprim|mesh-list
154095965|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
154095966|NCT00870298|Warfarin|warfarin|mesh-list
154095967|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
153725990|NCT03271879|Empagliflozin|empagliflozin|mesh-list
154095968|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154095969|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154095970|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
154095971|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154095972|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154095973|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154095974|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154095975|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095976|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154095977|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154095978|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154095992|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154095993|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154095994|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154095995|NCT00805233|Bromfenac|bromfenac|mesh-list
154095996|NCT00805233|Ranibizumab|ranibizumab|mesh-list
154095997|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154095998|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154095999|NCT00805233|Growth Substances|growth substances|mesh-ancestor
154096000|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096001|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
154096002|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096003|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154096004|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154096005|NCT00805233|Analgesics|analgesics|mesh-ancestor
154096006|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
154096007|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096008|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096009|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096010|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
154096011|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154096012|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154096013|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096014|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154096015|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154096016|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
154096017|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096018|NCT00725400|Cetuximab|cetuximab|mesh-list
154096019|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154096020|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096037|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154096038|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096039|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154096040|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154096041|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154096042|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096043|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
154096044|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096045|NCT00862264|Beclomethasone|beclomethasone|mesh-list
154096046|NCT00862264|Norflurane|norflurane|mesh-list
154096047|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
154096048|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154096049|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
154096050|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096051|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096052|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154096053|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
154096054|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154096055|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154096056|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154096057|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
154096058|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096060|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096088|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
154096089|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096090|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096091|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096092|NCT01951274|Serlopitant|serlopitant|mesh-list
154096093|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154096094|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096095|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096096|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096097|NCT03355794|Everolimus|everolimus|mesh-list
154096098|NCT03355794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154096099|NCT03355794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096100|NCT03355794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096101|NCT03355794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096102|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154096103|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
154096104|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096105|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096106|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154096107|NCT01487174|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154096108|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096109|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096110|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096111|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096112|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154096113|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154096114|NCT00725634|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154096115|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096116|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096117|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096118|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096126|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096127|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154096128|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154096129|NCT00862342|Growth Substances|growth substances|mesh-ancestor
154096130|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096131|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
154096132|NCT02544724|Interleukin-12|interleukin-12|mesh-list
154096133|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154096134|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
154096135|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096136|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154096137|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154096138|NCT02544724|Growth Substances|growth substances|mesh-ancestor
154096139|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
154096140|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096141|NCT00862420|Ticlopidine|ticlopidine|mesh-list
154096142|NCT00862420|Clopidogrel|clopidogrel|mesh-list
154096143|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154096144|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154096145|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154096146|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154096147|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
154096148|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096149|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096150|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096151|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154096152|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154096153|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154096154|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154096155|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096156|NCT00321698|Docetaxel|docetaxel|mesh-list
154096157|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096158|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
154096159|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
154096160|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
154096162|NCT02569970|Fluoxetine|fluoxetine|mesh-list
154096163|NCT02569970|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153419399|NCT04503460|Fluticasone|fluticasone|mesh-list
154096164|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154096165|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154096166|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096167|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096168|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
154096169|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096170|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154096171|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
154096172|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154096173|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154096174|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154096175|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096176|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154096177|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
154096178|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154096179|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154096180|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096181|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096213|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096214|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096215|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154096216|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154096217|NCT00726804|Analgesics|analgesics|mesh-ancestor
154096218|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
154096219|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096220|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096221|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096222|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154096223|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
154096224|NCT00726960|Buprenorphine|buprenorphine|mesh-list
154096225|NCT00726960|Aprepitant|aprepitant|mesh-list
154096226|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154096227|NCT00726960|Narcotics|narcotics|mesh-ancestor
154096228|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154096229|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096230|NCT00726960|Analgesics|analgesics|mesh-ancestor
154096231|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
154096232|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096233|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154096234|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
154096235|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
154096236|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096237|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154096238|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096239|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096240|NCT00727038|Ranibizumab|ranibizumab|mesh-list
154096241|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154096242|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154096243|NCT00727038|Growth Substances|growth substances|mesh-ancestor
154096244|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096245|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
154096246|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096253|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154096254|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
154096255|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
154096256|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154096257|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154096258|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154096259|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096260|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096261|NCT02569814|Amlodipine|amlodipine|mesh-list
154096262|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154096263|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154096264|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154096265|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154096266|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096267|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154096268|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096269|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
154096270|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154096271|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154096272|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
154096273|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154096274|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154096275|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096276|NCT00726570|Heparin|heparin|mesh-list
154096277|NCT00726570|Calcium heparin|calcium heparin|mesh-list
154096278|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154096279|NCT00726570|Tinzaparin|tinzaparin|mesh-list
154096280|NCT00726570|Dalteparin|dalteparin|mesh-list
154096281|NCT00726570|Anticoagulants|anticoagulants|mesh-list
154096282|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154096283|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154096284|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096296|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154096297|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154096298|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154096299|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154096300|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154096301|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154096302|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154096303|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
154096304|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
154096305|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
154096306|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
154096307|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096308|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096309|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
154096310|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154096311|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154096312|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096313|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154096314|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154096315|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
154096316|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154096317|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096318|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154096319|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154096320|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154096322|NCT00726726|Coagulants|coagulants|mesh-ancestor
154096323|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
154096344|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096346|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
154096347|NCT00654381|Vitamins|vitamins|mesh-ancestor
154096348|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
154096349|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
154096350|NCT04018482|Povidone|povidone|mesh-list
154096351|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
154096352|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
154096353|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154096354|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096355|NCT00805311|Aspirin|aspirin|mesh-list
154096356|NCT00805311|Losartan|losartan|mesh-list
154096357|NCT00805311|Amlodipine|amlodipine|mesh-list
154096358|NCT00805311|Atorvastatin|atorvastatin|mesh-list
154096359|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154096360|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154096361|NCT00805311|Analgesics|analgesics|mesh-ancestor
154096362|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
154096363|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096364|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096365|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096366|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096367|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154096368|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154096369|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096370|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154096371|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154096372|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096373|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
154096374|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154096375|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154096376|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
154096377|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154096378|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154096384|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154096385|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154096386|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154096387|NCT00732290|Fluoxetine|fluoxetine|mesh-list
154096388|NCT00732290|Clopidogrel|clopidogrel|mesh-list
154096389|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154096390|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154096391|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154096392|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154096393|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
154096394|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096395|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096396|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096397|NCT00732290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154096398|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154096399|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154096400|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
154096401|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154096402|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
154096403|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154096404|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154096405|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154096406|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096407|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154096408|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
154096409|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096410|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
154096411|NCT00732446|Dexamethasone|dexamethasone|mesh-list
154096412|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
154096413|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154096414|NCT00732446|BB 1101|bb 1101|mesh-list
154096421|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
154096422|NCT00732446|Hormones|hormones|mesh-ancestor
154096423|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154096424|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154096425|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096426|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
154096427|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096428|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096429|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154096430|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096431|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154096432|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154096433|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154096434|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
154096435|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154096436|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154096437|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154096438|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154096439|NCT00732524|Glipizide|glipizide|mesh-list
154096440|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154096441|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096442|NCT00657267|Temozolomide|temozolomide|mesh-list
154096443|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154096444|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
154096445|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096446|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096447|NCT00733850|Gemcitabine|gemcitabine|mesh-list
154096448|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154096449|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
154096450|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096452|NCT00727766|Clofarabine|clofarabine|mesh-list
154096460|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154096461|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154096462|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154096463|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153783295|NCT00236015|Tiagabine|tiagabine|mesh-list
154096464|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154096466|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096467|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154096468|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
154096469|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154096470|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096471|NCT04066920|Ibrutinib|ibrutinib|mesh-list
154096472|NCT04066920|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154096473|NCT04066920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096474|NCT04066920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096475|NCT04066920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096476|NCT00732836|Paclitaxel|paclitaxel|mesh-list
154096477|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154096478|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154096479|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096480|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
154096481|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
154096482|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
154096483|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096484|NCT00799149|Etoricoxib|etoricoxib|mesh-list
154096485|NCT00799149|Gabapentin|gabapentin|mesh-list
154096486|NCT00799149|Analgesics|analgesics|mesh-ancestor
154096487|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
154096488|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096489|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096490|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
154096491|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154096492|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154096493|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154096495|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154096496|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154096497|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096498|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096499|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
154096500|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154096501|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154096502|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096503|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096504|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154096505|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154096506|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096507|NCT00732914|Sorafenib|sorafenib|mesh-list
154096508|NCT00732914|Sunitinib|sunitinib|mesh-list
154096509|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096510|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096511|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096512|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096513|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154096514|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154096515|NCT00732914|Growth Substances|growth substances|mesh-ancestor
154096516|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096517|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
154096518|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
154096519|NCT00808275|Calcium|calcium|mesh-list
154096520|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154096521|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096522|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154096523|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
154096524|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154096525|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726082|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
154096526|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154096527|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154096528|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096531|NCT00728000|Gemcitabine|gemcitabine|mesh-list
154096534|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154096536|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096537|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096538|NCT00728000|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154096539|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096540|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096542|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
154096543|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096544|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154096545|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154096546|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096547|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096548|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154096549|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154096550|NCT00728078|Thalidomide|thalidomide|mesh-list
154096551|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154096552|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
154096553|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096554|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
154096555|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154096556|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096557|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154096558|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154096559|NCT00728078|Growth Substances|growth substances|mesh-ancestor
154096560|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
154096583|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096584|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154096585|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
154096586|NCT01528046|Metformin|metformin|mesh-list
154096587|NCT01528046|Irinotecan|irinotecan|mesh-list
154096588|NCT01528046|Camptothecin|camptothecin|mesh-list
154096589|NCT01528046|Vincristine|vincristine|mesh-list
154096590|NCT01528046|Temozolomide|temozolomide|mesh-list
154096591|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154096592|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096593|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154096594|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154096595|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096596|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096597|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096598|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154096599|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
154096600|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
154096601|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
154096602|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154096603|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
154096604|NCT00652899|Aldesleukin|aldesleukin|mesh-list
154096605|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
154096606|NCT00652899|Fludarabine|fludarabine|mesh-list
154096607|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
154096608|NCT00652899|Interleukin-2|interleukin-2|mesh-list
154096609|NCT00652899|Allopurinol|allopurinol|mesh-list
154096610|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154096611|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
154096612|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096613|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096614|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154096615|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
154096616|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096622|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096623|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154096624|NCT00652899|Analgesics|analgesics|mesh-ancestor
154096625|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
154096626|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096627|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154096628|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154096629|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096630|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
154096631|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154096632|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
154096633|NCT00652899|Protective Agents|protective agents|mesh-ancestor
154096634|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
154096635|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154096636|NCT04066452|Antibodies|antibodies|mesh-list
154096637|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
154096638|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096639|NCT00728520|Azacitidine|azacitidine|mesh-list
154096640|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154096641|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
154096642|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096643|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096644|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096645|NCT04065308|Daratumumab|daratumumab|mesh-list
154096646|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096647|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
154096648|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154096649|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096650|NCT00728156|Clopidogrel|clopidogrel|mesh-list
154096651|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154096652|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154096653|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154096654|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154096655|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
154096656|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096658|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096661|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096662|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154096663|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096664|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096665|NCT00734318|Fluticasone|fluticasone|mesh-list
154096666|NCT00734318|Xhance|xhance|mesh-list
154096667|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
154096668|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154096669|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
154096670|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096671|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096672|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154096673|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
154096674|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154096675|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154096676|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154096677|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
154096678|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096679|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096680|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096681|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
154096682|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154096683|NCT00733616|Docetaxel|docetaxel|mesh-list
154096684|NCT00733616|Capecitabine|capecitabine|mesh-list
154096686|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096687|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
154096688|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
154096689|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
154096690|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096691|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154096692|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
154096693|NCT00728832|Morphine|morphine|mesh-list
154096694|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154096695|NCT00728832|Narcotics|narcotics|mesh-ancestor
154096696|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154096697|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096699|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
154096700|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096701|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154096702|NCT00728312|Aripiprazole|aripiprazole|mesh-list
154096703|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
154096704|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154096705|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154096706|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154096707|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154096708|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096709|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
154096710|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
154096711|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096712|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096713|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154096714|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154096715|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
154096716|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154096717|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154096718|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154096719|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154096720|NCT00728390|Dacomitinib|dacomitinib|mesh-list
154096721|NCT00728390|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154096722|NCT00728390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096723|NCT00728390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096724|NCT00728390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096725|NCT00728546|Isoniazid|isoniazid|mesh-list
154096726|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
154096727|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154096728|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096729|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154096730|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154096740|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
154096741|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096742|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154096743|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154096744|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096745|NCT04066296|Bupivacaine|bupivacaine|mesh-list
154096746|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
154096747|NCT04066296|Anesthetics|anesthetics|mesh-list
154096748|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154096749|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096750|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
154096751|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096752|NCT02341014|Lenalidomide|lenalidomide|mesh-list
154096753|NCT02341014|Romidepsin|romidepsin|mesh-list
154096754|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
154096755|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096756|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154096757|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154096758|NCT02341014|Growth Substances|growth substances|mesh-ancestor
154096759|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
154096760|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096761|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154096762|NCT02341014|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154096763|NCT02341014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096764|NCT02341014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096765|NCT00868426|Budesonide|budesonide|mesh-list
154096766|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
154096767|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154096768|NCT00868426|Charcoal|charcoal|mesh-list
154096769|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096770|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154096771|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
154096772|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096773|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096778|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154096779|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154096780|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154096781|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154096782|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
154096783|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096784|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096785|NCT00868426|Antidotes|antidotes|mesh-ancestor
154096786|NCT00868426|Protective Agents|protective agents|mesh-ancestor
154096787|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
154096788|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
154096789|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096790|NCT00868738|Vitamin D|vitamin d|mesh-list
154096791|NCT00868738|Vitamins|vitamins|mesh-ancestor
154096792|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
154096793|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096794|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154096795|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
154096796|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096797|NCT02569866|Cephalexin|cephalexin|mesh-list
154096798|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154096799|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096800|NCT00868894|Latanoprost|latanoprost|mesh-list
154096801|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154096802|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154096803|NCT00730938|Cefuroxime|cefuroxime|mesh-list
154096804|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
154096805|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154096806|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096807|NCT00712010|Caseins|caseins|mesh-list
154096808|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
154096809|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
154096810|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096820|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154096821|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096822|NCT00799539|Prednisone|prednisone|mesh-list
154096823|NCT00799539|Bortezomib|bortezomib|mesh-list
154096824|NCT00799539|Melphalan|melphalan|mesh-list
154096825|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096826|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
154096827|NCT00799539|Hormones|hormones|mesh-ancestor
154096828|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154096829|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096830|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154096831|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096832|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154096833|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
154096834|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096835|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154096836|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154096837|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
154096839|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
154096840|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154096841|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
154096842|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096843|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154096844|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096845|NCT00738842|Ticagrelor|ticagrelor|mesh-list
154096846|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154096847|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154096848|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154096849|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154096850|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
153921537|NCT05857384|Hormones|hormones|mesh-ancestor
154096851|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096862|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154096863|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154096864|NCT00729222|Rolofylline|rolofylline|mesh-list
154096865|NCT00729222|Diuretics|diuretics|mesh-ancestor
154096866|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
154096867|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096868|NCT00808743|Celecoxib|celecoxib|mesh-list
154096869|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
154096870|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154096871|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154096872|NCT00808743|Analgesics|analgesics|mesh-ancestor
154096873|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
154096874|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096875|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096876|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096877|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096878|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154096879|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154096880|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096881|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096882|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154096883|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096884|NCT00869596|Fluticasone|fluticasone|mesh-list
154096885|NCT00869596|Xhance|xhance|mesh-list
154096886|NCT00869596|Albuterol|albuterol|mesh-list
154096887|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096888|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154096889|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
154096890|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096891|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096892|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154096893|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
154096894|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
154096895|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154096902|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096903|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096905|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154096906|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
154096907|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154096908|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
154096909|NCT03728478|Etanercept|etanercept|mesh-list
154096910|NCT03728478|Methotrexate|methotrexate|mesh-list
154096911|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154096912|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
154096913|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154096914|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096915|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154096916|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
154096917|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096918|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096919|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
154096920|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096921|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154096922|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154096923|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
154096924|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096925|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154096926|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154096927|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154096928|NCT03728478|Analgesics|analgesics|mesh-ancestor
154096929|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
153726258|NCT00480610|Tacrolimus|tacrolimus|mesh-list
154096930|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096931|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096932|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154096945|NCT00808977|Analgesics|analgesics|mesh-ancestor
154096946|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
154096947|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154096948|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096949|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096950|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154096951|NCT00735020|Vaccines|vaccines|mesh-list
154096952|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
154096953|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096954|NCT04065906|Methylphenidate|methylphenidate|mesh-list
154096955|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154096956|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154096957|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096958|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154096959|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154096960|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154096961|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096962|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
154096963|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154096964|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154096965|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
154096966|NCT00739388|Azacitidine|azacitidine|mesh-list
154096967|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154096968|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
154096969|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096970|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154096971|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096972|NCT00809211|Nilotinib|nilotinib|mesh-list
154096973|NCT00809211|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154096974|NCT00809211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154096975|NCT00809211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096976|NCT00809211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096977|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
154096978|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
154096979|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153563358|NCT01662700|Chloroquine|chloroquine|mesh-list
154096980|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154096981|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154096982|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096983|NCT00862888|Urological Agents|urological agents|mesh-ancestor
154096985|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154096986|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154096987|NCT00862966|Heparin|heparin|mesh-list
154096988|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
153726316|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154096989|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154096990|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154096991|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154096992|NCT02569320|Dexamethasone|dexamethasone|mesh-list
154096993|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
154096994|NCT02569320|Pomalidomide|pomalidomide|mesh-list
154096995|NCT02569320|Ichthammol|ichthammol|mesh-list
154096996|NCT02569320|BB 1101|bb 1101|mesh-list
154096997|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154096998|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154096999|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
154097000|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
154097001|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097002|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097003|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154097004|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
154097005|NCT02569320|Hormones|hormones|mesh-ancestor
154097006|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097007|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154097008|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097009|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
154097018|NCT00739466|Alendronate|alendronate|mesh-list
154097025|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154097026|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
154097027|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
154097028|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097029|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097030|NCT00739622|Rilpivirine|rilpivirine|mesh-list
154097031|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154097032|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154097033|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097034|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097035|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
154097036|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097037|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154097038|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154097039|NCT00731562|Varenicline|varenicline|mesh-list
154097040|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154097041|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154097042|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
154097043|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097044|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097077|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
154097078|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097079|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154097080|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154097081|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097082|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154097083|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
154097084|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154097085|NCT00871156|Chloroquine|chloroquine|mesh-list
154097086|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
154097087|NCT00871156|Tafenoquine|tafenoquine|mesh-list
154097088|NCT00871156|Amebicides|amebicides|mesh-ancestor
154097089|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154097090|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154097091|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097092|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
154097093|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097094|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154097095|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154097096|NCT00871156|Analgesics|analgesics|mesh-ancestor
154097097|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
154097098|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097099|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097100|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154097101|NCT00871156|Filaricides|filaricides|mesh-ancestor
154097102|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
154097103|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
154097104|NCT00734448|Inositol|inositol|mesh-list
154097127|NCT00729404|Estrogens|estrogens|mesh-ancestor
154097128|NCT00729404|Hormones|hormones|mesh-ancestor
154097129|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097130|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154097131|NCT00729404|Progestins|progestins|mesh-ancestor
154097132|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154097133|NCT00731952|Bortezomib|bortezomib|mesh-list
154097134|NCT00731952|Vorinostat|vorinostat|mesh-list
154097135|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097136|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154097137|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097138|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097139|NCT04065932|Deucravacitinib|deucravacitinib|mesh-list
154097140|NCT04065932|Famotidine|famotidine|mesh-list
154097141|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154097142|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154097143|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154097144|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
154097145|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
154097146|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097147|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097148|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097149|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
154097150|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154097151|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097152|NCT06147648|Tacrolimus|tacrolimus|mesh-list
154097153|NCT06147648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097154|NCT06147648|Immunologic Factors|immunologic factors|mesh-ancestor
154097155|NCT06147648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097156|NCT06147648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154097157|NCT06147648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097158|NCT06147648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097159|NCT06147375|Cyclosporine|cyclosporine|mesh-list
154097160|NCT06147375|Tacrolimus|tacrolimus|mesh-list
154097161|NCT06147375|Cyclosporins|cyclosporins|mesh-list
154097162|NCT06147375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097163|NCT06147375|Immunologic Factors|immunologic factors|mesh-ancestor
154097164|NCT06147375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097165|NCT06147375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154097166|NCT06147375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097167|NCT06147375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097168|NCT06147375|Antifungal Agents|antifungal agents|mesh-ancestor
154097169|NCT06147375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097170|NCT06147375|Dermatologic Agents|dermatologic agents|mesh-ancestor
154097171|NCT06147375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097172|NCT06147232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154097173|NCT06147232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154097174|NCT06147232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097175|NCT06147232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097176|NCT06147232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097177|NCT06147050|Metformin|metformin|mesh-list
154097178|NCT06147050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097179|NCT06147050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097180|NCT06146920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154097181|NCT06146920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097182|NCT06146920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097183|NCT06146920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097184|NCT06146881|Hyaluronic Acid|hyaluronic acid|mesh-list
154097185|NCT06146881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154097186|NCT06146881|Immunologic Factors|immunologic factors|mesh-ancestor
154097187|NCT06146881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097188|NCT06146881|Viscosupplements|viscosupplements|mesh-ancestor
154097189|NCT06146881|Protective Agents|protective agents|mesh-ancestor
154097190|NCT06146842|Bupivacaine|bupivacaine|mesh-list
154097191|NCT06146842|Anesthetics, Local|anesthetics, local|mesh-ancestor
154097192|NCT06146842|Anesthetics|anesthetics|mesh-ancestor
154097194|NCT06146842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097206|NCT06146478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154097207|NCT06146478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420465|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
154097208|NCT06146478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154097209|NCT06146478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154097210|NCT06146478|Growth Substances|growth substances|mesh-ancestor
154097211|NCT06146478|Growth Inhibitors|growth inhibitors|mesh-ancestor
154097212|NCT06146478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097213|NCT06146309|Aflibercept|aflibercept|mesh-list
154097214|NCT06146309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154097215|NCT06146309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154097216|NCT06146309|Growth Substances|growth substances|mesh-ancestor
154097217|NCT06146309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097218|NCT06146309|Growth Inhibitors|growth inhibitors|mesh-ancestor
154097219|NCT06146309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097220|NCT06146296|Vitamins|vitamins|mesh-list
154097221|NCT06146296|Ascorbic Acid|ascorbic acid|mesh-list
154097222|NCT06146296|Micronutrients|micronutrients|mesh-ancestor
154097223|NCT06146296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097224|NCT06146296|Antioxidants|antioxidants|mesh-ancestor
154097225|NCT06146296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097226|NCT06146296|Protective Agents|protective agents|mesh-ancestor
154097227|NCT06146192|Colchicine|colchicine|mesh-list
154097228|NCT06146192|Gout Suppressants|gout suppressants|mesh-ancestor
154097229|NCT06146192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097230|NCT06146192|Tubulin Modulators|tubulin modulators|mesh-ancestor
154097231|NCT06146192|Antimitotic Agents|antimitotic agents|mesh-ancestor
154097232|NCT06146192|Mitosis Modulators|mitosis modulators|mesh-ancestor
154097233|NCT06146192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097234|NCT06146192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097250|NCT06145633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097251|NCT06145633|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154097252|NCT06145633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097253|NCT06145633|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154097254|NCT06145633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097255|NCT06145633|Antimetabolites|antimetabolites|mesh-ancestor
154097256|NCT06145633|Antiviral Agents|antiviral agents|mesh-ancestor
154097257|NCT06145490|Caffeine|caffeine|mesh-list
154097258|NCT06145490|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154097259|NCT06145490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097260|NCT06145490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154097261|NCT06145490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097262|NCT06145490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097263|NCT06145490|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154097264|NCT06145490|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154097265|NCT06145490|Purinergic Agents|purinergic agents|mesh-ancestor
154097266|NCT06145490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097267|NCT06145438|Leuprolide|leuprolide|mesh-list
154097268|NCT06145438|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154097269|NCT06145438|Dienogest|dienogest|mesh-list
154097270|NCT06145438|Medroxyprogesterone|medroxyprogesterone|mesh-list
154097271|NCT06145438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154097272|NCT06145438|Contraceptive Agents|contraceptive agents|mesh-list
154097273|NCT06145438|Contraceptives, Oral|contraceptives, oral|mesh-list
154097274|NCT06145438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154097275|NCT06145438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154097276|NCT06145438|Fertility Agents|fertility agents|mesh-ancestor
154097277|NCT06145438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154097278|NCT06145438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097279|NCT06145438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154097280|NCT06145438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097281|NCT06145438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153420531|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097282|NCT06145438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154097283|NCT06145438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153654597|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
154097287|NCT06145438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097288|NCT06145438|Estrogens|estrogens|mesh-ancestor
154097290|NCT06145412|Cisplatin|cisplatin|mesh-list
154097291|NCT06145412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097292|NCT06145399|Deoxyglucose|deoxyglucose|mesh-list
154097293|NCT06145399|Methyltestosterone|methyltestosterone|mesh-list
154097294|NCT06145399|Testosterone|testosterone|mesh-list
154097295|NCT06145399|Testosterone undecanoate|testosterone undecanoate|mesh-list
154097296|NCT06145399|Testosterone enanthate|testosterone enanthate|mesh-list
154097297|NCT06145399|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154097298|NCT06145399|Dihydrotestosterone|dihydrotestosterone|mesh-list
154097299|NCT06145399|Androgens|androgens|mesh-ancestor
154097300|NCT06145399|Hormones|hormones|mesh-ancestor
154097301|NCT06145399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097302|NCT06145399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097303|NCT06145399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154097304|NCT06145399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097305|NCT06145399|Anabolic Agents|anabolic agents|mesh-ancestor
154097306|NCT06145399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097307|NCT06145399|Antimetabolites|antimetabolites|mesh-ancestor
154097308|NCT06145399|Antiviral Agents|antiviral agents|mesh-ancestor
154097309|NCT06145399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097310|NCT06145269|Warfarin|warfarin|mesh-list
154097311|NCT06145269|Rivaroxaban|rivaroxaban|mesh-list
154097312|NCT06145269|Anticoagulants|anticoagulants|mesh-list
154097313|NCT06145269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154097314|NCT06145269|Antithrombins|antithrombins|mesh-ancestor
154097315|NCT06145269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154097316|NCT06145269|Protease Inhibitors|protease inhibitors|mesh-ancestor
154097317|NCT06145269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097334|NCT06145165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097335|NCT06145165|Sensory System Agents|sensory system agents|mesh-ancestor
154097336|NCT06145165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097337|NCT06140823|Liver Extracts|liver extracts|mesh-list
154097338|NCT06140823|Hematinics|hematinics|mesh-ancestor
154097339|NCT06132698|Pemetrexed|pemetrexed|mesh-list
154097340|NCT06132698|Tislelizumab|tislelizumab|mesh-list
154097341|NCT06132698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097342|NCT06132698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097343|NCT06132698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097344|NCT06132698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154097345|NCT06132698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154097346|NCT06132698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097347|NCT06129643|Edetic Acid|edetic acid|mesh-list
154097348|NCT06129643|Anticoagulants|anticoagulants|mesh-ancestor
154097349|NCT06129643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154097350|NCT06129643|Chelating Agents|chelating agents|mesh-ancestor
154097351|NCT06129643|Sequestering Agents|sequestering agents|mesh-ancestor
154097352|NCT06129643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097353|NCT06128096|Dapagliflozin|dapagliflozin|mesh-list
154097354|NCT06128096|Empagliflozin|empagliflozin|mesh-list
154097355|NCT06128096|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154097356|NCT06128096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097357|NCT06128096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097358|NCT06128096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097359|NCT06117839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153726369|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
154097360|NCT06117839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097361|NCT06116409|Bupivacaine|bupivacaine|mesh-list
154097371|NCT06091904|Sufentanil|sufentanil|mesh-list
154097380|NCT06091904|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154097381|NCT06091904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154097382|NCT06091904|Anesthetics, General|anesthetics, general|mesh-ancestor
154097383|NCT06091904|Anesthetics|anesthetics|mesh-ancestor
154097384|NCT06087757|Clemastine|clemastine|mesh-list
154097385|NCT06087757|Antipruritics|antipruritics|mesh-ancestor
154097386|NCT06087757|Dermatologic Agents|dermatologic agents|mesh-ancestor
154097387|NCT06087757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154097388|NCT06087757|Histamine Antagonists|histamine antagonists|mesh-ancestor
154097389|NCT06087757|Histamine Agents|histamine agents|mesh-ancestor
154097390|NCT06087757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097391|NCT06087757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097392|NCT06087757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097393|NCT06087757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154097394|NCT06060210|Ketamine|ketamine|mesh-list
154097395|NCT06060210|Analgesics|analgesics|mesh-ancestor
154097396|NCT06060210|Sensory System Agents|sensory system agents|mesh-ancestor
154097397|NCT06060210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097398|NCT06060210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097399|NCT06060210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154097400|NCT06060210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154097401|NCT06060210|Anesthetics, General|anesthetics, general|mesh-ancestor
154097402|NCT06060210|Anesthetics|anesthetics|mesh-ancestor
154097403|NCT06060210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097404|NCT06060210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154097405|NCT06060210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154097406|NCT06060210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097407|NCT06060210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097408|NCT06017284|Thalidomide|thalidomide|mesh-list
154097409|NCT06017284|Paclitaxel|paclitaxel|mesh-list
154097410|NCT06017284|Gemcitabine|gemcitabine|mesh-list
154097411|NCT06017284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154097423|NCT06017284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154097424|NCT06017284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097425|NCT06017284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154097426|NCT06017284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154097428|NCT06017284|Growth Inhibitors|growth inhibitors|mesh-ancestor
154097429|NCT05991453|Propofol|propofol|mesh-list
154097430|NCT05991453|Anesthetics|anesthetics|mesh-list
154097431|NCT05991453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154097432|NCT05991453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097433|NCT05991453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097434|NCT05991453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154097435|NCT05991453|Anesthetics, General|anesthetics, general|mesh-ancestor
154097436|NCT05987657|Progesterone|progesterone|mesh-list
154097437|NCT05987657|Progestins|progestins|mesh-ancestor
154097438|NCT05987657|Hormones|hormones|mesh-ancestor
154097439|NCT05987657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097440|NCT05987657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097441|NCT05983588|Glycerol|glycerol|mesh-list
154097442|NCT05983588|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154097443|NCT05983588|Protective Agents|protective agents|mesh-ancestor
154097444|NCT05983588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097476|NCT05950646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154097477|NCT05950646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154097478|NCT05950646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154097479|NCT05950646|Adrenergic Agents|adrenergic agents|mesh-ancestor
154097480|NCT05950646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097481|NCT05950646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097482|NCT05950646|Antidepressive Agents|antidepressive agents|mesh-ancestor
154097483|NCT05950646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154097484|NCT05949008|Metformin|metformin|mesh-list
154097485|NCT05949008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097486|NCT05949008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097487|NCT05942911|Hydroxychloroquine|hydroxychloroquine|mesh-list
154097488|NCT05942911|Cannabidiol|cannabidiol|mesh-list
154097489|NCT05942911|Antimalarials|antimalarials|mesh-ancestor
154097490|NCT05942911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154097491|NCT05942911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154097492|NCT05942911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097493|NCT05942911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097494|NCT05942911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097495|NCT05942911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097496|NCT05942911|Anticonvulsants|anticonvulsants|mesh-ancestor
154097497|NCT05940896|Disitamab vedotin|disitamab vedotin|mesh-list
154097498|NCT05940896|Immunoconjugates|immunoconjugates|mesh-ancestor
154097499|NCT05940896|Immunologic Factors|immunologic factors|mesh-ancestor
154097500|NCT05940896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097501|NCT05895773|Povidone-Iodine|povidone-iodine|mesh-list
154097502|NCT05895773|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
154097503|NCT05895773|Povidone|povidone|mesh-list
154097504|NCT05895773|Plasma Substitutes|plasma substitutes|mesh-ancestor
154097505|NCT05895773|Blood Substitutes|blood substitutes|mesh-ancestor
154097506|NCT05895773|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154097507|NCT05895773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097508|NCT05895773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154097509|NCT05866354|Tisotumab vedotin|tisotumab vedotin|mesh-list
154097519|NCT05863442|Immunologic Factors|immunologic factors|mesh-ancestor
154097520|NCT05863442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097521|NCT05855746|Colchicine|colchicine|mesh-list
154097522|NCT05855746|Gout Suppressants|gout suppressants|mesh-ancestor
154097523|NCT05855746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097524|NCT05855746|Tubulin Modulators|tubulin modulators|mesh-ancestor
154097525|NCT05855746|Antimitotic Agents|antimitotic agents|mesh-ancestor
154097526|NCT05855746|Mitosis Modulators|mitosis modulators|mesh-ancestor
154097527|NCT05855746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097528|NCT05855746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097529|NCT05827068|Vaccines|vaccines|mesh-list
154097530|NCT05827068|Immunologic Factors|immunologic factors|mesh-ancestor
154097531|NCT05827068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097532|NCT05821933|Aflutinib|aflutinib|mesh-list
154097533|NCT05821933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154097534|NCT05821933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097535|NCT05821933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097536|NCT05819853|Metformin|metformin|mesh-list
154097537|NCT05819853|Semaglutide|semaglutide|mesh-list
154097538|NCT05819853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097539|NCT05819853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097540|NCT05819853|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154097541|NCT05815264|Vaccines|vaccines|mesh-list
154097542|NCT05815264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154097543|NCT05815264|Immunologic Factors|immunologic factors|mesh-ancestor
154097544|NCT05815264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097545|NCT05788458|Bupivacaine|bupivacaine|mesh-list
154097546|NCT05788458|Anesthetics, Local|anesthetics, local|mesh-ancestor
154097567|NCT05732883|Glucocorticoids|glucocorticoids|mesh-ancestor
154097568|NCT05732883|Hormones|hormones|mesh-ancestor
154097569|NCT05732883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097570|NCT05732883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154097571|NCT05732883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097572|NCT05727189|Idazoxan|idazoxan|mesh-list
154097573|NCT05727189|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154097574|NCT05727189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154097575|NCT05727189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154097576|NCT05727189|Adrenergic Agents|adrenergic agents|mesh-ancestor
154097577|NCT05727189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097578|NCT05727189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097579|NCT05727189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097580|NCT05704036|Estradiol|estradiol|mesh-list
154097581|NCT05704036|Estrogens|estrogens|mesh-list
154097582|NCT05704036|Progesterone|progesterone|mesh-list
154097583|NCT05704036|Hormones|hormones|mesh-ancestor
154097584|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097585|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097587|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
154097588|NCT05703048|Esmolol|esmolol|mesh-list
154097589|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154097590|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097591|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097592|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154097593|NCT05703048|Analgesics|analgesics|mesh-ancestor
154097594|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
154097595|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097596|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154097608|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097609|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097610|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097611|NCT05696938|Niacinamide|niacinamide|mesh-list
154097612|NCT05696938|Niacin|niacin|mesh-list
154097613|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
154097614|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
154097615|NCT05696938|Vitamins|vitamins|mesh-ancestor
154097616|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
154097617|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097618|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154097619|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
154097620|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097621|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154097622|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
154097623|NCT05683171|Rituximab|rituximab|mesh-list
154097624|NCT05683171|Lenalidomide|lenalidomide|mesh-list
154097625|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097667|NCT05588219|Tislelizumab|tislelizumab|mesh-list
154097668|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154097669|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097670|NCT05588219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097671|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097672|NCT05585346|Thiamine|thiamine|mesh-list
154097673|NCT05585346|Vitamins|vitamins|mesh-ancestor
154097674|NCT05585346|Micronutrients|micronutrients|mesh-ancestor
154097675|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097676|NCT05585346|Vitamin B Complex|vitamin b complex|mesh-ancestor
154097677|NCT05555706|Paclitaxel|paclitaxel|mesh-list
154097678|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154097679|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097680|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
154097681|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
154097682|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
154097683|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097684|NCT05545384|Rituximab|rituximab|mesh-list
154097685|NCT05545384|Azathioprine|azathioprine|mesh-list
154097686|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154097687|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097688|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
154097689|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097690|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097691|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
154097694|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097715|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154097716|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154097717|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097718|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097719|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154097720|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
154097721|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097722|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097723|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
154097724|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
154097725|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
154097726|NCT05439564|Morphine|morphine|mesh-list
154097727|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154097728|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154097729|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097730|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154097731|NCT05439564|Analgesics|analgesics|mesh-ancestor
153420980|NCT06289205|Methotrexate|methotrexate|mesh-list
154097732|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
154097733|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097734|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154097735|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154097736|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154097737|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
154097738|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097739|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097740|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154097741|NCT05439564|Narcotics|narcotics|mesh-ancestor
154097743|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097744|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
154097745|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154097746|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
154097747|NCT05400603|Irinotecan|irinotecan|mesh-list
154097748|NCT05400603|Temozolomide|temozolomide|mesh-list
154097754|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097755|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154097756|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
154097757|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154097758|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097759|NCT05359068|Valsartan|valsartan|mesh-list
154097760|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154097761|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154097762|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154097763|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097764|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
154097765|NCT05357027|Fludarabine|fludarabine|mesh-list
154097766|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097767|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
154097768|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097769|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097770|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154097771|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
154097773|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097808|NCT05292404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154097809|NCT05292209|Riluzole|riluzole|mesh-list
154097810|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
154097811|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154097812|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154097813|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097814|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097815|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097816|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154097817|NCT05292209|Protective Agents|protective agents|mesh-ancestor
154097818|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154097819|NCT05275894|Metronidazole|metronidazole|mesh-list
154097820|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154097821|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154097822|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154097824|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
154097825|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097826|NCT05255159|Furosemide|furosemide|mesh-list
154097827|NCT05255159|Diuretics|diuretics|mesh-ancestor
154097828|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
154097829|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097830|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154097831|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154097833|NCT05222555|Lenalidomide|lenalidomide|mesh-list
154097860|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097861|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097862|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154097863|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154097864|NCT05199324|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154097865|NCT05199324|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154097866|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154097867|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
154097868|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154097869|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154097870|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154097871|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154097872|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154097873|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154097874|NCT05169866|Amiodarone|amiodarone|mesh-list
154097875|NCT05169866|Nifekalant|nifekalant|mesh-list
154097876|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154097877|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
154097878|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154097879|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154097880|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097881|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154097882|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154097906|NCT05073692|Liraglutide|liraglutide|mesh-list
154097907|NCT05073692|Exenatide|exenatide|mesh-list
154097908|NCT05073692|Empagliflozin|empagliflozin|mesh-list
154097909|NCT05073692|Glimepiride|glimepiride|mesh-list
154097910|NCT05073692|Linagliptin|linagliptin|mesh-list
154097911|NCT05073692|Saxagliptin|saxagliptin|mesh-list
154097912|NCT05073692|Alogliptin|alogliptin|mesh-list
154097913|NCT05073692|Glipizide|glipizide|mesh-list
154097914|NCT05073692|Glucagon|glucagon|mesh-list
154097915|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154097916|NCT05073692|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154097917|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154097918|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097919|NCT05073692|Incretins|incretins|mesh-ancestor
154097920|NCT05073692|Hormones|hormones|mesh-ancestor
154097921|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154097922|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154097923|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097924|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154097925|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154097926|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097927|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
154097928|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154097929|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
154097930|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097931|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154097932|NCT05046314|Vincristine|vincristine|mesh-list
154097933|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154097934|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097935|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
154097936|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
154097937|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
154097951|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
154097952|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154097953|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154097954|NCT05009992|Protective Agents|protective agents|mesh-ancestor
154097955|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154097956|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154097957|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154097958|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097959|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154097961|NCT05001555|Analgesics|analgesics|mesh-ancestor
154097962|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
154097963|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154097964|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154097965|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097966|NCT04978584|Prednisone|prednisone|mesh-list
154097967|NCT04978584|Cortisone|cortisone|mesh-list
154097968|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
154097969|NCT04978584|Rituximab|rituximab|mesh-list
154097970|NCT04978584|Doxorubicin|doxorubicin|mesh-list
154097971|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154097972|NCT04978584|Vincristine|vincristine|mesh-list
154097973|NCT04978584|Lenalidomide|lenalidomide|mesh-list
154097974|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
154097975|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154097976|NCT04978584|Antibodies|antibodies|mesh-list
154097977|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
154097978|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154097979|NCT04978584|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154097980|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154097981|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
154097982|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154097983|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154097997|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154097998|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154097999|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
154098000|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
154098001|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
154098002|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154098003|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154098004|NCT04978584|Growth Substances|growth substances|mesh-ancestor
154098005|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
154098006|NCT04978584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098008|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154098009|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154098010|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098011|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098012|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154098013|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154098014|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154098015|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154098016|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
154098017|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
154098018|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
154098019|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
154098020|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098021|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098022|NCT04970576|Warfarin|warfarin|mesh-list
154098023|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
154098024|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
154098025|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154098026|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
154098027|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154098028|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
154098029|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098031|NCT04941716|Venetoclax|venetoclax|mesh-list
154098041|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
154098042|NCT04933331|Protective Agents|protective agents|mesh-ancestor
154098043|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098044|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154098045|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098046|NCT04900155|Atorvastatin|atorvastatin|mesh-list
154098047|NCT04900155|Ezetimibe|ezetimibe|mesh-list
154098048|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154098049|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154098050|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
154098051|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098052|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154098053|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154098054|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098055|NCT04896164|Curcumin|curcumin|mesh-list
154098056|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154098057|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154098058|NCT04896164|Analgesics|analgesics|mesh-ancestor
154098059|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
154098060|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098061|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098094|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154098095|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098096|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
154098097|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
154098098|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
154098099|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098100|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098101|NCT04821817|Rocuronium|rocuronium|mesh-list
154098102|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154098103|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154098104|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154098105|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098106|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098107|NCT04787341|Panitumumab|panitumumab|mesh-list
154098108|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098109|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098110|NCT04786275|Fentanyl|fentanyl|mesh-list
154098111|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154098113|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098114|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098115|NCT04786275|Analgesics|analgesics|mesh-ancestor
154098116|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
154098117|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098118|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154098119|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154098143|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098144|NCT04707196|Fulvestrant|fulvestrant|mesh-list
154098145|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154098146|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098147|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098148|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154098149|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154098150|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
154098151|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098152|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098153|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154098154|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098155|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098156|NCT04667663|Dexamethasone|dexamethasone|mesh-list
154098157|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
154098158|NCT04667663|Daratumumab|daratumumab|mesh-list
154098159|NCT04667663|Pomalidomide|pomalidomide|mesh-list
154098160|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154098161|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
154098162|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098163|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098164|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154098165|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
154098166|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098167|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098168|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154098169|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098170|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
154098171|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
154098172|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098173|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098174|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
154098181|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
154098182|NCT04652076|Paclitaxel|paclitaxel|mesh-list
154098183|NCT04652076|Carboplatin|carboplatin|mesh-list
154098185|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154098186|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098187|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
154098188|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
154098189|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
154098190|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098191|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098192|NCT04652076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154098193|NCT04632758|Crizotinib|crizotinib|mesh-list
154098194|NCT04632758|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154098195|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098196|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098197|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098198|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098199|NCT04629209|TIC10 compound|tic10 compound|mesh-list
154098200|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098201|NCT04627285|Lacosamide|lacosamide|mesh-list
154098202|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
153726472|NCT00481819|Protective Agents|protective agents|mesh-ancestor
154098203|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154098204|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154098205|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154098206|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098207|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154098208|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
154098209|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098226|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098227|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098228|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154098229|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154098230|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
154098231|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154098232|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154098233|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
154098234|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098235|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098236|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154098237|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154098238|NCT04551963|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154098239|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098240|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098241|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154098242|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154098280|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
154098281|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098282|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098283|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154098284|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154098285|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154098286|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154098287|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154098288|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
154098289|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
154098290|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
154098291|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
154098292|NCT04347434|Atorvastatin|atorvastatin|mesh-list
154098293|NCT04347434|Ezetimibe|ezetimibe|mesh-list
154098294|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154098295|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154098296|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
154098297|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098298|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154098299|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154098300|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098301|NCT04343170|Folic Acid|folic acid|mesh-list
154098302|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
154098303|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
154098304|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
154098305|NCT04343170|Vitamins|vitamins|mesh-ancestor
154098306|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
154098307|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098308|NCT04343170|Hematinics|hematinics|mesh-ancestor
154098309|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
154098310|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
154098311|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098312|NCT04336046|Bupivacaine|bupivacaine|mesh-list
154098313|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
154098314|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
154098315|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098316|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098317|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
154098318|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098320|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154098321|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098322|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098323|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154098324|NCT04331418|Analgesics|analgesics|mesh-ancestor
154098325|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
154098326|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098327|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154098395|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
154098396|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098397|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098398|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154098399|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
154098400|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098401|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098402|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154098403|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154098404|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098405|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
154098406|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098407|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
154098408|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154098410|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154098411|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
154098412|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154098414|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
154098415|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
154098416|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098417|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098418|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
154098419|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098420|NCT04187352|Cisplatin|cisplatin|mesh-list
154098421|NCT04187352|Fluorouracil|fluorouracil|mesh-list
154098422|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098423|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
154098424|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098425|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154098426|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154098427|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
154098428|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098438|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154098439|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154098440|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098441|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098442|NCT04120311|Dexamethasone|dexamethasone|mesh-list
154098443|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
154098444|NCT04120311|BB 1101|bb 1101|mesh-list
154098445|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098446|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
154098447|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
154098448|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098449|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098450|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098451|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
154098452|NCT04120311|Hormones|hormones|mesh-ancestor
154098453|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098454|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098455|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098456|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
154098457|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098458|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098459|NCT04116528|Ketamine|ketamine|mesh-list
154098460|NCT04116528|Buprenorphine|buprenorphine|mesh-list
154098461|NCT04116528|Analgesics|analgesics|mesh-ancestor
154098462|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
154098463|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098464|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098465|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154098466|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154098467|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
154098482|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098483|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154098484|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154098486|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154098488|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154098489|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
154098490|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098491|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154098492|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154098493|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
154098494|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154098496|NCT04017650|Cetuximab|cetuximab|mesh-list
154098497|NCT04017650|Antibodies|antibodies|mesh-list
154098498|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
154098499|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154098500|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
154098501|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098502|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098503|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154098504|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098505|NCT04005430|Dexamethasone|dexamethasone|mesh-list
154098506|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
154098507|NCT04005430|BB 1101|bb 1101|mesh-list
154098508|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098509|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
154098510|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
154098511|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098512|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098513|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098514|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
154098515|NCT04005430|Hormones|hormones|mesh-ancestor
154098516|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098517|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098518|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098523|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154098524|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
154098525|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098526|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098527|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
154098528|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154098529|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
154098530|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098531|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
154098532|NCT03906877|Protective Agents|protective agents|mesh-ancestor
154098533|NCT03901001|Sirolimus|sirolimus|mesh-list
154098534|NCT03901001|Oseltamivir|oseltamivir|mesh-list
154098535|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154098536|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098537|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154098538|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098539|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
154098540|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154098541|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
154098542|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098543|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098544|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098545|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
154098546|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
154098547|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154098548|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
154098549|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098550|NCT03900988|Expectorants|expectorants|mesh-ancestor
154098551|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
154098552|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154098553|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
154098554|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098555|NCT03900988|Protective Agents|protective agents|mesh-ancestor
154098557|NCT03900988|Antidotes|antidotes|mesh-ancestor
154098565|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154098566|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098567|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098568|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
154098569|NCT03824327|Urological Agents|urological agents|mesh-ancestor
154098570|NCT03809013|Trastuzumab|trastuzumab|mesh-list
154098571|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098572|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098573|NCT03802240|Pemetrexed|pemetrexed|mesh-list
154098574|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098575|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098576|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098577|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154098578|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154098579|NCT03796572|Ropivacaine|ropivacaine|mesh-list
154098580|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
154098581|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
154098582|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098583|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098584|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
154098585|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098586|NCT03786237|ON 01910|on 01910|mesh-list
154098587|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098588|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098589|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098590|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098591|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154098592|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
154098593|NCT03734237|Vaccines|vaccines|mesh-list
154098609|NCT03693872|Protective Agents|protective agents|mesh-ancestor
154098610|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154098611|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154098612|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154098613|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154098614|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
154098615|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098616|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098617|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098618|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
154098619|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098621|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154098622|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
154098623|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098624|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098625|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098626|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154098627|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098628|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154098629|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
154098637|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098638|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098639|NCT03529201|Analgesics|analgesics|mesh-ancestor
154098640|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
154098641|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098642|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154098643|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154098644|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
154098645|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
154098646|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154098647|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154098648|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154098649|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154098652|NCT03510208|Panitumumab|panitumumab|mesh-list
154098653|NCT03510208|Antibodies|antibodies|mesh-list
154098654|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
154098655|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154098656|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
154098657|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098658|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098659|NCT03496623|Treprostinil|treprostinil|mesh-list
154098660|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154098661|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154098662|NCT03473561|Racecadotril|racecadotril|mesh-list
154098663|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
154098664|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098665|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
154098666|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098667|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098668|NCT03471260|Azacitidine|azacitidine|mesh-list
154098669|NCT03471260|Venetoclax|venetoclax|mesh-list
154098670|NCT03471260|Ivosidenib|ivosidenib|mesh-list
154098671|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154098672|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
154098673|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098674|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098675|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098681|NCT03455517|Rituximab|rituximab|mesh-list
154098682|NCT03455517|Venetoclax|venetoclax|mesh-list
154098683|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098684|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098685|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
154098686|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098687|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098688|NCT03431168|Azithromycin|azithromycin|mesh-list
154098689|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154098690|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154098691|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098692|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154098698|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098699|NCT03419481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154098700|NCT03419481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098701|NCT03404908|Acetaminophen|acetaminophen|mesh-list
154098703|NCT03404908|Ketoprofen|ketoprofen|mesh-list
154098704|NCT03404908|Morphine|morphine|mesh-list
154098705|NCT03404908|Ropivacaine|ropivacaine|mesh-list
154098706|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153345543|NCT00016718|Didanosine|didanosine|mesh-list
154098707|NCT03404908|Narcotics|narcotics|mesh-ancestor
154098708|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154098709|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098710|NCT03404908|Analgesics|analgesics|mesh-ancestor
154098711|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
154098712|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098713|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
154098715|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154098716|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
154098717|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154098718|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098719|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154098720|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154098721|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098722|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098723|NCT03399032|Caspofungin|caspofungin|mesh-list
154098724|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
154098725|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098726|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098727|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098728|NCT03366272|Rituximab|rituximab|mesh-list
154098729|NCT03366272|Nivolumab|nivolumab|mesh-list
154098730|NCT03366272|Gemcitabine|gemcitabine|mesh-list
154098731|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
154098732|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098733|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098737|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154098739|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098740|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154098741|NCT03363217|Trametinib|trametinib|mesh-list
154098742|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098743|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098744|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098745|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098746|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154098747|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098748|NCT03313804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098749|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098750|NCT03229200|Ibrutinib|ibrutinib|mesh-list
154098751|NCT03229200|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154098752|NCT03229200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098753|NCT03229200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098754|NCT03229200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098755|NCT03224507|Dexamethasone|dexamethasone|mesh-list
154098756|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
154098757|NCT03224507|Lenalidomide|lenalidomide|mesh-list
154098758|NCT03224507|Daratumumab|daratumumab|mesh-list
154098759|NCT03224507|BB 1101|bb 1101|mesh-list
154098760|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154098761|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098762|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
154098763|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
154098764|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098765|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098766|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098767|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
154098768|NCT03224507|Hormones|hormones|mesh-ancestor
154098769|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098770|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098775|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
154098776|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154098777|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154098778|NCT03224507|Growth Substances|growth substances|mesh-ancestor
154098779|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
154098780|NCT03215030|Dexamethasone|dexamethasone|mesh-list
154098781|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098782|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
154098783|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
154098784|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422034|NCT04908189|Apremilast|apremilast|mesh-list
154098785|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098786|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098787|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
154098788|NCT03215030|Hormones|hormones|mesh-ancestor
154098789|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098790|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098791|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098792|NCT03193190|Leucovorin|leucovorin|mesh-list
154098793|NCT03193190|Paclitaxel|paclitaxel|mesh-list
154098794|NCT03193190|Bevacizumab|bevacizumab|mesh-list
154098795|NCT03193190|Gemcitabine|gemcitabine|mesh-list
154098796|NCT03193190|Fluorouracil|fluorouracil|mesh-list
154098797|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
154098798|NCT03193190|Atezolizumab|atezolizumab|mesh-list
154098799|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154098800|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098801|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
154098802|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
154098803|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
154098804|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098805|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098806|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154098807|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154098808|NCT03193190|Growth Substances|growth substances|mesh-ancestor
154098810|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
154098815|NCT03193190|Antidotes|antidotes|mesh-ancestor
154098816|NCT03193190|Protective Agents|protective agents|mesh-ancestor
154098817|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
154098818|NCT03193190|Vitamins|vitamins|mesh-ancestor
154098819|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
154098820|NCT03193190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154098821|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154098822|NCT03169985|Ezetimibe|ezetimibe|mesh-list
154098823|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154098824|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154098825|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
154098826|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098827|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154098828|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154098829|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098830|NCT03153527|Prednisone|prednisone|mesh-list
154098831|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098832|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
154098833|NCT03153527|Hormones|hormones|mesh-ancestor
154098834|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098835|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098836|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098837|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098838|NCT03119012|Aspirin|aspirin|mesh-list
154098839|NCT03119012|Clopidogrel|clopidogrel|mesh-list
154098840|NCT03119012|Ticagrelor|ticagrelor|mesh-list
154098841|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154098842|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154098843|NCT03119012|Analgesics|analgesics|mesh-ancestor
154098844|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
154098845|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098846|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098858|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154098859|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
154098860|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098861|NCT03117010|Dexamethasone|dexamethasone|mesh-list
154098862|NCT03117010|Etoposide|etoposide|mesh-list
154098863|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154098864|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
154098865|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
154098866|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098867|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098868|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098869|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
154098870|NCT03117010|Hormones|hormones|mesh-ancestor
154098871|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098872|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098873|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098874|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098875|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098876|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154098877|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154098878|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154098879|NCT03085147|Olaparib|olaparib|mesh-list
154098880|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154098881|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098882|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098883|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098884|NCT03046862|Gemcitabine|gemcitabine|mesh-list
154098885|NCT03046862|Durvalumab|durvalumab|mesh-list
154098886|NCT03046862|Tremelimumab|tremelimumab|mesh-list
154098887|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098888|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154098889|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
154098890|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098891|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154098892|NCT03031210|Amoxicillin|amoxicillin|mesh-list
154098897|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098898|NCT02988921|Paclitaxel|paclitaxel|mesh-list
154098899|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154098900|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098901|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
154098902|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
154098903|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
154098904|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098905|NCT02981615|Levofloxacin|levofloxacin|mesh-list
153726709|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
154098906|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154098907|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154098908|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154098909|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154098910|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154098911|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098912|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098913|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098914|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154098915|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154098916|NCT02944799|Vitamin D|vitamin d|mesh-list
154098917|NCT02944799|Alendronate|alendronate|mesh-list
154098918|NCT02944799|Calcium|calcium|mesh-list
154098919|NCT02944799|Vitamins|vitamins|mesh-ancestor
154098920|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
154098921|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098922|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154098923|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154098924|NCT02923947|Osimertinib|osimertinib|mesh-list
154098925|NCT02923947|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154098926|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098938|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098939|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
154098941|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154098942|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154098943|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098944|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
154098945|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098946|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098947|NCT02864004|Apomorphine|apomorphine|mesh-list
154098948|NCT02864004|Emetics|emetics|mesh-ancestor
154098949|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098950|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
154098951|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154098952|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154098953|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
154098954|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
154098955|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154098956|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098957|NCT02842424|Ramipril|ramipril|mesh-list
154098958|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154098959|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
154098960|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098961|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154098962|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154098968|NCT02716012|Sorafenib|sorafenib|mesh-list
154098969|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098970|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154098971|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154098981|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
154098982|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154098983|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154098984|NCT02521493|Cytarabine|cytarabine|mesh-list
154098985|NCT02521493|Etoposide|etoposide|mesh-list
154098986|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
154098987|NCT02521493|Daunorubicin|daunorubicin|mesh-list
154098988|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
154098989|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
154098990|NCT02521493|Asparaginase|asparaginase|mesh-list
154098991|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
154098992|NCT02521493|Thioguanine|thioguanine|mesh-list
154098993|NCT02521493|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
154098994|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
154098995|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154098996|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154098997|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154098998|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154098999|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099000|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099001|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154099002|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
154099003|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
154099004|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099005|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354300|NCT02184416|Sorafenib|sorafenib|mesh-list
154099006|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
154099007|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099008|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099009|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154099011|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
154099012|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099013|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
154099014|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
154099027|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
154099028|NCT02419495|Capecitabine|capecitabine|mesh-list
154099029|NCT02419495|Fluorouracil|fluorouracil|mesh-list
154099030|NCT02419495|Nivolumab|nivolumab|mesh-list
154099031|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
154099032|NCT02419495|Irinotecan|irinotecan|mesh-list
154099033|NCT02419495|Pemetrexed|pemetrexed|mesh-list
154099034|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154099035|NCT02419495|Ipilimumab|ipilimumab|mesh-list
154099036|NCT02419495|Daunorubicin|daunorubicin|mesh-list
154099037|NCT02419495|Topotecan|topotecan|mesh-list
154099038|NCT02419495|Olaparib|olaparib|mesh-list
154099039|NCT02419495|Calcium|calcium|mesh-list
154099040|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
154099041|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154099042|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099043|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
154099044|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
154099045|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
154099046|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099047|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099048|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
154099049|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099050|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099051|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154099052|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
154099053|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154099054|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099055|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154099056|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154099057|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099058|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099059|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154099060|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154099068|NCT02419495|Vitamins|vitamins|mesh-ancestor
154099071|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154099072|NCT02419495|Hematinics|hematinics|mesh-ancestor
154099073|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154099074|NCT02385617|Octreotide|octreotide|mesh-list
154099075|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099076|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154099077|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099078|NCT02381249|Octreotide|octreotide|mesh-list
154099079|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099080|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154099081|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099082|NCT02339922|Rituximab|rituximab|mesh-list
154099083|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154099085|NCT02339922|Antibodies|antibodies|mesh-list
154099086|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
154099087|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154099088|NCT02339922|Glycine|glycine|mesh-list
154099089|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
154099090|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099091|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099092|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099093|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099094|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
154099095|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099096|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
154099097|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099098|NCT02332356|Adalimumab|adalimumab|mesh-list
154099099|NCT02332356|Infliximab|infliximab|mesh-list
154099100|NCT02332356|Azathioprine|azathioprine|mesh-list
154099101|NCT02332356|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154099102|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154099103|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099104|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
154099105|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099115|NCT02193620|Narcotics|narcotics|mesh-ancestor
154099116|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099117|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099118|NCT02193620|Analgesics|analgesics|mesh-ancestor
154099119|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
154099120|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099121|NCT02183168|Indomethacin|indomethacin|mesh-list
154099122|NCT02183168|Meloxicam|meloxicam|mesh-list
154099123|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154099124|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154099125|NCT02183168|Analgesics|analgesics|mesh-ancestor
154099126|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
154099127|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099128|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099129|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154099130|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099131|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
154099132|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
154099133|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154099134|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154099135|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099136|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099137|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154099138|NCT02183129|Diclofenac|diclofenac|mesh-list
154099139|NCT02183129|Meloxicam|meloxicam|mesh-list
154099140|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154099141|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154099142|NCT02183129|Analgesics|analgesics|mesh-ancestor
154099143|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
154099144|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099145|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099146|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154099147|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099148|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154099152|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
154099153|NCT02176967|Carboplatin|carboplatin|mesh-list
154099154|NCT02176967|Doxorubicin|doxorubicin|mesh-list
154099155|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154099156|NCT02176967|Etoposide|etoposide|mesh-list
154099157|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
154099158|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
154099159|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099160|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
154099161|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099162|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099163|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154099164|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
154099165|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099166|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099167|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154099168|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099169|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154099170|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154099171|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099172|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154099173|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
154099174|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
154099175|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
154099176|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
154099177|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
154099178|NCT01843530|Cortisone|cortisone|mesh-list
154099179|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154099180|NCT01720563|Leucovorin|leucovorin|mesh-list
154099181|NCT01720563|Tegafur|tegafur|mesh-list
154099182|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099183|NCT01720563|Antidotes|antidotes|mesh-ancestor
154099184|NCT01720563|Protective Agents|protective agents|mesh-ancestor
154099185|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099186|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
154099187|NCT01720563|Vitamins|vitamins|mesh-ancestor
154099188|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
154099193|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154099194|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
154099195|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099196|NCT01502280|Protective Agents|protective agents|mesh-ancestor
154099197|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099198|NCT01502280|Vitamins|vitamins|mesh-ancestor
154099199|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
154099200|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154099201|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
154099202|NCT01485809|Gefitinib|gefitinib|mesh-list
154099203|NCT01485809|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154099204|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099205|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099206|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099207|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099208|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
154099209|NCT01413100|Plerixafor|plerixafor|mesh-list
154099210|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
154099211|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
154099212|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154099213|NCT01413100|Lenograstim|lenograstim|mesh-list
154099214|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099215|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
154099216|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099217|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099218|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154099219|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
154099220|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099221|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099222|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154099223|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154099237|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
154099238|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099239|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099240|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099241|NCT01331681|Aflibercept|aflibercept|mesh-list
154099242|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154099243|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154099244|NCT01331681|Growth Substances|growth substances|mesh-ancestor
154099245|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099246|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
154099247|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099248|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
154099249|NCT01286272|Bortezomib|bortezomib|mesh-list
154099250|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154099251|NCT01286272|Ofatumumab|ofatumumab|mesh-list
154099252|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154099253|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154099254|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099255|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154099256|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
154099257|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099258|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154099259|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
154099260|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
154099261|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099262|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
154099263|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099264|NCT01215136|Paclitaxel|paclitaxel|mesh-list
154099265|NCT01215136|Everolimus|everolimus|mesh-list
154099266|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154099267|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099268|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
154099269|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
154099270|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
154099271|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099272|NCT01215136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154099273|NCT01215136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099274|NCT01215136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099275|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099276|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
154099277|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099278|NCT01142401|Bortezomib|bortezomib|mesh-list
154099279|NCT01142401|Fulvestrant|fulvestrant|mesh-list
154099280|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099281|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154099282|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154099283|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154099284|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
153726844|NCT01241383|Bosentan|bosentan|mesh-list
154099285|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099286|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099287|NCT00870636|Bevacizumab|bevacizumab|mesh-list
154099288|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154099289|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099290|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154099291|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154099292|NCT00870636|Growth Substances|growth substances|mesh-ancestor
154099293|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099294|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
154099328|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154099329|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154099330|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099331|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154099333|NCT00482807|Goserelin|goserelin|mesh-list
154099334|NCT00482807|Bicalutamide|bicalutamide|mesh-list
154099335|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099336|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
154099337|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
154099338|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
154099339|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099340|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154099341|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
154099342|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
154099343|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099345|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154099384|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099385|NCT00729638|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154099386|NCT00729638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099387|NCT00729638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099388|NCT00729638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099389|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099390|NCT00734682|Irinotecan|irinotecan|mesh-list
154099391|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154099392|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154099393|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099394|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099395|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099396|NCT00732108|Topiramate|topiramate|mesh-list
154099397|NCT00732108|Lactulose|lactulose|mesh-list
154099398|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
154099399|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154099400|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099401|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099402|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
154099403|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
154099404|NCT00876616|Tacrolimus|tacrolimus|mesh-list
153726845|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154099405|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099406|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
154099407|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099408|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099409|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154099410|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
154099434|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099435|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099436|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099437|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
154099438|NCT00729794|Hormones|hormones|mesh-ancestor
154099439|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099440|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154099441|NCT00729794|Protective Agents|protective agents|mesh-ancestor
154099442|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154099443|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154099444|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
154099445|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099446|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099447|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154099448|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154099449|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154099450|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
154099451|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
154099452|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
154099453|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154099454|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
154099455|NCT00729794|Coagulants|coagulants|mesh-ancestor
154099488|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099489|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
154099490|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099491|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099492|NCT00876850|Linezolid|linezolid|mesh-list
154099493|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154099494|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099495|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154099496|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099497|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099498|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154099499|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154099502|NCT05157412|Doxycycline|doxycycline|mesh-list
154099550|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099551|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099552|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154099553|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154099554|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154099555|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154099556|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154099557|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154099558|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154099559|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154099560|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154099561|NCT00872248|Anesthetics|anesthetics|mesh-list
154099562|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099563|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099564|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
154099565|NCT00732576|Vitamin K|vitamin k|mesh-list
154099566|NCT00732576|Menaquinone 7|menaquinone 7|mesh-list
154099567|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154099568|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154099569|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099570|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
154099571|NCT00732576|Coagulants|coagulants|mesh-ancestor
154099572|NCT00732576|Vitamins|vitamins|mesh-ancestor
154099573|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
154099574|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099575|NCT00863902|Cetirizine|cetirizine|mesh-list
154099576|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154099577|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154099578|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154099579|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
154099580|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
154099581|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099582|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099583|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099584|NCT00732810|Capecitabine|capecitabine|mesh-list
154099588|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099589|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099590|NCT00732810|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154099591|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099592|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099593|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
154099594|NCT00732888|Calcium|calcium|mesh-list
154099595|NCT00732888|Nilotinib|nilotinib|mesh-list
154099596|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154099597|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099598|NCT00732888|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154099599|NCT00732888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099600|NCT00732888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099601|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099602|NCT00732888|Antacids|antacids|mesh-ancestor
154099603|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154099644|NCT00577460|Protective Agents|protective agents|mesh-ancestor
154099645|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099646|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154099647|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154099648|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
154099649|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
154099650|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099651|NCT00863980|Telmisartan|telmisartan|mesh-list
154099652|NCT00863980|Candesartan|candesartan|mesh-list
154099653|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
154099654|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154099655|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154099656|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154099657|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099658|NCT00415519|Edaravone|edaravone|mesh-list
154099659|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154099660|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
154099702|NCT00736346|Paroxetine|paroxetine|mesh-list
154099703|NCT00736346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154099704|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154099705|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154099706|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099707|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099708|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
154099709|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099710|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154099711|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
154099712|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154099713|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154099714|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154099715|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099716|NCT00864058|Gabapentin|gabapentin|mesh-list
154099717|NCT00864058|Analgesics|analgesics|mesh-ancestor
154099718|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
154099719|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099720|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099721|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
154099722|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154099723|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154099724|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099725|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154099730|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
154099749|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099750|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099751|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
154099752|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099753|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099754|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154099755|NCT00428389|Protective Agents|protective agents|mesh-ancestor
154099756|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
154099757|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154099758|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099760|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154099761|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099762|NCT01324063|Cytarabine|cytarabine|mesh-list
154099763|NCT01324063|Daunorubicin|daunorubicin|mesh-list
154099764|NCT01324063|Amsacrine|amsacrine|mesh-list
154099765|NCT01324063|Sargramostim|sargramostim|mesh-list
154099766|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154099767|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
154099768|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099769|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099770|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
154099771|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154099772|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154099773|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
154099774|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099775|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099776|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154099777|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154099778|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099779|NCT00864448|Ramipril|ramipril|mesh-list
154099780|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154099781|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
153726954|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153726955|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153726956|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153726957|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153726958|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153727004|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727006|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
153727007|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727008|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727009|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
153727010|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153727012|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
154099782|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099783|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099790|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099791|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154099792|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154099793|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099794|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154099795|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154099796|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
154099797|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154099798|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
154099799|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154099800|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154099801|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154099802|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099803|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099804|NCT00864526|Ibuprofen|ibuprofen|mesh-list
154099805|NCT00864526|Oxycodone|oxycodone|mesh-list
154099806|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154099807|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154099808|NCT00864526|Analgesics|analgesics|mesh-ancestor
154099809|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
154099810|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099811|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099813|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154099842|NCT00711594|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154099843|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099844|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099845|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099846|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099847|NCT00864760|Gabapentin|gabapentin|mesh-list
154099848|NCT00864760|Analgesics|analgesics|mesh-ancestor
154099849|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
154099850|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154099851|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099852|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
154099853|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154099854|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154099855|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154099856|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154099857|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154099858|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154099859|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099860|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099894|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154099895|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
154099896|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154099897|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154099898|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
154099899|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099900|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
154099901|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154099902|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154099903|NCT00573430|Candesartan|candesartan|mesh-list
154099904|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
154099905|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154099906|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154099907|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154099908|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099910|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154099911|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099912|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154099913|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154099914|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154099915|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099917|NCT00864838|Acetazolamide|acetazolamide|mesh-list
154099918|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154099919|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154099920|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154099921|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154099922|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
154099923|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154099924|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099926|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
154099931|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153566028|NCT06144944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153566029|NCT06144944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153566031|NCT06144944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154099932|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154099933|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099934|NCT00615550|Progesterone|progesterone|mesh-list
154099935|NCT00615550|Progestins|progestins|mesh-ancestor
154099936|NCT00615550|Hormones|hormones|mesh-ancestor
154099937|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154099938|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099939|NCT00736164|Selenium|selenium|mesh-list
154099940|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
154099941|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099942|NCT00736164|Protective Agents|protective agents|mesh-ancestor
154099943|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099944|NCT00736164|Trace Elements|trace elements|mesh-ancestor
154099945|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
154099946|NCT00739830|Sirolimus|sirolimus|mesh-list
154099947|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154099948|NCT00739830|Megestrol|megestrol|mesh-list
154099949|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
154099950|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
154099951|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154099952|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154099953|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154099954|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
154099955|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154099956|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099973|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154099974|NCT00577382|Growth Substances|growth substances|mesh-ancestor
154099975|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154099976|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
154099977|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154099978|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099979|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099980|NCT00733434|Alprostadil|alprostadil|mesh-list
154099981|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154099982|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
154099983|NCT00733434|Urological Agents|urological agents|mesh-ancestor
154099984|NCT00736320|Vincristine|vincristine|mesh-list
154099985|NCT00736320|Doxorubicin|doxorubicin|mesh-list
154099986|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153423232|NCT02157948|Denosumab|denosumab|mesh-list
154099987|NCT00736320|Dacarbazine|dacarbazine|mesh-list
154099988|NCT00736320|Bleomycin|bleomycin|mesh-list
154099989|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154099990|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154099991|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
154099992|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
154099993|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
154099994|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154099995|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154099996|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154099997|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154099998|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154099999|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154100000|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
154100001|NCT04065282|Capecitabine|capecitabine|mesh-list
154100002|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
154100003|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100004|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
154100005|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100006|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100007|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154100011|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154100012|NCT00873262|Estrone|estrone|mesh-list
154100013|NCT00873262|Progesterone|progesterone|mesh-list
154100014|NCT00873262|Estrogens|estrogens|mesh-ancestor
154100015|NCT00873262|Hormones|hormones|mesh-ancestor
154100016|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100017|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100018|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154100019|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
154100020|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154100021|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154100022|NCT00873262|Progestins|progestins|mesh-ancestor
154100023|NCT00736970|Sirolimus|sirolimus|mesh-list
154100024|NCT00736970|Trastuzumab|trastuzumab|mesh-list
154100025|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154100026|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100027|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154100028|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100029|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154100030|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
154100031|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100066|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100067|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100068|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100069|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154100071|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154100072|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
154100073|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
154100074|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100075|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100076|NCT00740142|Lactulose|lactulose|mesh-list
154100077|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
154100078|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154100079|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
154100080|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154100081|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100082|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100083|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100084|NCT00873652|Vaccines|vaccines|mesh-list
154100085|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
154100086|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100087|NCT00423319|Enoxaparin|enoxaparin|mesh-list
154100088|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
154100089|NCT00423319|Apixaban|apixaban|mesh-list
154100090|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
154100091|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154100092|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154100093|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100094|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154100095|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
154100096|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154100097|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
154100098|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100099|NCT05224492|Sulforaphane|sulforaphane|mesh-list
154100109|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100110|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100112|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
154100113|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
154100114|NCT04039126|Tetracycline|tetracycline|mesh-list
154100115|NCT04039126|Povidone|povidone|mesh-list
154100116|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153727143|NCT00487123|Diuretics|diuretics|mesh-ancestor
154100117|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100118|NCT04039126|Trace Elements|trace elements|mesh-ancestor
154100119|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
154100120|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100121|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
154100122|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
154100123|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154100124|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154100125|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100126|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100127|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
154100128|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
154100129|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
154100130|NCT00873808|Tetracycline|tetracycline|mesh-list
154100131|NCT00873808|Demeclocycline|demeclocycline|mesh-list
154100162|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154100163|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100164|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154100165|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
154100166|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154100167|NCT00874042|Gemcitabine|gemcitabine|mesh-list
154100168|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100169|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
154100170|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100171|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100172|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
154100173|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154100174|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
154100175|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100176|NCT00736866|Expectorants|expectorants|mesh-ancestor
154100177|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
154100178|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154100179|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
154100180|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100181|NCT00736866|Protective Agents|protective agents|mesh-ancestor
154100182|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100183|NCT00736866|Antidotes|antidotes|mesh-ancestor
154100184|NCT00879424|Vitamin D|vitamin d|mesh-list
154100185|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
154100186|NCT00879424|Vitamins|vitamins|mesh-ancestor
154100187|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
154100188|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100189|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154100190|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154100191|NCT00710684|Donepezil|donepezil|mesh-list
154100192|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154100193|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100194|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100195|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
154100198|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
154100203|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
154100204|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154100205|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100206|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154100207|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154100208|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154100209|NCT00710606|Estrogens|estrogens|mesh-ancestor
154100210|NCT00710606|Hormones|hormones|mesh-ancestor
154100211|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100212|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154100213|NCT00710606|Progestins|progestins|mesh-ancestor
154100214|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
154100215|NCT00713544|Etanercept|etanercept|mesh-list
153355045|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153727150|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154100216|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154100217|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154100218|NCT00713544|Analgesics|analgesics|mesh-ancestor
154100219|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
154100220|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100221|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100222|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154100223|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154100224|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154100225|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100226|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
154100227|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154100228|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100229|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154100230|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154100231|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
154100232|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100233|NCT00737126|Folic Acid|folic acid|mesh-list
154100241|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100243|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154100244|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154100245|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154100246|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
154100247|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100248|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100249|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154100250|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
154100251|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
154100252|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
154100253|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154100254|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154100255|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
154100256|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100257|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100258|NCT00740922|Becaplermin|becaplermin|mesh-list
154100259|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
154100260|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154100261|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154100262|NCT00740922|Growth Substances|growth substances|mesh-ancestor
154100263|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100264|NCT00741078|Amlodipine|amlodipine|mesh-list
154100265|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154100266|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154100267|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154100268|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100269|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154100270|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100271|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
154100272|NCT02568800|Cefepime|cefepime|mesh-list
154100273|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154100274|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100275|NCT00741234|Azacitidine|azacitidine|mesh-list
154100276|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100277|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
154100278|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100279|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100280|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100282|NCT00713258|Hormones|hormones|mesh-list
154100283|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
154100284|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100285|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100286|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154100287|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154100288|NCT00710034|Nicotine|nicotine|mesh-list
154100289|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154100290|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
154100291|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100292|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100293|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154100294|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154100295|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
154100296|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100297|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100298|NCT02567942|Propofol|propofol|mesh-list
154100299|NCT02567942|Sevoflurane|sevoflurane|mesh-list
154100300|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154100301|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100326|NCT00414661|Tofacitinib|tofacitinib|mesh-list
154100327|NCT00414661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154100328|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154100329|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100330|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100331|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
154100332|NCT01608451|Vitamin D|vitamin d|mesh-list
154100333|NCT01608451|Progesterone|progesterone|mesh-list
154100334|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154100335|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100336|NCT01608451|Vitamins|vitamins|mesh-ancestor
154100337|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
154100338|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154100339|NCT01608451|Progestins|progestins|mesh-ancestor
154100340|NCT01608451|Hormones|hormones|mesh-ancestor
154100341|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100342|NCT00405067|Ezetimibe|ezetimibe|mesh-list
154100343|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154100344|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154100345|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
154100346|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100347|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154100348|NCT00708708|Etanercept|etanercept|mesh-list
154100349|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154100350|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154100351|NCT00708708|Analgesics|analgesics|mesh-ancestor
154100352|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
154100353|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100354|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100355|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154100356|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154100357|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154100358|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100359|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
154100360|NCT00404755|Bupropion|bupropion|mesh-list
154100361|NCT00404755|Imipramine|imipramine|mesh-list
154100362|NCT00404755|Escitalopram|escitalopram|mesh-list
154100365|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154100366|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100367|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100368|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
154100369|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100370|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154100371|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
154100372|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154100373|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154100374|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
154100375|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154100376|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154100377|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100378|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154100379|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154100380|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
154100381|NCT03904381|Fluorouracil|fluorouracil|mesh-list
154100382|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
154100383|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100384|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100385|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100386|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100387|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
154100388|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100414|NCT00713310|Analgesics|analgesics|mesh-ancestor
154100415|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
154100416|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100417|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100418|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154100419|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154100420|NCT05740488|Hormones|hormones|mesh-list
154100421|NCT05740488|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154100422|NCT05740488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100423|NCT05740488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100424|NCT05742126|Heparin|heparin|mesh-list
154100425|NCT05742126|Calcium heparin|calcium heparin|mesh-list
154100426|NCT05742126|Anticoagulants|anticoagulants|mesh-ancestor
154100427|NCT05742126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154100428|NCT05742126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154100429|NCT05742126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100430|NCT00882856|Bisoprolol|bisoprolol|mesh-list
154100431|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154100432|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
154100433|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
154100434|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100435|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100436|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154100437|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154100438|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154100457|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
154100458|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100459|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154100460|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154100461|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154100462|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154100463|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154100464|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154100465|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154100466|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154100467|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
154100468|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154100469|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154100470|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154100471|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
154100472|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154100473|NCT00880828|Acetaminophen|acetaminophen|mesh-list
154100474|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154100475|NCT00880828|Analgesics|analgesics|mesh-ancestor
154100476|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
154100477|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100478|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100479|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
154100480|NCT00712920|Azelastine|azelastine|mesh-list
154100481|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154100482|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
154100483|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100484|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566527|NCT06234813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100502|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100503|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154100504|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154100505|NCT00874744|Growth Substances|growth substances|mesh-ancestor
154100506|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100507|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
154100508|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154100509|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
153423757|NCT02175966|Ribavirin|ribavirin|mesh-list
154100511|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100512|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100513|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
154100514|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100515|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100516|NCT05736744|Magnesium Sulfate|magnesium sulfate|mesh-list
154100517|NCT05736744|Bromides|bromides|mesh-list
154100518|NCT05736744|Rocuronium|rocuronium|mesh-list
154100519|NCT05736744|Atracurium|atracurium|mesh-list
154100520|NCT05736744|Cisatracurium|cisatracurium|mesh-list
154100521|NCT05736744|Anticonvulsants|anticonvulsants|mesh-ancestor
154100522|NCT05736744|Analgesics|analgesics|mesh-ancestor
154100523|NCT05736744|Sensory System Agents|sensory system agents|mesh-ancestor
154100524|NCT05736744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100525|NCT05736744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100526|NCT05736744|Anesthetics|anesthetics|mesh-ancestor
154100527|NCT05736744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100528|NCT05736744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154100542|NCT00920868|Bevacizumab|bevacizumab|mesh-list
154100547|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100548|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154100549|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154100550|NCT00920868|Growth Substances|growth substances|mesh-ancestor
154100551|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100552|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
154100553|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100554|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
154100555|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100556|NCT00920868|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154100557|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154100558|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100559|NCT05741814|Propofol|propofol|mesh-list
154100560|NCT05741814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154100561|NCT05741814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100562|NCT05741814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100563|NCT05741814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153727314|NCT00489385|Ribavirin|ribavirin|mesh-list
153727315|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
153727316|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727317|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
153727318|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727319|NCT01242631|Everolimus|everolimus|mesh-list
153727320|NCT01242631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154100564|NCT05741814|Anesthetics, General|anesthetics, general|mesh-ancestor
153727321|NCT01242631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153727328|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
153727329|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
153727332|NCT01242904|Icodextrin|icodextrin|mesh-list
153727364|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100565|NCT05741814|Anesthetics|anesthetics|mesh-ancestor
154100566|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
154100567|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154100568|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
154100569|NCT04721626|Tetracycline|tetracycline|mesh-list
154100570|NCT04721626|Doxycycline|doxycycline|mesh-list
154100571|NCT04721626|Povidone|povidone|mesh-list
154100572|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154100573|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100574|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
154100575|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
154100576|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
154100577|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
154100578|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154100579|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154100589|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100590|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154100591|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154100592|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154100593|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
154100594|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154100595|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154100596|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
154100597|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100598|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
154100599|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154100600|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154100601|NCT05733078|Vitamins|vitamins|mesh-list
154100602|NCT05733078|Ascorbic Acid|ascorbic acid|mesh-list
154100603|NCT05733078|Micronutrients|micronutrients|mesh-ancestor
154100604|NCT05733078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100605|NCT05733078|Antioxidants|antioxidants|mesh-ancestor
154100606|NCT05733078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100607|NCT05733078|Protective Agents|protective agents|mesh-ancestor
154100608|NCT00874978|Lenalidomide|lenalidomide|mesh-list
154100642|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
154100643|NCT00612586|Antidotes|antidotes|mesh-ancestor
154100644|NCT00612586|Protective Agents|protective agents|mesh-ancestor
154100645|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
154100646|NCT00612586|Vitamins|vitamins|mesh-ancestor
154100647|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
154100648|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
154100649|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153727365|NCT00122018|Protective Agents|protective agents|mesh-ancestor
153727366|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727367|NCT00122018|Antidotes|antidotes|mesh-ancestor
153727368|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153727369|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
153727370|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
153727371|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
153727372|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727373|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153727374|NCT00489775|Paroxetine|paroxetine|mesh-list
153727375|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154100650|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154100651|NCT00614380|Amlodipine|amlodipine|mesh-list
154100652|NCT00614380|Telmisartan|telmisartan|mesh-list
154100653|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
154100709|NCT00612508|Estrogens|estrogens|mesh-ancestor
154100710|NCT00612508|Hormones|hormones|mesh-ancestor
154100711|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100712|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100713|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154100714|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
154100715|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154100716|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154100717|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154100718|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154100719|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154100720|NCT00612508|Progestins|progestins|mesh-ancestor
154100721|NCT00881218|Regadenoson|regadenoson|mesh-list
154100722|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154100723|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154100724|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
154100725|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
154100726|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100727|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100728|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100729|NCT00613834|Lidocaine|lidocaine|mesh-list
154100730|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
154100731|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
154100732|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100733|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100734|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
154100735|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100736|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154100737|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154100739|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154100740|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100741|NCT00875368|Maraviroc|maraviroc|mesh-list
154100742|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154100745|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154100747|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
154100748|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100749|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154100750|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
154100751|NCT03912298|Narcotics|narcotics|mesh-ancestor
154100752|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100753|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100754|NCT03912298|Analgesics|analgesics|mesh-ancestor
154100755|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
154100756|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100757|NCT02543710|Taxane|taxane|mesh-list
154100758|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100759|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
154100760|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154100761|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
154100762|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154100763|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100764|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154100765|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154100766|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154100767|NCT00881296|Carboplatin|carboplatin|mesh-list
154100768|NCT00881296|Gemcitabine|gemcitabine|mesh-list
154100769|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100770|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100771|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
154100772|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100773|NCT00613366|Misoprostol|misoprostol|mesh-list
154100774|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
154100775|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153727381|NCT00489775|Analgesics|analgesics|mesh-ancestor
154100776|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
154100792|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100793|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100794|NCT00884494|Insulin|insulin|mesh-list
154100795|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154100796|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100797|NCT00881686|Adenosine|adenosine|mesh-list
154100798|NCT00881686|Analgesics|analgesics|mesh-ancestor
154100799|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
153783345|NCT00236093|Narcotics|narcotics|mesh-ancestor
154100800|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100801|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100802|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154100803|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
154100804|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154100805|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
154100806|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
154100807|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100808|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100809|NCT00885508|Lenalidomide|lenalidomide|mesh-list
154100810|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
154100811|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100812|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154100813|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154100814|NCT00885508|Growth Substances|growth substances|mesh-ancestor
154100815|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
154100816|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100817|NCT02543086|Piperaquine|piperaquine|mesh-list
154100818|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
154100819|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154100820|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154100821|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100822|NCT00885586|Gabapentin|gabapentin|mesh-list
154100823|NCT00885586|Analgesics|analgesics|mesh-ancestor
154100824|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
154100825|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100826|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100831|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154100832|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154100833|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154100834|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100835|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100836|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
154100837|NCT02542930|Thymalfasin|thymalfasin|mesh-list
154100838|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154100839|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
154100840|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100841|NCT00881764|Anesthetics|anesthetics|mesh-list
154100842|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100843|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100844|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
154100846|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
154100847|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100848|NCT04037878|Tramadol|tramadol|mesh-list
154100849|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154100850|NCT04037878|Narcotics|narcotics|mesh-ancestor
154100851|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154100852|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100853|NCT04037878|Analgesics|analgesics|mesh-ancestor
154100854|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
154100855|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100856|NCT00651261|Cytarabine|cytarabine|mesh-list
154100857|NCT00651261|Dexamethasone|dexamethasone|mesh-list
154100858|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
154100859|NCT00651261|Daunorubicin|daunorubicin|mesh-list
154100860|NCT00651261|Midostaurin|midostaurin|mesh-list
154100861|NCT00651261|BB 1101|bb 1101|mesh-list
154100862|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154100863|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
154100864|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
154100865|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100866|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100867|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154100868|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
154100869|NCT00651261|Hormones|hormones|mesh-ancestor
154100870|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100871|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154100872|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100873|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154100874|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
154100875|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100876|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
154100877|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154100878|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100879|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
154100880|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154100881|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154100882|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154100883|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100884|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154100885|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
154100886|NCT00885820|Prednisone|prednisone|mesh-list
154100887|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
154100888|NCT00885820|Tacrolimus|tacrolimus|mesh-list
154100889|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154100890|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
154100891|NCT00885820|Hormones|hormones|mesh-ancestor
154100892|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100893|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100894|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154100895|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100896|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154100897|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
154100898|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154100899|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100900|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100901|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
154100911|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100912|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
154100913|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154100914|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154100915|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154100916|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154100917|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154100918|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100919|NCT00651183|Pramipexole|pramipexole|mesh-list
154100920|NCT00651183|Dexpramipexole|dexpramipexole|mesh-list
154100921|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
154100922|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100923|NCT00651183|Protective Agents|protective agents|mesh-ancestor
154100924|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100925|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154100926|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154100927|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
153727420|NCT00490204|Cetirizine|cetirizine|mesh-list
154100928|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
154100929|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154100930|NCT00810381|Nitroprusside|nitroprusside|mesh-list
154100931|NCT00810381|Isosorbide|isosorbide|mesh-list
154100932|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154100933|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154100934|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
154100935|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
154100936|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154100937|NCT00810381|Diuretics|diuretics|mesh-ancestor
154100938|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
154100939|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100940|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154100941|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100942|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154100943|NCT00800319|ALKS-33|alks-33|mesh-list
154100944|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154100952|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154100953|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
154100954|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100955|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154100956|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154100957|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154100958|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100959|NCT00810849|Prednisolone|prednisolone|mesh-list
154100960|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154100961|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
154100962|NCT00810849|Hormones|hormones|mesh-ancestor
154100963|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154100964|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154100965|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154100966|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154100968|NCT00922311|Renin Inhibitors|renin inhibitors|mesh-ancestor
154100969|NCT00922311|Protease Inhibitors|protease inhibitors|mesh-ancestor
154100970|NCT00922311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154100971|NCT00922311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154100972|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
154100973|NCT00811005|Methoxsalen|methoxsalen|mesh-list
154100974|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154100975|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
154100977|NCT00813735|Dexetimide|dexetimide|mesh-list
154101001|NCT00811083|Succimer|succimer|mesh-list
154101002|NCT00811083|Antidotes|antidotes|mesh-ancestor
154101003|NCT00811083|Protective Agents|protective agents|mesh-ancestor
154101004|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101005|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
154101006|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
154101007|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101008|NCT00642759|Paclitaxel|paclitaxel|mesh-list
154101009|NCT00642759|Bevacizumab|bevacizumab|mesh-list
153727432|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727433|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727434|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153727435|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154101010|NCT00642759|Carboplatin|carboplatin|mesh-list
154101011|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154101012|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101013|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
154101014|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
154101015|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
154101016|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101017|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154101018|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154101019|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154101020|NCT00642759|Growth Substances|growth substances|mesh-ancestor
154101021|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101022|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
154101023|NCT00813891|Ranibizumab|ranibizumab|mesh-list
154101024|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154101025|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154101026|NCT00813891|Growth Substances|growth substances|mesh-ancestor
153347863|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
154101027|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101028|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
154101029|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101030|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154101031|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154101032|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154101033|NCT00611026|Fesoterodine|fesoterodine|mesh-list
154101034|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154101035|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154101036|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
154101037|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101038|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101039|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101040|NCT00611026|Urological Agents|urological agents|mesh-ancestor
154101041|NCT02552589|Fluorides|fluorides|mesh-list
154101042|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
154101043|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
154101044|NCT02552589|Protective Agents|protective agents|mesh-ancestor
154101045|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101046|NCT00811239|Antivenins|antivenins|mesh-list
154101047|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
154101048|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101049|NCT00814047|Yohimbine|yohimbine|mesh-list
154101050|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
154101051|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
154101052|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101053|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101054|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154101055|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154101056|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154101057|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
154101058|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101059|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101060|NCT00814047|Urological Agents|urological agents|mesh-ancestor
154101061|NCT00814125|Tamoxifen|tamoxifen|mesh-list
154101062|NCT00814125|Anastrozole|anastrozole|mesh-list
154101063|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154101064|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
154101065|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154101083|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154101084|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154101085|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
154101086|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
153727453|NCT00490243|Hormones|hormones|mesh-ancestor
154101087|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
154101088|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101089|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101091|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154101092|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101093|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
154101094|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101095|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101096|NCT00814281|Montelukast|montelukast|mesh-list
154101097|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154101098|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
154101099|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154101100|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
154101101|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154101102|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101103|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154101104|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154101105|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101106|NCT00814359|Benzydamine|benzydamine|mesh-list
154101107|NCT00814359|Sucralfate|sucralfate|mesh-list
154101108|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154101109|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154101110|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154101111|NCT00612040|Insulin|insulin|mesh-list
154101112|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154101113|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
154101114|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
154101115|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
154101116|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154101117|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101118|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
154101119|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
154101121|NCT00422227|Methotrexate|methotrexate|mesh-list
154101122|NCT00422227|Leflunomide|leflunomide|mesh-list
154101123|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154101124|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
154101125|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154101126|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101127|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154101128|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
154101129|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101130|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101131|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
154101132|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101133|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154101134|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101135|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
154101136|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101137|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154101138|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
154101139|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154101140|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154101141|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727465|NCT00490360|Gemcitabine|gemcitabine|mesh-list
153727466|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101142|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154101143|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154101144|NCT00422227|Analgesics|analgesics|mesh-ancestor
154101145|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
154101171|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154101172|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154101173|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
154101174|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154101175|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154101176|NCT00421993|Analgesics|analgesics|mesh-ancestor
154101177|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
154101178|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101179|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101180|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154101181|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101182|NCT00884884|Topiramate|topiramate|mesh-list
154101183|NCT00884884|Aripiprazole|aripiprazole|mesh-list
154101184|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
154101185|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154101186|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154101187|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154101188|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101189|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101190|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
154101191|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
154101192|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101193|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101194|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154101195|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154101196|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
154101197|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154101198|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154101208|NCT02551029|Capsaicin|capsaicin|mesh-list
154101216|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
154101217|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101218|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154101219|NCT00413959|Dexamethasone|dexamethasone|mesh-list
154101220|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
154101221|NCT00413959|Rituximab|rituximab|mesh-list
154101222|NCT00413959|Bortezomib|bortezomib|mesh-list
154101223|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101224|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
154101225|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101226|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101227|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154101228|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
154101229|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101230|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101231|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154101232|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154101233|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
154101234|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
154101235|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101236|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154101237|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
154101238|NCT00413959|Hormones|hormones|mesh-ancestor
154101239|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727557|NCT00491725|Repaglinide|repaglinide|mesh-list
154101270|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101271|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101272|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154101273|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101274|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
154101275|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154101276|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154101277|NCT00886132|Sunitinib|sunitinib|mesh-list
154101278|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101279|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154101280|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154101330|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
154101331|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154101332|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154101333|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154101334|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101335|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101336|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
154101337|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101338|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101339|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154101340|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101341|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
154101342|NCT00885274|Citric Acid|citric acid|mesh-list
154101343|NCT00885274|Antacids|antacids|mesh-ancestor
154101344|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101345|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154101346|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
154101347|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154101348|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
154101349|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
154101350|NCT00402727|Amoxicillin|amoxicillin|mesh-list
154101351|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
154101352|NCT00402727|Tazobactam|tazobactam|mesh-list
154101353|NCT00402727|Piperacillin|piperacillin|mesh-list
154101354|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
154101355|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
154101356|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
154101357|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154101358|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154101359|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101360|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154101373|NCT00923494|Ropivacaine|ropivacaine|mesh-list
154101374|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
154101375|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
154101376|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101377|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101378|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
154101379|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101380|NCT00888784|Propranolol|propranolol|mesh-list
154101381|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154101382|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154101383|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
154101384|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101385|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101386|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101387|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154101388|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154101389|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
154101390|NCT00886678|Carboplatin|carboplatin|mesh-list
154101391|NCT00886678|Pemetrexed|pemetrexed|mesh-list
154101392|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101393|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101394|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101395|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154101396|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154101397|NCT00402337|Linaclotide|linaclotide|mesh-list
154101398|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
154101399|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
154101400|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101401|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154101402|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154101414|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
154101415|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101416|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101417|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154101418|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154101419|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
154101420|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101421|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154101422|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154101423|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
154101424|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154101425|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
154101426|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101427|NCT00650091|Expectorants|expectorants|mesh-ancestor
154101428|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
154101429|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154101430|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
154101431|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101432|NCT00650091|Protective Agents|protective agents|mesh-ancestor
154101433|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101434|NCT00650091|Antidotes|antidotes|mesh-ancestor
154101435|NCT00889018|Carboplatin|carboplatin|mesh-list
154101436|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101437|NCT00889096|Propranolol|propranolol|mesh-list
154101438|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154101439|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154101440|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
154101462|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
154101464|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154101465|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154101466|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101467|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101468|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
154101469|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
154101470|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101471|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154101472|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154101473|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
154101474|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101475|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101476|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154101477|NCT01154335|Everolimus|everolimus|mesh-list
154101478|NCT01154335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154101479|NCT01154335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154101480|NCT01154335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101481|NCT01154335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101482|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101483|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
154101484|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101511|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
154101512|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154101513|NCT02541526|Mirtazapine|mirtazapine|mesh-list
154101514|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
154101515|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154101516|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154101517|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
154101518|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
154101519|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101520|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101521|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101522|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154101523|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154101524|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101525|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154101526|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154101527|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154101528|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
154101529|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154101565|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154101566|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101567|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101568|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101569|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
154101570|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154101571|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154101572|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154101573|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154101574|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
154101575|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154101576|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154101577|NCT01038349|Methotrexate|methotrexate|mesh-list
154101578|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154101579|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
154101580|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154101581|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101582|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154101583|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
154101584|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101585|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101586|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
154101587|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101588|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154101589|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101590|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
154101591|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101592|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154101593|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
154101607|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
154101608|NCT01038505|Tacrolimus|tacrolimus|mesh-list
154101609|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101610|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
154101611|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101612|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154101613|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101614|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101615|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154101616|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101617|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154101618|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101619|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
154101620|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154101621|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
154101622|NCT01038583|Aspirin|aspirin|mesh-list
154101623|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154101624|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154101625|NCT01038583|Analgesics|analgesics|mesh-ancestor
154101626|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
154101627|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101628|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101629|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154101630|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101638|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
154101656|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
154101657|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
154101658|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101659|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
154101660|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
154101661|NCT01038817|Protective Agents|protective agents|mesh-ancestor
154101662|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101663|NCT00420511|Metformin|metformin|mesh-list
154101664|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154101665|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154101666|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101667|NCT00420511|Incretins|incretins|mesh-ancestor
154101668|NCT00420511|Hormones|hormones|mesh-ancestor
154101669|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154101670|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154101671|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
154101672|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101673|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101674|NCT01038895|Ramipril|ramipril|mesh-list
154101675|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154101676|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
154101677|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101680|NCT00420199|Abatacept|abatacept|mesh-list
154101706|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154101707|NCT00402103|Aliskiren|aliskiren|mesh-list
154101708|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154101709|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154101710|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101711|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101712|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154101713|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101714|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
154101715|NCT00402103|Diuretics|diuretics|mesh-ancestor
154101716|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
154101717|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154101718|NCT00402103|Renin Inhibitors|renin inhibitors|mesh-ancestor
154101719|NCT00402103|Protease Inhibitors|protease inhibitors|mesh-ancestor
154101720|NCT00402103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101721|NCT00812175|Sorafenib|sorafenib|mesh-list
154101722|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101723|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154101724|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101725|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101726|NCT00815373|Timolol|timolol|mesh-list
154101727|NCT00815373|Dorzolamide|dorzolamide|mesh-list
154101728|NCT00815373|Latanoprost|latanoprost|mesh-list
154101729|NCT00815373|Maleic acid|maleic acid|mesh-list
154101730|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101731|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101751|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154101752|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
154101753|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
154101754|NCT00704184|Interferons|interferons|mesh-list
154101755|NCT00704184|Ribavirin|ribavirin|mesh-list
154101756|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101757|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
154101758|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101759|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
154101760|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101761|NCT00641043|Pioglitazone|pioglitazone|mesh-list
154101762|NCT00641043|Linagliptin|linagliptin|mesh-list
154101763|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154101764|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101765|NCT00641043|Incretins|incretins|mesh-ancestor
154101766|NCT00641043|Hormones|hormones|mesh-ancestor
154101767|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154101768|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154101769|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
154101770|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101771|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101772|NCT02567916|Propofol|propofol|mesh-list
154101773|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154101774|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101775|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101776|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154101777|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
154101778|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
154101779|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
154101780|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154101781|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101782|NCT00609622|Bevacizumab|bevacizumab|mesh-list
154101783|NCT00609622|Sunitinib|sunitinib|mesh-list
154101784|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154101785|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101786|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154101787|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154101788|NCT00609622|Growth Substances|growth substances|mesh-ancestor
154101789|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101790|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
154101791|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154101792|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101793|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101795|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154101796|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154101797|NCT00818415|Analgesics|analgesics|mesh-ancestor
154101798|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
154101799|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101800|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101801|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154101802|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101803|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
154101804|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154101805|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101806|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101807|NCT00815841|Methylphenidate|methylphenidate|mesh-list
154101808|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154101809|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101810|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154101837|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154101838|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154101839|NCT00890110|Sunitinib|sunitinib|mesh-list
154101840|NCT00890110|Vaccines|vaccines|mesh-list
154101841|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
154101842|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101843|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101844|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154101845|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154101846|NCT00890110|Growth Substances|growth substances|mesh-ancestor
154101847|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
154101848|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154101849|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101850|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101851|NCT02566824|Methylphenidate|methylphenidate|mesh-list
154101852|NCT02566824|Amphetamine|amphetamine|mesh-list
154101853|NCT02566824|Adderall|adderall|mesh-list
154101854|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
154101855|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154101856|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101857|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154101858|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154101859|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154101888|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
153727632|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355919|NCT01790282|Hormones|hormones|mesh-ancestor
154101889|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101890|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
154101891|NCT04037566|Fludarabine|fludarabine|mesh-list
154101892|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101893|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
154101894|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101895|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154101896|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154101897|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
154101898|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101899|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101900|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154101901|NCT00888082|Goserelin|goserelin|mesh-list
154101902|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154101903|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101904|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
154101905|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154101906|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
154101907|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101908|NCT00627705|Expectorants|expectorants|mesh-ancestor
154101909|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
154101910|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154101911|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
154101912|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101915|NCT00627705|Antidotes|antidotes|mesh-ancestor
154101939|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154101940|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154101941|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
154101942|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154101943|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101945|NCT00890500|Fludarabine|fludarabine|mesh-list
154101946|NCT00890500|Melphalan|melphalan|mesh-list
154101947|NCT00890500|Tacrolimus|tacrolimus|mesh-list
154101948|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154101949|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154101950|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154101951|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101952|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
154101953|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101954|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154101955|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101956|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154101957|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154101958|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154101959|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
154101960|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154101961|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
154101962|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154101963|NCT04061772|Prednisone|prednisone|mesh-list
154101964|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
154101965|NCT04061772|Etoposide|etoposide|mesh-list
154101966|NCT04061772|Bortezomib|bortezomib|mesh-list
154101967|NCT04061772|Epirubicin|epirubicin|mesh-list
154101968|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154101969|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
154101970|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101983|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154101984|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154101985|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154101986|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154101987|NCT00644787|Fentanyl|fentanyl|mesh-list
154101988|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154101989|NCT00644787|Narcotics|narcotics|mesh-ancestor
154101990|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154101991|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154101992|NCT00644787|Analgesics|analgesics|mesh-ancestor
154101993|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
154101994|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154101995|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154101996|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154101997|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
154101999|NCT00821301|Fluphenazine|fluphenazine|mesh-list
154102000|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
154102001|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
154102002|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154102003|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154102004|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102005|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102006|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154102007|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154102008|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
154102009|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102010|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102011|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
154102012|NCT00699348|Hematinics|hematinics|mesh-ancestor
154102030|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102031|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154102032|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
154102033|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154102034|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102035|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154102036|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154102038|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154102039|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154102040|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102041|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154102042|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154102043|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
154102044|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102045|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154102046|NCT04062006|Aldesleukin|aldesleukin|mesh-list
154102047|NCT04062006|Interleukin-2|interleukin-2|mesh-list
154102048|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102049|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102050|NCT04062006|Analgesics|analgesics|mesh-ancestor
154102051|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
154102052|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102053|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102054|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154102078|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154102079|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102080|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102081|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102082|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102083|NCT00888394|Imidacloprid|imidacloprid|mesh-list
154102084|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
153425343|NCT02147834|Ranolazine|ranolazine|mesh-list
154102085|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102086|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102087|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102088|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
154102089|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102090|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
154102091|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154102092|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
154102093|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154102094|NCT00627393|Dexamethasone|dexamethasone|mesh-list
154102095|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102096|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
154102097|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
154102098|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727657|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102099|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102100|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154102101|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
154102102|NCT00627393|Hormones|hormones|mesh-ancestor
154102103|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154102104|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154102105|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102106|NCT00822081|Timolol|timolol|mesh-list
154102107|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
154102120|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154102121|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154102122|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154102123|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154102124|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154102125|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154102126|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154102127|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102128|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102129|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102130|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102131|NCT00696774|Analgesics|analgesics|mesh-ancestor
154102132|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
154102133|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102134|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
154102135|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154102136|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
154102137|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
154102138|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154102139|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154102140|NCT00626925|Topiramate|topiramate|mesh-list
154102141|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
154102144|NCT00816543|Docetaxel|docetaxel|mesh-list
154102169|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102170|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154102171|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154102172|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
154102173|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102174|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154102175|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154102176|NCT00609466|Morphine|morphine|mesh-list
154102177|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154102178|NCT00609466|Narcotics|narcotics|mesh-ancestor
154102179|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102180|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102181|NCT00609466|Analgesics|analgesics|mesh-ancestor
154102182|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
154102183|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102184|NCT00822315|Efavirenz|efavirenz|mesh-list
154102185|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
154102186|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154102187|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154102188|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102189|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102190|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
154102191|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102192|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154102193|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154102194|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154102195|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154102196|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154102197|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154102198|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154102199|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154102200|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154102201|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154102202|NCT00696696|Gemcitabine|gemcitabine|mesh-list
154102203|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154102204|NCT00696696|Sorafenib|sorafenib|mesh-list
154102206|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
154102207|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102208|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102209|NCT00696696|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154102210|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154102211|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102212|NCT00822393|Busulfan|busulfan|mesh-list
154102213|NCT00822393|Treosulfan|treosulfan|mesh-list
154102214|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
154102215|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102216|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154102217|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
154102218|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102219|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154102220|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102221|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154102222|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
154102223|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
154102224|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154102225|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
154102226|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102227|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154102228|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102229|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
154102230|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
154102231|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154102255|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154102256|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154102257|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102258|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
154102259|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102260|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102261|NCT00891670|Aspirin|aspirin|mesh-list
154102262|NCT00891670|Cilostazol|cilostazol|mesh-list
154102263|NCT00891670|Clopidogrel|clopidogrel|mesh-list
154102264|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154102265|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102266|NCT00891670|Analgesics|analgesics|mesh-ancestor
154102267|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
154102268|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102269|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102270|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102271|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102272|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154102273|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154102274|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102275|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154102276|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154102277|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102278|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
154102279|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154102302|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154102303|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154102304|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154102305|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
154102306|NCT00921180|Entecavir|entecavir|mesh-list
154102307|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
154102308|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102309|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
154102310|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102311|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
154102312|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154102313|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102314|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154102315|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
154102316|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154102317|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102318|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102319|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102320|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154102321|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154102322|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154102323|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102324|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102325|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102326|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102348|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102349|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154102350|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154102351|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102352|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102353|NCT02566356|Oxytocin|oxytocin|mesh-list
154102354|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
154102355|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154102356|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102357|NCT00892450|Oxybutynin|oxybutynin|mesh-list
154102358|NCT00892450|Darifenacin|darifenacin|mesh-list
154102359|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
154102360|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
154102361|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102362|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102363|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154102364|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154102365|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
154102366|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102367|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102368|NCT00892450|Urological Agents|urological agents|mesh-ancestor
154102369|NCT01566565|Theophylline|theophylline|mesh-list
154102370|NCT01566565|Bambuterol|bambuterol|mesh-list
154102371|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154102372|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
154102373|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102374|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102375|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154102376|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
154102377|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154102378|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102379|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102380|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
154102381|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154102385|NCT01039363|Cytarabine|cytarabine|mesh-list
154102387|NCT01039363|Idarubicin|idarubicin|mesh-list
154102388|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
154102389|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154102390|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
154102391|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102392|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102393|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
154102394|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102395|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154102396|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
154102397|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102398|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154102399|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102400|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154102401|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154102402|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154102403|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154102404|NCT01039363|Immunotoxins|immunotoxins|mesh-ancestor
154102405|NCT01039363|Immunoconjugates|immunoconjugates|mesh-ancestor
154102406|NCT01039441|Bupivacaine|bupivacaine|mesh-list
154102407|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
154102408|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
154102409|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102410|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102411|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
154102412|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102413|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154102414|NCT01034917|Etravirine|etravirine|mesh-list
154102415|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
154102416|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102417|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154102418|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154102419|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102420|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102421|NCT00816699|Anesthetics|anesthetics|mesh-list
154102425|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154102426|NCT00822549|Narcotics|narcotics|mesh-ancestor
154102427|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102428|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102429|NCT00822549|Analgesics|analgesics|mesh-ancestor
154102430|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
154102431|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102432|NCT00819351|Asparaginase|asparaginase|mesh-list
154102433|NCT00819351|Pegaspargase|pegaspargase|mesh-list
154102434|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727825|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102435|NCT00699998|Aspirin|aspirin|mesh-list
154102436|NCT00699998|Clopidogrel|clopidogrel|mesh-list
154102437|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154102438|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154102439|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102440|NCT00699998|Analgesics|analgesics|mesh-ancestor
154102441|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
154102442|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102443|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102444|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102445|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102446|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154102447|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154102450|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153727826|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154102476|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
154102477|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102478|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
154102479|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154102480|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154102481|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
154102482|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102483|NCT00822783|Omalizumab|omalizumab|mesh-list
154102484|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154102485|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154102486|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
154102487|NCT00634647|Prednisone|prednisone|mesh-list
154102488|NCT00634647|Satraplatin|satraplatin|mesh-list
154102489|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102490|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
154102491|NCT00634647|Hormones|hormones|mesh-ancestor
154102492|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154102493|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102494|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154102495|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102496|NCT00576732|Risperidone|risperidone|mesh-list
154102497|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154102498|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
154102499|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102500|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102501|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102502|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154102503|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154102504|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102505|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154102506|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154102507|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
154102508|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154102517|NCT00817011|Nortriptyline|nortriptyline|mesh-list
154102518|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154102519|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
154102520|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154102521|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154102522|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154102523|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102524|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102525|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
154102526|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102527|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102528|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154102529|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154102530|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102531|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154102532|NCT00817011|Analgesics|analgesics|mesh-ancestor
154102533|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
154102534|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102535|NCT00817011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154102536|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
154102537|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154102538|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
154102539|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
154102540|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154102541|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154102542|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102543|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154102544|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154102545|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154102546|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
154102547|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154102548|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154102554|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102555|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102556|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102557|NCT00697788|Analgesics|analgesics|mesh-ancestor
154102558|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
153356282|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102559|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102560|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154102561|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154102562|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154102563|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
154102564|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102565|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102566|NCT00400153|Ipratropium|ipratropium|mesh-list
154102567|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154102568|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
154102569|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102570|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102571|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154102572|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
154102573|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154102574|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
154102575|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102576|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102577|NCT04062890|Vigabatrin|vigabatrin|mesh-list
154102578|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
154102579|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102580|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102601|NCT02550483|Protective Agents|protective agents|mesh-ancestor
154102602|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102603|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102604|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154102605|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154102606|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102607|NCT02550483|Provitamins|provitamins|mesh-ancestor
154102608|NCT02550483|Vitamins|vitamins|mesh-ancestor
154102609|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
154102610|NCT04063358|Ranibizumab|ranibizumab|mesh-list
154102611|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154102612|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154102613|NCT04063358|Growth Substances|growth substances|mesh-ancestor
154102614|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102615|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
154102616|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102617|NCT00631917|Ramipril|ramipril|mesh-list
154102618|NCT00631917|Aliskiren|aliskiren|mesh-list
154102619|NCT00631917|Renin Inhibitors|renin inhibitors|mesh-ancestor
154102620|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
154102621|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102622|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102623|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154102624|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154102625|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
154102626|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154102627|NCT00419341|Antibodies|antibodies|mesh-list
154102628|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
154102629|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102630|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
154102633|NCT03922620|Bupivacaine|bupivacaine|mesh-list
154102647|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154102648|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102649|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102650|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102651|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
154102652|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102653|NCT00921414|Rituximab|rituximab|mesh-list
154102654|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154102655|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102656|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
154102657|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102658|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102659|NCT04060914|Clopidogrel|clopidogrel|mesh-list
154102660|NCT04060914|Ticagrelor|ticagrelor|mesh-list
154102661|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154102662|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154102663|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154102664|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154102665|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
154102666|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102667|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102669|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
154102670|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102671|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154102672|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154102673|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154102674|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102675|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102676|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
154102677|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102678|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102679|NCT05324904|Vitamin D|vitamin d|mesh-list
154102681|NCT05324904|Vitamins|vitamins|mesh-ancestor
154102682|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
154102686|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102687|NCT02085265|Telmisartan|telmisartan|mesh-list
154102688|NCT02085265|Perindopril|perindopril|mesh-list
154102689|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154102690|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154102691|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154102692|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102693|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154102694|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
154102695|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102696|NCT00699842|Lenalidomide|lenalidomide|mesh-list
154102697|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
154102698|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102699|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154102700|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154102701|NCT00699842|Growth Substances|growth substances|mesh-ancestor
154102743|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
154102744|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
154102745|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
154102746|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102747|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
154102748|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102749|NCT00699608|Zopiclone|zopiclone|mesh-list
154102750|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154102751|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102752|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102753|NCT00895570|Modafinil|modafinil|mesh-list
154102754|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154102755|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102756|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154102757|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154102758|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154102759|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102760|NCT00895648|Pemetrexed|pemetrexed|mesh-list
154102761|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102762|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102763|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102764|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154102766|NCT00893854|Triamcinolone|triamcinolone|mesh-list
154102791|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
154102792|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
154102793|NCT00895882|Interferons|interferons|mesh-list
154102794|NCT00895882|Ribavirin|ribavirin|mesh-list
154102795|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102796|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
154102797|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102798|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
154102799|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102800|NCT00706706|Sunitinib|sunitinib|mesh-list
154102801|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102802|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154102803|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154102804|NCT00706706|Growth Substances|growth substances|mesh-ancestor
154102805|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102806|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
154102808|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102850|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102851|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102852|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102853|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
154102854|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154102855|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102856|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154102857|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154102858|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102859|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102860|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102861|NCT00896428|Gallopamil|gallopamil|mesh-list
154102862|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154102863|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154102864|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102865|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154102866|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102867|NCT02962050|Capsaicin|capsaicin|mesh-list
154102868|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
154102903|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102905|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102906|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102907|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
154102908|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102909|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
154102910|NCT00418717|Etanercept|etanercept|mesh-list
154102911|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154102912|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102913|NCT00418717|Analgesics|analgesics|mesh-ancestor
154102914|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
154102915|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102916|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102917|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154102918|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154102919|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154102920|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727868|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102921|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
154102922|NCT00572572|Aprepitant|aprepitant|mesh-list
154102923|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
154102924|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
154102925|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102926|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102927|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154102928|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154102929|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154102930|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102931|NCT00897130|Azacitidine|azacitidine|mesh-list
154102932|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154102933|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
154102934|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102935|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102937|NCT00398047|Mitogens|mitogens|mesh-list
154102946|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154102947|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154102948|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154102949|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154102950|NCT00631371|Growth Substances|growth substances|mesh-ancestor
154102951|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102952|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
154102953|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
154102954|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102955|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
154102956|NCT00631371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154102957|NCT00631371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154102958|NCT00631371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102959|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154102960|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154102961|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154102962|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
154102963|NCT00409747|Minocycline|minocycline|mesh-list
154102964|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154102965|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154102966|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
154102967|NCT04016740|Ketamine|ketamine|mesh-list
154102968|NCT04016740|Remifentanil|remifentanil|mesh-list
154102969|NCT04016740|Propofol|propofol|mesh-list
154102970|NCT04016740|Ropivacaine|ropivacaine|mesh-list
154102971|NCT04016740|Sevoflurane|sevoflurane|mesh-list
154102972|NCT04016740|Rocuronium|rocuronium|mesh-list
154102973|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154102974|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154102975|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154102976|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154102977|NCT04016740|Analgesics|analgesics|mesh-ancestor
154102978|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
154102979|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154102985|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154102986|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154102987|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
154102989|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154102990|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154102991|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154102992|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
154102993|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154102994|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154102995|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154102996|NCT04016740|Narcotics|narcotics|mesh-ancestor
154102997|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154102998|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154102999|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154103000|NCT02540512|Acetaminophen|acetaminophen|mesh-list
154103001|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154103002|NCT02540512|Hydrocodone|hydrocodone|mesh-list
154103003|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154103004|NCT02540512|Analgesics|analgesics|mesh-ancestor
154103005|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
154103006|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103007|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103008|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
154103009|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154103010|NCT02540512|Narcotics|narcotics|mesh-ancestor
154103012|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
154103031|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154103032|NCT00894712|Sulforaphane|sulforaphane|mesh-list
154103033|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154103034|NCT00894712|Protective Agents|protective agents|mesh-ancestor
154103035|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103036|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103037|NCT00823641|Infliximab|infliximab|mesh-list
154103038|NCT00823641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154103039|NCT00823641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103040|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
154103041|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154103042|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103043|NCT00823875|Cilostazol|cilostazol|mesh-list
154103044|NCT00823875|Probucol|probucol|mesh-list
154103045|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154103046|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
154103047|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103048|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103049|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154103088|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154103089|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103090|NCT00819975|Caseins|caseins|mesh-list
154103091|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
154103092|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
154103093|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103094|NCT04044417|Curcumin|curcumin|mesh-list
154103095|NCT04044417|Simvastatin|simvastatin|mesh-list
154103096|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154103097|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154103098|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
154103099|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103100|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154103101|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154103102|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103103|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154103104|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154103105|NCT04044417|Analgesics|analgesics|mesh-ancestor
154103106|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
154103107|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103108|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103109|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103110|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103111|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103112|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154103113|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154103114|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154103115|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103126|NCT00820053|Epirubicin|epirubicin|mesh-list
154103133|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103134|NCT00572728|Alovudine|alovudine|mesh-list
154103135|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
154103136|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
154103137|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727926|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
153727927|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153727928|NCT01244230|Fexofenadine|fexofenadine|mesh-list
153727929|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153727930|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153727931|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154103138|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
154103139|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103140|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154103141|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154103142|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103143|NCT00699374|Sorafenib|sorafenib|mesh-list
154103144|NCT00699374|Sunitinib|sunitinib|mesh-list
154103145|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103146|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154103147|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103148|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103149|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154103150|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154103151|NCT00699374|Growth Substances|growth substances|mesh-ancestor
154103152|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103153|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
154103154|NCT00898534|Chrysarobin|chrysarobin|mesh-list
154103155|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154103156|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154103157|NCT00898534|Analgesics|analgesics|mesh-ancestor
154103158|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
154103159|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103160|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103161|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103162|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103163|NCT00606892|Nicotine|nicotine|mesh-list
154103164|NCT00606892|Varenicline|varenicline|mesh-list
154103175|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103176|NCT01035853|Colistin|colistin|mesh-list
154103177|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103178|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103179|NCT01042717|Plerixafor|plerixafor|mesh-list
154103180|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154103181|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154103182|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
154103183|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103184|NCT00898846|Tegafur|tegafur|mesh-list
154103185|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154103186|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
154103187|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103188|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103189|NCT00826371|Ranibizumab|ranibizumab|mesh-list
154103190|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154103191|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154103192|NCT00826371|Growth Substances|growth substances|mesh-ancestor
154103193|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103194|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
154103195|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103197|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103198|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154103199|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103200|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103201|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
154103202|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154103203|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154103204|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
153426466|NCT03704467|Carboplatin|carboplatin|mesh-list
154103205|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103206|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103207|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103216|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103217|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103219|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103220|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154103221|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154103222|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103223|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154103224|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154103225|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103226|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
154103227|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154103228|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154103229|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154103230|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
154103231|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103232|NCT02550249|Nivolumab|nivolumab|mesh-list
154103233|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154103234|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103235|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154103236|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103237|NCT00824811|Fluorometholone|fluorometholone|mesh-list
154103238|NCT00824811|Cyclosporine|cyclosporine|mesh-list
154103239|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154103240|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
154103241|NCT00824811|Cyclosporins|cyclosporins|mesh-list
154103242|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103243|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103244|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154103245|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
154103255|NCT00824811|Hormones|hormones|mesh-ancestor
154103257|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154103258|NCT00606580|Paromomycin|paromomycin|mesh-list
154103259|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103260|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103261|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154103262|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154103263|NCT02550327|Paclitaxel|paclitaxel|mesh-list
154103264|NCT02550327|Gemcitabine|gemcitabine|mesh-list
154103265|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154103266|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154103267|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103268|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
154103269|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
154103270|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
154103271|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103272|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154103273|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
154103274|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103275|NCT00825045|Risperidone|risperidone|mesh-list
154103276|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154103277|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
154103278|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103279|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103280|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103281|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154103282|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154103283|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103284|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154103285|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154103286|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
154103287|NCT00606502|Vitamins|vitamins|mesh-list
154103288|NCT00606502|Folic Acid|folic acid|mesh-list
154103289|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
154103290|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
154103291|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154103292|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
154103297|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103298|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103299|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103300|NCT00606502|Hematinics|hematinics|mesh-ancestor
153727946|NCT00127010|Vaccines|vaccines|mesh-list
154103301|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154103302|NCT00825123|Metoprolol|metoprolol|mesh-list
154103303|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154103304|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154103305|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
154103306|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
154103307|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103308|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103309|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154103310|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154103311|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154103312|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103313|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103314|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103315|NCT00826839|Leuprolide|leuprolide|mesh-list
154103316|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
154103317|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
154103351|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103352|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
154103353|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103354|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154103355|NCT00820911|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154103356|NCT00820911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154103357|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103358|NCT00605722|Bevacizumab|bevacizumab|mesh-list
154103359|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154103360|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154103361|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103362|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154103363|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154103364|NCT00605722|Growth Substances|growth substances|mesh-ancestor
154103365|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103366|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
154103367|NCT00605722|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154103368|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154103369|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103370|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103371|NCT00882076|Etoposide|etoposide|mesh-list
154103372|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
154103373|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
154103374|NCT00882076|Clofarabine|clofarabine|mesh-list
154103375|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154103376|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103398|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103399|NCT00825591|Protective Agents|protective agents|mesh-ancestor
154103400|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103401|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103402|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
154103403|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154103404|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
154103405|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103406|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
154103407|NCT00882232|Protective Agents|protective agents|mesh-ancestor
154103408|NCT00900172|Paclitaxel|paclitaxel|mesh-list
154103409|NCT00900172|Bevacizumab|bevacizumab|mesh-list
154103410|NCT00900172|Carboplatin|carboplatin|mesh-list
154103411|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154103412|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103413|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
154103414|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
154103415|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
154103416|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103417|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154103418|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154103420|NCT00900172|Growth Substances|growth substances|mesh-ancestor
154103450|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154103451|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154103452|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103453|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
154103454|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154103455|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154103456|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154103457|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
154103458|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103459|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154103460|NCT00396877|Clopidogrel|clopidogrel|mesh-list
154103461|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154103462|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154103463|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154103464|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154103465|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
154103466|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103467|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103468|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103469|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154103470|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
154103503|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154103504|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154103505|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
154103506|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103507|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103508|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154103509|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
154103510|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154103511|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154103512|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154103513|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154103514|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
154103515|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154103516|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154103517|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103518|NCT00901732|Calcium|calcium|mesh-list
154103519|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154103520|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103521|NCT00882700|Cefdinir|cefdinir|mesh-list
154103522|NCT00882700|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154103523|NCT00882700|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154103524|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103525|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103526|NCT00408499|Cetuximab|cetuximab|mesh-list
154103527|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154103528|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154103529|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103534|NCT00837369|Regadenoson|regadenoson|mesh-list
154103543|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
154103544|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154103545|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
154103546|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103547|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103548|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153728052|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
154103549|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
154103550|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154103551|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154103552|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154103553|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103554|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103555|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103556|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
154103557|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154103558|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
154103559|NCT00901888|Nitroprusside|nitroprusside|mesh-list
154103560|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154103561|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
154103562|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154103563|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103564|NCT00908362|Fluticasone|fluticasone|mesh-list
154103565|NCT00908362|Xhance|xhance|mesh-list
154103566|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154103567|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154103568|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103569|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154103589|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154103591|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
154103592|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103593|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103594|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103595|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103596|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
154103597|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154103598|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103599|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103600|NCT02548533|Lidocaine|lidocaine|mesh-list
154103601|NCT02548533|Epinephrine|epinephrine|mesh-list
154103602|NCT02548533|Prilocaine|prilocaine|mesh-list
154103603|NCT02548533|Carticaine|carticaine|mesh-list
154103604|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154103605|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
154103606|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
154103607|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103608|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103609|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
154103610|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103611|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154103612|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154103613|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154103614|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154103615|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103616|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154103617|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154103618|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103619|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103620|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154103621|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154103622|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
154103623|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154103624|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
154103626|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
154103627|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154103628|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154103629|NCT02549391|Cinacalcet|cinacalcet|mesh-list
154103630|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154103631|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728333|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154103632|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154103633|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
154103634|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154103635|NCT02538172|Valganciclovir|valganciclovir|mesh-list
154103636|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
154103637|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103638|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
154103639|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
154103640|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
154103641|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154103642|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
154103643|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
154103644|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103645|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103646|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103647|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154103648|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
154103649|NCT00908674|Cyproterone|cyproterone|mesh-list
154103677|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103678|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
154103679|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
154103680|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154103681|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154103682|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103683|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103684|NCT00902512|Urological Agents|urological agents|mesh-ancestor
154103685|NCT00827307|Tamoxifen|tamoxifen|mesh-list
154103686|NCT00827307|Goserelin|goserelin|mesh-list
154103687|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154103688|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
154103689|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154103690|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103691|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154103692|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103693|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154103694|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154103695|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154103696|NCT00837915|Loratadine|loratadine|mesh-list
154103697|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
154103698|NCT00837915|Ephedrine|ephedrine|mesh-list
154103699|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
154103700|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
154103701|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154103702|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154103703|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154103704|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
154103705|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
154103706|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103707|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103708|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103716|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154103717|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
154103718|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103719|NCT00908986|Rituximab|rituximab|mesh-list
153728342|NCT00402623|Protective Agents|protective agents|mesh-ancestor
154103720|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154103721|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103722|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
154103723|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729663|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
154103724|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103725|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
154103726|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154103727|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103728|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
154103729|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154103730|NCT00838071|Antibodies|antibodies|mesh-list
154103731|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
154103732|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103733|NCT02547519|Insulin|insulin|mesh-list
154103734|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154103735|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103736|NCT00909454|Vitamin D|vitamin d|mesh-list
154103737|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
154103738|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
154103739|NCT00909454|Vitamins|vitamins|mesh-list
154103740|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
154103741|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103742|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154103743|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154103744|NCT04035070|Clindamycin|clindamycin|mesh-list
154103745|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
154103746|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
154103747|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154103749|NCT04035070|Eusol|eusol|mesh-list
154103758|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154103759|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154103760|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154103761|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103762|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103763|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103764|NCT00408421|Analgesics|analgesics|mesh-ancestor
153728396|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153728397|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
153728399|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103765|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
154103766|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103767|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
154103768|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154103769|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
154103770|NCT00604786|Omalizumab|omalizumab|mesh-list
154103771|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154103772|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154103773|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
154103774|NCT01042873|Dobutamine|dobutamine|mesh-list
154103775|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154103776|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
154103777|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
154103778|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103779|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103780|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154103781|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154103782|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154103783|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
154103784|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103785|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103786|NCT01042873|Protective Agents|protective agents|mesh-ancestor
154103788|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
154103789|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103790|NCT01037023|Topotecan|topotecan|mesh-list
154103799|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103800|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103801|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103803|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
154103804|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154103805|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154103806|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103807|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103808|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103809|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154103810|NCT00903214|Protective Agents|protective agents|mesh-ancestor
154103811|NCT04034836|Parecoxib|parecoxib|mesh-list
154103812|NCT04034836|Ropivacaine|ropivacaine|mesh-list
154103813|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
154103814|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
154103815|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103816|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103817|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
154103818|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103819|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154103820|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154103821|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103822|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103823|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154103824|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154103825|NCT04034836|Analgesics|analgesics|mesh-ancestor
154103826|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103827|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103828|NCT00407797|Pregabalin|pregabalin|mesh-list
154103829|NCT00407797|Analgesics|analgesics|mesh-ancestor
154103830|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
154103831|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103832|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103833|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
154103834|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154103836|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103837|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154103838|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154103839|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154103840|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103841|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154103843|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154103844|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103845|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103846|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103847|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154103848|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154103849|NCT00903292|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154103850|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154103851|NCT00903838|Pramipexole|pramipexole|mesh-list
154103852|NCT00903838|Dexpramipexole|dexpramipexole|mesh-list
154103853|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
154103854|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103855|NCT00903838|Protective Agents|protective agents|mesh-ancestor
154103856|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103857|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153350681|NCT05312151|Psilocybin|psilocybin|mesh-list
154103859|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
154103884|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103885|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154103886|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154103887|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154103888|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103889|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103890|NCT00924742|Tazobactam|tazobactam|mesh-list
154103891|NCT00924742|Piperacillin|piperacillin|mesh-list
154103892|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154103893|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154103894|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154103895|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103896|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103897|NCT00407563|Paclitaxel|paclitaxel|mesh-list
154103898|NCT00407563|Bevacizumab|bevacizumab|mesh-list
154103899|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154103900|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154103901|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103902|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
154103903|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
154103904|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
154103905|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103906|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154103907|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154103908|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154103909|NCT00407563|Growth Substances|growth substances|mesh-ancestor
154103910|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103911|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
154103912|NCT00906724|Insulin|insulin|mesh-list
154103915|NCT01037101|Cycloserine|cycloserine|mesh-list
154103928|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154103929|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
154103930|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
154103931|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103932|NCT00623103|Rivastigmine|rivastigmine|mesh-list
154103933|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154103934|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154103935|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103936|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
154103937|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154103938|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103939|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154103940|NCT00623103|Protective Agents|protective agents|mesh-ancestor
154103941|NCT01043341|Vaccines|vaccines|mesh-list
154103942|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
154103943|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103944|NCT01043419|Xenon|xenon|mesh-list
154103945|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153729665|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
154103946|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
154103947|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
154103948|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103949|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103950|NCT01037335|Morphine|morphine|mesh-list
154103951|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154103952|NCT01037335|Narcotics|narcotics|mesh-ancestor
153728502|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154103953|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103954|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103955|NCT01037335|Analgesics|analgesics|mesh-ancestor
154103956|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
154103957|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103958|NCT04015492|Factor VIII|factor viii|mesh-list
154103959|NCT04015492|BAX 855|bax 855|mesh-list
154103960|NCT04015492|Coagulants|coagulants|mesh-ancestor
154103961|NCT00904462|Lidocaine|lidocaine|mesh-list
154103962|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
154103963|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
154103964|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154103966|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
154103967|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103968|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154103969|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154103970|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154103971|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154103972|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154103973|NCT00396565|Olanzapine|olanzapine|mesh-list
154103974|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154103975|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
154103976|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
154103977|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154103978|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154103979|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154103980|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154103981|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154104022|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154104023|NCT00394771|Estrogens|estrogens|mesh-ancestor
154104024|NCT00394771|Hormones|hormones|mesh-ancestor
154104025|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154104026|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104027|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154104028|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
154104029|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154104030|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154104031|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154104032|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154104033|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154104034|NCT00396409|Omalizumab|omalizumab|mesh-list
154104035|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154104036|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154104037|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
154104038|NCT04060836|Factor VIII|factor viii|mesh-list
154104039|NCT04060836|Coagulants|coagulants|mesh-ancestor
154104040|NCT00693420|Bimatoprost|bimatoprost|mesh-list
154104041|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154104042|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154104043|NCT04034524|Insulin|insulin|mesh-list
154104044|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154104045|NCT04034524|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154104046|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153728507|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
154104047|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104048|NCT00925912|Bupivacaine|bupivacaine|mesh-list
154104049|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
154104050|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
154104051|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104052|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104053|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
154104054|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104055|NCT00695136|Donepezil|donepezil|mesh-list
154104065|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154104066|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154104067|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154104068|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104069|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154104070|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104071|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
154104072|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154104073|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154104075|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
154104076|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154104077|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154104078|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154104079|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104080|NCT00605176|Imiquimod|imiquimod|mesh-list
154104081|NCT00605176|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154104082|NCT00605176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104083|NCT00605176|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154104084|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
154104085|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104086|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154104087|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104088|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
154104089|NCT00743028|Navitoclax|navitoclax|mesh-list
154104090|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104091|NCT00905398|Nilotinib|nilotinib|mesh-list
154104092|NCT00905398|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154104093|NCT00905398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104094|NCT00905398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104095|NCT00905398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104096|NCT00926302|Levetiracetam|levetiracetam|mesh-list
154104101|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
154104102|NCT00907036|Melphalan|melphalan|mesh-list
154104103|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
154104104|NCT00907036|Cyclosporins|cyclosporins|mesh-list
154104105|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104106|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154104107|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
154104108|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728555|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153728556|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
153728557|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728558|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728559|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153728560|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104109|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154104110|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
154104111|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104112|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104113|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
154104114|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104115|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
154104116|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104117|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154104118|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154104119|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
154104120|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154104121|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104122|NCT00926614|Pioglitazone|pioglitazone|mesh-list
154104123|NCT00926614|Atorvastatin|atorvastatin|mesh-list
154104124|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154104125|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154104126|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
154104127|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104128|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154104130|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104148|NCT00745914|Pioglitazone|pioglitazone|mesh-list
154104149|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104150|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104151|NCT00746070|Spironolactone|spironolactone|mesh-list
154104152|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154104153|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
154104154|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154104155|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104156|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154104157|NCT00746070|Diuretics|diuretics|mesh-ancestor
154104158|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
154104159|NCT00396331|Plerixafor|plerixafor|mesh-list
154104160|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154104161|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154104162|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
154104163|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104164|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
154104165|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
154104166|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154104167|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104168|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104170|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154104171|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104172|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104173|NCT00926926|Oxybutynin|oxybutynin|mesh-list
154104174|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
154104175|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
154104176|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728567|NCT00499135|Alovudine|alovudine|mesh-list
154104177|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104178|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154104179|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154104180|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
154104181|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104183|NCT00926926|Urological Agents|urological agents|mesh-ancestor
154104186|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154104187|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104188|NCT00927004|Etoricoxib|etoricoxib|mesh-list
154104189|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154104190|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154104191|NCT00927004|Analgesics|analgesics|mesh-ancestor
154104192|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
154104193|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104194|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104195|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154104196|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104197|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154104198|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154104199|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104200|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104201|NCT00931450|Sunitinib|sunitinib|mesh-list
154104202|NCT00931450|Exemestane|exemestane|mesh-list
154104203|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104204|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104205|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104206|NCT00931450|Growth Substances|growth substances|mesh-ancestor
154104207|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104208|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104209|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104210|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104211|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104212|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154104213|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154104230|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154104231|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104232|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154104233|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104235|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154104236|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
154104237|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104238|NCT00931840|Irinotecan|irinotecan|mesh-list
154104239|NCT00931840|Cetuximab|cetuximab|mesh-list
154104240|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154104241|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154104242|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104243|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104244|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104289|NCT00932464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104290|NCT00932464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104291|NCT00932464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104292|NCT00932542|Lidocaine|lidocaine|mesh-list
154104293|NCT00932542|Prilocaine|prilocaine|mesh-list
154104294|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154104295|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
154104296|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104297|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104298|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
154104299|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104300|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154104301|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154104302|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154104303|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154104304|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104305|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
154104306|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154104307|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104308|NCT01043575|Rifampin|rifampin|mesh-list
154104309|NCT01043575|Rifapentine|rifapentine|mesh-list
154104310|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154104311|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
154104312|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154104313|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104314|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
154104335|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104336|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104337|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
154104338|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154104339|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154104340|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104341|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154104342|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154104343|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154104344|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104345|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104346|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
154104347|NCT00907894|Telbivudine|telbivudine|mesh-list
154104348|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
154104349|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104350|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154104351|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104352|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104353|NCT04014556|Aflibercept|aflibercept|mesh-list
154104354|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104355|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104356|NCT04014556|Growth Substances|growth substances|mesh-ancestor
154104357|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104358|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104359|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104360|NCT00929812|Glucagon|glucagon|mesh-list
154104361|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154104362|NCT00929812|Hormones|hormones|mesh-ancestor
154104363|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154104364|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104365|NCT00907972|Vitamin D|vitamin d|mesh-list
154104366|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
154104367|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
154104369|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
154104376|NCT00933634|Propafenone|propafenone|mesh-list
154104377|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154104378|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154104379|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154104380|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154104381|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104382|NCT00933790|Rifampin|rifampin|mesh-list
154104383|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
154104384|NCT00933790|Ethambutol|ethambutol|mesh-list
154104385|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154104386|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
154104387|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154104388|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104389|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
154104390|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154104391|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104392|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104393|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154104394|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154104395|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154104396|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154104397|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154104398|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154104399|NCT00566254|Zonisamide|zonisamide|mesh-list
154104400|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
154104401|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154104402|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154104403|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104404|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154104405|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104406|NCT00930202|Conivaptan|conivaptan|mesh-list
154104407|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153654598|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654599|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154104408|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104410|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104411|NCT00393367|Prednisone|prednisone|mesh-list
154104412|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
154104413|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154104414|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154104415|NCT00393367|Prednisolone|prednisolone|mesh-list
154104416|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
154104417|NCT00393367|Budesonide|budesonide|mesh-list
154104418|NCT00393367|Bromides|bromides|mesh-list
154104419|NCT00393367|Albuterol|albuterol|mesh-list
154104420|NCT00393367|Ipratropium|ipratropium|mesh-list
154104421|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154104422|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
154104423|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154104424|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
154104425|NCT00393367|Hormones|hormones|mesh-ancestor
154104426|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154104427|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104428|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154104429|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104430|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
154104431|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
154104432|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104433|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154104434|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154104435|NCT00393367|Protective Agents|protective agents|mesh-ancestor
154104436|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154104437|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154104438|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
154104439|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
154104440|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
154104454|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104455|NCT00392665|Sulindac|sulindac|mesh-list
154104456|NCT00392665|Bevacizumab|bevacizumab|mesh-list
154104457|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154104458|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104459|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104460|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104461|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104463|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104464|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104465|NCT00392665|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154104466|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104467|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104468|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104469|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154104470|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154104471|NCT00392665|Analgesics|analgesics|mesh-ancestor
154104472|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
154104473|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104474|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154104475|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104476|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154104477|NCT01043965|Metformin|metformin|mesh-list
154104478|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104479|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104497|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104498|NCT00366457|Growth Substances|growth substances|mesh-ancestor
154104499|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104500|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104501|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154104502|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
154104503|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104504|NCT00366457|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154104505|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104506|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104507|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154104508|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
154104509|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104510|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
154104511|NCT01049425|Docetaxel|docetaxel|mesh-list
154104512|NCT01049425|Epirubicin|epirubicin|mesh-list
154104513|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154104515|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104516|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104517|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154104518|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
154104519|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104520|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104521|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154104522|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
154104523|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
154104524|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
154104525|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154104526|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154104527|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154104528|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104529|NCT00838227|Modafinil|modafinil|mesh-list
153728609|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153728610|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728611|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
153728612|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
153728613|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
153728614|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728624|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728626|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728627|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728628|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153728635|NCT00499876|Mefloquine|mefloquine|mesh-list
154104530|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154104531|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104532|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154104533|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153654600|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154104534|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154104535|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104537|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
154104538|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104539|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104540|NCT00838305|Citalopram|citalopram|mesh-list
154104541|NCT00838305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154104542|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154104543|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154104544|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104545|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104546|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
154104547|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104548|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154104549|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
154104550|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154104551|NCT00622713|Rivastigmine|rivastigmine|mesh-list
154104552|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154104553|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104554|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104555|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
154104556|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104557|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104558|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154104559|NCT00622713|Protective Agents|protective agents|mesh-ancestor
154104560|NCT01046227|Vaccines|vaccines|mesh-list
154104561|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
154104562|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104563|NCT00392197|Aripiprazole|aripiprazole|mesh-list
154104577|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154104578|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154104579|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154104580|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154104581|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154104582|NCT00391807|Norethindrone|norethindrone|mesh-list
154104583|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
154104584|NCT00391807|Estradiol|estradiol|mesh-list
154104585|NCT00391807|Estrogens|estrogens|mesh-ancestor
154104586|NCT00391807|Hormones|hormones|mesh-ancestor
153351423|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
154104587|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154104588|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104589|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154104590|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
154104591|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154104592|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154104593|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154104594|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154104595|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154104596|NCT00624585|Dasatinib|dasatinib|mesh-list
154104597|NCT00624585|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154104598|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104599|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104601|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104624|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154104625|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154104626|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
154104627|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104628|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104629|NCT00391027|Insulin|insulin|mesh-list
154104630|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154104631|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
154104632|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104633|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104634|NCT00622401|Interleukin-12|interleukin-12|mesh-list
154104635|NCT00622401|Vaccines|vaccines|mesh-list
154104636|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
154104637|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104638|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154104639|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104640|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104641|NCT00622401|Growth Substances|growth substances|mesh-ancestor
154104642|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104643|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104644|NCT04018365|Empagliflozin|empagliflozin|mesh-list
154104645|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154104646|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104647|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104648|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104649|NCT00828087|Cobalt|cobalt|mesh-list
154104650|NCT00828087|Chromium|chromium|mesh-list
154104651|NCT00828087|Everolimus|everolimus|mesh-list
154104652|NCT00828087|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154104669|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
154104670|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154104671|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104672|NCT00839163|Vitamin K|vitamin k|mesh-list
154104673|NCT00839163|Enoxaparin|enoxaparin|mesh-list
154104674|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
154104675|NCT00839163|Vitamins|vitamins|mesh-ancestor
154104676|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
154104677|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104678|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154104679|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
154104680|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154104681|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
154104682|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104683|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104684|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
154104685|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154104686|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154104687|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154104688|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
154104689|NCT00839163|Coagulants|coagulants|mesh-ancestor
154104690|NCT02549001|Amorolfine|amorolfine|mesh-list
154104691|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
154104692|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104693|NCT00621543|Copper|copper|mesh-list
154104694|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
153728650|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154104695|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154104696|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
154104697|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154104698|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104699|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154104700|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154104701|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154104702|NCT00621543|Trace Elements|trace elements|mesh-ancestor
154104703|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
154104704|NCT00623805|Bevacizumab|bevacizumab|mesh-list
154104705|NCT00623805|Capecitabine|capecitabine|mesh-list
154104706|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
154104707|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104708|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104709|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104710|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104711|NCT00623805|Growth Substances|growth substances|mesh-ancestor
154104712|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104713|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104714|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154104715|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
154104716|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104717|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
154104718|NCT02548923|Propofol|propofol|mesh-list
154104719|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154104720|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104721|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104722|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154104723|NCT02548923|Analgesics|analgesics|mesh-ancestor
154104724|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
154104725|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104726|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154104727|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154104728|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154104729|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
154104730|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104731|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104732|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154104733|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
154104734|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
154104735|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154104736|NCT00832221|Raclopride|raclopride|mesh-list
154104737|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
154104738|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154104739|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154104740|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154104741|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104749|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154104750|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154104751|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104752|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104753|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
154104754|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104755|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154104756|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
154104757|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154104758|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154104759|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154104760|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104761|NCT00828477|Nepafenac|nepafenac|mesh-list
154104762|NCT00828477|Bromfenac|bromfenac|mesh-list
154104763|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154104764|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154104765|NCT00828477|Analgesics|analgesics|mesh-ancestor
154104766|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
154104767|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104768|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104769|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154104770|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104771|NCT00621309|Rifampin|rifampin|mesh-list
154104772|NCT00621309|Rifamycins|rifamycins|mesh-list
154104773|NCT00621309|Sulforaphane|sulforaphane|mesh-list
154104774|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154104775|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
154104776|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154104777|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104787|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154104788|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154104790|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104791|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104792|NCT00839553|Minocycline|minocycline|mesh-list
154104793|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154104794|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104795|NCT00832689|Gemcitabine|gemcitabine|mesh-list
154104796|NCT00832689|Irinotecan|irinotecan|mesh-list
154104797|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154104798|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
154104799|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104800|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104801|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154104802|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154104803|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104804|NCT00567190|Docetaxel|docetaxel|mesh-list
154104805|NCT00567190|Trastuzumab|trastuzumab|mesh-list
154104806|NCT00567190|Pertuzumab|pertuzumab|mesh-list
154104807|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104808|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
154104809|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
154104810|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
154104811|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104812|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104813|NCT00922389|Lenograstim|lenograstim|mesh-list
154104814|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154104815|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
154104816|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104817|NCT00691938|Decitabine|decitabine|mesh-list
154104833|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
154104834|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104835|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154104836|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154104837|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
154104838|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104839|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104840|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154104841|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154104842|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154104843|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154104844|NCT00365365|Growth Substances|growth substances|mesh-ancestor
154104845|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104846|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
154104847|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
154104848|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
154104849|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154104850|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154104851|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154104852|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104853|NCT01046461|Dexamethasone|dexamethasone|mesh-list
154104854|NCT01046461|Aprepitant|aprepitant|mesh-list
154104855|NCT01046461|Ramosetron|ramosetron|mesh-list
154104856|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154104857|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
154104858|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
154104859|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104860|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104861|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154104862|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
154104863|NCT01046461|Hormones|hormones|mesh-ancestor
154104864|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154104865|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154104872|NCT00623727|Factor VIII|factor viii|mesh-list
154104874|NCT01046539|Buprenorphine|buprenorphine|mesh-list
154104875|NCT01046539|ALKS-33|alks-33|mesh-list
154104876|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154104877|NCT01046539|Narcotics|narcotics|mesh-ancestor
154104878|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104879|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104880|NCT01046539|Analgesics|analgesics|mesh-ancestor
154104881|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
154104882|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104883|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154104884|NCT01044199|Vaccines|vaccines|mesh-list
154104885|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
154104886|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104887|NCT00828789|Tenofovir|tenofovir|mesh-list
154104888|NCT00828789|Efavirenz|efavirenz|mesh-list
154104889|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
154104890|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104891|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154104892|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154104893|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104894|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104895|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154104896|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154104897|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154104898|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154104899|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154104900|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154104901|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154104902|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154104903|NCT00930358|Anesthetics|anesthetics|mesh-list
154104904|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104905|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104906|NCT00372775|Sunitinib|sunitinib|mesh-list
154104907|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154104912|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
154104913|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154104914|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104915|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104916|NCT00936676|Rasagiline|rasagiline|mesh-list
154104917|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154104918|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104919|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104920|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154104921|NCT00936676|Protective Agents|protective agents|mesh-ancestor
154104922|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104923|NCT00839787|Morphine|morphine|mesh-list
154104924|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154104925|NCT00839787|Narcotics|narcotics|mesh-ancestor
154104926|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154104927|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104928|NCT00839787|Analgesics|analgesics|mesh-ancestor
154104929|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
154104930|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154104931|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154104932|NCT00934258|Fenofibrate|fenofibrate|mesh-list
154104933|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154104934|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154104935|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
153728686|NCT01245868|Lidocaine|lidocaine|mesh-list
153728687|NCT01245868|Bupivacaine|bupivacaine|mesh-list
154104936|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104937|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154104938|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154104940|NCT00372697|Octreotide|octreotide|mesh-list
154104958|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351799|NCT02111798|Bupropion|bupropion|mesh-list
154104959|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154104960|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154104961|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154104962|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154104963|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
154104964|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154104965|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154104966|NCT00934570|Metformin|metformin|mesh-list
154104967|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154104968|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104969|NCT00930670|Esomeprazole|esomeprazole|mesh-list
154104970|NCT00930670|Omeprazole|omeprazole|mesh-list
154104971|NCT00930670|Pantoprazole|pantoprazole|mesh-list
154104972|NCT00930670|Ranitidine|ranitidine|mesh-list
154104973|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154104974|NCT00930670|Atorvastatin|atorvastatin|mesh-list
154104975|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154104976|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154104977|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154104978|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
154104979|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104980|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153428272|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
154104981|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154104982|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154104983|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154104984|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154104985|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154104986|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154104987|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
154104988|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
154104989|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154104990|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154104996|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154104997|NCT00937144|Urological Agents|urological agents|mesh-ancestor
154104999|NCT00937300|Fludarabine|fludarabine|mesh-list
154105000|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
154105001|NCT00937300|Interleukin-2|interleukin-2|mesh-list
154105002|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105003|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
154105004|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105005|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105006|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154105007|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
154105008|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105009|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105010|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153728732|NCT00146913|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728733|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728734|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728735|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728736|NCT00501124|Clevudine|clevudine|mesh-list
153728737|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
153728738|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105011|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154105012|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
154105013|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154105014|NCT00937300|Analgesics|analgesics|mesh-ancestor
154105015|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
154105016|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105017|NCT00935116|Etoricoxib|etoricoxib|mesh-list
154105018|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154105019|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154105020|NCT00935116|Analgesics|analgesics|mesh-ancestor
154105021|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
154105022|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105023|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105024|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105025|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105026|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154105027|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154105030|NCT00931138|Cytarabine|cytarabine|mesh-list
154105037|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105038|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154105039|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
154105040|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
154105041|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105042|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105043|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
154105044|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105046|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
154105047|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105048|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105049|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105050|NCT00690378|Imipenem|imipenem|mesh-list
154105051|NCT00690378|Ceftazidime|ceftazidime|mesh-list
154105052|NCT00690378|Avibactam|avibactam|mesh-list
154105053|NCT00690378|Cilastatin|cilastatin|mesh-list
154105054|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154105055|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105092|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105093|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105095|NCT00935506|Clopidogrel|clopidogrel|mesh-list
154105096|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154105097|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154105098|NCT00935506|Analgesics|analgesics|mesh-ancestor
154105099|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
154105100|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105101|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105102|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105103|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105104|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154105105|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153351950|NCT01658904|Melphalan|melphalan|mesh-list
154105106|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105107|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154105108|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154105109|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105110|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
154105111|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154105112|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153728742|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
154105113|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154105114|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
154105115|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105116|NCT00833157|Ibuprofen|ibuprofen|mesh-list
154105117|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154105118|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154105119|NCT00833157|Analgesics|analgesics|mesh-ancestor
154105120|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
154105121|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105122|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105124|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105131|NCT00829257|Fluticasone|fluticasone|mesh-list
154105132|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154105133|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105134|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154105135|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
154105136|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105137|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105138|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154105139|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
154105140|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
154105141|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154105142|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
154105143|NCT00829257|Hormones|hormones|mesh-ancestor
154105144|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105145|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
154105146|NCT03978832|Risperidone|risperidone|mesh-list
154105147|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154105148|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
154105149|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105150|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105151|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105152|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154105153|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154105154|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154105155|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154105156|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154105157|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
154105158|NCT00840333|Levofloxacin|levofloxacin|mesh-list
154105159|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154105160|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105161|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154105162|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154105163|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154105164|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105166|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105168|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154105170|NCT00840489|Colchicine|colchicine|mesh-list
154105171|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
154105172|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105173|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
154105174|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105175|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
154105176|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105177|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
153728747|NCT01246180|Amiloride|amiloride|mesh-list
153728748|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153728749|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153728750|NCT01246180|Analgesics|analgesics|mesh-ancestor
153728751|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
153728752|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728753|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105178|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
154105179|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
154105180|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105181|NCT00743496|Antibodies|antibodies|mesh-list
154105182|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
154105183|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105184|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154105185|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154105186|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154105187|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154105188|NCT00840645|Mirabegron|mirabegron|mesh-list
154105189|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154105190|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154105191|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154105192|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
154105193|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105194|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105195|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105196|NCT00840645|Urological Agents|urological agents|mesh-ancestor
154105197|NCT00566722|Adalimumab|adalimumab|mesh-list
154105198|NCT00566722|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154105199|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105200|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105201|NCT00691704|Prednisone|prednisone|mesh-list
154105202|NCT00691704|Lenalidomide|lenalidomide|mesh-list
154105203|NCT00691704|Bortezomib|bortezomib|mesh-list
153428504|NCT00378313|Paclitaxel|paclitaxel|mesh-list
154105204|NCT00691704|Melphalan|melphalan|mesh-list
154105206|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
154105207|NCT00691704|Hormones|hormones|mesh-ancestor
154105208|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105209|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105210|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154105211|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105212|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105213|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
154105214|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154105215|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154105216|NCT00691704|Growth Substances|growth substances|mesh-ancestor
154105217|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
154105218|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154105219|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
154105220|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154105221|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105222|NCT00829647|Lenalidomide|lenalidomide|mesh-list
154105223|NCT00829647|Dasatinib|dasatinib|mesh-list
154105224|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
154105225|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105226|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154105227|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154105228|NCT00829647|Growth Substances|growth substances|mesh-ancestor
154105229|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
154105254|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154105255|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154105256|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105257|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
154105258|NCT04014244|Hormones|hormones|mesh-ancestor
154105259|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105260|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105261|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105262|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
154105263|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105264|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105265|NCT02548611|Clopidogrel|clopidogrel|mesh-list
154105266|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154105267|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154105268|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154105269|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154105270|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154105271|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
154105272|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105273|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105274|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105275|NCT00743886|Mitogens|mitogens|mesh-list
154105276|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
154105282|NCT00830193|Expectorants|expectorants|mesh-ancestor
154105305|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105306|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154105307|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154105308|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154105309|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105310|NCT00830349|Risperidone|risperidone|mesh-list
154105311|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154105312|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
154105313|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105314|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105315|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105316|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154105317|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154105318|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154105319|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154105320|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154105321|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
154105322|NCT00841113|Goserelin|goserelin|mesh-list
154105323|NCT00841113|Bicalutamide|bicalutamide|mesh-list
154105324|NCT00841113|Abarelix|abarelix|mesh-list
154105325|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154105326|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105327|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
154105328|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
154105329|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105330|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105331|NCT00830505|Fluticasone|fluticasone|mesh-list
154105332|NCT00830505|Xhance|xhance|mesh-list
154105333|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154105334|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154105335|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105336|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154105337|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
154105338|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105339|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105342|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
154105343|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154105344|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154105345|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154105346|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154105347|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
154105348|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105349|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105350|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
154105351|NCT00830505|Hormones|hormones|mesh-ancestor
154105352|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105353|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
154105354|NCT00566020|Lamotrigine|lamotrigine|mesh-list
154105355|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
154105356|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154105357|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154105358|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105359|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154105360|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105361|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154105362|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154105363|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154105364|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154105365|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154105366|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
154105367|NCT02563782|Tacrolimus|tacrolimus|mesh-list
154105368|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105369|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
154105370|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105371|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154105372|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105373|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105374|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154105375|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105380|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154105381|NCT00841191|Siltuximab|siltuximab|mesh-list
154105382|NCT00841191|Antibodies|antibodies|mesh-list
154105383|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
154105384|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154105385|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
154105386|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105387|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105388|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
154105389|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
154105390|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
154105391|NCT00843453|Vitamins|vitamins|mesh-ancestor
154105392|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
154105393|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105394|NCT00843453|Hematinics|hematinics|mesh-ancestor
154105395|NCT00921726|Oseltamivir|oseltamivir|mesh-list
154105396|NCT00921726|Zanamivir|zanamivir|mesh-list
154105397|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
154105398|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105399|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105400|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105401|NCT00938236|Cyclosporine|cyclosporine|mesh-list
154105402|NCT00938236|Cyclosporins|cyclosporins|mesh-list
154105403|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105404|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105405|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105406|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
154105407|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105408|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
154105409|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105410|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
154105411|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105412|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154105414|NCT00741780|Lenograstim|lenograstim|mesh-list
154105415|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154105416|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
154105417|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105418|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154105421|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105423|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154105424|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105425|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154105426|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154105427|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105428|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105429|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154105430|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
154105431|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105432|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105433|NCT00744354|Doxorubicin|doxorubicin|mesh-list
154105434|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154105435|NCT00744354|Bortezomib|bortezomib|mesh-list
154105436|NCT00744354|Vorinostat|vorinostat|mesh-list
154105437|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154105438|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105439|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154105440|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154105441|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105442|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105443|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154105444|NCT04043325|Antibodies|antibodies|mesh-list
154105445|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
154105446|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105447|NCT00936520|Lifitegrast|lifitegrast|mesh-list
154105448|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154105449|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154105450|NCT00835029|Clotrimazole|clotrimazole|mesh-list
154105451|NCT00835029|Miconazole|miconazole|mesh-list
154105452|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154105453|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105454|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
154105455|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154105456|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154105457|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105458|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105459|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154105460|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
154105461|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105462|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105463|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154105464|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154105465|NCT00835107|Ziprasidone|ziprasidone|mesh-list
154105466|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154105467|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
154105468|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105469|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105470|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105471|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154105472|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154105473|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154105474|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154105475|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154105476|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
154105478|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
154105479|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154105480|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154105481|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154105482|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105483|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
154105484|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
154105485|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154105486|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154105487|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105488|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105489|NCT00742014|Urological Agents|urological agents|mesh-ancestor
154105490|NCT00742092|Miglustat|miglustat|mesh-list
154105491|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105492|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105493|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154105494|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153728791|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105495|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
154105496|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105497|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154105498|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154105499|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105500|NCT00841581|Ranibizumab|ranibizumab|mesh-list
154105501|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154105502|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154105503|NCT00841581|Growth Substances|growth substances|mesh-ancestor
154105504|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105505|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
154105506|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105507|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
154105508|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154105509|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
154105510|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105511|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105512|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154105513|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
154105514|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154105515|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154105516|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154105517|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
154105518|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105519|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105520|NCT04249167|Paclitaxel|paclitaxel|mesh-list
154105521|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154105522|NCT04249167|Atezolizumab|atezolizumab|mesh-list
154105523|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154105524|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154105525|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105535|NCT00621153|Candesartan|candesartan|mesh-list
154105536|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
154105537|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154105538|NCT00621153|Diuretics|diuretics|mesh-ancestor
154105539|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
154105540|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105541|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154105542|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154105543|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105544|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154105545|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154105546|NCT00574119|Spironolactone|spironolactone|mesh-list
154105547|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154105548|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
154105549|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105550|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105551|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154105552|NCT00574119|Diuretics|diuretics|mesh-ancestor
154105553|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
154105554|NCT00705614|Infliximab|infliximab|mesh-list
154105555|NCT00705614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154105556|NCT00705614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105557|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
154105558|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154105559|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105560|NCT00844155|Oseltamivir|oseltamivir|mesh-list
154105561|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
154105562|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105563|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105564|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105565|NCT00844233|Irinotecan|irinotecan|mesh-list
154105566|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154105567|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154105568|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105573|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105574|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154105575|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105576|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154105577|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154105578|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105580|NCT02547597|Carvedilol|carvedilol|mesh-list
154105581|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154105582|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154105583|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
154105584|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105585|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105586|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105587|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154105588|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
154105589|NCT02547597|Protective Agents|protective agents|mesh-ancestor
154105590|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154105591|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154105592|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154105593|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
154105594|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154105595|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154105596|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154105597|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
154105598|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
154105599|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105600|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154105601|NCT00842127|Methylphenidate|methylphenidate|mesh-list
154105618|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105619|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105620|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154105621|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
154105622|NCT00835965|Hormones|hormones|mesh-ancestor
154105623|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105624|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154105625|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105626|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
154105627|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105628|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105629|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154105630|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105631|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
154105632|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154105633|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154105634|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154105635|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
154105636|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105637|NCT00842205|Interferons|interferons|mesh-list
154105638|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105639|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
153728824|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105640|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105641|NCT00738296|Simvastatin|simvastatin|mesh-list
154105664|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154105665|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
154105666|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154105667|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105668|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154105669|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105670|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
154105671|NCT05664542|Ropivacaine|ropivacaine|mesh-list
154105672|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154105673|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154105674|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105675|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154105676|NCT05664542|Analgesics|analgesics|mesh-ancestor
154105677|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
154105678|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105679|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154105680|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154105681|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154105682|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
154105683|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105684|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105685|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
154105686|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
154105687|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
154105688|NCT00562978|Etoposide|etoposide|mesh-list
154105689|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154105690|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
154105691|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105692|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105693|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154105694|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
154105695|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105696|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105697|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154105698|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154105703|NCT00842595|Rituximab|rituximab|mesh-list
154105704|NCT00842595|Vinorelbine|vinorelbine|mesh-list
154105705|NCT00842595|Ifosfamide|ifosfamide|mesh-list
154105706|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
154105707|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154105708|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105709|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
154105710|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105711|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154105712|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154105713|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
154105714|NCT00842595|Hormones|hormones|mesh-ancestor
154105715|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105730|NCT00938626|Antibodies|antibodies|mesh-list
154105765|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154105766|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154105767|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154105768|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154105769|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
154105770|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154105771|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154105772|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
154105773|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154105774|NCT00940420|Ribavirin|ribavirin|mesh-list
154105775|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154105776|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
154105777|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
154105778|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105779|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
154105780|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105781|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
154105782|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105783|NCT00842907|Tretinoin|tretinoin|mesh-list
154105784|NCT00842907|Isotretinoin|isotretinoin|mesh-list
154105785|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105786|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
154105787|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
154105788|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
154105789|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154105790|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105791|NCT00940654|Acetaminophen|acetaminophen|mesh-list
154105792|NCT00940654|Antipyretics|antipyretics|mesh-list
154105793|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154105794|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154105795|NCT00940654|Analgesics|analgesics|mesh-ancestor
154105796|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
153429100|NCT00002552|Leucovorin|leucovorin|mesh-list
154105797|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105798|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105799|NCT00843063|Pantoprazole|pantoprazole|mesh-list
154105800|NCT00843063|Famotidine|famotidine|mesh-list
154105801|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153654601|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154105802|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154105803|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154105804|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105805|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105806|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154105807|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
154105808|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
154105809|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105810|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105811|NCT04013464|Escitalopram|escitalopram|mesh-list
154105812|NCT04013464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154105813|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154105814|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154105815|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105816|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105817|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
154105818|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105819|NCT04012918|Capecitabine|capecitabine|mesh-list
154105820|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154105821|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154105822|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
154105823|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105824|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728866|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153728867|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153728868|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728869|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
153728870|NCT00147381|Tacrolimus|tacrolimus|mesh-list
153728871|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728872|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
153728873|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728874|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153358680|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153358681|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153358682|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358683|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154105825|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154105826|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105827|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154105828|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
154105830|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105845|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105846|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
154105847|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105849|NCT00845559|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154105850|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154105851|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105852|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154105853|NCT00845559|Incretins|incretins|mesh-ancestor
154105854|NCT00845559|Hormones|hormones|mesh-ancestor
154105855|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105856|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
154105857|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
154105858|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105859|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
154105860|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105861|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105862|NCT05107778|Entecavir|entecavir|mesh-list
154105863|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
154105864|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105865|NCT00372619|Cytarabine|cytarabine|mesh-list
154105866|NCT00372619|Methotrexate|methotrexate|mesh-list
154105867|NCT00372619|Clofarabine|clofarabine|mesh-list
154105868|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154105869|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
154105870|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154105895|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105896|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154105897|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154105899|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
154105900|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154105901|NCT02566226|Morphine|morphine|mesh-list
154105902|NCT02566226|Bupivacaine|bupivacaine|mesh-list
154105903|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
154105904|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
154105905|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154105906|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105907|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
154105908|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154105909|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154105910|NCT02566226|Narcotics|narcotics|mesh-ancestor
153728875|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728876|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728877|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728879|NCT00502567|Leucovorin|leucovorin|mesh-list
154105911|NCT02566226|Analgesics|analgesics|mesh-ancestor
154105912|NCT00837135|Vaccines|vaccines|mesh-list
154105913|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
154105914|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154105915|NCT00562588|Dipyridamole|dipyridamole|mesh-list
154105916|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
154105917|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154105918|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154105919|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154105945|NCT02546349|Hormones|hormones|mesh-ancestor
154105946|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154105947|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
154105948|NCT00851487|Amoxicillin|amoxicillin|mesh-list
154105949|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154105950|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105951|NCT00372385|Interferons|interferons|mesh-list
154105952|NCT00372385|Ribavirin|ribavirin|mesh-list
154105953|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
154105954|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
154105955|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154105956|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154105957|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
154105958|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154105959|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
154105963|NCT03830281|Insulin|insulin|mesh-list
154106006|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106007|NCT00561730|Pantoprazole|pantoprazole|mesh-list
154106008|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154106009|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154106010|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154106011|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106012|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106013|NCT00697112|Sirolimus|sirolimus|mesh-list
154106014|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106015|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106016|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154106017|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106018|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
154106019|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106020|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
154106021|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106023|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
154106024|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153728905|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153728906|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153728907|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106025|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
154106026|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106027|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106028|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
154106029|NCT00851565|Infliximab|infliximab|mesh-list
154106030|NCT00851565|Antibodies|antibodies|mesh-list
154106031|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
154106032|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106033|NCT00851565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154106034|NCT00851565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106035|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
154106036|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154106037|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106038|NCT00561574|Mirtazapine|mirtazapine|mesh-list
154106039|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
154106040|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154106041|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154106042|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
154106046|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106047|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154106048|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154106049|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106050|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154106051|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154106052|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154106053|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
154106054|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154106055|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154106056|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
154106057|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154106058|NCT00619827|Immunomodulating Agents|immunomodulating agents|mesh-list
154106059|NCT00619827|Immunologic Factors|immunologic factors|mesh-ancestor
154106060|NCT00619827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106061|NCT00687804|Ranibizumab|ranibizumab|mesh-list
154106062|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154106063|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154106064|NCT00687804|Growth Substances|growth substances|mesh-ancestor
154106065|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106066|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
154106067|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106068|NCT02563704|Artesunate|artesunate|mesh-list
154106069|NCT02563704|Quinine|quinine|mesh-list
154106070|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
154106071|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154106072|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154106074|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106075|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
154106095|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106096|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
154106097|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
154106098|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106099|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106100|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154106102|NCT00742404|Hormones|hormones|mesh-ancestor
154106103|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106104|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154106105|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106106|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154106107|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154106108|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153728925|NCT00502684|Analgesics|analgesics|mesh-ancestor
153728926|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
154106109|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106110|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106111|NCT00744666|Prednisolone|prednisolone|mesh-list
154106112|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154106113|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106114|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
154106115|NCT00744666|Hormones|hormones|mesh-ancestor
154106116|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106119|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106142|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
154106143|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106144|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154106145|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154106146|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154106147|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154106148|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106150|NCT04012606|Etoposide|etoposide|mesh-list
154106151|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106152|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154106153|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154106154|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154106204|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106205|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106206|NCT00945022|Anesthetics|anesthetics|mesh-list
154106207|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106208|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106209|NCT02565212|Montelukast|montelukast|mesh-list
154106210|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154106211|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
154106212|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154106213|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
154106214|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106215|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106216|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154106217|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154106218|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106219|NCT00747708|Lenograstim|lenograstim|mesh-list
154106220|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154106221|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
154106222|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106223|NCT05602064|Acetaminophen|acetaminophen|mesh-list
154106226|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106255|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153728927|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728928|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153728929|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728930|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153728931|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153728932|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728933|NCT00502762|Topotecan|topotecan|mesh-list
153728935|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153728941|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153728942|NCT00502879|Analgesics|analgesics|mesh-ancestor
153728943|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
153728944|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106256|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106257|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154106258|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
154106259|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154106260|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154106261|NCT00945178|Naproxen|naproxen|mesh-list
154106262|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154106263|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106264|NCT00945178|Analgesics|analgesics|mesh-ancestor
154106265|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
154106266|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106267|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106268|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106269|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106270|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
154106271|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154106272|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106273|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106274|NCT00749346|Pemetrexed|pemetrexed|mesh-list
154106308|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154106309|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154106310|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
154106311|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106312|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106313|NCT00749502|Niraparib|niraparib|mesh-list
154106314|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154106315|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429639|NCT05599555|Vaccines|vaccines|mesh-list
154106316|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106318|NCT00560794|Blinatumomab|blinatumomab|mesh-list
154106319|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154106320|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106321|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
154106322|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106323|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
154106324|NCT00749736|Vitamin D|vitamin d|mesh-list
154106325|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
154106326|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154106327|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106363|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106364|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
154106365|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106366|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106367|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
154106368|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
153728946|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153728947|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728948|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153728949|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728950|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
153728952|NCT00503152|Benazepril|benazepril|mesh-list
153728953|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153728954|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153728955|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153728956|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728957|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154106369|NCT00619359|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154106370|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154106372|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106373|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154106374|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
154106375|NCT00848991|Propofol|propofol|mesh-list
154106376|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154106377|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106378|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106379|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154106380|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
154106381|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
154106382|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106383|NCT00848991|Analgesics|analgesics|mesh-ancestor
154106384|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
154106385|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106386|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154106387|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154106388|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154106393|NCT00950794|Tulobuterol|tulobuterol|mesh-list
154106412|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106413|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106414|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
154106415|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
154106416|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
154106417|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106418|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
154106419|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154106420|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
154106421|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154106422|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154106423|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106424|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154106425|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106426|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106427|NCT00372229|Valganciclovir|valganciclovir|mesh-list
154106428|NCT00372229|Ganciclovir|ganciclovir|mesh-list
154106429|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154106430|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
154106431|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106432|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154106433|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106434|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106435|NCT05301010|Docetaxel|docetaxel|mesh-list
154106436|NCT05301010|Trastuzumab|trastuzumab|mesh-list
154106437|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106438|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
154106439|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154106440|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154106441|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353294|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154106443|NCT00855699|Acamprosate|acamprosate|mesh-list
154106444|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154106445|NCT00855777|Ibuprofen|ibuprofen|mesh-list
154106446|NCT00855777|Etoricoxib|etoricoxib|mesh-list
154106447|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154106451|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106452|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106453|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106454|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106455|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154106456|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106457|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106458|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154106459|NCT04012294|Allopurinol|allopurinol|mesh-list
154106460|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
154106461|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106462|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106463|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
154106464|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106465|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154106466|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
154106467|NCT04012294|Protective Agents|protective agents|mesh-ancestor
153728962|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106468|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106469|NCT00849459|Interleukin-12|interleukin-12|mesh-list
154106470|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154106471|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
154106472|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106473|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154106474|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154106475|NCT00849459|Growth Substances|growth substances|mesh-ancestor
154106476|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
154106477|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106478|NCT00852345|Clofazimine|clofazimine|mesh-list
154106479|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106480|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
154106481|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106482|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106495|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106496|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
154106497|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
154106498|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154106499|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
154106500|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
154106501|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154106502|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106503|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154106504|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
154106505|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106506|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106507|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106508|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106509|NCT00849537|Triamcinolone|triamcinolone|mesh-list
154106510|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106511|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
154106512|NCT00849537|Hormones|hormones|mesh-ancestor
154106513|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106514|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106515|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
154106516|NCT01049815|Calcium|calcium|mesh-list
154106517|NCT01049815|Sevelamer|sevelamer|mesh-list
154106518|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154106548|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
154106549|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154106550|NCT00946036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154106551|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154106552|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154106553|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106554|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106555|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
154106556|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106557|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
154106558|NCT00688740|Docetaxel|docetaxel|mesh-list
154106559|NCT00688740|Doxorubicin|doxorubicin|mesh-list
154106560|NCT00688740|Fluorouracil|fluorouracil|mesh-list
154106561|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106562|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
154106563|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106564|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106565|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153728963|NCT00503386|Palonosetron|palonosetron|mesh-list
154106566|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
154106567|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106568|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106602|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154106603|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106604|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106605|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154106606|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154106607|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154106608|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154106609|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
154106610|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106611|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
154106612|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106613|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
154106614|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106615|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106616|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154106617|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
154106618|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106619|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106620|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154106621|NCT00942214|Natalizumab|natalizumab|mesh-list
154106622|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
154106655|NCT00748644|Azathioprine|azathioprine|mesh-list
154106656|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106657|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106658|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
154106659|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106660|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106661|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
154106662|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106663|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154106664|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106665|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154106666|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154106667|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106668|NCT00686634|Incretins|incretins|mesh-ancestor
154106669|NCT00686634|Hormones|hormones|mesh-ancestor
154106670|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154106671|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154106672|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
154106673|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106674|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106676|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106677|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154106678|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
154106679|NCT00560404|Hematinics|hematinics|mesh-ancestor
154106680|NCT00942526|Nystatin|nystatin|mesh-list
154106681|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106682|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106683|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
154106702|NCT00619983|Analgesics|analgesics|mesh-ancestor
154106703|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
154106704|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106705|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106706|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
154106707|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154106708|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154106709|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106710|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154106711|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154106712|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154106713|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106714|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106715|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
154106762|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154106763|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154106764|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
154106765|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106766|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106767|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154106768|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
154106769|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106770|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106771|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154106772|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106773|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
154106774|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106775|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
154106776|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154106777|NCT00755820|Cycloserine|cycloserine|mesh-list
154106778|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154106779|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106780|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154106781|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
154106782|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106783|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
154106784|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106785|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
154106786|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154106787|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106788|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154106789|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
154106790|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154106791|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106792|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106794|NCT00750126|Fludarabine|fludarabine|mesh-list
154106800|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
154106801|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106802|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
154106803|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154106804|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154106806|NCT00755976|Epirubicin|epirubicin|mesh-list
154106807|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154106808|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106809|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154106810|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154106811|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728994|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153728995|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153728996|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153358976|NCT06212973|Autonomic Agents|autonomic agents|mesh-ancestor
153728997|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728998|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106812|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106813|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154106814|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106815|NCT00755976|Analgesics|analgesics|mesh-ancestor
154106816|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
154106817|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106818|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106819|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154106820|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154106821|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154106822|NCT00752310|Darunavir|darunavir|mesh-list
154106823|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154106849|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154106850|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106851|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106852|NCT00854529|Bevacizumab|bevacizumab|mesh-list
154106853|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106854|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106855|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154106856|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154106857|NCT00854529|Growth Substances|growth substances|mesh-ancestor
154106858|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106859|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
154106860|NCT00952432|Carbamazepine|carbamazepine|mesh-list
154106861|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
154106862|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
154106863|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154106864|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106865|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106866|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154106867|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106868|NCT00952432|Analgesics|analgesics|mesh-ancestor
154106869|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
154106870|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106871|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154106872|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154106873|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106874|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154106875|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154106897|NCT00861627|Carboplatin|carboplatin|mesh-list
154106898|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154106899|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106900|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
154106901|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
154106902|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
154106903|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106904|NCT00943930|Dronabinol|dronabinol|mesh-list
154106905|NCT00943930|Amphetamine|amphetamine|mesh-list
154106906|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
153729003|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
153729005|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106907|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154106908|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106909|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
154106910|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
154106911|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106912|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
154106913|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106914|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106915|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
154106916|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154106917|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154106918|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154106919|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154106920|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
154106921|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154106922|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154106939|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106940|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106941|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
154106942|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154106943|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154106944|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106945|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154106946|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
154106947|NCT00861783|Irinotecan|irinotecan|mesh-list
154106948|NCT00861783|Camptothecin|camptothecin|mesh-list
154106949|NCT00861783|ON 01910|on 01910|mesh-list
154106950|NCT00861783|Glycine|glycine|mesh-list
154106951|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106952|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154106953|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154106954|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154106955|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106956|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154106957|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154106958|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
154106959|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154106960|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106961|NCT00947128|Ondansetron|ondansetron|mesh-list
154106962|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
154106963|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
154106964|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154106965|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154106966|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154106987|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
154106988|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106989|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154106990|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154106991|NCT04280536|Trifluridine|trifluridine|mesh-list
154106992|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
154106993|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154106994|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
154106995|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154106996|NCT00944242|Sertraline|sertraline|mesh-list
154106997|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
154106998|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154106999|NCT00944242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154107000|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154107001|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107002|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107003|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107004|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
154107005|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107006|NCT00363649|Interferons|interferons|mesh-list
154107007|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
154107008|NCT00363649|Sargramostim|sargramostim|mesh-list
154107009|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107010|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
154107011|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107012|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
154107013|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107014|NCT00855153|Cycloserine|cycloserine|mesh-list
154107015|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154107020|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
154107027|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107029|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154107030|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
154107031|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107032|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154107033|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154107034|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107035|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107036|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
154107037|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107038|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107039|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154107040|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154107041|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107042|NCT00953134|Folic Acid|folic acid|mesh-list
154107043|NCT00953134|Micronutrients|micronutrients|mesh-list
154107044|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
154107045|NCT00953134|Trace Elements|trace elements|mesh-list
154107046|NCT00953134|Hematinics|hematinics|mesh-ancestor
154107047|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
154107048|NCT00953134|Vitamins|vitamins|mesh-ancestor
154107049|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107050|NCT00944398|Vitamins|vitamins|mesh-list
154107051|NCT00944398|Zinc|zinc|mesh-list
154107052|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
154107053|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
154107054|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
154107055|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107056|NCT00944398|Trace Elements|trace elements|mesh-ancestor
154107057|NCT00944398|Astringents|astringents|mesh-ancestor
154107058|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
154107059|NCT00855387|Pancrelipase|pancrelipase|mesh-list
154107060|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107061|NCT00947596|Atropine|atropine|mesh-list
154107062|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154107069|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
154107070|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
154107071|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
154107072|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154107073|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154107074|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
154107075|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107076|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107077|NCT00865059|Gabapentin|gabapentin|mesh-list
154107078|NCT00865059|Analgesics|analgesics|mesh-ancestor
154107079|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
154107080|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107081|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107082|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
154107083|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154107084|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154107085|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154107086|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107087|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154107088|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154107089|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107090|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107091|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
154107092|NCT00865137|Tacrolimus|tacrolimus|mesh-list
154107093|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154107094|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
154107095|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107096|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154107097|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107098|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107108|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154107109|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154107110|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
154107112|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154107113|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154107114|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
154107115|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107116|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154107117|NCT00862095|Analgesics|analgesics|mesh-ancestor
154107118|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
154107119|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107120|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154107121|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154107167|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107168|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154107169|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154107170|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
154107171|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
154107172|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154107173|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154107174|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107175|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729088|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107176|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
154107177|NCT00618813|Ifosfamide|ifosfamide|mesh-list
154107178|NCT00618813|Doxorubicin|doxorubicin|mesh-list
154107179|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154107180|NCT00618813|Etoposide|etoposide|mesh-list
154107181|NCT00618813|Vincristine|vincristine|mesh-list
154107182|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
154107183|NCT00618813|Topotecan|topotecan|mesh-list
154107184|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154107185|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
154107186|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107187|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154107188|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154107189|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
154107190|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107191|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107192|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154107193|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154107194|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154107195|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154107196|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107197|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154107210|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107211|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154107212|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
154107213|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107214|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
154107215|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154107216|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
154107217|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154107218|NCT02566928|Bacitracin|bacitracin|mesh-list
154107219|NCT02566928|Mupirocin|mupirocin|mesh-list
154107220|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154107221|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107222|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
154107223|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
154107224|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107225|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154107226|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107227|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107229|NCT00865605|Halobetasol|halobetasol|mesh-list
154107230|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154107231|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154107232|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
154107233|NCT00865605|Hormones|hormones|mesh-ancestor
154107234|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154107235|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107236|NCT00956644|Amlodipine|amlodipine|mesh-list
154107259|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107260|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107261|NCT02565836|Thrombin|thrombin|mesh-list
154107262|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
154107263|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
154107264|NCT02565836|Coagulants|coagulants|mesh-ancestor
154107265|NCT00865761|Alprazolam|alprazolam|mesh-list
154107266|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154107267|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154107268|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107269|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154107271|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107272|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
154107273|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
153729111|NCT00503815|Laxatives|laxatives|mesh-ancestor
154107274|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107275|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107276|NCT00865839|Metformin|metformin|mesh-list
154107277|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154107278|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107279|NCT00865917|Metoprolol|metoprolol|mesh-list
154107280|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154107281|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154107282|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154107283|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
154107284|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
154107285|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107286|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107287|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154107288|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154107289|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
154107290|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107291|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107303|NCT00862329|Caseins|caseins|mesh-list
154107304|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
154107305|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
154107306|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107307|NCT00866073|Decitabine|decitabine|mesh-list
154107308|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154107309|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
154107310|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107311|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107312|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107313|NCT00752466|Topiramate|topiramate|mesh-list
154107314|NCT00752466|Flunarizine|flunarizine|mesh-list
154107315|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
154107316|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154107317|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107318|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154107319|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107320|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107321|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154107322|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154107323|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
154107324|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
154107325|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107326|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
154107327|NCT00957190|Timolol|timolol|mesh-list
154107328|NCT00957190|Dorzolamide|dorzolamide|mesh-list
154107329|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154107330|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154107331|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
154107332|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107340|NCT00866229|Simvastatin|simvastatin|mesh-list
154107346|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154107348|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154107349|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154107350|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107351|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107352|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
154107353|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107354|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107355|NCT00948220|Ribavirin|ribavirin|mesh-list
154107356|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154107357|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
154107358|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107359|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
154107360|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107361|NCT00756990|Naltrexone|naltrexone|mesh-list
154107362|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154107363|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154107364|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107365|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
154107366|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107367|NCT00957346|Misoprostol|misoprostol|mesh-list
154107368|NCT00957346|Mifepristone|mifepristone|mesh-list
154107369|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154107370|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
154107371|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154107372|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107373|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154107374|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107392|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107393|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107394|NCT00751062|Timolol|timolol|mesh-list
154107395|NCT00751062|Latanoprost|latanoprost|mesh-list
153729133|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729134|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153729135|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153729136|NCT00147771|Imiquimod|imiquimod|mesh-list
153729137|NCT00147771|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153729138|NCT00147771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729139|NCT00147771|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153729140|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
153729141|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729142|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154107396|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154107397|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154107398|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154107399|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107400|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107401|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107402|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154107403|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154107404|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154107405|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154107406|NCT00751374|Gentamicins|gentamicins|mesh-list
154107407|NCT00751374|Mupirocin|mupirocin|mesh-list
154107408|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107409|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107410|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154107411|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107412|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107413|NCT00954304|Loperamide|loperamide|mesh-list
154107414|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
154107415|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107416|NCT00363415|Carboplatin|carboplatin|mesh-list
154107417|NCT00363415|Etoposide|etoposide|mesh-list
154107418|NCT00363415|Pemetrexed|pemetrexed|mesh-list
154107419|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354259|NCT02129426|Analgesics|analgesics|mesh-ancestor
154107420|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154107421|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154107422|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154107423|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107434|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107435|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154107436|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107437|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154107438|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
154107439|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
154107440|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107441|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107442|NCT00696020|Bromides|bromides|mesh-list
154107443|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
154107444|NCT00696020|Olodaterol|olodaterol|mesh-list
154107445|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154107446|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
154107447|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107448|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107449|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154107450|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
154107451|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
154107452|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154107453|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
154107454|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107455|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107456|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
154107457|NCT00576576|Atorvastatin|atorvastatin|mesh-list
154107458|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154107459|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154107460|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
154107461|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107478|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
154107479|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
154107480|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154107481|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
154107482|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
154107483|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107484|NCT00757458|Antidotes|antidotes|mesh-ancestor
154107485|NCT00757458|Protective Agents|protective agents|mesh-ancestor
154107486|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154107487|NCT00923247|Bortezomib|bortezomib|mesh-list
154107488|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107489|NCT00757692|Bicalutamide|bicalutamide|mesh-list
154107490|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
154107491|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
154107492|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154107493|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107494|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107495|NCT00753168|Timolol|timolol|mesh-list
154107496|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154107497|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154107499|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154107530|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
154107531|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107532|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107533|NCT00684996|Bevacizumab|bevacizumab|mesh-list
154107534|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154107535|NCT00684996|Antibodies|antibodies|mesh-list
154107536|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
154107537|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154107538|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107539|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154107540|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154107541|NCT00684996|Growth Substances|growth substances|mesh-ancestor
154107542|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107543|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
154107544|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
154107545|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
154107546|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154107547|NCT05325008|Antibodies|antibodies|mesh-list
154107548|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
154107549|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154107550|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
154107551|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107552|NCT00684762|Cilostazol|cilostazol|mesh-list
154107553|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154107554|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
154107555|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107556|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107557|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154107558|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
154107559|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154107560|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154107561|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107562|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153337168|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107571|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107572|NCT00695786|Rituximab|rituximab|mesh-list
154107573|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154107574|NCT00695786|Lenalidomide|lenalidomide|mesh-list
154107575|NCT00695786|Antibodies|antibodies|mesh-list
154107576|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
154107577|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154107578|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
154107579|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107580|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107581|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154107582|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154107583|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154107584|NCT00695786|Growth Substances|growth substances|mesh-ancestor
154107585|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
154107586|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154107587|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
153729147|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
154107588|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107589|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154107590|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154107591|NCT00387127|Lapatinib|lapatinib|mesh-list
154107592|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107593|NCT00387127|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154107594|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154107595|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107596|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107597|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
154107598|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
154107599|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107600|NCT00683592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154107601|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154107602|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107603|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107604|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107605|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
154107607|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154107608|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154107609|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
154107610|NCT00695396|Hematinics|hematinics|mesh-ancestor
154107611|NCT00753402|Epinephrine|epinephrine|mesh-list
154107612|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154107613|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154107614|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
154107615|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107616|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107617|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107618|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154107619|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154107620|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
154107621|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107622|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154107623|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
154107624|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
154107625|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
154107626|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154107627|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
154107628|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107629|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
154107630|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
154107631|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
154107660|NCT00753558|Polymyxins|polymyxins|mesh-list
154107661|NCT00753558|Colistin|colistin|mesh-list
154107662|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107663|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107664|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154107665|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107666|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107667|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
154107668|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154107669|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154107670|NCT00753792|Prednisolone|prednisolone|mesh-list
154107671|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
154107672|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154107673|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
154107674|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729170|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153729171|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
153729175|NCT00503971|Vorinostat|vorinostat|mesh-list
154107675|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
154107676|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
154107677|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107678|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107679|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107680|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
154107681|NCT00753792|Hormones|hormones|mesh-ancestor
154107682|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154107683|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154107684|NCT00753792|Protective Agents|protective agents|mesh-ancestor
154107685|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154107686|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107687|NCT00575094|Tigecycline|tigecycline|mesh-list
154107688|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107689|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107691|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107704|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107705|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107706|NCT00958204|Fluoxetine|fluoxetine|mesh-list
154107707|NCT00958204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154107708|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154107709|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107710|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107711|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107712|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
154107713|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107714|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154107715|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
154107716|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107717|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154107718|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154107719|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107721|NCT00617409|Tretinoin|tretinoin|mesh-list
154107722|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154107723|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107724|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
154107725|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
154107726|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
154107727|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107728|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
154107729|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
154107730|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154107731|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154107732|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
154107733|NCT00695318|Hormones|hormones|mesh-ancestor
154107744|NCT00694304|Vortioxetine|vortioxetine|mesh-list
154107746|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154107747|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154107749|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154107750|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107751|NCT00694304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154107752|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154107753|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154107754|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107755|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107756|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
154107757|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154107758|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154107759|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154107760|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154107761|NCT00866853|Simeprevir|simeprevir|mesh-list
153359368|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107762|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
154107763|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107764|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
154107765|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107766|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107767|NCT00682890|Metformin|metformin|mesh-list
154107768|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154107769|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107770|NCT02565368|Metformin|metformin|mesh-list
154107797|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107798|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154107799|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154107800|NCT00698516|Growth Substances|growth substances|mesh-ancestor
154107801|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107802|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
154107803|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154107804|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154107805|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107806|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107807|NCT00679302|Trimethoprim|trimethoprim|mesh-list
154107808|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154107809|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
154107810|NCT00679302|Simethicone|simethicone|mesh-list
154107811|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154107812|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154107813|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
154107814|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154107815|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154107816|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154107817|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107818|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107819|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154107820|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154107821|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154107823|NCT00679302|Emollients|emollients|mesh-ancestor
154107824|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
154107825|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154107826|NCT04011124|Rifampin|rifampin|mesh-list
154107827|NCT04011124|Fluzoparib|fluzoparib|mesh-list
154107828|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154107835|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107836|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153729179|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729180|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729190|NCT02275039|Vaccines|vaccines|mesh-list
154107837|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154107838|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154107839|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154107840|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154107841|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154107842|NCT04011124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154107843|NCT04011124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107845|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154107846|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
154107847|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
154107848|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154107849|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107850|NCT02544165|Caffeine|caffeine|mesh-list
154107851|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154107852|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107853|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154107854|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107855|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107856|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154107857|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154107858|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
154107859|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107860|NCT05343156|Dexamethasone|dexamethasone|mesh-list
154107861|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154107862|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154107863|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
154107864|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
154107865|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107866|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107867|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107868|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
154107869|NCT05343156|Hormones|hormones|mesh-ancestor
153337442|NCT00000976|Zidovudine|zidovudine|mesh-list
154107871|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154107872|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107873|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153729192|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729193|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153729194|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
153729196|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729199|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153729200|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729201|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
153729202|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
153729204|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359418|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359419|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153359420|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153359421|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
153359423|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107875|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154107877|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154107878|NCT00955162|Narcotics|narcotics|mesh-ancestor
154107879|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154107880|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107881|NCT00955162|Analgesics|analgesics|mesh-ancestor
154107882|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
154107883|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107884|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154107885|NCT00949546|Etanercept|etanercept|mesh-list
154107886|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154107887|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154107888|NCT00949546|Analgesics|analgesics|mesh-ancestor
154107889|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
154107890|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107891|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107892|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154107893|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154107894|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154107895|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154107896|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
154107898|NCT00949624|Axitinib|axitinib|mesh-list
154107899|NCT00949624|Crenolanib|crenolanib|mesh-list
154107900|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107901|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
154107902|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
154107903|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
154107904|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107905|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154107906|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107911|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154107912|NCT04005339|Leucovorin|leucovorin|mesh-list
154107913|NCT04005339|Fluorouracil|fluorouracil|mesh-list
154107914|NCT04005339|Irinotecan|irinotecan|mesh-list
154107915|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
154107916|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107917|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154107918|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107919|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154107920|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
154107921|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107922|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154107923|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154107924|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154107925|NCT04005339|Antidotes|antidotes|mesh-ancestor
154107926|NCT04005339|Protective Agents|protective agents|mesh-ancestor
154107927|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
154107928|NCT04005339|Vitamins|vitamins|mesh-ancestor
154107929|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
154107930|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
154107931|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154107932|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154107933|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107934|NCT02544243|Gemcitabine|gemcitabine|mesh-list
154107935|NCT02544243|Vinorelbine|vinorelbine|mesh-list
154107936|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107937|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154107938|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
154107939|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107940|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154107941|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
154107942|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
154107943|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154107944|NCT04011670|Caffeine|caffeine|mesh-list
154107952|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
154107953|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154107954|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
154107955|NCT01581073|Hematinics|hematinics|mesh-ancestor
154107956|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
154107957|NCT00742820|Calcium|calcium|mesh-list
154107958|NCT00742820|Calcium acetate|calcium acetate|mesh-list
154107959|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154107960|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107961|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154107962|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
154107963|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
154107964|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107965|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154107966|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
154107967|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
154107968|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154107969|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107970|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
154107971|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154107972|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154107974|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154107975|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
154107976|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
154107977|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
154107978|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
154107979|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154107980|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107981|NCT00955240|Fluorouracil|fluorouracil|mesh-list
154107982|NCT00955240|Cetuximab|cetuximab|mesh-list
154107983|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154107984|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
154107985|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154107990|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154107991|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
154107992|NCT00867867|Trace Elements|trace elements|mesh-ancestor
154107993|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
154107994|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107995|NCT00955318|Apomorphine|apomorphine|mesh-list
154107996|NCT00955318|Emetics|emetics|mesh-ancestor
154107997|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154107998|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
154107999|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108000|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154108001|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
154108002|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
154108003|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108004|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108005|NCT00860223|Digoxin|digoxin|mesh-list
154108006|NCT00860223|Neratinib|neratinib|mesh-list
154108007|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154108008|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154108009|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729218|NCT01248481|Acarbose|acarbose|mesh-list
154108010|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108011|NCT00860223|Protective Agents|protective agents|mesh-ancestor
154108012|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108013|NCT00860223|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154108014|NCT00860223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154108015|NCT00698204|Celecoxib|celecoxib|mesh-list
154108016|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154108017|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154108018|NCT00698204|Analgesics|analgesics|mesh-ancestor
154108019|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
154108020|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108021|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108023|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108031|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108032|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108033|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108034|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154108035|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154108036|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154108037|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108038|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108039|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108040|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154108041|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154108042|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
154108043|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154108044|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154108045|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
154108046|NCT00863187|Rituximab|rituximab|mesh-list
154108047|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108048|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108049|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
154108050|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108051|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108052|NCT00754884|Calcitonin|calcitonin|mesh-list
154108053|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
154108054|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
154108055|NCT00754884|Glycerol|glycerol|mesh-list
154108056|NCT00754884|Katacalcin|katacalcin|mesh-list
154108057|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154108058|NCT00754884|Protective Agents|protective agents|mesh-ancestor
154108059|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108060|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154108061|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154108062|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
154108063|NCT00371761|Interferons|interferons|mesh-list
154108072|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
153359518|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359519|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359521|NCT05032235|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154108073|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108074|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154108075|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154108076|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108077|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108078|NCT00754962|Protriptyline|protriptyline|mesh-list
154108079|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154108080|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
154108081|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108082|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154108083|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154108084|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108086|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108121|NCT00755118|Cetuximab|cetuximab|mesh-list
154108122|NCT00755118|Fluorouracil|fluorouracil|mesh-list
154108123|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
154108124|NCT00755118|Irinotecan|irinotecan|mesh-list
154108125|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108126|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108127|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154108128|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154108129|NCT00755118|Growth Substances|growth substances|mesh-ancestor
154108130|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108131|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
154108132|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
154108133|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108134|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154108135|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154108136|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
154108137|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154108138|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154108139|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108140|NCT00755118|Antidotes|antidotes|mesh-ancestor
154108141|NCT00755118|Protective Agents|protective agents|mesh-ancestor
154108142|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
154108143|NCT00755118|Vitamins|vitamins|mesh-ancestor
154108144|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
154108145|NCT00755352|Pravastatin|pravastatin|mesh-list
154108146|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154108147|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154108148|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154108149|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
154108150|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108151|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154108166|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
154108167|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154108168|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
153729269|NCT01249690|Doxorubicin|doxorubicin|mesh-list
153729270|NCT01249690|BB 1101|bb 1101|mesh-list
153729271|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729272|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
153729273|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
153729274|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729275|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729276|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729277|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
153729278|NCT01249690|Hormones|hormones|mesh-ancestor
153729279|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359606|NCT04674254|Bevacizumab|bevacizumab|mesh-list
154108169|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108170|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108171|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
154108172|NCT00863577|Bemiparin|bemiparin|mesh-list
154108173|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
154108174|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
154108175|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154108176|NCT00868413|Rituximab|rituximab|mesh-list
154108177|NCT00868413|Fludarabine|fludarabine|mesh-list
154108178|NCT00868413|Navitoclax|navitoclax|mesh-list
154108179|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154108180|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
154108181|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108182|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108183|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154108184|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
154108185|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108186|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108187|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154108188|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108189|NCT03897348|Lacosamide|lacosamide|mesh-list
154108190|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
154108191|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154108192|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154108193|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108194|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108195|NCT00868491|Cisplatin|cisplatin|mesh-list
154108196|NCT00868491|Docetaxel|docetaxel|mesh-list
154108197|NCT00868491|Fluorouracil|fluorouracil|mesh-list
154108198|NCT00868491|Cetuximab|cetuximab|mesh-list
154108199|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108200|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
154108201|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
154108202|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
154108203|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108204|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
154108205|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154108206|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154108207|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
154108208|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108209|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108210|NCT00955630|Ranibizumab|ranibizumab|mesh-list
154108211|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154108212|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154108213|NCT00955630|Growth Substances|growth substances|mesh-ancestor
154108214|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108215|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
154108216|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108217|NCT00868569|Leucovorin|leucovorin|mesh-list
154108218|NCT00868569|Fluorouracil|fluorouracil|mesh-list
154108219|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
154108220|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
153729280|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153729281|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729282|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
153729283|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729284|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729285|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153729286|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
153729295|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153729296|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153729297|NCT03712826|Ustekinumab|ustekinumab|mesh-list
153729298|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
154108221|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108222|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154108223|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108224|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154108225|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
154108226|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108227|NCT00868569|Antidotes|antidotes|mesh-ancestor
154108228|NCT00868569|Protective Agents|protective agents|mesh-ancestor
154108229|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
154108230|NCT00868569|Vitamins|vitamins|mesh-ancestor
154108231|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
154108250|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
154108251|NCT00860925|Clonidine|clonidine|mesh-list
154108252|NCT00860925|Analgesics|analgesics|mesh-ancestor
154108253|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
154108254|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108255|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108256|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154108257|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
154108258|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
154108259|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154108260|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154108261|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154108262|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108263|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108264|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108265|NCT04237012|Dexamethasone|dexamethasone|mesh-list
154108266|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
154108267|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108268|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
154108269|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
154108270|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108271|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108272|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154108273|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
154108300|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108302|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
154108303|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154108304|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
154108305|NCT00863889|Hormones|hormones|mesh-ancestor
154108306|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154108307|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154108308|NCT00863889|Protective Agents|protective agents|mesh-ancestor
154108309|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154108310|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108312|NCT00677352|Paroxetine|paroxetine|mesh-list
154108313|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
154108314|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108315|NCT00677352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154108316|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154108317|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108318|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108319|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108320|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
154108321|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108322|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154108323|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154108324|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154108325|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108326|NCT00864045|Olanzapine|olanzapine|mesh-list
154108327|NCT00864045|Sertindole|sertindole|mesh-list
154108328|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
154108329|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
154108330|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108331|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108332|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153337915|NCT00000316|Cocaine|cocaine|mesh-list
154108340|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108341|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108342|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
154108343|NCT00755508|Gabapentin|gabapentin|mesh-list
154108344|NCT00755508|Analgesics|analgesics|mesh-ancestor
154108345|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
154108346|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108347|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108348|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
154108349|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154108350|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154108351|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108352|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108353|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154108354|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154108355|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108356|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108357|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
154108358|NCT03680352|Cefepime|cefepime|mesh-list
154108359|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
154108360|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154108361|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108362|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154108363|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108364|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108365|NCT00864201|Bosentan|bosentan|mesh-list
154108366|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154108367|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154108368|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108369|NCT00864279|Cetirizine|cetirizine|mesh-list
154108370|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154108371|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154108372|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154108373|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
154108374|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
154108375|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108377|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108378|NCT02559648|Denosumab|denosumab|mesh-list
154108379|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153355232|NCT00621530|Ketorolac|ketorolac|mesh-list
154108380|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108381|NCT00864357|Ibuprofen|ibuprofen|mesh-list
154108382|NCT00864357|Oxycodone|oxycodone|mesh-list
154108383|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154108384|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154108385|NCT00864357|Analgesics|analgesics|mesh-ancestor
153729299|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
153729300|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153729301|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153729302|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729303|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
153729304|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
153729305|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
153729306|NCT00504244|Azathioprine|azathioprine|mesh-list
153729307|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
154108386|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
154108387|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729309|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153729358|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154108388|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108389|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108390|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108391|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154108392|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729359|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
153729360|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108393|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108394|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154108395|NCT00864357|Narcotics|narcotics|mesh-ancestor
154108396|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108397|NCT00864435|Carvedilol|carvedilol|mesh-list
154108398|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154108399|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154108400|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108401|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108402|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108403|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108404|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154108405|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
154108406|NCT00864435|Protective Agents|protective agents|mesh-ancestor
154108413|NCT00755664|Vitamins|vitamins|mesh-list
154108420|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
154108421|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154108422|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
154108423|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154108424|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154108425|NCT00956098|Protective Agents|protective agents|mesh-ancestor
154108426|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108427|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108428|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154108429|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154108430|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108431|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108432|NCT00864591|Adenosine|adenosine|mesh-list
154108433|NCT00864591|Analgesics|analgesics|mesh-ancestor
154108434|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
154108435|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108436|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108437|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154108438|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
154108439|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154108440|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
153729361|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153729362|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153729363|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729364|NCT04054830|Diclofenac|diclofenac|mesh-list
153729365|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154108441|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
154108442|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108443|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108444|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
154108445|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154108446|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154108447|NCT05350384|Prednisolone|prednisolone|mesh-list
154108448|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
154108449|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154108450|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
154108451|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108452|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
154108453|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
154108454|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108458|NCT05350384|Hormones|hormones|mesh-ancestor
154108459|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154108460|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154108461|NCT05350384|Protective Agents|protective agents|mesh-ancestor
154108462|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154108463|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108464|NCT00870441|Valacyclovir|valacyclovir|mesh-list
154108465|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
154108466|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108467|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154108468|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
154108469|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108470|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154108471|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154108472|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108473|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108474|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154108475|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154108476|NCT00864669|Metformin|metformin|mesh-list
154108477|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154108478|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108479|NCT00864747|Propranolol|propranolol|mesh-list
154108480|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154108481|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154108482|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108483|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108484|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108485|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108486|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154108487|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154108488|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
154108489|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154108496|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154108497|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154108498|NCT02559102|Analgesics|analgesics|mesh-ancestor
154108499|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
154108500|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108501|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154108502|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153729366|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153729367|NCT04054830|Analgesics|analgesics|mesh-ancestor
153729368|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
153729369|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729370|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729371|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729372|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729383|NCT03999723|Vitamins|vitamins|mesh-ancestor
154108503|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154108504|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108505|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108506|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108507|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154108508|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154108509|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
154108510|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154108511|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108512|NCT05348668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108513|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108514|NCT00864825|Allopurinol|allopurinol|mesh-list
154108515|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
154108516|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108517|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108518|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
154108519|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108520|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154108521|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
154108522|NCT00864825|Protective Agents|protective agents|mesh-ancestor
154108523|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108524|NCT00956176|Cidofovir|cidofovir|mesh-list
154108525|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
154108526|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108527|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108528|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108529|NCT00864981|Bupropion|bupropion|mesh-list
154108530|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154108531|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
153338146|NCT00000352|Levomethorphan|levomethorphan|mesh-list
154108533|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154108534|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154108535|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108536|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108537|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
154108538|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108539|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108540|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154108541|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154108542|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108543|NCT00371683|Enoxaparin|enoxaparin|mesh-list
154108544|NCT00371683|Apixaban|apixaban|mesh-list
154108545|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
154108546|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154108547|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154108548|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108549|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154108550|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
154108551|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154108552|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
153729416|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
153729417|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729418|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153729419|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153729420|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729421|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729422|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153729423|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153729424|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153729425|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153729426|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108553|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108554|NCT00876135|Albuterol|albuterol|mesh-list
154108555|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154108556|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
154108557|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108558|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108559|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154108560|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
154108561|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
154108562|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154108563|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154108564|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154108565|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154108566|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108567|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108569|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
154108571|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
154108572|NCT04039815|Vitamins|vitamins|mesh-ancestor
154108573|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
154108574|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108575|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108576|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
154108577|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
154108578|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108579|NCT04039815|Protective Agents|protective agents|mesh-ancestor
154108580|NCT00870987|Vaccines|vaccines|mesh-list
154108581|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
154108582|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108583|NCT00962026|Rilonacept|rilonacept|mesh-list
154108584|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108585|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
154108586|NCT00616239|Salicylates|salicylates|mesh-list
154108587|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108588|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
154108589|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
154108590|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
154108591|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154108592|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154108593|NCT00616239|Analgesics|analgesics|mesh-ancestor
154108594|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
154108595|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108596|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108597|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108598|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108599|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154108600|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108601|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108602|NCT00547534|Rituximab|rituximab|mesh-list
154108603|NCT00547534|Bortezomib|bortezomib|mesh-list
154108604|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154108605|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108610|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154108612|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108613|NCT00871455|Baclofen|baclofen|mesh-list
154108614|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154108615|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108616|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153729427|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
153729428|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
153729429|NCT04725942|Posaconazole|posaconazole|mesh-list
153729430|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
153729431|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729432|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153729433|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153729434|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153729435|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154108617|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108618|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154108619|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
154108620|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
154108621|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108622|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108623|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
154108624|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
154108625|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154108626|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153729438|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108627|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
154108628|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108629|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
154108630|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108631|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108632|NCT00877149|Telbivudine|telbivudine|mesh-list
154108633|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
154108634|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108635|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154108636|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108637|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108638|NCT00877227|Leucovorin|leucovorin|mesh-list
154108639|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
154108640|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
154108641|NCT00877227|Antidotes|antidotes|mesh-ancestor
154108651|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154108652|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
154108653|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154108654|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154108655|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
154108656|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108658|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
154108659|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108660|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108661|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108662|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
154108663|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
154108664|NCT00877539|Fluticasone|fluticasone|mesh-list
154108665|NCT00877539|Xhance|xhance|mesh-list
154108666|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108667|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154108668|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
154108669|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108670|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108671|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153729439|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153729440|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
153729441|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729442|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729443|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
153729444|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
153729445|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153729446|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153922187|NCT05172245|Cisplatin|cisplatin|mesh-list
153729447|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729455|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783532|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
153783533|NCT00269217|Simvastatin|simvastatin|mesh-list
154108672|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
154108673|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
154108674|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154108675|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154108676|NCT00872235|Quinapril|quinapril|mesh-list
154108677|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154108678|NCT00872235|Diuretics|diuretics|mesh-ancestor
154108679|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
154108680|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108681|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154108682|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108683|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108684|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154108686|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108687|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
154108690|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108691|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
154108692|NCT00872469|Coagulants|coagulants|mesh-ancestor
154108693|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
154108694|NCT00872625|Docetaxel|docetaxel|mesh-list
154108695|NCT00872625|Fluorouracil|fluorouracil|mesh-list
154108696|NCT00872625|Epirubicin|epirubicin|mesh-list
154108697|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154108698|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
154108699|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108700|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108701|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154108702|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
154108703|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108704|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108705|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154108706|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
154108707|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
154108708|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
154108709|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
154108710|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154108711|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154108712|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154108713|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154108714|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108715|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154108717|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154108718|NCT00872781|Diuretics|diuretics|mesh-ancestor
154108719|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
154108720|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108721|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154108736|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108737|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108738|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154108739|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154108740|NCT00361231|Growth Substances|growth substances|mesh-ancestor
154108741|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108742|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
154108743|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154108744|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
154108745|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108746|NCT00676650|Prednisone|prednisone|mesh-list
154108747|NCT00676650|Sunitinib|sunitinib|mesh-list
154108748|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108749|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
154108750|NCT00676650|Hormones|hormones|mesh-ancestor
153729456|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729457|NCT03890952|Growth Substances|growth substances|mesh-ancestor
153729458|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108751|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154108752|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108753|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154108754|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108755|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154108756|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154108757|NCT00676650|Growth Substances|growth substances|mesh-ancestor
154108758|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
154108759|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154108760|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108762|NCT01045369|Etravirine|etravirine|mesh-list
154108782|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108784|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154108785|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108787|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
154108788|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
154108789|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
154108790|NCT00382993|Naproxen|naproxen|mesh-list
154108791|NCT00382993|Sumatriptan|sumatriptan|mesh-list
154108792|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154108793|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154108794|NCT00382993|Analgesics|analgesics|mesh-ancestor
154108795|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
154108796|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108797|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108798|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154108799|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108800|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
154108801|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154108802|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108803|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108804|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154108805|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154108806|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154108807|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
154108808|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108809|NCT00760968|Methotrexate|methotrexate|mesh-list
154108810|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154108811|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
154108812|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154108813|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108814|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154108815|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
154108823|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154108824|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154108825|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
154108827|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154108828|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108829|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154108830|NCT00878865|Alprazolam|alprazolam|mesh-list
154108831|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154108832|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108833|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108834|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154108835|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154108836|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108837|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
154108838|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
154108839|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108840|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108841|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154108842|NCT00873483|Gestodene|gestodene|mesh-list
154108843|NCT00873483|Femovan|femovan|mesh-list
154108844|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154108845|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154108846|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154108847|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
154108848|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154108849|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108850|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154108851|NCT00873483|Estrogens|estrogens|mesh-ancestor
154108870|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108872|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154108873|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
154108874|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154108875|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
154108876|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154108877|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108878|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154108879|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154108880|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108881|NCT01050595|Naltrexone|naltrexone|mesh-list
154108882|NCT01050595|Bromides|bromides|mesh-list
154108883|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
154108884|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
154108885|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154108886|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108887|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
154108888|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108889|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154108890|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
154108891|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108892|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
154108893|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154108894|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154108895|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108896|NCT00878943|Urological Agents|urological agents|mesh-ancestor
154108897|NCT00873639|Insulin|insulin|mesh-list
154108899|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
154108915|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108916|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108918|NCT00879099|Paroxetine|paroxetine|mesh-list
154108919|NCT00879099|Maleic acid|maleic acid|mesh-list
154108920|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108921|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108922|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154108923|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154108924|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
154108925|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108926|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108927|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154108928|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154108929|NCT00879099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154108930|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154108931|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154108932|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
154108933|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154108934|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
154108935|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154108936|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154108937|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154108939|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
154108940|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154108941|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154108942|NCT00369655|Growth Substances|growth substances|mesh-ancestor
154108943|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108944|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
154108945|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154108946|NCT00879177|Varenicline|varenicline|mesh-list
154108947|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154108948|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154108949|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
154108950|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108952|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108954|NCT00676338|Pioglitazone|pioglitazone|mesh-list
154108955|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154108956|NCT00676338|Exenatide|exenatide|mesh-list
154108957|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154108958|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108959|NCT00676338|Incretins|incretins|mesh-ancestor
154108960|NCT00676338|Hormones|hormones|mesh-ancestor
154108961|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154108962|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154108963|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
154108964|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154108965|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108966|NCT00676338|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154108967|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154108968|NCT02534623|Fentanyl|fentanyl|mesh-list
154108969|NCT02534623|Bupivacaine|bupivacaine|mesh-list
154108970|NCT02534623|Anesthetics|anesthetics|mesh-list
154108971|NCT02534623|Propofol|propofol|mesh-list
154108972|NCT02534623|Sevoflurane|sevoflurane|mesh-list
154108973|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
154108974|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108975|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108976|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
154108977|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154108978|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154108979|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154108980|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
154108982|NCT02534623|Narcotics|narcotics|mesh-ancestor
154108983|NCT02534623|Analgesics|analgesics|mesh-ancestor
154108984|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154108985|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154108986|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154108987|NCT00873795|Aripiprazole|aripiprazole|mesh-list
154108988|NCT00873795|Sertraline|sertraline|mesh-list
154108989|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
154108993|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154108994|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154108995|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
154108996|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
154108997|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154108998|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154108999|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154109000|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154109001|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
154109002|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154109003|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154109004|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154109005|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154109006|NCT00873795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154109007|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154109008|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154109010|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
154109011|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
154109012|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109013|NCT00874107|Paclitaxel|paclitaxel|mesh-list
154109014|NCT00874107|Bevacizumab|bevacizumab|mesh-list
154109015|NCT00874107|Carboplatin|carboplatin|mesh-list
154109016|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154109017|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109018|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109028|NCT00761358|Z 338|z 338|mesh-list
154109041|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154109042|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729469|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
153729470|NCT02952092|Hematinics|hematinics|mesh-ancestor
153729471|NCT00139152|Omalizumab|omalizumab|mesh-list
154109043|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154109044|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
154109045|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109046|NCT00874419|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154109047|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109048|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109049|NCT00381043|Acamprosate|acamprosate|mesh-list
154109050|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154109051|NCT01050985|Sirolimus|sirolimus|mesh-list
154109052|NCT01050985|Capecitabine|capecitabine|mesh-list
154109053|NCT01050985|Temsirolimus|temsirolimus|mesh-list
154109054|NCT01050985|MTOR Inhibitors|mtor inhibitors|mesh-list
154109055|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154109056|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
154109057|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109058|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109059|NCT01050985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109060|NCT01050985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109061|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154109062|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
154109063|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109064|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154109065|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109090|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154109091|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154109092|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
154109093|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154109094|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
154109095|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154109096|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109097|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154109098|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154109099|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154109100|NCT00369577|Loxapine|loxapine|mesh-list
154109101|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154109102|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154109103|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109104|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109105|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154109106|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154109107|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
154109108|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109109|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109110|NCT00879957|Heparin|heparin|mesh-list
154109111|NCT00879957|Calcium heparin|calcium heparin|mesh-list
154109112|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
154109113|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154109114|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153729478|NCT02824523|Analgesics|analgesics|mesh-ancestor
153729479|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
153729480|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729481|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729482|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729483|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729484|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153729496|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729498|NCT03682029|Vitamins|vitamins|mesh-ancestor
153729499|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
154109115|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109116|NCT00874809|Insulin|insulin|mesh-list
154109117|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
154109118|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154109119|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109120|NCT00875355|Temozolomide|temozolomide|mesh-list
154109121|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154109122|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
154109123|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109129|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109130|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109131|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109132|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109134|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154109135|NCT00880815|Methotrexate|methotrexate|mesh-list
154109136|NCT00880815|Fludarabine|fludarabine|mesh-list
154109137|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154109138|NCT00880815|Antibodies|antibodies|mesh-list
154109139|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
154109140|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154109141|NCT00880815|Lenograstim|lenograstim|mesh-list
154109142|NCT00880815|Tacrolimus|tacrolimus|mesh-list
154109143|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
154109144|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154109145|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
154109146|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109147|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109148|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154109149|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154109150|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
154109151|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154109152|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154109153|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
154109154|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109177|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109178|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109179|NCT00881127|Cetirizine|cetirizine|mesh-list
154109180|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
154109181|NCT00881127|Ephedrine|ephedrine|mesh-list
154109182|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154109183|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154109184|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154109185|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
154109186|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
154109187|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109188|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109189|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109190|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154109191|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
154109192|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109193|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154109194|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
154109195|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
154109196|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154109197|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153729500|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729501|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
153729502|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729503|NCT03682029|Protective Agents|protective agents|mesh-ancestor
153729504|NCT00139230|Leucovorin|leucovorin|mesh-list
153729505|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
153729506|NCT00139230|Fluorouracil|fluorouracil|mesh-list
153729507|NCT00139230|Docetaxel|docetaxel|mesh-list
153729508|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729509|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
154109198|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
154109199|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
154109200|NCT00369265|Lansoprazole|lansoprazole|mesh-list
154109201|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
154109202|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154109203|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154109204|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154109205|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109206|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109221|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154109222|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109223|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109224|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
154109225|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
154109226|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109227|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154109228|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154109229|NCT00368875|Growth Substances|growth substances|mesh-ancestor
154109230|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109231|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
154109232|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
154109233|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154109234|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109235|NCT00614055|Insulin|insulin|mesh-list
154109236|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154109237|NCT00614055|Metformin|metformin|mesh-list
154109238|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
154109239|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
154109240|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
154109241|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154109242|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154109243|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109244|NCT00613821|Lidocaine|lidocaine|mesh-list
154109245|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
154109246|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
154109247|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109248|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109249|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
154109250|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109251|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154109252|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154109253|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154109254|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154109255|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109258|NCT00882765|Protective Agents|protective agents|mesh-ancestor
154109259|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109260|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109261|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109262|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109263|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109264|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
154109265|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154109266|NCT00882765|Estrogens|estrogens|mesh-ancestor
154109267|NCT00882765|Hormones|hormones|mesh-ancestor
154109268|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154109269|NCT00548548|Bevacizumab|bevacizumab|mesh-list
154109270|NCT00548548|Capecitabine|capecitabine|mesh-list
154109271|NCT00548548|Fluorouracil|fluorouracil|mesh-list
154109272|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154109273|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109274|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154109275|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154109276|NCT00548548|Growth Substances|growth substances|mesh-ancestor
154109277|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109278|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
154109280|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
154109310|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154109311|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154109312|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109313|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
154109314|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109315|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109316|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154109317|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154109318|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109319|NCT00881673|Dexamethasone|dexamethasone|mesh-list
154109320|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154109321|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154109322|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154109323|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
154109324|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
154109325|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109326|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109327|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154109328|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
154109329|NCT00881673|Hormones|hormones|mesh-ancestor
154109330|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154109333|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154109359|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
154109361|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154109363|NCT00612807|Nortriptyline|nortriptyline|mesh-list
154109364|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154109365|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
154109366|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154109367|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154109368|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154109369|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154109370|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109371|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
154109372|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109373|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109374|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154109375|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154109376|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109377|NCT00612807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154109378|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
153489823|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
154109379|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154109380|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109410|NCT04038411|Etoposide|etoposide|mesh-list
154109411|NCT04038411|Lenalidomide|lenalidomide|mesh-list
154109412|NCT04038411|Antibodies|antibodies|mesh-list
154109413|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
154109414|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109415|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154109416|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109417|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154109418|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154109419|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109420|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109421|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154109422|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154109423|NCT04038411|Growth Substances|growth substances|mesh-ancestor
154109424|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
154109425|NCT00882375|Nicotine|nicotine|mesh-list
154109426|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154109427|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
154109429|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109430|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154109431|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154109432|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
154109433|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109434|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109435|NCT00882453|Interferons|interferons|mesh-list
154109436|NCT00882453|Interferon-beta|interferon-beta|mesh-list
154109437|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
154109438|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109439|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
154109444|NCT00882531|Isotretinoin|isotretinoin|mesh-list
154109458|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
154109459|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109460|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154109461|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154109462|NCT00883623|Growth Substances|growth substances|mesh-ancestor
154109463|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
154109464|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109465|NCT00959218|Dronabinol|dronabinol|mesh-list
154109466|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
154109467|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109468|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154109469|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154109470|NCT00959218|Analgesics|analgesics|mesh-ancestor
154109471|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
154109472|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109473|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154109474|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154109475|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109476|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109477|NCT00959218|Hormones|hormones|mesh-ancestor
154109478|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154109479|NCT00678210|Tofacitinib|tofacitinib|mesh-list
154109480|NCT00678210|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154109481|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109482|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109483|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109484|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154109485|NCT00611715|Letrozole|letrozole|mesh-list
154109486|NCT00611715|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154109487|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109488|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109490|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109498|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154109499|NCT04722718|Carboplatin|carboplatin|mesh-list
154109500|NCT04722718|Apatinib|apatinib|mesh-list
154109501|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154109502|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109503|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109504|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
154109505|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
154109506|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109507|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109508|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109510|NCT00761670|Amisulpride|amisulpride|mesh-list
154109511|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154109512|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
154109513|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109514|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109515|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109516|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154109517|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154109518|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109519|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154109520|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154109521|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
154109522|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154109523|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
154109524|NCT00963664|Interferons|interferons|mesh-list
154109525|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
154109526|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
154109527|NCT00963664|Lovastatin|lovastatin|mesh-list
154109528|NCT00963664|L 647318|l 647318|mesh-list
154109529|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
154109545|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154109546|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109547|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154109548|NCT00761904|Simvastatin|simvastatin|mesh-list
154109549|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154109550|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154109551|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
154109552|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109553|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154109554|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154109555|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109556|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154109557|NCT00761904|Diuretics|diuretics|mesh-ancestor
154109558|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
154109559|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109560|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154109561|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154109562|NCT00963976|Enalapril|enalapril|mesh-list
154109563|NCT00963976|Labetalol|labetalol|mesh-list
154109564|NCT00963976|Hydralazine|hydralazine|mesh-list
154109565|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154109566|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
154109567|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109568|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109569|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154109592|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109593|NCT00883935|Ritonavir|ritonavir|mesh-list
154109594|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154109595|NCT00883935|Dolutegravir|dolutegravir|mesh-list
154109596|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154109597|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154109598|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
154109599|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109600|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109601|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154109602|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154109603|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
154109604|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109605|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154109606|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154109607|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154109608|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154109609|NCT00675948|Nabiximols|nabiximols|mesh-list
154109610|NCT00675948|Analgesics|analgesics|mesh-ancestor
154109611|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
154109612|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109613|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109614|NCT00885885|Panitumumab|panitumumab|mesh-list
154109615|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154109616|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109617|NCT00610935|Peramivir|peramivir|mesh-list
154109618|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
154109619|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109620|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109621|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109622|NCT02303028|Topotecan|topotecan|mesh-list
154109623|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153729530|NCT00139269|Docetaxel|docetaxel|mesh-list
154109635|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
154109636|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109637|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154109638|NCT00610857|Antibodies|antibodies|mesh-list
154109639|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
154109640|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154109641|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
154109642|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109643|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109644|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
154109645|NCT00672984|Guanfacine|guanfacine|mesh-list
154109646|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154109647|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109648|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154109649|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154109650|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109651|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109652|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109653|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109655|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154109656|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154109657|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154109658|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
154109659|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109660|NCT02543697|Epinephrine|epinephrine|mesh-list
154109661|NCT02543697|Racepinephrine|racepinephrine|mesh-list
154109662|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
154109663|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154109664|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154109665|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
154109675|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
154109680|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154109681|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109682|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109683|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154109684|NCT00886275|Analgesics|analgesics|mesh-ancestor
154109685|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
154109686|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109687|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154109688|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154109689|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154109690|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
154109691|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109692|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109693|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154109694|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154109695|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154109696|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154109697|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154109698|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
154109699|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
154109700|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
154109701|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
154109702|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
154109703|NCT04017897|Nivolumab|nivolumab|mesh-list
154109704|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154109705|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109706|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154109707|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109708|NCT02542137|Thymalfasin|thymalfasin|mesh-list
154109709|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154109710|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
154109711|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109712|NCT00886509|Lenograstim|lenograstim|mesh-list
154109713|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154109714|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
154109720|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109721|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109722|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154109723|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154109724|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
154109725|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
154109726|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356582|NCT01028846|Diazoxide|diazoxide|mesh-list
154109727|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154109728|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154109729|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154109730|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109731|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
154109732|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154109733|NCT00884481|Natalizumab|natalizumab|mesh-list
154109734|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
154109735|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109736|NCT02543229|Ranibizumab|ranibizumab|mesh-list
154109737|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154109738|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154109739|NCT02543229|Growth Substances|growth substances|mesh-ancestor
154109740|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109741|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
154109742|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109743|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
154109768|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109769|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109770|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109772|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
154109773|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
154109774|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109775|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109776|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
154109777|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154109778|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154109779|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154109780|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154109781|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154109782|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109783|NCT05955001|Tadalafil|tadalafil|mesh-list
154109784|NCT05955001|Vasodilator Agents|vasodilator agents|mesh-ancestor
154109785|NCT05955001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154109786|NCT05955001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154109787|NCT05955001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109788|NCT05955001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109789|NCT05955001|Urological Agents|urological agents|mesh-ancestor
154109790|NCT05954897|Lenvatinib|lenvatinib|mesh-list
154109791|NCT05954897|Tislelizumab|tislelizumab|mesh-list
154109792|NCT05954897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109793|NCT05954897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109794|NCT05954897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109795|NCT05954897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109796|NCT05954897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154109797|NCT05954806|Antivenins|antivenins|mesh-list
154109798|NCT05954806|Immunologic Factors|immunologic factors|mesh-ancestor
154109799|NCT05954806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109800|NCT05954078|Leucovorin|leucovorin|mesh-list
154109808|NCT05954078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109809|NCT05954078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154109810|NCT05954078|Immunologic Factors|immunologic factors|mesh-ancestor
154109811|NCT05954078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109812|NCT05954078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154109813|NCT05954078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154109814|NCT05954078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109815|NCT05954078|Antidotes|antidotes|mesh-ancestor
154109816|NCT05954078|Protective Agents|protective agents|mesh-ancestor
153729542|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
153729543|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154109817|NCT05954078|Vitamin B Complex|vitamin b complex|mesh-ancestor
154109818|NCT05954078|Vitamins|vitamins|mesh-ancestor
154109819|NCT05954078|Micronutrients|micronutrients|mesh-ancestor
153729549|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729550|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729551|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153729552|NCT00403364|Amoxicillin|amoxicillin|mesh-list
154109820|NCT05953909|Paclitaxel|paclitaxel|mesh-list
154109821|NCT05953909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154109822|NCT05953909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109823|NCT05953909|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109824|NCT05953909|Antimitotic Agents|antimitotic agents|mesh-ancestor
154109825|NCT05953909|Mitosis Modulators|mitosis modulators|mesh-ancestor
154109826|NCT05953909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109827|NCT05953896|Hyaluronic Acid|hyaluronic acid|mesh-list
154109828|NCT05953896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154109829|NCT05953896|Immunologic Factors|immunologic factors|mesh-ancestor
153490271|NCT02568852|Anesthetics|anesthetics|mesh-list
154109830|NCT05953896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109831|NCT05953896|Viscosupplements|viscosupplements|mesh-ancestor
154109832|NCT05953896|Protective Agents|protective agents|mesh-ancestor
154109833|NCT05953714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154109834|NCT05953714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109855|NCT05953350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109856|NCT05953350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109857|NCT05953350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109858|NCT05953350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154109859|NCT05953350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109860|NCT05953350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109861|NCT05928312|Oxaliplatin|oxaliplatin|mesh-list
154109862|NCT05928312|Irinotecan|irinotecan|mesh-list
154109863|NCT05928312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109864|NCT05928312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154109865|NCT05928312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154109866|NCT05928312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109867|NCT05928312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109868|NCT05919147|Pioglitazone|pioglitazone|mesh-list
154109869|NCT05919147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154109870|NCT05919147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109871|NCT05919030|Paclitaxel|paclitaxel|mesh-list
154109872|NCT05919030|Tislelizumab|tislelizumab|mesh-list
154109873|NCT05919030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154109874|NCT05919030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109875|NCT05919030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109876|NCT05919030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154109909|NCT05895201|Protease Inhibitors|protease inhibitors|mesh-ancestor
154109910|NCT05895201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109911|NCT05870956|Nintedanib|nintedanib|mesh-list
154109912|NCT05870956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109913|NCT05870956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154109914|NCT05870956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154109915|NCT05870956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729553|NCT00403364|Clarithromycin|clarithromycin|mesh-list
153729554|NCT00403364|Tinidazole|tinidazole|mesh-list
153729555|NCT00403364|Pantoprazole|pantoprazole|mesh-list
153729556|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153729557|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729558|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153729559|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729560|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729561|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154109916|NCT05847348|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154109917|NCT05847348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154109918|NCT05847348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109919|NCT05843383|Propofol|propofol|mesh-list
154109920|NCT05843383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154109921|NCT05843383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154109922|NCT05843383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109923|NCT05843383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154109924|NCT05843383|Anesthetics, General|anesthetics, general|mesh-ancestor
154109925|NCT05843383|Anesthetics|anesthetics|mesh-ancestor
154109926|NCT05836753|Sarecycline|sarecycline|mesh-list
154109927|NCT05836753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154109928|NCT05836753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109929|NCT05836753|Dermatologic Agents|dermatologic agents|mesh-ancestor
154109930|NCT05827211|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154109931|NCT05827211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154109932|NCT05827211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154109933|NCT05827211|Antitubercular Agents|antitubercular agents|mesh-ancestor
154109934|NCT05822063|Lidocaine|lidocaine|mesh-list
154109955|NCT05814354|Paclitaxel|paclitaxel|mesh-list
154109957|NCT05814354|Capecitabine|capecitabine|mesh-list
154109958|NCT05814354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154109959|NCT05814354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109960|NCT05814354|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109961|NCT05814354|Antimitotic Agents|antimitotic agents|mesh-ancestor
154109962|NCT05814354|Mitosis Modulators|mitosis modulators|mesh-ancestor
154109963|NCT05814354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109964|NCT05814354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154109965|NCT05814354|Antimetabolites|antimetabolites|mesh-ancestor
154109966|NCT05794659|Paclitaxel|paclitaxel|mesh-list
154109967|NCT05794659|Carboplatin|carboplatin|mesh-list
154109968|NCT05794659|Molgramostim|molgramostim|mesh-list
154109969|NCT05794659|Sargramostim|sargramostim|mesh-list
154109970|NCT05794659|Immunologic Factors|immunologic factors|mesh-ancestor
154109971|NCT05794659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109972|NCT05794659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154109973|NCT05794659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154109974|NCT05794659|Tubulin Modulators|tubulin modulators|mesh-ancestor
154109975|NCT05794659|Antimitotic Agents|antimitotic agents|mesh-ancestor
154109976|NCT05794659|Mitosis Modulators|mitosis modulators|mesh-ancestor
153729562|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153729563|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153729564|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729565|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153729566|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
153729567|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153729568|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153729569|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153729570|NCT00403442|Bevacizumab|bevacizumab|mesh-list
153729585|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154109977|NCT05794659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154109978|NCT05771584|Sargramostim|sargramostim|mesh-list
154109979|NCT05771584|Immunologic Factors|immunologic factors|mesh-ancestor
154109980|NCT05771584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109982|NCT05761041|Fluorides|fluorides|mesh-list
154109983|NCT05761041|Sodium Fluoride|sodium fluoride|mesh-list
154109984|NCT05761041|Fluorides, Topical|fluorides, topical|mesh-list
154109985|NCT05761041|Cariostatic Agents|cariostatic agents|mesh-ancestor
154109986|NCT05761041|Protective Agents|protective agents|mesh-ancestor
154109987|NCT05761041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154109988|NCT05761041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154110004|NCT05750966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154110005|NCT05750966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154110006|NCT05750966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154110007|NCT05750966|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154110008|NCT05750966|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154110009|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
154110010|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110011|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110012|NCT05679921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154110013|NCT05679921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110014|NCT05658380|Atropine|atropine|mesh-list
154110015|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154110016|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154110017|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154110018|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
154110019|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110020|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110021|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154110022|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
154110023|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
154110024|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
154110025|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154110026|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154110027|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
154110028|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729586|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729587|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
153729588|NCT00402974|Vitamin K|vitamin k|mesh-list
153729589|NCT00402974|Menaquinone 7|menaquinone 7|mesh-list
153922260|NCT05063552|Cetuximab|cetuximab|mesh-list
153729590|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153729591|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153729592|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110029|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110031|NCT05512481|Apatinib|apatinib|mesh-list
154110032|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154110033|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
154110034|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110040|NCT05473273|Estradiol|estradiol|mesh-list
154110046|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110047|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154110048|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
154110049|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154110050|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154110051|NCT05473273|Progestins|progestins|mesh-ancestor
154110052|NCT05464680|Dimercaprol|dimercaprol|mesh-list
153490497|NCT02607618|Iclaprim|iclaprim|mesh-list
154110053|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
154110054|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
154110055|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110056|NCT05389813|Pregabalin|pregabalin|mesh-list
154110057|NCT05389813|Oxycodone|oxycodone|mesh-list
154110058|NCT05389813|Analgesics|analgesics|mesh-ancestor
154110059|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
154110060|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110061|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110062|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
154110063|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154110064|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154110065|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110066|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154110098|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
154110099|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110100|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110101|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154110102|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154110103|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110104|NCT05293132|Vitamins|vitamins|mesh-ancestor
154110105|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
154110106|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
154110107|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
154110108|NCT05231980|Clomiphene|clomiphene|mesh-list
154110109|NCT05231980|Enclomiphene|enclomiphene|mesh-list
154110110|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
154110111|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110112|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154110113|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110114|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154110115|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154110116|NCT05231980|Protective Agents|protective agents|mesh-ancestor
154110117|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110118|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
154110119|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154110120|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
154110121|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
154110122|NCT05231980|Vitamins|vitamins|mesh-ancestor
154110123|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
154110124|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154110125|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
154110126|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110127|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154110128|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
153729593|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
153729594|NCT00402974|Coagulants|coagulants|mesh-ancestor
153729595|NCT00402974|Vitamins|vitamins|mesh-ancestor
153729596|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
153729597|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729598|NCT03510078|Insulin|insulin|mesh-list
153729599|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153729600|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110129|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154110130|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154110138|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
154110139|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110140|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
154110141|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154110142|NCT05140941|Velpatasvir|velpatasvir|mesh-list
154110143|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
154110144|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110145|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
154110146|NCT05068440|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154110147|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154110148|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110149|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110150|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110151|NCT05050305|Dexamethasone|dexamethasone|mesh-list
154110152|NCT05050305|Pomalidomide|pomalidomide|mesh-list
154110153|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110154|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
154110155|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
154110156|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110157|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110158|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154110159|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
154110160|NCT05050305|Hormones|hormones|mesh-ancestor
154110161|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110162|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154110163|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110164|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
154110187|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
154110188|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
154110189|NCT04947527|Protective Agents|protective agents|mesh-ancestor
154110190|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110192|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154110193|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110194|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154110195|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110196|NCT04907032|Mirabegron|mirabegron|mesh-list
154110197|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154110198|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154110199|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154110200|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
154110201|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110202|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110203|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110204|NCT04907032|Urological Agents|urological agents|mesh-ancestor
154110205|NCT04861051|Ketamine|ketamine|mesh-list
154110206|NCT04861051|Analgesics|analgesics|mesh-ancestor
154110207|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
154110208|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110209|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110237|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
154110238|NCT04712903|Carboplatin|carboplatin|mesh-list
154110239|NCT04712903|Etoposide|etoposide|mesh-list
154110240|NCT04712903|Durvalumab|durvalumab|mesh-list
154110241|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110242|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154110243|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154110244|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154110245|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110246|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110248|NCT04710927|Fluorides|fluorides|mesh-list
154110304|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110305|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110306|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
154110307|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110308|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153783539|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154110309|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
154110310|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154110311|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154110312|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110313|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154110314|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
154110315|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154110316|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154110317|NCT04539249|Narcotics|narcotics|mesh-ancestor
154110318|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154110319|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154110320|NCT04492891|Cyclosporine|cyclosporine|mesh-list
154110321|NCT04492891|Cyclosporins|cyclosporins|mesh-list
154110322|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110323|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110324|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154110325|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
154110326|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110327|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
154110328|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110329|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
154110330|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154110331|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154110332|NCT04449198|Resveratrol|resveratrol|mesh-list
154110333|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
154110334|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110335|NCT04449198|Protective Agents|protective agents|mesh-ancestor
154110336|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110337|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110344|NCT04271189|Incretins|incretins|mesh-ancestor
154110345|NCT04271189|Hormones|hormones|mesh-ancestor
154110346|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110347|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154110348|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
154110349|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110350|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110351|NCT04221945|Cisplatin|cisplatin|mesh-list
154110352|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
154110353|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110354|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110355|NCT04221945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154110356|NCT04221945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110358|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
154110359|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110360|NCT04199325|Protective Agents|protective agents|mesh-ancestor
154110361|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110362|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154110363|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154110364|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110365|NCT04157725|Clomiphene|clomiphene|mesh-list
154110396|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154110397|NCT04101721|Growth Substances|growth substances|mesh-ancestor
154110398|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110399|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
154110400|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110401|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
154110402|NCT03968640|Vitamins|vitamins|mesh-ancestor
154110403|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
154110404|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110406|NCT03948074|Cannabidiol|cannabidiol|mesh-list
153729602|NCT00139581|Tacrolimus|tacrolimus|mesh-list
153729603|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153729604|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153729605|NCT00139581|Analgesics|analgesics|mesh-ancestor
153729606|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
153729607|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110407|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
154110408|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
154110409|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110410|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154110411|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154110412|NCT03948074|Analgesics|analgesics|mesh-ancestor
154110413|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
154110414|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110415|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154110416|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154110417|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110418|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110419|NCT03948074|Hormones|hormones|mesh-ancestor
154110420|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110421|NCT03932318|Azacitidine|azacitidine|mesh-list
154110422|NCT03932318|Venetoclax|venetoclax|mesh-list
154110423|NCT03932318|Lintuzumab|lintuzumab|mesh-list
154110424|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154110445|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154110446|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
154110447|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110448|NCT03718234|Hormones|hormones|mesh-ancestor
154110449|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110450|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110451|NCT03643107|Prednisolone|prednisolone|mesh-list
154110452|NCT03643107|Irofulven|irofulven|mesh-list
154110453|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110454|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
154110455|NCT03643107|Hormones|hormones|mesh-ancestor
154110456|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110457|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110458|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154110459|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110460|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154110461|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
154110462|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110463|NCT03623243|Siponimod|siponimod|mesh-list
154110464|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154110465|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110466|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154110467|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
154110468|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110469|NCT03619707|Progesterone|progesterone|mesh-list
154110470|NCT03619707|Progestins|progestins|mesh-ancestor
154110471|NCT03619707|Hormones|hormones|mesh-ancestor
154110472|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110473|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110474|NCT03597568|Resveratrol|resveratrol|mesh-list
154110475|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
154110476|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110485|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154110486|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729610|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729611|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
153729612|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153729613|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
153729614|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153729615|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729616|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729617|NCT03500913|Hormones|hormones|mesh-list
154110487|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110488|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154110489|NCT03593408|Analgesics|analgesics|mesh-ancestor
154110490|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
154110491|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110492|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154110493|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154110494|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154110495|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
154110496|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110497|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110498|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154110499|NCT03593408|Narcotics|narcotics|mesh-ancestor
154110500|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154110501|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154110502|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154110503|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154110504|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153490961|NCT02665728|Laxatives|laxatives|mesh-list
154110505|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
154110507|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
154110508|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
154110509|NCT03572582|Nivolumab|nivolumab|mesh-list
154110510|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110511|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110512|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154110513|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110514|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154110515|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110516|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110517|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110518|NCT03432871|Niacinamide|niacinamide|mesh-list
154110519|NCT03432871|Niacin|niacin|mesh-list
154110524|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110525|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154110526|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
154110527|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110528|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154110529|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
154110530|NCT03389139|Anesthetics|anesthetics|mesh-list
154110531|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110532|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110533|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
154110534|NCT03382938|Ropivacaine|ropivacaine|mesh-list
154110535|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154110536|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110537|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110538|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154110539|NCT03382938|Analgesics|analgesics|mesh-ancestor
154110540|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
154110541|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110542|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154110543|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154110544|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154110545|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
154110546|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110547|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110573|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
154110574|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154110575|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
154110576|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154110577|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110578|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154110579|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154110580|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110582|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110583|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110584|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
154110585|NCT02981069|Exenatide|exenatide|mesh-list
154110586|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154110587|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110588|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154110589|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110590|NCT02981069|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154110591|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154110592|NCT02981069|Incretins|incretins|mesh-ancestor
154110593|NCT02981069|Hormones|hormones|mesh-ancestor
154110595|NCT02980991|Pemetrexed|pemetrexed|mesh-list
154110601|NCT02923128|Sufentanil|sufentanil|mesh-list
154110624|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154110625|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358136|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
154110626|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110627|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
154110628|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110629|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110630|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154110631|NCT02839642|Protective Agents|protective agents|mesh-ancestor
154110632|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
154110633|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
154110634|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154110635|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154110636|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
154110637|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110638|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
154110639|NCT02612311|Chlorambucil|chlorambucil|mesh-list
154110640|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110641|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110642|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154110643|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
154110644|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110645|NCT02607319|Bemiparin|bemiparin|mesh-list
154110646|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
154110647|NCT02581085|Tocotrienols|tocotrienols|mesh-list
154110648|NCT02581085|Vitamin E|vitamin e|mesh-list
154110649|NCT02581085|Tocopherols|tocopherols|mesh-list
154110650|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
154110651|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110652|NCT02581085|Protective Agents|protective agents|mesh-ancestor
154110653|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110654|NCT02581085|Vitamins|vitamins|mesh-ancestor
154110655|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
154110656|NCT02575963|Cytarabine|cytarabine|mesh-list
154110657|NCT02575963|Lintuzumab|lintuzumab|mesh-list
154110665|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110666|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154110667|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
154110668|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110669|NCT02575963|Diuretics|diuretics|mesh-ancestor
154110670|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
154110671|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154110672|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154110673|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154110674|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
154110675|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110676|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154110677|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110679|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154110680|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110681|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
154110682|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110683|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
154110684|NCT02501096|Lenvatinib|lenvatinib|mesh-list
154110685|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154110686|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110687|NCT02501096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154110688|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729626|NCT00130481|Atorvastatin|atorvastatin|mesh-list
154110689|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154110690|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110709|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
154110710|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
154110711|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
154110712|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154110713|NCT02122562|Ketamine|ketamine|mesh-list
154110714|NCT02122562|Analgesics|analgesics|mesh-ancestor
154110715|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
154110716|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110717|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110718|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154110719|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154110720|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
154110721|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
154110722|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110723|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154110724|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154110725|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154110726|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110727|NCT02115724|Vitamins|vitamins|mesh-list
154110728|NCT02115724|Vitamin E|vitamin e|mesh-list
154110729|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
154110730|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
154110731|NCT02115724|Antioxidants|antioxidants|mesh-list
154110732|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
154110763|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154110764|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154110765|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
154110766|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154110767|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154110768|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
154110769|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110770|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
154110771|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110772|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154110773|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154110774|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154110775|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
154110776|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110777|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154110778|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
154110779|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
154110780|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
154110781|NCT01267604|Inositol|inositol|mesh-list
154110782|NCT01267604|Melatonin|melatonin|mesh-list
154110783|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
154110784|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110785|NCT01267604|Protective Agents|protective agents|mesh-ancestor
154110786|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110787|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110788|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
154110789|NCT01267604|Vitamins|vitamins|mesh-ancestor
154110790|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
154110791|NCT01244399|Inositol|inositol|mesh-list
154110792|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
154110793|NCT01244399|Vitamins|vitamins|mesh-ancestor
154110794|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
154110795|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110796|NCT01063517|Paclitaxel|paclitaxel|mesh-list
154110797|NCT01063517|Olaparib|olaparib|mesh-list
154110798|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154110799|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110800|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
153363973|NCT01728974|Anesthetics|anesthetics|mesh-list
153654602|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153654603|NCT00018018|Zidovudine|zidovudine|mesh-list
154110801|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
154110802|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
154110803|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110804|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154110805|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110806|NCT00920621|Vitamin D|vitamin d|mesh-list
154110807|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
154110808|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
154110809|NCT00920621|Vitamins|vitamins|mesh-list
154110810|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
154110811|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110812|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154110813|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154110814|NCT00964756|Ganciclovir|ganciclovir|mesh-list
154110815|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
154110816|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
154110817|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110818|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154110819|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110820|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110821|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154110822|NCT00964834|Doxycycline|doxycycline|mesh-list
154110823|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154110824|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110825|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
154110826|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
154110829|NCT00612105|Ezogabine|ezogabine|mesh-list
154110848|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154110849|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154110850|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154110851|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110853|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
154110854|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
154110855|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154110856|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
154110857|NCT04017741|Hormones|hormones|mesh-ancestor
154110858|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154110859|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154110860|NCT04017741|Protective Agents|protective agents|mesh-ancestor
154110861|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154110862|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110863|NCT00546052|Losartan|losartan|mesh-list
154110864|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154110865|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154110866|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154110867|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154110868|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154110869|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110870|NCT00546052|Diuretics|diuretics|mesh-ancestor
154110871|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
154110872|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110875|NCT00887601|Donepezil|donepezil|mesh-list
154110897|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110898|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154110899|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154110900|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154110901|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110902|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154110903|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154110904|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154110905|NCT00673920|Methotrexate|methotrexate|mesh-list
154110906|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
154110907|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154110908|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
154110909|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154110910|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110911|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154110912|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
154110913|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110914|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110915|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
154110916|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154110917|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154110918|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154110919|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
154110920|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154110921|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154110922|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154110923|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154110924|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
154110925|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110927|NCT00379795|Ranibizumab|ranibizumab|mesh-list
154110928|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154110929|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154110930|NCT00379795|Growth Substances|growth substances|mesh-ancestor
154110931|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340508|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
153654604|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
154110932|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
154110933|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110934|NCT04588948|Aflibercept|aflibercept|mesh-list
154110935|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154110936|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154110937|NCT04588948|Growth Substances|growth substances|mesh-ancestor
154110938|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110939|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
154110940|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110941|NCT00765024|Ivermectin|ivermectin|mesh-list
154110942|NCT00765024|Albendazole|albendazole|mesh-list
154110943|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154110944|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110945|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
154110946|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
154110947|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154110948|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154110949|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
154110950|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
154110951|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
154110952|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110953|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110954|NCT02557932|Bismuth|bismuth|mesh-list
154110955|NCT02557932|Antacids|antacids|mesh-ancestor
154110956|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110957|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154110958|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
154110960|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154110961|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110962|NCT00960232|Vitamins|vitamins|mesh-ancestor
154110963|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
154110964|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154110965|NCT00960310|Bicalutamide|bicalutamide|mesh-list
154110966|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
154110967|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
154110975|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154110976|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154110977|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
154110978|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154110979|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154110980|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110981|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154110982|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154110983|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154110984|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110985|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154110986|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154110987|NCT00610155|Narcotics|narcotics|mesh-ancestor
154110988|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
154110989|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154110990|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
153365704|NCT02487030|Ledipasvir|ledipasvir|mesh-list
154110991|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154110992|NCT00960544|Capecitabine|capecitabine|mesh-list
154110993|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154110994|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
154110995|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154110996|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154110997|NCT04488952|Anesthetics|anesthetics|mesh-list
154110998|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154110999|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340622|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154111022|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111023|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154111024|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154111025|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154111026|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154111027|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154111028|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111029|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111030|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111031|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111032|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111033|NCT00759720|Glyburide|glyburide|mesh-list
154111034|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111035|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111036|NCT00379639|Gemcitabine|gemcitabine|mesh-list
154111037|NCT00379639|Romidepsin|romidepsin|mesh-list
154111038|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154111039|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
154111040|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111041|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111042|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154111043|NCT00379639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154111044|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111045|NCT00609765|Dexamethasone|dexamethasone|mesh-list
154111046|NCT00609765|Bevacizumab|bevacizumab|mesh-list
154111047|NCT00609765|Doxorubicin|doxorubicin|mesh-list
154111048|NCT00609765|Fluorouracil|fluorouracil|mesh-list
154111049|NCT00609765|Streptozocin|streptozocin|mesh-list
154111050|NCT00609765|Ondansetron|ondansetron|mesh-list
154111051|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154111052|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111053|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154111054|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154111055|NCT00609765|Growth Substances|growth substances|mesh-ancestor
154111058|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111059|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
154111060|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
154111061|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111062|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111063|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
154111064|NCT00609765|Hormones|hormones|mesh-ancestor
154111065|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111066|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111067|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154111068|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154111069|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154111070|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111071|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111072|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
154111073|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154111074|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111075|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
154111076|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
154111077|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
154111078|NCT00609765|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154111079|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154111080|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
154111081|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111082|NCT01051219|Losartan|losartan|mesh-list
153729634|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154111083|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154111084|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154111085|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154111086|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154111087|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111088|NCT00961324|Insulin|insulin|mesh-list
154111089|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154111093|NCT00766350|Amitriptyline|amitriptyline|mesh-list
154111099|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154111100|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111101|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153491539|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
154111102|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154111103|NCT00766350|Analgesics|analgesics|mesh-ancestor
154111104|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
154111105|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111106|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154111107|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154111108|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111109|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111110|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111111|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111113|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154111114|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154111115|NCT00889161|Analgesics|analgesics|mesh-ancestor
154111116|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
154111117|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111118|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111119|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111120|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154111121|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111122|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111123|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111124|NCT03992755|Treprostinil|treprostinil|mesh-list
154111125|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154111126|NCT01563328|Dolutegravir|dolutegravir|mesh-list
154111127|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154111128|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154111141|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111142|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111143|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154111144|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154111145|NCT00961480|Metformin|metformin|mesh-list
154111146|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154111147|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111148|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111149|NCT00961480|Incretins|incretins|mesh-ancestor
154111150|NCT00961480|Hormones|hormones|mesh-ancestor
154111151|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111152|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154111153|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
154111154|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111155|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111156|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
154111157|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
154111158|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154111159|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
154111160|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154111161|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154111162|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111163|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154111164|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111165|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111166|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154111168|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154111169|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154111170|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154111171|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111172|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111174|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111180|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154111181|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111182|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111183|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111184|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111185|NCT00966004|Urological Agents|urological agents|mesh-ancestor
154111186|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154111187|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154111188|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
154111189|NCT00966082|Propranolol|propranolol|mesh-list
154111190|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154111191|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154111192|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111193|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111194|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111195|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111196|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154111197|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154111198|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
154111199|NCT00889629|Vitamin D|vitamin d|mesh-list
154111200|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
154111201|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
154111202|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
154111203|NCT00889629|Vitamins|vitamins|mesh-ancestor
154111204|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
154111205|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111206|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154111207|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154111208|NCT00966160|Ritonavir|ritonavir|mesh-list
154111209|NCT00966160|Lopinavir|lopinavir|mesh-list
154111223|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154111224|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154111225|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154111226|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154111227|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
154111228|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153729648|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154111229|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154111230|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154111231|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154111232|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154111234|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154111235|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154111236|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
154111237|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111238|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111239|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154111240|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154111241|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
154111242|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111243|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154111244|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154111246|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154111247|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154111248|NCT00966316|Analgesics|analgesics|mesh-ancestor
154111249|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
154111261|NCT00892827|Rituximab|rituximab|mesh-list
154111268|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154111269|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154111270|NCT00766896|Analgesics|analgesics|mesh-ancestor
154111271|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
154111272|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111273|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111274|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111275|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154111276|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154111277|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154111278|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111279|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154111280|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154111281|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111282|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
154111283|NCT00763620|Dimercaprol|dimercaprol|mesh-list
154111284|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
154111285|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
154111286|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111287|NCT00973804|Sirolimus|sirolimus|mesh-list
154111288|NCT00973804|Tacrolimus|tacrolimus|mesh-list
154111289|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111290|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
154111291|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111292|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154111293|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111294|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111295|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154111296|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111297|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154111310|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154111311|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111312|NCT00973882|Carboplatin|carboplatin|mesh-list
154111313|NCT00973882|Etoposide|etoposide|mesh-list
154111314|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111315|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154111316|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154111317|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154111318|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111319|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111320|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154111321|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154111322|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
154111323|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111324|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111325|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154111326|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
154111327|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154111328|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154111329|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154111330|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111331|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111332|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111333|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
154111334|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154111335|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154111336|NCT05279482|Prednisolone|prednisolone|mesh-list
154111337|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
154111338|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154111339|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
154111353|NCT00890175|Loxapine|loxapine|mesh-list
154111354|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154111355|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154111356|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154111357|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111358|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154111359|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154111360|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
154111361|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111362|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111363|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154111364|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154111365|NCT00966472|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154111366|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154111367|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111368|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111369|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111370|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154111371|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154111372|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
154111373|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154111374|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154111375|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
154111376|NCT00890253|Prednisone|prednisone|mesh-list
154111377|NCT00890253|Prednisolone|prednisolone|mesh-list
154111378|NCT00890253|Everolimus|everolimus|mesh-list
154111379|NCT00890253|Basiliximab|basiliximab|mesh-list
154111380|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111381|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
154111382|NCT00890253|Hormones|hormones|mesh-ancestor
154111383|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111384|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111394|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154111395|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
154111396|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154111397|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111399|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
154111400|NCT00674154|Vitamins|vitamins|mesh-ancestor
154111401|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
154111402|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111403|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154111404|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154111405|NCT00967954|Hormones|hormones|mesh-list
154111406|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
154111407|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111408|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111409|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
154111410|NCT00767286|Cobalt|cobalt|mesh-list
154111411|NCT00767286|Goserelin|goserelin|mesh-list
154111412|NCT00767286|Flutamide|flutamide|mesh-list
154111413|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111414|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111415|NCT00767286|Trace Elements|trace elements|mesh-ancestor
153783869|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
154111448|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111450|NCT00608517|Protective Agents|protective agents|mesh-ancestor
154111451|NCT00966706|Gemcitabine|gemcitabine|mesh-list
154111452|NCT00966706|Docetaxel|docetaxel|mesh-list
154111453|NCT00966706|Capecitabine|capecitabine|mesh-list
154111454|NCT00966706|Epirubicin|epirubicin|mesh-list
154111455|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111456|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154111457|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
154111458|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111459|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
154111460|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
154111461|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
154111462|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154111463|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154111464|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154111465|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111466|NCT00893061|Tamoxifen|tamoxifen|mesh-list
154111467|NCT00893061|Letrozole|letrozole|mesh-list
154111468|NCT00893061|Anastrozole|anastrozole|mesh-list
154111469|NCT00893061|Exemestane|exemestane|mesh-list
154111470|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111471|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111472|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154111473|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154111474|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111475|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154111476|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
154111494|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111495|NCT00974584|Paclitaxel|paclitaxel|mesh-list
154111496|NCT00974584|Bevacizumab|bevacizumab|mesh-list
154111497|NCT00974584|Carboplatin|carboplatin|mesh-list
154111498|NCT00974584|Pemetrexed|pemetrexed|mesh-list
154111499|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154111500|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111501|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
154111502|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
154111503|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
154111504|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111505|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154111506|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154111507|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154111508|NCT00974584|Growth Substances|growth substances|mesh-ancestor
154111509|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111510|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
154111511|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111512|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154111513|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154111514|NCT00608205|Fluorouracil|fluorouracil|mesh-list
154111515|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111545|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111546|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111547|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154111548|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154111549|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111550|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111551|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154111552|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154111553|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
154111554|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154111555|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
154111556|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
154111557|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
154111558|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154111559|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
154111560|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154111561|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
154111562|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111563|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
154111564|NCT00890487|Protective Agents|protective agents|mesh-ancestor
154111565|NCT00890565|Granisetron|granisetron|mesh-list
154111566|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
154111567|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
154111568|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111569|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111570|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111571|NCT00890565|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154111572|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154111573|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
154111574|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111575|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111576|NCT00890643|Prazosin|prazosin|mesh-list
154111577|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154111578|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154111579|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154111580|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154111581|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111582|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111583|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111584|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111585|NCT00893217|Interferons|interferons|mesh-list
154111586|NCT00893217|Interferon-beta|interferon-beta|mesh-list
154111587|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
154111588|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111589|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
154111590|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111591|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
154111592|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111593|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154111594|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
154111595|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154111596|NCT00767598|Udenafil|udenafil|mesh-list
154111597|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
154111599|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154111600|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111601|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111602|NCT00767598|Urological Agents|urological agents|mesh-ancestor
154111603|NCT00670800|Metformin|metformin|mesh-list
154111604|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111605|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111606|NCT00764166|Docetaxel|docetaxel|mesh-list
154111607|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154111608|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111609|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
154111610|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
154111611|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
154111629|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154111630|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154111631|NCT00767754|Paroxetine|paroxetine|mesh-list
154111632|NCT00767754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154111633|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154111634|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111635|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111636|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111637|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
154111638|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111639|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154111640|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
154111641|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154111642|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154111643|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154111644|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111645|NCT00764244|Triamcinolone|triamcinolone|mesh-list
154111646|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154111647|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154111648|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154111649|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111650|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
154111651|NCT00764244|Hormones|hormones|mesh-ancestor
154111652|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111653|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111654|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111655|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
154111656|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111658|NCT00770640|Insulin|insulin|mesh-list
154111670|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111672|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154111673|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111675|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154111676|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154111677|NCT00545740|Analgesics|analgesics|mesh-ancestor
154111678|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
154111679|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111680|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111681|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111682|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154111683|NCT05208190|Clozapine|clozapine|mesh-list
154111684|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154111685|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
154111686|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111687|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111688|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111689|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154111690|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154111691|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154111692|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154111693|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
154111694|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
154111718|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111719|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111720|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111721|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111722|NCT00673452|Analgesics|analgesics|mesh-ancestor
154111723|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
154111724|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111725|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
154111726|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154111727|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
153783879|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153783911|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783912|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783913|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153783914|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
153783915|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783916|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
153783917|NCT00237536|Lonidamine|lonidamine|mesh-list
153783918|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783919|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154111728|NCT00967174|Nicotine|nicotine|mesh-list
154111729|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154111730|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
154111731|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111732|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111733|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154111734|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154111735|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
154111736|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111737|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111738|NCT00967252|Atorvastatin|atorvastatin|mesh-list
154111739|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154111740|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154111741|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
154111742|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111743|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153359225|NCT05776524|Paclitaxel|paclitaxel|mesh-list
154111744|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154111745|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111761|NCT00975052|Incretins|incretins|mesh-ancestor
154111762|NCT00975052|Hormones|hormones|mesh-ancestor
154111763|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111764|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154111765|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
154111766|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111767|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111768|NCT00891033|Bortezomib|bortezomib|mesh-list
154111769|NCT00891033|Panobinostat|panobinostat|mesh-list
154111770|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111771|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154111772|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111773|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111774|NCT00770952|Pioglitazone|pioglitazone|mesh-list
154111775|NCT00770952|Glimepiride|glimepiride|mesh-list
154111776|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111777|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111778|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154111779|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111780|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
154111781|NCT00764556|Insulin|insulin|mesh-list
154111782|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111783|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111784|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
154111785|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154111786|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154111787|NCT00968578|Prednisolone|prednisolone|mesh-list
154111788|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
154111789|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154111790|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
154111791|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111792|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
154111793|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
153783920|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783921|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153783922|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
153783923|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153783924|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153783925|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154111794|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111796|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111801|NCT00968578|Protective Agents|protective agents|mesh-ancestor
154111802|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111803|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111804|NCT00893373|Sorafenib|sorafenib|mesh-list
154111805|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111806|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154111807|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111808|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111809|NCT00891267|Amlodipine|amlodipine|mesh-list
154111810|NCT00891267|Olmesartan|olmesartan|mesh-list
154111811|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154111812|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154111813|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154111814|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111815|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111816|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154111817|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111818|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
154111819|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154111820|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154111821|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154111822|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154111823|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111824|NCT00545584|Incretins|incretins|mesh-ancestor
154111825|NCT00545584|Hormones|hormones|mesh-ancestor
154111849|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154111850|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111851|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111852|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154111853|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154111854|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154111855|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
154111856|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154111857|NCT00893451|Vitamin D|vitamin d|mesh-list
154111858|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
154111859|NCT00893451|Vitamins|vitamins|mesh-ancestor
154111860|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
154111861|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111862|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154111863|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154111864|NCT00967408|Escitalopram|escitalopram|mesh-list
154111865|NCT00967408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154111866|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154111867|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111868|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111869|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111903|NCT03620643|Crizotinib|crizotinib|mesh-list
154111904|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154111905|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111906|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154111907|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154111908|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
154111909|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111910|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111911|NCT03620643|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154111912|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154111913|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154111914|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111915|NCT04008316|Colchicine|colchicine|mesh-list
154111916|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
154111917|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154111918|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
154111919|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
154111920|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
154111921|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111922|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111923|NCT00893607|Methoxamine|methoxamine|mesh-list
154111924|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
154111925|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
154111926|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111927|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111928|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154111929|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154111930|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154111931|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154111932|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
154111933|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154111934|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111935|NCT00969046|Epothilone B|epothilone b|mesh-list
154111942|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
154111943|NCT05008354|Vitamins|vitamins|mesh-ancestor
154111944|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
154111945|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111946|NCT00975754|Budesonide|budesonide|mesh-list
154111947|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111948|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154111949|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
154111950|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111951|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111952|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154111953|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
154111954|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
154111955|NCT00975754|Hormones|hormones|mesh-ancestor
154111956|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111957|NCT01045681|Dexamethasone|dexamethasone|mesh-list
154111958|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
154111959|NCT01045681|Bortezomib|bortezomib|mesh-list
154111960|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154111961|NCT01045681|BB 1101|bb 1101|mesh-list
154111962|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154111963|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
154111964|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
154111965|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154111966|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154111967|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154111968|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
154111969|NCT01045681|Hormones|hormones|mesh-ancestor
153783967|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153783969|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153359450|NCT05249556|Ganaxolone|ganaxolone|mesh-list
154111970|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154111972|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111973|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
154111986|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154111987|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154111988|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154111989|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111990|NCT03617913|Cisplatin|cisplatin|mesh-list
154111991|NCT03617913|Fluorouracil|fluorouracil|mesh-list
154111992|NCT03617913|Mitomycins|mitomycins|mesh-list
154111993|NCT03617913|Mitomycin|mitomycin|mesh-list
154111994|NCT03617913|Avelumab|avelumab|mesh-list
154111995|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154111996|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154111997|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
154111998|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154111999|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154112000|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112001|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
154112002|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112003|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154112004|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
154112005|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154112006|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112007|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154112009|NCT00975988|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154112010|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154112011|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112012|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112013|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112014|NCT00976066|Naltrexone|naltrexone|mesh-list
154112015|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154112016|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154112018|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
154112030|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154112031|NCT00976222|Ranibizumab|ranibizumab|mesh-list
154112032|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154112033|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154112034|NCT00976222|Growth Substances|growth substances|mesh-ancestor
154112035|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112036|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
154112037|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112038|NCT00976300|Cyclosporine|cyclosporine|mesh-list
154112039|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
154112040|NCT00976300|Cyclosporins|cyclosporins|mesh-list
154112041|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112042|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
154112043|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112044|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154112045|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154112046|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
154112047|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112048|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112049|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154112050|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112051|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
154112052|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112053|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
154112054|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154112057|NCT00979966|Temsirolimus|temsirolimus|mesh-list
154112082|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112083|NCT00969904|Protective Agents|protective agents|mesh-ancestor
154112084|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112085|NCT00969904|Antidotes|antidotes|mesh-ancestor
154112086|NCT00976612|Nilotinib|nilotinib|mesh-list
154112087|NCT00976612|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154112088|NCT00976612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154112089|NCT00976612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783977|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154112090|NCT00976612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112091|NCT00976690|Mesalamine|mesalamine|mesh-list
154112092|NCT00976690|Azathioprine|azathioprine|mesh-list
154112093|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
154112094|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112095|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154112096|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112097|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112098|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
154112099|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112100|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154112101|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154112102|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154112103|NCT00976690|Analgesics|analgesics|mesh-ancestor
154112104|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
154112105|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112106|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154112107|NCT00976768|Fluorouracil|fluorouracil|mesh-list
154112108|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
154112116|NCT00608985|Zolpidem|zolpidem|mesh-list
154112125|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112127|NCT00969982|Mifepristone|mifepristone|mesh-list
154112128|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154112129|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
154112130|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154112131|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112132|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154112133|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154112134|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
154112135|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154112136|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154112137|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154112138|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154112139|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
154112140|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154112141|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154112142|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
154112143|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112144|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
154112145|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154112146|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154112147|NCT00970138|Apatinib|apatinib|mesh-list
154112148|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435513|NCT05751421|Meloxicam|meloxicam|mesh-list
154112149|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154112150|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112151|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112152|NCT00892125|Carbamazepine|carbamazepine|mesh-list
153784010|NCT00269724|Urological Agents|urological agents|mesh-ancestor
153784011|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153784012|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
153784013|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
153784014|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153784015|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154112153|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154112154|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154112155|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154112156|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112157|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112162|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112163|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112164|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154112165|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154112166|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
154112167|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
154112168|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
154112169|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154112170|NCT00892125|Analgesics|analgesics|mesh-ancestor
154112171|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
154112172|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112173|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154112174|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154112175|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154112176|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154112177|NCT00980356|Vildagliptin|vildagliptin|mesh-list
154112178|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154112179|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112180|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154112181|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
154112182|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112183|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112215|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154112216|NCT00970450|Analgesics|analgesics|mesh-ancestor
154112217|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
154112218|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112219|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112220|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
154112221|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
154112222|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
154112223|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154112224|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154112225|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154112226|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
154112227|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112228|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112229|NCT00970528|Acarbose|acarbose|mesh-list
154112230|NCT00970528|Voglibose|voglibose|mesh-list
154112231|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154112232|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112233|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112234|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154112235|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112236|NCT00970762|Rocuronium|rocuronium|mesh-list
154112237|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
154112238|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154112239|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154112240|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154112241|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112242|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784022|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
153784030|NCT04538521|Niacin|niacin|mesh-list
154112243|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154112244|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154112245|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
154112248|NCT00978172|Artesunate|artesunate|mesh-list
154112258|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
154112259|NCT03923530|Eplerenone|eplerenone|mesh-list
154112260|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154112261|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
154112262|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112263|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112264|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154112265|NCT03923530|Diuretics|diuretics|mesh-ancestor
154112266|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
154112267|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154112268|NCT00608907|Rifampin|rifampin|mesh-list
154112269|NCT00608907|Dexamethasone|dexamethasone|mesh-list
154112270|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
154112271|NCT00608907|Bortezomib|bortezomib|mesh-list
154112272|NCT00608907|BB 1101|bb 1101|mesh-list
154112273|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154112274|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
154112275|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
154112276|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112277|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112278|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154112279|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
154112280|NCT00608907|Hormones|hormones|mesh-ancestor
154112299|NCT00970996|Interferons|interferons|mesh-list
154112312|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112313|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
154112314|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112315|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154112316|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
154112317|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
154112318|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112319|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154112320|NCT00970996|Analgesics|analgesics|mesh-ancestor
154112321|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
154112322|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112323|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
154112324|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154112325|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112326|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
154112327|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112328|NCT00869193|Protective Agents|protective agents|mesh-ancestor
154112329|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112330|NCT04009018|Anesthetics|anesthetics|mesh-list
153784033|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
154112331|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112332|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112333|NCT00869271|Leucovorin|leucovorin|mesh-list
154112334|NCT00869271|Fluorouracil|fluorouracil|mesh-list
154112335|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
154112336|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
154112337|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112338|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154112339|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112340|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112341|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
154112342|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112355|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154112356|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112358|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154112359|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112360|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154112361|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
154112362|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154112363|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112364|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112365|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112366|NCT00978328|Oxycodone|oxycodone|mesh-list
154112367|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154112368|NCT00978328|Narcotics|narcotics|mesh-ancestor
154112369|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112370|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112371|NCT00978328|Analgesics|analgesics|mesh-ancestor
154112372|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
154112373|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112374|NCT00892359|Anidulafungin|anidulafungin|mesh-list
154112375|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
154112376|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112377|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154112378|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154112379|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154112380|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112381|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112382|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153784056|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153784057|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
153784058|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784059|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
153784060|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784061|NCT00269802|Methylphenidate|methylphenidate|mesh-list
153784068|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
154112383|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154112384|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154112385|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
154112386|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112387|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112388|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154112395|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154112396|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154112397|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154112398|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112399|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112400|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
154112401|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154112402|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
154112403|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112404|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112405|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154112406|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
154112407|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154112408|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154112409|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154112410|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
154112411|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112412|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112413|NCT00377455|Bosentan|bosentan|mesh-list
154112414|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154112415|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154112416|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112417|NCT00895557|Varenicline|varenicline|mesh-list
154112418|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154112419|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154112420|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
154112421|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112422|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112423|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112435|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154112436|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112437|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154112438|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112439|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784069|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784070|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153784071|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153784072|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153784073|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
153784074|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784075|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153784076|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153784077|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784078|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
153370601|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112440|NCT04008784|Triamcinolone|triamcinolone|mesh-list
154112441|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154112442|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153784079|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153784080|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
154112443|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154112444|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154112445|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
154112446|NCT04008784|Hormones|hormones|mesh-ancestor
154112447|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112448|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435815|NCT00002581|Tamoxifen|tamoxifen|mesh-list
154112449|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112450|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
154112451|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112489|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112490|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154112491|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
154112492|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112493|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112495|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154112496|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154112497|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
154112498|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
154112499|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112500|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112501|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112502|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154112503|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
154112504|NCT03472365|Capecitabine|capecitabine|mesh-list
154112505|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
154112507|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154112535|NCT05178628|Paclitaxel|paclitaxel|mesh-list
154112543|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112544|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154112545|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
154112546|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
154112547|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154112548|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154112549|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154112550|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154112551|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154112552|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154112553|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
154112554|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154112555|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112556|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154112557|NCT00896571|Estrogens|estrogens|mesh-ancestor
154112558|NCT00896571|Hormones|hormones|mesh-ancestor
154112559|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784081|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784084|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153784086|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784087|NCT00237614|Protective Agents|protective agents|mesh-ancestor
153784088|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784089|NCT00237614|Antidotes|antidotes|mesh-ancestor
153784090|NCT00269841|Infliximab|infliximab|mesh-list
153784091|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153784092|NCT00269841|Antibodies|antibodies|mesh-list
153784093|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
153784094|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154112560|NCT00896727|Antibodies|antibodies|mesh-list
154112561|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
154112562|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112563|NCT00981838|Rituximab|rituximab|mesh-list
154112564|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154112565|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112566|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
154112567|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112568|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154112569|NCT02533765|Olaparib|olaparib|mesh-list
154112570|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154112571|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112572|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112573|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112574|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154112583|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
154112584|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112585|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112586|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
154112587|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112588|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154112589|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112590|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
154112591|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154112592|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154112593|NCT00367237|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154112594|NCT00367237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154112595|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154112596|NCT00901407|Lamotrigine|lamotrigine|mesh-list
154112597|NCT00901407|Paroxetine|paroxetine|mesh-list
154112598|NCT00901407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154112599|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154112640|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112641|NCT02539641|Hormones|hormones|mesh-list
154112642|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112643|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112644|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154112645|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154112646|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154112647|NCT00544882|Desogestrel|desogestrel|mesh-list
154112648|NCT00544882|Oviol|oviol|mesh-list
154112649|NCT00544882|Estradiol|estradiol|mesh-list
154112650|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153784095|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
153784096|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784097|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784098|NCT00269841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153784099|NCT00269841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784100|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
153784101|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153784102|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784103|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
154112651|NCT00544882|Estrogens|estrogens|mesh-ancestor
154112652|NCT00544882|Hormones|hormones|mesh-ancestor
154112653|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112654|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112655|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154112656|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
154112657|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154112658|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154112659|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154112660|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154112661|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154112662|NCT00544882|Progestins|progestins|mesh-ancestor
154112663|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154112664|NCT04035603|Cycloserine|cycloserine|mesh-list
154112665|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154112666|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112667|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154112668|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
154112669|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154112670|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
154112683|NCT00972790|Bupivacaine|bupivacaine|mesh-list
154112684|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
154112685|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
154112686|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112687|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112690|NCT00901875|Buprenorphine|buprenorphine|mesh-list
154112753|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
154112754|NCT00359281|Vitamins|vitamins|mesh-ancestor
154112755|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
154112756|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112757|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
154112758|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
154112759|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154112760|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154112761|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154112762|NCT00359281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154112763|NCT00359281|Narcotics|narcotics|mesh-ancestor
154112764|NCT00359281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112765|NCT00359281|Analgesics|analgesics|mesh-ancestor
154112766|NCT00359281|Sensory System Agents|sensory system agents|mesh-ancestor
154112767|NCT00359281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112768|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154112769|NCT00902031|Sennosides|sennosides|mesh-list
154112770|NCT00902031|Senna Extract|senna extract|mesh-list
154112771|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
154112772|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154112773|NCT00902031|Laxatives|laxatives|mesh-ancestor
154112774|NCT00902031|Cathartics|cathartics|mesh-ancestor
154112775|NCT00985348|Levetiracetam|levetiracetam|mesh-list
154112776|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
154112777|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
154112778|NCT00973336|Vitamin D|vitamin d|mesh-list
154112779|NCT00973336|Calcium|calcium|mesh-list
154112780|NCT00973336|Vitamins|vitamins|mesh-ancestor
154112781|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
154112782|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112783|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154112784|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154112785|NCT00902187|Fesoterodine|fesoterodine|mesh-list
154112786|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154112798|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
154112799|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
154112800|NCT01052311|Vitamins|vitamins|mesh-ancestor
153784146|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784147|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153784148|NCT00237653|Valganciclovir|valganciclovir|mesh-list
153784149|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
153784150|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112801|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
154112802|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112803|NCT00988078|Metformin|metformin|mesh-list
154112804|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154112805|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112806|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
154112807|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
154112808|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154112809|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154112810|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112811|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154112812|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154112813|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112814|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112815|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112816|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154112817|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
154112854|NCT00982618|Anesthetics|anesthetics|mesh-list
154112855|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154112856|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112857|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
154112858|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112859|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154112860|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154112861|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154112862|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154112863|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112864|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154112865|NCT00982618|Narcotics|narcotics|mesh-ancestor
154112866|NCT00982618|Analgesics|analgesics|mesh-ancestor
154112867|NCT00895167|Curcumin|curcumin|mesh-list
154112868|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154112869|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154112871|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
154112872|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112873|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112874|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154112875|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154112876|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112877|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112878|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112879|NCT00902421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154112880|NCT00902421|Serotonin|serotonin|mesh-list
153371388|NCT04425239|Vitamins|vitamins|mesh-ancestor
154112881|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
154112882|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154112883|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153436272|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
154112895|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112896|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154112897|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112898|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
154112900|NCT00350545|Prednisone|prednisone|mesh-list
154112901|NCT00350545|Rituximab|rituximab|mesh-list
154112902|NCT00350545|Tacrolimus|tacrolimus|mesh-list
154112903|NCT00350545|Cyclosporins|cyclosporins|mesh-list
154112904|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154112905|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154112906|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
154112907|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112908|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154112909|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154112910|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
154112911|NCT00350545|Hormones|hormones|mesh-ancestor
154112912|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154112913|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154112914|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154112915|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154112916|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112917|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112918|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
153784167|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784168|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
153784169|NCT00269997|Hematinics|hematinics|mesh-ancestor
154112919|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154112920|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
154112921|NCT04006054|Midazolam|midazolam|mesh-list
154112940|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153784170|NCT00237731|Morphine|morphine|mesh-list
153784171|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153784178|NCT04542226|Bromides|bromides|mesh-list
153784195|NCT00237887|Adalimumab|adalimumab|mesh-list
154112941|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
154112943|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
154112944|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
154112945|NCT00897975|Red yeast rice|red yeast rice|mesh-list
154112946|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154112947|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154112948|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154112949|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
154112950|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154112951|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154112952|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154112953|NCT01052389|Haloperidol|haloperidol|mesh-list
154112954|NCT01052389|Olanzapine|olanzapine|mesh-list
154112955|NCT01052389|Aripiprazole|aripiprazole|mesh-list
154112956|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
154112957|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
154112958|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
154112959|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154112960|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154112961|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154112962|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154112963|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154112994|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
154112995|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
154112996|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154112997|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154112998|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154112999|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
154113000|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113001|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113002|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154113003|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
154113004|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154113005|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
154113006|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
154113007|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154113008|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
154113009|NCT00902655|Coagulants|coagulants|mesh-ancestor
154113010|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154113011|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
154113012|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113013|NCT01052623|Clonidine|clonidine|mesh-list
154113014|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154113015|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154113016|NCT01052623|Estradiol|estradiol|mesh-list
154113017|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154113018|NCT01052623|Hormones|hormones|mesh-ancestor
154113019|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113020|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113038|NCT00902811|Artesunate|artesunate|mesh-list
154113042|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154113043|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113044|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113045|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
154113046|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
154113047|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154113048|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
153784272|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784273|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
153784274|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153784275|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113049|NCT00898287|Gemcitabine|gemcitabine|mesh-list
154113050|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154113051|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
154113052|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113053|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113054|NCT04034823|Docetaxel|docetaxel|mesh-list
154113055|NCT04034823|Trastuzumab|trastuzumab|mesh-list
154113056|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113057|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
154113058|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
154113059|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
154113060|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113061|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113062|NCT00606021|Pemetrexed|pemetrexed|mesh-list
154113063|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113064|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113065|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113066|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154113067|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154113068|NCT00337675|Montelukast|montelukast|mesh-list
154113069|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154113070|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
154113071|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154113072|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
154113084|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154113085|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113086|NCT00903045|Propiverine|propiverine|mesh-list
154113087|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
154113088|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
154113089|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113090|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113091|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154113092|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154113093|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
154113094|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113095|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113096|NCT00903045|Urological Agents|urological agents|mesh-ancestor
154113097|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154113098|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154113099|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113100|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154113101|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154113102|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154113103|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113104|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
154113105|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113106|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
154113107|NCT04035525|Ubiquinone|ubiquinone|mesh-list
154113108|NCT04035525|Vitamins|vitamins|mesh-ancestor
154113109|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
154113110|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113111|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154113112|NCT00905853|Amiodarone|amiodarone|mesh-list
154113113|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
154113114|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154113115|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154113117|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154113122|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154113123|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154113124|NCT00905931|Lycopene|lycopene|mesh-list
154113125|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154113126|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
154113127|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113128|NCT00905931|Protective Agents|protective agents|mesh-ancestor
154113129|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113130|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154113131|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154113132|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113133|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
154113134|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154113135|NCT04035135|Antibodies|antibodies|mesh-list
154113136|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
154113137|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154113138|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
154113139|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113140|NCT00903279|Retapamulin|retapamulin|mesh-list
154113141|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113142|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113143|NCT02539017|Immunomodulating Agents|immunomodulating agents|mesh-list
154113144|NCT02539017|Immunologic Factors|immunologic factors|mesh-ancestor
154113145|NCT02539017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113171|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113172|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113173|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113174|NCT00903747|Laxatives|laxatives|mesh-ancestor
154113175|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154113176|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154113177|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154113178|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
154113179|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113180|NCT02538627|Trametinib|trametinib|mesh-list
154113181|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113182|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154113183|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113184|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784423|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154113185|NCT00903825|Lidocaine|lidocaine|mesh-list
154113186|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
154113187|NCT00903825|Anesthetics|anesthetics|mesh-list
154113228|NCT00904293|Warfarin|warfarin|mesh-list
154113229|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
154113230|NCT00904449|Oxymorphone|oxymorphone|mesh-list
154113231|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154113232|NCT00904449|Narcotics|narcotics|mesh-ancestor
154113233|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113234|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113235|NCT00904449|Analgesics|analgesics|mesh-ancestor
154113236|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
154113237|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113238|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154113239|NCT00348595|Lenalidomide|lenalidomide|mesh-list
154113240|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
154113241|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113242|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154113243|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154113244|NCT00348595|Growth Substances|growth substances|mesh-ancestor
154113245|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
154113246|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113247|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
154113248|NCT02538939|Antidotes|antidotes|mesh-ancestor
154113249|NCT02538939|Protective Agents|protective agents|mesh-ancestor
154113250|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113251|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
154113252|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113253|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
154113254|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113255|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113256|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
154113257|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
154113258|NCT00904605|Celecoxib|celecoxib|mesh-list
154113273|NCT00905073|Cyclosporins|cyclosporins|mesh-list
154113274|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154113275|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
154113276|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154113277|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784589|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113278|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154113279|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
153784590|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784591|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153784592|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
153784593|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
154113280|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113281|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113282|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
154113283|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113284|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154113285|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113286|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
154113287|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154113288|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154113289|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
154113290|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113291|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154113292|NCT00905229|Vitamins|vitamins|mesh-list
154113293|NCT00905229|Vitamin K|vitamin k|mesh-list
154113294|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
154113310|NCT00348283|Adalimumab|adalimumab|mesh-list
154113327|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113328|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154113329|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154113330|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154113331|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113332|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113333|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154113334|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
154113335|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
154113336|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113337|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113338|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
154113339|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113340|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729674|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113342|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
154113343|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113344|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154113345|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
154113346|NCT00336583|Hormones|hormones|mesh-ancestor
154113347|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784657|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
154113348|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154113349|NCT00336583|Protective Agents|protective agents|mesh-ancestor
154113350|NCT00336505|Clarithromycin|clarithromycin|mesh-list
154113351|NCT00336505|Cethromycin|cethromycin|mesh-list
154113374|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154113375|NCT00335959|Capecitabine|capecitabine|mesh-list
154113376|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
154113377|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154113378|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
154113379|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113380|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113382|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
154113383|NCT01053169|Coagulants|coagulants|mesh-ancestor
154113384|NCT01059331|Pregabalin|pregabalin|mesh-list
154113385|NCT01059331|Analgesics|analgesics|mesh-ancestor
154113386|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
154113387|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113388|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113389|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
154113390|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154113391|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154113392|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113393|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154113394|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154113395|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154113396|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113397|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154113398|NCT01059955|Dexamethasone|dexamethasone|mesh-list
154113399|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
154113400|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154113401|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154113402|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154113403|NCT01059955|BB 1101|bb 1101|mesh-list
154113404|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154113405|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
154113406|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
154113407|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113408|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113416|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113417|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113418|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
154113419|NCT01060189|Urinastatin|urinastatin|mesh-list
154113420|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154113421|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154113422|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113423|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
154113424|NCT01060189|Coagulants|coagulants|mesh-ancestor
154113425|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154113426|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154113427|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
154113428|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113429|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154113430|NCT01060267|Erythromycin|erythromycin|mesh-list
154113431|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
154113432|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154113433|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
154113434|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113435|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154113436|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154113437|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113438|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113439|NCT01060423|Irinotecan|irinotecan|mesh-list
154113440|NCT01060423|Cetuximab|cetuximab|mesh-list
154113441|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154113442|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154113467|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154113468|NCT00671658|Prednisolone|prednisolone|mesh-list
154113469|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
154113470|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
154113471|NCT00671658|Rituximab|rituximab|mesh-list
154113472|NCT00671658|Doxorubicin|doxorubicin|mesh-list
154113473|NCT00671658|Methotrexate|methotrexate|mesh-list
154113474|NCT00671658|Vincristine|vincristine|mesh-list
154113475|NCT00671658|Asparaginase|asparaginase|mesh-list
154113476|NCT00671658|Pegaspargase|pegaspargase|mesh-list
154113477|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154113478|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
154113479|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113480|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
154113481|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113482|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154113483|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154113484|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
154113485|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113486|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113487|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154113489|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
154113522|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
154113523|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
154113524|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113525|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113526|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
154113527|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113528|NCT00768612|Risperidone|risperidone|mesh-list
154113529|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154113530|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
154113531|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113532|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113533|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113534|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154113535|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154113536|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113537|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154113538|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154113539|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
154113540|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
154113541|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113575|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113576|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
154113577|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
154113578|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113579|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
154113580|NCT00906867|Miotics|miotics|mesh-ancestor
154113581|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
154113582|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113583|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113584|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153784791|NCT05853120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113585|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
154113586|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
154113587|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154113588|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154113589|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
154113590|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113591|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113592|NCT00768690|Ketoconazole|ketoconazole|mesh-list
154113593|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
154113594|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113595|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154113596|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154113597|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113598|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113599|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154113600|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
154113601|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113602|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113603|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154113604|NCT00768768|Terbinafine|terbinafine|mesh-list
154113605|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
154113606|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113607|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113609|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154113613|NCT00775086|Estrogens|estrogens|mesh-ancestor
154113614|NCT00775086|Hormones|hormones|mesh-ancestor
154113615|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113616|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113617|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154113618|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154113619|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154113620|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154113621|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154113622|NCT02557854|Doxorubicin|doxorubicin|mesh-list
154113623|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154113624|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154113625|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113626|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154113627|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154113628|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113629|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113630|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
154113631|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
154113632|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
154113633|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113634|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113637|NCT00986050|Sirolimus|sirolimus|mesh-list
154113664|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154113665|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
154113666|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
154113667|NCT00771342|Protective Agents|protective agents|mesh-ancestor
154113668|NCT00775164|Metformin|metformin|mesh-list
154113669|NCT00775164|Pioglitazone|pioglitazone|mesh-list
154113670|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154113671|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113672|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
154113673|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154113674|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154113675|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
154113676|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113677|NCT04767256|Dexamethasone|dexamethasone|mesh-list
154113678|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
154113679|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154113680|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
154113681|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
154113682|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113683|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113684|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154113718|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113719|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154113720|NCT00988780|Efavirenz|efavirenz|mesh-list
154113721|NCT00988780|Maraviroc|maraviroc|mesh-list
154113722|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154113723|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153784889|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154113724|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113725|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113726|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
154113727|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113728|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154113729|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154113730|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154113731|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154113732|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154113733|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154113734|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154113735|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154113736|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154113737|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154113738|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154113739|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154113740|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154113741|NCT00775242|Estradiol|estradiol|mesh-list
154113742|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154113743|NCT00775242|Estrogens|estrogens|mesh-list
154113744|NCT00775242|Progesterone|progesterone|mesh-list
154113745|NCT00775242|Progestins|progestins|mesh-list
154113746|NCT00775242|Hormones|hormones|mesh-ancestor
154113747|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113748|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113749|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154113756|NCT00769158|Topiramate|topiramate|mesh-list
154113757|NCT00769158|Naltrexone|naltrexone|mesh-list
154113758|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154113759|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154113760|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113761|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
154113762|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154113763|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
154113764|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154113765|NCT00983164|Antioxidants|antioxidants|mesh-list
154113766|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113767|NCT00983164|Protective Agents|protective agents|mesh-ancestor
154113768|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113769|NCT00333775|Bevacizumab|bevacizumab|mesh-list
154113770|NCT00333775|Docetaxel|docetaxel|mesh-list
154113771|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113772|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113773|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154113774|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154113775|NCT00333775|Growth Substances|growth substances|mesh-ancestor
154113776|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113777|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
154113778|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
154113779|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
153785006|NCT03939182|Ibrutinib|ibrutinib|mesh-list
154113780|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
154113781|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113782|NCT03860428|Acetaminophen|acetaminophen|mesh-list
154113783|NCT03860428|Ibuprofen|ibuprofen|mesh-list
154113784|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
154113785|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154113786|NCT03860428|Analgesics|analgesics|mesh-ancestor
154113787|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
153729676|NCT00130871|Simendan|simendan|mesh-list
153494241|NCT03042780|Folfirinox|folfirinox|mesh-list
154113799|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154113800|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113801|NCT00986596|Vitamin D|vitamin d|mesh-list
154113802|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
154113803|NCT00986596|Vitamins|vitamins|mesh-ancestor
154113804|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
154113805|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113806|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154113807|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154113808|NCT00769470|Carboplatin|carboplatin|mesh-list
154113809|NCT00769470|Docetaxel|docetaxel|mesh-list
154113810|NCT00769470|Trastuzumab|trastuzumab|mesh-list
154113811|NCT00769470|Lapatinib|lapatinib|mesh-list
154113812|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113813|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
154113814|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
154113815|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
154113816|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113817|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113818|NCT00769470|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154113819|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154113820|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113821|NCT00605319|Fesoterodine|fesoterodine|mesh-list
154113822|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154113823|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154113824|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
154113825|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154113826|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113827|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113828|NCT00605319|Urological Agents|urological agents|mesh-ancestor
154113829|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154113831|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154113832|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154113833|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154113843|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
154113845|NCT00983398|Antidotes|antidotes|mesh-list
154113846|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113847|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154113848|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
154113849|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785120|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154113850|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154113851|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113852|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
154113853|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113854|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154113855|NCT00983398|Diuretics|diuretics|mesh-ancestor
154113856|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
154113857|NCT00983398|Protective Agents|protective agents|mesh-ancestor
154113858|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
154113859|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
154113860|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154113861|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113862|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
154113863|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
154113864|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
154113865|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154113866|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113868|NCT00769548|Flutamide|flutamide|mesh-list
154113869|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154113870|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113871|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
154113872|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
154113873|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154113874|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113875|NCT05277675|Bevacizumab|bevacizumab|mesh-list
154113886|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113887|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113888|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
154113889|NCT03984409|Diuretics|diuretics|mesh-ancestor
154113890|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
154113891|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113892|NCT03984409|Expectorants|expectorants|mesh-ancestor
154113893|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
154113894|NCT00983554|Anastrozole|anastrozole|mesh-list
154113895|NCT00983554|Testosterone|testosterone|mesh-list
154113896|NCT00983554|Dutasteride|dutasteride|mesh-list
154113897|NCT00983554|Androgens|androgens|mesh-ancestor
154113898|NCT00983554|Hormones|hormones|mesh-ancestor
154113899|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785192|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154113900|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113901|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154113902|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113903|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154113904|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154113905|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154113906|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113907|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
154113908|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154113909|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154113910|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
154113911|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154113912|NCT00908817|Triamcinolone|triamcinolone|mesh-list
154113913|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154113914|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154113915|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154113916|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154113917|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154113929|NCT00332839|Cyclosporine|cyclosporine|mesh-list
154113930|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
154113931|NCT00332839|Everolimus|everolimus|mesh-list
154113932|NCT00332839|Tacrolimus|tacrolimus|mesh-list
154113933|NCT00332839|Cyclosporins|cyclosporins|mesh-list
154113934|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154113935|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
154113936|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154113937|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154113938|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494389|NCT02133534|Atorvastatin|atorvastatin|mesh-list
154113939|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154113940|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
154113942|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
154113943|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154113993|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154113994|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154113995|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154113996|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153785251|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154113997|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154113998|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785252|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
154113999|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114000|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
153785253|NCT00915837|Triamcinolone|triamcinolone|mesh-list
154114001|NCT00983944|Hormones|hormones|mesh-ancestor
154114002|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114003|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154114004|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114005|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114006|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114007|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114008|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154114009|NCT00927537|Telmisartan|telmisartan|mesh-list
154114010|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154114011|NCT00927537|Diuretics|diuretics|mesh-ancestor
154114012|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
154114013|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114014|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154114015|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785311|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154114016|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114017|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154114020|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
154114040|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154114041|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114042|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154114043|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154114044|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154114045|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
154114046|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114047|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154114048|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
154114049|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114050|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114051|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154114052|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154114053|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154114054|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
154114055|NCT00927615|Abciximab|abciximab|mesh-list
154114056|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
154114057|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154114058|NCT03990103|Paclitaxel|paclitaxel|mesh-list
154114059|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154114060|NCT03990103|Bevacizumab|bevacizumab|mesh-list
154114061|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
154114093|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114094|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114095|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114096|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
154114097|NCT01581151|Hormones|hormones|mesh-ancestor
154114098|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114099|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154114100|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114101|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154114102|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154114103|NCT01581151|Growth Substances|growth substances|mesh-ancestor
154114104|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
154114105|NCT01053481|Vitamin D|vitamin d|mesh-list
154114106|NCT01053481|Vitamins|vitamins|mesh-ancestor
154114107|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
154114108|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114109|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154114110|NCT00927771|Azelaic acid|azelaic acid|mesh-list
154114111|NCT00927771|Hydroquinone|hydroquinone|mesh-list
154114112|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114113|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
154114114|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
154114115|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114116|NCT00927771|Protective Agents|protective agents|mesh-ancestor
154114117|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114118|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154114119|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
154114120|NCT01053559|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154114121|NCT01053559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114122|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114123|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
154114137|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154114138|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
154114139|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
154114140|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154114141|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114142|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114144|NCT00928161|Lansoprazole|lansoprazole|mesh-list
154114145|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154114146|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114147|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154114148|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114149|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114150|NCT00909519|Naproxen|naproxen|mesh-list
154114151|NCT00909519|Furosemide|furosemide|mesh-list
154114152|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
154114153|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154114154|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154114155|NCT00909519|Analgesics|analgesics|mesh-ancestor
154114156|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
154114157|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114158|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114159|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114160|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114161|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
154114162|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154114163|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114164|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114165|NCT00909519|Diuretics|diuretics|mesh-ancestor
154114181|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114182|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114183|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153785561|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785562|NCT01642030|Buprenorphine|buprenorphine|mesh-list
154114184|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154114185|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154114186|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
154114187|NCT00544648|Paclitaxel|paclitaxel|mesh-list
154114188|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154114189|NCT00544648|Carboplatin|carboplatin|mesh-list
154114190|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114191|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114192|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114193|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114194|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114195|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114196|NCT01053871|Midazolam|midazolam|mesh-list
154114197|NCT01053871|Fentanyl|fentanyl|mesh-list
154114198|NCT01053871|Propofol|propofol|mesh-list
154114199|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154114200|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154114201|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114202|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154114203|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
154114234|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
154114235|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114236|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114237|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154114238|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
154114239|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
154114240|NCT00987454|Hematinics|hematinics|mesh-ancestor
154114241|NCT04005664|Phenylephrine|phenylephrine|mesh-list
154114242|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
154114244|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
154114245|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
154114246|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114247|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114248|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
154114249|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154114250|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
154114251|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
154114252|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154114253|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154114254|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154114255|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
154114256|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114257|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114258|NCT04005664|Protective Agents|protective agents|mesh-ancestor
154114259|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154114260|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154114261|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154114262|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154114263|NCT00924573|Metformin|metformin|mesh-list
154114264|NCT00924573|Glimepiride|glimepiride|mesh-list
154114281|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
154114282|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154114283|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154114284|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154114285|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
154114286|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372618|NCT01267136|Tramadol|tramadol|mesh-list
154114287|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114289|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
154114290|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154114291|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154114292|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
154114293|NCT01054105|Iloprost|iloprost|mesh-list
154114294|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154114295|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
154114296|NCT00330343|Naloxone|naloxone|mesh-list
154114297|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154114298|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114299|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
154114300|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114301|NCT00987766|Gemcitabine|gemcitabine|mesh-list
154114302|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
154114303|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154114304|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154114305|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
153922963|NCT04093323|Celecoxib|celecoxib|mesh-list
154114306|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114307|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114308|NCT00987766|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154114309|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154114310|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114311|NCT00330187|Bupropion|bupropion|mesh-list
154114312|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154114313|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
154114314|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154114315|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154114320|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114321|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114322|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154114323|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154114324|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114326|NCT00987844|Laxatives|laxatives|mesh-ancestor
154114327|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114328|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154114329|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154114330|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
154114331|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114332|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114333|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114334|NCT03986905|Scopolamine|scopolamine|mesh-list
154114335|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154114336|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154114337|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
154114338|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
154114339|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114340|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114341|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114342|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
154114343|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154114344|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
154114345|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114346|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114347|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154114348|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
154114349|NCT00329797|Vitamin D|vitamin d|mesh-list
154114350|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
154114351|NCT00329797|Calcium|calcium|mesh-list
154114352|NCT00329797|Vitamins|vitamins|mesh-ancestor
154114363|NCT00541450|Hormones|hormones|mesh-ancestor
154114364|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114365|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154114366|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
154114367|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114368|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114369|NCT01056679|Doxorubicin|doxorubicin|mesh-list
154114370|NCT01056679|Lenalidomide|lenalidomide|mesh-list
154114371|NCT01056679|Vinblastine|vinblastine|mesh-list
154114372|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154114373|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114374|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154114375|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154114376|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114377|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114378|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
154114379|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114380|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154114381|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154114382|NCT01056679|Growth Substances|growth substances|mesh-ancestor
154114383|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
154114384|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114385|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114386|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114387|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114388|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154114389|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
154114408|NCT00540046|Copper|copper|mesh-list
154114409|NCT00540046|Trace Elements|trace elements|mesh-ancestor
154114410|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
154114411|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114412|NCT04613830|Tramadol|tramadol|mesh-list
154114413|NCT04613830|Bupivacaine|bupivacaine|mesh-list
154114414|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
154114415|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
154114416|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154114417|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114418|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
154114419|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114420|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154114421|NCT04613830|Narcotics|narcotics|mesh-ancestor
154114422|NCT04613830|Analgesics|analgesics|mesh-ancestor
154114423|NCT00689936|Thalidomide|thalidomide|mesh-list
154114424|NCT00689936|Dexamethasone|dexamethasone|mesh-list
154114425|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
154114426|NCT00689936|Prednisone|prednisone|mesh-list
154114427|NCT00689936|Lenalidomide|lenalidomide|mesh-list
154114428|NCT00689936|Melphalan|melphalan|mesh-list
154114429|NCT00689936|BB 1101|bb 1101|mesh-list
154114430|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114431|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
154114432|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
154114433|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114434|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114435|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114436|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
154114437|NCT00689936|Hormones|hormones|mesh-ancestor
154114438|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114439|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154114455|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114456|NCT01563718|Naltrexone|naltrexone|mesh-list
154114457|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154114458|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154114459|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114460|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
154114461|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114462|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
154114463|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154114464|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114465|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154114466|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154114467|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
154114468|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114469|NCT00671034|Cytarabine|cytarabine|mesh-list
154114470|NCT00671034|Dexamethasone|dexamethasone|mesh-list
154114471|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
154114472|NCT00671034|Prednisone|prednisone|mesh-list
154114473|NCT00671034|Cortisone|cortisone|mesh-list
154114474|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
154114475|NCT00671034|Doxorubicin|doxorubicin|mesh-list
154114476|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154114477|NCT00671034|Methotrexate|methotrexate|mesh-list
154114478|NCT00671034|Vincristine|vincristine|mesh-list
154114479|NCT00671034|Daunorubicin|daunorubicin|mesh-list
154114480|NCT00671034|Asparaginase|asparaginase|mesh-list
154114509|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154114510|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
153786091|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
153786094|NCT00240656|Carvedilol|carvedilol|mesh-list
154114511|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154114512|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154114513|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
154114514|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
154114515|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154114516|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154114517|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
154114518|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114519|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114520|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
154114521|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
154114522|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
154114523|NCT04425070|Carboplatin|carboplatin|mesh-list
154114524|NCT04425070|Gemcitabine|gemcitabine|mesh-list
154114525|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
154114526|NCT04425070|Etoposide|etoposide|mesh-list
154114527|NCT04425070|Ifosfamide|ifosfamide|mesh-list
154114528|NCT04425070|Tislelizumab|tislelizumab|mesh-list
154114529|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114530|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154114531|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
154114532|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114533|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114534|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154114558|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154114559|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
154114560|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114561|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114562|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
154114563|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114564|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154114565|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114566|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
154114567|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114568|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154114569|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
154114570|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114571|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154114572|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154114573|NCT04047654|Anticoagulants|anticoagulants|mesh-list
154114574|NCT00772356|Insulin|insulin|mesh-list
154114575|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154114617|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114618|NCT04050436|Cemiplimab|cemiplimab|mesh-list
154114619|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154114620|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114621|NCT01093976|Dronabinol|dronabinol|mesh-list
154114622|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
154114623|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114624|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154114625|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154114626|NCT01093976|Analgesics|analgesics|mesh-ancestor
154114627|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
154114628|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114629|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154114630|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154114631|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114632|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114633|NCT01093976|Hormones|hormones|mesh-ancestor
154114634|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114635|NCT00329719|Sirolimus|sirolimus|mesh-list
154114636|NCT00329719|Sorafenib|sorafenib|mesh-list
154114637|NCT00329719|Temsirolimus|temsirolimus|mesh-list
154114638|NCT00329719|MTOR Inhibitors|mtor inhibitors|mesh-list
154114639|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114640|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154114641|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114642|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114643|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154114644|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114645|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154114650|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
154114662|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154114663|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154114664|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114665|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154114666|NCT00743834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154114667|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154114668|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154114669|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114670|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114671|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
154114672|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154114673|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
154114674|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154114675|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154114676|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114677|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154114678|NCT00743912|Rifaximin|rifaximin|mesh-list
154114718|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114720|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
154114721|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114722|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
154114723|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114724|NCT01056835|Epoprostenol|epoprostenol|mesh-list
154114725|NCT01056835|Tezosentan|tezosentan|mesh-list
153786278|NCT01688947|Pregabalin|pregabalin|mesh-list
154114726|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154114727|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154114728|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
154114729|NCT03986515|Apatinib|apatinib|mesh-list
154114730|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114731|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154114732|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114733|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114734|NCT00567489|Icodextrin|icodextrin|mesh-list
154114735|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
154114736|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154114737|NCT02538393|Sorafenib|sorafenib|mesh-list
154114738|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114739|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154114740|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114741|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114754|NCT00669864|Metformin|metformin|mesh-list
154114769|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154114770|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154114771|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154114772|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
154114773|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
154114774|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114775|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114776|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114777|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154114778|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154114779|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154114780|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114781|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114782|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
154114783|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114784|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154114785|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154114823|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
154114825|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114826|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114827|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114829|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154114830|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
154114831|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114832|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114833|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154114834|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154114835|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
154114836|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114837|NCT00667992|Budesonide|budesonide|mesh-list
154114838|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114839|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154114840|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
154114881|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114882|NCT00776802|Dexamethasone|dexamethasone|mesh-list
154114883|NCT00776802|Etoposide|etoposide|mesh-list
153786326|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154114884|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114885|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
154114886|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
154114887|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114888|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114889|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154114891|NCT00776802|Hormones|hormones|mesh-ancestor
154114892|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114893|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154114894|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114895|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154114896|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154114897|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154114898|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114899|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114900|NCT00773916|Methylphenidate|methylphenidate|mesh-list
154114901|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154114902|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114903|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154114904|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154114905|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154114906|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114907|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
154114908|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154114909|NCT00774072|Tobramycin|tobramycin|mesh-list
154114910|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154114911|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154114912|NCT00780780|Triamcinolone|triamcinolone|mesh-list
154114915|NCT00780780|Nepafenac|nepafenac|mesh-list
154114922|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154114923|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
154114924|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114925|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114926|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154114928|NCT00780780|Analgesics|analgesics|mesh-ancestor
154114929|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
154114930|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114931|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114932|NCT00780858|Ganirelix|ganirelix|mesh-list
154114933|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
154114934|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154114935|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114936|NCT00777114|Bortezomib|bortezomib|mesh-list
154114937|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114938|NCT00669396|Copper|copper|mesh-list
154114939|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
154114940|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154114941|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
154114942|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154114943|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114944|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154114945|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154114946|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154114947|NCT00669396|Trace Elements|trace elements|mesh-ancestor
154114948|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
154114949|NCT00774462|Rituximab|rituximab|mesh-list
154114950|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154114951|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114952|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
154114953|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114954|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114955|NCT00669318|Rituximab|rituximab|mesh-list
154114956|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
154114957|NCT00669318|Pentostatin|pentostatin|mesh-list
154114958|NCT00669318|Sargramostim|sargramostim|mesh-list
154114959|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153654605|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654606|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153786490|NCT02219737|Rituximab|rituximab|mesh-list
154114960|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154114961|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
154114962|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114963|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114964|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154114965|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114966|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114967|NCT00774540|Ketorolac|ketorolac|mesh-list
154114968|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154114969|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154114970|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154114971|NCT00774540|Analgesics|analgesics|mesh-ancestor
154114972|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
154114973|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154114974|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154114975|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154114976|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154114977|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154114978|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154114979|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154114980|NCT00669240|Varenicline|varenicline|mesh-list
154114981|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154114982|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154114983|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
154115009|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115010|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154115011|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154115012|NCT02556060|Lamotrigine|lamotrigine|mesh-list
154115013|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
154115014|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154115015|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115016|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115017|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154115018|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115019|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154115020|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154115021|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115022|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154115023|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154115024|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
154115025|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154115026|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
154115027|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115028|NCT00354770|Expectorants|expectorants|mesh-ancestor
154115029|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
154115030|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154115031|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
154115061|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
154115062|NCT00744302|Calcium|calcium|mesh-list
154115063|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154115064|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115065|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154115066|NCT00666588|Cytarabine|cytarabine|mesh-list
154115067|NCT00666588|Etoposide|etoposide|mesh-list
154115068|NCT00666588|Idarubicin|idarubicin|mesh-list
154115069|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
154115070|NCT00666588|Bortezomib|bortezomib|mesh-list
154115071|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154115072|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115073|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154115074|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154115075|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115076|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115077|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154115079|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
153786608|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154115080|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115081|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154115082|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
154115083|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115084|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154115085|NCT00689390|Ribavirin|ribavirin|mesh-list
154115086|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154115087|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
154115088|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115089|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
154115090|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115091|NCT00567879|Trastuzumab|trastuzumab|mesh-list
154115092|NCT00567879|Panobinostat|panobinostat|mesh-list
154115106|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
154115107|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
154115108|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115109|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115110|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154115111|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115112|NCT00777504|Growth Substances|growth substances|mesh-ancestor
154115113|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115114|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115115|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115116|NCT00781482|Zolpidem|zolpidem|mesh-list
154115117|NCT00781482|Eszopiclone|eszopiclone|mesh-list
154115118|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154115119|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154115120|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115121|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115122|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154115123|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
154115124|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
154115125|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115126|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115127|NCT00603915|Carboplatin|carboplatin|mesh-list
154115128|NCT00603915|Gemcitabine|gemcitabine|mesh-list
154115156|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115157|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
154115158|NCT04034199|Denosumab|denosumab|mesh-list
154115159|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154115160|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115161|NCT02538237|Ibuprofen|ibuprofen|mesh-list
154115162|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154115163|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154115164|NCT02538237|Analgesics|analgesics|mesh-ancestor
154115165|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
154115166|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115167|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115168|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115169|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115170|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154115171|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115172|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115173|NCT00691028|Infliximab|infliximab|mesh-list
154115174|NCT00691028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154115175|NCT00691028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115176|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
154115177|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154115207|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154115208|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115209|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
154115210|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154115211|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115212|NCT00784446|Bevacizumab|bevacizumab|mesh-list
154115213|NCT00784446|Capecitabine|capecitabine|mesh-list
154115214|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
154115215|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
154115216|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153786672|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115217|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115218|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115219|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115220|NCT00784446|Growth Substances|growth substances|mesh-ancestor
154115221|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115222|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115223|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154115224|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
154115225|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115226|NCT00784446|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154115227|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154115228|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115229|NCT00744536|Lenalidomide|lenalidomide|mesh-list
154115230|NCT00744536|Melphalan|melphalan|mesh-list
154115231|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
154115232|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115233|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115234|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115235|NCT00744536|Growth Substances|growth substances|mesh-ancestor
154115236|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115237|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115238|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154115239|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
154115247|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115248|NCT00744770|Rilpivirine|rilpivirine|mesh-list
154115249|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154115250|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154115251|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115252|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115253|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
154115254|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115255|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154115256|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154115257|NCT00784680|Tamoxifen|tamoxifen|mesh-list
154115258|NCT00784680|Anastrozole|anastrozole|mesh-list
154115259|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154115260|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
154115261|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115262|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115263|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154115264|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115265|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154115266|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154115267|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154115268|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154115269|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154115270|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115271|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115272|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
154115273|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154115274|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115275|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154115276|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115277|NCT02556840|Insulin|insulin|mesh-list
154115278|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154115279|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115280|NCT00929877|Ketoprofen|ketoprofen|mesh-list
154115281|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154115282|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154115284|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
154115285|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115286|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115287|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115288|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115289|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154115290|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115291|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115292|NCT00741884|Varenicline|varenicline|mesh-list
154115293|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154115294|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154115295|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
154115296|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438707|NCT00005762|Ritonavir|ritonavir|mesh-list
154115297|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115298|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115338|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154115340|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
154115341|NCT00929955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154115342|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154115343|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
154115344|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115345|NCT00784914|Sirolimus|sirolimus|mesh-list
154115346|NCT00784914|Temsirolimus|temsirolimus|mesh-list
154115347|NCT00784914|MTOR Inhibitors|mtor inhibitors|mesh-list
154115348|NCT00784914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154115349|NCT00784914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115350|NCT00784914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115351|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154115352|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
154115353|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115354|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115355|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154115356|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115357|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154115358|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
154115359|NCT00745004|Ondansetron|ondansetron|mesh-list
154115360|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
154115361|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
154115362|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115363|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115390|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
154115391|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115392|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153786934|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
154115393|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115394|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115395|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154115396|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
154115397|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115398|NCT00778050|Amoxicillin|amoxicillin|mesh-list
154115399|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154115400|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115401|NCT00746486|Budesonide|budesonide|mesh-list
154115402|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115403|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154115404|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
154115405|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115446|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115447|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115448|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154115449|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
154115450|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
154115451|NCT00782652|Protective Agents|protective agents|mesh-ancestor
154115452|NCT00785382|Pregabalin|pregabalin|mesh-list
154115453|NCT00785382|Analgesics|analgesics|mesh-ancestor
154115454|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
154115455|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115456|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115457|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
154115458|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154115459|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115460|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115461|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154115462|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154115463|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154115464|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115465|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154115466|NCT00667368|Metronidazole|metronidazole|mesh-list
154115467|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115468|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154115469|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154115470|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154115471|NCT00785460|Benphothiamine|benphothiamine|mesh-list
154115472|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154115473|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
154115474|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115491|NCT00567567|Topotecan|topotecan|mesh-list
154115492|NCT00567567|Tretinoin|tretinoin|mesh-list
154115493|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
154115494|NCT00567567|Isotretinoin|isotretinoin|mesh-list
154115495|NCT00567567|Lenograstim|lenograstim|mesh-list
154115496|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154115497|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
154115498|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115499|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115500|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154115501|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
154115502|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115503|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115504|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154115505|NCT00567567|Vitamins|vitamins|mesh-ancestor
154115506|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
154115507|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154115508|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154115509|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154115510|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115511|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154115512|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154115513|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
154115514|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
154115515|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
154115516|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154115517|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
154115518|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
154115519|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
154115520|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
154115521|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153787183|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
154115522|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154115523|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115534|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154115535|NCT00778674|Benazepril|benazepril|mesh-list
154115536|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154115537|NCT00778674|Diuretics|diuretics|mesh-ancestor
154115538|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
154115539|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115540|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154115541|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115542|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115543|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154115544|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
154115545|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115546|NCT00778752|Lenalidomide|lenalidomide|mesh-list
154115547|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
154115593|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154115594|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154115595|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154115596|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154115597|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
154115598|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153729677|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154115599|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154115600|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154115601|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154115602|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
154115603|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
154115604|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154115605|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154115606|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154115607|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154115608|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
154115609|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154115610|NCT00930033|Sunitinib|sunitinib|mesh-list
154115611|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115612|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115613|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115614|NCT00930033|Growth Substances|growth substances|mesh-ancestor
154115615|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115616|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115639|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787248|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
154115640|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154115641|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154115642|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115644|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154115645|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154115646|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154115647|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154115648|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
154115649|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115650|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115651|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115652|NCT00688688|Urological Agents|urological agents|mesh-ancestor
154115653|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154115654|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154115655|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
154115656|NCT00930189|Triamcinolone|triamcinolone|mesh-list
154115695|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154115696|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115697|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115698|NCT00930345|Sunitinib|sunitinib|mesh-list
154115699|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115700|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115701|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115702|NCT00930345|Growth Substances|growth substances|mesh-ancestor
154115703|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115704|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115705|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154115706|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115707|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115708|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
154115709|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154115710|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115711|NCT00746720|Etoricoxib|etoricoxib|mesh-list
154115712|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154115713|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154115714|NCT00746720|Analgesics|analgesics|mesh-ancestor
154115715|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
154115716|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115717|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115718|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115719|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154115720|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154115721|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154115722|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115723|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115724|NCT00686972|Glucagon|glucagon|mesh-list
154115725|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154115726|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154115727|NCT00686972|Hormones|hormones|mesh-ancestor
154115728|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115729|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115730|NCT00686972|Incretins|incretins|mesh-ancestor
153654607|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154115732|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
154115733|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115734|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115735|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115736|NCT00665652|Growth Substances|growth substances|mesh-ancestor
154115737|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115738|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115739|NCT00752024|Hemostatics|hemostatics|mesh-list
154115740|NCT00752024|Coagulants|coagulants|mesh-ancestor
154115741|NCT00937677|Natalizumab|natalizumab|mesh-list
154115742|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
154115743|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115744|NCT00786240|Fesoterodine|fesoterodine|mesh-list
154115745|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154115746|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154115747|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
154115748|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115749|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115750|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115751|NCT00786240|Urological Agents|urological agents|mesh-ancestor
154115752|NCT04498923|Dexamethasone|dexamethasone|mesh-list
154115753|NCT04498923|Epinephrine|epinephrine|mesh-list
154115754|NCT04498923|Bupivacaine|bupivacaine|mesh-list
154115755|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115756|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
154115757|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
154115758|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115759|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115760|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154115761|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
154115762|NCT04498923|Hormones|hormones|mesh-ancestor
154115764|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154115774|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115775|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153787533|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
154115776|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154115777|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154115778|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
154115779|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
154115780|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
154115781|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154115782|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
154115783|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154115784|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
154115785|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154115786|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
154115787|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115788|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115789|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
154115790|NCT04046874|Analgesics|analgesics|mesh-list
154115791|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
154115792|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115793|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115794|NCT00932217|Lenograstim|lenograstim|mesh-list
154115795|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154115827|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154115828|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
154115829|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115830|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115831|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
154115832|NCT00930891|Bevacizumab|bevacizumab|mesh-list
154115833|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154115834|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115835|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154115836|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154115837|NCT00930891|Growth Substances|growth substances|mesh-ancestor
154115838|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115839|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
154115840|NCT00938379|Insect Repellents|insect repellents|mesh-list
154115841|NCT00938379|Protective Agents|protective agents|mesh-ancestor
154115842|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787656|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115843|NCT00661830|Gemcitabine|gemcitabine|mesh-list
154115844|NCT00661830|Sorafenib|sorafenib|mesh-list
154115845|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154115846|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
154115847|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115848|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115849|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154115850|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115851|NCT00932529|Olanzapine|olanzapine|mesh-list
154115852|NCT00932529|Risperidone|risperidone|mesh-list
154115853|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154115854|NCT00932529|Ziprasidone|ziprasidone|mesh-list
154115855|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154115856|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
154115857|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115871|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154115872|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115873|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
154115874|NCT00783744|Insulin|insulin|mesh-list
154115875|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154115876|NCT00783744|Metformin|metformin|mesh-list
154115877|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
154115878|NCT00783744|Glimepiride|glimepiride|mesh-list
154115879|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
154115880|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
154115881|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
154115882|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154115883|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115884|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154115885|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154115886|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
154115887|NCT00932607|Immunomodulating Agents|immunomodulating agents|mesh-list
154115888|NCT00932607|Immunologic Factors|immunologic factors|mesh-ancestor
154115889|NCT00932607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115890|NCT00932685|Midazolam|midazolam|mesh-list
154115891|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154115892|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154115893|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154115894|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115895|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154115896|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154115897|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154115898|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154115899|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
154115900|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
154115901|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
154115902|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
154115903|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115904|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115913|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154115914|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154115915|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154115916|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115917|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154115918|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115919|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
154115920|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154115921|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
154115922|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154115924|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154115925|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154115926|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
154115927|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
154115928|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115929|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115930|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154115931|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154115932|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154115933|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
154115934|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154115935|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115936|NCT00938613|Budesonide|budesonide|mesh-list
154115937|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115938|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154115939|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
154115940|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115941|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115942|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154115943|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
154115944|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
154115945|NCT00938613|Hormones|hormones|mesh-ancestor
154115946|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154115947|NCT00786552|Paclitaxel|paclitaxel|mesh-list
154115948|NCT00786552|Pemetrexed|pemetrexed|mesh-list
154115949|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154115950|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115951|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
154115952|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
154115953|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
154115954|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115955|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154115956|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154115957|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154115958|NCT04047186|Nivolumab|nivolumab|mesh-list
154115959|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154115960|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154115961|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154115962|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154115963|NCT00931203|Celecoxib|celecoxib|mesh-list
154115964|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154115965|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154115966|NCT00931203|Analgesics|analgesics|mesh-ancestor
154115967|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
154115968|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154115969|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154115970|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154115999|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
154116000|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
154116001|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154116002|NCT00931281|Ritonavir|ritonavir|mesh-list
154116003|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154116004|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154116005|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
154116006|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116007|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116008|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154116009|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154116010|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
153731270|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154116011|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116012|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154116013|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154116014|NCT04014855|Lactoferrin|lactoferrin|mesh-list
154116015|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116016|NCT00571922|Acamprosate|acamprosate|mesh-list
154116017|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154116018|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
154116019|NCT00933231|Prednisone|prednisone|mesh-list
154116020|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
154116021|NCT00933231|Ramipril|ramipril|mesh-list
154116022|NCT00933231|Irbesartan|irbesartan|mesh-list
154116023|NCT00933231|Tacrolimus|tacrolimus|mesh-list
154116024|NCT00933231|Basiliximab|basiliximab|mesh-list
154116025|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116026|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
154116027|NCT00933231|Hormones|hormones|mesh-ancestor
154116028|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116029|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116043|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154116044|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154116045|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
154116046|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116047|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116048|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154116049|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
154116050|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154116051|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154116052|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154116055|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
154116056|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
154116057|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116058|NCT00752180|Insulin|insulin|mesh-list
154116059|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154116060|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154116061|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116062|NCT00784290|Orantinib|orantinib|mesh-list
154116063|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154116064|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787860|NCT00278382|Sorafenib|sorafenib|mesh-list
154116065|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116066|NCT00752414|Levofloxacin|levofloxacin|mesh-list
154116067|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154116068|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116069|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116070|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154116071|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154116072|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116073|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116074|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116086|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116087|NCT00328627|Incretins|incretins|mesh-ancestor
154116088|NCT00328627|Hormones|hormones|mesh-ancestor
154116089|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116090|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154116091|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
154116092|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116093|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116094|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
154116095|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154116096|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116097|NCT00663858|Cetrorelix|cetrorelix|mesh-list
154116098|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154116099|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
154116100|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154116101|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116102|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
154116103|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116104|NCT05223400|Clindamycin|clindamycin|mesh-list
154116105|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
154116106|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
154116107|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116108|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116109|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154116110|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116111|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116112|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
153787921|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116113|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154116114|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
154116115|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116116|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116117|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154116119|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154116125|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
154116126|NCT00790608|Protective Agents|protective agents|mesh-ancestor
154116127|NCT00749450|Capecitabine|capecitabine|mesh-list
154116128|NCT00749450|Fluorouracil|fluorouracil|mesh-list
154116129|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
154116130|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154116131|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
154116132|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116133|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116134|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116135|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
154116136|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116137|NCT00795444|Maraviroc|maraviroc|mesh-list
154116138|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154116139|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154116140|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116141|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154116142|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154116143|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
154116144|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116145|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154116146|NCT02561936|Rilpivirine|rilpivirine|mesh-list
154116147|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154116148|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154116149|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116150|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116151|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
154116152|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116153|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154116168|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116169|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116170|NCT01060735|Vitamin D|vitamin d|mesh-list
154116171|NCT01060735|Vitamins|vitamins|mesh-ancestor
154116172|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
154116173|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116174|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154116175|NCT00683774|Diazoxide|diazoxide|mesh-list
154116176|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154116177|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
154116178|NCT00787410|Gefitinib|gefitinib|mesh-list
154116179|NCT00787410|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154116180|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154116181|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116182|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116183|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116184|NCT03989557|Aspirin|aspirin|mesh-list
154116185|NCT03989557|Clopidogrel|clopidogrel|mesh-list
154116186|NCT03989557|Ticagrelor|ticagrelor|mesh-list
154116187|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154116188|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154116224|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
154116225|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154116226|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154116227|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116228|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116230|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154116231|NCT00540514|Carboplatin|carboplatin|mesh-list
154116232|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154116233|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116234|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116235|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116236|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116237|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116238|NCT00663702|Abatacept|abatacept|mesh-list
154116239|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154116240|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116241|NCT00663702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154116242|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116279|NCT00795678|Capecitabine|capecitabine|mesh-list
154116280|NCT00795678|Trastuzumab|trastuzumab|mesh-list
154116281|NCT00795678|Lapatinib|lapatinib|mesh-list
154116282|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154116283|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116284|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116285|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116286|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116287|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116288|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116289|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
154116290|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116291|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116292|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154116293|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
154116294|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154116295|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154116296|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
154116304|NCT00753038|Paclitaxel|paclitaxel|mesh-list
154116335|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116336|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116337|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154116338|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154116339|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154116340|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116341|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116342|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154116343|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154116344|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154116345|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
154116346|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116347|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116348|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154116349|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154116350|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
154116351|NCT01563952|Sirolimus|sirolimus|mesh-list
154116352|NCT01563952|Umirolimus|umirolimus|mesh-list
154116353|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116354|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116355|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154116356|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116357|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
154116358|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116359|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
154116360|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116361|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116362|NCT00795912|Atorvastatin|atorvastatin|mesh-list
154116363|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154116364|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154116365|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
154116366|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116367|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154116368|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154116369|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116370|NCT00788034|Vortioxetine|vortioxetine|mesh-list
153654608|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116371|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
154116372|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154116373|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154116374|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154116375|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116376|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116377|NCT00788034|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154116378|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154116379|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788140|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
154116380|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116381|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116382|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
154116383|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154116384|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154116385|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154116386|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154116388|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154116389|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
154116390|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154116391|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116392|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154116393|NCT00688064|Doxycycline|doxycycline|mesh-list
154116394|NCT00688064|Adapalene|adapalene|mesh-list
154116395|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116396|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116418|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116419|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154116420|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153788142|NCT00249704|Vitamin D|vitamin d|mesh-list
154116421|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154116422|NCT00791544|Sorafenib|sorafenib|mesh-list
154116423|NCT00791544|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154116424|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154116425|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116426|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116427|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116428|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154116429|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154116430|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154116431|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
154116432|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116433|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154116434|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154116435|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116436|NCT00663234|Atorvastatin|atorvastatin|mesh-list
154116437|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154116438|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154116439|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
154116467|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116468|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154116469|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154116470|NCT00326911|Growth Substances|growth substances|mesh-ancestor
154116471|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116472|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
154116473|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154116474|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
154116475|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116476|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154116477|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154116478|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154116479|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116480|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116481|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154116482|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154116483|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154116523|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
154116524|NCT01057615|Vitamins|vitamins|mesh-ancestor
153788173|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
154116525|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
154116526|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116527|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
154116528|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116529|NCT01057615|Protective Agents|protective agents|mesh-ancestor
154116530|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
154116531|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154116532|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
154116533|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116534|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116535|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154116536|NCT00788424|Protective Agents|protective agents|mesh-ancestor
154116537|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154116538|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154116539|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116540|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116580|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
154116581|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116582|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116583|NCT00990418|Fentanyl|fentanyl|mesh-list
154116584|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154116585|NCT00990418|Narcotics|narcotics|mesh-ancestor
154116586|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116587|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116588|NCT00990418|Analgesics|analgesics|mesh-ancestor
154116589|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
154116590|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116591|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154116592|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154116593|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
154116594|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
154116595|NCT02562950|Midazolam|midazolam|mesh-list
154116596|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154116639|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
154116640|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154116641|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497071|NCT00002586|Tocotrienols|tocotrienols|mesh-list
154116642|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116643|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154116644|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116645|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154116646|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
154116647|NCT00990496|Fludarabine|fludarabine|mesh-list
154116648|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116700|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154116701|NCT00539500|Carboplatin|carboplatin|mesh-list
154116702|NCT00539500|Etoposide|etoposide|mesh-list
154116703|NCT00539500|Melphalan|melphalan|mesh-list
154116704|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116705|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154116706|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154116707|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154116708|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116709|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116710|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154116711|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
154116712|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154116713|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116714|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
154116716|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154116717|NCT00662532|Minocycline|minocycline|mesh-list
154116718|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116719|NCT00792324|Efavirenz|efavirenz|mesh-list
154116720|NCT00792324|Etravirine|etravirine|mesh-list
154116721|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154116722|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153788334|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154116723|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116724|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116725|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
154116726|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116727|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154116728|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154116729|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154116730|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154116731|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154116732|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154116733|NCT00990808|Atorvastatin|atorvastatin|mesh-list
154116740|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154116741|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116743|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154116744|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116745|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334928|NCT01451060|Metaraminol|metaraminol|mesh-list
153334929|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153334930|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334931|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
153334932|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
153334935|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
153334943|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334944|NCT01451294|Phenylephrine|phenylephrine|mesh-list
153334945|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
153334946|NCT01451294|Ephedrine|ephedrine|mesh-list
153923694|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
153788380|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788381|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153788382|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153788383|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153788384|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153788385|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788386|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153788394|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
153788395|NCT00251030|Nelfinavir|nelfinavir|mesh-list
153788396|NCT00251030|Omeprazole|omeprazole|mesh-list
153788397|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153788398|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788399|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153788400|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116746|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154116747|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
154116748|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
154116749|NCT00682448|Metformin|metformin|mesh-list
154116750|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154116751|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116752|NCT04003792|Bevacizumab|bevacizumab|mesh-list
154116753|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
154116754|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154116755|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116756|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154116757|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154116758|NCT04003792|Growth Substances|growth substances|mesh-ancestor
154116759|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116760|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
154116762|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
154116763|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
154116764|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116765|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116768|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
154116790|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154116791|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
154116792|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154116793|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116794|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116795|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116796|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154116797|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
154116798|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154116799|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154116800|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154116801|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116802|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116803|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
154116804|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154116805|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
154116806|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116807|NCT00539188|Expectorants|expectorants|mesh-ancestor
154116808|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
154116809|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154116810|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
154116812|NCT00539188|Protective Agents|protective agents|mesh-ancestor
154116844|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154116845|NCT00326599|Carboplatin|carboplatin|mesh-list
154116846|NCT00326599|Gemcitabine|gemcitabine|mesh-list
154116847|NCT00326599|Cediranib|cediranib|mesh-list
154116848|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116849|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154116850|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
154116851|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116852|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116853|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154116854|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
154116855|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154116856|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
154116857|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116858|NCT00750386|Paclitaxel|paclitaxel|mesh-list
154116859|NCT00750386|Carboplatin|carboplatin|mesh-list
154116860|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154116861|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154116862|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
154116863|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
154116864|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
154116865|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116866|NCT00539032|Vaccines|vaccines|mesh-list
154116867|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
154116896|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
154116897|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154116898|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
154116899|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154116900|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116901|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116902|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153788549|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116903|NCT00792714|Mannitol|mannitol|mesh-list
154116904|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154116905|NCT00792714|Diuretics|diuretics|mesh-ancestor
154116906|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
154116907|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116908|NCT04961554|Anesthetics|anesthetics|mesh-list
154116909|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154116910|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116911|NCT00354601|Docetaxel|docetaxel|mesh-list
154116912|NCT00354601|Capecitabine|capecitabine|mesh-list
154116920|NCT01563640|Permethrin|permethrin|mesh-list
154116955|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154116956|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
154116957|NCT03827473|Protective Agents|protective agents|mesh-ancestor
154116958|NCT03827473|Vitamins|vitamins|mesh-ancestor
154116959|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
154116960|NCT03827473|Estrogens|estrogens|mesh-ancestor
154116961|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
154116962|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
154116963|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
154116964|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154116965|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154116966|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154116967|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116968|NCT00800592|Urological Agents|urological agents|mesh-ancestor
154116969|NCT00797784|Etanercept|etanercept|mesh-list
154116970|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154116971|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154116972|NCT00797784|Analgesics|analgesics|mesh-ancestor
154116973|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
154116974|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154116975|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116976|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154116977|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154116978|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154116979|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154116980|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
154116981|NCT00747968|Exenatide|exenatide|mesh-list
154116982|NCT00747968|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154116983|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154116984|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154116985|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154116986|NCT00747968|Incretins|incretins|mesh-ancestor
154116987|NCT00747968|Hormones|hormones|mesh-ancestor
153788632|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
154116988|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154116989|NCT00755924|Acetic Acid|acetic acid|mesh-list
154116990|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154116991|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116992|NCT00800748|Ribavirin|ribavirin|mesh-list
154116994|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
154116995|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154116996|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
154116997|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154116998|NCT00798252|Paclitaxel|paclitaxel|mesh-list
154116999|NCT00798252|Docetaxel|docetaxel|mesh-list
154117000|NCT00798252|Doxorubicin|doxorubicin|mesh-list
154117001|NCT00798252|Capecitabine|capecitabine|mesh-list
154117002|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154117003|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117004|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
154117005|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
154117006|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
154117007|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117008|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154117009|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154117010|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154117053|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117054|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117055|NCT00748202|Complement C1s|complement c1s|mesh-list
154117056|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154117057|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154117058|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
154117059|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117060|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154117061|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117062|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154117063|NCT00325897|Azithromycin|azithromycin|mesh-list
154117064|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117065|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
154117066|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154117067|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117068|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117069|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154117070|NCT00800826|Analgesics|analgesics|mesh-ancestor
154117071|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
154117072|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117073|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154117074|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154117075|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154117101|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
154117102|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117103|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117104|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117105|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117106|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117107|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117108|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117109|NCT01055041|Budesonide|budesonide|mesh-list
154117110|NCT01055041|Doxofylline|doxofylline|mesh-list
154117111|NCT01055041|Montelukast|montelukast|mesh-list
154117112|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117113|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154117114|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
154117115|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117116|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117117|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154117118|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
154117119|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
154117120|NCT01055041|Hormones|hormones|mesh-ancestor
154117121|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117122|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154117123|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
154117124|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154117125|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154117126|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117127|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
154117128|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154117129|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117130|NCT00325819|Acetaminophen|acetaminophen|mesh-list
154117131|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154117132|NCT00325819|Analgesics|analgesics|mesh-ancestor
154117137|NCT00748358|Sunitinib|sunitinib|mesh-list
154117142|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788756|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
154117143|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
154117144|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154117145|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117146|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117147|NCT00748436|Betahistine|betahistine|mesh-list
154117148|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
154117149|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
154117150|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
154117151|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117152|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117153|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117154|NCT00756860|Sevelamer|sevelamer|mesh-list
154117155|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
154117156|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
154117157|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117158|NCT00757016|Triamcinolone|triamcinolone|mesh-list
154117159|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154117160|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154117161|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154117162|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117163|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
154117164|NCT00757016|Hormones|hormones|mesh-ancestor
154117165|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117166|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117167|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117168|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
154117169|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117170|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117171|NCT00687362|Infliximab|infliximab|mesh-list
154117172|NCT00687362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154117173|NCT00687362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117184|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117185|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117186|NCT00751478|Analgesics|analgesics|mesh-ancestor
154117187|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
154117188|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117189|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154117190|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154117191|NCT00751556|Naproxen|naproxen|mesh-list
154117192|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154117193|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154117194|NCT00751556|Analgesics|analgesics|mesh-ancestor
154117195|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
154117196|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117197|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117198|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117199|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117200|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
154117201|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154117202|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117203|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117204|NCT00685334|Olanzapine|olanzapine|mesh-list
154117205|NCT00685334|Aripiprazole|aripiprazole|mesh-list
154117206|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
154117207|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
154117208|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117233|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154117234|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117235|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117236|NCT00801294|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154117237|NCT04013919|Insulin|insulin|mesh-list
154117238|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154117239|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154117240|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117241|NCT00344461|Tenofovir|tenofovir|mesh-list
154117242|NCT00344461|Nevirapine|nevirapine|mesh-list
154117243|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
154117244|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117245|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154117246|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154117247|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117248|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117249|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154117250|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153788835|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
154117251|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154117252|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154117253|NCT00685178|Topiramate|topiramate|mesh-list
154117254|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
154117255|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154117256|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117257|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
154117258|NCT00537394|Maraviroc|maraviroc|mesh-list
154117259|NCT00537394|Darunavir|darunavir|mesh-list
154117260|NCT00537394|Tipranavir|tipranavir|mesh-list
154117261|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
154117262|NCT00537394|Etravirine|etravirine|mesh-list
154117263|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154117264|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154117265|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
154117266|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117276|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
154117277|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154117278|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154117279|NCT00933309|Metformin|metformin|mesh-list
154117280|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
154117281|NCT00933309|Exemestane|exemestane|mesh-list
154117282|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154117283|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117284|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117285|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154117286|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154117287|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117288|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117289|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154117290|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
154117291|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117292|NCT00352885|Escitalopram|escitalopram|mesh-list
154117293|NCT00352885|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154117294|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154117295|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154117296|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117297|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117298|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
154117299|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117300|NCT00933387|Paclitaxel|paclitaxel|mesh-list
154117301|NCT00933387|Cetuximab|cetuximab|mesh-list
154117302|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154117303|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117304|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
154117305|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154117306|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154117307|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117308|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154117309|NCT00660660|Esomeprazole|esomeprazole|mesh-list
154117314|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117315|NCT02560766|Gabapentin|gabapentin|mesh-list
154117316|NCT02560766|Analgesics|analgesics|mesh-ancestor
154117317|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
154117318|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117319|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117320|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
154117321|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154117322|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154117323|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117324|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154117325|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154117326|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154117327|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117328|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117329|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
154117330|NCT00933465|Loperamide|loperamide|mesh-list
154117331|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
154117332|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117333|NCT00757874|Clobetasol|clobetasol|mesh-list
154117334|NCT00757874|Tacrolimus|tacrolimus|mesh-list
154117335|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117336|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
154117337|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117338|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154117365|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117366|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117367|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117368|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
154117369|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117370|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117371|NCT00660816|Docetaxel|docetaxel|mesh-list
154117372|NCT00660816|Pemetrexed|pemetrexed|mesh-list
154117373|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154117374|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117375|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
154117376|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
154117377|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
154117378|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117379|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117380|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154117381|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154117382|NCT00660816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154117383|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154117384|NCT00801528|Diclofenac|diclofenac|mesh-list
154117385|NCT00801528|Ropivacaine|ropivacaine|mesh-list
154117386|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
154117387|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
154117388|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117389|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117390|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
154117391|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117392|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154117394|NCT00801528|Analgesics|analgesics|mesh-ancestor
154117396|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117410|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
154117411|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117412|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
154117413|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
154117414|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117415|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117416|NCT00576056|Sorafenib|sorafenib|mesh-list
153473789|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154117417|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117418|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154117419|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117420|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117421|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
154117422|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
154117423|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117424|NCT05360602|Protective Agents|protective agents|mesh-ancestor
154117425|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117426|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
154117427|NCT05360602|Vitamins|vitamins|mesh-ancestor
154117428|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
154117429|NCT00991744|Cytarabine|cytarabine|mesh-list
154117430|NCT00991744|Cortisone|cortisone|mesh-list
154117431|NCT00991744|Prednisolone|prednisolone|mesh-list
154117432|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154117433|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
154117434|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154117435|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
154117436|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154117437|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
154117456|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154117457|NCT00991744|Protective Agents|protective agents|mesh-ancestor
154117458|NCT00798876|Vitamin E|vitamin e|mesh-list
154117459|NCT00798876|Vitamins|vitamins|mesh-ancestor
154117460|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
154117461|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117462|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
154117463|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117464|NCT00798876|Protective Agents|protective agents|mesh-ancestor
154117465|NCT00989404|Zanamivir|zanamivir|mesh-list
154117466|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
154117467|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497911|NCT00002838|Fludarabine|fludarabine|mesh-list
154117468|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117469|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117470|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154117471|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154117472|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154117473|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117474|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117475|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154117476|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154117477|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154117478|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
154117479|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117480|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117481|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154117482|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154117483|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
154117484|NCT00991822|Timolol|timolol|mesh-list
154117485|NCT00991822|Dorzolamide|dorzolamide|mesh-list
154117486|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154117487|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154117496|NCT00798954|Sirolimus|sirolimus|mesh-list
154117497|NCT00798954|Paclitaxel|paclitaxel|mesh-list
154117498|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154117499|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117500|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
154117501|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
154117502|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
154117503|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117504|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154117505|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117506|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154117507|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
154117508|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117509|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
154117510|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117511|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154117512|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154117513|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117514|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
154117515|NCT00934167|Heparin|heparin|mesh-list
154117516|NCT00934167|Calcium heparin|calcium heparin|mesh-list
154117551|NCT00934323|Glimepiride|glimepiride|mesh-list
154117552|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154117553|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117554|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154117555|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117556|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
154117557|NCT00575666|Insulin|insulin|mesh-list
154117558|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154117559|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117560|NCT00934479|Lubiprostone|lubiprostone|mesh-list
153335614|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117561|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154117562|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154117563|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117564|NCT00658632|Esomeprazole|esomeprazole|mesh-list
154117565|NCT00658632|Rabeprazole|rabeprazole|mesh-list
154117566|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154117567|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117568|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154117569|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117570|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117571|NCT00677534|Vitamin D|vitamin d|mesh-list
154117572|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
154117573|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
154117574|NCT00677534|Vitamins|vitamins|mesh-ancestor
154117575|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
153789198|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117576|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117577|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154117578|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154117579|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
154117580|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
154117581|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
154117582|NCT00660348|Morphine|morphine|mesh-list
154117583|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154117584|NCT00660348|Narcotics|narcotics|mesh-ancestor
154117594|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
154117595|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117596|NCT03734198|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154117597|NCT03734198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154117598|NCT03734198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117599|NCT03734198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117600|NCT01564108|Ranibizumab|ranibizumab|mesh-list
154117601|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154117602|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154117603|NCT01564108|Growth Substances|growth substances|mesh-ancestor
154117604|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117605|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
154117606|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117607|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
154117608|NCT00801918|Ifosfamide|ifosfamide|mesh-list
154117609|NCT00801918|Etoposide|etoposide|mesh-list
154117610|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
154117611|NCT00801918|Interleukin-2|interleukin-2|mesh-list
154117612|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117613|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
154117648|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154117649|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
154117650|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
154117651|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
153789199|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153789202|NCT00281307|Tocopherols|tocopherols|mesh-list
154117652|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117653|NCT05408104|Tolvaptan|tolvaptan|mesh-list
154117654|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154117655|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117656|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
154117657|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117658|NCT00343291|Paclitaxel|paclitaxel|mesh-list
154117659|NCT00343291|Bevacizumab|bevacizumab|mesh-list
154117660|NCT00343291|Carboplatin|carboplatin|mesh-list
154117661|NCT00343291|Cetuximab|cetuximab|mesh-list
154117662|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154117663|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117664|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
154117665|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
154117666|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
154117667|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117668|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154117669|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154117670|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154117671|NCT00343291|Growth Substances|growth substances|mesh-ancestor
154117672|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117673|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
154117674|NCT05407870|Propofol|propofol|mesh-list
154117675|NCT05407870|Etomidate|etomidate|mesh-list
154117676|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154117677|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117678|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117679|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154117687|NCT00658788|Calcitriol|calcitriol|mesh-list
154117688|NCT00658788|Clobetasol|clobetasol|mesh-list
154117689|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154117690|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117691|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154117692|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153441134|NCT00003253|Paclitaxel|paclitaxel|mesh-list
154117693|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117694|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154117695|NCT00658788|Vitamins|vitamins|mesh-ancestor
154117696|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
154117697|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154117698|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117699|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
154117700|NCT00658788|Hormones|hormones|mesh-ancestor
154117701|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154117702|NCT01060969|Acetazolamide|acetazolamide|mesh-list
154117703|NCT01060969|Tadalafil|tadalafil|mesh-list
154117704|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
154117705|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154117706|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154117707|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117708|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117709|NCT01060969|Urological Agents|urological agents|mesh-ancestor
154117710|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
154117711|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154117712|NCT01060969|Diuretics|diuretics|mesh-ancestor
154117713|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
154117732|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117733|NCT00802308|Morphine|morphine|mesh-list
154117734|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154117735|NCT00802308|Narcotics|narcotics|mesh-ancestor
154117736|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154117737|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117738|NCT00802308|Analgesics|analgesics|mesh-ancestor
154117739|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
154117740|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117741|NCT00562965|Dexamethasone|dexamethasone|mesh-list
154117742|NCT00562965|Prednisone|prednisone|mesh-list
154117743|NCT00562965|Prednisolone|prednisolone|mesh-list
154117744|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
154117745|NCT00562965|Rituximab|rituximab|mesh-list
154117746|NCT00562965|Fludarabine|fludarabine|mesh-list
154117747|NCT00562965|Vincristine|vincristine|mesh-list
154117748|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
154117749|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154117750|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117751|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
154117752|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117753|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117754|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154117755|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
154117756|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117757|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117758|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154117782|NCT05406934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154117783|NCT05406934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117784|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
154117785|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117786|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117787|NCT00794898|Infliximab|infliximab|mesh-list
154117788|NCT00794898|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154117789|NCT00794898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154117790|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
154117791|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117792|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154117793|NCT00800280|Cimetidine|cimetidine|mesh-list
154117794|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154117795|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154117796|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154117797|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
154117798|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
154117799|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117800|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117801|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789266|NCT00253058|Cetirizine|cetirizine|mesh-list
154117802|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153335839|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789302|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154117803|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154117804|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117805|NCT00800358|Calcitriol|calcitriol|mesh-list
154117806|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154117807|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117808|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154117809|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154117810|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117811|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154117812|NCT00800358|Vitamins|vitamins|mesh-ancestor
154117815|NCT00934713|Montelukast|montelukast|mesh-list
154117822|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154117823|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154117824|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117826|NCT01057849|Risperidone|risperidone|mesh-list
154117827|NCT01057849|Aripiprazole|aripiprazole|mesh-list
154117828|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154117829|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
154117830|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154117831|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117832|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117833|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154117882|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
154117883|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
154117884|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
154117885|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117886|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154117887|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
154117888|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117889|NCT00805662|Oxytocin|oxytocin|mesh-list
154117890|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
154117891|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154117892|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154117893|NCT04978012|Fluzoparib|fluzoparib|mesh-list
154117894|NCT04978012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154117895|NCT04978012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117897|NCT04978012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154117939|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154117940|NCT00324649|Lamivudine|lamivudine|mesh-list
154117941|NCT00324649|Zidovudine|zidovudine|mesh-list
154117942|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154117943|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154117944|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154117945|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154117946|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154117947|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
154117948|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154117949|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154117950|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154117951|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
154117999|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154118000|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154118001|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
154118002|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118003|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154118004|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154118005|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
154118006|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118008|NCT00935961|Everolimus|everolimus|mesh-list
154118009|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118010|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
154118011|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
154118012|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
154118013|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118014|NCT00935961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154118015|NCT00935961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118058|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154118059|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154118060|NCT00680186|Warfarin|warfarin|mesh-list
154118061|NCT00680186|Dabigatran|dabigatran|mesh-list
154118062|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
154118063|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
154118064|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154118065|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
154118066|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118067|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118068|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154118069|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154118070|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
154118071|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118072|NCT00936429|Antacids|antacids|mesh-ancestor
154118073|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118074|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154118075|NCT00656292|Simvastatin|simvastatin|mesh-list
154118076|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154118077|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154118078|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
154118079|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118080|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154118081|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154118082|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118083|NCT00352417|Atreleuton|atreleuton|mesh-list
154118084|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154118085|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118086|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118087|NCT00944541|Maraviroc|maraviroc|mesh-list
154118088|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154118089|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154118090|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118091|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154118092|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154118093|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
154118096|NCT00944619|Insulin|insulin|mesh-list
154118097|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154118098|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118099|NCT00323869|Bevacizumab|bevacizumab|mesh-list
154118100|NCT00323869|Carboplatin|carboplatin|mesh-list
154118101|NCT00323869|Gemcitabine|gemcitabine|mesh-list
154118102|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154118103|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118104|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154118105|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154118106|NCT00323869|Growth Substances|growth substances|mesh-ancestor
154118107|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118108|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
154118109|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154118110|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
154118152|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118153|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
154118154|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154118155|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118156|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118157|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154118158|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118159|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118160|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154118161|NCT03988075|Narcotics|narcotics|mesh-ancestor
154118162|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154118163|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
154118164|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
154118165|NCT00944853|Zinc|zinc|mesh-list
154118166|NCT00944853|Trace Elements|trace elements|mesh-ancestor
154118167|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
154118168|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118210|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154118211|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118212|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118213|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118215|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
154118216|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118217|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
154118218|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154118219|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
154118220|NCT02558972|Droxidopa|droxidopa|mesh-list
154118221|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154118222|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154118223|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
154118224|NCT00809718|Rifapentine|rifapentine|mesh-list
154118225|NCT00809718|Rifampin|rifampin|mesh-list
154118226|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154118227|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154118228|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
154118229|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118230|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154118231|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154118263|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118264|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154118265|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154118266|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118267|NCT00537316|Infliximab|infliximab|mesh-list
154118268|NCT00537316|Azathioprine|azathioprine|mesh-list
154118269|NCT00537316|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154118270|NCT00537316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118271|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
154118272|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154118273|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118274|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
154118275|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118276|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154118277|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118278|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118279|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
154118280|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118281|NCT00803868|Varenicline|varenicline|mesh-list
154118282|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154118283|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154118284|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
154118285|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118286|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118287|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118313|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118314|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118315|NCT02533141|Simvastatin|simvastatin|mesh-list
154118316|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154118317|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154118318|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
154118319|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118320|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154118321|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154118322|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118323|NCT00809796|Pentamidine|pentamidine|mesh-list
154118324|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
154118325|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118326|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154118327|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154118328|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154118330|NCT05589454|Atorvastatin|atorvastatin|mesh-list
154118331|NCT05589454|Calcium|calcium|mesh-list
154118332|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154118333|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118334|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153789406|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154118335|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154118336|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154118337|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
154118338|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118339|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154118340|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154118341|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118342|NCT00803946|Ibuprofen|ibuprofen|mesh-list
154118343|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154118345|NCT00803946|Analgesics|analgesics|mesh-ancestor
154118353|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118354|NCT00676130|Trimethoprim|trimethoprim|mesh-list
154118355|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154118356|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
154118357|NCT00676130|Cephalexin|cephalexin|mesh-list
154118358|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154118359|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118360|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
154118361|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154118362|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153441813|NCT00004495|Hematinics|hematinics|mesh-ancestor
154118363|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154118364|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118365|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118366|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154118367|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154118368|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154118369|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154118370|NCT00809874|Caseins|caseins|mesh-list
154118371|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
154118372|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
154118373|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118374|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
154118375|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154118376|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
154118377|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118378|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
154118379|NCT05436002|Protective Agents|protective agents|mesh-ancestor
154118380|NCT02560376|Exenatide|exenatide|mesh-list
154118381|NCT02560376|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154118382|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154118383|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118384|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154118392|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154118393|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
153789438|NCT00287859|Topotecan|topotecan|mesh-list
154118394|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
154118395|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118396|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118397|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154118398|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154118399|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154118400|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154118401|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154118402|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154118403|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
154118404|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154118405|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154118406|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
154118407|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154118409|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154118410|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154118411|NCT00921830|Analgesics|analgesics|mesh-ancestor
154118412|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
154118413|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118414|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118415|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118416|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118420|NCT02560220|Mitomycins|mitomycins|mesh-list
154118440|NCT02783300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154118441|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118442|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118443|NCT00675506|Hormones|hormones|mesh-list
154118444|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
154118445|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118446|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118447|NCT05435378|Vitamins|vitamins|mesh-list
154118448|NCT05435378|Folic Acid|folic acid|mesh-list
154118449|NCT05435378|Niacinamide|niacinamide|mesh-list
154118450|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
154118451|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
154118452|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118453|NCT05435378|Hematinics|hematinics|mesh-ancestor
154118454|NCT03895840|Triamcinolone|triamcinolone|mesh-list
154118455|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154118456|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154118457|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154118458|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118459|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
154118460|NCT03895840|Hormones|hormones|mesh-ancestor
154118461|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118462|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118463|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118464|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
154118465|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118467|NCT00310375|Ezogabine|ezogabine|mesh-list
154118487|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118488|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154118489|NCT00309907|Protective Agents|protective agents|mesh-ancestor
154118490|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154118491|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118492|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153789496|NCT01685398|Timolol|timolol|mesh-list
154118493|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154118494|NCT00309907|Analgesics|analgesics|mesh-ancestor
154118495|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
154118496|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118497|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118498|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
154118499|NCT00655824|Ofatumumab|ofatumumab|mesh-list
154118500|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118501|NCT03985969|Indomethacin|indomethacin|mesh-list
154118547|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
154118548|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118549|NCT00760916|Treprostinil|treprostinil|mesh-list
154118550|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154118551|NCT00761228|Apomorphine|apomorphine|mesh-list
154118552|NCT00761228|Emetics|emetics|mesh-ancestor
154118553|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118554|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
154118555|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118556|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154118557|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
154118558|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
154118559|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118560|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118561|NCT00758732|Carboplatin|carboplatin|mesh-list
154118562|NCT00758732|Docetaxel|docetaxel|mesh-list
154118563|NCT00758732|Doxorubicin|doxorubicin|mesh-list
154118564|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154118565|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118601|NCT00759200|Interferons|interferons|mesh-list
154118602|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
154118603|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
154118604|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118605|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
154118606|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118607|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
154118608|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118609|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
154118610|NCT02558816|Venetoclax|venetoclax|mesh-list
154118611|NCT02558816|Ibrutinib|ibrutinib|mesh-list
154118612|NCT02558816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154118613|NCT02558816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118614|NCT02558816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118615|NCT02558816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118616|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154118617|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118618|NCT01299753|Propranolol|propranolol|mesh-list
154118619|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154118620|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154118621|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
154118622|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118623|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118624|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118625|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154118626|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154118627|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
154118628|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
154118629|NCT02559440|Phenylephrine|phenylephrine|mesh-list
154118630|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
154118631|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118632|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
154118645|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
154118646|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154118648|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154118649|NCT02559440|Protective Agents|protective agents|mesh-ancestor
154118650|NCT00674570|Cycloserine|cycloserine|mesh-list
154118651|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
154118652|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118653|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154118654|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154118655|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154118656|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
154118657|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154118658|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
154118659|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118660|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
154118661|NCT00940563|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154118662|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118663|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118664|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118665|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118667|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118668|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118669|NCT00940719|Vitamin D|vitamin d|mesh-list
154118670|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
154118671|NCT00940719|Vitamins|vitamins|mesh-ancestor
154118672|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
154118673|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118674|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154118675|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154118676|NCT00940953|Azelastine|azelastine|mesh-list
154118677|NCT00940953|Budesonide|budesonide|mesh-list
154118678|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118679|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154118686|NCT00940953|Hormones|hormones|mesh-ancestor
154118687|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118688|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154118689|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118690|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118691|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154118692|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154118693|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154118694|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
154118695|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
154118696|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118697|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
154118698|NCT00759824|Doxorubicin|doxorubicin|mesh-list
154118699|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154118700|NCT00759824|Vindesine|vindesine|mesh-list
154118701|NCT00759824|Valproic Acid|valproic acid|mesh-list
154118702|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118703|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
154118704|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118705|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154118706|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154118707|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
154118708|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118709|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118710|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154118711|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154118712|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154118713|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154118714|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118715|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
154118716|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
154118717|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118726|NCT00561951|Fesoterodine|fesoterodine|mesh-list
154118728|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154118729|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
154118730|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118731|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118732|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118733|NCT00561951|Urological Agents|urological agents|mesh-ancestor
154118734|NCT00762398|Chrysarobin|chrysarobin|mesh-list
154118735|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154118736|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154118737|NCT00762398|Analgesics|analgesics|mesh-ancestor
154118738|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
154118739|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789612|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153789685|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154118740|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118790|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154118791|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154118792|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154118793|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
154118794|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118795|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118796|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118797|NCT00941343|Urological Agents|urological agents|mesh-ancestor
154118798|NCT00561795|Paclitaxel|paclitaxel|mesh-list
154118799|NCT00561795|Carboplatin|carboplatin|mesh-list
154118800|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154118801|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118802|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
154118803|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
154118804|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
154118805|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118806|NCT00652626|Azacitidine|azacitidine|mesh-list
154118807|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154118808|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
154118809|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118810|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118811|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118812|NCT00560703|Doxycycline|doxycycline|mesh-list
154118841|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118842|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154118843|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154118844|NCT00941499|Antidotes|antidotes|mesh-ancestor
154118845|NCT00941499|Protective Agents|protective agents|mesh-ancestor
154118846|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
154118847|NCT00941499|Vitamins|vitamins|mesh-ancestor
154118848|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
154118849|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
154118850|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
154118851|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154118852|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
154118853|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118854|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118855|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154118856|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
154118857|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154118858|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
154118859|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118860|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154118896|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118897|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118898|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118899|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118900|NCT00655746|Dasatinib|dasatinib|mesh-list
154118901|NCT00655746|Omeprazole|omeprazole|mesh-list
154118902|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154118903|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154118904|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154118905|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118906|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118907|NCT00655746|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154118908|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154118909|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118955|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118957|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
154118958|NCT00942201|BB 1101|bb 1101|mesh-list
154118959|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154118960|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
154118961|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
154118962|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154118963|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154118964|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154118965|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
154118966|NCT00942201|Hormones|hormones|mesh-ancestor
154118967|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154118968|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154118969|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154118970|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
154118971|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154118972|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154118973|NCT00942435|Darexaban|darexaban|mesh-list
154118974|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153789713|NCT01687699|Diuretics|diuretics|mesh-ancestor
154119010|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
154119011|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789763|NCT01688206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119012|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154119013|NCT00946335|Temozolomide|temozolomide|mesh-list
154119014|NCT00946335|Veliparib|veliparib|mesh-list
154119015|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154119016|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
154119017|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119018|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119019|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154119020|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119021|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
154119022|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154119023|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119024|NCT00762944|Cimetidine|cimetidine|mesh-list
154119025|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154119026|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154119027|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154119028|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
154119029|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
154119030|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119031|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119032|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119058|NCT00308581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154119059|NCT00308581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154119060|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119061|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
154119062|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119063|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154119064|NCT00678080|Metformin|metformin|mesh-list
154119065|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154119066|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119067|NCT00658320|Cyclosporine|cyclosporine|mesh-list
154119068|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
154119069|NCT00658320|Everolimus|everolimus|mesh-list
154119070|NCT00658320|Cyclosporins|cyclosporins|mesh-list
154119071|NCT00658320|Basiliximab|basiliximab|mesh-list
154119072|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119073|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119074|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119075|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
154119076|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119077|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
154119078|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119079|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
154119080|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154119081|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154119082|NCT00658320|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154119083|NCT00658320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154119084|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119085|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154119086|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154119087|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
154119088|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119089|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
154119090|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154119091|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119092|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154119093|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119094|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154119095|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
154119096|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
154119097|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119098|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154119099|NCT00806754|Ciclesonide|ciclesonide|mesh-list
154119100|NCT00806754|Azelastine|azelastine|mesh-list
154119101|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
154119102|NCT00806754|Hormones|hormones|mesh-ancestor
154119103|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154119104|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119105|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154119106|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154119107|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
154119108|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119109|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154119110|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
154119111|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154119112|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119113|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119114|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153499567|NCT00004260|Rituximab|rituximab|mesh-list
154119115|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154119116|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
154119117|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
154119118|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119119|NCT00764816|Caseins|caseins|mesh-list
154119120|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
154119121|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
154119122|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119140|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119141|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119142|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119144|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119145|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154119146|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154119147|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119148|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119149|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154119150|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
154119151|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154119152|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119153|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
154119154|NCT00805116|Vitamins|vitamins|mesh-ancestor
154119155|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
154119156|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119157|NCT03985735|Anesthetics|anesthetics|mesh-list
154119193|NCT00672620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154119194|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
154119195|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154119196|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154119197|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154119198|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154119199|NCT00764972|Sorafenib|sorafenib|mesh-list
154119200|NCT00764972|Vinorelbine|vinorelbine|mesh-list
154119201|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119202|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789804|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119203|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119204|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119205|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154119206|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
154119207|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
154119208|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
154119209|NCT00673790|Losartan|losartan|mesh-list
154119210|NCT00673790|Lisinopril|lisinopril|mesh-list
154119211|NCT00673790|Nebivolol|nebivolol|mesh-list
153789823|NCT00414947|Vildagliptin|vildagliptin|mesh-list
154119212|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154119213|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154119214|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154119215|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154119216|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119217|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154119218|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
154119219|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119239|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119240|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
154119241|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119242|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154119243|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154119244|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154119245|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119246|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119247|NCT00657150|Enoxaparin|enoxaparin|mesh-list
154119248|NCT00657150|Dabigatran|dabigatran|mesh-list
154119249|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
154119250|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154119251|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154119252|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119253|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
154119254|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154119255|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
154119256|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119257|NCT00770354|Letrozole|letrozole|mesh-list
154119258|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119259|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154119260|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154119261|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119262|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119263|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154119264|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
154119265|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154119266|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119267|NCT00670748|Aldesleukin|aldesleukin|mesh-list
154119268|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
154119269|NCT00670748|Fludarabine|fludarabine|mesh-list
154119270|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
154119271|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119272|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
154119274|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154119277|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119278|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119279|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154119280|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154119281|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
154119282|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154119283|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154119284|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
154119285|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119286|NCT00646776|Ritonavir|ritonavir|mesh-list
154119287|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154119288|NCT00646776|Rifabutin|rifabutin|mesh-list
154119289|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154119290|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154119291|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
154119292|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119293|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119294|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154119295|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154119333|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119334|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119335|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
154119336|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
154119337|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154119339|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154119340|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119341|NCT00811200|Triamcinolone|triamcinolone|mesh-list
154119342|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154119343|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154119344|NCT00811200|Ranibizumab|ranibizumab|mesh-list
154119345|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154119346|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154119347|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154119348|NCT00811200|Growth Substances|growth substances|mesh-ancestor
154119349|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119350|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
154119351|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119352|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154119353|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
154119354|NCT00811200|Hormones|hormones|mesh-ancestor
154119355|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154119356|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119357|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
154119358|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119359|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119360|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
154119361|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154119362|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154119363|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154119364|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
154119365|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119366|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154119367|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154119368|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789853|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348998|NCT01149785|Crizotinib|crizotinib|mesh-list
154119370|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119371|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154119372|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
154119373|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154119374|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119375|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154119376|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154119377|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154119378|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119379|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119380|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154119430|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154119432|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154119433|NCT00770978|Cephalosporins|cephalosporins|mesh-list
154119434|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119435|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119436|NCT00764426|Ethanol|ethanol|mesh-list
154119437|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154119438|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119439|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119440|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119441|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
154119442|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
154119443|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
154119444|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
154119445|NCT00764582|Levofloxacin|levofloxacin|mesh-list
154119446|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154119447|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154119448|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119449|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119450|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154119451|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154119452|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119453|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119454|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119455|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154119456|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154119457|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154119458|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
154119459|NCT04048226|Ketamine|ketamine|mesh-list
154119460|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154119461|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119462|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119463|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154119464|NCT04048226|Analgesics|analgesics|mesh-ancestor
154119469|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154119470|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
154119471|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119472|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119473|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154119474|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154119475|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
154119476|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
154119477|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154119478|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154119479|NCT00811746|Eszopiclone|eszopiclone|mesh-list
154119480|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154119481|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442946|NCT02062944|Sirolimus|sirolimus|mesh-list
154119482|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119483|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
154119484|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154119485|NCT04048070|Sufentanil|sufentanil|mesh-list
154119486|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154119487|NCT04048070|Narcotics|narcotics|mesh-ancestor
154119488|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119489|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119490|NCT04048070|Analgesics|analgesics|mesh-ancestor
154119491|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
154119492|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119518|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119519|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154119520|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
154119521|NCT00775034|Coagulants|coagulants|mesh-ancestor
154119522|NCT00813696|Gemcitabine|gemcitabine|mesh-list
154119523|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119524|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154119525|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
154119526|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119527|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
154119528|NCT00813774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154119529|NCT00813774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154119530|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119531|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
154119532|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119533|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154119534|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
154119535|NCT02557490|Raltitrexed|raltitrexed|mesh-list
154119536|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119537|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154119538|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
154119539|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119540|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154119541|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119568|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
154119569|NCT05589064|Vitamins|vitamins|mesh-ancestor
154119570|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
154119571|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119572|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153789949|NCT00288561|Growth Substances|growth substances|mesh-ancestor
153789953|NCT01607086|Lamotrigine|lamotrigine|mesh-list
154119573|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154119574|NCT00807690|Tacrolimus|tacrolimus|mesh-list
154119575|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119576|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
154119577|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119578|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154119579|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119580|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119581|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154119582|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
154119583|NCT00814008|Insulin|insulin|mesh-list
154119584|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154119585|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119586|NCT00814086|Paclitaxel|paclitaxel|mesh-list
154119587|NCT00814086|Cisplatin|cisplatin|mesh-list
154119588|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154119589|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119590|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
154119591|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
154119592|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
154119593|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119594|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154119595|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154119596|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154119597|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119598|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119599|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119600|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119609|NCT00654732|Vinblastine|vinblastine|mesh-list
154119610|NCT00654732|Antibodies|antibodies|mesh-list
154119611|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
154119612|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154119613|NCT00654732|Imidazole|imidazole|mesh-list
154119614|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
154119615|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119616|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119617|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154119618|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154119619|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154119620|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154119621|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119622|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119623|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154119624|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
154119625|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154119626|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
154119627|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
154119628|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
154119629|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
154119630|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154119631|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
154119632|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119633|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119634|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154119635|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
154119636|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154119637|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
154119638|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119639|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119640|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154119641|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
154119642|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
154119651|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
154119652|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154119653|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
154119654|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
154119655|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154119656|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154119657|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119658|NCT00767468|Sorafenib|sorafenib|mesh-list
154119659|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119660|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154119661|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119662|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119663|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
154119664|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154119665|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
154119666|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119667|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
154119668|NCT00669032|Protective Agents|protective agents|mesh-ancestor
154119669|NCT00775580|Atenolol|atenolol|mesh-list
154119670|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154119671|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154119672|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
154119673|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
154119674|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119675|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119676|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154119677|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154119678|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154119679|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
154119680|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119681|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119682|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
154119683|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154119684|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654609|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
154119687|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119688|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119689|NCT00654498|Pramipexole|pramipexole|mesh-list
154119690|NCT00654498|Dexpramipexole|dexpramipexole|mesh-list
154119691|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
154119692|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119693|NCT00654498|Protective Agents|protective agents|mesh-ancestor
154119694|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119695|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154119696|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154119697|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
154119698|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
154119699|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119700|NCT00670046|Valproic Acid|valproic acid|mesh-list
154119701|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
154119702|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119703|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119704|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
154119705|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119706|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119707|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
154119708|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154119709|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119710|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154119711|NCT00560391|Dexamethasone|dexamethasone|mesh-list
154119712|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
154119714|NCT00560391|Dasatinib|dasatinib|mesh-list
154119736|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154119737|NCT00775736|Insulin|insulin|mesh-list
154119738|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154119739|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
154119740|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
154119741|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154119742|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
154119743|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154119744|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154119745|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119746|NCT00537238|Pregabalin|pregabalin|mesh-list
154119747|NCT00537238|Levetiracetam|levetiracetam|mesh-list
154119748|NCT00537238|Analgesics|analgesics|mesh-ancestor
154119749|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
154119750|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119751|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119752|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
154119753|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154119754|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119755|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119756|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154119757|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154119758|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154119759|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154119760|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154119761|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
154119762|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
154119781|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154119782|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119783|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154119784|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154119786|NCT00942747|Temsirolimus|temsirolimus|mesh-list
154119787|NCT00942747|MTOR Inhibitors|mtor inhibitors|mesh-list
154119788|NCT00942747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154119789|NCT00942747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119790|NCT00942747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119791|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119792|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
154119793|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119794|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119795|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119796|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119797|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154119798|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
154119799|NCT00946491|Haloperidol|haloperidol|mesh-list
154119800|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
154119801|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
154119802|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
154119803|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119804|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119805|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154119831|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119832|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119833|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119834|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119835|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154119836|NCT00552669|Sirolimus|sirolimus|mesh-list
154119837|NCT00552669|Paclitaxel|paclitaxel|mesh-list
154119838|NCT00552669|Temsirolimus|temsirolimus|mesh-list
154119839|NCT00552669|MTOR Inhibitors|mtor inhibitors|mesh-list
154119840|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154119841|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119842|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
154119843|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
154119844|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
154119845|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119846|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119847|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119848|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154119849|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
154119850|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119851|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
154119855|NCT00943059|Acipimox|acipimox|mesh-list
154119883|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119884|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
154119885|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154119886|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
154119887|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
154119888|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154119889|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
154119890|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119891|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119892|NCT00776282|Loratadine|loratadine|mesh-list
154119893|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
154119894|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
154119895|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154119896|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154119897|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154119898|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
154119899|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
154119900|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154119901|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119902|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119903|NCT00943293|Fludarabine|fludarabine|mesh-list
154119904|NCT00943293|Melphalan|melphalan|mesh-list
154119905|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
154119906|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790238|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154119907|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119908|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154119909|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
154119910|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119911|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154119912|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
154119926|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154119927|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154119928|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154119930|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443384|NCT02006628|Cannabidiol|cannabidiol|mesh-list
154119931|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119933|NCT03041740|Bromides|bromides|mesh-list
154119934|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
154119935|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154119936|NCT00772694|Sorafenib|sorafenib|mesh-list
154119937|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119938|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154119939|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119940|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119941|NCT00776438|Vaccines|vaccines|mesh-list
154119942|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
154119943|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119944|NCT00943449|Sorafenib|sorafenib|mesh-list
154119945|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154119946|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154119982|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
154119983|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154119984|NCT00776516|Rifampin|rifampin|mesh-list
154119985|NCT00776516|Mirabegron|mirabegron|mesh-list
154119986|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154119987|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
154119988|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154119989|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154119990|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
154119991|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154119992|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154119993|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154119994|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154119995|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154119996|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154119997|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154119998|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154119999|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154120000|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154120001|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154120002|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154120003|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
154120004|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120005|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120006|NCT00776516|Urological Agents|urological agents|mesh-ancestor
154120029|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120030|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120031|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154120032|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154120033|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120034|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154120035|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154120036|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
153790294|NCT00270270|Hematinics|hematinics|mesh-ancestor
154120037|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153790338|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154120038|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154120039|NCT00570908|Capecitabine|capecitabine|mesh-list
154120040|NCT00570908|Sunitinib|sunitinib|mesh-list
154120041|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154120042|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
154120043|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120044|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120045|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154120046|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154120047|NCT00570908|Growth Substances|growth substances|mesh-ancestor
154120048|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120049|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
154120050|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120051|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120052|NCT00773084|Lisinopril|lisinopril|mesh-list
154120079|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120080|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120081|NCT00534976|Montelukast|montelukast|mesh-list
153443534|NCT01998906|Paclitaxel|paclitaxel|mesh-list
154120082|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154120083|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
154120084|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154120085|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
154120086|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120087|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120088|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154120089|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154120090|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120091|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154120092|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
154120093|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154120094|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154120095|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154120096|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120097|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120098|NCT00776828|Cilostazol|cilostazol|mesh-list
154120099|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154120100|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
154120101|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120102|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120103|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154120104|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
154120105|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154120122|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154120123|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120124|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
154120125|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120126|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120127|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120128|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
154120129|NCT02556866|Hormones|hormones|mesh-ancestor
154120130|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120131|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154120132|NCT00308113|Ubiquinone|ubiquinone|mesh-list
154120133|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
154120134|NCT00308113|Prednisone|prednisone|mesh-list
154120135|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120136|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
154120137|NCT00308113|Hormones|hormones|mesh-ancestor
154120138|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120139|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120140|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154120141|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120142|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
154120143|NCT00308113|Vitamins|vitamins|mesh-ancestor
154120144|NCT03903640|Nivolumab|nivolumab|mesh-list
154120145|NCT03903640|Ipilimumab|ipilimumab|mesh-list
154120146|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154120173|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154120174|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154120175|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154120176|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154120177|NCT04047758|Letrozole|letrozole|mesh-list
154120178|NCT04047758|Palbociclib|palbociclib|mesh-list
154120179|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120180|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154120181|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154120182|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120183|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120184|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154120185|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
154120186|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120187|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120188|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120230|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120231|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154120232|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154120233|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120234|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154120235|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154120236|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
153790396|NCT00270543|Leucovorin|leucovorin|mesh-list
154120237|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120238|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120239|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154120240|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
154120241|NCT04098653|Busulfan|busulfan|mesh-list
154120242|NCT04098653|Decitabine|decitabine|mesh-list
154120243|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154120244|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
154120245|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120246|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120247|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154120248|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
154120249|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120250|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120251|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154120252|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154120253|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
154120254|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120255|NCT05297123|Tretinoin|tretinoin|mesh-list
154120278|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154120279|NCT00773630|Protective Agents|protective agents|mesh-ancestor
154120280|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154120281|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154120282|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120283|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154120284|NCT04016922|Hematinics|hematinics|mesh-ancestor
154120285|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
154120286|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154120287|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154120288|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120289|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
154120290|NCT03646474|Coagulants|coagulants|mesh-ancestor
154120291|NCT00808002|Tenofovir|tenofovir|mesh-list
154120292|NCT00808002|Emtricitabine|emtricitabine|mesh-list
154120293|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
154120294|NCT00808002|Maraviroc|maraviroc|mesh-list
154120295|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
154120296|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120299|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120335|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120336|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
154120337|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154120338|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154120339|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
154120340|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120341|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154120342|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154120343|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120344|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120345|NCT00762359|Lansoprazole|lansoprazole|mesh-list
154120346|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
154120347|NCT00762359|Gefarnate|gefarnate|mesh-list
154120348|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154120349|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154120350|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154120351|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120352|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120353|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154120354|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
154120355|NCT00777530|Bosutinib|bosutinib|mesh-list
154120356|NCT00777530|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154120357|NCT00777530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120358|NCT00777530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120386|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154120387|NCT00654186|Growth Substances|growth substances|mesh-ancestor
154120388|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
154120389|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120390|NCT03275818|Paclitaxel|paclitaxel|mesh-list
154120391|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154120392|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120393|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
154120394|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
154120395|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
154120396|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120397|NCT03979105|Ketamine|ketamine|mesh-list
154120398|NCT03979105|Analgesics|analgesics|mesh-ancestor
154120399|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
154120400|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120401|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120402|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154120403|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154120404|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
154120405|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
154120406|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120407|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154120408|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154120409|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120410|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120411|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
154120412|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154120413|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120414|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
154120415|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154120416|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154120418|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
154120427|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154120428|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154120429|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154120430|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
154120431|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120432|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154120433|NCT00761891|Aspirin|aspirin|mesh-list
154120434|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154120435|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154120436|NCT00761891|Analgesics|analgesics|mesh-ancestor
154120437|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
154120438|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120439|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120440|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120441|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120442|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154120443|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154120444|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120445|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154120446|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154120447|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120448|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
154120449|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
154120450|NCT00321685|Leucovorin|leucovorin|mesh-list
154120451|NCT00321685|Folic Acid|folic acid|mesh-list
154120452|NCT00321685|Bevacizumab|bevacizumab|mesh-list
154120453|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154120454|NCT00321685|Capecitabine|capecitabine|mesh-list
154120455|NCT00321685|Fluorouracil|fluorouracil|mesh-list
154120474|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
154120475|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120476|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154120477|NCT00321685|Antidotes|antidotes|mesh-ancestor
154120478|NCT00321685|Protective Agents|protective agents|mesh-ancestor
154120479|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
154120480|NCT00321685|Vitamins|vitamins|mesh-ancestor
154120481|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
154120482|NCT00321685|Hematinics|hematinics|mesh-ancestor
154120483|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
154120484|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154120485|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
154120486|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120487|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
154120488|NCT00778076|Protective Agents|protective agents|mesh-ancestor
154120489|NCT00306787|Valacyclovir|valacyclovir|mesh-list
154120490|NCT00306787|Famciclovir|famciclovir|mesh-list
154120491|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
153424756|NCT05313386|Analgesics|analgesics|mesh-ancestor
154120492|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790548|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
154120493|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154120494|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120495|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120496|NCT00778232|Gabapentin|gabapentin|mesh-list
154120497|NCT00778232|Analgesics|analgesics|mesh-ancestor
154120498|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
154120499|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120500|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120501|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
154120521|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120522|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154120523|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154120524|NCT01066195|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154120525|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120526|NCT00774644|Clarithromycin|clarithromycin|mesh-list
154120527|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153500984|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
154120528|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120529|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154120530|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120531|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120532|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154120533|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154120534|NCT05123092|Morphine|morphine|mesh-list
154120535|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154120536|NCT05123092|Narcotics|narcotics|mesh-ancestor
154120537|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120538|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120539|NCT05123092|Analgesics|analgesics|mesh-ancestor
154120540|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
154120541|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120542|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154120543|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154120544|NCT00769067|Dacomitinib|dacomitinib|mesh-list
154120545|NCT00769067|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154120546|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120547|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120548|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120549|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120550|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
154120551|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
154120553|NCT00667394|Bevacizumab|bevacizumab|mesh-list
154120559|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120560|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
154120561|NCT05357326|Atropine|atropine|mesh-list
154120562|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154120563|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154120564|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154120566|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154120567|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
154120568|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120569|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120570|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154120571|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
154120572|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
154120573|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
154120574|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154120579|NCT00778466|Metformin|metformin|mesh-list
154120620|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154120621|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153790549|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153790550|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
154120622|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
154120624|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120625|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120626|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120627|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154120628|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154120629|NCT05265910|Analgesics|analgesics|mesh-ancestor
154120630|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
154120631|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120632|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120633|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120634|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
154120635|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
154120636|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
154120637|NCT00814866|Adalimumab|adalimumab|mesh-list
154120638|NCT00814866|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154120639|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120640|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120641|NCT00991978|Bevacizumab|bevacizumab|mesh-list
154120642|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
154120643|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154120644|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120645|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154120646|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154120647|NCT00991978|Growth Substances|growth substances|mesh-ancestor
154120648|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120649|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
154120650|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154120651|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120652|NCT00645528|Insulin|insulin|mesh-list
154120653|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154120654|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120655|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
154120656|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
153654610|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120657|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120659|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120660|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154120661|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154120662|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120663|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154120664|NCT00295633|Metformin|metformin|mesh-list
154120665|NCT00295633|Pioglitazone|pioglitazone|mesh-list
154120666|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
154120667|NCT00295633|Saxagliptin|saxagliptin|mesh-list
153790560|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154120668|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154120669|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120670|NCT00295633|Incretins|incretins|mesh-ancestor
154120671|NCT00295633|Hormones|hormones|mesh-ancestor
154120672|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120673|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154120674|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
154120675|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120676|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120677|NCT00570674|Paclitaxel|paclitaxel|mesh-list
154120678|NCT00570674|Carboplatin|carboplatin|mesh-list
154120679|NCT00570674|Cetuximab|cetuximab|mesh-list
154120680|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154120681|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154120682|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120683|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
154120684|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
154120685|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
154120687|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154120702|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154120703|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
154120704|NCT00768989|Ritonavir|ritonavir|mesh-list
154120705|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154120706|NCT00768989|Tenofovir|tenofovir|mesh-list
154120707|NCT00768989|Emtricitabine|emtricitabine|mesh-list
154120708|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
154120709|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154120710|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154120711|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
154120712|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120713|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120714|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154120715|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154120716|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
154120717|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120718|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154120719|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154120720|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154120721|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154120722|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154120723|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154120724|NCT00779714|Cytarabine|cytarabine|mesh-list
154120725|NCT00779714|Paclitaxel|paclitaxel|mesh-list
154120726|NCT00779714|Cisplatin|cisplatin|mesh-list
154120727|NCT00779714|Dacarbazine|dacarbazine|mesh-list
154120728|NCT00779714|Treosulfan|treosulfan|mesh-list
154120729|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154120730|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120731|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
154120732|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
154120733|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
154120734|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120735|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154120736|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
154120737|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
154120738|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120739|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153350341|NCT05902221|Amoxicillin|amoxicillin|mesh-list
154120740|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
154120741|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120742|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154120743|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
154120744|NCT00812760|Levodopa|levodopa|mesh-list
154120745|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154120746|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154120747|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
154120748|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120749|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120750|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120751|NCT00814944|Sirolimus|sirolimus|mesh-list
154120752|NCT00814944|Temsirolimus|temsirolimus|mesh-list
154120753|NCT00814944|MTOR Inhibitors|mtor inhibitors|mesh-list
154120754|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154120755|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120756|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154120757|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120758|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
154120759|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154120760|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
154120761|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120762|NCT00814944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154120763|NCT00814944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120764|NCT00814944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120765|NCT00779792|Triamcinolone|triamcinolone|mesh-list
154120766|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154120768|NCT00779792|Clobetasol|clobetasol|mesh-list
154120788|NCT00992134|Rituximab|rituximab|mesh-list
154120789|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154120790|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154120791|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790653|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120793|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120794|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154120795|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154120796|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
154120797|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120798|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
154120799|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120800|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154120801|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154120802|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
154120803|NCT02551536|Fexofenadine|fexofenadine|mesh-list
154120804|NCT02551536|Montelukast|montelukast|mesh-list
154120805|NCT02551536|Levocetirizine|levocetirizine|mesh-list
154120806|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154120807|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
154120808|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154120809|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
154120810|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120811|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120812|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154120813|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154120814|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120815|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154120816|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154120817|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154120818|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
154120819|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
154120820|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154120821|NCT00815022|Fentanyl|fentanyl|mesh-list
154120828|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
154120829|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120830|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154120831|NCT00815022|Narcotics|narcotics|mesh-ancestor
154120832|NCT00815022|Analgesics|analgesics|mesh-ancestor
154120833|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154120834|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154120835|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
154120836|NCT00774722|Metronidazole|metronidazole|mesh-list
154120837|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120838|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154120839|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154120840|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154120841|NCT00808392|Vaccines|vaccines|mesh-list
154120842|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
154120843|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120844|NCT04045548|Dinoprostone|dinoprostone|mesh-list
154120845|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
154120846|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154120847|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120848|NCT00780104|Cytarabine|cytarabine|mesh-list
154120849|NCT00780104|Sirolimus|sirolimus|mesh-list
154120850|NCT00780104|Etoposide|etoposide|mesh-list
154120851|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
154120852|NCT00780104|Temsirolimus|temsirolimus|mesh-list
154120853|NCT00780104|MTOR Inhibitors|mtor inhibitors|mesh-list
153790695|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154120854|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154120855|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120856|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154120871|NCT00780104|Analgesics|analgesics|mesh-ancestor
154120878|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154120879|NCT04047680|Ledipasvir|ledipasvir|mesh-list
154120880|NCT04047680|Velpatasvir|velpatasvir|mesh-list
154120881|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154120882|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154120883|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154120884|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
154120885|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120886|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120887|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154120888|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154120889|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
154120890|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120891|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154120892|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154120893|NCT00774878|Fulvestrant|fulvestrant|mesh-list
154120894|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154120895|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120896|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154120897|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154120898|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
154120899|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120900|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120901|NCT00815256|Riboflavin|riboflavin|mesh-list
153350573|NCT05736861|Ivermectin|ivermectin|mesh-list
154120926|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
154120927|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120928|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
154120929|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154120930|NCT00784394|Protective Agents|protective agents|mesh-ancestor
154120931|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120932|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120933|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
154120934|NCT00305695|Imidazole|imidazole|mesh-list
154120935|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154120936|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120937|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120938|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120939|NCT00784472|Morphine|morphine|mesh-list
154120940|NCT00784472|Oxycodone|oxycodone|mesh-list
154120941|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154120942|NCT00784472|Narcotics|narcotics|mesh-ancestor
154120943|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154120944|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120945|NCT00784472|Analgesics|analgesics|mesh-ancestor
154120946|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
154120947|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154120948|NCT00779012|Infliximab|infliximab|mesh-list
154120949|NCT00779012|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154120950|NCT00779012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154120951|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
154120976|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154120977|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154120978|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
154120979|NCT03978559|Hormones|hormones|mesh-ancestor
154120980|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154120981|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154120982|NCT03978559|Protective Agents|protective agents|mesh-ancestor
154120983|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154120984|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154120985|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
154120986|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154120987|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154120988|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154120989|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154120990|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154120991|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154120992|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154120993|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154120994|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
154120995|NCT00813072|Docetaxel|docetaxel|mesh-list
154120996|NCT00813072|Irinotecan|irinotecan|mesh-list
154120997|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154120998|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
154120999|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
154121000|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
154121001|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121002|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154121023|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154121024|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154121025|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154121026|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121027|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
154121028|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154121029|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
154121030|NCT00815568|Fludarabine|fludarabine|mesh-list
154121031|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
154121032|NCT00815568|Busulfan|busulfan|mesh-list
154121033|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121034|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154121035|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
154121036|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121037|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154121038|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
154121039|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121040|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
154121041|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154121042|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154121043|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
154121044|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
154121045|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153380923|NCT02342886|Rifampin|rifampin|mesh-list
154121046|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154121047|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121048|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121049|NCT00815646|Urological Agents|urological agents|mesh-ancestor
154121050|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
154121051|NCT01066351|Hematinics|hematinics|mesh-ancestor
154121052|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154121053|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154121054|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121055|NCT00661778|Bevacizumab|bevacizumab|mesh-list
154121056|NCT00661778|Docetaxel|docetaxel|mesh-list
154121057|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154121058|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121062|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121063|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
154121064|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
154121065|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
154121066|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
154121067|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121069|NCT01062139|Levocetirizine|levocetirizine|mesh-list
154121070|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154121071|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154121072|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
154121073|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
154121074|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121075|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121076|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121077|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154121078|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154121079|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154121080|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154121081|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154121082|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121083|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
154121114|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154121115|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121116|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121117|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
154121118|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
154121119|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154121120|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154121121|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121122|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121123|NCT00780728|Urological Agents|urological agents|mesh-ancestor
154121124|NCT00809172|Cyclosporine|cyclosporine|mesh-list
154121125|NCT00809172|Methotrexate|methotrexate|mesh-list
154121126|NCT00809172|Cyclosporins|cyclosporins|mesh-list
154121127|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154121128|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
154121129|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154121130|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121131|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154121132|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
154121133|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501581|NCT00384540|Dobutamine|dobutamine|mesh-list
154121134|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121135|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121136|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121137|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154121138|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154121139|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
154121140|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154121141|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154121142|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
154121143|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121144|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154121145|NCT00784862|Tamoxifen|tamoxifen|mesh-list
154121146|NCT00784862|Anastrozole|anastrozole|mesh-list
154121147|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154121148|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
153350734|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154121149|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121150|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121151|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154121152|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121153|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154121154|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154121155|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154121156|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154121157|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154121158|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121159|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121160|NCT00784940|Tamoxifen|tamoxifen|mesh-list
154121161|NCT00784940|Anastrozole|anastrozole|mesh-list
154121162|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154121163|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
154121164|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121165|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121166|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154121167|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121168|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154121169|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154121170|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154121171|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154121172|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154121173|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121174|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121175|NCT00790244|Doxorubicin|doxorubicin|mesh-list
154121176|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154121177|NCT00790244|Ifosfamide|ifosfamide|mesh-list
154121178|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
154121179|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154121183|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121186|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
154121187|NCT00785018|Complement C1s|complement c1s|mesh-list
154121188|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
154121189|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
154121190|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
154121191|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121192|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154121193|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154121194|NCT00534352|Ritonavir|ritonavir|mesh-list
153790881|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121195|NCT00534352|Darunavir|darunavir|mesh-list
154121196|NCT00534352|Etravirine|etravirine|mesh-list
154121197|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154121198|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154121199|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
154121200|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121201|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121202|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154121203|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154121204|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
154121205|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121206|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153501664|NCT00421980|Etanercept|etanercept|mesh-list
154121207|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154121208|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154121209|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154121210|NCT00642174|Clopidogrel|clopidogrel|mesh-list
154121211|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154121212|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154121213|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154121214|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154121215|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154121216|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
154121227|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
154121228|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154121229|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154121230|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154121231|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
154121232|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121233|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121234|NCT00665366|Valproic Acid|valproic acid|mesh-list
154121235|NCT00665366|Aripiprazole|aripiprazole|mesh-list
154121236|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
154121237|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154121238|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154121239|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154121240|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121241|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121242|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
154121243|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
154121244|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121245|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121246|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154121247|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154121248|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
154121249|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154121250|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154121251|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154121252|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154121272|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154121274|NCT02556008|Cannabidiol|cannabidiol|mesh-list
154121275|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
154121276|NCT00992524|Misoprostol|misoprostol|mesh-list
154121277|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154121278|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
154121279|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154121280|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121281|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154121282|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121284|NCT00642018|Prednisone|prednisone|mesh-list
154121285|NCT00642018|Docetaxel|docetaxel|mesh-list
154121286|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121287|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
154121288|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
154121289|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
154121290|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121291|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121292|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
154121293|NCT00642018|Hormones|hormones|mesh-ancestor
154121294|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121295|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121296|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154121297|NCT00532948|Capecitabine|capecitabine|mesh-list
154121298|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154121299|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
154121300|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121301|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121302|NCT00998920|Equol|equol|mesh-list
154121303|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
154121319|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121320|NCT00995332|Cytarabine|cytarabine|mesh-list
154121321|NCT00995332|Tretinoin|tretinoin|mesh-list
154121322|NCT00995332|Valproic Acid|valproic acid|mesh-list
154121323|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154121324|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
153790931|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154121325|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121326|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121327|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
154121328|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121329|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154121330|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
154121331|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121332|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
154121333|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121334|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
154121335|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121336|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
154121337|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121338|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
154121339|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154121340|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121341|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154121342|NCT00992914|Lidocaine|lidocaine|mesh-list
154121343|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
154121344|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
154121345|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121346|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121347|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
154121348|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121349|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154121350|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154121351|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154121360|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121361|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154121362|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121363|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121364|NCT00993070|Capsaicin|capsaicin|mesh-list
154121365|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
154121366|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121367|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
154121368|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121369|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121370|NCT00993304|Liraglutide|liraglutide|mesh-list
154121371|NCT00993304|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154121372|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154121373|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121374|NCT00993304|Incretins|incretins|mesh-ancestor
153791031|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121375|NCT00993304|Hormones|hormones|mesh-ancestor
154121376|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121377|NCT05189002|Dalteparin|dalteparin|mesh-list
154121415|NCT00821496|Estradiol|estradiol|mesh-list
154121416|NCT00821496|Estrogens|estrogens|mesh-ancestor
154121417|NCT00821496|Hormones|hormones|mesh-ancestor
154121418|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121419|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121420|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154121421|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
154121422|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154121423|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154121424|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154121425|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154121426|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154121427|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154121428|NCT02550912|Vitamin D|vitamin d|mesh-list
154121429|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
154121430|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
154121431|NCT02550912|Vitamins|vitamins|mesh-list
154121432|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
154121433|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121434|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154121435|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154121437|NCT00999700|Docetaxel|docetaxel|mesh-list
154121438|NCT00999700|Fluorouracil|fluorouracil|mesh-list
154121439|NCT00999700|Cetuximab|cetuximab|mesh-list
154121441|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
154121465|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154121466|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154121467|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154121468|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121469|NCT00821574|Diuretics|diuretics|mesh-ancestor
154121470|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
154121471|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121472|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154121473|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154121474|NCT00995800|Fluticasone|fluticasone|mesh-list
154121475|NCT00995800|Xhance|xhance|mesh-list
154121476|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
154121477|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121478|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154121479|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
154121480|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121481|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121482|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154121483|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
154121484|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121485|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154121486|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154121487|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154121488|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154121489|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
154121490|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121491|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121493|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
153351140|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154121510|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121511|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154121513|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154121514|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154121515|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154121516|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154121517|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
154121518|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
154121519|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
154121520|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
154121521|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121522|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121523|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
154121524|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
154121525|NCT00994006|Levulinic acid|levulinic acid|mesh-list
154121526|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121527|NCT00994006|Cathartics|cathartics|mesh-ancestor
154121528|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121529|NCT00994006|Antacids|antacids|mesh-ancestor
154121530|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121531|NCT00818610|Amoxicillin|amoxicillin|mesh-list
154121532|NCT00818610|Clarithromycin|clarithromycin|mesh-list
154121533|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154121534|NCT00818610|Cefuroxime|cefuroxime|mesh-list
154121535|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
154121536|NCT00818610|Lactams|lactams|mesh-list
154121537|NCT00818610|beta-Lactams|beta-lactams|mesh-list
154121538|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154121539|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121540|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154121541|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121542|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121551|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154121552|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154121553|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154121554|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
154121555|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121556|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121557|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154121558|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154121559|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
154121560|NCT00627042|Ramucirumab|ramucirumab|mesh-list
154121561|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154121562|NCT00627042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154121563|NCT00627042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154121564|NCT00627042|Growth Substances|growth substances|mesh-ancestor
154121565|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121566|NCT00627042|Growth Inhibitors|growth inhibitors|mesh-ancestor
154121567|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121568|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
154121569|NCT00319111|Bosentan|bosentan|mesh-list
153791057|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
154121570|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154121571|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154121572|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121573|NCT00994396|Vitamin D|vitamin d|mesh-list
154121574|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
154121575|NCT00994396|Vitamins|vitamins|mesh-ancestor
154121576|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
154121577|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121578|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154121579|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154121580|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
154121581|NCT00816426|Rifampin|rifampin|mesh-list
154121582|NCT00816426|Isoniazid|isoniazid|mesh-list
154121583|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
154121585|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154121594|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
154121595|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154121596|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154121597|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154121598|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154121599|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154121600|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154121601|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154121602|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154121603|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154121604|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
154121605|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154121606|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154121607|NCT00996190|Phenylephrine|phenylephrine|mesh-list
154121608|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
154121609|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154121610|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
154121611|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
154121612|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121613|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121614|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
154121615|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154121616|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
154121617|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
154121618|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154121626|NCT00640224|Drospirenone|drospirenone|mesh-list
154121640|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154121641|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154121642|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
154121643|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154121644|NCT00640224|Diuretics|diuretics|mesh-ancestor
154121645|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
154121646|NCT01000792|Cetirizine|cetirizine|mesh-list
154121647|NCT01000792|Levocetirizine|levocetirizine|mesh-list
154121648|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154121649|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154121650|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
154121651|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
154121652|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121655|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154121702|NCT00318643|Mitomycins|mitomycins|mesh-list
154121703|NCT00318643|Mitomycin|mitomycin|mesh-list
154121704|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154121705|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121706|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
154121707|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121708|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154121709|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121710|NCT00994708|Esomeprazole|esomeprazole|mesh-list
154121711|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154121712|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121713|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154121714|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121715|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121716|NCT01064557|Tretinoin|tretinoin|mesh-list
154121717|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121718|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
154121719|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121720|NCT01001962|Metformin|metformin|mesh-list
154121721|NCT01001962|Empagliflozin|empagliflozin|mesh-list
154121722|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154121723|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121724|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154121725|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121726|NCT01066429|Dexamethasone|dexamethasone|mesh-list
154121727|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
154121728|NCT01066429|BB 1101|bb 1101|mesh-list
154121729|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121730|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
154121731|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
154121747|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121749|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154121750|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154121751|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121752|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154121753|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154121754|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154121755|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121756|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154121757|NCT00994942|Morphine|morphine|mesh-list
154121758|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154121759|NCT00994942|Narcotics|narcotics|mesh-ancestor
154121760|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121761|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121762|NCT00994942|Analgesics|analgesics|mesh-ancestor
154121763|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
154121764|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121765|NCT01002898|Ritonavir|ritonavir|mesh-list
154121766|NCT01002898|Lopinavir|lopinavir|mesh-list
154121767|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154121768|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154121769|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
154121770|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121771|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121773|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154121774|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
154121775|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121776|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154121777|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154121791|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154121792|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121793|NCT01004068|Clomiphene|clomiphene|mesh-list
154121794|NCT01004068|Enclomiphene|enclomiphene|mesh-list
154121795|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
154121796|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154121797|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
154121798|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121799|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121800|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154121801|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
154121802|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154121803|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154121804|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154121805|NCT01004224|Infigratinib|infigratinib|mesh-list
154121806|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502260|NCT01271010|Fludarabine|fludarabine|mesh-list
154121807|NCT00530920|Ritonavir|ritonavir|mesh-list
154121809|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154121810|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154121811|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
154121812|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121813|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121814|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154121815|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154121816|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
154121817|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121818|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154121819|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154121820|NCT01004380|Carboplatin|carboplatin|mesh-list
154121821|NCT01004380|Farletuzumab|farletuzumab|mesh-list
154121822|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121823|NCT01003522|Anesthetics|anesthetics|mesh-list
154121824|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
154121825|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121826|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121830|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121831|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121832|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
154121833|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154121834|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
154121835|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
154121836|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121837|NCT04000126|Lidocaine|lidocaine|mesh-list
154121838|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
154121839|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
154121840|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121841|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121842|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
154121843|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121844|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154121845|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154121846|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154121847|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154121848|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121849|NCT01008982|Belimumab|belimumab|mesh-list
154121850|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154121851|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
154121852|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121853|NCT01005160|Metformin|metformin|mesh-list
154121854|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154121855|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121856|NCT01005238|Lamivudine|lamivudine|mesh-list
154121857|NCT01005238|Telbivudine|telbivudine|mesh-list
154121858|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154121860|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121874|NCT01005472|Growth Substances|growth substances|mesh-ancestor
154121875|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121876|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
154121877|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154121878|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121879|NCT01005550|Ropivacaine|ropivacaine|mesh-list
154121880|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
154121881|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
154121882|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154121883|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121884|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
154121885|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121886|NCT03999580|Vitamin D|vitamin d|mesh-list
154121887|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
154121888|NCT03999580|Vitamins|vitamins|mesh-ancestor
154121889|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
154121890|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121891|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154121892|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153791190|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154121893|NCT00768755|Pemetrexed|pemetrexed|mesh-list
154121894|NCT00768755|Axitinib|axitinib|mesh-list
154121895|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791233|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121896|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121897|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121898|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154121899|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154121900|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154121901|NCT01005628|Bortezomib|bortezomib|mesh-list
154121902|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121903|NCT00530842|Fluticasone|fluticasone|mesh-list
154121904|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
154121918|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
154121919|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121920|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121921|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154121922|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154121923|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154121924|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
154121925|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
154121927|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121928|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
154121929|NCT01005784|Cetrorelix|cetrorelix|mesh-list
154121930|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154121931|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
154121932|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154121933|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121934|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
154121935|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121936|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154121937|NCT01006096|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154121938|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154121939|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154121940|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154121966|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121967|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121968|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154121969|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
154121971|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121972|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121973|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154121974|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
154121975|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
154121976|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154121977|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
154121978|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
154121979|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121980|NCT01007500|Dexamethasone|dexamethasone|mesh-list
154121981|NCT01007500|Ondansetron|ondansetron|mesh-list
154121982|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154121983|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
154121984|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
154121985|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154121986|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154121987|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154121988|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
154121989|NCT01007500|Hormones|hormones|mesh-ancestor
154121990|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154121991|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154121992|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154121993|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
154121994|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
154121995|NCT01007500|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154121996|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154121997|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
154121998|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154121999|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122006|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122007|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122008|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154122009|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
154122010|NCT00642954|Hormones|hormones|mesh-ancestor
154122011|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122012|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154122013|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122014|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
154122015|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154122016|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154122017|NCT00642954|Growth Substances|growth substances|mesh-ancestor
154122018|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
154122019|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154122020|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122021|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122022|NCT00816660|Factor VIII|factor viii|mesh-list
154122023|NCT00816660|Coagulants|coagulants|mesh-ancestor
154122024|NCT00819000|Interferon-beta|interferon-beta|mesh-list
154122025|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
154122026|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
154122027|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
154122028|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154122029|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
154122030|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122031|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122032|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122033|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122034|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
154122035|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122036|NCT00640146|Bromides|bromides|mesh-list
154122037|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
154122038|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
154122039|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153791289|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
154122040|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122041|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
154122042|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122043|NCT00819078|Bupropion|bupropion|mesh-list
153654611|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154122044|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154122045|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
154122046|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154122047|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154122048|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154122049|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154122050|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122051|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
154122052|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122053|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122054|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154122055|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154122056|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122057|NCT01008046|Metformin|metformin|mesh-list
154122058|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
154122059|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154122060|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154122061|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122062|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
154122063|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122064|NCT01008046|Expectorants|expectorants|mesh-ancestor
154122067|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
154122095|NCT00303667|Vidarabine|vidarabine|mesh-list
154122096|NCT00303667|Aldesleukin|aldesleukin|mesh-list
154122097|NCT00303667|Cyclosporine|cyclosporine|mesh-list
154122098|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
154122099|NCT00303667|Fludarabine|fludarabine|mesh-list
154122100|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
154122101|NCT00303667|Interleukin-2|interleukin-2|mesh-list
154122102|NCT00303667|Cyclosporins|cyclosporins|mesh-list
154122103|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
154122104|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122105|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
154122106|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122107|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122108|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154122109|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
154122110|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122111|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122112|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154122113|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154122114|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
154122115|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
154122116|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122117|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122118|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
154122119|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
154122120|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154122121|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154122122|NCT00303667|Analgesics|analgesics|mesh-ancestor
154122125|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154122145|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154122146|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
154122147|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
154122148|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122149|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122150|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122152|NCT01062529|Hormones|hormones|mesh-ancestor
154122153|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122154|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122155|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
154122156|NCT00760877|Nilotinib|nilotinib|mesh-list
154122157|NCT00760877|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154122158|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154122159|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122160|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122161|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122162|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154122163|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154122164|NCT00302731|Hormones|hormones|mesh-list
154122165|NCT00302731|Estradiol|estradiol|mesh-list
154122166|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154122167|NCT00302731|Progesterone|progesterone|mesh-list
154122168|NCT00302731|Estrogens|estrogens|mesh-list
154122169|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122170|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122171|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154122172|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
154122173|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154122174|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154122175|NCT00302731|Progestins|progestins|mesh-ancestor
154122176|NCT00780143|Cytarabine|cytarabine|mesh-list
154122177|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154122178|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
154122180|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122183|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122184|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
154122185|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122186|NCT01007968|Panobinostat|panobinostat|mesh-list
154122187|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122188|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154122189|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122190|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122191|NCT00779909|Vitamin D|vitamin d|mesh-list
154122192|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
154122193|NCT00779909|Vitamins|vitamins|mesh-ancestor
154122194|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
154122195|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122196|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154122197|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154122198|NCT00302107|Mirtazapine|mirtazapine|mesh-list
154122199|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
154122200|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154122201|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154122202|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
154122203|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
154122204|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122205|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122206|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122207|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154122208|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154122209|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122210|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154122211|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154122212|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154122213|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
154122225|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122226|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154122227|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154122229|NCT04988152|Antiviral Agents|antiviral agents|mesh-ancestor
154122230|NCT04988152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122231|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
154122232|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154122233|NCT00636168|Ipilimumab|ipilimumab|mesh-list
154122234|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122235|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122236|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154122237|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122238|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154122239|NCT00759941|Latanoprost|latanoprost|mesh-list
154122240|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154122241|NCT00759941|Brinzolamide|brinzolamide|mesh-list
154122242|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154122243|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122244|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122245|NCT00315445|Acetaminophen|acetaminophen|mesh-list
154122247|NCT00315445|Oxycodone|oxycodone|mesh-list
154122277|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122278|NCT04102943|Tacrolimus|tacrolimus|mesh-list
154122279|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122280|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
154122281|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122282|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154122283|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122284|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122285|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154122286|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
153791492|NCT06301204|Coagulants|coagulants|mesh-ancestor
154122287|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122288|NCT00300781|Neratinib|neratinib|mesh-list
154122289|NCT00300781|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154122290|NCT00300781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154122291|NCT00300781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122292|NCT00300781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122293|NCT00315055|Vaccines|vaccines|mesh-list
154122294|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
154122295|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122296|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
154122297|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154122298|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122299|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
154122300|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122301|NCT00293293|Taxane|taxane|mesh-list
154122302|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122303|NCT05774574|Cannabidiol|cannabidiol|mesh-list
154122304|NCT05774574|Anticonvulsants|anticonvulsants|mesh-ancestor
154122305|NCT05774275|Doxorubicin|doxorubicin|mesh-list
154122306|NCT05774275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154122307|NCT05774275|Antibodies|antibodies|mesh-list
154122308|NCT05774275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154122309|NCT05774275|Immunologic Factors|immunologic factors|mesh-ancestor
154122310|NCT05774275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122311|NCT05774275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154122318|NCT05774028|Gemcitabine|gemcitabine|mesh-list
154122319|NCT05774028|Etoposide|etoposide|mesh-list
154122320|NCT05774028|Mitoxantrone|mitoxantrone|mesh-list
154122321|NCT05774028|Pegaspargase|pegaspargase|mesh-list
154122322|NCT05774028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122323|NCT05774028|Antiemetics|antiemetics|mesh-ancestor
154122324|NCT05774028|Autonomic Agents|autonomic agents|mesh-ancestor
154122325|NCT05774028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122326|NCT05774028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122327|NCT05774028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154122328|NCT05774028|Glucocorticoids|glucocorticoids|mesh-ancestor
154122329|NCT05774028|Hormones|hormones|mesh-ancestor
154122330|NCT05774028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122331|NCT05774028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154122332|NCT05774028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122333|NCT05774028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154122334|NCT05774028|Antimetabolites|antimetabolites|mesh-ancestor
154122335|NCT05774028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122337|NCT05774028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154122338|NCT05774028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154122339|NCT05774028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122340|NCT05774028|Analgesics|analgesics|mesh-ancestor
154122341|NCT05774028|Sensory System Agents|sensory system agents|mesh-ancestor
154122342|NCT05773911|Chitosan|chitosan|mesh-list
154122343|NCT05773911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154122344|NCT05773911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154122345|NCT05773911|Antimetabolites|antimetabolites|mesh-ancestor
154122346|NCT05773911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122347|NCT05773911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154122348|NCT05773911|Chelating Agents|chelating agents|mesh-ancestor
154122350|NCT05773911|Hemostatics|hemostatics|mesh-ancestor
154122365|NCT05773183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122366|NCT05773183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122369|NCT05732051|Nicotinic Acids|nicotinic acids|mesh-list
154122370|NCT05732051|Vitamin B Complex|vitamin b complex|mesh-ancestor
154122371|NCT05732051|Vitamins|vitamins|mesh-ancestor
154122372|NCT05732051|Micronutrients|micronutrients|mesh-ancestor
154122373|NCT05732051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122374|NCT05732051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154122375|NCT05732051|Antimetabolites|antimetabolites|mesh-ancestor
154122376|NCT05732051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122377|NCT05732051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154122378|NCT05732051|Vasodilator Agents|vasodilator agents|mesh-ancestor
154122379|NCT05667922|Tacrolimus|tacrolimus|mesh-list
154122380|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122381|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
154122382|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122383|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154122384|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122385|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122386|NCT05667909|Rituximab|rituximab|mesh-list
154122387|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122388|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122389|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
154122390|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122391|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122392|NCT05667896|Tacrolimus|tacrolimus|mesh-list
154122393|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
154122394|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122395|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
154122410|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122411|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122412|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154122413|NCT05667883|Hormones|hormones|mesh-ancestor
154122414|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122415|NCT05667805|Thrombin|thrombin|mesh-list
154122416|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
154122417|NCT05667805|Coagulants|coagulants|mesh-ancestor
154122418|NCT05554978|Landiolol|landiolol|mesh-list
154122419|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154122420|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154122421|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
153791632|NCT06300138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122422|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122423|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122424|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122425|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154122426|NCT05441267|Semaglutide|semaglutide|mesh-list
154122427|NCT05441267|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154122428|NCT05441267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154122429|NCT05441267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122430|NCT05438888|Warfarin|warfarin|mesh-list
154122431|NCT05438888|Apixaban|apixaban|mesh-list
154122432|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
154122433|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154122459|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154122460|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154122461|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
154122462|NCT05335928|Abatacept|abatacept|mesh-list
154122463|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154122464|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122465|NCT05335928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122466|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122467|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122468|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
154122469|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122470|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122471|NCT05286957|Tislelizumab|tislelizumab|mesh-list
154122472|NCT05286957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122473|NCT05286957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122474|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
154122475|NCT05282108|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154122476|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154122477|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122478|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122479|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122480|NCT05255276|Itraconazole|itraconazole|mesh-list
154122481|NCT05255276|Rifampin|rifampin|mesh-list
154122482|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
154122483|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122484|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154122485|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154122503|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154122505|NCT05243199|Irbesartan|irbesartan|mesh-list
154122506|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154122507|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154122508|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154122509|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154122510|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122511|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
154122512|NCT05227716|Analgesics|analgesics|mesh-ancestor
154122513|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
154122514|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122515|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122516|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
154122517|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122518|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154122519|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
154122520|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154122557|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154122558|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154122559|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154122560|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154122561|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
154122562|NCT04974216|Rituximab|rituximab|mesh-list
154122563|NCT04974216|Lenalidomide|lenalidomide|mesh-list
154122564|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122565|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122566|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
154122567|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122568|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122569|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154122570|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154122571|NCT04974216|Growth Substances|growth substances|mesh-ancestor
154122572|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
154122573|NCT04972552|Ubiquinone|ubiquinone|mesh-list
154122574|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
154122575|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
154122576|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122577|NCT04972552|Vitamins|vitamins|mesh-ancestor
154122578|NCT04924699|Trastuzumab|trastuzumab|mesh-list
154122579|NCT04924699|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154122580|NCT04924699|Maytansine|maytansine|mesh-list
154122581|NCT04924699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122582|NCT04924699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122583|NCT04924699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154122584|NCT04924699|Tubulin Modulators|tubulin modulators|mesh-ancestor
154122585|NCT04924699|Antimitotic Agents|antimitotic agents|mesh-ancestor
154122586|NCT04924699|Mitosis Modulators|mitosis modulators|mesh-ancestor
154122587|NCT04924699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122588|NCT04924699|Immunotoxins|immunotoxins|mesh-ancestor
154122589|NCT04924699|Immunoconjugates|immunoconjugates|mesh-ancestor
154122601|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122602|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154122603|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154122604|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
154122605|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122606|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122607|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154122608|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154122609|NCT04802590|Venetoclax|venetoclax|mesh-list
154122610|NCT04802590|Ibrutinib|ibrutinib|mesh-list
154122611|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122612|NCT04802590|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154122613|NCT04802590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154122614|NCT04802590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122615|NCT04802590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122616|NCT04776993|Methimazole|methimazole|mesh-list
154122617|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
154122618|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
154122619|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122620|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791796|NCT06279234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154122621|NCT04545944|Midazolam|midazolam|mesh-list
154122622|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154122623|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154122624|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122625|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122626|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154122627|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153503046|NCT01720290|Metformin|metformin|mesh-list
154122628|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154122630|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
154122644|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154122645|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122646|NCT04391283|Osimertinib|osimertinib|mesh-list
154122647|NCT04391283|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154122648|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154122649|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122650|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122651|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122652|NCT04374799|Heparin|heparin|mesh-list
154122653|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
154122654|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154122655|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154122656|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122657|NCT04266275|Curcumin|curcumin|mesh-list
154122658|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154122659|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154122660|NCT04266275|Analgesics|analgesics|mesh-ancestor
154122661|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
154122662|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122663|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122664|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122665|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122666|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122667|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122668|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122669|NCT04194359|Bevacizumab|bevacizumab|mesh-list
154122670|NCT04194359|Capecitabine|capecitabine|mesh-list
154122671|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
154122672|NCT04194359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122673|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122676|NCT04194359|Growth Substances|growth substances|mesh-ancestor
154122685|NCT04041232|Glycerol|glycerol|mesh-list
154122686|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154122687|NCT04041232|Protective Agents|protective agents|mesh-ancestor
154122688|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122689|NCT04030000|Paclitaxel|paclitaxel|mesh-list
154122690|NCT04030000|Carboplatin|carboplatin|mesh-list
154122691|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154122692|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122693|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
154122694|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
154122695|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
154122696|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122697|NCT03957590|Paclitaxel|paclitaxel|mesh-list
154122698|NCT03957590|Tislelizumab|tislelizumab|mesh-list
154122699|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153503123|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
154122700|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122701|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
154122702|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
154122703|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
154122704|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122705|NCT03957590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154122706|NCT03921866|Palbociclib|palbociclib|mesh-list
154122707|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122708|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154122709|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122710|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122711|NCT03760588|Valsartan|valsartan|mesh-list
154122729|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
154122730|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122731|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154122732|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
154122733|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
154122734|NCT03573700|Fludarabine|fludarabine|mesh-list
154122735|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122736|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
154122737|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122738|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122739|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154122740|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
154122741|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122742|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122743|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154122744|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
154122745|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154122746|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122747|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122748|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154122749|NCT03530371|Analgesics|analgesics|mesh-ancestor
154122750|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
154122751|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122752|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154122753|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154122754|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154122755|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
154122756|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122757|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122758|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
154122759|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154122768|NCT03448783|Apixaban|apixaban|mesh-list
154122771|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154122772|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
153729679|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154122773|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122774|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122775|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
154122776|NCT03418649|Eplerenone|eplerenone|mesh-list
154122777|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154122778|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
154122779|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791844|NCT06208410|Paclitaxel|paclitaxel|mesh-list
154122780|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122781|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154122782|NCT03418649|Diuretics|diuretics|mesh-ancestor
154122783|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
154122784|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154122785|NCT03315832|Valsartan|valsartan|mesh-list
154122786|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154122787|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154122788|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154122789|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122790|NCT03122652|Teriflunomide|teriflunomide|mesh-list
154122791|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154122792|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154122793|NCT03122652|Analgesics|analgesics|mesh-ancestor
154122794|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
154122795|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122814|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154122815|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154122816|NCT02944578|Analgesics|analgesics|mesh-ancestor
154122817|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
154122818|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154122819|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122820|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122821|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122822|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122823|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122824|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122825|NCT02889523|Prednisolone|prednisolone|mesh-list
154122826|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
154122827|NCT02889523|Rituximab|rituximab|mesh-list
154122828|NCT02889523|Doxorubicin|doxorubicin|mesh-list
154122829|NCT02889523|Vincristine|vincristine|mesh-list
154122830|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154122870|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122871|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154122872|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122873|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
154122874|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154122875|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154122876|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122877|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
154122878|NCT02314988|Coagulants|coagulants|mesh-ancestor
154122879|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
154122880|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154122881|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154122882|NCT01850355|Buspirone|buspirone|mesh-list
154122883|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154122884|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153791852|NCT06208410|Mitosis Modulators|mitosis modulators|mesh-ancestor
154122885|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154122886|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122887|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154122888|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154122889|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
154122890|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154122923|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154122924|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
154122925|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122926|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154122927|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154122928|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154122929|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
154122930|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154122931|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154122932|NCT00602459|Growth Substances|growth substances|mesh-ancestor
154122933|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
154122934|NCT00199069|Cytarabine|cytarabine|mesh-list
154122935|NCT00199069|Dexamethasone|dexamethasone|mesh-list
154122936|NCT00199069|Prednisolone|prednisolone|mesh-list
154122937|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
154122938|NCT00199069|Ifosfamide|ifosfamide|mesh-list
154122939|NCT00199069|Methotrexate|methotrexate|mesh-list
154122940|NCT00199069|Vincristine|vincristine|mesh-list
154122941|NCT00199069|Doxorubicin|doxorubicin|mesh-list
154122942|NCT00199069|Daunorubicin|daunorubicin|mesh-list
154122943|NCT00199069|Asparaginase|asparaginase|mesh-list
154122944|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
154122979|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
154122980|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154122981|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154122982|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154122983|NCT00199069|Analgesics|analgesics|mesh-ancestor
154122984|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
154122985|NCT00199043|Allopurinol|allopurinol|mesh-list
154122986|NCT00199043|Rasburicase|rasburicase|mesh-list
154122987|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
154122988|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154122989|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154122990|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
154122991|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154122992|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154122993|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
153791926|NCT06162455|Antioxidants|antioxidants|mesh-ancestor
154122994|NCT00199043|Protective Agents|protective agents|mesh-ancestor
153503412|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
154122995|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154122996|NCT02601989|Tadalafil|tadalafil|mesh-list
154122997|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
154122998|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154122999|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154123000|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123001|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123002|NCT02601989|Urological Agents|urological agents|mesh-ancestor
154123003|NCT01067053|Bevacizumab|bevacizumab|mesh-list
154123028|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
154123029|NCT01067365|Enclomiphene|enclomiphene|mesh-list
154123032|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
154123033|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154123034|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
154123035|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
154123036|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123037|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154123038|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
154123039|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123040|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123041|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154123042|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
154123043|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154123044|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154123045|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154123046|NCT00568776|Inositol|inositol|mesh-list
154123047|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
154123048|NCT00568776|Vitamins|vitamins|mesh-ancestor
154123049|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
154123050|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123051|NCT01067443|Amphotericin B|amphotericin b|mesh-list
154123052|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154123053|NCT01067443|Miltefosine|miltefosine|mesh-list
154123054|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154123055|NCT01067443|Amebicides|amebicides|mesh-ancestor
154123056|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154123078|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
154123079|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123080|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123081|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123082|NCT00816816|Docetaxel|docetaxel|mesh-list
154123083|NCT00816816|Fluorouracil|fluorouracil|mesh-list
154123084|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123085|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
154123086|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
154123087|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
154123088|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123089|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
154123090|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154123091|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154123092|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
154123093|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123094|NCT00816894|Olanzapine|olanzapine|mesh-list
154123095|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
154123096|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
154123097|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123098|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123099|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123100|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154123101|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154123102|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123103|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123104|NCT00816894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154123105|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123106|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123107|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123108|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123109|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
154123110|NCT00635154|Dexamethasone|dexamethasone|mesh-list
154123111|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
154123114|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154123117|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123118|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123119|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123120|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
154123121|NCT00635154|Hormones|hormones|mesh-ancestor
154123122|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123123|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154123124|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123125|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154123126|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
154123127|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123128|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123129|NCT00822744|Escitalopram|escitalopram|mesh-list
154123130|NCT00822744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154123131|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123132|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123133|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123134|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123135|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
154123136|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123167|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154123168|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154123169|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154123170|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154123171|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
154123172|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154123173|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123175|NCT00756275|Varenicline|varenicline|mesh-list
154123176|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154123177|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
154123178|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123179|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123180|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154123181|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154123182|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
154123183|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123184|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123185|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
154123186|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154123187|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
154123188|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154123189|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
154123190|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123218|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
154123219|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
154123220|NCT01067677|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154123221|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153503636|NCT02242812|Metoprolol|metoprolol|mesh-list
154123222|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
153791979|NCT06136598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123223|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123224|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123225|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154123226|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154123227|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123228|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
154123229|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
154123230|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
154123231|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154123232|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
154123233|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
154123234|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154123235|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154123239|NCT03979651|Trametinib|trametinib|mesh-list
154123278|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123279|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123280|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154123281|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
154123282|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
154123283|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
154123284|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123285|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123286|NCT02600741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154123287|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123288|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123289|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
154123290|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
154123291|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154123292|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154123293|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153792020|NCT06040099|Bevacizumab|bevacizumab|mesh-list
154123294|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154123295|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153503720|NCT02244294|Tamsulosin|tamsulosin|mesh-list
154123296|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
154123297|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
154123298|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154123299|NCT01065649|Nortriptyline|nortriptyline|mesh-list
154123300|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154123301|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
154123302|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123303|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154123304|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123305|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123320|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154123321|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154123322|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123323|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123324|NCT01065805|Alovudine|alovudine|mesh-list
154123325|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
154123326|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123327|NCT00311623|Sirolimus|sirolimus|mesh-list
154123328|NCT00311623|Temsirolimus|temsirolimus|mesh-list
154123329|NCT00311623|MTOR Inhibitors|mtor inhibitors|mesh-list
154123330|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154123331|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123332|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154123333|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123334|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
154123335|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154123336|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
154123337|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123338|NCT00311623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154123339|NCT00311623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123340|NCT00311623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123341|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
154123342|NCT01067989|Pamidronate|pamidronate|mesh-list
154123344|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
154123345|NCT01067989|Capecitabine|capecitabine|mesh-list
154123346|NCT01067989|Methotrexate|methotrexate|mesh-list
154123347|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154123348|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
154123349|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123367|NCT01067989|Analgesics|analgesics|mesh-ancestor
154123368|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
154123369|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123370|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154123371|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154123372|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154123373|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154123374|NCT00633594|Rituximab|rituximab|mesh-list
154123375|NCT00633594|Lenalidomide|lenalidomide|mesh-list
154123376|NCT00633594|Bortezomib|bortezomib|mesh-list
153792058|NCT06009107|Cyclophosphamide|cyclophosphamide|mesh-list
154123377|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154123378|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123379|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
154123380|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123381|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154123382|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154123383|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154123384|NCT00633594|Growth Substances|growth substances|mesh-ancestor
154123385|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
154123387|NCT04840888|Carbamazepine|carbamazepine|mesh-list
154123388|NCT04840888|Omeprazole|omeprazole|mesh-list
154123389|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154123390|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123391|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154123392|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123393|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123394|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
154123395|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123396|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154123397|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154123398|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154123399|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
154123400|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123401|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123407|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123408|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154123409|NCT04840888|Analgesics|analgesics|mesh-ancestor
154123410|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
154123411|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123412|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154123413|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123414|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154123415|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154123416|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154123417|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154123418|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123419|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123420|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123421|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123422|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123423|NCT00755807|Analgesics|analgesics|mesh-ancestor
154123424|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
154123425|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123426|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
154123427|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123428|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
154123429|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
154123430|NCT05372224|Vitamin D|vitamin d|mesh-list
154123431|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154123432|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123433|NCT05372224|Vitamins|vitamins|mesh-ancestor
154123434|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
154123451|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154123452|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154123453|NCT00817284|Growth Substances|growth substances|mesh-ancestor
154123454|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123455|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
154123456|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154123457|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154123458|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123459|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123460|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154123461|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
154123462|NCT04096157|Isavuconazole|isavuconazole|mesh-list
154123463|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
154123464|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123465|NCT00823290|Sorafenib|sorafenib|mesh-list
154123466|NCT00823290|Panobinostat|panobinostat|mesh-list
154123467|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123468|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154123469|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123470|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123471|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154123472|NCT00755417|Gabapentin|gabapentin|mesh-list
154123473|NCT00755417|Analgesics|analgesics|mesh-ancestor
154123474|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
154123475|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123476|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123477|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
154123478|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154123479|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154123480|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123481|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353099|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
154123492|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123493|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123494|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
154123495|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123496|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123497|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154123498|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123499|NCT00825864|Dexamethasone|dexamethasone|mesh-list
154123501|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
154123502|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154123503|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154123504|NCT00825864|BB 1101|bb 1101|mesh-list
154123505|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154123506|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
154123507|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
154123508|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123509|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123510|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154123511|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
154123512|NCT00825864|Hormones|hormones|mesh-ancestor
154123513|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123514|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154123515|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123516|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154123517|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154123518|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154123519|NCT00825864|Analgesics|analgesics|mesh-ancestor
154123520|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
154123521|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154123522|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154123523|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446980|NCT00002489|Vitamins|vitamins|mesh-ancestor
154123525|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
154123534|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123535|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123536|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
154123537|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123538|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154123539|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154123540|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
154123541|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154123542|NCT00527332|Narcotics|narcotics|mesh-ancestor
154123543|NCT00527332|Analgesics|analgesics|mesh-ancestor
154123544|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154123545|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
154123546|NCT00820092|Hormones|hormones|mesh-ancestor
154123547|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123548|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123549|NCT00823602|Buserelin|buserelin|mesh-list
154123550|NCT00823602|Ganirelix|ganirelix|mesh-list
154123551|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
154123552|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123553|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123554|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154123586|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123587|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
154123588|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123589|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
154123590|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154123591|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154123592|NCT00755183|Testosterone|testosterone|mesh-list
154123593|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
154123594|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
154123595|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154123596|NCT00755183|Androgens|androgens|mesh-ancestor
154123597|NCT00755183|Hormones|hormones|mesh-ancestor
154123598|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123599|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123600|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154123601|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123602|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
154123604|NCT00826254|Vitamin K|vitamin k|mesh-list
154123605|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
154123606|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123607|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154123608|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154123609|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123610|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
154123611|NCT00826254|Coagulants|coagulants|mesh-ancestor
154123612|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154123613|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
154123614|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123615|NCT00820404|BLI-489|bli-489|mesh-list
154123616|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154123617|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874650|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154123618|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123619|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154123620|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123621|NCT00820482|Menotropins|menotropins|mesh-list
154123622|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154123625|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123626|NCT00754793|Dexetimide|dexetimide|mesh-list
154123627|NCT00754793|Citalopram|citalopram|mesh-list
154123628|NCT00754793|Escitalopram|escitalopram|mesh-list
154123629|NCT00754793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154123630|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123631|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123632|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123633|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123634|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
154123635|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123636|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154123637|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154123638|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
154123639|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
154123640|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123641|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154123642|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154123643|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
154123644|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154123645|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
154123646|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123676|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154123677|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
154123678|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123679|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123680|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154123681|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
154123682|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154123683|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
154123684|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123685|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123686|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154123687|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
154123688|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
154123689|NCT00626028|Protective Agents|protective agents|mesh-ancestor
154123690|NCT00826644|Etoposide|etoposide|mesh-list
154123691|NCT00826644|Belotecan|belotecan|mesh-list
154123692|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123693|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154123694|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154123695|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154123696|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123699|NCT00826722|Levetiracetam|levetiracetam|mesh-list
154123728|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154123729|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154123730|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154123731|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
154123732|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123733|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123734|NCT00821028|Paclitaxel|paclitaxel|mesh-list
154123735|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154123736|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123737|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
154123738|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
154123739|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
154123740|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123741|NCT00826878|Tivozanib|tivozanib|mesh-list
154123742|NCT00826878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154123743|NCT00826878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123744|NCT00826878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123745|NCT00827034|Warfarin|warfarin|mesh-list
153504152|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154123747|NCT02600585|Vaccines|vaccines|mesh-list
154123780|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
154123781|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154123782|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154123783|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154123784|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123785|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123786|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154123787|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154123789|NCT00821262|Sevoflurane|sevoflurane|mesh-list
154123790|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154123791|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154123792|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123793|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154123794|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
154123795|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
154123796|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154123797|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154123798|NCT00524368|Ritonavir|ritonavir|mesh-list
154123799|NCT00524368|Darunavir|darunavir|mesh-list
154123800|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154123834|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
154123835|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154123836|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154123837|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154123838|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
154123839|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154123840|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123841|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154123842|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154123843|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154123844|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154123845|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
154123846|NCT01068067|Tacrolimus|tacrolimus|mesh-list
154123847|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154123849|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123850|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154123851|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123852|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123853|NCT00524134|Carvedilol|carvedilol|mesh-list
154123854|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154123855|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154123856|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
154123857|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123858|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123859|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123860|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154123861|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
154123878|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123879|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154123880|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154123881|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123882|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123883|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
154123884|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154123885|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154123886|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
154123887|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154123888|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154123889|NCT00297037|Analgesics|analgesics|mesh-ancestor
154123890|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
154123891|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123892|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123932|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154123933|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123934|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123935|NCT04095299|Capecitabine|capecitabine|mesh-list
154123936|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154123937|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
154123938|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123939|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154123940|NCT00296725|Fluoxetine|fluoxetine|mesh-list
154123941|NCT00296725|Imipramine|imipramine|mesh-list
154123942|NCT00296725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154123943|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123944|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123945|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123946|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123947|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
154123948|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123949|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154123950|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
154123951|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123952|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154123953|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154123954|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154123955|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154123956|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153792302|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153792303|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154123978|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154123979|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154123980|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154123981|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154123982|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
154123983|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154123984|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154123985|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154123986|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
154123987|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154123988|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154123989|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154123990|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154123992|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154123993|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154123995|NCT00754013|Donepezil|donepezil|mesh-list
153353677|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154124034|NCT00752219|Ceftazidime|ceftazidime|mesh-list
154124035|NCT00752219|Avibactam|avibactam|mesh-list
154124036|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124037|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154124038|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154124039|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154124040|NCT00752219|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154124041|NCT00752219|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154124042|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154124043|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124044|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124045|NCT02598791|Glucagon|glucagon|mesh-list
154124046|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154124047|NCT02598791|Incretins|incretins|mesh-ancestor
154124048|NCT02598791|Hormones|hormones|mesh-ancestor
154124049|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154124050|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124051|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124052|NCT00827346|Clopidogrel|clopidogrel|mesh-list
154124053|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154124054|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154124055|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154124056|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154124057|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
154124058|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124059|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124060|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124061|NCT00997750|Lornoxicam|lornoxicam|mesh-list
154124062|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154124063|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154124064|NCT00997750|Analgesics|analgesics|mesh-ancestor
154124065|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
154124066|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124067|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124068|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154124071|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154124072|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124073|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154124074|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154124075|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124076|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124077|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124078|NCT00997828|Everolimus|everolimus|mesh-list
154124079|NCT00997828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154124080|NCT00997828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124081|NCT00997828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124082|NCT00997828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124083|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154124084|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
154124085|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124086|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124087|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
154124088|NCT02598635|Vitamin D|vitamin d|mesh-list
154124089|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154124090|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124091|NCT02598635|Vitamins|vitamins|mesh-ancestor
154124092|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
154124093|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154124094|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
154124095|NCT04093271|Promethazine|promethazine|mesh-list
154124096|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154124097|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154124098|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124099|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124100|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
154124101|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
154124102|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
154124103|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124111|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124112|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154124113|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
154124114|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
154124116|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124117|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124119|NCT04094909|Cisplatin|cisplatin|mesh-list
154124120|NCT04094909|Carboplatin|carboplatin|mesh-list
154124121|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
154124122|NCT04094909|Pemetrexed|pemetrexed|mesh-list
154124123|NCT04094909|Endostatins|endostatins|mesh-list
154124124|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154124125|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124126|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
154124127|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
154124128|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
154124129|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792310|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154124130|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154124131|NCT04094909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154124132|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124133|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154124134|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154124135|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154124136|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154124137|NCT04094909|Growth Substances|growth substances|mesh-ancestor
154124138|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124139|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
154124140|NCT02599571|Nicotine|nicotine|mesh-list
154124141|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154124142|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
154124143|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124146|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154124155|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154124156|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154124157|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
154124158|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124159|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124160|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154124161|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
154124162|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
154124163|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154124164|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154124165|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154124166|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154124167|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
154124168|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124169|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124170|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154124171|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
154124172|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154124173|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154124174|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154124175|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
154124176|NCT00296491|Hormones|hormones|mesh-ancestor
154124177|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
154124178|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154124179|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154124180|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124181|NCT02599493|Rifampin|rifampin|mesh-list
154124183|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
154124200|NCT00296335|Mitomycin|mitomycin|mesh-list
154124201|NCT00296335|Doxifluridine|doxifluridine|mesh-list
153792361|NCT05552144|Listerine|listerine|mesh-list
154124202|NCT00296335|Floxuridine|floxuridine|mesh-list
154124203|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124204|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154124205|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
154124206|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124207|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154124208|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124209|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154124210|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
154124211|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154124212|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
154124213|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124214|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
154124215|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154124216|NCT04094597|Lactoferrin|lactoferrin|mesh-list
154124217|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124218|NCT01065961|Dexamethasone|dexamethasone|mesh-list
154124219|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
154124220|NCT01065961|BB 1101|bb 1101|mesh-list
154124221|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154124222|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
154124223|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
154124224|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124225|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124226|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124248|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124249|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154124250|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154124251|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
154124252|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792379|NCT05546853|Leucovorin|leucovorin|mesh-list
154124253|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124254|NCT01068301|Plerixafor|plerixafor|mesh-list
154124255|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154124256|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154124257|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
154124258|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124259|NCT01564810|Cetuximab|cetuximab|mesh-list
154124260|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154124261|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124262|NCT04094051|Ibrutinib|ibrutinib|mesh-list
153504668|NCT04677959|Albuterol|albuterol|mesh-list
154124263|NCT04094051|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154124264|NCT04094051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124265|NCT04094051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124266|NCT04094051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124267|NCT04093895|Taurolidine|taurolidine|mesh-list
154124268|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124269|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154124270|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124271|NCT00624780|Pregabalin|pregabalin|mesh-list
154124272|NCT00624780|Lorazepam|lorazepam|mesh-list
154124273|NCT00624780|Analgesics|analgesics|mesh-ancestor
154124274|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
154124275|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124277|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
154124294|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124295|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124297|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124298|NCT00831636|Cytarabine|cytarabine|mesh-list
154124299|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154124300|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
154124301|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124302|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124303|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
154124304|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124305|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154124306|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
154124307|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124308|NCT00750737|Amphotericin B|amphotericin b|mesh-list
154124309|NCT00750737|Posaconazole|posaconazole|mesh-list
154124310|NCT00750737|Amebicides|amebicides|mesh-ancestor
154124311|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154124312|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154124313|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124314|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154124315|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
154124316|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154124317|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154124318|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154124319|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124320|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124341|NCT02597699|Sufentanil|sufentanil|mesh-list
154124342|NCT02597699|Remifentanil|remifentanil|mesh-list
154124343|NCT02597699|Dsuvia|dsuvia|mesh-list
154124344|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
154124345|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
154124346|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124347|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124348|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
154124349|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124350|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154124351|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154124352|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154124353|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124354|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124355|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154124356|NCT02597699|Narcotics|narcotics|mesh-ancestor
154124357|NCT02597699|Analgesics|analgesics|mesh-ancestor
154124358|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154124359|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154124360|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
154124361|NCT00744653|Bleomycin|bleomycin|mesh-list
154124363|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124396|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154124397|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
154124398|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
154124399|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124400|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124401|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124402|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
154124403|NCT04089605|Hormones|hormones|mesh-ancestor
154124404|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154124405|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154124406|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124407|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
154124408|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124409|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124410|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154124411|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154124412|NCT04089605|Growth Substances|growth substances|mesh-ancestor
154124413|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
154124414|NCT00521404|Gemcitabine|gemcitabine|mesh-list
154124415|NCT00521404|Antibodies|antibodies|mesh-list
154124416|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
154124417|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124418|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154124419|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
154124420|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124421|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124422|NCT00311155|Amlodipine|amlodipine|mesh-list
154124423|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154124424|NCT00311155|Olmesartan|olmesartan|mesh-list
154124425|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154124426|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154124427|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154124428|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124429|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124433|NCT00311155|Diuretics|diuretics|mesh-ancestor
154124434|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
154124435|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154124436|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154124437|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154124438|NCT03981601|Lovastatin|lovastatin|mesh-list
154124439|NCT03981601|L 647318|l 647318|mesh-list
154124440|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
154124441|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154124442|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154124443|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
154124444|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124445|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154124446|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154124447|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124448|NCT00274651|Belinostat|belinostat|mesh-list
154124449|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124450|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154124451|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124452|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124453|NCT00274261|Nonoxynol|nonoxynol|mesh-list
154124454|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154124455|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154124456|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124457|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154124458|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
154124459|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154124460|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154124479|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124480|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124481|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154124482|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
154124483|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
154124484|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154124485|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154124486|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124487|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154124488|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
154124489|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154124490|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
154124491|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154124492|NCT01068847|Analgesics|analgesics|mesh-ancestor
154124493|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
154124494|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154124495|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154124496|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
154124497|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
154124498|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154124499|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154124500|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154124529|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124531|NCT00521014|Rituximab|rituximab|mesh-list
154124532|NCT00521014|Etoposide|etoposide|mesh-list
154124533|NCT00521014|Melphalan|melphalan|mesh-list
154124534|NCT00521014|Carmustine|carmustine|mesh-list
154124535|NCT00521014|Sargramostim|sargramostim|mesh-list
154124536|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154124537|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124538|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
154124539|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124540|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154124541|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154124542|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154124543|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154124544|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124545|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124546|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154124547|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
154124548|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
154124549|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124550|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154124551|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154124552|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
154124553|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154124554|NCT00825552|Risperidone|risperidone|mesh-list
154124555|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154124556|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
154124557|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124558|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124559|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124560|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153448035|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154124572|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124573|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154124574|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154124575|NCT00291577|Growth Substances|growth substances|mesh-ancestor
154124576|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124577|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
154124578|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124579|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124580|NCT00520936|Pemetrexed|pemetrexed|mesh-list
154124581|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124582|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124583|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124584|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154124585|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154124586|NCT02549430|Letrozole|letrozole|mesh-list
154124587|NCT02549430|Fulvestrant|fulvestrant|mesh-list
154124588|NCT02549430|Palbociclib|palbociclib|mesh-list
154124629|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
154124630|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124631|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154124632|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154124633|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124634|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
153792628|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154124635|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154124636|NCT00952575|Antibodies|antibodies|mesh-list
154124637|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153505054|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
154124638|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
154124639|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
154124640|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124641|NCT03865732|Pregnanolone|pregnanolone|mesh-list
154124642|NCT03865732|Ganaxolone|ganaxolone|mesh-list
154124643|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
154124644|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124645|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124646|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124647|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
154124648|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
154124649|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
154124650|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124651|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
154124652|NCT00944307|Antacids|antacids|mesh-list
154124653|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
154124654|NCT00944307|TEMPO|tempo|mesh-list
154124655|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154124656|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154124657|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
154124658|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124659|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154124672|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124673|NCT00953355|Metformin|metformin|mesh-list
154124674|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154124675|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124676|NCT00944463|Gemcitabine|gemcitabine|mesh-list
154124677|NCT00944463|Simvastatin|simvastatin|mesh-list
154124678|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154124679|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
154124680|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124681|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124682|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154124683|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154124734|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124735|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
154124736|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154124737|NCT00947895|Protective Agents|protective agents|mesh-ancestor
154124738|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154124739|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124740|NCT00623766|Dexamethasone|dexamethasone|mesh-list
154124741|NCT00623766|Prednisone|prednisone|mesh-list
154124742|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
154124743|NCT00623766|Prednisolone|prednisolone|mesh-list
154124744|NCT00623766|Triamcinolone|triamcinolone|mesh-list
154124745|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
154124746|NCT00623766|Betamethasone|betamethasone|mesh-list
154124747|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
154124748|NCT00623766|Ipilimumab|ipilimumab|mesh-list
154124749|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154124750|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
154124756|NCT00623766|Hormones|hormones|mesh-ancestor
154124794|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154124795|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124796|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124797|NCT00832806|Varenicline|varenicline|mesh-list
154124798|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154124799|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154124800|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
154124801|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124802|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124803|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124804|NCT00832884|Lacosamide|lacosamide|mesh-list
154124805|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
154124806|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154124807|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154124808|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124809|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124810|NCT02549118|Tenoxicam|tenoxicam|mesh-list
154124811|NCT02549118|Meperidine|meperidine|mesh-list
154124812|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154124813|NCT02549118|Narcotics|narcotics|mesh-ancestor
154124814|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124815|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124816|NCT02549118|Analgesics|analgesics|mesh-ancestor
154124817|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
154124818|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124819|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154124820|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154124821|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154124822|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154124823|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154124824|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154124825|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124826|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124828|NCT00957177|Analgesics|analgesics|mesh-ancestor
154124834|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154124835|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124836|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154124838|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154124839|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124840|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154124841|NCT00828594|Sorafenib|sorafenib|mesh-list
154124842|NCT00828594|Everolimus|everolimus|mesh-list
154124843|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154124844|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124845|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124846|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124847|NCT00828594|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154124848|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154124849|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
154124851|NCT00550407|Lamotrigine|lamotrigine|mesh-list
154124890|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124891|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154124892|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
154124893|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124894|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124895|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154124896|NCT00954603|Haloperidol|haloperidol|mesh-list
154124897|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154124898|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
154124899|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
154124900|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154124901|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154124902|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154124903|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124904|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124905|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
154124906|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
154124907|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154124908|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154124909|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154124910|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
154124911|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124912|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124913|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154124914|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153792775|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
154124915|NCT00531934|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154124916|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154124917|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124918|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124935|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154124936|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154124937|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154124938|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
154124939|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124940|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124941|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124942|NCT00549939|Urological Agents|urological agents|mesh-ancestor
154124943|NCT00272779|Emtricitabine|emtricitabine|mesh-list
154124944|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154124945|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
154124946|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154124947|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154124948|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154124949|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154124950|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124951|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154124990|NCT00998608|Risperidone|risperidone|mesh-list
154124991|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154124992|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
154124993|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154124994|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154124995|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154124996|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154124997|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154124998|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154124999|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154125000|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154125001|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
154125002|NCT04011813|Antioxidants|antioxidants|mesh-list
154125003|NCT04011813|Hypotaurine|hypotaurine|mesh-list
154125004|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125005|NCT04011813|Protective Agents|protective agents|mesh-ancestor
154125006|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125007|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154125008|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154125009|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125010|NCT00998686|Incretins|incretins|mesh-ancestor
154125011|NCT00998686|Hormones|hormones|mesh-ancestor
154125012|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125013|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154125014|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
154125015|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125016|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125017|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154125018|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154125019|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125020|NCT00958269|Incretins|incretins|mesh-ancestor
154125021|NCT00958269|Hormones|hormones|mesh-ancestor
154125022|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125030|NCT02547402|Pravastatin|pravastatin|mesh-list
154125031|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
154125032|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154125033|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154125034|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
154125035|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125036|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154125037|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154125038|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125039|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154125040|NCT01068925|Dolutegravir|dolutegravir|mesh-list
154125041|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154125042|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154125043|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125044|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125045|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154125046|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154125047|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
154125048|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125049|NCT00834600|Amlodipine|amlodipine|mesh-list
154125050|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154125051|NCT00834600|Olmesartan|olmesartan|mesh-list
154125052|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154125053|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154125054|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154125055|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154125056|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125057|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154125058|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125059|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
154125060|NCT00834600|Diuretics|diuretics|mesh-ancestor
154125061|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
154125062|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153354677|NCT05540743|Adalimumab|adalimumab|mesh-list
153654612|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153654613|NCT00043927|Cisplatin|cisplatin|mesh-list
153654614|NCT00043927|Etoposide|etoposide|mesh-list
153654615|NCT00043927|Topotecan|topotecan|mesh-list
153654616|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654617|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153354709|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125063|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154125064|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154125065|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
154125066|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154125067|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
154125068|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125069|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
154125070|NCT00958425|Protective Agents|protective agents|mesh-ancestor
154125071|NCT02547480|Irinotecan|irinotecan|mesh-list
154125072|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154125073|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154125074|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125075|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125076|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125077|NCT00838656|Paclitaxel|paclitaxel|mesh-list
154125078|NCT00838656|Carboplatin|carboplatin|mesh-list
154125079|NCT00838656|Gemcitabine|gemcitabine|mesh-list
154125080|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154125081|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125082|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654618|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153654619|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654631|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654632|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153654633|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153654634|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
153654635|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654636|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153654637|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153654638|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153654639|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153654640|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153654641|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153654642|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
153654643|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654644|NCT04731727|Riboflavin|riboflavin|mesh-list
153654645|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
153654646|NCT04731727|Vitamins|vitamins|mesh-ancestor
153654647|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
153654648|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654649|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153654650|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
153654651|NCT00044278|Lamotrigine|lamotrigine|mesh-list
153654652|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
153654653|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153654654|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654655|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654656|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153654657|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654658|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153654659|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153654660|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153654661|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154125084|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
154125085|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125086|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154125087|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
154125088|NCT00829608|Vaccines|vaccines|mesh-list
154125089|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
154125090|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125091|NCT00553605|Ketoprofen|ketoprofen|mesh-list
154125092|NCT00553605|Parecoxib|parecoxib|mesh-list
154125093|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154125094|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154125095|NCT00553605|Analgesics|analgesics|mesh-ancestor
154125096|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
154125097|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125098|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125099|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153654662|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153654663|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
153654664|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654665|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654666|NCT00044434|Bupropion|bupropion|mesh-list
153654667|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153654668|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
153654669|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153654670|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153654671|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153654672|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654673|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654674|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
153654675|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654676|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654677|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153654678|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153792850|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
153654679|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654680|NCT00044473|Levofloxacin|levofloxacin|mesh-list
153654681|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153654713|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
153654714|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654715|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654716|NCT00397384|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153654717|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654718|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654719|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654720|NCT00397423|Lenograstim|lenograstim|mesh-list
153654721|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153654722|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
153654723|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654724|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
153654725|NCT00397501|Carboplatin|carboplatin|mesh-list
153654726|NCT00397501|Methotrexate|methotrexate|mesh-list
153654727|NCT00397501|Trastuzumab|trastuzumab|mesh-list
153654728|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654745|NCT00397501|Protective Agents|protective agents|mesh-ancestor
153654746|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
153654747|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
153354745|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125100|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125101|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154125102|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125103|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125104|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154125105|NCT00838968|Interferons|interferons|mesh-list
154125106|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
154125107|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125108|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
154125109|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125110|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
154125111|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125112|NCT04010955|Edoxaban|edoxaban|mesh-list
154125113|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154125114|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
154125115|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154125116|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
154125117|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125118|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125119|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
154125120|NCT00948987|Aspirin|aspirin|mesh-list
154125121|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154125122|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154125123|NCT00948987|Analgesics|analgesics|mesh-ancestor
154125124|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
153792851|NCT04729114|Hormones|hormones|mesh-ancestor
154125125|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125126|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125127|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154125128|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125129|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154125130|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154125131|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125132|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154125133|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153354782|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125139|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125140|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
154125141|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
154125142|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
154125143|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125144|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154125145|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
154125146|NCT00744497|Hormones|hormones|mesh-ancestor
154125147|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125148|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125149|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154125150|NCT00744497|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154125151|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154125152|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125153|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
153654748|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654749|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654750|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
153654751|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
153654752|NCT00018174|Fluoxetine|fluoxetine|mesh-list
153654753|NCT00018174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153654754|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153654755|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654756|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654757|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654758|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
153654759|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654760|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153654761|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
153654762|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153654763|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153654764|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153654765|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792863|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153654766|NCT00044629|Zolpidem|zolpidem|mesh-list
153654767|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153654768|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153654769|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153654770|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654771|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153654772|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
153654773|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
153654774|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654775|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654776|NCT00044668|Exenatide|exenatide|mesh-list
153654777|NCT00044668|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153654778|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153654779|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654780|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153654781|NCT00044668|Incretins|incretins|mesh-ancestor
153654782|NCT00044668|Hormones|hormones|mesh-ancestor
153654783|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654784|NCT00044707|Pramlintide|pramlintide|mesh-list
153654799|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654800|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154125154|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154125155|NCT00949065|Antibodies|antibodies|mesh-list
154125156|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
154125157|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154125158|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
154125159|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125160|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154125161|NCT00955149|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154125162|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154125163|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125164|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125165|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125166|NCT00955227|Ezetimibe|ezetimibe|mesh-list
154125167|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154125168|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154125169|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
154125170|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125171|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154125172|NCT00949299|Buprenorphine|buprenorphine|mesh-list
154125173|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154125174|NCT00949299|Narcotics|narcotics|mesh-ancestor
154125175|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154125176|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125177|NCT00949299|Analgesics|analgesics|mesh-ancestor
154125178|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
154125179|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125180|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154125181|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154125182|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154125183|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154125184|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
154125185|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125186|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153654801|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654802|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654803|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
153654804|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654805|NCT00044785|Antidotes|antidotes|mesh-ancestor
153654806|NCT00044785|Protective Agents|protective agents|mesh-ancestor
153654807|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
153654808|NCT00044785|Vitamins|vitamins|mesh-ancestor
153654809|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
154125187|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153792898|NCT04564885|Meloxicam|meloxicam|mesh-list
154125189|NCT00271609|Bevacizumab|bevacizumab|mesh-list
154125190|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125191|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125192|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154125193|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154125194|NCT00271609|Growth Substances|growth substances|mesh-ancestor
154125195|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125196|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
154125197|NCT00548847|Interferons|interferons|mesh-list
154125198|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
154125199|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
154125200|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154125201|NCT00548847|Molgramostim|molgramostim|mesh-list
153654810|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153654811|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654812|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654813|NCT00044824|Fexofenadine|fexofenadine|mesh-list
153654814|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153912734|NCT01030341|Insulin|insulin|mesh-list
153654815|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153654816|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153654817|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
153654818|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
153654819|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654820|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654821|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654822|NCT00018213|Naltrexone|naltrexone|mesh-list
153654823|NCT00018213|Nicotine|nicotine|mesh-list
153654824|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153654825|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
153654826|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654827|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654828|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153654829|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153654830|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
153654831|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654832|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654833|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153654834|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153654835|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
153654836|NCT00044863|Cetuximab|cetuximab|mesh-list
153654837|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153654838|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654839|NCT00044902|Epratuzumab|epratuzumab|mesh-list
153654840|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153654841|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654842|NCT00045136|Melphalan|melphalan|mesh-list
153654843|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153654844|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
153654845|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654846|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654867|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654868|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654869|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
153654870|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153654871|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
153654872|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153654873|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153654874|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
154125202|NCT00548847|Sargramostim|sargramostim|mesh-list
154125203|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125204|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
154125205|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125206|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
154125207|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125208|NCT00949377|Bromides|bromides|mesh-list
154125209|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
154125210|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
154125211|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154125212|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125213|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
154125214|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125215|NCT00290407|Rituximab|rituximab|mesh-list
154125216|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125217|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125218|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
154125219|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125220|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125221|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
154125222|NCT02597387|Analgesics|analgesics|mesh-ancestor
154125223|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
154125224|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125225|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125226|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125227|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154125228|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154125229|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125230|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125248|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125249|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
154125250|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
154125251|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125252|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154125253|NCT00955695|Gefitinib|gefitinib|mesh-list
154125254|NCT00955695|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154125255|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154125256|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125257|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125258|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125259|NCT00955773|Everolimus|everolimus|mesh-list
154125260|NCT00955773|Trametinib|trametinib|mesh-list
154125261|NCT00955773|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154125262|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154125263|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125264|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125265|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125266|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
154125267|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125268|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125269|NCT00549549|Celecoxib|celecoxib|mesh-list
154125270|NCT00549549|Indomethacin|indomethacin|mesh-list
153354893|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
153654875|NCT00045175|Topotecan|topotecan|mesh-list
153654876|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153654877|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153654878|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654879|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654880|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654881|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654882|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654883|NCT00045292|Valacyclovir|valacyclovir|mesh-list
153654884|NCT00045292|Acyclovir|acyclovir|mesh-list
153654885|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
153654886|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654887|NCT00045370|Interferons|interferons|mesh-list
153654888|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
153654889|NCT00045370|Sirolimus|sirolimus|mesh-list
153654890|NCT00045370|Temsirolimus|temsirolimus|mesh-list
153654891|NCT00045370|MTOR Inhibitors|mtor inhibitors|mesh-list
153654892|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654893|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
153654894|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654895|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
153654896|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654897|NCT00045370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654898|NCT00045370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654899|NCT00045370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654900|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654901|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654902|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153354915|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125271|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154125272|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154125273|NCT00549549|Analgesics|analgesics|mesh-ancestor
154125274|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
154125275|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125276|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125277|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154125278|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125279|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154125280|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154125281|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125282|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125283|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
154125284|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
154125285|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154125286|NCT00622284|Glimepiride|glimepiride|mesh-list
154125287|NCT00622284|Linagliptin|linagliptin|mesh-list
154125288|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154125289|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154125290|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125291|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125292|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
154125293|NCT00622284|Incretins|incretins|mesh-ancestor
154125294|NCT00622284|Hormones|hormones|mesh-ancestor
154125295|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125296|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154125297|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
154125298|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125299|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125300|NCT00269113|Rituximab|rituximab|mesh-list
154125301|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125302|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125303|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
154125304|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125305|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125306|NCT01069159|Propranolol|propranolol|mesh-list
154125307|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154125308|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154125309|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
154125310|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125311|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125312|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125313|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154125314|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154125315|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
154125316|NCT03975205|Doxorubicin|doxorubicin|mesh-list
154125317|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154125318|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125319|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154125320|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154125321|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125322|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125323|NCT01325779|Heparin|heparin|mesh-list
154125324|NCT01325779|Enoxaparin|enoxaparin|mesh-list
154125325|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
154125326|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154125327|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154125328|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125329|NCT05170659|Relatlimab|relatlimab|mesh-list
154125330|NCT05170659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125331|NCT05170659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125332|NCT05170659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154125333|NCT05170659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125334|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
154125335|NCT05352165|Fluorouracil|fluorouracil|mesh-list
154125336|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125337|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125338|NCT05352165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154125349|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
154125350|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
154125351|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
154125352|NCT00956163|Protective Agents|protective agents|mesh-ancestor
154125353|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125354|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154125355|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125356|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154125357|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125358|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154125359|NCT00956319|Estazolam|estazolam|mesh-list
154125360|NCT00956319|Zolpidem|zolpidem|mesh-list
154125361|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153874775|NCT01203787|Sorafenib|sorafenib|mesh-list
154125362|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154125363|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154125364|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125365|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154125366|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
154125367|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
153654903|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
153654922|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654923|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654924|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
153654925|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654926|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654927|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
153654928|NCT00045448|Growth Substances|growth substances|mesh-ancestor
153654929|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654931|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654932|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153654933|NCT00045526|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153654934|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654935|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654936|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654937|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654938|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
153654939|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654940|NCT00045604|Irinotecan|irinotecan|mesh-list
153654941|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
153654942|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654943|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153654944|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654945|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654946|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654947|NCT00045604|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153654948|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153654949|NCT00045682|Paclitaxel|paclitaxel|mesh-list
153654950|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153654951|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153654952|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153654953|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654954|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654955|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
153355013|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154125368|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125369|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125370|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
154125371|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154125372|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154125373|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154125374|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
154125375|NCT00835848|Exenatide|exenatide|mesh-list
154125376|NCT00835848|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154125377|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154125378|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125379|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154125380|NCT00835848|Incretins|incretins|mesh-ancestor
154125381|NCT00835848|Hormones|hormones|mesh-ancestor
154125382|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125383|NCT00961857|Metformin|metformin|mesh-list
154125384|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154125385|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154125386|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125387|NCT00961857|Incretins|incretins|mesh-ancestor
154125388|NCT00961857|Hormones|hormones|mesh-ancestor
154125389|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125390|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154125391|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
154125392|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125393|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125394|NCT02547792|Vaccines|vaccines|mesh-list
154125395|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
154125396|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125397|NCT00830466|Sirolimus|sirolimus|mesh-list
154125398|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154125399|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125400|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153654956|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654957|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654958|NCT00045721|Carmustine|carmustine|mesh-list
153654967|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
153654968|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
153654969|NCT04731766|Protective Agents|protective agents|mesh-ancestor
153654970|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125401|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125402|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
154125403|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125404|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
154125405|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125406|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154125407|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154125408|NCT00843570|Nafarelin|nafarelin|mesh-list
154125409|NCT00843570|Estradiol|estradiol|mesh-list
154125410|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154125411|NCT00843570|Progesterone|progesterone|mesh-list
154125412|NCT00843570|Estrogens|estrogens|mesh-ancestor
154125414|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125415|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125416|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154125417|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
154125418|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154125419|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154125420|NCT00843570|Progestins|progestins|mesh-ancestor
154125421|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154125422|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
154125423|NCT02547870|Rilpivirine|rilpivirine|mesh-list
154125424|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154125425|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154125426|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125427|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125428|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
154125429|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125430|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154125431|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154125432|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
154125433|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
154125434|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
154125435|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153654971|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153654972|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654973|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153654974|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654975|NCT00018447|Fluorides|fluorides|mesh-list
153654976|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
153654977|NCT00018447|Protective Agents|protective agents|mesh-ancestor
153654978|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654979|NCT00001688|Ritonavir|ritonavir|mesh-list
154125436|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125437|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
154125438|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125439|NCT00621504|Clarithromycin|clarithromycin|mesh-list
154125440|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
154125441|NCT00621504|Ceftaroline|ceftaroline|mesh-list
154125442|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154125443|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125444|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154125445|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125446|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125447|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154125448|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154125449|NCT00621504|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154125450|NCT00621504|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154125451|NCT00548145|Ezetimibe|ezetimibe|mesh-list
154125452|NCT00548145|Pitavastatin|pitavastatin|mesh-list
154125453|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154125454|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154125455|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
154125456|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125457|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154125458|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154125459|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125460|NCT00547911|Carbidopa|carbidopa|mesh-list
154125461|NCT00547911|Entacapone|entacapone|mesh-list
154125462|NCT00547911|Droxidopa|droxidopa|mesh-list
154125463|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154125464|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154125465|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
153355079|NCT03007381|Ketorolac|ketorolac|mesh-list
153654980|NCT00001688|Nevirapine|nevirapine|mesh-list
153654981|NCT00001688|Stavudine|stavudine|mesh-list
153654982|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153793121|NCT04198428|Analgesics|analgesics|mesh-ancestor
153654983|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153654984|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
153654985|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654986|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654987|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153654988|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153654989|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
153654990|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654991|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153654992|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154125466|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125467|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125468|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125469|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154125471|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154125472|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
154125473|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
154125475|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
154125476|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125477|NCT00836628|Busulfan|busulfan|mesh-list
154125478|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
154125479|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125480|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125481|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
154125482|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125483|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154125484|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125485|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154125487|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
154125488|NCT00962637|Enclomiphene|enclomiphene|mesh-list
154125489|NCT00962637|Clomiphene|clomiphene|mesh-list
154125490|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
154125491|NCT00962637|Testosterone|testosterone|mesh-list
154125492|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
154125493|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154125494|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
154125495|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
154125496|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125497|NCT00962637|Androgens|androgens|mesh-ancestor
154125498|NCT00962637|Hormones|hormones|mesh-ancestor
154125499|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125500|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125501|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154125502|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
154125503|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153654993|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153654994|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154125505|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154125506|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154125507|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154125508|NCT00839358|Midodrine|midodrine|mesh-list
154125509|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
154125510|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
154125511|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125512|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125513|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154125514|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154125515|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154125516|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154125517|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
154125518|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125519|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125520|NCT00962715|Interferons|interferons|mesh-list
154125521|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
154125522|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
154125523|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154125524|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125525|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
154125526|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125527|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
154125528|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125529|NCT00963027|Treprostinil|treprostinil|mesh-list
154125530|NCT00963027|Esomeprazole|esomeprazole|mesh-list
154125531|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154125532|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154125533|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154125534|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355143|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355144|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153355145|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
153355146|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355147|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
153654995|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153654996|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154125535|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125536|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154125537|NCT00837174|Bortezomib|bortezomib|mesh-list
154125538|NCT00837174|Vorinostat|vorinostat|mesh-list
154125539|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125540|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154125541|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125542|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125543|NCT04042974|Dinoprostone|dinoprostone|mesh-list
154125544|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
154125545|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154125546|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125547|NCT00844350|Letrozole|letrozole|mesh-list
154125548|NCT00844350|Oxytocin|oxytocin|mesh-list
154125549|NCT00844350|Clomiphene|clomiphene|mesh-list
154125550|NCT00844350|Enclomiphene|enclomiphene|mesh-list
154125551|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
154125552|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125553|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
154125554|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154125555|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125556|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125557|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154125558|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154125559|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125560|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154125561|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
153453349|NCT01732770|Denosumab|denosumab|mesh-list
154125562|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125563|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154125564|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
154125565|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154125576|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154125577|NCT00839826|Enoxaparin|enoxaparin|mesh-list
154125578|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
154125579|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154125580|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
154125581|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154125582|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
154125583|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125584|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125585|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
154125586|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154125587|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154125588|NCT00844662|Sevelamer|sevelamer|mesh-list
154125589|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
154125590|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
154125591|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125592|NCT04678089|Bortezomib|bortezomib|mesh-list
154125593|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125594|NCT00963573|Loratadine|loratadine|mesh-list
154125595|NCT00963573|Betamethasone|betamethasone|mesh-list
154125596|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154125597|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
154125598|NCT00963573|Hormones|hormones|mesh-ancestor
154125599|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125600|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125601|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154125602|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
154125603|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
154125604|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
154125605|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154125606|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154125607|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154125608|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
154125609|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
154125610|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125611|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355251|NCT00621686|Sorafenib|sorafenib|mesh-list
154125616|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125617|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125618|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125619|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154125620|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154125621|NCT00844740|Cinacalcet|cinacalcet|mesh-list
154125622|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154125623|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125624|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154125625|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
154125626|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125627|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
154125628|NCT00963729|Docetaxel|docetaxel|mesh-list
154125629|NCT00963729|Fluorouracil|fluorouracil|mesh-list
154125630|NCT00963729|Letrozole|letrozole|mesh-list
154125631|NCT00963729|Epirubicin|epirubicin|mesh-list
154125632|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125633|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
154125634|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125635|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125636|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154125637|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
154125638|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125639|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125640|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154125641|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
154125642|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
154125643|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
154125644|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
154125645|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154125646|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154125647|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154125648|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125649|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154125650|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
153654997|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
153654998|NCT00389402|Ritonavir|ritonavir|mesh-list
153654999|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153655000|NCT00389402|Saquinavir|saquinavir|mesh-list
154125651|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125652|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154125653|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154125654|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154125655|NCT00964041|Cycloserine|cycloserine|mesh-list
154125656|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154125657|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125658|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154125659|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
154125660|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154125661|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
154125662|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125663|NCT04009317|Crizotinib|crizotinib|mesh-list
154125664|NCT04009317|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154125665|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154125666|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125667|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125668|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125669|NCT03641547|Capecitabine|capecitabine|mesh-list
154125670|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125671|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655001|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153655002|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153655003|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
153655004|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655005|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655006|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153491971|NCT05032183|BB 1101|bb 1101|mesh-list
153655007|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153655008|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
153655009|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655010|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153655011|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153655012|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
153655013|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153655014|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
153655015|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655017|NCT00045799|Cimetidine|cimetidine|mesh-list
153655018|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
153655019|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153655020|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655021|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153655022|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655023|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655024|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153655025|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
153655026|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
153655058|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655059|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655060|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154125673|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125675|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154125676|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154125677|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
154125678|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
154125679|NCT00967629|Calcium|calcium|mesh-list
154125680|NCT00967629|Sevelamer|sevelamer|mesh-list
154125681|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154125682|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125683|NCT00967629|Antacids|antacids|mesh-ancestor
154125684|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125685|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154125686|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
154125687|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
153655061|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655062|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655064|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153655065|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153655066|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153655067|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
153655068|NCT04380207|QPX7728|qpx7728|mesh-list
153655081|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655082|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153655083|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153655084|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655085|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153655086|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153655087|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153655088|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
153655089|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
153655090|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655091|NCT00046033|Ritonavir|ritonavir|mesh-list
153655092|NCT00046033|Lopinavir|lopinavir|mesh-list
153655093|NCT00046033|Saquinavir|saquinavir|mesh-list
153655094|NCT00046033|Amprenavir|amprenavir|mesh-list
153655095|NCT00046033|Tenofovir|tenofovir|mesh-list
153793296|NCT03519945|Analgesics|analgesics|mesh-ancestor
153655096|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153655097|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153655098|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
153655099|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655100|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655101|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153655102|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153655103|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
153655104|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655105|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153655106|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153655107|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153655108|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153655109|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153655110|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
153655111|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153655112|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153655113|NCT04369560|Hematinics|hematinics|mesh-ancestor
153655114|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153655115|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154125688|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153449168|NCT00003599|Vitamin E|vitamin e|mesh-list
154125689|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
154125690|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125692|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154125693|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154125694|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154125695|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125696|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154125697|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154125698|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
154125699|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125700|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125701|NCT00840684|Cytarabine|cytarabine|mesh-list
154125702|NCT00840684|Melphalan|melphalan|mesh-list
154125703|NCT00840684|Busulfan|busulfan|mesh-list
154125704|NCT00840684|Daunorubicin|daunorubicin|mesh-list
154125705|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
153655116|NCT00046111|Topotecan|topotecan|mesh-list
153655117|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153655118|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153655119|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655120|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655121|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655122|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
153655123|NCT00001724|Analgesics|analgesics|mesh-ancestor
153655124|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
153655125|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655126|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655127|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153655128|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153793297|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
153655148|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655150|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655152|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153655153|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153655154|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
153655155|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655156|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655157|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153655158|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153655159|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
153655160|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655162|NCT00397657|Ezetimibe|ezetimibe|mesh-list
153655163|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153655164|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153655165|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
153655166|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655167|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153655168|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
153655169|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
153655170|NCT00397657|Vitamins|vitamins|mesh-ancestor
153655171|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
153655172|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655173|NCT00001763|Interleukin-12|interleukin-12|mesh-list
153655174|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153655175|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
153655176|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655177|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154125706|NCT00840684|Amsacrine|amsacrine|mesh-list
154125707|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154125708|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
154125709|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125710|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125711|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
154125712|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125713|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125714|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
154125715|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125716|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154125717|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
154125718|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154125719|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154125720|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154125721|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154125722|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125723|NCT00840684|Analgesics|analgesics|mesh-ancestor
154125724|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
154125725|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125727|NCT00574080|Thalidomide|thalidomide|mesh-list
154125728|NCT00574080|Dexamethasone|dexamethasone|mesh-list
154125729|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
154125730|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
154125731|NCT00574080|Melphalan|melphalan|mesh-list
154125732|NCT00574080|Carmustine|carmustine|mesh-list
154125733|NCT00574080|Cisplatin|cisplatin|mesh-list
154125734|NCT00574080|Etoposide|etoposide|mesh-list
153655178|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153655179|NCT00001763|Growth Substances|growth substances|mesh-ancestor
153655180|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
153655181|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655182|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
153655183|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153655184|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
153655185|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655186|NCT00397735|Expectorants|expectorants|mesh-ancestor
153655194|NCT00046384|Aripiprazole|aripiprazole|mesh-list
153655195|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
153655196|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655197|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153655198|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153655199|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655200|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655201|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
153655202|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
153655203|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655204|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655205|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153655206|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153655207|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
154125735|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
154125736|NCT00574080|Doxorubicin|doxorubicin|mesh-list
154125737|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154125738|NCT00574080|Bortezomib|bortezomib|mesh-list
154125739|NCT00574080|BB 1101|bb 1101|mesh-list
154125740|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125741|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
154125742|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125743|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125744|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154125745|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
154125746|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125747|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125748|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154125749|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154125750|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
154125751|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
154125752|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125753|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154125754|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
154125755|NCT00574080|Hormones|hormones|mesh-ancestor
154125756|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154125757|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154125758|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
154125759|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125760|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154125761|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793364|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125762|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154125763|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154125764|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
154125765|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
154125766|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125767|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153655208|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153655209|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153655210|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153655211|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153655212|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153655213|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655214|NCT04258410|Quercetin|quercetin|mesh-list
153655215|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
153655216|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125768|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
154125769|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154125770|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154125771|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154125772|NCT00574080|Growth Substances|growth substances|mesh-ancestor
154125773|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
154125774|NCT00845364|Perhexiline|perhexiline|mesh-list
154125775|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154125776|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154125777|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125778|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154125779|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125780|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
154125781|NCT00267865|Leucovorin|leucovorin|mesh-list
154125782|NCT00267865|Rituximab|rituximab|mesh-list
154125783|NCT00267865|Methotrexate|methotrexate|mesh-list
154125784|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125785|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125786|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
154125787|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125788|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125789|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154125790|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
154125791|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154125792|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154125793|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
154125794|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125795|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
154125796|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125797|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154125798|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154125799|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154125800|NCT00267865|Antidotes|antidotes|mesh-ancestor
154125801|NCT00267865|Protective Agents|protective agents|mesh-ancestor
154125802|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
154125806|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
154125807|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
154125808|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154125809|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125810|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
154125811|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793465|NCT02464696|Protective Agents|protective agents|mesh-ancestor
154125812|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154125813|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154125814|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154125815|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154125816|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125817|NCT00546117|Lansoprazole|lansoprazole|mesh-list
154125818|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
154125819|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154125820|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154125821|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154125822|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125823|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125824|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154125825|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154125826|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154125827|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
154125828|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125829|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154125830|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153355440|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
153355441|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
153655217|NCT04258410|Protective Agents|protective agents|mesh-ancestor
153655218|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655219|NCT00046462|Metformin|metformin|mesh-list
153655220|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
153655221|NCT00046462|Glyburide|glyburide|mesh-list
153655222|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153655223|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153655224|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655225|NCT00001766|Ritonavir|ritonavir|mesh-list
153655226|NCT00001766|Nelfinavir|nelfinavir|mesh-list
153655227|NCT00001766|Amprenavir|amprenavir|mesh-list
153655228|NCT00001766|Abacavir|abacavir|mesh-list
153655229|NCT00001766|Efavirenz|efavirenz|mesh-list
153655230|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153655231|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153655232|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
153655233|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655234|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655236|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153655237|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
154125832|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
154125833|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154125834|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154125835|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125836|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
154125837|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
154125838|NCT00967707|Gabapentin|gabapentin|mesh-list
154125839|NCT00967707|Donepezil|donepezil|mesh-list
154125840|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154125841|NCT00967707|Analgesics|analgesics|mesh-ancestor
154125842|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
154125843|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125844|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125845|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
154125846|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154125847|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154125848|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154125849|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153793576|NCT00861705|Antibodies|antibodies|mesh-list
154125850|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154125851|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154125852|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125853|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125854|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
154125855|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154125856|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125857|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
154125858|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
154125859|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154125867|NCT00845598|Fluticasone|fluticasone|mesh-list
154125876|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
154125877|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
154125878|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154125879|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154125880|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125881|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125882|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154125883|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154125884|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
154125885|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
154125886|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154125887|NCT00251719|Lansoprazole|lansoprazole|mesh-list
154125888|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
154125889|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154125890|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154125891|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154125892|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125893|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125894|NCT00845754|Ketorolac|ketorolac|mesh-list
154125895|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154125896|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154125897|NCT00845754|Analgesics|analgesics|mesh-ancestor
154125898|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
154125899|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154125900|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125901|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154125902|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125903|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154125904|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125905|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125906|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154125907|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
154125908|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
154125909|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125910|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
154125911|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125912|NCT00841386|Riboflavin|riboflavin|mesh-list
154125913|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
154125914|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
154125915|NCT00841386|Vitamins|vitamins|mesh-ancestor
154125916|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
153793632|NCT00588770|Carboplatin|carboplatin|mesh-list
154125917|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125918|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154125919|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
154125920|NCT03952143|Insulin|insulin|mesh-list
154125921|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154125922|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
154125923|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
154125924|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154125925|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125926|NCT00968331|Rituximab|rituximab|mesh-list
154125927|NCT00968331|Lenalidomide|lenalidomide|mesh-list
154125928|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125929|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125930|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
154125931|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125932|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154125933|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154125934|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154125935|NCT00968331|Growth Substances|growth substances|mesh-ancestor
154125936|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
154125937|NCT00852228|Cetuximab|cetuximab|mesh-list
154125938|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
154125939|NCT00852228|Irinotecan|irinotecan|mesh-list
154125940|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125941|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125942|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154125943|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153355546|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655238|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655239|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153655240|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153655241|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153655242|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153655243|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153655244|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153655245|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154125944|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125945|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125947|NCT00267007|Hematinics|hematinics|mesh-ancestor
154125948|NCT00841854|Metronidazole|metronidazole|mesh-list
154125949|NCT00841854|Tetracycline|tetracycline|mesh-list
154125950|NCT00841854|Pantoprazole|pantoprazole|mesh-list
154125951|NCT00841854|Bismuth|bismuth|mesh-list
154125952|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154125953|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154125954|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154125955|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154125956|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154125957|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154125958|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154125959|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154125960|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125961|NCT00841854|Antacids|antacids|mesh-ancestor
154125962|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154125963|NCT00848562|Nicorandil|nicorandil|mesh-list
154125964|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154125965|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154125966|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
154125967|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
154125968|NCT00848562|Vitamins|vitamins|mesh-ancestor
154125969|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
154125970|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125971|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154125972|NCT02546154|Hematinics|hematinics|mesh-ancestor
154125973|NCT03943095|Fluorides|fluorides|mesh-list
154125974|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
154125975|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
154125976|NCT03943095|Protective Agents|protective agents|mesh-ancestor
154125977|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154125978|NCT00848640|Sorafenib|sorafenib|mesh-list
154125979|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125980|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154125981|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655246|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153655247|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153655248|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153655249|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
153655250|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154125982|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125984|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
154125985|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
154125986|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154125987|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
154125988|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
154125989|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125990|NCT00848796|Heparin|heparin|mesh-list
154125991|NCT00848796|Calcium heparin|calcium heparin|mesh-list
154125992|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
154125993|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154125994|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154125995|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154125997|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154125998|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154125999|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
154126000|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126001|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126002|NCT04042506|Nivolumab|nivolumab|mesh-list
154126003|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154126004|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126005|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153793819|NCT00290901|Analgesics|analgesics|mesh-ancestor
154126006|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126007|NCT00251641|Infliximab|infliximab|mesh-list
154126008|NCT00251641|Methotrexate|methotrexate|mesh-list
154126009|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154126010|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
154126011|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154126012|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126013|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154126014|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
153355613|NCT00686582|Antiviral Agents|antiviral agents|mesh-ancestor
153655251|NCT00046501|Insulin|insulin|mesh-list
153655252|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
153655253|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153655254|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
153655271|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655273|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153655274|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
153655275|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655276|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126015|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126016|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126017|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
154126018|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126019|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154126020|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126021|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
154126022|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126023|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154126024|NCT00251641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154126025|NCT00251641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126026|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154126028|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
154126029|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154126030|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154126031|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154126032|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126033|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126034|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
153794134|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126035|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
154126036|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126037|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126038|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154126039|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154126040|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
154126041|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154126042|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154126043|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154126044|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154126046|NCT00849030|Anastrozole|anastrozole|mesh-list
153355681|NCT00687908|Adapalene|adapalene|mesh-list
154126055|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154126056|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154126057|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154126058|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126059|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126060|NCT00842400|Metformin|metformin|mesh-list
154126061|NCT00842400|Probenecid|probenecid|mesh-list
154126062|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126063|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126064|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
154126065|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
154126066|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126067|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
154126068|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126069|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126071|NCT00849264|Endostar protein|endostar protein|mesh-list
154126072|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
154126073|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126074|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154126075|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126076|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126077|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
154126078|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126079|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153355682|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153355686|NCT00687908|Analgesics|analgesics|mesh-ancestor
153655277|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153655278|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153655279|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
153655280|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655281|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655282|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
153655283|NCT00046852|Melphalan|melphalan|mesh-list
153655284|NCT00046852|Carmustine|carmustine|mesh-list
153655285|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153794136|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655286|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655287|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
153655288|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655289|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655290|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655291|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
153655292|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655293|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655294|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153655295|NCT00046969|Cisplatin|cisplatin|mesh-list
153655296|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655297|NCT00001805|Rituximab|rituximab|mesh-list
154126080|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154126081|NCT00849264|Growth Substances|growth substances|mesh-ancestor
154126082|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
154126084|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126085|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126086|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
154126087|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154126088|NCT00842556|Glimepiride|glimepiride|mesh-list
154126089|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154126090|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126091|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126092|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126094|NCT00842556|Hormones|hormones|mesh-ancestor
154126095|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126096|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154126097|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
154126098|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126099|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154126100|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126101|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
154126102|NCT00849654|Ibrutinib|ibrutinib|mesh-list
154126103|NCT00849654|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154126104|NCT00849654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126105|NCT00849654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126106|NCT00849654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126107|NCT00849966|Celecoxib|celecoxib|mesh-list
154126108|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154126109|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154126110|NCT00849966|Analgesics|analgesics|mesh-ancestor
154126111|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
154126112|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126113|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126115|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126119|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126120|NCT00853008|Cytarabine|cytarabine|mesh-list
154126121|NCT00853008|Dexamethasone|dexamethasone|mesh-list
154126122|NCT00853008|Prednisone|prednisone|mesh-list
154126123|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
154126124|NCT00853008|Methotrexate|methotrexate|mesh-list
154126125|NCT00853008|Vincristine|vincristine|mesh-list
154126126|NCT00853008|Daunorubicin|daunorubicin|mesh-list
154126127|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
154126128|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
154126129|NCT00853008|Teniposide|teniposide|mesh-list
154126130|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126131|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
154126132|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
153794202|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
154126133|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794203|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
154126134|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126135|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154126136|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
154126137|NCT00853008|Hormones|hormones|mesh-ancestor
154126138|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126139|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154126140|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126141|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154126142|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
154126143|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154126144|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154126145|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
154126146|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126147|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
154126148|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126149|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154126150|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126151|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
154126152|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126154|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
154126161|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154126162|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154126163|NCT00853008|Analgesics|analgesics|mesh-ancestor
154126164|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
154126165|NCT02545530|Clonidine|clonidine|mesh-list
154126166|NCT02545530|Analgesics|analgesics|mesh-ancestor
154126167|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
154126168|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126169|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126170|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154126171|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
154126172|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
154126173|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154126174|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154126175|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154126176|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
154126177|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126178|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126180|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154126181|NCT00853320|Narcotics|narcotics|mesh-ancestor
154126182|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126183|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126184|NCT00853320|Analgesics|analgesics|mesh-ancestor
154126185|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
154126186|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126187|NCT00547521|Methotrexate|methotrexate|mesh-list
154126188|NCT00547521|Abatacept|abatacept|mesh-list
154126189|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154126190|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
154126191|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154126192|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355789|NCT00592124|Tenofovir|tenofovir|mesh-list
153655298|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655299|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655300|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
153655301|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655302|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655303|NCT00047047|Gemcitabine|gemcitabine|mesh-list
153655304|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655305|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655306|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
153655307|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655308|NCT04733781|Lidocaine|lidocaine|mesh-list
153655309|NCT04733781|Epinephrine|epinephrine|mesh-list
154126193|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154126194|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
154126195|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126196|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126197|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
154126198|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126199|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154126200|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126201|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
154126202|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126203|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154126204|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154126205|NCT00547521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154126206|NCT00850044|Ritonavir|ritonavir|mesh-list
154126207|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154126208|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154126209|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
154126210|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126211|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126212|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154126213|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154126214|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
154126215|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126244|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154126245|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126246|NCT00968955|Ropivacaine|ropivacaine|mesh-list
154126247|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
154126248|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
154126249|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126250|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126251|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
154126252|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126253|NCT00853554|Hydromorphone|hydromorphone|mesh-list
154126254|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154126255|NCT00853554|Narcotics|narcotics|mesh-ancestor
154126256|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126257|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126258|NCT00853554|Analgesics|analgesics|mesh-ancestor
154126259|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
154126260|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126261|NCT00969033|Irinotecan|irinotecan|mesh-list
154126262|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154126263|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154126264|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126265|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126266|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126267|NCT00573768|Diclofenac|diclofenac|mesh-list
154126268|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154126269|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154126270|NCT00573768|Analgesics|analgesics|mesh-ancestor
153355870|NCT00595556|Zonisamide|zonisamide|mesh-list
153655310|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
153655311|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
153655312|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655340|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
153655341|NCT00047203|Growth Substances|growth substances|mesh-ancestor
153655342|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655343|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153655344|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655345|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655347|NCT04163874|Pancrelipase|pancrelipase|mesh-list
153655348|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655349|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153655350|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655351|NCT00047242|Irinotecan|irinotecan|mesh-list
153655353|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153655354|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153655355|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655356|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126271|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
154126272|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126273|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126274|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126275|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126276|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154126277|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126278|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126279|NCT00965913|Nicotine|nicotine|mesh-list
154126280|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154126281|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
154126282|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126283|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126284|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154126285|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154126286|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
154126287|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126288|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126289|NCT00853866|Reboxetine|reboxetine|mesh-list
154126290|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
153794364|NCT00292344|Loperamide|loperamide|mesh-list
154126291|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154126292|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154126293|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153355900|NCT00597818|Analgesics|analgesics|mesh-ancestor
153655369|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655370|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655371|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153655372|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153655373|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153655374|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153655375|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655376|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153655377|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153655379|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
153655380|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655381|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153655382|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153655383|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153655384|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
153655385|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153655386|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655387|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153655388|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153655389|NCT00047281|Growth Substances|growth substances|mesh-ancestor
153655390|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
153655391|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153655392|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153655393|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126294|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154126295|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126296|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
154126297|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126298|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126300|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
154126301|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126302|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154126303|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154126304|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126305|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126306|NCT00853944|Incretins|incretins|mesh-ancestor
154126307|NCT00853944|Hormones|hormones|mesh-ancestor
154126308|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126309|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
154126310|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126311|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126312|NCT02545452|Anastrozole|anastrozole|mesh-list
154126313|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
154126314|NCT02545452|Nonoxynol|nonoxynol|mesh-list
153355918|NCT01790282|Estrogens|estrogens|mesh-ancestor
153655394|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153655395|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655396|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655397|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655398|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
153655399|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655400|NCT00047554|Travoprost|travoprost|mesh-list
153655401|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153655402|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153655403|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153655404|NCT00047632|Interferons|interferons|mesh-list
153655405|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
153655406|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655407|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
153655408|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655409|NCT00047671|Citalopram|citalopram|mesh-list
153655410|NCT00047671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153655411|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655412|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655413|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655414|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655415|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
153655416|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655447|NCT00047827|Amebicides|amebicides|mesh-ancestor
153655448|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153655449|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153655450|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655451|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153655452|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
153355942|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154126315|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154126317|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154126318|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154126319|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126320|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126321|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154126322|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
154126323|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126324|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126325|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154126326|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
154126327|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154126328|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154126329|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154126330|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154126331|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154126332|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154126333|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154126334|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
154126335|NCT00547365|Antibodies|antibodies|mesh-list
154126336|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
154126337|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153355943|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
153415622|NCT02028806|Leucovorin|leucovorin|mesh-list
153355944|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655453|NCT00048139|Capecitabine|capecitabine|mesh-list
153655455|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655456|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
153655457|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655458|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655459|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153655460|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153655484|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153655486|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655487|NCT05641337|Incretins|incretins|mesh-ancestor
153655488|NCT05641337|Hormones|hormones|mesh-ancestor
153655489|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153655491|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
153655492|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655493|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655495|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
153655496|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655497|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655498|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
153655499|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655500|NCT00048607|Aprepitant|aprepitant|mesh-list
154126338|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154126339|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
154126340|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126341|NCT00854178|Anesthetics|anesthetics|mesh-list
154126342|NCT00854178|Isoflurane|isoflurane|mesh-list
154126343|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126344|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126345|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
154126346|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154126347|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
154126348|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
154126349|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126350|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
154126351|NCT00850746|Z 338|z 338|mesh-list
154126352|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154126353|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126354|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154126355|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154126356|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126357|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126358|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126359|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126360|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154126361|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
154126362|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126363|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154126364|NCT00969813|Tofacitinib|tofacitinib|mesh-list
154126365|NCT00969813|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154126366|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126367|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126368|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126369|NCT00854256|Mitomycins|mitomycins|mesh-list
154126370|NCT00854256|Mitomycin|mitomycin|mesh-list
154126371|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153355967|NCT00601718|Rituximab|rituximab|mesh-list
153655501|NCT00048607|Paroxetine|paroxetine|mesh-list
153655502|NCT00048607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153655503|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655504|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655505|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126372|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126373|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
154126374|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794530|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154126375|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154126376|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126377|NCT00855972|Naltrexone|naltrexone|mesh-list
154126378|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154126379|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154126380|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794587|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154126381|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
154126382|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126383|NCT02544906|Propofol|propofol|mesh-list
154126384|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154126385|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126386|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126387|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154126388|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
154126390|NCT00861276|Nicotine|nicotine|mesh-list
154126391|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154126392|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
154126393|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126394|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126395|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154126396|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154126397|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
154126398|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126399|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126400|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154126401|NCT02544828|Hematinics|hematinics|mesh-ancestor
154126402|NCT00861510|ON 01910|on 01910|mesh-list
154126403|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126404|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126405|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126406|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126407|NCT01095003|Capecitabine|capecitabine|mesh-list
154126409|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
154126411|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126413|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126414|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126415|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126416|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126417|NCT00856362|Moxidectin|moxidectin|mesh-list
154126418|NCT00856362|Midazolam|midazolam|mesh-list
154126419|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154126420|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154126421|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126422|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126423|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154126424|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154126425|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154126426|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154126427|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
154126428|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
154126429|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
154126430|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
154126431|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126432|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126433|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
154126434|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154126435|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126436|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
154126437|NCT00854802|Ribavirin|ribavirin|mesh-list
154126438|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154126439|NCT00854802|Cyclosporine|cyclosporine|mesh-list
154126440|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
153356038|NCT00646646|Analgesics|analgesics|mesh-ancestor
153655506|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655507|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
153655508|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655509|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153655510|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
153655511|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655528|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655529|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655530|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153655531|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
153655532|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153655533|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153655534|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655535|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153655536|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
154126441|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126442|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
154126444|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
154126445|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
154126446|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126447|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126448|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
154126449|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126450|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126451|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154126453|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154126454|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126455|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
154126456|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154126457|NCT00966771|Copper|copper|mesh-list
154126458|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
154126459|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154126460|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
154126461|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154126462|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126463|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154126464|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154126465|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154126466|NCT00966771|Trace Elements|trace elements|mesh-ancestor
154126468|NCT00856596|Sertaconazole|sertaconazole|mesh-list
154126469|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
154126470|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126471|NCT00855114|Everolimus|everolimus|mesh-list
154126472|NCT00855114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154126473|NCT00855114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126474|NCT00855114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126475|NCT00855114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655537|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153655538|NCT00048763|Protective Agents|protective agents|mesh-ancestor
153655539|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153655540|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153655541|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655542|NCT05576298|Insulin|insulin|mesh-list
153655543|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153655544|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
153655545|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153655546|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126476|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126477|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
154126478|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126479|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126480|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
154126481|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126482|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
154126483|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154126484|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
154126485|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126486|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126487|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154126488|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
154126489|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
154126490|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154126491|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
154126492|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126493|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126494|NCT00970905|Ondansetron|ondansetron|mesh-list
154126495|NCT00970905|Aprepitant|aprepitant|mesh-list
154126496|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
154126497|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
154126498|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126499|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126500|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154126526|NCT00973713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126527|NCT00973713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126528|NCT00973713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126529|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126530|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
154126531|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126532|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126533|NCT00857142|Oxymorphone|oxymorphone|mesh-list
154126534|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154126535|NCT00857142|Narcotics|narcotics|mesh-ancestor
154126536|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126537|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126538|NCT00857142|Analgesics|analgesics|mesh-ancestor
154126539|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
154126540|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126541|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154126542|NCT00865176|Eplerenone|eplerenone|mesh-list
154126543|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154126544|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
154126545|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126546|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126547|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154126548|NCT00865176|Diuretics|diuretics|mesh-ancestor
154126549|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
154126550|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154126551|NCT00973869|Curcumin|curcumin|mesh-list
154126552|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154126553|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154126554|NCT00973869|Analgesics|analgesics|mesh-ancestor
154126555|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
154126559|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126568|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126569|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126570|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126571|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126572|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
154126573|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154126574|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126575|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126576|NCT04041492|Vitamin D|vitamin d|mesh-list
154126577|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
154126578|NCT04041492|Vitamins|vitamins|mesh-ancestor
154126579|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
154126580|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126581|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154126582|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154126583|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
154126584|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
154126585|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126586|NCT00857376|Protective Agents|protective agents|mesh-ancestor
154126587|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126588|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
154126589|NCT00857376|Vitamins|vitamins|mesh-ancestor
154126590|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
154126591|NCT00618072|Metformin|metformin|mesh-list
154126592|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
154126593|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126594|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126595|NCT00959517|Artesunate|artesunate|mesh-list
154126596|NCT00959517|Chloroquine|chloroquine|mesh-list
154126597|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
154126598|NCT00959517|Primaquine|primaquine|mesh-list
154126599|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
154126600|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154126601|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
154126602|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154126603|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154126604|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126609|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
154126611|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126612|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154126613|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126614|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794702|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154126615|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154126616|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154126617|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
154126618|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
154126619|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126620|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126621|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
154126622|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126623|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154126624|NCT00865410|Bupropion|bupropion|mesh-list
154126625|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154126626|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
154126627|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154126628|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153655547|NCT00048802|Valproic Acid|valproic acid|mesh-list
153655548|NCT00048802|Olanzapine|olanzapine|mesh-list
153655549|NCT00048802|Risperidone|risperidone|mesh-list
153655550|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153655551|NCT00048802|Ziprasidone|ziprasidone|mesh-list
153655552|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153655553|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
153655554|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655555|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655556|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655557|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153655558|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153655559|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655560|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655561|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153655562|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
153655563|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
153655564|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
153655565|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655566|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655567|NCT00048802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153655568|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655586|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
153655587|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655588|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655589|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
153655590|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655591|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
153655593|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153655594|NCT00049114|Tipifarnib|tipifarnib|mesh-list
153655595|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655596|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
153655599|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655601|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126629|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154126630|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154126631|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126632|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
154126633|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126634|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126635|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154126636|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154126637|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126638|NCT00974181|Paclitaxel|paclitaxel|mesh-list
154126639|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154126640|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154126641|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126642|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
154126643|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
154126644|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
154126645|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126646|NCT00971607|Sevoflurane|sevoflurane|mesh-list
154126647|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154126648|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154126649|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
154126650|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
154126651|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126652|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126653|NCT00971685|Dexamethasone|dexamethasone|mesh-list
154126654|NCT00971685|Lenalidomide|lenalidomide|mesh-list
154126655|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154126656|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
154126657|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
154126658|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126659|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126660|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153356254|NCT01230593|Dexamethasone|dexamethasone|mesh-list
153492581|NCT00577122|Progestins|progestins|mesh-ancestor
153655602|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655603|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153655604|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153655605|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153655606|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153655607|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655608|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
153655609|NCT00049192|Oblimersen|oblimersen|mesh-list
154126662|NCT00971685|Hormones|hormones|mesh-ancestor
154126663|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126664|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154126665|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126666|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
154126667|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154126668|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154126669|NCT00971685|Growth Substances|growth substances|mesh-ancestor
154126670|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
154126671|NCT03861052|Dulaglutide|dulaglutide|mesh-list
154126672|NCT03861052|Tirzepatide|tirzepatide|mesh-list
154126673|NCT03861052|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154126674|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126675|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126676|NCT03861052|Incretins|incretins|mesh-ancestor
154126678|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126679|NCT00971763|Prednisolone|prednisolone|mesh-list
154126680|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
154126681|NCT00971763|Rituximab|rituximab|mesh-list
154126682|NCT00971763|Gemcitabine|gemcitabine|mesh-list
154126683|NCT00971763|Vincristine|vincristine|mesh-list
154126684|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126685|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
154126702|NCT00971763|Hormones|hormones|mesh-ancestor
153794814|NCT00299013|Prednisolone|prednisolone|mesh-list
153356333|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126713|NCT00865644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126714|NCT00865644|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154126715|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
154126716|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126717|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154126718|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126719|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
154126720|NCT00785330|Rituximab|rituximab|mesh-list
154126721|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154126722|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126723|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
154126724|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126725|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154126726|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154126727|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154126728|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126729|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154126730|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154126731|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154126732|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126733|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
154126734|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126735|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
154126736|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154126737|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154126738|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126739|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
154126740|NCT05279469|Coagulants|coagulants|mesh-ancestor
154126741|NCT00790946|Valsartan|valsartan|mesh-list
154126742|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153450233|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
154126743|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154126744|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154126745|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126746|NCT05179239|Paclitaxel|paclitaxel|mesh-list
154126747|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154126749|NCT05179239|Carboplatin|carboplatin|mesh-list
154126750|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154126751|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126752|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
154126753|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
154126754|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
154126755|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126756|NCT00972075|Melatonin|melatonin|mesh-list
154126757|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
154126758|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126759|NCT00972075|Protective Agents|protective agents|mesh-ancestor
154126760|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126761|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126762|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154126763|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154126764|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
154126765|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126766|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126767|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154126768|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
154126769|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
154126770|NCT00974805|Hormones|hormones|mesh-ancestor
154126771|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126772|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
154126773|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
154126774|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154126775|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
154126776|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
154126777|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126778|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126779|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154126780|NCT00781352|Analgesics|analgesics|mesh-ancestor
154126781|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
154126782|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126784|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
154126785|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
154126786|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126787|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126788|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
154126789|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126790|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154126791|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154126792|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154126793|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154126795|NCT00781430|Neratinib|neratinib|mesh-list
154126845|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
154126846|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126847|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126848|NCT00781586|Caffeine|caffeine|mesh-list
154126849|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126850|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154126851|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154126852|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126853|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126854|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154126855|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154126856|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
154126857|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126858|NCT00510952|Insulin|insulin|mesh-list
154126859|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154126860|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
154126861|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
154126862|NCT00510952|Protamines|protamines|mesh-list
154126863|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126864|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126865|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
154126866|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126867|NCT00510952|Coagulants|coagulants|mesh-ancestor
154126868|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
154126869|NCT00617604|Alefacept|alefacept|mesh-list
154126870|NCT00617604|Tacrolimus|tacrolimus|mesh-list
154126871|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154126872|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
154126874|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154126892|NCT00661622|Sargramostim|sargramostim|mesh-list
154126893|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
154126894|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126895|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126896|NCT00781820|Bifonazole|bifonazole|mesh-list
154126897|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
154126898|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126899|NCT00786110|Paclitaxel|paclitaxel|mesh-list
154126900|NCT00786110|Sorafenib|sorafenib|mesh-list
154126901|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154126902|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154126903|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154126904|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154126905|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154126906|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126907|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154126908|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126909|NCT00791804|Fentanyl|fentanyl|mesh-list
154126910|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154126911|NCT00791804|Narcotics|narcotics|mesh-ancestor
154126912|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126913|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126914|NCT00791804|Analgesics|analgesics|mesh-ancestor
154126915|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
154126916|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126917|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154126918|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154126919|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
154126920|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
154126921|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
154126922|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
154126932|NCT00792350|Sorafenib|sorafenib|mesh-list
154126938|NCT00792584|Etravirine|etravirine|mesh-list
154126939|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154126940|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154126941|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154126942|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126943|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
154126944|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126945|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154126946|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154126947|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154126948|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154126949|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154126950|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154126951|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
154126952|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
154126953|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154126954|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
154126955|NCT04093752|Tirzepatide|tirzepatide|mesh-list
154126956|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154126957|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126958|NCT04093752|Incretins|incretins|mesh-ancestor
154126959|NCT04093752|Hormones|hormones|mesh-ancestor
154126960|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154126961|NCT02544282|Acetaminophen|acetaminophen|mesh-list
154126962|NCT02544282|Sufentanil|sufentanil|mesh-list
154126963|NCT02544282|Tramadol|tramadol|mesh-list
154126964|NCT02544282|Pirinitramide|pirinitramide|mesh-list
154126965|NCT02544282|Propofol|propofol|mesh-list
154126966|NCT02544282|Sevoflurane|sevoflurane|mesh-list
154126967|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
153655610|NCT00049192|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153655611|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153655612|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655613|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655614|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655615|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
153655616|NCT05576181|Fludarabine|fludarabine|mesh-list
153655617|NCT05576181|Etoposide|etoposide|mesh-list
153655618|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655619|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
153655620|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655621|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655622|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655623|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
153655624|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655625|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655644|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
154126968|NCT02544282|Atracurium|atracurium|mesh-list
154126969|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154126970|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154126971|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154126972|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154126973|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
154126974|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
154126975|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154126976|NCT02544282|Analgesics|analgesics|mesh-ancestor
154126977|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
154126978|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154126979|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
154126980|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154126981|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154126982|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154126983|NCT02544282|Narcotics|narcotics|mesh-ancestor
154126984|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154126985|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
154126986|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154126987|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154126988|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153356583|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153356584|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
153356585|NCT04386122|Loxoprofen|loxoprofen|mesh-list
153356588|NCT04386122|Analgesics|analgesics|mesh-ancestor
153655645|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655646|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655647|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
153655648|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655649|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
153655650|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153655651|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
153655652|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655653|NCT00391911|Expectorants|expectorants|mesh-ancestor
153655654|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
153655655|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153655656|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
153655657|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655658|NCT00391911|Protective Agents|protective agents|mesh-ancestor
153655659|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655660|NCT00391911|Antidotes|antidotes|mesh-ancestor
153655661|NCT02970409|Heparin|heparin|mesh-list
153655662|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
153655663|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153655664|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153655665|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655666|NCT00049582|Decitabine|decitabine|mesh-list
153655667|NCT00049582|Azacitidine|azacitidine|mesh-list
153655668|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655669|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
153655670|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126989|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153795242|NCT06257537|Analgesics|analgesics|mesh-ancestor
154126990|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154126991|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
154126992|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154126993|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154126994|NCT04041648|Treprostinil|treprostinil|mesh-list
154126995|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154126996|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154126997|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
154126999|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154127000|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
154127001|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127002|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127003|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154127005|NCT00663962|Analgesics|analgesics|mesh-ancestor
154127006|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
154127007|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127008|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127009|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
154127010|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154127011|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154127012|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127013|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154127014|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154127015|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154127016|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127017|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356604|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
153356605|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356606|NCT02995304|Midazolam|midazolam|mesh-list
153356607|NCT02995304|Morphine|morphine|mesh-list
153356608|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153356609|NCT02995304|Narcotics|narcotics|mesh-ancestor
153356610|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356611|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655671|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655672|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655673|NCT00049660|Capecitabine|capecitabine|mesh-list
154127018|NCT00858624|Ketamine|ketamine|mesh-list
154127019|NCT00858624|Analgesics|analgesics|mesh-ancestor
154127020|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
154127021|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127022|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127023|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154127024|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154127025|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
154127026|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
154127027|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127028|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154127029|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154127030|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127031|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127032|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154127033|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154127034|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127035|NCT00960453|Incretins|incretins|mesh-ancestor
154127036|NCT00960453|Hormones|hormones|mesh-ancestor
154127037|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127038|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154127039|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
154127040|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127041|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655674|NCT00049660|Vinorelbine|vinorelbine|mesh-list
153655675|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655676|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
153655677|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655678|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655679|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153655680|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
153655681|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
153655682|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
153655683|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
153655701|NCT00049777|Tinzaparin|tinzaparin|mesh-list
153655702|NCT00049777|Dalteparin|dalteparin|mesh-list
153655703|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
153655705|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153655706|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655707|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655708|NCT00392028|Ertapenem|ertapenem|mesh-list
153655709|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153655710|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655711|NCT00392067|Calcipotriene|calcipotriene|mesh-list
153655712|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
153655713|NCT00389558|Amikacin|amikacin|mesh-list
153655714|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153655715|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655716|NCT00049972|Paroxetine|paroxetine|mesh-list
153655717|NCT00049972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154127043|NCT00265759|Anastrozole|anastrozole|mesh-list
154127044|NCT00265759|Exemestane|exemestane|mesh-list
154127045|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127046|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154127047|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154127048|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127049|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127050|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154127051|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
154127052|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127053|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127054|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154127055|NCT00972387|Prednisone|prednisone|mesh-list
154127056|NCT00972387|Prednisolone|prednisolone|mesh-list
154127057|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
154127058|NCT00972387|Doxorubicin|doxorubicin|mesh-list
154127059|NCT00972387|Vincristine|vincristine|mesh-list
154127060|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127097|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127098|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127100|NCT00792818|Curcumin|curcumin|mesh-list
154127101|NCT00792818|Turmeric extract|turmeric extract|mesh-list
154127102|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154127103|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154127104|NCT00792818|Analgesics|analgesics|mesh-ancestor
154127105|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
154127106|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127107|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127108|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154127109|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154127110|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154127111|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127112|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127113|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127114|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
154127115|NCT00792818|Protective Agents|protective agents|mesh-ancestor
153450605|NCT05727098|Ketamine|ketamine|mesh-list
154127116|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
154127117|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154127118|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127119|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
154127120|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127121|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
154127122|NCT00975351|Vitamins|vitamins|mesh-ancestor
154127123|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
154127124|NCT01071187|Varenicline|varenicline|mesh-list
154127125|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154127126|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154127140|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154127141|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154127143|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154127144|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
154127145|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127146|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127147|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154127148|NCT00793052|Dexamethasone|dexamethasone|mesh-list
154127149|NCT00793052|Etoricoxib|etoricoxib|mesh-list
154127150|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154127151|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
154127152|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
154127153|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127154|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127155|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154127156|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
154127157|NCT00793052|Hormones|hormones|mesh-ancestor
153795577|NCT05741372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154127158|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127159|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154127160|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127161|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154127162|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154127163|NCT00793052|Analgesics|analgesics|mesh-ancestor
154127164|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
154127165|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154127166|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154127167|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154127168|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655718|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655719|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655720|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655721|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655722|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
153655723|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655724|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153655725|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
153655726|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655727|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153655728|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153655729|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655730|NCT00389636|Becaplermin|becaplermin|mesh-list
153655731|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
153655732|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
154127169|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127170|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
154127171|NCT02555852|Esomeprazole|esomeprazole|mesh-list
154127172|NCT02555852|Omeprazole|omeprazole|mesh-list
154127173|NCT02555852|Rabeprazole|rabeprazole|mesh-list
154127174|NCT02555852|Pantoprazole|pantoprazole|mesh-list
154127175|NCT02555852|Lansoprazole|lansoprazole|mesh-list
154127176|NCT02555852|Famotidine|famotidine|mesh-list
154127177|NCT02555852|Ranitidine|ranitidine|mesh-list
154127178|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154127179|NCT02555852|Cimetidine|cimetidine|mesh-list
154127180|NCT02555852|Nizatidine|nizatidine|mesh-list
154127181|NCT02555852|Lafutidine|lafutidine|mesh-list
154127182|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
154127183|NCT02555852|Bismuth|bismuth|mesh-list
154127184|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154127185|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
154127186|NCT02555852|Histamine|histamine|mesh-list
154127187|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
154127188|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127189|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154127190|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153507582|NCT06066905|Azacitidine|azacitidine|mesh-list
154127191|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127192|NCT02555852|Antacids|antacids|mesh-ancestor
154127193|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
154127194|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
154127195|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127196|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127197|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
154127198|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154127199|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154127200|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127201|NCT04091009|Buprenorphine|buprenorphine|mesh-list
154127202|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154127203|NCT04091009|Naloxone|naloxone|mesh-list
154127204|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153655733|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153655734|NCT00389636|Growth Substances|growth substances|mesh-ancestor
153655735|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655736|NCT00050206|Olanzapine|olanzapine|mesh-list
153655737|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
153655738|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
153655739|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127205|NCT04091009|Narcotics|narcotics|mesh-ancestor
154127206|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127207|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127208|NCT04091009|Analgesics|analgesics|mesh-ancestor
154127209|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
154127210|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127211|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154127212|NCT02597231|Melatonin|melatonin|mesh-list
154127213|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
154127214|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127215|NCT02597231|Protective Agents|protective agents|mesh-ancestor
154127216|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127217|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127218|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
154127219|NCT00545571|Hematinics|hematinics|mesh-ancestor
154127220|NCT00783380|Vaccines|vaccines|mesh-list
154127221|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
154127222|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127223|NCT04008225|Dimercaprol|dimercaprol|mesh-list
154127224|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
154127225|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
154127226|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127227|NCT00748709|Afatinib|afatinib|mesh-list
154127228|NCT00748709|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154127229|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356829|NCT01297595|Crizotinib|crizotinib|mesh-list
153655740|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655741|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655742|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153655792|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153655794|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655795|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655796|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
153655797|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655798|NCT00050479|Celecoxib|celecoxib|mesh-list
153655799|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153655800|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153655801|NCT00050479|Analgesics|analgesics|mesh-ancestor
153655802|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
153655803|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655804|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655805|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153655806|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655807|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153655808|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153655809|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655810|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655811|NCT00050596|Docetaxel|docetaxel|mesh-list
153655812|NCT00050596|Ipilimumab|ipilimumab|mesh-list
153655813|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127230|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127231|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127232|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127233|NCT02597309|Canagliflozin|canagliflozin|mesh-list
154127234|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154127235|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127236|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154127237|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127238|NCT00863148|Busulfan|busulfan|mesh-list
154127239|NCT00863148|Clofarabine|clofarabine|mesh-list
154127240|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
154127241|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127242|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127243|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
154127244|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127245|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154127246|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127247|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153356841|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
153655814|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
153655815|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
153655816|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
153655817|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655818|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655819|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153655820|NCT00050635|Octreotide|octreotide|mesh-list
153655821|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655822|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153655823|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655824|NCT00050674|Lenograstim|lenograstim|mesh-list
153655825|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153655826|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
153655829|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153655830|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655831|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153655832|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655833|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
153655834|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655835|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
153655836|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655837|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
153655838|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
153655856|NCT00051142|Travoprost|travoprost|mesh-list
153655857|NCT00051142|Latanoprost|latanoprost|mesh-list
153655858|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153655859|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153655860|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153655861|NCT00051181|Travoprost|travoprost|mesh-list
153655862|NCT00051181|Latanoprost|latanoprost|mesh-list
153655863|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153655864|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153655865|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153655866|NCT00051259|Bupropion|bupropion|mesh-list
153655867|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153655868|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
154127248|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154127250|NCT00786734|Pitavastatin|pitavastatin|mesh-list
154127251|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154127252|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154127253|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154127254|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
154127255|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127256|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127257|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154127258|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
154127259|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154127260|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127261|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127262|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154127263|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154127264|NCT00867126|Pioglitazone|pioglitazone|mesh-list
154127265|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154127266|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127267|NCT00748553|Paclitaxel|paclitaxel|mesh-list
153450764|NCT05160896|Cetuximab|cetuximab|mesh-list
154127268|NCT00748553|Azacitidine|azacitidine|mesh-list
154127269|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154127270|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154127271|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127272|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
154127273|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
154127274|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
154127275|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127276|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154127277|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
154127278|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127279|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
154127280|NCT00661388|Hematinics|hematinics|mesh-ancestor
154127281|NCT00972855|Bicalutamide|bicalutamide|mesh-list
154127282|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
153655869|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655870|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153655871|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655872|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154127283|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
153455639|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127284|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127285|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127286|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127288|NCT00786812|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154127289|NCT00786812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154127290|NCT00786812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127291|NCT00786812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127292|NCT00972933|Ipilimumab|ipilimumab|mesh-list
154127293|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154127294|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127295|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154127296|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127297|NCT00263575|Fentanyl|fentanyl|mesh-list
154127298|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154127299|NCT00263575|Narcotics|narcotics|mesh-ancestor
154127300|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127301|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127302|NCT00263575|Analgesics|analgesics|mesh-ancestor
154127303|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
154127304|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127305|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154127306|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154127307|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
154127308|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
154127309|NCT00975663|Tacrolimus|tacrolimus|mesh-list
154127310|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127311|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
153356896|NCT01270412|Mitogens|mitogens|mesh-list
153655873|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655874|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
153655875|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655876|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655877|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153655878|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153655879|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655880|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
153655881|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153655882|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655883|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655884|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153655885|NCT05639777|Analgesics|analgesics|mesh-ancestor
153655886|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
153655887|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127312|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127314|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127315|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127316|NCT00570128|Donepezil|donepezil|mesh-list
154127317|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154127318|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127319|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127320|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
154127321|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127322|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795943|NCT05184335|RP5063|rp5063|mesh-list
154127323|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
154127324|NCT00960921|Iron|iron|mesh-list
154127325|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154127326|NCT00960921|Trace Elements|trace elements|mesh-ancestor
154127327|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
154127328|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127329|NCT00960921|Hematinics|hematinics|mesh-ancestor
154127330|NCT00863460|Cytarabine|cytarabine|mesh-list
154127331|NCT00863460|Prednisone|prednisone|mesh-list
154127332|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
154127333|NCT00863460|Busulfan|busulfan|mesh-list
154127334|NCT00863460|Thiotepa|thiotepa|mesh-list
154127335|NCT00863460|Carmustine|carmustine|mesh-list
154127336|NCT00863460|Methotrexate|methotrexate|mesh-list
154127337|NCT00863460|Etoposide|etoposide|mesh-list
154127338|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127339|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
154127340|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127341|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154127342|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154127343|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
154127344|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127345|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127346|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153655888|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153655889|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153655890|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153655891|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
153655892|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655893|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655921|NCT00051493|Carboplatin|carboplatin|mesh-list
153655922|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127348|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
154127350|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127351|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154127352|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154127353|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
154127354|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154127355|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154127356|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
154127357|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
154127358|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127359|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154127360|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154127361|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154127362|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154127363|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154127364|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
154127365|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127366|NCT00262951|Interferons|interferons|mesh-list
154127367|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
154127368|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
154127369|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154127370|NCT00262951|Cisplatin|cisplatin|mesh-list
154127371|NCT00262951|Fluorouracil|fluorouracil|mesh-list
154127372|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127373|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
154127374|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127375|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154127376|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127377|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
154127378|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127379|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
154127380|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127381|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
154127382|NCT02597153|Analgesics|analgesics|mesh-ancestor
153356996|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127386|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127387|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154127388|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154127389|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127390|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127391|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
154127392|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154127393|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
154127394|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154127395|NCT00262873|Bortezomib|bortezomib|mesh-list
154127396|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127397|NCT00975819|Sirolimus|sirolimus|mesh-list
154127398|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154127399|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127400|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154127401|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127402|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
154127403|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127404|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
154127405|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127406|NCT00859872|Haloperidol|haloperidol|mesh-list
153655923|NCT00051532|Seocalcitol|seocalcitol|mesh-list
153655924|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655925|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655926|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
153655927|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655928|NCT00051571|Docetaxel|docetaxel|mesh-list
153655929|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655930|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
153655931|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
153655932|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
153655933|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655934|NCT05573958|Aspirin|aspirin|mesh-list
153655935|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
153655936|NCT05573958|Clopidogrel|clopidogrel|mesh-list
153655937|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153655938|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153655939|NCT05573958|Analgesics|analgesics|mesh-ancestor
153655940|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
153655941|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655969|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153655971|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655973|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655974|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153655975|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153655977|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153655978|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
153655979|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655980|NCT00052039|Interferons|interferons|mesh-list
153655981|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
153655982|NCT00052039|Azathioprine|azathioprine|mesh-list
153655983|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655984|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
153655985|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127407|NCT00859872|Risperidone|risperidone|mesh-list
154127408|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
154127409|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154127410|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
154127411|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127412|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127413|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127414|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154127415|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154127416|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127417|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154127418|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154127419|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
154127420|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
154127421|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
154127422|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127423|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154127424|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154127426|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154127427|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127428|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
154127429|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
154127430|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
154127431|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127432|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
154127433|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127434|NCT05147493|Dexamethasone|dexamethasone|mesh-list
154127435|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
154127436|NCT05147493|Lenalidomide|lenalidomide|mesh-list
154127437|NCT05147493|Bortezomib|bortezomib|mesh-list
154127438|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127439|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
154127440|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127441|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154127442|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154127443|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
153655986|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
153655987|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656015|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127444|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127445|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127446|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153455640|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154127447|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154127448|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
154127449|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
154127450|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127451|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154127452|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
154127454|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127455|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154127456|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154127457|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154127458|NCT05147493|Growth Substances|growth substances|mesh-ancestor
154127459|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
154127460|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154127461|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154127462|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127463|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154127464|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154127465|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154127466|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127467|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
154127468|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127469|NCT03974425|Aflibercept|aflibercept|mesh-list
154127470|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154127471|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154127472|NCT03974425|Growth Substances|growth substances|mesh-ancestor
154127473|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127474|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
154127475|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127476|NCT00975897|Leucovorin|leucovorin|mesh-list
154127477|NCT00975897|Bevacizumab|bevacizumab|mesh-list
154127478|NCT00975897|Cetuximab|cetuximab|mesh-list
154127479|NCT00975897|Fluorouracil|fluorouracil|mesh-list
153357053|NCT02991950|Parnaparin|parnaparin|mesh-list
154127480|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
154127481|NCT00975897|Irinotecan|irinotecan|mesh-list
154127482|NCT00975897|Calcium|calcium|mesh-list
154127483|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
154127484|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154127485|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127486|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154127487|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154127488|NCT00975897|Growth Substances|growth substances|mesh-ancestor
154127489|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127490|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
154127491|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154127492|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
154127493|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127494|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154127495|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127496|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
154127497|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154127498|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154127499|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127500|NCT00975897|Antidotes|antidotes|mesh-ancestor
154127501|NCT00975897|Protective Agents|protective agents|mesh-ancestor
154127502|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
154127503|NCT00975897|Vitamins|vitamins|mesh-ancestor
154127504|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
154127505|NCT00867672|Decitabine|decitabine|mesh-list
154127506|NCT00867672|Tretinoin|tretinoin|mesh-list
154127507|NCT00867672|Valproic Acid|valproic acid|mesh-list
154127508|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154127509|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
154127510|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127511|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127512|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127513|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
154127514|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
154127515|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
154127516|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
154127521|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127522|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154127523|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
154127525|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
154127526|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127527|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
154127528|NCT00783926|Coagulants|coagulants|mesh-ancestor
154127529|NCT01071499|Morphine|morphine|mesh-list
154127530|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153729680|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153729681|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729682|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729683|NCT00130871|Protective Agents|protective agents|mesh-ancestor
153729684|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729685|NCT00130910|Albendazole|albendazole|mesh-list
153729686|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
153729687|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153729688|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729689|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
153729690|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154127531|NCT01071499|Narcotics|narcotics|mesh-ancestor
154127532|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153656017|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153656018|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656019|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656020|NCT00052351|Metronidazole|metronidazole|mesh-list
153656021|NCT00052351|Paclitaxel|paclitaxel|mesh-list
153656022|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
153656023|NCT00052351|Doxorubicin|doxorubicin|mesh-list
153656024|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153656025|NCT00052351|Vaccines|vaccines|mesh-list
153656026|NCT00052351|Sargramostim|sargramostim|mesh-list
153656027|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
153656028|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656029|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153656030|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656031|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656032|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656033|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656034|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656054|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153656055|NCT00052390|Growth Substances|growth substances|mesh-ancestor
153656056|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656057|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
153656058|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153656059|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153656060|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656061|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656062|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656064|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153656065|NCT00052468|Carboplatin|carboplatin|mesh-list
153656066|NCT00052468|Gemcitabine|gemcitabine|mesh-list
153656067|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153656068|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127533|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127534|NCT01071499|Analgesics|analgesics|mesh-ancestor
154127535|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
154127536|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127537|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
154127538|NCT00961155|Montelukast|montelukast|mesh-list
154127539|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154127540|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
153796252|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127541|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127542|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127543|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154127544|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
154127545|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154127546|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154127547|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154127548|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
154127549|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127550|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127551|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154127552|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
154127553|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127554|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154127555|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154127556|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153471225|NCT05766384|Xenon|xenon|mesh-list
154127557|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154127558|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154127559|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154127560|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127561|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
154127562|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127563|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127564|NCT00973245|Warfarin|warfarin|mesh-list
154127565|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
154127571|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127572|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127573|NCT00793754|Aspirin|aspirin|mesh-list
154127574|NCT00793754|Atorvastatin|atorvastatin|mesh-list
154127575|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154127576|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154127577|NCT00793754|Analgesics|analgesics|mesh-ancestor
154127578|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
154127579|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127580|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127581|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154127582|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154127583|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154127584|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154127585|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127586|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154127587|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154127588|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127589|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
154127590|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154127591|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154127592|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
154127593|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154127594|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154127595|NCT02596763|Baclofen|baclofen|mesh-list
154127596|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154127597|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127598|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154127599|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127600|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154127601|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
154127602|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
154127603|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153656069|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656070|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656071|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656072|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656073|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656075|NCT00052507|Bortezomib|bortezomib|mesh-list
153656076|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127604|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127606|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
154127607|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
154127608|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154127609|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
154127610|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154127611|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
154127612|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127613|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127614|NCT00793988|Anesthetics|anesthetics|mesh-list
154127615|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127616|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127617|NCT00973401|Insulin|insulin|mesh-list
154127618|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154127619|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127620|NCT04040322|Iloprost|iloprost|mesh-list
154127621|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154127622|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
154127623|NCT00787436|Thalidomide|thalidomide|mesh-list
154127624|NCT00787436|Timolol|timolol|mesh-list
154127625|NCT00787436|Propranolol|propranolol|mesh-list
154127626|NCT00787436|Nadolol|nadolol|mesh-list
154127627|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127628|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
153656077|NCT00052585|Leucovorin|leucovorin|mesh-list
153656078|NCT00052585|Fluorouracil|fluorouracil|mesh-list
153656079|NCT00052585|Irinotecan|irinotecan|mesh-list
153656080|NCT00052585|Gefitinib|gefitinib|mesh-list
153656081|NCT00052585|Calcium|calcium|mesh-list
153656082|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
153656083|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153656084|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656085|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
153656086|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656087|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656088|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656089|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656120|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656121|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656122|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153656123|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656124|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153656125|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153656126|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656127|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656128|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153656129|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
153656131|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656132|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153656133|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153656134|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
154127629|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127631|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154127632|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127633|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154127634|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154127635|NCT00787436|Growth Substances|growth substances|mesh-ancestor
154127636|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
154127637|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127638|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154127639|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154127640|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
154127641|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127642|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127643|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154127644|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154127645|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
154127646|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
154127647|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
154127648|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127649|NCT03945981|Lamivudine|lamivudine|mesh-list
154127650|NCT03945981|Dolutegravir|dolutegravir|mesh-list
154127651|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154127652|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154127653|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127654|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127655|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
154127656|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127657|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154127658|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154127659|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154127660|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154127661|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
154127662|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127663|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
154127664|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127667|NCT00979563|Irinotecan|irinotecan|mesh-list
154127668|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154127669|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154127670|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127671|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127672|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127673|NCT00745901|Drospirenone|drospirenone|mesh-list
154127674|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154127675|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154127676|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154127677|NCT00745901|Norgestimate|norgestimate|mesh-list
154127678|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154127679|NCT00745901|Estradiol|estradiol|mesh-list
154127680|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154127681|NCT00745901|Estrogens|estrogens|mesh-ancestor
154127682|NCT00745901|Hormones|hormones|mesh-ancestor
154127683|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127684|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127685|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154127686|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
154127687|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154127688|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153796812|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127689|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154127690|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154127691|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154127692|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
154127693|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154127694|NCT00745901|Diuretics|diuretics|mesh-ancestor
154127695|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
154127696|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154127697|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154127698|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154127707|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154127708|NCT00860340|Diuretics|diuretics|mesh-ancestor
154127709|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
154127710|NCT00784316|Metoprolol|metoprolol|mesh-list
154127711|NCT00784316|Amiodarone|amiodarone|mesh-list
154127712|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154127713|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154127714|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
154127715|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
154127716|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127717|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127718|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154127719|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154127720|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154127721|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
154127722|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127723|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127724|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
154127725|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154127726|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154127727|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154127728|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154127729|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154127730|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127731|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154127732|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154127733|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154127735|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154127736|NCT00286429|Alogliptin|alogliptin|mesh-list
154127737|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154127738|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127739|NCT00286429|Incretins|incretins|mesh-ancestor
154127740|NCT00286429|Hormones|hormones|mesh-ancestor
154127741|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127746|NCT00665444|Aripiprazole|aripiprazole|mesh-list
154127747|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
154127748|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154127749|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154127750|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154127751|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127752|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127753|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
154127754|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
154127755|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127756|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127757|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154127758|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154127759|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
154127760|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154127761|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154127762|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154127763|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154127764|NCT00864006|Valproic Acid|valproic acid|mesh-list
154127765|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
154127766|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127767|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127768|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
154127769|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154127770|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127771|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
154127772|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154127773|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127774|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154127775|NCT00860496|Cyclosporine|cyclosporine|mesh-list
154127776|NCT00860496|Tacrolimus|tacrolimus|mesh-list
154127777|NCT00860496|Cyclosporins|cyclosporins|mesh-list
154127778|NCT00860496|Tofacitinib|tofacitinib|mesh-list
153656135|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656136|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656154|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
153656155|NCT00053131|Sargramostim|sargramostim|mesh-list
153656156|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656157|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
153656158|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656159|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656160|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
154127779|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127780|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
154127781|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127782|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154127783|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127784|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127785|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
154127786|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127787|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
154127788|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154127789|NCT00860496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154127790|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154127791|NCT00864162|Ramipril|ramipril|mesh-list
154127792|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154127793|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
154127794|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127795|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127796|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154127797|NCT00787826|Vaccines|vaccines|mesh-list
154127798|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
154127799|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127800|NCT00795314|Fentanyl|fentanyl|mesh-list
154127801|NCT00795314|Butorphanol|butorphanol|mesh-list
154127802|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154127803|NCT00795314|Narcotics|narcotics|mesh-ancestor
154127804|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127805|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127806|NCT00795314|Analgesics|analgesics|mesh-ancestor
153358051|NCT01250717|Docetaxel|docetaxel|mesh-list
153656161|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656162|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656163|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
153656164|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656165|NCT00053131|Analgesics|analgesics|mesh-ancestor
153656166|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
153656167|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656168|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153656169|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656170|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656171|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
153656172|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
153656173|NCT00053248|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153656174|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153656175|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656176|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656177|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127807|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
154127808|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127809|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154127810|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154127812|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
154127813|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
154127814|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
154127815|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154127816|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154127817|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
154127818|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127819|NCT00864240|Clobetasol|clobetasol|mesh-list
154127820|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154127821|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
154127822|NCT00864240|Hormones|hormones|mesh-ancestor
154127823|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127824|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127825|NCT00979641|Docetaxel|docetaxel|mesh-list
154127826|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127827|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
154127828|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
154127829|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
153455641|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154127830|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127831|NCT00864318|Paclitaxel|paclitaxel|mesh-list
154127832|NCT00864318|Etoposide|etoposide|mesh-list
153656178|NCT00053287|Thalidomide|thalidomide|mesh-list
153656179|NCT00053287|Carboplatin|carboplatin|mesh-list
153656180|NCT00053287|Fludarabine|fludarabine|mesh-list
153656181|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
153656182|NCT00053287|Topotecan|topotecan|mesh-list
153656183|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656184|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656185|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
153656186|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656187|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656188|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
153656189|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656190|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153656191|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656192|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656193|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
153656194|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153656195|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656222|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656223|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153656224|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153656225|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656226|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656228|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153358105|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154127833|NCT00864318|Ifosfamide|ifosfamide|mesh-list
154127834|NCT00864318|Carboplatin|carboplatin|mesh-list
154127835|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154127836|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127837|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
154127838|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
154127839|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
154127840|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127841|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154127842|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154127843|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127844|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154127845|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
154127846|NCT00788060|Everolimus|everolimus|mesh-list
154127847|NCT00788060|Sunitinib|sunitinib|mesh-list
154127848|NCT00788060|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154127849|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154127850|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127851|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656229|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153656230|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153656231|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153656232|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153656233|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153656234|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153656235|NCT00053716|Alprostadil|alprostadil|mesh-list
153656236|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153656237|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
153656238|NCT00053716|Urological Agents|urological agents|mesh-ancestor
153656239|NCT02970175|Terlipressin|terlipressin|mesh-list
153656240|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153656241|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153656242|NCT00053833|Irinotecan|irinotecan|mesh-list
153656243|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153656245|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656256|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153656257|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
153656258|NCT00053911|Tamoxifen|tamoxifen|mesh-list
153656259|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
153656260|NCT00053911|Docetaxel|docetaxel|mesh-list
153656261|NCT00053911|Fluorouracil|fluorouracil|mesh-list
153656262|NCT00053911|Epirubicin|epirubicin|mesh-list
153656263|NCT00053911|Anastrozole|anastrozole|mesh-list
153656264|NCT00053911|Goserelin|goserelin|mesh-list
153656265|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656266|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
153656267|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656268|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153656269|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153656270|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
153656271|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656272|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656273|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153656274|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656275|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
153415780|NCT02666846|Salicylates|salicylates|mesh-list
154127852|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127853|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
154127854|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127855|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127856|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154127857|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154127858|NCT00788060|Growth Substances|growth substances|mesh-ancestor
154127859|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
154127860|NCT00788138|Vitamin D|vitamin d|mesh-list
154127861|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
154127862|NCT00788138|Vitamins|vitamins|mesh-ancestor
154127864|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127865|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154127866|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154127867|NCT00864396|Lansoprazole|lansoprazole|mesh-list
154127868|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154127869|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154127870|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154127871|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127872|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127873|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154127874|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
154127875|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154127876|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154127877|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127878|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127879|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
154127880|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127882|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154127883|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154127884|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154127885|NCT00961467|Thalidomide|thalidomide|mesh-list
153656276|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656277|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
153656278|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656279|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153656280|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153656281|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656282|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656283|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153656284|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
154127886|NCT00961467|Prednisone|prednisone|mesh-list
154127887|NCT00961467|Melphalan|melphalan|mesh-list
154127888|NCT00961467|Lenalidomide|lenalidomide|mesh-list
154127889|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154127890|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
154127891|NCT00961467|Hormones|hormones|mesh-ancestor
154127892|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127893|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127894|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154127895|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127896|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154127897|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
154127898|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127899|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154127900|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127901|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
154127902|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154127903|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154127904|NCT00961467|Growth Substances|growth substances|mesh-ancestor
154127905|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
154127906|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
154127907|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154127908|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127909|NCT00980031|Eplerenone|eplerenone|mesh-list
154127910|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154127911|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
154127912|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154127913|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127914|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154127915|NCT00980031|Diuretics|diuretics|mesh-ancestor
153656285|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656286|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153656287|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153656288|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153656289|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153656290|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153656291|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153656292|NCT00053950|NSC 366140|nsc 366140|mesh-list
153656293|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656294|NCT00054067|Cisplatin|cisplatin|mesh-list
153656295|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656296|NCT00054184|Paclitaxel|paclitaxel|mesh-list
153656297|NCT00054184|Docetaxel|docetaxel|mesh-list
153656298|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
154127916|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
154127917|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154127918|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
154127919|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154127920|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127921|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154127922|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127923|NCT00980109|Oseltamivir|oseltamivir|mesh-list
154127924|NCT00980109|Zanamivir|zanamivir|mesh-list
154127925|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
154127926|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127927|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127928|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127929|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154127930|NCT00980187|Indapamide|indapamide|mesh-list
154127931|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154127932|NCT00980187|Diuretics|diuretics|mesh-ancestor
154127933|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
154127934|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729691|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154127935|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154127936|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154127937|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127938|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
154127939|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154127940|NCT00284089|Ranibizumab|ranibizumab|mesh-list
154127941|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154127942|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154127943|NCT00284089|Growth Substances|growth substances|mesh-ancestor
153358188|NCT00783614|Analgesics|analgesics|mesh-ancestor
153656299|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153656300|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656301|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656302|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656303|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656304|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656305|NCT00054340|Cyclosporine|cyclosporine|mesh-list
153656306|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
153656308|NCT00054340|Methotrexate|methotrexate|mesh-list
153656309|NCT00054340|Cyclosporins|cyclosporins|mesh-list
153656310|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153656311|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656319|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153656320|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153656321|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
154127944|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127945|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
154127946|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127947|NCT00984633|Bromides|bromides|mesh-list
154127948|NCT00984633|Propofol|propofol|mesh-list
154127949|NCT00984633|Sevoflurane|sevoflurane|mesh-list
154127950|NCT00984633|Rocuronium|rocuronium|mesh-list
154127951|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154127952|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154127953|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127954|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154127955|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
154127956|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
154127957|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154127958|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154127959|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
154127960|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154127961|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154127962|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154127963|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127964|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153656322|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153656323|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656325|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
153656326|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656327|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153656328|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153656329|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
153656330|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656331|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153656332|NCT00054418|Vitamin D|vitamin d|mesh-list
153656333|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
153656334|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
153656335|NCT00054418|Calcium|calcium|mesh-list
153656336|NCT00054418|Vitamins|vitamins|mesh-ancestor
153656337|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
153656338|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656339|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153656340|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153656341|NCT00054418|Antacids|antacids|mesh-ancestor
153656342|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656343|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153656344|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153656345|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153656346|NCT00054457|Docetaxel|docetaxel|mesh-list
153656347|NCT00054457|Capecitabine|capecitabine|mesh-list
153656348|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656349|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656350|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656351|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656352|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656353|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656354|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
154127965|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127966|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127967|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127968|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154127970|NCT00976755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154127971|NCT00976755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154127972|NCT00976755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154127973|NCT00976755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127974|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154127975|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
154127976|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127977|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154127978|NCT00864474|Maraviroc|maraviroc|mesh-list
154127979|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154127980|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154127981|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127982|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154127983|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154127984|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
154127985|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154127986|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154127987|NCT00283387|Betaine|betaine|mesh-list
154127988|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154127989|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
154127990|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154127991|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
153797329|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358232|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656355|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153656356|NCT00054496|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153656357|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153656358|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656359|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656360|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656361|NCT00054535|Aldesleukin|aldesleukin|mesh-list
153656362|NCT00054535|Vaccines|vaccines|mesh-list
153656363|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
153656364|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656365|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656366|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153656367|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153656368|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
153656369|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656370|NCT00054574|Panitumumab|panitumumab|mesh-list
153656371|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656372|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656373|NCT00054613|Methoxsalen|methoxsalen|mesh-list
153656374|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153656375|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
153656376|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
153358256|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154127992|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154127993|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154127994|NCT00788294|Tanezumab|tanezumab|mesh-list
154127995|NCT00788294|Analgesics|analgesics|mesh-ancestor
154127996|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
154127997|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154127998|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154127999|NCT00795548|Azacitidine|azacitidine|mesh-list
154128000|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154128001|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
154128002|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128003|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128004|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128005|NCT00282919|Azithromycin|azithromycin|mesh-list
154128006|NCT00282919|Chloroquine|chloroquine|mesh-list
154128007|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154128008|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128009|NCT00282919|Amebicides|amebicides|mesh-ancestor
154128010|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154128011|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154128012|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
154128013|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128014|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154128015|NCT00984789|Gestodene|gestodene|mesh-list
154128016|NCT00984789|Norelgestromin|norelgestromin|mesh-list
154128017|NCT00984789|Femovan|femovan|mesh-list
154128018|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154128019|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154128020|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154128021|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
154128022|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154128023|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128024|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154128025|NCT00984789|Estrogens|estrogens|mesh-ancestor
154128026|NCT00984789|Hormones|hormones|mesh-ancestor
153656377|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153656378|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656393|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153656394|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153656395|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153656396|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128027|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128028|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154128029|NCT00984789|Progestins|progestins|mesh-ancestor
154128030|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154128032|NCT00864552|Coagulants|coagulants|mesh-ancestor
154128033|NCT04046822|Liraglutide|liraglutide|mesh-list
154128034|NCT04046822|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154128035|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154128036|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128037|NCT04046822|Incretins|incretins|mesh-ancestor
154128038|NCT04046822|Hormones|hormones|mesh-ancestor
154128039|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128040|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154128041|NCT04007835|Gefitinib|gefitinib|mesh-list
154128042|NCT04007835|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154128043|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154128044|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128045|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128046|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128047|NCT00800930|Butyric Acid|butyric acid|mesh-list
154128048|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
154128049|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
153656397|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153656398|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153656399|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153656400|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153656401|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
153656403|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
153656404|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
153656405|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153656406|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656407|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153656408|NCT02970097|Narcotics|narcotics|mesh-ancestor
153656409|NCT02970097|Analgesics|analgesics|mesh-ancestor
153656410|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
153656411|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656412|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
153656413|NCT00398281|Dutasteride|dutasteride|mesh-list
153656414|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153656415|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153656416|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656417|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656418|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
153656419|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656420|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656421|NCT00055042|Vitamin E|vitamin e|mesh-list
153656422|NCT00055042|Vitamins|vitamins|mesh-ancestor
153656423|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
153656424|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656425|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
153656426|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656427|NCT00055042|Protective Agents|protective agents|mesh-ancestor
154128050|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128051|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128052|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128054|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
154128055|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
154128056|NCT00742781|Vitamin D|vitamin d|mesh-list
154128057|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
154128058|NCT00742781|Vitamins|vitamins|mesh-ancestor
154128059|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
154128060|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128061|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154128062|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154128063|NCT00280735|Carboplatin|carboplatin|mesh-list
154128064|NCT00280735|Docetaxel|docetaxel|mesh-list
154128065|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128066|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656428|NCT00055120|Ritonavir|ritonavir|mesh-list
153656429|NCT00055120|Lopinavir|lopinavir|mesh-list
153656430|NCT00055120|Tenofovir|tenofovir|mesh-list
153656432|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153656433|NCT00055120|Stavudine|stavudine|mesh-list
153656434|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153656435|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153656436|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
153656437|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656438|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656439|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153656440|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153656455|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656456|NCT05525325|Anesthetics|anesthetics|mesh-list
153656457|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153656458|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656459|NCT00055393|Bupropion|bupropion|mesh-list
153656460|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153656461|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
153656462|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153656463|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153656464|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153656465|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455642|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
153656466|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656467|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
153656468|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153656469|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656470|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153656471|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153656472|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656473|NCT00055432|Gemcitabine|gemcitabine|mesh-list
153656474|NCT00055432|Pemetrexed|pemetrexed|mesh-list
153656475|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656476|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
153656477|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656478|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656479|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656480|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153656481|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153656482|NCT00055549|Levomethorphan|levomethorphan|mesh-list
153656483|NCT00055549|Lorazepam|lorazepam|mesh-list
153656484|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
154128067|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
154128068|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
154128069|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128070|NCT03975283|Bupivacaine|bupivacaine|mesh-list
154128071|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
154128072|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
154128073|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128074|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128075|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
154128076|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128077|NCT01070407|Cloricromen|cloricromen|mesh-list
154128078|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154128079|NCT00801086|Ethanol|ethanol|mesh-list
154128081|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154128082|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128083|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128084|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358308|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153656485|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
153656486|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
153656487|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153656488|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153656489|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153656490|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656491|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656492|NCT00055549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153656493|NCT00055549|Narcotics|narcotics|mesh-ancestor
153656494|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153656495|NCT00055549|Analgesics|analgesics|mesh-ancestor
153656496|NCT00055549|Sensory System Agents|sensory system agents|mesh-ancestor
153656497|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656498|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
153656499|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
153656500|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
153656534|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
153656535|NCT00055861|Bevacizumab|bevacizumab|mesh-list
153656536|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153656537|NCT00055861|Docetaxel|docetaxel|mesh-list
153656538|NCT00055861|Antibodies|antibodies|mesh-list
153656539|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
153656540|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153656541|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656542|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153656543|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153656544|NCT00055861|Growth Substances|growth substances|mesh-ancestor
153656545|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656546|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
153656577|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153656578|NCT00055978|Analgesics|analgesics|mesh-ancestor
153656579|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
153656580|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656581|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656583|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153656584|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153656585|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154128086|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508476|NCT05274113|Dexamethasone|dexamethasone|mesh-list
154128087|NCT00801086|Protective Agents|protective agents|mesh-ancestor
154128088|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154128089|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128090|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154128091|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154128092|NCT00788606|Bevacizumab|bevacizumab|mesh-list
154128093|NCT00788606|Rituximab|rituximab|mesh-list
154128094|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154128095|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128096|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154128097|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154128098|NCT00788606|Growth Substances|growth substances|mesh-ancestor
154128099|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128100|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
154128101|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
154128102|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128103|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
154128104|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
153358325|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
153656586|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656587|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656589|NCT00056056|Methoxsalen|methoxsalen|mesh-list
153656614|NCT00056329|Vitamin E|vitamin e|mesh-list
153656615|NCT00056329|Tocopherols|tocopherols|mesh-list
153656616|NCT00056329|Vitamins|vitamins|mesh-ancestor
153656617|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
153656618|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656619|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
153656620|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656621|NCT00056329|Protective Agents|protective agents|mesh-ancestor
153656622|NCT00056368|Fluconazole|fluconazole|mesh-list
153656623|NCT00056368|Anidulafungin|anidulafungin|mesh-list
153656624|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
153656625|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656626|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153656627|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153656628|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656629|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656630|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153656631|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
153656632|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656633|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656634|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153656635|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153656636|NCT00056446|Vatalanib|vatalanib|mesh-list
153656637|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153656638|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656639|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656640|NCT00398437|Trastuzumab|trastuzumab|mesh-list
153656652|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128105|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154128106|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154128107|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128108|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128109|NCT00795938|Urological Agents|urological agents|mesh-ancestor
154128110|NCT00260065|Decitabine|decitabine|mesh-list
154128111|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154128112|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
154128113|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128114|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128115|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128116|NCT01071655|Fluorouracil|fluorouracil|mesh-list
154128117|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
154128118|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358335|NCT01309451|Growth Substances|growth substances|mesh-ancestor
153358337|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
153656653|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
153656654|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656655|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153656656|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
153656657|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153656658|NCT00056797|Interleukin-2|interleukin-2|mesh-list
153656659|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360521|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
153656660|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153656661|NCT00056797|Analgesics|analgesics|mesh-ancestor
153656662|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
153656663|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656664|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656665|NCT00056836|Ranibizumab|ranibizumab|mesh-list
153656666|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153656667|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153656668|NCT00056836|Growth Substances|growth substances|mesh-ancestor
153656669|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656670|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
153656671|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656672|NCT05495321|Aldesleukin|aldesleukin|mesh-list
153656673|NCT05495321|Interleukin-2|interleukin-2|mesh-list
153656674|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656675|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153656676|NCT05495321|Analgesics|analgesics|mesh-ancestor
153656677|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
153656678|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656679|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656680|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153656681|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153656682|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
153797648|NCT00415844|Carbidopa|carbidopa|mesh-list
153797649|NCT00415844|Entacapone|entacapone|mesh-list
153656683|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656684|NCT00056875|Mitogens|mitogens|mesh-list
153656685|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656686|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656687|NCT05410197|Gemcitabine|gemcitabine|mesh-list
153656688|NCT05410197|Lenvatinib|lenvatinib|mesh-list
153656689|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656690|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656691|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
153656693|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153656694|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656695|NCT03262454|Atezolizumab|atezolizumab|mesh-list
154128119|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154128120|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128121|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128122|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
154128123|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128124|NCT02531581|Furosemide|furosemide|mesh-list
154128125|NCT02531581|Diuretics|diuretics|mesh-list
154128126|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
154128127|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128128|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154128129|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154128130|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128131|NCT04046510|Oxytocin|oxytocin|mesh-list
154128132|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
154128133|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154128134|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128135|NCT00506350|Vaccines|vaccines|mesh-list
154128136|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
154128137|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128138|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
154128139|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
154128140|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
154128141|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154128142|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128143|NCT00742625|Cytarabine|cytarabine|mesh-list
154128144|NCT00742625|Bortezomib|bortezomib|mesh-list
154128145|NCT00742625|Daunorubicin|daunorubicin|mesh-list
154128146|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656696|NCT03262454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153656697|NCT03262454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656698|NCT03262454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656699|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656700|NCT00057031|Calcitriol|calcitriol|mesh-list
153656701|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153656702|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656713|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153656714|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656715|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656717|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656718|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153656719|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153656720|NCT00057343|Rituximab|rituximab|mesh-list
153656721|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656722|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656723|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
153656724|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358379|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128147|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
154128148|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128149|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128150|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
154128151|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128152|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128153|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
154128154|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128155|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154128156|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154128157|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154128158|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128159|NCT00801788|Oxycodone|oxycodone|mesh-list
154128160|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154128161|NCT00801788|Narcotics|narcotics|mesh-ancestor
154128162|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128164|NCT00801788|Analgesics|analgesics|mesh-ancestor
154128165|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
154128166|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128167|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154128168|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128169|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
154128170|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154128171|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128172|NCT00796250|Prednisolone|prednisolone|mesh-list
154128173|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154128174|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
154128175|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154128176|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
154128177|NCT00796250|Infliximab|infliximab|mesh-list
154128178|NCT00796250|Azathioprine|azathioprine|mesh-list
154128179|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154128180|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
154128181|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128182|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
154128183|NCT00796250|Hormones|hormones|mesh-ancestor
154128184|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656725|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128185|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128186|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154128187|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128188|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
154128189|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
154128190|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128191|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128192|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154128193|NCT00796250|Protective Agents|protective agents|mesh-ancestor
154128194|NCT00796250|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154128195|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
154128196|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128197|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
154128198|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128199|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154128200|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128201|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
154128202|NCT00788918|Interferons|interferons|mesh-list
154128203|NCT00788918|Ribavirin|ribavirin|mesh-list
154128204|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128205|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
154128206|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128207|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
154128208|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128209|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
154128210|NCT02596373|Analgesics|analgesics|mesh-ancestor
154128211|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
154128212|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128213|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656726|NCT00057382|Doxorubicin|doxorubicin|mesh-list
153656727|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153656728|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656729|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153656730|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656731|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656732|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656733|NCT00057421|Prednisolone|prednisolone|mesh-list
153656734|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153656735|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
153656736|NCT00057421|Hormones|hormones|mesh-ancestor
153656737|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656738|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656739|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153656740|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656741|NCT00057616|Lenalidomide|lenalidomide|mesh-list
153656742|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
154128214|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128215|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154128216|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154128217|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128218|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128219|NCT00801866|Bevacizumab|bevacizumab|mesh-list
154128220|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154128221|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128222|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154128223|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154128224|NCT00801866|Growth Substances|growth substances|mesh-ancestor
154128225|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128226|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
154128227|NCT03973879|Atezolizumab|atezolizumab|mesh-list
154128228|NCT03973879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154128229|NCT03973879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128230|NCT03973879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154128231|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128232|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154128233|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154128234|NCT00860964|Estradiol|estradiol|mesh-list
154128235|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154128236|NCT00860964|Estrogens|estrogens|mesh-ancestor
154128237|NCT00860964|Hormones|hormones|mesh-ancestor
154128238|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128239|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128240|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154128241|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
153656743|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656744|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153798002|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
153656745|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153656746|NCT00057616|Growth Substances|growth substances|mesh-ancestor
153656747|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
153656748|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656749|NCT02969746|Charcoal|charcoal|mesh-list
153656750|NCT02969746|Antidotes|antidotes|mesh-ancestor
153656751|NCT02969746|Protective Agents|protective agents|mesh-ancestor
153656752|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656753|NCT00057850|Cisplatin|cisplatin|mesh-list
153656754|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656755|NCT00057889|Ipilimumab|ipilimumab|mesh-list
153656756|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656757|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656758|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154128242|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154128243|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154128244|NCT04088903|Daratumumab|daratumumab|mesh-list
154128245|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128246|NCT00861120|Doxorubicin|doxorubicin|mesh-list
154128247|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154128248|NCT00861120|Panitumumab|panitumumab|mesh-list
154128249|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154128250|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128251|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154128252|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154128253|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128254|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128255|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154128256|NCT00740051|Glimepiride|glimepiride|mesh-list
154128257|NCT00740051|Linagliptin|linagliptin|mesh-list
154128258|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154128259|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154128260|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128261|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128262|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
154128263|NCT00740051|Incretins|incretins|mesh-ancestor
154128264|NCT00740051|Hormones|hormones|mesh-ancestor
154128265|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128266|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154128267|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
154128268|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656759|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656760|NCT00057928|Paclitaxel|paclitaxel|mesh-list
153656761|NCT00057928|Gemcitabine|gemcitabine|mesh-list
153656762|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153656763|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656764|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656765|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656766|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656777|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153656778|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153656780|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
153656781|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656782|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656783|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153656784|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153656785|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153656786|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153656788|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656789|NCT00058045|Aldesleukin|aldesleukin|mesh-list
153656790|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656791|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153358496|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128269|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128270|NCT00864864|Sunitinib|sunitinib|mesh-list
154128271|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128272|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154128273|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154128274|NCT00864864|Growth Substances|growth substances|mesh-ancestor
154128275|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128276|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
154128277|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154128278|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128279|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128280|NCT00868764|Granisetron|granisetron|mesh-list
154128281|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
154128282|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
154128283|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128284|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128285|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128286|NCT00868764|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154128287|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154128288|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
154128289|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128290|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128291|NCT00518986|Modafinil|modafinil|mesh-list
154128292|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154128293|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128294|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154128295|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154128296|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153358498|NCT01258049|Analgesics|analgesics|mesh-ancestor
153656792|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153656793|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
153656794|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656795|NCT00058084|Prednisone|prednisone|mesh-list
153656796|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
153656797|NCT00058084|Epothilone B|epothilone b|mesh-list
153656798|NCT00058084|Epothilones|epothilones|mesh-list
153656799|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153656800|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
153656801|NCT00058084|Hormones|hormones|mesh-ancestor
153656802|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656803|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128297|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128298|NCT00864942|Lenalidomide|lenalidomide|mesh-list
154128299|NCT00864942|Rituximab|rituximab|mesh-list
154128300|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154128301|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
154128302|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128303|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154128304|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154128305|NCT00864942|Growth Substances|growth substances|mesh-ancestor
154128306|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
154128307|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128308|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154128309|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128310|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154128311|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
154128312|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128313|NCT00870402|Spironolactone|spironolactone|mesh-list
154128314|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154128315|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
154128316|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128317|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128318|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154128319|NCT00870402|Diuretics|diuretics|mesh-ancestor
154128320|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
154128321|NCT00742235|Vitamin D|vitamin d|mesh-list
154128322|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
154128323|NCT00742235|Vitamins|vitamins|mesh-ancestor
154128324|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
154128325|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128326|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154128327|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154128328|NCT00742079|Cycloserine|cycloserine|mesh-list
154128329|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154128330|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128331|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153656804|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153656805|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656806|NCT00058084|Analgesics|analgesics|mesh-ancestor
154128332|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
154128333|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154128334|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
154128335|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128336|NCT04730362|Propofol|propofol|mesh-list
154128337|NCT04730362|Sevoflurane|sevoflurane|mesh-list
154128338|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
154128339|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128340|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128341|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154128342|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154128343|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
154128344|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154128345|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154128346|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
154128347|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154128348|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154128349|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
154128350|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128351|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128352|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154128353|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
154128354|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
154128355|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154128356|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
154128357|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358559|NCT02199041|Prednisolone|prednisolone|mesh-list
153656807|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
153656808|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656809|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153656810|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656811|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656812|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656813|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656814|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656815|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656816|NCT02969629|Apomorphine|apomorphine|mesh-list
153656817|NCT02969629|Emetics|emetics|mesh-ancestor
153656818|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656819|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
153656820|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656821|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153656822|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
153656823|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
153656824|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153656825|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656826|NCT00058201|Leucovorin|leucovorin|mesh-list
153656827|NCT00058201|Gemcitabine|gemcitabine|mesh-list
153358590|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128358|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128359|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154128360|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154128361|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154128362|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
154128364|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154128365|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154128366|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128367|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128368|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
154128369|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128370|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128371|NCT00870480|Urological Agents|urological agents|mesh-ancestor
154128372|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
154128373|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128374|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154128375|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154128376|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154128377|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154128378|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
153656828|NCT00058201|Fluorouracil|fluorouracil|mesh-list
153656829|NCT00058201|Calcium|calcium|mesh-list
153656830|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
153656831|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656832|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
153656848|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153656849|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656851|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153656852|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
153656853|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656854|NCT00058318|Gemcitabine|gemcitabine|mesh-list
153656855|NCT00058318|Capecitabine|capecitabine|mesh-list
153656856|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656857|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
153656858|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656859|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656860|NCT00058357|Lidocaine|lidocaine|mesh-list
153656861|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
153656862|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
153656863|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153656864|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656865|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
153656866|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153656867|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153656868|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153656869|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153656870|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153358613|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
154128379|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154128380|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128382|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
154128383|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154128384|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
154128385|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154128386|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154128387|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
154128388|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128389|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128390|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128391|NCT00801944|Urological Agents|urological agents|mesh-ancestor
154128392|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154128393|NCT00870714|Ketoconazole|ketoconazole|mesh-list
154128395|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128396|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
154128397|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
154128398|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
154128399|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128400|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
154128401|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128402|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154128403|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154128404|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128405|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154128406|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
154128407|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656871|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656872|NCT00058435|Abagovomab|abagovomab|mesh-list
153656873|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656874|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656875|NCT00058474|Capecitabine|capecitabine|mesh-list
153656876|NCT00058474|Fluorouracil|fluorouracil|mesh-list
153656877|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
153656880|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656881|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656882|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656884|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656885|NCT00392262|Amlodipine|amlodipine|mesh-list
153656886|NCT00392262|Valsartan|valsartan|mesh-list
153656887|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153656888|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153358641|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
154128408|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128409|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154128410|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154128411|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
154128412|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128413|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
154128415|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
154128416|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128417|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
154128418|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128419|NCT00869310|Dexamethasone|dexamethasone|mesh-list
154128420|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
154128421|NCT00869310|Aprepitant|aprepitant|mesh-list
154128422|NCT00869310|Metoclopramide|metoclopramide|mesh-list
154128423|NCT00869310|BB 1101|bb 1101|mesh-list
154128424|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128425|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
154128426|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
154128427|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128428|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128429|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128430|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
154128431|NCT00869310|Hormones|hormones|mesh-ancestor
154128432|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128433|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154128434|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128435|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
154128436|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128437|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128438|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154128439|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153656889|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153656890|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656904|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153656905|NCT00058903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153656906|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153656907|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153656908|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656909|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358670|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128440|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154128441|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154128442|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
154128443|NCT00662558|Celecoxib|celecoxib|mesh-list
154128444|NCT00662558|Tramadol|tramadol|mesh-list
154128445|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154128446|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154128447|NCT00662558|Analgesics|analgesics|mesh-ancestor
154128448|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
154128449|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128450|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128451|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128452|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128453|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154128454|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154128455|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358672|NCT04351763|Amiodarone|amiodarone|mesh-list
153656910|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
153656911|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656912|NCT02969473|Cisplatin|cisplatin|mesh-list
153656913|NCT02969473|Docetaxel|docetaxel|mesh-list
153656914|NCT02969473|Fluorouracil|fluorouracil|mesh-list
153656915|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656916|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656917|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656918|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656919|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656920|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
153656921|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656922|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656923|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
153656924|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656925|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
153656926|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656927|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656928|NCT01349907|Asenapine|asenapine|mesh-list
153656929|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153656930|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153656931|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153656932|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656933|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153656934|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153656935|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153656936|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656938|NCT00059722|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153656939|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153656940|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656941|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656942|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656943|NCT02969239|Phenylephrine|phenylephrine|mesh-list
153656944|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
153656945|NCT02969239|Norepinephrine|norepinephrine|mesh-list
153656946|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153656947|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153656948|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
153656949|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
153656969|NCT00059800|Trace Elements|trace elements|mesh-ancestor
153656970|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
154128457|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154128458|NCT00662558|Narcotics|narcotics|mesh-ancestor
154128459|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128460|NCT00869700|Lumefantrine|lumefantrine|mesh-list
154128461|NCT00869700|Artemether|artemether|mesh-list
154128462|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154128463|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
154128464|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154128465|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154128466|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128467|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
154128468|NCT00869856|Hematinics|hematinics|mesh-ancestor
154128469|NCT00876486|genexol-PM|genexol-pm|mesh-list
154128470|NCT00876486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128471|NCT00876486|Tubulin Modulators|tubulin modulators|mesh-ancestor
154128472|NCT00876486|Antimitotic Agents|antimitotic agents|mesh-ancestor
154128473|NCT00876486|Mitosis Modulators|mitosis modulators|mesh-ancestor
154128474|NCT00876486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128475|NCT00802334|Ritonavir|ritonavir|mesh-list
154128476|NCT00802334|Lopinavir|lopinavir|mesh-list
154128477|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154128478|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154128479|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
154128481|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128482|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154128483|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154128484|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
154128485|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128486|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153358686|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153656971|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656972|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
153656973|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153656974|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153656975|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656976|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
153656977|NCT03216083|Coagulants|coagulants|mesh-ancestor
153656978|NCT00059878|Interferons|interferons|mesh-list
153656979|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
153656980|NCT00059878|Voriconazole|voriconazole|mesh-list
153656981|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656982|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
153656983|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656996|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128487|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154128488|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154128489|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154128490|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154128491|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128492|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128493|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154128494|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154128495|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154128496|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
154128497|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128498|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128499|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154128500|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154128501|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
154128502|NCT00796796|Sirolimus|sirolimus|mesh-list
154128503|NCT00796796|Temsirolimus|temsirolimus|mesh-list
154128504|NCT00796796|MTOR Inhibitors|mtor inhibitors|mesh-list
154128505|NCT00796796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154128506|NCT00796796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128507|NCT00796796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128508|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128509|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
154128510|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128511|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128512|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153656997|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153656998|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656999|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657000|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657001|NCT00060112|Gemcitabine|gemcitabine|mesh-list
153657002|NCT00060112|Oblimersen|oblimersen|mesh-list
153657003|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153657013|NCT02968927|Vitamin D|vitamin d|mesh-list
153657014|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
153657015|NCT02968927|Rifabutin|rifabutin|mesh-list
153657016|NCT02968927|Everolimus|everolimus|mesh-list
153657017|NCT02968927|Auranofin|auranofin|mesh-list
153657018|NCT02968927|CC-11050|cc-11050|mesh-list
153657019|NCT02968927|Vitamins|vitamins|mesh-ancestor
153657020|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
153657021|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657022|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153657023|NCT02968927|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153657024|NCT02968927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657025|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657026|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657027|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657028|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
154128514|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154128515|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
154128516|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
154128517|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
154128518|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
154128519|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128520|NCT03794076|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154128521|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128522|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154128523|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
154128524|NCT00739973|Amlodipine|amlodipine|mesh-list
154128525|NCT00739973|Aliskiren|aliskiren|mesh-list
154128526|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154128527|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154128528|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154128529|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128530|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154128531|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128532|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
153657029|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657030|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153657031|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153657032|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657033|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153657034|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
153657035|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657036|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153657037|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153657038|NCT00398515|Sirolimus|sirolimus|mesh-list
153657039|NCT00398515|Lenalidomide|lenalidomide|mesh-list
153657040|NCT00398515|Temsirolimus|temsirolimus|mesh-list
153657041|NCT00398515|MTOR Inhibitors|mtor inhibitors|mesh-list
153657042|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
153657043|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657044|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153657045|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153657046|NCT00398515|Growth Substances|growth substances|mesh-ancestor
153657047|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
153657048|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798681|NCT00271349|Budesonide|budesonide|mesh-list
153657049|NCT00398515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657050|NCT00398515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657051|NCT00398515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657052|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657053|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153657055|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153657056|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
153657057|NCT05105685|Hormones|hormones|mesh-list
153657058|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153657059|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657060|NCT05325164|Morphine|morphine|mesh-list
153657061|NCT05325164|Methadone|methadone|mesh-list
153657062|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153657063|NCT05325164|Narcotics|narcotics|mesh-ancestor
154128533|NCT00739973|Renin Inhibitors|renin inhibitors|mesh-ancestor
154128534|NCT00739973|Protease Inhibitors|protease inhibitors|mesh-ancestor
154128535|NCT00739973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128536|NCT00802568|Fludarabine|fludarabine|mesh-list
154128537|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
154128538|NCT00802568|Busulfan|busulfan|mesh-list
154128539|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154128540|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128541|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154128542|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
154128543|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128544|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128545|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
154128546|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128547|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
154128548|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154128549|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154128550|NCT00802802|Efavirenz|efavirenz|mesh-list
154128551|NCT00802802|Rifampin|rifampin|mesh-list
154128552|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153731276|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154128553|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154128554|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128555|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128556|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
154128557|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358763|NCT01318967|Furosemide|furosemide|mesh-list
153657064|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657065|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657066|NCT05325164|Analgesics|analgesics|mesh-ancestor
153657067|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
153657068|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657069|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
153657087|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153657088|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153657089|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657090|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153657091|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
153657092|NCT00060385|Hormones|hormones|mesh-ancestor
153657093|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153657094|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153657095|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153657096|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
153657097|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
153657098|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
153657099|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
153657100|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
153657101|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154128558|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154128559|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154128560|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154128561|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154128562|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154128563|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154128564|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154128565|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
154128566|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154128567|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
154128568|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154128569|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154128570|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154128571|NCT00802958|Clobetasol|clobetasol|mesh-list
154128572|NCT00802958|Halobetasol|halobetasol|mesh-list
154128573|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154128574|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128575|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
154128576|NCT00802958|Hormones|hormones|mesh-ancestor
154128577|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128578|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358774|NCT01348607|Modafinil|modafinil|mesh-list
153657102|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657103|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153657104|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153657105|NCT02968693|Vancomycin|vancomycin|mesh-list
153657106|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153657107|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153657108|NCT02968693|Calcium|calcium|mesh-list
153657109|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153657110|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657111|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657112|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
153657113|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
153657114|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153657115|NCT02968693|Protective Agents|protective agents|mesh-ancestor
153657116|NCT00060502|Infliximab|infliximab|mesh-list
153657117|NCT00060502|Gemcitabine|gemcitabine|mesh-list
153657118|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153657119|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
153657120|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657121|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657122|NCT00060502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153657123|NCT00060502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153657124|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
153657125|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153657126|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657127|NCT05312372|Paclitaxel|paclitaxel|mesh-list
153360607|NCT01277159|Narcotics|narcotics|mesh-ancestor
153657128|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154128579|NCT01565512|Bupivacaine|bupivacaine|mesh-list
154128580|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
154128581|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
154128582|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128583|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128584|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
154128585|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128586|NCT04895930|Aflutinib|aflutinib|mesh-list
154128587|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154128588|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128589|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128590|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154128591|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154128592|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
154128593|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128594|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128595|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154128596|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
154128597|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154128598|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154128599|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153358809|NCT06214468|Niacin|niacin|mesh-list
153657153|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153657154|NCT00060931|Metoprolol|metoprolol|mesh-list
153657155|NCT00060931|Carvedilol|carvedilol|mesh-list
153657156|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153657157|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153657158|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
153657159|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
153657160|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657161|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657162|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153657163|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153657164|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153657165|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
153657166|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657167|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657168|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
153657170|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153657171|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153657172|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153657173|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
153657174|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153657175|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153798764|NCT00271973|Narcotics|narcotics|mesh-ancestor
153657176|NCT00061087|Methylphenidate|methylphenidate|mesh-list
153657177|NCT00061087|Bupropion|bupropion|mesh-list
153657208|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153657209|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153657211|NCT00061360|Sirolimus|sirolimus|mesh-list
153657212|NCT00061360|Cyclosporins|cyclosporins|mesh-list
153657213|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657214|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128600|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
154128601|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128602|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128603|NCT00789308|Cyclosporine|cyclosporine|mesh-list
154128604|NCT00789308|Sirolimus|sirolimus|mesh-list
154128605|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
154128606|NCT00789308|Etanercept|etanercept|mesh-list
154128607|NCT00789308|Heparin|heparin|mesh-list
154128608|NCT00789308|Dextrans|dextrans|mesh-list
154128609|NCT00789308|Tacrolimus|tacrolimus|mesh-list
154128610|NCT00789308|Cyclosporins|cyclosporins|mesh-list
154128611|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
154128612|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154128613|NCT00789308|Basiliximab|basiliximab|mesh-list
154128614|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128615|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
154128616|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128617|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154128618|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128619|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128620|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
154128621|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128622|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
154128623|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128624|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153358825|NCT06214377|Dopamine|dopamine|mesh-list
153657215|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657242|NCT06197555|Calcium Carbonate|calcium carbonate|mesh-list
153657244|NCT06197555|Fluorides|fluorides|mesh-list
153657245|NCT06197555|Tin Fluorides|tin fluorides|mesh-list
153657246|NCT06197555|Fluorophosphate|fluorophosphate|mesh-list
153657247|NCT06197555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153657248|NCT06197555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657249|NCT06197555|Cariostatic Agents|cariostatic agents|mesh-ancestor
153657250|NCT06197555|Protective Agents|protective agents|mesh-ancestor
153657251|NCT06197555|Antacids|antacids|mesh-ancestor
153657252|NCT06197555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657253|NCT06197555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153657254|NCT06197529|Capsaicin|capsaicin|mesh-list
153657255|NCT06197529|Antipruritics|antipruritics|mesh-ancestor
153657256|NCT06197529|Dermatologic Agents|dermatologic agents|mesh-ancestor
153657257|NCT06197529|Sensory System Agents|sensory system agents|mesh-ancestor
153657258|NCT06197529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657259|NCT06197529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657260|NCT06197438|Leucovorin|leucovorin|mesh-list
153657261|NCT06197438|Paclitaxel|paclitaxel|mesh-list
153657262|NCT06197438|Fluorouracil|fluorouracil|mesh-list
153657263|NCT06197438|Oxaliplatin|oxaliplatin|mesh-list
153657289|NCT06197425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657291|NCT06197425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657292|NCT06197022|Sirolimus|sirolimus|mesh-list
153657293|NCT06197022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153657294|NCT06197022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657295|NCT06197022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153657296|NCT06197022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128625|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128626|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154128627|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
154128628|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154128629|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
154128630|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154128631|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154128632|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154128633|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154128634|NCT00789308|Analgesics|analgesics|mesh-ancestor
154128635|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
154128636|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128637|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128638|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128639|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
154128640|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
154128641|NCT00518284|Paclitaxel|paclitaxel|mesh-list
154128642|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154128643|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154128644|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128645|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
154128646|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
154128647|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
154128648|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128649|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
154128650|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154128651|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128652|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154128653|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154128654|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128655|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657297|NCT06197022|Antifungal Agents|antifungal agents|mesh-ancestor
153657298|NCT06197022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657299|NCT06197022|Immunologic Factors|immunologic factors|mesh-ancestor
153657300|NCT06197022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657301|NCT06196918|Rivaroxaban|rivaroxaban|mesh-list
153657302|NCT06196918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153657303|NCT06196918|Antithrombins|antithrombins|mesh-ancestor
153657304|NCT06196918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153657305|NCT06196918|Protease Inhibitors|protease inhibitors|mesh-ancestor
153657306|NCT06196918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657307|NCT06196918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657308|NCT06196918|Anticoagulants|anticoagulants|mesh-ancestor
154128656|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128657|NCT00871104|Vancomycin|vancomycin|mesh-list
154128658|NCT00871104|Imipenem|imipenem|mesh-list
154128659|NCT00871104|Fosfomycin|fosfomycin|mesh-list
154128660|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154128661|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128662|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
154128663|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154128664|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128665|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
154128666|NCT00727415|Fludarabine|fludarabine|mesh-list
154128667|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
154128668|NCT00727415|Lenalidomide|lenalidomide|mesh-list
154128669|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128670|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
154128671|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128672|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128673|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154128674|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
154128675|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128676|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128677|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154128678|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154128679|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
154128680|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154128681|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154128682|NCT00727415|Growth Substances|growth substances|mesh-ancestor
154128683|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
154128684|NCT00803192|Famotidine|famotidine|mesh-list
154128685|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154128686|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128687|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154128688|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
154128689|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
154128690|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358871|NCT06213987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657309|NCT06196853|Aminophylline|aminophylline|mesh-list
153657310|NCT06196853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153657312|NCT06196853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657313|NCT06196853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657314|NCT06196853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154128691|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128692|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128693|NCT00544557|Etanercept|etanercept|mesh-list
154128694|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154128695|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154128696|NCT00544557|Analgesics|analgesics|mesh-ancestor
154128697|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
154128698|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128699|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128700|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128701|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128702|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128703|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128704|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
154128705|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
154128706|NCT00877110|Vincristine|vincristine|mesh-list
153657336|NCT06196697|Antimetabolites|antimetabolites|mesh-ancestor
153657337|NCT06196697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657338|NCT06196697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657343|NCT06196606|Botulinum Toxins|botulinum toxins|mesh-list
153657344|NCT06196606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153657345|NCT06196606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153657346|NCT06196606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153657347|NCT06196606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153657348|NCT06196606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657349|NCT06196606|Cholinergic Agents|cholinergic agents|mesh-ancestor
153657350|NCT06196606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657351|NCT06196606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657352|NCT06196606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153657353|NCT06196606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657354|NCT06196554|Paclitaxel|paclitaxel|mesh-list
153657355|NCT06196554|Pembrolizumab|pembrolizumab|mesh-list
153657356|NCT06196554|Nivolumab|nivolumab|mesh-list
153657357|NCT06196554|Fluorouracil|fluorouracil|mesh-list
153657358|NCT06196554|Oxaliplatin|oxaliplatin|mesh-list
153657359|NCT06196554|Irinotecan|irinotecan|mesh-list
153657360|NCT06196554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153657361|NCT06196554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657362|NCT06196554|Tubulin Modulators|tubulin modulators|mesh-ancestor
153657363|NCT06196554|Antimitotic Agents|antimitotic agents|mesh-ancestor
153657364|NCT06196554|Mitosis Modulators|mitosis modulators|mesh-ancestor
153657365|NCT06196554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657366|NCT06196554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657367|NCT06196554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153657368|NCT06196554|Antimetabolites|antimetabolites|mesh-ancestor
153657369|NCT06196554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153657370|NCT06196554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657371|NCT06196554|Immunologic Factors|immunologic factors|mesh-ancestor
153657372|NCT06196554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657392|NCT06196047|Autonomic Agents|autonomic agents|mesh-ancestor
153657393|NCT06196047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657394|NCT06196047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153657395|NCT06196047|Respiratory System Agents|respiratory system agents|mesh-ancestor
153657396|NCT06196047|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153657397|NCT06196047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153657398|NCT06196047|Vasodilator Agents|vasodilator agents|mesh-ancestor
153657399|NCT06196047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153657400|NCT06196047|Protective Agents|protective agents|mesh-ancestor
153657401|NCT06196047|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154128708|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128709|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
154128710|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128711|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128712|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154128713|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
154128714|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128715|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128716|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154128717|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154128718|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
154128719|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
154128720|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
154128721|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154128722|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154128723|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128724|NCT00727259|Ribavirin|ribavirin|mesh-list
154128725|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154128726|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
154128727|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128728|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
154128729|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128730|NCT00789386|Midazolam|midazolam|mesh-list
154128731|NCT00789386|Remifentanil|remifentanil|mesh-list
154128732|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154128733|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154128734|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128735|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128736|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154128737|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154128738|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154128739|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153657402|NCT06196047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153657403|NCT06196047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657404|NCT06193200|Dexamethasone|dexamethasone|mesh-list
153657405|NCT06193200|Dexamethasone acetate|dexamethasone acetate|mesh-list
153657406|NCT06193200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153657407|NCT06193200|BB 1101|bb 1101|mesh-list
153657408|NCT06193200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153494369|NCT02345772|Pertuzumab|pertuzumab|mesh-list
153657409|NCT06193200|Antiemetics|antiemetics|mesh-ancestor
153657410|NCT06193200|Autonomic Agents|autonomic agents|mesh-ancestor
153657411|NCT06193200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128740|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
154128742|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
154128743|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
153799087|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154128744|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128745|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128746|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154128747|NCT00789386|Narcotics|narcotics|mesh-ancestor
154128748|NCT00789386|Analgesics|analgesics|mesh-ancestor
154128749|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
154128750|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128751|NCT00789464|Trimethoprim|trimethoprim|mesh-list
154128752|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
154128753|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154128754|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128755|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
154128756|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154128757|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154128758|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154128759|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128760|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128761|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154128762|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154128763|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154128765|NCT00797030|Cyclosporins|cyclosporins|mesh-list
154128766|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128767|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128768|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128769|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
154128770|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128771|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
154128772|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657412|NCT06193200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657413|NCT06193200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153657414|NCT06193200|Glucocorticoids|glucocorticoids|mesh-ancestor
153657415|NCT06193200|Hormones|hormones|mesh-ancestor
153657416|NCT06193200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153657417|NCT06193200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153657418|NCT06193200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657419|NCT06193200|Protease Inhibitors|protease inhibitors|mesh-ancestor
153657420|NCT06193200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657421|NCT06193200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657422|NCT06193044|Amlodipine|amlodipine|mesh-list
154128773|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
154128774|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128775|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154128776|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
154128777|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
154128778|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128779|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
154128780|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
154128781|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154128783|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154128784|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128785|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154128786|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154128787|NCT00877266|Mepivacaine|mepivacaine|mesh-list
154128788|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
154128789|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
154128790|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358982|NCT06212973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657423|NCT06193044|Valsartan|valsartan|mesh-list
153657424|NCT06193044|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153657425|NCT06193044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153657426|NCT06193044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153657451|NCT06192238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657453|NCT06192238|Respiratory System Agents|respiratory system agents|mesh-ancestor
153657454|NCT06192238|Mydriatics|mydriatics|mesh-ancestor
153657455|NCT06192238|Sympathomimetics|sympathomimetics|mesh-ancestor
153657456|NCT06192238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153657457|NCT06189781|Lidocaine|lidocaine|mesh-list
153657458|NCT06189781|Bupivacaine|bupivacaine|mesh-list
153657459|NCT06189781|Ropivacaine|ropivacaine|mesh-list
153657460|NCT06189781|Anesthetics, Local|anesthetics, local|mesh-ancestor
153657461|NCT06189781|Anesthetics|anesthetics|mesh-ancestor
153657462|NCT06189781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657463|NCT06189781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657464|NCT06189781|Sensory System Agents|sensory system agents|mesh-ancestor
153657465|NCT06189781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657466|NCT06189781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153657467|NCT06189781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153657468|NCT06189781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153657469|NCT06189781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153657470|NCT06189781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657471|NCT06183437|Tin Fluorides|tin fluorides|mesh-list
153657472|NCT06183437|Cariostatic Agents|cariostatic agents|mesh-ancestor
153657473|NCT06183437|Protective Agents|protective agents|mesh-ancestor
153657497|NCT06135389|Acetaminophen|acetaminophen|mesh-list
153657498|NCT06135389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153657499|NCT06135389|Analgesics|analgesics|mesh-ancestor
153657500|NCT06135389|Sensory System Agents|sensory system agents|mesh-ancestor
153657501|NCT06135389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657502|NCT06135389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657503|NCT06135389|Antipyretics|antipyretics|mesh-ancestor
153657504|NCT06084364|Triamcinolone|triamcinolone|mesh-list
153657505|NCT06084364|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153657506|NCT06084364|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153657507|NCT06084364|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153657508|NCT06084364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153657509|NCT06084364|Glucocorticoids|glucocorticoids|mesh-ancestor
153657510|NCT06084364|Hormones|hormones|mesh-ancestor
154128791|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128792|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
154128793|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128794|NCT02553824|Topiramate|topiramate|mesh-list
154128795|NCT02553824|Phentermine|phentermine|mesh-list
154128796|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
154128797|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154128798|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128799|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154128800|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
154128801|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154128802|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
154128803|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
153418136|NCT02785406|Suvorexant|suvorexant|mesh-list
154128804|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128805|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
154128806|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128807|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128808|NCT04039854|Propofol|propofol|mesh-list
154128809|NCT04039854|Sevoflurane|sevoflurane|mesh-list
154128810|NCT04039854|Desflurane|desflurane|mesh-list
154128811|NCT04039854|Isoflurane|isoflurane|mesh-list
154128812|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154128813|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128814|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128815|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154128816|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
154128817|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
154128818|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154128819|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154128820|NCT04045730|Paclitaxel|paclitaxel|mesh-list
153657511|NCT06084364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153657512|NCT06084364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657513|NCT06084364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657514|NCT06084364|Immunologic Factors|immunologic factors|mesh-ancestor
153657515|NCT06084364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657516|NCT06084364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657517|NCT06081907|Lenvatinib|lenvatinib|mesh-list
153657518|NCT06081907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657519|NCT06081907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657520|NCT06081907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657521|NCT06081907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657522|NCT06077422|Bupivacaine|bupivacaine|mesh-list
153657523|NCT06077422|Anesthetics, Local|anesthetics, local|mesh-ancestor
153657524|NCT06077422|Anesthetics|anesthetics|mesh-ancestor
153657525|NCT06077422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128822|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
154128823|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154128824|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128825|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
154128826|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
154128827|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
154128828|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128829|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154128830|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
154128831|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154128832|NCT04045730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154128833|NCT00977223|Aprepitant|aprepitant|mesh-list
154128834|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
154128835|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
154128836|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
154128837|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128838|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128839|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128840|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154128841|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128842|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128843|NCT00977301|Ritonavir|ritonavir|mesh-list
154128844|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
154128845|NCT00977301|Olanzapine|olanzapine|mesh-list
154128846|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154128847|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154128848|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
153657526|NCT06077422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657542|NCT06068543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153657544|NCT06053658|Tivozanib|tivozanib|mesh-list
153657545|NCT06053658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657546|NCT06053658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657547|NCT06053658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153657548|NCT06053658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657549|NCT06053658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657550|NCT06053658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657551|NCT06053567|Nicotine|nicotine|mesh-list
153657552|NCT06053567|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153657553|NCT06053567|Autonomic Agents|autonomic agents|mesh-ancestor
153657554|NCT06053567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657555|NCT06053567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657556|NCT06053567|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153657557|NCT06053567|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153657558|NCT06053567|Cholinergic Agents|cholinergic agents|mesh-ancestor
153494513|NCT01683864|Cisplatin|cisplatin|mesh-list
153657559|NCT06053567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359081|NCT06209606|Antiemetics|antiemetics|mesh-ancestor
154128849|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128850|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128851|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154128852|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154128853|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
154128854|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128855|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154128856|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154128857|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
154128858|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
154128859|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128860|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128861|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128862|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154128863|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154128864|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128865|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154128866|NCT00977301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154128867|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154128868|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154128869|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128870|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
154128871|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154128872|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154128873|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128874|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154128875|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153657560|NCT06053567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657561|NCT06045247|Prednisone|prednisone|mesh-list
153657562|NCT06045247|Cyclophosphamide|cyclophosphamide|mesh-list
153657563|NCT06045247|Rituximab|rituximab|mesh-list
153657564|NCT06045247|Vincristine|vincristine|mesh-list
153657565|NCT06045247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657566|NCT06045247|Immunologic Factors|immunologic factors|mesh-ancestor
153657567|NCT06045247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657568|NCT06045247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657569|NCT06045247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153657570|NCT06045247|Alkylating Agents|alkylating agents|mesh-ancestor
153657571|NCT06045247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657572|NCT06045247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657573|NCT06045247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153657574|NCT06045247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657575|NCT06045247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128876|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154128877|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128878|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
154128879|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128880|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
154128881|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128882|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
154128883|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128884|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128885|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154128886|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
154128887|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128888|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128889|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154128890|NCT00984945|Vaccines|vaccines|mesh-list
154128891|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
154128892|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128893|NCT00879918|Nicotine|nicotine|mesh-list
154128894|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154128895|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
154128896|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128897|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128898|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154128899|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154128900|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
154128901|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359110|NCT06200194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657576|NCT06045247|Glucocorticoids|glucocorticoids|mesh-ancestor
153657577|NCT06045247|Hormones|hormones|mesh-ancestor
153657578|NCT06045247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153657579|NCT06045247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153657580|NCT06045247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153657581|NCT06045247|Tubulin Modulators|tubulin modulators|mesh-ancestor
153657582|NCT06045247|Antimitotic Agents|antimitotic agents|mesh-ancestor
153657583|NCT06045247|Mitosis Modulators|mitosis modulators|mesh-ancestor
153657584|NCT06039358|Caffeine|caffeine|mesh-list
153657585|NCT06039358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153657622|NCT05820763|Lenalidomide|lenalidomide|mesh-list
153657623|NCT05820763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153657624|NCT05820763|Antiemetics|antiemetics|mesh-ancestor
153657625|NCT05820763|Autonomic Agents|autonomic agents|mesh-ancestor
153657651|NCT05769530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657652|NCT05769530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657654|NCT05769530|Analgesics|analgesics|mesh-ancestor
153657655|NCT05769530|Sensory System Agents|sensory system agents|mesh-ancestor
153657656|NCT05769530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128902|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128904|NCT01565590|Propofol|propofol|mesh-list
154128905|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154128906|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128907|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128908|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154128909|NCT01565590|Analgesics|analgesics|mesh-ancestor
154128910|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
154128911|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128912|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154128913|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154128914|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154128915|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
154128916|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128917|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128918|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154128919|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
154128920|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
154128921|NCT00877422|Vitamin D|vitamin d|mesh-list
154128922|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
154128923|NCT00877422|Vitamins|vitamins|mesh-ancestor
153359139|NCT06089577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153657657|NCT05769530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153657658|NCT05769530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153657659|NCT05769530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153657660|NCT05769530|Adrenergic Agents|adrenergic agents|mesh-ancestor
153657661|NCT05769530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657662|NCT05769530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657663|NCT05769530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153657664|NCT05769530|Narcotics|narcotics|mesh-ancestor
153657665|NCT05724589|Mitogens|mitogens|mesh-list
153657666|NCT05724589|Mitosis Modulators|mitosis modulators|mesh-ancestor
153657667|NCT05724589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657668|NCT05701059|Meloxicam|meloxicam|mesh-list
153657669|NCT05701059|Cimetidine|cimetidine|mesh-list
153657670|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153657671|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153657672|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153657673|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
153657674|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
153657682|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153657683|NCT05701059|Analgesics|analgesics|mesh-ancestor
153657684|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
153657685|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657686|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153657687|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657688|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153657689|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153657690|NCT05672667|Oxytocin|oxytocin|mesh-list
153657691|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
153657692|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154128924|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
154128925|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128926|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154128927|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154128928|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
154128929|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154128930|NCT04039698|Velpatasvir|velpatasvir|mesh-list
154128932|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154128933|NCT04006821|Apatinib|apatinib|mesh-list
154128934|NCT04006821|Antibodies|antibodies|mesh-list
154128935|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
154128936|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128937|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128938|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154128939|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128940|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128941|NCT00803816|Everolimus|everolimus|mesh-list
154128942|NCT00803816|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154128943|NCT00803816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154128944|NCT00803816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128945|NCT00803816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128946|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154128947|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
154128948|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128949|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128950|NCT00797264|Ketamine|ketamine|mesh-list
154128951|NCT00797264|Morphine|morphine|mesh-list
154128952|NCT00797264|Analgesics|analgesics|mesh-ancestor
154128953|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
154128954|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128955|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128956|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153875210|NCT01647984|Vitamin E|vitamin e|mesh-list
154128957|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154128958|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
154128959|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
153783518|NCT00236444|Risperidone|risperidone|mesh-list
153657693|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657694|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
153657695|NCT05669417|Analgesics|analgesics|mesh-ancestor
153657696|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
154128960|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154128961|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154128962|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154128963|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154128964|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128965|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154128966|NCT00797264|Narcotics|narcotics|mesh-ancestor
154128967|NCT00981201|Celecoxib|celecoxib|mesh-list
154128968|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154128969|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154128970|NCT00981201|Analgesics|analgesics|mesh-ancestor
154128971|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
154128972|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128973|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128974|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128975|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154128976|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154128977|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154128978|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154128979|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154128980|NCT05279391|Dexamethasone|dexamethasone|mesh-list
154128981|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154128982|NCT05279391|Heparin|heparin|mesh-list
154128983|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154128984|NCT05279391|Tinzaparin|tinzaparin|mesh-list
153657697|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657698|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657699|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
153657700|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657701|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153657702|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
153657703|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153657704|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153657705|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494672|NCT01031550|Propofol|propofol|mesh-list
153657706|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153657707|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
153657708|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153657709|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
153657710|NCT05664217|Antithrombins|antithrombins|mesh-list
153657711|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153657712|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
153657713|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657714|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657715|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
153657716|NCT05657652|Cytarabine|cytarabine|mesh-list
153657717|NCT05657652|Venetoclax|venetoclax|mesh-list
153657718|NCT05657652|Cladribine|cladribine|mesh-list
153657719|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153359214|NCT05782608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154128985|NCT05279391|Dalteparin|dalteparin|mesh-list
154128986|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154128988|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
154128989|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154128990|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154128991|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154128992|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
154128993|NCT05279391|Hormones|hormones|mesh-ancestor
154128994|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154128995|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154128996|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154128997|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
154128998|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154128999|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154129000|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129001|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129002|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154129003|NCT00789620|Lidocaine|lidocaine|mesh-list
154129004|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
154129005|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
154129006|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129007|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129008|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
153799836|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
154129009|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129010|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153359216|NCT05782608|Analgesics|analgesics|mesh-ancestor
153657720|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
153657721|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657722|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657723|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
153657724|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657725|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657726|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
153657727|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657730|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657731|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153657732|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153657733|NCT05642026|Ropivacaine|ropivacaine|mesh-list
153657734|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
153657735|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
153657736|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657737|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657738|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
153657757|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657758|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129011|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154129012|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154129013|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154129014|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129015|NCT03970265|Meropenem|meropenem|mesh-list
154129016|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154129017|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129018|NCT00803894|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
154129019|NCT00803894|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154129020|NCT00803894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129021|NCT00803894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129022|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154129023|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
154129024|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154129025|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
154129026|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129027|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154129028|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154129029|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154129030|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154129031|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657759|NCT05574036|Vitamin E|vitamin e|mesh-list
153657760|NCT05574036|Febuxostat|febuxostat|mesh-list
153657761|NCT05574036|Vitamins|vitamins|mesh-ancestor
153657762|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
153657763|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657764|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
153657765|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657766|NCT05574036|Protective Agents|protective agents|mesh-ancestor
153657767|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
153657768|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657769|NCT05573204|Vitamin E|vitamin e|mesh-list
153657770|NCT05573204|Vitamins|vitamins|mesh-ancestor
153657771|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
153657772|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657773|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
153657774|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657775|NCT05573204|Protective Agents|protective agents|mesh-ancestor
153657776|NCT05526417|Coal Tar|coal tar|mesh-list
153657777|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
153657778|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
153657779|NCT05512949|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153657780|NCT05512949|Antiviral Agents|antiviral agents|mesh-ancestor
153657781|NCT05512949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657782|NCT05497804|Dexamethasone|dexamethasone|mesh-list
153657783|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
153657784|NCT05497804|Lenalidomide|lenalidomide|mesh-list
153657785|NCT05497804|Daratumumab|daratumumab|mesh-list
153657786|NCT05497804|Ichthammol|ichthammol|mesh-list
153657787|NCT05497804|BB 1101|bb 1101|mesh-list
153657788|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129032|NCT00797420|Fluconazole|fluconazole|mesh-list
154129033|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
154129034|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129035|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154129036|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154129037|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129038|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129039|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154129040|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
154129041|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154129042|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129043|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154129044|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154129045|NCT00981513|Vaccines|vaccines|mesh-list
153800024|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
154129046|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
154129047|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657789|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
153657790|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
153657791|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657792|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657793|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153657794|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
153657795|NCT05497804|Hormones|hormones|mesh-ancestor
153657796|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153657797|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153657798|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657834|NCT05423379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657835|NCT05423379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360666|NCT04311710|Nivolumab|nivolumab|mesh-list
153657867|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
153657868|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657869|NCT05388006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657870|NCT05388006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657871|NCT05388006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657872|NCT05381597|Fluorouracil|fluorouracil|mesh-list
153657873|NCT05381597|Calcipotriene|calcipotriene|mesh-list
153657874|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
153657875|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657876|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153657877|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657890|NCT05279833|Dronedarone|dronedarone|mesh-list
153657891|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153657892|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153657893|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
153657894|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657895|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657896|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657900|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657904|NCT05260008|Epinephrine|epinephrine|mesh-list
153657905|NCT05260008|Bupivacaine|bupivacaine|mesh-list
153657906|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
153657907|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
153657908|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657909|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657910|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
154129049|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154129050|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154129051|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154129052|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
154129053|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129054|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129055|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509455|NCT02810457|Paclitaxel|paclitaxel|mesh-list
154129056|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154129057|NCT00872586|Olmesartan|olmesartan|mesh-list
154129058|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154129059|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154129060|NCT00872586|Diuretics|diuretics|mesh-ancestor
154129061|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
154129062|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129063|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154129064|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153359275|NCT05723601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153657911|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657912|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153657913|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153657914|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
153657915|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657916|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657917|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153657918|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153657919|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
153657920|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153657921|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
153657922|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
153657923|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
153657924|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153657925|NCT05253131|Durvalumab|durvalumab|mesh-list
153657926|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657927|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657928|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153657929|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657930|NCT05248022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657931|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657932|NCT05168930|Venetoclax|venetoclax|mesh-list
153494886|NCT05403762|Protective Agents|protective agents|mesh-list
153657933|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
153657934|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657935|NCT05168930|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153657936|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657937|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657938|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657939|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
153657959|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657960|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
153657961|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
153800105|NCT00416819|Methotrexate|methotrexate|mesh-list
153657962|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657963|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657964|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154129065|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129066|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154129068|NCT00726557|Interferons|interferons|mesh-list
154129069|NCT00726557|Ribavirin|ribavirin|mesh-list
154129070|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
154129071|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
154129072|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154129073|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129074|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
154129075|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129076|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
154129077|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129078|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
154129079|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129080|NCT00803972|Insulin|insulin|mesh-list
154129081|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154129082|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
154129083|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154129084|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129085|NCT00880386|Losartan|losartan|mesh-list
154129086|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154129087|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154129088|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153359293|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
153657965|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153657966|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153657967|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657968|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
153657969|NCT05065736|Clofarabine|clofarabine|mesh-list
153657970|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153657971|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
153657972|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657973|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657974|NCT05062356|Ketorolac|ketorolac|mesh-list
153657975|NCT05062356|Epinephrine|epinephrine|mesh-list
153657976|NCT05062356|Bupivacaine|bupivacaine|mesh-list
153657977|NCT05062356|Prilocaine|prilocaine|mesh-list
153657978|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153657979|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
153657980|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
153657981|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657982|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657983|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
153657984|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657985|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153657986|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153657987|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
153657988|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459074|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154129089|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154129090|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129091|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154129092|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154129093|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
154129094|NCT00804050|Vitamins|vitamins|mesh-list
154129095|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
154129096|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129097|NCT00877734|Baclofen|baclofen|mesh-list
154129098|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154129099|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129100|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154129101|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129102|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
154129103|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
154129104|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
154129105|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359318|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657989|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657990|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153657992|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
153657993|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153657994|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
153657995|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
153494960|NCT00558870|Morphine|morphine|mesh-list
153658009|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153658010|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153658011|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658012|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153658013|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
153658014|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658015|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153658016|NCT05056727|Protective Agents|protective agents|mesh-ancestor
153658017|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658018|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
153658019|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153658020|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153658021|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153658022|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153658023|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658024|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
153658025|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658026|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658027|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153658028|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658053|NCT04967196|Ipilimumab|ipilimumab|mesh-list
153658054|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658055|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658056|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658057|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658058|NCT04957095|Levodopa|levodopa|mesh-list
153658059|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153658060|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153658061|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
153658062|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658063|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129106|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129107|NCT00981591|Iloprost|iloprost|mesh-list
154129108|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154129109|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
154129110|NCT00978159|Esomeprazole|esomeprazole|mesh-list
154129111|NCT00978159|Famotidine|famotidine|mesh-list
154129112|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154129113|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154129114|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154129115|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129116|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129117|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154129118|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
154129119|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
154129120|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129121|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129122|NCT00804206|Bevacizumab|bevacizumab|mesh-list
154129123|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129124|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129125|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154129126|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154129127|NCT00804206|Growth Substances|growth substances|mesh-ancestor
154129128|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359337|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
153658064|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658065|NCT04940546|Bevacizumab|bevacizumab|mesh-list
153658066|NCT04940546|Capecitabine|capecitabine|mesh-list
153658067|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
153658068|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658069|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658070|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153658071|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153658072|NCT04940546|Growth Substances|growth substances|mesh-ancestor
153658073|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658074|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
153658075|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153658076|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
153658077|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658078|NCT04883645|Imiquimod|imiquimod|mesh-list
153360744|NCT00815360|Hormones|hormones|mesh-ancestor
153658079|NCT04883645|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153658097|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800353|NCT00281489|Anesthetics|anesthetics|mesh-list
153658098|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658099|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153658100|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
153658101|NCT04873583|Hormones|hormones|mesh-ancestor
153658102|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658103|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153658104|NCT04873583|Protective Agents|protective agents|mesh-ancestor
153658105|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658106|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129129|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
154129130|NCT00877812|Glycine|glycine|mesh-list
154129131|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
154129132|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129133|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129134|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129136|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154129137|NCT00981903|Dalteparin|dalteparin|mesh-list
154129138|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
154129139|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154129140|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154129141|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129142|NCT00738881|Pemetrexed|pemetrexed|mesh-list
154129143|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154129144|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129145|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129146|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129147|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154129148|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153359361|NCT05498025|Charcoal|charcoal|mesh-list
153658107|NCT04869449|Ketoconazole|ketoconazole|mesh-list
153658108|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
153658109|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658110|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153658111|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153658112|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658113|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658114|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153658116|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658117|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658118|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153658119|NCT04851457|Tirofiban|tirofiban|mesh-list
153658120|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153658121|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153658122|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658123|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153658124|NCT04825275|Posaconazole|posaconazole|mesh-list
153658125|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
153658126|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658127|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153658128|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153658129|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153658130|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153658131|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153658132|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658133|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658134|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153658135|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
153658147|NCT04770272|Epirubicin|epirubicin|mesh-list
153658148|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153658149|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153658150|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359377|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129149|NCT00738881|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154129150|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154129152|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154129153|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
154129154|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129155|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129156|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154129157|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154129158|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
154129159|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129160|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129161|NCT03921723|Dolutegravir|dolutegravir|mesh-list
154129162|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154129163|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154129164|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129165|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129166|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154129167|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154129168|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
154129169|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129170|NCT00872664|Carotenoids|carotenoids|mesh-list
154129171|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
153359378|NCT05444699|Prednisolone|prednisolone|mesh-list
153658151|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
153658152|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
153658153|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
153658154|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658155|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658156|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
153658157|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658158|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658159|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153658160|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
153658161|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153658162|NCT04770272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658163|NCT04770272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658164|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153658165|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153658166|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153658167|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658168|NCT04713098|Coal Tar|coal tar|mesh-list
153658169|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
153658170|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
153360746|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658179|NCT04672330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658180|NCT04672330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658181|NCT04658147|Nivolumab|nivolumab|mesh-list
153658182|NCT04658147|Relatlimab|relatlimab|mesh-list
154129172|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129173|NCT00872664|Protective Agents|protective agents|mesh-ancestor
154129174|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129175|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
154129176|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154129177|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154129179|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
154129180|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
154129181|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129182|NCT00878124|Vitamins|vitamins|mesh-ancestor
154129183|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
154129184|NCT00978315|Vitamin D|vitamin d|mesh-list
154129185|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154129186|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129187|NCT00978315|Vitamins|vitamins|mesh-ancestor
154129188|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
154129189|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154129190|NCT00978393|Liraglutide|liraglutide|mesh-list
153359401|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153658183|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658184|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658185|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658186|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658187|NCT04530149|Acetaminophen|acetaminophen|mesh-list
153658188|NCT04530149|Bupivacaine|bupivacaine|mesh-list
153658189|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
153658190|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
153658191|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153658192|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658193|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
153658194|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658195|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153658196|NCT04530149|Analgesics|analgesics|mesh-ancestor
153658197|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
153658198|NCT04508400|Dexamethasone|dexamethasone|mesh-list
153658199|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
153658215|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
153658216|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658217|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658218|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
153658219|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
153658220|NCT04508400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153658224|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153658225|NCT04502550|Propofol|propofol|mesh-list
153658226|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153658227|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153658228|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658229|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153658230|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
153658231|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
153658232|NCT04492319|Neostigmine|neostigmine|mesh-list
153658233|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153658234|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658235|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658236|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
153359416|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154129191|NCT00978393|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154129192|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154129193|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129194|NCT00978393|Incretins|incretins|mesh-ancestor
154129195|NCT00978393|Hormones|hormones|mesh-ancestor
154129196|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154129197|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
154129198|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129199|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129200|NCT04740996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154129201|NCT04740996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129202|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154129203|NCT00872976|Dasatinib|dasatinib|mesh-list
154129204|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154129205|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
153359417|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658237|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658238|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658239|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153658240|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
153658241|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658242|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
153658243|NCT04485013|Cetuximab|cetuximab|mesh-list
153658244|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658245|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658246|NCT04485013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658247|NCT04485013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658248|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
153658249|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658250|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658251|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153658252|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153658253|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153658254|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153658255|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658256|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658257|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658258|NCT04313335|Analgesics|analgesics|mesh-ancestor
153658264|NCT04297618|Lifitegrast|lifitegrast|mesh-list
153658265|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153658266|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153658267|NCT04282109|Paclitaxel|paclitaxel|mesh-list
153658268|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153658269|NCT04282109|Nivolumab|nivolumab|mesh-list
153658270|NCT04282109|Cetuximab|cetuximab|mesh-list
153658271|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153658272|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658273|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
153658274|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
153658275|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
153658276|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658277|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658278|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658279|NCT04240054|Dexamethasone|dexamethasone|mesh-list
153452700|NCT01609218|Charcoal|charcoal|mesh-list
154129206|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129207|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129208|NCT00872976|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154129209|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154129210|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129211|NCT00544167|Paclitaxel|paclitaxel|mesh-list
153800547|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
154129212|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
154129213|NCT00544167|Doxorubicin|doxorubicin|mesh-list
154129214|NCT00544167|Sorafenib|sorafenib|mesh-list
154129215|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154129216|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129217|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
154129218|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
154129219|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
154129220|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129221|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154129222|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
154129223|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129224|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129225|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154129226|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
154129227|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154129228|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154129229|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154129230|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154129231|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129232|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154129234|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
154129235|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
154129236|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154129237|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129238|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129239|NCT05225844|Apatinib|apatinib|mesh-list
153658280|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
153658281|NCT04240054|Bortezomib|bortezomib|mesh-list
153658282|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658283|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
153658284|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658285|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658286|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154129241|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154129242|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129243|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129244|NCT00878514|Alprazolam|alprazolam|mesh-list
154129245|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154129246|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129247|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129248|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154129249|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154129250|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154129251|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
154129252|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
154129253|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129254|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129255|NCT00804440|Ibuprofen|ibuprofen|mesh-list
153455643|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129256|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154129257|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154129258|NCT00804440|Analgesics|analgesics|mesh-ancestor
154129259|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
154129260|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129261|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129262|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129263|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129264|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154129265|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129266|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129267|NCT00880854|Tremelimumab|tremelimumab|mesh-list
154129268|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129269|NCT00543855|Donepezil|donepezil|mesh-list
154129270|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154129271|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129272|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129280|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
154129281|NCT00797810|Ifosfamide|ifosfamide|mesh-list
154129282|NCT00797810|Rituximab|rituximab|mesh-list
154129283|NCT00797810|Vincristine|vincristine|mesh-list
154129284|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154129285|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
154129286|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129287|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129288|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154129289|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
154129290|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129291|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129292|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154129293|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658287|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
153658288|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658289|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658290|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153658291|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658292|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
153658293|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
153658294|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658295|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153658296|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
153658297|NCT04240054|Hormones|hormones|mesh-ancestor
153658306|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658307|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153658308|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153658309|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658310|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658311|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153658312|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153658313|NCT04218851|Posaconazole|posaconazole|mesh-list
153800729|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
153658314|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
153658315|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658316|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153658317|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153658318|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153658319|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153658320|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153658321|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658322|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658323|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153658324|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
153658325|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658326|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658327|NCT04198662|Epinephrine|epinephrine|mesh-list
153658342|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
153658343|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153658344|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
153658345|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
153658346|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
153658347|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153658348|NCT04197310|Nivolumab|nivolumab|mesh-list
153658349|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658350|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658351|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658352|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658354|NCT04169828|Folic Acid|folic acid|mesh-list
153658355|NCT04169828|Methotrexate|methotrexate|mesh-list
153658356|NCT04169828|Ondansetron|ondansetron|mesh-list
153658357|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
154129294|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
154129295|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
154129296|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129297|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154129298|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
154129299|NCT00797810|Hormones|hormones|mesh-ancestor
154129300|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154129301|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154129302|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129303|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154129304|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
154129305|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
154129306|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129307|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154129308|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
154129309|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
154129310|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
154129311|NCT00873210|Sunitinib|sunitinib|mesh-list
154129312|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129313|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154129314|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154129315|NCT00873210|Growth Substances|growth substances|mesh-ancestor
154129316|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129317|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
153658358|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153658359|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
153658360|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153658361|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658362|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153658363|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
153658364|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658365|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658366|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
153658367|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658368|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153658369|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658370|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
153658371|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658372|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153658373|NCT04169828|Antidotes|antidotes|mesh-ancestor
153658374|NCT04169828|Protective Agents|protective agents|mesh-ancestor
153658375|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
153658376|NCT04169828|Vitamins|vitamins|mesh-ancestor
153658377|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
153658380|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658381|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153658382|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
153658383|NCT04169828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153658384|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153658385|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
154129318|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154129319|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129320|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129321|NCT00978471|Thiotepa|thiotepa|mesh-list
154129322|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154129323|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
154129324|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129325|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129326|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154129327|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154129328|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
154129329|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129330|NCT00804674|Bupivacaine|bupivacaine|mesh-list
154129331|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
154129332|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
154129333|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129334|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129335|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
154129336|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129338|NCT00881088|Nadroparin|nadroparin|mesh-list
154129339|NCT00881088|Fondaparinux|fondaparinux|mesh-list
154129340|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154129341|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
154129342|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153658386|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658387|NCT04169828|Hematinics|hematinics|mesh-ancestor
153658388|NCT04167033|Hormones|hormones|mesh-list
153658408|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658409|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658410|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153658411|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
153658412|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658413|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658414|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153658415|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658416|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
153658417|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
153658418|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658419|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153658420|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
153658421|NCT03909412|Hormones|hormones|mesh-ancestor
153658422|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658423|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658424|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153658425|NCT03875287|Decitabine|decitabine|mesh-list
153658426|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153658427|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
153658428|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658429|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129343|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
154129344|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129345|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129346|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
154129347|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154129348|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154129350|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129351|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
154129352|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
154129353|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
154129354|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509758|NCT01513187|Interferons|interferons|mesh-list
154129355|NCT00656084|Rituximab|rituximab|mesh-list
154129356|NCT00656084|Gemcitabine|gemcitabine|mesh-list
154129357|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
154129358|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129359|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129360|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
154129361|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129362|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129363|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154129364|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
154129365|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129366|NCT00656084|Analgesics|analgesics|mesh-ancestor
154129367|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
154129368|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129369|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154129390|NCT00804752|Vitamin D|vitamin d|mesh-list
154129391|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
153800966|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154129392|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
154129393|NCT00804752|Vitamins|vitamins|mesh-list
154129394|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
154129395|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129396|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154129397|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154129398|NCT05225766|Bupivacaine|bupivacaine|mesh-list
154129399|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
154129400|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
154129401|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129402|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129403|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
154129404|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129405|NCT00804830|Bevacizumab|bevacizumab|mesh-list
154129406|NCT00804830|Doxorubicin|doxorubicin|mesh-list
154129407|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129408|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658430|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658431|NCT03870529|Vitamins|vitamins|mesh-list
153658432|NCT03870529|Vitamin A|vitamin a|mesh-list
153658433|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
153658434|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
153658435|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
153658436|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658437|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
153658438|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658439|NCT03870529|Protective Agents|protective agents|mesh-ancestor
153658440|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153658441|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658442|NCT03865212|Interferons|interferons|mesh-list
153658443|NCT03865212|Interferon-beta|interferon-beta|mesh-list
153658448|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658449|NCT03815344|Misoprostol|misoprostol|mesh-list
153658450|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153658451|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
153658453|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658454|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153658455|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153495407|NCT00000444|Nicotine|nicotine|mesh-list
153658457|NCT03773562|Erenumab|erenumab|mesh-list
153658458|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153658459|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658460|NCT03773562|Analgesics|analgesics|mesh-ancestor
153658461|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
153658462|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658463|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658464|NCT03769714|Bupivacaine|bupivacaine|mesh-list
153658465|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
153658466|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
153658467|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153658468|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658469|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
153658470|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658471|NCT03698162|Bevacizumab|bevacizumab|mesh-list
153658472|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153800968|NCT00319215|Zopiclone|zopiclone|mesh-list
154129409|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154129410|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154129411|NCT00804830|Growth Substances|growth substances|mesh-ancestor
154129412|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129413|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
154129414|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154129415|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154129416|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154129417|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129418|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129419|NCT00982215|Acetaminophen|acetaminophen|mesh-list
154129420|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154129421|NCT00982215|Analgesics|analgesics|mesh-ancestor
154129422|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
154129423|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129424|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129425|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
154129427|NCT00613938|Tapentadol|tapentadol|mesh-list
154129428|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154129429|NCT00613938|Narcotics|narcotics|mesh-ancestor
154129430|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129431|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129432|NCT00613938|Analgesics|analgesics|mesh-ancestor
154129433|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
154129434|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129435|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154129436|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154129437|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154129438|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129439|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
154129440|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129450|NCT00805064|Growth Substances|growth substances|mesh-ancestor
154129451|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129453|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129454|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
154129456|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154129457|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
154129458|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154129459|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
154129460|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129461|NCT00655928|Expectorants|expectorants|mesh-ancestor
154129462|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
154129463|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154129464|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
154129465|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129466|NCT00655928|Protective Agents|protective agents|mesh-ancestor
154129467|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129468|NCT00655928|Antidotes|antidotes|mesh-ancestor
154129469|NCT00873756|Bevacizumab|bevacizumab|mesh-list
154129470|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129471|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129472|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154129473|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153658473|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658474|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153658475|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153658478|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
153658479|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
153658480|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658481|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658482|NCT03657641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658483|NCT03657641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658484|NCT03651518|Rituximab|rituximab|mesh-list
153658485|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153658486|NCT03651518|Ustekinumab|ustekinumab|mesh-list
153658487|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658488|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658489|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
153658490|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658491|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658492|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
153658493|NCT03618641|Nivolumab|nivolumab|mesh-list
153658494|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658495|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658496|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658497|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658498|NCT03600831|Docetaxel|docetaxel|mesh-list
153658499|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658500|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
153658501|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
153658502|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
153459075|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154129476|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
154129477|NCT00873834|Fluoxetine|fluoxetine|mesh-list
154129478|NCT00873834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154129479|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154129480|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154129481|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129482|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129483|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
154129484|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129485|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154129486|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
154129487|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154129488|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154129489|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154129490|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129491|NCT00655850|Paclitaxel|paclitaxel|mesh-list
154129492|NCT00655850|Gemcitabine|gemcitabine|mesh-list
154129493|NCT00655850|Bevacizumab|bevacizumab|mesh-list
154129494|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153658503|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658504|NCT03580928|Venetoclax|venetoclax|mesh-list
153658505|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
153658506|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
153658507|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658508|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658509|NCT03580928|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153658510|NCT03580928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153658511|NCT03580928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658512|NCT03580928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658513|NCT03506360|Dexamethasone|dexamethasone|mesh-list
153658523|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658524|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658525|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153658526|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
153658527|NCT03506360|Hormones|hormones|mesh-ancestor
153658528|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658529|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153495487|NCT00000654|Fialuridine|fialuridine|mesh-list
153658530|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658531|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
153658532|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658533|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658534|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658535|NCT03506360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658536|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
154129496|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
154129497|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
154129498|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
154129499|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129500|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154129501|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
154129502|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129503|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154129504|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154129505|NCT00655850|Growth Substances|growth substances|mesh-ancestor
154129506|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129507|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
154129508|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
154129509|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913865|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
154129510|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129511|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
154129512|NCT00805298|Epinephrine|epinephrine|mesh-list
154129513|NCT00805298|Racepinephrine|racepinephrine|mesh-list
154129514|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
154129515|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129516|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
154129517|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
154129518|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129519|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129520|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154129521|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
154129522|NCT00805298|Hormones|hormones|mesh-ancestor
153658537|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
153658538|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658539|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
153658540|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
153658542|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
153658543|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658544|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
153658545|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658546|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658547|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153658548|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
153658549|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658550|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658551|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153658552|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658553|NCT03420521|Nivolumab|nivolumab|mesh-list
153658554|NCT03420521|Ipilimumab|ipilimumab|mesh-list
153658555|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658556|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129523|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154129524|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154129525|NCT00805298|Protective Agents|protective agents|mesh-ancestor
154129526|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154129527|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154129528|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
154129529|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129530|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129531|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154129532|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154129533|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154129534|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
154129536|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
154129537|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154129539|NCT00881400|Cephalosporins|cephalosporins|mesh-list
154129540|NCT00881400|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154129541|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154129542|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129543|NCT00246571|Sunitinib|sunitinib|mesh-list
154129544|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129545|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154129546|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153658558|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658559|NCT03411096|Ropivacaine|ropivacaine|mesh-list
153658560|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
153658561|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
153658562|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153658563|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658564|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
153658565|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658566|NCT03334305|Vaccines|vaccines|mesh-list
153658567|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
153658568|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658569|NCT03330821|Cytarabine|cytarabine|mesh-list
153658570|NCT03330821|Idarubicin|idarubicin|mesh-list
153658571|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153658572|NCT03330821|Pevonedistat|pevonedistat|mesh-list
153658573|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153658574|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
153658575|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658576|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658577|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
153658578|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658579|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658580|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
153658581|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658617|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
153658618|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658619|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129547|NCT00246571|Growth Substances|growth substances|mesh-ancestor
154129548|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129549|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
154129550|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154129551|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129552|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129553|NCT02553044|Vitamin D|vitamin d|mesh-list
154129554|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
154129555|NCT02553044|Vitamins|vitamins|mesh-ancestor
154129556|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
154129557|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129558|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154129559|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154129560|NCT00545103|Mesalamine|mesalamine|mesh-list
154129561|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154129562|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154129563|NCT00545103|Analgesics|analgesics|mesh-ancestor
154129564|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
154129565|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129566|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129567|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129568|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129569|NCT00586157|Methylphenidate|methylphenidate|mesh-list
154129570|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154129571|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129572|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154129573|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154129574|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154129575|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129576|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
154129581|NCT00809744|Vitamin D|vitamin d|mesh-list
154129590|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129591|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129592|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129593|NCT01581853|Ritonavir|ritonavir|mesh-list
154129594|NCT01581853|Lopinavir|lopinavir|mesh-list
154129595|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154129596|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154129597|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
154129598|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129599|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129600|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154129601|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154129602|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
154129603|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129604|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154129605|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154129606|NCT01070641|Carvedilol|carvedilol|mesh-list
154129607|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154129608|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154129609|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
154129610|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129611|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129612|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129613|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154129614|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
154129615|NCT01070641|Protective Agents|protective agents|mesh-ancestor
154129616|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154129617|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154129618|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154129619|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
154129620|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154129621|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154129622|NCT00982449|Fialuridine|fialuridine|mesh-list
154129623|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
154129625|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154129626|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129627|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129628|NCT02593721|Ibuprofen|ibuprofen|mesh-list
154129629|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154129630|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154129631|NCT02593721|Analgesics|analgesics|mesh-ancestor
154129632|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
154129633|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129634|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129635|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129636|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129637|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154129638|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129639|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129640|NCT00985647|Lamivudine|lamivudine|mesh-list
154129641|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154129642|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154129643|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129644|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129645|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
154129646|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129647|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154129648|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154129649|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154129650|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
154129651|NCT00806468|Coagulants|coagulants|mesh-ancestor
154129652|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154129653|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
153658620|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153801321|NCT00417404|Protective Agents|protective agents|mesh-ancestor
153658621|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
153658622|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658637|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153658638|NCT03113422|Venetoclax|venetoclax|mesh-list
153658639|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658640|NCT03040596|Fluticasone|fluticasone|mesh-list
153658641|NCT03040596|Xhance|xhance|mesh-list
153658642|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658643|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153658644|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
153658645|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658646|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658647|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154129654|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129655|NCT00982527|Fenoldopam|fenoldopam|mesh-list
154129656|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154129657|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
154129658|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
154129659|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
154129660|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129661|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129662|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129663|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
154129664|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154129665|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
154129666|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154129667|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129668|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154129669|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154129670|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154129671|NCT00725621|Infliximab|infliximab|mesh-list
154129672|NCT00725621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154129673|NCT00725621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129674|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
154129675|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154129676|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129678|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129679|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154129680|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154129681|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154129682|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658648|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
153658649|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
153658650|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153658651|NCT02840240|Gabapentin|gabapentin|mesh-list
153658652|NCT02840240|Analgesics|analgesics|mesh-ancestor
153658653|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
153658654|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658655|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658656|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
153753718|NCT00177567|Mirtazapine|mirtazapine|mesh-list
153753719|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
153753720|NCT00177567|Bupropion|bupropion|mesh-list
153753721|NCT00177567|Paroxetine|paroxetine|mesh-list
153753722|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153753723|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153753724|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
153801339|NCT00313482|Docetaxel|docetaxel|mesh-list
153753725|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753726|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129683|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129685|NCT00725543|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154129686|NCT00725543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129687|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
154129688|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154129689|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129690|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
154129691|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154129692|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129693|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154129694|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
154129695|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154129696|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129697|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129698|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129699|NCT00616434|Interferons|interferons|mesh-list
154129700|NCT00616434|Interferon-beta|interferon-beta|mesh-list
154129701|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
154129702|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129703|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
154129704|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129705|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
154129706|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129707|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154129708|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154129709|NCT00652340|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154129710|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154129711|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129712|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129713|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129714|NCT00257725|Methylphenidate|methylphenidate|mesh-list
154129715|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153753727|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753728|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153753729|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153753730|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753731|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753732|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154129716|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129717|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154129718|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154129719|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154129720|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129722|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129723|NCT00544869|Tolvaptan|tolvaptan|mesh-list
154129724|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154129725|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129726|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
154129727|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129728|NCT02593643|Midazolam|midazolam|mesh-list
154129729|NCT02593643|Ketamine|ketamine|mesh-list
154129730|NCT02593643|Analgesics|analgesics|mesh-ancestor
154129731|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
154129732|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129733|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129734|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154129735|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154129736|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
153753733|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
153753734|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
153753735|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
153753736|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753737|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753738|NCT00177567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153753739|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153753740|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153753741|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153753743|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153753744|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153753745|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153753746|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753747|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
153753748|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153753749|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
153801480|NCT00287534|Tamoxifen|tamoxifen|mesh-list
153753750|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153753757|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153753758|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153753759|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153753760|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
153753761|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153753762|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153753763|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
153753764|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153753765|NCT00195156|Valproic Acid|valproic acid|mesh-list
153753766|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
153753767|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753768|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129738|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129739|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154129740|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154129741|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129742|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129743|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154129744|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154129745|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154129746|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154129747|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154129748|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
154129749|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
154129750|NCT00881556|Fludarabine|fludarabine|mesh-list
154129751|NCT00881556|Busulfan|busulfan|mesh-list
154129752|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
154129753|NCT00881556|Lorazepam|lorazepam|mesh-list
154129754|NCT00881556|Tacrolimus|tacrolimus|mesh-list
154129755|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129756|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129757|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753769|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
153753770|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753771|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753772|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
153753773|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153753774|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416165|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
153416169|NCT02670343|Testosterone|testosterone|mesh-list
153753775|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753776|NCT00167375|Eszopiclone|eszopiclone|mesh-list
153753777|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153753778|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753779|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753780|NCT00195000|Cytarabine|cytarabine|mesh-list
153753781|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
153753782|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153753783|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
153626777|NCT02018991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816122|NCT00457860|Immunotoxins|immunotoxins|mesh-list
153816123|NCT00457860|Immunoconjugates|immunoconjugates|mesh-ancestor
153816124|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
153816125|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816126|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816127|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153816128|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
153816129|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153816130|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153816131|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153816132|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153816133|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816134|NCT00351884|Vildagliptin|vildagliptin|mesh-list
153816135|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153816136|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457455|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153457456|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129760|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154129761|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129762|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
154129763|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154129764|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154129765|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154129766|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
154129767|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
154129768|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
154129769|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129770|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154129771|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154129772|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129773|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154129774|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154129775|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154129776|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
154129777|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
154129778|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129779|NCT00881634|Cetirizine|cetirizine|mesh-list
154129780|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
154129781|NCT00881634|Ephedrine|ephedrine|mesh-list
154129782|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154129783|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154129784|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154129785|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
154129786|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
154129787|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753784|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753785|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753786|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
153753787|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753788|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753789|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
153753790|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753791|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153753792|NCT00195000|Immunotoxins|immunotoxins|mesh-ancestor
153753793|NCT00195000|Immunoconjugates|immunoconjugates|mesh-ancestor
153753794|NCT00195195|Sirolimus|sirolimus|mesh-list
153753795|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753796|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753797|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153753798|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129788|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129789|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129790|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154129791|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
154129792|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129793|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154129794|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
154129795|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
154129796|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154129797|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153801600|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154129798|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
154129799|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
154129800|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
154129801|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154129802|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154129803|NCT00878670|Analgesics|analgesics|mesh-ancestor
154129804|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
154129805|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129806|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129808|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129809|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154129810|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
154129811|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129812|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154129813|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
154129814|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154129815|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154129816|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154129817|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154129818|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129819|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129820|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129821|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153753799|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
153753800|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753801|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
153753802|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129822|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
154129823|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154129825|NCT00652028|Fentanyl|fentanyl|mesh-list
154129826|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
154129827|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154129828|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129829|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129830|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154129831|NCT00652028|Analgesics|analgesics|mesh-ancestor
154129832|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
153801604|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
154129833|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129834|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154129835|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154129836|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154129837|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
154129838|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129839|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801622|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154129840|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154129841|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154129842|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154129843|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154129844|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154129845|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
154129846|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
154129847|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
154129848|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
154129849|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154129850|NCT00652028|Narcotics|narcotics|mesh-ancestor
154129851|NCT00799136|Prednisone|prednisone|mesh-list
154129852|NCT00799136|Vincristine|vincristine|mesh-list
154129853|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129854|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
154129855|NCT00799136|Hormones|hormones|mesh-ancestor
154129856|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753803|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
153753804|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153753805|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753806|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153753807|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
153753808|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753809|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129857|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129858|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154129859|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129860|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154129862|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
154129863|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
154129864|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129865|NCT02592395|Folfirinox|folfirinox|mesh-list
154129866|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129867|NCT00799214|Metronidazole|metronidazole|mesh-list
154129868|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129869|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154129870|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154129871|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154129872|NCT00733421|Etoricoxib|etoricoxib|mesh-list
153753810|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753811|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753812|NCT00177684|Amphotericin B|amphotericin b|mesh-list
153753813|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153753814|NCT00177684|Amebicides|amebicides|mesh-ancestor
153753815|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153753816|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153753817|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753818|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753821|NCT00532090|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153753822|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753823|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753824|NCT00195312|Bupivacaine|bupivacaine|mesh-list
153753825|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
153753826|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
153753827|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753828|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753829|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
153753830|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753831|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153753832|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153753833|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
153753834|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753835|NCT03888079|Anesthetics|anesthetics|mesh-list
153753836|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
153753837|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
153753838|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753839|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753840|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
153753841|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753842|NCT00167648|Leuprolide|leuprolide|mesh-list
153753843|NCT00167648|Goserelin|goserelin|mesh-list
153753844|NCT00167648|Estradiol|estradiol|mesh-list
153753845|NCT00167648|Estrogens|estrogens|mesh-ancestor
153753846|NCT00167648|Hormones|hormones|mesh-ancestor
153753847|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753848|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753849|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153753865|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753866|NCT02906995|Nicotine|nicotine|mesh-list
153753867|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153753868|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
154129874|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154129876|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129877|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129878|NCT00733421|Analgesics|analgesics|mesh-ancestor
154129879|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
153510274|NCT01400217|Beclomethasone|beclomethasone|mesh-list
154129880|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154129881|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154129882|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154129883|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129884|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129885|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153801652|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153753869|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753870|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753871|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153753872|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153753873|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
153753874|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753875|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753876|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153753877|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
153753878|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753879|NCT02906800|Digoxin|digoxin|mesh-list
153753880|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153753881|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153753882|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753883|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753884|NCT02906800|Protective Agents|protective agents|mesh-ancestor
153753885|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753886|NCT00195468|Cyclosporine|cyclosporine|mesh-list
153753887|NCT00195468|Cyclosporins|cyclosporins|mesh-list
153753888|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753889|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753890|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753891|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
153753892|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753893|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
153753895|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
153753896|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153753897|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153753898|NCT00167765|Abciximab|abciximab|mesh-list
153753905|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153753907|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153753908|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153753909|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753910|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153753911|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753912|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753913|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153753914|NCT02906059|Irinotecan|irinotecan|mesh-list
153753915|NCT02906059|Adavosertib|adavosertib|mesh-list
153753916|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153753917|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153591014|NCT01816958|Analgesics|analgesics|mesh-ancestor
153753918|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753919|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753920|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129887|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129888|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129889|NCT00613080|Leucovorin|leucovorin|mesh-list
154129890|NCT00613080|Capecitabine|capecitabine|mesh-list
154129891|NCT00613080|Fluorouracil|fluorouracil|mesh-list
154129892|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
154129893|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154129894|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
154129895|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129896|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129897|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154129898|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
154129899|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129901|NCT00613080|Protective Agents|protective agents|mesh-ancestor
154129902|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
154129903|NCT00613080|Vitamins|vitamins|mesh-ancestor
154129904|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
154129905|NCT00917891|Dapivirine|dapivirine|mesh-list
154129906|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154129907|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154129908|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
154129909|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129910|NCT00732875|Infliximab|infliximab|mesh-list
154129911|NCT00732875|Methotrexate|methotrexate|mesh-list
154129912|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154129913|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
154129914|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154129915|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129916|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153753921|NCT02906176|Voriconazole|voriconazole|mesh-list
153753922|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
153753923|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753924|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153753925|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153753926|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753927|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753928|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153753929|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
153753930|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753931|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753932|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153753933|NCT02905864|Liraglutide|liraglutide|mesh-list
154129918|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129920|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
154129921|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129922|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154129923|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154129924|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
154129925|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154129926|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154129927|NCT00732875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154129928|NCT00732875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154129929|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154129930|NCT00881790|Fluorides|fluorides|mesh-list
154129931|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
154129932|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
154129933|NCT00881790|Protective Agents|protective agents|mesh-ancestor
154129934|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129935|NCT00810446|Rifabutin|rifabutin|mesh-list
154129936|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154129937|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753934|NCT02905864|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153753938|NCT02905864|Hormones|hormones|mesh-ancestor
153753943|NCT00167882|Analgesics|analgesics|mesh-ancestor
153753944|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
153753945|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753946|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753947|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753948|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153753949|NCT02905708|Charcoal|charcoal|mesh-list
153753950|NCT02905708|Antidotes|antidotes|mesh-ancestor
153753951|NCT02905708|Protective Agents|protective agents|mesh-ancestor
153753952|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753953|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153753954|NCT00167921|Estrogens|estrogens|mesh-ancestor
153753955|NCT00167921|Hormones|hormones|mesh-ancestor
153753956|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753957|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753958|NCT00167960|Tazobactam|tazobactam|mesh-list
153753959|NCT00167960|Piperacillin|piperacillin|mesh-list
153753960|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153753961|NCT00167960|Lactams|lactams|mesh-list
153753962|NCT00167960|beta-Lactams|beta-lactams|mesh-list
153753963|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753964|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753965|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153753966|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753967|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753968|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
153753969|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153753970|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753971|NCT00167999|Tazobactam|tazobactam|mesh-list
154129941|NCT00810524|Adefovir|adefovir|mesh-list
154129942|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154129943|NCT00810524|Telbivudine|telbivudine|mesh-list
154129944|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154129945|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154129946|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154129947|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129948|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
154129949|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129950|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154129951|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154129952|NCT00810680|Valproic Acid|valproic acid|mesh-list
154129953|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
154129954|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453448|NCT01755156|Metformin|metformin|mesh-list
154129955|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154129956|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
154129957|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129958|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129959|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
153753972|NCT00167999|Piperacillin|piperacillin|mesh-list
153753973|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153753974|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153457457|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153457458|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457459|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457460|NCT05365464|Progesterone|progesterone|mesh-list
153457461|NCT05365464|Progestins|progestins|mesh-ancestor
153457462|NCT05365464|Hormones|hormones|mesh-ancestor
153457463|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457464|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457465|NCT01383486|Naproxen|naproxen|mesh-list
153753975|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753976|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153753977|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753978|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753979|NCT00177996|Sertraline|sertraline|mesh-list
153753980|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
153753981|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753982|NCT00177996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153753983|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153753984|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153753985|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753986|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154129961|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154129962|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154129963|NCT00799448|Insulin|insulin|mesh-list
154129964|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154129965|NCT00799448|Repaglinide|repaglinide|mesh-list
154129966|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
154129967|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
154129968|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
154129969|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154129970|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129971|NCT00806936|Insulin|insulin|mesh-list
154129972|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154129973|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154129974|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129975|NCT00799682|Travoprost|travoprost|mesh-list
154129976|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154129977|NCT00799682|Latanoprost|latanoprost|mesh-list
154129979|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154129980|NCT03829020|Metformin|metformin|mesh-list
154129981|NCT03829020|Nelfinavir|nelfinavir|mesh-list
154129982|NCT03829020|Bortezomib|bortezomib|mesh-list
154129983|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154129984|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129985|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154129986|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154129987|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154129988|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
154129989|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753987|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
153753988|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753989|NCT00168077|Thrombin|thrombin|mesh-list
153591098|NCT01817348|Lidocaine|lidocaine|mesh-list
153753990|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
153753991|NCT00168077|Coagulants|coagulants|mesh-ancestor
153753992|NCT00195585|Leucovorin|leucovorin|mesh-list
153753993|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
153753994|NCT00195585|Antidotes|antidotes|mesh-ancestor
153753995|NCT00195585|Protective Agents|protective agents|mesh-ancestor
153753996|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753997|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
153753998|NCT00195585|Vitamins|vitamins|mesh-ancestor
153753999|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
153754000|NCT02905045|Ketoprofen|ketoprofen|mesh-list
153754001|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153754002|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153754003|NCT02905045|Analgesics|analgesics|mesh-ancestor
153754004|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
153754005|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754006|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154129991|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154129992|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154129993|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
154129994|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154129995|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
154129996|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
154129997|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154129998|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
154129999|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130000|NCT00874926|Factor VIII|factor viii|mesh-list
154130001|NCT00874926|Coagulants|coagulants|mesh-ancestor
154130002|NCT00810914|Bupivacaine|bupivacaine|mesh-list
154130003|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
154130004|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
154130005|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130006|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130007|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
154130008|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130009|NCT00878904|Epirubicin|epirubicin|mesh-list
154130010|NCT00878904|Panobinostat|panobinostat|mesh-list
154130011|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154130012|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130013|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154130014|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153754007|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754008|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754009|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153754010|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626778|NCT02018991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754011|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754012|NCT02904772|Cyclosporine|cyclosporine|mesh-list
153801908|NCT06139952|Expectorants|expectorants|mesh-ancestor
153754013|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
153754014|NCT02904772|Prednisolone|prednisolone|mesh-list
153754015|NCT02904772|Cyclosporins|cyclosporins|mesh-list
153754016|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754017|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754018|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754019|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
153754020|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754021|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
153754022|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754023|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
153754024|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754025|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153754026|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153754027|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754028|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153754029|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
154130016|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130017|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154130018|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
154130019|NCT00737711|Hematinics|hematinics|mesh-ancestor
154130020|NCT00807326|Simethicone|simethicone|mesh-list
154130021|NCT00807326|Loperamide|loperamide|mesh-list
154130022|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
154130023|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130024|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
154130025|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130026|NCT00807326|Emollients|emollients|mesh-ancestor
154130027|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
154130028|NCT00875082|Montelukast|montelukast|mesh-list
154130029|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154130030|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
153510422|NCT01401036|Umirolimus|umirolimus|mesh-list
154130031|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154130032|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
154130033|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153754030|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153754031|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754032|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
153754033|NCT02904772|Hormones|hormones|mesh-ancestor
153754034|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153754035|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153754036|NCT00195741|Valproic Acid|valproic acid|mesh-list
153754037|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
153754038|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754039|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754040|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
153754054|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754055|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153754056|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
153754057|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153754068|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
153754069|NCT02904538|Hormones|hormones|mesh-ancestor
153754070|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153754071|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153754072|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754073|NCT02963103|Tacrolimus|tacrolimus|mesh-list
153754074|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754075|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
153754076|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754077|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153754078|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754079|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754080|NCT00407264|Fluticasone|fluticasone|mesh-list
153754081|NCT00407264|Xhance|xhance|mesh-list
153754082|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754083|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153754084|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
153457466|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153457467|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153754085|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130034|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130035|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154130036|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154130037|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130039|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154130040|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154130041|NCT02552342|Prednisolone|prednisolone|mesh-list
154130042|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
154130043|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154130044|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
154130045|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154130046|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
154130047|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
154130048|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130049|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754086|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754087|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153754088|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
153754089|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
153754090|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153754091|NCT02904499|Dabigatran|dabigatran|mesh-list
153754092|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
153754093|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153754094|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
153754095|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754096|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754097|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
153754098|NCT00195780|Valproic Acid|valproic acid|mesh-list
153754099|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
153754100|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754101|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754102|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
153754103|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754104|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754105|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
153754106|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153754107|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754108|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153754109|NCT00407342|Alefacept|alefacept|mesh-list
153754110|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
153754111|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
153754112|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455667|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153754122|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
153754123|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754124|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754125|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754126|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754127|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153754128|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754129|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754130|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153754131|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
153754132|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
153754133|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
153754134|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153754135|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
153754136|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
153754137|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154130051|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
154130052|NCT02552342|Hormones|hormones|mesh-ancestor
154130053|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154130054|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154130055|NCT02552342|Protective Agents|protective agents|mesh-ancestor
154130056|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154130057|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130058|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154130059|NCT00811226|Olmesartan|olmesartan|mesh-list
154130060|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154130061|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154130062|NCT00811226|Diuretics|diuretics|mesh-ancestor
153802092|NCT06083480|Acetylcysteine|acetylcysteine|mesh-list
154130063|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
154130064|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130065|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154130066|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153754138|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153754139|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153754140|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
153754141|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754142|NCT02904304|Protective Agents|protective agents|mesh-ancestor
153754143|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153754144|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
153754145|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153754146|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153754147|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
153754148|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
153754150|NCT00407459|Carboplatin|carboplatin|mesh-list
153754151|NCT00407459|Pemetrexed|pemetrexed|mesh-list
153754153|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754154|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153754155|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153754157|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754158|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
153754159|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754160|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754161|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153754162|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153754163|NCT02904031|Leucovorin|leucovorin|mesh-list
153754164|NCT02904031|Fluorouracil|fluorouracil|mesh-list
153754165|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
153754166|NCT02904031|Panitumumab|panitumumab|mesh-list
153754167|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
153754168|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
153754169|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754212|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153754213|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754214|NCT00168350|Memantine|memantine|mesh-list
153754215|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153754216|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153754217|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
153754218|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754219|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754220|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754221|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154130067|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130068|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154130069|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154130070|NCT00238303|Vorinostat|vorinostat|mesh-list
153802197|NCT05848375|Anesthetics|anesthetics|mesh-ancestor
154130071|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130072|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154130073|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130074|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130075|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154130076|NCT00811460|Incretins|incretins|mesh-ancestor
154130077|NCT00811460|Hormones|hormones|mesh-ancestor
154130078|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154130079|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130080|NCT00875238|Doxorubicin|doxorubicin|mesh-list
154130081|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154130082|NCT00875238|Trastuzumab|trastuzumab|mesh-list
154130083|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154130084|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130085|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154130086|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154130087|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130088|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130089|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154130090|NCT00732251|Allopurinol|allopurinol|mesh-list
154130091|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
154130092|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130093|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130094|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
153754222|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153754223|NCT02903485|Anesthetics|anesthetics|mesh-list
153754224|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754225|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754226|NCT05995912|Naproxen|naproxen|mesh-list
153754227|NCT05995912|Etoricoxib|etoricoxib|mesh-list
153754228|NCT05995912|Tramadol|tramadol|mesh-list
153754229|NCT05995912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153754230|NCT05995912|Narcotics|narcotics|mesh-ancestor
153754231|NCT05995912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754269|NCT05994742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153754270|NCT05994742|Antitubercular Agents|antitubercular agents|mesh-ancestor
153754271|NCT05994742|Leprostatic Agents|leprostatic agents|mesh-ancestor
153754272|NCT05994742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153754273|NCT05994742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130096|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154130097|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
154130098|NCT00732251|Protective Agents|protective agents|mesh-ancestor
154130099|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130100|NCT00882024|Tranilast|tranilast|mesh-list
154130101|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154130102|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154130103|NCT00882024|Analgesics|analgesics|mesh-ancestor
154130104|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
154130105|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130106|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130107|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154130108|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154130109|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154130110|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154130111|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130112|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154130113|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154130114|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
154130115|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
154130116|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130117|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154130118|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154130120|NCT00799760|Zanamivir|zanamivir|mesh-list
154130121|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
154130122|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130123|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130124|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130125|NCT00799838|Amoxicillin|amoxicillin|mesh-list
154130126|NCT00799838|Ketoprofen|ketoprofen|mesh-list
154130127|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154130128|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130129|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154130130|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154130131|NCT00799838|Analgesics|analgesics|mesh-ancestor
154130133|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130134|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130135|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154130136|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154130137|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154130138|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130139|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130141|NCT00737477|Hematinics|hematinics|mesh-ancestor
154130142|NCT00800150|Fludarabine|fludarabine|mesh-list
154130143|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
154130145|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130146|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154130147|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
154130148|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130149|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154130150|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
154130151|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130152|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154130153|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
154130154|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154130155|NCT00800306|Simendan|simendan|mesh-list
154130156|NCT00800306|Dobutamine|dobutamine|mesh-list
154130157|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154130158|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
153754274|NCT05994742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754275|NCT05994742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153754276|NCT05994742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153802314|NCT05541497|Varenicline|varenicline|mesh-list
153754277|NCT05994742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153754278|NCT05994742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153754279|NCT05994742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153754280|NCT05994742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153754281|NCT05994742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153754282|NCT05994742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153754283|NCT05994742|Antimetabolites|antimetabolites|mesh-ancestor
153754284|NCT05994742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153754285|NCT05994742|Vitamin B Complex|vitamin b complex|mesh-ancestor
153754286|NCT05994742|Vitamins|vitamins|mesh-ancestor
153754287|NCT05994742|Micronutrients|micronutrients|mesh-ancestor
153754288|NCT05994742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754289|NCT05994599|NuvaRing|nuvaring|mesh-list
153754290|NCT05994599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153754291|NCT05994599|Contraceptive Agents|contraceptive agents|mesh-ancestor
153754292|NCT05994599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154130159|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154130160|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154130161|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130162|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130163|NCT00800306|Protective Agents|protective agents|mesh-ancestor
154130164|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130165|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
154130166|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
154130167|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130168|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
154130169|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154130170|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154130171|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
154130172|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130173|NCT01581775|Valproic Acid|valproic acid|mesh-list
154130174|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
154130175|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130176|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130177|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
154130178|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130179|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130180|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
154130181|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154130182|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130183|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130184|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154130185|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754317|NCT05994001|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153802349|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153754318|NCT05994001|Immunologic Factors|immunologic factors|mesh-ancestor
153754319|NCT05994001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754320|NCT05983224|Quercetin|quercetin|mesh-list
153754321|NCT05983224|Antioxidants|antioxidants|mesh-ancestor
153754322|NCT05983224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754323|NCT05983224|Protective Agents|protective agents|mesh-ancestor
153754324|NCT05983224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754325|NCT05880459|Magnesium Sulfate|magnesium sulfate|mesh-list
153754326|NCT05880459|Nalbuphine|nalbuphine|mesh-list
153754327|NCT05880459|Propofol|propofol|mesh-list
153754328|NCT05880459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153754329|NCT05880459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754330|NCT05880459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754331|NCT05880459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153754332|NCT05880459|Anesthetics, General|anesthetics, general|mesh-ancestor
153754333|NCT05880459|Anesthetics|anesthetics|mesh-ancestor
153754334|NCT05880459|Analgesics|analgesics|mesh-ancestor
153754376|NCT05788016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754378|NCT05755048|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153754379|NCT05755048|Maytansine|maytansine|mesh-list
153754380|NCT05755048|Antibodies|antibodies|mesh-list
154130186|NCT01072747|Heparin|heparin|mesh-list
154130187|NCT01072747|Calcium heparin|calcium heparin|mesh-list
154130188|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
154130189|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154130190|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154130191|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130192|NCT00879372|Tianeptine|tianeptine|mesh-list
154130193|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154130194|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
154130195|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130196|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
154130197|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154130198|NCT00731783|Mupirocin|mupirocin|mesh-list
154130199|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154130200|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130201|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
154130202|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
154130203|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154130204|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154130205|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130206|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130207|NCT02592083|Tamoxifen|tamoxifen|mesh-list
154130208|NCT02592083|Goserelin|goserelin|mesh-list
154130209|NCT02592083|Palbociclib|palbociclib|mesh-list
154130210|NCT02592083|Exemestane|exemestane|mesh-list
154130211|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154130212|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154130213|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
154130215|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130234|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130236|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130237|NCT00724373|Ribavirin|ribavirin|mesh-list
154130238|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154130239|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
154130240|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130241|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
154130242|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130243|NCT02594579|Vitamin D|vitamin d|mesh-list
154130244|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
154130245|NCT02594579|Vitamins|vitamins|mesh-ancestor
154130246|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
154130247|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130248|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154130249|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154130250|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154130251|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154130252|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154130253|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130254|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130286|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154130287|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154130288|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130290|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154130291|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154130292|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154130293|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
154130294|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130295|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130296|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130297|NCT00731549|Aripiprazole|aripiprazole|mesh-list
154130298|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
154130299|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130300|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154130301|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154130302|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130303|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130304|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
154130305|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
154130306|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130307|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130308|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154130309|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154130310|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
154130311|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154130312|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154130313|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154130314|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154130315|NCT00882570|Cefdinir|cefdinir|mesh-list
154130316|NCT00882570|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154130317|NCT00882570|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154130318|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154130319|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130320|NCT00882882|Metformin|metformin|mesh-list
153754381|NCT05755048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153754382|NCT05755048|Immunologic Factors|immunologic factors|mesh-ancestor
153754383|NCT05755048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130321|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154130322|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130323|NCT00882960|Fentanyl|fentanyl|mesh-list
154130324|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154130325|NCT00882960|Narcotics|narcotics|mesh-ancestor
154130326|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130327|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130328|NCT00882960|Analgesics|analgesics|mesh-ancestor
154130329|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
154130330|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130331|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153510724|NCT01403363|Fentanyl|fentanyl|mesh-list
154130332|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154130333|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
154130334|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
154130335|NCT00883194|Ropivacaine|ropivacaine|mesh-list
154130336|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
154130337|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
154130338|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130339|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130340|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
154130341|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754384|NCT05755048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754385|NCT05755048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754386|NCT05755048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153754387|NCT05755048|Tubulin Modulators|tubulin modulators|mesh-ancestor
153754388|NCT05755048|Antimitotic Agents|antimitotic agents|mesh-ancestor
153754389|NCT05755048|Mitosis Modulators|mitosis modulators|mesh-ancestor
153754390|NCT05755048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754391|NCT05755048|Immunotoxins|immunotoxins|mesh-ancestor
153754392|NCT05755048|Immunoconjugates|immunoconjugates|mesh-ancestor
153754393|NCT05750199|Immunomodulating Agents|immunomodulating agents|mesh-list
153802517|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153754394|NCT05750199|Immunologic Factors|immunologic factors|mesh-ancestor
153754395|NCT05750199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754396|NCT05706779|Cetuximab|cetuximab|mesh-list
153754397|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754398|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754399|NCT05622201|Rituximab|rituximab|mesh-list
153754400|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754401|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754403|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754404|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754405|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
153754406|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153754407|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754419|NCT05438979|Calcium|calcium|mesh-list
153754420|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153754421|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754422|NCT05379803|Aflutinib|aflutinib|mesh-list
153754423|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153754424|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754425|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754426|NCT05365451|Metformin|metformin|mesh-list
153754427|NCT05365451|Probenecid|probenecid|mesh-list
153754428|NCT05365451|Furosemide|furosemide|mesh-list
154130342|NCT00888732|Insulin|insulin|mesh-list
154130343|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154130344|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
154130345|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
154130346|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154130347|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154130348|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130349|NCT00730925|Paclitaxel|paclitaxel|mesh-list
154130350|NCT00730925|Afatinib|afatinib|mesh-list
154130351|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154130352|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130353|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
154130354|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
154130355|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
154130356|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130357|NCT00730925|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154130358|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154130359|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130360|NCT00236899|Paclitaxel|paclitaxel|mesh-list
154130361|NCT00236899|Docetaxel|docetaxel|mesh-list
154130362|NCT00236899|Gemcitabine|gemcitabine|mesh-list
154130363|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153754429|NCT05365451|Cimetidine|cimetidine|mesh-list
153754430|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153754431|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754432|NCT05365451|Diuretics|diuretics|mesh-ancestor
153754433|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
153754434|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153754435|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153754436|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754437|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
153754438|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
153754439|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754440|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153754441|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153754442|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153754443|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
153754444|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
153754445|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754446|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153754447|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153754448|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754449|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153455645|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
153754450|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754451|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754452|NCT05294146|Clofazimine|clofazimine|mesh-list
153754460|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153754461|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754462|NCT05131204|Eculizumab|eculizumab|mesh-list
153754463|NCT05131204|Ravulizumab|ravulizumab|mesh-list
153754464|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153754465|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754466|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
153754467|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754468|NCT05106335|Docetaxel|docetaxel|mesh-list
154130364|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130365|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
154130366|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
154130367|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
154130368|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130369|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154130370|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
154130371|NCT00611130|Vigabatrin|vigabatrin|mesh-list
154130372|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
154130373|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130374|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130375|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
154130376|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130377|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130378|NCT00885690|Olanzapine|olanzapine|mesh-list
154130379|NCT00885690|Sertindole|sertindole|mesh-list
154130380|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
154130381|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
154130382|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130383|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130384|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130385|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154130386|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154130387|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130388|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130389|NCT00885690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154130390|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154130391|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153754469|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754470|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
153754471|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
153754472|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
153754473|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754474|NCT05073679|Naltrexone|naltrexone|mesh-list
153754475|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153754476|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153754477|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754478|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
153754479|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754480|NCT04956094|Uric Acid|uric acid|mesh-list
153754481|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
153802607|NCT04495088|Vitamins|vitamins|mesh-ancestor
153802628|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
153754482|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754483|NCT04956094|Protective Agents|protective agents|mesh-ancestor
153754484|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754485|NCT04929392|Paclitaxel|paclitaxel|mesh-list
153754486|NCT04929392|Carboplatin|carboplatin|mesh-list
154130393|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130394|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
154130395|NCT00888810|Topotecan|topotecan|mesh-list
154130396|NCT00888810|Lapatinib|lapatinib|mesh-list
154130397|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154130398|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154130399|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130400|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130401|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130402|NCT00888810|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154130403|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154130404|NCT00256243|Paclitaxel|paclitaxel|mesh-list
154130405|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
154130406|NCT00256243|Carboplatin|carboplatin|mesh-list
154130407|NCT00256243|Doxorubicin|doxorubicin|mesh-list
153453899|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
154130408|NCT00256243|Trastuzumab|trastuzumab|mesh-list
154130409|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153754487|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
153754488|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153754489|NCT04929392|Lenvatinib|lenvatinib|mesh-list
153754490|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153754491|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754492|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
153754493|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
153754494|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
153754501|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
153754502|NCT04828694|Naltrexone|naltrexone|mesh-list
153754503|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153754504|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153754505|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754506|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
153754507|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754508|NCT04820309|Xanomeline|xanomeline|mesh-list
153754509|NCT04820309|Trospium chloride|trospium chloride|mesh-list
153754510|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
153754511|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
153754512|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754513|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754514|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153754515|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153754516|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
153754517|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754518|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591612|NCT01821040|Prednisone|prednisone|mesh-list
153754519|NCT04820309|Urological Agents|urological agents|mesh-ancestor
153754520|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153754521|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153754555|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754557|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754558|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153754559|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754560|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754561|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
153754562|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154130410|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802632|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
154130412|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
154130413|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
154130414|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130415|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154130416|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
154130417|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130418|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154130419|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154130420|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
154130421|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154130422|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154130423|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154130424|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154130425|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130426|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154130427|NCT00236197|Rabeprazole|rabeprazole|mesh-list
154130428|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154130429|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130430|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154130431|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130432|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130433|NCT02541708|Folic Acid|folic acid|mesh-list
154130434|NCT02541708|Hematinics|hematinics|mesh-ancestor
154130435|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
153754563|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153754564|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754565|NCT04796948|Antidotes|antidotes|mesh-ancestor
153754566|NCT04796948|Protective Agents|protective agents|mesh-ancestor
153754567|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
153754568|NCT04796948|Vitamins|vitamins|mesh-ancestor
153754569|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
153754570|NCT04692467|Amlodipine|amlodipine|mesh-list
153754571|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153754572|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153754573|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153754574|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754575|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153754576|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754577|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
153754578|NCT04692077|Tenofovir|tenofovir|mesh-list
153754579|NCT04692077|Emtricitabine|emtricitabine|mesh-list
153754580|NCT04692077|Cabotegravir|cabotegravir|mesh-list
153754581|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
153754582|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754583|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153754584|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153754585|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130437|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
154130438|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130439|NCT03973567|Norepinephrine|norepinephrine|mesh-list
154130440|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
154130441|NCT03973567|Serotonin|serotonin|mesh-list
154130442|NCT03973567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154130443|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130444|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154130445|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
154130446|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130447|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130448|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130449|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154130450|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154130451|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
154130452|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
154130453|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
154130454|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130455|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154130456|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154130457|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154130458|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154130459|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
154130460|NCT00885924|Coagulants|coagulants|mesh-ancestor
154130461|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154130462|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
154130463|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130464|NCT01071889|Flumazenil|flumazenil|mesh-list
154130465|NCT01071889|Antidotes|antidotes|mesh-ancestor
154130466|NCT01071889|Protective Agents|protective agents|mesh-ancestor
154130467|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130468|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
154130469|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
153754586|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754587|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153754588|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153754589|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153754590|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153754591|NCT04531982|Pimavanserin|pimavanserin|mesh-list
153754592|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153754593|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154130470|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130471|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130472|NCT03973411|Ondansetron|ondansetron|mesh-list
154130473|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
154130474|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
154130475|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130476|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802727|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
154130477|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130478|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
154130479|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
154130480|NCT03973411|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154130481|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154130482|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
154130483|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130484|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130486|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154130487|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
154130488|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130489|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130490|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154130491|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154130492|NCT00883506|Protective Agents|protective agents|mesh-ancestor
154130493|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130494|NCT00278395|Vorinostat|vorinostat|mesh-list
154130495|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130496|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154130497|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130498|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130499|NCT00889044|Clopidogrel|clopidogrel|mesh-list
154130500|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154130501|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154130502|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154130503|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154130504|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
154130505|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130506|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130507|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130510|NCT00886002|Naloxone|naloxone|mesh-list
154130511|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154130512|NCT00886002|Narcotics|narcotics|mesh-ancestor
154130513|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130514|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130515|NCT00886002|Analgesics|analgesics|mesh-ancestor
154130516|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
154130517|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130518|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154130519|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154130520|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
154130521|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
154130522|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154130523|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
154130524|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154130525|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
154130526|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154130527|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130528|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153754594|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153754595|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153754596|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754597|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754598|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153754599|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153754600|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153754601|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
153754602|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754603|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754604|NCT04497961|Lenalidomide|lenalidomide|mesh-list
153754605|NCT04497961|Daratumumab|daratumumab|mesh-list
153754606|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
153754607|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754608|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153754609|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153754610|NCT04497961|Growth Substances|growth substances|mesh-ancestor
153754611|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
153754612|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754613|NCT04464629|Prednisolone|prednisolone|mesh-list
153754614|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153754615|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
153754616|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153754642|NCT04414722|Amoxicillin|amoxicillin|mesh-list
153754643|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
153754644|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
153754645|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153754646|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153754647|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130529|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154130530|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154130531|NCT00883818|Azithromycin|azithromycin|mesh-list
154130532|NCT00883818|Doxycycline|doxycycline|mesh-list
154130533|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154130534|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130535|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
154130536|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154130537|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154130538|NCT00889356|Clindamycin|clindamycin|mesh-list
154130539|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
154130540|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
154130541|NCT00889356|Amphotericin B|amphotericin b|mesh-list
154130542|NCT00889356|Tetracycline|tetracycline|mesh-list
154130543|NCT00889356|Ketoconazole|ketoconazole|mesh-list
154130544|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154130545|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154130546|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130547|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154130548|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130549|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130550|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
153803021|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154130551|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153754648|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153754649|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754650|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754651|NCT04392037|Dexamethasone|dexamethasone|mesh-list
153754652|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
153754653|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754654|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
153754655|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754656|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754657|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153754658|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
153754659|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754660|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754661|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153754662|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754663|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
153754664|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
153754665|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754666|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153754667|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
153754669|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153754670|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153754671|NCT04287062|Suvorexant|suvorexant|mesh-list
153754672|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153754673|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153754674|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754677|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754680|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
153754681|NCT04229368|Vitamins|vitamins|mesh-ancestor
153754682|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
153361444|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153361445|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
153361446|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
153362033|NCT05943080|Mydriatics|mydriatics|mesh-ancestor
154130552|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154130553|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154130554|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
154130555|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154130556|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729692|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
154130557|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154130559|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154130560|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154130561|NCT00889434|Tocotrienols|tocotrienols|mesh-list
154130562|NCT00889434|Vitamin E|vitamin e|mesh-list
154130563|NCT00889434|Tocopherols|tocopherols|mesh-list
154130564|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
154130565|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130566|NCT00889434|Protective Agents|protective agents|mesh-ancestor
154130567|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803059|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
154130568|NCT00889434|Vitamins|vitamins|mesh-ancestor
154130569|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
154130570|NCT00612534|Sufentanil|sufentanil|mesh-list
154130572|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154130573|NCT00612534|Narcotics|narcotics|mesh-ancestor
154130574|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130575|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130576|NCT00612534|Analgesics|analgesics|mesh-ancestor
154130577|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
154130578|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130579|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154130580|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153754683|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754684|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153754685|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153754686|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
153754687|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754688|NCT03989271|Quercetin|quercetin|mesh-list
153754689|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
153754690|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754691|NCT03989271|Protective Agents|protective agents|mesh-ancestor
153754692|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362524|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130581|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
154130583|NCT02542254|Albuterol|albuterol|mesh-list
154130584|NCT02542254|Ipratropium|ipratropium|mesh-list
154130585|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154130586|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
154130587|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130588|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130589|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154130590|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
154130591|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
154130592|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154130593|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154130594|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154130595|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154130596|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
154130597|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130598|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130599|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154130600|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
154130601|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
154130602|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154130603|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130604|NCT00736853|Acetaminophen|acetaminophen|mesh-list
154130605|NCT00736853|Tramadol|tramadol|mesh-list
154130606|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154130607|NCT00736853|Analgesics|analgesics|mesh-ancestor
154130608|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
154130609|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130610|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130611|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
154130612|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154130613|NCT00736853|Narcotics|narcotics|mesh-ancestor
154130614|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130615|NCT04037514|Acetaminophen|acetaminophen|mesh-list
154130616|NCT04037514|Ibuprofen|ibuprofen|mesh-list
153754693|NCT03961334|Aspirin|aspirin|mesh-list
153754694|NCT03961334|Dabigatran|dabigatran|mesh-list
153754695|NCT03961334|Apixaban|apixaban|mesh-list
153754696|NCT03961334|Edoxaban|edoxaban|mesh-list
153362611|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
154130617|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154130618|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154130619|NCT04037514|Analgesics|analgesics|mesh-ancestor
154130620|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
154130621|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130622|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130623|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154130624|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154130625|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154130626|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130627|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130628|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
154130629|NCT00730847|Vaccines|vaccines|mesh-list
154130630|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
153511018|NCT01404507|Abciximab|abciximab|mesh-list
154130631|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130632|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
154130633|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154130634|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130635|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130636|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154130637|NCT00573066|Analgesics|analgesics|mesh-ancestor
154130638|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
154130639|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130640|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154130641|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154130642|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154130643|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
154130644|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130645|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130646|NCT02541552|Ropivacaine|ropivacaine|mesh-list
154130647|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
154130648|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
154130653|NCT00886314|Midazolam|midazolam|mesh-list
153363630|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363669|NCT01724606|Sorafenib|sorafenib|mesh-list
154130654|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154130655|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154130656|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130657|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130658|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154130659|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154130660|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130661|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154130662|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
154130663|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
154130664|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
154130665|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
154130666|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130667|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130668|NCT00890214|Epoprostenol|epoprostenol|mesh-list
154130669|NCT00890214|Heparin|heparin|mesh-list
154130670|NCT00890214|Calcium heparin|calcium heparin|mesh-list
154130671|NCT00890214|Tezosentan|tezosentan|mesh-list
154130672|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
154130673|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154130674|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154130675|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130676|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154130677|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154130678|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
154130679|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154130680|NCT00730691|Vortioxetine|vortioxetine|mesh-list
154130681|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154130682|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154130683|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154130684|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130685|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754697|NCT03961334|Clopidogrel|clopidogrel|mesh-list
153754698|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153754699|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153754700|NCT03961334|Analgesics|analgesics|mesh-ancestor
153754701|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
153754702|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754703|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130686|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130687|NCT00730691|Analgesics|analgesics|mesh-ancestor
154130688|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
154130689|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130690|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
154130691|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130692|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
154130693|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154130694|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154130695|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130696|NCT00730691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154130697|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
154130698|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154130699|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154130700|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154130701|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154130702|NCT00886860|Misoprostol|misoprostol|mesh-list
154130703|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154130704|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
154130705|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154130706|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729693|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
154130707|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154130708|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130709|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
154130710|NCT00884442|Nifedipine|nifedipine|mesh-list
154130711|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154130712|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154130713|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363920|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153754704|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754705|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754706|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153754707|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153754708|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754709|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153754711|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754726|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153754727|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754728|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
153754729|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
153754736|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754738|NCT03535298|Interferon-beta|interferon-beta|mesh-list
154130714|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154130715|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130716|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
154130717|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
154130718|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154130719|NCT02543034|Petrolatum|petrolatum|mesh-list
154130720|NCT02543034|Emollients|emollients|mesh-ancestor
154130721|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
154130722|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
154130723|NCT00278161|Rituximab|rituximab|mesh-list
154130724|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154130725|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
154130726|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130727|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154130728|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154130729|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
154130730|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130731|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130732|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154130733|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154130734|NCT02541396|Ketamine|ketamine|mesh-list
154130735|NCT02541396|Oxycodone|oxycodone|mesh-list
154130736|NCT02541396|Analgesics|analgesics|mesh-ancestor
154130737|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
154130738|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130739|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130740|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154130741|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154130742|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
154130743|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
154130744|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153754739|NCT03535298|Teriflunomide|teriflunomide|mesh-list
153754740|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
153754741|NCT03535298|Ofatumumab|ofatumumab|mesh-list
153754742|NCT03535298|Cladribine|cladribine|mesh-list
153754743|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
153754744|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153754745|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
153754746|NCT03535298|Natalizumab|natalizumab|mesh-list
153803226|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
153754747|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153754748|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
153754749|NCT03535298|Ozanimod|ozanimod|mesh-list
153754750|NCT03535298|Ponesimod|ponesimod|mesh-list
153754751|NCT03535298|Siponimod|siponimod|mesh-list
153754752|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754753|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754754|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
153754755|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365151|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130745|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154130746|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154130747|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130748|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130749|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154130750|NCT02541396|Narcotics|narcotics|mesh-ancestor
154130751|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
154130752|NCT00255151|Lansoprazole|lansoprazole|mesh-list
154130753|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154130754|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130755|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154130756|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130757|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130758|NCT03973957|Fentanyl|fentanyl|mesh-list
154130759|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154130760|NCT03973957|Narcotics|narcotics|mesh-ancestor
154130761|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130762|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130763|NCT03973957|Analgesics|analgesics|mesh-ancestor
154130764|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
154130765|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130766|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154130767|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154130768|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
154130769|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
154130770|NCT00658658|Panitumumab|panitumumab|mesh-list
154130771|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154130772|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130773|NCT00723203|Panobinostat|panobinostat|mesh-list
154130774|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130775|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154130776|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130777|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130778|NCT00891072|Acetic Acid|acetic acid|mesh-list
154130779|NCT00891072|Paclitaxel|paclitaxel|mesh-list
154130780|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
154130784|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154130785|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130786|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
154130787|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
154130788|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
154130789|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130790|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154130791|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130792|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154130793|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
154130794|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130795|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154130796|NCT00891072|Protective Agents|protective agents|mesh-ancestor
154130797|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154130798|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
154130799|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154130800|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154130801|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
154130802|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
154130803|NCT02591927|Insulin|insulin|mesh-list
154130804|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154130805|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130806|NCT00891150|Oxytocin|oxytocin|mesh-list
154130807|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
154130808|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154130809|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130810|NCT00800462|Bromides|bromides|mesh-list
154130811|NCT00800462|Oxybutynin|oxybutynin|mesh-list
154130812|NCT00800462|Darifenacin|darifenacin|mesh-list
154130813|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
153754756|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754757|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
153754758|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754759|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754760|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153754771|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153754773|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
153754774|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754775|NCT03493178|Expectorants|expectorants|mesh-ancestor
153754776|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
153754777|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153754778|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
153754779|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754780|NCT03493178|Protective Agents|protective agents|mesh-ancestor
153754781|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754782|NCT03493178|Antidotes|antidotes|mesh-ancestor
153754783|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
154130814|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
154130815|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
154130816|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130817|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130818|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154130819|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154130820|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
154130821|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130822|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130823|NCT00800462|Urological Agents|urological agents|mesh-ancestor
154130824|NCT00233389|Rebamipide|rebamipide|mesh-list
153803383|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130825|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154130826|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130827|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
154130828|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130829|NCT00233389|Protective Agents|protective agents|mesh-ancestor
154130830|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130831|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130832|NCT00891306|Cyclosporine|cyclosporine|mesh-list
154130833|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
154130834|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
154130835|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154130836|NCT00891306|Cyclosporins|cyclosporins|mesh-list
153365710|NCT02486952|Vincristine|vincristine|mesh-list
153754784|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153754785|NCT03406650|Durvalumab|durvalumab|mesh-list
153754786|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754787|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754788|NCT03377725|Decitabine|decitabine|mesh-list
153754789|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
153754790|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153754791|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
153754792|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754793|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754794|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754795|NCT03346135|Melphalan|melphalan|mesh-list
153754796|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
153754797|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153754798|NCT03346135|Daratumumab|daratumumab|mesh-list
153754799|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153754800|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
153754801|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754802|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754803|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153754804|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754805|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
153754806|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754807|NCT03282916|Valacyclovir|valacyclovir|mesh-list
153754808|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
153754809|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754810|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
153754811|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754812|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365754|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153365755|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154130837|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130838|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130839|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154130840|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
154130841|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130842|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
154130843|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130844|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
154130845|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154130846|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154130847|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154130848|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130849|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154130850|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
154130851|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154130852|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154130853|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
154130854|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
154130855|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130856|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130857|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
154130858|NCT00891306|Hormones|hormones|mesh-ancestor
154130859|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154130860|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154130861|NCT00891306|Protective Agents|protective agents|mesh-ancestor
154130862|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154130864|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154130865|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
154130866|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130867|NCT00813722|Losartan|losartan|mesh-list
154130868|NCT00813722|Atenolol|atenolol|mesh-list
154130869|NCT00813722|Amlodipine|amlodipine|mesh-list
154130870|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154130871|NCT00813722|Calcium|calcium|mesh-list
153754813|NCT03215693|Ensartinib|ensartinib|mesh-list
153754828|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754829|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
153754830|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365783|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365875|NCT02449902|Estrogens|estrogens|mesh-ancestor
153365877|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154130872|NCT00813722|Diuretics|diuretics|mesh-list
154130873|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154130874|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154130875|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130876|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154130877|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154130878|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154130879|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130880|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
154130881|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154130882|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154130883|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154130884|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
154130885|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154130886|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154130887|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
154130888|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130889|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
154130890|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
154130891|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130892|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154130893|NCT00812318|Cabotegravir|cabotegravir|mesh-list
154130894|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154130895|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154130896|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130897|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130898|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154130909|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154130910|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130911|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154130912|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130913|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
154130914|NCT00807950|Simvastatin|simvastatin|mesh-list
154130915|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154130916|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154130917|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
154130918|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130919|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154130920|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154130921|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130922|NCT00649220|Memantine|memantine|mesh-list
154130923|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154130924|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154130925|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
154130926|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130927|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130928|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130929|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154130930|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154130931|NCT00654368|Etanercept|etanercept|mesh-list
154130932|NCT00654368|Methotrexate|methotrexate|mesh-list
154130933|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153803491|NCT00289835|Paclitaxel|paclitaxel|mesh-list
153754831|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153754832|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
153754833|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153754834|NCT03044977|Octreotide|octreotide|mesh-list
153754835|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816137|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153754836|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153754837|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754838|NCT03009201|Doxorubicin|doxorubicin|mesh-list
153754839|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153754840|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153754841|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754842|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153754843|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153754844|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754845|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754846|NCT02985749|Oxytocin|oxytocin|mesh-list
153754847|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
153754848|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153754849|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754850|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
153754851|NCT02905591|Paclitaxel|paclitaxel|mesh-list
154130934|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
154130935|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154130936|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130937|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154130939|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130940|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130941|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
154130942|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130943|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154130944|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154130945|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
154130946|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154130947|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154130948|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154130949|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154130950|NCT00654368|Analgesics|analgesics|mesh-ancestor
154130951|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
154130952|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154130953|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154130954|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154130955|NCT00812864|Capecitabine|capecitabine|mesh-list
154130956|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154130957|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
153366764|NCT02457546|Coagulants|coagulants|mesh-ancestor
153366765|NCT01016834|Sumatriptan|sumatriptan|mesh-list
153366766|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153754852|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153754853|NCT02905591|Carboplatin|carboplatin|mesh-list
153754854|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153754855|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754856|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
153754857|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
153754858|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
153754859|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754860|NCT02905591|Vitamins|vitamins|mesh-ancestor
153754861|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
153754862|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754863|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
153754864|NCT02905591|Protective Agents|protective agents|mesh-ancestor
153754865|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
153754866|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754867|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754868|NCT02635672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153754870|NCT02589600|Vitamin D|vitamin d|mesh-list
153754878|NCT02222155|Cyclophosphamide|cyclophosphamide|mesh-list
153754879|NCT02222155|Rituximab|rituximab|mesh-list
153754880|NCT02222155|Glucocorticoids|glucocorticoids|mesh-list
153754882|NCT02222155|Immunologic Factors|immunologic factors|mesh-ancestor
153754883|NCT02222155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754884|NCT02222155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154130958|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130959|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130960|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
154130962|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154130963|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154130964|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154130965|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154130966|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154130967|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154130968|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154130969|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154130970|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
154130971|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
154130972|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
154130973|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
154130974|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130975|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130976|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154130977|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154130978|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
154130979|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154130980|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154130981|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154130982|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130983|NCT00647426|Carboplatin|carboplatin|mesh-list
154130984|NCT00647426|Docetaxel|docetaxel|mesh-list
154130985|NCT00647426|Sorafenib|sorafenib|mesh-list
153783544|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
153366786|NCT00961532|Coagulants|coagulants|mesh-ancestor
153366787|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153366788|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
153366789|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366790|NCT02447718|Vaccines|vaccines|mesh-list
153754885|NCT02222155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153754886|NCT02222155|Alkylating Agents|alkylating agents|mesh-ancestor
153754887|NCT02222155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754888|NCT02222155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754889|NCT02222155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153754890|NCT02222155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754891|NCT02222155|Hormones|hormones|mesh-ancestor
153754892|NCT02222155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153754893|NCT02020070|Ipilimumab|ipilimumab|mesh-list
153367089|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154130986|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154130987|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
154130988|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
154130989|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
154130990|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130991|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154130992|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154130993|NCT00647348|Simvastatin|simvastatin|mesh-list
154130994|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154130995|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154130996|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
154130997|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154130998|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154130999|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154131000|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131001|NCT00813020|Semaglutide|semaglutide|mesh-list
154131002|NCT00813020|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154131003|NCT00813020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154131004|NCT00813020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131005|NCT00647270|Adalimumab|adalimumab|mesh-list
153367090|NCT00982592|Leucovorin|leucovorin|mesh-list
153367091|NCT00982592|Fluorouracil|fluorouracil|mesh-list
153367092|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
153367093|NCT00982592|Calcium|calcium|mesh-list
153754894|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153754895|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754896|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153754897|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754898|NCT01465100|Liver Extracts|liver extracts|mesh-list
153754899|NCT01465100|Hematinics|hematinics|mesh-ancestor
153754900|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
153754901|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
153754902|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
153754903|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754904|NCT01029002|Vitamin D|vitamin d|mesh-list
153754905|NCT01029002|Vitamins|vitamins|mesh-ancestor
153591974|NCT01823393|Heparin|heparin|mesh-list
153754906|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
153754907|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754909|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153754919|NCT00799864|Emtricitabine|emtricitabine|mesh-list
153754920|NCT00799864|Zidovudine|zidovudine|mesh-list
153754921|NCT00799864|Abacavir|abacavir|mesh-list
153754922|NCT00799864|Rilpivirine|rilpivirine|mesh-list
153754923|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
153754924|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754925|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153754926|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153754927|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754928|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131006|NCT00647270|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154131007|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154131008|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154131009|NCT00645944|Eszopiclone|eszopiclone|mesh-list
154131010|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154131011|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131012|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131013|NCT00813332|Docetaxel|docetaxel|mesh-list
154131014|NCT00813332|Endostar protein|endostar protein|mesh-list
154131015|NCT00813332|Endostatins|endostatins|mesh-list
154131016|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131017|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131018|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
154131019|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131020|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131021|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131022|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131023|NCT00813332|Growth Substances|growth substances|mesh-ancestor
154131024|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131025|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
154131026|NCT04708496|Efavirenz|efavirenz|mesh-list
154131027|NCT04708496|Dolutegravir|dolutegravir|mesh-list
154131028|NCT04708496|Lumefantrine|lumefantrine|mesh-list
154131029|NCT04708496|Artemether|artemether|mesh-list
154131030|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154131031|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154131032|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154131033|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367160|NCT00990236|Enoxaparin|enoxaparin|mesh-list
153754929|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153754930|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153754931|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
153754932|NCT00695279|Vaccines|vaccines|mesh-list
153754933|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
153754934|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754935|NCT00272714|Afimoxifene|afimoxifene|mesh-list
153754936|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754937|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153754938|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
153754939|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153754940|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754941|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153754942|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153754943|NCT02903719|Ropivacaine|ropivacaine|mesh-list
153754944|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
153754945|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
153754946|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367209|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131034|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131035|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
154131036|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131037|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154131038|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154131039|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154131040|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154131041|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154131042|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154131043|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154131044|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154131045|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154131046|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154131047|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
154131048|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154131049|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154131050|NCT00646958|Linezolid|linezolid|mesh-list
154131051|NCT00646958|Radezolid|radezolid|mesh-list
154131052|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
154131053|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131054|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131055|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154131056|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131057|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131058|NCT00813410|Insulin|insulin|mesh-list
154131059|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154131060|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131061|NCT00642746|Leucovorin|leucovorin|mesh-list
154131062|NCT00642746|Fluorouracil|fluorouracil|mesh-list
154131063|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
154131064|NCT00642746|Irinotecan|irinotecan|mesh-list
154131065|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154131066|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
154131067|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131068|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153754947|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754948|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
153754949|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367397|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131069|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131070|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154131071|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
154131072|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131073|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154131074|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154131075|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875623|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154131076|NCT00642746|Antidotes|antidotes|mesh-ancestor
154131077|NCT00642746|Protective Agents|protective agents|mesh-ancestor
154131078|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
154131079|NCT00642746|Vitamins|vitamins|mesh-ancestor
154131080|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
154131081|NCT00642746|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154131082|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153454569|NCT01579812|Metformin|metformin|mesh-list
154131083|NCT00814268|Aspirin|aspirin|mesh-list
154131084|NCT00814268|Clopidogrel|clopidogrel|mesh-list
154131085|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154131086|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154131087|NCT00814268|Analgesics|analgesics|mesh-ancestor
154131088|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
154131089|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131090|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131091|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754950|NCT00178269|Docetaxel|docetaxel|mesh-list
153754951|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754961|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153754962|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
153754963|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754964|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754965|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153754966|NCT00195936|Cinacalcet|cinacalcet|mesh-list
153754967|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153754968|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754969|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153754970|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
153754971|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153754973|NCT00168506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153754974|NCT00168506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153754975|NCT00168506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754977|NCT00168506|Serotonin Agents|serotonin agents|mesh-ancestor
153592050|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153754978|NCT00168506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754979|NCT02902861|Methotrexate|methotrexate|mesh-list
153754980|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153754981|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
153754982|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153754983|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367692|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
154131092|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154131093|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154131094|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154131095|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131096|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154131097|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154131098|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131100|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154131101|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154131102|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154131103|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
154131104|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131105|NCT00817622|Vitamin E|vitamin e|mesh-list
154131106|NCT00817622|Vitamins|vitamins|mesh-ancestor
154131107|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
154131108|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131109|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
154131110|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131111|NCT00817622|Protective Agents|protective agents|mesh-ancestor
154131112|NCT00808418|Docetaxel|docetaxel|mesh-list
154131113|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131114|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131115|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
153367693|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153754984|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153754985|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
153754986|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754987|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754988|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
153754989|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816138|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
153816139|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816140|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816141|NCT00458055|Niacin|niacin|mesh-list
153816142|NCT00458055|Atorvastatin|atorvastatin|mesh-list
153816143|NCT00458055|Fenofibrate|fenofibrate|mesh-list
153816144|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153816145|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153754990|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153754991|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754992|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
153754993|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153754994|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153754995|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
153754996|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153754997|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153754998|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367746|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
153367787|NCT02485184|Warfarin|warfarin|mesh-list
154131116|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131117|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131118|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
154131119|NCT00642668|Hematinics|hematinics|mesh-ancestor
154131120|NCT00817934|Bisacodyl|bisacodyl|mesh-list
154131121|NCT00817934|Cathartics|cathartics|mesh-ancestor
154131122|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154131123|NCT00817934|Laxatives|laxatives|mesh-ancestor
154131124|NCT00729833|Sunitinib|sunitinib|mesh-list
154131125|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131126|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131127|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131128|NCT00729833|Growth Substances|growth substances|mesh-ancestor
154131129|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131130|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
154131131|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154131132|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131133|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131134|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
154131135|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131136|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131137|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154131138|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154131139|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131140|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754999|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
153755000|NCT02903017|Coagulants|coagulants|mesh-ancestor
153755001|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153755002|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153755003|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
153755004|NCT02902744|Hormones|hormones|mesh-ancestor
153755005|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153755006|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755007|NCT00168584|Vitamin A|vitamin a|mesh-list
153755008|NCT00168584|Vitamins|vitamins|mesh-ancestor
153755009|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
153755010|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755011|NCT02902666|Acetaminophen|acetaminophen|mesh-list
153755012|NCT02902666|Codeine|codeine|mesh-list
153755013|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153755014|NCT02902666|Analgesics|analgesics|mesh-ancestor
153755015|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
153755016|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755017|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755018|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
153755019|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153755020|NCT02902666|Narcotics|narcotics|mesh-ancestor
153755022|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
153755035|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
154131141|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131142|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154131143|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154131144|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
154131145|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131146|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154131147|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154131148|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131149|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131150|NCT00814736|Urological Agents|urological agents|mesh-ancestor
154131151|NCT00818090|Paclitaxel|paclitaxel|mesh-list
154131152|NCT00818090|Cisplatin|cisplatin|mesh-list
154131153|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154131154|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131155|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131156|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
154131157|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131158|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131159|NCT00642356|Levodopa|levodopa|mesh-list
154131160|NCT00642356|Carbidopa|carbidopa|mesh-list
154131161|NCT00642356|Entacapone|entacapone|mesh-list
153368083|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153755036|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755037|NCT02902315|Vitamins|vitamins|mesh-list
153803781|NCT00324480|Growth Substances|growth substances|mesh-ancestor
153755038|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
153755039|NCT02902315|Tocopherols|tocopherols|mesh-list
153755040|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
153755041|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
153755042|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755043|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
153755044|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755045|NCT02902315|Protective Agents|protective agents|mesh-ancestor
153755046|NCT02902432|Endostar protein|endostar protein|mesh-list
153755047|NCT02902432|Endostatins|endostatins|mesh-list
153755048|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153755049|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153755052|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
153755053|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755054|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
153755055|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755056|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755057|NCT02902042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153755058|NCT02902042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755060|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755061|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755062|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
153755064|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755083|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
153755084|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755085|NCT00168896|Carboplatin|carboplatin|mesh-list
153755086|NCT00168896|Irinotecan|irinotecan|mesh-list
153755087|NCT00168896|Etoposide|etoposide|mesh-list
153755088|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755089|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154131162|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154131163|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154131164|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154131166|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131167|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131168|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131169|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154131170|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131171|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153731282|NCT00137345|Sirolimus|sirolimus|mesh-list
154131172|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154131173|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
153368624|NCT02557035|Hormones|hormones|mesh-ancestor
153755090|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153755091|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755092|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755093|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153755094|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153755095|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
153755096|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
153755097|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755098|NCT02901379|Atorvastatin|atorvastatin|mesh-list
153755099|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153755100|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153755101|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
153755102|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755103|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153755104|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153755105|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755106|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153755107|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153755108|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755109|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
153755110|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755111|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
153755128|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755129|NCT02901301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153755130|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755131|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153755133|NCT00169013|Gabapentin|gabapentin|mesh-list
153755134|NCT00169013|Analgesics|analgesics|mesh-ancestor
153755135|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
153755136|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755137|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755138|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
153755139|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153755140|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755141|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755142|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755143|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153755144|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153755145|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755146|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755147|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
153755148|NCT00169091|Haloperidol|haloperidol|mesh-list
153755149|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
153755150|NCT00169091|Clozapine|clozapine|mesh-list
153755151|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
153755152|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
153755153|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131174|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
154131175|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154131177|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154131178|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131179|NCT00642278|Incretins|incretins|mesh-ancestor
154131180|NCT00642278|Hormones|hormones|mesh-ancestor
154131181|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131182|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154131183|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
154131184|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131185|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131186|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154131187|NCT00812786|Cyclosporine|cyclosporine|mesh-list
154131188|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
154131189|NCT00812786|Everolimus|everolimus|mesh-list
154131190|NCT00812786|Tacrolimus|tacrolimus|mesh-list
154131191|NCT00812786|Cyclosporins|cyclosporins|mesh-list
154131192|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154131193|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
154131194|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131195|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154131196|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368634|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
153755177|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755178|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755179|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153755180|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153755181|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153755184|NCT00178620|Reteplase|reteplase|mesh-list
153755185|NCT00178620|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153755186|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153755187|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153755188|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755189|NCT00169169|Rituximab|rituximab|mesh-list
153755190|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755191|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755192|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
153755193|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755194|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755195|NCT00169208|Rituximab|rituximab|mesh-list
153755196|NCT00169208|Fludarabine|fludarabine|mesh-list
153755197|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
153803938|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
153755198|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755199|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755200|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
153755201|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755202|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755203|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755204|NCT00169208|Analgesics|analgesics|mesh-ancestor
153755223|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755224|NCT02899507|Amoxicillin|amoxicillin|mesh-list
153368671|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131197|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131198|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
154131199|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131200|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
154131201|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154131202|NCT00812786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154131203|NCT00812786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154131204|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131205|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154131206|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154131207|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
154131208|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131210|NCT00815048|Fentanyl|fentanyl|mesh-list
154131211|NCT00815048|Remifentanil|remifentanil|mesh-list
154131212|NCT00815048|Succinylcholine|succinylcholine|mesh-list
154131213|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154131214|NCT00815048|Narcotics|narcotics|mesh-ancestor
154131215|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131216|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131217|NCT00815048|Analgesics|analgesics|mesh-ancestor
154131218|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
153755225|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153755226|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
153755227|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
153755228|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153755229|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755230|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153755231|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755232|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755233|NCT00178854|Risperidone|risperidone|mesh-list
153755234|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153755235|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
153755236|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755237|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755238|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755239|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153755240|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755241|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755242|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755243|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153755244|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
153755245|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
153755246|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153755247|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
153755248|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153755249|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755250|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153755251|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153755252|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153755253|NCT02898961|Gentamicins|gentamicins|mesh-list
154131220|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154131221|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154131222|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
154131223|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
154131224|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154131225|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154131226|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
154131227|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154131228|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
154131229|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
154131230|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
154131231|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154131232|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154131233|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
154131234|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131235|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131236|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
154131237|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154131239|NCT02551796|Levofloxacin|levofloxacin|mesh-list
154131240|NCT02551796|Ofloxacin|ofloxacin|mesh-list
154131241|NCT02551796|Tobramycin|tobramycin|mesh-list
154131242|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154131243|NCT02551796|Dexamethasone|dexamethasone|mesh-list
154131244|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
154131245|NCT02551796|BB 1101|bb 1101|mesh-list
154131246|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
153755254|NCT02898961|Amikacin|amikacin|mesh-list
153755255|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153816146|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
153816147|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816148|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153914676|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
153457469|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
153457470|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755256|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755257|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153755258|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755259|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755261|NCT00553618|Interleukin-2|interleukin-2|mesh-list
153755262|NCT00553618|Dacarbazine|dacarbazine|mesh-list
153755263|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755264|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153755265|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153755266|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
153755267|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755268|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153755269|NCT00553618|Analgesics|analgesics|mesh-ancestor
153755270|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
153755271|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131247|NCT02551796|Dipivefrin|dipivefrin|mesh-list
154131248|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154131249|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
154131250|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
154131251|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131252|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131253|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154131254|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
154131255|NCT02551796|Hormones|hormones|mesh-ancestor
154131256|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131257|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154131258|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131259|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
154131260|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368954|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
153755272|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755273|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153755274|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
153755275|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755276|NCT02898376|Tocopherols|tocopherols|mesh-list
153755278|NCT02898376|Tocotrienols|tocotrienols|mesh-list
153755279|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
153592354|NCT01826396|Irinotecan|irinotecan|mesh-list
153755280|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
153755281|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153755282|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755283|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755284|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153755285|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153755300|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153755301|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755302|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755303|NCT00169520|Docetaxel|docetaxel|mesh-list
153755304|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755305|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
153755306|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
153755307|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
153455646|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755308|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755309|NCT02897986|Vinorelbine|vinorelbine|mesh-list
153755310|NCT02897986|Propranolol|propranolol|mesh-list
153755311|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153755312|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755313|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
153755314|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
153755315|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
153755316|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755317|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153755318|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153755319|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
153755320|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755321|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755322|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153755323|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755324|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
153755325|NCT00169559|Fenofibrate|fenofibrate|mesh-list
153755326|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153755327|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
153755328|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755329|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153755330|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
154131261|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131262|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154131263|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131264|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131265|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154131266|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154131267|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154131268|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154131269|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154131270|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
154131271|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
154131272|NCT02551796|Protective Agents|protective agents|mesh-ancestor
154131273|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154131274|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
154131275|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131276|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154131277|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154131278|NCT00723125|Paclitaxel|paclitaxel|mesh-list
154131279|NCT00723125|Bevacizumab|bevacizumab|mesh-list
154131280|NCT00723125|Carboplatin|carboplatin|mesh-list
154131281|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154131282|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153755331|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153755339|NCT00408252|Sunitinib|sunitinib|mesh-list
153755341|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153755342|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153755343|NCT00408252|Growth Substances|growth substances|mesh-ancestor
153755344|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755345|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
153755346|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153755347|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755348|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755349|NCT02897869|Amikacin|amikacin|mesh-list
153755350|NCT02897869|Murepavadin|murepavadin|mesh-list
153755351|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153755352|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755353|NCT02897830|Dexamethasone|dexamethasone|mesh-list
153755354|NCT02897830|Lenalidomide|lenalidomide|mesh-list
153755355|NCT02897830|Ixazomib|ixazomib|mesh-list
153755356|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153755357|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
153755358|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
153755359|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755360|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755361|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755362|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
153755363|NCT02897830|Hormones|hormones|mesh-ancestor
153755364|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153755367|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
153755368|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153755369|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153755388|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154131283|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131284|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131285|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
154131286|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131287|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131288|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154131289|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131290|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131291|NCT00723125|Growth Substances|growth substances|mesh-ancestor
154131292|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131293|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
154131294|NCT00640562|Risperidone|risperidone|mesh-list
154131295|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154131296|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154131297|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
154131298|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131299|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131300|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804137|NCT00293345|Gemcitabine|gemcitabine|mesh-list
154131301|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154131302|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154131303|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131304|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154131305|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153369535|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
153755389|NCT00408330|Azelaic acid|azelaic acid|mesh-list
153755390|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755391|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
153755392|NCT00408369|Pafuramidine|pafuramidine|mesh-list
153755393|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153755394|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153755395|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153755396|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755397|NCT02897206|Imipenem|imipenem|mesh-list
153755398|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
153755399|NCT02897206|Cilastatin|cilastatin|mesh-list
153755400|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153755401|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755402|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
153755403|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755404|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755405|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
153755406|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
153755407|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755408|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
153755409|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755410|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755411|NCT02897011|Methotrexate|methotrexate|mesh-list
153755412|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153755413|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
153755414|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153755427|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
153369768|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
153369769|NCT05655273|Tacrolimus|tacrolimus|mesh-list
154131306|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
154131307|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
154131308|NCT00815204|Dexamethasone|dexamethasone|mesh-list
154131309|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154131310|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
154131311|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
153729694|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131312|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131313|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131314|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154131315|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
154131316|NCT00815204|Hormones|hormones|mesh-ancestor
154131317|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131318|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154131319|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131320|NCT00721955|Loxapine|loxapine|mesh-list
154131321|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154131322|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154131323|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131324|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131325|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154131326|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154131327|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
153369770|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755435|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153755436|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153755437|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455647|NCT05500690|Folic Acid|folic acid|mesh-list
153804195|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
153755438|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755439|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153755440|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153755441|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153755442|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153755443|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153755444|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153755445|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153755446|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153755447|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
153755448|NCT00178971|Buspirone|buspirone|mesh-list
153755449|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153755450|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755451|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755452|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755453|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755454|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153755455|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
153755456|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755457|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370104|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154131328|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131329|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131330|NCT00585689|Carboplatin|carboplatin|mesh-list
154131331|NCT00585689|Gemcitabine|gemcitabine|mesh-list
154131332|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154131333|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131334|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154131335|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
154131336|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131337|NCT00815282|Vaccines|vaccines|mesh-list
154131338|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
154131339|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131340|NCT02593019|Adavosertib|adavosertib|mesh-list
154131341|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131342|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131343|NCT00729365|Ramipril|ramipril|mesh-list
154131344|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154131345|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
154131346|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131347|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131348|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154131349|NCT00818870|Omeprazole|omeprazole|mesh-list
154131350|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154131351|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154131352|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154131353|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131354|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131355|NCT00254293|Abatacept|abatacept|mesh-list
154131356|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154131357|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154131358|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131359|NCT00254293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153755458|NCT02896621|Amlodipine|amlodipine|mesh-list
153755459|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
153755460|NCT02896621|Amiloride|amiloride|mesh-list
153755461|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755462|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153457471|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457472|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154131360|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131361|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154131362|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
154131363|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131364|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154131365|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154131366|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
154131367|NCT00585221|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154131368|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154131369|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131370|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131371|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131372|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
154131373|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131374|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
154131375|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154131376|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370395|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
153457473|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457474|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
153457475|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153457476|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457477|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457478|NCT04766736|Antibodies|antibodies|mesh-list
153457479|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
153457480|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457482|NCT01396278|Xhance|xhance|mesh-list
153457483|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153755473|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153755474|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153755475|NCT00196638|Interferons|interferons|mesh-list
153755476|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
153755477|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153755478|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755479|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
153755480|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755481|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
153755482|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755483|NCT02896270|Valproic Acid|valproic acid|mesh-list
153755484|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
153755485|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755486|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755487|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
153755488|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755489|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804427|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
153804428|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755490|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
153755491|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755492|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755493|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755494|NCT00196677|Vitamins|vitamins|mesh-list
153755495|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
153755496|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755497|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153755499|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755500|NCT00169949|Aripiprazole|aripiprazole|mesh-list
153755501|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
153755502|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755503|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154131377|NCT00253747|Methylphenidate|methylphenidate|mesh-list
154131378|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154131379|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131380|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154131381|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154131382|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154131383|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131384|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
154131385|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131386|NCT00252733|Candesartan|candesartan|mesh-list
154131387|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
154131388|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154131389|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154131390|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153370552|NCT00365001|Simvastatin|simvastatin|mesh-list
153755504|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755505|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755506|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755507|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
153755508|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
153755509|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755510|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755511|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153755512|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153755513|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
153755514|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153755515|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153755516|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153755517|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153755518|NCT00196755|Calcium|calcium|mesh-list
153755519|NCT00196755|Sevelamer|sevelamer|mesh-list
153755520|NCT00196755|Calcium acetate|calcium acetate|mesh-list
153804429|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153804431|NCT00295100|Tamoxifen|tamoxifen|mesh-list
153804469|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755521|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153755522|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755523|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
153755524|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
153755526|NCT00169988|Risperidone|risperidone|mesh-list
153755539|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
153755548|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153755550|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755551|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153755552|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
153755553|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153755554|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755555|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153755556|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
153755557|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153755558|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153755559|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755560|NCT02895061|Vitamins|vitamins|mesh-ancestor
153755561|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
153755562|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153755563|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
153755564|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755565|NCT00170222|Doxycycline|doxycycline|mesh-list
153370560|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131391|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131392|NCT03974035|Ropivacaine|ropivacaine|mesh-list
154131393|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
154131394|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
154131395|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131396|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131397|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
154131398|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131399|NCT00275821|Ranibizumab|ranibizumab|mesh-list
154131400|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131401|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131402|NCT00275821|Growth Substances|growth substances|mesh-ancestor
154131403|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131404|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
154131405|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131406|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
154131407|NCT00275509|Dexamethasone|dexamethasone|mesh-list
154131408|NCT00275509|Prednisone|prednisone|mesh-list
154131409|NCT00275509|Tacrolimus|tacrolimus|mesh-list
153755566|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153755567|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755568|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
153755569|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153755570|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153755571|NCT02894983|Calpastatin|calpastatin|mesh-list
153755572|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153755573|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
153755574|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755575|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755576|NCT02895022|Lidocaine|lidocaine|mesh-list
153755577|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
153755578|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
153755579|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755580|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755581|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
153755582|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755583|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153755584|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153755585|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153755586|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755587|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755588|NCT00409851|Amlodipine|amlodipine|mesh-list
153755589|NCT00409851|Valsartan|valsartan|mesh-list
153755590|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755591|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153755592|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755593|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755594|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153755595|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755596|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
153755597|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153755598|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153755600|NCT00409890|Bromides|bromides|mesh-list
154131410|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
154131411|NCT00275509|Daclizumab|daclizumab|mesh-list
154131412|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154131413|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
154131414|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
154131415|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131416|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131417|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154131418|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
154131419|NCT00275509|Hormones|hormones|mesh-ancestor
153755613|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755614|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153755615|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
153755631|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755633|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755634|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755635|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153755636|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153755637|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755638|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
153755639|NCT00196872|Epirubicin|epirubicin|mesh-list
153755640|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755655|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
153755656|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755658|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755659|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755660|NCT00179283|Sertraline|sertraline|mesh-list
153755661|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153755662|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
153755663|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755664|NCT00179283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153755665|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153755666|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755667|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755668|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755669|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
153755670|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755671|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153755672|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153755673|NCT05420350|Lamotrigine|lamotrigine|mesh-list
153755674|NCT05420350|Bupropion|bupropion|mesh-list
153755675|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153755676|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
153755677|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755678|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153755679|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153755680|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755681|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755682|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
153755683|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755684|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755694|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153755695|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
153755696|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153755697|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153755698|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153755699|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755700|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131420|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131421|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154131422|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131423|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154131424|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
154131425|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153804578|NCT00295919|Ketoconazole|ketoconazole|mesh-list
154131426|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131427|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131428|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154131429|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154131430|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
154131431|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131432|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131433|NCT01072045|Prednisone|prednisone|mesh-list
154131434|NCT01072045|Propranolol|propranolol|mesh-list
154131435|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154131436|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
154131437|NCT01072045|Hormones|hormones|mesh-ancestor
154131438|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131439|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131440|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154131441|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131442|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154131443|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154131444|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
153755701|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
153755702|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755703|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755704|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153755705|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755706|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153755707|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153755708|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755710|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153755711|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153816149|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153816150|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755712|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755713|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
153755714|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
153755715|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755716|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153755717|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153755718|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
153755719|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755720|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131446|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131447|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154131448|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154131449|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131451|NCT01073059|Valproic Acid|valproic acid|mesh-list
153804741|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804742|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154131452|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
154131453|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131454|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131455|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
154131456|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131457|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131458|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
154131459|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153371200|NCT02613897|Hormones|hormones|mesh-ancestor
153755721|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153755722|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
153755723|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755725|NCT00170690|Busulfan|busulfan|mesh-list
153755726|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153755727|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
153755728|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755729|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755730|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153755731|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
153755732|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755733|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153755734|NCT00196989|Pioglitazone|pioglitazone|mesh-list
153755735|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153755736|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755737|NCT00170729|Prednisolone|prednisolone|mesh-list
153755738|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153755739|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
153755740|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153755741|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
153755742|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153755754|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755755|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153755756|NCT00170729|Protective Agents|protective agents|mesh-ancestor
153755757|NCT00170768|Oxybutynin|oxybutynin|mesh-list
153755759|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
153755761|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755762|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755763|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153755764|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153755765|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
153755766|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755767|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755768|NCT00170768|Urological Agents|urological agents|mesh-ancestor
153755769|NCT02655562|Montelukast|montelukast|mesh-list
153755770|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153755771|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
153755772|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153755773|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
153755774|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153755775|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755776|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154131460|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131461|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154131462|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131463|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131464|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
153804743|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154131465|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
154131466|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154131467|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131468|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131469|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
153804750|NCT00296933|Escitalopram|escitalopram|mesh-list
154131470|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154131471|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131472|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131473|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
154131474|NCT00252499|Fenofibrate|fenofibrate|mesh-list
154131475|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153371205|NCT02615535|Alprostadil|alprostadil|mesh-list
153816151|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
153816152|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
153816153|NCT00458055|Vitamins|vitamins|mesh-ancestor
153816154|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
153816155|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816156|NCT00450762|Carboplatin|carboplatin|mesh-list
153816157|NCT00450762|Gemcitabine|gemcitabine|mesh-list
153816158|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816159|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153816160|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
153816161|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816162|NCT00450840|Simvastatin|simvastatin|mesh-list
153816163|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153457484|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153457485|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
153457486|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457487|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457488|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153457489|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
153457490|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
153457491|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153457492|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
153457493|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
153457494|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
153457495|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755777|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153755778|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755779|NCT00170885|Everolimus|everolimus|mesh-list
153755780|NCT00170885|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153755781|NCT00170885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153755782|NCT00170885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755783|NCT00170885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755784|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804756|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
153755785|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
153755786|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755787|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755788|NCT02607748|Listerine|listerine|mesh-list
153755789|NCT02607748|Fluorides|fluorides|mesh-list
153755790|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
153755791|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
153755792|NCT02607748|Protective Agents|protective agents|mesh-ancestor
153755793|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755794|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154131477|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154131478|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
154131479|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131480|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154131481|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154131482|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
154131483|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131484|NCT00163657|Cyclosporine|cyclosporine|mesh-list
154131485|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
154131486|NCT00163657|Tacrolimus|tacrolimus|mesh-list
154131487|NCT00163657|Cyclosporins|cyclosporins|mesh-list
154131488|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154131489|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
154131490|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131491|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154131492|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131493|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371385|NCT04425239|Antidotes|antidotes|mesh-ancestor
153755795|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755796|NCT02502253|Resveratrol|resveratrol|mesh-list
153755797|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
153755798|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755799|NCT02502253|Protective Agents|protective agents|mesh-ancestor
153755800|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755801|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755802|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153755803|NCT00170924|Valsartan|valsartan|mesh-list
153755804|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755805|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153755842|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755843|NCT00171080|Valsartan|valsartan|mesh-list
153755844|NCT00171080|Irbesartan|irbesartan|mesh-list
153755845|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755846|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153755848|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755850|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153755851|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755852|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153755853|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755854|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755855|NCT00171119|Valsartan|valsartan|mesh-list
153755856|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755857|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153755858|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153755859|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755860|NCT05349448|Triamcinolone|triamcinolone|mesh-list
153755861|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153755862|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153755863|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
153755864|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153755865|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153755866|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755868|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371427|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
154131494|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
154131495|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131496|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
154131497|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154131498|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154131499|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131500|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154131501|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
154131502|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131503|NCT01073683|Docetaxel|docetaxel|mesh-list
154131504|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131505|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131506|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
154131507|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131508|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131509|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153755897|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
153755898|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755899|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755900|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755901|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153755902|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153755903|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755904|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
153755906|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153804909|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
153755907|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755908|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153755909|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
153755910|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153755911|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755912|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755913|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755914|NCT00171431|Tegaserod|tegaserod|mesh-list
153755915|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153755916|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
153755917|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755918|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755919|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755920|NCT01330030|Selegiline|selegiline|mesh-list
153755921|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
153755931|NCT00171470|Tegaserod|tegaserod|mesh-list
153755944|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
153755945|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755946|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
153755947|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755948|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153755950|NCT00179712|Lenalidomide|lenalidomide|mesh-list
153755951|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153755952|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153755953|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755954|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755955|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755956|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
153755957|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755958|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153755959|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131510|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
154131511|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131512|NCT00230971|Metronidazole|metronidazole|mesh-list
154131513|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
154131514|NCT00230971|Tigecycline|tigecycline|mesh-list
154131515|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131516|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131517|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154131518|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154131519|NCT00230971|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154131520|NCT00230971|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154131521|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154131522|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131523|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131524|NCT00211081|Spironolactone|spironolactone|mesh-list
154131525|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154131526|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
154131527|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131528|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131529|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153372067|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755960|NCT00179712|Growth Substances|growth substances|mesh-ancestor
153755961|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
153755962|NCT00611572|Flumazenil|flumazenil|mesh-list
153755963|NCT00611572|Antidotes|antidotes|mesh-ancestor
153755964|NCT00611572|Protective Agents|protective agents|mesh-ancestor
153755965|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755966|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
153755967|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
153755968|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755969|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755970|NCT00197340|Ropivacaine|ropivacaine|mesh-list
153755971|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
153755983|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153755984|NCT00171626|Analgesics|analgesics|mesh-ancestor
153755985|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
153755986|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755987|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755988|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153755989|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153755990|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153755991|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755992|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755993|NCT00171665|Diclofenac|diclofenac|mesh-list
153755994|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153755995|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153755996|NCT00171665|Analgesics|analgesics|mesh-ancestor
153755997|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
153755998|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755999|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756000|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756001|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756002|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153372140|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154131530|NCT00211081|Diuretics|diuretics|mesh-ancestor
154131531|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
154131533|NCT00884676|Epothilone B|epothilone b|mesh-list
154131534|NCT00884676|Epothilones|epothilones|mesh-list
154131535|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131536|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131537|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131538|NCT00884676|Growth Substances|growth substances|mesh-ancestor
154131539|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131540|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
154131541|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154131542|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131543|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131544|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131545|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
154131546|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756003|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756005|NCT00179751|Gemcitabine|gemcitabine|mesh-list
153756027|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756028|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153756029|NCT00171782|Valsartan|valsartan|mesh-list
153756030|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153756031|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153756032|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153756033|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153756034|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756035|NCT00171782|Diuretics|diuretics|mesh-ancestor
153756036|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
153756037|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756038|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153756039|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153756040|NCT00197379|Roxithromycin|roxithromycin|mesh-list
153756041|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153756042|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756043|NCT00197418|Amoxicillin|amoxicillin|mesh-list
153756044|NCT00197418|Metronidazole|metronidazole|mesh-list
153756045|NCT00197418|Clarithromycin|clarithromycin|mesh-list
153756046|NCT00197418|Rabeprazole|rabeprazole|mesh-list
153756047|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153756048|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756049|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153756050|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153756051|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153756052|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756053|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756054|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153756055|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153756056|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153756057|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153756067|NCT05054023|Analgesics|analgesics|mesh-ancestor
153756068|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
153756069|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756070|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756071|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756072|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154131548|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
154131549|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131550|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131551|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131552|NCT00891384|Growth Substances|growth substances|mesh-ancestor
154131553|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
154131554|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131555|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154131556|NCT00887328|Plasminogen|plasminogen|mesh-list
154131557|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154131558|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154131559|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131560|NCT00609336|Gemcitabine|gemcitabine|mesh-list
154131561|NCT00609336|Capecitabine|capecitabine|mesh-list
153372453|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756073|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153756074|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756076|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
153756115|NCT02240407|Sirolimus|sirolimus|mesh-list
153756116|NCT02240407|Rituximab|rituximab|mesh-list
153756117|NCT02240407|Lidocaine|lidocaine|mesh-list
153756118|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153756119|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756120|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
153756121|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756122|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756123|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
153756124|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
153756125|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756126|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
153756127|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756128|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153756129|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153756130|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153756131|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153756132|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756133|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153756134|NCT02240407|Analgesics|analgesics|mesh-ancestor
153756135|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
153756136|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153756137|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756138|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153756139|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
153756140|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756141|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153756142|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153756143|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
153756144|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
153756145|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153756159|NCT00197613|Nevirapine|nevirapine|mesh-list
153756160|NCT00197613|Didanosine|didanosine|mesh-list
153756161|NCT00197613|Stavudine|stavudine|mesh-list
153756162|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153756163|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153756164|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756165|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756166|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
153756167|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756168|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153756169|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154131563|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
154131564|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154131565|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
154131566|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131567|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131568|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131569|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
154131570|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131571|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
154131572|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154131573|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131574|NCT02541084|Aflibercept|aflibercept|mesh-list
154131575|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131576|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131577|NCT02541084|Growth Substances|growth substances|mesh-ancestor
154131578|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131579|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
154131580|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131582|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
154131583|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
154131584|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153372597|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372598|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
153756170|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
153756171|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153756172|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153756173|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153756174|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153756175|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153756202|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153756205|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
153756206|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
153756207|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
153756208|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756209|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756210|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153756211|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153756212|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153756213|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756214|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153756215|NCT00202293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153756216|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153756217|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153756218|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756219|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756220|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
153756221|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153756222|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
154131585|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131586|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131587|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154131588|NCT04397406|Analgesics|analgesics|mesh-ancestor
154131589|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
154131590|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131591|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154131592|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154131593|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154131594|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
154131595|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131596|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131597|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154131598|NCT04397406|Narcotics|narcotics|mesh-ancestor
154131599|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154131600|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154131601|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
153372616|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756223|NCT00197730|Folic Acid|folic acid|mesh-list
153756224|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
153756225|NCT00197730|Vitamins|vitamins|mesh-ancestor
153756226|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
153756227|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756228|NCT00197730|Hematinics|hematinics|mesh-ancestor
153756229|NCT00172172|Calcium|calcium|mesh-list
153914413|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
153756238|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
153756239|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756240|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153756242|NCT02908438|Hormones|hormones|mesh-list
153756243|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756244|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756245|NCT00172367|Lycopene|lycopene|mesh-list
153756246|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756247|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
153756248|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756249|NCT00172367|Protective Agents|protective agents|mesh-ancestor
153756250|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756251|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153756252|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153756253|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756254|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
153756255|NCT04632316|Fludarabine|fludarabine|mesh-list
153756256|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756277|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
153756278|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756279|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756280|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756281|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756282|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153756283|NCT02908165|Estrogens|estrogens|mesh-ancestor
153756284|NCT02908165|Hormones|hormones|mesh-ancestor
153756285|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756286|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756287|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153756288|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
153372747|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154131602|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
154131603|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
154131604|NCT00891540|Ropivacaine|ropivacaine|mesh-list
154131605|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
154131606|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
154131607|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131608|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131609|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
154131610|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805183|NCT00300716|Memantine|memantine|mesh-list
154131611|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154131612|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
154131613|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131614|NCT00891696|Sirolimus|sirolimus|mesh-list
154131615|NCT00891696|Nitroprusside|nitroprusside|mesh-list
153372748|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
153756289|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153756290|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756291|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153756292|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756293|NCT02908282|Povidone|povidone|mesh-list
153756294|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
153756295|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
153756296|NCT02908126|Oxytocin|oxytocin|mesh-list
153756297|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
153756298|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153756299|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756300|NCT00202605|Amphetamine|amphetamine|mesh-list
153756301|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
153756302|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153756303|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756304|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
153756305|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
153756306|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756307|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
153756308|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756309|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756315|NCT00198120|Cycloserine|cycloserine|mesh-list
153756316|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153756317|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756318|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153756319|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
153756320|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153756321|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
153756331|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153756332|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756333|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
153756334|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153756335|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153756336|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756337|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756338|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153756339|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
153756340|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756341|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756342|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153756343|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153756344|NCT00553345|Vitamin E|vitamin e|mesh-list
153372758|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154131616|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131617|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131618|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154131619|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131620|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
154131621|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154131622|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
154131623|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131624|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131625|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154131626|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131627|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154131628|NCT00640328|Ofatumumab|ofatumumab|mesh-list
154131629|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154131630|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131631|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
154131632|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131633|NCT04036890|Minocycline|minocycline|mesh-list
154131634|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131635|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131636|NCT00162097|Efavirenz|efavirenz|mesh-list
154131637|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154131638|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154131639|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154131640|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756345|NCT00553345|Selenium|selenium|mesh-list
153756346|NCT00553345|Vitamins|vitamins|mesh-ancestor
153756347|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
153756348|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756349|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
153756350|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756351|NCT00553345|Protective Agents|protective agents|mesh-ancestor
153756352|NCT00553345|Trace Elements|trace elements|mesh-ancestor
153756353|NCT00407771|Tirofiban|tirofiban|mesh-list
153756354|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153756355|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153756356|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756357|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153756358|NCT00198198|Aripiprazole|aripiprazole|mesh-list
153756359|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
153756360|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153756361|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153756362|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153756363|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756364|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756365|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
153756366|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
153756367|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756368|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131641|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131642|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
154131643|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805268|NCT00301301|Gemcitabine|gemcitabine|mesh-list
154131644|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154131645|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154131646|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154131647|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154131648|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154131649|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154131650|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
154131651|NCT02550782|Bupivacaine|bupivacaine|mesh-list
154131652|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
154131653|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
153372781|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153756369|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153756370|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153756371|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
153756372|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153756373|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153756374|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153756376|NCT02206087|Heparin|heparin|mesh-list
153756394|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153756395|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756396|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
153756397|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756398|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756399|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756400|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756401|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
153756402|NCT02158585|Lamotrigine|lamotrigine|mesh-list
153756403|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
153756404|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153756405|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153756406|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756407|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153756408|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756409|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153756410|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153756411|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756412|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153756413|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153756414|NCT00202917|Fludarabine|fludarabine|mesh-list
153756415|NCT00202917|Melphalan|melphalan|mesh-list
153756416|NCT00202917|Thiotepa|thiotepa|mesh-list
153756417|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756418|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756419|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756420|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
153756421|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756439|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
153756440|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756441|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756442|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
153756443|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756444|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153756445|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756446|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
153756447|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154131654|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131655|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131656|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
154131657|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131658|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154131659|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154131660|NCT02550782|Analgesics|analgesics|mesh-ancestor
154131661|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154131662|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154131663|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154131664|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
154131665|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131666|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131667|NCT05278728|Irinotecan|irinotecan|mesh-list
154131668|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
154131669|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154131670|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154131671|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131672|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131673|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131674|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154131675|NCT01073761|Ritonavir|ritonavir|mesh-list
154131676|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154131677|NCT01073761|Darunavir|darunavir|mesh-list
154131678|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154131679|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154131680|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
154131681|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131682|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131683|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154131684|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153756448|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153756449|NCT00198393|Gemcitabine|gemcitabine|mesh-list
153756450|NCT00198393|Docetaxel|docetaxel|mesh-list
153756451|NCT00198393|Gefitinib|gefitinib|mesh-list
153756452|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756453|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
153756454|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756455|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756456|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
153805397|NCT00302393|Methylphenidate|methylphenidate|mesh-list
153756457|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756458|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131685|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
154131686|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512065|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
154131687|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154131688|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154131689|NCT00819104|Metoprolol|metoprolol|mesh-list
154131690|NCT00819104|Amlodipine|amlodipine|mesh-list
154131691|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154131692|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154131693|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154131694|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131695|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154131696|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131697|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131698|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154131699|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
154131700|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
154131701|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372953|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153756459|NCT00198393|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756460|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756461|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756462|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
153756463|NCT02103322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756464|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756466|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756467|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756468|NCT00554827|Vitamins|vitamins|mesh-list
153756469|NCT00554827|Folic Acid|folic acid|mesh-list
153756470|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
153756471|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
153756472|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
153756473|NCT00554827|Aminopterin|aminopterin|mesh-list
153756474|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
153756475|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816164|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153816165|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
153816166|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805446|NCT00302666|Dienogest|dienogest|mesh-list
153816167|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153756476|NCT00554827|Hematinics|hematinics|mesh-ancestor
153756477|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153756478|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756479|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756480|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756481|NCT00203034|Rasagiline|rasagiline|mesh-list
153756482|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153756483|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756484|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756485|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153756486|NCT00203034|Protective Agents|protective agents|mesh-ancestor
153756487|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756488|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
153756489|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
153756490|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
153756491|NCT00203073|Analgesics|analgesics|mesh-ancestor
153756492|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
153756493|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131702|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154131703|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154131704|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154131705|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
154131706|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131707|NCT02542098|Hydrocodone|hydrocodone|mesh-list
154131708|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154131709|NCT02542098|Narcotics|narcotics|mesh-ancestor
154131710|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131711|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131712|NCT02542098|Analgesics|analgesics|mesh-ancestor
154131713|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
154131714|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131715|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
154131716|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
154131717|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154131718|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
154131719|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131720|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
154131721|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153756495|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756496|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153756497|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153756498|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756499|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756500|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153756501|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
153756502|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756503|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756504|NCT00198432|Paclitaxel|paclitaxel|mesh-list
153756505|NCT00198432|Vinorelbine|vinorelbine|mesh-list
153756521|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153756522|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
153756523|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756524|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153756525|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756526|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
153756527|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153756528|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153756529|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
153756530|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756531|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153756532|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756533|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153756534|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756535|NCT00203112|Minocycline|minocycline|mesh-list
153756536|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
153756537|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
153756538|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153756539|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756540|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153756541|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
153756542|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131722|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131723|NCT00885066|Gemcitabine|gemcitabine|mesh-list
154131724|NCT00885066|Capecitabine|capecitabine|mesh-list
154131725|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154131726|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154131727|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
154131728|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131729|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131730|NCT00885066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154131731|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154131732|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373032|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
153756543|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756544|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756545|NCT02057380|Dexamethasone|dexamethasone|mesh-list
153756546|NCT02057380|Paclitaxel|paclitaxel|mesh-list
153756568|NCT02050828|Ranibizumab|ranibizumab|mesh-list
153756569|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153756570|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153756571|NCT02050828|Growth Substances|growth substances|mesh-ancestor
153756572|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756573|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
153756574|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756575|NCT02046694|Allopurinol|allopurinol|mesh-list
153756576|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
153756577|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756578|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756579|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
153756580|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756581|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153756582|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
153756583|NCT02046694|Protective Agents|protective agents|mesh-ancestor
153756584|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756585|NCT00203190|Topiramate|topiramate|mesh-list
153756586|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
153756587|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153756588|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756589|NCT02019589|Progesterone|progesterone|mesh-list
153756590|NCT02019589|Progestins|progestins|mesh-ancestor
153756591|NCT02019589|Hormones|hormones|mesh-ancestor
153756592|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756593|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756594|NCT02018926|Azacitidine|azacitidine|mesh-list
153756595|NCT02018926|Mocetinostat|mocetinostat|mesh-list
153756596|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756597|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
153756598|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756599|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756603|NCT01989325|Filanesib|filanesib|mesh-list
153756612|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
153756613|NCT01989325|Hormones|hormones|mesh-ancestor
153756614|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756615|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153756616|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756617|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153756618|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
153756619|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
153756620|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756621|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756622|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756623|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756624|NCT01978366|Halofuginone|halofuginone|mesh-list
153756625|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756626|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
154131734|NCT00888108|Navitoclax|navitoclax|mesh-list
154131735|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131736|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
154131737|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
154131738|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
154131739|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131740|NCT00885300|Cloxacillin|cloxacillin|mesh-list
154131741|NCT00885300|Heparin|heparin|mesh-list
154131742|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
154131743|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154131744|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154131745|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131746|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131747|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131748|NCT00888186|Levodopa|levodopa|mesh-list
154131749|NCT00888186|Carbidopa|carbidopa|mesh-list
154131750|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154131751|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153373044|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756627|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153756628|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153756629|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756630|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153756631|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756632|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756633|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153756634|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153756635|NCT01978366|Growth Substances|growth substances|mesh-ancestor
153756636|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756637|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
153756638|NCT02962986|Phenylephrine|phenylephrine|mesh-list
153756639|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
153756640|NCT02962986|Norepinephrine|norepinephrine|mesh-list
153756641|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153756642|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
153756643|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
153756655|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756656|NCT02962986|Protective Agents|protective agents|mesh-ancestor
153756657|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
153756658|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153756659|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756660|NCT04677361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153756661|NCT04677361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756662|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
153756663|NCT01968733|Solithromycin|solithromycin|mesh-list
153756664|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153756665|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756666|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153756667|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153756668|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756669|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756670|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756671|NCT00410553|Gemcitabine|gemcitabine|mesh-list
153756672|NCT00410553|Halichondrin B|halichondrin b|mesh-list
153756673|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756674|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
153373061|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154131752|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
154131753|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131754|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455648|NCT05500690|Hematinics|hematinics|mesh-ancestor
154131755|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131756|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154131757|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512140|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
154131758|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154131759|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154131760|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154131761|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131762|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131763|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154131764|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154131765|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154131766|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
154131767|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131768|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131769|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153373135|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
153373136|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756675|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756676|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756677|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
153756678|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
153756679|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
153756680|NCT00410592|Esomeprazole|esomeprazole|mesh-list
153756681|NCT00410592|Pantoprazole|pantoprazole|mesh-list
153756682|NCT00410592|Lansoprazole|lansoprazole|mesh-list
153756683|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
153756684|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153756685|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153756686|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153756687|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756688|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816168|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153816169|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816170|NCT00352196|Risperidone|risperidone|mesh-list
153816171|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153816172|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
153816173|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756689|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
153593775|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
153756690|NCT00410631|Melphalan|melphalan|mesh-list
153756691|NCT00410631|Ifosfamide|ifosfamide|mesh-list
153756692|NCT00410631|Dacarbazine|dacarbazine|mesh-list
153756693|NCT00410631|Carboplatin|carboplatin|mesh-list
153756694|NCT00410631|Doxorubicin|doxorubicin|mesh-list
153756695|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153756696|NCT00410631|Etoposide|etoposide|mesh-list
153756697|NCT00410631|Vincristine|vincristine|mesh-list
154131770|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154131771|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
154131772|NCT00892398|Ranibizumab|ranibizumab|mesh-list
154131773|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131774|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131775|NCT00892398|Growth Substances|growth substances|mesh-ancestor
154131776|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131777|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
154131778|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131779|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
154131781|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154131782|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131783|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154131784|NCT02541786|Rabeprazole|rabeprazole|mesh-list
154131785|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
154131786|NCT02541786|Lansoprazole|lansoprazole|mesh-list
154131787|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154131788|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154131789|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153756699|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
153756700|NCT00410631|Vindesine|vindesine|mesh-list
153756701|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153756702|NCT00410631|Isotretinoin|isotretinoin|mesh-list
153756703|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756704|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
153756705|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756706|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756707|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153756708|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
153756709|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756710|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756711|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153756712|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153756713|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153756714|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153756715|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756716|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153756739|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756740|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153756741|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756742|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
153756743|NCT00198588|Argatroban|argatroban|mesh-list
153756744|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
153756745|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153756746|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
153756747|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756748|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756749|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
153756750|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153756751|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153756752|NCT01887886|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756753|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756754|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756755|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756756|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131790|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131791|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131793|NCT00888342|Zopiclone|zopiclone|mesh-list
154131794|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154131795|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131796|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131797|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131798|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154131799|NCT00608868|Gefitinib|gefitinib|mesh-list
154131800|NCT00608868|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154131801|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154131802|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131803|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131804|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131805|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154131806|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
154131807|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131808|NCT04036500|Estradiol|estradiol|mesh-list
154131809|NCT04036500|Estrogens|estrogens|mesh-ancestor
154131810|NCT04036500|Hormones|hormones|mesh-ancestor
154131811|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131812|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131813|NCT00895674|Sorafenib|sorafenib|mesh-list
154131814|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374326|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756757|NCT01877395|Vaccines|vaccines|mesh-list
153756758|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
153756759|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756760|NCT01874626|Ibuprofen|ibuprofen|mesh-list
153756761|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153756762|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153756763|NCT01874626|Analgesics|analgesics|mesh-ancestor
153756764|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
153756765|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756766|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756767|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756768|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153756769|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153756770|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816174|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816175|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816176|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153816177|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153914677|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
153457499|NCT01383096|Artefenomel|artefenomel|mesh-list
153455649|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
153374349|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131815|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154131816|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131817|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131818|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
154131819|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154131820|NCT04035330|Eusol|eusol|mesh-list
154131821|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
154131822|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131823|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154131824|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131825|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
154131826|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
154131827|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131828|NCT04035096|Protective Agents|protective agents|mesh-ancestor
154131829|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131830|NCT04035096|Vitamins|vitamins|mesh-ancestor
154131831|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
154131832|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
154131833|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154131834|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
154131835|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131836|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131837|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154131838|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
154131839|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154131841|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756771|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756772|NCT00410748|Hydromorphone|hydromorphone|mesh-list
153756773|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153756774|NCT00410748|Narcotics|narcotics|mesh-ancestor
153756775|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756776|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756777|NCT00410748|Analgesics|analgesics|mesh-ancestor
153756778|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
153756779|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756780|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153756781|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153455650|NCT05500690|Vitamins|vitamins|mesh-ancestor
153805913|NCT00304850|Analgesics|analgesics|mesh-ancestor
153756782|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756783|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153756784|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
153756785|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153756787|NCT01862224|Methotrexate|methotrexate|mesh-list
153756788|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153756789|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
153756790|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153374870|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131842|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131843|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154131844|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131845|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
154131846|NCT00608322|Protective Agents|protective agents|mesh-ancestor
154131847|NCT00608244|Tacrolimus|tacrolimus|mesh-list
154131848|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154131849|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
154131850|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131851|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154131852|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131853|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131854|NCT00893100|Diltiazem|diltiazem|mesh-list
154131855|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154131856|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154131857|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154131858|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131859|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153756791|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756792|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153756793|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
153756794|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756819|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
153756820|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153756821|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
153756822|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756823|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756824|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153756825|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
153756826|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
153756827|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153756828|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
153756829|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756830|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756831|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
153756832|NCT00203385|Valproic Acid|valproic acid|mesh-list
153756833|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
153756834|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756835|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756836|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
153756837|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756838|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756839|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
153756840|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153756841|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756842|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153756843|NCT00555100|Dexamethasone|dexamethasone|mesh-list
153756844|NCT00555100|Lenalidomide|lenalidomide|mesh-list
153756845|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756846|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
153756847|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
153756848|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756849|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131860|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131861|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131862|NCT00896376|Trastuzumab|trastuzumab|mesh-list
153806030|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
154131863|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154131864|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131865|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
154131866|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
154131867|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154131868|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131869|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154131870|NCT00893256|Risperidone|risperidone|mesh-list
154131871|NCT00893256|Citalopram|citalopram|mesh-list
154131872|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154131873|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
154131874|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131875|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131876|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131877|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154131878|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154131879|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131880|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154131881|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154131882|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
154131883|NCT00893256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154131884|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153756850|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153756851|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
153756853|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756854|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153756855|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756857|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153756858|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153756859|NCT00555100|Growth Substances|growth substances|mesh-ancestor
153756860|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
153756861|NCT00555139|Alprazolam|alprazolam|mesh-list
153756862|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153756863|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756864|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756865|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153756866|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153756867|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153756868|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
153756869|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
153756870|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756871|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756872|NCT00203463|Topiramate|topiramate|mesh-list
153756873|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
153756874|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154131885|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153806043|NCT00333021|PENTA|penta|mesh-list
154131886|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154131887|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
154131888|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154131889|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154131890|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
154131891|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131892|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131893|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154131894|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
154131895|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
154131896|NCT00901368|Hormones|hormones|mesh-ancestor
154131897|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131898|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
154131899|NCT00901524|Interferons|interferons|mesh-list
154131900|NCT00901524|Ribavirin|ribavirin|mesh-list
154131901|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
154131902|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
154131903|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154131904|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131905|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
154131906|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131907|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
154131908|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131909|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
154131910|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131911|NCT00893412|Tramadol|tramadol|mesh-list
154131912|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154131913|NCT00893412|Narcotics|narcotics|mesh-ancestor
153756875|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756876|NCT00407849|Triamcinolone|triamcinolone|mesh-list
153756877|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153756878|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153756879|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153756880|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756881|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
153756882|NCT00407849|Hormones|hormones|mesh-ancestor
153756883|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153756884|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756885|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153756887|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756888|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756889|NCT00407927|Epinastine|epinastine|mesh-list
153756899|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153756900|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153756901|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375720|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131914|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154131915|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131916|NCT00893412|Analgesics|analgesics|mesh-ancestor
154131917|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
154131918|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131919|NCT00893490|Mitomycins|mitomycins|mesh-list
154131920|NCT00893490|Mitomycin|mitomycin|mesh-list
154131921|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154131922|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131924|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131925|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154131926|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131927|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
154131928|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131929|NCT00638690|Prednisone|prednisone|mesh-list
154131930|NCT00638690|Prednisolone|prednisolone|mesh-list
154131931|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
154131932|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375721|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153375722|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
153756902|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
153756903|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756904|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756905|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153756906|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756907|NCT01807546|ON 01910|on 01910|mesh-list
153756908|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756909|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756910|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756911|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756912|NCT03454984|Guadecitabine|guadecitabine|mesh-list
153756913|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756914|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
153756915|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153756916|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
153756917|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153756918|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756919|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153756920|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
153756921|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
153756922|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153756923|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
153756924|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756925|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756926|NCT00203580|Tinzaparin|tinzaparin|mesh-list
153756927|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153756928|NCT00203580|Dalteparin|dalteparin|mesh-list
153756929|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
153756930|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153756931|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153756939|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756940|NCT01773928|Vaccines|vaccines|mesh-list
153756941|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
154131934|NCT00638690|Hormones|hormones|mesh-ancestor
154131935|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154131936|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131937|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154131938|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131939|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154131940|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131941|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131942|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
154131943|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154131944|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
154131945|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154131946|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131947|NCT00893724|Tocopherols|tocopherols|mesh-list
154131948|NCT00893724|Vitamin E|vitamin e|mesh-list
154131949|NCT00893724|Tocotrienols|tocotrienols|mesh-list
154131950|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
154131951|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
154131952|NCT00893724|Niacinamide|niacinamide|mesh-list
154131953|NCT00893724|Niacin|niacin|mesh-list
154131954|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
154131955|NCT00893724|Ubiquinone|ubiquinone|mesh-list
154131956|NCT00893724|Minocycline|minocycline|mesh-list
154131957|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
154131958|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153756942|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756943|NCT01768975|Dapansutrile|dapansutrile|mesh-list
153756944|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153756945|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153756946|NCT01756924|Vancomycin|vancomycin|mesh-list
153756947|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
153756948|NCT01756924|Levofloxacin|levofloxacin|mesh-list
153756949|NCT01756924|Rifampin|rifampin|mesh-list
153756950|NCT01756924|Cefazolin|cefazolin|mesh-list
153756951|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
153756952|NCT01756924|Linezolid|linezolid|mesh-list
153756953|NCT01756924|Daptomycin|daptomycin|mesh-list
153756954|NCT01756924|Ceftaroline|ceftaroline|mesh-list
153756955|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153756956|NCT01756924|Oxacillin|oxacillin|mesh-list
153756957|NCT01756924|Nafcillin|nafcillin|mesh-list
153756958|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
153756959|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756960|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153756961|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
153756962|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153756963|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153756964|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756965|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756966|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756967|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153376058|NCT06191640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153376060|NCT06191497|Chlorhexidine|chlorhexidine|mesh-list
154131959|NCT00893724|Vitamins|vitamins|mesh-ancestor
154131960|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
154131961|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131962|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
154131963|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131964|NCT00893724|Protective Agents|protective agents|mesh-ancestor
154131965|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154131966|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154131967|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
154131968|NCT00893724|Expectorants|expectorants|mesh-ancestor
154131969|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
154131970|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154131971|NCT00893724|Antidotes|antidotes|mesh-ancestor
154131972|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
154131973|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154131974|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
154131975|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154131976|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131977|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
154131978|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154131979|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
154131980|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154131981|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131982|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154131983|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
153756968|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153756969|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153756970|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
153756971|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153756972|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153756982|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153756983|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153756984|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
153756985|NCT01756339|Solithromycin|solithromycin|mesh-list
153756986|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153756989|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153756990|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756991|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756992|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756993|NCT00174200|Risperidone|risperidone|mesh-list
153756994|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153756995|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
153756996|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153756997|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756998|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756999|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153757000|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154131984|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154131985|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
154131986|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154131987|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154131988|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154131989|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
154131990|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
154131991|NCT00893880|Protective Agents|protective agents|mesh-ancestor
154131992|NCT00815594|Bevacizumab|bevacizumab|mesh-list
154131993|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154131994|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154131995|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154131996|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154131997|NCT00815594|Growth Substances|growth substances|mesh-ancestor
154131998|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154131999|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
154132000|NCT00897312|Interferons|interferons|mesh-list
154132001|NCT00897312|Ribavirin|ribavirin|mesh-list
154132002|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
154132003|NCT00897312|Infliximab|infliximab|mesh-list
154132004|NCT00897312|Tremelimumab|tremelimumab|mesh-list
154132005|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132006|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
154132007|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132008|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
154132009|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757001|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757002|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153757003|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153757004|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
153757006|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153757007|NCT00203658|Dalteparin|dalteparin|mesh-list
153757008|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
153757009|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153757010|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153757011|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757012|NCT00174239|Levodopa|levodopa|mesh-list
153757013|NCT00174239|Carbidopa|carbidopa|mesh-list
153757014|NCT00174239|Cabergoline|cabergoline|mesh-list
153757015|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153757016|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153757017|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
153757018|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757019|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457500|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153757020|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757021|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153757022|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757023|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
153757024|NCT00203697|Minocycline|minocycline|mesh-list
153377414|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377415|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132010|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
154132011|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132012|NCT00897312|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154132013|NCT00897312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154132014|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
154132015|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154132016|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154132017|NCT02540460|Delpazolid|delpazolid|mesh-list
154132018|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
154132019|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154132020|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132021|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154132022|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132023|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132024|NCT00543387|Docetaxel|docetaxel|mesh-list
154132025|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132026|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757025|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153757026|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757027|NCT00174317|Celecoxib|celecoxib|mesh-list
153757028|NCT00174317|Diclofenac|diclofenac|mesh-list
153757029|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153757030|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153757031|NCT00174317|Analgesics|analgesics|mesh-ancestor
153757032|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
153757033|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757034|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757035|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757036|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757037|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153757038|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153757039|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757040|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757041|NCT01737892|Epinephrine|epinephrine|mesh-list
153757042|NCT01737892|Racepinephrine|racepinephrine|mesh-list
153757043|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
153806164|NCT00305903|Memantine|memantine|mesh-list
153757044|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153757045|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153757046|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
153757047|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757048|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757049|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757050|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153757051|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153757052|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
153757053|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757054|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153757056|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
153757058|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153757059|NCT00203736|Artesunate|artesunate|mesh-list
153757060|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
153757061|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
153757062|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153757064|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153757065|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154132027|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
154132028|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
154132029|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132030|NCT03455556|Atezolizumab|atezolizumab|mesh-list
154132031|NCT03455556|Maytansine|maytansine|mesh-list
154132032|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154132033|NCT03455556|Anetumab ravtansine|anetumab ravtansine|mesh-list
154132034|NCT03455556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154132035|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132036|NCT03455556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132037|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132038|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
154132039|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132040|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154132041|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154132042|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154132043|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154132044|NCT03455556|Immunoconjugates|immunoconjugates|mesh-ancestor
154132045|NCT04017624|Nicotine|nicotine|mesh-list
154132046|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154132047|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
154132048|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132049|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132050|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154132051|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154132052|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
154132053|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377430|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
153757066|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757067|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757068|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
153594157|NCT01847521|Quercetin|quercetin|mesh-list
153757069|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
153757070|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153757071|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
153757072|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153757073|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757074|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757075|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153757076|NCT00174356|Paclitaxel|paclitaxel|mesh-list
153757077|NCT00174356|Carboplatin|carboplatin|mesh-list
153757078|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757079|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757080|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757081|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757082|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
153757083|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132054|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132055|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
154132056|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132057|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
154132058|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132059|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132060|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154132061|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154132062|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
154132063|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132064|NCT00983151|Tramadol|tramadol|mesh-list
154132065|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154132066|NCT00983151|Narcotics|narcotics|mesh-ancestor
154132067|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132068|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132069|NCT00983151|Analgesics|analgesics|mesh-ancestor
154132070|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
154132071|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132072|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
154132073|NCT00635570|NuvaRing|nuvaring|mesh-list
154132074|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154132075|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153377653|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
153757084|NCT01718158|Ribavirin|ribavirin|mesh-list
153757085|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153757086|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
153757087|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757088|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
153757089|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757090|NCT00174395|Eletriptan|eletriptan|mesh-list
153757091|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153757092|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
153757093|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806220|NCT00333372|Z 338|z 338|mesh-list
153757094|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757095|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757097|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153757098|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
153757099|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757100|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757101|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757102|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153757103|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153757104|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757105|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153757106|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153757107|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
153757108|NCT00555256|Sirolimus|sirolimus|mesh-list
153757109|NCT00555256|Sunitinib|sunitinib|mesh-list
153757110|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757111|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153757112|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153757113|NCT00555256|Growth Substances|growth substances|mesh-ancestor
153377757|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
154132076|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
154132077|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154132078|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132079|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154132080|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154132081|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154132082|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154132083|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132084|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154132085|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154132086|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132087|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132088|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132089|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
154132090|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154132091|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132092|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154132093|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
154132094|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154132095|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132096|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377761|NCT03935451|Apixaban|apixaban|mesh-list
153757114|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757115|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
153757116|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153757117|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757118|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757119|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153757120|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781935|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757143|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153757144|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
153757145|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153757146|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153757147|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757148|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757149|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
153757150|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
153757151|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153757152|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
153757153|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153757154|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757155|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757156|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153757157|NCT00174473|Voriconazole|voriconazole|mesh-list
153757158|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
153457501|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
153457502|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153457503|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153457504|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457505|NCT01382940|Acetaminophen|acetaminophen|mesh-list
153377778|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132097|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132098|NCT00986115|Memantine|memantine|mesh-list
154132099|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154132100|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154132101|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
154132102|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132103|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132104|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132105|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154132106|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154132107|NCT04035876|Apatinib|apatinib|mesh-list
154132108|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132109|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132110|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132111|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132112|NCT00902070|Rocuronium|rocuronium|mesh-list
154132113|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154132114|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154132115|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154132116|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132117|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132118|NCT00635492|Insulin|insulin|mesh-list
154132119|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154132120|NCT00635492|Exenatide|exenatide|mesh-list
154132121|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153457506|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
153457508|NCT01382940|Methotrexate|methotrexate|mesh-list
153457509|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
153457510|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153457513|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
153457514|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457515|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457516|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153757167|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757168|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153757169|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
153757170|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153757171|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757172|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153757173|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153757174|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757175|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757176|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757177|NCT00199017|Cytarabine|cytarabine|mesh-list
153757178|NCT00199017|Dexamethasone|dexamethasone|mesh-list
153757179|NCT00199017|Prednisolone|prednisolone|mesh-list
153757180|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
154132122|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132123|NCT00635492|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154132124|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154132125|NCT00635492|Incretins|incretins|mesh-ancestor
154132126|NCT00635492|Hormones|hormones|mesh-ancestor
154132127|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154132128|NCT00543309|Milrinone|milrinone|mesh-list
154132129|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154132130|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154132131|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154132132|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
154132133|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154132134|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154132135|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512514|NCT01414608|Cisplatin|cisplatin|mesh-list
154132136|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132137|NCT00543309|Protective Agents|protective agents|mesh-ancestor
153352958|NCT01461499|Aliskiren|aliskiren|mesh-list
154132138|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132139|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
154132140|NCT00569582|Mifepristone|mifepristone|mesh-list
153378121|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757181|NCT00199017|Methotrexate|methotrexate|mesh-list
153757182|NCT00199017|Vincristine|vincristine|mesh-list
153757183|NCT00199017|Doxorubicin|doxorubicin|mesh-list
153757184|NCT00199017|Daunorubicin|daunorubicin|mesh-list
153757185|NCT00199017|Asparaginase|asparaginase|mesh-list
153757186|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
153757187|NCT00199017|Thioguanine|thioguanine|mesh-list
153757188|NCT00199017|Cladribine|cladribine|mesh-list
153757189|NCT00199017|Vindesine|vindesine|mesh-list
153757190|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757191|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
153757192|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757193|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757194|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153757205|NCT00199017|Hormones|hormones|mesh-ancestor
153757216|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153757217|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
153757218|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757219|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757220|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757221|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757222|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
153757223|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153757224|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153757225|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153757226|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153757227|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
153757228|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757229|NCT01660633|Melphalan|melphalan|mesh-list
153757230|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153757231|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
153757232|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757233|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757234|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154132141|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154132142|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
154132143|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154132144|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132145|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154132147|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154132148|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
154132149|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154132150|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154132151|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
154132152|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154132153|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
154132154|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154132155|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154132156|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
154132157|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154132158|NCT00988845|Protective Agents|protective agents|mesh-ancestor
153757235|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757236|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
153757237|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757238|NCT00174551|Prazosin|prazosin|mesh-list
153757239|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153757240|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153757263|NCT01652482|Leucovorin|leucovorin|mesh-list
153757264|NCT01652482|Fluorouracil|fluorouracil|mesh-list
153757265|NCT01652482|Irinotecan|irinotecan|mesh-list
153757266|NCT01652482|Cetuximab|cetuximab|mesh-list
153757267|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
153757268|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757269|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757270|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757271|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757272|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
153757273|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757274|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153757275|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153757276|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757277|NCT01652482|Antidotes|antidotes|mesh-ancestor
153757278|NCT01652482|Protective Agents|protective agents|mesh-ancestor
153757279|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
153757280|NCT01652482|Vitamins|vitamins|mesh-ancestor
153757281|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
153757282|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153757283|NCT00174629|Gemcitabine|gemcitabine|mesh-list
153757284|NCT00174629|Docetaxel|docetaxel|mesh-list
153757285|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757286|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
153757287|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757288|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757289|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757290|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757291|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
153757292|NCT02962947|Propranolol|propranolol|mesh-list
153757293|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153757294|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153757295|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
153757296|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132159|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132160|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132161|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154132162|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154132163|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132164|NCT00902460|Midazolam|midazolam|mesh-list
154132165|NCT00902460|Tofacitinib|tofacitinib|mesh-list
154132166|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154132167|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154132168|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132169|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132170|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154132171|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154132172|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154132173|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154132174|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
154132175|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
154132176|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
154132177|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
153757306|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757307|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757308|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
153757309|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757310|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153757311|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153757313|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
153757314|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153757315|NCT00174668|Insulin|insulin|mesh-list
153757316|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153757317|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
153757318|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
153757319|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153757320|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757321|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
153757322|NCT00174707|Docetaxel|docetaxel|mesh-list
153757366|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
153757367|NCT00712582|Ifosfamide|ifosfamide|mesh-list
153757368|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
153594451|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
153757369|NCT00712582|Carmustine|carmustine|mesh-list
153757370|NCT00712582|Rituximab|rituximab|mesh-list
153757371|NCT00712582|Carboplatin|carboplatin|mesh-list
153757372|NCT00712582|Etoposide|etoposide|mesh-list
153757373|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
153757374|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
153757375|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757376|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
153757377|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757378|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757379|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153757380|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
153757381|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757382|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757383|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153757384|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153757385|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757386|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153757387|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153757388|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378513|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154132178|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132179|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132180|NCT00902460|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154132181|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132182|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132183|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
154132184|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154132185|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132186|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154132187|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132188|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154132189|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
154132190|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154132191|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
154132192|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132193|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
154132194|NCT00809198|Protective Agents|protective agents|mesh-ancestor
154132195|NCT00809198|Laxatives|laxatives|mesh-ancestor
154132196|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154132198|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
154132199|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
153378520|NCT05045937|Hormones|hormones|mesh-ancestor
153757390|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
153757391|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757392|NCT00174902|Aspirin|aspirin|mesh-list
153757393|NCT00174902|Propranolol|propranolol|mesh-list
153757394|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153757395|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153757396|NCT00174902|Analgesics|analgesics|mesh-ancestor
153757397|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
153757398|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757407|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757408|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
153757409|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153757410|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153757411|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
153757412|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757413|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153757414|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153757415|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
153757417|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
153757418|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153757419|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153757420|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757421|NCT00373711|Trace Elements|trace elements|mesh-ancestor
153757422|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
153757423|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757424|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153757425|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378671|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379004|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132200|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132201|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132202|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
154132203|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132204|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154132205|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154132206|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154132207|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154132208|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132210|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
154132212|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
154132213|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132214|NCT00902772|Lorazepam|lorazepam|mesh-list
154132215|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
154132216|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
154132217|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
154132218|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132219|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132220|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154132221|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153455651|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
154132222|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379231|NCT01594424|Antibodies|antibodies|mesh-list
153757426|NCT00199212|Trastuzumab|trastuzumab|mesh-list
153757427|NCT00199212|Bortezomib|bortezomib|mesh-list
153757428|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153757429|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757430|NCT00555373|Sirolimus|sirolimus|mesh-list
153757431|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153757432|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757433|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153757457|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153757458|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153757459|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
153757460|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153757461|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153757462|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
153757463|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757464|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
153757465|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153757466|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
153757467|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153757468|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757469|NCT00199329|Ondansetron|ondansetron|mesh-list
153757470|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
153757471|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
153379238|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153379239|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154132223|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154132224|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154132225|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154132226|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
154132227|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
154132228|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132229|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132230|NCT00894660|Amodiaquine|amodiaquine|mesh-list
154132231|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
154132232|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154132233|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154132234|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132235|NCT00721409|Letrozole|letrozole|mesh-list
154132236|NCT00721409|Palbociclib|palbociclib|mesh-list
154132237|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132238|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154132239|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154132240|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132241|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132242|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154132243|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
153379240|NCT01595282|Analgesics|analgesics|mesh-ancestor
153379241|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
153757472|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757473|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757474|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153757475|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
153757476|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
153757477|NCT00199329|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153757478|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153757479|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
153757480|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757481|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757482|NCT00555607|Prednisolone|prednisolone|mesh-list
153757483|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757502|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757503|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
153757504|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757506|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153757507|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153757508|NCT00175370|Vancomycin|vancomycin|mesh-list
153757509|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153757510|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757511|NCT00204243|Naltrexone|naltrexone|mesh-list
153757512|NCT00204243|Methadone|methadone|mesh-list
153757514|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153757515|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757516|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
153757517|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379349|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154132244|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154132245|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132246|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132247|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
154132248|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154132249|NCT00542997|Antibodies|antibodies|mesh-list
154132250|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
154132251|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132252|NCT00903084|Tenofovir|tenofovir|mesh-list
154132253|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
154132254|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132255|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154132256|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154132257|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132258|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132259|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154132260|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153757518|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153757519|NCT00204243|Narcotics|narcotics|mesh-ancestor
153594602|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
153757520|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757521|NCT00204243|Analgesics|analgesics|mesh-ancestor
153757522|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
153757523|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
153757524|NCT04675372|Midazolam|midazolam|mesh-list
153757525|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
153757526|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153757527|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757528|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757550|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757551|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757552|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757553|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153757554|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
153757555|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757556|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757557|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757558|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
153757559|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757560|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153757561|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
153757562|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153757563|NCT00199407|Istradefylline|istradefylline|mesh-list
153757564|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153757565|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153757566|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153757567|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
153757568|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757569|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757570|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757571|NCT00199446|Istradefylline|istradefylline|mesh-list
153757572|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153379401|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154132261|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
154132262|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154132263|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
154132264|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132265|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132266|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154132267|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
154132268|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
154132269|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154132270|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
154132271|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132272|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132273|NCT02591771|Epinephrine|epinephrine|mesh-list
154132274|NCT02591771|Racepinephrine|racepinephrine|mesh-list
154132275|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
154132276|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154132277|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154132278|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
154132279|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132280|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132281|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132282|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154132283|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154132284|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
154132285|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132286|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153379402|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
153379403|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
153757573|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153757574|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153757575|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
153757576|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757577|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757592|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
153757593|NCT04306393|Protective Agents|protective agents|mesh-ancestor
153757595|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153757596|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757597|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153757598|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757599|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
153757600|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757601|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
153757602|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132287|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
154132288|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
154132289|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
154132290|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154132291|NCT00986817|Terlipressin|terlipressin|mesh-list
154132292|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154132293|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154132294|NCT00572832|Vaccines|vaccines|mesh-list
154132295|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
154132296|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132297|NCT02591849|Glucagon|glucagon|mesh-list
154132298|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154132299|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154132300|NCT02591849|Hormones|hormones|mesh-ancestor
154132301|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154132302|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132303|NCT02591849|Incretins|incretins|mesh-ancestor
154132304|NCT00898794|Bevacizumab|bevacizumab|mesh-list
154132305|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132306|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379486|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153757603|NCT00175565|Fluticasone|fluticasone|mesh-list
153757604|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757605|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153757606|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
153757607|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757608|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806746|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806753|NCT00420615|Omeprazole|omeprazole|mesh-list
153757609|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153757610|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
153757611|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
153757612|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153757613|NCT04230187|Leucovorin|leucovorin|mesh-list
153757614|NCT04230187|Bevacizumab|bevacizumab|mesh-list
153757615|NCT04230187|Fluorouracil|fluorouracil|mesh-list
153757616|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
153757617|NCT04230187|Irinotecan|irinotecan|mesh-list
153757618|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
153757619|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153757620|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757634|NCT04230187|Antidotes|antidotes|mesh-ancestor
153757642|NCT00175643|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153757643|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
153757644|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757645|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153757646|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757647|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
153757648|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153757649|NCT00204438|Desogestrel|desogestrel|mesh-list
153757650|NCT00204438|Estradiol|estradiol|mesh-list
153757651|NCT00204438|Estrogens|estrogens|mesh-ancestor
153757652|NCT00204438|Hormones|hormones|mesh-ancestor
153757653|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757654|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757655|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153757656|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
153757657|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153757658|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153379691|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132307|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154132308|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154132309|NCT00898794|Growth Substances|growth substances|mesh-ancestor
154132310|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132311|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
154132313|NCT04086719|Deucravacitinib|deucravacitinib|mesh-list
154132314|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
154132315|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154132316|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154132317|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132318|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154132319|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132320|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132321|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
154132322|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132323|NCT00898950|Aspirin|aspirin|mesh-list
154132324|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
154132325|NCT00898950|Salicylates|salicylates|mesh-list
154132326|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154132327|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154132328|NCT00898950|Analgesics|analgesics|mesh-ancestor
154132329|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
154132330|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132331|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132332|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154132333|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154132334|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154132335|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154132336|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757659|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153757660|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153757661|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153757662|NCT00204438|Progestins|progestins|mesh-ancestor
153757663|NCT00175682|Prazosin|prazosin|mesh-list
153757664|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153757665|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153757666|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153757667|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153757687|NCT04171453|Analgesics|analgesics|mesh-ancestor
153757688|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
153757689|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132337|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154132338|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154132339|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132340|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
154132341|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132342|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
154132343|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
154132344|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
154132345|NCT03622515|Anesthetics|anesthetics|mesh-list
154132346|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132347|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132348|NCT05279235|Favipiravir|favipiravir|mesh-list
154132349|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
154132350|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132351|NCT00229723|Gefitinib|gefitinib|mesh-list
154132352|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132353|NCT00229723|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154132354|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132355|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132356|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132357|NCT04035798|Memantine|memantine|mesh-list
154132358|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154132359|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153455846|NCT04588727|Aspirin|aspirin|mesh-list
154132360|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
154132361|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132362|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379855|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153379928|NCT03039543|Rocuronium|rocuronium|mesh-list
153757690|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757691|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
153757692|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153757693|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153757694|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806806|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
153806807|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
153757695|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153757696|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153757697|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153757698|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757699|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153757700|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
153757701|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
153757702|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153757703|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153757704|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757705|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757706|NCT00199563|Urological Agents|urological agents|mesh-ancestor
154132363|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132364|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154132365|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154132367|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132368|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132369|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
154132370|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132371|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154132372|NCT01075555|Sorafenib|sorafenib|mesh-list
154132374|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132375|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132376|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132377|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132378|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154132379|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154132380|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
154132381|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153379988|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153379989|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153757707|NCT04679506|Cytarabine|cytarabine|mesh-list
153757708|NCT04679506|Etoposide|etoposide|mesh-list
153757709|NCT04679506|Cladribine|cladribine|mesh-list
153757710|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757711|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757712|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153757713|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153757714|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757717|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
153757731|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153806899|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153757732|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153757733|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
153757734|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
153757735|NCT00199602|Heparin|heparin|mesh-list
153757736|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
153757737|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153757738|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153757739|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757740|NCT00554125|Sirolimus|sirolimus|mesh-list
153757741|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153757742|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757743|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153757744|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757745|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
153757746|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757747|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
153815306|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
153757748|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757750|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
153757751|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153757752|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153757753|NCT00175838|Analgesics|analgesics|mesh-ancestor
153757769|NCT00204555|Imiquimod|imiquimod|mesh-list
153757784|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757785|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757786|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757787|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
154132382|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154132383|NCT00627926|Interferons|interferons|mesh-list
154132384|NCT00627926|Ribavirin|ribavirin|mesh-list
154132385|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
154132386|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
154132387|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154132388|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132389|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
154132390|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132391|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
154132392|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132393|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
154132394|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132395|NCT00228553|Modafinil|modafinil|mesh-list
154132396|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154132397|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132398|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154132399|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154132400|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154132401|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757788|NCT00204633|Hematinics|hematinics|mesh-ancestor
153757789|NCT00199719|Ribavirin|ribavirin|mesh-list
153757790|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
153757791|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757792|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
153757793|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757794|NCT03430882|Paclitaxel|paclitaxel|mesh-list
153757795|NCT03430882|Carboplatin|carboplatin|mesh-list
153757796|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153757797|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757798|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757799|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757800|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757801|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
153757802|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757803|NCT00199758|Gemcitabine|gemcitabine|mesh-list
153757804|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757805|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757806|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
153757807|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757808|NCT03291886|Exemestane|exemestane|mesh-list
153757809|NCT03291886|Entinostat|entinostat|mesh-list
153757810|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757811|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153757812|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153757813|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757814|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757825|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757826|NCT03184090|Palbociclib|palbociclib|mesh-list
153757827|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757828|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153757829|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757830|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380150|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154132402|NCT00922506|Doxazosin|doxazosin|mesh-list
154132403|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154132404|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154132405|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154132406|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
154132407|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132408|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132409|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132410|NCT00922506|Urological Agents|urological agents|mesh-ancestor
154132411|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154132412|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154132413|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154132414|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154132415|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
154132416|NCT00816140|Clarithromycin|clarithromycin|mesh-list
154132417|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154132418|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132419|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154132420|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132421|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132422|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154132423|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154132424|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154132425|NCT00895128|Dasatinib|dasatinib|mesh-list
154132426|NCT00895128|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154132427|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132428|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455652|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806939|NCT00230204|Antibodies|antibodies|mesh-list
154132429|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757831|NCT03160846|Milrinone|milrinone|mesh-list
153757832|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153757833|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153757834|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
153757835|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153757836|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153757837|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757838|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757839|NCT03160846|Protective Agents|protective agents|mesh-ancestor
153757840|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757841|NCT00204789|Eflornithine|eflornithine|mesh-list
153757842|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757843|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153757844|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153380304|NCT05376722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132431|NCT00903942|Paclitaxel|paclitaxel|mesh-list
154132432|NCT00903942|Carboplatin|carboplatin|mesh-list
153512812|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
154132433|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154132434|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154132435|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132436|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
154132437|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
154132438|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
154132439|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132440|NCT00895362|Cetuximab|cetuximab|mesh-list
154132441|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154132442|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132443|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132444|NCT00895362|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154132445|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132446|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132447|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132448|NCT00904098|Frovatriptan|frovatriptan|mesh-list
154132449|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154132450|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
154132451|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132452|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132453|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416708|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132454|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
153380305|NCT04737057|Fluorides|fluorides|mesh-list
153757845|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153757846|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757847|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153757848|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757849|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757850|NCT00176540|Levomethorphan|levomethorphan|mesh-list
153757851|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
153757852|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
153757870|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
153757871|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757872|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757873|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757874|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757875|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757876|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132456|NCT00904176|Warfarin|warfarin|mesh-list
154132457|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154132458|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132459|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154132460|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132461|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
154132462|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154132463|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154132464|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132465|NCT00904176|Protective Agents|protective agents|mesh-ancestor
154132466|NCT02540070|Ketorolac|ketorolac|mesh-list
154132467|NCT02540070|Epinephrine|epinephrine|mesh-list
154132468|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
154132469|NCT02540070|Morphine|morphine|mesh-list
154132470|NCT02540070|Ropivacaine|ropivacaine|mesh-list
154132471|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154132472|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132473|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132474|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154132475|NCT02540070|Analgesics|analgesics|mesh-ancestor
153783553|NCT00236483|Tramadol|tramadol|mesh-list
153757877|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757879|NCT00410787|Hydromorphone|hydromorphone|mesh-list
153757880|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153757881|NCT00410787|Narcotics|narcotics|mesh-ancestor
153807131|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153455653|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153807134|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153757882|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757883|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757884|NCT00410787|Analgesics|analgesics|mesh-ancestor
153757885|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
153757886|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757887|NCT00554164|Prednisone|prednisone|mesh-list
153757888|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
153757889|NCT00554164|Doxorubicin|doxorubicin|mesh-list
153757890|NCT00554164|Vincristine|vincristine|mesh-list
153757891|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757892|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
153757893|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594977|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153757894|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757895|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153757896|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
153757897|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757898|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757899|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153757900|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153757901|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153757902|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153757903|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820690|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153757904|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757905|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
153757906|NCT00554164|Hormones|hormones|mesh-ancestor
153757907|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757908|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153380472|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154132476|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
154132477|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132478|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154132479|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154132480|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154132481|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
154132482|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132483|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132484|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154132485|NCT02540070|Narcotics|narcotics|mesh-ancestor
154132486|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
154132487|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
154132488|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154132489|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154132490|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
154132491|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154132492|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
154132493|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
153380473|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153380474|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
153380475|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153757909|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757910|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
153757911|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
153757912|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
153757913|NCT02572141|Leucovorin|leucovorin|mesh-list
153757914|NCT02572141|Capecitabine|capecitabine|mesh-list
153757915|NCT02572141|Fluorouracil|fluorouracil|mesh-list
153757916|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
153757917|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
153757918|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757919|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
153757920|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807179|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153757921|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757922|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757923|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
153757924|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757925|NCT02572141|Antidotes|antidotes|mesh-ancestor
153757926|NCT02572141|Protective Agents|protective agents|mesh-ancestor
153757927|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
153757928|NCT02572141|Vitamins|vitamins|mesh-ancestor
153757929|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
153757930|NCT02470039|Insulin|insulin|mesh-list
153757931|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153757932|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
153757933|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153757934|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757935|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
153757936|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757937|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153757938|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153757939|NCT00554203|Analgesics|analgesics|mesh-ancestor
153757940|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
153757941|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132494|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
154132495|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154132496|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154132497|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154132498|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154132499|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154132500|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132501|NCT00905814|Axitinib|axitinib|mesh-list
154132502|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132503|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132504|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132505|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132506|NCT00900510|Trimethoprim|trimethoprim|mesh-list
154132507|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154132508|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
154132509|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154132510|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132511|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
154132512|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154132513|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154132514|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154132515|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132516|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132517|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154132518|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154132519|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154132520|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154132522|NCT00160693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154132523|NCT00160693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154132524|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154132525|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
154132526|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132527|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154132528|NCT00906048|Levofloxacin|levofloxacin|mesh-list
154132529|NCT00906048|Rifampin|rifampin|mesh-list
154132530|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154132531|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132532|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154132533|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154132534|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154132535|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132536|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132537|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132538|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154132539|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154132540|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154132541|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
154132542|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
154132543|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154132544|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154132545|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154132546|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154132547|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154132548|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154132549|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154132550|NCT00906126|Misoprostol|misoprostol|mesh-list
153380584|NCT00374985|Docetaxel|docetaxel|mesh-list
153380649|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153380650|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380651|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
153380652|NCT01924169|Lenalidomide|lenalidomide|mesh-list
153783555|NCT00236483|Analgesics|analgesics|mesh-ancestor
153380654|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
153380655|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757942|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757943|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153757944|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153757945|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153757946|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
153757947|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
153757948|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
153757949|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757950|NCT00554242|Protective Agents|protective agents|mesh-ancestor
153757951|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757964|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153757965|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757966|NCT00410943|Analgesics|analgesics|mesh-ancestor
153757967|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
153380764|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153380765|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380766|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132551|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154132552|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
154132553|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154132554|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132555|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154132556|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154132558|NCT00900744|Tamoxifen|tamoxifen|mesh-list
154132559|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154132560|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
153455654|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
153807219|NCT00338052|Estradiol|estradiol|mesh-list
154132561|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154132562|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132563|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154132564|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132565|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154132566|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154132567|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154132568|NCT00643760|Pregabalin|pregabalin|mesh-list
154132569|NCT00643760|Gabapentin|gabapentin|mesh-list
154132570|NCT00643760|Analgesics|analgesics|mesh-ancestor
154132571|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
154132572|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757968|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153757969|NCT00176774|Leucovorin|leucovorin|mesh-list
153757970|NCT00176774|Fluorouracil|fluorouracil|mesh-list
153757971|NCT00176774|Irinotecan|irinotecan|mesh-list
153757972|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153757973|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
153757974|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757975|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757976|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757977|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153757978|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
153757979|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153757980|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153757981|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153757982|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757983|NCT00176774|Antidotes|antidotes|mesh-ancestor
153757984|NCT00176774|Protective Agents|protective agents|mesh-ancestor
153757985|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
153757986|NCT00176774|Vitamins|vitamins|mesh-ancestor
153757987|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
153757988|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
153757989|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
153757990|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153757991|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153757992|NCT00176774|Growth Substances|growth substances|mesh-ancestor
154132574|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
154132575|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154132576|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154132577|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132578|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154132579|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154132580|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154132581|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132582|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154132583|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154132584|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154132585|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132586|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
154132587|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
154132588|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153380909|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153380913|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
153757993|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
153757994|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
153757995|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153757996|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
153757997|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153757998|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153757999|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758000|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153758001|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758002|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153758003|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758004|NCT00410982|Rituximab|rituximab|mesh-list
153758005|NCT00410982|Gemcitabine|gemcitabine|mesh-list
153758006|NCT00410982|Melphalan|melphalan|mesh-list
153758007|NCT00410982|Busulfan|busulfan|mesh-list
153758008|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153758009|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758019|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758021|NCT02372578|Analgesics|analgesics|mesh-ancestor
153758022|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
153758023|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758024|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758025|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
153758026|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153758027|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758028|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758029|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153758030|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153758031|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153758032|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758033|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153758034|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
153758035|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153758036|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153758037|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
153758038|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132589|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154132590|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
154132592|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154132593|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154132594|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132595|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132596|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154132597|NCT00906360|Cetuximab|cetuximab|mesh-list
154132598|NCT00906360|Sunitinib|sunitinib|mesh-list
154132599|NCT00906360|Antibodies|antibodies|mesh-list
154132600|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
154132601|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154132602|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
154132603|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132604|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132605|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154132606|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154132607|NCT00906360|Growth Substances|growth substances|mesh-ancestor
154132608|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
154132609|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132610|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132611|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132612|NCT00603798|Imiquimod|imiquimod|mesh-list
153380927|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758039|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153758040|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153758041|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758042|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758044|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153758045|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153758046|NCT00554476|Indomethacin|indomethacin|mesh-list
153758047|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153758048|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153758049|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
153758051|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758052|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758053|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758054|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
153758055|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758056|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758057|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153758058|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153758059|NCT00554476|Analgesics|analgesics|mesh-ancestor
153758060|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
153758061|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758062|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758063|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
153758064|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
153758065|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153758066|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153758067|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154132613|NCT00603798|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154132614|NCT00603798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132615|NCT00603798|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154132616|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
154132617|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132618|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154132619|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132620|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
154132621|NCT00819572|Antibodies|antibodies|mesh-list
154132622|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
154132623|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
154132624|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132625|NCT00630812|Mannitol|mannitol|mesh-list
154132626|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154132627|NCT00630812|Diuretics|diuretics|mesh-ancestor
154132628|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
154132629|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132630|NCT00906516|Bevacizumab|bevacizumab|mesh-list
154132631|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132632|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132633|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154132634|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154132635|NCT00906516|Growth Substances|growth substances|mesh-ancestor
153758068|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
153758069|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758070|NCT00204906|Vitamin D|vitamin d|mesh-list
153758071|NCT00204906|Vitamins|vitamins|mesh-ancestor
153758072|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
153758075|NCT02335918|Nivolumab|nivolumab|mesh-list
153758081|NCT00176813|Gemcitabine|gemcitabine|mesh-list
153758082|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758083|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153758084|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
153758085|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758086|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153758087|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153758088|NCT00176813|Analgesics|analgesics|mesh-ancestor
153758089|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
153758090|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758091|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758092|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153758093|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758094|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153758095|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153758096|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758097|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
153758098|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153758099|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758100|NCT02320708|Acetaminophen|acetaminophen|mesh-list
153758101|NCT02320708|Ibuprofen|ibuprofen|mesh-list
153758102|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153758103|NCT02320708|Analgesics|analgesics|mesh-ancestor
153758104|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
153381144|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
153381145|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154132636|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132637|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
154132638|NCT00629798|Fludarabine|fludarabine|mesh-list
154132639|NCT00629798|Melphalan|melphalan|mesh-list
154132640|NCT00629798|Busulfan|busulfan|mesh-list
154132641|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154132642|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132643|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132644|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154132645|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
154132646|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807337|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154132647|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154132648|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
154132649|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154132650|NCT00160615|Levetiracetam|levetiracetam|mesh-list
154132651|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
154132652|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
154132653|NCT00906594|Latanoprost|latanoprost|mesh-list
154132654|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154132655|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154132656|NCT03970759|Fluorides|fluorides|mesh-list
154132657|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
154132658|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
154132659|NCT03970759|Protective Agents|protective agents|mesh-ancestor
154132660|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132661|NCT00905190|Ondansetron|ondansetron|mesh-list
154132662|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
154132663|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
154132664|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132665|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132666|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154132677|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154132678|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
154132679|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132680|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132681|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154132682|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
154132683|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154132684|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154132685|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154132686|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
154132687|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132688|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132689|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154132690|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
154132691|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154132693|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
154132694|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132695|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
154132696|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132697|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132698|NCT00909168|Immunotoxins|immunotoxins|mesh-ancestor
154132699|NCT00909168|Immunoconjugates|immunoconjugates|mesh-ancestor
154132700|NCT00909168|Immunologic Factors|immunologic factors|mesh-ancestor
153758105|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758106|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807391|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153758107|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
153758108|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153758109|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153758110|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758111|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153758119|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
153758120|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153758121|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153758122|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758123|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758124|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758125|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
153758126|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
153758127|NCT02295865|Toreforant|toreforant|mesh-list
153758128|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
153758129|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
153758130|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758131|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758132|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758133|NCT02282215|Lenograstim|lenograstim|mesh-list
153758134|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153758135|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
153758136|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758137|NCT00176969|Capsaicin|capsaicin|mesh-list
153758138|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
153381390|NCT05738681|Antioxidants|antioxidants|mesh-ancestor
154132701|NCT00909168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132702|NCT00816218|Pioglitazone|pioglitazone|mesh-list
154132703|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154132704|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132705|NCT00819728|Docetaxel|docetaxel|mesh-list
154132706|NCT00819728|Irinotecan|irinotecan|mesh-list
154132707|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132708|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
154132709|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
154132710|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
154132711|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132712|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154132713|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154132714|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132715|NCT00906828|Levodopa|levodopa|mesh-list
154132716|NCT00906828|Carbidopa|carbidopa|mesh-list
154132717|NCT00906828|Entacapone|entacapone|mesh-list
154132718|NCT00906828|Tolcapone|tolcapone|mesh-list
154132719|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154132720|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154132721|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
154132722|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132723|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132724|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132725|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153381419|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758139|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
153758140|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
153758141|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758142|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758143|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153758144|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
153758145|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758146|NCT00177008|Aripiprazole|aripiprazole|mesh-list
153758147|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
153758148|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153758149|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153758150|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153758151|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758152|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758159|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
153758160|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153758161|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153758162|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153758163|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153758164|NCT04677985|Analgesics|analgesics|mesh-list
153758165|NCT04677985|Menthol|menthol|mesh-list
153456796|NCT01470144|Tezosentan|tezosentan|mesh-list
154132726|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132727|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
154132728|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
154132729|NCT00819806|Vaccines|vaccines|mesh-list
154132730|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
154132731|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132732|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154132733|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154132734|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154132735|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
154132736|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132737|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132738|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154132739|NCT00909402|Capecitabine|capecitabine|mesh-list
154132740|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132741|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154132742|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
154132743|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132745|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154132746|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154132747|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132748|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
154132749|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
154132750|NCT00821444|Ziprasidone|ziprasidone|mesh-list
154132751|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154132752|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
154132753|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132754|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132755|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381515|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758167|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758168|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758169|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
153758170|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
153758171|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153758172|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153758173|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153758174|NCT00554632|Norgestimate|norgestimate|mesh-list
153807555|NCT00309920|Epirubicin|epirubicin|mesh-list
153758175|NCT00554632|Norelgestromin|norelgestromin|mesh-list
153758218|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
153758219|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758220|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758221|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
153381790|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
154132756|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154132757|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154132758|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132759|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154132760|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154132761|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
154132762|NCT00909558|Immunomodulating Agents|immunomodulating agents|mesh-list
154132763|NCT00909558|Immunologic Factors|immunologic factors|mesh-ancestor
154132764|NCT00909558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132765|NCT00819962|Bupivacaine|bupivacaine|mesh-list
154132766|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
154132767|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
154132768|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381791|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
153381793|NCT03325647|Androgens|androgens|mesh-ancestor
153758222|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
153758223|NCT00554710|Budesonide|budesonide|mesh-list
153758224|NCT00554710|Infliximab|infliximab|mesh-list
153758225|NCT00554710|Azathioprine|azathioprine|mesh-list
153758226|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153758227|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
153758228|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
153758229|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758230|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758231|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153758232|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
153758233|NCT00554710|Hormones|hormones|mesh-ancestor
153758234|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758235|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153758236|NCT00554710|Protective Agents|protective agents|mesh-ancestor
153758237|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758238|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153758239|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153758240|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
153758241|NCT00554710|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153758242|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
153758243|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758268|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153758269|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758270|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153758271|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153758272|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153758273|NCT00177281|Belotecan|belotecan|mesh-list
153758274|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153758275|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153758276|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758277|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758278|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758279|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
153758280|NCT00200226|Pyridoxal|pyridoxal|mesh-list
153758281|NCT00200226|Pyridoxine|pyridoxine|mesh-list
153758282|NCT00200226|Misoprostol|misoprostol|mesh-list
153758283|NCT00200226|Vitamins|vitamins|mesh-ancestor
153758284|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
153758285|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758286|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153758287|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
153758288|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153758289|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153758290|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381830|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154132769|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132770|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
154132771|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132772|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154132773|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154132774|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154132775|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154132776|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132777|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132778|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
154132779|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132780|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154132781|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154132782|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154132783|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154132784|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
154132785|NCT00927498|Cytarabine|cytarabine|mesh-list
154132786|NCT00927498|Daunorubicin|daunorubicin|mesh-list
154132787|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
154132788|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153758291|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
153758292|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
153758293|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153758294|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
153758295|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758296|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
153758297|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758298|NCT04658134|Glycine|glycine|mesh-list
153816178|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153816179|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153816180|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153816181|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
153816182|NCT00352235|KRN 7000|krn 7000|mesh-list
153816183|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153816184|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
153816185|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816186|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816189|NCT00450957|Lycopene|lycopene|mesh-list
153816190|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816191|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
153758299|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
153758300|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758301|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807616|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
153758302|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758303|NCT00200382|Bortezomib|bortezomib|mesh-list
153758304|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758305|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153758306|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153758307|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758308|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758309|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
153758310|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132789|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132790|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154132791|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154132792|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132793|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132794|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132796|NCT00927498|Immunoconjugates|immunoconjugates|mesh-ancestor
154132797|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
154132798|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132799|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154132800|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
154132801|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
154132802|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132803|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154132804|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
154132805|NCT00159913|Citric Acid|citric acid|mesh-list
154132806|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
153758311|NCT00177398|Insulin|insulin|mesh-list
153758312|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153758313|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
153758314|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153758315|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758316|NCT00200421|Atenolol|atenolol|mesh-list
153758317|NCT00200421|Nebivolol|nebivolol|mesh-list
153758318|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153758319|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153758353|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153758354|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
153758355|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153758356|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153758357|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153758358|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
153758359|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758360|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758361|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758362|NCT00200499|Nebivolol|nebivolol|mesh-list
153758363|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153758364|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
153758365|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153758366|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153758367|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153758368|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
153758369|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758370|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758371|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758372|NCT00200538|Memantine|memantine|mesh-list
153758373|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153758374|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153758375|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
153816192|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816193|NCT00450957|Protective Agents|protective agents|mesh-ancestor
153816194|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457517|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
153457518|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153457519|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153457520|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
154132807|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
154132808|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154132810|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
154132811|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132812|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
154132813|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154132814|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154132815|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132816|NCT00159913|Urological Agents|urological agents|mesh-ancestor
154132817|NCT05498259|Rituximab|rituximab|mesh-list
154132818|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154132819|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132820|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
154132821|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132822|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154132823|NCT00821600|Risperidone|risperidone|mesh-list
154132824|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154132825|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
154132826|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132827|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132828|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132829|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154132830|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154132831|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132832|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154132833|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154132834|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
154132835|NCT00987207|Cyclosporine|cyclosporine|mesh-list
154132836|NCT00987207|Cyclosporins|cyclosporins|mesh-list
153382104|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457521|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457522|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
153457523|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457524|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153457525|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457526|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153457527|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457528|NCT01382940|Analgesics|analgesics|mesh-ancestor
153457529|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
153457530|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457531|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
153457532|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153457533|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
154132837|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132838|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132839|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154132840|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
154132841|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132842|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
154132843|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132844|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
154132845|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154132846|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154132847|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154132849|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154132850|NCT00604188|Narcotics|narcotics|mesh-ancestor
154132851|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132852|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132853|NCT00604188|Analgesics|analgesics|mesh-ancestor
154132854|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
154132855|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457534|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
153457535|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153457536|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
153457537|NCT01382940|Hormones|hormones|mesh-ancestor
153758376|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758377|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758378|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758379|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153758380|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153758381|NCT00177710|Amphotericin B|amphotericin b|mesh-list
153758382|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153758383|NCT00177710|Amebicides|amebicides|mesh-ancestor
153758384|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153758385|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153758386|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758387|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758388|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
153758389|NCT00177749|Posaconazole|posaconazole|mesh-list
153758390|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
153758391|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758392|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153758393|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153758394|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153758395|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153758396|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153758397|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758398|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758399|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153758400|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
153758401|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758402|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758403|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153758404|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153807891|NCT00312104|Insulin|insulin|mesh-list
153758413|NCT04654819|Anesthetics|anesthetics|mesh-list
153758416|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153758417|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
154132856|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154132857|NCT00820352|Bosentan|bosentan|mesh-list
154132858|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154132859|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154132860|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132861|NCT00927654|Iloprost|iloprost|mesh-list
154132862|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154132863|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
154132864|NCT00927732|Quinidine|quinidine|mesh-list
154132865|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
154132866|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154132867|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
154132868|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
154132869|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132870|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132871|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154132872|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154132873|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
154132874|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132875|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132876|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
154132877|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154132878|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154132879|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154132880|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132881|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154132882|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154132883|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
154132884|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154132886|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154132887|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154132888|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154132889|NCT00227539|Pemetrexed|pemetrexed|mesh-list
154132890|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154132891|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132892|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758418|NCT04654741|Ganirelix|ganirelix|mesh-list
153595508|NCT01856946|Vitamins|vitamins|mesh-ancestor
153758419|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153758420|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153382467|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
154132893|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132894|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154132895|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154132896|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154132898|NCT00927966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154132899|NCT00927966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132900|NCT00927966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132901|NCT00927966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132902|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154132903|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
154132904|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132905|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132906|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154132907|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
154132908|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154132909|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154132910|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154132911|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132912|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132913|NCT00720941|Sunitinib|sunitinib|mesh-list
154132914|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132915|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154132916|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154132917|NCT00720941|Growth Substances|growth substances|mesh-ancestor
154132918|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132919|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
154132920|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132921|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132922|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132923|NCT00924222|Propofol|propofol|mesh-list
154132924|NCT00924222|Sevoflurane|sevoflurane|mesh-list
153382468|NCT01688336|Vitamins|vitamins|mesh-ancestor
153758421|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153758422|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
153758423|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153758424|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758425|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153758426|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153758427|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154132925|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154132926|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132927|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132928|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154132929|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
154132930|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
154132931|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154132932|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154132933|NCT01075711|Prednisone|prednisone|mesh-list
154132934|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154132935|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
154132936|NCT01075711|Hormones|hormones|mesh-ancestor
154132937|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807937|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132938|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132939|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154132940|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132941|NCT01073371|Prilocaine|prilocaine|mesh-list
154132942|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
154132943|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
154132944|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154132945|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132946|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
154132977|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
154132978|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132979|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154132980|NCT00585533|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154132981|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154132982|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154132983|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132984|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154132985|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
154132986|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154132987|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
154132988|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154132989|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154132990|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154132991|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
154132992|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154132993|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154132994|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154132995|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
154132996|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154132997|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154132998|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154132999|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154133000|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133001|NCT00987441|Sufentanil|sufentanil|mesh-list
154133002|NCT00987441|Dsuvia|dsuvia|mesh-list
154133003|NCT00987441|Ropivacaine|ropivacaine|mesh-list
154133004|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
154133005|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
154133006|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133007|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133011|NCT00987441|Narcotics|narcotics|mesh-ancestor
154133019|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
154133020|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133021|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154133022|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
154133023|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133024|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133025|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154133026|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
154133027|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
154133028|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154133029|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154133030|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154133031|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133032|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133033|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133034|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
154133035|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
154133036|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154133037|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154133038|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
154133039|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154133040|NCT00584987|Protective Agents|protective agents|mesh-ancestor
154133041|NCT00727961|Doxorubicin|doxorubicin|mesh-list
154133042|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154133044|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133045|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154133046|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154133047|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133048|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133049|NCT00568958|Naltrexone|naltrexone|mesh-list
154133050|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154133051|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154133063|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
154133064|NCT00727649|Loperamide|loperamide|mesh-list
154133065|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
154133066|NCT00727649|Psyllium|psyllium|mesh-list
154133067|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154133068|NCT00727649|Cathartics|cathartics|mesh-ancestor
154133069|NCT04006041|Paclitaxel|paclitaxel|mesh-list
154133070|NCT04006041|Cisplatin|cisplatin|mesh-list
154133071|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154133072|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133073|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
154133074|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
154133075|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133076|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133077|NCT00225277|Pioglitazone|pioglitazone|mesh-list
154133078|NCT00225277|Glimepiride|glimepiride|mesh-list
154133079|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154133080|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133081|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154133082|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133083|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
154133084|NCT00821054|Lapatinib|lapatinib|mesh-list
154133085|NCT00821054|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154133086|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154133087|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133088|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133089|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133090|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154133091|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154133092|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
154133093|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133094|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133095|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153758428|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153758429|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758430|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
153758431|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758432|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
153758433|NCT04654195|Doxorubicin|doxorubicin|mesh-list
153758434|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758435|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
154133097|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154133098|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154133099|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154133100|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133101|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133102|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133103|NCT04388319|Zonisamide|zonisamide|mesh-list
154133104|NCT04388319|Bupropion|bupropion|mesh-list
154133105|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154133106|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
154133107|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153456588|NCT01474512|Ixekizumab|ixekizumab|mesh-list
154133108|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154133109|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154133110|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133111|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133112|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
154133113|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133114|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133115|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153758467|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153758468|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758469|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
153758470|NCT04653493|Fludarabine|fludarabine|mesh-list
153758471|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758472|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
153758473|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758474|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758475|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153758476|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
153758477|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758478|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758479|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153758480|NCT00200694|Valsartan|valsartan|mesh-list
153758481|NCT00200694|Ramipril|ramipril|mesh-list
153758482|NCT00200694|Furosemide|furosemide|mesh-list
153758483|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153758484|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153758485|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153758486|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758487|NCT00200694|Diuretics|diuretics|mesh-ancestor
153758488|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
153758489|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758500|NCT00557713|Growth Substances|growth substances|mesh-ancestor
153758501|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758502|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
153758503|NCT00178100|Paroxetine|paroxetine|mesh-list
153758504|NCT00178100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153808358|NCT00314561|Pioglitazone|pioglitazone|mesh-list
153758505|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154133116|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154133117|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133118|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
154133119|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154133120|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154133121|NCT04085627|Amlodipine|amlodipine|mesh-list
154133122|NCT04085627|Valsartan|valsartan|mesh-list
154133123|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
154133124|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154133125|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154133126|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133127|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133128|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154133129|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133130|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
154133131|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154133132|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154133133|NCT04085393|Granisetron|granisetron|mesh-list
154133134|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
154133135|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
154133136|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133137|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133138|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154133139|NCT04085393|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153758506|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758507|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808542|NCT00315848|Analgesics|analgesics|mesh-ancestor
153758508|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758509|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
153758510|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758511|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153758512|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
153816195|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153816196|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153816197|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816198|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
153816199|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153816200|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
153816201|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816202|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816203|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153816204|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
153816205|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153816206|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
153816207|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758513|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153729695|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133140|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154133141|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
154133142|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133143|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133144|NCT00717275|Temozolomide|temozolomide|mesh-list
154133145|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154133146|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
153808649|NCT06165042|Sympathomimetics|sympathomimetics|mesh-ancestor
154133147|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133148|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133150|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154133151|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
154133152|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154133153|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133154|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
154133155|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154133156|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133157|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133158|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154133159|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154133160|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154133161|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154133162|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154133163|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154133164|NCT01075789|Lidocaine|lidocaine|mesh-list
154133165|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
154133166|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
154133167|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133168|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758514|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153758515|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153758517|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
153758518|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153758519|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153758520|NCT04653415|Prednisolone|prednisolone|mesh-list
153758521|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
153758522|NCT04653415|Gabapentin|gabapentin|mesh-list
153758523|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153758524|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
153758525|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383148|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153383149|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154133169|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
154133170|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133171|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154133172|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154133173|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154133174|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133175|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133176|NCT04515849|Semaglutide|semaglutide|mesh-list
154133177|NCT04515849|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154133178|NCT04515849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154133179|NCT04515849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133180|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
154133181|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133182|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
154133183|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133184|NCT00584909|Paclitaxel|paclitaxel|mesh-list
154133185|NCT00584909|Carboplatin|carboplatin|mesh-list
154133186|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154133187|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133188|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
154133189|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
154133190|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133191|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133193|NCT03947099|Analgesics|analgesics|mesh-ancestor
154133194|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
154133195|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133196|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133197|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154133198|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153758526|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
153758527|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
153758528|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758529|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758530|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153758531|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
153758532|NCT04653415|Hormones|hormones|mesh-ancestor
153758533|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758534|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153758535|NCT04653415|Protective Agents|protective agents|mesh-ancestor
153383236|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154133199|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
154133200|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
154133201|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133202|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154133203|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154133204|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133205|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133206|NCT00929058|Bevacizumab|bevacizumab|mesh-list
154133207|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154133208|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133209|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154133210|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154133211|NCT00929058|Growth Substances|growth substances|mesh-ancestor
154133212|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133213|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
154133214|NCT00907452|Thalidomide|thalidomide|mesh-list
154133215|NCT00907452|Dexamethasone|dexamethasone|mesh-list
154133216|NCT00907452|Prednisone|prednisone|mesh-list
154133217|NCT00907452|Lenalidomide|lenalidomide|mesh-list
154133218|NCT00907452|Melphalan|melphalan|mesh-list
154133219|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133220|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
153758536|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153758537|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595672|NCT01857596|Trazodone|trazodone|mesh-list
153758564|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153758565|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153758566|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153758567|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758568|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758569|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153758570|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153758571|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153758572|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153758573|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
153758574|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
153758575|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153758576|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153758577|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153758578|NCT04652323|Calcium|calcium|mesh-list
153758579|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153758580|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758581|NCT04652011|Analgesics|analgesics|mesh-list
153758582|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
153758583|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758584|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758585|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
153758586|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153758587|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758588|NCT00205725|Olanzapine|olanzapine|mesh-list
153758589|NCT00205725|Ziprasidone|ziprasidone|mesh-list
153758590|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
153383281|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154133221|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
154133222|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133223|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133224|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154133225|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
154133226|NCT00907452|Hormones|hormones|mesh-ancestor
154133227|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154133228|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154133229|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133230|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
154133231|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154133232|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154133233|NCT00907452|Growth Substances|growth substances|mesh-ancestor
154133234|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
154133235|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154133236|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
154133237|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133238|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154133239|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133240|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
154133241|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154133242|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133243|NCT00717197|Capecitabine|capecitabine|mesh-list
154133244|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154133245|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
154133246|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133247|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133248|NCT00925392|Doripenem|doripenem|mesh-list
154133249|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154133250|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133251|NCT05315271|Ketamine|ketamine|mesh-list
154133252|NCT05315271|Bupivacaine|bupivacaine|mesh-list
154133253|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
154133254|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
154133259|NCT05315271|Analgesics|analgesics|mesh-ancestor
154133260|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154133261|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154133262|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
154133263|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154133264|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154133265|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133266|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133267|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
154133268|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154133269|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154133270|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133271|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154133272|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154133273|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
154133274|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133275|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154133276|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
154133277|NCT05313477|Vitamin D|vitamin d|mesh-list
154133278|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
154133279|NCT05313477|Calcium|calcium|mesh-list
154133280|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154133281|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133282|NCT05313477|Antacids|antacids|mesh-ancestor
153816208|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808997|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816209|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153816210|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
153816211|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
153816212|NCT00352430|Protective Agents|protective agents|mesh-ancestor
153816213|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153816214|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
153457538|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457539|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153457540|NCT01382940|Protective Agents|protective agents|mesh-ancestor
153457541|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
153457542|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457543|NCT01381926|Exenatide|exenatide|mesh-list
153457544|NCT01381926|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153457545|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153457546|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457547|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153457549|NCT01381926|Hormones|hormones|mesh-ancestor
153758591|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
153758592|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133283|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133285|NCT05313477|Vitamins|vitamins|mesh-ancestor
154133286|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
154133287|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154133288|NCT00224107|Silodosin|silodosin|mesh-list
154133289|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154133290|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154133291|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154133292|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133293|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133294|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133295|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133296|NCT00224107|Urological Agents|urological agents|mesh-ancestor
154133297|NCT04004871|Paclitaxel|paclitaxel|mesh-list
154133298|NCT04004871|Cisplatin|cisplatin|mesh-list
154133299|NCT04004871|Fluorouracil|fluorouracil|mesh-list
154133300|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154133301|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133302|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
154133303|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
153809043|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
154133304|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133305|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133306|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
154133307|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154133308|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133309|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
154133310|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133311|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154133312|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153456818|NCT01443078|Carboplatin|carboplatin|mesh-list
154133327|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133328|NCT00822380|Hematinics|hematinics|mesh-ancestor
154133329|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
154133330|NCT00822380|Vitamins|vitamins|mesh-ancestor
154133331|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
154133332|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133333|NCT00822380|Protective Agents|protective agents|mesh-ancestor
154133335|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133336|NCT00209131|Tamsulosin|tamsulosin|mesh-list
154133337|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154133338|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154133339|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154133340|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133341|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133342|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133343|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133344|NCT00209131|Urological Agents|urological agents|mesh-ancestor
154133345|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
154133346|NCT00907608|Hematinics|hematinics|mesh-ancestor
154133347|NCT00224029|Oxybutynin|oxybutynin|mesh-list
154133348|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
154133349|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
154133350|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133351|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133352|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154133353|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154133354|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
154133355|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133356|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133357|NCT00224029|Urological Agents|urological agents|mesh-ancestor
154133358|NCT00929370|Glycine|glycine|mesh-list
154133359|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
154133360|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133361|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758593|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758594|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154133362|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133363|NCT00907764|Regadenoson|regadenoson|mesh-list
154133364|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154133365|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154133366|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
154133367|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
154133368|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133369|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133370|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133371|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154133372|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
154133373|NCT02550314|Coagulants|coagulants|mesh-ancestor
154133374|NCT01073527|Adenosine|adenosine|mesh-list
154133375|NCT01073527|Albuterol|albuterol|mesh-list
154133376|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154133377|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
154133378|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133379|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133380|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154133381|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
154133382|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
154133383|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154133384|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154133385|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154133386|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154133387|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133388|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133389|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133390|NCT01073527|Analgesics|analgesics|mesh-ancestor
154133391|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
153758595|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153758596|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153758598|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153758599|NCT00205725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153758600|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153758601|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758602|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758603|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758604|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
153758605|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153758606|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153758607|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
153758609|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153758610|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383990|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154133392|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154133393|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
154133394|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154133395|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
154133396|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
154133397|NCT02538432|Gemcitabine|gemcitabine|mesh-list
154133398|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154133399|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
154133400|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133401|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133402|NCT00719849|Cyclosporine|cyclosporine|mesh-list
154133403|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
154133404|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
154133405|NCT00719849|Fludarabine|fludarabine|mesh-list
154133406|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
154133407|NCT00719849|Cyclosporins|cyclosporins|mesh-list
154133408|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154133409|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133410|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
154133411|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133412|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154133413|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154133414|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
154133415|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133416|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133417|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154133418|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154133419|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
154133420|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133421|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
154133422|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133423|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
154133424|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154133425|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154133426|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153758611|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153758612|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153384124|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154133427|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
154133428|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154133429|NCT00822536|Aspirin|aspirin|mesh-list
154133430|NCT00822536|Clopidogrel|clopidogrel|mesh-list
154133431|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154133432|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154133433|NCT00822536|Analgesics|analgesics|mesh-ancestor
154133434|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
154133435|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133436|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133437|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133438|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154133439|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154133440|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154133441|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133442|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153809540|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153809541|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154133443|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154133444|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133445|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
154133446|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154133447|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154133448|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154133449|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
154133450|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133451|NCT00826826|Amiodarone|amiodarone|mesh-list
154133452|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154133453|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
154133454|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154133455|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133456|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133457|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154133458|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154133459|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154133460|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758613|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153758614|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758615|NCT00205764|Melphalan|melphalan|mesh-list
154133461|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154133462|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154133463|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154133464|NCT02592941|Deflazacort|deflazacort|mesh-list
154133465|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133466|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133467|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
154133468|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133469|NCT00822614|Fentanyl|fentanyl|mesh-list
154133470|NCT00822614|Morphine|morphine|mesh-list
154133471|NCT00822614|Oxycodone|oxycodone|mesh-list
154133472|NCT00822614|Hydromorphone|hydromorphone|mesh-list
154133473|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154133474|NCT00822614|Narcotics|narcotics|mesh-ancestor
154133475|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133476|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133477|NCT00822614|Analgesics|analgesics|mesh-ancestor
154133478|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
154133479|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133480|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154133481|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154133484|NCT04087967|Cytarabine|cytarabine|mesh-list
154133485|NCT04087967|Decitabine|decitabine|mesh-list
154133486|NCT04087967|Idarubicin|idarubicin|mesh-list
154133487|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154133488|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
154133489|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384279|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
153758616|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153758617|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
153758618|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758619|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758620|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153758621|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457550|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457551|NCT01395888|Fluticasone|fluticasone|mesh-list
153457553|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
153457554|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153457555|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153457556|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
153809610|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
153457557|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758622|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
153758623|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758624|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
153758625|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153758626|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
153758627|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758628|NCT00558142|Expectorants|expectorants|mesh-ancestor
153384304|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154133490|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133491|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
154133492|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133493|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133494|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
154133495|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133496|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133497|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154133498|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154133499|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154133500|NCT00926016|Pioglitazone|pioglitazone|mesh-list
154133501|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154133502|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133503|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154133504|NCT04017104|Edotreotide|edotreotide|mesh-list
154133505|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154133506|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809649|NCT02094261|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153809650|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809651|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133507|NCT00827138|Rebastinib|rebastinib|mesh-list
154133508|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133509|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154133510|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133511|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133512|NCT00817466|Epinephrine|epinephrine|mesh-list
154133513|NCT00817466|Racepinephrine|racepinephrine|mesh-list
154133514|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
154133515|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154133516|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154133517|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133518|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133519|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133520|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133521|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154133531|NCT00930072|Bupivacaine|bupivacaine|mesh-list
154133532|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
154133533|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
154133534|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133535|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133536|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
154133537|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133538|NCT00930072|Analgesics|analgesics|mesh-ancestor
154133539|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154133540|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
154133541|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
154133542|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154133543|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154133544|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154133545|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133546|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133547|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133548|NCT00626522|Bromides|bromides|mesh-list
154133549|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
154133550|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154133551|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
154133552|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133553|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133554|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154133555|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
154133556|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154133557|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154133558|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154133559|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133560|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133561|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133562|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
154133563|NCT00926640|Etoposide|etoposide|mesh-list
153809702|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
154133564|NCT00926640|Belinostat|belinostat|mesh-list
153384459|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
153758629|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
153758630|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153758631|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
154133565|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133566|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154133567|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154133568|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154133569|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133570|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133571|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154133572|NCT00931398|Methylphenidate|methylphenidate|mesh-list
154133573|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154133574|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133575|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154133576|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154133577|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133578|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133579|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
154133580|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133581|NCT00827216|Erythromycin|erythromycin|mesh-list
154133582|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
154133583|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154133584|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
154133585|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154133586|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133587|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154133588|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154133589|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133590|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133591|NCT00822848|Sorafenib|sorafenib|mesh-list
154133592|NCT00822848|Epirubicin|epirubicin|mesh-list
154133593|NCT00822848|Ifosfamide|ifosfamide|mesh-list
154133594|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133595|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154133596|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133597|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133598|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153758632|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758633|NCT00558142|Protective Agents|protective agents|mesh-ancestor
153758634|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758635|NCT00558142|Antidotes|antidotes|mesh-ancestor
153384572|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133599|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154133600|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154133601|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154133602|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
154133603|NCT00926718|Remifentanil|remifentanil|mesh-list
154133605|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154133606|NCT00926718|Narcotics|narcotics|mesh-ancestor
154133607|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133608|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133609|NCT00926718|Analgesics|analgesics|mesh-ancestor
154133610|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
154133611|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133612|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154133613|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154133614|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154133615|NCT00823004|Letrozole|letrozole|mesh-list
154133616|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
154133617|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
154133618|NCT00823004|Buserelin|buserelin|mesh-list
154133619|NCT00823004|Ganirelix|ganirelix|mesh-list
154133620|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133621|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154133622|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154133623|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133624|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133625|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153758636|NCT00205842|Alvimopan|alvimopan|mesh-list
153595732|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
153758637|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153758638|NCT00178451|Abciximab|abciximab|mesh-list
153758639|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
153758640|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153758641|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153758642|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
153758643|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153758644|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153758645|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153758646|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758647|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758648|NCT00206154|Budesonide|budesonide|mesh-list
153758649|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
153758650|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153758651|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153758652|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
153758653|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758654|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133626|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
154133627|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154133628|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133629|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154133630|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154133631|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154133632|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
154133634|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154133635|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133636|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154133637|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809895|NCT00316472|Niacin|niacin|mesh-list
154133638|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133639|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154133640|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154133641|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
154133642|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133643|NCT00930306|Tolbutamide|tolbutamide|mesh-list
153758655|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153457558|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457559|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153457560|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
153457561|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
153457562|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153758656|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
153758666|NCT00559702|Natalizumab|natalizumab|mesh-list
153758667|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
153758668|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758669|NCT00559741|Leucovorin|leucovorin|mesh-list
153758670|NCT00559741|Fluorouracil|fluorouracil|mesh-list
153758671|NCT00559741|Irinotecan|irinotecan|mesh-list
153758672|NCT00559741|Cetuximab|cetuximab|mesh-list
153758673|NCT00559741|Calcium|calcium|mesh-list
153758674|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
153809955|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153758675|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153758676|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758677|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
153758678|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758679|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153758680|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758681|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758682|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
153758683|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153758684|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153758685|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758686|NCT00559741|Antidotes|antidotes|mesh-ancestor
153758701|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758702|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
153758703|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758705|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
153758706|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
153758707|NCT00559858|Vitamins|vitamins|mesh-ancestor
153758708|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
153758709|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758710|NCT00559975|Vaccines|vaccines|mesh-list
153758711|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
153384740|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
154133645|NCT00930306|Caffeine|caffeine|mesh-list
154133646|NCT00930306|Omeprazole|omeprazole|mesh-list
154133647|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154133648|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154133649|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133650|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133651|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154133652|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154133653|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154133654|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154133655|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
154133656|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
154133657|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
154133658|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
154133659|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133660|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133661|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154133662|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154133663|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133664|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154133665|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154133666|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
154133667|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154133668|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154133669|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154133670|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154133671|NCT00830882|Albuterol|albuterol|mesh-list
153758712|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758713|NCT00206193|Misoprostol|misoprostol|mesh-list
153758714|NCT00206193|Sulprostone|sulprostone|mesh-list
153758715|NCT00206193|Mifepristone|mifepristone|mesh-list
153758716|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153758718|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153758719|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758720|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153758721|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153758722|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
153758723|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153758724|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153758725|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153457563|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
153457564|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153457565|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
153816215|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153816216|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153816217|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154133673|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
154133674|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133675|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133676|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154133677|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
154133678|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
154133679|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154133680|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154133681|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154133682|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154133683|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
154133684|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133685|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133686|NCT00823238|Tobramycin|tobramycin|mesh-list
154133687|NCT00823238|Ceftazidime|ceftazidime|mesh-list
154133688|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384828|NCT00559754|Bevacizumab|bevacizumab|mesh-list
153816218|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153816219|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816220|NCT00451074|Gentamicins|gentamicins|mesh-list
153758726|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153758727|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
153758728|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153758729|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153758730|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
153758731|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758732|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
153758733|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153758734|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153758735|NCT04638439|Entecavir|entecavir|mesh-list
153758736|NCT04638439|Nivolumab|nivolumab|mesh-list
153758737|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153758738|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810182|NCT00317798|Sirolimus|sirolimus|mesh-list
153758739|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153758740|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758741|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
153758742|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758743|NCT00178802|Interferons|interferons|mesh-list
153758744|NCT00178802|Doxorubicin|doxorubicin|mesh-list
153758745|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153758746|NCT00178802|Fluorouracil|fluorouracil|mesh-list
153758747|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153758748|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758749|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153758750|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153758751|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758752|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758753|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
153758754|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153758770|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758771|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758772|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758773|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153758774|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153384839|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133689|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133690|NCT00823238|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154133691|NCT00823238|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154133692|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
154133693|NCT00827684|Sirolimus|sirolimus|mesh-list
154133694|NCT00827684|Irinotecan|irinotecan|mesh-list
154133695|NCT00827684|Temsirolimus|temsirolimus|mesh-list
154133696|NCT00827684|MTOR Inhibitors|mtor inhibitors|mesh-list
154133697|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154133698|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154133699|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133700|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133701|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457203|NCT03814200|Rifampin|rifampin|mesh-list
154133702|NCT00827684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154133703|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133704|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
154133705|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133706|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153758775|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758776|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758777|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
153758778|NCT00560092|Analgesics|analgesics|mesh-ancestor
153758779|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
153758780|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153758781|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758782|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
153758783|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758784|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153758785|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
153758786|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153758787|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758788|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758789|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153758790|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
153758791|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153758792|NCT00560170|Simvastatin|simvastatin|mesh-list
153758793|NCT00560170|Ezetimibe|ezetimibe|mesh-list
153758794|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153758795|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153758796|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153758797|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
153758798|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758799|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153758800|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153758801|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758802|NCT04637152|Valsartan|valsartan|mesh-list
153758803|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153758806|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153758807|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758808|NCT04636918|Cyclosporine|cyclosporine|mesh-list
153758809|NCT04636918|Cyclosporins|cyclosporins|mesh-list
153384872|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154133707|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133708|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154133709|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
154133711|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
154133712|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133713|NCT00927030|Protective Agents|protective agents|mesh-ancestor
154133714|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133715|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133716|NCT00931866|Diclofenac|diclofenac|mesh-list
154133717|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154133718|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154133719|NCT00931866|Analgesics|analgesics|mesh-ancestor
154133720|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
154133721|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133722|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133723|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133724|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154133725|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154133726|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758811|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758812|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758813|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
153758814|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758815|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
153758816|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153758817|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
153758818|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758819|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153758820|NCT00560209|Landiolol|landiolol|mesh-list
153758821|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153758822|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153758823|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
153758861|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758862|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153758863|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758864|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758865|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153758866|NCT00560443|Narcotics|narcotics|mesh-ancestor
153758868|NCT00179114|Baclofen|baclofen|mesh-list
153758930|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758931|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153758932|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153758933|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
153758934|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758935|NCT00201396|Antidotes|antidotes|mesh-ancestor
153758936|NCT00201396|Protective Agents|protective agents|mesh-ancestor
153758937|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
153758938|NCT00201396|Vitamins|vitamins|mesh-ancestor
153758940|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153758995|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153758996|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
153758997|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133727|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133728|NCT00827840|Risperidone|risperidone|mesh-list
154133729|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154133730|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154133731|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
154133732|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133733|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810387|NCT00319007|Analgesics|analgesics|mesh-ancestor
154133734|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133735|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154133736|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154133737|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133738|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154133739|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154133740|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
154133741|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154133742|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154133743|NCT00827996|Adalimumab|adalimumab|mesh-list
154133744|NCT00827996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154133745|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133746|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154133747|NCT00936780|Paclitaxel|paclitaxel|mesh-list
154133748|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154133749|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133750|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
154133751|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
153758998|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758999|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759000|NCT00201630|Alfuzosin|alfuzosin|mesh-list
153759001|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153759002|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153759003|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153759004|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
153759005|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759006|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759007|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759008|NCT00201630|Urological Agents|urological agents|mesh-ancestor
153759009|NCT00179231|Olanzapine|olanzapine|mesh-list
153759010|NCT00179231|Clozapine|clozapine|mesh-list
153759011|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
153759012|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
153759013|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759014|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759015|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759016|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153759017|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153759018|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153759044|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759045|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154133752|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133753|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133754|NCT00823550|Lamivudine|lamivudine|mesh-list
154133755|NCT00823550|Entecavir|entecavir|mesh-list
154133756|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154133757|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154133758|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133759|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133760|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
154133761|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133762|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154133763|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154133764|NCT00932100|Heparin|heparin|mesh-list
154133765|NCT00932100|Calcium heparin|calcium heparin|mesh-list
154133766|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154133767|NCT00932100|Tinzaparin|tinzaparin|mesh-list
154133768|NCT00932100|Dalteparin|dalteparin|mesh-list
154133769|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
154133770|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154133771|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154133772|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133773|NCT00828230|Budesonide|budesonide|mesh-list
154133774|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133775|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154133776|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
153810525|NCT00319865|Dexamethasone|dexamethasone|mesh-list
153357111|NCT00717626|Coagulants|coagulants|mesh-ancestor
153357112|NCT01272128|Interferons|interferons|mesh-list
153357113|NCT01272128|Interferon-beta|interferon-beta|mesh-list
153357114|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
153357115|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357116|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
153357117|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357118|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
153357119|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357120|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153357121|NCT00719186|Letrozole|letrozole|mesh-list
153357122|NCT00719186|Clomiphene|clomiphene|mesh-list
153357123|NCT00719186|Enclomiphene|enclomiphene|mesh-list
153810526|NCT00319865|Doxorubicin|doxorubicin|mesh-list
153810527|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153810528|NCT00319865|Bortezomib|bortezomib|mesh-list
153810529|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153810530|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
153810531|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
153876290|NCT01196104|Insulin|insulin|mesh-list
154133777|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457274|NCT01388790|Cetuximab|cetuximab|mesh-list
153384981|NCT02303262|Gemcitabine|gemcitabine|mesh-list
153759046|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759047|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759048|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759049|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759050|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759051|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759052|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759053|NCT04632121|Nicorandil|nicorandil|mesh-list
153759054|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153759055|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153759056|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
153759057|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
153759058|NCT04632121|Vitamins|vitamins|mesh-ancestor
153759059|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
153759060|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759061|NCT00179699|Pemetrexed|pemetrexed|mesh-list
153759062|NCT00179699|Lenalidomide|lenalidomide|mesh-list
153759063|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759064|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759065|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759066|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153759067|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154133779|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154133780|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
154133781|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
154133782|NCT00828230|Hormones|hormones|mesh-ancestor
154133783|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154133785|NCT04469556|Paclitaxel|paclitaxel|mesh-list
154133786|NCT04469556|Gemcitabine|gemcitabine|mesh-list
153810538|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153357177|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153417059|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153417060|NCT04891718|Nivolumab|nivolumab|mesh-list
154133787|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
154133788|NCT04469556|Irinotecan|irinotecan|mesh-list
154133789|NCT04469556|Folfirinox|folfirinox|mesh-list
154133790|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154133791|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133792|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
154133793|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
154133794|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133795|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133796|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154133797|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
154133798|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154133799|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154133800|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133801|NCT04469556|Antidotes|antidotes|mesh-ancestor
154133802|NCT04469556|Protective Agents|protective agents|mesh-ancestor
153759069|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759070|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153759071|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153759072|NCT00179699|Growth Substances|growth substances|mesh-ancestor
153759073|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
153759074|NCT00201747|Mitomycins|mitomycins|mesh-list
153759089|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759091|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
153759092|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759093|NCT04631341|Protective Agents|protective agents|mesh-ancestor
153759094|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759095|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153759096|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153759097|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153759098|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153759099|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153759100|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759148|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153759149|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153759150|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
153759151|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759152|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417061|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153417062|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417065|NCT03770689|Capecitabine|capecitabine|mesh-list
153484700|NCT05661942|Calcium|calcium|mesh-list
153759153|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759154|NCT00561028|Antibodies|antibodies|mesh-list
153759155|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
153759156|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759157|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
153759158|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153385152|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133803|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133804|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
154133805|NCT04469556|Vitamins|vitamins|mesh-ancestor
154133806|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
154133807|NCT00937092|Dopamine|dopamine|mesh-list
154133808|NCT00937092|Furosemide|furosemide|mesh-list
154133809|NCT00937092|Diuretics|diuretics|mesh-ancestor
154133810|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
154133811|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133812|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154133813|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133814|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133815|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154133816|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
154133817|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
154133818|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133819|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
154133820|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133821|NCT00937092|Protective Agents|protective agents|mesh-ancestor
154133822|NCT04124601|Nivolumab|nivolumab|mesh-list
154133823|NCT04124601|Ipilimumab|ipilimumab|mesh-list
154133824|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154133825|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133826|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154133827|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133828|NCT05046639|Lidocaine|lidocaine|mesh-list
154133829|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
153759159|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153759160|NCT00561067|Prednisolone|prednisolone|mesh-list
153759161|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
153759162|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
153759166|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
153759208|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759209|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759210|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759211|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759212|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759213|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153876306|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876307|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153876308|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876309|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153876310|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
153876314|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
153810548|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153810549|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810550|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153759214|NCT00201981|Rebamipide|rebamipide|mesh-list
153759215|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153759276|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759277|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153759278|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
153759279|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
153759280|NCT00180089|Hormones|hormones|mesh-ancestor
153759281|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759282|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
153385314|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154133830|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
154133831|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154133832|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133833|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
154133834|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133835|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154133836|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154133837|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154133838|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133839|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133840|NCT00931008|Docetaxel|docetaxel|mesh-list
154133841|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133842|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
154133843|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
154133844|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133845|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133846|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
154133847|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154133848|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154133849|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133850|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154133851|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154133852|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133853|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133854|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759283|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153759284|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
153759285|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759286|NCT00575419|Expectorants|expectorants|mesh-ancestor
153759287|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
153759288|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153810564|NCT00320099|Insulin|insulin|mesh-list
153810565|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153810566|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
153810567|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153810568|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153759289|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
153759290|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759291|NCT00575419|Protective Agents|protective agents|mesh-ancestor
153759292|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759293|NCT00575419|Antidotes|antidotes|mesh-ancestor
153759294|NCT00180128|Cytarabine|cytarabine|mesh-list
153759332|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153759333|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759334|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
153759335|NCT00576238|Hormones|hormones|mesh-ancestor
153759336|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153759337|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759338|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154133855|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154133856|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
154133857|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154133858|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133859|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154133860|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154133861|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154133863|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154133864|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154133865|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154133866|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133867|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154133868|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133869|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
154133870|NCT00937482|Cediranib|cediranib|mesh-list
154133871|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133872|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133873|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810579|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886955|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
154133874|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154133875|NCT00931086|Belimumab|belimumab|mesh-list
154133876|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133877|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
154133878|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133879|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
154133880|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154133881|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
154133882|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154133883|NCT04453839|Protective Agents|protective agents|mesh-ancestor
154133884|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133885|NCT03977454|Ropivacaine|ropivacaine|mesh-list
154133886|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
154133887|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
153759339|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
153759340|NCT00576394|Insulin|insulin|mesh-list
153759341|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153759342|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153759343|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759394|NCT00576706|Protective Agents|protective agents|mesh-ancestor
153759395|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759396|NCT00576784|Pioglitazone|pioglitazone|mesh-list
153759397|NCT00576784|Glimepiride|glimepiride|mesh-list
154133889|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133890|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
154133891|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133892|NCT02549066|Milrinone|milrinone|mesh-list
154133893|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154133894|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154133895|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
154133896|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154133897|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154133898|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876343|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154133899|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133900|NCT02549066|Protective Agents|protective agents|mesh-ancestor
154133901|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133902|NCT00831350|Ranibizumab|ranibizumab|mesh-list
154133903|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154133904|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154133905|NCT00831350|Growth Substances|growth substances|mesh-ancestor
154133906|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133907|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
154133908|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133909|NCT00938184|Paroxetine|paroxetine|mesh-list
154133910|NCT00938184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154133911|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154133912|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153759398|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153759399|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759400|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153759401|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759402|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
153759403|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
153759404|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153759405|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810581|NCT00346749|Xhance|xhance|mesh-list
153759406|NCT00202020|Aspirin|aspirin|mesh-list
153759407|NCT00202020|Cilostazol|cilostazol|mesh-list
153759408|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153759409|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153759410|NCT00202020|Analgesics|analgesics|mesh-ancestor
153759454|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
153759455|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759456|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759457|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
153759458|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759459|NCT00187005|Cytarabine|cytarabine|mesh-list
153759460|NCT00187005|Dexamethasone|dexamethasone|mesh-list
153759461|NCT00187005|Prednisone|prednisone|mesh-list
153759462|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
153759463|NCT00187005|Methotrexate|methotrexate|mesh-list
153759464|NCT00187005|Etoposide|etoposide|mesh-list
153385443|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154133913|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133914|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133915|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
154133916|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133917|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154133918|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
154133919|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154133920|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154133921|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154133922|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133923|NCT00938262|Rifampin|rifampin|mesh-list
154133924|NCT00938262|Ketoconazole|ketoconazole|mesh-list
153876394|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154133925|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154133926|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
154133927|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154133928|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154133929|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
154133930|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154133931|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133932|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133933|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154133934|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154133935|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154133936|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154133937|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153385447|NCT00552578|Naloxone|naloxone|mesh-list
153759465|NCT00187005|Vincristine|vincristine|mesh-list
153759466|NCT00187005|Daunorubicin|daunorubicin|mesh-list
153759467|NCT00187005|Asparaginase|asparaginase|mesh-list
153759468|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
153759469|NCT00187005|Idarubicin|idarubicin|mesh-list
153759470|NCT00187005|Pegaspargase|pegaspargase|mesh-list
153759471|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759472|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
153759473|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759474|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153759475|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759476|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
153759477|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759478|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759479|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154133938|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154133939|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
154133940|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154133941|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154133942|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154133943|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
154133944|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154133945|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133946|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154133947|NCT00933426|Paclitaxel|paclitaxel|mesh-list
154133948|NCT00933426|Lenalidomide|lenalidomide|mesh-list
154133949|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154133950|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133951|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
154133952|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
154133953|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
154133954|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133955|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
154133956|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133957|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154133958|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154133959|NCT00933426|Growth Substances|growth substances|mesh-ancestor
154133960|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
154133961|NCT04013958|Ketamine|ketamine|mesh-list
154133962|NCT04013958|Analgesics|analgesics|mesh-ancestor
154133963|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
154133964|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133965|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133966|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153484953|NCT01740258|Growth Substances|growth substances|mesh-ancestor
153484959|NCT01740414|Ibudilast|ibudilast|mesh-list
154133967|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154133968|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
154133969|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
154133970|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153759480|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153759481|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
153759482|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
153759483|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759484|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153759485|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
154133971|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154133972|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154133973|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154133974|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133976|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154133977|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154133978|NCT00933582|Analgesics|analgesics|mesh-ancestor
154133979|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
154133980|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154133981|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133982|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385693|NCT00377559|Docetaxel|docetaxel|mesh-list
153759500|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759501|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
153759502|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759503|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759504|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759505|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759506|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153759507|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
153759508|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153759509|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759510|NCT00577369|Desflurane|desflurane|mesh-list
153759511|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153759512|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
153759513|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
153759514|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153759516|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153759562|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
153759563|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
153759564|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153759565|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153759566|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759567|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153485065|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153485066|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153485067|NCT01760304|Budesonide|budesonide|mesh-list
153485068|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
153485069|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153485070|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153485071|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
153485072|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485073|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485074|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153485075|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
153485076|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
153485077|NCT01760304|Hormones|hormones|mesh-ancestor
153485085|NCT01763346|Metformin|metformin|mesh-list
153759568|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759569|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153759570|NCT00578149|Paclitaxel|paclitaxel|mesh-list
153759571|NCT00578149|Bevacizumab|bevacizumab|mesh-list
153759572|NCT00578149|Carboplatin|carboplatin|mesh-list
153759575|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759576|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759577|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759578|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759579|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153759580|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153759581|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153759582|NCT00578149|Growth Substances|growth substances|mesh-ancestor
153759615|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153759616|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759617|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
153596706|NCT01863641|Vitamins|vitamins|mesh-ancestor
153759618|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
153759619|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759620|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153759623|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759682|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759683|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153759684|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
153759685|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154133983|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154133984|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
154133985|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154133986|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154133987|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133989|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
154133990|NCT00933816|Fluorouracil|fluorouracil|mesh-list
154133991|NCT00933816|Sorafenib|sorafenib|mesh-list
154133992|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154133993|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
154133994|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154133995|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153457552|NCT01395888|Xhance|xhance|mesh-list
153810584|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153357218|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357219|NCT01271504|Sorafenib|sorafenib|mesh-list
153357220|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357221|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153357222|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357223|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357224|NCT02144714|Adalimumab|adalimumab|mesh-list
153357225|NCT02144714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153357226|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153357227|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417200|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153357228|NCT00741026|Olanzapine|olanzapine|mesh-list
153357229|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
153357230|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
154133996|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154133997|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
154133998|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154133999|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154134000|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134001|NCT00538785|Palivizumab|palivizumab|mesh-list
154134002|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
154134003|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134005|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153759686|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153759687|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
153759688|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
153759689|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153759690|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153759691|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759692|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
153759693|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759694|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
153759695|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
153759696|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
153759697|NCT00579475|Mifepristone|mifepristone|mesh-list
153759698|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153759699|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
153759700|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153759701|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759736|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759737|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759738|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759739|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
153759740|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153759741|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153759742|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
153759743|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759745|NCT01054248|Piperaquine|piperaquine|mesh-list
153759746|NCT01054248|Artenimol|artenimol|mesh-list
153759747|NCT01054248|Mefloquine|mefloquine|mesh-list
153759748|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
153759749|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153759750|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153759751|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134006|NCT01563939|Narcotics|narcotics|mesh-ancestor
154134007|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134008|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810585|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
153810586|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810587|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810588|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153810589|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
153810590|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
153810591|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153810592|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153810594|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154134009|NCT01563939|Analgesics|analgesics|mesh-ancestor
154134010|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
154134011|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134013|NCT03287271|Carboplatin|carboplatin|mesh-list
154134014|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154134015|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134016|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
154134017|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
154134018|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
154134019|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134020|NCT00990405|Amoxicillin|amoxicillin|mesh-list
154134021|NCT00990405|Clarithromycin|clarithromycin|mesh-list
154134022|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154134023|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134024|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154134025|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134026|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134027|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154134028|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154134029|NCT00990639|Candesartan|candesartan|mesh-list
154134030|NCT00990639|Candesartan cilexetil|candesartan cilexetil|mesh-list
154134031|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134032|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153385786|NCT02985801|Pancrelipase|pancrelipase|mesh-list
153759752|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759753|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
153759754|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
153759755|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153759756|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
153759757|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
153759758|NCT00180830|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153759759|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153759760|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759761|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759763|NCT00202176|Bromides|bromides|mesh-list
153759786|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759787|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153759788|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153759857|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759858|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153759859|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153385838|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134034|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134035|NCT03742947|Hemostatics|hemostatics|mesh-list
154134036|NCT03742947|Coagulants|coagulants|mesh-ancestor
154134037|NCT05359497|Liver Extracts|liver extracts|mesh-list
154134038|NCT05359497|Hematinics|hematinics|mesh-ancestor
154134039|NCT00990795|Cyclosporine|cyclosporine|mesh-list
154134040|NCT00990795|Cyclosporins|cyclosporins|mesh-list
154134041|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134042|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134043|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154134044|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
154134045|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134046|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
154134047|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134048|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
154134049|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134050|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154134051|NCT00622700|Teriflunomide|teriflunomide|mesh-list
154134052|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154134053|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154134054|NCT00622700|Analgesics|analgesics|mesh-ancestor
154134055|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
154134056|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153759860|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
153759861|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
153759862|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153759864|NCT00209118|Paroxetine|paroxetine|mesh-list
153759865|NCT00209118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153759866|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153759867|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153759868|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759869|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759870|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
153759871|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759872|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153759873|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
153759874|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153759875|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153759876|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153759877|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759878|NCT00181025|Melphalan|melphalan|mesh-list
153759879|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153759880|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
153759887|NCT00209313|Acyclovir|acyclovir|mesh-list
153759904|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
153759905|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759906|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
153385913|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134057|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134058|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134059|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134060|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154134061|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
154134062|NCT00831506|Digoxin|digoxin|mesh-list
154134063|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154134064|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154134065|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134066|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134067|NCT00831506|Protective Agents|protective agents|mesh-ancestor
154134068|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134069|NCT02842359|Irbesartan|irbesartan|mesh-list
154134070|NCT02842359|Atorvastatin|atorvastatin|mesh-list
154134071|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154134072|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154134073|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
154134074|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134075|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154134076|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154134077|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134078|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134079|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154134080|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154134081|NCT00828776|Heparin|heparin|mesh-list
154134082|NCT00828776|Calcium heparin|calcium heparin|mesh-list
154134083|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
154134084|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154134085|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154134086|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386008|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154134098|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
154134099|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
154134100|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134101|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134102|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154134103|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154134104|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154134105|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154134106|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134107|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134108|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134109|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154134110|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154134111|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
154134113|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
154134114|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134115|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
154134116|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134117|NCT00537771|Tamoxifen|tamoxifen|mesh-list
154134118|NCT00537771|Anastrozole|anastrozole|mesh-list
154134119|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154134120|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
154134121|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876455|NCT04532931|Acetaminophen|acetaminophen|mesh-list
153810602|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
153357235|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154134122|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134123|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154134124|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134125|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154134126|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154134127|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154134128|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154134129|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154134130|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759907|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153759908|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153759909|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759910|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153759911|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153386089|NCT01309581|Methohexital|methohexital|mesh-list
154134131|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134132|NCT00823940|Glucagon|glucagon|mesh-list
154134133|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154134134|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154134135|NCT00823940|Hormones|hormones|mesh-ancestor
154134136|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134137|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134138|NCT00823940|Incretins|incretins|mesh-ancestor
154134139|NCT00829322|Modafinil|modafinil|mesh-list
154134140|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154134141|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134142|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153810604|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357237|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154134143|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154134144|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154134145|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134146|NCT00623480|Factor VIII|factor viii|mesh-list
154134147|NCT00623480|Coagulants|coagulants|mesh-ancestor
154134148|NCT02513667|Ceritinib|ceritinib|mesh-list
154134149|NCT02513667|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154134150|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154134151|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759912|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
153759913|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759914|NCT00181181|Atorvastatin|atorvastatin|mesh-list
153759915|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153759916|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153759917|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
153759918|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759919|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153759920|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153759921|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759922|NCT00181220|Valproic Acid|valproic acid|mesh-list
153759923|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
153759924|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153759925|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759926|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
153759927|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759928|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759953|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
153759954|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153759955|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759956|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759957|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153759958|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153759959|NCT00583180|Capsaicin|capsaicin|mesh-list
153759960|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
153759961|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
153759962|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
153759963|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386196|NCT01280643|Growth Substances|growth substances|mesh-ancestor
153876484|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876486|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153876487|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876488|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134152|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134153|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134154|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
154134155|NCT03823911|Grazoprevir|grazoprevir|mesh-list
154134156|NCT03823911|Ledipasvir|ledipasvir|mesh-list
154134157|NCT03823911|Velpatasvir|velpatasvir|mesh-list
154134158|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
154134159|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
154134160|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
154134161|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134162|NCT00829634|Methamphetamine|methamphetamine|mesh-list
154134163|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154134164|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134165|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
154134166|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
154134167|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134168|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
154134169|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134170|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134171|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134172|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154134173|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154134174|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134175|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154134176|NCT04003467|Teriparatide|teriparatide|mesh-list
154134177|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154134178|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134179|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154134180|NCT00832208|Amphotericin B|amphotericin b|mesh-list
154134181|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154134182|NCT00832208|Amebicides|amebicides|mesh-ancestor
154134183|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154134184|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154134185|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153759964|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153759965|NCT00583258|Alfuzosin|alfuzosin|mesh-list
153759966|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153760011|NCT00187707|Analgesics|analgesics|mesh-ancestor
154134186|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153876489|NCT01195090|Incretins|incretins|mesh-ancestor
153417266|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153485456|NCT06011746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134187|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
154134189|NCT05361057|Azacitidine|azacitidine|mesh-list
154134190|NCT05361057|Daunorubicin|daunorubicin|mesh-list
154134191|NCT05361057|Venetoclax|venetoclax|mesh-list
154134192|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154134193|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
154134194|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134195|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134196|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
154134197|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134198|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154134199|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
154134200|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134201|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134202|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154134203|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154134204|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154134205|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
154134206|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154134207|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134208|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154134209|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154134210|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134211|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134212|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134213|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154134214|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153760012|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
153760013|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760014|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760015|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
153760016|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153760017|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153417267|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
153417268|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417269|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153417270|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153417271|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417272|NCT02754518|Valsartan|valsartan|mesh-list
153417273|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153417274|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153417275|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153417276|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153760018|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760019|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760020|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153760021|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153760022|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760023|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760024|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
153760026|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153760027|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
153760028|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760029|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154134215|NCT00832364|Etanercept|etanercept|mesh-list
154134216|NCT00832364|Acitretin|acitretin|mesh-list
154134217|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154134218|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154134219|NCT00832364|Analgesics|analgesics|mesh-ancestor
154134220|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
154134221|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134222|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134223|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134224|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134225|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154134226|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154134227|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
154134228|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
154134229|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
154134231|NCT00832442|Carvedilol|carvedilol|mesh-list
154134232|NCT00832442|Nebivolol|nebivolol|mesh-list
154134233|NCT00832442|Bisoprolol|bisoprolol|mesh-list
154134234|NCT00832442|Bucindolol|bucindolol|mesh-list
154134235|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154134236|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154134237|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134238|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
154134239|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
154134240|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876506|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876507|NCT02216799|Insulin|insulin|mesh-list
153876508|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153876509|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
153876510|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876511|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876512|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
153876513|NCT02216877|Antacids|antacids|mesh-ancestor
153876514|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876516|NCT02214563|Vitamin D|vitamin d|mesh-list
153485577|NCT05833529|Cocaine|cocaine|mesh-list
154134241|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134242|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154134243|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154134244|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134245|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134246|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134247|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
154134248|NCT00832442|Protective Agents|protective agents|mesh-ancestor
154134249|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154134250|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134251|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154134256|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154134257|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154134258|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
154134259|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
154134260|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
154134261|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154134262|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154134263|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154134264|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
154134265|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154134266|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134267|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154134268|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154134269|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154134270|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154134271|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134272|NCT00830492|Clomiphene|clomiphene|mesh-list
154134273|NCT00830492|Enclomiphene|enclomiphene|mesh-list
154134274|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
154134275|NCT00830492|Buserelin|buserelin|mesh-list
154134276|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154134277|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
153760030|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153760031|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760032|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760033|NCT00181688|Anastrozole|anastrozole|mesh-list
153760034|NCT00181688|Gefitinib|gefitinib|mesh-list
153485586|NCT05833529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153760035|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153760059|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760060|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760061|NCT00584155|Ofloxacin|ofloxacin|mesh-list
153760062|NCT00584155|Levofloxacin|levofloxacin|mesh-list
153760063|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153760064|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760065|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153760066|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153760067|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153760068|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760069|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760070|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760071|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153760072|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153760073|NCT00411372|Fluticasone|fluticasone|mesh-list
153760075|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153760076|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153760077|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760078|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153760079|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
153760080|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760081|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386547|NCT02318901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134278|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134279|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134280|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154134281|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
154134282|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154134283|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154134284|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154134285|NCT00830570|Warfarin|warfarin|mesh-list
154134286|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
154134287|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
154134288|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154134289|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134290|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134291|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154134292|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417297|NCT05349032|Curcumin|curcumin|mesh-list
153876536|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134293|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154134294|NCT04043702|Topiramate|topiramate|mesh-list
154134295|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
154134296|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134297|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134298|NCT02550080|Dapsone|dapsone|mesh-list
154134299|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134300|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
154134301|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154134302|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154134303|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154134304|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134305|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134308|NCT02547350|Pirarubicin|pirarubicin|mesh-list
154134320|NCT00838214|Hormones|hormones|mesh-ancestor
154134321|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134322|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134323|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154134324|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134325|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154134326|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
154134327|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134328|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154134329|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
154134330|NCT00621764|Vaccines|vaccines|mesh-list
154134331|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
154134332|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134333|NCT00838370|Capecitabine|capecitabine|mesh-list
154134334|NCT00838370|Fluorouracil|fluorouracil|mesh-list
154134335|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154134336|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
154134337|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134338|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134339|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154134340|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
154134341|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134342|NCT00537381|Prednisone|prednisone|mesh-list
154134343|NCT00537381|Docetaxel|docetaxel|mesh-list
154134344|NCT00537381|Intetumumab|intetumumab|mesh-list
154134345|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134346|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
154134347|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
154134348|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
154134349|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134350|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134351|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
153760082|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153760083|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
153760084|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
153760085|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153760086|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153816221|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153816222|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816223|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153816224|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134353|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134354|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134355|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154134356|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154134357|NCT00833300|Haloperidol|haloperidol|mesh-list
154134358|NCT00833300|Olanzapine|olanzapine|mesh-list
154134359|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
154134360|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
154134361|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
154134362|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134363|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134364|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154134365|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154134366|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154134367|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134368|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154134369|NCT00833300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154134370|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154134371|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134372|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134373|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134374|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
154134375|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154134376|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
154134377|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154134378|NCT00833378|Ritonavir|ritonavir|mesh-list
154134379|NCT00833378|Lopinavir|lopinavir|mesh-list
154134380|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154134381|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154134382|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
154134383|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134384|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134391|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154134392|NCT05359341|Empagliflozin|empagliflozin|mesh-list
154134393|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154134394|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
154134395|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134396|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876537|NCT02216747|Prednisone|prednisone|mesh-list
153357249|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357250|NCT01273298|Bisoprolol|bisoprolol|mesh-list
153357251|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153357252|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
153357253|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
153357254|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810612|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153810613|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
153810614|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153810615|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153810616|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153810617|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153810618|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154134397|NCT05359341|Incretins|incretins|mesh-ancestor
154134398|NCT05359341|Hormones|hormones|mesh-ancestor
154134399|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134400|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
154134401|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134402|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134403|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154134404|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154134405|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134406|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134407|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134408|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134409|NCT00838760|Darunavir|darunavir|mesh-list
154134410|NCT00838760|TMC-310911|tmc-310911|mesh-list
154134411|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154134412|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154134413|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
154134414|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134415|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134416|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154134417|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154134418|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
154134419|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134420|NCT03791398|Nivolumab|nivolumab|mesh-list
154134421|NCT03791398|TIC10 compound|tic10 compound|mesh-list
153387030|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153816225|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816226|NCT00465621|Latanoprost|latanoprost|mesh-list
153810620|NCT00346827|Emetics|emetics|mesh-ancestor
153810621|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810622|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
153810623|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810624|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810625|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
153876576|NCT01177540|Decitabine|decitabine|mesh-list
153816227|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153816228|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153816229|NCT00352625|Ketoprofen|ketoprofen|mesh-list
153816230|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153816231|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816232|NCT00352625|Analgesics|analgesics|mesh-ancestor
153816233|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
153816234|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387144|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154134422|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154134423|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134424|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154134425|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134426|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
154134427|NCT00838838|Testosterone|testosterone|mesh-list
154134428|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
154134429|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
154134430|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154134431|NCT00838838|Androgens|androgens|mesh-ancestor
154134432|NCT00838838|Hormones|hormones|mesh-ancestor
154134433|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134434|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134435|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154134436|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134437|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
154134438|NCT05360979|Endostatins|endostatins|mesh-list
154134439|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134440|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154134441|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154134442|NCT05360979|Growth Substances|growth substances|mesh-ancestor
154134443|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134444|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
154134445|NCT00833534|Rituximab|rituximab|mesh-list
154134446|NCT00833534|Lenalidomide|lenalidomide|mesh-list
154134447|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154134448|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134449|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
154134450|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134451|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134452|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154134453|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154134454|NCT00833534|Growth Substances|growth substances|mesh-ancestor
154134455|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
154134457|NCT00517192|Darunavir|darunavir|mesh-list
153816235|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816236|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816237|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387200|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134458|NCT00517192|Tipranavir|tipranavir|mesh-list
154134459|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154134460|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154134461|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
154134462|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134463|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134464|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154134465|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154134466|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
154134467|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134468|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154134469|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154134470|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
154134471|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154134472|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134473|NCT00833768|Sevelamer|sevelamer|mesh-list
154134474|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
154134475|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
154134476|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134477|NCT00510484|Pancrelipase|pancrelipase|mesh-list
154134478|NCT00510484|Pancreatin|pancreatin|mesh-list
154134479|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154134480|NCT00839228|Perhexiline|perhexiline|mesh-list
154134481|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154134482|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134483|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134484|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154134491|NCT00839462|Vitamins|vitamins|mesh-ancestor
154134503|NCT01156389|Pyronaridine|pyronaridine|mesh-list
154134504|NCT01156389|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
154134505|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154134506|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154134507|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
154134508|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134509|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134510|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154134511|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154134512|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
154134513|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134514|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154134515|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154134516|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
154134517|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154134518|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154134519|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134520|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
154134521|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153514904|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
154134523|NCT04043624|Lidocaine|lidocaine|mesh-list
154134524|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
154134525|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
154134526|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134527|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134528|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
154134529|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134530|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154134531|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154134532|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153816238|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153760087|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153760088|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153760089|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
153760090|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760091|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760092|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
153760093|NCT00411372|Hormones|hormones|mesh-ancestor
153760094|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760095|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
153417347|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417348|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153417351|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
153760096|NCT00181922|Ziprasidone|ziprasidone|mesh-list
153760097|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153760098|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
154134533|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134534|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134535|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
154134536|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154134537|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154134538|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134539|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
154134540|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
154134541|NCT03693430|Semaglutide|semaglutide|mesh-list
154134542|NCT03693430|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154134543|NCT03693430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134544|NCT03693430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134545|NCT00625742|Ibuprofen|ibuprofen|mesh-list
154134546|NCT00625742|Atenolol|atenolol|mesh-list
154134547|NCT00625742|Melatonin|melatonin|mesh-list
154134548|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154134549|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154134550|NCT00625742|Analgesics|analgesics|mesh-ancestor
154134551|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
154134552|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134553|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134554|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134555|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134556|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153876588|NCT01177384|Hormones|hormones|mesh-ancestor
153810627|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134557|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134558|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134559|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
154134560|NCT00625742|Protective Agents|protective agents|mesh-ancestor
154134561|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134562|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153387354|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760099|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760100|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760101|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760144|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153760145|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
153760155|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
153760156|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153760157|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760158|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760159|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760160|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153760161|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154134563|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134565|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
154134566|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154134567|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154134568|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154134569|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134570|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134571|NCT05589441|Insulin|insulin|mesh-list
154134572|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154134573|NCT05589441|Albuterol|albuterol|mesh-list
154134574|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134575|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134576|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154134577|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
154134578|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134579|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154134580|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
154134581|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
154134582|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154134583|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153487115|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134584|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154134585|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154134586|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134587|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134588|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134589|NCT00825188|Amlodipine|amlodipine|mesh-list
154134590|NCT00825188|Eplerenone|eplerenone|mesh-list
154134591|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134592|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154134593|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134594|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134595|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153760162|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760163|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760164|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
153760165|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
153760166|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153760167|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153760168|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154134596|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134597|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
154134598|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154134599|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
154134600|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134601|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154134603|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
154134604|NCT00834470|Atropine|atropine|mesh-list
154134605|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154134606|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154134607|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154134608|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
153417371|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153487183|NCT01908972|Hormones|hormones|mesh-ancestor
154134609|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134610|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134611|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154134612|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
154134613|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
154134614|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
154134615|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154134616|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154134617|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
154134618|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134619|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134620|NCT03997864|Prazosin|prazosin|mesh-list
154134621|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134622|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154134623|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154134624|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154134625|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134626|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134627|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134628|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134629|NCT05407467|Curcumin|curcumin|mesh-list
154134630|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153760169|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153816239|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816240|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457566|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469222|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153469223|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153469224|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
153469230|NCT05370885|Vancomycin|vancomycin|mesh-list
153469231|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153469232|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153469233|NCT05335954|Norepinephrine|norepinephrine|mesh-list
153469234|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153469235|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153469236|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
153469237|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469238|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469240|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
154134631|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154134632|NCT05407467|Analgesics|analgesics|mesh-ancestor
154134633|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
154134634|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134635|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134636|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134637|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134638|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134639|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134640|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134641|NCT01010152|Codeine|codeine|mesh-list
154134642|NCT01010152|Analgesics|analgesics|mesh-ancestor
154134643|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
154134644|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134645|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134646|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154134647|NCT01010152|Narcotics|narcotics|mesh-ancestor
154134648|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134649|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
153469263|NCT05305924|Fulvestrant|fulvestrant|mesh-list
153469264|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153469265|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134661|NCT05407155|Bevacizumab|bevacizumab|mesh-list
154134662|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154134663|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134664|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
154134665|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
154134666|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
154134667|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134668|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154134669|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154134670|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154134671|NCT05407155|Growth Substances|growth substances|mesh-ancestor
154134672|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134673|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
154134675|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154134676|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
154134677|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134678|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134679|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154134680|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154134681|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
154134682|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134683|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134685|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154134686|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154134687|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134688|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820711|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154134689|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154134690|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154134700|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134701|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134702|NCT02548286|Amlodipine|amlodipine|mesh-list
154134703|NCT02548286|Candesartan|candesartan|mesh-list
154134704|NCT02548286|Candesartan cilexetil|candesartan cilexetil|mesh-list
154134705|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134706|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154134707|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134708|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134709|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154134710|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134711|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
154134712|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154134713|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154134714|NCT05360433|Oxycodone|oxycodone|mesh-list
154134715|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154134716|NCT05360433|Narcotics|narcotics|mesh-ancestor
154134717|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134718|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134719|NCT05360433|Analgesics|analgesics|mesh-ancestor
154134720|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
154134721|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134722|NCT00834860|Ribavirin|ribavirin|mesh-list
154134723|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154134724|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
154134725|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134726|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
153457567|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457568|NCT01381692|Sirolimus|sirolimus|mesh-list
153457569|NCT01381692|Dexamethasone|dexamethasone|mesh-list
153457570|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
153457571|NCT01381692|Rituximab|rituximab|mesh-list
153457572|NCT01381692|Bortezomib|bortezomib|mesh-list
153457573|NCT01381692|Temsirolimus|temsirolimus|mesh-list
153457574|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153457575|NCT01381692|MTOR Inhibitors|mtor inhibitors|mesh-list
153457576|NCT01381692|Antibodies|antibodies|mesh-list
153457577|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
153457578|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153457580|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
153760170|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760171|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
153760172|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760173|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760174|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153760175|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760176|NCT00585091|Phenylephrine|phenylephrine|mesh-list
153760177|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
153760178|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154134727|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134728|NCT00825422|Ropivacaine|ropivacaine|mesh-list
153876629|NCT01642433|Prazosin|prazosin|mesh-list
154134729|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
154134730|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
154134731|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134732|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134733|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
154134734|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134735|NCT00505414|Morphine|morphine|mesh-list
154134736|NCT00505414|Tapentadol|tapentadol|mesh-list
154134737|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154134738|NCT00505414|Narcotics|narcotics|mesh-ancestor
154134739|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134740|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134741|NCT00505414|Analgesics|analgesics|mesh-ancestor
154134742|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
154134743|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134744|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154134745|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154134746|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134747|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134748|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134749|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134751|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
154134752|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134753|NCT02549924|Protective Agents|protective agents|mesh-ancestor
154134754|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134755|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134756|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154134757|NCT01813227|Dexamethasone|dexamethasone|mesh-list
154134758|NCT01813227|Rituximab|rituximab|mesh-list
154134759|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134760|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
154134761|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
154134762|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469361|NCT05112601|Nivolumab|nivolumab|mesh-list
153760179|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
153760180|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
153760181|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760182|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134763|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134764|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154134765|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
154134766|NCT01813227|Hormones|hormones|mesh-ancestor
154134767|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487418|NCT05738616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487419|NCT05738460|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153487420|NCT05738460|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153487421|NCT05738460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487422|NCT05738460|Antitubercular Agents|antitubercular agents|mesh-ancestor
153487424|NCT05738382|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153487425|NCT05738382|Fertility Agents|fertility agents|mesh-ancestor
153487426|NCT05738382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153487427|NCT05738382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487428|NCT05738382|Hormone Antagonists|hormone antagonists|mesh-ancestor
153487429|NCT05738382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487430|NCT05737680|Hydroxychloroquine|hydroxychloroquine|mesh-list
154134768|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154134769|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134770|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154134771|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
154134772|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134773|NCT01012882|Immunomodulating Agents|immunomodulating agents|mesh-list
154134774|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
154134775|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134776|NCT00989469|Irinotecan|irinotecan|mesh-list
154134777|NCT00989469|Sorafenib|sorafenib|mesh-list
154134778|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154134779|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154134780|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134781|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134782|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134783|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154134784|NCT01010308|Nadolol|nadolol|mesh-list
154134785|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154134786|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154134787|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134788|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134789|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760183|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
153760184|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153760200|NCT00585442|Vitamin D|vitamin d|mesh-list
153760229|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760230|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760231|NCT00209547|Fospropofol|fospropofol|mesh-list
153760232|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153760233|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760234|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760235|NCT00585871|Metoprolol|metoprolol|mesh-list
153760236|NCT00585871|Clonidine|clonidine|mesh-list
153760237|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153760238|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153760239|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
153760240|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
153760241|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760242|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760243|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153760244|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154134790|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134791|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154134792|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134794|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
154134795|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134796|NCT02548052|Betamethasone|betamethasone|mesh-list
154134797|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
154134798|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154134799|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
154134800|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154134801|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134802|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
154134803|NCT02548052|Hormones|hormones|mesh-ancestor
154134804|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134805|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134806|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154134807|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
154134808|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
154134809|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154134810|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154134811|NCT04590417|Estradiol|estradiol|mesh-list
154134812|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154134813|NCT04590417|Cyproterone|cyproterone|mesh-list
153760245|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153760246|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
153760247|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760248|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760249|NCT00585871|Analgesics|analgesics|mesh-ancestor
153760250|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
153760251|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153760252|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153760253|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153760254|NCT03452722|Plasminogen|plasminogen|mesh-list
153760255|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153760256|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153760257|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153760258|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760271|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760272|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153760274|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153760275|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153760276|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760277|NCT00408551|Antidotes|antidotes|mesh-ancestor
153760278|NCT00408551|Protective Agents|protective agents|mesh-ancestor
153760279|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
153760281|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
153357257|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153760282|NCT04575415|Bevacizumab|bevacizumab|mesh-list
153760283|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153760284|NCT04575415|Gefitinib|gefitinib|mesh-list
153760285|NCT04575415|Osimertinib|osimertinib|mesh-list
153760286|NCT04575415|Afatinib|afatinib|mesh-list
153760333|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134814|NCT04590417|Estrogens|estrogens|mesh-ancestor
154134815|NCT04590417|Hormones|hormones|mesh-ancestor
154134816|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134817|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134818|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154134820|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154134821|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154134822|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
154134823|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
154134824|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134825|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154134826|NCT00825656|Capsaicin|capsaicin|mesh-list
154134827|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
154134828|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
154134829|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
154134830|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134831|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134832|NCT00989625|Naproxen|naproxen|mesh-list
154134833|NCT00989625|Sumatriptan|sumatriptan|mesh-list
154134834|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154134835|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154134836|NCT00989625|Analgesics|analgesics|mesh-ancestor
154134837|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
154134838|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134839|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134840|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134841|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134842|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
154134843|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154134844|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134845|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134846|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154134847|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153760334|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153760335|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760336|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153760337|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153760338|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
153760339|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760340|NCT00209664|Irinotecan|irinotecan|mesh-list
153760341|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154134848|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154134849|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
154134850|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134851|NCT00841256|Glycerol|glycerol|mesh-list
154134852|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154134853|NCT00841256|Protective Agents|protective agents|mesh-ancestor
154134854|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134855|NCT00989703|Methotrexate|methotrexate|mesh-list
154134856|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154134857|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
154134858|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154134859|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134860|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154134861|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
154134862|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134863|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810632|NCT00346866|Growth Substances|growth substances|mesh-ancestor
153810633|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876671|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
154134864|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
154134865|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134866|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154134867|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153760342|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153760343|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760346|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
153760396|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
153760397|NCT00209703|Vitamins|vitamins|mesh-ancestor
153760398|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
153760399|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
153760400|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153760401|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760402|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760403|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760404|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
153760405|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153760406|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760459|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
153760460|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760461|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760462|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153760464|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153760465|NCT00216684|Narcotics|narcotics|mesh-ancestor
153760466|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760467|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760468|NCT00216684|Analgesics|analgesics|mesh-ancestor
153760469|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
153760470|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760471|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153760472|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153760473|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
153760474|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
153760475|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
153760476|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153760477|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153760478|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760514|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154134868|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
154134869|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134870|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154134871|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
154134872|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154134873|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134874|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
154134875|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154134876|NCT02547116|Rifampin|rifampin|mesh-list
154134877|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154134878|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
154134879|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154134880|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134881|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
154134882|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154134883|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134884|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134885|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154134886|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154134887|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154134888|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154134889|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153458411|NCT04026282|Hormones|hormones|mesh-ancestor
154134890|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154134891|NCT02549690|Testosterone|testosterone|mesh-list
154134892|NCT02549690|Androgens|androgens|mesh-ancestor
154134893|NCT02549690|Hormones|hormones|mesh-ancestor
154134894|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134895|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134896|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
154134897|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154134898|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154134901|NCT02549768|Analgesics|analgesics|mesh-ancestor
154134906|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154134907|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
154134908|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154134909|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134910|NCT00841724|Fludarabine|fludarabine|mesh-list
154134911|NCT00841724|Busulfan|busulfan|mesh-list
154134912|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
154134913|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134914|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134915|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154134916|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
154134917|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134918|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
154134919|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154134920|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154134921|NCT00843362|Dinoprostone|dinoprostone|mesh-list
154134922|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
154134923|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154134924|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134925|NCT00841802|Prednisone|prednisone|mesh-list
154134926|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
153810636|NCT00320723|Bupropion|bupropion|mesh-list
154134927|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134928|NCT00841802|Hormones|hormones|mesh-ancestor
154134929|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154134930|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134931|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154134932|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134933|NCT00621140|Linagliptin|linagliptin|mesh-list
154134950|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134951|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154134952|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154134953|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154134954|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154134955|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154134956|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134957|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
154134958|NCT00843440|Bevacizumab|bevacizumab|mesh-list
154134959|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154134960|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134961|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154134962|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153515352|NCT01428908|Vaccines|vaccines|mesh-list
154134963|NCT00843440|Growth Substances|growth substances|mesh-ancestor
154134964|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134965|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
154134967|NCT00504556|Edoxaban|edoxaban|mesh-list
154134968|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
154134969|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154134970|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
154134971|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154134972|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
154134973|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154134974|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134975|NCT00206323|Topiramate|topiramate|mesh-list
154134976|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
154134977|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154134978|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876718|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
153876739|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
154134979|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
154134980|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154134981|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154134982|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
154134983|NCT00842114|Interferons|interferons|mesh-list
154134984|NCT00842114|Prednisone|prednisone|mesh-list
154134985|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
154134986|NCT00842114|Vincristine|vincristine|mesh-list
154134987|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154134988|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
154134989|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154134990|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154134991|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154134992|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
154134993|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154134994|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154134995|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154134996|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154134997|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
154134999|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135000|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154135001|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
154135002|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135003|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154135004|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
154135005|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
154135006|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
154135007|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
154135008|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154135009|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135010|NCT00536991|Calcitriol|calcitriol|mesh-list
154135011|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
154135012|NCT00536991|Ketoconazole|ketoconazole|mesh-list
154135013|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
154135014|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154135015|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154135016|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154135017|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135018|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
153360170|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
153760515|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
153760516|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153760517|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
153760518|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760519|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
153760520|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153760521|NCT00216723|Aripiprazole|aripiprazole|mesh-list
153760522|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
153760523|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760524|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153760539|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
154135019|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135020|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154135021|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154135023|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135024|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154135025|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
154135026|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135027|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135028|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153487666|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135029|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154135030|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154135031|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154135032|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154135033|NCT00536991|Vitamins|vitamins|mesh-ancestor
154135034|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
154135035|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154135036|NCT00504166|Alendronate|alendronate|mesh-list
154135037|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154135038|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135039|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
154135040|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154135041|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154135042|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154135044|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135045|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154135046|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154135047|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135048|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154135049|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154135052|NCT00842504|Micafungin|micafungin|mesh-list
154135060|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135062|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
154135063|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135064|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135065|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135066|NCT00842660|Gemcitabine|gemcitabine|mesh-list
154135067|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135068|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
154135069|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135070|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135071|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154135072|NCT00509236|Glipizide|glipizide|mesh-list
154135073|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154135074|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135075|NCT00509236|Incretins|incretins|mesh-ancestor
154135076|NCT00509236|Hormones|hormones|mesh-ancestor
154135077|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135078|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154135079|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
154135080|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135081|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135082|NCT00842894|Insulin|insulin|mesh-list
153487750|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153487751|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153487752|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487753|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487754|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487755|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487756|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
153487757|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
153487758|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487772|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153487802|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135083|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154135084|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
154135085|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
154135086|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
153760572|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
153760573|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
153760574|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153760575|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153760576|NCT00182663|Growth Substances|growth substances|mesh-ancestor
153760577|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
153760578|NCT00216762|Rituximab|rituximab|mesh-list
153760579|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153760580|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760581|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
153760582|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760583|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153760584|NCT00182702|Epothilones|epothilones|mesh-list
153760585|NCT00182702|Epothilone B|epothilone b|mesh-list
153760586|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
153760587|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153760588|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153760589|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760590|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760591|NCT00588835|Dexamethasone|dexamethasone|mesh-list
153760592|NCT00588835|Ondansetron|ondansetron|mesh-list
153760593|NCT00588835|Aprepitant|aprepitant|mesh-list
154135087|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154135088|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154135089|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135090|NCT00508924|Heparin|heparin|mesh-list
154135091|NCT00508924|Argatroban|argatroban|mesh-list
154135092|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
154135093|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154135094|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154135095|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135096|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
154135097|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154135098|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
153487863|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357263|NCT01270802|Emtricitabine|emtricitabine|mesh-list
153487864|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153487865|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
153487876|NCT02025426|Ephedrine|ephedrine|mesh-list
153487877|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153487878|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
153487879|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
153878948|NCT03202628|Hormones|hormones|mesh-ancestor
153487880|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487881|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135099|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135100|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154135101|NCT00836576|Benazepril|benazepril|mesh-list
153487911|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153487912|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154135102|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153731300|NCT00153543|Vaccines|vaccines|mesh-list
154135103|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
154135104|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135105|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135106|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154135108|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154135109|NCT00844064|Trabedersen|trabedersen|mesh-list
154135110|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135111|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
154135112|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
154135113|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153760594|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760595|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
153760596|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
153760597|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760598|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760599|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153760600|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
153760601|NCT00588835|Hormones|hormones|mesh-ancestor
153760602|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760605|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
153760617|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153760618|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
153760619|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153760620|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760621|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153760623|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760624|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760625|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
153760626|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760627|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153760628|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135114|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135115|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135116|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
154135117|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154135118|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135119|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135120|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
154135122|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154135123|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154135124|NCT00844142|Analgesics|analgesics|mesh-ancestor
154135125|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
154135126|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135127|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135128|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135129|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135130|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154135131|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135132|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
154135133|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135134|NCT00837044|Naproxen|naproxen|mesh-list
154135135|NCT00837044|Sumatriptan|sumatriptan|mesh-list
154135136|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154135137|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154135138|NCT00837044|Analgesics|analgesics|mesh-ancestor
154135139|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
153760629|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
153760630|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153760631|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153760632|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
153760633|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760634|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153760635|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760636|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
153760637|NCT00209859|Hormones|hormones|mesh-ancestor
153760638|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760639|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153760640|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
153760641|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
153760642|NCT00588913|Aldesleukin|aldesleukin|mesh-list
153760643|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760659|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760660|NCT00182741|Analgesics|analgesics|mesh-ancestor
153760661|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
153597797|NCT01871480|Gefitinib|gefitinib|mesh-list
153760662|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760674|NCT00589186|Celecoxib|celecoxib|mesh-list
153760699|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760700|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760701|NCT00216840|Betamethasone|betamethasone|mesh-list
153760702|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
154135140|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135141|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135142|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135143|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135144|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
154135145|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154135146|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135147|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135148|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154135149|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154135150|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154135151|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
154135152|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135153|NCT01013272|Lamivudine|lamivudine|mesh-list
154135154|NCT01013272|Entecavir|entecavir|mesh-list
154135155|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154135156|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154135157|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135158|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135159|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
154135160|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135161|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154135162|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154135163|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
154135164|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154135165|NCT01010698|Acyclovir|acyclovir|mesh-list
154135166|NCT01010698|Cimetidine|cimetidine|mesh-list
154135167|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
154135168|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135169|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154135170|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154135171|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154135172|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
153760703|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153760704|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
153760705|NCT00216840|Calcipotriene|calcipotriene|mesh-list
153760706|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153760707|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760708|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
153760709|NCT00216840|Hormones|hormones|mesh-ancestor
153760710|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760711|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760712|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153469912|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
153810642|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153488017|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153488018|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135173|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
154135174|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135175|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135176|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135177|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154135178|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154135179|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135180|NCT03541486|Gemcitabine|gemcitabine|mesh-list
154135181|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135182|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
154135183|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135184|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135186|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154135187|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154135188|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135189|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
154135190|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135191|NCT02547896|Diclofenac|diclofenac|mesh-list
154135192|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154135193|NCT02547896|Codeine|codeine|mesh-list
154135194|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154135195|NCT02547896|Analgesics|analgesics|mesh-ancestor
154135196|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
154135197|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135198|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135199|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135200|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135201|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154135202|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135203|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135204|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154135205|NCT02547896|Narcotics|narcotics|mesh-ancestor
154135206|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760713|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
153760714|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
153760715|NCT00589732|Valsartan|valsartan|mesh-list
154135207|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
154135208|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
154135209|NCT01564251|Gemcitabine|gemcitabine|mesh-list
154135210|NCT01564251|GDC-0575|gdc-0575|mesh-list
154135211|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135212|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
154135213|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135214|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135215|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135216|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135217|NCT00508144|Pemetrexed|pemetrexed|mesh-list
154135218|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135219|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135220|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135221|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154135222|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154135223|NCT00844454|Ethanol|ethanol|mesh-list
154135224|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154135225|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810643|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153876811|NCT06032039|Hormones|hormones|mesh-ancestor
154135226|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135227|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135228|NCT02545712|Ethanol|ethanol|mesh-list
154135229|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
154135230|NCT02545712|Sorbitol|sorbitol|mesh-list
154135231|NCT02545712|Glycerol|glycerol|mesh-list
154135232|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154135233|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135234|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135235|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135236|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154135237|NCT02545712|Protective Agents|protective agents|mesh-ancestor
154135238|NCT02545712|Cathartics|cathartics|mesh-ancestor
154135239|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154135240|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
153760716|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153760717|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153760718|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153760719|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760720|NCT00216879|Betamethasone|betamethasone|mesh-list
153760721|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
153760723|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
154135241|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
154135242|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
154135243|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135244|NCT01011010|Doxorubicin|doxorubicin|mesh-list
154135245|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154135246|NCT01011010|Mitomycins|mitomycins|mesh-list
154135247|NCT01011010|Mitomycin|mitomycin|mesh-list
154135248|NCT01011010|Sorafenib|sorafenib|mesh-list
154135249|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154135250|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135251|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154135252|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154135253|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135254|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876829|NCT06048913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154135255|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135256|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
154135257|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154135258|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
154135259|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154135260|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
154135261|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135262|NCT00851708|Expectorants|expectorants|mesh-ancestor
154135263|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
154135264|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154135265|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
154135266|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135267|NCT00851708|Protective Agents|protective agents|mesh-ancestor
153760747|NCT00589927|Protective Agents|protective agents|mesh-ancestor
153760748|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153760749|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153760750|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760751|NCT00209937|Gaboxadol|gaboxadol|mesh-list
153760752|NCT00209937|Analgesics|analgesics|mesh-ancestor
153760753|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
153760754|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760755|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760756|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
153760757|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
153760758|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
153760759|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760760|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760761|NCT00590278|Raltitrexed|raltitrexed|mesh-list
153760808|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
153760810|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153760811|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153760812|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
153760813|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760814|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760815|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154135268|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135269|NCT00851708|Antidotes|antidotes|mesh-ancestor
154135270|NCT01011166|Ribavirin|ribavirin|mesh-list
154135271|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154135272|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
154135273|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135274|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
154135275|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135276|NCT00621842|Lamotrigine|lamotrigine|mesh-list
154135277|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
154135278|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154135279|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154135280|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135281|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154135282|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135283|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154135284|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154135285|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135286|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154135287|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154135288|NCT04849455|Morphine|morphine|mesh-list
154135289|NCT04849455|Ropivacaine|ropivacaine|mesh-list
154135290|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
154135291|NCT04849455|Anesthetics|anesthetics|mesh-list
154135292|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154135293|NCT04849455|Narcotics|narcotics|mesh-ancestor
154135294|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135295|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135296|NCT04849455|Analgesics|analgesics|mesh-ancestor
154135297|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
154135298|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135299|NCT02545010|Paclitaxel|paclitaxel|mesh-list
154135300|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153760816|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153760817|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153760818|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153760819|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760820|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153760821|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
153760822|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760823|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153760832|NCT00477295|Zonisamide|zonisamide|mesh-list
154135301|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135302|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
153876853|NCT06048367|Trace Elements|trace elements|mesh-ancestor
154135303|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
154135304|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
154135305|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135306|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154135307|NCT01013506|Letrozole|letrozole|mesh-list
154135308|NCT01013506|Goserelin|goserelin|mesh-list
154135309|NCT01013506|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154135310|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135311|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135312|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135313|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135314|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154135315|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154135316|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154135317|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
154135318|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135319|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135320|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154135321|NCT00844688|Gemcitabine|gemcitabine|mesh-list
154135323|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135324|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
154135325|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135326|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135327|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135328|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135329|NCT04541680|Nintedanib|nintedanib|mesh-list
154135330|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135331|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135332|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135334|NCT00855530|Amibegron|amibegron|mesh-list
154135341|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135342|NCT00855530|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154135343|NCT00855608|Adalimumab|adalimumab|mesh-list
154135344|NCT00855608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154135345|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135346|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135347|NCT00851864|Tinzaparin|tinzaparin|mesh-list
154135348|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154135349|NCT00851864|Dalteparin|dalteparin|mesh-list
154135350|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
154135351|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154135352|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154135353|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135354|NCT00851942|Cosyntropin|cosyntropin|mesh-list
154135355|NCT00851942|Hormones|hormones|mesh-ancestor
154135356|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135357|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135358|NCT00503776|Amifostine|amifostine|mesh-list
154135359|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154135360|NCT00503776|Protective Agents|protective agents|mesh-ancestor
154135361|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135362|NCT02545634|Sulfalene|sulfalene|mesh-list
154135363|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135364|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154135365|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
154135366|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154135367|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154135368|NCT00855686|Memantine|memantine|mesh-list
154135369|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154135370|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154135371|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
154135372|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135373|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135374|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135381|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135382|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
154135383|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
154135384|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135385|NCT00845156|Protective Agents|protective agents|mesh-ancestor
154135386|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135387|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
154135388|NCT00845156|Vitamins|vitamins|mesh-ancestor
154135389|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
154135390|NCT00852332|Curcumin|curcumin|mesh-list
154135391|NCT00852332|Docetaxel|docetaxel|mesh-list
154135392|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135393|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
154135394|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
154135395|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
154135396|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135397|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154135398|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154135399|NCT00852332|Analgesics|analgesics|mesh-ancestor
154135400|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
154135401|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135402|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135403|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135404|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135405|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135406|NCT00852410|Lidocaine|lidocaine|mesh-list
153488227|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135407|NCT00852410|Epinephrine|epinephrine|mesh-list
154135408|NCT00852410|Racepinephrine|racepinephrine|mesh-list
154135409|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
154135410|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
154135411|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
154135412|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135413|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135414|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
154135415|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135417|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154135418|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153760863|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153760864|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760865|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154135419|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154135420|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135421|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154135422|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154135423|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
154135424|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135425|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154135426|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154135427|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
154135428|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154135429|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
154135430|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
154135431|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
154135432|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154135433|NCT00992121|Bevacizumab|bevacizumab|mesh-list
154135434|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154135435|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135436|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154135437|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154135438|NCT00992121|Growth Substances|growth substances|mesh-ancestor
154135439|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135440|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
153876857|NCT06047860|Endostatins|endostatins|mesh-list
153488321|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153488347|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153488348|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153488349|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488350|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488351|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153488352|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154135441|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154135443|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
154135444|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154135445|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154135446|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135447|NCT00992199|Fluorouracil|fluorouracil|mesh-list
154135448|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135449|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
154135451|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135461|NCT02773485|Cisplatin|cisplatin|mesh-list
154135462|NCT02773485|Gemcitabine|gemcitabine|mesh-list
154135463|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135464|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135465|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
154135466|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135467|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
154135468|NCT04042220|Hormones|hormones|mesh-ancestor
154135469|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135470|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135471|NCT00992355|Tobramycin|tobramycin|mesh-list
154135472|NCT00992355|Dexamethasone|dexamethasone|mesh-list
154135473|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
154135474|NCT00992355|Ketorolac|ketorolac|mesh-list
154135475|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154135476|NCT00992355|BB 1101|bb 1101|mesh-list
154135477|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135478|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
154135479|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
154135480|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135481|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135482|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154135483|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
154135484|NCT00992355|Hormones|hormones|mesh-ancestor
154135485|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135486|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154135487|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135488|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
153515875|NCT01432106|Valsartan|valsartan|mesh-list
154135489|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135490|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135491|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154135492|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153760866|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153760867|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153760869|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
153760870|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153760871|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153760872|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153760873|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760874|NCT00476593|Cathartics|cathartics|mesh-ancestor
153760875|NCT00210132|Ropivacaine|ropivacaine|mesh-list
153470408|NCT02379377|Fluorides|fluorides|mesh-list
154135494|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
154135495|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135496|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154135497|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154135498|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135499|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
154135500|NCT00852566|Dasatinib|dasatinib|mesh-list
154135501|NCT00852566|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153810646|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810647|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153488425|NCT02233296|Lasmiditan|lasmiditan|mesh-list
154135502|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135503|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135504|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135505|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135506|NCT00856622|Timolol|timolol|mesh-list
154135507|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154135508|NCT00856622|Latanoprost|latanoprost|mesh-list
154135509|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154135510|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154135511|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154135512|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
154135513|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135514|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135515|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135516|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154135517|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154135518|NCT00856700|Incretins|incretins|mesh-list
154135519|NCT00856700|Hormones|hormones|mesh-ancestor
154135520|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135521|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135522|NCT00618956|Milnacipran|milnacipran|mesh-list
154135523|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
154135524|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154135525|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154135526|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154135527|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135529|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135530|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154135531|NCT00618956|Analgesics|analgesics|mesh-ancestor
154135532|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
154135533|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135534|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
154135535|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154135536|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154135537|NCT00845546|Loratadine|loratadine|mesh-list
154135538|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
154135539|NCT00845546|Ephedrine|ephedrine|mesh-list
154135540|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
154135541|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
154135542|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154135543|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154135544|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154135545|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
154135546|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
154135547|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135548|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135549|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135550|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154135551|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
154135552|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135553|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154135554|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
154135555|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
154135556|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154135557|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154135558|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
154135559|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
154135560|NCT00852956|Betahistine|betahistine|mesh-list
154135561|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
153470481|NCT01711554|Vitamin A|vitamin a|mesh-list
153760923|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
153760924|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153760925|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153488501|NCT02251236|Tenofovir|tenofovir|mesh-list
153760926|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153760927|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153760928|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760929|NCT00476086|Gemcitabine|gemcitabine|mesh-list
154135562|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
154135564|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135565|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135566|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135567|NCT00716417|Afatinib|afatinib|mesh-list
154135568|NCT00716417|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154135569|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135570|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135571|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135572|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135573|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
154135574|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154135575|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135576|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135577|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154135578|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154135579|NCT02592863|Protective Agents|protective agents|mesh-ancestor
154135580|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135581|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
154135582|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154135583|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
154135584|NCT00719537|Aspirin|aspirin|mesh-list
154135585|NCT00719537|Progesterone|progesterone|mesh-list
154135586|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154135587|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154135588|NCT00719537|Analgesics|analgesics|mesh-ancestor
154135589|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
154135590|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470521|NCT01475123|Vitamins|vitamins|mesh-ancestor
153760930|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
153760931|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153417634|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
153417635|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417636|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417637|NCT00372008|Testosterone|testosterone|mesh-list
153417638|NCT00372008|Androgens|androgens|mesh-ancestor
153417640|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488604|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488605|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488606|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153488607|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153488608|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153488609|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
153488610|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
153488612|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153760932|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
153760933|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760934|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760935|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
153760936|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760937|NCT00217191|Ibuprofen|ibuprofen|mesh-list
153760938|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153760980|NCT00183911|Floxuridine|floxuridine|mesh-list
153760981|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
153760982|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760983|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135591|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135592|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135594|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154135595|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154135596|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135597|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154135598|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154135599|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135600|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
154135601|NCT00719537|Progestins|progestins|mesh-ancestor
154135602|NCT00719537|Hormones|hormones|mesh-ancestor
154135603|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135604|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
154135605|NCT00853190|Hydrocodone|hydrocodone|mesh-list
154135606|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135607|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154135608|NCT00853190|Narcotics|narcotics|mesh-ancestor
154135609|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135610|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135611|NCT00853190|Analgesics|analgesics|mesh-ancestor
154135612|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
154135613|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135614|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
154135615|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
154135616|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
154135617|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
154135618|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154135619|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
153470589|NCT00565266|Hormones|hormones|mesh-ancestor
153760984|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760985|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153760986|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
153760987|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876872|NCT06047860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760988|NCT00183911|Antidotes|antidotes|mesh-ancestor
153760989|NCT00183911|Protective Agents|protective agents|mesh-ancestor
153760990|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
153760991|NCT00183911|Vitamins|vitamins|mesh-ancestor
153760992|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
153760993|NCT00412152|Oxycodone|oxycodone|mesh-list
153760994|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153761043|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
153761044|NCT00210366|Idarubicin|idarubicin|mesh-list
153761045|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153761046|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761047|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154135620|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
154135621|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135622|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154135623|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
154135624|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
154135625|NCT00573794|Adalimumab|adalimumab|mesh-list
154135626|NCT00573794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154135627|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135628|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135629|NCT00715793|Temozolomide|temozolomide|mesh-list
154135630|NCT00715793|Decitabine|decitabine|mesh-list
154135631|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154135632|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
154135633|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135634|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135635|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135636|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
154135637|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135638|NCT00924014|Furosemide|furosemide|mesh-list
154135639|NCT00924014|Conivaptan|conivaptan|mesh-list
154135640|NCT00924014|Diuretics|diuretics|mesh-ancestor
154135641|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
154135642|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135643|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154135644|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154135645|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135646|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154135648|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154135649|NCT00853268|Narcotics|narcotics|mesh-ancestor
154135650|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135651|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135652|NCT00853268|Analgesics|analgesics|mesh-ancestor
154135653|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
154135654|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135655|NCT00845780|Amiodarone|amiodarone|mesh-list
154135656|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154135657|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
153470598|NCT05363202|Xhance|xhance|mesh-list
154135659|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154135660|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135661|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154135662|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154135663|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154135664|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135665|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154135666|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154135667|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154135668|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
154135669|NCT00853502|Testosterone|testosterone|mesh-list
154135670|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
154135671|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
154135672|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154135673|NCT00853502|Androgens|androgens|mesh-ancestor
154135674|NCT00853502|Hormones|hormones|mesh-ancestor
153455655|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810648|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
153357270|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135675|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135676|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135677|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154135678|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135679|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
154135680|NCT00853736|Oxycodone|oxycodone|mesh-list
154135681|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154135682|NCT00853736|Narcotics|narcotics|mesh-ancestor
154135683|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135684|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135685|NCT00853736|Analgesics|analgesics|mesh-ancestor
154135686|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
154135687|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135688|NCT00857168|Testosterone|testosterone|mesh-list
154135689|NCT00857168|Androgens|androgens|mesh-ancestor
154135690|NCT00857168|Hormones|hormones|mesh-ancestor
154135691|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135692|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135693|NCT00857324|Vorinostat|vorinostat|mesh-list
153470698|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470699|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470700|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470701|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153470702|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153470703|NCT01797666|Pioglitazone|pioglitazone|mesh-list
153470704|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153470705|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470706|NCT05017194|Emodepside|emodepside|mesh-list
154135696|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135697|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135698|NCT00853892|Oxycodone|oxycodone|mesh-list
154135699|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154135700|NCT00853892|Narcotics|narcotics|mesh-ancestor
154135701|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135702|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135703|NCT00853892|Analgesics|analgesics|mesh-ancestor
154135704|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
154135705|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135706|NCT00857558|Saxagliptin|saxagliptin|mesh-list
154135707|NCT00857558|Incretins|incretins|mesh-ancestor
154135708|NCT00857558|Hormones|hormones|mesh-ancestor
154135709|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135710|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135711|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154135712|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
154135713|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135714|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135715|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154135716|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154135717|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
154135729|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135730|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154135731|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135732|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
154135733|NCT05684861|Isotretinoin|isotretinoin|mesh-list
154135734|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
154135735|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
154135736|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153488913|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
154135737|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154135738|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135739|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
154135740|NCT04042688|Coagulants|coagulants|mesh-ancestor
154135741|NCT02590133|Fluorouracil|fluorouracil|mesh-list
154135742|NCT02590133|Endostar protein|endostar protein|mesh-list
154135743|NCT02590133|Endostatins|endostatins|mesh-list
154135744|NCT02590133|Nedaplatin|nedaplatin|mesh-list
154135745|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
154135746|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135747|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135748|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135749|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135750|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
154135751|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135752|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154135753|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154135754|NCT02590133|Growth Substances|growth substances|mesh-ancestor
154135755|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
154135756|NCT00854204|Darunavir|darunavir|mesh-list
154135757|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154135758|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154135759|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
154135774|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135775|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135776|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154135777|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154135778|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135779|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154135780|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154135781|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
154135782|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154135783|NCT00854750|Hormones|hormones|mesh-ancestor
154135784|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135785|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135786|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154135787|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
154135788|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154135789|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135790|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
154135791|NCT00858338|Floxuridine|floxuridine|mesh-list
154135792|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135793|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
154135794|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135795|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135796|NCT00515086|Everolimus|everolimus|mesh-list
154135797|NCT00515086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153470794|NCT01798914|Insulin|insulin|mesh-list
153761048|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761049|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761050|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761051|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
153761052|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153761053|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153761054|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153761055|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153457316|NCT01422876|Linagliptin|linagliptin|mesh-list
153761057|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
153761101|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761102|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761103|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
153761104|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761105|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761106|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153761107|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761108|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
153761109|NCT00475306|Promethazine|promethazine|mesh-list
153810649|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761110|NCT00475306|Metoclopramide|metoclopramide|mesh-list
153761111|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153761112|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153761116|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
153761162|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154135798|NCT00515086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135799|NCT00515086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135800|NCT00515086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135801|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135802|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
154135803|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135804|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135805|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
154135806|NCT00858806|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154135807|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135808|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135809|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135810|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135811|NCT00849368|Azathioprine|azathioprine|mesh-list
154135812|NCT00849368|Allopurinol|allopurinol|mesh-list
154135813|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
154135814|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470824|NCT05097846|Antacids|antacids|mesh-ancestor
153761163|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761164|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761165|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761166|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
153761167|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761168|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153761169|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
153761170|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761171|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153761172|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153761173|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761174|NCT00210483|Almotriptan|almotriptan|mesh-list
153417651|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417652|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
153417653|NCT05339581|Tislelizumab|tislelizumab|mesh-list
153417654|NCT05339581|Lenvatinib|lenvatinib|mesh-list
153417655|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153417656|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417657|NCT05339581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153417658|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417659|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153417660|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761175|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153761180|NCT00210561|Acetaminophen|acetaminophen|mesh-list
153761222|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761223|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153761224|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153761225|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153761226|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153761227|NCT00217503|Growth Substances|growth substances|mesh-ancestor
153761228|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
153761229|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153761230|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153761231|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761232|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761233|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153761234|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
153761235|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153761283|NCT00217659|Anastrozole|anastrozole|mesh-list
153761284|NCT00217659|Goserelin|goserelin|mesh-list
153761285|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153761286|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761287|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153761288|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153761289|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761290|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135815|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135816|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
154135817|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154135818|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154135819|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
154135820|NCT00849368|Protective Agents|protective agents|mesh-ancestor
154135821|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810650|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153357272|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153876904|NCT06046963|Paclitaxel|paclitaxel|mesh-list
153810651|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153357273|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154135822|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135823|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135824|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135825|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
154135826|NCT02544932|Warfarin|warfarin|mesh-list
154135827|NCT02544932|Dabigatran|dabigatran|mesh-list
154135828|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
154135829|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
154135830|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154135831|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
154135832|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135833|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135834|NCT02544854|Propofol|propofol|mesh-list
154135835|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154135836|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154135837|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135838|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154135839|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
154135840|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
154135841|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
154135842|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
154135843|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135844|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135845|NCT02544776|Amlodipine|amlodipine|mesh-list
154135846|NCT02544776|Clomiphene|clomiphene|mesh-list
153761291|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153761292|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
153761293|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761295|NCT00184574|Metformin|metformin|mesh-list
153761349|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153761350|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153761351|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
153761352|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761353|NCT00184847|Analgesics|analgesics|mesh-ancestor
153761354|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
153761355|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761356|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153761357|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
154135847|NCT02544776|Enclomiphene|enclomiphene|mesh-list
154135848|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
154135849|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135850|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154135851|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154135852|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154135853|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154135854|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135855|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
154135856|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154135857|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
154135858|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135859|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154135860|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
154135861|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154135862|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154135863|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154135865|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135866|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135867|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135868|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135869|NCT00849602|Chloroquine|chloroquine|mesh-list
154135870|NCT00849602|Amebicides|amebicides|mesh-ancestor
154135871|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154135872|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154135873|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135894|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154135895|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154135896|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
154135897|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
154135898|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
154135899|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
154135900|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135901|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135902|NCT00861926|Beclomethasone|beclomethasone|mesh-list
154135903|NCT00861926|Albuterol|albuterol|mesh-list
154135904|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
154135905|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154135906|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
154135907|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135908|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135909|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154135910|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
154135911|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154135912|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154135913|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154135914|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
154135915|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135916|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135917|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
154135918|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154135919|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135920|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
154135921|NCT00861926|Hormones|hormones|mesh-ancestor
154135922|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154135923|NCT00849992|Imiquimod|imiquimod|mesh-list
154135924|NCT00849992|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154135925|NCT00849992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135926|NCT00849992|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154135927|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
154135928|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135929|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154135931|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
154135932|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
154135933|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
154135934|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154135936|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
154135937|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135938|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
154135939|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153516334|NCT01435213|Insulin|insulin|mesh-list
154135940|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
154135941|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154135942|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135943|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154135944|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
154135945|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154135946|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154135947|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154135948|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
154135949|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135950|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135951|NCT00862472|Timolol|timolol|mesh-list
154135952|NCT00862472|Cloprostenol|cloprostenol|mesh-list
154135953|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
154135954|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154135955|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
154135956|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154135957|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417679|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154135958|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154135959|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154135960|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154135961|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
154135962|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154135963|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135964|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154135965|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154135966|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
154135968|NCT00850382|Cytarabine|cytarabine|mesh-list
154135969|NCT00850382|Daunorubicin|daunorubicin|mesh-list
154135970|NCT00850382|Dasatinib|dasatinib|mesh-list
154135971|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154135972|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
154135973|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135974|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154135975|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
154135976|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154135977|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154135978|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
154135979|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135980|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154135981|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154135982|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154135983|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154135984|NCT00850382|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154135985|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154135986|NCT00860366|Uric Acid|uric acid|mesh-list
154135987|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
154135988|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135989|NCT00860366|Protective Agents|protective agents|mesh-ancestor
154135990|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135991|NCT00862628|Rebamipide|rebamipide|mesh-list
154135992|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154135993|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154135994|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
154135995|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154135996|NCT00862628|Protective Agents|protective agents|mesh-ancestor
154135997|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154135998|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136000|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
154136001|NCT00507442|Lenalidomide|lenalidomide|mesh-list
154136002|NCT00507442|Bortezomib|bortezomib|mesh-list
154136003|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136004|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
154136005|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136006|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136007|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154136008|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
154136009|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136010|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136011|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154136012|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136013|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
153516402|NCT01435486|Caffeine|caffeine|mesh-list
154136014|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
154136015|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136016|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154136017|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
154136018|NCT00507442|Hormones|hormones|mesh-ancestor
154136019|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136020|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154136021|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154136022|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154136023|NCT00507442|Growth Substances|growth substances|mesh-ancestor
154136024|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
154136025|NCT00862706|Telbivudine|telbivudine|mesh-list
154136026|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
154136027|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136028|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154136029|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136030|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136031|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154136032|NCT04041362|UB-421|ub-421|mesh-list
154136033|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
154136034|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136035|NCT00850850|Physostigmine|physostigmine|mesh-list
154136036|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154136042|NCT00850850|Miotics|miotics|mesh-ancestor
154136047|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154136048|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154136049|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154136050|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136051|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136052|NCT00863096|Vaccines|vaccines|mesh-list
154136053|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
154136054|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136055|NCT00870272|Misoprostol|misoprostol|mesh-list
154136056|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154136057|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
154136058|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154136059|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136060|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154136061|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154136062|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
154136063|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
154136064|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154136065|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136066|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154136067|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
154136068|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136069|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136070|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136071|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136072|NCT00502996|Rituximab|rituximab|mesh-list
154136073|NCT00502996|Methotrexate|methotrexate|mesh-list
154136074|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154136075|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136076|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
154136077|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761358|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153761359|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
153761360|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153761361|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
153761362|NCT00184886|Methotrexate|methotrexate|mesh-list
153761364|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
153761409|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153761410|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153761411|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153761412|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
153761413|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761415|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154136078|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136079|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154136080|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
154136081|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154136082|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136083|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
154136084|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136085|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
154136086|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136087|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154136088|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136089|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154136090|NCT00865436|Metformin|metformin|mesh-list
154136091|NCT00865436|Glyburide|glyburide|mesh-list
154136092|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154136093|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136094|NCT00715403|Nintedanib|nintedanib|mesh-list
154136095|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136096|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154136097|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136098|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136099|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
154136100|NCT01013584|Vitamin D|vitamin d|mesh-list
154136101|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154136102|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136103|NCT01013584|Vitamins|vitamins|mesh-ancestor
154136104|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
154136105|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154136106|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
153471171|NCT01107886|Hormones|hormones|mesh-ancestor
153761416|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153761417|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153761418|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761419|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
153761420|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761421|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761423|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153761424|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153761425|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153761426|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153761427|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761428|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
153761429|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153761430|NCT00218127|Narcotics|narcotics|mesh-ancestor
154136108|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154136109|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136110|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
154136111|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
154136112|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136113|NCT00864188|Beta Carotene|beta carotene|mesh-list
154136114|NCT00864188|Carotenoids|carotenoids|mesh-list
154136115|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
154136116|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136117|NCT00864188|Protective Agents|protective agents|mesh-ancestor
154136118|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136119|NCT00864188|Provitamins|provitamins|mesh-ancestor
154136120|NCT00864188|Vitamins|vitamins|mesh-ancestor
154136121|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
154136122|NCT00865670|Azithromycin|azithromycin|mesh-list
154136123|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136124|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136125|NCT00864344|Sertraline|sertraline|mesh-list
154136126|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
154136127|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154136128|NCT00864344|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154136129|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154136130|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136131|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136132|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136133|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
154136134|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136135|NCT00864500|Clobetasol|clobetasol|mesh-list
154136136|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136137|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
154136138|NCT00864500|Hormones|hormones|mesh-ancestor
154136139|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136140|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761431|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761432|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761433|NCT00218127|Analgesics|analgesics|mesh-ancestor
153761434|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
153761435|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761436|NCT00185198|Testosterone|testosterone|mesh-list
153761437|NCT00185198|Androgens|androgens|mesh-ancestor
154136141|NCT00864734|Metformin|metformin|mesh-list
154136142|NCT00864734|Glyburide|glyburide|mesh-list
154136143|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154136144|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136145|NCT00864812|Fluticasone|fluticasone|mesh-list
154136146|NCT00864812|Xhance|xhance|mesh-list
154136147|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
154136148|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154136149|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
154136150|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136151|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154136152|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
154136153|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136154|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136155|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154136156|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
154136157|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
154136158|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154136159|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
154136160|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154136161|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
154136162|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136163|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136164|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154136165|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154136166|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154136167|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
154136168|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
154136169|NCT00864812|Hormones|hormones|mesh-ancestor
153471228|NCT05766384|Anesthetics|anesthetics|mesh-ancestor
153761438|NCT00185198|Hormones|hormones|mesh-ancestor
153761439|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153761440|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761450|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153761451|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761452|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153761453|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761454|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153761455|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
153761456|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761457|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761458|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153761459|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153761460|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153761461|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761462|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153761463|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
154136170|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136171|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
154136172|NCT02590055|Gemcitabine|gemcitabine|mesh-list
154136173|NCT02590055|Docetaxel|docetaxel|mesh-list
154136174|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136175|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
154136176|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136177|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136178|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
154136179|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
154136180|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
154136181|NCT00864890|Dexetimide|dexetimide|mesh-list
154136182|NCT00864890|Citalopram|citalopram|mesh-list
154136183|NCT00864890|Escitalopram|escitalopram|mesh-list
154136184|NCT00864890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154136185|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154136186|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136187|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136188|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136189|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
153761464|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
153761465|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153761466|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153761506|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153761507|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153761508|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153761509|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876926|NCT06046560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761510|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761511|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153761512|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761513|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153761514|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761515|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153761516|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
153761517|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153761518|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
153761519|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153761563|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153761564|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
153761565|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153761566|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153761567|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153761568|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153761569|NCT00218283|Nicotine|nicotine|mesh-list
153761570|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153761571|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
153761572|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153761573|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761574|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153761575|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153761576|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
153761577|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761620|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136190|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136191|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154136192|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
154136193|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154136194|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154136195|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154136196|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
154136197|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
154136198|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136199|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154136200|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154136201|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
154136202|NCT00919295|Mirtazapine|mirtazapine|mesh-list
154136203|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
154136204|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154136205|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154136206|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
154136207|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
154136208|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136209|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136210|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136211|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154136212|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154136213|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136214|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154136215|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154136216|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154136217|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
154136218|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154136219|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153761621|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
153761622|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815070|NCT00448110|Analgesics|analgesics|mesh-ancestor
153761623|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761624|NCT00218361|Hydromorphone|hydromorphone|mesh-list
153761625|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153761626|NCT00218361|Narcotics|narcotics|mesh-ancestor
153761627|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153761628|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761629|NCT00218361|Analgesics|analgesics|mesh-ancestor
153761630|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
153761683|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761684|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136220|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
154136221|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154136222|NCT00865748|Metformin|metformin|mesh-list
154136223|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154136224|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136225|NCT00865982|Docetaxel|docetaxel|mesh-list
154136226|NCT00865982|Capecitabine|capecitabine|mesh-list
154136227|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136228|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
154136229|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
154136230|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
154136231|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136232|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136233|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
154136234|NCT00866060|Memantine|memantine|mesh-list
154136235|NCT00866060|Donepezil|donepezil|mesh-list
154136236|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154136237|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136238|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136239|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
154136240|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136241|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136242|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
154136243|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154136244|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154136245|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
154136246|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154136247|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154136248|NCT00871052|Vitamin D|vitamin d|mesh-list
154136249|NCT00871052|Calcipotriene|calcipotriene|mesh-list
154136250|NCT00871052|Vitamins|vitamins|mesh-ancestor
154136251|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
154136252|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136253|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154136254|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
153761685|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153761686|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
153761687|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761688|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761689|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153761690|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
154136255|NCT00502840|Rituximab|rituximab|mesh-list
154136256|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154136257|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136258|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
154136259|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136260|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136261|NCT00514540|Carboplatin|carboplatin|mesh-list
154136262|NCT00514540|Docetaxel|docetaxel|mesh-list
154136263|NCT00514540|Etoposide|etoposide|mesh-list
154136264|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136265|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
153815072|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136266|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
154136267|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
154136268|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136269|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154136270|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154136271|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154136272|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136273|NCT03121534|Dexamethasone|dexamethasone|mesh-list
154136274|NCT03121534|Nivolumab|nivolumab|mesh-list
154136275|NCT03121534|Blinatumomab|blinatumomab|mesh-list
153761750|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153761752|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153761753|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
153761754|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
153761755|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
153761756|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153761757|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153761762|NCT00211848|Ribavirin|ribavirin|mesh-list
153761819|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153761820|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761821|NCT00219180|Aliskiren|aliskiren|mesh-list
153761822|NCT00219180|Renin Inhibitors|renin inhibitors|mesh-ancestor
153761823|NCT00219180|Protease Inhibitors|protease inhibitors|mesh-ancestor
153761824|NCT00219180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761825|NCT00219180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761826|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
153761827|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153761828|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761829|NCT00187928|Topiramate|topiramate|mesh-list
153761830|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
153761831|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153761832|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761833|NCT00212199|Orlistat|orlistat|mesh-list
153761834|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761841|NCT00188006|Heparin|heparin|mesh-list
153761878|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153761879|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153761880|NCT00219375|Sivelestat|sivelestat|mesh-list
153761881|NCT00219375|Glycine|glycine|mesh-list
153761882|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153761883|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
153761884|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153761885|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761886|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
153761887|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153761888|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136276|NCT03121534|Ibrutinib|ibrutinib|mesh-list
154136277|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136278|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
154136279|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
154136280|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136281|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136282|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154136283|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
154136284|NCT03121534|Hormones|hormones|mesh-ancestor
154136285|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136286|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154136287|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136288|NCT03121534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154136289|NCT03121534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154136290|NCT03121534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136291|NCT03121534|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154136292|NCT03121534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154136293|NCT03121534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136294|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154136295|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
154136296|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154136297|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
154136298|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136299|NCT04615624|Furosemide|furosemide|mesh-list
154136300|NCT04615624|Diuretics|diuretics|mesh-ancestor
154136301|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
154136302|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136303|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154136304|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136305|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136306|NCT00713609|Clindamycin|clindamycin|mesh-list
154136307|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
154136316|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
154136317|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
154136318|NCT00513682|Pancrelipase|pancrelipase|mesh-list
154136319|NCT00513682|Pancreatin|pancreatin|mesh-list
154136320|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154136321|NCT00493012|Vitamin D|vitamin d|mesh-list
154136322|NCT00493012|Vitamins|vitamins|mesh-ancestor
154136323|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
154136324|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136325|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154136326|NCT00918593|Bleomycin|bleomycin|mesh-list
154136327|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154136328|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136329|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
154136330|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
154136331|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
154136332|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136333|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136334|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
154136335|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136336|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154136337|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136338|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136339|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
154136340|NCT05238233|Pilocarpine|pilocarpine|mesh-list
154136341|NCT05238233|Tropicamide|tropicamide|mesh-list
154136342|NCT05238233|Miotics|miotics|mesh-ancestor
154136343|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
153761889|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153455656|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417736|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
153876964|NCT06045936|Lidocaine|lidocaine|mesh-list
153810655|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153761942|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761943|NCT00188630|Protective Agents|protective agents|mesh-ancestor
153761944|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761946|NCT00188669|Tocopherols|tocopherols|mesh-list
153761947|NCT00188669|Vitamin E|vitamin e|mesh-list
153761948|NCT00188669|Tocotrienols|tocotrienols|mesh-list
153761949|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
153761950|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
153761951|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153761960|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
153762008|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
153762009|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762010|NCT00219765|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153762011|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153762012|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762013|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153762014|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153762015|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153762018|NCT00212589|Capecitabine|capecitabine|mesh-list
153762019|NCT00212589|Fluorouracil|fluorouracil|mesh-list
153876987|NCT06045286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762020|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
154136344|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136345|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136346|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154136347|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154136348|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
154136349|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136350|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136351|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
154136352|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154136353|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154136354|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
154136355|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
154136356|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136357|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
154136358|NCT00617708|Gemcitabine|gemcitabine|mesh-list
154136359|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154136360|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154136361|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136362|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
154136363|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136364|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136365|NCT00617708|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154136366|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154136367|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136368|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
154136369|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136370|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
154136371|NCT04083209|Narcotics|narcotics|mesh-ancestor
154136372|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136373|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136374|NCT04083209|Analgesics|analgesics|mesh-ancestor
154136375|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
154136376|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136377|NCT00864968|Nabumetone|nabumetone|mesh-list
154136378|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153762021|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762022|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
153471491|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154136379|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154136380|NCT00864968|Analgesics|analgesics|mesh-ancestor
154136381|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
154136382|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136383|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136384|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136385|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810657|NCT00351546|Vildagliptin|vildagliptin|mesh-list
154136386|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154136387|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154136388|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136389|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136390|NCT00876044|Aflibercept|aflibercept|mesh-list
154136391|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154136392|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154136393|NCT00876044|Growth Substances|growth substances|mesh-ancestor
154136394|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136395|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
154136396|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136397|NCT00866216|Azithromycin|azithromycin|mesh-list
154136398|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136399|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136400|NCT00871208|Retapamulin|retapamulin|mesh-list
154136401|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
154136402|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154136403|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154136404|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154136405|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
154136406|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
154136407|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136408|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136409|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136410|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154136411|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154136412|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154136413|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136414|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136415|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136416|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136417|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154136418|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
154136419|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154136420|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
154136421|NCT00866450|Calcium|calcium|mesh-list
154136422|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154136423|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136424|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154136425|NCT03894969|Vaccines|vaccines|mesh-list
154136426|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
154136427|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136428|NCT00876434|Sirolimus|sirolimus|mesh-list
154136429|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136430|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136431|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154136432|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136433|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
154136434|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136435|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
154136436|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136437|NCT00871442|Fentanyl|fentanyl|mesh-list
153762023|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762024|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762025|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153762028|NCT00212589|Antidotes|antidotes|mesh-ancestor
153762067|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762068|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762069|NCT00188942|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153762070|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762071|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762072|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762073|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762074|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
153762075|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153762076|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
153762077|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153762078|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153762079|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762080|NCT00219882|Turmeric extract|turmeric extract|mesh-list
153762081|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
153762122|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153762123|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153762124|NCT00189176|Growth Substances|growth substances|mesh-ancestor
153762125|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762126|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
153762127|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136438|NCT00871442|Bupivacaine|bupivacaine|mesh-list
154136439|NCT00871442|Anesthetics|anesthetics|mesh-list
154136440|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
154136441|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136442|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136443|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
154136444|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136445|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154136446|NCT00871442|Narcotics|narcotics|mesh-ancestor
154136447|NCT00871442|Analgesics|analgesics|mesh-ancestor
154136448|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154136449|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154136450|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
154136452|NCT05355597|Epinephrine|epinephrine|mesh-list
154136453|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154136454|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154136455|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
154136456|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136457|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136458|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136459|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154136460|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154136461|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
154136462|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136463|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154136464|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
154136465|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
154136466|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
154136467|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153876993|NCT06045195|Pembrolizumab|pembrolizumab|mesh-list
153813938|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428441|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
154136468|NCT05355597|Analgesics|analgesics|mesh-ancestor
154136469|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
154136471|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
153887386|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153471567|NCT04656301|Psilocybin|psilocybin|mesh-list
153762129|NCT00189371|Carboplatin|carboplatin|mesh-list
153762130|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
153762131|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153762132|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762133|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
153762137|NCT00189371|Hematinics|hematinics|mesh-ancestor
153762185|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762186|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762187|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153762188|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
153762189|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136472|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154136473|NCT00866528|Paclitaxel|paclitaxel|mesh-list
154136474|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154136475|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136476|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
154136477|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
154136478|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
154136479|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136480|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154136481|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
154136482|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136483|NCT00992667|Acetovanillone|acetovanillone|mesh-list
154136484|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154136485|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154136486|NCT00992667|Analgesics|analgesics|mesh-ancestor
154136487|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
154136488|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136489|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136490|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136491|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136492|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
154136493|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136494|NCT00992667|Protective Agents|protective agents|mesh-ancestor
154136495|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136496|NCT05171972|Ofatumumab|ofatumumab|mesh-list
154136497|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762190|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153762191|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153762192|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153762193|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762250|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153762251|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153762252|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153813939|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762253|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417771|NCT00372476|Vinorelbine|vinorelbine|mesh-list
153417772|NCT00372476|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153762254|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153762255|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762256|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
153762257|NCT00220233|Diuretics|diuretics|mesh-ancestor
153762258|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
153762259|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153762260|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153762309|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
153762310|NCT00213252|Hormones|hormones|mesh-ancestor
153762311|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153762312|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762313|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154136498|NCT00992823|Iron|iron|mesh-list
154136499|NCT00992823|Trace Elements|trace elements|mesh-ancestor
154136500|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
154136501|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136502|NCT03894813|Metronidazole|metronidazole|mesh-list
154136503|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136504|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136505|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154136506|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154136507|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
154136508|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154136509|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
154136510|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136511|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136512|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154136513|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
154136514|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
154136515|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154136516|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
154136517|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136518|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136519|NCT00876824|Amphotericin B|amphotericin b|mesh-list
154136520|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154136521|NCT00876824|Amebicides|amebicides|mesh-ancestor
154136522|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154136523|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154136524|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136525|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136526|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
154136527|NCT00866684|Cyclosporine|cyclosporine|mesh-list
154136528|NCT00866684|Sirolimus|sirolimus|mesh-list
154136529|NCT00866684|Azathioprine|azathioprine|mesh-list
154136530|NCT00866684|Tacrolimus|tacrolimus|mesh-list
154136531|NCT00866684|Cyclosporins|cyclosporins|mesh-list
154136532|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153887398|NCT01072357|Growth Substances|growth substances|mesh-ancestor
153813940|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
153813941|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154136542|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154136543|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136544|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136545|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
153516927|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
154136546|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136547|NCT00993057|Insulin|insulin|mesh-list
154136548|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154136549|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136550|NCT00866762|Vorinostat|vorinostat|mesh-list
154136551|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154136552|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136553|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136554|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136555|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
154136556|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154136557|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
154136558|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136559|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154136560|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136561|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
154136562|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136563|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
154136564|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154136565|NCT00876902|Protective Agents|protective agents|mesh-ancestor
154136566|NCT00993135|Methotrexate|methotrexate|mesh-list
154136567|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154136568|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
154136569|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154136570|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136571|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136572|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
154136573|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136574|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136575|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
153762314|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762315|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
153762378|NCT00412581|Growth Substances|growth substances|mesh-ancestor
153762379|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
154136576|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136577|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154136578|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136579|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
154136580|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136581|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154136582|NCT00866996|Methylphenidate|methylphenidate|mesh-list
154136583|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154136584|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154136585|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136586|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154136587|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154136588|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136589|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136590|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
154136591|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136592|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154136593|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
154136594|NCT00871910|Dexamethasone|dexamethasone|mesh-list
154136595|NCT00871910|Ondansetron|ondansetron|mesh-list
154136596|NCT00871910|Aprepitant|aprepitant|mesh-list
153417773|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153417774|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417775|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417776|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417777|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153417778|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
153879115|NCT06079983|Paclitaxel|paclitaxel|mesh-list
154136597|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136598|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
154136599|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
154136600|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136601|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136602|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154136603|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
154136604|NCT00871910|Hormones|hormones|mesh-ancestor
154136605|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136606|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153762380|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762381|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153762382|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
153762383|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762384|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
153762385|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153762404|NCT00190268|Amifampridine|amifampridine|mesh-list
153762442|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
153762443|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762444|NCT00190463|Amphotericin B|amphotericin b|mesh-list
153762445|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154136607|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136608|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
154136609|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
154136610|NCT00871910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154136611|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154136612|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
154136613|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136614|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136615|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154136616|NCT01564329|Endostar protein|endostar protein|mesh-list
154136617|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154136618|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153517002|NCT04078906|SMOFlipid|smoflipid|mesh-list
154136619|NCT01564329|Growth Substances|growth substances|mesh-ancestor
154136620|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136621|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
154136622|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136623|NCT00993525|Ranibizumab|ranibizumab|mesh-list
154136624|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154136625|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154136626|NCT00993525|Growth Substances|growth substances|mesh-ancestor
154136627|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136628|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
154136629|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136630|NCT00993681|Vaccines|vaccines|mesh-list
154136631|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
154136632|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136633|NCT03892707|Folic Acid|folic acid|mesh-list
154136634|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
153762446|NCT00190463|Amebicides|amebicides|mesh-ancestor
153762447|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153762448|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153762449|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762450|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153762451|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
153762505|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153762506|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762507|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153762509|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762510|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153762511|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
153762512|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762513|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153762514|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813944|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428465|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153762515|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
153762516|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136635|NCT03892707|Celecoxib|celecoxib|mesh-list
154136636|NCT03892707|Etoricoxib|etoricoxib|mesh-list
154136637|NCT03892707|Meloxicam|meloxicam|mesh-list
154136638|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
154136639|NCT03892707|Nimesulide|nimesulide|mesh-list
154136640|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154136641|NCT03892707|Benphothiamine|benphothiamine|mesh-list
154136642|NCT03892707|Vitamins|vitamins|mesh-ancestor
154136643|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
154136644|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136645|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154136646|NCT03892707|Analgesics|analgesics|mesh-ancestor
154136647|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
154136648|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136649|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136650|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154136651|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154136652|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136653|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136654|NCT03892707|Hematinics|hematinics|mesh-ancestor
154136655|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154136656|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
154136657|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
154136658|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
154136659|NCT00513604|Aldesleukin|aldesleukin|mesh-list
154136660|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
154136661|NCT00513604|Fludarabine|fludarabine|mesh-list
154136662|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
154136663|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136664|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
154136665|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136666|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136667|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154136668|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
154136669|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136673|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
154136677|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136678|NCT00872144|Nabiximols|nabiximols|mesh-list
154136679|NCT00872144|Analgesics|analgesics|mesh-ancestor
154136680|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
154136681|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136682|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136683|NCT00867152|Ritonavir|ritonavir|mesh-list
154136684|NCT00867152|Lopinavir|lopinavir|mesh-list
154136685|NCT00867152|Darunavir|darunavir|mesh-list
154136686|NCT00867152|Dolutegravir|dolutegravir|mesh-list
154136687|NCT00867152|Etravirine|etravirine|mesh-list
154136688|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154136689|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154136690|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
154136691|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136692|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136693|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154136694|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154136695|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
154136696|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136697|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154136698|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154136699|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154136700|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154136701|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154136702|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154136703|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
154136704|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
154136705|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136706|NCT00872378|Exenatide|exenatide|mesh-list
154136707|NCT00872378|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154136712|NCT00872378|Hormones|hormones|mesh-ancestor
154136720|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154136721|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136722|NCT00994149|Diazoxide|diazoxide|mesh-list
154136723|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154136724|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
154136725|NCT00573248|Nicotine|nicotine|mesh-list
154136726|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154136727|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
154136728|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136729|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136730|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154136731|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154136732|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
154136733|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136734|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136735|NCT04039880|Olorofim|olorofim|mesh-list
154136736|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
154136737|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136738|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
154136739|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154136740|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
154136741|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136742|NCT00994305|Expectorants|expectorants|mesh-ancestor
154136743|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
154136744|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154136745|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
154136746|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136747|NCT00994305|Protective Agents|protective agents|mesh-ancestor
154136748|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136749|NCT00994305|Antidotes|antidotes|mesh-ancestor
153813783|NCT00437307|Topotecan|topotecan|mesh-list
153762517|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153762518|NCT00213564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153762519|NCT00213564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153762520|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153762561|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762562|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762563|NCT00213759|Lenograstim|lenograstim|mesh-list
153762564|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153762565|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
153762566|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762567|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153762568|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153762569|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154136750|NCT00877760|Interferons|interferons|mesh-list
154136751|NCT00877760|Entecavir|entecavir|mesh-list
154136752|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136753|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
154136754|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136755|NCT04083911|Cytarabine|cytarabine|mesh-list
154136756|NCT04083911|Decitabine|decitabine|mesh-list
154136757|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
154136758|NCT04083911|Aclarubicin|aclarubicin|mesh-list
154136759|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154136760|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
154136761|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136762|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887423|NCT04972396|Warfarin|warfarin|mesh-list
154136763|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
154136764|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136765|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136766|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
154136767|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136768|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136769|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154136770|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154136771|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154136772|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154136773|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154136775|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154136776|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154136777|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
154136778|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136779|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154136780|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154136781|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762570|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762572|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762620|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153762622|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762623|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
153762624|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762625|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762626|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
153762627|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
153762628|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762630|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153762680|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762681|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136782|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136783|NCT00994383|Morphine|morphine|mesh-list
154136784|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154136785|NCT00994383|Narcotics|narcotics|mesh-ancestor
154136786|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136787|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136788|NCT00994383|Analgesics|analgesics|mesh-ancestor
154136789|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
154136790|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136791|NCT02588417|Dexamethasone|dexamethasone|mesh-list
154136792|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
154136793|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154136794|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
154136795|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
154136796|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136797|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136798|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154136799|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
154136800|NCT02588417|Hormones|hormones|mesh-ancestor
154136801|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136802|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154136803|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136804|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
154136805|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
154136806|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455657|NCT05414500|Immunotoxins|immunotoxins|mesh-ancestor
154136807|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
154136808|NCT00532935|Metformin|metformin|mesh-list
153762682|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762683|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762684|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762685|NCT00191204|Analgesics|analgesics|mesh-ancestor
153762686|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
153762687|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762688|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
153762689|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762690|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
153762691|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
153762692|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153762693|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762694|NCT00191243|Gemcitabine|gemcitabine|mesh-list
153762695|NCT00191243|Docetaxel|docetaxel|mesh-list
153762738|NCT06116461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762739|NCT06116253|Pentetic Acid|pentetic acid|mesh-list
153762740|NCT06116253|Antidotes|antidotes|mesh-ancestor
153762741|NCT06116253|Protective Agents|protective agents|mesh-ancestor
153762742|NCT06116253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762743|NCT06116253|Chelating Agents|chelating agents|mesh-ancestor
153762744|NCT06116253|Sequestering Agents|sequestering agents|mesh-ancestor
153599858|NCT01878695|Antidotes|antidotes|mesh-ancestor
154136809|NCT00532935|Pioglitazone|pioglitazone|mesh-list
154136810|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154136811|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154136812|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136813|NCT00532935|Incretins|incretins|mesh-ancestor
154136814|NCT00532935|Hormones|hormones|mesh-ancestor
154136815|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136816|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154136817|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
154136818|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136819|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136820|NCT00994539|Morphine|morphine|mesh-list
154136821|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154136822|NCT00994539|Narcotics|narcotics|mesh-ancestor
154136823|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136824|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136825|NCT00994539|Analgesics|analgesics|mesh-ancestor
154136826|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
154136827|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136828|NCT00878306|Ritonavir|ritonavir|mesh-list
154136829|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154136830|NCT00878306|Efavirenz|efavirenz|mesh-list
154136831|NCT00878306|Disulfiram|disulfiram|mesh-list
154136832|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154136833|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154136834|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
154136835|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136836|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136837|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154136838|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154136839|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
153762745|NCT06116253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762746|NCT06116253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153762749|NCT06116240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153762750|NCT06116240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762751|NCT06116240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153762752|NCT06116240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153762753|NCT06116214|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153762793|NCT06111573|Vitamin D|vitamin d|mesh-list
153762794|NCT06111573|Diclofenac|diclofenac|mesh-list
153813946|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
153813947|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
153762795|NCT06111573|Vitamins|vitamins|mesh-ancestor
153762796|NCT06111573|Micronutrients|micronutrients|mesh-ancestor
153762797|NCT06111573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762798|NCT06111573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153472116|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136840|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136841|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154136842|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154136843|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154136844|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154136845|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154136846|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154136847|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153517217|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
154136848|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154136849|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154136850|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154136851|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
154136853|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154136854|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154136855|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154136856|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154136857|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154136858|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136859|NCT00994617|Diuretics|diuretics|mesh-ancestor
154136860|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
154136861|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136862|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154136863|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136864|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
153762799|NCT06111573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153762800|NCT06111573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153762801|NCT06111573|Analgesics|analgesics|mesh-ancestor
153762802|NCT06111573|Sensory System Agents|sensory system agents|mesh-ancestor
153762803|NCT06111573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762804|NCT06111573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153762809|NCT06108193|Minoxidil|minoxidil|mesh-list
153762855|NCT05913232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762856|NCT05913232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153762857|NCT05913232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153762858|NCT05895513|Pimavanserin|pimavanserin|mesh-list
153762859|NCT05895513|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153762860|NCT05895513|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153762861|NCT05895513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153762862|NCT05895513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153762863|NCT05895513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136866|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154136867|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
154136868|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
154136869|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136870|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136871|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136872|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
154136873|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
154136874|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154136875|NCT00919451|Cyclosporine|cyclosporine|mesh-list
154136876|NCT00919451|Cyclosporins|cyclosporins|mesh-list
154136877|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136878|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136879|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154136880|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
153810662|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357280|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153813948|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153357281|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153357282|NCT01273454|Hydromorphone|hydromorphone|mesh-list
154136881|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136882|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
154136883|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136884|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
154136885|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154136886|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154136887|NCT03016312|Atezolizumab|atezolizumab|mesh-list
154136888|NCT03016312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154136889|NCT03016312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136890|NCT03016312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154136891|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136892|NCT05059223|Reboxetine|reboxetine|mesh-list
154136893|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
154136894|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154136895|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153762864|NCT05895513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762865|NCT05895513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762866|NCT05895513|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153762867|NCT05895513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153762868|NCT05895513|Serotonin Agents|serotonin agents|mesh-ancestor
153762869|NCT05895513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762913|NCT06319183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153762914|NCT06319183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153762915|NCT06319183|Adrenergic Agents|adrenergic agents|mesh-ancestor
153762916|NCT06319183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762917|NCT06319183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762919|NCT06319170|Antiemetics|antiemetics|mesh-ancestor
154136896|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154136897|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154136898|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136899|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
154136900|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136901|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136902|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154136903|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
154136904|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154136905|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154136906|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154136907|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357283|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153357284|NCT01273454|Narcotics|narcotics|mesh-ancestor
153357285|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357286|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357287|NCT01273454|Analgesics|analgesics|mesh-ancestor
153877006|NCT06045013|Antiemetics|antiemetics|mesh-ancestor
154136908|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136909|NCT01014052|Retinol acetate|retinol acetate|mesh-list
154136910|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154136911|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
154136912|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136913|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154136914|NCT01014052|Protective Agents|protective agents|mesh-ancestor
154136915|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136916|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
154136917|NCT00512902|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154136918|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154136919|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136920|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136943|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136944|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136945|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154136946|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154136947|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154136948|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
154136949|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154136950|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136951|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136952|NCT02589041|Ropivacaine|ropivacaine|mesh-list
154136953|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
154136954|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
154136955|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136956|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136957|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
154136958|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154136960|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154136961|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154136962|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154136963|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154136964|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154136965|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
154136966|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
154136967|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154136968|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136969|NCT02587871|Cytarabine|cytarabine|mesh-list
154136970|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153428519|NCT00002372|Nelfinavir|nelfinavir|mesh-list
154136971|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
154136972|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136973|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154136974|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
154136975|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136984|NCT00491764|Posaconazole|posaconazole|mesh-list
154136985|NCT00491764|Terbinafine|terbinafine|mesh-list
154136986|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
154136987|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154136988|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154136989|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154136990|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154136991|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154136992|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154136993|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154136994|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154136995|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154136996|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
154136997|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154136998|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137000|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154137001|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154137002|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137003|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137004|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154137005|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137006|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
154137007|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
154137008|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
154137009|NCT00615836|Coagulants|coagulants|mesh-ancestor
154137010|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154137011|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
154137012|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137013|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
154137014|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154137015|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137016|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137017|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154137018|NCT05139212|Analgesics|analgesics|mesh-ancestor
154137020|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137021|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154137022|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154137023|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154137024|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
154137025|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137026|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137027|NCT00872924|Sumatriptan|sumatriptan|mesh-list
154137028|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154137029|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154137030|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154137031|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
154137032|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137033|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137034|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137035|NCT00878540|Mirtazapine|mirtazapine|mesh-list
154137036|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
154137037|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154137038|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154137039|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
153810670|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137040|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
154137041|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153428527|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137055|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
154137069|NCT00873002|Sorafenib|sorafenib|mesh-list
154137070|NCT00873002|Panobinostat|panobinostat|mesh-list
154137071|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137072|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154137073|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137074|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137075|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154137076|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
154137077|NCT00491530|Atorvastatin|atorvastatin|mesh-list
154137078|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154137079|NCT00491530|Simvastatin|simvastatin|mesh-list
154137080|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
154137081|NCT00491530|Calcium|calcium|mesh-list
154137082|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154137083|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137084|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154137085|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154137086|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154137087|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
154137088|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137089|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154137090|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154137091|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137092|NCT00617240|Metformin|metformin|mesh-list
154137093|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154137094|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137095|NCT00615290|Tipranavir|tipranavir|mesh-list
154137096|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154137097|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154137098|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
154137099|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137100|NCT02587169|Doxorubicin|doxorubicin|mesh-list
154137101|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154137102|NCT02587169|Nilotinib|nilotinib|mesh-list
154137103|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154137110|NCT02587169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154137111|NCT00873236|Interferons|interferons|mesh-list
154137112|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
154137113|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
154137114|NCT00873236|Bevacizumab|bevacizumab|mesh-list
154137115|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154137116|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137117|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154137118|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154137119|NCT00873236|Growth Substances|growth substances|mesh-ancestor
154137120|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137121|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
154137122|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
154137123|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137124|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
154137126|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154137127|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137128|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137129|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
154137130|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137131|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137132|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
154137133|NCT05683301|Amlodipine|amlodipine|mesh-list
154137134|NCT05683301|Perindopril|perindopril|mesh-list
154137135|NCT05683301|Indapamide|indapamide|mesh-list
154137160|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
154137161|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154137162|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154137163|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137164|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154137165|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154137166|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137167|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137168|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137169|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154137170|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
154137171|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154137172|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137173|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154137174|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154137175|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154137176|NCT00879164|Bupivacaine|bupivacaine|mesh-list
154137177|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
154137178|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
154137213|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137214|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
154137215|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137216|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137217|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154137218|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154137219|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137220|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
154137221|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
154137222|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154137223|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154137224|NCT04634669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154137225|NCT04634669|Narcotics|narcotics|mesh-ancestor
154137226|NCT04634669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137227|NCT04634669|Analgesics|analgesics|mesh-ancestor
154137228|NCT04634669|Sensory System Agents|sensory system agents|mesh-ancestor
154137229|NCT04634669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137230|NCT02585531|Dexamethasone|dexamethasone|mesh-list
154137231|NCT02585531|Epinephrine|epinephrine|mesh-list
154137232|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137233|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
154137234|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
154137235|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137236|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137237|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137238|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
154137239|NCT02585531|Hormones|hormones|mesh-ancestor
154137240|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137241|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154137258|NCT00920153|Gemcitabine|gemcitabine|mesh-list
154137259|NCT00920153|Doxorubicin|doxorubicin|mesh-list
154137260|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154137261|NCT00920153|Etoposide|etoposide|mesh-list
154137262|NCT00920153|Vincristine|vincristine|mesh-list
154137263|NCT00920153|Melphalan|melphalan|mesh-list
154137264|NCT00920153|Vinorelbine|vinorelbine|mesh-list
154137265|NCT00920153|Ifosfamide|ifosfamide|mesh-list
154137266|NCT00920153|Dacarbazine|dacarbazine|mesh-list
154137267|NCT00920153|Carmustine|carmustine|mesh-list
154137268|NCT00920153|Bleomycin|bleomycin|mesh-list
154137269|NCT00920153|Vindesine|vindesine|mesh-list
154137270|NCT00920153|Mitoguazone|mitoguazone|mesh-list
154137271|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137272|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813951|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813952|NCT00437892|Atorvastatin|atorvastatin|mesh-list
153887459|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887460|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153887461|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154137273|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
154137274|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
154137275|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137276|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137277|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137278|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
154137279|NCT00920153|Hormones|hormones|mesh-ancestor
154137280|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137281|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154137282|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154137283|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
154137284|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137285|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154137286|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154137287|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154137288|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137290|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
154137304|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154137305|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
154137306|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137307|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137308|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154137309|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
154137310|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
154137311|NCT04080713|Hormones|hormones|mesh-ancestor
154137312|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137313|NCT05519189|Ropivacaine|ropivacaine|mesh-list
154137314|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
154137315|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
154137316|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137317|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137318|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
154137319|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137320|NCT04080323|Dinoprostone|dinoprostone|mesh-list
154137321|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
154137322|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154137323|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137324|NCT03930017|Vaccines|vaccines|mesh-list
154137325|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
154137326|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137327|NCT00533949|Paclitaxel|paclitaxel|mesh-list
154137328|NCT00533949|Carboplatin|carboplatin|mesh-list
154137354|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137356|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
154137357|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137359|NCT00920465|Mifepristone|mifepristone|mesh-list
154137360|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154137361|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
154137362|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154137363|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137364|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154137365|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517741|NCT01441531|Analgesics|analgesics|mesh-ancestor
154137366|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
154137367|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154137368|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154137369|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154137370|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154137371|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
154137372|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154137373|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154137374|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
154137375|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137376|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
154137377|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154137378|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154137379|NCT00994773|Tenofovir|tenofovir|mesh-list
154137380|NCT00994773|Entecavir|entecavir|mesh-list
154137401|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137402|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
154137403|NCT03084237|Docetaxel|docetaxel|mesh-list
154137404|NCT03084237|Trastuzumab|trastuzumab|mesh-list
154137405|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137406|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
154137407|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
154137408|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
154137409|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137410|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154137411|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
154137412|NCT00996021|Dolutegravir|dolutegravir|mesh-list
154137413|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154137414|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154137415|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137416|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154137417|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154137418|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137420|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137456|NCT02584751|Protective Agents|protective agents|mesh-ancestor
154137457|NCT00999219|Zolpidem|zolpidem|mesh-list
154137458|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154137459|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154137460|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137461|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137462|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154137463|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
154137464|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
154137465|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137466|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137467|NCT00996177|Fentanyl|fentanyl|mesh-list
154137468|NCT00996177|Morphine|morphine|mesh-list
154137469|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154137470|NCT00996177|Narcotics|narcotics|mesh-ancestor
154137471|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154137472|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137473|NCT00996177|Analgesics|analgesics|mesh-ancestor
154137474|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
154137475|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137476|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154137477|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154137478|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
154137479|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
154137508|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137509|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154137510|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
154137511|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154137512|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154137513|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154137514|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137515|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137516|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
154137517|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137518|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154137519|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153357289|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137520|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137521|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154137522|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
154137523|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137524|NCT00996411|Salvinorin A|salvinorin a|mesh-list
154137525|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
154137526|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137527|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154137528|NCT00996567|Cetuximab|cetuximab|mesh-list
154137529|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154137558|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154137559|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137560|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137561|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154137562|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
154137563|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137564|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137565|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154137566|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154137567|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154137568|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137569|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154137570|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
154137618|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
154137619|NCT02582177|BB 1101|bb 1101|mesh-list
154137620|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137621|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
154137622|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
154137623|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137624|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137625|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137626|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
154137627|NCT02582177|Hormones|hormones|mesh-ancestor
154137628|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137629|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154137630|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137631|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
154137632|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137633|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137634|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154137635|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
154137636|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
154137637|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137638|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154137641|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
154137668|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
154137669|NCT00997191|Hormones|hormones|mesh-ancestor
154137670|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137671|NCT00997269|Ubiquinone|ubiquinone|mesh-list
154137672|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
154137673|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
154137674|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137675|NCT00997269|Vitamins|vitamins|mesh-ancestor
154137676|NCT02582099|Gentamicins|gentamicins|mesh-list
154137677|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154137678|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137679|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154137680|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137681|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137682|NCT00997347|Misoprostol|misoprostol|mesh-list
154137683|NCT00997347|Mifepristone|mifepristone|mesh-list
154137684|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154137685|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
154137686|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154137687|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137688|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154137689|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137690|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
154137691|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154137692|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154137693|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154137716|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137717|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
154137718|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
154137719|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154137720|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154137721|NCT05183139|Dexamethasone|dexamethasone|mesh-list
154137723|NCT05183139|Pomalidomide|pomalidomide|mesh-list
154137724|NCT05183139|Ixazomib|ixazomib|mesh-list
153810671|NCT00320879|Irbesartan|irbesartan|mesh-list
154137725|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137726|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
154137727|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
154137728|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137729|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137730|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137731|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
154137732|NCT05183139|Hormones|hormones|mesh-ancestor
154137733|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137734|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154137735|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137736|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
154137737|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154137738|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154137770|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137771|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
154137772|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154137773|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137774|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154137775|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137776|NCT04077983|Paclitaxel|paclitaxel|mesh-list
154137777|NCT04077983|Gemcitabine|gemcitabine|mesh-list
154137778|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154137779|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137780|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
154137781|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
154137782|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
154137783|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137784|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154137785|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
153810672|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153417831|NCT04647110|Crizotinib|crizotinib|mesh-list
153813953|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154137786|NCT03822845|Edetic Acid|edetic acid|mesh-list
154137787|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154137788|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
154137789|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
154137826|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154137827|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154137828|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137829|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137830|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154137831|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154137832|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
154137833|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
154137834|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154137835|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137836|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154137837|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
154137838|NCT04077905|Hormones|hormones|mesh-ancestor
154137839|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154137840|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154137841|NCT04077905|Protective Agents|protective agents|mesh-ancestor
154137842|NCT04471246|Cephalexin|cephalexin|mesh-list
154137843|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154137844|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137845|NCT00499486|Sirolimus|sirolimus|mesh-list
154137846|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154137847|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137848|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154137849|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137850|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
154137851|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154137854|NCT01019278|Cisplatin|cisplatin|mesh-list
154137872|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154137873|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
154137874|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154137875|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154137876|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154137877|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137878|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
154137880|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137881|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154137882|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
154137883|NCT01019434|Sirolimus|sirolimus|mesh-list
154137884|NCT01019434|Temozolomide|temozolomide|mesh-list
154137885|NCT01019434|Temsirolimus|temsirolimus|mesh-list
154137886|NCT01019434|MTOR Inhibitors|mtor inhibitors|mesh-list
154137887|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154137888|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
154137889|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137890|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137891|NCT01019434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154137892|NCT01019434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154137893|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813955|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
154137894|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
153813956|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137895|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137896|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154137897|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154137898|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154137899|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
154137900|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154137918|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154137919|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137920|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154137921|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154137923|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154137924|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154137925|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137927|NCT00532155|Dexamethasone|dexamethasone|mesh-list
154137982|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154137983|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154137984|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154137985|NCT03996473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154137986|NCT03996473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137987|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
154137988|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
154137989|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154137990|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
154137991|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154137992|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154137993|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154137994|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154137995|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154137996|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154137997|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154137998|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
154137999|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138000|NCT00483574|Vaccines|vaccines|mesh-list
154138001|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
154138002|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138003|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154138004|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154138005|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154138006|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154138007|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138024|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154138025|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138026|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138027|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154138028|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154138029|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
154138031|NCT01000857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154138032|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154138033|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154138034|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138044|NCT01004445|Amikacin|amikacin|mesh-list
154138086|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138087|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154138089|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154138090|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154138091|NCT00482170|Analgesics|analgesics|mesh-ancestor
154138092|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
154138093|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154138094|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138095|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813959|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813960|NCT00437970|Metformin|metformin|mesh-list
154138097|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154138098|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154138099|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
154138100|NCT05228249|Cytarabine|cytarabine|mesh-list
154138101|NCT05228249|Etoposide|etoposide|mesh-list
154138102|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
154138103|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
154138104|NCT05228249|Melphalan|melphalan|mesh-list
154138105|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
154138106|NCT05228249|Carmustine|carmustine|mesh-list
154138135|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
154138143|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154138144|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138146|NCT01004601|Pemetrexed|pemetrexed|mesh-list
154138147|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154138148|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
154138149|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
154138150|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
154138151|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138152|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138153|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154138154|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154138155|NCT01001247|Rilpivirine|rilpivirine|mesh-list
154138156|NCT01001247|Omeprazole|omeprazole|mesh-list
154138157|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154138158|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153417844|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154138159|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154138160|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154138161|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154138162|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154138163|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154138164|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
154138165|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154138166|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154138167|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154138168|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
153658657|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153658658|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153658659|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153658660|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153658661|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153658662|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153658663|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658664|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658665|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
153658666|NCT02718820|Docetaxel|docetaxel|mesh-list
153658669|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
153658670|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
153658671|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
153658672|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658673|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658674|NCT02718820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153417845|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153879191|NCT06078696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153879193|NCT06078670|Paclitaxel|paclitaxel|mesh-list
153877059|NCT06044467|Immunoglobulins|immunoglobulins|mesh-list
153658675|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
153658676|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658677|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658678|NCT02609503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658679|NCT02609503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658681|NCT02539537|Folic Acid|folic acid|mesh-list
153658682|NCT02539537|Gemcitabine|gemcitabine|mesh-list
153658683|NCT02539537|Fluorouracil|fluorouracil|mesh-list
153658694|NCT02539537|Antidotes|antidotes|mesh-ancestor
153658695|NCT02539537|Protective Agents|protective agents|mesh-ancestor
153658696|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658741|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153658742|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
153658743|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658744|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153658745|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153658746|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153658747|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153658748|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153658749|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153658750|NCT02268851|Ibrutinib|ibrutinib|mesh-list
153658751|NCT02268851|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153658752|NCT02268851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153658753|NCT02268851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658754|NCT02268851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658773|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658774|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658775|NCT02245230|Protective Agents|protective agents|mesh-ancestor
153658776|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153658777|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
153658778|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153658779|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153658812|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658813|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658814|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153658815|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153658844|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658845|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658846|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153658847|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658848|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
153658849|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
153658850|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658851|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153658852|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
153658853|NCT01228331|Hormones|hormones|mesh-ancestor
153658854|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658855|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658856|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153658857|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153813961|NCT00437970|Pioglitazone|pioglitazone|mesh-list
153813962|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153658858|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153658859|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658860|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153658861|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
153658862|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153658863|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153658864|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
153658865|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
153658886|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658888|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658889|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153658890|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153658892|NCT02968342|Progestins|progestins|mesh-ancestor
153877060|NCT06044467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153658893|NCT02968342|Hormones|hormones|mesh-ancestor
153658894|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658895|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658898|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153658899|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658900|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658901|NCT00061516|Brinzolamide|brinzolamide|mesh-list
153658902|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153658903|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658904|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658905|NCT00061594|Ranibizumab|ranibizumab|mesh-list
153658906|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153658907|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153658908|NCT00061594|Growth Substances|growth substances|mesh-ancestor
153658909|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877061|NCT06044467|Immunologic Factors|immunologic factors|mesh-ancestor
153877062|NCT06044467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877063|NCT06044467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887488|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153887489|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153887490|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153887491|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153887492|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887494|NCT04306627|Perindopril|perindopril|mesh-list
153887495|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153887496|NCT04306627|Atorvastatin|atorvastatin|mesh-list
153658910|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
153658911|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658912|NCT00061711|Hormones|hormones|mesh-list
153658913|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
153658914|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658971|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153658972|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658973|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658974|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
153658976|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658996|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658997|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153658998|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153658999|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659000|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659001|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153659002|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
153659003|NCT00062023|Aspirin|aspirin|mesh-list
153659004|NCT00062023|Sulindac|sulindac|mesh-list
153659005|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153659006|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153659007|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659008|NCT00062023|Analgesics|analgesics|mesh-ancestor
153659009|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
153659010|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659011|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659012|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659013|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659014|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153659015|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153659016|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659054|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659055|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659056|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659057|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659058|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153659059|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659060|NCT00062101|Analgesics|analgesics|mesh-ancestor
153659061|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
153659062|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659063|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659064|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659065|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659066|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153659067|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153659069|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659070|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
153659131|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659132|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659133|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659134|NCT00062803|Heparin|heparin|mesh-list
153659135|NCT00062803|Warfarin|warfarin|mesh-list
153659136|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
153659137|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
153659138|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153659139|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153659140|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659141|NCT00062842|Irinotecan|irinotecan|mesh-list
153813963|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659142|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153659166|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153659167|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659168|NCT00063388|Cetuximab|cetuximab|mesh-list
153659169|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153659170|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659171|NCT00063583|Pirfenidone|pirfenidone|mesh-list
153659187|NCT00064012|Docetaxel|docetaxel|mesh-list
153659274|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659275|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
153659276|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659277|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659278|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
153659279|NCT00398749|Hematinics|hematinics|mesh-ancestor
153659295|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659296|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153659297|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153659298|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153659299|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
153659300|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659301|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659303|NCT00065455|Vitamins|vitamins|mesh-ancestor
153659325|NCT00065923|Topiramate|topiramate|mesh-list
153659360|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659361|NCT00066196|Dacarbazine|dacarbazine|mesh-list
153659362|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153659363|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
153659364|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659365|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659367|NCT00066274|Fluorouracil|fluorouracil|mesh-list
153659368|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
153659369|NCT00066274|Irinotecan|irinotecan|mesh-list
153659370|NCT00066274|Calcium|calcium|mesh-list
153659371|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
153659372|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153659373|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659374|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
153659375|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659376|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659377|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659378|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659379|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
153659380|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153659432|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659433|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659434|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
153659435|NCT00066625|Bortezomib|bortezomib|mesh-list
153659436|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659437|NCT00066859|Sertraline|sertraline|mesh-list
153659438|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
153659439|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153659440|NCT00066859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153659441|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153659442|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153659443|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659444|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659445|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
153659446|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659447|NCT04235673|Melatonin|melatonin|mesh-list
153659448|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
153659525|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153659526|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153659527|NCT02967094|Expectorants|expectorants|mesh-list
153659528|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
153813966|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153659529|NCT00067561|Alosetron|alosetron|mesh-list
153659530|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153659531|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153659532|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
153659533|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659534|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659535|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659536|NCT00067600|Calcium|calcium|mesh-list
153659537|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153659538|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659539|NCT05010707|Spironolactone|spironolactone|mesh-list
153659540|NCT05010707|Hormones|hormones|mesh-list
153659541|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659542|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659601|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659602|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
153659603|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659604|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
153659605|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659606|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
153659607|NCT00068458|Calcium|calcium|mesh-list
153659608|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153659609|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659610|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153659611|NCT00068497|Gefitinib|gefitinib|mesh-list
153659612|NCT00068497|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153659613|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659614|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659615|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659616|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659617|NCT00068653|Celecoxib|celecoxib|mesh-list
153659618|NCT00068653|Gefitinib|gefitinib|mesh-list
153659619|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153659620|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659621|NCT00068653|Analgesics|analgesics|mesh-ancestor
153659622|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
153659641|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153659642|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659643|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153659644|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
153659645|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153659646|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
153659647|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
153659648|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153659649|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659650|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153659651|NCT00399061|Cyclosporine|cyclosporine|mesh-list
153659660|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
153659661|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659662|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153659663|NCT00069355|Propranolol|propranolol|mesh-list
153659664|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153659665|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153659666|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
153659667|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659668|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659669|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659670|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153357292|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153877076|NCT06043908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877077|NCT06043908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877078|NCT06043908|Immunologic Factors|immunologic factors|mesh-ancestor
153877079|NCT06043908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877080|NCT06043908|Antifungal Agents|antifungal agents|mesh-ancestor
153659671|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153659672|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
153659673|NCT00069550|Levomethorphan|levomethorphan|mesh-list
153659674|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
153659676|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153659677|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659703|NCT04958720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659704|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153659705|NCT00069706|Latanoprost|latanoprost|mesh-list
153659706|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153659707|NCT00069901|Paclitaxel|paclitaxel|mesh-list
153659708|NCT00069901|Carboplatin|carboplatin|mesh-list
153659709|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153659748|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
153659749|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659750|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659751|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153659752|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153659753|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
153659754|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153659755|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659756|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
153659757|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
153659758|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659759|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153659760|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153659761|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153659762|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153659763|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153659764|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
153659765|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153659766|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
153659767|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153659768|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153659769|NCT00070174|Analgesics|analgesics|mesh-ancestor
153659770|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
153659771|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659772|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153659773|NCT00070174|Immunotoxins|immunotoxins|mesh-ancestor
153659774|NCT00070174|Immunoconjugates|immunoconjugates|mesh-ancestor
153659775|NCT00070213|Leucovorin|leucovorin|mesh-list
153659776|NCT00070213|Capecitabine|capecitabine|mesh-list
153659777|NCT00070213|Fluorouracil|fluorouracil|mesh-list
153659778|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
153659779|NCT00070213|Calcium|calcium|mesh-list
153659780|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
153659791|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
153659792|NCT00070213|Vitamins|vitamins|mesh-ancestor
153659793|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
153659794|NCT00070252|Docetaxel|docetaxel|mesh-list
153659795|NCT00070252|Capecitabine|capecitabine|mesh-list
153659796|NCT00070252|Tipifarnib|tipifarnib|mesh-list
153659821|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153659822|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153659823|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659824|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659825|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
153659827|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659828|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153659829|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153659830|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
153659831|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
153659832|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
153659833|NCT03959865|Glucagon|glucagon|mesh-list
153659834|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153417847|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
153813967|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
153659835|NCT03959865|Incretins|incretins|mesh-ancestor
153659836|NCT03959865|Hormones|hormones|mesh-ancestor
153659837|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659838|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659839|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153659840|NCT00070486|Celecoxib|celecoxib|mesh-list
153659841|NCT00070486|Zileuton|zileuton|mesh-list
153659842|NCT00070486|Carboplatin|carboplatin|mesh-list
153659843|NCT00070486|Gemcitabine|gemcitabine|mesh-list
153659844|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659845|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659846|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
153659847|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659873|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659874|NCT00070837|Antibodies|antibodies|mesh-list
153659875|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153659878|NCT00071188|Paclitaxel|paclitaxel|mesh-list
153659880|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153659881|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659882|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
153659883|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
153659884|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
153659885|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659886|NCT00071227|Triamcinolone|triamcinolone|mesh-list
153659887|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153659888|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153659889|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153659890|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659891|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
153659893|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659894|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659895|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659896|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
153659910|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
153659911|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659912|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153659913|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153659914|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659946|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153659947|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153659948|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659949|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659950|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659951|NCT00071695|Analgesics|analgesics|mesh-ancestor
153659952|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
153659953|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659954|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
153659955|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153659956|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
153659957|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153659958|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
153660009|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660010|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660011|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
153660012|NCT00072007|Hormones|hormones|mesh-ancestor
153660013|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153660014|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153660015|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153660016|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
153428572|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153428573|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
153660017|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660018|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
153660019|NCT00072046|Interferons|interferons|mesh-list
153660020|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
153660021|NCT00072046|Bevacizumab|bevacizumab|mesh-list
153660022|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660023|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660024|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153660025|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153660073|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660074|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153660075|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153660076|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153660077|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153660078|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660079|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153660080|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660081|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153660082|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660083|NCT03959436|Carbetocin|carbetocin|mesh-list
153660084|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
153660085|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153660086|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660087|NCT00072124|Dacarbazine|dacarbazine|mesh-list
153660088|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660089|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660090|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
153660091|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660092|NCT00072163|Thalidomide|thalidomide|mesh-list
153660093|NCT00072163|Temozolomide|temozolomide|mesh-list
153660094|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660095|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
153660096|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660099|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
153815074|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660100|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660115|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
153660135|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660136|NCT00072436|Gemcitabine|gemcitabine|mesh-list
153660137|NCT00072436|Alvocidib|alvocidib|mesh-list
153660138|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660139|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
153660140|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660141|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660142|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
153660143|NCT00072436|Growth Substances|growth substances|mesh-ancestor
153660144|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660145|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153660146|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660147|NCT00072553|Leucovorin|leucovorin|mesh-list
153660148|NCT00072553|Celecoxib|celecoxib|mesh-list
153660149|NCT00072553|Fluorouracil|fluorouracil|mesh-list
153660150|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
153660151|NCT00072553|Calcium|calcium|mesh-list
153660152|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
153660155|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
153660198|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660199|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153660200|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660201|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660202|NCT00072787|Cisplatin|cisplatin|mesh-list
153660203|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660204|NCT00072826|Acetylcholine|acetylcholine|mesh-list
153660205|NCT00072826|Oxypurinol|oxypurinol|mesh-list
153660206|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
153660207|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153660208|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
153660209|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660210|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887512|NCT04306471|Evolocumab|evolocumab|mesh-list
153660211|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660212|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660213|NCT00072865|Carboplatin|carboplatin|mesh-list
153660214|NCT00072865|Pemetrexed|pemetrexed|mesh-list
153660215|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660216|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660217|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660218|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153660219|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153660220|NCT00072904|Repaglinide|repaglinide|mesh-list
153660221|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153660222|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660223|NCT00072943|Interferons|interferons|mesh-list
153660224|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
153660225|NCT00072943|Antibodies|antibodies|mesh-list
153660226|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153660227|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
153660228|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660229|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660230|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
153660231|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660269|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153660270|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660271|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660273|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660274|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660275|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
153660276|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153660300|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660301|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153660302|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
153815075|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660303|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
153660304|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153660305|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153660306|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153660307|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153660308|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
153660309|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660310|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660311|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
153660312|NCT00073879|Fludarabine|fludarabine|mesh-list
153660313|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
153660314|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
153660315|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660316|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
153762920|NCT06319170|Autonomic Agents|autonomic agents|mesh-ancestor
153762921|NCT06319170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153762922|NCT06319170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762923|NCT06319170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153762924|NCT06319170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153762925|NCT06319170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153762926|NCT06319170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762927|NCT06319170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153762928|NCT06319170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153762929|NCT06319170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153762930|NCT06319170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153762931|NCT06319170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153762932|NCT06319170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153762966|NCT06318546|Fentanyl|fentanyl|mesh-list
153762967|NCT06318546|Dexmedetomidine|dexmedetomidine|mesh-list
153762968|NCT06318546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153762969|NCT06318546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153762970|NCT06318546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153762971|NCT06318546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153762972|NCT06318546|Analgesics|analgesics|mesh-ancestor
153762973|NCT06318546|Sensory System Agents|sensory system agents|mesh-ancestor
153660317|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660318|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660319|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660320|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
153660321|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660322|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660323|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153660324|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660325|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
153660326|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660353|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660354|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153660355|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
153660356|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153660357|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660358|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
153660359|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660360|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
153660361|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660362|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153660363|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660364|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
153660365|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660366|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153660367|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
153660368|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475636|NCT04603248|Nivolumab|nivolumab|mesh-list
153762974|NCT06318546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763032|NCT06318234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153815076|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153763033|NCT06318234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763035|NCT06318104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153763036|NCT06318104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763037|NCT06318104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153763038|NCT06318104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763039|NCT06318104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600161|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
153763040|NCT06317870|Morphine|morphine|mesh-list
153763041|NCT06317870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153763043|NCT06317870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763044|NCT06317870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763045|NCT06317870|Analgesics|analgesics|mesh-ancestor
153763046|NCT06317870|Sensory System Agents|sensory system agents|mesh-ancestor
153763047|NCT06317870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763048|NCT06317805|Treprostinil|treprostinil|mesh-list
153763049|NCT06317805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153660369|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660370|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
153660371|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
153660372|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153660373|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
153660374|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660375|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660386|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660388|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660389|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153660390|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
153660391|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660392|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
153660393|NCT02966080|Heparin|heparin|mesh-list
153660394|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
153660395|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153660396|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153660397|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660398|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
153660399|NCT04767776|Charcoal|charcoal|mesh-list
153660400|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153660401|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
153660402|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153660403|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
153660404|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660405|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660406|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
153660407|NCT04767776|Antidotes|antidotes|mesh-ancestor
153660408|NCT04767776|Protective Agents|protective agents|mesh-ancestor
153660409|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660410|NCT04730245|Rifaximin|rifaximin|mesh-list
153660411|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153660412|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660414|NCT00074620|Hirudins|hirudins|mesh-list
153660421|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153660422|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153660423|NCT02972333|Osimertinib|osimertinib|mesh-list
153660424|NCT02972333|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153877084|NCT06043908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153877085|NCT06043908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153877086|NCT06043544|Hyaluronic Acid|hyaluronic acid|mesh-list
153877087|NCT06043544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153877088|NCT06043544|Immunologic Factors|immunologic factors|mesh-ancestor
153877089|NCT06043544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877090|NCT06043544|Viscosupplements|viscosupplements|mesh-ancestor
153877091|NCT06043544|Protective Agents|protective agents|mesh-ancestor
153877092|NCT06043349|Minoxidil|minoxidil|mesh-list
153660425|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153660426|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660427|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660428|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660429|NCT00074737|Cytarabine|cytarabine|mesh-list
153660430|NCT00074737|Idarubicin|idarubicin|mesh-list
153660431|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660433|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660435|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
153660436|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660437|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660438|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
153660439|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660440|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660441|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660442|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660460|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660462|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763050|NCT06317662|Leucovorin|leucovorin|mesh-list
153763051|NCT06317662|Cytarabine|cytarabine|mesh-list
153763052|NCT06317662|Dexamethasone|dexamethasone|mesh-list
153763053|NCT06317662|Dexamethasone acetate|dexamethasone acetate|mesh-list
153763054|NCT06317662|Prednisone|prednisone|mesh-list
153763055|NCT06317662|Prednisolone|prednisolone|mesh-list
153763056|NCT06317662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153763057|NCT06317662|Methylprednisolone|methylprednisolone|mesh-list
153763058|NCT06317662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153763059|NCT06317662|Prednisolone acetate|prednisolone acetate|mesh-list
153763082|NCT06317662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153763083|NCT06317662|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153763084|NCT06317662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153763085|NCT06317662|Prednisolone phosphate|prednisolone phosphate|mesh-list
153763086|NCT06317662|BB 1101|bb 1101|mesh-list
153763087|NCT06317662|2-Aminopurine|2-aminopurine|mesh-list
153763088|NCT06317662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763089|NCT06317662|Immunologic Factors|immunologic factors|mesh-ancestor
153763098|NCT06317662|Antiemetics|antiemetics|mesh-ancestor
153763150|NCT06317636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763151|NCT06317636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153763152|NCT06317636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153763153|NCT06317636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763154|NCT06317636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763155|NCT06317597|Magnesium Sulfate|magnesium sulfate|mesh-list
153763156|NCT06317597|Sodium sulfate|sodium sulfate|mesh-list
153763157|NCT06317597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153763158|NCT06317597|Analgesics|analgesics|mesh-ancestor
153763159|NCT06317597|Sensory System Agents|sensory system agents|mesh-ancestor
153763160|NCT06317597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763161|NCT06317597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660463|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
153660464|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
153660465|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660466|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660467|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
153660468|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153660469|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153660470|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153660472|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
153660473|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417863|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153660474|NCT04729595|Protective Agents|protective agents|mesh-ancestor
153660475|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660476|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153660477|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660478|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153660479|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153417864|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417865|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660480|NCT00075205|Rimonabant|rimonabant|mesh-list
153660481|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153660482|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153660483|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153660484|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660485|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660486|NCT00075205|Hormones|hormones|mesh-ancestor
153660487|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153660488|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660489|NCT00075439|Gefitinib|gefitinib|mesh-list
153660490|NCT00075439|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153660491|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153660492|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660493|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660494|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660495|NCT00075517|Gemcitabine|gemcitabine|mesh-list
153660496|NCT00075517|Docetaxel|docetaxel|mesh-list
153763162|NCT06317597|Anesthetics|anesthetics|mesh-ancestor
153660521|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
153660522|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153660523|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660524|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660525|NCT00075595|Antidotes|antidotes|mesh-ancestor
153660526|NCT00075595|Protective Agents|protective agents|mesh-ancestor
153660527|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
153660529|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
153660530|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
153660531|NCT00075634|Doxorubicin|doxorubicin|mesh-list
153660532|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153660533|NCT00075634|Decitabine|decitabine|mesh-list
153660534|NCT00075634|Azacitidine|azacitidine|mesh-list
153660535|NCT00075634|Lenograstim|lenograstim|mesh-list
153660536|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660537|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
153660538|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417866|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153417867|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
153417868|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153417869|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
153417870|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417871|NCT04792021|Expectorants|expectorants|mesh-ancestor
153417872|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417873|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153417874|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
153417875|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813968|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660539|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660540|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660541|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
153660542|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660543|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660544|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153660545|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153476079|NCT00886626|Exenatide|exenatide|mesh-list
153763163|NCT06317597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763164|NCT06317597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153763165|NCT06317597|Anticonvulsants|anticonvulsants|mesh-ancestor
153763166|NCT06317597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153763167|NCT06317597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153763168|NCT06317597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763169|NCT06317597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153763170|NCT06317597|Tocolytic Agents|tocolytic agents|mesh-ancestor
153763171|NCT06317597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153763172|NCT06317597|Cathartics|cathartics|mesh-ancestor
153763200|NCT06317142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763201|NCT06317142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153763203|NCT06317064|Aprepitant|aprepitant|mesh-list
153763204|NCT06317064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
153763205|NCT06317064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153763206|NCT06317064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153763207|NCT06317064|Analgesics|analgesics|mesh-ancestor
153763208|NCT06317064|Sensory System Agents|sensory system agents|mesh-ancestor
153763209|NCT06317064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763210|NCT06317064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763211|NCT06317064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763212|NCT06317064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763213|NCT06317064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153763214|NCT06317064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476148|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660546|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660547|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660548|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660549|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153660550|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660552|NCT00075673|Celecoxib|celecoxib|mesh-list
153660553|NCT00075673|Vinorelbine|vinorelbine|mesh-list
153660554|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153660555|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153660556|NCT00075673|Analgesics|analgesics|mesh-ancestor
153660592|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660593|NCT00075907|Ritonavir|ritonavir|mesh-list
153660594|NCT00075907|Lopinavir|lopinavir|mesh-list
153660595|NCT00075907|Efavirenz|efavirenz|mesh-list
153660615|NCT03958383|Ipilimumab|ipilimumab|mesh-list
153660616|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660617|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660618|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153660619|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660620|NCT00076414|Acetylcholine|acetylcholine|mesh-list
153660621|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
153660622|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153660623|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
153660624|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660625|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763215|NCT06317064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763216|NCT06317064|Antiemetics|antiemetics|mesh-ancestor
153763217|NCT06317064|Autonomic Agents|autonomic agents|mesh-ancestor
153763218|NCT06317064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763222|NCT06317051|Ezetimibe|ezetimibe|mesh-list
153763255|NCT06316960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763256|NCT06316908|Ethanol|ethanol|mesh-list
153763257|NCT06316908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153763258|NCT06316908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763259|NCT06316908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763260|NCT06316908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763261|NCT06316570|Aspirin|aspirin|mesh-list
153763264|NCT06316570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153763319|NCT06311422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153763320|NCT06311422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763321|NCT06311422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763322|NCT06311422|Antimanic Agents|antimanic agents|mesh-ancestor
153763323|NCT06311422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153763324|NCT06311422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763325|NCT06311422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763329|NCT06293326|Calcium, Dietary|calcium, dietary|mesh-list
153763330|NCT06293326|Calcium Carbonate|calcium carbonate|mesh-list
153763331|NCT06293326|Calcium|calcium|mesh-list
153763332|NCT06293326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153660626|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660627|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
153660628|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153660629|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
153660630|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660631|NCT00399256|Expectorants|expectorants|mesh-ancestor
153660632|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
153660633|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153660634|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
153660635|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660636|NCT00399256|Protective Agents|protective agents|mesh-ancestor
153660637|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660638|NCT00399256|Antidotes|antidotes|mesh-ancestor
153660639|NCT00399295|Naltrexone|naltrexone|mesh-list
153660640|NCT00399295|Hydromorphone|hydromorphone|mesh-list
153660641|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
153660642|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153660643|NCT00399295|Narcotics|narcotics|mesh-ancestor
153660644|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153660645|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660646|NCT00399295|Analgesics|analgesics|mesh-ancestor
153660647|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
153660648|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660656|NCT00076492|Vitamins|vitamins|mesh-ancestor
153660657|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
153660658|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660659|NCT00076531|Leuprolide|leuprolide|mesh-list
153660660|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153660661|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
153660662|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153660663|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660664|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153660665|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660666|NCT00076609|Capecitabine|capecitabine|mesh-list
153660667|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153813972|NCT00335933|Gabapentin|gabapentin|mesh-list
153660668|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
153660669|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476172|NCT00899574|Imiquimod|imiquimod|mesh-list
153763333|NCT06293326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660670|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660671|NCT00076726|Infliximab|infliximab|mesh-list
153660672|NCT00076726|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153660673|NCT00076726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660674|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
153660675|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877095|NCT06043336|Dexamethasone|dexamethasone|mesh-list
153660676|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660677|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153660678|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660679|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660680|NCT00077077|Capecitabine|capecitabine|mesh-list
153660681|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660682|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
153660683|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660684|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660686|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
153660687|NCT00077116|Busulfan|busulfan|mesh-list
153660688|NCT00077116|Idarubicin|idarubicin|mesh-list
153660689|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
153660690|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660691|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
153660692|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660693|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660694|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660695|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
153660696|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660697|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660698|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153660699|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660700|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
153660701|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
153763334|NCT06293326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153763335|NCT06293326|Antacids|antacids|mesh-ancestor
153763337|NCT06293326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877096|NCT06043336|Palonosetron|palonosetron|mesh-list
153877097|NCT06043336|Granisetron|granisetron|mesh-list
153877098|NCT06043336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877099|NCT06043336|Antiemetics|antiemetics|mesh-ancestor
153877100|NCT06043336|Autonomic Agents|autonomic agents|mesh-ancestor
153877101|NCT06043336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877102|NCT06043336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877103|NCT06043336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153887551|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153763375|NCT06276231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153763376|NCT06276231|Respiratory System Agents|respiratory system agents|mesh-ancestor
153763377|NCT06276231|Tocolytic Agents|tocolytic agents|mesh-ancestor
153763378|NCT06276231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153763379|NCT06276231|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153763380|NCT06276231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153763381|NCT06276231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153763382|NCT06276231|Adrenergic Agents|adrenergic agents|mesh-ancestor
153763383|NCT06276231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763384|NCT06260566|Acetylcysteine|acetylcysteine|mesh-list
153660702|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660703|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660704|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660705|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660706|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660707|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660709|NCT00077116|Immunoconjugates|immunoconjugates|mesh-ancestor
153660710|NCT03951207|Amlodipine|amlodipine|mesh-list
153660711|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153660712|NCT03951207|Atorvastatin|atorvastatin|mesh-list
153660713|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153660714|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153660715|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
153660716|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660717|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153476253|NCT00908466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763385|NCT06260566|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153763386|NCT06260566|Antiviral Agents|antiviral agents|mesh-ancestor
153763387|NCT06260566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763388|NCT06260566|Expectorants|expectorants|mesh-ancestor
153763389|NCT06260566|Respiratory System Agents|respiratory system agents|mesh-ancestor
153763390|NCT06260566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153763391|NCT06260566|Antioxidants|antioxidants|mesh-ancestor
153763434|NCT06241118|Analgesics|analgesics|mesh-ancestor
153763435|NCT06241118|Sensory System Agents|sensory system agents|mesh-ancestor
153763436|NCT06241118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763437|NCT06241118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763438|NCT06241118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763439|NCT06241118|Dermatologic Agents|dermatologic agents|mesh-ancestor
153763440|NCT06239220|Cetuximab|cetuximab|mesh-list
153763441|NCT06239220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763442|NCT06239220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763443|NCT06227117|Cyclophosphamide|cyclophosphamide|mesh-list
153763444|NCT06227117|Carboplatin|carboplatin|mesh-list
153763445|NCT06227117|Epirubicin|epirubicin|mesh-list
153763446|NCT06227117|Disitamab vedotin|disitamab vedotin|mesh-list
153763447|NCT06227117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153763448|NCT06227117|Immunologic Factors|immunologic factors|mesh-ancestor
153763449|NCT06227117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763450|NCT06227117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763451|NCT06227117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153763494|NCT06225622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763495|NCT06206512|Torsemide|torsemide|mesh-list
153763496|NCT06206512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153763497|NCT06206512|Diuretics|diuretics|mesh-ancestor
153763498|NCT06206512|Natriuretic Agents|natriuretic agents|mesh-ancestor
153763499|NCT06206512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455658|NCT05414500|Immunoconjugates|immunoconjugates|mesh-ancestor
153877106|NCT06043336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357294|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813974|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
153763500|NCT06206512|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153763501|NCT06206512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153763502|NCT06206512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763503|NCT06200467|Moxifloxacin|moxifloxacin|mesh-list
153763504|NCT06200467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153763505|NCT06200467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153763506|NCT06200467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763507|NCT06200467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153763508|NCT06200467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153763509|NCT06200467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660729|NCT00077194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153660730|NCT00077194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660731|NCT00077194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660733|NCT00077233|Fluorouracil|fluorouracil|mesh-list
153660734|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
153660735|NCT00077233|Irinotecan|irinotecan|mesh-list
153660736|NCT00077233|Cetuximab|cetuximab|mesh-list
153660737|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660738|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
153660739|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660740|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660741|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660742|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660743|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
153660744|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153660745|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660746|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660747|NCT00077233|Antidotes|antidotes|mesh-ancestor
153660748|NCT00077233|Protective Agents|protective agents|mesh-ancestor
153660749|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
153660750|NCT00077233|Vitamins|vitamins|mesh-ancestor
153660751|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
153660752|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660753|NCT02958631|Losartan|losartan|mesh-list
153660754|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153660755|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153660756|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153660757|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153660758|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660759|NCT00077311|Docetaxel|docetaxel|mesh-list
153660760|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
153660761|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
153763510|NCT06200467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763511|NCT06200467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763512|NCT06200467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153763513|NCT06200467|Contraceptive Agents|contraceptive agents|mesh-ancestor
153763515|NCT06200467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763516|NCT06200467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153763519|NCT06192108|Dapagliflozin|dapagliflozin|mesh-list
153763543|NCT06179303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153763544|NCT06179303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153763545|NCT06179303|Hormones|hormones|mesh-list
153660762|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660763|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
153660764|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660765|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
153660766|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660768|NCT00077311|Protective Agents|protective agents|mesh-ancestor
153660769|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660770|NCT00077350|Gemcitabine|gemcitabine|mesh-list
153660771|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660772|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
153810682|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660773|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660774|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660775|NCT00077389|Carboplatin|carboplatin|mesh-list
153660776|NCT00077389|Doxorubicin|doxorubicin|mesh-list
153660777|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153660778|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660789|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660790|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660791|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660792|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660793|NCT00077467|Bortezomib|bortezomib|mesh-list
153476322|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153763546|NCT06179303|Estradiol|estradiol|mesh-list
153763547|NCT06179303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153763548|NCT06179303|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153763549|NCT06179303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153763550|NCT06179303|Fluorides|fluorides|mesh-list
153763551|NCT06179303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763552|NCT06179303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763553|NCT06179303|Estrogens|estrogens|mesh-ancestor
153763554|NCT06179303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153763555|NCT06179303|Contraceptive Agents|contraceptive agents|mesh-ancestor
153763556|NCT06179303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153763557|NCT06179303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153763558|NCT06179303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763600|NCT06152653|Respiratory System Agents|respiratory system agents|mesh-ancestor
153763601|NCT06152653|Tocolytic Agents|tocolytic agents|mesh-ancestor
153763602|NCT06152653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153763603|NCT06152653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153763604|NCT06152653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153763605|NCT06152653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153763606|NCT06152653|Adrenergic Agents|adrenergic agents|mesh-ancestor
153763607|NCT06152653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763608|NCT06152653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763609|NCT06152653|Antiviral Agents|antiviral agents|mesh-ancestor
153763610|NCT06152653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763611|NCT06152653|Expectorants|expectorants|mesh-ancestor
153763612|NCT06152653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153763613|NCT06152653|Antioxidants|antioxidants|mesh-ancestor
153763614|NCT06152653|Protective Agents|protective agents|mesh-ancestor
153763615|NCT06152653|Antidotes|antidotes|mesh-ancestor
153660794|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660795|NCT00077545|Cisplatin|cisplatin|mesh-list
153660796|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660797|NCT00077584|Bosentan|bosentan|mesh-list
153660798|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153660799|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153660800|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660801|NCT00077779|Adalimumab|adalimumab|mesh-list
153660802|NCT00077779|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153660803|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660804|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660805|NCT00077818|Enoxaparin|enoxaparin|mesh-list
153660806|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
153660807|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
153660808|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153660809|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153660810|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660811|NCT00078130|Buprenorphine|buprenorphine|mesh-list
153660812|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153813975|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660813|NCT00078130|Naloxone|naloxone|mesh-list
153660814|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153660815|NCT00078130|Narcotics|narcotics|mesh-ancestor
153660816|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153660817|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660818|NCT00078130|Analgesics|analgesics|mesh-ancestor
153660819|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
153660820|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660821|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153660822|NCT00399451|Polidocanol|polidocanol|mesh-list
153660823|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153660824|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153660825|NCT04711213|Dexamethasone|dexamethasone|mesh-list
153660826|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
153660827|NCT04711213|BB 1101|bb 1101|mesh-list
153660828|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660829|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
153660830|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
153660833|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153660834|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
153660835|NCT04711213|Hormones|hormones|mesh-ancestor
153660836|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153660837|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153660838|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660839|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
153660840|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660841|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660842|NCT00078247|Lamivudine|lamivudine|mesh-list
153660843|NCT00078247|Zidovudine|zidovudine|mesh-list
153660844|NCT00078247|Abacavir|abacavir|mesh-list
153660875|NCT00078793|Etanercept|etanercept|mesh-list
153660876|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153660877|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153660878|NCT00078793|Analgesics|analgesics|mesh-ancestor
153660879|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
153660880|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660881|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660882|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660883|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660886|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
153660887|NCT00078832|Anastrozole|anastrozole|mesh-list
153763616|NCT06151574|Carboplatin|carboplatin|mesh-list
153763617|NCT06151574|Pembrolizumab|pembrolizumab|mesh-list
153763618|NCT06151574|Pemetrexed|pemetrexed|mesh-list
153763619|NCT06151574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763620|NCT06151574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763621|NCT06151574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153763653|NCT06132113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763654|NCT06132113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763655|NCT06108947|Aspirin|aspirin|mesh-list
153763656|NCT06108947|Salicylic Acid|salicylic acid|mesh-list
153763657|NCT06108947|Salicylates|salicylates|mesh-list
153763658|NCT06108947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153763659|NCT06108947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153763660|NCT06108947|Analgesics|analgesics|mesh-ancestor
153763661|NCT06108947|Sensory System Agents|sensory system agents|mesh-ancestor
153763662|NCT06108947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153763663|NCT06108947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763664|NCT06108947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153763665|NCT06108947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153763666|NCT06108947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153763667|NCT06108947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153763668|NCT06108947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763669|NCT06108947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153763710|NCT06091657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153763711|NCT06091657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153763712|NCT06091657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153763713|NCT06086626|Cefiderocol|cefiderocol|mesh-list
153763714|NCT06086626|Siderophores|siderophores|mesh-ancestor
153763715|NCT06086626|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153763716|NCT06086626|Chelating Agents|chelating agents|mesh-ancestor
153763717|NCT06086626|Sequestering Agents|sequestering agents|mesh-ancestor
153476451|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660888|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153660919|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153660920|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153660922|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
153660923|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660924|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660925|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660926|NCT00078988|Carboplatin|carboplatin|mesh-list
153660927|NCT00078988|Etoposide|etoposide|mesh-list
153660928|NCT00078988|Thiotepa|thiotepa|mesh-list
153660929|NCT00078988|Isotretinoin|isotretinoin|mesh-list
153660930|NCT00078988|Lenograstim|lenograstim|mesh-list
153660939|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660940|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660941|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
153660942|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153660943|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660944|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
153660945|NCT00079027|Doxorubicin|doxorubicin|mesh-list
153497938|NCT00002880|Etoposide|etoposide|mesh-list
153660946|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153660947|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660948|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660949|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660950|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660951|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660952|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660953|NCT00079105|Prednisolone|prednisolone|mesh-list
153660954|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
153660955|NCT00079105|Etoposide|etoposide|mesh-list
153660956|NCT00079105|Vincristine|vincristine|mesh-list
153660957|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
153660958|NCT00079105|Bleomycin|bleomycin|mesh-list
153660959|NCT00079105|Vinblastine|vinblastine|mesh-list
153763718|NCT06086626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763719|NCT06086626|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153763720|NCT06086626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153763774|NCT06073184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153763775|NCT06063967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153763776|NCT06063967|Immunologic Factors|immunologic factors|mesh-ancestor
153763777|NCT06063967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660960|NCT00079105|Procarbazine|procarbazine|mesh-list
153660961|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
153660962|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660963|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
153660964|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660965|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660966|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660967|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
153660968|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660969|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660970|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153660971|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153660972|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660973|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660974|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660975|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
153660976|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660977|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
153660978|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660979|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
153660980|NCT00079105|Hormones|hormones|mesh-ancestor
153660981|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153660982|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153660983|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660984|NCT00079105|Analgesics|analgesics|mesh-ancestor
153660985|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
153660986|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660987|NCT03647124|Lenalidomide|lenalidomide|mesh-list
153660988|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
153660989|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660990|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153660991|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153660992|NCT03647124|Growth Substances|growth substances|mesh-ancestor
153660993|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
153660994|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660995|NCT00079144|Aldesleukin|aldesleukin|mesh-list
153763781|NCT06059391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763782|NCT06059391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153763784|NCT06050252|Gemcitabine|gemcitabine|mesh-list
153661007|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661008|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153661009|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153661010|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
153661011|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153661012|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153661013|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153661014|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
153661015|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661016|NCT00079222|Itraconazole|itraconazole|mesh-list
153661017|NCT00079222|Voriconazole|voriconazole|mesh-list
153661018|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
153661019|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661020|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153661021|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153661022|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661023|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661024|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153661025|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
153661026|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661027|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661028|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153661029|NCT00079261|Prednisone|prednisone|mesh-list
153661030|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
153661031|NCT00079261|Gemcitabine|gemcitabine|mesh-list
153661032|NCT00079261|Doxorubicin|doxorubicin|mesh-list
153661033|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153661034|NCT00079261|Vincristine|vincristine|mesh-list
153661035|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813979|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153763785|NCT06050252|Durvalumab|durvalumab|mesh-list
153763786|NCT06050252|Immunoglobulins|immunoglobulins|mesh-list
153763787|NCT06050252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153763788|NCT06050252|Immunoglobulin G|immunoglobulin g|mesh-list
153763831|NCT06032923|Niacin|niacin|mesh-list
153763835|NCT06032923|Micronutrients|micronutrients|mesh-ancestor
153763836|NCT06032923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763837|NCT06032923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153763838|NCT06032923|Antimetabolites|antimetabolites|mesh-ancestor
153763839|NCT06032923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763840|NCT06032923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153763841|NCT06032923|Vasodilator Agents|vasodilator agents|mesh-ancestor
153763842|NCT06017921|Eszopiclone|eszopiclone|mesh-list
153763843|NCT06017921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153763844|NCT06017921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763845|NCT06017921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763846|NCT06016972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153476601|NCT00967044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153661036|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
153661037|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661038|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661039|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153661040|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
153661041|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661042|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661043|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153661044|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153661045|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
153661046|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153661047|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153661048|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153661049|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661050|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153661051|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
153661053|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661054|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153661055|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153661056|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661057|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661058|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
153661064|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661066|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661067|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
153661068|NCT00079378|Decitabine|decitabine|mesh-list
153661069|NCT00079378|Azacitidine|azacitidine|mesh-list
153661070|NCT00079378|Valproic Acid|valproic acid|mesh-list
153661071|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153661072|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
153661073|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661074|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476610|NCT00973752|Cytarabine|cytarabine|mesh-list
153763847|NCT06016972|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153763900|NCT05930197|Bismuth|bismuth|mesh-list
153763901|NCT05930197|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153763902|NCT05930197|Antacids|antacids|mesh-ancestor
153661076|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
153661077|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
153661078|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661079|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661080|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
153661081|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153661082|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661083|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661084|NCT00079456|Sirolimus|sirolimus|mesh-list
153661085|NCT00079456|Temsirolimus|temsirolimus|mesh-list
153813980|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813981|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661086|NCT00079456|MTOR Inhibitors|mtor inhibitors|mesh-list
153661087|NCT00079456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153661088|NCT00079456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661089|NCT00079456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661090|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661091|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
153661092|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661093|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661094|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153661095|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661096|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153661097|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
153661098|NCT04467086|Propranolol|propranolol|mesh-list
153661099|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153661100|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153661101|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
153661102|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661103|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661104|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661105|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153661106|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153661107|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
153661108|NCT00079612|Sorafenib|sorafenib|mesh-list
153661109|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661110|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153661111|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476677|NCT00976248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153661112|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661113|NCT03526107|Theobromine|theobromine|mesh-list
153661114|NCT03526107|Caffeine|caffeine|mesh-list
153661115|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153661116|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661117|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153661118|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661119|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661120|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153661121|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153661122|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
153661123|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661124|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153661125|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
153661126|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661161|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
153661162|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661163|NCT00079963|Protective Agents|protective agents|mesh-ancestor
153661164|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
153661165|NCT00392886|Temozolomide|temozolomide|mesh-list
153661166|NCT00392886|Thiotepa|thiotepa|mesh-list
153661193|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661194|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
153661195|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
153661196|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763903|NCT05930197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763904|NCT05930197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153763905|NCT05930197|Antidiarrheals|antidiarrheals|mesh-ancestor
153763906|NCT05926960|Pembrolizumab|pembrolizumab|mesh-list
153763907|NCT05926960|Nivolumab|nivolumab|mesh-list
153763969|NCT05837091|Sodium Oxybate|sodium oxybate|mesh-list
153763970|NCT05837091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153763971|NCT05837091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153763972|NCT05837091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153417900|NCT04430959|Candesartan|candesartan|mesh-list
153763973|NCT05837091|Anesthetics, General|anesthetics, general|mesh-ancestor
153763974|NCT05837091|Anesthetics|anesthetics|mesh-ancestor
153763975|NCT05837091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153763976|NCT05827549|Blinatumomab|blinatumomab|mesh-list
153763977|NCT05827549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763978|NCT05818124|Oseltamivir|oseltamivir|mesh-list
153763979|NCT05818124|Molnupiravir|molnupiravir|mesh-list
153763980|NCT05818124|Antiviral Agents|antiviral agents|mesh-ancestor
153763981|NCT05818124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153763982|NCT05818124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153763983|NCT05818124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153763984|NCT05804370|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153763985|NCT05804370|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153661197|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153661198|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
153661200|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661201|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661202|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661203|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
153661204|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661205|NCT00080158|Mirtazapine|mirtazapine|mesh-list
153661206|NCT00080158|Citalopram|citalopram|mesh-list
153661207|NCT00080158|Bupropion|bupropion|mesh-list
153661208|NCT00080158|Fluoxetine|fluoxetine|mesh-list
153661209|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153661210|NCT00080158|Sertraline|sertraline|mesh-list
153661211|NCT00080158|Escitalopram|escitalopram|mesh-list
153661212|NCT00080158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153661213|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153661214|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153661223|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
153661224|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153661225|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153661226|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661227|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153661228|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661229|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153661230|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153661231|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
153763986|NCT05804370|Dermatologic Agents|dermatologic agents|mesh-ancestor
153763987|NCT05785767|Cemiplimab|cemiplimab|mesh-list
153763988|NCT05785767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153763989|NCT05785767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764024|NCT05768139|Hormone Antagonists|hormone antagonists|mesh-ancestor
153764025|NCT05768139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764026|NCT05768139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764027|NCT05761171|Cytarabine|cytarabine|mesh-list
153764028|NCT05761171|Prednisone|prednisone|mesh-list
153764029|NCT05761171|Prednisolone|prednisolone|mesh-list
153764030|NCT05761171|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153764092|NCT05748171|Immunologic Factors|immunologic factors|mesh-ancestor
153764093|NCT05748171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764094|NCT05734001|Hemostatics|hemostatics|mesh-list
153764095|NCT05734001|Coagulants|coagulants|mesh-ancestor
153764096|NCT05724134|Insulin|insulin|mesh-list
153764097|NCT05724134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153764098|NCT05724134|Octreotide|octreotide|mesh-list
153764099|NCT05724134|Glucagon|glucagon|mesh-list
153601209|NCT01888744|Cetrorelix|cetrorelix|mesh-list
153764100|NCT05724134|Hormones|hormones|mesh-list
153764101|NCT05724134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153764107|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
153661232|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
153661233|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153455659|NCT05414500|Immunologic Factors|immunologic factors|mesh-ancestor
153661234|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153661235|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153661236|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153661237|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153661238|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153661239|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153661240|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153661241|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153661242|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661243|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153661244|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661245|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661248|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153661249|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153661250|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
153661251|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661252|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153661253|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153661254|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661255|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
153661256|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
153661258|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
153661259|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877131|NCT06042985|Citric Acid|citric acid|mesh-list
153661260|NCT00393003|Anesthetics|anesthetics|mesh-list
153661261|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661262|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661263|NCT00080314|Aripiprazole|aripiprazole|mesh-list
153661264|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
153661265|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661266|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153661267|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153764156|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
153661270|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
153661271|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
153661272|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661273|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661274|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153661275|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153661276|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
153661277|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153661289|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
153661290|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661291|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661292|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
153661293|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661294|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661296|NCT03506373|Ibrutinib|ibrutinib|mesh-list
153661297|NCT03506373|Glycine|glycine|mesh-list
153661298|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661299|NCT03506373|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153661300|NCT03506373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153661301|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661302|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661303|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
153661304|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
153661305|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661306|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661307|NCT02972411|Acetazolamide|acetazolamide|mesh-list
153661308|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
153661309|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153661310|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661311|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661312|NCT02972411|Diuretics|diuretics|mesh-ancestor
153661313|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
153661314|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661320|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661322|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
153661323|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661324|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661325|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661326|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
153661327|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476846|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877160|NCT06037993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877161|NCT06037993|Antiviral Agents|antiviral agents|mesh-ancestor
153877162|NCT06037993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877163|NCT06037993|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153417923|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153417924|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
153764157|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764158|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764159|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153764160|NCT05679401|Hormones|hormones|mesh-ancestor
153764163|NCT05661552|Ezetimibe|ezetimibe|mesh-list
153764164|NCT05661552|Evolocumab|evolocumab|mesh-list
153764167|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
153764221|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153877164|NCT06037993|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153764222|NCT05564390|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153764223|NCT05564390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764224|NCT05552976|Dexamethasone|dexamethasone|mesh-list
153764225|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764226|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
153764227|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
153764228|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153764229|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764230|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153764231|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
153764232|NCT05552976|Hormones|hormones|mesh-ancestor
153764233|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764234|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153764235|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764236|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153764237|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764238|NCT05536154|Cytarabine|cytarabine|mesh-list
153764239|NCT05536154|Etoposide|etoposide|mesh-list
153764277|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153764278|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
153764279|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153764280|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153764281|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764282|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764283|NCT05450328|Protective Agents|protective agents|mesh-ancestor
153877165|NCT06037993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877166|NCT06037993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877167|NCT06037993|Hormones|hormones|mesh-ancestor
153877168|NCT06037993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877169|NCT06034873|Fentanyl|fentanyl|mesh-list
153887623|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
153887624|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
153877170|NCT06034873|Bupivacaine|bupivacaine|mesh-list
153764284|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764285|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153764286|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
153764287|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764288|NCT05429970|Etodolac|etodolac|mesh-list
153764289|NCT05429970|Propofol|propofol|mesh-list
153764290|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153764291|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764292|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764337|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
153764338|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764339|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764340|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153764341|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
153764342|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764343|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764344|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153764345|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764346|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
153764347|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764348|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764349|NCT05382338|Protective Agents|protective agents|mesh-ancestor
153661328|NCT00080665|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153661329|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153661330|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661331|NCT00080743|Tamoxifen|tamoxifen|mesh-list
153661332|NCT00080743|Gefitinib|gefitinib|mesh-list
153661333|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661334|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153661335|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
153661336|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661337|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661338|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153661339|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661340|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153661341|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153661353|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661354|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661355|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153661356|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153661357|NCT00080782|Analgesics|analgesics|mesh-ancestor
153661358|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
153661359|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661360|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661361|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153661362|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661363|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153476863|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
153764350|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
153764351|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
153764352|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153764353|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764354|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
153877171|NCT06034873|Propofol|propofol|mesh-list
153877172|NCT06034873|Anesthetics, Local|anesthetics, local|mesh-ancestor
153877173|NCT06034873|Anesthetics|anesthetics|mesh-ancestor
153877174|NCT06034873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877175|NCT06034873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877176|NCT06034873|Sensory System Agents|sensory system agents|mesh-ancestor
153879357|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153813982|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153813983|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153764355|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
153764356|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153764357|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
153764359|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
153810692|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153764391|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153764393|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764394|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764395|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153764396|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153764397|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153764398|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
153764399|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153764400|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153764401|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661364|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153661365|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153661366|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153661367|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661368|NCT00080977|Aldesleukin|aldesleukin|mesh-list
153661369|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661370|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153661371|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153661372|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
153661373|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661374|NCT00081055|Cyclosporine|cyclosporine|mesh-list
153661375|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
153661376|NCT00081055|Busulfan|busulfan|mesh-list
153661377|NCT00081055|Methotrexate|methotrexate|mesh-list
153661378|NCT00081055|Cyclosporins|cyclosporins|mesh-list
153661379|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661380|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
153661381|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661382|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661383|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153661384|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
153661385|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661386|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661387|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153476883|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153764402|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
153764513|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764514|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764515|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764516|NCT05064085|Capecitabine|capecitabine|mesh-list
153764517|NCT05064085|Cemiplimab|cemiplimab|mesh-list
153764518|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153764519|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
153764520|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764521|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764522|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764523|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
153764524|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153764525|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153764526|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153764527|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764528|NCT05061550|Paclitaxel|paclitaxel|mesh-list
153764529|NCT05061550|Cisplatin|cisplatin|mesh-list
153764530|NCT05061550|Carboplatin|carboplatin|mesh-list
153764531|NCT05061550|Pemetrexed|pemetrexed|mesh-list
153764532|NCT05061550|Durvalumab|durvalumab|mesh-list
153764533|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764534|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764535|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
153764536|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764537|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
153476935|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661388|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153661389|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
153661390|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153661391|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153661392|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
153661393|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
153661394|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661395|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153661396|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153661397|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
153661398|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661399|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153736426|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736427|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
153661400|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153661401|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153661402|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661403|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
153661404|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
153661405|NCT00081133|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153661443|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661470|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661472|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661473|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153661474|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153661475|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153661476|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153661477|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153661478|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153661479|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153476960|NCT01010568|Ofatumumab|ofatumumab|mesh-list
153764538|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764539|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764540|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153764541|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153764542|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764543|NCT05041335|Heparin|heparin|mesh-list
153764544|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
153661480|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153661481|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153661482|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661483|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153661484|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
153661485|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153661486|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661487|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153661514|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661515|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153661516|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153661517|NCT00082576|Azithromycin|azithromycin|mesh-list
153661518|NCT00082576|Chloroquine|chloroquine|mesh-list
153813987|NCT00336167|Bezafibrate|bezafibrate|mesh-list
153661519|NCT00082576|Mefloquine|mefloquine|mesh-list
153661520|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153661521|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661522|NCT00082576|Amebicides|amebicides|mesh-ancestor
153661523|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153661524|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153661525|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
153661526|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661527|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
153661528|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153661529|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661530|NCT00082966|Bortezomib|bortezomib|mesh-list
153661531|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661532|NCT00083005|Thalidomide|thalidomide|mesh-list
153661533|NCT00083005|Docetaxel|docetaxel|mesh-list
153661534|NCT00083005|Estramustine|estramustine|mesh-list
153661535|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476983|NCT01015170|Bupropion|bupropion|mesh-list
153764545|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153764546|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153764547|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764548|NCT05014282|Nicotine|nicotine|mesh-list
153764549|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153764598|NCT04931342|Bevacizumab|bevacizumab|mesh-list
153764599|NCT04931342|Trastuzumab|trastuzumab|mesh-list
153764600|NCT04931342|Atezolizumab|atezolizumab|mesh-list
153764601|NCT04931342|Letrozole|letrozole|mesh-list
153764602|NCT04931342|Olaparib|olaparib|mesh-list
153764603|NCT04931342|Palbociclib|palbociclib|mesh-list
153764604|NCT04931342|Ipatasertib|ipatasertib|mesh-list
153764605|NCT04931342|Hormones|hormones|mesh-list
153764606|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153764607|NCT04931342|Inavolisib|inavolisib|mesh-list
153764608|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764609|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764610|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
153477025|NCT05395962|Carboplatin|carboplatin|mesh-list
153661536|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661537|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661538|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153661575|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153661576|NCT03151863|Analgesics|analgesics|mesh-ancestor
153661577|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
153661588|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661589|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
153661590|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661591|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661592|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153661593|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
153661594|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661595|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661596|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153661597|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153661598|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153661599|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153661600|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661602|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153661603|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661604|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153661605|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661607|NCT00083434|Hematinics|hematinics|mesh-ancestor
153661608|NCT00083590|Huperzine A|huperzine a|mesh-list
153764611|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764612|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764613|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764614|NCT04931342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764615|NCT04931342|Immunologic Factors|immunologic factors|mesh-ancestor
153764616|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764617|NCT04931342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764618|NCT04931342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153764619|NCT04931342|Alkylating Agents|alkylating agents|mesh-ancestor
153764620|NCT04931342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153764621|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764622|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153764623|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153764624|NCT04931342|Growth Substances|growth substances|mesh-ancestor
153764638|NCT04904614|Letermovir|letermovir|mesh-list
153764652|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153764653|NCT04865770|Semaglutide|semaglutide|mesh-list
153764654|NCT04865770|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153764655|NCT04865770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153661609|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153661610|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661611|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661612|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
153661613|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661614|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661615|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153661616|NCT00083590|Protective Agents|protective agents|mesh-ancestor
153661617|NCT03151746|Gabapentin|gabapentin|mesh-list
153661618|NCT03151746|Analgesics|analgesics|mesh-ancestor
153661619|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
153661620|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661621|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661622|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
153661623|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153661624|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153661625|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661626|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661627|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153661628|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153661629|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913878|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153417968|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
153877178|NCT06034873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153877179|NCT06034873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153877180|NCT06034873|Anesthetics, General|anesthetics, general|mesh-ancestor
153877181|NCT06034873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153877182|NCT06034873|Narcotics|narcotics|mesh-ancestor
153877183|NCT06034873|Analgesics|analgesics|mesh-ancestor
153877184|NCT06034873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153877185|NCT06034379|Atropine|atropine|mesh-list
153877186|NCT06034379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153877205|NCT06034158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153661630|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661631|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
153661632|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
153764656|NCT04865770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764657|NCT04862650|Paclitaxel|paclitaxel|mesh-list
153764658|NCT04862650|Carboplatin|carboplatin|mesh-list
153764659|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153764660|NCT04862650|Cemiplimab|cemiplimab|mesh-list
153764661|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764662|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764663|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
153764664|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764665|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764666|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764667|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764668|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
153764669|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153764670|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
153764671|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764672|NCT04777539|Natalizumab|natalizumab|mesh-list
153764673|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
153764674|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816241|NCT00352742|Bortezomib|bortezomib|mesh-list
153816242|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153816243|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816244|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
153816245|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
153764684|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764685|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661633|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153661634|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661635|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153661636|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153661637|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153428705|NCT04331210|Analgesics|analgesics|mesh-ancestor
153661638|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661639|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661640|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661646|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153661647|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153661648|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
153661649|NCT00083707|Thalidomide|thalidomide|mesh-list
153661650|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661651|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
153661652|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661653|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
153813991|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153661654|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153661655|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661656|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153661657|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153661658|NCT00083707|Growth Substances|growth substances|mesh-ancestor
153661659|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
153661660|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661661|NCT00083785|Talaporfin|talaporfin|mesh-list
153661662|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661663|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153661664|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
153661665|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
153661666|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153661667|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661668|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661669|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153661670|NCT03151668|Analgesics|analgesics|mesh-ancestor
153661671|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
153661672|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477122|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
153764686|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764687|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764688|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
153764689|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153661673|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153661674|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153661675|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153661676|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
153661677|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661678|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661680|NCT05568082|Sotorasib|sotorasib|mesh-list
153661681|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
153661682|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661683|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153661684|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153661685|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360874|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153661686|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661687|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153661688|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
153661689|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661690|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661691|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153661692|NCT05568082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153661693|NCT05568082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153661694|NCT05568082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661695|NCT05567653|Sulfalene|sulfalene|mesh-list
153661696|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661697|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153661698|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
153661727|NCT00135499|Bleomycin|bleomycin|mesh-list
153661728|NCT00135499|Vindesine|vindesine|mesh-list
153661729|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661730|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
153661731|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661732|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661733|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153661734|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
153661735|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661736|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661737|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153661738|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153661739|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153661740|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153661741|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153661742|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661743|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153661744|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
153661745|NCT00135499|Hormones|hormones|mesh-ancestor
153661746|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661747|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153661748|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153661749|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661750|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661751|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
153661752|NCT03151434|Hydromorphone|hydromorphone|mesh-list
153661753|NCT03151434|Bupivacaine|bupivacaine|mesh-list
153661754|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
153661755|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
153661756|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661757|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661758|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
153477197|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764690|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764691|NCT04696055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153764692|NCT04696055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764693|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153764694|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
153764695|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
153764696|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661759|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661760|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153661762|NCT03151434|Analgesics|analgesics|mesh-ancestor
153661763|NCT00135577|Alvimopan|alvimopan|mesh-list
153661764|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877206|NCT06034158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153661765|NCT00135733|Alefacept|alefacept|mesh-list
153661766|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877207|NCT06034158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813994|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661767|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
153661768|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661769|NCT00135811|Cyclosporine|cyclosporine|mesh-list
153661770|NCT00135811|Dexamethasone|dexamethasone|mesh-list
153661771|NCT00135811|Cyclosporins|cyclosporins|mesh-list
153661772|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153661773|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
153661793|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153661794|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
153661795|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661797|NCT00135967|Prednisone|prednisone|mesh-list
153661798|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
153661799|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153661800|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153661801|NCT00135967|Prednisolone|prednisolone|mesh-list
153661802|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
153661803|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153661804|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
153661805|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153661806|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
153764697|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877208|NCT06034158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877209|NCT06034158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417969|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153417970|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417972|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
153417973|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417974|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417975|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813995|NCT00336245|Copper|copper|mesh-list
153764698|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
153764702|NCT04665856|Etoposide|etoposide|mesh-list
153764733|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153764734|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
153764735|NCT04614311|Triamcinolone|triamcinolone|mesh-list
153764737|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153764738|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153764739|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764742|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764743|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764744|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764745|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
153764746|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764747|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764748|NCT04607421|Leucovorin|leucovorin|mesh-list
153764749|NCT04607421|Bevacizumab|bevacizumab|mesh-list
153764750|NCT04607421|Cetuximab|cetuximab|mesh-list
153764751|NCT04607421|Capecitabine|capecitabine|mesh-list
153764752|NCT04607421|Fluorouracil|fluorouracil|mesh-list
153764753|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
153764791|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764792|NCT04534881|Progesterone|progesterone|mesh-list
153764793|NCT04534881|Progestins|progestins|mesh-ancestor
153764794|NCT04534881|Hormones|hormones|mesh-ancestor
153661807|NCT00135967|Hormones|hormones|mesh-ancestor
153661808|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661809|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661810|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153661811|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661812|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153661813|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153661814|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
153661815|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153661816|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661817|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661818|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661819|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
153661820|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
153661821|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661822|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153661823|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153661824|NCT00135967|Protective Agents|protective agents|mesh-ancestor
153661825|NCT00136045|Rotigotine|rotigotine|mesh-list
153661826|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
153661827|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
153661828|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153764795|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764796|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764797|NCT04534582|Denosumab|denosumab|mesh-list
153764798|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153764799|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764800|NCT04527380|Adalimumab|adalimumab|mesh-list
153764801|NCT04527380|Ixekizumab|ixekizumab|mesh-list
153764802|NCT04527380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153764803|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153764804|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153764805|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
153764806|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153764807|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
153764808|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153764809|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153764810|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153764811|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153764812|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764813|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
153764814|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153764815|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153764816|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153764817|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153764818|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764826|NCT04488081|Remdesivir|remdesivir|mesh-list
153764839|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764840|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153764841|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
153764842|NCT04488081|Hormones|hormones|mesh-ancestor
153764843|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661850|NCT00136474|Protective Agents|protective agents|mesh-ancestor
153813996|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
153887678|NCT02875717|Analgesics|analgesics|mesh-ancestor
153661851|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661853|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153661854|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661855|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
153661856|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661857|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661858|NCT00136591|Bortezomib|bortezomib|mesh-list
153661859|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661860|NCT03151161|Carboplatin|carboplatin|mesh-list
153661861|NCT03151161|Pemetrexed|pemetrexed|mesh-list
153661862|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661863|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661864|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661865|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153661866|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153661867|NCT00404053|Clopidogrel|clopidogrel|mesh-list
153661868|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153661869|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153661870|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153661871|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153661872|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
153661873|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661874|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661875|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661876|NCT03991130|Nivolumab|nivolumab|mesh-list
153661877|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153661878|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661879|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153661880|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661902|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153764844|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153764845|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764846|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764847|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764904|NCT04449549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764905|NCT04449549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764906|NCT04443348|Paclitaxel|paclitaxel|mesh-list
153764907|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
153764908|NCT04443348|Carboplatin|carboplatin|mesh-list
153764909|NCT04443348|Doxorubicin|doxorubicin|mesh-list
153764910|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
153477322|NCT05821452|Antimitotic Agents|antimitotic agents|mesh-ancestor
153661903|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
153661904|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661905|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661906|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661907|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153661908|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153661909|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
153661910|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153661911|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
153661912|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661913|NCT00136825|Expectorants|expectorants|mesh-ancestor
153661914|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
153661915|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153661916|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
153661917|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661918|NCT00136825|Protective Agents|protective agents|mesh-ancestor
153913882|NCT01222247|Betamethasone|betamethasone|mesh-list
153813997|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153877210|NCT06034158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813998|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813999|NCT00336245|Trace Elements|trace elements|mesh-ancestor
153661919|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661920|NCT00136825|Antidotes|antidotes|mesh-ancestor
153661921|NCT00393198|Misoprostol|misoprostol|mesh-list
153661922|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
153661923|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153477323|NCT05821452|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764911|NCT04443348|Capecitabine|capecitabine|mesh-list
153764912|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153764913|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764914|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
153764915|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
153764916|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
153764917|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764918|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153764966|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153764967|NCT04336189|Artenimol|artenimol|mesh-list
153764968|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
153764969|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153764970|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153764972|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153764973|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764974|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153764975|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153764976|NCT04307576|Dexamethasone|dexamethasone|mesh-list
153764977|NCT04307576|Doxorubicin|doxorubicin|mesh-list
153764978|NCT04307576|Vincristine|vincristine|mesh-list
153764979|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
153877211|NCT06034158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153764980|NCT04307576|Blinatumomab|blinatumomab|mesh-list
153764981|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153764982|NCT04307576|Thioguanine|thioguanine|mesh-list
153764983|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765024|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765025|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765026|NCT04204980|Daratumumab|daratumumab|mesh-list
153765027|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153661925|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153661926|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661927|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153661928|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153661929|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153661930|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153661931|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
153661948|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661949|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153661950|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153661951|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661952|NCT00137020|Ziprasidone|ziprasidone|mesh-list
153661953|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153661954|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
153661955|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661956|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661957|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661958|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153661959|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153877212|NCT06034158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153810694|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814004|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814005|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887685|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153887686|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887688|NCT04334837|Copper|copper|mesh-list
153661960|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661961|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661962|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153661963|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
153661964|NCT00137059|Acetaminophen|acetaminophen|mesh-list
153661965|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153661966|NCT00137059|Analgesics|analgesics|mesh-ancestor
153661967|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
153765028|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765029|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
153765030|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765031|NCT04194944|Carboplatin|carboplatin|mesh-list
153765032|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
153765034|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765035|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765036|NCT04194944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765086|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765087|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153765088|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
153765089|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153765090|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153765091|NCT03902418|Tenofovir|tenofovir|mesh-list
153765092|NCT03902418|Emtricitabine|emtricitabine|mesh-list
153765093|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
153661969|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661970|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
153661972|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153661973|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661974|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153661975|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661976|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661977|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153661978|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153661979|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
153661980|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661981|NCT00137254|Insulin|insulin|mesh-list
153661982|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153661983|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661984|NCT03151044|Rituximab|rituximab|mesh-list
153661985|NCT03151044|Epirubicin|epirubicin|mesh-list
153661986|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153661987|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661988|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
153661989|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661990|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661999|NCT00137410|Analgesics|analgesics|mesh-ancestor
153662000|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
153662001|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662002|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662003|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877213|NCT06034158|Vasodilator Agents|vasodilator agents|mesh-ancestor
153877214|NCT06034158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877215|NCT06034158|Dopamine Agents|dopamine agents|mesh-ancestor
153428749|NCT05701436|Vitamins|vitamins|mesh-ancestor
153662004|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662005|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153765094|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765095|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153765096|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153765097|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765101|NCT03889743|Dexamethasone|dexamethasone|mesh-list
153765150|NCT03789318|Narcotics|narcotics|mesh-ancestor
153765151|NCT03789318|Analgesics|analgesics|mesh-ancestor
153765152|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153765153|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153765154|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
153765155|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153765156|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
153765157|NCT03768063|Bevacizumab|bevacizumab|mesh-list
153765158|NCT03768063|Pembrolizumab|pembrolizumab|mesh-list
153765159|NCT03768063|Pemetrexed|pemetrexed|mesh-list
153765160|NCT03768063|Atezolizumab|atezolizumab|mesh-list
153765161|NCT03768063|Sunitinib|sunitinib|mesh-list
153662006|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153662007|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662008|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662009|NCT00137527|Anesthetics|anesthetics|mesh-list
153662010|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662011|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662012|NCT00137566|Acetaminophen|acetaminophen|mesh-list
153662013|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153662014|NCT00137566|Analgesics|analgesics|mesh-ancestor
153662015|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
153662016|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662017|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662018|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
153662019|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153662020|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
153662021|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662022|NCT00137761|Docetaxel|docetaxel|mesh-list
153662023|NCT00137761|Gefitinib|gefitinib|mesh-list
153662024|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662025|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
153662026|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662027|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662028|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662029|NCT00137761|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153662030|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153765162|NCT03768063|Venetoclax|venetoclax|mesh-list
153765163|NCT03768063|Niraparib|niraparib|mesh-list
153765164|NCT03768063|Vemurafenib|vemurafenib|mesh-list
153765165|NCT03768063|Rucaparib|rucaparib|mesh-list
153765166|NCT03768063|Alectinib|alectinib|mesh-list
153765167|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765170|NCT03768063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153765212|NCT03564873|Azacitidine|azacitidine|mesh-list
153765213|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
153765214|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765215|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
153765216|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765217|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765218|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765219|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153765220|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153765221|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153765222|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153765223|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153765224|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765225|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765226|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
153765227|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877218|NCT06018688|Aspirin|aspirin|mesh-list
153765228|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153662031|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662032|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153662033|NCT00137800|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153662034|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153662035|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662036|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662037|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662039|NCT00137995|Dexamethasone|dexamethasone|mesh-list
153662040|NCT00137995|Rituximab|rituximab|mesh-list
153662041|NCT00137995|Etoposide|etoposide|mesh-list
153662042|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
153662043|NCT00137995|Melphalan|melphalan|mesh-list
153662044|NCT00137995|Ifosfamide|ifosfamide|mesh-list
153662045|NCT00137995|Carboplatin|carboplatin|mesh-list
153662046|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153662047|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
153662048|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
153662049|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662050|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662051|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153662052|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
153662053|NCT00137995|Hormones|hormones|mesh-ancestor
153662054|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153662055|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153662056|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662085|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153662087|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662088|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662114|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153662115|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153662116|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153662117|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662118|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662119|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
153662120|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
153662121|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662122|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662123|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153662124|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153662125|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
153662126|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153662127|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153662128|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153662129|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153662130|NCT00138619|Vildagliptin|vildagliptin|mesh-list
153662131|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153662132|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662133|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153662134|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
153662135|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662136|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662137|NCT03893825|Risperidone|risperidone|mesh-list
153357300|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153662138|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153662139|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
153662140|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662141|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662142|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662143|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153662156|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153662157|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
153662159|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153662160|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
153662161|NCT00138970|Hormones|hormones|mesh-ancestor
153662162|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153662163|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662164|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153662165|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662181|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662182|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
153662183|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662184|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153662185|NCT00139009|Cyclosporine|cyclosporine|mesh-list
153662186|NCT00139009|Cyclosporins|cyclosporins|mesh-list
153662187|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662188|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662189|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662190|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
153662191|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662192|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
153662193|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662194|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
153662195|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662196|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153662197|NCT03890666|Albuterol|albuterol|mesh-list
153662198|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153662199|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
153662200|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662201|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662202|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153662203|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
153360890|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
153662204|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
153765229|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153765230|NCT03518086|Mirikizumab|mirikizumab|mesh-list
153457593|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765231|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153765232|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153662205|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153662206|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153662207|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153662208|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153662209|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
153662210|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662211|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662212|NCT00139165|Budesonide|budesonide|mesh-list
153662213|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153662214|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153879415|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
153810711|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153810712|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662215|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
153662216|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662217|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662218|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153662219|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
153662220|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
153662221|NCT00139165|Hormones|hormones|mesh-ancestor
153662222|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153662223|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
153662224|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153662251|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153662252|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153662253|NCT00139282|Growth Substances|growth substances|mesh-ancestor
153662254|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
153662255|NCT00139360|Bevacizumab|bevacizumab|mesh-list
153765233|NCT03518086|Analgesics|analgesics|mesh-ancestor
153765234|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
153765235|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765236|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765237|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765238|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765239|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153765240|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153765241|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153765253|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153765255|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
153765256|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765257|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765258|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765259|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765260|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153765261|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153765318|NCT02944071|Paclitaxel|paclitaxel|mesh-list
153765319|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153810713|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153810714|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
153810715|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153810716|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357322|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
153814010|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887703|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153765320|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765321|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
153765322|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
153765323|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662256|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662257|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662258|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153662259|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153662260|NCT00139360|Growth Substances|growth substances|mesh-ancestor
153662261|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662262|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
153662263|NCT00139516|Nicotine|nicotine|mesh-list
153662264|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153662265|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
153662266|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662267|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662268|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153662269|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153662270|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
153662271|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662272|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662273|NCT00139555|Amlodipine|amlodipine|mesh-list
153662274|NCT00139555|Benazepril|benazepril|mesh-list
153662275|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153662293|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662294|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153662295|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153662296|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499273|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153662324|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
153662325|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662326|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662327|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
153662328|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662329|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662330|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
153662331|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153662332|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662333|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153662334|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153662345|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
153662346|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662347|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153662348|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153662349|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
153662350|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
153662351|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662352|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662353|NCT03150459|Rifaximin|rifaximin|mesh-list
153662354|NCT03150459|Simvastatin|simvastatin|mesh-list
153662355|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153662356|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153662357|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
153662358|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662359|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153662360|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153662361|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662362|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662363|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662364|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153662365|NCT00140023|Azithromycin|azithromycin|mesh-list
153662366|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153877223|NCT06018688|Sensory System Agents|sensory system agents|mesh-ancestor
153877224|NCT06018688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877225|NCT06018688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877226|NCT06018688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765324|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765325|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
153765326|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765327|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765328|NCT02899793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765329|NCT02899793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765330|NCT02675231|Trastuzumab|trastuzumab|mesh-list
153662367|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662368|NCT00140062|Latanoprost|latanoprost|mesh-list
153662369|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153662370|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153662371|NCT00140101|Paclitaxel|paclitaxel|mesh-list
153662372|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153662373|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662374|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
153662375|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662376|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662377|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662378|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
153662379|NCT03150420|Antidotes|antidotes|mesh-ancestor
153662380|NCT03150420|Protective Agents|protective agents|mesh-ancestor
153662381|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662382|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
153662383|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662384|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
153662385|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662386|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662387|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
153662388|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
153662389|NCT00140218|Pramipexole|pramipexole|mesh-list
153662390|NCT00140218|Dexpramipexole|dexpramipexole|mesh-list
153662391|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
153662392|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662393|NCT00140218|Protective Agents|protective agents|mesh-ancestor
153662394|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765377|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765378|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765379|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153765380|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765381|NCT02398656|Tenecteplase|tenecteplase|mesh-list
153765382|NCT02398656|Clopidogrel|clopidogrel|mesh-list
153765383|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153814015|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153765384|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153814016|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153765385|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153765386|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153765387|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
153765388|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153765389|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765437|NCT02085148|Vincristine|vincristine|mesh-list
153765438|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153765439|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153765440|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765441|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662395|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153662396|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153662397|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
153662399|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662418|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
153662419|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662420|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662421|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153662422|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153662423|NCT00140452|Growth Substances|growth substances|mesh-ancestor
153662424|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
153662425|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662427|NCT00140530|Paclitaxel|paclitaxel|mesh-list
153662428|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153662429|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662430|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
153662431|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662432|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662433|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662434|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662435|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662436|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153662437|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
153662438|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662439|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
153662440|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662474|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153662475|NCT00138736|Lectins|lectins|mesh-list
153662476|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
153662477|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
153662478|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662479|NCT00138736|Coagulants|coagulants|mesh-ancestor
153662480|NCT00140920|Diclofenac|diclofenac|mesh-list
153662481|NCT00140920|Rofecoxib|rofecoxib|mesh-list
153662482|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153662483|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153662484|NCT00140920|Analgesics|analgesics|mesh-ancestor
153662485|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
153662486|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662487|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662488|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153662489|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662490|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153877235|NCT06018688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153879431|NCT05223010|Sevoflurane|sevoflurane|mesh-list
153879432|NCT05223010|Melatonin|melatonin|mesh-list
153662491|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662492|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662493|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153662494|NCT03136497|Rituximab|rituximab|mesh-list
153662495|NCT03136497|Venetoclax|venetoclax|mesh-list
153662496|NCT03136497|Ibrutinib|ibrutinib|mesh-list
153662497|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662498|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662499|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
153662500|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662501|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662504|NCT03136497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662531|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662533|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153662534|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153662535|NCT00141193|Analgesics|analgesics|mesh-ancestor
153662536|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
153662537|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662538|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662539|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153662540|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662541|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153662542|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153662543|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662544|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662545|NCT00141232|Atorvastatin|atorvastatin|mesh-list
153662546|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153662547|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153662548|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
153662549|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662550|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153662551|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153662552|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662553|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
153662554|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662555|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
153662556|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153662557|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153662558|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662559|NCT00141310|Urological Agents|urological agents|mesh-ancestor
153765442|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765443|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153765444|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
153765445|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
153765446|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
153765447|NCT02035787|Metformin|metformin|mesh-list
153765499|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
153765500|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765501|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765503|NCT05712941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765504|NCT05712941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153765505|NCT05712941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153765506|NCT05712941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662560|NCT00141388|Pregabalin|pregabalin|mesh-list
153662561|NCT00141388|Analgesics|analgesics|mesh-ancestor
153662562|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
153814020|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662563|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662564|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662565|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
153662566|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153662567|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153662568|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662569|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153662570|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153662571|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153662572|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662573|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153662574|NCT00404404|Paclitaxel|paclitaxel|mesh-list
153662575|NCT00404404|Bevacizumab|bevacizumab|mesh-list
153662576|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153662577|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153662578|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662579|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
153478010|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153478011|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153765507|NCT05712941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765508|NCT05712941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153765509|NCT05712941|Hormone Antagonists|hormone antagonists|mesh-ancestor
153765510|NCT05712941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765511|NCT05712941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765512|NCT05701007|Docetaxel|docetaxel|mesh-list
153765513|NCT05701007|Goserelin|goserelin|mesh-list
153765514|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153765515|NCT05701007|Leuprolide|leuprolide|mesh-list
153765516|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765517|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
153765518|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
153765519|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
153765520|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765521|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153765522|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
153765523|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153765524|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
153765525|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153765526|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765527|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153765528|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153765529|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
153765530|NCT05694936|Cetuximab|cetuximab|mesh-list
153765531|NCT05694936|Panitumumab|panitumumab|mesh-list
153816246|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816247|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816248|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153662580|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662581|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662594|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
153662595|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662596|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
153662597|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662598|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
153662599|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662600|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153662602|NCT00141427|Analgesics|analgesics|mesh-ancestor
153662603|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
153662604|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662605|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662606|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
153662607|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814021|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
153814022|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662608|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153662609|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662610|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153662611|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153662612|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153662613|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662614|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153662615|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
153662616|NCT00141544|Estrogens|estrogens|mesh-list
153662617|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
153662618|NCT00141544|Estrone|estrone|mesh-list
153662619|NCT00141544|Testosterone|testosterone|mesh-list
153662620|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
153662621|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
153662622|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153662623|NCT00141544|Hormones|hormones|mesh-ancestor
153662624|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153662625|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662626|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153816249|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153816250|NCT00352742|Growth Substances|growth substances|mesh-ancestor
153816251|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662627|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662628|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
153662629|NCT00141544|Androgens|androgens|mesh-ancestor
153662630|NCT00141583|Candesartan|candesartan|mesh-list
153662631|NCT00141583|Candesartan cilexetil|candesartan cilexetil|mesh-list
153662632|NCT00141583|Enalapril|enalapril|mesh-list
153662633|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153662634|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153662635|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153662636|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662637|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153662638|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
153662639|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662640|NCT00141700|Rituximab|rituximab|mesh-list
153662641|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662642|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662660|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
153662661|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153662662|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
153662663|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662664|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662665|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153662666|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
153662667|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
153662668|NCT00142051|Protective Agents|protective agents|mesh-ancestor
153662669|NCT00142129|Bortezomib|bortezomib|mesh-list
153662670|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662671|NCT02825979|Sotalol|sotalol|mesh-list
153662672|NCT02825979|Flecainide|flecainide|mesh-list
153816252|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
153765532|NCT05694936|Valproic Acid|valproic acid|mesh-list
153765533|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765534|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153765535|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
153765536|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765537|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765538|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
153765539|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153765540|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765541|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
153765596|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765597|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
153765598|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153765599|NCT05376553|Docetaxel|docetaxel|mesh-list
153765600|NCT05376553|Cemiplimab|cemiplimab|mesh-list
153765601|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662673|NCT02825979|Dronedarone|dronedarone|mesh-list
153662674|NCT02825979|Propafenone|propafenone|mesh-list
153662675|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153662676|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153662677|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153662678|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
153662679|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662680|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662681|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662682|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
153662683|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
153662684|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662685|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153662686|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153662687|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153662688|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
153662689|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
153662690|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153662691|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
153662692|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153662693|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153662694|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662695|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153662696|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662697|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662698|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153662699|NCT00142246|Amodiaquine|amodiaquine|mesh-list
153662700|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
153662701|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153765602|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
153765603|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
153765604|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
153765605|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765606|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153765607|NCT05332483|Megestrol|megestrol|mesh-list
153765608|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
153765610|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153877236|NCT06018688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153877237|NCT06018688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887737|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887738|NCT00594269|Risperidone|risperidone|mesh-list
153814023|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
153814024|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
153887739|NCT00594269|Citalopram|citalopram|mesh-list
153765655|NCT05220358|Fostemsavir|fostemsavir|mesh-list
153765656|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153765657|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153765658|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
153765659|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765660|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153765661|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153765663|NCT05206955|Tadalafil|tadalafil|mesh-list
153662718|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662721|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
153662722|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662723|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662724|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153662725|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153662726|NCT00142480|Growth Substances|growth substances|mesh-ancestor
153662727|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662728|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
153662729|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153662730|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
153662731|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662732|NCT02806050|Letrozole|letrozole|mesh-list
153662733|NCT02806050|Palbociclib|palbociclib|mesh-list
153662734|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662735|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153662736|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153662737|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662738|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662739|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153662740|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
153662741|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153662742|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662743|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153662744|NCT00142870|Bupropion|bupropion|mesh-list
153662745|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153662746|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
153765723|NCT04862221|Prednisolone|prednisolone|mesh-list
153765724|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
153765725|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153765726|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
153765727|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153765728|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765729|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
153765730|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
153765731|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765732|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765733|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153765734|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
153765736|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765737|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153765747|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
153765784|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153765785|NCT04677114|Buprenorphine|buprenorphine|mesh-list
153662747|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153662748|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153662749|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153662750|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153662751|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662752|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
153662753|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662754|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662755|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153810725|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814025|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
153662756|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153662757|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662786|NCT00143026|Entacapone|entacapone|mesh-list
153662787|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153662788|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153662789|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
153662790|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662791|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662792|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662796|NCT00404599|Simvastatin|simvastatin|mesh-list
153662873|NCT04726345|Terfenadine|terfenadine|mesh-list
153662874|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153662875|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153662876|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153662877|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
153662878|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
153662879|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662880|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662881|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662882|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
153662883|NCT00143533|Cefpodoxime Proxetil|cefpodoxime proxetil|mesh-list
153662884|NCT00143533|Irinotecan|irinotecan|mesh-list
153662885|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153662886|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153662887|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662888|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662889|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662890|NCT00143533|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153662891|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662892|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662893|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
153662894|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499879|NCT00004758|Valproic Acid|valproic acid|mesh-list
153662895|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
153662896|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662897|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662898|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153662899|NCT00393315|Paclitaxel|paclitaxel|mesh-list
153662900|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153662901|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662911|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153662912|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153662914|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478237|NCT01103934|Fluticasone|fluticasone|mesh-list
153765786|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153765787|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765788|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
153765789|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153765790|NCT04677114|Narcotics|narcotics|mesh-ancestor
153765793|NCT04677114|Analgesics|analgesics|mesh-ancestor
153662915|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662916|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153662917|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153662918|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
153662919|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662920|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153662921|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153662922|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153662923|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153662924|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
153418021|NCT00372853|Tremelimumab|tremelimumab|mesh-list
153662925|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153662926|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153662927|NCT00143728|Lamivudine|lamivudine|mesh-list
153662928|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153662929|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153662930|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662931|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662932|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
153662933|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662934|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153662935|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153662936|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153662937|NCT00140803|Verteporfin|verteporfin|mesh-list
153662938|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153662939|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
153662940|NCT00140803|Hormones|hormones|mesh-ancestor
153662941|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153662942|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662960|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
153662961|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153662962|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662963|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153662964|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153662965|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662966|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
153662967|NCT00144118|Sevoflurane|sevoflurane|mesh-list
153662968|NCT00144118|Isoflurane|isoflurane|mesh-list
153662984|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153662985|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153662986|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153662987|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153662989|NCT00144274|Expectorants|expectorants|mesh-ancestor
153662990|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
153662991|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
153662992|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
153662993|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153662994|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
153765849|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153765850|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
153765851|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
153765852|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153765853|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153765854|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
153765855|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765856|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153418022|NCT00372853|Ipilimumab|ipilimumab|mesh-list
153765857|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153765858|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153418023|NCT00372853|Sunitinib|sunitinib|mesh-list
153418024|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418025|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153418030|NCT00372853|Growth Substances|growth substances|mesh-ancestor
153765859|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
153765860|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
153765861|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
153765863|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
153765864|NCT04332874|Melphalan|melphalan|mesh-list
153765883|NCT04232085|Melphalan|melphalan|mesh-list
153765908|NCT04057300|Aspirin|aspirin|mesh-list
153765909|NCT04057300|Clopidogrel|clopidogrel|mesh-list
153765910|NCT04057300|Ticagrelor|ticagrelor|mesh-list
153418031|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765911|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153765912|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153765913|NCT04057300|Analgesics|analgesics|mesh-ancestor
153765914|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
153765915|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153765916|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153765917|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153765918|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153765919|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153765920|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153765921|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153765922|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153765923|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153765924|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153765965|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153765966|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662995|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153662996|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153662997|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662998|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153662999|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663000|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663001|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153663002|NCT00144430|Pentostatin|pentostatin|mesh-list
153663003|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663004|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153663005|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663006|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663007|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153663008|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
153663009|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663010|NCT00404716|Cilostazol|cilostazol|mesh-list
153663011|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153663012|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
153663013|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663014|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418032|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
153814027|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
153814028|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153428858|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
153663015|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153663016|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
153663017|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153663018|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153663019|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663020|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153765967|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153765968|NCT03782207|Atezolizumab|atezolizumab|mesh-list
153765969|NCT03782207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153766033|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153766034|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766035|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153766037|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
153766038|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766039|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766040|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
153766041|NCT03579875|Hormones|hormones|mesh-ancestor
153766042|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766043|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153766044|NCT03579875|Protective Agents|protective agents|mesh-ancestor
153766045|NCT03451799|Temozolomide|temozolomide|mesh-list
153766046|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153766093|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153766094|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153766095|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766096|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766097|NCT03222492|Immunotoxins|immunotoxins|mesh-ancestor
153663021|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
153663022|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153663023|NCT00404716|Protective Agents|protective agents|mesh-ancestor
153663024|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153663025|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153663026|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663041|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663042|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153663043|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663044|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153663045|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
153663046|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153663047|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663048|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663049|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
153663050|NCT00404794|Hormones|hormones|mesh-ancestor
153663051|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153663052|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153663053|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
153663054|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
153663055|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663056|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663057|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153663058|NCT00404794|Protective Agents|protective agents|mesh-ancestor
153766098|NCT03222492|Immunoconjugates|immunoconjugates|mesh-ancestor
153766099|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
153766100|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428860|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766101|NCT03156790|Asparaginase|asparaginase|mesh-list
153766102|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766103|NCT03097783|Lidocaine|lidocaine|mesh-list
153766104|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
153766105|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
153766106|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766107|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766154|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766155|NCT02595866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153766156|NCT02595866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766157|NCT02595866|Antiviral Agents|antiviral agents|mesh-ancestor
153766159|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
153766160|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
153766161|NCT02563769|Cocaine|cocaine|mesh-list
153766162|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153766163|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766164|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766166|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153766220|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153766221|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153766222|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153766223|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
153663059|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
153663060|NCT00404833|Prednisolone|prednisolone|mesh-list
153663061|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153663062|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
153663063|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153663064|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
153663065|NCT00404833|Chlorambucil|chlorambucil|mesh-list
153663066|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153663067|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
153663068|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153663069|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663070|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153663071|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
153663072|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153663073|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663074|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663075|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663076|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663077|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
153663078|NCT00404833|Hormones|hormones|mesh-ancestor
153663079|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153663080|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663081|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153663082|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
153663083|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
153663084|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663085|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663086|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153766224|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153766225|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766226|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
153766227|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
153766228|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153766230|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
153766286|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766287|NCT01962636|Cyclosporine|cyclosporine|mesh-list
153766288|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
153766289|NCT01962636|Fludarabine|fludarabine|mesh-list
153877257|NCT06007846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153766290|NCT01962636|Cyclosporins|cyclosporins|mesh-list
153877258|NCT05986331|Pembrolizumab|pembrolizumab|mesh-list
153877259|NCT05986331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877260|NCT05986331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766291|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153766292|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
153766293|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766353|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766354|NCT00400946|Leucovorin|leucovorin|mesh-list
153766355|NCT00400946|Cytarabine|cytarabine|mesh-list
153766356|NCT00400946|Dexamethasone|dexamethasone|mesh-list
153766357|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
153766358|NCT00400946|Prednisolone|prednisolone|mesh-list
153663087|NCT00404833|Protective Agents|protective agents|mesh-ancestor
153663088|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153663089|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
153663090|NCT05595109|Silymarin|silymarin|mesh-list
153663101|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663102|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663103|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663104|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153663105|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153663106|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663107|NCT01807455|Lidocaine|lidocaine|mesh-list
153663108|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
153663109|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
153663110|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663111|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663112|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
153663113|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663114|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153663115|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153663116|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153663117|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153663118|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663119|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
153663120|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
153663121|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663122|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
153663123|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663124|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663125|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153663126|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
153478460|NCT03616782|Ixazomib|ixazomib|mesh-list
153478466|NCT02410512|Antibodies|antibodies|mesh-list
153766359|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
153766360|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153766361|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153766362|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153766363|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
153603463|NCT01911598|Paclitaxel|paclitaxel|mesh-list
153766364|NCT00400946|Doxorubicin|doxorubicin|mesh-list
153766365|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153663127|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663128|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663129|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153663130|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153663131|NCT03092453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153663132|NCT01807377|Midazolam|midazolam|mesh-list
153663133|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153663134|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153663135|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663136|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877266|NCT05984238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877267|NCT05975684|Baclofen|baclofen|mesh-list
153418035|NCT02885636|Albuterol|albuterol|mesh-list
153810727|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
153663137|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153663138|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153663139|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153663140|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153663141|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
153663142|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
153663143|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
153663144|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
153663145|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663146|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663147|NCT03090737|Nivolumab|nivolumab|mesh-list
153663148|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153663149|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663150|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153663151|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663152|NCT02972255|Meropenem|meropenem|mesh-list
153663153|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153663176|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
153663177|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
153663178|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663179|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663180|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
153663181|NCT05461807|Apixaban|apixaban|mesh-list
153663182|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153663183|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
153663187|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663189|NCT03079427|Cisplatin|cisplatin|mesh-list
153663190|NCT03079427|Gemcitabine|gemcitabine|mesh-list
153663191|NCT03079427|Capecitabine|capecitabine|mesh-list
153663192|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663193|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663194|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
153663195|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663196|NCT00390923|Selegiline|selegiline|mesh-list
153663197|NCT00390923|Nicotine|nicotine|mesh-list
153663198|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153663199|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
153663200|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663201|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663202|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153663203|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153810728|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
153663204|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
153663205|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663206|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663207|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
153663208|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153663209|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153663210|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153663221|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663222|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663223|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
153814033|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663224|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663225|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153766366|NCT00400946|Methotrexate|methotrexate|mesh-list
153766419|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153766420|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766421|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153766422|NCT00123305|Plasminogen|plasminogen|mesh-list
153766423|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
153766424|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153766425|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153766426|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766428|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153766429|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
153766430|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766431|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766432|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153766433|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663226|NCT01806948|Ramosetron|ramosetron|mesh-list
153663227|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
153663228|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
153663229|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663230|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663231|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663232|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153663233|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
153663234|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663235|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663236|NCT02958163|Doxorubicin|doxorubicin|mesh-list
153663237|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153663238|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663239|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153663240|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153663241|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663242|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663243|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153663244|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153663245|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663246|NCT02985866|Pancrelipase|pancrelipase|mesh-list
153663247|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663248|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
153663249|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
153663250|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
153663251|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153663252|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663253|NCT01806792|Vitamins|vitamins|mesh-ancestor
153663254|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
153663255|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153663256|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814034|NCT00444522|Alprazolam|alprazolam|mesh-list
153663257|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153663258|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663259|NCT05228431|Capecitabine|capecitabine|mesh-list
153766434|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153766475|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766476|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
153766477|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766478|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153766479|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153663260|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663262|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663263|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663264|NCT01806753|Midazolam|midazolam|mesh-list
153663265|NCT01806753|Propofol|propofol|mesh-list
153663266|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153663267|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663268|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663269|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153663270|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
153500265|NCT00005634|Vorinostat|vorinostat|mesh-list
153663271|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
153663272|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153663273|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153663274|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153663286|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663287|NCT02762981|Paclitaxel|paclitaxel|mesh-list
153663288|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153663289|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153663290|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663291|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
153663292|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
153663293|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
153663294|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663295|NCT04958044|Calcium|calcium|mesh-list
153663296|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153663297|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663298|NCT01806363|Telmisartan|telmisartan|mesh-list
153663299|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
153663300|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153663301|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153478636|NCT01150500|Sirolimus|sirolimus|mesh-list
153766480|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766481|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766482|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153766483|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153766484|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
153766485|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766486|NCT00123383|Modafinil|modafinil|mesh-list
153766487|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153663303|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663304|NCT01806363|Diuretics|diuretics|mesh-ancestor
153663305|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
153663306|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663307|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153663308|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153663309|NCT02964403|Indomethacin|indomethacin|mesh-list
153663310|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153663311|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153663312|NCT02964403|Analgesics|analgesics|mesh-ancestor
153663313|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
153663314|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663315|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418039|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418040|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153418041|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
153814035|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153814036|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663316|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663317|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663318|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
153663319|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
153766488|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766489|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153766490|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153766491|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153766493|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
153766528|NCT00191555|Olanzapine|olanzapine|mesh-list
153766529|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
153766530|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
153766531|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
153766551|NCT00123539|Estrogens|estrogens|mesh-list
153766598|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766599|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153766600|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153766601|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153766602|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766603|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153766604|NCT00221481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153766605|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153766606|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766607|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766608|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766612|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
153766659|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766660|NCT00221637|Valproic Acid|valproic acid|mesh-list
153766661|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
153766662|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766663|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766664|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
153766665|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766666|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766667|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
153766671|NCT00123656|Fluticasone|fluticasone|mesh-list
153766723|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766724|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766725|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153766726|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
153766727|NCT00191867|Teriparatide|teriparatide|mesh-list
153663320|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153663321|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153663322|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455662|NCT05367960|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153418042|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
153418043|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153418044|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153418045|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153418046|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153418047|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
153418048|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877269|NCT05975684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814037|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428871|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153663323|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663325|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
153663326|NCT00393393|Protective Agents|protective agents|mesh-ancestor
153663327|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810729|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663328|NCT00405262|Ketorolac|ketorolac|mesh-list
153663329|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153663330|NCT00405262|Bupivacaine|bupivacaine|mesh-list
153663331|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
153663332|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
153663333|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663334|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663335|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
153663336|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663337|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153663358|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153663359|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153663360|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153663362|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153663363|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766728|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153766729|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766730|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153766731|NCT00123851|Capecitabine|capecitabine|mesh-list
153766732|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
153766733|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153603842|NCT01914133|Acarbose|acarbose|mesh-list
153766734|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766735|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
153766736|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766737|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766738|NCT00123851|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153766739|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153766740|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766776|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
153766777|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766778|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766779|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153766780|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
153814038|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153766781|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
153766782|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
153766783|NCT00192101|Gemcitabine|gemcitabine|mesh-list
153766784|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877270|NCT05975684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153766785|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766786|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
153766787|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663364|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
153663365|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663366|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663368|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153663369|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663370|NCT02647892|Lidocaine|lidocaine|mesh-list
153663371|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
153663372|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
153663373|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663374|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663375|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
153663376|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663377|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153663378|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153663379|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153663380|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153663381|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663382|NCT01806090|Clopidogrel|clopidogrel|mesh-list
153663383|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153663384|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153663385|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153663386|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153663387|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
153663388|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663426|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153663449|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153663451|NCT01805817|Estrogens|estrogens|mesh-ancestor
153663452|NCT01805817|Hormones|hormones|mesh-ancestor
153766836|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153766837|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153766838|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
153766839|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877271|NCT05975684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877272|NCT05975684|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153814041|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
153814042|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
153887824|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887825|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
153887826|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887827|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153766840|NCT00474253|Rocuronium|rocuronium|mesh-list
153766841|NCT00474253|Succinylcholine|succinylcholine|mesh-list
153766842|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153766843|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153766844|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153766845|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766846|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766847|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153766848|NCT00221871|Ketamine|ketamine|mesh-list
153766849|NCT00221871|Analgesics|analgesics|mesh-ancestor
153663453|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153663454|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663455|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153663456|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
153663457|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153663458|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153663459|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153663460|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153663461|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153663462|NCT01805817|Trace Elements|trace elements|mesh-ancestor
153663463|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
153663464|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153663465|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
153663466|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153663467|NCT01805817|Diuretics|diuretics|mesh-ancestor
153663468|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
153663469|NCT04206046|Anesthetics|anesthetics|mesh-list
153663470|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663471|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663472|NCT00405418|Insulin|insulin|mesh-list
153663473|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153663474|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
153663475|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
153663476|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153663477|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663478|NCT02157077|Aflibercept|aflibercept|mesh-list
153663479|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153663480|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153663481|NCT02157077|Growth Substances|growth substances|mesh-ancestor
153663505|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663507|NCT00391157|Bortezomib|bortezomib|mesh-list
153663508|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663509|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
153663510|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
153663511|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663512|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663513|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663514|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
153663515|NCT00391157|Hormones|hormones|mesh-ancestor
153663516|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887831|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887832|NCT00596531|Acamprosate|acamprosate|mesh-list
153887833|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153887834|NCT00596609|Morphine|morphine|mesh-list
153887835|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153887836|NCT00596609|Narcotics|narcotics|mesh-ancestor
153887837|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887838|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663517|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153663518|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663519|NCT03781063|Fulvestrant|fulvestrant|mesh-list
153663520|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153663521|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663522|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153663523|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153663524|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
153663525|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153663526|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663527|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
153663528|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153663529|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
153663530|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153663531|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
153663532|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663567|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153663568|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153663569|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153663570|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153663571|NCT01723839|Growth Substances|growth substances|mesh-ancestor
153663572|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
153663573|NCT03421483|Folic Acid|folic acid|mesh-list
153663574|NCT03421483|Hematinics|hematinics|mesh-ancestor
153663575|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
153663576|NCT03421483|Vitamins|vitamins|mesh-ancestor
153766850|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
153766851|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153766852|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766853|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153766854|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153766856|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
153766857|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153766887|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153766888|NCT04571437|Capecitabine|capecitabine|mesh-list
153766890|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153766891|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
153766892|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766893|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153766894|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153766895|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153766896|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766897|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153663625|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153663626|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
153663627|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153663628|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663629|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
153663630|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153877273|NCT05975684|GABA Agonists|gaba agonists|mesh-ancestor
153877274|NCT05975684|GABA Agents|gaba agents|mesh-ancestor
153877275|NCT05975684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877276|NCT05975684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810730|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814043|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887839|NCT00596609|Analgesics|analgesics|mesh-ancestor
153887840|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
153887841|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663631|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153387525|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663632|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153663633|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663634|NCT00391313|Chloroquine|chloroquine|mesh-list
153663635|NCT00391313|Amebicides|amebicides|mesh-ancestor
153663636|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153663637|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153663638|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663639|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
153663640|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663641|NCT01466517|Ibuprofen|ibuprofen|mesh-list
153663642|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153663643|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153663644|NCT01466517|Analgesics|analgesics|mesh-ancestor
153663645|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
153663646|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663647|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663648|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663649|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663650|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153500632|NCT00359658|Cyclosporins|cyclosporins|mesh-list
153663652|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663653|NCT01466478|Calcitriol|calcitriol|mesh-list
153663654|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153663669|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663670|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
153663671|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663673|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
153663674|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663675|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
153663676|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663677|NCT00048113|Alicaforsen|alicaforsen|mesh-list
153663678|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663679|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663680|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
153663681|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663703|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663704|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153663705|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153663706|NCT00001832|Analgesics|analgesics|mesh-ancestor
153663707|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
153663708|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663709|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153663710|NCT01466244|Cetuximab|cetuximab|mesh-list
153663711|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663712|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153663713|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
153478890|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153766898|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
153766899|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153766948|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153766949|NCT00124241|Lamivudine|lamivudine|mesh-list
153766950|NCT00124241|Telbivudine|telbivudine|mesh-list
153766951|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153604059|NCT01915602|Sorafenib|sorafenib|mesh-list
153766952|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153766953|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153766954|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153766955|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
153766956|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766957|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153766958|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153766960|NCT00124280|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153766961|NCT00124280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153766962|NCT00124280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767010|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153767011|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
153767012|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767013|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767014|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153767015|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
153767016|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153767017|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153663714|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
153663715|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
153663716|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663717|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663718|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663719|NCT01466127|Oxytocin|oxytocin|mesh-list
153663720|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
153663721|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153663722|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663723|NCT00009191|Sertraline|sertraline|mesh-list
153663724|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
153663725|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153663726|NCT00009191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153663727|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153663728|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153663729|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663730|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663731|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
153663732|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663733|NCT01466088|Donepezil|donepezil|mesh-list
153663734|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153663749|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663750|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153767018|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153767019|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
153767020|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767021|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767022|NCT00192608|Saquinavir|saquinavir|mesh-list
153767023|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153767024|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153767025|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
153767026|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767065|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
153767066|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153767067|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153767068|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767069|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153767070|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767071|NCT00222144|Docetaxel|docetaxel|mesh-list
153767072|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
153767073|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767074|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767075|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767076|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767077|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767078|NCT00222144|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153814044|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887854|NCT01064401|Interferon-beta|interferon-beta|mesh-list
153767079|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153767080|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767081|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
153663751|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153663752|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663753|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663755|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
153663756|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153663757|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
153663758|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736428|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663759|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663760|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663761|NCT00009620|Phenobarbital|phenobarbital|mesh-list
153663762|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
153663763|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153663764|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663765|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663766|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153663767|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153663768|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663769|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663770|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
153663771|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
153663772|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153663773|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153663774|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153663775|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
153663776|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153663777|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
153663778|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153663779|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478948|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153767082|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153767083|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816253|NCT00352859|Interferons|interferons|mesh-list
153816254|NCT00352859|Gemcitabine|gemcitabine|mesh-list
153457581|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457583|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
153457584|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
153457588|NCT01381692|Hormones|hormones|mesh-ancestor
153663780|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153663781|NCT00009698|Aldesleukin|aldesleukin|mesh-list
153663782|NCT00009698|Interleukin-2|interleukin-2|mesh-list
153663783|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663784|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153663785|NCT00009698|Analgesics|analgesics|mesh-ancestor
153663786|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
153420338|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887859|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887860|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
153887861|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887862|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153887863|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153887864|NCT00597389|Propranolol|propranolol|mesh-list
153887865|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153887866|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153887867|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
153428921|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
153428924|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
153663787|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663788|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663789|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153663790|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153663791|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
153663792|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663793|NCT01465893|Vitamin D|vitamin d|mesh-list
153663808|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153663809|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663811|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
153663812|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
153663813|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663814|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
153663815|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663816|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663817|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663818|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
153663819|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663820|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
153663821|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663822|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153663823|NCT00009815|Leucovorin|leucovorin|mesh-list
153663824|NCT00009815|Etoposide|etoposide|mesh-list
153663825|NCT00009815|Tegafur|tegafur|mesh-list
153663826|NCT00009815|Calcium|calcium|mesh-list
153663827|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
153663828|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153663829|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663830|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153663835|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663837|NCT00009815|Protective Agents|protective agents|mesh-ancestor
153663838|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
153663839|NCT00009815|Vitamins|vitamins|mesh-ancestor
153663840|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
153663841|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663842|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
153663843|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153663844|NCT01465815|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153663845|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153663846|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663847|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357343|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357344|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357345|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153357346|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153814047|NCT00336791|Doxorubicin|doxorubicin|mesh-list
153814048|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153428927|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428928|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153428929|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428930|NCT00002498|Analgesics|analgesics|mesh-ancestor
153428931|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
153428932|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428933|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428934|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428935|NCT00002504|Interferons|interferons|mesh-list
153663848|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663849|NCT00009854|Ethanol|ethanol|mesh-list
153663850|NCT00009854|Carmustine|carmustine|mesh-list
153663851|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153663852|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663853|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663854|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663855|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153663856|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
153663868|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153663869|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663870|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663871|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
153663872|NCT00009893|Antidotes|antidotes|mesh-ancestor
153457589|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457590|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153457591|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457592|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
153457594|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457595|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457596|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153457597|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457598|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153457599|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
153457600|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457601|NCT01381692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153457603|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
153457604|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153457605|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
153457606|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457607|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663873|NCT00009893|Protective Agents|protective agents|mesh-ancestor
153663874|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
153663875|NCT00009893|Vitamins|vitamins|mesh-ancestor
153663876|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
153663878|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663879|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153663880|NCT00009971|Protective Agents|protective agents|mesh-ancestor
153663881|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663882|NCT00010010|Exemestane|exemestane|mesh-list
153663883|NCT00010010|Goserelin|goserelin|mesh-list
153663884|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663885|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153663886|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153663887|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663888|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663889|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153663890|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
153663891|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357347|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153357348|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153357349|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153357350|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
153357351|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
153663892|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663893|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153663894|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
153663895|NCT00010049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153663896|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153663897|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663898|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663899|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663900|NCT00010088|Leucovorin|leucovorin|mesh-list
153663901|NCT00010088|Gemcitabine|gemcitabine|mesh-list
153663902|NCT00010088|Fluorouracil|fluorouracil|mesh-list
153663903|NCT00010088|Calcium|calcium|mesh-list
153663904|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
153479103|NCT01238640|Nicotine|nicotine|mesh-list
153457608|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153457609|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
153457610|NCT01394952|Dulaglutide|dulaglutide|mesh-list
153457611|NCT01394952|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153457612|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153767084|NCT00222183|Analgesics|analgesics|mesh-ancestor
153767085|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
153767086|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767087|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767088|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767089|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767090|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
153767091|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767092|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
153663905|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663907|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663908|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663909|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153663910|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663911|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663912|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
153663913|NCT00010088|Antidotes|antidotes|mesh-ancestor
153663914|NCT00010088|Protective Agents|protective agents|mesh-ancestor
153663915|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
153663916|NCT00010088|Vitamins|vitamins|mesh-ancestor
153663917|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
153663918|NCT01465503|Heparin|heparin|mesh-list
153663919|NCT01465503|Calcium heparin|calcium heparin|mesh-list
153663920|NCT01465503|Hirudins|hirudins|mesh-list
153663921|NCT01465503|Bivalirudin|bivalirudin|mesh-list
153663922|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
153663923|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153663953|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663954|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663956|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153663957|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
153663958|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663959|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663960|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153663961|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153663962|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
153663963|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663964|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663965|NCT00010283|Beclomethasone|beclomethasone|mesh-list
153810750|NCT00321230|Laxatives|laxatives|mesh-ancestor
153810751|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810752|NCT00351663|Enoxaparin|enoxaparin|mesh-list
153810753|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
153810754|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153877291|NCT05944510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877292|NCT05944510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663966|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663967|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
153663968|NCT00010283|Hormones|hormones|mesh-ancestor
153664034|NCT01464723|Growth Substances|growth substances|mesh-ancestor
153664041|NCT01464606|Doxorubicin|doxorubicin|mesh-list
153664042|NCT01464606|Vincristine|vincristine|mesh-list
153664043|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664044|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
153664045|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664046|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664081|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153664082|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153664083|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664084|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664085|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153664121|NCT00847860|Analgesics|analgesics|mesh-ancestor
153664146|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
153664147|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153664148|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664149|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153664150|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153664151|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153664152|NCT00009932|Paclitaxel|paclitaxel|mesh-list
153664153|NCT00009932|Fenretinide|fenretinide|mesh-list
153664154|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664155|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664156|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664157|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664158|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664159|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767093|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153767094|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767095|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767096|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
153767097|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767098|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
153767099|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767100|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767101|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153767102|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
153767103|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767136|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767137|NCT00411996|Ritonavir|ritonavir|mesh-list
153767138|NCT00411996|Indinavir|indinavir|mesh-list
153767139|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153767140|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153767141|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
153767142|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767143|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767144|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153479223|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
153664160|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153664161|NCT00009932|Protective Agents|protective agents|mesh-ancestor
153664162|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664163|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
153664164|NCT00847587|Etonogestrel|etonogestrel|mesh-list
153664165|NCT00847587|Desogestrel|desogestrel|mesh-list
153664166|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153664167|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664168|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153664169|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153664170|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153877293|NCT05944510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153877294|NCT05944510|Narcotics|narcotics|mesh-ancestor
153664200|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664201|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664202|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664203|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664204|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664205|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479224|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
153767145|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153767146|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
153767147|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767148|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153767149|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153767150|NCT00222261|Aspirin|aspirin|mesh-list
153767151|NCT00222261|Clopidogrel|clopidogrel|mesh-list
153767152|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153767153|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153767154|NCT00222261|Analgesics|analgesics|mesh-ancestor
153767155|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
153767156|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767157|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767189|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767190|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767191|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
153767192|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767193|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153767194|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
153767195|NCT00193115|Docetaxel|docetaxel|mesh-list
153767196|NCT00193115|Doxorubicin|doxorubicin|mesh-list
153767197|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767198|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
153767199|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767200|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767201|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153767202|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
153767203|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767204|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767205|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153767206|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767207|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767208|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767209|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153767210|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153664207|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664208|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664209|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153664210|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664211|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
153664212|NCT00011960|Paclitaxel|paclitaxel|mesh-list
153664213|NCT00011960|Cisplatin|cisplatin|mesh-list
153664214|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664215|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664216|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664243|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664244|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664245|NCT00012116|Temozolomide|temozolomide|mesh-list
153664246|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664247|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
153664248|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664249|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501272|NCT00376584|Niacin|niacin|mesh-list
153664250|NCT00847119|Bevacizumab|bevacizumab|mesh-list
153664251|NCT00847119|Capecitabine|capecitabine|mesh-list
153814053|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
153814054|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664252|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153664253|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664254|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153664255|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153767211|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767239|NCT00193232|Bortezomib|bortezomib|mesh-list
153767240|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767241|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767242|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767243|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
153767244|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767245|NCT00222495|Olanzapine|olanzapine|mesh-list
153767246|NCT00222495|Risperidone|risperidone|mesh-list
153767247|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153767248|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153767249|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
153767250|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153767251|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767252|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767253|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153767254|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153767255|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767297|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153767298|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767299|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767300|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767301|NCT00193349|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153664256|NCT00847119|Growth Substances|growth substances|mesh-ancestor
153664257|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664258|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
153664259|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664261|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664262|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153664263|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153664282|NCT00012311|Thiotepa|thiotepa|mesh-list
153664283|NCT00012311|Carboplatin|carboplatin|mesh-list
153767302|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153767304|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153767305|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767306|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767307|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767308|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767309|NCT00215709|Docetaxel|docetaxel|mesh-list
153767310|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767311|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
153767312|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
153767356|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
153767357|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767358|NCT00124358|Buprenorphine|buprenorphine|mesh-list
153767359|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153767360|NCT00124358|Narcotics|narcotics|mesh-ancestor
153767361|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767362|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767363|NCT00124358|Analgesics|analgesics|mesh-ancestor
153767364|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
153767365|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767422|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153767424|NCT00473746|Prednisone|prednisone|mesh-list
153767425|NCT00473746|Prednisolone|prednisolone|mesh-list
153767426|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
153767427|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767428|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
153767429|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
153767430|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814055|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
153428950|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767431|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767432|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153767433|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
153767434|NCT00473746|Hormones|hormones|mesh-ancestor
153767435|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767436|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153767437|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767438|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153767439|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767440|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767441|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
153767442|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153767444|NCT00409643|Valsartan|valsartan|mesh-list
153767472|NCT00193622|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153767473|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153767474|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767475|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767476|NCT00473590|Bevacizumab|bevacizumab|mesh-list
153767477|NCT00473590|Bortezomib|bortezomib|mesh-list
153767478|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153767479|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767480|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153767481|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153767482|NCT00473590|Growth Substances|growth substances|mesh-ancestor
153767535|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767537|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153664284|NCT00012311|Docetaxel|docetaxel|mesh-list
153664285|NCT00012311|Doxorubicin|doxorubicin|mesh-list
153664286|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153664287|NCT00012311|Fluorouracil|fluorouracil|mesh-list
153664288|NCT00012311|Methotrexate|methotrexate|mesh-list
153664289|NCT00012311|Etoposide|etoposide|mesh-list
153664290|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664291|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
153664292|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664293|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664294|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664295|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
153664296|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664297|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664298|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153664299|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664300|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664301|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664302|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153664303|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153664304|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664305|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664306|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
153664307|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664308|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153479286|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767538|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767539|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
153767540|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767541|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
153767542|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767543|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767544|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153767545|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
153767546|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767547|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767594|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153767595|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767596|NCT00223743|Zonisamide|zonisamide|mesh-list
153767597|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
153767598|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153767599|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153767600|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767601|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153767602|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767603|NCT00193973|Methotrexate|methotrexate|mesh-list
153767604|NCT00193973|Idarubicin|idarubicin|mesh-list
153767605|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153767606|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
153664309|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
153664310|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153664311|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
153664312|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153664313|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153664314|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664315|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153664316|NCT00847002|Laxatives|laxatives|mesh-ancestor
153664317|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153664318|NCT00012350|Tipifarnib|tipifarnib|mesh-list
153664319|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664341|NCT00012467|Fluconazole|fluconazole|mesh-list
153664342|NCT00012467|Amphotericin B|amphotericin b|mesh-list
153664343|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153664344|NCT00012467|Flucytosine|flucytosine|mesh-list
153664345|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664346|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
153664347|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664348|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
153664349|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153664350|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153664351|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664352|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664353|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153664354|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
153664355|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153664356|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664357|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153479309|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
153767607|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153767608|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767609|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153767610|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
153767611|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767612|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767613|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
153767614|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767615|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153767616|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767617|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
153767618|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153604734|NCT01919294|Hormones|hormones|mesh-ancestor
153767641|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
153810757|NCT00321347|Lidocaine|lidocaine|mesh-list
153814056|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814057|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767642|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153767643|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
153664358|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153664359|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153664360|NCT00012467|Amebicides|amebicides|mesh-ancestor
153664361|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153664362|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153664363|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153664364|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
153664366|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153664367|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153664368|NCT00012506|Analgesics|analgesics|mesh-ancestor
153664369|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
153664370|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664395|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153664396|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153664397|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664398|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153664400|NCT00846690|Phenylephrine|phenylephrine|mesh-list
153664401|NCT00846690|Benzocaine|benzocaine|mesh-list
153664402|NCT00846690|Tetracaine|tetracaine|mesh-list
153664403|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
153664404|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
153664405|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664406|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664407|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
153664408|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664409|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153664410|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153664411|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153664412|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479339|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767644|NCT00411879|Coagulants|coagulants|mesh-ancestor
153767645|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153767646|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
153767647|NCT00193505|Rituximab|rituximab|mesh-list
153767648|NCT00193505|Carboplatin|carboplatin|mesh-list
153767649|NCT00193505|Etoposide|etoposide|mesh-list
153767650|NCT00193505|Ifosfamide|ifosfamide|mesh-list
153767651|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153767652|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767664|NCT00223860|Hormones|hormones|mesh-list
153767706|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767707|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767708|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457970|NCT03596502|Warfarin|warfarin|mesh-list
153767709|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
153664413|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664414|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153664415|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
153664416|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
153664417|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
153664418|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153664419|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
153664453|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
153664454|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153664455|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153664456|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664457|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664458|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664459|NCT00012857|Acetaminophen|acetaminophen|mesh-list
153664460|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153664476|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
153418066|NCT02779166|Analgesics|analgesics|mesh-ancestor
153418067|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
153664477|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664478|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153664479|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153664480|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664481|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153664483|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153664484|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664485|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664486|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153479368|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153767710|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767711|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767712|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153767713|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
153767714|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153767772|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153767773|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153767774|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153767775|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153767776|NCT00194402|Niacin|niacin|mesh-list
153767777|NCT00194402|Niacinamide|niacinamide|mesh-list
153767778|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
153767779|NCT00194402|Atorvastatin|atorvastatin|mesh-list
153767780|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153767781|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153767782|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
153767783|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767784|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153767785|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153767786|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664487|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153664488|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664489|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664490|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
153664491|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664492|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664493|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153664494|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153664495|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664498|NCT00846144|Trace Elements|trace elements|mesh-ancestor
153664499|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
153664500|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664501|NCT00846144|Antidotes|antidotes|mesh-ancestor
153664502|NCT00846144|Protective Agents|protective agents|mesh-ancestor
153664503|NCT00846144|Emetics|emetics|mesh-ancestor
153664504|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
153664505|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664506|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153767787|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
153767788|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
153767789|NCT00194402|Vitamins|vitamins|mesh-ancestor
153767790|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
153418077|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153357360|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767791|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767792|NCT00473512|Dexamethasone|dexamethasone|mesh-list
153767793|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
153767794|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767795|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
153767796|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
153767797|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767798|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767801|NCT00473512|Hormones|hormones|mesh-ancestor
153767821|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153767823|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
153767824|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153767825|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767826|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153767827|NCT00125489|Filaricides|filaricides|mesh-ancestor
153767828|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
153767829|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
153767830|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153767831|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767832|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767833|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153767834|NCT00206661|Molgramostim|molgramostim|mesh-list
153767835|NCT00206661|Sargramostim|sargramostim|mesh-list
153767836|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
153767879|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153767880|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767881|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153767883|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153767884|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767885|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153767886|NCT00194480|Interferons|interferons|mesh-list
153767887|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767888|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
153664508|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664509|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664510|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153664511|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153664512|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664513|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664514|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
153664515|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
153664516|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664554|NCT00013520|Stavudine|stavudine|mesh-list
153664555|NCT00013520|Didanosine|didanosine|mesh-list
153664583|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664584|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664585|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
153664586|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664587|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
153664588|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153664589|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153479418|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479426|NCT01304238|PENTA|penta|mesh-list
153767889|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153767890|NCT00472420|Rituximab|rituximab|mesh-list
153767891|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153767892|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153767893|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
153767894|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767895|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153767896|NCT00194519|Acyclovir|acyclovir|mesh-list
153767897|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
153814059|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767898|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877303|NCT05934253|Anesthetics, Local|anesthetics, local|mesh-ancestor
153767899|NCT00206700|Sargramostim|sargramostim|mesh-list
153767933|NCT00206778|Valproic Acid|valproic acid|mesh-list
153767934|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
153767935|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153767936|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153767937|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153767938|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153767939|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153767941|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153767942|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153767996|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153767997|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153767998|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153767999|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
153768000|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768001|NCT00125918|Tadalafil|tadalafil|mesh-list
153768002|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
153768003|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153768004|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153768005|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664590|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153664591|NCT00277017|Growth Substances|growth substances|mesh-ancestor
153664592|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
153664594|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664595|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664596|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153664597|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153664598|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664599|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664600|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
153664601|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
153664630|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664631|NCT00276783|Pemetrexed|pemetrexed|mesh-list
153479438|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153768060|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768061|NCT00194948|Escitalopram|escitalopram|mesh-list
153768062|NCT00194948|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153768063|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153768064|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153768065|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768066|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768067|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
153768068|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605189|NCT01931098|Topotecan|topotecan|mesh-list
153768069|NCT00206973|Mannitol|mannitol|mesh-list
153768070|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153768071|NCT00206973|Diuretics|diuretics|mesh-ancestor
153768072|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
153768073|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768074|NCT00471445|Ketamine|ketamine|mesh-list
153768075|NCT00471445|Amitriptyline|amitriptyline|mesh-list
153768076|NCT00471445|Analgesics|analgesics|mesh-ancestor
153768077|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
153768078|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768079|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877304|NCT05934253|Anesthetics|anesthetics|mesh-ancestor
153877305|NCT05934253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877306|NCT05934253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879538|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153768080|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153768081|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153768082|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
153768083|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
153768084|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768106|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
153768107|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768108|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768109|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
153768110|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153768111|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153768112|NCT00224679|Aspirin|aspirin|mesh-list
153768113|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153768114|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153768115|NCT00224679|Analgesics|analgesics|mesh-ancestor
153768173|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153768174|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153768175|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153768176|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768177|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153768178|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768179|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
153768180|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153664632|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664633|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664634|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664635|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153664636|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153664637|NCT00276705|Thalidomide|thalidomide|mesh-list
153664638|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
153664639|NCT00276705|Doxorubicin|doxorubicin|mesh-list
153664640|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153664641|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664642|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
153664643|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664644|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664681|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664712|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664713|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664714|NCT00014261|Interferons|interferons|mesh-list
153664715|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
153664716|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
153664717|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153664718|NCT00014261|Temozolomide|temozolomide|mesh-list
153664719|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664720|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
153664721|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664722|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664723|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
153664724|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664725|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
153664726|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664760|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768181|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153768182|NCT00413127|Lidocaine|lidocaine|mesh-list
153768183|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
153768184|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
153768185|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768186|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768187|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
153768188|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814061|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153428978|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768189|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153768190|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153768191|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153887904|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768192|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664762|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153664763|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664764|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664765|NCT00014573|Aldesleukin|aldesleukin|mesh-list
153664766|NCT00014573|Paclitaxel|paclitaxel|mesh-list
153664767|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
153664768|NCT00014573|Carmustine|carmustine|mesh-list
153664799|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153664800|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664801|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664802|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664803|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664805|NCT00014651|Analgesics|analgesics|mesh-ancestor
153664806|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
153664807|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664808|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664809|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664810|NCT00014690|Topotecan|topotecan|mesh-list
153664811|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153664885|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664886|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
153664887|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664888|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664920|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153664921|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664922|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664923|NCT00275652|Lamivudine|lamivudine|mesh-list
153664924|NCT00275652|Telbivudine|telbivudine|mesh-list
153664925|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153664926|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153664927|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768225|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768226|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153768227|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768230|NCT00195299|MTOR Inhibitors|mtor inhibitors|mesh-list
153768231|NCT00195299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153768232|NCT00195299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768233|NCT00195299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768234|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768235|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
153664965|NCT00275535|Prednisone|prednisone|mesh-list
153664999|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153665001|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887905|NCT00598091|Gemcitabine|gemcitabine|mesh-list
153887906|NCT00598091|Dasatinib|dasatinib|mesh-list
153665002|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665003|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153665005|NCT00275457|Dexpramipexole|dexpramipexole|mesh-list
153665006|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
153665038|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153665039|NCT00015821|Growth Substances|growth substances|mesh-ancestor
153665040|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
153665041|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665043|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
153665044|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
153665045|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665046|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665047|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153665048|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153665049|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153665050|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
153665051|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479565|NCT01318278|Dopamine|dopamine|mesh-list
153768236|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768237|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768238|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153768239|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768240|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153768241|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
153768242|NCT00471328|Sunitinib|sunitinib|mesh-list
153768243|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
153768244|NCT00471328|Nilotinib|nilotinib|mesh-list
153768245|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768246|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153768247|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153768248|NCT00471328|Growth Substances|growth substances|mesh-ancestor
153768249|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768250|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
153768251|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153768252|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768271|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768272|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
153768273|NCT00225108|Tinzaparin|tinzaparin|mesh-list
153768274|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153768275|NCT00225108|Dalteparin|dalteparin|mesh-list
153768276|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
153768277|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153768278|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153768279|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768280|NCT00195416|Etanercept|etanercept|mesh-list
153768281|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153768282|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153768283|NCT00195416|Analgesics|analgesics|mesh-ancestor
153768335|NCT00195533|Tazobactam|tazobactam|mesh-list
153768336|NCT00195533|Piperacillin|piperacillin|mesh-list
153768337|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153665072|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153665073|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665074|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665076|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665077|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665078|NCT00275106|Leucovorin|leucovorin|mesh-list
153665079|NCT00275106|Cytarabine|cytarabine|mesh-list
153665080|NCT00275106|Dexamethasone|dexamethasone|mesh-list
153665081|NCT00275106|Prednisolone|prednisolone|mesh-list
153665082|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
153665083|NCT00275106|Doxorubicin|doxorubicin|mesh-list
153665084|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153665085|NCT00275106|Methotrexate|methotrexate|mesh-list
153665086|NCT00275106|Vincristine|vincristine|mesh-list
153357361|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
153887907|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665087|NCT00275106|Daunorubicin|daunorubicin|mesh-list
153665088|NCT00275106|Asparaginase|asparaginase|mesh-list
153665089|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
153665090|NCT00275106|Thioguanine|thioguanine|mesh-list
153665091|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
153665092|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665093|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
153665094|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479569|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
153768338|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153768339|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768340|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153768341|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768342|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768343|NCT00207558|Folic Acid|folic acid|mesh-list
153768403|NCT00225381|Anesthetics|anesthetics|mesh-list
153768404|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153768405|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768406|NCT00195728|Acetaminophen|acetaminophen|mesh-list
153768407|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153768408|NCT00195728|Hydrocodone|hydrocodone|mesh-list
153768409|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153768410|NCT00195728|Analgesics|analgesics|mesh-ancestor
153768411|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
153768412|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768413|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768414|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
153768415|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153768416|NCT00195728|Narcotics|narcotics|mesh-ancestor
153768465|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153768466|NCT00479713|Simvastatin|simvastatin|mesh-list
153768468|NCT00479713|Calcium|calcium|mesh-list
153768469|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153768470|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768471|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153768472|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153768478|NCT00207753|Ivermectin|ivermectin|mesh-list
153768532|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153768533|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768534|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153768535|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153768536|NCT00472693|Growth Substances|growth substances|mesh-ancestor
153665095|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665096|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665097|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
153665098|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665099|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665100|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153665101|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153665102|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
153665103|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
153665104|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665105|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153665127|NCT00275106|Vitamins|vitamins|mesh-ancestor
153665128|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
153665129|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153665130|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665131|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665132|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665133|NCT00015938|Docetaxel|docetaxel|mesh-list
153665134|NCT00015938|Vinorelbine|vinorelbine|mesh-list
153665135|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665136|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665137|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665138|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665139|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479600|NCT01328184|Empagliflozin|empagliflozin|mesh-list
153768537|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768538|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
153768539|NCT00195845|Galantamine|galantamine|mesh-list
153768540|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153768541|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768595|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
153768596|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768597|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768598|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153605713|NCT01934634|Paclitaxel|paclitaxel|mesh-list
153768599|NCT00411333|Triamcinolone|triamcinolone|mesh-list
153768600|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153768601|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153768602|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153768603|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768604|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
153768606|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153768607|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768608|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768609|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
153768610|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768611|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768612|NCT00225849|Aspirin|aspirin|mesh-list
153768613|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153768614|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153665140|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153665141|NCT00275067|Temozolomide|temozolomide|mesh-list
153665142|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
153665143|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665144|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
153665145|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665146|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665148|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153665149|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153665150|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665151|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
153665152|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665153|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665154|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665155|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
153665156|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665157|NCT00015977|Interleukin-12|interleukin-12|mesh-list
153665158|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153665188|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479619|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153768615|NCT00225849|Analgesics|analgesics|mesh-ancestor
153768616|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
153768620|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768647|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153768648|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768649|NCT00202865|Infliximab|infliximab|mesh-list
153768650|NCT00202865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153768651|NCT00202865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153768652|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
153768653|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768654|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768655|NCT00226005|Vatalanib|vatalanib|mesh-list
153768656|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153768657|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768658|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768659|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
153768660|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153768661|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
153768662|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153768663|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768664|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153768665|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153768666|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153768667|NCT00226044|Omeprazole|omeprazole|mesh-list
153768668|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153768669|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153768670|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153768671|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768672|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768673|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
153768694|NCT00196391|Progestins|progestins|mesh-ancestor
153665189|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153665190|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
153665191|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
153665192|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153665193|NCT00274950|Carboplatin|carboplatin|mesh-list
153665194|NCT00274950|Etoposide|etoposide|mesh-list
153665195|NCT00274950|Ifosfamide|ifosfamide|mesh-list
153665196|NCT00274950|Bleomycin|bleomycin|mesh-list
153665197|NCT00274950|Vinblastine|vinblastine|mesh-list
153665198|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665199|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153479656|NCT01330290|Rotigotine|rotigotine|mesh-list
153768695|NCT00196391|Hormones|hormones|mesh-ancestor
153768696|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153768697|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768698|NCT00203060|Rasagiline|rasagiline|mesh-list
153768699|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153768700|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768701|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768702|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153768759|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768760|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153768761|NCT00226200|Omalizumab|omalizumab|mesh-list
153768762|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153768763|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153768764|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
153768765|NCT00203138|Rasagiline|rasagiline|mesh-list
153768766|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153768767|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768768|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768769|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153768770|NCT00203138|Protective Agents|protective agents|mesh-ancestor
153768771|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768772|NCT00196547|Montelukast|montelukast|mesh-list
153768773|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153768774|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
153768775|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153768776|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
153768777|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153768778|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768782|NCT00203177|Rasagiline|rasagiline|mesh-list
153768813|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768814|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
153768815|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768816|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153768817|NCT00196586|Analgesics|analgesics|mesh-ancestor
153768818|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
153768819|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153768820|NCT00226317|Aripiprazole|aripiprazole|mesh-list
153768821|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
153768822|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153768823|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153768824|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153418108|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153418109|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153768874|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153768875|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
153768876|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153768877|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153768878|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153768879|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153768880|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
153768881|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153768882|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153768883|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
153768940|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153768941|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153665200|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665201|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665202|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665203|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665204|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665205|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
153665238|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665239|NCT00016055|Temozolomide|temozolomide|mesh-list
153665240|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665241|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
153665242|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665243|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665244|NCT00016094|Bevacizumab|bevacizumab|mesh-list
153665245|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153665246|NCT00016094|Antibodies|antibodies|mesh-list
153665278|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665279|NCT00016133|Antidotes|antidotes|mesh-ancestor
153665280|NCT00016133|Protective Agents|protective agents|mesh-ancestor
153665281|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
153665282|NCT00016133|Vitamins|vitamins|mesh-ancestor
153665373|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665374|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153665375|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665376|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153665377|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
153665379|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153665380|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665406|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665408|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665409|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665410|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665411|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665412|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
153665413|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665414|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665415|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665416|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
153418110|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814065|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665417|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153665418|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153665419|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665420|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665421|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665422|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
153479730|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
153768942|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
153768943|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153768944|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768945|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153768946|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153768947|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153768948|NCT00413322|Fluorouracil|fluorouracil|mesh-list
153768949|NCT00413322|Belinostat|belinostat|mesh-list
153768950|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
153768951|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153768952|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153768953|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153768954|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153768998|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769000|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153769001|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769002|NCT00410735|Pranlukast|pranlukast|mesh-list
153769003|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153769004|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
153769005|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153769006|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
153769007|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769008|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769009|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
153665423|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665424|NCT00016445|Hormones|hormones|mesh-list
153665425|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665426|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665427|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
153665428|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153665453|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
153665454|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153665455|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153887928|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887929|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
153887930|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153887931|NCT00598169|Dexamethasone|dexamethasone|mesh-list
153428987|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153428988|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428989|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428990|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665456|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153665457|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665458|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665459|NCT00016601|Ritonavir|ritonavir|mesh-list
153665460|NCT00016601|Nelfinavir|nelfinavir|mesh-list
153665461|NCT00016601|Indinavir|indinavir|mesh-list
153665462|NCT00016601|Nevirapine|nevirapine|mesh-list
153665463|NCT00016601|Efavirenz|efavirenz|mesh-list
153665464|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153665465|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
153665466|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153665467|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153665468|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
153479792|NCT06244277|GABA Agonists|gaba agonists|mesh-ancestor
153769010|NCT00203372|Bevacizumab|bevacizumab|mesh-list
153769011|NCT00203372|Docetaxel|docetaxel|mesh-list
153769012|NCT00203372|Doxorubicin|doxorubicin|mesh-list
153769013|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769014|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
153769055|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153769056|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769057|NCT00208533|Aripiprazole|aripiprazole|mesh-list
153769058|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
153769059|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769060|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153769061|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153769062|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769063|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769064|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
153769065|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
153769066|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769067|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769112|NCT00203528|Valproic Acid|valproic acid|mesh-list
153769113|NCT00203528|Risperidone|risperidone|mesh-list
153769114|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153769115|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
153769116|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769117|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769118|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769119|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153606238|NCT06066866|GABA Agents|gaba agents|mesh-ancestor
153769120|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153769121|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769122|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153665469|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665470|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665471|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153665472|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153665473|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
153665474|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665475|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153877341|NCT05888896|Antihypertensive Agents|antihypertensive agents|mesh-list
153877342|NCT05888896|Methyldopa|methyldopa|mesh-list
153877344|NCT05888896|Autonomic Agents|autonomic agents|mesh-ancestor
153877345|NCT05888896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877346|NCT05888896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877349|NCT05888896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153814070|NCT00444561|Pramlintide|pramlintide|mesh-list
153665476|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153665477|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153665500|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665501|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153814087|NCT00444717|Pitavastatin|pitavastatin|mesh-list
153665502|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665503|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
153665504|NCT00016835|Metronidazole|metronidazole|mesh-list
153665505|NCT00016835|Doxycycline|doxycycline|mesh-list
153665506|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665507|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153665508|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153665509|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153665510|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
153665512|NCT00016874|Cisplatin|cisplatin|mesh-list
153665513|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153665514|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665515|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665516|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665517|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665518|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665519|NCT00016952|Leucovorin|leucovorin|mesh-list
153665520|NCT00016952|Fluorouracil|fluorouracil|mesh-list
153665521|NCT00016952|Irinotecan|irinotecan|mesh-list
153665522|NCT00016952|Calcium|calcium|mesh-list
153665523|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
153665524|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153665525|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479801|NCT06244212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769123|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153769124|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
153769125|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
153769126|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665527|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665559|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665560|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665561|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665562|NCT00017030|Trabectedin|trabectedin|mesh-list
153665563|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665564|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
153665565|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665566|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665567|NCT00017069|Dexamethasone|dexamethasone|mesh-list
153665568|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
153665569|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153665570|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
153665606|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665634|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665635|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665637|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665638|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665639|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
153769127|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
153769128|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
153769129|NCT00208611|Vitamins|vitamins|mesh-list
153769130|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
153769131|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
153769132|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
153769133|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
153769134|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769135|NCT00208611|Hematinics|hematinics|mesh-ancestor
153769136|NCT00203567|Carbamazepine|carbamazepine|mesh-list
153769137|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
153769138|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
153769139|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153769140|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769159|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769160|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153769162|NCT00203606|Interferons|interferons|mesh-list
153769163|NCT00203606|Ribavirin|ribavirin|mesh-list
153769164|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
153769165|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
153769166|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153769167|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769168|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
153769169|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769170|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
153769171|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769172|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
153769173|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769174|NCT00203684|Flunisolide|flunisolide|mesh-list
153769175|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769176|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153769177|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
153769178|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
153769179|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153769180|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769181|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665640|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665641|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153665642|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665643|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665644|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665645|NCT00017186|Gemcitabine|gemcitabine|mesh-list
153665646|NCT00017186|Epirubicin|epirubicin|mesh-list
153665647|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665648|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
153665649|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665650|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665651|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153665652|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665691|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665692|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153665693|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
153665715|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153665716|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665717|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665718|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665719|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665720|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665722|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
153769182|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153769183|NCT00226785|Analgesics|analgesics|mesh-ancestor
153769184|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
153769208|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769210|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153769211|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
153769212|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769213|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769277|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
153769279|NCT00208923|Fludarabine|fludarabine|mesh-list
153769280|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153769281|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
153769282|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769283|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153769284|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769285|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
153769286|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769287|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769288|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153769289|NCT00227136|Serotonin|serotonin|mesh-list
153769290|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153814090|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153769291|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
153769292|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458155|NCT03023358|Vincristine|vincristine|mesh-list
153769297|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153769298|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153769299|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
153665723|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665724|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
153665725|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665726|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665727|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
153665728|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665729|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665730|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
153665731|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665732|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153665733|NCT00128739|Budesonide|budesonide|mesh-list
153665734|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153665735|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153665736|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
153665737|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665738|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479907|NCT06243133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153769300|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769301|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769302|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769303|NCT00197444|Nedaplatin|nedaplatin|mesh-list
153769304|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769321|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769322|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769323|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
153769324|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769325|NCT00197483|Pergolide|pergolide|mesh-list
153769326|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
153769327|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
153769328|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769329|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769330|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769331|NCT00230529|Infliximab|infliximab|mesh-list
153769332|NCT00230529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153769333|NCT00230529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769334|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
153769335|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769336|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814091|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
153814092|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814093|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814094|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153814095|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
153814096|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153814097|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153814098|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814099|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
153814100|NCT00421317|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153814102|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814103|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814104|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814105|NCT00337259|Gemcitabine|gemcitabine|mesh-list
153769337|NCT00230568|Donepezil|donepezil|mesh-list
153769338|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153769339|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769340|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769376|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153769378|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769379|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153769380|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153769381|NCT00227448|Phenylephrine|phenylephrine|mesh-list
153769382|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
153769383|NCT00227448|Midodrine|midodrine|mesh-list
153769384|NCT00227448|Norepinephrine|norepinephrine|mesh-list
153769385|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153769386|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
153769387|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
153769388|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769389|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769390|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
153769401|NCT00204191|Tacrolimus|tacrolimus|mesh-list
153769437|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153665739|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153665740|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
153665741|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
153665742|NCT00128739|Hormones|hormones|mesh-ancestor
153665743|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665744|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
153665745|NCT00017381|Rituximab|rituximab|mesh-list
153665781|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
153665782|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769438|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153769440|NCT00204308|Emtricitabine|emtricitabine|mesh-list
153769441|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
153769442|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769443|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153769444|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153769445|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769446|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769447|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153769448|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153769449|NCT00204347|Risperidone|risperidone|mesh-list
153769450|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153769451|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
153769452|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769453|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769496|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769497|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769498|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153769499|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153769500|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153769501|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153769503|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
153420427|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153769504|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769505|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769506|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
153769507|NCT04721964|Trace Elements|trace elements|mesh-ancestor
153769508|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
153769509|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769510|NCT00197834|Valproic Acid|valproic acid|mesh-list
153769556|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769558|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769559|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769560|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
153769561|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153769562|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769563|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153769564|NCT00204542|Diclofenac|diclofenac|mesh-list
153769565|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153769566|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153769567|NCT00204542|Analgesics|analgesics|mesh-ancestor
153769568|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
153769569|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877354|NCT05886582|Dopamine Agonists|dopamine agonists|mesh-ancestor
153877355|NCT05886582|Dopamine Agents|dopamine agents|mesh-ancestor
153877356|NCT05886582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877357|NCT05886582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877358|NCT05886582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877359|NCT05885932|Aspirin|aspirin|mesh-list
153877360|NCT05885932|Sirolimus|sirolimus|mesh-list
153877361|NCT05885932|Clopidogrel|clopidogrel|mesh-list
153877362|NCT05885932|Ticagrelor|ticagrelor|mesh-list
153877363|NCT05885932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153877364|NCT05885932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887932|NCT00598169|Rituximab|rituximab|mesh-list
153887933|NCT00598169|Carboplatin|carboplatin|mesh-list
153887934|NCT00598169|Etoposide|etoposide|mesh-list
153887935|NCT00598169|Bortezomib|bortezomib|mesh-list
153887936|NCT00598169|Ifosfamide|ifosfamide|mesh-list
153887937|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887938|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
153887939|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
153887940|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887941|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887942|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153887943|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
153887944|NCT00598169|Hormones|hormones|mesh-ancestor
153887945|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887947|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769570|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769571|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769576|NCT00230958|Interferons|interferons|mesh-list
153769613|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769614|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153769615|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
153769616|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769617|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
153769618|NCT00204581|Aldesleukin|aldesleukin|mesh-list
153769619|NCT00204581|Interleukin-2|interleukin-2|mesh-list
153769620|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769680|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769681|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769682|NCT00228267|Propofol|propofol|mesh-list
153769683|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153665783|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153665784|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665816|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
153665817|NCT00017654|Cyclosporins|cyclosporins|mesh-list
153665818|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153665819|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665820|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
153502799|NCT01831674|Metformin|metformin|mesh-list
153665821|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665822|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665823|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665824|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
153665858|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153665859|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153665860|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
153665861|NCT00017693|Interleukin-4|interleukin-4|mesh-list
153665862|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153665863|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
153665864|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665865|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665866|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665867|NCT00128466|Gentamicins|gentamicins|mesh-list
153665892|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153665893|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
153665894|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
153665895|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153665896|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153665897|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153665898|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153665899|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769684|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153769685|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769686|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153769687|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
153769688|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
153769689|NCT00231348|Nefazodone|nefazodone|mesh-list
153769746|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877365|NCT05885932|Analgesics|analgesics|mesh-ancestor
153769747|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418129|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153418130|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418131|NCT02906696|Bosutinib|bosutinib|mesh-list
153418132|NCT02906696|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153418133|NCT02906696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153418134|NCT02906696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418140|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418141|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153879596|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
153769748|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153769749|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153769750|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153769751|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
153769752|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153769753|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769755|NCT00198614|Protective Agents|protective agents|mesh-ancestor
153665900|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
153665901|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
153665902|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665903|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153665904|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153665905|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
153665906|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665907|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665908|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153665909|NCT00018083|Efavirenz|efavirenz|mesh-list
153665910|NCT00018083|Isoniazid|isoniazid|mesh-list
153665911|NCT00018083|Rifabutin|rifabutin|mesh-list
153665912|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153665913|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153665914|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665915|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665916|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
153665917|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665947|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665948|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153665949|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153665950|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
153665951|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153479973|NCT06192979|Dexamethasone|dexamethasone|mesh-list
153769756|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153769757|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153769758|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153769759|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
153769760|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153769761|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153769762|NCT00231582|Paclitaxel|paclitaxel|mesh-list
153769763|NCT00231582|Etoposide|etoposide|mesh-list
153769764|NCT00231582|Carboplatin|carboplatin|mesh-list
153769765|NCT00231582|Epirubicin|epirubicin|mesh-list
153769766|NCT00231582|Ifosfamide|ifosfamide|mesh-list
153769768|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606915|NCT04471987|Interleukin-12|interleukin-12|mesh-list
153429021|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429022|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429023|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153814109|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429024|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153429025|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153429026|NCT02341495|Vitamin D|vitamin d|mesh-list
153429027|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
153429028|NCT02341495|Azacitidine|azacitidine|mesh-list
153429029|NCT02341495|Deferasirox|deferasirox|mesh-list
153769799|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769800|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769801|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153769802|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153769803|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153769804|NCT00198848|Folic Acid|folic acid|mesh-list
153769805|NCT00198848|Hematinics|hematinics|mesh-ancestor
153769806|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
153769807|NCT00198848|Vitamins|vitamins|mesh-ancestor
153769808|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
153769809|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769810|NCT00478426|Sunitinib|sunitinib|mesh-list
153769811|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769814|NCT00478426|Growth Substances|growth substances|mesh-ancestor
153769859|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736429|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153665953|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
153665954|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
153665955|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665956|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153665957|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153665958|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
153665981|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
153665982|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665983|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665984|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665985|NCT00018954|Cytarabine|cytarabine|mesh-list
153665986|NCT00018954|Prednisone|prednisone|mesh-list
153665987|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
153665988|NCT00018954|Ifosfamide|ifosfamide|mesh-list
153665989|NCT00018954|Doxorubicin|doxorubicin|mesh-list
153665990|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153665991|NCT00018954|Methotrexate|methotrexate|mesh-list
153665992|NCT00018954|Etoposide|etoposide|mesh-list
153665993|NCT00018954|Vincristine|vincristine|mesh-list
153665994|NCT00018954|Daunorubicin|daunorubicin|mesh-list
153665995|NCT00018954|Asparaginase|asparaginase|mesh-list
153665996|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
153665997|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665998|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
153665999|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666000|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666001|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153769860|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153769861|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153769862|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153877366|NCT05885932|Sensory System Agents|sensory system agents|mesh-ancestor
153877367|NCT05885932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877368|NCT05885932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877369|NCT05885932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877370|NCT05885932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877371|NCT05885932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153769863|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
153769864|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153769865|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153769866|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
153769925|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153769926|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
153769927|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
153769928|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153769929|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769930|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
153769931|NCT00477412|Hormones|hormones|mesh-ancestor
153769932|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769933|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153769934|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153769935|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153769936|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666002|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
153666003|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666004|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666005|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153666006|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666007|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666008|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666009|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666035|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666037|NCT00019032|Antibodies|antibodies|mesh-list
153666038|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153666039|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
153666040|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666041|NCT00019071|Cladribine|cladribine|mesh-list
153666042|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666043|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666044|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
153666045|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666046|NCT04734119|Anesthetics|anesthetics|mesh-list
153666047|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666048|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666049|NCT00018356|Testosterone|testosterone|mesh-list
153666050|NCT00018356|Androgens|androgens|mesh-ancestor
153666052|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666053|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666054|NCT00019227|Calcium|calcium|mesh-list
153666055|NCT00019227|Daclizumab|daclizumab|mesh-list
153666056|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
153769937|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153769938|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153769939|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
153769940|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153769941|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153769942|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
153769943|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
153769944|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153769945|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153769946|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
153769947|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153769948|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153769949|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
153769950|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
153769951|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
153877374|NCT05885932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153877375|NCT05885932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153877376|NCT05885932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877377|NCT05885932|Antipyretics|antipyretics|mesh-ancestor
153769952|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
153769953|NCT00410774|Bevacizumab|bevacizumab|mesh-list
153769954|NCT00410774|Gemcitabine|gemcitabine|mesh-list
153769955|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153769957|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153666080|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666082|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153666083|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153666084|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
153666085|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666086|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153666087|NCT00019422|Carboplatin|carboplatin|mesh-list
153666088|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666089|NCT00018551|Folic Acid|folic acid|mesh-list
153666090|NCT00018551|Hematinics|hematinics|mesh-ancestor
153666091|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
153666092|NCT00018551|Vitamins|vitamins|mesh-ancestor
153666093|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
153666094|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666095|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
153666096|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666097|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153666098|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153666099|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666100|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153666101|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666102|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153666103|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153666104|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
153666105|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666106|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666107|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153480072|NCT06012331|Mitogens|mitogens|mesh-list
153769958|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153769959|NCT00410774|Growth Substances|growth substances|mesh-ancestor
153769960|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769961|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
153769962|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153769964|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769965|NCT00228930|Tamoxifen|tamoxifen|mesh-list
153769966|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153769967|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
153769968|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153769969|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769970|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153666108|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153666109|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153666140|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666142|NCT00142454|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153666143|NCT00142454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666144|NCT00142454|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153666145|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
153666146|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814119|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153887966|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
153666147|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153666148|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666149|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
153666150|NCT00020124|Doxorubicin|doxorubicin|mesh-list
153666151|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153666152|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666153|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666177|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153666179|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480105|NCT05995249|Efavirenz|efavirenz|mesh-list
153769971|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769972|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153769973|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153769974|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153769975|NCT00410852|Insulin|insulin|mesh-list
153769976|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153769977|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153769978|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769979|NCT01086982|Octreotide|octreotide|mesh-list
153769980|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153769981|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153769982|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153769983|NCT00410930|Immunomodulating Agents|immunomodulating agents|mesh-list
153769986|NCT00204893|Calcium|calcium|mesh-list
153770011|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770019|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770021|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153770022|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
153770023|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770024|NCT00229125|Gabapentin|gabapentin|mesh-list
153770068|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153770069|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
153770070|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
153770071|NCT00205322|Leucovorin|leucovorin|mesh-list
153770072|NCT00205322|Capecitabine|capecitabine|mesh-list
153770073|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
153770074|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153770075|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
153770076|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770077|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770078|NCT00205322|Antidotes|antidotes|mesh-ancestor
153770079|NCT00205322|Protective Agents|protective agents|mesh-ancestor
153770080|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770081|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
153770082|NCT00205322|Vitamins|vitamins|mesh-ancestor
153770083|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
153770084|NCT00232206|Docetaxel|docetaxel|mesh-list
153770085|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666180|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153666181|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
153666182|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666183|NCT00020397|Aldesleukin|aldesleukin|mesh-list
153666184|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666185|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153666186|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153666187|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
153418145|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153666188|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666189|NCT05576480|Capecitabine|capecitabine|mesh-list
153666190|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
153666191|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666192|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
153666193|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666194|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666195|NCT00020631|Pirfenidone|pirfenidone|mesh-list
153666196|NCT00020631|Analgesics|analgesics|mesh-ancestor
153666197|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
153666198|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666199|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666200|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153666201|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153666202|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153666203|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666204|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666206|NCT05576324|Elexacaftor|elexacaftor|mesh-list
153666207|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153666243|NCT00020865|Levofloxacin|levofloxacin|mesh-list
153666244|NCT00020865|Cefepime|cefepime|mesh-list
153666245|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153666279|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666281|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153666282|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
153770086|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153770087|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153770088|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153770090|NCT00229242|Diuretics|diuretics|mesh-list
153770124|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770125|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
153770126|NCT00205751|Hormones|hormones|mesh-ancestor
153770127|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770128|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770129|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666284|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666285|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153666286|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153666287|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
153666317|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418146|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
153418147|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418148|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418149|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153418150|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418151|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153418152|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153418153|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153418154|NCT02780869|Thrombin|thrombin|mesh-list
153418155|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
153418156|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
153814122|NCT00337298|Amlodipine|amlodipine|mesh-list
153814123|NCT00337298|Lisinopril|lisinopril|mesh-list
153666318|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153666319|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153666320|NCT00021060|Growth Substances|growth substances|mesh-ancestor
153666321|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666322|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
153666323|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
153666325|NCT00021099|Epothilone B|epothilone b|mesh-list
153666326|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666327|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666328|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666329|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666330|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770130|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153770131|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
153770132|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770133|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153770134|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770143|NCT00229476|Sertraline|sertraline|mesh-list
153770184|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
153770185|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153770186|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153770187|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153770188|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153770189|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
153770190|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
153770191|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153770192|NCT00229515|Protective Agents|protective agents|mesh-ancestor
153770193|NCT00206024|Esomeprazole|esomeprazole|mesh-list
153770194|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153770195|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770196|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153770197|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770198|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770199|NCT00206063|Ximelagatran|ximelagatran|mesh-list
153770200|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
153770201|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153770242|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770244|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
153770245|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770246|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153770247|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770248|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
153770249|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429072|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770250|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153770251|NCT00206219|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153770252|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153770254|NCT00206258|Glucagon|glucagon|mesh-list
153770255|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153770256|NCT00206258|Hormones|hormones|mesh-ancestor
153666331|NCT05574257|Propofol|propofol|mesh-list
153666332|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153666333|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666334|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666335|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153666363|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
153666364|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666365|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153666366|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153666367|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153666368|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
153666369|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666370|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666371|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153666372|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153666373|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153666374|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153666375|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153666376|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
153666378|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
153666379|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
153666380|NCT00021216|Bortezomib|bortezomib|mesh-list
153666381|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666382|NCT00021294|Eflornithine|eflornithine|mesh-list
153666383|NCT00021294|Triamcinolone|triamcinolone|mesh-list
153666413|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153666414|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
153666415|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153666416|NCT00392093|Estrogens|estrogens|mesh-list
153666417|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153666418|NCT00392093|Hormones|hormones|mesh-ancestor
153480211|NCT05925140|Protease Inhibitors|protease inhibitors|mesh-ancestor
153770257|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153770258|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770298|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814127|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814128|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153814129|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814130|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
153814131|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153814132|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
153814133|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814134|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153814135|NCT00337298|Protective Agents|protective agents|mesh-ancestor
153814136|NCT00337376|Sirolimus|sirolimus|mesh-list
153814137|NCT00337376|Paclitaxel|paclitaxel|mesh-list
153814154|NCT00337493|Tacrolimus|tacrolimus|mesh-list
153814155|NCT00337493|Cyclosporins|cyclosporins|mesh-list
153770299|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770300|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
153770301|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770302|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153770303|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
153770304|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770305|NCT00206414|Gefitinib|gefitinib|mesh-list
153770306|NCT00206414|Fulvestrant|fulvestrant|mesh-list
153770307|NCT00206414|Anastrozole|anastrozole|mesh-list
153666419|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666420|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666421|NCT00018161|Mecamylamine|mecamylamine|mesh-list
153666422|NCT00018161|Nicotine|nicotine|mesh-list
153666423|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153666424|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
153666425|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666426|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666427|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153666446|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666447|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666448|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153666449|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
153666450|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153666451|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666452|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666453|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666454|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153666455|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153666456|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
153666457|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153666458|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153666459|NCT00021528|Mirtazapine|mirtazapine|mesh-list
153666460|NCT00021528|Buspirone|buspirone|mesh-list
153666461|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
153666462|NCT00021528|Sertraline|sertraline|mesh-list
153770308|NCT00206414|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153770360|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770361|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770362|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153770363|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
153770364|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
153770365|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153770366|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153770367|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153770368|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153770369|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
153770370|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770371|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770372|NCT00206765|Risperidone|risperidone|mesh-list
153770373|NCT00206765|Paroxetine|paroxetine|mesh-list
153770374|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153770375|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
153770376|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770377|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770415|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770416|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770417|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153666463|NCT00021528|Citalopram|citalopram|mesh-list
153666464|NCT00021528|Nortriptyline|nortriptyline|mesh-list
153666465|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
153666466|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153666467|NCT00021528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153877379|NCT05885932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153877380|NCT05885932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153877381|NCT05885932|Purinergic Agents|purinergic agents|mesh-ancestor
153666468|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153666469|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153666470|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666471|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666472|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
153666473|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461722|NCT03193866|Rituximab|rituximab|mesh-list
153666474|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666475|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153666476|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666477|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153666478|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153666479|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
153666480|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
153666481|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153666482|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153666513|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
153480299|NCT05766124|Plasminogen|plasminogen|mesh-list
153770418|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770419|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770420|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770421|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
153770422|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770423|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770425|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153770426|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153770479|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
153770480|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770481|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770482|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770483|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153770484|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153770485|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153770486|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153770487|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770488|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770489|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770490|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770491|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770492|NCT00233025|Analgesics|analgesics|mesh-ancestor
153770493|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
153770498|NCT00207428|Carbamazepine|carbamazepine|mesh-list
153770531|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666514|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666515|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666516|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153666517|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666519|NCT00022074|Analgesics|analgesics|mesh-ancestor
153666520|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
153666521|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666522|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666523|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
153666524|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153666525|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153666526|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666554|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153666556|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666557|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666558|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666559|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666560|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
153877389|NCT05885932|Immunologic Factors|immunologic factors|mesh-ancestor
153877390|NCT05884671|Sulpiride|sulpiride|mesh-list
153888004|NCT00598793|Metformin|metformin|mesh-list
153888005|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
153666561|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666562|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666563|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
153666564|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666565|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666566|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153666567|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
153666568|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153666569|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666570|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666571|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666572|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666573|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153666595|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666596|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
153666597|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770533|NCT00207701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153770534|NCT00207701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153770535|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
153770536|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153666599|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153666600|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666601|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666602|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
153666603|NCT00022542|Epothilones|epothilones|mesh-list
153666604|NCT00022542|Epothilone B|epothilone b|mesh-list
153666605|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666606|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666607|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666608|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666609|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666610|NCT00022581|Thalidomide|thalidomide|mesh-list
153666611|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666612|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
153666613|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666614|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
153666615|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153666616|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666617|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153666618|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153666619|NCT00022581|Growth Substances|growth substances|mesh-ancestor
153666620|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
153666621|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666622|NCT05551871|Simvastatin|simvastatin|mesh-list
153666700|NCT00022893|Antibodies|antibodies|mesh-list
153666711|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153666712|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666713|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
153666714|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666715|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666716|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
153666717|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
153666718|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
153666719|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153666720|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
153666755|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153666757|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666758|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666759|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666760|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153666761|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153666762|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666788|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666789|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666790|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
153666791|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153666792|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666793|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666794|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
153666795|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666796|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
153666797|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666798|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153666799|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666800|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
153666801|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
153666802|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666803|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153666804|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153503771|NCT02247414|Tinzaparin|tinzaparin|mesh-list
153770537|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153770539|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
153770540|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153770541|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153770543|NCT00230373|Imiquimod|imiquimod|mesh-list
153666805|NCT00023244|Protective Agents|protective agents|mesh-ancestor
153666806|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153666807|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
153666808|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153666809|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153666810|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153666811|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153666812|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153666813|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153666833|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666834|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666835|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153666836|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153666837|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
153666838|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736431|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
153666839|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153666840|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153666841|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
153666842|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
153666843|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153357367|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357368|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153429074|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
153814164|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
153814165|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814166|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153888019|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888020|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888021|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153888022|NCT01062763|Diuretics|diuretics|mesh-ancestor
153666844|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153666845|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666846|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
153666847|NCT05359172|Coagulants|coagulants|mesh-ancestor
153666848|NCT00023634|Sargramostim|sargramostim|mesh-list
153666849|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
153666850|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666851|NCT00023751|Leucovorin|leucovorin|mesh-list
153666852|NCT00023751|Fluorouracil|fluorouracil|mesh-list
153666853|NCT00023751|Calcium|calcium|mesh-list
153666854|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
153480501|NCT05583552|Imetelstat|imetelstat|mesh-list
153770595|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
153770596|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770597|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770598|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
153770599|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153770600|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770601|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770602|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153770603|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153770604|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770605|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666855|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153666856|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666857|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
153666858|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666859|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666860|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666861|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666862|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
153666863|NCT00023751|Antidotes|antidotes|mesh-ancestor
153666864|NCT00023751|Protective Agents|protective agents|mesh-ancestor
153666865|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
153666866|NCT00023751|Vitamins|vitamins|mesh-ancestor
153666867|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
153666868|NCT00023790|Silicon|silicon|mesh-list
153666869|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
153666870|NCT00023790|Trace Elements|trace elements|mesh-ancestor
153666871|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
153666872|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666873|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
153666904|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
153666905|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666906|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153666907|NCT00023829|Bicalutamide|bicalutamide|mesh-list
153666909|NCT00023829|Hormones|hormones|mesh-list
153877391|NCT05884671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153877392|NCT05884671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153877393|NCT05884671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418157|NCT02780869|Coagulants|coagulants|mesh-ancestor
153418158|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
153418159|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
153418160|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153418161|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153418163|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418164|NCT02908490|Urological Agents|urological agents|mesh-ancestor
153418165|NCT02911844|Fulvestrant|fulvestrant|mesh-list
153888026|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
153666910|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666911|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666912|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
153666913|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
153666914|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666915|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153770606|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770607|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153770608|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153770609|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770610|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770611|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
153770612|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153770616|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
153770646|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153770647|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770648|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153770649|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
153770650|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770651|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153770652|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153666916|NCT00023868|Leucovorin|leucovorin|mesh-list
153666917|NCT00023868|Doxorubicin|doxorubicin|mesh-list
153666918|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153666919|NCT00023868|Fluorouracil|fluorouracil|mesh-list
153666920|NCT00023868|Irinotecan|irinotecan|mesh-list
153666945|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666946|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666947|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666948|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666949|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666950|NCT00023946|Epothilones|epothilones|mesh-list
153666951|NCT00023946|Epothilone B|epothilone b|mesh-list
153666952|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666953|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666954|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666955|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666956|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666957|NCT05268185|Vaccines|vaccines|mesh-list
153666958|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
153666959|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666960|NCT00024063|Orantinib|orantinib|mesh-list
153666961|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153666962|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666963|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666964|NCT00024141|Fluorouracil|fluorouracil|mesh-list
153666965|NCT00024141|Irinotecan|irinotecan|mesh-list
153666966|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
153666967|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418166|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153814171|NCT00444756|Lidocaine|lidocaine|mesh-list
153814172|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
153814173|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
153429105|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153666968|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666969|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666970|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666971|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
153770653|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
153770654|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
153770656|NCT00233532|Trandolapril|trandolapril|mesh-list
153770657|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153770658|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153770659|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153770660|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770661|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153770662|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770663|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
153770700|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770701|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153770702|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
153666972|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666993|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666994|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153666995|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153666996|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153666997|NCT00024375|Paclitaxel|paclitaxel|mesh-list
153666998|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666999|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667000|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667001|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667002|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667003|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667004|NCT00024414|Paclitaxel|paclitaxel|mesh-list
153667005|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667006|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667007|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667008|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667009|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667010|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667011|NCT00024453|Teicoplanin|teicoplanin|mesh-list
153667012|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153667013|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667014|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
153667015|NCT00024492|Analgesics|analgesics|mesh-ancestor
153770703|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770704|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770705|NCT00208169|Aripiprazole|aripiprazole|mesh-list
153814184|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153814185|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153814186|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
153814187|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814188|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814189|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814205|NCT00444873|Lanreotide|lanreotide|mesh-list
153770706|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
153770707|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153770708|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153770709|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770763|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153770764|NCT01085734|Growth Substances|growth substances|mesh-ancestor
153770765|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770766|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
153770767|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153770768|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
153770769|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153770770|NCT00208403|Protective Agents|protective agents|mesh-ancestor
153770771|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770772|NCT01084603|Nicotine|nicotine|mesh-list
153770773|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153770774|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
153458277|NCT04406610|Immunomodulating Agents|immunomodulating agents|mesh-list
153770826|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770827|NCT00208559|Ziprasidone|ziprasidone|mesh-list
153770828|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153770829|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
153770830|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153770831|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667016|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
153667017|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667018|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667019|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667020|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153667021|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667022|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667023|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667024|NCT00024531|Atorvastatin|atorvastatin|mesh-list
153667061|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
153667062|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667063|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667064|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667065|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667091|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667092|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
153667093|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667094|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667095|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667096|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153667097|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
153667098|NCT05051891|Hormones|hormones|mesh-ancestor
153667099|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153667100|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153667101|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667102|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667103|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667104|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667105|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153667106|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153667107|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153504088|NCT00556920|Carvedilol|carvedilol|mesh-list
153814216|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153814217|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153814218|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153480633|NCT05400265|Antibodies|antibodies|mesh-list
153770832|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770833|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153770834|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153770835|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153667108|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667109|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667110|NCT00025194|Estramustine|estramustine|mesh-list
153667111|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667113|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667114|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667115|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153667116|NCT00025272|Carboplatin|carboplatin|mesh-list
153667117|NCT00025272|Etoposide|etoposide|mesh-list
153667143|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667145|NCT00025389|Bevacizumab|bevacizumab|mesh-list
153667146|NCT00025389|Carboplatin|carboplatin|mesh-list
153667147|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667148|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667149|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667150|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667151|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667152|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667153|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153667154|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153667155|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153667156|NCT00025389|Growth Substances|growth substances|mesh-ancestor
153667157|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667158|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
153667159|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
153667160|NCT00025428|Carboplatin|carboplatin|mesh-list
153770887|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
153770888|NCT00208793|Vitamins|vitamins|mesh-list
153770889|NCT00208793|Calcium|calcium|mesh-list
153770890|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
153770891|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770892|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153770893|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153770894|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
153770895|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153770898|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153770957|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770958|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153770959|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153770960|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
153770961|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770962|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770963|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153770964|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153770965|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
153770966|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
153770967|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770968|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153667162|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153667163|NCT00025428|Etoposide|etoposide|mesh-list
153667164|NCT00025428|Vincristine|vincristine|mesh-list
153667165|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667194|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
153667195|NCT00025545|Methotrexate|methotrexate|mesh-list
153667196|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667197|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
153667198|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667199|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814219|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814220|NCT00451113|Incretins|incretins|mesh-ancestor
153814221|NCT00451113|Hormones|hormones|mesh-ancestor
153667200|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667201|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
153667202|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667203|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667204|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667205|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153667206|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
153667207|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153667208|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667209|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
153667210|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
153667241|NCT00025740|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153480702|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
153480703|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
153771016|NCT00234234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153771017|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153771018|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153771019|NCT00237588|Losartan|losartan|mesh-list
153771020|NCT00237588|Amlodipine|amlodipine|mesh-list
153771021|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153771022|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153771023|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771024|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771025|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153771026|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771027|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
153771028|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153771029|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153771074|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153771075|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
153771076|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
153771077|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771078|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771079|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153771080|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
153771081|NCT00209495|Hormones|hormones|mesh-ancestor
153771082|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153771083|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153667242|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153667243|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153667244|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667245|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667246|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
153667247|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667248|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153667249|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
153667250|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667251|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153667252|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153667253|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667254|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
153667255|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
153667274|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153667276|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667277|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667278|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667279|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153667280|NCT00026052|Protective Agents|protective agents|mesh-ancestor
153815078|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667281|NCT00026091|Fenretinide|fenretinide|mesh-list
153667282|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667283|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153667284|NCT00026091|Protective Agents|protective agents|mesh-ancestor
153667285|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667286|NCT00026130|Gemcitabine|gemcitabine|mesh-list
153667287|NCT00026130|Fluorouracil|fluorouracil|mesh-list
153667288|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667289|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
153480735|NCT05199571|Ofatumumab|ofatumumab|mesh-list
153480736|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480737|NCT05195918|Pirfenidone|pirfenidone|mesh-list
153480738|NCT05195918|Nintedanib|nintedanib|mesh-list
153480739|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153480740|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771084|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771085|NCT00209495|Analgesics|analgesics|mesh-ancestor
153771086|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
153667290|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667291|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667292|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667293|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
153667294|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667295|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
153667296|NCT00026169|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153667297|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153667298|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667299|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667300|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667301|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153667302|NCT04808414|Polymyxins|polymyxins|mesh-list
153667303|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667304|NCT00026364|Leucovorin|leucovorin|mesh-list
153667305|NCT00026364|Fluorouracil|fluorouracil|mesh-list
153667306|NCT00026364|Irinotecan|irinotecan|mesh-list
153667307|NCT00026364|Gefitinib|gefitinib|mesh-list
153667308|NCT00026364|Calcium|calcium|mesh-list
153667309|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
153667310|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153667311|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667331|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
153667332|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667334|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667335|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
153667336|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667337|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480765|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480766|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480767|NCT05188508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480768|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480769|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153480770|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
153667338|NCT00026520|Interferons|interferons|mesh-list
153667339|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
153667340|NCT00026520|Thalidomide|thalidomide|mesh-list
153667341|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667342|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
153667343|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667344|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
153667345|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667346|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667347|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
153667348|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153667349|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153667350|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815079|NCT00448149|Everolimus|everolimus|mesh-list
153815080|NCT00448149|Sorafenib|sorafenib|mesh-list
153888044|NCT01048099|Pertuzumab|pertuzumab|mesh-list
153888045|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153667351|NCT00026520|Growth Substances|growth substances|mesh-ancestor
153667352|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
153667353|NCT00026637|Sertraline|sertraline|mesh-list
153667354|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
153667355|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667356|NCT00026637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153667357|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153667358|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153667359|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667360|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667361|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
153667362|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667363|NCT00027066|Aspirin|aspirin|mesh-list
153667364|NCT00027066|Warfarin|warfarin|mesh-list
153667365|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153667366|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153667367|NCT00027066|Analgesics|analgesics|mesh-ancestor
153667445|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667447|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667448|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153667449|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
153667450|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153667451|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667453|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
153667482|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153667483|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
153667484|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667485|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
153667486|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153667487|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
153667488|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
153667489|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153667490|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480872|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153480873|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153480874|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153480875|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
153480876|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480877|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480878|NCT04862260|Atorvastatin|atorvastatin|mesh-list
153480879|NCT04862260|Ezetimibe|ezetimibe|mesh-list
153480880|NCT04862260|Evolocumab|evolocumab|mesh-list
153480881|NCT04862260|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
153815061|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480887|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153667491|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153667493|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
153667494|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667495|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
153667496|NCT00027885|Bevacizumab|bevacizumab|mesh-list
153667498|NCT00027885|Doxorubicin|doxorubicin|mesh-list
153667499|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153667500|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667501|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
153667502|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667518|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153667519|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667520|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667522|NCT00027924|Methotrexate|methotrexate|mesh-list
153667523|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
153667524|NCT00027924|Fludarabine|fludarabine|mesh-list
153667525|NCT00027924|Busulfan|busulfan|mesh-list
153667526|NCT00027924|Cyclosporins|cyclosporins|mesh-list
153667527|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153667528|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
153667529|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153667530|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667531|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667532|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
153667533|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667534|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480888|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480889|NCT04862260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153480890|NCT04862260|Protease Inhibitors|protease inhibitors|mesh-ancestor
153480891|NCT04848584|Vaccines|vaccines|mesh-list
153480892|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
153480905|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
153480906|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480908|NCT04781088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153667535|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153667536|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667537|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153667538|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667539|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
153667540|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667541|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153667542|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
153667543|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667544|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153667545|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
153667546|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667547|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667548|NCT04022876|Carboplatin|carboplatin|mesh-list
153667549|NCT04022876|Pemetrexed|pemetrexed|mesh-list
153667550|NCT04022876|Topotecan|topotecan|mesh-list
153667551|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667552|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667553|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667554|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153667555|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153667556|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153667557|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153814230|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814231|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814232|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
153814233|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667558|NCT00027963|Gabapentin|gabapentin|mesh-list
153667559|NCT00027963|Analgesics|analgesics|mesh-ancestor
153667560|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
153667561|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667586|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153667587|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
153667588|NCT03960125|Imipramine|imipramine|mesh-list
153667589|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153667591|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667592|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153667593|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153667594|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153667595|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667596|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
153667597|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667598|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667599|NCT00395655|Hydralazine|hydralazine|mesh-list
153667600|NCT00395655|Valproic Acid|valproic acid|mesh-list
153360918|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153667601|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
153667602|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667603|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667604|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
153667605|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667606|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667607|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
153667608|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153667609|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153667645|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153667646|NCT00028314|Nevirapine|nevirapine|mesh-list
153667647|NCT00028314|Abacavir|abacavir|mesh-list
153667648|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153667649|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153667650|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
153667651|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667671|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153667673|NCT03959852|Ketamine|ketamine|mesh-list
153667674|NCT03959852|Analgesics|analgesics|mesh-ancestor
153667675|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
153667676|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480976|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480977|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153667677|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667678|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153667679|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153667680|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
153667682|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153667683|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153667684|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153667685|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667686|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667687|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153667688|NCT03959852|Narcotics|narcotics|mesh-ancestor
153667689|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153667690|NCT00028431|Ipilimumab|ipilimumab|mesh-list
153667691|NCT00028431|Antibodies|antibodies|mesh-list
153667692|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
153667693|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481019|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481020|NCT04482309|Immunoconjugates|immunoconjugates|mesh-ancestor
153481021|NCT04482309|Immunologic Factors|immunologic factors|mesh-ancestor
153481022|NCT04482309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481023|NCT04431453|Remdesivir|remdesivir|mesh-list
153481024|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
153481025|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481026|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
153481027|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481028|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153481029|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
153481030|NCT04420585|Coagulants|coagulants|mesh-ancestor
153481031|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153481032|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
153481033|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481034|NCT04387227|Carboplatin|carboplatin|mesh-list
153481035|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
153481036|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771087|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
153771088|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153771089|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771090|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771091|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153667694|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153667695|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667696|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153667697|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667698|NCT00028587|Paclitaxel|paclitaxel|mesh-list
153667699|NCT00028587|Carboplatin|carboplatin|mesh-list
153667700|NCT00028587|Bortezomib|bortezomib|mesh-list
153667701|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667735|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153667736|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
153667737|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667738|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667739|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667740|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153667741|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667743|NCT00028743|Carboplatin|carboplatin|mesh-list
153667744|NCT00028743|Topotecan|topotecan|mesh-list
153667775|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153667777|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667778|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667779|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667780|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
153481037|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481038|NCT04387227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481039|NCT04387227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481040|NCT04357795|Cyclosporine|cyclosporine|mesh-list
153481054|NCT04344262|Atracurium|atracurium|mesh-list
153771092|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153771093|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153771094|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771095|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771096|NCT00234390|Budesonide|budesonide|mesh-list
153771205|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
153771206|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771207|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153771208|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
153771209|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
153771210|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
153771236|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153771237|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153771238|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771239|NCT01089790|Incretins|incretins|mesh-ancestor
153771240|NCT01089790|Hormones|hormones|mesh-ancestor
153771241|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153771242|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153667781|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667782|NCT03959384|Poractant alfa|poractant alfa|mesh-list
153667783|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153877394|NCT05884671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877395|NCT05884671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667784|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
153667786|NCT00028860|Carboplatin|carboplatin|mesh-list
153667787|NCT00028860|Gemcitabine|gemcitabine|mesh-list
153667821|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153667822|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667823|NCT00028938|Paclitaxel|paclitaxel|mesh-list
153667824|NCT00028938|Carboplatin|carboplatin|mesh-list
153667825|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
153667826|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667828|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667829|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667830|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667831|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667867|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667868|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
153667869|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667870|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667885|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153667886|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153667888|NCT00029679|Borage oil|borage oil|mesh-list
153667889|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667890|NCT03958799|Vaccines|vaccines|mesh-list
153667891|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
153667892|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667893|NCT00029757|Estrogens|estrogens|mesh-list
153667894|NCT00029757|Hormones|hormones|mesh-ancestor
153667895|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153667896|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667897|NCT00029835|Rimonabant|rimonabant|mesh-list
153667898|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153667899|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153481060|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153771243|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
153771301|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153771302|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
153771303|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667900|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153667901|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667902|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667903|NCT00029835|Hormones|hormones|mesh-ancestor
153667904|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877402|NCT05846568|Immunoglobulins|immunoglobulins|mesh-list
153877403|NCT05846568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153418167|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420498|NCT03098420|Ropivacaine|ropivacaine|mesh-list
153814252|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
153814255|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153814256|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814257|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814258|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
153814259|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814260|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814261|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153814262|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
153814263|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814264|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
153429147|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153667905|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667906|NCT00395772|Vitamin K|vitamin k|mesh-list
153667907|NCT00395772|Heparin|heparin|mesh-list
153667908|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
153667909|NCT00395772|Vitamins|vitamins|mesh-ancestor
153667910|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
153667911|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667912|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
153667913|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153667914|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153667915|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667916|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153667917|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
153667918|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153667919|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
153667920|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667921|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153667922|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
153667923|NCT00395772|Coagulants|coagulants|mesh-ancestor
153667924|NCT00029874|Minocycline|minocycline|mesh-list
153667925|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153667926|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771304|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771330|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771331|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771332|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
153771333|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771334|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153771335|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153771336|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153771337|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771338|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771339|NCT00209885|Analgesics|analgesics|mesh-ancestor
153771340|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153771341|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153771363|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153771364|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771365|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771366|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
153771367|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771368|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667928|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
153667929|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667930|NCT00030030|Protective Agents|protective agents|mesh-ancestor
153667931|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667932|NCT00030069|Calcitriol|calcitriol|mesh-list
153667944|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667945|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153667946|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153667947|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153667948|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667949|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153667950|NCT00030069|Vitamins|vitamins|mesh-ancestor
153667951|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
153667952|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153667953|NCT03958097|Antibodies|antibodies|mesh-list
153667954|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
153667955|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429153|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667956|NCT00030342|Interferons|interferons|mesh-list
153667957|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
153667958|NCT00030342|Fluorouracil|fluorouracil|mesh-list
153667959|NCT00030342|Sargramostim|sargramostim|mesh-list
153667960|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
153360920|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
153667961|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667962|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667963|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667964|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667965|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
153667966|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667967|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
153667968|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771369|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153816986|NCT00427388|Prednisolone|prednisolone|mesh-list
153771500|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771501|NCT00210392|Bortezomib|bortezomib|mesh-list
153771502|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771511|NCT02210104|Ipilimumab|ipilimumab|mesh-list
153771546|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153771547|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153771548|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153771549|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608732|NCT01942291|Niacin|niacin|mesh-list
153771550|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771551|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667970|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153667971|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667972|NCT00030420|Celecoxib|celecoxib|mesh-list
153667973|NCT00030420|Docetaxel|docetaxel|mesh-list
153667974|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667975|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667976|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667977|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667978|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667979|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153667980|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153667981|NCT00030420|Analgesics|analgesics|mesh-ancestor
153667982|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
153667983|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667984|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667985|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153667986|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667987|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153481216|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153481217|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481235|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481237|NCT03984357|Antibodies|antibodies|mesh-list
153481238|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
153481239|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
153481240|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481241|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481242|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481243|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
153481244|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481245|NCT03913845|Lidocaine|lidocaine|mesh-list
153481246|NCT03913845|Epinephrine|epinephrine|mesh-list
153771552|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153429165|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
153771553|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153771554|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
153771555|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771556|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771558|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153771559|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
153771561|NCT00210587|Hematinics|hematinics|mesh-ancestor
153771562|NCT00210665|Trabectedin|trabectedin|mesh-list
153771563|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153771564|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
153667988|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153667989|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667990|NCT00030459|Vinorelbine|vinorelbine|mesh-list
153667991|NCT00030459|Mitomycins|mitomycins|mesh-list
153667992|NCT00030459|Mitomycin|mitomycin|mesh-list
153667993|NCT00030459|Vinblastine|vinblastine|mesh-list
153667994|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667995|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667996|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668029|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668030|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668032|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153668033|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
153668034|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
153668071|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
153668072|NCT03852407|Melphalan|melphalan|mesh-list
153668100|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668101|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668102|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153668103|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153668104|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668105|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153668106|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153668107|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668108|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
153668109|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153668110|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153668111|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153668112|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
153481252|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481253|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
153481254|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481255|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153481269|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
153771565|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771566|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771567|NCT04570345|Aspirin|aspirin|mesh-list
153771568|NCT04570345|Ticagrelor|ticagrelor|mesh-list
153771570|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153771596|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153771597|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
153771598|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153668113|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668114|NCT00030732|Gemcitabine|gemcitabine|mesh-list
153668115|NCT00030732|Capecitabine|capecitabine|mesh-list
153810772|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153814277|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153814278|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153814279|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153814280|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814281|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814282|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
153814283|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
153814284|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888077|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
153668116|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153668117|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
153668118|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668155|NCT03698006|Ropivacaine|ropivacaine|mesh-list
153668156|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153668191|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153668192|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153668227|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668228|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668229|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153668230|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153668231|NCT04711668|Lidocaine|lidocaine|mesh-list
153668232|NCT04711668|Ketamine|ketamine|mesh-list
153668233|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
153668267|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
153668268|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153668269|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153668270|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153668271|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668289|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
153668290|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668291|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153668292|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153668293|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668294|NCT00031395|Clonidine|clonidine|mesh-list
153668295|NCT00031395|Methylphenidate|methylphenidate|mesh-list
153668296|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153668297|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668298|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153668299|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153771599|NCT04570306|Belimumab|belimumab|mesh-list
153771600|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153771601|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
153771602|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771603|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
153668300|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153668301|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668302|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
153668303|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668304|NCT00031395|Analgesics|analgesics|mesh-ancestor
153668305|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
153668306|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668307|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153668308|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
153668309|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
153668310|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153668311|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153668312|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153668313|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
153668315|NCT00031434|Ganciclovir|ganciclovir|mesh-list
153668316|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153668317|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
153668318|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668319|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153668320|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668321|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668322|NCT03152123|Phentermine|phentermine|mesh-list
153668323|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153668324|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668325|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
153418172|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418173|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
153418174|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153418176|NCT02790788|Prednisolone|prednisolone|mesh-list
153668326|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153668327|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
153668328|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
153668329|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668330|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
153668352|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153668353|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668362|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153668363|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668364|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153668365|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153668366|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668367|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668368|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
153668369|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153668371|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
153668372|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
153668373|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668374|NCT00031785|Megestrol|megestrol|mesh-list
153668375|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
153668376|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153668377|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153668378|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153668379|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
153668380|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153668381|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668382|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153668383|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153668459|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668488|NCT00032019|Vincristine|vincristine|mesh-list
153668489|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668490|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
153771604|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153771605|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771606|NCT00234858|Losartan|losartan|mesh-list
153771607|NCT00234858|Verapamil|verapamil|mesh-list
153771608|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153771609|NCT00234858|Trandolapril|trandolapril|mesh-list
153771610|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153771615|NCT00234858|Diuretics|diuretics|mesh-ancestor
153771653|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153771654|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153771655|NCT00237861|Olanzapine|olanzapine|mesh-list
153771656|NCT00237861|Risperidone|risperidone|mesh-list
153771657|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153771658|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153771659|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
153771660|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771661|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771662|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771663|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153771664|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153668492|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668493|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153668494|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
153668495|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668496|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668497|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153668498|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153418182|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418184|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
153418185|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418186|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814285|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815081|NCT00448149|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153481395|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153481396|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
153481397|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481398|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481399|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153481400|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153481401|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771665|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771666|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771667|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153771668|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
153771669|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
153771670|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
153771671|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771672|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153771673|NCT00237861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153771674|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153771675|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153771677|NCT00237900|Leucovorin|leucovorin|mesh-list
153771704|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771705|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771706|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
153771707|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
153771708|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771709|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771710|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153771711|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153771712|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
153771713|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153771714|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153771715|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153771716|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153771718|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153771719|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771720|NCT00210860|Topiramate|topiramate|mesh-list
153771721|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
153771722|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153771723|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771724|NCT00210899|Vancomycin|vancomycin|mesh-list
153771725|NCT00210899|Ceftazidime|ceftazidime|mesh-list
153771726|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
153771727|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
153771728|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153771729|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771730|NCT00210899|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153771731|NCT00210899|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153771732|NCT04568863|Melatonin|melatonin|mesh-list
153668499|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153668500|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153668501|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153668502|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668503|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668504|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
153668506|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668540|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
153668541|NCT00032136|Tamoxifen|tamoxifen|mesh-list
153668542|NCT00032136|Exemestane|exemestane|mesh-list
153668543|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668544|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153668545|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
153668546|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668547|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668563|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153668564|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
153668565|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668566|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668567|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
153668568|NCT04712279|Ivermectin|ivermectin|mesh-list
153668569|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
153668570|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153668571|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153668572|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668573|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668574|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668593|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153668594|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
153668595|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668596|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668597|NCT00032838|Urological Agents|urological agents|mesh-ancestor
153668598|NCT03150680|Clopidogrel|clopidogrel|mesh-list
153668599|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153668600|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153668601|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153668602|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153668603|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
153668604|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668605|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668615|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668617|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668618|NCT00396396|Antidotes|antidotes|mesh-ancestor
153668619|NCT00032955|Buprenorphine|buprenorphine|mesh-list
153668620|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153668621|NCT00032955|Naloxone|naloxone|mesh-list
153668622|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153668623|NCT00032955|Narcotics|narcotics|mesh-ancestor
153668624|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668625|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668626|NCT00032955|Analgesics|analgesics|mesh-ancestor
153668627|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
153668628|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668629|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153668630|NCT03150524|Verapamil|verapamil|mesh-list
153668631|NCT03150524|Nimodipine|nimodipine|mesh-list
153668632|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153668633|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153668635|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668636|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153668637|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668638|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
153668639|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153668640|NCT00033033|Reserpine|reserpine|mesh-list
153668641|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153668642|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153668643|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153668644|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668645|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668646|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153481495|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153771733|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
153771734|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771735|NCT04568863|Protective Agents|protective agents|mesh-ancestor
153771736|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771746|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771747|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771748|NCT00211016|Doripenem|doripenem|mesh-list
153771749|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153771750|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771751|NCT00238017|Artesunate|artesunate|mesh-list
153771752|NCT00238017|Amodiaquine|amodiaquine|mesh-list
153771753|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
153771754|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153771755|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153771756|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771757|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771758|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
153771759|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
153771760|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153771761|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
153771762|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
153771763|NCT00238056|Domperidone|domperidone|mesh-list
153771764|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
153771765|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
153771766|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771767|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771768|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153771769|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153771800|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
153771801|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771802|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153771803|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153771804|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
153771805|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771870|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153771872|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771873|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153771874|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
153771875|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153771876|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771877|NCT00211328|Anecortave|anecortave|mesh-list
153771878|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153771879|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153771880|NCT00211328|Growth Substances|growth substances|mesh-ancestor
153771881|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771882|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
153771883|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771884|NCT00238329|Interferons|interferons|mesh-list
153668648|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153668649|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153668650|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668651|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
153668652|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668653|NCT03150368|Docetaxel|docetaxel|mesh-list
153668654|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668655|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668656|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668657|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668658|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668659|NCT00033072|Selegiline|selegiline|mesh-list
153668660|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
153668661|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153481508|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481509|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481510|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
153481511|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481512|NCT03283761|Antidotes|antidotes|mesh-ancestor
153481513|NCT03283761|Protective Agents|protective agents|mesh-ancestor
153481514|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
153481515|NCT03283761|Vitamins|vitamins|mesh-ancestor
153481516|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
153481517|NCT03258723|Metformin|metformin|mesh-list
153481518|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153481519|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481520|NCT03230916|Relebactam|relebactam|mesh-list
153481521|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153481522|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668662|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153668663|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153668664|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153668665|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668666|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668667|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153668668|NCT00033072|Protective Agents|protective agents|mesh-ancestor
153668684|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668687|NCT00033267|Temsirolimus|temsirolimus|mesh-list
153668688|NCT00033267|MTOR Inhibitors|mtor inhibitors|mesh-list
153668689|NCT00033267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153668690|NCT00033267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668691|NCT00033267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668692|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668693|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
153668694|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668695|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481524|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153481525|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481526|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
153481527|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481528|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481529|NCT03149822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481530|NCT03149822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888102|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481531|NCT03139305|Glucagon|glucagon|mesh-list
153481532|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153481533|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481534|NCT03139305|Hormones|hormones|mesh-ancestor
153481535|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481536|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481537|NCT03139305|Incretins|incretins|mesh-ancestor
153481538|NCT03114319|Nazartinib|nazartinib|mesh-list
153481540|NCT03065062|Palbociclib|palbociclib|mesh-list
153668696|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153668697|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668698|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153668699|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
153668701|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153668702|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153668703|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668704|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668705|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668706|NCT02984384|Aspirin|aspirin|mesh-list
153668707|NCT02984384|Heparin|heparin|mesh-list
153668708|NCT02984384|Enoxaparin|enoxaparin|mesh-list
153668709|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153668710|NCT02984384|Tinzaparin|tinzaparin|mesh-list
153668711|NCT02984384|Dalteparin|dalteparin|mesh-list
153668712|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153668713|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153668714|NCT02984384|Analgesics|analgesics|mesh-ancestor
153668715|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
153668716|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814287|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153814288|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
153828026|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
153828027|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828028|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
153828029|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828030|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
153828031|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828032|NCT00483210|Fenofibrate|fenofibrate|mesh-list
153828033|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153668717|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828034|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
153828035|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828036|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153828037|NCT00487994|Atorvastatin|atorvastatin|mesh-list
153828038|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153828039|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153828040|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
153828041|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828042|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153668718|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668719|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668720|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153668721|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153668722|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668726|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
153668755|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
153668756|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668757|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668758|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
153668759|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668760|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
153668761|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153668762|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668763|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668764|NCT00033618|Epothilones|epothilones|mesh-list
153668765|NCT00033618|Epothilone B|epothilone b|mesh-list
153668766|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668767|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668768|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668769|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668770|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668771|NCT00033696|Paclitaxel|paclitaxel|mesh-list
153668772|NCT00033696|Etoposide|etoposide|mesh-list
153668773|NCT00033696|Carboplatin|carboplatin|mesh-list
153668774|NCT00033696|Topotecan|topotecan|mesh-list
153668775|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153668776|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668777|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668778|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668779|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668780|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481597|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481598|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153481599|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153481600|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481601|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481602|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481605|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
153771885|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
153771886|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
153771887|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153771888|NCT00238329|Thalidomide|thalidomide|mesh-list
153771889|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771890|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
153771891|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153771904|NCT00211367|Anecortave|anecortave|mesh-list
153771925|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668781|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153668782|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153668783|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668784|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153668785|NCT00033735|Fluorouracil|fluorouracil|mesh-list
153668786|NCT00033735|Irofulven|irofulven|mesh-list
153668787|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
153668788|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668789|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153668790|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668824|NCT02271893|Analgesics|analgesics|mesh-ancestor
153668825|NCT02271893|Sensory System Agents|sensory system agents|mesh-ancestor
153668826|NCT02271893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668827|NCT02149823|Oxytocin|oxytocin|mesh-list
153668828|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
153668829|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153668830|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668831|NCT02971410|Simvastatin|simvastatin|mesh-list
153668861|NCT00034086|Didanosine|didanosine|mesh-list
153668862|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153668863|NCT00034086|Vaccines|vaccines|mesh-list
153668864|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153668865|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
153668866|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668867|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153668868|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153668917|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
153668918|NCT01807286|Hormones|hormones|mesh-ancestor
153668919|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668920|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668921|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668922|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153668923|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
153668924|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668956|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153668957|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
153668958|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668959|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668960|NCT00034671|Posaconazole|posaconazole|mesh-list
153668961|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
153481679|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481690|NCT01659606|Cyclosporine|cyclosporine|mesh-list
153481691|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
153481692|NCT01659606|Fludarabine|fludarabine|mesh-list
153481693|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
153481694|NCT01659606|Tacrolimus|tacrolimus|mesh-list
153771926|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153771927|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
153771928|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771929|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771930|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153771931|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153771932|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153771933|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153771934|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153771935|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771936|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153771938|NCT00238368|Hormones|hormones|mesh-ancestor
153771940|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153771989|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
153771990|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
153771991|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771992|NCT02894515|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
153771993|NCT02894515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153771994|NCT02894515|Serotonin Agents|serotonin agents|mesh-ancestor
153771995|NCT02894515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771996|NCT02894515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771997|NCT02894515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771998|NCT00211445|Verteporfin|verteporfin|mesh-list
153771999|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153772000|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772001|NCT02894710|Lidocaine|lidocaine|mesh-list
153772002|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
153772003|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
153772004|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772006|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
153772040|NCT00211562|Vitamins|vitamins|mesh-ancestor
153772041|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
153668962|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668963|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153668964|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153668965|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153669000|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153669001|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
153669002|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153669035|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153669036|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
153669037|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669038|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669039|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669040|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153669041|NCT00034905|Risperidone|risperidone|mesh-list
153669042|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153669043|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153669044|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
153669071|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669072|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669073|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153669074|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828054|NCT01308580|Prednisone|prednisone|mesh-list
153669075|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669078|NCT01806272|Vitamins|vitamins|mesh-ancestor
153669079|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
153669080|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669081|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
153481705|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
153772042|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772043|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
153772044|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
153772045|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772046|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153772047|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153772048|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153772049|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772050|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153772051|NCT00211562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153772057|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
153772102|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772104|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772105|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772106|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153772107|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153772108|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
153669082|NCT01806272|Hematinics|hematinics|mesh-ancestor
153669083|NCT00034983|Aprepitant|aprepitant|mesh-list
153669084|NCT00034983|Paroxetine|paroxetine|mesh-list
153669085|NCT00034983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153669086|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153669087|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669088|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669089|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669090|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
153669122|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669123|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669124|NCT00035139|Methylphenidate|methylphenidate|mesh-list
153669125|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153669126|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669127|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153669128|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153669129|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669130|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669151|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481733|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
153772109|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772110|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153772111|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153772112|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153772113|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153772114|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153772115|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153772116|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
153772117|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153772118|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153772119|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153772120|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153772121|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772122|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
153772123|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772124|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772125|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153772126|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772147|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
153772148|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153772149|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772150|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153772151|NCT05426824|Pegaspargase|pegaspargase|mesh-list
153772152|NCT05426824|Asparaginase|asparaginase|mesh-list
153772153|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772218|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153772219|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153772220|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669152|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153669153|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153669154|NCT00035295|Aprepitant|aprepitant|mesh-list
153669155|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
153669156|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
153669157|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669158|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669159|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669160|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153669161|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669162|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669163|NCT01806116|Decitabine|decitabine|mesh-list
153669164|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153669165|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
153669166|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669167|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669168|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669169|NCT00035451|Sotalol|sotalol|mesh-list
153669170|NCT00035451|Azimilide|azimilide|mesh-list
153669171|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153669172|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153669173|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
153669174|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669175|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669176|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669177|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153669178|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
153669179|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
153481769|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
153481770|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772221|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609395|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
153772222|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
153772223|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153772224|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772284|NCT04668469|Lactoferrin|lactoferrin|mesh-list
153772285|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
153772286|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
153772287|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772288|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153772289|NCT04668469|Analgesics|analgesics|mesh-ancestor
153772290|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
153772291|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669180|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669181|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153669182|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669183|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669184|NCT01805999|Psyllium|psyllium|mesh-list
153669211|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
153828163|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153828164|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828165|NCT00488384|Acitretin|acitretin|mesh-list
153828166|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
153828167|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
153368166|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
153368167|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153368168|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
153368169|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669212|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153669213|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669214|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
153669215|NCT04732377|Bupivacaine|bupivacaine|mesh-list
153669216|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
153669217|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
153669218|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669219|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736433|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736434|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
153360932|NCT02348762|Antidotes|antidotes|mesh-ancestor
153669220|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
153669221|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669222|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153669223|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153669224|NCT04732377|Analgesics|analgesics|mesh-ancestor
153669225|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153669226|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153669227|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153669228|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
153669229|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669230|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669231|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
153669232|NCT01805726|Alfentanil|alfentanil|mesh-list
153669233|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153669234|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669254|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669255|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
153772292|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
153772293|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772294|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772295|NCT04668469|Trace Elements|trace elements|mesh-ancestor
153772296|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
153772297|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153772298|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153772299|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669257|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669258|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669259|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153669260|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669261|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153669262|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
153669263|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153669264|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153669265|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
153669266|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669267|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
153669268|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669269|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153669270|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153669271|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
153669272|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153669273|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153669274|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153669275|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153669276|NCT00035958|Analgesics|analgesics|mesh-ancestor
153669277|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
153669278|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669279|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368209|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368212|NCT00363285|Hormones|hormones|mesh-list
153506248|NCT01390766|Azathioprine|azathioprine|mesh-list
153669281|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153669282|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153669283|NCT01805687|Analgesics|analgesics|mesh-ancestor
153669284|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
153669285|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669286|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669287|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669288|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772300|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772301|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772302|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
153772343|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772344|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772345|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669289|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153669290|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669320|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153669321|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669322|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669323|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
153669325|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669326|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669327|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153669328|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153669330|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153669331|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153669363|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153669364|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153669365|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153669366|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669367|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877404|NCT05846568|Antibodies|antibodies|mesh-list
153877405|NCT05846568|Immunologic Factors|immunologic factors|mesh-ancestor
153877406|NCT05846568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877407|NCT05845450|Trastuzumab|trastuzumab|mesh-list
153877409|NCT05845450|Panitumumab|panitumumab|mesh-list
153877410|NCT05845450|Sotorasib|sotorasib|mesh-list
153877411|NCT05845450|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153877412|NCT05845450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877413|NCT05845450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877414|NCT05845450|Immunoconjugates|immunoconjugates|mesh-ancestor
153877415|NCT05845450|Immunologic Factors|immunologic factors|mesh-ancestor
153879683|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877416|NCT05845450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669368|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669393|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153669394|NCT00036387|Infliximab|infliximab|mesh-list
153772346|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153772347|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153772348|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772349|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153772350|NCT00239109|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153772409|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153772410|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
153772411|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153772412|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772413|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153772414|NCT00212342|Estrogens|estrogens|mesh-ancestor
153772415|NCT00212342|Hormones|hormones|mesh-ancestor
153772416|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153772417|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153772418|NCT00414414|Prednisone|prednisone|mesh-list
153772419|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772420|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
153772421|NCT00414414|Hormones|hormones|mesh-ancestor
153772422|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153772423|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772424|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153772425|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772426|NCT00239304|Gefitinib|gefitinib|mesh-list
153772427|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772428|NCT00239304|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153772432|NCT00239343|Gefitinib|gefitinib|mesh-list
153772462|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
153669395|NCT00036387|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153669396|NCT00036387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669398|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669399|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153669400|NCT00036426|Immunomodulating Agents|immunomodulating agents|mesh-list
153669401|NCT00036426|Immunologic Factors|immunologic factors|mesh-ancestor
153669402|NCT00036426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669403|NCT01466543|Udenafil|udenafil|mesh-list
153669404|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153669405|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153669406|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669407|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669408|NCT01466465|Vitamin D|vitamin d|mesh-list
153669409|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
153669410|NCT01466465|Vitamins|vitamins|mesh-ancestor
153828242|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828243|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828244|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
153828245|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153828246|NCT04515732|Apremilast|apremilast|mesh-list
153828247|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153828248|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828249|NCT04515732|Analgesics|analgesics|mesh-ancestor
153669411|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
153669412|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669413|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153481938|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153481939|NCT01363128|BB 1101|bb 1101|mesh-list
153481940|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481941|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
153481942|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481943|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481944|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153481945|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
153481946|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481947|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481948|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153481949|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772463|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
153772464|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153772465|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772466|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153772467|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
153772468|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772469|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772470|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153772483|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
153772526|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153669414|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669415|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
153669416|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153669417|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669418|NCT00036543|Atrasentan|atrasentan|mesh-list
153669441|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669442|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
153669444|NCT01466114|Norethindrone|norethindrone|mesh-list
153669445|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
153669446|NCT01466114|Progestins|progestins|mesh-list
153669447|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153669448|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153669449|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153669450|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
153669451|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153669452|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669453|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153669454|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153669455|NCT01466114|Hormones|hormones|mesh-ancestor
153669456|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669457|NCT00036777|Carboplatin|carboplatin|mesh-list
153669458|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153669459|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669460|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153669461|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481960|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153772527|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153772528|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
153772529|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772530|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772531|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772532|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153772533|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153772534|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
153772535|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
153772536|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772537|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153772538|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153772585|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772586|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
153772587|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
153772588|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153772589|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153772590|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772591|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153772592|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
153772593|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772594|NCT00213278|Vinblastine|vinblastine|mesh-list
153669462|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669463|NCT01465919|Mirtazapine|mirtazapine|mesh-list
153669464|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669465|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669466|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153669467|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
153669468|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
153669489|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
153669490|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669491|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153669492|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153669493|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669494|NCT00036855|Rituximab|rituximab|mesh-list
153669495|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153669496|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153669497|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669498|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
153669499|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481980|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153481981|NCT01365624|Analgesics|analgesics|mesh-ancestor
153482004|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482005|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482006|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153772595|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153772596|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772597|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
153772598|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
153772644|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153772645|NCT00240045|Octreotide|octreotide|mesh-list
153772646|NCT00240045|Midodrine|midodrine|mesh-list
153772647|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153772648|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153772649|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772650|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
153772651|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
153772652|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772653|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772654|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153772655|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153772656|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153772657|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153772658|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
153772659|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772660|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772661|NCT00243672|Atorvastatin|atorvastatin|mesh-list
153772662|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
153772663|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153772664|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153772665|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
153669500|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153669501|NCT00036894|Lenalidomide|lenalidomide|mesh-list
153669502|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
153669503|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669504|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153669505|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153669506|NCT00036894|Growth Substances|growth substances|mesh-ancestor
153669507|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
153669508|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669509|NCT01465685|Methylphenidate|methylphenidate|mesh-list
153669510|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153669511|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153669512|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669513|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153669514|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153669515|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669516|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669517|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
153669518|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669519|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
153669520|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669592|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
153669639|NCT00037596|Immunotoxins|immunotoxins|mesh-ancestor
153669640|NCT00037596|Immunoconjugates|immunoconjugates|mesh-ancestor
153669641|NCT00037635|Cinacalcet|cinacalcet|mesh-list
153669642|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669643|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669644|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153669645|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
153669646|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669647|NCT00037674|Topiramate|topiramate|mesh-list
153669648|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
153669649|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153669650|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669651|NCT00037752|Sibutramine|sibutramine|mesh-list
153669652|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669653|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669678|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153669679|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669680|NCT00038025|Pentostatin|pentostatin|mesh-list
153669681|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669682|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153669683|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669684|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482092|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153482103|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482104|NCT01399866|Cycloserine|cycloserine|mesh-list
153482105|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153482106|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482107|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153482108|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
153482109|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772666|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772667|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153772668|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153772669|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772670|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153772671|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153772672|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153772686|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772687|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
153772688|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
153772689|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
153772690|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772691|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
153669685|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
153877417|NCT05845450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153828349|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
153669686|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
153669687|NCT00393770|Vitamins|vitamins|mesh-ancestor
153669688|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
153669689|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669690|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
153669691|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
153669692|NCT00038064|Hematinics|hematinics|mesh-ancestor
153669693|NCT00038181|Thalidomide|thalidomide|mesh-list
153669694|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153669695|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
153669696|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669697|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
153669698|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153669699|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669700|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153669701|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153669702|NCT00038181|Growth Substances|growth substances|mesh-ancestor
153669703|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
153669704|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669705|NCT00038220|Ritonavir|ritonavir|mesh-list
153669706|NCT00038220|Lopinavir|lopinavir|mesh-list
153669707|NCT00038220|Tenofovir|tenofovir|mesh-list
153669708|NCT00038220|Lamivudine|lamivudine|mesh-list
153669709|NCT00038220|Efavirenz|efavirenz|mesh-list
153669725|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153669726|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153482125|NCT01403376|Analgesics|analgesics|mesh-ancestor
153669727|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153669730|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153669731|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153669732|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
153669733|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669735|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669736|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669737|NCT05433597|Cisplatin|cisplatin|mesh-list
153669738|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669739|NCT00847262|Amlodipine|amlodipine|mesh-list
153669740|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153669741|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153669742|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669743|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669744|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669745|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669746|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
153669747|NCT00847223|Tipifarnib|tipifarnib|mesh-list
153669748|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669749|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
153669750|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153669751|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669752|NCT00847106|Daclizumab|daclizumab|mesh-list
153669753|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153669754|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
153669755|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669756|NCT00396669|Bupropion|bupropion|mesh-list
153482150|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
153482151|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813855|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153813856|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
153482152|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153482153|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
153482154|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153772692|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
153669757|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153669758|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669759|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669760|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153669761|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153669762|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669763|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669764|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
153669765|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669785|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669786|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153669788|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669789|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669790|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
153669791|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669792|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153669793|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153669794|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
153669795|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153669796|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153669797|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669798|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
153669799|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
153506766|NCT01393925|Analgesics|analgesics|mesh-ancestor
153669800|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669801|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669802|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
153669803|NCT00396747|Hormones|hormones|mesh-ancestor
153482230|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482231|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482232|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
153482233|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153482234|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153482282|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
153669804|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669805|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153669806|NCT00396747|Protective Agents|protective agents|mesh-ancestor
153669807|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153669808|NCT00396747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153669809|NCT00846950|Lorazepam|lorazepam|mesh-list
153669810|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
153669811|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
153669812|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
153669813|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
153669814|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669815|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669816|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669817|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153669818|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669819|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153669820|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153669834|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153669836|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669837|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669838|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153669839|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
153669840|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153669841|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669842|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153669843|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153669844|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153669845|NCT00846872|Mannitol|mannitol|mesh-list
153669846|NCT00846872|Hormones|hormones|mesh-list
153669847|NCT00846872|Secretagogues|secretagogues|mesh-list
153669848|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669849|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669850|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153669851|NCT00846872|Diuretics|diuretics|mesh-ancestor
153669852|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
153669855|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669856|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
153669857|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
153669858|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669859|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669860|NCT00846716|Pioglitazone|pioglitazone|mesh-list
153669861|NCT00846716|Biguanides|biguanides|mesh-list
153669862|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153669863|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669864|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153669865|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153669866|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669867|NCT00846677|Vitamin D|vitamin d|mesh-list
153669868|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
153669869|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
153669870|NCT00846677|Vitamins|vitamins|mesh-list
153669871|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
153669872|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669873|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153669874|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669875|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
153669876|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669877|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
153669878|NCT05428683|Triamcinolone|triamcinolone|mesh-list
153669879|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153669880|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669881|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153482393|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153482394|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153482395|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482396|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482397|NCT01478256|Erythromycin|erythromycin|mesh-list
153482398|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
153482401|NCT01478256|Besifloxacin|besifloxacin|mesh-list
153772693|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153772694|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153772695|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
153772696|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
153772697|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772698|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669917|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669919|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
153669920|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153669942|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153669943|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153669944|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669945|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153669946|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
153669947|NCT00845936|Metformin|metformin|mesh-list
153669948|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153669949|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669950|NCT00277082|Camptothecin|camptothecin|mesh-list
153828474|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828475|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669951|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153669952|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669953|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153669954|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153669955|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669956|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669957|NCT04888377|Aspirin|aspirin|mesh-list
153669958|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153669959|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153669960|NCT04888377|Analgesics|analgesics|mesh-ancestor
153669961|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
153669962|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669963|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669964|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669965|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153482420|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153482421|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
153482422|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482423|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482424|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153482425|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153772699|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153772700|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153772701|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153772702|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153772703|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
153772704|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669966|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153669967|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153669968|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669969|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153669970|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153669971|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669972|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
153669974|NCT00277043|Docetaxel|docetaxel|mesh-list
153669975|NCT00277043|Taxane|taxane|mesh-list
153669999|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670000|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670001|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670002|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670003|NCT00396786|Enoxaparin|enoxaparin|mesh-list
153670004|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
153670005|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153670006|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
153670007|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153670008|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
153670009|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670010|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670011|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
153670012|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153670013|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153670014|NCT00276848|Vidarabine|vidarabine|mesh-list
153670015|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
153670016|NCT00276848|Fludarabine|fludarabine|mesh-list
153670017|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
153670018|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670019|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
153670020|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670021|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670022|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153670023|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
153670024|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670045|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
153670046|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670047|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670048|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153670049|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153670050|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
153670051|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
153670052|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670053|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153670054|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
153670055|NCT00276809|Hormones|hormones|mesh-ancestor
153670056|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153670057|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153670058|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153670059|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
153670060|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153670061|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153670062|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153670063|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670064|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
153670065|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670066|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670067|NCT00276770|Fluorides|fluorides|mesh-list
153670068|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
153670069|NCT00276770|Protective Agents|protective agents|mesh-ancestor
153670070|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670071|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
153670072|NCT00276731|Carboplatin|carboplatin|mesh-list
153670073|NCT00276731|Etoposide|etoposide|mesh-list
153670074|NCT00276731|Vincristine|vincristine|mesh-list
153670075|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670076|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
153670077|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482565|NCT01520688|Fluticasone|fluticasone|mesh-list
153772705|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153772706|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153772707|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772708|NCT00243750|Methotrexate|methotrexate|mesh-list
153772709|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153772710|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
153772711|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153772732|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
153670079|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153670080|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
153670081|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670082|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670083|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153670084|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153670085|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153670086|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153670087|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670101|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670102|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153670103|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153670104|NCT00276575|Growth Substances|growth substances|mesh-ancestor
153670105|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670106|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
153670107|NCT00276575|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153670108|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670109|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670110|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670111|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670112|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
153670113|NCT00276575|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153670114|NCT00276536|Interferons|interferons|mesh-list
153670115|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
153670116|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153670117|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670118|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
153670119|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670120|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
153670121|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670122|NCT00276497|Pioglitazone|pioglitazone|mesh-list
153670123|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153670132|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153670133|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670134|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670135|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
153670136|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670137|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670138|NCT00276146|Dipyridamole|dipyridamole|mesh-list
153670139|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153670140|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670141|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670142|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153670143|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
153670144|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153670145|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
153670146|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670147|NCT04201665|Oxytocin|oxytocin|mesh-list
153670148|NCT04201665|Carbetocin|carbetocin|mesh-list
153670149|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
153670165|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153670166|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
153670168|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670169|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153670170|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153670171|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
153670172|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670173|NCT00276029|Etanercept|etanercept|mesh-list
153670174|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153670175|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153670176|NCT00276029|Analgesics|analgesics|mesh-ancestor
153670177|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
153670178|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670179|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670180|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153670181|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670182|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153670183|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670184|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
153670185|NCT00397059|Escitalopram|escitalopram|mesh-list
153670186|NCT00397059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153670187|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153670188|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670189|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670190|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670191|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
153670192|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670194|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670195|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670196|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
153670197|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
153670198|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153670199|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153670200|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670201|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670202|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153670203|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153670204|NCT00397098|Amibegron|amibegron|mesh-list
153670228|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153670230|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153670231|NCT00275756|Dorzolamide|dorzolamide|mesh-list
153670232|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153670233|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153670234|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
153670235|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670236|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670237|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772733|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153772734|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
153772737|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772738|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
153772739|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
153772740|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
153772742|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153772797|NCT00214370|Narcotics|narcotics|mesh-ancestor
153772798|NCT00214370|Analgesics|analgesics|mesh-ancestor
153772799|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
153828663|NCT00485004|Sirolimus|sirolimus|mesh-list
153670238|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153670239|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153670240|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153670241|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153670242|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153670243|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153670244|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670245|NCT00275639|Losartan|losartan|mesh-list
153670246|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153670247|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153670248|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153670249|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153670272|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670274|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
153670275|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670276|NCT00275405|Protective Agents|protective agents|mesh-ancestor
153670277|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670278|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153670279|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670280|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153670281|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670282|NCT00275249|Levorphanol|levorphanol|mesh-list
153670283|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153670284|NCT00275249|Narcotics|narcotics|mesh-ancestor
153670285|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153670286|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670287|NCT00275249|Analgesics|analgesics|mesh-ancestor
153670288|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
153670289|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670290|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
153670291|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482774|NCT06114225|Gemcitabine|gemcitabine|mesh-list
153772800|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772801|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153772802|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153772866|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153772867|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772868|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
153772869|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
153772870|NCT00214682|Vitamins|vitamins|mesh-ancestor
153772871|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
153670292|NCT00041535|Miglustat|miglustat|mesh-list
153670293|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670294|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670295|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153670296|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153670297|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
153670298|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670299|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153670300|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153670301|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670302|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
153670303|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153670328|NCT00275093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670329|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670330|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
153670331|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670332|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670333|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153670334|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670335|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153670336|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
153670337|NCT00041652|Labetuzumab|labetuzumab|mesh-list
153670338|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670339|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670340|NCT03430596|Pramipexole|pramipexole|mesh-list
153670341|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
153670342|NCT03430596|Dexpramipexole|dexpramipexole|mesh-list
153670343|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
153670344|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670345|NCT03430596|Protective Agents|protective agents|mesh-ancestor
153670346|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670395|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670427|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153670428|NCT03062826|Aspirin|aspirin|mesh-list
153670429|NCT03062826|Clopidogrel|clopidogrel|mesh-list
153670430|NCT03062826|Ticagrelor|ticagrelor|mesh-list
153670431|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153670432|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153670433|NCT03062826|Analgesics|analgesics|mesh-ancestor
153670434|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
153670435|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670467|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
153670468|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153670469|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670470|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153670471|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153670472|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
153670473|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670474|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153670475|NCT00041691|Labetuzumab|labetuzumab|mesh-list
153670476|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670511|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153670595|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
153670596|NCT00103389|Docetaxel|docetaxel|mesh-list
153670597|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670598|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
153670599|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
153670600|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
153670601|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670602|NCT00128921|Bortezomib|bortezomib|mesh-list
153670603|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670604|NCT00128804|Beta Carotene|beta carotene|mesh-list
153670605|NCT00128804|Carotenoids|carotenoids|mesh-list
153670606|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
153670607|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670608|NCT00128804|Protective Agents|protective agents|mesh-ancestor
153670609|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670641|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670642|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670643|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153670644|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670645|NCT00128453|Colchicine|colchicine|mesh-list
153670646|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
153670647|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670648|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
153670649|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
153670650|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
153670651|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368767|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153670652|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670653|NCT00128414|Colchicine|colchicine|mesh-list
153670654|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
153670655|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670673|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153670674|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
153670675|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670676|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670677|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153670678|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153670679|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
153670680|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670681|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153670682|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153670683|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153670684|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153670685|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153670686|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153670687|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153670688|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153670689|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153670690|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153670691|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
153670692|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153670694|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670695|NCT05770687|Dapagliflozin|dapagliflozin|mesh-list
153670696|NCT05770687|Empagliflozin|empagliflozin|mesh-list
153670697|NCT05770687|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153670698|NCT05770687|Ertugliflozin|ertugliflozin|mesh-list
153670699|NCT05770687|Ipragliflozin|ipragliflozin|mesh-list
153670700|NCT05770687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670701|NCT05770687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483040|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483041|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153483042|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
153483043|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
153483044|NCT05475873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153483045|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153772872|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772873|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
153772874|NCT00214682|Hematinics|hematinics|mesh-ancestor
153772875|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
153772876|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153772877|NCT00240513|Minocycline|minocycline|mesh-list
153772878|NCT00240513|Tretinoin|tretinoin|mesh-list
153772879|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153772880|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670702|NCT05770687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670703|NCT05770323|Uric Acid|uric acid|mesh-list
153670704|NCT05770323|Antioxidants|antioxidants|mesh-ancestor
153670705|NCT05770323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670706|NCT05770323|Protective Agents|protective agents|mesh-ancestor
153810777|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877425|NCT05842213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877426|NCT05811377|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153877427|NCT05811377|Hematinics|hematinics|mesh-ancestor
153877428|NCT05811377|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153877429|NCT05811377|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153828772|NCT04513509|Nebivolol|nebivolol|mesh-list
153828773|NCT04513509|Bisoprolol|bisoprolol|mesh-list
153828774|NCT04513509|Diltiazem|diltiazem|mesh-list
153368798|NCT02246816|Analgesics|analgesics|mesh-ancestor
153670707|NCT05770323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670708|NCT05769738|Furosemide|furosemide|mesh-list
153670709|NCT05769738|Diuretics|diuretics|mesh-list
153670710|NCT05769738|Natriuretic Agents|natriuretic agents|mesh-ancestor
153670711|NCT05769738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670712|NCT05769738|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153670730|NCT05768997|Hematinics|hematinics|mesh-ancestor
153670731|NCT05768945|Semaglutide|semaglutide|mesh-list
153670732|NCT05768945|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153670733|NCT05768945|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153670734|NCT05768945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153670735|NCT05768945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670736|NCT05768945|Protease Inhibitors|protease inhibitors|mesh-ancestor
153670737|NCT05768945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670738|NCT05768945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670739|NCT05765305|Chromium|chromium|mesh-list
153670740|NCT05765305|Letrozole|letrozole|mesh-list
153670741|NCT05765305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670742|NCT05765305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153670743|NCT05765305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153670744|NCT05765305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483066|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483067|NCT05288283|Cannabidiol|cannabidiol|mesh-list
153483068|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
153483069|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
153483070|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
153483071|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153483072|NCT05186363|Amodiaquine|amodiaquine|mesh-list
153483073|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
153483074|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153483075|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153483076|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153772881|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670745|NCT05765305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670746|NCT05765305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153670747|NCT05765305|Hormone Antagonists|hormone antagonists|mesh-ancestor
153670748|NCT05765305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368814|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
153368815|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368816|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
153368817|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368818|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153368819|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153828783|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
153828784|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
153828785|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
153828786|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828787|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153828788|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153828789|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828790|NCT04513509|Protective Agents|protective agents|mesh-ancestor
153828791|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153828792|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153828793|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153670749|NCT05765305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670750|NCT05765305|Trace Elements|trace elements|mesh-ancestor
153670751|NCT05765305|Micronutrients|micronutrients|mesh-ancestor
153670752|NCT05760612|Trastuzumab|trastuzumab|mesh-list
153670753|NCT05760612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670754|NCT05760612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670755|NCT05760144|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153670756|NCT05760144|Etonogestrel|etonogestrel|mesh-list
153670757|NCT05760144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153670758|NCT05760144|Contraceptive Agents|contraceptive agents|mesh-ancestor
153670759|NCT05760144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153670760|NCT05760144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670761|NCT05760144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153670762|NCT05760144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153670763|NCT05760144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153670764|NCT05760144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670765|NCT05744674|Ropivacaine|ropivacaine|mesh-list
153670766|NCT05744674|Anesthetics, Local|anesthetics, local|mesh-ancestor
153670767|NCT05744674|Anesthetics|anesthetics|mesh-ancestor
153670768|NCT05744674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153670799|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153670800|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670801|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670802|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
153670803|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153483091|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483092|NCT05045872|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153483093|NCT05045872|Hematinics|hematinics|mesh-ancestor
153483094|NCT05045872|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153483095|NCT05045872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153483098|NCT05021562|Niraparib|niraparib|mesh-list
153772882|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
153772928|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772929|NCT00240630|Naproxen|naproxen|mesh-list
153483140|NCT04919369|Protective Agents|protective agents|mesh-ancestor
153670804|NCT05595603|Protective Agents|protective agents|mesh-ancestor
153670805|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670806|NCT05457465|Cannabidiol|cannabidiol|mesh-list
153670807|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
153670808|NCT05453955|Propofol|propofol|mesh-list
153670809|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153670810|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153670811|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670826|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670827|NCT05402553|Ondansetron|ondansetron|mesh-list
153670828|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
153670829|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
153670830|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670831|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670832|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153670833|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
153670834|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
153670835|NCT05402553|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153670836|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153670837|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
153670838|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670839|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670840|NCT05379322|Adalimumab|adalimumab|mesh-list
153483141|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153368840|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368841|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368842|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368843|NCT01138514|Clindamycin|clindamycin|mesh-list
153368844|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
153368845|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
153368846|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153828815|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153483142|NCT04908956|Osimertinib|osimertinib|mesh-list
153483143|NCT04908956|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153483144|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153483145|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483146|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483147|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483148|NCT04812379|Aripiprazole|aripiprazole|mesh-list
153483149|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
153483150|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153483151|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153483152|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153772930|NCT00240630|Sumatriptan|sumatriptan|mesh-list
153670841|NCT05379322|Golimumab|golimumab|mesh-list
153670842|NCT05379322|Etanercept|etanercept|mesh-list
153670843|NCT05379322|Upadacitinib|upadacitinib|mesh-list
153670844|NCT05379322|Tofacitinib|tofacitinib|mesh-list
153670845|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153670846|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153507814|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153670847|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153670848|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670849|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153670850|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153670852|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
153670853|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670854|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670855|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153670856|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670857|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
153670858|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670859|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670860|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670861|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153670862|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153670863|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670864|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
153670865|NCT05298696|Cilostazol|cilostazol|mesh-list
153670866|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153670867|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
153670868|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670869|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670870|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153670871|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
153670908|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
153670909|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
153670910|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153670911|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670912|NCT05049603|Atorvastatin|atorvastatin|mesh-list
153670913|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153670914|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153670915|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
153670916|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670917|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153670918|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153670919|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670920|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
153670921|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153670922|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153670923|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670924|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
153670925|NCT05037162|Coagulants|coagulants|mesh-ancestor
153670946|NCT04985721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670947|NCT04985721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153368882|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368883|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368884|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153670948|NCT04985721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670949|NCT04985721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670950|NCT04864366|Tenofovir|tenofovir|mesh-list
153670951|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
153670952|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670953|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153670954|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153670955|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483253|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153483254|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483255|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
153483256|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153483257|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153483258|NCT04484623|Growth Substances|growth substances|mesh-ancestor
153772931|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153670956|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670957|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153670958|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153670960|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
153670961|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670962|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153670963|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153670964|NCT04859296|Analgesics|analgesics|mesh-ancestor
153670965|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
153670966|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670967|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153670968|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153670969|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670970|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670971|NCT04859296|Hormones|hormones|mesh-ancestor
153670972|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153670973|NCT04857684|Bevacizumab|bevacizumab|mesh-list
153670974|NCT04857684|Atezolizumab|atezolizumab|mesh-list
153670975|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670976|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670977|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153670978|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153670979|NCT04857684|Growth Substances|growth substances|mesh-ancestor
153671008|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153671050|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671051|NCT04629534|Vitamins|vitamins|mesh-ancestor
153671052|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
153671053|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153671054|NCT04602065|Antibodies|antibodies|mesh-list
153671055|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153671056|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
153671057|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671058|NCT04598815|Sirolimus|sirolimus|mesh-list
153671059|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153671060|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671061|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153671062|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671063|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
153671064|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671065|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
153671066|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671067|NCT04584112|Paclitaxel|paclitaxel|mesh-list
153671068|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153671069|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
153671070|NCT04584112|Carboplatin|carboplatin|mesh-list
153671071|NCT04584112|Doxorubicin|doxorubicin|mesh-list
153671072|NCT04584112|Atezolizumab|atezolizumab|mesh-list
153671073|NCT04584112|Molgramostim|molgramostim|mesh-list
153671074|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153671075|NCT04584112|Lenograstim|lenograstim|mesh-list
153671076|NCT04584112|Sargramostim|sargramostim|mesh-list
153671077|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153671078|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772932|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153772933|NCT00240630|Analgesics|analgesics|mesh-ancestor
153772934|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
153772935|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153772936|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772937|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153772938|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153772939|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
153772940|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153772941|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153772942|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772943|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153772946|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
153772984|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153772985|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153772986|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153772987|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153772988|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153772989|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153772990|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153671079|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
153671080|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
153671081|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
153671082|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671083|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671084|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
153671085|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671086|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671123|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671124|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
153671135|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
153671136|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671137|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671138|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
153671139|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
153671140|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671141|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
153671142|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671143|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153671144|NCT04256343|Protective Agents|protective agents|mesh-ancestor
153671145|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671146|NCT04243629|Pramlintide|pramlintide|mesh-list
153671147|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
153671148|NCT04243629|Pancrelipase|pancrelipase|mesh-list
153671149|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153671150|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671151|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671152|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
153483436|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
153772991|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153772992|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
153772993|NCT00215345|Celecoxib|celecoxib|mesh-list
153772994|NCT00215345|Docetaxel|docetaxel|mesh-list
153772995|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153772996|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
153772997|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
153772998|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
153772999|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773000|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153773001|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153773002|NCT00215345|Analgesics|analgesics|mesh-ancestor
153773003|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
153773004|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773005|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773006|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773007|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671154|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153671155|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671156|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
153671157|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671158|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671159|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153671160|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
153671161|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671162|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671163|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153671176|NCT04134936|Lenalidomide|lenalidomide|mesh-list
153671177|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
153671178|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671179|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153671180|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153671181|NCT04134936|Growth Substances|growth substances|mesh-ancestor
153671182|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
153671183|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671184|NCT04115111|Durvalumab|durvalumab|mesh-list
153671185|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671186|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671187|NCT04042233|Vancomycin|vancomycin|mesh-list
153671188|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153671189|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671227|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153671244|NCT03492125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671245|NCT03356873|Vitamin D|vitamin d|mesh-list
153483461|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153483462|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153483463|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483465|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153773008|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153773009|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153773010|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773011|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
153773012|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153773016|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773018|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153773019|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
153773020|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671246|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
153671247|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
153671249|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
153671250|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671251|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153671252|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153671253|NCT03305341|Molgramostim|molgramostim|mesh-list
153671254|NCT03305341|Sargramostim|sargramostim|mesh-list
153671255|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
153671256|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671257|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671258|NCT03255473|Dexamethasone|dexamethasone|mesh-list
153671259|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
153671260|NCT03255473|Prednisone|prednisone|mesh-list
153671261|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153671262|NCT03255473|BB 1101|bb 1101|mesh-list
153671263|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671264|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
153671265|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
153671266|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671267|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671268|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671269|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
153671270|NCT03255473|Hormones|hormones|mesh-ancestor
153671271|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483497|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
153483498|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483499|NCT03105843|Mannitol|mannitol|mesh-list
153483500|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
153483501|NCT03105843|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153483502|NCT03105843|Diuretics|diuretics|mesh-ancestor
153483503|NCT03105843|Natriuretic Agents|natriuretic agents|mesh-ancestor
153483504|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483505|NCT03105843|Miotics|miotics|mesh-ancestor
153483506|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
153773021|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773022|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153773023|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
153773024|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153773025|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153773026|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153671272|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153671273|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671275|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828961|NCT00505947|Infliximab|infliximab|mesh-list
153671276|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671277|NCT03176277|Venetoclax|venetoclax|mesh-list
153671278|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671279|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
153671280|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153671281|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153671282|NCT03098225|Prednisolone|prednisolone|mesh-list
153671283|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
153671284|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153671285|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
153671286|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671287|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
153671288|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
153671304|NCT02855944|Paclitaxel|paclitaxel|mesh-list
153671305|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153671306|NCT02855944|Cisplatin|cisplatin|mesh-list
153671307|NCT02855944|Carboplatin|carboplatin|mesh-list
153671308|NCT02855944|Gemcitabine|gemcitabine|mesh-list
153671309|NCT02855944|Rucaparib|rucaparib|mesh-list
153671310|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153671311|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671312|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
153671313|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
153671314|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
153671315|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671316|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153483523|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
153483524|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153813881|NCT00437619|Calcipotriene|calcipotriene|mesh-list
153483526|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
153483527|NCT02925195|Vitamin D|vitamin d|mesh-list
153773076|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773077|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773078|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153773079|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153773080|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671317|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
153671318|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153671319|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671320|NCT02603848|Ibuprofen|ibuprofen|mesh-list
153671321|NCT02603848|Morphine|morphine|mesh-list
153671322|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153671323|NCT02603848|Narcotics|narcotics|mesh-ancestor
153671324|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671325|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671326|NCT02603848|Analgesics|analgesics|mesh-ancestor
153671327|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
153671328|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671329|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153671330|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153671331|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671332|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671333|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153671334|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671335|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671336|NCT02512887|Anesthetics|anesthetics|mesh-list
153671337|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671338|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671339|NCT02484261|Bortezomib|bortezomib|mesh-list
153671340|NCT02484261|Pravastatin|pravastatin|mesh-list
153671341|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671342|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153671343|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153671344|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
153671345|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828992|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828993|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153828994|NCT00485771|Lamotrigine|lamotrigine|mesh-list
153483552|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153483560|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483562|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483563|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153483564|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153483565|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
153483566|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671346|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153671347|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153671348|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671378|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153671379|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153671380|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671381|NCT01969227|Ketamine|ketamine|mesh-list
153671382|NCT01969227|Analgesics|analgesics|mesh-ancestor
153671383|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
153671384|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671385|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671386|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153671387|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153671388|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
153671389|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
153671390|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671391|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153671412|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671413|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671415|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
153671416|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671417|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671418|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671419|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
153671420|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
153671421|NCT00289952|Valproic Acid|valproic acid|mesh-list
153671422|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
153671423|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671424|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671425|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
153671426|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671427|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483589|NCT01428089|Progesterone|progesterone|mesh-list
153671429|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153671430|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671431|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153671432|NCT05772832|Dexmedetomidine|dexmedetomidine|mesh-list
153671433|NCT05772832|Remifentanil|remifentanil|mesh-list
153671434|NCT05772832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153671435|NCT05772832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671436|NCT05772832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671437|NCT05772832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153671438|NCT05772832|Analgesics|analgesics|mesh-ancestor
153671439|NCT05772832|Sensory System Agents|sensory system agents|mesh-ancestor
153671440|NCT05772832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671441|NCT05772832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153671442|NCT05772832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153671443|NCT05772832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153671444|NCT05772832|Adrenergic Agents|adrenergic agents|mesh-ancestor
153671477|NCT05772377|Cisplatin|cisplatin|mesh-list
153671478|NCT05772377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671479|NCT05772208|Nimotuzumab|nimotuzumab|mesh-list
153671480|NCT05772208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671481|NCT05772208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671482|NCT05772039|Listerine|listerine|mesh-list
153671483|NCT05772039|Fluorides|fluorides|mesh-list
153671484|NCT05772039|Sodium Fluoride|sodium fluoride|mesh-list
153671485|NCT05772039|Cariostatic Agents|cariostatic agents|mesh-ancestor
153671486|NCT05772039|Protective Agents|protective agents|mesh-ancestor
153671505|NCT05771181|Tislelizumab|tislelizumab|mesh-list
153671506|NCT05771181|Vitamins|vitamins|mesh-ancestor
153671507|NCT05771181|Micronutrients|micronutrients|mesh-ancestor
153671508|NCT05771181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671509|NCT05771181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671524|NCT05771012|Antifungal Agents|antifungal agents|mesh-ancestor
153671525|NCT05771012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671526|NCT05771012|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671527|NCT05771012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671528|NCT05771012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153671530|NCT05770960|Naloxegol|naloxegol|mesh-list
153671531|NCT05770960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153671532|NCT05770960|Narcotics|narcotics|mesh-ancestor
153671533|NCT05770960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671534|NCT05770960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671535|NCT05770960|Analgesics|analgesics|mesh-ancestor
153671536|NCT05770960|Sensory System Agents|sensory system agents|mesh-ancestor
153671537|NCT05770960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671538|NCT05770960|Antitussive Agents|antitussive agents|mesh-ancestor
153671539|NCT05770960|Respiratory System Agents|respiratory system agents|mesh-ancestor
153671540|NCT05770960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153671541|NCT05768282|Prednisolone|prednisolone|mesh-list
153671542|NCT05768282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671543|NCT05768282|Glucocorticoids|glucocorticoids|mesh-ancestor
153671544|NCT05768282|Hormones|hormones|mesh-ancestor
153671573|NCT05757011|Bupivacaine|bupivacaine|mesh-list
153671574|NCT05757011|Anesthetics, Local|anesthetics, local|mesh-ancestor
153671575|NCT05757011|Anesthetics|anesthetics|mesh-ancestor
153671576|NCT05757011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671577|NCT05757011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671578|NCT05757011|Sensory System Agents|sensory system agents|mesh-ancestor
153483677|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153773081|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773082|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153773083|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
153773084|NCT00556621|Gemcitabine|gemcitabine|mesh-list
153773085|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773086|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153773087|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
153773139|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153773140|NCT00240825|Analgesics|analgesics|mesh-ancestor
153773141|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
153773142|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153773143|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773144|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
153773145|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153773146|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773147|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153773148|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153773149|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773150|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773151|NCT04666675|Upadacitinib|upadacitinib|mesh-list
153773152|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153773154|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671581|NCT05750875|Gabapentin|gabapentin|mesh-list
153671582|NCT05750875|Analgesics|analgesics|mesh-ancestor
153671583|NCT05750875|Sensory System Agents|sensory system agents|mesh-ancestor
153671584|NCT05750875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671585|NCT05750875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671586|NCT05750875|Anticonvulsants|anticonvulsants|mesh-ancestor
153671587|NCT05750875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153671588|NCT05750875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153671615|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671616|NCT05646992|Azathioprine|azathioprine|mesh-list
153671617|NCT05646992|Tacrolimus|tacrolimus|mesh-list
153671618|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671619|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
153671620|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671621|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153671622|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483722|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
153483723|NCT00077285|Ifosfamide|ifosfamide|mesh-list
153418218|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
153418219|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418220|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369088|NCT02579343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153369089|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153369090|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483724|NCT00077285|Carboplatin|carboplatin|mesh-list
153483725|NCT00077285|Doxorubicin|doxorubicin|mesh-list
153483726|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153483727|NCT00077285|Irinotecan|irinotecan|mesh-list
153483728|NCT00077285|Etoposide|etoposide|mesh-list
153483729|NCT00077285|Vincristine|vincristine|mesh-list
153483730|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
153483731|NCT00077285|Razoxane|razoxane|mesh-list
153483732|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483733|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
153483734|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773196|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153773197|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153773198|NCT04666324|Simethicone|simethicone|mesh-list
153773199|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
153773200|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773201|NCT04666324|Emollients|emollients|mesh-ancestor
153773202|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
153773203|NCT04720833|Vitamin D|vitamin d|mesh-list
153773204|NCT04720833|Calcium|calcium|mesh-list
153773205|NCT04720833|Vitamins|vitamins|mesh-ancestor
153773206|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
153773207|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773208|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153773209|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153773210|NCT00244608|Budesonide|budesonide|mesh-list
153773211|NCT00244608|Terbutaline|terbutaline|mesh-list
153773212|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
153773213|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671623|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671624|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
153671625|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671626|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671627|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671628|NCT05549206|Vaccines|vaccines|mesh-list
153671629|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
153671630|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671631|NCT05533684|Gabapentin|gabapentin|mesh-list
153671632|NCT05533684|Analgesics|analgesics|mesh-ancestor
153671633|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
153671634|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671635|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671636|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
153671653|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
153671654|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671655|NCT05408247|Protective Agents|protective agents|mesh-ancestor
153671656|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671657|NCT05408247|Antidotes|antidotes|mesh-ancestor
153671658|NCT05375942|Infliximab|infliximab|mesh-list
153671659|NCT05375942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153671660|NCT05375942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671661|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671662|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671663|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671665|NCT05209308|Venetoclax|venetoclax|mesh-list
153671666|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671667|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773214|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153773221|NCT00244608|Hormones|hormones|mesh-ancestor
153773252|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153773253|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773255|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153773256|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
153773257|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773319|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773320|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153773321|NCT00241020|Octreotide|octreotide|mesh-list
153773322|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810780|NCT00351975|Belinostat|belinostat|mesh-list
153773323|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153773324|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773325|NCT00216047|Trastuzumab|trastuzumab|mesh-list
153773326|NCT00216047|Vatalanib|vatalanib|mesh-list
153773327|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153773328|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773329|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153773330|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671668|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
153671669|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671670|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671672|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
153671673|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671674|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153671675|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
153671676|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153671677|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
153671678|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153671679|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671680|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153671681|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153671682|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671683|NCT04916418|Ropivacaine|ropivacaine|mesh-list
153671684|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
153671685|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
153671686|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671687|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671688|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
153671689|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671690|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153671691|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153671692|NCT04892511|Nitroprusside|nitroprusside|mesh-list
153671693|NCT04892511|Labetalol|labetalol|mesh-list
153483781|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
153671695|NCT04892511|Phenylephrine|phenylephrine|mesh-list
153671696|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153671707|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153671708|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
153671709|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671710|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671711|NCT04892511|Protective Agents|protective agents|mesh-ancestor
153671712|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153671713|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
153671714|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153671715|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153671716|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153671717|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153671718|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153671719|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153671721|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153671722|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671723|NCT04785118|Scopolamine|scopolamine|mesh-list
153671724|NCT04785118|Ondansetron|ondansetron|mesh-list
153671725|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153671726|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
153671727|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
153671728|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483802|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483803|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153483804|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153483805|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483806|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483807|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153483808|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
153483809|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483810|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483811|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
153483812|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671729|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671730|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671731|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
153671732|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671733|NCT04785118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153671734|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153671735|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
153671736|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671737|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671738|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153671740|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153671741|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
153671742|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153671743|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
153671744|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
153671745|NCT04702256|Prednisone|prednisone|mesh-list
153671746|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
153671747|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153671748|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153671749|NCT04702256|Prednisolone|prednisolone|mesh-list
153671750|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
153671751|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
153671752|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153671753|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
153671754|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
153671755|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153483827|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483828|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483829|NCT01553058|Adalimumab|adalimumab|mesh-list
153483831|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671756|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
153671757|NCT04702256|Hormones|hormones|mesh-ancestor
153671758|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153671759|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671760|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153671761|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671795|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671797|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153671798|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153671799|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153671800|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153671828|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671829|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671830|NCT04541108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153671831|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671833|NCT04512079|Apixaban|apixaban|mesh-list
153671834|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
153671835|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153671836|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153671837|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671838|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153671839|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
153671840|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153671841|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
153671842|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671843|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
153671844|NCT04323657|Fludarabine|fludarabine|mesh-list
153671845|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671846|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
153810781|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671847|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671865|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671867|NCT04189107|Dexamethasone|dexamethasone|mesh-list
153671868|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
153671869|NCT04189107|BB 1101|bb 1101|mesh-list
153671870|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671871|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
153671872|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
153671873|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671874|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671875|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671876|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
153671877|NCT04189107|Hormones|hormones|mesh-ancestor
153671878|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153671879|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153671880|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671881|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
153671882|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671883|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671884|NCT04124991|Durvalumab|durvalumab|mesh-list
153671885|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671886|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671887|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
153671888|NCT04004221|Tislelizumab|tislelizumab|mesh-list
153671889|NCT04004221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671890|NCT04004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671891|NCT03844997|Palbociclib|palbociclib|mesh-list
153671892|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671893|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153671894|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671895|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671896|NCT03589729|Cytarabine|cytarabine|mesh-list
153671897|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
153483884|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
153483885|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483886|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153773331|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773332|NCT04665310|Tacrolimus|tacrolimus|mesh-list
153773333|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773334|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
153773335|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773336|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153773337|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773338|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773339|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
153773340|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153773341|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773342|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153610523|NCT01947608|Ceritinib|ceritinib|mesh-list
153773343|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
153773344|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153773345|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671898|NCT03589729|Idarubicin|idarubicin|mesh-list
153671899|NCT03589729|Cladribine|cladribine|mesh-list
153671900|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
153671901|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
153671902|NCT03589729|Razoxane|razoxane|mesh-list
153671903|NCT03589729|Calicheamicins|calicheamicins|mesh-list
153369189|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153369190|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
153369191|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
153369192|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
153369193|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671904|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671905|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
153671906|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671922|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
153671923|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
153671924|NCT03585686|Cytarabine|cytarabine|mesh-list
153671925|NCT03585686|Vemurafenib|vemurafenib|mesh-list
153671926|NCT03585686|Cladribine|cladribine|mesh-list
153671927|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671928|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
153671929|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671930|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671931|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
153671932|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671933|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671934|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
153671935|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671936|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153671937|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483928|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153483929|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
153483930|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483931|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483932|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153483933|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153483934|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
153483935|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153483936|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153483937|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
153483938|NCT01569126|Fluoxetine|fluoxetine|mesh-list
153773346|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773347|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773348|NCT00216164|Rituximab|rituximab|mesh-list
153773349|NCT00216164|Gemcitabine|gemcitabine|mesh-list
153773358|NCT04664803|Cefdinir|cefdinir|mesh-list
153773360|NCT04664803|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153671938|NCT03479307|Ketotifen|ketotifen|mesh-list
153671939|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153671940|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153671941|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
153671942|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671943|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153671944|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
153671945|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
153671946|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671947|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671948|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671949|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153671950|NCT03390933|Fluoxetine|fluoxetine|mesh-list
153671951|NCT03390933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153671952|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153671953|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369229|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153369230|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369231|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369232|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369233|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
153829178|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153829179|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671954|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671955|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671956|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
153671957|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671958|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153671959|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
153671960|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153671961|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153671962|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153671963|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671964|NCT03387787|Insulin|insulin|mesh-list
153671965|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153671986|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153672000|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672001|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
153672002|NCT02954536|Capecitabine|capecitabine|mesh-list
153672003|NCT02954536|Fluorouracil|fluorouracil|mesh-list
153672004|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
153672005|NCT02954536|Trastuzumab|trastuzumab|mesh-list
153672006|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672007|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153672008|NCT02954536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153672009|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672010|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153360952|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
153672011|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
153672012|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672013|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
153672014|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672015|NCT02899611|Valproic Acid|valproic acid|mesh-list
153672016|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
153672017|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672018|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672019|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
153672020|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672042|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672043|NCT02575677|Analgesics|analgesics|mesh-ancestor
153672044|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
153672045|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672047|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153672048|NCT02573831|Narcotics|narcotics|mesh-ancestor
153672049|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672050|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672051|NCT02573831|Analgesics|analgesics|mesh-ancestor
153672052|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
153672053|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672054|NCT02571881|Oxycodone|oxycodone|mesh-list
153773361|NCT04664803|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153773362|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153773363|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773364|NCT04664725|Repaglinide|repaglinide|mesh-list
153773366|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153773367|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
153672055|NCT02571881|Naloxone|naloxone|mesh-list
153672056|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153672057|NCT02571881|Narcotics|narcotics|mesh-ancestor
153672058|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672059|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672060|NCT02571881|Analgesics|analgesics|mesh-ancestor
153672061|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
153672062|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672063|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153672064|NCT02571179|Fentanyl|fentanyl|mesh-list
153672065|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153672066|NCT02571179|Narcotics|narcotics|mesh-ancestor
153672067|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672068|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672069|NCT02571179|Analgesics|analgesics|mesh-ancestor
153672070|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
153672071|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672072|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153672073|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153672074|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
153672075|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
153672076|NCT02511418|Simvastatin|simvastatin|mesh-list
153672077|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153672138|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672139|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672140|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672141|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672142|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672143|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672145|NCT00018668|Risperidone|risperidone|mesh-list
153672146|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153672147|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153672148|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
153672149|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672157|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
153672158|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
153672159|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
153672160|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672161|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153672162|NCT00018668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153672163|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153672164|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153672165|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
153736435|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672166|NCT00042354|Clofarabine|clofarabine|mesh-list
153672191|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153672192|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
153672193|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672194|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
153672195|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153672196|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672197|NCT00038805|Immunotoxins|immunotoxins|mesh-ancestor
153672198|NCT00038805|Immunoconjugates|immunoconjugates|mesh-ancestor
153672199|NCT00038805|Immunologic Factors|immunologic factors|mesh-ancestor
153672200|NCT00038805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672201|NCT00018824|Naltrexone|naltrexone|mesh-list
153672202|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153672203|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153672204|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672205|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
153672206|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484114|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
153484115|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773368|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773369|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153773370|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153773371|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153773372|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773373|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
153773374|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773419|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773420|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
153773421|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153773422|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153773423|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773424|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
153773425|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418221|NCT02781649|Ribavirin|ribavirin|mesh-list
153418222|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
153877438|NCT05801835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877439|NCT05801835|Antiviral Agents|antiviral agents|mesh-ancestor
153672207|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
153672208|NCT00038844|Rituximab|rituximab|mesh-list
153672209|NCT00038844|Fludarabine|fludarabine|mesh-list
153672210|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
153672211|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
153672212|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672213|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
153672214|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672215|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153509193|NCT03359239|Poly ICLC|poly iclc|mesh-list
153672216|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153672246|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153672247|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
153672248|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153672249|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153672250|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153672251|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672252|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153672254|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672255|NCT00018941|Aldesleukin|aldesleukin|mesh-list
153672256|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672257|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672258|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672293|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153672294|NCT00019058|Protective Agents|protective agents|mesh-ancestor
153672295|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672296|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
153672334|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484186|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484187|NCT01605942|Dexamethasone|dexamethasone|mesh-list
153484189|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
153672336|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672337|NCT00019214|Aldesleukin|aldesleukin|mesh-list
153672338|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672371|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153672373|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153672374|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
153672375|NCT00019409|Methotrexate|methotrexate|mesh-list
153672376|NCT00019409|Vincristine|vincristine|mesh-list
153672377|NCT00019409|Daunorubicin|daunorubicin|mesh-list
153672378|NCT00019409|Asparaginase|asparaginase|mesh-list
153672379|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
153672380|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672381|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
153672382|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672383|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153672405|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672406|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672407|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672408|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672409|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153672410|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153672411|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672412|NCT00019487|Aldesleukin|aldesleukin|mesh-list
153672413|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
153672414|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672415|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672416|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672417|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
153672418|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672419|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153672420|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
153672421|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672423|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
153672424|NCT00039351|Vincristine|vincristine|mesh-list
153484212|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672425|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672426|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
153672427|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672428|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153672429|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153672430|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
153672431|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672432|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672433|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153672434|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153672435|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
153672460|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
153672461|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672462|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153672463|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
153672464|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672466|NCT00039468|Irinotecan|irinotecan|mesh-list
153672467|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153672468|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672469|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672470|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672471|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672472|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672473|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
153672474|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672475|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
153672476|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153672477|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672478|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153672479|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153672480|NCT00039468|Growth Substances|growth substances|mesh-ancestor
153672481|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
153672482|NCT00019838|Fludarabine|fludarabine|mesh-list
153672494|NCT00019916|Aldesleukin|aldesleukin|mesh-list
153672495|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484254|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
153672496|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672497|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672498|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
153877448|NCT05790681|Insulin|insulin|mesh-list
153672499|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672500|NCT00039546|Paclitaxel|paclitaxel|mesh-list
153672501|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
153672502|NCT00039546|Gemcitabine|gemcitabine|mesh-list
153672503|NCT00039546|Epirubicin|epirubicin|mesh-list
153672504|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672505|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672506|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672507|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672508|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672509|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672510|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672511|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
153672512|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672513|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153672514|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153672515|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
153672516|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153509476|NCT02729701|Estrogens|estrogens|mesh-list
153672517|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672518|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
153672519|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153672520|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153672521|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672522|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672523|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
153672524|NCT00039585|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153484361|NCT01640340|Dexamethasone|dexamethasone|mesh-list
153484362|NCT01640340|Ondansetron|ondansetron|mesh-list
153773426|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773427|NCT00216437|Capecitabine|capecitabine|mesh-list
153773428|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153773429|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
153773430|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773431|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773433|NCT00244920|Leuprolide|leuprolide|mesh-list
153773434|NCT00244920|Bicalutamide|bicalutamide|mesh-list
153773435|NCT00244920|Hormones|hormones|mesh-list
153773436|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
153773437|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773438|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773472|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153672525|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153672526|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672527|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672528|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672529|NCT00019994|Aldesleukin|aldesleukin|mesh-list
153672530|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
153672531|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672532|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672533|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672534|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
153672535|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672536|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153672537|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
153672538|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672539|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
153672540|NCT00039663|Pravastatin|pravastatin|mesh-list
153672541|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
153672542|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153672543|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672544|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153672545|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153672546|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
153672579|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672580|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672581|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153672582|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153672583|NCT00020189|Analgesics|analgesics|mesh-ancestor
153672584|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
153672585|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672616|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672617|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
153672628|NCT00040053|Ondansetron|ondansetron|mesh-list
153672629|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
153672630|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
153672664|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672665|NCT00020501|Antidotes|antidotes|mesh-ancestor
153672666|NCT00020501|Protective Agents|protective agents|mesh-ancestor
153672667|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
153672668|NCT00020501|Vitamins|vitamins|mesh-ancestor
153672669|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
153672670|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153672671|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
153672672|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153672673|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
153672697|NCT00040248|Daclizumab|daclizumab|mesh-list
153672698|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672699|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
153672700|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672701|NCT00020618|Morphine|morphine|mesh-list
153672702|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153672703|NCT00020618|Narcotics|narcotics|mesh-ancestor
153672704|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672705|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672706|NCT00020618|Analgesics|analgesics|mesh-ancestor
153672707|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
153672708|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672709|NCT00020657|Ondansetron|ondansetron|mesh-list
153672710|NCT00020657|Granisetron|granisetron|mesh-list
153672711|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
153672712|NCT00020657|Dolasetron|dolasetron|mesh-list
153672713|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
153672714|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
153672715|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672716|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672717|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153672718|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
153672719|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
153672720|NCT00020657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153672725|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153672726|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153672761|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672763|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153672764|NCT00020774|Gemcitabine|gemcitabine|mesh-list
153672792|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672794|NCT00021047|Capecitabine|capecitabine|mesh-list
153672795|NCT00021047|Epirubicin|epirubicin|mesh-list
153672796|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672797|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672798|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
153672799|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672800|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153672801|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153672802|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672803|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672804|NCT00021164|Aldesleukin|aldesleukin|mesh-list
153672805|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
153672806|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672807|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672808|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672809|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
153672810|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672811|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153672812|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
153672813|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672841|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672842|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672843|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153672844|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
153672845|NCT00021242|Docetaxel|docetaxel|mesh-list
153672846|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672851|NCT00040950|Rituximab|rituximab|mesh-list
153672858|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672859|NCT00021281|Leucovorin|leucovorin|mesh-list
153672860|NCT00021281|Fluorouracil|fluorouracil|mesh-list
153672861|NCT00021281|Irinotecan|irinotecan|mesh-list
153672862|NCT00021281|Calcium|calcium|mesh-list
153672863|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
153672864|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153672865|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672885|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672886|NCT00041106|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153672887|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153672888|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672890|NCT00021320|Fluorouracil|fluorouracil|mesh-list
153672891|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672892|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672893|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672894|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672895|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672896|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672897|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
153672898|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672899|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672900|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
153672901|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672902|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
153672903|NCT00041223|Procyanidin|procyanidin|mesh-list
153672904|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
153672905|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672906|NCT00041223|Protective Agents|protective agents|mesh-ancestor
153672907|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672908|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153484635|NCT01707420|Gabapentin|gabapentin|mesh-list
153773473|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
153773612|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
153773613|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773614|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773615|NCT04660786|Vitamin D|vitamin d|mesh-list
153773616|NCT04660786|Triamcinolone|triamcinolone|mesh-list
153773617|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153773618|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153773619|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153773662|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153773663|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
153672909|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153672910|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672911|NCT00021359|Dexamethasone|dexamethasone|mesh-list
153672912|NCT00021359|Isotretinoin|isotretinoin|mesh-list
153672913|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153672914|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
153672915|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
153672916|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672917|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829374|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829375|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829376|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153829377|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
153672918|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153672919|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
153672920|NCT00021359|Hormones|hormones|mesh-ancestor
153672921|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153672922|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153672952|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
153672953|NCT00021398|Vitamins|vitamins|mesh-ancestor
153672954|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
153672955|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153672956|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
153672957|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672958|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
153672959|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153672960|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153672961|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672962|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672963|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672964|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
153672965|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672966|NCT00049023|Octreotide|octreotide|mesh-list
153672967|NCT00049023|Edotreotide|edotreotide|mesh-list
153672968|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153672969|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153672994|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153672995|NCT00049062|Gefitinib|gefitinib|mesh-list
153672996|NCT00049062|Anastrozole|anastrozole|mesh-list
153672997|NCT00049062|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153672998|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153773664|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773665|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153672999|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673000|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673001|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673002|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153673003|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153673004|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153673005|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153673006|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
153673007|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153673008|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673009|NCT00049101|Leucovorin|leucovorin|mesh-list
153673010|NCT00049101|Fluorouracil|fluorouracil|mesh-list
153673011|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
153673012|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153673013|NCT00049101|Calcium|calcium|mesh-list
153673014|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
153673015|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153673016|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673017|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
153673018|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673019|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673046|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673047|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673048|NCT00049179|Immunotoxins|immunotoxins|mesh-ancestor
153773666|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153773667|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773668|NCT04659499|Paclitaxel|paclitaxel|mesh-list
153773669|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153773670|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773671|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
153773675|NCT00241527|Esomeprazole|esomeprazole|mesh-list
153773725|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153773726|NCT00558220|Immunomodulating Agents|immunomodulating agents|mesh-list
153773733|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153773734|NCT00245427|Lactams|lactams|mesh-list
153773735|NCT00245427|beta-Lactams|beta-lactams|mesh-list
153773736|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153773737|NCT00245427|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-list
153773738|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773739|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
153773740|NCT00558298|Risperidone|risperidone|mesh-list
153773787|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773788|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
153773789|NCT04646824|Pemetrexed|pemetrexed|mesh-list
153773790|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773791|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773792|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773793|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153773794|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673050|NCT00394745|Valsartan|valsartan|mesh-list
153673051|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153510002|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153673052|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153673053|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153673054|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673055|NCT00049218|Carboplatin|carboplatin|mesh-list
153673056|NCT00049218|Etoposide|etoposide|mesh-list
153673057|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673058|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673059|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153673060|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673061|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673062|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673063|NCT00049296|Thalidomide|thalidomide|mesh-list
153673064|NCT00049296|Docetaxel|docetaxel|mesh-list
153673065|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673066|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673067|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673085|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153673087|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673088|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
153673089|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484732|NCT01309074|Sertraline|sertraline|mesh-list
153484733|NCT01309074|Analgesics|analgesics|mesh-ancestor
153484734|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
153484735|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484736|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484737|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
153673090|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673091|NCT00049374|Thalidomide|thalidomide|mesh-list
153673092|NCT00049374|Dexamethasone|dexamethasone|mesh-list
153673094|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153673095|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
153673096|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
153673097|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673098|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673099|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153673100|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
153673101|NCT00049374|Hormones|hormones|mesh-ancestor
153673102|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153673103|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153673104|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673105|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673106|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
153673107|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
153673108|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673109|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673110|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153673111|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153673112|NCT00049374|Growth Substances|growth substances|mesh-ancestor
153673113|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
153673114|NCT00021983|Immunotoxins|immunotoxins|mesh-list
153673115|NCT00021983|Immunoconjugates|immunoconjugates|mesh-ancestor
153673116|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
153673117|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484756|NCT01074294|Dopamine Agonists|dopamine agonists|mesh-ancestor
153484757|NCT01074294|Dopamine Agents|dopamine agents|mesh-ancestor
153484758|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
153484759|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484760|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484761|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153773795|NCT00217451|Clindamycin|clindamycin|mesh-list
153773796|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
153773797|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
153773798|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
153773799|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153773848|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153773849|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
153773850|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153673118|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
153673120|NCT00049413|Pentostatin|pentostatin|mesh-list
153673121|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673122|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
153673141|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673142|NCT00022139|Paclitaxel|paclitaxel|mesh-list
153673143|NCT00022139|Carboplatin|carboplatin|mesh-list
153673144|NCT00022139|Fluorouracil|fluorouracil|mesh-list
153673145|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673146|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673147|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673148|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673149|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673150|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673151|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
153673152|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673153|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673154|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
153673155|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673156|NCT00049569|Leucovorin|leucovorin|mesh-list
153673157|NCT00049569|Cytarabine|cytarabine|mesh-list
153673158|NCT00049569|Prednisone|prednisone|mesh-list
153673159|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
153673160|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153673161|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153673162|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153673163|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
153673164|NCT00049569|Doxorubicin|doxorubicin|mesh-list
153673165|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153673166|NCT00049569|Methotrexate|methotrexate|mesh-list
153673167|NCT00049569|Etoposide|etoposide|mesh-list
153673168|NCT00049569|Vincristine|vincristine|mesh-list
153673169|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
153673170|NCT00049569|Asparaginase|asparaginase|mesh-list
153673171|NCT00049569|Pegaspargase|pegaspargase|mesh-list
153673172|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
153673173|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673174|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
153673175|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673179|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673201|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673203|NCT00049569|Protective Agents|protective agents|mesh-ancestor
153673204|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
153673205|NCT00049569|Vitamins|vitamins|mesh-ancestor
153673206|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
153673207|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673208|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673209|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673210|NCT00049569|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153673211|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153673212|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
153484852|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
153484853|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153484854|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484855|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153484856|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153484857|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153484858|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
153484859|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484860|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
153484861|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153484862|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484863|NCT05316246|Tislelizumab|tislelizumab|mesh-list
153484864|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153484865|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153484866|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673213|NCT00022178|Doxorubicin|doxorubicin|mesh-list
153673214|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153673215|NCT00022178|Fluorouracil|fluorouracil|mesh-list
153673216|NCT00022178|Vincristine|vincristine|mesh-list
153673218|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673219|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
153673220|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673221|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673222|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673223|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
153673224|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673225|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673226|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153673227|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153673228|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153673229|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673230|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673231|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
153673232|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673264|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
153673265|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484867|NCT05316246|Immunotoxins|immunotoxins|mesh-ancestor
153773851|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773852|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153773853|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773854|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
153773855|NCT00241722|Alvimopan|alvimopan|mesh-list
153773856|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773857|NCT00558337|Levodopa|levodopa|mesh-list
153773858|NCT00558337|Carbidopa|carbidopa|mesh-list
153773859|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153773860|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153773861|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153773862|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
153773863|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153773864|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773865|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773866|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153773867|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773868|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153773869|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
153773870|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
153773871|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153773872|NCT00558376|Laxatives|laxatives|mesh-ancestor
153773873|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153773874|NCT00217646|Sorafenib|sorafenib|mesh-list
153773875|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773876|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153773877|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773878|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773879|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
153773880|NCT00558454|Hematinics|hematinics|mesh-ancestor
153773881|NCT00558493|Clevudine|clevudine|mesh-list
153673267|NCT00397761|Paclitaxel|paclitaxel|mesh-list
153673268|NCT00397761|Capecitabine|capecitabine|mesh-list
153673269|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153673270|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673271|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673272|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673273|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673274|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673275|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673302|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673303|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673305|NCT00022607|Bevacizumab|bevacizumab|mesh-list
153673306|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673307|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673308|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153673309|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153673310|NCT00022607|Growth Substances|growth substances|mesh-ancestor
153673311|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673312|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
153673313|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673314|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
153673315|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
153673316|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673317|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673318|NCT00049998|Topotecan|topotecan|mesh-list
153673319|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153673320|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673321|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673322|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673323|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484890|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153484891|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
153484892|NCT03162510|Tegafur|tegafur|mesh-list
153673363|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
153673396|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
153673397|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673399|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153673400|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153673401|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153673402|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153673403|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
153673404|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484930|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153484931|NCT01733472|Narcotics|narcotics|mesh-ancestor
153484932|NCT01733472|Analgesics|analgesics|mesh-ancestor
153484933|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
153484934|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484935|NCT01736358|Ketorolac|ketorolac|mesh-list
153484936|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153484937|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153484938|NCT01736358|Analgesics|analgesics|mesh-ancestor
153484939|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
153484940|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484941|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484942|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153484943|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153484944|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153484945|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673405|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673442|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153673466|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153673467|NCT00050895|Ritonavir|ritonavir|mesh-list
153673468|NCT00050895|Lopinavir|lopinavir|mesh-list
153673469|NCT00050895|Tenofovir|tenofovir|mesh-list
153673470|NCT00050895|Lamivudine|lamivudine|mesh-list
153673471|NCT00050895|Zidovudine|zidovudine|mesh-list
153673472|NCT00050895|Stavudine|stavudine|mesh-list
153673473|NCT00050895|Efavirenz|efavirenz|mesh-list
153673474|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153673475|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153673476|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
153673477|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673478|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673479|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153673480|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153673481|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
153673482|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673483|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153673484|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153673485|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153673486|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673487|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
153673488|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153418237|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673489|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153673490|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153673491|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153673492|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153673493|NCT00023387|Isoniazid|isoniazid|mesh-list
153673494|NCT00023387|Rifapentine|rifapentine|mesh-list
153673495|NCT00023387|Rifampin|rifampin|mesh-list
153673496|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
153673497|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673557|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153673558|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153673559|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153673560|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153673561|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153673563|NCT00023621|Celecoxib|celecoxib|mesh-list
153673564|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153673565|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153673566|NCT00023621|Analgesics|analgesics|mesh-ancestor
153673567|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
153673568|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673569|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673570|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153673571|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673572|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153673573|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153673574|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673575|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673576|NCT00023660|Celecoxib|celecoxib|mesh-list
153673577|NCT00023660|Fluorouracil|fluorouracil|mesh-list
153673578|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673579|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
153673580|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673581|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673582|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673594|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673596|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153673597|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
153673598|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153673599|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153673600|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673601|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673602|NCT00051285|Protective Agents|protective agents|mesh-ancestor
153673603|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673604|NCT00023699|Gefitinib|gefitinib|mesh-list
153673605|NCT00023699|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153673607|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673608|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673609|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673610|NCT00051441|Benzydamine|benzydamine|mesh-list
153673611|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153673612|NCT00023738|Doxorubicin|doxorubicin|mesh-list
153673613|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153673614|NCT00023738|Ifosfamide|ifosfamide|mesh-list
153673615|NCT00023738|Dacarbazine|dacarbazine|mesh-list
153673616|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153673617|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673618|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153673619|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673620|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673621|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673622|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673623|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
153673624|NCT00397917|Folic Acid|folic acid|mesh-list
153673625|NCT00397917|Hematinics|hematinics|mesh-ancestor
153673626|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
153673627|NCT00397917|Vitamins|vitamins|mesh-ancestor
153673628|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
153673629|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673630|NCT00397956|Ertapenem|ertapenem|mesh-list
153673631|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673632|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673633|NCT00023777|Cytarabine|cytarabine|mesh-list
153673634|NCT00023777|Daunorubicin|daunorubicin|mesh-list
153673635|NCT00023777|Sargramostim|sargramostim|mesh-list
153673636|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673637|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
153673638|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673639|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485078|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485079|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153485080|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153485081|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153773882|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
153673641|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673642|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673643|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
153673644|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673645|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153673646|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153673647|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673678|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673679|NCT00023972|Gemcitabine|gemcitabine|mesh-list
153673680|NCT00023972|Exatecan|exatecan|mesh-list
153673681|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673682|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
153673683|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673684|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673685|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153673686|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673687|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673688|NCT00024011|Bortezomib|bortezomib|mesh-list
153673689|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673690|NCT00051753|Amoxicillin|amoxicillin|mesh-list
153673691|NCT00051753|Levofloxacin|levofloxacin|mesh-list
153673692|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
153673693|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
153673728|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673730|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673766|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673767|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
153673768|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485108|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153485109|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
153773889|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153773891|NCT04645303|Hormones|hormones|mesh-ancestor
153773892|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773893|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773894|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153773895|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
153773896|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773897|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817239|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
153773904|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
153773905|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673769|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673805|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153673806|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
153673807|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153673808|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153673830|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673831|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673832|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153673833|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673834|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
153673835|NCT00024518|Interferons|interferons|mesh-list
153673836|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
153673837|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673838|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
153673839|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673840|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
153418240|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153418241|NCT03002012|Fluconazole|fluconazole|mesh-list
153418242|NCT03002012|Sertraline|sertraline|mesh-list
153418243|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
153418244|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153673841|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673842|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
153673843|NCT00052221|Hematinics|hematinics|mesh-ancestor
153673844|NCT00052299|Cytarabine|cytarabine|mesh-list
153673845|NCT00052299|Etoposide|etoposide|mesh-list
153673846|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
153673847|NCT00052299|Idarubicin|idarubicin|mesh-list
153673848|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
153673849|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673850|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673851|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153673852|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673853|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673854|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673855|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673856|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
153673857|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
153673858|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673859|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673860|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
153485165|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
153673861|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673862|NCT00052299|Analgesics|analgesics|mesh-ancestor
153673863|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
153673864|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673865|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153673888|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673889|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673890|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153673891|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153673892|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
153673893|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673894|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153673895|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
153673896|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153673897|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153673898|NCT00052377|Growth Substances|growth substances|mesh-ancestor
153673899|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
153673900|NCT00052416|Thalidomide|thalidomide|mesh-list
153673901|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673902|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
153673903|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673904|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
153673905|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673906|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673907|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153673908|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153673909|NCT00052416|Growth Substances|growth substances|mesh-ancestor
153673910|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
153673911|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673912|NCT00052455|Vincristine|vincristine|mesh-list
153673913|NCT00052455|Temozolomide|temozolomide|mesh-list
153673914|NCT00052455|Lomustine|lomustine|mesh-list
153673915|NCT00052455|Procarbazine|procarbazine|mesh-list
153673916|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673917|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673918|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673919|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673921|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673954|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153673955|NCT00052611|Celecoxib|celecoxib|mesh-list
153673956|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153673957|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153510897|NCT01404130|Isotretinoin|isotretinoin|mesh-list
153673959|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
153673960|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673961|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673984|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
153673985|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153673986|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673987|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153673988|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673989|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153673990|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153673991|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153673992|NCT00395369|Aprotinin|aprotinin|mesh-list
153673993|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
153485298|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485299|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485300|NCT01818414|Vitamins|vitamins|mesh-list
153485301|NCT01818414|Folic Acid|folic acid|mesh-list
153485302|NCT01818414|Misoprostol|misoprostol|mesh-list
153485303|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
153485304|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485305|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153485306|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
153485307|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153485310|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
153673994|NCT00395369|Coagulants|coagulants|mesh-ancestor
153673995|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153673996|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153673997|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
153673998|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673999|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674000|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
153674001|NCT00052845|Docetaxel|docetaxel|mesh-list
153674002|NCT00052845|Estramustine|estramustine|mesh-list
153674003|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674004|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674005|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674006|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674007|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674008|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674009|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
153674010|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153674011|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153674012|NCT00052845|Protective Agents|protective agents|mesh-ancestor
153674035|NCT00052923|Etoposide|etoposide|mesh-list
153674036|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674037|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
153674038|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674039|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674040|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674041|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
153674042|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674043|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674044|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153674045|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153674046|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674047|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153674048|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674049|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773952|NCT04644406|Trastuzumab|trastuzumab|mesh-list
153773953|NCT04644406|Pertuzumab|pertuzumab|mesh-list
153773954|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153773955|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674050|NCT00025064|Prednisolone|prednisolone|mesh-list
153674051|NCT00025064|Doxorubicin|doxorubicin|mesh-list
153674052|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153674053|NCT00025064|Etoposide|etoposide|mesh-list
153674054|NCT00025064|Vincristine|vincristine|mesh-list
153674055|NCT00025064|Melphalan|melphalan|mesh-list
153674056|NCT00025064|Ifosfamide|ifosfamide|mesh-list
153674057|NCT00025064|Dacarbazine|dacarbazine|mesh-list
153674058|NCT00025064|Bleomycin|bleomycin|mesh-list
153674059|NCT00025064|Vinblastine|vinblastine|mesh-list
153674060|NCT00025064|Procarbazine|procarbazine|mesh-list
153674061|NCT00025064|Chlorambucil|chlorambucil|mesh-list
153674062|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674063|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153674064|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153674065|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674066|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674067|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674068|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153773956|NCT04643821|Calcitriol|calcitriol|mesh-list
153773957|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
153773958|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153773959|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
153773960|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774010|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
153774011|NCT00245895|Hematinics|hematinics|mesh-ancestor
153774012|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
153774013|NCT00559195|Hematinics|hematinics|mesh-ancestor
153774014|NCT00245934|Etanercept|etanercept|mesh-list
153774015|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153774016|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774017|NCT00245934|Analgesics|analgesics|mesh-ancestor
153774018|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
153774019|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774020|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774021|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774022|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774023|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153774024|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774025|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
153774026|NCT00218231|Bupropion|bupropion|mesh-list
153774027|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153774028|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
153774029|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153774030|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153774031|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153774032|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153774033|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774034|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
153774035|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774036|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774037|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153774056|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
153774057|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774058|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774059|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
153774060|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153774061|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153774062|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153774063|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153674107|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674171|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369663|NCT03010436|Benralizumab|benralizumab|mesh-list
153369664|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153369671|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153369672|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153369673|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369675|NCT02517021|Palonosetron|palonosetron|mesh-list
153360971|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
153674172|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674173|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674174|NCT00025220|Growth Substances|growth substances|mesh-ancestor
153674175|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674176|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674177|NCT00053157|Sargramostim|sargramostim|mesh-list
153674178|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
153674179|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674180|NCT00025298|Paclitaxel|paclitaxel|mesh-list
153674181|NCT00025298|Carboplatin|carboplatin|mesh-list
153674182|NCT00025298|Amifostine|amifostine|mesh-list
153674183|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674184|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674185|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674186|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674187|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674188|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674189|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153674190|NCT00025298|Protective Agents|protective agents|mesh-ancestor
153674191|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674192|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
153674193|NCT00053196|Methotrexate|methotrexate|mesh-list
153674194|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
153674195|NCT00053196|Fludarabine|fludarabine|mesh-list
153674218|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
153774064|NCT00559312|Fluticasone|fluticasone|mesh-list
153774065|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153774066|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153774067|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774068|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153774069|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
153774070|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774113|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
153774114|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774115|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774116|NCT00559429|Analgesics|analgesics|mesh-ancestor
153774117|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
153774118|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774119|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774120|NCT00218621|Buprenorphine|buprenorphine|mesh-list
153774121|NCT00218621|Methadone|methadone|mesh-list
153774122|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153774124|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774125|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674220|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674221|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
153674222|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674223|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153674224|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
153674225|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153674226|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
153674227|NCT00053196|Protective Agents|protective agents|mesh-ancestor
153674228|NCT00025337|Leucovorin|leucovorin|mesh-list
153674229|NCT00025337|Bevacizumab|bevacizumab|mesh-list
153674230|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153674231|NCT00025337|Fluorouracil|fluorouracil|mesh-list
153674232|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
153674233|NCT00025337|Antibodies|antibodies|mesh-list
153674234|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
153674235|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153674236|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
153674237|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674238|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674239|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674240|NCT00025337|Growth Substances|growth substances|mesh-ancestor
153674241|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674242|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674243|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
153674244|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
153674245|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674246|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674247|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674248|NCT00025337|Antidotes|antidotes|mesh-ancestor
153674249|NCT00025337|Protective Agents|protective agents|mesh-ancestor
153674279|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774127|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
153774128|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774129|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153774130|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
153774131|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774132|NCT00246168|Acetaminophen|acetaminophen|mesh-list
153774133|NCT00246168|Tramadol|tramadol|mesh-list
153774134|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774135|NCT00246168|Analgesics|analgesics|mesh-ancestor
153774164|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153774165|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774166|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
153774167|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774169|NCT04639804|Naproxen|naproxen|mesh-list
153774170|NCT04639804|Aceclofenac|aceclofenac|mesh-list
153674280|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674281|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674282|NCT00053430|Growth Substances|growth substances|mesh-ancestor
153674283|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674284|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674286|NCT00025610|Carboplatin|carboplatin|mesh-list
153674287|NCT00025610|Doxorubicin|doxorubicin|mesh-list
153674288|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153674289|NCT00025610|Etoposide|etoposide|mesh-list
153674290|NCT00025610|Vincristine|vincristine|mesh-list
153674291|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674292|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
153674293|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674294|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674295|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674296|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
153674297|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674332|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674333|NCT00025688|Paclitaxel|paclitaxel|mesh-list
153674334|NCT00025688|Carboplatin|carboplatin|mesh-list
153674335|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674336|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674337|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674338|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674339|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674358|NCT00053820|Fluorouracil|fluorouracil|mesh-list
153674359|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
153674360|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674361|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674362|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674363|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674364|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
153674365|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674366|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
153674368|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153674373|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674374|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
153674375|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153674376|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674377|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674378|NCT00053937|Pirfenidone|pirfenidone|mesh-list
153674379|NCT00053937|Analgesics|analgesics|mesh-ancestor
153674380|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
153674381|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674382|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674383|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153674384|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153674385|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674386|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674387|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674388|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
153674389|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153674390|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153674391|NCT00053976|Prednisolone|prednisolone|mesh-list
153674392|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
153674393|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153674394|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
153674395|NCT00053976|Daclizumab|daclizumab|mesh-list
153674396|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674397|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
153674424|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674425|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674426|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
153674446|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674469|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
153674470|NCT00026234|Floxuridine|floxuridine|mesh-list
153674471|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674472|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
153674473|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
153674474|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674475|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674476|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153674477|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
153674478|NCT00026234|Hormones|hormones|mesh-ancestor
153674479|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674480|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153674481|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674482|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674483|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
153674484|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674485|NCT00054288|Gemcitabine|gemcitabine|mesh-list
153674486|NCT00054288|Irinotecan|irinotecan|mesh-list
153674487|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674488|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
153674489|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674490|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674491|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153674492|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674493|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674494|NCT00026273|Leucovorin|leucovorin|mesh-list
153674495|NCT00026273|Fluorouracil|fluorouracil|mesh-list
153674496|NCT00026273|Irinotecan|irinotecan|mesh-list
153674497|NCT00026273|Calcium|calcium|mesh-list
153674498|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
153674499|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153674500|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674533|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674541|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153674542|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674543|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674544|NCT00054444|Topotecan|topotecan|mesh-list
153674579|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674580|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153674581|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674582|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153674583|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153674584|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153674585|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674613|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153674614|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674615|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674616|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153674617|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153674618|NCT00026819|Analgesics|analgesics|mesh-ancestor
153674619|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
153674620|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877461|NCT05766631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877462|NCT05766631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369711|NCT05857982|Antiemetics|antiemetics|mesh-ancestor
153674621|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485614|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485615|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
153485616|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153485617|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153485618|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
153485619|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153485620|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153774171|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153774172|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774173|NCT04639804|Analgesics|analgesics|mesh-ancestor
153774174|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
153774175|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774176|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774177|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774178|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774179|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153774180|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153774181|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774182|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674623|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674624|NCT00054834|Epratuzumab|epratuzumab|mesh-list
153674625|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153674626|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674627|NCT00054873|Fluorouracil|fluorouracil|mesh-list
153674628|NCT00054873|Tezacitabine|tezacitabine|mesh-list
153674629|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
153674630|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674631|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674668|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
153674700|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
153674701|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674702|NCT00027287|Protective Agents|protective agents|mesh-ancestor
153674703|NCT00055419|Cetuximab|cetuximab|mesh-list
153674704|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153674705|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674706|NCT00055536|Natalizumab|natalizumab|mesh-list
153674707|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
153485640|NCT05633147|Clarithromycin|clarithromycin|mesh-list
153485641|NCT05633147|Midazolam|midazolam|mesh-list
153485642|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153485653|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
153485654|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485655|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485656|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485657|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485658|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153485659|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485660|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153485661|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153485662|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
153485663|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
153485664|NCT05622318|Tacrolimus|tacrolimus|mesh-list
153485665|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774183|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
153774184|NCT00218855|Thalidomide|thalidomide|mesh-list
153774185|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774186|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
153774187|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674708|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674709|NCT00027443|Cyclosporine|cyclosporine|mesh-list
153674710|NCT00027443|Cyclosporins|cyclosporins|mesh-list
153674711|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
153877463|NCT05766631|Analgesics|analgesics|mesh-ancestor
153877468|NCT05753306|Cisplatin|cisplatin|mesh-list
153674712|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674733|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153674734|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674735|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674736|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674737|NCT00027599|Growth Substances|growth substances|mesh-ancestor
153674738|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674739|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674740|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
153674742|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
153674743|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
153674744|NCT00055653|Melphalan|melphalan|mesh-list
153674745|NCT00055653|Busulfan|busulfan|mesh-list
153674746|NCT00055653|Fludarabine|fludarabine|mesh-list
153485670|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
153485671|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485672|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485673|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153485674|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153485675|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485676|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153485677|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153485678|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
153774188|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
153774189|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153774190|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774211|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
153774212|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774213|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774214|NCT04628884|Heparin|heparin|mesh-list
153774215|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
153774216|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153774217|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153774218|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774219|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153774220|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
153774221|NCT00412334|Ribavirin|ribavirin|mesh-list
153774222|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
153774223|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774224|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
153774225|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774226|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
153774227|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774228|NCT00561379|Rituximab|rituximab|mesh-list
153774229|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153674747|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
153674748|NCT00055653|Cyclosporins|cyclosporins|mesh-list
153674749|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153674750|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674751|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
153674752|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674753|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674754|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674755|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
153674756|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674757|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674758|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153674759|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674760|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
153674761|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674762|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
153674763|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674764|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
153674765|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153674766|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674791|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153674792|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674793|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674794|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674795|NCT00027638|Growth Substances|growth substances|mesh-ancestor
153674796|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674797|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674798|NCT00055809|Interferons|interferons|mesh-list
153674799|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
153674800|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
153485689|NCT05528848|Narcotics|narcotics|mesh-ancestor
153774230|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774231|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
153774232|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774233|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774265|NCT00219011|Renin Inhibitors|renin inhibitors|mesh-ancestor
153774266|NCT00219011|Protease Inhibitors|protease inhibitors|mesh-ancestor
153774267|NCT00219011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774268|NCT00219011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774269|NCT00242268|Simvastatin|simvastatin|mesh-list
153774270|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153774271|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153774272|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
153774273|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774274|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153674801|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153674802|NCT00055809|Bevacizumab|bevacizumab|mesh-list
153674803|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153674804|NCT00055809|Antibodies|antibodies|mesh-list
153674805|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
153674806|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153674807|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674808|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674809|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674810|NCT00055809|Growth Substances|growth substances|mesh-ancestor
153674811|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674812|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674813|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
153674814|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
153674815|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674816|NCT00027677|Halofuginone|halofuginone|mesh-list
153674817|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674818|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
153674819|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153674853|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153674854|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674855|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153674856|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
153674857|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674858|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153674859|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
153674860|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153736437|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674882|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
153674883|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153674884|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674885|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674886|NCT00027833|Antidotes|antidotes|mesh-ancestor
153674887|NCT00027833|Protective Agents|protective agents|mesh-ancestor
153674888|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
153674889|NCT00027833|Vitamins|vitamins|mesh-ancestor
153485733|NCT05372367|Rifampin|rifampin|mesh-list
153774275|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153774278|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
153774279|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674891|NCT00027872|Tipifarnib|tipifarnib|mesh-list
153674892|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674893|NCT00027911|Sargramostim|sargramostim|mesh-list
153674894|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
153674895|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674896|NCT00027989|Gemcitabine|gemcitabine|mesh-list
153674897|NCT00027989|Doxorubicin|doxorubicin|mesh-list
153674898|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153674899|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674900|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
153674901|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674902|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674903|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153674904|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153674905|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674906|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674907|NCT00056004|Zileuton|zileuton|mesh-list
153674908|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153674909|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153674910|NCT00056004|Analgesics|analgesics|mesh-ancestor
153674911|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
153674912|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674913|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674914|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674915|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674946|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674947|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674948|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674949|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674950|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153611493|NCT05874583|Hemostatics|hemostatics|mesh-ancestor
153774321|NCT00219128|Protease Inhibitors|protease inhibitors|mesh-ancestor
153774322|NCT00219128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774323|NCT00219128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774325|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153774326|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774327|NCT04628143|Analgesics|analgesics|mesh-ancestor
153774328|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
153774329|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774330|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774331|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774332|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774333|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
153774334|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
153674951|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153674952|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674953|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674955|NCT04730973|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153674956|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153674977|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674978|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153674982|NCT00028535|Paclitaxel|paclitaxel|mesh-list
153675086|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
153675088|NCT00028886|Dexamethasone|dexamethasone|mesh-list
153675277|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675278|NCT00029822|Urological Agents|urological agents|mesh-ancestor
153675279|NCT00395681|Propofol|propofol|mesh-list
153675390|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153675391|NCT00057564|Growth Substances|growth substances|mesh-ancestor
153675393|NCT00030368|Paclitaxel|paclitaxel|mesh-list
153675531|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675532|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675542|NCT00030758|Lenograstim|lenograstim|mesh-list
153675638|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153675639|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153675940|NCT00059865|Pemetrexed|pemetrexed|mesh-list
153675941|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675942|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
153675943|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675944|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675945|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675973|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
153675974|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675975|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675986|NCT00059943|Docetaxel|docetaxel|mesh-list
153676068|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
153676069|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
153676070|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676071|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153676072|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676223|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676224|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676225|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153676226|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153676227|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
153676450|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676451|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153676452|NCT00061620|Tezacitabine|tezacitabine|mesh-list
153676453|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676454|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676455|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676456|NCT00034151|Paclitaxel|paclitaxel|mesh-list
153676497|NCT00034463|Folic Acid|folic acid|mesh-list
153676597|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153676764|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153676765|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676766|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676926|NCT00035984|Incretins|incretins|mesh-ancestor
153676959|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153676960|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153676961|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153677219|NCT00037583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677221|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153677222|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
153677223|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677224|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
153677225|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677226|NCT00064857|Protective Agents|protective agents|mesh-ancestor
153677227|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153677251|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677252|NCT00037817|Celecoxib|celecoxib|mesh-list
153677253|NCT00037817|Decitabine|decitabine|mesh-list
153677254|NCT00037817|Romidepsin|romidepsin|mesh-list
153677255|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153677256|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153677257|NCT00037817|Analgesics|analgesics|mesh-ancestor
153677258|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
153677259|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677260|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677261|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153810787|NCT00321581|Cediranib|cediranib|mesh-list
153677262|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677263|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153677264|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153677265|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677266|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677267|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677268|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
153677269|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677270|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153774335|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774336|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774337|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153774338|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153774339|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153774340|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774341|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
153774342|NCT00219167|Aliskiren|aliskiren|mesh-list
153774343|NCT00219167|Renin Inhibitors|renin inhibitors|mesh-ancestor
153774344|NCT00219167|Protease Inhibitors|protease inhibitors|mesh-ancestor
153774370|NCT00219323|Omalizumab|omalizumab|mesh-list
153774371|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153774372|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153774373|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774374|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
153774375|NCT00246597|Hematinics|hematinics|mesh-ancestor
153774376|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
153677271|NCT00037817|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153677273|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153677274|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
153677275|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
153677276|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
153677277|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
153677278|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153677279|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677280|NCT00065169|Celecoxib|celecoxib|mesh-list
153677281|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153677282|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153677283|NCT00065169|Analgesics|analgesics|mesh-ancestor
153677284|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
153677285|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677304|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677305|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153677306|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
153677307|NCT00038090|Hormones|hormones|mesh-ancestor
153677308|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677309|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153677310|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677311|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677312|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
153677313|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
153677314|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153677315|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677318|NCT00038090|Growth Substances|growth substances|mesh-ancestor
153677338|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677339|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677340|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677341|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153677373|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677374|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677375|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
153677376|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677377|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
153677378|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153677379|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677380|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153677381|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153677382|NCT00038246|Growth Substances|growth substances|mesh-ancestor
153677383|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
153677384|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153677411|NCT00396578|Vancomycin|vancomycin|mesh-list
153677412|NCT00396578|Gentamicins|gentamicins|mesh-list
153677413|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153677414|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677415|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153677416|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677417|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677418|NCT00398853|Chromium|chromium|mesh-list
153677419|NCT00398853|Picolinic acid|picolinic acid|mesh-list
153677420|NCT00398853|Trace Elements|trace elements|mesh-ancestor
153677421|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
153774377|NCT04626739|Fludarabine|fludarabine|mesh-list
153774378|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774379|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
153774380|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774381|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774382|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153774383|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
153774384|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774385|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774386|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153774387|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153774388|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
153774389|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774390|NCT04627129|Itraconazole|itraconazole|mesh-list
153774391|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
153774392|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611569|NCT05799820|Antimetabolites|antimetabolites|mesh-ancestor
153774393|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153774394|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153774398|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
153677422|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677423|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153677425|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
153677426|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677427|NCT05433896|Dasatinib|dasatinib|mesh-list
153677428|NCT05433896|Omeprazole|omeprazole|mesh-list
153677429|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153677430|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153677431|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153677454|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153677455|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677457|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153677458|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
153677459|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
153677460|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677461|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
153677462|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153677463|NCT00069966|Cytarabine|cytarabine|mesh-list
153677464|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
153677465|NCT00069966|Rituximab|rituximab|mesh-list
153677466|NCT00069966|Pixantrone|pixantrone|mesh-list
153677467|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677469|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
153677519|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677520|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153677521|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153677522|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153677523|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153677524|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677525|NCT00070083|Prednisone|prednisone|mesh-list
153677526|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
153677527|NCT00070083|Rituximab|rituximab|mesh-list
153677528|NCT00070083|Doxorubicin|doxorubicin|mesh-list
153677529|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153677530|NCT00070083|Vincristine|vincristine|mesh-list
153677531|NCT00070083|Oblimersen|oblimersen|mesh-list
153677532|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677533|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
153677534|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677535|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677555|NCT00070122|Leucovorin|leucovorin|mesh-list
153677556|NCT00070122|Bevacizumab|bevacizumab|mesh-list
153677557|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153677558|NCT00070122|Capecitabine|capecitabine|mesh-list
153677559|NCT00070122|Fluorouracil|fluorouracil|mesh-list
153677560|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
153677561|NCT00070122|Antibodies|antibodies|mesh-list
153677562|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
153677563|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153677564|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
153677565|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677566|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153677567|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153677568|NCT00070122|Growth Substances|growth substances|mesh-ancestor
153677569|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677570|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
153677571|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
153514492|NCT05386160|Growth Substances|growth substances|mesh-ancestor
153677572|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677573|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
153487256|NCT01932060|Oxytocin|oxytocin|mesh-list
153774417|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774418|NCT00219479|Phenytoin|phenytoin|mesh-list
153774419|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
153774420|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153677574|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677575|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677576|NCT00070122|Antidotes|antidotes|mesh-ancestor
153677577|NCT00070122|Protective Agents|protective agents|mesh-ancestor
153677578|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
153677579|NCT00070122|Vitamins|vitamins|mesh-ancestor
153677580|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
153677581|NCT00070161|Donepezil|donepezil|mesh-list
153677582|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153677583|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677584|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677585|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
153677586|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153677587|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677588|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
153677589|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
153677616|NCT00066339|Gefitinib|gefitinib|mesh-list
153677617|NCT00066339|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153677618|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153677619|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677620|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677621|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677622|NCT00070239|Alvocidib|alvocidib|mesh-list
153677623|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153677624|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153677625|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677626|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677627|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677628|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
153677632|NCT00070278|Paclitaxel|paclitaxel|mesh-list
153677670|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
153677671|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
153677672|NCT00066417|Thiotepa|thiotepa|mesh-list
153677673|NCT00066417|Fludarabine|fludarabine|mesh-list
153677674|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
153677675|NCT00066417|Cyclosporins|cyclosporins|mesh-list
153677676|NCT00066417|Immunomodulating Agents|immunomodulating agents|mesh-list
153677677|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677678|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
153677679|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677680|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677681|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153677682|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
153677683|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677684|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677685|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153677686|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677687|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
153677688|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677704|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677706|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677707|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677708|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677709|NCT00070434|Leucovorin|leucovorin|mesh-list
153677710|NCT00070434|Pyridoxine|pyridoxine|mesh-list
153677711|NCT00070434|Capecitabine|capecitabine|mesh-list
153677712|NCT00070434|Fluorouracil|fluorouracil|mesh-list
153677713|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
153677714|NCT00070434|Irinotecan|irinotecan|mesh-list
153677715|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
153677716|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677718|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
153677733|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153677734|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677735|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677736|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
153677737|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153677738|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153677739|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677740|NCT00070473|Pemetrexed|pemetrexed|mesh-list
153677741|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677742|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677743|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677744|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153677745|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153677747|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153677748|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153677749|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677766|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153677767|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487423|NCT05738382|Cetrorelix|cetrorelix|mesh-list
153774421|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153774422|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153774423|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774424|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153774425|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153774426|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153774427|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153774428|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774429|NCT04626973|Ezetimibe|ezetimibe|mesh-list
153774430|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153774431|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153774432|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153774433|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
153817303|NCT06188767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774434|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774470|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
153774471|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774472|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774473|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774474|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153774475|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153774476|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153774477|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153774479|NCT04626193|Doxycycline|doxycycline|mesh-list
153774480|NCT04626193|Levofloxacin|levofloxacin|mesh-list
153774481|NCT04626193|Esomeprazole|esomeprazole|mesh-list
153774482|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153774483|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774484|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153774485|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153774486|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153774487|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774488|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677768|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677769|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677770|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677771|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677772|NCT01349595|Bortezomib|bortezomib|mesh-list
153677773|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677774|NCT05184920|Nicotine|nicotine|mesh-list
153677775|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153677776|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
153677777|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677778|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677779|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153677780|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153677781|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
153677782|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487436|NCT05737680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487437|NCT05737680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487438|NCT05737680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487439|NCT05737680|Gout Suppressants|gout suppressants|mesh-ancestor
153774489|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
153774490|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153418259|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418260|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153879784|NCT03721653|Bevacizumab|bevacizumab|mesh-list
153877485|NCT05752734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153774524|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774525|NCT00242697|Anesthetics|anesthetics|mesh-list
153774526|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153774527|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774528|NCT04625179|Melatonin|melatonin|mesh-list
153774529|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
153774530|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
153774531|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774532|NCT04625179|Protective Agents|protective agents|mesh-ancestor
153774533|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774588|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774589|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774590|NCT00242775|Fluticasone|fluticasone|mesh-list
153774591|NCT00242775|Budesonide|budesonide|mesh-list
153774592|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
153774593|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153774594|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774595|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153774596|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
153774597|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774655|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
153774656|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774657|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153774658|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153774659|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153774660|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774661|NCT00247026|Ubiquinone|ubiquinone|mesh-list
153774662|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
153774663|NCT00247026|Curcumin|curcumin|mesh-list
153774664|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153774665|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153774666|NCT00247026|Analgesics|analgesics|mesh-ancestor
153774667|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
153774668|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774669|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774676|NCT00247026|Vitamins|vitamins|mesh-ancestor
153677783|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677784|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
153677785|NCT02958501|Vitamin D|vitamin d|mesh-list
153677786|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153677787|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677788|NCT02958501|Vitamins|vitamins|mesh-ancestor
153677789|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
153677790|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153677791|NCT00066651|Immunotoxins|immunotoxins|mesh-list
153677792|NCT00066651|Immunoconjugates|immunoconjugates|mesh-ancestor
153677793|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
153677794|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677795|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
153677796|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
153677797|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677798|NCT00398892|Protective Agents|protective agents|mesh-ancestor
153677799|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677800|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
153677801|NCT00398892|Vitamins|vitamins|mesh-ancestor
153677802|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
153774712|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774713|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153774715|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774716|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153774717|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153774718|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
153774719|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
153774720|NCT00242853|Protective Agents|protective agents|mesh-ancestor
153774721|NCT00220259|Fluticasone|fluticasone|mesh-list
153774722|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153774723|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153774724|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
153774725|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153774726|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774727|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153774769|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
153774770|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
153774772|NCT00220298|Androgens|androgens|mesh-ancestor
153774773|NCT00220298|Hormones|hormones|mesh-ancestor
153774774|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774775|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774776|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153774777|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774778|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
153774779|NCT00412412|Trastuzumab|trastuzumab|mesh-list
153774780|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153774781|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774782|NCT04621669|Metformin|metformin|mesh-list
153774783|NCT04621669|Digoxin|digoxin|mesh-list
153774784|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153774829|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153774830|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153774831|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
153774832|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153774833|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153774834|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153677804|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677806|NCT00066768|Gemcitabine|gemcitabine|mesh-list
153677807|NCT00066768|Docetaxel|docetaxel|mesh-list
153677808|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677809|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
153677810|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677811|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677850|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677889|NCT00067119|Dipyridamole|dipyridamole|mesh-list
153677919|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153677921|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
153677922|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153677923|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153677924|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677925|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677926|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
153677927|NCT00067158|Nicotine|nicotine|mesh-list
153677928|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153677929|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
153677930|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677958|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677959|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153677960|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153677961|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
153677962|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153677963|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
153677964|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153677965|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
153774835|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774836|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774837|NCT04621513|Montelukast|montelukast|mesh-list
153774838|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153774839|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
153774840|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153774841|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
153774842|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153774843|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774844|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153774845|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153774846|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774848|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153360995|NCT01492673|Bevacizumab|bevacizumab|mesh-list
153677966|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677967|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677968|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
153677969|NCT00067431|Valproic Acid|valproic acid|mesh-list
153677970|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
153677971|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677972|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677973|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
153677974|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153677975|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677976|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
153677977|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153677978|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678005|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678006|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678007|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678008|NCT00071253|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153678009|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153678010|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153678011|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678012|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678013|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
153678014|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
153678015|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678016|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
153678017|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
153678018|NCT00067548|EKB 569|ekb 569|mesh-list
153678019|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678020|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678021|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678022|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678023|NCT00071331|Tolvaptan|tolvaptan|mesh-list
153678024|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153678025|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678026|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
153678027|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678065|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678100|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678101|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678102|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
153678103|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678104|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678105|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153678106|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
153678122|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678123|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153678124|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678125|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153678126|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678127|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
153678128|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
153678129|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153678130|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
153678131|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678132|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
153678133|NCT00144820|Protective Agents|protective agents|mesh-ancestor
153678134|NCT00071643|Escitalopram|escitalopram|mesh-list
153678135|NCT00071643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153678136|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153678137|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153678138|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678139|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678142|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153678143|NCT00144976|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153678144|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678145|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678146|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678147|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678148|NCT00038480|Ritonavir|ritonavir|mesh-list
153678149|NCT00038480|Lopinavir|lopinavir|mesh-list
153678150|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153678151|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153678152|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
153678153|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678154|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678155|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153678156|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153678157|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
153678158|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678159|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153678160|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153678161|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
153678162|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
153678163|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678164|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678197|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678198|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678199|NCT00038558|Doxorubicin|doxorubicin|mesh-list
153678200|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153487587|NCT02534376|Simvastatin|simvastatin|mesh-list
153487588|NCT02534376|Ezetimibe|ezetimibe|mesh-list
153487589|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153487590|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153487591|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
153487592|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487593|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153487595|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678201|NCT00038558|Bleomycin|bleomycin|mesh-list
153678202|NCT00038558|Dacarbazine|dacarbazine|mesh-list
153678203|NCT00038558|Vinblastine|vinblastine|mesh-list
153678204|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153678205|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678206|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153678207|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153678208|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678239|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
153678240|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678241|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678242|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153678243|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153678244|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
153678245|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678246|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153678247|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153678248|NCT00071838|Daclizumab|daclizumab|mesh-list
153678249|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678250|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
153678271|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153370002|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
153370003|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370004|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370005|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
153370011|NCT04165824|Edaravone|edaravone|mesh-list
153678272|NCT00203125|Protective Agents|protective agents|mesh-ancestor
153678273|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678274|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
153678275|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
153678276|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678277|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153678278|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153678279|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153678280|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
153678281|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678282|NCT00203164|Rasagiline|rasagiline|mesh-list
153678283|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153678284|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487616|NCT01086540|Promethazine|promethazine|mesh-list
153487617|NCT01086540|Prednisone|prednisone|mesh-list
153487618|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
153487619|NCT01086540|Rituximab|rituximab|mesh-list
153678285|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678286|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153678287|NCT00203164|Protective Agents|protective agents|mesh-ancestor
153678288|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678289|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
153678290|NCT00203281|Tacrolimus|tacrolimus|mesh-list
153678291|NCT00203281|Daclizumab|daclizumab|mesh-list
153678292|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
153678293|NCT00203281|Antibodies|antibodies|mesh-list
153678294|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
153678295|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153678296|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153678297|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678298|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
153678299|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678300|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153678301|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678302|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678303|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153678304|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678305|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153678306|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
153678307|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153678342|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
153678343|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678344|NCT00038831|Fludarabine|fludarabine|mesh-list
153678345|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
153678346|NCT00038831|Melphalan|melphalan|mesh-list
153678347|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
153678348|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153678349|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
153678374|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678375|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
153678376|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153678388|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678389|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678391|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678392|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678393|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678394|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153678395|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
153678396|NCT00072033|Docetaxel|docetaxel|mesh-list
153877486|NCT05752734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877487|NCT05741905|Levofloxacin|levofloxacin|mesh-list
153877488|NCT05741905|Ofloxacin|ofloxacin|mesh-list
153877489|NCT05741905|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153877490|NCT05741905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877491|NCT05741905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153678397|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678398|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
153678399|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
153678400|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
153487721|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153487722|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
153487723|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153487724|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487725|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153487726|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153487727|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487728|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487729|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487730|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153487731|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487732|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153487733|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153678430|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
153678431|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678432|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678433|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678434|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678435|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153678436|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153678437|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
153678438|NCT00204022|Azathioprine|azathioprine|mesh-list
153678439|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153678440|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678441|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153678442|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
153678443|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153678444|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678476|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
153678478|NCT00039026|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153678479|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153678480|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678481|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153678482|NCT00039026|Incretins|incretins|mesh-ancestor
153678483|NCT00039026|Hormones|hormones|mesh-ancestor
153678484|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678485|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153678513|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153678514|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678515|NCT00204568|Doxorubicin|doxorubicin|mesh-list
153678516|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153678534|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153678563|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
153678564|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678565|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678566|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678567|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678568|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
153678569|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153678570|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678571|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678572|NCT00039338|Cisplatin|cisplatin|mesh-list
153678573|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678574|NCT00072228|Gemcitabine|gemcitabine|mesh-list
153678575|NCT00072228|Soblidotin|soblidotin|mesh-list
153678576|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153678577|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
153678578|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370053|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
153678603|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678604|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
153678605|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153678606|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678607|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153678608|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153678609|NCT00072345|Growth Substances|growth substances|mesh-ancestor
153678610|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
153678611|NCT00039455|Trastuzumab|trastuzumab|mesh-list
153678612|NCT00039455|Alvocidib|alvocidib|mesh-list
153678613|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153678614|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678615|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
153678616|NCT00039455|Growth Substances|growth substances|mesh-ancestor
153678617|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678618|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678619|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678620|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678621|NCT00205231|Etanercept|etanercept|mesh-list
153678622|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153678623|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153678624|NCT00205231|Analgesics|analgesics|mesh-ancestor
153678625|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
153678626|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678627|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678650|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678651|NCT00039494|Temozolomide|temozolomide|mesh-list
153678652|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153678653|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153678654|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
153678655|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678656|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678657|NCT00039494|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153678658|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678659|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678661|NCT00205738|Risperidone|risperidone|mesh-list
153678662|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153678663|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
153678664|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678665|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678666|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678667|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153678668|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678669|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678670|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678671|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153678672|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
153678673|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
153678674|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
153678675|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678676|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153678677|NCT00205738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153678713|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678714|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678715|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
153678716|NCT00072579|Sargramostim|sargramostim|mesh-list
153678739|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153678740|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153678741|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
153678742|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678743|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678744|NCT00039611|Leucovorin|leucovorin|mesh-list
153678745|NCT00039611|Fluorouracil|fluorouracil|mesh-list
153678746|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
153678747|NCT00039611|Calcium|calcium|mesh-list
153678748|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
153678749|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153678750|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678751|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
153678752|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678753|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153678754|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678755|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678756|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
153678757|NCT00039611|Antidotes|antidotes|mesh-ancestor
153487885|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
153487886|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153774849|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153774880|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774881|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153774882|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
153774884|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153774885|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
153774886|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774887|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153774888|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153774889|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
153774890|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774891|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678758|NCT00039611|Protective Agents|protective agents|mesh-ancestor
153678759|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
153678760|NCT00039611|Vitamins|vitamins|mesh-ancestor
153678761|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
153678762|NCT00068289|Bortezomib|bortezomib|mesh-list
153678763|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678764|NCT00039767|Lepirudin|lepirudin|mesh-list
153678765|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
153678766|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153678767|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
153678768|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678769|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678799|NCT00411034|Narcotics|narcotics|mesh-ancestor
153678800|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678801|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678802|NCT00411034|Analgesics|analgesics|mesh-ancestor
153678803|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
153678804|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678805|NCT00411073|Darapladib|darapladib|mesh-list
153678806|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153678807|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678808|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678809|NCT00411190|Acetaminophen|acetaminophen|mesh-list
153678810|NCT00411190|Ibuprofen|ibuprofen|mesh-list
153678811|NCT00411190|Atorvastatin|atorvastatin|mesh-list
153678812|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153678813|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153678814|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
153736439|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736440|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736441|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153736442|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153736443|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153678843|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153678845|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
153678846|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678847|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153678848|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
153678849|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678850|NCT00424333|Insulin|insulin|mesh-list
153678851|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153678852|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153678853|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678854|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153678855|NCT00206557|Estradiol|estradiol|mesh-list
153678856|NCT00206557|Estrogens|estrogens|mesh-ancestor
153678857|NCT00206557|Hormones|hormones|mesh-ancestor
153678858|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678859|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678860|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153774892|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153774944|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
153774945|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153774946|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153774947|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
153774948|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
153774949|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153774950|NCT04619875|Lactulose|lactulose|mesh-list
153774951|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153774952|NCT04619290|Methylene Blue|methylene blue|mesh-list
153774953|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153774954|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153774955|NCT04619563|Docetaxel|docetaxel|mesh-list
153775005|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775006|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775007|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
153775008|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775009|NCT00221039|Methoxsalen|methoxsalen|mesh-list
153775010|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153775011|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775012|NCT00562939|Vaccines|vaccines|mesh-list
153775013|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153775014|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
153775016|NCT00221156|Acarbose|acarbose|mesh-list
153775067|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
153775068|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153775069|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775070|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153775075|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775076|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153775077|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678861|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
153678862|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153678863|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153678864|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153678866|NCT00068484|Topotecan|topotecan|mesh-list
153678867|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678868|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153678869|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153678870|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678871|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678872|NCT00206596|Sargramostim|sargramostim|mesh-list
153678873|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
153678874|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678875|NCT00206635|Interferons|interferons|mesh-list
153678876|NCT00206635|Interferon-beta|interferon-beta|mesh-list
153678877|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
153678878|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678879|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
153678880|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678881|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
153678882|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487998|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488000|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
153488001|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153488002|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153488003|NCT02054754|Hormones|hormones|mesh-ancestor
153488004|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488005|NCT02057640|Dexamethasone|dexamethasone|mesh-list
153488006|NCT02057640|Ixazomib|ixazomib|mesh-list
153488007|NCT02057640|Panobinostat|panobinostat|mesh-list
153488008|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775078|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
153775079|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153775080|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153775081|NCT00221390|Ropinirole|ropinirole|mesh-list
153775082|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153775083|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153775123|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153775124|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
153775125|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775126|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775127|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678884|NCT00206674|Sargramostim|sargramostim|mesh-list
153678904|NCT00068523|Cyclosporine|cyclosporine|mesh-list
153678905|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
153678906|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
153370132|NCT03096041|Analgesics|analgesics|mesh-list
153678907|NCT00068523|Fludarabine|fludarabine|mesh-list
153678908|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
153678909|NCT00068523|Cyclosporins|cyclosporins|mesh-list
153678910|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153678911|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678912|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
153678913|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678914|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678915|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153678916|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
153678917|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678918|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678919|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153488019|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
153775128|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775129|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153775130|NCT00563095|Interferons|interferons|mesh-list
153775131|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775132|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
153775190|NCT06178159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775191|NCT06178159|Immunoconjugates|immunoconjugates|mesh-ancestor
153775192|NCT06178159|Immunologic Factors|immunologic factors|mesh-ancestor
153775193|NCT06178159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775194|NCT06178146|Mycophenolic Acid|mycophenolic acid|mesh-list
153775195|NCT06178146|Prednisone|prednisone|mesh-list
153775196|NCT06178146|Cortisone|cortisone|mesh-list
153775197|NCT06178146|Tacrolimus|tacrolimus|mesh-list
153775198|NCT06178146|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153775199|NCT06178146|Thymalfasin|thymalfasin|mesh-list
153775200|NCT06178146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775201|NCT06178146|Glucocorticoids|glucocorticoids|mesh-ancestor
153775202|NCT06178146|Hormones|hormones|mesh-ancestor
153775203|NCT06178146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775204|NCT06178146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775205|NCT06178146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153775206|NCT06178146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775249|NCT06177496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775250|NCT06177444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153775251|NCT06177444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153775252|NCT06177405|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
153775253|NCT06177405|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153775254|NCT06177405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153775255|NCT06177405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775256|NCT06177405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775257|NCT06177405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775258|NCT06177288|Bevacizumab|bevacizumab|mesh-list
153775259|NCT06177288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775266|NCT06177249|Vaccines|vaccines|mesh-list
153775311|NCT06177028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153775312|NCT06177028|Growth Substances|growth substances|mesh-ancestor
153775313|NCT06177028|Growth Inhibitors|growth inhibitors|mesh-ancestor
153775314|NCT06177028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775315|NCT06176976|Lugol's solution|lugol's solution|mesh-list
153678920|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153678921|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
153678922|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678923|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
153678924|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678925|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
153678926|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153678927|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678928|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
153678929|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
153678930|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678931|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153678932|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
153678933|NCT00068523|Hormones|hormones|mesh-ancestor
153678934|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678935|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153678936|NCT00068523|Protective Agents|protective agents|mesh-ancestor
153678937|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
153678938|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153678968|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
153678969|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
153488034|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488035|NCT02061384|Calcitriol|calcitriol|mesh-list
153488036|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153488037|NCT02061384|Tretinoin|tretinoin|mesh-list
153488038|NCT02061384|Isotretinoin|isotretinoin|mesh-list
153488039|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488040|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
153488041|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
153488042|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153488043|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488044|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153488045|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488047|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153678970|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
153678971|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678972|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153678973|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678975|NCT00206986|Analgesics|analgesics|mesh-ancestor
153678976|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
153678977|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678978|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678979|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153678980|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
153678981|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
153678982|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153678983|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153678984|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153678985|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
153679018|NCT00040391|Irinotecan|irinotecan|mesh-list
153679019|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
153679020|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679021|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679022|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679023|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153488055|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488056|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488057|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
153488058|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
153488059|NCT02062710|Promethazine|promethazine|mesh-list
153488060|NCT02062710|Phenylephrine|phenylephrine|mesh-list
153488061|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
153488062|NCT02062710|Levomethorphan|levomethorphan|mesh-list
153488072|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
153488073|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153488074|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153488075|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153488076|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488077|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775316|NCT06176976|Hemostatics|hemostatics|mesh-ancestor
153775317|NCT06176976|Coagulants|coagulants|mesh-ancestor
153679024|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
153418261|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153418262|NCT00373646|Thalidomide|thalidomide|mesh-list
153418263|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153418264|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
153418265|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679025|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679026|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153679027|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679079|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679080|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679081|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679082|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679083|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679084|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
153679085|NCT00072930|Hormones|hormones|mesh-ancestor
153679086|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679087|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679088|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153679089|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153679090|NCT00411307|Hydromorphone|hydromorphone|mesh-list
153679091|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153679092|NCT00411307|Narcotics|narcotics|mesh-ancestor
153679093|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679094|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679095|NCT00411307|Analgesics|analgesics|mesh-ancestor
153679096|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
153679097|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679098|NCT00040508|Sirolimus|sirolimus|mesh-list
153679099|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153488087|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153488088|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153488089|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
153488090|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
153775318|NCT06176937|Hyaluronic Acid|hyaluronic acid|mesh-list
153775319|NCT06176937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153775320|NCT06176937|Immunologic Factors|immunologic factors|mesh-ancestor
153775321|NCT06176937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775322|NCT06176937|Viscosupplements|viscosupplements|mesh-ancestor
153775323|NCT06176937|Protective Agents|protective agents|mesh-ancestor
153775324|NCT06176911|Teriflunomide|teriflunomide|mesh-list
153775374|NCT06167057|Gemcitabine|gemcitabine|mesh-list
153775376|NCT06167057|Mitomycin|mitomycin|mesh-list
153775377|NCT06167057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153775378|NCT06167057|Antimetabolites|antimetabolites|mesh-ancestor
153775379|NCT06167057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775380|NCT06167057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775381|NCT06167057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153775383|NCT06167057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153679100|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679101|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153679102|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679103|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
153679104|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679105|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
153679106|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679107|NCT00424411|Insulin|insulin|mesh-list
153679108|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153679109|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679110|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679111|NCT00072969|Daclizumab|daclizumab|mesh-list
153679112|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679113|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
153679114|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679115|NCT00424606|Docetaxel|docetaxel|mesh-list
153679116|NCT00424606|Epirubicin|epirubicin|mesh-list
153679117|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679118|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679119|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679120|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679121|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679122|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153679123|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153679124|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153488112|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488113|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
153488114|NCT02134314|Complement C1s|complement c1s|mesh-list
153488115|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153488116|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153488117|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
153488118|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488119|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153488120|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153775384|NCT06167057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775385|NCT06166394|Bupivacaine|bupivacaine|mesh-list
153775386|NCT06166394|Anesthetics, Local|anesthetics, local|mesh-list
153775387|NCT06166394|Mepivacaine|mepivacaine|mesh-list
153775388|NCT06166394|Anesthetics|anesthetics|mesh-list
153775389|NCT06166394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775432|NCT06140186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153775433|NCT06140186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679125|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679127|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153679128|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
153679129|NCT02962921|Insulin|insulin|mesh-list
153679130|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153679131|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
153679152|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679153|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
153679154|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679155|NCT00208117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153679156|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153679157|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679158|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679159|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
153679160|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877503|NCT05717049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877504|NCT05717049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153830174|NCT00496223|Sunitinib|sunitinib|mesh-list
153679161|NCT00208156|Mifepristone|mifepristone|mesh-list
153679162|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153679163|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
153679164|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153679165|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679166|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153679167|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153516069|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
153488140|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
153488141|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
153679168|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153679169|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
153679170|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153679171|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153679172|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
153679173|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679174|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
153679175|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153679176|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153679178|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679179|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679180|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679181|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153679182|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153679183|NCT00208195|Valproic Acid|valproic acid|mesh-list
153679184|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
153679240|NCT00208546|Bevacizumab|bevacizumab|mesh-list
153679241|NCT00208546|Cetuximab|cetuximab|mesh-list
153679243|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
153679244|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153679245|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488164|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488165|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488166|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488167|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679246|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153679247|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153679248|NCT00208546|Growth Substances|growth substances|mesh-ancestor
153679249|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679250|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
153679251|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679252|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
153679253|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679255|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
153679256|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679257|NCT00208585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153679258|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153679259|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679260|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679261|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679262|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
153679263|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679264|NCT00040859|Capecitabine|capecitabine|mesh-list
153679265|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
153679266|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679267|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
153679268|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679269|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679270|NCT00208702|Sertraline|sertraline|mesh-list
153679271|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
153679272|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679273|NCT00208702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153679274|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153679275|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488183|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488184|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488186|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488188|NCT02156154|Acetaminophen|acetaminophen|mesh-list
153775434|NCT06140186|Glucocorticoids|glucocorticoids|mesh-ancestor
153775435|NCT06140186|Hormones|hormones|mesh-ancestor
153459076|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679305|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679308|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153679309|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679310|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679311|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153679312|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
153679313|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
153679314|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
153679315|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679316|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153679317|NCT00208819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153679318|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153679319|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679345|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679346|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679347|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679348|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
153679349|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679350|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153679351|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
153679352|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679353|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153679354|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153679355|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679356|NCT00208936|Fluorouracil|fluorouracil|mesh-list
153679357|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679358|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
153679388|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153679389|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153679390|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153679391|NCT00041054|Analgesics|analgesics|mesh-ancestor
153679392|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
153679393|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679394|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679395|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153679396|NCT00209209|Interferons|interferons|mesh-list
153679397|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
153679398|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
153679400|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
153679401|NCT00209209|Rituximab|rituximab|mesh-list
153679402|NCT00209209|Doxorubicin|doxorubicin|mesh-list
153679403|NCT00209209|Fludarabine|fludarabine|mesh-list
153679404|NCT00209209|Vincristine|vincristine|mesh-list
153679405|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679406|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
153679407|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679408|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153679409|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153679411|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679412|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679413|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153679414|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153679457|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679459|NCT00209521|Fospropofol|fospropofol|mesh-list
153830202|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153679460|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153679461|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679462|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679463|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153679464|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
153679465|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
153679466|NCT00209638|Irinotecan|irinotecan|mesh-list
153679467|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153679468|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679470|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679471|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679472|NCT00399126|Paclitaxel|paclitaxel|mesh-list
153679473|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153679474|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679475|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679476|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679477|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679478|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679479|NCT00209677|Gemcitabine|gemcitabine|mesh-list
153679480|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679481|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
153679482|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679529|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
153679530|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679531|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153679532|NCT00041210|Prednisone|prednisone|mesh-list
153679533|NCT00041210|Doxorubicin|doxorubicin|mesh-list
153679534|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153679535|NCT00041210|Bleomycin|bleomycin|mesh-list
153679536|NCT00041210|Etoposide|etoposide|mesh-list
153679537|NCT00041210|Vincristine|vincristine|mesh-list
153679538|NCT00041210|Dacarbazine|dacarbazine|mesh-list
153679539|NCT00041210|Vinblastine|vinblastine|mesh-list
153679573|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679575|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153679576|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153679577|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
153679578|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153679579|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153679614|NCT00041288|Fludarabine|fludarabine|mesh-list
153679615|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
153679616|NCT00041288|Tacrolimus|tacrolimus|mesh-list
153679617|NCT00041288|Cyclosporins|cyclosporins|mesh-list
153679618|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679619|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
153679620|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679621|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153679622|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153679686|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679687|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679688|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153679689|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
153679690|NCT00411541|Hormones|hormones|mesh-ancestor
153679691|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488402|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
153488403|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679692|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153516595|NCT01437007|TKM-080301|tkm-080301|mesh-list
153679693|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679694|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153679695|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679696|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679697|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679698|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679699|NCT00210379|Rituximab|rituximab|mesh-list
153679700|NCT00210379|Methotrexate|methotrexate|mesh-list
153679701|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153679702|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679703|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
153679704|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679705|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153679743|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679769|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679770|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679771|NCT00210574|Topiramate|topiramate|mesh-list
153679772|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
153679773|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679774|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679775|NCT00210691|Risperidone|risperidone|mesh-list
153679776|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153679777|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
153679778|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679779|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679780|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679781|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153679782|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153679783|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679784|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679785|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153679786|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
153679787|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
153679788|NCT00210730|Hematinics|hematinics|mesh-ancestor
153679789|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153679790|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153679791|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153679792|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679793|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679794|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679828|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153679829|NCT00210925|Topiramate|topiramate|mesh-list
153679830|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
153679831|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679832|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679833|NCT00211003|Doripenem|doripenem|mesh-list
153679834|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153679835|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679836|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
153679860|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153679861|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679862|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679863|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153679864|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
153679865|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679866|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679867|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153679868|NCT00211432|Anecortave|anecortave|mesh-list
153679869|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153679870|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153679871|NCT00211432|Growth Substances|growth substances|mesh-ancestor
153679872|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679873|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
153679874|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679875|NCT00211471|Anecortave|anecortave|mesh-list
153679878|NCT00211471|Growth Substances|growth substances|mesh-ancestor
153679880|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
153679881|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679882|NCT00211588|Galantamine|galantamine|mesh-list
153679883|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153679884|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679885|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679886|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
153679887|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679916|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153679917|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679918|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
153516823|NCT05578859|Sotorasib|sotorasib|mesh-list
153679919|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
153679920|NCT00211978|Calcium|calcium|mesh-list
153679921|NCT00211978|Calcium acetate|calcium acetate|mesh-list
153679922|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153679923|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679924|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
153679925|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
153679926|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679927|NCT00212017|Voglibose|voglibose|mesh-list
153679928|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679929|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679930|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153679931|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679932|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679933|NCT00212095|Ketoconazole|ketoconazole|mesh-list
153679969|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679970|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679971|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679993|NCT02966730|Ibrutinib|ibrutinib|mesh-list
153679998|NCT00212680|Landiolol|landiolol|mesh-list
153680004|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680005|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153680007|NCT00212875|Hematinics|hematinics|mesh-ancestor
153680008|NCT00213070|Miglitol|miglitol|mesh-list
153680009|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680010|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680011|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153680012|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680013|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153680014|NCT00213109|Miglitol|miglitol|mesh-list
153680015|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680016|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680017|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153680018|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680019|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153680020|NCT00213226|Dexamethasone|dexamethasone|mesh-list
153680021|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153680022|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
153680023|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
153680043|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
153680044|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680045|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680046|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
153680047|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680048|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153680049|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153680050|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
153680051|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680052|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153680053|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
153680054|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153680055|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153680056|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680057|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
153680062|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680063|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
153680064|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
153680065|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
153680066|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680067|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153680068|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153680069|NCT00213694|Analgesics|analgesics|mesh-ancestor
153680070|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
153680071|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680072|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680073|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153680074|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680075|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153680148|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153680185|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153680186|NCT00214942|Narcotics|narcotics|mesh-ancestor
153680274|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153680275|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153680276|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153680277|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680278|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680279|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680280|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
153680281|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153680311|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680312|NCT00215839|Ribavirin|ribavirin|mesh-list
153680313|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
153680314|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680315|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
153680316|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680317|NCT00215956|Topotecan|topotecan|mesh-list
153680318|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153680319|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153680320|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680321|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680322|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680323|NCT00215995|Cisplatin|cisplatin|mesh-list
153680324|NCT00215995|Irinotecan|irinotecan|mesh-list
153680325|NCT00215995|Gefitinib|gefitinib|mesh-list
153680326|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680327|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153680361|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
153680363|NCT00216112|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153680399|NCT00216346|Paromomycin|paromomycin|mesh-list
153680400|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153680401|NCT00216346|Amebicides|amebicides|mesh-ancestor
153736446|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
153680402|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153680403|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153680404|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680405|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153680406|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
153680408|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153680409|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680410|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153680411|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153680412|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153680413|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153680414|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680415|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680416|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680417|NCT00216424|Capecitabine|capecitabine|mesh-list
153680418|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680419|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
153680420|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680421|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680422|NCT00216463|Mipomersen|mipomersen|mesh-list
153680423|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153680424|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153680425|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
153680426|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680444|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680445|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680446|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680447|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153680448|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153680452|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
153680456|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680457|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680458|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153680459|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
153680460|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153680462|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680463|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680464|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153680465|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
153680466|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
153680467|NCT00041561|Protective Agents|protective agents|mesh-ancestor
153680468|NCT00216619|Topiramate|topiramate|mesh-list
153680469|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
153680470|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153680471|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680472|NCT00216658|Fentanyl|fentanyl|mesh-list
153680473|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153680474|NCT00216658|Narcotics|narcotics|mesh-ancestor
153680475|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680476|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680477|NCT00216658|Analgesics|analgesics|mesh-ancestor
153680478|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
153680479|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680480|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153680481|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153680482|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
153680483|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
153680484|NCT00216697|Bortezomib|bortezomib|mesh-list
153680485|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680486|NCT00216775|Interferons|interferons|mesh-list
153680506|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680507|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153680508|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
153680509|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
153680510|NCT00216931|Iloprost|iloprost|mesh-list
153680511|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153680512|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
153517427|NCT01439438|Topiramate|topiramate|mesh-list
153680513|NCT00217009|Furocoumarins|furocoumarins|mesh-list
153680515|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153680516|NCT00217048|Yohimbine|yohimbine|mesh-list
153680517|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
153680518|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
153680519|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680520|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680521|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153680522|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153680523|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153680524|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680525|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680526|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680527|NCT00217048|Urological Agents|urological agents|mesh-ancestor
153680528|NCT00217204|Pancrelipase|pancrelipase|mesh-list
153680529|NCT00217204|Pancreatin|pancreatin|mesh-list
153680530|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153680531|NCT00412126|Insulin|insulin|mesh-list
153680532|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153680533|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680625|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680627|NCT00217828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153680628|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153680629|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153680630|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680631|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680641|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680642|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680643|NCT00073437|Infliximab|infliximab|mesh-list
153680644|NCT00073437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153680645|NCT00073437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153680646|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
153680647|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153680648|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680649|NCT00218101|Buprenorphine|buprenorphine|mesh-list
153680650|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153680651|NCT00218101|Narcotics|narcotics|mesh-ancestor
153680652|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680653|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680654|NCT00218101|Analgesics|analgesics|mesh-ancestor
153680655|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
153680656|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680657|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153680658|NCT00218140|Nicotine|nicotine|mesh-list
153680659|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153680660|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
153680662|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680663|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153680664|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153680665|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
153680666|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680667|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680668|NCT00042029|Aprepitant|aprepitant|mesh-list
153680669|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
153680670|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
153680671|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680672|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680673|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153680674|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153680675|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680676|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680677|NCT00218218|Nicotine|nicotine|mesh-list
153680678|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153680679|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
153680680|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680681|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680682|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153680683|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153680684|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
153680685|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680686|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680687|NCT00218374|Gabapentin|gabapentin|mesh-list
153680730|NCT00218569|Naltrexone|naltrexone|mesh-list
153680737|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153680738|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153680739|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680740|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680761|NCT00219076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680762|NCT00219076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680764|NCT00219115|Renin Inhibitors|renin inhibitors|mesh-ancestor
153680765|NCT00219115|Protease Inhibitors|protease inhibitors|mesh-ancestor
153680766|NCT00219115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680767|NCT00219115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680769|NCT00219154|Renin Inhibitors|renin inhibitors|mesh-ancestor
153680770|NCT00219154|Protease Inhibitors|protease inhibitors|mesh-ancestor
153680771|NCT00219154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680772|NCT00219154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680877|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680878|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153680879|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
153680880|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
153680881|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153680903|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153680904|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
153680905|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680906|NCT00219973|Bemiparin|bemiparin|mesh-list
153680907|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
153680908|NCT00220051|Capecitabine|capecitabine|mesh-list
153680909|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
153680910|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680911|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
153680912|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680913|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680914|NCT00077415|Gemcitabine|gemcitabine|mesh-list
153680915|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680916|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
153680917|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680918|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680974|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680975|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680976|NCT00077454|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153680977|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153680978|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680979|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153680980|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153680981|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153680982|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153681011|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681012|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
153681013|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153681014|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
153681015|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681016|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
153681018|NCT00220480|Escitalopram|escitalopram|mesh-list
153681019|NCT00220480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153681063|NCT00220987|Insulin|insulin|mesh-list
153681149|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153681150|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681151|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
153681152|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681153|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153681154|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681181|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
153518100|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153681182|NCT00077532|Ipilimumab|ipilimumab|mesh-list
153681183|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
153681184|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153681185|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681186|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153681187|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681188|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153681189|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
153681190|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681191|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153681192|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153681246|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681247|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153681248|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153681249|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153681250|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153681278|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153681279|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153681280|NCT00043004|Growth Substances|growth substances|mesh-ancestor
153681281|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681282|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
153681283|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153681284|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
153681285|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681286|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681287|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681288|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
153681289|NCT00043004|Antidotes|antidotes|mesh-ancestor
153681290|NCT00043004|Protective Agents|protective agents|mesh-ancestor
153681291|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
153681292|NCT00043004|Vitamins|vitamins|mesh-ancestor
153681293|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
153681294|NCT00123331|Cyclosporine|cyclosporine|mesh-list
153681295|NCT00123331|Sirolimus|sirolimus|mesh-list
153681296|NCT00123331|Cyclosporins|cyclosporins|mesh-list
153681297|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681298|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681299|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681330|NCT00077805|Enoxaparin|enoxaparin|mesh-list
153681331|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
153681332|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
153681333|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153681334|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153681335|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681336|NCT00043082|Carboplatin|carboplatin|mesh-list
153681337|NCT00043082|Doxorubicin|doxorubicin|mesh-list
153681338|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153681339|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681340|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153681341|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153681361|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153681362|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
153681363|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
153681364|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153681365|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153681366|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153681367|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153681368|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
153681369|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681370|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681371|NCT02970539|Paclitaxel|paclitaxel|mesh-list
153681372|NCT02970539|Ramucirumab|ramucirumab|mesh-list
153681373|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153681374|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681375|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
153681376|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
153681377|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
153681378|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681379|NCT02970539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153681381|NCT02970539|Growth Substances|growth substances|mesh-ancestor
153681423|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153681424|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153681425|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153681426|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681427|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681429|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
153681430|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681431|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681432|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153681433|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
153681434|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681435|NCT00073905|Gemcitabine|gemcitabine|mesh-list
153681436|NCT00073905|Capecitabine|capecitabine|mesh-list
153681437|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681438|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
153681439|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681440|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681441|NCT00124267|Quinine|quinine|mesh-list
153681442|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
153681443|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153681444|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153681445|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681446|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153681447|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681448|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153681467|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681468|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
153681469|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681470|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681471|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681472|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
153681485|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681486|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
153681487|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681488|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153681489|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681490|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681491|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153681492|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153681493|NCT00402415|Growth Substances|growth substances|mesh-ancestor
153681494|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
153681495|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153681496|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153681497|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681498|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153681499|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681500|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681501|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681502|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
153681503|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681504|NCT00124306|Amitriptyline|amitriptyline|mesh-list
153681505|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153681506|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
153681536|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153681537|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
153681538|NCT00124696|Cocaethylene|cocaethylene|mesh-list
153681539|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153681543|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
153681573|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153681574|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153681575|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681576|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681579|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
153681580|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681581|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681582|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153681583|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153681584|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153681585|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681586|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153681587|NCT00124930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153681588|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681589|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681590|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681591|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681592|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
153681593|NCT00124969|Amlodipine|amlodipine|mesh-list
153681594|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153681595|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153681596|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681597|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681598|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153681599|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681650|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153681681|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681682|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153681683|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153681684|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153681685|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
153681686|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681687|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681688|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153681689|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153681690|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
153681691|NCT00125905|Bupropion|bupropion|mesh-list
153681692|NCT00125905|Nicotine|nicotine|mesh-list
153681693|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153681708|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
153681709|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153681710|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153681711|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681712|NCT00078117|Buprenorphine|buprenorphine|mesh-list
153681713|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153681714|NCT00078117|Narcotics|narcotics|mesh-ancestor
153681715|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681716|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681747|NCT00126022|Protective Agents|protective agents|mesh-ancestor
153681748|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681749|NCT00402454|Rifampin|rifampin|mesh-list
153681750|NCT00402454|Isoniazid|isoniazid|mesh-list
153681751|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
153681752|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153681753|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
153681786|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153681787|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153681788|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153681789|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153681790|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
153681791|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681792|NCT00402532|Everolimus|everolimus|mesh-list
153681818|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681819|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153681820|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153681821|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
153681822|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681823|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681824|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153681825|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
153681826|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681827|NCT00126100|Lenograstim|lenograstim|mesh-list
153681828|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153681829|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
153681831|NCT00123253|Tesamorelin|tesamorelin|mesh-list
153681882|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153681883|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153681884|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153681885|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681886|NCT00126373|Bupropion|bupropion|mesh-list
153681887|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153681888|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
153681889|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153681890|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153681915|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681916|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681917|NCT00126607|Trastuzumab|trastuzumab|mesh-list
153682021|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682022|NCT00399477|Levodopa|levodopa|mesh-list
153682023|NCT00399477|Pramipexole|pramipexole|mesh-list
153682024|NCT00399477|Rasagiline|rasagiline|mesh-list
153682025|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153682026|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153682027|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
153682028|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682029|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682030|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682031|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153682032|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682033|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153682034|NCT00399477|Protective Agents|protective agents|mesh-ancestor
153682035|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
153682036|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
153682037|NCT00127270|Darifenacin|darifenacin|mesh-list
153682038|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153682072|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682073|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
153682074|NCT00043862|Topotecan|topotecan|mesh-list
153682075|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153682160|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
153682161|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682162|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153682163|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
153682164|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
153682165|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682166|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682167|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153682168|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
153682181|NCT00127972|Stavudine|stavudine|mesh-list
153682182|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153682183|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153682184|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682185|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682186|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
153682187|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682188|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153682189|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153682190|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153682191|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153682192|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153682222|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153682223|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153682224|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153682225|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682226|NCT00044135|Clevudine|clevudine|mesh-list
153682227|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
153682228|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682229|NCT00078195|Omalizumab|omalizumab|mesh-list
153682230|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
153682255|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153682256|NCT00078234|Rituximab|rituximab|mesh-list
153682257|NCT00078234|Fludarabine|fludarabine|mesh-list
153682258|NCT00078234|Oblimersen|oblimersen|mesh-list
153682259|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153682260|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682261|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
153682262|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682263|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682264|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
153682265|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682266|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682267|NCT00078351|Hylan|hylan|mesh-list
153682268|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
153682271|NCT00044447|Glimepiride|glimepiride|mesh-list
153682318|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682319|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682320|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153682321|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153682322|NCT00044564|IDN 5109|idn 5109|mesh-list
153682323|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682324|NCT00078546|Antibodies|antibodies|mesh-list
153682325|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153682326|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
153682327|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682328|NCT00044642|Lorazepam|lorazepam|mesh-list
153682329|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
153682330|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
153682331|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
153682332|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682333|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682334|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153682335|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153682363|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
153682364|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682365|NCT00403000|Dutasteride|dutasteride|mesh-list
153682366|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153682367|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153682368|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682369|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682370|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
153682371|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682372|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682373|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
153682374|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153682375|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682376|NCT00403039|Ranibizumab|ranibizumab|mesh-list
153682377|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153682415|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153682416|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153682417|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682418|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682419|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
153682420|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682421|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153682422|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
153682423|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153682424|NCT00074841|Azithromycin|azithromycin|mesh-list
153682425|NCT00074841|Chloroquine|chloroquine|mesh-list
153682448|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682449|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682450|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153682451|NCT00078975|Gemcitabine|gemcitabine|mesh-list
153682452|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682453|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
153682454|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682455|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682456|NCT04535557|Mobocertinib|mobocertinib|mesh-list
153682457|NCT04535557|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153682458|NCT04535557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153682459|NCT04535557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682460|NCT04535557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682461|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153682462|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
153682464|NCT00044837|Estrogens|estrogens|mesh-ancestor
153682503|NCT00397475|Vitamins|vitamins|mesh-ancestor
153682504|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
153682505|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153682506|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
153682507|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153682508|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153682509|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
153682510|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682511|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682512|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682513|NCT04263298|Capecitabine|capecitabine|mesh-list
153682514|NCT04263298|Fulvestrant|fulvestrant|mesh-list
153682515|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682516|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
153682517|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682518|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682519|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153682520|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153682521|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153682522|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
153682615|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153682616|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153682617|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
153682618|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682619|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682620|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682621|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153682622|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153682623|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
153682648|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682649|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682650|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153682651|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153682652|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153682653|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153682656|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153682657|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775436|NCT06140186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775437|NCT06140186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153612620|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153775438|NCT06140186|Respiratory System Agents|respiratory system agents|mesh-ancestor
153775439|NCT06100146|Folic Acid|folic acid|mesh-list
153775440|NCT06100146|Vitamin B 12|vitamin b 12|mesh-list
153775441|NCT06100146|Hydroxocobalamin|hydroxocobalamin|mesh-list
153775442|NCT06100146|Vitamins|vitamins|mesh-ancestor
153775443|NCT06100146|Micronutrients|micronutrients|mesh-ancestor
153775444|NCT06100146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775445|NCT06100146|Hematinics|hematinics|mesh-ancestor
153775446|NCT06100146|Vitamin B Complex|vitamin b complex|mesh-ancestor
153775447|NCT06097273|Vaccines|vaccines|mesh-list
153775491|NCT06035744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153775492|NCT06035744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775494|NCT06035536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153775495|NCT06035536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775496|NCT06017817|Anti-Infective Agents|anti-infective agents|mesh-list
153775497|NCT06015750|Folic Acid|folic acid|mesh-list
153775498|NCT06015750|Rituximab|rituximab|mesh-list
153775499|NCT06015750|Methotrexate|methotrexate|mesh-list
153775500|NCT06015750|Bortezomib|bortezomib|mesh-list
153775501|NCT06015750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775502|NCT06015750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775503|NCT06015750|Immunologic Factors|immunologic factors|mesh-ancestor
153370643|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
153775504|NCT06015750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775505|NCT06015750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153775506|NCT06015750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153775507|NCT06015750|Abortifacient Agents|abortifacient agents|mesh-ancestor
153459077|NCT05353062|Epinephrine|epinephrine|mesh-list
153682658|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682659|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153682660|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
153682661|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
153682662|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153682663|NCT03928366|Narcotics|narcotics|mesh-ancestor
153682664|NCT03928366|Analgesics|analgesics|mesh-ancestor
153682665|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
153682666|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682667|NCT00045422|Interferons|interferons|mesh-list
153682668|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
153682669|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
153682670|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682671|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
153682672|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682673|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
153682674|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682675|NCT00045422|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153682699|NCT00075231|Lamivudine|lamivudine|mesh-list
153682700|NCT00075231|Zidovudine|zidovudine|mesh-list
153682701|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153682702|NCT00075231|Efavirenz|efavirenz|mesh-list
153682703|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153682704|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153682705|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
153682757|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153682758|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
153682759|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153682760|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682761|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
153682762|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682763|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682764|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
153682765|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682766|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153682767|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682768|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
153682769|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682770|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153682771|NCT00045539|Antidotes|antidotes|mesh-ancestor
153682772|NCT00045539|Protective Agents|protective agents|mesh-ancestor
153682773|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
153682791|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153682792|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153682793|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
153682794|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682795|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682796|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153682797|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153682798|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153682799|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682800|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682802|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
153682803|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153682804|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153682805|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682806|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153682808|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
153682813|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
153682814|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682815|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682816|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153682817|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153682818|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153682819|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153682820|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153682821|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
153682822|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
153682823|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
153682824|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
153682825|NCT00079287|Paclitaxel|paclitaxel|mesh-list
153682826|NCT00079287|Vinorelbine|vinorelbine|mesh-list
153682827|NCT00079287|Docetaxel|docetaxel|mesh-list
153682828|NCT00079287|Carboplatin|carboplatin|mesh-list
153682829|NCT00079287|Gemcitabine|gemcitabine|mesh-list
153682830|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153682831|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682832|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
153682833|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
153682834|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
153682835|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682860|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153682861|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153682862|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
153682863|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682864|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153682865|NCT00079443|Rituximab|rituximab|mesh-list
153682866|NCT00079443|Fludarabine|fludarabine|mesh-list
153682867|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
153682868|NCT00079443|Romidepsin|romidepsin|mesh-list
153682875|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
153682882|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153682883|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153682884|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682885|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682897|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682899|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
153682900|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682901|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153682902|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153682903|NCT00079560|Analgesics|analgesics|mesh-ancestor
153682904|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
153682905|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682906|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153682907|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153682908|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682909|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682910|NCT00079560|Hormones|hormones|mesh-ancestor
153682911|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682912|NCT00046163|Midodrine|midodrine|mesh-list
153810791|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810792|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
153357389|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153418304|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
153877546|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
153830698|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
153682913|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
153682914|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
153682915|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682916|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682924|NCT00079638|Niacin|niacin|mesh-list
153682943|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
153682944|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153682945|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153682946|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153682975|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
153682976|NCT00130546|Sirolimus|sirolimus|mesh-list
153682977|NCT00130546|Paclitaxel|paclitaxel|mesh-list
153682978|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153682979|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682980|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
153682981|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
153682982|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
153682983|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682984|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682985|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682986|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153682987|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
153682988|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682989|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
153682991|NCT00130585|Folic Acid|folic acid|mesh-list
153683045|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683046|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683047|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683048|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153683084|NCT00131053|Methotrexate|methotrexate|mesh-list
153683085|NCT00131053|Vincristine|vincristine|mesh-list
153830728|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153830730|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830731|NCT00498953|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153830732|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153830733|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830734|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153830735|NCT00503126|Bivalirudin|bivalirudin|mesh-list
153830736|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
153830737|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153830738|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
153370792|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153370793|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153370794|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370795|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153370797|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
153370798|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153370799|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
153888240|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153683086|NCT00131053|Asparaginase|asparaginase|mesh-list
153683087|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
153683088|NCT00131053|Pirarubicin|pirarubicin|mesh-list
153683105|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683107|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153683108|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
153683109|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153683110|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153683111|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
153683112|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
153683113|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683114|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153683115|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153683116|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
153683117|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683118|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153683119|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683120|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683121|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683122|NCT00079911|Valacyclovir|valacyclovir|mesh-list
153683123|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
153683124|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683125|NCT00397592|Hormones|hormones|mesh-list
153683126|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683127|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683128|NCT00131326|Hylan|hylan|mesh-list
153683129|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
153683130|NCT00131326|Protective Agents|protective agents|mesh-ancestor
153683131|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775508|NCT06015750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153775509|NCT06015750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153612694|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153775510|NCT06015750|Antimetabolites|antimetabolites|mesh-ancestor
153775511|NCT06015750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683132|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
153683133|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153683134|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153683135|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683136|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683138|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683139|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683140|NCT00131443|Topiramate|topiramate|mesh-list
153683141|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
153683142|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153683143|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683180|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683181|NCT00131521|Protective Agents|protective agents|mesh-ancestor
153683208|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153683209|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
153683210|NCT00403663|Fentanyl|fentanyl|mesh-list
153683211|NCT00403663|Morphine|morphine|mesh-list
153683212|NCT00403663|Bupivacaine|bupivacaine|mesh-list
153683213|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
153775543|NCT05887609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153775544|NCT05887609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775545|NCT05887609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775546|NCT05887609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830759|NCT05145543|Analgesics|analgesics|mesh-ancestor
153830760|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
153830761|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153830762|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153830763|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
153830764|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
153830765|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
153830766|NCT00503204|Cediranib|cediranib|mesh-list
153775547|NCT05887609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153775548|NCT05887609|Tubulin Modulators|tubulin modulators|mesh-ancestor
153775549|NCT05887609|Antimitotic Agents|antimitotic agents|mesh-ancestor
153775550|NCT05887609|Mitosis Modulators|mitosis modulators|mesh-ancestor
153775552|NCT05887609|Immunologic Factors|immunologic factors|mesh-ancestor
153775553|NCT05887609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775555|NCT05837845|Hallucinogens|hallucinogens|mesh-ancestor
153775603|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
153775604|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775607|NCT05402111|Risperidone|risperidone|mesh-list
153775608|NCT05402111|Aripiprazole|aripiprazole|mesh-list
153775609|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153775610|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
153775611|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153775612|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
153775669|NCT05221645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153775670|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775671|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153775672|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153775673|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153775674|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153775676|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
153775677|NCT05136846|Paclitaxel|paclitaxel|mesh-list
153775678|NCT05136846|Carboplatin|carboplatin|mesh-list
153775681|NCT05136846|Durvalumab|durvalumab|mesh-list
153775682|NCT05136846|Papaverine|papaverine|mesh-list
153775683|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
153775684|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153775727|NCT05096169|Citric Acid|citric acid|mesh-list
153775728|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
153775729|NCT05096169|Clomiphene|clomiphene|mesh-list
153775730|NCT05096169|Enclomiphene|enclomiphene|mesh-list
153775731|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
153775799|NCT04970901|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153775800|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775801|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775802|NCT04970901|Immunoconjugates|immunoconjugates|mesh-ancestor
153775803|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
153775804|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775805|NCT04940013|Misoprostol|misoprostol|mesh-list
153775806|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153775807|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
153775808|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153775809|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775810|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153775811|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153775812|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
153775813|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
153775814|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153775860|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
153775861|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
153775862|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153775863|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153775864|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153775865|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153775866|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153775867|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153775868|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
153775869|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
153775870|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153775871|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
153775872|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
153775873|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775874|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153775875|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
153775876|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775918|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153775919|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153877547|NCT05672407|Coagulants|coagulants|mesh-ancestor
153370834|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
153775920|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153775922|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153775923|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
153775924|NCT04517435|Hormones|hormones|mesh-ancestor
153775925|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775926|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153775927|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153775928|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
153775929|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
153775930|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
153775931|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153775932|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153775933|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
153775934|NCT04398537|Hormones|hormones|mesh-ancestor
153775935|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153775936|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153775937|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153775938|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775971|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153775972|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775973|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153775974|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775975|NCT04283604|Methylphenidate|methylphenidate|mesh-list
153775976|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153775977|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776178|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153776239|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
153776240|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776241|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776242|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153776308|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153776309|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153776311|NCT03165994|Carboplatin|carboplatin|mesh-list
153776312|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776313|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776314|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776315|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776316|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776317|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776318|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
153776319|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153776320|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776321|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458773|NCT03585036|Narcotics|narcotics|mesh-ancestor
153776369|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153830826|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153830827|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153830828|NCT05145270|Protective Agents|protective agents|mesh-ancestor
153830829|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370866|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370867|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153370868|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370869|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
153370870|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370871|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776370|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776431|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
153776432|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
153776434|NCT02626338|Crenolanib|crenolanib|mesh-list
153776435|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776436|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153776437|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
153459078|NCT05353062|Hemostatics|hemostatics|mesh-list
153776441|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776497|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776498|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153776500|NCT02332902|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153776501|NCT02332902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776502|NCT02332902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776503|NCT02332902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776504|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776505|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
153776506|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776507|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776508|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153776509|NCT02324608|Cetuximab|cetuximab|mesh-list
153776510|NCT02324608|Antibodies|antibodies|mesh-list
153776511|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
153776512|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153776513|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
153776514|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776515|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776516|NCT02305654|Paclitaxel|paclitaxel|mesh-list
153776517|NCT02305654|Ifosfamide|ifosfamide|mesh-list
153776526|NCT02229084|Paclitaxel|paclitaxel|mesh-list
153776552|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153776553|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153776554|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776555|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776556|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
153776557|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
153776558|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776559|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153776560|NCT01750073|Paclitaxel|paclitaxel|mesh-list
153776561|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
153776562|NCT01750073|Doxorubicin|doxorubicin|mesh-list
153776563|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153776564|NCT01750073|Trastuzumab|trastuzumab|mesh-list
153776616|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153429335|NCT00002618|Hormones|hormones|mesh-ancestor
153370906|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153370907|NCT01720277|Vaccines|vaccines|mesh-list
153370908|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
153370909|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429336|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429337|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429338|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153830851|NCT05144295|Bisacodyl|bisacodyl|mesh-list
153830852|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
153830853|NCT05144295|Lubiprostone|lubiprostone|mesh-list
153830854|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153830855|NCT05144295|Cathartics|cathartics|mesh-ancestor
153830856|NCT05144295|Laxatives|laxatives|mesh-ancestor
153830857|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153830858|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153776617|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153776618|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153776619|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
153776620|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153776621|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153776623|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153776624|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153776625|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153776628|NCT01356628|Palbociclib|palbociclib|mesh-list
153776678|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
153776679|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153776680|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
153776681|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153776682|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153776683|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153776684|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153776685|NCT00254423|Dasatinib|dasatinib|mesh-list
153776686|NCT00254423|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153776687|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776688|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776689|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776690|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776741|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776743|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153776744|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
153776745|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776746|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
153776747|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776748|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153776749|NCT04614727|Calcium|calcium|mesh-list
153776750|NCT04614727|Fluorides|fluorides|mesh-list
153776751|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153776752|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776754|NCT04614727|Protective Agents|protective agents|mesh-ancestor
153776755|NCT04614298|Brodalumab|brodalumab|mesh-list
153776764|NCT00412763|Silymarin|silymarin|mesh-list
153776804|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776805|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
153776806|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153776807|NCT00251355|Gemcitabine|gemcitabine|mesh-list
153776808|NCT00251355|Fluorouracil|fluorouracil|mesh-list
153776809|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153776810|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
153776811|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776812|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776813|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776814|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
153776815|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776816|NCT02962388|Anagrelide|anagrelide|mesh-list
153776817|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153776821|NCT04613167|Evolocumab|evolocumab|mesh-list
153776864|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153776865|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776866|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
153776867|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370918|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
153370920|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776868|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776869|NCT00221975|Lamotrigine|lamotrigine|mesh-list
153776870|NCT00221975|Valproic Acid|valproic acid|mesh-list
153776871|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153614039|NCT01965626|Hormones|hormones|mesh-ancestor
153776872|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776873|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776874|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
153776875|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153776876|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776877|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776878|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
153776879|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153776880|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153776884|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
153776920|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776921|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
153776922|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153776923|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153776924|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153776925|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153776926|NCT00222053|Growth Substances|growth substances|mesh-ancestor
153776927|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
153776928|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776929|NCT00222053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153776930|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
153776931|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153776981|NCT04611685|Narcotics|narcotics|mesh-ancestor
153776982|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153776983|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776984|NCT04611685|Analgesics|analgesics|mesh-ancestor
153776985|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
153776986|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776987|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153776988|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153776989|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776990|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153776991|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153777044|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
153810795|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153357392|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357393|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
153830899|NCT01246622|Lenalidomide|lenalidomide|mesh-list
153830900|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830901|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
153830902|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830903|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830904|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
153830905|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830906|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153830907|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
153830908|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830909|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153830911|NCT01246622|Growth Substances|growth substances|mesh-ancestor
153777045|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153777046|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777047|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153777048|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153777049|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153777050|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777051|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153777052|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153777053|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153777054|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
153777055|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
153777056|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777057|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
153777063|NCT00222443|Irinotecan|irinotecan|mesh-list
153777104|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777105|NCT00564187|Irbesartan|irbesartan|mesh-list
153777106|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153777107|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153777108|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153777109|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777110|NCT00222677|Aspirin|aspirin|mesh-list
153777111|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153777112|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153777113|NCT00222677|Analgesics|analgesics|mesh-ancestor
153777114|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
153777115|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777116|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777163|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153777164|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153777165|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153777166|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153777167|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777168|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
153777169|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777229|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
153777230|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153777231|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153777232|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370969|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153370970|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370971|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370972|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
153370973|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370974|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830915|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830916|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830917|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
153830918|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830919|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830920|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
153830922|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830923|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153777233|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
153777234|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
153777235|NCT00199160|Sorafenib|sorafenib|mesh-list
153777236|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777237|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153777238|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777239|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777240|NCT04607629|Omalizumab|omalizumab|mesh-list
153777241|NCT04607629|Budesonide|budesonide|mesh-list
153777242|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
153777243|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153614416|NCT01968005|Analgesics|analgesics|mesh-ancestor
153777244|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153777253|NCT04607629|Hormones|hormones|mesh-ancestor
153777284|NCT00564655|Epinephrine|epinephrine|mesh-list
153777285|NCT00564655|Racepinephrine|racepinephrine|mesh-list
153777286|NCT00564655|Bupivacaine|bupivacaine|mesh-list
153777287|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
153777288|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
153777289|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
153777290|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777291|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777292|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
153777293|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777296|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
153777297|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777298|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777344|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153777345|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777346|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777349|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
153777350|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153777351|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153777352|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
153777353|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455663|NCT05367960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153830935|NCT01246817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153830936|NCT01246817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830937|NCT01246817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830938|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153830939|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
153830940|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830941|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830942|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153830943|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830944|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153830945|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
153830946|NCT00499538|Bosutinib|bosutinib|mesh-list
153830947|NCT00499538|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153830948|NCT00499538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153830949|NCT00499538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830950|NCT00499538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370992|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370994|NCT01337336|Xhance|xhance|mesh-list
153777354|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777355|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153777356|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153777357|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
153777358|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153777361|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153777404|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
153777405|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
153777406|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777407|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777408|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777409|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
153777410|NCT04603729|Hormones|hormones|mesh-ancestor
153777411|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777468|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153777469|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
153777470|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153777471|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153777472|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153777473|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153777474|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153777475|NCT00565240|Progestins|progestins|mesh-ancestor
153777535|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777536|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
153777537|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
153777538|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153777539|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153777540|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777541|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777544|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777545|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777546|NCT04601389|Omalizumab|omalizumab|mesh-list
153777547|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153777594|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153777595|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777596|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
153777597|NCT04599205|Coagulants|coagulants|mesh-ancestor
153777598|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
153777599|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
153777600|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777601|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777602|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777603|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
153777604|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153777605|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153777606|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777653|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153777654|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153777655|NCT04598542|Lorecivivint|lorecivivint|mesh-list
153777656|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153777657|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777658|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
153777721|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153777723|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153418366|NCT02791945|Protective Agents|protective agents|mesh-ancestor
153418367|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418368|NCT02791945|Antidotes|antidotes|mesh-ancestor
153418369|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153877579|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153877581|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153777724|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777725|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
153777726|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777728|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
153777729|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777730|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153777731|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
153777732|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
153777733|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153777781|NCT00566332|Chlorambucil|chlorambucil|mesh-list
153777782|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777783|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777784|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153777785|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
153777786|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
153777798|NCT04595929|Leucovorin|leucovorin|mesh-list
153777852|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153777853|NCT04635683|Growth Substances|growth substances|mesh-ancestor
153777854|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
153777855|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777856|NCT00249405|Citalopram|citalopram|mesh-list
153777857|NCT00249405|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153777858|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153777859|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153777860|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777861|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153777864|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153777865|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
153777866|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153777867|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
153777868|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153777869|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
153777870|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153777871|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777872|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153777873|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153777903|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
153777904|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153777905|NCT00566683|Narcotics|narcotics|mesh-ancestor
153361274|NCT00825344|Etanercept|etanercept|mesh-list
153777906|NCT00566683|Analgesics|analgesics|mesh-ancestor
153777907|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
153777908|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777909|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153777910|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
153615081|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
153777911|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
153777912|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
153777913|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777914|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153777915|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153777966|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153777967|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153777968|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153777969|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
153777970|NCT04593706|Hormones|hormones|mesh-ancestor
153777971|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153777972|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153777973|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153777974|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153777975|NCT04593706|Protective Agents|protective agents|mesh-ancestor
153877588|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
153777976|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153777977|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
153777978|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153777979|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153777980|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153777981|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
153778022|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
153778023|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778025|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153778026|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153778027|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778028|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
153778029|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778030|NCT04484363|Azacitidine|azacitidine|mesh-list
153778031|NCT04484363|Pevonedistat|pevonedistat|mesh-list
153778032|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153778033|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
153778034|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778035|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778036|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778037|NCT04592380|Clevidipine|clevidipine|mesh-list
153778038|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153778039|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153778040|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153778041|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153778042|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153778043|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778044|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778045|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153361282|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153778046|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778047|NCT00253188|Galantamine|galantamine|mesh-list
153778048|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153778067|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153778068|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778069|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778070|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
153778071|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153778072|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778073|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153778077|NCT04719585|Analgesics|analgesics|mesh-ancestor
153778131|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
153778132|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778133|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778134|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778136|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153778137|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778138|NCT04590742|Melatonin|melatonin|mesh-list
153778139|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
153778140|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778195|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778196|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153778197|NCT00567658|Esomeprazole|esomeprazole|mesh-list
153778198|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153778199|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153778200|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153778201|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778202|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778203|NCT00567697|Ranibizumab|ranibizumab|mesh-list
153615378|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778204|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778205|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153778258|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778259|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778260|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153778261|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778262|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778263|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153778264|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778265|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778266|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
153778267|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
153778268|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778269|NCT04588090|Cisplatin|cisplatin|mesh-list
153778270|NCT04588090|Paclitaxel|paclitaxel|mesh-list
153778271|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814352|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153778272|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153778273|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
153778274|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
153778275|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
153778319|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
153778320|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
153778321|NCT00403247|Pyridoxine|pyridoxine|mesh-list
153778322|NCT00403247|Vitamins|vitamins|mesh-ancestor
153778323|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
153778324|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778325|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
153778326|NCT00403247|Hematinics|hematinics|mesh-ancestor
153778327|NCT00253773|Acetaminophen|acetaminophen|mesh-list
153778383|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153778384|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455664|NCT05367960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418383|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153371117|NCT04343001|Analgesics|analgesics|mesh-ancestor
153371125|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371126|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371127|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153371128|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371129|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
153371130|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153371131|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153371132|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
153371133|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153371135|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153778385|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153778386|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153778387|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778388|NCT00223223|Levetiracetam|levetiracetam|mesh-list
153778389|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
153778390|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
153778391|NCT00567931|Tryptophan|tryptophan|mesh-list
153778392|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153778393|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
153778404|NCT04585321|Diclofenac|diclofenac|mesh-list
153778446|NCT00568048|Bevacizumab|bevacizumab|mesh-list
153778447|NCT00568048|Temozolomide|temozolomide|mesh-list
153778448|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387528|NCT00355277|Amitriptyline|amitriptyline|mesh-list
153778449|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778450|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778451|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153778452|NCT00568048|Growth Substances|growth substances|mesh-ancestor
153778453|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778454|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
153778455|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153778456|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
153778508|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
153778509|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778510|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778511|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153778512|NCT04584307|Growth Substances|growth substances|mesh-ancestor
153778513|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
153778514|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778515|NCT04584034|Albuterol|albuterol|mesh-list
153778516|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
153778517|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
153778518|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153778519|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778522|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
153778569|NCT00223691|Ibuprofen|ibuprofen|mesh-list
153778570|NCT00223691|Celecoxib|celecoxib|mesh-list
153778571|NCT00223691|Indomethacin|indomethacin|mesh-list
153831073|NCT06126419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831074|NCT06126419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831089|NCT06039566|Acetylcysteine|acetylcysteine|mesh-list
153371136|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153371137|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153371138|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153371139|NCT04743063|Losartan|losartan|mesh-list
153371140|NCT04743063|Valsartan|valsartan|mesh-list
153371141|NCT04743063|Telmisartan|telmisartan|mesh-list
153371142|NCT04743063|Candesartan|candesartan|mesh-list
153371143|NCT04743063|Olmesartan|olmesartan|mesh-list
153371144|NCT04743063|Irbesartan|irbesartan|mesh-list
153778572|NCT00223691|Octreotide|octreotide|mesh-list
153778573|NCT00223691|Phenylephrine|phenylephrine|mesh-list
153778574|NCT00223691|Acetazolamide|acetazolamide|mesh-list
153778575|NCT00223691|Midodrine|midodrine|mesh-list
153778576|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
153778577|NCT00223691|Ephedrine|ephedrine|mesh-list
153778578|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
153778579|NCT00223691|Ergotamine|ergotamine|mesh-list
153778580|NCT00223691|Bromides|bromides|mesh-list
153778581|NCT00223691|Levodopa|levodopa|mesh-list
153778582|NCT00223691|Carbidopa|carbidopa|mesh-list
153778583|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153778584|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
153778585|NCT00223691|Caffeine|caffeine|mesh-list
153778586|NCT00223691|Methylphenidate|methylphenidate|mesh-list
153778587|NCT00223691|Modafinil|modafinil|mesh-list
153778588|NCT00223691|Rivastigmine|rivastigmine|mesh-list
153778589|NCT00223691|Ranitidine|ranitidine|mesh-list
153778590|NCT00223691|Yohimbine|yohimbine|mesh-list
153778591|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153778592|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153778629|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153778630|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
153778631|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
153778632|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153778633|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
153778634|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
153778635|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153778698|NCT00223769|Androgens|androgens|mesh-ancestor
153778699|NCT00223769|Hormones|hormones|mesh-ancestor
153778700|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153778701|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778702|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
153778703|NCT04582084|Etanercept|etanercept|mesh-list
153778704|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153778705|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153778706|NCT04582084|Analgesics|analgesics|mesh-ancestor
153778707|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
153778764|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778765|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
153778766|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778767|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153778768|NCT00568711|Doxycycline|doxycycline|mesh-list
153778769|NCT00568711|Rifampin|rifampin|mesh-list
153778770|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153778771|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778772|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
153778773|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153778829|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153778830|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
153778831|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153778832|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778833|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778834|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153778835|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153778836|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153778837|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778895|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153778896|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778897|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153778898|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153736450|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153736451|NCT02420847|Ixazomib|ixazomib|mesh-list
153736452|NCT02420847|Glycine|glycine|mesh-list
153778899|NCT00254319|Growth Substances|growth substances|mesh-ancestor
153778900|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778901|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
153778902|NCT00569452|Insulin|insulin|mesh-list
153778903|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153778904|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153778905|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778906|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
153778907|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
153778908|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153778909|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153778917|NCT00224471|Vaccines|vaccines|mesh-list
153778954|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778956|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153778957|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153778958|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
153778959|NCT00224549|Amlodipine|amlodipine|mesh-list
153778960|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153778962|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153778963|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153778964|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153778965|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153778966|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153778967|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153778968|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
153778969|NCT00224549|Diuretics|diuretics|mesh-ancestor
153778970|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
153778988|NCT00224588|Ketamine|ketamine|mesh-list
153736453|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153361354|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
153814355|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815082|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153779012|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153779013|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779014|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153779015|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153779016|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153779018|NCT00570856|Hematinics|hematinics|mesh-ancestor
153779019|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
153779020|NCT00570856|Vitamins|vitamins|mesh-ancestor
153779021|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
153779022|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779023|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
153779024|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
153779025|NCT00570934|Vitamin D|vitamin d|mesh-list
153779026|NCT00570934|Calcium|calcium|mesh-list
153779027|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153779028|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779029|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153779072|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
153779073|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779075|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
153779076|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
153779077|NCT00571285|Vitamins|vitamins|mesh-list
153779078|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
153779079|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779080|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153779081|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153779082|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153779108|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779111|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
153779112|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153779113|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779114|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153779173|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779174|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779175|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
153779176|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779177|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153779178|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
153779179|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779188|NCT00572299|Alendronate|alendronate|mesh-list
153831127|NCT05915104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779235|NCT00572689|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153779236|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153779237|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779238|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153779239|NCT00572689|Incretins|incretins|mesh-ancestor
153779240|NCT00572689|Hormones|hormones|mesh-ancestor
153779241|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779242|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
153779243|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153779244|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779245|NCT00224978|Chloroquine|chloroquine|mesh-list
153779246|NCT00224978|Amebicides|amebicides|mesh-ancestor
153779247|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153779248|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153779249|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779250|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
153779251|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153779252|NCT00572884|Permethrin|permethrin|mesh-list
153779291|NCT00225056|Capecitabine|capecitabine|mesh-list
153779292|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779293|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
153779294|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
153779295|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
153779296|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779297|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153779299|NCT00225173|Prednisone|prednisone|mesh-list
153779300|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
153779301|NCT00225173|Gemcitabine|gemcitabine|mesh-list
153779358|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153779359|NCT00225290|Thalidomide|thalidomide|mesh-list
153779360|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153779361|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
153779362|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779363|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
153779364|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153779365|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779366|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153779367|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153779368|NCT00225290|Growth Substances|growth substances|mesh-ancestor
153779369|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
153779370|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779371|NCT00573547|Fluoxetine|fluoxetine|mesh-list
153779372|NCT00573547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153779373|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153779374|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779375|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779376|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779377|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
153779413|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779414|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153779415|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153779416|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153779417|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153779459|NCT00574366|Everolimus|everolimus|mesh-list
153779460|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153779461|NCT00574366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153779462|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153779463|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153779464|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779465|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153779466|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
153779467|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779468|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779469|NCT00574366|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153779470|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153779471|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153779520|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779521|NCT00255255|Budesonide|budesonide|mesh-list
153779522|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
153779523|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779524|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153779525|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
153779526|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779527|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779528|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153779529|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
153779530|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
153779531|NCT00255255|Hormones|hormones|mesh-ancestor
153779532|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779533|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153779534|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153779539|NCT00574756|Ranolazine|ranolazine|mesh-list
153779577|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779578|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153779579|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
153779580|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153779581|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817611|NCT06186388|TEMPO|tempo|mesh-list
153779582|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
153779583|NCT00255372|Lactulose|lactulose|mesh-list
153779584|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153779585|NCT00225914|Paroxetine|paroxetine|mesh-list
153779586|NCT00225914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153779587|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153779590|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779639|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779640|NCT03451435|Antidotes|antidotes|mesh-ancestor
153779641|NCT04575064|Remdesivir|remdesivir|mesh-list
153779642|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
153779643|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779710|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153779711|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153779712|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
153779713|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779714|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779723|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
153779778|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153779779|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
153779781|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779782|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153779783|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153779784|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779785|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779786|NCT00226382|Interferons|interferons|mesh-list
153814362|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779787|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
153779796|NCT01580839|Plasminogen|plasminogen|mesh-list
153779844|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153779846|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
153779847|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153779848|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153779849|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153779850|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
153779852|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
153779853|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779854|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810798|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
153831198|NCT05750264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779855|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153779908|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153779909|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153779910|NCT00226538|Analgesics|analgesics|mesh-ancestor
153779911|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
153779912|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153779913|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779914|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153779915|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153779918|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779919|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153779920|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
153779921|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153779922|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153779923|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
153779924|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153779925|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153779926|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153779927|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153779928|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153779929|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153779930|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153779931|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
153779952|NCT00226694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153779953|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153779954|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153779955|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779956|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153779957|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
153779958|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779959|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153779960|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
153780018|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780020|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
153780021|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
153780022|NCT00198133|Pemetrexed|pemetrexed|mesh-list
153780023|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780070|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
153780071|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
153780073|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780074|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153780075|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153780076|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780077|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780078|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153780079|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
153780080|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780134|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
153780135|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780136|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780138|NCT00227942|Estrogens|estrogens|mesh-list
153780139|NCT00227942|Hormones|hormones|mesh-ancestor
153780140|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780141|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780142|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153780143|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153831240|NCT05555732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831241|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831242|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831243|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153831245|NCT05480111|Anesthetics|anesthetics|mesh-list
153780144|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780145|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153780146|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
153780147|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
153780148|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780149|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780150|NCT00227981|Fluoxetine|fluoxetine|mesh-list
153780151|NCT00227981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153780152|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153780153|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153780154|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780155|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780156|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
153780157|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780158|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153780159|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
153780160|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153780161|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153780162|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153780164|NCT00236028|Infliximab|infliximab|mesh-list
153780176|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
153780177|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780178|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153780179|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153780180|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153780182|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780183|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
153780184|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153780185|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153780187|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
153780188|NCT00228020|Prednisone|prednisone|mesh-list
153780189|NCT00228020|Cyclosporins|cyclosporins|mesh-list
153780190|NCT00228020|Basiliximab|basiliximab|mesh-list
153780191|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780192|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
153780193|NCT00228020|Hormones|hormones|mesh-ancestor
153780194|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780195|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780196|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153780229|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153780231|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780232|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780235|NCT00236145|Fentanyl|fentanyl|mesh-list
153780299|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153780300|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
153780301|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780302|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780303|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831264|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153831266|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
153780304|NCT00228488|Gefitinib|gefitinib|mesh-list
153780305|NCT00228488|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153780306|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153780307|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780308|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780309|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814368|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780310|NCT00228527|Esomeprazole|esomeprazole|mesh-list
153780311|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153780312|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780357|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153780358|NCT00228839|Infliximab|infliximab|mesh-list
153780359|NCT00228839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153780360|NCT00228839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780361|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
153780362|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780363|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780364|NCT00191269|Gemcitabine|gemcitabine|mesh-list
153780365|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153617549|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
153780366|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
153780367|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780368|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780369|NCT00228878|Insulin|insulin|mesh-list
153780370|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
153780371|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780372|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780373|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
153780374|NCT00228995|Hematinics|hematinics|mesh-ancestor
153780375|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
153780376|NCT00413946|Hematinics|hematinics|mesh-ancestor
153780377|NCT00229112|Tazobactam|tazobactam|mesh-list
153780378|NCT00229112|Piperacillin|piperacillin|mesh-list
153780379|NCT00229112|Ertapenem|ertapenem|mesh-list
153780380|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153780381|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780382|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780383|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780384|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153780385|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780386|NCT00256737|Omeprazole|omeprazole|mesh-list
153780387|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153780388|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780389|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153780390|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780397|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153780398|NCT00414024|Tegaserod|tegaserod|mesh-list
153780399|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153780400|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
153780401|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780402|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780518|NCT00229697|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153780519|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153780520|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780521|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780577|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780578|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780579|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153780580|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153780581|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371358|NCT01746095|Vancomycin|vancomycin|mesh-list
153780582|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153780585|NCT00236496|Topiramate|topiramate|mesh-list
153780591|NCT00199277|Trace Elements|trace elements|mesh-ancestor
153780592|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
153780594|NCT00199277|Hematinics|hematinics|mesh-ancestor
153780639|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
153780640|NCT00196339|Cyproterone|cyproterone|mesh-list
153780641|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
153780642|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
153780643|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780644|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780645|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780646|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153780647|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
153780648|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153780649|NCT00257361|Cycloserine|cycloserine|mesh-list
153780650|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153780651|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780652|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153780653|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
153780654|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780655|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
153780656|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780657|NCT00199355|Istradefylline|istradefylline|mesh-list
153780694|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780695|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
153780696|NCT00199433|Istradefylline|istradefylline|mesh-list
153780697|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153780698|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153780699|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153780700|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
153780701|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780702|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780703|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780704|NCT00199472|Diuretics|diuretics|mesh-list
153780705|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
153780706|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780707|NCT00199511|Mannitol|mannitol|mesh-list
153780708|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153780709|NCT00199511|Diuretics|diuretics|mesh-ancestor
153780710|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
153780711|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780712|NCT00236613|Topiramate|topiramate|mesh-list
153780713|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
153780714|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780715|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780716|NCT00236652|Levofloxacin|levofloxacin|mesh-list
153780717|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153780718|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780719|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780720|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153780721|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153780722|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780723|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780727|NCT00257595|Cetirizine|cetirizine|mesh-list
153780737|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153780738|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780739|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153780740|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
153617922|NCT04309552|Alovudine|alovudine|mesh-list
153780741|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780742|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780743|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780744|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780745|NCT00236691|Topiramate|topiramate|mesh-list
153780746|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
153780747|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780748|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780749|NCT00236730|Topiramate|topiramate|mesh-list
153780751|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780752|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780753|NCT00199745|Atorvastatin|atorvastatin|mesh-list
153780754|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153780755|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153780756|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
153780757|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780758|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153780759|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153780760|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780761|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
153780786|NCT00236769|Estrogens|estrogens|mesh-ancestor
153780787|NCT00236769|Hormones|hormones|mesh-ancestor
153780788|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780789|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780790|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153780791|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
153780792|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153780793|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153780794|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153780795|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153780797|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
153780798|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
153780799|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780800|NCT00415311|Coagulants|coagulants|mesh-ancestor
153780801|NCT00199940|Ziprasidone|ziprasidone|mesh-list
153780802|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153780803|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
153780804|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780806|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780841|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780842|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
153780843|NCT00257634|Hormones|hormones|mesh-ancestor
153780844|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780845|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153780846|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780847|NCT00236847|Topiramate|topiramate|mesh-list
153780848|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
153780849|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780850|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780851|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
153780852|NCT00410306|Testosterone|testosterone|mesh-list
153780853|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
153780854|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
153780855|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153780856|NCT00410306|Androgens|androgens|mesh-ancestor
153780857|NCT00410306|Hormones|hormones|mesh-ancestor
153814384|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153814385|NCT00451776|Propofol|propofol|mesh-list
153814386|NCT00451776|Etomidate|etomidate|mesh-list
153814387|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153814388|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814389|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814390|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153814397|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153814398|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814399|NCT00338936|Diuretics|diuretics|mesh-ancestor
153780858|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780859|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780860|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153780861|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780862|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
153831383|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831384|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
153831385|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780863|NCT00257712|Hormones|hormones|mesh-list
153780864|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
153780865|NCT00257712|Tesamorelin|tesamorelin|mesh-list
153780866|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153780867|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780868|NCT00257712|Growth Substances|growth substances|mesh-ancestor
153780869|NCT00179647|Dexamethasone|dexamethasone|mesh-list
153780870|NCT00179647|Lenalidomide|lenalidomide|mesh-list
153780871|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780872|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
153780873|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
153780874|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780882|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
153780883|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153780884|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153780885|NCT00179647|Growth Substances|growth substances|mesh-ancestor
153780888|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
153780889|NCT00257751|Coagulants|coagulants|mesh-ancestor
153780890|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153780891|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153780896|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
153780897|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
153780898|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153780899|NCT00179413|Colchicine|colchicine|mesh-list
153780900|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780901|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
153780902|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153780940|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780941|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780942|NCT00257829|Diuretics|diuretics|mesh-ancestor
153780943|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
153780944|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780945|NCT02484664|Celecoxib|celecoxib|mesh-list
153780946|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153780947|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153780948|NCT02484664|Analgesics|analgesics|mesh-ancestor
153780949|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
153780950|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153780951|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780952|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153780953|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780954|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153780955|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153780956|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780957|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780958|NCT00257868|Rivastigmine|rivastigmine|mesh-list
153780959|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153780960|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780961|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371473|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153371474|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
153371475|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
153371476|NCT04292483|Protective Agents|protective agents|mesh-ancestor
153371477|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
153371478|NCT01347008|Citric Acid|citric acid|mesh-list
153371479|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
153371480|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
153371481|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153371482|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
153780962|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
153780963|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780964|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780965|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153780966|NCT00257868|Protective Agents|protective agents|mesh-ancestor
153780967|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
153780968|NCT00176605|Etoposide|etoposide|mesh-list
153816259|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816260|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
153816261|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816262|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816263|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816264|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
153816265|NCT00105183|Antibodies|antibodies|mesh-list
153816266|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
153816267|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153816268|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153816269|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
153816270|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153816271|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
153816272|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816273|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816274|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153781983|NCT04557202|Urological Agents|urological agents|mesh-ancestor
153780969|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153780970|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
153780972|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153780973|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153780974|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
153780975|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780976|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780977|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153780978|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153780979|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153780980|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153780981|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780982|NCT00176488|Vinorelbine|vinorelbine|mesh-list
153780983|NCT00176488|Epirubicin|epirubicin|mesh-list
153387529|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153814405|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
153780984|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153780985|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153780986|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
153780987|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
153780988|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
153780990|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153781019|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781021|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
153781022|NCT00200525|Apomorphine|apomorphine|mesh-list
153781024|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781025|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
153781028|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
153781029|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
153781030|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781031|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781032|NCT00174967|Febuxostat|febuxostat|mesh-list
153781033|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
153781034|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781035|NCT00200564|Ketamine|ketamine|mesh-list
153781036|NCT00200564|Analgesics|analgesics|mesh-ancestor
153781037|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
153781038|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781039|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781040|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153781041|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153781042|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
153781043|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
153781044|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153781045|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153781046|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153781067|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153781068|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781069|NCT00200681|Bortezomib|bortezomib|mesh-list
153781070|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781071|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153781072|NCT00258063|Norelgestromin|norelgestromin|mesh-list
153781073|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
153781074|NCT00258063|Estradiol|estradiol|mesh-list
153781075|NCT00258063|Estrogens|estrogens|mesh-ancestor
153781076|NCT00258063|Hormones|hormones|mesh-ancestor
153781077|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781078|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781079|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153781080|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153781081|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153781082|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153781083|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153781086|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781087|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153781088|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153781089|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153781090|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781091|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781092|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781093|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153781109|NCT00258297|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153781110|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153781111|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153781112|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781113|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781115|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
153781116|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153781117|NCT00258336|Antibodies|antibodies|mesh-list
153781118|NCT00258336|Sargramostim|sargramostim|mesh-list
153781119|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153781120|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153781121|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781122|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
153781126|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
153781128|NCT00171925|Vitamins|vitamins|mesh-ancestor
153781129|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
153781130|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781131|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153781132|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153781133|NCT00201305|Leucovorin|leucovorin|mesh-list
153781134|NCT00201305|Gemcitabine|gemcitabine|mesh-list
153781135|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153781136|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
153781137|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781138|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781139|NCT00201305|Antidotes|antidotes|mesh-ancestor
153814408|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781143|NCT00201305|Vitamins|vitamins|mesh-ancestor
153781155|NCT00265551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153781156|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153781157|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781158|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781159|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781160|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
153781161|NCT00201344|Leucovorin|leucovorin|mesh-list
153781162|NCT00201344|Antidotes|antidotes|mesh-ancestor
153781163|NCT00201344|Protective Agents|protective agents|mesh-ancestor
153781164|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781165|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
153781166|NCT00201344|Vitamins|vitamins|mesh-ancestor
153781167|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
153781168|NCT00201383|Cisplatin|cisplatin|mesh-list
153781169|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781170|NCT00201422|Amoxicillin|amoxicillin|mesh-list
153781171|NCT00201422|Clarithromycin|clarithromycin|mesh-list
153781172|NCT00201422|Omeprazole|omeprazole|mesh-list
153781173|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153781174|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781175|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153781176|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781177|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153781178|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781179|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781180|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153831458|NCT04729543|Azacitidine|azacitidine|mesh-list
153781181|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153781182|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153387530|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
153781183|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
153781184|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153781185|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153781189|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
153781197|NCT00201539|Morphine|morphine|mesh-list
153781198|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153781199|NCT00201539|Narcotics|narcotics|mesh-ancestor
153781200|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153781201|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781202|NCT00201539|Analgesics|analgesics|mesh-ancestor
153781203|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
153781204|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781205|NCT00265824|Bevacizumab|bevacizumab|mesh-list
153781206|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153781207|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153781208|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781209|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153781210|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153781211|NCT00265824|Growth Substances|growth substances|mesh-ancestor
153781212|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781213|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
153781214|NCT00265824|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153781215|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153781217|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781218|NCT00201695|Dexamethasone|dexamethasone|mesh-list
153781219|NCT00201695|Doxorubicin|doxorubicin|mesh-list
153781220|NCT00201695|Vincristine|vincristine|mesh-list
153781222|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153781223|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
153781224|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
153781225|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781244|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
153781245|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153781246|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781247|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153781248|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153781249|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153781250|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
153781251|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153781252|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153781253|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
153781254|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781255|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
153781256|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153781257|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153781258|NCT00265863|Mitomycins|mitomycins|mesh-list
153781259|NCT00265863|Mitomycin|mitomycin|mesh-list
153781260|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153781261|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781262|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
153781263|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781264|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153781265|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781266|NCT00410462|Doxorubicin|doxorubicin|mesh-list
153781267|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153781268|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153781288|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781289|NCT00410540|Analgesics|analgesics|mesh-ancestor
153781290|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
153781291|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781292|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
153781293|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153781294|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781295|NCT00201812|Dexamethasone|dexamethasone|mesh-list
153781297|NCT00201812|Docetaxel|docetaxel|mesh-list
153781298|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
153781299|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153781300|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
153781301|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
153781302|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831495|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781303|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781304|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781305|NCT00201812|Hormones|hormones|mesh-ancestor
153781306|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781307|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153781308|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781309|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
153781310|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
153814412|NCT00339014|Zonisamide|zonisamide|mesh-list
153781311|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
153781312|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781313|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153781314|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153781315|NCT00201812|Analgesics|analgesics|mesh-ancestor
153781316|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
153781317|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781318|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816275|NCT00466089|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153816276|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816277|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816278|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816279|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816280|NCT00466128|Indomethacin|indomethacin|mesh-list
153816281|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153816282|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816283|NCT00466128|Analgesics|analgesics|mesh-ancestor
153816284|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
153816285|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457613|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781319|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
153781321|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
153781322|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781323|NCT04709094|Bupropion|bupropion|mesh-list
153781324|NCT04709094|Warfarin|warfarin|mesh-list
153781325|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153781326|NCT04709094|Norethindrone|norethindrone|mesh-list
153781327|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
153781328|NCT04709094|Norinyl|norinyl|mesh-list
153781329|NCT04709094|Estradiol|estradiol|mesh-list
153781330|NCT04709094|Estrogens|estrogens|mesh-ancestor
153781331|NCT04709094|Hormones|hormones|mesh-ancestor
153781332|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781333|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781335|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
153781336|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153781337|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153781338|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
153781339|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153781340|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
153781341|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153781342|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153781343|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153781344|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781345|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781346|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
153781347|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781355|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
153781363|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
153781364|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781365|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371598|NCT01248416|Hormones|hormones|mesh-list
153781366|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153781367|NCT00171301|Deferasirox|deferasirox|mesh-list
153781368|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153781369|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
153781370|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
153781372|NCT00266058|Ritonavir|ritonavir|mesh-list
153781373|NCT00266058|Lopinavir|lopinavir|mesh-list
153781374|NCT00266058|Efavirenz|efavirenz|mesh-list
153781375|NCT00266058|Lumefantrine|lumefantrine|mesh-list
153781376|NCT00266058|Artemether|artemether|mesh-list
153781377|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153781378|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153781379|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153781380|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
153781381|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781382|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781383|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153781384|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153781385|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
153781386|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781387|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153781388|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153781389|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153781390|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153781407|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
153781408|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153781410|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
153781411|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153781412|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153781413|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
153781414|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781416|NCT00266097|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153781417|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153781419|NCT00202163|Testosterone|testosterone|mesh-list
153781420|NCT00202163|Androgens|androgens|mesh-ancestor
153781421|NCT00202163|Hormones|hormones|mesh-ancestor
153781422|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781423|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781424|NCT00476554|Sapacitabine|sapacitabine|mesh-list
153781426|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153781427|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153781428|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
153781429|NCT00202241|Testosterone|testosterone|mesh-list
153781430|NCT00202241|Androgens|androgens|mesh-ancestor
153781431|NCT00202241|Hormones|hormones|mesh-ancestor
153781432|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814417|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153781457|NCT00230594|Coagulants|coagulants|mesh-ancestor
153781458|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153781459|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
153781460|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781461|NCT00259077|Omeprazole|omeprazole|mesh-list
153781462|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153781463|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781464|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153781465|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781466|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781467|NCT00479674|Paclitaxel|paclitaxel|mesh-list
153781468|NCT00479674|Bevacizumab|bevacizumab|mesh-list
153781469|NCT00479674|Carboplatin|carboplatin|mesh-list
153781470|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153781471|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153781472|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781473|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
153877605|NCT05610657|Enzyme Activators|enzyme activators|mesh-ancestor
153781474|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
153781475|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
153781476|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781477|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153781478|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153781479|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153781480|NCT00479674|Growth Substances|growth substances|mesh-ancestor
153781481|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781482|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
153781483|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153781484|NCT02962310|Calcium|calcium|mesh-list
153457614|NCT01394718|Acetaminophen|acetaminophen|mesh-list
153457615|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457616|NCT01394718|Analgesics|analgesics|mesh-ancestor
153457617|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
153457618|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457619|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457620|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
153457621|NCT01394250|Lidocaine|lidocaine|mesh-list
153457622|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
153457623|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
153457624|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457625|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457626|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
153457627|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457628|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153457629|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153457630|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153457631|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153457632|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781485|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153781486|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781489|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
153781490|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781491|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153781984|NCT00232349|Galantamine|galantamine|mesh-list
153781492|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153781493|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781494|NCT00259116|Methocarbamol|methocarbamol|mesh-list
153781495|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153781496|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781497|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153781498|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781499|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
153781501|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457633|NCT01380990|Busulfan|busulfan|mesh-list
153457634|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
153457636|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457637|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
153457638|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457639|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153457640|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457641|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153457642|NCT05361330|Fluoxetine|fluoxetine|mesh-list
153457643|NCT05361330|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153457644|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153457645|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153457646|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457647|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816286|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816287|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816288|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816289|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
153816290|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
153816291|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153816292|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153816293|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816294|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816295|NCT00353015|Cisplatin|cisplatin|mesh-list
153816296|NCT00353015|Irinotecan|irinotecan|mesh-list
153816297|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816298|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153816299|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153816300|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816301|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816302|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153816303|NCT00466284|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153816304|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816305|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816306|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387531|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153781502|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
153781503|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
153781504|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
153781505|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781506|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153781507|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781508|NCT00259155|Rifaximin|rifaximin|mesh-list
153781509|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153781510|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781511|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781512|NCT00479401|Pramipexole|pramipexole|mesh-list
153781513|NCT00479401|Dexpramipexole|dexpramipexole|mesh-list
153781514|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
153781515|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781516|NCT00479401|Protective Agents|protective agents|mesh-ancestor
153781517|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781518|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153781519|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153781520|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
153781521|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
153781522|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781523|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153781524|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153781525|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153781526|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
153816307|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816308|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
153816309|NCT00353054|Antacids|antacids|mesh-ancestor
153816310|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816311|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816312|NCT00466401|Simvastatin|simvastatin|mesh-list
153816313|NCT00466401|Ezetimibe|ezetimibe|mesh-list
153816314|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153816315|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153816316|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
153816318|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153816319|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153816320|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457648|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
153457649|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457650|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153457651|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
153457652|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153457653|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153457654|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153457655|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457657|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153781528|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781529|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781530|NCT00230789|Urological Agents|urological agents|mesh-ancestor
153781531|NCT00478777|Dexamethasone|dexamethasone|mesh-list
153781532|NCT00478777|Lenalidomide|lenalidomide|mesh-list
153781533|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153781534|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
153781535|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
153781536|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781537|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781541|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781542|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153781543|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781544|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
153781545|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153781546|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153781547|NCT00478777|Growth Substances|growth substances|mesh-ancestor
153781548|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
153781549|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
153781550|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
153781551|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781552|NCT00477607|Protective Agents|protective agents|mesh-ancestor
153781553|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781554|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
153781555|NCT00477607|Vitamins|vitamins|mesh-ancestor
153781556|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
153781557|NCT00230867|Acyclovir|acyclovir|mesh-list
153781558|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
153618843|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618844|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618845|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153814425|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153814426|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814427|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
153814428|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814429|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153814430|NCT00420953|Amiodarone|amiodarone|mesh-list
153814431|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153814432|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
153814433|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153814434|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814435|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814436|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153814437|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153618848|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
153618849|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618850|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153618851|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
153618852|NCT00501826|Hormones|hormones|mesh-ancestor
153618853|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618854|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618855|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
153618856|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618857|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153618858|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153618859|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153618860|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153618861|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
153618862|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153618863|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153618864|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
153618865|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
153618866|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153618867|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153618868|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
153618869|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618870|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153618871|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618872|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
153545887|NCT06297772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457658|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457659|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153831824|NCT03151005|Exenatide|exenatide|mesh-list
153457660|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153457661|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153545889|NCT06297772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153545890|NCT06297772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153545891|NCT06297772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545892|NCT06297499|Ondansetron|ondansetron|mesh-list
153545893|NCT06297499|Antiemetics|antiemetics|mesh-ancestor
153781567|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153781568|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153781569|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153781570|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781573|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153781574|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781575|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
153781576|NCT00230984|Testosterone|testosterone|mesh-list
153781577|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
153781578|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
153781579|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153781580|NCT00230984|Androgens|androgens|mesh-ancestor
153781581|NCT00230984|Hormones|hormones|mesh-ancestor
153781582|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781583|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781584|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153781585|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781586|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
153781587|NCT00415350|Azithromycin|azithromycin|mesh-list
153781588|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153781589|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781590|NCT00231023|Triamcinolone|triamcinolone|mesh-list
153781591|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153781592|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153457662|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457663|NCT03592212|Albuterol|albuterol|mesh-list
153457664|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153814440|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153813965|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153457665|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
153457666|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457667|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457668|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153457669|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
153457670|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
153457671|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153457672|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153457673|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153781593|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153781594|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153781595|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
153781596|NCT00231023|Hormones|hormones|mesh-ancestor
153418386|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
153418387|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153418388|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153418389|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153418390|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418391|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418392|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
153781597|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781598|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566765|NCT06233565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153566766|NCT06233565|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566767|NCT06233565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566768|NCT06233565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566770|NCT06233344|Hallucinogens|hallucinogens|mesh-ancestor
153566772|NCT06233344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153566773|NCT06233318|Ropivacaine|ropivacaine|mesh-list
153566774|NCT06233318|Anesthetics, Local|anesthetics, local|mesh-ancestor
153566775|NCT06233318|Anesthetics|anesthetics|mesh-ancestor
153566776|NCT06233318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566777|NCT06233318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566778|NCT06233318|Sensory System Agents|sensory system agents|mesh-ancestor
153566779|NCT06233318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566781|NCT06233266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153566782|NCT06233266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153566783|NCT06233266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153566784|NCT06233266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153566785|NCT06233266|Purinergic Agents|purinergic agents|mesh-ancestor
153566792|NCT06233240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566794|NCT06233240|Hormones|hormones|mesh-ancestor
153566795|NCT06233240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566796|NCT06233240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153566797|NCT06233240|Protease Inhibitors|protease inhibitors|mesh-ancestor
153566798|NCT06233240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566799|NCT06233240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566800|NCT06233227|Dutasteride|dutasteride|mesh-list
153566801|NCT06233227|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153566802|NCT06233227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153566803|NCT06233227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566804|NCT06233227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566805|NCT06233227|Hormone Antagonists|hormone antagonists|mesh-ancestor
153566806|NCT06233227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566807|NCT06233227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566808|NCT06233201|Metformin|metformin|mesh-list
153566809|NCT06233201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153566810|NCT06233201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153566811|NCT06233201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566812|NCT06233201|Incretins|incretins|mesh-ancestor
153566813|NCT06233201|Hormones|hormones|mesh-ancestor
153566815|NCT06233201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153566836|NCT06233084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153781599|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153566837|NCT06233084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153566838|NCT06233084|Contraceptive Agents|contraceptive agents|mesh-ancestor
153566839|NCT06233084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153566840|NCT06233084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566841|NCT06233084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153566842|NCT06233084|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153566843|NCT06233084|Progestins|progestins|mesh-ancestor
153566845|NCT06233084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566846|NCT06233058|Drospirenone|drospirenone|mesh-list
153566847|NCT06233058|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153566848|NCT06233058|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153566849|NCT06233058|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153566850|NCT06233058|Estradiol|estradiol|mesh-list
153566851|NCT06233058|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153566852|NCT06233058|Estrogens|estrogens|mesh-ancestor
153566853|NCT06233058|Hormones|hormones|mesh-ancestor
153566854|NCT06233058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566855|NCT06233058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566856|NCT06233058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153566857|NCT06233058|Contraceptive Agents|contraceptive agents|mesh-ancestor
153566858|NCT06233058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153566859|NCT06233058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153566860|NCT06233058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153566882|NCT06233032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153566885|NCT06233032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566886|NCT06233032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566887|NCT06233032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153566895|NCT06233019|Antifungal Agents|antifungal agents|mesh-ancestor
153566896|NCT06233019|Keratolytic Agents|keratolytic agents|mesh-ancestor
153566897|NCT06233019|Dermatologic Agents|dermatologic agents|mesh-ancestor
153566898|NCT06233019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153566899|NCT06233019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153566900|NCT06233019|Analgesics|analgesics|mesh-ancestor
153566901|NCT06233019|Sensory System Agents|sensory system agents|mesh-ancestor
153566902|NCT06233019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566903|NCT06233019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566904|NCT06233019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566905|NCT06233019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153566906|NCT06233019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153566907|NCT06233019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566908|NCT06233019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566909|NCT06232993|Salicylic Acid|salicylic acid|mesh-list
153566910|NCT06232993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566911|NCT06232993|Antifungal Agents|antifungal agents|mesh-ancestor
153566912|NCT06232993|Keratolytic Agents|keratolytic agents|mesh-ancestor
153566913|NCT06232993|Dermatologic Agents|dermatologic agents|mesh-ancestor
153566914|NCT06232902|Bevacizumab|bevacizumab|mesh-list
153566915|NCT06232902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566916|NCT06232902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566919|NCT06232902|Growth Substances|growth substances|mesh-ancestor
153566920|NCT06232902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566921|NCT06232902|Growth Inhibitors|growth inhibitors|mesh-ancestor
153566922|NCT06232785|Ibuprofen|ibuprofen|mesh-list
153566923|NCT06232785|Sufentanil|sufentanil|mesh-list
153566924|NCT06232785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153566925|NCT06232785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153566926|NCT06232785|Analgesics|analgesics|mesh-ancestor
153566927|NCT06232785|Sensory System Agents|sensory system agents|mesh-ancestor
153566928|NCT06232785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566929|NCT06232785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566930|NCT06232785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566931|NCT06232785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153566932|NCT06232785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153566933|NCT06232785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566934|NCT06232785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566935|NCT06232785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153566936|NCT06232785|Narcotics|narcotics|mesh-ancestor
153566937|NCT06232785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566938|NCT06232785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153566939|NCT06232785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153566940|NCT06232785|Anesthetics, General|anesthetics, general|mesh-ancestor
153566941|NCT06232785|Anesthetics|anesthetics|mesh-ancestor
153566942|NCT06232694|Cytarabine|cytarabine|mesh-list
153566945|NCT06232694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153566946|NCT06232694|Antimetabolites|antimetabolites|mesh-ancestor
153566947|NCT06232694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566948|NCT06232694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816321|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153816322|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153816323|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153816324|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153816325|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153816326|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
153816327|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816328|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816329|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816330|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153566961|NCT06232642|Lactoferrin|lactoferrin|mesh-list
153566962|NCT06232642|Trace Elements|trace elements|mesh-ancestor
153566963|NCT06232642|Micronutrients|micronutrients|mesh-ancestor
153566964|NCT06232642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566965|NCT06232642|Hematinics|hematinics|mesh-ancestor
153566966|NCT06232642|Vitamin B Complex|vitamin b complex|mesh-ancestor
153566967|NCT06232642|Vitamins|vitamins|mesh-ancestor
153566968|NCT06232642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566981|NCT06230757|Psilocybin|psilocybin|mesh-list
153566982|NCT06230757|Hallucinogens|hallucinogens|mesh-ancestor
153816331|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153816332|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816334|NCT00466518|Hormones|hormones|mesh-ancestor
153816335|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153816336|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153816337|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
153816338|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816339|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816340|NCT00353561|Fluconazole|fluconazole|mesh-list
153566983|NCT06230757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566984|NCT06230757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153566985|NCT06227143|Anesthetics|anesthetics|mesh-list
153566986|NCT06227143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566987|NCT06227143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566988|NCT06220266|Phytoestrogens|phytoestrogens|mesh-list
153566989|NCT06220266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153566990|NCT06220266|Estrogens|estrogens|mesh-ancestor
153566992|NCT06220266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566993|NCT06220266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566995|NCT06195540|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153566996|NCT06195540|Dalteparin|dalteparin|mesh-list
153566997|NCT06195540|Rivaroxaban|rivaroxaban|mesh-list
153566998|NCT06195540|Anticoagulants|anticoagulants|mesh-ancestor
153566999|NCT06195540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153567000|NCT06195540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153567001|NCT06195540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567002|NCT06195540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153567003|NCT06195540|Antithrombins|antithrombins|mesh-ancestor
153567004|NCT06195540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153567005|NCT06195540|Protease Inhibitors|protease inhibitors|mesh-ancestor
153567006|NCT06195540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567007|NCT06192420|Diclofenac|diclofenac|mesh-list
153567008|NCT06192420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153567009|NCT06192420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816341|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
153816342|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816343|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153816344|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153816345|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816346|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816348|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
153816349|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457677|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457678|NCT03024450|Trastuzumab|trastuzumab|mesh-list
153457679|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153457680|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457682|NCT04263090|ON 01910|on 01910|mesh-list
153731762|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457684|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457685|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153457686|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457687|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153567010|NCT06192420|Analgesics|analgesics|mesh-ancestor
153567011|NCT06192420|Sensory System Agents|sensory system agents|mesh-ancestor
153567012|NCT06192420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372060|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153567013|NCT06192420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567014|NCT06192420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153567015|NCT06192420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153567016|NCT06192420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153567017|NCT06192420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567018|NCT06192420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567019|NCT06192355|Hemostatics|hemostatics|mesh-list
153567020|NCT06192355|Coagulants|coagulants|mesh-ancestor
153567021|NCT06182124|Vaccines|vaccines|mesh-list
153567022|NCT06182124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153567023|NCT06182124|Immunologic Factors|immunologic factors|mesh-ancestor
153567024|NCT06182124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567025|NCT06136390|Oxytocin|oxytocin|mesh-list
153567026|NCT06136390|Oxytocics|oxytocics|mesh-ancestor
153567027|NCT06136390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153567028|NCT06136390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567029|NCT06134362|Cabotegravir|cabotegravir|mesh-list
153567030|NCT06134362|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153567031|NCT06134362|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153567032|NCT06134362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567033|NCT06134362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567034|NCT06134362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153567035|NCT06134362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153567036|NCT06134362|Antiviral Agents|antiviral agents|mesh-ancestor
153567037|NCT06134362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567038|NCT06132477|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153361974|NCT05946005|Plasma Substitutes|plasma substitutes|mesh-ancestor
153387533|NCT00355277|Analgesics|analgesics|mesh-ancestor
153567056|NCT06116955|Sufentanil|sufentanil|mesh-list
153567057|NCT06116955|Dsuvia|dsuvia|mesh-list
153567058|NCT06116955|Propofol|propofol|mesh-list
153567059|NCT06116955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567060|NCT06116955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567061|NCT06116955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567062|NCT06116955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153567063|NCT06116955|Anesthetics, General|anesthetics, general|mesh-ancestor
153567064|NCT06116955|Anesthetics|anesthetics|mesh-ancestor
153567065|NCT06116955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153567066|NCT06116955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153567067|NCT06116955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153567068|NCT06116955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153567069|NCT06116955|GABA Modulators|gaba modulators|mesh-ancestor
153567070|NCT06116955|GABA Agents|gaba agents|mesh-ancestor
153567071|NCT06116955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567072|NCT06116955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567073|NCT06116955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153567074|NCT06116955|Narcotics|narcotics|mesh-ancestor
153567075|NCT06116955|Analgesics|analgesics|mesh-ancestor
153567076|NCT06116955|Sensory System Agents|sensory system agents|mesh-ancestor
153567077|NCT06116955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567078|NCT06112392|Antiparkinson Agents|antiparkinson agents|mesh-list
153567079|NCT06112392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153567080|NCT06080399|Apomorphine|apomorphine|mesh-list
153567081|NCT06080399|Emetics|emetics|mesh-ancestor
153567084|NCT06080399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567085|NCT06080399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153567086|NCT06080399|Dopamine Agonists|dopamine agonists|mesh-ancestor
153567087|NCT06080399|Dopamine Agents|dopamine agents|mesh-ancestor
153567088|NCT06080399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457688|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457689|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
153457690|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153457693|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153457694|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457695|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567091|NCT06071416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153567092|NCT06071416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567095|NCT06010329|Maleic acid|maleic acid|mesh-list
153567096|NCT06010329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567097|NCT06010329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567098|NCT06003049|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153567099|NCT06003049|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153567100|NCT06003049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153567101|NCT06003049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567102|NCT06003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567103|NCT06003049|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153567104|NCT06003049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153567105|NCT06003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567106|NCT06003049|Cholinergic Agents|cholinergic agents|mesh-ancestor
153567107|NCT06003049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567108|NCT05986591|Bromides|bromides|mesh-list
153567109|NCT05986591|Tiotropium Bromide|tiotropium bromide|mesh-list
153567110|NCT05986591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153567111|NCT05986591|Autonomic Agents|autonomic agents|mesh-ancestor
153567112|NCT05986591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567113|NCT05986591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567114|NCT05986591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153567115|NCT05986591|Respiratory System Agents|respiratory system agents|mesh-ancestor
153567116|NCT05986591|Parasympatholytics|parasympatholytics|mesh-ancestor
153567117|NCT05986591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153567118|NCT05986591|Cholinergic Agents|cholinergic agents|mesh-ancestor
153567119|NCT05986591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567120|NCT05986591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567121|NCT05986591|Anticonvulsants|anticonvulsants|mesh-ancestor
153567122|NCT05978102|Pembrolizumab|pembrolizumab|mesh-list
153567123|NCT05978102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567124|NCT05978102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567125|NCT05978102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153567126|NCT05978102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567127|NCT05971537|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153567128|NCT05971537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153567129|NCT05971537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567130|NCT05971537|Antitubercular Agents|antitubercular agents|mesh-ancestor
153567132|NCT05928546|Antioxidants|antioxidants|mesh-ancestor
153567133|NCT05928546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567134|NCT05928546|Protective Agents|protective agents|mesh-ancestor
153567135|NCT05928546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567136|NCT05921370|Silodosin|silodosin|mesh-list
153567137|NCT05921370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153567138|NCT05921370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153567139|NCT05921370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153567142|NCT05921370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567143|NCT05921370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567144|NCT05921370|Urological Agents|urological agents|mesh-ancestor
153567145|NCT05916937|Omalizumab|omalizumab|mesh-list
153567146|NCT05916937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153567147|NCT05916937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153567148|NCT05916937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153567149|NCT05916937|Respiratory System Agents|respiratory system agents|mesh-ancestor
153567150|NCT05916937|Immunologic Factors|immunologic factors|mesh-ancestor
153567151|NCT05916937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567152|NCT05902169|Carboplatin|carboplatin|mesh-list
153567153|NCT05902169|Temozolomide|temozolomide|mesh-list
153567155|NCT05902169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457696|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457697|NCT05632692|Menthol|menthol|mesh-list
153832112|NCT05146713|Eusol|eusol|mesh-list
153457698|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
153457699|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
153457700|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
153457701|NCT03594162|Fludarabine|fludarabine|mesh-list
153457702|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457703|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
153457704|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457705|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457706|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153457707|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
153457708|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457709|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567156|NCT05902169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153567157|NCT05902169|Alkylating Agents|alkylating agents|mesh-ancestor
153567158|NCT05902169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567160|NCT05892432|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153567161|NCT05892432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153567162|NCT05892432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567164|NCT05888311|Antidotes|antidotes|mesh-ancestor
153567165|NCT05888311|Protective Agents|protective agents|mesh-ancestor
153567166|NCT05888311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567167|NCT05878691|Pembrolizumab|pembrolizumab|mesh-list
153567168|NCT05878691|Atezolizumab|atezolizumab|mesh-list
153567169|NCT05878691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567170|NCT05878691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567171|NCT05878691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153567172|NCT05878691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567173|NCT05840952|Itraconazole|itraconazole|mesh-list
153567174|NCT05840952|Carbamazepine|carbamazepine|mesh-list
153567175|NCT05840952|Midazolam|midazolam|mesh-list
153567176|NCT05840952|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153567177|NCT05840952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567178|NCT05840952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567179|NCT05840952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567180|NCT05840952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153567181|NCT05840952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153816350|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816351|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153816352|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153816353|NCT00466596|Vitamins|vitamins|mesh-list
153816354|NCT00466596|Vitamin E|vitamin e|mesh-list
153816355|NCT00466596|Tocopherols|tocopherols|mesh-list
153816356|NCT00466596|Tocotrienols|tocotrienols|mesh-list
153816357|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
153816358|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
153816359|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
153814459|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387534|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
153731763|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731765|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
153731766|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
153816360|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816361|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
153816362|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816363|NCT00466596|Protective Agents|protective agents|mesh-ancestor
153816364|NCT00353678|Darexaban|darexaban|mesh-list
153816365|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153816366|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
153816367|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153816368|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
153816369|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816370|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816371|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
153816372|NCT00458250|Cyclosporine|cyclosporine|mesh-list
153567182|NCT05840952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153567183|NCT05840952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153567184|NCT05840952|Anesthetics, General|anesthetics, general|mesh-ancestor
153567185|NCT05840952|Anesthetics|anesthetics|mesh-ancestor
153567186|NCT05840952|GABA Modulators|gaba modulators|mesh-ancestor
153567187|NCT05840952|GABA Agents|gaba agents|mesh-ancestor
153567188|NCT05840952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567189|NCT05840952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567190|NCT05840952|Antifungal Agents|antifungal agents|mesh-ancestor
153567191|NCT05840952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567192|NCT05840952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153731768|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
153731769|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
153731770|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153731771|NCT00161304|Androgens|androgens|mesh-ancestor
153731772|NCT00161304|Hormones|hormones|mesh-ancestor
153362055|NCT05867147|Moxifloxacin|moxifloxacin|mesh-list
153567193|NCT05840952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153567195|NCT05840952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153567196|NCT05840952|Hormone Antagonists|hormone antagonists|mesh-ancestor
153567197|NCT05840952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567198|NCT05840952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153567199|NCT05840952|Anticonvulsants|anticonvulsants|mesh-ancestor
153567200|NCT05840952|Antimanic Agents|antimanic agents|mesh-ancestor
153567201|NCT05840952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567202|NCT05840952|Analgesics|analgesics|mesh-ancestor
153567203|NCT05840952|Sensory System Agents|sensory system agents|mesh-ancestor
153567204|NCT05840952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567205|NCT05840952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153567206|NCT05840952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153567207|NCT05840952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153567208|NCT05840952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153567209|NCT05815199|Nicotine|nicotine|mesh-list
153567210|NCT05815199|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153567211|NCT05815199|Autonomic Agents|autonomic agents|mesh-ancestor
153567212|NCT05815199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567213|NCT05815199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567214|NCT05815199|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153567215|NCT05815199|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153567216|NCT05815199|Cholinergic Agents|cholinergic agents|mesh-ancestor
153816373|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
153816374|NCT00458250|Busulfan|busulfan|mesh-list
153816375|NCT00458250|Methotrexate|methotrexate|mesh-list
153816376|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
153567217|NCT05815199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814462|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567218|NCT05815199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567220|NCT05782894|Propofol|propofol|mesh-list
153567221|NCT05782894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567222|NCT05782894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567223|NCT05782894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567224|NCT05782894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153567225|NCT05782894|Anesthetics, General|anesthetics, general|mesh-ancestor
153567226|NCT05782894|Anesthetics|anesthetics|mesh-ancestor
153567227|NCT05782894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153567228|NCT05782894|Narcotics|narcotics|mesh-ancestor
153567229|NCT05782894|Analgesics|analgesics|mesh-ancestor
153567230|NCT05782894|Sensory System Agents|sensory system agents|mesh-ancestor
153567231|NCT05782894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567232|NCT05782244|Sildenafil Citrate|sildenafil citrate|mesh-list
153567233|NCT05782244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567234|NCT05782244|Vasodilator Agents|vasodilator agents|mesh-ancestor
153567235|NCT05782244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153567236|NCT05782244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153567237|NCT05782244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567238|NCT05782244|Urological Agents|urological agents|mesh-ancestor
153567239|NCT05773664|Dexamethasone|dexamethasone|mesh-list
153567240|NCT05773664|Dexamethasone acetate|dexamethasone acetate|mesh-list
153877620|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877621|NCT05569811|Letrozole|letrozole|mesh-list
153877622|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
153877623|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877624|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153877625|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153877626|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567241|NCT05773664|Ichthammol|ichthammol|mesh-list
153567242|NCT05773664|BB 1101|bb 1101|mesh-list
153567243|NCT05773664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153567244|NCT05773664|Antiemetics|antiemetics|mesh-ancestor
153567245|NCT05773664|Autonomic Agents|autonomic agents|mesh-ancestor
153816377|NCT00458250|Cyclosporins|cyclosporins|mesh-list
153816378|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816379|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
153816380|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816381|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816382|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153816383|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
153816384|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816385|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816386|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153816387|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153816388|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
153816389|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153816390|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153457718|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567247|NCT05773664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567248|NCT05773664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153567249|NCT05773664|Glucocorticoids|glucocorticoids|mesh-ancestor
153567269|NCT05746039|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153567271|NCT05746039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567272|NCT05741229|Nitroglycerin|nitroglycerin|mesh-list
153567273|NCT05741229|Vasodilator Agents|vasodilator agents|mesh-ancestor
153567274|NCT05728944|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153567275|NCT05728944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153457719|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457721|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457722|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153457723|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153457724|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457725|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153457726|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153457727|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457728|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
153457729|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153457730|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153567277|NCT05728944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153567278|NCT05728944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153567279|NCT05728944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153567280|NCT05728944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153567281|NCT05728944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153567282|NCT05728944|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567283|NCT05728944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567284|NCT05728944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567285|NCT05728944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567286|NCT05728944|Miotics|miotics|mesh-ancestor
153567287|NCT05728944|Autonomic Agents|autonomic agents|mesh-ancestor
153567288|NCT05728944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567289|NCT05728944|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153567290|NCT05725512|Prednisolone|prednisolone|mesh-list
153567292|NCT05725512|Glucocorticoids|glucocorticoids|mesh-ancestor
153567293|NCT05725512|Hormones|hormones|mesh-ancestor
153567294|NCT05725512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567295|NCT05725512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567296|NCT05725512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153567297|NCT05725512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567298|NCT05722561|Nicotine|nicotine|mesh-list
153567299|NCT05722561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153567300|NCT05722561|Autonomic Agents|autonomic agents|mesh-ancestor
153567301|NCT05722561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567302|NCT05722561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567303|NCT05722561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153567304|NCT05722561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153567305|NCT05722561|Cholinergic Agents|cholinergic agents|mesh-ancestor
153567306|NCT05722561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567307|NCT05722561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457732|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
153457733|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457734|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153457735|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
153457736|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153457737|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
153457738|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
153457739|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153457740|NCT04407312|Protective Agents|protective agents|mesh-ancestor
153457741|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153567308|NCT05713630|Tranexamic Acid|tranexamic acid|mesh-list
153567309|NCT05713630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153567310|NCT05713630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153567311|NCT05713630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567312|NCT05713630|Hemostatics|hemostatics|mesh-ancestor
153567313|NCT05713630|Coagulants|coagulants|mesh-ancestor
153567314|NCT05704634|Cemiplimab|cemiplimab|mesh-list
153567315|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567316|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567318|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153567319|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567320|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
153567321|NCT05688345|Propofol|propofol|mesh-list
153567322|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567323|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567324|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567325|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567326|NCT05688345|Analgesics|analgesics|mesh-ancestor
153567327|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
153567328|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567329|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153567330|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153567331|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153567332|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567336|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
153567337|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
153567338|NCT05666362|Benoxinate|benoxinate|mesh-list
153567339|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
153567352|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153567353|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153567354|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153567355|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153567356|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567357|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567358|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567359|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567361|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
153877630|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832331|NCT01245998|Tinzaparin|tinzaparin|mesh-list
153567362|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567363|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153567364|NCT05649943|Androgens|androgens|mesh-list
153567365|NCT05649943|Hormones|hormones|mesh-ancestor
153567366|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567367|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567370|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567371|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567372|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153567373|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
153567374|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567375|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567376|NCT05607199|Calcium|calcium|mesh-list
153567377|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153567378|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567379|NCT05603832|Acetaminophen|acetaminophen|mesh-list
153457742|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153457743|NCT04326738|Midazolam|midazolam|mesh-list
153457744|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153816391|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
153816392|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
153816393|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816394|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153816395|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153816396|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
153816397|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816398|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153816399|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153816400|NCT00353717|Paclitaxel|paclitaxel|mesh-list
153816401|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153567380|NCT05603832|Bupivacaine|bupivacaine|mesh-list
153567381|NCT05603832|Methocarbamol|methocarbamol|mesh-list
153567382|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
153567383|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
153567384|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567385|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567386|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
153567387|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567388|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567389|NCT05603832|Analgesics|analgesics|mesh-ancestor
153567390|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
153567391|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153567394|NCT05602038|Bupivacaine|bupivacaine|mesh-list
153567395|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
153567396|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
153567397|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567398|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567399|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
153567400|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567401|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153567402|NCT05602038|Narcotics|narcotics|mesh-ancestor
153567403|NCT05602038|Analgesics|analgesics|mesh-ancestor
153567404|NCT05601154|Listerine|listerine|mesh-list
153567405|NCT05601154|Fluorides|fluorides|mesh-list
153567406|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
153567407|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
153816402|NCT00353717|Cetuximab|cetuximab|mesh-list
153816403|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153816404|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816405|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
153816406|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
153816407|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153816408|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816409|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153457745|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153816410|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
153816411|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153816414|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153816415|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816416|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153816417|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153459487|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
153816418|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153816419|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567409|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567410|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153567411|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567412|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153567413|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153567414|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567415|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567416|NCT05579249|Liraglutide|liraglutide|mesh-list
153567417|NCT05579249|Semaglutide|semaglutide|mesh-list
153567418|NCT05579249|Topiramate|topiramate|mesh-list
153567419|NCT05579249|Orlistat|orlistat|mesh-list
153567420|NCT05579249|Phentermine|phentermine|mesh-list
153567470|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153567471|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567472|NCT05478993|Dexamethasone|dexamethasone|mesh-list
153567473|NCT05478993|Pomalidomide|pomalidomide|mesh-list
153567474|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153567475|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
153567476|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
153567477|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567478|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567480|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
153567482|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567483|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153567484|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567485|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
153567486|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153567487|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153567488|NCT05478993|Growth Substances|growth substances|mesh-ancestor
153567489|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
153567490|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
153567491|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153567492|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567493|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
153567494|NCT05426174|Vaccines|vaccines|mesh-list
153567495|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
153567496|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567497|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153567498|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153567499|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153567500|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153816421|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816422|NCT00353912|Amlodipine|amlodipine|mesh-list
153816423|NCT00353912|Valsartan|valsartan|mesh-list
153816424|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153816425|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153816426|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153816427|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816429|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567501|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567502|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567503|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567504|NCT05396014|Analgesics|analgesics|mesh-ancestor
153567505|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
153567506|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567507|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
153877631|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877632|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877634|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
153877635|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877636|NCT05525247|Gemcitabine|gemcitabine|mesh-list
153418402|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153418403|NCT02933372|Varenicline|varenicline|mesh-list
153567508|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153567509|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
153567510|NCT05390710|Paclitaxel|paclitaxel|mesh-list
153567511|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153567512|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567513|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
153567514|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
153567515|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
153567516|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567518|NCT05388669|Lazertinib|lazertinib|mesh-list
153567519|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153567520|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153567522|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567524|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567525|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
153567526|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567527|NCT05384691|Luspatercept|luspatercept|mesh-list
153567528|NCT05384691|Hematinics|hematinics|mesh-ancestor
153567529|NCT05378503|Topiramate|topiramate|mesh-list
153567530|NCT05378503|Phentermine|phentermine|mesh-list
153567531|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
153567547|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567548|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362230|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567549|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567550|NCT05327595|Midazolam|midazolam|mesh-list
153567551|NCT05327595|Atorvastatin|atorvastatin|mesh-list
153567552|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153567553|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567554|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567555|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567556|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153567557|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153567558|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153567559|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153567560|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
153567561|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
153567562|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
153567563|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
153567564|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567565|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567566|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153567567|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153567568|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
153567569|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153567570|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153567571|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567572|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
153567573|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567574|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567575|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567576|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567577|NCT05321121|Analgesics|analgesics|mesh-ancestor
153567578|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
153567579|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418404|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153418405|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153418406|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
153418407|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418408|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418409|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418410|NCT02902237|Thromboplastin|thromboplastin|mesh-list
153418411|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
153418412|NCT02902237|Coagulants|coagulants|mesh-ancestor
153877637|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153567582|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153567586|NCT05278858|Triamcinolone|triamcinolone|mesh-list
153567587|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153567588|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
153567589|NCT05278858|Hormones|hormones|mesh-ancestor
153567590|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567591|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567593|NCT05261139|Nirmatrelvir|nirmatrelvir|mesh-list
153567594|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153567595|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153567596|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
153567597|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567598|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567599|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153567600|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153567601|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
153567602|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567644|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567646|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
153567647|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567648|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
153567649|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567650|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567651|NCT05145907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153567652|NCT05145907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567653|NCT05144009|Rituximab|rituximab|mesh-list
153567654|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153567655|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567656|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567657|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
153567658|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567659|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153567660|NCT05128734|Temozolomide|temozolomide|mesh-list
153567661|NCT05128734|Olaparib|olaparib|mesh-list
153567662|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153567663|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
153567664|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567665|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567666|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153567667|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567668|NCT05112991|Lenvatinib|lenvatinib|mesh-list
153567669|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567670|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153567671|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567672|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567673|NCT05107856|Azacitidine|azacitidine|mesh-list
153567674|NCT05107856|Venetoclax|venetoclax|mesh-list
153567684|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
153567685|NCT05054439|Paclitaxel|paclitaxel|mesh-list
153567686|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153567687|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567688|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
153567689|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
153567690|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
153387536|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567691|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567692|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
153567693|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567694|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567695|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810803|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
153832527|NCT00501410|Vitamins|vitamins|mesh-ancestor
153567696|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567697|NCT05031026|Analgesics|analgesics|mesh-ancestor
153567698|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
153567699|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567700|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153567701|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153567702|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153567703|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567704|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567705|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567706|NCT05024214|Sunitinib|sunitinib|mesh-list
153567707|NCT05024214|Lenvatinib|lenvatinib|mesh-list
153567775|NCT04906772|Ketamine|ketamine|mesh-list
153567776|NCT04906772|Propofol|propofol|mesh-list
153567777|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153567778|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153567779|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567780|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567781|NCT04906772|Analgesics|analgesics|mesh-ancestor
153567782|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
153567783|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567784|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153567785|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153567786|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153567787|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567788|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567789|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567790|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153567791|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
153567792|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
153567793|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153567794|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153567795|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153567796|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
153567797|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153567798|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
153567799|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567800|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567801|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153567819|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
153567820|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
153567821|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
153567822|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567823|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567825|NCT04870203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153567826|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153567827|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153567828|NCT04862767|Aldesleukin|aldesleukin|mesh-list
153567829|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567830|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153567831|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153567832|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
153567833|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567835|NCT04860713|Ketamine|ketamine|mesh-list
153567836|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153567837|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153567838|NCT04860713|Analgesics|analgesics|mesh-ancestor
153567839|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
153567840|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567841|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567842|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153567843|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153567866|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153567867|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814481|NCT00446082|Hormones|hormones|mesh-ancestor
153567868|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153567869|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153567870|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567871|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567872|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
153567873|NCT04848064|Fludarabine|fludarabine|mesh-list
153567874|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
153567875|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
153567876|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
153567877|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153567878|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
153567879|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567880|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153567881|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153567882|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
153567883|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567884|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567885|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153567887|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567888|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567889|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
153567890|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153567891|NCT04777994|Mitogens|mitogens|mesh-list
153567892|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
153567893|NCT04777994|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153567894|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
153567895|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567896|NCT04777994|Growth Substances|growth substances|mesh-ancestor
153567897|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567898|NCT04777994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153567899|NCT04777994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567900|NCT04762498|Methotrexate|methotrexate|mesh-list
153567906|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
153567907|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567908|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567909|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
153567910|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567911|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153567912|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153567913|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
153567914|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153567915|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153567916|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153567917|NCT04682847|Hematinics|hematinics|mesh-ancestor
153567918|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153567919|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153567920|NCT04682366|Tamsulosin|tamsulosin|mesh-list
153567921|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153567922|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153567923|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153567924|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
153567926|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567929|NCT04679818|Fentanyl|fentanyl|mesh-list
153567958|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567959|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567960|NCT04621500|Vitamin D|vitamin d|mesh-list
153567961|NCT04621500|Ergocalciferols|ergocalciferols|mesh-list
153567962|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
153567963|NCT04621500|Vitamins|vitamins|mesh-list
153567964|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
153731773|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567966|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153877638|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
153567967|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153567972|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
153567973|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567974|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567975|NCT04564417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153567976|NCT04564417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567977|NCT04511702|Methotrexate|methotrexate|mesh-list
153567978|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153567979|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
153567980|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153567981|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567982|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153567983|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
153567984|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567985|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567986|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
153567987|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567988|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153567989|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153567990|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
153567991|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816430|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
153816431|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153816432|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153816433|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
153457764|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457765|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567992|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153815084|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567993|NCT04502095|Levofloxacin|levofloxacin|mesh-list
153567994|NCT04502095|Ofloxacin|ofloxacin|mesh-list
153567995|NCT04502095|Trimethoprim|trimethoprim|mesh-list
153567996|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153567997|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
153567998|NCT04502095|Clindamycin|clindamycin|mesh-list
153567999|NCT04502095|Ertapenem|ertapenem|mesh-list
153568000|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
153568001|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153568002|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568003|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153568004|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153568005|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153568006|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568007|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568008|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568009|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153568010|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153568011|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153568012|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
153568013|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153568014|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153568015|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153568016|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153568040|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568042|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153877647|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568043|NCT04458545|Narcotics|narcotics|mesh-ancestor
153568044|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568045|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568046|NCT04458545|Analgesics|analgesics|mesh-ancestor
153568047|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
153568048|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568051|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
153568052|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568053|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
153568054|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568055|NCT04404387|Protective Agents|protective agents|mesh-ancestor
153568056|NCT04403282|Eflornithine|eflornithine|mesh-list
153568057|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568058|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153568059|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153568060|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153568061|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568062|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153568063|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568064|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568065|NCT04386811|Calcitriol|calcitriol|mesh-list
153568066|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153568067|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568068|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153568069|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153568071|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153568085|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568086|NCT04322357|Hormones|hormones|mesh-ancestor
153568087|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568088|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568089|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153568091|NCT04312841|Acetic Acid|acetic acid|mesh-list
153568092|NCT04312841|Letermovir|letermovir|mesh-list
153568093|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153568094|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568095|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568096|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153568097|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568098|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568099|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
153568100|NCT04254627|Etanercept|etanercept|mesh-list
153568101|NCT04254627|Mifepristone|mifepristone|mesh-list
153568102|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153568103|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153568104|NCT04254627|Analgesics|analgesics|mesh-ancestor
153568105|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
153568106|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568107|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357399|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153877648|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877649|NCT05513209|Anesthetics|anesthetics|mesh-list
153877650|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418418|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418419|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372798|NCT01812005|Rituximab|rituximab|mesh-list
153568108|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568109|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568110|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153568127|NCT04250805|Lidocaine|lidocaine|mesh-list
153568131|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568132|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568133|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
153568134|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568135|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153568136|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153568137|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153568138|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153815090|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153568139|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568140|NCT04248335|Midazolam|midazolam|mesh-list
153568141|NCT04248335|Pantoprazole|pantoprazole|mesh-list
153568142|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153568143|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153568144|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568145|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568146|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153568147|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153568148|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153568149|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153568150|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
153568151|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
153568152|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
153568153|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
153568154|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568156|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153568181|NCT04200651|Dexamethasone|dexamethasone|mesh-list
153568182|NCT04200651|Prednisolone|prednisolone|mesh-list
153568183|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153568184|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
153568185|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153568186|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
153568187|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153781986|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568188|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
153568189|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568190|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
153568191|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
153568192|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568193|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568194|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153568195|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
153568197|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568198|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153568199|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814482|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568201|NCT04200651|Protective Agents|protective agents|mesh-ancestor
153568203|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153568204|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568205|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568206|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568207|NCT04094311|Tisagenlecleucel|tisagenlecleucel|mesh-list
153568208|NCT04094311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568209|NCT04094311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568210|NCT03977467|Atezolizumab|atezolizumab|mesh-list
153568211|NCT03977467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568212|NCT03977467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418425|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153568219|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568221|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
153568222|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568223|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568224|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153568225|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
153568226|NCT03952091|Hormones|hormones|mesh-ancestor
153568227|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568228|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153568229|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568230|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
153568231|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568232|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568233|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
153568234|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568235|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568236|NCT03952091|Growth Substances|growth substances|mesh-ancestor
153568237|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
153814490|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153568238|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153568239|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
153568240|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568241|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568242|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153568243|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568244|NCT03919292|Valproic Acid|valproic acid|mesh-list
153568245|NCT03919292|Neratinib|neratinib|mesh-list
153568246|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
153568247|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568248|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568249|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
153568250|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568259|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568260|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545894|NCT06297499|Autonomic Agents|autonomic agents|mesh-ancestor
153568261|NCT03881488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568262|NCT03881488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568263|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153568264|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153568265|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568266|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
153568267|NCT03860038|Dexamethasone|dexamethasone|mesh-list
153568268|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568269|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
153568270|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
153568271|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568272|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568273|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153568274|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
153568276|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568277|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153568278|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568279|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
153568280|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153568281|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568307|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
153568308|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568309|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153568310|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
153568311|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568312|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568313|NCT03768440|Ropivacaine|ropivacaine|mesh-list
153568314|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
153568315|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
153568316|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568317|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568318|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
153568319|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568321|NCT03767582|Vaccines|vaccines|mesh-list
153568322|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
153568323|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568324|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568325|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568326|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568327|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568328|NCT03739931|Durvalumab|durvalumab|mesh-list
153568329|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568330|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568331|NCT03698461|Leucovorin|leucovorin|mesh-list
153568332|NCT03698461|Bevacizumab|bevacizumab|mesh-list
153568333|NCT03698461|Atezolizumab|atezolizumab|mesh-list
153568334|NCT03698461|Fluorouracil|fluorouracil|mesh-list
153568335|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
153568336|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
153568337|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568338|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568339|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153814494|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153814495|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568340|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568341|NCT03698461|Growth Substances|growth substances|mesh-ancestor
153568343|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
153568347|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568348|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
153568349|NCT03698461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568350|NCT03698461|Antidotes|antidotes|mesh-ancestor
153568351|NCT03698461|Protective Agents|protective agents|mesh-ancestor
153568352|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
153568353|NCT03698461|Vitamins|vitamins|mesh-ancestor
153568354|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
153568355|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
153568356|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153568357|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153568358|NCT03583866|Candesartan|candesartan|mesh-list
153568359|NCT03583866|Candesartan cilexetil|candesartan cilexetil|mesh-list
153568360|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153568361|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153568362|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153568363|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568364|NCT03560752|Vaccines|vaccines|mesh-list
153568365|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
153568366|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568367|NCT03511664|Pluvicto|pluvicto|mesh-list
153568368|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153568369|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568370|NCT03508232|Doxycycline|doxycycline|mesh-list
153568371|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153568373|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
153568374|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153568375|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153568376|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153568377|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153568378|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153568379|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153568381|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
153568382|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153568383|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
153568386|NCT03457194|Vaccines|vaccines|mesh-list
153568387|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
153568388|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568389|NCT03399981|Natalizumab|natalizumab|mesh-list
153568390|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
153568391|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568392|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153568393|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
153568394|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153814498|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
153568395|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568396|NCT03367754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568397|NCT03367754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877651|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877652|NCT05511610|Sevoflurane|sevoflurane|mesh-list
153568399|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
153568400|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153568401|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153568402|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568403|NCT03289962|Atezolizumab|atezolizumab|mesh-list
153568404|NCT03289962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568405|NCT03289962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568406|NCT03289962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568407|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568408|NCT03245489|Aspirin|aspirin|mesh-list
153568409|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
153568410|NCT03245489|Clopidogrel|clopidogrel|mesh-list
153568411|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568412|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568413|NCT03245489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568414|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568430|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153568431|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153568432|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
153568433|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568435|NCT03197922|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153568436|NCT03197922|Protective Agents|protective agents|mesh-ancestor
153568437|NCT03197922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568438|NCT03177460|Daratumumab|daratumumab|mesh-list
153568439|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568440|NCT03152409|Aspirin|aspirin|mesh-list
153568441|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
153568442|NCT03152409|Salicylates|salicylates|mesh-list
153568443|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153568444|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153568491|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568492|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568493|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153568494|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
153568495|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568496|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568497|NCT03012230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568498|NCT03012230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568499|NCT02996227|Bupivacaine|bupivacaine|mesh-list
153568500|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
153568501|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
153568502|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568552|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568553|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568554|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568555|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568556|NCT02840409|Growth Substances|growth substances|mesh-ancestor
153568557|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568558|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
153348490|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
153568559|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153568560|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
153568561|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
153568562|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
153568563|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568565|NCT02768337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153568566|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153568567|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568568|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568569|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568570|NCT02695628|Misonidazole|misonidazole|mesh-list
153568571|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568572|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153568573|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153568574|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568575|NCT02690064|Vitamins|vitamins|mesh-list
153568576|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
153568577|NCT02690064|Vitamin E|vitamin e|mesh-list
153568578|NCT02690064|Tocopherols|tocopherols|mesh-list
153568579|NCT02690064|Tocotrienols|tocotrienols|mesh-list
153568580|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
153568597|NCT02671435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568598|NCT02671435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568599|NCT02671435|Growth Substances|growth substances|mesh-ancestor
153568600|NCT02671435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568601|NCT02671435|Growth Inhibitors|growth inhibitors|mesh-ancestor
153568602|NCT02624765|Digoxin|digoxin|mesh-list
153568603|NCT02624765|Sotalol|sotalol|mesh-list
153568604|NCT02624765|Flecainide|flecainide|mesh-list
153568605|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153568606|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153568607|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568608|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568609|NCT02624765|Protective Agents|protective agents|mesh-ancestor
153568610|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568611|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153568612|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153568613|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
153568614|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568615|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
153568616|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
153568617|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568618|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153568651|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153568652|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568653|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153568654|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
153568655|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153568656|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568657|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568658|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568659|NCT01937468|Interleukin-2|interleukin-2|mesh-list
153568660|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568661|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153568662|NCT01937468|Analgesics|analgesics|mesh-ancestor
153568663|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
153568664|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568708|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568709|NCT01684397|Bevacizumab|bevacizumab|mesh-list
153568710|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153568712|NCT01684397|Antibodies|antibodies|mesh-list
153568713|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
153568714|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153568715|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
153568716|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568717|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568718|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568719|NCT01684397|Growth Substances|growth substances|mesh-ancestor
153568720|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568721|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
153568722|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
153568723|NCT01680549|Gabapentin|gabapentin|mesh-list
153568724|NCT01680549|Analgesics|analgesics|mesh-ancestor
153568725|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
153568727|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568728|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
153568729|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153568730|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153568731|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568760|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
153568762|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568763|NCT01316250|Nilotinib|nilotinib|mesh-list
153568764|NCT01316250|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153568765|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153568766|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568767|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568768|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
153568769|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568770|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
153568771|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568772|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153568773|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153568774|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
153568775|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568776|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568777|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153568778|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
153568779|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
153568780|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153568781|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568782|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568783|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
153568784|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153568785|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153568786|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568787|NCT01049347|Amitriptyline|amitriptyline|mesh-list
153568788|NCT01049347|Paroxetine|paroxetine|mesh-list
153568789|NCT01049347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153568790|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153457766|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153457767|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
153457769|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
153457770|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153457771|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153457772|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
153457773|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568791|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153568792|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568794|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
153568795|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568796|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153568797|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
153568798|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153568799|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153568800|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153568801|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568803|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153568805|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
153568806|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568807|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153568808|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
153568809|NCT00703222|Interleukin-2|interleukin-2|mesh-list
153568810|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568811|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153568812|NCT00703222|Analgesics|analgesics|mesh-ancestor
153568813|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
153568814|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568815|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568816|NCT00401167|Memantine|memantine|mesh-list
153568817|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153568818|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153568820|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568821|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568822|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457774|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457776|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457777|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153457778|NCT05632224|Aprepitant|aprepitant|mesh-list
153457779|NCT05632224|Granisetron|granisetron|mesh-list
153568823|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153568824|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153568825|NCT00390026|Bevacizumab|bevacizumab|mesh-list
153568826|NCT00390026|Verteporfin|verteporfin|mesh-list
153568827|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568828|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568829|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568830|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568831|NCT00390026|Growth Substances|growth substances|mesh-ancestor
153568832|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568833|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
153568834|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153568835|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
153568837|NCT00099086|Leuprolide|leuprolide|mesh-list
153568838|NCT00099086|Goserelin|goserelin|mesh-list
153568839|NCT00099086|Bicalutamide|bicalutamide|mesh-list
153568840|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568841|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
153568842|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
153568843|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
153568844|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568845|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153568846|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
153568847|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153568848|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568849|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153568850|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
153568851|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
153568852|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568853|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
153568854|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568855|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457780|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
153568862|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568863|NCT05308654|Dexamethasone|dexamethasone|mesh-list
153568864|NCT05308654|Lenalidomide|lenalidomide|mesh-list
153568865|NCT05308654|Daratumumab|daratumumab|mesh-list
153568866|NCT05308654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568867|NCT05308654|Antiemetics|antiemetics|mesh-ancestor
153568868|NCT05308654|Autonomic Agents|autonomic agents|mesh-ancestor
153568869|NCT05308654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568870|NCT05308654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568871|NCT05308654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153568872|NCT05308654|Glucocorticoids|glucocorticoids|mesh-ancestor
153568873|NCT05308654|Hormones|hormones|mesh-ancestor
153568874|NCT05308654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568875|NCT05308654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153568876|NCT05308654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568877|NCT05308654|Immunologic Factors|immunologic factors|mesh-ancestor
153568878|NCT05308654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153568879|NCT05308654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153568880|NCT05308654|Growth Substances|growth substances|mesh-ancestor
153568881|NCT05308654|Growth Inhibitors|growth inhibitors|mesh-ancestor
153568882|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
153568883|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153568884|NCT05284552|Tinzaparin|tinzaparin|mesh-list
153568885|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153568886|NCT05284552|Dalteparin|dalteparin|mesh-list
153568887|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
153814518|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
153568888|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153568889|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153568890|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568891|NCT05282277|Raclopride|raclopride|mesh-list
153568892|NCT05282277|Estradiol|estradiol|mesh-list
153568893|NCT05282277|Progesterone|progesterone|mesh-list
153833051|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153568894|NCT05282277|Estrogens|estrogens|mesh-ancestor
153568895|NCT05282277|Hormones|hormones|mesh-ancestor
153568896|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153568897|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568904|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
153568905|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568906|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568907|NCT05254743|Ibrutinib|ibrutinib|mesh-list
153568908|NCT05254743|Pirtobrutinib|pirtobrutinib|mesh-list
153568909|NCT05254743|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153568910|NCT05254743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153568911|NCT05254743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568912|NCT05254743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568913|NCT05225558|Vancomycin|vancomycin|mesh-list
153568914|NCT05225558|Delpazolid|delpazolid|mesh-list
153568915|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
153568916|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153568917|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568918|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153568919|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568920|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153568921|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
153568922|NCT05203445|Olaparib|olaparib|mesh-list
153362758|NCT03215498|Insulin|insulin|mesh-list
153387537|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153568923|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153568938|NCT05098210|Poly I-C|poly i-c|mesh-list
153568959|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153568960|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153568961|NCT05065905|Interferons|interferons|mesh-list
153568962|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
153568963|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153568964|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
153568965|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568966|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
153568967|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153568968|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
153568969|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153568970|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
153568971|NCT04995003|Nivolumab|nivolumab|mesh-list
153568972|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153568973|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569019|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
153569020|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569021|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569022|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569023|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
153569025|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569026|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153569027|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153569028|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153569029|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569030|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153569031|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
153569032|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569033|NCT04883346|Liraglutide|liraglutide|mesh-list
153569034|NCT04883346|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153569035|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153569036|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569037|NCT04883346|Incretins|incretins|mesh-ancestor
153569038|NCT04883346|Hormones|hormones|mesh-ancestor
153569039|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569040|NCT04848688|Ivermectin|ivermectin|mesh-list
153569041|NCT04848688|Moxidectin|moxidectin|mesh-list
153569042|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153813989|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
153813990|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569043|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569044|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
153569045|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
153569046|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
153569047|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569048|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569049|NCT04795661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153877653|NCT05511610|Desflurane|desflurane|mesh-list
153569050|NCT04795661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569051|NCT04763343|Ketamine|ketamine|mesh-list
153569052|NCT04763343|Analgesics|analgesics|mesh-ancestor
153569058|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
153569059|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
153569060|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569061|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153569062|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153569063|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569064|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569066|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153569067|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
153569068|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
153814525|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569069|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569070|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569071|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
153569073|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
153569074|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569075|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
153569076|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569077|NCT04747795|Protective Agents|protective agents|mesh-ancestor
153569078|NCT04731363|Erythritol|erythritol|mesh-list
153569079|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
153569080|NCT04710134|Reslizumab|reslizumab|mesh-list
153569081|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153349017|NCT01173029|Diuretics|diuretics|mesh-list
153569082|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
153569084|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153569085|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569087|NCT04693468|Axitinib|axitinib|mesh-list
153569088|NCT04693468|Crizotinib|crizotinib|mesh-list
153569089|NCT04693468|Talazoparib|talazoparib|mesh-list
153569090|NCT04693468|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153569091|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569092|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569093|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569096|NCT04693169|Choline|choline|mesh-list
153569100|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569102|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153569103|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
153569104|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
153569105|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
153569106|NCT04662255|Ibrutinib|ibrutinib|mesh-list
153569107|NCT04662255|Pirtobrutinib|pirtobrutinib|mesh-list
153569108|NCT04662255|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153569109|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569110|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569111|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569112|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569113|NCT04648358|Dexamethasone|dexamethasone|mesh-list
153569114|NCT04648358|Bupivacaine|bupivacaine|mesh-list
153569115|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569116|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
153569117|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
153569118|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569119|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569120|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569121|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
153569123|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569124|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153569125|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569126|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
153569127|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
153569147|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569151|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569153|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
153569154|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153569155|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
153569156|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569157|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569159|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
153569160|NCT04553536|Sufentanil|sufentanil|mesh-list
153569161|NCT04553536|Remifentanil|remifentanil|mesh-list
153569162|NCT04553536|Dsuvia|dsuvia|mesh-list
153569163|NCT04553536|Bromides|bromides|mesh-list
153569164|NCT04553536|Propofol|propofol|mesh-list
153569165|NCT04553536|Esketamine|esketamine|mesh-list
153569167|NCT04553536|Cisatracurium|cisatracurium|mesh-list
153569168|NCT04553536|Atracurium|atracurium|mesh-list
153569169|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153569170|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569172|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153569173|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
153569174|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
153569175|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153569176|NCT04553536|Narcotics|narcotics|mesh-ancestor
153569177|NCT04553536|Analgesics|analgesics|mesh-ancestor
153569178|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
153569179|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569180|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
153569181|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153457781|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
153457782|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457783|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457784|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153457785|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153457786|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457787|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457788|NCT05632224|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153457789|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153457790|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
153569182|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153569183|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153569184|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
153569185|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153569186|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153569187|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153569188|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
153569189|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569190|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569191|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153569192|NCT04548219|Mirikizumab|mirikizumab|mesh-list
153569193|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153569194|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153569195|NCT04548219|Analgesics|analgesics|mesh-ancestor
153569196|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
153569197|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569198|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569199|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569200|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569201|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153569204|NCT04523818|Fluorouracil|fluorouracil|mesh-list
153569205|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153569206|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
153569207|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569208|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569209|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569228|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
153569229|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
153569230|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
153569231|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569232|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153569233|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
153569234|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569235|NCT04390763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569236|NCT04339062|Sirolimus|sirolimus|mesh-list
153569237|NCT04339062|Prednisone|prednisone|mesh-list
153569238|NCT04339062|Everolimus|everolimus|mesh-list
153569239|NCT04339062|Cemiplimab|cemiplimab|mesh-list
153569240|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569241|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
153569242|NCT04339062|Hormones|hormones|mesh-ancestor
153569243|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569244|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569245|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877655|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153877657|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
153569246|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569247|NCT04339062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153569249|NCT04339062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569250|NCT04339062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569251|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569252|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
153569253|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153569254|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569255|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153569275|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569276|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569277|NCT04144517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569278|NCT04144517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569279|NCT04090567|Olaparib|olaparib|mesh-list
153569280|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153569281|NCT04090567|Cediranib|cediranib|mesh-list
153569282|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569283|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569284|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569285|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569286|NCT04017546|Venetoclax|venetoclax|mesh-list
153569287|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569288|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
153569289|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153569297|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
153569298|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153569299|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153569300|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569301|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
153569302|NCT03780894|Coagulants|coagulants|mesh-ancestor
153569303|NCT03739554|Venetoclax|venetoclax|mesh-list
153569304|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569305|NCT03729271|Rifaximin|rifaximin|mesh-list
153569306|NCT03729271|Lactulose|lactulose|mesh-list
153569307|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153569308|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569309|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569310|NCT03719768|Avelumab|avelumab|mesh-list
153569311|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569312|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569313|NCT03689972|Natalizumab|natalizumab|mesh-list
153569316|NCT03662100|Mirikizumab|mirikizumab|mesh-list
153569317|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153569318|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153569319|NCT03662100|Analgesics|analgesics|mesh-ancestor
153569320|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
153569321|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569322|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569323|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569324|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569325|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153569326|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569328|NCT03648905|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153569329|NCT03648905|Sympathomimetics|sympathomimetics|mesh-ancestor
153569330|NCT03648905|Autonomic Agents|autonomic agents|mesh-ancestor
153569331|NCT03648905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569332|NCT03648905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569333|NCT03648905|Dopamine Agents|dopamine agents|mesh-ancestor
153569334|NCT03648905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569335|NCT03648905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569336|NCT03648905|Protective Agents|protective agents|mesh-ancestor
153569338|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
153569339|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153569340|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569341|NCT03535688|Cycloserine|cycloserine|mesh-list
153569342|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153569343|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569370|NCT03511118|Gabapentin|gabapentin|mesh-list
153569371|NCT03511118|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153569372|NCT03511118|Levetiracetam|levetiracetam|mesh-list
153569373|NCT03511118|Ondansetron|ondansetron|mesh-list
153569374|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
153569375|NCT03511118|Trazodone|trazodone|mesh-list
153569376|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
153569377|NCT03511118|Methylphenidate|methylphenidate|mesh-list
153569378|NCT03511118|Citalopram|citalopram|mesh-list
153569381|NCT03511118|Paroxetine|paroxetine|mesh-list
153569382|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153569383|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
153569384|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153569385|NCT03511118|Escitalopram|escitalopram|mesh-list
153569386|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153569387|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569388|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153569389|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569390|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153569391|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153569392|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
153569393|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569394|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153569395|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153569397|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153569398|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153569399|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
153569400|NCT03511118|Coagulants|coagulants|mesh-ancestor
153569402|NCT03511118|Narcotics|narcotics|mesh-ancestor
153569419|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
153569420|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
153569421|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153569422|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
153569423|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
153569424|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569425|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
153569426|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
153569427|NCT03511118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153569428|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153569429|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153569430|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153569431|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
153569432|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153569433|NCT03511118|Diuretics|diuretics|mesh-ancestor
153569434|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
153569435|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153569436|NCT03511118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153569437|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153569438|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
153569439|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153569440|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153569441|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153569442|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153569443|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153569444|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569445|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153569446|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153569447|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153569448|NCT03511118|Nootropic Agents|nootropic agents|mesh-ancestor
153569449|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153569450|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
153569451|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153569452|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153569456|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153569457|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569458|NCT03511118|Antitussive Agents|antitussive agents|mesh-ancestor
153569459|NCT03511118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153569460|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153569461|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153569462|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153569463|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
153569464|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153569465|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153569466|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153569467|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153569468|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
153569470|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153569471|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153569472|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153569473|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153569483|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569484|NCT03442556|Carboplatin|carboplatin|mesh-list
153569502|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569503|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153569504|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
153569505|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569506|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
153569507|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569508|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569509|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569510|NCT03295240|Rituximab|rituximab|mesh-list
153569511|NCT03295240|Venetoclax|venetoclax|mesh-list
153569512|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153814545|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
153569513|NCT03295240|Ibrutinib|ibrutinib|mesh-list
153569514|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569515|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569516|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
153569517|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569518|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569519|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569520|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
153569521|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569522|NCT03295240|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153569523|NCT03295240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569524|NCT03295240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569525|NCT03223883|Curcumin|curcumin|mesh-list
153569526|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153569527|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153569528|NCT03223883|Analgesics|analgesics|mesh-ancestor
153569529|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
153457791|NCT03024840|Propofol|propofol|mesh-list
153457792|NCT03024840|Sevoflurane|sevoflurane|mesh-list
153457793|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153457794|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457795|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457796|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153816434|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153816435|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816437|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153569530|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810805|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
153810806|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373424|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153569531|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569532|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569533|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569534|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569535|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569536|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569537|NCT03188510|Mirikizumab|mirikizumab|mesh-list
153569538|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153569539|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153569540|NCT03188510|Analgesics|analgesics|mesh-ancestor
153569541|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
153569542|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569543|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569545|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569546|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153569547|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569548|NCT03120780|Fentanyl|fentanyl|mesh-list
153569554|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
153569555|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569556|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153569557|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153569558|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
153569559|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
153569560|NCT03102125|Regadenoson|regadenoson|mesh-list
153569561|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153569562|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153569563|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
153569564|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
153569565|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816438|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816439|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569566|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814549|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814550|NCT00446589|Teriparatide|teriparatide|mesh-list
153569567|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569568|NCT03075527|Durvalumab|durvalumab|mesh-list
153569569|NCT03075527|Tremelimumab|tremelimumab|mesh-list
153569570|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569571|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569572|NCT03068624|Aldesleukin|aldesleukin|mesh-list
153569573|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
153569574|NCT03068624|Ipilimumab|ipilimumab|mesh-list
153569575|NCT03068624|Interleukin-2|interleukin-2|mesh-list
153569576|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569577|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
153569578|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569579|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153569580|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569581|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
153569582|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569583|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569584|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153569585|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569586|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569587|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153814557|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
153569588|NCT03068624|Analgesics|analgesics|mesh-ancestor
153569589|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
153569616|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
153569617|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153569618|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569619|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877659|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877660|NCT05509569|Icatibant|icatibant|mesh-list
153877662|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153373488|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
153569620|NCT02688712|Capecitabine|capecitabine|mesh-list
153569621|NCT02688712|Fluorouracil|fluorouracil|mesh-list
153569622|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153569623|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
153569624|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569625|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569626|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569627|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
153569628|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569629|NCT02677922|Azacitidine|azacitidine|mesh-list
153569630|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153569631|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
153569632|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569633|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569670|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569671|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569672|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
153569673|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153569674|NCT02567799|Estrogens|estrogens|mesh-ancestor
153569677|NCT02306954|Aldesleukin|aldesleukin|mesh-list
153569678|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569679|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153569680|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153569682|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569683|NCT02088060|Cannabidiol|cannabidiol|mesh-list
153569684|NCT02088060|Olanzapine|olanzapine|mesh-list
153569685|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
153569686|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
153569687|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569688|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569689|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569690|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153569691|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153569692|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569693|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153569694|NCT02088060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153569695|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153569696|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153569697|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569699|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
153569700|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
153569701|NCT02078427|BAX 855|bax 855|mesh-list
153569702|NCT02078427|Coagulants|coagulants|mesh-ancestor
153569703|NCT02073968|Paclitaxel|paclitaxel|mesh-list
153569704|NCT02073968|Carboplatin|carboplatin|mesh-list
153569705|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153816440|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
153816441|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816442|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814563|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816444|NCT00354068|Temozolomide|temozolomide|mesh-list
153816445|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
153816446|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569706|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153569707|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569708|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
153569709|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
153569710|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
153569711|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569712|NCT01682577|Perindopril|perindopril|mesh-list
153569713|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153569714|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
153569715|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569716|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569717|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153569718|NCT01683760|Fluconazole|fluconazole|mesh-list
153569719|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
153569720|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373568|NCT02701257|Glucagon|glucagon|mesh-list
153569721|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153569722|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153569723|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569724|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569725|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153569726|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
153569727|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569753|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153569754|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
153569755|NCT01685034|Immunomodulating Agents|immunomodulating agents|mesh-list
153569756|NCT01685034|Immunologic Factors|immunologic factors|mesh-ancestor
153569757|NCT01685034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569758|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
153569760|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569762|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
153569763|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
153569764|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569765|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153569766|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
153569767|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569768|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153569770|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569771|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
153569772|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153569773|NCT01685489|Protective Agents|protective agents|mesh-ancestor
153569775|NCT01686386|Lenalidomide|lenalidomide|mesh-list
153569776|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153569777|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153569778|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
153569779|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
153569780|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569781|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569782|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569783|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
153569784|NCT01686386|Hormones|hormones|mesh-ancestor
153577498|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814568|NCT00452556|Leuprolide|leuprolide|mesh-list
153814569|NCT00452556|Androgens|androgens|mesh-list
153814570|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814571|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
153814572|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
153814573|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
153814574|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569785|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569786|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153569787|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816447|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
153816448|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816449|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569788|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
153569789|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153569790|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153569791|NCT01686386|Growth Substances|growth substances|mesh-ancestor
153569792|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
153569793|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153569794|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
153569795|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569796|NCT01686594|Methoxsalen|methoxsalen|mesh-list
153569797|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153569798|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
153569799|NCT01687517|Vaccines|vaccines|mesh-list
153569800|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
153569801|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569802|NCT01687751|Midazolam|midazolam|mesh-list
153569803|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
153569804|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153569805|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569806|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569807|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153569808|NCT01687751|Analgesics|analgesics|mesh-ancestor
153569809|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
153569810|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569811|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153569812|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153569813|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153459980|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
153569814|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
153569815|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569816|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569817|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153569833|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153569834|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
153569835|NCT01688362|Hormones|hormones|mesh-ancestor
153569836|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153569837|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153569838|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569839|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
153569840|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
153569841|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569842|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
153569843|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153569844|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153569846|NCT01689753|Citric Acid|citric acid|mesh-list
153569847|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
153569848|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
153569849|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153569850|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
153569851|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
153569853|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
153569886|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153569887|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153569888|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153569889|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569890|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153569892|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
153569893|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153569894|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
153569895|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569896|NCT01690286|Ketoconazole|ketoconazole|mesh-list
153569897|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
153569898|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569899|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153569900|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153569901|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569902|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569903|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153569904|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
153569940|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153569941|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153569942|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569943|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569944|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153569945|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153569946|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
153569947|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569948|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569949|NCT01690364|Anesthetics|anesthetics|mesh-list
153569950|NCT01690364|Cisatracurium|cisatracurium|mesh-list
153569951|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
153569952|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569953|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569954|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153569955|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153569956|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153569957|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153569958|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153569959|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153569960|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
153569961|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153569962|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569963|NCT01690403|Rifapentine|rifapentine|mesh-list
153569964|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153569965|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
153569966|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153569967|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569968|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
153569969|NCT01690468|Carboplatin|carboplatin|mesh-list
153569970|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569972|NCT01690507|Decitabine|decitabine|mesh-list
153569973|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
153569974|NCT01690507|Lenograstim|lenograstim|mesh-list
153569975|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153577499|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
153569980|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569981|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153569982|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
153569983|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153569984|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569985|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153569986|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153569987|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
153569988|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153569990|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153569991|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153569992|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153569993|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153569994|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569995|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569996|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153569997|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
153569998|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153570029|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153570030|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570036|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570037|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360209|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570038|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570039|NCT01690702|Paclitaxel|paclitaxel|mesh-list
153570040|NCT01690702|Docetaxel|docetaxel|mesh-list
153570041|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
153570042|NCT01690702|Epirubicin|epirubicin|mesh-list
153570043|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153570044|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570045|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
153570046|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668016|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570047|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570048|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570049|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570050|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
153570051|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570052|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570053|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153570054|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
153570055|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153570056|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153570057|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153570058|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153570059|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570060|NCT01690767|Lidocaine|lidocaine|mesh-list
153570062|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
153570063|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570069|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153570070|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570071|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570072|NCT01690780|Ibuprofen|ibuprofen|mesh-list
153570073|NCT01690780|Morphine|morphine|mesh-list
153387800|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153570074|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153570075|NCT01690780|Narcotics|narcotics|mesh-ancestor
153570076|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570077|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570078|NCT01690780|Analgesics|analgesics|mesh-ancestor
153570079|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
153570080|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570081|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153570082|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153570083|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570084|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570085|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153570086|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570087|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570088|NCT01690832|Fenoldopam|fenoldopam|mesh-list
153570089|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153570090|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
153570091|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
153570092|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
153570093|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570094|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570095|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570096|NCT01690871|Dactolisib|dactolisib|mesh-list
153570097|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570098|NCT01690884|Adenosine|adenosine|mesh-list
153570099|NCT01690884|Analgesics|analgesics|mesh-ancestor
153570100|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
153570101|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570102|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570103|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153570104|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
153570106|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
153570107|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
153570113|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
153570114|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
153570115|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570116|NCT01690962|Hematinics|hematinics|mesh-ancestor
153570117|NCT01690975|Benzonatate|benzonatate|mesh-list
153570118|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
153570119|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
153570120|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
153570121|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153570122|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570123|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570124|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153570125|NCT01691001|Analgesics|analgesics|mesh-ancestor
153570126|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
153570127|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570128|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153570129|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153570131|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
153570132|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570133|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570134|NCT01691053|Spironolactone|spironolactone|mesh-list
153570135|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153570136|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
153570137|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570138|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570139|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153570146|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
153570147|NCT01691365|Antioxidants|antioxidants|mesh-list
153570148|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
153570149|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570150|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570151|NCT01691365|Protective Agents|protective agents|mesh-ancestor
153570152|NCT01691404|Quercetin|quercetin|mesh-list
153570153|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
153570154|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570155|NCT01691404|Protective Agents|protective agents|mesh-ancestor
153570156|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570157|NCT01691456|Montelukast|montelukast|mesh-list
153363184|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
153814586|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360212|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
153814013|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
153570158|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153570159|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
153570160|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153570161|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
153570162|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570163|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570164|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153570165|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153570166|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570167|NCT01691469|Montelukast|montelukast|mesh-list
153570168|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153570169|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
153570170|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153570171|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
153570172|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570173|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570174|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153570175|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153570176|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816450|NCT00354068|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153816451|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816452|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816453|NCT00466869|Betahistine|betahistine|mesh-list
153816454|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
153816455|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
153816456|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
153570177|NCT01691495|PENTA|penta|mesh-list
153570178|NCT01691495|Fondaparinux|fondaparinux|mesh-list
153570179|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153570180|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
153570181|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153570182|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
153570183|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570184|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570185|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
153570186|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153570187|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153570188|NCT01691625|Immunomodulating Agents|immunomodulating agents|mesh-list
153570189|NCT01691625|Immunologic Factors|immunologic factors|mesh-ancestor
153570190|NCT01691625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570191|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
153570192|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153570193|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153570194|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153570195|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570196|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570197|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
153570198|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570199|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570200|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153570201|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570202|NCT01691677|Beclomethasone|beclomethasone|mesh-list
153570203|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570204|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
153570205|NCT01691677|Hormones|hormones|mesh-ancestor
153570206|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387540|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570207|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570208|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153570214|NCT01691807|Ofatumumab|ofatumumab|mesh-list
153570217|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570219|NCT01691872|Ezogabine|ezogabine|mesh-list
153570220|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
153570221|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570222|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570223|NCT01691937|Sufentanil|sufentanil|mesh-list
153570224|NCT01691937|Ropivacaine|ropivacaine|mesh-list
153570225|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
153570226|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
153814589|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360213|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
153387541|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
153570227|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570228|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570229|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
153570230|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570231|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153570232|NCT01691937|Narcotics|narcotics|mesh-ancestor
153570233|NCT01691937|Analgesics|analgesics|mesh-ancestor
153570234|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153570235|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153570236|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
153570237|NCT01691976|Estrogens|estrogens|mesh-list
153570238|NCT01691976|Hormones|hormones|mesh-ancestor
153570239|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570240|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570241|NCT01692132|Prucalopride|prucalopride|mesh-list
153570242|NCT01692132|Laxatives|laxatives|mesh-ancestor
153570243|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153570244|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153570245|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153570246|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
153387542|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570247|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570248|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570249|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570250|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
153816457|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816458|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816459|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816460|NCT00354146|Tipifarnib|tipifarnib|mesh-list
153816461|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816462|NCT00458367|Risperidone|risperidone|mesh-list
153570252|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570253|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570254|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153570256|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
153570257|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570258|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153570259|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153570260|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153570261|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
153570262|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570263|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570264|NCT01692457|Golimumab|golimumab|mesh-list
153570265|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153570266|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570267|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570268|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
153570269|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570270|NCT01692483|Prednisone|prednisone|mesh-list
153570271|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
153570272|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570273|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
153816463|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153816464|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
153457798|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
153457799|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153457800|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153457801|NCT05631678|Itraconazole|itraconazole|mesh-list
153457802|NCT05631678|Rifampin|rifampin|mesh-list
153457803|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
153457804|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457805|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153457806|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153457807|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457808|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457809|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153457810|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
153457811|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457812|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457813|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153457814|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153457815|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
153457816|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153457817|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
153457818|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153877672|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153877673|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877674|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
153877675|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153833940|NCT00516438|Topotecan|topotecan|mesh-list
153457819|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153570274|NCT01692483|Hormones|hormones|mesh-ancestor
153814594|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570275|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570276|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570277|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153570279|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153570280|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570281|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570282|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
153570283|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153570284|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153570285|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153570287|NCT01692678|Trabectedin|trabectedin|mesh-list
153570288|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153570289|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
153570290|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570291|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570292|NCT01692704|Gemcitabine|gemcitabine|mesh-list
153570293|NCT01692704|Floxuridine|floxuridine|mesh-list
153570294|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570295|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153570296|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
153570297|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570298|NCT01692808|Vitamin D|vitamin d|mesh-list
153570303|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570304|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153457820|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153457825|NCT03599778|Apatinib|apatinib|mesh-list
153816466|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816467|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816468|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153816469|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153816470|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153816471|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153816472|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153816473|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
153816474|NCT00354185|Belinostat|belinostat|mesh-list
153816475|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816476|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153570305|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153570306|NCT01692834|Cyclosporine|cyclosporine|mesh-list
153570307|NCT01692834|Cyclosporins|cyclosporins|mesh-list
153570308|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570309|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570310|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570311|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
153570312|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570313|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
153570314|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570315|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
153570316|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570317|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153570318|NCT01692886|Vaccines|vaccines|mesh-list
153570319|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153570320|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
153570321|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570322|NCT01692925|Factor VIII|factor viii|mesh-list
153570323|NCT01692925|Coagulants|coagulants|mesh-ancestor
153570324|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
153570326|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
153570327|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570328|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781602|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570357|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570358|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153570359|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
153570361|NCT01693289|Letrozole|letrozole|mesh-list
153570362|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153570363|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570364|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570365|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153570366|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153570367|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570368|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570369|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153570370|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
153570371|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570372|NCT01693302|Insulin|insulin|mesh-list
153570373|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153570374|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153570375|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570376|NCT01693328|Fentanyl|fentanyl|mesh-list
153570377|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153570378|NCT01693328|Narcotics|narcotics|mesh-ancestor
153570379|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570380|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570381|NCT01693328|Analgesics|analgesics|mesh-ancestor
153570382|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
153570383|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570384|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153570385|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153570387|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
153570388|NCT01693393|Cyclosporine|cyclosporine|mesh-list
153570389|NCT01693393|Cyclosporins|cyclosporins|mesh-list
153570390|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570391|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816477|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816478|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570392|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570393|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
153570394|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570395|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
153570396|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570397|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
153570398|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570399|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153814600|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153570401|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153570402|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153570403|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
153570404|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570405|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570406|NCT01693419|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153570407|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153570408|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570409|NCT01693432|Docetaxel|docetaxel|mesh-list
153570410|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570411|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
153570412|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
153570413|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570414|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570415|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
153570416|NCT01693445|Irinotecan|irinotecan|mesh-list
153570417|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570418|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153570439|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570440|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153570441|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153570442|NCT01693809|Caffeine|caffeine|mesh-list
153570443|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153570444|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374116|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153374117|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
153374118|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
153570445|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153570446|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570447|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570450|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
153387543|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153814601|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
153570502|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570503|NCT05288179|Pirfenidone|pirfenidone|mesh-list
153570504|NCT05288179|Analgesics|analgesics|mesh-ancestor
153570505|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
153781603|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153570506|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570507|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570508|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153570509|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153570510|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570511|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570512|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570513|NCT05288127|Talazoparib|talazoparib|mesh-list
153570514|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153570515|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570516|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570517|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570519|NCT05291455|Phenobarbital|phenobarbital|mesh-list
153570520|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
153387544|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
153570521|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153570522|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153570553|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
153570554|NCT05291052|Capecitabine|capecitabine|mesh-list
153570555|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
153570557|NCT05291052|Tislelizumab|tislelizumab|mesh-list
153570558|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153570559|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
153570560|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570562|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153570563|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570564|NCT05291052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153570565|NCT05290948|Bevacizumab|bevacizumab|mesh-list
153570566|NCT05290948|Acetazolamide|acetazolamide|mesh-list
153570567|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153570568|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570569|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153570570|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153570571|NCT05290948|Growth Substances|growth substances|mesh-ancestor
153570572|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570573|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
153570574|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
153570575|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153570576|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570577|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570578|NCT05290948|Diuretics|diuretics|mesh-ancestor
153570579|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
153816479|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153816480|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816481|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
153816482|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
153816483|NCT00354302|Alendronate|alendronate|mesh-list
153816484|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
153816485|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
153816486|NCT00354302|Calcium|calcium|mesh-list
153816487|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153816488|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816489|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153816492|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
153816493|NCT00354302|Antacids|antacids|mesh-ancestor
153816494|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816495|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153816496|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153816497|NCT04714229|Vaccines|vaccines|mesh-list
153816498|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
153816499|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816500|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
153570580|NCT05290935|Paclitaxel|paclitaxel|mesh-list
153570582|NCT05290935|Antibodies|antibodies|mesh-list
153570583|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153570584|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570585|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
153570586|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
153570587|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570588|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570589|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
153570590|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570591|NCT05290506|Linagliptin|linagliptin|mesh-list
153570592|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153570593|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153570594|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570595|NCT05290506|Incretins|incretins|mesh-ancestor
153363398|NCT03211052|Leuprolide|leuprolide|mesh-list
153570596|NCT05290506|Hormones|hormones|mesh-ancestor
153570597|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570598|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
153570599|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570600|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570601|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
153570602|NCT05290337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153570603|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153570604|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570605|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570606|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570607|NCT05290324|Midazolam|midazolam|mesh-list
153570608|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153570609|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153570610|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570611|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570612|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153570613|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153816502|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816503|NCT00354380|Artesunate|artesunate|mesh-list
153816505|NCT00354380|Methylene Blue|methylene blue|mesh-list
153816506|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
153570614|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153570615|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153570616|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
153570617|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
153570618|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
153570619|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
153570620|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570621|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570622|NCT05292742|Capecitabine|capecitabine|mesh-list
153570623|NCT05292742|Trastuzumab|trastuzumab|mesh-list
153570625|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153570626|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
153570627|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570628|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570629|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153570630|NCT05292677|Anesthetics|anesthetics|mesh-list
153570631|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570632|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570633|NCT05292573|Metformin|metformin|mesh-list
153570634|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153570635|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570636|NCT05291910|Paclitaxel|paclitaxel|mesh-list
153570637|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153387545|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570638|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153570639|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570640|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
153570641|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
153570642|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570643|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570644|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
153816507|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153816508|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153816509|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816510|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816511|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
153816512|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
153816513|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153816514|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
153816515|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457844|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
153457845|NCT03595254|Nicotine|nicotine|mesh-list
153457846|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153457847|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
153457848|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570645|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153570646|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153570647|NCT05291793|Prednisolone|prednisolone|mesh-list
153570648|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
153570649|NCT05291793|Tenoxicam|tenoxicam|mesh-list
153570650|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153570651|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
153570652|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570653|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
153570654|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
153570655|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360214|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153781604|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
153781605|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153570657|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153570658|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
153570659|NCT05291793|Hormones|hormones|mesh-ancestor
153570660|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570661|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153570662|NCT05291793|Protective Agents|protective agents|mesh-ancestor
153570663|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153570664|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570665|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153570666|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153570667|NCT05291793|Analgesics|analgesics|mesh-ancestor
153570668|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
153570697|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153570698|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570700|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153570701|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
153570702|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570703|NCT05294744|Expectorants|expectorants|mesh-ancestor
153570704|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
153570705|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153570706|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
153570707|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570708|NCT05294744|Protective Agents|protective agents|mesh-ancestor
153570709|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570710|NCT05294744|Antidotes|antidotes|mesh-ancestor
153570711|NCT05294666|Cyclosporine|cyclosporine|mesh-list
153570712|NCT05294666|Tacrolimus|tacrolimus|mesh-list
153570713|NCT05294666|Cyclosporins|cyclosporins|mesh-list
153570714|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570715|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
153570716|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570717|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153570718|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570719|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570720|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
153570721|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570730|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153570731|NCT05294484|Indapamide|indapamide|mesh-list
153570732|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153570733|NCT05294484|Diuretics|diuretics|mesh-ancestor
153570734|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
153570735|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570736|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153570737|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570738|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570739|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
153570740|NCT05294393|Ropivacaine|ropivacaine|mesh-list
153570741|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
153570742|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
153570743|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570744|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570745|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
153570746|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570747|NCT05294393|Analgesics|analgesics|mesh-ancestor
153570748|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153570749|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
153570750|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153570751|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570752|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570753|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153570754|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
153570759|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153570761|NCT05293704|Analgesics|analgesics|mesh-ancestor
153457849|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457850|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153457851|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153457852|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
153457853|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457854|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457855|NCT03599466|Lisinopril|lisinopril|mesh-list
153820691|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153570762|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
153570763|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570764|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570765|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570766|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153731775|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153731777|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
153731778|NCT01242748|Goserelin|goserelin|mesh-list
153731779|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153731780|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731781|NCT00139373|Donepezil|donepezil|mesh-list
153731782|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153731783|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731784|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731785|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
153731786|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731787|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570767|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153570768|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570769|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153570770|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570771|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
153570772|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153570773|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153570774|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570775|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570776|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570777|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
153570778|NCT05293574|Norethindrone|norethindrone|mesh-list
153570779|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
153570780|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153570781|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153570782|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153570783|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
153570784|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153570785|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570786|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153731788|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
153731790|NCT00161421|Testosterone|testosterone|mesh-list
153731791|NCT00161421|Dutasteride|dutasteride|mesh-list
153731792|NCT00161421|Androgens|androgens|mesh-ancestor
153731793|NCT00161421|Hormones|hormones|mesh-ancestor
153570787|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153570788|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
153570789|NCT05293119|Tofacitinib|tofacitinib|mesh-list
153570790|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570791|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
153570792|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153570793|NCT05293119|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153570794|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153570795|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626780|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457856|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153457857|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
153457858|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820692|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153570796|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570797|NCT05296863|Minoxidil|minoxidil|mesh-list
153570798|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153570799|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
153570800|NCT05296369|Folic Acid|folic acid|mesh-list
153570801|NCT05296369|Hematinics|hematinics|mesh-ancestor
153570802|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
153570803|NCT05296369|Vitamins|vitamins|mesh-ancestor
153570804|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
153570805|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570806|NCT05296005|Leucovorin|leucovorin|mesh-list
153781606|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153570807|NCT05296005|Docetaxel|docetaxel|mesh-list
153570808|NCT05296005|Capecitabine|capecitabine|mesh-list
153570809|NCT05296005|Fluorouracil|fluorouracil|mesh-list
153570810|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
153570811|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731794|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731795|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731796|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153731797|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731798|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153731799|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
153731800|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153731801|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153731802|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153731803|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731804|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731805|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
153731806|NCT00139568|Tegaserod|tegaserod|mesh-list
153731807|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153731808|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
153731809|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731810|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731811|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731812|NCT00139646|Diclofenac|diclofenac|mesh-list
153731813|NCT00139646|Parecoxib|parecoxib|mesh-list
153570812|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153570813|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153570815|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570816|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153570817|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
153570818|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570819|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
153570820|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457859|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457860|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153457861|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153457862|NCT03599466|Protective Agents|protective agents|mesh-ancestor
153457865|NCT03986970|Emtricitabine|emtricitabine|mesh-list
153457866|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
153457867|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457868|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153457869|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153457870|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457871|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457872|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153816516|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816517|NCT00354419|Cyclosporine|cyclosporine|mesh-list
153816518|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
153816519|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
153816520|NCT00354419|Cyclosporins|cyclosporins|mesh-list
153816521|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
153816522|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153816523|NCT00354419|Lenograstim|lenograstim|mesh-list
153816524|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
153731828|NCT00406302|Cetuximab|cetuximab|mesh-list
153731829|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731830|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
153816525|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816526|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
153816527|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816528|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816529|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153570822|NCT05296005|Protective Agents|protective agents|mesh-ancestor
153570823|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
153570824|NCT05296005|Vitamins|vitamins|mesh-ancestor
153570825|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
153570826|NCT05295836|Glycerol|glycerol|mesh-list
153570827|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153570828|NCT05295836|Protective Agents|protective agents|mesh-ancestor
153570829|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570830|NCT05294900|Paclitaxel|paclitaxel|mesh-list
153570831|NCT05294900|Carboplatin|carboplatin|mesh-list
153570832|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153570833|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570834|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
153570835|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
153570836|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
153570837|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570838|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153570839|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153570840|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816530|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
153816531|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816532|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816533|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153816534|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153816535|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816536|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
153816537|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816538|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
153816539|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153816540|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153816541|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153816542|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
153816543|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153816544|NCT00354458|Rolofylline|rolofylline|mesh-list
153816545|NCT00354458|Diuretics|diuretics|mesh-ancestor
153816546|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
153816547|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816548|NCT00458718|Rimonabant|rimonabant|mesh-list
153816549|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153816550|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153816551|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153816552|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816556|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816558|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153816559|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
153816560|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
153816561|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
153457893|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457894|NCT04407078|Neostigmine|neostigmine|mesh-list
153457895|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153457896|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570841|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570842|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153570843|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570844|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570845|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
153570846|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570848|NCT05273242|Infliximab|infliximab|mesh-list
153570849|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570850|NCT05273242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153570851|NCT05273242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153570852|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
153570853|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153570854|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570855|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
153570856|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153731831|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
153570857|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153570858|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570859|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
153570860|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
153570861|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153570862|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
153570863|NCT05269095|Anesthetics|anesthetics|mesh-list
153570864|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570865|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570866|NCT05267938|Lidocaine|lidocaine|mesh-list
153570867|NCT05267938|Epinephrine|epinephrine|mesh-list
153570868|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
153570869|NCT05267938|Anesthetics|anesthetics|mesh-list
153570870|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626781|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
153457897|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457898|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
153457899|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457900|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457901|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153457902|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
153457903|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457904|NCT00217620|Sorafenib|sorafenib|mesh-list
153457905|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457906|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153457907|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457908|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457909|NCT00217464|Fulvestrant|fulvestrant|mesh-list
153457910|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153570871|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570872|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
153814610|NCT00452634|Simvastatin|simvastatin|mesh-list
153814611|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570873|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570874|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153570875|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153570876|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153570877|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570878|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570879|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153570880|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153570881|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
153570882|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570884|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153570885|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
153570886|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153570887|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
153570888|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
153570889|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
153570890|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153570891|NCT05267431|Methotrexate|methotrexate|mesh-list
153570892|NCT05267431|Hydroquinone|hydroquinone|mesh-list
153570893|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153570894|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
153570895|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153570898|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
153570917|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153570918|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153570919|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
153570920|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153570921|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
153570922|NCT05264584|Febuxostat|febuxostat|mesh-list
153570923|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153570924|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
153570926|NCT05264584|Expectorants|expectorants|mesh-ancestor
153570927|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
153570928|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153570929|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
153570930|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570931|NCT05264584|Protective Agents|protective agents|mesh-ancestor
153570932|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570933|NCT05264584|Antidotes|antidotes|mesh-ancestor
153570934|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
153570935|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153570936|NCT05262686|Aldesleukin|aldesleukin|mesh-list
153570937|NCT05262686|Interleukin-2|interleukin-2|mesh-list
153570938|NCT05262686|Belimumab|belimumab|mesh-list
153570939|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570940|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153570941|NCT05262686|Analgesics|analgesics|mesh-ancestor
153570942|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
153570943|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570944|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570945|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153570946|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
153570947|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153570948|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153570949|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
153382823|NCT01710332|Aflibercept|aflibercept|mesh-list
153570950|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570951|NCT05236608|Nivolumab|nivolumab|mesh-list
153570952|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153570953|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570954|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153570955|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570956|NCT05225402|Norepinephrine|norepinephrine|mesh-list
153570957|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153570962|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570963|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
153570964|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
153570965|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570966|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153570967|NCT05220826|Ethanol|ethanol|mesh-list
153570968|NCT05220826|Ethylene|ethylene|mesh-list
153570969|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153570970|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570971|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457911|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816562|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816563|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816564|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816565|NCT00425711|Acamprosate|acamprosate|mesh-list
153816566|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153816567|NCT03274011|Apatinib|apatinib|mesh-list
153816568|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816569|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816570|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816571|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816572|NCT00425906|Nicotine|nicotine|mesh-list
153816573|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153816574|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
153816575|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816576|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816577|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153816578|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153816579|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
153816581|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816582|NCT00467376|Insulin|insulin|mesh-list
153816583|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153816584|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
153457913|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153816585|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
153816586|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153816587|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816588|NCT00426023|Ketotifen|ketotifen|mesh-list
153816589|NCT00426023|Cyclosporine|cyclosporine|mesh-list
153816590|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153816591|NCT00426023|Cyclosporins|cyclosporins|mesh-list
153816592|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816593|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816594|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816595|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
153816596|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816597|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
153668017|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816598|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570972|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570974|NCT05220826|Growth Substances|growth substances|mesh-ancestor
153570975|NCT05210413|Spartalizumab|spartalizumab|mesh-list
153570976|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153570977|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570978|NCT05210413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153570979|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570980|NCT05203705|Enoxaparin|enoxaparin|mesh-list
153570981|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
153570982|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153570983|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153570984|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570985|NCT05202561|Vaccines|vaccines|mesh-list
153570986|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
153570987|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570988|NCT05192629|Midazolam|midazolam|mesh-list
153570989|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
153570990|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153570991|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153570992|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570993|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153570994|NCT05192629|Analgesics|analgesics|mesh-ancestor
153570995|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
153570996|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570997|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153570998|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153570999|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153571000|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
153571001|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571002|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571003|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153571004|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153571005|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153571011|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
153571012|NCT05189444|Amoxicillin|amoxicillin|mesh-list
153571013|NCT05189444|Clarithromycin|clarithromycin|mesh-list
153571014|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
153571015|NCT05189444|Esomeprazole|esomeprazole|mesh-list
153571016|NCT05189444|Bismuth|bismuth|mesh-list
153571017|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571018|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571019|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571020|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153571021|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571022|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153571023|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571024|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153571025|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153571026|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153571028|NCT05189444|Diuretics|diuretics|mesh-ancestor
153571029|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
153571030|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571031|NCT05189444|Expectorants|expectorants|mesh-ancestor
153571032|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
153571033|NCT05175274|Colchicine|colchicine|mesh-list
153571034|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
153571035|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571036|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
153571037|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
153571038|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
153571039|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571040|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571042|NCT05129137|Nefopam|nefopam|mesh-list
153571057|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
153571058|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571059|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153571060|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153571061|NCT05096325|Insulin|insulin|mesh-list
153571062|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153571063|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571064|NCT05096065|Leuprolide|leuprolide|mesh-list
153571065|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153571066|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
153571067|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153571068|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571069|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153571070|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571071|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153571072|NCT05083572|Rifaximin|rifaximin|mesh-list
153571073|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571074|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571075|NCT05030025|Lamivudine|lamivudine|mesh-list
153571076|NCT05030025|Abacavir|abacavir|mesh-list
153571079|NCT05030025|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
153571080|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153571081|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153571082|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571083|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571084|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
153571085|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571086|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153571102|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571104|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571105|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571106|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
153571107|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571108|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571109|NCT04989049|Folic Acid|folic acid|mesh-list
153571111|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
153571112|NCT04989049|Vitamins|vitamins|mesh-ancestor
153571113|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
153571114|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571115|NCT04984044|Vitamin D|vitamin d|mesh-list
153571116|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
153571117|NCT04984044|Vitamins|vitamins|mesh-ancestor
153571118|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
153571119|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571120|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153814618|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
153814619|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153571121|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153571122|NCT04975802|Caffeine|caffeine|mesh-list
153571123|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153571124|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571125|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153571127|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816600|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816601|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153816602|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153816603|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
153816604|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153816605|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
153816606|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
153816607|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816608|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153816609|NCT00467454|Naltrexone|naltrexone|mesh-list
153842866|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816610|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153816611|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153816612|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816613|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
153816614|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816615|NCT00426101|Cyclosporine|cyclosporine|mesh-list
153816616|NCT00426101|Dexamethasone|dexamethasone|mesh-list
153457951|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457952|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
153457953|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457954|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457955|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153571128|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153571129|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153571130|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
153571131|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571132|NCT04964700|Natalizumab|natalizumab|mesh-list
153571133|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
153571134|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571135|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153571136|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
153571137|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153571138|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153571139|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153571140|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571141|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571142|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
153571144|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571146|NCT04897802|Exenatide|exenatide|mesh-list
153571147|NCT04897802|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153571148|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153571149|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571150|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153571151|NCT04897802|Incretins|incretins|mesh-ancestor
153571152|NCT04897802|Hormones|hormones|mesh-ancestor
153571153|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153571154|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
153571155|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
153571156|NCT04882332|Vitamins|vitamins|mesh-ancestor
153571157|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
153571158|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571159|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
153457956|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
153457957|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457958|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457959|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153457960|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153457961|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
153457962|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457963|NCT03592836|Furosemide|furosemide|mesh-list
153457965|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153457966|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
153457967|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571160|NCT04882332|Hematinics|hematinics|mesh-ancestor
153571161|NCT04871425|Fentanyl|fentanyl|mesh-list
153571162|NCT04871425|Ketamine|ketamine|mesh-list
153571163|NCT04871425|Analgesics|analgesics|mesh-ancestor
153571164|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
153571165|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571167|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153571168|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153571169|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
153571170|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
153571171|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571172|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153571173|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153571174|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571175|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571176|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153571177|NCT04871425|Narcotics|narcotics|mesh-ancestor
153571178|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153571179|NCT04869605|Chrysarobin|chrysarobin|mesh-list
153571180|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153571181|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153571182|NCT04869605|Analgesics|analgesics|mesh-ancestor
153571183|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
153571184|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571185|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457968|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153457969|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457972|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
153457973|NCT04197570|Analgesics|analgesics|mesh-list
153457974|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
153457975|NCT04197570|Anesthetics|anesthetics|mesh-list
153457976|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457977|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457978|NCT04197570|Narcotics|narcotics|mesh-ancestor
153816618|NCT00426101|Cyclosporins|cyclosporins|mesh-list
153816619|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816620|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
153816621|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
153816622|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816623|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816624|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816625|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
153816626|NCT00426101|Hormones|hormones|mesh-ancestor
153820693|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
153571186|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571187|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571188|NCT04835584|Dasatinib|dasatinib|mesh-list
153571189|NCT04835584|Nilotinib|nilotinib|mesh-list
153571190|NCT04835584|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153571191|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153571192|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571193|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571194|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571195|NCT04774315|Omalizumab|omalizumab|mesh-list
153571196|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153571197|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153571198|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
153571199|NCT04767503|Propofol|propofol|mesh-list
153571200|NCT04767503|Desflurane|desflurane|mesh-list
153571201|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153363832|NCT01726478|Oxytocin|oxytocin|mesh-list
153814624|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571202|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571203|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571204|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153571205|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
153571206|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
153571207|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153571208|NCT04722679|Anticoagulants|anticoagulants|mesh-list
153571209|NCT04696380|Nicotine|nicotine|mesh-list
153571210|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153571211|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
153571212|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571213|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571214|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153571215|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153571216|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
153816627|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153816628|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153816629|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816630|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153816631|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153877688|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153877689|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
153816632|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153816633|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816634|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816635|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816636|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
153816637|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
153816638|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816639|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571217|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571218|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571220|NCT04672772|Cetuximab|cetuximab|mesh-list
153571221|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153571222|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571223|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
153571224|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
153571225|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
153571226|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571227|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571228|NCT04671082|Tolperisone|tolperisone|mesh-list
153571231|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153571232|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571234|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571235|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153571236|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571237|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571238|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
153571239|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153571240|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
153571241|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571242|NCT04658823|Vitamin E|vitamin e|mesh-list
153571243|NCT04658823|Tocopherols|tocopherols|mesh-list
153571244|NCT04658823|Tocotrienols|tocotrienols|mesh-list
153571245|NCT04658823|Tocovid|tocovid|mesh-list
153571246|NCT04658823|Vitamins|vitamins|mesh-ancestor
153571247|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
153571248|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571249|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
153816640|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816641|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153816642|NCT00426140|Epothilone B|epothilone b|mesh-list
153816643|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816644|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
153816645|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
153816646|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
153820694|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571250|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571251|NCT04658823|Protective Agents|protective agents|mesh-ancestor
153571252|NCT04640818|Rituximab|rituximab|mesh-list
153571253|NCT04640818|Cladribine|cladribine|mesh-list
153571254|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
153571255|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571256|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571257|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
153571258|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571259|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571260|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153571261|NCT04588857|Dexamethasone|dexamethasone|mesh-list
153571262|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571263|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
153571264|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
153571265|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877690|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
153877691|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877692|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877693|NCT05499390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153877694|NCT05499390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877695|NCT05440383|Leuprolide|leuprolide|mesh-list
153418467|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571266|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571267|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571268|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
153571269|NCT04588857|Hormones|hormones|mesh-ancestor
153571270|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153571271|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153571272|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571273|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
153571274|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
153571275|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814630|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
153360215|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153571276|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571277|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571278|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
153571279|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
153571280|NCT04542980|Autoantibodies|autoantibodies|mesh-list
153571281|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
153571282|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816647|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816648|NCT00467493|Anastrozole|anastrozole|mesh-list
153816649|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153816650|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816651|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153816652|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153816653|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571283|NCT04529499|Favipiravir|favipiravir|mesh-list
153571284|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
153571285|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571286|NCT04523428|Venetoclax|venetoclax|mesh-list
153571287|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
153571288|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571289|NCT04523428|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153571290|NCT04523428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153571291|NCT04523428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571292|NCT04523428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571293|NCT04508504|Ropivacaine|ropivacaine|mesh-list
153571294|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
153571295|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
153571296|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571297|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571298|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
153571299|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571301|NCT04490707|Azacitidine|azacitidine|mesh-list
153571302|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
153571303|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571304|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153571305|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153571306|NCT04490707|Growth Substances|growth substances|mesh-ancestor
153571307|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
153571308|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571309|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153571310|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
153571311|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571312|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816654|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816655|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153816656|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
153816657|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153577731|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153577732|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153577733|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577734|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577735|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
153577736|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577740|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577741|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577743|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
153577744|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577745|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153577746|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153577747|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577748|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577749|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
153577750|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577751|NCT01719614|Metformin|metformin|mesh-list
153577752|NCT01719614|Rilpivirine|rilpivirine|mesh-list
153577753|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153817759|NCT06117969|Hormone Antagonists|hormone antagonists|mesh-ancestor
153817760|NCT06117969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817761|NCT06117969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817762|NCT06117969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153817763|NCT06117969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153817764|NCT06117969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817765|NCT06117969|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153817766|NCT06117969|Anabolic Agents|anabolic agents|mesh-ancestor
153817767|NCT06117969|Hormones|hormones|mesh-ancestor
153817768|NCT06110793|Lenvatinib|lenvatinib|mesh-list
153828124|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828125|NCT00483626|Urological Agents|urological agents|mesh-ancestor
153828127|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
153828128|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
153828129|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153828130|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
153828131|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
153828132|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828133|NCT05644210|Aspirin|aspirin|mesh-list
153828134|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
153828135|NCT05644210|Prednisone|prednisone|mesh-list
153828136|NCT05644210|Rituximab|rituximab|mesh-list
153828137|NCT05644210|Warfarin|warfarin|mesh-list
153828138|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153828139|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368453|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
153368454|NCT04743687|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153368455|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368456|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368498|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153368499|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368500|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368501|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153368517|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153368519|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153368520|NCT02481219|Erythromycin|erythromycin|mesh-list
153368521|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
153368522|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153368523|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
153368524|NCT02481219|Metoclopramide|metoclopramide|mesh-list
153368525|NCT02481219|Bisacodyl|bisacodyl|mesh-list
153368526|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153368557|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368558|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153368559|NCT01165112|Rituximab|rituximab|mesh-list
153368560|NCT01165112|Carboplatin|carboplatin|mesh-list
153418477|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153418478|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153418479|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
153368561|NCT01165112|Etoposide|etoposide|mesh-list
153368562|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153577788|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153577789|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153577790|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577791|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820844|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153820845|NCT04702061|Anesthetics|anesthetics|mesh-list
153820846|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820847|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360833|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
153360834|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828577|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153828578|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
153828579|NCT00484640|Warfarin|warfarin|mesh-list
153828580|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
153368588|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368592|NCT01166126|Sirolimus|sirolimus|mesh-list
153577793|NCT01719835|Prednisolone|prednisolone|mesh-list
153577794|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
153577795|NCT01719835|Gemcitabine|gemcitabine|mesh-list
153577796|NCT01719835|Doxorubicin|doxorubicin|mesh-list
153577797|NCT01719835|Vincristine|vincristine|mesh-list
153577798|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459163|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459164|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153459165|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459167|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459168|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577799|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
153577800|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577801|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577802|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153577803|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
153577804|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577805|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577806|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153577807|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153820848|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
153360835|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153360837|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153828587|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153828588|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
153828589|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828590|NCT00484809|Etanercept|etanercept|mesh-list
153828591|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153828592|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828593|NCT00484809|Analgesics|analgesics|mesh-ancestor
153828594|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
153828595|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828596|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577808|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
153577809|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153577810|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153577811|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153577812|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577813|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153577824|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153577825|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153577826|NCT01719835|Protective Agents|protective agents|mesh-ancestor
153817782|NCT06097676|Analgesics|analgesics|mesh-ancestor
153817783|NCT06097676|Sensory System Agents|sensory system agents|mesh-ancestor
153817784|NCT06097676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817785|NCT06097676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817786|NCT06097676|Anticonvulsants|anticonvulsants|mesh-ancestor
153817787|NCT06097676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153817788|NCT06097676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153817789|NCT06097676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360838|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153817790|NCT06097676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153820701|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
153577827|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153577828|NCT01719926|Indomethacin|indomethacin|mesh-list
153577829|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153577830|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153577831|NCT01719926|Analgesics|analgesics|mesh-ancestor
153577832|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
153577833|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577834|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577835|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577836|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577837|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
153577838|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
153577839|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153577840|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153577841|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577842|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577843|NCT01719952|Oxytocin|oxytocin|mesh-list
153577844|NCT01719952|Carbetocin|carbetocin|mesh-list
153577845|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
153577846|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153817791|NCT06097676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153817792|NCT06097676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153817793|NCT06097676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817794|NCT06097676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817795|NCT06097676|Antimanic Agents|antimanic agents|mesh-ancestor
153817796|NCT06097676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153817797|NCT06097676|GABA Modulators|gaba modulators|mesh-ancestor
153817798|NCT06097676|GABA Agents|gaba agents|mesh-ancestor
153817799|NCT06088030|Arsenic Trioxide|arsenic trioxide|mesh-list
153817800|NCT06088030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817801|NCT06056245|Methadone|methadone|mesh-list
153817802|NCT06056245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153817803|NCT06056245|Narcotics|narcotics|mesh-ancestor
153459169|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459170|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
153459171|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153459172|NCT01675362|Selenium|selenium|mesh-list
153828637|NCT01241409|Rabeprazole|rabeprazole|mesh-list
153459173|NCT01675362|Losartan|losartan|mesh-list
153459174|NCT01675362|Verapamil|verapamil|mesh-list
153877696|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153459175|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
153459176|NCT01675362|Calcium|calcium|mesh-list
153459177|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153459178|NCT01675362|Antioxidants|antioxidants|mesh-list
153459179|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153459180|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459182|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153459183|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153459184|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459185|NCT01675362|Protective Agents|protective agents|mesh-ancestor
153459186|NCT01675362|Trace Elements|trace elements|mesh-ancestor
153459187|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
153459188|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459190|NCT01675518|ASP7991|asp7991|mesh-list
153577847|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577849|NCT01719978|Racepinephrine|racepinephrine|mesh-list
153577850|NCT01719978|Mepivacaine|mepivacaine|mesh-list
153577851|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
153577852|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153577853|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153577854|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
153577855|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577856|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577857|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577858|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153577859|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153577860|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
153577861|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577862|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153577863|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
153577864|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
153577865|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
153577866|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153577867|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
153577868|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
153577869|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820852|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360839|NCT01476449|Growth Substances|growth substances|mesh-ancestor
153360840|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360841|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
153828673|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153828674|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153828675|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577870|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
153459191|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153459192|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
153459193|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459194|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459195|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
153459196|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
153459197|NCT01675986|Pregabalin|pregabalin|mesh-list
153459198|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
153459199|NCT01675986|Analgesics|analgesics|mesh-ancestor
153817804|NCT06056245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817805|NCT06056245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817806|NCT06056245|Analgesics|analgesics|mesh-ancestor
153817807|NCT06056245|Sensory System Agents|sensory system agents|mesh-ancestor
153817808|NCT06056245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817809|NCT06056245|Antitussive Agents|antitussive agents|mesh-ancestor
153817810|NCT06056245|Respiratory System Agents|respiratory system agents|mesh-ancestor
153817811|NCT06041048|Modafinil|modafinil|mesh-list
153877697|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
153877698|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153877699|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877700|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153357404|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817812|NCT06041048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153817813|NCT06041048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817814|NCT06041048|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153817815|NCT06041048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153817816|NCT06041048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153459200|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
153817817|NCT06041048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817818|NCT06005480|Prilocaine|prilocaine|mesh-list
153817819|NCT06005480|Mepivacaine|mepivacaine|mesh-list
153817820|NCT06005480|Anesthetics, Local|anesthetics, local|mesh-ancestor
153577871|NCT01720459|Resveratrol|resveratrol|mesh-list
153577872|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
153368714|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368715|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
153368717|NCT01168934|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153368718|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368719|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368720|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368721|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368722|NCT01170884|Timolol|timolol|mesh-list
153368723|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153368724|NCT01170884|Bimatoprost|bimatoprost|mesh-list
153368725|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153368726|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153368727|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577873|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577874|NCT01720459|Protective Agents|protective agents|mesh-ancestor
153577875|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577876|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577877|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153577878|NCT01720537|Bococizumab|bococizumab|mesh-list
153577879|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153577880|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153577881|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153828696|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153828697|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828698|NCT00485160|Analgesics|analgesics|mesh-ancestor
153828699|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
153828700|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828701|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828702|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828703|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828704|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153828705|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828706|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828707|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
153577882|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
153577883|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577884|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153817822|NCT06005480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817823|NCT06005480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817824|NCT06005480|Sensory System Agents|sensory system agents|mesh-ancestor
153817825|NCT06005480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817826|NCT06003218|Dexmedetomidine|dexmedetomidine|mesh-list
153817827|NCT06003218|Remifentanil|remifentanil|mesh-list
153817828|NCT06003218|Oxycodone|oxycodone|mesh-list
153817829|NCT06003218|Esketamine|esketamine|mesh-list
153817830|NCT06003218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153817831|NCT06003218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817832|NCT06003218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817833|NCT06003218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817834|NCT06003218|Analgesics|analgesics|mesh-ancestor
153817835|NCT06003218|Sensory System Agents|sensory system agents|mesh-ancestor
153817836|NCT06003218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368736|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153360846|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360847|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817837|NCT06003218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153817838|NCT06003218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153817839|NCT06003218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153817840|NCT06003218|Adrenergic Agents|adrenergic agents|mesh-ancestor
153817841|NCT06003218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817842|NCT06003218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817843|NCT06003218|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153817844|NCT06003218|Narcotics|narcotics|mesh-ancestor
153817845|NCT06003218|Antidepressive Agents|antidepressive agents|mesh-ancestor
153817846|NCT06003218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153459214|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153459215|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
153459216|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
153459217|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459218|NCT03875664|Bupivacaine|bupivacaine|mesh-list
153459219|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
153459220|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
153459221|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459222|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459223|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
153459224|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459225|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
153459226|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
153459227|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153459228|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153459229|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459230|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577886|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577887|NCT01720719|Vitamin E|vitamin e|mesh-list
153577888|NCT01720719|Atorvastatin|atorvastatin|mesh-list
153828721|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577889|NCT01720719|Vitamins|vitamins|mesh-ancestor
153577890|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
153577891|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577892|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153577893|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153577894|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
153577895|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577896|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153577897|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153577898|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577899|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
153577900|NCT01720719|Protective Agents|protective agents|mesh-ancestor
153577901|NCT01722214|Adalimumab|adalimumab|mesh-list
153577902|NCT01722214|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153577903|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577943|NCT01724450|Protective Agents|protective agents|mesh-ancestor
153577944|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153577945|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577946|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153577947|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
153577948|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153577949|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153577950|NCT01724723|Entecavir|entecavir|mesh-list
153577951|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
153577952|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577953|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153577955|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577964|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153577965|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577966|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153577967|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153577968|NCT01727427|Aspirin|aspirin|mesh-list
153577969|NCT01727427|Vitamin K|vitamin k|mesh-list
153459231|NCT01670136|Urological Agents|urological agents|mesh-ancestor
153459232|NCT03873480|Epinephrine|epinephrine|mesh-list
153459233|NCT03873480|Bupivacaine|bupivacaine|mesh-list
153459234|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153459235|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153577970|NCT01727427|Heparin|heparin|mesh-list
153577971|NCT01727427|Enoxaparin|enoxaparin|mesh-list
153577972|NCT01727427|Dalteparin|dalteparin|mesh-list
153820863|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153368768|NCT01136798|Incretins|incretins|mesh-ancestor
153577973|NCT01727427|Tinzaparin|tinzaparin|mesh-list
153577975|NCT01727427|Nadroparin|nadroparin|mesh-list
153577976|NCT01727427|Warfarin|warfarin|mesh-list
153577977|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
153577978|NCT01727427|Dabigatran|dabigatran|mesh-list
153577979|NCT01727427|Apixaban|apixaban|mesh-list
153577980|NCT01727427|Fondaparinux|fondaparinux|mesh-list
153577981|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
153577982|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
153577983|NCT01727427|Bemiparin|bemiparin|mesh-list
153577984|NCT01727427|Vitamins|vitamins|mesh-ancestor
153577985|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
153577986|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577987|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153577988|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153577989|NCT01727427|Analgesics|analgesics|mesh-ancestor
153577990|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
153577991|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817847|NCT06002607|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153817848|NCT06002607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153817849|NCT06002607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817850|NCT06002607|Antitubercular Agents|antitubercular agents|mesh-ancestor
153817851|NCT05987956|Alectinib|alectinib|mesh-list
153817852|NCT05987956|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153817853|NCT05987956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153817854|NCT05987956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817862|NCT05981118|Glucocorticoids|glucocorticoids|mesh-ancestor
153817864|NCT05981118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817865|NCT05981118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817866|NCT05981118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153817867|NCT05981118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153817868|NCT05956769|Tranexamic Acid|tranexamic acid|mesh-list
153459237|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459238|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577992|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577993|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577994|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153577995|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153843412|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577996|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577997|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153577998|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153577999|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578000|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
153578001|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
153578002|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153578003|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
153578004|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153578005|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
153578006|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153578007|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
153578008|NCT01727427|Coagulants|coagulants|mesh-ancestor
153578010|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
153578011|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
153578012|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578013|NCT01728025|Ranolazine|ranolazine|mesh-list
153578014|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153578015|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626788|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459239|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459240|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153459241|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153459242|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
153459243|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459244|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153459245|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
153459246|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
153459247|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
153459248|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153459249|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
153459250|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
153459251|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459252|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
153459253|NCT04764084|Niraparib|niraparib|mesh-list
153459254|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153459255|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459256|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828781|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153828782|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153368796|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820867|NCT00465192|Estrogens|estrogens|mesh-ancestor
153820868|NCT00465192|Hormones|hormones|mesh-ancestor
153360853|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459257|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459258|NCT03866538|Budesonide|budesonide|mesh-list
153459259|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153459260|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153578016|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578017|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
153578018|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153578019|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578020|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153578030|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153578031|NCT01730157|Ipilimumab|ipilimumab|mesh-list
153578032|NCT01730157|Antibodies|antibodies|mesh-list
153578033|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
153578034|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153578035|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
153578036|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578037|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578038|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153578039|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578040|NCT01730209|Everolimus|everolimus|mesh-list
153578041|NCT01730209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153578042|NCT01730209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153578043|NCT01730209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578044|NCT01730209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578045|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153578046|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
153820702|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
153578047|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578048|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578050|NCT01730222|Gemcitabine|gemcitabine|mesh-list
153578051|NCT01730222|Capecitabine|capecitabine|mesh-list
153578052|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153578053|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578054|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
153578055|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
153578056|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
153578057|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578058|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153578059|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
153578060|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
153578061|NCT01730287|Calcium|calcium|mesh-list
153578062|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153578063|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578064|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153578065|NCT01730326|Acetaminophen|acetaminophen|mesh-list
153578066|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153578067|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578068|NCT01730326|Analgesics|analgesics|mesh-ancestor
153578069|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
153578070|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578071|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578072|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
153578073|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153578074|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578077|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578078|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578079|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368821|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
153368822|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368823|NCT01138124|Gabapentin|gabapentin|mesh-list
153368824|NCT01138124|Analgesics|analgesics|mesh-ancestor
153368825|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
153368826|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368827|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368828|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
153578080|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153578081|NCT01730495|Etanercept|etanercept|mesh-list
153578082|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153578083|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578084|NCT01730495|Analgesics|analgesics|mesh-ancestor
153578085|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
153578086|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578087|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578088|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578089|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578090|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578091|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153578092|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
153817874|NCT05931601|Norepinephrine|norepinephrine|mesh-list
153817875|NCT05931601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153817876|NCT05931601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153817877|NCT05931601|Adrenergic Agents|adrenergic agents|mesh-ancestor
153817878|NCT05931601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817879|NCT05931601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817880|NCT05931601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383638|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
153817881|NCT05931601|Sympathomimetics|sympathomimetics|mesh-ancestor
153817882|NCT05931601|Autonomic Agents|autonomic agents|mesh-ancestor
153817883|NCT05931601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817884|NCT05931601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153817885|NCT05918029|Potassium Citrate|potassium citrate|mesh-list
153828808|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828809|NCT00489593|Olanzapine|olanzapine|mesh-list
153828810|NCT00489593|Fluoxetine|fluoxetine|mesh-list
153828811|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
153828812|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
153828813|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828814|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817886|NCT05918029|Diuretics|diuretics|mesh-ancestor
153817887|NCT05918029|Natriuretic Agents|natriuretic agents|mesh-ancestor
153817888|NCT05918029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817889|NCT05918029|Expectorants|expectorants|mesh-ancestor
153817890|NCT05918029|Respiratory System Agents|respiratory system agents|mesh-ancestor
153817891|NCT05859477|Capecitabine|capecitabine|mesh-list
153817892|NCT05859477|Nivolumab|nivolumab|mesh-list
153817893|NCT05859477|Oxaliplatin|oxaliplatin|mesh-list
153459261|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
153459262|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459263|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459264|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153459265|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
153459266|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
153459267|NCT03866538|Hormones|hormones|mesh-ancestor
153459268|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459269|NCT01677390|Everolimus|everolimus|mesh-list
153459270|NCT01677390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153459271|NCT01677390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368848|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368849|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153368850|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368851|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368852|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
153368853|NCT02561481|Sulforaphane|sulforaphane|mesh-list
153368854|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153368855|NCT02561481|Protective Agents|protective agents|mesh-ancestor
153368856|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368857|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368858|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
153368859|NCT01173848|Vitamin D|vitamin d|mesh-list
153368860|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
153368861|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153368862|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368863|NCT01173848|Vitamins|vitamins|mesh-ancestor
153459272|NCT01677390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459273|NCT01677390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459274|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459275|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
153459276|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459277|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459278|NCT03749070|Silymarin|silymarin|mesh-list
153459279|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
153578094|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
153578095|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578096|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
153578097|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578098|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
153578099|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578102|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
153578113|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
153578114|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578115|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820703|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
153578116|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578117|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
153578118|NCT01730664|Ertapenem|ertapenem|mesh-list
153578119|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153578120|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578121|NCT01730677|Vinorelbine|vinorelbine|mesh-list
153578122|NCT01730677|Lapatinib|lapatinib|mesh-list
153578123|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153578124|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578125|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
153578126|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
153578127|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
153578128|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578129|NCT01730677|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153578130|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153578131|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578132|NCT01730976|Vitamin D|vitamin d|mesh-list
153578133|NCT01730976|Vitamins|vitamins|mesh-list
153578134|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
153578135|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578136|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153817894|NCT05859477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153817895|NCT05859477|Antimetabolites|antimetabolites|mesh-ancestor
153817897|NCT05859477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817898|NCT05859477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817899|NCT05859477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153817900|NCT05855200|Dostarlimab|dostarlimab|mesh-list
153817901|NCT05855200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817902|NCT05851924|Capecitabine|capecitabine|mesh-list
153817903|NCT05851924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153817904|NCT05851924|Antimetabolites|antimetabolites|mesh-ancestor
153817905|NCT05851924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817906|NCT05851924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817907|NCT05841290|Anesthetics|anesthetics|mesh-list
153817908|NCT05841290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817909|NCT05841290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817910|NCT05825963|Psyllium|psyllium|mesh-list
153817911|NCT05825963|Cathartics|cathartics|mesh-ancestor
153459280|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459281|NCT03749070|Protective Agents|protective agents|mesh-ancestor
153459282|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459284|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153459285|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
153459286|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578137|NCT01731067|Fexofenadine|fexofenadine|mesh-list
153578138|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
153578139|NCT01731067|Midazolam|midazolam|mesh-list
153578140|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
153578141|NCT01731067|Caffeine|caffeine|mesh-list
153578142|NCT01731067|Bupropion|bupropion|mesh-list
153578143|NCT01731067|Omeprazole|omeprazole|mesh-list
153578144|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153578145|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153578146|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578147|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578148|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153452462|NCT01846416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828863|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
153578149|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153578150|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153578151|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153877709|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877710|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153877711|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153877713|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
153877714|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
153578152|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
153578153|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
153578154|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
153578155|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
153578156|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578157|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578158|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153578159|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153578160|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578161|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153578162|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153578163|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
153578164|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153578165|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578166|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153578167|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153578168|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
153578169|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153578170|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153578171|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459287|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459288|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153459289|NCT01345656|Diuretics|diuretics|mesh-ancestor
153578173|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153578174|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153578175|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
153578176|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
153578177|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153578178|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153578179|NCT01731067|Analgesics|analgesics|mesh-ancestor
153578180|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
153578181|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578182|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153820902|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820903|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153820904|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153828894|NCT01302067|Fesoterodine|fesoterodine|mesh-list
153578183|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578198|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153578199|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153578200|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153578201|NCT01731132|Trace Elements|trace elements|mesh-ancestor
153578202|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
153578203|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
153578204|NCT01731158|Bevacizumab|bevacizumab|mesh-list
153578205|NCT01731158|Sunitinib|sunitinib|mesh-list
153578206|NCT01731158|Everolimus|everolimus|mesh-list
153578207|NCT01731158|Sorafenib|sorafenib|mesh-list
153578208|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153578209|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578210|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153578211|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153578212|NCT01731158|Growth Substances|growth substances|mesh-ancestor
153578213|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578214|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
153877717|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877718|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
153877719|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
153843691|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
153578215|NCT01731158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153578216|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153578217|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817912|NCT05825963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817913|NCT05823480|Azacitidine|azacitidine|mesh-list
153817914|NCT05823480|Magrolimab|magrolimab|mesh-list
153817915|NCT05823480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153817916|NCT05823480|Antimetabolites|antimetabolites|mesh-ancestor
153817917|NCT05823480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817919|NCT05823480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817920|NCT05823480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817921|NCT05816057|Semaglutide|semaglutide|mesh-list
153817922|NCT05816057|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153817923|NCT05816057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153817924|NCT05816057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817925|NCT05806346|Tranexamic Acid|tranexamic acid|mesh-list
153817926|NCT05806346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153817927|NCT05806346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153817928|NCT05806346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817929|NCT05806346|Hemostatics|hemostatics|mesh-ancestor
153817930|NCT05806346|Coagulants|coagulants|mesh-ancestor
153820905|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153820906|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828901|NCT01302067|Urological Agents|urological agents|mesh-ancestor
153828902|NCT00485550|Methylphenidate|methylphenidate|mesh-list
153828903|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153828904|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153828905|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828906|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153828922|NCT00485576|Eculizumab|eculizumab|mesh-list
153817931|NCT05782361|Pembrolizumab|pembrolizumab|mesh-list
153817932|NCT05782361|Tepotinib|tepotinib|mesh-list
153578218|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578219|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153578220|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
153578221|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
153578222|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578223|NCT01731184|Midazolam|midazolam|mesh-list
153578224|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153578225|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153578226|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578227|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578228|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153578229|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153578230|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153578231|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153578232|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
153578233|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
153578234|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
153578235|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
153578236|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578237|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578238|NCT01731275|Quetmolimab|quetmolimab|mesh-list
153578239|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153578240|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578241|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
153820909|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
153578242|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578243|NCT01731301|Ribavirin|ribavirin|mesh-list
153578244|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
153817933|NCT05782361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817934|NCT05782361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817935|NCT05782361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153459305|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459307|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153459308|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
153459309|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153459310|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
153459311|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153459312|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
153459313|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153459314|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
153459315|NCT03649152|Propagermanium|propagermanium|mesh-list
153459316|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459317|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
153843749|NCT02920190|Hormones|hormones|mesh-ancestor
153459318|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
153459319|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459320|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
153459321|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153459322|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
153578245|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578247|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578248|NCT01731327|Tofacitinib|tofacitinib|mesh-list
153578249|NCT01731327|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153578250|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153578251|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578252|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578253|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
153578255|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153368990|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
153368991|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368992|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153368995|NCT02494713|Ketoconazole|ketoconazole|mesh-list
153578256|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817936|NCT05782361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817938|NCT05768711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817939|NCT05756621|Topiramate|topiramate|mesh-list
153817940|NCT05756621|Lacosamide|lacosamide|mesh-list
153578264|NCT01731457|Analgesics|analgesics|mesh-ancestor
153578265|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
153578266|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578267|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578268|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578269|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578270|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578271|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153578272|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
153578273|NCT01731561|Rituximab|rituximab|mesh-list
153578274|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153578275|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578276|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
153578277|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578278|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578279|NCT01731574|Dapivirine|dapivirine|mesh-list
153578280|NCT01731574|Miconazole|miconazole|mesh-list
153578281|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153578282|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153578283|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
153578284|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578285|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
153578286|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153578287|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153578288|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817941|NCT05756621|Phenytoin|phenytoin|mesh-list
153817942|NCT05756621|Midazolam|midazolam|mesh-list
153817943|NCT05756621|Ketamine|ketamine|mesh-list
153817944|NCT05756621|Levetiracetam|levetiracetam|mesh-list
153817945|NCT05756621|Thiopental|thiopental|mesh-list
153817946|NCT05756621|Anticonvulsants|anticonvulsants|mesh-list
153817947|NCT05756621|Propofol|propofol|mesh-list
153817948|NCT05756621|Anesthetics|anesthetics|mesh-list
153817949|NCT05756621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153817950|NCT05756621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357406|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153357407|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
153817951|NCT05756621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817953|NCT05756621|Anesthetics, General|anesthetics, general|mesh-ancestor
153817954|NCT05756621|Analgesics|analgesics|mesh-ancestor
153817955|NCT05756621|Sensory System Agents|sensory system agents|mesh-ancestor
153817956|NCT05756621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817957|NCT05756621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153817958|NCT05756621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153459327|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153459328|NCT02082678|Ondansetron|ondansetron|mesh-list
153459329|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
153459330|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
153459331|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459332|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459333|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459334|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
153578289|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578290|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153578291|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
153578292|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578293|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578294|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153578295|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153578296|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
153578297|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153578298|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
153578299|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578300|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578301|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153578302|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
153578303|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578304|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578305|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153578307|NCT01731652|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153578308|NCT01731652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578309|NCT01731652|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153578310|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
153578311|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578312|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153578313|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578314|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
153578315|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
153578316|NCT01731756|Salicylates|salicylates|mesh-list
153578317|NCT01731756|Petrolatum|petrolatum|mesh-list
153578318|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578319|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
153578320|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
153369012|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153369014|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369015|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369016|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153369017|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153820911|NCT04702334|Protective Agents|protective agents|mesh-ancestor
153820912|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
153360891|NCT01376297|Hormones|hormones|mesh-ancestor
153578321|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
153578322|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153578323|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578324|NCT01731756|Analgesics|analgesics|mesh-ancestor
153578326|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578327|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843841|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
153578328|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578329|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578330|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153578331|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578332|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578333|NCT01731756|Emollients|emollients|mesh-ancestor
153578334|NCT01731795|Dexamethasone|dexamethasone|mesh-list
153578335|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
153578336|NCT01731795|BB 1101|bb 1101|mesh-list
153578337|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578338|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
153578339|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
153578340|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415258|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
153828985|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153828986|NCT00490178|Metformin|metformin|mesh-list
153828987|NCT00490178|Fenofibrate|fenofibrate|mesh-list
153828988|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153578341|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578342|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578343|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
153578344|NCT01731795|Hormones|hormones|mesh-ancestor
153578345|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459340|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459341|NCT01677468|Doxorubicin|doxorubicin|mesh-list
153459342|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153459343|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
153459344|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153459345|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459346|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153578351|NCT01731899|Agomelatine|agomelatine|mesh-list
153578352|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153578353|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578354|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578355|NCT01731925|Sunitinib|sunitinib|mesh-list
153578356|NCT01731925|Lanreotide|lanreotide|mesh-list
153578357|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578358|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153578359|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153578360|NCT01731925|Growth Substances|growth substances|mesh-ancestor
153578361|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578362|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
153578363|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153578364|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578365|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578366|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
153820913|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153360892|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153578367|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153578368|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153578369|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
153578370|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153578371|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
153578372|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153578373|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578374|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153578375|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153578376|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578377|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153578381|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153578382|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578383|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153578384|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153578385|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877720|NCT05418244|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153877721|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153578386|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
153578387|NCT01732146|Hematinics|hematinics|mesh-ancestor
153578388|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153578389|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
153578390|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578391|NCT01732224|Tenofovir|tenofovir|mesh-list
153578392|NCT01732224|Telbivudine|telbivudine|mesh-list
153578393|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
153578394|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578395|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153578396|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153578397|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358276|NCT01218971|Naltrexone|naltrexone|mesh-list
153578398|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578399|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153578400|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153578430|NCT01732380|Raltitrexed|raltitrexed|mesh-list
153578431|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578432|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153578433|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
153578434|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578435|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153829015|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153829016|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829017|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
153578436|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578437|NCT01732393|Quercetin|quercetin|mesh-list
153578438|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
153578439|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578440|NCT01732393|Protective Agents|protective agents|mesh-ancestor
153578441|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578442|NCT01732666|Remifentanil|remifentanil|mesh-list
153578443|NCT01732666|Nefopam|nefopam|mesh-list
153578444|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153578445|NCT01732666|Narcotics|narcotics|mesh-ancestor
153578446|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578490|NCT01733043|Analgesics|analgesics|mesh-ancestor
153578491|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
153578492|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578493|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153578494|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153578495|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153578496|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
153578497|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578498|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578499|NCT01733095|Ambrisentan|ambrisentan|mesh-list
153578500|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153578501|NCT01733108|Canagliflozin|canagliflozin|mesh-list
153578502|NCT01733108|Glyburide|glyburide|mesh-list
153578550|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578551|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153578552|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153578553|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578555|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153578556|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578557|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
153578558|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
153578559|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
153578560|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153578614|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578615|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153578617|NCT01734044|Dexamethasone|dexamethasone|mesh-list
153578618|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
153578619|NCT01734044|BB 1101|bb 1101|mesh-list
153578620|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578621|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
153578622|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
153578627|NCT01734044|Hormones|hormones|mesh-ancestor
153578680|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384029|NCT00356447|Estradiol|estradiol|mesh-list
153578681|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153578682|NCT01734473|Caseins|caseins|mesh-list
153578683|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
153578684|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
153578685|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578686|NCT01734564|Poly I-C|poly i-c|mesh-list
153578687|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153578750|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578751|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153578752|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153578753|NCT01735071|Growth Substances|growth substances|mesh-ancestor
153578754|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578755|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
153578756|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153578757|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
153578758|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578759|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153578760|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
153578761|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578762|NCT01735097|Vitamin E|vitamin e|mesh-list
153578763|NCT01735097|Vitamins|vitamins|mesh-ancestor
153578764|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
153578765|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578766|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
153578767|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578768|NCT01735097|Protective Agents|protective agents|mesh-ancestor
153578769|NCT01735123|Caseins|caseins|mesh-list
153369073|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153369074|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369075|NCT01650558|Chloroquine|chloroquine|mesh-list
153578770|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
153578771|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
153578772|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578773|NCT01735227|Omeprazole|omeprazole|mesh-list
153578798|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153578799|NCT01735318|Protective Agents|protective agents|mesh-ancestor
153578800|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578801|NCT01735344|Lisinopril|lisinopril|mesh-list
153578802|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153578803|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
153578804|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578867|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578868|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153578870|NCT01735864|Indirubin|indirubin|mesh-list
153578871|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153578872|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578873|NCT01735890|Amlodipine|amlodipine|mesh-list
153578874|NCT01735890|Valsartan|valsartan|mesh-list
153578875|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153578876|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153578877|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153578878|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153578879|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578880|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153578881|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820916|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153820917|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153820918|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578882|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
153578883|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153578884|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153843956|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153578885|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
153578886|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
153578887|NCT01736020|Ketamine|ketamine|mesh-list
153578888|NCT01736020|Propofol|propofol|mesh-list
153578889|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153578890|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153578891|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578892|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153578893|NCT01736020|Analgesics|analgesics|mesh-ancestor
153578894|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
153578895|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578896|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153578897|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153578898|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153578899|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
153578902|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153578903|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
153578904|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
153578905|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153578906|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153578907|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153578908|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153578966|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
153578967|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153578968|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578969|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153578970|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153578971|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153578972|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
153369112|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415260|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
153820919|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820920|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360897|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578973|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578974|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578975|NCT01736514|Allopurinol|allopurinol|mesh-list
153578977|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
153578978|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578979|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578980|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
153578981|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578982|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153578983|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
153578984|NCT01736514|Protective Agents|protective agents|mesh-ancestor
153578985|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578986|NCT01736670|Triamcinolone|triamcinolone|mesh-list
153578987|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153578988|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153579017|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153579018|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
153579019|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579020|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579021|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153579022|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153579023|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579024|NCT01736813|Maraviroc|maraviroc|mesh-list
153579025|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153579026|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153579027|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579028|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153579029|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153579030|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
153579031|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579032|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153579034|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579035|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153579036|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579037|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579038|NCT01736891|Rasagiline|rasagiline|mesh-list
153579039|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153579040|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579045|NCT01737008|Dacomitinib|dacomitinib|mesh-list
153579065|NCT01737177|Lenalidomide|lenalidomide|mesh-list
153579066|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153579067|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153579068|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579069|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
153579070|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579071|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579073|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153579074|NCT01737177|Growth Substances|growth substances|mesh-ancestor
153579075|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
153579076|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153579077|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
153579078|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579079|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
153579125|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579126|NCT01737411|Urological Agents|urological agents|mesh-ancestor
153579127|NCT01737541|Fluoxetine|fluoxetine|mesh-list
153579128|NCT01737541|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153579129|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153579130|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153579131|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579132|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579133|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
153579136|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
153579189|NCT01738087|Xhance|xhance|mesh-list
153579190|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
153579191|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579192|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153579193|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
153579194|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369139|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153369140|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
153820922|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
153360898|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153579195|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579196|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153579197|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
153579255|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579257|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
153579258|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579260|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153579261|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153579262|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
153579263|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579264|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
153579265|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
153579266|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579267|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579269|NCT01738451|Dabrafenib|dabrafenib|mesh-list
153579320|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153579321|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579322|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
153579323|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579324|NCT01738893|Gabapentin|gabapentin|mesh-list
153579325|NCT01738893|Analgesics|analgesics|mesh-ancestor
153579326|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
153579327|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579328|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579329|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
153579380|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153579381|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384210|NCT01815008|Aspirin|aspirin|mesh-list
153579382|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
153579383|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579384|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829104|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153579385|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153579386|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153579387|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579388|NCT01739218|Paclitaxel|paclitaxel|mesh-list
153579389|NCT01739218|Bevacizumab|bevacizumab|mesh-list
153579390|NCT01739218|Carboplatin|carboplatin|mesh-list
153579391|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153579392|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153579393|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
153579394|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
153579395|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
153579437|NCT01739582|Clomiphene|clomiphene|mesh-list
153579438|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
153579439|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153579440|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
153579441|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579442|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579443|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153579445|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153579446|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153579447|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153579448|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
153579503|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
153579504|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579505|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579506|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
153579507|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579508|NCT01739985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153579509|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153579571|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579572|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
153579573|NCT01740921|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153579574|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153579575|NCT01740921|Incretins|incretins|mesh-ancestor
153579576|NCT01740921|Hormones|hormones|mesh-ancestor
153579577|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579578|NCT01740947|Amphotericin B|amphotericin b|mesh-list
153579579|NCT01740947|Tobramycin|tobramycin|mesh-list
153579639|NCT01741285|Hormones|hormones|mesh-ancestor
153579640|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579641|NCT01741324|Vitamin D|vitamin d|mesh-list
153579642|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
153579643|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
153579644|NCT01741324|Vitamins|vitamins|mesh-list
153579645|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
153579646|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579647|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153579648|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153579649|NCT01741376|Progesterone|progesterone|mesh-list
153579650|NCT01741376|Progestins|progestins|mesh-ancestor
153579651|NCT01741376|Hormones|hormones|mesh-ancestor
153579652|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153579653|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579654|NCT01741389|Melatonin|melatonin|mesh-list
153579655|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
153579656|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579657|NCT01741389|Protective Agents|protective agents|mesh-ancestor
153579658|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579659|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153579660|NCT01741493|Upadacitinib|upadacitinib|mesh-list
153579661|NCT01741493|Tofacitinib|tofacitinib|mesh-list
153579667|NCT01741506|Dalteparin|dalteparin|mesh-list
153579692|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579694|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
153579695|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579696|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153579697|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153579698|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
153579699|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579700|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153579701|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
153579702|NCT01741558|Vitamins|vitamins|mesh-ancestor
153579703|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
153579704|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153579705|NCT01741623|Bisoprolol|bisoprolol|mesh-list
153579706|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153579707|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
153579708|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
153829139|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
153579709|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579750|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153579751|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153579752|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153579753|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153579754|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
153579755|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579756|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153579757|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153579760|NCT01742247|Hormones|hormones|mesh-ancestor
153579816|NCT01742429|Tetracycline|tetracycline|mesh-list
153579817|NCT01742429|Bismuth|bismuth|mesh-list
153579818|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153579819|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153579820|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153579821|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579822|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153579823|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153579824|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153579825|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153579826|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153579880|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153579881|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153579882|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153579883|NCT01742689|Indomethacin|indomethacin|mesh-list
153579885|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153579887|NCT01742689|Analgesics|analgesics|mesh-ancestor
153579888|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
153579889|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153579890|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153579899|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
153579943|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153579944|NCT01742793|Growth Substances|growth substances|mesh-ancestor
153579945|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
153579946|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580014|NCT01743157|Ipilimumab|ipilimumab|mesh-list
153580015|NCT01743157|Interleukin-2|interleukin-2|mesh-list
153580016|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153580017|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580018|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153580019|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153580020|NCT01743157|Growth Substances|growth substances|mesh-ancestor
153580021|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580022|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
153580023|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153580024|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580025|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153580026|NCT01743157|Analgesics|analgesics|mesh-ancestor
153580027|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
153580028|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580029|NCT01743235|Buspirone|buspirone|mesh-list
153580030|NCT01743235|Testosterone|testosterone|mesh-list
153580031|NCT01743235|Androgens|androgens|mesh-ancestor
153829159|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369186|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369187|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153369188|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
153360900|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
153360901|NCT00859040|Pasireotide|pasireotide|mesh-list
153360902|NCT00859040|Hormones|hormones|mesh-ancestor
153820924|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820925|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153820926|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153580032|NCT01743235|Hormones|hormones|mesh-ancestor
153580033|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153580034|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580069|NCT01743365|Afatinib|afatinib|mesh-list
153580070|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580071|NCT01743365|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153580072|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580073|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580074|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580075|NCT01743378|Ropivacaine|ropivacaine|mesh-list
153580076|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
153580136|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580137|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580138|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580139|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580140|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153580141|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153580142|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
153580143|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
153580144|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
153580145|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580202|NCT01744236|Exenatide|exenatide|mesh-list
153580203|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153360903|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360904|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580204|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580205|NCT01744236|Incretins|incretins|mesh-ancestor
153580206|NCT01744236|Hormones|hormones|mesh-ancestor
153580207|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153580208|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153580209|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
153580210|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580211|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580212|NCT01744236|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153580213|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153580263|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580264|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
153580265|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153580266|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153580267|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580268|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580269|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153580270|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153580271|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580331|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580332|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
153580333|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153580334|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153580335|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
153829165|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829166|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153829167|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829168|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829169|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153829170|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153829171|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829172|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829173|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829174|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829175|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829176|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829177|NCT04511715|Bevacizumab|bevacizumab|mesh-list
153369204|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153580397|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153580398|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
153580399|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
153580400|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580401|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580402|NCT01745601|Dexetimide|dexetimide|mesh-list
153580403|NCT01745601|Citalopram|citalopram|mesh-list
153580404|NCT01745601|Escitalopram|escitalopram|mesh-list
153580405|NCT01745601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153580406|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153580407|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153580408|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580409|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580410|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
153580411|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369217|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369219|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153369220|NCT02504775|Analgesics|analgesics|mesh-ancestor
153369221|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
153820932|NCT00435305|Piperacillin|piperacillin|mesh-list
153820933|NCT00435305|Ceftazidime|ceftazidime|mesh-list
153820934|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153820935|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153820936|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820937|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153580412|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153580413|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153580414|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
153580415|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
153580454|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153580455|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153580456|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580457|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580458|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580459|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580460|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153580520|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
153580521|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
153580522|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580523|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580524|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153580526|NCT01746277|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153580527|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580528|NCT01746485|Treprostinil|treprostinil|mesh-list
153580529|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153580530|NCT01746563|Ranibizumab|ranibizumab|mesh-list
153580531|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153580532|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153580533|NCT01746563|Growth Substances|growth substances|mesh-ancestor
153580534|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580535|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
153580536|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580537|NCT01746602|Timolol|timolol|mesh-list
153580538|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153580539|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153580540|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
153580541|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580542|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580571|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153580572|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153384410|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
153580573|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
153580574|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580575|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153580576|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153580577|NCT01746719|Etodolac|etodolac|mesh-list
153580578|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153580579|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153580580|NCT01746719|Analgesics|analgesics|mesh-ancestor
153580638|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153580639|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153580640|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153580641|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153580642|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580705|NCT01747226|Fluorides|fluorides|mesh-list
153580707|NCT01747226|Protective Agents|protective agents|mesh-ancestor
153580708|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580709|NCT01747252|Resveratrol|resveratrol|mesh-list
153580710|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
153580711|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580712|NCT01747252|Protective Agents|protective agents|mesh-ancestor
153580713|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580714|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153580715|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153580716|NCT01747278|Trimethoprim|trimethoprim|mesh-list
153580717|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
153580767|NCT01747616|Expectorants|expectorants|mesh-ancestor
153580768|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
153580769|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153580770|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
153580771|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580772|NCT01747616|Protective Agents|protective agents|mesh-ancestor
153580773|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580774|NCT01747616|Antidotes|antidotes|mesh-ancestor
153580775|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153580776|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153580777|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
153580778|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153580779|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
153580832|NCT01747993|Urological Agents|urological agents|mesh-ancestor
153580833|NCT01748019|Namitecan|namitecan|mesh-list
153580834|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153580835|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580836|NCT01748084|Rituximab|rituximab|mesh-list
153461713|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153829208|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
153580837|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153580838|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153580839|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
153580841|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153580896|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153580897|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580898|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580899|NCT01748370|Vitamin D|vitamin d|mesh-list
153580900|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
153580901|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
153580902|NCT01748370|Vitamins|vitamins|mesh-list
153580903|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
153580904|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580905|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153580906|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153580907|NCT01748396|Calcitriol|calcitriol|mesh-list
153580959|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153580960|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580961|NCT01748539|Brodalumab|brodalumab|mesh-list
153580962|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
153580963|NCT01748630|Midazolam|midazolam|mesh-list
153580964|NCT01748630|Fentanyl|fentanyl|mesh-list
153580965|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
153580966|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153580967|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153580968|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580969|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581026|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153581027|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581028|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
153581029|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153581030|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153581031|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
153581093|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
153581094|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369271|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153369272|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
153369273|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153369274|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369275|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153369276|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153369277|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153369278|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369279|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369280|NCT01149434|Everolimus|everolimus|mesh-list
153369281|NCT01149434|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153369282|NCT01149434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153829228|NCT00490997|Analgesics|analgesics|mesh-ancestor
153581095|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153581096|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153581097|NCT01749150|Ritonavir|ritonavir|mesh-list
153581098|NCT01749150|Ribavirin|ribavirin|mesh-list
153581099|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153581100|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
153581101|NCT01749150|Lactams|lactams|mesh-list
153581102|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153581103|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153581104|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
153581105|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829230|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581106|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581157|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153581158|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
153581159|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581160|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153581161|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153581162|NCT01749384|Growth Substances|growth substances|mesh-ancestor
153581163|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581164|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
153581165|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
153581167|NCT01749397|Floxuridine|floxuridine|mesh-list
153581168|NCT01749397|Veliparib|veliparib|mesh-list
153581169|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
153581219|NCT01749579|Fentanyl|fentanyl|mesh-list
153581220|NCT01749579|Propofol|propofol|mesh-list
153581221|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153581222|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581223|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581224|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153581225|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
153581226|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
153581227|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153581228|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153581240|NCT01750060|Fentanyl|fentanyl|mesh-list
153581288|NCT06176573|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153581289|NCT06176573|Chlorhexidine|chlorhexidine|mesh-list
153581290|NCT06176573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581291|NCT06176573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153581292|NCT06176573|Disinfectants|disinfectants|mesh-ancestor
153581293|NCT06176560|Mesalamine|mesalamine|mesh-list
153581294|NCT06176560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153581295|NCT06176560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581296|NCT06176560|Analgesics|analgesics|mesh-ancestor
153581357|NCT06175806|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153581358|NCT06175806|Serotonin Agents|serotonin agents|mesh-ancestor
153581359|NCT06175806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581360|NCT06175806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581361|NCT06175702|Cytarabine|cytarabine|mesh-list
153581362|NCT06175702|Dexamethasone|dexamethasone|mesh-list
153581363|NCT06175702|Cyclophosphamide|cyclophosphamide|mesh-list
153581364|NCT06175702|Methotrexate|methotrexate|mesh-list
153581365|NCT06175702|Fludarabine|fludarabine|mesh-list
153581366|NCT06175702|Vincristine|vincristine|mesh-list
153581367|NCT06175702|Imatinib Mesylate|imatinib mesylate|mesh-list
153581368|NCT06175702|Mercaptopurine|mercaptopurine|mesh-list
153581369|NCT06175702|Ponatinib|ponatinib|mesh-list
153369285|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153369286|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
153369287|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844388|NCT04942730|Busulfan|busulfan|mesh-list
153369288|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461714|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369289|NCT01150760|Alvimopan|alvimopan|mesh-list
153369290|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369291|NCT01150838|Propofol|propofol|mesh-list
153369292|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153369293|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581421|NCT06175663|Antihypertensive Agents|antihypertensive agents|mesh-list
153581422|NCT06175507|Baclofen|baclofen|mesh-list
153581423|NCT06175507|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153581424|NCT06175507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581425|NCT06175507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153581426|NCT06175507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581427|NCT06175507|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153581428|NCT06175507|GABA Agonists|gaba agonists|mesh-ancestor
153581429|NCT06175507|GABA Agents|gaba agents|mesh-ancestor
153581489|NCT06111079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581490|NCT06111079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581491|NCT06111079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581492|NCT06111079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153581493|NCT06111079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153581494|NCT06111079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581495|NCT06111079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153581496|NCT06111079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153581581|NCT05996133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153581582|NCT05996133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581583|NCT05996133|Anesthetics, Local|anesthetics, local|mesh-ancestor
153581584|NCT05996133|Anesthetics|anesthetics|mesh-ancestor
153581585|NCT05996133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581586|NCT05996133|Sensory System Agents|sensory system agents|mesh-ancestor
153581587|NCT05996133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153581590|NCT05996133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581591|NCT05996133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581592|NCT05996133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153581593|NCT05996133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153581594|NCT05996133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153581643|NCT05781620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153581644|NCT05769881|Anesthetics|anesthetics|mesh-list
153581645|NCT05769881|Anesthetics, Local|anesthetics, local|mesh-list
153581646|NCT05769881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581647|NCT05769881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581648|NCT05769881|Sensory System Agents|sensory system agents|mesh-ancestor
153581649|NCT05769881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581650|NCT05757466|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153581651|NCT05757466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581652|NCT05757466|Alkylating Agents|alkylating agents|mesh-ancestor
153581653|NCT05757466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581654|NCT05757466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581655|NCT05746208|Pembrolizumab|pembrolizumab|mesh-list
153581656|NCT05746208|Lenvatinib|lenvatinib|mesh-list
153581657|NCT05746208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581658|NCT05746208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820940|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153829257|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829259|NCT00486564|Nifurtimox|nifurtimox|mesh-list
153829260|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153829261|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153829262|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153829263|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829264|NCT00486668|Paclitaxel|paclitaxel|mesh-list
153829266|NCT00486668|Doxorubicin|doxorubicin|mesh-list
153581659|NCT05746208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153581660|NCT05746208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581661|NCT05746208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153581662|NCT05746208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384541|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
153581663|NCT05715814|Empagliflozin|empagliflozin|mesh-list
153581664|NCT05715814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153581665|NCT05715814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581666|NCT05715814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153581667|NCT05715814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581668|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
153581669|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581670|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581673|NCT05661461|Sirolimus|sirolimus|mesh-list
153581685|NCT05661461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581686|NCT05661461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581688|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581689|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
153581690|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581691|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581692|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581693|NCT05590377|Daratumumab|daratumumab|mesh-list
153581694|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581695|NCT05584644|Palbociclib|palbociclib|mesh-list
153581696|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581697|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153581700|NCT05574101|Cemiplimab|cemiplimab|mesh-list
153581748|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
153369313|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369314|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369315|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153369316|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153369317|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153369318|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369319|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369320|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153369321|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369322|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820942|NCT00435305|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153820943|NCT00435500|Fluorides|fluorides|mesh-list
153820944|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
153360911|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360912|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369323|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
153369324|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369325|NCT03010202|Dexamethasone|dexamethasone|mesh-list
153369326|NCT03010202|Rituximab|rituximab|mesh-list
153369327|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153369328|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
153581749|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829277|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829278|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153820945|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
153820946|NCT00435500|Protective Agents|protective agents|mesh-ancestor
153820947|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820948|NCT03272412|Progesterone|progesterone|mesh-list
153829279|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153829280|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
153829281|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153829282|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153829283|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153829284|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153581750|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153581751|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153581752|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581753|NCT05426252|Sirolimus|sirolimus|mesh-list
153581754|NCT05426252|Abatacept|abatacept|mesh-list
153581755|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153581756|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581814|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153581815|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581816|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
153581817|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581818|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581819|NCT05249959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153581820|NCT05249959|Antimetabolites|antimetabolites|mesh-ancestor
153581821|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844459|NCT02071862|Everolimus|everolimus|mesh-list
153581822|NCT05249959|Antiviral Agents|antiviral agents|mesh-ancestor
153581823|NCT05249959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153581824|NCT05249959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581825|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153369335|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369337|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369338|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153369339|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
153369340|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461721|NCT03193866|Interferon-beta|interferon-beta|mesh-list
153369341|NCT01191320|Enclomiphene|enclomiphene|mesh-list
153369342|NCT01191320|Clomiphene|clomiphene|mesh-list
153369343|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
153369344|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153369345|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
153369346|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369347|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369348|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153581826|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
153581827|NCT05231629|Dexamethasone|dexamethasone|mesh-list
153581828|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
153581829|NCT05231629|Melphalan|melphalan|mesh-list
153581830|NCT05231629|Lenalidomide|lenalidomide|mesh-list
153581831|NCT05231629|Bortezomib|bortezomib|mesh-list
153581832|NCT05231629|Daratumumab|daratumumab|mesh-list
153581833|NCT05231629|BB 1101|bb 1101|mesh-list
153581834|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153581835|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153581836|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
153581837|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
153581842|NCT05231629|Hormones|hormones|mesh-ancestor
153581865|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581866|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
153581867|NCT05173298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153581868|NCT05173298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581871|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
153581872|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153581873|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581874|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153581875|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
153581876|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
153581877|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153581878|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
153581879|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153581880|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581881|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153581882|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
153581883|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581884|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
153581885|NCT05106296|Etoposide|etoposide|mesh-list
153581886|NCT05106296|Ibrutinib|ibrutinib|mesh-list
153581887|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581888|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
153581889|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581890|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581891|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153581892|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
153581893|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581902|NCT05106192|Triamcinolone|triamcinolone|mesh-list
153581910|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
153581911|NCT05106192|Hormones|hormones|mesh-ancestor
153581912|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581913|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153581914|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153581915|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
153581916|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829308|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153829309|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153581917|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581918|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
153581920|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581973|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153581974|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153581975|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153581976|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153581977|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153581978|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153581979|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153581980|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
153581981|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153581982|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153582035|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
153582036|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153582037|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582038|NCT04816643|Vaccines|vaccines|mesh-list
153582039|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
153582040|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582041|NCT04786548|Celecoxib|celecoxib|mesh-list
153582042|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153582043|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582044|NCT04786548|Analgesics|analgesics|mesh-ancestor
153582045|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
153582046|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582047|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582048|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582049|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153582050|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153582051|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153582052|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582053|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582054|NCT04733547|Furosemide|furosemide|mesh-list
153582089|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153582090|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153582091|NCT04518306|Diuretics|diuretics|mesh-ancestor
153582092|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
153582159|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153369364|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
153369365|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369366|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369367|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153369368|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
153369369|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
153369370|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
153369371|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153369372|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153369373|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
153582160|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582161|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153582162|NCT04307134|Immunotoxins|immunotoxins|mesh-ancestor
153582163|NCT04307134|Immunoconjugates|immunoconjugates|mesh-ancestor
153582164|NCT04307134|Immunologic Factors|immunologic factors|mesh-ancestor
153582165|NCT04307134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582223|NCT04123366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153582224|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582225|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153582226|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582227|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
153582228|NCT04049669|Temozolomide|temozolomide|mesh-list
153582229|NCT04049669|Lomustine|lomustine|mesh-list
153582230|NCT04049669|Etoposide|etoposide|mesh-list
153877724|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877725|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
153582231|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153582232|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
153582290|NCT03783936|Avelumab|avelumab|mesh-list
153582291|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
153582292|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582293|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153582294|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582295|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153582296|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
153582297|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582359|NCT03703167|Growth Substances|growth substances|mesh-ancestor
153582360|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
153582361|NCT03703167|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153582362|NCT03703167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153829329|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153582363|NCT03703167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582364|NCT03703167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582382|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
153582383|NCT03659734|Narcotics|narcotics|mesh-ancestor
153582384|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153582385|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582386|NCT03659734|Analgesics|analgesics|mesh-ancestor
153582387|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
153582388|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582390|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153582391|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153582419|NCT03250975|Budesonide|budesonide|mesh-list
153582420|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582421|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153582422|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
153582423|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582424|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582425|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153582426|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
153582427|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
153582428|NCT03250975|Hormones|hormones|mesh-ancestor
153582429|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582430|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582431|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582432|NCT03191162|Benzonidazole|benzonidazole|mesh-list
153582440|NCT03169972|Factor VIII|factor viii|mesh-list
153582481|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153582482|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153582483|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582484|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153582485|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153582486|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582487|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
153582488|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153582548|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582549|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582550|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153582551|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153582553|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582554|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582555|NCT02470702|Oritavancin|oritavancin|mesh-list
153582556|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582557|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582558|NCT02357524|Oritavancin|oritavancin|mesh-list
153844582|NCT01267825|Bupivacaine|bupivacaine|mesh-list
153582559|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153582560|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582561|NCT02340988|Oritavancin|oritavancin|mesh-list
153582562|NCT02340988|Warfarin|warfarin|mesh-list
153829341|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153829342|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153829343|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153829344|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
153829345|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582563|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
153582610|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
153582611|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582612|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153582613|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153582614|NCT01514864|Dasatinib|dasatinib|mesh-list
153582615|NCT01514864|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153582616|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153582617|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582677|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153582678|NCT00328614|Ethylene|ethylene|mesh-list
153582679|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153582680|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582681|NCT00328614|Hormones|hormones|mesh-ancestor
153582682|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582683|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582684|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
153582685|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582686|NCT00328614|Protective Agents|protective agents|mesh-ancestor
153582687|NCT00328614|Vitamins|vitamins|mesh-ancestor
153582688|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
153582689|NCT00328614|Estrogens|estrogens|mesh-ancestor
153582690|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
153582691|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
153582692|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
153582693|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153582694|NCT00328614|Growth Substances|growth substances|mesh-ancestor
153582695|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153582699|NCT01750359|Curcumin|curcumin|mesh-list
153369401|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
153369402|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153369403|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369404|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153369405|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153369406|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153820951|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820952|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820953|NCT00473616|Irinotecan|irinotecan|mesh-list
153360915|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153582733|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153582735|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153582736|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582737|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153582738|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153582739|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153582740|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153582741|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153582799|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582801|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
153582802|NCT01750801|Propolis|propolis|mesh-list
153582803|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153582804|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153582805|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
153582806|NCT01750866|Prednisone|prednisone|mesh-list
153582807|NCT01750866|Lenograstim|lenograstim|mesh-list
153829366|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
153829367|NCT01242098|Fluticasone|fluticasone|mesh-list
153829368|NCT01242098|Beclomethasone|beclomethasone|mesh-list
153829369|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
153829370|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153829371|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153829372|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153829373|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
153582808|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153582809|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
153582810|NCT01750866|Hormones|hormones|mesh-ancestor
153582811|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153582817|NCT01750983|Lenalidomide|lenalidomide|mesh-list
153582862|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
153582863|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582864|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153582865|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153582866|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153582867|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153582868|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153582869|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582870|NCT01751321|Incretins|incretins|mesh-ancestor
153582871|NCT01751321|Hormones|hormones|mesh-ancestor
153582874|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
153582927|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582928|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582984|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153582985|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153582986|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153582987|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153582988|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153582989|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582990|NCT01752517|Vinorelbine|vinorelbine|mesh-list
153582991|NCT01752517|Ifosfamide|ifosfamide|mesh-list
153582992|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153582993|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153582994|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
153582995|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
153582996|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
153582999|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
153583042|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583043|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583045|NCT01752998|Narcotics|narcotics|mesh-ancestor
153829387|NCT01242098|Hormones|hormones|mesh-ancestor
153369416|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369417|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
153820954|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153369418|NCT01154192|Hormones|hormones|mesh-ancestor
153369419|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369420|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369421|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369422|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153583046|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583048|NCT01752998|Analgesics|analgesics|mesh-ancestor
153583112|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583113|NCT01753752|Protective Agents|protective agents|mesh-ancestor
153583114|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583115|NCT01753752|Antidotes|antidotes|mesh-ancestor
153583116|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153583117|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153583118|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
153583119|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153583120|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
153583121|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
153583122|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
153583123|NCT01753752|Coagulants|coagulants|mesh-ancestor
153583124|NCT01753882|Escitalopram|escitalopram|mesh-list
153583125|NCT01753882|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153583126|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153583127|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153583129|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583168|NCT01754285|Octreotide|octreotide|mesh-list
153583169|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153583170|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407244|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583171|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583172|NCT01754324|Methadone|methadone|mesh-list
153583173|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153583174|NCT01754324|Narcotics|narcotics|mesh-ancestor
153583175|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583176|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583177|NCT01754324|Analgesics|analgesics|mesh-ancestor
153583178|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
153583179|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583180|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
153583181|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
153583182|NCT01754649|Misoprostol|misoprostol|mesh-list
153583183|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153583184|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
153583185|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153583186|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583187|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153583188|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153583189|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
153583190|NCT01754701|Iron|iron|mesh-list
153583223|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153583224|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583225|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
153583226|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583227|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583228|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153583229|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153583230|NCT01754870|Growth Substances|growth substances|mesh-ancestor
153583231|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
153583232|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153583233|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
153583234|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583235|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
153583236|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
153583237|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153583238|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583239|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583240|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
153583241|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153583242|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583243|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583244|NCT01754961|Vitamin D|vitamin d|mesh-list
153829401|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829402|NCT05642689|Iron|iron|mesh-list
153583275|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583276|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
153583277|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583278|NCT01755182|Somatostatin|somatostatin|mesh-list
153583279|NCT01755182|Hormones|hormones|mesh-ancestor
153583280|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583281|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583282|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
153583283|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153583284|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583285|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153583336|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153583337|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583338|NCT01755468|Insulin|insulin|mesh-list
153583339|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153583340|NCT01755468|Metformin|metformin|mesh-list
153583341|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
153583342|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
153583343|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583344|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583345|NCT01755494|Metformin|metformin|mesh-list
153583346|NCT01755494|Saxagliptin|saxagliptin|mesh-list
153583347|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583348|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583349|NCT01755494|Incretins|incretins|mesh-ancestor
153583350|NCT01755494|Hormones|hormones|mesh-ancestor
153583351|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583352|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153583353|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
153583354|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583356|NCT01755520|Aspirin|aspirin|mesh-list
153583395|NCT01755572|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153407295|NCT01166113|Hormones|hormones|mesh-ancestor
153583396|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583397|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583398|NCT01755572|Incretins|incretins|mesh-ancestor
153583399|NCT01755572|Hormones|hormones|mesh-ancestor
153583400|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583401|NCT01755611|Minocycline|minocycline|mesh-list
153583402|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153583403|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153583404|NCT01755663|Metoprolol|metoprolol|mesh-list
153583405|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153583406|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153583407|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
153583408|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
153583409|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583410|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583411|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153583412|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153583413|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153583414|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
153583415|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153583416|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583448|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583449|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153583450|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153583451|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583452|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583453|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
153583454|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583458|NCT01755923|Docetaxel|docetaxel|mesh-list
153583512|NCT01756417|Canagliflozin|canagliflozin|mesh-list
153583513|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583514|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545897|NCT06297499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781630|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153583515|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153583516|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583576|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153583578|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153583579|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583580|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
153583601|NCT01756638|Hormones|hormones|mesh-ancestor
153583647|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153583648|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583649|NCT01756989|Thalidomide|thalidomide|mesh-list
153583650|NCT01756989|Celecoxib|celecoxib|mesh-list
153583651|NCT01756989|Etoposide|etoposide|mesh-list
153583652|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
153583653|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153583654|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583655|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153583656|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153583657|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583658|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583659|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153583660|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153583661|NCT01756989|Analgesics|analgesics|mesh-ancestor
153583708|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583709|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583710|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153369490|NCT01159262|Morphine|morphine|mesh-list
153829433|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153829434|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153829435|NCT00487032|Fluticasone|fluticasone|mesh-list
153829436|NCT00487032|Xhance|xhance|mesh-list
153829437|NCT00487032|Prazosin|prazosin|mesh-list
153829438|NCT00487032|Phenylephrine|phenylephrine|mesh-list
153829439|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
153829440|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583711|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153583712|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153583713|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153583714|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153844746|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583715|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153583716|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153583769|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583770|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583771|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153583772|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
153583773|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583774|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583775|NCT01757639|Ipilimumab|ipilimumab|mesh-list
153583776|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153583777|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583778|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153583779|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583780|NCT01757756|Midazolam|midazolam|mesh-list
153583781|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153583782|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153583783|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153583784|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583785|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153583786|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153583787|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153583788|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153583789|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
153583790|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
153583791|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
153583792|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
153583793|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829459|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153829461|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153829462|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153829463|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153829464|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153829465|NCT00491426|Metronidazole|metronidazole|mesh-list
153829466|NCT00491426|Tazobactam|tazobactam|mesh-list
153829467|NCT00491426|Piperacillin|piperacillin|mesh-list
153829468|NCT00491426|Amphotericin B|amphotericin b|mesh-list
153829469|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153829470|NCT00491426|Acyclovir|acyclovir|mesh-list
153829471|NCT00491426|Ampicillin|ampicillin|mesh-list
153583794|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583796|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153583797|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153583813|NCT01757860|Vitamins|vitamins|mesh-ancestor
153583814|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
153583815|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583816|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153583817|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
153583818|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153583819|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153583820|NCT01757899|Prednisolone|prednisolone|mesh-list
153583821|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
153583822|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153583823|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
153583824|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583825|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
153583826|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
153583827|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153583828|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583829|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153583830|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
153583831|NCT01757899|Hormones|hormones|mesh-ancestor
153583832|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583833|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153583834|NCT01757899|Protective Agents|protective agents|mesh-ancestor
153583835|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153583865|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153583867|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
153583868|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583869|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
153583870|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583871|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583872|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153583873|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
153583874|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583875|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583876|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153583877|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583878|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
153583880|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583881|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153583882|NCT01758146|Tamoxifen|tamoxifen|mesh-list
153583883|NCT01758146|Letrozole|letrozole|mesh-list
153583884|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583885|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153583886|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153583887|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583888|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583889|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153583890|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
153583891|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153583892|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583893|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153829496|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153829497|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829498|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829499|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153829500|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153829501|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153829502|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
153829503|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829504|NCT00487110|Acetaminophen|acetaminophen|mesh-list
153829505|NCT00487110|Tropisetron|tropisetron|mesh-list
153829506|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153829507|NCT00487110|Analgesics|analgesics|mesh-ancestor
153583903|NCT01758198|Methotrexate|methotrexate|mesh-list
153583907|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153583908|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583909|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153583910|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
153583911|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153583912|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583913|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
153583914|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583915|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153583916|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153583917|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
153583918|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153583919|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153583920|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153583921|NCT01758198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153583922|NCT01758263|Metoprolol|metoprolol|mesh-list
153583923|NCT01758263|Nebivolol|nebivolol|mesh-list
153583924|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153583961|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369554|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153369555|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153369556|NCT00363753|Analgesics|analgesics|mesh-ancestor
153369557|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
153369558|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369559|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369560|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360921|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153583962|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153583963|NCT01758471|Acarbose|acarbose|mesh-list
153583964|NCT01758471|Glipizide|glipizide|mesh-list
153583965|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153583966|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583967|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810813|NCT00352170|Vitamin D|vitamin d|mesh-list
153357409|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153583968|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153583969|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583970|NCT01758627|Icodextrin|icodextrin|mesh-list
153583971|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
153583972|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153583973|NCT01758640|Warfarin|warfarin|mesh-list
153583974|NCT01758640|Phenindione|phenindione|mesh-list
153583975|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
153583976|NCT01758666|Leucovorin|leucovorin|mesh-list
153583977|NCT01758666|Methotrexate|methotrexate|mesh-list
153583978|NCT01758666|Calcium|calcium|mesh-list
153583979|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
153583980|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153583981|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153583982|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153583983|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
153583984|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153583985|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407368|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153583986|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
153584012|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
153584013|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584014|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584015|NCT01758913|Ibuprofen|ibuprofen|mesh-list
153584016|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153584017|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584018|NCT01758913|Analgesics|analgesics|mesh-ancestor
153584019|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
153584020|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584079|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153584080|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153584081|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153584082|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
153584083|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584085|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153584150|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584151|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
153584152|NCT01759732|Fludarabine|fludarabine|mesh-list
153584153|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153584154|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153584155|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
153584156|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584157|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584158|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153584159|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
153584160|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584161|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584162|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153584164|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
153584165|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584166|NCT01759875|Ritonavir|ritonavir|mesh-list
153584167|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153584168|NCT01759875|Rabeprazole|rabeprazole|mesh-list
153584169|NCT01759875|Betaine|betaine|mesh-list
153584208|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
153584209|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584210|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
153584211|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584212|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
153584213|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584214|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153584215|NCT01760096|Hormones|hormones|mesh-ancestor
153584217|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153584273|NCT01760278|Progestins|progestins|mesh-ancestor
153584274|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153584275|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
153584276|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153584277|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
153584278|NCT01760330|Acetaminophen|acetaminophen|mesh-list
153844872|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
153584279|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584280|NCT01760330|Analgesics|analgesics|mesh-ancestor
153584281|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
153584284|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
153584285|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
153584286|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
153584287|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153584288|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153584289|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584290|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584291|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584292|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584293|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
153584294|NCT01760460|Anacetrapib|anacetrapib|mesh-list
153584295|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153584296|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153584297|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
153584298|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584299|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153584300|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584301|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153584302|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584319|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584320|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
153584321|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584322|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584323|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153584324|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584325|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153584326|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
153584327|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
153584328|NCT01760577|Protective Agents|protective agents|mesh-ancestor
153584329|NCT01760642|Rifampin|rifampin|mesh-list
153584330|NCT01760642|Ketoconazole|ketoconazole|mesh-list
153584331|NCT01760642|Midazolam|midazolam|mesh-list
153584332|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153369593|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820960|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360927|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153584333|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153584334|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584335|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584336|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153584376|NCT01760694|Protective Agents|protective agents|mesh-ancestor
153584377|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584378|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
153584380|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
153584381|NCT01760746|Bevacizumab|bevacizumab|mesh-list
153584382|NCT01760746|Ranibizumab|ranibizumab|mesh-list
153584383|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153584384|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584385|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153584386|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153584387|NCT01760746|Growth Substances|growth substances|mesh-ancestor
153584394|NCT01760811|Cetuximab|cetuximab|mesh-list
153584438|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584439|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153584440|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
153584441|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584442|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584443|NCT01761071|Diclofenac|diclofenac|mesh-list
153584444|NCT01761071|Ketorolac|ketorolac|mesh-list
153584445|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153584447|NCT01761071|Analgesics|analgesics|mesh-ancestor
153584504|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153584505|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153584506|NCT01761318|Liraglutide|liraglutide|mesh-list
153584507|NCT01761318|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153584508|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153584509|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584510|NCT01761318|Incretins|incretins|mesh-ancestor
153584511|NCT01761318|Hormones|hormones|mesh-ancestor
153584512|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584513|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
153584514|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584515|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
153584516|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584518|NCT01761487|Polymyxins|polymyxins|mesh-list
153584519|NCT01761487|Colistin|colistin|mesh-list
153584520|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153584521|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153584522|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153584523|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584531|NCT01761526|Rotigotine|rotigotine|mesh-list
153584559|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153584560|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
153584561|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584562|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153584563|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153584564|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584565|NCT01761669|Vitamin D|vitamin d|mesh-list
153584566|NCT01761669|Vitamins|vitamins|mesh-ancestor
153584567|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
153584568|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584569|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153584570|NCT01761916|Clonidine|clonidine|mesh-list
153584571|NCT01761916|Captopril|captopril|mesh-list
153584572|NCT01761916|Analgesics|analgesics|mesh-ancestor
153584620|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153584621|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584623|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153584624|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153584625|NCT01762163|Analgesics|analgesics|mesh-ancestor
153584626|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
153584627|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584628|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584629|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153584630|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153584631|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153584632|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153584633|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584634|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153584635|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153584636|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584637|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
153584638|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
153584639|NCT01762202|Fludarabine|fludarabine|mesh-list
153584640|NCT01762202|Ofatumumab|ofatumumab|mesh-list
153584641|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153584642|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
153584675|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
153584676|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153584677|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153584680|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
153584681|NCT01762332|Remifentanil|remifentanil|mesh-list
153584682|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153584683|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153584684|NCT01762332|Narcotics|narcotics|mesh-ancestor
153584685|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153584686|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584687|NCT01762332|Analgesics|analgesics|mesh-ancestor
153584688|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
153584689|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584690|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153584691|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
153584692|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153584693|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584728|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584729|NCT01762644|Cyclosporine|cyclosporine|mesh-list
153584730|NCT01762644|Omeprazole|omeprazole|mesh-list
153584731|NCT01762644|Cyclosporins|cyclosporins|mesh-list
153584732|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584733|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584734|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153584798|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153584799|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153584800|NCT01762787|Protective Agents|protective agents|mesh-ancestor
153584801|NCT01762826|Inositol|inositol|mesh-list
153584802|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
153584803|NCT01762826|Vitamins|vitamins|mesh-ancestor
153584804|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
153584805|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584806|NCT01762852|Belimumab|belimumab|mesh-list
153584810|NCT01762878|Nemiralisib|nemiralisib|mesh-list
153584863|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153584864|NCT01763021|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153584865|NCT01763021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153584866|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
153584868|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584869|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584870|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153584926|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584927|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584928|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153584929|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
153584930|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153584931|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584932|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153584933|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
153369639|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
153407423|NCT00606294|Misonidazole|misonidazole|mesh-list
153360931|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584934|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153584935|NCT01763658|Dexamethasone|dexamethasone|mesh-list
153584936|NCT01763658|Prednisolone|prednisolone|mesh-list
153584944|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
153584989|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584990|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153584991|NCT01764126|Vaccines|vaccines|mesh-list
153584992|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
153584993|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153584994|NCT01764139|Vitamin D|vitamin d|mesh-list
153584995|NCT01764139|Vitamins|vitamins|mesh-ancestor
153584996|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
153584999|NCT01764178|Valsartan|valsartan|mesh-list
153585056|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585057|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585058|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
153585059|NCT01764581|Tacrolimus|tacrolimus|mesh-list
153585060|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153585061|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
153585062|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585063|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153585064|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585065|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585066|NCT01764672|Methylphenidate|methylphenidate|mesh-list
153585075|NCT01764750|Vancomycin|vancomycin|mesh-list
153585120|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
153585121|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153585122|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
153585123|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
153585124|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153585125|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153585126|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585127|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153585128|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153585129|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153585130|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
153585181|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153585182|NCT01765257|Protective Agents|protective agents|mesh-ancestor
153585183|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585184|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
153585185|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153585186|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585187|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585188|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
153418518|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153418519|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
153585189|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585190|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585191|NCT01765374|Rituximab|rituximab|mesh-list
153585239|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153585240|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153585241|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153585242|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153585243|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153585245|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
153585246|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
153585247|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585248|NCT01765829|Droperidol|droperidol|mesh-list
153585251|NCT01765829|Olanzapine|olanzapine|mesh-list
153585252|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
153585304|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153585305|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
153585306|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153585307|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585308|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153585310|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
153585311|NCT01765946|Metformin|metformin|mesh-list
153585312|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153585314|NCT01766063|Interferons|interferons|mesh-list
153585371|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585372|NCT01766375|Cyclosporine|cyclosporine|mesh-list
153585373|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
153585374|NCT01766375|Methotrexate|methotrexate|mesh-list
153585375|NCT01766375|Cyclosporins|cyclosporins|mesh-list
153585376|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153585377|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
153585378|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153585379|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585380|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153585381|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
153365246|NCT03283007|Nintedanib|nintedanib|mesh-list
153585382|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585384|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
153585385|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585386|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153585387|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153585388|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
153585389|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585390|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153585398|NCT01766414|Complement C1s|complement c1s|mesh-list
153585423|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153585424|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153585425|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153585426|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153820966|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585427|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
153585428|NCT01766609|Hormones|hormones|mesh-ancestor
153585429|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585430|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585431|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153585488|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
153585489|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585490|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585491|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585492|NCT01767298|Valsartan|valsartan|mesh-list
153585493|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153585532|NCT01767454|Trametinib|trametinib|mesh-list
153585555|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585556|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153585557|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
153585558|NCT01767545|Hormones|hormones|mesh-ancestor
153585559|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585560|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153585561|NCT01767571|Cephalexin|cephalexin|mesh-list
153585562|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585563|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585564|NCT01767584|Cephalexin|cephalexin|mesh-list
153585565|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585566|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585567|NCT01767623|Vemurafenib|vemurafenib|mesh-list
153585568|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585617|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153585618|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585619|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153585620|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
153585621|NCT01768182|Leucovorin|leucovorin|mesh-list
153585622|NCT01768182|Folic Acid|folic acid|mesh-list
153585623|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
153585624|NCT01768182|Antidotes|antidotes|mesh-ancestor
153585625|NCT01768182|Protective Agents|protective agents|mesh-ancestor
153585626|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585683|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585686|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
153585687|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153585688|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153585689|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153585690|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153585691|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
153585747|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153585748|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153820968|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153360933|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
153820969|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153585749|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153585750|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
153585751|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
153585752|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
153585753|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153585754|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153585755|NCT01768377|Narcotics|narcotics|mesh-ancestor
153585756|NCT01768377|Analgesics|analgesics|mesh-ancestor
153585812|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153585813|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153585814|NCT01768741|Liver Extracts|liver extracts|mesh-list
153585815|NCT01768741|Hematinics|hematinics|mesh-ancestor
153585816|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
153585817|NCT01768780|Bupivacaine|bupivacaine|mesh-list
153585818|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153585819|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
153585820|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
153585821|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585823|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
153585877|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153585878|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153585879|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153585880|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153585881|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153585882|NCT01769040|Rifaximin|rifaximin|mesh-list
153585883|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153585884|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153585885|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153585886|NCT01769066|Pemetrexed|pemetrexed|mesh-list
153585887|NCT01769066|Gefitinib|gefitinib|mesh-list
153585888|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153585889|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585890|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585939|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
153585941|NCT01769625|Vitamins|vitamins|mesh-ancestor
153585942|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
153585943|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585944|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153585945|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153585946|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153585947|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153585948|NCT01769625|Analgesics|analgesics|mesh-ancestor
153585949|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
153585950|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153585951|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153585952|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153585953|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153585954|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153585955|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153585956|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153585957|NCT01769651|Methadone|methadone|mesh-list
153585958|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153585959|NCT01769651|Narcotics|narcotics|mesh-ancestor
153585962|NCT01769651|Analgesics|analgesics|mesh-ancestor
153585994|NCT01769768|Bupropion|bupropion|mesh-list
153585995|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153585996|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
153585997|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153585998|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153585999|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153586000|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153586001|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586002|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
153586003|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586004|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586006|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153586007|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586008|NCT01769781|Anastrozole|anastrozole|mesh-list
153586009|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153586010|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586011|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153586012|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153586013|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586014|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586015|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153586016|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
153586018|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586042|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
153586043|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586044|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153586045|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
153586046|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369665|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
153369666|NCT02432040|Atorvastatin|atorvastatin|mesh-list
153369667|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153369668|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153369669|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
153369670|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369674|NCT02517021|Dexamethasone|dexamethasone|mesh-list
153586047|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586112|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153586113|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586114|NCT01770132|Gemcitabine|gemcitabine|mesh-list
153586115|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153586116|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
153586117|NCT01770132|Trioxsalen|trioxsalen|mesh-list
153586118|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153586119|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
153586120|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586176|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586177|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
153586178|NCT01770444|Cytarabine|cytarabine|mesh-list
153586179|NCT01770444|Thioguanine|thioguanine|mesh-list
153586180|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153586181|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
153586182|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586183|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586184|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
153586185|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586186|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153586187|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
153586188|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586189|NCT01770470|Chitosan|chitosan|mesh-list
153586190|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153586191|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153418524|NCT02934698|Ivacaftor|ivacaftor|mesh-list
153418525|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153418526|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153418527|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418528|NCT03021343|Colchicine|colchicine|mesh-list
153586192|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
153586193|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586194|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153586195|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
153586196|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
153586197|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
153586198|NCT01770470|Coagulants|coagulants|mesh-ancestor
153586199|NCT01770600|Risperidone|risperidone|mesh-list
153586200|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153586201|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
153586202|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586226|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586227|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586229|NCT01770795|Antimitotic Agents|antimitotic agents|mesh-ancestor
153586230|NCT01770795|Mitosis Modulators|mitosis modulators|mesh-ancestor
153586231|NCT01770899|Montelukast|montelukast|mesh-list
153586232|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153586233|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
153586234|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153586235|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
153586236|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586237|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586238|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153586239|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153586240|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586241|NCT01770964|Pregabalin|pregabalin|mesh-list
153586242|NCT01770964|Analgesics|analgesics|mesh-ancestor
153586243|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
153586244|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586246|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
153586247|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153586248|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153586249|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586250|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153586251|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153586252|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153586269|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586270|NCT01771185|Metformin|metformin|mesh-list
153586271|NCT01771185|Gliclazide|gliclazide|mesh-list
153586272|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153586273|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586274|NCT01771198|Simvastatin|simvastatin|mesh-list
153586275|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153586276|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153586277|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
153829652|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369679|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820975|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
153820976|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
153369680|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586278|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586279|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153545899|NCT06297499|Dermatologic Agents|dermatologic agents|mesh-ancestor
153586280|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153586281|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586283|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586284|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
153586285|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
153586326|NCT01771458|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153586327|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153586328|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153586329|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153586330|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
153586331|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586332|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153586333|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153586334|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153586335|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153586336|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153586337|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586338|NCT05318365|Laxatives|laxatives|mesh-ancestor
153586339|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153586340|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153586341|NCT01771783|Renin Inhibitors|renin inhibitors|mesh-list
153586380|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586381|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153586382|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586384|NCT01772056|Fluticasone|fluticasone|mesh-list
153586385|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586386|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153586387|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
153586388|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586389|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586390|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153586391|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
153586392|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
153586393|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153586394|NCT01772212|Terbinafine|terbinafine|mesh-list
153586395|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
153586396|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586397|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586399|NCT01772238|Amoxicillin|amoxicillin|mesh-list
153586400|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153586401|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
153586402|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
153586403|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586404|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586405|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153586426|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586427|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153586428|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153586429|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153586431|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586432|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
153586433|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
153586434|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586435|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586436|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586437|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
153586438|NCT01772381|Hormones|hormones|mesh-ancestor
153586439|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586440|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153586442|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
153586484|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586485|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586486|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153586487|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153586488|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
153586489|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586490|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153586491|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153586492|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153586493|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153586494|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
153586495|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153586496|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153586544|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586546|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586547|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
153586548|NCT01773174|Dabigatran|dabigatran|mesh-list
153586549|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
153586550|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153586551|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
153586552|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586553|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586554|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
153586555|NCT01773408|Cytarabine|cytarabine|mesh-list
153586556|NCT01773408|Daunorubicin|daunorubicin|mesh-list
153586557|NCT01773408|Idarubicin|idarubicin|mesh-list
153429411|NCT00002654|Cobalt|cobalt|mesh-list
153586558|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153586559|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
153586560|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586561|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586562|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
153586563|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586600|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153586601|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
153586602|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153586603|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586604|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
153586605|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586606|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153586607|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153586608|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153586609|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
153586610|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153586611|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586612|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586613|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586614|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153586615|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
153586617|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153586634|NCT01773772|Hormones|hormones|mesh-ancestor
153586654|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153586655|NCT01773876|Micafungin|micafungin|mesh-list
153586656|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
153586657|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153586658|NCT01774370|Dabigatran|dabigatran|mesh-list
153586659|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
153586660|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153586661|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
153586662|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586663|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586664|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
153586665|NCT01774396|Lidocaine|lidocaine|mesh-list
153586669|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586715|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153586716|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153586717|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586718|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
153586719|NCT01774812|Vitamin D|vitamin d|mesh-list
153586720|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
153586721|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153586722|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153586723|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586724|NCT01774812|Vitamins|vitamins|mesh-ancestor
153586725|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
153586777|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586778|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153586779|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153586780|NCT01775579|Metformin|metformin|mesh-list
153586781|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153586782|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153586783|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586784|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153586844|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586845|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586846|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
153586847|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586848|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153586849|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153586850|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153586851|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
153429415|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
153586852|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153586853|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153586854|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153586855|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
153586856|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153586857|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586858|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153586859|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153586860|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153586861|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153586862|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586863|NCT01776320|Alprostadil|alprostadil|mesh-list
153586864|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153586865|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
153586866|NCT01776320|Urological Agents|urological agents|mesh-ancestor
153369717|NCT05857982|Hormones|hormones|mesh-ancestor
153369718|NCT05857982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369719|NCT05857982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369720|NCT05857982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369721|NCT05857982|Analgesics|analgesics|mesh-ancestor
153369729|NCT05836025|Sirolimus|sirolimus|mesh-list
153820980|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407543|NCT00096174|Cetuximab|cetuximab|mesh-list
153586867|NCT01776437|Talazoparib|talazoparib|mesh-list
153586868|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153586869|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153586870|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586871|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153586872|NCT01776515|Acetaminophen|acetaminophen|mesh-list
153817959|NCT05756621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153817960|NCT05756621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817961|NCT05756621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817962|NCT05756621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153817963|NCT05756621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153817964|NCT05756621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153817965|NCT05756621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153817966|NCT05756621|GABA Modulators|gaba modulators|mesh-ancestor
153817967|NCT05756621|GABA Agents|gaba agents|mesh-ancestor
153817968|NCT05756621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153817969|NCT05756621|Nootropic Agents|nootropic agents|mesh-ancestor
153817970|NCT05756621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153586874|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153586875|NCT01776515|Analgesics|analgesics|mesh-ancestor
153586876|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
153586877|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153586878|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586879|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
153586880|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153586881|NCT01776515|Narcotics|narcotics|mesh-ancestor
153586882|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153586883|NCT01776567|Everolimus|everolimus|mesh-list
153586940|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153586941|NCT01777100|Narcotics|narcotics|mesh-ancestor
153586942|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829676|NCT00506298|Analgesics|analgesics|mesh-ancestor
153829677|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
153829678|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829679|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829680|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153829681|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153829682|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153829683|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829684|NCT01242215|Glimepiride|glimepiride|mesh-list
153829685|NCT01242215|Gliclazide|gliclazide|mesh-list
153810814|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
153810815|NCT00352170|Calcium|calcium|mesh-list
153357410|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153829686|NCT01242215|Glyburide|glyburide|mesh-list
153829687|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
153829688|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153829689|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153829690|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829691|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153829692|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
153586943|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586944|NCT01777100|Analgesics|analgesics|mesh-ancestor
153587006|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
153587007|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153587008|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153587009|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
153587010|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587011|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587013|NCT01777919|Temozolomide|temozolomide|mesh-list
153587014|NCT01777919|Disulfiram|disulfiram|mesh-list
153587015|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153587016|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
153587017|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587018|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587019|NCT01777919|Trace Elements|trace elements|mesh-ancestor
153587020|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
153587021|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587022|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153587023|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153587024|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587026|NCT01778075|Tramadol|tramadol|mesh-list
153587027|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153587028|NCT01778075|Analgesics|analgesics|mesh-ancestor
153587029|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
153587030|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587031|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587032|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
153587033|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153587034|NCT01778075|Narcotics|narcotics|mesh-ancestor
153587035|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587036|NCT01778101|Lansoprazole|lansoprazole|mesh-list
153587037|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
153817971|NCT05756621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153817972|NCT05756621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153817973|NCT05756621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153817974|NCT05756621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153817975|NCT05728333|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153817976|NCT05728333|Tirofiban|tirofiban|mesh-list
153817977|NCT05728333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153817978|NCT05728333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153459347|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153459348|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459349|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459350|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
153459351|NCT01677468|Coagulants|coagulants|mesh-ancestor
153459352|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
153587038|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153587039|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153587040|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153587041|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587042|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587043|NCT01778114|Vitamin D|vitamin d|mesh-list
153587044|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
153587045|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
153587046|NCT01778114|Vitamins|vitamins|mesh-list
153587047|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
153587048|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587053|NCT01778192|Citric Acid|citric acid|mesh-list
153587103|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153587104|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153587105|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153587106|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153587107|NCT01778686|Pindolol|pindolol|mesh-list
153587108|NCT01778686|Citalopram|citalopram|mesh-list
153587109|NCT01778686|Tryptophan|tryptophan|mesh-list
153587110|NCT01778686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153587111|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153587112|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153360943|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153360945|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153360946|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
153587113|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587115|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
153587116|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587117|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153587118|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
153587119|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153587120|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153587121|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153587122|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
153587123|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153587124|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153587125|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
153587126|NCT01778803|Paclitaxel|paclitaxel|mesh-list
153587127|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153587149|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587150|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587151|NCT01779245|Calcium|calcium|mesh-list
153587152|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153587153|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587154|NCT01779258|Desonide|desonide|mesh-list
153587155|NCT01779258|Glycerol|glycerol|mesh-list
153587156|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153587157|NCT01779258|Protective Agents|protective agents|mesh-ancestor
153587158|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587159|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153587160|NCT01779271|Loxoprofen|loxoprofen|mesh-list
153587161|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153587162|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153587163|NCT01779271|Analgesics|analgesics|mesh-ancestor
153587169|NCT01779284|Timolol|timolol|mesh-list
153587208|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
153587209|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153587210|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153587211|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153587212|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
153587213|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587214|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153587215|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
153587216|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153587217|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
153587218|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
153587219|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153587220|NCT01779401|Protective Agents|protective agents|mesh-ancestor
153587271|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
153587272|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587273|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153587274|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153587275|NCT01779791|Ibrutinib|ibrutinib|mesh-list
153587276|NCT01779791|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153587277|NCT01779791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587278|NCT01779791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587279|NCT01779791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587280|NCT01779830|Zolpidem|zolpidem|mesh-list
153587281|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153587282|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153587283|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877738|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877739|NCT05410860|Etripamil|etripamil|mesh-list
153877740|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153845521|NCT01258738|Analgesics|analgesics|mesh-ancestor
153587284|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587285|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153587286|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
153587287|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
153587288|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587289|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587290|NCT01779843|Cytarabine|cytarabine|mesh-list
153587291|NCT01779843|Idarubicin|idarubicin|mesh-list
153587292|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153587293|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
153587294|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587295|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587296|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
153587320|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153587321|NCT01779921|Thrombin|thrombin|mesh-list
153587322|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
153587323|NCT01779921|Coagulants|coagulants|mesh-ancestor
153587326|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153587327|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587328|NCT01780181|Gemcitabine|gemcitabine|mesh-list
153587329|NCT01780181|Docetaxel|docetaxel|mesh-list
153587330|NCT01780181|Vinorelbine|vinorelbine|mesh-list
153587333|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587334|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587335|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
153587336|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
153587337|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
153587339|NCT01780233|Fentanyl|fentanyl|mesh-list
153587382|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587384|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
153587385|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
153587386|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587387|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153587390|NCT01780467|Dopamine|dopamine|mesh-list
153587448|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587449|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587450|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153587451|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
153587452|NCT01780610|Progestins|progestins|mesh-ancestor
153587453|NCT01780740|Atorvastatin|atorvastatin|mesh-list
153587454|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153587455|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153587456|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
153587457|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587458|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153587459|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153587460|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587461|NCT01780753|Primaquine|primaquine|mesh-list
153587462|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
153587463|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153587464|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153587465|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587466|NCT01780909|Paromomycin|paromomycin|mesh-list
153877741|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877742|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877743|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153877744|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877745|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153877746|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
153587467|NCT01780909|Domperidone|domperidone|mesh-list
153587468|NCT01780909|Loperamide|loperamide|mesh-list
153587469|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
153587470|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
153587471|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
153587472|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587473|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587474|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153587475|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153587476|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
153587477|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587493|NCT01780948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587494|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153369810|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820995|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153820996|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
153587495|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
153587496|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587497|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587498|NCT01781052|Iloprost|iloprost|mesh-list
153587499|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153587500|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
153587501|NCT01781273|Ethanol|ethanol|mesh-list
153587502|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153587503|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587504|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587505|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587506|NCT01781377|Metoclopramide|metoclopramide|mesh-list
153587507|NCT01781377|Propofol|propofol|mesh-list
153587508|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153587509|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587510|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587511|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153587512|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
153587513|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
153587514|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
153587515|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
153587516|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587517|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153587518|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153587538|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153587539|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153587540|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153587541|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
153587542|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
153587543|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587544|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587545|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587598|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587599|NCT01782261|Liraglutide|liraglutide|mesh-list
153587600|NCT01782261|Saxagliptin|saxagliptin|mesh-list
153587601|NCT01782261|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153587602|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153587603|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587604|NCT01782261|Incretins|incretins|mesh-ancestor
153587605|NCT01782261|Hormones|hormones|mesh-ancestor
153587606|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587607|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153587608|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
153587609|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587610|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587611|NCT01782274|Vaccines|vaccines|mesh-list
153587612|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
153360954|NCT01490723|Methotrexate|methotrexate|mesh-list
153360955|NCT01490723|Fludarabine|fludarabine|mesh-list
153360956|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
153587613|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587614|NCT01782287|Vaccines|vaccines|mesh-list
153587615|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
153587616|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587617|NCT01782300|Vaccines|vaccines|mesh-list
153587618|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
153587620|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
153587653|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587654|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587655|NCT01782651|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153587656|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587657|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587658|NCT01782781|Epinephrine|epinephrine|mesh-list
153587659|NCT01782781|Ropivacaine|ropivacaine|mesh-list
153587660|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
153587661|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
153587662|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153587663|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587664|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
153587665|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587667|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153587714|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153587715|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153587716|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153587717|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153587718|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153587719|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153587720|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
153587721|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153587722|NCT01782976|Bevacizumab|bevacizumab|mesh-list
153587723|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153587724|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587733|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
153587777|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153587778|NCT01783756|Capecitabine|capecitabine|mesh-list
153587779|NCT01783756|Everolimus|everolimus|mesh-list
153587780|NCT01783756|Lapatinib|lapatinib|mesh-list
153587783|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587849|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153587850|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
153587851|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
153587852|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153587853|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153587854|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153587855|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
153587856|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153587857|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153369820|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
153587858|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
153587859|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587860|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153587861|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153587862|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587863|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587865|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153587866|NCT01784315|Primaquine|primaquine|mesh-list
153587867|NCT01784315|Artemisinins|artemisinins|mesh-list
153587868|NCT01784315|Artemisinin|artemisinin|mesh-list
153587869|NCT01784315|Amebicides|amebicides|mesh-ancestor
153587877|NCT01784315|Analgesics|analgesics|mesh-ancestor
153587903|NCT01784445|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153587904|NCT01784445|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153587905|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153587906|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153587908|NCT01784549|Docetaxel|docetaxel|mesh-list
153587909|NCT01784549|Pemetrexed|pemetrexed|mesh-list
153587910|NCT01784549|Vinorelbine|vinorelbine|mesh-list
153587911|NCT01784549|Gefitinib|gefitinib|mesh-list
153587912|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587913|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153587914|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
153587915|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810816|NCT00352170|Vitamins|vitamins|mesh-ancestor
153587916|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
153587917|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
153587918|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
153587919|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587920|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153587921|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153587922|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153587923|NCT01784549|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153587924|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587925|NCT01784562|Riociguat|riociguat|mesh-list
153587926|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
153587927|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587928|NCT01784640|Pemetrexed|pemetrexed|mesh-list
153587929|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820997|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820998|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360957|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153829796|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
153781633|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587930|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587931|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587932|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153587936|NCT01784900|Catumaxomab|catumaxomab|mesh-list
153587945|NCT01784978|Sunitinib|sunitinib|mesh-list
153587946|NCT01784978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153587947|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153587948|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153587949|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587950|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153587951|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
153587952|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587953|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153587954|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153587955|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153587956|NCT01784978|Growth Substances|growth substances|mesh-ancestor
153587957|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
153587958|NCT01785004|Vitamin D|vitamin d|mesh-list
153587959|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
153588005|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588006|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588007|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153781634|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
153588014|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588015|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153588016|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153588017|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153588021|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
153588067|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
153588068|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588069|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588070|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153588071|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
153588072|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153588073|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
153369857|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369858|NCT05265286|Factor VIII|factor viii|mesh-list
153369859|NCT05265286|Coagulants|coagulants|mesh-ancestor
153369860|NCT05233202|Simendan|simendan|mesh-list
153369861|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153369862|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
153369863|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153369864|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153369865|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369866|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588074|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
153588135|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
153588136|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588137|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153588138|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588139|NCT01785979|Analgesics|analgesics|mesh-ancestor
153588140|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
153588141|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588142|NCT01785979|Filaricides|filaricides|mesh-ancestor
153588143|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
153588144|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
153588145|NCT01786018|Cyclosporine|cyclosporine|mesh-list
153588146|NCT01786018|Methotrexate|methotrexate|mesh-list
153588147|NCT01786018|Busulfan|busulfan|mesh-list
153588148|NCT01786018|Thiotepa|thiotepa|mesh-list
153588195|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153588196|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153588197|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588199|NCT01786226|Mifepristone|mifepristone|mesh-list
153588200|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153588201|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
153588202|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588203|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588204|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153588205|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153588207|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
153588208|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153588209|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153588210|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
153588211|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588212|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
153588213|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153588214|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153588215|NCT01786382|Midazolam|midazolam|mesh-list
153588216|NCT01786382|Omeprazole|omeprazole|mesh-list
153588217|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153588218|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153588219|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588220|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588221|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153588222|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153588223|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153588224|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153588225|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
153588226|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
153459353|NCT00003816|Melphalan|melphalan|mesh-list
153459354|NCT00003816|Busulfan|busulfan|mesh-list
153459355|NCT00003816|Thiotepa|thiotepa|mesh-list
153459356|NCT00003816|Carboplatin|carboplatin|mesh-list
153459357|NCT00003816|Fludarabine|fludarabine|mesh-list
153459358|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
153459359|NCT00003816|Etoposide|etoposide|mesh-list
153459360|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153588227|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
153588228|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
153588229|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588230|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588231|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153588232|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153588233|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153588234|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588235|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
153588236|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153588237|NCT01786538|Leucovorin|leucovorin|mesh-list
153588238|NCT01786538|Fluorouracil|fluorouracil|mesh-list
153588239|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
153588240|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
153588241|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588242|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153588243|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588244|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153588245|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
153877747|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
153877749|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588246|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588248|NCT01786538|Protective Agents|protective agents|mesh-ancestor
153588249|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
153588250|NCT01786538|Vitamins|vitamins|mesh-ancestor
153588251|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
153588252|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
153588253|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153588254|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
153588255|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588256|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588257|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153588258|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
153588259|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153588260|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153588261|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153588262|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
153588263|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588264|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588265|NCT01786655|Epinephrine|epinephrine|mesh-list
153588266|NCT01786655|Bupivacaine|bupivacaine|mesh-list
153588267|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
153588268|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
153588269|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
153588270|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588271|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588272|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
153588273|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588274|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153588275|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153588276|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
153588277|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588278|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588279|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153588280|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153588281|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
153588282|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153588283|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
153588284|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
153588285|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
153588286|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153369899|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
153369900|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369901|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153369902|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
153369903|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
153588287|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153588314|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153588316|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153588317|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153588318|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588319|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
153588320|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588321|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588322|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153588323|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588324|NCT01787357|Canagliflozin|canagliflozin|mesh-list
153588326|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153588327|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153588328|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153588329|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153588330|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418536|NCT03025945|Nepafenac|nepafenac|mesh-list
153385928|NCT00378729|Metformin|metformin|mesh-list
153588331|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588332|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588333|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588334|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153588368|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588369|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
153588370|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
153588371|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588372|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153588373|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
153588375|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588376|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153588377|NCT01788007|Imiquimod|imiquimod|mesh-list
153588378|NCT01788007|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153588379|NCT01788007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588380|NCT01788007|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153821006|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821008|NCT00481572|Vasopressins|vasopressins|mesh-list
153821009|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
153360965|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360966|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153829861|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
153588381|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
153588382|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588383|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153588384|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588385|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
153588386|NCT01788072|Oxytocin|oxytocin|mesh-list
153588387|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
153588388|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588389|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588390|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
153588391|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153588392|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588393|NCT01788189|Lenalidomide|lenalidomide|mesh-list
153588401|NCT01788254|Talinolol|talinolol|mesh-list
153588416|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
153588417|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
153588418|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588419|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588420|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153588421|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153588422|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
153588423|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153588424|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153588425|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588426|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153588427|NCT01788254|Narcotics|narcotics|mesh-ancestor
153588428|NCT01788254|Analgesics|analgesics|mesh-ancestor
153588429|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
153588430|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588431|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
153588432|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
153385973|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
153588433|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153588434|NCT01788254|Diuretics|diuretics|mesh-ancestor
153588435|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
153588436|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153588437|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369921|NCT04893291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369922|NCT04893291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369923|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153369932|NCT04803422|Amoxicillin|amoxicillin|mesh-list
153588438|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153588439|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153588440|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
153588441|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153588442|NCT01788280|Bevacizumab|bevacizumab|mesh-list
153588463|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153588464|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153588465|NCT01788384|Clindamycin|clindamycin|mesh-list
153588466|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
153588467|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
153588468|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153588469|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153588470|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153588471|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153588472|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588473|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588474|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
153588476|NCT01788462|Growth Substances|growth substances|mesh-ancestor
153588477|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588478|NCT01788501|Cyclosporine|cyclosporine|mesh-list
153588480|NCT01788501|Tacrolimus|tacrolimus|mesh-list
153588520|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153588521|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
153588522|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153588523|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588524|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153588525|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153588526|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153821013|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
153360968|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
153360969|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153360970|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153588527|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153588528|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
153588529|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588530|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153588531|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588532|NCT01788969|Escitalopram|escitalopram|mesh-list
153588533|NCT01788969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153588534|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153588535|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153588536|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588537|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153588539|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588572|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588573|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588574|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588575|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588576|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153588577|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588578|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588579|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
153588580|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153588581|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153588582|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153588583|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153588584|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153588585|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588630|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
153588632|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588633|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153588634|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588635|NCT01789619|Tacrolimus|tacrolimus|mesh-list
153588636|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153588637|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
153588638|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588639|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153588640|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588641|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588642|NCT01789710|Bupropion|bupropion|mesh-list
153588643|NCT01789710|Nicotine|nicotine|mesh-list
153588644|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153588645|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
153588663|NCT01789723|Leucovorin|leucovorin|mesh-list
153588690|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588692|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
153588693|NCT01789892|Hormones|hormones|mesh-ancestor
153588694|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588696|NCT01789892|Protective Agents|protective agents|mesh-ancestor
153588697|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153588698|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588699|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153588700|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588701|NCT01789957|Exenatide|exenatide|mesh-list
153588702|NCT01789957|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153588703|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153588704|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588705|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153588706|NCT01789957|Incretins|incretins|mesh-ancestor
153588707|NCT01789957|Hormones|hormones|mesh-ancestor
153588708|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588709|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153588710|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153588711|NCT01792063|Sevoflurane|sevoflurane|mesh-list
153588712|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153588713|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153588714|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
153588715|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
153588716|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153588717|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588718|NCT01792570|Darunavir|darunavir|mesh-list
153588719|NCT01792570|Rilpivirine|rilpivirine|mesh-list
153588720|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153588721|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153588722|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
153588723|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588724|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588727|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
153588728|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153588729|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153588730|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153588731|NCT01792804|Vancomycin|vancomycin|mesh-list
153880156|NCT02703610|Analgesics|analgesics|mesh-ancestor
153880160|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
153588732|NCT01792804|Clindamycin|clindamycin|mesh-list
153588733|NCT01792804|Cefazolin|cefazolin|mesh-list
153588734|NCT01792804|Linezolid|linezolid|mesh-list
153588735|NCT01792804|Daptomycin|daptomycin|mesh-list
153588736|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153588737|NCT01792804|Floxacillin|floxacillin|mesh-list
153588738|NCT01792804|Cloxacillin|cloxacillin|mesh-list
153588739|NCT01792804|Trimethoprim|trimethoprim|mesh-list
153588740|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
153588741|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153588742|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369970|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
153369971|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369972|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153369973|NCT04577404|Protective Agents|protective agents|mesh-ancestor
153369974|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369975|NCT04452747|Dinoprostone|dinoprostone|mesh-list
153369976|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
153369977|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153369978|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821018|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
153588743|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153588744|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588745|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588746|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153588783|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588784|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
153588785|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588786|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153588787|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153588788|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153588789|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153588791|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153588847|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153588848|NCT01796327|Dacomitinib|dacomitinib|mesh-list
153588849|NCT01796327|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153588850|NCT01796327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153588851|NCT01796327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588852|NCT01796327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588853|NCT01796418|Beraprost|beraprost|mesh-list
153588854|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153588912|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588913|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588914|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153588915|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
153588916|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153588917|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360973|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
153829928|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
153588918|NCT01797718|Androgens|androgens|mesh-ancestor
153588919|NCT01797718|Hormones|hormones|mesh-ancestor
153588920|NCT01797796|Capsaicin|capsaicin|mesh-list
153588921|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
153588922|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
153588923|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
153588924|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588925|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588926|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153588927|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588928|NCT01798446|Axitinib|axitinib|mesh-list
153588929|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153588931|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588932|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588965|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153588966|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153588967|NCT01799863|Analgesics|analgesics|mesh-ancestor
153588968|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
153588969|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153588970|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153588971|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153588972|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153588973|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153588974|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588975|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153588976|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153589027|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589028|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589029|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153589031|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153589032|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153589033|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589034|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153589035|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153589036|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589037|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
153589038|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153589039|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
153589040|NCT01800396|Caseins|caseins|mesh-list
153589041|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
153589042|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
153589043|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589044|NCT01800422|Progesterone|progesterone|mesh-list
153589045|NCT01800422|Progestins|progestins|mesh-ancestor
153589046|NCT01800422|Hormones|hormones|mesh-ancestor
153589047|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589048|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589049|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
153589056|NCT01800487|Silymarin|silymarin|mesh-list
153589077|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829950|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829951|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153829952|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829953|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
153829954|NCT00506844|Capecitabine|capecitabine|mesh-list
153369983|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369984|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369986|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153369987|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
153369989|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589078|NCT01800643|Busulfan|busulfan|mesh-list
153589079|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
153589080|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589081|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589082|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
153589083|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589084|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153589085|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589086|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153589087|NCT01800695|Temozolomide|temozolomide|mesh-list
153589088|NCT01800695|ABT-414|abt-414|mesh-list
153589141|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589142|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
153589143|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589144|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589145|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
153589146|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589147|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589148|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
153589151|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
153589152|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589153|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153589154|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153589155|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589156|NCT01801137|Everolimus|everolimus|mesh-list
153589157|NCT01801137|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153589196|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153589198|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589199|NCT01801774|Triamcinolone|triamcinolone|mesh-list
153589200|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153589201|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153589202|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153459367|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459368|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459369|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153459370|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153459371|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
153459372|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459373|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153459374|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153817979|NCT05728333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817980|NCT05728333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153817981|NCT05723562|Dostarlimab|dostarlimab|mesh-list
153817982|NCT05723562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817983|NCT05719285|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153817984|NCT05719285|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153817985|NCT05719285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817986|NCT05719285|Antitubercular Agents|antitubercular agents|mesh-ancestor
153817987|NCT05698407|Sufentanil|sufentanil|mesh-list
153817988|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
153817989|NCT05698407|Dsuvia|dsuvia|mesh-list
153817990|NCT05698407|Ropivacaine|ropivacaine|mesh-list
153817991|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153589211|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589212|NCT01802255|Midazolam|midazolam|mesh-list
153589213|NCT01802255|Sevoflurane|sevoflurane|mesh-list
153589214|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153589215|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153589216|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589217|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589218|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153589219|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153589274|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153589275|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153589276|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153589277|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153589278|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153589279|NCT01802593|Methotrexate|methotrexate|mesh-list
153589280|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
153589281|NCT01802593|Azathioprine|azathioprine|mesh-list
153589282|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153589283|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
153589287|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
153589339|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
153589341|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
153589342|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153589343|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589344|NCT01802684|Aflibercept|aflibercept|mesh-list
153589345|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153589346|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153589347|NCT01802684|Growth Substances|growth substances|mesh-ancestor
153589348|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589349|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
153589350|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589351|NCT01802892|Plerixafor|plerixafor|mesh-list
153589352|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153589400|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370013|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
153370014|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370015|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153589401|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589402|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153589403|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
153589404|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153589405|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153589406|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153589407|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
153589408|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153589409|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589411|NCT01803191|Fosfomycin|fosfomycin|mesh-list
153589412|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589413|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589414|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153589415|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153589416|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589417|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589418|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589419|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153589420|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153589421|NCT01803321|Rilonacept|rilonacept|mesh-list
153589422|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153589423|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153589424|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
153589425|NCT01803347|Coagulants|coagulants|mesh-ancestor
153589426|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
153589435|NCT01803503|Docetaxel|docetaxel|mesh-list
153589449|NCT01803659|Vitamin A|vitamin a|mesh-list
153589450|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
153589451|NCT01803659|Carotenoids|carotenoids|mesh-list
153589452|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
153589453|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589454|NCT01803659|Protective Agents|protective agents|mesh-ancestor
153589455|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589456|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153589457|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821020|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153360976|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153360977|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153360978|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829976|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153829977|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153829978|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589458|NCT01803659|Vitamins|vitamins|mesh-ancestor
153589459|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
153589460|NCT01803763|Omalizumab|omalizumab|mesh-list
153589461|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153589462|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153589509|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
153589510|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589511|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153589512|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153781635|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781636|NCT00266487|Vitamins|vitamins|mesh-list
153781637|NCT00266487|Folic Acid|folic acid|mesh-list
153781703|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589514|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
153589516|NCT01804361|Cyclosporins|cyclosporins|mesh-list
153589517|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589518|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589519|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589520|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
153589521|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589522|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
153589523|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589524|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877755|NCT05403385|Pemetrexed|pemetrexed|mesh-list
153877756|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589525|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589526|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153589527|NCT01804374|Everolimus|everolimus|mesh-list
153589528|NCT01804374|Sorafenib|sorafenib|mesh-list
153589529|NCT01804374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153589530|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589531|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589569|NCT01804595|Protective Agents|protective agents|mesh-ancestor
153589571|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
153589572|NCT01804712|Rituximab|rituximab|mesh-list
153589573|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153589574|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589575|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
153589576|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589577|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589578|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153589579|NCT01804777|Amiloride|amiloride|mesh-list
153589580|NCT01804777|Diuretics|diuretics|mesh-ancestor
153589581|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
153830002|NCT00495872|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153830003|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153830005|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589582|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589630|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589631|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
153589632|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589633|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153589634|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153589635|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153589636|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153589637|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153589638|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153589639|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153589640|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153589641|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
153589642|NCT01805310|Cathartics|cathartics|mesh-ancestor
153589643|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153589644|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153589645|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589646|NCT01807741|Asenapine|asenapine|mesh-list
153589647|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153589648|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153589649|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589650|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589651|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153589652|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
153589653|NCT01807767|Everolimus|everolimus|mesh-list
153589654|NCT01807767|Tacrolimus|tacrolimus|mesh-list
153589655|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589656|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
153589676|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
153589677|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153589678|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
153370064|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370065|NCT03554044|Tamoxifen|tamoxifen|mesh-list
153370066|NCT03554044|Paclitaxel|paclitaxel|mesh-list
153370067|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153370068|NCT03554044|Carboplatin|carboplatin|mesh-list
153830006|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
153830007|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
153830008|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830009|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
153830010|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153830011|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830012|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153830013|NCT00507117|Eszopiclone|eszopiclone|mesh-list
153589679|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589680|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153589681|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153589682|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
153589683|NCT01807962|Lidocaine|lidocaine|mesh-list
153589684|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
153589685|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
153589686|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153589687|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589688|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
153589689|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589690|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153589695|NCT01808014|Nefopam|nefopam|mesh-list
153589736|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589737|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
153589738|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153589739|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
153589740|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589741|NCT01808521|Expectorants|expectorants|mesh-ancestor
153589742|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
153589743|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153360979|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153589744|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
153589745|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589746|NCT01808521|Protective Agents|protective agents|mesh-ancestor
153589747|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589748|NCT01808521|Antidotes|antidotes|mesh-ancestor
153589749|NCT01808586|Dexamethasone|dexamethasone|mesh-list
153589750|NCT01808586|Betamethasone|betamethasone|mesh-list
153589752|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153589753|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
153589754|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
153589755|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153589792|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
153589794|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
153589795|NCT01808911|Rituximab|rituximab|mesh-list
153589796|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589797|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
153589798|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589861|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589862|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153589863|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589864|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153589865|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153589866|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
153589867|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153589868|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153589869|NCT01809626|Zolpidem|zolpidem|mesh-list
153589870|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153589875|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
153589927|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
153589928|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153589929|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
153589930|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153589931|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589932|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
153589933|NCT01810315|Estradiol|estradiol|mesh-list
153589934|NCT01810315|Estrogens|estrogens|mesh-ancestor
153589936|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589937|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589938|NCT01810354|Cefazolin|cefazolin|mesh-list
153589991|NCT01810458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153589992|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153589993|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
153589994|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
153589995|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153589996|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153589997|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153589998|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153589999|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590000|NCT01810601|Progesterone|progesterone|mesh-list
153357411|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
153357412|NCT01273844|Bortezomib|bortezomib|mesh-list
153357413|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590001|NCT01810601|Progestins|progestins|mesh-ancestor
153590002|NCT01810601|Hormones|hormones|mesh-ancestor
153590003|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590004|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590005|NCT01810640|Liver Extracts|liver extracts|mesh-list
153590055|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590056|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153590057|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
153590058|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153590059|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590060|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
153590061|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590062|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
153590063|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590064|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153590065|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153590066|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153590067|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
153590068|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590113|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590114|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153590115|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153590116|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153590117|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590118|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153590119|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
153590120|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590121|NCT01811381|Curcumin|curcumin|mesh-list
153590123|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153590180|NCT01812018|Endostar protein|endostar protein|mesh-list
153590181|NCT01812018|Endostatins|endostatins|mesh-list
153590182|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590183|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
153590184|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590185|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590186|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
153590187|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
153590188|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
153590190|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153590191|NCT01812018|Growth Substances|growth substances|mesh-ancestor
153590192|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590193|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
153590195|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590239|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
153590240|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590241|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590242|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590244|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153590245|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
153590246|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
153590247|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590248|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590249|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153590250|NCT01812356|Analgesics|analgesics|mesh-ancestor
153590251|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
153590253|NCT01812369|Gemcitabine|gemcitabine|mesh-list
153590298|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590299|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590300|NCT01812720|Dexamethasone|dexamethasone|mesh-list
153590301|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590302|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
153590303|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
153590304|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590305|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590306|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590364|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590365|NCT01813162|Tenofovir|tenofovir|mesh-list
153590366|NCT01813162|Metronidazole|metronidazole|mesh-list
153590367|NCT01813162|Terconazole|terconazole|mesh-list
153590368|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
153590369|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
153590370|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590371|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153590372|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153590373|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590374|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590375|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153590376|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153590377|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153590378|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153590379|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153590380|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153590381|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590382|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
153590383|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
153590384|NCT01813201|Testosterone|testosterone|mesh-list
153590385|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
153590386|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
153590387|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153590388|NCT01813201|Androgens|androgens|mesh-ancestor
153590416|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590417|NCT01813513|Simeprevir|simeprevir|mesh-list
153590418|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
153590419|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590420|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
153590421|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590422|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590423|NCT01813552|Ritonavir|ritonavir|mesh-list
153590424|NCT01813552|Omeprazole|omeprazole|mesh-list
153590425|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153590426|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153590427|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
153590428|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590429|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590430|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153590431|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153590432|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
153590433|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590434|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153590443|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
153590444|NCT01813565|Protective Agents|protective agents|mesh-ancestor
153590445|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153590446|NCT01813591|Hormones|hormones|mesh-ancestor
153817992|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817993|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817994|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817995|NCT05698407|Analgesics|analgesics|mesh-ancestor
153817996|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
153817997|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817998|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153817999|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153818000|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153818001|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
153590447|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590448|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590449|NCT01813604|Vaccines|vaccines|mesh-list
153590450|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
153590451|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590452|NCT01813617|Prednisone|prednisone|mesh-list
153590453|NCT01813617|Methotrexate|methotrexate|mesh-list
153590454|NCT01813617|Azathioprine|azathioprine|mesh-list
153590455|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153370135|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370137|NCT02889159|Histamine|histamine|mesh-list
153370138|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
153370139|NCT02889159|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153370141|NCT02889159|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153590456|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590457|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
153590458|NCT01813617|Hormones|hormones|mesh-ancestor
153590459|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590460|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590461|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153590462|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590463|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153818002|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818003|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818004|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
153818005|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
153818006|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153459377|NCT03618654|Durvalumab|durvalumab|mesh-list
153459378|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
153459379|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153459380|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
153459381|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153459382|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459383|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459384|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459385|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
153459386|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
153459387|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153459388|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459389|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153459390|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153459391|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459392|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459393|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459394|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153459395|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153459396|NCT03609060|Dexamethasone|dexamethasone|mesh-list
153459397|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153459398|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
153590474|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153590475|NCT01813643|Risperidone|risperidone|mesh-list
153590476|NCT01813643|Aripiprazole|aripiprazole|mesh-list
153590477|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153590478|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
153590479|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590480|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590481|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590482|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153590483|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153590484|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590485|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153590486|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153590487|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
153590488|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
153590489|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
153590490|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153590491|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153590492|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153590493|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153590494|NCT01813656|Aripiprazole|aripiprazole|mesh-list
153590495|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
153590496|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153590497|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153590498|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153590499|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590500|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590501|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
153590502|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
153668018|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153418563|NCT02937506|Narcotics|narcotics|mesh-ancestor
153418564|NCT02937506|Analgesics|analgesics|mesh-ancestor
153590503|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590504|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590505|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153590506|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153590507|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
153590508|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153590509|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153590510|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153590511|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153590512|NCT01813773|Aflibercept|aflibercept|mesh-list
153590513|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153590514|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153590515|NCT01813773|Growth Substances|growth substances|mesh-ancestor
153590516|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590517|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
153590518|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590519|NCT01813812|Rebamipide|rebamipide|mesh-list
153590520|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153590521|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590522|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
153590523|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590524|NCT01813812|Protective Agents|protective agents|mesh-ancestor
153590525|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370144|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153590526|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590540|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153590541|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
153590542|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590543|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153590544|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153590545|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153590546|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
153590547|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590548|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590549|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153590550|NCT01814059|Sirolimus|sirolimus|mesh-list
153590551|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153590552|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590553|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153590554|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590572|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590573|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
153418565|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
153418566|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418567|NCT03026803|Capecitabine|capecitabine|mesh-list
153418568|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
153418569|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153418570|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
153880190|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
153877771|NCT05395052|Interleukin-2|interleukin-2|mesh-list
153810818|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846524|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590574|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590576|NCT01814163|Bevacizumab|bevacizumab|mesh-list
153590577|NCT01814163|Carboplatin|carboplatin|mesh-list
153590578|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153590579|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590580|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
153590581|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
153590582|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
153590583|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590584|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153590585|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153360984|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153830128|NCT01297465|Hormones|hormones|mesh-ancestor
153590586|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153590587|NCT01814163|Growth Substances|growth substances|mesh-ancestor
153590588|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590589|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
153590590|NCT01814189|Promethazine|promethazine|mesh-list
153590591|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
153590592|NCT01814189|Sumatriptan|sumatriptan|mesh-list
153590593|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153590594|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153590595|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153590596|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
153590597|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818008|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153818009|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153818010|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
153818011|NCT05690087|Lidocaine|lidocaine|mesh-list
153818012|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
153818013|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
153818014|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153818022|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818023|NCT05676112|Pirfenidone|pirfenidone|mesh-list
153818024|NCT05676112|Nintedanib|nintedanib|mesh-list
153818025|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818026|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153818027|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459399|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
153459400|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459401|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590598|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590600|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
153590601|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
153590602|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153821034|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
153360987|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
153360988|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
153590603|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
153590604|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
153590605|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153590606|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153590607|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153590608|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590609|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
153590610|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
153590611|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
153590612|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590613|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
153590614|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
153590615|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810819|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153590616|NCT01814319|Probenecid|probenecid|mesh-list
153590617|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
153590618|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
153590619|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590620|NCT01814410|Ethanol|ethanol|mesh-list
153590621|NCT01814410|Nicotine|nicotine|mesh-list
153590622|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153590623|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
153590624|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590625|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459402|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459403|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
153459405|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459406|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153459407|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459408|NCT03704766|Defensins|defensins|mesh-list
153459409|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
153459410|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459411|NCT03826992|Cytarabine|cytarabine|mesh-list
153459412|NCT03826992|Daunorubicin|daunorubicin|mesh-list
153459413|NCT03826992|Venetoclax|venetoclax|mesh-list
153590626|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153590627|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153590628|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
153590629|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590630|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590631|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153590632|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590633|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590635|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153590636|NCT01814423|Amebicides|amebicides|mesh-ancestor
153590637|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153590654|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153590655|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153590656|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590657|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590658|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153590659|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
153590660|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590661|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590662|NCT01814475|Vidarabine|vidarabine|mesh-list
153590663|NCT01814475|Fludarabine|fludarabine|mesh-list
153590664|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
153590665|NCT01814475|Busulfan|busulfan|mesh-list
153590666|NCT01814475|Thiotepa|thiotepa|mesh-list
153590667|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590668|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590669|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
153590670|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590671|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153590672|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
153818028|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818029|NCT05676112|Analgesics|analgesics|mesh-ancestor
153818030|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
153818031|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818032|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818033|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153877772|NCT05395052|Avelumab|avelumab|mesh-list
153877773|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
153877774|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877775|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
153877776|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877777|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877778|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153877786|NCT05395052|Analgesics|analgesics|mesh-ancestor
153877791|NCT05361720|Nivolumab|nivolumab|mesh-list
153590673|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590676|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
153590677|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153590678|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153590679|NCT01814501|Leucovorin|leucovorin|mesh-list
153590680|NCT01814501|Fluorouracil|fluorouracil|mesh-list
153590681|NCT01814501|Irinotecan|irinotecan|mesh-list
153590682|NCT01814501|Panitumumab|panitumumab|mesh-list
153590683|NCT01814501|Calcium|calcium|mesh-list
153590684|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
153590685|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153590686|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590687|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
153590688|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590689|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590690|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590691|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153590692|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
153590693|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153590694|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153590695|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590696|NCT01814501|Antidotes|antidotes|mesh-ancestor
153590698|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
153590699|NCT01814501|Vitamins|vitamins|mesh-ancestor
153459419|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459420|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459421|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
153459422|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459423|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153590700|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
153590701|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153590702|NCT01814514|Timolol|timolol|mesh-list
153590703|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153590704|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153590705|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
153590706|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153590707|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590708|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590709|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153590710|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153590711|NCT01814618|Budesonide|budesonide|mesh-list
153590712|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590713|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153590724|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153590725|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153590726|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590727|NCT01814709|Itraconazole|itraconazole|mesh-list
153590729|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
153590730|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590731|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153590732|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153590733|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590734|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590735|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153590736|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
153590737|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590738|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590739|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153590740|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153590741|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
153590742|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153818041|NCT05668650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818042|NCT05656599|Letermovir|letermovir|mesh-list
153818043|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153818044|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830190|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818045|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818046|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818047|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
153818049|NCT05642078|Vaccines|vaccines|mesh-list
153818050|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
153459432|NCT00004092|Thiotepa|thiotepa|mesh-list
153459433|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459434|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459435|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
153459436|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
153459437|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
153459438|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459439|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459440|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
153459441|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459442|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590743|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
153590744|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153590745|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153590746|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153590747|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153590748|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153590749|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153590750|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153590751|NCT01814826|Azacitidine|azacitidine|mesh-list
153590752|NCT01814826|Pevonedistat|pevonedistat|mesh-list
153590753|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590754|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
153590755|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590756|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590757|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590758|NCT01814865|Prednisone|prednisone|mesh-list
153590759|NCT01814865|Anastrozole|anastrozole|mesh-list
153590760|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
153459443|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153459444|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
153459445|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153459446|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153459447|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153459448|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153459449|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459450|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
153459451|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818054|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153818055|NCT05641246|Analgesics|analgesics|mesh-ancestor
153818056|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
153818057|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818058|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818059|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818060|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153818061|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153818062|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818063|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818064|NCT05609565|Bupivacaine|bupivacaine|mesh-list
153818066|NCT05609565|Anesthetics|anesthetics|mesh-list
153818067|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
153818068|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153818069|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818070|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
153818071|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459452|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153459453|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459454|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590762|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590763|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
153590765|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590766|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590767|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153590768|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590769|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153590770|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590771|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590772|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153590773|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
153590774|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153590776|NCT01814891|Vitamins|vitamins|mesh-ancestor
153590777|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
153590778|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590779|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
153590780|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590781|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
153590782|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153590783|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590784|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
153590785|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
153590786|NCT01815021|Calcium|calcium|mesh-list
153590787|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153459455|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153459456|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459457|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153459458|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
153459459|NCT03825198|Dexamethasone|dexamethasone|mesh-list
153459460|NCT03825198|Ketorolac|ketorolac|mesh-list
153459461|NCT03825198|Sufentanil|sufentanil|mesh-list
153459462|NCT03825198|Morphine|morphine|mesh-list
153459463|NCT03825198|Bromides|bromides|mesh-list
153459464|NCT03825198|Propofol|propofol|mesh-list
153459465|NCT03825198|Sevoflurane|sevoflurane|mesh-list
153459466|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
153459467|NCT03825198|Rocuronium|rocuronium|mesh-list
153459468|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153459469|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
153459470|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
153459471|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459472|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459473|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590788|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590789|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153590790|NCT01815021|Antacids|antacids|mesh-ancestor
153590791|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590792|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590793|NCT01815047|Vitamin D|vitamin d|mesh-list
153810820|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153877792|NCT05361720|Ipilimumab|ipilimumab|mesh-list
153877793|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877794|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590794|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
153590795|NCT01815047|Vitamins|vitamins|mesh-ancestor
153590796|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
153590797|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590798|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153590799|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153590801|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
153590802|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590803|NCT01815125|Ondansetron|ondansetron|mesh-list
153590804|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
153590847|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590848|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
153590849|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590850|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590851|NCT01815437|Vitamin D|vitamin d|mesh-list
153590852|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
153590853|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
153590854|NCT01815437|Vitamins|vitamins|mesh-list
153590855|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
153590856|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590857|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153590858|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153590859|NCT01815528|Catumaxomab|catumaxomab|mesh-list
153590860|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590861|NCT01815541|Teicoplanin|teicoplanin|mesh-list
153590862|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153590875|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590876|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153590877|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153590878|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590880|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
153590881|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
153590882|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590883|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590884|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
153590885|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590886|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153590887|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590888|NCT01816035|Trastuzumab|trastuzumab|mesh-list
153590889|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153590890|NCT01816035|Maytansine|maytansine|mesh-list
153590891|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
153590892|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153590893|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590894|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153590895|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
153590907|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153590908|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590909|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
153590910|NCT01816321|Ganirelix|ganirelix|mesh-list
153590911|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
153590912|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590913|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590914|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
153877795|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153418571|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418572|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418573|NCT03027661|Bupivacaine|bupivacaine|mesh-list
153418574|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
153418575|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
153418576|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418580|NCT03022526|Fentanyl|fentanyl|mesh-list
153590915|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153590916|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153590917|NCT01816334|Prednisolone|prednisolone|mesh-list
153590918|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
153590919|NCT01816334|Ketoprofen|ketoprofen|mesh-list
153590920|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153590921|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
153590922|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590923|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
153590924|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
153590925|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370304|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370305|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370306|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153370307|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153370308|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
153370309|NCT01530373|Urological Agents|urological agents|mesh-ancestor
153830245|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153830246|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830247|NCT01296412|Incretins|incretins|mesh-ancestor
153830248|NCT01296412|Hormones|hormones|mesh-ancestor
153830249|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153830250|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153408024|NCT05436054|Cathartics|cathartics|mesh-ancestor
153590926|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590927|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590928|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
153590929|NCT01816334|Hormones|hormones|mesh-ancestor
153590935|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153590936|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153590937|NCT01816334|Analgesics|analgesics|mesh-ancestor
153590938|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
153590939|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590940|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153590941|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590942|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590943|NCT01816412|Paclitaxel|paclitaxel|mesh-list
153590944|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153781708|NCT00259428|Dronedarone|dronedarone|mesh-list
153590945|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590946|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
153590947|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
153590948|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
153590949|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818096|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
153818097|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818098|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459476|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459477|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153459478|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459479|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153459480|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459481|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153459482|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
153459483|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
153459484|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153459485|NCT03825198|Narcotics|narcotics|mesh-ancestor
153386973|NCT01621737|Oxytocin|oxytocin|mesh-list
153459486|NCT03825198|Analgesics|analgesics|mesh-ancestor
153459489|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153590960|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153590961|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590963|NCT01816555|Vitamin D|vitamin d|mesh-list
153590964|NCT01816555|Vitamins|vitamins|mesh-ancestor
153590965|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
153590966|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590967|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153590968|NCT01816581|Morphine|morphine|mesh-list
153590969|NCT01816581|Naloxone|naloxone|mesh-list
153590970|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153590971|NCT01816581|Narcotics|narcotics|mesh-ancestor
153590972|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153590973|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590974|NCT01816581|Analgesics|analgesics|mesh-ancestor
153590975|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
153590976|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590977|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153590978|NCT01816620|Dexamethasone|dexamethasone|mesh-list
153590979|NCT01816620|Lenalidomide|lenalidomide|mesh-list
153590980|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590981|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
153590982|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
153590983|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590984|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590985|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590987|NCT01816620|Hormones|hormones|mesh-ancestor
153590988|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590989|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153590991|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
153590992|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153590993|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153590994|NCT01816620|Growth Substances|growth substances|mesh-ancestor
153590995|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
153590996|NCT01816646|Cidofovir|cidofovir|mesh-list
153590997|NCT01816646|Probenecid|probenecid|mesh-list
153590998|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
153590999|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
153591000|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153591001|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
153591002|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591011|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153591012|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591013|NCT01816958|Ketamine|ketamine|mesh-list
153591016|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591017|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591018|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153591019|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153591020|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
153591021|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
153591022|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591023|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153591024|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153591025|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591026|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591027|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153459491|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153459492|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153459493|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153459494|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459495|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459497|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153459498|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153459499|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153459500|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153459501|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
153459506|NCT06125873|Metformin|metformin|mesh-list
153846906|NCT00534807|Rifampin|rifampin|mesh-list
153459507|NCT06125873|Glucagon|glucagon|mesh-list
153591037|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591038|NCT01817036|Vitamin D|vitamin d|mesh-list
153591039|NCT01817036|Vitamins|vitamins|mesh-ancestor
153591040|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
153591041|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591042|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153591043|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
153591044|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153591045|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153591046|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153591047|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153591048|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
153591049|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153591050|NCT01817257|Heparin|heparin|mesh-list
153591051|NCT01817257|Enoxaparin|enoxaparin|mesh-list
153591052|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153591053|NCT01817257|Tinzaparin|tinzaparin|mesh-list
153591054|NCT01817257|Dalteparin|dalteparin|mesh-list
153591055|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
153591056|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153591057|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153591058|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591059|NCT01817283|Triptolide|triptolide|mesh-list
153591060|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153591061|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591062|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153591063|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
153591064|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153591065|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153591066|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
153591067|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153591068|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
153591069|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591070|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591071|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
153591072|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
153591073|NCT01817322|Prednisolone|prednisolone|mesh-list
153591074|NCT01817322|Deflazacort|deflazacort|mesh-list
153591075|NCT01817322|Basiliximab|basiliximab|mesh-list
153591076|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153591077|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
153591078|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
153591079|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591080|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591081|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153591082|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
153591083|NCT01817322|Hormones|hormones|mesh-ancestor
153591084|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591095|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591096|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153591097|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
153591100|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
153591101|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591102|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591103|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
153591104|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591105|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153880215|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153877796|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877797|NCT05359653|Clemastine|clemastine|mesh-list
153877798|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
153877799|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877800|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153877801|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
153591106|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153591107|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153591108|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591109|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591111|NCT01817400|Pioglitazone|pioglitazone|mesh-list
153591112|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153591113|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153591114|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153591115|NCT01817400|Analgesics|analgesics|mesh-ancestor
153591116|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
153591119|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153591142|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153591143|NCT01817699|Vitamin D|vitamin d|mesh-list
153591144|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
153591145|NCT01817699|Vitamins|vitamins|mesh-ancestor
153591146|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
153591147|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591148|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153591149|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591150|NCT01817803|Metolazone|metolazone|mesh-list
153591151|NCT01817803|Furosemide|furosemide|mesh-list
153591152|NCT01817803|Spironolactone|spironolactone|mesh-list
153591153|NCT01817803|Diuretics|diuretics|mesh-ancestor
153591154|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
153591155|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591156|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153591157|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591158|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591159|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153591160|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
153591161|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591162|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153591163|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591168|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591169|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591170|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153591171|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591172|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591174|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591175|NCT01817829|Acetaminophen|acetaminophen|mesh-list
153591176|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153821054|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
153821055|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408079|NCT02973659|Oxybutynin|oxybutynin|mesh-list
153914597|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
153361003|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591177|NCT01817829|Analgesics|analgesics|mesh-ancestor
153591178|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
153591179|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591180|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591181|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
153591182|NCT01817868|Factor VIII|factor viii|mesh-list
153591183|NCT01817868|Coagulants|coagulants|mesh-ancestor
153591184|NCT01817894|Eflornithine|eflornithine|mesh-list
153591185|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591186|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153591187|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153591188|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153591189|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591190|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153591191|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591192|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591193|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
153591194|NCT01817972|Azathioprine|azathioprine|mesh-list
153591195|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
153591196|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591197|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153591198|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591199|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153591200|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
153591201|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818118|NCT05571644|Leucovorin|leucovorin|mesh-list
153818119|NCT05571644|Fluorouracil|fluorouracil|mesh-list
153818120|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
153818121|NCT05571644|Irinotecan|irinotecan|mesh-list
153818122|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
153818123|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
153818124|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818125|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818126|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818127|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818128|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
153818129|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818130|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153459508|NCT06125873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153459509|NCT06125873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459510|NCT06125873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459511|NCT06125873|Hormones|hormones|mesh-ancestor
153830335|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
153459512|NCT06125873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459513|NCT06125834|Trastuzumab|trastuzumab|mesh-list
153459514|NCT06125834|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153459516|NCT06125834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459517|NCT06125834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459518|NCT06125834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153591202|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153591203|NCT01817972|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153591204|NCT01817972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153591205|NCT01817985|Velpatasvir|velpatasvir|mesh-list
153591206|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
153591207|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591208|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153591209|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
153591210|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591212|NCT01818648|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153591221|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153591222|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591223|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153591224|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153591225|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591226|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591227|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
153591228|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
153591229|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591230|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
153591231|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591232|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591234|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153591235|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153591236|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153591237|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
153818131|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153818132|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818133|NCT05571644|Antidotes|antidotes|mesh-ancestor
153818134|NCT05571644|Protective Agents|protective agents|mesh-ancestor
153818135|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
153818136|NCT05571644|Vitamins|vitamins|mesh-ancestor
153818143|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153818144|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
153818145|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153818146|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153818147|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818148|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459525|NCT06125834|Immunologic Factors|immunologic factors|mesh-ancestor
153459526|NCT06125834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459527|NCT06125587|Metformin|metformin|mesh-list
153459528|NCT06125587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153459529|NCT06125587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459530|NCT06125392|Adenosine|adenosine|mesh-list
153459531|NCT06125392|Acetylcholine|acetylcholine|mesh-list
153459532|NCT06125392|Papaverine|papaverine|mesh-list
153459533|NCT06125392|Analgesics|analgesics|mesh-ancestor
153459534|NCT06125392|Sensory System Agents|sensory system agents|mesh-ancestor
153459535|NCT06125392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459536|NCT06125392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459537|NCT06125392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153459538|NCT06125392|Vasodilator Agents|vasodilator agents|mesh-ancestor
153459539|NCT06125392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153459540|NCT06125392|Purinergic Agonists|purinergic agonists|mesh-ancestor
153459541|NCT06125392|Purinergic Agents|purinergic agents|mesh-ancestor
153459542|NCT06125392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591238|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591239|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591240|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153591241|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153591242|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
153591243|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591244|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153591245|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153591247|NCT01818869|Analgesics|analgesics|mesh-ancestor
153591248|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
153591249|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591250|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591251|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153591252|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591253|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153591254|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
153591255|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
153591256|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591257|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591258|NCT01818908|Prednisone|prednisone|mesh-list
153591259|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
153591260|NCT01818908|Doxorubicin|doxorubicin|mesh-list
153591261|NCT01818908|Etoposide|etoposide|mesh-list
153459543|NCT06125392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459544|NCT06125392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153459545|NCT06125392|Cholinergic Agents|cholinergic agents|mesh-ancestor
153459546|NCT06125392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153459547|NCT06125392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459548|NCT06125392|Urological Agents|urological agents|mesh-ancestor
153914598|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153361004|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361005|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153361006|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153361007|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153877802|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
153877803|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877804|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877805|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361008|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153361009|NCT01492673|Growth Substances|growth substances|mesh-ancestor
153361010|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
153361011|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153361012|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153459550|NCT06125353|Antioxidants|antioxidants|mesh-ancestor
153459551|NCT06125353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459552|NCT06125353|Protective Agents|protective agents|mesh-ancestor
153459553|NCT06125353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459554|NCT06125353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459555|NCT06125184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153459556|NCT06125171|Apatinib|apatinib|mesh-list
153459557|NCT06125171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459558|NCT06125171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153459559|NCT06125171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818152|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818153|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591263|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153591264|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
153591265|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591266|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153591267|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153591268|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
153591269|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591270|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591271|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153591272|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153591273|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153591274|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153591275|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591276|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153591277|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
153591278|NCT01818908|Hormones|hormones|mesh-ancestor
153591279|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591280|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153591281|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153591282|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
153591283|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
153361013|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810822|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153810823|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357416|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418601|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
153418602|NCT02794441|Hormones|hormones|mesh-ancestor
153418603|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418604|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153421072|NCT06287944|Fludarabine|fludarabine|mesh-list
153421073|NCT06287944|Melphalan|melphalan|mesh-list
153421074|NCT06287944|Mechlorethamine|mechlorethamine|mesh-list
153421075|NCT06287944|Daratumumab|daratumumab|mesh-list
153361014|NCT00818324|Rebamipide|rebamipide|mesh-list
153361015|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153361016|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153361017|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
153361018|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361019|NCT00818324|Protective Agents|protective agents|mesh-ancestor
153361020|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361021|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361022|NCT01419275|Xenon|xenon|mesh-list
153361023|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153361024|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
153361025|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
153361026|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821058|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153361027|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361028|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
153821059|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821060|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153821061|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153821062|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821063|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821064|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821065|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153821066|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153821067|NCT00436709|Paclitaxel|paclitaxel|mesh-list
153821068|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
153821069|NCT00436709|Bevacizumab|bevacizumab|mesh-list
153821070|NCT00436709|Doxorubicin|doxorubicin|mesh-list
153821071|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153821072|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153821073|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153821074|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821075|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
153821076|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
153370463|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370464|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
153370465|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153370466|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370467|NCT01286402|Bupropion|bupropion|mesh-list
153370468|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153370469|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
153370470|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153830409|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153830410|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
153830411|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830412|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821081|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821082|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361029|NCT02155010|Bupivacaine|bupivacaine|mesh-list
153421076|NCT06287944|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153421077|NCT06287944|Tacrolimus|tacrolimus|mesh-list
153421078|NCT06287944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153421079|NCT06287944|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153421080|NCT06287944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421081|NCT06287944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421082|NCT06287944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153421083|NCT06287944|Immunologic Factors|immunologic factors|mesh-ancestor
153421084|NCT06287944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421086|NCT06287944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591284|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
153591285|NCT01818973|Bevacizumab|bevacizumab|mesh-list
153591286|NCT01818973|Capecitabine|capecitabine|mesh-list
153591287|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
153830423|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
153830424|NCT00497237|Hormones|hormones|mesh-ancestor
153830425|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153830426|NCT00497315|Pemetrexed|pemetrexed|mesh-list
153830427|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821084|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
153408158|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153830428|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591288|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153591289|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591290|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153591291|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153591292|NCT01818973|Growth Substances|growth substances|mesh-ancestor
153591293|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591294|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
153591302|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591303|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591304|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
153591305|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153591306|NCT01819155|Vaccines|vaccines|mesh-list
153591307|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
153591308|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591309|NCT01819220|Amlodipine|amlodipine|mesh-list
153591310|NCT01819220|Valsartan|valsartan|mesh-list
153591311|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153591312|NCT01819220|Telmisartan|telmisartan|mesh-list
153591313|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153591314|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
153591315|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153830448|NCT00494624|Hormones|hormones|mesh-ancestor
153591316|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153591317|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591318|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591319|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591320|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591321|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591322|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153591323|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153591324|NCT01819220|Diuretics|diuretics|mesh-ancestor
153591325|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
153591326|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153591327|NCT01819259|Nicotine|nicotine|mesh-list
153591328|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153591329|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
153591330|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591331|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591332|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153591333|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153591334|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
153591336|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591337|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153847479|NCT00551733|Paclitaxel|paclitaxel|mesh-list
153591339|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591340|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591341|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
153591342|NCT01819389|Nilotinib|nilotinib|mesh-list
153591343|NCT01819389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153591344|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153591345|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591346|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591347|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591348|NCT01819402|Pioglitazone|pioglitazone|mesh-list
153591349|NCT01819402|Glimepiride|glimepiride|mesh-list
153591350|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153591351|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591352|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153591353|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153591354|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
153591355|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153591356|NCT01819441|Perindopril|perindopril|mesh-list
153370512|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153370513|NCT04932915|Niclosamide|niclosamide|mesh-list
153370514|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
153821088|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153361034|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
153591357|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591358|NCT01819441|Diuretics|diuretics|mesh-ancestor
153818155|NCT05486065|Semaglutide|semaglutide|mesh-list
153818156|NCT05486065|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153818157|NCT05486065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818158|NCT05486065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818159|NCT05468242|Bevacizumab|bevacizumab|mesh-list
153818160|NCT05468242|Tislelizumab|tislelizumab|mesh-list
153818161|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818162|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818163|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153818164|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153818165|NCT05468242|Growth Substances|growth substances|mesh-ancestor
153818166|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818167|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153818168|NCT05454709|Glucagon|glucagon|mesh-list
153818169|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153818170|NCT05454709|Hormones|hormones|mesh-ancestor
153818171|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818172|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818174|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153818175|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
153818176|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818180|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
153591359|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
153591360|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591361|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153591362|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591363|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591364|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153591365|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
153591366|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591367|NCT01819610|Ketorolac|ketorolac|mesh-list
153591368|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153591369|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153591370|NCT01819610|Analgesics|analgesics|mesh-ancestor
153591371|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
153591372|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591373|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591374|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153591375|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153591376|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153591377|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591378|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591380|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
153591381|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591382|NCT01819649|Protective Agents|protective agents|mesh-ancestor
153591383|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821091|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153830496|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153830497|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830498|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153830499|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830500|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591384|NCT01819649|Trace Elements|trace elements|mesh-ancestor
153591385|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
153591386|NCT01819701|Ubiquinone|ubiquinone|mesh-list
153591387|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
153591390|NCT01819701|Vitamins|vitamins|mesh-ancestor
153591401|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591402|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591403|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591404|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591405|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591406|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153591407|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153591408|NCT01819857|Ondansetron|ondansetron|mesh-list
153591409|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
153591410|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
153591411|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591412|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591413|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153591414|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
153591415|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
153591416|NCT01819857|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153591417|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153591418|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
153591419|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591420|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591421|NCT01819870|Carvedilol|carvedilol|mesh-list
153818181|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459560|NCT06125171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459561|NCT06125106|Blinatumomab|blinatumomab|mesh-list
153459562|NCT06125106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459563|NCT06125080|Bevacizumab|bevacizumab|mesh-list
153459564|NCT06125080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459565|NCT06125080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459566|NCT06125080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153830524|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830525|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830526|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
153830527|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153830528|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
153830529|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830530|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830531|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153830532|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
153830533|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153370569|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153370570|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153370571|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153370572|NCT01289912|Everolimus|everolimus|mesh-list
153370573|NCT01289912|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153370574|NCT01289912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153370575|NCT01289912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370576|NCT01289912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370577|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459567|NCT06125080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153459568|NCT06125080|Growth Substances|growth substances|mesh-ancestor
153459569|NCT06125080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459570|NCT06125080|Growth Inhibitors|growth inhibitors|mesh-ancestor
153459571|NCT06125041|Carboplatin|carboplatin|mesh-list
153459572|NCT06125041|Etoposide|etoposide|mesh-list
153459573|NCT06125041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370585|NCT03069963|Antacids|antacids|mesh-ancestor
153459574|NCT06125041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459575|NCT06125041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153459576|NCT06125041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153459577|NCT06125041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459578|NCT06125041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459579|NCT06125028|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153459580|NCT06125028|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153459581|NCT06125028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459582|NCT06124729|Bevacizumab|bevacizumab|mesh-list
153459583|NCT06124729|Antibodies|antibodies|mesh-list
153459584|NCT06124729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153459585|NCT06124729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459586|NCT06124729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591422|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153591423|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153591424|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
153591425|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591426|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591427|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591428|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591429|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
153591430|NCT01819870|Protective Agents|protective agents|mesh-ancestor
153591431|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153591432|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591433|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591434|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
153818186|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
153818187|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818188|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591445|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153591448|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153591449|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591450|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153591451|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591452|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591453|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
153591454|NCT01820091|Antidotes|antidotes|mesh-ancestor
153591455|NCT01820091|Protective Agents|protective agents|mesh-ancestor
153591456|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591457|NCT01820104|Lansoprazole|lansoprazole|mesh-list
153591458|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
153591459|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153591460|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153591461|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153591462|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591463|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591464|NCT01820143|Esomeprazole|esomeprazole|mesh-list
153591465|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153591466|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153591467|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153591468|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591469|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591471|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
153591472|NCT01820299|Vitamins|vitamins|mesh-ancestor
153591473|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
153591474|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591475|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153591476|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153877811|NCT05358704|Irinotecan|irinotecan|mesh-list
153877812|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153877813|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
153877814|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591477|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591478|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
153818189|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153818190|NCT05388058|Cannabidiol|cannabidiol|mesh-list
153818191|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
153818192|NCT05370911|Psilocybin|psilocybin|mesh-list
153818193|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
153818194|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591479|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821104|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153821105|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153821106|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153821107|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153821108|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153591480|NCT01820299|Protective Agents|protective agents|mesh-ancestor
153591482|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153591483|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591484|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
153591485|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
153591486|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
153591487|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591488|NCT01820325|Paclitaxel|paclitaxel|mesh-list
153591489|NCT01820325|Carboplatin|carboplatin|mesh-list
153591490|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153591491|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591492|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
153591493|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
153591494|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
153591495|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591496|NCT01820442|Lofexidine|lofexidine|mesh-list
153591497|NCT01820442|Clonidine|clonidine|mesh-list
153591498|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591499|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153591500|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591501|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
153818198|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
153818199|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818200|NCT05253053|Paclitaxel|paclitaxel|mesh-list
153818201|NCT05253053|Atezolizumab|atezolizumab|mesh-list
153818202|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153821113|NCT00481728|Urological Agents|urological agents|mesh-ancestor
153361055|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153361056|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153818203|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818204|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818205|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
153818206|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
153818207|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818208|NCT05253053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153459587|NCT06124729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153459588|NCT06124729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153459589|NCT06124729|Growth Substances|growth substances|mesh-ancestor
153459590|NCT06124729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459591|NCT06124729|Growth Inhibitors|growth inhibitors|mesh-ancestor
153459592|NCT06124729|Immunologic Factors|immunologic factors|mesh-ancestor
153459593|NCT06124573|Metformin|metformin|mesh-list
153459594|NCT06124573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153459595|NCT06124573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153459596|NCT06124573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459597|NCT06124573|Incretins|incretins|mesh-ancestor
153459598|NCT06124573|Hormones|hormones|mesh-ancestor
153459599|NCT06124573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459600|NCT06124573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153459601|NCT06124573|Protease Inhibitors|protease inhibitors|mesh-ancestor
153459602|NCT06124573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459603|NCT06124573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591502|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591503|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153591504|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153591505|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153591506|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
153591507|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361059|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361060|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153361061|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
153361062|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153361063|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
153361064|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
153361065|NCT01379183|Erythromycin|erythromycin|mesh-list
153591508|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591510|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
153591511|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
153591512|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
153591513|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153591514|NCT01820455|Mupirocin|mupirocin|mesh-list
153591515|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153591516|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591517|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
153591518|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
153591519|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153591520|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153459610|NCT06124560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459611|NCT06124560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153459613|NCT06124560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818209|NCT05253053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818210|NCT05236673|Empagliflozin|empagliflozin|mesh-list
153591525|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
153591526|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153370695|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153821125|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153821126|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
153821127|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821128|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153821129|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153821130|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821131|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
153821132|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153821133|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153821134|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821135|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153370696|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153591527|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591528|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591529|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
153591530|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153591531|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591532|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591533|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591534|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
153591535|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
153821136|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
153821137|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
153821138|NCT00481884|Petrolatum|petrolatum|mesh-list
153821139|NCT00481884|Emollients|emollients|mesh-ancestor
153821146|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821148|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821149|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821150|NCT00481962|Tigecycline|tigecycline|mesh-list
153821151|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153821152|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821153|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153821154|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914600|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153361099|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
153361100|NCT00862784|Vitamins|vitamins|mesh-ancestor
153361101|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
153361102|NCT00862784|Hematinics|hematinics|mesh-ancestor
153361103|NCT00862784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153821171|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361146|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361147|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
153361148|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361149|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
153361150|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370751|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153370752|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370753|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370754|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
153830686|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830687|NCT02954913|Liver Extracts|liver extracts|mesh-list
153821218|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153591536|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
153591537|NCT01820767|Atorvastatin|atorvastatin|mesh-list
153591538|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153591539|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153591540|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
153591541|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591542|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153818211|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153818212|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818213|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818214|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818215|NCT05230589|Semaglutide|semaglutide|mesh-list
153818216|NCT05230589|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153818217|NCT05230589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818218|NCT05230589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818219|NCT05185089|Maleic acid|maleic acid|mesh-list
153818220|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821219|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153821220|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821221|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821223|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821224|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821242|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821243|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821244|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
153821245|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821246|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
153821247|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821248|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821249|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
153821250|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153821251|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821252|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821253|NCT03270176|Avelumab|avelumab|mesh-list
153821266|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
153821267|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
153821268|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153821269|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153847900|NCT01234402|Growth Inhibitors|growth inhibitors|mesh-ancestor
153821270|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153821271|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821272|NCT00437996|Clonidine|clonidine|mesh-list
153830720|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153370755|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153370756|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153370757|NCT01231334|Analgesics|analgesics|mesh-ancestor
153370758|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
153370759|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370760|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370761|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818221|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370786|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153370787|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830721|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830723|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
153830724|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
153830725|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830726|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
153830729|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
153361221|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361222|NCT00825266|Pioglitazone|pioglitazone|mesh-list
153361243|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821321|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821322|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
153821323|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
153821324|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821325|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
153821326|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821327|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370790|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370791|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153370796|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
153361316|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361317|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361318|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153361319|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
153361320|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
153361321|NCT00825734|Sorafenib|sorafenib|mesh-list
153361322|NCT00825734|Epothilones|epothilones|mesh-list
153361323|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361324|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153361325|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361326|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361327|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
153361328|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
153361329|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
153361330|NCT00872534|Aspirin|aspirin|mesh-list
153361331|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153821391|NCT00474591|Fondaparinux|fondaparinux|mesh-list
153821392|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153821393|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
153361341|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361345|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
153361346|NCT02513160|Beclomethasone|beclomethasone|mesh-list
153361347|NCT02513160|Albuterol|albuterol|mesh-list
153361348|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153361349|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
153361352|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153821394|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153821395|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
153361369|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821445|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153821446|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821448|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153821449|NCT00475098|Dalteparin|dalteparin|mesh-list
153821450|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
153821451|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153821452|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153821494|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
153821495|NCT00438737|Vitamins|vitamins|mesh-ancestor
153818222|NCT05181735|Luspatercept|luspatercept|mesh-list
153818223|NCT05181735|Hematinics|hematinics|mesh-ancestor
153818224|NCT05175131|Mebeverine|mebeverine|mesh-list
153818225|NCT05175131|Simethicone|simethicone|mesh-list
153818226|NCT05175131|Alverine|alverine|mesh-list
153818227|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
153818228|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818229|NCT05175131|Emollients|emollients|mesh-ancestor
153818230|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
153818231|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
153818232|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
153818233|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
153459614|NCT06124560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459617|NCT06124547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153459618|NCT06124547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459619|NCT06124547|Incretins|incretins|mesh-ancestor
153459620|NCT06124547|Hormones|hormones|mesh-ancestor
153459621|NCT06124547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459622|NCT06124547|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153459623|NCT06124547|Protease Inhibitors|protease inhibitors|mesh-ancestor
153459624|NCT06124547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821513|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153821514|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
153821515|NCT00475410|Coagulants|coagulants|mesh-ancestor
153821516|NCT00475527|Amoxicillin|amoxicillin|mesh-list
153821517|NCT00475527|Metronidazole|metronidazole|mesh-list
153361465|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361466|NCT01392989|Cyclosporine|cyclosporine|mesh-list
153361467|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
153361468|NCT01392989|Cyclosporins|cyclosporins|mesh-list
153361469|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
153361470|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153361471|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361472|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361474|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
153361475|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361476|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
153361477|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361478|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
153361479|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361480|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153361481|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153361482|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361483|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153361484|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
153361485|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153361487|NCT01393457|Carbidopa|carbidopa|mesh-list
153361488|NCT01393457|Ropinirole|ropinirole|mesh-list
153361489|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153361500|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153361501|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153357418|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
153361503|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
153591543|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153591545|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591546|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591547|NCT01820767|Vitamins|vitamins|mesh-ancestor
153591548|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
153591549|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153361505|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361506|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361507|NCT02479230|Gemcitabine|gemcitabine|mesh-list
153361508|NCT02479230|Vaccines|vaccines|mesh-list
153361509|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
153361510|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361511|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153361512|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
153361513|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361514|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361515|NCT04985136|Sorafenib|sorafenib|mesh-list
153361516|NCT04985136|Apatinib|apatinib|mesh-list
153361517|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361518|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153821561|NCT00439283|Methotrexate|methotrexate|mesh-list
153821562|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153821563|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
153821564|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153821565|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821566|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153821567|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
153830792|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591550|NCT01820793|Cefoxitin|cefoxitin|mesh-list
153591551|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153591552|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591553|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
153591554|NCT01820832|Calcitriol|calcitriol|mesh-list
153591555|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591556|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591557|NCT01820832|Vitamins|vitamins|mesh-ancestor
153591558|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
153591559|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153591560|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153591561|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459625|NCT06124547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459626|NCT06124495|Metformin|metformin|mesh-list
153459627|NCT06124495|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153821568|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361519|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361520|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361522|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
153361523|NCT04411446|Vitamins|vitamins|mesh-ancestor
153361524|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
153361525|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361526|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153361527|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153361528|NCT01510379|Promethazine|promethazine|mesh-list
153361529|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
153361530|NCT01510379|Ondansetron|ondansetron|mesh-list
153361534|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361536|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
153361537|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
153361538|NCT01510379|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153361539|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153361540|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
153361541|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361542|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361543|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153361544|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
153361545|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
153361546|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153361547|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153361548|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153361549|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153361550|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
153361551|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
153361552|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
153361553|NCT01363986|Trastuzumab|trastuzumab|mesh-list
153459628|NCT06124495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153459629|NCT06124495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459631|NCT06124495|Hormones|hormones|mesh-ancestor
153459632|NCT06124495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459633|NCT06124495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153459634|NCT06124495|Protease Inhibitors|protease inhibitors|mesh-ancestor
153459635|NCT06124495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361561|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361562|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361563|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361564|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153361566|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
153361567|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361568|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
153361569|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821602|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821603|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153821604|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
153821605|NCT00475917|Gemcitabine|gemcitabine|mesh-list
153821606|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153821607|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
153821608|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821609|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848156|NCT03540758|Vitamins|vitamins|mesh-ancestor
153821610|NCT00474669|Docetaxel|docetaxel|mesh-list
153821611|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821612|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
153821613|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
153821614|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
153459636|NCT06124495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459637|NCT06124417|Sertraline|sertraline|mesh-list
153459638|NCT06124417|Antidepressive Agents|antidepressive agents|mesh-ancestor
153459639|NCT06124417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153459640|NCT06124417|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153459641|NCT06124417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153459642|NCT06124417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821615|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361591|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153361594|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
153821619|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
153361598|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361599|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153361600|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361601|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
153361602|NCT03439280|Dexamethasone|dexamethasone|mesh-list
153361603|NCT03439280|Pomalidomide|pomalidomide|mesh-list
153361604|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153361605|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
153361606|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
153361607|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361608|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361609|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153361610|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
153361612|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361613|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153361614|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361615|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
153361616|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153459643|NCT06124417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459644|NCT06124417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370905|NCT01719653|Laxatives|laxatives|mesh-ancestor
153821644|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821645|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153821646|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
153821647|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821648|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821649|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153821650|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
153821651|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
153821652|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153821653|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153821654|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153821655|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153821656|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
153821657|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821658|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821659|NCT00476268|Beclomethasone|beclomethasone|mesh-list
153821667|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153821668|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153821669|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153821670|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
153821671|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821672|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821674|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
153821675|NCT00476268|Hormones|hormones|mesh-ancestor
153821676|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821677|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153459645|NCT06124417|Serotonin Agents|serotonin agents|mesh-ancestor
153459646|NCT06124417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459647|NCT06124300|Hormones|hormones|mesh-list
153459648|NCT06124300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818237|NCT05162976|Azacitidine|azacitidine|mesh-list
153818238|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818239|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818240|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818241|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821678|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153821679|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153361633|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153361634|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361635|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153361636|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153361637|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
153361638|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361639|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361640|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153361641|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153818242|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818243|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
153818244|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591562|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591563|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153591565|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153591566|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
153591567|NCT01820897|Fosfomycin|fosfomycin|mesh-list
153591569|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591571|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153591572|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153591573|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153591574|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591575|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591576|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153591577|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153591578|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153591579|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153591580|NCT01820936|Ibrutinib|ibrutinib|mesh-list
153591581|NCT01820936|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153818245|NCT05139875|Triamcinolone|triamcinolone|mesh-list
153818246|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153818247|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153818248|NCT05139875|Betamethasone|betamethasone|mesh-list
153818249|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
153821691|NCT00476346|Calcium|calcium|mesh-list
153821692|NCT00476346|Vitamins|vitamins|mesh-ancestor
153821693|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
153821694|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821695|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153821696|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153821697|NCT00476424|Efavirenz|efavirenz|mesh-list
153821698|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153821710|NCT00439712|Levocetirizine|levocetirizine|mesh-list
153821711|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153821712|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153821713|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
153821714|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
153821715|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388399|NCT00001095|Stavudine|stavudine|mesh-list
153821716|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361701|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153361703|NCT00882206|Cytarabine|cytarabine|mesh-list
153361704|NCT00882206|Prednisone|prednisone|mesh-list
153361705|NCT00882206|Doxorubicin|doxorubicin|mesh-list
153361706|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153361707|NCT00882206|Methotrexate|methotrexate|mesh-list
153361708|NCT00882206|Vincristine|vincristine|mesh-list
153818250|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153818251|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
153818252|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
153818253|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153818254|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153818255|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818256|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
153818257|NCT05139875|Hormones|hormones|mesh-ancestor
153818258|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818259|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821751|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821752|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361740|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153361752|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153361754|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361755|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153361757|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361758|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153361759|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818260|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818261|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
153818262|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818263|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818264|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153818265|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
153818266|NCT05124210|Sotrovimab|sotrovimab|mesh-list
153818267|NCT05124210|Antiviral Agents|antiviral agents|mesh-ancestor
153818268|NCT05124210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818269|NCT05104723|Tofacitinib|tofacitinib|mesh-list
153818270|NCT05104723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153459649|NCT06124300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459650|NCT06123962|Dimercaprol|dimercaprol|mesh-list
153810826|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153459651|NCT06123962|Chelating Agents|chelating agents|mesh-ancestor
153459652|NCT06123962|Sequestering Agents|sequestering agents|mesh-ancestor
153459653|NCT06123962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459654|NCT06123884|Paclitaxel|paclitaxel|mesh-list
153459655|NCT06123884|Bevacizumab|bevacizumab|mesh-list
153591582|NCT01820936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153591584|NCT01820936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591585|NCT01820962|Heparin|heparin|mesh-list
153591586|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
153591587|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591588|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153591589|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153591590|NCT01821001|Bromocriptine|bromocriptine|mesh-list
153591591|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153591592|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153591593|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
153821796|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821797|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821798|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153821799|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821800|NCT00438321|Anastrozole|anastrozole|mesh-list
153821802|NCT00438321|Testosterone|testosterone|mesh-list
153821803|NCT00438321|Androgens|androgens|mesh-ancestor
153821804|NCT00438321|Hormones|hormones|mesh-ancestor
153361760|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361761|NCT00885638|Incretins|incretins|mesh-ancestor
153591594|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459656|NCT06123884|Carboplatin|carboplatin|mesh-list
153459657|NCT06123884|Antibodies|antibodies|mesh-list
153459658|NCT06123884|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153459659|NCT06123884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459660|NCT06123884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459661|NCT06123884|Tubulin Modulators|tubulin modulators|mesh-ancestor
153459662|NCT06123884|Antimitotic Agents|antimitotic agents|mesh-ancestor
153459663|NCT06123884|Mitosis Modulators|mitosis modulators|mesh-ancestor
153459664|NCT06123884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459665|NCT06123884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459666|NCT06123884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153459667|NCT06123884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153591606|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153591607|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153591608|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591609|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153591610|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153591611|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591613|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153591614|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
153591616|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591617|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591618|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153818271|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153818272|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818273|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818274|NCT05089604|Tacrolimus|tacrolimus|mesh-list
153818275|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370955|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361762|NCT00885638|Hormones|hormones|mesh-ancestor
153361763|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361764|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153361765|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
153361766|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361767|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818276|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
153818277|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818278|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153818279|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818280|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818281|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
153818282|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818283|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818284|NCT05081609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153591628|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153591629|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153591630|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153591631|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153591632|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591633|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591635|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153591636|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591637|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153591638|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153591639|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459674|NCT06123637|Anesthetics|anesthetics|mesh-list
153459675|NCT06123637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459676|NCT06123637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459677|NCT06123624|Sevoflurane|sevoflurane|mesh-list
153459678|NCT06123624|Desflurane|desflurane|mesh-list
153459679|NCT06123624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153459680|NCT06123624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153459681|NCT06123624|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153459682|NCT06123624|Anesthetics, General|anesthetics, general|mesh-ancestor
153459683|NCT06123624|Anesthetics|anesthetics|mesh-ancestor
153459684|NCT06123624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821842|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821843|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459685|NCT06123624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459686|NCT06123364|Mirabegron|mirabegron|mesh-list
153459687|NCT06123364|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153459688|NCT06123364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153459689|NCT06123364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153459690|NCT06123364|Adrenergic Agents|adrenergic agents|mesh-ancestor
153459691|NCT06123364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459692|NCT06123364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591648|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
153591649|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153591650|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153591651|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591652|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153591653|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153591654|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153591655|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591656|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591657|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
153591658|NCT01821248|Cisplatin|cisplatin|mesh-list
153591659|NCT01821248|Gemcitabine|gemcitabine|mesh-list
153591660|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591661|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818291|NCT05068960|Bupivacaine|bupivacaine|mesh-list
153818292|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
153818293|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
153818294|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153818295|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818296|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
153821845|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153821846|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153821847|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
153821848|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153361803|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361804|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153848449|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361805|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153361806|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153361807|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
153361808|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361809|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361810|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153361811|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
153361813|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153361814|NCT02203019|Narcotics|narcotics|mesh-ancestor
153361815|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153818297|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818298|NCT05056402|Vaccines|vaccines|mesh-list
153818299|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
153818300|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591662|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
153591663|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591664|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
153591665|NCT01821261|Fluorides|fluorides|mesh-list
153591666|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
153591667|NCT01821261|Protective Agents|protective agents|mesh-ancestor
153591668|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591669|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153591670|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591671|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
153591672|NCT01821274|Diltiazem|diltiazem|mesh-list
153591673|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591674|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153591675|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591676|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591677|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591678|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591679|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591680|NCT01821404|Atorvastatin|atorvastatin|mesh-list
153591681|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153591682|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153821890|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821891|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153821892|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821894|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821896|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153821897|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153821898|NCT00440804|Analgesics|analgesics|mesh-ancestor
153821899|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
153821900|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821901|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821902|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153361859|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153361860|NCT03855332|Protective Agents|protective agents|mesh-ancestor
153591683|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
153591684|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591686|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153591687|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591707|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153361908|NCT02504892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361910|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
153361911|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361912|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361913|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153361914|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
153361915|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361938|NCT05946148|Dulaglutide|dulaglutide|mesh-list
153361939|NCT05946148|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153361940|NCT05946148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361941|NCT05946148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153361942|NCT05946148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361943|NCT05946148|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153361954|NCT05946122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153361956|NCT05946122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361957|NCT05946122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153361958|NCT05946122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153361960|NCT05946005|Povidone-Iodine|povidone-iodine|mesh-list
153361962|NCT05946005|Povidone|povidone|mesh-list
153822002|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
153822003|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153822004|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822005|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
153822006|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153822007|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153822008|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
153361966|NCT05946005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361967|NCT05946005|Sensory System Agents|sensory system agents|mesh-ancestor
153361968|NCT05946005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362120|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362122|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
153362123|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362124|NCT05531942|Aspirin|aspirin|mesh-list
153362125|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153362126|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153362127|NCT05531942|Analgesics|analgesics|mesh-ancestor
153362128|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
153362129|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362130|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362131|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153362231|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362232|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153362234|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
153362235|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362236|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153362237|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153362238|NCT04512365|Analgesics|analgesics|mesh-ancestor
153822314|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153822315|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362267|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362268|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362292|NCT03933631|Hormones|hormones|mesh-ancestor
153461727|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153362307|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362308|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153362309|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153362310|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362311|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153362312|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153822344|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822346|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822347|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
153822348|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153822349|NCT03278522|Ramosetron|ramosetron|mesh-list
153822350|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
153822351|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
153822352|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822353|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822354|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822355|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153822356|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
153822357|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822358|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822359|NCT00440622|Gemcitabine|gemcitabine|mesh-list
153822360|NCT00440622|Capecitabine|capecitabine|mesh-list
153362313|NCT03919435|Trimethoprim|trimethoprim|mesh-list
153362314|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153362315|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
153362316|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153362317|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362318|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
153362319|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153362320|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153591708|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591709|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591710|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
153591711|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591712|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362335|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153822383|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822384|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822385|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
153822387|NCT00440739|Urological Agents|urological agents|mesh-ancestor
153822389|NCT00443573|Anticoagulants|anticoagulants|mesh-list
153822390|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153822391|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153822392|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822393|NCT00478764|Triamcinolone|triamcinolone|mesh-list
153822394|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822395|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
153822396|NCT00478764|Hormones|hormones|mesh-ancestor
153822397|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153822398|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822399|NCT00440778|Abciximab|abciximab|mesh-list
153822400|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
153822401|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153822402|NCT03278405|Avelumab|avelumab|mesh-list
153822403|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153362357|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
153362358|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153362359|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
153362364|NCT03740100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362365|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153362366|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
153362367|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362368|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362369|NCT03456700|Sirolimus|sirolimus|mesh-list
153362370|NCT03456700|Auranofin|auranofin|mesh-list
153362371|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362372|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362373|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153822431|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
153362392|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362393|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153362394|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
153362395|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
153362396|NCT03356483|Vitamins|vitamins|mesh-ancestor
153362397|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
153362414|NCT02764762|Methotrexate|methotrexate|mesh-list
153362415|NCT02764762|Vedolizumab|vedolizumab|mesh-list
153362416|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153362417|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
153461728|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
153822454|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153371184|NCT01742117|Ticagrelor|ticagrelor|mesh-list
153591713|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153591714|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591715|NCT01821612|Leucovorin|leucovorin|mesh-list
153591716|NCT01821612|Gemcitabine|gemcitabine|mesh-list
153591717|NCT01821612|Capecitabine|capecitabine|mesh-list
153591718|NCT01821612|Fluorouracil|fluorouracil|mesh-list
153591719|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
153591720|NCT01821612|Irinotecan|irinotecan|mesh-list
153591721|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153591722|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
153591723|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591724|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591725|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153591726|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
153591727|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591728|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153822456|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822457|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153822458|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
153822459|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
153822460|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822461|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822462|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
153822463|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
153362418|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362419|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362420|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153362421|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
153362422|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362423|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362424|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
153362425|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362426|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153362427|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153362428|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
153362429|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362430|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153362431|NCT02764762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153362432|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153362433|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153362434|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153362435|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153362436|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362437|NCT02521363|Taxane|taxane|mesh-list
153362438|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362439|NCT02340962|Interferons|interferons|mesh-list
153362440|NCT02340962|Ribavirin|ribavirin|mesh-list
153362441|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
153362442|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
153362443|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362444|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
153362445|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822480|NCT00441246|Guaifenesin|guaifenesin|mesh-list
153371236|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822481|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153822482|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153822483|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
153822484|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822485|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362472|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
153362473|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362474|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362475|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362476|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153362477|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153362478|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
153362479|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362480|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153362481|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
153362505|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362506|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153362507|NCT01401023|Tigecycline|tigecycline|mesh-list
153362508|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153822529|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822530|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
153822531|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822533|NCT00441519|Omeprazole|omeprazole|mesh-list
153822534|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153591729|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153591730|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591731|NCT01821612|Antidotes|antidotes|mesh-ancestor
153591732|NCT01821612|Protective Agents|protective agents|mesh-ancestor
153591733|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
153591734|NCT01821612|Vitamins|vitamins|mesh-ancestor
153591735|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
153591736|NCT01821664|Heparin|heparin|mesh-list
153591737|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
153591738|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153591739|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153591750|NCT01821846|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153591752|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591753|NCT01821846|Incretins|incretins|mesh-ancestor
153591754|NCT01821846|Hormones|hormones|mesh-ancestor
153591755|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591756|NCT01821872|Acetaminophen|acetaminophen|mesh-list
153591757|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153591758|NCT01821872|Analgesics|analgesics|mesh-ancestor
153822535|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822536|NCT00441519|Analgesics|analgesics|mesh-ancestor
153822537|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
153822538|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822539|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822540|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822572|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822573|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153822574|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
153822575|NCT00444314|Sunitinib|sunitinib|mesh-list
153822576|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822577|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153362531|NCT01519271|Rivastigmine|rivastigmine|mesh-list
153362532|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153362533|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362534|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362535|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
153362536|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822578|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153822579|NCT00444314|Growth Substances|growth substances|mesh-ancestor
153822580|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822581|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
153822582|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153822583|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822584|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822586|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153822587|NCT02274051|Growth Substances|growth substances|mesh-ancestor
153822588|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362581|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153362583|NCT00837200|Doxorubicin|doxorubicin|mesh-list
153362584|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153362585|NCT00837200|Asparaginase|asparaginase|mesh-list
153362586|NCT00837200|Pegaspargase|pegaspargase|mesh-list
153362587|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153362588|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362589|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153362590|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153362591|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362592|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362593|NCT00837512|Insulin|insulin|mesh-list
153362601|NCT00837590|Analgesics|analgesics|mesh-ancestor
153822620|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822621|NCT00479661|Analgesics|analgesics|mesh-ancestor
153822622|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
153822623|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822653|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153822654|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822655|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822656|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
153822657|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153822658|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153822659|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153822660|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
153822661|NCT00441909|UC-781|uc-781|mesh-list
153822662|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153822663|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
153822664|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822665|NCT00445016|Anesthetics|anesthetics|mesh-list
153822666|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822668|NCT00445055|Droperidol|droperidol|mesh-list
153822683|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822684|NCT00479739|Fluticasone|fluticasone|mesh-list
153822686|NCT00479739|Budesonide|budesonide|mesh-list
153822687|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
153822688|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153822689|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822690|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153362640|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
153362641|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362665|NCT01520519|Ibrutinib|ibrutinib|mesh-list
153362666|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153362667|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362668|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
153362669|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362670|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362671|NCT01520519|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153362672|NCT01520519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153362673|NCT01520519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461729|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153822691|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
153822692|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822693|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822694|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153822695|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
153822696|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
153822697|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153822698|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
153822699|NCT00479739|Hormones|hormones|mesh-ancestor
153822700|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153822701|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153822702|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153822703|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153591759|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
153591760|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591761|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362686|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362687|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362688|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
153362689|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362690|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153362691|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153362692|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153362693|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362694|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822726|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153822727|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
153822728|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153822729|NCT00442026|Gemcitabine|gemcitabine|mesh-list
153822730|NCT00442026|Docetaxel|docetaxel|mesh-list
153822731|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153822732|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
153822733|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822734|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822735|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
153822736|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
153822737|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
153822738|NCT00479895|Chrysarobin|chrysarobin|mesh-list
153822739|NCT00479895|HBOC 201|hboc 201|mesh-list
153822740|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822741|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822742|NCT00479895|Analgesics|analgesics|mesh-ancestor
153822743|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
153822744|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831235|NCT05555732|Carboplatin|carboplatin|mesh-list
153591762|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
153591763|NCT01821989|Lactoferrin|lactoferrin|mesh-list
153591764|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591765|NCT01822028|Miglustat|miglustat|mesh-list
153591766|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
153591767|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591768|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591769|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153591770|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153591771|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
153591772|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591773|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153591774|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153591775|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591776|NCT01822080|Dienogest|dienogest|mesh-list
153822745|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822746|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822747|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822748|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
153822749|NCT00445250|Calcipotriene|calcipotriene|mesh-list
153822750|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
153822751|NCT03279120|Tenofovir|tenofovir|mesh-list
153822752|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
153822753|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
153822754|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822755|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153822756|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153822757|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408834|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
153822758|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822759|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153362709|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153362710|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362712|NCT05310344|Bevacizumab|bevacizumab|mesh-list
153362713|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153831262|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
153591777|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153591778|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
153591779|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153591780|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591782|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153591791|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591792|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591793|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
153591794|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822786|NCT03274700|Urological Agents|urological agents|mesh-ancestor
153822787|NCT00442221|Naproxen|naproxen|mesh-list
153822788|NCT00442221|Sumatriptan|sumatriptan|mesh-list
153822789|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822790|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822791|NCT00442221|Analgesics|analgesics|mesh-ancestor
153822792|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
153822793|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822794|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822795|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822796|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822797|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
153822798|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153362750|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153362751|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153362752|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362753|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362754|NCT03215966|Urological Agents|urological agents|mesh-ancestor
153362755|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153362756|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153362757|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153362759|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153591795|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591796|NCT01822405|Tocopherols|tocopherols|mesh-list
153591797|NCT01822405|Vitamin E|vitamin e|mesh-list
153591801|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153591802|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591803|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591804|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153591805|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153591806|NCT01822405|Protective Agents|protective agents|mesh-ancestor
153591807|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591808|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591809|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153591810|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
153591811|NCT01822405|Vitamins|vitamins|mesh-ancestor
153591812|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
153591813|NCT01822418|Agomelatine|agomelatine|mesh-list
153591814|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153591815|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362760|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
153362761|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
153822799|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822800|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822801|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153822802|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153822803|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153822804|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
153822805|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822806|NCT00454259|Fentanyl|fentanyl|mesh-list
153822807|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153822808|NCT00454259|Narcotics|narcotics|mesh-ancestor
153822809|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822810|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362779|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362780|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
153362781|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153362782|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362783|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
153362784|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153362785|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362786|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
153591816|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591817|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153591818|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591819|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591836|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591837|NCT01822613|Paclitaxel|paclitaxel|mesh-list
153591838|NCT01822613|Docetaxel|docetaxel|mesh-list
153591839|NCT01822613|Irinotecan|irinotecan|mesh-list
153591840|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153591841|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591842|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
153591843|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
153591844|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
153591845|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591846|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153591847|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153591848|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591849|NCT01822639|Amlodipine|amlodipine|mesh-list
153591850|NCT01822639|Enalapril|enalapril|mesh-list
153591851|NCT01822639|Enalaprilat|enalaprilat|mesh-list
153591852|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591853|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153591854|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591855|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591856|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153591857|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591858|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
153818301|NCT05054140|Calcium|calcium|mesh-list
153818302|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153818303|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818304|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
153818305|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153357419|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818306|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818307|NCT05047094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818308|NCT05047094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818309|NCT05041062|Nivolumab|nivolumab|mesh-list
153818310|NCT05041062|Ipilimumab|ipilimumab|mesh-list
153818311|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459693|NCT06123364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459694|NCT06123364|Urological Agents|urological agents|mesh-ancestor
153459695|NCT06122948|Midazolam|midazolam|mesh-list
153459696|NCT06122948|Ketamine|ketamine|mesh-list
153459697|NCT06122948|Analgesics|analgesics|mesh-ancestor
153459698|NCT06122948|Sensory System Agents|sensory system agents|mesh-ancestor
153459699|NCT06122948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459700|NCT06122948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362819|NCT00895934|Calicheamicins|calicheamicins|mesh-list
153362820|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153362821|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
153822859|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822860|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153822881|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
153362830|NCT00895934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362831|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153362832|NCT01550471|Ciclesonide|ciclesonide|mesh-list
153362833|NCT01550471|Beclomethasone|beclomethasone|mesh-list
153362834|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153362835|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
153362837|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153362838|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362839|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153459701|NCT06122948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153459702|NCT06122948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153459703|NCT06122948|Anesthetics, General|anesthetics, general|mesh-ancestor
153459704|NCT06122948|Anesthetics|anesthetics|mesh-ancestor
153459705|NCT06122948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459706|NCT06122948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153459707|NCT06122948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153459708|NCT06122948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459709|NCT06122948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591867|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591868|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591870|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153591871|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591872|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153591873|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153591874|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
153362841|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153362842|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
153362843|NCT03215264|Entinostat|entinostat|mesh-list
153362844|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
153362845|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153362846|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153362847|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362848|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362849|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362850|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362851|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362852|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153362853|NCT01447511|Rifampin|rifampin|mesh-list
153362854|NCT01447511|Fluconazole|fluconazole|mesh-list
153822894|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153822895|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153831349|NCT05037812|Analgesics|analgesics|mesh-ancestor
153831350|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
153831351|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591875|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153591876|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153591877|NCT01822808|Hydralazine|hydralazine|mesh-list
153591879|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153591880|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153591881|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153591882|NCT01822808|Diuretics|diuretics|mesh-ancestor
153591883|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
153591884|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591885|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591886|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153591887|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591888|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591889|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153591890|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
153591891|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153591892|NCT01822860|Diuretics|diuretics|mesh-ancestor
153591893|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
153591894|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591895|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153591896|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591897|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591898|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
153591899|NCT01822951|Donepezil|donepezil|mesh-list
153591900|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153822897|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822898|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153822899|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153822901|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822902|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822904|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153822906|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362855|NCT01447511|Warfarin|warfarin|mesh-list
153362856|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
153362857|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153362858|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
153362859|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362860|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362861|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
153362862|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153362863|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362864|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362865|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153362866|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153362883|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153362884|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153831376|NCT05019638|Racepinephrine|racepinephrine|mesh-list
153831377|NCT05019638|Morphine|morphine|mesh-list
153831378|NCT05019638|Bupivacaine|bupivacaine|mesh-list
153831379|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
153831380|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
153831381|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
153831382|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153591901|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810828|NCT00352287|Pioglitazone|pioglitazone|mesh-list
153810829|NCT00352287|Hormones|hormones|mesh-list
153591902|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371460|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
153362896|NCT04380818|Dalteparin|dalteparin|mesh-list
153362897|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153362898|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153362899|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
153362900|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362901|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362902|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153362903|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153362904|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
153362905|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362906|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153362907|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153362908|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
153591903|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
153591904|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591905|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591906|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
153591907|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153781710|NCT00231647|Topiramate|topiramate|mesh-list
153591908|NCT01822951|Protective Agents|protective agents|mesh-ancestor
153591909|NCT01822977|Omeprazole|omeprazole|mesh-list
153591910|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153591911|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153591912|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153591913|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591914|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591915|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
153591916|NCT01823029|Hematinics|hematinics|mesh-ancestor
153591917|NCT01822509|Nivolumab|nivolumab|mesh-list
153591918|NCT01822509|Ipilimumab|ipilimumab|mesh-list
153591919|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153591920|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591945|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591946|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153591947|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591948|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153822988|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362934|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362935|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153823014|NCT00455936|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153823015|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823016|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823017|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823018|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823019|NCT00443235|Thalidomide|thalidomide|mesh-list
153823020|NCT00443235|Prednisone|prednisone|mesh-list
153823021|NCT00443235|Melphalan|melphalan|mesh-list
153823022|NCT00443235|Bortezomib|bortezomib|mesh-list
153823023|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153823024|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
153823025|NCT00443235|Hormones|hormones|mesh-ancestor
153823075|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153823076|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
153823077|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
153823078|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823079|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153823080|NCT04700436|Ezetimibe|ezetimibe|mesh-list
153823081|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153823082|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153823083|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
153831408|NCT05019430|Cocaine|cocaine|mesh-list
153831409|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
153831410|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
153831411|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
153591949|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153591950|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153591951|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
153591952|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591953|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153591954|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153823085|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153363029|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363030|NCT02475564|Resveratrol|resveratrol|mesh-list
153363031|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
153363032|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363033|NCT02475564|Protective Agents|protective agents|mesh-ancestor
153363034|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363035|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363036|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153363037|NCT00893984|Nebivolol|nebivolol|mesh-list
153363038|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153363039|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
153363040|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153363041|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153363042|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153363043|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
153363044|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363045|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363046|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363047|NCT01832870|Ipilimumab|ipilimumab|mesh-list
153591955|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591956|NCT01823159|Ezogabine|ezogabine|mesh-list
153591957|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
153591958|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591959|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591960|NCT01823172|Methylene Blue|methylene blue|mesh-list
153591961|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591962|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591963|NCT01823185|Clopidogrel|clopidogrel|mesh-list
153591964|NCT01823185|Ticagrelor|ticagrelor|mesh-list
153818312|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818313|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818320|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818321|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818322|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
153818323|NCT04992312|Glucagon|glucagon|mesh-list
153818324|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153818325|NCT04992312|Hormones|hormones|mesh-ancestor
153818326|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818327|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818328|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153459710|NCT06122948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153459711|NCT06122948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153459712|NCT06122948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153459713|NCT06122948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153459714|NCT06122948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153459715|NCT06122948|GABA Modulators|gaba modulators|mesh-ancestor
153459716|NCT06122948|GABA Agents|gaba agents|mesh-ancestor
153459717|NCT06121466|Lidocaine|lidocaine|mesh-list
153459718|NCT06121466|Anesthetics, Local|anesthetics, local|mesh-ancestor
153459719|NCT06121466|Anesthetics|anesthetics|mesh-ancestor
153459720|NCT06121466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831420|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831421|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
153363048|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153363049|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823086|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153823087|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823088|NCT00480597|Gemcitabine|gemcitabine|mesh-list
153823089|NCT00480597|Capecitabine|capecitabine|mesh-list
153823090|NCT00480597|Vinorelbine|vinorelbine|mesh-list
153823091|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823092|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823093|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
153823094|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823095|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153823096|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
153823097|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
153823098|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
153823099|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153823100|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153823101|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
153823103|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823104|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823105|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153823106|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
153823107|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153823108|NCT00480675|Prednisolone|prednisolone|mesh-list
153823109|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
153823110|NCT00480675|Bupivacaine|bupivacaine|mesh-list
153831422|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459721|NCT06121466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459722|NCT06121466|Sensory System Agents|sensory system agents|mesh-ancestor
153459723|NCT06121466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459724|NCT06121466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153363083|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
153363084|NCT01533077|Levodopa|levodopa|mesh-list
153363085|NCT01533077|Carbidopa|carbidopa|mesh-list
153363086|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153363087|NCT01533077|Opicapone|opicapone|mesh-list
153363088|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153363089|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153363090|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
153363091|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363092|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363093|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363094|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153371492|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153459725|NCT06121466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153459726|NCT06121466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153591965|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153591966|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153591967|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153591968|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153591969|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153591970|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
153591971|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591972|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591973|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591975|NCT01823393|Calcium heparin|calcium heparin|mesh-list
153363095|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823131|NCT00456560|Paroxetine|paroxetine|mesh-list
153823132|NCT00456560|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153823133|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153823134|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153823135|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823136|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823137|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
153823138|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823139|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153823140|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
153823141|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153823142|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153823143|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153823144|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823145|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153823146|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153823147|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409025|NCT02460133|Ritonavir|ritonavir|mesh-list
153823148|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153823166|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823167|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823168|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153823170|NCT00456833|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153823171|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823172|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823173|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591976|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
153591977|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153591978|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153591979|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591980|NCT01823523|Clindamycin|clindamycin|mesh-list
153591981|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
153371537|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
153823174|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363122|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363123|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
153363124|NCT03213392|Anesthetics|anesthetics|mesh-list
153363125|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363126|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363127|NCT03219788|Remifentanil|remifentanil|mesh-list
153363128|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153363129|NCT03219788|Narcotics|narcotics|mesh-ancestor
153363130|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823189|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153823190|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823191|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
153823192|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
153823193|NCT00457067|Ranibizumab|ranibizumab|mesh-list
153823194|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153823195|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153823196|NCT00457067|Growth Substances|growth substances|mesh-ancestor
153823197|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363147|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153363148|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153363149|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363150|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
153363151|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
153363152|NCT03219710|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153363153|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153591982|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
153591983|NCT01823523|Cefazolin|cefazolin|mesh-list
153849206|NCT06049160|Oxytocics|oxytocics|mesh-ancestor
153591984|NCT01823523|Cephalexin|cephalexin|mesh-list
153591985|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153591986|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153591987|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153591988|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591989|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591990|NCT01823744|Micronutrients|micronutrients|mesh-list
153591991|NCT01823744|Trace Elements|trace elements|mesh-list
153591992|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363154|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
153363155|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363156|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363157|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153363158|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153363159|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363160|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153823198|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823199|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823200|NCT00480870|Donepezil|donepezil|mesh-list
153823201|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153823202|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823203|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823204|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
153363178|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
153363179|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363180|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363181|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153591993|NCT01823770|Rotigotine|rotigotine|mesh-list
153591994|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
153591995|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
153591996|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591997|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591998|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591999|NCT01823809|Adenosine|adenosine|mesh-list
153592005|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
153592006|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153592007|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
153592009|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592010|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592012|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153592013|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153371576|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153371577|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
153371578|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
153371579|NCT01748045|Protective Agents|protective agents|mesh-ancestor
153823222|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153823223|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153823224|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153823225|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
153823226|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153823227|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153823228|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823229|NCT00457145|Ranibizumab|ranibizumab|mesh-list
153823230|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153823231|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153823232|NCT00457145|Growth Substances|growth substances|mesh-ancestor
153823233|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363182|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153363183|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
153363185|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363186|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153363187|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153363188|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363189|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363190|NCT03219554|Palbociclib|palbociclib|mesh-list
153363191|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363192|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153363193|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363209|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363210|NCT03837938|Dipropizine|dipropizine|mesh-list
153363211|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
153363212|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
153823269|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153823271|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823272|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823273|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153823274|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153363250|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
153363251|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153363253|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
153363254|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363255|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363256|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363258|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
153363259|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363260|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
153363261|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363262|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363263|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153363264|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
153363265|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823300|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
153823301|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
153823302|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823304|NCT00457964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153823305|NCT00457964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823306|NCT00457964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823307|NCT00457964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831540|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831541|NCT04473053|Analgesics|analgesics|mesh-ancestor
153831542|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
153831543|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831544|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831545|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831546|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831547|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
153831548|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
153363299|NCT03212456|Narcotics|narcotics|mesh-ancestor
153363300|NCT03212456|Analgesics|analgesics|mesh-ancestor
153363301|NCT03217838|Azacitidine|azacitidine|mesh-list
153363304|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153363305|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
153363306|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363307|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363308|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363310|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363311|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153363312|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363324|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371616|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153371617|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
153371618|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371619|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371620|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153371621|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
153371622|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153371623|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153371625|NCT01250210|Estrogens|estrogens|mesh-ancestor
153371626|NCT01250210|Hormones|hormones|mesh-ancestor
153823372|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153823373|NCT00458315|Growth Substances|growth substances|mesh-ancestor
153823374|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823375|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823376|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823377|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
153823378|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153823379|NCT00444015|Dasatinib|dasatinib|mesh-list
153363352|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153363353|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
153363354|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363355|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363356|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363357|NCT01457573|Urological Agents|urological agents|mesh-ancestor
153363358|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153363361|NCT01560143|Tigecycline|tigecycline|mesh-list
153831564|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831565|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153831566|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831567|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831568|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
153831569|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
153831570|NCT04387201|Dulaglutide|dulaglutide|mesh-list
153831571|NCT04387201|Vitamins|vitamins|mesh-ancestor
153363376|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823394|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153823395|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
153823396|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
153823397|NCT00444132|Clopidogrel|clopidogrel|mesh-list
153823398|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153363384|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153592014|NCT01823965|Growth Substances|growth substances|mesh-ancestor
153592015|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592016|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
153592017|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592018|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153592019|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153592020|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592021|NCT01824199|Omeprazole|omeprazole|mesh-list
153592022|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153592023|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592024|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153592025|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592026|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592027|NCT01824225|Aflibercept|aflibercept|mesh-list
153371642|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153371643|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371644|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371645|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371646|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153371647|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153371648|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153371649|NCT01312844|Scopolamine|scopolamine|mesh-list
153371650|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153823485|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823487|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363439|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153363441|NCT01561703|Azithromycin|azithromycin|mesh-list
153363442|NCT01561703|Clindamycin|clindamycin|mesh-list
153363443|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
153363444|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153363445|NCT01561703|Cephalexin|cephalexin|mesh-list
153363446|NCT01561703|Cefdinir|cefdinir|mesh-list
153363447|NCT01561703|Cefaclor|cefaclor|mesh-list
153363448|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363449|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153363450|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363451|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831591|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831592|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831593|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
153831594|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831595|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831596|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153831597|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
153831598|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153831599|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831600|NCT04177095|Sirolimus|sirolimus|mesh-list
153831601|NCT04177095|Prednisone|prednisone|mesh-list
153831602|NCT04177095|Everolimus|everolimus|mesh-list
153823517|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153823518|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153823519|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823520|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823521|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
153823522|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363476|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153363477|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153363478|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
153823557|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823558|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153363544|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153363545|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153363546|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
153363547|NCT01839812|Hormones|hormones|mesh-ancestor
153363548|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153363549|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363550|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363551|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363552|NCT01839890|Paclitaxel|paclitaxel|mesh-list
153363553|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153363554|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823589|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823590|NCT00460382|Ritonavir|ritonavir|mesh-list
153823591|NCT00460382|Darunavir|darunavir|mesh-list
153823592|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
153823593|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
153823594|NCT00460382|Etravirine|etravirine|mesh-list
153823595|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153823596|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153823597|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
153363602|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363603|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363604|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153363605|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
153823646|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
153823647|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823648|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823649|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823650|NCT00495651|Isoniazid|isoniazid|mesh-list
153823651|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153823652|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
153823653|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823654|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823655|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153823656|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153823657|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
153823658|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823659|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153823660|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
153823661|NCT00460733|Vitamin D|vitamin d|mesh-list
153823662|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
153823663|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
153823664|NCT00460733|Calcium|calcium|mesh-list
153823665|NCT00460733|Vitamins|vitamins|mesh-ancestor
153823667|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823668|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153823669|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153823670|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153823671|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153823672|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823673|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153363632|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363633|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153363634|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
153363635|NCT02498652|Protective Agents|protective agents|mesh-ancestor
153363636|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823731|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
153823732|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592028|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153592029|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153592030|NCT01824225|Growth Substances|growth substances|mesh-ancestor
153592031|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592032|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
153592033|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371712|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153371713|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153371714|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
153823733|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153823734|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153823735|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823736|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823737|NCT00489138|Ertapenem|ertapenem|mesh-list
153823738|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823739|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823740|NCT00461396|Interferons|interferons|mesh-list
153823741|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
153823742|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823743|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
153823744|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823745|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153363703|NCT00910208|Morphine|morphine|mesh-list
153363704|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153363705|NCT00910208|Narcotics|narcotics|mesh-ancestor
153363706|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363707|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363708|NCT00910208|Analgesics|analgesics|mesh-ancestor
153363709|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
153363710|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363711|NCT01566539|Vasopressins|vasopressins|mesh-list
153823746|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
153831652|NCT04083183|Antibodies|antibodies|mesh-list
153592034|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
153592035|NCT01824238|Anacetrapib|anacetrapib|mesh-list
153592036|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153592037|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153592038|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
153823747|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823749|NCT01327651|Emtricitabine|emtricitabine|mesh-list
153823750|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
153823751|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823752|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153363741|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153363742|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153363743|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363744|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363745|NCT01725776|Protective Agents|protective agents|mesh-ancestor
153363746|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363748|NCT01830296|Remifentanil|remifentanil|mesh-list
153823830|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823831|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
153823832|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153823845|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153823846|NCT00489372|Protective Agents|protective agents|mesh-ancestor
153823847|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823848|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823850|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153831683|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
153831684|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
153831685|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831686|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831687|NCT04069273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831688|NCT04069273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153831689|NCT04069273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153831690|NCT04069273|Growth Substances|growth substances|mesh-ancestor
153831691|NCT04069273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831692|NCT04069273|Growth Inhibitors|growth inhibitors|mesh-ancestor
153831693|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
153831694|NCT04052334|Fludarabine|fludarabine|mesh-list
153831695|NCT04052334|Interleukin-2|interleukin-2|mesh-list
153831697|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
153363847|NCT03409250|Growth Substances|growth substances|mesh-ancestor
153363848|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363849|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
153363850|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363851|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153363852|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153363861|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153363946|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153831707|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
153831708|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831709|NCT04004416|Lorazepam|lorazepam|mesh-list
153831710|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
153831711|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
153371762|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371763|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371773|NCT01315574|Travoprost|travoprost|mesh-list
153824018|NCT00489723|Tamsulosin|tamsulosin|mesh-list
153824019|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153824020|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153824021|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153824022|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
153824023|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824024|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849350|NCT05526469|Bupivacaine|bupivacaine|mesh-list
153824025|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824026|NCT00489723|Urological Agents|urological agents|mesh-ancestor
153824027|NCT00105443|Sorafenib|sorafenib|mesh-list
153824028|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824029|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153824030|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824031|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824032|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
153824033|NCT00489840|Anecortave|anecortave|mesh-list
153824034|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153824035|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824036|NCT00489840|Growth Substances|growth substances|mesh-ancestor
153824037|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824038|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
153364024|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364026|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153364040|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
153831712|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
153831713|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831714|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831715|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153831716|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153831717|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831718|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153831719|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153831720|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153831721|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
153831722|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
153831723|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831724|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831729|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364041|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364042|NCT02469246|Lamivudine|lamivudine|mesh-list
153824076|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
153831733|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831734|NCT03795701|Liraglutide|liraglutide|mesh-list
153831735|NCT03795701|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153371786|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364061|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153364093|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
153364094|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364095|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364096|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153364097|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153364098|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
153824124|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
153824125|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153824126|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824127|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824128|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153824129|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
153824130|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153824131|NCT00490464|Nicardipine|nicardipine|mesh-list
153824132|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153824133|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153824134|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824135|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824136|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153824137|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824138|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
153364127|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824141|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153824142|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
153824143|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824144|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831737|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831738|NCT03795701|Incretins|incretins|mesh-ancestor
153831739|NCT03795701|Hormones|hormones|mesh-ancestor
153831740|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831741|NCT03733067|Abatacept|abatacept|mesh-list
153831742|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831743|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831744|NCT03733067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831745|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831746|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831750|NCT03664895|Goserelin|goserelin|mesh-list
153824183|NCT00497562|Fluoxetine|fluoxetine|mesh-list
153824184|NCT00497562|Hormones|hormones|mesh-list
153364143|NCT03405584|Antacids|antacids|mesh-ancestor
153364144|NCT03405584|Diuretics|diuretics|mesh-ancestor
153364145|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
153364146|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371821|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
153371822|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
153371823|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
153371824|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371825|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153371826|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
153371827|NCT00366873|Calcium|calcium|mesh-list
153371828|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153824304|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364288|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364306|NCT03405194|Cobicistat|cobicistat|mesh-list
153364307|NCT03405194|Elvitegravir|elvitegravir|mesh-list
153364308|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153364309|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153364310|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364311|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824338|NCT00498225|Gemcitabine|gemcitabine|mesh-list
153824339|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153824340|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
153824341|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824342|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824343|NCT00466622|Metformin|metformin|mesh-list
153824344|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824345|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824346|NCT01327612|Leucovorin|leucovorin|mesh-list
153824347|NCT01327612|Bevacizumab|bevacizumab|mesh-list
153824348|NCT01327612|Conatumumab|conatumumab|mesh-list
153824349|NCT01327612|Fluorouracil|fluorouracil|mesh-list
153364358|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153831764|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831765|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831766|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
153831767|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831768|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831769|NCT03352765|Rituximab|rituximab|mesh-list
153831770|NCT03352765|Melphalan|melphalan|mesh-list
153831771|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153849391|NCT05359731|Hormones|hormones|mesh-ancestor
153831772|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831773|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831774|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
153831775|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831776|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831777|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153371829|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371833|NCT04182399|Zonisamide|zonisamide|mesh-list
153364397|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153364398|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364399|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
153364400|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153364401|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153371837|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371838|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153371839|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371841|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153371842|NCT04246619|Analgesics|analgesics|mesh-ancestor
153371843|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
153371844|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371845|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371846|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
153371847|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153371848|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371849|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364501|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
153364502|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153364503|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153364504|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364505|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153364506|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153364507|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153364508|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
153831778|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
153831779|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831780|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153831781|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831782|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
153364576|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
153364577|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364578|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364579|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153364580|NCT01041638|Analgesics|analgesics|mesh-ancestor
153824599|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153824601|NCT00592111|Vinblastine|vinblastine|mesh-list
153824602|NCT00592111|Procarbazine|procarbazine|mesh-list
153824603|NCT00592111|Mitogens|mitogens|mesh-list
153824604|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824605|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
153364611|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153364613|NCT01725620|Analgesics|analgesics|mesh-ancestor
153364614|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
153364615|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364616|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364617|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153364618|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364619|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364647|NCT05014919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153364648|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153364670|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371864|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371865|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153371867|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
153371868|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371869|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153371870|NCT02618187|Vancomycin|vancomycin|mesh-list
153371871|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153371872|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371873|NCT05316857|Itraconazole|itraconazole|mesh-list
153371874|NCT05316857|Rifampin|rifampin|mesh-list
153371875|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
153371876|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371879|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824754|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824755|NCT00492141|Temozolomide|temozolomide|mesh-list
153824756|NCT00492141|Camptothecin|camptothecin|mesh-list
153824757|NCT00492141|Rubitecan|rubitecan|mesh-list
153824758|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153824759|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
153824784|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
153364957|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
153364958|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
153364959|NCT02223065|Saxagliptin|saxagliptin|mesh-list
153825037|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
153825038|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825039|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
153825040|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153825041|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153825042|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
153825043|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825044|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825045|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365010|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365038|NCT04083755|Hematinics|hematinics|mesh-ancestor
153365039|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
153849478|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
153365040|NCT04372082|Niclosamide|niclosamide|mesh-list
153365042|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
153365043|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153365044|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153365045|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365046|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365047|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365048|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153365049|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153365050|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153365051|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365052|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153365053|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365054|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
153365055|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
153831833|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153831834|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153831835|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153831836|NCT03143153|Fluorouracil|fluorouracil|mesh-list
153831837|NCT03143153|Nivolumab|nivolumab|mesh-list
153831838|NCT03143153|Ipilimumab|ipilimumab|mesh-list
153831839|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831840|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
153831841|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831842|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831843|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831844|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
153831845|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831846|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831847|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831848|NCT02927392|Leuprolide|leuprolide|mesh-list
153825258|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153825259|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153825260|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825396|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
153825411|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153825412|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825413|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153825414|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
153825415|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825416|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825417|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153825435|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153825479|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
153825480|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365484|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365505|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153365506|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825527|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
153825528|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
153825529|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153825530|NCT01606111|Protective Agents|protective agents|mesh-ancestor
153825531|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825532|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
153825533|NCT00493428|Baclofen|baclofen|mesh-list
153825534|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153365557|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365559|NCT01639157|Buspirone|buspirone|mesh-list
153365560|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153365561|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153365578|NCT00928772|Midazolam|midazolam|mesh-list
153365579|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153365580|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153365581|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365582|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365583|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153365584|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153365585|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153592039|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592040|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153592042|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153592043|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592044|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
153592045|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153592046|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
153592047|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153371929|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371930|NCT01251536|Cetuximab|cetuximab|mesh-list
153831858|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831859|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
153831860|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
153831861|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365669|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153365670|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
153365671|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365672|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365673|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365674|NCT04356872|Doxorubicin|doxorubicin|mesh-list
153365675|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153365676|NCT04356872|Ifosfamide|ifosfamide|mesh-list
153365677|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153365678|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825719|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
153371936|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371937|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371938|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
153365899|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365900|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
153365901|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
153365902|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
153365903|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
153365904|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365905|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365907|NCT00942578|Hormones|hormones|mesh-ancestor
153365924|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153365925|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153365926|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365927|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
153365946|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153365947|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
153365998|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365999|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153366001|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153366002|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366003|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366004|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
153366118|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
153366119|NCT02158520|Antibodies|antibodies|mesh-list
153366120|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
153366121|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153826164|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826165|NCT01246362|Etoricoxib|etoricoxib|mesh-list
153366142|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153366143|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366145|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
153366146|NCT04359524|Vitamins|vitamins|mesh-ancestor
153366147|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
153366148|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366149|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153366150|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153366151|NCT01658657|Metoprolol|metoprolol|mesh-list
153366152|NCT01658657|Amlodipine|amlodipine|mesh-list
153366153|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153366154|NCT01658657|Lisinopril|lisinopril|mesh-list
153366155|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
153366156|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153366157|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153366158|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366159|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366160|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153366161|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826166|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153826167|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371982|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
153371983|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371984|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
153371985|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153371986|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153371987|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371988|NCT01357148|Metformin|metformin|mesh-list
153831917|NCT02363374|Vitamins|vitamins|mesh-ancestor
153831918|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
153831919|NCT02363374|Hematinics|hematinics|mesh-ancestor
153831920|NCT02314481|Trastuzumab|trastuzumab|mesh-list
153831921|NCT02314481|Atezolizumab|atezolizumab|mesh-list
153831922|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153831923|NCT02314481|Vemurafenib|vemurafenib|mesh-list
153831924|NCT02314481|Maytansine|maytansine|mesh-list
153831925|NCT02314481|Alectinib|alectinib|mesh-list
153831926|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153366200|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826372|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826374|NCT00493662|Protective Agents|protective agents|mesh-ancestor
153826375|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
153826376|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153826377|NCT00470912|Protective Agents|protective agents|mesh-ancestor
153826378|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826379|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
153826380|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153826381|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
153826382|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826383|NCT00476138|Protective Agents|protective agents|mesh-ancestor
153366370|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366371|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
153366372|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831954|NCT02174666|Protective Agents|protective agents|mesh-ancestor
153831955|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831956|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153366413|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153366414|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153366416|NCT02238977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153366419|NCT03034382|Epinephrine|epinephrine|mesh-list
153366420|NCT03034382|Morphine|morphine|mesh-list
153366421|NCT03034382|Nalbuphine|nalbuphine|mesh-list
153366422|NCT03034382|Bupivacaine|bupivacaine|mesh-list
153366423|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
153366424|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
153826424|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826425|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153826426|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826427|NCT00502788|Ribavirin|ribavirin|mesh-list
153826428|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153826429|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
153826430|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826431|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
153826432|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826433|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
153826434|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
153826435|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826436|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153366425|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366426|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366427|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
153366549|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153366550|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153826596|NCT00471809|Hormones|hormones|mesh-ancestor
153826611|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153826612|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826613|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153826614|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153826615|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153826616|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826617|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826618|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826619|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153826620|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153826621|NCT00471965|Leucovorin|leucovorin|mesh-list
153826622|NCT00471965|Doxorubicin|doxorubicin|mesh-list
153826623|NCT00471965|Fluorouracil|fluorouracil|mesh-list
153826624|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
153826627|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153826628|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153826629|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826630|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826631|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
153826632|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826633|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366646|NCT03016832|Irbesartan|irbesartan|mesh-list
153366647|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153366648|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153366649|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153366651|NCT00955916|Cytarabine|cytarabine|mesh-list
153826637|NCT00471965|Protective Agents|protective agents|mesh-ancestor
153826638|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
153826639|NCT00471965|Vitamins|vitamins|mesh-ancestor
153826640|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
153826641|NCT00472004|Tibolone|tibolone|mesh-list
153826642|NCT00472004|Estradiol|estradiol|mesh-list
153826643|NCT00472004|Estrogens|estrogens|mesh-ancestor
153826644|NCT00472004|Hormones|hormones|mesh-ancestor
153826645|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826646|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826647|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
153826648|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
153826649|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153826650|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153826651|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826652|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153826653|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
153826654|NCT00494715|Valsartan|valsartan|mesh-list
153826655|NCT00494715|Benazepril|benazepril|mesh-list
153832032|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153832033|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153832034|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832035|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153832036|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
153832037|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153832038|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832039|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
153832040|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
153832041|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832042|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832043|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
153832044|NCT00752479|Hormones|hormones|mesh-ancestor
153832045|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153366684|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366685|NCT03023306|Antiemetics|antiemetics|mesh-list
153366686|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
153826733|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153826734|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826735|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153826736|NCT00494832|Analgesics|analgesics|mesh-ancestor
153826737|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
153826752|NCT01323673|Hormones|hormones|mesh-ancestor
153826753|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826755|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153826757|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826758|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
153826759|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826760|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826761|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
153826762|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826763|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153826764|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
153826765|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826766|NCT01323634|Fluticasone|fluticasone|mesh-list
153826767|NCT01323634|Xhance|xhance|mesh-list
153826768|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153826769|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826770|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153826771|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
153826772|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826773|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826774|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153826775|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
153826776|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
153826777|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153826778|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153826779|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153826780|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153826781|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153826789|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
153826790|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826791|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153826792|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153826793|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153826794|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153826795|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826796|NCT00494988|Insulin|insulin|mesh-list
153366814|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366815|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
153366816|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366817|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153366818|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153366819|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
153366820|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366821|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366822|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153366823|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826829|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826830|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826831|NCT04325581|Liraglutide|liraglutide|mesh-list
153826832|NCT04325581|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153826833|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153826834|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826835|NCT04325581|Incretins|incretins|mesh-ancestor
153826836|NCT04325581|Hormones|hormones|mesh-ancestor
153826837|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826838|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
153826839|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153826840|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826841|NCT01322386|Vancomycin|vancomycin|mesh-list
153826842|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153826843|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826844|NCT00495066|Ipilimumab|ipilimumab|mesh-list
153832078|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372159|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153372160|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372161|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372162|NCT04351412|Fluorides|fluorides|mesh-list
153372163|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
153372164|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
153372165|NCT04351412|Protective Agents|protective agents|mesh-ancestor
153372166|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372167|NCT01364090|Interferons|interferons|mesh-list
153372168|NCT01364090|Ribavirin|ribavirin|mesh-list
153372169|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
153826845|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153826846|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826847|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153826848|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826849|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
153826850|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153826851|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366838|NCT00964496|Hematinics|hematinics|mesh-ancestor
153366839|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
153366840|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
153826861|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826863|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153826864|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826865|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153826866|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372196|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153372197|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153372198|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153372199|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153372200|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153372201|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
153372203|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
153372204|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
153372205|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372206|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372207|NCT01323140|Testosterone|testosterone|mesh-list
153826974|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826975|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153826976|NCT01247337|Gemcitabine|gemcitabine|mesh-list
153826977|NCT01247337|Capecitabine|capecitabine|mesh-list
153826978|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
153827050|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
153827051|NCT02891395|Nilotinib|nilotinib|mesh-list
153827052|NCT02891395|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153827053|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153827054|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827055|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827056|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827057|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
153827058|NCT00478517|Hematinics|hematinics|mesh-ancestor
153827059|NCT01321879|Telavancin|telavancin|mesh-list
153827060|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153827061|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827062|NCT01321723|Teriparatide|teriparatide|mesh-list
153827063|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153827064|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367054|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367055|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827102|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827103|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153827104|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153827105|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153827106|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367096|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367098|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367099|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153367100|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592048|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
153592049|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592052|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153592053|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592054|NCT01824264|Incretins|incretins|mesh-ancestor
153592055|NCT01824264|Hormones|hormones|mesh-ancestor
153592056|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592057|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153372229|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
153372230|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372231|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
153372232|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153372233|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372234|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372235|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
153832162|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153832163|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153832164|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832165|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832166|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
153832167|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153832168|NCT01245881|Protective Agents|protective agents|mesh-ancestor
153832170|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
153367139|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367146|NCT01023776|Vaccines|vaccines|mesh-list
153827129|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827130|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153827131|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827132|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
153827133|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827134|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827135|NCT01248078|Cephalexin|cephalexin|mesh-list
153827173|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827174|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827213|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
153827214|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153827215|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827216|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153827217|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827219|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153827220|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827221|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
153827222|NCT00478985|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153827223|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153367213|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827240|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827241|NCT01315678|Tobramycin|tobramycin|mesh-list
153827242|NCT01315678|Amikacin|amikacin|mesh-list
153827243|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153827245|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153372267|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153832189|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153832190|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832191|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
153832192|NCT00508209|Bortezomib|bortezomib|mesh-list
153832193|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389798|NCT00002289|Thymopentin|thymopentin|mesh-list
153832194|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
153832195|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153832196|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832197|NCT00507585|Leucovorin|leucovorin|mesh-list
153832198|NCT00507585|Bevacizumab|bevacizumab|mesh-list
153832199|NCT00507585|Fluorouracil|fluorouracil|mesh-list
153827259|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827338|NCT01248858|Trametinib|trametinib|mesh-list
153372276|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
153372277|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
153372278|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153372279|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153372280|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372281|NCT01365650|Analgesics|analgesics|mesh-ancestor
153372282|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
153372283|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153827450|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
153827451|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153367475|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
153367477|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367478|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367479|NCT01054742|Ribavirin|ribavirin|mesh-list
153367480|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153827479|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827481|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153827482|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153827483|NCT01313221|Analgesics|analgesics|mesh-ancestor
153827484|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
153827485|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827486|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827487|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153827488|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153827489|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832222|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153832223|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
153832224|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
153832225|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832226|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832227|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832228|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832229|NCT00507663|Atenolol|atenolol|mesh-list
153832230|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153832231|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153832232|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
153832233|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
153367559|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153367560|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153367561|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367562|NCT01061528|Nicotine|nicotine|mesh-list
153827539|NCT00480272|Prednisone|prednisone|mesh-list
153827540|NCT00480272|Adalimumab|adalimumab|mesh-list
153827541|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153827542|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
153367851|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367852|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
153367853|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
153367854|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153367855|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367856|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153367857|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
153367858|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153367859|NCT01083368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153367860|NCT01083368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367861|NCT01083368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367863|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
153367864|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153389828|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
153367865|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153367866|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367867|NCT02440854|Afatinib|afatinib|mesh-list
153367868|NCT02440854|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153367869|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153367870|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367871|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367872|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367873|NCT01084148|V0034CR|v0034cr|mesh-list
153367874|NCT01084148|Emollients|emollients|mesh-ancestor
153367875|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
153367876|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
153367877|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153832242|NCT00508287|Exenatide|exenatide|mesh-list
153372316|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
153372317|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153372318|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
153372319|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153372320|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153372321|NCT04769297|Ketamine|ketamine|mesh-list
153372322|NCT04769297|Analgesics|analgesics|mesh-ancestor
153372323|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
153372324|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372325|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372326|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153372327|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153372328|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
153832257|NCT00507858|Dexamethasone|dexamethasone|mesh-list
153827914|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827915|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827916|NCT04517214|Gemcitabine|gemcitabine|mesh-list
153827917|NCT04517214|Capecitabine|capecitabine|mesh-list
153827918|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827919|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153827920|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
153827922|NCT00483054|Efavirenz|efavirenz|mesh-list
153898523|NCT00605683|Dexpramipexole|dexpramipexole|mesh-list
153898524|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153898525|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153898526|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
153898527|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
153898528|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898529|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898530|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439815|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153898531|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
153898532|NCT00605683|Protective Agents|protective agents|mesh-ancestor
153898533|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
153898534|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898535|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153898536|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
153898537|NCT00605683|Emetics|emetics|mesh-ancestor
153898538|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
153898539|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898540|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153898541|NCT01266902|Rilpivirine|rilpivirine|mesh-list
153898542|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153898543|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153898544|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898545|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898546|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
153898547|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898548|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153898549|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153898550|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
153898551|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153898552|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153439849|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153439850|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
153439851|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439852|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153439853|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439854|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439855|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439856|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439857|NCT00002839|Fluorouracil|fluorouracil|mesh-list
153439858|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439859|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
153439860|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439861|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439862|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898565|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898566|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898567|NCT01266590|Protective Agents|protective agents|mesh-ancestor
153898568|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898569|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153898570|NCT01265498|Cathartics|cathartics|mesh-ancestor
153898571|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153898572|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
153898574|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153898575|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
153898576|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898577|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898578|NCT01263782|Bevacizumab|bevacizumab|mesh-list
153898579|NCT01263782|Carboplatin|carboplatin|mesh-list
153898580|NCT01263782|Pemetrexed|pemetrexed|mesh-list
153898581|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898582|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898583|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153898584|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153898585|NCT01263782|Growth Substances|growth substances|mesh-ancestor
153898586|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898587|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
153898588|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898589|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898590|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153898591|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439921|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439922|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439923|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439924|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439925|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439926|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439927|NCT00003073|Cytarabine|cytarabine|mesh-list
153439928|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439930|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898622|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
153898623|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898624|NCT04322240|Protective Agents|protective agents|mesh-ancestor
153898625|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898626|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
153898628|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
153898629|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153898630|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
153898631|NCT01262456|Coagulants|coagulants|mesh-ancestor
153898632|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153898633|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
153439931|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439932|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
153439935|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
153898664|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153898665|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153898666|NCT00932893|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153898667|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153898669|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
153898670|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
153439985|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
153439987|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440014|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
153849737|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
153440015|NCT00003091|Aldesleukin|aldesleukin|mesh-list
153440016|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440017|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
153440018|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440019|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
153440020|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440021|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153440023|NCT00003619|Vitamin E|vitamin e|mesh-list
153898731|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898733|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153898734|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
153898735|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153898737|NCT00608179|Glyburide|glyburide|mesh-list
153898738|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153898739|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153898740|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898741|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440030|NCT00003619|Isotretinoin|isotretinoin|mesh-list
153440031|NCT00003619|Vitamins|vitamins|mesh-ancestor
153440032|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
153440034|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898782|NCT05937711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153898783|NCT05937711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153898784|NCT05937711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153898785|NCT05937711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898786|NCT05937711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898787|NCT05937711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898788|NCT05937711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898789|NCT05937711|Analgesics|analgesics|mesh-ancestor
153898790|NCT05937711|Sensory System Agents|sensory system agents|mesh-ancestor
153898791|NCT05937711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440097|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
153440098|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153440099|NCT00003937|Protective Agents|protective agents|mesh-ancestor
153440100|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440101|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440103|NCT00003625|Etoposide|etoposide|mesh-list
153440104|NCT00003625|Vincristine|vincristine|mesh-list
153440105|NCT00003625|Cyclosporins|cyclosporins|mesh-list
153440106|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440107|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440108|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440109|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440110|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440111|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440112|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440113|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
153832330|NCT01245998|Dalteparin|dalteparin|mesh-list
153372410|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372411|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
153372412|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372413|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
153372414|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153372415|NCT02255513|Methylphenidate|methylphenidate|mesh-list
153372416|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153372417|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832344|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832345|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440115|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898802|NCT05937490|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153898803|NCT05937490|Fertility Agents|fertility agents|mesh-ancestor
153898804|NCT05937490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153898805|NCT05937490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898806|NCT05937490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153898807|NCT05937490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898808|NCT05937490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153898809|NCT05937490|Contraceptive Agents|contraceptive agents|mesh-ancestor
153898810|NCT05937490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153898941|NCT05768191|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153440291|NCT00003679|Tamoxifen|tamoxifen|mesh-list
153440292|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
153440293|NCT00003679|Docetaxel|docetaxel|mesh-list
153440294|NCT00003679|Doxorubicin|doxorubicin|mesh-list
153440295|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153440296|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440297|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
153898982|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153898983|NCT05381753|Sunitinib|sunitinib|mesh-list
153898984|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
153898985|NCT05381753|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153898986|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440372|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
153440373|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440374|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440375|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
153440376|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899039|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153899040|NCT04480554|Naloxone|naloxone|mesh-list
153899041|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153899042|NCT04480554|Narcotics|narcotics|mesh-ancestor
153899043|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899044|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899045|NCT04480554|Analgesics|analgesics|mesh-ancestor
153899046|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
153899047|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899048|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153899049|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153899050|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
153899051|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899052|NCT04268498|Acetaminophen|acetaminophen|mesh-list
153899053|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
153899054|NCT04268498|Promethazine|promethazine|mesh-list
153899055|NCT04268498|Dexamethasone|dexamethasone|mesh-list
153899065|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153899066|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
153899067|NCT04268498|Hormones|hormones|mesh-ancestor
153899068|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153440386|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440387|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440388|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440389|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440390|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
153440391|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440392|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440393|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440394|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440395|NCT00003691|Paclitaxel|paclitaxel|mesh-list
153440396|NCT00003691|Doxorubicin|doxorubicin|mesh-list
153440397|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153899070|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899071|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
153899072|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153899073|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153899074|NCT04268498|Growth Substances|growth substances|mesh-ancestor
153899075|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
153899076|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153899077|NCT04268498|Analgesics|analgesics|mesh-ancestor
153899078|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
153899079|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
153440418|NCT00003697|Vadimezan|vadimezan|mesh-list
153899081|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899082|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153899083|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
153899084|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153899085|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153899086|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899087|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153899088|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153899089|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899090|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
153899091|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
153899092|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153899093|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
153899094|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
153899095|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899096|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153899097|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
153899098|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
153899099|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
153899100|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153440436|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440438|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
153440439|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440440|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440441|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
153440442|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440443|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440444|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440445|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153440446|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440447|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153440448|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
153440449|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153440450|NCT00004039|Interferons|interferons|mesh-list
153440451|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
153440452|NCT00004039|Prednisone|prednisone|mesh-list
153440453|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
153440454|NCT00004039|Rituximab|rituximab|mesh-list
153832413|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153832414|NCT00501254|Analgesics|analgesics|mesh-ancestor
153832415|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
153832416|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832417|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832418|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832419|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153832420|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153832421|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832422|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832423|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153832424|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153832425|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153899112|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899113|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899114|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153899115|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440467|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153440468|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440469|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440470|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153372485|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153372486|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153372487|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
153372488|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372489|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372490|NCT02850419|Doxorubicin|doxorubicin|mesh-list
153372491|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153372492|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153372493|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372494|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153372495|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153372496|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372497|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899156|NCT06268873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899157|NCT06268873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153440491|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440492|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153440493|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153440494|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153440495|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153440496|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153832435|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153832436|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153832437|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153832438|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832439|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832440|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832441|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
153832442|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153832445|NCT02953743|Lenvatinib|lenvatinib|mesh-list
153440535|NCT00003727|Melphalan|melphalan|mesh-list
153440536|NCT00003727|Carmustine|carmustine|mesh-list
153440537|NCT00003727|Gemcitabine|gemcitabine|mesh-list
153440538|NCT00003727|Etoposide|etoposide|mesh-list
153440539|NCT00003727|Sargramostim|sargramostim|mesh-list
153440540|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440541|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
153440542|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440543|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440544|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440545|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
153440546|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440547|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899241|NCT06268327|Antimetabolites|antimetabolites|mesh-ancestor
153899242|NCT06268327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899243|NCT06268301|Budesonide|budesonide|mesh-list
153899244|NCT06268301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153899245|NCT06268301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153899246|NCT06268301|Autonomic Agents|autonomic agents|mesh-ancestor
153899247|NCT06268301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899248|NCT06268301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899249|NCT06268301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153899250|NCT06268301|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899251|NCT06268301|Glucocorticoids|glucocorticoids|mesh-ancestor
153899252|NCT06268301|Hormones|hormones|mesh-ancestor
153899254|NCT06268275|Esmolol|esmolol|mesh-list
153832500|NCT00509613|Sorafenib|sorafenib|mesh-list
153832501|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832502|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832503|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832504|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832505|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153832506|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832507|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153832508|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
153440593|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153440594|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
153440595|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440596|NCT00003745|Topotecan|topotecan|mesh-list
153899262|NCT06268249|Urinastatin|urinastatin|mesh-list
153899263|NCT06268249|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153899264|NCT06268249|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153899265|NCT06268249|Protease Inhibitors|protease inhibitors|mesh-ancestor
153899266|NCT06268249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899267|NCT06268249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899268|NCT06268210|Carboplatin|carboplatin|mesh-list
153899269|NCT06268210|Pemetrexed|pemetrexed|mesh-list
153899270|NCT06268210|Lazertinib|lazertinib|mesh-list
153899295|NCT06267872|Immunologic Factors|immunologic factors|mesh-ancestor
153899296|NCT06267872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810832|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153357422|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357423|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153440630|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
153440631|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153440632|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
153440633|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440634|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440636|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153440656|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
153440657|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440658|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440659|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440660|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
153440661|NCT00004099|Antidotes|antidotes|mesh-ancestor
153440662|NCT00004099|Protective Agents|protective agents|mesh-ancestor
153899306|NCT06267820|Sensory System Agents|sensory system agents|mesh-ancestor
153899307|NCT06267820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899308|NCT06267820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153899309|NCT06267820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153899310|NCT06267820|Analgesics|analgesics|mesh-ancestor
153899311|NCT06267820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153899312|NCT06267820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440690|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440691|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440692|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440693|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440694|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440695|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440696|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153899334|NCT06267118|Epinephrine|epinephrine|mesh-list
153899335|NCT06267118|Racepinephrine|racepinephrine|mesh-list
153899336|NCT06267118|Epinephryl borate|epinephryl borate|mesh-list
153899337|NCT06267118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153899338|NCT06267118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153899339|NCT06267118|Adrenergic Agents|adrenergic agents|mesh-ancestor
153440697|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
153440698|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153440699|NCT00003187|Cytarabine|cytarabine|mesh-list
153899340|NCT06267118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899341|NCT06267118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899342|NCT06267118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899343|NCT06267118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153899359|NCT06267066|Glucocorticoids|glucocorticoids|mesh-ancestor
153899360|NCT06267066|Hormones|hormones|mesh-ancestor
153899361|NCT06267066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899362|NCT06267066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899363|NCT06267066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153899364|NCT06267066|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899365|NCT06267066|Emollients|emollients|mesh-ancestor
153899366|NCT06267066|Dermatologic Agents|dermatologic agents|mesh-ancestor
153899367|NCT06267053|Vitamin D|vitamin d|mesh-list
153440721|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153440722|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153440723|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
153440724|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440725|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
153440726|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153440727|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153440728|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
153440729|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
153440730|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440731|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153440732|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
153440734|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153440735|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153440736|NCT00003187|Protective Agents|protective agents|mesh-ancestor
153440737|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
153440738|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440739|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899385|NCT06266975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899387|NCT06266962|Epinephrine|epinephrine|mesh-list
153899388|NCT06266962|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153899389|NCT06266962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153899390|NCT06266962|Adrenergic Agents|adrenergic agents|mesh-ancestor
153899391|NCT06266962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849987|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
153899396|NCT06266962|Autonomic Agents|autonomic agents|mesh-ancestor
153899416|NCT06266832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440773|NCT00004135|Fludarabine|fludarabine|mesh-list
153440774|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
153440775|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440776|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
153440777|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440778|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440779|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440780|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
153440781|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440782|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440783|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440784|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440785|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
153440786|NCT00004141|Dacarbazine|dacarbazine|mesh-list
153440787|NCT00004141|Molgramostim|molgramostim|mesh-list
153440788|NCT00004141|Sargramostim|sargramostim|mesh-list
153440789|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899422|NCT06266767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899423|NCT06266767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899424|NCT06266767|Analgesics|analgesics|mesh-ancestor
153899425|NCT06266767|Sensory System Agents|sensory system agents|mesh-ancestor
153899426|NCT06266767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899427|NCT06266767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153899428|NCT06266767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153899429|NCT06266767|Anesthetics, General|anesthetics, general|mesh-ancestor
153899430|NCT06266767|Anesthetics|anesthetics|mesh-ancestor
153899431|NCT06266767|Anesthetics, Local|anesthetics, local|mesh-ancestor
153899432|NCT06266598|Metformin|metformin|mesh-list
153899433|NCT06266598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153440790|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440791|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
153899434|NCT06266598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899435|NCT06265870|Ivermectin|ivermectin|mesh-list
153899436|NCT06265870|Albendazole|albendazole|mesh-list
153899437|NCT06265870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153899442|NCT06265870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153899443|NCT06265870|Tubulin Modulators|tubulin modulators|mesh-ancestor
153899463|NCT06263816|Carvedilol|carvedilol|mesh-list
153440804|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153440805|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440806|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
153440807|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440808|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440809|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440810|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440811|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
153440812|NCT00003799|Antidotes|antidotes|mesh-ancestor
153440813|NCT00003799|Protective Agents|protective agents|mesh-ancestor
153440814|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
153440815|NCT00003799|Vitamins|vitamins|mesh-ancestor
153440816|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
153440817|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
153440818|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153440819|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
153440820|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440821|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440822|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
153440823|NCT00003211|Vincristine|vincristine|mesh-list
153440824|NCT00003211|Amifostine|amifostine|mesh-list
153440825|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440826|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
153440827|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440828|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440829|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440830|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
153440832|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899464|NCT06263816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153899503|NCT06238245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153899504|NCT06238245|Alkylating Agents|alkylating agents|mesh-ancestor
153899505|NCT06238245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899506|NCT06238245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899507|NCT06238245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153899508|NCT06233864|Gemcitabine|gemcitabine|mesh-list
153899509|NCT06233864|Disitamab vedotin|disitamab vedotin|mesh-list
153440851|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440852|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440853|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440854|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440855|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440870|NCT00003811|Protective Agents|protective agents|mesh-ancestor
153440871|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440872|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153440874|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
153440875|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153440876|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
153440877|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440878|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440879|NCT00003817|Ondansetron|ondansetron|mesh-list
153440880|NCT00003817|Granisetron|granisetron|mesh-list
153440881|NCT00003817|Tropisetron|tropisetron|mesh-list
153440882|NCT00003817|Dolasetron|dolasetron|mesh-list
153899510|NCT06233864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153899535|NCT06192082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899536|NCT06192082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899537|NCT06191692|Rifampin|rifampin|mesh-list
153899538|NCT06191692|Rifapentine|rifapentine|mesh-list
153899539|NCT06191692|Isoniazid|isoniazid|mesh-list
153899540|NCT06191692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153899541|NCT06191692|Antitubercular Agents|antitubercular agents|mesh-ancestor
153899543|NCT06191692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899544|NCT06191692|Leprostatic Agents|leprostatic agents|mesh-ancestor
153440907|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440908|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
153440909|NCT04329403|Adapalene|adapalene|mesh-list
153440910|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153440911|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153440912|NCT04329403|Analgesics|analgesics|mesh-ancestor
153440913|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
153440914|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440915|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440916|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153440917|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440918|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440919|NCT00003217|Cytarabine|cytarabine|mesh-list
153440920|NCT00003217|Dexamethasone|dexamethasone|mesh-list
153440921|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
153440922|NCT00003217|Doxorubicin|doxorubicin|mesh-list
153440923|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153440924|NCT00003217|Methotrexate|methotrexate|mesh-list
153440925|NCT00003217|Vincristine|vincristine|mesh-list
153440926|NCT00003217|Lenograstim|lenograstim|mesh-list
153440927|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440948|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440949|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153440950|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
153440951|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153440952|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440953|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
153440954|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440955|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153440956|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153440957|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
153899594|NCT06155981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899596|NCT06155981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899597|NCT06137469|Acetaminophen|acetaminophen|mesh-list
153899598|NCT06137469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153899599|NCT06137469|Analgesics|analgesics|mesh-ancestor
153899600|NCT06137469|Sensory System Agents|sensory system agents|mesh-ancestor
153899601|NCT06137469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899602|NCT06137469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899603|NCT06137469|Antipyretics|antipyretics|mesh-ancestor
153899604|NCT06137287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153899605|NCT06137287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153899606|NCT06137287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153899607|NCT06137287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899608|NCT06137287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899609|NCT06137287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153899610|NCT06137287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153440958|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440959|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153914609|NCT00930046|Ropivacaine|ropivacaine|mesh-list
153440960|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440961|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440962|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440963|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440964|NCT00004183|Capecitabine|capecitabine|mesh-list
153440965|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440966|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
153440970|NCT00003223|Retinamide|retinamide|mesh-list
153440973|NCT00003223|Protective Agents|protective agents|mesh-ancestor
153899622|NCT06128109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153899623|NCT06128109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153899624|NCT06128109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153899625|NCT06128109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899626|NCT06122311|Acetylcysteine|acetylcysteine|mesh-list
153899627|NCT06122311|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153899628|NCT06122311|Antiviral Agents|antiviral agents|mesh-ancestor
153899629|NCT06122311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899630|NCT06122311|Expectorants|expectorants|mesh-ancestor
153899631|NCT06122311|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899632|NCT06122311|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153899633|NCT06122311|Antioxidants|antioxidants|mesh-ancestor
153899634|NCT06122311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899635|NCT06122311|Protective Agents|protective agents|mesh-ancestor
153899636|NCT06122311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440982|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440983|NCT00003835|Leucovorin|leucovorin|mesh-list
153440984|NCT00003835|Fluorouracil|fluorouracil|mesh-list
153899637|NCT06122311|Antidotes|antidotes|mesh-ancestor
153899638|NCT06117722|Eplerenone|eplerenone|mesh-list
153899639|NCT06117722|Torsemide|torsemide|mesh-list
153899640|NCT06117722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153899641|NCT06117722|Hormone Antagonists|hormone antagonists|mesh-ancestor
153899642|NCT06117722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899643|NCT06117722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899644|NCT06117722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153899645|NCT06117722|Diuretics|diuretics|mesh-ancestor
153899646|NCT06117722|Natriuretic Agents|natriuretic agents|mesh-ancestor
153899647|NCT06117722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153899648|NCT06117722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153899650|NCT06117722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899651|NCT06112353|Glycopyrrolate|glycopyrrolate|mesh-list
153899652|NCT06112353|Neostigmine|neostigmine|mesh-list
153899653|NCT06112353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153899674|NCT06065670|Histamine Antagonists|histamine antagonists|mesh-ancestor
153899675|NCT06065670|Histamine Agents|histamine agents|mesh-ancestor
153899676|NCT06065670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899677|NCT06065670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899678|NCT06065670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899679|NCT06065670|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153899680|NCT06041789|Donepezil|donepezil|mesh-list
153899681|NCT06041789|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153899682|NCT06041789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899683|NCT06041789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899684|NCT06041789|Cholinergic Agents|cholinergic agents|mesh-ancestor
153899685|NCT06041789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899686|NCT06041789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899687|NCT06041789|Nootropic Agents|nootropic agents|mesh-ancestor
153899688|NCT06039137|Cetirizine|cetirizine|mesh-list
153899689|NCT06039137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153899690|NCT06039137|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153899691|NCT06039137|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153914657|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
153441047|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441048|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
153441049|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441050|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
153441051|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441052|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
153372914|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153372915|NCT02641353|Growth Substances|growth substances|mesh-ancestor
153372916|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
153372917|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441054|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441056|NCT00003859|Carboplatin|carboplatin|mesh-list
153441057|NCT00003859|Etoposide|etoposide|mesh-list
153441058|NCT00003859|Vincristine|vincristine|mesh-list
153441059|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441060|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
153441061|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441062|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441063|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153441064|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
153441065|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441066|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441067|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441068|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441069|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441070|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441071|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899692|NCT06039137|Histamine Antagonists|histamine antagonists|mesh-ancestor
153899693|NCT06039137|Histamine Agents|histamine agents|mesh-ancestor
153899694|NCT06039137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899711|NCT06019507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153899712|NCT06019507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153899713|NCT06019507|Antitubercular Agents|antitubercular agents|mesh-ancestor
153899714|NCT06019507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153899715|NCT06019507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899716|NCT05991518|Cisplatin|cisplatin|mesh-list
153899717|NCT05991518|Gemcitabine|gemcitabine|mesh-list
153899718|NCT05991518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899719|NCT05991518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153899720|NCT05991518|Antimetabolites|antimetabolites|mesh-ancestor
153441077|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441078|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153441079|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153441080|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
153441081|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441082|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441083|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153441090|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441091|NCT00004219|Granisetron|granisetron|mesh-list
153441092|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
153441093|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
153441094|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441095|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441096|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441097|NCT00004219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153441098|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153441099|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
153441100|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153441101|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441102|NCT00003877|Paclitaxel|paclitaxel|mesh-list
153441103|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
153441104|NCT00003877|Carboplatin|carboplatin|mesh-list
153441105|NCT00003877|Thiotepa|thiotepa|mesh-list
153441106|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153899725|NCT05976763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899726|NCT05976763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899728|NCT05976763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899729|NCT05976763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153899730|NCT05976763|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153899731|NCT05976763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899732|NCT05976763|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153899733|NCT05976763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153899737|NCT05950997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899738|NCT05950997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899739|NCT05950997|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153899740|NCT05950997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153899741|NCT05950997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899742|NCT05950997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899759|NCT05895136|Anticoagulants|anticoagulants|mesh-ancestor
153899760|NCT05895136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153899761|NCT05895136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153899762|NCT05895136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899763|NCT05894564|Fluvoxamine|fluvoxamine|mesh-list
153899764|NCT05894564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899765|NCT05894564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441140|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441141|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
153441142|NCT00004237|Doxorubicin|doxorubicin|mesh-list
153441143|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153441144|NCT00004237|Vinorelbine|vinorelbine|mesh-list
153441145|NCT00004237|Epirubicin|epirubicin|mesh-list
153441146|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
153441147|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441148|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
153441149|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441150|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441151|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153441152|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
153441153|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899801|NCT05870917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899802|NCT05870917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153899803|NCT05870917|Glucocorticoids|glucocorticoids|mesh-ancestor
153899804|NCT05870917|Hormones|hormones|mesh-ancestor
153899805|NCT05870917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899806|NCT05870917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153441173|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441174|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
153441175|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
153441177|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153441178|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441179|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
153441180|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441181|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441182|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153899812|NCT05870917|Growth Inhibitors|growth inhibitors|mesh-ancestor
153899814|NCT05864144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899815|NCT05864144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899816|NCT05851768|Dexmedetomidine|dexmedetomidine|mesh-list
153899817|NCT05851768|Bupivacaine|bupivacaine|mesh-list
153899818|NCT05851768|Anesthetics, Local|anesthetics, local|mesh-ancestor
153899819|NCT05851768|Anesthetics|anesthetics|mesh-ancestor
153899820|NCT05851768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899821|NCT05851768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899822|NCT05851768|Sensory System Agents|sensory system agents|mesh-ancestor
153899823|NCT05851768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899824|NCT05851768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153899825|NCT05851768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153899826|NCT05851768|Analgesics|analgesics|mesh-ancestor
153899827|NCT05851768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153899828|NCT05851768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153899829|NCT05851768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153899830|NCT05851768|Adrenergic Agents|adrenergic agents|mesh-ancestor
153899831|NCT05851768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899832|NCT05851768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899833|NCT05812807|Pembrolizumab|pembrolizumab|mesh-list
153899835|NCT05812807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899836|NCT05812807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153899837|NCT05812807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899838|NCT05784012|Niraparib|niraparib|mesh-list
153899839|NCT05784012|Dostarlimab|dostarlimab|mesh-list
153899840|NCT05784012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592058|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
153899841|NCT05784012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153899842|NCT05784012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914658|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
153441203|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441204|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153441205|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153441206|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
153441207|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441208|NCT00003925|Leucovorin|leucovorin|mesh-list
153441209|NCT00003925|Gemcitabine|gemcitabine|mesh-list
153441210|NCT00003925|Tegafur|tegafur|mesh-list
153441211|NCT00003925|Calcium|calcium|mesh-list
153441212|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
153441213|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441214|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
153441215|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441216|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441217|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153441218|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441219|NCT00003925|Antidotes|antidotes|mesh-ancestor
153441220|NCT00003925|Protective Agents|protective agents|mesh-ancestor
153441221|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
153441222|NCT00003925|Vitamins|vitamins|mesh-ancestor
153441223|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
153441224|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
153441225|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
153441226|NCT00004255|Fludarabine|fludarabine|mesh-list
153441227|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
153441228|NCT00004255|Tacrolimus|tacrolimus|mesh-list
153899843|NCT05784012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899844|NCT05775861|Dexmedetomidine|dexmedetomidine|mesh-list
153899845|NCT05775861|Ropivacaine|ropivacaine|mesh-list
153899846|NCT05775861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153899847|NCT05775861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899848|NCT05775861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899849|NCT05775861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153899850|NCT05775861|Analgesics|analgesics|mesh-ancestor
153592059|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592060|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899851|NCT05775861|Sensory System Agents|sensory system agents|mesh-ancestor
153899852|NCT05775861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899853|NCT05775861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153899854|NCT05775861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153899856|NCT05775861|Adrenergic Agents|adrenergic agents|mesh-ancestor
153899857|NCT05775861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899858|NCT05775861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899859|NCT05775861|Anesthetics, Local|anesthetics, local|mesh-ancestor
153899860|NCT05775861|Anesthetics|anesthetics|mesh-ancestor
153441229|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153441230|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441231|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
153441232|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899861|NCT05766514|Cytarabine|cytarabine|mesh-list
153899862|NCT05766514|Decitabine|decitabine|mesh-list
153899863|NCT05766514|Venetoclax|venetoclax|mesh-list
153899864|NCT05766514|Cladribine|cladribine|mesh-list
153899865|NCT05766514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153899866|NCT05766514|Antimetabolites|antimetabolites|mesh-ancestor
153899867|NCT05766514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899868|NCT05766514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899869|NCT05766514|Antiviral Agents|antiviral agents|mesh-ancestor
153899870|NCT05766514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899871|NCT05766514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153899872|NCT05766514|Immunologic Factors|immunologic factors|mesh-ancestor
153899873|NCT05766514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899874|NCT05766514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899875|NCT05759949|Fulvestrant|fulvestrant|mesh-list
153899876|NCT05759949|Palbociclib|palbociclib|mesh-list
153899877|NCT05759949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153899878|NCT05759949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441263|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441264|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153441265|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153441272|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441274|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153441275|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153441276|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153441277|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
153441278|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
153441279|NCT00004855|Ritonavir|ritonavir|mesh-list
153899888|NCT05756348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899889|NCT05751668|Paclitaxel|paclitaxel|mesh-list
153899890|NCT05751668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153899891|NCT05751668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899892|NCT05751668|Tubulin Modulators|tubulin modulators|mesh-ancestor
153899893|NCT05751668|Antimitotic Agents|antimitotic agents|mesh-ancestor
153899894|NCT05751668|Mitosis Modulators|mitosis modulators|mesh-ancestor
153899895|NCT05751668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899896|NCT05743179|Zoledronic Acid|zoledronic acid|mesh-list
153899897|NCT05743179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153899898|NCT05743179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441280|NCT00004855|Lopinavir|lopinavir|mesh-list
153441281|NCT00004855|Lamivudine|lamivudine|mesh-list
153899918|NCT05720637|Serotonin|serotonin|mesh-list
153899919|NCT05720637|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153899920|NCT05720637|Serotonin Agents|serotonin agents|mesh-ancestor
153899930|NCT05718934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899931|NCT05718934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899932|NCT05718934|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153441301|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153441302|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441303|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153441304|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441305|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441306|NCT00004861|Gemcitabine|gemcitabine|mesh-list
153441328|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441329|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153441330|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441331|NCT00003313|Paclitaxel|paclitaxel|mesh-list
153899933|NCT05718934|Autonomic Agents|autonomic agents|mesh-ancestor
153899934|NCT05718934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899935|NCT05718934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153899936|NCT05718934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153899937|NCT05718934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153899938|NCT05710406|Cetuximab|cetuximab|mesh-list
153899940|NCT05710406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899949|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899950|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899951|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153899952|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899953|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899954|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899956|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899957|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899958|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
153899959|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899960|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899961|NCT05669352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153899962|NCT05669352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441332|NCT00003313|Carboplatin|carboplatin|mesh-list
153441333|NCT00003313|Amifostine|amifostine|mesh-list
153441334|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441335|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441336|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441337|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441338|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441339|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441340|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441341|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153441342|NCT00003313|Protective Agents|protective agents|mesh-ancestor
153441343|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153441344|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153441345|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441346|NCT00004873|Docetaxel|docetaxel|mesh-list
153441347|NCT00004873|Fluorouracil|fluorouracil|mesh-list
153441348|NCT00004873|Epirubicin|epirubicin|mesh-list
153441349|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441350|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441351|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441352|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
153833079|NCT00504413|Digoxin|digoxin|mesh-list
153899985|NCT05641194|Caffeine|caffeine|mesh-list
153899986|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153441357|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
153441358|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441359|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153441360|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441361|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441362|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441363|NCT00004879|Panitumumab|panitumumab|mesh-list
153441364|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153441365|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441366|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153441367|NCT00004339|Trientine|trientine|mesh-list
153441368|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
153441369|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
153441370|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441371|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441372|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153441373|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153441374|NCT00004339|Growth Substances|growth substances|mesh-ancestor
153441375|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441376|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
153441377|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441378|NCT00003331|Leucovorin|leucovorin|mesh-list
153441379|NCT00003331|Fluorouracil|fluorouracil|mesh-list
153441380|NCT00003331|Topotecan|topotecan|mesh-list
153441381|NCT00003331|Calcium|calcium|mesh-list
153441382|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
153441383|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153441384|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441385|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
153373181|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373182|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373183|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833120|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833121|NCT01249664|Aflibercept|aflibercept|mesh-list
153833122|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153833123|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153833124|NCT01249664|Growth Substances|growth substances|mesh-ancestor
153833128|NCT00513162|Etoposide|etoposide|mesh-list
153899990|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899991|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153899992|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153899993|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
153899994|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899995|NCT05639946|Brivaracetam|brivaracetam|mesh-list
153899996|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
153899997|NCT05638880|Empagliflozin|empagliflozin|mesh-list
153899998|NCT05638880|Valsartan|valsartan|mesh-list
153899999|NCT05638880|Levocetirizine|levocetirizine|mesh-list
153900000|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153900001|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153900002|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153733425|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
153441404|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153900023|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
153900033|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900035|NCT05610163|Capecitabine|capecitabine|mesh-list
153900036|NCT05610163|Fluorouracil|fluorouracil|mesh-list
153900037|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
153900040|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
153900041|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153900042|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441416|NCT00004885|Protective Agents|protective agents|mesh-ancestor
153441417|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
153441419|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
153441438|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441439|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441440|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441441|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833156|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833157|NCT00512265|Protective Agents|protective agents|mesh-ancestor
153833158|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833159|NCT00512265|Antidotes|antidotes|mesh-ancestor
153833161|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
153373200|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
153373201|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
153373202|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373203|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900044|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
153900045|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900046|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900047|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900048|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
153900049|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153900050|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153900052|NCT05610163|Antidotes|antidotes|mesh-ancestor
153833172|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153833173|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833174|NCT00513513|Ritonavir|ritonavir|mesh-list
153833175|NCT00513513|Darunavir|darunavir|mesh-list
153373215|NCT01387178|Xhance|xhance|mesh-list
153373216|NCT01387178|Bromides|bromides|mesh-list
153373217|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
153373218|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153373219|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373220|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153373221|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
153373222|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373223|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373224|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153373225|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373226|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
153900087|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
153900088|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
153900089|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153441463|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441464|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
153833176|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153833177|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153833178|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
153833179|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833180|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833181|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153833182|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153833183|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
153833184|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833185|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153833186|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153833187|NCT00504959|Ranibizumab|ranibizumab|mesh-list
153900090|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153900095|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900097|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
153900098|NCT05459402|Methadone|methadone|mesh-list
153900099|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153900100|NCT05459402|Narcotics|narcotics|mesh-ancestor
153900101|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900102|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900103|NCT05459402|Analgesics|analgesics|mesh-ancestor
153900104|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
153900105|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833189|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153373232|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373233|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153373234|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153373235|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153373238|NCT01389284|Naproxen|naproxen|mesh-list
153441508|NCT00004921|Carboplatin|carboplatin|mesh-list
153441509|NCT00004921|Melphalan|melphalan|mesh-list
153441510|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441511|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441512|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441513|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441514|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441515|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441516|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441517|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
153441518|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441519|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441520|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153441521|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
153441522|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441523|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
153441524|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
153441525|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900141|NCT05303792|Dexamethasone|dexamethasone|mesh-list
153833191|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833192|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
153833193|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833194|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
153833195|NCT00512616|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153833196|NCT00512616|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153833197|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833198|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833199|NCT00505037|Sevelamer|sevelamer|mesh-list
153833200|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
153833201|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
153900152|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
153441526|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
153441527|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441528|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441529|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153441530|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441531|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153441532|NCT00004981|Lamivudine|lamivudine|mesh-list
153441533|NCT00004981|Zidovudine|zidovudine|mesh-list
153441534|NCT00004981|Abacavir|abacavir|mesh-list
153441535|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
153441536|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153441549|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441550|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153441551|NCT00004999|Lamivudine|lamivudine|mesh-list
153441552|NCT00004999|Zidovudine|zidovudine|mesh-list
153441553|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153441554|NCT00004999|Capravirine|capravirine|mesh-list
153441555|NCT00004999|Nelfinavir|nelfinavir|mesh-list
153441556|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153900163|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900165|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
153900166|NCT05303792|Hormones|hormones|mesh-ancestor
153900167|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900168|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900169|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900170|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153900171|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153900172|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153900173|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900174|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153900175|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
153900176|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153900177|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900178|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
153900179|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
153900180|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153900181|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153900182|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
153900183|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900184|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153900185|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900186|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
153900187|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
153900188|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153900189|NCT05303792|Protective Agents|protective agents|mesh-ancestor
153900190|NCT05303792|Immunotoxins|immunotoxins|mesh-ancestor
153373294|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
153373295|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153373296|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153373297|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373298|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153373299|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373300|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373301|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
153373302|NCT04351490|Vitamin D|vitamin d|mesh-list
153392961|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
153373303|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153900218|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153900219|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900220|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900221|NCT05168865|Letrozole|letrozole|mesh-list
153900222|NCT05168865|Estradiol|estradiol|mesh-list
153900223|NCT05168865|Progesterone|progesterone|mesh-list
153900224|NCT05168865|Estrogens|estrogens|mesh-ancestor
153900248|NCT05100264|Acetic Acid|acetic acid|mesh-list
153900249|NCT05100264|Retinol acetate|retinol acetate|mesh-list
153900250|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153900251|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900252|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153852847|NCT05854537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429643|NCT00002738|Trimetrexate|trimetrexate|mesh-list
153900253|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
153441692|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441693|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
153441694|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153441695|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441696|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441697|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153441698|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
153441699|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
153441700|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441701|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441702|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153441703|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153441704|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153441705|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
153441706|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900309|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153900310|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153900311|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900312|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153900313|NCT04939090|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153900314|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153900315|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153900316|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900317|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900318|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
153900319|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153900320|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153900321|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153900322|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
153900330|NCT04934514|Gemcitabine|gemcitabine|mesh-list
153833284|NCT00512850|Vitamins|vitamins|mesh-ancestor
153833285|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
153833286|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833287|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
153900336|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153900337|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153900338|NCT04926818|Siponimod|siponimod|mesh-list
153900339|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441715|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441716|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
153441717|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153441718|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441719|NCT00005059|Paclitaxel|paclitaxel|mesh-list
153441720|NCT00005059|Carboplatin|carboplatin|mesh-list
153441721|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441722|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441723|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441724|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441725|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441726|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441727|NCT00005065|Paclitaxel|paclitaxel|mesh-list
153441728|NCT00005065|Carboplatin|carboplatin|mesh-list
153441743|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
153441744|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373342|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153373343|NCT01391858|Pregabalin|pregabalin|mesh-list
153373344|NCT01391858|Analgesics|analgesics|mesh-ancestor
153373345|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
153373346|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900350|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
153900351|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900352|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900353|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
153900354|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900355|NCT04903119|Trametinib|trametinib|mesh-list
153393069|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900356|NCT04903119|Dabrafenib|dabrafenib|mesh-list
153900357|NCT04903119|Nilotinib|nilotinib|mesh-list
153900358|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900359|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900360|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900361|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900362|NCT04903119|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153900363|NCT04886453|Morphine|morphine|mesh-list
153900364|NCT04886453|Anesthetics|anesthetics|mesh-list
153900365|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900366|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900367|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153441763|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441764|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441765|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441766|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441767|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441769|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441770|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441771|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153833305|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153833306|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153833307|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833308|NCT01246973|Curcumin|curcumin|mesh-list
153900370|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
153900371|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900372|NCT04862143|Fulvestrant|fulvestrant|mesh-list
153900373|NCT04862143|Goserelin|goserelin|mesh-list
153900374|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900375|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900376|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153900377|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153900378|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
153900379|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900380|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900381|NCT04799288|Teriflunomide|teriflunomide|mesh-list
153900382|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153441791|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153441792|NCT00004489|Antacids|antacids|mesh-ancestor
153441793|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441794|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441795|NCT00005593|Carboplatin|carboplatin|mesh-list
153441796|NCT00005593|Fludarabine|fludarabine|mesh-list
153441797|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
153441798|NCT00005593|Topotecan|topotecan|mesh-list
153373374|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
153373375|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373376|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373377|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153373378|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373379|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
153373380|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153373381|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153373382|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373383|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900416|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
153900417|NCT04734535|Coagulants|coagulants|mesh-ancestor
153900419|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900420|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900421|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900422|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900423|NCT04708067|Atezolizumab|atezolizumab|mesh-list
153900424|NCT04708067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153900425|NCT04708067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900426|NCT04708067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900427|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900428|NCT04671966|Cetrorelix|cetrorelix|mesh-list
153900429|NCT04671966|Estradiol|estradiol|mesh-list
153900430|NCT04671966|Estrogens|estrogens|mesh-ancestor
153900431|NCT04671966|Hormones|hormones|mesh-ancestor
153900432|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900433|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441815|NCT00004495|Vitamins|vitamins|mesh-ancestor
153441816|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
153441817|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441818|NCT00005089|Prednisone|prednisone|mesh-list
153441825|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
153441826|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833337|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833338|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833339|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153833340|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153833341|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
153833342|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833343|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153833344|NCT00513981|Antidotes|antidotes|mesh-ancestor
153833345|NCT00513981|Protective Agents|protective agents|mesh-ancestor
153833346|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
153833347|NCT00513981|Vitamins|vitamins|mesh-ancestor
153441833|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153441834|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153833348|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
153833349|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153833350|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
153833351|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900434|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153900435|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153900436|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
153900437|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
153900438|NCT04660240|Sirolimus|sirolimus|mesh-list
153900439|NCT04660240|Temsirolimus|temsirolimus|mesh-list
153900440|NCT04660240|MTOR Inhibitors|mtor inhibitors|mesh-list
153900441|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153900442|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900443|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153900444|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900445|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
153900446|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900447|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
153900448|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900449|NCT04660240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900450|NCT04660240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900451|NCT04660240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900452|NCT04655976|Docetaxel|docetaxel|mesh-list
153900453|NCT04655976|Dostarlimab|dostarlimab|mesh-list
153900454|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900455|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441862|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
153441863|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153441864|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441865|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900456|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
153900457|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
153900458|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900459|NCT04600336|Oxybutynin|oxybutynin|mesh-list
153900460|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
153900461|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
153900467|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833355|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833356|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833357|NCT01245140|Alitretinoin|alitretinoin|mesh-list
153833358|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833359|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833360|NCT02951637|Carboplatin|carboplatin|mesh-list
153833361|NCT02951637|Pemetrexed|pemetrexed|mesh-list
153833362|NCT02951637|Gefitinib|gefitinib|mesh-list
153833363|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833364|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833365|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833366|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153833367|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153833368|NCT02951637|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153833369|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153833370|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
153900468|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900469|NCT04600336|Urological Agents|urological agents|mesh-ancestor
153900470|NCT04570150|Neostigmine|neostigmine|mesh-list
153900471|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153900472|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833383|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833384|NCT01244984|Fluticasone|fluticasone|mesh-list
153833385|NCT01244984|Xhance|xhance|mesh-list
153833386|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833387|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153833388|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
153833389|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833390|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833391|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153833392|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
153833393|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833394|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153833395|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153833396|NCT04695483|Hormones|hormones|mesh-ancestor
153833398|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900505|NCT04561648|Heparin|heparin|mesh-list
153900506|NCT04561648|Calcium heparin|calcium heparin|mesh-list
153373452|NCT05327621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900510|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900511|NCT04457596|Trastuzumab|trastuzumab|mesh-list
153900512|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153900513|NCT04457596|Maytansine|maytansine|mesh-list
153900514|NCT04457596|Tucatinib|tucatinib|mesh-list
153900515|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900516|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900517|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153900518|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900519|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
153833405|NCT01244126|Analgesics|analgesics|mesh-ancestor
153833406|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
153833407|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833408|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153833409|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153833410|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
153441929|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441930|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441931|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441932|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441933|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153441935|NCT00005641|Cyclosporine|cyclosporine|mesh-list
153441936|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
153441937|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
153441938|NCT00005641|Busulfan|busulfan|mesh-list
153441939|NCT00005641|Methotrexate|methotrexate|mesh-list
153441940|NCT00005641|Cyclosporins|cyclosporins|mesh-list
153441941|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153441942|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
153441943|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441944|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
153441945|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441946|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441947|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153900541|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
153900542|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900543|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153900544|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
153900545|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
153900546|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153900547|NCT04405102|Ozanimod|ozanimod|mesh-list
153900548|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153900553|NCT04404283|Rituximab|rituximab|mesh-list
153373475|NCT01415960|Leuprolide|leuprolide|mesh-list
153373476|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153373477|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
153373478|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153373479|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373480|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900558|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
153900559|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853357|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153900560|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900561|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153900562|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153900563|NCT04404283|Growth Substances|growth substances|mesh-ancestor
153900564|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
153900565|NCT04404283|Immunotoxins|immunotoxins|mesh-ancestor
153900566|NCT04404283|Immunoconjugates|immunoconjugates|mesh-ancestor
153900567|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
153900568|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900569|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900570|NCT04374877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153900571|NCT04374877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441955|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441956|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
153441957|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
153441958|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441959|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153441960|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153441962|NCT00005641|Protective Agents|protective agents|mesh-ancestor
153441976|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441977|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153441979|NCT00005647|Semaxinib|semaxinib|mesh-list
153441980|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441981|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441982|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
153833433|NCT02955641|Dexamethasone|dexamethasone|mesh-list
153833434|NCT02955641|Nepafenac|nepafenac|mesh-list
153833435|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153833436|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833437|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
153833438|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
153833439|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833440|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833441|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153833442|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
153833443|NCT02955641|Hormones|hormones|mesh-ancestor
153833444|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153833445|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153833446|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833447|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153833448|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153441985|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373498|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373499|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373500|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153373501|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153373502|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153373504|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153373505|NCT01416584|Narcotics|narcotics|mesh-ancestor
153373506|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373507|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373508|NCT01416584|Analgesics|analgesics|mesh-ancestor
153373509|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
153373510|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373511|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
153373512|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373513|NCT02698215|Naltrexone|naltrexone|mesh-list
153373514|NCT02698215|Varenicline|varenicline|mesh-list
153900600|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442006|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
153833457|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853425|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833458|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
153833459|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153833460|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153833461|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
153833462|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
153833463|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833464|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833465|NCT01242176|Empagliflozin|empagliflozin|mesh-list
153833466|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153833467|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833468|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153833469|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833470|NCT00515151|Ethanol|ethanol|mesh-list
153833471|NCT00515151|Octenidine|octenidine|mesh-list
153900620|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153900621|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153900622|NCT04194203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153373524|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373526|NCT04172961|Lifitegrast|lifitegrast|mesh-list
153373527|NCT04172961|Cyclosporins|cyclosporins|mesh-list
153373528|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373529|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373530|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153373531|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
153373532|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373533|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
153373534|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373535|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
153373536|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833478|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
153833479|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833480|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153833481|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153833482|NCT01241786|Growth Substances|growth substances|mesh-ancestor
153833483|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
153833484|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833485|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833486|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
153833487|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833488|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833489|NCT00514410|Folic Acid|folic acid|mesh-list
153833490|NCT00514410|Hematinics|hematinics|mesh-ancestor
153833491|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
153442035|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153442036|NCT00004759|Prednisolone|prednisolone|mesh-list
153442037|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
153442038|NCT00004759|Tirilazad|tirilazad|mesh-list
153442040|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
153442041|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442042|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
153442043|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
153442046|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153900662|NCT03994796|Adagrasib|adagrasib|mesh-list
153900663|NCT03994796|Entrectinib|entrectinib|mesh-list
153900664|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900665|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900666|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900667|NCT03994796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900668|NCT03971500|Ticagrelor|ticagrelor|mesh-list
153900669|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900670|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442060|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153853490|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853491|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442061|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442062|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153442063|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442064|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153442065|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
153442066|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153442067|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153442068|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442069|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442070|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153442071|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153442072|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
153442073|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442074|NCT00004807|Topiramate|topiramate|mesh-list
153442075|NCT00004807|Levomethorphan|levomethorphan|mesh-list
153373596|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373597|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153373598|NCT02706249|Enoxaparin|enoxaparin|mesh-list
153373599|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
153442098|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153900686|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900687|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900688|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900689|NCT03886948|Mirikizumab|mirikizumab|mesh-list
153900690|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153900691|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153900692|NCT03886948|Analgesics|analgesics|mesh-ancestor
153900693|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
153900694|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900695|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900696|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153900697|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900698|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153900699|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153900700|NCT03884075|Semaglutide|semaglutide|mesh-list
153900701|NCT03884075|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153900702|NCT03884075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153900703|NCT03884075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900704|NCT03863613|Progesterone|progesterone|mesh-list
153900705|NCT03863613|Progestins|progestins|mesh-ancestor
153900706|NCT03863613|Hormones|hormones|mesh-ancestor
153900707|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900708|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900709|NCT03860480|Bupivacaine|bupivacaine|mesh-list
153900710|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
153900723|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900724|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
153900725|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900726|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900727|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900728|NCT03743649|Lorazepam|lorazepam|mesh-list
153900729|NCT03743649|Haloperidol|haloperidol|mesh-list
153900730|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
153900731|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
153900732|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
153900733|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900734|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900735|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153900736|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153900737|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153442129|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153442130|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153442131|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153442132|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442145|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153442146|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
153442147|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
153442148|NCT00005773|Protective Agents|protective agents|mesh-ancestor
153442149|NCT00005779|Interleukin-12|interleukin-12|mesh-list
153442150|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153442151|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
153442152|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833573|NCT03459105|Bupivacaine|bupivacaine|mesh-list
153853532|NCT04120766|Nicorandil|nicorandil|mesh-list
153833574|NCT03459105|Anesthetics|anesthetics|mesh-list
153833575|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
153833576|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833577|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833578|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
153833579|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833580|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153833581|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153833582|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
153833583|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153833584|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
153833585|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833586|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
153442196|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153442197|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442198|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153442199|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153442200|NCT00005815|Growth Substances|growth substances|mesh-ancestor
153833620|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833621|NCT00516243|Protective Agents|protective agents|mesh-ancestor
153833622|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833623|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153833624|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153833625|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833626|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153833627|NCT01240889|Fluticasone|fluticasone|mesh-list
153833628|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833629|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153833630|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
153833631|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833632|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900814|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900815|NCT03401788|Belzutifan|belzutifan|mesh-list
153373730|NCT05084859|Prednisone|prednisone|mesh-list
153373731|NCT05084859|Docetaxel|docetaxel|mesh-list
153373732|NCT05084859|Panitumumab|panitumumab|mesh-list
153373733|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373734|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
153373735|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
153373736|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
153833671|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153833672|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153833673|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833674|NCT04696848|Durvalumab|durvalumab|mesh-list
153833675|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153833676|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833677|NCT01244256|Gentamicins|gentamicins|mesh-list
153900871|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153900872|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153900873|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
153900874|NCT03326947|Docetaxel|docetaxel|mesh-list
153900875|NCT03326947|Fluorouracil|fluorouracil|mesh-list
153442270|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442272|NCT02128932|Semaglutide|semaglutide|mesh-list
153442273|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153442274|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442275|NCT02128932|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153900880|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900882|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900883|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900884|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
153900885|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900886|NCT03313180|Nintedanib|nintedanib|mesh-list
153900887|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900888|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900889|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900890|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900891|NCT03275285|Dexamethasone|dexamethasone|mesh-list
153900892|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153900893|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
153900894|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
153900895|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900896|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900897|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153900898|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
153900899|NCT03275285|Hormones|hormones|mesh-ancestor
153900900|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900901|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900902|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900903|NCT03256344|Atezolizumab|atezolizumab|mesh-list
153900904|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153900905|NCT03256344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153442302|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442303|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
153442304|NCT02124798|Belimumab|belimumab|mesh-list
153442305|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153442306|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
153442309|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
153442321|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442323|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
153442324|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153442325|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153442326|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442327|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900906|NCT03256344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900907|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900908|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900909|NCT03150732|Nalbuphine|nalbuphine|mesh-list
153900910|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153900911|NCT03150732|Narcotics|narcotics|mesh-ancestor
153900912|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900913|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900914|NCT03150732|Analgesics|analgesics|mesh-ancestor
153900915|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
153900916|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373769|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373770|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153373771|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
153373772|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153373773|NCT01848041|Protective Agents|protective agents|mesh-ancestor
153373774|NCT02724033|Dexamethasone|dexamethasone|mesh-list
153373775|NCT02724033|Ondansetron|ondansetron|mesh-list
153373776|NCT02724033|Antiemetics|antiemetics|mesh-list
153373777|NCT02724033|Bupivacaine|bupivacaine|mesh-list
153373778|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442352|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
153442353|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442354|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
153442355|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153442369|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442370|NCT02099682|Lansoprazole|lansoprazole|mesh-list
153442371|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
153442372|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153442373|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153442374|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153900981|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900982|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900983|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900984|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900985|NCT03004183|Valacyclovir|valacyclovir|mesh-list
153900986|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
153900987|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900989|NCT03004183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153900990|NCT03004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900991|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
153900992|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900993|NCT03000439|Tofacitinib|tofacitinib|mesh-list
153442395|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442396|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
153442397|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442398|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153442399|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153442400|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442401|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153442402|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
153442403|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153442404|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442405|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153442406|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153442407|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153442408|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153442409|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153442410|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442411|NCT02122380|Incretins|incretins|mesh-ancestor
153442412|NCT02122380|Hormones|hormones|mesh-ancestor
153442413|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153442414|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153373784|NCT02724033|Hormones|hormones|mesh-ancestor
153592061|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153592062|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
153592063|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153442422|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153900994|NCT03000439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153900995|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900996|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900998|NCT02949128|Ravulizumab|ravulizumab|mesh-list
153901010|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153901011|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
153901012|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901013|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
153901014|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153901015|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901016|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901017|NCT02719574|Cytarabine|cytarabine|mesh-list
153442431|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
153442432|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442433|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153442434|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153442435|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442436|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442437|NCT02096952|Methylphenidate|methylphenidate|mesh-list
153442438|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153442439|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442440|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153442441|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153442442|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442443|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442444|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
153442445|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442446|NCT02120898|Imiquimod|imiquimod|mesh-list
153442447|NCT02120898|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153442448|NCT02120898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442449|NCT02120898|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153442450|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
153442451|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442452|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153442453|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853832|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373825|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373827|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153833756|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
153833757|NCT04510649|Rifampin|rifampin|mesh-list
153833758|NCT04510649|Rabeprazole|rabeprazole|mesh-list
153833759|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153833760|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153833761|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153833762|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833763|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833764|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153833765|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
153833766|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833767|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833768|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
153833769|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153901029|NCT02675452|Itraconazole|itraconazole|mesh-list
153901030|NCT02675452|Azacitidine|azacitidine|mesh-list
153901031|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153901032|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
153901033|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442470|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442471|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153442472|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153442473|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442474|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442475|NCT02119650|Pemetrexed|pemetrexed|mesh-list
153442476|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442477|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442478|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442479|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153442480|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153442481|NCT02119416|Caffeine|caffeine|mesh-list
153442482|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153442483|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442484|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153442485|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442486|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901060|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
153901061|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
153901062|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153901063|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153901064|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901065|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901066|NCT02284737|Urological Agents|urological agents|mesh-ancestor
153901067|NCT02226276|Copper|copper|mesh-list
153901068|NCT02226276|Trastuzumab|trastuzumab|mesh-list
153901069|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153901070|NCT02226276|Maytansine|maytansine|mesh-list
153901071|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153901072|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
153901073|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901074|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901082|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
153901083|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
153901084|NCT02226276|Immunotoxins|immunotoxins|mesh-ancestor
153901085|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
153901089|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901090|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153901092|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
153901093|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901094|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153901095|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153901096|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153901097|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
153901098|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901099|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901100|NCT01937117|Trastuzumab|trastuzumab|mesh-list
153901101|NCT01937117|Pertuzumab|pertuzumab|mesh-list
153901102|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901103|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901104|NCT01910402|Ritonavir|ritonavir|mesh-list
153901105|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153901106|NCT01910402|Tenofovir|tenofovir|mesh-list
153901107|NCT01910402|Lamivudine|lamivudine|mesh-list
153901108|NCT01910402|Emtricitabine|emtricitabine|mesh-list
153901109|NCT01910402|Dolutegravir|dolutegravir|mesh-list
153442511|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442512|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153373858|NCT01852175|Ticagrelor|ticagrelor|mesh-list
153373859|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153373860|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153442538|NCT02138916|Benralizumab|benralizumab|mesh-list
153442539|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153442540|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442541|NCT02118012|Ribavirin|ribavirin|mesh-list
153442542|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
153442543|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901110|NCT01910402|Abacavir|abacavir|mesh-list
153733437|NCT05148169|Serotonin Agents|serotonin agents|mesh-ancestor
153833804|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
153833805|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153833806|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833807|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833808|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
153833809|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833810|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833811|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833812|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442550|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
153442551|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153442552|NCT02092350|Grazoprevir|grazoprevir|mesh-list
153442553|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
153442554|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442555|NCT02138136|Lubiprostone|lubiprostone|mesh-list
153442556|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153442557|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442558|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442559|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
153442560|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
153442561|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
153442562|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
153442563|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442564|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153373881|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373882|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373883|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
153373884|NCT00558467|Pramipexole|pramipexole|mesh-list
153373885|NCT00558467|Dexpramipexole|dexpramipexole|mesh-list
153373886|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
153373887|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373888|NCT00558467|Protective Agents|protective agents|mesh-ancestor
153373889|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373890|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153373891|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153373892|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
153373893|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
153373894|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373895|NCT02401230|Tenofovir|tenofovir|mesh-list
153373896|NCT02401230|Emtricitabine|emtricitabine|mesh-list
153373897|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153901148|NCT01754402|Pomalidomide|pomalidomide|mesh-list
153394311|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394312|NCT01769365|Amoxicillin|amoxicillin|mesh-list
153394313|NCT01769365|Metronidazole|metronidazole|mesh-list
153394314|NCT01769365|Clarithromycin|clarithromycin|mesh-list
153394315|NCT01769365|Pantoprazole|pantoprazole|mesh-list
153394318|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153854084|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153901149|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901150|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
153901151|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
153373912|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153373913|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373914|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153373915|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153373916|NCT01854593|Growth Substances|growth substances|mesh-ancestor
153373917|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373918|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
153373919|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153901184|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733444|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
153901185|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153901186|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153901187|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153442591|NCT04731558|Enoxaparin|enoxaparin|mesh-list
153442592|NCT04731558|Dalteparin|dalteparin|mesh-list
153442593|NCT04731558|Tinzaparin|tinzaparin|mesh-list
153442594|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153442595|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
153442596|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153442597|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153442601|NCT02116530|Doxorubicin|doxorubicin|mesh-list
153442602|NCT02116530|Ondansetron|ondansetron|mesh-list
153442603|NCT02116530|Olanzapine|olanzapine|mesh-list
153442604|NCT02116530|Aprepitant|aprepitant|mesh-list
153442605|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
153833854|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442621|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153442622|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
153901202|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
153901203|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
153901204|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153901205|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
153901206|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901207|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153901208|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901209|NCT00887146|Vincristine|vincristine|mesh-list
153901210|NCT00887146|Temozolomide|temozolomide|mesh-list
153901211|NCT00887146|Procarbazine|procarbazine|mesh-list
153901212|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153901213|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901214|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
153901215|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
153901216|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
153901217|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901218|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153901219|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
153901220|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153901221|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901222|NCT03222076|Nivolumab|nivolumab|mesh-list
153901223|NCT03222076|Ipilimumab|ipilimumab|mesh-list
153901224|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901225|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901226|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153373943|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153373944|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153373945|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373946|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
153373947|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833872|NCT01246206|Tacrolimus|tacrolimus|mesh-list
153833873|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
153442658|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153442659|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442660|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
153442661|NCT04730856|Tinzaparin|tinzaparin|mesh-list
153442662|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153442663|NCT04730856|Dalteparin|dalteparin|mesh-list
153901232|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
153901233|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901234|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901235|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901236|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153442688|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
153442690|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
153442691|NCT02111850|Fludarabine|fludarabine|mesh-list
153442692|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153442693|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
153442694|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442695|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153442696|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153442697|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
153452463|NCT01846416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153733447|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
153733448|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733449|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153733450|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
153733451|NCT05146687|Bevacizumab|bevacizumab|mesh-list
153733452|NCT05146687|Ranibizumab|ranibizumab|mesh-list
153442698|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442699|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442700|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153442701|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153442702|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153442703|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
153442704|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442705|NCT02085252|Bicalutamide|bicalutamide|mesh-list
153442707|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
153442708|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
153442709|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153442710|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442711|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901290|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153901292|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
153901293|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
153901294|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442713|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
153442714|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153442715|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153442716|NCT02084238|Interleukin-2|interleukin-2|mesh-list
153442717|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442718|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153442719|NCT02084238|Analgesics|analgesics|mesh-ancestor
153442720|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
153373994|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153373995|NCT01421186|Growth Substances|growth substances|mesh-ancestor
153373996|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
153373997|NCT01860287|Buprenorphine|buprenorphine|mesh-list
153373998|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153373999|NCT01860287|Narcotics|narcotics|mesh-ancestor
153374000|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374001|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374002|NCT01860287|Analgesics|analgesics|mesh-ancestor
153374003|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
153374004|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374005|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153374006|NCT01421498|Lifitegrast|lifitegrast|mesh-list
153374007|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153374008|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153374009|NCT01422200|Vaccines|vaccines|mesh-list
153442724|NCT02084082|Linagliptin|linagliptin|mesh-list
153442725|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153833945|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833946|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833947|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833948|NCT02275988|Clarithromycin|clarithromycin|mesh-list
153833949|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833950|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833951|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153833952|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833953|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833954|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153833955|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153833956|NCT02950155|Rituximab|rituximab|mesh-list
153901329|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153901330|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
153901331|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901332|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
153901333|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901334|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153901335|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901336|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
153442775|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153442776|NCT02082912|Cycloserine|cycloserine|mesh-list
153442777|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153442778|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442779|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153442780|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
153442781|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153442792|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442793|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
153442794|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153442795|NCT02082210|Ramucirumab|ramucirumab|mesh-list
153442796|NCT02082210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153442797|NCT02082210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153442798|NCT02082210|Growth Substances|growth substances|mesh-ancestor
153442799|NCT02082210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442800|NCT02082210|Growth Inhibitors|growth inhibitors|mesh-ancestor
153442801|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442802|NCT02107014|Naltrexone|naltrexone|mesh-list
153442803|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153442804|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153442805|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442806|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
153442807|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442808|NCT01624974|Montelukast|montelukast|mesh-list
153442809|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153442810|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442811|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153442812|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
153442813|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901384|NCT02412670|Carboplatin|carboplatin|mesh-list
153901385|NCT02412670|Gemcitabine|gemcitabine|mesh-list
153901386|NCT02412670|Doxorubicin|doxorubicin|mesh-list
153733455|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153733456|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153411489|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901387|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153901388|NCT02412670|Methotrexate|methotrexate|mesh-list
153901389|NCT02412670|Vinblastine|vinblastine|mesh-list
153901390|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901392|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
153833994|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
153833995|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833996|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153833997|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153833998|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
153833999|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153834000|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
153834002|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
153834003|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834004|NCT00505427|Protective Agents|protective agents|mesh-ancestor
153901401|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901402|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
153901403|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153901404|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901405|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
153901406|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153442845|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153442846|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442847|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442848|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
153442849|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153442850|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
153901413|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
153901414|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
153901415|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901416|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901417|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153901418|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901420|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
153901421|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
153901422|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901423|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901424|NCT00992238|Urological Agents|urological agents|mesh-ancestor
153901425|NCT00858897|Insulin|insulin|mesh-list
153901426|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153901427|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153901428|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901430|NCT05940909|Perindopril|perindopril|mesh-list
153901431|NCT05940909|Indapamide|indapamide|mesh-list
153901432|NCT05940909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153901433|NCT05940909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153901434|NCT05940909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153901435|NCT05940909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901436|NCT05940909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153901437|NCT05940909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901438|NCT05940909|Vasodilator Agents|vasodilator agents|mesh-ancestor
153901439|NCT05940909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153901440|NCT05940909|Protease Inhibitors|protease inhibitors|mesh-ancestor
153901441|NCT05940909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592064|NCT01824420|Oxybutynin|oxybutynin|mesh-list
153592065|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153592066|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153592067|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
153374092|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153374093|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153374094|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
153374095|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374096|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374097|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374098|NCT05437029|Plant Lectins|plant lectins|mesh-list
153374099|NCT05437029|Agglutinins|agglutinins|mesh-ancestor
153901442|NCT05940909|Diuretics|diuretics|mesh-ancestor
153901443|NCT05940909|Natriuretic Agents|natriuretic agents|mesh-ancestor
153901444|NCT05940909|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153901445|NCT05940701|Listerine|listerine|mesh-list
153901446|NCT05940701|Sodium Fluoride|sodium fluoride|mesh-list
153901447|NCT05940701|Cariostatic Agents|cariostatic agents|mesh-ancestor
153901448|NCT05940701|Protective Agents|protective agents|mesh-ancestor
153901449|NCT05940701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901450|NCT05940701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153901451|NCT05940701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901452|NCT05940441|Capecitabine|capecitabine|mesh-list
153901458|NCT05940376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153901459|NCT05940376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901460|NCT05940233|Letrozole|letrozole|mesh-list
153901461|NCT05940233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901462|NCT05940233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153901463|NCT05940233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153901464|NCT05940233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901465|NCT05940233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901466|NCT05940233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153733457|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153411527|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
153901467|NCT05940233|Hormone Antagonists|hormone antagonists|mesh-ancestor
153901468|NCT05940233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901469|NCT05940233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901470|NCT05940064|Rituximab|rituximab|mesh-list
153901471|NCT05940064|Zanubrutinib|zanubrutinib|mesh-list
153901472|NCT05940064|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153901473|NCT05940064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901474|NCT05940064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901475|NCT05940064|Immunologic Factors|immunologic factors|mesh-ancestor
153901476|NCT05940064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901477|NCT05940064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901478|NCT05940064|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153901479|NCT05940064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153901480|NCT05940064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901640|NCT05933642|Diuretics|diuretics|mesh-ancestor
153443218|NCT02036502|Growth Substances|growth substances|mesh-ancestor
153443219|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
153443250|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901894|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901895|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901896|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153901897|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
153901898|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153394703|NCT04744571|Ticagrelor|ticagrelor|mesh-list
153901899|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901900|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901901|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153901902|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153901903|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
153901904|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
153443321|NCT01363440|Growth Substances|growth substances|mesh-ancestor
153443322|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443323|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
153443387|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
153443388|NCT02029638|Promethazine|promethazine|mesh-list
153902088|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153902089|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153443550|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153443551|NCT01967550|Analgesics|analgesics|mesh-ancestor
153443552|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
153443612|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153733540|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
153733597|NCT05141344|Protective Agents|protective agents|mesh-ancestor
153733677|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
153733739|NCT00148551|Triamcinolone|triamcinolone|mesh-list
153443687|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
153443714|NCT01984242|Sunitinib|sunitinib|mesh-list
153902316|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902317|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902321|NCT01622335|Analgesics|analgesics|mesh-ancestor
153733946|NCT00157482|Ezetimibe|ezetimibe|mesh-list
153734161|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153734322|NCT06245902|Acetaminophen|acetaminophen|mesh-list
153443843|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902477|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
153902478|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153734525|NCT06191094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153734526|NCT06191094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153734527|NCT06191094|Growth Substances|growth substances|mesh-ancestor
153734528|NCT06191094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734529|NCT06191094|Growth Inhibitors|growth inhibitors|mesh-ancestor
153734530|NCT06191094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153734531|NCT06188832|Psyllium|psyllium|mesh-list
153734532|NCT06188832|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
153734533|NCT06188832|Cathartics|cathartics|mesh-ancestor
153734534|NCT06188832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153734535|NCT06181591|Mirabegron|mirabegron|mesh-list
153734536|NCT06181591|Oxybutynin|oxybutynin|mesh-list
153734537|NCT06181591|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153734538|NCT06181591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153734539|NCT06181591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153734540|NCT06181591|Adrenergic Agents|adrenergic agents|mesh-ancestor
153734579|NCT06120075|Docetaxel|docetaxel|mesh-list
153443912|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
153734640|NCT06042920|Deucravacitinib|deucravacitinib|mesh-list
153734799|NCT05867251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153734800|NCT05867251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153734801|NCT05867251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153734802|NCT05867251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153734803|NCT05862688|Anti-Infective Agents|anti-infective agents|mesh-list
153734804|NCT05862688|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153735117|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
153735230|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
153735370|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
153444139|NCT00377975|Ephedrine|ephedrine|mesh-list
153735462|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153902747|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
153444240|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153444311|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
153902943|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444556|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
153444558|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153444559|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153735653|NCT04434170|Valsartan|valsartan|mesh-list
153903197|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153735665|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735667|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
153444718|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444720|NCT00379067|Urological Agents|urological agents|mesh-ancestor
153903393|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903418|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
153903419|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903472|NCT00910039|Sunitinib|sunitinib|mesh-list
153903490|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
153903579|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153903580|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903583|NCT01280591|Naproxen|naproxen|mesh-list
153445098|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903621|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153903801|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
153903802|NCT01260467|Memantine|memantine|mesh-list
153903803|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153903804|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153903805|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
153903806|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903807|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903808|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903809|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153903810|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153903811|NCT01260311|Fesoterodine|fesoterodine|mesh-list
153445282|NCT00281879|Hormones|hormones|mesh-ancestor
153445320|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445321|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445322|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153445323|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445325|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
153735803|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445395|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
153903928|NCT01258595|Vaccines|vaccines|mesh-list
153445441|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445442|NCT00000923|Lamivudine|lamivudine|mesh-list
153445476|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153735804|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
153445512|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445559|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
153445560|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445561|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153445562|NCT00000233|Buprenorphine|buprenorphine|mesh-list
153445563|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153445564|NCT00000233|Narcotics|narcotics|mesh-ancestor
153445609|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445629|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445660|NCT03055247|Ibuprofen|ibuprofen|mesh-list
153735807|NCT04128696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153445661|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153445662|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153445663|NCT03055247|Analgesics|analgesics|mesh-ancestor
153445664|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
153445671|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445673|NCT00001049|Didanosine|didanosine|mesh-list
153445674|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
153445675|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445676|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153445677|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445678|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904218|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153904281|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153904341|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
153904342|NCT00993616|Carboplatin|carboplatin|mesh-list
153904397|NCT02868580|Lamivudine|lamivudine|mesh-list
153445936|NCT00001865|Daclizumab|daclizumab|mesh-list
153854699|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153904451|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904471|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445994|NCT00001901|Analgesics|analgesics|mesh-ancestor
153904582|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153904734|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446223|NCT00001409|Analgesics|analgesics|mesh-ancestor
153446254|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153446275|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446286|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446287|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446288|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446289|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
153446290|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153904819|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153904833|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
153904834|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153904835|NCT01116687|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153446331|NCT00000731|Zidovudine|zidovudine|mesh-list
153446332|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153446333|NCT00000731|Analgesics|analgesics|mesh-ancestor
153446334|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
153446335|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446336|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904889|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153904910|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904933|NCT04290442|Ropivacaine|ropivacaine|mesh-list
153904978|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905012|NCT04319900|Chloroquine|chloroquine|mesh-list
153905040|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153446544|NCT00002345|Megestrol|megestrol|mesh-list
153446635|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153446636|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
153446637|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446638|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446639|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446668|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446670|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446702|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153446733|NCT00002399|Posaconazole|posaconazole|mesh-list
153446734|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
153446735|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446736|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153446737|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446738|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446739|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446740|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153446741|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
153446742|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153446743|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446744|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153905233|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153905260|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905261|NCT00625911|Ketamine|ketamine|mesh-list
153905283|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153905334|NCT05051007|Analgesics|analgesics|mesh-ancestor
153905335|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153905336|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153905376|NCT01109979|Diuretics|diuretics|mesh-ancestor
153905393|NCT01253408|Dronabinol|dronabinol|mesh-list
153905413|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905414|NCT02879721|Candesartan|candesartan|mesh-list
153905415|NCT02879721|Candesartan cilexetil|candesartan cilexetil|mesh-list
153905416|NCT02879721|Enalapril|enalapril|mesh-list
153905417|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153446934|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446935|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153446936|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153446937|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
153446938|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446939|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446940|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153446941|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153446943|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153905452|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153905453|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905503|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153905504|NCT01101165|Analgesics|analgesics|mesh-ancestor
153905505|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
153905516|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153905517|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447045|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
153905575|NCT01097421|Pramipexole|pramipexole|mesh-list
153905611|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
153905631|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153447220|NCT00002261|Vaccines|vaccines|mesh-list
153905711|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
153905721|NCT02877225|Ibrutinib|ibrutinib|mesh-list
153447246|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
153447247|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447248|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153905737|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447307|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153447326|NCT00002531|Vitamins|vitamins|mesh-ancestor
153447327|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
153447328|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
153447329|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
153447330|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
153447331|NCT00002531|Analgesics|analgesics|mesh-ancestor
153447333|NCT00002537|Topotecan|topotecan|mesh-list
153905818|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153905830|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447368|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910735|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153447369|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153905845|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153905846|NCT01198548|Fluorouracil|fluorouracil|mesh-list
153905847|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
153905894|NCT00977548|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153905895|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153905896|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905898|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905911|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153905912|NCT01090011|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153905913|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153905914|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153905915|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905917|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
153905928|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153905930|NCT01251653|Docetaxel|docetaxel|mesh-list
153905931|NCT01251653|Afatinib|afatinib|mesh-list
153905932|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153905966|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906068|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906098|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153906127|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906129|NCT01080807|Modafinil|modafinil|mesh-list
153906171|NCT00907777|Vaccines|vaccines|mesh-list
153906231|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153447827|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447833|NCT05749445|Ritonavir|ritonavir|mesh-list
153906282|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447843|NCT05749445|Antiviral Agents|antiviral agents|mesh-ancestor
153447844|NCT05749445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447878|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447881|NCT05522465|Dexamethasone|dexamethasone|mesh-list
153447903|NCT04824053|Caseins|caseins|mesh-list
153447904|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
153447905|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447906|NCT04824053|Protective Agents|protective agents|mesh-ancestor
153447907|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447908|NCT04824053|Trace Elements|trace elements|mesh-ancestor
153447909|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
153447923|NCT00382421|Aspirin|aspirin|mesh-list
153447965|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153447966|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153448004|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
153448017|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
153448018|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
153448019|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
153448020|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153448021|NCT04563533|Vaccines|vaccines|mesh-list
153448022|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
153448033|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448053|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448083|NCT00383045|Narcotics|narcotics|mesh-ancestor
153448099|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448100|NCT00002939|Paclitaxel|paclitaxel|mesh-list
153448101|NCT00002939|Irinotecan|irinotecan|mesh-list
153448128|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448129|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448130|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448131|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
153448132|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448133|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448134|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448135|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448136|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448137|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448138|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448139|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448140|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
153906561|NCT04413253|Lifitegrast|lifitegrast|mesh-list
153906562|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153906563|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906564|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
153906565|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
153448141|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
153448142|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448143|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153448144|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153448145|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448146|NCT00002951|Fluorouracil|fluorouracil|mesh-list
153448147|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
153448148|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
153448149|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448150|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448151|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906572|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153906625|NCT04304157|Analgesics|analgesics|mesh-ancestor
153906626|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
153906627|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906628|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153906629|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153906630|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153448214|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153448215|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153448216|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
153448217|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448218|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153448219|NCT00002993|Doxorubicin|doxorubicin|mesh-list
153448220|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153448221|NCT00002993|Mitomycins|mitomycins|mesh-list
153448222|NCT00002993|Mitomycin|mitomycin|mesh-list
153448223|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448224|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448225|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153906673|NCT02848963|Analgesics|analgesics|mesh-ancestor
153906674|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
153906675|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906676|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153906677|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153906678|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153906679|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906680|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906681|NCT01070043|Amlodipine|amlodipine|mesh-list
153906682|NCT01070043|Valsartan|valsartan|mesh-list
153906683|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153906684|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153906685|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153906686|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906687|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153906688|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906689|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
153906690|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153448305|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448306|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448307|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448308|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448309|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448320|NCT00003041|NSC 366140|nsc 366140|mesh-list
153906696|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448382|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448383|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
153448384|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448385|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448386|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448413|NCT01545557|Lidocaine|lidocaine|mesh-list
153448426|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153448427|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
153448428|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
153448429|NCT01545557|Protective Agents|protective agents|mesh-ancestor
153448430|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
153448431|NCT00003119|Carboplatin|carboplatin|mesh-list
153448432|NCT00003119|Doxorubicin|doxorubicin|mesh-list
153448433|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153448434|NCT00003119|Etoposide|etoposide|mesh-list
153448440|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448441|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
153448442|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448443|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448444|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448445|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448446|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448451|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448452|NCT00003401|Dexamethasone|dexamethasone|mesh-list
153448453|NCT00003401|Paclitaxel|paclitaxel|mesh-list
153448454|NCT00003401|Etoposide|etoposide|mesh-list
153448455|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
153448456|NCT00003401|Gemcitabine|gemcitabine|mesh-list
153448457|NCT00003401|Melphalan|melphalan|mesh-list
153448458|NCT00003401|Carmustine|carmustine|mesh-list
153448459|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448460|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448461|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
153906854|NCT00903175|Everolimus|everolimus|mesh-list
153906867|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
153906868|NCT01229735|Topiramate|topiramate|mesh-list
153906869|NCT01229735|Levetiracetam|levetiracetam|mesh-list
153906870|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
153906871|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906872|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448467|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448468|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448469|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448470|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
153448471|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153448472|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153448473|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
153448474|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
153448475|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418295|NCT03001843|Ketamine|ketamine|mesh-list
153840051|NCT05917275|Diuretics|diuretics|mesh-ancestor
153592068|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592069|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592070|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592087|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
153592088|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153906874|NCT03866200|Resveratrol|resveratrol|mesh-list
153906875|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
153906876|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906877|NCT03866200|Protective Agents|protective agents|mesh-ancestor
153906878|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906879|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906880|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153906881|NCT02848183|Cytarabine|cytarabine|mesh-list
153906882|NCT02848183|Etoposide|etoposide|mesh-list
153448476|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153448477|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
153448478|NCT00003401|Hormones|hormones|mesh-ancestor
153448479|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448480|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448481|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448482|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
153906890|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906891|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153906893|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
153906894|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153906895|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153906896|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
153906897|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906899|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
153906900|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906901|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153906902|NCT00974974|Levodopa|levodopa|mesh-list
153906903|NCT00974974|Carbidopa|carbidopa|mesh-list
153906904|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153906905|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153906906|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153906907|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
153906908|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153906909|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906916|NCT02848417|Curcumin|curcumin|mesh-list
153906917|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153906918|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153906919|NCT02848417|Analgesics|analgesics|mesh-ancestor
153906920|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
153906921|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906922|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906923|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153906924|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153906925|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906928|NCT02847403|Exenatide|exenatide|mesh-list
153906935|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153906936|NCT02848339|Aspirin|aspirin|mesh-list
153906937|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153906938|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153906939|NCT02848339|Analgesics|analgesics|mesh-ancestor
153906940|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
153906941|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735843|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153735844|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153906968|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153906969|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906970|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
153906971|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153906972|NCT01233869|Bosutinib|bosutinib|mesh-list
153906973|NCT01233869|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153906974|NCT01233869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153906975|NCT01233869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906976|NCT01233869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906977|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
153906978|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153906979|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153906980|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153810837|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906981|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448580|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153448581|NCT00003143|Protective Agents|protective agents|mesh-ancestor
153448582|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448583|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
153448589|NCT00003149|Interleukin-12|interleukin-12|mesh-list
153735845|NCT04111315|Analgesics|analgesics|mesh-ancestor
153418420|NCT02903407|Analgesics|analgesics|mesh-ancestor
153906982|NCT02846935|Decitabine|decitabine|mesh-list
153906983|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
153906984|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153906985|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
153906986|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153906987|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906988|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906989|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
153906990|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153906991|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
153906992|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153906993|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907002|NCT04201951|Coagulants|coagulants|mesh-ancestor
153907003|NCT04753723|Gentamicins|gentamicins|mesh-list
153907004|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153907005|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907006|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153907007|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907008|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907009|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
153448626|NCT00003437|Hormones|hormones|mesh-ancestor
153735846|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
153907018|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907019|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
153907020|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153907021|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
153907022|NCT02844517|Pancrelipase|pancrelipase|mesh-list
153907023|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907024|NCT03901729|Furosemide|furosemide|mesh-list
153907025|NCT03901729|Diuretics|diuretics|mesh-ancestor
153907026|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
153907027|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907028|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153907029|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153907030|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907031|NCT02846857|Insulin|insulin|mesh-list
153907032|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153907033|NCT02846857|Glucagon|glucagon|mesh-list
153907034|NCT02846857|Hormones|hormones|mesh-list
153418468|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
153907037|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153907038|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907039|NCT04672525|Rifampin|rifampin|mesh-list
153907040|NCT04672525|Rifabutin|rifabutin|mesh-list
153907041|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153907042|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
153907043|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153907044|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907045|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
153907046|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153907047|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907048|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418491|NCT03018925|Golimumab|golimumab|mesh-list
153907055|NCT00992446|Cytarabine|cytarabine|mesh-list
153907056|NCT00992446|Rituximab|rituximab|mesh-list
153907057|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153907058|NCT00992446|Etoposide|etoposide|mesh-list
153907059|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
153907060|NCT00992446|Bortezomib|bortezomib|mesh-list
153907061|NCT00992446|Melphalan|melphalan|mesh-list
153907062|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
153907063|NCT00992446|Vorinostat|vorinostat|mesh-list
153907064|NCT00992446|Carmustine|carmustine|mesh-list
153907065|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
153907066|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153907067|NCT00992446|Antibodies|antibodies|mesh-list
153907068|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
153907069|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153907070|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
153395453|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
153907071|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907072|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907073|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907074|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153907075|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448678|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448679|NCT00002801|Antidotes|antidotes|mesh-ancestor
153448680|NCT00002801|Protective Agents|protective agents|mesh-ancestor
153448681|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
153448682|NCT00002801|Vitamins|vitamins|mesh-ancestor
153448683|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
153448684|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448685|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
153448686|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907076|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153907077|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907078|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907079|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153907080|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
153907081|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
153907082|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907083|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907084|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153907085|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
153907086|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153907087|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153907088|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
153907089|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
153907090|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
153907091|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
153907092|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
153907093|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153907094|NCT04452565|Dexamethasone|dexamethasone|mesh-list
153448698|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
153448699|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448722|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448723|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448724|NCT00002831|Cyclosporine|cyclosporine|mesh-list
153448725|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
153448726|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153448727|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153448728|NCT00002831|Prednisolone|prednisolone|mesh-list
153448729|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
153735847|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418529|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
153907127|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153907128|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153907129|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907130|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907131|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907132|NCT02846701|Analgesics|analgesics|mesh-ancestor
153907133|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
153907134|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907135|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
153907136|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153907147|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153907148|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
153907149|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153907150|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907151|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153907152|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153907153|NCT05242783|Terlipressin|terlipressin|mesh-list
153907154|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153907155|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153907157|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153907158|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448769|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448770|NCT00002837|Paclitaxel|paclitaxel|mesh-list
153735848|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907159|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907160|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907161|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907162|NCT00900757|Palonosetron|palonosetron|mesh-list
153907163|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
153907164|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
153907165|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907166|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907167|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907168|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153448780|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448781|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
153448782|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448783|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153448791|NCT00003461|Antibodies|antibodies|mesh-list
153907169|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153907171|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907172|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907173|NCT04136743|Dexamethasone|dexamethasone|mesh-list
153907174|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907175|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
153907176|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
153907177|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907178|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907182|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153907183|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153907184|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907186|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153907187|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153907188|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153907189|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907190|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153907191|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153840726|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153840727|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153840728|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840729|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153840730|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
153735849|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153735850|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907195|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
153907196|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
153907197|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
153907198|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907199|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907200|NCT02846155|Simethicone|simethicone|mesh-list
153907201|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
153907202|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907203|NCT02846155|Emollients|emollients|mesh-ancestor
153907204|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
153907205|NCT02845843|Interferons|interferons|mesh-list
153907207|NCT02845843|Lopinavir|lopinavir|mesh-list
153907208|NCT02845843|Interferon-beta|interferon-beta|mesh-list
153907209|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
153907210|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592089|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153907212|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153907213|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153907214|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153448828|NCT00002855|Nilutamide|nilutamide|mesh-list
153448853|NCT00003173|Thiotepa|thiotepa|mesh-list
153907246|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380938|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153380939|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153380940|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153380941|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153380942|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153380943|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153380944|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153380945|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153380946|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
153907247|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907248|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153448861|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448862|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153448863|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
153448864|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153380947|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153380949|NCT04350281|Interferon-beta|interferon-beta|mesh-list
153448865|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153448866|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153907250|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
153907251|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907252|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153907253|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153907254|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153907255|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
153907256|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907257|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907258|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153907259|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153907266|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
153907267|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
153907268|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153907269|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907270|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907272|NCT01723579|Estrogens|estrogens|mesh-ancestor
153907273|NCT01723579|Hormones|hormones|mesh-ancestor
153907274|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153907275|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907276|NCT00901927|Rituximab|rituximab|mesh-list
153907277|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153907278|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
153907279|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907280|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907281|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
153907282|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448895|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
153907283|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907284|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153907285|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
153907286|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907287|NCT00901927|Analgesics|analgesics|mesh-ancestor
153840880|NCT04526288|Cytarabine|cytarabine|mesh-list
153907288|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
153907289|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907290|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153907291|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153907292|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907293|NCT05335837|Anesthetics|anesthetics|mesh-list
153907294|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153448921|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448922|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153448923|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
153448924|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448925|NCT00384527|Vancomycin|vancomycin|mesh-list
153448926|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
153448927|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153448928|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153448929|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153448956|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448957|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153448958|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153448959|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448960|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395704|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153448961|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
153448962|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153448963|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153448964|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
153448965|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153448966|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
153907329|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907330|NCT03691090|Paclitaxel|paclitaxel|mesh-list
153907332|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153907333|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907334|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
153907335|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
153907336|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
153907337|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907338|NCT00783211|Fexofenadine|fexofenadine|mesh-list
153907339|NCT00783211|Desloratadine|desloratadine|mesh-list
153907340|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153907341|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
153907342|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907343|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907344|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448974|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153448975|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153448976|NCT00003959|Sargramostim|sargramostim|mesh-list
153448977|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
153448978|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448980|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153448981|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448982|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
153448983|NCT00003203|Cisplatin|cisplatin|mesh-list
153448996|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
153448997|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
153448998|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
153448999|NCT00003575|Etoposide|etoposide|mesh-list
153449000|NCT00003575|Ifosfamide|ifosfamide|mesh-list
153449001|NCT00003575|Interleukin-12|interleukin-12|mesh-list
153449002|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449003|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449004|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449005|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449026|NCT00003209|Fluorouracil|fluorouracil|mesh-list
153449027|NCT00003209|Methotrexate|methotrexate|mesh-list
153449028|NCT00003209|Ifosfamide|ifosfamide|mesh-list
153449029|NCT00003209|Mitomycins|mitomycins|mesh-list
153907390|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153907391|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
153907392|NCT05334043|Curcumin|curcumin|mesh-list
153907393|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153907394|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153907395|NCT05334043|Analgesics|analgesics|mesh-ancestor
153907396|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
153449046|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153449047|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449048|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153449049|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153449050|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
153907411|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
153907412|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907413|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449070|NCT00003215|Cytarabine|cytarabine|mesh-list
153449071|NCT00003215|Prednisone|prednisone|mesh-list
153449072|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
153449073|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
153449074|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153907430|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153907431|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907432|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153907433|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907434|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
153907435|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153907436|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153907437|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153907438|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
153907439|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907440|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
153907441|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907450|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
153907451|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907452|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907453|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153907454|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907455|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153907456|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153907457|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449119|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
153907504|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153907505|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907506|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907507|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
153907509|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153907510|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
153907511|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153907531|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907532|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153907533|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381454|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153381455|NCT05238467|Antibodies|antibodies|mesh-list
153907534|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907535|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
153449197|NCT00003617|Omeprazole|omeprazole|mesh-list
153449198|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153449199|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153449200|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153449201|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449202|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449203|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153907554|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
153907555|NCT01228175|Vitamins|vitamins|mesh-ancestor
153907556|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
153907557|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153907558|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
153907560|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153449218|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449219|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449220|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449221|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449222|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449223|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153449224|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
153449225|NCT00004001|Hormones|hormones|mesh-ancestor
153449226|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153449227|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449229|NCT00004001|Analgesics|analgesics|mesh-ancestor
153449245|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449246|NCT00004025|Aldesleukin|aldesleukin|mesh-list
153449247|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449248|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153449249|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153449250|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
153449251|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449252|NCT00004037|Docetaxel|docetaxel|mesh-list
153449253|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449254|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449255|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449256|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449257|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449258|NCT00004043|Calcitriol|calcitriol|mesh-list
153449259|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153907603|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153907606|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
153907630|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153449260|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449261|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153449262|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153449263|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449264|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153449265|NCT00004043|Vitamins|vitamins|mesh-ancestor
153449266|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
153449267|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153449268|NCT00004055|Paclitaxel|paclitaxel|mesh-list
153449269|NCT00004055|Topotecan|topotecan|mesh-list
153449270|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153907631|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907632|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153907633|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
153907634|NCT00895843|Ibuprofen|ibuprofen|mesh-list
153907635|NCT00895843|Epinephrine|epinephrine|mesh-list
153907636|NCT00895843|Bupivacaine|bupivacaine|mesh-list
153907637|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
153907638|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
153907639|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153907640|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907641|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
153907642|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153449271|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592090|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153592091|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592092|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153449272|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449273|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449274|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449275|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449276|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153449277|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449278|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449279|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
153449281|NCT00004061|Etoposide|etoposide|mesh-list
153449297|NCT00004067|Doxorubicin|doxorubicin|mesh-list
153449298|NCT00004067|Trastuzumab|trastuzumab|mesh-list
153449299|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153449300|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449301|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449302|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
153449303|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
153449304|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
153449305|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449306|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449307|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
153449322|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449323|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449324|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153449325|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153449326|NCT00004085|Antibodies|antibodies|mesh-list
153449327|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153449328|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
153449329|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449330|NCT00004091|Antibodies|antibodies|mesh-list
153449331|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
153449332|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449333|NCT00004097|Paclitaxel|paclitaxel|mesh-list
153449334|NCT00004097|Gemcitabine|gemcitabine|mesh-list
153449335|NCT00004097|Fluorouracil|fluorouracil|mesh-list
153449352|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907705|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153907706|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907707|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907708|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153907709|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153907710|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153907711|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
153449373|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
153449374|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449375|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153907722|NCT02840929|Esomeprazole|esomeprazole|mesh-list
153907723|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153907724|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153907725|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153907726|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153907727|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907728|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
153907729|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153907730|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907731|NCT00892957|Thrombin|thrombin|mesh-list
153907732|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153907733|NCT00892957|Aprotinin|aprotinin|mesh-list
153907734|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
153907735|NCT00892957|Coagulants|coagulants|mesh-ancestor
153907736|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153907737|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153449381|NCT00004115|Antibodies|antibodies|mesh-list
153907746|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907747|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907748|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153907749|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
153907750|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907751|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153907752|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153907753|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153907754|NCT00968812|Metformin|metformin|mesh-list
153907755|NCT00968812|Glimepiride|glimepiride|mesh-list
153907756|NCT00968812|Canagliflozin|canagliflozin|mesh-list
153907757|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153907758|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907759|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153907760|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449391|NCT00004127|Leucovorin|leucovorin|mesh-list
153449392|NCT00004127|Fluorouracil|fluorouracil|mesh-list
153449393|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
153907761|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
153907762|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153907763|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907764|NCT02834845|Sevoflurane|sevoflurane|mesh-list
153907767|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153907768|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
153907769|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
153907770|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153907771|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907778|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907779|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907780|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153907781|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153907782|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153907783|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
153907784|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153907785|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907786|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
153907787|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153907788|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153907789|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153907790|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153907791|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153907792|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449431|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449432|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449433|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
153449434|NCT00004145|Fludarabine|fludarabine|mesh-list
153449435|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
153449436|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153449437|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449438|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
153449439|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449451|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
153449496|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449498|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449499|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153735859|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153907849|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153907850|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449509|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
153449510|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449511|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
153449512|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449513|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449514|NCT00384137|Tacrolimus|tacrolimus|mesh-list
153449515|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449516|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
153449524|NCT00003293|Procarbazine|procarbazine|mesh-list
153449525|NCT00003293|Leflunomide|leflunomide|mesh-list
153449526|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449527|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449528|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449529|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
153449530|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449531|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449532|NCT00004199|Gemcitabine|gemcitabine|mesh-list
153449533|NCT00004199|Prinomastat|prinomastat|mesh-list
153419262|NCT05001724|Docetaxel|docetaxel|mesh-list
153449558|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449559|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153449560|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
153449561|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153449562|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449563|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153449564|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153449565|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153449566|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153449568|NCT00003305|Calcium|calcium|mesh-list
153449569|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
153907907|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907908|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153907909|NCT00970684|Bevacizumab|bevacizumab|mesh-list
153907910|NCT00970684|Gemcitabine|gemcitabine|mesh-list
153907911|NCT00970684|Docetaxel|docetaxel|mesh-list
153907912|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449580|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449581|NCT00003311|Cytarabine|cytarabine|mesh-list
153449582|NCT00003311|Dexamethasone|dexamethasone|mesh-list
153855875|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
153449583|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
153449584|NCT00003311|Doxorubicin|doxorubicin|mesh-list
153449585|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153449586|NCT00003311|Methotrexate|methotrexate|mesh-list
153449587|NCT00003311|Vincristine|vincristine|mesh-list
153449588|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449589|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
153449605|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153449606|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153449607|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449608|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153449609|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449610|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153449611|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
153449612|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153449639|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
153449640|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449641|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449642|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
153449643|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449645|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449646|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153907981|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907982|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
153907983|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153907984|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153907985|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153907986|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153907987|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153907988|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153907992|NCT04285528|Analgesics|analgesics|mesh-ancestor
153449665|NCT00004229|Growth Substances|growth substances|mesh-ancestor
153449666|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908004|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908006|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908007|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
153908008|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908009|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
153908010|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908012|NCT00961636|Niacinamide|niacinamide|mesh-list
153908013|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
153908014|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153908015|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
153908016|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908017|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153908018|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
153908019|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
153908020|NCT00961636|Vitamins|vitamins|mesh-ancestor
153908021|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
153449688|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449689|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
153449690|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449691|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
153449692|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449693|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153908025|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153908026|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
153908027|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908028|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908029|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908030|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153908031|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
153908032|NCT00964678|Protective Agents|protective agents|mesh-ancestor
153908033|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153908034|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153908042|NCT00964366|Dapsone|dapsone|mesh-list
153449719|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153449720|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908049|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
153908050|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
153908051|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153908052|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153908053|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153908054|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
153908055|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153908056|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153908057|NCT02860936|Lenvatinib|lenvatinib|mesh-list
153908058|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908059|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153908060|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908062|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
153449734|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153449735|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153449736|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449737|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449738|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449739|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
153449740|NCT00003365|Protective Agents|protective agents|mesh-ancestor
153449741|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153449761|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449762|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
153449763|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449764|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449765|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
153449766|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449767|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449768|NCT00004361|Citric Acid|citric acid|mesh-list
153449769|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
153449770|NCT00004361|Calcium|calcium|mesh-list
153908098|NCT04284202|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153908099|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153908100|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908101|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908102|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908103|NCT01227629|Warfarin|warfarin|mesh-list
153908104|NCT01227629|Dabigatran|dabigatran|mesh-list
153449786|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
153449787|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153449788|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449789|NCT00004871|Azacitidine|azacitidine|mesh-list
153449790|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153449791|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449792|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
153449793|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449794|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449795|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449813|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153449814|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153449815|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449816|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
153449817|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153449818|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153449819|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
153449846|NCT00385307|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153449847|NCT00004901|Fluorouracil|fluorouracil|mesh-list
153449848|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
153449849|NCT00004901|Eniluracil|eniluracil|mesh-list
153449850|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
153449851|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449852|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449853|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449877|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153449878|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
153449879|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153449880|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449881|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
153810838|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810839|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810840|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
153449882|NCT00004913|Antidotes|antidotes|mesh-ancestor
153908206|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153908207|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153908208|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153908209|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
153908210|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908211|NCT02861482|Oxytocin|oxytocin|mesh-list
153908212|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
153908213|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
153449909|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
153449910|NCT00004931|Calcium|calcium|mesh-list
153449911|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
153908232|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908233|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908234|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153908235|NCT02861716|Narcotics|narcotics|mesh-ancestor
153908236|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153908237|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153908238|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
153908239|NCT00960934|Vitamin D|vitamin d|mesh-list
153908240|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
153908241|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
153908242|NCT00960934|Calcium|calcium|mesh-list
153908243|NCT00960934|Vitamins|vitamins|mesh-ancestor
153908244|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
153449939|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153449940|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
153449941|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153449942|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153449943|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153449944|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153449945|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
153449946|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908295|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
153908296|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908297|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153908298|NCT00958438|Rilonacept|rilonacept|mesh-list
153908299|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153908300|NCT02835469|Menotropins|menotropins|mesh-list
153908301|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153908302|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
153908303|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153908304|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908305|NCT02832973|Ramipril|ramipril|mesh-list
153908306|NCT02832973|Bisoprolol|bisoprolol|mesh-list
153908307|NCT02832973|Amiloride|amiloride|mesh-list
153908308|NCT02832973|Furosemide|furosemide|mesh-list
153908309|NCT02832973|Spironolactone|spironolactone|mesh-list
153908310|NCT02832973|Diuretics|diuretics|mesh-list
153908311|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153908312|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
153908313|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908314|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153908315|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153449974|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153908317|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153735860|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908319|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153908320|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153908321|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908322|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908323|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153908325|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
153908326|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908327|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153908347|NCT02860234|Capecitabine|capecitabine|mesh-list
153908348|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
153908349|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153908350|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
153908351|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908352|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908353|NCT00630370|ATI 7505|ati 7505|mesh-list
153908354|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153908355|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153908379|NCT02831179|Capecitabine|capecitabine|mesh-list
153908380|NCT02831179|Temozolomide|temozolomide|mesh-list
153908381|NCT02831179|Veliparib|veliparib|mesh-list
153908382|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153908383|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
153908421|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153908422|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908423|NCT01243424|Glimepiride|glimepiride|mesh-list
153908424|NCT01243424|Linagliptin|linagliptin|mesh-list
153908425|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153908426|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153908427|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908428|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153908429|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
153908430|NCT01243424|Incretins|incretins|mesh-ancestor
153450101|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
153908431|NCT01243424|Hormones|hormones|mesh-ancestor
153908433|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153908459|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908460|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
153908461|NCT04244695|Hormones|hormones|mesh-ancestor
153908462|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153908463|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153908464|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908465|NCT00887809|Bevacizumab|bevacizumab|mesh-list
153908466|NCT00887809|Gemcitabine|gemcitabine|mesh-list
153908467|NCT00887809|Docetaxel|docetaxel|mesh-list
153908468|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153908469|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908470|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153908471|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153908472|NCT00887809|Growth Substances|growth substances|mesh-ancestor
153908473|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908474|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
153908475|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153908476|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
153908477|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908478|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
153908479|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
153908480|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
153908481|NCT02827747|Vitamin A|vitamin a|mesh-list
153908482|NCT02827747|Antioxidants|antioxidants|mesh-list
153396438|NCT04485065|Azacitidine|azacitidine|mesh-list
153592093|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
153592094|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592095|NCT01824524|Hydromorphone|hydromorphone|mesh-list
153382898|NCT01717742|Plasminogen|plasminogen|mesh-list
153842755|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842756|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
153908483|NCT02827747|Vitamins|vitamins|mesh-ancestor
153450141|NCT00005081|Carmustine|carmustine|mesh-list
153450142|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153450143|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450144|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
153450145|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450146|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450147|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450148|NCT00005087|Paclitaxel|paclitaxel|mesh-list
153450149|NCT00005087|Cisplatin|cisplatin|mesh-list
153450150|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153450151|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450152|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450153|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450154|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450155|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450157|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
153450158|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450159|NCT00005093|Gemcitabine|gemcitabine|mesh-list
153450160|NCT00005093|Tacedinaline|tacedinaline|mesh-list
153450161|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153450162|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
153450163|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450164|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450165|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153450166|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450167|NCT00004811|Itraconazole|itraconazole|mesh-list
153450168|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
153592096|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153592097|NCT01824524|Narcotics|narcotics|mesh-ancestor
153592098|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592103|NCT01824615|Sunitinib|sunitinib|mesh-list
153592104|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592105|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153908485|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908486|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908487|NCT02827747|Protective Agents|protective agents|mesh-ancestor
153908488|NCT04281628|Ketamine|ketamine|mesh-list
153908489|NCT04281628|Analgesics|analgesics|mesh-ancestor
153908490|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
153908491|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908492|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908493|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153908494|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153908495|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
153908496|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
153908497|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908498|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153908499|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153908500|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908501|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908502|NCT00886795|Abatacept|abatacept|mesh-list
153908503|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153908504|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908505|NCT00886795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153908506|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908507|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153908508|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
153908509|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450169|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450170|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153592106|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153592107|NCT01824615|Growth Substances|growth substances|mesh-ancestor
153592108|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450171|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153450172|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450173|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450174|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153450175|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
153450176|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450177|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450178|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153450180|NCT00004817|Valproic Acid|valproic acid|mesh-list
153450181|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
153450182|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450183|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450184|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
153450185|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450186|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450187|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
153450188|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153450189|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153450190|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153450191|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153450192|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153450193|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450194|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153450195|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153592109|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
153592110|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153592111|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592112|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592113|NCT01824758|Lidocaine|lidocaine|mesh-list
153818342|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
153818343|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818344|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459727|NCT06121466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459728|NCT06121466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459729|NCT06119893|Dexamethasone|dexamethasone|mesh-list
153459730|NCT06119893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153459731|NCT06119893|Antiemetics|antiemetics|mesh-ancestor
153459732|NCT06119893|Autonomic Agents|autonomic agents|mesh-ancestor
153459733|NCT06119893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459734|NCT06119893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592117|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
153592118|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592119|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810842|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357430|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153357431|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153592120|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
153592121|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592122|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153450196|NCT00005117|Pravastatin|pravastatin|mesh-list
153450197|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153450198|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153450199|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
153450200|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450201|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153450202|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153450203|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908510|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153908511|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
153908512|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
153908513|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153908514|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153908515|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
153908516|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908517|NCT00953680|Losartan|losartan|mesh-list
153908518|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153908519|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153908520|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153908521|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153908522|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153908523|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908524|NCT00953680|Diuretics|diuretics|mesh-ancestor
153908525|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
153908526|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908527|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153908528|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153908529|NCT00890929|Lenalidomide|lenalidomide|mesh-list
153908530|NCT00890929|Azacitidine|azacitidine|mesh-list
153908531|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
153908532|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908533|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153908534|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153908535|NCT00890929|Growth Substances|growth substances|mesh-ancestor
153908536|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
153908537|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908538|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153908539|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
153908540|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908541|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908542|NCT04246567|Fentanyl|fentanyl|mesh-list
153908543|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153908544|NCT04246567|Narcotics|narcotics|mesh-ancestor
153908545|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153450205|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153450206|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
153450207|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153450208|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450209|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
153450210|NCT00385463|Montelukast|montelukast|mesh-list
153450211|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153450212|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153450213|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
153450214|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153450215|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
153450216|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450217|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450218|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153450219|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153450220|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450221|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153450223|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450225|NCT00385463|Hormones|hormones|mesh-ancestor
153450226|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
153450227|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
153450228|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153450229|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
153592123|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153592124|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153592125|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592126|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735866|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
153908546|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908548|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
153908549|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908550|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153908551|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153908552|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
153908553|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
153908554|NCT02830243|Sevoflurane|sevoflurane|mesh-list
153908555|NCT02830243|Desflurane|desflurane|mesh-list
153908556|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153908557|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153908558|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
153908559|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
153908560|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908561|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908562|NCT00889603|Donepezil|donepezil|mesh-list
153908563|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153908564|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908565|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908566|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
153908567|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592127|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153592128|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153592129|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153592130|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153592131|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153592132|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153592133|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153592134|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592135|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
153818345|NCT04967417|Paclitaxel|paclitaxel|mesh-list
153818347|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
153818348|NCT04967417|Pemetrexed|pemetrexed|mesh-list
153818349|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153818350|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383034|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
153383035|NCT02029703|Protective Agents|protective agents|mesh-ancestor
153383036|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383037|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153383038|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153383039|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383040|NCT02406443|Incretins|incretins|mesh-ancestor
153908568|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908569|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
153908570|NCT02829385|Apatinib|apatinib|mesh-list
153908571|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450230|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450231|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
153450232|NCT00423371|Protective Agents|protective agents|mesh-ancestor
153450234|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450235|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450236|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450237|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450238|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450239|NCT00005585|Leucovorin|leucovorin|mesh-list
153450240|NCT00005585|Cytarabine|cytarabine|mesh-list
153450241|NCT00005585|Dexamethasone|dexamethasone|mesh-list
153450242|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
153450243|NCT00005585|Methotrexate|methotrexate|mesh-list
153450244|NCT00005585|Vincristine|vincristine|mesh-list
153450245|NCT00005585|Daunorubicin|daunorubicin|mesh-list
153450246|NCT00005585|Asparaginase|asparaginase|mesh-list
153450247|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
153450248|NCT00005585|Pegaspargase|pegaspargase|mesh-list
153450249|NCT00005585|Thioguanine|thioguanine|mesh-list
153450250|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
153450251|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153450252|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
153450253|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450254|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450255|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450256|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
153450257|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450258|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450260|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153450261|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
153450262|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
153450263|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450264|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908572|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153908573|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908574|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908575|NCT02826343|Xenon|xenon|mesh-list
153908576|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153908577|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153908578|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
153908579|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
153908580|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908581|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908582|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153908583|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
153908584|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908585|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153908586|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
153908587|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
153908588|NCT02826343|Hormones|hormones|mesh-ancestor
153908589|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153908590|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
153908591|NCT04246255|Lidocaine|lidocaine|mesh-list
153908592|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
153908593|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
153908594|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842925|NCT02933645|Insulin|insulin|mesh-list
153818351|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818352|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
153818353|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
153818354|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592136|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153383064|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383065|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153383066|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153383067|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383068|NCT02342327|Menthol|menthol|mesh-list
153383069|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
153383070|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
153383071|NCT01721564|Bosentan|bosentan|mesh-list
153383072|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383073|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153908595|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908596|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
153908597|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908598|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153908599|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153908600|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153908601|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450265|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
153450266|NCT00005585|Hormones|hormones|mesh-ancestor
153450267|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450299|NCT01926444|Trimebutine|trimebutine|mesh-list
153908602|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908603|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153908604|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
153908605|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
153908606|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153419787|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153908607|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
153908608|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153908609|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908610|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908611|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908612|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
153908613|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
153908614|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153908615|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
153908616|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908617|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
153908618|NCT02826031|Protective Agents|protective agents|mesh-ancestor
153908619|NCT02829697|Ropivacaine|ropivacaine|mesh-list
153908620|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
153908621|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
153908622|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908623|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908624|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
153908625|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908626|NCT02829151|Aspirin|aspirin|mesh-list
153908627|NCT02829151|Cilostazol|cilostazol|mesh-list
153908628|NCT02829151|Clopidogrel|clopidogrel|mesh-list
153908629|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153908630|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153908631|NCT02829151|Analgesics|analgesics|mesh-ancestor
153908632|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
153842974|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842975|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153842976|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842977|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
153842978|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842979|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842980|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153450302|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
153450303|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450304|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450305|NCT00005597|Temozolomide|temozolomide|mesh-list
153450306|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450307|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
153450308|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450309|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450310|NCT00005603|Cytarabine|cytarabine|mesh-list
153450311|NCT00005603|Dexamethasone|dexamethasone|mesh-list
153450312|NCT00005603|Prednisone|prednisone|mesh-list
153450313|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
153450314|NCT00005603|Doxorubicin|doxorubicin|mesh-list
153450315|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153450316|NCT00005603|Methotrexate|methotrexate|mesh-list
153450317|NCT00005603|Vincristine|vincristine|mesh-list
153908644|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153908645|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153908646|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153908647|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
153908648|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908649|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153908650|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
153908651|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153908652|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
153908653|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
153908654|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153908655|NCT02829151|Protective Agents|protective agents|mesh-ancestor
153908656|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153908657|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153908658|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
153908659|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
153908660|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153908661|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153908662|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908663|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
153908664|NCT02825719|Coagulants|coagulants|mesh-ancestor
153908665|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153908666|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
153908667|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153450335|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153450336|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
153450337|NCT00005603|Hormones|hormones|mesh-ancestor
153450340|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153450358|NCT00005609|Rituximab|rituximab|mesh-list
153450359|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153908668|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908669|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153908670|NCT04241653|Sevoflurane|sevoflurane|mesh-list
153908671|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153908672|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153908673|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
153908674|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
153908675|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908676|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908677|NCT04241731|Cetuximab|cetuximab|mesh-list
153908678|NCT04241731|Raltitrexed|raltitrexed|mesh-list
153908679|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153908680|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908681|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153908682|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
153908683|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908684|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153908685|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908686|NCT04241887|Anesthetics|anesthetics|mesh-list
153908687|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908688|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908689|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153908690|NCT02825797|Antibodies|antibodies|mesh-list
153908691|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
153908692|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153908693|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
153908694|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908695|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908696|NCT02824315|Simeprevir|simeprevir|mesh-list
153908697|NCT02824315|Odalasvir|odalasvir|mesh-list
153908698|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
153908699|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908706|NCT02823925|Pamidronate|pamidronate|mesh-list
153383168|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908707|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153908708|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908709|NCT04201249|Piroxicam|piroxicam|mesh-list
153908710|NCT04201249|Lidocaine|lidocaine|mesh-list
153908711|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
153908712|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
153908713|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908714|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908715|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
153908716|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908717|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153450386|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450387|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450388|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450389|NCT00005663|Valacyclovir|valacyclovir|mesh-list
153450390|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
153450391|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450392|NCT00385853|Temozolomide|temozolomide|mesh-list
153450393|NCT00385853|Vatalanib|vatalanib|mesh-list
153450394|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450395|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
153450396|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450397|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450398|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153450399|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450400|NCT00005765|Nicotine|nicotine|mesh-list
153450401|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153450402|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
153450403|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450404|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450405|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153450406|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153450407|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
153450408|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450409|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450413|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
153908718|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153908719|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153908720|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153908721|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908722|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153908723|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153908724|NCT04201249|Analgesics|analgesics|mesh-ancestor
153908725|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153908726|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153908727|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153908728|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908729|NCT00633685|Fluoxetine|fluoxetine|mesh-list
153908730|NCT00633685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153908731|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153908732|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450414|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450417|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
153908733|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908734|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908735|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
153908736|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908737|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153908738|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
153908739|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153908740|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153908741|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153908742|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908744|NCT02823691|Lanreotide|lanreotide|mesh-list
153908745|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153908746|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856663|NCT02914886|Insulin|insulin|mesh-list
153856664|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153908747|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153908748|NCT02825095|Lidocaine|lidocaine|mesh-list
153908749|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
153908750|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
153592137|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153908751|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908752|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908753|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
153908754|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908755|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153908756|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153908757|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153908758|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450430|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450431|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153450432|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153450433|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153450436|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153450437|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450438|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
153450439|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450440|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153450441|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450442|NCT00005807|Epothilones|epothilones|mesh-list
153450443|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450444|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450445|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450446|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450447|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450448|NCT00005813|Antibodies|antibodies|mesh-list
153450449|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153450450|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
153450451|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450452|NCT00003647|Dacarbazine|dacarbazine|mesh-list
153450453|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450454|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
153843121|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908759|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908760|NCT04195009|Anesthetics|anesthetics|mesh-list
153908761|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908762|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908764|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
153908765|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
153908766|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908767|NCT02821897|Anesthetics|anesthetics|mesh-list
153908768|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908769|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908770|NCT02820493|Vedolizumab|vedolizumab|mesh-list
153908771|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153908773|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153908774|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
153908775|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908776|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153908777|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908778|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908779|NCT00633763|Fallypride|fallypride|mesh-list
153908780|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153908781|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153908782|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
153908783|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843122|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
153592138|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153592139|NCT01824992|Interferons|interferons|mesh-list
153592140|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592141|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
153592142|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592143|NCT01825031|Azithromycin|azithromycin|mesh-list
153592145|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
153592146|NCT01825031|Fluconazole|fluconazole|mesh-list
153592147|NCT01825031|Albendazole|albendazole|mesh-list
153592148|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153908784|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908785|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908786|NCT02820025|Doxapram|doxapram|mesh-list
153450460|NCT05895526|Protective Agents|protective agents|mesh-ancestor
153450461|NCT05895526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450462|NCT05895448|Sofosbuvir|sofosbuvir|mesh-list
153450463|NCT05895448|Velpatasvir|velpatasvir|mesh-list
153450464|NCT05895448|Antiviral Agents|antiviral agents|mesh-ancestor
153450465|NCT05895448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450466|NCT05895370|Interleukin-2|interleukin-2|mesh-list
153450467|NCT05895370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450468|NCT05895370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153450469|NCT05895370|Analgesics|analgesics|mesh-ancestor
153450470|NCT05895370|Sensory System Agents|sensory system agents|mesh-ancestor
153450471|NCT05895370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450472|NCT05895370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450473|NCT05895305|Paclitaxel|paclitaxel|mesh-list
153450474|NCT05895305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153450475|NCT05895305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450476|NCT05895305|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450477|NCT05895305|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450478|NCT05895305|Mitosis Modulators|mitosis modulators|mesh-ancestor
153383259|NCT01748240|Azacitidine|azacitidine|mesh-list
153592149|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592150|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153592151|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153592152|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
153592153|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153592154|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153592155|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592156|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592157|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
153908787|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153908788|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908789|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
153908790|NCT02819869|Metformin|metformin|mesh-list
153908791|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153908792|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908793|NCT02820883|Vaccines|vaccines|mesh-list
153908794|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
153908795|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908796|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
153908797|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153908798|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908799|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908800|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153908801|NCT02819089|Analgesics|analgesics|mesh-ancestor
153908802|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
153908803|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450479|NCT05895305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450480|NCT05895240|Urinastatin|urinastatin|mesh-list
153450481|NCT05895240|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153592158|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153592159|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153592160|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153592161|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
153592162|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592163|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592164|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153592165|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153592166|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
153818355|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818356|NCT04967417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818357|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818358|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153818359|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153459742|NCT06118619|Interferon-gamma|interferon-gamma|mesh-list
153383313|NCT05718011|Ketamine|ketamine|mesh-list
153383314|NCT05718011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153383315|NCT05718011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383316|NCT05718011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383317|NCT05718011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383318|NCT05718011|Analgesics|analgesics|mesh-ancestor
153383319|NCT05718011|Sensory System Agents|sensory system agents|mesh-ancestor
153383320|NCT05718011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383321|NCT05718011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153843189|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153843190|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450482|NCT05895240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153450483|NCT05895240|Protease Inhibitors|protease inhibitors|mesh-ancestor
153843217|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
153908807|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
153908808|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908809|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908810|NCT04238923|Vancomycin|vancomycin|mesh-list
153908811|NCT04238923|Gentamicins|gentamicins|mesh-list
153908812|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153908813|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908814|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153908815|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908816|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908817|NCT02815657|Valsartan|valsartan|mesh-list
153908818|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153908819|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153908820|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153908821|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908822|NCT04597333|Dinoprostone|dinoprostone|mesh-list
153908823|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
153908824|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153908825|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908826|NCT00957580|Niacinamide|niacinamide|mesh-list
153450503|NCT05894889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450504|NCT05894889|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450505|NCT05894889|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450506|NCT05894889|Mitosis Modulators|mitosis modulators|mesh-ancestor
153843219|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843220|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153843221|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
153843222|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
153843223|NCT02933814|Bupivacaine|bupivacaine|mesh-list
153843224|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
153843225|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
153843226|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843227|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450527|NCT05894447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450528|NCT05894447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153450529|NCT05894447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450530|NCT05894447|Immunoconjugates|immunoconjugates|mesh-ancestor
153450531|NCT05894447|Immunologic Factors|immunologic factors|mesh-ancestor
153450532|NCT05894447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450534|NCT05894200|Cariostatic Agents|cariostatic agents|mesh-ancestor
153450535|NCT05894200|Protective Agents|protective agents|mesh-ancestor
153450536|NCT05894200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908827|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
153856808|NCT02057172|Exenatide|exenatide|mesh-list
153908828|NCT00957580|Vitamins|vitamins|mesh-ancestor
153908829|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
153908830|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908831|NCT00957424|Nicotine|nicotine|mesh-list
153908832|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153908833|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
153908849|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153908850|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153908851|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153908852|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
153908853|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908854|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908855|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
153908856|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153908857|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153908858|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908859|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153450537|NCT05893654|Melphalan|melphalan|mesh-list
153450538|NCT05893654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450539|NCT05893654|Alkylating Agents|alkylating agents|mesh-ancestor
153450540|NCT05893654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450541|NCT05893654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450542|NCT05893654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153450543|NCT05893654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153450544|NCT05893654|Immunologic Factors|immunologic factors|mesh-ancestor
153450545|NCT05893654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450546|NCT05893511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153450547|NCT05893511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450548|NCT05893472|Venetoclax|venetoclax|mesh-list
153450549|NCT05893472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450550|NCT05892913|Atropine|atropine|mesh-list
153450551|NCT05892913|Ephedrine|ephedrine|mesh-list
153450552|NCT05892913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153450553|NCT05892913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153450554|NCT05892913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153450555|NCT05892913|Autonomic Agents|autonomic agents|mesh-ancestor
153450556|NCT05892913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450557|NCT05892913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383351|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153459743|NCT06118619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459744|NCT06118619|Antiviral Agents|antiviral agents|mesh-ancestor
153459745|NCT06118619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459752|NCT06067438|Amiodarone|amiodarone|mesh-list
153459753|NCT06067438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153459754|NCT06067438|Vasodilator Agents|vasodilator agents|mesh-ancestor
153459755|NCT06067438|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153459756|NCT06067438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450558|NCT05892913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153450559|NCT05892913|Respiratory System Agents|respiratory system agents|mesh-ancestor
153450561|NCT05892913|Parasympatholytics|parasympatholytics|mesh-ancestor
153450562|NCT05892913|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153450563|NCT05892913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153450564|NCT05892913|Cholinergic Agents|cholinergic agents|mesh-ancestor
153450565|NCT05892913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450566|NCT05892913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908870|NCT01061151|Lopinavir|lopinavir|mesh-list
153908871|NCT01061151|Tenofovir|tenofovir|mesh-list
153908872|NCT01061151|Lamivudine|lamivudine|mesh-list
153908873|NCT01061151|Emtricitabine|emtricitabine|mesh-list
153450567|NCT05892913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153908874|NCT01061151|Zidovudine|zidovudine|mesh-list
153908875|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153908876|NCT01061151|Nevirapine|nevirapine|mesh-list
153908877|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153908878|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153908879|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153908880|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
153908881|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153908882|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908883|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153908884|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153908885|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
153908886|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153908887|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153450585|NCT05885230|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153450586|NCT05885230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153450587|NCT05885230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450588|NCT05885230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450590|NCT05861258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153450591|NCT05861258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450592|NCT05784571|Insulin|insulin|mesh-list
153450593|NCT05784571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153450594|NCT05784571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450606|NCT05727098|Bupivacaine|bupivacaine|mesh-list
153450607|NCT05727098|Anesthetics, Local|anesthetics, local|mesh-list
153450608|NCT05727098|Anesthetics|anesthetics|mesh-list
153450609|NCT05727098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153450610|NCT05727098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450611|NCT05727098|Sensory System Agents|sensory system agents|mesh-ancestor
153450612|NCT05727098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908903|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908904|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908905|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153908906|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
153908907|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908908|NCT04748523|Mirtazapine|mirtazapine|mesh-list
153908909|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
153908910|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153908911|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153908912|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
153908913|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
153908914|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450613|NCT05727098|Analgesics|analgesics|mesh-ancestor
153908915|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908916|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153908917|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153908918|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153908919|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592167|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153592168|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153908920|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153908921|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153908922|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153908923|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
153908924|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153908925|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153908926|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
153908927|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153908929|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153908930|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153908931|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153908932|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908933|NCT00948922|Fludarabine|fludarabine|mesh-list
153908934|NCT00948922|Bortezomib|bortezomib|mesh-list
153908935|NCT00948922|Melphalan|melphalan|mesh-list
153450631|NCT05590468|Niacin|niacin|mesh-list
153843340|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
153843341|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843342|NCT02922491|Protective Agents|protective agents|mesh-ancestor
153843343|NCT02922179|Insulin|insulin|mesh-list
153843344|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
153843345|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153843346|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843347|NCT02921984|Docetaxel|docetaxel|mesh-list
153908944|NCT00634309|Candesartan|candesartan|mesh-list
153908945|NCT00634309|Candesartan cilexetil|candesartan cilexetil|mesh-list
153908946|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153908947|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153856966|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153908948|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153908949|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908950|NCT01239992|Niacin|niacin|mesh-list
153908951|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153908952|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
153908953|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908954|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153908955|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
153908956|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
153908957|NCT01239992|Vitamins|vitamins|mesh-ancestor
153908958|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
153450664|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153383465|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383466|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383467|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153383468|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153383469|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153383470|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383471|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383472|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153383473|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
153383474|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
153383478|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
153450665|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153450666|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450667|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450668|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153450669|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450670|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450671|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
153450672|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450673|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153450674|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153450675|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153843363|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
153843364|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
153843365|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843366|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153843367|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153843368|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
153843369|NCT03981341|Estrogens|estrogens|mesh-list
153843370|NCT03981341|Hormones|hormones|mesh-ancestor
153843371|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843372|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843373|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153908981|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153908982|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
153908983|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450712|NCT05319873|Antibodies|antibodies|mesh-list
153450713|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
153450714|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153450715|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
153450716|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450717|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450718|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450719|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450720|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450721|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450722|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153450723|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153909011|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909013|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909014|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153909015|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909016|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909017|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
153909018|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
153909019|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
153856992|NCT02911961|Acetaminophen|acetaminophen|mesh-list
153450724|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153909020|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
153909048|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153909049|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153909050|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153450733|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450736|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153450737|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
153450738|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450739|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450740|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450752|NCT05164653|Valsartan|valsartan|mesh-list
153450753|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
153450754|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153450755|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153450756|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153450757|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153450758|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153450759|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450760|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153450761|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
153450762|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450763|NCT05160896|Bevacizumab|bevacizumab|mesh-list
153450765|NCT05160896|Irinotecan|irinotecan|mesh-list
153450766|NCT05160896|Raltitrexed|raltitrexed|mesh-list
153450767|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153450768|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450769|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153909067|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
153909068|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
153909069|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909070|NCT00627003|Cabergoline|cabergoline|mesh-list
153909071|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153909072|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153909073|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
153909074|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
153909075|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909076|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909077|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909078|NCT04238221|Doxofylline|doxofylline|mesh-list
153909079|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
153909080|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
153909081|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153909082|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
153909083|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909084|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909085|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153909086|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153909087|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909088|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909089|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153909090|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153909091|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153909092|NCT01238120|Ibuprofen|ibuprofen|mesh-list
153450773|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
153450774|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153450777|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450778|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153450782|NCT05129670|Antacids|antacids|mesh-ancestor
153450791|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450792|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450793|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450794|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153450795|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
153450796|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450797|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450798|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450799|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
153909093|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153909094|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153909095|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909096|NCT01238120|Analgesics|analgesics|mesh-ancestor
153909097|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
153909098|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909099|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909100|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909101|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153909102|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383576|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592169|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
153592170|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153592171|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
153592172|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153592173|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
153592174|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153592175|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153592176|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
153592177|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
153592178|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
153592179|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592180|NCT01825044|Cyclosporine|cyclosporine|mesh-list
153592181|NCT01825044|Cyclosporins|cyclosporins|mesh-list
153592182|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909103|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909104|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153909105|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
153909106|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153909107|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909108|NCT04237987|Cyclosporine|cyclosporine|mesh-list
153909109|NCT04237987|Aldesleukin|aldesleukin|mesh-list
153909110|NCT04237987|Interleukin-2|interleukin-2|mesh-list
153909111|NCT04237987|Cyclosporins|cyclosporins|mesh-list
153909112|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909113|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909114|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153909115|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
153909116|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909117|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
153909118|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909119|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
153450800|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153450801|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153450802|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153450803|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153450804|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450805|NCT05107375|Vaccines|vaccines|mesh-list
153450806|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
153450807|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450808|NCT05031520|Metoprolol|metoprolol|mesh-list
153450809|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
153450810|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153450811|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153450812|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
153450813|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
153450814|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450827|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450828|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450829|NCT04988035|Remdesivir|remdesivir|mesh-list
153909120|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909121|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153909122|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909123|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909124|NCT04237987|Analgesics|analgesics|mesh-ancestor
153909125|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
153909126|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909127|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153909128|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153909129|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
153909130|NCT01045707|Insulin|insulin|mesh-list
153909131|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153909132|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
153909133|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
153909134|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909135|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909136|NCT02874807|Empagliflozin|empagliflozin|mesh-list
153909137|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153909138|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909139|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909140|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909141|NCT01054599|Memantine|memantine|mesh-list
153909142|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153909143|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153909144|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
153909145|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909146|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383631|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153592183|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909147|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909148|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153909149|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153450830|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
153450831|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450832|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
153450833|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450834|NCT04939792|Vitamin D|vitamin d|mesh-list
153450835|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
153450836|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
153450837|NCT04939792|Vitamins|vitamins|mesh-list
153450838|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
153450840|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153450841|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153450842|NCT04763135|Mirtazapine|mirtazapine|mesh-list
153450843|NCT04763135|Escitalopram|escitalopram|mesh-list
153450844|NCT04763135|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153450845|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153450846|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153450847|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450848|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450849|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
153450850|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909154|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
153909155|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
153909156|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909157|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
153909158|NCT04275661|Ketamine|ketamine|mesh-list
153909159|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
153909160|NCT04275661|Analgesics|analgesics|mesh-ancestor
153909161|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
153909162|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909163|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909164|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153909165|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153909166|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
153909167|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
153909168|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909169|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153909170|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153909171|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909172|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909173|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153909174|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
153909175|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153909176|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909177|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153450859|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153450860|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153450861|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153450862|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
153450864|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153450873|NCT04723134|Protective Agents|protective agents|mesh-ancestor
153450874|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
153450875|NCT04723134|Vitamins|vitamins|mesh-ancestor
153450876|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
153450877|NCT04723134|Hematinics|hematinics|mesh-ancestor
153450878|NCT04666272|Trametinib|trametinib|mesh-list
153450879|NCT04666272|Dabrafenib|dabrafenib|mesh-list
153450880|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909178|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
153909179|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153909180|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
153909181|NCT00948766|Rivastigmine|rivastigmine|mesh-list
153909182|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153909183|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909184|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909185|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
153909186|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909187|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909188|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153909189|NCT00948766|Protective Agents|protective agents|mesh-ancestor
153909190|NCT01053663|Oseltamivir|oseltamivir|mesh-list
153909191|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
153909192|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909193|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909194|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909195|NCT01235546|Azithromycin|azithromycin|mesh-list
153909196|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153909217|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
153909218|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
153909219|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153909220|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
153909221|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909222|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909224|NCT00948688|Vorinostat|vorinostat|mesh-list
153909225|NCT00948688|Fluorouracil|fluorouracil|mesh-list
153909226|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909227|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153909229|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909230|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
153450914|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450915|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153450916|NCT04608487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153592184|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153592185|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
153592186|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592187|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
153592188|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459763|NCT06067438|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153459764|NCT06067438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153592189|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
153592190|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153592191|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153592193|NCT01825083|Analgesics|analgesics|mesh-ancestor
153592194|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
153592195|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592196|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592197|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153592198|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153592199|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
153592200|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
153592201|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909232|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153909233|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
153909234|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909236|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
153909237|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153909238|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153909239|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909240|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909241|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909242|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
153909243|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
153909244|NCT01049217|Pregabalin|pregabalin|mesh-list
153909245|NCT01049217|Analgesics|analgesics|mesh-ancestor
153909246|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
153909247|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909248|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909249|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
153909250|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153450957|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
153450958|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450959|NCT04484259|Aspirin|aspirin|mesh-list
153450960|NCT04484259|Clopidogrel|clopidogrel|mesh-list
153450961|NCT04484259|Ticagrelor|ticagrelor|mesh-list
153450962|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153450963|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153450964|NCT04484259|Analgesics|analgesics|mesh-ancestor
153450965|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
153450966|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450967|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450968|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153450969|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909253|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153909254|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153909255|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153909256|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909257|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153909258|NCT01232738|Rasagiline|rasagiline|mesh-list
153909259|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153909260|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909261|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909262|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153909263|NCT01232738|Protective Agents|protective agents|mesh-ancestor
153909264|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909265|NCT00957268|Alogliptin|alogliptin|mesh-list
153909272|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
153909273|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909274|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909275|NCT02888444|Varenicline|varenicline|mesh-list
153909276|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153909277|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153909278|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
153909279|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909280|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450970|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153450971|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153450972|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450973|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153450974|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153450975|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450976|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
153450977|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153450978|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153450979|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153450980|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
153450981|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450982|NCT04463693|Etonogestrel|etonogestrel|mesh-list
153450983|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153450984|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
153450985|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153450986|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450987|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153450988|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
153450989|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153450990|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450991|NCT04348916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153450992|NCT04348916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450993|NCT04299113|Vinorelbine|vinorelbine|mesh-list
153450999|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
153451000|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451001|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153451002|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909281|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909283|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153909284|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909285|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
153909286|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909287|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909303|NCT02888054|Lesinurad|lesinurad|mesh-list
153843738|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153843739|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383842|NCT01312922|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153383843|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153383844|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153451016|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451017|NCT04231539|Nicotine|nicotine|mesh-list
153451018|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153451019|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
153451020|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451021|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451022|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153451023|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153451024|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
153451025|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451026|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451027|NCT04200248|Aflibercept|aflibercept|mesh-list
153843740|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843741|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153843742|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
153843743|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153843744|NCT02920190|Liraglutide|liraglutide|mesh-list
153843745|NCT02920190|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153843746|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909339|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909340|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153909341|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153909342|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153909343|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
153909344|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909345|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909346|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
153451037|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
153451038|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153451039|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451040|NCT04095273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153451041|NCT04095273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397766|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451043|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153451044|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
153451045|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
153451046|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153451047|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153451048|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
153451049|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451067|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451068|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153451069|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
153451070|NCT03872791|Paclitaxel|paclitaxel|mesh-list
153451071|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153451072|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451073|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
153909347|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909348|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909349|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153909350|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909351|NCT02810275|Leucovorin|leucovorin|mesh-list
153909352|NCT02810275|Folic Acid|folic acid|mesh-list
153909353|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
153909355|NCT02810275|Protective Agents|protective agents|mesh-ancestor
153909356|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909357|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
153909358|NCT02810275|Vitamins|vitamins|mesh-ancestor
153909359|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
153909360|NCT02810275|Hematinics|hematinics|mesh-ancestor
153909361|NCT00948064|Azacitidine|azacitidine|mesh-list
153909362|NCT00948064|Vorinostat|vorinostat|mesh-list
153909363|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153909364|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
153909365|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909366|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909367|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909379|NCT02858206|Paclitaxel|paclitaxel|mesh-list
153451082|NCT03864042|Modafinil|modafinil|mesh-list
153451083|NCT03864042|Bupropion|bupropion|mesh-list
153451084|NCT03864042|Omeprazole|omeprazole|mesh-list
153451085|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153451086|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153451087|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153451088|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451089|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451090|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153451091|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153451092|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153451093|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153451094|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
153451095|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
153451096|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
153451097|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
153451098|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909386|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153592202|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153592203|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153592204|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592205|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592206|NCT01825109|Vaccines|vaccines|mesh-list
153592207|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
153781711|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
153592208|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592210|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153592211|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592212|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818360|NCT04963725|Ustekinumab|ustekinumab|mesh-list
153818361|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
153818362|NCT04939662|Bevacizumab|bevacizumab|mesh-list
153810845|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
153357432|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357433|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818363|NCT04939662|Olaparib|olaparib|mesh-list
153818364|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153909387|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909388|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153909389|NCT02815189|Acetaminophen|acetaminophen|mesh-list
153909390|NCT02815189|Ibuprofen|ibuprofen|mesh-list
153909391|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909392|NCT02815189|Analgesics|analgesics|mesh-ancestor
153909393|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
153909394|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909395|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909396|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
153909397|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153909398|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909399|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909400|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153909401|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909402|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909403|NCT02809963|Eplerenone|eplerenone|mesh-list
153909404|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153735883|NCT04071756|Tazarotene|tazarotene|mesh-list
153735884|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
153909405|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
153914668|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451099|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451100|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153451101|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153451102|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
153451103|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153451104|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153451105|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451106|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153451107|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153843837|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153843838|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
153843839|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451117|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153451118|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153451119|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
153451120|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153909406|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153909407|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909408|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153909410|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
153909411|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153909412|NCT02815111|Acetaminophen|acetaminophen|mesh-list
153909413|NCT02815111|Lidocaine|lidocaine|mesh-list
153909414|NCT02815111|Ketamine|ketamine|mesh-list
153909415|NCT02815111|Gabapentin|gabapentin|mesh-list
153909416|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
153909417|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
153909418|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909419|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909420|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
153909421|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909422|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153909423|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153909424|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153909448|NCT04303377|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153909449|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153909450|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153909451|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
153909452|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397882|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909453|NCT04303377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153909454|NCT04303377|Protease Inhibitors|protease inhibitors|mesh-ancestor
153909455|NCT04303377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909456|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153451148|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153451149|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
153451150|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451151|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451152|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451153|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
153451154|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451155|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451156|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153451157|NCT03597594|Fludarabine|fludarabine|mesh-list
153451158|NCT03597594|Busulfan|busulfan|mesh-list
153451159|NCT03597594|Thiotepa|thiotepa|mesh-list
153451160|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
153451161|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153451162|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451163|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451164|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153451165|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
153451166|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451167|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
153909459|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909460|NCT02809573|Prednisone|prednisone|mesh-list
153909461|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
153909462|NCT02809573|Vincristine|vincristine|mesh-list
153909463|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153909464|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
153909465|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909466|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909467|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153909468|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
153909469|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909470|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909471|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153909472|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909473|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
153909475|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153909476|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153909477|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153909478|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
153909479|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
153909480|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
153909481|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
153909482|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153909483|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
153909484|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909485|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909486|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153383970|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153383971|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383972|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383973|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383974|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
153383976|NCT00357149|Cisplatin|cisplatin|mesh-list
153818365|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818366|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153818367|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153818368|NCT04939662|Growth Substances|growth substances|mesh-ancestor
153909487|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
153909488|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153909489|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
153909490|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909491|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909492|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153397986|NCT01910311|Rifampin|rifampin|mesh-list
153909493|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
153909494|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
153909495|NCT04388683|Protective Agents|protective agents|mesh-ancestor
153451188|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153451189|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153451190|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153451191|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451192|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451193|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
153451194|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153451195|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153451196|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451197|NCT03347617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153451198|NCT03347617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451199|NCT03347617|Hematinics|hematinics|mesh-ancestor
153451200|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153451201|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153451202|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
153451203|NCT03328273|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153451204|NCT03328273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153451205|NCT03328273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451206|NCT03328273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451207|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451208|NCT03136029|Antioxidants|antioxidants|mesh-list
153451209|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451210|NCT03136029|Protective Agents|protective agents|mesh-ancestor
153451217|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
153909497|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
153909498|NCT01040403|Olodaterol|olodaterol|mesh-list
153909499|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153909500|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
153909501|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909502|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909503|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153909504|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
153909505|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
153909506|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153909507|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
153909508|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909509|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909510|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
153909511|NCT00957034|Testosterone|testosterone|mesh-list
153909512|NCT00957034|Androgens|androgens|mesh-ancestor
153909513|NCT00957034|Hormones|hormones|mesh-ancestor
153909514|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153909515|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909516|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
153909517|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
153909518|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153909519|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909520|NCT02812693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153909521|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909522|NCT02812693|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153735885|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
153909523|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153451218|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451219|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451220|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153451222|NCT02333370|Letrozole|letrozole|mesh-list
153451223|NCT02333370|Fulvestrant|fulvestrant|mesh-list
153451224|NCT02333370|Goserelin|goserelin|mesh-list
153451225|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451226|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153451227|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153451228|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451229|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451230|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153451231|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
153451232|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451233|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909528|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909529|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
153909530|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153909531|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909532|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909533|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909534|NCT02689999|Rabeprazole|rabeprazole|mesh-list
153909535|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153909536|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153909537|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153909538|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909539|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909540|NCT02809105|Linaclotide|linaclotide|mesh-list
153909541|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153909542|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
153909543|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909544|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153909545|NCT00953056|Vaccines|vaccines|mesh-list
153384065|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
153909547|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909549|NCT02811289|Glycerol|glycerol|mesh-list
153909550|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153909551|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153909552|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153909553|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
153909554|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909555|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909556|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909557|NCT02811289|Urological Agents|urological agents|mesh-ancestor
153909558|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153909559|NCT02811289|Protective Agents|protective agents|mesh-ancestor
153909560|NCT02808949|Dapivirine|dapivirine|mesh-list
153909561|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153909562|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153909563|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
153909564|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909565|NCT02812147|Droxidopa|droxidopa|mesh-list
153909566|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153909567|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153909568|NCT04303065|Dexamethasone|dexamethasone|mesh-list
153451234|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153909569|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909570|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
153909571|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
153909572|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909573|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909574|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153909580|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153909581|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909582|NCT00952822|Factor VIII|factor viii|mesh-list
153909583|NCT00952822|Coagulants|coagulants|mesh-ancestor
153451276|NCT00003653|Leuprolide|leuprolide|mesh-list
153451277|NCT00003653|Goserelin|goserelin|mesh-list
153451278|NCT00003653|Flutamide|flutamide|mesh-list
153451279|NCT00003653|Bicalutamide|bicalutamide|mesh-list
153451280|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
153451281|NCT00003653|Nilutamide|nilutamide|mesh-list
153451282|NCT00003653|Buserelin|buserelin|mesh-list
153451283|NCT00003653|Cyproterone|cyproterone|mesh-list
153451284|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153451285|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
153451286|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153451287|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451288|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153451289|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451290|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
153451291|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
153451292|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451293|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153451294|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
153451295|NCT00003671|Leucovorin|leucovorin|mesh-list
153451296|NCT00003671|Cytarabine|cytarabine|mesh-list
153451297|NCT00003671|Dexamethasone|dexamethasone|mesh-list
153451298|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
153451299|NCT00003671|Methotrexate|methotrexate|mesh-list
153818371|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153818372|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592213|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153592214|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592215|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592216|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153592217|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592218|NCT01825447|Naltrexone|naltrexone|mesh-list
153592219|NCT01825447|Oxycodone|oxycodone|mesh-list
153909585|NCT02854072|Capecitabine|capecitabine|mesh-list
153909586|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153909587|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
153909588|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909589|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909590|NCT02537314|Benzocaine|benzocaine|mesh-list
153909591|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
153909592|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
153909593|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909594|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909595|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
153909596|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909597|NCT00631150|Levetiracetam|levetiracetam|mesh-list
153909598|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
153909599|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
153735886|NCT04067609|Dexamethasone|dexamethasone|mesh-list
153735887|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909601|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153909602|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
153909603|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909604|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909605|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153451301|NCT00003671|Daunorubicin|daunorubicin|mesh-list
153451302|NCT00003671|Asparaginase|asparaginase|mesh-list
153451303|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
153451304|NCT00003671|Thioguanine|thioguanine|mesh-list
153451305|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
153451313|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451314|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153451315|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451316|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
153451317|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
153451318|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451319|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451320|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
153451321|NCT00003671|Hormones|hormones|mesh-ancestor
153451322|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451323|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153451324|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153451325|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
153451326|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153451327|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451328|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
153909638|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909639|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153451336|NCT00003671|Protective Agents|protective agents|mesh-ancestor
153451337|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
153451339|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
153451340|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153451341|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
153451342|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451343|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
153451344|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153451345|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153451346|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153451347|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
153451348|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451349|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
153451350|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451351|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
153451352|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451353|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
153451354|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153451355|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153451356|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451357|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451358|NCT00384605|Hormones|hormones|mesh-ancestor
153451359|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451360|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451361|NCT00003683|Doxorubicin|doxorubicin|mesh-list
153451362|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153451363|NCT00003683|Ifosfamide|ifosfamide|mesh-list
153451364|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153451365|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909640|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909641|NCT02808091|Bortezomib|bortezomib|mesh-list
153909644|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909645|NCT02811991|Analgesics|analgesics|mesh-ancestor
153909646|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
153909647|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909648|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909649|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
153909650|NCT04237675|Anesthetics|anesthetics|mesh-list
153909651|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909652|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909653|NCT05598853|Nivolumab|nivolumab|mesh-list
153909654|NCT05598853|Ipilimumab|ipilimumab|mesh-list
153909655|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153909656|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909657|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153909658|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909659|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153909660|NCT01229150|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153909661|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153909662|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909663|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909664|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909665|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153909666|NCT02814409|Plasminogen|plasminogen|mesh-list
153909667|NCT02814409|Tenecteplase|tenecteplase|mesh-list
153909668|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153909669|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153909670|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909671|NCT01227902|Ezogabine|ezogabine|mesh-list
153909672|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
153909673|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844096|NCT05459792|Lidocaine|lidocaine|mesh-list
153451382|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451383|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451384|NCT00003725|Valrubicin|valrubicin|mesh-list
153451385|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451386|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153451387|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153451388|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451389|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451390|NCT00003731|Temozolomide|temozolomide|mesh-list
153451391|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451392|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
153451393|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451394|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451395|NCT00003743|Aldesleukin|aldesleukin|mesh-list
153451396|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451397|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153451398|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153451399|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
153451400|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451401|NCT00384917|Ketoconazole|ketoconazole|mesh-list
153451402|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
153451403|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451404|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153451405|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153451406|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451407|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909682|NCT00946192|Estrogens|estrogens|mesh-ancestor
153909683|NCT00946192|Hormones|hormones|mesh-ancestor
153909684|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592220|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153592221|NCT01825447|Narcotics|narcotics|mesh-ancestor
153592222|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592223|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592224|NCT01825447|Analgesics|analgesics|mesh-ancestor
153592225|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
153592226|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909685|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909686|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153909687|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
153909688|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153909689|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153909690|NCT00946192|Progestins|progestins|mesh-ancestor
153909691|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153909692|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153909693|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153909694|NCT01037127|Trametinib|trametinib|mesh-list
153909695|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909696|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153909697|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909698|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909699|NCT02806999|Insulin|insulin|mesh-list
153909700|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153909701|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909702|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909703|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
153909704|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
153909705|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153909706|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153909707|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909708|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909709|NCT00946114|Urological Agents|urological agents|mesh-ancestor
153909711|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153909712|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
153909713|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153909714|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451408|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153451409|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
153844135|NCT05281185|Factor VIII|factor viii|mesh-list
153451419|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451420|NCT00003797|Gemcitabine|gemcitabine|mesh-list
153451421|NCT00003797|Trastuzumab|trastuzumab|mesh-list
153451422|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451423|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
153451424|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451425|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451426|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153451428|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451429|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451430|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
153844136|NCT05281185|Coagulants|coagulants|mesh-ancestor
153844137|NCT00532532|Tolperisone|tolperisone|mesh-list
153844138|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153844139|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592227|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153592228|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153592229|NCT01825473|Erythromycin|erythromycin|mesh-list
153592230|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
153592231|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153592232|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
153592233|NCT01825473|Phenobarbital|phenobarbital|mesh-list
153592234|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153592235|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592236|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592237|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153592238|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592239|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592240|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
153592241|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153592242|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592243|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592244|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153592245|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153909715|NCT04302441|Capecitabine|capecitabine|mesh-list
153909716|NCT04302441|Vinorelbine|vinorelbine|mesh-list
153909717|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153909718|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
153909719|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909720|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909721|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153909723|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
153909724|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
153909725|NCT02800447|Procarbazine|procarbazine|mesh-list
153909726|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909727|NCT01038921|Melatonin|melatonin|mesh-list
153909728|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
153909729|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909730|NCT01038921|Protective Agents|protective agents|mesh-ancestor
153909731|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909732|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909733|NCT02856568|Cisplatin|cisplatin|mesh-list
153909734|NCT02856568|Gemcitabine|gemcitabine|mesh-list
153909735|NCT02856568|Ricolinostat|ricolinostat|mesh-list
153909736|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909737|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153909738|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
153909739|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451431|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451432|NCT00003815|Cytarabine|cytarabine|mesh-list
153451433|NCT00003815|Prednisolone|prednisolone|mesh-list
153451434|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
153451435|NCT00003815|Melphalan|melphalan|mesh-list
153451436|NCT00003815|Carmustine|carmustine|mesh-list
153451437|NCT00003815|Doxorubicin|doxorubicin|mesh-list
153451439|NCT00003815|Etoposide|etoposide|mesh-list
153451449|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451450|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153451451|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153451452|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153451453|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153451454|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451455|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153451456|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451457|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
153451458|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
153451459|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451460|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810848|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451461|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451462|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
153909740|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153909741|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909742|NCT04081831|Aspirin|aspirin|mesh-list
153909743|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153909744|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909745|NCT04081831|Analgesics|analgesics|mesh-ancestor
153909746|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
153909747|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909748|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909749|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451463|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909750|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451464|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
153909751|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153909770|NCT01038609|Morphine|morphine|mesh-list
153909771|NCT01038609|Hydrocodone|hydrocodone|mesh-list
153909772|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153909773|NCT01038609|Narcotics|narcotics|mesh-ancestor
153909774|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909775|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909776|NCT01038609|Analgesics|analgesics|mesh-ancestor
153909777|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
153735888|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
153735889|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
153909778|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909779|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909780|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
153909781|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
153451475|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451476|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
153451477|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451478|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451479|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
153451480|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451481|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153451482|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
153451483|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451484|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153451485|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153451486|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451487|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153451488|NCT00003827|Protective Agents|protective agents|mesh-ancestor
153451489|NCT00003851|Gemcitabine|gemcitabine|mesh-list
153451490|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451491|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
153451492|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451493|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451494|NCT00003881|Paclitaxel|paclitaxel|mesh-list
153451502|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451503|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153451504|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
153451505|NCT00003893|Doxorubicin|doxorubicin|mesh-list
153451506|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153909782|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
153909783|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153909784|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909785|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909786|NCT02857582|Metronidazole|metronidazole|mesh-list
153909787|NCT02857582|Vancomycin|vancomycin|mesh-list
153909788|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909789|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153909790|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153909791|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153909792|NCT04301895|Remifentanil|remifentanil|mesh-list
153909793|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153909794|NCT04301895|Narcotics|narcotics|mesh-ancestor
153909795|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909796|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909797|NCT04301895|Analgesics|analgesics|mesh-ancestor
153400097|NCT02396732|Aspirin|aspirin|mesh-list
153909798|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
153909799|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909800|NCT02853526|Propranolol|propranolol|mesh-list
153909801|NCT02853526|Warfarin|warfarin|mesh-list
153909802|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
153909803|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153909804|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153909805|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
153909806|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909807|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909808|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909816|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153451508|NCT00003893|Methotrexate|methotrexate|mesh-list
153451509|NCT00003893|Epirubicin|epirubicin|mesh-list
153451510|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
153451511|NCT00003893|Mitomycins|mitomycins|mesh-list
153451512|NCT00003893|Mitomycin|mitomycin|mesh-list
153451513|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153451514|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
153451515|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451516|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451517|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451518|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
153451519|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451520|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451521|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153451522|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153451523|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153451524|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153451525|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451526|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
153451527|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451528|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153909817|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909818|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909819|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
153909820|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909821|NCT04269460|Bupivacaine|bupivacaine|mesh-list
153909822|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
153909823|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
153909840|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909841|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
153909842|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909843|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909844|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153909845|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
153909846|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909847|NCT02690155|Vitamin K|vitamin k|mesh-list
153451529|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
153909848|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
153909849|NCT02690155|Vitamins|vitamins|mesh-ancestor
153909850|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
153909851|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909852|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153909853|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
153909854|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153909855|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
153909856|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909857|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909858|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
153909859|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153909860|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153909861|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
153909862|NCT02690155|Coagulants|coagulants|mesh-ancestor
153909863|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
153909864|NCT02806375|Busulfan|busulfan|mesh-list
153909865|NCT02806375|Fludarabine|fludarabine|mesh-list
153400200|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909866|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
153909867|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153909868|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
153909869|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451561|NCT00003923|Trioxsalen|trioxsalen|mesh-list
153451562|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451563|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
153451565|NCT00003929|Lomustine|lomustine|mesh-list
153451573|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451574|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451575|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451576|NCT04568837|Dexamethasone|dexamethasone|mesh-list
153592246|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818373|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818374|NCT04862923|Semaglutide|semaglutide|mesh-list
153818375|NCT04862923|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153818376|NCT04862923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818377|NCT04862923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592247|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
153592248|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
153592249|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153592250|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153592251|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153592252|NCT01824043|Ranibizumab|ranibizumab|mesh-list
153592253|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153592254|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153592255|NCT01824043|Growth Substances|growth substances|mesh-ancestor
153592256|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592257|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
153592258|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592259|NCT01825551|Lenograstim|lenograstim|mesh-list
153592260|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153592261|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
153592262|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592263|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
153592264|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153592265|NCT01825616|Vitamin D|vitamin d|mesh-list
153592266|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
153592267|NCT01825616|Vitamins|vitamins|mesh-ancestor
153592268|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
153592269|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592270|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153592271|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153592272|NCT01825720|Insulin|insulin|mesh-list
153592273|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153592274|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592275|NCT01825733|Palonosetron|palonosetron|mesh-list
153592276|NCT01825733|Ramosetron|ramosetron|mesh-list
153592277|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
153592278|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
153592291|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592292|NCT01825863|Ropivacaine|ropivacaine|mesh-list
153592293|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
153592294|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
153909870|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153909872|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
153909873|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909874|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909875|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153909876|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153420537|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
153909879|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153400282|NCT02877485|Triamcinolone|triamcinolone|mesh-list
153909880|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
153909881|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153909882|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909883|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153384448|NCT03357393|Midazolam|midazolam|mesh-list
153592295|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592296|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592297|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
153592298|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592299|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153592300|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153592301|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592302|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153592303|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153592304|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153592305|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592306|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592307|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153592308|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153592309|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153592310|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
153592311|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592312|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592313|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153592314|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153592315|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
153592316|NCT01825993|Morphine|morphine|mesh-list
153592317|NCT01825993|Bupivacaine|bupivacaine|mesh-list
153592318|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
153592319|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
153451577|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
153451578|NCT04568837|Prednisone|prednisone|mesh-list
153451579|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153451580|NCT04568837|BB 1101|bb 1101|mesh-list
153451581|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451582|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
153451583|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
153451584|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451585|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451586|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451587|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
153451588|NCT04568837|Hormones|hormones|mesh-ancestor
153451589|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451590|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153451591|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451592|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
153451593|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451594|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592320|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592321|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592322|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
153592323|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909886|NCT00943852|Losartan|losartan|mesh-list
153909887|NCT00943852|Isosorbide|isosorbide|mesh-list
153909888|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153909889|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153909890|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153909891|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153909892|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153909893|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153909894|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909895|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153909896|NCT00943852|Diuretics|diuretics|mesh-ancestor
153909897|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
153909898|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909899|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
153909900|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153909901|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
153909902|NCT02853136|BI 409306|bi 409306|mesh-list
153451595|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
153451596|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153451597|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
153451598|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153451599|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
153451600|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451601|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592330|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592331|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153592332|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
153592333|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
153592334|NCT01826175|Clopidogrel|clopidogrel|mesh-list
153592335|NCT01826175|Ticagrelor|ticagrelor|mesh-list
153592336|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153592337|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153592338|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153592339|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153592340|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
153592341|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592342|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592343|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592344|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153592345|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
153592346|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
153592347|NCT01826279|Resveratrol|resveratrol|mesh-list
153451602|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
153451604|NCT04564469|Diuretics|diuretics|mesh-ancestor
153451605|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
153451606|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844408|NCT01272193|Insulin|insulin|mesh-list
153592348|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
153592349|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592350|NCT01826279|Protective Agents|protective agents|mesh-ancestor
153592351|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592352|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592353|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153818378|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
153818379|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153818380|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
153818381|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818382|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153818383|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153459765|NCT06050954|Pembrolizumab|pembrolizumab|mesh-list
153459766|NCT06050954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459767|NCT06050954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459768|NCT06050954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153459769|NCT06050954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459770|NCT06027723|Nicotine|nicotine|mesh-list
153459771|NCT06027723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153459772|NCT06027723|Autonomic Agents|autonomic agents|mesh-ancestor
153459773|NCT06027723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459774|NCT06027723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459775|NCT06027723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153459776|NCT06027723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153459777|NCT06027723|Cholinergic Agents|cholinergic agents|mesh-ancestor
153459778|NCT06027723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459779|NCT06027723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459780|NCT06001112|Etoricoxib|etoricoxib|mesh-list
153459781|NCT06001112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153592355|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153592356|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153592357|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909904|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153909905|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909907|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153909908|NCT02853136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153909909|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153909910|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909911|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909912|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592358|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592359|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592360|NCT01826526|Taurolidine|taurolidine|mesh-list
153592361|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592362|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153592363|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592364|NCT01826747|Progesterone|progesterone|mesh-list
153592365|NCT01826747|Progestins|progestins|mesh-ancestor
153592366|NCT01826747|Hormones|hormones|mesh-ancestor
153592367|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592368|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592369|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
153592370|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592371|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592372|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
153592373|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592374|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592375|NCT01826864|Sargramostim|sargramostim|mesh-list
153592376|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
153592377|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592378|NCT01826916|Ecallantide|ecallantide|mesh-list
153459782|NCT06001112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153459783|NCT06001112|Analgesics|analgesics|mesh-ancestor
153459784|NCT06001112|Sensory System Agents|sensory system agents|mesh-ancestor
153459785|NCT06001112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459786|NCT06001112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459787|NCT06001112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153459788|NCT06001112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153459789|NCT06001112|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153459790|NCT06001112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153459791|NCT06001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459792|NCT06001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459793|NCT05991427|Vaccines|vaccines|mesh-list
153459794|NCT05991427|Immunologic Factors|immunologic factors|mesh-ancestor
153459795|NCT05991427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459796|NCT05990192|Niraparib|niraparib|mesh-list
153459797|NCT05990192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153818384|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
153818385|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818386|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909913|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
153451607|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153451608|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153451609|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451610|NCT04564001|Infliximab|infliximab|mesh-list
153451611|NCT04564001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153451612|NCT04564001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451613|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
153451614|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451615|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451616|NCT04563299|Prednisolone|prednisolone|mesh-list
153451617|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153451618|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
153451619|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153451620|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
153451621|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153451622|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
153451623|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451624|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
153451625|NCT04563299|Hormones|hormones|mesh-ancestor
153451626|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451627|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818387|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818388|NCT04742959|Paclitaxel|paclitaxel|mesh-list
153818389|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153818390|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818391|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818392|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
153592379|NCT01826916|Analgesics|analgesics|mesh-ancestor
153592380|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
153592381|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592382|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592383|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153592384|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909914|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153909915|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
153909916|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153909917|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153909918|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909919|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153909920|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153909921|NCT02806141|Colistin|colistin|mesh-list
153909923|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909924|NCT00952276|Vaccines|vaccines|mesh-list
153909925|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
153909926|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909927|NCT02805829|Trastuzumab|trastuzumab|mesh-list
153909928|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153909929|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909930|NCT02856178|Caspofungin|caspofungin|mesh-list
153909931|NCT02856178|Olorofim|olorofim|mesh-list
153909932|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
153909933|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909934|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914669|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
153592385|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153592386|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153592387|NCT01827007|Polygeline|polygeline|mesh-list
153592388|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
153592389|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
153592390|NCT01827020|Lidocaine|lidocaine|mesh-list
153592391|NCT01827020|Ketamine|ketamine|mesh-list
153592392|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
153592393|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
153592394|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592396|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
153592397|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592398|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153592399|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153592400|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153592401|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592402|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592403|NCT01827020|Analgesics|analgesics|mesh-ancestor
153818393|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
153451628|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153451629|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451630|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
153451631|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
153451632|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451633|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451634|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153451635|NCT04563299|Protective Agents|protective agents|mesh-ancestor
153451636|NCT04561817|Paclitaxel|paclitaxel|mesh-list
153451637|NCT04561817|Ipatasertib|ipatasertib|mesh-list
153451638|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153451639|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451640|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
153451641|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451642|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
153451643|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451644|NCT04561817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153451645|NCT04561817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451646|NCT02211833|Pemetrexed|pemetrexed|mesh-list
153451647|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451648|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451649|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844495|NCT05471453|Vitamin E|vitamin e|mesh-list
153818394|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818395|NCT04742673|Guanfacine|guanfacine|mesh-list
153818396|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153818397|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153818398|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153909935|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909936|NCT02800135|Furosemide|furosemide|mesh-list
153909937|NCT02800135|Diuretics|diuretics|mesh-ancestor
153909938|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
153909939|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909940|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153909941|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153909942|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909944|NCT02802163|Lenalidomide|lenalidomide|mesh-list
153909945|NCT02802163|Panobinostat|panobinostat|mesh-list
153735890|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735891|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909946|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909947|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
153909948|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
153909949|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909950|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909951|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153909952|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
153818399|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153818400|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
153818401|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818402|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818403|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818404|NCT04706715|Cemiplimab|cemiplimab|mesh-list
153818405|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818406|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818407|NCT04669288|Azithromycin|azithromycin|mesh-list
153818408|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153818409|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818410|NCT04666987|Liraglutide|liraglutide|mesh-list
153818411|NCT04666987|Xultophy|xultophy|mesh-list
153818412|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818413|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818414|NCT04666987|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153818415|NCT04666987|Incretins|incretins|mesh-ancestor
153818416|NCT04666987|Hormones|hormones|mesh-ancestor
153592404|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153592405|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153592406|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
153592407|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153592408|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153592409|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592411|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153592412|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153909953|NCT02802163|Hormones|hormones|mesh-ancestor
153909954|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451650|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153451651|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153451653|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153451654|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
153451655|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451656|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
153451657|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153451658|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
153451659|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451660|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
153451661|NCT02211521|Protective Agents|protective agents|mesh-ancestor
153451662|NCT01597908|Trametinib|trametinib|mesh-list
153451663|NCT01597908|Dabrafenib|dabrafenib|mesh-list
153451664|NCT01597908|Vemurafenib|vemurafenib|mesh-list
153451665|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810849|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451666|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153451667|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592413|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592414|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
153592415|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
153592416|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592417|NCT01827124|Oxytocin|oxytocin|mesh-list
153592418|NCT01827124|Carbetocin|carbetocin|mesh-list
153592419|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
153592420|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153592421|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818417|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818418|NCT04666454|Adenosine|adenosine|mesh-list
153818419|NCT04666454|Dipyridamole|dipyridamole|mesh-list
153818420|NCT04666454|Apixaban|apixaban|mesh-list
153818421|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153818422|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
153909955|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153909956|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909957|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
153909958|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153909959|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153909960|NCT02802163|Growth Substances|growth substances|mesh-ancestor
153909961|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
153909962|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153909963|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153909964|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909965|NCT02805049|Caspofungin|caspofungin|mesh-list
153909966|NCT02805049|Micafungin|micafungin|mesh-list
153909967|NCT02805049|Echinocandins|echinocandins|mesh-list
153909968|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
153909969|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909970|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451668|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818423|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153459806|NCT05895266|Midazolam|midazolam|mesh-list
153459807|NCT05895266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153459808|NCT05895266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153459809|NCT05895266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459810|NCT05895266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459811|NCT05895266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153459812|NCT05895266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153459813|NCT05895266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153459814|NCT05895266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153459815|NCT05895266|Anesthetics, General|anesthetics, general|mesh-ancestor
153459816|NCT05895266|Anesthetics|anesthetics|mesh-ancestor
153459817|NCT05895266|GABA Modulators|gaba modulators|mesh-ancestor
153459818|NCT05895266|GABA Agents|gaba agents|mesh-ancestor
153459819|NCT05895266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459820|NCT05895266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459821|NCT05876390|Acetaminophen|acetaminophen|mesh-list
153459822|NCT05876390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153459831|NCT05786768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459832|NCT05786768|Immunologic Factors|immunologic factors|mesh-ancestor
153459833|NCT05786768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451671|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153451672|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451673|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451674|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153451675|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153451676|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153451677|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153451678|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
153451679|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
153451680|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
153451681|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
153451682|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451683|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451684|NCT01925274|Irinotecan|irinotecan|mesh-list
153451685|NCT01925274|Cetuximab|cetuximab|mesh-list
153451686|NCT01925274|Gedatolisib|gedatolisib|mesh-list
153451687|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153451688|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153451689|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451690|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451691|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844578|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
153459834|NCT05786768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153459835|NCT05765084|Pemetrexed|pemetrexed|mesh-list
153384723|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153909971|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909972|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
153909973|NCT02799589|Remifentanil|remifentanil|mesh-list
153909974|NCT02799589|Ropivacaine|ropivacaine|mesh-list
153909975|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153909976|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153909977|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153909978|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153909979|NCT02799589|Analgesics|analgesics|mesh-ancestor
153909980|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
153909981|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153909982|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153909984|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153909985|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
153909986|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153909987|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153909988|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
153909989|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
153909990|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153909991|NCT02799589|Narcotics|narcotics|mesh-ancestor
153909992|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153909993|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451692|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153451694|NCT01948830|Ranibizumab|ranibizumab|mesh-list
153451695|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153451696|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153451697|NCT01948830|Growth Substances|growth substances|mesh-ancestor
153451698|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451699|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
153451700|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451701|NCT01972464|Progesterone|progesterone|mesh-list
153459836|NCT05765084|Atezolizumab|atezolizumab|mesh-list
153459837|NCT05765084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459838|NCT05765084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459839|NCT05765084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459840|NCT05765084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153592422|NCT01827137|Lenalidomide|lenalidomide|mesh-list
153451702|NCT01972464|Progestins|progestins|mesh-ancestor
153451703|NCT01972464|Hormones|hormones|mesh-ancestor
153451704|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451705|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451706|NCT01924182|Morphine|morphine|mesh-list
153451707|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153451708|NCT01924182|Narcotics|narcotics|mesh-ancestor
153451709|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451710|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451711|NCT01924182|Analgesics|analgesics|mesh-ancestor
153451712|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
153451713|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451714|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
153451715|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
153451716|NCT01946880|Chloroquine|chloroquine|mesh-list
153451717|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153451718|NCT01946880|Prednisone|prednisone|mesh-list
153451719|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451720|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
153451721|NCT01946880|Hormones|hormones|mesh-ancestor
153451722|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451723|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592423|NCT01827137|Molgramostim|molgramostim|mesh-list
153592424|NCT01827137|Sargramostim|sargramostim|mesh-list
153592425|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
153592426|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592427|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153592428|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153592429|NCT01827137|Growth Substances|growth substances|mesh-ancestor
153592430|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
153781712|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153592431|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592432|NCT01827202|Candesartan|candesartan|mesh-list
153592433|NCT01827202|Candesartan cilexetil|candesartan cilexetil|mesh-list
153592435|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153592436|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153592437|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153592438|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592439|NCT01827202|Renin Inhibitors|renin inhibitors|mesh-ancestor
153592440|NCT01827202|Protease Inhibitors|protease inhibitors|mesh-ancestor
153592441|NCT01827202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592442|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
153592443|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
153592444|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592445|NCT01827280|Vildagliptin|vildagliptin|mesh-list
153909994|NCT02801383|Interferons|interferons|mesh-list
153909995|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153909996|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
153909997|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153909998|NCT02799355|Interferons|interferons|mesh-list
153909999|NCT02799355|Ribavirin|ribavirin|mesh-list
153910000|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
153910001|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910002|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
153910003|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910004|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
153910005|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910006|NCT02801305|Diltiazem|diltiazem|mesh-list
153910007|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
153910008|NCT02801305|Petrolatum|petrolatum|mesh-list
153910009|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
153910010|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153910011|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153910012|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153910013|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910014|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153910015|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910016|NCT02801305|Emollients|emollients|mesh-ancestor
153910017|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
153592446|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153592447|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592448|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153592449|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
153592450|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592451|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592452|NCT01827293|Promethazine|promethazine|mesh-list
153592453|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
153592454|NCT01827293|Lorazepam|lorazepam|mesh-list
153592455|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
153592456|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
153592457|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
153592458|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592459|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592460|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592461|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153860597|NCT05824468|Lenvatinib|lenvatinib|mesh-list
153592462|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592463|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153592464|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153592465|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153592466|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
153592467|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
153592468|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420693|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910018|NCT00637975|Pregabalin|pregabalin|mesh-list
153910019|NCT00637975|Oxycodone|oxycodone|mesh-list
153910020|NCT00637975|Analgesics|analgesics|mesh-ancestor
153910021|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
153910022|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910023|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910024|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
153910025|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153451724|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153451725|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451726|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153451727|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153451728|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
153451729|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153451730|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451732|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451734|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153451735|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153451736|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451737|NCT01946880|Amebicides|amebicides|mesh-ancestor
153451738|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153451739|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153451740|NCT01946880|Analgesics|analgesics|mesh-ancestor
153451741|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
153451742|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451743|NCT01946880|Filaricides|filaricides|mesh-ancestor
153451744|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
153451745|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
153451746|NCT01972152|Glucagon|glucagon|mesh-list
153592469|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592470|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
153592471|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
153592472|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153592473|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
153592474|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
153592475|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153592476|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153910027|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910028|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153910029|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153910030|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153910031|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910032|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153910033|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153910034|NCT00637975|Narcotics|narcotics|mesh-ancestor
153910035|NCT02801227|Oxytocin|oxytocin|mesh-list
153910036|NCT02801227|Dinoprostone|dinoprostone|mesh-list
153592477|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
153592478|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
153592479|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
153592482|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
153592483|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592484|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153592485|NCT01827397|Vaccines|vaccines|mesh-list
153818424|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
153818425|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818426|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818427|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
153818428|NCT04666454|Analgesics|analgesics|mesh-ancestor
153818429|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
153818430|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818431|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818432|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153818433|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
153818434|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153818435|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
153818436|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
153818437|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818438|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153592486|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
153592487|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592488|NCT01827540|Dolutegravir|dolutegravir|mesh-list
153592489|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
153592490|NCT01827540|Midazolam|midazolam|mesh-list
153592491|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153592492|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153910037|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
153910038|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910042|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153910043|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
153910044|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910045|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451747|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451748|NCT01972152|Hormones|hormones|mesh-ancestor
153451749|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451750|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451751|NCT01972074|Memantine|memantine|mesh-list
153451752|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153451753|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153451754|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
153451755|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451756|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451757|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451758|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153451759|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153451760|NCT01618266|Dexamethasone|dexamethasone|mesh-list
153451761|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451762|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
153451763|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
153451764|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451765|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451766|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451767|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
153451768|NCT01618266|Hormones|hormones|mesh-ancestor
153451769|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451770|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153451771|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451772|NCT01918332|Valsartan|valsartan|mesh-list
153451773|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153592493|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592494|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592495|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153592496|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153592497|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153592498|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153592500|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
153592501|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
153451774|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153451775|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153451776|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
153910046|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153910047|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
153910048|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910049|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910050|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
153910051|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910052|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153910053|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910054|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
153910055|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910056|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153910057|NCT02795299|Hematinics|hematinics|mesh-ancestor
153910058|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
153910060|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
153910061|NCT02799277|Testosterone|testosterone|mesh-list
153910062|NCT02799277|Androgens|androgens|mesh-ancestor
153910063|NCT02799277|Hormones|hormones|mesh-ancestor
153910064|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910065|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910066|NCT01198002|Methotrexate|methotrexate|mesh-list
153910067|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153910068|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
153910069|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910070|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592502|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
153592503|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592504|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592505|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153818439|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153818440|NCT04616534|Gemcitabine|gemcitabine|mesh-list
153818441|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153844762|NCT01462890|Paclitaxel|paclitaxel|mesh-list
153910071|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153910072|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
153910738|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910073|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910074|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910075|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
153910076|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451777|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451778|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153451779|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153451780|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451781|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153451782|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153451783|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153451785|NCT01922934|Phentermine|phentermine|mesh-list
153451786|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
153451787|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153451788|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451789|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153451790|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
153451791|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153451792|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
153451793|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
153451794|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451795|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
153451796|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818442|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
153818443|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818444|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818445|NCT04601753|Semaglutide|semaglutide|mesh-list
153860676|NCT05822674|Protease Inhibitors|protease inhibitors|mesh-ancestor
153860677|NCT05822674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860678|NCT05822674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860679|NCT05822674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153818446|NCT04601753|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153818447|NCT04601753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818448|NCT04601753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818449|NCT04589754|Doxorubicin|doxorubicin|mesh-list
153818450|NCT04589754|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153818451|NCT04589754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153818452|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818453|NCT04589754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153818454|NCT04589754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153818455|NCT04589754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459841|NCT05765084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153459842|NCT05765084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153459843|NCT05765084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459844|NCT05745350|Pembrolizumab|pembrolizumab|mesh-list
153844786|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153451797|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451799|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153451800|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451801|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451802|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451803|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
153451804|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153451806|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153451807|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153451808|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451809|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
153451810|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910077|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153910078|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910079|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
153910080|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910081|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153910082|NCT02795065|Enoxaparin|enoxaparin|mesh-list
153910083|NCT02795065|Bemiparin|bemiparin|mesh-list
153910084|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
153910085|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153910086|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153910087|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910088|NCT04233697|Romidepsin|romidepsin|mesh-list
153910089|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153910090|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459845|NCT05745350|Etoposide|etoposide|mesh-list
153459846|NCT05745350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459847|NCT05745350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459848|NCT05745350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153459849|NCT05745350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459850|NCT05745350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459851|NCT05745350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153459852|NCT05745350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153459853|NCT05745350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592511|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592512|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153592513|NCT01827618|Sirolimus|sirolimus|mesh-list
153910091|NCT04233697|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153910092|NCT04233697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910093|NCT04233697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910095|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153910096|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910097|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910098|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910099|NCT02798653|Progesterone|progesterone|mesh-list
153910100|NCT02798653|Progestins|progestins|mesh-ancestor
153910101|NCT02798653|Hormones|hormones|mesh-ancestor
153810850|NCT00352482|Urological Agents|urological agents|mesh-ancestor
153910102|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910103|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910104|NCT03863587|Ramucirumab|ramucirumab|mesh-list
153910105|NCT03863587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153910106|NCT03863587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153910107|NCT03863587|Growth Substances|growth substances|mesh-ancestor
153910108|NCT03863587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910109|NCT03863587|Growth Inhibitors|growth inhibitors|mesh-ancestor
153910110|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451811|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451813|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451815|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153451816|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153451817|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153451818|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
153451819|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
153451820|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451821|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451822|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451823|NCT01915914|Fluticasone|fluticasone|mesh-list
153451824|NCT01915914|Xhance|xhance|mesh-list
153451825|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451832|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
153451833|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153910111|NCT04233463|Budesonide|budesonide|mesh-list
153910112|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910113|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153910114|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
153910115|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910116|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592514|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153592515|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592516|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153592517|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592518|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
153592519|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153592520|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
153592521|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592522|NCT01827722|Dexamethasone|dexamethasone|mesh-list
153592523|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
153592524|NCT01827722|Ranibizumab|ranibizumab|mesh-list
153592525|NCT01827722|BB 1101|bb 1101|mesh-list
153592526|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153592527|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
153592528|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
153592529|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592530|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592531|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592532|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
153592533|NCT01827722|Hormones|hormones|mesh-ancestor
153459861|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
153459862|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592534|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592535|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153810851|NCT00322400|Paclitaxel|paclitaxel|mesh-list
153357434|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592536|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592537|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
153592538|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592539|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592540|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153910118|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
153910119|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
153910120|NCT04233463|Hormones|hormones|mesh-ancestor
153910121|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910122|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
153910123|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153910124|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
153910125|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910126|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
153910127|NCT02793739|Protective Agents|protective agents|mesh-ancestor
153910128|NCT02793505|Metformin|metformin|mesh-list
153910129|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910130|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910131|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153910132|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153451834|NCT01968954|Bococizumab|bococizumab|mesh-list
153451835|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153451836|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153451837|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
153451838|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451839|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153451840|NCT01919190|Bupivacaine|bupivacaine|mesh-list
153451841|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
153451842|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
153451843|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451844|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451845|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
153451846|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451847|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153451848|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153451849|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153910133|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910134|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
153910135|NCT04234321|Mitogens|mitogens|mesh-list
153910136|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
153910137|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910138|NCT02797717|Prednisone|prednisone|mesh-list
153910139|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
153910140|NCT02797717|Dacarbazine|dacarbazine|mesh-list
153910141|NCT02797717|Doxorubicin|doxorubicin|mesh-list
153910142|NCT02797717|Etoposide|etoposide|mesh-list
153910143|NCT02797717|Vincristine|vincristine|mesh-list
153910144|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910145|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
153910146|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910147|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910148|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153910149|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
153910150|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592541|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153592542|NCT01827722|Growth Substances|growth substances|mesh-ancestor
153592543|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
153592544|NCT01827735|Aldesleukin|aldesleukin|mesh-list
153592545|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592546|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153592547|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153592548|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
153592549|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592550|NCT01827865|Etodolac|etodolac|mesh-list
153818459|NCT04572165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818460|NCT04572165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818461|NCT04563871|Osimertinib|osimertinib|mesh-list
153818462|NCT04563871|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153818463|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153818464|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818465|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818466|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910152|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153910153|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153910154|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153910157|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910158|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
153451859|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153451860|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153451861|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
153451862|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153451863|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153451864|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
153451865|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153451866|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153451867|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153451868|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153451869|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451870|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451871|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451873|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
153451874|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451875|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
153451876|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153451877|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
153451878|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
153451879|NCT01913340|Hematinics|hematinics|mesh-ancestor
153451880|NCT01912872|Omalizumab|omalizumab|mesh-list
153451881|NCT01912872|Budesonide|budesonide|mesh-list
153451882|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
153818467|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
153910160|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910161|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153910162|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153910163|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
153910164|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
153910165|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153910166|NCT04235569|Enoxaparin|enoxaparin|mesh-list
153910167|NCT04235569|Warfarin|warfarin|mesh-list
153910168|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
153910169|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
153910170|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153910171|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153910172|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910173|NCT01197378|Cysteamine|cysteamine|mesh-list
153910174|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153910175|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910176|NCT02792491|Prednisone|prednisone|mesh-list
153910177|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
153910178|NCT02792491|Rituximab|rituximab|mesh-list
153910179|NCT02792491|Doxorubicin|doxorubicin|mesh-list
153910180|NCT02792491|Vincristine|vincristine|mesh-list
153910181|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910182|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
153910183|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910184|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451883|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451884|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153451885|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
153818468|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153818469|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
153818470|NCT04563325|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153818471|NCT04563325|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153818472|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153818473|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818474|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153818475|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451886|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420778|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153451887|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451888|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153451889|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
153451890|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
153451891|NCT01912872|Hormones|hormones|mesh-ancestor
153451892|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451893|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153451894|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153451895|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153451896|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
153451897|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153451899|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153910185|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153910186|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
153910187|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910188|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910189|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153910190|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153910191|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153910192|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153910193|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153910194|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910195|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910217|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910218|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153910219|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153910220|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910221|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153910222|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153910223|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910224|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
153910225|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910226|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
153910227|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
153910228|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
153910229|NCT02792335|Warfarin|warfarin|mesh-list
153910230|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
153910231|NCT02792335|Dabigatran|dabigatran|mesh-list
153910232|NCT02792335|Apixaban|apixaban|mesh-list
153910233|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
153910234|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153910235|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
153910236|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153910237|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
153910238|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910239|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910240|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
153910241|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153910242|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451941|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451942|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910739|NCT02780011|Immunotoxins|immunotoxins|mesh-ancestor
153451943|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153451944|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153451959|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153451960|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153451961|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153451962|NCT01889862|Dextrans|dextrans|mesh-list
153451963|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
153451964|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
153451965|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
153451966|NCT01887288|Capecitabine|capecitabine|mesh-list
153451967|NCT01887288|Digoxin|digoxin|mesh-list
153451968|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451969|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
153451970|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451971|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451972|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153451973|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153451974|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451975|NCT01887288|Protective Agents|protective agents|mesh-ancestor
153451976|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451977|NCT03405714|Brivaracetam|brivaracetam|mesh-list
153910244|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153910245|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910246|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910247|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910248|NCT04200235|Analgesics|analgesics|mesh-ancestor
153910249|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
153910250|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910251|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153910252|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153910268|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910269|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910270|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
153910271|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910272|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
153910273|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
153910274|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
153910275|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910276|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451979|NCT01885182|Oxycodone|oxycodone|mesh-list
153451980|NCT01885182|Naloxone|naloxone|mesh-list
153735892|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451981|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153451982|NCT01885182|Narcotics|narcotics|mesh-ancestor
153451983|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451984|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451985|NCT01885182|Analgesics|analgesics|mesh-ancestor
153451986|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
153451987|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451988|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153451989|NCT01885104|Bisacodyl|bisacodyl|mesh-list
153451990|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153451991|NCT01885104|Laxatives|laxatives|mesh-list
153451992|NCT01885104|Cathartics|cathartics|mesh-ancestor
153451993|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451994|NCT01906008|Minocycline|minocycline|mesh-list
153910281|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910282|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
153910283|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153910284|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910285|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910286|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153910287|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153910288|NCT02796469|Protective Agents|protective agents|mesh-ancestor
153910289|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910290|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
153910291|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153910292|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
153910293|NCT02796157|Everolimus|everolimus|mesh-list
153910294|NCT02796157|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153910295|NCT02796157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153910296|NCT02796157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910297|NCT02796157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910298|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910299|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
153910300|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910301|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910302|NCT01196052|Trastuzumab|trastuzumab|mesh-list
153910303|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153910304|NCT01196052|Maytansine|maytansine|mesh-list
153910305|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153910306|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910307|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153910308|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
153910309|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
153910310|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
153910311|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452015|NCT01881126|Bimatoprost|bimatoprost|mesh-list
153452016|NCT01881126|Travoprost|travoprost|mesh-list
153452023|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153452024|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153452025|NCT01880736|Insulin|insulin|mesh-list
153452026|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153452027|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
153452028|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452029|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452030|NCT01880424|Linaclotide|linaclotide|mesh-list
153452031|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153452032|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
153452033|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452034|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153452035|NCT01862874|Vaccines|vaccines|mesh-list
153452036|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
153452037|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452038|NCT01903434|Evacetrapib|evacetrapib|mesh-list
153452039|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153452040|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153452041|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
153452042|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452043|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153452044|NCT01903356|Linagliptin|linagliptin|mesh-list
153452045|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452046|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452047|NCT01903356|Incretins|incretins|mesh-ancestor
153452048|NCT01903356|Hormones|hormones|mesh-ancestor
153452049|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910312|NCT01196052|Immunotoxins|immunotoxins|mesh-ancestor
153910313|NCT01196052|Immunoconjugates|immunoconjugates|mesh-ancestor
153910314|NCT01196052|Immunologic Factors|immunologic factors|mesh-ancestor
153910317|NCT02689921|Pertuzumab|pertuzumab|mesh-list
153910327|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910328|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153910329|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
153910330|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910331|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910332|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153910333|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153910334|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
153910335|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910336|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
153910337|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
153910338|NCT03116425|Vitamins|vitamins|mesh-ancestor
153910339|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
153910340|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910341|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
153910342|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153910343|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910344|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910345|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452050|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153452051|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
153810855|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810856|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810857|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
153860923|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
153452052|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735893|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
153735894|NCT04067609|Hormones|hormones|mesh-ancestor
153452053|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452054|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
153452055|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
153452076|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153452077|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910346|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
153910347|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153910348|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153910349|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153910350|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153910351|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910352|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
153910353|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910354|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910355|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153910356|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910357|NCT03028519|Vitamin D|vitamin d|mesh-list
153910358|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
153910359|NCT03028519|Vitamins|vitamins|mesh-ancestor
153910360|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
153910361|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452078|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
153452079|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
153910362|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153910363|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153910364|NCT02786641|Cisplatin|cisplatin|mesh-list
153910365|NCT02786641|Docetaxel|docetaxel|mesh-list
153910366|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910367|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
153910368|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
153910369|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
153910370|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910371|NCT02787967|Beclomethasone|beclomethasone|mesh-list
153910372|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
153910373|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153910374|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
153910382|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
153910383|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910384|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910385|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910387|NCT02787967|Hormones|hormones|mesh-ancestor
153910388|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910389|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153452096|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
153420843|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
153452097|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452098|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452100|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153452101|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153452102|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452103|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452104|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452106|NCT04414800|Ketamine|ketamine|mesh-list
153452107|NCT04414800|Analgesics|analgesics|mesh-ancestor
153452108|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
153452109|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452110|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452111|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153452112|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153452113|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
153452114|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
153452115|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452116|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153910391|NCT02788123|Bismuth|bismuth|mesh-list
153910392|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153910393|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153910394|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153910395|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910396|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910397|NCT02788123|Antacids|antacids|mesh-ancestor
153910398|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910399|NCT01194804|Eculizumab|eculizumab|mesh-list
153910400|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153910401|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910402|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
153910403|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910404|NCT02785549|Acetaminophen|acetaminophen|mesh-list
153910405|NCT02785549|Amoxicillin|amoxicillin|mesh-list
153910406|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
153910407|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
153910408|NCT02785549|Ibuprofen|ibuprofen|mesh-list
153910409|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910410|NCT02785549|Analgesics|analgesics|mesh-ancestor
153910411|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
153910412|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910413|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910414|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
153910415|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153452131|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452132|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
153452133|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153452134|NCT01898130|Bevacizumab|bevacizumab|mesh-list
153452135|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153452137|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
153452138|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153452139|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452140|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153452141|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153452142|NCT01898130|Growth Substances|growth substances|mesh-ancestor
153452143|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452144|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
153452145|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
153452146|NCT01876368|Olmesartan|olmesartan|mesh-list
153452147|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153452148|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153452149|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153452150|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153452151|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153452152|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452153|NCT01873950|Quinidine|quinidine|mesh-list
153910417|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910418|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153910419|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910420|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910421|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153910422|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910423|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153910424|NCT02785705|Vaccines|vaccines|mesh-list
153910425|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
153910435|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910436|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910437|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153910438|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153910439|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910440|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153910441|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
153910443|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153910444|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153910445|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153910446|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153910447|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
153910448|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910449|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910450|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910451|NCT02787031|Anesthetics|anesthetics|mesh-list
153910452|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910453|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910454|NCT02784223|Choline|choline|mesh-list
153910455|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
153910456|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153452163|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452165|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153452166|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153452167|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153452168|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
153452169|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452184|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153452185|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
153452186|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153452187|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452188|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153452189|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153452190|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153452191|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153452192|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153452193|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153910457|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
153910458|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910459|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153910460|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153910461|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
153910462|NCT05262751|Nintedanib|nintedanib|mesh-list
153910463|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910464|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153910465|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910466|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910467|NCT04231123|Anesthetics|anesthetics|mesh-list
153910468|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
153910469|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910470|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910471|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
153910472|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910473|NCT04231279|Secretin|secretin|mesh-list
153357469|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861038|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861039|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861040|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153861041|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153861042|NCT03762018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153861043|NCT03456882|RNS60|rns60|mesh-list
153401355|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
153401358|NCT02051335|Scopolamine|scopolamine|mesh-list
153910474|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153910475|NCT04231279|Hormones|hormones|mesh-ancestor
153910476|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910478|NCT02782273|Ketorolac|ketorolac|mesh-list
153910482|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910483|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910485|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
153910486|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910487|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153910488|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910489|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452194|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153452195|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153452196|NCT01856790|Liraglutide|liraglutide|mesh-list
153452197|NCT01856790|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153452198|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452199|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452200|NCT01856790|Incretins|incretins|mesh-ancestor
153452201|NCT01856790|Hormones|hormones|mesh-ancestor
153452202|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910492|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910493|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910494|NCT05342389|Apatinib|apatinib|mesh-list
153910495|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910496|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153910497|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910498|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910499|NCT02268175|Prednisone|prednisone|mesh-list
153910500|NCT02268175|Leuprolide|leuprolide|mesh-list
153910501|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
153910502|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910503|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
153910504|NCT02268175|Hormones|hormones|mesh-ancestor
153910505|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910506|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910507|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153910508|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910509|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153910510|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
153910511|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153810859|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910512|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153452218|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452219|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452221|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153452222|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
153452223|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452224|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452226|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153452241|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452242|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153452243|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153452244|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
153452245|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452246|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153452247|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153452248|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153452249|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
153910513|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910514|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910515|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
153910516|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153910517|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
153910518|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153910519|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
153910520|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910521|NCT02783989|Protective Agents|protective agents|mesh-ancestor
153910522|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910523|NCT02782429|Ketamine|ketamine|mesh-list
153910524|NCT02782429|Analgesics|analgesics|mesh-ancestor
153910525|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
153910526|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910527|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910528|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153910529|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153910530|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
153910531|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
153910532|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910533|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153910534|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153910535|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910536|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910537|NCT04229719|Melatonin|melatonin|mesh-list
153910538|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
153910541|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910542|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910543|NCT01855867|Tenofovir|tenofovir|mesh-list
153910544|NCT01855867|Emtricitabine|emtricitabine|mesh-list
153910545|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
153910546|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910547|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153910548|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153910549|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910550|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910551|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153452259|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153452261|NCT01894152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153452262|NCT01894152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153452263|NCT01894152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452264|NCT01894152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452265|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452266|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
153910740|NCT02780011|Immunoconjugates|immunoconjugates|mesh-ancestor
153452267|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452268|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452269|NCT01854528|Interferons|interferons|mesh-list
153452270|NCT01854528|Ribavirin|ribavirin|mesh-list
153452271|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452272|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
153452273|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452274|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
153452275|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452276|NCT01853982|Tazobactam|tazobactam|mesh-list
153452277|NCT01853982|Piperacillin|piperacillin|mesh-list
153452278|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153452279|NCT01853982|Ceftolozane|ceftolozane|mesh-list
153452280|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153810877|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
153810878|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153810879|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153810880|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
153810881|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401450|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153401451|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153401452|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452281|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153452286|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153452287|NCT01853280|Methylphenidate|methylphenidate|mesh-list
153452288|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153452289|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452290|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153452291|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153452292|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153910552|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153910553|NCT02689843|Metformin|metformin|mesh-list
153910554|NCT02689843|Pioglitazone|pioglitazone|mesh-list
153910555|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
153910556|NCT02689843|Spironolactone|spironolactone|mesh-list
153910557|NCT02689843|Cyproterone|cyproterone|mesh-list
153910558|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910559|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910560|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153910561|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
153910562|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910563|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153910564|NCT02689843|Diuretics|diuretics|mesh-ancestor
153910565|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
153910566|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
153910567|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910568|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153910569|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
153910570|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910571|NCT05341999|Ibuprofen|ibuprofen|mesh-list
153910572|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153910573|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910574|NCT05341999|Analgesics|analgesics|mesh-ancestor
153910575|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
153910576|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910577|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818476|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910578|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910579|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910580|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153910581|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910582|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910583|NCT02781805|Alendronate|alendronate|mesh-list
153910584|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153452293|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452294|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
153452295|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401476|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401477|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153401478|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
153401479|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153401480|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401481|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401482|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401483|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153861134|NCT01792934|Growth Substances|growth substances|mesh-ancestor
153861135|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861136|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
153452296|NCT01891890|Lamotrigine|lamotrigine|mesh-list
153452297|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
153452298|NCT01891890|Levetiracetam|levetiracetam|mesh-list
153452299|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
153452300|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
153452301|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153452302|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153736469|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420970|NCT06289283|Disinfectants|disinfectants|mesh-list
153452303|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452304|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153452305|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452306|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153452307|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153452308|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452309|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153452310|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153452311|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153452312|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153452313|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153452314|NCT01852812|Montelukast|montelukast|mesh-list
153452315|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153452316|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
153452317|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153452318|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
153459863|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452320|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452321|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153452322|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153910585|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910586|NCT02781493|Prucalopride|prucalopride|mesh-list
153910587|NCT02781493|Laxatives|laxatives|mesh-ancestor
153910588|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153910589|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153910590|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153910591|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
153910592|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910593|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910594|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910595|NCT02783053|Metformin|metformin|mesh-list
153401485|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153401486|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
153861175|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153861176|NCT00521222|Ipratropium|ipratropium|mesh-list
153861177|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153861178|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861179|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153861180|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
153861181|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861182|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861183|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153861184|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
153861185|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
153861186|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153861187|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153861188|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153910596|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910597|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910598|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153910599|NCT02781415|Morphine|morphine|mesh-list
153910600|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153910601|NCT02781415|Narcotics|narcotics|mesh-ancestor
153910602|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910603|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910604|NCT02781415|Analgesics|analgesics|mesh-ancestor
153910605|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
153592556|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592557|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153592558|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153592559|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153592560|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153592561|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592562|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592563|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153592564|NCT01827878|Lisinopril|lisinopril|mesh-list
153592565|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
153592566|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153592567|NCT01827878|Diuretics|diuretics|mesh-ancestor
153592568|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
153592569|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592570|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153385541|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
153910606|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910607|NCT02785003|Acetaminophen|acetaminophen|mesh-list
153910608|NCT02785003|Ketamine|ketamine|mesh-list
153910609|NCT02785003|Morphine|morphine|mesh-list
153910610|NCT02785003|Narcotics|narcotics|mesh-list
153910611|NCT02785003|Alvimopan|alvimopan|mesh-list
153910612|NCT02785003|Analgesics|analgesics|mesh-ancestor
153910613|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
153910614|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910615|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910616|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153910617|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153861197|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
153861199|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861200|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
153861201|NCT00545012|Levetiracetam|levetiracetam|mesh-list
153861202|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
153861203|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
153861204|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
153861205|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861206|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452323|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452325|NCT01869192|Docetaxel|docetaxel|mesh-list
153452326|NCT01869192|Capecitabine|capecitabine|mesh-list
153452327|NCT01869192|Epirubicin|epirubicin|mesh-list
153452328|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452329|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
153420996|NCT06289062|Paclitaxel|paclitaxel|mesh-list
153452330|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452331|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452332|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153452333|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
153452334|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452335|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452336|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153452337|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
153452338|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
153452339|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
153452340|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153452341|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
153452342|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153452343|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153452344|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153452345|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452346|NCT01851720|Fentanyl|fentanyl|mesh-list
153452347|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153452348|NCT01851720|Narcotics|narcotics|mesh-ancestor
153452349|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452350|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452352|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
153452353|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452354|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153452355|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153452356|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
153452357|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
153910618|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
153910619|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
153910620|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910621|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153910622|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153910623|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910624|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910625|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153861232|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
153861233|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
153861234|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861235|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861236|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
153861237|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
153861238|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861239|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153861240|NCT00545558|Tenofovir|tenofovir|mesh-list
153861241|NCT00545558|Emtricitabine|emtricitabine|mesh-list
153401555|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401556|NCT02344225|Ibuprofen|ibuprofen|mesh-list
153910626|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910627|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
153910628|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153910629|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
153910630|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153910631|NCT02782897|Antibodies|antibodies|mesh-list
153910632|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
153910633|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910634|NCT00638131|Bosentan|bosentan|mesh-list
153910635|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153910636|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153910637|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910638|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
153910654|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153910656|NCT02784457|Cetrorelix|cetrorelix|mesh-list
153910657|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153910658|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
153910659|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153452367|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153452368|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452369|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
153452370|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
153452371|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
153452372|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452373|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452374|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153452375|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153452376|NCT01850004|Dasatinib|dasatinib|mesh-list
153452377|NCT01850004|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153452378|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153452379|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452380|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452381|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452382|NCT01867710|Dexamethasone|dexamethasone|mesh-list
153452383|NCT01867710|Prednisone|prednisone|mesh-list
153452384|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
153452385|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452386|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
153452387|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
153452388|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910660|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861265|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153861266|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153861268|NCT00545675|Valproic Acid|valproic acid|mesh-list
153861269|NCT00545675|Aripiprazole|aripiprazole|mesh-list
153861270|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
153861271|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153861272|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153861273|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153861274|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910661|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
153910662|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910663|NCT02780323|Celecoxib|celecoxib|mesh-list
153910664|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153910665|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910666|NCT02780323|Analgesics|analgesics|mesh-ancestor
153910667|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
153910668|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910669|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910670|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910671|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910672|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153910673|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153910674|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910675|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910676|NCT05331859|Insulin|insulin|mesh-list
153910677|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910678|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910679|NCT04229407|Vitamins|vitamins|mesh-list
153910680|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
153910681|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
153910682|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452417|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452418|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452421|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452422|NCT04414956|Vitamin K|vitamin k|mesh-list
153452423|NCT04414956|Agglutinins|agglutinins|mesh-list
153452424|NCT04414956|Vitamins|vitamins|mesh-ancestor
153452425|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
153452426|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452427|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153452428|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153910691|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910692|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153910693|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153861312|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153861313|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153861314|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
153861315|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861316|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861317|NCT00546065|Esomeprazole|esomeprazole|mesh-list
153861318|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153861323|NCT00546143|Omalizumab|omalizumab|mesh-list
153910694|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910695|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153910696|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153910697|NCT04231435|Protective Agents|protective agents|mesh-ancestor
153910698|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153910699|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153910700|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910701|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910702|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153910703|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153910705|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
153910728|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910729|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153910730|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153910731|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
153452445|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
153452446|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153452447|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452448|NCT01848834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153452449|NCT01848834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452450|NCT01848210|Troxerutin|troxerutin|mesh-list
153452451|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
153745673|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745674|NCT03056040|Eculizumab|eculizumab|mesh-list
153745675|NCT03056040|Ravulizumab|ravulizumab|mesh-list
153745676|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153745677|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745678|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
153745679|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745680|NCT02924038|Poly ICLC|poly iclc|mesh-list
153745681|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
153745682|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
153745683|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745684|NCT02726581|Dexamethasone|dexamethasone|mesh-list
153745685|NCT02726581|Nivolumab|nivolumab|mesh-list
153745686|NCT02726581|Pomalidomide|pomalidomide|mesh-list
153745687|NCT02726581|Elotuzumab|elotuzumab|mesh-list
153745688|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745689|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
153745690|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
153745691|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745692|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745693|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153745694|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
153745695|NCT02726581|Hormones|hormones|mesh-ancestor
153745696|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745697|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153861335|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
153861336|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861337|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153861338|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
153861339|NCT00560079|Protective Agents|protective agents|mesh-ancestor
153861340|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861341|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153861342|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153861343|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
153861344|NCT00560118|Fotemustine|fotemustine|mesh-list
153745698|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745699|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153745700|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153745701|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745702|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
153745703|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153745704|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153745705|NCT02726581|Growth Substances|growth substances|mesh-ancestor
153745706|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
153745707|NCT02700048|Naloxone|naloxone|mesh-list
153745708|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153745709|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745710|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
153745711|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745712|NCT02535832|Pioglitazone|pioglitazone|mesh-list
153745713|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153582771|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153745714|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745716|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153745717|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
153745718|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745719|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745720|NCT02406209|Prednisolone|prednisolone|mesh-list
153745721|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153745722|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
153745723|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153745724|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
153745759|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745761|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745762|NCT01964989|Vaccines|vaccines|mesh-list
153745763|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
153745764|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745765|NCT01575860|Lenalidomide|lenalidomide|mesh-list
153745766|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
153745767|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745768|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810889|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153861375|NCT00558480|Protective Agents|protective agents|mesh-ancestor
153861376|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153861377|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861378|NCT00546650|Sumatriptan|sumatriptan|mesh-list
153861379|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153861380|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153861381|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153861382|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
153861383|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861384|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861385|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401717|NCT05992987|Sensory System Agents|sensory system agents|mesh-ancestor
153745769|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153745770|NCT01575860|Growth Substances|growth substances|mesh-ancestor
153745771|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
153745772|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745773|NCT01416831|Interleukin-2|interleukin-2|mesh-list
153745774|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745775|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153745776|NCT01416831|Analgesics|analgesics|mesh-ancestor
153745777|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
153745778|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745779|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745780|NCT00635700|Ziprasidone|ziprasidone|mesh-list
153745781|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153745782|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
153745783|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153582850|NCT01751204|Calcium|calcium|mesh-list
153745784|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745785|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745786|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153745817|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153745818|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153745819|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745821|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153745822|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745823|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153745828|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745829|NCT00149981|Everolimus|everolimus|mesh-list
153745830|NCT00149981|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153481815|NCT01337700|Milnacipran|milnacipran|mesh-list
153745840|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
153745841|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745843|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
153745844|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745845|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
153745846|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153745847|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745848|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153745849|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
153745850|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745851|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745852|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745853|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401744|NCT05992610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153401745|NCT05992610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401746|NCT05992610|Tubulin Modulators|tubulin modulators|mesh-ancestor
153401747|NCT05992610|Antimitotic Agents|antimitotic agents|mesh-ancestor
153401748|NCT05992610|Mitosis Modulators|mitosis modulators|mesh-ancestor
153401749|NCT05992610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401750|NCT05992220|Bevacizumab|bevacizumab|mesh-list
153401751|NCT05992220|Atezolizumab|atezolizumab|mesh-list
153401752|NCT05992220|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153401753|NCT05992220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153745854|NCT02914678|Fentanyl|fentanyl|mesh-list
153745855|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153745856|NCT02914678|Narcotics|narcotics|mesh-ancestor
153745857|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745858|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745859|NCT02914678|Analgesics|analgesics|mesh-ancestor
153582921|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
153745860|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
153745886|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
153745887|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153745888|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745889|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153745890|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
153745891|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745892|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745893|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745894|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745908|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153745909|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153745910|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
153745911|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745912|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153745913|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153745914|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745915|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153745916|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153745917|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153745918|NCT02914054|Dexamethasone|dexamethasone|mesh-list
153745919|NCT02914054|Prednisone|prednisone|mesh-list
153745920|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745921|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
153745922|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
153745923|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745924|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745925|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153745926|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
153745927|NCT02914054|Hormones|hormones|mesh-ancestor
153745928|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745929|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153745930|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592571|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153861450|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
153861451|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861452|NCT00560430|Telmisartan|telmisartan|mesh-list
153861453|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153861454|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153401780|NCT05990894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401781|NCT05990894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401782|NCT05990894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153401783|NCT05990894|Glucocorticoids|glucocorticoids|mesh-ancestor
153401784|NCT05990894|Hormones|hormones|mesh-ancestor
153592572|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592573|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153745932|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153745933|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153745934|NCT00150059|Analgesics|analgesics|mesh-ancestor
153745935|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
153745936|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745937|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745938|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745939|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153745940|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
153745941|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745942|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
153745943|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153745944|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745945|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745946|NCT00171132|Atenolol|atenolol|mesh-list
153745947|NCT00171132|Valsartan|valsartan|mesh-list
153745948|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153745949|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153745950|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153745951|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153745952|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745953|NCT00171132|Diuretics|diuretics|mesh-ancestor
153745954|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
153745955|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745956|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153745957|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745980|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745981|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153745982|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153745983|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153745984|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745985|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153745986|NCT00150215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153745987|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153385801|NCT02988440|Sorafenib|sorafenib|mesh-list
153745989|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745990|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745991|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
153745992|NCT00171171|Deferasirox|deferasirox|mesh-list
153745993|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153745994|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
153745995|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
153745996|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745997|NCT02913430|Tamoxifen|tamoxifen|mesh-list
153745998|NCT02913430|Fulvestrant|fulvestrant|mesh-list
153745999|NCT02913430|Palbociclib|palbociclib|mesh-list
153746000|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153746001|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
153746002|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746003|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746004|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153746005|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746006|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153746007|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153746029|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746030|NCT00150254|Varenicline|varenicline|mesh-list
153746031|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153746032|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153746033|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
153746034|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746035|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746036|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746037|NCT02913508|Vedolizumab|vedolizumab|mesh-list
153401804|NCT05988788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401805|NCT05988788|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153401806|NCT05988788|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153861520|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861521|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861522|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
153861523|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861524|NCT00548678|Aspirin|aspirin|mesh-list
153401856|NCT05987345|Antibodies|antibodies|mesh-list
153746038|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385851|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746053|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153746054|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746055|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746056|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153746057|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153746058|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153746059|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153746060|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153746073|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746074|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746075|NCT00150332|Linezolid|linezolid|mesh-list
153746076|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153746077|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746078|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153746079|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746080|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746081|NCT00150371|Atorvastatin|atorvastatin|mesh-list
153746082|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153746083|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153746084|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
153746085|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746086|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153452452|NCT01830816|Ixazomib|ixazomib|mesh-list
153746087|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153746088|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746089|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
153746090|NCT02912494|Hematinics|hematinics|mesh-ancestor
153746092|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153746093|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746094|NCT00171288|Ezetimibe|ezetimibe|mesh-list
153746095|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153746096|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153592574|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
153592575|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459865|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153459866|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459867|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459868|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153746097|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
153746098|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746099|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153746100|NCT00150449|Pregabalin|pregabalin|mesh-list
153746101|NCT00150449|Analgesics|analgesics|mesh-ancestor
153746102|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
153746103|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746104|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746105|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
153746106|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153746107|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746108|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861550|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
153401893|NCT05986344|Micronutrients|micronutrients|mesh-ancestor
153401894|NCT05986201|Hemostatics|hemostatics|mesh-list
153401933|NCT05985070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153401935|NCT05984511|Atezolizumab|atezolizumab|mesh-list
153861621|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861622|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
153861623|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
153861625|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153746109|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153746110|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153746111|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153746112|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153746113|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153746114|NCT02912182|Prednisolone|prednisolone|mesh-list
153746115|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153746116|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
153746117|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153746118|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
153746119|NCT02912182|Betamethasone|betamethasone|mesh-list
153746120|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153746121|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
153746122|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153746123|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
153746124|NCT02912182|Hormones|hormones|mesh-ancestor
153746125|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746126|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746168|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153746169|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
153746170|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
153746171|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746172|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746173|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153746174|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
153746199|NCT02911480|Oxytocin|oxytocin|mesh-list
153746200|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
153746201|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153746202|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746203|NCT00171366|Amlodipine|amlodipine|mesh-list
153746204|NCT00171366|Benazepril|benazepril|mesh-list
153746205|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153746206|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153746207|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746208|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746209|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153746210|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746211|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
153746212|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153746213|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
153746214|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746215|NCT00150605|Carbamazepine|carbamazepine|mesh-list
153746216|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
153746217|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
153746218|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153746219|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153746220|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746262|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746263|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153746264|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153746266|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153746267|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746268|NCT00150722|Atorvastatin|atorvastatin|mesh-list
153810892|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401963|NCT05983055|Autonomic Agents|autonomic agents|mesh-ancestor
153401964|NCT05983055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401965|NCT05983055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401966|NCT05983055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459869|NCT05662865|Ertugliflozin|ertugliflozin|mesh-list
153746269|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153746270|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153746271|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
153746272|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746273|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153746274|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153746275|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746276|NCT00150761|Levocetirizine|levocetirizine|mesh-list
153746277|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153746278|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153746279|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
153746280|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
153746281|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746282|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746283|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746284|NCT00171483|Tegaserod|tegaserod|mesh-list
153746285|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153746286|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
153746287|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746288|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746289|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746290|NCT03777904|Iron|iron|mesh-list
153746291|NCT03777904|Trace Elements|trace elements|mesh-ancestor
153746292|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
153746293|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746294|NCT00150839|Mirtazapine|mirtazapine|mesh-list
153746295|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153402005|NCT05900882|Bortezomib|bortezomib|mesh-list
153402006|NCT05900882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153402007|NCT05900882|Antiemetics|antiemetics|mesh-ancestor
153402008|NCT05900882|Autonomic Agents|autonomic agents|mesh-ancestor
153402009|NCT05900882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402010|NCT05900882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402011|NCT05900882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153402012|NCT05900882|Glucocorticoids|glucocorticoids|mesh-ancestor
153402014|NCT05900882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153402015|NCT05900882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153402016|NCT05900882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402017|NCT05900882|Immunologic Factors|immunologic factors|mesh-ancestor
153402018|NCT05900882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153402019|NCT05900882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153402020|NCT05900882|Growth Substances|growth substances|mesh-ancestor
153402021|NCT05900882|Growth Inhibitors|growth inhibitors|mesh-ancestor
153402022|NCT05875857|Analgesics, Opioid|analgesics, opioid|mesh-list
153402023|NCT05875857|Narcotics|narcotics|mesh-ancestor
153861683|NCT00550004|Gemcitabine|gemcitabine|mesh-list
153746296|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153746297|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153746298|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746299|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746300|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746301|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746302|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153459870|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459871|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153746303|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
153746304|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153746305|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153746306|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
153746307|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
153746308|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153746309|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153746310|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153746311|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153746312|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153746313|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153746314|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
153746315|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153746316|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153746317|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
153746318|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153746319|NCT03782740|Melatonin|melatonin|mesh-list
153746320|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
153746357|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
153746376|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153746377|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153583441|NCT01755845|Paclitaxel|paclitaxel|mesh-list
153746378|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153746379|NCT00532285|Paclitaxel|paclitaxel|mesh-list
153746380|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153746381|NCT00532285|Gemcitabine|gemcitabine|mesh-list
153861686|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402024|NCT05875857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402025|NCT05875857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402027|NCT05875857|Sensory System Agents|sensory system agents|mesh-ancestor
153402028|NCT05875857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402029|NCT05862233|Cyclosporine|cyclosporine|mesh-list
153402030|NCT05862233|Cyclosporins|cyclosporins|mesh-list
153402031|NCT05862233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746382|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153746383|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746384|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
153746385|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
153746386|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
153746400|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153746401|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
153746402|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153746403|NCT02817451|Vaccines|vaccines|mesh-list
153746404|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
153746405|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746406|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153746407|NCT00171522|Tegaserod|tegaserod|mesh-list
153746408|NCT00171522|Laxatives|laxatives|mesh-ancestor
153746409|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153746410|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153746411|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
153746412|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746438|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746440|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153746441|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746442|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
153746443|NCT00532324|Mupirocin|mupirocin|mesh-list
153746444|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153746445|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746446|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
153746447|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153746448|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153746449|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583517|NCT01756430|Carvedilol|carvedilol|mesh-list
153746450|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746451|NCT00171600|Valsartan|valsartan|mesh-list
153746452|NCT00171600|Lisinopril|lisinopril|mesh-list
153746453|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153746454|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153746455|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153746456|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482430|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
153746490|NCT05467189|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153746491|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153746492|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746495|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746496|NCT05466604|Dexamethasone|dexamethasone|mesh-list
153746497|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153746498|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
153746522|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
153746523|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
153746524|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746525|NCT05466019|Antidotes|antidotes|mesh-ancestor
153746526|NCT05466019|Protective Agents|protective agents|mesh-ancestor
153746527|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746528|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
153746529|NCT05466019|Vitamins|vitamins|mesh-ancestor
153746530|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
153746531|NCT05465902|Vaccines|vaccines|mesh-list
153746532|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
153746533|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746534|NCT00151346|Fentanyl|fentanyl|mesh-list
153746535|NCT00151346|Bupivacaine|bupivacaine|mesh-list
153746536|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
153746537|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
153746538|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861701|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861702|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
153861703|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
153861704|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153861705|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
153861716|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153402075|NCT05814640|Olanzapine|olanzapine|mesh-list
153746539|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746540|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
153746541|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746542|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153746543|NCT00151346|Narcotics|narcotics|mesh-ancestor
153746544|NCT00151346|Analgesics|analgesics|mesh-ancestor
153746545|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153746546|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153746547|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
153746548|NCT00164424|Acyclovir|acyclovir|mesh-list
153746549|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
153746550|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746551|NCT00532519|Citalopram|citalopram|mesh-list
153746552|NCT00532519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153746560|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
153746568|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746569|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153746570|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746571|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153746572|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746573|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746574|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
153746575|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746576|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
153746577|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153746578|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153746579|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746580|NCT00151463|Urological Agents|urological agents|mesh-ancestor
153746581|NCT00171717|Cyclosporine|cyclosporine|mesh-list
153746582|NCT00171717|Cyclosporins|cyclosporins|mesh-list
153746583|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746584|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746585|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153746586|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
153746587|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746588|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
153746589|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746590|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
153861750|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861751|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
153402092|NCT05814640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402093|NCT05814640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402094|NCT05814640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402096|NCT05814640|Antidepressive Agents|antidepressive agents|mesh-ancestor
153402097|NCT05814640|Dopamine Agonists|dopamine agonists|mesh-ancestor
153402098|NCT05814640|Dopamine Agents|dopamine agents|mesh-ancestor
153402099|NCT05814640|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153402100|NCT05814640|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153402101|NCT05814640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153402102|NCT05814640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153402104|NCT05814640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153746591|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746592|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153746613|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
153746614|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153746615|NCT00171756|Atenolol|atenolol|mesh-list
153746616|NCT00171756|Valsartan|valsartan|mesh-list
153746617|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153746618|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153746619|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153746651|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746652|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746653|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
153746654|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153746655|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153746656|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153746657|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746658|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746659|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
153746660|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153746661|NCT00151580|Ribavirin|ribavirin|mesh-list
153482640|NCT01535976|Ketamine|ketamine|mesh-list
153746673|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153746674|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153746675|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746676|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746677|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153746678|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746680|NCT00532675|Lenalidomide|lenalidomide|mesh-list
153746703|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153746704|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746705|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153746706|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153746707|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746708|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
153746709|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153746710|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
153746711|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153746712|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
153746713|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
153746714|NCT05293600|Acetazolamide|acetazolamide|mesh-list
153746715|NCT05293600|Eszopiclone|eszopiclone|mesh-list
153746716|NCT05293600|Trazodone|trazodone|mesh-list
153810893|NCT00322595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153402119|NCT05810597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402121|NCT05804084|Anticonvulsants|anticonvulsants|mesh-ancestor
153402122|NCT05804084|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153402123|NCT05804084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402124|NCT05804084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402125|NCT05804084|Diuretics|diuretics|mesh-ancestor
153402126|NCT05804084|Natriuretic Agents|natriuretic agents|mesh-ancestor
153402127|NCT05804084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402128|NCT05758831|Rituximab|rituximab|mesh-list
153402129|NCT05758831|Ocrelizumab|ocrelizumab|mesh-list
153402130|NCT05758831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861788|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153861790|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746717|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153746718|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153746719|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153746720|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746721|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746722|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
153482673|NCT06115174|Protective Agents|protective agents|mesh-ancestor
153746756|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746758|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153746759|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153746760|NCT00151736|Analgesics|analgesics|mesh-ancestor
153482746|NCT06114641|Enoxaparin|enoxaparin|mesh-list
153746790|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153746802|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153746803|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
153482782|NCT06114121|Morphine|morphine|mesh-list
153746826|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153583900|NCT01758185|Vaccines|vaccines|mesh-list
153746827|NCT00151970|Methylphenidate|methylphenidate|mesh-list
153746828|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153746829|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746830|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153746831|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153746832|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746833|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746834|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
153746835|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746836|NCT00152048|Eflornithine|eflornithine|mesh-list
153746837|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746838|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153746839|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153746840|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153746841|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746842|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153746843|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861794|NCT00551096|Gemcitabine|gemcitabine|mesh-list
153861795|NCT00551096|Capecitabine|capecitabine|mesh-list
153861796|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153402131|NCT05758831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402132|NCT05758831|Immunologic Factors|immunologic factors|mesh-ancestor
153402133|NCT05758831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402134|NCT05758831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153402135|NCT05752916|Clopidogrel|clopidogrel|mesh-list
153861805|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861806|NCT00551252|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153861807|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153861809|NCT01125761|Clemastine|clemastine|mesh-list
153861810|NCT01125761|Dexamethasone|dexamethasone|mesh-list
153861811|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
153746844|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746881|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746883|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153746884|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153746885|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
153746886|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746887|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
153735902|NCT04055012|Metformin|metformin|mesh-list
153735903|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153735904|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735905|NCT04047355|Propranolol|propranolol|mesh-list
153735906|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153735907|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153735908|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
153735909|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153735910|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735911|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735912|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153735913|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153735914|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
153735915|NCT04037254|Niraparib|niraparib|mesh-list
153735916|NCT04037254|Hormones|hormones|mesh-list
153421239|NCT06116578|Olaparib|olaparib|mesh-list
153746888|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153746889|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746890|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
153746891|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
153746892|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153746893|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
153746894|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153746895|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746911|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153746912|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
153746913|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153746914|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153482873|NCT05997732|Propranolol|propranolol|mesh-list
153746937|NCT00152282|Estrogens|estrogens|mesh-ancestor
153402153|NCT05752409|Analgesics|analgesics|mesh-ancestor
153402154|NCT05752409|Sensory System Agents|sensory system agents|mesh-ancestor
153402155|NCT05752409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402156|NCT05752409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153402157|NCT05752409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153888631|NCT01312961|Xhance|xhance|mesh-list
153888632|NCT01312961|Albuterol|albuterol|mesh-list
153402158|NCT05752409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153402159|NCT05752409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746939|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746940|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746941|NCT00152360|Orlistat|orlistat|mesh-list
153746942|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746943|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746944|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153746945|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153746946|NCT00164892|Rofecoxib|rofecoxib|mesh-list
153746947|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153746948|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153746949|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746950|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746951|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153746952|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153746953|NCT00164892|Analgesics|analgesics|mesh-ancestor
153735917|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153735918|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153735919|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746954|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
153746955|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746956|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746957|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747002|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747003|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153747004|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153747005|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747006|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747007|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153747008|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
153747013|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
153747014|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153747015|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153747016|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153747017|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747018|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747020|NCT00152633|Metoprolol|metoprolol|mesh-list
153747021|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153747022|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747023|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153747024|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153747025|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810902|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861837|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861839|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
153861849|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
153861850|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861852|NCT00553124|Selenium|selenium|mesh-list
153861853|NCT00553124|Vitamins|vitamins|mesh-ancestor
153861854|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
153861855|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861856|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
153861857|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861858|NCT00553124|Protective Agents|protective agents|mesh-ancestor
153861859|NCT00553124|Trace Elements|trace elements|mesh-ancestor
153747026|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
153747027|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
153747028|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747029|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747030|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153747031|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153747032|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153747033|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747034|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747049|NCT03457753|Riluzole|riluzole|mesh-list
153747050|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
153747051|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153747052|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153910741|NCT02780011|Immunologic Factors|immunologic factors|mesh-ancestor
153747053|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747054|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747055|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747056|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153747057|NCT03457753|Protective Agents|protective agents|mesh-ancestor
153747058|NCT02936830|Listerine|listerine|mesh-list
153747059|NCT02936830|Fluorides|fluorides|mesh-list
153747060|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
153747061|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
153747062|NCT02936830|Glycerol|glycerol|mesh-list
153747063|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
153747064|NCT02936830|Protective Agents|protective agents|mesh-ancestor
153747065|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747066|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153747067|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747068|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153747069|NCT00165048|Rofecoxib|rofecoxib|mesh-list
153747070|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153747071|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153747072|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747073|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747074|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747075|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747076|NCT00165048|Analgesics|analgesics|mesh-ancestor
153747096|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153747098|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747100|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153747111|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
153747112|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
153747113|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153402220|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861881|NCT00559455|Antidotes|antidotes|mesh-ancestor
153861882|NCT00559455|Protective Agents|protective agents|mesh-ancestor
153861883|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
153861884|NCT00559455|Vitamins|vitamins|mesh-ancestor
153861885|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
153861886|NCT00559494|Minocycline|minocycline|mesh-list
153861887|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153861888|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747114|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153747115|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153747116|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747117|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747118|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747119|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
153747120|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153747121|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153747122|NCT00152828|Celecoxib|celecoxib|mesh-list
153747123|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747124|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747125|NCT00152828|Analgesics|analgesics|mesh-ancestor
153747126|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
153747127|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747128|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747129|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747130|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747131|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153747163|NCT00152867|Hormones|hormones|mesh-ancestor
153747164|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153747165|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153747166|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747167|NCT02935972|Lidocaine|lidocaine|mesh-list
153747168|NCT02935972|Diazepam|diazepam|mesh-list
153747169|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
153747170|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
153747171|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747172|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747198|NCT02935855|Dabigatran|dabigatran|mesh-list
153747206|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747207|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747208|NCT02935582|Betamethasone|betamethasone|mesh-list
153747209|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
153747210|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153747211|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
153747212|NCT02935582|Calcipotriene|calcipotriene|mesh-list
153747213|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153747214|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153402263|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153402264|NCT05516849|Oxandrolone|oxandrolone|mesh-list
153402265|NCT05516849|Androgens|androgens|mesh-ancestor
153402266|NCT05516849|Hormones|hormones|mesh-ancestor
153402267|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153402268|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402269|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
153402270|NCT05510427|Bevacizumab|bevacizumab|mesh-list
153888649|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861932|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
153747215|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
153747216|NCT02935582|Hormones|hormones|mesh-ancestor
153747217|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153747218|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747219|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153747220|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
153747221|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
153747222|NCT00406172|Bevacizumab|bevacizumab|mesh-list
153747223|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153747224|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747225|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153747226|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153747227|NCT00406172|Growth Substances|growth substances|mesh-ancestor
153747228|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747229|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
153747230|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153747231|NCT00152945|Glycerol|glycerol|mesh-list
153747286|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153747287|NCT02934919|Nalmefene|nalmefene|mesh-list
153747288|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153747289|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747290|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
153747291|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747292|NCT00172419|Atorvastatin|atorvastatin|mesh-list
153747293|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153747294|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153747295|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
153747296|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747297|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153747298|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153747299|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402290|NCT05493501|Osimertinib|osimertinib|mesh-list
153402291|NCT05493501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153402292|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402293|NCT05493501|Tubulin Modulators|tubulin modulators|mesh-ancestor
153402294|NCT05493501|Antimitotic Agents|antimitotic agents|mesh-ancestor
153402295|NCT05493501|Mitosis Modulators|mitosis modulators|mesh-ancestor
153402296|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402297|NCT05493501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153402298|NCT05493501|Antimetabolites|antimetabolites|mesh-ancestor
153402299|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402300|NCT05493501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153402301|NCT05493501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153402302|NCT05493501|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153402303|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402304|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
153402305|NCT05478278|Psilocybin|psilocybin|mesh-list
153861964|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
153861965|NCT04628559|Ketamine|ketamine|mesh-list
153861966|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153747300|NCT00153023|Valsartan|valsartan|mesh-list
153747301|NCT00153023|Telmisartan|telmisartan|mesh-list
153747302|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747303|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153747304|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153735920|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747305|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747306|NCT00165204|Tibolone|tibolone|mesh-list
153747307|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
153747308|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
153747309|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153747310|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747311|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747312|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153747313|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747314|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153747315|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
153747325|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747326|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
153747327|NCT04689958|Vitamin D|vitamin d|mesh-list
153747328|NCT04689958|Vitamins|vitamins|mesh-ancestor
153747329|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
153747330|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747331|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153747332|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153747333|NCT00153140|Laxatives|laxatives|mesh-ancestor
153747334|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153747335|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153747336|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153747337|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
153747338|NCT00153296|Carbamazepine|carbamazepine|mesh-list
153747339|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
153747340|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
153861972|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861973|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153861974|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153861975|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153861976|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
153861977|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861978|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861979|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153861980|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153747341|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153747342|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483306|NCT04082442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747371|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
153747372|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153747373|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153747374|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
153747375|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
153747376|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153747377|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153747378|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153747379|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747380|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747381|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747383|NCT02934217|Cyclosporins|cyclosporins|mesh-list
153747384|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747385|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747386|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153747387|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
153747401|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153747402|NCT02933905|Growth Substances|growth substances|mesh-ancestor
153747403|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747404|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
153747405|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747406|NCT02933788|Aspirin|aspirin|mesh-list
153747407|NCT02933788|Cilostazol|cilostazol|mesh-list
153747408|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747409|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747410|NCT02933788|Analgesics|analgesics|mesh-ancestor
153747411|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
153747412|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747413|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747414|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747415|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747416|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153747417|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153747418|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153584488|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153747419|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153747420|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153747421|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747423|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153747424|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
153747425|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153747426|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
153747427|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
153747428|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153747429|NCT02933788|Protective Agents|protective agents|mesh-ancestor
153747433|NCT00165399|Goserelin|goserelin|mesh-list
153747446|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153747447|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
153747448|NCT02933593|Labetalol|labetalol|mesh-list
153747449|NCT02933593|Hydralazine|hydralazine|mesh-list
153747450|NCT02933593|Nifedipine|nifedipine|mesh-list
153747451|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153747452|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153747453|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483420|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
153747463|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747464|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
153747465|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
153747466|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747467|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153747515|NCT00165516|Protective Agents|protective agents|mesh-ancestor
153747516|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402350|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153747517|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
153747518|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747527|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747529|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153747530|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
153747531|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153747532|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747533|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153747534|NCT00407784|Diuretics|diuretics|mesh-ancestor
153747535|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
153747536|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153747537|NCT02932774|Cetirizine|cetirizine|mesh-list
153747538|NCT02932774|Loratadine|loratadine|mesh-list
153747539|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153747540|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153747541|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153747542|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
153747543|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
153747544|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747545|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747546|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747547|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
153747574|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153747575|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
153747576|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747577|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747578|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
153747579|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747580|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153747581|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
153747582|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747583|NCT00180102|Analgesics|analgesics|mesh-ancestor
153747584|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
153747585|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747586|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153747596|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747597|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
153747598|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
153747599|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
153747600|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747601|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153862035|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153862036|NCT01214434|Emollients|emollients|mesh-list
153862037|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
153862038|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
153862039|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153862040|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862041|NCT01214239|Linagliptin|linagliptin|mesh-list
153862042|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153862043|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862044|NCT01214239|Incretins|incretins|mesh-ancestor
153862045|NCT01214239|Hormones|hormones|mesh-ancestor
153862046|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862048|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
153747602|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
153747603|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
153747604|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747605|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747606|NCT00180141|Analgesics|analgesics|mesh-ancestor
153747607|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
153747608|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747609|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747611|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747627|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153747628|NCT00153998|Leucovorin|leucovorin|mesh-list
153747629|NCT00153998|Folic Acid|folic acid|mesh-list
153747630|NCT00153998|Fluorouracil|fluorouracil|mesh-list
153747631|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
153747632|NCT00153998|Irinotecan|irinotecan|mesh-list
153747633|NCT00153998|Cetuximab|cetuximab|mesh-list
153747634|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
153747635|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
153747636|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747637|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153747638|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747639|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153747640|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
153747641|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747642|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153747643|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153747644|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747645|NCT00153998|Antidotes|antidotes|mesh-ancestor
153747646|NCT00153998|Protective Agents|protective agents|mesh-ancestor
153747647|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
153747649|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
153747650|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153747651|NCT00153998|Hematinics|hematinics|mesh-ancestor
153747652|NCT02925130|Albuterol|albuterol|mesh-list
153747653|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153747654|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
153747655|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747656|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747657|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153747680|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153386471|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747693|NCT00154076|Zonisamide|zonisamide|mesh-list
153402417|NCT05308901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402418|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402419|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402420|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862078|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862079|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862081|NCT04657107|Esketamine|esketamine|mesh-list
153862082|NCT04657107|Analgesics|analgesics|mesh-ancestor
153862083|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
153747694|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
153747695|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153747696|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747697|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153747698|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153747699|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747700|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153747701|NCT00154115|Simendan|simendan|mesh-list
153747702|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153747703|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
153747704|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153747705|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153747706|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747707|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747708|NCT00154115|Protective Agents|protective agents|mesh-ancestor
153747709|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747710|NCT02924506|Meloxicam|meloxicam|mesh-list
153747711|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747712|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747722|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747723|NCT02924233|Nivolumab|nivolumab|mesh-list
153747724|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153747725|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747726|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153747727|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747728|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153747729|NCT02923999|Antibodies|antibodies|mesh-list
153747730|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
153747731|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153747732|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
153747733|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747734|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747735|NCT00154193|Cyclosporine|cyclosporine|mesh-list
153747738|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747739|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153747740|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
153747741|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747742|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
153747743|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747744|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
153747745|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747746|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153747747|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
153747748|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153747749|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747750|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153747751|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
153747752|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153747753|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747754|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747755|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747756|NCT00154271|Valsartan|valsartan|mesh-list
153747757|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153862101|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153862102|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153862103|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
153862104|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
153862105|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862106|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862107|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862108|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
153747758|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153747759|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153747760|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747761|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
153747762|NCT00154349|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153747763|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153747764|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747765|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747766|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747767|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
153747782|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747783|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747784|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747785|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747786|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153747787|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747788|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747789|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
153747790|NCT00154388|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153747791|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153584867|NCT01763281|Hormones|hormones|mesh-ancestor
153747792|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747793|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747794|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747796|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747797|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
153747798|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
153747799|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
153747800|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747801|NCT02923336|Propranolol|propranolol|mesh-list
153747802|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153747803|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153747804|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747805|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747806|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747807|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747808|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153747826|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747827|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747828|NCT02922673|Aspirin|aspirin|mesh-list
153747829|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747830|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153402491|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402492|NCT05154136|Itraconazole|itraconazole|mesh-list
153402493|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
153862147|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862148|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
153862149|NCT04711304|Protective Agents|protective agents|mesh-ancestor
153862150|NCT04710719|Triamcinolone|triamcinolone|mesh-list
153862151|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153862157|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153747831|NCT02922673|Analgesics|analgesics|mesh-ancestor
153747832|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
153747833|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747834|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747835|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747836|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747837|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153747838|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153452453|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735921|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153747839|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747840|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153747841|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153747842|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747843|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
153747844|NCT02922283|Interleukin-2|interleukin-2|mesh-list
153747845|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153584942|NCT01763658|Antioxidants|antioxidants|mesh-list
153747864|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747865|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153747866|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153747890|NCT04689100|Protective Agents|protective agents|mesh-ancestor
153747891|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
153747892|NCT04689100|Vitamins|vitamins|mesh-ancestor
153747893|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
153747894|NCT00188136|Fludarabine|fludarabine|mesh-list
153747895|NCT00188136|Melphalan|melphalan|mesh-list
153747896|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747897|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747898|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153747899|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
153747900|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747901|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153747906|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747907|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153747908|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153747910|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747911|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
153747912|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153747913|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153747914|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747915|NCT02921269|Bevacizumab|bevacizumab|mesh-list
153747916|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153747917|NCT02921269|Atezolizumab|atezolizumab|mesh-list
153747918|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
153747919|NCT02921269|Antibodies|antibodies|mesh-list
153747920|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
153747921|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153747922|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
153459872|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459873|NCT05622071|Tislelizumab|tislelizumab|mesh-list
153459874|NCT05622071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459875|NCT05622071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459876|NCT05566054|Azacitidine|azacitidine|mesh-list
153459877|NCT05566054|Venetoclax|venetoclax|mesh-list
153459878|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153402536|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
153402537|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402538|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
153402539|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
153402540|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
153402541|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402542|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402543|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
153459879|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
153592582|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592583|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592584|NCT01828203|Minocycline|minocycline|mesh-list
153592585|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153592586|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592587|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
153592588|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153592589|NCT01828294|Antibodies|antibodies|mesh-list
153592590|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
153592591|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592592|NCT01828346|Azacitidine|azacitidine|mesh-list
153747923|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747924|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153747925|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153747926|NCT02921269|Growth Substances|growth substances|mesh-ancestor
153747927|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747928|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
153747929|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
153747930|NCT02921269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153747931|NCT02921269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747932|NCT00406406|Bosutinib|bosutinib|mesh-list
153747933|NCT00406406|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153747934|NCT00406406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153735922|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735923|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747935|NCT00406406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747936|NCT00406406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747938|NCT02920801|Saxagliptin|saxagliptin|mesh-list
153747939|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153747940|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747941|NCT02920801|Incretins|incretins|mesh-ancestor
153747942|NCT02920801|Hormones|hormones|mesh-ancestor
153747943|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153747944|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153747945|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
153747946|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747947|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747948|NCT00180843|Bromides|bromides|mesh-list
153747949|NCT00180843|Albuterol|albuterol|mesh-list
153747950|NCT00180843|Ipratropium|ipratropium|mesh-list
153862229|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862230|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862231|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153862232|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
153862233|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862234|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862235|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153862237|NCT04626726|Fludarabine|fludarabine|mesh-list
153862238|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862239|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
153862240|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862241|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862242|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153862243|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
153862245|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747965|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747966|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153747967|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
153747968|NCT02920567|Octreotide|octreotide|mesh-list
153747969|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153747970|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153747971|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747972|NCT00180882|Rituximab|rituximab|mesh-list
153747992|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747993|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153747995|NCT02920489|Analgesics|analgesics|mesh-ancestor
153747996|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153747997|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153747998|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
153747999|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
153748000|NCT02920372|Hematinics|hematinics|mesh-ancestor
153748001|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
153748002|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153748003|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748004|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748005|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153748006|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153748007|NCT00154661|Protective Agents|protective agents|mesh-ancestor
153748008|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748009|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
153748010|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153748011|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
153748012|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
153748013|NCT00180960|Irinotecan|irinotecan|mesh-list
153748014|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748015|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153748016|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153748017|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748018|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748019|NCT00154700|Folic Acid|folic acid|mesh-list
153452454|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
153735925|NCT04033237|Nicotine|nicotine|mesh-list
153735926|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153735927|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
153735928|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735929|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748026|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810913|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862281|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862282|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
153862283|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862284|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862285|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
153402624|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
153748027|NCT00154700|Hematinics|hematinics|mesh-ancestor
153748028|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
153748029|NCT00154700|Vitamins|vitamins|mesh-ancestor
153748058|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748059|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153748060|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153748061|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153748062|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748063|NCT00154778|Leucovorin|leucovorin|mesh-list
153748064|NCT00154778|Antidotes|antidotes|mesh-ancestor
153748065|NCT00154778|Protective Agents|protective agents|mesh-ancestor
153748066|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748067|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
153748068|NCT00154778|Vitamins|vitamins|mesh-ancestor
153748069|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
153748070|NCT02919202|Listerine|listerine|mesh-list
153748071|NCT02919202|Fluorides|fluorides|mesh-list
153748072|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
153748073|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
153748074|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
153748075|NCT02919202|Protective Agents|protective agents|mesh-ancestor
153748076|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748077|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153748078|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748079|NCT00154895|Minocycline|minocycline|mesh-list
153748116|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
153748117|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
153748118|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153748119|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153748138|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153748139|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748140|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748141|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
153748142|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153748143|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748144|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748145|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153748146|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153748147|NCT00155246|Protective Agents|protective agents|mesh-ancestor
153748148|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748149|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
153748150|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153748151|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
153748152|NCT02909413|Sevoflurane|sevoflurane|mesh-list
153748153|NCT02909413|Desflurane|desflurane|mesh-list
153748154|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153748155|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153748156|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
153748157|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
153748158|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748159|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748160|NCT02909257|Bupivacaine|bupivacaine|mesh-list
153748161|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
153748162|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
153748163|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748164|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748197|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153748198|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153748199|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153748200|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748201|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810914|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862304|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153862305|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
153862306|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862314|NCT04626063|Analgesics|analgesics|mesh-ancestor
153748202|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748203|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748204|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153748205|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
153748206|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748207|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
153748208|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153748209|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153748210|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153748211|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748212|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748213|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153748214|NCT00533299|Hydralazine|hydralazine|mesh-list
153748215|NCT00533299|Valproic Acid|valproic acid|mesh-list
153748216|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
153748217|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748218|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748219|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
153748220|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748221|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748222|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
153748223|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748240|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748241|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748242|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748243|NCT00533416|ON 01910|on 01910|mesh-list
153748244|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748245|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153484220|NCT01611948|Aprepitant|aprepitant|mesh-list
153748282|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
153748283|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452455|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748285|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748321|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748322|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748323|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
153748344|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
153748345|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748346|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748347|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153748348|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748349|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
153748408|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153748409|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
153748410|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748411|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153748412|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153748413|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748414|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748415|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
153748416|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748417|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748418|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153748419|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153748455|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
153862346|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862347|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862348|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862349|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862350|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153862351|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153862352|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402687|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748456|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748457|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153748458|NCT00181935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153748459|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153484468|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748471|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153748501|NCT02500147|Metformin|metformin|mesh-list
153748502|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153748503|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748504|NCT00182013|Olanzapine|olanzapine|mesh-list
153748505|NCT00182013|Risperidone|risperidone|mesh-list
153748506|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153748507|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153748508|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
153748509|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748510|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748511|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748512|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153748513|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748514|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748515|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748516|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153748517|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
153748518|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
153748519|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
153748520|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748521|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153748562|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153748563|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748564|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748565|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153748566|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
153748567|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
153748568|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153748569|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153748570|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748571|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748572|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
153748573|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
153748574|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748575|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748576|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153748577|NCT04686058|Narcotics|narcotics|mesh-ancestor
153748578|NCT04686058|Analgesics|analgesics|mesh-ancestor
153748579|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
153748580|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748630|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153748631|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153748632|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153748633|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153748634|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748635|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748636|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
153748637|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153748638|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153748639|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153748640|NCT05470582|Vaccines|vaccines|mesh-list
153748641|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
153748642|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421592|NCT05709652|Ivermectin|ivermectin|mesh-list
153748643|NCT00156377|Mupirocin|mupirocin|mesh-list
153748644|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153748645|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748697|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153748698|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153748699|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748700|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862374|NCT02905058|Ketoprofen|ketoprofen|mesh-list
153748701|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
153748702|NCT00156611|Abciximab|abciximab|mesh-list
153748703|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
153748704|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153748705|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153748706|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
153748707|NCT00156650|Testosterone|testosterone|mesh-list
153748708|NCT00156650|Acyline|acyline|mesh-list
153748709|NCT00156650|Androgens|androgens|mesh-ancestor
153748710|NCT00156650|Hormones|hormones|mesh-ancestor
153748711|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748712|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748713|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153748714|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748715|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153748716|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153748717|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153748718|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
153748719|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153748720|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153748721|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153748722|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153748723|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
153748724|NCT00536419|Methylphenidate|methylphenidate|mesh-list
153748769|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748778|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748781|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
153748782|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
153748783|NCT00536653|Vitamins|vitamins|mesh-list
153748784|NCT00536653|Goserelin|goserelin|mesh-list
153748785|NCT00536653|Bicalutamide|bicalutamide|mesh-list
153748786|NCT00536653|Calcium|calcium|mesh-list
153748787|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153748788|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
153748789|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748790|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153748791|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153748792|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153748793|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748794|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
153748795|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
153748796|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748797|NCT00536653|Hormones|hormones|mesh-ancestor
153748798|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
153748799|NCT05467852|Progestins|progestins|mesh-ancestor
153748800|NCT05467852|Hormones|hormones|mesh-ancestor
153748801|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748802|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748803|NCT00536692|Mecamylamine|mecamylamine|mesh-list
153748804|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153748805|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153748806|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
153810915|NCT00331188|Vapreotide|vapreotide|mesh-list
153402777|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
153402778|NCT04865887|Lenvatinib|lenvatinib|mesh-list
153402779|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402780|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402781|NCT04865887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402782|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402784|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748807|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748808|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748809|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153748810|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153748821|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748822|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153748823|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748824|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
153748825|NCT00156962|Hematinics|hematinics|mesh-ancestor
153748826|NCT00182442|Olanzapine|olanzapine|mesh-list
153748827|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153748828|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
153748829|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
153748830|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748831|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748832|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153748833|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153748834|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748835|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748836|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748837|NCT00182442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153748838|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153748839|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748840|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748848|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
153748849|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748850|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748851|NCT00536770|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153748852|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153748853|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748854|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153748855|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748856|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153748857|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748858|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153748859|NCT00536770|Vitamins|vitamins|mesh-ancestor
153748860|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
153748861|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153748862|NCT04685512|Tenofovir|tenofovir|mesh-list
153748864|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
153748865|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748866|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153748867|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153748868|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748869|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748870|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153748871|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153748872|NCT00157040|Factor VIII|factor viii|mesh-list
153748873|NCT00157040|Coagulants|coagulants|mesh-ancestor
153748874|NCT00189384|Gentamicins|gentamicins|mesh-list
153748875|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
153748876|NCT00189384|Penicillins|penicillins|mesh-list
153748877|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153748878|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
153748879|NCT00189384|Penicillin G|penicillin g|mesh-list
153748880|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153748881|NCT00189384|Procaine|procaine|mesh-list
153748882|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153748883|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748884|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153748885|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748886|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748887|NCT00189384|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153748888|NCT00189384|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153748890|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
153862469|NCT04652427|Analgesics|analgesics|mesh-ancestor
153748937|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748938|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
153748939|NCT00182520|Topiramate|topiramate|mesh-list
153748940|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
153748941|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153748942|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748943|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
153748944|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153748945|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748946|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
153748947|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
153748948|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153748949|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
153748950|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748951|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153748952|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153748953|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153748954|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153748955|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748956|NCT00182559|Cyclosporine|cyclosporine|mesh-list
153748957|NCT00182559|Tacrolimus|tacrolimus|mesh-list
153748958|NCT00182559|Cyclosporins|cyclosporins|mesh-list
153748959|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153748960|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
153748991|NCT00189618|Clopidogrel|clopidogrel|mesh-list
153748992|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153748993|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748994|NCT00189618|Analgesics|analgesics|mesh-ancestor
153748995|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
153748996|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748997|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748998|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153748999|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862508|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862509|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153862510|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153862511|NCT00562185|Carboplatin|carboplatin|mesh-list
153862512|NCT00562185|Doxorubicin|doxorubicin|mesh-list
153862513|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153862514|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862515|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153862516|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153749019|NCT00534391|Polymyxins|polymyxins|mesh-list
153749022|NCT00534391|Gramicidin|gramicidin|mesh-list
153749023|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
153749024|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153749025|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153749026|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749027|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749028|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153749029|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749030|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749031|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153749032|NCT00534508|Tacrolimus|tacrolimus|mesh-list
153749033|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153749034|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
153749035|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749036|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153749037|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749038|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749039|NCT00182715|Leucovorin|leucovorin|mesh-list
153749040|NCT00182715|Capecitabine|capecitabine|mesh-list
153749041|NCT00182715|Fluorouracil|fluorouracil|mesh-list
153749042|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
153749043|NCT00182715|Cetuximab|cetuximab|mesh-list
153749044|NCT00182715|Calcium|calcium|mesh-list
153749045|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
153749046|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153749047|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749048|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749049|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
153749050|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749051|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749053|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
153386944|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
153735936|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735937|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153735938|NCT04009967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153749065|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153749066|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485052|NCT01758588|Interferons|interferons|mesh-list
153749092|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749093|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153749094|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862523|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862524|NCT02903069|Temozolomide|temozolomide|mesh-list
153862525|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153862526|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
153862527|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862528|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862529|NCT04623840|Tadalafil|tadalafil|mesh-list
153862530|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
153862531|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153862532|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153862533|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862534|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749095|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153749096|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749097|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749167|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
153749168|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749169|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153749206|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749207|NCT00182871|Testosterone|testosterone|mesh-list
153749208|NCT00182871|Androgens|androgens|mesh-ancestor
153749210|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153749211|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749212|NCT00189774|Nateglinide|nateglinide|mesh-list
153749213|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153749214|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749215|NCT04686643|Niacin|niacin|mesh-list
153749216|NCT04686643|Amlodipine|amlodipine|mesh-list
153749217|NCT04686643|Valsartan|valsartan|mesh-list
153749218|NCT04686643|Indapamide|indapamide|mesh-list
153749219|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153749220|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153749221|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749222|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749223|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153749224|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749225|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
153749226|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153749227|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153749228|NCT04686643|Diuretics|diuretics|mesh-ancestor
153749229|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
153749230|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153749250|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153749251|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749252|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153749253|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153749254|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
153749255|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
153749256|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749257|NCT00157859|Chloroquine|chloroquine|mesh-list
153749258|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
153749259|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
153749260|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153749261|NCT00157859|Amebicides|amebicides|mesh-ancestor
153749262|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153749263|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153749264|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749320|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153749321|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749322|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153749323|NCT03429946|Diuretics|diuretics|mesh-ancestor
153749324|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
153749325|NCT00189930|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153749326|NCT00189930|Antiviral Agents|antiviral agents|mesh-ancestor
153749327|NCT00189930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749329|NCT00158132|Propranolol|propranolol|mesh-list
153749330|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153749331|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153749332|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
153749333|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749334|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749335|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749367|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749368|NCT00158210|Rivastigmine|rivastigmine|mesh-list
153749369|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153749414|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153749415|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153749416|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153749417|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
153749418|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153749419|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153749420|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153749421|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153749422|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153749424|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
153749425|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749426|NCT00158522|Interferons|interferons|mesh-list
153749427|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
153749428|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
153749429|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153749430|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749431|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
153749432|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749433|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
153749434|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749435|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
153749436|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
153749437|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153749438|NCT00158561|Dapsone|dapsone|mesh-list
153749439|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
153749440|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
153749441|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153749442|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153749443|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749444|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153749450|NCT05169229|Vancomycin|vancomycin|mesh-list
153749463|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749464|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153749465|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749466|NCT00538330|Tamoxifen|tamoxifen|mesh-list
153749467|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153749468|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
153749469|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153749470|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749471|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153749534|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153749535|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
153749536|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749537|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749538|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153749539|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
153749540|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
153749541|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153749542|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153749543|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153749544|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153749545|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
153749548|NCT00538720|Vitamin D|vitamin d|mesh-list
153749606|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153402962|NCT04575311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402963|NCT04575311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402964|NCT04575311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402965|NCT04565730|Anesthetics|anesthetics|mesh-list
153402986|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153402987|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402988|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
153402989|NCT04521569|Regadenoson|regadenoson|mesh-list
153749607|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749608|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749609|NCT00537121|Antidotes|antidotes|mesh-ancestor
153749610|NCT00537121|Protective Agents|protective agents|mesh-ancestor
153749611|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
153749612|NCT00537121|Vitamins|vitamins|mesh-ancestor
153749613|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
153749614|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153749615|NCT00406991|Aspirin|aspirin|mesh-list
153749616|NCT00406991|Clopidogrel|clopidogrel|mesh-list
153749617|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153749618|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153749619|NCT00406991|Analgesics|analgesics|mesh-ancestor
153749620|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
153749621|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749622|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749623|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153749624|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153749625|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153749626|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153749627|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749674|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
153749675|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153749676|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749678|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749679|NCT00159107|Acamprosate|acamprosate|mesh-list
153749680|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153749681|NCT00537550|Methotrexate|methotrexate|mesh-list
153749682|NCT00537550|Vincristine|vincristine|mesh-list
153749683|NCT00537550|Asparaginase|asparaginase|mesh-list
153749684|NCT00537550|Daunorubicin|daunorubicin|mesh-list
153749685|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153749686|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
153749687|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153749688|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862638|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
153862639|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862641|NCT04622982|Vitamins|vitamins|mesh-ancestor
153862642|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
153862643|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862644|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153862645|NCT04622202|Pregabalin|pregabalin|mesh-list
153862646|NCT04622202|Analgesics|analgesics|mesh-ancestor
153862647|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
153749689|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749690|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
153749691|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749692|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749693|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
153749694|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749697|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
153749731|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153749733|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749734|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749735|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749736|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153749737|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153749738|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153749739|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153749740|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153749741|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
153749742|NCT00539149|Amoxicillin|amoxicillin|mesh-list
153749743|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749744|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749745|NCT00183807|Celecoxib|celecoxib|mesh-list
153749746|NCT00183807|Irinotecan|irinotecan|mesh-list
153749747|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749805|NCT00540202|Quinine|quinine|mesh-list
153749806|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
153749807|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153749808|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153749809|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749810|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153749811|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749812|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153749813|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749814|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153749815|NCT00540202|Analgesics|analgesics|mesh-ancestor
153749816|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
153749817|NCT00540241|Pemetrexed|pemetrexed|mesh-list
153749818|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749819|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749820|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749821|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153749822|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153749823|NCT00159224|Ritonavir|ritonavir|mesh-list
153749824|NCT00159224|Lopinavir|lopinavir|mesh-list
153749825|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153749826|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153749827|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
153749828|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749836|NCT00540280|Gemcitabine|gemcitabine|mesh-list
153749862|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749863|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153749864|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
153749865|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
153749866|NCT00159302|Protective Agents|protective agents|mesh-ancestor
153749867|NCT00540631|Immunomodulating Agents|immunomodulating agents|mesh-list
153749868|NCT00540631|Immunologic Factors|immunologic factors|mesh-ancestor
153749869|NCT00540631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749871|NCT00183885|Mitomycin|mitomycin|mesh-list
153749872|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749873|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153749874|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
153749875|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749876|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153749877|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749878|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
153749879|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153749880|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749881|NCT00540748|Oxytocin|oxytocin|mesh-list
153749882|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
153749883|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153749884|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749885|NCT00540787|Quinidine|quinidine|mesh-list
153749919|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749920|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153749921|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153749922|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
153749923|NCT00159380|Pimagedine|pimagedine|mesh-list
153749924|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749925|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749926|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153749927|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153749928|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153749929|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749930|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749931|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
153749932|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749933|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749934|NCT00540943|Irinotecan|irinotecan|mesh-list
153749935|NCT00540943|Cetuximab|cetuximab|mesh-list
153749936|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153749937|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749938|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749939|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749940|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749941|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153749968|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153749969|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153749970|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153749971|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153749972|NCT00541177|Atropine|atropine|mesh-list
153749973|NCT00541177|Tropicamide|tropicamide|mesh-list
153749974|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153749975|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153749976|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153749978|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862701|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862702|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
153862703|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153862704|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
153862705|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862706|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153862707|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862708|NCT02901236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862709|NCT04621617|Midodrine|midodrine|mesh-list
153862710|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
153862711|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
153862712|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862721|NCT01212757|Thalidomide|thalidomide|mesh-list
153749979|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750005|NCT00541372|Insulin|insulin|mesh-list
153750080|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750082|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750083|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153750084|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750085|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750086|NCT00190476|Docetaxel|docetaxel|mesh-list
153750087|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750088|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
153750089|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
153750090|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
153750091|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750092|NCT00159653|Timolol|timolol|mesh-list
153750093|NCT00159653|Latanoprost|latanoprost|mesh-list
153750094|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153750095|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153750096|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
153750153|NCT00159731|Pregabalin|pregabalin|mesh-list
153750154|NCT00159731|Analgesics|analgesics|mesh-ancestor
153750155|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
153750156|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750157|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750158|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
153750159|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153750160|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750161|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750162|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153750163|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153750164|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153750165|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750166|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750167|NCT00408915|Lisuride|lisuride|mesh-list
153750168|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153750169|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153750170|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153750171|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
153750172|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750173|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750174|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750175|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
153750176|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
153750177|NCT00542347|Esomeprazole|esomeprazole|mesh-list
153750178|NCT00542347|Omeprazole|omeprazole|mesh-list
153750179|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153750180|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153750181|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153587256|NCT01779609|Bosentan|bosentan|mesh-list
153750200|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750201|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750202|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153750203|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153750204|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750206|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153750207|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
153750208|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
153750209|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
153750210|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750211|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153750212|NCT00159770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153750213|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750214|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750215|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750216|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153750217|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153750218|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
153750219|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750220|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750221|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153750222|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153750223|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153750224|NCT00542893|Dacarbazine|dacarbazine|mesh-list
153750225|NCT00542893|Oblimersen|oblimersen|mesh-list
153750227|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
153750291|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750292|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750294|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
153750295|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153750296|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153750297|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
153750298|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750299|NCT00543205|Oblimersen|oblimersen|mesh-list
153750300|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750301|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
153750302|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750303|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
153750304|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153750305|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153750306|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750309|NCT00543244|Ribavirin|ribavirin|mesh-list
153750365|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153750366|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750367|NCT00543634|Estrogens|estrogens|mesh-ancestor
153750368|NCT00543634|Hormones|hormones|mesh-ancestor
153750369|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750370|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
153750371|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153750372|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750373|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750374|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
153750375|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750376|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750377|NCT00543829|Tamoxifen|tamoxifen|mesh-list
153750378|NCT00543829|Docetaxel|docetaxel|mesh-list
153750379|NCT00543829|Doxorubicin|doxorubicin|mesh-list
153750380|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153750381|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750382|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
153750383|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
153750384|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
153750385|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750386|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153750387|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153750388|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153750389|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750390|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153750391|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
153750392|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750393|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750394|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153750395|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153750396|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153750397|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153750398|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153750399|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153403147|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
153750401|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750402|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750403|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750404|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750405|NCT00190827|Analgesics|analgesics|mesh-ancestor
153750406|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
153750407|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750408|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750409|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750428|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153750430|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
153750431|NCT00544219|Rituximab|rituximab|mesh-list
153750432|NCT00544219|Doxorubicin|doxorubicin|mesh-list
153750433|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153750434|NCT00544219|Vincristine|vincristine|mesh-list
153750435|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750436|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
153750437|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750438|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750439|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153750440|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
153750441|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750442|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750443|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153750444|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153750445|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153750446|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153750494|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153750495|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750496|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750497|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750498|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750499|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750501|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
153750502|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750503|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750504|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750530|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750531|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750532|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750533|NCT00544804|Lapatinib|lapatinib|mesh-list
153750534|NCT00544804|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153750535|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153750536|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750537|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750539|NCT00160277|Moxonidine|moxonidine|mesh-list
153387625|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810917|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
153357495|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153888652|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153862797|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153862798|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
153862799|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862801|NCT04621110|Fentanyl|fentanyl|mesh-list
153862802|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
153862803|NCT04621110|Ketamine|ketamine|mesh-list
153750580|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750581|NCT00160316|Progestins|progestins|mesh-ancestor
153750582|NCT00545194|Dinoprostone|dinoprostone|mesh-list
153750583|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
153750584|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153750585|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750586|NCT00190944|Teriparatide|teriparatide|mesh-list
153750587|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153750588|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750589|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153750590|NCT03456466|Rituximab|rituximab|mesh-list
153750591|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153750592|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750593|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
153750594|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750595|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750596|NCT00160355|Fludarabine|fludarabine|mesh-list
153750597|NCT00160355|Melphalan|melphalan|mesh-list
153750598|NCT00160355|Thiotepa|thiotepa|mesh-list
153750599|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750601|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750653|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750654|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750655|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
153750656|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
153750657|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750658|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750659|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153750660|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153750661|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
153750662|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153750663|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153750664|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153750665|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153750667|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153750668|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750669|NCT00545935|Artesunate|artesunate|mesh-list
153750670|NCT00545935|Amodiaquine|amodiaquine|mesh-list
153750671|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
153750672|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153750705|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750708|NCT00546130|Cisplatin|cisplatin|mesh-list
153750756|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153750757|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750758|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750759|NCT00546325|Hormones|hormones|mesh-ancestor
153750760|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750761|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750762|NCT00546403|Modafinil|modafinil|mesh-list
153750763|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153750764|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750765|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153750766|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153750767|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153750768|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750769|NCT00546442|Metformin|metformin|mesh-list
153750770|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153403222|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
153750771|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750772|NCT00191256|Paclitaxel|paclitaxel|mesh-list
153750773|NCT00191256|Carboplatin|carboplatin|mesh-list
153750774|NCT00191256|Gemcitabine|gemcitabine|mesh-list
153750783|NCT00546520|Ciclesonide|ciclesonide|mesh-list
153750784|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
153750785|NCT00546520|Hormones|hormones|mesh-ancestor
153750786|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750787|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750788|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153750811|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153750812|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153750813|NCT00546832|Analgesics|analgesics|mesh-ancestor
153750814|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
153750815|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750816|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750817|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750818|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750819|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153750820|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153750821|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750822|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750823|NCT00184587|Candesartan|candesartan|mesh-list
153750824|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
153750825|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
153750826|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153750827|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153750828|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153750829|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750830|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153750831|NCT00547144|Gemcitabine|gemcitabine|mesh-list
153750832|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750833|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
153750834|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750835|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750836|NCT00547183|Tadalafil|tadalafil|mesh-list
153750837|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
153750838|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153750839|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153750879|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750880|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750881|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750882|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750883|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750884|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750885|NCT00547573|Tadalafil|tadalafil|mesh-list
153750886|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
153486893|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153750894|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750895|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
153750896|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750897|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750898|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153750899|NCT00547612|Substance P|substance p|mesh-list
153750900|NCT00547612|Neurokinin A|neurokinin a|mesh-list
153750901|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750902|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750903|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750904|NCT00547768|Fexofenadine|fexofenadine|mesh-list
153750905|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153750906|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153750907|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153750908|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
153750909|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
153750910|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750911|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750931|NCT00547885|Narcotics|narcotics|mesh-ancestor
153750932|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750933|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750934|NCT00547885|Analgesics|analgesics|mesh-ancestor
153750935|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
153750936|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750937|NCT00161018|Risperidone|risperidone|mesh-list
153588025|NCT01785329|Alirocumab|alirocumab|mesh-list
153750938|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153750939|NCT00161018|Fluphenazine|fluphenazine|mesh-list
153750940|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
153750941|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
153750942|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153750943|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
153750944|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750945|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750946|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750947|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153750948|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153750949|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153750950|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750951|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153750952|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
153750953|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750954|NCT00191412|Pemetrexed|pemetrexed|mesh-list
153750970|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153750972|NCT00191490|Gemcitabine|gemcitabine|mesh-list
153750996|NCT00184821|Analgesics|analgesics|mesh-ancestor
153750997|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
153750998|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750999|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751000|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153751001|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
153751002|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153751003|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
153751004|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
153751005|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751006|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751007|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153751008|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153751009|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751010|NCT00548509|Vitamin K|vitamin k|mesh-list
153751011|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
153751012|NCT00548509|Menatetrenone|menatetrenone|mesh-list
153751013|NCT00548509|Vitamins|vitamins|mesh-ancestor
153751014|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
153751025|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153751026|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153751027|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751028|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751029|NCT00548704|Protective Agents|protective agents|mesh-ancestor
153751030|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751031|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
153751055|NCT00161291|Growth Substances|growth substances|mesh-ancestor
153751056|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751057|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
153751058|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153751059|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153751060|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751061|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751062|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153751063|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
153751064|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751065|NCT00548899|Sorafenib|sorafenib|mesh-list
153751066|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751067|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153751068|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751121|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751122|NCT00549289|Cyclosporine|cyclosporine|mesh-list
153751123|NCT00549289|Cyclosporins|cyclosporins|mesh-list
153751124|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751125|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751126|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153751127|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
153751128|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751129|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
153751130|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751131|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
153751132|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751133|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153751134|NCT00184977|Fluticasone|fluticasone|mesh-list
153751135|NCT00184977|Xhance|xhance|mesh-list
153751136|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
153751137|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153751138|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153751139|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153751140|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
153751141|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751143|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153751179|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153751180|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153751181|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153751182|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751183|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751184|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751185|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751186|NCT00191685|Analgesics|analgesics|mesh-ancestor
153751187|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
153751188|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751189|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
153751190|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153751191|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
153751192|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
153751193|NCT00161486|Testosterone|testosterone|mesh-list
153751194|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
153751195|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
153751196|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153751244|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
153751245|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751246|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751247|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153751248|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153735947|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153422147|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
153751249|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153751250|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
153751251|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751252|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
153751253|NCT00550303|Estrogens|estrogens|mesh-list
153751254|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153751255|NCT00550303|Hormones|hormones|mesh-ancestor
153751256|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751257|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751258|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153751259|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153751260|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
153751261|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153751262|NCT00550342|Rituximab|rituximab|mesh-list
153751263|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153751264|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751265|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
153751266|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751267|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751268|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
153751269|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153751305|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153751306|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751307|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
153751308|NCT00550810|Sunitinib|sunitinib|mesh-list
153751309|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751310|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153751311|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153751312|NCT00550810|Growth Substances|growth substances|mesh-ancestor
153751313|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751314|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
153751315|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153751316|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751317|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751318|NCT00191841|Gemcitabine|gemcitabine|mesh-list
153751319|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751320|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153751321|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
153751322|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751323|NCT00550927|Bevacizumab|bevacizumab|mesh-list
153751324|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153751325|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751326|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153751349|NCT00551005|Etoposide|etoposide|mesh-list
153751373|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153751374|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
153751375|NCT00161759|Coagulants|coagulants|mesh-ancestor
153751376|NCT00551122|Paclitaxel|paclitaxel|mesh-list
153751377|NCT00551122|Gemcitabine|gemcitabine|mesh-list
153751378|NCT00551122|Ifosfamide|ifosfamide|mesh-list
153751379|NCT00551122|Lenograstim|lenograstim|mesh-list
153751380|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153751381|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751382|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
153751383|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
153751384|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
153751385|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751386|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153751398|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751443|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
153751444|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751445|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
153751446|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153751447|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
153751448|NCT00161837|Vaccines|vaccines|mesh-list
153751449|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
153751450|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751451|NCT00551512|Cisplatin|cisplatin|mesh-list
153751461|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153588538|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
153751462|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751463|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153751464|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
153751465|NCT00161915|Coagulants|coagulants|mesh-ancestor
153751466|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153751467|NCT00185172|Olmesartan|olmesartan|mesh-list
153751468|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153751469|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153751470|NCT00185172|Diuretics|diuretics|mesh-ancestor
153751471|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
153751472|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751473|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153751474|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153863017|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
153863018|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751475|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751476|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153751477|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153751478|NCT00191997|Olanzapine|olanzapine|mesh-list
153751479|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
153751480|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
153751481|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751482|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751483|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153751484|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153751485|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153751487|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153751490|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751491|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751492|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751493|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
153751494|NCT00551824|Mitomycins|mitomycins|mesh-list
153751495|NCT00551824|Mitomycin|mitomycin|mesh-list
153751496|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153751497|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751498|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
153751499|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751500|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153751501|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751502|NCT00185250|Interferons|interferons|mesh-list
153751503|NCT00185250|Interferon-beta|interferon-beta|mesh-list
153751504|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
153751505|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751506|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
153751507|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751508|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
153751509|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751510|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153751511|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
153751512|NCT00161993|Antibodies|antibodies|mesh-list
153751513|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
153751514|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153751515|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153751516|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
153751525|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751527|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153751545|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153751546|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153751549|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153751550|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153751551|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751552|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751553|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
153751554|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751555|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153751556|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153751557|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153751558|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153751559|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153751560|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153751561|NCT00162227|Efavirenz|efavirenz|mesh-list
153751562|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153751563|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153751617|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153751618|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153751619|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751621|NCT00162383|Debrisoquin|debrisoquin|mesh-list
153751622|NCT00162383|Mephenytoin|mephenytoin|mesh-list
153751623|NCT00162383|Caffeine|caffeine|mesh-list
153751624|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153751625|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751626|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153751627|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751628|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751629|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153751630|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153751631|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
153751632|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751645|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
153751646|NCT00162422|Albuterol|albuterol|mesh-list
153751647|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153751648|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
153751649|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751650|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751651|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153751652|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
153751653|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
153751654|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153751655|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153751656|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153751657|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153751658|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
153751659|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751660|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751661|NCT04355143|Colchicine|colchicine|mesh-list
153751662|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
153751663|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751664|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
153592593|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153751665|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
153751666|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
153751667|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751668|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751669|NCT00185445|Fludarabine|fludarabine|mesh-list
153751670|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
153751671|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751672|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153751673|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
153751674|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751675|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153751676|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
153751677|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751678|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
153751679|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153588763|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153751680|NCT04233034|Verapamil|verapamil|mesh-list
153751681|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153751682|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153751683|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751684|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751685|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153751686|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751687|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
153751688|NCT00162461|Phenytoin|phenytoin|mesh-list
153751689|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
153751690|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153751691|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153751692|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751718|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153751719|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751720|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751721|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153751722|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
153751723|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
153751724|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
153751725|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
153751726|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153751727|NCT00162734|Interferons|interferons|mesh-list
153751728|NCT00162734|Ribavirin|ribavirin|mesh-list
153751729|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
153751730|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751731|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
153751732|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751733|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
153751734|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751735|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153751736|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
153751737|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751738|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153751799|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153751808|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751809|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
153751810|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
153751811|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153751812|NCT03541447|Octreotide|octreotide|mesh-list
153751813|NCT03541447|Tolvaptan|tolvaptan|mesh-list
153751814|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153751815|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153751816|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751817|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153751818|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751819|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
153751820|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751821|NCT00192621|Lamivudine|lamivudine|mesh-list
153751822|NCT00192621|Zidovudine|zidovudine|mesh-list
153751875|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
153751876|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751877|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153751878|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153751879|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153751880|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751881|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751883|NCT00192660|Nelfinavir|nelfinavir|mesh-list
153751884|NCT00192660|Indinavir|indinavir|mesh-list
153751885|NCT00192660|Saquinavir|saquinavir|mesh-list
153751886|NCT00192660|Amprenavir|amprenavir|mesh-list
153751887|NCT00192660|Tenofovir|tenofovir|mesh-list
153751888|NCT00192660|Lamivudine|lamivudine|mesh-list
153751889|NCT00192660|Zidovudine|zidovudine|mesh-list
153751890|NCT00192660|Nevirapine|nevirapine|mesh-list
153751891|NCT00192660|Abacavir|abacavir|mesh-list
153751892|NCT00192660|Didanosine|didanosine|mesh-list
153751893|NCT00192660|Stavudine|stavudine|mesh-list
153751894|NCT00192660|Tipranavir|tipranavir|mesh-list
153751895|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
153751896|NCT00192660|Efavirenz|efavirenz|mesh-list
153751897|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153751898|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153751899|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
153751900|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751901|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751902|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153751903|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153751904|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
153751925|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
153487933|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153751931|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153751932|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751933|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751934|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
153751935|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153751936|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153751937|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153863169|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
153751938|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153751939|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751940|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751941|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751942|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751943|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153751944|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
153751945|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153751946|NCT00163319|Ciclesonide|ciclesonide|mesh-list
153751947|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
153751949|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751950|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751951|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153751964|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
153751965|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
153751966|NCT02556931|Fludarabine|fludarabine|mesh-list
153751967|NCT02556931|Tacrolimus|tacrolimus|mesh-list
153592594|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
153592595|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592596|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592597|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592598|NCT01828359|Losartan|losartan|mesh-list
153592599|NCT01828359|Amlodipine|amlodipine|mesh-list
153592600|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153592601|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153751968|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153751969|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
153751970|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751971|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751972|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153751973|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
153751974|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751975|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751976|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153751977|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153751978|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751979|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153751980|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153751981|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
153751982|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153751983|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751984|NCT00163358|Ciclesonide|ciclesonide|mesh-list
153751985|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
153751986|NCT00163358|Hormones|hormones|mesh-ancestor
153751989|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153752028|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
153752029|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
153752030|NCT00066040|Protective Agents|protective agents|mesh-ancestor
153752031|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752032|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153752033|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752034|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
153752036|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153752037|NCT00163553|Narcotics|narcotics|mesh-ancestor
153752038|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752039|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752040|NCT00163553|Analgesics|analgesics|mesh-ancestor
153752041|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
153752042|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752043|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153752044|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153752045|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
153752046|NCT00163592|Coagulants|coagulants|mesh-ancestor
153848143|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153752089|NCT05808231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752090|NCT05808231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153752091|NCT05808231|Analgesics|analgesics|mesh-ancestor
153752092|NCT05808231|Sensory System Agents|sensory system agents|mesh-ancestor
153752093|NCT05808192|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153752094|NCT05808192|Immunologic Factors|immunologic factors|mesh-ancestor
153752095|NCT05808192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752096|NCT05808049|Antioxidants|antioxidants|mesh-list
153752097|NCT05808049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752098|NCT05808049|Protective Agents|protective agents|mesh-ancestor
153752099|NCT05808049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752100|NCT05807945|Ropivacaine|ropivacaine|mesh-list
153752101|NCT05807945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153752102|NCT05807945|Anesthetics, Local|anesthetics, local|mesh-ancestor
153752103|NCT05807945|Anesthetics|anesthetics|mesh-ancestor
153752104|NCT05807945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752105|NCT05807945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752106|NCT05807945|Sensory System Agents|sensory system agents|mesh-ancestor
153752107|NCT05807945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752108|NCT05807893|Bevacizumab|bevacizumab|mesh-list
153752109|NCT05807893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153388304|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153752156|NCT05807347|Azacitidine|azacitidine|mesh-list
153752157|NCT05807347|Venetoclax|venetoclax|mesh-list
153752158|NCT05807347|Aclacinomycins|aclacinomycins|mesh-list
153752159|NCT05807347|Lenograstim|lenograstim|mesh-list
153752160|NCT05807347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752161|NCT05807347|Antimetabolites|antimetabolites|mesh-ancestor
153752162|NCT05807347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752163|NCT05807347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752164|NCT05807347|Antiviral Agents|antiviral agents|mesh-ancestor
153752165|NCT05807347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752166|NCT05807347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752167|NCT05807347|Immunologic Factors|immunologic factors|mesh-ancestor
153752168|NCT05807347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752169|NCT05807347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752170|NCT05807347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153752171|NCT05807347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153752172|NCT05807165|Memantine|memantine|mesh-list
153752173|NCT05807165|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153752174|NCT05807165|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153752175|NCT05807165|Dopamine Agents|dopamine agents|mesh-ancestor
153752176|NCT05807165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752177|NCT05807165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752178|NCT05807165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752179|NCT05807165|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153752180|NCT05807165|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153752181|NCT05807100|Salicylic Acid|salicylic acid|mesh-list
153752182|NCT05807100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752183|NCT05807100|Antifungal Agents|antifungal agents|mesh-ancestor
153488203|NCT02159976|Bismuth|bismuth|mesh-list
153752204|NCT05709509|Colchicine|colchicine|mesh-list
153752205|NCT05709509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153752207|NCT05709509|Analgesics|analgesics|mesh-ancestor
153752208|NCT05709509|Sensory System Agents|sensory system agents|mesh-ancestor
153752209|NCT05709509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752210|NCT05709509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752215|NCT05709509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752216|NCT05709509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153752217|NCT05709509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153752218|NCT05709509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752219|NCT05709509|Antipyretics|antipyretics|mesh-ancestor
153752220|NCT05709509|Gout Suppressants|gout suppressants|mesh-ancestor
153752221|NCT05709509|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403605|NCT03192995|Cocaine|cocaine|mesh-list
153752222|NCT05709509|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752223|NCT05709509|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752224|NCT05709509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752225|NCT05693844|Paclitaxel|paclitaxel|mesh-list
153752226|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
153752227|NCT05693844|Fludarabine|fludarabine|mesh-list
153752228|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153752229|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153752230|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752231|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752232|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752233|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752282|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153752283|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153752284|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153752285|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153752286|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752287|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
153752288|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752289|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752290|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153752291|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752292|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153752293|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153752294|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
153752295|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
153752296|NCT05546658|Psilocybin|psilocybin|mesh-list
153752297|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
153752298|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752299|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153752300|NCT05494580|Pamiparib|pamiparib|mesh-list
153752301|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153752302|NCT05494580|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153752303|NCT05494580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153752304|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752305|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752307|NCT05464654|Estrogens|estrogens|mesh-list
153752336|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
153752337|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
153752338|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153752339|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
153752340|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752341|NCT04916080|Expectorants|expectorants|mesh-ancestor
153752342|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
153863262|NCT05153525|Cisatracurium|cisatracurium|mesh-list
153863263|NCT05153525|Atracurium|atracurium|mesh-list
153863264|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153863265|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153863266|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863267|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863268|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153863269|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153863270|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153863271|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
153863272|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752343|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153752344|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
153752345|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752346|NCT04916080|Protective Agents|protective agents|mesh-ancestor
153752347|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752348|NCT04916080|Antidotes|antidotes|mesh-ancestor
153752349|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153752350|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153752351|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153589431|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752352|NCT04833140|Estradiol|estradiol|mesh-list
153752353|NCT04833140|Estrogens|estrogens|mesh-ancestor
153752354|NCT04833140|Hormones|hormones|mesh-ancestor
153752355|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752356|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752399|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
153752400|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
153752401|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
153752402|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752403|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752404|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
153752405|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752406|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153752407|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153752408|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
153752409|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752410|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752411|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153752412|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153752413|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
153752414|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153752415|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
153752416|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
153752417|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
153752418|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153752419|NCT04531176|Liraglutide|liraglutide|mesh-list
153752420|NCT04531176|Topiramate|topiramate|mesh-list
153752421|NCT04531176|Orlistat|orlistat|mesh-list
153752422|NCT04531176|Phentermine|phentermine|mesh-list
153752423|NCT04531176|Naltrexone|naltrexone|mesh-list
153752424|NCT04531176|Bupropion|bupropion|mesh-list
153752425|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153752432|NCT04531176|Incretins|incretins|mesh-ancestor
153752457|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
153752458|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
153752459|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
153752461|NCT04409860|Cisplatin|cisplatin|mesh-list
153752462|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153752463|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752464|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752465|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752466|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752467|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752468|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153752469|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
153752470|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752471|NCT04303390|Cefazolin|cefazolin|mesh-list
153752472|NCT04303390|Cefuroxime|cefuroxime|mesh-list
153752473|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
153863293|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153863294|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863295|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153863296|NCT05125796|Analgesics|analgesics|mesh-ancestor
153863297|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
153863298|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153863299|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153752474|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153752538|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752539|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153752540|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153752541|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
153752542|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752543|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153752544|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752545|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752546|NCT03406299|Leucovorin|leucovorin|mesh-list
153752547|NCT03406299|Gemcitabine|gemcitabine|mesh-list
153752548|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
153752549|NCT03406299|Tegafur|tegafur|mesh-list
153752550|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752551|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752552|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
153752553|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752571|NCT03396445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153752572|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752573|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153752574|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153752575|NCT03355469|Metformin|metformin|mesh-list
153752576|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153752577|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752608|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752610|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
153752611|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
153752612|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153752613|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
153752614|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
153752628|NCT03311555|Hormones|hormones|mesh-ancestor
153752629|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752630|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752631|NCT03271866|Metformin|metformin|mesh-list
153752632|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153752633|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752634|NCT03217565|Tedizolid|tedizolid|mesh-list
153752635|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
153752636|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
153752637|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153752638|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752639|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153752640|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752641|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752642|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
153752643|NCT02992743|Fludarabine|fludarabine|mesh-list
153752644|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752645|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
153752646|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752647|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752648|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153752649|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
153752650|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752651|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153589733|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
153388548|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153735958|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572995|NCT02886286|Hydromorphone|hydromorphone|mesh-list
153735959|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153735961|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
153735962|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735963|NCT03963752|Leuprolide|leuprolide|mesh-list
153735964|NCT03963752|Megestrol|megestrol|mesh-list
153735965|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
153735966|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153735967|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
153422464|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153752655|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752656|NCT02853344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153752657|NCT02853344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752658|NCT02738229|Valacyclovir|valacyclovir|mesh-list
153752659|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
153752660|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752661|NCT02675426|Upadacitinib|upadacitinib|mesh-list
153752662|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153752663|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153752664|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752665|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752666|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752667|NCT02579473|Rotigotine|rotigotine|mesh-list
153752668|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
153752669|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
153752670|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752671|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752672|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752697|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153752698|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752699|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153752701|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
153752702|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
153752703|NCT01359956|Dacarbazine|dacarbazine|mesh-list
153752704|NCT01359956|Fotemustine|fotemustine|mesh-list
153752705|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752706|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
153735968|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153735969|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752707|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752708|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
153752709|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752763|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153752764|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153752765|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153752766|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752767|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752768|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153752769|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153752770|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153752772|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153752773|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153752774|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153752775|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752776|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752777|NCT00407186|Cisplatin|cisplatin|mesh-list
153752778|NCT00407186|Capecitabine|capecitabine|mesh-list
153752779|NCT00407186|Epirubicin|epirubicin|mesh-list
153422516|NCT03500328|(T,G)-A-L|(t,g)-a-l|mesh-list
153752831|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752832|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153752834|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153752835|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153752836|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403780|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
153403781|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403782|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403783|NCT02536300|Idelalisib|idelalisib|mesh-list
153403784|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403785|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403786|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403787|NCT02525692|TIC10 compound|tic10 compound|mesh-list
153403789|NCT02514382|Dexamethasone|dexamethasone|mesh-list
153752837|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752838|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752839|NCT00193245|Docetaxel|docetaxel|mesh-list
153752840|NCT00193245|Topotecan|topotecan|mesh-list
153752841|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752842|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752843|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752844|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752845|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752846|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153752847|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153752848|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752849|NCT00193284|Carboplatin|carboplatin|mesh-list
153752850|NCT00193284|Docetaxel|docetaxel|mesh-list
153752851|NCT00193284|Fluorouracil|fluorouracil|mesh-list
153752852|NCT00193284|Gefitinib|gefitinib|mesh-list
153752853|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752854|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752855|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752856|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752857|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752858|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
153752859|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752860|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752861|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
153752862|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752897|NCT00193401|Topotecan|topotecan|mesh-list
153752898|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153752899|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153752900|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752901|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752902|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752904|NCT00553189|Veliparib|veliparib|mesh-list
153752905|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153752906|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153752907|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752908|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752909|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752910|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153752911|NCT00193440|Rituximab|rituximab|mesh-list
153752912|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752913|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752914|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
153752915|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752916|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752917|NCT05077969|Celecoxib|celecoxib|mesh-list
153752928|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153752929|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752930|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752931|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153752932|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153752933|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153752934|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
153752935|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
153752936|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752937|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
153752938|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752939|NCT00164216|Artesunate|artesunate|mesh-list
153752940|NCT00164216|Mefloquine|mefloquine|mesh-list
153752941|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
153863489|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863490|NCT04609397|Hemay005|hemay005|mesh-list
153863491|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863492|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153863493|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153863494|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863495|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752942|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153752943|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153752944|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752946|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
153752947|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
153752948|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153752949|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
153752950|NCT00193557|Bortezomib|bortezomib|mesh-list
153752951|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590044|NCT01810926|Rituximab|rituximab|mesh-list
153752952|NCT00164255|Artesunate|artesunate|mesh-list
153752953|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
153752954|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
153752956|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153752957|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153752958|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153752959|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752960|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
153752961|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
153752962|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153752963|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
153752964|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153752965|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752968|NCT00409656|Basiliximab|basiliximab|mesh-list
153753019|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
153753020|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753021|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153753022|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153753023|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
153753024|NCT00193869|Dexamethasone|dexamethasone|mesh-list
153753025|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753026|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
153753027|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
153753028|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753029|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753030|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753031|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
153753032|NCT00193869|Hormones|hormones|mesh-ancestor
153753033|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753034|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153753035|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753036|NCT00176241|Paclitaxel|paclitaxel|mesh-list
153753037|NCT00176241|Gemcitabine|gemcitabine|mesh-list
153753038|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153753039|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753040|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388717|NCT00002103|Antidotes|antidotes|mesh-ancestor
153753111|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153422571|NCT03273023|Chromium|chromium|mesh-list
153753112|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753113|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153753114|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753115|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
153753116|NCT00194064|Olanzapine|olanzapine|mesh-list
153753117|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
153753118|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
153753119|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753120|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753121|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753122|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153753123|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153863548|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
153863549|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863550|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153863551|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153863552|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153863553|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
153863570|NCT02187302|Sunitinib|sunitinib|mesh-list
153753124|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753125|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753126|NCT00194064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153753127|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153753128|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153753129|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753177|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753178|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
153753179|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753180|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
153753181|NCT00165230|Thalidomide|thalidomide|mesh-list
153753182|NCT00165230|Temozolomide|temozolomide|mesh-list
153753183|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753184|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
153753185|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753186|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
153753187|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753188|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753189|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153753190|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153753191|NCT00165230|Growth Substances|growth substances|mesh-ancestor
153753197|NCT00176553|Levomethorphan|levomethorphan|mesh-list
153753274|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
153753275|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753276|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753277|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753278|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153753279|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
153753280|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153753281|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753282|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753283|NCT00165659|Donepezil|donepezil|mesh-list
153753284|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153404009|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153404010|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404011|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
153404012|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404013|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153404014|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153404015|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153863618|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153753285|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753286|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753287|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
153753288|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753289|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753290|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
153753291|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
153753292|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
153753293|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153753294|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153753295|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753296|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753297|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753330|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153753331|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753332|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
153753333|NCT00165815|Donepezil|donepezil|mesh-list
153753334|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153753335|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753336|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753337|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
153753338|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753339|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753340|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
153753341|NCT00177021|Imiquimod|imiquimod|mesh-list
153753342|NCT00177021|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153753343|NCT00177021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753344|NCT00177021|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153753345|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
153753346|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753347|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153753348|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863641|NCT04611711|Decitabine|decitabine|mesh-list
153863642|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863643|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
153404046|NCT00792662|Methylphenidate|methylphenidate|mesh-list
153863655|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863656|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
153863657|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
153863658|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863659|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863660|NCT02092454|Benzocaine|benzocaine|mesh-list
153863662|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
153863666|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863667|NCT02083289|Latanoprost|latanoprost|mesh-list
153863668|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153863669|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153863670|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
153753349|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
153753401|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153753402|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
153753403|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753404|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753405|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753406|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753407|NCT00537901|Bevacizumab|bevacizumab|mesh-list
153753408|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153735974|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153753409|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753410|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153753411|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153753412|NCT00537901|Growth Substances|growth substances|mesh-ancestor
153753413|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753414|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
153753415|NCT00166127|Simendan|simendan|mesh-list
153753416|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153753417|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
153753418|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153753419|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153753420|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753421|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753468|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753469|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
153753470|NCT00194727|Capecitabine|capecitabine|mesh-list
153753471|NCT00194727|Vinorelbine|vinorelbine|mesh-list
153753472|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153753473|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
153590575|NCT01814163|Paclitaxel|paclitaxel|mesh-list
153753474|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753475|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753476|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153753477|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
153753478|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
153753479|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
153753480|NCT00166400|Metoprolol|metoprolol|mesh-list
153753481|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153753515|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753516|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153753518|NCT00166478|Analgesics|analgesics|mesh-ancestor
153753519|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
153753520|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753521|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753530|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753531|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
153753533|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753534|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
153753535|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753536|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153753537|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753551|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153753552|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
153753554|NCT05259631|Sevoflurane|sevoflurane|mesh-list
153753555|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153753556|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753557|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753558|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153753559|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
153753560|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
153753561|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153753562|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153753563|NCT00408135|Telithromycin|telithromycin|mesh-list
153753564|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753565|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753566|NCT00407225|Difluprednate|difluprednate|mesh-list
153753567|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
153753568|NCT00407225|Hormones|hormones|mesh-ancestor
153753569|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753570|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753571|NCT05124067|Dexamethasone|dexamethasone|mesh-list
153753572|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
153753573|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
153753574|NCT05124067|Ondansetron|ondansetron|mesh-list
153753616|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153753617|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753618|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753619|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153753620|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753621|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153753622|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
153753623|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753624|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753625|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
153753626|NCT00177333|Doxycycline|doxycycline|mesh-list
153753627|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753628|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753629|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
153753630|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153753679|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753680|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
153753681|NCT04660045|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153753682|NCT04660045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153753683|NCT04660045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753684|NCT04660045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753685|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753686|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153753687|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153753688|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153753689|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153753690|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753691|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753692|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753693|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153753694|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
153753695|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153753696|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
153753697|NCT04566250|Analgesics|analgesics|mesh-ancestor
153753698|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
153753699|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753700|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753701|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
153910744|NCT02780479|Prednisone|prednisone|mesh-list
153735976|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153753702|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753703|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
153753704|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753705|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153753710|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
153683245|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153683246|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683247|NCT00403858|Laxatives|laxatives|mesh-ancestor
153683248|NCT00046553|Mifepristone|mifepristone|mesh-list
153683249|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153683250|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
153683251|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153683252|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683253|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153683254|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153683255|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153683256|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
153683257|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153683258|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153683259|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
153683260|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683261|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
153683262|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153683263|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153683264|NCT00131989|Sorafenib|sorafenib|mesh-list
153683265|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683266|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153683269|NCT00132067|Vorinostat|vorinostat|mesh-list
153683304|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153683305|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153683306|NCT00132418|Analgesics|analgesics|mesh-ancestor
153683307|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
153683308|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683309|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683310|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683311|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683312|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683313|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683314|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
153683315|NCT00132535|Chloroquine|chloroquine|mesh-list
153683316|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
153683317|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
153683318|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153683319|NCT00132535|Amebicides|amebicides|mesh-ancestor
153683320|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153683321|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153683322|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683323|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
153683324|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683371|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153683372|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
153683373|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
153683374|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153683375|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683376|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
153683377|NCT00133198|Pramipexole|pramipexole|mesh-list
153683378|NCT00133198|Dexpramipexole|dexpramipexole|mesh-list
153683379|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
153683380|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683381|NCT00133198|Protective Agents|protective agents|mesh-ancestor
153683382|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683383|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153683384|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153683385|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
153683386|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
153683387|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683388|NCT00046826|Thalidomide|thalidomide|mesh-list
153683389|NCT00046826|Docetaxel|docetaxel|mesh-list
153683390|NCT00046826|Estramustine|estramustine|mesh-list
153683391|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683392|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683393|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683394|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683395|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683396|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683397|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
153683398|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683399|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
153683400|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153683401|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683402|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153683413|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683414|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683415|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683442|NCT00133315|Adalimumab|adalimumab|mesh-list
153683443|NCT00133315|Infliximab|infliximab|mesh-list
153683444|NCT00133315|Etanercept|etanercept|mesh-list
153683445|NCT00133315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153683446|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683447|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683448|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
153683449|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683450|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153683451|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153683514|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683515|NCT00080613|Exemestane|exemestane|mesh-list
153683516|NCT00080613|Hormones|hormones|mesh-list
153683517|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683518|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683519|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683520|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153683521|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153683522|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683532|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683533|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
153683534|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683535|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683536|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
153683538|NCT00047021|Analgesics|analgesics|mesh-ancestor
153389068|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389069|NCT00002355|Fomivirsen|fomivirsen|mesh-list
153683585|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683586|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683587|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153683588|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
153683589|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683590|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683591|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153683613|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683614|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683616|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153683632|NCT00134095|Irinotecan|irinotecan|mesh-list
153683687|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153683688|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683689|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683690|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683691|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
153683693|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683694|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153683695|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153683727|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153683728|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
153683729|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
153683730|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
153683731|NCT00134290|Metformin|metformin|mesh-list
153683732|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153683733|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683734|NCT00047216|Tipifarnib|tipifarnib|mesh-list
153683735|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683736|NCT00080925|Cytarabine|cytarabine|mesh-list
153683737|NCT00080925|Cyclosporine|cyclosporine|mesh-list
153683738|NCT00080925|Prednisone|prednisone|mesh-list
153683739|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
153683740|NCT00080925|Rituximab|rituximab|mesh-list
153683741|NCT00080925|Doxorubicin|doxorubicin|mesh-list
153683742|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153683770|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
153683771|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683815|NCT00047294|Temozolomide|temozolomide|mesh-list
153683816|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153683817|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
153683818|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683819|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683820|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153683821|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153683822|NCT00047294|Analgesics|analgesics|mesh-ancestor
153683823|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
153683824|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683825|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683826|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683827|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683828|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153683829|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153683830|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683831|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683832|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
153683833|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
153683889|NCT00134875|Narcotics|narcotics|mesh-ancestor
153683890|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153683891|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683892|NCT00134875|Analgesics|analgesics|mesh-ancestor
153683893|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
153683894|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683895|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153683896|NCT00134914|Buprenorphine|buprenorphine|mesh-list
153683897|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153683898|NCT00134914|Narcotics|narcotics|mesh-ancestor
153683899|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153683900|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683901|NCT00134914|Analgesics|analgesics|mesh-ancestor
153683911|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683913|NCT00134953|Protective Agents|protective agents|mesh-ancestor
153683914|NCT00042861|Leucovorin|leucovorin|mesh-list
153683915|NCT00042861|Fluorouracil|fluorouracil|mesh-list
153683916|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153683917|NCT00042861|Calcium|calcium|mesh-list
153683918|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
153683919|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153683920|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683921|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
153683922|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683923|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153683924|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683925|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683927|NCT00042861|Antidotes|antidotes|mesh-ancestor
153683947|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683948|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
153683949|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
153683950|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683951|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683952|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153683953|NCT00134992|Protective Agents|protective agents|mesh-ancestor
153683954|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
153683955|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153683956|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683958|NCT00135187|Bortezomib|bortezomib|mesh-list
153683959|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683960|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
153683961|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
153683962|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683963|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683964|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683965|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
153683966|NCT00135187|Hormones|hormones|mesh-ancestor
153683967|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683968|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153683992|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683993|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
153683994|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
153422835|NCT03374839|Nivolumab|nivolumab|mesh-list
153683995|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684033|NCT00145444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153684034|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153684035|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153684036|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684037|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684038|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
153684039|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153684040|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153684041|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
153684042|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
153684043|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
153684044|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153684045|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153684046|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684047|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684048|NCT00145483|Urological Agents|urological agents|mesh-ancestor
153684050|NCT00145522|Estradiol|estradiol|mesh-list
153684051|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
153684052|NCT00145522|Estrogens|estrogens|mesh-ancestor
153684053|NCT00145522|Hormones|hormones|mesh-ancestor
153684054|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684055|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684056|NCT00145522|Progestins|progestins|mesh-ancestor
153684057|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
153684058|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
153684059|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153684060|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153684061|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684062|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153684063|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
153684064|NCT00081315|Amifostine|amifostine|mesh-list
153684065|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153684066|NCT00081315|Protective Agents|protective agents|mesh-ancestor
153684067|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684074|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684075|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153684076|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153684077|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
153684078|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684079|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153684080|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153684081|NCT00145639|Carboplatin|carboplatin|mesh-list
153684097|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153684098|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684099|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153684100|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
153684101|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684102|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
153684104|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
153521027|NCT05288348|Analgesics|analgesics|mesh-ancestor
153684105|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684106|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684107|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153684108|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153684109|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
153684110|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153684111|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153684112|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
153810924|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
153810925|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153357500|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153357501|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
153863863|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863864|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863865|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153863869|NCT00561054|Cetuximab|cetuximab|mesh-list
153684139|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684140|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684152|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
153684155|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153684156|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153684157|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153684158|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684159|NCT00146380|Lamivudine|lamivudine|mesh-list
153684160|NCT00146380|Zidovudine|zidovudine|mesh-list
153684161|NCT00146380|Nevirapine|nevirapine|mesh-list
153684162|NCT00146380|Nelfinavir|nelfinavir|mesh-list
153684163|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153684164|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153684165|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684166|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684167|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
153684168|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684169|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153684170|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153684171|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
153684172|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153684173|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153684174|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153684175|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153684176|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
153684177|NCT00081588|Darunavir|darunavir|mesh-list
153684178|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153684179|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153684180|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
153684181|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684192|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684193|NCT00146497|Budesonide|budesonide|mesh-list
153684194|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153684195|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153684196|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153684197|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
153684198|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684199|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684200|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153684201|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
153684202|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
153684203|NCT00146497|Hormones|hormones|mesh-ancestor
153684204|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684216|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153404302|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153404303|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
153404304|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404305|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404306|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404307|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153404308|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153404309|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
153404310|NCT04344782|Bevacizumab|bevacizumab|mesh-list
153404311|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153684217|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684218|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684219|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
153684220|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684221|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
153684222|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684223|NCT00146614|Sirolimus|sirolimus|mesh-list
153684224|NCT00146614|Methotrexate|methotrexate|mesh-list
153684225|NCT00146614|Tacrolimus|tacrolimus|mesh-list
153684226|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153684227|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
153684228|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389229|NCT02977169|Carboplatin|carboplatin|mesh-list
153389230|NCT02977169|Pemetrexed|pemetrexed|mesh-list
153684252|NCT00047762|Growth Substances|growth substances|mesh-ancestor
153521177|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
153684253|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684254|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
153684255|NCT00047762|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153684256|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153684257|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684258|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684259|NCT00042978|Carboplatin|carboplatin|mesh-list
153684260|NCT00042978|Etoposide|etoposide|mesh-list
153684261|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
153684262|NCT00042978|Oblimersen|oblimersen|mesh-list
153684263|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684264|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153684265|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153684266|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153684267|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684286|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153684288|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153684289|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
153684290|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684291|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684292|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153684293|NCT00047801|Docetaxel|docetaxel|mesh-list
153684294|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684295|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
153684296|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
153684297|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
153684298|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684299|NCT00146731|Artesunate|artesunate|mesh-list
153684300|NCT00146731|Amodiaquine|amodiaquine|mesh-list
153684301|NCT00146731|Dapsone|dapsone|mesh-list
153684302|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
153684303|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
153684304|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153389241|NCT00002409|Lamivudine|lamivudine|mesh-list
153684307|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684309|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
153684310|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153684311|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
153684312|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153684313|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404312|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404313|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153404314|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153404315|NCT04344782|Growth Substances|growth substances|mesh-ancestor
153404316|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404317|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
153404318|NCT00357188|Ritonavir|ritonavir|mesh-list
153404319|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153404320|NCT00357188|Efavirenz|efavirenz|mesh-list
153684314|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684315|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
153684316|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684317|NCT00047840|Docetaxel|docetaxel|mesh-list
153684318|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684319|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
153684320|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
153684321|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
153684322|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684323|NCT00146926|Lidocaine|lidocaine|mesh-list
153684324|NCT00146926|Ephedrine|ephedrine|mesh-list
153684333|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153684334|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153684335|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153684336|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684337|NCT00146926|Analgesics|analgesics|mesh-ancestor
153684338|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153684339|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153684340|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
153684341|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153684342|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153684343|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684345|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
153389263|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153684359|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153684360|NCT00147160|Temozolomide|temozolomide|mesh-list
153684361|NCT00147160|Cisplatin|cisplatin|mesh-list
153684362|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153684363|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
153684364|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684365|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684366|NCT04732104|Lidocaine|lidocaine|mesh-list
153684367|NCT04732104|Xylometazoline|xylometazoline|mesh-list
153684368|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
153684369|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
153684370|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
153684371|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684372|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684373|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
153684374|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684375|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153684376|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153684377|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153684378|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153684379|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684380|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153684381|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
153404336|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153404337|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153404338|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153404340|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153404341|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153404342|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
153404343|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404344|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404345|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404346|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153404347|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153404348|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
153684382|NCT00147355|Acetaminophen|acetaminophen|mesh-list
153684383|NCT00147355|Ibuprofen|ibuprofen|mesh-list
153684384|NCT00147355|Codeine|codeine|mesh-list
153684385|NCT00147355|Ondansetron|ondansetron|mesh-list
153684386|NCT00147355|Metoclopramide|metoclopramide|mesh-list
153684387|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153684388|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153684389|NCT00147355|Analgesics|analgesics|mesh-ancestor
153684390|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
153684391|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684411|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153849108|NCT06084000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153684418|NCT00048152|Cyclosporins|cyclosporins|mesh-list
153684419|NCT00048152|Daclizumab|daclizumab|mesh-list
153684420|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684421|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684422|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153684423|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
153684424|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684425|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684426|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684427|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684428|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
153684429|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
153684430|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684431|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
153684432|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684433|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153684434|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153684435|NCT00147394|Risperidone|risperidone|mesh-list
153684436|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153684437|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
153684438|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684439|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684440|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810926|NCT00331305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153404357|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
153404358|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
153404359|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153404360|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153404361|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
153404362|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
153404363|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153404364|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404365|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404366|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153404367|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153404368|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153404369|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153404370|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153404371|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153404372|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153404373|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
153684441|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153684442|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153684443|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684444|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153684445|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153684446|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
153684484|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153684495|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153684496|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
153684497|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684498|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684499|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153684500|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153389293|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684502|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684504|NCT00147784|Ribavirin|ribavirin|mesh-list
153684505|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684506|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
153684507|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684508|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
153684509|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684510|NCT00081744|Tigecycline|tigecycline|mesh-list
153422932|NCT04275362|Cimetidine|cimetidine|mesh-list
153684511|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684512|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684513|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153684514|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684515|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684516|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
153684517|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153684518|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153684519|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684520|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
153684521|NCT00147862|Coagulants|coagulants|mesh-ancestor
153684522|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
153684523|NCT00147901|Fludarabine|fludarabine|mesh-list
153684524|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
153684525|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684526|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
153684527|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684528|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153684529|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153684530|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
153684531|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684532|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684533|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153684534|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153684535|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
153684537|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
153684538|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
153684539|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684540|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684541|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153684542|NCT02957851|Analgesics|analgesics|mesh-ancestor
153684543|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
153684544|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684545|NCT00147979|Heparin|heparin|mesh-list
153684546|NCT00147979|Calcium heparin|calcium heparin|mesh-list
153684547|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
153684548|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153684549|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153684561|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684562|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153684563|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684565|NCT00081822|Clofarabine|clofarabine|mesh-list
153684566|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684567|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
153684568|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684569|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684570|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
153684571|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684572|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684573|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
153684574|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684575|NCT00048425|Simendan|simendan|mesh-list
153684576|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153684577|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
153684578|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153684579|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153684580|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684581|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684582|NCT00048425|Protective Agents|protective agents|mesh-ancestor
153592602|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592603|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592604|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153592605|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684583|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684584|NCT00148135|Carboplatin|carboplatin|mesh-list
153684585|NCT00148135|Gemcitabine|gemcitabine|mesh-list
153684586|NCT00148135|Capecitabine|capecitabine|mesh-list
153684587|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684588|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684589|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
153684590|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684591|NCT00399711|Metformin|metformin|mesh-list
153684592|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
153684593|NCT00399711|Repaglinide|repaglinide|mesh-list
153684594|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153684595|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389341|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389342|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684691|NCT00148603|Montelukast|montelukast|mesh-list
153684692|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153684693|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
153684694|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153684695|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
153684696|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684697|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684698|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153684699|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153684700|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684701|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
153684738|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684767|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684768|NCT00149110|Analgesics|analgesics|mesh-ancestor
153684769|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
153684770|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684771|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
153684772|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153684773|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
153684774|NCT00149188|Lanreotide|lanreotide|mesh-list
153684775|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684776|NCT00043212|Immunomodulating Agents|immunomodulating agents|mesh-list
153684777|NCT00043212|Immunologic Factors|immunologic factors|mesh-ancestor
153684778|NCT00043212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684779|NCT00048776|Cilostazol|cilostazol|mesh-list
153684780|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153684781|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
153684789|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153684800|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
153684801|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153684802|NCT00048854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153684803|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153684804|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153684805|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684806|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684807|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
153864029|NCT04629846|Trastuzumab|trastuzumab|mesh-list
153684808|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684809|NCT00081978|Etravirine|etravirine|mesh-list
153684810|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153684811|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153684812|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684813|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684814|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
153684815|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153735981|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153684872|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153684873|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
153684874|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684875|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684876|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684877|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
153684878|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684879|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684880|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153684881|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
153684882|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684883|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684884|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684885|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684886|NCT00049088|Bevacizumab|bevacizumab|mesh-list
153684887|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153684888|NCT00049088|Docetaxel|docetaxel|mesh-list
153684889|NCT00049088|Antibodies|antibodies|mesh-list
153684890|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
153684891|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153684892|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684893|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153684894|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153684895|NCT00049088|Growth Substances|growth substances|mesh-ancestor
153684896|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684897|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
153684898|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
153684899|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
153684900|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
153684901|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
153684902|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684903|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
153684921|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684922|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153684923|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153684924|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153684925|NCT04725448|Growth Substances|growth substances|mesh-ancestor
153684926|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684927|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
153684929|NCT00405925|Zidovudine|zidovudine|mesh-list
153404450|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
153404451|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
153404452|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153404453|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153404454|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404455|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404456|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404457|NCT02368093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153404458|NCT02368093|Narcotics|narcotics|mesh-ancestor
153404459|NCT02368093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404460|NCT02368093|Analgesics|analgesics|mesh-ancestor
153684930|NCT00405925|Abacavir|abacavir|mesh-list
153684931|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153684932|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153684933|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684934|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684935|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
153684936|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684937|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153684938|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153684939|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
153684940|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153684941|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684942|NCT00049166|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153684943|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153684944|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684945|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684946|NCT00082212|Cetuximab|cetuximab|mesh-list
153684949|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
153849223|NCT06046937|Mupirocin|mupirocin|mesh-list
153684969|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684970|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684971|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684972|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
153684973|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684987|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684988|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
153684989|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
153684991|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
153684992|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684993|NCT00049244|Capecitabine|capecitabine|mesh-list
153684994|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684995|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
153684996|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684997|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684998|NCT00150124|Methimazole|methimazole|mesh-list
153684999|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
153685000|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
153685001|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153685002|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685003|NCT00049283|Docetaxel|docetaxel|mesh-list
153685004|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153685005|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685006|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
153685007|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
153685008|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
153685009|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685010|NCT00049283|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153685011|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153685012|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685013|NCT00150241|Varenicline|varenicline|mesh-list
153685014|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153685015|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153685016|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
153685017|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685021|NCT00150280|Celecoxib|celecoxib|mesh-list
153685022|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153864080|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153404471|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
153404472|NCT05718661|Methamphetamine|methamphetamine|mesh-list
153404473|NCT05718661|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153404474|NCT05718661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404475|NCT05718661|Sympathomimetics|sympathomimetics|mesh-ancestor
153404476|NCT05718661|Autonomic Agents|autonomic agents|mesh-ancestor
153404477|NCT05718661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404478|NCT05718661|Dopamine Agents|dopamine agents|mesh-ancestor
153685023|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685024|NCT00150280|Analgesics|analgesics|mesh-ancestor
153685025|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
153685026|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685027|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685028|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685029|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685030|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153685031|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685032|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685033|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153685034|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
153685035|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685049|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685050|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
153685051|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153685052|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685053|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153735982|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153735983|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685054|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153685055|NCT00049361|Growth Substances|growth substances|mesh-ancestor
153685056|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
153685058|NCT00150436|Analgesics|analgesics|mesh-ancestor
153685059|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
153685060|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685061|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685062|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
153685063|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153685064|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685065|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685066|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153685067|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153685068|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685069|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685070|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685071|NCT00150553|Carbamazepine|carbamazepine|mesh-list
153685072|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
153685073|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
153685074|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685075|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685076|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685077|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685078|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685079|NCT00150553|Analgesics|analgesics|mesh-ancestor
153685080|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
153685081|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685082|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153685083|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685084|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685085|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153685086|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153685087|NCT00150631|Candesartan|candesartan|mesh-list
153685088|NCT00150631|Candesartan cilexetil|candesartan cilexetil|mesh-list
153389443|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685133|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685135|NCT00049556|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153685136|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153735984|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153404506|NCT05718037|Immunologic Factors|immunologic factors|mesh-ancestor
153404507|NCT05718037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404508|NCT05717881|Propolis|propolis|mesh-list
153404509|NCT05717881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404510|NCT00355303|Misoprostol|misoprostol|mesh-list
153735985|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153735986|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153735987|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882148|NCT01681979|Xhance|xhance|mesh-list
153685137|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685138|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685139|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685140|NCT00150982|Alefacept|alefacept|mesh-list
153685141|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
153685142|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
153685143|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685144|NCT00049634|Cyclosporine|cyclosporine|mesh-list
153685145|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
153685146|NCT00049634|Busulfan|busulfan|mesh-list
153685147|NCT00049634|Methotrexate|methotrexate|mesh-list
153685148|NCT00049634|Cyclosporins|cyclosporins|mesh-list
153685149|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685150|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
153685151|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685152|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685153|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685154|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
153685155|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685156|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685157|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153849278|NCT05948813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685222|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
153685223|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685224|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685225|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
153522147|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
153685226|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685227|NCT00151255|Analgesics|analgesics|mesh-ancestor
153685228|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
153685229|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685230|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153685231|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153685232|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685233|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153685234|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
153685235|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
153685236|NCT00049751|Adalimumab|adalimumab|mesh-list
153685237|NCT00049751|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153685238|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685239|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685240|NCT00151294|Dexetimide|dexetimide|mesh-list
153685241|NCT00151294|Citalopram|citalopram|mesh-list
153685242|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
153685243|NCT00151294|Escitalopram|escitalopram|mesh-list
153685244|NCT00151294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153685245|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153685246|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685247|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685248|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685249|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
153685250|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685252|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153685253|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
153592606|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
153592607|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153592608|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153592609|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153592610|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
153592611|NCT01828385|Analgesics|analgesics|mesh-ancestor
153592612|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
153592613|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592614|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389462|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685254|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
153685255|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685256|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153685257|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153685258|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
153685259|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153685260|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685273|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685274|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685275|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685276|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153685277|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153685278|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685279|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153685280|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
153685281|NCT00151489|Pregabalin|pregabalin|mesh-list
153685282|NCT00151489|Analgesics|analgesics|mesh-ancestor
153685283|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
153685284|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685285|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685286|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
153685287|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153685288|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685289|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685290|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153685291|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153685292|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685293|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685294|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685295|NCT00049790|Paclitaxel|paclitaxel|mesh-list
153522224|NCT06039540|Metoprolol|metoprolol|mesh-list
153685304|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153685305|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153685306|NCT00049790|Growth Substances|growth substances|mesh-ancestor
153685307|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685308|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
153685309|NCT00082524|Caspofungin|caspofungin|mesh-list
153685310|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
153685311|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685312|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685313|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685314|NCT00406003|Paroxetine|paroxetine|mesh-list
153685315|NCT00406003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153685316|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153685317|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685318|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685319|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685332|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153685333|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
153685334|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153685335|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
153685336|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153685337|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
153685338|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685339|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
153685341|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153685342|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153735989|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153735990|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
153685343|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153685344|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685345|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
153685346|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
153685347|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849303|NCT05867030|Rituximab|rituximab|mesh-list
153685354|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153685355|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685356|NCT00082563|Amebicides|amebicides|mesh-ancestor
153685357|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153685358|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153685359|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
153685360|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685361|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153685362|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685363|NCT00082563|Analgesics|analgesics|mesh-ancestor
153685364|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
153685365|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685366|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685367|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685368|NCT00082563|Filaricides|filaricides|mesh-ancestor
153685369|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
153685370|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
153685371|NCT00151528|Pregabalin|pregabalin|mesh-list
153685372|NCT00151528|Analgesics|analgesics|mesh-ancestor
153685373|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
153685374|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685375|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685376|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
153685377|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153685378|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685379|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685380|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153685381|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153685414|NCT00151567|Urological Agents|urological agents|mesh-ancestor
153685415|NCT00397826|Simvastatin|simvastatin|mesh-list
153685416|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153685417|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153685418|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
153685419|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685420|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153592615|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
153685438|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
153685439|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685440|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153685441|NCT04725253|Niacinamide|niacinamide|mesh-list
153685442|NCT04725253|Niacin|niacin|mesh-list
153685443|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
153685444|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
153685445|NCT04725253|Vitamins|vitamins|mesh-ancestor
153685446|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
153685447|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685448|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153685449|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
153685450|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685451|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153685452|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153685453|NCT00082719|Interferons|interferons|mesh-list
153685454|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
153685455|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
153685456|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685457|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
153685458|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685459|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
153685460|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864157|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153864159|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685461|NCT00151957|Methylphenidate|methylphenidate|mesh-list
153685462|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153685463|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685464|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153685465|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153685466|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685495|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153685496|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685497|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153685498|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
153685499|NCT00049985|Hematinics|hematinics|mesh-ancestor
153685500|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
153685501|NCT00152191|Fluorouracil|fluorouracil|mesh-list
153685502|NCT00152191|Methotrexate|methotrexate|mesh-list
153685503|NCT00152191|Tegafur|tegafur|mesh-list
153685504|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685505|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
153685506|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685507|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685508|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685509|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
153685510|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685511|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685512|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153685513|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
153685514|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685515|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153685516|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
153685517|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153685518|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
153685519|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685520|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153685521|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153685522|NCT00152230|Tegafur|tegafur|mesh-list
153685523|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685524|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
153685525|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389507|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153389512|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685540|NCT00152308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685541|NCT00152308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685542|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153685543|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685568|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685569|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153685570|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
153685571|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153685572|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
153735991|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685573|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685574|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685575|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153685576|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
153685577|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
153685578|NCT00152542|Protective Agents|protective agents|mesh-ancestor
153685579|NCT00043680|Celecoxib|celecoxib|mesh-list
153685580|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153685581|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685582|NCT00043680|Analgesics|analgesics|mesh-ancestor
153685583|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
153685584|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685585|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685586|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685587|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864173|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864174|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864175|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
153864176|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685588|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153685589|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153685590|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685591|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685592|NCT00152581|Interferons|interferons|mesh-list
153685593|NCT00152581|Ribavirin|ribavirin|mesh-list
153592616|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592617|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153592618|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
153592619|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153592620|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592621|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685594|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
153685606|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153685607|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153685609|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
153685610|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153685611|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
153685612|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685613|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
153685614|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
153685615|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685616|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685617|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153685618|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
153685619|NCT00152620|Hormones|hormones|mesh-ancestor
153685620|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153685621|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153685622|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685623|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153685624|NCT00152620|Protective Agents|protective agents|mesh-ancestor
153685625|NCT00050141|Tipifarnib|tipifarnib|mesh-list
153685626|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685627|NCT04725214|Temozolomide|temozolomide|mesh-list
153685628|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685629|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
153685630|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685631|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685632|NCT00050180|Indinavir|indinavir|mesh-list
153685633|NCT00050180|Saquinavir|saquinavir|mesh-list
153685634|NCT00050180|Midazolam|midazolam|mesh-list
153685635|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153685636|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153592622|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153592623|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
153818477|NCT04559815|Semaglutide|semaglutide|mesh-list
153818478|NCT04559815|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153818479|NCT04559815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818480|NCT04559815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818481|NCT04540692|Paclitaxel|paclitaxel|mesh-list
153818482|NCT04540692|Docetaxel|docetaxel|mesh-list
153818483|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
153685637|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685638|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685639|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153685640|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685641|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685642|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153404603|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
153685643|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
153685644|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
153685645|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
153685646|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
153685647|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685648|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685649|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153685650|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153685651|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
153685652|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685653|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153685654|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153685655|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
153685656|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685657|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153685690|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
153685731|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685732|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685734|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153685735|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685736|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
153685737|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685738|NCT00050375|Oregovomab|oregovomab|mesh-list
153685739|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153685740|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685741|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153685742|NCT00153049|Telmisartan|telmisartan|mesh-list
153685743|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
153685744|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153685745|NCT00153049|Diuretics|diuretics|mesh-ancestor
153685746|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
153685747|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685748|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153685749|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685750|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685751|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153685752|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153685753|NCT00153088|Telmisartan|telmisartan|mesh-list
153685754|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153685755|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153685801|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685802|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153685803|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685804|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153685805|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685806|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685807|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685808|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153685810|NCT00153283|Analgesics|analgesics|mesh-ancestor
153685832|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685833|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
153685834|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685835|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
153685836|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685837|NCT00050531|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153685838|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153685839|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685840|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685841|NCT00083148|Capecitabine|capecitabine|mesh-list
153685843|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685844|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
153685845|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685846|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685847|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153685848|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153685849|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685850|NCT00153517|Metronidazole|metronidazole|mesh-list
153685855|NCT00153556|Vaccines|vaccines|mesh-list
153849439|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685893|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685894|NCT00050609|Urological Agents|urological agents|mesh-ancestor
153685896|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153685897|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685898|NCT00153673|Analgesics|analgesics|mesh-ancestor
153685899|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
153685900|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685901|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685902|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685903|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685904|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153685905|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153685906|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685907|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685908|NCT00050648|Cyclosporine|cyclosporine|mesh-list
153685931|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
153685932|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
153685933|NCT00050726|Interleukin-2|interleukin-2|mesh-list
153685934|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685935|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685936|NCT00050726|Analgesics|analgesics|mesh-ancestor
153685937|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
153685938|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685939|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685941|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153685942|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
153685943|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685944|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153685945|NCT00153946|Protective Agents|protective agents|mesh-ancestor
153592636|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592637|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592638|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153592639|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592640|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
153592641|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
153592642|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592643|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592644|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153592645|NCT01828437|Protective Agents|protective agents|mesh-ancestor
153592646|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
153592647|NCT01828437|Vitamins|vitamins|mesh-ancestor
153592648|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
153389625|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685946|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685947|NCT00154024|Irbesartan|irbesartan|mesh-list
153685948|NCT00154024|Atorvastatin|atorvastatin|mesh-list
153685949|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153685950|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153685951|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
153685952|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685953|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153685954|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153685955|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685956|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153685957|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153685958|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153685959|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153685960|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
153685961|NCT00154141|Coagulants|coagulants|mesh-ancestor
153685962|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153685978|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153685979|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153685980|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685981|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685982|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153685983|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685984|NCT00154219|Analgesics|analgesics|mesh-ancestor
153685985|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
153685986|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686005|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686006|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686007|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686008|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153686009|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153686010|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686011|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686012|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
153686013|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
153686014|NCT00154336|Methotrexate|methotrexate|mesh-list
153686015|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
153686016|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153686017|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
153686018|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153686019|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686020|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153686021|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
153686042|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686044|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
153686045|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153686095|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686096|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686098|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686099|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153686100|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
153686101|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686102|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153686103|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153686104|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686105|NCT00083343|Caspofungin|caspofungin|mesh-list
153686106|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
153686107|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686108|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686109|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686110|NCT00406471|Ranibizumab|ranibizumab|mesh-list
153686111|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686112|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686113|NCT00406471|Growth Substances|growth substances|mesh-ancestor
153686114|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686115|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686116|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523042|NCT01506856|Paclitaxel|paclitaxel|mesh-list
153686117|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153686118|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153686119|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
153686120|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686122|NCT00154687|Fluorouracil|fluorouracil|mesh-list
153686123|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153686124|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686125|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686126|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686127|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686153|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686154|NCT00083460|Growth Substances|growth substances|mesh-ancestor
153686155|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686157|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153686158|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686159|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686160|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686161|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686162|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686163|NCT00154804|Paclitaxel|paclitaxel|mesh-list
153686164|NCT00154804|Cisplatin|cisplatin|mesh-list
153686165|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153686166|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686167|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686168|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686169|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686170|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686171|NCT00154843|Lycopene|lycopene|mesh-list
153686172|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153686173|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
153686174|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686175|NCT00154843|Protective Agents|protective agents|mesh-ancestor
153686176|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686177|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153686178|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153686179|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686180|NCT00043953|Ritonavir|ritonavir|mesh-list
153686181|NCT00043953|Lopinavir|lopinavir|mesh-list
153686182|NCT00043953|Saquinavir|saquinavir|mesh-list
153686183|NCT00043953|Lamivudine|lamivudine|mesh-list
153686184|NCT00043953|Zidovudine|zidovudine|mesh-list
153686185|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153686186|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153592649|NCT01828463|Nitisinone|nitisinone|mesh-list
153592650|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592651|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592652|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
153592653|NCT01828489|Analgesics|analgesics|mesh-ancestor
153592654|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
153592655|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592656|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686187|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153686219|NCT00155233|Morphine|morphine|mesh-list
153686220|NCT00155233|Nalbuphine|nalbuphine|mesh-list
153686221|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153686222|NCT00155233|Narcotics|narcotics|mesh-ancestor
153686223|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686224|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686225|NCT00155233|Analgesics|analgesics|mesh-ancestor
153686226|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
153686227|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686228|NCT00051116|Lenalidomide|lenalidomide|mesh-list
153686229|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
153686230|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686231|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686232|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686247|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686248|NCT00155350|Pioglitazone|pioglitazone|mesh-list
153686249|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153686250|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686251|NCT00051155|Timolol|timolol|mesh-list
153686252|NCT00051155|Travoprost|travoprost|mesh-list
153686253|NCT00051155|Latanoprost|latanoprost|mesh-list
153686254|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153686255|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153686256|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
153686257|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686258|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686264|NCT00083538|Thalidomide|thalidomide|mesh-list
153686280|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153686282|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
153686283|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686284|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153686285|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
153686287|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153686288|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153686289|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153686290|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153686291|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153686292|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686293|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153686294|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
153686295|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686305|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
153686306|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686307|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686308|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686309|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686310|NCT00083577|Growth Substances|growth substances|mesh-ancestor
153686311|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686312|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686313|NCT00154414|Liraglutide|liraglutide|mesh-list
153686314|NCT00154414|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153686315|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153686316|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686317|NCT00154414|Incretins|incretins|mesh-ancestor
153686318|NCT00154414|Hormones|hormones|mesh-ancestor
153686319|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153686320|NCT00406744|Bevacizumab|bevacizumab|mesh-list
153686321|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153686322|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686323|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686324|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686325|NCT00406744|Growth Substances|growth substances|mesh-ancestor
153686326|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686327|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686328|NCT00399750|Bevacizumab|bevacizumab|mesh-list
153686329|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
153686330|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153686331|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686332|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686333|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686334|NCT00399750|Growth Substances|growth substances|mesh-ancestor
153686335|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686336|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686337|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
153686338|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686339|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686340|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
153686341|NCT00156286|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153686342|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153686343|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523262|NCT04279054|Morphine|morphine|mesh-list
153686344|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686345|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686346|NCT00156325|Escitalopram|escitalopram|mesh-list
153686347|NCT00156325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153686348|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153686349|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686350|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686351|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686354|NCT00156403|Amlodipine|amlodipine|mesh-list
153849538|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686429|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153686430|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153686431|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686432|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
153686433|NCT00157300|Hematinics|hematinics|mesh-ancestor
153686434|NCT00157378|Haloperidol|haloperidol|mesh-list
153686435|NCT00157378|Risperidone|risperidone|mesh-list
153686436|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
153686437|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153686438|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
153686439|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153429794|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
153686440|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686441|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686442|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153686443|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153686444|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686445|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686446|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153686447|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
153686448|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
153686449|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
153686450|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686451|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153686462|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686464|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153686465|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
153686466|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686485|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686486|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153686487|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686488|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
153686489|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
153686490|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686491|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686492|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686493|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686494|NCT00406978|Growth Substances|growth substances|mesh-ancestor
153686495|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686496|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153686497|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153686498|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153686500|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
153686501|NCT00044343|Lapatinib|lapatinib|mesh-list
153686502|NCT00044343|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153686503|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153686504|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686505|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686506|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686507|NCT00157690|Alendronate|alendronate|mesh-list
153686508|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153686573|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153686574|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
153686575|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686576|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686577|NCT00051623|Infliximab|infliximab|mesh-list
153686578|NCT00051623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153686579|NCT00051623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153686580|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
153686581|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153686582|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686583|NCT00158236|Buprenorphine|buprenorphine|mesh-list
153686584|NCT00158236|Hydromorphone|hydromorphone|mesh-list
153686585|NCT00158236|Naloxone|naloxone|mesh-list
153686586|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153686587|NCT00158236|Narcotics|narcotics|mesh-ancestor
153686588|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686589|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686590|NCT00158236|Analgesics|analgesics|mesh-ancestor
153686591|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
153686592|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686593|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153686594|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
153686595|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686596|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
153686597|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686598|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686599|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
153686600|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153686601|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686602|NCT00158470|Lamivudine|lamivudine|mesh-list
153592657|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592658|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153592659|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153592660|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592661|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592662|NCT01828606|Monensin|monensin|mesh-list
153592663|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
153592664|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592665|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153592666|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153818484|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153818485|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818486|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818487|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
153389742|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153389743|NCT00002535|Aldesleukin|aldesleukin|mesh-list
153389744|NCT00002535|Indomethacin|indomethacin|mesh-list
153686603|NCT00158470|Efavirenz|efavirenz|mesh-list
153686604|NCT00158470|Didanosine|didanosine|mesh-list
153686605|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153686606|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153686607|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686608|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686609|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
153686610|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686611|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153686612|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153686613|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153686614|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153686615|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153686616|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153686617|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153686618|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153686619|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
153686621|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
153686622|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686623|NCT00158548|Artesunate|artesunate|mesh-list
153686624|NCT00158548|Chloroquine|chloroquine|mesh-list
153686625|NCT00158548|Primaquine|primaquine|mesh-list
153686626|NCT00158548|Amodiaquine|amodiaquine|mesh-list
153849576|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686672|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153686673|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153686674|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
153686675|NCT05568147|Aspirin|aspirin|mesh-list
153686682|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153686683|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686684|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153686685|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153686686|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686687|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153686688|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153686689|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686691|NCT00051896|Vanoxerine|vanoxerine|mesh-list
153686692|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153686693|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153686694|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686695|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686696|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
153686697|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686698|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686699|NCT04724473|Tretinoin|tretinoin|mesh-list
153686700|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686701|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
153818488|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
153818489|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818490|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818491|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
153818492|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818493|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153592667|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
153592668|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
153592669|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
153592670|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592671|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592674|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
153592675|NCT01828736|Cisplatin|cisplatin|mesh-list
153592676|NCT01828736|Carboplatin|carboplatin|mesh-list
153592677|NCT01828736|Gemcitabine|gemcitabine|mesh-list
153592678|NCT01828736|Trastuzumab|trastuzumab|mesh-list
153592679|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592680|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153592681|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
153592682|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592683|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153592684|NCT01828788|Ropivacaine|ropivacaine|mesh-list
153592685|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
153592686|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
153592687|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686702|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
153686703|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
153686704|NCT00159016|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153686705|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153686706|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686707|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686708|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686709|NCT00159094|Vinorelbine|vinorelbine|mesh-list
153686710|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153686711|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686712|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686713|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686714|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686715|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686716|NCT02965053|Sevelamer|sevelamer|mesh-list
153686717|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
153686718|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
153686719|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686720|NCT00159133|Lorazepam|lorazepam|mesh-list
153686721|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
153686722|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
153686723|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
153686724|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
153735993|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153686725|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686726|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686727|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153686728|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153686729|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686730|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153686731|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153686802|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153686803|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686804|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153686805|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153686806|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686807|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153686808|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686809|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
153686811|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153686812|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
153686813|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686814|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686815|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686816|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153686817|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153686818|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686819|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686820|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153686821|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
153686822|NCT00159835|Atorvastatin|atorvastatin|mesh-list
153686823|NCT00159835|Simvastatin|simvastatin|mesh-list
153686824|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153686825|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153686826|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
153686827|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686828|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153686829|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153686831|NCT00052169|Docetaxel|docetaxel|mesh-list
153389783|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686858|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153686859|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686860|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686861|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686862|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686863|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153686864|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153686866|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
153686867|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686868|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153686869|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686870|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153686871|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153686872|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153686873|NCT00160030|Cisplatin|cisplatin|mesh-list
153686874|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686875|NCT00160069|Sagopilone|sagopilone|mesh-list
153686876|NCT00160069|Epothilones|epothilones|mesh-list
153686956|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686957|NCT00160576|Levetiracetam|levetiracetam|mesh-list
153686958|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
153686959|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
153686960|NCT00160849|Lopinavir|lopinavir|mesh-list
153686961|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153686962|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153686963|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
153686964|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686965|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686966|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153686967|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153686968|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
153686969|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686970|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153686971|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153686972|NCT00160888|Nitroprusside|nitroprusside|mesh-list
153686973|NCT00160888|Acetylcholine|acetylcholine|mesh-list
153686974|NCT00160888|Bradykinin|bradykinin|mesh-list
153686975|NCT00160888|Kininogens|kininogens|mesh-list
153686976|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153686977|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
153686978|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153687030|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687031|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153687032|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153687033|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687035|NCT00044577|Lamivudine|lamivudine|mesh-list
153687036|NCT00044577|Abacavir|abacavir|mesh-list
153687037|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
153687038|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
153687039|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687040|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153687041|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153687042|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687043|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687044|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153687045|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153687046|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
153687047|NCT00161122|Vaccines|vaccines|mesh-list
153687048|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153687049|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
153687050|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687127|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687129|NCT00052754|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153687130|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153687131|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687132|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687133|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687134|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
153687135|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687136|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687137|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
153687138|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687139|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687140|NCT00161668|Immunotoxins|immunotoxins|mesh-ancestor
153687141|NCT00161668|Immunoconjugates|immunoconjugates|mesh-ancestor
153687142|NCT00161668|Immunologic Factors|immunologic factors|mesh-ancestor
153687143|NCT00161668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687144|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153687145|NCT00052832|Vitamins|vitamins|mesh-ancestor
153687146|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
153687147|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687148|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153687149|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153687150|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
153687151|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153687152|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153687153|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
153687154|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687155|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687156|NCT00044538|Taxane|taxane|mesh-list
153687157|NCT00044538|IDN 5109|idn 5109|mesh-list
153687158|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687202|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687203|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153687204|NCT04731116|Cannabidiol|cannabidiol|mesh-list
153687205|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
153687206|NCT00407056|Difluprednate|difluprednate|mesh-list
153687207|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
153687208|NCT00407056|Hormones|hormones|mesh-ancestor
153687228|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
153687229|NCT00053105|Pixantrone|pixantrone|mesh-list
153687230|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153687231|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
153687232|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687233|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153687234|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
153687235|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687236|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
153687237|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687238|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687239|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
153687240|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687241|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153687242|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
153687243|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
153687244|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153735995|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
153687245|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687246|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
153687248|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687249|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153687250|NCT00053105|Protective Agents|protective agents|mesh-ancestor
153687300|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687302|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
153687303|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153687304|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153687305|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
153687318|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153687319|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153687320|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
153687321|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687322|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687323|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153687324|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153687325|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
153687326|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687327|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153687328|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153687329|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153687330|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153687331|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
153687332|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153687333|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153687362|NCT00162760|Thalidomide|thalidomide|mesh-list
153687363|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687364|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
153687365|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687366|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
153687367|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687368|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687395|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153687396|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687397|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687399|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687400|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153687401|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
153687402|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153687403|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
153687404|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153687405|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687406|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
153687407|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153687408|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687409|NCT00163111|Amphotericin B|amphotericin b|mesh-list
153687410|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153687411|NCT00163111|Fluconazole|fluconazole|mesh-list
153687412|NCT00163111|Amebicides|amebicides|mesh-ancestor
153687413|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153687414|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153687415|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687426|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153687427|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153687429|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153687430|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153687431|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
153687432|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687438|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153687439|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153687440|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153687441|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
153687442|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687443|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687444|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687445|NCT00163306|Pantoprazole|pantoprazole|mesh-list
153687446|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153687447|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687448|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153687449|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687450|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687451|NCT00044889|Clofarabine|clofarabine|mesh-list
153687452|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153687453|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
153687454|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687455|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687456|NCT00163345|Ciclesonide|ciclesonide|mesh-list
153687457|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
153687459|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687460|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687461|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153687462|NCT00163384|Ciclesonide|ciclesonide|mesh-list
153687463|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
153687464|NCT00163384|Hormones|hormones|mesh-ancestor
153687465|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687466|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524433|NCT01463592|Iodine|iodine|mesh-list
153687499|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687500|NCT00163501|Ciclesonide|ciclesonide|mesh-list
153687501|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
153687502|NCT00163501|Hormones|hormones|mesh-ancestor
153687503|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687504|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687505|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153687506|NCT00163540|Formaldehyde|formaldehyde|mesh-list
153687507|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
153687508|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687509|NCT00053339|Tamoxifen|tamoxifen|mesh-list
153687510|NCT00053339|Trastuzumab|trastuzumab|mesh-list
153687511|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687512|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687513|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153687514|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
153687515|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687516|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687517|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153687518|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153687519|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153687520|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153687521|NCT00163618|Formaldehyde|formaldehyde|mesh-list
153687522|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
153687523|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687569|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153687570|NCT00164125|Laxatives|laxatives|mesh-ancestor
153687571|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687572|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153687573|NCT00164164|Laxatives|laxatives|mesh-ancestor
153687574|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687575|NCT00164242|Galantamine|galantamine|mesh-list
153687576|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153687577|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687578|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687579|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
153687580|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687581|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687582|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153687594|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687595|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153687596|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153687597|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
153687598|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687599|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153687600|NCT00044928|Tazobactam|tazobactam|mesh-list
153687601|NCT00044928|Piperacillin|piperacillin|mesh-list
153687602|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153687603|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687604|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687605|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153687606|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687607|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687628|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
153687629|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687630|NCT00045006|Vorinostat|vorinostat|mesh-list
153687631|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687632|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153687633|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687634|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687635|NCT00164710|Artesunate|artesunate|mesh-list
153687636|NCT00164710|Lumefantrine|lumefantrine|mesh-list
153687637|NCT00164710|Artemether|artemether|mesh-list
153687638|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
153687639|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
153687640|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153687641|NCT00164710|Amodiaquine|amodiaquine|mesh-list
153687642|NCT00164710|Dapsone|dapsone|mesh-list
153687643|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
153687644|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
153687645|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153687646|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153687647|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687648|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687649|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
153687666|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
153687667|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687668|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687697|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687699|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153687700|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
153687701|NCT00053768|Hormones|hormones|mesh-ancestor
153687702|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687703|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153687704|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153687705|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
153687706|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
153687707|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
153687729|NCT00165139|Lenograstim|lenograstim|mesh-list
153687730|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687731|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
153687732|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687733|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687734|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153687735|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
153687736|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687737|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687738|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153687739|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153687740|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153687741|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687742|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687778|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687779|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
153687780|NCT00165178|Hormones|hormones|mesh-ancestor
153687781|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687782|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153687783|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687784|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153687785|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153687786|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687787|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687788|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687789|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153687790|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
153687791|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153687792|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153687793|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
153687794|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
153687795|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153687796|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153735996|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687805|NCT00165178|Vitamins|vitamins|mesh-ancestor
153687829|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687830|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
153687831|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153687832|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153687833|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687834|NCT00165295|Urological Agents|urological agents|mesh-ancestor
153687835|NCT00053885|Vatalanib|vatalanib|mesh-list
153687842|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687843|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153687844|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
153687845|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
153687846|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
153524775|NCT01467531|Dolutegravir|dolutegravir|mesh-list
153687847|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687849|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687850|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153687851|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153687852|NCT00165373|Growth Substances|growth substances|mesh-ancestor
153687853|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687854|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
153687855|NCT00165451|Thalidomide|thalidomide|mesh-list
153687856|NCT00165451|Celecoxib|celecoxib|mesh-list
153687857|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
153687884|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153687885|NCT00165451|Growth Substances|growth substances|mesh-ancestor
153687886|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
153687888|NCT00165490|Cetuximab|cetuximab|mesh-list
153687889|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687890|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153687891|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687892|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687893|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687894|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687895|NCT00165568|Bevacizumab|bevacizumab|mesh-list
153687896|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687897|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687898|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153687899|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153687900|NCT00165568|Growth Substances|growth substances|mesh-ancestor
153687901|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687902|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
153687903|NCT00165685|Sibutramine|sibutramine|mesh-list
153687909|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
153687910|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
153687911|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153687912|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687913|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
153687914|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687915|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
153687916|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687917|NCT00053963|Romidepsin|romidepsin|mesh-list
153687918|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153687919|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687920|NCT00053963|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153687921|NCT00053963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687922|NCT00053963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687923|NCT00165763|Donepezil|donepezil|mesh-list
153687924|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153592688|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592689|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
153592690|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592691|NCT01828879|Tacrolimus|tacrolimus|mesh-list
153592692|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390035|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153687925|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687926|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687927|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
153687928|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687929|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687930|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
153687931|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153687932|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687933|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153687934|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687935|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687936|NCT00045318|Exatecan|exatecan|mesh-list
153687937|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153687938|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687939|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687940|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687941|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687942|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153687943|NCT00054002|Trioxsalen|trioxsalen|mesh-list
153687944|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687945|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
153687946|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153687947|NCT00054041|Vaccines|vaccines|mesh-list
153687948|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
153687949|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687950|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
153687951|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153687952|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687953|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153687954|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
153687955|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687956|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592693|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
153592694|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592695|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153818494|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153818495|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
153818496|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153818497|NCT04532372|Leflunomide|leflunomide|mesh-list
153818498|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687958|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687960|NCT00054197|Vinorelbine|vinorelbine|mesh-list
153687961|NCT00054197|Gemcitabine|gemcitabine|mesh-list
153687962|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153687963|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153687964|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687965|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
153687966|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
153687967|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
153687968|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687969|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153687970|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
153687971|NCT00045396|Tipifarnib|tipifarnib|mesh-list
153687972|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687973|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
153687974|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687982|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153687983|NCT00166426|Analgesics|analgesics|mesh-ancestor
153687984|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
153687985|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687986|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153687987|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687988|NCT00166465|Leucovorin|leucovorin|mesh-list
153687989|NCT00166465|Fluorouracil|fluorouracil|mesh-list
153687990|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
153687991|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
153687992|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688013|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
153688014|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
153688015|NCT00054236|Fludarabine|fludarabine|mesh-list
153688016|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
153688017|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153688018|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688019|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
153688020|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688021|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688022|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153688023|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
153688024|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688025|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688026|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153688027|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688028|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
153688029|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688030|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
153688031|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
153688032|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688033|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153688034|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
153688036|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153688037|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153688038|NCT00054236|Protective Agents|protective agents|mesh-ancestor
153688039|NCT00054392|Paclitaxel|paclitaxel|mesh-list
153688040|NCT00054392|Carboplatin|carboplatin|mesh-list
153688143|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688144|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688145|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153688146|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153688147|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153688148|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688150|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688151|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
153688153|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153688154|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688155|NCT00167557|Interferons|interferons|mesh-list
153688156|NCT00167557|Ribavirin|ribavirin|mesh-list
153688157|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688158|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
153688159|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688160|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
153688161|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688162|NCT00167674|Zidovudine|zidovudine|mesh-list
153688163|NCT00167674|Nevirapine|nevirapine|mesh-list
153688164|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
153688165|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688166|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153688167|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153688168|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688207|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153688208|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153688209|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688210|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688211|NCT00167908|Amifostine|amifostine|mesh-list
153688212|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153688213|NCT00167908|Protective Agents|protective agents|mesh-ancestor
153688214|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688215|NCT00167947|Cyclosporine|cyclosporine|mesh-list
153688216|NCT00167947|Sirolimus|sirolimus|mesh-list
153688217|NCT00167947|Cyclosporins|cyclosporins|mesh-list
153688218|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688219|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688220|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688221|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
153688222|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688223|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
153688224|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688225|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
153688226|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688227|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153688228|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153688229|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153390160|NCT05805631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153390161|NCT05805553|Nandrolone Decanoate|nandrolone decanoate|mesh-list
153688274|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
153688275|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
153688276|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153688277|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153688278|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688279|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688280|NCT00407446|Urological Agents|urological agents|mesh-ancestor
153688281|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
153688282|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153688283|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153688284|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153688285|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153688286|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688287|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
153688288|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688289|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688290|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153688291|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688292|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
153688293|NCT00168493|Serotonin|serotonin|mesh-list
153688294|NCT00168493|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153688295|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153688333|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688334|NCT00168688|Micronutrients|micronutrients|mesh-list
153688335|NCT00168688|Trace Elements|trace elements|mesh-list
153688336|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688337|NCT00168766|Interferons|interferons|mesh-list
153688338|NCT00168766|Interferon-beta|interferon-beta|mesh-list
153688339|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
153688340|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
153688341|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688342|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
153688343|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688344|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688345|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
153688346|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
153688347|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688348|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688349|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153688350|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
153688351|NCT00168766|Hormones|hormones|mesh-ancestor
153688352|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153688357|NCT00168883|Paclitaxel|paclitaxel|mesh-list
153688399|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153688401|NCT00169000|Capecitabine|capecitabine|mesh-list
153688402|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688403|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688404|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688405|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688406|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688407|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688408|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
153688409|NCT00045747|Fluorouracil|fluorouracil|mesh-list
153688410|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153688411|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
153688412|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688413|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688414|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688415|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688416|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
153688417|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688418|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153688419|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688420|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
153688421|NCT00169039|Clozapine|clozapine|mesh-list
153688422|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153688423|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
153688432|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
153688463|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153688465|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688466|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688467|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153688468|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688469|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153688470|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153688471|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153688472|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688473|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688474|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
153688475|NCT00169156|Hormones|hormones|mesh-ancestor
153688476|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153688477|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153688478|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153688479|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688535|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688536|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688537|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153688538|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153864899|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153688539|NCT00169624|Metformin|metformin|mesh-list
153688540|NCT00169624|Gliclazide|gliclazide|mesh-list
153688541|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153688542|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688543|NCT00407641|Heparin|heparin|mesh-list
153688544|NCT00407641|Tinzaparin|tinzaparin|mesh-list
153688545|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153688546|NCT00407641|Dalteparin|dalteparin|mesh-list
153688547|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
153688548|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153688549|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153688550|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688611|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688612|NCT00170404|Hematinics|hematinics|mesh-ancestor
153688613|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
153688614|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
153688615|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688616|NCT00170404|Protective Agents|protective agents|mesh-ancestor
153688617|NCT00055367|Natalizumab|natalizumab|mesh-list
153688618|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
153688636|NCT00170794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153688637|NCT00170794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688638|NCT00170794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688639|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850143|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153850144|NCT01207687|Growth Substances|growth substances|mesh-ancestor
153850145|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850146|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
153850147|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
153688697|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153688698|NCT00171067|Protective Agents|protective agents|mesh-ancestor
153688771|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153688772|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688773|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153688774|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688775|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
153688776|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153688777|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153688778|NCT00171574|Valsartan|valsartan|mesh-list
153688779|NCT00171574|Lisinopril|lisinopril|mesh-list
153688780|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153688781|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153688782|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153390413|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
153390414|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
153390415|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390416|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153390417|NCT04389177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153688871|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688872|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153688873|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
153688874|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153688875|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688876|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
153688877|NCT00055679|Fluorouracil|fluorouracil|mesh-list
153688878|NCT00055679|Epirubicin|epirubicin|mesh-list
153688879|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688880|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
153688881|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688882|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688883|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153688884|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
153688885|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688886|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864916|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
153864917|NCT04631315|Difluprednate|difluprednate|mesh-list
153688887|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153688888|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
153688889|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688890|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153688891|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153688892|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153688893|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688894|NCT00171886|Octreotide|octreotide|mesh-list
153688895|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153688896|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153688897|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688916|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153688917|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153688918|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
153688919|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688920|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153688921|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153688922|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688923|NCT00055835|Paclitaxel|paclitaxel|mesh-list
153688924|NCT00055835|Carboplatin|carboplatin|mesh-list
153688925|NCT00055835|Gemcitabine|gemcitabine|mesh-list
153688926|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153688927|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688928|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688929|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688930|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688931|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688932|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688933|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
153688934|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
153688935|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688936|NCT00055874|Interferons|interferons|mesh-list
153688937|NCT00055874|Cytarabine|cytarabine|mesh-list
153688938|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
153850250|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850252|NCT04658732|Gabapentin|gabapentin|mesh-list
153850253|NCT04658732|Alprazolam|alprazolam|mesh-list
153850254|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153850255|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850256|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850257|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850258|NCT04658732|Analgesics|analgesics|mesh-ancestor
153688979|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688980|NCT00045864|Aldesleukin|aldesleukin|mesh-list
153688981|NCT00045864|Rituximab|rituximab|mesh-list
153688982|NCT00045864|Interleukin-2|interleukin-2|mesh-list
153688983|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688984|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688986|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688987|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688988|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153688989|NCT00045864|Analgesics|analgesics|mesh-ancestor
153689056|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153689057|NCT00174304|Atorvastatin|atorvastatin|mesh-list
153689058|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153689059|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153689060|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
153689061|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689062|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153689063|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153689064|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689156|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689157|NCT00174694|Telithromycin|telithromycin|mesh-list
153689158|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153689159|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689160|NCT00174733|Ciclesonide|ciclesonide|mesh-list
153689161|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
153689163|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689164|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689165|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153689166|NCT00056264|Infliximab|infliximab|mesh-list
153689167|NCT00056264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153689168|NCT00056264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153689172|NCT00174772|Cisplatin|cisplatin|mesh-list
153689233|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689234|NCT00175357|Methadone|methadone|mesh-list
153689235|NCT00175357|Heroin|heroin|mesh-list
153689236|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153689237|NCT00175357|Narcotics|narcotics|mesh-ancestor
153689238|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689239|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850355|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850356|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153850357|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153689345|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153689346|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689347|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689348|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153689349|NCT00175903|Analgesics|analgesics|mesh-ancestor
153689350|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
153689351|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689352|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153689353|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689354|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153689355|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153689357|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153689358|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
153689367|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153689368|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689369|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689370|NCT00175981|Urological Agents|urological agents|mesh-ancestor
153689371|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153689372|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153689373|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689374|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689375|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689376|NCT00175981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153689380|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
153689393|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689394|NCT04420533|Urological Agents|urological agents|mesh-ancestor
153689395|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
153689479|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689480|NCT00046293|Abciximab|abciximab|mesh-list
153689481|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
153689482|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153689504|NCT00398489|Docetaxel|docetaxel|mesh-list
153689505|NCT00398489|Trastuzumab|trastuzumab|mesh-list
153689506|NCT00398489|Epirubicin|epirubicin|mesh-list
153689507|NCT00398489|Anastrozole|anastrozole|mesh-list
153689508|NCT00398489|Goserelin|goserelin|mesh-list
153689509|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689510|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
153689511|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689512|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689513|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153689514|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
153689515|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689516|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689517|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153689518|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
153689519|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
153689520|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
153689521|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153689522|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153689523|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153689563|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
153689564|NCT00397566|BMS-707035|bms-707035|mesh-list
153689565|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
153689566|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689567|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689568|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153689569|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153689570|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
153689571|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689572|NCT00177424|Sertraline|sertraline|mesh-list
153689573|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
153689574|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153526499|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
153689575|NCT00177424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153689576|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689577|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689578|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689579|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689580|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
153689581|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689623|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689703|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689704|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153689705|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153689706|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689708|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
153689709|NCT00179023|Ephedrine|ephedrine|mesh-list
153689710|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
153689711|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153689712|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
153689713|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689714|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689715|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153689716|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
153689717|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
153689743|NCT00179062|Olanzapine|olanzapine|mesh-list
153689778|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153689779|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
153689780|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423883|NCT03537404|Ritonavir|ritonavir|mesh-list
153689781|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153689800|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153689801|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153689802|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153689803|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
153689804|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153689805|NCT00179608|Lenalidomide|lenalidomide|mesh-list
153689806|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
153689807|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689808|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153689810|NCT00179608|Growth Substances|growth substances|mesh-ancestor
153689870|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689871|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153689872|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
153689873|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
153689874|NCT00180076|Hormones|hormones|mesh-ancestor
153689875|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689876|NCT00180115|Cytarabine|cytarabine|mesh-list
153689877|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153689878|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
153689880|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689951|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689952|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153689953|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153689954|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689955|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689956|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
153689957|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689964|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690021|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690022|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
153690119|NCT00182533|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153690120|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153690121|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690122|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690123|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690124|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
153690125|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690195|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153690196|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690197|NCT00183040|Androgens|androgens|mesh-ancestor
153690233|NCT00183742|Docetaxel|docetaxel|mesh-list
153690288|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690298|NCT00183937|Docetaxel|docetaxel|mesh-list
153690373|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690374|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
153690375|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
153690376|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153690377|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690378|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
153690379|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153690380|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690381|NCT00058097|Tipifarnib|tipifarnib|mesh-list
153690382|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690383|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153690384|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153690385|NCT00184795|Norethindrone|norethindrone|mesh-list
153690386|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
153690387|NCT00184795|Estradiol|estradiol|mesh-list
153690388|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153690389|NCT00184795|Estrogens|estrogens|mesh-ancestor
153690390|NCT00184795|Hormones|hormones|mesh-ancestor
153690391|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153690473|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153690474|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153690475|NCT00185107|Simvastatin|simvastatin|mesh-list
153690476|NCT00185107|Ezetimibe|ezetimibe|mesh-list
153690556|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153690557|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153690558|NCT00185419|Progestins|progestins|mesh-ancestor
153690559|NCT00185419|Hormones|hormones|mesh-ancestor
153690560|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153690561|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153690562|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153690563|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153690564|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690649|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153690650|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153690651|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690652|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
153690767|NCT00187174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690768|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690769|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
153690770|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690771|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690772|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
153690773|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153690774|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
153690775|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690776|NCT00187330|Expectorants|expectorants|mesh-ancestor
153690777|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
153690778|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153690843|NCT00046995|Vitamins|vitamins|mesh-ancestor
153690844|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
153690845|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
153391150|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690945|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690946|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
153690947|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690948|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
153690949|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690950|NCT00188383|Amantadine|amantadine|mesh-list
153690951|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153690952|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153690953|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
153391165|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153391166|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
153391167|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153391168|NCT01631149|Rocuronium|rocuronium|mesh-list
153391169|NCT01631149|Atracurium|atracurium|mesh-list
153391170|NCT01631149|Mivacurium|mivacurium|mesh-list
153391171|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153391172|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153691020|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
153691021|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153691022|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
153691090|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
153691091|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691092|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153691093|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153691094|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691095|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153691096|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153691097|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
153691098|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691099|NCT00189163|Pioglitazone|pioglitazone|mesh-list
153691100|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153691101|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691102|NCT00189358|Tamoxifen|tamoxifen|mesh-list
153691103|NCT00189358|Gefitinib|gefitinib|mesh-list
153691104|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153691119|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691120|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691121|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691122|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691123|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
153691124|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691125|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153691127|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153691128|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691129|NCT00189553|Paclitaxel|paclitaxel|mesh-list
153691152|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
153691153|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153691154|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691251|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
153691252|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153691253|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153691254|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153691255|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153691256|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
153691257|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153691258|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153691264|NCT03238365|Nivolumab|nivolumab|mesh-list
153851081|NCT06022198|Sequestering Agents|sequestering agents|mesh-ancestor
153691323|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691324|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691325|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691326|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691327|NCT00190567|Analgesics|analgesics|mesh-ancestor
153691328|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
153691329|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691330|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
153691424|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153691425|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691426|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691427|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691428|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691517|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153691518|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153691519|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691520|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391417|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
153391418|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153691593|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691595|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153691668|NCT00192712|Irinotecan|irinotecan|mesh-list
153691669|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691670|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
153691671|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691672|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691673|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153405491|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153405492|NCT05445440|Analgesics|analgesics|mesh-ancestor
153691674|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153691675|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691676|NCT00047658|Interferons|interferons|mesh-list
153691677|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
153691678|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691679|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
153691680|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691681|NCT00193024|Docetaxel|docetaxel|mesh-list
153691682|NCT00193024|Epirubicin|epirubicin|mesh-list
153691759|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153691881|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691882|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
153691883|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691884|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691885|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
153691886|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691887|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153691888|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691889|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
153691890|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153691891|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691892|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
153691894|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153691895|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
153691966|NCT00195208|Pantoprazole|pantoprazole|mesh-list
153691967|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153692068|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153692069|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
153692070|NCT00195637|Antibodies|antibodies|mesh-list
153692171|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692172|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692174|NCT00084279|Ribavirin|ribavirin|mesh-list
153529127|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692175|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
153692176|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
153692177|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
153692178|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692179|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
153692180|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692181|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
153692182|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692243|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153692244|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153692245|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153692246|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153692247|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153692248|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153692251|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153692344|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
153692345|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
153692346|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
153692347|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692355|NCT02962999|Ketamine|ketamine|mesh-list
153851466|NCT05009927|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153851467|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153851468|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851469|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692522|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153692523|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153692524|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692525|NCT00084708|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692533|NCT00084708|Vitamins|vitamins|mesh-ancestor
153692635|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692784|NCT00084981|Valproic Acid|valproic acid|mesh-list
153692785|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153692786|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
153692787|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692788|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810929|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692789|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692895|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
153692896|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692897|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
153391814|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391815|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693045|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153693168|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693169|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153693170|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153693171|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693172|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693173|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153693174|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153693175|NCT00222079|Esomeprazole|esomeprazole|mesh-list
153693176|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153693177|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153693178|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153693179|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693180|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693181|NCT00222235|Cycloserine|cycloserine|mesh-list
153693182|NCT00222235|Glycine|glycine|mesh-list
153693183|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153693184|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693185|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153693186|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
153693187|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153693188|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
153693189|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693190|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
153693191|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693192|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693210|NCT00222547|Vitamins|vitamins|mesh-ancestor
153693213|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693214|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693215|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
153693216|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153693217|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693218|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
153693219|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153693310|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153693311|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153693312|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
153693313|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693314|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693315|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693316|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153693317|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693318|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693319|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693320|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153693321|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
153693322|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693323|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153693324|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693325|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693326|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153693393|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153693423|NCT00223717|Urological Agents|urological agents|mesh-ancestor
153693539|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153693540|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693541|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693557|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153693558|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
153693559|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693566|NCT00224458|Efavirenz|efavirenz|mesh-list
153693637|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
153693638|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693639|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153693640|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153693641|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693642|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693643|NCT00224809|Aspirin|aspirin|mesh-list
153693644|NCT00224809|Spironolactone|spironolactone|mesh-list
153693645|NCT00224809|Clopidogrel|clopidogrel|mesh-list
153693646|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153693647|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153693648|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153693776|NCT00062426|Leucovorin|leucovorin|mesh-list
153693777|NCT00062426|Bevacizumab|bevacizumab|mesh-list
153693778|NCT00062426|Capecitabine|capecitabine|mesh-list
153693779|NCT00062426|Fluorouracil|fluorouracil|mesh-list
153693780|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
153693881|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153693882|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153693883|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
153693884|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693885|NCT00225667|Irbesartan|irbesartan|mesh-list
153693886|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693887|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153693888|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153693967|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693968|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
153693969|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
153693970|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693971|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693998|NCT00226135|Lamotrigine|lamotrigine|mesh-list
153693999|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153392128|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153392129|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153392130|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392131|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694064|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694065|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694066|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694181|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694183|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
153694217|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694311|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694312|NCT00096369|Tamoxifen|tamoxifen|mesh-list
153694313|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153694314|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
153694315|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694316|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694317|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153694318|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694319|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153694320|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153694321|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153694322|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
153694323|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694324|NCT00228046|Valproic Acid|valproic acid|mesh-list
153694325|NCT00228046|Methylphenidate|methylphenidate|mesh-list
153694326|NCT00228046|Amphetamine|amphetamine|mesh-list
153694327|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
153694328|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153694329|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694378|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153694379|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153694380|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694382|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
153694383|NCT00228319|Vitamin E|vitamin e|mesh-list
153694384|NCT00228319|Vitamin A|vitamin a|mesh-list
153694385|NCT00228319|Carboplatin|carboplatin|mesh-list
153694386|NCT00228319|Carotenoids|carotenoids|mesh-list
153694387|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694463|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694464|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153694465|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
153694466|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694467|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694500|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153694501|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153694502|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852031|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
153694597|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153694598|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694603|NCT00229684|Pioglitazone|pioglitazone|mesh-list
153852062|NCT02908191|Tenofovir|tenofovir|mesh-list
153694694|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852078|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852079|NCT04647773|Pregabalin|pregabalin|mesh-list
153694786|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694787|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
153694788|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694789|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153694790|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531762|NCT01498796|Analgesics|analgesics|mesh-ancestor
153694791|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
153694792|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153694793|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153694807|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694808|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694855|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694960|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
153694961|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694962|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153694963|NCT00232102|Tegaserod|tegaserod|mesh-list
153694964|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153695068|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153695069|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153695070|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153695071|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153695072|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
153695073|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
153695074|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695075|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695076|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153695077|NCT00063947|Gemcitabine|gemcitabine|mesh-list
153695078|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153695079|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153695181|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
153695182|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
153695183|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153695185|NCT00097344|Letrozole|letrozole|mesh-list
153695444|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
153695445|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695446|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695473|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153695474|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153695475|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695476|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
153695477|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153695478|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153695479|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695480|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
153695481|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
153695482|NCT00234637|Memantine|memantine|mesh-list
153695483|NCT00234637|Rivastigmine|rivastigmine|mesh-list
153695639|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153695640|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695641|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153392455|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392456|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
153392457|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392458|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153695721|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695722|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153852263|NCT06237751|Urological Agents|urological agents|mesh-ancestor
153392469|NCT02987270|Piperaquine|piperaquine|mesh-list
153392470|NCT02987270|Artenimol|artenimol|mesh-list
153695806|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153695838|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
153695839|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
153695840|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695841|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153695842|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695843|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695844|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
153695845|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695846|NCT00065117|Antidotes|antidotes|mesh-ancestor
153695847|NCT00065117|Protective Agents|protective agents|mesh-ancestor
153695848|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
153852264|NCT06237660|Dimercaprol|dimercaprol|mesh-list
153695936|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
153695937|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695938|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695939|NCT00065273|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153695940|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153695941|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153695942|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
153695943|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
153695944|NCT00237445|Azithromycin|azithromycin|mesh-list
153695945|NCT00237445|Telithromycin|telithromycin|mesh-list
153695946|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695947|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695948|NCT00237484|Interferons|interferons|mesh-list
153695949|NCT00237484|Ribavirin|ribavirin|mesh-list
153695950|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
153695951|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
153695987|NCT04710160|Calcium|calcium|mesh-list
153695990|NCT00065351|Lenalidomide|lenalidomide|mesh-list
153696149|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696150|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533115|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
153696152|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
153852303|NCT06237478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696320|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
153696321|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696322|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153696323|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153696324|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
153696325|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153696326|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153696327|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153696328|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
153696329|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696330|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696331|NCT00239395|Meloxicam|meloxicam|mesh-list
153696332|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153696333|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153696334|NCT00239395|Analgesics|analgesics|mesh-ancestor
153696335|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
153696336|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696337|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865243|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153696338|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153696339|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696340|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153696341|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153696342|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696343|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696344|NCT00076635|Interferons|interferons|mesh-list
153696345|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
153392523|NCT00000723|Vitamins|vitamins|mesh-ancestor
153392524|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
153392525|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153696373|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153696374|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
153696375|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696376|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696377|NCT00239512|Ibuprofen|ibuprofen|mesh-list
153696378|NCT00239512|Indomethacin|indomethacin|mesh-list
153696379|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153696380|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153696440|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153696441|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153696442|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696443|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153533411|NCT01506388|Misoprostol|misoprostol|mesh-list
153852334|NCT06237153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153852335|NCT06237153|Immunologic Factors|immunologic factors|mesh-ancestor
153852336|NCT06237153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392547|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696524|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153696525|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153696526|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696527|NCT00240409|Pramipexole|pramipexole|mesh-list
153696528|NCT00240409|Bromocriptine|bromocriptine|mesh-list
153696529|NCT00240409|Dexpramipexole|dexpramipexole|mesh-list
153696530|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
153696531|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696532|NCT00240409|Protective Agents|protective agents|mesh-ancestor
153696533|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696534|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153696622|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696623|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153696624|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
153696625|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153696626|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696627|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696732|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696733|NCT00241540|Esomeprazole|esomeprazole|mesh-list
153696734|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153696735|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153696736|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153696737|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696738|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696739|NCT00098982|Leucovorin|leucovorin|mesh-list
153696740|NCT00098982|Fluorouracil|fluorouracil|mesh-list
153696741|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
153696742|NCT00098982|Bortezomib|bortezomib|mesh-list
153696743|NCT00098982|Calcium|calcium|mesh-list
153696744|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
153696745|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153696746|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696791|NCT00099060|Lapatinib|lapatinib|mesh-list
153736008|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696845|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
153696855|NCT00077025|Anastrozole|anastrozole|mesh-list
153696856|NCT00077025|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153696857|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696858|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696859|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696930|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153696931|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
153696932|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153696933|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696934|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
153696935|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153696936|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696937|NCT00242749|Gefitinib|gefitinib|mesh-list
153696938|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696941|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697004|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
153697005|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
153697007|NCT00099333|Exenatide|exenatide|mesh-list
153392646|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153392647|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153697109|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153697110|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697111|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
153697112|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
153697113|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
153697114|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697116|NCT00244426|Indobufen|indobufen|mesh-list
153534087|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
153697117|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153697118|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153697120|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
153697121|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697122|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697179|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
153697180|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697181|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697182|NCT00067301|Citalopram|citalopram|mesh-list
153392687|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
153392688|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392689|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153392690|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153392691|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153392692|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
153392695|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
153697263|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153697264|NCT00077298|Growth Substances|growth substances|mesh-ancestor
153697265|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697266|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
153697267|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
153357504|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153357505|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
153865345|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153865346|NCT04601259|Analgesics|analgesics|mesh-ancestor
153865347|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
153865348|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865349|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865350|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865351|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865352|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153405766|NCT05920928|Capecitabine|capecitabine|mesh-list
153697268|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153697336|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697337|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153697351|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852503|NCT06235567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392714|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
153392715|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392716|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392717|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153392718|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153392719|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
153392720|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392721|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153392722|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
153392723|NCT01706263|Salicylates|salicylates|mesh-list
153697427|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153697428|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153697429|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697430|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153697484|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
153697485|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
153697486|NCT00424801|Vitamins|vitamins|mesh-ancestor
153697487|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
153697488|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153697489|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153534462|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153697490|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153697491|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153697492|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
153697493|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
153697494|NCT00246298|Hematinics|hematinics|mesh-ancestor
153697595|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153697596|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
153697597|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697599|NCT00247702|Warfarin|warfarin|mesh-list
153697673|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153697674|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153697675|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697676|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697677|NCT00248443|Dimercaprol|dimercaprol|mesh-list
153697678|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
153697679|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
153697680|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697681|NCT00248482|Cisplatin|cisplatin|mesh-list
153697682|NCT00248482|Irinotecan|irinotecan|mesh-list
153697683|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
153697684|NCT00248482|Camptothecin|camptothecin|mesh-list
153697685|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697686|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153697687|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153697688|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697701|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697702|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
153697703|NCT00248716|Hematinics|hematinics|mesh-ancestor
153697704|NCT00067925|Calcium|calcium|mesh-list
153697705|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153697739|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153697740|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697743|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
153697744|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
153697747|NCT00249223|Risperidone|risperidone|mesh-list
153697876|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153697877|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697878|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153865365|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
153697879|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153697880|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697882|NCT04720573|Neostigmine|neostigmine|mesh-list
153697975|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153697976|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697977|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
153697978|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697979|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697980|NCT00099996|Ezetimibe|ezetimibe|mesh-list
153697981|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153697982|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153697983|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
153697984|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697985|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153697986|NCT00250744|Gabapentin|gabapentin|mesh-list
153697987|NCT00250744|Aprepitant|aprepitant|mesh-list
153698052|NCT00103701|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153698053|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153698054|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698055|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698056|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698058|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153698059|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698060|NCT00251056|Mannitol|mannitol|mesh-list
153698061|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153698149|NCT00100152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698233|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698234|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153698235|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
153698236|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698237|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
153698238|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153698239|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698240|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153698241|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153698242|NCT00251797|Growth Substances|growth substances|mesh-ancestor
153698243|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
153698245|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153698246|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153698247|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153698248|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698249|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698250|NCT00100269|Antioxidants|antioxidants|mesh-list
153852656|NCT06135259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852657|NCT06135259|Hematinics|hematinics|mesh-ancestor
153852664|NCT06126991|Cetirizine|cetirizine|mesh-list
153852665|NCT06126991|Midazolam|midazolam|mesh-list
153852666|NCT06126991|Fentanyl|fentanyl|mesh-list
153852667|NCT06126991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153852668|NCT06126991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153852669|NCT06126991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852670|NCT06126991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698302|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698303|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698304|NCT04719715|Antibodies|antibodies|mesh-list
153698365|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153698366|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698367|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153698368|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153698369|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698473|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153698474|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
153698475|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
153698476|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
153698477|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698478|NCT04719481|Pravastatin|pravastatin|mesh-list
153698479|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153698480|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153698481|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
153392933|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392934|NCT04230681|Fentanyl|fentanyl|mesh-list
153392935|NCT04230681|Hydromorphone|hydromorphone|mesh-list
153392936|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153698551|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698552|NCT00254449|Capsaicin|capsaicin|mesh-list
153698553|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
153698554|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
153698643|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698644|NCT00069875|Gemcitabine|gemcitabine|mesh-list
153698645|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698646|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698647|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
153698648|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698649|NCT00255268|Goserelin|goserelin|mesh-list
153698650|NCT00255268|Bicalutamide|bicalutamide|mesh-list
153698651|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153698652|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698653|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
153698654|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
153698655|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698656|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698657|NCT00104442|Rivastigmine|rivastigmine|mesh-list
153698658|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153698659|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698660|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698661|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
153698662|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698663|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698664|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153698666|NCT00255385|Micronutrients|micronutrients|mesh-list
153698715|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153698716|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
153698717|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698718|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153698719|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698720|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153698721|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
153405869|NCT05857514|Indomethacin|indomethacin|mesh-list
153405870|NCT05857514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153405871|NCT05857514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153405872|NCT05857514|Analgesics|analgesics|mesh-ancestor
153405873|NCT05857514|Sensory System Agents|sensory system agents|mesh-ancestor
153405874|NCT05857514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405875|NCT05857514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405876|NCT05857514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865434|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865435|NCT00567372|Bevacizumab|bevacizumab|mesh-list
153865436|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153865437|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698821|NCT00415285|Capecitabine|capecitabine|mesh-list
153698822|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698823|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
153698824|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
153698825|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
153698828|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
153698924|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698925|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
153698926|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
153698927|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
153698928|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698929|NCT00256711|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153698930|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153698931|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698932|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
153698933|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
153698934|NCT00070382|Hematinics|hematinics|mesh-ancestor
153698935|NCT00256828|Lamivudine|lamivudine|mesh-list
153698936|NCT00256828|Efavirenz|efavirenz|mesh-list
153698937|NCT00256828|Didanosine|didanosine|mesh-list
153698938|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153698939|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153698940|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698941|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698942|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
153698943|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698944|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153698945|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153698946|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153698947|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153698948|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153698949|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153698950|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153865439|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153865440|NCT00567372|Growth Substances|growth substances|mesh-ancestor
153865441|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865442|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
153865443|NCT00562133|Insulin|insulin|mesh-list
153865444|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153865445|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
153865446|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153865447|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698951|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153698952|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
153852799|NCT05970263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153852800|NCT05970263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153852801|NCT05970263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153852802|NCT05970263|Adrenergic Agents|adrenergic agents|mesh-ancestor
153852803|NCT05970263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852804|NCT05970263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852805|NCT05970263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153852806|NCT05970263|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153852807|NCT05970263|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153698987|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
153698988|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698989|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698990|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153698991|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153698992|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
153698993|NCT00257062|Levofloxacin|levofloxacin|mesh-list
153698994|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153699040|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699041|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153699042|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153699043|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699044|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699045|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699046|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699047|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153699048|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
153699049|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699050|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153699114|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
153699115|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153699116|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699117|NCT00401115|Sirolimus|sirolimus|mesh-list
153699118|NCT00401115|Temsirolimus|temsirolimus|mesh-list
153699119|NCT00401115|MTOR Inhibitors|mtor inhibitors|mesh-list
153699120|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699121|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699122|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153536106|NCT01520181|Lactams|lactams|mesh-list
153699123|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699124|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
153699125|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699126|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
153699127|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852850|NCT05854537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153852851|NCT05854537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852852|NCT05854537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852853|NCT05823441|Oxytocin|oxytocin|mesh-list
153852854|NCT05823441|Oxytocics|oxytocics|mesh-ancestor
153852855|NCT05823441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153852856|NCT05823441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699190|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852861|NCT05822076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852863|NCT05822076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852864|NCT05814523|Ganaxolone|ganaxolone|mesh-list
153852865|NCT05814523|Neurosteroids|neurosteroids|mesh-ancestor
153852866|NCT05814523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852867|NCT05814523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699283|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699284|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
153699285|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699286|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699287|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
153699288|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
153699289|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
153699290|NCT00259051|Omeprazole|omeprazole|mesh-list
153699291|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153699292|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699293|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153393113|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153393114|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393115|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153699353|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699355|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
153699356|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153699378|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
153699379|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699380|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
153699381|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153699382|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153699383|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
153699384|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153910750|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699386|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699388|NCT00259792|Budesonide|budesonide|mesh-list
153699434|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699435|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
153699436|NCT00259987|Lapatinib|lapatinib|mesh-list
153699437|NCT00259987|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153699438|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153699439|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699441|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699512|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699513|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699514|NCT00071747|Lamotrigine|lamotrigine|mesh-list
153699515|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
153699516|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153699517|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153699595|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699596|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
153699597|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
153699598|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
153699610|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
153699611|NCT00261820|Sirolimus|sirolimus|mesh-list
153699612|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
153699613|NCT00261820|Prednisolone|prednisolone|mesh-list
153699614|NCT00261820|Tacrolimus|tacrolimus|mesh-list
153699615|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699616|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
153405919|NCT05823987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405920|NCT05823987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405921|NCT05823467|Trimethoprim|trimethoprim|mesh-list
153405922|NCT05823467|Sulfamethoxazole|sulfamethoxazole|mesh-list
153405923|NCT05823467|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153405924|NCT05823467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405925|NCT05823467|Antimalarials|antimalarials|mesh-ancestor
153405926|NCT05823467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153405927|NCT05823467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153405928|NCT05823467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153699617|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699618|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153852967|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
153852968|NCT05616013|Semaglutide|semaglutide|mesh-list
153852969|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153699696|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153699697|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699698|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153852994|NCT05479032|Amantadine|amantadine|mesh-list
153699794|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153699795|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699796|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153853006|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853007|NCT05477576|Everolimus|everolimus|mesh-list
153853008|NCT05477576|Sunitinib|sunitinib|mesh-list
153853009|NCT05477576|Octreotide|octreotide|mesh-list
153853010|NCT05477576|Lanreotide|lanreotide|mesh-list
153853011|NCT05477576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153853012|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853013|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699881|NCT00263302|Hormones|hormones|mesh-ancestor
153699882|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699892|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699893|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153699894|NCT00101712|Vildagliptin|vildagliptin|mesh-list
153699895|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153699896|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393263|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153393264|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
153393265|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153699941|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699942|NCT04709029|Dexamethasone|dexamethasone|mesh-list
153699943|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
153699945|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699946|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
153699947|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
153699948|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699949|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699959|NCT00072722|Pomalidomide|pomalidomide|mesh-list
153699960|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
153699961|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699962|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153699963|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153699964|NCT00072722|Growth Substances|growth substances|mesh-ancestor
153699965|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
153700004|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700006|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153700007|NCT00265018|Bleomycin|bleomycin|mesh-list
153700008|NCT00265018|Vinblastine|vinblastine|mesh-list
153700009|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153700010|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700011|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153700012|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700013|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700029|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
153865500|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153865501|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153865502|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
153700089|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
153700090|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153865503|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153865504|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
153865505|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153865506|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153700091|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153700092|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700093|NCT00266149|Lamotrigine|lamotrigine|mesh-list
153700094|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
153700095|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153700096|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700097|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700098|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153700099|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700175|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700176|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153700177|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
153700178|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700179|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700180|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153853101|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
153853102|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853103|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153700271|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
153700272|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700273|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153700274|NCT00425620|Amphotericin B|amphotericin b|mesh-list
153700275|NCT00425620|Amebicides|amebicides|mesh-ancestor
153700276|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153700277|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153700278|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700279|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153700280|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
153700281|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153700282|NCT00267943|Telmisartan|telmisartan|mesh-list
153700283|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153700284|NCT00267943|Diuretics|diuretics|mesh-ancestor
153700285|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
153700286|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700287|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153700288|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700289|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700290|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153700291|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153888729|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
153865513|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153865514|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865515|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153865516|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153865517|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
153865518|NCT00562289|Aspirin|aspirin|mesh-list
153405946|NCT05796791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153700292|NCT04711265|Vaccines|vaccines|mesh-list
153700293|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
153700294|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700329|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700330|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700331|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153700332|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
153700333|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700334|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153700335|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153700336|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153700337|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153700338|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
153700339|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700340|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700342|NCT00073580|Anticoagulants|anticoagulants|mesh-list
153700343|NCT00073580|Bivalirudin|bivalirudin|mesh-list
153700344|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
153700345|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153700346|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
153700347|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700348|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700349|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153700350|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153700351|NCT00073658|Risperidone|risperidone|mesh-list
153700352|NCT00073658|Citalopram|citalopram|mesh-list
153393351|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153393352|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
153393353|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393354|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393355|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153393356|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
153393357|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
153700403|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700404|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700405|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700406|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
153700407|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700408|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153700409|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153700410|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
153853132|NCT05266937|Atezolizumab|atezolizumab|mesh-list
153700455|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
153700456|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700457|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700458|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153700459|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153700460|NCT00268528|Methotrexate|methotrexate|mesh-list
153700461|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
153700462|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153700463|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
153700464|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700465|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700466|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700467|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
153700468|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700469|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700470|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700471|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700472|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153700473|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700479|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
153393375|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153393376|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
153393377|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393378|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153405962|NCT05749926|Immunologic Factors|immunologic factors|mesh-ancestor
153405963|NCT05749926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405964|NCT05730205|Etonogestrel|etonogestrel|mesh-list
153393379|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153393380|NCT01727089|Growth Substances|growth substances|mesh-ancestor
153393381|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393382|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
153393383|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
153393384|NCT01727791|Pregabalin|pregabalin|mesh-list
153700548|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153700549|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
153700550|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700551|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700552|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153700553|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
153700554|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
153700555|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700556|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153700557|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153700558|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153700607|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700608|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153700609|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153700610|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700611|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700612|NCT00269035|Risperidone|risperidone|mesh-list
153700613|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153700614|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
153700615|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700616|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700617|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700618|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153700619|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153700620|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700621|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153700622|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153700623|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
153700624|NCT00074009|Bortezomib|bortezomib|mesh-list
153700625|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700626|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
153700627|NCT00269386|Clarithromycin|clarithromycin|mesh-list
153700628|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153700629|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853170|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853171|NCT05105256|Prednisolone|prednisolone|mesh-list
153853172|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153853173|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
153853174|NCT05105256|Hormones|hormones|mesh-ancestor
153853175|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153853176|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853177|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153853178|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853179|NCT05084599|Metaraminol|metaraminol|mesh-list
153853180|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
153853181|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
153700679|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
153865557|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865558|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153888736|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
153700680|NCT00416143|Prednisone|prednisone|mesh-list
153700681|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700682|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
153700683|NCT00416143|Hormones|hormones|mesh-ancestor
153700684|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393417|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393418|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153393419|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393420|NCT02245087|Atorvastatin|atorvastatin|mesh-list
153700740|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153700741|NCT00269893|Abciximab|abciximab|mesh-list
153700742|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
153700743|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153700744|NCT00074321|Capecitabine|capecitabine|mesh-list
153700745|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
153700746|NCT00074321|Irinotecan|irinotecan|mesh-list
153700747|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700748|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
153700749|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700750|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700751|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153700752|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700753|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700754|NCT00102609|Dexamethasone|dexamethasone|mesh-list
153700755|NCT00102609|Doxorubicin|doxorubicin|mesh-list
153700756|NCT00102609|Trabectedin|trabectedin|mesh-list
153700757|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700758|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
153700759|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
153700781|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700782|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700783|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853193|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853194|NCT05000658|Dexamethasone|dexamethasone|mesh-list
153853195|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153853196|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700807|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
153700808|NCT00270088|Hematinics|hematinics|mesh-ancestor
153853206|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853207|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153853208|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853209|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153853210|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153853211|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153853212|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700901|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
153700902|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153700903|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153700904|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700905|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153700906|NCT04730375|Analgesics|analgesics|mesh-ancestor
153700907|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
153853224|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153853225|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853226|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153853227|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153700966|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153700967|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700968|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153700969|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153700970|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
153700971|NCT02965859|Adefovir|adefovir|mesh-list
153700972|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153700973|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
153700974|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700975|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153700976|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153865576|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
153700977|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700978|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700979|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
153700980|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153700981|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700982|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700983|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153700984|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153700985|NCT00271336|Protective Agents|protective agents|mesh-ancestor
153700986|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700987|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
153700988|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153700989|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
153701018|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701019|NCT00271804|Bortezomib|bortezomib|mesh-list
153701020|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701021|NCT00107601|Insulin|insulin|mesh-list
153701022|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153701023|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701024|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
153701025|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153701026|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701027|NCT00272116|Vitamins|vitamins|mesh-list
153701028|NCT00272116|Vitamin A|vitamin a|mesh-list
153701029|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
153701030|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
153701031|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701032|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
153701033|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701034|NCT00272116|Protective Agents|protective agents|mesh-ancestor
153853244|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853245|NCT04901741|Pembrolizumab|pembrolizumab|mesh-list
153853246|NCT04901741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853247|NCT04901741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853248|NCT04901741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853249|NCT04901741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853250|NCT04844866|Rituximab|rituximab|mesh-list
153853251|NCT04844866|Gemcitabine|gemcitabine|mesh-list
153853252|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
153853253|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153853254|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153853255|NCT04844866|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153853256|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
153701089|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701090|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701091|NCT00416533|Prednisone|prednisone|mesh-list
153701092|NCT00416533|Docetaxel|docetaxel|mesh-list
153701093|NCT00416533|Doxorubicin|doxorubicin|mesh-list
153393493|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
153393494|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393495|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153701146|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701147|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153701148|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153701149|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153701150|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153701151|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701152|NCT00107874|Misoprostol|misoprostol|mesh-list
153701153|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153701154|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
153701155|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153701156|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701157|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153701158|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701159|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
153701160|NCT00074828|Enoxaparin|enoxaparin|mesh-list
153701161|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
153701162|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153701163|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153701164|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701165|NCT00273247|Interferons|interferons|mesh-list
153701166|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
153701167|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
153701168|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701169|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
153701170|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701206|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153701207|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701208|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153701209|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153701210|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153701211|NCT00273520|Telithromycin|telithromycin|mesh-list
153701212|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153701213|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701214|NCT00273559|Prednisone|prednisone|mesh-list
153701215|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153701216|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
153701217|NCT00273559|Hormones|hormones|mesh-ancestor
153701218|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701219|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701220|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153701221|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701222|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153701223|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153701224|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701225|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
153701275|NCT00274066|Ipratropium|ipratropium|mesh-list
153701276|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153701277|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
153701278|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701279|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701280|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153701281|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701282|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
153701283|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153701284|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
153701285|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701286|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701287|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
153701288|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
153701289|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153701290|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153701294|NCT00274105|Telmisartan|telmisartan|mesh-list
153701339|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701340|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
153701342|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153701343|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
153701344|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701345|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
153701346|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701347|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153701348|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701349|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
153701350|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153701351|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153701352|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
153701353|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701354|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393539|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393541|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153393542|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
153393543|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153393544|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153393545|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153393546|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153393547|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393548|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
153701408|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701409|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153701410|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153701474|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701475|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153701476|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
153701477|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
153701478|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701479|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701490|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
153701491|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153701493|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153701495|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
153701496|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701497|NCT00075452|Gemcitabine|gemcitabine|mesh-list
153701498|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
153701499|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153701500|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
153701501|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701502|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701541|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153701542|NCT00277693|Diuretics|diuretics|mesh-ancestor
153701567|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701568|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
153701569|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
153701570|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
153810936|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357510|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357511|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153865676|NCT01152580|Protective Agents|protective agents|mesh-ancestor
153865677|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865678|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865679|NCT02884453|Ibrutinib|ibrutinib|mesh-list
153865680|NCT02884453|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153865681|NCT02884453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153865682|NCT02884453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865683|NCT02884453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865684|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153865685|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
153701571|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701572|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
153701573|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701574|NCT00075647|Sirolimus|sirolimus|mesh-list
153701575|NCT00075647|Temsirolimus|temsirolimus|mesh-list
153701576|NCT00075647|MTOR Inhibitors|mtor inhibitors|mesh-list
153701577|NCT00075647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153701578|NCT00075647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701579|NCT00075647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701580|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701581|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
153701582|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701583|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701584|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153701585|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701586|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153701587|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
153701588|NCT00278278|Prednisone|prednisone|mesh-list
153701589|NCT00278278|Methotrexate|methotrexate|mesh-list
153701590|NCT00278278|Etoposide|etoposide|mesh-list
153701591|NCT00278278|Vincristine|vincristine|mesh-list
153701592|NCT00278278|Ifosfamide|ifosfamide|mesh-list
153701593|NCT00278278|Lomustine|lomustine|mesh-list
153701594|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701595|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888751|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153701596|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
153701597|NCT00278278|Hormones|hormones|mesh-ancestor
153701615|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153701616|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153701617|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
153701618|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853338|NCT04749914|Dabigatran|dabigatran|mesh-list
153818499|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459886|NCT05552001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459888|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153701619|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
153701620|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153701621|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
153701623|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153701624|NCT00108771|Narcotics|narcotics|mesh-ancestor
153701625|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701626|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701627|NCT00108771|Analgesics|analgesics|mesh-ancestor
153701628|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
153701629|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701630|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153701631|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153701632|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
153701633|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
153701634|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
153701637|NCT00075686|Gemcitabine|gemcitabine|mesh-list
153701699|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153701700|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153701701|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701702|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701703|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
153701738|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701753|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701754|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153701756|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701757|NCT00279565|Analgesics|analgesics|mesh-ancestor
153701758|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
153701759|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701760|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153701761|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
153701762|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701763|NCT00075998|Interferons|interferons|mesh-list
153701764|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
153701765|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701766|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
153701768|NCT00109161|Antibodies|antibodies|mesh-list
153701801|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153701802|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701803|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
153701830|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153701831|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701832|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153701833|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153701834|NCT00109239|Growth Substances|growth substances|mesh-ancestor
153701835|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701836|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
153701837|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153701838|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153701839|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
153701840|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701842|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701843|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701844|NCT00109278|Vaccines|vaccines|mesh-list
153810939|NCT00352950|Panitumumab|panitumumab|mesh-list
153810940|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153357514|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
153406147|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153406148|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406149|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406150|NCT05303090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406151|NCT05243329|Psilocybin|psilocybin|mesh-list
153406152|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
153406153|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406154|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153406155|NCT05237297|Celecoxib|celecoxib|mesh-list
153406156|NCT05237297|Naproxen|naproxen|mesh-list
153701845|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
153701846|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701847|NCT00280267|Testosterone|testosterone|mesh-list
153701848|NCT00280267|Androgens|androgens|mesh-ancestor
153701849|NCT00280267|Hormones|hormones|mesh-ancestor
153701850|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701851|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701852|NCT00076232|Acyclovir|acyclovir|mesh-list
153701869|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701870|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153701871|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701872|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
153701874|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153701875|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153701876|NCT00280501|Sulpiride|sulpiride|mesh-list
153701877|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
153701878|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701879|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153701880|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153701881|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701882|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701883|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153701884|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
153701885|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701886|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701887|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153701888|NCT00280540|Valsartan|valsartan|mesh-list
153701889|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153701890|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701891|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153701892|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153701894|NCT00280540|Diuretics|diuretics|mesh-ancestor
153701988|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153701989|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153701990|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153701991|NCT00109746|Chromium|chromium|mesh-list
153701992|NCT00109746|Picolinic acid|picolinic acid|mesh-list
153701993|NCT00109746|Trace Elements|trace elements|mesh-ancestor
153701994|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
153701995|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701996|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153701997|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
153701998|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
153701999|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702000|NCT04730297|Acetaminophen|acetaminophen|mesh-list
153702001|NCT04730297|Ibuprofen|ibuprofen|mesh-list
153702002|NCT04730297|Codeine|codeine|mesh-list
153702003|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153702004|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153702005|NCT04730297|Analgesics|analgesics|mesh-ancestor
153702077|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153702078|NCT00281515|Lonafarnib|lonafarnib|mesh-list
153702079|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702133|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702134|NCT00281788|Paclitaxel|paclitaxel|mesh-list
153702135|NCT00281788|Carboplatin|carboplatin|mesh-list
153702136|NCT00281788|Capecitabine|capecitabine|mesh-list
153702137|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153702149|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702151|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
153702152|NCT00281905|Carboplatin|carboplatin|mesh-list
153702153|NCT00281905|Methotrexate|methotrexate|mesh-list
153702154|NCT00281905|Vincristine|vincristine|mesh-list
153702155|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153426436|NCT00089414|Drospirenone|drospirenone|mesh-list
153702156|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
153702157|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702158|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702159|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153702160|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
153702161|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702162|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702163|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153702164|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153702165|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
153702166|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153702167|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702168|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
153702169|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
153702170|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702171|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153702172|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153702173|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153702174|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
153702175|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
153702176|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
153702177|NCT00110058|Interferons|interferons|mesh-list
153702178|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
153702179|NCT00110058|Cyclosporine|cyclosporine|mesh-list
153702180|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
153702183|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
153702184|NCT00110058|Cyclosporins|cyclosporins|mesh-list
153702185|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702186|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702187|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
153702188|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702189|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702190|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
153702191|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702192|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
153702193|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702194|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702195|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
153702196|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
153702197|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702198|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153702199|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153702200|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153702213|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702214|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702215|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702216|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702217|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
153702218|NCT00281944|Antidotes|antidotes|mesh-ancestor
153702219|NCT00281944|Protective Agents|protective agents|mesh-ancestor
153702220|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
153702222|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
153702223|NCT00281983|Cyclosporine|cyclosporine|mesh-list
153702224|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
153702225|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
153702226|NCT00281983|Busulfan|busulfan|mesh-list
153702227|NCT00281983|Rituximab|rituximab|mesh-list
153702228|NCT00281983|Methotrexate|methotrexate|mesh-list
153702240|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702241|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702242|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153702243|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736014|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702244|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153702245|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
153702246|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153702247|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702248|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
153702249|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
153702250|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702251|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153702252|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153702253|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
153702254|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853543|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153853544|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853546|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153853547|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
153853548|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853549|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853550|NCT04027647|Dacomitinib|dacomitinib|mesh-list
153853551|NCT04027647|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153853552|NCT04027647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853553|NCT04027647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702314|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153702315|NCT00282217|Sirolimus|sirolimus|mesh-list
153702316|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153702317|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702318|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153702339|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
153702340|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702342|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
153393799|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
153393800|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
153393801|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702397|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702398|NCT00283309|Riluzole|riluzole|mesh-list
153702399|NCT00283309|Memantine|memantine|mesh-list
153702400|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153702401|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153702402|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
153702403|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702404|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702405|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702406|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153702407|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153702408|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
153702409|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153702410|NCT00283309|Protective Agents|protective agents|mesh-ancestor
153702411|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153702412|NCT00417157|Ganirelix|ganirelix|mesh-list
153702413|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
153702414|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702498|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
153736016|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153702499|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702500|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702501|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153702502|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
153702503|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153702504|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
153702505|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
153702506|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702507|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702508|NCT04718701|Paclitaxel|paclitaxel|mesh-list
153702509|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153702510|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702511|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
153702512|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
153702513|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
153702514|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702515|NCT00077168|Tamoxifen|tamoxifen|mesh-list
153702516|NCT00077168|Anastrozole|anastrozole|mesh-list
153702538|NCT00284791|Lamotrigine|lamotrigine|mesh-list
153853598|NCT03798626|Irinotecan|irinotecan|mesh-list
153702569|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702570|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153702585|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702586|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153702587|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702589|NCT00077246|Paclitaxel|paclitaxel|mesh-list
153853625|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
153702658|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153702659|NCT00077363|Capecitabine|capecitabine|mesh-list
153702660|NCT00077363|Tipifarnib|tipifarnib|mesh-list
153702661|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702662|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
153702663|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702664|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702665|NCT00285415|Carboplatin|carboplatin|mesh-list
153702666|NCT00285415|Docetaxel|docetaxel|mesh-list
153406245|NCT05120141|Listerine|listerine|mesh-list
153406246|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153406247|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406248|NCT05103904|Lenvatinib|lenvatinib|mesh-list
153702667|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702668|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
153702669|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
153702670|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
153702671|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702672|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153702674|NCT00285727|Ropinirole|ropinirole|mesh-list
153393878|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
153393879|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702731|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153702732|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
153702733|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702734|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702735|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153702736|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153702737|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
153702738|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702739|NCT00077519|Tipifarnib|tipifarnib|mesh-list
153702740|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702741|NCT00286117|Tamoxifen|tamoxifen|mesh-list
153702742|NCT00286117|Anastrozole|anastrozole|mesh-list
153702743|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153702744|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
153702745|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702746|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702747|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153702748|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702749|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153702750|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153702770|NCT00286273|Dalteparin|dalteparin|mesh-list
153702771|NCT00286273|Nadroparin|nadroparin|mesh-list
153702799|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702800|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702801|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
153702802|NCT00110955|Hematinics|hematinics|mesh-ancestor
153702803|NCT00286585|Propofol|propofol|mesh-list
153702804|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
153702805|NCT00286585|Anesthetics|anesthetics|mesh-list
153702806|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153702840|NCT00077597|Hematinics|hematinics|mesh-ancestor
153702841|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
153702842|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153702843|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702844|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153702845|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
153539849|NCT01535989|Immunotoxins|immunotoxins|mesh-ancestor
153853657|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153853658|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
153853659|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853660|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702900|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153702901|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153702902|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153702903|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702904|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702905|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153702906|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153702907|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153702908|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
153702909|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702910|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702930|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153702931|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702932|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702933|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153702935|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
153702936|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702937|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702938|NCT00111306|Epratuzumab|epratuzumab|mesh-list
153702939|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153393921|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393922|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702963|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153702964|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
153702965|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153702966|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702967|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702968|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153702987|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702988|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702989|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153702990|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
153702991|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153702992|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153702993|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702994|NCT00077948|Protective Agents|protective agents|mesh-ancestor
153702996|NCT00111345|Idarubicin|idarubicin|mesh-list
153702997|NCT00111345|Cladribine|cladribine|mesh-list
153702998|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153702999|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853694|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153853695|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
153703046|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703047|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703048|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703049|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153703050|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153703051|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153703052|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153703053|NCT00287560|Propofol|propofol|mesh-list
153703054|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153703055|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153703056|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703057|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153703058|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
153703059|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
153703060|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
153703061|NCT00111462|Hematinics|hematinics|mesh-ancestor
153703062|NCT00287677|Hormones|hormones|mesh-list
153703063|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703064|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703065|NCT00287794|Diazepam|diazepam|mesh-list
153703066|NCT00287794|Melatonin|melatonin|mesh-list
153703067|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
153703068|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703069|NCT00287794|Protective Agents|protective agents|mesh-ancestor
153703070|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703071|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153703072|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153703073|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
153703074|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
153853697|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853698|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853699|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853700|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853701|NCT03173560|Everolimus|everolimus|mesh-list
153853702|NCT03173560|Lenvatinib|lenvatinib|mesh-list
153853703|NCT03173560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153853704|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853705|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853706|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853708|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
153703202|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
153703203|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703204|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153865843|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
153703205|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153703206|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153703207|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703208|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703209|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703210|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703211|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153703212|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
153703213|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703214|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
153703215|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
153703216|NCT00288769|Vitamins|vitamins|mesh-ancestor
153703217|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
153703218|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703219|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
153703220|NCT00288769|Hematinics|hematinics|mesh-ancestor
153703221|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
153703222|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153703223|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153703224|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703225|NCT00289042|Enoxaparin|enoxaparin|mesh-list
153703226|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
153703271|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703272|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703273|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703274|NCT00401661|Urological Agents|urological agents|mesh-ancestor
153703275|NCT00289861|Risperidone|risperidone|mesh-list
153703276|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153703277|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
153703278|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703279|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703280|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703281|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153703282|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153703283|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153703284|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703285|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153703286|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
153703287|NCT00290017|Pemetrexed|pemetrexed|mesh-list
153703342|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153703343|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
153703344|NCT00290602|Hormones|hormones|mesh-ancestor
153703345|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703346|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153703347|NCT00290602|Protective Agents|protective agents|mesh-ancestor
153703348|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153703349|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703350|NCT00290641|Cyclosporine|cyclosporine|mesh-list
153703351|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
153703352|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
153426677|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153703353|NCT00290641|Fludarabine|fludarabine|mesh-list
153703354|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
153703355|NCT00290641|Cyclosporins|cyclosporins|mesh-list
153703356|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703391|NCT02960815|Imiquimod|imiquimod|mesh-list
153703392|NCT02960815|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153703393|NCT02960815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703394|NCT02960815|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153703419|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703420|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703421|NCT04729556|Chitosan|chitosan|mesh-list
153703422|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153703424|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
153853760|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853761|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853762|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853764|NCT02939573|Colchicine|colchicine|mesh-list
153703466|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153703467|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153703468|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153703469|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153703470|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703471|NCT00291148|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153703472|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153703473|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703474|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
153703475|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153703476|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
153703477|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153703478|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153703479|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703480|NCT00291382|Fluticasone|fluticasone|mesh-list
153703481|NCT00291382|Xhance|xhance|mesh-list
153703482|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153703483|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703484|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153703526|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153703527|NCT00078572|Capecitabine|capecitabine|mesh-list
153703529|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703530|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
153703531|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703532|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703533|NCT00078572|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153703534|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703535|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703536|NCT00291733|Levetiracetam|levetiracetam|mesh-list
153703537|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
153703538|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
153703539|NCT00112515|Modafinil|modafinil|mesh-list
153703540|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153703541|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703542|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153703543|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153703544|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153703545|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703546|NCT00291772|Pramlintide|pramlintide|mesh-list
153703547|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153703548|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703549|NCT00078611|Natalizumab|natalizumab|mesh-list
153703550|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
153703581|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703583|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703584|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
153703585|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703586|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
153703587|NCT00112632|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153703588|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703589|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703590|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703591|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703592|NCT00078845|Amifostine|amifostine|mesh-list
153703593|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153703594|NCT00078845|Protective Agents|protective agents|mesh-ancestor
153703595|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703596|NCT00275314|Valganciclovir|valganciclovir|mesh-list
153703597|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
153703598|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703599|NCT00275275|Pramipexole|pramipexole|mesh-list
153703600|NCT00275275|Ropinirole|ropinirole|mesh-list
153703601|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
153703602|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703603|NCT00275275|Protective Agents|protective agents|mesh-ancestor
153703604|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703631|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703632|NCT00275119|Gemcitabine|gemcitabine|mesh-list
153703654|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703656|NCT00275041|Irinotecan|irinotecan|mesh-list
153703657|NCT00275041|Cetuximab|cetuximab|mesh-list
153703658|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153865922|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
153703659|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703660|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703661|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703662|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703663|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153703664|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153703665|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
153703666|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153703667|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
153703668|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703669|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703670|NCT00274963|Analgesics|analgesics|mesh-ancestor
153703671|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
153703672|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703673|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703674|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153703675|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703676|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703677|NCT00102765|Fluticasone|fluticasone|mesh-list
153703678|NCT00102765|Xhance|xhance|mesh-list
153703679|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153703680|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153703681|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703740|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
153703742|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
153703743|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
153703744|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703745|NCT00079118|Docetaxel|docetaxel|mesh-list
153703746|NCT00079118|Irinotecan|irinotecan|mesh-list
153703747|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703748|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
153703749|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
153703750|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
153703751|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703752|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153703753|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703754|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703755|NCT00130195|Cytarabine|cytarabine|mesh-list
153703756|NCT00130195|Dexamethasone|dexamethasone|mesh-list
153703757|NCT00130195|Prednisolone|prednisolone|mesh-list
153703822|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153703823|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153703824|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
153703825|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703826|NCT00130156|Doxazosin|doxazosin|mesh-list
153703827|NCT00130156|Bunazosin|bunazosin|mesh-list
153703828|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153703829|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153406390|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406391|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153406392|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153406393|NCT04647877|Phenytoin|phenytoin|mesh-list
153406394|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
153406395|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153406396|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153406397|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888762|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406398|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406399|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153406400|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153703830|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153703831|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153703832|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703833|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703834|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703835|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703836|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
153703837|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
153703838|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153853856|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853857|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853858|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853859|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153703916|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153703917|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703918|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703919|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
153703920|NCT00079352|Growth Substances|growth substances|mesh-ancestor
153703921|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703922|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703923|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
153703924|NCT00119496|Beclomethasone|beclomethasone|mesh-list
153703925|NCT00119496|Theophylline|theophylline|mesh-list
153703926|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703927|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703928|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153703929|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703930|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703931|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
153703932|NCT00119496|Hormones|hormones|mesh-ancestor
153703933|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703934|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153703935|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
153703936|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153703937|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
153703938|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703939|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153703940|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
153703945|NCT00298285|Enoxaparin|enoxaparin|mesh-list
153394120|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703957|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703995|NCT00298636|Adenosine|adenosine|mesh-list
153704017|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153704018|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
153704019|NCT00079469|Bupropion|bupropion|mesh-list
153704020|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153704021|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
153704022|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153704023|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153704024|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153704025|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153704026|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704027|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
153704028|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704029|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704030|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153704032|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704124|NCT00299455|Amoxicillin|amoxicillin|mesh-list
153704125|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
153704126|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
153704127|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153704128|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704129|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704130|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153704131|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704132|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704133|NCT00299572|Alendronate|alendronate|mesh-list
153426844|NCT00000224|Buprenorphine|buprenorphine|mesh-list
153704134|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153704135|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704136|NCT00299611|Levetiracetam|levetiracetam|mesh-list
153704138|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
153704171|NCT00299806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704172|NCT00299845|Lansoprazole|lansoprazole|mesh-list
153704173|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
153704174|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153704175|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153704218|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704219|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153704221|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
153704222|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704223|NCT00299962|Interferons|interferons|mesh-list
153704224|NCT00299962|Interferon-beta|interferon-beta|mesh-list
153704225|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704226|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
153704227|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704228|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
153704230|NCT00418171|Olanzapine|olanzapine|mesh-list
153704350|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704351|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
153704352|NCT00079313|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153704353|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153704354|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704355|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704356|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704357|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
153704358|NCT00086268|Carboplatin|carboplatin|mesh-list
153704359|NCT00086268|Docetaxel|docetaxel|mesh-list
153704360|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704361|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
153704362|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
153704363|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
153704364|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704365|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153394212|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
153394213|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394215|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153394216|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153394217|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
153394218|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394219|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704432|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704433|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153704434|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704435|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704436|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153704502|NCT00301522|Paclitaxel|paclitaxel|mesh-list
153704528|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
153704529|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
153704530|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704531|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704532|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153704533|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
153704534|NCT00080444|Hormones|hormones|mesh-ancestor
153704535|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704536|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153704537|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704538|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
153704539|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704540|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704541|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
153704542|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
153704543|NCT00080444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153704544|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153704595|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153853989|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810941|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810942|NCT00322907|Mefloquine|mefloquine|mesh-list
153866023|NCT00569400|Insulin|insulin|mesh-list
153853990|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153853991|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153853992|NCT01130519|Growth Substances|growth substances|mesh-ancestor
153853993|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853994|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
153853995|NCT01130519|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153853996|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853997|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853998|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394257|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394258|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394259|NCT01766713|Ezetimibe|ezetimibe|mesh-list
153394260|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153394261|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153394262|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
153394263|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704678|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394269|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394270|NCT01769209|Cytarabine|cytarabine|mesh-list
153394271|NCT01769209|Dexamethasone|dexamethasone|mesh-list
153394272|NCT01769209|Doxorubicin|doxorubicin|mesh-list
153394273|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153394274|NCT01769209|Methotrexate|methotrexate|mesh-list
153394275|NCT01769209|Vincristine|vincristine|mesh-list
153394276|NCT01769209|Bortezomib|bortezomib|mesh-list
153394277|NCT01769209|Asparaginase|asparaginase|mesh-list
153394278|NCT01769209|Pegaspargase|pegaspargase|mesh-list
153394279|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394280|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
153394281|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
153394282|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394283|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394284|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153704786|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153704787|NCT00087048|Topotecan|topotecan|mesh-list
153704788|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153704789|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153704828|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153854032|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153854034|NCT00984490|Metformin|metformin|mesh-list
153854035|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153854036|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854037|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
153854038|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153854039|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854040|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
153704831|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
153704926|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153704927|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153704928|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
153704929|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704930|NCT00120198|Rituximab|rituximab|mesh-list
153704931|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704932|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704933|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
153704934|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704935|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704936|NCT00302224|Ketoconazole|ketoconazole|mesh-list
153704937|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
153704938|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705090|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705091|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
153705092|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
153705093|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
153705094|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406522|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
153406523|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406524|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153406525|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
153705095|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
153705096|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153705097|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153705098|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705099|NCT00302692|Metoprolol|metoprolol|mesh-list
153705100|NCT00302692|Esmolol|esmolol|mesh-list
153705101|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153705102|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153705103|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
153705104|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
153705105|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705106|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705107|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153705108|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153705109|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153705110|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
153705111|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705125|NCT00303004|Bosentan|bosentan|mesh-list
153705186|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153705187|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153705189|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153705190|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153705191|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
153705192|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705193|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705194|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705195|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153705196|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153705198|NCT00303550|Iclaprim|iclaprim|mesh-list
153705199|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153705200|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705201|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153705202|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705204|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153705258|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
153854075|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854076|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854077|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
153854078|NCT00408005|Hormones|hormones|mesh-ancestor
153854079|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854080|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153854081|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
153854082|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854083|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153705259|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
153705260|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153705261|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153705262|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153705263|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
153705328|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153705329|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705330|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705331|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705333|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
153705334|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705335|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705336|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
153705337|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705338|NCT00304213|Testosterone|testosterone|mesh-list
153705339|NCT00304213|Androgens|androgens|mesh-ancestor
153705340|NCT00304213|Hormones|hormones|mesh-ancestor
153705341|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705342|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705343|NCT00304252|Interferons|interferons|mesh-list
153705377|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705378|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705379|NCT00304369|Metronidazole|metronidazole|mesh-list
153705380|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705381|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153705425|NCT00082199|Aripiprazole|aripiprazole|mesh-list
153705468|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705470|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
153705471|NCT00304993|Fenofibrate|fenofibrate|mesh-list
153705472|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153705473|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705474|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153705475|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
153705507|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153394364|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736019|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705612|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
153705613|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705614|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705615|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
153705616|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705617|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705618|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705619|NCT00082667|Gefitinib|gefitinib|mesh-list
153705717|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705718|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705719|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705720|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
153705721|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153705722|NCT00120744|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153705723|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153705756|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153705757|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705759|NCT00083096|Lonafarnib|lonafarnib|mesh-list
153705760|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153705761|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
153705762|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705763|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705764|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705792|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705793|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705794|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153705795|NCT00307645|Protective Agents|protective agents|mesh-ancestor
153705796|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
153705797|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705798|NCT00120783|Ritonavir|ritonavir|mesh-list
153705799|NCT00120783|Indinavir|indinavir|mesh-list
153705877|NCT00418756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153705878|NCT00418756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705879|NCT00418756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705881|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
153705882|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
153705883|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153705884|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
153705885|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705886|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705887|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153705888|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
153705889|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153705890|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153705891|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153705892|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
153705893|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705894|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705895|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
153705898|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
153394429|NCT04744727|Analgesics|analgesics|mesh-ancestor
153394430|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
153394431|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394432|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854170|NCT02905890|Norethindrone|norethindrone|mesh-list
153854171|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
153854172|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
153854173|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153854174|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153854175|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153854176|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
153854177|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153854178|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542921|NCT01555580|Molgramostim|molgramostim|mesh-list
153705939|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705940|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
153705941|NCT00308542|Hormones|hormones|mesh-ancestor
153705942|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705943|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153705944|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705980|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
153705981|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
153705982|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706007|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706009|NCT00309283|Hormones|hormones|mesh-ancestor
153706010|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706011|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706012|NCT00083525|Capecitabine|capecitabine|mesh-list
153543001|NCT01556191|Gefitinib|gefitinib|mesh-list
153706013|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153706014|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
153706015|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427132|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
153706016|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706017|NCT00309322|Phentolamine|phentolamine|mesh-list
153706018|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153706019|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153706020|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
153706021|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706068|NCT00309517|Vitamins|vitamins|mesh-ancestor
153854202|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854203|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854204|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
153854205|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854206|NCT00558818|Clevudine|clevudine|mesh-list
153854207|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
153854208|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854209|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
153706104|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706105|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153706106|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
153706107|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153706108|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153706109|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153706110|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153706111|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706112|NCT00402207|Fluticasone|fluticasone|mesh-list
153706113|NCT00402207|Beclomethasone|beclomethasone|mesh-list
153394472|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394474|NCT02115997|Prednisone|prednisone|mesh-list
153394475|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
153394476|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153394477|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153394478|NCT02115997|Prednisolone|prednisolone|mesh-list
153394479|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
153706176|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
153706177|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706178|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706179|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153706208|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706209|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706210|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153706211|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
153706212|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706266|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706267|NCT00310492|Immunomodulating Agents|immunomodulating agents|mesh-list
153706268|NCT00310492|Immunologic Factors|immunologic factors|mesh-ancestor
153706269|NCT00310492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706270|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153706271|NCT00310531|Estradiol|estradiol|mesh-list
153706272|NCT00310531|Estrogens|estrogens|mesh-ancestor
153706273|NCT00310531|Hormones|hormones|mesh-ancestor
153706274|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153427190|NCT03979807|Bromides|bromides|mesh-list
153706275|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706276|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153706277|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
153706278|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153706281|NCT00309673|Lidocaine|lidocaine|mesh-list
153706334|NCT00311038|Landiolol|landiolol|mesh-list
153706335|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153706336|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153706337|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
153706338|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706339|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706340|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706341|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153706342|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
153706343|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153706344|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706345|NCT00311116|Vitamin E|vitamin e|mesh-list
153706346|NCT00311116|Vitamins|vitamins|mesh-ancestor
153706347|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
153706432|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153706433|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
153706435|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153706436|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706437|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153706438|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153706439|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706440|NCT00311740|Diuretics|diuretics|mesh-ancestor
153706441|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
153706442|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706443|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153706444|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153706445|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
153706446|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153706448|NCT00121407|Verteporfin|verteporfin|mesh-list
153706507|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153854303|NCT02899026|Prednisone|prednisone|mesh-list
153854304|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153854305|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854306|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
153854307|NCT02899026|Hormones|hormones|mesh-ancestor
153854308|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854309|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854310|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153854311|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854312|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
153854313|NCT00559169|Verapamil|verapamil|mesh-list
153854314|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153854315|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153854316|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153854317|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854320|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
153706571|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706572|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
153706573|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
153706574|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706575|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706576|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706577|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
153706578|NCT00312520|Hormones|hormones|mesh-ancestor
153706579|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706580|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153706581|NCT00312520|Protective Agents|protective agents|mesh-ancestor
153706596|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706597|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706598|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
153706599|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854342|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854343|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153854344|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854345|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153706661|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706662|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
153706663|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
153706664|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
153706665|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706666|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706667|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
153706668|NCT00293371|Hormones|hormones|mesh-ancestor
153706669|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706670|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706671|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153706672|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153706673|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706674|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
153706675|NCT00293410|Clofarabine|clofarabine|mesh-list
153706676|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153706677|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
153706678|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706679|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706680|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153706681|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
153706682|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706683|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706684|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153706686|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
153706701|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706702|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706722|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706723|NCT00423969|Galantamine|galantamine|mesh-list
153706724|NCT00423969|Escitalopram|escitalopram|mesh-list
153706725|NCT00423969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153706726|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153706727|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153706728|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706729|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706730|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
153706731|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706732|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
153706733|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810943|NCT00322907|Quinine|quinine|mesh-list
153706734|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
153706735|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153706736|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706737|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153706738|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
153706740|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
153706741|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
153706828|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153706830|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153706831|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
153706832|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153706833|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153706834|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153543829|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
153706835|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153706836|NCT00294502|Minocycline|minocycline|mesh-list
153706837|NCT00294502|Gentamicins|gentamicins|mesh-list
153706838|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706839|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153706840|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706841|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153706842|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706843|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153706844|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
153706845|NCT00089349|Methotrexate|methotrexate|mesh-list
153706846|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
153706847|NCT00089349|Antibodies|antibodies|mesh-list
153706848|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
153706865|NCT00294619|Hormones|hormones|mesh-list
153706866|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706867|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706868|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153706869|NCT00294736|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153706870|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153706871|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706873|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854388|NCT02898012|Temozolomide|temozolomide|mesh-list
153706886|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153706887|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706888|NCT00294892|Nevirapine|nevirapine|mesh-list
153706889|NCT00294892|Carbamazepine|carbamazepine|mesh-list
153706890|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153706891|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153706892|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706893|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706894|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
153706895|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706896|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153706897|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153706898|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153706899|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153706900|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
153706901|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
153706902|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153706903|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153706913|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153706915|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706916|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706917|NCT00294931|Bevacizumab|bevacizumab|mesh-list
153706918|NCT00294931|Carboplatin|carboplatin|mesh-list
153706919|NCT00294931|Irinotecan|irinotecan|mesh-list
153706920|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153706921|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706922|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153706923|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153706924|NCT00294931|Growth Substances|growth substances|mesh-ancestor
153706925|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706926|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
153706927|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153706928|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153706929|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459889|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459890|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
153394655|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394656|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153394657|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
153394658|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
153394659|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
153706931|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
153854423|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
153854424|NCT00559481|Ketoconazole|ketoconazole|mesh-list
153854425|NCT00559481|Dexamethasone|dexamethasone|mesh-list
153854426|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
153707014|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707015|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
153707016|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707017|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153707018|NCT00295945|Fentanyl|fentanyl|mesh-list
153707019|NCT00295945|Hydromorphone|hydromorphone|mesh-list
153707020|NCT00295945|Ropivacaine|ropivacaine|mesh-list
153707032|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
153707034|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153707035|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707036|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707037|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707038|NCT00295984|Nicotine|nicotine|mesh-list
153707039|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153736021|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153707040|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
153707041|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707042|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707043|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153707044|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153707045|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
153707046|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707047|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707048|NCT00296023|Methotrexate|methotrexate|mesh-list
153707049|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
153707068|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153854428|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153854429|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153854430|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854431|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
153854432|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
153854433|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854434|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854435|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854436|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
153854437|NCT00559481|Hormones|hormones|mesh-ancestor
153866353|NCT00571740|Leucovorin|leucovorin|mesh-list
153854440|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707069|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153707070|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
153394699|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394700|NCT04744571|Aspirin|aspirin|mesh-list
153394701|NCT04744571|Metoprolol|metoprolol|mesh-list
153707136|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866365|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707137|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
153707138|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153707139|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153707140|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153707155|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
153707156|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
153707157|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707158|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707159|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153707160|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153707161|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153707162|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707163|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707164|NCT00090012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153707165|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153707166|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153707168|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707199|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707200|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153707214|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153707215|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153707216|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153707217|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
153707218|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707219|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707220|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707221|NCT00090090|Elsamicin A|elsamicin a|mesh-list
153888764|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153888765|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
153888766|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153888767|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866366|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
153866367|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153866368|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
153866369|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866378|NCT00563342|Ethanol|ethanol|mesh-list
153866379|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153866380|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866381|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406817|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406818|NCT03635489|Paclitaxel|paclitaxel|mesh-list
153406819|NCT03635489|Bevacizumab|bevacizumab|mesh-list
153406820|NCT03635489|Carboplatin|carboplatin|mesh-list
153707222|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153707223|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707224|NCT00296959|Topiramate|topiramate|mesh-list
153707225|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
153707226|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153707227|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707228|NCT00297076|Aplaviroc|aplaviroc|mesh-list
153707229|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153707230|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153736022|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
153707231|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707232|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153707233|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153707261|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707262|NCT00297505|Citalopram|citalopram|mesh-list
153707297|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707299|NCT00090207|Aprepitant|aprepitant|mesh-list
153707319|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153707320|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153707321|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707322|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707323|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153707324|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
153707325|NCT00090246|Ondansetron|ondansetron|mesh-list
153707326|NCT00090246|Aprepitant|aprepitant|mesh-list
153707327|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
153707328|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
153707329|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707330|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707331|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153707332|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
153707389|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
153707390|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707391|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153707392|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707393|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
153707394|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707395|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
153707396|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153707397|NCT00298168|Protective Agents|protective agents|mesh-ancestor
153707398|NCT00122304|Eculizumab|eculizumab|mesh-list
153707399|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153707400|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707401|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
153707402|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707403|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
153707404|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153707405|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153707406|NCT00322543|Analgesics|analgesics|mesh-ancestor
153707407|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
153707408|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707409|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707410|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153707433|NCT00122343|Sirolimus|sirolimus|mesh-list
153707434|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153406821|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153406822|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406823|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
153406824|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
153406825|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
153406826|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406841|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
153406842|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
153888771|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707435|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707436|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153707437|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707459|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707460|NCT00090480|Vaccines|vaccines|mesh-list
153707461|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
153707462|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707463|NCT00322660|Epinephrine|epinephrine|mesh-list
153707464|NCT00322660|Racepinephrine|racepinephrine|mesh-list
153707489|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707490|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
153707491|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
153707492|NCT00323011|Leucovorin|leucovorin|mesh-list
153707493|NCT00323011|Folic Acid|folic acid|mesh-list
153707494|NCT00323011|Bevacizumab|bevacizumab|mesh-list
153707561|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707562|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153707563|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153707564|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
153707565|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707566|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707567|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153707568|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153707569|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153707570|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153707571|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707572|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153707574|NCT00323323|Hormones|hormones|mesh-ancestor
153707578|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
153854521|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
153854522|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
153854523|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854525|NCT01235728|MK 0873|mk 0873|mesh-list
153854526|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153854527|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854528|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153854529|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153854530|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707709|NCT06001619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153707710|NCT06001619|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707711|NCT06001619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707712|NCT06001619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707713|NCT06001619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707751|NCT06000137|Dsuvia|dsuvia|mesh-list
153707797|NCT05999890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707798|NCT05999890|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707799|NCT05999890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707800|NCT05999487|Dobutamine|dobutamine|mesh-list
153707801|NCT05999487|Milrinone|milrinone|mesh-list
153707802|NCT05999487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153707803|NCT05999487|Sympathomimetics|sympathomimetics|mesh-ancestor
153707804|NCT05999487|Autonomic Agents|autonomic agents|mesh-ancestor
153707805|NCT05999487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707806|NCT05999487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707807|NCT05999487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153707808|NCT05999487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153707809|NCT05999487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153707810|NCT05999487|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707811|NCT05999487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707812|NCT05999487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707813|NCT05999487|Protective Agents|protective agents|mesh-ancestor
153707814|NCT05999487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153707815|NCT05999487|Vasodilator Agents|vasodilator agents|mesh-ancestor
153707816|NCT05999487|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153707817|NCT05999487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153707818|NCT05999487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707819|NCT05999474|Tioconazole|tioconazole|mesh-list
153866383|NCT04583046|Iloprost|iloprost|mesh-list
153707820|NCT05999474|Antifungal Agents|antifungal agents|mesh-ancestor
153707861|NCT05998551|Bupivacaine|bupivacaine|mesh-list
153707862|NCT05998551|Anesthetics, Local|anesthetics, local|mesh-ancestor
153707863|NCT05998551|Anesthetics|anesthetics|mesh-ancestor
153707864|NCT05998551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707865|NCT05998551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707866|NCT05998551|Sensory System Agents|sensory system agents|mesh-ancestor
153707867|NCT05998551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707868|NCT05998551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153707869|NCT05998551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153707870|NCT05998551|Analgesics|analgesics|mesh-ancestor
153707871|NCT05998551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153707872|NCT05998551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153707873|NCT05998551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153707874|NCT05998551|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707878|NCT05998551|Narcotics|narcotics|mesh-ancestor
153854569|NCT04639193|Eszopiclone|eszopiclone|mesh-list
153854570|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153854571|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153707930|NCT05997784|Nitric Oxide|nitric oxide|mesh-list
153707931|NCT05997784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153707932|NCT05997784|Autonomic Agents|autonomic agents|mesh-ancestor
153707933|NCT05997784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707934|NCT05997784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707935|NCT05997784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153707936|NCT05997784|Respiratory System Agents|respiratory system agents|mesh-ancestor
153707937|NCT05997784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153707938|NCT05997784|Antioxidants|antioxidants|mesh-ancestor
153707939|NCT05997784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707940|NCT05997784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707941|NCT05997784|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153707942|NCT05997784|Vasodilator Agents|vasodilator agents|mesh-ancestor
153707943|NCT05997784|Gasotransmitters|gasotransmitters|mesh-ancestor
153707944|NCT05997784|Protective Agents|protective agents|mesh-ancestor
153707945|NCT05997524|Capecitabine|capecitabine|mesh-list
153406853|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406855|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153888777|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406856|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
153406857|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866420|NCT00563615|Tegaserod|tegaserod|mesh-list
153394841|NCT02531321|Estradiol|estradiol|mesh-list
153708010|NCT05997043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708011|NCT05997043|Cholinergic Agents|cholinergic agents|mesh-ancestor
153708012|NCT05997043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708013|NCT05997043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708014|NCT05997043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153708015|NCT05996848|Semaglutide|semaglutide|mesh-list
153708016|NCT05996848|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153708017|NCT05996848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153708018|NCT05996848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708019|NCT05996588|Propofol|propofol|mesh-list
153708020|NCT05996588|Anesthetics|anesthetics|mesh-list
153708021|NCT05996588|Sevoflurane|sevoflurane|mesh-list
153708022|NCT05996588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
153708023|NCT05996588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153708024|NCT05996588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708055|NCT05996406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708056|NCT05996406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153394850|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153394851|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153708134|NCT05990985|Sensory System Agents|sensory system agents|mesh-ancestor
153708135|NCT05990985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153708136|NCT05990985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153708137|NCT05990985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708139|NCT05984550|Vitamin B Complex|vitamin b complex|mesh-ancestor
153708140|NCT05984550|Vitamins|vitamins|mesh-ancestor
153708141|NCT05984550|Micronutrients|micronutrients|mesh-ancestor
153708142|NCT05984550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708143|NCT05980546|Dexamethasone|dexamethasone|mesh-list
153708144|NCT05980546|Dexamethasone acetate|dexamethasone acetate|mesh-list
153708145|NCT05980546|Fentanyl|fentanyl|mesh-list
153708146|NCT05980546|Bupivacaine|bupivacaine|mesh-list
153708147|NCT05980546|Mepivacaine|mepivacaine|mesh-list
153708148|NCT05980546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708149|NCT05980546|Antiemetics|antiemetics|mesh-ancestor
153394859|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394860|NCT02417129|Rituximab|rituximab|mesh-list
153394861|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394862|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394863|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
153394864|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394865|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394866|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
153708208|NCT05952713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708209|NCT05952713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153810947|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357517|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153357518|NCT01275638|Protective Agents|protective agents|mesh-ancestor
153406861|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153406862|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
153406863|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406864|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406865|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153406866|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
153406867|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
153406868|NCT03576885|Protective Agents|protective agents|mesh-ancestor
153406869|NCT03576612|Valacyclovir|valacyclovir|mesh-list
153406870|NCT03576612|Acyclovir|acyclovir|mesh-list
153406871|NCT03576612|Nivolumab|nivolumab|mesh-list
153708210|NCT05952713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153708211|NCT05952713|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153708212|NCT05952713|Analgesics|analgesics|mesh-ancestor
153708213|NCT05952713|Sensory System Agents|sensory system agents|mesh-ancestor
153708214|NCT05952713|Dopamine Agents|dopamine agents|mesh-ancestor
153708215|NCT05952713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153854613|NCT00559715|Ranibizumab|ranibizumab|mesh-list
153854614|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153854615|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854616|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153708273|NCT05828966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153708274|NCT05828966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708275|NCT05828966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708276|NCT05828966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153708277|NCT05828966|Tocolytic Agents|tocolytic agents|mesh-ancestor
153708278|NCT05828966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153708279|NCT05827042|Tenecteplase|tenecteplase|mesh-list
153708280|NCT05827042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153708281|NCT05827042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153708282|NCT05827042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708284|NCT05826964|Sirolimus|sirolimus|mesh-list
153708285|NCT05826964|Capecitabine|capecitabine|mesh-list
153708286|NCT05826964|Everolimus|everolimus|mesh-list
153708287|NCT05826964|Letrozole|letrozole|mesh-list
153708288|NCT05826964|Vinorelbine|vinorelbine|mesh-list
153708338|NCT05826574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153708339|NCT05826574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153708340|NCT05826574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153708341|NCT05826574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153708342|NCT05826574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153708343|NCT05826574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153708344|NCT05826574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153708346|NCT05741866|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153708347|NCT05741866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153708348|NCT05741866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708349|NCT05741866|Disinfectants|disinfectants|mesh-ancestor
153406877|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153406878|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
153406879|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
153406880|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406881|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
153406882|NCT03576105|Methylene Blue|methylene blue|mesh-list
153406883|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406884|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406885|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
153406886|NCT03568318|Upadacitinib|upadacitinib|mesh-list
153406887|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153406888|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153406889|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406891|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708350|NCT05741866|Dermatologic Agents|dermatologic agents|mesh-ancestor
153708352|NCT05734053|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153708353|NCT05734053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153708354|NCT05734053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708355|NCT05734053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708356|NCT05733351|Docetaxel|docetaxel|mesh-list
153708357|NCT05733351|Antibodies|antibodies|mesh-list
153708358|NCT05733351|Immunoglobulins|immunoglobulins|mesh-list
153708359|NCT05733351|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153854639|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854640|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
153854641|NCT00553683|Poly ICLC|poly iclc|mesh-list
153854642|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153708441|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153708442|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708443|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
153708444|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153708445|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153708447|NCT05686863|Propofol|propofol|mesh-list
153708448|NCT05686863|Esketamine|esketamine|mesh-list
153708449|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153708450|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708451|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708452|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153708453|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
153708454|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
153708455|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153708456|NCT05686863|Narcotics|narcotics|mesh-ancestor
153708457|NCT05686863|Analgesics|analgesics|mesh-ancestor
153394909|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394910|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153394911|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
153708505|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153708506|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
153708507|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153708508|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708509|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153708510|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153708511|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
153708512|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153708513|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
153708514|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
153708515|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
153708516|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
153708517|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708518|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153708519|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708520|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708521|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153708522|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153708523|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708524|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153708525|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708526|NCT05561751|Propranolol|propranolol|mesh-list
153708527|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153708528|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153708529|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
153708540|NCT05558982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708541|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153708556|NCT05480865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153708557|NCT05480865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708558|NCT05480865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708559|NCT05480865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708561|NCT05476354|Irbesartan|irbesartan|mesh-list
153708562|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153708563|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153708564|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708565|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708566|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153708567|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708568|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
153708569|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153708570|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153708571|NCT05475665|Amlodipine|amlodipine|mesh-list
153708572|NCT05475665|Irbesartan|irbesartan|mesh-list
153708579|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
153708623|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153545604|NCT06304597|Nivolumab|nivolumab|mesh-list
153708624|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153708625|NCT05401916|Analgesics|analgesics|mesh-ancestor
153708626|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
153708627|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708628|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708629|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708630|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708631|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153708632|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708633|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708634|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
153708635|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153708636|NCT05401916|Narcotics|narcotics|mesh-ancestor
153708637|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708638|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
153708639|NCT05382650|Antibodies|antibodies|mesh-list
153708640|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
153708641|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153708642|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153708643|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
153708644|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708645|NCT05375903|Gemcitabine|gemcitabine|mesh-list
153708646|NCT05375903|Imiquimod|imiquimod|mesh-list
153708678|NCT05331664|Polymyxins|polymyxins|mesh-list
153394937|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394938|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153394940|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153708689|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
153708690|NCT05331664|Hormones|hormones|mesh-ancestor
153708691|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708692|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736025|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
153708693|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153708694|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708695|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
153708696|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708697|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153708698|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708699|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153545682|NCT06303739|Psilocybin|psilocybin|mesh-list
153708700|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153708701|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708702|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708703|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153708730|NCT05321940|Interferons|interferons|mesh-list
153854686|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153854687|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854688|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708747|NCT05289830|Escitalopram|escitalopram|mesh-list
153708748|NCT05289830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153708749|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153708750|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708751|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708752|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708753|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
153708754|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708755|NCT05288023|Azithromycin|azithromycin|mesh-list
153708756|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153708757|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708758|NCT05280405|Infliximab|infliximab|mesh-list
153708759|NCT05280405|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153708760|NCT05280405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708761|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
153708762|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153708763|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708764|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
153708765|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153866483|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
153866484|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866485|NCT00572208|Gabapentin|gabapentin|mesh-list
153406923|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153406924|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406925|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406926|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406927|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406928|NCT03341273|Azithromycin|azithromycin|mesh-list
153406929|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153406930|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406931|NCT03319901|Venetoclax|venetoclax|mesh-list
153406932|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406933|NCT03301766|Lidocaine|lidocaine|mesh-list
153406934|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
153406935|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
153406936|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406937|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708766|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153708767|NCT05227742|Psilocybin|psilocybin|mesh-list
153708768|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
153708769|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708770|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545745|NCT06302673|Antiemetics|antiemetics|mesh-list
153708771|NCT05221749|Fluorides|fluorides|mesh-list
153708772|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
153708811|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
153708812|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708813|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153708814|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153708815|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
153708816|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
153708817|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708818|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153708819|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153708820|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
153708821|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153708822|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
153708823|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
153708824|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
153708825|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153708826|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153708827|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
153708828|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708829|NCT05063734|Aflibercept|aflibercept|mesh-list
153708830|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153708831|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153708832|NCT05063734|Growth Substances|growth substances|mesh-ancestor
153708843|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708845|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708846|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153708847|NCT05035407|Aldesleukin|aldesleukin|mesh-list
153708848|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
153708849|NCT05035407|Fludarabine|fludarabine|mesh-list
153708850|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153708851|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
153708852|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708853|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708854|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153854700|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708856|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708858|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153708859|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153708860|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153708861|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
153708862|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708863|NCT05011383|Testosterone|testosterone|mesh-list
153708864|NCT05011383|Androgens|androgens|mesh-list
153708865|NCT05011383|Hormones|hormones|mesh-ancestor
153708866|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708867|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708868|NCT04989491|Rituximab|rituximab|mesh-list
153708869|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708870|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708871|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
153708872|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708873|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708874|NCT04984369|Cetuximab|cetuximab|mesh-list
153708875|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708876|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708877|NCT04981158|Anesthetics|anesthetics|mesh-list
153708882|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
153854714|NCT02896101|Analgesics|analgesics|mesh-ancestor
153854715|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
153854716|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854717|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854718|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854719|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854720|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
153854721|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854722|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
153854723|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153708916|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
153708917|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708918|NCT04885530|Metformin|metformin|mesh-list
153708919|NCT04885530|Fluticasone|fluticasone|mesh-list
153708920|NCT04885530|Xhance|xhance|mesh-list
153708921|NCT04885530|Ivermectin|ivermectin|mesh-list
153708922|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
153708923|NCT04885530|Montelukast|montelukast|mesh-list
153708924|NCT04885530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153708925|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708926|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545816|NCT06300099|Dexamethasone|dexamethasone|mesh-list
153708927|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153708928|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
153708929|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708930|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153708931|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
153854726|NCT02896023|Menotropins|menotropins|mesh-list
153394968|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394969|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394970|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
153394971|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394972|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153394973|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153394974|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153394975|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708954|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153708955|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153708956|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153708957|NCT04872790|Prednisone|prednisone|mesh-list
153708984|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708985|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
153708986|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708987|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153708988|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153708989|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153708990|NCT04872790|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153708991|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153708992|NCT04843111|Vaccines|vaccines|mesh-list
153708993|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
153708995|NCT04802837|Vancomycin|vancomycin|mesh-list
153854727|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153854728|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
153854729|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153854730|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854731|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
153854732|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153854733|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153854734|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
153709030|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153709031|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
153709032|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709033|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709045|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
153709111|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153709112|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709113|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709115|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709116|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
153709126|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153709127|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
153709128|NCT04558736|Fludarabine|fludarabine|mesh-list
153709129|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
153709130|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153709131|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709132|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
153709133|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709134|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709135|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153709136|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
153709137|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709138|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709139|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153709140|NCT04526197|Celecoxib|celecoxib|mesh-list
153709141|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153709142|NCT04526197|Choline|choline|mesh-list
153709143|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153709144|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153709145|NCT04526197|Analgesics|analgesics|mesh-ancestor
153709146|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
153709147|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709148|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709149|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153709150|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709151|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153709152|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153709153|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709155|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
153709156|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153709157|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
153709158|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709159|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153709160|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
153709161|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
153709162|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
153709163|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153709164|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709165|NCT04526197|Growth Substances|growth substances|mesh-ancestor
153866553|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866554|NCT04611464|Misoprostol|misoprostol|mesh-list
153407011|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407012|NCT02992522|Growth Substances|growth substances|mesh-ancestor
153407013|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407014|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407015|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407016|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
153407017|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709166|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709167|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709169|NCT04434664|Amlodipine|amlodipine|mesh-list
153709170|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153709171|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153709172|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153709173|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709174|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153709175|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709176|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
153709218|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709219|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709220|NCT04262687|Bevacizumab|bevacizumab|mesh-list
153709221|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
153709222|NCT04262687|Capecitabine|capecitabine|mesh-list
153709223|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
153709224|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709225|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709226|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153709227|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709292|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153709293|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
153709294|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709295|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709296|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153709297|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
153709298|NCT04227275|Fludarabine|fludarabine|mesh-list
153709299|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153709300|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709301|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
153709302|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709303|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709304|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153709363|NCT04092101|Nicotine|nicotine|mesh-list
153709364|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153709365|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
153709366|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709367|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709368|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153709369|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153709370|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
153709371|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709372|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709373|NCT04090879|Nicotine|nicotine|mesh-list
153709392|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
153709393|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709394|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709395|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153709396|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
153709397|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866557|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153866558|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866559|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153866560|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153866561|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
153866562|NCT04611776|Paclitaxel|paclitaxel|mesh-list
153709398|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709399|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153709400|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
153709401|NCT03996772|Apixaban|apixaban|mesh-list
153709402|NCT03996772|Edoxaban|edoxaban|mesh-list
153709403|NCT03996772|Dabigatran|dabigatran|mesh-list
153709404|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153709405|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
153709406|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153854831|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153854832|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709430|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709448|NCT03821792|Prednisone|prednisone|mesh-list
153709449|NCT03821792|Cortisone|cortisone|mesh-list
153709450|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
153709451|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153709452|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
153709454|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153709455|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709456|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153854850|NCT04635566|Alverine|alverine|mesh-list
153854851|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
153854852|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
153854853|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
153854854|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854855|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709529|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
153709530|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
153709531|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709532|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709533|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709534|NCT03649230|Palonosetron|palonosetron|mesh-list
153709535|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
153709536|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
153709537|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709538|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709539|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709540|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153709555|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709557|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709558|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709559|NCT03557749|Dimercaprol|dimercaprol|mesh-list
153709560|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
153709588|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153709589|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153709590|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709591|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
153709592|NCT03505723|Coagulants|coagulants|mesh-ancestor
153709593|NCT03502330|Nivolumab|nivolumab|mesh-list
153709594|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709595|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709596|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709597|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709598|NCT03463057|Atezolizumab|atezolizumab|mesh-list
153810950|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153709614|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709615|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
153709616|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709617|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
153709618|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709619|NCT03430297|Dacarbazine|dacarbazine|mesh-list
153709620|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153709621|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
153709622|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709623|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709624|NCT03425838|Letrozole|letrozole|mesh-list
153709625|NCT03425838|Fulvestrant|fulvestrant|mesh-list
153709626|NCT03425838|Palbociclib|palbociclib|mesh-list
153709652|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153709653|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153709654|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709655|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709656|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
153709678|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
153709679|NCT03283384|Letrozole|letrozole|mesh-list
153709680|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709681|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153709682|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153709683|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709684|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709685|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153709749|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709750|NCT03121586|Pimavanserin|pimavanserin|mesh-list
153709751|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153709752|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153709753|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153709754|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153709755|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153709756|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709757|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153709758|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153709759|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153709760|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
153709761|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709762|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709763|NCT03107793|Ustekinumab|ustekinumab|mesh-list
153709764|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
153709766|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709778|NCT02886962|Vitamins|vitamins|mesh-ancestor
153709779|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
153709780|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709781|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153709782|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153709783|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709784|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
153709785|NCT02886962|Coagulants|coagulants|mesh-ancestor
153709786|NCT02885753|Leucovorin|leucovorin|mesh-list
153709787|NCT02885753|Folic Acid|folic acid|mesh-list
153709788|NCT02885753|Bevacizumab|bevacizumab|mesh-list
153459891|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459892|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
153459893|NCT05482542|Rituximab|rituximab|mesh-list
153459894|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459895|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
153459896|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592696|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592697|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592698|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153592700|NCT01828892|Meropenem|meropenem|mesh-list
153592701|NCT01828892|Ceftazidime|ceftazidime|mesh-list
153592702|NCT01828892|Cefotaxime|cefotaxime|mesh-list
153592703|NCT01828892|Cefoxitin|cefoxitin|mesh-list
153592704|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592705|NCT01828892|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153592706|NCT01828892|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153592707|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
153592708|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153592709|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592710|NCT01829178|Cisplatin|cisplatin|mesh-list
153592711|NCT01829178|Docetaxel|docetaxel|mesh-list
153709789|NCT02885753|Panitumumab|panitumumab|mesh-list
153709790|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
153709791|NCT02885753|Irinotecan|irinotecan|mesh-list
153709792|NCT02885753|Fluorouracil|fluorouracil|mesh-list
153709793|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
153709794|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709795|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709796|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153709797|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709798|NCT02885753|Growth Substances|growth substances|mesh-ancestor
153709799|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709800|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709803|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709863|NCT02471391|Venetoclax|venetoclax|mesh-list
153709864|NCT02471391|Ibrutinib|ibrutinib|mesh-list
153709865|NCT02471391|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153709866|NCT02471391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153709867|NCT02471391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709868|NCT02471391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709869|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709870|NCT02426125|Docetaxel|docetaxel|mesh-list
153709871|NCT02426125|Ramucirumab|ramucirumab|mesh-list
153709872|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709873|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
153709874|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
153709875|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
153709876|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709877|NCT02426125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153709878|NCT02426125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709879|NCT02426125|Growth Substances|growth substances|mesh-ancestor
153709880|NCT02426125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854996|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153854997|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854998|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153854999|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153855000|NCT00445406|Growth Substances|growth substances|mesh-ancestor
153855001|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855002|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
153855003|NCT00445523|Interferons|interferons|mesh-list
153709940|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153709941|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153709942|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709943|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153709944|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709945|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
153709946|NCT02046395|Diuretics|diuretics|mesh-ancestor
153395264|NCT00559507|Saracatinib|saracatinib|mesh-list
153395265|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395266|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395267|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395268|NCT04969627|Metformin|metformin|mesh-list
153395269|NCT04969627|Exenatide|exenatide|mesh-list
153395270|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153710000|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153710001|NCT01454154|Glyburide|glyburide|mesh-list
153710002|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153710003|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407078|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153407079|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710004|NCT01367301|Paclitaxel|paclitaxel|mesh-list
153710005|NCT01367301|Carboplatin|carboplatin|mesh-list
153710006|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153710007|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710008|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710009|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
153710010|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710033|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710034|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153710035|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
153710037|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395282|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
153395283|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
153395284|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395285|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395286|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
153395287|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395288|NCT02499497|Androgens|androgens|mesh-list
153395289|NCT02499497|Hormones|hormones|mesh-ancestor
153710080|NCT00039130|Ifosfamide|ifosfamide|mesh-list
153710081|NCT00039130|Rituximab|rituximab|mesh-list
153710082|NCT00039130|Doxorubicin|doxorubicin|mesh-list
153710083|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153710084|NCT00039130|Methotrexate|methotrexate|mesh-list
153710085|NCT00039130|Etoposide|etoposide|mesh-list
153710086|NCT00039130|Vincristine|vincristine|mesh-list
153710087|NCT00039130|Allopurinol|allopurinol|mesh-list
153710088|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
153710089|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710090|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
153710091|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710092|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710093|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153710094|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
153710095|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710096|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710097|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153710098|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710099|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
153710121|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
153710122|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866639|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
153866640|NCT01149460|Valacyclovir|valacyclovir|mesh-list
153866641|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
153866642|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866644|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153866645|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153866646|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153866647|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
153866648|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866649|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866650|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866651|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
153710123|NCT00039130|Antidotes|antidotes|mesh-ancestor
153710124|NCT00039130|Protective Agents|protective agents|mesh-ancestor
153710125|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
153710126|NCT00039130|Vitamins|vitamins|mesh-ancestor
153710127|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
153710158|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153710159|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153710160|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153710161|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153710233|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
153710234|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710235|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153710236|NCT04984070|Diuretics|diuretics|mesh-ancestor
153710250|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153710251|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153710252|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153710253|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
153710254|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710255|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710256|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
153710257|NCT00314509|Hormones|hormones|mesh-ancestor
153710258|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710259|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153710260|NCT00314548|Epoprostenol|epoprostenol|mesh-list
153710261|NCT00314548|Alprostadil|alprostadil|mesh-list
153710262|NCT00314548|Tezosentan|tezosentan|mesh-list
153710263|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153710264|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
153710265|NCT00314548|Urological Agents|urological agents|mesh-ancestor
153710266|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153710267|NCT00314626|Lamivudine|lamivudine|mesh-list
153710268|NCT00314626|Efavirenz|efavirenz|mesh-list
153710269|NCT00314626|Abacavir|abacavir|mesh-list
153710270|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153710271|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153710272|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710273|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710274|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
153710275|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710276|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153710284|NCT00314665|Thalidomide|thalidomide|mesh-list
153855100|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710288|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
153710289|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153710290|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710291|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153710292|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407113|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153407114|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407115|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
153407116|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407117|NCT02359175|Narcotics|narcotics|mesh-ancestor
153407118|NCT02359175|Analgesics|analgesics|mesh-ancestor
153407119|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153407120|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153710293|NCT00314665|Growth Substances|growth substances|mesh-ancestor
153710294|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
153710295|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710296|NCT00314704|Dopamine|dopamine|mesh-list
153710297|NCT00314704|Norepinephrine|norepinephrine|mesh-list
153710298|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153710310|NCT00314704|Protective Agents|protective agents|mesh-ancestor
153710311|NCT00090909|Dexamethasone|dexamethasone|mesh-list
153710312|NCT00090909|Gemcitabine|gemcitabine|mesh-list
153710313|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710314|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710315|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
153710316|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
153710317|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710318|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710319|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710320|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
153710321|NCT00090909|Hormones|hormones|mesh-ancestor
153710322|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710323|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153710324|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710325|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
153710326|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710327|NCT04943627|Gemcitabine|gemcitabine|mesh-list
153710328|NCT04943627|Irinotecan|irinotecan|mesh-list
153710329|NCT04943627|Pemetrexed|pemetrexed|mesh-list
153710330|NCT04943627|Topotecan|topotecan|mesh-list
153710331|NCT04943627|Vinorelbine|vinorelbine|mesh-list
153710332|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153710333|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
153855101|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
153592712|NCT01829178|Fluorouracil|fluorouracil|mesh-list
153592713|NCT01829178|Silymarin|silymarin|mesh-list
153395367|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
153710334|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710335|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710336|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153710337|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153710338|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710339|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153710340|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153710341|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153710342|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710343|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
153710344|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710345|NCT00314743|Dexamethasone|dexamethasone|mesh-list
153710346|NCT00314743|Ondansetron|ondansetron|mesh-list
153710347|NCT00314743|Aprepitant|aprepitant|mesh-list
153710348|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710349|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
153710350|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
153710351|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710352|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710353|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710354|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
153710355|NCT00314743|Hormones|hormones|mesh-ancestor
153866671|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153866672|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153866673|NCT04600271|Norepinephrine|norepinephrine|mesh-list
153866674|NCT04600271|Analgesics|analgesics|mesh-list
153866675|NCT04600271|Diuretics|diuretics|mesh-list
153866676|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
153866677|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866678|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866679|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
153866680|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153866681|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153855122|NCT00446420|Propofol|propofol|mesh-list
153855123|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153855124|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855125|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855126|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153710378|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710379|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
153710380|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710381|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153710382|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153710383|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153710384|NCT00314821|Ropinirole|ropinirole|mesh-list
153710385|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153710386|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153710387|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
153710388|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
153710389|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710390|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710391|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710392|NCT00314860|Ropinirole|ropinirole|mesh-list
153710393|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153710394|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153710395|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
153710396|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
153710397|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710398|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855139|NCT00446420|Analgesics|analgesics|mesh-ancestor
153855140|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
153855141|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855142|NCT00446537|Methylphenidate|methylphenidate|mesh-list
153855143|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153855144|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855145|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153855146|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153710422|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
153710423|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710424|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
153710425|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710426|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710427|NCT00313456|Satraplatin|satraplatin|mesh-list
153710439|NCT00313534|Analgesics|analgesics|mesh-ancestor
153710440|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
153710441|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710442|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710443|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710444|NCT00313690|Docetaxel|docetaxel|mesh-list
153710445|NCT00313690|Bortezomib|bortezomib|mesh-list
153710446|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710447|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710448|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
153710451|NCT00313885|SR 46349B|sr 46349b|mesh-list
153395401|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153395402|NCT02505269|Imidazole|imidazole|mesh-list
153395403|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153395404|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395405|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153710474|NCT04635280|Pancrelipase|pancrelipase|mesh-list
153710476|NCT00122733|Loxapine|loxapine|mesh-list
153710588|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866697|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153866698|NCT00565487|Capecitabine|capecitabine|mesh-list
153866699|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153866700|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153866701|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
153866702|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866703|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710589|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153710591|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710592|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710593|NCT03690544|Apremilast|apremilast|mesh-list
153710594|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153710595|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710596|NCT03690544|Analgesics|analgesics|mesh-ancestor
153710597|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
153710620|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
153855176|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153855177|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855178|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153855179|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855180|NCT04319419|Micronutrients|micronutrients|mesh-list
153710630|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710631|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710632|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153710633|NCT00315016|Diuretics|diuretics|mesh-ancestor
153710634|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
153710635|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153710636|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153710637|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
153710638|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710639|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710640|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
153710641|NCT00419068|Vitamin D|vitamin d|mesh-list
153710642|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153710644|NCT00419068|Vitamins|vitamins|mesh-ancestor
153395452|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
153710687|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710689|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
153710690|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710691|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153710692|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710693|NCT00123201|Analgesics|analgesics|mesh-ancestor
153710694|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
153710695|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710696|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153710697|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153710698|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710699|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710701|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710702|NCT03031483|Clarithromycin|clarithromycin|mesh-list
153710703|NCT03031483|Lenalidomide|lenalidomide|mesh-list
153710704|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
153710705|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710706|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153710707|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153710708|NCT03031483|Growth Substances|growth substances|mesh-ancestor
153710709|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
153395464|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395465|NCT02508077|Antidotes|antidotes|mesh-ancestor
153395466|NCT02508077|Protective Agents|protective agents|mesh-ancestor
153395467|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
153395468|NCT02508077|Vitamins|vitamins|mesh-ancestor
153395469|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
153395470|NCT02508077|Hematinics|hematinics|mesh-ancestor
153855224|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855225|NCT04699214|Endostar protein|endostar protein|mesh-list
153855226|NCT04699214|Endostatins|endostatins|mesh-list
153855227|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153710746|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153710747|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153710748|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153710749|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153710750|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153710751|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153710752|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710753|NCT00123279|Plasminogen|plasminogen|mesh-list
153710754|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153710805|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153710806|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710807|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153710808|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153710809|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710810|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
153710811|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
153710812|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
153710814|NCT04716868|Psyllium|psyllium|mesh-list
153710815|NCT04716868|Cathartics|cathartics|mesh-ancestor
153710816|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710817|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710818|NCT00327769|Fulvestrant|fulvestrant|mesh-list
153710819|NCT00327769|Anastrozole|anastrozole|mesh-list
153710820|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153710821|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710822|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153710823|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153710824|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
153710825|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710826|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710827|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153710828|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153710829|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710830|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710831|NCT00092001|Sunitinib|sunitinib|mesh-list
153710832|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710833|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153710834|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153710835|NCT00092001|Growth Substances|growth substances|mesh-ancestor
153710836|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710846|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
153710847|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710849|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
153710853|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710854|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
153710855|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153710856|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153710857|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710858|NCT03883919|Antidotes|antidotes|mesh-ancestor
153710859|NCT03883919|Protective Agents|protective agents|mesh-ancestor
153710860|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
153710861|NCT00327808|Budesonide|budesonide|mesh-list
153710862|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710863|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153710864|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
153710865|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710866|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710867|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153710868|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
153710869|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
153710870|NCT00327808|Hormones|hormones|mesh-ancestor
153710871|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710872|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
153710873|NCT00092079|Vitamin D|vitamin d|mesh-list
153710874|NCT00092079|Alendronate|alendronate|mesh-list
153710875|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153710876|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547861|NCT05253651|Leucovorin|leucovorin|mesh-list
153710877|NCT00092079|Vitamins|vitamins|mesh-ancestor
153710903|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710904|NCT00315367|Donepezil|donepezil|mesh-list
153710905|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153710918|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
153710919|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
153710920|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710921|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710922|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710924|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
153710925|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
153710926|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710927|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710928|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710929|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153710930|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710931|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710932|NCT00315601|Azithromycin|azithromycin|mesh-list
153710933|NCT00315601|Telithromycin|telithromycin|mesh-list
153710934|NCT00315601|Dimercaprol|dimercaprol|mesh-list
153711005|NCT00123552|Artesunate|artesunate|mesh-list
153711006|NCT00123552|Lumefantrine|lumefantrine|mesh-list
153711007|NCT00123552|Artemether|artemether|mesh-list
153711008|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
153711009|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
153711010|NCT00123552|Amodiaquine|amodiaquine|mesh-list
153711011|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153711012|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
153711013|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153711014|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153711035|NCT03352427|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153711038|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711039|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
153711040|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711041|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711042|NCT00092352|Celecoxib|celecoxib|mesh-list
153711043|NCT00092352|Rofecoxib|rofecoxib|mesh-list
153711044|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153711045|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711046|NCT00092352|Analgesics|analgesics|mesh-ancestor
153711047|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
153711048|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711049|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711050|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711051|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711052|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153711053|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153711054|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711085|NCT00316849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711086|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711087|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
153711088|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711089|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711090|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711091|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153711092|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
153711093|NCT02959957|Cefotaxime|cefotaxime|mesh-list
153711094|NCT02959957|Cefoxitin|cefoxitin|mesh-list
153711095|NCT02959957|Temocillin|temocillin|mesh-list
153711096|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711097|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866765|NCT00575913|Alfuzosin|alfuzosin|mesh-list
153711098|NCT00316927|Aspirin|aspirin|mesh-list
153866767|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153711099|NCT00316927|Dexamethasone|dexamethasone|mesh-list
153711100|NCT00316927|Fosfestrol|fosfestrol|mesh-list
153711101|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
153711102|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711103|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
153711104|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
153711105|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711106|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711107|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153711108|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
153711151|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153711152|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711153|NCT02960035|Analgesics|analgesics|mesh-ancestor
153711154|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
153711155|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711156|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711157|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711158|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711159|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153711160|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711161|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
153711162|NCT00317434|Lapatinib|lapatinib|mesh-list
153711163|NCT00317434|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153711164|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153711165|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711166|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711167|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711168|NCT00328120|Fulvestrant|fulvestrant|mesh-list
153711169|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153711170|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711171|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153711172|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153711173|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
153711174|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153711175|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711176|NCT00328393|Pioglitazone|pioglitazone|mesh-list
153711177|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153711178|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711205|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711206|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711207|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711208|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153711209|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
153711210|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711211|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153711212|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153711213|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711214|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711215|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
153711216|NCT00420043|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153711217|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153711218|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711219|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711220|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711221|NCT00420082|Cetirizine|cetirizine|mesh-list
153711222|NCT00420082|Fexofenadine|fexofenadine|mesh-list
153711223|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153711224|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153711225|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153711226|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
153711227|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
153866781|NCT00565682|Etoricoxib|etoricoxib|mesh-list
153711228|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711229|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855407|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
153855408|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
153855409|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855410|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153855411|NCT00448214|Warfarin|warfarin|mesh-list
153711253|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711254|NCT00328939|Enoxaparin|enoxaparin|mesh-list
153711255|NCT00328939|PENTA|penta|mesh-list
153711256|NCT00328939|Fondaparinux|fondaparinux|mesh-list
153711271|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711272|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711273|NCT00329095|Bimatoprost|bimatoprost|mesh-list
153711274|NCT00329095|Travoprost|travoprost|mesh-list
153711275|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
153711276|NCT00329095|Latanoprost|latanoprost|mesh-list
153711277|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153711278|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153711279|NCT00329134|Quinine|quinine|mesh-list
153711280|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
153711281|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153711282|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153711283|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711284|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153711285|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711286|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153711287|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711288|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711289|NCT00329134|Analgesics|analgesics|mesh-ancestor
153711290|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
153711291|NCT00329173|Atorvastatin|atorvastatin|mesh-list
153711292|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153711293|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153407261|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
153407262|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407263|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407264|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407265|NCT01216683|Rituximab|rituximab|mesh-list
153407266|NCT01216683|Lenalidomide|lenalidomide|mesh-list
153407267|NCT01216683|Bortezomib|bortezomib|mesh-list
153407268|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153407269|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407270|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407271|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
153407272|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407273|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407281|NCT01166113|Prednisone|prednisone|mesh-list
153866798|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866799|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
153866800|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
153711294|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153711295|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
153711300|NCT00123825|Gemcitabine|gemcitabine|mesh-list
153855412|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
153855413|NCT00448292|Naluzotan|naluzotan|mesh-list
153855414|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153855415|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153855416|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
153855417|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855418|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855420|NCT02901561|Misoprostol|misoprostol|mesh-list
153711305|NCT00329329|Capecitabine|capecitabine|mesh-list
153711306|NCT00329329|Satraplatin|satraplatin|mesh-list
153711307|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711376|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153711377|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
153711378|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711379|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711380|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
153711395|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711396|NCT00329680|Protective Agents|protective agents|mesh-ancestor
153711397|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153711398|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711399|NCT00329680|Analgesics|analgesics|mesh-ancestor
153711400|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
153711401|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711402|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711403|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711404|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153711405|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
153711406|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153711407|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
153711408|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153711409|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153711454|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711455|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
153711456|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711457|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
153711458|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711460|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153711461|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
153711462|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711463|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711464|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153711465|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153711466|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
153711467|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711468|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153711469|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153711470|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
153711471|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153711472|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153711473|NCT00330499|Cisplatin|cisplatin|mesh-list
153711525|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711526|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711527|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
153711528|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711529|NCT00317512|Chrysarobin|chrysarobin|mesh-list
153711530|NCT00317512|HBOC 201|hboc 201|mesh-list
153711531|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153711532|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711533|NCT00317512|Analgesics|analgesics|mesh-ancestor
153711534|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
153711535|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711536|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711537|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711589|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711590|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
153711591|NCT00124098|Hematinics|hematinics|mesh-ancestor
153711592|NCT00324142|Tinidazole|tinidazole|mesh-list
153711593|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
153711594|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711595|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711596|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711597|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153711598|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153711599|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153711600|NCT00324298|Etoposide|etoposide|mesh-list
153711601|NCT00324298|Bleomycin|bleomycin|mesh-list
153711602|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711603|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153711604|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153711605|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153711606|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711607|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711608|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153711609|NCT00124137|Diuretics|diuretics|mesh-list
153711610|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
153711665|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153711666|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153711667|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153711668|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
153711669|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711670|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153711671|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153711672|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
153711673|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711674|NCT00093288|Bupropion|bupropion|mesh-list
153711675|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153711676|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
153711677|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711678|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153711698|NCT00324571|Sevelamer|sevelamer|mesh-list
153711734|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711735|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711736|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153711737|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153711738|NCT00324727|Melphalan|melphalan|mesh-list
153711739|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153711740|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
153711741|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711742|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711743|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153711744|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711745|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
153711746|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711747|NCT00324766|Simendan|simendan|mesh-list
153711748|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153711749|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
153711750|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153711751|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153711759|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711760|NCT00084578|Analgesics|analgesics|mesh-ancestor
153711761|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
153711762|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711793|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711794|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153711795|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711796|NCT00325000|Analgesics|analgesics|mesh-ancestor
153711797|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
153711798|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711799|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153711800|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
153711801|NCT00318448|Zolpidem|zolpidem|mesh-list
153711802|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153711803|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153711804|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711805|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711806|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153711807|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
153711808|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
153711809|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711811|NCT00325117|Vildagliptin|vildagliptin|mesh-list
153711865|NCT00325390|Clopidogrel|clopidogrel|mesh-list
153711866|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153711867|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153711868|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153711869|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153711870|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
153711871|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711872|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711873|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711874|NCT00325429|Vildagliptin|vildagliptin|mesh-list
153711875|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153711876|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711877|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153711878|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
153711879|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711888|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711889|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
153711890|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711892|NCT00084773|Fluorouracil|fluorouracil|mesh-list
153711925|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
153711926|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711927|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711928|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153545818|NCT06300099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711929|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
153711930|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
153711931|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153711932|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153711933|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153711934|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
153711935|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153711936|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711937|NCT00093561|Lycopene|lycopene|mesh-list
153711938|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153711939|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
153711940|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711941|NCT00093561|Protective Agents|protective agents|mesh-ancestor
153711942|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711943|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153711956|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153711957|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711958|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153711959|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711960|NCT00085124|Cytarabine|cytarabine|mesh-list
153711961|NCT00085124|Daunorubicin|daunorubicin|mesh-list
153711962|NCT00085124|Oblimersen|oblimersen|mesh-list
153711963|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711964|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
153711965|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711966|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711967|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
153711968|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711969|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711970|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
153711973|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153711974|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153711975|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711976|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
153711977|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153711978|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153711979|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711980|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153711981|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711982|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153711983|NCT00325858|Tramadol|tramadol|mesh-list
153711984|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153711985|NCT00325858|Narcotics|narcotics|mesh-ancestor
153711986|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711987|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711988|NCT00325858|Analgesics|analgesics|mesh-ancestor
153711989|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
153711990|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711991|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
153711992|NCT00318955|Propofol|propofol|mesh-list
153711993|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153711994|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153711995|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711996|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711997|NCT00318955|Analgesics|analgesics|mesh-ancestor
153712029|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712030|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153712031|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153712033|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810951|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407355|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407356|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407357|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407358|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407359|NCT01079780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153712034|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712035|NCT00319033|Bosentan|bosentan|mesh-list
153712036|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153712037|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153712038|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712039|NCT00085163|Leucovorin|leucovorin|mesh-list
153712040|NCT00085163|Celecoxib|celecoxib|mesh-list
153712041|NCT00085163|Fluorouracil|fluorouracil|mesh-list
153712042|NCT00085163|Calcium|calcium|mesh-list
153712043|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
153712044|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153712045|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712046|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
153712047|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712048|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153712049|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712050|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712051|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
153712052|NCT00085163|Antidotes|antidotes|mesh-ancestor
153712053|NCT00085163|Protective Agents|protective agents|mesh-ancestor
153712054|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
153712055|NCT00085163|Vitamins|vitamins|mesh-ancestor
153712056|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
153712058|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153712087|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
153712088|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712089|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712090|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153712091|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
153712092|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
153712093|NCT00326053|Hormones|hormones|mesh-ancestor
153712094|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712095|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153712096|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153712157|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153712159|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153712160|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
153712161|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712162|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712163|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153712164|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
153712165|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
153712166|NCT00319306|Hormones|hormones|mesh-ancestor
153712167|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712168|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153712169|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153712170|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153712171|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
153712172|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712173|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712174|NCT00085358|Paclitaxel|paclitaxel|mesh-list
153712175|NCT00085358|Docetaxel|docetaxel|mesh-list
153712176|NCT00085358|Bevacizumab|bevacizumab|mesh-list
153712177|NCT00085358|Carboplatin|carboplatin|mesh-list
153712178|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153712179|NCT00085358|Antibodies|antibodies|mesh-list
153712180|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
153712181|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153712182|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153712183|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712184|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
153712185|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
153712186|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
153712187|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712194|NCT00093678|Celecoxib|celecoxib|mesh-list
153712199|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866902|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153866903|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866904|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712200|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712221|NCT00326404|Estradiol|estradiol|mesh-list
153712222|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153712223|NCT00326404|Estrogens|estrogens|mesh-ancestor
153712224|NCT00326404|Hormones|hormones|mesh-ancestor
153712225|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712226|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712227|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153712228|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
153712229|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153712230|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153712231|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153712232|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153712233|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153712234|NCT00326404|Progestins|progestins|mesh-ancestor
153712235|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
153712236|NCT00085475|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712237|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712238|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712239|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712241|NCT00319618|Docetaxel|docetaxel|mesh-list
153712274|NCT00400335|Hormones|hormones|mesh-ancestor
153712275|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712276|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712277|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153712278|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712279|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
153712280|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153712281|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153712282|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712283|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712284|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
153712285|NCT00319852|Vaccines|vaccines|mesh-list
153712286|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
153712287|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712288|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
153712289|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
153712290|NCT00326833|Vitamins|vitamins|mesh-ancestor
153712291|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
153712292|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712293|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
153712294|NCT00326833|Hematinics|hematinics|mesh-ancestor
153712295|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153712296|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153712297|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153712298|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153712299|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545819|NCT06300099|Antiemetics|antiemetics|mesh-ancestor
153712300|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712301|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153712302|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153712303|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
153712304|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712307|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153396136|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396137|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396138|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153396139|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
153396140|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712316|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153712317|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712318|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153712319|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712320|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153712321|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
153712322|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
153712413|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153712414|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153712415|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153712416|NCT00327184|PENTA|penta|mesh-list
153712417|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
153712418|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153712419|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153712420|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712421|NCT00419302|Insulin|insulin|mesh-list
153712422|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153396172|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396173|NCT02989129|Protective Agents|protective agents|mesh-ancestor
153396174|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396175|NCT01847131|Phenylephrine|phenylephrine|mesh-list
153396176|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
153396177|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153396183|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
153712483|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
153712484|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712485|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712486|NCT00320827|Antibodies|antibodies|mesh-list
153712487|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
153712488|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712489|NCT00320983|Topotecan|topotecan|mesh-list
153712490|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712491|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153712492|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712493|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712527|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153712528|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
153712529|NCT00086294|Levodopa|levodopa|mesh-list
153712530|NCT00086294|Pimavanserin|pimavanserin|mesh-list
153712531|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153712540|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712541|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153712542|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153712543|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
153712544|NCT05458492|Sirolimus|sirolimus|mesh-list
153712545|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153712546|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712547|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153712548|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855935|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855937|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153855938|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855939|NCT04262817|Nicotine|nicotine|mesh-list
153855940|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153855941|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
153855942|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855943|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712561|NCT05458180|Etoposide|etoposide|mesh-list
153712562|NCT05458180|Vincristine|vincristine|mesh-list
153712563|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
153712564|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712565|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
153712566|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712567|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712568|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153712569|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
153866943|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866944|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
153866945|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866946|NCT00577161|Vidarabine|vidarabine|mesh-list
153866947|NCT00577161|Rituximab|rituximab|mesh-list
153866948|NCT00577161|Fludarabine|fludarabine|mesh-list
153866949|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
153866950|NCT00577161|Pixantrone|pixantrone|mesh-list
153866951|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866957|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
153712570|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712571|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712572|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153712573|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712574|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
153712575|NCT05458180|Hormones|hormones|mesh-ancestor
153712576|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712577|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153712578|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153712579|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153712580|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712581|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712582|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
153712583|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
153712584|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
153855956|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855957|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153855958|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
153855959|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
153855960|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855961|NCT01187446|Vorinostat|vorinostat|mesh-list
153855962|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712593|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
153549621|NCT03993912|Hormones|hormones|mesh-ancestor
153712594|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712595|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712596|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153712597|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153712598|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153712624|NCT00086489|Tremelimumab|tremelimumab|mesh-list
153712625|NCT00086489|Ipilimumab|ipilimumab|mesh-list
153712626|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712627|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153712628|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153712629|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712630|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
153712631|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712632|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
153712633|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712634|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712635|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153712636|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
153712637|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712638|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712639|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153855964|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712667|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153712668|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712669|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153712670|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712671|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712672|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712673|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153712674|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153712675|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
153712676|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
153712677|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
153712678|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153712679|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
153712681|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153712682|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153712683|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153712684|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712685|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712686|NCT00086606|Omalizumab|omalizumab|mesh-list
153712690|NCT00124566|Prednisone|prednisone|mesh-list
153712735|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153712736|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153712737|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
153712739|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153712740|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153712741|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
153712742|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712743|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153712744|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153712745|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712746|NCT00124605|Pamidronate|pamidronate|mesh-list
153712747|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
153712748|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712749|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153712750|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712751|NCT05457361|Azacitidine|azacitidine|mesh-list
153712752|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
153712753|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153712754|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
153712755|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712756|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712757|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396267|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153396268|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
153396269|NCT00550771|Doxorubicin|doxorubicin|mesh-list
153396270|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153396271|NCT00550771|Trastuzumab|trastuzumab|mesh-list
153396272|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153396273|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396274|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
153396275|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
153396276|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
153396277|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396278|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396279|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
153712801|NCT00086840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712802|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712803|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
153712804|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712805|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712806|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856030|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712853|NCT00322036|Tarenflurbil|tarenflurbil|mesh-list
153712854|NCT00322036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153712855|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712856|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712857|NCT00322036|Analgesics|analgesics|mesh-ancestor
153712858|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
153712859|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712860|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712861|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153712862|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153712863|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712864|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712865|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153712866|NCT00094614|Atropine|atropine|mesh-list
153712867|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153712868|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153712869|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153712870|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
153712871|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867012|NCT00577668|Thalidomide|thalidomide|mesh-list
153712872|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712873|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153712874|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
153712875|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
153712876|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
153712877|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153712878|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153856050|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856051|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856052|NCT00553878|Dutasteride|dutasteride|mesh-list
153856053|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153856054|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153856055|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856056|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856057|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
153856059|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712915|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712916|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153712917|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
153712918|NCT00332176|Ribavirin|ribavirin|mesh-list
153713009|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
153713010|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713011|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153713012|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
153713013|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713014|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153713015|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153713016|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153713017|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713018|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
153713019|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713020|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153713021|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153713022|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713023|NCT00419848|Azithromycin|azithromycin|mesh-list
153713024|NCT00419848|Doxycycline|doxycycline|mesh-list
153713025|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153713026|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713027|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
153713028|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153713029|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153713030|NCT00094848|Mapatumumab|mapatumumab|mesh-list
153713031|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713032|NCT00087425|Rituximab|rituximab|mesh-list
153713033|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
153713034|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153713035|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713036|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
153713073|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
153713074|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713075|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713076|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713077|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153713078|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153713079|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713080|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713081|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153713082|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
153713083|NCT00087464|Tenofovir|tenofovir|mesh-list
153867028|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
153867029|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867030|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153867031|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153867032|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
153713084|NCT00087464|Emtricitabine|emtricitabine|mesh-list
153713085|NCT00087464|Nevirapine|nevirapine|mesh-list
153713086|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
153713087|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713088|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153713089|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153713090|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713091|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713092|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153713093|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153713094|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153713095|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153713096|NCT00331045|Alvimopan|alvimopan|mesh-list
153713097|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153713098|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153713141|NCT00331123|Testosterone|testosterone|mesh-list
153713142|NCT00331123|Androgens|androgens|mesh-ancestor
153713143|NCT00331123|Hormones|hormones|mesh-ancestor
153713144|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713145|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713146|NCT00087542|Pimavanserin|pimavanserin|mesh-list
153713147|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153713148|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153713149|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153713150|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153713151|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713152|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713153|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713154|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153713155|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153713156|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
153713169|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153713170|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153713171|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153713172|NCT00124956|Doxorubicin|doxorubicin|mesh-list
153713173|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153713174|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713175|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153713176|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153713177|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856159|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856160|NCT02927951|Pregabalin|pregabalin|mesh-list
153856161|NCT02927951|Analgesics|analgesics|mesh-ancestor
153856162|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
153856163|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856164|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856165|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
153713203|NCT00331513|Vorinostat|vorinostat|mesh-list
153713204|NCT00331513|Idarubicin|idarubicin|mesh-list
153713205|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713206|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153713207|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407527|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407528|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407529|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407530|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153407531|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
153407532|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407533|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407534|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
153407535|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407536|NCT00104884|Romidepsin|romidepsin|mesh-list
153407537|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153407538|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713208|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713287|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
153713288|NCT00331786|Protective Agents|protective agents|mesh-ancestor
153713289|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153713290|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
153713291|NCT00331825|Olanzapine|olanzapine|mesh-list
153713292|NCT00331825|Risperidone|risperidone|mesh-list
153713293|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153713294|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
153713295|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713296|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713297|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713298|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153713299|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153713300|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713301|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713302|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153713303|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
153713304|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
153713305|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
153713306|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713307|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153713308|NCT00331825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153713309|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153713310|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153713311|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
153713312|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153713313|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713314|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153713315|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
153713316|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153713317|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713318|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713319|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396448|NCT03769129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396450|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153396451|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
153396452|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153396453|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713326|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713327|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153713328|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
153713329|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713330|NCT00331981|Amisulpride|amisulpride|mesh-list
153713331|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153713332|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153713335|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713426|NCT05831761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153713427|NCT05831761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153713428|NCT05831761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153713429|NCT05831761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713431|NCT05831566|Formoterol Fumarate|formoterol fumarate|mesh-list
153429889|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867074|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867075|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867076|NCT04594343|Disulfiram|disulfiram|mesh-list
153867077|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153867078|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153867079|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713432|NCT05831566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713433|NCT05831566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153713434|NCT05831566|Autonomic Agents|autonomic agents|mesh-ancestor
153713435|NCT05831566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713436|NCT05831566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713437|NCT05831566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153713438|NCT05831566|Respiratory System Agents|respiratory system agents|mesh-ancestor
153713439|NCT05831566|Glucocorticoids|glucocorticoids|mesh-ancestor
153713440|NCT05831566|Hormones|hormones|mesh-ancestor
153713441|NCT05831566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713455|NCT05831462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713456|NCT05831462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713457|NCT05831345|Sufentanil|sufentanil|mesh-list
153713458|NCT05831345|Dsuvia|dsuvia|mesh-list
153713459|NCT05831345|Methadone|methadone|mesh-list
153713460|NCT05831345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153713461|NCT05831345|Narcotics|narcotics|mesh-ancestor
153713462|NCT05831345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713464|NCT05831345|Analgesics|analgesics|mesh-ancestor
153713489|NCT05830604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713490|NCT05830604|Antifungal Agents|antifungal agents|mesh-ancestor
153713491|NCT05830604|Keratolytic Agents|keratolytic agents|mesh-ancestor
153713492|NCT05830604|Dermatologic Agents|dermatologic agents|mesh-ancestor
153713493|NCT05828758|Amoxicillin|amoxicillin|mesh-list
153713494|NCT05828758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153713495|NCT05828758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713496|NCT05820997|Ropivacaine|ropivacaine|mesh-list
153713497|NCT05820997|Anesthetics, Local|anesthetics, local|mesh-ancestor
153713498|NCT05820997|Anesthetics|anesthetics|mesh-ancestor
153713499|NCT05820997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713500|NCT05820997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713501|NCT05820997|Sensory System Agents|sensory system agents|mesh-ancestor
153713502|NCT05820997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713503|NCT05776017|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153713523|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713524|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
153713525|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
153713532|NCT05660447|Glycerol|glycerol|mesh-list
153713583|NCT05303857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713584|NCT05254639|Donepezil|donepezil|mesh-list
153713585|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153713586|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713587|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713588|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
153713589|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713590|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713591|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
153713592|NCT05243940|Lidocaine|lidocaine|mesh-list
153713593|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
153429315|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713594|NCT05243940|Ketamine|ketamine|mesh-list
153713595|NCT05243940|Remifentanil|remifentanil|mesh-list
153713596|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
153713597|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
153713598|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713600|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
153396519|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396520|NCT02280811|Aldesleukin|aldesleukin|mesh-list
153396521|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
153396522|NCT02280811|Fludarabine|fludarabine|mesh-list
153396523|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153713664|NCT05126719|Mitosis Modulators|mitosis modulators|mesh-ancestor
153713665|NCT05126719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713666|NCT05126719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153713667|NCT05126719|Antimetabolites|antimetabolites|mesh-ancestor
153713668|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
153713669|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153713670|NCT05097261|Ketamine|ketamine|mesh-list
153713671|NCT05097261|Analgesics|analgesics|mesh-ancestor
153713672|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
153713673|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713674|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713675|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153713676|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153713677|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
153867115|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
153713687|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713688|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
153713689|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713690|NCT04857931|Colchicine|colchicine|mesh-list
153713691|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
153713692|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153713693|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
153713694|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
153713695|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
153713696|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713698|NCT04800393|Propofol|propofol|mesh-list
153713714|NCT04419493|Calcium heparin|calcium heparin|mesh-list
153713715|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153713716|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
153713717|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153713718|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153713719|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713720|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
153713721|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153713722|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
153713723|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713724|NCT04394975|Sunitinib|sunitinib|mesh-list
153713725|NCT04394975|Axitinib|axitinib|mesh-list
153713726|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713727|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153713728|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153713729|NCT04394975|Growth Substances|growth substances|mesh-ancestor
153713730|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713731|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
153713732|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153713733|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713734|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713735|NCT04381910|Irinotecan|irinotecan|mesh-list
153713736|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153713737|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153713738|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713740|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396571|NCT04893629|Furosemide|furosemide|mesh-list
153396572|NCT04893629|Diuretics|diuretics|mesh-ancestor
153396573|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
153396574|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396575|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153856307|NCT04485273|Anesthetics|anesthetics|mesh-list
153856308|NCT04485273|Sevoflurane|sevoflurane|mesh-list
153856309|NCT04485273|Bupivacaine|bupivacaine|mesh-list
153856310|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
153856311|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153856312|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856313|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856314|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153856315|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153856316|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
153713782|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153713783|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153713784|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153713785|NCT04006288|Analgesics|analgesics|mesh-ancestor
153713786|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
153713787|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713788|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713789|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713790|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153713791|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153407614|NCT00060346|Hormones|hormones|mesh-ancestor
153713792|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153550816|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
153713869|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
153713870|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713871|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713872|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
153713873|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
153713874|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713875|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713876|NCT03498261|Gabapentin|gabapentin|mesh-list
153713877|NCT03498261|Analgesics|analgesics|mesh-ancestor
153713878|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
153713879|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713880|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713881|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
153713882|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153713883|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153713884|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713885|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713886|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153713887|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153713888|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713889|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713890|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
153713891|NCT03495921|Irinotecan|irinotecan|mesh-list
153713892|NCT03495921|Camptothecin|camptothecin|mesh-list
153713920|NCT03114072|Methamphetamine|methamphetamine|mesh-list
153713921|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153856337|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856338|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856339|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153713965|NCT02636725|Axitinib|axitinib|mesh-list
153713966|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153713967|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713968|NCT02636725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153713969|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713970|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153713971|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713972|NCT02573493|Paclitaxel|paclitaxel|mesh-list
153713973|NCT02573493|Cisplatin|cisplatin|mesh-list
153713974|NCT02573493|Cetuximab|cetuximab|mesh-list
153713975|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153713976|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713977|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
153713978|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
153713979|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
153713980|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713981|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153713982|NCT02327078|Nivolumab|nivolumab|mesh-list
153713983|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153713984|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713985|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153713986|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713987|NCT02304458|Nivolumab|nivolumab|mesh-list
153713988|NCT02304458|Ipilimumab|ipilimumab|mesh-list
153713989|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153713990|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713991|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153714000|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153714001|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153407649|NCT00049530|Interferons|interferons|mesh-list
153407650|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
153856363|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153856365|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856366|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856367|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856368|NCT02153502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153856369|NCT02153502|Narcotics|narcotics|mesh-ancestor
153856370|NCT02153502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856371|NCT02153502|Analgesics|analgesics|mesh-ancestor
153714035|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153714036|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153714037|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714038|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153714039|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
153714040|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714041|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
153714042|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714043|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
153714044|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153714045|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153714046|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714047|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
153714048|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153714049|NCT01958021|Letrozole|letrozole|mesh-list
153714050|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714051|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153714052|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153714053|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714084|NCT05953168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714085|NCT05952921|Chlorhexidine|chlorhexidine|mesh-list
153714086|NCT05952921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153714087|NCT05952921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714088|NCT05952921|Disinfectants|disinfectants|mesh-ancestor
153714089|NCT05952596|Vaccines|vaccines|mesh-list
153545820|NCT06300099|Autonomic Agents|autonomic agents|mesh-ancestor
153714091|NCT05952596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714092|NCT05952505|Vaccines|vaccines|mesh-list
153714093|NCT05952505|Immunologic Factors|immunologic factors|mesh-ancestor
153714094|NCT05952505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714095|NCT05952206|Sirolimus|sirolimus|mesh-list
153714096|NCT05952206|Temsirolimus|temsirolimus|mesh-list
153714097|NCT05952206|MTOR Inhibitors|mtor inhibitors|mesh-list
153714098|NCT05952206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714099|NCT05952206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714100|NCT05952206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153714101|NCT05952206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714102|NCT05952206|Antifungal Agents|antifungal agents|mesh-ancestor
153714103|NCT05952206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153714104|NCT05952206|Immunologic Factors|immunologic factors|mesh-ancestor
153714105|NCT05952206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714106|NCT05952206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153714107|NCT05952206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714108|NCT05952206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714109|NCT05952128|Fluzoparib|fluzoparib|mesh-list
153714110|NCT05952128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153714111|NCT05952128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714112|NCT05952128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714114|NCT05952050|Dexmedetomidine|dexmedetomidine|mesh-list
153714141|NCT05951686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714142|NCT05951686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714143|NCT05951686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153714144|NCT05951686|Anesthetics, General|anesthetics, general|mesh-ancestor
153714145|NCT05951686|Anesthetics|anesthetics|mesh-ancestor
153714146|NCT05951686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153714147|NCT05951686|Narcotics|narcotics|mesh-ancestor
153714148|NCT05951686|Analgesics|analgesics|mesh-ancestor
153714149|NCT05951686|Sensory System Agents|sensory system agents|mesh-ancestor
153714150|NCT05951686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714151|NCT05951686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153714152|NCT05951569|Insulin|insulin|mesh-list
153714153|NCT05951569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153714154|NCT05951569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714155|NCT05951413|Sildenafil Citrate|sildenafil citrate|mesh-list
153714156|NCT05951413|Estradiol|estradiol|mesh-list
153714157|NCT05951413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714158|NCT05951413|Estrogens|estrogens|mesh-ancestor
153714159|NCT05951413|Hormones|hormones|mesh-ancestor
153714160|NCT05951413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714161|NCT05951413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714162|NCT05951413|Vasodilator Agents|vasodilator agents|mesh-ancestor
153714163|NCT05951413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153714164|NCT05951413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153714165|NCT05951413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714166|NCT05951413|Urological Agents|urological agents|mesh-ancestor
153714168|NCT05951361|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153714169|NCT05951361|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153714170|NCT05951361|Benzocaine|benzocaine|mesh-list
153714171|NCT05951361|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153714172|NCT05951361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856388|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153856391|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153714185|NCT05951361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714186|NCT05951309|Metformin|metformin|mesh-list
153714187|NCT05951309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153714199|NCT05936671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714200|NCT05936671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153714201|NCT05936671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153714202|NCT05936671|Anesthetics, General|anesthetics, general|mesh-ancestor
153714203|NCT05936671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153714204|NCT05936671|Narcotics|narcotics|mesh-ancestor
153714205|NCT05936671|Analgesics|analgesics|mesh-ancestor
153714206|NCT05936671|Sensory System Agents|sensory system agents|mesh-ancestor
153714207|NCT05936671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714208|NCT05925179|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153714209|NCT05925179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714210|NCT05925179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714211|NCT05925179|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153714212|NCT05925179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714213|NCT05925179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714214|NCT05921968|Iron|iron|mesh-list
153714215|NCT05921968|Lactoferrin|lactoferrin|mesh-list
153714216|NCT05921968|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153714217|NCT05921968|Trace Elements|trace elements|mesh-ancestor
153714218|NCT05921968|Micronutrients|micronutrients|mesh-ancestor
153714219|NCT05921968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714220|NCT05921968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714221|NCT05921968|Hematinics|hematinics|mesh-ancestor
153714241|NCT05811390|Vasodilator Agents|vasodilator agents|mesh-ancestor
153714243|NCT05794997|Atenolol|atenolol|mesh-list
153714244|NCT05794997|Sotalol|sotalol|mesh-list
153714245|NCT05794997|Carvedilol|carvedilol|mesh-list
153714246|NCT05794997|Bisoprolol|bisoprolol|mesh-list
153714247|NCT05794997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153714248|NCT05794997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153714249|NCT05794997|Adrenergic Agents|adrenergic agents|mesh-ancestor
153714250|NCT05794997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714251|NCT05794997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714252|NCT05794997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714253|NCT05794997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153714268|NCT05742399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153714335|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714336|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714337|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153714338|NCT05633966|Hormones|hormones|mesh-list
153714339|NCT05633966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714340|NCT05633966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714341|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
153714342|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714343|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714344|NCT05491083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153867253|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153714345|NCT05491083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714346|NCT05473585|Nicotine|nicotine|mesh-list
153714347|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153714348|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
153714349|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714350|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714351|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153714352|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153714353|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
153714354|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714355|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714356|NCT05457855|Fluticasone|fluticasone|mesh-list
153714357|NCT05457855|Montelukast|montelukast|mesh-list
153714409|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
153714410|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714411|NCT05125276|Aspirin|aspirin|mesh-list
153714412|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153714413|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153714414|NCT05125276|Analgesics|analgesics|mesh-ancestor
153714415|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
153714416|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714417|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714429|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
153714430|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153714431|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153714432|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714433|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714434|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714435|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153714436|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153714437|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714438|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153714439|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714440|NCT05074823|Ketamine|ketamine|mesh-list
153714441|NCT05074823|Analgesics|analgesics|mesh-ancestor
153714442|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
153714443|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714444|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714445|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153714446|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153714447|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
153714448|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
153714449|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714450|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153714451|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153714452|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714453|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714454|NCT05059600|Pregnanolone|pregnanolone|mesh-list
153396751|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153396752|NCT02646449|Mirtazapine|mirtazapine|mesh-list
153396753|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
153396754|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396755|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153396756|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
153396757|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
153396758|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396759|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396760|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396761|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153396762|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153856491|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153856492|NCT02916602|Diuretics|diuretics|mesh-ancestor
153714457|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714458|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714459|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
153714460|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714462|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
153714515|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714516|NCT04696042|Lanreotide|lanreotide|mesh-list
153714517|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714518|NCT04635189|Dexamethasone|dexamethasone|mesh-list
153714519|NCT04635189|Lenalidomide|lenalidomide|mesh-list
153714520|NCT04635189|Daratumumab|daratumumab|mesh-list
153714521|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153714522|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
153714523|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
153714524|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714525|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714526|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153714528|NCT04635189|Hormones|hormones|mesh-ancestor
153714595|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714596|NCT04318405|Iron|iron|mesh-list
153714597|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153714598|NCT04318405|Trace Elements|trace elements|mesh-ancestor
153714599|NCT04318405|Micronutrients|micronutrients|mesh-ancestor
153714600|NCT04318405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714601|NCT04318405|Hematinics|hematinics|mesh-ancestor
153714602|NCT04313790|Heparin|heparin|mesh-list
153714630|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153714631|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153714632|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714633|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153714634|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153714635|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153714636|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
153714637|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714638|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153714639|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
153714640|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153714641|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153714642|NCT04276480|Tazobactam|tazobactam|mesh-list
153714643|NCT04276480|Piperacillin|piperacillin|mesh-list
153714644|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153714645|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714646|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714647|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153714648|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714649|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714650|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153714651|NCT04263896|Laxatives|laxatives|mesh-ancestor
153714652|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153396814|NCT02658461|Trastuzumab|trastuzumab|mesh-list
153396815|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153396816|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396817|NCT00367913|Clarithromycin|clarithromycin|mesh-list
153396818|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
153396819|NCT00367913|Rifampin|rifampin|mesh-list
153396820|NCT00367913|Ethambutol|ethambutol|mesh-list
153856548|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153856549|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
153856550|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714672|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714673|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714674|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
153714679|NCT03774810|Zolpidem|zolpidem|mesh-list
153856576|NCT01669980|Vancomycin|vancomycin|mesh-list
153856577|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
153714719|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
153714738|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714739|NCT03426891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153714740|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714741|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153714742|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
153714743|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714744|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153714745|NCT03422536|Cetuximab|cetuximab|mesh-list
153714746|NCT03422536|Antibodies|antibodies|mesh-list
153714747|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
153714748|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153714749|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
153714750|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714751|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714752|NCT03358693|Infliximab|infliximab|mesh-list
153714753|NCT03358693|Upadacitinib|upadacitinib|mesh-list
153714754|NCT03358693|Ustekinumab|ustekinumab|mesh-list
153714755|NCT03358693|Ixekizumab|ixekizumab|mesh-list
153714756|NCT03358693|Brodalumab|brodalumab|mesh-list
153714757|NCT03358693|Abrocitinib|abrocitinib|mesh-list
153714758|NCT03358693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153714759|NCT03358693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153714760|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
153714762|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153714763|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153714764|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153714765|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714766|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714767|NCT03228394|Ganaxolone|ganaxolone|mesh-list
153714768|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
153714769|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714821|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856579|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856580|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856581|NCT01669980|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153856582|NCT01669980|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153856583|NCT02915666|Trametinib|trametinib|mesh-list
153856584|NCT02915666|Dabrafenib|dabrafenib|mesh-list
153856585|NCT02915666|Digoxin|digoxin|mesh-list
153714822|NCT02594384|Rituximab|rituximab|mesh-list
153714823|NCT02594384|Atezolizumab|atezolizumab|mesh-list
153714824|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714825|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714826|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
153714827|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714828|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153714829|NCT02594384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153714830|NCT02594384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714831|NCT02592707|Dexamethasone|dexamethasone|mesh-list
153714832|NCT02592707|Ondansetron|ondansetron|mesh-list
153714833|NCT02592707|Antiemetics|antiemetics|mesh-list
153714834|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153714836|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
153396857|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396858|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
153396859|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
153396860|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
153396861|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396862|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714878|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153714879|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153714880|NCT01291719|Insulin|insulin|mesh-list
153810955|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153357525|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714881|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153714882|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714883|NCT01176474|Nivolumab|nivolumab|mesh-list
153714884|NCT01176474|Ipilimumab|ipilimumab|mesh-list
153714885|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153714886|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
153714887|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714888|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714889|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714890|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153714891|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714892|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153714894|NCT01141309|Sorafenib|sorafenib|mesh-list
153714895|NCT01141309|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153714896|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153714897|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714898|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714899|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153714900|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
153714901|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714902|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714903|NCT00914823|Hormones|hormones|mesh-list
153714904|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714905|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714906|NCT00859781|Ketoconazole|ketoconazole|mesh-list
153714907|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
153714908|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153714910|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714911|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153714912|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153714913|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714914|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714915|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153714916|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
153714917|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714945|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153714946|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153714947|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
153714948|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714949|NCT00087815|Dexamethasone|dexamethasone|mesh-list
153714950|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153714951|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
153714952|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
153714953|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714954|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714955|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153714956|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
153714958|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714959|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153714960|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867405|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153867406|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153867407|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867408|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153867409|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
153407883|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407884|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153407887|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153407888|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407890|NCT03472469|Analgesics|analgesics|mesh-ancestor
153396899|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153396900|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396901|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396902|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
153396903|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396904|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396905|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153396906|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396907|NCT04651595|Morphine|morphine|mesh-list
153396908|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153396909|NCT04651595|Narcotics|narcotics|mesh-ancestor
153715005|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
153715006|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
153715007|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153715008|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153715009|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153715010|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153715011|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153715012|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153715013|NCT00088088|Paclitaxel|paclitaxel|mesh-list
153715014|NCT00088088|Carboplatin|carboplatin|mesh-list
153715015|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715046|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153715047|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
153856657|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856658|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856659|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856662|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715081|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
153715082|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153715083|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153715084|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153715085|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
153715086|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715087|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715088|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715089|NCT00333112|Urological Agents|urological agents|mesh-ancestor
153715090|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153715091|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153715092|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
153715093|NCT00333151|Metformin|metformin|mesh-list
153715094|NCT00333151|Liraglutide|liraglutide|mesh-list
153715095|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
153715096|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153715097|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715098|NCT00333151|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153715099|NCT00333151|Incretins|incretins|mesh-ancestor
153715100|NCT00333151|Hormones|hormones|mesh-ancestor
153715101|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715102|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153715103|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
153715104|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715105|NCT00088556|Paclitaxel|paclitaxel|mesh-list
153715119|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153715120|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715121|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153715122|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736035|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715123|NCT00125424|Midazolam|midazolam|mesh-list
153715124|NCT00125424|Fospropofol|fospropofol|mesh-list
153715125|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153715132|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153867410|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153867411|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
153715133|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
153715134|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
153715135|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
153715136|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
153715137|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715138|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715139|NCT00333346|Tramadol|tramadol|mesh-list
153715140|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153715141|NCT00333346|Narcotics|narcotics|mesh-ancestor
153715142|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715143|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715145|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
153715146|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715147|NCT00333385|Ceftazidime|ceftazidime|mesh-list
153715149|NCT00333385|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153396935|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
153715178|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
153715179|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153715180|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153715181|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153715182|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715183|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153715184|NCT00088946|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153715185|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153715186|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715187|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715188|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715189|NCT00421018|Montelukast|montelukast|mesh-list
153715190|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153715191|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
153715192|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153715193|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
153715194|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715209|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153715210|NCT00333931|Phenytoin|phenytoin|mesh-list
153715211|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
153715212|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153715213|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153715236|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
153715237|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715238|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715239|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153715240|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153715241|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
153715242|NCT00089219|Sargramostim|sargramostim|mesh-list
153715243|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
153715244|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
153715245|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715246|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153715247|NCT00334321|Paclitaxel|paclitaxel|mesh-list
153715248|NCT00334321|Carboplatin|carboplatin|mesh-list
153715249|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715250|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715251|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
153715252|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
153715253|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
153715285|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715286|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
153810956|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153810957|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153715287|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715288|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153592714|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592715|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
153592716|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
153592717|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
153592718|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592719|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
153592720|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153592721|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153592722|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
153592723|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592724|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
153592725|NCT01829178|Protective Agents|protective agents|mesh-ancestor
153592726|NCT01829334|Listerine|listerine|mesh-list
153592727|NCT01829334|Fluorides|fluorides|mesh-list
153592728|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
153592729|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
153592730|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
153592731|NCT01829334|Protective Agents|protective agents|mesh-ancestor
153459897|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153592735|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
153592736|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153592737|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
153592738|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592739|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
153592740|NCT01829451|Protective Agents|protective agents|mesh-ancestor
153592741|NCT01829529|Amoxicillin|amoxicillin|mesh-list
153592742|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153592743|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592745|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153592746|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153396963|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396965|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153396966|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
153396967|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153396968|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396969|NCT02283762|Riociguat|riociguat|mesh-list
153396970|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
153396971|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396972|NCT02692391|Indomethacin|indomethacin|mesh-list
153396973|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153396974|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153396975|NCT02692391|Analgesics|analgesics|mesh-ancestor
153396976|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
153715289|NCT00334477|Tadalafil|tadalafil|mesh-list
153715290|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
153715291|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153715292|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153715293|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715294|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715301|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153715302|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715303|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
153715304|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
153856722|NCT01628094|Ribavirin|ribavirin|mesh-list
153856723|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153856724|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153856725|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
153856726|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856727|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715333|NCT00334672|Dexamethasone|dexamethasone|mesh-list
153715334|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
153715335|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153715336|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153715337|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153715338|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
153715339|NCT00334672|Busulfan|busulfan|mesh-list
153407938|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397008|NCT02283294|Warfarin|warfarin|mesh-list
153397009|NCT02283294|Apixaban|apixaban|mesh-list
153397010|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
153397011|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153397012|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
153397013|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153397014|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
153397015|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715401|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715402|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153715403|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
153715404|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153715405|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153715406|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715407|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153715408|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153715409|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
153715410|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715411|NCT00127686|Levomethorphan|levomethorphan|mesh-list
153715412|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
153715413|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
153715426|NCT00334789|Vitamin A|vitamin a|mesh-list
153856776|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153856777|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
153856778|NCT02063997|Protective Agents|protective agents|mesh-ancestor
153856779|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856780|NCT02063685|Prednisone|prednisone|mesh-list
153715458|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153715459|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153715460|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715461|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715462|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
153715463|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
153715464|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
153715465|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153888811|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407959|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153407960|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153407961|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153407962|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153407963|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407964|NCT04960202|Ritonavir|ritonavir|mesh-list
153407965|NCT04960202|Nirmatrelvir|nirmatrelvir|mesh-list
153407966|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153407967|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153407968|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
153407969|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715466|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153715467|NCT00334867|Protective Agents|protective agents|mesh-ancestor
153715468|NCT04715152|Dexamethasone|dexamethasone|mesh-list
153715469|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
153715470|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
153715471|NCT04715152|BB 1101|bb 1101|mesh-list
153715472|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153715473|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
153715474|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
153715475|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715476|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715477|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715478|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
153715479|NCT04715152|Hormones|hormones|mesh-ancestor
153715480|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715481|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153715490|NCT00334906|Memantine|memantine|mesh-list
153856781|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
153856782|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153856783|NCT02063685|Rituximab|rituximab|mesh-list
153856784|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153856785|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715519|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715520|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715521|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
153715522|NCT00127764|Hormones|hormones|mesh-ancestor
153715523|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715524|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153715525|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715526|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
153715527|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715528|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
153715529|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715530|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715531|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153715532|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
153715533|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715534|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715535|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153715536|NCT00343096|Lorazepam|lorazepam|mesh-list
153715537|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
153715538|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
153715539|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
153715540|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715541|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715542|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715543|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153715544|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715545|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153715557|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715558|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153715559|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715561|NCT00089765|Ranibizumab|ranibizumab|mesh-list
153592747|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153397045|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397046|NCT02703779|Plerixafor|plerixafor|mesh-list
153397047|NCT02703779|Bortezomib|bortezomib|mesh-list
153397048|NCT02703779|Lenograstim|lenograstim|mesh-list
153397049|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153715562|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153715563|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153715564|NCT00089765|Growth Substances|growth substances|mesh-ancestor
153715565|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715566|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
153715567|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715568|NCT00343135|Amoxicillin|amoxicillin|mesh-list
153715569|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
153715570|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
153715571|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153715572|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153715573|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715574|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153715575|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715576|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715577|NCT00343174|Ancrod|ancrod|mesh-list
153715578|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
153715579|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153715580|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153715609|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715610|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
153715625|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153715627|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715628|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715629|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
153715630|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
153715631|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
153715632|NCT02958111|Capecitabine|capecitabine|mesh-list
153715633|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153715634|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
153715635|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715636|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715637|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
153715638|NCT00343447|Rituximab|rituximab|mesh-list
153715639|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715640|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
153715641|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715642|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715643|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153715644|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
153715645|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715646|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715688|NCT00343798|Cyclosporins|cyclosporins|mesh-list
153715689|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715690|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
153715691|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715692|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715693|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153715694|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
153715695|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715696|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715697|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153715698|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153715699|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
153715700|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715701|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
153715702|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715703|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
153715704|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153715705|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153397109|NCT02712047|Xhance|xhance|mesh-list
153715759|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715760|NCT00344227|Ranibizumab|ranibizumab|mesh-list
153715761|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153715762|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153715763|NCT00344227|Growth Substances|growth substances|mesh-ancestor
153715764|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715765|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
153715766|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715767|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153715768|NCT00344383|Norgestimate|norgestimate|mesh-list
153715769|NCT00344383|Estradiol|estradiol|mesh-list
153715770|NCT00344383|Estrogens|estrogens|mesh-ancestor
153715771|NCT00344383|Hormones|hormones|mesh-ancestor
153715772|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715773|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397127|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397128|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397129|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153397130|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153397131|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397132|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153397133|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153397134|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
153397135|NCT05215925|Carboplatin|carboplatin|mesh-list
153397136|NCT05215925|Docetaxel|docetaxel|mesh-list
153715824|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153715825|NCT00402792|Narcotics|narcotics|mesh-ancestor
153715826|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715827|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
153715832|NCT00127959|Tenofovir|tenofovir|mesh-list
153715858|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153856884|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153856885|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153715859|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153715878|NCT00127998|Mefloquine|mefloquine|mesh-list
153715879|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
153715880|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153715881|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153715882|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715883|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715884|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
153715885|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
153715886|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153408015|NCT02257632|Ranibizumab|ranibizumab|mesh-list
153408016|NCT02257632|Aflibercept|aflibercept|mesh-list
153408017|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153408018|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153715887|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
153715888|NCT00127998|Amebicides|amebicides|mesh-ancestor
153715889|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153715890|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153715891|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715892|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552920|NCT01587625|Oxytocin|oxytocin|mesh-list
153856894|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856895|NCT02912702|Dexamethasone|dexamethasone|mesh-list
153856896|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
153856897|NCT02912702|Doxorubicin|doxorubicin|mesh-list
153715936|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715937|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715938|NCT00344812|Analgesics|analgesics|mesh-ancestor
153715939|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
153715940|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715941|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153715942|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
153715943|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
153715945|NCT00344851|Exenatide|exenatide|mesh-list
153715946|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153715947|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715948|NCT00344851|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153715949|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153715950|NCT00344851|Incretins|incretins|mesh-ancestor
153715951|NCT00344851|Hormones|hormones|mesh-ancestor
153715952|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715953|NCT00090155|Ondansetron|ondansetron|mesh-list
153715954|NCT00090155|Aprepitant|aprepitant|mesh-list
153715955|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
153715956|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
153715957|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715958|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716011|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153429956|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
153716012|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153716013|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
153716014|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716015|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716016|NCT00128154|Chromium|chromium|mesh-list
153716017|NCT00128154|Picolinic acid|picolinic acid|mesh-list
153716018|NCT00128154|Trace Elements|trace elements|mesh-ancestor
153716019|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
153716020|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716054|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716055|NCT00345787|Buprenorphine|buprenorphine|mesh-list
153716056|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153716057|NCT00345787|Narcotics|narcotics|mesh-ancestor
153716058|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716059|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716060|NCT00345787|Analgesics|analgesics|mesh-ancestor
153716061|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
153716062|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716063|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153716064|NCT00128271|Bavituximab|bavituximab|mesh-list
153716081|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153867544|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867545|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867546|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153408025|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153408026|NCT01642914|Linaclotide|linaclotide|mesh-list
153408027|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153408039|NCT02256540|Estradiol|estradiol|mesh-list
153716082|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716083|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
153716084|NCT02959762|Coagulants|coagulants|mesh-ancestor
153716085|NCT00345826|Dasatinib|dasatinib|mesh-list
153716086|NCT00345826|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153716087|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153716088|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716089|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716090|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716091|NCT00345982|Sertindole|sertindole|mesh-list
153716092|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153716093|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153716094|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716099|NCT00346099|Panitumumab|panitumumab|mesh-list
153716100|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153716101|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
153716102|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716103|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716104|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716105|NCT00125736|Rabeprazole|rabeprazole|mesh-list
153716106|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153716107|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716108|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153716109|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716110|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716111|NCT00090428|Caseins|caseins|mesh-list
153716112|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
153716113|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
153716114|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716115|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
153716116|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716117|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716118|NCT00346255|Immunotoxins|immunotoxins|mesh-ancestor
153716119|NCT00346255|Immunoconjugates|immunoconjugates|mesh-ancestor
153716120|NCT00346255|Immunologic Factors|immunologic factors|mesh-ancestor
153716121|NCT00346255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716122|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153716123|NCT00346294|Etanercept|etanercept|mesh-list
153716146|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
153397206|NCT00085735|Cisplatin|cisplatin|mesh-list
153397207|NCT00085735|Vincristine|vincristine|mesh-list
153397208|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153397209|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
153397210|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397211|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397212|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153397213|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
153397214|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397215|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716168|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716169|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153716170|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153716171|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
153716172|NCT00090623|Ranibizumab|ranibizumab|mesh-list
153716173|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153716174|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153716175|NCT00090623|Growth Substances|growth substances|mesh-ancestor
153716176|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716177|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
153716178|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716187|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153716189|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716190|NCT00346684|Rituximab|rituximab|mesh-list
153716191|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716192|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716193|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
153716194|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716213|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153716214|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153716215|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716216|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716217|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153716218|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153716219|NCT00346801|Analgesics|analgesics|mesh-ancestor
153716220|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
153716221|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716222|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716223|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153716224|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716225|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153716226|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153716227|NCT00346840|Misoprostol|misoprostol|mesh-list
153716228|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153716229|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
153716230|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153716231|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716232|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153716233|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716234|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
153716235|NCT00346879|PENTA|penta|mesh-list
153716236|NCT00346879|Fondaparinux|fondaparinux|mesh-list
153592748|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153592749|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
153592750|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592752|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592788|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592789|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153592790|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153592791|NCT01829841|Growth Substances|growth substances|mesh-ancestor
153592792|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592793|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
153592794|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153592795|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592796|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592797|NCT01829893|Tamsulosin|tamsulosin|mesh-list
153592798|NCT01829893|Finasteride|finasteride|mesh-list
153592799|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153592800|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153592801|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153592802|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
153592803|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592804|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592805|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592806|NCT01829893|Urological Agents|urological agents|mesh-ancestor
153592807|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153592808|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153592809|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716237|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153736037|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153736038|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153716238|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
153716239|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153716240|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
153716241|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716242|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716243|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
153716244|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153716245|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153716266|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716268|NCT00346957|Anecortave|anecortave|mesh-list
153716269|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153716270|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153553289|NCT01592032|Heparin|heparin|mesh-list
153716271|NCT00346957|Growth Substances|growth substances|mesh-ancestor
153716272|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716273|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
153716274|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716275|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153716276|NCT00346996|Insulin|insulin|mesh-list
153716277|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153716278|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
153716279|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
153716280|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
153716281|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
153716315|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716316|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
153716317|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716318|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716319|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
153716320|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153716321|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716322|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716323|NCT00090896|Ipilimumab|ipilimumab|mesh-list
153716324|NCT00090896|Antibodies|antibodies|mesh-list
153716325|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153716326|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
153716327|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716328|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716329|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716330|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153716331|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716332|NCT00402558|Aldesleukin|aldesleukin|mesh-list
153716333|NCT00402558|Methotrexate|methotrexate|mesh-list
153716334|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
153716335|NCT00402558|Fludarabine|fludarabine|mesh-list
153716336|NCT00402558|Busulfan|busulfan|mesh-list
153716337|NCT00402558|Interleukin-2|interleukin-2|mesh-list
153716338|NCT00402558|Tacrolimus|tacrolimus|mesh-list
153716339|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
153716340|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153716380|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716381|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716382|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153716383|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153716384|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716385|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716386|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153716387|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
153716388|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
153716389|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
153716390|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716391|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716392|NCT00347425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153716393|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153716394|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153716395|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
153716396|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
153716397|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153716398|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153716399|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153716400|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153716401|NCT00126048|Atorvastatin|atorvastatin|mesh-list
153716402|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153397300|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397301|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
153397302|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397304|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397305|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397306|NCT01948141|Nintedanib|nintedanib|mesh-list
153397307|NCT01948141|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153397308|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397309|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153397310|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716451|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153716452|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153716453|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153716454|NCT00421252|Clopidogrel|clopidogrel|mesh-list
153716455|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153716456|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153857054|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153716515|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716516|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716517|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153716518|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153716519|NCT04705519|Growth Substances|growth substances|mesh-ancestor
153716520|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716521|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
153716522|NCT00126282|Cycloserine|cycloserine|mesh-list
153716523|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153716524|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716525|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153716526|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
153716527|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716528|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
153716529|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716530|NCT04705129|Tislelizumab|tislelizumab|mesh-list
153716531|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
153716532|NCT04705129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716551|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
153716552|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153716553|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
153857069|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
153857070|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857071|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857072|NCT02910518|Insulin|insulin|mesh-list
153857073|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153857074|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
153857075|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
153857076|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
153857077|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
153857078|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
153857079|NCT02910518|Heparin|heparin|mesh-list
153857081|NCT02910518|Glucagon|glucagon|mesh-list
153716582|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153716583|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153716584|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153716585|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
153716586|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716588|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
153736039|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153716680|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153716681|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867640|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716682|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153716683|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153716684|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716685|NCT00091715|Bosentan|bosentan|mesh-list
153716686|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153716689|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
153857093|NCT01217437|Irinotecan|irinotecan|mesh-list
153716715|NCT00091910|Hematinics|hematinics|mesh-ancestor
153716717|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153716718|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153553750|NCT01594502|Dutasteride|dutasteride|mesh-list
153716719|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153716720|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
153716721|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716722|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716723|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716724|NCT00427882|Urological Agents|urological agents|mesh-ancestor
153716725|NCT04704622|Midazolam|midazolam|mesh-list
153716726|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
153716727|NCT04704622|Ketamine|ketamine|mesh-list
153716728|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153716729|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716730|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857106|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
153857107|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
153857108|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153857109|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153857110|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857111|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857112|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153857113|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
153857114|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153857115|NCT00624364|Metformin|metformin|mesh-list
153857116|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
153397358|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397360|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
153397361|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153397362|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
153397363|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716777|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716778|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153397366|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
153397367|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153397368|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397369|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
153397370|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153397371|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397372|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867690|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867691|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153397373|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153397374|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153397375|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153397376|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153716817|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153716818|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153716819|NCT00092300|Analgesics|analgesics|mesh-ancestor
153716820|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
153716821|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716822|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716823|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153857117|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
153857118|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153857119|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857120|NCT02910596|Bethanechol|bethanechol|mesh-list
153716940|NCT00424034|Ambrisentan|ambrisentan|mesh-list
153716941|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153857137|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857138|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
153857139|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153857140|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153857141|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153717048|NCT05543109|Analgesics|analgesics|mesh-ancestor
153717049|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153717050|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153717051|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153717052|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153717053|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153717054|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153717055|NCT00093665|Fluorouracil|fluorouracil|mesh-list
153717056|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717057|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
153717058|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717059|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717060|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717061|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
153717062|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717063|NCT00093704|Ganciclovir|ganciclovir|mesh-list
153429938|NCT01122511|Growth Substances|growth substances|mesh-ancestor
153867702|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153867703|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153867704|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153867705|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867706|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867707|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867709|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
153867710|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867711|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
153867712|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153867713|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
153867714|NCT00567060|Piracetam|piracetam|mesh-list
153867715|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153867716|NCT00567060|Protective Agents|protective agents|mesh-ancestor
153867717|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717064|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153717065|NCT00093704|Bortezomib|bortezomib|mesh-list
153717066|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717067|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
153717068|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717069|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153717070|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717071|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717072|NCT01055314|Dactinomycin|dactinomycin|mesh-list
153397410|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153397411|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153397412|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397413|NCT05437601|Carotenoids|carotenoids|mesh-list
153397414|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
153397415|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397416|NCT05437601|Protective Agents|protective agents|mesh-ancestor
153397417|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397418|NCT05447039|Montelukast|montelukast|mesh-list
153397422|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
153717102|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
153717103|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
153717104|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
153717105|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
153717106|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153717107|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717108|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153717172|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
153717173|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
153717174|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717175|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
153717176|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
153717177|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717178|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717179|NCT00094484|Cinacalcet|cinacalcet|mesh-list
153717180|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153717181|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717182|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153717183|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
153717184|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717185|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
153717186|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153717187|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153717188|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
153717189|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717190|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717191|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153717210|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153717211|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153717212|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717213|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717214|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153717215|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153717216|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153717218|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
153717219|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
153857187|NCT06226532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153717231|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717232|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
153717233|NCT02415309|Melatonin|melatonin|mesh-list
153717234|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
153717235|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717236|NCT02415309|Protective Agents|protective agents|mesh-ancestor
153717237|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717238|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153717239|NCT00403338|Sirolimus|sirolimus|mesh-list
153717240|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153717241|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717242|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153717243|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717244|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
153717245|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717246|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
153717267|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153717268|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153717269|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717270|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153717271|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153717272|NCT00095225|Growth Substances|growth substances|mesh-ancestor
153717274|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
153397454|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717310|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153717311|NCT00095459|Growth Substances|growth substances|mesh-ancestor
153717312|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717313|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
153717314|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717315|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717316|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717317|NCT00429208|Nicotine|nicotine|mesh-list
153717318|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153717319|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
153717320|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717321|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717322|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153717323|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153717324|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
153717325|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717326|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717327|NCT00429247|Trastuzumab|trastuzumab|mesh-list
153717328|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153717329|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717331|NCT00095654|Ramipril|ramipril|mesh-list
153717332|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153717359|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717360|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153717361|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153717362|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717363|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
153717364|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153717365|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
153717366|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717387|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717388|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717389|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153717390|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153717391|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
153717392|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153717393|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153408263|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717394|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153717395|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153717396|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
153717397|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153717398|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717399|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153717443|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153857236|NCT06225440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153857237|NCT06225440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153857238|NCT06225440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857239|NCT06225440|Antiviral Agents|antiviral agents|mesh-ancestor
153857240|NCT06225440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857241|NCT06225440|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153857242|NCT06225440|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153857243|NCT06225440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857244|NCT06225440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717512|NCT00096005|Bortezomib|bortezomib|mesh-list
153717513|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717514|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
153717515|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717516|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
153717517|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717518|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717519|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153717520|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
153717521|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717522|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717523|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153717524|NCT00430144|Belotecan|belotecan|mesh-list
153717525|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153717526|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153717527|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717528|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717529|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717530|NCT00430261|Sunitinib|sunitinib|mesh-list
153717531|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717532|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153717533|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153717534|NCT00430261|Growth Substances|growth substances|mesh-ancestor
153717535|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717536|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
153717538|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857270|NCT06219226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153397513|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
153397514|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397515|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717575|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153717576|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717577|NCT00096317|Ketoconazole|ketoconazole|mesh-list
153717578|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
153717579|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717580|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153717581|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153717582|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717583|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717584|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153717585|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
153717586|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717646|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
153717647|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153717648|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153717649|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717650|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717651|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717652|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717653|NCT00096668|Paclitaxel|paclitaxel|mesh-list
153717654|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153717655|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717656|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
153717665|NCT00430846|Immunologic Factors|immunologic factors|mesh-ancestor
153717666|NCT00430846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717667|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
153717668|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153717669|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
153717670|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153717671|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
153717672|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717673|NCT00430924|Eplerenone|eplerenone|mesh-list
153717674|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153717675|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
153717676|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717677|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717678|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153717679|NCT00430924|Diuretics|diuretics|mesh-ancestor
153717680|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
153717681|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153717682|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
153717683|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
153717685|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
153717697|NCT05102409|Lifitegrast|lifitegrast|mesh-list
153717698|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153717699|NCT01053247|Tacrolimus|tacrolimus|mesh-list
153717700|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717701|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
153554767|NCT05690321|Opium|opium|mesh-list
153717702|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717703|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153717704|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717705|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717706|NCT00096863|Haloperidol|haloperidol|mesh-list
153717707|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
153717708|NCT00096863|Ziprasidone|ziprasidone|mesh-list
153717709|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
153717710|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
153717711|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717712|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717713|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717714|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153717715|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153717716|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153717717|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153717718|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153717719|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
153717720|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717721|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717771|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
153397577|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153397578|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397579|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
153397580|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
153397581|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397582|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717772|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717773|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717774|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
153717811|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717812|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153408323|NCT05430048|Bisoprolol|bisoprolol|mesh-list
153717907|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153717908|NCT00431665|Hormones|hormones|mesh-ancestor
153717909|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717910|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717911|NCT04703608|Ivermectin|ivermectin|mesh-list
153717912|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153717943|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153717944|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717945|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
153717946|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717947|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717948|NCT01052038|Dexamethasone|dexamethasone|mesh-list
153717949|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
153717950|NCT01052038|BB 1101|bb 1101|mesh-list
153717951|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153717952|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
153717953|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
153717954|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717955|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717956|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717991|NCT00432367|Amodiaquine|amodiaquine|mesh-list
153717992|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
153717993|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153717994|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153717995|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857346|NCT06004037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153857347|NCT06004037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857348|NCT06004037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153857349|NCT06004037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857354|NCT05947071|Vaccines|vaccines|mesh-list
153718044|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718045|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
153718046|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718047|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
153718048|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718049|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153718050|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153718051|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153718065|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153810963|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357529|NCT00724568|Hormones|hormones|mesh-ancestor
153867835|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867836|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153867837|NCT04575675|Diuretics|diuretics|mesh-ancestor
153867838|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
153867839|NCT04575675|Hormones|hormones|mesh-ancestor
153867840|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
153867841|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153867842|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867843|NCT00568412|Analgesics|analgesics|mesh-ancestor
153867848|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867849|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
153867850|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153867851|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
153867852|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153867853|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867855|NCT00568529|Capecitabine|capecitabine|mesh-list
153718066|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
153397631|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153397632|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153718112|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153718113|NCT00403026|Growth Substances|growth substances|mesh-ancestor
153718114|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718115|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
153718116|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
153718146|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718148|NCT04702906|Trimetazidine|trimetazidine|mesh-list
153718149|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
153718150|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
153718151|NCT00131313|Rituximab|rituximab|mesh-list
153555169|NCT05702190|Opium|opium|mesh-list
153718152|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718153|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
153718154|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718155|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718156|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153718157|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
153718158|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718181|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
153718182|NCT00433225|Hormones|hormones|mesh-ancestor
153718183|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718184|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718186|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469166|NCT05479812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736041|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736042|NCT03864068|Inositol|inositol|mesh-list
153736043|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
153736044|NCT03864068|Vitamins|vitamins|mesh-ancestor
153736045|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
153430364|NCT00476827|Irinotecan|irinotecan|mesh-list
153718235|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
153718236|NCT00433459|Hormones|hormones|mesh-ancestor
153718237|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718238|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153718239|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153718240|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
153718241|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
153718242|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
153718243|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153718244|NCT00433498|Carboplatin|carboplatin|mesh-list
153718245|NCT00433498|Etoposide|etoposide|mesh-list
153718246|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
153718247|NCT00433498|Pravastatin|pravastatin|mesh-list
153857389|NCT05892744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857390|NCT05892744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857391|NCT05892744|Serotonin Agents|serotonin agents|mesh-ancestor
153718329|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867867|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867868|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
153867869|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153718330|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718332|NCT00433927|Protective Agents|protective agents|mesh-ancestor
153718333|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
153718334|NCT00433927|Vitamins|vitamins|mesh-ancestor
153718335|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
153718336|NCT00433927|Hematinics|hematinics|mesh-ancestor
153718337|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
153718338|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153718339|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153718340|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718341|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718342|NCT00131430|Hormones|hormones|mesh-ancestor
153452456|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718343|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718344|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718345|NCT00098462|Sirolimus|sirolimus|mesh-list
153718346|NCT00098462|Gefitinib|gefitinib|mesh-list
153718347|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718348|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718351|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
153857406|NCT05773989|Clopidogrel|clopidogrel|mesh-list
153857407|NCT05773989|Ticagrelor|ticagrelor|mesh-list
153857408|NCT05773989|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153857409|NCT05773989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857410|NCT05773989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857411|NCT05773989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153857412|NCT05773989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153857413|NCT05773989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153857414|NCT05773989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153857415|NCT05773989|Purinergic Agents|purinergic agents|mesh-ancestor
153857416|NCT05773989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857417|NCT05763004|Pembrolizumab|pembrolizumab|mesh-list
153857418|NCT05763004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857419|NCT05763004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857420|NCT05763004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857421|NCT05763004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718389|NCT00434044|Analgesics|analgesics|mesh-ancestor
153718390|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
153718391|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718392|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718393|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718433|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718434|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718436|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
153718437|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
153718438|NCT00098618|Sorafenib|sorafenib|mesh-list
153718439|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718440|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
153718441|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718442|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718443|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718444|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718445|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
153718446|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430406|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718447|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153718448|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153718449|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718450|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718451|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
153718452|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718453|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
153718454|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153718455|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718456|NCT01059448|Brodalumab|brodalumab|mesh-list
153718457|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
153718458|NCT00098891|Entinostat|entinostat|mesh-list
153718459|NCT00098891|Isotretinoin|isotretinoin|mesh-list
153718460|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153718461|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
153718462|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718475|NCT04702516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718477|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153718478|NCT00099008|Protective Agents|protective agents|mesh-ancestor
153718479|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718480|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718481|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718505|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718506|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718508|NCT00099125|Temozolomide|temozolomide|mesh-list
153718509|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153718510|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153718511|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718512|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718513|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718514|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153718515|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
153718516|NCT00131703|Chloroquine|chloroquine|mesh-list
153718517|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
153857453|NCT05708859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857454|NCT05507580|Upadacitinib|upadacitinib|mesh-list
153857455|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153857456|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857457|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857458|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857459|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857460|NCT05502315|Nivolumab|nivolumab|mesh-list
153718553|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718554|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153718555|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153718556|NCT04621149|Lactoferrin|lactoferrin|mesh-list
153718557|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
153718558|NCT04621149|Famotidine|famotidine|mesh-list
153718559|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153718560|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153718561|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153718562|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
153718563|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
153397738|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
153397739|NCT00371111|Hormones|hormones|mesh-ancestor
153397740|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397741|NCT05454683|Melatonin|melatonin|mesh-list
153397742|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
153397743|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397744|NCT05454683|Protective Agents|protective agents|mesh-ancestor
153857476|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857477|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
153857478|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
153718602|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718603|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
153718614|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153718615|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
153718616|NCT00403806|Hormones|hormones|mesh-ancestor
153718619|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718658|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718659|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718660|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718661|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718662|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718663|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718664|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153408395|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153408399|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718665|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153718666|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718667|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718668|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
153718704|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153718705|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153718706|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718733|NCT00100412|Dobutamine|dobutamine|mesh-list
153718734|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
153718735|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153718736|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
153718737|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
153718738|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718739|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718740|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
153718741|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153718742|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
153718743|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
153718744|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153718745|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153397747|NCT05139095|Apatinib|apatinib|mesh-list
153592810|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
153545901|NCT06297499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153592811|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592813|NCT01830153|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153592814|NCT01830153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153592815|NCT01830153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592818|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
153592830|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153592831|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592832|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
153592833|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
153592834|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
153592835|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592836|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153592837|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153857499|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153857500|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
153857501|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857502|NCT05384262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153857503|NCT05384262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153857504|NCT05384262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153857505|NCT05384262|Antimetabolites|antimetabolites|mesh-ancestor
153857510|NCT05367245|Butyric Acid|butyric acid|mesh-list
153718746|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153718747|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
153718748|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718749|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555767|NCT01600599|Coagulants|coagulants|mesh-ancestor
153718750|NCT00100412|Protective Agents|protective agents|mesh-ancestor
153718751|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153718752|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153718765|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718766|NCT00132444|UC-781|uc-781|mesh-list
153718767|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153397785|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397786|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
153397787|NCT01898689|Ropivacaine|ropivacaine|mesh-list
153397788|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
153397789|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
153397790|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397791|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397792|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
153397793|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397794|NCT05062577|Buprenorphine|buprenorphine|mesh-list
153718805|NCT04728659|Desogestrel|desogestrel|mesh-list
153718806|NCT04728659|Ganirelix|ganirelix|mesh-list
153718807|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153718808|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153718809|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153718810|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
153718811|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153718865|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153718866|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
153718867|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718868|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153718869|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153718870|NCT00100685|Growth Substances|growth substances|mesh-ancestor
153718871|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
153718872|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718874|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153718875|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
153718876|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718877|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718878|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153718879|NCT00100880|Lenalidomide|lenalidomide|mesh-list
153718880|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
153718881|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718882|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153718884|NCT00100880|Growth Substances|growth substances|mesh-ancestor
153718931|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718932|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
153718933|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718934|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153718935|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153718936|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153718937|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718939|NCT00132951|Telithromycin|telithromycin|mesh-list
153718940|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718941|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718942|NCT00400790|Propofol|propofol|mesh-list
153718943|NCT00400790|Desflurane|desflurane|mesh-list
153718944|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153718945|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153718946|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718947|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153718948|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
153718949|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
153718950|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153718962|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718963|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718964|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153718965|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
153718966|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
153718967|NCT00135408|Hormones|hormones|mesh-ancestor
153718968|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718969|NCT00101231|Alvocidib|alvocidib|mesh-list
153718970|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718971|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
153718972|NCT00101231|Growth Substances|growth substances|mesh-ancestor
153718973|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718974|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718975|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718976|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718977|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
153592838|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153592839|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592840|NCT01830530|Telmisartan|telmisartan|mesh-list
153592841|NCT01830530|Nifedipine|nifedipine|mesh-list
153397836|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397837|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
153397838|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397840|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
153718978|NCT00101270|Irinotecan|irinotecan|mesh-list
153718979|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718980|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153718981|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153718982|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718984|NCT00101309|Aldesleukin|aldesleukin|mesh-list
153719050|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
153719051|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153719052|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719053|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719054|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719055|NCT00135681|Nedocromil|nedocromil|mesh-list
153719056|NCT00135681|Budesonide|budesonide|mesh-list
153719057|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153719058|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153719059|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
153719060|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719061|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719062|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153719063|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
153719064|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
153719065|NCT00135681|Hormones|hormones|mesh-ancestor
153397866|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153397867|NCT01901575|Remifentanil|remifentanil|mesh-list
153397868|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153397869|NCT01901575|Narcotics|narcotics|mesh-ancestor
153397870|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397871|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397872|NCT01901575|Analgesics|analgesics|mesh-ancestor
153397873|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
153397874|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397875|NCT01901809|Dopamine|dopamine|mesh-list
153397876|NCT01901809|Furosemide|furosemide|mesh-list
153397877|NCT01901809|Diuretics|diuretics|mesh-ancestor
153397878|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
153397879|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397880|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153719154|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153857620|NCT04965493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857622|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153857623|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857624|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153857625|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857626|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
153719211|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719212|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
153719213|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
153719214|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719215|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719216|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153719217|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153719218|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
153719219|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153719220|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153719221|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153719222|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153719223|NCT00135954|Prednisolone|prednisolone|mesh-list
153719224|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
153719225|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719226|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
153719227|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719228|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719229|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153719230|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
153719231|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719232|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719233|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153719234|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153719235|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
153719292|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719293|NCT00133458|Albendazole|albendazole|mesh-list
153719294|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
153719295|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153719296|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719297|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
153719298|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153719299|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153719300|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
153719301|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
153719302|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
153719303|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719304|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719305|NCT00102752|Gemcitabine|gemcitabine|mesh-list
153719306|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153719307|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
153719308|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719309|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719310|NCT00102830|Trebananib|trebananib|mesh-list
153397908|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397909|NCT01904071|Analgesics|analgesics|mesh-ancestor
153397910|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
153397911|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397912|NCT01907113|Empagliflozin|empagliflozin|mesh-list
153397913|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153857645|NCT04892017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857646|NCT04892017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857647|NCT04869943|Exemestane|exemestane|mesh-list
153857648|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857649|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153857650|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153857651|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857653|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153719363|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
153719364|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153719365|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719366|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153719367|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153719368|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153719369|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719374|NCT00102986|Ritonavir|ritonavir|mesh-list
153857656|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857658|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153857659|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857660|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153857661|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153857662|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719399|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719400|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
153719401|NCT00136383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153719402|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
153719403|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153719404|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153719423|NCT00103103|Vitamins|vitamins|mesh-ancestor
153719424|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
153719425|NCT00133692|Atenolol|atenolol|mesh-list
153719426|NCT00133692|Verapamil|verapamil|mesh-list
153719427|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153719428|NCT00133692|Trandolapril|trandolapril|mesh-list
153719429|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153857664|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857665|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153857666|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153719485|NCT00136461|Tretinoin|tretinoin|mesh-list
153430695|NCT00655057|Citalopram|citalopram|mesh-list
153719486|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
153719487|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719488|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
153719489|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
153719490|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153719491|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
153719492|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719493|NCT00133770|Pantoprazole|pantoprazole|mesh-list
153719494|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153719495|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153719496|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153719497|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719498|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719499|NCT00133848|Retapamulin|retapamulin|mesh-list
153719500|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153719501|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719502|NCT00133887|Sirolimus|sirolimus|mesh-list
153556517|NCT01613963|Hormones|hormones|mesh-ancestor
153719503|NCT00133887|Cyclosporine|cyclosporine|mesh-list
153719504|NCT00133887|Tacrolimus|tacrolimus|mesh-list
153719539|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
153719540|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
153719541|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719542|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719543|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153719544|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153719545|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153719546|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719547|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719548|NCT00103571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153719549|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153719550|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719551|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719552|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719553|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
153719554|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
153719565|NCT00103649|Xaliproden|xaliproden|mesh-list
153719621|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153719622|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719623|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153719624|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719625|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719626|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
153719627|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153719628|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153719629|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153408609|NCT03674294|Dexamethasone|dexamethasone|mesh-list
153408611|NCT03674294|Palonosetron|palonosetron|mesh-list
153408612|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153408613|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
153408614|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
153408615|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408616|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408617|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153408618|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
153408619|NCT03674294|Hormones|hormones|mesh-ancestor
153868114|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153868115|NCT00571298|Protective Agents|protective agents|mesh-ancestor
153868116|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868117|NCT00571298|Antidotes|antidotes|mesh-ancestor
153868118|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
153868119|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
153868120|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868121|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868122|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
153719630|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153719631|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719632|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
153719634|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
153719635|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719636|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
153719637|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153719638|NCT04729088|Isosorbide|isosorbide|mesh-list
153719639|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153719640|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153719641|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153719642|NCT04729088|Diuretics|diuretics|mesh-ancestor
153719643|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
153857688|NCT04821375|Hormones|hormones|mesh-ancestor
153857689|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857690|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857691|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153857692|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153857693|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
153857694|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153857695|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
153719651|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153719652|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153719653|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719654|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719655|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
153719656|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719698|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153719699|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719700|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719702|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719703|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153719704|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153719705|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153719706|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153719707|NCT00136968|Voriconazole|voriconazole|mesh-list
153719708|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
153719709|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719710|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153719711|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153719712|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719720|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719721|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153719722|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153719723|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
153719724|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719725|NCT00137007|Azithromycin|azithromycin|mesh-list
153719726|NCT00137007|Ampicillin|ampicillin|mesh-list
153719727|NCT00137007|Sulbactam|sulbactam|mesh-list
153719728|NCT00137007|Sultamicillin|sultamicillin|mesh-list
153719729|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153719730|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719731|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153719732|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719733|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719734|NCT00137085|Ketamine|ketamine|mesh-list
153408641|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408642|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
153408643|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408644|NCT05369364|Dexamethasone|dexamethasone|mesh-list
153408645|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
153408646|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153408647|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
153719735|NCT00137085|Analgesics|analgesics|mesh-ancestor
153857707|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857708|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719750|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
153719751|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719752|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153719753|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153719754|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719755|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
153719756|NCT00104546|Coagulants|coagulants|mesh-ancestor
153719757|NCT00134394|Etanercept|etanercept|mesh-list
153719758|NCT00134394|Tacrolimus|tacrolimus|mesh-list
153719759|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719760|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
153719761|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719762|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153719763|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719764|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719765|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153719766|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153719767|NCT00134394|Analgesics|analgesics|mesh-ancestor
153719768|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
153719769|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719770|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153719771|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719772|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153719773|NCT00104624|Docetaxel|docetaxel|mesh-list
153719774|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719775|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
153857712|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857713|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857714|NCT04712851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857715|NCT04712851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857716|NCT04700124|Cisplatin|cisplatin|mesh-list
153857717|NCT04700124|Gemcitabine|gemcitabine|mesh-list
153719810|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153719811|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153719812|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719813|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
153719907|NCT00105209|Analgesics|analgesics|mesh-ancestor
153719908|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
153719909|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719910|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719911|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153719912|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719913|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153719914|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153720013|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720014|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720015|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153720016|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720017|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153720018|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153720019|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868174|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153868175|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153868176|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
153720020|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153720021|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153720022|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720023|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
153720024|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720025|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
153720026|NCT01054144|Dexamethasone|dexamethasone|mesh-list
153720027|NCT01054144|Prednisone|prednisone|mesh-list
153720089|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720090|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
153720091|NCT00137826|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153720092|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720093|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720095|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
153720168|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720169|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153720170|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153720171|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153720172|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
153720181|NCT00435292|Naproxen|naproxen|mesh-list
153720265|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720266|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720267|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153720268|NCT00436033|Analgesics|analgesics|mesh-ancestor
153720269|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
153720270|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720271|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
153720337|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153720338|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720339|NCT00106301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153720340|NCT00106301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720341|NCT00106301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720344|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720345|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720346|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720347|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720348|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
153720349|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720350|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
153720351|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153720413|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720414|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720415|NCT00437359|Toremifene|toremifene|mesh-list
153720416|NCT00437359|Anastrozole|anastrozole|mesh-list
153720417|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720418|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153720419|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720420|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153720421|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153720514|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720515|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153720516|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720517|NCT00438217|Hormones|hormones|mesh-ancestor
153720518|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153720519|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
153720520|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153720521|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
153720522|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153720523|NCT03279757|Lidocaine|lidocaine|mesh-list
153720524|NCT03279757|Epinephrine|epinephrine|mesh-list
153720525|NCT03279757|Racepinephrine|racepinephrine|mesh-list
153720526|NCT03279757|Tetracaine|tetracaine|mesh-list
153720527|NCT03279757|Carticaine|carticaine|mesh-list
153720528|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
153720529|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
153720585|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720586|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153720587|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153720588|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
153720589|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720590|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720591|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153720682|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153720683|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153720685|NCT00439855|Enoxaparin|enoxaparin|mesh-list
153720686|NCT00439855|Calcium heparin|calcium heparin|mesh-list
153720687|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
153720688|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153720689|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153720690|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720691|NCT00107354|Cytarabine|cytarabine|mesh-list
153720692|NCT00107354|Aldesleukin|aldesleukin|mesh-list
153720693|NCT00107354|Etoposide|etoposide|mesh-list
153720694|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
153720695|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153557716|NCT01621256|Ancrod|ancrod|mesh-list
153720696|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720697|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153720698|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720699|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720700|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720701|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720702|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
153720703|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
153398163|NCT05738317|Growth Inhibitors|growth inhibitors|mesh-ancestor
153398164|NCT02284555|Mupirocin|mupirocin|mesh-list
153398165|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398166|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398167|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153720754|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720755|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720756|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
153720758|NCT00107432|Sorafenib|sorafenib|mesh-list
153720826|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153720827|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720828|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
153720829|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736054|NCT03859687|Protective Agents|protective agents|mesh-ancestor
153736055|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153720830|NCT00404196|Calcipotriene|calcipotriene|mesh-list
153720831|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
153720832|NCT00107510|Carboplatin|carboplatin|mesh-list
153720833|NCT00107510|Docetaxel|docetaxel|mesh-list
153720834|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720835|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
153720836|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
153720837|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
153720839|NCT00440245|Albuterol|albuterol|mesh-list
153720952|NCT00441415|Adapalene|adapalene|mesh-list
153720953|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153720954|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153720955|NCT00441415|Analgesics|analgesics|mesh-ancestor
153720956|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
153720957|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720958|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720959|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153408717|NCT02974712|Narcotics|narcotics|mesh-ancestor
153868188|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720960|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153720961|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
153720962|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
153720963|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153720964|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153720965|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153720966|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720967|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720968|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
153720969|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720970|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857938|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
153857939|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153857940|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857941|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857943|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
153721094|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
153721095|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153721096|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153721097|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153721098|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721099|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721190|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153721191|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721192|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153721193|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153721194|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153721195|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153721196|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
153721197|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
153721198|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
153721199|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
153857999|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
153858000|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153721270|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
153721271|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153721272|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
153721277|NCT00138606|Vildagliptin|vildagliptin|mesh-list
153721346|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
153721347|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153721349|NCT00443716|Hormones|hormones|mesh-ancestor
153721350|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721351|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721352|NCT00443794|Aspirin|aspirin|mesh-list
153721360|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
153721403|NCT00443950|Etanercept|etanercept|mesh-list
153721439|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
153721442|NCT04698772|Morphine|morphine|mesh-list
153721443|NCT04698772|Analgesics|analgesics|mesh-ancestor
153721444|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
153721445|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721561|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721562|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721565|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721566|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153721567|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721568|NCT00108992|Diclofenac|diclofenac|mesh-list
153721569|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153721570|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153721571|NCT00108992|Analgesics|analgesics|mesh-ancestor
153558603|NCT01627262|Analgesics|analgesics|mesh-ancestor
153858068|NCT02607202|Gemcitabine|gemcitabine|mesh-list
153721647|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721648|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721650|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721652|NCT00452296|Insulin|insulin|mesh-list
153721723|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153721724|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
153721725|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721726|NCT00452920|Docetaxel|docetaxel|mesh-list
153721727|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721728|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
153721729|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
153558761|NCT01628055|Antibodies|antibodies|mesh-list
153721730|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
153721792|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153721793|NCT00453232|Etoposide|etoposide|mesh-list
153721794|NCT00453232|Bleomycin|bleomycin|mesh-list
153721795|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721796|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153721797|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153721798|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153721799|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558842|NCT01628952|Curare|curare|mesh-list
153858106|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858107|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721910|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721911|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153721912|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
153721914|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858123|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
153722024|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722025|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153722026|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
153722027|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153722051|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153722147|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153722148|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722149|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153722150|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
153722151|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153722152|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722153|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
153722154|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
153722155|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722157|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153722158|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153722218|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722220|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153722221|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
153722222|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153722223|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153722224|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153722225|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722227|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
153722289|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722290|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153722291|NCT00456976|Protective Agents|protective agents|mesh-ancestor
153722293|NCT00144066|Gefitinib|gefitinib|mesh-list
153722413|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153722414|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153722415|NCT00465751|Cathartics|cathartics|mesh-ancestor
153722426|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722427|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153722428|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
153722429|NCT00465907|Paclitaxel|paclitaxel|mesh-list
153722430|NCT00465907|Carboplatin|carboplatin|mesh-list
153722502|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153408743|NCT03557333|Analgesics|analgesics|mesh-ancestor
153722503|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153722504|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153722505|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
153722506|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722507|NCT00144378|Irinotecan|irinotecan|mesh-list
153722508|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153722509|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153722510|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722511|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722537|NCT00113802|Antibodies|antibodies|mesh-list
153722620|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153722621|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
153722623|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153722758|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722759|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722760|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153722761|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
153722849|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
153722850|NCT00111644|Lactams|lactams|mesh-list
153722851|NCT00111644|beta-Lactams|beta-lactams|mesh-list
153722852|NCT00111644|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153722853|NCT00111644|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153722945|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
153722946|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722947|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153722948|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
153722949|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722950|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
153722957|NCT00350467|Olanzapine|olanzapine|mesh-list
153723025|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723026|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723027|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153723028|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
153723029|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153723030|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723031|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153723131|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
153723132|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723133|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153723134|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
153723237|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
153723238|NCT00112346|Gemcitabine|gemcitabine|mesh-list
153723239|NCT00112346|Cetuximab|cetuximab|mesh-list
153723240|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723241|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
153723242|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858411|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858412|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858413|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153858414|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153858415|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
153858416|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
153723316|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153723317|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
153723318|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153723319|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153858425|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153858426|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153810967|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153810968|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153810969|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
153810970|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
153810971|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810972|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858427|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
153858428|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
153723410|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723411|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
153723412|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153723413|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
153723414|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153723415|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153858446|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
153858447|NCT04674423|Tenofovir|tenofovir|mesh-list
153723504|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153723505|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723506|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723507|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723508|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723509|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153723510|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153723511|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723512|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153858465|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153858467|NCT00555984|Remifentanil|remifentanil|mesh-list
153858468|NCT00555984|Propofol|propofol|mesh-list
153858469|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
153858470|NCT00555984|Anesthetics|anesthetics|mesh-list
153723576|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153723577|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560638|NCT01639092|Tenofovir|tenofovir|mesh-list
153723689|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153723690|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153723719|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153723720|NCT00444808|Katacalcin|katacalcin|mesh-list
153723721|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723722|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723723|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153858514|NCT01902381|Vitamins|vitamins|mesh-ancestor
153723819|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153858515|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
153858516|NCT04673799|Denosumab|denosumab|mesh-list
153858517|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153723820|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
153723821|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153723822|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153723935|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723936|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723938|NCT00401765|Siltuximab|siltuximab|mesh-list
153723939|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723940|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723941|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724008|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153724009|NCT00446836|Paclitaxel|paclitaxel|mesh-list
153724010|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153724011|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153858559|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153858560|NCT04673214|Analgesics|analgesics|mesh-ancestor
153858561|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
153724108|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
153724109|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724110|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724111|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724112|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153724113|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724114|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153724115|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153724116|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153724208|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
153858584|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
153858585|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858586|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153858587|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153858588|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858589|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858590|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153858591|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153858592|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
153858593|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153724209|NCT00448786|Imetelstat|imetelstat|mesh-list
153724210|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724211|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724212|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724213|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
153724214|NCT00448786|Vitamins|vitamins|mesh-ancestor
153724217|NCT00114803|Calcitonin|calcitonin|mesh-list
153724270|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724271|NCT00115752|Valdecoxib|valdecoxib|mesh-list
153724272|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
153724274|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724354|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
153724355|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724356|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153724357|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153724358|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724359|NCT00115154|Imiquimod|imiquimod|mesh-list
153724360|NCT00115154|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153724361|NCT00115154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736065|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736066|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153736067|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724448|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153724449|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153724450|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724452|NCT05536362|Clonidine|clonidine|mesh-list
153724532|NCT00458458|Norethindrone|norethindrone|mesh-list
153724552|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724554|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153724555|NCT00458731|Cediranib|cediranib|mesh-list
153724556|NCT00458731|Antibodies|antibodies|mesh-list
153724557|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
153724671|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153724672|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153724673|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153724674|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724676|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724677|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724678|NCT00115817|Atorvastatin|atorvastatin|mesh-list
153724679|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153724680|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153724681|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
153724682|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724683|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153724776|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153724777|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
153724778|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
153724779|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724780|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153724781|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153724783|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153858717|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724882|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153724883|NCT00461617|Mitiglinide|mitiglinide|mesh-list
153724884|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724886|NCT00116064|Lorazepam|lorazepam|mesh-list
153725164|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858735|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
153858736|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
153858737|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
153858738|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153725165|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725167|NCT00116493|Mebendazole|mebendazole|mesh-list
153725168|NCT00116493|Piperazine|piperazine|mesh-list
153725169|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
153725170|NCT00116493|DMP 777|dmp 777|mesh-list
153725171|NCT00116493|Hematinics|hematinics|mesh-ancestor
153725172|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
153725173|NCT00116493|Vitamins|vitamins|mesh-ancestor
153725174|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
153725175|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725176|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
153725177|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
153725178|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153725179|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725180|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
153725181|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
153725182|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
153725183|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725184|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725185|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725186|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153736088|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
153725233|NCT00116870|Lovastatin|lovastatin|mesh-list
153725234|NCT00116870|L 647318|l 647318|mesh-list
153725235|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
153725236|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153725354|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725355|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153725356|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
153725358|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399097|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399098|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725490|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153725491|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
153725492|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
153725493|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
153725494|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153725508|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153725510|NCT00474838|Glimepiride|glimepiride|mesh-list
153725511|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153725512|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725513|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153725514|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725515|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
153725516|NCT00474916|KRN 5500|krn 5500|mesh-list
153725581|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868306|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153725582|NCT02964195|Rifaximin|rifaximin|mesh-list
153725583|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153725584|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725586|NCT00475462|Metoprolol|metoprolol|mesh-list
153725696|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153725697|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153725698|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
153725699|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725700|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725701|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153725702|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153725703|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
153725704|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725705|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153725706|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153725874|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153725875|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153725876|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725877|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153725878|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725879|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153725880|NCT00476983|Ritonavir|ritonavir|mesh-list
153858858|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
153858859|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858860|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726019|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
153726020|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
153726021|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
153726022|NCT00118976|Lisinopril|lisinopril|mesh-list
153726024|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
153726126|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726127|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153726128|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153726225|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726226|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153726227|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153726228|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153726229|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726311|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726312|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153726313|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153726314|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726345|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
153726490|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153726491|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726492|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153726493|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726494|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
153726495|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153726496|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153726497|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153726567|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
153726568|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726569|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726570|NCT00482989|Sifalimumab|sifalimumab|mesh-list
153726571|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
153726572|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726573|NCT00120380|Iloprost|iloprost|mesh-list
153726574|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153726647|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726648|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153726729|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153726730|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868318|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726731|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726732|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726733|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153726735|NCT00120653|Metoclopramide|metoclopramide|mesh-list
153399360|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153399361|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399362|NCT01969747|Empagliflozin|empagliflozin|mesh-list
153399363|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153399364|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399365|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726804|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726805|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726806|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
153726807|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153726808|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726809|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726810|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153399368|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153399369|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153399370|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
153399371|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399372|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399373|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399374|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153399375|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153399376|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399377|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726877|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153726878|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726879|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726918|NCT00485680|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153726919|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153726920|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153736132|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153726993|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726994|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726995|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
153726996|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726997|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
153726998|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153726999|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727079|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
153727080|NCT00486694|Amebicides|amebicides|mesh-ancestor
153727081|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153727082|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153727083|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727085|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153727166|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153727167|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
153727168|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727169|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727170|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727236|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727237|NCT00145236|Nebivolol|nebivolol|mesh-list
153727238|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153868334|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868352|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727272|NCT00489151|Adefovir|adefovir|mesh-list
153727346|NCT00489658|Nifurtimox|nifurtimox|mesh-list
153727347|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727348|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153727349|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153727350|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153727351|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727352|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153727353|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727493|NCT00122291|Capecitabine|capecitabine|mesh-list
153727494|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727495|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
153727496|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727515|NCT00490867|Protective Agents|protective agents|mesh-ancestor
153727516|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727517|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
153727519|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
153727520|NCT00122330|Eculizumab|eculizumab|mesh-list
153727521|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153727522|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727523|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
153727524|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727593|NCT00492037|Conivaptan|conivaptan|mesh-list
153727594|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153727595|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727596|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
153727597|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727598|NCT00402272|Everolimus|everolimus|mesh-list
153727599|NCT00402272|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153727600|NCT00402272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153727601|NCT00402272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727603|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727703|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727704|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727705|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153727706|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153727707|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
153727709|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153727710|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153727711|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153727712|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727713|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727739|NCT00493324|Alefacept|alefacept|mesh-list
153727808|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727809|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727810|NCT00145938|Urological Agents|urological agents|mesh-ancestor
153727811|NCT00493480|Propranolol|propranolol|mesh-list
153727812|NCT00493480|Carvedilol|carvedilol|mesh-list
153727813|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153727814|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153727815|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
153727921|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153727922|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153727950|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153727951|NCT00494572|Montelukast|montelukast|mesh-list
153810980|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668019|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408890|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408891|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408892|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153408893|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
153408894|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
153408895|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153408896|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
153408899|NCT05722951|Metformin|metformin|mesh-list
153727952|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153727953|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
153727954|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153727955|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
153727961|NCT00494611|Cetuximab|cetuximab|mesh-list
153545833|NCT06300099|Sensory System Agents|sensory system agents|mesh-ancestor
153545834|NCT06300099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153545835|NCT06300099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153545836|NCT06300099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153545837|NCT06300099|Adrenergic Agents|adrenergic agents|mesh-ancestor
153545838|NCT06300099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545839|NCT06300099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545841|NCT06299891|Phentermine|phentermine|mesh-list
153545842|NCT06299891|Anticonvulsants|anticonvulsants|mesh-ancestor
153545843|NCT06299891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153545844|NCT06299891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545845|NCT06299891|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153545854|NCT06299137|Ropivacaine|ropivacaine|mesh-list
153859358|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
153859359|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153859360|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153859361|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
153728025|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153728027|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153728098|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153728099|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153728101|NCT00496405|Bevacizumab|bevacizumab|mesh-list
153728175|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
153728176|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728177|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728178|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
153728179|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728180|NCT01244971|Acarbose|acarbose|mesh-list
153728181|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153728182|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728183|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728184|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153728185|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728191|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
153728242|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728243|NCT00127868|Selenium|selenium|mesh-list
153728244|NCT00127868|Ketoconazole|ketoconazole|mesh-list
153728245|NCT00127868|Ciclopirox|ciclopirox|mesh-list
153728246|NCT00127868|Griseofulvin|griseofulvin|mesh-list
153728247|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
153728248|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
153728249|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399756|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
153728314|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728315|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728316|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153728317|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153728421|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
153728422|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153728423|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
153728424|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153728425|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728426|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153728427|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153728428|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153728429|NCT00498901|Letrozole|letrozole|mesh-list
153728430|NCT00498901|Leuprolide|leuprolide|mesh-list
153728431|NCT00498901|Goserelin|goserelin|mesh-list
153728432|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728433|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153728434|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153868414|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
153868415|NCT01138657|Hormones|hormones|mesh-ancestor
153728435|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728453|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728454|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
153728455|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728456|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153728457|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
153728458|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728459|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153728460|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
153728461|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
153728462|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
153728463|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153728464|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153728465|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
153728466|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153728467|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
153728469|NCT01245205|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728470|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728482|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728483|NCT00405717|Atorvastatin|atorvastatin|mesh-list
153728484|NCT00405717|Pravastatin|pravastatin|mesh-list
153728486|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153859524|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859525|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859526|NCT01183390|Anastrozole|anastrozole|mesh-list
153859527|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153859528|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859529|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153859530|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153859531|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728673|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728696|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153728697|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153728698|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728699|NCT00500422|Gemcitabine|gemcitabine|mesh-list
153728700|NCT00500422|Doxorubicin|doxorubicin|mesh-list
153728701|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153728702|NCT00500422|Bortezomib|bortezomib|mesh-list
153728703|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153728704|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
153728705|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736139|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
153728706|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728707|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153728708|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153728709|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153728710|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728711|NCT01245946|Doxycycline|doxycycline|mesh-list
153728712|NCT01245946|Adapalene|adapalene|mesh-list
153728713|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728714|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728715|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
153728716|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153728720|NCT01245946|Analgesics|analgesics|mesh-ancestor
153728761|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153728762|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153728763|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153728764|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153728765|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153728766|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
153728980|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728981|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728982|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729012|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729013|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153729014|NCT00147615|Diuretics|diuretics|mesh-ancestor
153868450|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729017|NCT05561036|Doxorubicin|doxorubicin|mesh-list
153729197|NCT01248403|Paclitaxel|paclitaxel|mesh-list
153729198|NCT01248403|Everolimus|everolimus|mesh-list
153729220|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729221|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729222|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153729223|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729224|NCT01249339|Lobeline|lobeline|mesh-list
153729225|NCT01249339|Nicotine|nicotine|mesh-list
153729226|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153729329|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153729330|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153729331|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
153729332|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
153729333|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153729334|NCT00504283|Morphine|morphine|mesh-list
153729335|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153729336|NCT00504283|Narcotics|narcotics|mesh-ancestor
153729337|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153729338|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729339|NCT00504283|Analgesics|analgesics|mesh-ancestor
153729340|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
153729341|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729342|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153729343|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153729344|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729345|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729346|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153729347|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729400|NCT00403325|Ranibizumab|ranibizumab|mesh-list
153729401|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153729402|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729403|NCT00403325|Growth Substances|growth substances|mesh-ancestor
153729404|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729405|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729406|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729407|NCT04725747|Midazolam|midazolam|mesh-list
153729408|NCT04725747|Ketamine|ketamine|mesh-list
153729409|NCT04725747|Analgesics|analgesics|mesh-ancestor
153729410|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
153729411|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729412|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729413|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153729414|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153729415|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
153729448|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153729449|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729450|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153729451|NCT03890952|Bevacizumab|bevacizumab|mesh-list
153729452|NCT03890952|Nivolumab|nivolumab|mesh-list
153729453|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
153729578|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729579|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153729580|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
153729581|NCT00139386|Candesartan|candesartan|mesh-list
153729582|NCT00139386|Candesartan cilexetil|candesartan cilexetil|mesh-list
153729583|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153729584|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153729619|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783979|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783980|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
153783981|NCT04543123|Escitalopram|escitalopram|mesh-list
153783983|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153784136|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153784137|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
153784172|NCT00237731|Narcotics|narcotics|mesh-ancestor
153784173|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784174|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400010|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153784395|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
153784396|NCT02216227|Trace Elements|trace elements|mesh-ancestor
153784397|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
153784506|NCT00238667|Dipyridamole|dipyridamole|mesh-list
153784507|NCT00238667|Warfarin|warfarin|mesh-list
153784518|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153784519|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153784520|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784521|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153784522|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153784523|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784524|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
153784639|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784640|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153784641|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
153784642|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784827|NCT05815758|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153784861|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
153784862|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784863|NCT05669079|Hematinics|hematinics|mesh-ancestor
153785036|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785037|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153785038|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153785039|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785041|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785043|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
153785044|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785045|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785046|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785047|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
153785048|NCT03598426|Hormones|hormones|mesh-ancestor
153785148|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785150|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153785186|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785187|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
153785188|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785224|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153785225|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153785226|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153785261|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785262|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785264|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785287|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785288|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153785289|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785290|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
153785291|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
153785292|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785293|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785294|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
153785295|NCT02217163|Hormones|hormones|mesh-ancestor
153785296|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785297|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153785298|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153785299|NCT02217202|Laxatives|laxatives|mesh-ancestor
153785300|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785301|NCT00239174|Surinabant|surinabant|mesh-list
153785302|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153785337|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785338|NCT04531072|Ritonavir|ritonavir|mesh-list
153785339|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153785340|NCT04531072|Lumefantrine|lumefantrine|mesh-list
153785341|NCT04531072|Artemether|artemether|mesh-list
153409031|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409032|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153409033|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153409034|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
153409035|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785342|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153785343|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153785344|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153785345|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
153785346|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785347|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785349|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153785350|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
153785477|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153785478|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785480|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153785481|NCT02218021|Narcotics|narcotics|mesh-ancestor
153785482|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785483|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785484|NCT02218021|Analgesics|analgesics|mesh-ancestor
153785485|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
153785486|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785487|NCT00239369|Telmisartan|telmisartan|mesh-list
153785488|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153785489|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153785490|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153785493|NCT00239369|Diuretics|diuretics|mesh-ancestor
153785688|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153785689|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153785690|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785691|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
153785692|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
153785693|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
153785694|NCT01644955|Carboplatin|carboplatin|mesh-list
153785695|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785696|NCT01644994|Cisplatin|cisplatin|mesh-list
153785697|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785698|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
153785699|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153785700|NCT04528888|Heparin|heparin|mesh-list
153785701|NCT04528888|Enoxaparin|enoxaparin|mesh-list
153785702|NCT04528888|Calcium heparin|calcium heparin|mesh-list
153785703|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785704|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
153785705|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
153785706|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785707|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785708|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785750|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153785751|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
153785752|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785753|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785754|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785770|NCT01646281|Flecainide|flecainide|mesh-list
153785900|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
153785901|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153785902|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
153785903|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785904|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
153785905|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
153785906|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785907|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785908|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785910|NCT01647685|Hormones|hormones|mesh-ancestor
153786113|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786114|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153786115|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
153786116|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153786117|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153786118|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153786119|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
153859969|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153859970|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859971|NCT00540137|Ritonavir|ritonavir|mesh-list
153859972|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153859973|NCT00540137|Nevirapine|nevirapine|mesh-list
153859974|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153786290|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786291|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153786293|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153786294|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153736159|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153736160|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
153736161|NCT03651271|Nivolumab|nivolumab|mesh-list
153786295|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153786296|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153786297|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786298|NCT00241007|Diuretics|diuretics|mesh-ancestor
153786299|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
153786300|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786301|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153786302|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786303|NCT01689142|Insulin|insulin|mesh-list
153786304|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153332752|NCT04198948|Gliclazide|gliclazide|mesh-list
153786305|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
153786306|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153786307|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786308|NCT00241046|Letrozole|letrozole|mesh-list
153786309|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786340|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153786341|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153786342|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153859975|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153592842|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153592843|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153592844|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153592845|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592846|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153592847|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592880|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786343|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786344|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153786346|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868565|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786347|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153786450|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786452|NCT02219152|Coagulants|coagulants|mesh-ancestor
153786453|NCT00264615|Lamotrigine|lamotrigine|mesh-list
153786454|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
153332899|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
153786455|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153786738|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786739|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786740|NCT00242879|Ritonavir|ritonavir|mesh-list
153786848|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153786850|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786981|NCT00244166|Hormones|hormones|mesh-ancestor
153786983|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787090|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
153787091|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153787093|NCT00244517|Analgesics|analgesics|mesh-ancestor
153787094|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
153787095|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787096|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
153787097|NCT00274092|Ipratropium|ipratropium|mesh-list
153787098|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153787099|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
153787100|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787101|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787102|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153787103|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
153787104|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
153787159|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153787160|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787161|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153787162|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153787163|NCT00244907|Protective Agents|protective agents|mesh-ancestor
153787290|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787291|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153787292|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
153787293|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
153787294|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153787295|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
153787296|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400488|NCT00374699|Bortezomib|bortezomib|mesh-list
153787373|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153787374|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153787375|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153787376|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787378|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
153787452|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
153787453|NCT00284271|Vincristine|vincristine|mesh-list
153787454|NCT00284271|Bleomycin|bleomycin|mesh-list
153787455|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
153787456|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787545|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153787546|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153787621|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787622|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153787623|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
153787814|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153409123|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
153409124|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153409125|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153409126|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409127|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787815|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787845|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787846|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787848|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
153787849|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787855|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
153788026|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788027|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788028|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788060|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788061|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788062|NCT00279045|Metformin|metformin|mesh-list
153788063|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
153788064|NCT00279045|Glyburide|glyburide|mesh-list
153788065|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153788066|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788067|NCT00249353|Methylphenidate|methylphenidate|mesh-list
153788197|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788198|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153788199|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153788200|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788201|NCT00250094|Topotecan|topotecan|mesh-list
153788202|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153788203|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153788204|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334847|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
153788305|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
153788306|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153788307|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153788308|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153788309|NCT00250796|Growth Substances|growth substances|mesh-ancestor
153788310|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
153788311|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788312|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153788313|NCT00286416|Omalizumab|omalizumab|mesh-list
153788314|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153788315|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153788345|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153788346|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153788347|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153788353|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
153788468|NCT01640782|Irinotecan|irinotecan|mesh-list
153788469|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
153788470|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788471|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788472|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
153788473|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
153788474|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788646|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
153400671|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400672|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400673|NCT02050334|Caffeic acid|caffeic acid|mesh-list
153400674|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
153400675|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400676|NCT02050334|Protective Agents|protective agents|mesh-ancestor
153400677|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400678|NCT02371850|Nicotine|nicotine|mesh-list
153788849|NCT00280878|Vinorelbine|vinorelbine|mesh-list
153788850|NCT00280878|Ifosfamide|ifosfamide|mesh-list
153788851|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153788852|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788853|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
153788854|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788855|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153788856|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788857|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
153788858|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788859|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153788860|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788861|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
153788862|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
153788863|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153788864|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
153788865|NCT00287313|Vitamin K|vitamin k|mesh-list
153788866|NCT00287313|Vitamins|vitamins|mesh-ancestor
153788867|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
153788868|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788869|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153788870|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153788871|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788872|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
153788873|NCT00287313|Coagulants|coagulants|mesh-ancestor
153788874|NCT01680250|Sirolimus|sirolimus|mesh-list
153788875|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153788876|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788877|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153788878|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788909|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153788910|NCT00280995|Mipomersen|mipomersen|mesh-list
153788911|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153788912|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153788913|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
153788914|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788915|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153592881|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860388|NCT00543608|Iclaprim|iclaprim|mesh-list
153788916|NCT05139667|Tacrolimus|tacrolimus|mesh-list
153788917|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788918|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
153788919|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788920|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153788921|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788922|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788958|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788959|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788961|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788962|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153788963|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789031|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153789032|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
153789033|NCT01680796|Hormones|hormones|mesh-ancestor
153789034|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789035|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153789036|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789037|NCT00252785|Budesonide|budesonide|mesh-list
153789038|NCT00252785|Theophylline|theophylline|mesh-list
153789039|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
153789040|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153789041|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153789042|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
153592882|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153592883|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153592884|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
153592885|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153592886|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
153592887|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153592888|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153592889|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592890|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592891|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153592892|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153592893|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
153592894|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153592895|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153592896|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592897|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153592898|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153592900|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
153592901|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
153592902|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592903|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592904|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
153592905|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789043|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789044|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789045|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153789046|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
153789047|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
153789048|NCT00252785|Hormones|hormones|mesh-ancestor
153789072|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789073|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335544|NCT04280406|Azithromycin|azithromycin|mesh-list
153789074|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153789075|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789076|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153789077|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
153789078|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153789079|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789080|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
153789081|NCT00252824|Budesonide|budesonide|mesh-list
153789082|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
153789083|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153789084|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153789085|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
153789187|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153789188|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
153789189|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789190|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789191|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153789192|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153789193|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
153789195|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153789196|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
153789197|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153335765|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789227|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153789230|NCT01683175|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153789231|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789232|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789233|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789234|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789235|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153789236|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
153789237|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
153789238|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789239|NCT01683253|Dopamine|dopamine|mesh-list
153789240|NCT01683253|Levodopa|levodopa|mesh-list
153789241|NCT01683253|Carbidopa|carbidopa|mesh-list
153789242|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
153789243|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153868686|NCT05204134|Insulin|insulin|mesh-list
153868687|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153868688|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868689|NCT05181436|Chrysarobin|chrysarobin|mesh-list
153868690|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868691|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153868692|NCT05181436|Analgesics|analgesics|mesh-ancestor
153868693|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
153868694|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868695|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868696|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409216|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
153789244|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153789245|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
153789270|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
153789271|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
153789272|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789273|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789274|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789275|NCT01683682|Carboplatin|carboplatin|mesh-list
153789276|NCT01683682|Vinorelbine|vinorelbine|mesh-list
153592906|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153592907|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153592908|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153400771|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789278|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789279|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153789280|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
153789281|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
153789282|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789283|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789284|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789285|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789286|NCT00287742|Risperidone|risperidone|mesh-list
153789287|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153789288|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
153789289|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789290|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789291|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789292|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153789293|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789324|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789325|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153789326|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789327|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592909|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592910|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592911|NCT01834820|Dexamethasone|dexamethasone|mesh-list
153592912|NCT01834820|Epinephrine|epinephrine|mesh-list
153592913|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153592914|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
153592915|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
153592916|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592917|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592918|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592919|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
153592920|NCT01834820|Hormones|hormones|mesh-ancestor
153592921|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592922|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153592923|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592924|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153592935|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153592937|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153592938|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592940|NCT01835418|Amlodipine|amlodipine|mesh-list
153592941|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153592942|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153592943|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592944|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592945|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153868721|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153868722|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153868725|NCT04674137|Histamine|histamine|mesh-list
153592946|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592947|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
153592948|NCT01835678|Linagliptin|linagliptin|mesh-list
153592949|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153860465|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153789328|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789329|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153789330|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
153789331|NCT01684306|Modafinil|modafinil|mesh-list
153736199|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153789332|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153789333|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789334|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153789335|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153789336|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153789363|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789364|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789365|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789366|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
153789367|NCT00416910|Fludarabine|fludarabine|mesh-list
153789368|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
153789369|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789370|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
153789371|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789372|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153789373|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153789374|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
153789375|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789377|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153789378|NCT00416910|Analgesics|analgesics|mesh-ancestor
153789379|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
153860466|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
153592950|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592951|NCT01835678|Incretins|incretins|mesh-ancestor
153592952|NCT01835678|Hormones|hormones|mesh-ancestor
153592953|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153592954|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153592955|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
153592956|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592957|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592959|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
153592960|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
153592961|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592962|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592963|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
153592964|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153592965|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153592966|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153888863|NCT01049503|Fluorides|fluorides|mesh-list
153868770|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868771|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153868772|NCT00587379|Atorvastatin|atorvastatin|mesh-list
153868773|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153868774|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153868775|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
153868776|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868777|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153592967|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153789380|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789381|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153789382|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153789383|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789384|NCT01684774|Bupivacaine|bupivacaine|mesh-list
153789385|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
153789440|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153789441|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789442|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789443|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789444|NCT01684969|Haloperidol|haloperidol|mesh-list
153789445|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
153789446|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
153789447|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
153789448|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335914|NCT05491902|Flutemetamol|flutemetamol|mesh-list
153789449|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789450|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153789451|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153789452|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789453|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789454|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789455|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153789456|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
153789457|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789458|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789459|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153592968|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153592969|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592970|NCT01837251|Bevacizumab|bevacizumab|mesh-list
153592971|NCT01837251|Carboplatin|carboplatin|mesh-list
153592972|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153592973|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153592974|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153592975|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153592976|NCT01837251|Growth Substances|growth substances|mesh-ancestor
153592977|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592978|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
153592980|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
153592981|NCT01837290|Bupivacaine|bupivacaine|mesh-list
153592982|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
153592983|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
153592984|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153592985|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592986|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
153592987|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400814|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400815|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400816|NCT03152591|Licogliflozin|licogliflozin|mesh-list
153400817|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153860499|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153860500|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789460|NCT01685125|Prednisone|prednisone|mesh-list
153789461|NCT01685125|Dasatinib|dasatinib|mesh-list
153789462|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
153409323|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153409324|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153409325|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868781|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868783|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868789|NCT00196326|Estradiol|estradiol|mesh-list
153789463|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153789464|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
153789465|NCT01685125|Hormones|hormones|mesh-ancestor
153789466|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789467|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789468|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153789469|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789470|NCT01685125|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153789471|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789472|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789473|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789474|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153789475|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
153789476|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153789511|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789512|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860508|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860509|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153860510|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
153860511|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153860512|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153789559|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
153789560|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789561|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789562|NCT01686217|Niacinamide|niacinamide|mesh-list
153789596|NCT01686607|Clotrimazole|clotrimazole|mesh-list
153789598|NCT01686607|Anidulafungin|anidulafungin|mesh-list
153789599|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789600|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153789601|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153789602|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789603|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789604|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153789605|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
153789620|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789621|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789622|NCT01686802|Analgesics|analgesics|mesh-ancestor
153789623|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
153789624|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789625|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868817|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
153868818|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
153868819|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868820|NCT00195663|Adalimumab|adalimumab|mesh-list
153868821|NCT00195663|Methotrexate|methotrexate|mesh-list
153409351|NCT02896712|Modafinil|modafinil|mesh-list
153789626|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153789627|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153789645|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153789646|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
153789647|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789648|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789649|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
153789650|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789651|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
153789652|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789653|NCT02274571|Estrogens|estrogens|mesh-list
153789654|NCT02274571|Hormones|hormones|mesh-ancestor
153789655|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789656|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789657|NCT00253799|Hylan|hylan|mesh-list
153736205|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736206|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
153789658|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
153789659|NCT00253799|Protective Agents|protective agents|mesh-ancestor
153789660|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789661|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
153789662|NCT00281931|Rituximab|rituximab|mesh-list
153789663|NCT00281931|Fludarabine|fludarabine|mesh-list
153789664|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
153789665|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789700|NCT01687582|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153789701|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153789736|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153789737|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153789738|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
153789781|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860535|NCT00544349|Leucovorin|leucovorin|mesh-list
153400830|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153400831|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400832|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
153400833|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153400834|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
153400835|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789782|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153789783|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153789784|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153789785|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789786|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789787|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789788|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153789789|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153789790|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153789791|NCT00288249|Sagopilone|sagopilone|mesh-list
153789792|NCT00288249|Epothilones|epothilones|mesh-list
153789822|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789824|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153789825|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789826|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153789827|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
153789828|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789829|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789830|NCT00288444|Docetaxel|docetaxel|mesh-list
153789831|NCT00288444|Lonafarnib|lonafarnib|mesh-list
153789832|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409352|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153409353|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409354|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153409355|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153409356|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153860536|NCT00544349|Fluorouracil|fluorouracil|mesh-list
153860537|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
153860538|NCT00544349|Cetuximab|cetuximab|mesh-list
153860539|NCT00544349|Calcium|calcium|mesh-list
153860540|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
153860541|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153860542|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860543|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
153860544|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860545|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153860546|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789878|NCT00417729|Glyburide|glyburide|mesh-list
153789897|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153736207|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
153736208|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789899|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153789900|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153789901|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
153789902|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789903|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789904|NCT01600807|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153789905|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789906|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789907|NCT00288483|Policosanol|policosanol|mesh-list
153789908|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153789909|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153789910|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
153789911|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789912|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153789913|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153789914|NCT01600963|Bedaquiline|bedaquiline|mesh-list
153789915|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
153789916|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
153789917|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153592988|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153592989|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153818503|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153818504|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
153818505|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153818506|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
153789918|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789919|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153789920|NCT00288522|Lanreotide|lanreotide|mesh-list
153789921|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789922|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
153789923|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789924|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789925|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789926|NCT01601002|Mirtazapine|mirtazapine|mesh-list
153810985|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153357544|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153868858|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
153868859|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153868860|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868861|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153868862|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
153868863|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409374|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153409375|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
153409376|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153789927|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
153789928|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789929|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153789955|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153789956|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153789957|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789958|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153789959|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789960|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153789961|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789962|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789963|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789964|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153789966|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
153789967|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789968|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153789969|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789970|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789971|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860551|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
153818507|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818508|NCT04494412|Zanamivir|zanamivir|mesh-list
153818509|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
153592998|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153592999|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153593000|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153593001|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153593002|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
153593003|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
153593004|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
153593005|NCT01837433|Prednisone|prednisone|mesh-list
153593006|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
153593007|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153593008|NCT01837433|Hormones|hormones|mesh-ancestor
153593009|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593010|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400877|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
153400878|NCT02049476|Dexamethasone|dexamethasone|mesh-list
153400879|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400880|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
153400881|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
153400882|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400883|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789972|NCT01607125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153789973|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153789974|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153789996|NCT00288717|Telmisartan|telmisartan|mesh-list
153789997|NCT00288717|Candesartan|candesartan|mesh-list
153789998|NCT00288717|Candesartan cilexetil|candesartan cilexetil|mesh-list
153789999|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153790000|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153790001|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153790002|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790003|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
153790004|NCT01601314|Analgesics|analgesics|mesh-ancestor
153790005|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
153790006|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790007|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790008|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
153790009|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790010|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153790011|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
153790012|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153790013|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153790015|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153790016|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
153790017|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153400886|NCT02049476|Hormones|hormones|mesh-ancestor
153593011|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153593012|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593013|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
153868922|NCT00195273|Sirolimus|sirolimus|mesh-list
153593014|NCT01837446|Promethazine|promethazine|mesh-list
153593015|NCT01837446|Lidocaine|lidocaine|mesh-list
153593016|NCT01837446|Morphine|morphine|mesh-list
153593017|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153593018|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
153593019|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
153593020|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
153790018|NCT00254657|Levetiracetam|levetiracetam|mesh-list
153790019|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
153790020|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
153790021|NCT02482753|Exemestane|exemestane|mesh-list
153790022|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790023|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153790024|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153790025|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469172|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153790060|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790061|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153790063|NCT01608139|Analgesics|analgesics|mesh-ancestor
153790064|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
153790100|NCT01608334|Narcotics|narcotics|mesh-ancestor
153790101|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790102|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790103|NCT01608334|Analgesics|analgesics|mesh-ancestor
153790104|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
153790105|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790124|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153790125|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
153790126|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790127|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153790128|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790129|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790130|NCT01608412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153790131|NCT01608412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153790132|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790133|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153790134|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
153790135|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790136|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153790137|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153790138|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790139|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593021|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593022|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818510|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818511|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400904|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
153400905|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
153400906|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
153790140|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
153868923|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
153868924|NCT00195273|Cyclosporins|cyclosporins|mesh-list
153868925|NCT00195273|Daclizumab|daclizumab|mesh-list
153790141|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790142|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153790143|NCT01608841|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153790144|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153790145|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790146|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790147|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790148|NCT00254930|Risperidone|risperidone|mesh-list
153790149|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153790150|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
153790151|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790152|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736209|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736210|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153790188|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790189|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153790190|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790191|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
153790192|NCT01588756|Growth Substances|growth substances|mesh-ancestor
153790193|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790300|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790301|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153790302|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153790303|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790304|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790306|NCT00289419|Epinephrine|epinephrine|mesh-list
153790307|NCT00289419|Racepinephrine|racepinephrine|mesh-list
153790308|NCT00289419|Morphine|morphine|mesh-list
153790309|NCT00289419|Ropivacaine|ropivacaine|mesh-list
153790310|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
153790311|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153790312|NCT00289419|Narcotics|narcotics|mesh-ancestor
153860610|NCT05824390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860611|NCT05824390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860612|NCT05824390|Immunologic Factors|immunologic factors|mesh-ancestor
153860613|NCT05824390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860614|NCT05824390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790322|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790323|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790324|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153790325|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790347|NCT00270348|Ciclesonide|ciclesonide|mesh-list
153790348|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
153790350|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153790351|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790352|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153790354|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153790355|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790356|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
153790357|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790358|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790359|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153790360|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
153790361|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790362|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
153790363|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
153790364|NCT00255710|Fludarabine|fludarabine|mesh-list
153790365|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
153790366|NCT00255710|Tacrolimus|tacrolimus|mesh-list
153810986|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357545|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
153868957|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868958|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
153409497|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790367|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153790368|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
153790369|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818512|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818513|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
153459900|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459901|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459902|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153459903|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459904|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
153459905|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153459906|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459907|NCT05432778|Letermovir|letermovir|mesh-list
153459908|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153459909|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790370|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790371|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153790372|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
153790373|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790374|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790375|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153790376|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153790407|NCT00270543|Protective Agents|protective agents|mesh-ancestor
153790408|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
153790409|NCT00270543|Vitamins|vitamins|mesh-ancestor
153790410|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
153336887|NCT00000802|Dapsone|dapsone|mesh-list
153790411|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790412|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
153790413|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
153790414|NCT02960919|Amoxicillin|amoxicillin|mesh-list
153790415|NCT02960919|Gentamicins|gentamicins|mesh-list
153790416|NCT02960919|Penicillins|penicillins|mesh-list
153790417|NCT02960919|Ampicillin|ampicillin|mesh-list
153790418|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153790419|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790420|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153790421|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790422|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790423|NCT00270582|Gemcitabine|gemcitabine|mesh-list
153790456|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153790457|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153790458|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153790459|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153790460|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
153790461|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790462|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
153860619|NCT05824156|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
153860620|NCT05824156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860621|NCT05823883|Metformin|metformin|mesh-list
153860622|NCT05823883|Empagliflozin|empagliflozin|mesh-list
153860623|NCT05823883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153860624|NCT05823883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860625|NCT05823883|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153860627|NCT05823870|Metformin|metformin|mesh-list
153790542|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790543|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790576|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
153790577|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153790578|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790579|NCT00290082|Midazolam|midazolam|mesh-list
153790580|NCT00290082|Loxapine|loxapine|mesh-list
153790581|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153790582|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153790583|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790584|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790585|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153790613|NCT02270437|Narcotics|narcotics|mesh-ancestor
153790614|NCT02270437|Analgesics|analgesics|mesh-ancestor
153790615|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153790616|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153790617|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
153790618|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153790619|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153790620|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
153790621|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790622|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790623|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153790624|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153790625|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
153790626|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153790627|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
153790633|NCT02270749|Vitamins|vitamins|mesh-ancestor
153400940|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
153400941|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400942|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400943|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400945|NCT03170219|Diuretics|diuretics|mesh-ancestor
153400946|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
153400947|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400948|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153400949|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153790634|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
153790635|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790636|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
153790637|NCT02270749|Hematinics|hematinics|mesh-ancestor
153790638|NCT02270788|Leucovorin|leucovorin|mesh-list
153790673|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790674|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790675|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153790676|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
153790677|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153790678|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153790679|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790680|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790706|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
153790707|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790708|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153790709|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153790710|NCT02271139|Alectinib|alectinib|mesh-list
153790711|NCT02271139|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153790712|NCT02271139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153790713|NCT02271139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790714|NCT02271139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431021|NCT00000781|Nevirapine|nevirapine|mesh-list
153790715|NCT02271295|Enoxaparin|enoxaparin|mesh-list
153860629|NCT05823870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153860630|NCT05823870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860631|NCT05823870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153860632|NCT05823870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790719|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790720|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153790721|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153790722|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153790723|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153790724|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790725|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790726|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790727|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
153790728|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790763|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790764|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153790765|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153790789|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790790|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153790791|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790792|NCT02272387|Vitamin D|vitamin d|mesh-list
153790793|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
153790794|NCT02272387|Vitamins|vitamins|mesh-ancestor
153790795|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
153790796|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790797|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153790798|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153790799|NCT00257114|Bortezomib|bortezomib|mesh-list
153790800|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790801|NCT00271206|Progesterone|progesterone|mesh-list
153459910|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459911|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459912|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
153459913|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459914|NCT05391828|Cimetidine|cimetidine|mesh-list
153593027|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153593028|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593029|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790803|NCT00271206|Hormones|hormones|mesh-ancestor
153790804|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153790805|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790806|NCT02272582|Heparin|heparin|mesh-list
153790807|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
153790808|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153790809|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153790810|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790811|NCT02272660|Parecoxib|parecoxib|mesh-list
153790812|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153790813|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153790814|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790837|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790839|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
153790840|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
153790841|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790842|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153790843|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
153790844|NCT00271245|Selenium|selenium|mesh-list
153790845|NCT00271245|Selenic Acid|selenic acid|mesh-list
153790846|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
153790847|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593030|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153593031|NCT01837446|Narcotics|narcotics|mesh-ancestor
153593032|NCT01837446|Analgesics|analgesics|mesh-ancestor
153593033|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153593034|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153593035|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
153593036|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
153593037|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593038|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153593039|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
153593040|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
153593041|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593042|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153593043|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
153593044|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
153593045|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153593046|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
153593048|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153593049|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153593050|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153593051|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153593052|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593053|NCT01839344|Acarbose|acarbose|mesh-list
153593054|NCT01839344|Quercetin|quercetin|mesh-list
153593055|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153593056|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593057|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593058|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153860657|NCT05822713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153860658|NCT05822713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153860659|NCT05822713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860660|NCT05822713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153860661|NCT05822713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153860662|NCT05822713|Dopamine Agents|dopamine agents|mesh-ancestor
153860663|NCT05822713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860664|NCT05822713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860665|NCT05822713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153860666|NCT05822713|Antidepressive Agents|antidepressive agents|mesh-ancestor
153860667|NCT05822674|Metformin|metformin|mesh-list
153860668|NCT05822674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153860669|NCT05822674|Empagliflozin|empagliflozin|mesh-list
153860670|NCT05822674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153860671|NCT05822674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736220|NCT03472092|Analgesics|analgesics|mesh-ancestor
153736221|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
153400985|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400986|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400987|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153400989|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153400990|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400991|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153400992|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153400993|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153790973|NCT01602289|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153790974|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860672|NCT05822674|Incretins|incretins|mesh-ancestor
153860673|NCT05822674|Hormones|hormones|mesh-ancestor
153860675|NCT05822674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153791006|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
153791007|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791008|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791009|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153337484|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153791044|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
153791045|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791046|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791047|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
153791048|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791049|NCT01602640|Midazolam|midazolam|mesh-list
153791076|NCT00290667|Vincristine|vincristine|mesh-list
153791077|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153791078|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
153791079|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791080|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791081|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153791082|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
153791083|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791084|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791085|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153337558|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
153791086|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153791087|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153791088|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153791089|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153791090|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791091|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153791092|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
153593059|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593060|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
153593061|NCT01839344|Protective Agents|protective agents|mesh-ancestor
153593062|NCT01839578|Heparin|heparin|mesh-list
153593063|NCT01839578|Calcium heparin|calcium heparin|mesh-list
153593064|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
153593065|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593066|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153593067|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153593068|NCT01839994|Androgens|androgens|mesh-list
153400996|NCT03086213|Lidocaine|lidocaine|mesh-list
153400997|NCT03086213|Sufentanil|sufentanil|mesh-list
153400998|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
153400999|NCT03086213|Dsuvia|dsuvia|mesh-list
153401000|NCT03086213|Ropivacaine|ropivacaine|mesh-list
153401001|NCT03086213|Propofol|propofol|mesh-list
153401002|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
153401003|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
153401004|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401005|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401006|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
153401007|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401008|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153401009|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153791094|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791095|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791096|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153791097|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
153791098|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
153860697|NCT05780567|Tamoxifen|tamoxifen|mesh-list
153860698|NCT05780567|Letrozole|letrozole|mesh-list
153860699|NCT05780567|Anastrozole|anastrozole|mesh-list
153860700|NCT05780567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810989|NCT00353028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153860701|NCT05780567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153860702|NCT05780567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153860703|NCT05780567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860704|NCT05780567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860705|NCT05780567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153860706|NCT05780567|Hormone Antagonists|hormone antagonists|mesh-ancestor
153860707|NCT05780567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860708|NCT05780567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860709|NCT05780567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791259|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791260|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153791261|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791262|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153791263|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153791264|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791265|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153791266|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153791267|NCT01603498|Dexamethasone|dexamethasone|mesh-list
153791268|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
153791298|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791299|NCT06302569|Pembrolizumab|pembrolizumab|mesh-list
153791300|NCT06302569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401014|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153401016|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153401017|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153401019|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
153401020|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401021|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153401022|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
153401023|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153401024|NCT03086213|Narcotics|narcotics|mesh-ancestor
153401025|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153401026|NCT02378714|Varenicline|varenicline|mesh-list
153401027|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153401028|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153401029|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
153791352|NCT06302218|Sensory System Agents|sensory system agents|mesh-ancestor
153791353|NCT06302218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791354|NCT06302062|Cyclophosphamide|cyclophosphamide|mesh-list
153791355|NCT06302062|Interleukin-2|interleukin-2|mesh-list
153791356|NCT06302062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153791357|NCT06302062|Immunologic Factors|immunologic factors|mesh-ancestor
153791390|NCT06301828|Growth Substances|growth substances|mesh-ancestor
153860711|NCT05780567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153860712|NCT05780567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153860713|NCT05751629|Bevacizumab|bevacizumab|mesh-list
153860714|NCT05751629|Niraparib|niraparib|mesh-list
153860715|NCT05751629|Dostarlimab|dostarlimab|mesh-list
153791510|NCT06301061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153791511|NCT06301061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153791512|NCT06301061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791513|NCT06301061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153791514|NCT06301061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153791515|NCT06301061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153791516|NCT06301061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791517|NCT06301061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153791518|NCT06301061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153791519|NCT06301061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153791520|NCT06301061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791560|NCT06300489|Antimetabolites|antimetabolites|mesh-ancestor
153791561|NCT06300489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791570|NCT06300346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791572|NCT06300346|Anesthetics, General|anesthetics, general|mesh-ancestor
153791573|NCT06300346|Anesthetics|anesthetics|mesh-ancestor
153791574|NCT06300346|Analgesics|analgesics|mesh-ancestor
153791575|NCT06300346|Sensory System Agents|sensory system agents|mesh-ancestor
153791576|NCT06300346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791577|NCT06300346|Anticonvulsants|anticonvulsants|mesh-ancestor
153791578|NCT06300346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153791579|NCT06300346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153791580|NCT06300346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791581|NCT06300346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153791582|NCT06300346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153791583|NCT06300346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153791584|NCT06300346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153860716|NCT05751629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153593069|NCT01839994|Hormones|hormones|mesh-ancestor
153401041|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153401042|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153401043|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153401044|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153401045|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
153401046|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791585|NCT06300333|Methotrexate|methotrexate|mesh-list
153791586|NCT06300333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153791587|NCT06300333|Abortifacient Agents|abortifacient agents|mesh-ancestor
153791588|NCT06300333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153791589|NCT06300333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791590|NCT06300333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153791591|NCT06300333|Antimetabolites|antimetabolites|mesh-ancestor
153791594|NCT06300333|Dermatologic Agents|dermatologic agents|mesh-ancestor
153860734|NCT05728294|Sensory System Agents|sensory system agents|mesh-ancestor
153860735|NCT05728294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860737|NCT05704829|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153860738|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860739|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860740|NCT05704829|Immunoconjugates|immunoconjugates|mesh-ancestor
153860741|NCT05704829|Immunologic Factors|immunologic factors|mesh-ancestor
153860742|NCT05704829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860743|NCT05564221|Omalizumab|omalizumab|mesh-list
153860744|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153401049|NCT02065687|Metformin|metformin|mesh-list
153791658|NCT06299670|Leprostatic Agents|leprostatic agents|mesh-ancestor
153791659|NCT06299670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153791660|NCT06299670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791661|NCT06299670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153791662|NCT06299670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153791663|NCT06299670|Growth Substances|growth substances|mesh-ancestor
153791664|NCT06299670|Growth Inhibitors|growth inhibitors|mesh-ancestor
153791665|NCT06299670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791666|NCT06299670|Antisickling Agents|antisickling agents|mesh-ancestor
153401073|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401074|NCT04736927|Midazolam|midazolam|mesh-list
153401075|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153401076|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153860746|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
153860747|NCT05431179|Ibrutinib|ibrutinib|mesh-list
153791725|NCT06293807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469173|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
153791741|NCT06293807|Respiratory System Agents|respiratory system agents|mesh-ancestor
153791742|NCT06293807|Mydriatics|mydriatics|mesh-ancestor
153791743|NCT06293807|Sympathomimetics|sympathomimetics|mesh-ancestor
153791744|NCT06293807|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153791746|NCT06293287|Enoxaparin sodium|enoxaparin sodium|mesh-list
153791747|NCT06293287|Anticoagulants|anticoagulants|mesh-ancestor
153791748|NCT06293287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153791749|NCT06293287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153791750|NCT06293287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791752|NCT06290050|Midazolam|midazolam|mesh-list
153791753|NCT06290050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153791771|NCT06285409|Carboprost tromethamine|carboprost tromethamine|mesh-list
153791773|NCT06285409|Oxytocics|oxytocics|mesh-ancestor
153791774|NCT06285409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153791775|NCT06285409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791776|NCT06285409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153791777|NCT06285409|Abortifacient Agents|abortifacient agents|mesh-ancestor
153791778|NCT06279234|Midazolam|midazolam|mesh-list
153791779|NCT06279234|Omeprazole|omeprazole|mesh-list
153791780|NCT06279234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153791781|NCT06279234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153791782|NCT06279234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153791783|NCT06279234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791784|NCT06279234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791785|NCT06279234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153791786|NCT06279234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153791812|NCT06239467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153791814|NCT06239467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791815|NCT06239467|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153791816|NCT06239467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153791817|NCT06239467|Hormone Antagonists|hormone antagonists|mesh-ancestor
153791818|NCT06239467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791819|NCT06239467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791820|NCT06237101|Remifentanil|remifentanil|mesh-list
153791821|NCT06237101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153791822|NCT06237101|Narcotics|narcotics|mesh-ancestor
153791823|NCT06237101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153338309|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791824|NCT06237101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791825|NCT06237101|Analgesics|analgesics|mesh-ancestor
153338310|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153791826|NCT06237101|Sensory System Agents|sensory system agents|mesh-ancestor
153338384|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153791827|NCT06237101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791829|NCT06218303|Anastrozole|anastrozole|mesh-list
153791830|NCT06218303|Exemestane|exemestane|mesh-list
153593070|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401087|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401088|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401089|NCT03810703|Amphetamine|amphetamine|mesh-list
153401090|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
153401091|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153401092|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401093|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
153791831|NCT06218303|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153791832|NCT06218303|Poly ICLC|poly iclc|mesh-list
153791833|NCT06218303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791860|NCT06208410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791861|NCT06208410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791862|NCT06208410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791863|NCT06208410|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153791864|NCT06186037|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153791865|NCT06186037|Ezetimibe|ezetimibe|mesh-list
153791866|NCT06186037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153791867|NCT06186037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153791868|NCT06186037|Antimetabolites|antimetabolites|mesh-ancestor
153791869|NCT06186037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791870|NCT06186037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153791871|NCT06186037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153791872|NCT06186037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791873|NCT06184373|Chrysarobin|chrysarobin|mesh-list
153791874|NCT06184373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153791875|NCT06184373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153791876|NCT06184373|Analgesics|analgesics|mesh-ancestor
153860774|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
153860775|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860776|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860777|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153791913|NCT06162663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791914|NCT06162663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791915|NCT06162663|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153791916|NCT06162663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791917|NCT06162663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791918|NCT06162455|Nitric Oxide|nitric oxide|mesh-list
153791919|NCT06162455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153791920|NCT06162455|Autonomic Agents|autonomic agents|mesh-ancestor
153791945|NCT06152575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791946|NCT06152575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791947|NCT06152575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791948|NCT06152575|Glucocorticoids|glucocorticoids|mesh-ancestor
153791949|NCT06152575|Hormones|hormones|mesh-ancestor
153791950|NCT06152575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791951|NCT06152575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791952|NCT06152575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791953|NCT06152575|Immunologic Factors|immunologic factors|mesh-ancestor
153791954|NCT06152575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153791955|NCT06152575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153791956|NCT06152575|Growth Substances|growth substances|mesh-ancestor
153791957|NCT06152575|Growth Inhibitors|growth inhibitors|mesh-ancestor
153791958|NCT06136598|Dexamethasone|dexamethasone|mesh-list
153791959|NCT06136598|Dexamethasone acetate|dexamethasone acetate|mesh-list
153791960|NCT06136598|Hydrocortisone|hydrocortisone|mesh-list
153791961|NCT06136598|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153791962|NCT06136598|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153791963|NCT06136598|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153860803|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153860804|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401107|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153401108|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401109|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401110|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153401111|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
153338458|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791970|NCT06136598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791971|NCT06136598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153792000|NCT06120491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792001|NCT06120491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792002|NCT06120491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153792003|NCT06119061|Telavancin|telavancin|mesh-list
153792004|NCT06119061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153792005|NCT06119061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792006|NCT06113237|Cannabidiol|cannabidiol|mesh-list
153792007|NCT06113237|Anticonvulsants|anticonvulsants|mesh-ancestor
153792008|NCT06095765|Colchicine|colchicine|mesh-list
153792009|NCT06095765|Gout Suppressants|gout suppressants|mesh-ancestor
153792010|NCT06095765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153792011|NCT06095765|Tubulin Modulators|tubulin modulators|mesh-ancestor
153792012|NCT06095765|Antimitotic Agents|antimitotic agents|mesh-ancestor
153792013|NCT06095765|Mitosis Modulators|mitosis modulators|mesh-ancestor
153792014|NCT06095765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792015|NCT06095765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792016|NCT06045221|Semaglutide|semaglutide|mesh-list
153792050|NCT06012695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792052|NCT06012240|Upadacitinib|upadacitinib|mesh-list
153792053|NCT06012240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153792054|NCT06012240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153792055|NCT06012240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792079|NCT05987644|Alectinib|alectinib|mesh-list
153792080|NCT05987644|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153792081|NCT05987644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153792082|NCT05987644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860805|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
153860806|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
153860807|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860808|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860811|NCT04968899|Hormones|hormones|mesh-ancestor
153792083|NCT05987644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792084|NCT05974774|Ascorbic Acid|ascorbic acid|mesh-list
153869220|NCT00564590|Omeprazole|omeprazole|mesh-list
153792085|NCT05974774|Methyltestosterone|methyltestosterone|mesh-list
153792086|NCT05974774|Androgens|androgens|mesh-list
153792087|NCT05974774|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153792088|NCT05974774|Hormones|hormones|mesh-ancestor
153792089|NCT05974774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792090|NCT05974774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792091|NCT05974774|Antioxidants|antioxidants|mesh-ancestor
153792092|NCT05974774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792093|NCT05974774|Protective Agents|protective agents|mesh-ancestor
153792094|NCT05974774|Vitamins|vitamins|mesh-ancestor
153792095|NCT05974774|Micronutrients|micronutrients|mesh-ancestor
153792096|NCT05974774|Estrogens|estrogens|mesh-ancestor
153792097|NCT05974774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153792098|NCT05974774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792099|NCT05974774|Anabolic Agents|anabolic agents|mesh-ancestor
153792100|NCT05972551|Diphosphonates|diphosphonates|mesh-list
153792101|NCT05972551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153792102|NCT05972551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792103|NCT05955170|Trastuzumab|trastuzumab|mesh-list
153792185|NCT05796167|Serotonin Agents|serotonin agents|mesh-ancestor
153401128|NCT02392208|Telavancin|telavancin|mesh-list
153792186|NCT05796167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792187|NCT05796167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792188|NCT05776875|Bevacizumab|bevacizumab|mesh-list
153792189|NCT05776875|Atezolizumab|atezolizumab|mesh-list
153792190|NCT05776875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792191|NCT05776875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792192|NCT05776875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153792193|NCT05776875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153792194|NCT05776875|Growth Substances|growth substances|mesh-ancestor
153792195|NCT05776875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792231|NCT05756166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792232|NCT05756166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792233|NCT05756166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153792234|NCT05756166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153792235|NCT05756166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153792271|NCT05720988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792273|NCT05720273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153792274|NCT05720273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792275|NCT05720273|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153792276|NCT05720273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153792313|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153792314|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
153792346|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
153792347|NCT05609968|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153792348|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792349|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792350|NCT05609968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153431030|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401129|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593071|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593072|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
153593073|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153593074|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593075|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593086|NCT01840384|Micronutrients|micronutrients|mesh-list
153593087|NCT01840384|Trace Elements|trace elements|mesh-list
153593088|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593089|NCT01840423|Levodopa|levodopa|mesh-list
153593090|NCT01840423|Carbidopa|carbidopa|mesh-list
153593091|NCT01840423|Entacapone|entacapone|mesh-list
153593092|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153860827|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153860828|NCT04873102|Danazol|danazol|mesh-list
153860829|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153860830|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
153860831|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860832|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860833|NCT04860141|Gabapentin|gabapentin|mesh-list
153860834|NCT04860141|Analgesics|analgesics|mesh-ancestor
153860835|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
153860836|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860837|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869248|NCT04605770|Pemetrexed|pemetrexed|mesh-list
153860838|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
153860839|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153860840|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153792351|NCT05609968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792352|NCT05609968|Immunoconjugates|immunoconjugates|mesh-ancestor
153792353|NCT05609968|Immunologic Factors|immunologic factors|mesh-ancestor
153792354|NCT05609968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792355|NCT05599984|Carboplatin|carboplatin|mesh-list
153792356|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792357|NCT05570422|Cisplatin|cisplatin|mesh-list
153792358|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792359|NCT05567458|Luspatercept|luspatercept|mesh-list
153792430|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
153792431|NCT05514405|Propofol|propofol|mesh-list
153792432|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153792433|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792434|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860841|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153860842|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153860843|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153860844|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153792550|NCT05337137|Nivolumab|nivolumab|mesh-list
153792551|NCT05337137|Relatlimab|relatlimab|mesh-list
153792552|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792553|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792554|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153792555|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153792556|NCT05337137|Growth Substances|growth substances|mesh-ancestor
153792557|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792558|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
153792559|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792560|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792589|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792590|NCT05256381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792591|NCT05256381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792592|NCT05213481|Tepotinib|tepotinib|mesh-list
153792593|NCT05213481|Carbamazepine|carbamazepine|mesh-list
153792594|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
153792595|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
153792596|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153792597|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792598|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792599|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153792600|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153792601|NCT05213481|Analgesics|analgesics|mesh-ancestor
153792602|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
153869278|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869279|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869280|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153869281|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153869299|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153869300|NCT00590070|Adenosine|adenosine|mesh-list
153869301|NCT00590070|Nitroprusside|nitroprusside|mesh-list
153869302|NCT00590070|Analgesics|analgesics|mesh-ancestor
153869303|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
153869304|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409826|NCT03822637|Albuterol|albuterol|mesh-list
153409845|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153792603|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792604|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153792605|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153792606|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792607|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153860848|NCT04823156|Calcium|calcium|mesh-list
153593093|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153593094|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
153860855|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
153860856|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
153860857|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860858|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860859|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153860860|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
153860861|NCT04813653|Hormones|hormones|mesh-ancestor
153860862|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860863|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153860864|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792708|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153792709|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153792710|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153792711|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792712|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153792713|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153792714|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153792716|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153401183|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401185|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
153401186|NCT02393378|Vitamins|vitamins|mesh-ancestor
153401187|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
153401188|NCT04949477|Acetaminophen|acetaminophen|mesh-list
153401189|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
153401190|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153792753|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792754|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153792781|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792783|NCT04905563|Narcotics|narcotics|mesh-ancestor
153792784|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792785|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
153792786|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
153792787|NCT04886531|Trastuzumab|trastuzumab|mesh-list
153792788|NCT04886531|Letrozole|letrozole|mesh-list
153792789|NCT04886531|Anastrozole|anastrozole|mesh-list
153792790|NCT04886531|Neratinib|neratinib|mesh-list
153792791|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792792|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792793|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153792794|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153792795|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792796|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792797|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153792798|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
153339290|NCT00002188|Alitretinoin|alitretinoin|mesh-list
153792834|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153792867|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
153792868|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792869|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792870|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153339435|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
153792871|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153792872|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
153401193|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153593095|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860868|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
153860869|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
153860870|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792873|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792899|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153792900|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153792901|NCT04564885|Analgesics|analgesics|mesh-ancestor
153792902|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
153792903|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792904|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792905|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792906|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153792907|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153792908|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153792909|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792910|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792911|NCT04551950|Paclitaxel|paclitaxel|mesh-list
153792912|NCT04551950|Bevacizumab|bevacizumab|mesh-list
153792913|NCT04551950|Carboplatin|carboplatin|mesh-list
153792914|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153792915|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792916|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
153792917|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
153792918|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
153792919|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792920|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792921|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153792949|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
153792950|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
153593096|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593097|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593098|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153593099|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593100|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153593102|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593103|NCT01840683|Heparin|heparin|mesh-list
153593104|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
153593105|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153593108|NCT01840696|Regadenoson|regadenoson|mesh-list
153593133|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593134|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593135|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
153593136|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593137|NCT01840813|Misoprostol|misoprostol|mesh-list
153792951|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
153792952|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792953|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792955|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153792956|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792957|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
153792958|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792959|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792960|NCT04478695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792961|NCT04478695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792962|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
153869351|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153869352|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153869353|NCT00590694|Growth Substances|growth substances|mesh-ancestor
153869354|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869355|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
153409891|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409892|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792963|NCT04420884|Fluorouracil|fluorouracil|mesh-list
153792964|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792965|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792966|NCT04420884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792967|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792968|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
153793001|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793002|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793003|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
153793004|NCT04270409|Hormones|hormones|mesh-ancestor
153793005|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793006|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793007|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793008|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
153793009|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153793010|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153793011|NCT04270409|Growth Substances|growth substances|mesh-ancestor
153793012|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
153793044|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
153793045|NCT04251715|Fluorouracil|fluorouracil|mesh-list
153793046|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
153793047|NCT04251715|Irinotecan|irinotecan|mesh-list
153793048|NCT04251715|Floxuridine|floxuridine|mesh-list
153593138|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153593139|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
153593140|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153593141|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593142|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153593143|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153401233|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
153401234|NCT02069041|Vitamins|vitamins|mesh-ancestor
153401235|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
153401236|NCT02069041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153401237|NCT02069041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153860900|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860901|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860902|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
153793049|NCT04251715|BB 1101|bb 1101|mesh-list
153736234|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153736235|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793050|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
153793051|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793052|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
153793053|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
153793054|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793055|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793056|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793127|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793128|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793129|NCT04151940|Immunomodulating Agents|immunomodulating agents|mesh-list
153793131|NCT04151940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793132|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
153793133|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153793134|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153793135|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793136|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
153793137|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
153793138|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793143|NCT04080895|Lumefantrine|lumefantrine|mesh-list
153793144|NCT04080895|Artemether|artemether|mesh-list
153793145|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153793146|NCT04080895|Amodiaquine|amodiaquine|mesh-list
153793147|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
153793148|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153793149|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153860916|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793151|NCT04076462|Octreotide|octreotide|mesh-list
153793194|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793195|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793196|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793197|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793198|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793199|NCT03917381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153793200|NCT03828201|Levofloxacin|levofloxacin|mesh-list
153793201|NCT03828201|Linezolid|linezolid|mesh-list
153793202|NCT03828201|Bedaquiline|bedaquiline|mesh-list
153793203|NCT03828201|Clofazimine|clofazimine|mesh-list
153793229|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
153793230|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793231|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153793232|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153793233|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793234|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793235|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153793236|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
153793237|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793238|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793239|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153793240|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153793241|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153793242|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153793243|NCT03756896|Dexamethasone|dexamethasone|mesh-list
153793244|NCT03756896|Pomalidomide|pomalidomide|mesh-list
153793245|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153593144|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
153593145|NCT01841008|Tacrolimus|tacrolimus|mesh-list
153593146|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153593147|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
153593148|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593149|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153593150|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593151|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593152|NCT01841099|Mesalamine|mesalamine|mesh-list
153593153|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153593154|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153593155|NCT01841099|Analgesics|analgesics|mesh-ancestor
153593156|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
153593157|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593158|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593159|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860931|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860932|NCT04609176|Apatinib|apatinib|mesh-list
153860933|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860934|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860935|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793321|NCT03456076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153793322|NCT03382561|Cisplatin|cisplatin|mesh-list
153793323|NCT03382561|Carboplatin|carboplatin|mesh-list
153793324|NCT03382561|Nivolumab|nivolumab|mesh-list
153793325|NCT03382561|Etoposide|etoposide|mesh-list
153793326|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
153793327|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
153793328|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793329|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793330|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153793331|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793332|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153793333|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793334|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793335|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793336|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
153793337|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
153793338|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
153401267|NCT00355862|Temsirolimus|temsirolimus|mesh-list
153401268|NCT00355862|Azathioprine|azathioprine|mesh-list
153401269|NCT00355862|MTOR Inhibitors|mtor inhibitors|mesh-list
153401270|NCT00355862|Tacrolimus|tacrolimus|mesh-list
153401271|NCT00355862|Cyclosporins|cyclosporins|mesh-list
153401272|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793385|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793386|NCT03009240|Decitabine|decitabine|mesh-list
153793387|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153793388|NCT03009240|Pevonedistat|pevonedistat|mesh-list
153793389|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153793390|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
153793391|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793392|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793393|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153793394|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153793395|NCT03007030|Antibodies|antibodies|mesh-list
153339890|NCT01003301|Omalizumab|omalizumab|mesh-list
153339894|NCT00002440|Ritonavir|ritonavir|mesh-list
153793396|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
153793397|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153339963|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793398|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
153793399|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
153793400|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793401|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793402|NCT03007030|Immunotoxins|immunotoxins|mesh-ancestor
153793403|NCT02972840|Rituximab|rituximab|mesh-list
153793404|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153793405|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
153793406|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793407|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793408|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
153860942|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860944|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793444|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
153793445|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793446|NCT02548559|Cannabidiol|cannabidiol|mesh-list
153793447|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
153793448|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
153793449|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153793450|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153793451|NCT02464696|Prednisolone|prednisolone|mesh-list
153793452|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
153793453|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153793454|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
153793455|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793456|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
153793457|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
153793458|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793459|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793479|NCT02367131|Empagliflozin|empagliflozin|mesh-list
153410045|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
153410046|NCT00003423|Hormones|hormones|mesh-ancestor
153793480|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153793481|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410047|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410048|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153410049|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153410050|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
153410051|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153410052|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410053|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
153410054|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
153793482|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153793483|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793484|NCT02282358|Mocetinostat|mocetinostat|mesh-list
153793485|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153793486|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593160|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153593161|NCT01841112|BI 409306|bi 409306|mesh-list
153593162|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153593163|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593167|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153593168|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593169|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593170|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593171|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
153593172|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593173|NCT01841164|Montelukast|montelukast|mesh-list
153593174|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153593175|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
153593176|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153593177|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
153593178|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593179|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545902|NCT06297499|Serotonin Agents|serotonin agents|mesh-ancestor
153593180|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153593181|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153593182|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401274|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401275|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153401276|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401277|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401278|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
153401279|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401280|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
153401281|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401282|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153793487|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793488|NCT02262325|Etoposide|etoposide|mesh-list
153793489|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
153793490|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793491|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153793492|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793493|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793494|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793495|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793496|NCT02248259|Itraconazole|itraconazole|mesh-list
153793497|NCT02248259|BI 409306|bi 409306|mesh-list
153793498|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
153793499|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793500|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153793501|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153793502|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793503|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793504|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153793505|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
153793506|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793507|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793508|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153793509|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153401283|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153593184|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
153593185|NCT01841242|Povidone|povidone|mesh-list
153593186|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153593187|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793543|NCT01898494|Cisplatin|cisplatin|mesh-list
153793544|NCT01898494|Carboplatin|carboplatin|mesh-list
153340114|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
153793545|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793546|NCT01892384|BI 409306|bi 409306|mesh-list
153793547|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153793548|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793549|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793550|NCT01611311|BI 409306|bi 409306|mesh-list
153793551|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153793552|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793554|NCT01505894|BI 409306|bi 409306|mesh-list
153860962|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860964|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153860965|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860966|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793560|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
153793561|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
153793562|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793563|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
153793564|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793565|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
153793566|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793567|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153793568|NCT00861705|Paclitaxel|paclitaxel|mesh-list
153793569|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
153793570|NCT00861705|Bevacizumab|bevacizumab|mesh-list
153793571|NCT00861705|Carboplatin|carboplatin|mesh-list
153793589|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793590|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793591|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153793592|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
153793593|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153793594|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153793595|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153793596|NCT00861705|Growth Substances|growth substances|mesh-ancestor
153793597|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
153793598|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153793599|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793600|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793601|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401301|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401302|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153401303|NCT02049307|Losartan|losartan|mesh-list
153401304|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153401305|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153793613|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793614|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793615|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793616|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
153793617|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153793618|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153793619|NCT00602641|Growth Substances|growth substances|mesh-ancestor
153793620|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
153340116|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
153793621|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153793622|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
153793623|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793624|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153793625|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793626|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
153793627|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153793628|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793629|NCT00588770|Bevacizumab|bevacizumab|mesh-list
153793647|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793648|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
153431041|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153793649|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793650|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793651|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
153793652|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153593188|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
153593189|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
153593190|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
153593191|NCT01841294|Lidocaine|lidocaine|mesh-list
153593192|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
153860978|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860979|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860980|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153860981|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860982|NCT04381091|Idebenone|idebenone|mesh-list
153860983|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
153860984|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860985|NCT04381091|Protective Agents|protective agents|mesh-ancestor
153793653|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793654|NCT00433511|Paclitaxel|paclitaxel|mesh-list
153793655|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
153793656|NCT00433511|Bevacizumab|bevacizumab|mesh-list
153793657|NCT00433511|Doxorubicin|doxorubicin|mesh-list
153793658|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153793659|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153793660|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153793661|NCT00433511|Antibodies|antibodies|mesh-list
153793662|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
153793663|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153793664|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
153793665|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
153793666|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153793667|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793668|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
153860987|NCT04225312|Natalizumab|natalizumab|mesh-list
153860993|NCT04129086|Ketamine|ketamine|mesh-list
153793684|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793685|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793686|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793687|NCT00334815|Bevacizumab|bevacizumab|mesh-list
153793688|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153793689|NCT00334815|Cisplatin|cisplatin|mesh-list
153793690|NCT00334815|Docetaxel|docetaxel|mesh-list
153793691|NCT00334815|Etoposide|etoposide|mesh-list
153793707|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793708|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793709|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793710|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793711|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153793712|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793713|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793714|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793715|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153793716|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
153793717|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
153793718|NCT00310180|Tamoxifen|tamoxifen|mesh-list
153793719|NCT00310180|Letrozole|letrozole|mesh-list
153793720|NCT00310180|Anastrozole|anastrozole|mesh-list
153793721|NCT00310180|Exemestane|exemestane|mesh-list
153869577|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153869578|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153869579|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153869580|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869581|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869582|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153869583|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793722|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793723|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793724|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153793725|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153793726|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793727|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153793728|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
153793729|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593193|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
153593194|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593195|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593196|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
153593197|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593199|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153593200|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153593201|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153793731|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793732|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153793733|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153793734|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153793736|NCT00097474|Melatonin|melatonin|mesh-list
153793737|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431042|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153793738|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
153793739|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793740|NCT00097474|Protective Agents|protective agents|mesh-ancestor
153793741|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793742|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153793743|NCT00095784|Decitabine|decitabine|mesh-list
153793744|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153793745|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
153793746|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793747|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793748|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793749|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
153793750|NCT00070499|Dasatinib|dasatinib|mesh-list
153793751|NCT00070499|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153793752|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153793753|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860995|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
153860996|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860997|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410134|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410135|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153410136|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153410137|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153410138|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153410140|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
153410141|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153860998|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153860999|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153861000|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
153469176|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
153793768|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153793769|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
153793770|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153340265|NCT05750290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153793771|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153793772|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153793773|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153793774|NCT01603693|Calcium|calcium|mesh-list
153793775|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153793776|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793777|NCT00258050|Lapatinib|lapatinib|mesh-list
153793778|NCT00258050|Midazolam|midazolam|mesh-list
153793779|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153793780|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153793781|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153793782|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793783|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153793784|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153793785|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153793786|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153793787|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
153793788|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
153793789|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
153793790|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
153793791|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593202|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593203|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
153593204|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
153593205|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
153593206|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593207|NCT01841307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153593208|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153593209|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153593210|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
153593211|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153593212|NCT01841320|Methadone|methadone|mesh-list
153593213|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153793792|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793793|NCT00258050|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153793794|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153793795|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869592|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153869593|NCT00565331|Rituximab|rituximab|mesh-list
153869594|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153869595|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869596|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
153869597|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869598|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793796|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869599|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153869600|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153869601|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153869602|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
153869603|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869604|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153793798|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
153793799|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153793800|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153793801|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793802|NCT00258089|Levofloxacin|levofloxacin|mesh-list
153793803|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153793804|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793805|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153793806|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793807|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793808|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793809|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793810|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793811|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153793834|NCT00258245|Dexamethasone|dexamethasone|mesh-list
153793835|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
153793836|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
153793837|NCT00258245|Bortezomib|bortezomib|mesh-list
153793838|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
153793839|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153793840|NCT00258245|BB 1101|bb 1101|mesh-list
153793841|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
153401328|NCT02049385|Diazoxide|diazoxide|mesh-list
153593214|NCT01841320|Narcotics|narcotics|mesh-ancestor
153593215|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593216|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593217|NCT01841320|Analgesics|analgesics|mesh-ancestor
153593218|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
153593219|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593220|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
153593221|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
153593222|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
153593223|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593249|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153593250|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593253|NCT01841502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153410166|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153410167|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153410168|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153410169|NCT00002805|Methotrexate|methotrexate|mesh-list
153410170|NCT00002805|Etoposide|etoposide|mesh-list
153410171|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
153410172|NCT00002805|Cladribine|cladribine|mesh-list
153410173|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153410174|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
153410175|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153869608|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153869609|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869610|NCT00473382|Ranibizumab|ranibizumab|mesh-list
153869611|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153869612|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153869613|NCT00473382|Growth Substances|growth substances|mesh-ancestor
153869614|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593254|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153593255|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153861015|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153861016|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
153861017|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861018|NCT03798639|Nivolumab|nivolumab|mesh-list
153861019|NCT03798639|Ipilimumab|ipilimumab|mesh-list
153861020|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861021|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861022|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153861023|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861024|NCT03774901|Avelumab|avelumab|mesh-list
153861025|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861026|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861027|NCT03762018|Bevacizumab|bevacizumab|mesh-list
153861028|NCT03762018|Atezolizumab|atezolizumab|mesh-list
153793842|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793843|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793844|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
153431044|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153793845|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
153793846|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793847|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793848|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
153793849|NCT00258245|Hormones|hormones|mesh-ancestor
153793850|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793851|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793852|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793880|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
153793882|NCT01604629|Infliximab|infliximab|mesh-list
153793883|NCT01604629|Golimumab|golimumab|mesh-list
153793884|NCT01604629|Etanercept|etanercept|mesh-list
153793885|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153793886|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153793887|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793888|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793889|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
153793890|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793891|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153793892|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153793893|NCT01604629|Analgesics|analgesics|mesh-ancestor
153793894|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
153793895|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793896|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793897|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793898|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
153793899|NCT00258284|Docetaxel|docetaxel|mesh-list
153793900|NCT00258284|Capecitabine|capecitabine|mesh-list
153793901|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793902|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793903|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793904|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869626|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869627|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153869628|NCT00472641|Ziprasidone|ziprasidone|mesh-list
153869629|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153869630|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
153869631|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869632|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869633|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869634|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153869635|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153793905|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793906|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153793907|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
153793908|NCT00290940|Metformin|metformin|mesh-list
153793909|NCT00290940|Pioglitazone|pioglitazone|mesh-list
153793910|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153593256|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593257|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593259|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593260|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153593261|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
153593262|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153593263|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153593264|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153593265|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593266|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153593267|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
153593268|NCT01841515|Coagulants|coagulants|mesh-ancestor
153593269|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153593270|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
153593271|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593272|NCT01841658|Folic Acid|folic acid|mesh-list
153401370|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
153401371|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401372|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153401373|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
153793911|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793912|NCT00258323|Fluorouracil|fluorouracil|mesh-list
153793913|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793914|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
153793915|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793916|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153793917|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793918|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
153793919|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340422|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793920|NCT01604863|Paclitaxel|paclitaxel|mesh-list
153793921|NCT01604863|Etoposide|etoposide|mesh-list
153793922|NCT01604863|Docetaxel|docetaxel|mesh-list
153793923|NCT01604863|Carboplatin|carboplatin|mesh-list
153793924|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153793925|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793926|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793927|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793928|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793929|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593273|NCT01841658|Hematinics|hematinics|mesh-ancestor
153593274|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
153593275|NCT01841658|Vitamins|vitamins|mesh-ancestor
153593276|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
153593277|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593278|NCT01841684|Anacetrapib|anacetrapib|mesh-list
153593279|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153593280|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153818518|NCT04418154|Paclitaxel|paclitaxel|mesh-list
153818519|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
153818520|NCT04418154|Epirubicin|epirubicin|mesh-list
153818521|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153818522|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153818523|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818524|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818525|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
153818526|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
153861044|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153861045|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153861046|NCT03456882|Analgesics|analgesics|mesh-ancestor
153869639|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
153869640|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
153869641|NCT04576208|Mobocertinib|mobocertinib|mesh-list
153410187|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153410188|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153861047|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
153861048|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861049|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861050|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861051|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861052|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153793930|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793931|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793932|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793933|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
153793934|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153793949|NCT01340014|Brinzolamide|brinzolamide|mesh-list
153793950|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153793951|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153793952|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153793953|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
153793954|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153793957|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153401380|NCT02300077|Fentanyl|fentanyl|mesh-list
153401381|NCT02300077|Morphine|morphine|mesh-list
153401382|NCT02300077|Methadone|methadone|mesh-list
153401383|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153401384|NCT02300077|Narcotics|narcotics|mesh-ancestor
153401385|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153793989|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793990|NCT01339273|Anesthetics|anesthetics|mesh-list
153793991|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
153793992|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153793993|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794001|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153794002|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794003|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794004|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
153794005|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153794007|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794008|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153794009|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153794010|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
153794011|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153794012|NCT01334710|Sorafenib|sorafenib|mesh-list
153794013|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794014|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153794015|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794016|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794017|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
153794018|NCT00271713|Vitamin D|vitamin d|mesh-list
153794019|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
153794020|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
153794021|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
153794022|NCT00271713|Vitamins|vitamins|mesh-list
153794023|NCT00271713|Calcium|calcium|mesh-list
153736236|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153794024|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
153861063|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861064|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861065|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
153794030|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153794031|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153794032|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794033|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794034|NCT01334554|Urological Agents|urological agents|mesh-ancestor
153794035|NCT00291213|Levetiracetam|levetiracetam|mesh-list
153794036|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
153794037|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
153794038|NCT01332799|Allopurinol|allopurinol|mesh-list
153794039|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
153794040|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794041|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794042|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
153794043|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794044|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153794045|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
153794046|NCT01332799|Protective Agents|protective agents|mesh-ancestor
153794047|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794048|NCT00258791|Ibuprofen|ibuprofen|mesh-list
153794049|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153794050|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794051|NCT00258791|Analgesics|analgesics|mesh-ancestor
153794052|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
153794053|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794054|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794055|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794056|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861066|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818527|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818528|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153593281|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
153593282|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593283|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153593284|NCT01841775|Interferons|interferons|mesh-list
153593285|NCT01841775|Ribavirin|ribavirin|mesh-list
153593286|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593287|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
153593288|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593289|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
153593290|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794057|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153794058|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794059|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794060|NCT00291369|Interferons|interferons|mesh-list
153794061|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
153794062|NCT00291369|Interleukin-2|interleukin-2|mesh-list
153794068|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
153794069|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794070|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794071|NCT00291369|Analgesics|analgesics|mesh-ancestor
153794072|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
153794073|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794074|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153794075|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153794076|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153794077|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
153794078|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153794079|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153794080|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153410221|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410222|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410223|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153794081|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153794082|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794083|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
153794084|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153794085|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
153794086|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794087|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794088|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153794089|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
153794090|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153593291|NCT01841827|Cilostazol|cilostazol|mesh-list
153593292|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153593293|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
153593294|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593295|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593296|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153593297|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
153593298|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153593299|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153593300|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593301|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153593302|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
153593303|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153593304|NCT01841827|Protective Agents|protective agents|mesh-ancestor
153593305|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153593306|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153401430|NCT03296345|Analgesics|analgesics|mesh-ancestor
153401431|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
153794091|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
153794092|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794093|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794094|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153794095|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
153794096|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
153794097|NCT00291408|Protective Agents|protective agents|mesh-ancestor
153794098|NCT00271791|Prednisone|prednisone|mesh-list
153794099|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869671|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
153869672|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153869673|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
153869674|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869675|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153869676|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153869677|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869678|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869679|NCT00583271|Ethanol|ethanol|mesh-list
153869680|NCT00583271|Triamcinolone|triamcinolone|mesh-list
153869681|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869682|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
153869683|NCT00583271|Hormones|hormones|mesh-ancestor
153736237|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794100|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
153794101|NCT00271791|Hormones|hormones|mesh-ancestor
153794102|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794103|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794104|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794105|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794106|NCT01332331|Ambrisentan|ambrisentan|mesh-list
153794107|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153794108|NCT00259064|Gefitinib|gefitinib|mesh-list
153794109|NCT00259064|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153794110|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153794111|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794114|NCT01332292|Fluticasone|fluticasone|mesh-list
153861094|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153861095|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153861096|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861099|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153794117|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153794118|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
153794119|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794120|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794121|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153794122|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
153794123|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
153794124|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153794125|NCT00259142|Chloroquine|chloroquine|mesh-list
153794126|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
153794127|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
153794128|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153794129|NCT00259142|Amebicides|amebicides|mesh-ancestor
153794130|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153794131|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153794132|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794133|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
153794150|NCT00291720|Spironolactone|spironolactone|mesh-list
153794151|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153794152|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
153794153|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794154|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794155|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153794156|NCT00291720|Diuretics|diuretics|mesh-ancestor
153794157|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
153794158|NCT00259220|Erythromycin|erythromycin|mesh-list
153794159|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
153794160|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153794161|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
153794162|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153794163|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794164|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593307|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593308|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153593309|NCT01842074|Bortezomib|bortezomib|mesh-list
153593310|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401438|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401439|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153401440|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153401441|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401442|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401443|NCT00421694|Bicalutamide|bicalutamide|mesh-list
153401444|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
153401445|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
153401446|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401447|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401448|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794165|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153794166|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794167|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794168|NCT00291759|Tamoxifen|tamoxifen|mesh-list
153794169|NCT00291759|Anastrozole|anastrozole|mesh-list
153794170|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153794171|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
153794172|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794173|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794174|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794175|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794176|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153794177|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153794178|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153794179|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153861116|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153861118|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153861119|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861120|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
153861121|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
153861122|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861123|NCT01941641|Capecitabine|capecitabine|mesh-list
153861124|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861125|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
153861126|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861127|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861128|NCT01792934|Bevacizumab|bevacizumab|mesh-list
153861129|NCT01792934|Irinotecan|irinotecan|mesh-list
153861131|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794207|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794208|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
153794209|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794210|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153794211|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153794247|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153794248|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
153794249|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794268|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153794269|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
153794270|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
153794271|NCT00259766|Hormones|hormones|mesh-ancestor
153794272|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794273|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153794274|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153794275|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153794276|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
153794277|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794278|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794279|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
153794280|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
153794281|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153794282|NCT00292071|Caspofungin|caspofungin|mesh-list
153794283|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
153794284|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794285|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794286|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794287|NCT00292110|Methadone|methadone|mesh-list
153794288|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153593311|NCT01842087|Iproplatin|iproplatin|mesh-list
153593312|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593313|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153593315|NCT01842113|Rifaximin|rifaximin|mesh-list
153593323|NCT01842139|Poly ICLC|poly iclc|mesh-list
153593324|NCT01842139|Basiliximab|basiliximab|mesh-list
153593325|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153593326|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
153593327|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593328|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
153593329|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153593330|NCT01842139|Laxatives|laxatives|mesh-ancestor
153593331|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593333|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593334|NCT01842230|Niacin|niacin|mesh-list
153593335|NCT01842230|Amlodipine|amlodipine|mesh-list
153593336|NCT01842230|Telmisartan|telmisartan|mesh-list
153593337|NCT01842230|Atorvastatin|atorvastatin|mesh-list
153593338|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153593339|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153593340|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
153593341|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593342|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153593343|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153401471|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794290|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153794291|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794292|NCT00292110|Analgesics|analgesics|mesh-ancestor
153794293|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
153340797|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794294|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794295|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
153794296|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
153794298|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153794299|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794300|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
153794301|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794302|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794304|NCT00259883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153794305|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153794330|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794331|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794332|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794333|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794334|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153794335|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153794336|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593344|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593345|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153593346|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153593347|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593348|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153593349|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593350|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
153593351|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153593352|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153593353|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
153818529|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
153818530|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818531|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153818532|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153459919|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
153459920|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153410272|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410273|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410274|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153410275|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153459921|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459922|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459923|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153459924|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153459925|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794337|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153794338|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153794339|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794340|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
153794341|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153794342|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
153794343|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153794344|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
153794345|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
153794346|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153794347|NCT00272454|Protective Agents|protective agents|mesh-ancestor
153794348|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153794349|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153794350|NCT00272493|Vaccines|vaccines|mesh-list
153794351|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
153794352|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794353|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
153794354|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153794383|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153794384|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
153794385|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794386|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794387|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794388|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
153794389|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794390|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794391|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
153794392|NCT00260390|Hormones|hormones|mesh-ancestor
153794393|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861172|NCT00521222|Fluticasone|fluticasone|mesh-list
153794420|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153794421|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
153794422|NCT00260819|Bosentan|bosentan|mesh-list
153794423|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153794424|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153794425|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794426|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
153794427|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
153736241|NCT03409198|Doxorubicin|doxorubicin|mesh-list
153736242|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153794428|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794429|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794430|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153794431|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153794432|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
153869730|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153410276|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410277|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410278|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410279|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410280|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
153410281|NCT00361621|Hormones|hormones|mesh-ancestor
153410282|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410283|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794433|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794434|NCT00292890|Insulin|insulin|mesh-list
153794435|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153794436|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794437|NCT00292929|Artesunate|artesunate|mesh-list
153794438|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
153794439|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153794440|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153794441|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794442|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794443|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
153794444|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
153340944|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
153794445|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153794446|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
153794447|NCT00424853|Cisplatin|cisplatin|mesh-list
153794448|NCT00424853|Gemcitabine|gemcitabine|mesh-list
153794449|NCT00424853|Docetaxel|docetaxel|mesh-list
153794450|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794451|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153794459|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153794460|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
153794461|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794462|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153794463|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794464|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794475|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794477|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794478|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
153794479|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153794480|NCT00424931|Modafinil|modafinil|mesh-list
153794481|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153794482|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810991|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869732|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153869733|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153869734|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153869735|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869736|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869737|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
153869738|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869739|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869740|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153869741|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153869742|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153794483|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153794484|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153794485|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153794486|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794487|NCT00298545|Calcitriol|calcitriol|mesh-list
153794488|NCT00298545|Calcium|calcium|mesh-list
153794489|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153794490|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794491|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153794492|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153794493|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794494|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153794495|NCT00298545|Vitamins|vitamins|mesh-ancestor
153794496|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
153794497|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153794498|NCT01331161|Vaccines|vaccines|mesh-list
153861174|NCT00521222|Albuterol|albuterol|mesh-list
153459926|NCT05390736|Vitamin D|vitamin d|mesh-list
153593354|NCT01842230|Vitamins|vitamins|mesh-ancestor
153593355|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
153593356|NCT01842256|Amlodipine|amlodipine|mesh-list
153593357|NCT01842256|Telmisartan|telmisartan|mesh-list
153593358|NCT01842256|Atorvastatin|atorvastatin|mesh-list
153593359|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153593360|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153593361|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
153593362|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593363|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153593364|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153593365|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401517|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
153401518|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
153401519|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
153401520|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
153401521|NCT03308669|Topiramate|topiramate|mesh-list
153401522|NCT03308669|Lasmiditan|lasmiditan|mesh-list
153401523|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
153401524|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153401525|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401526|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153401527|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
153401528|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401529|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401530|NCT00356252|Carotenoids|carotenoids|mesh-list
153794499|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
153794500|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794501|NCT00424970|Acetazolamide|acetazolamide|mesh-list
153794502|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
153794503|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153794504|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794505|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794506|NCT00424970|Diuretics|diuretics|mesh-ancestor
153794507|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
153736243|NCT03409198|Nivolumab|nivolumab|mesh-list
153736244|NCT03409198|Ipilimumab|ipilimumab|mesh-list
153410307|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
153410309|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410310|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
153410311|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410312|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410313|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410314|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
153410315|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410316|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410317|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153736245|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736246|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
153736247|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736248|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736249|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153736250|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
153736251|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736252|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736265|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153736266|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736267|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736268|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153736269|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
153736270|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
153794508|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794509|NCT01331005|Nepafenac|nepafenac|mesh-list
153794510|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153794511|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794512|NCT01331005|Analgesics|analgesics|mesh-ancestor
153794513|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
153794514|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794515|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794516|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794517|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341095|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
153794518|NCT01330459|Acetaminophen|acetaminophen|mesh-list
153794519|NCT01330459|Ibuprofen|ibuprofen|mesh-list
153794520|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153794521|NCT01330459|Lidocaine|lidocaine|mesh-list
153794522|NCT01330459|Hydrocodone|hydrocodone|mesh-list
153794523|NCT01330459|Lorazepam|lorazepam|mesh-list
153794524|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
153794537|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
153794538|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153794539|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861198|NCT00521222|Hormones|hormones|mesh-ancestor
153593366|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153593367|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153593368|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593369|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153593370|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593371|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
153593372|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153593373|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153593374|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
153593375|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153593376|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593377|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153593378|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
153593379|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593380|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593381|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861219|NCT00545246|Growth Substances|growth substances|mesh-ancestor
153869766|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869768|NCT00471237|Alendronate|alendronate|mesh-list
153869769|NCT00471237|Teriparatide|teriparatide|mesh-list
153869770|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153869771|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410319|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410320|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410321|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401533|NCT00356252|Protective Agents|protective agents|mesh-ancestor
153401534|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401535|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153401536|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
153401537|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153401538|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153401539|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153736271|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736272|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736273|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153736274|NCT03365882|Trastuzumab|trastuzumab|mesh-list
153736275|NCT03365882|Cetuximab|cetuximab|mesh-list
153736276|NCT03365882|Pertuzumab|pertuzumab|mesh-list
153736277|NCT03365882|Irinotecan|irinotecan|mesh-list
153736278|NCT03365882|Camptothecin|camptothecin|mesh-list
153736279|NCT03365882|Antibodies|antibodies|mesh-list
153736280|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
153736281|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153794540|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794541|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153794542|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794543|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153794544|NCT01330459|Narcotics|narcotics|mesh-ancestor
153794545|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
153794546|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
153794547|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
153794548|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
153794549|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
153794550|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153794551|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153794552|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153794553|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153794554|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153794555|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
153794556|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
153794557|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794558|NCT00293085|Docetaxel|docetaxel|mesh-list
153861220|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861221|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
153861223|NCT03456401|Sunitinib|sunitinib|mesh-list
153861224|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861225|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153861226|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861227|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794563|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794564|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153794565|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153794566|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153794567|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
153794568|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794569|NCT00298662|Interferons|interferons|mesh-list
153794570|NCT00298662|Interferon-beta|interferon-beta|mesh-list
153794571|NCT00298662|Tacrolimus|tacrolimus|mesh-list
153794572|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
153794573|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869773|NCT04570683|Nivolumab|nivolumab|mesh-list
153869774|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153869775|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869776|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153869777|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869778|NCT04570449|Fluoxetine|fluoxetine|mesh-list
153869779|NCT04570449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153869780|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153794574|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
153794575|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794576|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153794577|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
153794608|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
153794609|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794610|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794611|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153736282|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
153736283|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736284|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736285|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153736286|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153736287|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736288|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794612|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794614|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153794615|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
153794616|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153794617|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153794618|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153794619|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153794620|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794621|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
153794622|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861228|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153861229|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153861230|NCT03456401|Growth Substances|growth substances|mesh-ancestor
153593382|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593383|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
153593384|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593385|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153593397|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593398|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593399|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
153593400|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459933|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459934|NCT05353283|Tenofovir|tenofovir|mesh-list
153459935|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
153459936|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459937|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153818533|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
153818534|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153818535|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153818536|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153818537|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153818538|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818539|NCT04389294|Antibodies|antibodies|mesh-list
153818540|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
153401565|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401566|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401567|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401568|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401569|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153401570|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401571|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153401572|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153401573|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153794623|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794624|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153794625|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153794626|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794627|NCT00261287|Ciclesonide|ciclesonide|mesh-list
153794628|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
153794630|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794631|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794632|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153794633|NCT00261326|Simvastatin|simvastatin|mesh-list
153794634|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153794636|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
153861242|NCT00545558|Efavirenz|efavirenz|mesh-list
153861243|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153861244|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
153861245|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861246|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153861247|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153861248|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861249|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861250|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153861251|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153794708|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
153794709|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
153794710|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794711|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794712|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153794713|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794714|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794715|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794716|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153794717|NCT00293358|Carboplatin|carboplatin|mesh-list
153794718|NCT00293358|Etoposide|etoposide|mesh-list
153794719|NCT00293358|Ifosfamide|ifosfamide|mesh-list
153794720|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
153794721|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794722|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153794729|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
153794755|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153401583|NCT03769844|Molgramostim|molgramostim|mesh-list
153357551|NCT04274738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410369|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410370|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
153410371|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401584|NCT03769844|Sargramostim|sargramostim|mesh-list
153401585|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
153401586|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401587|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401588|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
153401589|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153401590|NCT02347345|Ledipasvir|ledipasvir|mesh-list
153401591|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
153401592|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794756|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794757|NCT00293436|Analgesics|analgesics|mesh-ancestor
153794758|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
153794759|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794760|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794761|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794762|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794763|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153794764|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153794765|NCT00261872|Methylphenidate|methylphenidate|mesh-list
153794766|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153794767|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794768|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153794769|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153794770|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153794771|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794772|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
153861259|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153861260|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153861262|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861263|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861264|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861267|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
153794788|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153794789|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
153794790|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153794791|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153794792|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
153794793|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794794|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
153794795|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794796|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153794797|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153794798|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153794799|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153794800|NCT00293475|Diuretics|diuretics|mesh-ancestor
153794801|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
153794802|NCT00293475|Protective Agents|protective agents|mesh-ancestor
153794817|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153794818|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
153736290|NCT03315299|Gilteritinib|gilteritinib|mesh-list
153736291|NCT03315299|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153736292|NCT03315299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153736293|NCT03315299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736294|NCT03315299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794819|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153794820|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
153794821|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794822|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
153794823|NCT00299013|Hormones|hormones|mesh-ancestor
153861283|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153861284|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153401603|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153869808|NCT00584168|Dexamethasone|dexamethasone|mesh-list
153401605|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
153401606|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401607|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401608|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401610|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153401611|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153401612|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401613|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153401614|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153794828|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
153794829|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
153794834|NCT00293514|Thrombin|thrombin|mesh-list
153861285|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153861286|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153861288|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861289|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
153861290|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
153861291|NCT00545831|Taurolidine|taurolidine|mesh-list
153861292|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861293|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153861294|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861295|NCT00545870|Bevacizumab|bevacizumab|mesh-list
153861296|NCT00545870|Ranibizumab|ranibizumab|mesh-list
153861297|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861298|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861299|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153794889|NCT00293631|Analgesics|analgesics|mesh-ancestor
153794890|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
153794891|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794892|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794893|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401627|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401628|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
153794938|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794939|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153794940|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153794942|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
153794943|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
153794944|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794945|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794946|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153794947|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153794948|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794949|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153794950|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
153810997|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153410395|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410396|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410397|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
153410398|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
153410399|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410400|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153410401|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
153410402|NCT00002835|Hormones|hormones|mesh-ancestor
153794952|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153794953|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
153794954|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794955|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153794956|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
153794957|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794958|NCT00262769|Cisplatin|cisplatin|mesh-list
153794959|NCT00262769|Gemcitabine|gemcitabine|mesh-list
153794960|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794961|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153794962|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
153794963|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794964|NCT00299520|Linezolid|linezolid|mesh-list
153794965|NCT00299520|Iclaprim|iclaprim|mesh-list
153401630|NCT02352259|Bleomycin|bleomycin|mesh-list
153818541|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593401|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153593402|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153593403|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153593404|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593405|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593406|NCT01842516|Delpazolid|delpazolid|mesh-list
153593410|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153593411|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593412|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593413|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
153861301|NCT00545870|Growth Substances|growth substances|mesh-ancestor
153861302|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861303|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
153861304|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
153861305|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861306|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861308|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153861309|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
153861310|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861311|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794966|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153341481|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153794967|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794968|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153794969|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794970|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794971|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153794972|NCT00261755|Analgesics|analgesics|mesh-list
153794973|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
153794974|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794975|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794976|NCT00262808|Leucovorin|leucovorin|mesh-list
153794977|NCT00262808|Fluorouracil|fluorouracil|mesh-list
153794978|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
153794979|NCT00262808|Calcium|calcium|mesh-list
153794980|NCT00262808|Sargramostim|sargramostim|mesh-list
153794981|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
153794983|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861325|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153861326|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153861327|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
153869839|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
153869840|NCT00470184|Capecitabine|capecitabine|mesh-list
153869841|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
153869842|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869843|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
153869844|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410403|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410409|NCT00003351|Irinotecan|irinotecan|mesh-list
153861328|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
153795007|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795008|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795009|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153795010|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153795011|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
153795012|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153795013|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795014|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153795015|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153795016|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
153795017|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153795018|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795019|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153795020|NCT00263003|Irbesartan|irbesartan|mesh-list
153795021|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153795022|NCT00263003|Diuretics|diuretics|mesh-ancestor
153795023|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
153795024|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795025|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153795026|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795027|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795028|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153795029|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153593414|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153593415|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593416|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593417|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
153593418|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593419|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593420|NCT01842893|Fentanyl|fentanyl|mesh-list
153593421|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153593422|NCT01842893|Narcotics|narcotics|mesh-ancestor
153593423|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593424|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593425|NCT01842893|Analgesics|analgesics|mesh-ancestor
153593426|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
153593427|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869848|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
153869849|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
153869850|NCT04570254|Melatonin|melatonin|mesh-list
153869852|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153869853|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
153869854|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869855|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869856|NCT04570254|Protective Agents|protective agents|mesh-ancestor
153869857|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869858|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153818545|NCT04361825|Durvalumab|durvalumab|mesh-list
153818546|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818547|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795031|NCT06259760|Nitroglycerin|nitroglycerin|mesh-list
153795032|NCT06259760|Vasodilator Agents|vasodilator agents|mesh-ancestor
153795033|NCT06259760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153795034|NCT06259760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153795035|NCT06259760|Adrenergic Agents|adrenergic agents|mesh-ancestor
153795036|NCT06259760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795037|NCT06259760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795038|NCT06259760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795039|NCT06259760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153795040|NCT06259760|Sympathomimetics|sympathomimetics|mesh-ancestor
153795041|NCT06259760|Autonomic Agents|autonomic agents|mesh-ancestor
153795042|NCT06259760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795043|NCT06259760|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153341555|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
153795044|NCT06259760|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153795046|NCT06259656|Myeloma Proteins|myeloma proteins|mesh-list
153795047|NCT06259656|Paraproteins|paraproteins|mesh-list
153795048|NCT06259656|Immunologic Factors|immunologic factors|mesh-ancestor
153795049|NCT06259656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795050|NCT06259630|Nicotine|nicotine|mesh-list
153795051|NCT06259630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153795052|NCT06259630|Autonomic Agents|autonomic agents|mesh-ancestor
153795053|NCT06259630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795054|NCT06259630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795055|NCT06259630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153795056|NCT06259630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153795073|NCT06259565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795074|NCT06259526|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153795075|NCT06259526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153410431|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
153410432|NCT03576001|Testosterone|testosterone|mesh-list
153410433|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
153410434|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
153410435|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153410436|NCT03576001|Androgens|androgens|mesh-ancestor
153410437|NCT03576001|Hormones|hormones|mesh-ancestor
153410438|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410439|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410440|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153410441|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795076|NCT06259526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153795077|NCT06259526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153736298|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736299|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153818548|NCT04317807|Levetiracetam|levetiracetam|mesh-list
153861330|NCT00560079|Allopurinol|allopurinol|mesh-list
153861331|NCT00560079|Dipyridamole|dipyridamole|mesh-list
153861332|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
153795079|NCT06259526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795080|NCT06259526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795081|NCT06259526|Analgesics|analgesics|mesh-ancestor
153795082|NCT06259526|Sensory System Agents|sensory system agents|mesh-ancestor
153795083|NCT06259526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795084|NCT06259526|Antidepressive Agents|antidepressive agents|mesh-ancestor
153795085|NCT06259526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795086|NCT06259526|Dopamine Agents|dopamine agents|mesh-ancestor
153795087|NCT06259383|Ivermectin|ivermectin|mesh-list
153795088|NCT06259383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153795089|NCT06259383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795090|NCT06259331|Viloxazine|viloxazine|mesh-list
153795091|NCT06259331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153795092|NCT06259331|Antidepressive Agents|antidepressive agents|mesh-ancestor
153795093|NCT06259331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795094|NCT06259331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153795095|NCT06259331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153795096|NCT06259331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795097|NCT06259331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795098|NCT06259331|Adrenergic Agents|adrenergic agents|mesh-ancestor
153795099|NCT06259331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795100|NCT06259331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795101|NCT06259175|Amlodipine|amlodipine|mesh-list
153795102|NCT06259175|Perindopril|perindopril|mesh-list
153795103|NCT06259175|Indapamide|indapamide|mesh-list
153795104|NCT06259175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153795105|NCT06259175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153795106|NCT06259175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795107|NCT06259175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795108|NCT06259175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153795109|NCT06259175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795110|NCT06259175|Vasodilator Agents|vasodilator agents|mesh-ancestor
153861334|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401684|NCT05993767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153401685|NCT05993767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153401686|NCT05993767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795124|NCT06259097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153795125|NCT06259097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795126|NCT06259097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153795127|NCT06259097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153795128|NCT06259097|Oxytocics|oxytocics|mesh-ancestor
153795130|NCT06258967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153795131|NCT06258967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795132|NCT06258967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795133|NCT06258967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153795134|NCT06258967|Anesthetics, General|anesthetics, general|mesh-ancestor
153795135|NCT06258967|Anesthetics|anesthetics|mesh-ancestor
153795136|NCT06258915|Mycophenolic Acid|mycophenolic acid|mesh-list
153795137|NCT06258915|Adalimumab|adalimumab|mesh-list
153795138|NCT06258915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153795139|NCT06258915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795140|NCT06258915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153795141|NCT06258915|Antitubercular Agents|antitubercular agents|mesh-ancestor
153795142|NCT06258915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153795143|NCT06258915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795144|NCT06258915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795145|NCT06258915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795146|NCT06258915|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153795147|NCT06258915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153795148|NCT06258915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153795149|NCT06258850|Vitamin D|vitamin d|mesh-list
153795150|NCT06258850|Calcifediol|calcifediol|mesh-list
153795151|NCT06258850|Vitamins|vitamins|mesh-ancestor
153795152|NCT06258850|Micronutrients|micronutrients|mesh-ancestor
153795153|NCT06258850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795154|NCT06258850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153795155|NCT06258668|Deucravacitinib|deucravacitinib|mesh-list
153818549|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
153818550|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
153861346|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153861347|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153861348|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153861349|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153861350|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861351|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861352|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861355|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795156|NCT06258668|Dermatologic Agents|dermatologic agents|mesh-ancestor
153795157|NCT06258668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153795158|NCT06258668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795159|NCT06258668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736300|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153736301|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153736302|NCT03181789|Growth Substances|growth substances|mesh-ancestor
153795161|NCT06258642|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153795162|NCT06258642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153795163|NCT06258642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795164|NCT06258642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795165|NCT06258642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795166|NCT06258265|Moxifloxacin|moxifloxacin|mesh-list
153795167|NCT06258265|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153795168|NCT06258265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153795169|NCT06258265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795170|NCT06258265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153795171|NCT06258265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153795172|NCT06258265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795186|NCT06258226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795187|NCT06258226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795188|NCT06258226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153341704|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153795189|NCT06258226|GABA Modulators|gaba modulators|mesh-ancestor
153401690|NCT05993767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153401691|NCT05993767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153401692|NCT05993455|Panitumumab|panitumumab|mesh-list
153401693|NCT05993455|Sotorasib|sotorasib|mesh-list
153401694|NCT05993455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401695|NCT05993455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401696|NCT05993455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153401697|NCT05993455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401698|NCT05993299|Cyclophosphamide|cyclophosphamide|mesh-list
153401699|NCT05993299|Fludarabine|fludarabine|mesh-list
153401700|NCT05993299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153795195|NCT06258174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153795196|NCT06258174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795197|NCT06258174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795198|NCT06258070|Botulinum Toxins|botulinum toxins|mesh-list
153795199|NCT06258070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153795200|NCT06258070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153795201|NCT06258070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153861364|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861365|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153861366|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153861367|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
153861368|NCT00558480|Vitamins|vitamins|mesh-list
153861369|NCT00558480|Vitamin A|vitamin a|mesh-list
153861370|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
153861371|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
153795246|NCT06257537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153795247|NCT06257537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153795248|NCT06257537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153795249|NCT06257537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795250|NCT06257537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795251|NCT06257485|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
153795252|NCT06257485|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153795253|NCT06257485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795254|NCT06257420|Sirolimus|sirolimus|mesh-list
153795255|NCT06257420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153795256|NCT06257420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795257|NCT06257420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153795258|NCT06257420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795259|NCT06257420|Antifungal Agents|antifungal agents|mesh-ancestor
153795260|NCT06257420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153795261|NCT06257420|Immunologic Factors|immunologic factors|mesh-ancestor
153795262|NCT06257420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795263|NCT06257394|Dasatinib|dasatinib|mesh-list
153341778|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
153341783|NCT04156828|Hormones|hormones|mesh-ancestor
153341864|NCT03836014|BB 1101|bb 1101|mesh-list
153795264|NCT06257394|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153795265|NCT06257394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153795266|NCT06257394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795267|NCT06257394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795268|NCT06257394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795269|NCT06256705|Edotreotide|edotreotide|mesh-list
153795270|NCT06256705|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153795271|NCT06256705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401708|NCT05993299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153401710|NCT05993143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153410466|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
153410467|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410468|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
153410469|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410470|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410471|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410472|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
153410473|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410474|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410475|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410476|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410478|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
153401711|NCT05993143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401713|NCT05992987|Antibodies|antibodies|mesh-list
153401714|NCT05992987|Immunologic Factors|immunologic factors|mesh-ancestor
153401715|NCT05992987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401716|NCT05992987|Analgesics|analgesics|mesh-ancestor
153795277|NCT06256146|Immunomodulating Agents|immunomodulating agents|mesh-list
153795278|NCT06256146|Immunologic Factors|immunologic factors|mesh-ancestor
153795279|NCT06256146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795280|NCT06254365|Hormones|hormones|mesh-list
153795281|NCT06254365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795282|NCT06254365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795283|NCT06250413|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153795284|NCT06250413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153795285|NCT06250413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795287|NCT06250413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861387|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153861388|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153861389|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153861390|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861391|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861392|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861394|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
153736304|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736305|NCT03140423|Mupirocin|mupirocin|mesh-list
153736306|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153795328|NCT06093126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795329|NCT06093126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153795330|NCT06093126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153795331|NCT06093126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795332|NCT06093126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795333|NCT06080100|Hydroxyzine|hydroxyzine|mesh-list
153795334|NCT06080100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795336|NCT06080100|Dermatologic Agents|dermatologic agents|mesh-ancestor
153795337|NCT06080100|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153795338|NCT06080100|Histamine Antagonists|histamine antagonists|mesh-ancestor
153795339|NCT06080100|Histamine Agents|histamine agents|mesh-ancestor
153795340|NCT06080100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795341|NCT06080100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795342|NCT06060340|Propolis|propolis|mesh-list
153795343|NCT06060340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795344|NCT06059118|Eflornithine|eflornithine|mesh-list
153795345|NCT06059118|Methyltestosterone|methyltestosterone|mesh-list
153815049|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153795346|NCT06059118|Hormones|hormones|mesh-list
153795347|NCT06059118|Testosterone|testosterone|mesh-list
153795348|NCT06059118|Testosterone undecanoate|testosterone undecanoate|mesh-list
153795349|NCT06059118|Testosterone enanthate|testosterone enanthate|mesh-list
153795350|NCT06059118|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153795351|NCT06059118|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153795352|NCT06059118|Relugolix|relugolix|mesh-list
153818551|NCT04284839|Warfarin|warfarin|mesh-list
153818552|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
153818553|NCT04284839|Dabigatran|dabigatran|mesh-list
153459938|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153459939|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861403|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
153401728|NCT05992883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401729|NCT05992883|Glucocorticoids|glucocorticoids|mesh-ancestor
153401730|NCT05992883|Hormones|hormones|mesh-ancestor
153401731|NCT05992883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401732|NCT05992883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401733|NCT05992883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401734|NCT05992883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401735|NCT05992883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153401736|NCT05992883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153401737|NCT05992883|Analgesics|analgesics|mesh-ancestor
153795359|NCT06059118|Androgen Antagonists|androgen antagonists|mesh-ancestor
153795360|NCT06059118|Hormone Antagonists|hormone antagonists|mesh-ancestor
153795361|NCT06059118|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153795362|NCT06059118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153795363|NCT06059118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153795364|NCT06059118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861404|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153861405|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153861406|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861407|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861408|NCT00547352|Urological Agents|urological agents|mesh-ancestor
153861409|NCT00547508|Tadalafil|tadalafil|mesh-list
153861410|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
153861411|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153795403|NCT06041711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153795404|NCT06041711|Anesthetics, General|anesthetics, general|mesh-ancestor
153795405|NCT06041711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153795406|NCT06041711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153795407|NCT06005558|Methylene Blue|methylene blue|mesh-list
153795408|NCT06005558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795409|NCT06005558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795410|NCT05997225|Varenicline|varenicline|mesh-list
153341935|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
153795411|NCT05997225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153795412|NCT05997225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153795413|NCT05997225|Cholinergic Agents|cholinergic agents|mesh-ancestor
153795414|NCT05997225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795415|NCT05997225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795416|NCT05997225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795417|NCT05974267|Atovaquone|atovaquone|mesh-list
153795418|NCT05974267|Pyronaridine|pyronaridine|mesh-list
153795419|NCT05974267|Proguanil|proguanil|mesh-list
153795421|NCT05974267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861412|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153861413|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401738|NCT05992883|Sensory System Agents|sensory system agents|mesh-ancestor
153401739|NCT05992883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401740|NCT05992883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401741|NCT05992883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153795447|NCT05964647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153795448|NCT05964647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795449|NCT05964647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410490|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
153410491|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153795450|NCT05964647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795451|NCT05964647|Serotonin Agents|serotonin agents|mesh-ancestor
153795452|NCT05964647|Anticonvulsants|anticonvulsants|mesh-ancestor
153795453|NCT05964647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153795454|NCT05964647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153795455|NCT05964647|GABA Modulators|gaba modulators|mesh-ancestor
153795456|NCT05964647|GABA Agents|gaba agents|mesh-ancestor
153795457|NCT05964647|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153795458|NCT05964647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153795459|NCT05964647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153795460|NCT05903352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153795461|NCT05903352|Anti-Infective Agents|anti-infective agents|mesh-list
153795462|NCT05894577|Montelukast|montelukast|mesh-list
153795463|NCT05894577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153861414|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861415|NCT00547508|Urological Agents|urological agents|mesh-ancestor
153861416|NCT00560274|Ribavirin|ribavirin|mesh-list
153861417|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153861418|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
153861419|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861420|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
153861421|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861422|NCT00547547|Selenium|selenium|mesh-list
153861423|NCT00547547|Capecitabine|capecitabine|mesh-list
153861424|NCT00547547|Irinotecan|irinotecan|mesh-list
153736310|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795517|NCT05867914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795518|NCT05867914|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153795519|NCT05867914|Vasodilator Agents|vasodilator agents|mesh-ancestor
153795520|NCT05867914|Gasotransmitters|gasotransmitters|mesh-ancestor
153795521|NCT05867914|Protective Agents|protective agents|mesh-ancestor
153795522|NCT05835999|Everolimus|everolimus|mesh-list
153795523|NCT05835999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153795524|NCT05835999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153795525|NCT05835999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795526|NCT05835999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795549|NCT05786599|Respiratory System Agents|respiratory system agents|mesh-ancestor
153795550|NCT05766683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153795551|NCT05766683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153795552|NCT05766683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153795553|NCT05766683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401762|NCT05992220|Immunologic Factors|immunologic factors|mesh-ancestor
153401766|NCT05991856|Antihypertensive Agents|antihypertensive agents|mesh-list
153401767|NCT05991830|Anesthetics|anesthetics|mesh-list
153401768|NCT05991830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401769|NCT05991830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401770|NCT05990894|Methylprednisolone|methylprednisolone|mesh-list
153401771|NCT05990894|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153401772|NCT05990894|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153401773|NCT05990894|Prednisolone|prednisolone|mesh-list
153401774|NCT05990894|Prednisolone acetate|prednisolone acetate|mesh-list
153401775|NCT05990894|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153401776|NCT05990894|Prednisolone phosphate|prednisolone phosphate|mesh-list
153795571|NCT05741372|Metformin|metformin|mesh-list
153795572|NCT05741372|Digoxin|digoxin|mesh-list
153795573|NCT05741372|Furosemide|furosemide|mesh-list
153795667|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153795668|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795669|NCT05618301|Natalizumab|natalizumab|mesh-list
153410500|NCT00002865|Antidotes|antidotes|mesh-ancestor
153410501|NCT00002865|Protective Agents|protective agents|mesh-ancestor
153410502|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
153410503|NCT00002865|Vitamins|vitamins|mesh-ancestor
153410504|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
153410505|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410506|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410507|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410508|NCT00002865|Trace Elements|trace elements|mesh-ancestor
153410509|NCT00361309|Sunitinib|sunitinib|mesh-list
153795670|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
153795671|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795672|NCT05543642|Vaccines|vaccines|mesh-list
153795673|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
153795674|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795675|NCT05540145|Paclitaxel|paclitaxel|mesh-list
153795676|NCT05540145|Antibodies|antibodies|mesh-list
153795677|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153795687|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795688|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153795689|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795690|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795691|NCT05523401|Psilocybin|psilocybin|mesh-list
153795692|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153795693|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
153795694|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
153795695|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795696|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795697|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
153795698|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795699|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795700|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153795701|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153795702|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795703|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
153795704|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153795705|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153459940|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459941|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153459942|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153869949|NCT00475020|Busulfan|busulfan|mesh-list
153869950|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
153869951|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153869952|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869954|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
153869955|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869956|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153869957|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
153869958|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869959|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
153869960|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153869961|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153869962|NCT00585455|Sertraline|sertraline|mesh-list
153410529|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
153459943|NCT05344209|Sargramostim|sargramostim|mesh-list
153593429|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153593430|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
153593431|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
153593432|NCT01842932|Bromides|bromides|mesh-list
153593433|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153593434|NCT01842932|Cimetropium|cimetropium|mesh-list
153593435|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
153593436|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
153401794|NCT05989386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153401795|NCT05989386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401796|NCT05988788|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153401797|NCT05988788|Eusol|eusol|mesh-list
153401798|NCT05988788|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153795706|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153795707|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
153795708|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153795709|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
153342228|NCT01555268|Cytarabine|cytarabine|mesh-list
153342303|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
153795710|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153795711|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
153795713|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795714|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795715|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153795716|NCT05510141|Analgesics|analgesics|mesh-ancestor
153795717|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
153795718|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795719|NCT05498181|Valsartan|valsartan|mesh-list
153795720|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153795721|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153795722|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153795723|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153795724|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795725|NCT05444946|Itraconazole|itraconazole|mesh-list
153795726|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153795727|NCT05444946|Prednisone|prednisone|mesh-list
153795760|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795761|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795762|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
153795764|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
153795765|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
153795766|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795767|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795768|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
153795769|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795770|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153795771|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153795772|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153795773|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795774|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795775|NCT05384119|Fulvestrant|fulvestrant|mesh-list
153795776|NCT05384119|Palbociclib|palbociclib|mesh-list
153795777|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153795778|NCT05384119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153795779|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795780|NCT05384119|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153795781|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153410542|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410544|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153410545|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795782|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
153795783|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861474|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861475|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153861476|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861488|NCT00548483|Hormones|hormones|mesh-ancestor
153795823|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153795824|NCT05283304|Narcotics|narcotics|mesh-ancestor
153795825|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795826|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795827|NCT05283304|Analgesics|analgesics|mesh-ancestor
153795828|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
153795829|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795830|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153795831|NCT05281328|Octreotide|octreotide|mesh-list
153795832|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153795833|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153795834|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795835|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
153736313|NCT03106779|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153736314|NCT03106779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153736315|NCT03106779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736316|NCT03106779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795836|NCT05271630|Immunomodulating Agents|immunomodulating agents|mesh-list
153795837|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
153795838|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795839|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795840|NCT05271630|Immunologic Factors|immunologic factors|mesh-ancestor
153401816|NCT05988034|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153401818|NCT05988034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401819|NCT05988034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153401820|NCT05988034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153401821|NCT05988034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410553|NCT00003375|Procarbazine|procarbazine|mesh-list
153410554|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410555|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401822|NCT05988034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401823|NCT05988034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401824|NCT05988034|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153795870|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153795871|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153795872|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
153795873|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
153795874|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
153795875|NCT05253833|Allopurinol|allopurinol|mesh-list
153795876|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
153795877|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795878|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861489|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861490|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153861491|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861493|NCT04635852|Morphine|morphine|mesh-list
153861494|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153861495|NCT04635852|Narcotics|narcotics|mesh-ancestor
153861496|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861497|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861498|NCT04635852|Analgesics|analgesics|mesh-ancestor
153401825|NCT05988034|Contraceptive Agents|contraceptive agents|mesh-ancestor
153401826|NCT05988034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153401827|NCT05988034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401828|NCT05988034|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153401829|NCT05988034|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153795915|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795916|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
153795917|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795918|NCT05189457|Docetaxel|docetaxel|mesh-list
153795991|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795992|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795993|NCT05028153|Azithromycin|azithromycin|mesh-list
153795994|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153795995|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153795996|NCT05011357|Phenylephrine|phenylephrine|mesh-list
153795997|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
153795998|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153795999|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
153796000|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
153342527|NCT00003466|Temozolomide|temozolomide|mesh-list
153342528|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153796001|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342602|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153796002|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796003|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
153796004|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153796005|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
153796006|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
153796007|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153796008|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153796009|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153796010|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
153796011|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796012|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796013|NCT05011357|Protective Agents|protective agents|mesh-ancestor
153861499|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
153861503|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
153796015|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153796016|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153796017|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153796018|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153736318|NCT03084523|Hematinics|hematinics|mesh-ancestor
153736319|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153796019|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153796020|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796021|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
153796022|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796023|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796024|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153796025|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796027|NCT04947085|Analgesics|analgesics|mesh-ancestor
153796028|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
153796064|NCT04892277|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153796065|NCT04892277|Fludarabine|fludarabine|mesh-list
153796066|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153796067|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
153796093|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153796094|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153796095|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153796096|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
153796097|NCT04824417|Itraconazole|itraconazole|mesh-list
153796098|NCT04824417|Voriconazole|voriconazole|mesh-list
153796099|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
153796100|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153796101|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153401839|NCT05987696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401840|NCT05987696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153401841|NCT05987696|Alkylating Agents|alkylating agents|mesh-ancestor
153401842|NCT05987696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401843|NCT05987696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401844|NCT05987696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153401845|NCT05987696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153401846|NCT05987696|Antimetabolites|antimetabolites|mesh-ancestor
153401847|NCT05987696|Antiviral Agents|antiviral agents|mesh-ancestor
153401848|NCT05987696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401849|NCT05987397|Ubiquinone|ubiquinone|mesh-list
153401850|NCT05987397|Idebenone|idebenone|mesh-list
153796136|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796137|NCT04741997|Nivolumab|nivolumab|mesh-list
153796138|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796139|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796140|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796141|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796142|NCT04678661|Insulin|insulin|mesh-list
153796143|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153796144|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796145|NCT04652518|Pirfenidone|pirfenidone|mesh-list
153796146|NCT04652518|Analgesics|analgesics|mesh-ancestor
153796187|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153861506|NCT00548561|Razoxane|razoxane|mesh-list
153861507|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861508|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153861509|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153861510|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153861511|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861512|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861513|NCT00548561|Protective Agents|protective agents|mesh-ancestor
153861514|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861515|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
153861516|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
153861517|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
153861518|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
153861519|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
153796188|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796189|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796190|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153796191|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153796192|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
153796193|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796194|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796195|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153796196|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796197|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796198|NCT04329728|Dexamethasone|dexamethasone|mesh-list
153796199|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153796200|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153796215|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796216|NCT04291599|Ketorolac|ketorolac|mesh-list
153796217|NCT04291599|Morphine|morphine|mesh-list
153796218|NCT04291599|Hydromorphone|hydromorphone|mesh-list
153796219|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153796220|NCT04291599|Narcotics|narcotics|mesh-ancestor
153796221|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796254|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
153796255|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796256|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
153796257|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153796258|NCT04067726|Vitamin D|vitamin d|mesh-list
153796259|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
153796260|NCT04067726|Denosumab|denosumab|mesh-list
153796261|NCT04067726|Calcium|calcium|mesh-list
153796262|NCT04067726|Vitamins|vitamins|mesh-ancestor
153796263|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
153796267|NCT04045795|Dexamethasone|dexamethasone|mesh-list
153796268|NCT04045795|Pomalidomide|pomalidomide|mesh-list
153796269|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153796270|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153796271|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
153796272|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
153796273|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796274|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796275|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796276|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
153796277|NCT04045795|Hormones|hormones|mesh-ancestor
153796278|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796280|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861526|NCT00548678|Ketorolac|ketorolac|mesh-list
153861527|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153861528|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153861529|NCT00548678|Analgesics|analgesics|mesh-ancestor
153861541|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
153796299|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153796300|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153796301|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796303|NCT03932409|Carboplatin|carboplatin|mesh-list
153796304|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
153796305|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153796306|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796307|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
153796308|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
153796309|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
153796310|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796311|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796312|NCT03932409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796314|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796315|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796316|NCT03828773|Fluconazole|fluconazole|mesh-list
153796317|NCT03828773|Posaconazole|posaconazole|mesh-list
153796318|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
153796319|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153796320|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153796321|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153796322|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796323|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796324|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153796325|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
153796326|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796327|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796328|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153796329|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153593437|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401876|NCT05986968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153401877|NCT05986968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153401878|NCT05986968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401880|NCT05986968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153401881|NCT05986968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153401882|NCT05986968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153401883|NCT05986968|Purinergic Agents|purinergic agents|mesh-ancestor
153401884|NCT05986968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401885|NCT05986734|Immunoglobulins|immunoglobulins|mesh-list
153401886|NCT05986734|Immunologic Factors|immunologic factors|mesh-ancestor
153401887|NCT05986734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401888|NCT05986344|Copper|copper|mesh-list
153401889|NCT05986344|Contraceptive Agents|contraceptive agents|mesh-list
153401890|NCT05986344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153401891|NCT05986344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401892|NCT05986344|Trace Elements|trace elements|mesh-ancestor
153796330|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153796331|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153796332|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153796333|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
153796334|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153796347|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796348|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153861551|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861552|NCT04684199|Protective Agents|protective agents|mesh-ancestor
153861553|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861554|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861555|NCT00560586|Budesonide|budesonide|mesh-list
153861556|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861557|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153796374|NCT03683069|Amlodipine|amlodipine|mesh-list
153796375|NCT03683069|Eplerenone|eplerenone|mesh-list
153796376|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153796377|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153796378|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153796379|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796381|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796382|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
153796383|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153796384|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
153796385|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796386|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153796387|NCT03683069|Diuretics|diuretics|mesh-ancestor
153796389|NCT03670056|Nivolumab|nivolumab|mesh-list
153401905|NCT05985798|Chlorotrianisene|chlorotrianisene|mesh-list
153401906|NCT05985798|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153401908|NCT05985798|Hormones|hormones|mesh-ancestor
153401909|NCT05985798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796426|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796427|NCT03567642|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153796428|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153796429|NCT03543839|Belimumab|belimumab|mesh-list
153796430|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153796431|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
153796432|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796433|NCT03534947|Imiquimod|imiquimod|mesh-list
153796434|NCT03534947|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153796435|NCT03534947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796436|NCT03534947|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153796437|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
153796438|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796439|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153796440|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796441|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
153796442|NCT03530124|Vaccines|vaccines|mesh-list
153796443|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153796444|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
153796445|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796446|NCT03522168|Risperidone|risperidone|mesh-list
153796447|NCT03522168|Aripiprazole|aripiprazole|mesh-list
153861568|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153861569|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861570|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153861571|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861572|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861573|NCT00549107|Simendan|simendan|mesh-list
153861574|NCT00549107|Milrinone|milrinone|mesh-list
153796484|NCT03435003|Desflurane|desflurane|mesh-list
153796485|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153796486|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153796487|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
153796488|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
153796489|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796490|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796491|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796492|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
153796493|NCT03435003|Hormones|hormones|mesh-ancestor
153796494|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796495|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796496|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796497|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
153796498|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796499|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153796500|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153796501|NCT03435003|Analgesics|analgesics|mesh-ancestor
153796502|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
153796503|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153796504|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153861575|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153861576|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
153861577|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153861578|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153861579|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410663|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410664|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410665|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410666|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410667|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
153410668|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410669|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410670|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410671|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
153410672|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410673|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410674|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153861580|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401910|NCT05985798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401911|NCT05985798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153401912|NCT05985798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401913|NCT05985278|Catalase|catalase|mesh-list
153401914|NCT05985278|Antioxidants|antioxidants|mesh-ancestor
153401915|NCT05985278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401916|NCT05985278|Protective Agents|protective agents|mesh-ancestor
153401917|NCT05985278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401918|NCT05985187|Docetaxel|docetaxel|mesh-list
153796510|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
153796511|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153796512|NCT03435003|Narcotics|narcotics|mesh-ancestor
153796513|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153796527|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
153796528|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153796533|NCT03365362|Varenicline|varenicline|mesh-list
153796560|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796561|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
153796562|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
153796563|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796564|NCT03238248|Azacitidine|azacitidine|mesh-list
153796565|NCT03238248|Pevonedistat|pevonedistat|mesh-list
153796566|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153796567|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
153796568|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796569|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796570|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796571|NCT03214510|Fentanyl|fentanyl|mesh-list
153796572|NCT03214510|Hydromorphone|hydromorphone|mesh-list
153796573|NCT03214510|Bupivacaine|bupivacaine|mesh-list
153796574|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
153796575|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
153796576|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796592|NCT03148418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796594|NCT03148418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153343129|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
153796595|NCT03148418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815050|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357552|NCT04274738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870097|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
153870098|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153870099|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
153870100|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870101|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796596|NCT03148418|Growth Substances|growth substances|mesh-ancestor
153796597|NCT03148418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796598|NCT03148418|Growth Inhibitors|growth inhibitors|mesh-ancestor
153593438|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593439|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593440|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
153593441|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
153593442|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593443|NCT01843010|Parecoxib|parecoxib|mesh-list
153593444|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153593445|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153593446|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861582|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861583|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153861584|NCT00549146|Fluticasone|fluticasone|mesh-list
153861585|NCT00549146|Xhance|xhance|mesh-list
153861586|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153796599|NCT03148418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796600|NCT03148418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796601|NCT03119584|Linaclotide|linaclotide|mesh-list
153796602|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153796603|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
153796604|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796605|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796606|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153796607|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153796609|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153796610|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
153796611|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796612|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796613|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153796614|NCT02964013|Carboplatin|carboplatin|mesh-list
153796615|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
153796616|NCT02964013|Etoposide|etoposide|mesh-list
153796617|NCT02964013|Pemetrexed|pemetrexed|mesh-list
153796618|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593447|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593448|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153593449|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153593450|NCT01843010|Analgesics|analgesics|mesh-ancestor
153593451|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
153593452|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593453|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593454|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153593455|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153459944|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
153459945|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459946|NCT05335148|Colchicine|colchicine|mesh-list
153459947|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
153459948|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861587|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153861588|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861589|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153401920|NCT05985187|Pertuzumab|pertuzumab|mesh-list
153401921|NCT05985187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410692|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153401922|NCT05985187|Tubulin Modulators|tubulin modulators|mesh-ancestor
153401923|NCT05985187|Antimitotic Agents|antimitotic agents|mesh-ancestor
153401924|NCT05985187|Mitosis Modulators|mitosis modulators|mesh-ancestor
153401925|NCT05985187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401926|NCT05985187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401927|NCT05985070|Vitamin D|vitamin d|mesh-list
153401928|NCT05985070|Cholecalciferol|cholecalciferol|mesh-list
153401929|NCT05985070|Vitamins|vitamins|mesh-ancestor
153401930|NCT05985070|Micronutrients|micronutrients|mesh-ancestor
153401931|NCT05985070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796619|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796620|NCT02964013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796621|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861590|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
153861591|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861592|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861593|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153861594|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
153861595|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
153861596|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153861597|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153861598|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153861599|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153861600|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
153861601|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861602|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861603|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
153796667|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
153343201|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343209|NCT00003634|Oregovomab|oregovomab|mesh-list
153796668|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
153796669|NCT02717624|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153796670|NCT02717624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153796671|NCT02717624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796673|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401937|NCT05984511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401938|NCT05984511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401939|NCT05984511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153401940|NCT05984511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153401941|NCT05984511|Growth Substances|growth substances|mesh-ancestor
153401942|NCT05984511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401943|NCT05984511|Growth Inhibitors|growth inhibitors|mesh-ancestor
153401944|NCT05984511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153401945|NCT05984511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401946|NCT05984511|Immunologic Factors|immunologic factors|mesh-ancestor
153401948|NCT05983952|Immunologic Factors|immunologic factors|mesh-ancestor
153401949|NCT05983952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401951|NCT05983237|Fluzoparib|fluzoparib|mesh-list
153401952|NCT05983237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153401953|NCT05983237|Alkylating Agents|alkylating agents|mesh-ancestor
153796714|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153796715|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
153796718|NCT02560805|Losartan|losartan|mesh-list
153861605|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861606|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
153861607|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
153861608|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153861609|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153861610|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861611|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
153870133|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153870135|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870136|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410714|NCT00004845|Rofecoxib|rofecoxib|mesh-list
153861612|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861613|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861614|NCT00549419|Dobutamine|dobutamine|mesh-list
153861615|NCT00549419|Norepinephrine|norepinephrine|mesh-list
153861616|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153861617|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153861618|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
153796749|NCT02542293|Paclitaxel|paclitaxel|mesh-list
153796750|NCT02542293|Cisplatin|cisplatin|mesh-list
153796751|NCT02542293|Carboplatin|carboplatin|mesh-list
153796752|NCT02542293|Gemcitabine|gemcitabine|mesh-list
153796753|NCT02542293|Pemetrexed|pemetrexed|mesh-list
153796754|NCT02542293|Durvalumab|durvalumab|mesh-list
153796755|NCT02542293|Tremelimumab|tremelimumab|mesh-list
153796756|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153796758|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
153861620|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401954|NCT05983237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401956|NCT05983237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153401957|NCT05983237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401958|NCT05983055|Dexamethasone|dexamethasone|mesh-list
153401959|NCT05983055|Dexamethasone acetate|dexamethasone acetate|mesh-list
153401960|NCT05983055|BB 1101|bb 1101|mesh-list
153401961|NCT05983055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401962|NCT05983055|Antiemetics|antiemetics|mesh-ancestor
153796808|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
153796809|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796810|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796811|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796840|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153796842|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
153796843|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153796844|NCT01940094|Hormones|hormones|mesh-ancestor
153796845|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796846|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796849|NCT01862991|Digoxin|digoxin|mesh-list
153796887|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
153343423|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
153796888|NCT01701674|Fludarabine|fludarabine|mesh-list
153796889|NCT01701674|Ipilimumab|ipilimumab|mesh-list
153796890|NCT01701674|Interleukin-2|interleukin-2|mesh-list
153796891|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153796892|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
153796893|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796894|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153796895|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153796896|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
153796897|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796898|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796899|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153796900|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796901|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796902|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153796903|NCT01701674|Analgesics|analgesics|mesh-ancestor
153796904|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
153796914|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796916|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
153796917|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796918|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153796919|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
153796920|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153796921|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153796922|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153796923|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796924|NCT01588431|Bevacizumab|bevacizumab|mesh-list
153796925|NCT01588431|Cetuximab|cetuximab|mesh-list
153796926|NCT01588431|Cisplatin|cisplatin|mesh-list
153796927|NCT01588431|Docetaxel|docetaxel|mesh-list
153796928|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796929|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796930|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153796931|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153796932|NCT01588431|Growth Substances|growth substances|mesh-ancestor
153459949|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
153796934|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
153796935|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
153796936|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
153796937|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
153796938|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870158|NCT00587015|Immunoconjugates|immunoconjugates|mesh-ancestor
153796939|NCT01330446|Modafinil|modafinil|mesh-list
153796940|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153796941|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796942|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153796943|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153796944|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153796945|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796946|NCT01323374|Carbidopa|carbidopa|mesh-list
153796947|NCT01323374|Droxidopa|droxidopa|mesh-list
153796948|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153796949|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153796950|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
153796951|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796952|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796953|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796954|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153796955|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796956|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153796957|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153796958|NCT01233297|Azithromycin|azithromycin|mesh-list
153796959|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153796960|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343499|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343573|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
153343574|NCT00003934|Tretinoin|tretinoin|mesh-list
153796961|NCT00876772|Olanzapine|olanzapine|mesh-list
153796962|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
153870159|NCT00587015|Immunologic Factors|immunologic factors|mesh-ancestor
153870160|NCT00587015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870161|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870162|NCT04568772|Atovaquone|atovaquone|mesh-list
153870163|NCT04568772|Proguanil|proguanil|mesh-list
153870164|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153870165|NCT04568772|Esomeprazole|esomeprazole|mesh-list
153870166|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153870167|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153870168|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153870169|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870172|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
153796963|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
153796964|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459950|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
153459951|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
153459952|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401990|NCT05911594|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153861629|NCT00549419|Protective Agents|protective agents|mesh-ancestor
153861631|NCT04643691|Spironolactone|spironolactone|mesh-list
153861632|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153861633|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153861634|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153861635|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153861636|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861637|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153861638|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
153861639|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861640|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796965|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796978|NCT00692939|Melphalan|melphalan|mesh-list
153796979|NCT00692939|Thiotepa|thiotepa|mesh-list
153796980|NCT00692939|Rituximab|rituximab|mesh-list
153796981|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
153796982|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
153796983|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153796984|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153796985|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
153796986|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796987|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797010|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797011|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153797012|NCT00577200|Narcotics|narcotics|mesh-ancestor
153797013|NCT00577200|Analgesics|analgesics|mesh-ancestor
153797014|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
153797015|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797016|NCT00299559|Camphor|camphor|mesh-list
153797017|NCT00299559|Menthol|menthol|mesh-list
153797018|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
153797019|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
153797020|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153797021|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797022|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153797023|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797024|NCT00263198|Letrozole|letrozole|mesh-list
153797025|NCT00263198|Vatalanib|vatalanib|mesh-list
153797026|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797027|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153797028|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153797029|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797061|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153797062|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
153797063|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153797064|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797065|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153797066|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593459|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593460|NCT01843075|Incretins|incretins|mesh-ancestor
153593461|NCT01843075|Hormones|hormones|mesh-ancestor
153593462|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593463|NCT01843088|Mannitol|mannitol|mesh-list
153593464|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153593465|NCT01843088|Diuretics|diuretics|mesh-ancestor
153593466|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
153593467|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593468|NCT01843127|Exenatide|exenatide|mesh-list
153593469|NCT01843127|Ranolazine|ranolazine|mesh-list
153593470|NCT01843127|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153593471|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153593472|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593473|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153593474|NCT01843127|Incretins|incretins|mesh-ancestor
153593475|NCT01843127|Hormones|hormones|mesh-ancestor
153593476|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593477|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153593478|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593479|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593480|NCT01843153|Ropivacaine|ropivacaine|mesh-list
153593481|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
153593482|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
153402001|NCT05911594|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153402002|NCT05911594|Urological Agents|urological agents|mesh-ancestor
153797067|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
153797068|NCT00263315|Amphotericin B|amphotericin b|mesh-list
153797081|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797083|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797084|NCT00299832|Aliskiren|aliskiren|mesh-list
153797085|NCT00299832|Renin Inhibitors|renin inhibitors|mesh-ancestor
153797086|NCT00299832|Protease Inhibitors|protease inhibitors|mesh-ancestor
153797087|NCT00299832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797088|NCT00299832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797089|NCT00263393|Atenolol|atenolol|mesh-list
153797090|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153797091|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153797092|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153797093|NCT00263393|Diuretics|diuretics|mesh-ancestor
153797094|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
153797095|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797096|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153797097|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797098|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797099|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153797100|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
153797101|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
153797102|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861656|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153861657|NCT00559026|Dacarbazine|dacarbazine|mesh-list
153861658|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153861659|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
153861660|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861661|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861662|NCT00549887|Insulin|insulin|mesh-list
153861663|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153861664|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153797107|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797108|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
153797109|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736323|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153736324|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736325|NCT03038672|Nivolumab|nivolumab|mesh-list
153736326|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
153797110|NCT00299910|Montelukast|montelukast|mesh-list
153797111|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153797112|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
153797113|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153797114|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
153797115|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797116|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797117|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153811000|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153811001|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153410781|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
153410782|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410783|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153861665|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861666|NCT00549926|Atorvastatin|atorvastatin|mesh-list
153861667|NCT00549926|Pravastatin|pravastatin|mesh-list
153861668|NCT00549926|Pitavastatin|pitavastatin|mesh-list
153402003|NCT05900882|Dexamethasone|dexamethasone|mesh-list
153402004|NCT05900882|Lenalidomide|lenalidomide|mesh-list
153797154|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797155|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153797156|NCT00263822|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153797157|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153797158|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797159|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797160|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797161|NCT00300222|Capsaicin|capsaicin|mesh-list
153797162|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
153797163|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
153797164|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
153797165|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797166|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797167|NCT00263978|Defibrotide|defibrotide|mesh-list
153797168|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153797169|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153797170|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797171|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153797172|NCT00264134|Carboplatin|carboplatin|mesh-list
153797173|NCT00264134|Docetaxel|docetaxel|mesh-list
153797174|NCT00264134|Irinotecan|irinotecan|mesh-list
153797175|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797176|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
153797177|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
153797178|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
153797179|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797180|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153797181|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153797182|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593483|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593484|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593486|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593487|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153593488|NCT01843166|Estrogens|estrogens|mesh-ancestor
153593489|NCT01843166|Hormones|hormones|mesh-ancestor
153797183|NCT00300339|Clopidogrel|clopidogrel|mesh-list
153797184|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153797185|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153797215|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153797216|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153797217|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797218|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797219|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797220|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797221|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
153797223|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
153797224|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153797225|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797226|NCT00294567|Amlodipine|amlodipine|mesh-list
153797251|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797252|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797253|NCT00294606|Protective Agents|protective agents|mesh-ancestor
153797254|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
153797255|NCT04708964|Analgesics|analgesics|mesh-ancestor
153593490|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593491|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593492|NCT01843179|Cytarabine|cytarabine|mesh-list
153593493|NCT01843179|Sulindac|sulindac|mesh-list
153593494|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153593495|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
153410798|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
153593496|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593497|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593498|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
153593499|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593500|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153593501|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
153593502|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861669|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153861670|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153861671|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
153861672|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861673|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153861674|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153861675|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861676|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
153861677|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153343801|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797256|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
153797257|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797258|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797259|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153797260|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797261|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797262|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797263|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153797264|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797265|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797266|NCT00264368|Ganciclovir|ganciclovir|mesh-list
153797267|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153797268|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
153797269|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797270|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153797271|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797272|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797274|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797296|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797297|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153797298|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153797306|NCT00264680|Valproic Acid|valproic acid|mesh-list
153357555|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
153410825|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153410826|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
153410827|NCT00003591|Paclitaxel|paclitaxel|mesh-list
153410828|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410829|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410830|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410831|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410832|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
153797307|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153797308|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797309|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797310|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153797311|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797312|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153797313|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153797314|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797315|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153797316|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153797317|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797318|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
153797319|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797320|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
153797321|NCT00300729|Celecoxib|celecoxib|mesh-list
153797322|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153797323|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797324|NCT00300729|Analgesics|analgesics|mesh-ancestor
153797325|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
153811002|NCT00353067|Analgesics|analgesics|mesh-ancestor
153797326|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797327|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797361|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797362|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797363|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153797364|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797365|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153402026|NCT05875857|Analgesics|analgesics|mesh-ancestor
153593503|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153593504|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153593505|NCT01843179|Analgesics|analgesics|mesh-ancestor
153593516|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593517|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
153593518|NCT01843296|Fentanyl|fentanyl|mesh-list
153593519|NCT01843296|Bupivacaine|bupivacaine|mesh-list
153593520|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
153593521|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
153593522|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593523|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593524|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
153593525|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593526|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153593527|NCT01843296|Narcotics|narcotics|mesh-ancestor
153593528|NCT01843296|Analgesics|analgesics|mesh-ancestor
153593529|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153861687|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861688|NCT04634721|Bupivacaine|bupivacaine|mesh-list
153861689|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
153861690|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
153861691|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861692|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861693|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
153861694|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861695|NCT00550160|Artesunate|artesunate|mesh-list
153861696|NCT00550160|Amodiaquine|amodiaquine|mesh-list
153861697|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
153797367|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153797398|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797399|NCT00265031|Prednisone|prednisone|mesh-list
153357556|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797400|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
153797401|NCT00265031|Etoposide|etoposide|mesh-list
153797402|NCT00265031|Vincristine|vincristine|mesh-list
153797403|NCT00265031|Doxorubicin|doxorubicin|mesh-list
153797452|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
153797453|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797454|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797455|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797456|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797457|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153797458|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153797459|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797460|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797461|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797462|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153797463|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153797464|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153797465|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797466|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797467|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
153797468|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797469|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797470|NCT00418275|Plasminogen|plasminogen|mesh-list
153797471|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153797472|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153797487|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153797488|NCT00265460|Lobeline|lobeline|mesh-list
153797489|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153797490|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
153797491|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797492|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797493|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153797494|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153797495|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
153797496|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797497|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797498|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
153861718|NCT04643301|Incretins|incretins|mesh-ancestor
153861719|NCT04643301|Hormones|hormones|mesh-ancestor
153861720|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861721|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
153797505|NCT00265694|Vinorelbine|vinorelbine|mesh-list
153797506|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797507|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153797508|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
153797509|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797510|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153797511|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
153797512|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
153797513|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
153797514|NCT00265733|Paclitaxel|paclitaxel|mesh-list
153797515|NCT00265733|Capecitabine|capecitabine|mesh-list
153797516|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153797517|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153797518|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797519|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
153797520|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
153797521|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
153797522|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797523|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153797524|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
153797525|NCT00265772|Prednisolone|prednisolone|mesh-list
153797526|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797527|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
153797528|NCT00265772|Hormones|hormones|mesh-ancestor
153797529|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797547|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
153344098|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
153797548|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797549|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797550|NCT00265928|Rituximab|rituximab|mesh-list
153402087|NCT05814640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153402088|NCT05814640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402089|NCT05814640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402090|NCT05814640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153402091|NCT05814640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153797557|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797558|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153797559|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797560|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797561|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797562|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
153797563|NCT00295347|Spironolactone|spironolactone|mesh-list
153797564|NCT00295347|Escitalopram|escitalopram|mesh-list
153797565|NCT00295347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153797566|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153797567|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797568|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797569|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797570|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
153797571|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797572|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153797573|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
153797574|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797575|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153797576|NCT00295347|Diuretics|diuretics|mesh-ancestor
153797577|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
153797578|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797579|NCT00265967|Irbesartan|irbesartan|mesh-list
153870271|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870272|NCT03452501|Infliximab|infliximab|mesh-list
153870273|NCT03452501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153870274|NCT03452501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153870275|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
153870276|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153870277|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870278|NCT00588302|Moexipril|moexipril|mesh-list
153870279|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153870280|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
153870281|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870282|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870284|NCT01084005|Linagliptin|linagliptin|mesh-list
153797580|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153593530|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153593531|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
153593532|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153593533|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
153593534|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153593535|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593536|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593537|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153593538|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
153818554|NCT04284839|Apixaban|apixaban|mesh-list
153818555|NCT04284839|Edoxaban|edoxaban|mesh-list
153797581|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153797582|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153797583|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797584|NCT00295386|Zopiclone|zopiclone|mesh-list
153797585|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153797597|NCT00295425|Cyclosporine|cyclosporine|mesh-list
153870301|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153797598|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
153797599|NCT00295425|Cyclosporins|cyclosporins|mesh-list
153797600|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797601|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797602|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153797603|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
153797604|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797606|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797607|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
153797608|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797609|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153797610|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153797611|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797612|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153797613|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
153797614|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153797615|NCT00266123|Sirolimus|sirolimus|mesh-list
153797616|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153797617|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797618|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153797619|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797620|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
153797621|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818556|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
153344246|NCT00384826|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153797622|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
153797623|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797625|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153797626|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153797627|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797628|NCT00295464|Betamethasone|betamethasone|mesh-list
153797629|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797630|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
153797632|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797633|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797634|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153797635|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
153797636|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153797637|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153797638|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797639|NCT00301392|Pitavastatin|pitavastatin|mesh-list
153797640|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153797641|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153797642|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153797643|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
153797644|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861752|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
153861753|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
153861754|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861755|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153861756|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
153861757|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861758|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861759|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153861760|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
153861761|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153861765|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
153818557|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153818558|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
153870311|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402110|NCT05814640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153402111|NCT05814640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402112|NCT05814640|Antimanic Agents|antimanic agents|mesh-ancestor
153797663|NCT00415883|Valsartan|valsartan|mesh-list
153797664|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153797665|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153797666|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153797667|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797668|NCT00295542|Atenolol|atenolol|mesh-list
153797669|NCT00295542|Valsartan|valsartan|mesh-list
153797670|NCT00295542|Telmisartan|telmisartan|mesh-list
153797671|NCT00295542|Carvedilol|carvedilol|mesh-list
153797672|NCT00295542|Olmesartan|olmesartan|mesh-list
153797673|NCT00295542|Enalapril|enalapril|mesh-list
153797674|NCT00295542|Lisinopril|lisinopril|mesh-list
153797675|NCT00295542|Nebivolol|nebivolol|mesh-list
153797676|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
153870312|NCT00588926|Analgesics|analgesics|mesh-ancestor
153870313|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
153870314|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870315|NCT00589082|Daunorubicin|daunorubicin|mesh-list
153870316|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153870317|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797677|NCT00295542|Doxazosin|doxazosin|mesh-list
153870318|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153870319|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153870320|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870321|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870322|NCT00589238|Paclitaxel|paclitaxel|mesh-list
153870323|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
153870324|NCT00589238|Carboplatin|carboplatin|mesh-list
153870325|NCT00589238|Doxorubicin|doxorubicin|mesh-list
153797678|NCT00295542|Indapamide|indapamide|mesh-list
153797679|NCT00295542|Quinapril|quinapril|mesh-list
153797680|NCT00295542|Torsemide|torsemide|mesh-list
153797681|NCT00295542|Spirapril|spirapril|mesh-list
153797682|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153797683|NCT00295542|Diuretics|diuretics|mesh-list
153797684|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153797685|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153797686|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797687|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153797688|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
153797689|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402113|NCT05814640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153402114|NCT05814640|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153402115|NCT05810597|Tirzepatide|tirzepatide|mesh-list
153402116|NCT05810597|Incretins|incretins|mesh-ancestor
153402118|NCT05810597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153402120|NCT05804084|Acetazolamide|acetazolamide|mesh-list
153818559|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153818560|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
153818561|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818562|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818563|NCT04263922|Valsartan|valsartan|mesh-list
153818564|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153818565|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153861771|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861772|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861773|NCT00550901|Protective Agents|protective agents|mesh-ancestor
153861774|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861775|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
153861776|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
153861777|NCT04633746|Endostatins|endostatins|mesh-list
153861778|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861779|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153861780|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153861781|NCT04633746|Growth Substances|growth substances|mesh-ancestor
153797690|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797691|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
153797692|NCT00295542|Protective Agents|protective agents|mesh-ancestor
153797693|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153797694|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797695|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153797696|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
153797697|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153797698|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153797700|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153797701|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
153797702|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797703|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153797717|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797718|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
153797720|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
153797732|NCT00301509|Ribavirin|ribavirin|mesh-list
153797733|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
153797734|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797735|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
153797736|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797737|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
153797738|NCT00295698|Filaricides|filaricides|mesh-ancestor
153797739|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
153797740|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
153797741|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153797742|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797743|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153797744|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797745|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797746|NCT00266552|Risperidone|risperidone|mesh-list
153797747|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153797748|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
153797749|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797750|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797751|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861782|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861783|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
153861784|NCT00551018|Tenofovir|tenofovir|mesh-list
153861785|NCT00551018|Emtricitabine|emtricitabine|mesh-list
153861786|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
153861787|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818566|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153818567|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818568|NCT04209595|Rucaparib|rucaparib|mesh-list
153818569|NCT04209595|Ondansetron|ondansetron|mesh-list
153818570|NCT04209595|Antiemetics|antiemetics|mesh-ancestor
153818571|NCT04209595|Autonomic Agents|autonomic agents|mesh-ancestor
153818572|NCT04209595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818573|NCT04209595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818574|NCT04209595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153818575|NCT04209595|Antipruritics|antipruritics|mesh-ancestor
153459959|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459960|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153459961|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153593539|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153593540|NCT01843309|Spironolactone|spironolactone|mesh-list
153593541|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153593542|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
153593543|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593549|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
153593550|NCT01843439|Vitamins|vitamins|mesh-ancestor
153593551|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
153593552|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593554|NCT01843452|Mitomycins|mitomycins|mesh-list
153593555|NCT01843452|Mitomycin|mitomycin|mesh-list
153402136|NCT05752916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153402137|NCT05752916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402138|NCT05752916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402139|NCT05752916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153402140|NCT05752916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153402141|NCT05752916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153402142|NCT05752916|Purinergic Agents|purinergic agents|mesh-ancestor
153402143|NCT05752916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402145|NCT05752409|Propofol|propofol|mesh-list
153402146|NCT05752409|Esketamine|esketamine|mesh-list
153402147|NCT05752409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153402148|NCT05752409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797753|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153797754|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797755|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153797756|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153797757|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
153797758|NCT00301587|Folic Acid|folic acid|mesh-list
153797759|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
153797760|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153797761|NCT00301587|Norgestimate|norgestimate|mesh-list
153410944|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
153797762|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153797763|NCT00301587|Estradiol|estradiol|mesh-list
153797764|NCT00301587|Estrogens|estrogens|mesh-ancestor
153861797|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
153861798|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861799|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861800|NCT00551252|Gemcitabine|gemcitabine|mesh-list
153861801|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
153861802|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861803|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
153861804|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797805|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797806|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797807|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153797808|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797810|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153797811|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797812|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153797813|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153797814|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
153797831|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797832|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797833|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153344395|NCT00004072|Carmustine|carmustine|mesh-list
153797850|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797851|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153797852|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
153797853|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797854|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153797855|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
153797856|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153797857|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
153797858|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153797859|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153797860|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797861|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797862|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153797863|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797864|NCT00267176|Analgesics|analgesics|mesh-ancestor
153797865|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
153797866|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797867|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797868|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797869|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797880|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861808|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593556|NCT01843452|Panitumumab|panitumumab|mesh-list
153593557|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153593558|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
153593559|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593560|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593561|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153593562|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
153593563|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153593564|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593565|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153593566|NCT01843647|Cisplatin|cisplatin|mesh-list
153459962|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
153459963|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459964|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459965|NCT05216432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153459966|NCT05216432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811003|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
153870374|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870378|NCT00589901|Capecitabine|capecitabine|mesh-list
153459967|NCT05216432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459968|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
153459969|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459970|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459971|NCT05200559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153459972|NCT05200559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459973|NCT05173987|Paclitaxel|paclitaxel|mesh-list
153459974|NCT05173987|Docetaxel|docetaxel|mesh-list
153459975|NCT05173987|Carboplatin|carboplatin|mesh-list
153459976|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
153459977|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153402163|NCT05746481|Carboplatin|carboplatin|mesh-list
153402164|NCT05746481|Pemetrexed|pemetrexed|mesh-list
153402165|NCT05746481|Atezolizumab|atezolizumab|mesh-list
153402166|NCT05746481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402167|NCT05746481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797882|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153797883|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153797884|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153797885|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153797886|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797887|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153797888|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
153797889|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153797890|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153797891|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
153797892|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
153797893|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153797894|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153797895|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
153797896|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153797897|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153797898|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797899|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459978|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459979|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
153593568|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593569|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153593570|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
153593571|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
153593572|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
153861816|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861817|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861818|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153861819|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
153861820|NCT01125761|Hormones|hormones|mesh-ancestor
153861821|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861822|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153861823|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861824|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
153797900|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153797901|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797902|NCT00267215|Analgesics|analgesics|mesh-ancestor
153797903|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
153797904|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736327|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
153797905|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797906|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797907|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797908|NCT00296049|Vancomycin|vancomycin|mesh-list
153870401|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153870402|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797909|NCT00296049|Daptomycin|daptomycin|mesh-list
153797910|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153797911|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797912|NCT00267254|Atorvastatin|atorvastatin|mesh-list
153797913|NCT00267254|Simvastatin|simvastatin|mesh-list
153797914|NCT00267254|Torcetrapib|torcetrapib|mesh-list
153344470|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
153797915|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153797916|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153797917|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
153797918|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797919|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153797920|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153797932|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797945|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153797946|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797947|NCT04718649|Analgesics|analgesics|mesh-ancestor
153797948|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
153797949|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797950|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797951|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797952|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797953|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153797954|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153797955|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797956|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797957|NCT00301860|Cyclosporine|cyclosporine|mesh-list
153797958|NCT00301860|Methotrexate|methotrexate|mesh-list
153797959|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
153797960|NCT00301860|Fludarabine|fludarabine|mesh-list
153797961|NCT00301860|Melphalan|melphalan|mesh-list
153797962|NCT00301860|Cyclosporins|cyclosporins|mesh-list
153797963|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153797964|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153797965|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
153797966|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153797967|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797968|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861825|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861826|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861827|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
153861828|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
153861829|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153861830|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
153861831|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
153861832|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861833|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153861834|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
153593573|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593574|NCT01843699|Topiramate|topiramate|mesh-list
153870424|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153870425|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870426|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
153870427|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870428|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870429|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153870430|NCT01081626|Hormones|hormones|mesh-ancestor
153870431|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153402184|NCT05715411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402185|NCT05715411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402186|NCT05715411|Adrenergic Agents|adrenergic agents|mesh-ancestor
153402187|NCT05715411|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153402188|NCT05715411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153402189|NCT05715411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402190|NCT05715411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153402191|NCT05714384|Calcium|calcium|mesh-list
153402192|NCT05714384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153402193|NCT05714384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402194|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153402195|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861835|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
153861836|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797969|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
153797970|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797971|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797972|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
153797973|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797974|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153797975|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153797976|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
153797977|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797978|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153797979|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
153798010|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798011|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153798012|NCT00267722|Visilizumab|visilizumab|mesh-list
153798013|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
153798014|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798015|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153798016|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798017|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153798018|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798019|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798020|NCT00296361|Tacrolimus|tacrolimus|mesh-list
153798021|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798022|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
153798023|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798024|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153798025|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798026|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798027|NCT00415922|Levodopa|levodopa|mesh-list
153798028|NCT00415922|Carbidopa|carbidopa|mesh-list
153798029|NCT00415922|Entacapone|entacapone|mesh-list
153798030|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153798031|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153798032|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153870441|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
153870442|NCT01080768|Renin Inhibitors|renin inhibitors|mesh-ancestor
153870443|NCT01080768|Protease Inhibitors|protease inhibitors|mesh-ancestor
153870444|NCT01080768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870445|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153870446|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153870447|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870448|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870452|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
153798033|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
153798034|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798035|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798036|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798037|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153798038|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861840|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
153861841|NCT05408312|Vaccines|vaccines|mesh-list
153861842|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
153861843|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861844|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153861845|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
153402202|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
153402203|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402204|NCT05646082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402205|NCT05621811|ATI 7505|ati 7505|mesh-list
153402206|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153798039|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153798040|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153798041|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
153798042|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
153798043|NCT00302016|Nilotinib|nilotinib|mesh-list
153798044|NCT00302016|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153798045|NCT00302016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153798046|NCT00302016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798047|NCT00302016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798048|NCT00415961|Paclitaxel|paclitaxel|mesh-list
153798049|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153798050|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798051|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798052|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798053|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798054|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798073|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798074|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798086|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798087|NCT00268229|Cytarabine|cytarabine|mesh-list
153798088|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
153798089|NCT00268229|Daunorubicin|daunorubicin|mesh-list
153798090|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153798091|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
153798092|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798093|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798094|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
153798095|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798096|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798097|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
153798098|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798099|NCT00268229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153798100|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153798101|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798102|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153798103|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153798104|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153798105|NCT00302289|Caffeine|caffeine|mesh-list
153798106|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153811005|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411076|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153870475|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870476|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
153798107|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798108|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153798109|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798110|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798111|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153798143|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798144|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153593575|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
153593576|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153593577|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593578|NCT01843725|Capecitabine|capecitabine|mesh-list
153593579|NCT01843725|Aflibercept|aflibercept|mesh-list
153593580|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153593581|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
153861867|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798145|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153798147|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153798148|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
153798149|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153798161|NCT00296751|Fentanyl|fentanyl|mesh-list
153798162|NCT00296751|Meperidine|meperidine|mesh-list
153798163|NCT00296751|Bupivacaine|bupivacaine|mesh-list
153798164|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
153798165|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
153798166|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798167|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798168|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
153798169|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798170|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153798171|NCT00296751|Narcotics|narcotics|mesh-ancestor
153798172|NCT00296751|Analgesics|analgesics|mesh-ancestor
153798173|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153798174|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153798175|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
153798176|NCT00302367|Methylphenidate|methylphenidate|mesh-list
153798177|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153798178|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798179|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153798180|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153798181|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593582|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593583|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593584|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153870477|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870478|NCT00590603|Protective Agents|protective agents|mesh-ancestor
153870479|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870480|NCT00590603|Vitamins|vitamins|mesh-ancestor
153870481|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
153870482|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
153870483|NCT01085097|Prednisone|prednisone|mesh-list
153870484|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
153870485|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153870486|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153870487|NCT01085097|Prednisolone|prednisolone|mesh-list
153593585|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153593586|NCT01843725|Growth Substances|growth substances|mesh-ancestor
153593587|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593588|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
153593589|NCT01843738|Vemurafenib|vemurafenib|mesh-list
153593590|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593591|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153593592|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593593|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593594|NCT01843829|Paclitaxel|paclitaxel|mesh-list
153593595|NCT01843829|Carboplatin|carboplatin|mesh-list
153593596|NCT01843829|Capecitabine|capecitabine|mesh-list
153593609|NCT01843868|Vincristine|vincristine|mesh-list
153593610|NCT01843868|Lorazepam|lorazepam|mesh-list
153593611|NCT01843868|Ondansetron|ondansetron|mesh-list
153593612|NCT01843868|Aprepitant|aprepitant|mesh-list
153593613|NCT01843868|Metoclopramide|metoclopramide|mesh-list
153593614|NCT01843868|Palonosetron|palonosetron|mesh-list
153593615|NCT01843868|Granisetron|granisetron|mesh-list
153593616|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
153402222|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
153402223|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153402224|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153402225|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402226|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402227|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153402228|NCT05584137|Antibodies|antibodies|mesh-list
153402229|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
153402230|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153402231|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
153798182|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798183|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
153798184|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798185|NCT00296790|Zolpidem|zolpidem|mesh-list
153798186|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153870494|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870495|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411107|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411108|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411109|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
153411110|NCT00004077|Paclitaxel|paclitaxel|mesh-list
153411111|NCT00004077|Ifosfamide|ifosfamide|mesh-list
153411112|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411113|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411114|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411115|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411116|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798187|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153798188|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798189|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798190|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153798191|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
153798192|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
153798193|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798204|NCT00268814|Methadone|methadone|mesh-list
153798209|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861878|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153861879|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
153861880|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798210|NCT00268814|Analgesics|analgesics|mesh-ancestor
153798211|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
153798212|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798229|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798230|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798231|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798232|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798234|NCT00296946|Ipratropium|ipratropium|mesh-list
153798235|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
153798236|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153798237|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
153798238|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798239|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798240|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153798241|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
153798242|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153798243|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
153798244|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798245|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798246|NCT00269048|Darapladib|darapladib|mesh-list
153798247|NCT00269048|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153798248|NCT00269048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798249|NCT00269048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798250|NCT00302523|Tacrolimus|tacrolimus|mesh-list
153798251|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798252|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
153402251|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402252|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153402253|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402254|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402255|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
153402256|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798265|NCT00269126|Xhance|xhance|mesh-list
153798266|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153798267|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153798268|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798269|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153798270|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
153798277|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153798278|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153798279|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153798280|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
153798281|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798282|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798283|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
153344866|NCT05297851|Niacin|niacin|mesh-list
153798284|NCT00269126|Hormones|hormones|mesh-ancestor
153798285|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798286|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
153798287|NCT00269204|Niacin|niacin|mesh-list
153798288|NCT00269204|Niacinamide|niacinamide|mesh-list
153798289|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
153798290|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153798291|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
153798292|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861908|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
153861909|NCT04639362|Ibrutinib|ibrutinib|mesh-list
153861910|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861911|NCT04639362|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153861912|NCT04639362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153861913|NCT04639362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861914|NCT04639362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861915|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153798301|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153798302|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
153798303|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798304|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798305|NCT00269243|Quinapril|quinapril|mesh-list
153798306|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153798307|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
153798308|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798309|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798310|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153798311|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153798312|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153798313|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798314|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798315|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
153798316|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798317|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
153798318|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
153798319|NCT00297219|Calcium|calcium|mesh-list
153593617|NCT01843868|Tropisetron|tropisetron|mesh-list
153870544|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870545|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153870546|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
153870547|NCT01083615|Hormones|hormones|mesh-ancestor
153870548|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411137|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411138|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411139|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411141|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411142|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411143|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411144|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
153411145|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153411147|NCT00004089|Paclitaxel|paclitaxel|mesh-list
153798320|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153798321|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798322|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153798323|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153798324|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
153798325|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153798326|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798327|NCT00418353|Dexamethasone|dexamethasone|mesh-list
153798328|NCT00418353|Betamethasone|betamethasone|mesh-list
153798329|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
153798330|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153798331|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
153798332|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
153798333|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153798334|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798335|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
153798336|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
153798337|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798338|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798359|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
153798360|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153798361|NCT00269555|Estrogens|estrogens|mesh-ancestor
153798363|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798364|NCT00418431|Bevacizumab|bevacizumab|mesh-list
153798365|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861916|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
153861917|NCT04639284|Antibodies|antibodies|mesh-list
153861918|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
153861919|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861920|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153861921|NCT04639284|Growth Substances|growth substances|mesh-ancestor
153861922|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
153861923|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861924|NCT00559689|Budesonide|budesonide|mesh-list
153861925|NCT00559689|Beclomethasone|beclomethasone|mesh-list
153593618|NCT01843868|Antiemetics|antiemetics|mesh-list
153593619|NCT01843868|Emetics|emetics|mesh-list
153593620|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153593621|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
153798367|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153798368|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153798369|NCT00418431|Growth Substances|growth substances|mesh-ancestor
153798370|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798371|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
153798372|NCT00269594|Lamotrigine|lamotrigine|mesh-list
153798373|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
153798374|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153798375|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153870549|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870550|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153870551|NCT00591188|Interferons|interferons|mesh-list
153870552|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
153870553|NCT00591188|Capecitabine|capecitabine|mesh-list
153870554|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153870555|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
153870556|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870557|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870558|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
153870559|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870560|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
153798376|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798377|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153798378|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798379|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153798380|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153798381|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798382|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153798383|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153798384|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153798385|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153798386|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593622|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593623|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153593624|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153593625|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
153593626|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593627|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593628|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153818576|NCT04209595|Dermatologic Agents|dermatologic agents|mesh-ancestor
153818577|NCT04209595|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153593629|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153593630|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153593631|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153861929|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861930|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861931|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153798387|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
153798407|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153798408|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798409|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153798410|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153798411|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153411185|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411186|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411187|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
153411188|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411189|NCT00004107|Epratuzumab|epratuzumab|mesh-list
153411190|NCT00004107|Antibodies|antibodies|mesh-list
153411193|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870575|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153870576|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
153870577|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870578|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
153870579|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798412|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798414|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798415|NCT00302913|Clopidogrel|clopidogrel|mesh-list
153798416|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153798417|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153798418|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153798419|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153798420|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
153798421|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798422|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798423|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798424|NCT00269828|Paclitaxel|paclitaxel|mesh-list
153798425|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153798431|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798432|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798433|NCT00269867|Infliximab|infliximab|mesh-list
153798434|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153798435|NCT00269867|Antibodies|antibodies|mesh-list
153798436|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
153798437|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153798438|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
153798439|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798440|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798464|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798465|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798466|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
153798467|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153798468|NCT00297375|Narcotics|narcotics|mesh-ancestor
153798469|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798470|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
153798471|NCT00270062|Hematinics|hematinics|mesh-ancestor
153798472|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
153798473|NCT00270101|Hematinics|hematinics|mesh-ancestor
153798474|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
153798475|NCT00270140|Hematinics|hematinics|mesh-ancestor
153798476|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
153411195|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411196|NCT00004113|Temozolomide|temozolomide|mesh-list
153411197|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411198|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
153411199|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411200|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411201|NCT00003675|Topotecan|topotecan|mesh-list
153411202|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153798477|NCT00270179|Hematinics|hematinics|mesh-ancestor
153798478|NCT00297570|Interferons|interferons|mesh-list
153798479|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
153593632|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593633|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153593634|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
153593635|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
153593636|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
153593637|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153593638|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
153593639|NCT01843868|Hormones|hormones|mesh-ancestor
153593640|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593641|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153593642|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
153593643|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593644|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593645|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
153593646|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
153593647|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153593648|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153593649|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
153593650|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593651|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153593652|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153593653|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153593654|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
153593655|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
153593656|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153593657|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402284|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153402286|NCT05493501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153402287|NCT05493501|Carboplatin|carboplatin|mesh-list
153402288|NCT05493501|Gemcitabine|gemcitabine|mesh-list
153798480|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798481|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
153798482|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798483|NCT00297570|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153798484|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153798485|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798486|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798487|NCT00270335|Propofol|propofol|mesh-list
153798488|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153798489|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798490|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798491|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153798492|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
153798493|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
153798494|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153798495|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
153798496|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798497|NCT00270491|Paclitaxel|paclitaxel|mesh-list
153798498|NCT00270491|Capecitabine|capecitabine|mesh-list
153798499|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153798514|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153798515|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798516|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798517|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153861943|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
153861944|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861945|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861946|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
153861948|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153861949|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153861950|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153861951|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153870605|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
153861952|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798523|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798524|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798525|NCT00270569|Cisplatin|cisplatin|mesh-list
153798526|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798527|NCT00297804|Paclitaxel|paclitaxel|mesh-list
153798528|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153798529|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798530|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798531|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798532|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798533|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798534|NCT00270647|Vitamins|vitamins|mesh-list
153798535|NCT00270647|Vitamin E|vitamin e|mesh-list
153798536|NCT00270647|Beta Carotene|beta carotene|mesh-list
153798537|NCT00270647|Carotenoids|carotenoids|mesh-list
153798538|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
153798539|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798540|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
153798542|NCT00270647|Protective Agents|protective agents|mesh-ancestor
153798552|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153798553|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798554|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153798555|NCT00297960|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153798556|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153798557|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153798558|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798559|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798560|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
153798592|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798593|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798594|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798595|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153798596|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798597|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798606|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153798608|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798609|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
153798610|NCT00306462|Nifedipine|nifedipine|mesh-list
153798611|NCT00306462|Analgesics|analgesics|mesh-ancestor
153798612|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
153861953|NCT00561522|Capecitabine|capecitabine|mesh-list
153861954|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861955|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
153861956|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861957|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861958|NCT03454620|Irinotecan|irinotecan|mesh-list
153861959|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153593658|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153411245|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411246|NCT00384657|Iron|iron|mesh-list
153411247|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153411248|NCT00384657|Trace Elements|trace elements|mesh-ancestor
153411249|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
153411250|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411251|NCT00384657|Hematinics|hematinics|mesh-ancestor
153411252|NCT00005013|Sertraline|sertraline|mesh-list
153411253|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
153411254|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153411255|NCT00005013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153870649|NCT04572620|Rituximab|rituximab|mesh-list
153818578|NCT04209595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153818579|NCT04209595|Serotonin Agents|serotonin agents|mesh-ancestor
153818580|NCT04209595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818581|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818582|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153818583|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818584|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818585|NCT04200443|Temozolomide|temozolomide|mesh-list
153818586|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153818587|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
153818588|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818589|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818590|NCT04182672|FX006|fx006|mesh-list
153593659|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153402306|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153402307|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402308|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153402309|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153402310|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402311|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402312|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402313|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402314|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
153798613|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798614|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798615|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
153798616|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798617|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153798618|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
153798619|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153798620|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153798621|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798622|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153870670|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153870672|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
153870673|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870674|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870675|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870676|NCT03450317|Aspirin|aspirin|mesh-list
153870677|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153870678|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153798623|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
153798624|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153798625|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
153798626|NCT00416390|Lycopene|lycopene|mesh-list
153798627|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798628|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
153798629|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798630|NCT00416390|Protective Agents|protective agents|mesh-ancestor
153798631|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736329|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736330|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736331|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153798638|NCT00416429|Aldesleukin|aldesleukin|mesh-list
153798639|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153798640|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
153798641|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798642|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
153798643|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798644|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
153798645|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798646|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153798647|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153798648|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153798649|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153798650|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153798651|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
153798652|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153798653|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153798654|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153798655|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153798656|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153798657|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153798658|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
153345302|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861962|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861963|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593660|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153593661|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
153593662|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
153593663|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153593664|NCT01843998|Sirolimus|sirolimus|mesh-list
153593665|NCT01843998|Temsirolimus|temsirolimus|mesh-list
153593666|NCT01843998|MTOR Inhibitors|mtor inhibitors|mesh-list
153593667|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593668|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593669|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153593670|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593671|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
153593672|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153593673|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
153593674|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593675|NCT01843998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153593676|NCT01843998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593677|NCT01843998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593678|NCT01844024|Misoprostol|misoprostol|mesh-list
153345303|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345304|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153870684|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870685|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153870686|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153870687|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870688|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153345305|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153345306|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153345307|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153798687|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153798688|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
153798689|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
153798691|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798692|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
153798693|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153798694|NCT00306696|Spironolactone|spironolactone|mesh-list
153798695|NCT00306696|Furosemide|furosemide|mesh-list
153798696|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153798697|NCT00306696|Diuretics|diuretics|mesh-ancestor
153798698|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
153798699|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798700|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153798701|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153798726|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
153798729|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
153861988|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153861989|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153861990|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402322|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
153402323|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
153402325|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402326|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593679|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153593680|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
153593681|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153593682|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593683|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153593684|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593685|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
153593686|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
153593687|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593688|NCT01844141|Ethanol|ethanol|mesh-list
153593689|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
153818591|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818592|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
153818593|NCT04182672|Hormones|hormones|mesh-ancestor
153870689|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153870690|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870691|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
153870692|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
153870693|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153870694|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870695|NCT04565496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153870696|NCT04565496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870697|NCT03450161|Fentanyl|fentanyl|mesh-list
153870698|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153870699|NCT03450161|Narcotics|narcotics|mesh-ancestor
153818594|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153818595|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818596|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818597|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
153818598|NCT04175431|Prednisone|prednisone|mesh-list
153402341|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
153402342|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402343|NCT05414240|Ibudilast|ibudilast|mesh-list
153402344|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153402345|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
153798730|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
153798731|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798732|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798733|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798734|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153798735|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153798736|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
153798737|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798738|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798739|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
153798740|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153798741|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
153798742|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153798743|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798744|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153798745|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153798746|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153798747|NCT00306774|Vitamin D|vitamin d|mesh-list
153798748|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
153798774|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798775|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153798776|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
153798777|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798778|NCT00272051|Xaliproden|xaliproden|mesh-list
153798789|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798790|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798791|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153798792|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153798793|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
153798794|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798795|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798796|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153798797|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
153798798|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153798828|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798829|NCT00272285|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153798830|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153798832|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870700|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870701|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870703|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
153870704|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870705|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153870706|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153870707|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
153870708|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
153870709|NCT04565184|Artesunate|artesunate|mesh-list
153870710|NCT04565184|Lumefantrine|lumefantrine|mesh-list
153798833|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798835|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153798836|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153798837|NCT00272324|Analgesics|analgesics|mesh-ancestor
153798838|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
153798839|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798840|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798841|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798842|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153798843|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153798844|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153798865|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798867|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153798868|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
153798869|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153798870|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153798871|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153798872|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153345447|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
153798873|NCT00272480|Lamivudine|lamivudine|mesh-list
153798874|NCT00272480|Zidovudine|zidovudine|mesh-list
153402375|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402376|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
153402377|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402378|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
153402380|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153870731|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870733|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153870734|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870735|NCT04997850|Lenvatinib|lenvatinib|mesh-list
153870736|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870737|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153870738|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870739|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870740|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153870741|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153870742|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153870743|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153870744|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153870745|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153870746|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153870747|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
153870748|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870749|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870750|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870752|NCT03456947|Analgesics|analgesics|mesh-ancestor
153411348|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402381|NCT05378555|Ketamine|ketamine|mesh-list
153402382|NCT05378555|Analgesics|analgesics|mesh-ancestor
153402383|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
153402384|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402385|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402386|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153798875|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153798876|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153798877|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798878|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798879|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
153798880|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798881|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153798882|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153798883|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
153798884|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
153798885|NCT00307671|Prednisone|prednisone|mesh-list
153798886|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
153798889|NCT00307671|Prednisolone|prednisolone|mesh-list
153862026|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798916|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798917|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153798918|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153798919|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153798920|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153798921|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
153798922|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153798923|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798924|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
153798925|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
153798926|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798927|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798928|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153798929|NCT00307671|Protective Agents|protective agents|mesh-ancestor
153411349|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153411350|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
153411351|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411352|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153411353|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411354|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411355|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411356|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411357|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411358|NCT00005049|Carboplatin|carboplatin|mesh-list
153411359|NCT00005049|Floxuridine|floxuridine|mesh-list
153411360|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411361|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411362|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
153798930|NCT00272558|Carboplatin|carboplatin|mesh-list
153798931|NCT00272558|Vinorelbine|vinorelbine|mesh-list
153798932|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798933|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153798934|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798935|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798936|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798937|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798938|NCT00272597|Risperidone|risperidone|mesh-list
153798939|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153798940|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
153798941|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798942|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798943|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798944|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153798945|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153798946|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459981|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
153459982|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459983|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459984|NCT05173987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153459986|NCT05171179|Bupivacaine|bupivacaine|mesh-list
153459987|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
153459988|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
153593690|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153593691|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153593692|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402389|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
153402390|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402391|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153402392|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153402393|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402394|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402395|NCT05319756|Oxycodone|oxycodone|mesh-list
153402396|NCT05319756|Gabapentin|gabapentin|mesh-list
153402397|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153402398|NCT05319756|Narcotics|narcotics|mesh-ancestor
153402399|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402400|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402401|NCT05319756|Analgesics|analgesics|mesh-ancestor
153402402|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
153798947|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153798948|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153798949|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
153798950|NCT00272636|Amiodarone|amiodarone|mesh-list
153798951|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153798952|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
153798953|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153798954|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153798955|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798956|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153870764|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153870765|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
153870766|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411363|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411364|NCT00004215|Cytarabine|cytarabine|mesh-list
153411365|NCT00004215|Daunorubicin|daunorubicin|mesh-list
153411366|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411367|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
153411368|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798957|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153798975|NCT00307827|Visilizumab|visilizumab|mesh-list
153798976|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
153798977|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798978|NCT00272753|Budesonide|budesonide|mesh-list
153798979|NCT00272753|Albuterol|albuterol|mesh-list
153798980|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
153798981|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798989|NCT00272753|Hormones|hormones|mesh-ancestor
153862054|NCT01214044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153798992|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153798993|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153798994|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
153798995|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798996|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798997|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
153798998|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153798999|NCT00272831|Cilostazol|cilostazol|mesh-list
153799000|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153799001|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
153799002|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799003|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799004|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153799005|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
153799006|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153799007|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153799008|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799009|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153799010|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
153799011|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153799012|NCT00272831|Protective Agents|protective agents|mesh-ancestor
153799013|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153799024|NCT00416468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799025|NCT00307944|Pantoprazole|pantoprazole|mesh-list
153799026|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153799027|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153799028|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153799029|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799030|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799031|NCT00416507|Gemcitabine|gemcitabine|mesh-list
153593693|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862055|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153862056|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862057|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862058|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862059|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
153799032|NCT00416507|Fluorouracil|fluorouracil|mesh-list
153799033|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799034|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153799035|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
153799036|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799037|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153799038|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
153799039|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799040|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
153799041|NCT00282126|Diuretics|diuretics|mesh-ancestor
153799042|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
153799043|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799044|NCT00282126|Expectorants|expectorants|mesh-ancestor
153799045|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
153799046|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153799047|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799048|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870806|NCT00198029|Hylan|hylan|mesh-list
153799049|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799051|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153799052|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153799053|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
153799054|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799055|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799056|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799057|NCT00282165|Naratriptan|naratriptan|mesh-list
153799058|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153799059|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153799069|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153799070|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153799071|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
153799072|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
153799073|NCT00273026|Fluticasone|fluticasone|mesh-list
153799075|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153799076|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345672|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153345673|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799090|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799091|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153799092|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799093|NCT00282360|Trimetazidine|trimetazidine|mesh-list
153799094|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
153799095|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
153799096|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153799097|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153799098|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799099|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799100|NCT00418626|Nilotinib|nilotinib|mesh-list
153799101|NCT00418626|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153799102|NCT00418626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153799103|NCT00418626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799104|NCT00418626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799105|NCT00418704|Docetaxel|docetaxel|mesh-list
153593694|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593695|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
153593696|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
153593697|NCT01844323|Palbociclib|palbociclib|mesh-list
153593706|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593707|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593709|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
153593710|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
153593711|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153411429|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153411430|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
153411431|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
153411432|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153411433|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153411434|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153411435|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153411436|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
153411437|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459989|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459990|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862069|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153862070|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
153862071|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862072|NCT01213966|Artefenomel|artefenomel|mesh-list
153862073|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
153862074|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153862075|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153862076|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799106|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153799107|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799108|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
153799109|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
153799110|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
153799111|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799112|NCT00418704|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153799113|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153799114|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799115|NCT00313950|Vaccines|vaccines|mesh-list
153799116|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
153799117|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799118|NCT00273299|Valsartan|valsartan|mesh-list
153799119|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153799120|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153799121|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153799122|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153799123|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799124|NCT00273299|Diuretics|diuretics|mesh-ancestor
153799125|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
153411452|NCT00004233|Protective Agents|protective agents|mesh-ancestor
153411453|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
153411456|NCT00003717|Paclitaxel|paclitaxel|mesh-list
153411457|NCT00003717|Estramustine|estramustine|mesh-list
153411458|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411459|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411460|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411461|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411462|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411463|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411464|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153870853|NCT00195650|Adalimumab|adalimumab|mesh-list
153870854|NCT00195650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153870855|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153870856|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870857|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
153870858|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153870859|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870860|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
153870861|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153870862|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153799126|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799127|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153799128|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153799129|NCT00418782|Naproxen|naproxen|mesh-list
153799130|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153799131|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153799138|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
153862077|NCT01213264|Anesthetics|anesthetics|mesh-list
153862080|NCT04657107|Ketamine|ketamine|mesh-list
153402424|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153799139|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153799140|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799141|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799142|NCT00273338|Calcitriol|calcitriol|mesh-list
153799143|NCT00273338|Docetaxel|docetaxel|mesh-list
153799144|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799145|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
153799146|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
153799147|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
153799148|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799149|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153799150|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799151|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153799152|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153799153|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153799154|NCT00273338|Vitamins|vitamins|mesh-ancestor
153799155|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
153799156|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153799157|NCT00273377|Dexamethasone|dexamethasone|mesh-list
153799158|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799159|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
153799160|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
153799161|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799162|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799163|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153799164|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
153402425|NCT05301361|Methylphenidate|methylphenidate|mesh-list
153402426|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153402436|NCT05273567|Guanfacine|guanfacine|mesh-list
153459991|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
153459992|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459993|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153459994|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153459995|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153459996|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357810|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153357811|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153888989|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888990|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153888991|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153411470|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411471|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411472|NCT00005061|Bevacizumab|bevacizumab|mesh-list
153411480|NCT00004245|Salicylates|salicylates|mesh-list
153459997|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459998|NCT05161754|Hemostatics|hemostatics|mesh-list
153459999|NCT05161754|Coagulants|coagulants|mesh-ancestor
153460000|NCT05160922|Crizotinib|crizotinib|mesh-list
153460001|NCT05160922|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153460002|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460004|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460005|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862087|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153862088|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
153862089|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
153862090|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862091|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153862092|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153862093|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862094|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862095|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
153862096|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862097|NCT00561717|Cetirizine|cetirizine|mesh-list
153862098|NCT00561717|Loratadine|loratadine|mesh-list
153862099|NCT00561717|Azelastine|azelastine|mesh-list
153862100|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153799165|NCT00273377|Hormones|hormones|mesh-ancestor
153799166|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345750|NCT00005596|Leucovorin|leucovorin|mesh-list
153799167|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153799168|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799169|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
153799198|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
153799199|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799205|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799206|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153799207|NCT00273689|Albuterol|albuterol|mesh-list
153799208|NCT00273689|Montelukast|montelukast|mesh-list
153799209|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153799210|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
153799211|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153799212|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
153799213|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153799214|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799215|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153799216|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153799217|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430098|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153411497|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153411498|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411499|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870889|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153870890|NCT00194987|Prednisone|prednisone|mesh-list
153870891|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
153870892|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153870893|NCT00194987|Antibodies|antibodies|mesh-list
153870894|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
153870895|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153870896|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153870897|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
153870898|NCT00194987|Hormones|hormones|mesh-ancestor
153799218|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153799219|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
153799220|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799221|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
153799222|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153799223|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153799224|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153799225|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153799226|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
153799227|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799228|NCT00308334|Domperidone|domperidone|mesh-list
153799229|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
153799230|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
153799231|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799232|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799233|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153799234|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153799235|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
153799236|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402474|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402475|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153402476|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153402477|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
153402478|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
153862113|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153862114|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
153862115|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153862116|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799242|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
153799243|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799244|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
153799245|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799246|NCT00314379|Protective Agents|protective agents|mesh-ancestor
153799247|NCT00273884|Cytarabine|cytarabine|mesh-list
153799248|NCT00273884|Amonafide|amonafide|mesh-list
153799249|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153799250|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
153799251|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799252|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799253|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
153799254|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799259|NCT00308373|Metformin|metformin|mesh-list
153799302|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153799303|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
153799304|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870902|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870903|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
153870905|NCT00194792|Vinorelbine|vinorelbine|mesh-list
153870906|NCT00194792|Capecitabine|capecitabine|mesh-list
153870907|NCT00194792|Methotrexate|methotrexate|mesh-list
153870908|NCT00194792|Exemestane|exemestane|mesh-list
153870909|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153870910|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153870911|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870912|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
153799305|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799306|NCT00314457|Bupivacaine|bupivacaine|mesh-list
153799307|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
153799308|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
153799309|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799310|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799311|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
153799312|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345898|NCT00004300|Bromocriptine|bromocriptine|mesh-list
153799314|NCT00308451|Biotin|biotin|mesh-list
153799315|NCT00308451|Picolinic acid|picolinic acid|mesh-list
153799316|NCT00308451|Trace Elements|trace elements|mesh-ancestor
153799349|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
153799350|NCT00308529|Bevacizumab|bevacizumab|mesh-list
153799351|NCT00308529|Carboplatin|carboplatin|mesh-list
153799352|NCT00308529|Irinotecan|irinotecan|mesh-list
153799353|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153799354|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799355|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153799356|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153799357|NCT00308529|Growth Substances|growth substances|mesh-ancestor
153799358|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799369|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153799370|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153799371|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799372|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153799373|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862131|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862132|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862133|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153799374|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402494|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402495|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153402496|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153870928|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153870929|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153870930|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153870931|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153870932|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
153870933|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870934|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
153870935|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153870936|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
153870939|NCT02486367|Clopidogrel|clopidogrel|mesh-list
153402497|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402498|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402499|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153402500|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
153402501|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153402502|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402503|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153402504|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153862145|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153862146|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
153799375|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153799376|NCT00274274|Insulin|insulin|mesh-list
153799377|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153799414|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799415|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153799416|NCT00314652|Buprenorphine|buprenorphine|mesh-list
153799417|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153799418|NCT00314652|Narcotics|narcotics|mesh-ancestor
153799419|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799420|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799421|NCT00314652|Analgesics|analgesics|mesh-ancestor
153799422|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
153799423|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799424|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153799455|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153799456|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
153799457|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799458|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799459|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153799460|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
153799461|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
153799462|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153799463|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
153799464|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346115|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
153799465|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799466|NCT00308763|Bupropion|bupropion|mesh-list
153799476|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799477|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153799479|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153799480|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153799481|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153799482|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153799483|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
153460006|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153593712|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153593713|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153593714|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153593715|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
153593716|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593717|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593718|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
153593719|NCT01844427|Memantine|memantine|mesh-list
153593720|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153593721|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153593722|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
153402520|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153402521|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
153402523|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402524|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153870954|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402525|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153402526|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402527|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402528|NCT05117125|Heparin|heparin|mesh-list
153402529|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
153862173|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153862174|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153799484|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153799485|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153799486|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799487|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153799488|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153799489|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
153799490|NCT00274820|Thalidomide|thalidomide|mesh-list
153799491|NCT00274820|Dexamethasone|dexamethasone|mesh-list
153799492|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
153799493|NCT00274820|Vitamins|vitamins|mesh-ancestor
153799502|NCT00274820|Hormones|hormones|mesh-ancestor
153799521|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799522|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799524|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799525|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153799526|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153799527|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153799528|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153799529|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799530|NCT00274859|Gemcitabine|gemcitabine|mesh-list
153799531|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
153799543|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153799544|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153799545|NCT00274898|Analgesics|analgesics|mesh-ancestor
153799546|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
153799547|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799548|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799549|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862175|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862176|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862177|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153862178|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862179|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862180|NCT04537598|Morphine|morphine|mesh-list
153862181|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153862182|NCT04537598|Narcotics|narcotics|mesh-ancestor
153862183|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862184|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862185|NCT04537598|Analgesics|analgesics|mesh-ancestor
153862186|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
153862187|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862188|NCT04627467|Chloroquine|chloroquine|mesh-list
153811345|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811346|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
153870978|NCT04563351|Anesthetics|anesthetics|mesh-list
153870979|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
153870980|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870981|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870982|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
153870984|NCT00192647|Ribavirin|ribavirin|mesh-list
153593723|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593724|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593725|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593726|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153593727|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153593728|NCT01844622|Domperidone|domperidone|mesh-list
153593729|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
153862195|NCT04627623|Antibodies|antibodies|mesh-list
153799550|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153799551|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153799552|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153799553|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799554|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
153799555|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153799556|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153799557|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799558|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
153799559|NCT00308880|Coagulants|coagulants|mesh-ancestor
153799560|NCT00277199|Abatacept|abatacept|mesh-list
153799561|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153799562|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799563|NCT00277199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153799564|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799565|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153799566|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
153799567|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799568|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153799569|NCT00277472|Valsartan|valsartan|mesh-list
153799570|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153799571|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153799572|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153799573|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153799574|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799575|NCT00277472|Diuretics|diuretics|mesh-ancestor
153799576|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
153799577|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799578|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153799579|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862199|NCT04656249|Lenvatinib|lenvatinib|mesh-list
153862200|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862201|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153862202|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862203|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862204|NCT04682795|Insulin|insulin|mesh-list
153862205|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153862206|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862207|NCT04655664|Vitamin D|vitamin d|mesh-list
153862208|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
153862209|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
153862210|NCT04655664|Vitamins|vitamins|mesh-list
153862211|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
153862212|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862213|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153799580|NCT00277511|Levofloxacin|levofloxacin|mesh-list
153799581|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153799582|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799583|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153799584|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153799585|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153799586|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799587|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799641|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799642|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
153799643|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799644|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
153411651|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153799645|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799646|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799647|NCT00278018|Immunomodulating Agents|immunomodulating agents|mesh-list
153799661|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153799662|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799663|NCT00278174|Interferons|interferons|mesh-list
153799664|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
153799665|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153799666|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799667|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
153799668|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799669|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
153799670|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799671|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
153799672|NCT00278213|Fludarabine|fludarabine|mesh-list
153799673|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
153799674|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
153799675|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
153799676|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153799677|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
153799678|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799679|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153799680|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153799681|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
153799682|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799683|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799684|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153799685|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153799686|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
153799687|NCT00278213|Analgesics|analgesics|mesh-ancestor
153799688|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
153799689|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799693|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153799694|NCT00278252|Etoposide|etoposide|mesh-list
153799695|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153799696|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799697|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153799698|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153799699|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411714|NCT00003783|Vincristine|vincristine|mesh-list
153411715|NCT00003783|Daunorubicin|daunorubicin|mesh-list
153411716|NCT00003783|Asparaginase|asparaginase|mesh-list
153411717|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
153411718|NCT00003783|Idarubicin|idarubicin|mesh-list
153799700|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799701|NCT00315432|Interferons|interferons|mesh-list
153799702|NCT00315432|Ribavirin|ribavirin|mesh-list
153799703|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799704|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
153799705|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799706|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
153799707|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799708|NCT00278330|Vorinostat|vorinostat|mesh-list
153799724|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153799726|NCT00278369|Aldesleukin|aldesleukin|mesh-list
153799727|NCT00278369|Interleukin-2|interleukin-2|mesh-list
153799728|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
153799729|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799730|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153799731|NCT00278369|Analgesics|analgesics|mesh-ancestor
153799732|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
153799733|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402587|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862224|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862225|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
153862226|NCT04626765|Fludarabine|fludarabine|mesh-list
153862227|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862236|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
153593730|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
153593731|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593732|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593733|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593734|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153593735|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
153593736|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593737|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593738|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
153593739|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
153593740|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593741|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153593742|NCT01844648|Tropicamide|tropicamide|mesh-list
153862246|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153799734|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799735|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153799736|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153799737|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
153799738|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799739|NCT00315549|Penicillins|penicillins|mesh-list
153799740|NCT00315549|Telithromycin|telithromycin|mesh-list
153799741|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153799742|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799744|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
153799746|NCT00278408|Doxorubicin|doxorubicin|mesh-list
153799747|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153799748|NCT00278408|Vincristine|vincristine|mesh-list
153799749|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153799750|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
153871161|NCT00176462|Leucovorin|leucovorin|mesh-list
153799751|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799752|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153799753|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153799754|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
153799755|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799756|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799757|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153799758|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153799759|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153799760|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153346335|NCT00005806|Carboplatin|carboplatin|mesh-list
153799761|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153799762|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799763|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799764|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
153799765|NCT00278408|Hormones|hormones|mesh-ancestor
153799766|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862247|NCT04654962|Anesthetics|anesthetics|mesh-list
153862248|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402615|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
153402616|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402617|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402618|NCT05053126|Pregabalin|pregabalin|mesh-list
153402619|NCT05053126|Oxycodone|oxycodone|mesh-list
153402620|NCT05053126|Analgesics|analgesics|mesh-ancestor
153402621|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
153799784|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153799785|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799786|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153799787|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
153799788|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799789|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799790|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153799791|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
153799792|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153799793|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153799794|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153799795|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153799796|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153799797|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
153799798|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862268|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153862269|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153862270|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153862271|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
153862272|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862273|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
153862274|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153862275|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862276|NCT02905994|Cytarabine|cytarabine|mesh-list
153862277|NCT02905994|Idarubicin|idarubicin|mesh-list
153799813|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
153799814|NCT00309543|Vitamins|vitamins|mesh-ancestor
153799815|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
153799816|NCT00315861|Pemetrexed|pemetrexed|mesh-list
153799817|NCT00315861|Topotecan|topotecan|mesh-list
153799818|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799819|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799820|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799821|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153799822|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153799823|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153799824|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153799840|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799841|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
153799842|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153799843|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
153799844|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799845|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153799846|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153799847|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
153799848|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153799849|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153799850|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153799851|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799852|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593755|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153862278|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153862279|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
153862280|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799853|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153799854|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153799855|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
153799856|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799857|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799858|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153799859|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153799860|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
153799861|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
153799862|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
153799863|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153799864|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153799865|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799866|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799867|NCT00309816|Urological Agents|urological agents|mesh-ancestor
153799868|NCT00279266|Thiamine|thiamine|mesh-list
153799869|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
153799870|NCT00279266|Vitamins|vitamins|mesh-ancestor
153799871|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
153799872|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799873|NCT00316095|Telmisartan|telmisartan|mesh-list
153799874|NCT00316095|Simvastatin|simvastatin|mesh-list
153799875|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153799876|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153411917|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411925|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411926|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411927|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153411928|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153871303|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871304|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153871305|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153871306|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871307|NCT00479765|Paclitaxel|paclitaxel|mesh-list
153799877|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
153799878|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799879|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153799880|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153799881|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799882|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153799883|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153799884|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153799885|NCT00279344|Fentanyl|fentanyl|mesh-list
153799886|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153799887|NCT00279344|Narcotics|narcotics|mesh-ancestor
153799905|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799906|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153799907|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153799908|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153799909|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799910|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153799911|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153799912|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799913|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
153799914|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153799915|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153799916|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153799917|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
153799918|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799919|NCT00316212|INS 50589|ins 50589|mesh-list
153799920|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153799921|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153799922|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
153799923|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799924|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871335|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871336|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871337|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153888997|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153888998|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153871338|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871339|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
153871340|NCT00478205|Donepezil|donepezil|mesh-list
153411953|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411954|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888999|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153889000|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153889001|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153411955|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411956|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411957|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
153411958|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411959|NCT00004647|Mexiletine|mexiletine|mesh-list
153889002|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153799925|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799926|NCT00309855|Anastrozole|anastrozole|mesh-list
153799927|NCT00309855|Testosterone|testosterone|mesh-list
153593757|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862287|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153862288|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153862289|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153862292|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
153799928|NCT00309855|Dutasteride|dutasteride|mesh-list
153799929|NCT00309855|Androgens|androgens|mesh-ancestor
153799930|NCT00309855|Hormones|hormones|mesh-ancestor
153799931|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153799932|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799933|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153799934|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799935|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153799936|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153799937|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799938|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799939|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
153799940|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153799941|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153799942|NCT00279383|Thrombin|thrombin|mesh-list
153799943|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
153799944|NCT00279383|Coagulants|coagulants|mesh-ancestor
153799945|NCT00279422|Visilizumab|visilizumab|mesh-list
153799967|NCT00279461|Vitamin D|vitamin d|mesh-list
153799968|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
153799969|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
153799970|NCT00279461|Vitamins|vitamins|mesh-list
153799971|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
153799972|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402662|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799995|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153871341|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153871342|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871343|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871344|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
153871345|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871346|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871347|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
153871348|NCT00477971|Dexamethasone|dexamethasone|mesh-list
153871349|NCT00477971|Melphalan|melphalan|mesh-list
153871350|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871351|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
153871352|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
153871353|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871354|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871355|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153871356|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
153871357|NCT00477971|Hormones|hormones|mesh-ancestor
153799996|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799997|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
153799998|NCT00279578|Coagulants|coagulants|mesh-ancestor
153800033|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153800034|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
153800035|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800036|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800037|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153800038|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
153800039|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
153800040|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
153800041|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153800061|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
153800062|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153800063|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
153346637|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
153800064|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800065|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346639|NCT01407523|Levetiracetam|levetiracetam|mesh-list
153800066|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153800067|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800068|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153800069|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153800070|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800071|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800072|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800074|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
153800086|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153800087|NCT00310128|Protective Agents|protective agents|mesh-ancestor
153800088|NCT00316563|Dronabinol|dronabinol|mesh-list
153800089|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
153800090|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800091|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153800092|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800093|NCT00316563|Analgesics|analgesics|mesh-ancestor
153800094|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
153800095|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800096|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153800097|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153800123|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153800124|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800125|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153800126|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153800127|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153800128|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800129|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
153800130|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800131|NCT00416819|Antidotes|antidotes|mesh-ancestor
153800132|NCT00416819|Protective Agents|protective agents|mesh-ancestor
153800133|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
153800134|NCT00416819|Vitamins|vitamins|mesh-ancestor
153800135|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
153800136|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153800137|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
153871360|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871361|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
153871362|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153871363|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
153871364|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871365|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153871366|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871368|NCT00477464|Lapatinib|lapatinib|mesh-list
153871369|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871370|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
153800138|NCT00310206|Vaccines|vaccines|mesh-list
153800139|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
153800140|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800141|NCT00280007|Bevacizumab|bevacizumab|mesh-list
153346714|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
153346789|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
153800142|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153800143|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862320|NCT04625985|Metformin|metformin|mesh-list
153593758|NCT01844674|Analgesics|analgesics|mesh-ancestor
153593759|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
153593760|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593761|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402681|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153402682|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153402683|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402684|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402685|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153402686|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153800144|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153800145|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153800146|NCT00280007|Growth Substances|growth substances|mesh-ancestor
153800159|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153800160|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800161|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153800162|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800163|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800164|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153800165|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153800166|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
153800167|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800168|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
153800178|NCT00280280|Baclofen|baclofen|mesh-list
153862330|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
153800184|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
153800185|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
153800186|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800187|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800188|NCT00316758|Metformin|metformin|mesh-list
153800189|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800190|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800191|NCT00280358|Fluticasone|fluticasone|mesh-list
153800192|NCT00280358|Xhance|xhance|mesh-list
153800193|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
153800194|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800195|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153800196|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
153800197|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412025|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
153412026|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
153412027|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153412028|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153412029|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153412030|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153871402|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871403|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
153871404|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871405|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153871406|NCT00476957|Sirolimus|sirolimus|mesh-list
153800198|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800199|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153800200|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
153800201|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
153800202|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153800203|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153800204|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153800205|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153800206|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
153800207|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800208|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800209|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
153800210|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800211|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153800235|NCT00280553|Bupivacaine|bupivacaine|mesh-list
153800236|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
153800237|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
153593762|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
153593763|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153593764|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153593765|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
153593766|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
153593767|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153593768|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153593769|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153593770|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
153593771|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593772|NCT01844791|Pentamidine|pentamidine|mesh-list
153593773|NCT01844791|Gemcitabine|gemcitabine|mesh-list
153800238|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800239|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800240|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
153800241|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800242|NCT00316875|Doxorubicin|doxorubicin|mesh-list
153800243|NCT00316875|Lapatinib|lapatinib|mesh-list
153800244|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153800245|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800246|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153800247|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800248|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800249|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800250|NCT00316875|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153800251|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153800252|NCT00316953|Dasatinib|dasatinib|mesh-list
153800253|NCT00316953|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153800254|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153800255|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800256|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800257|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800258|NCT00419172|Rifampin|rifampin|mesh-list
153800259|NCT00419172|Deferasirox|deferasirox|mesh-list
153800267|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800268|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153800269|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153800270|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153800271|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153800272|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153800273|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153800274|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153800286|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153800287|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800288|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800290|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153412080|NCT00004785|Dexamethasone|dexamethasone|mesh-list
153800291|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153800292|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800293|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153800294|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800295|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800296|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800297|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800298|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153800299|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
153800300|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153800301|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800302|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153800303|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153800304|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153800305|NCT00280865|Pioglitazone|pioglitazone|mesh-list
153800306|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800307|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800308|NCT00317031|Naltrexone|naltrexone|mesh-list
153800309|NCT00317031|Acamprosate|acamprosate|mesh-list
153800310|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153800311|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153800312|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800313|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
153800314|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800315|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153800316|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153800317|NCT00317070|Protective Agents|protective agents|mesh-ancestor
153800318|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800319|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153800320|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
153800321|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800325|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800326|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800355|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800356|NCT00317343|Anticoagulants|anticoagulants|mesh-list
153800357|NCT00317343|Bivalirudin|bivalirudin|mesh-list
153800358|NCT00317343|Thrombin|thrombin|mesh-list
153800359|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
153800360|NCT00317343|Coagulants|coagulants|mesh-ancestor
153800361|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
153800362|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153800363|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
153800364|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800365|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800366|NCT00416858|Fluorouracil|fluorouracil|mesh-list
153800367|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800368|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
153800369|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800370|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153800371|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800372|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
153800373|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800374|NCT00416897|Dexamethasone|dexamethasone|mesh-list
153800375|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800395|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153800396|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402733|NCT04939480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402734|NCT04939480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402735|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402736|NCT04927780|Leucovorin|leucovorin|mesh-list
153800397|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153800398|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
153800399|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
153800400|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
153800401|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800402|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153800403|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
153800404|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
153800405|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800406|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
153800407|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153800408|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153800409|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800410|NCT00317421|Urological Agents|urological agents|mesh-ancestor
153800411|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
153800414|NCT00417053|Carboplatin|carboplatin|mesh-list
153800415|NCT00417053|Doxorubicin|doxorubicin|mesh-list
153800416|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153800417|NCT00417053|Etoposide|etoposide|mesh-list
153800418|NCT00417053|Vincristine|vincristine|mesh-list
153800419|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
153800420|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800421|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
153800422|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800423|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800424|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153800425|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
153800426|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800427|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800428|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153800429|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153800430|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153800445|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153800446|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
153800447|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800448|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800450|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153800451|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800452|NCT00317499|Analgesics|analgesics|mesh-ancestor
153800453|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
153800454|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800455|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800456|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800457|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800458|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800459|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800460|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
153800461|NCT00281606|Ritonavir|ritonavir|mesh-list
153800462|NCT00281606|Lopinavir|lopinavir|mesh-list
153800463|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153800464|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153412190|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153412191|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153412192|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
153871569|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871570|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871571|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153871572|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
153871573|NCT00474188|Hormones|hormones|mesh-ancestor
153871576|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800465|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
153800466|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800467|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800468|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153800469|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153800470|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
153800471|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800472|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153800473|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153862419|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153862420|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
153862421|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862422|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153593774|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153593776|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818599|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
153818600|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818601|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
153818602|NCT04175431|Hormones|hormones|mesh-ancestor
153402789|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153402790|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153862425|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862426|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862427|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862428|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862429|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
153862430|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153862431|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
153862432|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153862433|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800475|NCT00317538|Etanercept|etanercept|mesh-list
153800476|NCT00317538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153800477|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800478|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
153800479|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800480|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800481|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153800482|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800483|NCT00317538|Analgesics|analgesics|mesh-ancestor
153800484|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
153800485|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800486|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800534|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153811347|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153412259|NCT00005637|Carmustine|carmustine|mesh-list
153800535|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800536|NCT00317733|Analgesics|analgesics|mesh-ancestor
153800537|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
153800538|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800539|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800553|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800554|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153800555|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800556|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
153800557|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800558|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
153800559|NCT00317811|Protective Agents|protective agents|mesh-ancestor
153800560|NCT00317811|Vitamins|vitamins|mesh-ancestor
153800561|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
153800562|NCT00282386|Rofecoxib|rofecoxib|mesh-list
153800563|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800564|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800565|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800566|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153800567|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153800568|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800569|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153800570|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800571|NCT00282386|Analgesics|analgesics|mesh-ancestor
153800572|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
153800573|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800574|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800575|NCT00317850|Gabapentin|gabapentin|mesh-list
153800576|NCT00317850|Analgesics|analgesics|mesh-ancestor
153800577|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
153800578|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800579|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800580|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
153800581|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153800582|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153800583|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800584|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153800585|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153800586|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153347175|NCT03014297|Everolimus|everolimus|mesh-list
153800587|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800588|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800590|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
153800591|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153800592|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153800593|NCT00282503|Prednisolone|prednisolone|mesh-list
153800594|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
153800595|NCT00282503|Methoxsalen|methoxsalen|mesh-list
153800596|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153800597|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
153800598|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800599|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
153800600|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
153800601|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800602|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800615|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402809|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
153402810|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402811|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402812|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800616|NCT00282698|Insulin|insulin|mesh-list
153800617|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800618|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800619|NCT00317967|Atorvastatin|atorvastatin|mesh-list
153800620|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153871696|NCT01088048|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153800621|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153800622|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
153800623|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800624|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153800625|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153800626|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800627|NCT00318084|Esomeprazole|esomeprazole|mesh-list
153800628|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153800629|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800630|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153800631|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800632|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800633|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153800634|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153800635|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153800636|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
153800637|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800638|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800639|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800640|NCT00282932|Urological Agents|urological agents|mesh-ancestor
153800641|NCT00318162|Naltrexone|naltrexone|mesh-list
153800642|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153800643|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153800644|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800645|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
153800646|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800647|NCT00283088|Plasminogen|plasminogen|mesh-list
153800648|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153800657|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153800658|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153800659|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153800660|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800661|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153800662|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800663|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
153800681|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153800683|NCT00318318|Hormones|hormones|mesh-ancestor
153800684|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800685|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800686|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
153800687|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153800688|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800689|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800690|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153800691|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
153800692|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
153800693|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153800694|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153800695|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800696|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800697|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800698|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800699|NCT00283556|Irinotecan|irinotecan|mesh-list
153412376|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153412377|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412378|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153412379|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412380|NCT01689987|Sirolimus|sirolimus|mesh-list
153412381|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
153412382|NCT01689987|Dexamethasone|dexamethasone|mesh-list
153871765|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871766|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153800700|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153800701|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800702|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800703|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800704|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800705|NCT00283634|Bortezomib|bortezomib|mesh-list
153800706|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153800707|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800708|NCT00283634|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153402838|NCT04751500|Misoprostol|misoprostol|mesh-list
153818603|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800709|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153800710|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800711|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800712|NCT00318513|Bevacizumab|bevacizumab|mesh-list
153800713|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153800714|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800715|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153800716|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153800717|NCT00318513|Growth Substances|growth substances|mesh-ancestor
153800718|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800719|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
153800744|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153800745|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153800746|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800747|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800748|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
153800749|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800750|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153800751|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
153800752|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153800753|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153800754|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153800755|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800756|NCT00283829|Docetaxel|docetaxel|mesh-list
153800757|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800758|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
153800759|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
153800760|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
153862497|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153818604|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818605|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153593777|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593778|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
153593779|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593780|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153593781|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153593782|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153593783|NCT01844804|Infliximab|infliximab|mesh-list
153593784|NCT01844804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153593785|NCT01844804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153593786|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
153593787|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593788|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800761|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871814|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800762|NCT00311961|Prednisolone|prednisolone|mesh-list
153800763|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153800764|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
153800765|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153800766|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
153800767|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153800768|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
153800769|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800770|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
153800780|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153800781|NCT00311961|Protective Agents|protective agents|mesh-ancestor
153800782|NCT00283946|Zolpidem|zolpidem|mesh-list
153800783|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153800784|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153800785|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800786|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800787|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153800788|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
153800789|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
153800790|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800791|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402872|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402873|NCT04723004|Bevacizumab|bevacizumab|mesh-list
153402874|NCT04723004|Sorafenib|sorafenib|mesh-list
153402875|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402876|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402877|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153402878|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153402879|NCT04723004|Growth Substances|growth substances|mesh-ancestor
153402880|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402881|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
153593789|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
153593790|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153593791|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593792|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153593793|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593794|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593795|NCT01844947|Sorafenib|sorafenib|mesh-list
153818606|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818607|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153800792|NCT00312000|Capecitabine|capecitabine|mesh-list
153800793|NCT00312000|Irinotecan|irinotecan|mesh-list
153800794|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153800795|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
153800796|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800797|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800798|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153800799|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800800|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800801|NCT00283985|Dexamethasone|dexamethasone|mesh-list
153800802|NCT00283985|Methotrexate|methotrexate|mesh-list
153800803|NCT00283985|Asparaginase|asparaginase|mesh-list
153800804|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412487|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153412488|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412489|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153412490|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
153412491|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871831|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
153800805|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
153800806|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
153800807|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800808|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347388|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153800809|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800810|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
153800812|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800813|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153800814|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800815|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153800816|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
153800817|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153800818|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153402895|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153402896|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402897|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402898|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402899|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
153818608|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818609|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818621|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818623|NCT04102189|Semaglutide|semaglutide|mesh-list
153460008|NCT05041127|Antibodies|antibodies|mesh-list
153460009|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
153460010|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153460011|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
153862541|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153800820|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800821|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
153800822|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800823|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153800824|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800825|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
153800826|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800827|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153800828|NCT00419250|Lenalidomide|lenalidomide|mesh-list
153800829|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
153800830|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800831|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153800832|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153800833|NCT00419250|Growth Substances|growth substances|mesh-ancestor
153800834|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
153800835|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800864|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
153800865|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800866|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862542|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862543|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
153862544|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153862545|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153862546|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153862547|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862548|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862549|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153862550|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153862551|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153862552|NCT02902640|Expectorants|expectorants|mesh-ancestor
153862553|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
153862554|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153862555|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153862556|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
153800867|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153800868|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412516|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
153800869|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153800870|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800872|NCT00312156|Insulin|insulin|mesh-list
153800873|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153800874|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
153800875|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
153800876|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
153800877|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
153800878|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
153800879|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800880|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800881|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
153800882|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153800898|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800899|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800900|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153800901|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
153800902|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153800903|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153800904|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800905|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800906|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153800907|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153800908|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
153800909|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862561|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
153862562|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
153460012|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460013|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460014|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153460015|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153460016|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
153460017|NCT04951050|Sirolimus|sirolimus|mesh-list
153460018|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153460019|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460020|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153460021|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460022|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
153460023|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460024|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
153460025|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460026|NCT04944836|Clomiphene|clomiphene|mesh-list
153402938|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
153402939|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402940|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402941|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153402942|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
153402943|NCT04610398|Hormones|hormones|mesh-ancestor
153800910|NCT00312273|Protective Agents|protective agents|mesh-ancestor
153800911|NCT00312312|Immunomodulating Agents|immunomodulating agents|mesh-list
153800912|NCT00312312|Immunologic Factors|immunologic factors|mesh-ancestor
153800913|NCT00312312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800914|NCT00284687|Artesunate|artesunate|mesh-list
153800915|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
153800916|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153800917|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153800918|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800919|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800920|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
153800921|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
153800922|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153800923|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
153800924|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
153800925|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153800926|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800927|NCT00284765|Analgesics|analgesics|mesh-ancestor
153811348|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153871925|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800928|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
153800929|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800930|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800931|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800932|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800933|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
153800940|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862585|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862586|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862587|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862589|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153801002|NCT00285389|Melphalan|melphalan|mesh-list
153801003|NCT00285389|Chlorambucil|chlorambucil|mesh-list
153801004|NCT00285389|Rituximab|rituximab|mesh-list
153801005|NCT00285389|Vincristine|vincristine|mesh-list
153801006|NCT00285389|Doxorubicin|doxorubicin|mesh-list
153801007|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801008|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
153801009|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801010|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801011|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153801012|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
153801013|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801014|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801015|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153801016|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153801017|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
153801018|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
153801019|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801020|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153801021|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
153801022|NCT00285389|Hormones|hormones|mesh-ancestor
153801023|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801024|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153801025|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153801057|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801058|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
153801059|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153801060|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153801061|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801062|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
153801063|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153801064|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153801065|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153801066|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153801067|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
153801068|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801069|NCT00285623|Thrombin|thrombin|mesh-list
153801070|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
153801071|NCT00285623|Coagulants|coagulants|mesh-ancestor
153801072|NCT00285662|Artesunate|artesunate|mesh-list
153801073|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
153801074|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
153801075|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153801076|NCT00285662|Amodiaquine|amodiaquine|mesh-list
153801077|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
153801078|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153801079|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153801080|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801081|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801082|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
153801083|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
153801084|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153801085|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
153801121|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357817|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153801122|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460027|NCT04944836|Enclomiphene|enclomiphene|mesh-list
153593796|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593797|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153593798|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593799|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593800|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
153593801|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153593802|NCT01845038|Timolol|timolol|mesh-list
153593803|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593804|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153593805|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153593806|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
153593807|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862596|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862597|NCT02902133|Diuretics|diuretics|mesh-ancestor
153862598|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
153862599|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801133|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153801135|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153801136|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153801137|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801138|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153801139|NCT00319761|Vitamins|vitamins|mesh-ancestor
153801140|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
153801141|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153801142|NCT00286130|Leucovorin|leucovorin|mesh-list
153801143|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
153801144|NCT00286130|Irinotecan|irinotecan|mesh-list
153801145|NCT00286130|Cetuximab|cetuximab|mesh-list
153801146|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801147|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153801148|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153801149|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801150|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801151|NCT00286130|Antidotes|antidotes|mesh-ancestor
153801152|NCT00286130|Protective Agents|protective agents|mesh-ancestor
153801153|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801154|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
153801155|NCT00286130|Vitamins|vitamins|mesh-ancestor
153801156|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
153801157|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153801158|NCT00286208|Misoprostol|misoprostol|mesh-list
153801159|NCT00286208|Mifepristone|mifepristone|mesh-list
153862600|NCT04623021|Nafamostat|nafamostat|mesh-list
153593808|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593809|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153593810|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153593811|NCT01845064|Kallikreins|kallikreins|mesh-list
153593812|NCT01845064|Coagulants|coagulants|mesh-ancestor
153593813|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153593814|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
153593815|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153593816|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593817|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
153593818|NCT01845090|Calcium|calcium|mesh-list
153593819|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153593820|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593821|NCT01845090|Antacids|antacids|mesh-ancestor
153402967|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402968|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153402969|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153402970|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402971|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402972|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153402973|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402974|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801160|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153801161|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
153801162|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153801163|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801164|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153801165|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153801167|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153801168|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153801169|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153801170|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153801171|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
153801172|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153801173|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153801174|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
153801175|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801176|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
153801177|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153801178|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153801179|NCT00319800|Irinotecan|irinotecan|mesh-list
153801180|NCT00319800|Gefitinib|gefitinib|mesh-list
153593822|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593823|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153593824|NCT01845142|Vitamin D|vitamin d|mesh-list
153593845|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153593846|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
153593847|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
153593848|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
153593849|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
153593850|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801181|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153801182|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153801183|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801184|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347763|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153347770|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
153801185|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801198|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153801199|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153801200|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801201|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801202|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153801203|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
153801204|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801205|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801206|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153801207|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153801208|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153412694|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
153412695|NCT02424968|Cyclosporins|cyclosporins|mesh-list
153412696|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
153412697|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153412698|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412699|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872033|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872034|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153872035|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153801209|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153593851|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593852|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153593853|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153593854|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593855|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153593856|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153593857|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
153593858|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153593859|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153593860|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
153593861|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
153593862|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862613|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153862614|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153862615|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153862616|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862617|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
153862618|NCT02901977|Ramipril|ramipril|mesh-list
153862619|NCT02901977|Doxazosin|doxazosin|mesh-list
153862620|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153801210|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
153801211|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153801212|NCT00319878|Cyclosporine|cyclosporine|mesh-list
153801213|NCT00319878|Sirolimus|sirolimus|mesh-list
153801214|NCT00319878|Cyclosporins|cyclosporins|mesh-list
153801215|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801216|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801217|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801218|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
153801219|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801220|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
153801221|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801222|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
153801223|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801224|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153801225|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153801226|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153801227|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801228|NCT00286364|Androgens|androgens|mesh-list
153801229|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153801230|NCT00286364|Hormones|hormones|mesh-ancestor
153862621|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
153862622|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801231|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801232|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801233|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153801234|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801235|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801236|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153801237|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
153801238|NCT00319917|Tacrolimus|tacrolimus|mesh-list
153801239|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801240|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
153801241|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889017|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412715|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412716|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412717|NCT02492750|Dexamethasone|dexamethasone|mesh-list
153412718|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
153801242|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153801243|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801244|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801245|NCT00286403|Fenoldopam|fenoldopam|mesh-list
153801246|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801247|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153862625|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153862626|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153862627|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153402975|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
153402976|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402977|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
153402978|NCT04523480|Testosterone|testosterone|mesh-list
153402979|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
153402980|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
153402981|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153402982|NCT04523480|Androgens|androgens|mesh-ancestor
153402983|NCT04523480|Hormones|hormones|mesh-ancestor
153402984|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153402985|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593863|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153593864|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153593865|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153593866|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
153593867|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153593868|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153593869|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
153593870|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153593871|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153402990|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153402991|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153402992|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
153402993|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
153402994|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402995|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402996|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801248|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
153801249|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
153801260|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801261|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153801262|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153801263|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811349|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
153889025|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153889026|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872101|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801265|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153801266|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
153801267|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801268|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801269|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153801270|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
153801271|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
153801272|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153801273|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153801274|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153801275|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153801276|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
153801277|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801279|NCT00320073|Pemetrexed|pemetrexed|mesh-list
153862628|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862629|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862630|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862631|NCT00553553|Morphine|morphine|mesh-list
153862632|NCT00553553|Remifentanil|remifentanil|mesh-list
153862633|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153862634|NCT00553553|Narcotics|narcotics|mesh-ancestor
153862635|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862636|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862637|NCT00553553|Analgesics|analgesics|mesh-ancestor
153801282|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801283|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801284|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153801285|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153801286|NCT00320073|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153801287|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153801288|NCT00286871|Tacrolimus|tacrolimus|mesh-list
153801289|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801290|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
153801291|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801292|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153801293|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801294|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801295|NCT00417326|Sivelestat|sivelestat|mesh-list
153801296|NCT00417326|Glycine|glycine|mesh-list
153801297|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153801298|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
153801299|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801300|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801301|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
153801302|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801303|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872130|NCT01087151|Navitoclax|navitoclax|mesh-list
153593872|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153801304|NCT00320229|Abciximab|abciximab|mesh-list
153801305|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
153736332|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801306|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153801307|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153801308|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
153801309|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153801310|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153801311|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153801340|NCT00313482|Sargramostim|sargramostim|mesh-list
153801341|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801342|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801343|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801344|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801345|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801346|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153801347|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
153801348|NCT00313482|Hormones|hormones|mesh-ancestor
153801349|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801350|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801351|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153801352|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
153801353|NCT00286988|Topiramate|topiramate|mesh-list
153801354|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
153801355|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153801356|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801357|NCT00320307|Abacavir|abacavir|mesh-list
153801358|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153801366|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
153801367|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862640|NCT04622982|Vitamin D|vitamin d|mesh-list
153593873|NCT01845194|Narcotics|narcotics|mesh-ancestor
153593874|NCT01845194|Analgesics|analgesics|mesh-ancestor
153593875|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
153593876|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
153593877|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
153593878|NCT01845194|Diuretics|diuretics|mesh-ancestor
153818624|NCT04102189|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153818625|NCT04102189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153818626|NCT04102189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818627|NCT04087317|Acetaminophen|acetaminophen|mesh-list
153818628|NCT04087317|Ibuprofen|ibuprofen|mesh-list
153818629|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153818630|NCT04087317|Analgesics|analgesics|mesh-ancestor
153403017|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403018|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153403019|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153801368|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153811350|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872156|NCT04671056|Pioglitazone|pioglitazone|mesh-list
153872157|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872158|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872159|NCT01082549|Carboplatin|carboplatin|mesh-list
153801369|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801370|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153801371|NCT02960906|Nivolumab|nivolumab|mesh-list
153801372|NCT02960906|Ipilimumab|ipilimumab|mesh-list
153801373|NCT02960906|Sunitinib|sunitinib|mesh-list
153801374|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153801375|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801376|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153801377|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801378|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153801379|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153801380|NCT02960906|Growth Substances|growth substances|mesh-ancestor
153801381|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801382|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
153801383|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153801384|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801385|NCT00287066|Insulin|insulin|mesh-list
153801386|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153801387|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153801388|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801389|NCT00313521|Thiotepa|thiotepa|mesh-list
153801390|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153801391|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
153818631|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
153818632|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862652|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862653|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862654|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153862655|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153862656|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153862657|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862658|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862659|NCT04622358|Rabeprazole|rabeprazole|mesh-list
153801392|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801393|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801394|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153801395|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801396|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
153801397|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801398|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
153801399|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153801400|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801401|NCT00313599|Paclitaxel|paclitaxel|mesh-list
153801402|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153801403|NCT00313599|Lapatinib|lapatinib|mesh-list
153801404|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801405|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801406|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801407|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
153348063|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153801408|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801409|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801410|NCT00313599|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153403028|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403029|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153403030|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
153403032|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153403033|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153403034|NCT04274179|Lamotrigine|lamotrigine|mesh-list
153403035|NCT04274179|Valproic Acid|valproic acid|mesh-list
153801460|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153801461|NCT00313833|Narcotics|narcotics|mesh-ancestor
153801462|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801463|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801464|NCT00313833|Analgesics|analgesics|mesh-ancestor
153801465|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
153801466|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801467|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153801468|NCT00287495|Sorafenib|sorafenib|mesh-list
153801469|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801488|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153801489|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153801490|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153801491|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153801492|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153801493|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801494|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801496|NCT00320697|Nicotine|nicotine|mesh-list
153862673|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153862674|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153862675|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862676|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
153862677|NCT04622397|Coagulants|coagulants|mesh-ancestor
153862678|NCT02901353|Sirolimus|sirolimus|mesh-list
153862679|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153801504|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801505|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801506|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153801507|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
153801508|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153801509|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153801510|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153801511|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153801512|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
153801513|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153811351|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412911|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
153412912|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153412913|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
153412914|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
153412915|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
153412916|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153412917|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153412918|NCT02519023|Narcotics|narcotics|mesh-ancestor
153412919|NCT02497040|Bupivacaine|bupivacaine|mesh-list
153412920|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
153412921|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
153872276|NCT00556127|Cytarabine|cytarabine|mesh-list
153801514|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153801515|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801516|NCT00287651|Insulin|insulin|mesh-list
153801517|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153801518|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153801519|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801520|NCT00322296|Bexarotene|bexarotene|mesh-list
153801521|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801522|NCT00320736|Galantamine|galantamine|mesh-list
153801548|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153801549|NCT00320814|Growth Substances|growth substances|mesh-ancestor
153801550|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801551|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
153801552|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801553|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
153801554|NCT00287846|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153801555|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153801558|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801559|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
153736333|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
153801560|NCT00322413|Hematinics|hematinics|mesh-ancestor
153801561|NCT00320853|Vitamin D|vitamin d|mesh-list
153801562|NCT00320853|Vitamins|vitamins|mesh-ancestor
153801563|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
153801564|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801565|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153801566|NCT00287885|Docetaxel|docetaxel|mesh-list
153801567|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801568|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801569|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801570|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801571|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801607|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153801608|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
153801609|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
153801610|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
153801648|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801676|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153801677|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153801678|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801679|NCT00288158|Allopurinol|allopurinol|mesh-list
153801680|NCT00288158|Probenecid|probenecid|mesh-list
153801681|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
153801682|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801683|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801684|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
153801685|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801686|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153801687|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
153801688|NCT00288158|Protective Agents|protective agents|mesh-ancestor
153801689|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862680|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801690|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
153801691|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153801692|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153412953|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412954|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412955|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153412956|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153412957|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153412958|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
153412961|NCT02524561|Estradiol|estradiol|mesh-list
153801693|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801694|NCT00288197|Voriconazole|voriconazole|mesh-list
153801695|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
153801710|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801711|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801712|NCT00288236|Hormones|hormones|mesh-ancestor
153801713|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801714|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801716|NCT00321126|Trace Elements|trace elements|mesh-ancestor
153801717|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
153801718|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801719|NCT00288353|Aripiprazole|aripiprazole|mesh-list
153801720|NCT00288353|Ziprasidone|ziprasidone|mesh-list
153801721|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
153801722|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153801723|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153801724|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153801725|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801726|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801727|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
153801728|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
153801729|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801730|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801731|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153801732|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153801733|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
153801734|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153801735|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153801736|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153801737|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153818633|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818634|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
153818635|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153818636|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818637|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801738|NCT00288431|Sirolimus|sirolimus|mesh-list
153801739|NCT00288431|Doxorubicin|doxorubicin|mesh-list
153801740|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153801741|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801742|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153801743|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153801744|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801745|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801746|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153801747|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413000|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153413001|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413002|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
153413003|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
153413004|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
153872347|NCT00478023|Tapentadol|tapentadol|mesh-list
153872348|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153872349|NCT00478023|Narcotics|narcotics|mesh-ancestor
153801749|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801750|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
153801757|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
153801758|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153801759|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153801760|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801761|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801762|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153801763|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153801764|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
153801766|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801767|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801768|NCT00322920|Topotecan|topotecan|mesh-list
153801769|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862713|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862714|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153862715|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153862716|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153862717|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153862718|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862719|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862720|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818638|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153818639|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818640|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460028|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
153460029|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153460030|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
153460031|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153403087|NCT04230304|Daratumumab|daratumumab|mesh-list
153403088|NCT04230304|Ibrutinib|ibrutinib|mesh-list
153403089|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403090|NCT04230304|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153403091|NCT04230304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153801770|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153801771|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153801772|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801773|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801774|NCT00321009|Enoxaparin|enoxaparin|mesh-list
153348358|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153348361|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
153801775|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
153801776|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153801777|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153801778|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801779|NCT00417677|Sirolimus|sirolimus|mesh-list
153801780|NCT00417677|Sunitinib|sunitinib|mesh-list
153801781|NCT00417677|Temsirolimus|temsirolimus|mesh-list
153801782|NCT00417677|MTOR Inhibitors|mtor inhibitors|mesh-list
153801783|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801784|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153801785|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153801786|NCT00417677|Growth Substances|growth substances|mesh-ancestor
153801787|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801788|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
153801789|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153801790|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801800|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801801|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153801802|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153801803|NCT00417716|Growth Substances|growth substances|mesh-ancestor
153801804|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801805|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
153801807|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
153801808|NCT00288470|Protective Agents|protective agents|mesh-ancestor
153801809|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801810|NCT00321360|Propofol|propofol|mesh-list
153801811|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153801812|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801813|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801814|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153801815|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
153801816|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
153801847|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
153801848|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801849|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348427|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801850|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153348500|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
153801851|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153801852|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
153801853|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153801854|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153801855|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153801856|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153801889|NCT06140095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460032|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460033|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153460034|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
153460035|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153460036|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153593879|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
153593880|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153593881|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593882|NCT01845246|Colistin|colistin|mesh-list
153593883|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593884|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593885|NCT01845259|Liraglutide|liraglutide|mesh-list
153403100|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801890|NCT06140095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153801891|NCT06140095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153801892|NCT06140095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801893|NCT06140095|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153801894|NCT06140095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153801895|NCT06140095|Protease Inhibitors|protease inhibitors|mesh-ancestor
153801896|NCT06139952|Acetylcysteine|acetylcysteine|mesh-list
153801897|NCT06139952|Atorvastatin|atorvastatin|mesh-list
153801898|NCT06139952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153801916|NCT06139926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153801917|NCT06139926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801918|NCT06139926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801919|NCT06139926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153801921|NCT06139926|Sensory System Agents|sensory system agents|mesh-ancestor
153801922|NCT06139926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801923|NCT06139926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153801924|NCT06139926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153801925|NCT06139926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153801926|NCT06139926|Adrenergic Agents|adrenergic agents|mesh-ancestor
153801927|NCT06139926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801928|NCT06139926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801929|NCT06139666|Bupivacaine|bupivacaine|mesh-list
153801930|NCT06139666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153801936|NCT06139666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801937|NCT06139419|Paclitaxel|paclitaxel|mesh-list
153801938|NCT06139419|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153801939|NCT06139419|Cisplatin|cisplatin|mesh-list
153801940|NCT06139419|Tislelizumab|tislelizumab|mesh-list
153801941|NCT06139419|Thymalfasin|thymalfasin|mesh-list
153801942|NCT06139419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801943|NCT06139419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801944|NCT06139419|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801945|NCT06139419|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801946|NCT06139419|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801947|NCT06139419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801948|NCT06139419|Immunologic Factors|immunologic factors|mesh-ancestor
153801949|NCT06139419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801950|NCT06139419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153801951|NCT06139419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153801952|NCT06139393|Febuxostat|febuxostat|mesh-list
153801953|NCT06139393|Gout Suppressants|gout suppressants|mesh-ancestor
153801954|NCT06139393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801955|NCT06139211|Leucovorin|leucovorin|mesh-list
153801956|NCT06139211|Paclitaxel|paclitaxel|mesh-list
153801976|NCT06139211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153801977|NCT06139211|Antimetabolites|antimetabolites|mesh-ancestor
153801978|NCT06139211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801979|NCT06139211|Immunologic Factors|immunologic factors|mesh-ancestor
153801980|NCT06139211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153801981|NCT06139211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153801982|NCT06139211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801983|NCT06139211|Antidotes|antidotes|mesh-ancestor
153801984|NCT06139211|Protective Agents|protective agents|mesh-ancestor
153801985|NCT06139211|Vitamin B Complex|vitamin b complex|mesh-ancestor
153801986|NCT06139211|Vitamins|vitamins|mesh-ancestor
153801987|NCT06139211|Micronutrients|micronutrients|mesh-ancestor
153801999|NCT06138834|Vasodilator Agents|vasodilator agents|mesh-ancestor
153802000|NCT06138834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153348573|NCT00201734|Paclitaxel|paclitaxel|mesh-list
153802001|NCT06138834|Protective Agents|protective agents|mesh-ancestor
153802002|NCT06138834|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153802003|NCT06138834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153802004|NCT06138834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802005|NCT06138821|Semaglutide|semaglutide|mesh-list
153802006|NCT06138821|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153802007|NCT06138821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153802008|NCT06138821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802009|NCT06138769|Lenvatinib|lenvatinib|mesh-list
153802010|NCT06138769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802011|NCT06138769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153802012|NCT06138769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802028|NCT06138574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802029|NCT06138574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153802030|NCT06138574|Narcotics|narcotics|mesh-ancestor
153802031|NCT06138535|Salicylic Acid|salicylic acid|mesh-list
153802032|NCT06138535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802033|NCT06138535|Antifungal Agents|antifungal agents|mesh-ancestor
153802034|NCT06138535|Keratolytic Agents|keratolytic agents|mesh-ancestor
153802035|NCT06138535|Dermatologic Agents|dermatologic agents|mesh-ancestor
153802036|NCT06138496|Lenvatinib|lenvatinib|mesh-list
153802037|NCT06138496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802038|NCT06138496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153802039|NCT06138496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593886|NCT01845259|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153593887|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153593888|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593889|NCT01845259|Incretins|incretins|mesh-ancestor
153593890|NCT01845259|Hormones|hormones|mesh-ancestor
153593891|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593892|NCT01845272|Amlodipine|amlodipine|mesh-list
153593893|NCT01845272|Candesartan|candesartan|mesh-list
153593894|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
153593895|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153593896|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153593897|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593898|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593899|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153593900|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593901|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
153593902|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153593903|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153593904|NCT01845298|Rifampin|rifampin|mesh-list
153593905|NCT01845298|Rifamycins|rifamycins|mesh-list
153593906|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153593907|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
153862784|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802040|NCT06138496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802041|NCT06138340|Dexmedetomidine|dexmedetomidine|mesh-list
153802042|NCT06138340|Propofol|propofol|mesh-list
153802043|NCT06138340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153802044|NCT06138340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802045|NCT06138340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802046|NCT06138340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153802047|NCT06138340|Analgesics|analgesics|mesh-ancestor
153802048|NCT06138340|Sensory System Agents|sensory system agents|mesh-ancestor
153802049|NCT06138340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802050|NCT06138340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153802051|NCT06138340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153802052|NCT06138340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153802053|NCT06138340|Adrenergic Agents|adrenergic agents|mesh-ancestor
153802054|NCT06138340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802055|NCT06138340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802056|NCT06138340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153802057|NCT06138340|Anesthetics, General|anesthetics, general|mesh-ancestor
153802058|NCT06138340|Anesthetics|anesthetics|mesh-ancestor
153802059|NCT06136754|Fluorides|fluorides|mesh-list
153802060|NCT06136754|Fluorides, Topical|fluorides, topical|mesh-list
153802061|NCT06136754|Cariostatic Agents|cariostatic agents|mesh-ancestor
153802101|NCT06083480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802102|NCT06083480|Protective Agents|protective agents|mesh-ancestor
153802103|NCT06083480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802105|NCT06083480|Glycine Agents|glycine agents|mesh-ancestor
153802106|NCT06083480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802107|NCT06060626|Fentanyl|fentanyl|mesh-list
153802108|NCT06060626|Propofol|propofol|mesh-list
153802109|NCT06060626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153802110|NCT06060626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802111|NCT06060626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802112|NCT06060626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153802113|NCT06060626|Anesthetics, General|anesthetics, general|mesh-ancestor
153802114|NCT06060626|Anesthetics|anesthetics|mesh-ancestor
153802115|NCT06060626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153802116|NCT06060626|Narcotics|narcotics|mesh-ancestor
153802117|NCT06060626|Analgesics|analgesics|mesh-ancestor
153802118|NCT06060626|Sensory System Agents|sensory system agents|mesh-ancestor
153802119|NCT06060626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802120|NCT06060626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153802121|NCT06059014|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153802122|NCT06059014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802136|NCT06002490|Sensory System Agents|sensory system agents|mesh-ancestor
153802137|NCT06002490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802138|NCT06002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802139|NCT06002490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802140|NCT06002490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153593908|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593909|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593919|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153593921|NCT01845363|Cefazolin|cefazolin|mesh-list
153593922|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153593923|NCT01845376|Anesthetics|anesthetics|mesh-list
153593924|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593925|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593926|NCT01845428|Pravastatin|pravastatin|mesh-list
153593927|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153593928|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153593929|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
153593930|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593931|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153593932|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153593933|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593934|NCT01845493|Sulforaphane|sulforaphane|mesh-list
153593935|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153593936|NCT01845493|Protective Agents|protective agents|mesh-ancestor
153593937|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802142|NCT06002490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153802143|NCT06002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802144|NCT06002490|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153802145|NCT06002490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153802146|NCT06002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802147|NCT06002490|Antipyretics|antipyretics|mesh-ancestor
153802148|NCT05969795|Progesterone|progesterone|mesh-list
153802149|NCT05969795|Progestins|progestins|mesh-ancestor
153802151|NCT05969795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802152|NCT05969795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802153|NCT05957081|Pembrolizumab|pembrolizumab|mesh-list
153802154|NCT05957081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802155|NCT05957081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802156|NCT05957081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153802157|NCT05957081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802158|NCT05931302|FAPI-46|fapi-46|mesh-list
153802159|NCT05931302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153802160|NCT05931302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802161|NCT05907057|Azacitidine|azacitidine|mesh-list
153802162|NCT05907057|Ivosidenib|ivosidenib|mesh-list
153802163|NCT05907057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802164|NCT05907057|Antimetabolites|antimetabolites|mesh-ancestor
153802165|NCT05907057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802166|NCT05907057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802167|NCT05907057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802168|NCT05886712|Naloxone|naloxone|mesh-list
153802169|NCT05886712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153802170|NCT05886712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802171|NCT05886712|Sensory System Agents|sensory system agents|mesh-ancestor
153802172|NCT05886712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802173|NCT05884866|Dapagliflozin|dapagliflozin|mesh-list
153802175|NCT05884866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802176|NCT05884866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153802177|NCT05884866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802178|NCT05875441|Moxidectin|moxidectin|mesh-list
153802179|NCT05875441|Anthelmintics|anthelmintics|mesh-ancestor
153802180|NCT05875441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153802181|NCT05875441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802182|NCT05875441|Antinematodal Agents|antinematodal agents|mesh-ancestor
153802183|NCT05863312|Temazepam|temazepam|mesh-list
153802184|NCT05863312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153802216|NCT05826912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153802224|NCT05799144|Pembrolizumab|pembrolizumab|mesh-list
153802276|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153802277|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153802278|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
153802279|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
153802280|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802281|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802282|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802284|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
153802285|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802286|NCT05638217|Listerine|listerine|mesh-list
153802287|NCT05638217|Fluorides|fluorides|mesh-list
153802288|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
153802289|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
153802290|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
153802291|NCT05638217|Protective Agents|protective agents|mesh-ancestor
153413309|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413334|NCT02514044|Adderall|adderall|mesh-list
153802292|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802293|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153802319|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802321|NCT05536219|Antibodies|antibodies|mesh-list
153802322|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
153802323|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802324|NCT05435547|Dexamethasone|dexamethasone|mesh-list
153802325|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802326|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
153802327|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
153802328|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802329|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802330|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153802331|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
153802332|NCT05435547|Hormones|hormones|mesh-ancestor
153802333|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802334|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802335|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802336|NCT05343572|Plerixafor|plerixafor|mesh-list
153802337|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153802340|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802350|NCT05313620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153802351|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153802352|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802353|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802354|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153802355|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
153802356|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802357|NCT05293288|Anesthetics|anesthetics|mesh-list
153802358|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802359|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802360|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
153802361|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802362|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
153802363|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802364|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802365|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153802366|NCT05278975|Thiostrepton|thiostrepton|mesh-list
153802367|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153802368|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802369|NCT05278494|Levomethorphan|levomethorphan|mesh-list
153802370|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
153802371|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
153802372|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
153348945|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802373|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153802374|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153802375|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802376|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802377|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802378|NCT05278494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153802381|NCT05278494|Analgesics|analgesics|mesh-ancestor
153862848|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862850|NCT02900417|Hormones|hormones|mesh-ancestor
153862851|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862852|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153862853|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
153862854|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802382|NCT05278494|Sensory System Agents|sensory system agents|mesh-ancestor
153802383|NCT05278494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802384|NCT05252585|Everolimus|everolimus|mesh-list
153802385|NCT05252585|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153802386|NCT05252585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153802387|NCT05252585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802388|NCT05252585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802389|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153802390|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
153802391|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802392|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802393|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
153802394|NCT05222529|Bromides|bromides|mesh-list
153802395|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
153802396|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153802397|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153802398|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153802399|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
153802400|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802401|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802402|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802403|NCT05194397|Niacinamide|niacinamide|mesh-list
153802404|NCT05194397|Niacin|niacin|mesh-list
153802405|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
153862855|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862856|NCT04620837|Tislelizumab|tislelizumab|mesh-list
153862858|NCT04620837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802406|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
153802407|NCT05194397|Vitamins|vitamins|mesh-ancestor
153802408|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
153802444|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802445|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153802446|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153802447|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
153802465|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802466|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
153802467|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802468|NCT04734262|Paclitaxel|paclitaxel|mesh-list
153802469|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153802470|NCT04734262|Tislelizumab|tislelizumab|mesh-list
153802471|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153802472|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802473|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
153802474|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
153802475|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
153802476|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802477|NCT04734262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802478|NCT04684212|Warfarin|warfarin|mesh-list
153802554|NCT04569747|Tamoxifen|tamoxifen|mesh-list
153802555|NCT04569747|Trastuzumab|trastuzumab|mesh-list
153802556|NCT04569747|Pertuzumab|pertuzumab|mesh-list
153802557|NCT04569747|Letrozole|letrozole|mesh-list
153802558|NCT04569747|Anastrozole|anastrozole|mesh-list
153802559|NCT04569747|Leuprolide|leuprolide|mesh-list
153802560|NCT04569747|Exemestane|exemestane|mesh-list
153802561|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802562|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802563|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153802564|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153802565|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802566|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802567|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153802568|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
153802569|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802570|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802571|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802572|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153802573|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153802574|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153802575|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153802576|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
153802577|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153802578|NCT04568616|Letrozole|letrozole|mesh-list
153802579|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802580|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153802581|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153802582|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802583|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802584|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153802585|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
153802586|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802587|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802588|NCT04543409|Benralizumab|benralizumab|mesh-list
153802589|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153403273|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153403274|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153403275|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153403276|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403277|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153403278|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153403279|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403280|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
153802590|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
153802591|NCT04495088|Leucovorin|leucovorin|mesh-list
153802592|NCT04495088|Folic Acid|folic acid|mesh-list
153802593|NCT04495088|Capecitabine|capecitabine|mesh-list
153802594|NCT04495088|Fluorouracil|fluorouracil|mesh-list
153357819|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413470|NCT02541565|Antibodies|antibodies|mesh-list
153413471|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
153413472|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153413473|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153413474|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
153413475|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413476|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413478|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
153413483|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153413484|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153413485|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413486|NCT02541565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153413487|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413488|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
153802595|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
153736335|NCT03014167|Albendazole|albendazole|mesh-list
153802596|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
153802597|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802598|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
153802599|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802600|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802601|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153802602|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
153802603|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802604|NCT04495088|Antidotes|antidotes|mesh-ancestor
153802605|NCT04495088|Protective Agents|protective agents|mesh-ancestor
153802636|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802637|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
153802638|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802640|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
153862915|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
153862916|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
153862917|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153862918|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862919|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802673|NCT04239339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153802674|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153802675|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153802676|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802677|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802678|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
153802679|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802680|NCT04222920|Adalimumab|adalimumab|mesh-list
153802681|NCT04222920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153802682|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802683|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802684|NCT04198506|Tacrolimus|tacrolimus|mesh-list
153802685|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153802686|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
153802687|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802688|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153802689|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802690|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802691|NCT04194827|Adalimumab|adalimumab|mesh-list
153802692|NCT04194827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153802693|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802694|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802695|NCT04126135|Nicotine|nicotine|mesh-list
153802696|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153802697|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
153802735|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872842|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153872843|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153872844|NCT04311658|Diuretics|diuretics|mesh-ancestor
153872845|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
153413504|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
153413505|NCT04707950|Coagulants|coagulants|mesh-ancestor
153889047|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153413506|NCT04044560|Blinatumomab|blinatumomab|mesh-list
153802736|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
153736336|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
153802738|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802739|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802740|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153802741|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153802742|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
153802743|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153802744|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153802745|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153802746|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153802747|NCT03973489|Methamphetamine|methamphetamine|mesh-list
153802748|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153802749|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802750|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
153349321|NCT00248534|Hormones|hormones|mesh-ancestor
153802751|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
153802752|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802753|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
153802754|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802755|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802756|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
153802757|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153403307|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403334|NCT03961698|Bevacizumab|bevacizumab|mesh-list
153802758|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153802759|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153802760|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153802761|NCT03961919|Fludarabine|fludarabine|mesh-list
153802762|NCT03961919|Treosulfan|treosulfan|mesh-list
153802763|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802764|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802776|NCT03942328|Vaccines|vaccines|mesh-list
153802777|NCT03942328|Antibodies|antibodies|mesh-list
153802778|NCT03942328|Immunoglobulins|immunoglobulins|mesh-list
153802779|NCT03942328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153802780|NCT03942328|Immunoglobulin G|immunoglobulin g|mesh-list
153802781|NCT03942328|Endothelial Growth Factors|endothelial growth factors|mesh-list
153802782|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
153802783|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802784|NCT03942328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802785|NCT03942328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153802786|NCT03942328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153802787|NCT03942328|Growth Substances|growth substances|mesh-ancestor
153802788|NCT03942328|Growth Inhibitors|growth inhibitors|mesh-ancestor
153802789|NCT03942328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153802790|NCT03942328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802791|NCT03929718|Spironolactone|spironolactone|mesh-list
153802792|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153802793|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
153802794|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802795|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802796|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153802797|NCT03929718|Diuretics|diuretics|mesh-ancestor
153403335|NCT03961698|Atezolizumab|atezolizumab|mesh-list
153862943|NCT04314739|Resveratrol|resveratrol|mesh-list
153862944|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
153593938|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593939|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153593940|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
153593942|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593943|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593944|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
153593945|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802798|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
153802799|NCT03927144|Erenumab|erenumab|mesh-list
153802800|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153802801|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802802|NCT03927144|Analgesics|analgesics|mesh-ancestor
153802803|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
153802804|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802805|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802806|NCT03904251|Cytarabine|cytarabine|mesh-list
153802807|NCT03904251|Daunorubicin|daunorubicin|mesh-list
153802808|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
153802809|NCT03904251|Calicheamicins|calicheamicins|mesh-list
153802810|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802811|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
153802812|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802813|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802814|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
153802815|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802816|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153802817|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
153802818|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802819|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153736337|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153802820|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153802821|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153802822|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802823|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802824|NCT03904251|Immunotoxins|immunotoxins|mesh-ancestor
153802825|NCT03904251|Immunoconjugates|immunoconjugates|mesh-ancestor
153802826|NCT03901339|Gemcitabine|gemcitabine|mesh-list
153802827|NCT03901339|Capecitabine|capecitabine|mesh-list
153802852|NCT03885713|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153802853|NCT03885713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153802854|NCT03885713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403361|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802855|NCT03885713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802856|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153802857|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
153802858|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802859|NCT03869892|Trifluridine|trifluridine|mesh-list
153802860|NCT03869892|Bevacizumab|bevacizumab|mesh-list
153802861|NCT03869892|Capecitabine|capecitabine|mesh-list
153802862|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802863|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802864|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153802865|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153802866|NCT03869892|Growth Substances|growth substances|mesh-ancestor
153802867|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802868|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
153802869|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802870|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
153802871|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802872|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
153802873|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413634|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802875|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
153802876|NCT03784677|SOR-C13|sor-c13|mesh-list
153802877|NCT03784677|Calcium|calcium|mesh-list
153802878|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153802879|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802880|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802889|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802890|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153802891|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153802892|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153802893|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
153802894|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802895|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802896|NCT03684811|Gemcitabine|gemcitabine|mesh-list
153802897|NCT03684811|Nivolumab|nivolumab|mesh-list
153802898|NCT03684811|Azacitidine|azacitidine|mesh-list
153862999|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153802899|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802900|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802901|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
153802902|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802903|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802904|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153802905|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802906|NCT03672773|Temozolomide|temozolomide|mesh-list
153802907|NCT03672773|Talazoparib|talazoparib|mesh-list
153802908|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153802909|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
153802910|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802911|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802912|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153802913|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802914|NCT03661723|Bevacizumab|bevacizumab|mesh-list
153802915|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
153802916|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802917|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802918|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153802919|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153863000|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153863001|NCT01165684|Insulin|insulin|mesh-list
153863002|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153863003|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
153863004|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
153863005|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153593966|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593967|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593968|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153593969|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153593970|NCT01845675|Growth Substances|growth substances|mesh-ancestor
153593971|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413675|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153593972|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
153593973|NCT01845701|Artesunate|artesunate|mesh-list
153593974|NCT01845701|Lumefantrine|lumefantrine|mesh-list
153593975|NCT01845701|Artemether|artemether|mesh-list
153593976|NCT01845701|Piperaquine|piperaquine|mesh-list
153593977|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153593978|NCT01845701|Amodiaquine|amodiaquine|mesh-list
153593979|NCT01845701|Artenimol|artenimol|mesh-list
153593980|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
153593981|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153593982|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153403381|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802920|NCT03661723|Growth Substances|growth substances|mesh-ancestor
153802921|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802922|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
153802934|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802935|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
153802936|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
153802937|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
153802938|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
153802939|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153802940|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153802941|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802942|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802943|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802969|NCT03502018|Bupivacaine|bupivacaine|mesh-list
153802970|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
153802971|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
153802972|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802973|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802974|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
153802975|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802977|NCT03484299|Folfirinox|folfirinox|mesh-list
153802978|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802979|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
153802980|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802981|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802982|NCT03471624|Tenofovir|tenofovir|mesh-list
153802983|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
153802984|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802985|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153802986|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153802987|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802988|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802989|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153802990|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153802991|NCT03441048|Cytarabine|cytarabine|mesh-list
153802996|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802997|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
153802998|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802999|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803000|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
153803001|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413727|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153413728|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413730|NCT05731778|Fluorides|fluorides|mesh-list
153803002|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803003|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
153803004|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803005|NCT03441048|Analgesics|analgesics|mesh-ancestor
153803006|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
153803007|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803008|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153803009|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153803040|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803041|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803042|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803044|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
153803045|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803046|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349611|NCT02106494|Hormones|hormones|mesh-ancestor
153349613|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153803047|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153803048|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
153803049|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803050|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803051|NCT03395847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153803052|NCT03395847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803054|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
153803055|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803074|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803083|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153803084|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
153803085|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153803086|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803087|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153803088|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153803089|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803090|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153803091|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
153803092|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153803093|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153803094|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153803095|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153803096|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153803097|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153803098|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153803099|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153803100|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153803101|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
153803102|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153803103|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
153803104|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
153803105|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803106|NCT03176953|Topiramate|topiramate|mesh-list
153803107|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
153803108|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803110|NCT03110978|Nivolumab|nivolumab|mesh-list
153803157|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803158|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153803159|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153803160|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153803161|NCT03004287|Growth Substances|growth substances|mesh-ancestor
153803162|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
153803163|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
153803190|NCT02668653|Daunorubicin|daunorubicin|mesh-list
153803191|NCT02668653|Idarubicin|idarubicin|mesh-list
153803192|NCT02668653|Quizartinib|quizartinib|mesh-list
153803193|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803194|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
153803195|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803196|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803197|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
153803198|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349758|NCT01225289|Protective Agents|protective agents|mesh-ancestor
153803199|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803200|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
153803201|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803202|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153803203|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153803204|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153803205|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803206|NCT02668653|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153803207|NCT02668653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153803208|NCT02652052|Dasatinib|dasatinib|mesh-list
153803209|NCT02652052|Quercetin|quercetin|mesh-list
153803210|NCT02652052|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153803211|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153803212|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803233|NCT02558010|Morphine|morphine|mesh-list
153803245|NCT02530502|Temozolomide|temozolomide|mesh-list
153803246|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803247|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803248|NCT02530502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153803249|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803250|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153803251|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
153803252|NCT02437318|Fulvestrant|fulvestrant|mesh-list
153803253|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153803254|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803255|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153803256|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153811353|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
153811354|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
153873169|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873170|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873171|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153803257|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
153803258|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153803259|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803260|NCT02305238|Aflibercept|aflibercept|mesh-list
153803261|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153803262|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153803263|NCT02305238|Growth Substances|growth substances|mesh-ancestor
153803264|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803265|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
153803266|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803296|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
153803297|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803298|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803309|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
153803310|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
153803311|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803312|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803313|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
153803314|NCT00288743|Insulin|insulin|mesh-list
153803315|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803316|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803317|NCT00321633|Carboplatin|carboplatin|mesh-list
153803318|NCT00321633|Docetaxel|docetaxel|mesh-list
153803319|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803320|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803345|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153803346|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
153803347|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803348|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349914|NCT00351416|Letrozole|letrozole|mesh-list
153803349|NCT01059825|Incretins|incretins|mesh-ancestor
153803350|NCT01059825|Hormones|hormones|mesh-ancestor
153803351|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153803352|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153803353|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
153803354|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803355|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803356|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153803357|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
153803358|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153803359|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153803360|NCT00321750|Analgesics|analgesics|mesh-ancestor
153803361|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
153803362|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803363|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803364|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153803365|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803402|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803403|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803404|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153803405|NCT00323505|Interferons|interferons|mesh-list
153803406|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
153803407|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
153803408|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803409|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
153803410|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803411|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
153803428|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153803429|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153803430|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803431|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803432|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153803433|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153803434|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
153803435|NCT00289445|Leucovorin|leucovorin|mesh-list
153803436|NCT00289445|Folic Acid|folic acid|mesh-list
153873189|NCT01124149|Analgesics|analgesics|mesh-ancestor
153803437|NCT00289445|Mitomycins|mitomycins|mesh-list
153803438|NCT00289445|Mitomycin|mitomycin|mesh-list
153803439|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
153803440|NCT00289445|Antidotes|antidotes|mesh-ancestor
153803441|NCT00289445|Protective Agents|protective agents|mesh-ancestor
153803442|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803443|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
153803444|NCT00289445|Vitamins|vitamins|mesh-ancestor
153803445|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
153803446|NCT00289445|Hematinics|hematinics|mesh-ancestor
153803447|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153803448|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803449|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
153803450|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803451|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153803462|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803463|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803464|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153803465|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803466|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
153803467|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803468|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803469|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
153803470|NCT00323583|Antidotes|antidotes|mesh-ancestor
153803496|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
153803497|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
153350056|NCT00310466|Immunomodulating Agents|immunomodulating agents|mesh-list
153803498|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803499|NCT00303225|Tecovirimat|tecovirimat|mesh-list
153803500|NCT00303225|Antiviral Agents|antiviral agents|mesh-ancestor
153803501|NCT00303225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803502|NCT00323934|Mocetinostat|mocetinostat|mesh-list
153803503|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153803504|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803505|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803507|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153803508|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153803509|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153803510|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
153803511|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803512|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803513|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803514|NCT00290030|Urological Agents|urological agents|mesh-ancestor
153803515|NCT00303264|Esomeprazole|esomeprazole|mesh-list
153413948|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153413949|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153413950|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413951|NCT02252016|Grazoprevir|grazoprevir|mesh-list
153413952|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
153413953|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413954|NCT02706847|Upadacitinib|upadacitinib|mesh-list
153413955|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153413956|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153873271|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153873272|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873273|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153873274|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873276|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153803552|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803553|NCT00290108|Propofol|propofol|mesh-list
153803554|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153803555|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803556|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803557|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153803558|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
153803559|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
153803560|NCT00323973|Bisoprolol|bisoprolol|mesh-list
153803561|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153803562|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
153803563|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
153803564|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803565|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803566|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153803567|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153803568|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153803569|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
153803570|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803606|NCT00324051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153803629|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153803630|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153803631|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403553|NCT03421288|Leucovorin|leucovorin|mesh-list
153863162|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153863163|NCT05376761|Analgesics|analgesics|mesh-ancestor
153593983|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593984|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593985|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
153593986|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
153593987|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153593988|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
153593989|NCT01845727|Amphotericin B|amphotericin b|mesh-list
153593990|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153593991|NCT01845727|Amebicides|amebicides|mesh-ancestor
153593992|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153460037|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153460038|NCT04865419|Voriconazole|voriconazole|mesh-list
153460039|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
153460040|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460041|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153460042|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153460043|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460044|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460045|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153460046|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
153818646|NCT04038515|Menthol|menthol|mesh-list
153818652|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153803633|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153803635|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803637|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803638|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803639|NCT00290849|Bivalirudin|bivalirudin|mesh-list
153803640|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
153803641|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153803642|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
153803643|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803644|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350204|NCT03561584|Analgesics|analgesics|mesh-ancestor
153803645|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
153803646|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
153803647|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803648|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803649|NCT00303576|Dapivirine|dapivirine|mesh-list
153803650|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153803651|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153803652|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
153803653|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803654|NCT00291005|Docetaxel|docetaxel|mesh-list
153803655|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803656|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803657|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153803658|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803659|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818653|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153818654|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
153818655|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818656|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818657|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
153818658|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
153818659|NCT04035278|Vaccines|vaccines|mesh-list
153818660|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
153818661|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818662|NCT04034927|Olaparib|olaparib|mesh-list
153818663|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153818664|NCT04034927|Tremelimumab|tremelimumab|mesh-list
153593993|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153593994|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593995|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593996|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
153593997|NCT01845844|Ranibizumab|ranibizumab|mesh-list
153593998|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153593999|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153403578|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403579|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403580|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803684|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
153803685|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153803686|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803687|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153803688|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153803689|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153803691|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153803692|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153803693|NCT00291122|Analgesics|analgesics|mesh-ancestor
153803694|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
153803695|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803696|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803697|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153803698|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803699|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153803700|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153803701|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803702|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803703|NCT00324363|Exenatide|exenatide|mesh-list
153803704|NCT00324363|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153803705|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153594000|NCT01845844|Growth Substances|growth substances|mesh-ancestor
153863193|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153863194|NCT04617483|Vaccines|vaccines|mesh-list
153863195|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
153863196|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863197|NCT04617249|Anesthetics|anesthetics|mesh-list
153803732|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803733|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
153803734|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153803735|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153803736|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803738|NCT00303771|Protective Agents|protective agents|mesh-ancestor
153803739|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
153803740|NCT00303771|Vitamins|vitamins|mesh-ancestor
153803741|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
153803742|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
153803743|NCT00303810|Thiotepa|thiotepa|mesh-list
153803744|NCT00303810|Lomustine|lomustine|mesh-list
153803745|NCT00303810|Carboplatin|carboplatin|mesh-list
153803746|NCT00303810|Methotrexate|methotrexate|mesh-list
153803747|NCT00303810|Etoposide|etoposide|mesh-list
153803748|NCT00303810|Vincristine|vincristine|mesh-list
153803749|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
153803750|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803751|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
153803752|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803753|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803754|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153803755|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
153803756|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803784|NCT00303888|Docetaxel|docetaxel|mesh-list
153803785|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803786|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803787|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403589|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153403590|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403591|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
153403592|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403593|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403594|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153403595|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153403596|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803799|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153803800|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
153803801|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153803802|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803824|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
153803825|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803826|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803827|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803828|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803829|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
153803830|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803831|NCT00291785|Antidotes|antidotes|mesh-ancestor
153803832|NCT00291785|Protective Agents|protective agents|mesh-ancestor
153803833|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
153803834|NCT00291785|Vitamins|vitamins|mesh-ancestor
153803836|NCT00291785|Hematinics|hematinics|mesh-ancestor
153803850|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
153803851|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803852|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811355|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153811356|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
153811357|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811359|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
153803853|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153803854|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153803855|NCT00304200|Growth Substances|growth substances|mesh-ancestor
153803856|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803857|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
153803858|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153803868|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803870|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153803871|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803872|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
153803873|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153803874|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153803875|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803876|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153803877|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803878|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153803880|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153594001|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594002|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
153594003|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594004|NCT01846026|Vitamin D|vitamin d|mesh-list
153594005|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
153594006|NCT01846026|Vitamins|vitamins|mesh-ancestor
153594007|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
153594008|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594009|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153594010|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153594011|NCT01846117|Vitamin D|vitamin d|mesh-list
153594012|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
153803881|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153803882|NCT00304317|Analgesics|analgesics|mesh-ancestor
153803883|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
153803884|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803885|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803886|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153803887|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803888|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153803889|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153803890|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803891|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803892|NCT00324792|Insulin|insulin|mesh-list
153803893|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803894|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803895|NCT00292214|Acetaminophen|acetaminophen|mesh-list
153803896|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153803897|NCT00292214|Analgesics|analgesics|mesh-ancestor
153803898|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
153803899|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803900|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803901|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
153803902|NCT00324831|Prednisone|prednisone|mesh-list
153803903|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
153803904|NCT00324831|Rituximab|rituximab|mesh-list
153803905|NCT00324831|Doxorubicin|doxorubicin|mesh-list
153803906|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153803907|NCT00324831|Vincristine|vincristine|mesh-list
153803908|NCT00324831|Vaccines|vaccines|mesh-list
153803909|NCT00324831|Antibodies|antibodies|mesh-list
153803910|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
153803911|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153803912|NCT00324831|Sargramostim|sargramostim|mesh-list
153803954|NCT00292409|Aripiprazole|aripiprazole|mesh-list
153803955|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
153803956|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153803957|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153803958|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153803959|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803960|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803961|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
153803962|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
153803963|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803964|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803965|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153803966|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153803967|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
153803968|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153803969|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153803995|NCT00304551|Ribavirin|ribavirin|mesh-list
153803996|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153803997|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
153803998|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
153803999|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804000|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
153804001|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804002|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
153804003|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804004|NCT00325026|Misoprostol|misoprostol|mesh-list
153804005|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153804006|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
153804007|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153804008|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804011|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
153804012|NCT00325104|Calcium|calcium|mesh-list
153804013|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
153804015|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153804016|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804017|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804044|NCT00292721|Analgesics|analgesics|mesh-ancestor
153804045|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
153804046|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804047|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804048|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153804049|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153804050|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153804051|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153804052|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804053|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811413|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804054|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
153804055|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153804056|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804057|NCT00325182|Levetiracetam|levetiracetam|mesh-list
153804058|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
153804059|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
153804061|NCT00292799|Orlistat|orlistat|mesh-list
153804062|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153804063|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804071|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804072|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
153804073|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804074|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804075|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153804076|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
153804077|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804078|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
153403641|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403642|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403645|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153403646|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
153403647|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804079|NCT00292838|Fluticasone|fluticasone|mesh-list
153804080|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153804081|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153804082|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
153804083|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804084|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804085|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153804086|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
153804087|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
153804088|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153804089|NCT00304668|Dapivirine|dapivirine|mesh-list
153804090|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153804091|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153804092|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
153804093|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804094|NCT00292955|Cetuximab|cetuximab|mesh-list
153804095|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350642|NCT05427474|Propranolol|propranolol|mesh-list
153350643|NCT05427474|Gabapentin|gabapentin|mesh-list
153804096|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804097|NCT00293072|Rituximab|rituximab|mesh-list
153804098|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153804099|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804100|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
153804102|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153804108|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804109|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804110|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153804111|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153804112|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153804113|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153804114|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804115|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804117|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153804118|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153804119|NCT00293150|Eplerenone|eplerenone|mesh-list
153804120|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153804121|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
153804122|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804123|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804124|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153804125|NCT00293150|Diuretics|diuretics|mesh-ancestor
153863258|NCT05181683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863259|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
153594013|NCT01846117|Vitamins|vitamins|mesh-ancestor
153594014|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
153594015|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594016|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153818665|NCT04034927|Ipilimumab|ipilimumab|mesh-list
153818666|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153818667|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818668|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818669|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818670|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
153818671|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818672|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818673|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818677|NCT03993327|Iodine|iodine|mesh-list
153818678|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153818679|NCT03993327|Antibodies|antibodies|mesh-list
153818680|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
153818681|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153818682|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
153818683|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818684|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818685|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153818686|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818687|NCT03993327|Trace Elements|trace elements|mesh-ancestor
153818688|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
153818689|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
153818690|NCT03969446|Venetoclax|venetoclax|mesh-list
153818691|NCT03969446|Decitabine|decitabine|mesh-list
153818692|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818693|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818694|NCT03969446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153594017|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
153594018|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153594019|NCT01846117|Estrogens|estrogens|mesh-ancestor
153594020|NCT01846117|Hormones|hormones|mesh-ancestor
153804126|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
153804127|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153804129|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
153804149|NCT00325455|Anacetrapib|anacetrapib|mesh-list
153804150|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153804151|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153804152|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
153804153|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804154|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153804156|NCT00293657|Piroxicam|piroxicam|mesh-list
153804157|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153804158|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153804159|NCT00293657|Analgesics|analgesics|mesh-ancestor
153804160|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
153804161|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804162|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804163|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863277|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863278|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
153863279|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863280|NCT05125796|Acetaminophen|acetaminophen|mesh-list
153863281|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153863282|NCT05125796|Ketoprofen|ketoprofen|mesh-list
153863283|NCT05125796|Lidocaine|lidocaine|mesh-list
153863284|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
153403649|NCT03110926|Paclitaxel|paclitaxel|mesh-list
153403650|NCT03110926|Carboplatin|carboplatin|mesh-list
153403651|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
153403652|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153403653|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403654|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403655|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
153594021|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594022|NCT01846143|Poly ICLC|poly iclc|mesh-list
153594023|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
153594024|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594025|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
153594026|NCT01846273|Ranibizumab|ranibizumab|mesh-list
153594027|NCT01846273|Verteporfin|verteporfin|mesh-list
153594028|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153594029|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153594030|NCT01846273|Growth Substances|growth substances|mesh-ancestor
153403662|NCT03110926|Vitamins|vitamins|mesh-ancestor
153403663|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
153403664|NCT03092856|Axitinib|axitinib|mesh-list
153403665|NCT03092856|Antibodies|antibodies|mesh-list
153403666|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
153403667|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403668|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403669|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153403670|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811451|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153811452|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811453|NCT00325676|Pantoprazole|pantoprazole|mesh-list
153811454|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153811455|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811456|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153403671|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403672|NCT03043950|Panitumumab|panitumumab|mesh-list
153804164|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153804165|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153804166|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804167|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804168|NCT00293696|Goserelin|goserelin|mesh-list
153804169|NCT00293696|Bicalutamide|bicalutamide|mesh-list
153804170|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153804171|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804172|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
153804173|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
153804174|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863285|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
153863286|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863287|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863288|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
153863289|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863290|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153863291|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153863292|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153804207|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153804208|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804209|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804210|NCT00293930|Tacrolimus|tacrolimus|mesh-list
153804211|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804212|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
153804213|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804214|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153804215|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804216|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804217|NCT00305019|Clevudine|clevudine|mesh-list
153804218|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
153804219|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804220|NCT00293969|Morphine|morphine|mesh-list
153804221|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153403686|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804260|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
153811475|NCT00426621|Diclofenac|diclofenac|mesh-list
153804261|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153804262|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153804263|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153804264|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153804265|NCT00294164|Hormones|hormones|mesh-list
153804266|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804267|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804268|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153804269|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153804270|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153804271|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153804272|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804273|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804274|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804275|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804276|NCT00417833|Bevacizumab|bevacizumab|mesh-list
153804277|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153804278|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804279|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153804280|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153804281|NCT00417833|Growth Substances|growth substances|mesh-ancestor
153804282|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804283|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
153804284|NCT00417872|Metronidazole|metronidazole|mesh-list
153804285|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
153804286|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804288|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153804289|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153804290|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
153804291|NCT00294203|Hematinics|hematinics|mesh-ancestor
153804292|NCT00305292|Modafinil|modafinil|mesh-list
153804293|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153804294|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804295|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153804296|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153804297|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153804298|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804299|NCT00305331|Domperidone|domperidone|mesh-list
153804300|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
153804301|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
153804302|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804303|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804304|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153804332|NCT00294359|Growth Substances|growth substances|mesh-ancestor
153804333|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804334|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
153804335|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153804336|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
153736338|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863310|NCT04616352|Cefuroxime|cefuroxime|mesh-list
153863311|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
153863312|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153863313|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863314|NCT00553943|Cytarabine|cytarabine|mesh-list
153863315|NCT00553943|Rituximab|rituximab|mesh-list
153863317|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804337|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804338|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153804339|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
153804340|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153804341|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804342|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
153804343|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153804344|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804345|NCT00305370|Aripiprazole|aripiprazole|mesh-list
153804346|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
153804347|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804348|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153804349|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153804350|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804351|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804352|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
153804353|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
153804364|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153804365|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
153804366|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804367|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804368|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153804370|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804371|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153804372|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
153804373|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153804374|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153804376|NCT00294593|Folic Acid|folic acid|mesh-list
153804377|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
153804378|NCT00294593|Antidotes|antidotes|mesh-ancestor
153804379|NCT00294593|Protective Agents|protective agents|mesh-ancestor
153804380|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804381|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
153804382|NCT00294593|Vitamins|vitamins|mesh-ancestor
153804383|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
153804384|NCT00294593|Hematinics|hematinics|mesh-ancestor
153863340|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153863341|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153804385|NCT00325845|Hylan|hylan|mesh-list
153804386|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
153804387|NCT00325845|Protective Agents|protective agents|mesh-ancestor
153804388|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804389|NCT00294710|Aliskiren|aliskiren|mesh-list
153804390|NCT00294710|Renin Inhibitors|renin inhibitors|mesh-ancestor
153804391|NCT00294710|Protease Inhibitors|protease inhibitors|mesh-ancestor
153804392|NCT00294710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804393|NCT00294710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804394|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
153804395|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153804396|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804397|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153804398|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153804399|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804400|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811705|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804401|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804402|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153804404|NCT00325962|Verapamil|verapamil|mesh-list
153804445|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804446|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804447|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153804448|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
153804449|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804450|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804452|NCT00295178|Daptomycin|daptomycin|mesh-list
153804453|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153804454|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804455|NCT00305838|Tamoxifen|tamoxifen|mesh-list
153804456|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153804457|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
153804458|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804459|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804460|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153804461|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804462|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153804463|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153351020|NCT03983057|Antibodies|antibodies|mesh-list
153804464|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153804485|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153804486|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
153804487|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
153804488|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153804489|NCT00326352|Narcotics|narcotics|mesh-ancestor
153804490|NCT00326352|Analgesics|analgesics|mesh-ancestor
153811997|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
153804491|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
153804492|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804493|NCT00419601|Fentanyl|fentanyl|mesh-list
153804494|NCT00419601|Remifentanil|remifentanil|mesh-list
153804495|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153804496|NCT00419601|Narcotics|narcotics|mesh-ancestor
153804497|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863349|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
153804499|NCT00419601|Analgesics|analgesics|mesh-ancestor
153804500|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
153804501|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804502|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153804503|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153804504|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
153804505|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
153804506|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153804507|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
153804508|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153804509|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
153804510|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
153804511|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804512|NCT00295607|Antibodies|antibodies|mesh-list
153804513|NCT00295607|Tacrolimus|tacrolimus|mesh-list
153804514|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
153804515|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804516|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804517|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153804518|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804519|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804520|NCT00326391|Methylphenidate|methylphenidate|mesh-list
153804521|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153804547|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804549|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804550|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
153804551|NCT00306267|Hematinics|hematinics|mesh-ancestor
153804552|NCT00326508|Daclizumab|daclizumab|mesh-list
153804553|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804554|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
153804559|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804560|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804561|NCT00295841|Cytarabine|cytarabine|mesh-list
153804562|NCT00295841|Clofarabine|clofarabine|mesh-list
153804563|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153804564|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
153812056|NCT00432627|Deferasirox|deferasirox|mesh-list
153804565|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804566|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804567|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
153804568|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804569|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804583|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153804584|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804585|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804586|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153804587|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
153804588|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804589|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804590|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153804591|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804592|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153804593|NCT00295919|Protective Agents|protective agents|mesh-ancestor
153804594|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
153804602|NCT00295997|Busulfan|busulfan|mesh-list
153863381|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153863382|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153863383|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863384|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863385|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153863387|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863388|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
153863389|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
153863390|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
153804620|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863391|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863392|NCT04615767|Inositol|inositol|mesh-list
153863393|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
153863394|NCT04615767|Vitamins|vitamins|mesh-ancestor
153863395|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
153863396|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804621|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
153804622|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
153804707|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812135|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
153804708|NCT00326859|Analgesics|analgesics|mesh-ancestor
153804709|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
153804710|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804711|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153804712|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153804713|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153804714|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153804715|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804716|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804717|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804718|NCT00296699|Analgesics|analgesics|mesh-ancestor
153804719|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
153804720|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804721|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
153804722|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804723|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
153804724|NCT00296777|Bupropion|bupropion|mesh-list
153804725|NCT00296777|Imipramine|imipramine|mesh-list
153804726|NCT00296777|Escitalopram|escitalopram|mesh-list
153804727|NCT00296777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153804728|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153804729|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153804730|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804731|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804732|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
153804761|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153804762|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
153804763|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153863409|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
153863410|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863411|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863412|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153863413|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863414|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
153863416|NCT04713371|Ipilimumab|ipilimumab|mesh-list
153863417|NCT04713371|Sargramostim|sargramostim|mesh-list
153804787|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153804788|NCT00327093|Growth Substances|growth substances|mesh-ancestor
153804789|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804790|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
153804791|NCT00297050|Peramivir|peramivir|mesh-list
153804792|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
153804793|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804794|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804795|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804796|NCT00297128|Capecitabine|capecitabine|mesh-list
153804797|NCT00297128|Cetuximab|cetuximab|mesh-list
153804803|NCT00327132|Amoxicillin|amoxicillin|mesh-list
153863420|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863421|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863422|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153403792|NCT02514382|Ichthammol|ichthammol|mesh-list
153403793|NCT02514382|BB 1101|bb 1101|mesh-list
153403794|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153403795|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
153403796|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
153403797|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403798|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403799|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153804824|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804825|NCT00297284|Modafinil|modafinil|mesh-list
153804826|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153804827|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804828|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153804829|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153804830|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153804831|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804832|NCT04392531|Cyclosporine|cyclosporine|mesh-list
153804833|NCT04392531|Cyclosporins|cyclosporins|mesh-list
153804834|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351399|NCT04750382|Gemcitabine|gemcitabine|mesh-list
153804835|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863423|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
153863424|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863425|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863426|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153863427|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863428|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153863429|NCT04683614|Norepinephrine|norepinephrine|mesh-list
153863430|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153804872|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
153804873|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804874|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
153804875|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
153804876|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153804877|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
153804878|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804879|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804880|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153804881|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
153804882|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153804883|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
153804884|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804885|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863431|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153863432|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
153863433|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863434|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863435|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863436|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
153403806|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403807|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403808|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
153403810|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153403811|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153403812|NCT02511067|Growth Substances|growth substances|mesh-ancestor
153403813|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804935|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153804936|NCT00298025|Hormones|hormones|mesh-list
153804937|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153804938|NCT00298025|Ganirelix|ganirelix|mesh-list
153804939|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804941|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
153863438|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863439|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153863440|NCT04613895|Fexuprazan|fexuprazan|mesh-list
153863441|NCT04613895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153863442|NCT04613700|Secretin|secretin|mesh-list
153863443|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153805009|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805010|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805011|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805012|NCT05457894|Vaccines|vaccines|mesh-list
153805013|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
153805014|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805015|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
153805016|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153805017|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805018|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153805019|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
153805020|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153805021|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805022|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805023|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805024|NCT00298922|Azithromycin|azithromycin|mesh-list
153805025|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153863446|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863447|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
153863448|NCT00563355|Hematinics|hematinics|mesh-ancestor
153863450|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153403819|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403821|NCT02409147|Prednisone|prednisone|mesh-list
153403822|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
153403823|NCT02409147|Basiliximab|basiliximab|mesh-list
153403824|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153805048|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153805062|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805063|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
153805064|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
153805065|NCT00299819|Sifalimumab|sifalimumab|mesh-list
153805066|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153805067|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
153805068|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805069|NCT00299858|Theophylline|theophylline|mesh-list
153873823|NCT02217852|Captopril|captopril|mesh-list
153805070|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153805071|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
153805072|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805073|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805074|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153805075|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
153805084|NCT05455944|Pregabalin|pregabalin|mesh-list
153863451|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863452|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153863453|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153863454|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153863455|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863456|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863457|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863458|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153805093|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153805094|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153805095|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153805096|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805097|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153805098|NCT00299936|Ribavirin|ribavirin|mesh-list
153805099|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153805100|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
153805101|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863467|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863468|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403840|NCT02402439|Pancreatin|pancreatin|mesh-list
153403841|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153805159|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153805160|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805185|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153805186|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
153805187|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805188|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805189|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805190|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153805191|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153805192|NCT00300794|Ketamine|ketamine|mesh-list
153805193|NCT00300794|Analgesics|analgesics|mesh-ancestor
153805194|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
153805195|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805196|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805197|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153805198|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153805199|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
153805200|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
153812425|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153805201|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805202|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153805203|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153805204|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805205|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805206|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
153805252|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805253|NCT00301223|Pregabalin|pregabalin|mesh-list
153805254|NCT00301223|Analgesics|analgesics|mesh-ancestor
153805255|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
153805256|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805273|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805274|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805275|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153805279|NCT00301535|HBOC 201|hboc 201|mesh-list
153805419|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805420|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
153805421|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805422|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153805423|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805424|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805425|NCT00419991|Tigecycline|tigecycline|mesh-list
153805426|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153805427|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352064|NCT05231694|Mitogens|mitogens|mesh-list
153805428|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153805429|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805430|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805431|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
153805432|NCT00302627|Vitamin D|vitamin d|mesh-list
153812547|NCT00434031|Doxorubicin|doxorubicin|mesh-list
153805433|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
153805434|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
153805435|NCT00302627|Pamidronate|pamidronate|mesh-list
153805436|NCT00302627|Vitamins|vitamins|mesh-list
153805437|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
153805438|NCT00302627|Calcium|calcium|mesh-list
153805439|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
153805447|NCT00302666|Nandrolone|nandrolone|mesh-list
153805448|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153805449|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
153805450|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153805451|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805452|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153805453|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153805454|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153805460|NCT00302666|Androgens|androgens|mesh-ancestor
153805471|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403898|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403899|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403900|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403901|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403902|NCT02108860|Abatacept|abatacept|mesh-list
153403903|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403904|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403905|NCT02108860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403906|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403907|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403908|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
153403909|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403910|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153403911|NCT02079181|Fluorides|fluorides|mesh-list
153403912|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
153403913|NCT02079181|Protective Agents|protective agents|mesh-ancestor
153805473|NCT00418496|Aldesleukin|aldesleukin|mesh-list
153863521|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153863522|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153805531|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153805532|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805533|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
153805534|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153805535|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805536|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805537|NCT00303056|Icatibant|icatibant|mesh-list
153805538|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153805539|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153805540|NCT00303056|Analgesics|analgesics|mesh-ancestor
153805541|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
153805542|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805543|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805544|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153805545|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805546|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153805547|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153805548|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805549|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153805550|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805551|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
153805552|NCT00328497|Bevacizumab|bevacizumab|mesh-list
153805553|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
153805554|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863535|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153805578|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805579|NCT00328692|Rolofylline|rolofylline|mesh-list
153805580|NCT00328692|Diuretics|diuretics|mesh-ancestor
153805581|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
153805582|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805584|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153805585|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153805586|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805587|NCT00303407|Nadroparin|nadroparin|mesh-list
153805588|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
153805589|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153805590|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153805591|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805592|NCT00303524|Goserelin|goserelin|mesh-list
153805593|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153805594|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805595|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
153805596|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153805597|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153805598|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805599|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805600|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153805601|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153805602|NCT00419796|Analgesics|analgesics|mesh-ancestor
153805603|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
153805604|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805605|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805606|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153805607|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805608|NCT00419835|Losartan|losartan|mesh-list
153805609|NCT00419835|Enalapril|enalapril|mesh-list
153805637|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805639|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805640|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153863540|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805644|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
153805645|NCT00303758|Vitamins|vitamins|mesh-ancestor
153805646|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
153805647|NCT00303797|Bortezomib|bortezomib|mesh-list
153805648|NCT00303797|Sorafenib|sorafenib|mesh-list
153805649|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805650|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153805651|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805652|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805653|NCT00303836|Aldesleukin|aldesleukin|mesh-list
153805654|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
153805655|NCT00303836|Fludarabine|fludarabine|mesh-list
153805656|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
153805686|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805688|NCT00304226|Valsartan|valsartan|mesh-list
153805689|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153805690|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153805691|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805692|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805693|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153805694|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805695|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
153805696|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153805697|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153863564|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863565|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403942|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
153403943|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
153403944|NCT01770145|Emetics|emetics|mesh-ancestor
153805736|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
153805737|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805738|NCT00304499|Oxybutynin|oxybutynin|mesh-list
153805739|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
153805740|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
153805741|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805742|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805743|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153805744|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153805745|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
153805746|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805747|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805748|NCT00304499|Urological Agents|urological agents|mesh-ancestor
153805774|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
153805775|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805776|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805777|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805778|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153805779|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153805780|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805781|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153805782|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153805783|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
153805784|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
153403945|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
153403946|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805785|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
153805786|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805787|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153805788|NCT00304616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153805789|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153805790|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805791|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
153805792|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
153805793|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153805794|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153805806|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153805807|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153805808|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153805809|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153805810|NCT00304655|Aripiprazole|aripiprazole|mesh-list
153805811|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
153805812|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153805813|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153863566|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
153863567|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
153805838|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805839|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153805840|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
153805841|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153805842|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153805843|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153805844|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153805845|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153805846|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153805847|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153805848|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805849|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153805850|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
153805851|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153805852|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153805853|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153805854|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
153805855|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153805874|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153863575|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863576|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153863577|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153805903|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805904|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
153805905|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805906|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153805907|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
153805908|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153805909|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153805910|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153805920|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
153805921|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805922|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153805923|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153805924|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805925|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805926|NCT00329316|Progesterone|progesterone|mesh-list
153805927|NCT00329316|Progestins|progestins|mesh-ancestor
153805929|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805930|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805931|NCT00332826|Insulin|insulin|mesh-list
153805932|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153805933|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805934|NCT00305201|Pravastatin|pravastatin|mesh-list
153805935|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153805936|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153805937|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
153805938|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805939|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153805950|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153403990|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403992|NCT01687127|Vitamins|vitamins|mesh-ancestor
153403993|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
153403994|NCT01565200|Trastuzumab|trastuzumab|mesh-list
153403995|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153403996|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403997|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403998|NCT01565200|Immunotoxins|immunotoxins|mesh-ancestor
153805951|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805952|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
153805953|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153805954|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805955|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805956|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153805957|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153805958|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153805959|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
153805960|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805961|NCT00332904|Propranolol|propranolol|mesh-list
153805962|NCT00332904|Spironolactone|spironolactone|mesh-list
153805963|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153805964|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153805965|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
153805966|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805967|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863606|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863607|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
153863608|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863609|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863610|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
153863611|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863612|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863613|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153863614|NCT02114060|Vaccines|vaccines|mesh-list
153863615|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
153863616|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806006|NCT00305474|Risperidone|risperidone|mesh-list
153806007|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153806008|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
153806009|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806010|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806011|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404008|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153806146|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153806147|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153806148|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806175|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806176|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
153806177|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153806178|NCT00305903|Protective Agents|protective agents|mesh-ancestor
153806179|NCT00329823|Etanercept|etanercept|mesh-list
153806180|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153806181|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806182|NCT00329823|Analgesics|analgesics|mesh-ancestor
153806183|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
153806184|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806185|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806186|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806187|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806188|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806189|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806190|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
153806191|NCT00306020|Morphine|morphine|mesh-list
153806192|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153806225|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806226|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806227|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806263|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806264|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
153806265|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153806266|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806267|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806268|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153806269|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153806270|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806271|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
153806272|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
153806273|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153806274|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153806275|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806276|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806277|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153806278|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806279|NCT00333567|Analgesics|analgesics|mesh-ancestor
153806280|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
153431213|NCT06315686|Pemetrexed|pemetrexed|mesh-list
153806281|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806332|NCT00451139|Lumefantrine|lumefantrine|mesh-list
153806333|NCT00451139|Artemether|artemether|mesh-list
153806334|NCT00451139|Quinine|quinine|mesh-list
153806335|NCT00451139|Atovaquone|atovaquone|mesh-list
153806336|NCT00451139|Proguanil|proguanil|mesh-list
153806337|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153806338|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153806339|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
153806340|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153806341|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153806342|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806343|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153806344|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806345|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153806346|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806347|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806348|NCT00451139|Analgesics|analgesics|mesh-ancestor
153806349|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
153806350|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806382|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153806383|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153806384|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153806385|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806386|NCT00333918|Analgesics|analgesics|mesh-ancestor
153806387|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
153806388|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806389|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806390|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806391|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153404039|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153404040|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153404041|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404042|NCT00871065|Urological Agents|urological agents|mesh-ancestor
153404043|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153404044|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153404045|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806424|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806425|NCT00330798|Analgesics|analgesics|mesh-ancestor
153806426|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
153806427|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806428|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806429|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806430|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806431|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153806432|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806433|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806435|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153806436|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806437|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153806438|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
153806439|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
153806440|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806441|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806442|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806443|NCT00451997|Cytarabine|cytarabine|mesh-list
153806444|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
153806490|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153806491|NCT00333996|Dexamethasone|dexamethasone|mesh-list
153806492|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806493|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
153806494|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
153806495|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806496|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806497|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806521|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153806522|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806523|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806525|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153806526|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806527|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153806528|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806529|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
153806530|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806531|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
153353182|NCT05028348|Elotuzumab|elotuzumab|mesh-list
153806532|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806533|NCT00334308|Caseins|caseins|mesh-list
153806534|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
153806535|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
153806536|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404065|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404067|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153404068|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
153404069|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153404070|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153404071|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404072|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404073|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
153806625|NCT00334698|Cetirizine|cetirizine|mesh-list
153806626|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
153806627|NCT00334698|Ephedrine|ephedrine|mesh-list
153806645|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
153806646|NCT00452660|Deferasirox|deferasirox|mesh-list
153806647|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153806648|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
153806649|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
153806650|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806651|NCT00334854|Doxorubicin|doxorubicin|mesh-list
153806652|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153806654|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153806655|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806656|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153863679|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153863680|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863681|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
153863683|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863684|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
153863685|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
153863686|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863687|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
153806700|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153806701|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806702|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806703|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806704|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806705|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153806707|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
153806708|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
153806709|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
153806710|NCT00452894|Varenicline|varenicline|mesh-list
153806711|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153806712|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153806713|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
153806714|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806715|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806716|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806717|NCT00335166|Pramipexole|pramipexole|mesh-list
153806718|NCT00335166|Dexpramipexole|dexpramipexole|mesh-list
153806738|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806739|NCT00453050|Imiquimod|imiquimod|mesh-list
153806740|NCT00453050|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153806741|NCT00453050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806742|NCT00453050|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153806770|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806771|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806772|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
153806773|NCT00420654|Hormones|hormones|mesh-list
153806774|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806775|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806776|NCT00420693|Sevoflurane|sevoflurane|mesh-list
153812777|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806777|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153806778|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153806779|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
153806780|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
153806781|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806782|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806783|NCT00453323|Paclitaxel|paclitaxel|mesh-list
153806784|NCT00453323|Capecitabine|capecitabine|mesh-list
153806785|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153806863|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153736340|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153736341|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153736342|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736343|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
153736344|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736345|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806865|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153806866|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153806867|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806868|NCT00336414|Prednisone|prednisone|mesh-list
153806869|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
153806870|NCT00336414|Azathioprine|azathioprine|mesh-list
153806882|NCT00336414|Hormones|hormones|mesh-ancestor
153806957|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
153806958|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806959|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806960|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806961|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806962|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153806963|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153806964|NCT00336765|XL647|xl647|mesh-list
153806965|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806966|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153806967|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812812|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806968|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806969|NCT00230477|Lamivudine|lamivudine|mesh-list
153806970|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153806971|NCT00230477|Adefovir|adefovir|mesh-list
153806972|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153806973|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153353555|NCT01395043|Epinephrine|epinephrine|mesh-list
153806974|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806975|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806976|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
153806977|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806978|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153806979|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153806980|NCT00230516|Lansoprazole|lansoprazole|mesh-list
153806981|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153806982|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806983|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153806984|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806985|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806986|NCT00336882|Midazolam|midazolam|mesh-list
153806987|NCT00336882|Propofol|propofol|mesh-list
153806988|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153806989|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806990|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806991|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153404124|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807011|NCT00336960|Celecoxib|celecoxib|mesh-list
153807012|NCT00336960|Fluorouracil|fluorouracil|mesh-list
153807013|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
153807014|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807015|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807016|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807017|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807018|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
153807019|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807020|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153807021|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153807022|NCT00336960|Analgesics|analgesics|mesh-ancestor
153807023|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
153807024|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807025|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807026|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153807027|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153807028|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153807029|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807030|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
153807031|NCT00306410|Vitamin D|vitamin d|mesh-list
153807032|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153807033|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807034|NCT00306410|Vitamins|vitamins|mesh-ancestor
153807035|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
153807036|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153807037|NCT00340080|Abacavir|abacavir|mesh-list
153807038|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153807039|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153807040|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807041|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807042|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
153807043|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807044|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153807045|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153353624|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807047|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807048|NCT02960711|Metformin|metformin|mesh-list
153353693|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807049|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153807050|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807051|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153807064|NCT00337389|Fluorouracil|fluorouracil|mesh-list
153431404|NCT06305754|Antipyretics|antipyretics|mesh-ancestor
153807065|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153807066|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807067|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153807068|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153807069|NCT00337389|Growth Substances|growth substances|mesh-ancestor
153807070|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807071|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
153807072|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
153807073|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807074|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807075|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807077|NCT00337389|Antidotes|antidotes|mesh-ancestor
153807111|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153807112|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
153807113|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807114|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153807115|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153807116|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807151|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153807152|NCT00307502|Darunavir|darunavir|mesh-list
153807153|NCT00307502|Nelfinavir|nelfinavir|mesh-list
153807154|NCT00307502|Indinavir|indinavir|mesh-list
153807155|NCT00307502|Saquinavir|saquinavir|mesh-list
153807156|NCT00307502|Amprenavir|amprenavir|mesh-list
153807157|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
153807184|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153807185|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807186|NCT00307619|Topiramate|topiramate|mesh-list
153807187|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
153807188|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153807189|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807190|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
153807191|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153807192|NCT00307658|Antibodies|antibodies|mesh-list
153807193|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
153807194|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
153807195|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153807196|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
153807197|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807198|NCT00337545|Everolimus|everolimus|mesh-list
153807199|NCT00337545|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153807200|NCT00337545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153807201|NCT00337545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807202|NCT00337545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807203|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807204|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
153807236|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153807239|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
153807244|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
153807245|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153807246|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807247|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
153807248|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807249|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
153469177|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807278|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807279|NCT00338247|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153807280|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153807281|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807283|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153807284|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
153807285|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153807286|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
153807287|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153807288|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
153807289|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807325|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807326|NCT00308438|Teduglutide|teduglutide|mesh-list
153807327|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807328|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153807329|NCT00308438|Protective Agents|protective agents|mesh-ancestor
153807348|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807349|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353917|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153807350|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
153807351|NCT00308594|Hormones|hormones|mesh-ancestor
153807352|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807353|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807354|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807355|NCT00308945|Travoprost|travoprost|mesh-list
153807356|NCT00308945|Latanoprost|latanoprost|mesh-list
153807357|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153807358|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153594031|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594032|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
153594033|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594034|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153594035|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
153594036|NCT01846325|Vitamin E|vitamin e|mesh-list
153807360|NCT00338481|Morphine|morphine|mesh-list
153807361|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153807362|NCT00338481|Narcotics|narcotics|mesh-ancestor
153807363|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153807364|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807365|NCT00338481|Analgesics|analgesics|mesh-ancestor
153807366|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
153807367|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807368|NCT00309101|Tacrolimus|tacrolimus|mesh-list
153807369|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807370|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
153807371|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807372|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153807373|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807374|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807375|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
153807376|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153807377|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153807378|NCT00309218|Prednisolone|prednisolone|mesh-list
153807379|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
153807380|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153807381|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
153807382|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807383|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
153807384|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
153431470|NCT06278285|Glucagon|glucagon|mesh-list
153807385|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807406|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153807422|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153807423|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153807424|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153807425|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153807426|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153807427|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812865|NCT00330902|Artesunate|artesunate|mesh-list
153807428|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807429|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
153807430|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807431|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
153807432|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
153807433|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
153807434|NCT00309530|Interferons|interferons|mesh-list
153807435|NCT00309530|Fluorouracil|fluorouracil|mesh-list
153807436|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
153807437|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807438|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807439|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807440|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807454|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
153807455|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807456|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807457|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153807485|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153807486|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807487|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807489|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807490|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807491|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153807492|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
153807493|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807494|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
153807495|NCT00338754|Adalimumab|adalimumab|mesh-list
153807496|NCT00338754|Antibodies|antibodies|mesh-list
153807497|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153807498|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
153807499|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807500|NCT00338754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153807501|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807528|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
153807529|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807530|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153807531|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153807532|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
153807533|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807534|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807535|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153807536|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153807537|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153807538|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153807579|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807580|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153807581|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153807582|NCT00309998|Growth Substances|growth substances|mesh-ancestor
153807583|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807584|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
153807585|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153807586|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807587|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
153807588|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
153807589|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807654|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153807655|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807656|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153807658|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153807672|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153807673|NCT00310778|Atenolol|atenolol|mesh-list
153807674|NCT00310778|Valsartan|valsartan|mesh-list
153807675|NCT00310778|Candesartan|candesartan|mesh-list
153807676|NCT00310778|Candesartan cilexetil|candesartan cilexetil|mesh-list
153807677|NCT00310778|Ramipril|ramipril|mesh-list
153807678|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153807679|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153807680|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153807681|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807682|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153807683|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
153807684|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807685|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153807686|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
153807687|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
153807688|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807689|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807690|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153807691|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153807714|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
153807715|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807716|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153807717|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
153807718|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
153807720|NCT00421122|Terbutaline|terbutaline|mesh-list
153807721|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
153807733|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153807735|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153807736|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
153807737|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807738|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807739|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
153807740|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
153807741|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153807742|NCT00311012|Aliskiren|aliskiren|mesh-list
153807743|NCT00311012|Renin Inhibitors|renin inhibitors|mesh-ancestor
153807747|NCT00311051|Ramatroban|ramatroban|mesh-list
153807807|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807809|NCT00339417|Albendazole|albendazole|mesh-list
153807810|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153807811|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807812|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
153807813|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
153807814|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153807815|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153807816|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807817|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
153807818|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
153807819|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736346|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736347|NCT02987465|Norepinephrine|norepinephrine|mesh-list
153736348|NCT02987465|Acetylcholine|acetylcholine|mesh-list
153807878|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153807880|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
153807881|NCT00311987|Hormones|hormones|mesh-ancestor
153807882|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807883|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807884|NCT00342849|Succimer|succimer|mesh-list
153807885|NCT00342849|Antidotes|antidotes|mesh-ancestor
153807886|NCT00342849|Protective Agents|protective agents|mesh-ancestor
153807913|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807914|NCT00312182|Nelfinavir|nelfinavir|mesh-list
153807915|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153807916|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153807917|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
153807918|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807919|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807920|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153807921|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153807922|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
153807923|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807924|NCT00312260|Gabapentin|gabapentin|mesh-list
153807925|NCT00312260|Amitriptyline|amitriptyline|mesh-list
153807926|NCT00312260|Analgesics|analgesics|mesh-ancestor
153807927|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
153807928|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807929|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807930|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
153807931|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153890611|NCT01074268|Insulin|insulin|mesh-list
153807932|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153807933|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863859|NCT01165138|Xhance|xhance|mesh-list
153807960|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807961|NCT00339768|Amoxicillin|amoxicillin|mesh-list
153807962|NCT00339768|Omeprazole|omeprazole|mesh-list
153807963|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153807964|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807965|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153807966|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807967|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153807968|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807969|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807970|NCT00343161|Esomeprazole|esomeprazole|mesh-list
153807971|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153807972|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
153807973|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153807974|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807975|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153807976|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807977|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807978|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153807979|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
153807980|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807981|NCT00343161|Antacids|antacids|mesh-ancestor
153807982|NCT00312533|Hylan|hylan|mesh-list
153807983|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
153807984|NCT00312533|Protective Agents|protective agents|mesh-ancestor
153812915|NCT00331097|Docetaxel|docetaxel|mesh-list
153807985|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807986|NCT00312650|Gemcitabine|gemcitabine|mesh-list
153807987|NCT00312650|Doxorubicin|doxorubicin|mesh-list
153807988|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153808022|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
153808023|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
153808024|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808025|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
153808026|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153808027|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153808028|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
153808029|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808030|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
153808031|NCT00313001|Exenatide|exenatide|mesh-list
153808032|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
153808033|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808034|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808035|NCT00313001|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153808036|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153808037|NCT00313001|Incretins|incretins|mesh-ancestor
153808039|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153808040|NCT00343278|Valacyclovir|valacyclovir|mesh-list
153808041|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
153863881|NCT00561093|Protective Agents|protective agents|mesh-ancestor
153863882|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863883|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
153863884|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153863885|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
153863886|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153863887|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153863888|NCT01165021|Folic Acid|folic acid|mesh-list
153863889|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
153863890|NCT01165021|Dexamethasone|dexamethasone|mesh-list
153863891|NCT01165021|Pemetrexed|pemetrexed|mesh-list
153863892|NCT01165021|Vitamins|vitamins|mesh-ancestor
153594037|NCT01846325|Vitamins|vitamins|mesh-ancestor
153594038|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
153594039|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594040|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
153594041|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594042|NCT01846325|Protective Agents|protective agents|mesh-ancestor
153594043|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153594044|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153594045|NCT01846364|Protective Agents|protective agents|mesh-ancestor
153594046|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594047|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594062|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594063|NCT01846806|Rifaximin|rifaximin|mesh-list
153404291|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812950|NCT00431028|Triamcinolone|triamcinolone|mesh-list
153812951|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808042|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808043|NCT00343317|Cefoxitin|cefoxitin|mesh-list
153808044|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153808045|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808046|NCT00313079|Vincristine|vincristine|mesh-list
153808047|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153808048|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808049|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
153808050|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
153808051|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
153808052|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808053|NCT00347724|Tramadol|tramadol|mesh-list
153808054|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153808055|NCT00347724|Narcotics|narcotics|mesh-ancestor
153808068|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
153808069|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808070|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808071|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153808072|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153808073|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153808074|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
153808075|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808076|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808077|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
153808078|NCT00313157|Protective Agents|protective agents|mesh-ancestor
153808079|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153808080|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404292|NCT04736225|Insulin|insulin|mesh-list
153404293|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153404294|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404295|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153404296|NCT03344861|Trioxsalen|trioxsalen|mesh-list
153404297|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404298|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
153404299|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153404300|NCT03348683|Propranolol|propranolol|mesh-list
153354661|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354662|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
153808090|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
153808091|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808092|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153808093|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808094|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153808095|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
153808096|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808097|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808098|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153808100|NCT00347802|Travoprost|travoprost|mesh-list
153808101|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153808102|NCT00313274|Clevudine|clevudine|mesh-list
153808103|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
153808104|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808105|NCT00419042|Gemcitabine|gemcitabine|mesh-list
153594064|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594065|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594066|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153594067|NCT01846832|Interferons|interferons|mesh-list
153808106|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153808107|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153808108|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
153808109|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808110|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808111|NCT00419042|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153808112|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153808113|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808114|NCT00347841|Bimatoprost|bimatoprost|mesh-list
153808115|NCT00347841|Latanoprost|latanoprost|mesh-list
153808116|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153808117|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153808118|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153808119|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
153808185|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
153808186|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808187|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
153808188|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808189|NCT00313547|Amlodipine|amlodipine|mesh-list
153808190|NCT00313547|Quinapril|quinapril|mesh-list
153808191|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153808192|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153808193|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153808194|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808195|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153808196|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808197|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
153469178|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
153808227|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153808228|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153808229|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153863903|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863909|NCT01165021|Hematinics|hematinics|mesh-ancestor
153404323|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
153808230|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
153808231|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153808232|NCT00343980|Insulin|insulin|mesh-list
153808233|NCT00343980|Glimepiride|glimepiride|mesh-list
153808234|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
153808235|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153808236|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808237|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808238|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153808239|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354811|NCT02138006|Insulin|insulin|mesh-list
153808240|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
153808241|NCT00313859|Simvastatin|simvastatin|mesh-list
153354886|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153808242|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153808256|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808257|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808258|NCT00313898|Urological Agents|urological agents|mesh-ancestor
153808259|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
153808260|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808261|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808262|NCT00313976|Interferons|interferons|mesh-list
153808263|NCT00313976|Interferon-beta|interferon-beta|mesh-list
153404324|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404325|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404326|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153404327|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153404328|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
153404329|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404332|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153808264|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
153808265|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808266|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
153808267|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808268|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
153808269|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808270|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153808271|NCT00348387|Vaccines|vaccines|mesh-list
153808272|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
153808273|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808274|NCT00314171|Timolol|timolol|mesh-list
153808275|NCT00314171|Dorzolamide|dorzolamide|mesh-list
153808276|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153808277|NCT00314171|Brinzolamide|brinzolamide|mesh-list
153808278|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153808279|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153808280|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153808281|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
153808282|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808283|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808284|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808285|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153808286|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153808287|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153808288|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808289|NCT00348426|Antitoxins|antitoxins|mesh-list
153808290|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
153808291|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
153808292|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808293|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153808294|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
153808295|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153808296|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153808297|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153808298|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808331|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153808332|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
153808333|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808334|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808335|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
153808336|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
153808337|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153808338|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153808339|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808340|NCT00348504|Simendan|simendan|mesh-list
153808341|NCT00348504|Dobutamine|dobutamine|mesh-list
153808342|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153808343|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
153808344|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153808345|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153808346|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808347|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808348|NCT00348504|Protective Agents|protective agents|mesh-ancestor
153808349|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808350|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
153808351|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
153808352|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808353|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153808354|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153808374|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153808375|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808377|NCT00314639|Modafinil|modafinil|mesh-list
153808394|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808395|NCT00344526|Dexamethasone|dexamethasone|mesh-list
153808396|NCT00344526|Melphalan|melphalan|mesh-list
153808397|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808398|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
153808399|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
153808400|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808401|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808402|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153808403|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
153808404|NCT00344526|Hormones|hormones|mesh-ancestor
153808405|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153808406|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153808407|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808408|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153808409|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
153808417|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153808418|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153808419|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153808420|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808422|NCT00314873|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153808423|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153808424|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808425|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808426|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808427|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
153808428|NCT00348738|Hematinics|hematinics|mesh-ancestor
153808429|NCT00314912|Tramiprosate|tramiprosate|mesh-list
153808430|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
153808431|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
153808432|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
153808433|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594068|NCT01846832|Ribavirin|ribavirin|mesh-list
153594069|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
153594070|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
153594071|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153594072|NCT01846832|Simeprevir|simeprevir|mesh-list
153594073|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594074|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
153594075|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594076|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
153808434|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808435|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808436|NCT00314990|Folic Acid|folic acid|mesh-list
153808437|NCT00314990|Pyridoxine|pyridoxine|mesh-list
153808438|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
153808439|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
153808440|NCT00314990|Hematinics|hematinics|mesh-ancestor
153808441|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
153808442|NCT00314990|Vitamins|vitamins|mesh-ancestor
153808443|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
153808444|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808445|NCT02960126|Aspirin|aspirin|mesh-list
153808446|NCT02960126|Clopidogrel|clopidogrel|mesh-list
153808447|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153808448|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153808449|NCT02960126|Analgesics|analgesics|mesh-ancestor
153808450|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
153808451|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808452|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808453|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808454|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808455|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153808456|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153808457|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813052|NCT00331994|Metronidazole|metronidazole|mesh-list
153808458|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153808459|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153808460|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808461|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
153594077|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594089|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153594090|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
153594091|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
153594092|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153818695|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818696|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460083|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153460084|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153460085|NCT04615013|Leucovorin|leucovorin|mesh-list
153460086|NCT04615013|Paclitaxel|paclitaxel|mesh-list
153460087|NCT04615013|Docetaxel|docetaxel|mesh-list
153460088|NCT04615013|Carboplatin|carboplatin|mesh-list
153460089|NCT04615013|Capecitabine|capecitabine|mesh-list
153460090|NCT04615013|Fluorouracil|fluorouracil|mesh-list
153460091|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
153460092|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153460093|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460094|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808470|NCT00344760|Tenofovir|tenofovir|mesh-list
153808471|NCT00344760|Lamivudine|lamivudine|mesh-list
153808472|NCT00344760|Efavirenz|efavirenz|mesh-list
153808473|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
153808474|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
153808475|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808476|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153808477|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153808492|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153808493|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153808494|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153808495|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153808496|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808497|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
153460095|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
153359563|NCT04873050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153594093|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
153594094|NCT01846962|Hormones|hormones|mesh-ancestor
153594095|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594096|NCT01846975|Abatacept|abatacept|mesh-list
153594097|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153594098|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594099|NCT01846975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153594100|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594101|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153594102|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
153594103|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808498|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808499|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808500|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
153808501|NCT00315536|Remifentanil|remifentanil|mesh-list
153808502|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153808503|NCT00315536|Narcotics|narcotics|mesh-ancestor
153808504|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808505|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808506|NCT00315536|Analgesics|analgesics|mesh-ancestor
153808507|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
153808508|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808509|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153808510|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153808511|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153808512|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
153736349|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
153736350|NCT02987465|Hematinics|hematinics|mesh-ancestor
153808578|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808595|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808596|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153808597|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
153808598|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153808599|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
153808600|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808601|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808602|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153808603|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
153808604|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
153808605|NCT00315965|Protective Agents|protective agents|mesh-ancestor
153808606|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
153808678|NCT06164535|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153808680|NCT06164535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813057|NCT00332033|Pirfenidone|pirfenidone|mesh-list
153808681|NCT06164535|Protease Inhibitors|protease inhibitors|mesh-ancestor
153808682|NCT06164535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808695|NCT06164327|Oxaliplatin|oxaliplatin|mesh-list
153808696|NCT06164327|Etoposide|etoposide|mesh-list
153808697|NCT06164327|Ifosfamide|ifosfamide|mesh-list
153808698|NCT06164327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153808699|NCT06164327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808700|NCT06164327|Immunologic Factors|immunologic factors|mesh-ancestor
153808701|NCT06164327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808702|NCT06164327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808703|NCT06164327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153808704|NCT06164327|Antimetabolites|antimetabolites|mesh-ancestor
153808705|NCT06164327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808706|NCT06164327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153808707|NCT06164327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153808708|NCT06164327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153808709|NCT06164327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808710|NCT06164327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153808711|NCT06164327|Alkylating Agents|alkylating agents|mesh-ancestor
153808712|NCT06164080|Betamethasone|betamethasone|mesh-list
153808713|NCT06164080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808714|NCT06164080|Glucocorticoids|glucocorticoids|mesh-ancestor
153808715|NCT06164080|Hormones|hormones|mesh-ancestor
153808716|NCT06164080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153808717|NCT06164080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808718|NCT06164080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153808734|NCT06163755|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153808735|NCT06163755|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153808737|NCT06163755|Prednisolone acetate|prednisolone acetate|mesh-list
153808738|NCT06163755|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153808739|NCT06163755|Prednisolone phosphate|prednisolone phosphate|mesh-list
153808740|NCT06163755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808741|NCT06163755|Antiemetics|antiemetics|mesh-ancestor
153808742|NCT06163755|Autonomic Agents|autonomic agents|mesh-ancestor
153808743|NCT06163755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808775|NCT06151080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153808776|NCT06151080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153808778|NCT06151080|Growth Inhibitors|growth inhibitors|mesh-ancestor
153808779|NCT06151080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808780|NCT06124677|Faricimab|faricimab|mesh-list
153808781|NCT06124677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153808782|NCT06124677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153808783|NCT06124677|Growth Substances|growth substances|mesh-ancestor
153808784|NCT06124677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808785|NCT06124677|Growth Inhibitors|growth inhibitors|mesh-ancestor
153808786|NCT06124677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808787|NCT06105684|Capecitabine|capecitabine|mesh-list
153808818|NCT05930613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808819|NCT05930613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813073|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808820|NCT05930613|Immunologic Factors|immunologic factors|mesh-ancestor
153808821|NCT05930613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808822|NCT05930613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808824|NCT05903807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153808825|NCT05903807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808837|NCT05809414|Amantadine|amantadine|mesh-list
153808838|NCT05809414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153808839|NCT05809414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153808840|NCT05809414|Antiviral Agents|antiviral agents|mesh-ancestor
153808841|NCT05809414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808842|NCT05809414|Dopamine Agents|dopamine agents|mesh-ancestor
153808849|NCT05809414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808850|NCT05795517|Ezetimibe|ezetimibe|mesh-list
153808851|NCT05795517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153808852|NCT05795517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153808853|NCT05795517|Antimetabolites|antimetabolites|mesh-ancestor
153808854|NCT05795517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808855|NCT05795517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153808856|NCT05739942|Temozolomide|temozolomide|mesh-list
153808857|NCT05739942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153808858|NCT05739942|Alkylating Agents|alkylating agents|mesh-ancestor
153808859|NCT05739942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808860|NCT05739942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808861|NCT05723510|Rivaroxaban|rivaroxaban|mesh-list
153808862|NCT05723510|Apixaban|apixaban|mesh-list
153808863|NCT05723510|Edoxaban|edoxaban|mesh-list
153808864|NCT05723510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153808865|NCT05723510|Antithrombins|antithrombins|mesh-ancestor
153808866|NCT05723510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153808867|NCT05723510|Protease Inhibitors|protease inhibitors|mesh-ancestor
153808868|NCT05723510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808869|NCT05723510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808870|NCT05723510|Anticoagulants|anticoagulants|mesh-ancestor
153813080|NCT00332072|Timolol|timolol|mesh-list
153808871|NCT05717400|Ribavirin|ribavirin|mesh-list
153808872|NCT05717400|Sofosbuvir|sofosbuvir|mesh-list
153808873|NCT05717400|Velpatasvir|velpatasvir|mesh-list
153808874|NCT05717400|Bevacizumab|bevacizumab|mesh-list
153808875|NCT05717400|Atezolizumab|atezolizumab|mesh-list
153808876|NCT05717400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153808877|NCT05717400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808878|NCT05717400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153808879|NCT05717400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153808880|NCT05717400|Growth Substances|growth substances|mesh-ancestor
153808881|NCT05717400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808882|NCT05717400|Growth Inhibitors|growth inhibitors|mesh-ancestor
153808883|NCT05717400|Antimetabolites|antimetabolites|mesh-ancestor
153808884|NCT05717400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808885|NCT05717400|Antiviral Agents|antiviral agents|mesh-ancestor
153594104|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594105|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153594106|NCT01847144|Gliclazide|gliclazide|mesh-list
153594107|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153808886|NCT05717400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808904|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808905|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153808906|NCT05676294|Olanzapine|olanzapine|mesh-list
153808907|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
153808908|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
153808909|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808910|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808911|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153808912|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153808913|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153808914|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808915|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153808916|NCT05676294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153808917|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153808918|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153808919|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808920|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808921|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
153808922|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
153808923|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153808924|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813090|NCT00431613|Carboplatin|carboplatin|mesh-list
153808925|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808926|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153808927|NCT05665088|Analgesics|analgesics|mesh-ancestor
153808928|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
153808929|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808930|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153808931|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153808932|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153808933|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
153808934|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808935|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808936|NCT05661669|Ketamine|ketamine|mesh-list
153808937|NCT05661669|Analgesics|analgesics|mesh-ancestor
153809017|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153809018|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153809019|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153809020|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153809021|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153594109|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594110|NCT01847144|Incretins|incretins|mesh-ancestor
153594111|NCT01847144|Hormones|hormones|mesh-ancestor
153594112|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594113|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
153809022|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153809046|NCT05317936|Pirtobrutinib|pirtobrutinib|mesh-list
153809047|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809048|NCT05317936|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153809049|NCT05317936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809050|NCT05317936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809051|NCT05317936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809052|NCT05285813|Acetaminophen|acetaminophen|mesh-list
153809053|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
153809054|NCT05285813|Promethazine|promethazine|mesh-list
153809055|NCT05285813|Dexamethasone|dexamethasone|mesh-list
153809056|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153809057|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
153809058|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
153809059|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809060|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809061|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153809062|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
153813102|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153813103|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809063|NCT05285813|Hormones|hormones|mesh-ancestor
153809064|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809065|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153809066|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809067|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153809068|NCT05285813|Analgesics|analgesics|mesh-ancestor
153809069|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
153809070|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
153809071|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153809072|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153809073|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809074|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
153809093|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153809094|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153809095|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
153809096|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809098|NCT05211336|Prednisone|prednisone|mesh-list
153809102|NCT05211336|Ibrutinib|ibrutinib|mesh-list
153809103|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153809104|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
153809105|NCT05211336|Hormones|hormones|mesh-ancestor
153809106|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809107|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809108|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153809109|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809110|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
153809111|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153809112|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153813124|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153809113|NCT05211336|Growth Substances|growth substances|mesh-ancestor
153809114|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
153809115|NCT05211336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153809116|NCT05211336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809117|NCT05211336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809118|NCT05211336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809119|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809120|NCT05201183|Fludarabine|fludarabine|mesh-list
153809121|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809122|NCT05183841|Fenoterol|fenoterol|mesh-list
153809123|NCT05183841|Ipratropium|ipratropium|mesh-list
153809124|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
153809125|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
153809126|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809127|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809128|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153809129|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
153864084|NCT01163266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153809161|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153809162|NCT04916951|Amoxicillin|amoxicillin|mesh-list
153809163|NCT04916951|Cephalexin|cephalexin|mesh-list
153809164|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153809165|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809166|NCT04897269|Progesterone|progesterone|mesh-list
153809167|NCT04897269|Progestins|progestins|mesh-ancestor
153809168|NCT04897269|Hormones|hormones|mesh-ancestor
153809169|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809170|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809171|NCT04891419|Lidocaine|lidocaine|mesh-list
153809172|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
153809173|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
153809174|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809175|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809176|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
153809177|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809178|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153809179|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153809180|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153809181|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153809182|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809183|NCT04832087|Teduglutide|teduglutide|mesh-list
153809184|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153809185|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153809186|NCT04832087|Protective Agents|protective agents|mesh-ancestor
153809187|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864085|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153864086|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153864087|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864088|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864089|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
153594114|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594115|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460096|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460097|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460098|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809188|NCT04780568|Osimertinib|osimertinib|mesh-list
153809189|NCT04780568|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153809190|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809191|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809192|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809193|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809206|NCT04771156|Analgesics|analgesics|mesh-ancestor
153809207|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
153809208|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809209|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809210|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153809211|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809212|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153809213|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809214|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809215|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153809216|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153809217|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
153809219|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153809220|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153809221|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153809222|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
153809223|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809224|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809225|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809226|NCT04666636|Urological Agents|urological agents|mesh-ancestor
153809227|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
153809228|NCT04618913|Apixaban|apixaban|mesh-list
153359662|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153809229|NCT04618913|Edoxaban|edoxaban|mesh-list
153809230|NCT04618913|Dabigatran|dabigatran|mesh-list
153809231|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153404500|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404501|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404502|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404503|NCT00425347|Elotuzumab|elotuzumab|mesh-list
153864099|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809232|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
153809233|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153809234|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
153809235|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809236|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809237|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
153809238|NCT04588792|Furosemide|furosemide|mesh-list
153809239|NCT04588792|Diuretics|diuretics|mesh-ancestor
153809240|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
153809241|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809242|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153809243|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153809244|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809245|NCT04568603|Islatravir|islatravir|mesh-list
153809246|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
153809247|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809248|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809249|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809250|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153809251|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153809252|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153809254|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
153809305|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
153809306|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809307|NCT04082767|Midazolam|midazolam|mesh-list
153809308|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
153809309|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153809310|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809311|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809312|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153809313|NCT04082767|Analgesics|analgesics|mesh-ancestor
153809314|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
153809315|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809316|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153809320|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809321|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809322|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153809323|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153809324|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153809325|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153809326|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153809327|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
153809328|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
153809329|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
153809330|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
153809331|NCT04068831|Avelumab|avelumab|mesh-list
153809332|NCT04068831|Talazoparib|talazoparib|mesh-list
153809333|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809334|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809335|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153809336|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809337|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809338|NCT04012138|Insulin|insulin|mesh-list
153809339|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153809340|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
153809341|NCT04012138|Albuterol|albuterol|mesh-list
153809342|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153809343|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809344|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153809345|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
153809346|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809347|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153809348|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
153809349|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
153809350|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153809351|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153809352|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153460099|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460100|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
153460101|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460102|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
153460103|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460104|NCT04615013|Antidotes|antidotes|mesh-ancestor
153594125|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
153809379|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809381|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
153809382|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809383|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153809384|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153809385|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153809386|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809387|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
153809388|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809389|NCT03793478|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153809390|NCT03793478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809392|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
153809393|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
153809394|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153809395|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
153809396|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153594126|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594127|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594128|NCT01847339|Bupivacaine|bupivacaine|mesh-list
153594129|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
153813185|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153388873|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
153388874|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
153388875|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388876|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388903|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153388905|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388906|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388907|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
153594130|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
153594131|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594132|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594133|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
153594134|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818697|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
153818698|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818699|NCT03960840|Ibrutinib|ibrutinib|mesh-list
153818700|NCT03960840|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153818701|NCT03960840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153818702|NCT03960840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818703|NCT03960840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818704|NCT03944304|Paclitaxel|paclitaxel|mesh-list
153818705|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153809397|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
153809398|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809399|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809400|NCT03587272|Sirolimus|sirolimus|mesh-list
153809401|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
153809402|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153809403|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809404|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153809405|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809406|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
153809407|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809408|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
153809409|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809410|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809411|NCT03579446|Oxymorphone|oxymorphone|mesh-list
153809412|NCT03579446|Morphine|morphine|mesh-list
153809413|NCT03579446|Oxycodone|oxycodone|mesh-list
153809468|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153809469|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
153809470|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153809472|NCT03330132|Vaccines|vaccines|mesh-list
153809473|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
153809474|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809475|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
153809476|NCT03330132|Coagulants|coagulants|mesh-ancestor
153809477|NCT03309007|Metformin|metformin|mesh-list
153809478|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
153809479|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153809480|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388910|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809481|NCT03309007|Antacids|antacids|mesh-ancestor
153388911|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
153388912|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388913|NCT00002145|Foscarnet|foscarnet|mesh-list
153388914|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153388915|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
153388916|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388917|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388918|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388919|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388920|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388921|NCT00002301|Foscarnet|foscarnet|mesh-list
153388935|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388936|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
153809482|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809483|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153809484|NCT03206671|Cytarabine|cytarabine|mesh-list
153809485|NCT03206671|Dexamethasone|dexamethasone|mesh-list
153809486|NCT03206671|Prednisolone|prednisolone|mesh-list
153809487|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
153809488|NCT03206671|Ifosfamide|ifosfamide|mesh-list
153809489|NCT03206671|Rituximab|rituximab|mesh-list
153809490|NCT03206671|Doxorubicin|doxorubicin|mesh-list
153809493|NCT03206671|Etoposide|etoposide|mesh-list
153809494|NCT03206671|Vincristine|vincristine|mesh-list
153809495|NCT03206671|Vindesine|vindesine|mesh-list
153809496|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809497|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
153809498|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809499|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809500|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153809501|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
153809502|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809503|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809504|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153356074|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809505|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153809506|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
153809507|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
153809508|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809542|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809544|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153809545|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153809546|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153809547|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
153809564|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809565|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
153809566|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809567|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
153809568|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809569|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
153809570|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809571|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153809573|NCT02917720|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153809574|NCT02917720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809575|NCT02917720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809576|NCT02917720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818706|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818707|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388940|NCT00002313|Didanosine|didanosine|mesh-list
153388941|NCT00002313|Nystatin|nystatin|mesh-list
153388942|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
153388943|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388944|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388945|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388946|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388947|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
153388948|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818708|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
153864155|NCT04609254|Acetaminophen|acetaminophen|mesh-list
153809577|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
153809578|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
153809579|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809580|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153356149|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153809581|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153809582|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153809583|NCT02710734|Doxorubicin|doxorubicin|mesh-list
153809584|NCT02710734|Methotrexate|methotrexate|mesh-list
153809585|NCT02710734|Mitomycins|mitomycins|mesh-list
153809586|NCT02710734|Mitomycin|mitomycin|mesh-list
153809587|NCT02710734|Vinblastine|vinblastine|mesh-list
153809588|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809589|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153809590|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153809591|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153809592|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809593|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809594|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153809595|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
153809596|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153809597|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809598|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809599|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
153809600|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
153864156|NCT04609254|Ibuprofen|ibuprofen|mesh-list
153864160|NCT04609254|Analgesics|analgesics|mesh-ancestor
153818709|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
153818710|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818711|NCT03934684|Dexamethasone|dexamethasone|mesh-list
153818712|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
153818713|NCT03934684|Lenalidomide|lenalidomide|mesh-list
153818714|NCT03934684|BB 1101|bb 1101|mesh-list
153818715|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818716|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
153818717|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
153818718|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460105|NCT04615013|Protective Agents|protective agents|mesh-ancestor
153594136|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594137|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594138|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153594139|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153594140|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153594141|NCT01847417|Pantoprazole|pantoprazole|mesh-list
153594142|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153594143|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153594144|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153809602|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809603|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
153809604|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469180|NCT05450718|Buprenorphine|buprenorphine|mesh-list
153809667|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809668|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809669|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153388962|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153388963|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153388964|NCT00002157|Growth Substances|growth substances|mesh-ancestor
153388965|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
153388966|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388968|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153388969|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153388970|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388971|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153809670|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809671|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
153809672|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153809673|NCT01697527|Analgesics|analgesics|mesh-ancestor
153809674|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
153809675|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809676|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153809677|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153809678|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
153809679|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809680|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153809681|NCT01632007|Alogliptin|alogliptin|mesh-list
153809682|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153809683|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809684|NCT01632007|Incretins|incretins|mesh-ancestor
153809685|NCT01632007|Hormones|hormones|mesh-ancestor
153809686|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404576|NCT05664139|Paclitaxel|paclitaxel|mesh-list
153594145|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594146|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594147|NCT01847456|Insulin|insulin|mesh-list
153594152|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153594153|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153594154|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594155|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594156|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594159|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594160|NCT01847521|Protective Agents|protective agents|mesh-ancestor
153594161|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594162|NCT01847599|Capecitabine|capecitabine|mesh-list
153594163|NCT01847599|Lapatinib|lapatinib|mesh-list
153594164|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153594165|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
153594166|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594167|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594168|NCT01847599|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153594175|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
153594176|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153594177|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594178|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594179|NCT01847677|Paclitaxel|paclitaxel|mesh-list
153809717|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809718|NCT01280682|Rituximab|rituximab|mesh-list
153809719|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809720|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809721|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
153809722|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809723|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809724|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153809725|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153809726|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153594180|NCT01847677|Bevacizumab|bevacizumab|mesh-list
153594181|NCT01847677|Carboplatin|carboplatin|mesh-list
153594182|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153809727|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153809728|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809729|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809730|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809731|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
153809732|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153809733|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
153388974|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388975|NCT00002163|Abacavir|abacavir|mesh-list
153388976|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388977|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388978|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809735|NCT00679029|Gemcitabine|gemcitabine|mesh-list
153809736|NCT00679029|Doxorubicin|doxorubicin|mesh-list
153809737|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153809738|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153809740|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
153809741|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153809742|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809743|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809744|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809774|NCT00518375|Cyclosporine|cyclosporine|mesh-list
153809775|NCT00518375|Sirolimus|sirolimus|mesh-list
153809776|NCT00518375|Cyclosporins|cyclosporins|mesh-list
153809777|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809778|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809779|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809780|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
153809781|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809782|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
153864179|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153864180|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153864181|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864182|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
153864184|NCT04609293|Apatinib|apatinib|mesh-list
153594183|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594184|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
153594185|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
153594186|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
153594187|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594188|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153594189|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153594190|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153594191|NCT01847677|Growth Substances|growth substances|mesh-ancestor
153594192|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594193|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
153809783|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809784|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
153809785|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809786|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153809787|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153809788|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153809789|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809790|NCT00195429|Sirolimus|sirolimus|mesh-list
153809824|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809825|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
153809826|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809827|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809828|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153809829|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153809830|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809854|NCT00349401|Morphine|morphine|mesh-list
153809855|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153809856|NCT00349401|Narcotics|narcotics|mesh-ancestor
153809857|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809858|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809859|NCT00349401|Analgesics|analgesics|mesh-ancestor
153809860|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
153809861|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388980|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
153388981|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389104|NCT00002367|Saquinavir|saquinavir|mesh-list
153389105|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389106|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389107|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389108|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389109|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
153809862|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153809863|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153809864|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153809865|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809866|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153809867|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809868|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809869|NCT00349440|Cyclosporine|cyclosporine|mesh-list
153809870|NCT00349440|Cyclosporins|cyclosporins|mesh-list
153809871|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809872|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594194|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
153594195|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153594196|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
153594197|NCT01847768|Dimercaprol|dimercaprol|mesh-list
153594198|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
153356448|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153809873|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809874|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
153809875|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809876|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
153809877|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809878|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
153809904|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153809905|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
153809906|NCT00349557|Bevacizumab|bevacizumab|mesh-list
153809907|NCT00349557|Goserelin|goserelin|mesh-list
153809908|NCT00349557|Bicalutamide|bicalutamide|mesh-list
153809909|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809910|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809911|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153809912|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153809913|NCT00349557|Growth Substances|growth substances|mesh-ancestor
153809914|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813186|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153809915|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
153389114|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389323|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389325|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389326|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
153389327|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389328|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153389329|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153809916|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153809917|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
153809918|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
153809919|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809920|NCT00349596|Decitabine|decitabine|mesh-list
153809921|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809922|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
153809923|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809924|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809925|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809926|NCT00349635|Metformin|metformin|mesh-list
153809927|NCT00349635|Fenofibrate|fenofibrate|mesh-list
153809928|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153809929|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809970|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153809971|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809972|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809973|NCT00344955|Atorvastatin|atorvastatin|mesh-list
153809974|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153809975|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153809987|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153809988|NCT00316940|Analgesics|analgesics|mesh-ancestor
153809989|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
153809990|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809991|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809992|NCT00344994|Pramipexole|pramipexole|mesh-list
153809993|NCT00344994|Dexpramipexole|dexpramipexole|mesh-list
153810058|NCT00317408|Ifosfamide|ifosfamide|mesh-list
153810059|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
153810060|NCT00317408|Idarubicin|idarubicin|mesh-list
153810061|NCT00317408|Thiotepa|thiotepa|mesh-list
153810062|NCT00317408|Carmustine|carmustine|mesh-list
153810063|NCT00317408|Vinblastine|vinblastine|mesh-list
153810064|NCT00317408|Lomustine|lomustine|mesh-list
153810065|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
153810066|NCT00317408|Vindesine|vindesine|mesh-list
153810067|NCT00317408|Cyclosporins|cyclosporins|mesh-list
153810068|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153390074|NCT05806723|Antimetabolites|antimetabolites|mesh-ancestor
153390143|NCT05806047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390144|NCT05806047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390145|NCT05805930|Prednisone|prednisone|mesh-list
153390146|NCT05805930|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153390147|NCT05805930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390148|NCT05805930|Glucocorticoids|glucocorticoids|mesh-ancestor
153390149|NCT05805930|Hormones|hormones|mesh-ancestor
153390205|NCT05775237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153390206|NCT05775237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153810069|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
153810070|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153810071|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
153810072|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
153810073|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810074|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810075|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810076|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
153810077|NCT00317408|Hormones|hormones|mesh-ancestor
153810078|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153810079|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153810080|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810081|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153810082|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
153810083|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153810084|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153810085|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
153810086|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810087|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
153810088|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810089|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153810104|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
153810105|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153810123|NCT02959554|Nivolumab|nivolumab|mesh-list
153810124|NCT02959554|Sunitinib|sunitinib|mesh-list
153810125|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810126|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810127|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153810128|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810129|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810130|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153810131|NCT02959554|Growth Substances|growth substances|mesh-ancestor
153810132|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810203|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
153810204|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
153810205|NCT00345657|Vitamins|vitamins|mesh-ancestor
153810206|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
153810207|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810208|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153810209|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153810210|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810211|NCT00317876|Cyclosporine|cyclosporine|mesh-list
153810212|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
153810213|NCT00317876|Methotrexate|methotrexate|mesh-list
153810214|NCT00317876|Cyclosporins|cyclosporins|mesh-list
153810215|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810216|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
153810217|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810218|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810219|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153810220|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
153810221|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390247|NCT05709093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390248|NCT05709093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390249|NCT05709093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390251|NCT05690646|Nirmatrelvir|nirmatrelvir|mesh-list
153390252|NCT05690646|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153390253|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153390254|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153390255|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153390256|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
153390257|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810244|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153810245|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810246|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153810248|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
153810249|NCT00317993|Simvastatin|simvastatin|mesh-list
153810250|NCT00317993|Ezetimibe|ezetimibe|mesh-list
153810251|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153810252|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153810253|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
153810254|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810255|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153810256|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153594199|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
153810257|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810258|NCT00350415|Mesalamine|mesalamine|mesh-list
153810259|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153810260|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153810261|NCT00350415|Analgesics|analgesics|mesh-ancestor
153810262|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
153810263|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810264|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810265|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153810266|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810267|NCT00345696|Bevacizumab|bevacizumab|mesh-list
153810268|NCT00345696|Capecitabine|capecitabine|mesh-list
153810269|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
153810270|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810271|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810287|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
153810288|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810289|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
153810290|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810291|NCT00350454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153810296|NCT00345735|Narcotics|narcotics|mesh-ancestor
153810327|NCT00318422|Glimepiride|glimepiride|mesh-list
153810328|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
153356893|NCT01270178|Entecavir|entecavir|mesh-list
153810329|NCT00318422|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153810361|NCT00318773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153810362|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153810363|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153810364|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810365|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810366|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
153810367|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810495|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153390259|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153390260|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153390261|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
153390262|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390263|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153390264|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153390265|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153390266|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153390290|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153810497|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810498|NCT00351195|Capecitabine|capecitabine|mesh-list
153810499|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
153810500|NCT00351195|Etoposide|etoposide|mesh-list
153810501|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153810502|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
153810503|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810504|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810505|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153810506|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153810507|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153810508|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810509|NCT00319709|Amibegron|amibegron|mesh-list
153810510|NCT00319709|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153810511|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153810512|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153810513|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
153810514|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810532|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810533|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810534|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810535|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
153810536|NCT00319865|Hormones|hormones|mesh-ancestor
153357182|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
153357183|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357184|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357185|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153357186|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153357187|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357188|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153357189|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153357190|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
153357191|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153357192|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153357193|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153357194|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153357195|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357196|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
153357197|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153357198|NCT04385654|Axitinib|axitinib|mesh-list
153357199|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357200|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153357201|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357202|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357203|NCT01273064|Interferons|interferons|mesh-list
153357204|NCT01273064|Ribavirin|ribavirin|mesh-list
153357205|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357206|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
153357207|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357213|NCT01272908|Rituximab|rituximab|mesh-list
153810570|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
153810571|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153810572|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810573|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390299|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153390300|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
153390301|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390302|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390303|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390304|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153390305|NCT05297448|Rifaximin|rifaximin|mesh-list
153390306|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390309|NCT05161156|Bromides|bromides|mesh-list
153810575|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810576|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153810577|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153810578|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357215|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594200|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594202|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
153594203|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594204|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594205|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153594268|NCT01848132|Hormones|hormones|mesh-ancestor
153594269|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594270|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153594271|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153594272|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
153594273|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
153594274|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
153594275|NCT01848197|Paclitaxel|paclitaxel|mesh-list
153594276|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153594277|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594278|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460116|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460117|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460118|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
153460119|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
153460120|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460121|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153460122|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153460123|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
153460124|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153460125|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153594296|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594325|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153594326|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153594327|NCT01848665|Analgesics|analgesics|mesh-ancestor
153594328|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
153594329|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594330|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460136|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460138|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153818719|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818720|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153818721|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
153390314|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390315|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153390316|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
153390317|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
153390318|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153390319|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
153390320|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390368|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153390369|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390370|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390371|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153818722|NCT03934684|Hormones|hormones|mesh-ancestor
153818723|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153460139|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
153460140|NCT04533997|Furosemide|furosemide|mesh-list
153818724|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153818725|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818726|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
153818727|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594350|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153594351|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594394|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594395|NCT01849016|Expectorants|expectorants|mesh-ancestor
153594569|NCT01850628|Trastuzumab|trastuzumab|mesh-list
153594570|NCT01850628|Pertuzumab|pertuzumab|mesh-list
153594571|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153594572|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594573|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
153594574|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
153594575|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
153594628|NCT01851005|Analgesics|analgesics|mesh-ancestor
153594629|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
153594633|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153594634|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
153594635|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594636|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594637|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153594638|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
153594639|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153594640|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153594641|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153594676|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594677|NCT01851408|Sirolimus|sirolimus|mesh-list
153594678|NCT01851408|Sorafenib|sorafenib|mesh-list
153594683|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594684|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818738|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153818739|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390378|NCT04655157|Ipilimumab|ipilimumab|mesh-list
153390379|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153390380|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390381|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153390382|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390383|NCT04650269|Emtricitabine|emtricitabine|mesh-list
153390384|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
153390385|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390386|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153390387|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153390388|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390389|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390390|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153390391|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153390392|NCT04578600|Lenalidomide|lenalidomide|mesh-list
153390393|NCT04578600|Azacitidine|azacitidine|mesh-list
153390394|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
153818740|NCT03899402|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153818752|NCT03864419|Doxorubicin|doxorubicin|mesh-list
153818753|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153818754|NCT03864419|Methotrexate|methotrexate|mesh-list
153818755|NCT03864419|Etoposide|etoposide|mesh-list
153818756|NCT03864419|Vincristine|vincristine|mesh-list
153818757|NCT03864419|Daunorubicin|daunorubicin|mesh-list
153460145|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153460146|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460147|NCT04511052|Carotenoids|carotenoids|mesh-list
153460148|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
153594703|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
153594704|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594705|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
153594706|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594707|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153460149|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460150|NCT04511052|Protective Agents|protective agents|mesh-ancestor
153594840|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153594841|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594843|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153594844|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153594845|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594846|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153594847|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153594848|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153594923|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
153594924|NCT01852903|Calcium|calcium|mesh-list
153460174|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460175|NCT04294966|Hormones|hormones|mesh-ancestor
153460176|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153460177|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
153460185|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594926|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594927|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153594928|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
153594929|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153594930|NCT01852903|Protective Agents|protective agents|mesh-ancestor
153594931|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
153594932|NCT01852994|Testosterone|testosterone|mesh-list
153390505|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390506|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153390507|NCT03767933|Narcotics|narcotics|mesh-ancestor
153390508|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153390509|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
153390510|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153390511|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153390512|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153390513|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390514|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
153390515|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390516|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390517|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153390518|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390519|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
153594933|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
153594934|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
153594935|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153594936|NCT01852994|Androgens|androgens|mesh-ancestor
153594937|NCT01852994|Hormones|hormones|mesh-ancestor
153594938|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153594939|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594940|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153595018|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153595019|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595020|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153595021|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153595022|NCT01853813|Growth Substances|growth substances|mesh-ancestor
153595023|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595024|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
153595026|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
153595027|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595028|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595117|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153595118|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153818837|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818838|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153595248|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595249|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153595250|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153595251|NCT01855334|Spironolactone|spironolactone|mesh-list
153595252|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153595253|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
153595254|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595255|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595320|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153595321|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595322|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595324|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
153595446|NCT01856374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153595447|NCT01856374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153595448|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390520|NCT03636152|Chloroquine|chloroquine|mesh-list
153390521|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
153390522|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153390523|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153390524|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390525|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783596|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153783597|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153390526|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390527|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390620|NCT02673359|Hormones|hormones|mesh-ancestor
153595467|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153595468|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153595470|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
153595471|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595472|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818872|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153818873|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818874|NCT03598270|Paclitaxel|paclitaxel|mesh-list
153818875|NCT03598270|Carboplatin|carboplatin|mesh-list
153818876|NCT03598270|Gemcitabine|gemcitabine|mesh-list
153818877|NCT03598270|Doxorubicin|doxorubicin|mesh-list
153818878|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153818879|NCT03598270|Atezolizumab|atezolizumab|mesh-list
153818880|NCT03598270|Niraparib|niraparib|mesh-list
153460265|NCT03914443|Cisplatin|cisplatin|mesh-list
153595479|NCT01856621|Charcoal|charcoal|mesh-list
153595480|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153595481|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
153595482|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153595483|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595484|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153595485|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
153595486|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
153595487|NCT01856621|Hormones|hormones|mesh-ancestor
153595755|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153595756|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153595810|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153595811|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595813|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
153595814|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153595815|NCT01858077|Everolimus|everolimus|mesh-list
153595816|NCT01858077|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153595817|NCT01858077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153595818|NCT01858077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595820|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153595864|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595865|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153818925|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818926|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
153818927|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
153818928|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390627|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390628|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390629|NCT02624518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153390690|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390693|NCT01323465|Nabiximols|nabiximols|mesh-list
153390694|NCT01323465|Omeprazole|omeprazole|mesh-list
153390695|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153390696|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153390697|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153390698|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390699|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390700|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153390701|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
153818929|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460330|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460331|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
153460332|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460333|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460334|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153460335|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153595917|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153595918|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595919|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595920|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
153595921|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595922|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595923|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153595925|NCT01858571|Celecoxib|celecoxib|mesh-list
153595926|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
153595927|NCT01858571|Etoposide|etoposide|mesh-list
153595928|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153595929|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
153595930|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595931|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153595975|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
153595976|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818945|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
153818946|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
153596001|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819005|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819007|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
153819008|NCT03384914|Immunomodulating Agents|immunomodulating agents|mesh-list
153819009|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819010|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
153819011|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153596259|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153596261|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153596262|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596263|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153596264|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
153596265|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460431|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460432|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460433|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153460434|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153460435|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
153460436|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153460437|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460446|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390708|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153390709|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153390710|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153390711|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153390712|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
153390713|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153390737|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390738|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153390739|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
153460447|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
153460448|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460449|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460450|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460451|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
153460452|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460453|NCT03336333|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153460454|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153596273|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153596314|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153596315|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153596316|NCT01860833|Analgesics|analgesics|mesh-ancestor
153596317|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
153596318|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596319|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553827|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553828|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553829|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153553830|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553832|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
153553833|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553834|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153553835|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153553836|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553837|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553838|NCT01595009|Everolimus|everolimus|mesh-list
153553860|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553861|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553862|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553863|NCT01595152|Urological Agents|urological agents|mesh-ancestor
153553865|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153553866|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
153553867|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553868|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553869|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
153553870|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553872|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153553873|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153553874|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153553875|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
153553876|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553877|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553878|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153553879|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
153553880|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
153553881|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
153553882|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153553883|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153553884|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
153596418|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553885|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553886|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553887|NCT01595425|Esomeprazole|esomeprazole|mesh-list
153553888|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153553889|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153553890|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153553891|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553924|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153373323|NCT05328635|Candesartan|candesartan|mesh-list
153554016|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153554017|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153554018|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
153554019|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153554020|NCT01596010|Norethindrone|norethindrone|mesh-list
153554021|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
153554022|NCT01596010|Estradiol|estradiol|mesh-list
153554023|NCT01596010|Estrogens|estrogens|mesh-ancestor
153554024|NCT01596010|Hormones|hormones|mesh-ancestor
153554025|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554026|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554027|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153554028|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
153554029|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153554030|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153554031|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153554032|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153554033|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153390787|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390788|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390789|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390790|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
153390791|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153390792|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554036|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
153554052|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153554053|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554054|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153554055|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
153554056|NCT01596166|Ketorolac|ketorolac|mesh-list
153554057|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153554058|NCT01596166|Metoclopramide|metoclopramide|mesh-list
153554059|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153596419|NCT01861990|Valproic Acid|valproic acid|mesh-list
153596420|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
153596421|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596422|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596423|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
153596424|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596425|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596426|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
153596427|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153596428|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596429|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153596430|NCT01862003|Leucovorin|leucovorin|mesh-list
153596431|NCT01862003|Folic Acid|folic acid|mesh-list
153596432|NCT01862003|Fluorouracil|fluorouracil|mesh-list
153596433|NCT01862003|Irinotecan|irinotecan|mesh-list
153596434|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
153596435|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
153596436|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410635|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554060|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153554061|NCT01596166|Analgesics|analgesics|mesh-ancestor
153554062|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
153554063|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554064|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554065|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153782613|NCT00234416|Gefitinib|gefitinib|mesh-list
153554066|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554067|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153782614|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153554068|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554069|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554070|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
153554071|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
153554072|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554073|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153554074|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153554075|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
153554076|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554077|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153554078|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153554079|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554080|NCT01596218|Immunotoxins|immunotoxins|mesh-ancestor
153554081|NCT01596218|Immunoconjugates|immunoconjugates|mesh-ancestor
153554082|NCT01596218|Immunologic Factors|immunologic factors|mesh-ancestor
153554083|NCT01596218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554084|NCT01596296|Dinoprostone|dinoprostone|mesh-list
153554085|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
153554086|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153410642|NCT00003945|Topotecan|topotecan|mesh-list
153554090|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359684|NCT04409834|Calcium heparin|calcium heparin|mesh-list
153359686|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
153390808|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390809|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
153390810|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390811|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554091|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554093|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
153554094|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
153554095|NCT01596400|Granisetron|granisetron|mesh-list
153554096|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
153554110|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554111|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554112|NCT01596413|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153554113|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153554114|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
153554115|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554116|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554117|NCT01596426|Granisetron|granisetron|mesh-list
153554118|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
153554119|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
153554120|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554121|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554122|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554123|NCT01596426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153554124|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153554125|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
153554126|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554127|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554128|NCT01596517|Ribavirin|ribavirin|mesh-list
153554129|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153554130|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
153554131|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
153870077|NCT00586430|Lorazepam|lorazepam|mesh-list
153870095|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
153554132|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554133|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
153554134|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554135|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
153373389|NCT01825889|Evacetrapib|evacetrapib|mesh-list
153554136|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554137|NCT01596556|Nicotine|nicotine|mesh-list
153554138|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153554139|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
153554140|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782615|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
153554141|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554142|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153554144|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
153554145|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554146|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554147|NCT01596634|Lactoferrin|lactoferrin|mesh-list
153554148|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554149|NCT01596647|Diclofenac|diclofenac|mesh-list
153554150|NCT01596647|Midazolam|midazolam|mesh-list
153554151|NCT01596647|Caffeine|caffeine|mesh-list
153554152|NCT01596647|Omeprazole|omeprazole|mesh-list
153554153|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153554154|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153359687|NCT04409834|Clopidogrel|clopidogrel|mesh-list
153359688|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153390817|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153390818|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
153390819|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
153390820|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
153390847|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390848|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153390849|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153554155|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870096|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153596437|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153596438|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596439|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596440|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
153596441|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596442|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153596443|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153819090|NCT03193814|Apatinib|apatinib|mesh-list
153819091|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819092|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153819093|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819094|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819095|NCT03178149|Trimethoprim|trimethoprim|mesh-list
153819096|NCT03178149|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153819097|NCT03178149|Sulfamethoxazole|sulfamethoxazole|mesh-list
153819098|NCT03178149|Acyclovir|acyclovir|mesh-list
153819099|NCT03178149|Nystatin|nystatin|mesh-list
153819100|NCT03178149|Tacrolimus|tacrolimus|mesh-list
153819101|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819102|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
153596444|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596445|NCT01862003|Antidotes|antidotes|mesh-ancestor
153596446|NCT01862003|Protective Agents|protective agents|mesh-ancestor
153554157|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153554158|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153554185|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
153554187|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554188|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554189|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
153554190|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554191|NCT01596673|Hydrocodone|hydrocodone|mesh-list
153554192|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153554193|NCT01596673|Narcotics|narcotics|mesh-ancestor
153554194|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554195|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554196|NCT01596673|Analgesics|analgesics|mesh-ancestor
153554197|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
153813191|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390856|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
153390857|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
153390858|NCT00995059|Sirolimus|sirolimus|mesh-list
153390859|NCT00995059|Bortezomib|bortezomib|mesh-list
153390860|NCT00995059|Melphalan|melphalan|mesh-list
153390861|NCT00995059|Tacrolimus|tacrolimus|mesh-list
153390862|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
153390863|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153390864|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
153390865|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390866|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
153390867|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390868|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153390869|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390870|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390871|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391093|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153554198|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554199|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
153554200|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
153554201|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
153554202|NCT01596686|Cathartics|cathartics|mesh-ancestor
153554203|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554204|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
153554205|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153554206|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153554218|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554220|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596447|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
153596448|NCT01862003|Vitamins|vitamins|mesh-ancestor
153596449|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
153596450|NCT01862003|Hematinics|hematinics|mesh-ancestor
153596451|NCT01862081|Paclitaxel|paclitaxel|mesh-list
153596460|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596461|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153596463|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
153596464|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596465|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596466|NCT01862263|Vildagliptin|vildagliptin|mesh-list
153596467|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153596468|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596469|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153596470|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
153596471|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819103|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554221|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153554222|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153554223|NCT01596764|Analgesics|analgesics|mesh-ancestor
153359689|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153391096|NCT01625923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153391097|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153391098|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783600|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153783601|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153391099|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391100|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391101|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
153391102|NCT00002751|Antibodies|antibodies|mesh-list
153391103|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153391104|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
153391213|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
153391214|NCT00002793|Antidotes|antidotes|mesh-ancestor
153391215|NCT00002793|Protective Agents|protective agents|mesh-ancestor
153391238|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391239|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554224|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554225|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554226|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
153554227|NCT01596777|Naltrexone|naltrexone|mesh-list
153554228|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
153554229|NCT01596777|Loperamide|loperamide|mesh-list
153554230|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
153554231|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554232|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554233|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153554234|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153554235|NCT01596777|Analgesics|analgesics|mesh-ancestor
153554236|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
153554237|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554238|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554239|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554240|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554241|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153554242|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153554243|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
153554244|NCT01596803|Vitamin E|vitamin e|mesh-list
153554245|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
153554246|NCT01596803|Tocopherols|tocopherols|mesh-list
153554247|NCT01596803|Antioxidants|antioxidants|mesh-list
153819104|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153819105|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819106|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819107|NCT03178149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153819108|NCT03178149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819109|NCT03178149|Antimalarials|antimalarials|mesh-ancestor
153819110|NCT03178149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153819111|NCT03178149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153819112|NCT03178149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153819113|NCT03178149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153819114|NCT03178149|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153460501|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460502|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460503|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460504|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460505|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460506|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
153460507|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460508|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596472|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596474|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
153596475|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
153596476|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
153596477|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554248|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373395|NCT02692755|Letrozole|letrozole|mesh-list
153391247|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391248|NCT00361907|Insulin|insulin|mesh-list
153391249|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153391250|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153391251|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391252|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153391266|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
153554249|NCT01596803|Protective Agents|protective agents|mesh-ancestor
153554250|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554251|NCT01596803|Vitamins|vitamins|mesh-ancestor
153554252|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
153554253|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
153554254|NCT01596855|Hematinics|hematinics|mesh-ancestor
153554255|NCT01596868|Cisplatin|cisplatin|mesh-list
153554256|NCT01596868|Gemcitabine|gemcitabine|mesh-list
153554257|NCT01596868|Docetaxel|docetaxel|mesh-list
153554258|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554259|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153554260|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
153554261|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554262|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
153554263|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
153554264|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
153554265|NCT01596894|Azithromycin|azithromycin|mesh-list
153554266|NCT01596894|Metronidazole|metronidazole|mesh-list
153554267|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153554268|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554269|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153554270|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153554271|NCT01596907|Ephedrine|ephedrine|mesh-list
153554272|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
153554273|NCT01596907|Caffeine|caffeine|mesh-list
153554274|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153554275|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554276|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153554277|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554292|NCT01596998|Epinephrine|epinephrine|mesh-list
153554293|NCT01596998|Racepinephrine|racepinephrine|mesh-list
153554294|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
153596478|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596479|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596480|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153596481|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153391385|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153596482|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391386|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391387|NCT00382083|Acetaminophen|acetaminophen|mesh-list
153391388|NCT00382083|Ibuprofen|ibuprofen|mesh-list
153391389|NCT00382083|Lidocaine|lidocaine|mesh-list
153391390|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391391|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
153391392|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391394|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
153391395|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391396|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153596483|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153596484|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153596485|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
153596486|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554297|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153554298|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
153554299|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554300|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554301|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554302|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153554303|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153554304|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
153554305|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554306|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153554307|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
153554308|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
153554309|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
153554310|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153554311|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
153554312|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
153554313|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554314|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
153554315|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153554316|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
153554317|NCT01597011|Coagulants|coagulants|mesh-ancestor
153554318|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
153554319|NCT01597167|Analgesics|analgesics|mesh-ancestor
153554320|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
153554321|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554322|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554323|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
153554324|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554325|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153554326|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
153596487|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391495|NCT03788291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391496|NCT03788291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391497|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153391498|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
153391499|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391616|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153391617|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153391618|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
153596488|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153596489|NCT01862354|Anesthetics|anesthetics|mesh-list
153596490|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596491|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596492|NCT01862497|Carvedilol|carvedilol|mesh-list
153781717|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596493|NCT01862497|Prazosin|prazosin|mesh-list
153870134|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
153554327|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153554328|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153554329|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554330|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153554331|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
153554332|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153554333|NCT01597206|Cobalt|cobalt|mesh-list
153554334|NCT01597206|Trace Elements|trace elements|mesh-ancestor
153554335|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
153554336|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554337|NCT01597232|Chrysarobin|chrysarobin|mesh-list
153554338|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153373425|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
153554351|NCT01597310|Warfarin|warfarin|mesh-list
153554352|NCT01597310|Dexpramipexole|dexpramipexole|mesh-list
153554353|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
153554354|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
153554355|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554356|NCT01597310|Protective Agents|protective agents|mesh-ancestor
153554357|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554358|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
153554359|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554360|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153554361|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153554362|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
153554363|NCT01597336|Plasminogen|plasminogen|mesh-list
153554364|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153554365|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153554366|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153554367|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554368|NCT01597427|Clonidine|clonidine|mesh-list
153554369|NCT01597427|Analgesics|analgesics|mesh-ancestor
153554370|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
153391892|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153391893|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
153391894|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391895|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783602|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153783603|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153391896|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153554371|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554372|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460509|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460510|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
153460511|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153596498|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554373|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153554374|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
153554375|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
153554376|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153554377|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153554378|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153554379|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
153554380|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554381|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554382|NCT01597518|Riluzole|riluzole|mesh-list
153554383|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
153554384|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153554385|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153554386|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554387|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554388|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554389|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153554390|NCT01597518|Protective Agents|protective agents|mesh-ancestor
153554391|NCT01597531|Liraglutide|liraglutide|mesh-list
153554392|NCT01597531|Orlistat|orlistat|mesh-list
153554393|NCT01597531|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153554394|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153554395|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554396|NCT01597531|Incretins|incretins|mesh-ancestor
153554397|NCT01597531|Hormones|hormones|mesh-ancestor
153554398|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554423|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153554424|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153554425|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153554426|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153554427|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153554428|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596499|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596501|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
153596502|NCT01862497|Protective Agents|protective agents|mesh-ancestor
153596503|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153596504|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596505|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153596506|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
153554429|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
153554430|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554431|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554432|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153554433|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153554434|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554435|NCT01597700|Ezetimibe|ezetimibe|mesh-list
153554436|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153554437|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153554438|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
153392167|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392169|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392170|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392418|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153392420|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
153392421|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
153554439|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554440|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153554441|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
153554442|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153782616|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782617|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554462|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
153554463|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554464|NCT01597765|Expectorants|expectorants|mesh-ancestor
153554465|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
153554466|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153554467|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
153554468|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554469|NCT01597765|Protective Agents|protective agents|mesh-ancestor
153554470|NCT01597765|Antidotes|antidotes|mesh-ancestor
153554471|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153554472|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
153554473|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
153554475|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153554476|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153554477|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
153554478|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554479|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153554480|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
153554481|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
153554486|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153554487|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554489|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153554490|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
153554491|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554492|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153554494|NCT01597934|Entecavir|entecavir|mesh-list
153554495|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153554496|NCT01597934|Adefovir|adefovir|mesh-list
153554497|NCT01597934|Lamivudine|lamivudine|mesh-list
153554498|NCT01597934|Telbivudine|telbivudine|mesh-list
153554499|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
153554500|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554501|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153554502|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153554503|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554504|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554534|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554535|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554536|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153554537|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554538|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554540|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153554541|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
153554542|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153554543|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
153554544|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813192|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153393164|NCT01710787|Protective Agents|protective agents|mesh-ancestor
153393165|NCT01711177|Travoprost|travoprost|mesh-list
153393166|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153393167|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153393168|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153393169|NCT01715233|Leucovorin|leucovorin|mesh-list
153393170|NCT01715233|Carboplatin|carboplatin|mesh-list
153393171|NCT01715233|Docetaxel|docetaxel|mesh-list
153393172|NCT01715233|Fluorouracil|fluorouracil|mesh-list
153554545|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554573|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153596507|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153596508|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153596509|NCT01862523|Capsaicin|capsaicin|mesh-list
153596510|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
153596511|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
153596512|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
153596513|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596514|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819115|NCT03178149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153819116|NCT03178149|Antiviral Agents|antiviral agents|mesh-ancestor
153819117|NCT03178149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153819118|NCT03178149|Antifungal Agents|antifungal agents|mesh-ancestor
153819119|NCT03178149|Ionophores|ionophores|mesh-ancestor
153554574|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153554575|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554576|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153554577|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153554578|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554579|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
153554580|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153554581|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153554582|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153554583|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
153554584|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554585|NCT01598402|Amoxicillin|amoxicillin|mesh-list
153554586|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
153554587|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
153554588|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153554589|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554590|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554591|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554592|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153554593|NCT01598441|Iloprost|iloprost|mesh-list
153731940|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153554623|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153554624|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153554625|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554626|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153554627|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153554628|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153393638|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393639|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393640|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393641|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
153393642|NCT00002955|Antidotes|antidotes|mesh-ancestor
153393643|NCT00002955|Protective Agents|protective agents|mesh-ancestor
153393644|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
153393645|NCT00002955|Vitamins|vitamins|mesh-ancestor
153393646|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
153393647|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
153554629|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
153554630|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153554631|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153554632|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
153554633|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153554634|NCT01598623|Oxytocin|oxytocin|mesh-list
153554635|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
153554636|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153819120|NCT03178149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153819121|NCT03125928|Paclitaxel|paclitaxel|mesh-list
153554637|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554639|NCT01598649|Caseins|caseins|mesh-list
153554667|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782620|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554668|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153554669|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
153554670|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554671|NCT01598948|Mipomersen|mipomersen|mesh-list
153554672|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153554673|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153554674|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
153554675|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554676|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153554677|NCT01599000|Lumefantrine|lumefantrine|mesh-list
153554678|NCT01599000|Artemether|artemether|mesh-list
153554679|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153554680|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
153554681|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153554682|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153554683|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554684|NCT01599013|Carboplatin|carboplatin|mesh-list
153554685|NCT01599013|Gemcitabine|gemcitabine|mesh-list
153554712|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554713|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
153554715|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554716|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554717|NCT01599312|Cobalt|cobalt|mesh-list
153393662|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153393663|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
153393697|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393698|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393699|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393700|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153393701|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
153415242|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393702|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393764|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394169|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394170|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394172|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153554718|NCT01599312|Trace Elements|trace elements|mesh-ancestor
153554719|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
153554720|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554721|NCT01599338|Liraglutide|liraglutide|mesh-list
153554722|NCT01599338|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153554723|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153554724|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819122|NCT03125928|Trastuzumab|trastuzumab|mesh-list
153819123|NCT03125928|Atezolizumab|atezolizumab|mesh-list
153819124|NCT03125928|Pertuzumab|pertuzumab|mesh-list
153819125|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153819126|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596515|NCT01862835|Anastrozole|anastrozole|mesh-list
153554725|NCT01599338|Incretins|incretins|mesh-ancestor
153554726|NCT01599338|Hormones|hormones|mesh-ancestor
153554727|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554728|NCT01599364|Ritonavir|ritonavir|mesh-list
153554729|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153554730|NCT01599364|Lamivudine|lamivudine|mesh-list
153554731|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153554732|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153554733|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
153554757|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
153554758|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
153554759|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554760|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554761|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554762|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153554763|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153554764|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
153554765|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554766|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554768|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153554769|NCT05690321|Narcotics|narcotics|mesh-ancestor
153554770|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813193|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813194|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153394181|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153394182|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394183|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153394184|NCT04062097|Vitamin K|vitamin k|mesh-list
153394185|NCT04062097|Dabigatran|dabigatran|mesh-list
153554771|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554773|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
153554774|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554775|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
153554776|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554777|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
153554778|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
153554780|NCT05690191|Lenalidomide|lenalidomide|mesh-list
153554781|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153554782|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554783|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
153554813|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153554814|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596516|NCT01862835|Testosterone|testosterone|mesh-list
153596517|NCT01862835|Estrogens|estrogens|mesh-list
153596518|NCT01862835|Androgens|androgens|mesh-ancestor
153596519|NCT01862835|Hormones|hormones|mesh-ancestor
153596520|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554815|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554816|NCT05689632|Vitamin D|vitamin d|mesh-list
153554817|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
153554818|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
153554819|NCT05689632|Vitamins|vitamins|mesh-list
153782621|NCT00234455|Sirolimus|sirolimus|mesh-list
153554820|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
153554821|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554822|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153554823|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153554824|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
153554825|NCT05689242|Nalbuphine|nalbuphine|mesh-list
153554846|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554847|NCT05688046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153554849|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153554850|NCT05688046|Growth Substances|growth substances|mesh-ancestor
153554851|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554852|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
153554853|NCT05618132|Acetylcholine|acetylcholine|mesh-list
153554854|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
153554855|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153554856|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
153554857|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554858|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554859|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554860|NCT05553808|Docetaxel|docetaxel|mesh-list
153554861|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554862|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
153554863|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
153554864|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
153395219|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395220|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395221|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395222|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395223|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153395224|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395225|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395226|NCT02498483|Acetaminophen|acetaminophen|mesh-list
153395227|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395228|NCT02498483|Analgesics|analgesics|mesh-ancestor
153554865|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554866|NCT05540184|Allopurinol|allopurinol|mesh-list
153554867|NCT05540184|Trimetazidine|trimetazidine|mesh-list
153554869|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554870|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554871|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
153554872|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554873|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153554874|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
153554875|NCT05540184|Protective Agents|protective agents|mesh-ancestor
153554876|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554877|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
153554878|NCT05473195|Isoniazid|isoniazid|mesh-list
153554879|NCT05473195|Ethionamide|ethionamide|mesh-list
153554901|NCT05344911|Narcotics|narcotics|mesh-ancestor
153554902|NCT05344911|Analgesics|analgesics|mesh-ancestor
153554903|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
153554904|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554905|NCT05338021|Vancomycin|vancomycin|mesh-list
153554906|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153554907|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554908|NCT05338008|Vancomycin|vancomycin|mesh-list
153554909|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153554910|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554911|NCT05251376|Morphine|morphine|mesh-list
153554912|NCT05251376|Methadone|methadone|mesh-list
153554913|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153554914|NCT05251376|Narcotics|narcotics|mesh-ancestor
153554915|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554916|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554917|NCT05251376|Analgesics|analgesics|mesh-ancestor
153554918|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
153554919|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554920|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
153554921|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
153554925|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
153554926|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153554927|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554928|NCT04938609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153554929|NCT04938609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554930|NCT04873557|Copper|copper|mesh-list
153554931|NCT04873557|Trace Elements|trace elements|mesh-ancestor
153554932|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
153554933|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554934|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
153596521|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395509|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
153395510|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395558|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395587|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395588|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395589|NCT04477733|Butorphanol|butorphanol|mesh-list
153395590|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153395591|NCT04477733|Narcotics|narcotics|mesh-ancestor
153783604|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395592|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596522|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153554954|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554955|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153554956|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153554957|NCT04753216|Growth Substances|growth substances|mesh-ancestor
153554958|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554959|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
153554960|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
153554961|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153554962|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153554963|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554964|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554966|NCT04714619|Anastrozole|anastrozole|mesh-list
153554967|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554968|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153554969|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153554970|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554971|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554972|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153554973|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
153554974|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554975|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554976|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153554977|NCT04689945|Morphine|morphine|mesh-list
153554978|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153554979|NCT04689945|Narcotics|narcotics|mesh-ancestor
153554980|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554981|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554982|NCT04689945|Analgesics|analgesics|mesh-ancestor
153555026|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
153555027|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153555028|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153555029|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
153555030|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
153555031|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555032|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555033|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
153555034|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555058|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555059|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555060|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555061|NCT03536728|Eflornithine|eflornithine|mesh-list
153555062|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395603|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395636|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
153395637|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153395638|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395639|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153395640|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153395641|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395642|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395643|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395644|NCT01834261|Oxytocin|oxytocin|mesh-list
153555063|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153555064|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153555065|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153555066|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555067|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153555068|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555069|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555070|NCT03517423|Brivaracetam|brivaracetam|mesh-list
153555071|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
153555073|NCT03462251|Bevacizumab|bevacizumab|mesh-list
153555074|NCT03462251|Capecitabine|capecitabine|mesh-list
153555075|NCT03462251|Fulvestrant|fulvestrant|mesh-list
153555076|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153555077|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153596523|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596524|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153596525|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153596526|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596527|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596528|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153596529|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
153596530|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
153596531|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153596532|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596533|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153596534|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153596535|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596536|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596537|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819128|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
153819129|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
153555078|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555079|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
153555080|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
153555081|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
153555099|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153555100|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
153555101|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555102|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555103|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153555104|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153555105|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
153555106|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555107|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555108|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
153555109|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555110|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555111|NCT03272334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555112|NCT03272334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813195|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359691|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153395713|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395714|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153461745|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153395749|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395785|NCT05249153|Narcotics|narcotics|mesh-ancestor
153555113|NCT03258281|Evolocumab|evolocumab|mesh-list
153555114|NCT03258281|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153555115|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153555116|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153555117|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
153782624|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153555118|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555119|NCT03258281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153555120|NCT03258281|Protease Inhibitors|protease inhibitors|mesh-ancestor
153555121|NCT03258281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555122|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153555123|NCT05705388|Liraglutide|liraglutide|mesh-list
153555124|NCT05705388|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153555125|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153555126|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819130|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460516|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460517|NCT02957968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460518|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460519|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
153460520|NCT02889653|Anticoagulants|anticoagulants|mesh-list
153555128|NCT05705388|Hormones|hormones|mesh-ancestor
153555129|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153555130|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
153555131|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153555132|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153555133|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555134|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
153555156|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
153555157|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153555158|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555159|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153555160|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555161|NCT05703997|Atezolizumab|atezolizumab|mesh-list
153555162|NCT05703997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555163|NCT05703997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555164|NCT05703997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555165|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555166|NCT05703984|Metformin|metformin|mesh-list
153555167|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153555168|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555170|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153555171|NCT05702190|Narcotics|narcotics|mesh-ancestor
153555172|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555173|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555174|NCT05702190|Analgesics|analgesics|mesh-ancestor
153555175|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
153555176|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555177|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
153555178|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153555179|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
153555180|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
153555182|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153555186|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
153555187|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555188|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
153555189|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
153782625|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555215|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555216|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555217|NCT05030506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555218|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555219|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555220|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555222|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153555223|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
153555224|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555225|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555226|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
153555227|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
153555228|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153555229|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153555230|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
153555231|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555232|NCT04764643|Expectorants|expectorants|mesh-ancestor
153555233|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
153555248|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555250|NCT04077515|Temsirolimus|temsirolimus|mesh-list
153555251|NCT04077515|MTOR Inhibitors|mtor inhibitors|mesh-list
153555252|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153555253|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555264|NCT03841110|Aldesleukin|aldesleukin|mesh-list
153555272|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555273|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555274|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153555275|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
153555276|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555277|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555278|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153555279|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555280|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555281|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153359703|NCT04332211|Ephedrine|ephedrine|mesh-list
153555282|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153555283|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
153555284|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555285|NCT03810313|Aflibercept|aflibercept|mesh-list
153555286|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153555287|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555288|NCT03810313|Growth Substances|growth substances|mesh-ancestor
153555289|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555290|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
153555291|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555292|NCT03802630|Aflibercept|aflibercept|mesh-list
153555293|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153731941|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153731942|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
153373609|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555294|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555333|NCT03624127|Apremilast|apremilast|mesh-list
153555337|NCT03624127|Analgesics|analgesics|mesh-ancestor
153782629|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153555338|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
153555339|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555340|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782630|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
153555341|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153555342|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555343|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153555344|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153555345|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555346|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555347|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
153555348|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555349|NCT03499899|Carboplatin|carboplatin|mesh-list
153555365|NCT03430700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555366|NCT03430700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555368|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153555369|NCT03106454|Norethindrone|norethindrone|mesh-list
153555370|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
153555371|NCT03106454|Estradiol|estradiol|mesh-list
153555372|NCT03106454|Estrogens|estrogens|mesh-ancestor
153555373|NCT03106454|Hormones|hormones|mesh-ancestor
153555374|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153555375|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460521|NCT02819518|Paclitaxel|paclitaxel|mesh-list
153460522|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153460523|NCT02819518|Carboplatin|carboplatin|mesh-list
153460524|NCT02819518|Gemcitabine|gemcitabine|mesh-list
153460525|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
153359710|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
153359711|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153359712|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153359713|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
153460526|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460527|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460528|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460529|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460530|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460531|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460532|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460533|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
153460534|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460535|NCT02819518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460536|NCT02718066|Nivolumab|nivolumab|mesh-list
153460537|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555376|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153555377|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
153555378|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153555379|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153555380|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153555381|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153555382|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153555383|NCT03106454|Trace Elements|trace elements|mesh-ancestor
153555384|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
153555386|NCT02990806|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153555387|NCT02990806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153555388|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
153555389|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153555390|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555391|NCT02420821|Bevacizumab|bevacizumab|mesh-list
153555392|NCT02420821|Atezolizumab|atezolizumab|mesh-list
153555393|NCT02420821|Sunitinib|sunitinib|mesh-list
153555394|NCT02420821|Antibodies|antibodies|mesh-list
153555395|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153555396|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555397|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555398|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153555399|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555400|NCT02420821|Growth Substances|growth substances|mesh-ancestor
153555401|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555402|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
153813196|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813197|NCT00431769|Bortezomib|bortezomib|mesh-list
153813198|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813199|NCT00332852|Letrozole|letrozole|mesh-list
153813200|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813201|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153396255|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153396256|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396257|NCT00551161|Memantine|memantine|mesh-list
153555403|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
153555404|NCT02420821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555405|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555406|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555407|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555408|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
153555428|NCT01970410|Teriflunomide|teriflunomide|mesh-list
153555430|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153555435|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153555436|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555437|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153555438|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
153555440|NCT01746173|Prednisone|prednisone|mesh-list
153555441|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
153555442|NCT01746173|Melphalan|melphalan|mesh-list
153555443|NCT01746173|Busulfan|busulfan|mesh-list
153555444|NCT01746173|Gemcitabine|gemcitabine|mesh-list
153555445|NCT01746173|Doxorubicin|doxorubicin|mesh-list
153555446|NCT01746173|Etoposide|etoposide|mesh-list
153555447|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
153555448|NCT01746173|Vincristine|vincristine|mesh-list
153555449|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153555450|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
153555451|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555452|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555453|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153555454|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
153555455|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555456|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555457|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153555458|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153555459|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
153555460|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153555461|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153555462|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153555463|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555464|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153555501|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555502|NCT03187769|Olanzapine|olanzapine|mesh-list
153555503|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
153555504|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
153555505|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555506|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555507|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153555509|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153555510|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555511|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153555512|NCT03187769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153555513|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153555514|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153555515|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555516|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555517|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
153555518|NCT03136731|Antibodies|antibodies|mesh-list
153555519|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
153555539|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153555540|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153555541|NCT02829931|Bevacizumab|bevacizumab|mesh-list
153555542|NCT02829931|Nivolumab|nivolumab|mesh-list
153555543|NCT02829931|Ipilimumab|ipilimumab|mesh-list
153555544|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555545|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555546|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153555547|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555548|NCT02829931|Growth Substances|growth substances|mesh-ancestor
153555549|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555550|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
153555551|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555552|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555553|NCT02815566|Tenofovir|tenofovir|mesh-list
153555554|NCT02815566|Emtricitabine|emtricitabine|mesh-list
153555560|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555562|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153555564|NCT02702492|Nivolumab|nivolumab|mesh-list
153555565|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555566|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555567|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555568|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555569|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153555570|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
153555571|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153555572|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
153555573|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
153555574|NCT02702492|Vitamins|vitamins|mesh-ancestor
153555589|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153555590|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
153555591|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555592|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555593|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153555594|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555595|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555596|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153555597|NCT02652455|Analgesics|analgesics|mesh-ancestor
153555598|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
153813209|NCT00332891|Amibegron|amibegron|mesh-list
153555599|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555600|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153460538|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460545|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460546|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
153596538|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
153596539|NCT01862926|Rituximab|rituximab|mesh-list
153596540|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596541|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
153596542|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596543|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596544|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153596545|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
153596546|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596547|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596548|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153596549|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153596550|NCT01862978|Heparin|heparin|mesh-list
153596551|NCT01862978|Nadroparin|nadroparin|mesh-list
153596552|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
153596553|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153596554|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153596555|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555601|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153555602|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
153555603|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555604|NCT02491983|Letrozole|letrozole|mesh-list
153555605|NCT02491983|Fulvestrant|fulvestrant|mesh-list
153555606|NCT02491983|Palbociclib|palbociclib|mesh-list
153555607|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555608|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153555609|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153555610|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555611|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555612|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153555613|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
153555614|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153731943|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373685|NCT03206151|Vitamins|vitamins|mesh-ancestor
153555615|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555616|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153555617|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153555618|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555619|NCT02467478|Linagliptin|linagliptin|mesh-list
153555620|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153555621|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555622|NCT02467478|Incretins|incretins|mesh-ancestor
153555623|NCT02467478|Hormones|hormones|mesh-ancestor
153396724|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396725|NCT00422435|Paclitaxel|paclitaxel|mesh-list
153396726|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153396727|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396728|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
153396729|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
153396730|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
153396731|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555624|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153555625|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153555626|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
153555664|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555665|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555666|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
153555667|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153555668|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153555669|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555670|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
153555671|NCT01599468|Coagulants|coagulants|mesh-ancestor
153555673|NCT01599572|Trace Elements|trace elements|mesh-ancestor
153555674|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
153555675|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555676|NCT01599598|Imidacloprid|imidacloprid|mesh-list
153555677|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
153555678|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555679|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555680|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555681|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153555682|NCT01599702|Hematinics|hematinics|mesh-ancestor
153555683|NCT01599728|Substance P|substance p|mesh-list
153555684|NCT01599728|Neurokinin A|neurokinin a|mesh-list
153555685|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555686|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555687|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555688|NCT01599819|Factor VIII|factor viii|mesh-list
153555718|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153555719|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
153555720|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555721|NCT01599884|Protective Agents|protective agents|mesh-ancestor
153555722|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555723|NCT01599884|Antidotes|antidotes|mesh-ancestor
153555724|NCT01599923|Antivenins|antivenins|mesh-list
153555725|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
153555726|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596556|NCT01863004|Bortezomib|bortezomib|mesh-list
153596557|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596558|NCT01863069|Interferons|interferons|mesh-list
153596559|NCT01863069|Interferon-beta|interferon-beta|mesh-list
153596564|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
153399258|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
153399259|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
153399260|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153399261|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399262|NCT03012191|Gentamicins|gentamicins|mesh-list
153399263|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153399264|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399265|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153399266|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399267|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399268|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
153399269|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
153399270|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596565|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596566|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153555728|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
153555729|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555730|NCT01599949|Ibrutinib|ibrutinib|mesh-list
153555731|NCT01599949|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153555732|NCT01599949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555753|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555756|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
153555757|NCT01600430|Vitamins|vitamins|mesh-list
153555758|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
153555759|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555760|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153555761|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153555762|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
153555763|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153555764|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153555765|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555766|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
153555768|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
153555769|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
153555770|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153555771|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153555772|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555773|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555774|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555775|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555776|NCT01602029|Ondansetron|ondansetron|mesh-list
153555777|NCT01602029|Simvastatin|simvastatin|mesh-list
153555778|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153555779|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153555780|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
153596567|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153596568|NCT01863147|Acarbose|acarbose|mesh-list
153596569|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153596570|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596571|NCT01863147|Incretins|incretins|mesh-ancestor
153596572|NCT01863147|Hormones|hormones|mesh-ancestor
153596575|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
153596578|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153596580|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153596581|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153596582|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
153596583|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
153596584|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555781|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555782|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153555783|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153555784|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399475|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555811|NCT01602887|Palbociclib|palbociclib|mesh-list
153399477|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153399478|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399789|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153399790|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153399791|NCT02944565|Daratumumab|daratumumab|mesh-list
153399792|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399793|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153399794|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153399795|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153399796|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
153555812|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555813|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555814|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555815|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555816|NCT01603264|Trastuzumab|trastuzumab|mesh-list
153555817|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555818|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555819|NCT01603680|Anesthetics|anesthetics|mesh-list
153555820|NCT01603680|Mepivacaine|mepivacaine|mesh-list
153555821|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
153555822|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555823|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555824|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
153555825|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555827|NCT01604213|Vildagliptin|vildagliptin|mesh-list
153555828|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153555829|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555852|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
153555853|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
153555854|NCT01605279|Dobutamine|dobutamine|mesh-list
153555855|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153555856|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
153555857|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
153555858|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555859|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555860|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153596585|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596586|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153596587|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153596588|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153596589|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
153596590|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596591|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596592|NCT01863199|Ranibizumab|ranibizumab|mesh-list
153596593|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153596594|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555863|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
153555864|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555865|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555866|NCT01605279|Protective Agents|protective agents|mesh-ancestor
153555867|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153555868|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
153555869|NCT01606072|Coagulants|coagulants|mesh-ancestor
153555870|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153555871|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
153820713|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
153820714|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400191|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400192|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153400193|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153400194|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153400195|NCT02061397|Sirolimus|sirolimus|mesh-list
153400196|NCT02061397|Everolimus|everolimus|mesh-list
153400197|NCT02061397|Simvastatin|simvastatin|mesh-list
153400412|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
153555872|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555873|NCT01606722|Ritonavir|ritonavir|mesh-list
153555874|NCT01606722|Darunavir|darunavir|mesh-list
153555875|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153731944|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153373739|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
153555876|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153555877|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
153555878|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555879|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555880|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153555881|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153555882|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
153555903|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153555904|NCT01608217|Analgesics|analgesics|mesh-ancestor
153555905|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
153555906|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555907|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555908|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
153555909|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
153555910|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153555911|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153555912|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153555913|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555914|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596595|NCT01863199|Growth Substances|growth substances|mesh-ancestor
153596596|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555916|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153555917|NCT01608594|Ipilimumab|ipilimumab|mesh-list
153555918|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555919|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555920|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555921|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555922|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153555923|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555924|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
153555925|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
153555926|NCT01608958|Oxytocin|oxytocin|mesh-list
153555927|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
153555928|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153555929|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555930|NCT01609153|Olanzapine|olanzapine|mesh-list
153555931|NCT01609153|Amisulpride|amisulpride|mesh-list
153555932|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
153555933|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
153555934|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400585|NCT02046200|Ethanol|ethanol|mesh-list
153400587|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153400588|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400702|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
153400703|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400704|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400705|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400706|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153400707|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153400708|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400710|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153555935|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555936|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153555965|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
153555966|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555967|NCT01610401|Metformin|metformin|mesh-list
153555968|NCT01610401|Caffeine|caffeine|mesh-list
153555969|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153555970|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555971|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153555972|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153555973|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555974|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555975|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153555976|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153555977|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
153555978|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555979|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
153555982|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153555983|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
153555996|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153555997|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
153555998|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
153555999|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556000|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556002|NCT01610934|Glimepiride|glimepiride|mesh-list
153556003|NCT01610934|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153556004|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556005|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556006|NCT01610934|Incretins|incretins|mesh-ancestor
153556007|NCT01610934|Hormones|hormones|mesh-ancestor
153556008|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556010|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153556011|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
153556012|NCT01610947|Adalimumab|adalimumab|mesh-list
153556013|NCT01610947|Infliximab|infliximab|mesh-list
153556014|NCT01610947|Golimumab|golimumab|mesh-list
153556015|NCT01610947|Etanercept|etanercept|mesh-list
153556016|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153556017|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153556018|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556019|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153556020|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
153556021|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153556022|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153556023|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153556024|NCT01610947|Analgesics|analgesics|mesh-ancestor
153556025|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
153556026|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556027|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556028|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153556029|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
153556030|NCT01610999|Plerixafor|plerixafor|mesh-list
153556031|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153556032|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153400717|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400718|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153400719|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400720|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153400721|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153400722|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400723|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153400724|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153556036|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153556037|NCT01611038|Protective Agents|protective agents|mesh-ancestor
153556038|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556039|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556040|NCT01611077|Amlodipine|amlodipine|mesh-list
153556041|NCT01611077|Candesartan|candesartan|mesh-list
153556042|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
153556043|NCT01611077|Olmesartan|olmesartan|mesh-list
153556044|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153556045|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153556046|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153556047|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153556048|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556062|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556063|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556064|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153556065|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153556066|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
153556067|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556068|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153556069|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
153556070|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
153556071|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
153556072|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153556073|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
153556074|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
153556075|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556076|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
153556077|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
153556078|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153556079|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556080|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153411009|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153596597|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
153596598|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596599|NCT01863225|Atorvastatin|atorvastatin|mesh-list
153596600|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153556081|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556083|NCT01611415|Furosemide|furosemide|mesh-list
153556084|NCT01611415|Diuretics|diuretics|mesh-ancestor
153556085|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
153556086|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556087|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153556088|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153556089|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813218|NCT00332930|Interferons|interferons|mesh-list
153813219|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
153403479|NCT03677973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403480|NCT03677973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403482|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153403483|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
153556090|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153556091|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556092|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
153556093|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153556094|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556095|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556096|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556098|NCT01611480|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153556099|NCT01611480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556100|NCT01611480|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153556101|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
153556102|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556103|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153556104|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556105|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
153556106|NCT01611506|Capecitabine|capecitabine|mesh-list
153556107|NCT01611506|Cetuximab|cetuximab|mesh-list
153556122|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153556123|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
153556124|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556125|NCT01611727|Cisplatin|cisplatin|mesh-list
153556126|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556127|NCT01611896|Selenium|selenium|mesh-list
153556128|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
153556129|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556135|NCT01611909|Expectorants|expectorants|mesh-ancestor
153556136|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
153556137|NCT01611961|Docetaxel|docetaxel|mesh-list
153556138|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556139|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
153556140|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
153556141|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
153556142|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556143|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153556144|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556145|NCT01612065|Misoprostol|misoprostol|mesh-list
153556146|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153556147|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
153556148|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153556149|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556150|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153556151|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153556152|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
153556153|NCT01612078|Droxidopa|droxidopa|mesh-list
153556154|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153556155|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153556156|NCT01612247|Aspirin|aspirin|mesh-list
153556157|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
153556158|NCT01612247|Methotrexate|methotrexate|mesh-list
153556159|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153556160|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
153556161|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556162|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411043|NCT00003633|Hormones|hormones|mesh-ancestor
153596601|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153596602|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153460547|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460548|NCT02505750|Capecitabine|capecitabine|mesh-list
153460549|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460550|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
153819131|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153813220|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813221|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
153813222|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813223|NCT00332969|Octreotide|octreotide|mesh-list
153403501|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153403502|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153819132|NCT03125928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153819133|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
153819134|NCT03113487|Vaccines|vaccines|mesh-list
153819135|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
153819136|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819137|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819138|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819139|NCT03113487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153819140|NCT03113487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819141|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
153556163|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153556164|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
153556165|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556166|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556167|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153556191|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153556192|NCT01612273|Analgesics|analgesics|mesh-ancestor
153556193|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
153556194|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556195|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556196|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556197|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153556198|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153556199|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153556200|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556201|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153556202|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153556203|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556204|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
153556205|NCT01612286|Endostatins|endostatins|mesh-list
153556206|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153556207|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153556208|NCT01612286|Growth Substances|growth substances|mesh-ancestor
153731945|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153556209|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556210|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
153556211|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556212|NCT01612299|Everolimus|everolimus|mesh-list
153556213|NCT01612299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153556214|NCT01612299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153556215|NCT01612299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819142|NCT03103971|Fludarabine|fludarabine|mesh-list
153819143|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819144|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
153819145|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596603|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
153596604|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596605|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153596606|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153596607|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596608|NCT01863238|Ivacaftor|ivacaftor|mesh-list
153596609|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153596610|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153556216|NCT01612299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556243|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556244|NCT01612468|Incretins|incretins|mesh-ancestor
153556246|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556247|NCT01612507|Ceftaroline|ceftaroline|mesh-list
153556248|NCT01612507|Cephalosporins|cephalosporins|mesh-list
153556249|NCT01612507|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153556250|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153556251|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556252|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153556253|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153556254|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556255|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556256|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153556257|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
153556258|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556259|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556260|NCT01612741|Acarbose|acarbose|mesh-list
153556261|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153556262|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556263|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556264|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556265|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556283|NCT01612871|Exemestane|exemestane|mesh-list
153556284|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556285|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153556286|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153556287|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556288|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596611|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596612|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153596613|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153596614|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153596615|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596617|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
153596618|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596619|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596620|NCT01863277|Melatonin|melatonin|mesh-list
153556289|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153556290|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
153556291|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556292|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556293|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153556294|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153556295|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153556296|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153556297|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153556298|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153556299|NCT01612910|Protective Agents|protective agents|mesh-ancestor
153556300|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556301|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556302|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153556303|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153556304|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556305|NCT01612975|Naproxen|naproxen|mesh-list
153556306|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153556308|NCT01612975|Analgesics|analgesics|mesh-ancestor
153556309|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
153556310|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556311|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556312|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556313|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407573|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407574|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153407575|NCT00070291|Cyclosporine|cyclosporine|mesh-list
153407576|NCT00070291|Cyclosporins|cyclosporins|mesh-list
153407577|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408288|NCT03952130|Insulin|insulin|mesh-list
153556314|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
153556315|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153870473|NCT00590603|Bortezomib|bortezomib|mesh-list
153870474|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
153596621|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
153596622|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596623|NCT01863277|Protective Agents|protective agents|mesh-ancestor
153596624|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596625|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819146|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819147|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153819148|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
153819149|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819150|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819151|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153819158|NCT03033225|Verteporfin|verteporfin|mesh-list
153819159|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153819160|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
153819161|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
153819162|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
153556317|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556318|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
153556319|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153556320|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153556321|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556352|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153556353|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
153556354|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153556355|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153556356|NCT01613092|Vancomycin|vancomycin|mesh-list
153556357|NCT01613092|Clindamycin|clindamycin|mesh-list
153556358|NCT01613092|Cefazolin|cefazolin|mesh-list
153556359|NCT01613092|Cephalexin|cephalexin|mesh-list
153556360|NCT01613092|Bacitracin|bacitracin|mesh-list
153556361|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153556362|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556363|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153556364|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556379|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
153556380|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556381|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
153556382|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556383|NCT01613209|Candesartan|candesartan|mesh-list
153556384|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
153556386|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153556387|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153556388|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153556389|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556390|NCT01613300|Ofatumumab|ofatumumab|mesh-list
153819163|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153819164|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153460551|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460552|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460553|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
153460554|NCT02413736|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153460555|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460556|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460557|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460558|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460559|NCT02407119|Amoxicillin|amoxicillin|mesh-list
153460560|NCT02407119|Clarithromycin|clarithromycin|mesh-list
153460561|NCT02407119|Omeprazole|omeprazole|mesh-list
153556391|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556392|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
153556393|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153556394|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153556395|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556396|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
153556397|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
153556398|NCT01613469|Leucovorin|leucovorin|mesh-list
153556399|NCT01613469|Antidotes|antidotes|mesh-ancestor
153556400|NCT01613469|Protective Agents|protective agents|mesh-ancestor
153556401|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556402|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
153556403|NCT01613469|Vitamins|vitamins|mesh-ancestor
153556404|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
153556405|NCT01613482|Trastuzumab|trastuzumab|mesh-list
153556406|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153556407|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556408|NCT01613534|Sucralfate|sucralfate|mesh-list
153556461|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
153556462|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
153556463|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556464|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153556465|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153556466|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556467|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556468|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153556469|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
153556470|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
153556471|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153556472|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
153556473|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153556474|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
153556475|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153556476|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
153556478|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556479|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153556480|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556481|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556482|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153556483|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153556484|NCT01613963|Cyclosporine|cyclosporine|mesh-list
153556485|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
153556486|NCT01613963|Prednisolone|prednisolone|mesh-list
153556487|NCT01613963|Adalimumab|adalimumab|mesh-list
153556488|NCT01613963|Infliximab|infliximab|mesh-list
153556489|NCT01613963|Etanercept|etanercept|mesh-list
153556490|NCT01613963|Methotrexate|methotrexate|mesh-list
153556491|NCT01613963|Azathioprine|azathioprine|mesh-list
153556492|NCT01613963|Cyclosporins|cyclosporins|mesh-list
153556493|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153556494|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556530|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596626|NCT01863355|Fentanyl|fentanyl|mesh-list
153596627|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153596628|NCT01863355|Narcotics|narcotics|mesh-ancestor
153596629|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596630|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596631|NCT01863355|Analgesics|analgesics|mesh-ancestor
153596632|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
153596633|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596634|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153596635|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153870520|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556531|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556532|NCT01614041|Tandospirone|tandospirone|mesh-list
153556563|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
153556564|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153556565|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153409960|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556566|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556567|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153556568|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153556569|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153556570|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556571|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153556572|NCT01614301|Pioglitazone|pioglitazone|mesh-list
153556573|NCT01614301|Sirolimus|sirolimus|mesh-list
153556574|NCT01614301|Etoricoxib|etoricoxib|mesh-list
153556575|NCT01614301|Temsirolimus|temsirolimus|mesh-list
153556576|NCT01614301|MTOR Inhibitors|mtor inhibitors|mesh-list
153556606|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556607|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153556608|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556611|NCT01614405|Lopinavir|lopinavir|mesh-list
153556612|NCT01614405|Tenofovir|tenofovir|mesh-list
153556613|NCT01614405|Emtricitabine|emtricitabine|mesh-list
153556614|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153556615|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153556616|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153556617|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
153556618|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556619|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556644|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153556645|NCT01614535|Narcotics|narcotics|mesh-ancestor
153556646|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556647|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556648|NCT01614535|Analgesics|analgesics|mesh-ancestor
153596636|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
153596637|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
153596638|NCT01863407|Metronidazole|metronidazole|mesh-list
153596639|NCT01863407|Dexamethasone|dexamethasone|mesh-list
153596640|NCT01863407|Allantoin|allantoin|mesh-list
153596641|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556649|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
153556650|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556651|NCT01614938|Cisplatin|cisplatin|mesh-list
153556652|NCT01614938|Docetaxel|docetaxel|mesh-list
153556653|NCT01614938|Cetuximab|cetuximab|mesh-list
153556654|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556655|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
153556656|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
153556657|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
153556658|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556659|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153820715|NCT01050257|Oseltamivir|oseltamivir|mesh-list
153411788|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411789|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411790|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
153411791|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153556660|NCT01614964|Lumefantrine|lumefantrine|mesh-list
153556661|NCT01614964|Artemether|artemether|mesh-list
153556662|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153556663|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
153556664|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153556665|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153556666|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556667|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153556668|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153556669|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153556670|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
153556671|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556691|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
153556692|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556693|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153556694|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
153556695|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153556696|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153556697|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153556698|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556699|NCT01615081|Insulin|insulin|mesh-list
153556700|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556701|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556702|NCT01615107|Oxytocin|oxytocin|mesh-list
153556703|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
153556704|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153596642|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
153556706|NCT01615185|Amisulpride|amisulpride|mesh-list
153556707|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153556708|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153556709|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556710|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556711|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153556712|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153556713|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
153556714|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556715|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556716|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153556717|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
153556718|NCT01615211|Letrozole|letrozole|mesh-list
153556719|NCT01615211|Trilostane|trilostane|mesh-list
153556720|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556721|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153556722|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153556723|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556724|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556725|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153556726|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
153556744|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
153556745|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153556746|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556747|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153556748|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153556749|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153556750|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153556751|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153556752|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153556756|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
153556770|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153556771|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153556772|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153556773|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
153556774|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556775|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556776|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153556777|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
153556804|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
153556805|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556806|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153556807|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
153556808|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556809|NCT01615796|Gepotidacin|gepotidacin|mesh-list
153556810|NCT01615796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153556811|NCT01615796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556812|NCT01615796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556813|NCT01615796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556815|NCT01615913|Terbinafine|terbinafine|mesh-list
153556816|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
153556817|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556818|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153556819|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153556820|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556821|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556822|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153556849|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556850|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556851|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556852|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153556853|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153596643|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
153596644|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596645|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596646|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596647|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
153596648|NCT01863407|Hormones|hormones|mesh-ancestor
153596649|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153596650|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153556855|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556856|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153556857|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
153556858|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
153556859|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
153556860|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153556861|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153556862|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
153556863|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153556864|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153556865|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556866|NCT01616069|Protective Agents|protective agents|mesh-ancestor
153556896|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
153556897|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
153556898|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153556899|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153556900|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813224|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413548|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153413549|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
153413550|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
153413551|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153556901|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556902|NCT01616381|Urological Agents|urological agents|mesh-ancestor
153556903|NCT01616407|Methylphenidate|methylphenidate|mesh-list
153556904|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153556905|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153556906|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556907|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153556908|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153556932|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556933|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556934|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153556935|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153556936|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153556937|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596651|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596652|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596653|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153596654|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153596655|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153596656|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
153596657|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153596658|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153460562|NCT02407119|Rabeprazole|rabeprazole|mesh-list
153556938|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153556939|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153556940|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556942|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153556943|NCT01616680|Antibodies|antibodies|mesh-list
153556944|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
153556945|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153556946|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
153556947|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
153556948|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556949|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153556950|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556951|NCT01616680|Immunotoxins|immunotoxins|mesh-ancestor
153556952|NCT01616732|Testosterone|testosterone|mesh-list
153556953|NCT01616732|Androgens|androgens|mesh-ancestor
153556954|NCT01616732|Hormones|hormones|mesh-ancestor
153556955|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556956|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556957|NCT01616784|Insulin|insulin|mesh-list
153556958|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153556959|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
153556960|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556985|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556986|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153556988|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
153556989|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153556990|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153556991|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153556992|NCT01616966|Narcotics|narcotics|mesh-ancestor
153556993|NCT01616966|Analgesics|analgesics|mesh-ancestor
153556994|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
153556995|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556996|NCT01616992|Bupivacaine|bupivacaine|mesh-list
153556997|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
153556998|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
153556999|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557000|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557003|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
153557004|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153557005|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557007|NCT01617135|Carbidopa|carbidopa|mesh-list
153413779|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
153557008|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153557009|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153557010|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153557011|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
153557039|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
153557040|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782638|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153557041|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153557042|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153782639|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153557043|NCT01617213|Growth Substances|growth substances|mesh-ancestor
153557044|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
153557045|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557046|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153557047|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
153557048|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557049|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153557050|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557051|NCT01617226|Azacitidine|azacitidine|mesh-list
153557052|NCT01617226|Vorinostat|vorinostat|mesh-list
153557053|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460563|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153460564|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153460565|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414252|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414253|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153414356|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153414365|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
153460566|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153460567|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153819165|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819166|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819167|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819168|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596659|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596660|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153596661|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153596662|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596663|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596665|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596666|NCT01863485|Vorolanib|vorolanib|mesh-list
153596667|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153596668|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596669|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596670|NCT01863511|Tolvaptan|tolvaptan|mesh-list
153596671|NCT01863511|Diuretics|diuretics|mesh-list
153596672|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153596673|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
153557054|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
153387594|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153557072|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557073|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153557074|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153557076|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557077|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557078|NCT01617538|Atorvastatin|atorvastatin|mesh-list
153557079|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153557080|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153557081|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
153557082|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557083|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153557084|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153557085|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557086|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153557087|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557088|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557089|NCT01617564|Bupivacaine|bupivacaine|mesh-list
153557090|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
153557091|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
153359721|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
153359722|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557092|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557093|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557094|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
153557095|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557096|NCT01617590|Methotrexate|methotrexate|mesh-list
153557097|NCT01617590|Leflunomide|leflunomide|mesh-list
153870585|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596674|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596675|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153596676|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596677|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596678|NCT01863589|Adefovir|adefovir|mesh-list
153596679|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
153596680|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596681|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153596682|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153596683|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819170|NCT03011567|Ibuprofen|ibuprofen|mesh-list
153819171|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153819172|NCT03011567|Analgesics|analgesics|mesh-ancestor
153557099|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
153557100|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153557101|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557102|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153557103|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
153557104|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557105|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557106|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
153557107|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557108|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153557109|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557127|NCT01617707|Midazolam|midazolam|mesh-list
153557128|NCT01617707|Propofol|propofol|mesh-list
153557129|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153557130|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557131|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557132|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153557133|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
153557134|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
153557135|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153414487|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
153414516|NCT05249023|Butyric Acid|butyric acid|mesh-list
153557136|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153557137|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153819174|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819175|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819177|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153819178|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153819179|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819180|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153819181|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819182|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819183|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
153819184|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
153819185|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
153819186|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819187|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819188|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819189|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153819190|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
153596684|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596686|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
153596687|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153596688|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596689|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596690|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153596691|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596692|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153596693|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153557139|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
153557140|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
153557141|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557142|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557143|NCT01617733|Pasireotide|pasireotide|mesh-list
153813227|NCT00333008|Prednisone|prednisone|mesh-list
153813228|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
153414541|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
153414916|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414918|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153414919|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
153414920|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414921|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
153414922|NCT02608489|Protective Agents|protective agents|mesh-ancestor
153414923|NCT02611765|Penicillins|penicillins|mesh-list
153557145|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557146|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557147|NCT01617746|Bosentan|bosentan|mesh-list
153557148|NCT01617746|Ambrisentan|ambrisentan|mesh-list
153557149|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153557150|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153557151|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557152|NCT01617772|Atorvastatin|atorvastatin|mesh-list
153557153|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153557154|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153557155|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
153557156|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557157|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153557158|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153557159|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557160|NCT01617798|Metolazone|metolazone|mesh-list
153557161|NCT01617798|Furosemide|furosemide|mesh-list
153557162|NCT01617798|Diuretics|diuretics|mesh-ancestor
153557175|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557177|NCT01617824|Hormones|hormones|mesh-ancestor
153731947|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
153731948|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596694|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596695|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153596696|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153596697|NCT01863615|Isotretinoin|isotretinoin|mesh-list
153596698|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
153596699|NCT01863641|Calcitriol|calcitriol|mesh-list
153596700|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153596701|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596702|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153596703|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596704|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596705|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153596707|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
153889211|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
153416041|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
153416042|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153416043|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
153416044|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153416045|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
153416046|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
153416047|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416048|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153416049|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153416050|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153416051|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153416053|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153416054|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153416055|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
153596708|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153596711|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
153557178|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557179|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153557180|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
153557181|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557182|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557183|NCT01617928|Paclitaxel|paclitaxel|mesh-list
153557184|NCT01617928|Carboplatin|carboplatin|mesh-list
153557185|NCT01617928|Veliparib|veliparib|mesh-list
153557186|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153557187|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557188|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
153557189|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
153557190|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
153557191|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557192|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153557193|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557194|NCT01618006|Aspirin|aspirin|mesh-list
153557195|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153557196|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153557197|NCT01618006|Analgesics|analgesics|mesh-ancestor
153557198|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
153557199|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557200|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557201|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557202|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153557203|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153557204|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153557205|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557206|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153557207|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153557208|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557210|NCT01618253|Sorafenib|sorafenib|mesh-list
153557218|NCT01618396|Propofol|propofol|mesh-list
153557219|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153557220|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557221|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557241|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153557242|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557243|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
153557244|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557245|NCT01618474|Docetaxel|docetaxel|mesh-list
153557246|NCT01618474|Capecitabine|capecitabine|mesh-list
153557247|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557248|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
153557249|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
153557250|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
153557251|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557252|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153557253|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
153557254|NCT01618513|Octreotide|octreotide|mesh-list
153557255|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153557256|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153557257|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782642|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557258|NCT01618539|Propofol|propofol|mesh-list
153557259|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153557260|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557261|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557262|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153557263|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
153557264|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
153813229|NCT00333008|Rituximab|rituximab|mesh-list
153416134|NCT00368576|Darapladib|darapladib|mesh-list
153557265|NCT01618591|Azithromycin|azithromycin|mesh-list
153557266|NCT01618591|Levofloxacin|levofloxacin|mesh-list
153557267|NCT01618591|Rifaximin|rifaximin|mesh-list
153557268|NCT01618591|Loperamide|loperamide|mesh-list
153557269|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
153557270|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153557271|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557272|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153596712|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153596713|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
153557274|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153557275|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557276|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557277|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557278|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153557301|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153557302|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
153557304|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153557305|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
153557306|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153557307|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153557308|NCT01618773|Analgesics|analgesics|mesh-ancestor
153557309|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
153557310|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557311|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557312|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557313|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153557314|NCT01618799|Lamotrigine|lamotrigine|mesh-list
153557315|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
153557316|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153557317|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557318|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557319|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153870660|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
153596714|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781718|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596715|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819191|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819192|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596716|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153596717|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153596718|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596719|NCT01863706|Misoprostol|misoprostol|mesh-list
153596720|NCT01863706|Oxytocin|oxytocin|mesh-list
153596721|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
153596722|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153417230|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417299|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153596723|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596724|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153596725|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
153596726|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153596727|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596728|NCT01863719|Colistin|colistin|mesh-list
153557320|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557321|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153557322|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153557323|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557324|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557325|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153557326|NCT01618825|Lamotrigine|lamotrigine|mesh-list
153557327|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
153557328|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153557329|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557330|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557356|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
153557357|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153557358|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
153557359|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557360|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557361|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153557362|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153557363|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557364|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
153557365|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153557452|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557453|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557454|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557456|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
153557457|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557458|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
153557459|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557460|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
153557461|NCT01619644|Valproic Acid|valproic acid|mesh-list
153557462|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
153557463|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557464|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557465|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
153557466|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557467|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557468|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
153557469|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153557470|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557471|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557472|NCT01619683|Enclomiphene|enclomiphene|mesh-list
153557498|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557499|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
153417448|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153557500|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557501|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153557502|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153557503|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
153870680|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
153596729|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153596730|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596731|NCT01863810|Pregabalin|pregabalin|mesh-list
153596732|NCT01863810|Analgesics|analgesics|mesh-ancestor
153596733|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
153596734|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596735|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596736|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
153596737|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153596738|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596739|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596740|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153596741|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153596742|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153596743|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596744|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153596745|NCT01863823|Amoxicillin|amoxicillin|mesh-list
153596746|NCT01863823|Tetracycline|tetracycline|mesh-list
153596747|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153596748|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557504|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557505|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557506|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153557507|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153557508|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
153557509|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153557510|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557511|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153557512|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153557513|NCT01619761|Growth Substances|growth substances|mesh-ancestor
153557514|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
153557515|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153557516|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153889227|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889228|NCT01288443|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153417577|NCT04336891|Androgens|androgens|mesh-ancestor
153557517|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
153557518|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153557519|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557520|NCT01619891|Vitamin D|vitamin d|mesh-list
153557521|NCT01619891|Vitamins|vitamins|mesh-ancestor
153557522|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
153557523|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557524|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153557525|NCT01620112|Lidocaine|lidocaine|mesh-list
153557526|NCT01620112|Clonidine|clonidine|mesh-list
153557527|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
153557543|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153557545|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
153557546|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557547|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153557548|NCT01620229|Antibodies|antibodies|mesh-list
153557549|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
153557550|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153557551|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
153557552|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
153557553|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557554|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153557555|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596749|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153596750|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596751|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596753|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
153557556|NCT01620229|Immunotoxins|immunotoxins|mesh-ancestor
153557557|NCT01620268|Leflunomide|leflunomide|mesh-list
153557558|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557559|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557560|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557561|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
153418878|NCT05829148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153418907|NCT05828199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153557562|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557564|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153557565|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557566|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153557567|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557568|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
153557569|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557570|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
153557571|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557572|NCT01620320|Dobutamine|dobutamine|mesh-list
153557573|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153557574|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
153557575|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
153557576|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557577|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557578|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153557579|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153557580|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153557581|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
153557582|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596754|NCT01863888|Charcoal|charcoal|mesh-list
153596755|NCT01863888|Antidotes|antidotes|mesh-ancestor
153596756|NCT01863888|Protective Agents|protective agents|mesh-ancestor
153596757|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596758|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153596759|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153596760|NCT01863888|Analgesics|analgesics|mesh-ancestor
153596761|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
153596762|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596763|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596764|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596765|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596815|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596816|NCT01864213|Tetracaine|tetracaine|mesh-list
153596817|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
153596818|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
153596819|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596820|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596821|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
153596822|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596823|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
153596824|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
153596825|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
153557583|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557585|NCT01620333|Insulin|insulin|mesh-list
153557586|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153557599|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153557600|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557601|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557602|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
153423743|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423745|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153557603|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
153557604|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557605|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557606|NCT01620450|Insulin|insulin|mesh-list
153557607|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153557608|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557609|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557610|NCT01620463|Liraglutide|liraglutide|mesh-list
153557611|NCT01620463|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153557612|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557613|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557614|NCT01620463|Incretins|incretins|mesh-ancestor
153557615|NCT01620463|Hormones|hormones|mesh-ancestor
153557616|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557617|NCT01620476|Liraglutide|liraglutide|mesh-list
153557618|NCT01620476|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153557619|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557620|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557621|NCT01620476|Incretins|incretins|mesh-ancestor
153557622|NCT01620476|Hormones|hormones|mesh-ancestor
153411303|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
153596826|NCT01864265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153596828|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596829|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
153596830|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596831|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596832|NCT01864551|Lamotrigine|lamotrigine|mesh-list
153596833|NCT01864551|Olanzapine|olanzapine|mesh-list
153596834|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
153596835|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
153596836|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596837|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596838|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596839|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153813234|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153424736|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153424846|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424847|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
153424848|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153424849|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
153359728|NCT04254107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153359729|NCT04254107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359730|NCT04254107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424850|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153596840|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153596841|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596842|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557623|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557625|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
153557626|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557627|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557628|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
153557629|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153557630|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153557631|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
153557632|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557633|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153557634|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153557635|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557636|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782644|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557637|NCT01620814|Misoprostol|misoprostol|mesh-list
153557638|NCT01620814|Dinoprostone|dinoprostone|mesh-list
153557639|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153557640|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
153557642|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557643|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153557644|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153557645|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
153557646|NCT01620840|Lacosamide|lacosamide|mesh-list
153557647|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
153557663|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153557664|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
153557665|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557666|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153557667|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153557668|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557679|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
153557680|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557681|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
153557682|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153557683|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557684|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557685|NCT01621165|Prazosin|prazosin|mesh-list
153557686|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153424929|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153424930|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424931|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
153424932|NCT00378872|Coagulants|coagulants|mesh-ancestor
153424933|NCT00378404|Docetaxel|docetaxel|mesh-list
153424934|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424935|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
153424936|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
153424937|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
153424938|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557687|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153557688|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153557689|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153557690|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
153557691|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557692|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557693|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557694|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
153557695|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153557696|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
153557697|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153557698|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
153557699|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557700|NCT01621217|Cetuximab|cetuximab|mesh-list
153557701|NCT01621217|Mitomycins|mitomycins|mesh-list
153557702|NCT01621217|Mitomycin|mitomycin|mesh-list
153557703|NCT01621217|Fluorouracil|fluorouracil|mesh-list
153557704|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153557705|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557733|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
153557734|NCT01621321|Hormones|hormones|mesh-ancestor
153557735|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153596847|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596861|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596862|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596863|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596865|NCT01864681|Gefitinib|gefitinib|mesh-list
153596866|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153596867|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596868|NCT01864681|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153596869|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153596870|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596871|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596872|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596873|NCT01864798|Denosumab|denosumab|mesh-list
153557736|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557737|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153557738|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557740|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557741|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153557742|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153557743|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557744|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557745|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153557746|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
153557747|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153557748|NCT01621373|Propofol|propofol|mesh-list
153813237|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813238|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813239|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153359732|NCT04254107|Immunoconjugates|immunoconjugates|mesh-ancestor
153557749|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153557750|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557751|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557752|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153557777|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557778|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557779|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557780|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153557781|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153557782|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153782645|NCT00415935|Methotrexate|methotrexate|mesh-list
153557783|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870732|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
153596874|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153596875|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596876|NCT01864824|Vitamins|vitamins|mesh-list
153596877|NCT01864824|Folic Acid|folic acid|mesh-list
153596878|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
153596879|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
153596880|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
153596881|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
153596882|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596883|NCT01864824|Hematinics|hematinics|mesh-ancestor
153596884|NCT01864863|Bosentan|bosentan|mesh-list
153596885|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153596886|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153596887|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596888|NCT01864915|Prucalopride|prucalopride|mesh-list
153596889|NCT01864915|Laxatives|laxatives|mesh-ancestor
153596890|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153557785|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153557786|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557787|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
153557788|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153557789|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153557790|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153557791|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
153557792|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557793|NCT01621620|Yohimbine|yohimbine|mesh-list
153557794|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
153557795|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
153557796|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557797|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557798|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153557799|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153557800|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153557801|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
153557802|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557826|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153557827|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
153557828|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557829|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427854|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
153427855|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
153427856|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
153427857|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
153557830|NCT01621750|Clopidogrel|clopidogrel|mesh-list
153870751|NCT03456947|Pregabalin|pregabalin|mesh-list
153819193|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153819194|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819195|NCT03006302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153819196|NCT02891824|Bevacizumab|bevacizumab|mesh-list
153819197|NCT02891824|Atezolizumab|atezolizumab|mesh-list
153819198|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819199|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819200|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153819201|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153819202|NCT02891824|Growth Substances|growth substances|mesh-ancestor
153819203|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460568|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460570|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153819204|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
153819205|NCT02891824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153596891|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153596892|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153596893|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
153596894|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596895|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596896|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596898|NCT01865175|Trace Elements|trace elements|mesh-ancestor
153596899|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
153557831|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153557832|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153557833|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153557834|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153557835|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
153557836|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557837|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557838|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557839|NCT01621763|Clopidogrel|clopidogrel|mesh-list
153557840|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153557841|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153557842|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153557843|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153557844|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
153557845|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557846|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557847|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557848|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
153428474|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153428475|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153428476|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153428477|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153428478|NCT02658877|Omalizumab|omalizumab|mesh-list
153557849|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153557850|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153557851|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557852|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153557853|NCT01621893|Calcium|calcium|mesh-list
153558002|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153558003|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558005|NCT01622946|Coagulants|coagulants|mesh-ancestor
153558006|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153558007|NCT01622972|Laxatives|laxatives|mesh-ancestor
153558008|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153558009|NCT01623024|Vitamin D|vitamin d|mesh-list
153558010|NCT01623024|Vitamins|vitamins|mesh-ancestor
153558011|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
153558012|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558013|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153558014|NCT01623102|Bevacizumab|bevacizumab|mesh-list
153558015|NCT01623102|Cisplatin|cisplatin|mesh-list
153558016|NCT01623102|Gemcitabine|gemcitabine|mesh-list
153558017|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153558018|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558019|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153558020|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153558021|NCT01623102|Growth Substances|growth substances|mesh-ancestor
153558022|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558023|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
153558044|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153558045|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558046|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558047|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558048|NCT01623362|Fluorides|fluorides|mesh-list
153558049|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
153558050|NCT01623362|Protective Agents|protective agents|mesh-ancestor
153558051|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558052|NCT01623375|Insulin|insulin|mesh-list
153558070|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153558071|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
153558072|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558073|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558074|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558075|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153558076|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
153558077|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558078|NCT01623570|Menotropins|menotropins|mesh-list
153359736|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359737|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359738|NCT04224480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153359740|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
153558079|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153558111|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558112|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
153558113|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558114|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
153558115|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558116|NCT01623817|Vancomycin|vancomycin|mesh-list
153558117|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153558118|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558119|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
153558120|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153558121|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558122|NCT01623921|Celecoxib|celecoxib|mesh-list
153558123|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153558124|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153558144|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
153558145|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
153558146|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
153558147|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558148|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153558149|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153558150|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153558151|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558152|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
153558153|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558154|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
153558155|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782649|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558157|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153558159|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558160|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
153558161|NCT01624064|Enalapril|enalapril|mesh-list
153813242|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
153813243|NCT00333008|Hormones|hormones|mesh-ancestor
153813244|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813245|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153813246|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153813247|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
153813248|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813249|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813250|NCT00435747|Parecoxib|parecoxib|mesh-list
153813251|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153813252|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153813253|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813254|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813255|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153813256|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153428682|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153428683|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153558162|NCT01624064|Calcium|calcium|mesh-list
153558163|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153558164|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153558165|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153558166|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558167|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153558168|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
153558169|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558170|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153558171|NCT01624103|Lidocaine|lidocaine|mesh-list
153558172|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
153558173|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
153558174|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
153558175|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153558176|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558177|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
153558196|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153558197|NCT01624129|Fluticasone|fluticasone|mesh-list
153558198|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558199|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153558207|NCT01624207|Atorvastatin|atorvastatin|mesh-list
153558224|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
153558226|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153558227|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782650|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558228|NCT01624428|Varenicline|varenicline|mesh-list
153558229|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153558230|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153558254|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558255|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558256|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
153558257|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558258|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153558259|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
153558260|NCT01624675|Risperidone|risperidone|mesh-list
153558261|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153558262|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
153558263|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558264|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558265|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558266|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153558267|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153558268|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153558269|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153558275|NCT01624766|Denosumab|denosumab|mesh-list
153428773|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153428775|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153428776|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428777|NCT02436265|Dexamethasone|dexamethasone|mesh-list
153428778|NCT02436265|Ropivacaine|ropivacaine|mesh-list
153428779|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428780|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
153428781|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
153428782|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428783|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428805|NCT05751746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558321|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153558322|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153558323|NCT01625429|Paclitaxel|paclitaxel|mesh-list
153558324|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153558325|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558326|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
153558327|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
153558328|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
153558329|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558330|NCT01625494|Amlodipine|amlodipine|mesh-list
153558331|NCT01625494|Irbesartan|irbesartan|mesh-list
153558354|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153558355|NCT01625572|Narcotics|narcotics|mesh-ancestor
153558356|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153558357|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558358|NCT01625572|Analgesics|analgesics|mesh-ancestor
153558359|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
153558360|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558361|NCT01625715|Ketotifen|ketotifen|mesh-list
153558362|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
153558363|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
153558364|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153558365|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
153558366|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
153558367|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374275|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
153558368|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558369|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558370|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153558371|NCT01625741|Rituximab|rituximab|mesh-list
153558372|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153558373|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558374|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
153558375|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558376|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153558377|NCT01625793|Interferons|interferons|mesh-list
153558378|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
153558379|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596900|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558380|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
153558381|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558382|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
153558400|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153558401|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153558402|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558403|NCT01625936|Bevacizumab|bevacizumab|mesh-list
153558404|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153558405|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558406|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153558407|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153558408|NCT01625936|Growth Substances|growth substances|mesh-ancestor
153558409|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558410|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
153558411|NCT01625156|Sirolimus|sirolimus|mesh-list
153558412|NCT01625156|Temsirolimus|temsirolimus|mesh-list
153558413|NCT01625156|MTOR Inhibitors|mtor inhibitors|mesh-list
153359751|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428905|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153428906|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153428907|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
153428908|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
153428909|NCT00002498|Fluorouracil|fluorouracil|mesh-list
153428910|NCT00002498|Methotrexate|methotrexate|mesh-list
153428911|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
153428912|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153428913|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
153558414|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153558415|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558416|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153558417|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558418|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
153558419|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558420|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
153558421|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558422|NCT01625156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153558423|NCT01625156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558424|NCT01625156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558425|NCT01626222|Everolimus|everolimus|mesh-list
153558426|NCT01626222|Exemestane|exemestane|mesh-list
153558427|NCT01626222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153558464|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153558465|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153558466|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153558467|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
153558468|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558469|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558470|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558471|NCT01626560|Vancomycin|vancomycin|mesh-list
153558472|NCT01626560|Daptomycin|daptomycin|mesh-list
153558473|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153558474|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558475|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
153558476|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153558477|NCT01626651|Ketoconazole|ketoconazole|mesh-list
153558478|NCT01626651|Ibrutinib|ibrutinib|mesh-list
153558479|NCT01626651|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153558480|NCT01626651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153558481|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558482|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558483|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
153558484|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558485|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153558486|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153558487|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153558488|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
153429439|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429440|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153429441|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153429442|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
153429443|NCT00381758|Methylphenidate|methylphenidate|mesh-list
153429444|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153429445|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429446|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153429447|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153429448|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153429449|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429450|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
153429451|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153429452|NCT01402531|Bevacizumab|bevacizumab|mesh-list
153429454|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558489|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558490|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558491|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153558517|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153596901|NCT01865188|Amlodipine|amlodipine|mesh-list
153596902|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153596903|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153596904|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153596905|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153596906|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596907|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153596908|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596909|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
153596910|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153596911|NCT01865201|Mannitol|mannitol|mesh-list
153596912|NCT01865201|Edaravone|edaravone|mesh-list
153596913|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153596914|NCT01865201|Diuretics|diuretics|mesh-ancestor
153558518|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
153558519|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153558520|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558521|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558522|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153558523|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153558525|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558526|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153558527|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153558528|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153558530|NCT01627132|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153558531|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153558532|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558533|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558534|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558535|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
153558536|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153558537|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153558538|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
153820716|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
153820717|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429923|NCT01122511|Dexamethasone|dexamethasone|mesh-list
153429924|NCT01122511|Ranibizumab|ranibizumab|mesh-list
153889270|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429925|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889271|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153889272|NCT01285323|Reslizumab|reslizumab|mesh-list
153429926|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
153889273|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153429927|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
153429928|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558539|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558540|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558541|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558557|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153558558|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153558559|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153558560|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153558561|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558562|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558564|NCT01627158|Protective Agents|protective agents|mesh-ancestor
153558573|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153558574|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558575|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558576|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
153558577|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558578|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153558579|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153558580|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
153558581|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153558582|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153558583|NCT01627236|Prednisolone|prednisolone|mesh-list
153558584|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
153558585|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153558586|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
153558587|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558588|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
153558589|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
153430296|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153889284|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430297|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153430298|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430299|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430300|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153430301|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153430302|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153430303|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153430304|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430305|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
153558590|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558591|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558592|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153558593|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
153558594|NCT01627236|Hormones|hormones|mesh-ancestor
153558595|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558596|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153558598|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153558599|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558600|NCT01627262|Mesalamine|mesalamine|mesh-list
153558601|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153558602|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153558622|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558623|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558624|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
153558625|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
153558626|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870852|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153596915|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
153596916|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596917|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153596918|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
153558627|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
153558628|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153430592|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430593|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153430594|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153430595|NCT04939844|Growth Substances|growth substances|mesh-ancestor
153430596|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430597|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430598|NCT05295212|Atezolizumab|atezolizumab|mesh-list
153430599|NCT05295212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153430600|NCT05295212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430601|NCT05295212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430602|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430603|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
153430604|NCT05286320|Lenvatinib|lenvatinib|mesh-list
153430665|NCT04828057|Latanoprost|latanoprost|mesh-list
153430666|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430414|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430415|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558629|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153558630|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153558631|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558632|NCT01627353|Analgesics|analgesics|mesh-ancestor
153558633|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
153558634|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153558635|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153558636|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
153558637|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153558638|NCT01627379|Panitumumab|panitumumab|mesh-list
153558639|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558640|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153558641|NCT01627431|Aspirin|aspirin|mesh-list
153558642|NCT01627431|Clopidogrel|clopidogrel|mesh-list
153558643|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153558644|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153558645|NCT01627431|Analgesics|analgesics|mesh-ancestor
153558646|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
153558647|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558694|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153558695|NCT01627678|Sargramostim|sargramostim|mesh-list
153558696|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
153558697|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374386|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558698|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558699|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153558700|NCT01627678|Antacids|antacids|mesh-ancestor
153558701|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558702|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153558703|NCT01627717|Maraviroc|maraviroc|mesh-list
153813261|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153430667|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153430668|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153430669|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
153430779|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430780|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430781|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153431285|NCT06315309|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153431286|NCT06315309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153431287|NCT06315309|Immunologic Factors|immunologic factors|mesh-ancestor
153431288|NCT06315309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431289|NCT06315309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153431290|NCT06315309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153431292|NCT06315283|Antiemetics|antiemetics|mesh-ancestor
153431293|NCT06315283|Autonomic Agents|autonomic agents|mesh-ancestor
153431294|NCT06315283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431295|NCT06315283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431296|NCT06315283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153431297|NCT06315283|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153431298|NCT06315283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153558704|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153558734|NCT01627873|Analgesics|analgesics|mesh-ancestor
153558735|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
153558736|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782658|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
153782659|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153558738|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153558739|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
153558740|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
153558741|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
153558742|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153558743|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558744|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
153558745|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
153558746|NCT01627938|Razoxane|razoxane|mesh-list
153558747|NCT01627938|Analgesics|analgesics|mesh-ancestor
153558784|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870888|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558785|NCT01628471|Decitabine|decitabine|mesh-list
153558786|NCT01628471|Genistein|genistein|mesh-list
153558787|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558788|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
153558789|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558790|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558791|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558792|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153558793|NCT01628471|Protective Agents|protective agents|mesh-ancestor
153558794|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558795|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153558796|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
153558797|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153558798|NCT01628471|Estrogens|estrogens|mesh-ancestor
153558799|NCT01628471|Hormones|hormones|mesh-ancestor
153558800|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558801|NCT01628562|Remifentanil|remifentanil|mesh-list
153558802|NCT01628562|Esmolol|esmolol|mesh-list
153558803|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153558804|NCT01628562|Narcotics|narcotics|mesh-ancestor
153558805|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153558806|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558807|NCT01628562|Analgesics|analgesics|mesh-ancestor
153558808|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
153558809|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558810|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153558811|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153558841|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558843|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153558844|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153558845|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153431309|NCT06315231|Antioxidants|antioxidants|mesh-ancestor
153431310|NCT06315231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431311|NCT06315231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153431312|NCT06315231|Protective Agents|protective agents|mesh-ancestor
153461762|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
153431434|NCT06293937|Adrenergic Agents|adrenergic agents|mesh-ancestor
153431435|NCT06293937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153431436|NCT06293937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153431437|NCT06293937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431438|NCT06293937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153431439|NCT06289725|Antiviral Agents|antiviral agents|mesh-list
153431440|NCT06289725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558846|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558847|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558848|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153558849|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153558850|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
153558851|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558852|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558853|NCT01629082|Lenalidomide|lenalidomide|mesh-list
153558854|NCT01629082|Clofarabine|clofarabine|mesh-list
153558855|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
153558856|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558857|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153558858|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153558859|NCT01629082|Growth Substances|growth substances|mesh-ancestor
153558860|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
153558861|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558862|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558863|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
153558864|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558865|NCT01629173|Ethylene|ethylene|mesh-list
153558866|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153558867|NCT01629173|Growth Substances|growth substances|mesh-ancestor
153558868|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558869|NCT01629199|Mitogens|mitogens|mesh-list
153558870|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
153558871|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558872|NCT01629212|Octylonium|octylonium|mesh-list
153558873|NCT01629212|Bromides|bromides|mesh-list
153558908|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153558909|NCT01629368|Analgesics|analgesics|mesh-ancestor
153432007|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432008|NCT05508867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432009|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153432010|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
153432011|NCT05487235|Atezolizumab|atezolizumab|mesh-list
153432013|NCT05487235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432014|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432015|NCT05487235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432016|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432017|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153432018|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153432019|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153432020|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432021|NCT05483933|Doxorubicin|doxorubicin|mesh-list
153432022|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153432023|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153432024|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432025|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153558925|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
153558930|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558931|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
153558932|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558933|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153558934|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153558935|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153558936|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
153558937|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558938|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558939|NCT01629511|Gemcitabine|gemcitabine|mesh-list
153558940|NCT01629511|Methotrexate|methotrexate|mesh-list
153558941|NCT01629511|Clofarabine|clofarabine|mesh-list
153558942|NCT01629511|Busulfan|busulfan|mesh-list
153558943|NCT01629511|Tacrolimus|tacrolimus|mesh-list
153558944|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
153558945|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153558946|NCT01629511|Lenograstim|lenograstim|mesh-list
153558947|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558948|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
153558949|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558951|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153558953|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153558954|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558955|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
153558956|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558957|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153558958|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558959|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
153558960|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153558961|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153558962|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153558963|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153558964|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
153558965|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153432026|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432027|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432028|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432029|NCT05469412|Midazolam|midazolam|mesh-list
153815031|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
153432030|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153432031|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153432032|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432033|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432159|NCT05169567|Fulvestrant|fulvestrant|mesh-list
153432160|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153558966|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153558968|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
153870904|NCT00194792|Paclitaxel|paclitaxel|mesh-list
153596919|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559003|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559005|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559006|NCT01630018|Topotecan|topotecan|mesh-list
153559007|NCT01630018|Belotecan|belotecan|mesh-list
153559008|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153559024|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
153559025|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
153559026|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559027|NCT01630083|Capecitabine|capecitabine|mesh-list
153559028|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
153559029|NCT01630083|Epirubicin|epirubicin|mesh-list
153559030|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559031|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
153559032|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559033|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559034|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153559035|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153559036|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153559037|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559038|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153559040|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153559041|NCT01630148|Bemiparin|bemiparin|mesh-list
153559042|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
153559043|NCT01630187|Carbetocin|carbetocin|mesh-list
153559044|NCT01630187|Oxytocin|oxytocin|mesh-list
153559045|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
153559046|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153559047|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559048|NCT01630226|Cisplatin|cisplatin|mesh-list
153559049|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559050|NCT01630278|Ibuprofen|ibuprofen|mesh-list
153559051|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153559052|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153596920|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153596921|NCT01865201|Protective Agents|protective agents|mesh-ancestor
153596922|NCT01865279|Insulin|insulin|mesh-list
153596923|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153819206|NCT02891824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559053|NCT01630278|Analgesics|analgesics|mesh-ancestor
153813262|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813263|NCT00333047|Letrozole|letrozole|mesh-list
153359752|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432179|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559054|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
153559055|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559056|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559057|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559058|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153559059|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153559060|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559061|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559062|NCT01630343|Acetaminophen|acetaminophen|mesh-list
153559063|NCT01630343|Tramadol|tramadol|mesh-list
153559064|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559065|NCT01630343|Analgesics|analgesics|mesh-ancestor
153559066|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
153559087|NCT01630564|Aldesleukin|aldesleukin|mesh-list
153559088|NCT01630564|Interleukin-2|interleukin-2|mesh-list
153559089|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559090|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559091|NCT01630564|Analgesics|analgesics|mesh-ancestor
153559092|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
153559093|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559094|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559095|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153559096|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153559097|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
153559098|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559099|NCT01630642|Clopidogrel|clopidogrel|mesh-list
153559100|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153559101|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153559103|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153559118|NCT01630720|Vitamins|vitamins|mesh-list
153559119|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
153559130|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559131|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153559132|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559133|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559134|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559135|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559136|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
153559137|NCT01630915|Clopidogrel|clopidogrel|mesh-list
153559138|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153559139|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153559140|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153559141|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153559142|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
153559143|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559144|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559145|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559146|NCT01630941|Denosumab|denosumab|mesh-list
153559147|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153559148|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559149|NCT01631058|Prednisone|prednisone|mesh-list
153559150|NCT01631058|Everolimus|everolimus|mesh-list
153559151|NCT01631058|Lactitol|lactitol|mesh-list
153559152|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559176|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
153432874|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432875|NCT03448042|Trastuzumab|trastuzumab|mesh-list
153432876|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432877|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432878|NCT03422822|Abrocitinib|abrocitinib|mesh-list
153432879|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432880|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432881|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559177|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559178|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559179|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153559180|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153559181|NCT01631201|Azithromycin|azithromycin|mesh-list
153559202|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153559203|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559204|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153559205|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559206|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559207|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153813264|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559208|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559209|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153559210|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153559211|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559212|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153559213|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153559214|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
153559215|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559216|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
153559217|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559219|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
153559220|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559221|NCT01631396|Neostigmine|neostigmine|mesh-list
153559222|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153559223|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559260|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
153559261|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153559262|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153559263|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153559264|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
153559265|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559266|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153559267|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153813265|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153559268|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559269|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
153559270|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153559271|NCT01631409|Diuretics|diuretics|mesh-ancestor
153559272|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
153559273|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153559274|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153559275|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
153559276|NCT01631448|Coagulants|coagulants|mesh-ancestor
153559277|NCT01631513|Tapentadol|tapentadol|mesh-list
153559278|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153559279|NCT01631513|Narcotics|narcotics|mesh-ancestor
153559280|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559281|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559282|NCT01631513|Analgesics|analgesics|mesh-ancestor
153559283|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
153559284|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559285|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153559286|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153559287|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559288|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559289|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
153411593|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153559320|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153559321|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153559322|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559323|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559325|NCT01631838|Vitamin E|vitamin e|mesh-list
153559326|NCT01631838|Tocopherols|tocopherols|mesh-list
153820718|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433248|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
153433249|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
153433250|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
153433251|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433252|NCT00309985|Hormones|hormones|mesh-ancestor
153433253|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153433254|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433255|NCT00053482|Vaccines|vaccines|mesh-list
153433256|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
153559327|NCT01631838|Tocovid|tocovid|mesh-list
153559328|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
153559329|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559330|NCT01631838|Protective Agents|protective agents|mesh-ancestor
153559331|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559333|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
153559334|NCT01631877|Enoxaparin|enoxaparin|mesh-list
153559335|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
153559336|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
153559337|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153559338|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153559339|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559340|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153559341|NCT01631968|Colistin|colistin|mesh-list
153559342|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559343|NCT01631994|Metoclopramide|metoclopramide|mesh-list
153559344|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
153559345|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
153559346|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559347|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559348|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153559349|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153559350|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153559372|NCT01632514|Vitamin D|vitamin d|mesh-list
153559386|NCT01632592|Tesamorelin|tesamorelin|mesh-list
153559387|NCT01632592|Growth Substances|growth substances|mesh-ancestor
153559388|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559389|NCT01632605|Sirolimus|sirolimus|mesh-list
153559390|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153559391|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559392|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153559393|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559394|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
153559395|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153559396|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
153559397|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559398|NCT01632722|Bevacizumab|bevacizumab|mesh-list
153559399|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153559400|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559401|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153559402|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153559403|NCT01632722|Growth Substances|growth substances|mesh-ancestor
153559426|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374481|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
153559427|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153559428|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
153559429|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153559430|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
153559431|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433376|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433427|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
153433429|NCT00000865|Zidovudine|zidovudine|mesh-list
153783632|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783633|NCT04545892|Capsaicin|capsaicin|mesh-list
153433431|NCT00000865|Didanosine|didanosine|mesh-list
153559432|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559433|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153559434|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
153559435|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
153559436|NCT01633086|Protective Agents|protective agents|mesh-ancestor
153559437|NCT01633099|Decitabine|decitabine|mesh-list
153559438|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559439|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
153559441|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559448|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559449|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153559450|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153559451|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153559452|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559453|NCT01633294|Gentamicins|gentamicins|mesh-list
153559476|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153559477|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559478|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559479|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
153782663|NCT02211391|Caseins|caseins|mesh-list
153782664|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
153559480|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559481|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559542|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559543|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559544|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
153559545|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559546|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559547|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
153559548|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559549|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153559550|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153559551|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
153559552|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153559553|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153559554|NCT01634061|Dactolisib|dactolisib|mesh-list
153559555|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559556|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
153559557|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559558|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
153559559|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559560|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559561|NCT01634295|Niacin|niacin|mesh-list
153559562|NCT01634295|Amlodipine|amlodipine|mesh-list
153559563|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559564|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153559565|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559566|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813266|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153433667|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433668|NCT00000967|Interferons|interferons|mesh-list
153433669|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
153433670|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
153433671|NCT00000967|Zidovudine|zidovudine|mesh-list
153433672|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433673|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
153433674|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433675|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
153559567|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559568|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559569|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
153559570|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153559571|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
153559599|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559612|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559613|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559614|NCT01634412|Amitriptyline|amitriptyline|mesh-list
153559615|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
153559616|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153559617|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
153559618|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153559619|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153559620|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559631|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559633|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559634|NCT01634438|Heparin|heparin|mesh-list
153559635|NCT01634438|Calcium heparin|calcium heparin|mesh-list
153559636|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
153559637|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153559638|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153559639|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559640|NCT01634594|Nicardipine|nicardipine|mesh-list
153559641|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
153559642|NCT01634594|Remifentanil|remifentanil|mesh-list
153559643|NCT01634594|Sevoflurane|sevoflurane|mesh-list
153559644|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153559645|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374523|NCT00367965|Zopiclone|zopiclone|mesh-list
153559646|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559647|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559648|NCT01634594|Analgesics|analgesics|mesh-ancestor
153559649|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
153559650|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559651|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153559665|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559666|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559667|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
153559668|NCT01634685|Capecitabine|capecitabine|mesh-list
153559669|NCT01634685|Bavituximab|bavituximab|mesh-list
153559670|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559671|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
153559672|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559673|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559674|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153559768|NCT01635387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559769|NCT01635400|Irinotecan|irinotecan|mesh-list
153559770|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153559771|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153559772|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559773|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559774|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559775|NCT01635530|Doxycycline|doxycycline|mesh-list
153559776|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
153559777|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153559778|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433797|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
153433798|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433799|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433800|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433801|NCT00000697|Foscarnet|foscarnet|mesh-list
153433802|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153433809|NCT00001009|Dextrans|dextrans|mesh-list
153559779|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
153559780|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153559842|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
153559843|NCT01635803|Bevacizumab|bevacizumab|mesh-list
153559844|NCT01635803|Ranibizumab|ranibizumab|mesh-list
153559846|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559847|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153559848|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153559849|NCT01635803|Growth Substances|growth substances|mesh-ancestor
153559850|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559851|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
153559853|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
153559854|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559855|NCT01635829|Carbamazepine|carbamazepine|mesh-list
153559856|NCT01635829|Phenytoin|phenytoin|mesh-list
153559857|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
153559859|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153559860|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559911|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153559912|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559913|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153559914|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
153559915|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
153559916|NCT01636128|Eflornithine|eflornithine|mesh-list
153559917|NCT01636128|Sulindac|sulindac|mesh-list
153559918|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559919|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153559920|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153559921|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153559922|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559923|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153560020|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560021|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560022|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
153434022|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
153434023|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434024|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
153434025|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434026|NCT00002323|Zidovudine|zidovudine|mesh-list
153434027|NCT00002323|Nevirapine|nevirapine|mesh-list
153434028|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
153434029|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434030|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434031|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434074|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434077|NCT00383864|Ribavirin|ribavirin|mesh-list
153434078|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434079|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
153434080|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434110|NCT00002347|Nevirapine|nevirapine|mesh-list
153560023|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153560024|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153560025|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560048|NCT01636609|Tosedostat|tosedostat|mesh-list
153560049|NCT01636609|Glycine|glycine|mesh-list
153560050|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153560051|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
153560052|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560053|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560054|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
153560055|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560056|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560057|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
153560058|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560059|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560060|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
153560061|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560062|NCT01636622|Paclitaxel|paclitaxel|mesh-list
153560063|NCT01636622|Carboplatin|carboplatin|mesh-list
153560064|NCT01636622|Vemurafenib|vemurafenib|mesh-list
153560113|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
153560114|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153560115|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153560116|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560117|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153560118|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434125|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434126|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434149|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
153434150|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153434151|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
153434152|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434153|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815033|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
153434154|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153434155|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
153560119|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560120|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153560122|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153560123|NCT01636908|Sorafenib|sorafenib|mesh-list
153560124|NCT01636908|Sunitinib|sunitinib|mesh-list
153560125|NCT01636908|Dasatinib|dasatinib|mesh-list
153560126|NCT01636908|Lapatinib|lapatinib|mesh-list
153560127|NCT01636908|Vemurafenib|vemurafenib|mesh-list
153560128|NCT01636908|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153560129|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153560130|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560131|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560132|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560133|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
153560154|NCT01637155|Vitamin D|vitamin d|mesh-list
153560184|NCT01637233|Zidovudine|zidovudine|mesh-list
153560185|NCT01637233|Maraviroc|maraviroc|mesh-list
153560186|NCT01637233|Abacavir|abacavir|mesh-list
153560187|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
153560188|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153560189|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
153560190|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153560191|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560192|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560193|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153560194|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153560195|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
153560196|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560197|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153560198|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153560199|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560200|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
153560201|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153560202|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153560203|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153560204|NCT01637259|Ritonavir|ritonavir|mesh-list
153560205|NCT01637259|Lopinavir|lopinavir|mesh-list
153560206|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153560234|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560235|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153560281|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813268|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359753|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153434174|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434175|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434176|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434177|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434178|NCT00001339|Doxorubicin|doxorubicin|mesh-list
153434179|NCT00001339|Etoposide|etoposide|mesh-list
153434180|NCT00001339|Vincristine|vincristine|mesh-list
153434211|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
153434212|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434213|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434214|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434216|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
153560282|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560284|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153560285|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
153560286|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560287|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153560288|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153560289|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153560290|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560291|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153560292|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153560359|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560360|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560374|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560376|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
153560377|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560378|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560379|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560380|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560381|NCT01637883|Benzydamine|benzydamine|mesh-list
153560382|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153560383|NCT01637948|Listerine|listerine|mesh-list
153560384|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153560385|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560452|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560453|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560454|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
153560455|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153560456|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153560457|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434434|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434435|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153560458|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153560459|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153560460|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153560527|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153560528|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560529|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560531|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560532|NCT01638715|Infliximab|infliximab|mesh-list
153560533|NCT01638715|Rituximab|rituximab|mesh-list
153560534|NCT01638715|Abatacept|abatacept|mesh-list
153560535|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153560536|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560537|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
153560538|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560539|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560540|NCT01638715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153560573|NCT01638962|Aspirin|aspirin|mesh-list
153411924|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
153560631|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560632|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153560633|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560634|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560635|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560636|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153560637|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153560639|NCT01639092|Entecavir|entecavir|mesh-list
153560640|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
153560641|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560642|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153560643|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560644|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560645|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560646|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153560647|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153560648|NCT01639261|Interferons|interferons|mesh-list
153560649|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
153560650|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560651|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
153560652|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560653|NCT01639326|Irinotecan|irinotecan|mesh-list
153560707|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560740|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153560741|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560742|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
153560743|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560744|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560745|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
153813269|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153430463|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153434492|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
153434493|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434494|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
153434495|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560746|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153560747|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153560748|NCT01639898|Growth Substances|growth substances|mesh-ancestor
153560749|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
153560750|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
153560815|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560832|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153560833|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153560834|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153560835|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153560836|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
153560837|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560838|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560839|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560842|NCT01643434|Analgesics|analgesics|mesh-ancestor
153560843|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
153560844|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560845|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560846|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153560847|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
153560849|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153560850|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153560852|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
153560853|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560854|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560855|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153560856|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
153560857|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153560858|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153560859|NCT01643434|Diuretics|diuretics|mesh-ancestor
153560860|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
153560861|NCT01643941|Vaccines|vaccines|mesh-list
153560862|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
153560863|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560864|NCT01643980|Progesterone|progesterone|mesh-list
153560865|NCT01643980|Progestins|progestins|mesh-ancestor
153819207|NCT02737046|Interferons|interferons|mesh-list
153819208|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
153819209|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
153819210|NCT02737046|Zidovudine|zidovudine|mesh-list
153819211|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153819212|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153596924|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
153596925|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
153596926|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
153560866|NCT01643980|Hormones|hormones|mesh-ancestor
153560867|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153560868|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813270|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
153434809|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
153434811|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560869|NCT01645228|Calcium|calcium|mesh-list
153560870|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153560871|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560893|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560894|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153560895|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560896|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153560897|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153560898|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560899|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153560900|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153560901|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560902|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
153560903|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153782675|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560904|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
153560905|NCT01646619|Analgesics|analgesics|mesh-ancestor
153560906|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
153560907|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560908|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560909|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
153560910|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560911|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153560912|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
153560913|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153560914|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153560915|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560916|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153560917|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
153560918|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153560919|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153560920|NCT01647880|Interferon beta-1b|interferon beta-1b|mesh-list
153596927|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
153560921|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153560922|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560951|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560952|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560953|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
153560954|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560955|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
153560956|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153560957|NCT01649024|Tremelimumab|tremelimumab|mesh-list
153560958|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560959|NCT01649960|Sirolimus|sirolimus|mesh-list
153560960|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153560961|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560962|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153560963|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560964|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
153560965|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560966|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
153560967|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560969|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153560970|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
153560989|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435038|NCT00002227|Stavudine|stavudine|mesh-list
153435039|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435040|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560991|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560992|NCT01650181|Protective Agents|protective agents|mesh-ancestor
153560993|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
153560994|NCT01650181|Vitamins|vitamins|mesh-ancestor
153560995|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
153560996|NCT01650181|Trace Elements|trace elements|mesh-ancestor
153560997|NCT01650272|Minoxidil|minoxidil|mesh-list
153560998|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153561001|NCT01650376|Paclitaxel|paclitaxel|mesh-list
153561014|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153561015|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
153561016|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561017|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
153561018|NCT01650415|Hematinics|hematinics|mesh-ancestor
153561019|NCT01650428|Bevacizumab|bevacizumab|mesh-list
153561020|NCT01650428|Fluorouracil|fluorouracil|mesh-list
153561021|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
153561022|NCT01650428|Irinotecan|irinotecan|mesh-list
153561023|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153561024|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561025|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153561026|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153561027|NCT01650428|Growth Substances|growth substances|mesh-ancestor
153561028|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561040|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153561042|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561043|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561044|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153561045|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
153561046|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153561047|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153561048|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153561049|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
153561050|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561051|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561052|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153561053|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
153561054|NCT01650441|Hormones|hormones|mesh-ancestor
153561074|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561076|NCT01650649|Clonidine|clonidine|mesh-list
153561077|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153561078|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153561079|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561080|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
153561081|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561082|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153561083|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153561084|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153561085|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
153561086|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561087|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561088|NCT01650649|Analgesics|analgesics|mesh-ancestor
153561089|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
153561090|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
153561091|NCT01650662|Cyclosporine|cyclosporine|mesh-list
153561104|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153561105|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561106|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
153561107|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561108|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153561109|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153561110|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153561111|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153561112|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153561113|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561114|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561115|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561117|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
153561118|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871367|NCT00477464|Capecitabine|capecitabine|mesh-list
153596928|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153596929|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596930|NCT01865292|Insulin|insulin|mesh-list
153596931|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153561119|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
153561120|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153561121|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
153561122|NCT01650870|Lactulose|lactulose|mesh-list
153561123|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561124|NCT01650883|Vitamin D|vitamin d|mesh-list
153561125|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
153561126|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
153561127|NCT01650883|Vitamins|vitamins|mesh-list
153561128|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
153561129|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561130|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153782678|NCT04561960|Protective Agents|protective agents|mesh-ancestor
153561131|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153561132|NCT01650961|Palonosetron|palonosetron|mesh-list
153561133|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
153561134|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
153561135|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561140|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
153561190|NCT01651325|Sensory System Agents|sensory system agents|mesh-ancestor
153561191|NCT01651325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561192|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
153561193|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561194|NCT01651364|Cabergoline|cabergoline|mesh-list
153561195|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153561196|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153561197|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
153561198|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
153561199|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561200|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561201|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561202|NCT01651377|Pramipexole|pramipexole|mesh-list
153561203|NCT01651377|Dexpramipexole|dexpramipexole|mesh-list
153813272|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813273|NCT00333086|Letrozole|letrozole|mesh-list
153435660|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561205|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561206|NCT01651377|Protective Agents|protective agents|mesh-ancestor
153561207|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561208|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153561209|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153561210|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
153561211|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
153561212|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561213|NCT01651390|Sirolimus|sirolimus|mesh-list
153561249|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153561250|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
153561289|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153561332|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
153561333|NCT01652014|Fludarabine|fludarabine|mesh-list
153561334|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
153561335|NCT01652014|Tacrolimus|tacrolimus|mesh-list
153561336|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561337|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
153561338|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561339|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153561340|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153561341|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
153561342|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561346|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
153561434|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153561435|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153561436|NCT01652378|Lidocaine|lidocaine|mesh-list
153561437|NCT01652378|Ondansetron|ondansetron|mesh-list
153561438|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
153561439|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
153561440|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153561441|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561442|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
153561443|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561444|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153561445|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153561446|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153561447|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153561448|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561449|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
153561451|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561452|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
153561453|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
153561454|NCT01652378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153561455|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153561456|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
153561457|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561458|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
153561479|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153561480|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153561481|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
153561482|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561483|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
153561484|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561488|NCT01652534|Analgesics|analgesics|mesh-ancestor
153561497|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153561498|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561499|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153561500|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153561501|NCT01652560|Growth Substances|growth substances|mesh-ancestor
153561502|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561503|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
153561504|NCT01652586|Midazolam|midazolam|mesh-list
153782682|NCT04561921|Mepivacaine|mepivacaine|mesh-list
153561505|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
153561506|NCT01652586|Remifentanil|remifentanil|mesh-list
153561507|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153561508|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153561509|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561510|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153561511|NCT01652586|Analgesics|analgesics|mesh-ancestor
153561512|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
153561537|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561538|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
153561540|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561600|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561601|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561603|NCT01653067|Sirolimus|sirolimus|mesh-list
153561604|NCT01653067|Dexamethasone|dexamethasone|mesh-list
153561605|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
153561606|NCT01653067|Rituximab|rituximab|mesh-list
153561607|NCT01653067|Temsirolimus|temsirolimus|mesh-list
153561608|NCT01653067|MTOR Inhibitors|mtor inhibitors|mesh-list
153561609|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153561610|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
153561611|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
153561612|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561613|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561614|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561615|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
153561616|NCT01653067|Hormones|hormones|mesh-ancestor
153561637|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
153561638|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561639|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153561640|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153561641|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561702|NCT01653470|Vitamins|vitamins|mesh-ancestor
153561703|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
153561704|NCT01653522|Doxycycline|doxycycline|mesh-list
153561705|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561706|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561707|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
153813275|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153435808|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435809|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
153561708|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153561709|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153561710|NCT01653561|Apatinib|apatinib|mesh-list
153561711|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561712|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153561713|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561714|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561715|NCT01653639|Factor VIII|factor viii|mesh-list
153561717|NCT01653665|Sargramostim|sargramostim|mesh-list
153561718|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
153561719|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561742|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561743|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561744|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153561745|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
153561746|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153561747|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561824|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153561825|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
153561826|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561827|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153561828|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153561829|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561830|NCT01654575|Methotrexate|methotrexate|mesh-list
153561831|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153561832|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
153561833|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153561834|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561835|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561836|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
153561837|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561838|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561839|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
153561840|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561841|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153561842|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561843|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
153561844|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153561845|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153561846|NCT01654640|Metformin|metformin|mesh-list
153561847|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153561848|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561849|NCT01654692|Ipilimumab|ipilimumab|mesh-list
153561850|NCT01654692|Fotemustine|fotemustine|mesh-list
153561851|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153561852|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561853|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153561854|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561855|NCT01654705|Pantoprazole|pantoprazole|mesh-list
153435968|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435969|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435970|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435984|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435986|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
153435987|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153435988|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153435989|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153435990|NCT00002599|Protective Agents|protective agents|mesh-ancestor
153435991|NCT00002599|Trace Elements|trace elements|mesh-ancestor
153436011|NCT00003446|Calcium|calcium|mesh-list
153561860|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561861|NCT01654718|Pantoprazole|pantoprazole|mesh-list
153561862|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153561863|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561864|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153561865|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561866|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561867|NCT01654809|Vaccines|vaccines|mesh-list
153561887|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561888|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153561889|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153561890|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561891|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561892|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561893|NCT01655004|Exemestane|exemestane|mesh-list
153561894|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561895|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153561896|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153561897|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561898|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561899|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153561900|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
153561901|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561902|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561903|NCT01655056|Darexaban|darexaban|mesh-list
153561904|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153561905|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
153561938|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
153561939|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561940|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561941|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
153561942|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153561943|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561944|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561945|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153561946|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153561947|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153561948|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153561949|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153561950|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153561951|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561952|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153412237|NCT00005625|Trabectedin|trabectedin|mesh-list
153562014|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153562015|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153562016|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889386|NCT01086358|Analgesics|analgesics|mesh-ancestor
153562017|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562018|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153562019|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153562020|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
153562021|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562022|NCT01655524|Protective Agents|protective agents|mesh-ancestor
153562023|NCT01655628|Cisplatin|cisplatin|mesh-list
153562024|NCT01655628|Gemcitabine|gemcitabine|mesh-list
153562025|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562026|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153562027|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
153562028|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562029|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
153562030|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153562031|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153562032|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562033|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
153562054|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153562055|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153562056|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153562057|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153562058|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153562059|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562061|NCT01655758|Bimatoprost|bimatoprost|mesh-list
153562062|NCT01655758|Travoprost|travoprost|mesh-list
153562063|NCT01655758|Dorzolamide|dorzolamide|mesh-list
153562064|NCT01655758|Latanoprost|latanoprost|mesh-list
153562065|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153562066|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153436274|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562067|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153596932|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
153596933|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153596934|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596935|NCT01865305|Insulin|insulin|mesh-list
153596936|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153596937|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
153596938|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
153562068|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562069|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562070|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562071|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153562072|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153562073|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153562074|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153562077|NCT01655810|Vitamin D|vitamin d|mesh-list
153562078|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
153562079|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
153562080|NCT01655810|Vitamins|vitamins|mesh-list
153562081|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
153562082|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
153562083|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562084|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562085|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153562086|NCT01655810|Antacids|antacids|mesh-ancestor
153562243|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562244|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562245|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
153562246|NCT01656512|Vitamin D|vitamin d|mesh-list
153562247|NCT01656512|Diphosphonates|diphosphonates|mesh-list
153562248|NCT01656512|Calcium|calcium|mesh-list
153562249|NCT01656512|Vitamins|vitamins|mesh-ancestor
153562250|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
153562251|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562252|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562253|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153562254|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153562255|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
153562342|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153562343|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153562344|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562345|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153562346|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153562347|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562348|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
153562349|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153562350|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153813276|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153359756|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153562351|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153562352|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
153562353|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562354|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
153562355|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153562356|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562357|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153562358|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153562359|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
153562360|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562422|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153562423|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562424|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153562425|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562455|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562456|NCT01657656|Vitamin D|vitamin d|mesh-list
153562457|NCT01657656|Vitamins|vitamins|mesh-ancestor
153562458|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
153562459|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562460|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153562461|NCT01657669|Aflibercept|aflibercept|mesh-list
153562462|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153562463|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153562464|NCT01657669|Growth Substances|growth substances|mesh-ancestor
153562465|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562466|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
153562467|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562468|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153782688|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153562491|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562493|NCT01657825|Warfarin|warfarin|mesh-list
153562494|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
153562495|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
153562496|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562497|NCT01657838|Ketoconazole|ketoconazole|mesh-list
153562498|NCT01657838|Isavuconazole|isavuconazole|mesh-list
153562499|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
153562500|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562501|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153562502|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153562503|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562504|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562505|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153562506|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
153562512|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153562513|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153562514|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153562515|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
153562516|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153436496|NCT00003284|Carboplatin|carboplatin|mesh-list
153436497|NCT00003284|Ifosfamide|ifosfamide|mesh-list
153436498|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436499|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436500|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436501|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436502|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436503|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436504|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153562517|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562549|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153562550|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
153562553|NCT01657513|Adalimumab|adalimumab|mesh-list
153562554|NCT01657513|Infliximab|infliximab|mesh-list
153562555|NCT01657513|Etanercept|etanercept|mesh-list
153562592|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153562593|NCT01658033|Growth Substances|growth substances|mesh-ancestor
153562616|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562618|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153562619|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
153562620|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562621|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562622|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153562623|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153562624|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
153562625|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562626|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562627|NCT01658215|Nicotine|nicotine|mesh-list
153562628|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153562629|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
153562630|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562631|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562632|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153562683|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562716|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153562717|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153562718|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153782693|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562719|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
153562720|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562721|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562751|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562752|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562753|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153562754|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153562755|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153562756|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153562757|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153562758|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562759|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562760|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
153562761|NCT01659099|Hormones|hormones|mesh-ancestor
153562762|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562763|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153562764|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153562765|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
153562766|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436610|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
153562767|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
153562768|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
153562769|NCT01659190|Antacids|antacids|mesh-ancestor
153562805|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
153562806|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
153596939|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153596940|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
153781719|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153596941|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153596942|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
153596943|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153596944|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596946|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153562807|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153562808|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
153562841|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
153562843|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562844|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562878|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
153562879|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153562880|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562881|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562882|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153562883|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562884|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562920|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562952|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153562953|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153562956|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562957|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562984|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153562985|NCT01660295|Analgesics|analgesics|mesh-ancestor
153562986|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
153562987|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562988|NCT01660373|Tirofiban|tirofiban|mesh-list
153562989|NCT01660373|Ticagrelor|ticagrelor|mesh-list
153562990|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153562991|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153562992|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153562993|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153562994|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
153562995|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562996|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813277|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359757|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
153562997|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562998|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153562999|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153563004|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563040|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
153563041|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563042|NCT01660594|Calcium|calcium|mesh-list
153563075|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563076|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153563112|NCT01660997|Ixazomib|ixazomib|mesh-list
153563113|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563146|NCT01661257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153563148|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
153563149|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563150|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563151|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153563152|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153563153|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153563154|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563155|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
153563192|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
153563193|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
153563194|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563225|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563226|NCT01661530|Protective Agents|protective agents|mesh-ancestor
153563227|NCT01661556|Miconazole|miconazole|mesh-list
153563228|NCT01661556|Hydroquinone|hydroquinone|mesh-list
153563229|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
153563230|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563231|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153563232|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153563233|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563263|NCT01661855|Protective Agents|protective agents|mesh-ancestor
153563265|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153563266|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563267|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563269|NCT01662037|Bosentan|bosentan|mesh-list
153563272|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563308|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563309|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
153359785|NCT04074967|Ipilimumab|ipilimumab|mesh-list
153359786|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359787|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359788|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153359789|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563310|NCT01662466|Testosterone|testosterone|mesh-list
153563311|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
153563312|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
153563313|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153563345|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563348|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
153563349|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563350|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563351|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563352|NCT01662687|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153563353|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153563354|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
153563355|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563356|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563357|NCT01662700|Artesunate|artesunate|mesh-list
153563428|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153563429|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
153563430|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563431|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563432|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563433|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153563434|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153563435|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871866|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563478|NCT01663805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563479|NCT01663805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563480|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153563481|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
153563482|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563483|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563485|NCT01663961|Mirabegron|mirabegron|mesh-list
153563486|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153563487|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153359790|NCT03973268|Complement Factor H|complement factor h|mesh-list
153359808|NCT03849651|Melphalan|melphalan|mesh-list
153359809|NCT03849651|Thiotepa|thiotepa|mesh-list
153359810|NCT03849651|Fludarabine|fludarabine|mesh-list
153563488|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563489|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563490|NCT01663961|Protective Agents|protective agents|mesh-ancestor
153563491|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563492|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153563493|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153563494|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153563521|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563523|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
153563524|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153563525|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
153563526|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563527|NCT01664260|Protective Agents|protective agents|mesh-ancestor
153563528|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563529|NCT01664260|Antidotes|antidotes|mesh-ancestor
153563530|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
153563531|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153563532|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563533|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563534|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153563535|NCT01664520|Analgesics|analgesics|mesh-ancestor
153563536|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
153563537|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563538|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153563541|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
153563542|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563579|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563610|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
153563611|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563612|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563613|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153563614|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153563615|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
153563616|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563617|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563618|NCT01665079|Propofol|propofol|mesh-list
153563619|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153563620|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563650|NCT01665235|Clopidogrel|clopidogrel|mesh-list
153563651|NCT01665235|Atorvastatin|atorvastatin|mesh-list
153563652|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153563653|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153563654|NCT01665235|Analgesics|analgesics|mesh-ancestor
153563655|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
153563656|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813321|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
153813322|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
153813323|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
153813324|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153813325|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153437442|NCT00003704|Capecitabine|capecitabine|mesh-list
153563657|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563658|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563659|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563660|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153563777|NCT01665742|Vitamins|vitamins|mesh-ancestor
153563778|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
153563779|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563780|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
153563781|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563782|NCT01665742|Protective Agents|protective agents|mesh-ancestor
153563783|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563784|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153563785|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153375271|NCT05451381|Propofol|propofol|mesh-list
153563786|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563787|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
153563788|NCT01665781|Hematinics|hematinics|mesh-ancestor
153563789|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153563790|NCT01665846|Hematinics|hematinics|mesh-ancestor
153563791|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153563792|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153563823|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153563824|NCT01666236|Growth Substances|growth substances|mesh-ancestor
153563825|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563826|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
153563827|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563828|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563829|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
153563831|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563832|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153563833|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
153563834|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
153563857|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
153563859|NCT01666418|Paclitaxel|paclitaxel|mesh-list
153563860|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153563861|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563862|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
153563863|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
153563864|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
153563865|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563866|NCT01666431|Lapatinib|lapatinib|mesh-list
153563868|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153563869|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563870|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563871|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563873|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
153563874|NCT01666522|Vitamins|vitamins|mesh-ancestor
153563875|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
153563876|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563877|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153563878|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153563879|NCT01666587|Ibuprofen|ibuprofen|mesh-list
153563880|NCT01666587|Antioxidants|antioxidants|mesh-list
153563881|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
153563882|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153563883|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153563884|NCT01666587|Analgesics|analgesics|mesh-ancestor
153563885|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
153563886|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563887|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563888|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563889|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563890|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153563923|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
153563924|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
153563925|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
153563926|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563927|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153563928|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
153563929|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
153563930|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563931|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153563959|NCT01667094|Cefepime|cefepime|mesh-list
153563960|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153563961|NCT01667094|Ticarcillin|ticarcillin|mesh-list
153563969|NCT01667094|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153563970|NCT01667211|Paclitaxel|paclitaxel|mesh-list
153563971|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153563972|NCT01667211|Nedaplatin|nedaplatin|mesh-list
153563974|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563975|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
153563976|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
153563977|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
153564008|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153564009|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564010|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
153564012|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
153564013|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564014|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
153564015|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564016|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437737|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153437761|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
153564017|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153564018|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564019|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153564038|NCT01667575|Antacids|antacids|mesh-ancestor
153564039|NCT01667575|Diuretics|diuretics|mesh-ancestor
153564040|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
153564041|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564042|NCT01667575|Expectorants|expectorants|mesh-ancestor
153564043|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
153564044|NCT01667614|Losartan|losartan|mesh-list
153564045|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153564046|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153564047|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153564048|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153564049|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564050|NCT01667692|Azithromycin|azithromycin|mesh-list
153564051|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564052|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564061|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564062|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564063|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153564064|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153564065|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153564066|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564067|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564068|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153564069|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153564070|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153564071|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564073|NCT01667718|Diuretics|diuretics|mesh-ancestor
153564074|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
153564075|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564076|NCT01667718|Expectorants|expectorants|mesh-ancestor
153564077|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
153564078|NCT01667874|Gentamicins|gentamicins|mesh-list
153564103|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153564104|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
153564105|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564106|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564107|NCT01668121|Budesonide|budesonide|mesh-list
153564108|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
153564109|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153564110|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564111|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153564112|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
153564113|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564114|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564115|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153564116|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
153564117|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
153564118|NCT01668121|Hormones|hormones|mesh-ancestor
153564119|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153564159|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153564160|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564161|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564162|NCT01668550|AZD-0424|azd-0424|mesh-list
153564183|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153564184|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153564185|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
153564186|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153564187|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153564188|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153564189|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153564190|NCT01668680|Analgesics|analgesics|mesh-ancestor
153564191|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
153564192|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564193|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564194|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153564195|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153564196|NCT01668901|Aspirin|aspirin|mesh-list
153564197|NCT01668901|Warfarin|warfarin|mesh-list
153564198|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153564199|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153564200|NCT01668901|Analgesics|analgesics|mesh-ancestor
153564201|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
153564202|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564203|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564204|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564205|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153564206|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153564207|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153564208|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564209|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153564243|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153564244|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564246|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153564248|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
153564249|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564250|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153564251|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153564252|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153564253|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
153564254|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564255|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564256|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153564257|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
153564258|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
153564259|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
153564260|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564261|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564262|NCT01669135|Anesthetics|anesthetics|mesh-list
153438352|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153438353|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438354|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153438355|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153438356|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
153438357|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438358|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438387|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438391|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
153564263|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564264|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564265|NCT01669213|Ondansetron|ondansetron|mesh-list
153564266|NCT01669213|Ramosetron|ramosetron|mesh-list
153564267|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
153564268|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
153564269|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412677|NCT02420041|Hormones|hormones|mesh-ancestor
153564318|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153564319|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564320|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564353|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564354|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
153564355|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564356|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153564357|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
153564358|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153564359|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153564360|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564361|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
153564362|NCT01669967|Promethazine|promethazine|mesh-list
153564363|NCT01669967|Lidocaine|lidocaine|mesh-list
153564364|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
153564365|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
153564396|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564399|NCT01670552|Esomeprazole|esomeprazole|mesh-list
153564400|NCT01670552|Pantoprazole|pantoprazole|mesh-list
153564401|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153564402|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564403|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153564404|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564405|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564406|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153564407|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153564408|NCT01670552|Analgesics|analgesics|mesh-ancestor
153564409|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
153564410|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564444|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153564445|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564446|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
153564447|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564448|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564450|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
153438455|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
153438456|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438457|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813331|NCT00333242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359815|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359816|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153359817|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153359818|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
153359819|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359820|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359821|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153564471|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153564473|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564474|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564476|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153564477|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153564478|NCT01675115|Analgesics|analgesics|mesh-ancestor
153564479|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
153564480|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564481|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564482|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564483|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153564484|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153564485|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153564486|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564487|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153564488|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153564489|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564490|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
153564491|NCT01675310|Metformin|metformin|mesh-list
153564492|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153564493|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564494|NCT01676649|Paclitaxel|paclitaxel|mesh-list
153564495|NCT01676649|Carboplatin|carboplatin|mesh-list
153564496|NCT01676649|Ipilimumab|ipilimumab|mesh-list
153564497|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153564498|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564499|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
153564500|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
153564501|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
153564502|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596947|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596948|NCT01865331|Insulin|insulin|mesh-list
153596949|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153819213|NCT02737046|Belinostat|belinostat|mesh-list
153819214|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819215|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
153819216|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819217|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
153819218|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819219|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
153819220|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564529|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153564530|NCT01677065|Narcotics|narcotics|mesh-ancestor
153564531|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564532|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564533|NCT01677065|Analgesics|analgesics|mesh-ancestor
153564534|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
153564535|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564536|NCT01677247|Glimepiride|glimepiride|mesh-list
153564537|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153564538|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153564539|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564540|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153564541|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
153782718|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782719|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153782720|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153782721|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153564543|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153564544|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564545|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
153564546|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
153564547|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564582|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
153564583|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782729|NCT00234845|Methotrexate|methotrexate|mesh-list
153564648|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564649|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564650|NCT01680198|Vitamin D|vitamin d|mesh-list
153564651|NCT01680198|Vitamins|vitamins|mesh-ancestor
153564652|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
153564653|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564654|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153564655|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
153564656|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153564657|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564658|NCT05596981|Sorafenib|sorafenib|mesh-list
153564659|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564660|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153564661|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564662|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564664|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564665|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153564666|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564667|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564668|NCT05596890|Paclitaxel|paclitaxel|mesh-list
153564669|NCT05596890|Carboplatin|carboplatin|mesh-list
153564670|NCT05596890|Tislelizumab|tislelizumab|mesh-list
153564671|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153564672|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564673|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
153564674|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153564675|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
153564676|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564677|NCT05596890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153564725|NCT05596227|Narcotics|narcotics|mesh-list
153564726|NCT05596227|Propofol|propofol|mesh-list
153564727|NCT05596227|Anesthetics|anesthetics|mesh-list
153564728|NCT05596227|Sevoflurane|sevoflurane|mesh-list
153564729|NCT05596227|Rocuronium|rocuronium|mesh-list
153564737|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
153564738|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564739|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153564740|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153564741|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153564742|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153564743|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153564744|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153564746|NCT05596149|Fluorides|fluorides|mesh-list
153782735|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
153782736|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813334|NCT00333242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813335|NCT00333281|Tadalafil|tadalafil|mesh-list
153813336|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
153813337|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153813338|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153782737|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782738|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564747|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
153564748|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
153564749|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
153564750|NCT05596149|Protective Agents|protective agents|mesh-ancestor
153782739|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782740|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153782741|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782742|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
153782743|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782744|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153782745|NCT00234845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153782746|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153782747|NCT02211625|Oxycodone|oxycodone|mesh-list
153782748|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153782749|NCT02211625|Narcotics|narcotics|mesh-ancestor
153782752|NCT02211625|Analgesics|analgesics|mesh-ancestor
153564798|NCT05539924|Vitamins|vitamins|mesh-ancestor
153564799|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
153564802|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
153564803|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564804|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
153564805|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153564806|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153564835|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153564836|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153564837|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
153564838|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564839|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564840|NCT05405621|Exatecan|exatecan|mesh-list
153564841|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153564842|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153564843|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564844|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564845|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564846|NCT05226923|Meropenem|meropenem|mesh-list
153564847|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564848|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782764|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782765|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153782766|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153782767|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
153564901|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782792|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153782793|NCT04551703|Epinephrine|epinephrine|mesh-list
153782794|NCT04551703|Racepinephrine|racepinephrine|mesh-list
153565041|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153565042|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153565043|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
153565044|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
153565071|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153565072|NCT03294083|Cemiplimab|cemiplimab|mesh-list
153565073|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565074|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565110|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153565111|NCT03119038|Analgesics|analgesics|mesh-ancestor
153565112|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153565113|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153565114|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153565115|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565140|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
153565141|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
153565142|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153430639|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153430642|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
153565143|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153565144|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565145|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565149|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153565150|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153782817|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153782818|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565213|NCT02450253|Tadalafil|tadalafil|mesh-list
153782829|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782830|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153782831|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782833|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
153565257|NCT05837689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565292|NCT05835726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565293|NCT05833217|Insulin|insulin|mesh-list
153565294|NCT05833217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153565295|NCT05833217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565296|NCT05814744|Dexmedetomidine|dexmedetomidine|mesh-list
153565297|NCT05814744|Bupivacaine|bupivacaine|mesh-list
153565298|NCT05814744|Anesthetics, Local|anesthetics, local|mesh-ancestor
153565299|NCT05814744|Anesthetics|anesthetics|mesh-ancestor
153565300|NCT05814744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565301|NCT05814744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565302|NCT05814744|Sensory System Agents|sensory system agents|mesh-ancestor
153782834|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782836|NCT02214004|Letrozole|letrozole|mesh-list
153782837|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782838|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782839|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153439097|NCT00002893|Antidotes|antidotes|mesh-ancestor
153782891|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782892|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153782893|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
153782894|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782895|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782896|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
153782897|NCT00235235|Gemcitabine|gemcitabine|mesh-list
153782898|NCT00235235|Doxorubicin|doxorubicin|mesh-list
153782899|NCT00235235|Capecitabine|capecitabine|mesh-list
153782900|NCT00235235|Vinorelbine|vinorelbine|mesh-list
153565456|NCT05180994|Infliximab|infliximab|mesh-list
153565457|NCT05180994|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153565458|NCT05180994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153565459|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
153565460|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813340|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565461|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153565462|NCT05118685|Estrogens|estrogens|mesh-list
153565463|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153565464|NCT05118685|Hormones|hormones|mesh-ancestor
153565465|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565518|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153565519|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153565520|NCT04404881|Growth Substances|growth substances|mesh-ancestor
153565521|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565522|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
153565523|NCT04335058|Iron|iron|mesh-list
153565524|NCT04335058|Lactoferrin|lactoferrin|mesh-list
153565525|NCT04335058|Trace Elements|trace elements|mesh-ancestor
153565526|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
153565527|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565528|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565529|NCT04319224|Nivolumab|nivolumab|mesh-list
153565530|NCT04319224|Ipilimumab|ipilimumab|mesh-list
153565531|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565532|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565533|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153565534|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782904|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782905|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153782906|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
153782907|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439180|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783660|NCT00236678|Hematinics|hematinics|mesh-ancestor
153889516|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889517|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153783661|NCT00269334|Paroxetine|paroxetine|mesh-list
153439193|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153782908|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782909|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153782911|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
153565579|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153565580|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565581|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565582|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
153565583|NCT03909529|Digoxin|digoxin|mesh-list
153565584|NCT03909529|Spironolactone|spironolactone|mesh-list
153565585|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153565586|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
153565587|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565588|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565589|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153565590|NCT03909529|Diuretics|diuretics|mesh-ancestor
153565591|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
153565592|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153565593|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153565594|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565595|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565596|NCT03909529|Protective Agents|protective agents|mesh-ancestor
153565611|NCT03318094|Nitroprusside|nitroprusside|mesh-list
153565612|NCT03318094|Phentolamine|phentolamine|mesh-list
153565613|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
153565614|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
153565615|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153565616|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
153565617|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153565618|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565619|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
153565620|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565622|NCT03268499|Cisplatin|cisplatin|mesh-list
153565638|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565639|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565640|NCT02638519|Xenon|xenon|mesh-list
153565641|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153565642|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
153565643|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
153565644|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565645|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565646|NCT02376699|Paclitaxel|paclitaxel|mesh-list
153565647|NCT02376699|Gemcitabine|gemcitabine|mesh-list
153565648|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
153565649|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153565650|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565651|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
153565652|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
153565653|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565654|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565655|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153565656|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
153565657|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565658|NCT02376699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153565693|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565694|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565732|NCT06225310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565733|NCT06225310|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153565734|NCT06225310|Protective Agents|protective agents|mesh-ancestor
153565735|NCT06225310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153565736|NCT06225310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565737|NCT06225271|Vitamins|vitamins|mesh-list
153565738|NCT06225271|Micronutrients|micronutrients|mesh-ancestor
153565741|NCT06225258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565742|NCT06225258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153565743|NCT06225258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153565760|NCT06225011|Antidepressive Agents|antidepressive agents|mesh-ancestor
153565761|NCT06225011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565762|NCT06225011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153565763|NCT06225011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153565764|NCT06225011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565766|NCT06224946|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565767|NCT06224946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565768|NCT06224894|Antiemetics|antiemetics|mesh-list
153565769|NCT06224894|Autonomic Agents|autonomic agents|mesh-ancestor
153565770|NCT06224894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565771|NCT06224894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565772|NCT06224894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153565773|NCT06224881|Ascorbic Acid|ascorbic acid|mesh-list
153565774|NCT06224881|Antioxidants|antioxidants|mesh-ancestor
153565775|NCT06224881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565776|NCT06224881|Protective Agents|protective agents|mesh-ancestor
153565777|NCT06224881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565778|NCT06224881|Vitamins|vitamins|mesh-ancestor
153565796|NCT06224790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565797|NCT06224790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565798|NCT06224790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153565799|NCT06224790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153565825|NCT06223880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153565826|NCT06223880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565828|NCT06223711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565829|NCT06223711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565830|NCT06223698|Tamoxifen|tamoxifen|mesh-list
153565831|NCT06223698|Letrozole|letrozole|mesh-list
153565832|NCT06223698|Anastrozole|anastrozole|mesh-list
153565833|NCT06223698|Exemestane|exemestane|mesh-list
153565834|NCT06223698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565835|NCT06223698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153565836|NCT06223698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153565837|NCT06223698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565838|NCT06223698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565839|NCT06223698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153565840|NCT06223698|Hormone Antagonists|hormone antagonists|mesh-ancestor
153565841|NCT06223698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565842|NCT06223698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565843|NCT06223698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439645|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439646|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153565844|NCT06223698|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153565845|NCT06223698|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153565846|NCT06223698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153565882|NCT06223074|Autonomic Agents|autonomic agents|mesh-ancestor
153565883|NCT06223074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565884|NCT06223074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565925|NCT06220344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565926|NCT06220344|Trace Elements|trace elements|mesh-ancestor
153565927|NCT06220344|Micronutrients|micronutrients|mesh-ancestor
153565928|NCT06220344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565929|NCT06218758|Anesthetics|anesthetics|mesh-list
153565930|NCT06218758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565931|NCT06218758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565932|NCT06218745|Anesthetics|anesthetics|mesh-list
153565933|NCT06218745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565934|NCT06218745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565935|NCT06217120|Colchicine|colchicine|mesh-list
153565936|NCT06217120|Gout Suppressants|gout suppressants|mesh-ancestor
153565937|NCT06217120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153565938|NCT06217120|Tubulin Modulators|tubulin modulators|mesh-ancestor
153565959|NCT06212284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153565960|NCT06212284|Antidepressive Agents|antidepressive agents|mesh-ancestor
153565961|NCT06212284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565962|NCT06207734|Palbociclib|palbociclib|mesh-list
153565963|NCT06207734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565964|NCT06207734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153566061|NCT06023641|Temozolomide|temozolomide|mesh-list
153566062|NCT06023641|Irinotecan|irinotecan|mesh-list
153566063|NCT06023641|Vincristine|vincristine|mesh-list
153566064|NCT06023641|Vinorelbine|vinorelbine|mesh-list
153782958|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
153566065|NCT06023641|Lenograstim|lenograstim|mesh-list
153782959|NCT00268398|Hematinics|hematinics|mesh-ancestor
153566066|NCT06023641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153566067|NCT06023641|Immunologic Factors|immunologic factors|mesh-ancestor
153566068|NCT06023641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375621|NCT01451996|Loratadine|loratadine|mesh-list
153566069|NCT06023641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153566106|NCT05995535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153566107|NCT05995535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153566129|NCT05994287|Sensory System Agents|sensory system agents|mesh-ancestor
153566130|NCT05994287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566131|NCT05994287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566132|NCT05994287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566133|NCT05994287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153566134|NCT05994287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153566135|NCT05994287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153566136|NCT05994287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566137|NCT05994287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153566138|NCT05994287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153566139|NCT05994287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782960|NCT00235313|Nicotine|nicotine|mesh-list
153782961|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153782962|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
153566190|NCT05991401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566208|NCT05899127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566209|NCT05899127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153566210|NCT05899127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153566211|NCT05899127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153566212|NCT05899127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153566213|NCT05899127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566214|NCT05899127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153359824|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
153439823|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
153439824|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439825|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153439826|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153566215|NCT05899127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153566217|NCT05899127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153566218|NCT05899127|Narcotics|narcotics|mesh-ancestor
153566219|NCT05899127|Analgesics|analgesics|mesh-ancestor
153566220|NCT05899127|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153566221|NCT05899127|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153566222|NCT05899127|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153566224|NCT05870800|Leucovorin|leucovorin|mesh-list
153566371|NCT05466279|Midazolam|midazolam|mesh-list
153566372|NCT05466279|Propofol|propofol|mesh-list
153566373|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153566374|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566375|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566376|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153566377|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
153566378|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
153566379|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153566380|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153566381|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153566417|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153566418|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153783022|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153783023|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
153783024|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153566425|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566426|NCT05428826|Prednisone|prednisone|mesh-list
153566427|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566428|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
153566429|NCT05428826|Hormones|hormones|mesh-ancestor
153566430|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566431|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566490|NCT06235151|Micronutrients|micronutrients|mesh-ancestor
153566491|NCT06235151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566521|NCT06234813|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153566522|NCT06234813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566523|NCT06234813|Antifungal Agents|antifungal agents|mesh-ancestor
153566524|NCT06234813|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153783028|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783029|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783030|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
153783031|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783032|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153783033|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783034|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
153783035|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783036|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153783037|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
153783038|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783039|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566525|NCT06234813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153566565|NCT06234592|Hemostatics|hemostatics|mesh-ancestor
153566632|NCT06234345|Cholinergic Agents|cholinergic agents|mesh-ancestor
153566633|NCT06234137|Carboplatin|carboplatin|mesh-list
153566634|NCT06234137|Docetaxel|docetaxel|mesh-list
153566635|NCT06234137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566636|NCT06234137|Tubulin Modulators|tubulin modulators|mesh-ancestor
153566637|NCT06234137|Antimitotic Agents|antimitotic agents|mesh-ancestor
153566638|NCT06234137|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440252|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153440253|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440254|NCT00003115|Analgesics|analgesics|mesh-ancestor
153440255|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
153440256|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440257|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
153440258|NCT00003667|Doxorubicin|doxorubicin|mesh-list
153440259|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153440260|NCT00003667|Vincristine|vincristine|mesh-list
153566639|NCT06234137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566640|NCT06234046|Ciprofloxacin|ciprofloxacin|mesh-list
153566641|NCT06234046|Rifaximin|rifaximin|mesh-list
153566642|NCT06234046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153566644|NCT06234046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153566645|NCT06234046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153566646|NCT06234046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566647|NCT06234046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566648|NCT06234046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566649|NCT06234046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153566650|NCT06234046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153566652|NCT06233994|Bevacizumab|bevacizumab|mesh-list
153566653|NCT06233994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566654|NCT06233994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566666|NCT06233799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153566667|NCT06233799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566668|NCT06233799|Sensory System Agents|sensory system agents|mesh-ancestor
153566669|NCT06233799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566671|NCT06233799|Antidepressive Agents|antidepressive agents|mesh-ancestor
153566688|NCT06233630|Sensory System Agents|sensory system agents|mesh-ancestor
153566689|NCT06233630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566691|NCT06233617|Dexmedetomidine|dexmedetomidine|mesh-list
153566692|NCT06233617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566693|NCT06233617|Antiemetics|antiemetics|mesh-ancestor
153566694|NCT06233617|Autonomic Agents|autonomic agents|mesh-ancestor
153566695|NCT06233617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566696|NCT06233617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566697|NCT06233617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153566698|NCT06233617|Glucocorticoids|glucocorticoids|mesh-ancestor
153566699|NCT06233617|Hormones|hormones|mesh-ancestor
153566700|NCT06233617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566701|NCT06233617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153566702|NCT06233617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566703|NCT06233617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153566704|NCT06233617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566705|NCT06233617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153566706|NCT06233617|Analgesics|analgesics|mesh-ancestor
153566707|NCT06233617|Sensory System Agents|sensory system agents|mesh-ancestor
153566708|NCT06233617|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153566709|NCT06233617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153566710|NCT06233617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153332112|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153332113|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
153332114|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
153332115|NCT01009619|Azithromycin|azithromycin|mesh-list
153332116|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153332117|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332118|NCT01010009|Resveratrol|resveratrol|mesh-list
153332119|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
153332120|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332121|NCT01010009|Protective Agents|protective agents|mesh-ancestor
153332122|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332123|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332124|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153332125|NCT04467424|Lidocaine|lidocaine|mesh-list
153332126|NCT04467424|Ketamine|ketamine|mesh-list
153332127|NCT04467424|Propofol|propofol|mesh-list
153813343|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
153359825|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
153889546|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153332158|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
153332159|NCT00377104|Growth Substances|growth substances|mesh-ancestor
153332252|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
153332253|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153332254|NCT04425850|Ivermectin|ivermectin|mesh-list
153332255|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153332256|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332257|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153332258|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153332259|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153332260|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332261|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332263|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332264|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332265|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153332290|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153332291|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153332292|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332293|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332294|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
153332295|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332296|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153332343|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153332344|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153332345|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153332346|NCT03649750|Guaifenesin|guaifenesin|mesh-list
153332347|NCT03649750|Expectorants|expectorants|mesh-ancestor
153332348|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
153332349|NCT04343092|Ivermectin|ivermectin|mesh-list
153332350|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153332351|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332352|NCT01105117|Epoprostenol|epoprostenol|mesh-list
153332353|NCT01105117|Tezosentan|tezosentan|mesh-list
153332354|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153332355|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153332356|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
153332357|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
153332358|NCT03885154|Valproic Acid|valproic acid|mesh-list
153332359|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
153332360|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441000|NCT00003835|Protective Agents|protective agents|mesh-ancestor
153441001|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
153441002|NCT00003835|Vitamins|vitamins|mesh-ancestor
153441003|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
153441004|NCT00003847|Doxorubicin|doxorubicin|mesh-list
153441005|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153441006|NCT00003847|Vincristine|vincristine|mesh-list
153441007|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153441008|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441009|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441010|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441233|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441234|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153441235|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
153441236|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441237|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332361|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332362|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
153332363|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332364|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332417|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153332418|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
153332419|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332420|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153332422|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
153332423|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153332424|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332425|NCT00957671|Hormones|hormones|mesh-list
153332426|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332427|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332428|NCT04322968|Ketorolac|ketorolac|mesh-list
153332462|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153332464|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
153332465|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153332466|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
153332467|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332468|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
153332469|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
153332470|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332504|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332505|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153332506|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153332507|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153332535|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153332536|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153332537|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153332538|NCT00962039|Citalopram|citalopram|mesh-list
153332539|NCT00962039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153332540|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153332541|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332542|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332543|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332544|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
153332545|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460609|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
153332547|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
153332548|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153332549|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
153332550|NCT03375385|Propofol|propofol|mesh-list
153783164|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153783165|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153332551|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153332570|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332571|NCT03018665|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153332573|NCT03018665|Incretins|incretins|mesh-ancestor
153332574|NCT03018665|Hormones|hormones|mesh-ancestor
153332575|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332576|NCT03012763|Acetaminophen|acetaminophen|mesh-list
153332577|NCT03012763|Fexofenadine|fexofenadine|mesh-list
153332578|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
153376064|NCT06191289|Estradiol|estradiol|mesh-list
153332579|NCT03012763|Valsartan|valsartan|mesh-list
153332580|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332581|NCT03012763|Analgesics|analgesics|mesh-ancestor
153332582|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
153332583|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332584|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332585|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
153332586|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153332587|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153332643|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441608|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441609|NCT00004393|Risperidone|risperidone|mesh-list
153441610|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153332644|NCT03670030|Sirolimus|sirolimus|mesh-list
153332645|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153332646|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332647|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153332648|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332649|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
153332650|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153332651|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
153332652|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332653|NCT03859960|Insulin|insulin|mesh-list
153332654|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153332688|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
153332690|NCT02066623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153332691|NCT02066623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153332692|NCT02066623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332693|NCT02066623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332694|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153332695|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
153332696|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332697|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332698|NCT04974151|Folic Acid|folic acid|mesh-list
153332738|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332855|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
153332856|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332857|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332858|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153332859|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153332860|NCT03805672|Enoxaparin|enoxaparin|mesh-list
153332861|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
153332862|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
153332863|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153332864|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153332865|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332866|NCT03802864|Bupivacaine|bupivacaine|mesh-list
153332867|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
153332868|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
153332869|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332870|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442339|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
153442340|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442341|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813356|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153332871|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
153332872|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332873|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
153332874|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
153332875|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153332876|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153332877|NCT03797872|Prednisolone|prednisolone|mesh-list
153332905|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332906|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332907|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
153332908|NCT03797872|Hormones|hormones|mesh-ancestor
153332909|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332910|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153332911|NCT03797872|Protective Agents|protective agents|mesh-ancestor
153332912|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153332913|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332914|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153332915|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332916|NCT03797872|Analgesics|analgesics|mesh-ancestor
153873036|NCT01125046|Antibodies|antibodies|mesh-list
153460610|NCT01678027|Clarithromycin|clarithromycin|mesh-list
153460611|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153332917|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
153332918|NCT01127581|Dinoprostone|dinoprostone|mesh-list
153332919|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
153332920|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153332921|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332922|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
153332923|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153332945|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153332946|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332947|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153332948|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
153332949|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153332950|NCT02186665|Calcitriol|calcitriol|mesh-list
153359835|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889554|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
153889555|NCT01016977|Clindamycin|clindamycin|mesh-list
153889556|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
153889557|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
153442501|NCT02119026|Irinotecan|irinotecan|mesh-list
153332951|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153332952|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332953|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153332954|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332955|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332956|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153332958|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
153332959|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153333009|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
153333010|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333011|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333012|NCT00983918|Propofol|propofol|mesh-list
153333013|NCT00983918|Sevoflurane|sevoflurane|mesh-list
153333014|NCT00983918|Desflurane|desflurane|mesh-list
153333015|NCT00983918|Isoflurane|isoflurane|mesh-list
153333016|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153333017|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153333018|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333019|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153333020|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
153333021|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
153333022|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153333191|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
153333192|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333193|NCT01177735|Pomalidomide|pomalidomide|mesh-list
153333194|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
153333195|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333197|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153333198|NCT01177735|Growth Substances|growth substances|mesh-ancestor
153333199|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
153333200|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333201|NCT01135069|Tretinoin|tretinoin|mesh-list
153333202|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333203|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
153333204|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
153333205|NCT01178281|Thalidomide|thalidomide|mesh-list
153333206|NCT01178281|Pomalidomide|pomalidomide|mesh-list
153333207|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
153333241|NCT02181517|Growth Substances|growth substances|mesh-ancestor
153333242|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333243|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
153333244|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442748|NCT02083380|Piperaquine|piperaquine|mesh-list
153442749|NCT02083380|Artefenomel|artefenomel|mesh-list
153333245|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153333246|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153333247|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
153333281|NCT00980174|Denosumab|denosumab|mesh-list
153333282|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153333283|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333284|NCT01138969|Esomeprazole|esomeprazole|mesh-list
153333285|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153333286|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153333287|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153333370|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333394|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
153333395|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
153333396|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333398|NCT04558502|Clarithromycin|clarithromycin|mesh-list
153333399|NCT04558502|Minocycline|minocycline|mesh-list
153333400|NCT04558502|Esomeprazole|esomeprazole|mesh-list
153333401|NCT04558502|Bismuth|bismuth|mesh-list
153333402|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333403|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333404|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153333405|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153333406|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153333407|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333408|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333409|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153333410|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153333411|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153333412|NCT04558502|Antacids|antacids|mesh-ancestor
153333413|NCT01218997|Naltrexone|naltrexone|mesh-list
153333414|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153333415|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153333416|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333417|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
153333418|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333419|NCT01219777|Paclitaxel|paclitaxel|mesh-list
153333451|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153333526|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333527|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
153333528|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333529|NCT05604638|Tenecteplase|tenecteplase|mesh-list
153333530|NCT05604638|Tirofiban|tirofiban|mesh-list
153333531|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153333532|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153333533|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333534|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153333535|NCT03033758|Budesonide|budesonide|mesh-list
153333536|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
153359837|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153359838|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153359839|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
153443567|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443568|NCT01989156|Menthol|menthol|mesh-list
153443569|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
153443570|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
153443571|NCT01965834|Fenofibrate|fenofibrate|mesh-list
153443572|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
153443573|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153443574|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
153443575|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333537|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333538|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153333539|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
153333540|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333541|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333542|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153333543|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
153333544|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
153333545|NCT03033758|Hormones|hormones|mesh-ancestor
153333546|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153333547|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153333548|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153333549|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153333550|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153333551|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333552|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333553|NCT01016483|Gemcitabine|gemcitabine|mesh-list
153333554|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333555|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
153333556|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333557|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333558|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
153333559|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
153873175|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
153333596|NCT04120454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153333597|NCT04120454|Growth Substances|growth substances|mesh-ancestor
153333598|NCT04120454|Growth Inhibitors|growth inhibitors|mesh-ancestor
153376217|NCT06190132|Gabapentin|gabapentin|mesh-list
153333599|NCT01017653|Irinotecan|irinotecan|mesh-list
153333600|NCT01017653|Panitumumab|panitumumab|mesh-list
153333601|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153333602|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153333638|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
153333639|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333640|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333671|NCT00972335|Growth Substances|growth substances|mesh-ancestor
153333672|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359840|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359841|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444362|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444363|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
153444364|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153444366|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153444367|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444368|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153333673|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
153333674|NCT00972335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153333675|NCT00972335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153333676|NCT00972335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333677|NCT00972335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333678|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333679|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
153783173|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333681|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
153333682|NCT03341156|Coagulants|coagulants|mesh-ancestor
153333683|NCT04122560|Fluconazole|fluconazole|mesh-list
153333684|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
153333685|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333686|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153333687|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153333688|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333723|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
153333724|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333725|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333753|NCT00973739|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153333754|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153333755|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333757|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333759|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153333760|NCT00974051|Terbutaline|terbutaline|mesh-list
153333761|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
153333762|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153333763|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333764|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
153333765|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333766|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333767|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153333768|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
153333784|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333785|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333786|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
153333787|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
153359843|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153444635|NCT02075021|Paclitaxel|paclitaxel|mesh-list
153444636|NCT02075021|Lenalidomide|lenalidomide|mesh-list
153444652|NCT00378677|Cyclosporine|cyclosporine|mesh-list
153444653|NCT00378677|Cyclosporins|cyclosporins|mesh-list
153444654|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444655|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333788|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153333789|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
153333790|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333791|NCT00977171|Droxidopa|droxidopa|mesh-list
153333792|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153333793|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153333794|NCT04129424|Insulin|insulin|mesh-list
153333795|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153333796|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333798|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153333799|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
153333805|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
153333826|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153333827|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
153333828|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333829|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
153333830|NCT02984228|Protective Agents|protective agents|mesh-ancestor
153333857|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333858|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333860|NCT03827876|Vitamins|vitamins|mesh-ancestor
153333861|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
153333862|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153333863|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
153333864|NCT03898934|Vitamin D|vitamin d|mesh-list
153333865|NCT03898934|Vitamins|vitamins|mesh-ancestor
153333866|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
153333867|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333868|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153333869|NCT04128800|Apatinib|apatinib|mesh-list
153333870|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333871|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153334045|NCT03826316|Nalbuphine|nalbuphine|mesh-list
153334046|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153334047|NCT03826316|Narcotics|narcotics|mesh-ancestor
153334114|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
153334115|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153334116|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153334117|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153334118|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334119|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334121|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153334122|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
153334123|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153334124|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153334125|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334126|NCT01222195|Lenalidomide|lenalidomide|mesh-list
153334152|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153334153|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153334154|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153334155|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153334156|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334157|NCT03829592|Misoprostol|misoprostol|mesh-list
153334158|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153334159|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
153445331|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445333|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153445334|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
153445335|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
153445336|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153445337|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153445338|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445413|NCT00000881|Cidofovir|cidofovir|mesh-list
153445414|NCT00000881|Probenecid|probenecid|mesh-list
153445415|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
153445416|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
153334160|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153334217|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334218|NCT03824834|Morphine|morphine|mesh-list
153334219|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153334220|NCT03824834|Narcotics|narcotics|mesh-ancestor
153334291|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334293|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153334295|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334296|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334297|NCT00982553|Ribavirin|ribavirin|mesh-list
153334298|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
153334332|NCT05509374|Dexamethasone|dexamethasone|mesh-list
153334333|NCT05509374|Pomalidomide|pomalidomide|mesh-list
153334334|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334335|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
153334336|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
153334337|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334338|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334339|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334340|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
153334341|NCT05509374|Hormones|hormones|mesh-ancestor
153387595|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153334371|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
153334372|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
153334373|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
153334374|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334375|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334377|NCT02565108|Clobazam|clobazam|mesh-list
153334378|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
153334379|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153334380|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153334381|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334382|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334383|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153334421|NCT02564952|Cannabidiol|cannabidiol|mesh-list
153334422|NCT02564952|Clobazam|clobazam|mesh-list
153334423|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
153334462|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334463|NCT03820622|Paclitaxel|paclitaxel|mesh-list
153334464|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153334465|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153334496|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153334497|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153334498|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153334499|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
153334500|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334501|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334502|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153334503|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153334504|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153334505|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153334506|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334507|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334508|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334509|NCT05508516|Analgesics|analgesics|mesh-ancestor
153334510|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
153446208|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446209|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446210|NCT00000653|Zalcitabine|zalcitabine|mesh-list
153446211|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
153446212|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446213|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153387596|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334548|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
153334549|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334550|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334551|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153334628|NCT05560308|Immunologic Factors|immunologic factors|mesh-ancestor
153334629|NCT05560308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334631|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
153334632|NCT01456208|Giapreza|giapreza|mesh-list
153334633|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
153334634|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153334635|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153334636|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
153334637|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334638|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334639|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334640|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
153731951|NCT04724187|Oxytocin|oxytocin|mesh-list
153731952|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
153731953|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153731954|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731955|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153731956|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
153731957|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153731958|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731959|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
153731960|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153334641|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
153334642|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334643|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153334644|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153334645|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
153334646|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334802|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153334803|NCT04391660|Eusol|eusol|mesh-list
153334804|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153334805|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153334806|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334807|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334808|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334809|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
153334810|NCT04842422|Imiquimod|imiquimod|mesh-list
153334811|NCT04842422|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153334812|NCT04842422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334813|NCT04842422|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153334814|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
153334815|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446845|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153446846|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153446847|NCT00002453|Tenofovir|tenofovir|mesh-list
153446848|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
153334816|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153334817|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334818|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
153334819|NCT04066426|Acetaminophen|acetaminophen|mesh-list
153334820|NCT04066426|Dexamethasone|dexamethasone|mesh-list
153334821|NCT04066426|Naproxen|naproxen|mesh-list
153334822|NCT04066426|Codeine|codeine|mesh-list
153334849|NCT01450514|Pipamperone|pipamperone|mesh-list
153334850|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153334851|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
153334852|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334853|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334854|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334855|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153334856|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153334857|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153731961|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
153376340|NCT06104449|Dexamethasone|dexamethasone|mesh-list
153334858|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153334859|NCT04758728|Epinephrine|epinephrine|mesh-list
153334860|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153334861|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153334862|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
153334863|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334864|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430716|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153430717|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153430718|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
153430719|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447199|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447524|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153447525|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
153447526|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447527|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447528|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153447529|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
153447530|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447531|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447532|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153447533|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447956|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
153447957|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447958|NCT00382499|Lidocaine|lidocaine|mesh-list
153447959|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
153430720|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153430721|NCT00000217|Carbamazepine|carbamazepine|mesh-list
153430722|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
153430723|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
153334865|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334866|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153334867|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153334868|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
153334869|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334870|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153334871|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334908|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153334909|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153334974|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153334976|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
153334977|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
153334978|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
153387598|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153335015|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
153335016|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335017|NCT01188109|Gemcitabine|gemcitabine|mesh-list
153335056|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153335094|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153335126|NCT05495724|Immunoconjugates|immunoconjugates|mesh-ancestor
153335127|NCT05495724|Immunologic Factors|immunologic factors|mesh-ancestor
153335128|NCT05495724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335129|NCT02559414|Aspirin|aspirin|mesh-list
153335130|NCT02559414|Clopidogrel|clopidogrel|mesh-list
153335131|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153335133|NCT02559414|Analgesics|analgesics|mesh-ancestor
153414098|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153335218|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153335219|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153335247|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
153447960|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
153447961|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153448310|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153448311|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448312|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448313|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153448314|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
153448315|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448316|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448317|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153448318|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153889584|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
153889585|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889586|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
153889587|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153889588|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
153889589|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335248|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335249|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335250|NCT05025644|Protective Agents|protective agents|mesh-ancestor
153335251|NCT05494710|Bleomycin|bleomycin|mesh-list
153335252|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153335253|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335254|NCT03810066|Osimertinib|osimertinib|mesh-list
153335255|NCT03810066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153335256|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153335257|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335258|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335259|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335260|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
153335261|NCT03992482|Antibodies|antibodies|mesh-list
153335262|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
153731962|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153376368|NCT06060405|Durvalumab|durvalumab|mesh-list
153335263|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153335264|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153335265|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
153335266|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335267|NCT00377494|Vaccines|vaccines|mesh-list
153783185|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153335301|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335302|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335303|NCT02880020|Nivolumab|nivolumab|mesh-list
153335317|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153335318|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
153335319|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335320|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335321|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335322|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153460612|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335323|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335324|NCT01459406|Levan|levan|mesh-list
153335325|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335326|NCT05489952|Iron|iron|mesh-list
153335327|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153335328|NCT05489952|Trace Elements|trace elements|mesh-ancestor
153335329|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
153335330|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335331|NCT05489952|Hematinics|hematinics|mesh-ancestor
153335332|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
153335333|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153335334|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
153335335|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335336|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
153335337|NCT01459640|Protective Agents|protective agents|mesh-ancestor
153335338|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
153335339|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153335340|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335341|NCT01500772|Ribavirin|ribavirin|mesh-list
153335342|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153335343|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
153335344|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335345|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
153335346|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335347|NCT04272476|Fluoxetine|fluoxetine|mesh-list
153335348|NCT04272476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153335349|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153335350|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153335351|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335352|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335353|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
153335354|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335355|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153335356|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
153335357|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153335360|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335363|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
153335364|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153335365|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153335430|NCT01472692|Febuxostat|febuxostat|mesh-list
153335431|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
153335432|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335433|NCT00378820|Caseins|caseins|mesh-list
153335434|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
153335435|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
153335436|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335437|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153335438|NCT02558400|Latanoprost|latanoprost|mesh-list
153783187|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153783188|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783189|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783190|NCT02212990|Acetaminophen|acetaminophen|mesh-list
153783191|NCT02212990|Ibuprofen|ibuprofen|mesh-list
153783192|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153783193|NCT02212990|Analgesics|analgesics|mesh-ancestor
153783194|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
153335463|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335465|NCT05493618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335466|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
153335467|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153430731|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430732|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153430733|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430734|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450360|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450361|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
153450362|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450363|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450364|NCT00005615|Interferons|interferons|mesh-list
153430735|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153430736|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153430737|NCT00000223|Buprenorphine|buprenorphine|mesh-list
153335468|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335469|NCT02936206|Tamoxifen|tamoxifen|mesh-list
153335470|NCT02936206|Fulvestrant|fulvestrant|mesh-list
153335471|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153335472|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
153335473|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335474|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335475|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153335476|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873454|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153460613|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153460614|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460615|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460616|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153460617|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153335477|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153335478|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153335479|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153335480|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153335481|NCT01891526|Tretinoin|tretinoin|mesh-list
153335482|NCT01891526|Alitretinoin|alitretinoin|mesh-list
153335483|NCT01891526|Isotretinoin|isotretinoin|mesh-list
153335484|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450423|NCT00385931|Simvastatin|simvastatin|mesh-list
153450424|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153450425|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153450426|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
153450427|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450428|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153450429|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153450568|NCT05892913|Sympathomimetics|sympathomimetics|mesh-ancestor
153450569|NCT05892913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153450570|NCT05892913|Adrenergic Agents|adrenergic agents|mesh-ancestor
153450571|NCT05887830|Nivolumab|nivolumab|mesh-list
153450572|NCT05887830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153450573|NCT05887830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450574|NCT05887830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153450575|NCT05887830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450576|NCT05885230|Lidocaine|lidocaine|mesh-list
153450577|NCT05885230|Bupivacaine|bupivacaine|mesh-list
153450578|NCT05885230|Anesthetics, Local|anesthetics, local|mesh-ancestor
153450579|NCT05885230|Anesthetics|anesthetics|mesh-ancestor
153450580|NCT05885230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335485|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
153335486|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
153335487|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
153335513|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153335514|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153783196|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335515|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153335516|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153335519|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153335520|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335521|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
153335522|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
153335523|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
153335524|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335526|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153335527|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
153335528|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335529|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335530|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359845|NCT03742349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153889606|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153889607|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153450617|NCT05727098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153450618|NCT05727098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153450619|NCT05727098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450621|NCT05656352|Chrysarobin|chrysarobin|mesh-list
153450622|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153450623|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153450624|NCT05656352|Analgesics|analgesics|mesh-ancestor
153450625|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
153450725|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
153450726|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450727|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153450728|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335531|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153335532|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153335533|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335534|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153335535|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153335536|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
153335537|NCT05021978|Pramoxine|pramoxine|mesh-list
153335559|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335560|NCT05599828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153335561|NCT05599828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335562|NCT05599828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335563|NCT01350232|Cytarabine|cytarabine|mesh-list
153335564|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
153335565|NCT01350232|Rituximab|rituximab|mesh-list
153335566|NCT01350232|Fludarabine|fludarabine|mesh-list
153335567|NCT01350232|Bortezomib|bortezomib|mesh-list
153335568|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153335569|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
153335570|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335571|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335572|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153335573|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
153335574|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335575|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335576|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153335577|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335578|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335580|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
153335581|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335582|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
153335583|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153783197|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
153783198|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153335584|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335585|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335586|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153335587|NCT05493228|Analgesics|analgesics|mesh-ancestor
153335588|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
153335589|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460618|NCT01121588|Crizotinib|crizotinib|mesh-list
153460619|NCT01121588|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153460620|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460621|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820705|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153596969|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153596971|NCT01865630|Analgesics|analgesics|mesh-ancestor
153596972|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
153335590|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153335591|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153335592|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153335593|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
153335594|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335595|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335597|NCT02758132|Prednisone|prednisone|mesh-list
153335598|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335635|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153335637|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
153335638|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
153335639|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
153335670|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153335671|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
153335672|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153335673|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
153335674|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
153335675|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153335676|NCT01892150|Protective Agents|protective agents|mesh-ancestor
153335677|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335678|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
153335679|NCT02663752|Deferasirox|deferasirox|mesh-list
153335680|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153335681|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
153335682|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
153335683|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335684|NCT01253668|Antibodies|antibodies|mesh-list
153335732|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
153335733|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
153335734|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335735|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335748|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
153335749|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335750|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335751|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
153335753|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153335754|NCT02549716|Analgesics|analgesics|mesh-ancestor
153335755|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
153335756|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335757|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335758|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
153451132|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153451133|NCT03864042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153451135|NCT03864042|Analgesics|analgesics|mesh-ancestor
153451136|NCT03864042|Sensory System Agents|sensory system agents|mesh-ancestor
153451137|NCT03864042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451138|NCT03737604|Bupivacaine|bupivacaine|mesh-list
153451139|NCT03737604|Ropivacaine|ropivacaine|mesh-list
153430749|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451140|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
153451141|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
153451142|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451143|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451242|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451243|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451245|NCT02246920|Xhance|xhance|mesh-list
153335759|NCT01207726|Azacitidine|azacitidine|mesh-list
153335760|NCT01207726|Entinostat|entinostat|mesh-list
153335761|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153335762|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335763|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
153335764|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335766|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335767|NCT02534038|Quinidine|quinidine|mesh-list
153335768|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
153335769|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
153335770|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
153335771|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153335772|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153335773|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335777|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153335788|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153335789|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153335790|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153335791|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153335792|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153335793|NCT01202110|Propranolol|propranolol|mesh-list
153335794|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153335795|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153335796|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
153335797|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335818|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153335819|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
153335820|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153335821|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153335822|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335823|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335824|NCT00379756|Urological Agents|urological agents|mesh-ancestor
153335826|NCT02518750|Dexamethasone|dexamethasone|mesh-list
153335827|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
153451265|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
153451266|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
153451267|NCT01210625|Psyllium|psyllium|mesh-list
153451268|NCT01210625|Cathartics|cathartics|mesh-ancestor
153451269|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451270|NCT01009190|Carboplatin|carboplatin|mesh-list
153451271|NCT01009190|Rucaparib|rucaparib|mesh-list
153451272|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451273|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153451274|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451275|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451366|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153451367|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153451368|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335828|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
153335829|NCT02518750|Methotrexate|methotrexate|mesh-list
153335830|NCT02518750|Etoposide|etoposide|mesh-list
153335831|NCT02518750|Vincristine|vincristine|mesh-list
153335832|NCT02518750|Bortezomib|bortezomib|mesh-list
153335833|NCT02518750|Asparaginase|asparaginase|mesh-list
153335834|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
153335835|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
153335836|NCT02518750|Clofarabine|clofarabine|mesh-list
153335837|NCT02518750|Panobinostat|panobinostat|mesh-list
153335838|NCT02518750|Pegaspargase|pegaspargase|mesh-list
153335840|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
153335849|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
153335850|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
153335851|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335872|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153335873|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
153335874|NCT02518750|Analgesics|analgesics|mesh-ancestor
153335875|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
153335876|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153335877|NCT01194856|Ritonavir|ritonavir|mesh-list
153335878|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153335879|NCT01194856|Efavirenz|efavirenz|mesh-list
153335880|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153335881|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153335882|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
153335883|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335884|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335885|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153783200|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335886|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153335887|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
153335888|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783201|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153335889|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153335890|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153335891|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153335892|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153335893|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153335894|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153335899|NCT01182610|Carboplatin|carboplatin|mesh-list
153335934|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153451535|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
153451536|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451537|NCT00003899|Paclitaxel|paclitaxel|mesh-list
153451538|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
153451539|NCT00003899|Melphalan|melphalan|mesh-list
153451540|NCT00003899|Thiotepa|thiotepa|mesh-list
153451541|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153451542|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451543|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
153451544|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
153451545|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
153451546|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335935|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335936|NCT05487300|Levodopa|levodopa|mesh-list
153335937|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153335938|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153335939|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
153335940|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335941|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335942|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335943|NCT01147042|Interferons|interferons|mesh-list
153335944|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
153335945|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335946|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
153335947|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335948|NCT05485272|Fluorides|fluorides|mesh-list
153335949|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
153335950|NCT05485272|Protective Agents|protective agents|mesh-ancestor
153335951|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335952|NCT01108666|Nelfinavir|nelfinavir|mesh-list
153335953|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153335954|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153335955|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
153335989|NCT02297230|Paclitaxel|paclitaxel|mesh-list
153414313|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336079|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153336080|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336105|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
153336106|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336107|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153783205|NCT00235859|Methotrexate|methotrexate|mesh-list
153783206|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153336108|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153336109|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336110|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336111|NCT05478876|Immunomodulating Agents|immunomodulating agents|mesh-list
153336112|NCT05478876|Immunologic Factors|immunologic factors|mesh-ancestor
153336113|NCT05478876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336114|NCT01188421|Clonidine|clonidine|mesh-list
153336115|NCT01188421|Buprenorphine|buprenorphine|mesh-list
153889654|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153889655|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153889656|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153889657|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
153451911|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153451912|NCT01911780|Diuretics|diuretics|mesh-ancestor
153451913|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
153451914|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153451915|NCT01911546|Everolimus|everolimus|mesh-list
153451916|NCT01911546|Tacrolimus|tacrolimus|mesh-list
153451917|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153336116|NCT01188421|Tramadol|tramadol|mesh-list
153336117|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153336118|NCT01188421|Naloxone|naloxone|mesh-list
153336119|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153336120|NCT01188421|Narcotics|narcotics|mesh-ancestor
153336121|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336122|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336123|NCT01188421|Analgesics|analgesics|mesh-ancestor
153336124|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
153336125|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336126|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153336127|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153336128|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
153336129|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
153596973|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596974|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460622|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460623|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460624|NCT00739986|Semapimod|semapimod|mesh-list
153460625|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153460626|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153460627|NCT00739986|Analgesics|analgesics|mesh-ancestor
153460628|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
153460629|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596975|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596976|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596977|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596978|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153596979|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
153336130|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153336154|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153359848|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153359849|NCT03703492|Estradiol|estradiol|mesh-list
153451939|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
153451940|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153452080|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
153452081|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452082|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153452083|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
153452084|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452085|NCT01862250|Clonidine|clonidine|mesh-list
153452086|NCT01862250|Analgesics|analgesics|mesh-ancestor
153452087|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
153452088|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452089|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452090|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153452091|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
153430793|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153430794|NCT00000259|Analgesics|analgesics|mesh-ancestor
153430795|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
153336155|NCT00996502|Growth Substances|growth substances|mesh-ancestor
153336156|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336157|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
153336158|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
153452162|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153336159|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
153336160|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
153336161|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336162|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336164|NCT00996502|Hormones|hormones|mesh-ancestor
153336165|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336166|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153336167|NCT00996502|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153336168|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153336169|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336170|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153336171|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336172|NCT05484024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336173|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336174|NCT02027272|Dexamethasone|dexamethasone|mesh-list
153336175|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
153336176|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336177|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
153336222|NCT04331626|Gemcitabine|gemcitabine|mesh-list
153452252|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153452253|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153452254|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
153783675|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452255|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452256|NCT01854918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153452257|NCT01854918|Protease Inhibitors|protease inhibitors|mesh-ancestor
153452258|NCT01854918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452358|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
153452359|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153452360|NCT01851330|Ledipasvir|ledipasvir|mesh-list
153336223|NCT04331626|Nivolumab|nivolumab|mesh-list
153336224|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153336225|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
153336226|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336227|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336228|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336229|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153336230|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153336231|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153336232|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153336233|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
153336234|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336266|NCT00932152|Anastrozole|anastrozole|mesh-list
153336267|NCT00932152|Analgesics|analgesics|mesh-list
153336268|NCT00932152|Antiemetics|antiemetics|mesh-list
153336269|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336270|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336271|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153336272|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153336273|NCT00932152|Growth Substances|growth substances|mesh-ancestor
153336274|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336275|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
153336276|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336277|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153336278|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153336279|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153336280|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
153336281|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336298|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153336299|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452435|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
153452436|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
153452437|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
153452438|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452439|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452440|NCT01867086|Carboplatin|carboplatin|mesh-list
153452441|NCT01867086|Vaccines|vaccines|mesh-list
153452442|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
153452443|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452444|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452467|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452468|NCT01803282|Leucovorin|leucovorin|mesh-list
153452469|NCT01803282|Paclitaxel|paclitaxel|mesh-list
153452470|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153452471|NCT01803282|Bevacizumab|bevacizumab|mesh-list
153452472|NCT01803282|Carboplatin|carboplatin|mesh-list
153452473|NCT01803282|Gemcitabine|gemcitabine|mesh-list
153452474|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
153452476|NCT01803282|Pemetrexed|pemetrexed|mesh-list
153452478|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336308|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336309|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153336310|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
153336311|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153336312|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153336313|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336314|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153336315|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
153336316|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153336318|NCT03428958|Bevacizumab|bevacizumab|mesh-list
153336319|NCT03428958|Cetuximab|cetuximab|mesh-list
153336320|NCT03428958|Panitumumab|panitumumab|mesh-list
153336321|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
153336322|NCT03428958|Irinotecan|irinotecan|mesh-list
153336323|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
153336324|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336325|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336326|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153336327|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153336328|NCT03428958|Growth Substances|growth substances|mesh-ancestor
153336329|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336330|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
153336331|NCT03428958|Antidotes|antidotes|mesh-ancestor
153336332|NCT03428958|Protective Agents|protective agents|mesh-ancestor
153596980|NCT01865669|Oxytocin|oxytocin|mesh-list
153596981|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
153596982|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153596983|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596984|NCT01865721|Entonox|entonox|mesh-list
153596985|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153596986|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
153596987|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596988|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596989|NCT01865760|Octreotide|octreotide|mesh-list
153596990|NCT01865760|Somatostatin|somatostatin|mesh-list
153596991|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153596992|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153596993|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596994|NCT01865760|Hormones|hormones|mesh-ancestor
153596995|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153596996|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452486|NCT01803282|Growth Substances|growth substances|mesh-ancestor
153452488|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
153452540|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
153452541|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
153452542|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153452643|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153452644|NCT01796964|Growth Substances|growth substances|mesh-ancestor
153452645|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452646|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
153783676|NCT04541251|Paclitaxel|paclitaxel|mesh-list
153783677|NCT04541251|Carboplatin|carboplatin|mesh-list
153452647|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452648|NCT01794780|Fluticasone|fluticasone|mesh-list
153452649|NCT01794780|Budesonide|budesonide|mesh-list
153452650|NCT01794780|Theophylline|theophylline|mesh-list
153596997|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
153596998|NCT01865916|Bisacodyl|bisacodyl|mesh-list
153596999|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
153819227|NCT02713607|Doxycycline|doxycycline|mesh-list
153819228|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153819229|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819230|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
153819231|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153597002|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336334|NCT03428958|Vitamins|vitamins|mesh-ancestor
153336335|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
153336336|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153336337|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153336338|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336339|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336340|NCT01844206|Morphine|morphine|mesh-list
153336341|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153336342|NCT01844206|Narcotics|narcotics|mesh-ancestor
153336343|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336378|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336379|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153336380|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
153336382|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153336383|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153336384|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153336410|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153336411|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
153336412|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336413|NCT00843310|Dexamethasone|dexamethasone|mesh-list
153336414|NCT00843310|Lenalidomide|lenalidomide|mesh-list
153336416|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336417|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
153336418|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
153336419|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336420|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336421|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153336422|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
153336423|NCT00843310|Hormones|hormones|mesh-ancestor
153336424|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452735|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452736|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452737|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153452738|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153452761|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153452762|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452763|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452765|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
153452766|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452767|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452768|NCT01792518|Linagliptin|linagliptin|mesh-list
153336425|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153597004|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
153597005|NCT01865916|Cathartics|cathartics|mesh-ancestor
153597006|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597007|NCT01865916|Laxatives|laxatives|mesh-ancestor
153597008|NCT01865968|Vaccines|vaccines|mesh-list
153597009|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
153597010|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597011|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153597012|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
153597013|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597014|NCT01866033|Ibrutinib|ibrutinib|mesh-list
153597015|NCT01866033|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153597016|NCT01866033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153597017|NCT01866033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336427|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
153336428|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153336429|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153336430|NCT00843310|Growth Substances|growth substances|mesh-ancestor
153336431|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
153336432|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153336433|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
153336435|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153336436|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153336437|NCT00809458|Vitamin E|vitamin e|mesh-list
153336466|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153336468|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
153336469|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153336470|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
153336471|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336472|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336473|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153336474|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
153889679|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889680|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889681|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889682|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452787|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452788|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153452790|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452791|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
153452792|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
153336475|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153336476|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153336477|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153336478|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153336479|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
153336480|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153336481|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153336482|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153336483|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336514|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336515|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153336516|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
153336517|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597018|NCT01866033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597019|NCT01866059|Methamphetamine|methamphetamine|mesh-list
153597020|NCT01866059|Calcium|calcium|mesh-list
153597021|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153597022|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597023|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153597024|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
153336518|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336519|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153336520|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
153336521|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
153336522|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153336523|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153336524|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153336525|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153336526|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
153336527|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336528|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336529|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
153336557|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
153336559|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336560|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336561|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
153336562|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336564|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
153336565|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336566|NCT00691444|Protective Agents|protective agents|mesh-ancestor
153336567|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336568|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813371|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452927|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452928|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889683|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153889684|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336569|NCT05482464|Caseins|caseins|mesh-list
153336570|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
153336571|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
153336572|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336573|NCT01530880|Acetaminophen|acetaminophen|mesh-list
153336655|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
153336689|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336690|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153336691|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153336692|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336693|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336695|NCT00529282|Cefepime|cefepime|mesh-list
153336696|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
153336697|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
153336698|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153336699|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336712|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
153336713|NCT02550288|Atorvastatin|atorvastatin|mesh-list
153336714|NCT02550288|Ezetimibe|ezetimibe|mesh-list
153336715|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153336716|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153336717|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
153336718|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336719|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153336720|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153336721|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336722|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
153336723|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
153336724|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153336725|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
153336726|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153336727|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153336728|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336729|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153336730|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336731|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336732|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153336734|NCT00500890|Carboplatin|carboplatin|mesh-list
153336735|NCT00500890|Etoposide|etoposide|mesh-list
153336736|NCT00500890|Vincristine|vincristine|mesh-list
153336737|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153336738|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
153819232|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153819233|NCT02698254|Bevacizumab|bevacizumab|mesh-list
153336739|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336741|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153336742|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
153336743|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889701|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889702|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
153889703|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
153889704|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430826|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430827|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430828|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153430829|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153430830|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430831|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
153430832|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336744|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336745|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153336746|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153336747|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153336748|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153336749|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336750|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
153336751|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153336752|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
153336753|NCT00000736|Zidovudine|zidovudine|mesh-list
153336754|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
153336755|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336756|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153336757|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153336758|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336759|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
153336790|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153336791|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153336792|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
153336793|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336798|NCT00000766|Foscarnet|foscarnet|mesh-list
153336844|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
153336845|NCT00000796|Levofloxacin|levofloxacin|mesh-list
153336846|NCT00000796|Cycloserine|cycloserine|mesh-list
153336847|NCT00000796|Rifampin|rifampin|mesh-list
153336848|NCT00000796|Isoniazid|isoniazid|mesh-list
153336849|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
153336850|NCT00000796|Amikacin|amikacin|mesh-list
153336851|NCT00000796|Ethambutol|ethambutol|mesh-list
153336852|NCT00000796|Clofazimine|clofazimine|mesh-list
153336853|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
153336854|NCT00000796|Streptomycin|streptomycin|mesh-list
153336886|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153336891|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153336892|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153336893|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153453014|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453015|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153453016|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
153453065|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153453066|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153453067|NCT01768572|Analgesics|analgesics|mesh-ancestor
153453068|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
153453069|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453072|NCT01783548|Beclomethasone|beclomethasone|mesh-list
153336894|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336895|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336926|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336927|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336929|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153336930|NCT00268450|Growth Substances|growth substances|mesh-ancestor
153336931|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336932|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
153336933|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153336934|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
153336935|NCT00000808|Nevirapine|nevirapine|mesh-list
153336936|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153336937|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153336938|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337020|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153337021|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
153337022|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337023|NCT00000844|Interferons|interferons|mesh-list
153337024|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
153337025|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337026|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
153337027|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337028|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
153337060|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153337061|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337062|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
153337064|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337065|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337066|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337067|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
153337068|NCT02634008|Ritonavir|ritonavir|mesh-list
153337069|NCT02634008|Ribavirin|ribavirin|mesh-list
153337070|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153337071|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153337072|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
153337073|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453093|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153453095|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
153453096|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153453097|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
153453098|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
153453099|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153453100|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
153453101|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453102|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
153453103|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
153453104|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453105|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453140|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153453143|NCT01808118|Adalimumab|adalimumab|mesh-list
153337074|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337095|NCT00000856|Ganciclovir|ganciclovir|mesh-list
153337096|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153337097|NCT00000856|Foscarnet|foscarnet|mesh-list
153337098|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153337099|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
153337100|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337101|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337102|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337105|NCT00001810|Voriconazole|voriconazole|mesh-list
153337116|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153337117|NCT00000862|Zidovudine|zidovudine|mesh-list
153337118|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
153337119|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337120|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337121|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337122|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337123|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
153337124|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337125|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153337126|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337162|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153337163|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153337164|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153337165|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337166|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
153337167|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153337229|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
153337230|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414595|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
153414596|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
153414597|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
153337296|NCT00000916|Indinavir|indinavir|mesh-list
153337297|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
153337298|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337299|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337332|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
153337333|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153337335|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
153337338|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337339|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337340|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
153337341|NCT05480280|Antidotes|antidotes|mesh-ancestor
153337342|NCT05480280|Protective Agents|protective agents|mesh-ancestor
153337343|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
153337344|NCT05480280|Vitamins|vitamins|mesh-ancestor
153337371|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
153337372|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359852|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337373|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
153337374|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153337375|NCT00000946|Protective Agents|protective agents|mesh-ancestor
153337376|NCT02543346|Cetirizine|cetirizine|mesh-list
153337377|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153337378|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153337379|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153337380|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
153337381|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
153337382|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337383|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337385|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
153873916|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337435|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337436|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783221|NCT00235859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153337508|NCT00000238|Narcotics|narcotics|mesh-ancestor
153337509|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337510|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337511|NCT00000238|Analgesics|analgesics|mesh-ancestor
153337544|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153337545|NCT00001954|Analgesics|analgesics|mesh-ancestor
153337546|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
153337547|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337548|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337549|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337587|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
153337588|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
153337589|NCT00000262|Sevoflurane|sevoflurane|mesh-list
153337590|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153453334|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153453335|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453336|NCT01732926|Rituximab|rituximab|mesh-list
153453337|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153453338|NCT01732926|Idelalisib|idelalisib|mesh-list
153453339|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153453340|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453341|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
153453342|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453343|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453344|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153453345|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
153453346|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453347|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453348|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
153453350|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153453382|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
153453383|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
153453384|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
153453385|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889724|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
153337622|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153337623|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153337625|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153337626|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
153337627|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
153337628|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153337629|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
153337666|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337667|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153337668|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337669|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
153337670|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337671|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
153337688|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
153337689|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337690|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153337691|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153819234|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153819235|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
153414637|NCT05345210|Tetracycline|tetracycline|mesh-list
153414638|NCT05345210|Furazolidone|furazolidone|mesh-list
153414639|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414640|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813377|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453388|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
153453389|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
153430853|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
153430854|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430855|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153430856|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
153453390|NCT01732458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153453391|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153453392|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
153453393|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453394|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453452|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453453|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153453454|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153453455|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
153453456|NCT01754376|Aldesleukin|aldesleukin|mesh-list
153453457|NCT01754376|Interleukin-2|interleukin-2|mesh-list
153453458|NCT01754376|Vemurafenib|vemurafenib|mesh-list
153453459|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414641|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153414642|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414643|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414644|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153873932|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153337692|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337693|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153873954|NCT02218398|Albuterol|albuterol|mesh-list
153337774|NCT02743598|Hormones|hormones|mesh-ancestor
153337775|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337777|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153337778|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153337779|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153337844|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153337845|NCT00000298|Narcotics|narcotics|mesh-ancestor
153337846|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337847|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337848|NCT00000298|Analgesics|analgesics|mesh-ancestor
153337849|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
153337850|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337851|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153337852|NCT00000304|Amphetamine|amphetamine|mesh-list
153337853|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
153337854|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153337855|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337856|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
153337857|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
153337858|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337859|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
153337860|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453464|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453465|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153453466|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153453467|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
153453468|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453469|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153453470|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453471|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453473|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453474|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153430869|NCT00584935|Rituximab|rituximab|mesh-list
153430870|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153453475|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153430871|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337885|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153337886|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153337887|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153337889|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873959|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153873960|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
153873961|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
153873962|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153873963|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153873964|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153873965|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153873966|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
153873967|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873968|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873969|NCT02218671|Brotizolam|brotizolam|mesh-list
153873970|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153337907|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153414683|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153414684|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
153414685|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
153414686|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414687|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783237|NCT00235898|Leucovorin|leucovorin|mesh-list
153783238|NCT00235898|Fluorouracil|fluorouracil|mesh-list
153783239|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
153387600|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338319|NCT00000412|Alendronate|alendronate|mesh-list
153338320|NCT00000412|Calcitriol|calcitriol|mesh-list
153731965|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338321|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153338322|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338323|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153338324|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153338325|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427683|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
153453536|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453537|NCT01729728|Tapentadol|tapentadol|mesh-list
153453538|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153453539|NCT01729728|Narcotics|narcotics|mesh-ancestor
153453540|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453541|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453542|NCT01729728|Analgesics|analgesics|mesh-ancestor
153453543|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
153453544|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453545|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153453546|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153453547|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153453548|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453581|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453582|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453583|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153338326|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338327|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153338329|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
153338330|NCT00002056|Pentamidine|pentamidine|mesh-list
153338331|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
153338359|NCT00000430|Estrogens|estrogens|mesh-list
153338360|NCT00000430|Progestins|progestins|mesh-list
153338361|NCT00000430|Hormones|hormones|mesh-ancestor
153338362|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338424|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153338425|NCT00000442|Naltrexone|naltrexone|mesh-list
153338452|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153338453|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338454|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
153338455|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338456|NCT00001318|Interferons|interferons|mesh-list
153338459|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
153338460|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338461|NCT00002074|Fluconazole|fluconazole|mesh-list
153338462|NCT00002074|Amphotericin B|amphotericin b|mesh-list
153338463|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153338464|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
153338465|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338466|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153338467|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153338468|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338469|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338470|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153338471|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
153338501|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338502|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153338503|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153338504|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
153338505|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338507|NCT00002080|Rifabutin|rifabutin|mesh-list
153873998|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873999|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874000|NCT01119859|Adalimumab|adalimumab|mesh-list
153874001|NCT01119859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153874002|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153874003|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874004|NCT02278926|Insulin|insulin|mesh-list
153874005|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453632|NCT01725126|Incretins|incretins|mesh-ancestor
153453665|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153453666|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153453667|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453668|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453669|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453670|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
153874006|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874007|NCT01119703|Vaccines|vaccines|mesh-list
153874008|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
153874009|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338628|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153338629|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153338630|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153338631|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
153338634|NCT00001426|Paclitaxel|paclitaxel|mesh-list
153414724|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414725|NCT02511535|Vaccines|vaccines|mesh-list
153414726|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
153414727|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414728|NCT03545035|Rituximab|rituximab|mesh-list
153414729|NCT03545035|Idelalisib|idelalisib|mesh-list
153414730|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153414731|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414732|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
153414733|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414734|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414735|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414736|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414737|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153414738|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153338756|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338757|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
153338758|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
153338759|NCT02688140|Cytarabine|cytarabine|mesh-list
153338760|NCT02688140|Methotrexate|methotrexate|mesh-list
153874028|NCT02881762|Maraviroc|maraviroc|mesh-list
153874029|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153874030|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153874031|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874032|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153874033|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153874034|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
153874035|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874036|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153338878|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153338879|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338880|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153338881|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
153359853|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338883|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153414759|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153414760|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153414761|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
153338952|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
153338977|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338978|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338979|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338980|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338982|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153338983|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153338984|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338985|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
153338986|NCT04389554|Coagulants|coagulants|mesh-ancestor
153338988|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153338989|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338990|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
153338991|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338992|NCT00000664|Zidovudine|zidovudine|mesh-list
153338993|NCT00000664|Interleukin-2|interleukin-2|mesh-list
153338994|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338995|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153338996|NCT00000664|Analgesics|analgesics|mesh-ancestor
153338997|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
153338998|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338999|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339000|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
153339001|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874071|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153874072|NCT02213159|Analgesics|analgesics|mesh-ancestor
153430891|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454036|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454037|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430892|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430893|NCT00000733|Ribavirin|ribavirin|mesh-list
153430894|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
153430895|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430896|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
153430897|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874073|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
153874074|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874075|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153874076|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153874077|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153874078|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
153874079|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414775|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339050|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153339051|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153339052|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339086|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339087|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
153339088|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153339089|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153339090|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153339091|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339092|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153339093|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339125|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339127|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339128|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339129|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
153339130|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339131|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339184|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153339185|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153339186|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339187|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
153339188|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153339221|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153339222|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153813384|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359856|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
153359857|NCT03568656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153359858|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359859|NCT03568656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359860|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359861|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153359862|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359863|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153359864|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
153813391|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153813392|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153813393|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813394|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454075|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153454076|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454077|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454078|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153339223|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153339224|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339225|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
153339226|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153339227|NCT00002320|Lamivudine|lamivudine|mesh-list
153339228|NCT00002320|Zidovudine|zidovudine|mesh-list
153339229|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339230|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339262|NCT02167217|Protective Agents|protective agents|mesh-ancestor
153339263|NCT00002326|Zidovudine|zidovudine|mesh-list
153339264|NCT00002326|Adefovir|adefovir|mesh-list
153339265|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
153339266|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339267|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339268|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339269|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339270|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
153339358|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153339359|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339360|NCT00002206|Adefovir|adefovir|mesh-list
153339361|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153339362|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
153339363|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339364|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339365|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339400|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
153339401|NCT02168309|Labetalol|labetalol|mesh-list
153339402|NCT02168309|Nifedipine|nifedipine|mesh-list
153339403|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153339404|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153731966|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
153731967|NCT04724226|Apatinib|apatinib|mesh-list
153731968|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731969|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153731970|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731971|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731972|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
153731973|NCT00140075|Epirubicin|epirubicin|mesh-list
153387602|NCT03465735|Heparin|heparin|mesh-list
153339430|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339431|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153414800|NCT00364429|Lorazepam|lorazepam|mesh-list
153819236|NCT02698254|Antibodies|antibodies|mesh-list
153819237|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
153819238|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153819239|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
153819240|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813395|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813396|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153813397|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
153813398|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
153813399|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153813400|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153813401|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153813402|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153813403|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
153359873|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153889756|NCT01309386|Morphine|morphine|mesh-list
153819241|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153819242|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153819243|NCT02698254|Growth Substances|growth substances|mesh-ancestor
153819244|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460630|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460631|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153460632|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460633|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460634|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
153460635|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
153460636|NCT00716976|Antidotes|antidotes|mesh-ancestor
153460637|NCT00716976|Protective Agents|protective agents|mesh-ancestor
153460638|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460639|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
153460640|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460641|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
153460642|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153460643|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460644|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
153597036|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153597037|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
153597038|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153597039|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889764|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889765|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153813407|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153813408|NCT00436059|Bortezomib|bortezomib|mesh-list
153813409|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359878|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153889766|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153889767|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153889768|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889769|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
153889770|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874096|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874098|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153874099|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153874100|NCT01118377|Capecitabine|capecitabine|mesh-list
153874101|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153874102|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
153874103|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874104|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874105|NCT02219178|Dexamethasone|dexamethasone|mesh-list
153874106|NCT02219178|Lenalidomide|lenalidomide|mesh-list
153874107|NCT02219178|Bortezomib|bortezomib|mesh-list
153874108|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153874109|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
153874110|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
153874111|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874115|NCT02219178|Hormones|hormones|mesh-ancestor
153339432|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153339433|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
153339495|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
153339496|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339497|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153339498|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339499|NCT00002386|Lamivudine|lamivudine|mesh-list
153339500|NCT00002386|Zidovudine|zidovudine|mesh-list
153339501|NCT00002386|Didanosine|didanosine|mesh-list
153339502|NCT00002386|Stavudine|stavudine|mesh-list
153339503|NCT00002386|Zalcitabine|zalcitabine|mesh-list
153339504|NCT00002386|Indinavir|indinavir|mesh-list
153339505|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339506|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339507|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339533|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153339535|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153339536|NCT02168855|Nicotine|nicotine|mesh-list
153339537|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153339538|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
153339539|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339540|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339541|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153339542|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153339543|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
153339544|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339545|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339546|NCT05751850|Leucovorin|leucovorin|mesh-list
153339547|NCT05751850|Paclitaxel|paclitaxel|mesh-list
153454469|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339548|NCT05751850|Gemcitabine|gemcitabine|mesh-list
153874123|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
153874124|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
153454470|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153454471|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153454473|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153454474|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
153454476|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
153454477|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153454478|NCT01582854|Actovegin|actovegin|mesh-list
153874125|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153874126|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874127|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
153874128|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874129|NCT02219217|Dolutegravir|dolutegravir|mesh-list
153874130|NCT02219217|Cobicistat|cobicistat|mesh-list
153874131|NCT02219217|Elvitegravir|elvitegravir|mesh-list
153874132|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153874133|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153874134|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874135|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874136|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153874137|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339598|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153339599|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
153339601|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153339634|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339636|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339637|NCT00997139|Polymyxins|polymyxins|mesh-list
153339638|NCT00997139|Neomycin|neomycin|mesh-list
153339639|NCT00997139|Bacitracin|bacitracin|mesh-list
153339640|NCT00997139|Polymyxin B|polymyxin b|mesh-list
153339641|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
153414839|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153414840|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414841|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414842|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414843|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414844|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153414845|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153339690|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153339691|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339692|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153339693|NCT01200433|Analgesics|analgesics|mesh-ancestor
153339694|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
153339695|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339696|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153454527|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454528|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
153454529|NCT01557504|Metformin|metformin|mesh-list
153454530|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153454531|NCT01557504|Hormones|hormones|mesh-list
153454532|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153454533|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454534|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454535|NCT01557504|Incretins|incretins|mesh-ancestor
153454536|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153454537|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
153454538|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454540|NCT01580670|Infliximab|infliximab|mesh-list
153339697|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153339731|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339732|NCT01924052|Calcitonin|calcitonin|mesh-list
153339733|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153339734|NCT01924052|Katacalcin|katacalcin|mesh-list
153339735|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153339736|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339737|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153339766|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153339767|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153339768|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153339769|NCT00381472|Ropinirole|ropinirole|mesh-list
153339770|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153339771|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153874144|NCT04577378|Isotretinoin|isotretinoin|mesh-list
153874145|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
153874146|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874147|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153874148|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153874149|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874150|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874151|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153874152|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
153874153|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874159|NCT02219412|Aspirin|aspirin|mesh-list
153339810|NCT05751304|Analgesics|analgesics|mesh-ancestor
153339811|NCT05751304|Sensory System Agents|sensory system agents|mesh-ancestor
153339812|NCT05751304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339813|NCT05751304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153339815|NCT05751304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153339816|NCT05751304|Adrenergic Agents|adrenergic agents|mesh-ancestor
153339817|NCT05751304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414875|NCT00365287|Fludarabine|fludarabine|mesh-list
153414876|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
153414877|NCT00365287|Cyclosporins|cyclosporins|mesh-list
153414878|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153414879|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153414880|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
153414881|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414882|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414883|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153414884|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
153414885|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414886|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339866|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
153454557|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153454558|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
153454559|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454579|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153454580|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153454581|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153454582|NCT01578486|Analgesics|analgesics|mesh-ancestor
153454583|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
153454584|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454585|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454586|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454587|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153339867|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339868|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153339869|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
153339870|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731975|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153339871|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339872|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153339873|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339874|NCT00002278|Diclazuril|diclazuril|mesh-list
153874171|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874172|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153874173|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153874174|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874175|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
153874176|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153874177|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153874178|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153339938|NCT01243957|Fluoxetine|fluoxetine|mesh-list
153339939|NCT01243957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153339940|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153339941|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153387606|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
153339962|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153339965|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153339966|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153339967|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153340032|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
153340033|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340034|NCT00002470|Interferons|interferons|mesh-list
153340035|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
153340036|NCT00002470|Fluorouracil|fluorouracil|mesh-list
153340037|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
153340038|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340039|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340040|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340077|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340078|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
153340079|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340080|NCT00002476|Trace Elements|trace elements|mesh-ancestor
153340081|NCT01876628|Clindamycin|clindamycin|mesh-list
153340082|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
153340083|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
153783683|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454984|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153454985|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153454986|NCT01514370|Analgesics|analgesics|mesh-ancestor
153454987|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
153454988|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454989|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454990|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454991|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454992|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454993|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454994|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
153454995|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153454996|NCT01519674|Insulin|insulin|mesh-list
153340084|NCT01876628|Floxacillin|floxacillin|mesh-list
153340123|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340124|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
153340125|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340150|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340151|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340152|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340153|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340154|NCT01245595|Aminophylline|aminophylline|mesh-list
153340155|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153597040|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153597041|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597042|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
153597043|NCT01866254|Morphine|morphine|mesh-list
153597044|NCT01866254|Hydromorphone|hydromorphone|mesh-list
153597045|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153460647|NCT00634634|Letrozole|letrozole|mesh-list
153460648|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460649|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460650|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460651|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460652|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153819245|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
153819246|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
153819247|NCT02669173|Bevacizumab|bevacizumab|mesh-list
153819248|NCT02669173|Capecitabine|capecitabine|mesh-list
153819249|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819250|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819251|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153819252|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153819253|NCT02669173|Growth Substances|growth substances|mesh-ancestor
153597047|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153340156|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
153340157|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340158|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813413|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
153455366|NCT06174753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455367|NCT06174753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455460|NCT06078904|Antimitotic Agents|antimitotic agents|mesh-ancestor
153455461|NCT06078904|Mitosis Modulators|mitosis modulators|mesh-ancestor
153455462|NCT06078904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455463|NCT06078904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455464|NCT06061926|Magnesium Oxide|magnesium oxide|mesh-list
153455466|NCT06061926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455467|NCT06061926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153455468|NCT06055621|Dasatinib|dasatinib|mesh-list
153455474|NCT06034314|Dronabinol|dronabinol|mesh-list
153455475|NCT06034314|Hallucinogens|hallucinogens|mesh-ancestor
153455476|NCT06034314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455486|NCT06034314|Hormones|hormones|mesh-ancestor
153340159|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153340160|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
153340161|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153340162|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153340163|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340164|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340165|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153340166|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153340167|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
153340168|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153340169|NCT01245595|Protective Agents|protective agents|mesh-ancestor
153340171|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153340172|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340173|NCT00002494|Leucovorin|leucovorin|mesh-list
153340174|NCT00002494|Cobalt|cobalt|mesh-list
153340199|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340201|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
153340202|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340203|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153340204|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
153340205|NCT00002494|Hormones|hormones|mesh-ancestor
153340206|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340207|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153340208|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340209|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340210|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340211|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427796|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
153427798|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153455545|NCT05834777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455546|NCT05834777|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153455547|NCT05834777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153455548|NCT05834777|Immunologic Factors|immunologic factors|mesh-ancestor
153455800|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455801|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
153455802|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153455803|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153455804|NCT04782115|Growth Substances|growth substances|mesh-ancestor
153455805|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455806|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
153455807|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455808|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
153455809|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
153455810|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153456025|NCT04073602|Trastuzumab|trastuzumab|mesh-list
153414942|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414943|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153414944|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153414945|NCT02616523|Analgesics|analgesics|mesh-ancestor
153340224|NCT00002494|Protective Agents|protective agents|mesh-ancestor
153340225|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
153340226|NCT00002494|Vitamins|vitamins|mesh-ancestor
153340227|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
153340260|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340262|NCT05750446|Enzyme Activators|enzyme activators|mesh-ancestor
153340263|NCT05750446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340266|NCT05750290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340267|NCT05750290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340268|NCT05750290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340299|NCT00002524|Prednisolone|prednisolone|mesh-list
153340300|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
153340301|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
153340302|NCT00002524|Ifosfamide|ifosfamide|mesh-list
153340303|NCT00002524|Doxorubicin|doxorubicin|mesh-list
153340304|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153340305|NCT00002524|Fluorouracil|fluorouracil|mesh-list
153340306|NCT00002524|Methotrexate|methotrexate|mesh-list
153340307|NCT00002524|Etoposide|etoposide|mesh-list
153340308|NCT00002524|Vincristine|vincristine|mesh-list
153340309|NCT00002524|Bleomycin|bleomycin|mesh-list
153340310|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153414948|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153597048|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597049|NCT01866254|Analgesics|analgesics|mesh-ancestor
153456032|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456033|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153456034|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456037|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597050|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
153597051|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597052|NCT01866267|Maraviroc|maraviroc|mesh-list
153597053|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153597054|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153597055|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597056|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153597057|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153597058|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
153597059|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597060|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153597061|NCT01866397|Cidofovir|cidofovir|mesh-list
153597062|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
153597063|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597064|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597065|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597066|NCT01866488|Misoprostol|misoprostol|mesh-list
153597068|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
153597069|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153597070|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597071|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153597072|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874232|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874233|NCT01642134|Aspirin|aspirin|mesh-list
153874234|NCT01642134|Clopidogrel|clopidogrel|mesh-list
153874235|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153874236|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153874237|NCT01642134|Analgesics|analgesics|mesh-ancestor
153874238|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
153874239|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874240|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874241|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153874242|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874243|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153874244|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153874245|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874246|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153874247|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153874248|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340311|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
153340312|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
153340313|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153874251|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153874253|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
153874254|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874255|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153456054|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153456055|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456056|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
153456057|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
153456058|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456059|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456060|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153456061|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456062|NCT03837353|Docetaxel|docetaxel|mesh-list
153456063|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427820|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153874256|NCT00581789|Sunitinib|sunitinib|mesh-list
153414957|NCT05732155|Hallucinogens|hallucinogens|mesh-ancestor
153340369|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340437|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340438|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153340439|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153340440|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153340441|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
153340442|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340443|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153340444|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153340445|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153340446|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153340447|NCT01156597|Pioglitazone|pioglitazone|mesh-list
153340448|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153731977|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376999|NCT05418868|Cabotegravir|cabotegravir|mesh-list
153340449|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340450|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
153874257|NCT00581789|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153874258|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153874259|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874260|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874261|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874262|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153340499|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
153340500|NCT02940509|Ketamine|ketamine|mesh-list
153340501|NCT02940509|Analgesics|analgesics|mesh-ancestor
153340502|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
153340536|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153340570|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153340571|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153340572|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340573|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340574|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153340601|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340602|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153340603|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
153340604|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
153340605|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340606|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153340607|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153340608|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153340609|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
153340610|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153340611|NCT04868708|Paclitaxel|paclitaxel|mesh-list
153340612|NCT04868708|Bevacizumab|bevacizumab|mesh-list
153340613|NCT04868708|Carboplatin|carboplatin|mesh-list
153340615|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340617|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340618|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456501|NCT01453140|Analgesics|analgesics|mesh-ancestor
153456502|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
153456503|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456504|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153456505|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
153456506|NCT01499940|Vitamin D|vitamin d|mesh-list
153456507|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
153456508|NCT01499940|Vitamins|vitamins|mesh-ancestor
153456509|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
153456510|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456511|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153340619|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340620|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153340621|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153340695|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340696|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153783266|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
153340697|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153340698|NCT00002560|Antibodies|antibodies|mesh-list
153340699|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153783267|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153340700|NCT00002560|Sargramostim|sargramostim|mesh-list
153340735|NCT00002578|Cytarabine|cytarabine|mesh-list
153340736|NCT00002578|Methotrexate|methotrexate|mesh-list
153340737|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
153340738|NCT00002578|Calcium|calcium|mesh-list
153340739|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
153340740|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153340741|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340742|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153340743|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
153340744|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153340745|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340746|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
153340782|NCT00199082|Dexamethasone|dexamethasone|mesh-list
153874279|NCT01117987|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153340865|NCT00002620|Trace Elements|trace elements|mesh-ancestor
153340866|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
153340867|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340869|NCT00002638|Cytarabine|cytarabine|mesh-list
153340870|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
153340871|NCT00002638|Carmustine|carmustine|mesh-list
153340872|NCT00002638|Etoposide|etoposide|mesh-list
153340873|NCT00002638|Sargramostim|sargramostim|mesh-list
153340874|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340875|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
153340876|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340877|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340878|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340910|NCT00002662|Paclitaxel|paclitaxel|mesh-list
153340911|NCT00002662|Docetaxel|docetaxel|mesh-list
153340912|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340913|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340914|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340915|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340916|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
153340917|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340918|NCT00054314|IDN 5109|idn 5109|mesh-list
153340919|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340920|NCT00002674|Cytarabine|cytarabine|mesh-list
153340921|NCT00002674|Etoposide|etoposide|mesh-list
153340922|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
153340923|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
153340954|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340955|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340956|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153874284|NCT02219490|Ritonavir|ritonavir|mesh-list
153597073|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
153781720|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153597092|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
153597093|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597094|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
153597095|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597096|NCT01866553|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153456734|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153597097|NCT01866553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153597098|NCT01866553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597099|NCT01866553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597100|NCT01866605|Midazolam|midazolam|mesh-list
153597101|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153597102|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153597103|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153340957|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
153340958|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340959|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340960|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340961|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153340962|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
153340963|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340964|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153340965|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153340999|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341000|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153731979|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341001|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
153341003|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341004|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341005|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341006|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
153341007|NCT01895348|Remifentanil|remifentanil|mesh-list
153341030|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153341031|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341032|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341033|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153341034|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153341035|NCT04784000|Analgesics|analgesics|mesh-ancestor
153341036|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
153341037|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341038|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153341039|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874307|NCT02211417|Evening primrose oil|evening primrose oil|mesh-list
153597104|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597105|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153597106|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153597107|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597108|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153597109|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
153597110|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
153597111|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
153597112|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
153597113|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597114|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597115|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
153597116|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153597117|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
153415039|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415040|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153415041|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415042|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415043|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
153415044|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
153341040|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341041|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153341042|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153341043|NCT01113476|Paclitaxel|paclitaxel|mesh-list
153341044|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153457272|NCT01402284|Growth Substances|growth substances|mesh-ancestor
153341045|NCT01113476|Bevacizumab|bevacizumab|mesh-list
153341046|NCT01113476|Gemcitabine|gemcitabine|mesh-list
153341047|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153341048|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341049|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
153341050|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
153341051|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
153341052|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341053|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153341054|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153341055|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153341056|NCT01113476|Growth Substances|growth substances|mesh-ancestor
153341057|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341058|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
153341059|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341089|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
153341090|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341091|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
153341092|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341093|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341094|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153415045|NCT02619799|Midazolam|midazolam|mesh-list
153597118|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597119|NCT01866644|Expectorants|expectorants|mesh-ancestor
153819254|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819255|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
153341096|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341097|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341098|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153341099|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341101|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
153341102|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341103|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341104|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
153341105|NCT00002704|Hormones|hormones|mesh-ancestor
153341106|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341107|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341131|NCT00002716|Leucovorin|leucovorin|mesh-list
153341132|NCT00002716|Dexamethasone|dexamethasone|mesh-list
153341133|NCT00002716|Fluorouracil|fluorouracil|mesh-list
153341134|NCT00002716|Floxuridine|floxuridine|mesh-list
153341135|NCT00002716|Calcium|calcium|mesh-list
153341136|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
153341137|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341138|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
153341139|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
153341140|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341141|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341142|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341143|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
153341144|NCT00002716|Hormones|hormones|mesh-ancestor
153341145|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341146|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341147|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341148|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153341150|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341151|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341152|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341153|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
153341154|NCT00002716|Antidotes|antidotes|mesh-ancestor
153819256|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153819257|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
153458593|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153819258|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415061|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
153415062|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415063|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153415064|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
153415065|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153415066|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415067|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153415068|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
153415069|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153415071|NCT04741165|Lenvatinib|lenvatinib|mesh-list
153341155|NCT00002716|Protective Agents|protective agents|mesh-ancestor
153341156|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
153341157|NCT00002716|Vitamins|vitamins|mesh-ancestor
153783273|NCT00235937|Anastrozole|anastrozole|mesh-list
153783274|NCT00235937|Goserelin|goserelin|mesh-list
153341158|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
153341159|NCT02533674|Gemcitabine|gemcitabine|mesh-list
153387609|NCT03465735|Edoxaban|edoxaban|mesh-list
153341228|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341229|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153341230|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153341231|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
153341232|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
153341233|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
153341234|NCT00002740|Protective Agents|protective agents|mesh-ancestor
153341235|NCT00002740|Trace Elements|trace elements|mesh-ancestor
153341238|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341239|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153341240|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153341241|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
153341242|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341243|NCT01049945|Dexamethasone|dexamethasone|mesh-list
153341244|NCT01049945|Lenalidomide|lenalidomide|mesh-list
153874350|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874351|NCT01643265|Caseins|caseins|mesh-list
153874352|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
153874353|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
153874354|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874355|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
153874356|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
153874357|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
153874358|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874359|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874360|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
153874361|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874362|NCT04551755|Doxycycline|doxycycline|mesh-list
153341285|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153341286|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153341287|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341288|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341289|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341290|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
153341291|NCT05167175|Prednisone|prednisone|mesh-list
153341317|NCT00002590|Asparaginase|asparaginase|mesh-list
153460600|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
153460601|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153460602|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153460603|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153460604|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153460605|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153460606|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153460607|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153460765|NCT03458598|Narcotics|narcotics|mesh-ancestor
153341318|NCT00002590|Pegaspargase|pegaspargase|mesh-list
153341319|NCT00002590|Thioguanine|thioguanine|mesh-list
153341320|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
153341321|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341322|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
153341323|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341341|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153341372|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
153341373|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341374|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341375|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
153341376|NCT00002788|Hormones|hormones|mesh-ancestor
153341377|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341378|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341379|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153341381|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153341382|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341383|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
153341384|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
153341385|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153387610|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
153341423|NCT04330300|Captopril|captopril|mesh-list
153341424|NCT04330300|Benazepril|benazepril|mesh-list
153341425|NCT04330300|Indapamide|indapamide|mesh-list
153341426|NCT04330300|Nicardipine|nicardipine|mesh-list
153341427|NCT04330300|Nimodipine|nimodipine|mesh-list
153341428|NCT04330300|Quinapril|quinapril|mesh-list
153341429|NCT04330300|Metolazone|metolazone|mesh-list
153341457|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
153341458|NCT04352855|Tazobactam|tazobactam|mesh-list
153341459|NCT04352855|Ceftolozane|ceftolozane|mesh-list
153341460|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153341461|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153341462|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341463|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153341464|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341465|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341466|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153341467|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
153341468|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153819259|NCT02661464|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153819260|NCT02661464|Antiviral Agents|antiviral agents|mesh-ancestor
153819261|NCT02661464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819262|NCT02647203|Fluorides|fluorides|mesh-list
153819263|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
153819264|NCT02647203|Protective Agents|protective agents|mesh-ancestor
153819265|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460656|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415102|NCT02625181|Aprepitant|aprepitant|mesh-list
153341469|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153341470|NCT04782128|Growth Substances|growth substances|mesh-ancestor
153341471|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341472|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
153341473|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341474|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
153341475|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153341476|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
153341477|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153341478|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341501|NCT02544750|Cannabidiol|cannabidiol|mesh-list
153341502|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
153341503|NCT01662050|Cytarabine|cytarabine|mesh-list
153341504|NCT01662050|Rituximab|rituximab|mesh-list
153341505|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153341506|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153341507|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341508|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
153341509|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341510|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341511|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153597120|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
153597121|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153597122|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
153597123|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597124|NCT01866644|Protective Agents|protective agents|mesh-ancestor
153597125|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597126|NCT01866644|Antidotes|antidotes|mesh-ancestor
153597127|NCT01866748|Semaglutide|semaglutide|mesh-list
153597128|NCT01866748|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153597129|NCT01866748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153874372|NCT01643499|Irinotecan|irinotecan|mesh-list
153874373|NCT01643499|Calcium|calcium|mesh-list
153341512|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
153341513|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341514|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
153341515|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341516|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341517|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341518|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
153341519|NCT04748848|Azacitidine|azacitidine|mesh-list
153341520|NCT04748848|Venetoclax|venetoclax|mesh-list
153341521|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
153341522|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341523|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
153341524|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341525|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341526|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341527|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153341528|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
153341529|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153341530|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153341531|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153341568|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341569|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153341570|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
153341571|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
153874374|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
153597130|NCT01866748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597131|NCT01867138|Vancomycin|vancomycin|mesh-list
153597132|NCT01867138|Cefazolin|cefazolin|mesh-list
153597133|NCT01867138|Amikacin|amikacin|mesh-list
153597134|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153597135|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597136|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153597137|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153597138|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153597139|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153597140|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460666|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460667|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460668|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460669|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460670|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153460671|NCT00049595|Prednisone|prednisone|mesh-list
153460672|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
153460673|NCT00049595|Dacarbazine|dacarbazine|mesh-list
153460674|NCT00049595|Doxorubicin|doxorubicin|mesh-list
153460675|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153460676|NCT00049595|Etoposide|etoposide|mesh-list
153874396|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
153341573|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
153341603|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153341604|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153341605|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731980|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
153377136|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341606|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341607|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341608|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153341610|NCT04349722|Scopolamine|scopolamine|mesh-list
153341611|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153341612|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153341613|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
153460677|NCT00049595|Vincristine|vincristine|mesh-list
153460678|NCT00049595|Bleomycin|bleomycin|mesh-list
153460679|NCT00049595|Vinblastine|vinblastine|mesh-list
153597144|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
153597145|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597147|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
153597148|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153597149|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597150|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597151|NCT01867268|Diuretics|diuretics|mesh-ancestor
153597152|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
153597153|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597154|NCT01867281|Aspirin|aspirin|mesh-list
153597155|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153597156|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153597157|NCT01867281|Analgesics|analgesics|mesh-ancestor
153597158|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
153597159|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597160|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597161|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153597162|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153597163|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153597164|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153597165|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597166|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153597167|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153597168|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597169|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
153597170|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153597171|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153597172|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
153597176|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597177|NCT01867502|Metformin|metformin|mesh-list
153597178|NCT01867502|Vildagliptin|vildagliptin|mesh-list
153597179|NCT01867502|Glyburide|glyburide|mesh-list
153597180|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153597184|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597185|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597186|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
153597187|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153597188|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597189|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
153597190|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153597191|NCT01867645|Antibodies|antibodies|mesh-list
153597192|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
153415118|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415119|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415120|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153415121|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
153415122|NCT02625181|Hormones|hormones|mesh-ancestor
153461747|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341614|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
153341615|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387674|NCT03360903|Caffeine|caffeine|mesh-list
153341649|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153341650|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341651|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341652|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153341653|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153341654|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153341655|NCT03014687|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153341656|NCT03014687|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153341657|NCT04199572|Acetaminophen|acetaminophen|mesh-list
153341658|NCT04199572|Diclofenac|diclofenac|mesh-list
153341659|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153341685|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153341686|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153341687|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341688|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341689|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153874399|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874400|NCT01640496|Vitamin D|vitamin d|mesh-list
153874401|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
153874402|NCT01640496|Vitamins|vitamins|mesh-ancestor
153874403|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
153874404|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341696|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341697|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153341698|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153341699|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153341700|NCT01059929|Midazolam|midazolam|mesh-list
153341701|NCT01059929|Fentanyl|fentanyl|mesh-list
153341702|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
153341703|NCT01059929|Propofol|propofol|mesh-list
153341705|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341706|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341734|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341736|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341737|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
153341738|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
153341739|NCT04896658|Dexamethasone|dexamethasone|mesh-list
153341740|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
153341741|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341742|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
153341743|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341744|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341745|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341746|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
153341747|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341748|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341749|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153341751|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
153341788|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341789|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
153341790|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341791|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153341815|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
153341816|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153341817|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341818|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341819|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
153377156|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153341820|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341821|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341822|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
153597193|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153597194|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
153597195|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597196|NCT01867697|Leucovorin|leucovorin|mesh-list
153597197|NCT01867697|Folic Acid|folic acid|mesh-list
153597198|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
153597199|NCT01867697|Irinotecan|irinotecan|mesh-list
153597200|NCT01867697|Cetuximab|cetuximab|mesh-list
153597201|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
153597202|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
153597203|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597204|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597205|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153597206|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153597207|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597208|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597209|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153597210|NCT01867697|Antidotes|antidotes|mesh-ancestor
153597211|NCT01867697|Protective Agents|protective agents|mesh-ancestor
153597212|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
153597213|NCT01867697|Vitamins|vitamins|mesh-ancestor
153597214|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
153597215|NCT01867697|Hematinics|hematinics|mesh-ancestor
153597216|NCT01867697|Antacids|antacids|mesh-ancestor
153597217|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597218|NCT01867775|Mirtazapine|mirtazapine|mesh-list
153597219|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
153597220|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597221|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153597222|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
153597223|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
153597224|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597225|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597226|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597227|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153597228|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153597229|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597230|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153597231|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153597232|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153597233|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
153597234|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153341823|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341824|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153341825|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341826|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
153341827|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341828|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153341829|NCT05426304|Agomelatine|agomelatine|mesh-list
153341830|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153341831|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341832|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341833|NCT00382954|Bortezomib|bortezomib|mesh-list
153341834|NCT00382954|Idarubicin|idarubicin|mesh-list
153341835|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341836|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153341837|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153415125|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597235|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153597236|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
153597237|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153597254|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597255|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153597256|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153597257|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597258|NCT01867892|Antidotes|antidotes|mesh-ancestor
153597259|NCT01867892|Protective Agents|protective agents|mesh-ancestor
153597260|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
153597261|NCT01867892|Vitamins|vitamins|mesh-ancestor
153597262|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
153597263|NCT01868048|Nabiximols|nabiximols|mesh-list
153597264|NCT01868048|Analgesics|analgesics|mesh-ancestor
153597265|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
153597266|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597267|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597268|NCT01868113|Fluticasone|fluticasone|mesh-list
153597269|NCT01868113|Xhance|xhance|mesh-list
153597278|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153597279|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153597280|NCT01868126|Latanoprost|latanoprost|mesh-list
153597281|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153597282|NCT01868191|Thiamine|thiamine|mesh-list
153597283|NCT01868191|Benphothiamine|benphothiamine|mesh-list
153597284|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153597285|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
153597286|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597287|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
153819284|NCT02502786|Antibodies|antibodies|mesh-list
153819285|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
153819286|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819287|NCT02478099|Atezolizumab|atezolizumab|mesh-list
153819288|NCT02478099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153819289|NCT02478099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819290|NCT02478099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819291|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819292|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
153819293|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
153819294|NCT02446964|Fludarabine|fludarabine|mesh-list
153597289|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597291|NCT01868191|Vitamins|vitamins|mesh-ancestor
153597292|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
153597293|NCT01868360|Aflibercept|aflibercept|mesh-list
153597294|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153341838|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153415140|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153415141|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153415143|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
153415144|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153341839|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341840|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341841|NCT01246063|Dexamethasone|dexamethasone|mesh-list
153783280|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341875|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341876|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341877|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
153341878|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341879|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341880|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
153341881|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153341882|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153341883|NCT03836014|Growth Substances|growth substances|mesh-ancestor
153341884|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
153341907|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153341908|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153341909|NCT01206595|Bupivacaine|bupivacaine|mesh-list
153341910|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
153341911|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
153341912|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341913|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341914|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
153341915|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415146|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
153597295|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153597296|NCT01868360|Growth Substances|growth substances|mesh-ancestor
153597297|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597298|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
153597299|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597300|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
153597301|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153597302|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
153597303|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597304|NCT01868529|Insulin|insulin|mesh-list
153597305|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153597306|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
153597307|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153341916|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153341917|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153341918|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341919|NCT01158703|Aspirin|aspirin|mesh-list
153341920|NCT01158703|Clopidogrel|clopidogrel|mesh-list
153341921|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153341922|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153341923|NCT01158703|Analgesics|analgesics|mesh-ancestor
153341924|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
153341925|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341926|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341927|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341928|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341929|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153341930|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153341931|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341932|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153341933|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153341934|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341969|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
153341970|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874424|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153597308|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597309|NCT01868555|Insulin|insulin|mesh-list
153597310|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153460683|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460684|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460685|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460686|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
153460687|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460688|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460689|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153460690|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153460691|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153460692|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460693|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460694|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153460695|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
153460696|NCT00049595|Hormones|hormones|mesh-ancestor
153460697|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153460698|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153597317|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153597318|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
153597319|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
153597320|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153597321|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
153597322|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153341971|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341972|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341973|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341974|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
153341975|NCT00002896|Antidotes|antidotes|mesh-ancestor
153377205|NCT05100017|Methocarbamol|methocarbamol|mesh-list
153427885|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341976|NCT00002896|Protective Agents|protective agents|mesh-ancestor
153341977|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
153342015|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342016|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342017|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342018|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597323|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153597324|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597325|NCT01868581|Insulin|insulin|mesh-list
153597326|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153597327|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
153597328|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
153597329|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153597330|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597331|NCT01868750|Calcitriol|calcitriol|mesh-list
153597332|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153597333|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597334|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153597335|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153597336|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597337|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153597338|NCT01868750|Vitamins|vitamins|mesh-ancestor
153597339|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
153597340|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153597341|NCT01868802|Ketamine|ketamine|mesh-list
153597342|NCT01868802|Analgesics|analgesics|mesh-ancestor
153597343|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
153597344|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597345|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597346|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153597347|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153597348|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
153597349|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
153597350|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597351|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153597352|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153597353|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597354|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597355|NCT01868906|Temozolomide|temozolomide|mesh-list
153597356|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153430910|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153597357|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
153597358|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597359|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597360|NCT01868945|Vitamin D|vitamin d|mesh-list
153597361|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
153597362|NCT01868945|Calcifediol|calcifediol|mesh-list
153597363|NCT01868945|Vitamins|vitamins|mesh-ancestor
153597364|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
153597365|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597366|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153597367|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153597368|NCT01868984|Paclitaxel|paclitaxel|mesh-list
153597369|NCT01868984|Heparin|heparin|mesh-list
153597370|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153597371|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597372|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342050|NCT01161121|Adenosine|adenosine|mesh-list
153342051|NCT01161121|Regadenoson|regadenoson|mesh-list
153342052|NCT01161121|Analgesics|analgesics|mesh-ancestor
153342053|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
153342054|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342055|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342056|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153342057|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
153342058|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153342059|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
153342081|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342082|NCT01214083|Protective Agents|protective agents|mesh-ancestor
153342083|NCT01214083|Antidotes|antidotes|mesh-ancestor
153342084|NCT01254877|Ondansetron|ondansetron|mesh-list
153342085|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
153342086|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
153342087|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342088|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342089|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153342090|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
153342091|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
153415177|NCT02630719|Timolol|timolol|mesh-list
153597373|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
153597374|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
153597375|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597376|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
153597377|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153597378|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153597379|NCT01869010|Tenofovir|tenofovir|mesh-list
153597399|NCT01869036|Analgesics|analgesics|mesh-ancestor
153597400|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
153597401|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597402|NCT01869205|Ivermectin|ivermectin|mesh-list
153597403|NCT01869205|Abamectin|abamectin|mesh-list
153597404|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153597405|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597406|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
153597407|NCT01869257|Triclosan|triclosan|mesh-list
153597408|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153597409|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597410|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153597411|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153597412|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
153597413|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597414|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153597415|NCT01869309|Ticagrelor|ticagrelor|mesh-list
153597416|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153597417|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153597418|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153597419|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153597420|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153597421|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
153597422|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415182|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153415183|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
153415184|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415185|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342092|NCT01254877|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153342093|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153342094|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
153342095|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342096|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342097|NCT02189317|Bupivacaine|bupivacaine|mesh-list
153342098|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
153342099|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
153342100|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153342101|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342102|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
153342104|NCT03713944|Bevacizumab|bevacizumab|mesh-list
153342105|NCT03713944|Atezolizumab|atezolizumab|mesh-list
153342106|NCT03713944|Carboplatin|carboplatin|mesh-list
153342107|NCT03713944|Pemetrexed|pemetrexed|mesh-list
153342108|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153342109|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342110|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153342111|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153342112|NCT03713944|Growth Substances|growth substances|mesh-ancestor
153597423|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597424|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597425|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
153597426|NCT01869491|Antacids|antacids|mesh-ancestor
153597427|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597428|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597429|NCT01869556|Oxytocin|oxytocin|mesh-list
153597430|NCT01869556|Carboprost|carboprost|mesh-list
153597431|NCT01869556|Carboprost tromethamine|carboprost tromethamine|mesh-list
153597432|NCT01869556|Ergonovine|ergonovine|mesh-list
153597433|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
153597434|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153597435|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874451|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
153874452|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342113|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342114|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
153342115|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342116|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342117|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153342118|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153342119|NCT03713944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153783283|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153342138|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342139|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342141|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342142|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342144|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342145|NCT00383812|Bevacizumab|bevacizumab|mesh-list
153342146|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153342147|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342148|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153342149|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153342150|NCT00383812|Growth Substances|growth substances|mesh-ancestor
153342152|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
153342153|NCT02189629|Trifarotene|trifarotene|mesh-list
153342154|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
153342155|NCT00002926|Cytarabine|cytarabine|mesh-list
153342156|NCT00002926|Etoposide|etoposide|mesh-list
153342157|NCT00002926|Idarubicin|idarubicin|mesh-list
153377234|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342158|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342159|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342160|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342161|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342162|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342163|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342165|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
153342167|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342168|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342169|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
153342170|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342171|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153342172|NCT01281007|Acyclovir|acyclovir|mesh-list
153342173|NCT01281007|Famciclovir|famciclovir|mesh-list
153342207|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342208|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342209|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
153783693|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342210|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342211|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153342212|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342213|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
153342214|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342232|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342234|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
153342235|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342236|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342237|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
153342238|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342239|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153415200|NCT04159519|Budesonide|budesonide|mesh-list
153597436|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153819305|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153819306|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153597437|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
153597438|NCT01869569|Pregabalin|pregabalin|mesh-list
153597439|NCT01869569|Analgesics|analgesics|mesh-ancestor
153597440|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
153597441|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597442|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597443|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
153597444|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153597445|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153597446|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597447|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153597448|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153597449|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153597450|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597451|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597452|NCT01869621|Metformin|metformin|mesh-list
153597453|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153597454|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597455|NCT01869673|Anesthetics|anesthetics|mesh-list
153597456|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597457|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597458|NCT01869751|Prucalopride|prucalopride|mesh-list
153597459|NCT01869751|Laxatives|laxatives|mesh-ancestor
153597460|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597461|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153415217|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153415218|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
153415219|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874479|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153874480|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153342240|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153342241|NCT01555268|Growth Substances|growth substances|mesh-ancestor
153342242|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
153342244|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153342245|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342246|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153342247|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153342248|NCT04781270|Growth Substances|growth substances|mesh-ancestor
153342249|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342250|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
153342251|NCT00003394|Paclitaxel|paclitaxel|mesh-list
153342252|NCT00003394|Carboplatin|carboplatin|mesh-list
153342253|NCT00003394|Leuprolide|leuprolide|mesh-list
153342254|NCT00003394|Goserelin|goserelin|mesh-list
153342255|NCT00003394|Estramustine|estramustine|mesh-list
153342256|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342257|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342258|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342259|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342260|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342261|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342262|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153342263|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
153342264|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153342265|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342266|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342267|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342268|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
153342269|NCT00003400|Melphalan|melphalan|mesh-list
153342309|NCT00002950|Sargramostim|sargramostim|mesh-list
153342310|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153342311|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342312|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342313|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342314|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342315|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
153342316|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342317|NCT00777140|Deferoxamine|deferoxamine|mesh-list
153342318|NCT00777140|Siderophores|siderophores|mesh-ancestor
153342325|NCT00003406|Ifosfamide|ifosfamide|mesh-list
153342326|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342327|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342328|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342329|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
153874504|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
153597462|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153597463|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
153597464|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597465|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819307|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
153819308|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153819309|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819310|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153819311|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153460699|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460700|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460701|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460702|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460703|NCT03575052|Pimavanserin|pimavanserin|mesh-list
153460704|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153460705|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153460706|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153460707|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153460708|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597466|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597468|NCT01869803|Calicheamicins|calicheamicins|mesh-list
153597469|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153597470|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597471|NCT01869803|Immunotoxins|immunotoxins|mesh-ancestor
153597472|NCT01869803|Immunoconjugates|immunoconjugates|mesh-ancestor
153597473|NCT01869803|Immunologic Factors|immunologic factors|mesh-ancestor
153597482|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
153597483|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597484|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597485|NCT01869907|Minocycline|minocycline|mesh-list
153597486|NCT01869907|Amitriptyline|amitriptyline|mesh-list
153597487|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153597488|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597489|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153597490|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
153597491|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597492|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153597493|NCT01869907|Analgesics|analgesics|mesh-ancestor
153415228|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415229|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
153415230|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342330|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342331|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342332|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
153342333|NCT00003412|Interleukin-12|interleukin-12|mesh-list
153342334|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153342335|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
153342336|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342337|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153342338|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153342339|NCT00003412|Growth Substances|growth substances|mesh-ancestor
153342340|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
153342341|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342342|NCT04780958|Vitamin A|vitamin a|mesh-list
153342343|NCT04780958|Vitamins|vitamins|mesh-ancestor
153415231|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153415233|NCT02634073|Cathartics|cathartics|mesh-ancestor
153460709|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460710|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153460711|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153460712|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153460713|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
153460714|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153460715|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460716|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
153460717|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
153460719|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153460720|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153460721|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460722|NCT04403724|Fentanyl|fentanyl|mesh-list
153460723|NCT04403724|Morphine|morphine|mesh-list
153460724|NCT04403724|Bupivacaine|bupivacaine|mesh-list
153460725|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
153460726|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
153460727|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153460728|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597495|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597496|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597497|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153597498|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153597499|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153597500|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597501|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
153597502|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597503|NCT01869946|Ropivacaine|ropivacaine|mesh-list
153597504|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
153597505|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
153597506|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597507|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597508|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
153597509|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597510|NCT01870011|Anesthetics|anesthetics|mesh-list
153597511|NCT01870011|Propofol|propofol|mesh-list
153597512|NCT01870011|Desflurane|desflurane|mesh-list
153342344|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
153342345|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342346|NCT00002968|Edrecolomab|edrecolomab|mesh-list
153342347|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153342348|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
153342349|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342350|NCT04780412|Alprostadil|alprostadil|mesh-list
153342351|NCT04780412|Misoprostol|misoprostol|mesh-list
153342352|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153342353|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
153342354|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153342355|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342356|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153342357|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153342358|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
153342359|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153342360|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
153342361|NCT04780412|Urological Agents|urological agents|mesh-ancestor
153342362|NCT00002974|Carboplatin|carboplatin|mesh-list
153597513|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597514|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597515|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153597516|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153597517|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
153460729|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
153460730|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819314|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819315|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
153819317|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153819318|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153819319|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153819320|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
153819321|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819322|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597518|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153597519|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
153597520|NCT01870024|Lorazepam|lorazepam|mesh-list
153597521|NCT01870024|Clonazepam|clonazepam|mesh-list
153874513|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153342363|NCT00002974|Etoposide|etoposide|mesh-list
153342364|NCT00002974|Ifosfamide|ifosfamide|mesh-list
153342365|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783284|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342366|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342367|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342368|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342369|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783285|NCT00261339|Pantoprazole|pantoprazole|mesh-list
153342370|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342371|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342372|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
153342373|NCT00754364|Carboplatin|carboplatin|mesh-list
153342374|NCT00754364|Gemcitabine|gemcitabine|mesh-list
153342375|NCT00754364|Pemetrexed|pemetrexed|mesh-list
153342376|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342377|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342378|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
153597522|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
153597523|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
153597524|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
153597525|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597526|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597527|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597528|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153597529|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597530|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153597531|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153597532|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597533|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
153597534|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
153597535|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597536|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597537|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153597538|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153597539|NCT01870050|Dapsone|dapsone|mesh-list
153597540|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597541|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
153597542|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153342379|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342381|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153342382|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153342383|NCT02612896|Praziquantel|praziquantel|mesh-list
153342384|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
153342385|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153342386|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342387|NCT00002980|Decitabine|decitabine|mesh-list
153342388|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342420|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153342421|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153342422|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342423|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342424|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
153342425|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342426|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153342427|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
153597543|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153597544|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153597545|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597546|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597548|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153597549|NCT01870115|Vitamin D|vitamin d|mesh-list
153597550|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
153819323|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
153819324|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819325|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153819326|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819327|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819328|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153819329|NCT02270814|Paclitaxel|paclitaxel|mesh-list
153819330|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153819331|NCT02270814|Cisplatin|cisplatin|mesh-list
153819332|NCT02270814|Carboplatin|carboplatin|mesh-list
153819333|NCT02270814|Cetuximab|cetuximab|mesh-list
153819334|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153597551|NCT01870115|Melatonin|melatonin|mesh-list
153597552|NCT01870115|Vitamins|vitamins|mesh-ancestor
153597553|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
153597554|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597555|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153597556|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597557|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153597558|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
153597559|NCT01870115|Protective Agents|protective agents|mesh-ancestor
153597560|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813418|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153359885|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
153597561|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
153597562|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
153597563|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
153597564|NCT01870128|Methotrexate|methotrexate|mesh-list
153597565|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153597566|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
153597567|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153597568|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597569|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342428|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153342447|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342448|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342450|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342452|NCT00003004|Alvocidib|alvocidib|mesh-list
153342453|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342454|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342455|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342456|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342457|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342458|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342459|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
153342460|NCT00003004|Growth Substances|growth substances|mesh-ancestor
153342461|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342462|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153342463|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342464|NCT04776512|Bupivacaine|bupivacaine|mesh-list
153387835|NCT00000273|Fentanyl|fentanyl|mesh-list
153597571|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597572|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597573|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
153819335|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819336|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
153819337|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
153819338|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
153819339|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819340|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819341|NCT02228681|Tamoxifen|tamoxifen|mesh-list
153819342|NCT02228681|Everolimus|everolimus|mesh-list
153819343|NCT02228681|Letrozole|letrozole|mesh-list
153460731|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153460732|NCT04403724|Narcotics|narcotics|mesh-ancestor
153460733|NCT04403724|Analgesics|analgesics|mesh-ancestor
153460734|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153460735|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153460736|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
153460737|NCT04403568|Ursolic Acid|ursolic acid|mesh-list
153460738|NCT04403568|Curcumin|curcumin|mesh-list
153460739|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153460740|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153460741|NCT04403568|Analgesics|analgesics|mesh-ancestor
153460742|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
153460743|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460744|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460745|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153460746|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460747|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460748|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460749|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460750|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597574|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597575|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153597576|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153597577|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
153597578|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153597579|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153597580|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153342467|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153342468|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342469|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
153342470|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342472|NCT04776590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153342473|NCT04776590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597581|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
153597582|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
153597583|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597584|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597585|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
153597586|NCT01870128|Hormones|hormones|mesh-ancestor
153597587|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153597588|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153597589|NCT01870128|Protective Agents|protective agents|mesh-ancestor
153597590|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
153597591|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153597592|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153597593|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597594|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153597595|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153597596|NCT01870128|Analgesics|analgesics|mesh-ancestor
153597597|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
153597598|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153597599|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153460751|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460752|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153460753|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
153460754|NCT03564756|Vitamins|vitamins|mesh-ancestor
153460755|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
153460756|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460757|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
153460758|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460759|NCT03564756|Protective Agents|protective agents|mesh-ancestor
153460760|NCT03462966|Rifaximin|rifaximin|mesh-list
153460761|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153460762|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460763|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153819344|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153819345|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
153819346|NCT02228681|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153819349|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819350|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819351|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
153597600|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597601|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153597602|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597603|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597605|NCT01870219|Anesthetics|anesthetics|mesh-list
153597606|NCT01870219|Sevoflurane|sevoflurane|mesh-list
153597607|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
153597608|NCT01870219|Analgesics|analgesics|mesh-ancestor
153597609|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
153597610|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597611|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597612|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153597613|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
153597614|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597615|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153597616|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153387928|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342474|NCT00003436|Cytarabine|cytarabine|mesh-list
153342475|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
153342476|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153342477|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153342478|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153342479|NCT00003436|Methotrexate|methotrexate|mesh-list
153342480|NCT00003436|Etoposide|etoposide|mesh-list
153342481|NCT00003436|Daunorubicin|daunorubicin|mesh-list
153342482|NCT00003436|Asparaginase|asparaginase|mesh-list
153342483|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
153342515|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342516|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153342517|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153783287|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783289|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342519|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
153597617|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597618|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597619|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153597620|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153597621|NCT01870284|Adalimumab|adalimumab|mesh-list
153597622|NCT01870284|Ixekizumab|ixekizumab|mesh-list
153597623|NCT01870284|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153597624|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153597625|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819352|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460764|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
153819353|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819354|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153819355|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153819356|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153819357|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819358|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819359|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819360|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153819361|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153819362|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153819363|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153819364|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153819365|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153819366|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
153819367|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153819368|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153360701|NCT01472549|Ethanol|ethanol|mesh-list
153597626|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
153597627|NCT01870427|Aflibercept|aflibercept|mesh-list
153597628|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153597629|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153597630|NCT01870427|Growth Substances|growth substances|mesh-ancestor
153597631|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597632|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
153597633|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597634|NCT01868880|Bisoprolol|bisoprolol|mesh-list
153597635|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153597636|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153597637|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
153597638|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597639|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342520|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342521|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153342522|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342523|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153342553|NCT00003484|Irinotecan|irinotecan|mesh-list
153342554|NCT00003484|Carmustine|carmustine|mesh-list
153342555|NCT00003484|Antibodies|antibodies|mesh-list
153342556|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153342557|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
153342558|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342559|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153342560|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342561|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342562|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342563|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342564|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342565|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
153342566|NCT00003490|Prednisone|prednisone|mesh-list
153342567|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
153342568|NCT00003490|Vincristine|vincristine|mesh-list
153342569|NCT00003490|Sargramostim|sargramostim|mesh-list
153342570|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342571|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
153342594|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342595|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342596|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342597|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153342598|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
153342599|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153342600|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597640|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597641|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153597642|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
153597643|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
153597644|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597645|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153597648|NCT01870440|BB 1101|bb 1101|mesh-list
153597649|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153597650|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
153597651|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
153597652|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597653|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597654|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597655|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
153597656|NCT01870440|Hormones|hormones|mesh-ancestor
153342601|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342605|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342606|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153342607|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153342609|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
153342610|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342611|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342612|NCT00003046|Interleukin-12|interleukin-12|mesh-list
153342613|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153342614|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
153342615|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597657|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153597658|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153597659|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597660|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
153597661|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819369|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153597662|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597663|NCT01870466|Cilostazol|cilostazol|mesh-list
153597664|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153597665|NCT01870466|Simvastatin|simvastatin|mesh-list
153597666|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153597667|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153597668|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
153597669|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597670|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153597671|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153597672|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597673|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153597674|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
153597675|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597676|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597677|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153597678|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
153597679|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153597680|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153597681|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153597682|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
153597683|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153597684|NCT01870466|Protective Agents|protective agents|mesh-ancestor
153597685|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153597686|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153597687|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153597688|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153597689|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153597690|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597691|NCT01870635|Ondansetron|ondansetron|mesh-list
153597692|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
153597693|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
153597694|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597695|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597697|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
153597698|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
153597699|NCT01870635|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153597700|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153597701|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
153597702|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597703|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342616|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153342617|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153342618|NCT00003046|Growth Substances|growth substances|mesh-ancestor
153342619|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
153342620|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342621|NCT00003052|Doxorubicin|doxorubicin|mesh-list
153342622|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153342623|NCT00003052|Etoposide|etoposide|mesh-list
153342624|NCT00003052|Ifosfamide|ifosfamide|mesh-list
153342651|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
153342652|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342653|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342654|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153342655|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153342656|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
153342657|NCT00003064|Paclitaxel|paclitaxel|mesh-list
153342658|NCT00003064|Etoposide|etoposide|mesh-list
153597704|NCT01870648|Ondansetron|ondansetron|mesh-list
153597705|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
153597706|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
153597707|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597708|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597709|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597710|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
153597711|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
153597712|NCT01870648|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153597713|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153597714|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
153597715|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597716|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597717|NCT01870674|Prucalopride|prucalopride|mesh-list
153597719|NCT01870674|Laxatives|laxatives|mesh-ancestor
153597720|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597721|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153597722|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153597723|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
153597724|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597725|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597726|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819370|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153819371|NCT02213107|Finasteride|finasteride|mesh-list
153819372|NCT02213107|Dutasteride|dutasteride|mesh-list
153819373|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153819374|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153819375|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819376|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819377|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819378|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819379|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819380|NCT02213107|Urological Agents|urological agents|mesh-ancestor
153819381|NCT02115282|Exemestane|exemestane|mesh-list
153819382|NCT02115282|Goserelin|goserelin|mesh-list
153460774|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460775|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
153460776|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153460777|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153597727|NCT01870804|Atorvastatin|atorvastatin|mesh-list
153597728|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153597729|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153597730|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153597731|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
153342659|NCT00003064|Carboplatin|carboplatin|mesh-list
153342660|NCT00003064|Topotecan|topotecan|mesh-list
153342661|NCT00003064|Thiotepa|thiotepa|mesh-list
153342662|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
153342663|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342664|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342665|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342666|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342667|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342668|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342669|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342670|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342703|NCT00384436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153342704|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153342705|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153342706|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342707|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342708|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
153342709|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342710|NCT00003562|Carboplatin|carboplatin|mesh-list
153342711|NCT00003562|Docetaxel|docetaxel|mesh-list
153597732|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597733|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153597734|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153597735|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597736|NCT01870895|Ramosetron|ramosetron|mesh-list
153597737|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
153597738|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
153597739|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597740|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597741|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153597742|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153597743|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
153597744|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597745|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597746|NCT01870908|Tacrolimus|tacrolimus|mesh-list
153597747|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153597748|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
153597749|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460778|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
153460779|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460780|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153460781|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153460782|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460783|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460784|NCT03524898|Paclitaxel|paclitaxel|mesh-list
153460785|NCT03524898|Gemcitabine|gemcitabine|mesh-list
153460786|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460787|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460788|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
153460789|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
153460790|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342713|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342749|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342750|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342751|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153342752|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153342753|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
153342754|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342778|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
153342779|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153342780|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153342781|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342782|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342783|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342784|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
153342785|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342786|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
153460791|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460792|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460793|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
153460794|NCT03524820|Cetuximab|cetuximab|mesh-list
153460795|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460796|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460797|NCT03524508|Fluorouracil|fluorouracil|mesh-list
153460798|NCT03524508|Irinotecan|irinotecan|mesh-list
153460799|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
153460800|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460802|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460803|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460804|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
153597754|NCT01870986|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153597755|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153597756|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153597758|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153597759|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597760|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597761|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153597762|NCT01871129|Analgesics|analgesics|mesh-ancestor
153597763|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
153597764|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597765|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153377607|NCT04231877|Antibodies|antibodies|mesh-list
153597767|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153597768|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
153597769|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597770|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597771|NCT01871363|Capecitabine|capecitabine|mesh-list
153460807|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153819383|NCT02115282|Entinostat|entinostat|mesh-list
153819384|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153819385|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819386|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153819387|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153819388|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342787|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
153342788|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
153342789|NCT00755560|Albendazole|albendazole|mesh-list
153342790|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
153377374|NCT04659044|Rituximab|rituximab|mesh-list
153342791|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153342792|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342793|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
153342794|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153342795|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153342796|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342797|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342798|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342799|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342800|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342801|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
153342802|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153342803|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342804|NCT00003118|Fluorouracil|fluorouracil|mesh-list
153388262|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819389|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819390|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153819391|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819392|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819393|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819394|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819395|NCT02111941|Vaccines|vaccines|mesh-list
153819396|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
153819397|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819398|NCT01991977|Temozolomide|temozolomide|mesh-list
153819399|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153819400|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
153819401|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597774|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
153597775|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597776|NCT01871376|Aflibercept|aflibercept|mesh-list
153597777|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153597778|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153597779|NCT01871376|Growth Substances|growth substances|mesh-ancestor
153597780|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597781|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
153597782|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597783|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
153597784|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153597785|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597786|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597787|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153597788|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153597789|NCT01871454|Protective Agents|protective agents|mesh-ancestor
153597790|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597791|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
153597792|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153597793|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
153597794|NCT01871467|Sargramostim|sargramostim|mesh-list
153342822|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153342824|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153342825|NCT00003580|Protective Agents|protective agents|mesh-ancestor
153342826|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342827|NCT00056498|Risperidone|risperidone|mesh-list
153342828|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153342829|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
153342830|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342831|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342832|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342833|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153342834|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153342835|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153342836|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153342837|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153342838|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
153342839|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
153342840|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
153342841|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153342842|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153342843|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342844|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342845|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342846|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342847|NCT00003130|Paclitaxel|paclitaxel|mesh-list
153342848|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342849|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342850|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342851|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
153597795|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
153597796|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819402|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819404|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153819405|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153819406|NCT01938261|Analgesics|analgesics|mesh-ancestor
153819407|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
153819408|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819409|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819410|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
153819411|NCT01934582|Treprostinil|treprostinil|mesh-list
153819412|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153460808|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460809|NCT03457818|Denosumab|denosumab|mesh-list
153342852|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342853|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342854|NCT00058370|Vincristine|vincristine|mesh-list
153342856|NCT00058370|Antibodies|antibodies|mesh-list
153342857|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153342858|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
153342859|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342860|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342861|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342862|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342863|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342891|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342892|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153342893|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
153460810|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153460811|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460812|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153460813|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
153460814|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
153460815|NCT01676844|Protective Agents|protective agents|mesh-ancestor
153460816|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460817|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
153460818|NCT04403334|Levofloxacin|levofloxacin|mesh-list
153597798|NCT01871480|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153597799|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153597800|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597801|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597802|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597803|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
153597804|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153597805|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597806|NCT01871649|Golimumab|golimumab|mesh-list
153597807|NCT01871649|Methotrexate|methotrexate|mesh-list
153597808|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153597809|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
153597810|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153597811|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597812|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153597813|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
153597814|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597815|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597816|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
153597817|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597818|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153597819|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153597820|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
153597821|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153597822|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153597823|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153597824|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153597825|NCT01871662|Interferons|interferons|mesh-list
153597826|NCT01871662|Ribavirin|ribavirin|mesh-list
153597827|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
153460819|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153460820|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460821|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153460822|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460823|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342895|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153342896|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153342897|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342899|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153342900|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
153342901|NCT00063362|Lamotrigine|lamotrigine|mesh-list
153342902|NCT00063362|Valproic Acid|valproic acid|mesh-list
153342903|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
153342904|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
153342905|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153342927|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
153342928|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342929|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342931|NCT00067028|Clofarabine|clofarabine|mesh-list
153342933|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460824|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460825|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460826|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153460827|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153460828|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153460829|NCT03779646|Bisoprolol|bisoprolol|mesh-list
153460830|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153460831|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
153460832|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
153597830|NCT01871662|Silybin|silybin|mesh-list
153597831|NCT01871662|Silymarin|silymarin|mesh-list
153597832|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597833|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
153597834|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597835|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
153597836|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597843|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153597844|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153597845|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597847|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597848|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153597849|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153597850|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
153597851|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597852|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
153597853|NCT01871701|Dexetimide|dexetimide|mesh-list
153597854|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153597855|NCT01871701|Citalopram|citalopram|mesh-list
153597856|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153597857|NCT01871701|Escitalopram|escitalopram|mesh-list
153460833|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460834|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460837|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153460838|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
153460839|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153460840|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460841|NCT00089778|Aldesleukin|aldesleukin|mesh-list
153820706|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
153597868|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597869|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153342935|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342936|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342937|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
153342938|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359889|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
153342939|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342940|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
153342941|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342942|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153342943|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342944|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342945|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342946|NCT00067808|Decitabine|decitabine|mesh-list
153342947|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342948|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
153342949|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342950|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342951|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342952|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
153342953|NCT00493870|Docetaxel|docetaxel|mesh-list
153342954|NCT00493870|Doxorubicin|doxorubicin|mesh-list
153342955|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342956|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
153342957|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342984|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342985|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
153342986|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342987|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342988|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153342989|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153342990|NCT00003136|Protective Agents|protective agents|mesh-ancestor
153342991|NCT00003598|Tretinoin|tretinoin|mesh-list
153342992|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342993|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
153342994|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
153342995|NCT00003604|Aldesleukin|aldesleukin|mesh-list
153342998|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153342999|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
153343000|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343001|NCT00002794|Carboplatin|carboplatin|mesh-list
153343002|NCT00002794|Vincristine|vincristine|mesh-list
153343003|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343004|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343005|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
153783293|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153343038|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343039|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343040|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343041|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
153343042|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343043|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343072|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153597870|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153597871|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153597872|NCT01871701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153597873|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153597874|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153597875|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597876|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
153597877|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153597878|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153819427|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
153819428|NCT01541709|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153819429|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153819430|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819431|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819432|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819433|NCT01508897|Liraglutide|liraglutide|mesh-list
153819434|NCT01508897|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153819435|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153819436|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819437|NCT01508897|Incretins|incretins|mesh-ancestor
153819439|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819440|NCT01394263|Goserelin|goserelin|mesh-list
153819441|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819442|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819443|NCT01263769|Axitinib|axitinib|mesh-list
153819444|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819445|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153597879|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
153597880|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
153597881|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597882|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153597883|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153597884|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
153597885|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153597886|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
153597887|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597888|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153460849|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460850|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343075|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343076|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343077|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343078|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343080|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
153343081|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460851|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460852|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153460853|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153460854|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
153460855|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460856|NCT00089544|Thalidomide|thalidomide|mesh-list
153460857|NCT00089544|Doxorubicin|doxorubicin|mesh-list
153460858|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153460859|NCT00089544|Ifosfamide|ifosfamide|mesh-list
153460860|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
153460861|NCT00089544|Dacarbazine|dacarbazine|mesh-list
153460862|NCT00089544|Imidazole|imidazole|mesh-list
153460863|NCT00089544|Lenograstim|lenograstim|mesh-list
153597896|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
153597897|NCT01871740|Vitamins|vitamins|mesh-ancestor
153597898|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
153597899|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597900|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597901|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597902|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153597903|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
153597904|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153597905|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
153597906|NCT01871792|Pitavastatin|pitavastatin|mesh-list
153597907|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153597908|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153597909|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153597910|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
153597911|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597912|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597913|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153597914|NCT01871844|Octreotide|octreotide|mesh-list
153597915|NCT01871844|Somatostatin|somatostatin|mesh-list
153597916|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153819457|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819458|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819459|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153819461|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153819462|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
153819463|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597918|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597919|NCT01871844|Hormones|hormones|mesh-ancestor
153597920|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153597921|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597922|NCT01871857|Epinephrine|epinephrine|mesh-list
153597923|NCT01871857|Racepinephrine|racepinephrine|mesh-list
153597924|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
153597925|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153597926|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153597927|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
153597928|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597929|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597930|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388871|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343082|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343083|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
153343084|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343085|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343086|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153343088|NCT00002806|Lomustine|lomustine|mesh-list
153343089|NCT00002806|Procarbazine|procarbazine|mesh-list
153343090|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343093|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343117|NCT00002812|Pegaspargase|pegaspargase|mesh-list
153343118|NCT00002812|Thioguanine|thioguanine|mesh-list
153343119|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343120|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
153388872|NCT00380913|Nabilone|nabilone|mesh-list
153597931|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153597932|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153597933|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
153597934|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597935|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153597936|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
153597937|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
153819464|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819465|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819466|NCT01004978|Cisplatin|cisplatin|mesh-list
153460864|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153460865|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460866|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153460867|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460868|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460869|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460870|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153460871|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
153460872|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460873|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460874|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
153460875|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460876|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
153460877|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153460878|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460879|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153460880|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153460881|NCT00089544|Growth Substances|growth substances|mesh-ancestor
153460882|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
153460883|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153460884|NCT00089076|Ipilimumab|ipilimumab|mesh-list
153460885|NCT00089076|Antibodies|antibodies|mesh-list
153813423|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460886|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
153460887|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153597941|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153597942|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153597943|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153597944|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
153597945|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597946|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597947|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153597948|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
153597949|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
153597950|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
153597951|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153597952|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153343121|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343122|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343123|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343124|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
153343125|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343126|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343127|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153343128|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153343130|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
153343131|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343132|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153343133|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
153343135|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153343136|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153343137|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343138|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343139|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343140|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343141|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153597953|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
153597954|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597955|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597956|NCT01871935|Sufentanil|sufentanil|mesh-list
153597957|NCT01871935|Remifentanil|remifentanil|mesh-list
153597958|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153597959|NCT01871935|Narcotics|narcotics|mesh-ancestor
153597960|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597961|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597962|NCT01871935|Analgesics|analgesics|mesh-ancestor
153597963|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
153597964|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597965|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153597966|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153597967|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
153597968|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
153597969|NCT01871961|Methotrexate|methotrexate|mesh-list
153597970|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153597971|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
153597972|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153597975|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
153597978|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
153597979|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597980|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153597981|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153597982|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
153597983|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153597984|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153597985|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153597986|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
153597987|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597988|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153343142|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
153343143|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153343144|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343146|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
153343147|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153343148|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343149|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
153343171|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
153343172|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343173|NCT00003166|Vincristine|vincristine|mesh-list
153343174|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
153343175|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343176|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343177|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343178|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343179|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343180|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343181|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153597989|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153597990|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597991|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597992|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153597993|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
153597994|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153597995|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153597996|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153597997|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597998|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597999|NCT01872013|ASP7991|asp7991|mesh-list
153598000|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153598001|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
153598002|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598003|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598004|NCT01872026|ASP7991|asp7991|mesh-list
153598005|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153598006|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
153598007|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598008|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598009|NCT01872039|Nicardipine|nicardipine|mesh-list
153598010|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153819469|NCT01004978|Sorafenib|sorafenib|mesh-list
153819470|NCT01004978|Mitomycins|mitomycins|mesh-list
153819471|NCT01004978|Mitomycin|mitomycin|mesh-list
153819473|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153819474|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153819475|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153819476|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598011|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153598012|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598013|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598014|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153598015|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598016|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
153598017|NCT01871311|Cetuximab|cetuximab|mesh-list
153598018|NCT01871311|Nilotinib|nilotinib|mesh-list
153343182|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
153343183|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343184|NCT00003172|Interferons|interferons|mesh-list
153343185|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
153343186|NCT00003172|Docetaxel|docetaxel|mesh-list
153343187|NCT00003172|Doxorubicin|doxorubicin|mesh-list
153343188|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153343189|NCT00003172|Fluorouracil|fluorouracil|mesh-list
153343190|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
153343191|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343192|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343193|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343194|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343195|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343196|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153388967|NCT00002319|Doxorubicin|doxorubicin|mesh-list
153598019|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153598020|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598021|NCT01871311|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153783727|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153598022|NCT01871311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153598023|NCT01871311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598024|NCT01871311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598025|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
153598026|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
153598027|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
153598028|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598029|NCT01872351|Protective Agents|protective agents|mesh-ancestor
153598030|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598031|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
153598032|NCT01872351|Vitamins|vitamins|mesh-ancestor
153598033|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
153598034|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
153598035|NCT01872403|Paclitaxel|paclitaxel|mesh-list
153819477|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819478|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153819479|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
153819480|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153819481|NCT00904540|Lidocaine|lidocaine|mesh-list
153819482|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
153819483|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
153819484|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819485|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819486|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
153819487|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819488|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153819489|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153819490|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153460888|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
153460889|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460890|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460891|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460892|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460893|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153460894|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153598036|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153598037|NCT01872403|Carboplatin|carboplatin|mesh-list
153598038|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343198|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343199|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343200|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
153343202|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343203|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
153343204|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343205|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
153598039|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598040|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
153598041|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
153598042|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
153598043|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598044|NCT01872416|Doxorubicin|doxorubicin|mesh-list
153598045|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153598046|NCT01872416|Ifosfamide|ifosfamide|mesh-list
153598047|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153598048|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598049|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153598050|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153598051|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598052|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598053|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153598054|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
153598055|NCT01872442|Interferons|interferons|mesh-list
153460898|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
153460899|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460900|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
153460901|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460902|NCT03770286|Fluorides|fluorides|mesh-list
153460903|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
153460904|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
153460905|NCT03770286|Protective Agents|protective agents|mesh-ancestor
153460906|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460907|NCT00087516|Metformin|metformin|mesh-list
153460908|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153460909|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153460910|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460911|NCT00087516|Incretins|incretins|mesh-ancestor
153460912|NCT00087516|Hormones|hormones|mesh-ancestor
153460913|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153460914|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153820707|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598063|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
153598064|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598065|NCT01872442|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153598066|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153598067|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598068|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598069|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
153598070|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
153598071|NCT01872494|Pentazocine|pentazocine|mesh-list
153598072|NCT01872494|Palonosetron|palonosetron|mesh-list
153598073|NCT01872494|Ropivacaine|ropivacaine|mesh-list
153598074|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
153598075|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
153598076|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598077|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598078|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
153598079|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598080|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
153598081|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
153598082|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598083|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153598084|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153598085|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
153598086|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343241|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343243|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
153343244|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153377478|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153343245|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343269|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
153343270|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343271|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153388979|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598087|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598088|NCT01872494|Analgesics|analgesics|mesh-ancestor
153598089|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153598090|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153598091|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153598092|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153598093|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153598100|NCT01872546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153598101|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153598102|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153598103|NCT01872702|Primaquine|primaquine|mesh-list
153598104|NCT01872702|Piperaquine|piperaquine|mesh-list
153598105|NCT01872702|Artenimol|artenimol|mesh-list
153598106|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
153598107|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153598108|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153598109|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598110|NCT01872728|Anesthetics|anesthetics|mesh-list
153598111|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598112|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598113|NCT01872754|Remifentanil|remifentanil|mesh-list
153598114|NCT01872754|Propofol|propofol|mesh-list
153819491|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153819492|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819493|NCT00904202|Lidocaine|lidocaine|mesh-list
153819494|NCT00904202|Gabapentin|gabapentin|mesh-list
153819495|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
153819496|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
153819497|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819498|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819499|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
153819500|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819501|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153819502|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153819503|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153819504|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153819505|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819506|NCT00904202|Analgesics|analgesics|mesh-ancestor
153819507|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
153819508|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153819509|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153819510|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153819511|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153819512|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153819513|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819514|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
153819515|NCT00904020|Lidocaine|lidocaine|mesh-list
153819516|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
153460915|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
153460916|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460917|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460918|NCT03768960|Daratumumab|daratumumab|mesh-list
153389111|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389112|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153343272|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343273|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343275|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343276|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343277|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343279|NCT01260649|Anesthetics|anesthetics|mesh-list
153343280|NCT01260649|Analgesics|analgesics|mesh-ancestor
153343281|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
153343282|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343283|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343284|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153343285|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153343286|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
153343287|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153343288|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153343289|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153343290|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343291|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343292|NCT01260883|Ketorolac|ketorolac|mesh-list
153343293|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153343294|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153343295|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153343296|NCT01260883|Analgesics|analgesics|mesh-ancestor
153343317|NCT00003190|Daunorubicin|daunorubicin|mesh-list
153343318|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
153343319|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343320|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343321|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343322|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343323|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343324|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389113|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
153598115|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153598116|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598117|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598118|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153598119|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
153343325|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343326|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
153343327|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
153343328|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343329|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343330|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
153343331|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343332|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343333|NCT00003652|Fluorouracil|fluorouracil|mesh-list
153343334|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343335|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
153343336|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343337|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343338|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343339|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
153343340|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343341|NCT04773236|Lidocaine|lidocaine|mesh-list
153343342|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
153343344|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153343345|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343346|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
153343347|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598121|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153598122|NCT01872754|Narcotics|narcotics|mesh-ancestor
153598123|NCT01872754|Analgesics|analgesics|mesh-ancestor
153598124|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
153598125|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598126|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
153598127|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153598128|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598129|NCT01872832|Verinurad|verinurad|mesh-list
153598130|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
153598131|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153598132|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153598133|NCT01872845|Pravastatin|pravastatin|mesh-list
153598134|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153598135|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153598136|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
153598137|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460926|NCT00086346|Cyclosporine|cyclosporine|mesh-list
153460927|NCT00086346|Sirolimus|sirolimus|mesh-list
153460928|NCT00086346|Tacrolimus|tacrolimus|mesh-list
153460929|NCT00086346|Cyclosporins|cyclosporins|mesh-list
153460930|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460931|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
153460932|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598139|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153598140|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598141|NCT01872858|Aspirin|aspirin|mesh-list
153598142|NCT01872858|Cilostazol|cilostazol|mesh-list
153598143|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153598144|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153598146|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
153598147|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343349|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153343350|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153343351|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153343386|NCT00003664|Interferons|interferons|mesh-list
153343387|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
153343388|NCT00003664|Aldesleukin|aldesleukin|mesh-list
153343389|NCT00003664|Gemcitabine|gemcitabine|mesh-list
153343390|NCT00003664|Fluorouracil|fluorouracil|mesh-list
153343391|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343392|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
153343424|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343426|NCT00002854|Etoposide|etoposide|mesh-list
153343427|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
153343428|NCT00002854|Carboplatin|carboplatin|mesh-list
153598148|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598149|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153598150|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153598151|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153598152|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153598153|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598154|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153598155|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153598156|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598157|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
153598158|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153598159|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
153598160|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153598161|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
153598162|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
153598163|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153598164|NCT01872858|Protective Agents|protective agents|mesh-ancestor
153598171|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598173|NCT01872871|Analgesics|analgesics|mesh-ancestor
153598174|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
153598175|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598176|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
153598177|NCT01872884|Remifentanil|remifentanil|mesh-list
153598178|NCT01872884|Sevoflurane|sevoflurane|mesh-list
153598179|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153598180|NCT01872884|Narcotics|narcotics|mesh-ancestor
153598181|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598182|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598183|NCT01872884|Analgesics|analgesics|mesh-ancestor
153598184|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
153598185|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819517|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
153819518|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819519|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819520|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
153819521|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819522|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153819523|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153819524|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153819525|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153819526|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819527|NCT00719966|Letrozole|letrozole|mesh-list
153819528|NCT00719966|Anastrozole|anastrozole|mesh-list
153819529|NCT00719966|Exemestane|exemestane|mesh-list
153819530|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819531|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153343430|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343431|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343432|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343433|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343434|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343435|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343470|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343471|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
153343472|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343473|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390246|NCT05709093|Antimetabolites|antimetabolites|mesh-ancestor
153819532|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153460933|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153460934|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460935|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460936|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
153460937|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460938|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
153460939|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460940|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153460941|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153460942|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460943|NCT00085566|Everolimus|everolimus|mesh-list
153460944|NCT00085566|Gefitinib|gefitinib|mesh-list
153460945|NCT00085566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153598187|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153598188|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
153598189|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
153598190|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
153598191|NCT01872897|Antacids|antacids|mesh-ancestor
153598192|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598193|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598194|NCT01872923|Bleomycin|bleomycin|mesh-list
153598195|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153598196|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598197|NCT01872936|Ribavirin|ribavirin|mesh-list
153598198|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
153598199|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598200|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
153598201|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598202|NCT01872962|Cisplatin|cisplatin|mesh-list
153598203|NCT01872962|Gemcitabine|gemcitabine|mesh-list
153598204|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598205|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460948|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460949|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460950|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
153598215|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153598216|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153378055|NCT03167905|Fentanyl|fentanyl|mesh-list
153598218|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
153598219|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153598220|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598221|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598222|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153598223|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598224|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598225|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
153598226|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598227|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153598228|NCT01873027|Sirolimus|sirolimus|mesh-list
153598229|NCT01873027|Umirolimus|umirolimus|mesh-list
153598230|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390258|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343474|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343475|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
153343476|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153343510|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343511|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153343512|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343514|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
153343515|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343516|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343517|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343518|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343550|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
153343551|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343552|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343553|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153343554|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
153343555|NCT00003682|Hormones|hormones|mesh-ancestor
153343556|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153343557|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153598231|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153598232|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
153598233|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598234|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153813427|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153359892|NCT03141359|Etoposide|etoposide|mesh-list
153359893|NCT03141359|Carboplatin|carboplatin|mesh-list
153598235|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598236|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153598237|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598238|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
153598239|NCT01873079|Esomeprazole|esomeprazole|mesh-list
153598240|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153598241|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598242|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153598243|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598244|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598245|NCT05855629|Inositol|inositol|mesh-list
153598246|NCT05855629|Adapalene|adapalene|mesh-list
153598247|NCT05855629|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153598248|NCT05855629|Dermatologic Agents|dermatologic agents|mesh-ancestor
153598249|NCT05855629|Vitamin B Complex|vitamin b complex|mesh-ancestor
153598250|NCT05855629|Vitamins|vitamins|mesh-ancestor
153598251|NCT05855629|Micronutrients|micronutrients|mesh-ancestor
153598252|NCT05855629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598253|NCT05855629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153598254|NCT05855629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153598255|NCT05855629|Analgesics|analgesics|mesh-ancestor
153598256|NCT05855629|Sensory System Agents|sensory system agents|mesh-ancestor
153598257|NCT05855629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598258|NCT05855629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153598259|NCT05855629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153598260|NCT05855616|Chlorhexidine|chlorhexidine|mesh-list
153598261|NCT05855616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153598284|NCT05855070|Viscosupplements|viscosupplements|mesh-ancestor
153343558|NCT00003682|Protective Agents|protective agents|mesh-ancestor
153343559|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153343576|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
153343577|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153343578|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343579|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343580|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
153343581|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343582|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343583|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
153343584|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343585|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153343586|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343587|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
153598285|NCT05855070|Protective Agents|protective agents|mesh-ancestor
153598286|NCT05855070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153598287|NCT05855070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153598288|NCT05855070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598289|NCT05855070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598290|NCT05855070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153598291|NCT05855070|Vasodilator Agents|vasodilator agents|mesh-ancestor
153598292|NCT05855018|Atropine|atropine|mesh-list
153598293|NCT05855018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153598294|NCT05855018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153598295|NCT05855018|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153598296|NCT05855018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153598297|NCT05855018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153598298|NCT05855018|Autonomic Agents|autonomic agents|mesh-ancestor
153598299|NCT05855018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598300|NCT05855018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598301|NCT05855018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153598302|NCT05855018|Respiratory System Agents|respiratory system agents|mesh-ancestor
153819533|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819534|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819535|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153819536|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819537|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819538|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819539|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819540|NCT00671008|Insulin|insulin|mesh-list
153819541|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153819548|NCT00644033|Frovatriptan|frovatriptan|mesh-list
153598304|NCT05855018|Parasympatholytics|parasympatholytics|mesh-ancestor
153598305|NCT05855018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153598306|NCT05855018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153598307|NCT05855018|Cholinergic Agents|cholinergic agents|mesh-ancestor
153598308|NCT05855018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598309|NCT05855018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598310|NCT05854849|Gemcitabine|gemcitabine|mesh-list
153598311|NCT05854849|Apatinib|apatinib|mesh-list
153598312|NCT05854849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598313|NCT05854849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153598314|NCT05854849|Antimetabolites|antimetabolites|mesh-ancestor
153598315|NCT05854849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598316|NCT05854849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153598317|NCT05854849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598318|NCT05854511|Sofosbuvir|sofosbuvir|mesh-list
153598319|NCT05854511|Antiviral Agents|antiviral agents|mesh-ancestor
153598320|NCT05854511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343589|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343590|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
153343591|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343592|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343593|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343594|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343595|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
153343596|NCT00003694|Cytarabine|cytarabine|mesh-list
153343597|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
153343598|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343599|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
153343600|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343601|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343602|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
153343603|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343604|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343605|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
153343606|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390312|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
153390313|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598321|NCT05854342|Calcium|calcium|mesh-list
153598322|NCT05854342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153598323|NCT05854342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598324|NCT05854225|Thiotepa|thiotepa|mesh-list
153819549|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153819550|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
153460951|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460952|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460953|NCT00085566|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153460954|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
153460955|NCT00085098|Cisplatin|cisplatin|mesh-list
153460956|NCT00085098|Carboplatin|carboplatin|mesh-list
153460957|NCT00085098|Etoposide|etoposide|mesh-list
153460958|NCT00085098|Lenograstim|lenograstim|mesh-list
153460959|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460960|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
153460961|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460962|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153460963|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460964|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
153460965|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460966|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460967|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153460968|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460969|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153460970|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460971|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460972|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153460973|NCT00084864|Calcitriol|calcitriol|mesh-list
153598325|NCT05854225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153598326|NCT05854225|Alkylating Agents|alkylating agents|mesh-ancestor
153598327|NCT05854225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343607|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343608|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153343609|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343611|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343612|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153343613|NCT00003250|Protective Agents|protective agents|mesh-ancestor
153343614|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343615|NCT00003256|Alvocidib|alvocidib|mesh-list
153343616|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343618|NCT00003256|Growth Substances|growth substances|mesh-ancestor
153343619|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343620|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153343621|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343622|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343623|NCT00003946|Danazol|danazol|mesh-list
153343651|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153343652|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153598328|NCT05854225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598329|NCT05854225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153598330|NCT05854225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153598331|NCT05854225|Immunologic Factors|immunologic factors|mesh-ancestor
153598332|NCT05854225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598333|NCT05854082|Lidocaine|lidocaine|mesh-list
153598334|NCT05854082|Anesthetics, Local|anesthetics, local|mesh-ancestor
153598335|NCT05854082|Anesthetics|anesthetics|mesh-ancestor
153598336|NCT05854082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598337|NCT05854082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813428|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783732|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153598338|NCT05854082|Sensory System Agents|sensory system agents|mesh-ancestor
153598339|NCT05854082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598349|NCT05853718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598350|NCT05853718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153598351|NCT05853718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153598352|NCT05853718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598353|NCT05853718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598354|NCT05853718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153598355|NCT05853718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153598356|NCT05853627|Propranolol|propranolol|mesh-list
153598357|NCT05853627|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153598358|NCT05853627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153598359|NCT05853627|Adrenergic Agents|adrenergic agents|mesh-ancestor
153598360|NCT05853627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598361|NCT05853627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598362|NCT05853627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598363|NCT05853627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153598364|NCT05853627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153598365|NCT05853627|Vasodilator Agents|vasodilator agents|mesh-ancestor
153598366|NCT05852730|Promethazine|promethazine|mesh-list
153598368|NCT05852730|Meclizine|meclizine|mesh-list
153598369|NCT05852730|Scopolamine|scopolamine|mesh-list
153598370|NCT05852730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153598371|NCT05852730|Antiemetics|antiemetics|mesh-ancestor
153598372|NCT05852730|Autonomic Agents|autonomic agents|mesh-ancestor
153598373|NCT05852730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598374|NCT05852730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598375|NCT05852730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598376|NCT05852730|Mydriatics|mydriatics|mesh-ancestor
153598377|NCT05852730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153343656|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
153343657|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343659|NCT00003700|Cytarabine|cytarabine|mesh-list
153343660|NCT00003700|Prednisone|prednisone|mesh-list
153343661|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
153343662|NCT00003700|Methotrexate|methotrexate|mesh-list
153343663|NCT00003700|Vincristine|vincristine|mesh-list
153783733|NCT04540627|Palivizumab|palivizumab|mesh-list
153783734|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
153343664|NCT00003700|Daunorubicin|daunorubicin|mesh-list
153343665|NCT00003700|Asparaginase|asparaginase|mesh-list
153343666|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
153343667|NCT00003700|Allopurinol|allopurinol|mesh-list
153343668|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
153343669|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343670|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
153343671|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343672|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343673|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153598378|NCT05852730|Cholinergic Agents|cholinergic agents|mesh-ancestor
153598379|NCT05852730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598380|NCT05852730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598381|NCT05852730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153598382|NCT05852730|Antipruritics|antipruritics|mesh-ancestor
153598383|NCT05852730|Dermatologic Agents|dermatologic agents|mesh-ancestor
153598384|NCT05852730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153598385|NCT05852730|Histamine Antagonists|histamine antagonists|mesh-ancestor
153598386|NCT05852730|Histamine Agents|histamine agents|mesh-ancestor
153598387|NCT05852730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153598388|NCT05852730|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153598389|NCT05852730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153598399|NCT05845489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153598400|NCT05845489|Purinergic Agents|purinergic agents|mesh-ancestor
153598401|NCT05845489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598402|NCT05845489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598403|NCT05845489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598404|NCT05826873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153598405|NCT05826873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598406|NCT05815602|Mebeverine|mebeverine|mesh-list
153598407|NCT05815602|Ebastine|ebastine|mesh-list
153598408|NCT05815602|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153598409|NCT05815602|Histamine Antagonists|histamine antagonists|mesh-ancestor
153598410|NCT05815602|Histamine Agents|histamine agents|mesh-ancestor
153598411|NCT05815602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598412|NCT05815602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598413|NCT05815602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598414|NCT05815602|Anticonvulsants|anticonvulsants|mesh-ancestor
153598423|NCT05755737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598424|NCT05755737|Antipruritics|antipruritics|mesh-ancestor
153598425|NCT05755737|Dermatologic Agents|dermatologic agents|mesh-ancestor
153598426|NCT05755737|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153819551|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819552|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819553|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598440|NCT05732506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153598442|NCT05732506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598443|NCT05732506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598444|NCT05732506|Anticoagulants|anticoagulants|mesh-ancestor
153598458|NCT05651633|Lidocaine|lidocaine|mesh-list
153598459|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
153598460|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
153343675|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343698|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
153343699|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343700|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343701|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343702|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343703|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343704|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343705|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343706|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
153343707|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153343708|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
153343709|NCT00003706|Pemetrexed|pemetrexed|mesh-list
153343710|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343711|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343712|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343713|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153343714|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343715|NCT00003958|Dactinomycin|dactinomycin|mesh-list
153343716|NCT00003958|Cactinomycin|cactinomycin|mesh-list
153343717|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
153343718|NCT00003958|Vincristine|vincristine|mesh-list
153343719|NCT00003958|Topotecan|topotecan|mesh-list
153343720|NCT00003958|Sargramostim|sargramostim|mesh-list
153343721|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343722|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
153343723|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343724|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153598461|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598462|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819554|NCT00643604|Treprostinil|treprostinil|mesh-list
153819555|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153598463|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
153598464|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598465|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153598466|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153598467|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153598468|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598469|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598470|NCT05648448|Oseltamivir|oseltamivir|mesh-list
153598471|NCT05648448|Favipiravir|favipiravir|mesh-list
153598472|NCT05648448|Zanamivir|zanamivir|mesh-list
153783735|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783736|NCT00236834|Levofloxacin|levofloxacin|mesh-list
153598473|NCT05648448|Molnupiravir|molnupiravir|mesh-list
153598474|NCT05648448|Baloxavir|baloxavir|mesh-list
153598475|NCT05648448|Peramivir|peramivir|mesh-list
153598476|NCT05648448|Laninamivir|laninamivir|mesh-list
153598477|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
153598478|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343725|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343726|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
153343727|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343729|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153343761|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343762|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343763|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
153343764|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343765|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343766|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
153343767|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343768|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343769|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343770|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343771|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343772|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153343773|NCT00003268|Protective Agents|protective agents|mesh-ancestor
153343806|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343807|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598479|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598480|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598481|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
153598482|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153598483|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598484|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598485|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153598486|NCT05641064|Analgesics|analgesics|mesh-ancestor
153598487|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
153598488|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598489|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153598510|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598511|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598512|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153889788|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153889789|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153598513|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153598514|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598516|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153598517|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
153598518|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153598519|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
153598520|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598521|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598522|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153598523|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153598524|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598526|NCT05458375|Estrogens|estrogens|mesh-ancestor
153598527|NCT05458375|Hormones|hormones|mesh-ancestor
153598528|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598529|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343809|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
153343810|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
153343811|NCT00085436|Aldesleukin|aldesleukin|mesh-list
153343812|NCT00085436|Vaccines|vaccines|mesh-list
153343813|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
153343814|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343815|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343816|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
153343817|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343818|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153343819|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153343820|NCT00384202|Tacrolimus|tacrolimus|mesh-list
153343821|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343844|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343845|NCT00384280|Rifampin|rifampin|mesh-list
153343846|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153343847|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
153598530|NCT05420584|Tislelizumab|tislelizumab|mesh-list
153598531|NCT05420584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153598532|NCT05420584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598533|NCT05416580|Metformin|metformin|mesh-list
153598534|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153598535|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153598536|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598539|NCT05385406|Acetic Acid|acetic acid|mesh-list
153598553|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598554|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153598555|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153598556|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
153598557|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598558|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598559|NCT05344833|Lenalidomide|lenalidomide|mesh-list
153598560|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
153598561|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598562|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153598563|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153598564|NCT05344833|Growth Substances|growth substances|mesh-ancestor
153598565|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
153598566|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598567|NCT05323838|Complement System Proteins|complement system proteins|mesh-list
153598568|NCT05323838|Immunologic Factors|immunologic factors|mesh-ancestor
153598569|NCT05323838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598570|NCT05302999|Gabapentin|gabapentin|mesh-list
153598571|NCT05302999|Analgesics|analgesics|mesh-ancestor
153598572|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
153598573|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598574|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598575|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
153598576|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153598577|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153598578|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598579|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153598580|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153598581|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153598582|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598583|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598584|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
153598585|NCT05265806|Oxytocin|oxytocin|mesh-list
153598586|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
153598593|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
153598594|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343848|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153343849|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343851|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343852|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343853|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343854|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153343855|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153343856|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153343857|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153343858|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153343859|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153343860|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153343861|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343862|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153343863|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343864|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598595|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598596|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153598597|NCT05242419|Protective Agents|protective agents|mesh-ancestor
153598598|NCT05232227|Primaquine|primaquine|mesh-list
153598599|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
153598600|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153598601|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153598602|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598603|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
153598604|NCT05225363|Fludarabine|fludarabine|mesh-list
153813430|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153598605|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153598606|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
153598607|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598608|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153598609|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153598620|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598621|NCT05184842|Venetoclax|venetoclax|mesh-list
153819556|NCT00585559|Acetaminophen|acetaminophen|mesh-list
153819557|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
153819558|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153819559|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153819560|NCT00585559|Analgesics|analgesics|mesh-ancestor
153819561|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
153819562|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819563|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819564|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
153819565|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
153819566|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819567|NCT00585559|Expectorants|expectorants|mesh-ancestor
153819568|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
153819569|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153819570|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
153819571|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819572|NCT00585559|Protective Agents|protective agents|mesh-ancestor
153460975|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153598623|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598624|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343866|NCT00003730|Vinorelbine|vinorelbine|mesh-list
153343867|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
153343868|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343869|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343899|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153343900|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
153343901|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153343902|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153343903|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
153343904|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
153343905|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343906|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153343907|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
153343908|NCT00003994|Carboplatin|carboplatin|mesh-list
153343909|NCT00003994|Fluorouracil|fluorouracil|mesh-list
153343910|NCT00003994|Vincristine|vincristine|mesh-list
153343911|NCT00003994|Amifostine|amifostine|mesh-list
153343912|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343913|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
153343914|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390795|NCT00002643|Cobalt|cobalt|mesh-list
153598625|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
153598626|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598627|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598628|NCT05135650|Sotrovimab|sotrovimab|mesh-list
153598629|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153598630|NCT05135650|Antibodies|antibodies|mesh-list
153598631|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
153598632|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153598633|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
153598634|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598635|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598636|NCT05135650|Antiviral Agents|antiviral agents|mesh-ancestor
153598637|NCT05135650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598638|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
153598639|NCT05073822|Tacrolimus|tacrolimus|mesh-list
153598640|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153598641|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
153460976|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
153460977|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
153460978|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460979|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460980|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153460981|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
153460982|NCT00084864|Hormones|hormones|mesh-ancestor
153460983|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153460984|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153460985|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460986|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153460987|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153598653|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
153598654|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153598655|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153598656|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153343951|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343953|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343987|NCT00089102|Irinotecan|irinotecan|mesh-list
153343988|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343989|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
153343990|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343991|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390797|NCT00002643|Ifosfamide|ifosfamide|mesh-list
153390798|NCT00002643|Doxorubicin|doxorubicin|mesh-list
153598657|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598658|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598659|NCT05047952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153598660|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153598661|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598662|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598663|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598664|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
153781722|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598665|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153598666|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153598667|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153598668|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153598669|NCT05001828|Azacitidine|azacitidine|mesh-list
153598671|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153598673|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598674|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598675|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598676|NCT04965454|Choline|choline|mesh-list
153598677|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
153598678|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153598679|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
153598680|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598681|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598682|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153598683|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
153598684|NCT04933552|Siponimod|siponimod|mesh-list
153598685|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153598686|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598687|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153598688|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
153598689|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598690|NCT04917484|Octreotide|octreotide|mesh-list
153598691|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153598692|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598693|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819581|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153819582|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153819583|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153819584|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819585|NCT00475514|Frovatriptan|frovatriptan|mesh-list
153598696|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598698|NCT04916613|Hormones|hormones|mesh-ancestor
153598699|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598700|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598701|NCT04865848|Anesthetics|anesthetics|mesh-list
153598702|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598703|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598704|NCT04859322|Glucagon|glucagon|mesh-list
153598705|NCT04859322|Somatostatin|somatostatin|mesh-list
153598706|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343993|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343994|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344024|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
153344025|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344026|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783298|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153344027|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153344028|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153344029|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
153344030|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598707|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598708|NCT04859322|Hormones|hormones|mesh-ancestor
153598709|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598710|NCT04839666|Propofol|propofol|mesh-list
153598711|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153598712|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598713|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598714|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153598715|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
153598716|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
153598717|NCT04804007|Etoposide|etoposide|mesh-list
153598718|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153598719|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598720|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153819586|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153819587|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
153460988|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153460989|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460990|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153460991|NCT00084864|Vitamins|vitamins|mesh-ancestor
153460992|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
153460993|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153460994|NCT01677702|Lactoferrin|lactoferrin|mesh-list
153460995|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460996|NCT01473108|Eplerenone|eplerenone|mesh-list
153460997|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153460998|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
153460999|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461000|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461001|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153461002|NCT01473108|Diuretics|diuretics|mesh-ancestor
153461003|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
153598721|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153598722|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598723|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598732|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153598733|NCT04757584|Propranolol|propranolol|mesh-list
153598734|NCT04757584|Metoprolol|metoprolol|mesh-list
153598735|NCT04757584|Atenolol|atenolol|mesh-list
153598736|NCT04757584|Sotalol|sotalol|mesh-list
153598738|NCT04757584|Acebutolol|acebutolol|mesh-list
153598740|NCT04757584|Nebivolol|nebivolol|mesh-list
153598741|NCT04757584|Bisoprolol|bisoprolol|mesh-list
153598742|NCT04757584|Labetalol|labetalol|mesh-list
153598743|NCT04757584|Pindolol|pindolol|mesh-list
153598744|NCT04757584|Betaxolol|betaxolol|mesh-list
153598745|NCT04757584|Penbutolol|penbutolol|mesh-list
153598746|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153598747|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153598748|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
153598749|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598750|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598751|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344032|NCT00003334|Paclitaxel|paclitaxel|mesh-list
153344033|NCT00003334|Doxorubicin|doxorubicin|mesh-list
153344034|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153344035|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344036|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344037|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344038|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344039|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344040|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344041|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344071|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344072|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153598752|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153598753|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153598754|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
153598755|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
153598756|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
153598758|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153598760|NCT04757584|Protective Agents|protective agents|mesh-ancestor
153598761|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153598762|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598763|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153598764|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153598765|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153598766|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153598767|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153598768|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153598769|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
153598770|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153598771|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
153598772|NCT04756791|Anesthetics|anesthetics|mesh-list
153598773|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598774|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598775|NCT04752475|Furosemide|furosemide|mesh-list
153598776|NCT04752475|Diuretics|diuretics|mesh-ancestor
153598777|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
153598778|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598779|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153598780|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598781|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598782|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
153598783|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153598794|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
153598795|NCT04700826|Apixaban|apixaban|mesh-list
153598796|NCT04700826|Edoxaban|edoxaban|mesh-list
153598797|NCT04700826|Dabigatran|dabigatran|mesh-list
153598798|NCT04700826|Anticoagulants|anticoagulants|mesh-list
153598799|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153598800|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
153598801|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153598802|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
153598803|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598804|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598805|NCT04549207|Denosumab|denosumab|mesh-list
153598806|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
153598807|NCT04549207|Pamidronate|pamidronate|mesh-list
153598808|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153598809|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598810|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
153598811|NCT04319328|Cefazolin|cefazolin|mesh-list
153598812|NCT04319328|Ceftazidime|ceftazidime|mesh-list
153344073|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344074|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344075|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344076|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
153344077|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
153344078|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153344079|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153344080|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344081|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344082|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344083|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344084|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
153344108|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344110|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344111|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153344112|NCT00004036|Protective Agents|protective agents|mesh-ancestor
153344113|NCT00003346|Acetaminophen|acetaminophen|mesh-list
153598813|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153598814|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598815|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153598816|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153598824|NCT04255160|Estradiol|estradiol|mesh-list
153598828|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598829|NCT04092387|Nicotine|nicotine|mesh-list
153598830|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153598831|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
153598832|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598833|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598834|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153598835|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153598836|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
153598837|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598838|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598839|NCT04041050|Celecoxib|celecoxib|mesh-list
153598840|NCT04041050|Navitoclax|navitoclax|mesh-list
153598841|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153598842|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153598843|NCT04041050|Analgesics|analgesics|mesh-ancestor
153598844|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
153598845|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359899|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
153598846|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598847|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153598848|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819593|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
153819594|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
153819595|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153819596|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819597|NCT00439946|Treprostinil|treprostinil|mesh-list
153819598|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153819599|NCT00383877|Insulin|insulin|mesh-list
153598853|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598855|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153598856|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153598857|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153598858|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
153598859|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
153598860|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598862|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
153344115|NCT00003346|Carmustine|carmustine|mesh-list
153344116|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153344117|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153344118|NCT00003346|Analgesics|analgesics|mesh-ancestor
153344119|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
153344120|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344121|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344122|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
153344123|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
153344124|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344125|NCT00003346|Expectorants|expectorants|mesh-ancestor
153344126|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
153344127|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153344128|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
153344129|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344130|NCT00003346|Protective Agents|protective agents|mesh-ancestor
153344131|NCT00003346|Antidotes|antidotes|mesh-ancestor
153344132|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344133|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
153344134|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344135|NCT00096122|Cytarabine|cytarabine|mesh-list
153344136|NCT00096122|Idarubicin|idarubicin|mesh-list
153344137|NCT00096122|Tipifarnib|tipifarnib|mesh-list
153344138|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344165|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
153344166|NCT00003784|Doxorubicin|doxorubicin|mesh-list
153344167|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153344168|NCT00003784|Vincristine|vincristine|mesh-list
153344169|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
153344170|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344171|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
153344172|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344173|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344174|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344175|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
153344185|NCT00003784|Hormones|hormones|mesh-ancestor
153344186|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344187|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153344205|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
153359901|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344206|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344207|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344208|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344209|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344210|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344211|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344212|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153344213|NCT00004048|Doxorubicin|doxorubicin|mesh-list
153344214|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153344215|NCT00004048|Antibodies|antibodies|mesh-list
153344216|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
153344217|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153344218|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
153344219|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344220|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344221|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344222|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344223|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344224|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344225|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344226|NCT00003358|Gemcitabine|gemcitabine|mesh-list
153344227|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344228|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344229|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
153344230|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598863|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153598864|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
153598865|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598866|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153598867|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
153598868|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
153598869|NCT03973203|Vitamins|vitamins|mesh-ancestor
153598870|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
153598871|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598872|NCT03916926|Fluorides|fluorides|mesh-list
153598873|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
153598874|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
153598875|NCT03916926|Protective Agents|protective agents|mesh-ancestor
153598876|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598877|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
153819600|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153819601|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
153391348|NCT05749575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344232|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153344233|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344234|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344235|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344236|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344237|NCT00384826|Paclitaxel|paclitaxel|mesh-list
153344238|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153344239|NCT00384826|Carboplatin|carboplatin|mesh-list
153344240|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344241|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344242|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344243|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344273|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344274|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
153344275|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344276|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344277|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344279|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344280|NCT00003370|Irofulven|irofulven|mesh-list
153819602|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
153819603|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
153819604|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
153461004|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153461005|NCT00084318|Docetaxel|docetaxel|mesh-list
153461006|NCT00084318|Cetuximab|cetuximab|mesh-list
153461007|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461008|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
153461009|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
153461010|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
153598886|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153598887|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598888|NCT03838263|Cisplatin|cisplatin|mesh-list
153598889|NCT03838263|Nivolumab|nivolumab|mesh-list
153598890|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598891|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153598892|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153598893|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598894|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
153598895|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153598896|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598897|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153598898|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598899|NCT03713645|Tacrolimus|tacrolimus|mesh-list
153598900|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153598901|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
153598902|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598903|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153598904|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598905|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598906|NCT03705507|Dexamethasone|dexamethasone|mesh-list
153598907|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153344282|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
153344283|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344284|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344285|NCT00003382|Gemcitabine|gemcitabine|mesh-list
153344286|NCT00003382|Topotecan|topotecan|mesh-list
153344287|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344288|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
153344306|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
153344307|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344308|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344310|NCT00004852|Zidovudine|zidovudine|mesh-list
153344311|NCT00004852|Efavirenz|efavirenz|mesh-list
153344312|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153344313|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153344314|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344315|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344316|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
153344317|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344318|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153344319|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153344321|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153344322|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153344323|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153344324|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153344325|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153344326|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153344327|NCT00004858|Genistein|genistein|mesh-list
153344328|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
153344329|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153344330|NCT00004858|Protective Agents|protective agents|mesh-ancestor
153344331|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344332|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344333|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153344334|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391393|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344336|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
153344337|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153344338|NCT00004858|Estrogens|estrogens|mesh-ancestor
153344339|NCT00004858|Hormones|hormones|mesh-ancestor
153344340|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344341|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
153344342|NCT00004864|Docetaxel|docetaxel|mesh-list
153344343|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344368|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153344369|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153344370|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153344371|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344372|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153344373|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344374|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344375|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
153344376|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
153344377|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
153344378|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344379|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153598908|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
153598909|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
153598910|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598911|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598912|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598913|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
153598914|NCT03705507|Hormones|hormones|mesh-ancestor
153598915|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598916|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153598917|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598935|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598937|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598938|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598939|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153598940|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598941|NCT03553810|Valsartan|valsartan|mesh-list
153598942|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153598943|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153598944|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153598945|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153598946|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598947|NCT03404596|Nicotine|nicotine|mesh-list
153598948|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153598956|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598958|NCT03340220|Antifungal Agents|antifungal agents|mesh-ancestor
153598959|NCT03340220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598960|NCT03340220|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153598961|NCT03340220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153344380|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344381|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
153344382|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344383|NCT00003850|Thalidomide|thalidomide|mesh-list
153344384|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344385|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
153344386|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344387|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
153344388|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153344389|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344390|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153344391|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153344392|NCT00003850|Growth Substances|growth substances|mesh-ancestor
153344393|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
153783311|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783312|NCT04553458|Ethanol|ethanol|mesh-list
153344405|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344406|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344407|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344408|NCT00003856|Temoporfin|temoporfin|mesh-list
153598962|NCT03340220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598963|NCT03340220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598964|NCT03340220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153598965|NCT03340220|Hormone Antagonists|hormone antagonists|mesh-ancestor
153598966|NCT03340220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598967|NCT03340220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598968|NCT03340220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153598970|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153598971|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153598972|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153598973|NCT02713945|Simvastatin|simvastatin|mesh-list
153598974|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153598975|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153598976|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
153598977|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598978|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153598979|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153598980|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598981|NCT02685605|Temozolomide|temozolomide|mesh-list
153598982|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153598983|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
153598984|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598985|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598986|NCT02664935|Docetaxel|docetaxel|mesh-list
153598987|NCT02664935|Durvalumab|durvalumab|mesh-list
153598988|NCT02664935|Palbociclib|palbociclib|mesh-list
153598989|NCT02664935|Osimertinib|osimertinib|mesh-list
153598990|NCT02664935|Crizotinib|crizotinib|mesh-list
153598991|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598992|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
153598993|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
153598994|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344410|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153344411|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
153344412|NCT00014222|Paclitaxel|paclitaxel|mesh-list
153344413|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
153344414|NCT00014222|Doxorubicin|doxorubicin|mesh-list
153344415|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153344416|NCT00014222|Fluorouracil|fluorouracil|mesh-list
153344417|NCT00014222|Epirubicin|epirubicin|mesh-list
153344418|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
153344419|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344420|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344421|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344422|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
153392043|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153598995|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598996|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153598997|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153598998|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598999|NCT02664935|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153599000|NCT02586207|Cisplatin|cisplatin|mesh-list
153599001|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
153599002|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599003|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599004|NCT02586207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153599005|NCT02586207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599006|NCT02573324|Temozolomide|temozolomide|mesh-list
153599007|NCT02573324|ABT-414|abt-414|mesh-list
153599008|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153599019|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153599022|NCT02523092|Hormones|hormones|mesh-ancestor
153599049|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153599050|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599051|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599052|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
153599053|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599054|NCT01342367|Bicalutamide|bicalutamide|mesh-list
153599055|NCT01342367|Finasteride|finasteride|mesh-list
153599056|NCT01342367|Dutasteride|dutasteride|mesh-list
153599057|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
153599058|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
153599059|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599060|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599061|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599062|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153599063|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153599064|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599065|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599066|NCT01342367|Urological Agents|urological agents|mesh-ancestor
153599067|NCT01185171|Gefitinib|gefitinib|mesh-list
153599068|NCT01185171|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153599069|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153599070|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599071|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599072|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599073|NCT00896493|Cyclosporine|cyclosporine|mesh-list
153599097|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
153599098|NCT00444093|Loperamide|loperamide|mesh-list
153599099|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153599100|NCT00003042|Tamoxifen|tamoxifen|mesh-list
153599101|NCT00003042|Paclitaxel|paclitaxel|mesh-list
153599102|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
153344424|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344426|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
153344427|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344428|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344429|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344430|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
153344431|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344432|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344433|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153599103|NCT00003042|Doxorubicin|doxorubicin|mesh-list
153599104|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153599105|NCT00003042|Melphalan|melphalan|mesh-list
153599107|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599163|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599164|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599165|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
153599166|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599167|NCT01873339|Midazolam|midazolam|mesh-list
153599168|NCT01873339|Darapladib|darapladib|mesh-list
153599169|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153599170|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153599171|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599172|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599173|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153599174|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153599175|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153599176|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153599223|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599224|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599225|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153599226|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153599289|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599291|NCT01874080|Hormones|hormones|mesh-ancestor
153599292|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599293|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153599294|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
153599352|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153599353|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153599354|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153599355|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153599356|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
153599357|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
153599358|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
153599359|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
153599360|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153599361|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599362|NCT01874730|Anesthetics|anesthetics|mesh-list
153599363|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599364|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599365|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153599366|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153599367|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153599368|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
153599369|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599370|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153599372|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344434|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344435|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344436|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
153344437|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344438|NCT00014222|Hematinics|hematinics|mesh-ancestor
153344439|NCT00004870|Irinotecan|irinotecan|mesh-list
153344440|NCT00004870|Oblimersen|oblimersen|mesh-list
153344458|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153344459|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153344460|NCT00004876|Growth Substances|growth substances|mesh-ancestor
153344461|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
153344462|NCT00003862|Leucovorin|leucovorin|mesh-list
153783313|NCT04553458|Sorafenib|sorafenib|mesh-list
153783314|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344463|NCT00003862|Paclitaxel|paclitaxel|mesh-list
153344464|NCT00003862|Fluorouracil|fluorouracil|mesh-list
153344465|NCT00003862|Calcium|calcium|mesh-list
153599406|NCT01875185|Aspirin|aspirin|mesh-list
153599407|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153599408|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153599409|NCT01875185|Analgesics|analgesics|mesh-ancestor
153599410|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
153599411|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599412|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599413|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599414|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599415|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153599416|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153599417|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599418|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153599419|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153599420|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599421|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
153599422|NCT01875224|Abatacept|abatacept|mesh-list
153599423|NCT01875224|Tacrolimus|tacrolimus|mesh-list
153599425|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
153599462|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153599463|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599464|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599465|NCT01875757|Vitamin D|vitamin d|mesh-list
153599466|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
153599467|NCT01875757|Vitamins|vitamins|mesh-ancestor
153599468|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
153599469|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599470|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153599471|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153599472|NCT01875822|Curcumin|curcumin|mesh-list
153599482|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599483|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599485|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
153599486|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599487|NCT01875939|Levonadifloxacin|levonadifloxacin|mesh-list
153599488|NCT01875939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153599489|NCT01875939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599490|NCT01875939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819605|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153819606|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819607|NCT00325403|Treprostinil|treprostinil|mesh-list
153819608|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153783315|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153344466|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
153344467|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344468|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344469|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344471|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344472|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344473|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153344474|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344475|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
153344476|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344477|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344478|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
153344479|NCT00003862|Antidotes|antidotes|mesh-ancestor
153344480|NCT00003862|Protective Agents|protective agents|mesh-ancestor
153813443|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813444|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359910|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344481|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
153344482|NCT00003862|Vitamins|vitamins|mesh-ancestor
153344483|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
153344484|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
153344485|NCT00003868|Methotrexate|methotrexate|mesh-list
153344486|NCT00003868|Antibodies|antibodies|mesh-list
153344487|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153344488|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344489|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
153344490|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344491|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344492|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344493|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
153344494|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344495|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819609|NCT00226421|Oxymorphone|oxymorphone|mesh-list
153819610|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153819611|NCT00226421|Narcotics|narcotics|mesh-ancestor
153461011|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461012|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461013|NCT00083616|Panitumumab|panitumumab|mesh-list
153461014|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599491|NCT01875939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599492|NCT01875939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599493|NCT01875952|Isoniazid|isoniazid|mesh-list
153599494|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
153599495|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153599496|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153599497|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153599498|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153599499|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
153344497|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153344532|NCT00004102|Protective Agents|protective agents|mesh-ancestor
153344533|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
153344534|NCT00004102|Vitamins|vitamins|mesh-ancestor
153344535|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
153344536|NCT00003880|Paclitaxel|paclitaxel|mesh-list
153344537|NCT00003880|Carboplatin|carboplatin|mesh-list
153344538|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344539|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344540|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344604|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344605|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
153344606|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344607|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344608|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153599500|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599501|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153599502|NCT01876004|Methotrexate|methotrexate|mesh-list
153599503|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153599504|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
153599505|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153599506|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599507|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153599508|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
153599509|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599510|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599511|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
153599512|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599513|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153599514|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599515|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
153599516|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599517|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153599518|NCT01876108|Amoxicillin|amoxicillin|mesh-list
153599519|NCT01876108|Azithromycin|azithromycin|mesh-list
153599521|NCT01876108|Omeprazole|omeprazole|mesh-list
153599536|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359912|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783758|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153783759|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153783760|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783761|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599537|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599538|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599539|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599602|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153599604|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153599605|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153599606|NCT01876615|Analgesics|analgesics|mesh-ancestor
153599607|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
153599608|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599665|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153599666|NCT01877122|Ibuprofen|ibuprofen|mesh-list
153599667|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153599668|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153599669|NCT01877122|Analgesics|analgesics|mesh-ancestor
153599670|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
153813447|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153599671|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599672|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344610|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344611|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344612|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344613|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344614|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344615|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344616|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344617|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153344618|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153344620|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153344621|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
153344622|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344624|NCT00004918|Sargramostim|sargramostim|mesh-list
153344625|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153344626|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
153344627|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344651|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344653|NCT05776940|Dexamethasone acetate|dexamethasone acetate|mesh-list
153344654|NCT05776940|Bortezomib|bortezomib|mesh-list
153344655|NCT05776940|Daratumumab|daratumumab|mesh-list
153344656|NCT05776940|BB 1101|bb 1101|mesh-list
153344657|NCT05776940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153344658|NCT05776940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153344659|NCT05776940|Antiemetics|antiemetics|mesh-ancestor
153344660|NCT05776940|Autonomic Agents|autonomic agents|mesh-ancestor
153344661|NCT05776940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344662|NCT05776940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344663|NCT05776940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153344664|NCT05776940|Glucocorticoids|glucocorticoids|mesh-ancestor
153344665|NCT05776940|Hormones|hormones|mesh-ancestor
153599673|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599674|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599675|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153599676|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599677|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599678|NCT01877226|Tapentadol|tapentadol|mesh-list
153599679|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153599725|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153599726|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599727|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
153599728|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344666|NCT05776940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344667|NCT05776940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153344668|NCT05776940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344670|NCT05776940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344671|NCT05776940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344672|NCT05776940|Immunologic Factors|immunologic factors|mesh-ancestor
153344673|NCT05776407|Cyclophosphamide|cyclophosphamide|mesh-list
153344674|NCT05776407|Fludarabine|fludarabine|mesh-list
153344675|NCT05776407|Etoposide|etoposide|mesh-list
153344676|NCT05776407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344677|NCT05776407|Immunologic Factors|immunologic factors|mesh-ancestor
153344678|NCT05776407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395151|NCT02489357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599729|NCT01877811|Agerafenib|agerafenib|mesh-list
153599730|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153599731|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599732|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599733|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
153599734|NCT01877889|Canagliflozin|canagliflozin|mesh-list
153599735|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153599736|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599737|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153599738|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599739|NCT01877954|Fluticasone|fluticasone|mesh-list
153599740|NCT01877954|Xhance|xhance|mesh-list
153599741|NCT01877954|Beclomethasone|beclomethasone|mesh-list
153599742|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599743|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153599744|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
153599745|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599746|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599747|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153599748|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
153599749|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
153599750|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153599751|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
153599752|NCT01877954|Hormones|hormones|mesh-ancestor
153599753|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599754|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153599755|NCT01878136|Plasminogen|plasminogen|mesh-list
153599756|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153599766|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153599767|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599768|NCT01878227|Fenofibrate|fenofibrate|mesh-list
153599769|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153599770|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
153599771|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599772|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153599773|NCT01878318|Methotrexate|methotrexate|mesh-list
153599774|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153599775|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
153599776|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153599777|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599778|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153599780|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813449|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
153359913|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153599781|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599782|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
153344708|NCT05775965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153344711|NCT05775965|Sensory System Agents|sensory system agents|mesh-ancestor
153344712|NCT05775965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344713|NCT05775965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344714|NCT05775965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153344715|NCT05775965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344716|NCT05775965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153344717|NCT05775965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153344718|NCT05775965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344719|NCT05775965|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153344720|NCT05775965|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153889800|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153344721|NCT05775965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344746|NCT05775692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153344747|NCT05775692|Hormone Antagonists|hormone antagonists|mesh-ancestor
153599783|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599784|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153599785|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599786|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
153599787|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599788|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153599808|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
153599809|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599810|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153599811|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599812|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
153599813|NCT01878422|Antidotes|antidotes|mesh-ancestor
153599814|NCT01878422|Protective Agents|protective agents|mesh-ancestor
153599815|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
153599816|NCT01878422|Vitamins|vitamins|mesh-ancestor
153599817|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
153599818|NCT01878513|Risperidone|risperidone|mesh-list
153599819|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153599832|NCT01878578|Phenytoin|phenytoin|mesh-list
153599874|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599875|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
153599876|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599877|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599878|NCT01878734|Micronutrients|micronutrients|mesh-list
153599879|NCT01878734|Trace Elements|trace elements|mesh-list
153599880|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599881|NCT01878864|Lidocaine|lidocaine|mesh-list
153599882|NCT01878864|Bupivacaine|bupivacaine|mesh-list
153599883|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
153599884|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
153599885|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599886|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599887|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
153599888|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599889|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153599949|NCT01879488|Antidotes|antidotes|mesh-ancestor
153599950|NCT01879488|Protective Agents|protective agents|mesh-ancestor
153599951|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599952|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
153599953|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
153599954|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599955|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153599956|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
153344749|NCT05775692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344750|NCT05775692|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153344751|NCT05775692|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153344752|NCT05775536|Aspirin|aspirin|mesh-list
153344753|NCT05775536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153344754|NCT05775536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153344755|NCT05775536|Analgesics|analgesics|mesh-ancestor
153344756|NCT05775536|Sensory System Agents|sensory system agents|mesh-ancestor
153344757|NCT05775536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344758|NCT05775536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344759|NCT05775536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153344760|NCT05775536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153359916|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153344761|NCT05775536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153599957|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153359917|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599958|NCT01879514|Prednisone|prednisone|mesh-list
153599961|NCT01879514|Hormones|hormones|mesh-ancestor
153599977|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153599978|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153599979|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153599981|NCT01879605|Sorbitol|sorbitol|mesh-list
153599982|NCT01879605|Cathartics|cathartics|mesh-ancestor
153599983|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153599984|NCT01879605|Laxatives|laxatives|mesh-ancestor
153599985|NCT01879748|Rasagiline|rasagiline|mesh-list
153599986|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153599987|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599988|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599989|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153599990|NCT01879748|Protective Agents|protective agents|mesh-ancestor
153599991|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599992|NCT01879917|Liraglutide|liraglutide|mesh-list
153599993|NCT01879917|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153599994|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153599995|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599996|NCT01879917|Incretins|incretins|mesh-ancestor
153599997|NCT01879917|Hormones|hormones|mesh-ancestor
153599998|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153599999|NCT01879930|Doxycycline|doxycycline|mesh-list
153600000|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153600001|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600002|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
153600027|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153600028|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600030|NCT01880307|Infliximab|infliximab|mesh-list
153600031|NCT01880307|Azathioprine|azathioprine|mesh-list
153600047|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
153600048|NCT01880346|Vitamin D|vitamin d|mesh-list
153600049|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
153600050|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
153600051|NCT01880346|Vitamins|vitamins|mesh-list
153600052|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
153600053|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600056|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
153600075|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
153600076|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600077|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600078|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153813452|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153813453|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153344763|NCT05775536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344764|NCT05775536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153344765|NCT05775536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153344766|NCT05775536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344767|NCT05775536|Antipyretics|antipyretics|mesh-ancestor
153344769|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
153344771|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344797|NCT05773222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153344798|NCT05773222|Antithrombins|antithrombins|mesh-ancestor
153344799|NCT05773222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153344800|NCT05773222|Protease Inhibitors|protease inhibitors|mesh-ancestor
153344801|NCT05773222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344802|NCT05773222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344803|NCT05773222|Anticoagulants|anticoagulants|mesh-ancestor
153344804|NCT05638594|Carboplatin|carboplatin|mesh-list
153344806|NCT05638594|Trastuzumab|trastuzumab|mesh-list
153344807|NCT05638594|Letrozole|letrozole|mesh-list
153344808|NCT05638594|Pertuzumab|pertuzumab|mesh-list
153600079|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153600080|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153600081|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153600142|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600144|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153600145|NCT01880931|Narcotics|narcotics|mesh-ancestor
153600146|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153600147|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600148|NCT01880931|Analgesics|analgesics|mesh-ancestor
153600149|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
153600150|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600151|NCT01881074|Listerine|listerine|mesh-list
153600152|NCT01881074|Triclosan|triclosan|mesh-list
153600153|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
153600154|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
153600155|NCT01881074|Protective Agents|protective agents|mesh-ancestor
153600156|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600157|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153600158|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600159|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153600160|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153600162|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600163|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153600164|NCT01881100|Listerine|listerine|mesh-list
153600165|NCT01881100|Fluorides|fluorides|mesh-list
153600166|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
153600167|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
153600168|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
153600169|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
153600170|NCT01881100|Protective Agents|protective agents|mesh-ancestor
153461016|NCT00083226|Doxorubicin|doxorubicin|mesh-list
153461017|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153461028|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153461029|NCT00082758|Analgesics|analgesics|mesh-ancestor
153461030|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
153461031|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461032|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344810|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344811|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344812|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344813|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344814|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344815|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153344816|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344817|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344818|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153344819|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153344820|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461034|NCT03438318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153600171|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600172|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153600173|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600175|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
153600176|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600177|NCT01881347|Protective Agents|protective agents|mesh-ancestor
153600178|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600179|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600180|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153600181|NCT01881464|Adalimumab|adalimumab|mesh-list
153600182|NCT01881464|Infliximab|infliximab|mesh-list
153813455|NCT00432315|Cisplatin|cisplatin|mesh-list
153359919|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359920|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813456|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813457|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153359921|NCT02971748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153600183|NCT01881464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153600184|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600185|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600186|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
153600187|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153600188|NCT01881503|HBOC 201|hboc 201|mesh-list
153600189|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
153600228|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600229|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153600230|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
153600231|NCT01882127|Hormones|hormones|mesh-ancestor
153600232|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600233|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153600234|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600235|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
153600236|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
153600237|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
153600291|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600292|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153600293|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
153600294|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153600295|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600296|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600297|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153600298|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600358|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153600359|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
153600360|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600361|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600362|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153600363|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
153600364|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600365|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600366|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153600367|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153344823|NCT05493475|Fentanyl|fentanyl|mesh-list
153344824|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153344825|NCT05493475|Narcotics|narcotics|mesh-ancestor
153344826|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153344863|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
153344864|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153344865|NCT05297851|Niacinamide|niacinamide|mesh-list
153344867|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
153344868|NCT05297851|Riboflavin|riboflavin|mesh-list
153344869|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
153344870|NCT05297851|Vitamins|vitamins|mesh-ancestor
153344871|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
153344872|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344933|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153344934|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600368|NCT01883323|Analgesics|analgesics|mesh-ancestor
153600374|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600375|NCT01883518|Vaccines|vaccines|mesh-list
153600376|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
153600377|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600413|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600414|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600415|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153600416|NCT01884116|Analgesics|analgesics|mesh-ancestor
153600417|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600418|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600419|NCT01884168|Immunomodulating Agents|immunomodulating agents|mesh-list
153600420|NCT01884168|Immunologic Factors|immunologic factors|mesh-ancestor
153600421|NCT01884168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600479|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153600480|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
153359922|NCT02971748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600481|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600482|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600483|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600484|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
153600485|NCT01884428|Hormones|hormones|mesh-ancestor
153600486|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600516|NCT01884506|Iron|iron|mesh-list
153600543|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600544|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153600545|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153600546|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
153600547|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600548|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153600549|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
153600550|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600552|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153600553|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153600554|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
153600555|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
153600556|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600610|NCT01885091|Kinetin|kinetin|mesh-list
153600681|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153600682|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
153600683|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600684|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600685|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
153600686|NCT01885715|Neostigmine|neostigmine|mesh-list
153344936|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344937|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
153344938|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153344939|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153344940|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344941|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
153344942|NCT04733157|Coagulants|coagulants|mesh-ancestor
153344943|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
153344944|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153344945|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344946|NCT04633122|Sunitinib|sunitinib|mesh-list
153344947|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344948|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153344949|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153344950|NCT04633122|Growth Substances|growth substances|mesh-ancestor
153344951|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344952|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
153344953|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153344954|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344955|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600687|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153600688|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600689|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600690|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
153600691|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600692|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600693|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153600694|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
153600739|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153600740|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153600741|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153600743|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
153600744|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600745|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600746|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600748|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600806|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
153600807|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600808|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600809|NCT01886638|Abacavir|abacavir|mesh-list
153600810|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153600873|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153600874|NCT01887249|Metronidazole|metronidazole|mesh-list
153600875|NCT01887249|Clarithromycin|clarithromycin|mesh-list
153600876|NCT01887249|Esomeprazole|esomeprazole|mesh-list
153600877|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600878|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153600879|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153600880|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153600881|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153344968|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
153344993|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344995|NCT03951753|Hormones|hormones|mesh-ancestor
153344996|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344997|NCT03947671|Acetaminophen|acetaminophen|mesh-list
153344998|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153345000|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
153345001|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345002|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345003|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
153345004|NCT03941964|Azacitidine|azacitidine|mesh-list
153345005|NCT03941964|Decitabine|decitabine|mesh-list
153345006|NCT03941964|Venetoclax|venetoclax|mesh-list
153345008|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
153345009|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345010|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345011|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345012|NCT03837509|Daratumumab|daratumumab|mesh-list
153345013|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345014|NCT03603184|Paclitaxel|paclitaxel|mesh-list
153345015|NCT03603184|Carboplatin|carboplatin|mesh-list
153345016|NCT03603184|Atezolizumab|atezolizumab|mesh-list
153345017|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345018|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345019|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345020|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345021|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345038|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345039|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345042|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345043|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345044|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
153600882|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153396111|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345045|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345046|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345047|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345048|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345049|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
153345050|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
153345051|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345052|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153345053|NCT03189719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153345054|NCT03189719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887493|NCT04306627|Amlodipine|amlodipine|mesh-list
153345055|NCT02889081|Vitamin D|vitamin d|mesh-list
153345056|NCT02889081|Vitamins|vitamins|mesh-ancestor
153345057|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
153345058|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345059|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153345060|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
153345061|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153600883|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153600884|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600885|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600886|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153600920|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600921|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153600922|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
153600923|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
153600924|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
153600925|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153600926|NCT01887457|Voriconazole|voriconazole|mesh-list
153600927|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
153781726|NCT00266643|Analgesics|analgesics|mesh-ancestor
153600986|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
153600987|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600988|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600989|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600990|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153601056|NCT01888042|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153601057|NCT01888042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153601058|NCT01888042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601059|NCT01888042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601060|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601062|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601063|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601064|NCT01888107|Risperidone|risperidone|mesh-list
153601065|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153601066|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
153601067|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601068|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601117|NCT01888302|Cisplatin|cisplatin|mesh-list
153601118|NCT01888302|Gemcitabine|gemcitabine|mesh-list
153601119|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601120|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153601121|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
153601122|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601123|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153601124|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396254|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153345062|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153345064|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153345065|NCT02856594|Analgesics|analgesics|mesh-ancestor
153345066|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
153345067|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345068|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153345069|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153345070|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153345071|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
153345072|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345073|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345074|NCT02840539|Cytarabine|cytarabine|mesh-list
153345075|NCT02840539|Dexamethasone|dexamethasone|mesh-list
153345076|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
153345077|NCT02840539|Bortezomib|bortezomib|mesh-list
153345078|NCT02840539|BB 1101|bb 1101|mesh-list
153345110|NCT02112864|Hormones|hormones|mesh-ancestor
153345111|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345112|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345113|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345114|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153345115|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153601125|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153601126|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
153601179|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153601180|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153601181|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153601182|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601183|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153601184|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153601185|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601186|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
153601187|NCT01888718|Fexofenadine|fexofenadine|mesh-list
153601224|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601225|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601226|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153601227|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601228|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153601229|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153601230|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601231|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153601232|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153601290|NCT01888978|Irinotecan|irinotecan|mesh-list
153601291|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
153601292|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345116|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345118|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153345119|NCT00723697|Narcotics|narcotics|mesh-ancestor
153345120|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153345121|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345122|NCT00723697|Analgesics|analgesics|mesh-ancestor
153345158|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345159|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345160|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
153345161|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345162|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345163|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153345164|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345165|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
153345166|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
153345180|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153345181|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345183|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345184|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345185|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345186|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345187|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345188|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153601293|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
153601294|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601295|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601296|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
153601297|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
153601298|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
153601299|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601359|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601419|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
153601420|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601421|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601422|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153601423|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153601424|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
153601425|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601426|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601427|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153601428|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153601429|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
153601430|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601431|NCT01889914|Insulin|insulin|mesh-list
153601480|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601481|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153601482|NCT01891487|Bimatoprost|bimatoprost|mesh-list
153345189|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345190|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345192|NCT00199056|Dexamethasone|dexamethasone|mesh-list
153345193|NCT00199056|Prednisolone|prednisolone|mesh-list
153345194|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
153345195|NCT00199056|Ifosfamide|ifosfamide|mesh-list
153345196|NCT00199056|Methotrexate|methotrexate|mesh-list
153345197|NCT00199056|Fludarabine|fludarabine|mesh-list
153345198|NCT00199056|Vincristine|vincristine|mesh-list
153345199|NCT00199056|Doxorubicin|doxorubicin|mesh-list
153345200|NCT00199056|Daunorubicin|daunorubicin|mesh-list
153345201|NCT00199056|Asparaginase|asparaginase|mesh-list
153345202|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
153345203|NCT00199056|Idarubicin|idarubicin|mesh-list
153359934|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
153359935|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
153345204|NCT00199056|Thioguanine|thioguanine|mesh-list
153345205|NCT00199056|Vindesine|vindesine|mesh-list
153396711|NCT02164955|Pomalidomide|pomalidomide|mesh-list
153601483|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153601484|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
153601485|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153601486|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601487|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
153601488|NCT01893229|Valproic Acid|valproic acid|mesh-list
153601489|NCT01893229|Olanzapine|olanzapine|mesh-list
153601490|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153601491|NCT01893229|Ziprasidone|ziprasidone|mesh-list
153601492|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
153601544|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153601545|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153601546|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601547|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153601548|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
153601549|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601550|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153601551|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153601552|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
153601553|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
153601554|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601555|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153601556|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153601605|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601606|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601607|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153601608|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153601613|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
153601672|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601673|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153601674|NCT01900041|Minoxidil|minoxidil|mesh-list
153601675|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153601676|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
153601677|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153601678|NCT01900093|Hormones|hormones|mesh-ancestor
153601679|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601680|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813469|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601681|NCT01900106|Ritonavir|ritonavir|mesh-list
153601682|NCT01900106|Darunavir|darunavir|mesh-list
153601683|NCT01900106|Lamivudine|lamivudine|mesh-list
153601684|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
153601685|NCT01900106|Abacavir|abacavir|mesh-list
153601686|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
153601687|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153601740|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153601741|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153601789|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153345206|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345207|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
153345208|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345209|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345210|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345211|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
153345212|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345213|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345214|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153345215|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345216|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
153345217|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
153345218|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345219|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345220|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
153345221|NCT00199056|Hormones|hormones|mesh-ancestor
153345222|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345223|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345224|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153345225|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
153345226|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153345229|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
153345230|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345260|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345261|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
153345262|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345263|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345264|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345265|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
153345266|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345267|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345268|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153345269|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345271|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
153601790|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601791|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
153601792|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345273|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345275|NCT00198978|Hormones|hormones|mesh-ancestor
153345276|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345277|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345278|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153345279|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153345280|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
153345281|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153345300|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153345301|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153345311|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
153345312|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345313|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397570|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153601793|NCT01900639|Aspirin|aspirin|mesh-list
153601794|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153601795|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153601796|NCT01900639|Analgesics|analgesics|mesh-ancestor
153601797|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
153601798|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601799|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601800|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153601851|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153601852|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
153601853|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601854|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
153601855|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601857|NCT01900938|Propofol|propofol|mesh-list
153601858|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153601859|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601860|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601861|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153601863|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
153601915|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601916|NCT01901198|Interferons|interferons|mesh-list
153601917|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
153601918|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
153601919|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601920|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
153601921|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153601922|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
153601923|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601924|NCT01901276|Omeprazole|omeprazole|mesh-list
153601925|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153601926|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153601927|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153601928|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601929|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601930|NCT01901380|Caseins|caseins|mesh-list
153601931|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
153601932|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
153601973|NCT01901601|Anesthetics|anesthetics|mesh-list
153601974|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601991|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
153601992|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153602027|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
153602028|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153887615|NCT04365725|Remdesivir|remdesivir|mesh-list
153345317|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345318|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345320|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153345321|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
153345322|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345323|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
153345324|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345326|NCT00004924|Irinotecan|irinotecan|mesh-list
153345327|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345328|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345329|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345330|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345331|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345332|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345333|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153345334|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345335|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345336|NCT00004144|Gemcitabine|gemcitabine|mesh-list
153345337|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
153345338|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153399256|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153602029|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
153602030|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
153602031|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602032|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602033|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153602095|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153602096|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153602097|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602098|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
153602099|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
153602100|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
153602101|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153602102|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602103|NCT01902498|Aspirin|aspirin|mesh-list
153602104|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153602158|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602159|NCT01902641|Rocuronium|rocuronium|mesh-list
153602160|NCT01902641|Succinylcholine|succinylcholine|mesh-list
153602161|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153602162|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153602163|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153602164|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602165|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602166|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153602167|NCT01902771|Imiquimod|imiquimod|mesh-list
153602168|NCT01902771|Vaccines|vaccines|mesh-list
153345340|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345341|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345342|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153345343|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
153345344|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345345|NCT00004150|Leucovorin|leucovorin|mesh-list
153345346|NCT00004150|Fluorouracil|fluorouracil|mesh-list
153345347|NCT00004150|Calcium|calcium|mesh-list
153345348|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
153345349|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153345418|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345419|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345420|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
153345421|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153602169|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
153602170|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602171|NCT01902771|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153602172|NCT01902771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602173|NCT01902771|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153602174|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153602175|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602176|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
153602177|NCT01902810|Propranolol|propranolol|mesh-list
153602178|NCT01902810|Metoprolol|metoprolol|mesh-list
153602272|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602273|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602275|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
153602276|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602277|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153602278|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
153602279|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602280|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
153602281|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602282|NCT01903681|Melatonin|melatonin|mesh-list
153602283|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
153602284|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602285|NCT01903681|Protective Agents|protective agents|mesh-ancestor
153602286|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602287|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602288|NCT01903694|Sorafenib|sorafenib|mesh-list
153602289|NCT01903694|Pravastatin|pravastatin|mesh-list
153602290|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602291|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153602292|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602325|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153602326|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153602327|NCT01904045|Tacrolimus|tacrolimus|mesh-list
153602328|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153602329|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
153602330|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602331|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153781729|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
153602332|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602333|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602334|NCT01904097|Pregabalin|pregabalin|mesh-list
153602335|NCT01904097|Analgesics|analgesics|mesh-ancestor
153602336|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
153602337|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602338|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345423|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153345424|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153345425|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153345426|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345427|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153345451|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345452|NCT01216735|Fluticasone|fluticasone|mesh-list
153345453|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345454|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153345455|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
153345456|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345457|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345458|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153345459|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
153345460|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
153345461|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153602339|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
153602340|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153602341|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153602342|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602343|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153602344|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153602345|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153602346|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602347|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153602348|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
153887656|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602349|NCT01904110|Vitamin D|vitamin d|mesh-list
153602350|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
153602351|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
153602352|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153602353|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602354|NCT01904110|Vitamins|vitamins|mesh-ancestor
153819617|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153819619|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153819620|NCT00226395|Narcotics|narcotics|mesh-ancestor
153602355|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
153602356|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153602357|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153602358|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153602359|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602360|NCT01904214|Siponimod|siponimod|mesh-list
153602361|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153602362|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602366|NCT01904253|Topotecan|topotecan|mesh-list
153602422|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153602423|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153602424|NCT01904643|Growth Substances|growth substances|mesh-ancestor
153602425|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
153602426|NCT01904643|Analgesics|analgesics|mesh-ancestor
153602427|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
153602428|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602429|NCT01904682|ON 01910|on 01910|mesh-list
153602430|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602431|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153602435|NCT01904695|Diuretics|diuretics|mesh-list
153345462|NCT00004186|Carboplatin|carboplatin|mesh-list
153345463|NCT00004186|Etoposide|etoposide|mesh-list
153345464|NCT00004186|Topotecan|topotecan|mesh-list
153345465|NCT00004186|Ifosfamide|ifosfamide|mesh-list
153345466|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345467|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345468|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345470|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345471|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345472|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153345473|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345474|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
153345476|NCT00005002|Zidovudine|zidovudine|mesh-list
153345477|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153345478|NCT00005002|Nelfinavir|nelfinavir|mesh-list
153345479|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153345480|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345481|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602485|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602486|NCT01905059|Lamivudine|lamivudine|mesh-list
153602487|NCT01905059|Lopinavir|lopinavir|mesh-list
153602488|NCT01905059|Darunavir|darunavir|mesh-list
153602489|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153602557|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602559|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153602560|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153602561|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153602562|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153602564|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602565|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602566|NCT01905566|Clopidogrel|clopidogrel|mesh-list
153602567|NCT01905566|Ticagrelor|ticagrelor|mesh-list
153602568|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153602569|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153602570|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153602571|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153602617|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
153602618|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602619|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153602620|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153602689|NCT01906762|Morphine|morphine|mesh-list
153602690|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153602691|NCT01906762|Narcotics|narcotics|mesh-ancestor
153602692|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602693|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602694|NCT01906762|Analgesics|analgesics|mesh-ancestor
153602695|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
153813484|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153602696|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602697|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153602698|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
153602758|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153602759|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153602760|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602834|NCT01907594|Cycloserine|cycloserine|mesh-list
153602835|NCT01907594|Nicotine|nicotine|mesh-list
153602836|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153602837|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
153602838|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345482|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345513|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
153345514|NCT00005014|Risperidone|risperidone|mesh-list
153345515|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153345516|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
153345517|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345518|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345519|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345520|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153345521|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153345522|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153345523|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153345524|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153345558|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
153345560|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
153345561|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153345562|NCT00004216|Cefixime|cefixime|mesh-list
153345563|NCT00004216|Trimethoprim|trimethoprim|mesh-list
153345564|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
153345565|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153345566|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345605|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153345632|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
153345633|NCT00005578|Razoxane|razoxane|mesh-list
153345634|NCT00005578|Lenograstim|lenograstim|mesh-list
153345635|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345636|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
153345637|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345657|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345658|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153345659|NCT00005578|Protective Agents|protective agents|mesh-ancestor
153345660|NCT00022490|Cytarabine|cytarabine|mesh-list
153345695|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345696|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345697|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345700|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
153345701|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345702|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345703|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153345704|NCT00097448|Protective Agents|protective agents|mesh-ancestor
153345705|NCT00004246|Fludarabine|fludarabine|mesh-list
153345707|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345708|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345709|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
153345741|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345742|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153345743|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345744|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345745|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345746|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345747|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345748|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153345749|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153345752|NCT00005596|Dexamethasone|dexamethasone|mesh-list
153345788|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
153602839|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602840|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153602841|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153602842|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
153602843|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602844|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602845|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153602846|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602847|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153602848|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
153602849|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153602850|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
153602851|NCT01907633|Domperidone|domperidone|mesh-list
153602852|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
153602853|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
153820719|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602854|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602878|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602879|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153602880|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602881|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345792|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
153345793|NCT00005596|Vitamins|vitamins|mesh-ancestor
153345794|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
153345828|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345829|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345830|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345831|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153345832|NCT00004264|Protective Agents|protective agents|mesh-ancestor
153345833|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345834|NCT00005074|Alvocidib|alvocidib|mesh-list
153345835|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345836|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
153345837|NCT00005074|Growth Substances|growth substances|mesh-ancestor
153345838|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345839|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153345840|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345841|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345842|NCT00005602|Carboplatin|carboplatin|mesh-list
153602882|NCT01907867|Finafloxacin|finafloxacin|mesh-list
153602883|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153602884|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602885|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153602886|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153602887|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153602888|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602889|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602890|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602891|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
153602892|NCT01907880|Pamidronate|pamidronate|mesh-list
153602893|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153602894|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602895|NCT01907984|Diclofenac|diclofenac|mesh-list
153602896|NCT01907984|Midazolam|midazolam|mesh-list
153602897|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153602898|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153602899|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153602901|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153602929|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153602930|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153602931|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602932|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153602933|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153602934|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
153602935|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153602936|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602937|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153602938|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
153602939|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
153345865|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345866|NCT00005086|Gemcitabine|gemcitabine|mesh-list
153345867|NCT00005086|Docetaxel|docetaxel|mesh-list
153345868|NCT00005086|Methotrexate|methotrexate|mesh-list
153345869|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345870|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345871|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
153345872|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345873|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345874|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345875|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345876|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153345877|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
153345878|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153345879|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345880|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
153345881|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345882|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153345883|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345884|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
153887787|NCT00595049|Bosentan|bosentan|mesh-list
153345887|NCT00005614|Gemcitabine|gemcitabine|mesh-list
153345936|NCT00005638|Irinotecan|irinotecan|mesh-list
153345937|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345938|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153345939|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345940|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345941|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345942|NCT00005104|Metformin|metformin|mesh-list
153345943|NCT00005104|Clomiphene|clomiphene|mesh-list
153345944|NCT00005104|Enclomiphene|enclomiphene|mesh-list
153345945|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
153345946|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153345947|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345948|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153345949|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
153345950|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345951|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153345952|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
153345971|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153345973|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345974|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345975|NCT00005668|Itraconazole|itraconazole|mesh-list
153345976|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
153345977|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346004|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
153346005|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346006|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346007|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153346072|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153346073|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153346074|NCT00004420|Analgesics|analgesics|mesh-ancestor
153346075|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
153346076|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346077|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346078|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153346079|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153346080|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153346081|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
153346082|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346083|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153346084|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
153346085|NCT00004426|Leuprolide|leuprolide|mesh-list
153346086|NCT00004426|Hormones|hormones|mesh-list
153346087|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346088|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346089|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153346090|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
153346091|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153346118|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
153346119|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346120|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153346139|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153346140|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
153346141|NCT02197273|Hormones|hormones|mesh-ancestor
153346142|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346143|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153346144|NCT02197273|Protective Agents|protective agents|mesh-ancestor
153346145|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153346164|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346165|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
153346166|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153346167|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153346168|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153346169|NCT00004450|Growth Substances|growth substances|mesh-ancestor
153346170|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
153346171|NCT00004468|Calcitriol|calcitriol|mesh-list
153346172|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153346178|NCT00004468|Vitamins|vitamins|mesh-ancestor
153346228|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153346229|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153346230|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346231|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346232|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
153346233|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346234|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346235|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153346236|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346237|NCT00004486|Fluoxetine|fluoxetine|mesh-list
153346238|NCT00004486|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153346239|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153346240|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346241|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346242|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346243|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
153346244|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346245|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153346246|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
153346247|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153346248|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153346288|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346289|NCT01290913|Omalizumab|omalizumab|mesh-list
153346290|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153346291|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153783320|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346292|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
153346293|NCT00004552|Acamprosate|acamprosate|mesh-list
153346294|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153346295|NCT00101660|Dasatinib|dasatinib|mesh-list
153346296|NCT00101660|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153346297|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153346298|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813485|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346300|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408286|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346361|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346362|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153346363|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153783321|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783323|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
153346364|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346365|NCT00004582|Ritonavir|ritonavir|mesh-list
153346366|NCT00004582|Lopinavir|lopinavir|mesh-list
153346401|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153346402|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153346403|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
153346404|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346405|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
153346406|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153346407|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346433|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346434|NCT00004804|Interferons|interferons|mesh-list
153359941|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359942|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153359943|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359944|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
153346435|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
153346436|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153731981|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346438|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346439|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
153346440|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346441|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
153346442|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153346443|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
153346444|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
153346445|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346446|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
153346447|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
153346448|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153346449|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346450|NCT00004816|Antibodies|antibodies|mesh-list
153346451|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153602941|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346452|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
153346453|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346454|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
153346455|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
153346477|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153346478|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
153346479|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346480|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
153346481|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346482|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
153346483|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153346484|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153346486|NCT01342549|Valproic Acid|valproic acid|mesh-list
153346487|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153346488|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153346489|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346490|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
153359947|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359948|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153346491|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346492|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
153346493|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346494|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346495|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
153346496|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346497|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
153346498|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153346499|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346500|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153346501|NCT01295515|Interferons|interferons|mesh-list
153346502|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
153346503|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
153346504|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153346505|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346506|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
153346507|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346508|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
153346509|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346533|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153346536|NCT00103376|Bortezomib|bortezomib|mesh-list
153346537|NCT00103376|Androgens|androgens|mesh-list
153346538|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
153346539|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346540|NCT00103376|Hormones|hormones|mesh-ancestor
153346541|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346542|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346543|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
153346544|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
153346545|NCT00042224|Clozapine|clozapine|mesh-list
153346546|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153346547|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
153346548|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346549|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346550|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346551|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153346552|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153346553|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346554|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153346555|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
153346556|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
153346557|NCT01296763|Irinotecan|irinotecan|mesh-list
153346558|NCT01296763|Olaparib|olaparib|mesh-list
153346559|NCT01296763|Mitomycins|mitomycins|mesh-list
153346560|NCT01296763|Mitomycin|mitomycin|mesh-list
153346576|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346603|NCT01351753|Topiramate|topiramate|mesh-list
153346604|NCT01351753|Orlistat|orlistat|mesh-list
153346605|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153346606|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346607|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
153346608|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346609|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346610|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153346611|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153346612|NCT00104858|Cyclosporine|cyclosporine|mesh-list
153346613|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
153346614|NCT00104858|Rituximab|rituximab|mesh-list
153346615|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153346616|NCT00104858|Fludarabine|fludarabine|mesh-list
153346617|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
153346618|NCT00104858|Antibodies|antibodies|mesh-list
153346619|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
153346620|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153346659|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153346677|NCT01410409|Pantoprazole|pantoprazole|mesh-list
153346678|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153346679|NCT01410409|Analgesics|analgesics|mesh-ancestor
153346680|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
153346681|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346682|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346683|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
153346684|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153346685|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153346686|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153346687|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346688|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346689|NCT01410565|Apaziquone|apaziquone|mesh-list
153346690|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346691|NCT01357135|Metformin|metformin|mesh-list
153346692|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153346696|NCT01357135|Hormones|hormones|mesh-ancestor
153346698|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153346699|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
153346700|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346701|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346702|NCT02324335|Brilacidin|brilacidin|mesh-list
153346703|NCT02324335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346706|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
153346707|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
153346708|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153346709|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
153346710|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
153346711|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346712|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153346713|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153346715|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346716|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346717|NCT01310179|Fludarabine|fludarabine|mesh-list
153346718|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
153346719|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346743|NCT01414153|Bevacizumab|bevacizumab|mesh-list
153346744|NCT01414153|Ranibizumab|ranibizumab|mesh-list
153346745|NCT01414153|Aflibercept|aflibercept|mesh-list
153346746|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153346747|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153346748|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346749|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153346751|NCT01414153|Growth Substances|growth substances|mesh-ancestor
153346809|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
153346810|NCT01363843|Vitamins|vitamins|mesh-ancestor
153346811|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
153346812|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
153346813|NCT02092298|Cisplatin|cisplatin|mesh-list
153346814|NCT02092298|Mitomycins|mitomycins|mesh-list
153346815|NCT02092298|Mitomycin|mitomycin|mesh-list
153346849|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346850|NCT01363999|Atorvastatin|atorvastatin|mesh-list
153346851|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
153346852|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153346853|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153346854|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
153346855|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346881|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
153346882|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153346884|NCT01364623|Hormones|hormones|mesh-ancestor
153346885|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346886|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346887|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153346888|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346889|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
153813496|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346890|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
153346891|NCT00258206|Rituximab|rituximab|mesh-list
153346892|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783326|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346893|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
153346894|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346896|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153346897|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
153346898|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346899|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346902|NCT01063907|Bortezomib|bortezomib|mesh-list
153346942|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153346943|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346944|NCT03016091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153813497|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
153346945|NCT03016091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346946|NCT03015701|Mifepristone|mifepristone|mesh-list
153346947|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153346948|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
153346978|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153346979|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153346980|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153347004|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347006|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
153347007|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
153347008|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347009|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153347010|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153347011|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153347012|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347014|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
153347015|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347016|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
153347017|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
153347018|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
153347019|NCT00117962|Carboplatin|carboplatin|mesh-list
153347020|NCT00117962|Pemetrexed|pemetrexed|mesh-list
153347021|NCT00117962|Cetuximab|cetuximab|mesh-list
153347022|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347023|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347024|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347067|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153347068|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153347070|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
153347071|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153347072|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153347073|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
153347103|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153347104|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
153347105|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153347106|NCT01111331|Empagliflozin|empagliflozin|mesh-list
153347107|NCT01111331|Warfarin|warfarin|mesh-list
153347108|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
153347109|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153347110|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347111|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153783334|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
153783335|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347112|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347114|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347115|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
153347198|NCT01114997|Esmolol|esmolol|mesh-list
153347199|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
153347200|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
153347201|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347202|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347203|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
153347204|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347205|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153347206|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153347207|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153347208|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153347209|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347210|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153347211|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153347212|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153347246|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347247|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153347304|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153347305|NCT01035749|Vaccines|vaccines|mesh-list
153347306|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
153347307|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347308|NCT00123110|Metformin|metformin|mesh-list
153347342|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153347343|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347344|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
153347345|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153347346|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153347347|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153347375|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347376|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153347378|NCT01319773|Cyclosporins|cyclosporins|mesh-list
153347379|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347380|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347381|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347382|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
153347383|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347384|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
153347385|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347386|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347387|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347389|NCT01319851|Alefacept|alefacept|mesh-list
153347390|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347391|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
153347392|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347393|NCT04351867|Docetaxel|docetaxel|mesh-list
153347394|NCT04351867|Capecitabine|capecitabine|mesh-list
153347395|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
153347396|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347422|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
153347423|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347424|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153347425|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
153347426|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
153347427|NCT00262964|Vitamins|vitamins|mesh-ancestor
153347431|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
153347432|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153347433|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
153347434|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153347435|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347436|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153347437|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153347438|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347439|NCT01899248|Sevoflurane|sevoflurane|mesh-list
153347440|NCT01899248|Desflurane|desflurane|mesh-list
153347441|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153347442|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153347443|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
153347477|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347478|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153347479|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347481|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153347482|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347483|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153347484|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153347485|NCT00176306|Levofloxacin|levofloxacin|mesh-list
153347486|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153347499|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347500|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153347501|NCT00265616|Pentobarbital|pentobarbital|mesh-list
153347502|NCT00265616|Thiopental|thiopental|mesh-list
153347503|NCT00265616|Propofol|propofol|mesh-list
153347504|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153347505|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347506|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347521|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
153347522|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153347523|NCT00176852|Lenograstim|lenograstim|mesh-list
153347524|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347525|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
153347526|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347527|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347528|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347529|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
153347530|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347531|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347532|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153347533|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347534|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
153347535|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
153347536|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347537|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153347538|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153347539|NCT01323517|Dactinomycin|dactinomycin|mesh-list
153347541|NCT01323517|Melphalan|melphalan|mesh-list
153347543|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347544|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153347584|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153347585|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153347586|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
153347587|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347588|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153347589|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153347590|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347591|NCT01325311|Vitamin D|vitamin d|mesh-list
153347592|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
153347593|NCT01325311|Genistein|genistein|mesh-list
153347594|NCT01325311|Vitamins|vitamins|mesh-ancestor
153347595|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
153347596|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347597|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153347598|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153347599|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153347600|NCT01325311|Protective Agents|protective agents|mesh-ancestor
153347601|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347602|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153347603|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347617|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153347619|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347620|NCT01080677|Propranolol|propranolol|mesh-list
153347621|NCT01080677|Caffeine|caffeine|mesh-list
153347622|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153347623|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347624|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153347625|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347626|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347627|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153347628|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153347629|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
153347630|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153602942|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
153602986|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602987|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153602988|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153602989|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
153602990|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
153347631|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153347632|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153783344|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153783346|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783347|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783348|NCT00236093|Analgesics|analgesics|mesh-ancestor
153783349|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
153783350|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347633|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
153347634|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153347635|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153347636|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
153347637|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
153347638|NCT01378273|Hematinics|hematinics|mesh-ancestor
153347639|NCT01432405|Pioglitazone|pioglitazone|mesh-list
153347640|NCT01432405|Exenatide|exenatide|mesh-list
153347641|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153347642|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347643|NCT01432405|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153347644|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153347645|NCT01432405|Incretins|incretins|mesh-ancestor
153347646|NCT01432405|Hormones|hormones|mesh-ancestor
153347647|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347648|NCT01432561|Cysteamine|cysteamine|mesh-list
153347649|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153347651|NCT01116401|Leuprolide|leuprolide|mesh-list
153347685|NCT01381471|Xhance|xhance|mesh-list
153347690|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347691|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347692|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153347693|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
153347694|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347695|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153347696|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153347697|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153347698|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153347699|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
153347700|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347701|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347702|NCT05422092|Pioglitazone|pioglitazone|mesh-list
153347703|NCT05422092|Canagliflozin|canagliflozin|mesh-list
153347704|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153347705|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347706|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153347707|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347708|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
153347709|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153347710|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153347711|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347712|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
153347713|NCT05448456|Coagulants|coagulants|mesh-ancestor
153347714|NCT05448378|Inositol|inositol|mesh-list
153347715|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
153347716|NCT05448378|Vitamins|vitamins|mesh-ancestor
153347753|NCT01118273|Naproxen|naproxen|mesh-list
153347771|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
153347772|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
153347773|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153347774|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153347775|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
153347776|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
153347777|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347778|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153347779|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
153603045|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153347780|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347781|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153347782|NCT01085903|Modafinil|modafinil|mesh-list
153347783|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153347784|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347785|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153347786|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153347787|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153347788|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347789|NCT01118741|Disulfiram|disulfiram|mesh-list
153347790|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153347791|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153347792|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347793|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347794|NCT01439815|Fluticasone|fluticasone|mesh-list
153347796|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347797|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153347798|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
153347799|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347800|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347801|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153347802|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
153347803|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347804|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153347805|NCT01332253|Ibuprofen|ibuprofen|mesh-list
153347806|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153347807|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153347808|NCT01332253|Analgesics|analgesics|mesh-ancestor
153347835|NCT01384591|Expectorants|expectorants|mesh-ancestor
153347845|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347846|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347847|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347849|NCT00265850|Folic Acid|folic acid|mesh-list
153347850|NCT00265850|Bevacizumab|bevacizumab|mesh-list
153347851|NCT00265850|Cetuximab|cetuximab|mesh-list
153347852|NCT00265850|Fluorouracil|fluorouracil|mesh-list
153347853|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
153347854|NCT00265850|Irinotecan|irinotecan|mesh-list
153347855|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
153347856|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153347857|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347858|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153347859|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153347860|NCT00265850|Growth Substances|growth substances|mesh-ancestor
153347861|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347862|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
153347864|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347865|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347866|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347867|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
153347868|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153347869|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153347870|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347871|NCT00265850|Antidotes|antidotes|mesh-ancestor
153347872|NCT00265850|Protective Agents|protective agents|mesh-ancestor
153347873|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
153347874|NCT00265850|Vitamins|vitamins|mesh-ancestor
153347897|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347898|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153347899|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153347900|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153347901|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153347902|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153347903|NCT01042145|Dexamethasone|dexamethasone|mesh-list
153347904|NCT01042145|Prednisone|prednisone|mesh-list
153347907|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
153347908|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347909|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347910|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153347911|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
153347913|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347914|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153347915|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347917|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347918|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
153347919|NCT01043393|Hormones|hormones|mesh-ancestor
153347920|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347921|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347922|NCT01087931|Bupivacaine|bupivacaine|mesh-list
153347923|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
153347924|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
153347925|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347926|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347927|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
153347951|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348050|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153348051|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
153348052|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348053|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153348054|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153348080|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153348081|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
153348083|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348084|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348085|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153348086|NCT03013439|Hematinics|hematinics|mesh-ancestor
153348087|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153348088|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153348089|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153348090|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348091|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348092|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348093|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348096|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348170|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348171|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
153348172|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153348173|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348174|NCT03013127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153348175|NCT03013127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348176|NCT01048697|Ethambutol|ethambutol|mesh-list
153348177|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
153348178|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153348179|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348180|NCT01049243|Fluocinonide|fluocinonide|mesh-list
153348181|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153348182|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
153348183|NCT01049243|Hormones|hormones|mesh-ancestor
153348184|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348185|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348186|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153348187|NCT03013205|Triamcinolone|triamcinolone|mesh-list
153348188|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153348189|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153348190|NCT03013205|Lidocaine|lidocaine|mesh-list
153348193|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
153348240|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348241|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153348242|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153348243|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
153348244|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
153348245|NCT01100255|Ketamine|ketamine|mesh-list
153348246|NCT01100255|Analgesics|analgesics|mesh-ancestor
153348247|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
153348248|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348249|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348250|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153348251|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153348252|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
153348253|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
153348254|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348255|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153348256|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153348257|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348258|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348259|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
153348260|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153348261|NCT03012347|Protective Agents|protective agents|mesh-ancestor
153348262|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348263|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
153348264|NCT01100723|Vitamin D|vitamin d|mesh-list
153348265|NCT01100723|Calcitriol|calcitriol|mesh-list
153348266|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153348267|NCT01100723|Cinacalcet|cinacalcet|mesh-list
153348268|NCT01100723|Vitamins|vitamins|mesh-ancestor
153348300|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
153348301|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783355|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
153348302|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153348303|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153348306|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
153348310|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348344|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153348345|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
153348346|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153348347|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153348348|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
153348380|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348381|NCT00189098|Trimethoprim|trimethoprim|mesh-list
153348382|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153348383|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
153348384|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153348385|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359950|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153348386|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
153348387|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153348388|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153348389|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153348403|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153348404|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153348405|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153348440|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153348441|NCT01447849|Lubiprostone|lubiprostone|mesh-list
153348442|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153348443|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348444|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348445|NCT00277394|Heparin|heparin|mesh-list
153348446|NCT00277394|Tinzaparin|tinzaparin|mesh-list
153348447|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
153348448|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153348449|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153348471|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
153348472|NCT01474213|Remifentanil|remifentanil|mesh-list
153348473|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153348476|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153348542|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153348543|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153348544|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153348545|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348546|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348548|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348564|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153348565|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153348566|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
153348567|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348568|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348569|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153348570|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153348571|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153348572|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
153348574|NCT00201734|Carboplatin|carboplatin|mesh-list
153348575|NCT00201734|Capecitabine|capecitabine|mesh-list
153348576|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153348577|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348578|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
153348579|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
153348580|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
153348581|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348582|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153348583|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
153348584|NCT00203216|Levetiracetam|levetiracetam|mesh-list
153348585|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
153348586|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
153348587|NCT00206336|Topiramate|topiramate|mesh-list
153348588|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
153348589|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153348590|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348592|NCT00210470|Indomethacin|indomethacin|mesh-list
153348593|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
153417620|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153417621|NCT05348239|Protective Agents|protective agents|mesh-ancestor
153417711|NCT02224560|Cannabidiol|cannabidiol|mesh-list
153417712|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
153417713|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
153417714|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153417715|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348599|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153348600|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
153348601|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348602|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348603|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153348604|NCT00210470|Trace Elements|trace elements|mesh-ancestor
153348605|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
153348606|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153348607|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348608|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153348650|NCT05215067|Docetaxel|docetaxel|mesh-list
153348687|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153348688|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153348690|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153348691|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153348692|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
153348693|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153348694|NCT00284180|Trastuzumab|trastuzumab|mesh-list
153348695|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153348696|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348697|NCT04087460|Vaccines|vaccines|mesh-list
153348698|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153348699|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
153348700|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348701|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153348702|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153348703|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153348704|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153348705|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348706|NCT00287222|Bevacizumab|bevacizumab|mesh-list
153348707|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153348708|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153348709|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348710|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153348819|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
153348820|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348821|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348822|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348823|NCT01898624|Urological Agents|urological agents|mesh-ancestor
153348824|NCT01140191|Gentamicins|gentamicins|mesh-list
153348825|NCT01140191|Paromomycin|paromomycin|mesh-list
153348826|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153348827|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348828|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153348829|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348830|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348832|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153348834|NCT01141049|Analgesics|analgesics|mesh-ancestor
153348835|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
153348836|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348837|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348838|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
153348839|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153348840|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153348841|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348842|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348843|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153348844|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153348847|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
153348949|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348950|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348951|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348953|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
153348954|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153348955|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153348956|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348957|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348958|NCT01169519|Urological Agents|urological agents|mesh-ancestor
153348959|NCT04071977|Antioxidants|antioxidants|mesh-list
153348960|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348961|NCT04071977|Protective Agents|protective agents|mesh-ancestor
153348962|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348963|NCT02101190|Opicapone|opicapone|mesh-list
153348964|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153348965|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348966|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348967|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153348968|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153348969|NCT01170533|Omeprazole|omeprazole|mesh-list
153348970|NCT01170533|Pantoprazole|pantoprazole|mesh-list
153348971|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153348972|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348973|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153348974|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348975|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783370|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349037|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349038|NCT01151813|Varenicline|varenicline|mesh-list
153349039|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153349040|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153349041|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
153349042|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349043|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349044|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349045|NCT03835949|Atezolizumab|atezolizumab|mesh-list
153349157|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349158|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
153349159|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
153349163|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153349164|NCT00301418|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153349165|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153349166|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349188|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
153349189|NCT01478581|Dexamethasone|dexamethasone|mesh-list
153349191|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349374|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153349376|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
153349377|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349378|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153349408|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
153783376|NCT02213848|Calcium|calcium|mesh-list
153783377|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153349409|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349410|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153349411|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
153349412|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349413|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349414|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349415|NCT05265962|Decitabine|decitabine|mesh-list
153349416|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153349417|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
153349418|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349419|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349420|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349421|NCT00324896|Eszopiclone|eszopiclone|mesh-list
153424909|NCT02892500|Betamethasone|betamethasone|mesh-list
153349500|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
153349501|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349502|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
153349503|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349504|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
153349505|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349506|NCT01481545|Leucovorin|leucovorin|mesh-list
153349507|NCT01481545|Bevacizumab|bevacizumab|mesh-list
153349508|NCT01481545|Fluorouracil|fluorouracil|mesh-list
153349509|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
153349510|NCT01481545|Raltitrexed|raltitrexed|mesh-list
153349511|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
153349512|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153349513|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349514|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153349515|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153349516|NCT01481545|Growth Substances|growth substances|mesh-ancestor
153349517|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349518|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
153349519|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
153349520|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349607|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349608|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349609|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153349610|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
153349612|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349614|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349615|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
153349616|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
153349617|NCT02106494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153349618|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153349619|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
153349620|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349621|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349622|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153349623|NCT00335504|Sulindac|sulindac|mesh-list
153349624|NCT00335504|Atorvastatin|atorvastatin|mesh-list
153349625|NCT00335504|Calcium|calcium|mesh-list
153349652|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
153349653|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
153349654|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349655|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349656|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153349657|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153349658|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349708|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349709|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349710|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153349711|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153349712|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
153349713|NCT01225055|Teriparatide|teriparatide|mesh-list
153349714|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153349715|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349716|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153349717|NCT01336140|Aminophylline|aminophylline|mesh-list
153349718|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153349719|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
153349720|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349749|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153349750|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349752|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
153349753|NCT01225289|Vitamins|vitamins|mesh-ancestor
153349754|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
153349755|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349756|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
153349757|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349759|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153349760|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426963|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
153349810|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349811|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
153349812|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349813|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153349814|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
153349832|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349833|NCT01229423|Bimatoprost|bimatoprost|mesh-list
153349834|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153349835|NCT01229891|Vitamin D|vitamin d|mesh-list
153349836|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
153349837|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
153349838|NCT01229891|Vitamins|vitamins|mesh-list
153349839|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
153349840|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349841|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153349842|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153349843|NCT01283555|Tenofovir|tenofovir|mesh-list
153349844|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
153349845|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349846|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153349847|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153349848|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349849|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349850|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153349852|NCT01194089|Nicotine|nicotine|mesh-list
153783381|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783382|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349853|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153349854|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
153349855|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349856|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349857|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153349865|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349866|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
153349867|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349868|NCT00349388|Mesalamine|mesalamine|mesh-list
153387676|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349895|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349896|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153349897|NCT00305084|Doxorubicin|doxorubicin|mesh-list
153349898|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153349899|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349900|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153349901|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153349902|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349903|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349904|NCT00305162|Clopidogrel|clopidogrel|mesh-list
153349905|NCT00305162|Cangrelor|cangrelor|mesh-list
153349906|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153349907|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153349909|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153349958|NCT01793636|Everolimus|everolimus|mesh-list
153349962|NCT01793636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349963|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349964|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
153349965|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349966|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349967|NCT00343460|Dexamethasone|dexamethasone|mesh-list
153349968|NCT00343460|Palonosetron|palonosetron|mesh-list
153349969|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349970|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
153349971|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
153349972|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349973|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349997|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349998|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153783383|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
153783384|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349999|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153350000|NCT00310076|Growth Substances|growth substances|mesh-ancestor
153350001|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
153350002|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350003|NCT00353834|Insulin|insulin|mesh-list
153350004|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153350005|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
153350006|NCT00353834|Exenatide|exenatide|mesh-list
153350007|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153350008|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350009|NCT00353834|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153350010|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153350011|NCT00353834|Incretins|incretins|mesh-ancestor
153350012|NCT00353834|Hormones|hormones|mesh-ancestor
153350013|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350014|NCT05344404|Niacinamide|niacinamide|mesh-list
153350016|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
153350017|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
153350018|NCT05344404|Vitamins|vitamins|mesh-ancestor
153350019|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
153350023|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350024|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153350059|NCT00355394|Metoclopramide|metoclopramide|mesh-list
153350060|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
153350061|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
153350062|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350063|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350064|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153350065|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153350066|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153350067|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
153350096|NCT01792700|Tetracycline|tetracycline|mesh-list
153350097|NCT01792700|Esomeprazole|esomeprazole|mesh-list
153350098|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153350099|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350100|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153350101|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153350102|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350103|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350104|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350105|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153350106|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153350107|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153350108|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153350109|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153350110|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153350111|NCT00315302|Atropine|atropine|mesh-list
153350112|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153350113|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153350141|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350142|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350143|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350144|NCT00318812|Iron|iron|mesh-list
153350145|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153350146|NCT00318812|Trace Elements|trace elements|mesh-ancestor
153603046|NCT01909037|Analgesics|analgesics|mesh-ancestor
153603047|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
153603048|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603049|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350148|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350149|NCT00318812|Hematinics|hematinics|mesh-ancestor
153350150|NCT00362882|Docetaxel|docetaxel|mesh-list
153350151|NCT00362882|Bortezomib|bortezomib|mesh-list
153783386|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153350152|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350153|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
153783387|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
153350154|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
153350155|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
153350156|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350157|NCT00365144|Bevacizumab|bevacizumab|mesh-list
153350158|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153350193|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153350194|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153350195|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350196|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
153350197|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153350213|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350214|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350215|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350216|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350217|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153350219|NCT00324272|Coagulants|coagulants|mesh-ancestor
153350220|NCT00369590|Aflibercept|aflibercept|mesh-list
153350221|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
153350222|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153603050|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153603051|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603052|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603053|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603054|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603055|NCT01909063|Vitamin D|vitamin d|mesh-list
153603056|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
153603057|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
153603058|NCT01909063|Vitamins|vitamins|mesh-list
153603059|NCT01909063|Vitamin E|vitamin e|mesh-list
153603060|NCT01909063|Vitamin A|vitamin a|mesh-list
153603061|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
153603062|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603063|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603064|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153603065|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
153603066|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603067|NCT01909063|Protective Agents|protective agents|mesh-ancestor
153603068|NCT01909115|Vitamin D|vitamin d|mesh-list
153603069|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
153350223|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153350225|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350226|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
153350227|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350228|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153783388|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350229|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153350230|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350231|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153350232|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153350233|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
153350234|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350235|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350236|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153350237|NCT00390182|Gemcitabine|gemcitabine|mesh-list
153350238|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153350239|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
153350240|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350241|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350242|NCT05366868|Metformin|metformin|mesh-list
153350243|NCT05366868|Vildagliptin|vildagliptin|mesh-list
153350244|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153350245|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350246|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153350247|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
153350248|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350249|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350250|NCT05610774|Dexmedetomidine|dexmedetomidine|mesh-list
153350251|NCT05610774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153603099|NCT01909752|Imiquimod|imiquimod|mesh-list
153603100|NCT01909752|Vaccines|vaccines|mesh-list
153603101|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
153603102|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603103|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153603104|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153603105|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153603106|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
153603107|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603108|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603109|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153603110|NCT01909752|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153603111|NCT01909752|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153350252|NCT05610774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350253|NCT05610774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350254|NCT05610774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153350255|NCT05610774|Analgesics|analgesics|mesh-ancestor
153350256|NCT05610774|Sensory System Agents|sensory system agents|mesh-ancestor
153350320|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350321|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350322|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350323|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153350325|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153350326|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153350327|NCT00392678|Analgesics|analgesics|mesh-ancestor
153350328|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
153350329|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350330|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350331|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153350332|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153350333|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153350334|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350335|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350397|NCT05901701|Antifungal Agents|antifungal agents|mesh-ancestor
153731983|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153731984|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153731985|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153731986|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153731987|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153731988|NCT00140114|Misoprostol|misoprostol|mesh-list
153731989|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153731990|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
153731991|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153731992|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783629|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153350399|NCT05901701|Dermatologic Agents|dermatologic agents|mesh-ancestor
153350401|NCT05901571|Citalopram|citalopram|mesh-list
153350402|NCT05901571|Escitalopram|escitalopram|mesh-list
153350403|NCT05901571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153350404|NCT05901571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153350405|NCT05901571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350406|NCT05901571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350407|NCT05901571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350408|NCT05901571|Serotonin Agents|serotonin agents|mesh-ancestor
153350409|NCT05901571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350410|NCT05901571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153350411|NCT05901571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153350412|NCT05901571|Parasympatholytics|parasympatholytics|mesh-ancestor
153350413|NCT05901571|Autonomic Agents|autonomic agents|mesh-ancestor
153350414|NCT05901571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350415|NCT05901571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153350452|NCT05901194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350453|NCT05901194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350454|NCT05901194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350455|NCT05901194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350483|NCT05899699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153350484|NCT05899699|Dermatologic Agents|dermatologic agents|mesh-ancestor
153350485|NCT05897151|Anesthetics|anesthetics|mesh-list
153350486|NCT05897151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350487|NCT05897151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350488|NCT05897138|Lenvatinib|lenvatinib|mesh-list
153350489|NCT05897138|Tislelizumab|tislelizumab|mesh-list
153350490|NCT05897138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350491|NCT05897138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350492|NCT05897138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350493|NCT05897138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603112|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153603160|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603161|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603162|NCT01910090|Analgesics|analgesics|mesh-ancestor
153603163|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
153603164|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350494|NCT05897138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350495|NCT05895162|Fluconazole|fluconazole|mesh-list
153350496|NCT05895162|Antifungal Agents|antifungal agents|mesh-ancestor
153350497|NCT05895162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732003|NCT00140309|Isoniazid|isoniazid|mesh-list
153732004|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
153732005|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153732006|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350498|NCT05895162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153350499|NCT05895162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153350500|NCT05895162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350501|NCT05895162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350527|NCT05837000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350528|NCT05837000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153350529|NCT05837000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153350530|NCT05837000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153350531|NCT05837000|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350532|NCT05837000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350533|NCT05837000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350534|NCT05837000|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153350535|NCT05837000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153350536|NCT05837000|Anesthetics, General|anesthetics, general|mesh-ancestor
153350537|NCT05837000|Anesthetics|anesthetics|mesh-ancestor
153350538|NCT05837000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153350539|NCT05837000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153350540|NCT05837000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153350541|NCT05837000|Anticonvulsants|anticonvulsants|mesh-ancestor
153350542|NCT05837000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153350543|NCT05837000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350544|NCT05837000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153350583|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
153350584|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350585|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350586|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153350587|NCT05705856|Ustekinumab|ustekinumab|mesh-list
153350588|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
153350589|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
153350590|NCT05672173|Nivolumab|nivolumab|mesh-list
153350591|NCT05672173|Fludarabine|fludarabine|mesh-list
153350592|NCT05672173|Ibrutinib|ibrutinib|mesh-list
153350593|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153350594|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
153350595|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350596|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153350597|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153350624|NCT05654649|Hormones|hormones|mesh-ancestor
153350625|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350626|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153350627|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350628|NCT05519111|Dronabinol|dronabinol|mesh-list
153350629|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
153350630|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350631|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153350632|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153350633|NCT05519111|Analgesics|analgesics|mesh-ancestor
153350634|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
153350635|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350636|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153781731|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
153603165|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153603222|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153603223|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153603224|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603225|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
153603236|NCT01910285|Sufentanil|sufentanil|mesh-list
153603289|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603291|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
153603356|NCT01910987|Dexamethasone|dexamethasone|mesh-list
153603357|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
153603358|NCT01910987|Bortezomib|bortezomib|mesh-list
153603359|NCT01910987|BB 1101|bb 1101|mesh-list
153603360|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153603361|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
153603362|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
153350637|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153350638|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350639|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387678|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350679|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
153350680|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350703|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350704|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153350706|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
153350707|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
153350708|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350709|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153350710|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153350711|NCT05123040|Protective Agents|protective agents|mesh-ancestor
153350712|NCT05096702|Primaquine|primaquine|mesh-list
153350713|NCT05096702|Tafenoquine|tafenoquine|mesh-list
153350714|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
153350715|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153350716|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153350717|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350718|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
153350719|NCT05017454|Valproic Acid|valproic acid|mesh-list
153350720|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153350721|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
153350722|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153350723|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
153350724|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350725|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350726|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
153350727|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350728|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429494|NCT00002684|Paclitaxel|paclitaxel|mesh-list
153603363|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603364|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603365|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603416|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603417|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
153603418|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603419|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603420|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153350729|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
153350730|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153350731|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350732|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153350733|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153350804|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
153350805|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350806|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350807|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
153350808|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350842|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350843|NCT04680221|Bupivacaine|bupivacaine|mesh-list
153350844|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
153350845|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
153350846|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350847|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350848|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
153350849|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350850|NCT04644796|Bupivacaine|bupivacaine|mesh-list
153350851|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
153350881|NCT04556370|Norepinephrine|norepinephrine|mesh-list
153350882|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153350883|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153350884|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350885|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350886|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350887|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350888|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
153350889|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
153350890|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430248|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
153603421|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603422|NCT01911455|Acamprosate|acamprosate|mesh-list
153603423|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153603424|NCT01911468|Metformin|metformin|mesh-list
153603425|NCT01911468|Liraglutide|liraglutide|mesh-list
153603426|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153603427|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603428|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603429|NCT01911468|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153603430|NCT01911468|Incretins|incretins|mesh-ancestor
153603431|NCT01911468|Hormones|hormones|mesh-ancestor
153603432|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350893|NCT04535687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153350894|NCT04535687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350895|NCT04535687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350896|NCT04535687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350897|NCT04527887|Dexamethasone|dexamethasone|mesh-list
153783394|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350928|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350930|NCT04385602|Analgesics|analgesics|mesh-ancestor
153350931|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
153350932|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350933|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153350934|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153350935|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153350936|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
153732007|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153732008|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153350937|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350938|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350939|NCT04379713|Vaccines|vaccines|mesh-list
153350940|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153350941|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
153350987|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
153603433|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
153603434|NCT01911494|Methyldopa|methyldopa|mesh-list
153603435|NCT01911494|Analgesics|analgesics|mesh-ancestor
153603436|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
153603437|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603438|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603439|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
153603440|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603465|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153603466|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603467|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
153603468|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
153603469|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
153603470|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603471|NCT01911624|Enoxaparin|enoxaparin|mesh-list
153603472|NCT01911624|Dabigatran|dabigatran|mesh-list
153603473|NCT01911624|Argatroban|argatroban|mesh-list
153603474|NCT01911624|Thrombin|thrombin|mesh-list
153603534|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153603535|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153603536|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603537|NCT01912053|Gemcitabine|gemcitabine|mesh-list
153603538|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603602|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350990|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350991|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
153350992|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351013|NCT04058067|Aflibercept|aflibercept|mesh-list
153351014|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153351015|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153351016|NCT04058067|Growth Substances|growth substances|mesh-ancestor
153351017|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351018|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
153351019|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351021|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153351022|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
153351023|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351024|NCT03759028|Acetaminophen|acetaminophen|mesh-list
153351025|NCT03759028|Ibuprofen|ibuprofen|mesh-list
153351026|NCT03759028|Oxycodone|oxycodone|mesh-list
153351027|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153351028|NCT03759028|Analgesics|analgesics|mesh-ancestor
153351029|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
153351030|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813504|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813505|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153813506|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153813507|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153359958|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153889825|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153351031|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351032|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
153351033|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153351034|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351035|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351036|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153351037|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431291|NCT06315283|Olanzapine|olanzapine|mesh-list
153603603|NCT01912573|Naloxone|naloxone|mesh-list
153603604|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153603605|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603606|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
153603607|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603608|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
153603609|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
153603678|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603680|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
153603681|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
153603682|NCT01912898|Vitamins|vitamins|mesh-list
153603683|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
153603684|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351038|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351040|NCT03759028|Narcotics|narcotics|mesh-ancestor
153351041|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351042|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153351043|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153351044|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351045|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
153351046|NCT03693560|Metformin|metformin|mesh-list
153351047|NCT03693560|Glimepiride|glimepiride|mesh-list
153783395|NCT04541719|Remifentanil|remifentanil|mesh-list
153351072|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
153351073|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153351074|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153351075|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351076|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153351077|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351078|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351079|NCT03417544|Trastuzumab|trastuzumab|mesh-list
153351080|NCT03417544|Atezolizumab|atezolizumab|mesh-list
153351082|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351083|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351084|NCT03417544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153351085|NCT03417544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351086|NCT03363464|Empagliflozin|empagliflozin|mesh-list
153351087|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153351088|NCT03363464|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153351089|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153351090|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351091|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153431307|NCT06315231|Edaravone|edaravone|mesh-list
153603685|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153603686|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603687|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153603715|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153603716|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603717|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153603718|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
153603719|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
153603720|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153351092|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351093|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
153351094|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351095|NCT03113851|Molgramostim|molgramostim|mesh-list
153351123|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351124|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351125|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351127|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153351128|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153351129|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153351130|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
153351131|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351132|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351133|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351134|NCT02462837|Urological Agents|urological agents|mesh-ancestor
153351135|NCT02346201|Methylphenidate|methylphenidate|mesh-list
153351136|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153351137|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351138|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153351139|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153351172|NCT01366612|Fludarabine|fludarabine|mesh-list
153351173|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
153351175|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351176|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153351177|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
153351178|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351215|NCT00392834|Vincristine|vincristine|mesh-list
153351216|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
153351217|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351218|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
153351219|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351220|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351221|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153351222|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
153603721|NCT01913054|Narcotics|narcotics|mesh-ancestor
153603722|NCT01913054|Analgesics|analgesics|mesh-ancestor
153351249|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
153351250|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351251|NCT00393380|Teriparatide|teriparatide|mesh-list
153351252|NCT00393380|Hormones|hormones|mesh-list
153351253|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
153351254|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351255|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351256|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153351257|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153351258|NCT05361642|Lidocaine|lidocaine|mesh-list
153351259|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
153351260|NCT05361642|Bupivacaine|bupivacaine|mesh-list
153351261|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
153351262|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
153351263|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351264|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351265|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
153783398|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351266|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351267|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153351280|NCT00395876|Tenecteplase|tenecteplase|mesh-list
153351281|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153351282|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153351283|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351284|NCT02662634|Paclitaxel|paclitaxel|mesh-list
153813508|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153351285|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153351286|NCT02662634|Cisplatin|cisplatin|mesh-list
153351287|NCT02662634|Carboplatin|carboplatin|mesh-list
153351288|NCT02662634|Pemetrexed|pemetrexed|mesh-list
153351289|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153351290|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351291|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
153603723|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
153603724|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153603725|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153603726|NCT01913106|Valacyclovir|valacyclovir|mesh-list
153603727|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
153603728|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603729|NCT01913119|Romidepsin|romidepsin|mesh-list
153603730|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153603774|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603776|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153603777|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351292|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
153351293|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
153351294|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351295|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351296|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153351297|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153351299|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153351300|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153732009|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351301|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351302|NCT02277782|Fentanyl|fentanyl|mesh-list
153351303|NCT02277782|Hydromorphone|hydromorphone|mesh-list
153351304|NCT02277782|Bupivacaine|bupivacaine|mesh-list
153351305|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
153351306|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
153351307|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351308|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351309|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
153351310|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351311|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153351312|NCT02277782|Narcotics|narcotics|mesh-ancestor
153351313|NCT02277782|Analgesics|analgesics|mesh-ancestor
153351314|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153351315|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153351316|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
153351373|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153351374|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153351375|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
153351376|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351409|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351410|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351411|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351412|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153351413|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153351414|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
153351415|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351416|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153351417|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
153359959|NCT02807558|Azacitidine|azacitidine|mesh-list
153351418|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
153351419|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
153351420|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153351421|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153351458|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351459|NCT00402896|Mitogens|mitogens|mesh-list
153351460|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
153351491|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351492|NCT05286008|Dexamethasone|dexamethasone|mesh-list
153351493|NCT05286008|Ropivacaine|ropivacaine|mesh-list
153351494|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351495|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
153351496|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
153351497|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351498|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351499|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153351500|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
153351501|NCT05286008|Hormones|hormones|mesh-ancestor
153351502|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351503|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153603778|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153603779|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
153603780|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
153603781|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153603783|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603839|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603840|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603841|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153351505|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
153351536|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351537|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153351538|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153351539|NCT05299476|Growth Substances|growth substances|mesh-ancestor
153351540|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351541|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
153351545|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351546|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351547|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153351548|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153351549|NCT00405938|Growth Substances|growth substances|mesh-ancestor
153351550|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351551|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
153351573|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153351574|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
153351576|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153351577|NCT01793480|Narcotics|narcotics|mesh-ancestor
153351578|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351579|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351580|NCT01793480|Analgesics|analgesics|mesh-ancestor
153351581|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
153351582|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351583|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
153351584|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
153351586|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153351587|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351588|NCT05256264|Ketamine|ketamine|mesh-list
153351589|NCT05256264|Analgesics|analgesics|mesh-ancestor
153351590|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
153351591|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351592|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432893|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
153603843|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
153603844|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603855|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351593|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153351594|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153351595|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
153351596|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
153813510|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
153813511|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
153351597|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351598|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153351634|NCT05256108|Narcotics|narcotics|mesh-ancestor
153351635|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351636|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351637|NCT05256108|Analgesics|analgesics|mesh-ancestor
153351638|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
153351699|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
153351700|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351701|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351702|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
153351703|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
153351704|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351705|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153351706|NCT05255406|Aflutinib|aflutinib|mesh-list
153351707|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351708|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351709|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351710|NCT05250050|Amoxicillin|amoxicillin|mesh-list
153351711|NCT05250050|Metronidazole|metronidazole|mesh-list
153351712|NCT05250050|Clarithromycin|clarithromycin|mesh-list
153351713|NCT05250050|Levofloxacin|levofloxacin|mesh-list
153351714|NCT05250050|Tetracycline|tetracycline|mesh-list
153351715|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
153351716|NCT05250050|Esomeprazole|esomeprazole|mesh-list
153351717|NCT05250050|Bismuth|bismuth|mesh-list
153351718|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351719|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153783401|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
153351757|NCT05292690|Caffeine|caffeine|mesh-list
153351758|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153351759|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351760|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153351761|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351762|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351763|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153351764|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153351765|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
153351766|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351767|NCT00382148|Omalizumab|omalizumab|mesh-list
153351768|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153351769|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153351770|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
153351771|NCT05292066|Pregabalin|pregabalin|mesh-list
153351772|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153351773|NCT05292066|Analgesics|analgesics|mesh-ancestor
153351774|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
153351775|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351776|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351810|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153351811|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153351812|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351846|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351847|NCT05290116|Apatinib|apatinib|mesh-list
153351848|NCT05290116|Tislelizumab|tislelizumab|mesh-list
153351849|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351850|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351851|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351852|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433176|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153603856|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
153603857|NCT01914211|Coagulants|coagulants|mesh-ancestor
153603858|NCT01914237|Castor Oil|castor oil|mesh-list
153603859|NCT01914237|Cathartics|cathartics|mesh-ancestor
153603860|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603861|NCT01914250|Analgesics|analgesics|mesh-list
153603862|NCT01914250|Tetracaine|tetracaine|mesh-list
153603867|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
153603892|NCT01914484|Nilotinib|nilotinib|mesh-list
153603893|NCT01914484|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153603894|NCT01914484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153603895|NCT01914484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351853|NCT05290116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351855|NCT00409292|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153351878|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153351879|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
153351880|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153351881|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351882|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153351883|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153351884|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
153351885|NCT05288400|Amlodipine|amlodipine|mesh-list
153351886|NCT05288400|Bisoprolol|bisoprolol|mesh-list
153351887|NCT05288400|Perindopril|perindopril|mesh-list
153351888|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153351889|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153351890|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153351891|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351892|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153351893|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351894|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
153351895|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
153351896|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
153351897|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351898|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153351899|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153351900|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153351901|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
153351902|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351906|NCT05474040|Morphine|morphine|mesh-list
153351986|NCT05236530|Lumefantrine|lumefantrine|mesh-list
153351987|NCT05236530|Midazolam|midazolam|mesh-list
153351988|NCT05236530|Levomethorphan|levomethorphan|mesh-list
153351989|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
153351990|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153351991|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153351992|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351993|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153351994|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153351995|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351996|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153352027|NCT05236530|Analgesics|analgesics|mesh-ancestor
153352028|NCT05236530|Sensory System Agents|sensory system agents|mesh-ancestor
153352029|NCT05236530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352030|NCT00455702|Cycloserine|cycloserine|mesh-list
153352031|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153352032|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352033|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153352034|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
153352035|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153352036|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
153352037|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352038|NCT00456014|Desipramine|desipramine|mesh-list
153352039|NCT00456014|Escitalopram|escitalopram|mesh-list
153352040|NCT00456014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153352041|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153352066|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352068|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153352069|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153352070|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153352071|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352079|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
153352080|NCT00458822|Dexamethasone|dexamethasone|mesh-list
153352081|NCT00458822|Bortezomib|bortezomib|mesh-list
153352082|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352083|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
153352084|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
153352085|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352086|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352087|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153352088|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
153352089|NCT00458822|Hormones|hormones|mesh-ancestor
153352090|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153352091|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153352092|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352121|NCT00462020|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153352122|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352123|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352124|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153352125|NCT05177718|Natalizumab|natalizumab|mesh-list
153352126|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
153352127|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352128|NCT00414206|Mecamylamine|mecamylamine|mesh-list
153352129|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153352130|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153352131|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
153352132|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352133|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352134|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153352135|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153352136|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
153352137|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603896|NCT01914484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603897|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153603898|NCT01914562|Cathartics|cathartics|mesh-ancestor
153603899|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153603900|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
153603901|NCT01914627|Salicylates|salicylates|mesh-list
153603902|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153603903|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
153603956|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
153603957|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153603958|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153603959|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153604025|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
153352138|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352158|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153352159|NCT00462644|Midazolam|midazolam|mesh-list
153352160|NCT00462644|Fentanyl|fentanyl|mesh-list
153352161|NCT00462644|Etomidate|etomidate|mesh-list
153352162|NCT00462644|Succinylcholine|succinylcholine|mesh-list
153352163|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153352164|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153352165|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352166|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352167|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153783402|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783403|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153352168|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153352169|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153783404|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
153352170|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153352171|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
153352172|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
153352173|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
153352174|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
153352175|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352176|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352177|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153352178|NCT00462644|Narcotics|narcotics|mesh-ancestor
153352179|NCT00462644|Analgesics|analgesics|mesh-ancestor
153352180|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
153352181|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352182|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153352183|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153352184|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153352185|NCT00462722|Ibuprofen|ibuprofen|mesh-list
153352228|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
153352229|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352230|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153352231|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153352232|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153352233|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153352235|NCT01795664|Xhance|xhance|mesh-list
153352236|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153352265|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352266|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
153352267|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352268|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153352269|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
153352270|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153352271|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153352272|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153352273|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
153352274|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
153352275|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352276|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153352277|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153352278|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
153352311|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
153352312|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153352313|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153813512|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
153352315|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153352316|NCT00531518|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153352317|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
153352318|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153783406|NCT00261612|Dexamethasone|dexamethasone|mesh-list
153352360|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153352362|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
153352363|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
153352364|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
153352365|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153352396|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153352397|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153352398|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153352400|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153352401|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352402|NCT00418028|Capecitabine|capecitabine|mesh-list
153352403|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153352404|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
153352405|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352436|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153352437|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352438|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
153352439|NCT00469508|Modafinil|modafinil|mesh-list
153352440|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153352441|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352442|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153352443|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153352444|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153352445|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352446|NCT05096832|Vaccines|vaccines|mesh-list
153352447|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
153352448|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352449|NCT00470600|Ibuprofen|ibuprofen|mesh-list
153352450|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153783410|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
153352469|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153352470|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153352471|NCT00471380|Timolol|timolol|mesh-list
153352472|NCT00471380|Travoprost|travoprost|mesh-list
153352473|NCT00471380|Dorzolamide|dorzolamide|mesh-list
153352474|NCT00471380|Brinzolamide|brinzolamide|mesh-list
153352475|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153352476|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153352477|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352478|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352479|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352480|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352481|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153352482|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153352483|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153352484|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352485|NCT00538850|Fentanyl|fentanyl|mesh-list
153352486|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153352487|NCT00538850|Narcotics|narcotics|mesh-ancestor
153352488|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352489|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352490|NCT00538850|Analgesics|analgesics|mesh-ancestor
153352491|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
153352492|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352493|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153352494|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153352495|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
153352496|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
153352497|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153352498|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153434159|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604026|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153604027|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153604028|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153604029|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153604031|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
153604095|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604096|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153604097|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
153604098|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153604099|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153604100|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604101|NCT01916174|Insulin|insulin|mesh-list
153604102|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153604103|NCT01916174|Liraglutide|liraglutide|mesh-list
153352499|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153352500|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153352501|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352502|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352503|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352504|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352505|NCT00418574|Abagovomab|abagovomab|mesh-list
153352529|NCT00419666|Calcitriol|calcitriol|mesh-list
153352530|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153352531|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352532|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153352533|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153352534|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352535|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153352536|NCT00419666|Vitamins|vitamins|mesh-ancestor
153352537|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
153352538|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153352598|NCT00423878|Aripiprazole|aripiprazole|mesh-list
153352599|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153352600|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153352601|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
153352602|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352603|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352604|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732010|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352605|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153783811|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153352606|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153352607|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352608|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153352609|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153352610|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
153352611|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
153352612|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
153352613|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352614|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783411|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
153352637|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352639|NCT00424502|Methotrexate|methotrexate|mesh-list
153352640|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153352641|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352642|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
153352643|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352644|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352645|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153352646|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
153352647|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153352648|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153352649|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
153434431|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153604104|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
153604105|NCT01916174|Xultophy|xultophy|mesh-list
153604106|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153604107|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604108|NCT01916174|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153604109|NCT01916174|Incretins|incretins|mesh-ancestor
153604110|NCT01916174|Hormones|hormones|mesh-ancestor
153604111|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153604112|NCT01916187|Imetelstat|imetelstat|mesh-list
153352650|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352652|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352653|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153352654|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153352655|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153352656|NCT00425672|Interleukin-2|interleukin-2|mesh-list
153352657|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
153352658|NCT00425672|Immunotoxins|immunotoxins|mesh-list
153352659|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352660|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153352661|NCT00425672|Analgesics|analgesics|mesh-ancestor
153352688|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153352689|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352690|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153352691|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
153352692|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153352693|NCT00544778|Protective Agents|protective agents|mesh-ancestor
153352792|NCT00431132|Estrogens|estrogens|mesh-ancestor
153352793|NCT00431132|Hormones|hormones|mesh-ancestor
153352794|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153352795|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352796|NCT00493064|Niacin|niacin|mesh-list
153352797|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
153352798|NCT00493064|Niacinamide|niacinamide|mesh-list
153352799|NCT00493064|Prednisolone|prednisolone|mesh-list
153352800|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153352801|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
153352802|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153352803|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
153352830|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352831|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352832|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153352833|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153352834|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
153352835|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352836|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352837|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
153352838|NCT00432458|Thalidomide|thalidomide|mesh-list
153352839|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153352840|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
153352842|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
153352843|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153352844|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352845|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153352846|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153352847|NCT00432458|Growth Substances|growth substances|mesh-ancestor
153352848|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
153352849|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352850|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153352851|NCT00433550|Capecitabine|capecitabine|mesh-list
153352852|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
153352853|NCT00433550|Irinotecan|irinotecan|mesh-list
153352854|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153352855|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
153352856|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352877|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
153352878|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153352879|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153352881|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
153352882|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352883|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153352885|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153352886|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153352887|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153352888|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
153352889|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153352890|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352891|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153352892|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153352893|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153352894|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153352895|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
153352896|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153352897|NCT03007927|Dexamethasone|dexamethasone|mesh-list
153352898|NCT03007927|Bupivacaine|bupivacaine|mesh-list
153352899|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352900|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
153352901|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
153352902|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352903|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352904|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153352905|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
153352906|NCT03007927|Hormones|hormones|mesh-ancestor
153352908|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153352954|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153352955|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352956|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352986|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
153352987|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352988|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153352989|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153352990|NCT00555464|Protective Agents|protective agents|mesh-ancestor
153352992|NCT01795976|Fludarabine|fludarabine|mesh-list
153352993|NCT01795976|Interleukin-2|interleukin-2|mesh-list
153352994|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153352995|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
153352996|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352997|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352998|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153352999|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
153353000|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353001|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353002|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153353003|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153353004|NCT01795976|Analgesics|analgesics|mesh-ancestor
153353040|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353041|NCT00556478|Lidocaine|lidocaine|mesh-list
153353042|NCT00556478|Prilocaine|prilocaine|mesh-list
153353043|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153353044|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
153353045|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
153353075|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353076|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353077|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353078|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153353079|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153353080|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353081|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353082|NCT03246620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153353083|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153604113|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
153353084|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353085|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353086|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353087|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
153353122|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
153353123|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353124|NCT01471639|Ketorolac|ketorolac|mesh-list
153353125|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153353126|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153359965|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353127|NCT01471639|Analgesics|analgesics|mesh-ancestor
153353128|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
153353129|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353130|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353131|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353163|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353164|NCT00438854|Dasatinib|dasatinib|mesh-list
153353165|NCT00438854|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153353166|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153378882|NCT01533116|Levodopa|levodopa|mesh-list
153353167|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353168|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353170|NCT01485055|Infliximab|infliximab|mesh-list
153353226|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153353263|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153353264|NCT05021094|Progestins|progestins|mesh-ancestor
153353265|NCT01364298|Pregabalin|pregabalin|mesh-list
153353286|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153353288|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353289|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353290|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153353291|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
153353292|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153353293|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153353295|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
153353296|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353297|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353298|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353299|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
153353300|NCT04421742|Hormones|hormones|mesh-ancestor
153353301|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353302|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
153353357|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353358|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153353359|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
153353360|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783415|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
153783416|NCT00261612|Hormones|hormones|mesh-ancestor
153353361|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353362|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153353364|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153353365|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
153353366|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353388|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153353389|NCT00511706|Growth Substances|growth substances|mesh-ancestor
153353390|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
153353391|NCT05067894|Vaccines|vaccines|mesh-list
153353392|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
153353393|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353394|NCT01493947|Metronidazole|metronidazole|mesh-list
153353395|NCT01493947|Ivermectin|ivermectin|mesh-list
153353396|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353397|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153353398|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153353399|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153353400|NCT00445484|Lenalidomide|lenalidomide|mesh-list
153353401|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153353402|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
153353403|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353404|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153353405|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153353406|NCT00445484|Growth Substances|growth substances|mesh-ancestor
153353407|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
153353408|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353410|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353421|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153353422|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353423|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153353444|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353445|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353446|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153353447|NCT00512876|Bevacizumab|bevacizumab|mesh-list
153353448|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153353449|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353450|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153353451|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153353452|NCT00512876|Growth Substances|growth substances|mesh-ancestor
153353453|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353454|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
153353455|NCT05127876|Ephedrine|ephedrine|mesh-list
153353456|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
153353457|NCT05127876|Ondansetron|ondansetron|mesh-list
153353458|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
153353459|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
153353460|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353461|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353462|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353463|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
153353464|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
153353465|NCT05127876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153353466|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153353467|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
153353468|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353469|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353470|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153353514|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153353515|NCT00517010|Growth Substances|growth substances|mesh-ancestor
153353516|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353517|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
153353518|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353519|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
153353520|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
153353521|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153353539|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353540|NCT05122884|Protective Agents|protective agents|mesh-ancestor
153353541|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353543|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153353544|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353545|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153353546|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153353547|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153353548|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353549|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153353550|NCT01796288|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153353551|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153353552|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353553|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353554|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353557|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
153353558|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
153353559|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353560|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353573|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
153353574|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
153353575|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153353576|NCT00521456|Ketorolac|ketorolac|mesh-list
153353577|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153353578|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153353604|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153378957|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
153353605|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353606|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353608|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353609|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353610|NCT01796444|Hormones|hormones|mesh-list
153353611|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353612|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353613|NCT01542541|Rifaximin|rifaximin|mesh-list
153353614|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153353615|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353616|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353617|NCT00524264|Ketorolac|ketorolac|mesh-list
153353618|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153353619|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153353620|NCT00524264|Analgesics|analgesics|mesh-ancestor
153353621|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
153353622|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353664|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353665|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153353666|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153353667|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
153353668|NCT00526292|Fludarabine|fludarabine|mesh-list
153353669|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353670|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
153353671|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353672|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353673|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153353674|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
153353675|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353676|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353713|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353714|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353747|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353748|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353749|NCT01550341|Analgesics|analgesics|mesh-ancestor
153353750|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
153353751|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353752|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153353753|NCT02125292|Mesalamine|mesalamine|mesh-list
153353787|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
153353789|NCT01508455|Midazolam|midazolam|mesh-list
153353840|NCT01510327|Analgesics|analgesics|mesh-ancestor
153353869|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153353870|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353871|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353872|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353873|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
153353874|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353875|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153353876|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153353877|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
153353878|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
153783422|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353879|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353880|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153353881|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153353882|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
153353883|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153353884|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
153359966|NCT02296229|Androgens|androgens|mesh-list
153353885|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353886|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
153353887|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153353918|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153353919|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
153353920|NCT03243890|Vitamin D|vitamin d|mesh-list
153353921|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
153353922|NCT03243890|Vitamin K|vitamin k|mesh-list
153353923|NCT03243890|Menaquinone 7|menaquinone 7|mesh-list
153353972|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153353973|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353974|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
153353975|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
153353976|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353977|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353978|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
153353980|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354003|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354005|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354006|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354007|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153354008|NCT00562328|Rituximab|rituximab|mesh-list
153354009|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
153354010|NCT00562328|Sargramostim|sargramostim|mesh-list
153354011|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153354012|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354013|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
153354014|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354015|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354016|NCT01514149|Metformin|metformin|mesh-list
153354017|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153354018|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354019|NCT05566093|Ethanol|ethanol|mesh-list
153354020|NCT05566093|Polidocanol|polidocanol|mesh-list
153354021|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153436010|NCT00003446|Fluorouracil|fluorouracil|mesh-list
153604114|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604115|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604149|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153604150|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
153604151|NCT01916252|Hormones|hormones|mesh-ancestor
153604152|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153604211|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604212|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604213|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
153604214|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604215|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153604216|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153354023|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354024|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354025|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153354026|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153354027|NCT01558063|Ketamine|ketamine|mesh-list
153354028|NCT01558063|Analgesics|analgesics|mesh-ancestor
153354029|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
153354030|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354031|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354032|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153354069|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354070|NCT01562041|Ranolazine|ranolazine|mesh-list
153354071|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153354100|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153354101|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
153354102|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354103|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153783424|NCT04547764|Calcium|calcium|mesh-list
153354104|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354105|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
153354106|NCT03303950|Busulfan|busulfan|mesh-list
153354160|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153354161|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153354162|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153354164|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354165|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354166|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354167|NCT05559398|Glenzocimab|glenzocimab|mesh-list
153354168|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
153354169|NCT00566150|Levetiracetam|levetiracetam|mesh-list
153354202|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
153354203|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354204|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354205|NCT01522963|Nicotine|nicotine|mesh-list
153354206|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153354207|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
153354208|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354209|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354210|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153354211|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153354231|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153354232|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
153354233|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
153354234|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153354235|NCT05533580|Narcotics|narcotics|mesh-ancestor
153354236|NCT05533580|Analgesics|analgesics|mesh-ancestor
153354237|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
153354238|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354240|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153354241|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153354242|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153354252|NCT02129426|Midazolam|midazolam|mesh-list
153354256|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354257|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354258|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153354260|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
153354261|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354262|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153354263|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153354264|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153354265|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
153354266|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354267|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354268|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153354269|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153354270|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
153354271|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
153354272|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153354307|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354308|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354310|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153354311|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
153354312|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354313|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354314|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153354315|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153354316|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
153354317|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354346|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153354347|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153354348|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153354349|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153354350|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354351|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
153354352|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354353|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354354|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153354355|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354356|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
153354357|NCT01529827|Methotrexate|methotrexate|mesh-list
153354358|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
153354359|NCT01529827|Fludarabine|fludarabine|mesh-list
153354360|NCT01529827|Melphalan|melphalan|mesh-list
153354361|NCT01529827|Tacrolimus|tacrolimus|mesh-list
153354362|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153354363|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
153354364|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153354365|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354414|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153354415|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354416|NCT02339246|Tacrolimus|tacrolimus|mesh-list
153354417|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354418|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
153354419|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354420|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153354421|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354422|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354423|NCT05085626|Fluzoparib|fluzoparib|mesh-list
153354424|NCT05085626|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153354425|NCT05085626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354426|NCT05085626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354427|NCT05085626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354428|NCT05041946|Methylphenidate|methylphenidate|mesh-list
153354429|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153354430|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354431|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153354432|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153354433|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153354434|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354435|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
153354472|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354475|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153354476|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354477|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
153354495|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354512|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
153354514|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
153354515|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354516|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153354517|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153354518|NCT01532089|Growth Substances|growth substances|mesh-ancestor
153354519|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354520|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
153354521|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
153354522|NCT01532089|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153354523|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153354524|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354525|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354526|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153354527|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153354528|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153354529|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
153354530|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354531|NCT05246072|Ivermectin|ivermectin|mesh-list
153354532|NCT05246072|Colchicine|colchicine|mesh-list
153354533|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
153354534|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354562|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354564|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
153354565|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354566|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
153354567|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354604|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354605|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153354606|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153354607|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354608|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
153354609|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153354610|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153354611|NCT01579513|Prednisolone|prednisolone|mesh-list
153354612|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
153354613|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153354614|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
153354615|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
153354616|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153354617|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
153354618|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
153354619|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354620|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354621|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153354622|NCT01579513|Hormones|hormones|mesh-ancestor
153354623|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354624|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153354625|NCT01579513|Protective Agents|protective agents|mesh-ancestor
153354626|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153354627|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354887|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
153354888|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354889|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354890|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153354891|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153354984|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153354985|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354986|NCT00614198|Caseins|caseins|mesh-list
153354987|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
153354988|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
153354989|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354990|NCT00616772|Choline|choline|mesh-list
153354991|NCT00616772|Atorvastatin|atorvastatin|mesh-list
153355202|NCT01592851|Protective Agents|protective agents|mesh-ancestor
153813523|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355203|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355205|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355206|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153355208|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379171|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
153355209|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355678|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153355679|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355680|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355740|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153355741|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355742|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153355743|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
153355781|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355782|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355783|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153355784|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153355785|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
153355786|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355787|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153355843|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355844|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153355845|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
153355846|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355847|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355848|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153355849|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355850|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
153356127|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356128|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
153356129|NCT02997800|Labetalol|labetalol|mesh-list
153783447|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153356130|NCT02997800|Fentanyl|fentanyl|mesh-list
153356131|NCT02997800|Esmolol|esmolol|mesh-list
153356132|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153356133|NCT02997800|Narcotics|narcotics|mesh-ancestor
153356134|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356135|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356136|NCT02997800|Analgesics|analgesics|mesh-ancestor
153356137|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
153356138|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356139|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153356140|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153356141|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
153356142|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
153356143|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153356144|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153356145|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153356146|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
153356180|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356185|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
153356324|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356326|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
153356327|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356328|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
153356329|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356330|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
153356331|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153356332|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153356403|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153356416|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356417|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
153356418|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356419|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356420|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153356421|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153356422|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
153356423|NCT00661544|Melphalan|melphalan|mesh-list
153356424|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
153356425|NCT00661544|Vitamins|vitamins|mesh-ancestor
153356426|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
153356427|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356428|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153356429|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
153356430|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356431|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356432|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153356433|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153356434|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
153356435|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
153356436|NCT00661544|Protective Agents|protective agents|mesh-ancestor
153356437|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153356438|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
153356442|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356443|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
153356444|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
153356445|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
153356446|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356447|NCT02999906|Treprostinil|treprostinil|mesh-list
153356449|NCT01238471|Propranolol|propranolol|mesh-list
153356450|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153356451|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153356452|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
153356453|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356454|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356455|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356456|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153356457|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153356458|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
153356460|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153356461|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356462|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153356463|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153356464|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356465|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153356466|NCT00664430|Vitamins|vitamins|mesh-ancestor
153356467|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
153356494|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356495|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153356496|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153356497|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153356540|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153356541|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
153356542|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356543|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356545|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153356546|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
153356547|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356548|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356549|NCT01511042|Norepinephrine|norepinephrine|mesh-list
153356550|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
153356552|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
153356553|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153356672|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153356673|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
153356674|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
153356675|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153356676|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153356677|NCT01294319|Dexamethasone|dexamethasone|mesh-list
153356678|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
153356679|NCT01294319|Spironolactone|spironolactone|mesh-list
153356680|NCT01294319|Mifepristone|mifepristone|mesh-list
153356681|NCT01294319|BB 1101|bb 1101|mesh-list
153356682|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356683|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
153356684|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
153356685|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356686|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356687|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153356688|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
153356689|NCT01294319|Hormones|hormones|mesh-ancestor
153356690|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153356691|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153356692|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356701|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153356702|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
153356703|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153356704|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153356705|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153356706|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153356707|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
153356708|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153356709|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153356710|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
153356741|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153356742|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153356744|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153356745|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153356746|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356747|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356748|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356749|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153356750|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
153356751|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356752|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356993|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358015|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358016|NCT03809156|Ambrisentan|ambrisentan|mesh-list
153358017|NCT03809156|Riociguat|riociguat|mesh-list
153359500|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153359501|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
153359502|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359503|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359504|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359625|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
153359627|NCT04580771|Vaccines|vaccines|mesh-list
153359628|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
153359629|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359630|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359631|NCT04527991|Paclitaxel|paclitaxel|mesh-list
153359632|NCT04527991|Docetaxel|docetaxel|mesh-list
153359633|NCT04527991|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153359634|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153359635|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359636|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
153365469|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
153366655|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
153381335|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153381336|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153813524|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381338|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153381339|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
153381340|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153382559|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382560|NCT03534635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153382561|NCT03534635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382562|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
153382563|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
153382564|NCT01999985|Dasatinib|dasatinib|mesh-list
153382565|NCT01999985|Afatinib|afatinib|mesh-list
153382566|NCT01999985|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153383653|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
153383654|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383655|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
153383656|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383657|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153383658|NCT01767506|Azithromycin|azithromycin|mesh-list
153383659|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153383660|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383661|NCT02383043|Cocaine|cocaine|mesh-list
153383662|NCT02383043|Amphetamine|amphetamine|mesh-list
153383663|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
153384445|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
153384447|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384449|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
153384450|NCT03357393|Scopolamine|scopolamine|mesh-list
153384451|NCT03357393|Morphine|morphine|mesh-list
153384452|NCT03357393|Propofol|propofol|mesh-list
153385998|NCT01880840|Azelastine|azelastine|mesh-list
153385999|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153386000|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
153386001|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386002|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386003|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153386004|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386005|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153386006|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387722|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153386393|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
153386394|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153386395|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153386603|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386604|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153386605|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153387029|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153387288|NCT03312530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387290|NCT05697965|Vancomycin|vancomycin|mesh-list
153387293|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
153387294|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153387295|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387296|NCT00183963|Tamoxifen|tamoxifen|mesh-list
153387297|NCT00183963|Fulvestrant|fulvestrant|mesh-list
153387298|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153387299|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
153387300|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387301|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469318|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153469319|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153469321|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
153469588|NCT04777201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153469589|NCT04777201|Growth Substances|growth substances|mesh-ancestor
153469590|NCT04777201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469591|NCT04777201|Growth Inhibitors|growth inhibitors|mesh-ancestor
153469592|NCT04777201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469621|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469622|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469623|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153469624|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469625|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469626|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469629|NCT04702893|Nintedanib|nintedanib|mesh-list
153469630|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469631|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469632|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469645|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469646|NCT04659811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153438447|NCT00004748|Methotrexate|methotrexate|mesh-list
153813763|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813764|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813765|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
153360171|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153469754|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153469755|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
153469756|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470196|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470197|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470198|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470199|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153470200|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
153470201|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
153470202|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153470243|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
153470244|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783839|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470245|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470246|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153470247|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
153470248|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470324|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153470325|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470326|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153470327|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153470328|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153470329|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
153470330|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470331|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470332|NCT02749799|Betamethasone|betamethasone|mesh-list
153470333|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
153470645|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470697|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
153470773|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153470774|NCT00605202|Diuretics|diuretics|mesh-ancestor
153470782|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153470783|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
153470784|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
153470785|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470911|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470913|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153470914|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153470915|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470916|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
153470917|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
153470918|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
153470919|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470920|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
153470921|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
153470922|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153470924|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153470925|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153470926|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
153470929|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813774|NCT00335192|Abacavir|abacavir|mesh-list
153813775|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
153813776|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470968|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153470969|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153471016|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
153471101|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
153471102|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153783840|NCT00262275|Aspirin|aspirin|mesh-list
153783841|NCT00262275|Clopidogrel|clopidogrel|mesh-list
153783842|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153471103|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153360176|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471104|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153471421|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471689|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153471690|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471692|NCT03775460|Hormones|hormones|mesh-ancestor
153471693|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471694|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153471695|NCT03439033|Edetic Acid|edetic acid|mesh-list
153471696|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
153471697|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
153471742|NCT02894398|Fulvestrant|fulvestrant|mesh-list
153471904|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471905|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153471906|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153471907|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153471943|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153471944|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153471945|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471946|NCT00651456|Bevacizumab|bevacizumab|mesh-list
153471947|NCT00651456|Cisplatin|cisplatin|mesh-list
153471948|NCT00651456|Pemetrexed|pemetrexed|mesh-list
153471949|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471950|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471951|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153471952|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153472224|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472225|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153472278|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153472279|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472280|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
153472281|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472282|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472292|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472328|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153472360|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472361|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472362|NCT04358562|Gefitinib|gefitinib|mesh-list
153472363|NCT04358562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153472364|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153472365|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472366|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472367|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472368|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153472369|NCT04358016|Terlipressin|terlipressin|mesh-list
153472370|NCT04358016|Somatostatin|somatostatin|mesh-list
153472371|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153472372|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153472373|NCT04358016|Hormones|hormones|mesh-ancestor
153472374|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472375|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472376|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153472377|NCT04357392|Prednisone|prednisone|mesh-list
153472378|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472379|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472380|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
153472381|NCT04357392|Hormones|hormones|mesh-ancestor
153472382|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472430|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472431|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
153472457|NCT04354662|Fluorouracil|fluorouracil|mesh-list
153472458|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
153472459|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472460|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
153472461|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
153472462|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
153472463|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472464|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
153379569|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
153472465|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153472466|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153472467|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
153472468|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472470|NCT04354662|Protective Agents|protective agents|mesh-ancestor
153472471|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
153472472|NCT04354662|Vitamins|vitamins|mesh-ancestor
153472473|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
153472474|NCT04354350|Telmisartan|telmisartan|mesh-list
153472475|NCT04354350|Ramipril|ramipril|mesh-list
153472476|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153472477|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153472478|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153472479|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472480|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153472481|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472482|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472511|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472512|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472513|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472514|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472516|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439091|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
153472525|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
153472526|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
153472527|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
153472528|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472529|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472530|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472531|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153472532|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153472533|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472534|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153472535|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153472536|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
153472537|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153472538|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472539|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153472540|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153472541|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
153472542|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
153472543|NCT04350684|Interferons|interferons|mesh-list
153472544|NCT04350684|Ritonavir|ritonavir|mesh-list
153472545|NCT04350684|Lopinavir|lopinavir|mesh-list
153472546|NCT04350684|Interferon-beta|interferon-beta|mesh-list
153472547|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
153472600|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
153472601|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153472602|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153472603|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472604|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472605|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
153472606|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472607|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472608|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472609|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472610|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472611|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472612|NCT04345458|Etanercept|etanercept|mesh-list
153604217|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153604223|NCT01916707|Enoxaparin|enoxaparin|mesh-list
153604268|NCT01916915|Narcotics|narcotics|mesh-ancestor
153604269|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472613|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153472657|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472658|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472659|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472660|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
153472661|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472662|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153472663|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153472665|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
153472666|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813527|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
153359968|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472667|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472668|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472670|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
153783844|NCT00262275|Analgesics|analgesics|mesh-ancestor
153783845|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
153472671|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
153472672|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
153472706|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153472707|NCT04340778|Dinoprostone|dinoprostone|mesh-list
153472708|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
153472709|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
153472710|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472711|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472712|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
153472713|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472714|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153472715|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153472716|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153472717|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153439242|NCT02283853|Interferons|interferons|mesh-list
153472773|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153472774|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
153472775|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472776|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472777|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153472778|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153472779|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153813792|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153813793|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153360187|NCT00802100|Perphenazine|perphenazine|mesh-list
153472780|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153472781|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
153472782|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472802|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472803|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472804|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153472805|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
153472806|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472807|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472809|NCT04335786|Valsartan|valsartan|mesh-list
153472810|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153472812|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153439384|NCT00003421|Bleomycin|bleomycin|mesh-list
153472849|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
153472873|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153472874|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
153472875|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
153472876|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472877|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472878|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
153472879|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153472880|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472881|NCT04332276|Protective Agents|protective agents|mesh-ancestor
153472882|NCT04332042|Tofacitinib|tofacitinib|mesh-list
153472903|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472904|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472906|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153472907|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153472908|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472909|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153472910|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153472911|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472912|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
153472914|NCT04330326|Cathartics|cathartics|mesh-ancestor
153472915|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472916|NCT04329858|Methamphetamine|methamphetamine|mesh-list
153472917|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153472918|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472919|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
153472920|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
153472921|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472922|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
153360188|NCT00802100|Simvastatin|simvastatin|mesh-list
153472975|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472976|NCT03035058|Vedolizumab|vedolizumab|mesh-list
153472977|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472978|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
153472979|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153472980|NCT03033654|Protective Agents|protective agents|mesh-ancestor
153472981|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472982|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
153472983|NCT03033732|Buprenorphine|buprenorphine|mesh-list
153472984|NCT03033732|Methadone|methadone|mesh-list
153472985|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153473007|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473009|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153473010|NCT03030690|Methamphetamine|methamphetamine|mesh-list
153473011|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153473012|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473013|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
153473014|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
153473015|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473016|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
153473017|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473018|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473019|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
153473020|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153473021|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153473022|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153473023|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153473024|NCT03030300|Metformin|metformin|mesh-list
153473025|NCT03030300|Pioglitazone|pioglitazone|mesh-list
153473026|NCT03030300|Insulin|insulin|mesh-list
153473040|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
153473041|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
153473042|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
153473043|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153473044|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153473045|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473046|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473047|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473048|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473049|NCT03019848|Curcumin|curcumin|mesh-list
153473050|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473051|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473052|NCT03019848|Analgesics|analgesics|mesh-ancestor
153473085|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153473086|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
153473087|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473088|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153473089|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153473090|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473091|NCT03017430|Ketorolac|ketorolac|mesh-list
153473092|NCT03017430|Phenazepam|phenazepam|mesh-list
153473093|NCT03017430|Clonidine|clonidine|mesh-list
153473094|NCT03017430|Pregabalin|pregabalin|mesh-list
153473095|NCT03017430|Metoclopramide|metoclopramide|mesh-list
153473096|NCT03017430|Loperamide|loperamide|mesh-list
153473097|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
153473098|NCT03017430|Analgesics|analgesics|mesh-ancestor
153473099|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
153473100|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473101|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439875|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473156|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473157|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473158|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153473159|NCT03016806|Protective Agents|protective agents|mesh-ancestor
153473161|NCT03016650|Ibuprofen|ibuprofen|mesh-list
153473162|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473163|NCT03016650|Analgesics|analgesics|mesh-ancestor
153473164|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
153473165|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473166|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473167|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
153473168|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473169|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473170|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473171|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153473172|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473173|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473174|NCT03016260|Adalimumab|adalimumab|mesh-list
153473198|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473206|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
153473207|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439982|NCT00003613|Carmustine|carmustine|mesh-list
153473256|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473257|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153473258|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153473259|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473260|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
153473261|NCT03008148|Temozolomide|temozolomide|mesh-list
153473262|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153473263|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
153473264|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473265|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473266|NCT03007992|Vinorelbine|vinorelbine|mesh-list
153473282|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153473283|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473284|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153473285|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153473286|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153473287|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
153473288|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473289|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153473290|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153473291|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473302|NCT03005496|Zinc|zinc|mesh-list
153440214|NCT00003661|Cyclosporins|cyclosporins|mesh-list
153473368|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473369|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473370|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473371|NCT03005184|Analgesics|analgesics|mesh-ancestor
153473411|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473412|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
153473413|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153473414|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153473415|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
153473416|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473417|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153473418|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
153473419|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473420|NCT03000660|Dexamethasone|dexamethasone|mesh-list
153473421|NCT03000660|Venetoclax|venetoclax|mesh-list
153473422|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473423|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
153473424|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
153473425|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473426|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473427|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153473435|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153473436|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473437|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153473438|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153473439|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473440|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473441|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
153473442|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
153473443|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
153473444|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153473465|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
153473466|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153473468|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153604270|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604271|NCT01916915|Analgesics|analgesics|mesh-ancestor
153604272|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
153604273|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604274|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
153604275|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
153440347|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473469|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
153473470|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473471|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473472|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153473473|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153473474|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
153473475|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473476|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473477|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153473478|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153473479|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153473480|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153473481|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473482|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473483|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473484|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
153473487|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153473488|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473489|NCT02987400|Venetoclax|venetoclax|mesh-list
153473490|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
153473491|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473492|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153473493|NCT02987244|Prednisone|prednisone|mesh-list
153473494|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
153440803|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
153473576|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
153473578|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
153473579|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473580|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153473581|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153473582|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473583|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
153473584|NCT02976246|Coagulants|coagulants|mesh-ancestor
153473585|NCT02976012|Aflibercept|aflibercept|mesh-list
153473599|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473600|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473601|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473602|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153473603|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153473604|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473605|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153473606|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153473607|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473608|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
153473609|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153473610|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153473611|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153473612|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
153473613|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473614|NCT02974920|Aspirin|aspirin|mesh-list
153473615|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
153473643|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473644|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153473645|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
153473646|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473647|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473648|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153473649|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153473650|NCT02959476|Ropivacaine|ropivacaine|mesh-list
153473654|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473655|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
153473656|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473658|NCT02958852|Fulvestrant|fulvestrant|mesh-list
153473659|NCT02958852|Atorvastatin|atorvastatin|mesh-list
153473660|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153473661|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153473662|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
153473663|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473664|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153473665|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153473666|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473690|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
153473691|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
153473693|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153473694|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
153473695|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473714|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153473715|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153473716|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
153473718|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153473730|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604276|NCT01916954|Lumefantrine|lumefantrine|mesh-list
153604277|NCT01916954|Artemether|artemether|mesh-list
153604278|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153604279|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
153604280|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153604333|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
153604334|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604335|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604336|NCT01917149|Metoprolol|metoprolol|mesh-list
153604337|NCT01917149|Valsartan|valsartan|mesh-list
153604338|NCT01917149|Benazepril|benazepril|mesh-list
153604339|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153604340|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153604341|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153604342|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604343|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153604344|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
153604396|NCT01917448|Narcotics|narcotics|mesh-ancestor
153604397|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604398|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473731|NCT04769076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153473732|NCT04768764|Bupivacaine|bupivacaine|mesh-list
153473733|NCT04768764|Anesthetics|anesthetics|mesh-list
153473734|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
153473735|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473736|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473737|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
153473738|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473739|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
153473740|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153473741|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473742|NCT04748562|Progesterone|progesterone|mesh-list
153473743|NCT04748562|Progestins|progestins|mesh-ancestor
153473745|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473746|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473747|NCT04745286|Ketamine|ketamine|mesh-list
153473748|NCT04745286|Esketamine|esketamine|mesh-list
153813532|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473749|NCT04745286|Analgesics|analgesics|mesh-ancestor
153473750|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
153473751|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473752|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473753|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153473754|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153473755|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
153473756|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
153473757|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473758|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153473759|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153473872|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
153473873|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473874|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813804|NCT00335270|Calcium|calcium|mesh-list
153473875|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153473876|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473879|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153473880|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473882|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
153473883|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473884|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473910|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473911|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473912|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153473913|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153473914|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473915|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473916|NCT00582894|Fludarabine|fludarabine|mesh-list
153473917|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
153473918|NCT00582894|Busulfan|busulfan|mesh-list
153473919|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473951|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473952|NCT03708354|Protective Agents|protective agents|mesh-ancestor
153473953|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473955|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
153473956|NCT03297684|Aflibercept|aflibercept|mesh-list
153473957|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153473958|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153441873|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473975|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473976|NCT01327638|Etoricoxib|etoricoxib|mesh-list
153473977|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
153473978|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473979|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473980|NCT01327638|Analgesics|analgesics|mesh-ancestor
153474026|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474027|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474028|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153474029|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153474049|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
153474050|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153474051|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
153474052|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474053|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474054|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153474055|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153474056|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474058|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474137|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
153474138|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
153474139|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153474140|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
153474141|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
153474142|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474143|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474144|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
153474145|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153474146|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
153474147|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
153474148|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153474149|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153474150|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153474151|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
153474152|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474153|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474171|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474172|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474173|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474174|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
153474175|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474176|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153474177|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
153474178|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153474179|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153474180|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153474181|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474182|NCT00626340|Hormones|hormones|mesh-ancestor
153474183|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474184|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
153474185|NCT00626574|Hematinics|hematinics|mesh-ancestor
153474186|NCT00626886|Bupivacaine|bupivacaine|mesh-list
153474187|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
153474188|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
153442164|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153474203|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
153474204|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153474205|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153474206|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
153474207|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474208|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474209|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153474210|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153474211|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
153474212|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474213|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153474214|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153474215|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153474216|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153474217|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153474218|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153474219|NCT00635232|Irbesartan|irbesartan|mesh-list
153474220|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153474221|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153474238|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153474239|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153474240|NCT00638820|Busulfan|busulfan|mesh-list
153474241|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
153474242|NCT00638820|Clofarabine|clofarabine|mesh-list
153474243|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
153474244|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474245|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153474246|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
153474278|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153474279|NCT00645450|Propranolol|propranolol|mesh-list
153474280|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153474281|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153474282|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
153474283|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474284|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474285|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474286|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153474287|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153474288|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
153474289|NCT00647400|Adalimumab|adalimumab|mesh-list
153474290|NCT00647400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153474308|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474309|NCT00661674|Palonosetron|palonosetron|mesh-list
153474310|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
153474311|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
153474317|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153474318|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
153474319|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474320|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474321|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
153474322|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
153474323|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153474324|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
153474325|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
153474326|NCT00662298|Prednisolone|prednisolone|mesh-list
153474327|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474328|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
153474329|NCT00662298|Hormones|hormones|mesh-ancestor
153474331|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474343|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474344|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153474345|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474346|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153474347|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153379955|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
153474348|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
153474349|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153474350|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153474351|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153474352|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153474354|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153474355|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
153474356|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153474376|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153474377|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474378|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153474379|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474388|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
153474389|NCT00671970|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153474390|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153474391|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474392|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474393|NCT00672204|Sirolimus|sirolimus|mesh-list
153474394|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
153474435|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474436|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474437|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153474438|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474439|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474440|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
153474441|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474442|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153474443|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
153474444|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
153474445|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153474446|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
153474492|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
153474493|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153474494|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153474495|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
153474496|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
153474497|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474498|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474499|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153474500|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
153474504|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
153474549|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474550|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474568|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153474569|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
153474570|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153474571|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153813535|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
153359971|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
153359972|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359973|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
153359974|NCT02180724|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153813551|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153813552|NCT00438087|Protective Agents|protective agents|mesh-ancestor
153813553|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153813554|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813555|NCT00334412|Caspofungin|caspofungin|mesh-list
153813556|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153813557|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
153813558|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474572|NCT00700440|Cetuximab|cetuximab|mesh-list
153474573|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474574|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474575|NCT00701376|Liver Extracts|liver extracts|mesh-list
153474576|NCT00701376|Hematinics|hematinics|mesh-ancestor
153474577|NCT00702780|Escitalopram|escitalopram|mesh-list
153474578|NCT00702780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153474579|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153474580|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474581|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474582|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474583|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
153474584|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474585|NCT00704028|Dextrans|dextrans|mesh-list
153474586|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
153474638|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153474639|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153474640|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
153474641|NCT00711828|Dexamethasone|dexamethasone|mesh-list
153474642|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
153474643|NCT00711828|Rituximab|rituximab|mesh-list
153474644|NCT00711828|Bortezomib|bortezomib|mesh-list
153474645|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813806|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474669|NCT00715884|MTOR Inhibitors|mtor inhibitors|mesh-list
153474670|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153474671|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604399|NCT01917448|Analgesics|analgesics|mesh-ancestor
153604400|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
153604401|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604402|NCT01917578|Paclitaxel|paclitaxel|mesh-list
153604403|NCT01917578|Docetaxel|docetaxel|mesh-list
153604404|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153604405|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
153604406|NCT01917578|Carboplatin|carboplatin|mesh-list
153604407|NCT01917578|Doxorubicin|doxorubicin|mesh-list
153604408|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153474672|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153474673|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474703|NCT00717054|Aprepitant|aprepitant|mesh-list
153474704|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153474705|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
153474706|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
153474707|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474708|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474709|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153474710|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153474711|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474712|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474713|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153474714|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
153474715|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153474717|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153474719|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
153813559|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813560|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783849|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153474772|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153474776|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153444468|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153474966|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153474967|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153475017|NCT00755040|Cyclosporins|cyclosporins|mesh-list
153475018|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475019|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475020|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475021|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
153475022|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475023|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
153475038|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153475039|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153475040|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153475041|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153475043|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
153475044|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475045|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475046|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153475047|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475048|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
153475049|NCT00759330|Analgesics|analgesics|mesh-ancestor
153475050|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
153475051|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475052|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475053|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153475054|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153475055|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153475056|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475057|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153475058|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475060|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
153475093|NCT00761202|Protective Agents|protective agents|mesh-ancestor
153475094|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153475095|NCT00761202|Laxatives|laxatives|mesh-ancestor
153475096|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153475097|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
153475098|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153475099|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153475100|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153475101|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153475102|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475103|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
153475104|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475105|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475106|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153475144|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475145|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153475147|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153475148|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153475149|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153475150|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
153475151|NCT00766116|Azacitidine|azacitidine|mesh-list
153445332|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153813811|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475293|NCT00789672|Carbidopa|carbidopa|mesh-list
153475294|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153475295|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153475296|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
153475297|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475298|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475299|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475300|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153475336|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153475337|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153380119|NCT02249078|Quetmolimab|quetmolimab|mesh-list
153475338|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153475339|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
153475340|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153475341|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153475423|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
153475424|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
153475473|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
153475530|NCT00806598|Hormones|hormones|mesh-ancestor
153475531|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475532|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153475533|NCT00806598|Protective Agents|protective agents|mesh-ancestor
153475534|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153475535|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475536|NCT00807768|Paclitaxel|paclitaxel|mesh-list
153475537|NCT00807768|Carboplatin|carboplatin|mesh-list
153475799|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153475800|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
153475801|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153475804|NCT00834210|Tazarotene|tazarotene|mesh-list
153475805|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475806|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
153475807|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153475808|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153476063|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
153476064|NCT00886236|Gabapentin|gabapentin|mesh-list
153476065|NCT00886236|Analgesics|analgesics|mesh-ancestor
153476066|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
153476428|NCT00931242|Thalidomide|thalidomide|mesh-list
153476429|NCT00931242|Apremilast|apremilast|mesh-list
153476675|NCT00976248|Everolimus|everolimus|mesh-list
153476676|NCT00976248|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153476793|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153476828|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476842|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476843|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
153476844|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
153476845|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
153477178|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153477179|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153477180|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
153477181|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446147|NCT00001997|Analgesics|analgesics|mesh-ancestor
153604409|NCT01917578|Fluorouracil|fluorouracil|mesh-list
153604410|NCT01917578|Trastuzumab|trastuzumab|mesh-list
153604411|NCT01917578|Epirubicin|epirubicin|mesh-list
153604412|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153604413|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604414|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
153477182|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477183|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153477184|NCT01043640|Cyclosporine|cyclosporine|mesh-list
153477185|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
153477186|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
153477187|NCT01043640|Busulfan|busulfan|mesh-list
153477188|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
153477189|NCT01043640|Cyclosporins|cyclosporins|mesh-list
153477190|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153477191|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
153477192|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477193|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477194|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153477195|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
153477472|NCT03695471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153477473|NCT03695471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477537|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477538|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153477539|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477540|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477541|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153477542|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153477543|NCT05498116|Montelukast|montelukast|mesh-list
153477544|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153477545|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
153477546|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153477558|NCT05398484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153477559|NCT05398484|Antimetabolites|antimetabolites|mesh-ancestor
153477560|NCT05398484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477593|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
153477594|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477596|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
153477597|NCT05270863|Protective Agents|protective agents|mesh-ancestor
153477598|NCT05237141|Etonogestrel|etonogestrel|mesh-list
153477603|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153477604|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
153477748|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477750|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153477751|NCT04682041|Antibodies|antibodies|mesh-list
153477752|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
153477753|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477754|NCT04652661|Midazolam|midazolam|mesh-list
153477755|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
153477756|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153477757|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477758|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477759|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477760|NCT04652661|Analgesics|analgesics|mesh-ancestor
153477761|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
153477762|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477763|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153477764|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153477765|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153477766|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
153477767|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477768|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477769|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153477770|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153477771|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153477877|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
153477878|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477879|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153477880|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153477883|NCT03636451|Lidocaine|lidocaine|mesh-list
153477892|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153477893|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153477894|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153477895|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477943|NCT02474368|Cisplatin|cisplatin|mesh-list
153813827|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477944|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477945|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
153477946|NCT01995344|Fludarabine|fludarabine|mesh-list
153477947|NCT01995344|Interleukin-2|interleukin-2|mesh-list
153477948|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153477949|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
153477950|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477951|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477952|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153477953|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
153477954|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477955|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477956|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153477957|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477958|NCT01995344|Analgesics|analgesics|mesh-ancestor
153477977|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
153477978|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478191|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153478192|NCT01098318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153478193|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153604443|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604444|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604445|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
153604446|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604447|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153604506|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604507|NCT01918124|Paclitaxel|paclitaxel|mesh-list
153604508|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
153604509|NCT01918124|Cisplatin|cisplatin|mesh-list
153604510|NCT01918124|Carboplatin|carboplatin|mesh-list
153604511|NCT01918124|Doxorubicin|doxorubicin|mesh-list
153604512|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153604513|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478194|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153478195|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478196|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478197|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
153478198|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478200|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478201|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153478202|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
153813830|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813831|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478203|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478204|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478205|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153478206|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
153478207|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
153478208|NCT01100112|Hormones|hormones|mesh-ancestor
153478209|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478210|NCT01100268|Methylphenidate|methylphenidate|mesh-list
153478211|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153478212|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478213|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153478214|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153478215|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153604514|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
153604515|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
153604516|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
153604517|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604518|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604519|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
153604520|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604521|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153604522|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153604523|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
153604524|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153604525|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153604526|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153604527|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153604528|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604530|NCT01918150|Chromium|chromium|mesh-list
153604531|NCT01918150|Trace Elements|trace elements|mesh-ancestor
153604558|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153604559|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153478216|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478231|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478233|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153478234|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
153478235|NCT01103934|Vitamin D|vitamin d|mesh-list
153478315|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153478316|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153478317|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
153732012|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153478318|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478319|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153478320|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153478321|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478322|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153478323|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478324|NCT01112670|Incretins|incretins|mesh-ancestor
153478325|NCT01112670|Hormones|hormones|mesh-ancestor
153478326|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478327|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153478328|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
153478561|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478563|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153478564|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153478876|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478877|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478878|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153478879|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
153478880|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153478881|NCT01207908|Mecasermin|mecasermin|mesh-list
153478882|NCT01207908|Growth Substances|growth substances|mesh-ancestor
153478883|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604560|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
153604561|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604562|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153604563|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153604623|NCT01918813|Vancomycin|vancomycin|mesh-list
153604624|NCT01918813|Mupirocin|mupirocin|mesh-list
153604625|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153478886|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
153478887|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153478888|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478889|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153479060|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479063|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153479076|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479176|NCT01254396|Urological Agents|urological agents|mesh-ancestor
153479177|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153479178|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
153479179|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
153479180|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479686|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153479687|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
153479688|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479689|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479690|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153479691|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153479692|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153479693|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
153479704|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153604626|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604627|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153604628|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153604638|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
153604639|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153604640|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
153604679|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153604680|NCT01918917|Narcotics|narcotics|mesh-ancestor
153604681|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
153604682|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
153604683|NCT01918995|Regadenoson|regadenoson|mesh-list
153604684|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153604685|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153604686|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
153604687|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
153604688|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604689|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604747|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
153604748|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604749|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604750|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153604751|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153479706|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153479708|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153479709|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
153479710|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153479711|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153479712|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
153479713|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479714|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
153479715|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153479716|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153479717|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
153479718|NCT01333488|Analgesics|analgesics|mesh-ancestor
153479719|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
153479720|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479721|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479722|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
153479723|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479724|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153479725|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
153380270|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479726|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153479727|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153480424|NCT05658874|Urological Agents|urological agents|mesh-ancestor
153480425|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153604752|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
153604753|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153604754|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153604755|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
153604758|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
153604812|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153604813|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153604814|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153604815|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153604816|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153604817|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
153604819|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
153604880|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604881|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604882|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
153604883|NCT01921374|Protective Agents|protective agents|mesh-ancestor
153604884|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153604885|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153604886|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
153450620|NCT05727098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480427|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480428|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153480429|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153480430|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153480431|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
153480432|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
153480433|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153480434|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153480435|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
153480436|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153480437|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480438|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153480439|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
153480441|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153480443|NCT05631899|Antibodies|antibodies|mesh-list
153480444|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
153480445|NCT05631899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153480446|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
153480447|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153480448|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
153480449|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480856|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
153480857|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
153480858|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480859|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480860|NCT04893109|Immunotoxins|immunotoxins|mesh-ancestor
153480861|NCT04893109|Immunoconjugates|immunoconjugates|mesh-ancestor
153481367|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153481442|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481443|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
153481444|NCT03457142|Hormones|hormones|mesh-ancestor
153481445|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481446|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153481447|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481448|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481449|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
153481450|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481451|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481452|NCT03457142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481453|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481454|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
153481455|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481456|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
153481457|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
153481575|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153481576|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481577|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153481580|NCT02817659|Hormones|hormones|mesh-ancestor
153481581|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481582|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481583|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
153481584|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481585|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
153481663|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481664|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481665|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
153481666|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481667|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481668|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153481669|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
153481670|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153481671|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153481672|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153481673|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153481674|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481675|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481677|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153481678|NCT01772472|Maytansine|maytansine|mesh-list
153482065|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153482066|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
153815065|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153451241|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153604887|NCT01921972|Memantine|memantine|mesh-list
153604888|NCT01921972|Galantamine|galantamine|mesh-list
153604889|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153604890|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153604904|NCT01923454|Acetazolamide|acetazolamide|mesh-list
153604942|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604943|NCT01925066|Vancomycin|vancomycin|mesh-list
153604944|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153604945|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153604946|NCT01927640|Cocaine|cocaine|mesh-list
153604947|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
153604948|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153604949|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153604950|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604951|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153604952|NCT01927640|Analgesics|analgesics|mesh-ancestor
153604953|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
153604998|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153604999|NCT01930019|Thiopental|thiopental|mesh-list
153605000|NCT01930019|Etomidate|etomidate|mesh-list
153605001|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
153605002|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605003|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605004|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153605005|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153605006|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
153605007|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
153605008|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
153451264|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153482067|NCT01391286|Bimatoprost|bimatoprost|mesh-list
153482068|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153482069|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153482070|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153482071|NCT01393392|Methadone|methadone|mesh-list
153482072|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153482073|NCT01393392|Narcotics|narcotics|mesh-ancestor
153482074|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482075|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482076|NCT01393392|Analgesics|analgesics|mesh-ancestor
153482077|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
153482078|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482079|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
153482080|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
153482081|NCT01393704|Vasopressins|vasopressins|mesh-list
153482082|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
153482083|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
153482084|NCT01393704|Coagulants|coagulants|mesh-ancestor
153482085|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153482086|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153482087|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
153482088|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482089|NCT01399008|Colchicine|colchicine|mesh-list
153482090|NCT01399008|Allopurinol|allopurinol|mesh-list
153482091|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
153482338|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
153482392|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153482562|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153482563|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153482564|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153482635|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482636|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
153482637|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153482683|NCT06114979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153482886|NCT05997732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153482887|NCT05997732|Vasodilator Agents|vasodilator agents|mesh-ancestor
153482888|NCT05997732|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153482890|NCT05997732|Autonomic Agents|autonomic agents|mesh-ancestor
153605009|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
153482892|NCT05997732|Sympathomimetics|sympathomimetics|mesh-ancestor
153482893|NCT05997732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153482894|NCT05997732|Nasal Decongestants|nasal decongestants|mesh-ancestor
153482895|NCT05997732|Respiratory System Agents|respiratory system agents|mesh-ancestor
153482896|NCT05997732|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153482897|NCT05997732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153482898|NCT05997732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153482921|NCT05918302|Edotreotide|edotreotide|mesh-list
153482922|NCT05918302|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
153482923|NCT05918302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153482924|NCT05918302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153482925|NCT05918302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482926|NCT05918302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482927|NCT05918302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153482928|NCT05918302|Immunologic Factors|immunologic factors|mesh-ancestor
153482929|NCT05918302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482930|NCT05918302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482931|NCT05918302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153482934|NCT05891548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153482935|NCT05891548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153482936|NCT05891548|Growth Substances|growth substances|mesh-ancestor
153482937|NCT05891548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482961|NCT05804708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153482962|NCT05804708|Serotonin Agents|serotonin agents|mesh-ancestor
153482963|NCT05804708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482964|NCT05804708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482965|NCT05804708|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153482970|NCT05724316|Vitamin D|vitamin d|mesh-list
153482971|NCT05724316|Cholecalciferol|cholecalciferol|mesh-list
153482972|NCT05724316|Vitamins|vitamins|mesh-ancestor
153605010|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819621|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819622|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819623|NCT00226395|Analgesics|analgesics|mesh-ancestor
153819624|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
153819625|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819626|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153819627|NCT00225797|Oxymorphone|oxymorphone|mesh-list
153461040|NCT03087942|Growth Substances|growth substances|mesh-ancestor
153819628|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153819629|NCT00225797|Narcotics|narcotics|mesh-ancestor
153482974|NCT05724316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483240|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483242|NCT04484623|Bortezomib|bortezomib|mesh-list
153483243|NCT04484623|Pomalidomide|pomalidomide|mesh-list
153483244|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153483245|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
153483246|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
153483247|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483248|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483249|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153483250|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
153483251|NCT04484623|Hormones|hormones|mesh-ancestor
153483252|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483351|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483352|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153483353|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153483354|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
153483355|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483356|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483357|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153483358|NCT03761056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483359|NCT03747120|Paclitaxel|paclitaxel|mesh-list
153483360|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
153483361|NCT03747120|Trastuzumab|trastuzumab|mesh-list
153483362|NCT03747120|Pertuzumab|pertuzumab|mesh-list
153483363|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153483364|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483365|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
153483366|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
153483367|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
153819630|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819631|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819632|NCT00225797|Analgesics|analgesics|mesh-ancestor
153819633|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
153819634|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819635|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153819636|NCT00147199|Treprostinil|treprostinil|mesh-list
153819637|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153819638|NCT00135668|Nitroprusside|nitroprusside|mesh-list
153819639|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153819640|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
153819641|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153483368|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483369|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483370|NCT03747120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153483371|NCT03586089|Diazepam|diazepam|mesh-list
153483372|NCT03586089|Phenobarbital|phenobarbital|mesh-list
153483660|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153483661|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153483662|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153483663|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153483664|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153483665|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153483666|NCT00653068|Antidotes|antidotes|mesh-ancestor
153483667|NCT00653068|Protective Agents|protective agents|mesh-ancestor
153483668|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
153483669|NCT00653068|Vitamins|vitamins|mesh-ancestor
153483670|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
153483671|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
153483672|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
153483673|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
153483674|NCT00653068|Hematinics|hematinics|mesh-ancestor
153483675|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
153483676|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
153483883|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483979|NCT01588158|Acetaminophen|acetaminophen|mesh-list
153483980|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153483981|NCT01588158|Hydrocodone|hydrocodone|mesh-list
153483982|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153483983|NCT01588158|Analgesics|analgesics|mesh-ancestor
153483984|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
153483985|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483986|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483987|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
153451934|NCT01908582|Evacetrapib|evacetrapib|mesh-list
153819642|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819644|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153819645|NCT00066703|Exemestane|exemestane|mesh-list
153819646|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153819647|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819648|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819649|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819650|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819651|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483989|NCT01588158|Narcotics|narcotics|mesh-ancestor
153483990|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483991|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
153483992|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
153484107|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153484108|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484109|NCT02407236|Ustekinumab|ustekinumab|mesh-list
153484110|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
153484111|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
153484112|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153484113|NCT05120076|Dexamethasone|dexamethasone|mesh-list
153484518|NCT01669434|Enalapril|enalapril|mesh-list
153484519|NCT01669434|Enalaprilat|enalaprilat|mesh-list
153484520|NCT01669434|Lisinopril|lisinopril|mesh-list
153813892|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484521|NCT01669434|Perindopril|perindopril|mesh-list
153484522|NCT01669434|Captopril|captopril|mesh-list
153484523|NCT01669434|Benazepril|benazepril|mesh-list
153484524|NCT01669434|Quinapril|quinapril|mesh-list
153484525|NCT01669434|Trandolapril|trandolapril|mesh-list
153484526|NCT01669434|Fosinopril|fosinopril|mesh-list
153484527|NCT01669434|Moexipril|moexipril|mesh-list
153484560|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
153484561|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153819652|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153819653|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153819654|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153461055|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
153461056|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
153461057|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
153461058|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
153605013|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605014|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605016|NCT01930292|Carboplatin|carboplatin|mesh-list
153605017|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153605018|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605019|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
153605023|NCT01930318|Parecoxib|parecoxib|mesh-list
153605078|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153605079|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153605080|NCT01930552|Growth Substances|growth substances|mesh-ancestor
153605081|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
153605082|NCT01930591|Clopidogrel|clopidogrel|mesh-list
153605083|NCT01930591|Ticagrelor|ticagrelor|mesh-list
153605084|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153605085|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153484564|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484565|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153484604|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484605|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
153484606|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484607|NCT01706952|Epinephrine|epinephrine|mesh-list
153484608|NCT01706952|Racepinephrine|racepinephrine|mesh-list
153484609|NCT01706952|Cocaine|cocaine|mesh-list
153484610|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153484611|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
153484612|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153484613|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153484614|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
153484998|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
153484999|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
153485297|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387798|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485516|NCT05972655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485517|NCT05972655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485518|NCT05971719|Glycerol|glycerol|mesh-list
153485519|NCT05971719|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153485520|NCT05971719|Protective Agents|protective agents|mesh-ancestor
153485549|NCT05877820|Lenvatinib|lenvatinib|mesh-list
153485550|NCT05877820|Tislelizumab|tislelizumab|mesh-list
153485551|NCT05877820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485611|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153485613|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153485802|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485804|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153485805|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485806|NCT05235737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153485807|NCT05235737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485808|NCT05175430|Paroxetine|paroxetine|mesh-list
153485809|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
153485810|NCT05175430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153485811|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153485812|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153485813|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485814|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485815|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
153485816|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485817|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153485818|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
153485819|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485820|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153485821|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153485822|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485823|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
153485824|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153485825|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153485826|NCT05133791|Annexin A5|annexin a5|mesh-list
153485827|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452539|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
153605086|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153605087|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153605088|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
153605089|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605090|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605091|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605092|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
153605093|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153605094|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153452733|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153485828|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485829|NCT05115513|Dronabinol|dronabinol|mesh-list
153485830|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
153485845|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153485846|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485847|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153485848|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
153485849|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485850|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
153485851|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485852|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153485855|NCT04921527|Chiauranib|chiauranib|mesh-list
153485856|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153485857|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485858|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
153485859|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
153485860|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
153485861|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485862|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485863|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485864|NCT04902378|Insulin|insulin|mesh-list
153485865|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153485866|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485867|NCT04898504|Floxuridine|floxuridine|mesh-list
153485868|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153485869|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
153485870|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485871|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485872|NCT04876079|Insulin|insulin|mesh-list
153485873|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153605095|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153605096|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605097|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605132|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605133|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605134|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605135|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
153605136|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153605137|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153605138|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153452789|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
153485874|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485875|NCT04811573|Thalidomide|thalidomide|mesh-list
153485876|NCT04811573|Apremilast|apremilast|mesh-list
153485877|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153813897|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485880|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
153485881|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485882|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485883|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153485884|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153485885|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153485886|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153485887|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485888|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485889|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153485900|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
153485901|NCT04774094|Avibactam|avibactam|mesh-list
153485902|NCT04774094|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153485903|NCT04774094|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153485904|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485905|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485906|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153485907|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485908|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485909|NCT04753437|Amoxicillin|amoxicillin|mesh-list
153485910|NCT04753437|Clarithromycin|clarithromycin|mesh-list
153485911|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
153485912|NCT04753437|Esomeprazole|esomeprazole|mesh-list
153485913|NCT04753437|Bismuth|bismuth|mesh-list
153485914|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485915|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485916|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485917|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153485918|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153485919|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153360004|NCT01853748|Immunoconjugates|immunoconjugates|mesh-ancestor
153605139|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153605140|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485920|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485921|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153485922|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153485923|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153485925|NCT04753437|Diuretics|diuretics|mesh-ancestor
153485926|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
153485927|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485928|NCT04753437|Expectorants|expectorants|mesh-ancestor
153485929|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
153485930|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
153485931|NCT04613557|Fludarabine|fludarabine|mesh-list
153485932|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
153485933|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153485934|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
153485935|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485936|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153485937|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153485938|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
153485939|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485940|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485941|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153485942|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153485943|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
153485944|NCT04605094|Benralizumab|benralizumab|mesh-list
153485945|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153485946|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
153485947|NCT04605081|Naltrexone|naltrexone|mesh-list
153485948|NCT04605081|Bupropion|bupropion|mesh-list
153485949|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153485950|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153485951|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485952|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
153485953|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485954|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153485955|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
153605141|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
153605142|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485962|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485963|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153813898|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153813899|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
153485965|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485966|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153485967|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153485968|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485969|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153485970|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153485971|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153485972|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485973|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
153485974|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485975|NCT04599478|Naltrexone|naltrexone|mesh-list
153485976|NCT04599478|Bupropion|bupropion|mesh-list
153485977|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153485978|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153485979|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485980|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
153485981|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485982|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153485983|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
153485984|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485985|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153485986|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153820840|NCT02957630|Estrogens|estrogens|mesh-ancestor
153452988|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
153605143|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605146|NCT01930812|Listerine|listerine|mesh-list
153605191|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153385070|NCT03666663|Lidocaine|lidocaine|mesh-list
153605193|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605194|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605195|NCT01931137|Insulin|insulin|mesh-list
153605196|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153605197|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605198|NCT01931189|Infliximab|infliximab|mesh-list
153605199|NCT01931189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153605200|NCT01931189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605201|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
153605204|NCT01931215|Clonidine|clonidine|mesh-list
153605257|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605258|NCT01931410|Misoprostol|misoprostol|mesh-list
153485987|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153485988|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485990|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485991|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153485992|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153485993|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485994|NCT04578639|Rituximab|rituximab|mesh-list
153485995|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
153485996|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153485997|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485998|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
153485999|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486000|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486001|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153486002|NCT04526210|Choline|choline|mesh-list
153486003|NCT04526210|Bupropion|bupropion|mesh-list
153486004|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153486005|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
153486006|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153486007|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153486008|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153486009|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153486010|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486011|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
153486012|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486013|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486014|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153486015|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153486016|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486017|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
153605330|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605331|NCT01931982|Incretins|incretins|mesh-ancestor
153605332|NCT01931982|Hormones|hormones|mesh-ancestor
153605333|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153605334|NCT01932151|Terlipressin|terlipressin|mesh-list
153605335|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153605336|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153605337|NCT01932177|Everolimus|everolimus|mesh-list
153605338|NCT01932177|Sorafenib|sorafenib|mesh-list
153605339|NCT01932177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153605340|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153486019|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
153486020|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153486021|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153486036|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820842|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
153820843|NCT00465036|Cathartics|cathartics|mesh-ancestor
153486037|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486038|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
153486039|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486040|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486041|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153486042|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153486043|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486044|NCT04377451|Metformin|metformin|mesh-list
153486045|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486047|NCT04329325|Dexamethasone|dexamethasone|mesh-list
153486048|NCT04329325|Methotrexate|methotrexate|mesh-list
153486050|NCT04329325|Blinatumomab|blinatumomab|mesh-list
153486051|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153486052|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
153486053|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
153486054|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486055|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486056|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153486057|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
153486058|NCT04329325|Hormones|hormones|mesh-ancestor
153486059|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486060|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153486061|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486062|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153486063|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
153486064|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153486065|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486066|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
153453094|NCT01809132|Prednisolone|prednisolone|mesh-list
153605341|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605342|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605343|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153605344|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
153605345|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486067|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486068|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
153486069|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486070|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153486071|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486072|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
153486073|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486074|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153486075|NCT04329325|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153486076|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153486077|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153486078|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
153486079|NCT04190056|Tamoxifen|tamoxifen|mesh-list
153486080|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
153486081|NCT04190056|Vorinostat|vorinostat|mesh-list
153486118|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153486119|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486121|NCT04076579|Trabectedin|trabectedin|mesh-list
153486180|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486181|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486182|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153486183|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153486184|NCT03694262|Growth Substances|growth substances|mesh-ancestor
153820853|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820854|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153360842|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360843|NCT01370369|Testosterone|testosterone|mesh-list
153360844|NCT01370369|Androgens|androgens|mesh-ancestor
153486185|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486186|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
153486187|NCT03694262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153486188|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486189|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153486190|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486191|NCT03639935|Nivolumab|nivolumab|mesh-list
153486192|NCT03639935|Rucaparib|rucaparib|mesh-list
153486193|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486194|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486195|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153486196|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486197|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153486198|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486199|NCT03624231|Durvalumab|durvalumab|mesh-list
153486200|NCT03624231|Tremelimumab|tremelimumab|mesh-list
153486201|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486202|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486203|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153486204|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153486205|NCT03564509|Hormones|hormones|mesh-ancestor
153605346|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605348|NCT01932203|Cilostazol|cilostazol|mesh-list
153605349|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153605350|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153605351|NCT01932203|Analgesics|analgesics|mesh-ancestor
153605352|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
153605353|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605354|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605355|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605356|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605357|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153605358|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153605364|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153605365|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
153605366|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153605367|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
153605368|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
153605369|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153605370|NCT01932203|Protective Agents|protective agents|mesh-ancestor
153486207|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486208|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153486209|NCT03556384|Temozolomide|temozolomide|mesh-list
153486210|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153486211|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
153486212|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486213|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486214|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
153486215|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153486216|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486217|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486218|NCT03240016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153486219|NCT03240016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486221|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153486222|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486239|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
153486240|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
153486241|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486242|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486243|NCT02830360|Amiodarone|amiodarone|mesh-list
153486244|NCT02830360|Sotalol|sotalol|mesh-list
153486245|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153820855|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153820856|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
153820857|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153820858|NCT00434486|Bosutinib|bosutinib|mesh-list
153461712|NCT05158062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153486246|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
153486247|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153380666|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605371|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153605372|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153605373|NCT01932229|Afatinib|afatinib|mesh-list
153605374|NCT01932229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153605375|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605376|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605377|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605378|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605379|NCT01932268|Rifampin|rifampin|mesh-list
153605380|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153605381|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
153605382|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153605416|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605417|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153605418|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
153605419|NCT01932372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153605420|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605421|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605422|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605423|NCT01932385|Sorafenib|sorafenib|mesh-list
153486248|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153486249|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486250|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153486251|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153486252|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153486253|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486254|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153486255|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153486256|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153486257|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153813900|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486258|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153486259|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
153486260|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486261|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486262|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
153486263|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
153486264|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486265|NCT02595060|Molgramostim|molgramostim|mesh-list
153486266|NCT02595060|Sargramostim|sargramostim|mesh-list
153486267|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486268|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
153486269|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486270|NCT02587065|Interferons|interferons|mesh-list
153486271|NCT02587065|Interferon-beta|interferon-beta|mesh-list
153486272|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
153486273|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486274|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
153486275|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486276|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
153486277|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486278|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153486279|NCT02492867|Paclitaxel|paclitaxel|mesh-list
153486307|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153486308|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
153453472|NCT01605396|Exemestane|exemestane|mesh-list
153605441|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605442|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153453580|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153486310|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486311|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820859|NCT00434486|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153820860|NCT00434486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153486313|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153486314|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486315|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153486316|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486317|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486318|NCT02120404|Esmolol|esmolol|mesh-list
153486319|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153486320|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153486321|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153486322|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
153486323|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486324|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486325|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486326|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
153486327|NCT02055456|Nandrolone|nandrolone|mesh-list
153486328|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
153486329|NCT02055456|Androgens|androgens|mesh-ancestor
153486338|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
153486339|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
153486340|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486341|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153486342|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153486343|NCT01995669|Growth Substances|growth substances|mesh-ancestor
153486344|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
153486345|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486346|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486348|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153486349|NCT01880567|Antibodies|antibodies|mesh-list
153486350|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
153486351|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153486352|NCT01880567|Ibrutinib|ibrutinib|mesh-list
153605443|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153605444|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
153605445|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
153605446|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605447|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605448|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153605449|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153453705|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
153486353|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
153486354|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486355|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486356|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486357|NCT01880567|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153486358|NCT01880567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153486359|NCT01880567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486360|NCT01880567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486361|NCT01750567|Metformin|metformin|mesh-list
153486362|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486363|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486364|NCT01740557|Aldesleukin|aldesleukin|mesh-list
153486365|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
153486366|NCT01740557|Fludarabine|fludarabine|mesh-list
153486367|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
153486368|NCT01740557|Interleukin-2|interleukin-2|mesh-list
153486376|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486377|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153486378|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486379|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
153486380|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153486381|NCT01740557|Analgesics|analgesics|mesh-ancestor
153486382|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
153486383|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486384|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153486385|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153486386|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
153486387|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486388|NCT01705977|Belimumab|belimumab|mesh-list
153486389|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486390|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
153486391|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486392|NCT01686711|Pioglitazone|pioglitazone|mesh-list
153486414|NCT01231906|Vincristine|vincristine|mesh-list
153486415|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
153486416|NCT01231906|Topotecan|topotecan|mesh-list
153486417|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
153486418|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
153486419|NCT01231906|Razoxane|razoxane|mesh-list
153486420|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
153486421|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486422|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
153486423|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486424|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486425|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153486426|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
153486427|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486428|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486429|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153486430|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153486431|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153486432|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153486433|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486434|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153486435|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486436|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
153486437|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
153486438|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153486439|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
153486440|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
153486441|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153486442|NCT01231906|Protective Agents|protective agents|mesh-ancestor
153486443|NCT00788164|Imiquimod|imiquimod|mesh-list
153486444|NCT00788164|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153605450|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153605451|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605453|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153605454|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153605455|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153605456|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153605457|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
153605458|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486450|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486451|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
153486453|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153486454|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
153486455|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813903|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
153813904|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486456|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486457|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153486458|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153486459|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
153486460|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486479|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153486480|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486481|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
153486482|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
153486484|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153486485|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153486486|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
153486487|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
153486488|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486489|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486490|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486491|NCT01820754|Paclitaxel|paclitaxel|mesh-list
153486492|NCT01820754|Carboplatin|carboplatin|mesh-list
153486493|NCT01820754|Ipilimumab|ipilimumab|mesh-list
153486495|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486510|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153486511|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
153360848|NCT01477463|Vitamin D|vitamin d|mesh-list
153360849|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
153360850|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
153486512|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486513|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486546|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486548|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
153486549|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486550|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
153486551|NCT01827930|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153486552|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153486553|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486554|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486555|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486556|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
153486557|NCT01828476|Navitoclax|navitoclax|mesh-list
153486583|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486584|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486585|NCT01835262|Ketamine|ketamine|mesh-list
153486586|NCT01835262|Morphine|morphine|mesh-list
153486587|NCT01835262|Analgesics|analgesics|mesh-ancestor
153486591|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153486592|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153486593|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
153486594|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
153486595|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153486596|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153486597|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153486598|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486599|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486600|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153732013|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
153486606|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486607|NCT01766076|Atorvastatin|atorvastatin|mesh-list
153486608|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153486618|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486619|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153486620|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153486621|NCT01767792|Growth Substances|growth substances|mesh-ancestor
153486622|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486623|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
153486624|NCT01797822|Dexamethasone|dexamethasone|mesh-list
153486625|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
153486626|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153486627|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
153486628|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
153486629|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486630|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486631|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153486632|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
153486633|NCT01797822|Hormones|hormones|mesh-ancestor
153486634|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486635|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153486636|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486637|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153486638|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153486639|NCT01809054|Aspirin|aspirin|mesh-list
153486640|NCT01809054|Fondaparinux|fondaparinux|mesh-list
153486641|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153454332|NCT01539642|Analgesics|analgesics|mesh-ancestor
153605459|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605460|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153820864|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153820865|NCT00465192|Estradiol|estradiol|mesh-list
153820866|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153360851|NCT01477463|Vitamins|vitamins|mesh-list
153360852|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
153605461|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153605462|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
153605463|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153605464|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153605465|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
153605467|NCT01932554|Fentanyl|fentanyl|mesh-list
153605468|NCT01932554|Morphine|morphine|mesh-list
153605469|NCT01932554|Hydromorphone|hydromorphone|mesh-list
153605470|NCT01932554|Narcotics|narcotics|mesh-list
153605471|NCT01932554|Abciximab|abciximab|mesh-list
153605472|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153605473|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605474|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461065|NCT03436056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461066|NCT03088176|Trametinib|trametinib|mesh-list
153461067|NCT03088176|Dabrafenib|dabrafenib|mesh-list
153461068|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153461069|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486643|NCT01809054|Analgesics|analgesics|mesh-ancestor
153486644|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
153486645|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486646|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486647|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153486648|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486649|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153486650|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153486651|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486652|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153486653|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153486654|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486655|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
153486656|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153486657|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
153486658|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153486659|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
153486660|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
153486661|NCT01833546|Gemcitabine|gemcitabine|mesh-list
153486662|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486663|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
153486664|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486665|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486666|NCT01842594|Sirolimus|sirolimus|mesh-list
153486667|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
153486699|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486700|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153486701|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153486702|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153486703|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486704|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
153486705|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153454475|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
153461070|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605537|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813578|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153813579|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153360008|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360009|NCT01757535|Azacitidine|azacitidine|mesh-list
153820869|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360854|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153820870|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360855|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153360856|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153605538|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
153605539|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
153605540|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
153605541|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813905|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486707|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153486708|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486709|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153486710|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153486711|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153732014|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
153486712|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153486713|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153486714|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153486715|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153486716|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153486718|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153486719|NCT01845636|Atropine|atropine|mesh-list
153486720|NCT01845636|Donepezil|donepezil|mesh-list
153486721|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153486722|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153486723|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153486724|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486725|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486726|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
153486727|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486760|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486761|NCT01848054|Analgesics|analgesics|mesh-ancestor
153486762|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
153486763|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486764|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153486765|NCT01849068|Ezetimibe|ezetimibe|mesh-list
153486766|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153486767|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153486768|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
153454517|NCT01534962|Ranolazine|ranolazine|mesh-list
153605543|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153605549|NCT01933347|Gefitinib|gefitinib|mesh-list
153605606|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605607|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
153605608|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605610|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605611|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605612|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486769|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486786|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153486787|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486788|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
153486789|NCT01850394|Coagulants|coagulants|mesh-ancestor
153486790|NCT01852344|Methylphenidate|methylphenidate|mesh-list
153486791|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153486792|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486793|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153486794|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153486795|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153486796|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486797|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
153486798|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486799|NCT01856712|Naltrexone|naltrexone|mesh-list
153486800|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153486801|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153486802|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486805|NCT01858428|Paclitaxel|paclitaxel|mesh-list
153486806|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153486807|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486808|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486809|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
153486810|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
153486811|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486812|NCT01861002|Cytarabine|cytarabine|mesh-list
153486813|NCT01861002|Methotrexate|methotrexate|mesh-list
153486814|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
153486815|NCT01861002|Azacitidine|azacitidine|mesh-list
153486816|NCT01861002|Fludarabine|fludarabine|mesh-list
153486817|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153486818|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
153486819|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153486820|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486822|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
153486825|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
153486826|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486837|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486838|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486839|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
153486840|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486841|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486842|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
153486843|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486844|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153486845|NCT01875510|SMOFlipid|smoflipid|mesh-list
153486846|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153486847|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153486848|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153486849|NCT01876212|Dasatinib|dasatinib|mesh-list
153486850|NCT01876212|Vaccines|vaccines|mesh-list
153454950|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486890|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
153486891|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486892|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153486919|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486920|NCT01643460|Ethanol|ethanol|mesh-list
153486921|NCT01643460|Paclitaxel|paclitaxel|mesh-list
153486922|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153486923|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153486924|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486925|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486926|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
153486927|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
153486928|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486929|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153486930|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486931|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813906|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153486932|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486933|NCT00954876|Capecitabine|capecitabine|mesh-list
153486934|NCT00954876|Cetuximab|cetuximab|mesh-list
153486935|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486936|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
153486937|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486938|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455083|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
153486964|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486965|NCT05215470|Nivolumab|nivolumab|mesh-list
153486966|NCT05215470|Ipilimumab|ipilimumab|mesh-list
153486967|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486968|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486969|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153486970|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486971|NCT05151588|Docetaxel|docetaxel|mesh-list
153486972|NCT05151588|Fluorouracil|fluorouracil|mesh-list
153486973|NCT05151588|Cisplatin|cisplatin|mesh-list
153486974|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486975|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486976|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
153486977|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
153486978|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486979|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
153486980|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486981|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486982|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
153486983|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486984|NCT04929834|Emollients|emollients|mesh-list
153486989|NCT04470804|MTOR Inhibitors|mtor inhibitors|mesh-list
153486990|NCT04470804|Cyclosporins|cyclosporins|mesh-list
153486991|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486992|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486993|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486994|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
153486995|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486996|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
153486997|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486998|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
153486999|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487000|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153487026|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813907|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153487027|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153487028|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153487029|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487030|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487031|NCT04360044|Hormones|hormones|mesh-ancestor
153487032|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487033|NCT04337814|Ibuprofen|ibuprofen|mesh-list
153487034|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153487035|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153487036|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153487037|NCT04337814|Analgesics|analgesics|mesh-ancestor
153487038|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
153487039|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487040|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487041|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487042|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487043|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153487044|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487045|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487046|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
153487047|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
153487048|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487049|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153487050|NCT04336332|Azithromycin|azithromycin|mesh-list
153487051|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
153487052|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153487053|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605613|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605675|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605676|NCT01934569|Losartan|losartan|mesh-list
153605677|NCT01934569|Midazolam|midazolam|mesh-list
153605678|NCT01934569|Caffeine|caffeine|mesh-list
153605679|NCT01934569|Omeprazole|omeprazole|mesh-list
153605680|NCT01934569|Pravastatin|pravastatin|mesh-list
153605681|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153605682|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153605683|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605693|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487054|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
153487055|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153487056|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153487057|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487058|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487059|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487060|NCT03064542|Carbimazole|carbimazole|mesh-list
153487061|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
153487062|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
153487063|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487064|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487065|NCT01430442|Sumatriptan|sumatriptan|mesh-list
153820882|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
153487066|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153487067|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153487078|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487079|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487145|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487146|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153487147|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
153487148|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487149|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487150|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153487151|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
153487152|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
153487153|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153487154|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153487155|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153487156|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153487157|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487158|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487159|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487160|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
153487161|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153487162|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
153487163|NCT01907334|Hormones|hormones|mesh-ancestor
153605694|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605733|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
153605734|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487221|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487223|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487224|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
153487225|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153487226|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153487227|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153487228|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487229|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487230|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487231|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487232|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
153487233|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153487234|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
153487235|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153487236|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153487237|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487238|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153487239|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487240|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153487241|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487242|NCT01929642|Sirolimus|sirolimus|mesh-list
153487243|NCT01929642|Everolimus|everolimus|mesh-list
153487244|NCT01929642|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153487245|NCT01929642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153487246|NCT01929642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487318|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153487320|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
153487321|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820883|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360865|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360866|NCT00857714|Lapatinib|lapatinib|mesh-list
153360867|NCT00857714|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153360868|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153360869|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487322|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487350|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
153487351|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153487352|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153487380|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487382|NCT05739786|Cholecalciferol|cholecalciferol|mesh-list
153487383|NCT05739786|Vitamins|vitamins|mesh-ancestor
153487384|NCT05739786|Micronutrients|micronutrients|mesh-ancestor
153487403|NCT05739630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153487404|NCT05739630|Antimetabolites|antimetabolites|mesh-ancestor
153487405|NCT05739630|Antiviral Agents|antiviral agents|mesh-ancestor
153487406|NCT05739630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487407|NCT05739630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153487408|NCT05739630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487409|NCT05739630|Analgesics|analgesics|mesh-ancestor
153487410|NCT05739630|Sensory System Agents|sensory system agents|mesh-ancestor
153487411|NCT05739630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487412|NCT05739630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153487413|NCT05739630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153487415|NCT05738616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487586|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487712|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487714|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153487715|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
153487716|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153487717|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153487718|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153487719|NCT01987752|Timolol|timolol|mesh-list
153487720|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153487771|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153487773|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487774|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487775|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605736|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605737|NCT01934777|Protective Agents|protective agents|mesh-ancestor
153605738|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
153605739|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153605740|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
153605741|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153605799|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
153605800|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487776|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487777|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153487778|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
153487779|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153487780|NCT01999920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153487781|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153487782|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153487783|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820884|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153820885|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820886|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
153820887|NCT00473070|Hormones|hormones|mesh-ancestor
153820888|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487784|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487785|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
153487948|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
153487949|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487951|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
153487952|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487953|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153487954|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
153487956|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487957|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153487958|NCT02044380|Afatinib|afatinib|mesh-list
153487959|NCT02044380|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153487960|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153487961|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487962|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487963|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487964|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
153487965|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153487966|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153487967|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
153487968|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487969|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487970|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605801|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153605802|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153605803|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153605804|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153605805|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488278|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153488279|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153488281|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153488282|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488283|NCT02181426|Analgesics|analgesics|mesh-ancestor
153488284|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
153813926|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488285|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488286|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488287|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153488288|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153488322|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153488324|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
153488325|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153488326|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153488327|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153488328|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
153488329|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488330|NCT02203578|Romidepsin|romidepsin|mesh-list
153488331|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153488332|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488333|NCT02203578|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153488334|NCT02203578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488335|NCT02203578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488336|NCT02206776|Midazolam|midazolam|mesh-list
153488337|NCT02206776|Ketamine|ketamine|mesh-list
153488338|NCT02206776|Analgesics|analgesics|mesh-ancestor
153488339|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
153488382|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153488383|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153488384|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
153488385|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488386|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153488387|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
153488388|NCT02218320|Dolutegravir|dolutegravir|mesh-list
153488389|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153488390|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153488391|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
153488392|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488393|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153488394|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153488395|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488396|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488398|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153488399|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153488400|NCT02222610|Growth Substances|growth substances|mesh-ancestor
153488401|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488507|NCT02251236|Elvitegravir|elvitegravir|mesh-list
153488517|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153488518|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153488520|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153488551|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488552|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153488553|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153488554|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153457262|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488661|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153488662|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488663|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488664|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153488665|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488666|NCT02284854|Analgesics|analgesics|mesh-ancestor
153488667|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
153488668|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488669|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488670|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488671|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488672|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153488673|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153488674|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488675|NCT02285634|Lidocaine|lidocaine|mesh-list
153488676|NCT02285634|Phenylephrine|phenylephrine|mesh-list
153488677|NCT02285634|Epinephrine|epinephrine|mesh-list
153488678|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
153488679|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488680|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
153488681|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488692|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488693|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488694|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153488695|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153488751|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
153488752|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
153488753|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153488754|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
153488786|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
153488787|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
153488788|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488789|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488791|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153488792|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488854|NCT02331108|Propofol|propofol|mesh-list
153813936|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153489003|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
153489021|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153489022|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
153489023|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489024|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489025|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153489026|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153489027|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153489028|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489029|NCT02401542|Docetaxel|docetaxel|mesh-list
153489030|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489031|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
153489032|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489033|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489034|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489035|NCT02411916|Misoprostol|misoprostol|mesh-list
153489036|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153489037|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
153489041|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153489042|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
153489058|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153489059|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
153489060|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153815068|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153381270|NCT05400993|Docetaxel|docetaxel|mesh-list
153605929|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605930|NCT01935648|Ropivacaine|ropivacaine|mesh-list
153605931|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
153605932|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
153605933|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605934|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333649|NCT00971789|Sirolimus|sirolimus|mesh-list
153605935|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
153605936|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605938|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153605939|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153605940|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153605979|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153605980|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153605981|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153605982|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153605983|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153606107|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153606108|NCT01936285|Colchicine|colchicine|mesh-list
153606109|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
153606110|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606111|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
153606112|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
153606113|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
153606114|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606115|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606116|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
153606117|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
153606118|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153606119|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153606120|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606169|NCT06070766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606171|NCT06070753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153606172|NCT06070753|Protective Agents|protective agents|mesh-ancestor
153606173|NCT06070753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606175|NCT06070740|Capecitabine|capecitabine|mesh-list
153606176|NCT06070740|Oxaliplatin|oxaliplatin|mesh-list
153606177|NCT06070740|Durvalumab|durvalumab|mesh-list
153606178|NCT06070740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153606179|NCT06070740|Antimetabolites|antimetabolites|mesh-ancestor
153606180|NCT06070740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606181|NCT06070740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606182|NCT06070740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606183|NCT06070636|Lenvatinib|lenvatinib|mesh-list
153606184|NCT06070636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606185|NCT06070636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153606186|NCT06070636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606188|NCT06070480|Propofol|propofol|mesh-list
153606189|NCT06070480|Desflurane|desflurane|mesh-list
153606226|NCT06066918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606227|NCT06066918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153606228|NCT06066866|Phenobarbital|phenobarbital|mesh-list
153606229|NCT06066866|Anticonvulsants|anticonvulsants|mesh-ancestor
153606230|NCT06066866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153606231|NCT06066866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153606232|NCT06066866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606233|NCT06066866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153820891|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153820892|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
153820893|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
153360872|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
153360873|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153606234|NCT06066866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153606235|NCT06066866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606291|NCT06037135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606292|NCT06037135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153606293|NCT06037135|Analgesics|analgesics|mesh-ancestor
153606294|NCT06037135|Sensory System Agents|sensory system agents|mesh-ancestor
153606295|NCT06037135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606296|NCT06037135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153606322|NCT05900401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606323|NCT05900401|Immunologic Factors|immunologic factors|mesh-ancestor
153606367|NCT05839119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606368|NCT05839119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153606369|NCT05839119|Antimetabolites|antimetabolites|mesh-ancestor
153606370|NCT05839119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606372|NCT05824767|Giapreza|giapreza|mesh-list
153606373|NCT05824767|Angiotensinogen|angiotensinogen|mesh-list
153606374|NCT05824767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153606375|NCT05824767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153606377|NCT05824767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606379|NCT05824351|Propolis|propolis|mesh-list
153606430|NCT05741502|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153606431|NCT05741502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153606432|NCT05741502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153606433|NCT05741502|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606434|NCT05741502|GABA Antagonists|gaba antagonists|mesh-ancestor
153606435|NCT05741502|GABA Agents|gaba agents|mesh-ancestor
153606436|NCT05706727|Phenylephrine|phenylephrine|mesh-list
153606437|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
153606438|NCT05706727|Mephentermine|mephentermine|mesh-list
153606439|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153606440|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
153606441|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
153606496|NCT05628038|Vitamins|vitamins|mesh-ancestor
153606497|NCT05628038|Micronutrients|micronutrients|mesh-ancestor
153606498|NCT05628038|Hematinics|hematinics|mesh-ancestor
153606499|NCT05628038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153606500|NCT05626829|Tranilast|tranilast|mesh-list
153606501|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153606502|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153606503|NCT05626829|Analgesics|analgesics|mesh-ancestor
153606504|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
153606505|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153606562|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
153606563|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606564|NCT05526924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606565|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
153606566|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606567|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153606568|NCT05526924|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153606627|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606629|NCT05355051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153387799|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153606630|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606631|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153606632|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
153606633|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606635|NCT05243641|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153606636|NCT05243641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153606637|NCT05243641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415256|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153820894|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606638|NCT05243641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606640|NCT05224336|Psilocybin|psilocybin|mesh-list
153606641|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153606642|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
153606643|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606644|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153606645|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
153606646|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
153606647|NCT05224336|Vitamins|vitamins|mesh-ancestor
153606672|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606673|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606674|NCT05109364|Urological Agents|urological agents|mesh-ancestor
153606675|NCT05097716|Tolbutamide|tolbutamide|mesh-list
153606676|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153606677|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606678|NCT05071703|Carboplatin|carboplatin|mesh-list
153606680|NCT05071703|Topotecan|topotecan|mesh-list
153606681|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606682|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153606734|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
153606735|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606736|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
153606737|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
153606738|NCT04836637|Calcium|calcium|mesh-list
153606739|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153606740|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606741|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153606742|NCT04836637|Antacids|antacids|mesh-ancestor
153606743|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606744|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153606745|NCT04828083|Lidocaine|lidocaine|mesh-list
153606746|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
153606747|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
153606792|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153606793|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153606794|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153606795|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153606796|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606797|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606798|NCT04781647|Interferons|interferons|mesh-list
153606799|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
153606800|NCT04781647|Entecavir|entecavir|mesh-list
153606801|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606860|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153606861|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153606862|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606885|NCT04594005|Paclitaxel|paclitaxel|mesh-list
153606920|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153606921|NCT04471987|Growth Substances|growth substances|mesh-ancestor
153606922|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
153606923|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606925|NCT04460352|Paclitaxel|paclitaxel|mesh-list
153606926|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153820897|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
153820898|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
153360875|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
153360876|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360877|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153360878|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153360879|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360880|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360881|NCT01376297|Dexamethasone|dexamethasone|mesh-list
153360882|NCT01376297|Aprepitant|aprepitant|mesh-list
153360883|NCT01376297|Palonosetron|palonosetron|mesh-list
153606927|NCT04460352|Carboplatin|carboplatin|mesh-list
153606928|NCT04460352|Fluorouracil|fluorouracil|mesh-list
153606929|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
153606930|NCT04460352|Calcium|calcium|mesh-list
153606932|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153606933|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606934|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
153606935|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
153606936|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
153606937|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606938|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153819658|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606951|NCT04419181|Trastuzumab|trastuzumab|mesh-list
153606953|NCT04419181|Maytansine|maytansine|mesh-list
153606954|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153606955|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606956|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
153606957|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
153606958|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
153606959|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606960|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153606961|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607013|NCT04265274|Disulfiram|disulfiram|mesh-list
153607014|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607015|NCT04265274|Trace Elements|trace elements|mesh-ancestor
153607016|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
153607017|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607018|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153607083|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153607084|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153607085|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153607086|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153607087|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607088|NCT04176419|Analgesics|analgesics|mesh-ancestor
153607089|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153607090|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153607091|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
153607092|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153607093|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153607218|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153607219|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607220|NCT03829319|Carboplatin|carboplatin|mesh-list
153607221|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
153607222|NCT03829319|Pemetrexed|pemetrexed|mesh-list
153607277|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607279|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
153607280|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607281|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607282|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607283|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
153820899|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820901|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
153360885|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
153360886|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
153360887|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607285|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607286|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153607287|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607288|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607341|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607342|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607343|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153607344|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607345|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
153607346|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
153607347|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607348|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607349|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
153607350|NCT03219359|Hormones|hormones|mesh-ancestor
153607351|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153607406|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607407|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607408|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
153607409|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607410|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607411|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607412|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607413|NCT02775435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607473|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607474|NCT01993810|Paclitaxel|paclitaxel|mesh-list
153607476|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
153607477|NCT01993810|Cisplatin|cisplatin|mesh-list
153607478|NCT01993810|Carboplatin|carboplatin|mesh-list
153607479|NCT01993810|Pemetrexed|pemetrexed|mesh-list
153607480|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153607481|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
153607482|NCT01993810|Durvalumab|durvalumab|mesh-list
153607483|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
153607484|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153607485|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
153607486|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153607487|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607488|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
153607489|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
153607490|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607491|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607492|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153607592|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
153607594|NCT01446133|Lenalidomide|lenalidomide|mesh-list
153607595|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607596|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607597|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
153607598|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607599|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607600|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153607601|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153607602|NCT01446133|Growth Substances|growth substances|mesh-ancestor
153607603|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
153607604|NCT01295645|Cidofovir|cidofovir|mesh-list
153607605|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
153607606|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607607|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607608|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607609|NCT01234025|Prednisone|prednisone|mesh-list
153607610|NCT01234025|Docetaxel|docetaxel|mesh-list
153820907|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820908|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153820910|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
153360888|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360889|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607611|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607612|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
153607646|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815071|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
153732015|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153607647|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153607649|NCT01177683|Doxorubicin|doxorubicin|mesh-list
153607651|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153607652|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153607712|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153607714|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607715|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607716|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
153607717|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607718|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153607719|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153607720|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
153607721|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153607722|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153607723|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153607724|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607725|NCT00116272|Etanercept|etanercept|mesh-list
153607726|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153607727|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153607728|NCT00116272|Analgesics|analgesics|mesh-ancestor
153607729|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
153607730|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607731|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607732|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153607737|NCT00080886|Cytarabine|cytarabine|mesh-list
153607765|NCT01936636|Analgesics|analgesics|mesh-ancestor
153607774|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153607829|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
153607830|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
153607831|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607832|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607833|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153607834|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153607835|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153607836|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
153607837|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153607838|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607839|NCT01937325|Ivacaftor|ivacaftor|mesh-list
153607840|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153607890|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153607891|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
153607893|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
153607894|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
153607895|NCT01937650|Metronidazole|metronidazole|mesh-list
153607896|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153607897|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153607898|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153607901|NCT01937728|Ribavirin|ribavirin|mesh-list
153607961|NCT01938092|Diazepam|diazepam|mesh-list
153607962|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153607963|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
153607964|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
153607965|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
153607966|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607967|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153607969|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153607970|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153607971|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153607972|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153820914|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153820915|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608027|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608028|NCT01938417|Tobramycin|tobramycin|mesh-list
153608029|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153608030|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608031|NCT01938443|Trametinib|trametinib|mesh-list
153608032|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608033|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153608034|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608035|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608036|NCT01938456|Docetaxel|docetaxel|mesh-list
153608037|NCT01938456|Trametinib|trametinib|mesh-list
153732016|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153381456|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
153608038|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608039|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
153608040|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
153608041|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
153608042|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608043|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153608044|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608046|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153608047|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608048|NCT01938612|Durvalumab|durvalumab|mesh-list
153608049|NCT01938612|Tremelimumab|tremelimumab|mesh-list
153608050|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608051|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608052|NCT01938729|Dexamethasone|dexamethasone|mesh-list
153608053|NCT01938729|Gemcitabine|gemcitabine|mesh-list
153608054|NCT01938729|Floxuridine|floxuridine|mesh-list
153608055|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153608090|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153608136|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608137|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608138|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153608139|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608140|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608141|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153608142|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
153608143|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
153608144|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
153608145|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
153608146|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608147|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153608148|NCT01939327|Rituximab|rituximab|mesh-list
153608149|NCT01939327|Lenalidomide|lenalidomide|mesh-list
153608150|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608151|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608152|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
153608153|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608154|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153608155|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153608156|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153608158|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
153608188|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
153608189|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608190|NCT01939444|Naloxone|naloxone|mesh-list
153608191|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153608192|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608193|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
153608194|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608195|NCT01939457|Misoprostol|misoprostol|mesh-list
153608196|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153608197|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
153781745|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153608249|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153608250|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
153608251|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608252|NCT01939639|Oxytocin|oxytocin|mesh-list
153608253|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
153608265|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153608266|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
153608267|NCT01939691|Hormones|hormones|mesh-ancestor
153608268|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360896|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153608269|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608270|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153608273|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
153608274|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608275|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153608276|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153608277|NCT01939691|Protective Agents|protective agents|mesh-ancestor
153608278|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153608279|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153608297|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153608298|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153608299|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153608300|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608301|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608302|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153608303|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153608304|NCT01939743|Analgesics|analgesics|mesh-ancestor
153608305|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153608363|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
153608364|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608365|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
153608366|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153608367|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153608368|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608369|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153608370|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153608428|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608430|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
153608431|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153608432|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153608433|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608434|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
153608435|NCT01940692|Coagulants|coagulants|mesh-ancestor
153608436|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
153608437|NCT01940718|Testosterone|testosterone|mesh-list
153608438|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
153608439|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
153608440|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153608441|NCT01940718|Androgens|androgens|mesh-ancestor
153608442|NCT01940718|Hormones|hormones|mesh-ancestor
153608443|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153608444|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608445|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153608446|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608447|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
153608448|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153608455|NCT01940952|Donepezil|donepezil|mesh-list
153608481|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153608482|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153608566|NCT01941407|Bevacizumab|bevacizumab|mesh-list
153608567|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153608568|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608569|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153608570|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153608571|NCT01941407|Growth Substances|growth substances|mesh-ancestor
153608572|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608573|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
153781746|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
153608574|NCT01941524|Poractant alfa|poractant alfa|mesh-list
153608575|NCT01941524|Beractant|beractant|mesh-list
153608577|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
153608581|NCT01941602|Enoxaparin|enoxaparin|mesh-list
153608588|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153608590|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608591|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608592|NCT01941732|Urological Agents|urological agents|mesh-ancestor
153608593|NCT01941758|Vaccines|vaccines|mesh-list
153608594|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
153608656|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153608721|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153608722|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153608723|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608724|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
153608725|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153608726|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153608727|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
153608787|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608788|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153813942|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
153813943|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608789|NCT01942460|Hematinics|hematinics|mesh-ancestor
153608790|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153608791|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153608793|NCT01942551|Dutasteride|dutasteride|mesh-list
153608794|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
153608797|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608852|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608853|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
153608854|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153608855|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
153608856|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608920|NCT01943630|Protective Agents|protective agents|mesh-ancestor
153608921|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153608922|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153608923|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608924|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608925|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
153608926|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608927|NCT01943760|Tramadol|tramadol|mesh-list
153608928|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153608929|NCT01943760|Narcotics|narcotics|mesh-ancestor
153608930|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608931|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608932|NCT01943760|Analgesics|analgesics|mesh-ancestor
153608982|NCT01944085|Ibuprofen|ibuprofen|mesh-list
153608983|NCT01944085|Vitamins|vitamins|mesh-ancestor
153608984|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
153608985|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608986|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153608987|NCT01944085|Analgesics|analgesics|mesh-ancestor
153608988|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
153609050|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609051|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153609052|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609055|NCT01944683|Midazolam|midazolam|mesh-list
153609056|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153609057|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153609058|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609059|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609060|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153609061|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153609062|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153609063|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153609064|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
153609065|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
153609115|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609116|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609117|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
153609173|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153609174|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153609175|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609176|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609177|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609178|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609179|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609180|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153609181|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609183|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153609184|NCT01945736|Narcotics|narcotics|mesh-ancestor
153609185|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609186|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609187|NCT01945736|Analgesics|analgesics|mesh-ancestor
153609188|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
153609189|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609190|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
153609191|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
153609192|NCT01945788|Teriparatide|teriparatide|mesh-list
153609193|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153609194|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609195|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153609196|NCT01945801|Furosemide|furosemide|mesh-list
153609197|NCT01945801|Spironolactone|spironolactone|mesh-list
153609198|NCT01945801|Diuretics|diuretics|mesh-ancestor
153609199|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
153813945|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153609200|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609201|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153609202|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609214|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609216|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609217|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153609218|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153609219|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153609220|NCT05410483|Docetaxel|docetaxel|mesh-list
153609221|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609222|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
153609223|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
153609224|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
153609279|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609280|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
153609281|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
153609282|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
153609283|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153609284|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153609285|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609286|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609287|NCT04908657|Urological Agents|urological agents|mesh-ancestor
153609288|NCT04887389|Listerine|listerine|mesh-list
153609289|NCT04887389|Fluorides|fluorides|mesh-list
153609290|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
153609291|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
153609343|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153609344|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153609359|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153609360|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153609398|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609399|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609400|NCT03941132|Ustekinumab|ustekinumab|mesh-list
153609401|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
153609402|NCT03873246|Varenicline|varenicline|mesh-list
153609403|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153609404|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153609405|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609406|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609408|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609461|NCT03148366|Levofloxacin|levofloxacin|mesh-list
153609462|NCT03148366|Bismuth|bismuth|mesh-list
153609463|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153609464|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609465|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153609466|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153609467|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153609468|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609469|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609470|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609525|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609526|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
153609527|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
153609528|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153609529|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153609531|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
153609594|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609595|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609596|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153609597|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153609598|NCT05303038|Growth Substances|growth substances|mesh-ancestor
153609599|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609600|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
153609601|NCT05042674|Ergothioneine|ergothioneine|mesh-list
153609602|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
153609603|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609604|NCT05042674|Protective Agents|protective agents|mesh-ancestor
153609605|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609657|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153609658|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
153609659|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153609660|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153609661|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
153609662|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
153609663|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
153609733|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
153609734|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153609735|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153609736|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153609737|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609738|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609741|NCT03395704|Hepcidins|hepcidins|mesh-list
153609782|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
153609783|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609784|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609786|NCT02625610|Capecitabine|capecitabine|mesh-list
153609787|NCT02625610|Fluorouracil|fluorouracil|mesh-list
153609788|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
153609789|NCT02625610|Avelumab|avelumab|mesh-list
153609852|NCT05414721|Desflurane|desflurane|mesh-list
153609853|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609854|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609855|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153609856|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
153609857|NCT05414669|Allopurinol|allopurinol|mesh-list
153609858|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
153609859|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609860|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609921|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
153609922|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153609923|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153609924|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153609990|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
153609991|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609992|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609993|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
153609994|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153609995|NCT05005455|Bevacizumab|bevacizumab|mesh-list
153609996|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153609997|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337714|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153609998|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153609999|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153610000|NCT05005455|Growth Substances|growth substances|mesh-ancestor
153610003|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
153610004|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153610005|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610006|NCT04641234|Aflibercept|aflibercept|mesh-list
153610007|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153610008|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153610009|NCT04641234|Growth Substances|growth substances|mesh-ancestor
153610010|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610011|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
153610012|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610037|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
153610038|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610039|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153610040|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153610041|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610042|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610043|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153610044|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153610046|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610047|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610048|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153610049|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153610050|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610051|NCT03962998|Lactulose|lactulose|mesh-list
153610052|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610053|NCT03859635|Bupivacaine|bupivacaine|mesh-list
153610054|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
153610055|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
153610056|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610057|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610058|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
153610079|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
153610080|NCT03626922|Pemetrexed|pemetrexed|mesh-list
153610081|NCT03626922|Vitamins|vitamins|mesh-ancestor
153610082|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
153610083|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610084|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610085|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
153610086|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
153610087|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610088|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610089|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
153610090|NCT03626922|Hormones|hormones|mesh-ancestor
153610091|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610092|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153610093|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610094|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153610095|NCT03626922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153610096|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610097|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610098|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153610132|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153610133|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153610134|NCT03578276|Analgesics|analgesics|mesh-ancestor
153610135|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
153610136|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153610137|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610138|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610139|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153610140|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153610141|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153610194|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610213|NCT02518009|Estrogens|estrogens|mesh-list
153610254|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610255|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610257|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
153610258|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
153610259|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153610260|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153610261|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610262|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153610263|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
153610264|NCT01197066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153610265|NCT01197066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610266|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153610267|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
153610268|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610269|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153610271|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610272|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610273|NCT01945879|Heparin|heparin|mesh-list
153610274|NCT01945879|Enoxaparin|enoxaparin|mesh-list
153610275|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153610276|NCT01945879|Tinzaparin|tinzaparin|mesh-list
153610277|NCT01945879|Dalteparin|dalteparin|mesh-list
153610278|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
153610279|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153610280|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153610281|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610282|NCT01945892|Dexamethasone|dexamethasone|mesh-list
153610283|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610284|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
153610296|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153610297|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610298|NCT01945983|Norepinephrine|norepinephrine|mesh-list
153610300|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153610301|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
153610302|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610303|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610304|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610305|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
153610306|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
153610309|NCT01946009|Cidofovir|cidofovir|mesh-list
153610361|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
153610362|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610363|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610364|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610430|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610431|NCT01946906|Rifaximin|rifaximin|mesh-list
153610432|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153610433|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610434|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610435|NCT01946971|Lansoprazole|lansoprazole|mesh-list
153610436|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
153610437|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153610438|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153610439|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153610440|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610441|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610442|NCT01946984|Diclofenac|diclofenac|mesh-list
153610443|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
153610444|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153610445|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153610446|NCT01946984|Analgesics|analgesics|mesh-ancestor
153338161|NCT00002032|Rifabutin|rifabutin|mesh-list
153610448|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610449|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610450|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153610451|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153610452|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153610453|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610454|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610455|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153610456|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
153610457|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610464|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610465|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153610466|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153610467|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
153610468|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610469|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610470|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153610471|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153610472|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153610473|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153610474|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610478|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153610479|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819659|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
153819670|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461071|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461072|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461073|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461074|NCT01678404|Rituximab|rituximab|mesh-list
153461075|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461076|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461077|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
153461078|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461079|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461080|NCT03087864|Paclitaxel|paclitaxel|mesh-list
153461081|NCT03087864|Carboplatin|carboplatin|mesh-list
153461082|NCT03087864|Atezolizumab|atezolizumab|mesh-list
153461083|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153461084|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461085|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
153461086|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
153461087|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
153461088|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461089|NCT03087864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153610480|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610482|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
153610483|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
153610484|NCT01947114|Analgesics|analgesics|mesh-ancestor
153610485|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
153610486|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610488|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153610489|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153610490|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610491|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610492|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153610494|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
153610495|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153610497|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
153820938|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610540|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
153610541|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153610542|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610543|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610544|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153610545|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153610546|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153610547|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153610548|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153610600|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610605|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153610665|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610666|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153610667|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
153610669|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153610670|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153610671|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153610672|NCT01948362|Sulforaphane|sulforaphane|mesh-list
153610673|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153610674|NCT01948362|Protective Agents|protective agents|mesh-ancestor
153610728|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153610729|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153610730|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153610731|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153610732|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610733|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153610734|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610735|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
153610736|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153610737|NCT01948921|Meperidine|meperidine|mesh-list
153610738|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153610739|NCT01948921|Narcotics|narcotics|mesh-ancestor
153610740|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610741|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610742|NCT01948921|Analgesics|analgesics|mesh-ancestor
153610743|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
153610744|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610745|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153610746|NCT01948960|Everolimus|everolimus|mesh-list
153610747|NCT01948960|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153610748|NCT01948960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153610781|NCT01949233|Irbesartan|irbesartan|mesh-list
153610782|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153732019|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153610783|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610784|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
153610785|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153610786|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153610787|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153610789|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153610851|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
153610852|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610853|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153610854|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153610855|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610856|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153610857|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610858|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
153610859|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153820939|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461716|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
153461717|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153610860|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
153610861|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610862|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
153610914|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610915|NCT01950000|Analgesics|analgesics|mesh-ancestor
153610916|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
153610991|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820941|NCT00435305|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153610992|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153610994|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153610995|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153610996|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153610997|NCT01950546|Fluorides|fluorides|mesh-list
153611038|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611039|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
153611040|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153611041|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153611042|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611043|NCT01950923|Urological Agents|urological agents|mesh-ancestor
153611045|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
153611046|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
153611047|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153611048|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153611049|NCT01951027|Lenograstim|lenograstim|mesh-list
153611050|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153611051|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
153611052|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611054|NCT01951053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153611055|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153611056|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153611058|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611093|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
153611094|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611095|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611096|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
153611097|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611098|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153611099|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
153611100|NCT01951404|Protective Agents|protective agents|mesh-ancestor
153611101|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611102|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153611103|NCT01951430|Cephalosporins|cephalosporins|mesh-list
153461719|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430950|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611104|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153611105|NCT01951430|Itraconazole|itraconazole|mesh-list
153611110|NCT01951430|Miconazole|miconazole|mesh-list
153611153|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153611154|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153611155|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153611157|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
153611158|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611159|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611172|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611174|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
153611175|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611176|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153611177|NCT01951677|Antacids|antacids|mesh-ancestor
153611178|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611179|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153611180|NCT01951729|Atropine|atropine|mesh-list
153611181|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153611182|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153611195|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611198|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153611200|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611201|NCT01951872|Caffeine|caffeine|mesh-list
153611202|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153611203|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611204|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153611258|NCT01952626|Ondansetron|ondansetron|mesh-list
153611259|NCT01952626|Palonosetron|palonosetron|mesh-list
153611260|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
153611261|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
153611262|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611263|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611264|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153611265|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
153611266|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
153611326|NCT05876585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611327|NCT05876585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153611328|NCT05876585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153611329|NCT05876585|Dopamine Agents|dopamine agents|mesh-ancestor
153611330|NCT05876481|Psilocybin|psilocybin|mesh-list
153611331|NCT05876481|Hallucinogens|hallucinogens|mesh-ancestor
153611341|NCT05876195|Antacids|antacids|mesh-ancestor
153611395|NCT05875519|Mepivacaine|mepivacaine|mesh-list
153611396|NCT05875519|Anesthetics|anesthetics|mesh-ancestor
153611397|NCT05875519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611398|NCT05875519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611399|NCT05875519|Anesthetics, Local|anesthetics, local|mesh-ancestor
153611400|NCT05875519|Sensory System Agents|sensory system agents|mesh-ancestor
153611401|NCT05875519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611402|NCT05875519|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153611403|NCT05875285|Methotrexate|methotrexate|mesh-list
153611404|NCT05875285|Coal Tar|coal tar|mesh-list
153611405|NCT05875285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153611406|NCT05875285|Abortifacient Agents|abortifacient agents|mesh-ancestor
153611407|NCT05875285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153611408|NCT05875285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611463|NCT05874700|Glycine|glycine|mesh-list
153611464|NCT05874700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153611465|NCT05874700|Protease Inhibitors|protease inhibitors|mesh-ancestor
153611466|NCT05874700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611467|NCT05874700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611469|NCT05874700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611511|NCT05872412|Carboplatin|carboplatin|mesh-list
153611512|NCT05872412|Doxorubicin|doxorubicin|mesh-list
153611513|NCT05872412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153611514|NCT05872412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461720|NCT03193866|Interferons|interferons|mesh-list
153611515|NCT05872412|Tubulin Modulators|tubulin modulators|mesh-ancestor
153611516|NCT05872412|Antimitotic Agents|antimitotic agents|mesh-ancestor
153611517|NCT05872412|Mitosis Modulators|mitosis modulators|mesh-ancestor
153611518|NCT05872412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611519|NCT05872412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153611520|NCT05872412|Immunologic Factors|immunologic factors|mesh-ancestor
153611521|NCT05872412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611522|NCT05872412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153611523|NCT05872412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153611575|NCT05790161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611576|NCT05790161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611577|NCT05790161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153611578|NCT05790161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153611579|NCT05790161|Purinergic Agents|purinergic agents|mesh-ancestor
153611580|NCT05790161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611581|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153611582|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
153611583|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611585|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153611586|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611587|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
153611588|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
153611589|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611590|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
153611591|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611631|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
153611632|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
153611633|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611634|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611635|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
153611636|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611637|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153611638|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153611639|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153611693|NCT04994431|Urological Agents|urological agents|mesh-ancestor
153611695|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153611696|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153611756|NCT04660760|Growth Inhibitors|growth inhibitors|mesh-ancestor
153611757|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
153611758|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
153611759|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153611828|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153611829|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
153611830|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153611831|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611832|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153611833|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153611834|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
153611835|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461774|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153461775|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153461776|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461777|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461778|NCT03165942|Ethanol|ethanol|mesh-list
153461779|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153461780|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461781|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461782|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461783|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
153820949|NCT03272412|Progestins|progestins|mesh-ancestor
153820950|NCT03272412|Hormones|hormones|mesh-ancestor
153611893|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153611895|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153611896|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153611897|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611898|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611900|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153611901|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611902|NCT03348423|Fentanyl|fentanyl|mesh-list
153611903|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153611904|NCT03348423|Narcotics|narcotics|mesh-ancestor
153611905|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611955|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611956|NCT02866747|Durvalumab|durvalumab|mesh-list
153611957|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153611958|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611959|NCT02766335|Docetaxel|docetaxel|mesh-list
153611960|NCT02766335|Durvalumab|durvalumab|mesh-list
153611961|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
153611962|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153611963|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
153611964|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153611965|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
153611966|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612021|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612023|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612024|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612025|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
153612026|NCT02344810|Antidotes|antidotes|mesh-ancestor
153612027|NCT02344810|Protective Agents|protective agents|mesh-ancestor
153612028|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
153612032|NCT02333565|Octreotide|octreotide|mesh-list
153612033|NCT02333565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153612034|NCT02333565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153612035|NCT02333565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612036|NCT02333565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612037|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612038|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
153612039|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612040|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612041|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153612089|NCT01840566|Cytarabine|cytarabine|mesh-list
153612090|NCT01840566|Etoposide|etoposide|mesh-list
153612091|NCT01840566|Melphalan|melphalan|mesh-list
153612135|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
153612136|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153612137|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612138|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153612139|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612140|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
153612141|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
153612142|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612144|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153612145|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153612146|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612147|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
153612148|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612149|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612150|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612151|NCT00318903|Docetaxel|docetaxel|mesh-list
153612152|NCT00318903|Irinotecan|irinotecan|mesh-list
153612153|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612154|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
153813958|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153612155|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612156|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612157|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612158|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153612159|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153612160|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612185|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
153612186|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612187|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612188|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612189|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
153612190|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612191|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
153612192|NCT01953107|Trace Elements|trace elements|mesh-ancestor
153612193|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
153612194|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612195|NCT01953172|Tocotrienols|tocotrienols|mesh-list
153612196|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
153612197|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
153612198|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612250|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153612251|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612252|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153612253|NCT01953731|Rifampin|rifampin|mesh-list
153612254|NCT01953731|Palbociclib|palbociclib|mesh-list
153612255|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612256|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153612257|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612258|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612302|NCT01953770|Hormones|hormones|mesh-ancestor
153612303|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612304|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612305|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153612306|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612307|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153612308|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
153612309|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153612310|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153612311|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
153612312|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612320|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
153612362|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
153612363|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612364|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612365|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612366|NCT01953887|Urological Agents|urological agents|mesh-ancestor
153612367|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153612368|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153612369|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
153612370|NCT01953952|Cisplatin|cisplatin|mesh-list
153612372|NCT01953978|Acetaminophen|acetaminophen|mesh-list
153612427|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153612428|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153612429|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153461855|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153612430|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153612431|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153612432|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612433|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153612434|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
153612435|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153612437|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612439|NCT01954108|Protective Agents|protective agents|mesh-ancestor
153612441|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
153612487|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612489|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153612490|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612491|NCT01954784|Cyclosporine|cyclosporine|mesh-list
153612492|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
153612493|NCT01954784|Fludarabine|fludarabine|mesh-list
153612494|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
153612495|NCT01954784|Lenalidomide|lenalidomide|mesh-list
153612496|NCT01954784|Bortezomib|bortezomib|mesh-list
153612497|NCT01954784|Cyclosporins|cyclosporins|mesh-list
153612498|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612499|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153612500|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
153612547|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153612548|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612549|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612550|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153612551|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
153612553|NCT01955135|Analgesics|analgesics|mesh-ancestor
153612554|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
153612555|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612556|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153612557|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153612558|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153612559|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612561|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153612597|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
153612598|NCT01955187|Hormones|hormones|mesh-ancestor
153612599|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153612600|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153612601|NCT01955187|Protective Agents|protective agents|mesh-ancestor
153612602|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153612603|NCT01955200|Cilostazol|cilostazol|mesh-list
153612604|NCT01955200|Clopidogrel|clopidogrel|mesh-list
153612605|NCT01955200|Ticagrelor|ticagrelor|mesh-list
153612606|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153612607|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153612608|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153612610|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
153612659|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153612660|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153612661|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153612662|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153612664|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612665|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612666|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612667|NCT01955655|Baclofen|baclofen|mesh-list
153612668|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153612669|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612670|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153612671|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612672|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153612673|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
153612674|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
153612675|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612676|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612677|NCT01955694|Eplerenone|eplerenone|mesh-list
153612678|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153612709|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153612718|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
153612719|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153612720|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612721|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
153360916|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153612728|NCT01955967|Lidocaine|lidocaine|mesh-list
153612768|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
153612769|NCT01956474|Vitamins|vitamins|mesh-ancestor
153612773|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
153612774|NCT01956487|Propafenone|propafenone|mesh-list
153612780|NCT01956591|Oxybutynin|oxybutynin|mesh-list
153612834|NCT01956929|Metformin|metformin|mesh-list
153612835|NCT01956929|Lactulose|lactulose|mesh-list
153612836|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153612837|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612838|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153612839|NCT01956955|Heparin|heparin|mesh-list
153612840|NCT01956955|Enoxaparin|enoxaparin|mesh-list
153612841|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153612898|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153612899|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
153612900|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
153612901|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153612902|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153612903|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153612904|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153612905|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
153612965|NCT01957631|Protective Agents|protective agents|mesh-ancestor
153612966|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153612967|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153612968|NCT01957839|Cabergoline|cabergoline|mesh-list
153612969|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153612970|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153612971|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
153612972|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
153612973|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612974|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612975|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612976|NCT01957852|Thrombin|thrombin|mesh-list
153612977|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
153613027|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153613028|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153613029|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153613030|NCT01958684|Trace Elements|trace elements|mesh-ancestor
153613031|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
153613032|NCT01958775|Glucagon|glucagon|mesh-list
153613033|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153613034|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153613035|NCT01958775|Hormones|hormones|mesh-ancestor
153613037|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613093|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153613095|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613096|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613097|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613098|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613099|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
153613100|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
153613101|NCT01959061|Raltitrexed|raltitrexed|mesh-list
153613162|NCT01959399|Peficitinib|peficitinib|mesh-list
153613224|NCT01959971|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153613225|NCT01959971|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153613226|NCT01959971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153613227|NCT01959971|Antimetabolites|antimetabolites|mesh-ancestor
153613228|NCT01959971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613229|NCT01959971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153613230|NCT01959971|Protease Inhibitors|protease inhibitors|mesh-ancestor
153613231|NCT01959971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613232|NCT01959971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153613233|NCT01960023|Cetuximab|cetuximab|mesh-list
153613234|NCT01960023|Neratinib|neratinib|mesh-list
153613235|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153613236|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613248|NCT01960153|Tadalafil|tadalafil|mesh-list
153613284|NCT01960426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153613285|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153613286|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153613287|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
153613288|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153613289|NCT01960543|Fentanyl|fentanyl|mesh-list
153613290|NCT01960543|Bupivacaine|bupivacaine|mesh-list
153613291|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
153613292|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613293|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
153613294|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613296|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
153613297|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613298|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153613346|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153613347|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153613348|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
153613349|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153613350|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
153613351|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613352|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613353|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
153613412|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
153613413|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613414|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613415|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
153613416|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613417|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153613418|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153613419|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153613420|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613422|NCT01961752|Triamcinolone|triamcinolone|mesh-list
153613475|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153613476|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153613477|NCT01962181|Methylphenidate|methylphenidate|mesh-list
153613478|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153613479|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613481|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153613482|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153613483|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613484|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
153613546|NCT01963299|Clonidine|clonidine|mesh-list
153613547|NCT01963299|Ropivacaine|ropivacaine|mesh-list
153613564|NCT01963325|Paclitaxel|paclitaxel|mesh-list
153613593|NCT01963546|Analgesics|analgesics|mesh-ancestor
153613594|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
153613595|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613596|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153613597|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153613598|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153613599|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
153613600|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613601|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613602|NCT01963559|Lidocaine|lidocaine|mesh-list
153613603|NCT01963559|Prilocaine|prilocaine|mesh-list
153613604|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153613605|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613606|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
153613607|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613608|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613609|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
153613610|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613611|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153613617|NCT01963663|Metformin|metformin|mesh-list
153613648|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613649|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153613650|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153613651|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
153613655|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
153613656|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
153613657|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153341432|NCT04330300|Eprosartan|eprosartan|mesh-list
153613658|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613659|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
153613660|NCT01963832|Fluoxetine|fluoxetine|mesh-list
153613662|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153613710|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613711|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
153613712|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613713|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613714|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
153613715|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613780|NCT01964287|Folfirinox|folfirinox|mesh-list
153613781|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153613782|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613783|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
153613784|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
153613785|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
153613787|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153613835|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
153613909|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613910|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153613911|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153613912|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
153613913|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153613914|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
153613917|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153613918|NCT01964846|Curcumin|curcumin|mesh-list
153613919|NCT01964846|Resveratrol|resveratrol|mesh-list
153613920|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153613921|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153613922|NCT01964846|Analgesics|analgesics|mesh-ancestor
153613923|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
153613924|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153613925|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613926|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153613927|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153613928|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613929|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613930|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613931|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
153613961|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153613962|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613963|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613964|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613965|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
153613966|NCT01965301|Promethazine|promethazine|mesh-list
153613967|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153613968|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153613969|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613970|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613971|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
153614026|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614027|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153614028|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153614029|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153614032|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614033|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
153614034|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
153614093|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153614094|NCT01966172|Narcotics|narcotics|mesh-ancestor
153614154|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153614156|NCT01966575|Progestins|progestins|mesh-list
153614157|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153614158|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153614159|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153614160|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
153614161|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153614162|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614163|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153614164|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153614178|NCT01966692|Xhance|xhance|mesh-list
153614211|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614212|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153614213|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153614214|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
153614215|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614216|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153614217|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153614218|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153614219|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153614220|NCT01966913|Bevacizumab|bevacizumab|mesh-list
153614221|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153614222|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614223|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153614224|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153614225|NCT01966913|Growth Substances|growth substances|mesh-ancestor
153614226|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614227|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
153614228|NCT01967017|Lidocaine|lidocaine|mesh-list
153614229|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
153614230|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
153614246|NCT01967199|Paclitaxel|paclitaxel|mesh-list
153614263|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614264|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614265|NCT01967264|Udenafil|udenafil|mesh-list
153614266|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153614267|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153614268|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614269|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614270|NCT01967368|Vaccines|vaccines|mesh-list
153614271|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
153614326|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
153614327|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614328|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153614329|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153342103|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614330|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614331|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
153614332|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614333|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153614334|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153614381|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
153614382|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614383|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153614384|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153614385|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614386|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614387|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153614388|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
153614389|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614390|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614391|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153614392|NCT01967979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153614393|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153614394|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153614395|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614396|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
153614397|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153614398|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
153614399|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153614400|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153614401|NCT01968005|Etodolac|etodolac|mesh-list
153614403|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
153614404|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
153614405|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614406|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614407|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
153614422|NCT01968018|Acetaminophen|acetaminophen|mesh-list
153614423|NCT01968018|Tramadol|tramadol|mesh-list
153614424|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153614425|NCT01968018|Analgesics|analgesics|mesh-ancestor
153614426|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
153614427|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614428|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614429|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
153614430|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153614431|NCT01968018|Narcotics|narcotics|mesh-ancestor
153614432|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614433|NCT01968044|Linagliptin|linagliptin|mesh-list
153614485|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153614486|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
153614487|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614488|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153614489|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153614568|NCT01969019|Protective Agents|protective agents|mesh-ancestor
153614569|NCT01969032|Paclitaxel|paclitaxel|mesh-list
153614570|NCT01969032|Doxorubicin|doxorubicin|mesh-list
153614571|NCT01969032|Capecitabine|capecitabine|mesh-list
153614572|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
153614573|NCT01969032|Carboplatin|carboplatin|mesh-list
153614574|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153614575|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614604|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
153813971|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614605|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614606|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153614607|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153614608|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153614609|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
153614610|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153614611|NCT01969149|Insulin|insulin|mesh-list
153614612|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153614613|NCT01969149|Exenatide|exenatide|mesh-list
153614668|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614669|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614670|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153614671|NCT01969682|Rifampin|rifampin|mesh-list
153614672|NCT01969682|Venetoclax|venetoclax|mesh-list
153614673|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614674|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153614675|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
153614676|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153614677|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614678|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
153614679|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153614680|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614681|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614726|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
153614727|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614728|NCT01969955|Paclitaxel|paclitaxel|mesh-list
153614729|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153614730|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153614731|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614732|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
153614745|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614746|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614747|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153394684|NCT02471651|Hormones|hormones|mesh-ancestor
153614780|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153614781|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614782|NCT01970215|Atorvastatin|atorvastatin|mesh-list
153614783|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153614784|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153614787|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614788|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153614789|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153614790|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614791|NCT01970280|Enoxaparin|enoxaparin|mesh-list
153614792|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
153614793|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153614794|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153614795|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614796|NCT01970358|Poly ICLC|poly iclc|mesh-list
153614836|NCT01971034|Metformin|metformin|mesh-list
153614837|NCT01971034|Paclitaxel|paclitaxel|mesh-list
153914679|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614838|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153614839|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614840|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
153614841|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
153614842|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
153614843|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614844|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153614845|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614846|NCT01971047|Insulin|insulin|mesh-list
153614847|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
153614900|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614901|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153614902|NCT01971450|Iloprost|iloprost|mesh-list
153614903|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153614904|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
153614905|NCT01971515|Tamoxifen|tamoxifen|mesh-list
153614906|NCT01971515|Trastuzumab|trastuzumab|mesh-list
153614907|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153614908|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614909|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153614910|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
153614911|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614912|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614913|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153614914|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153614915|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153614925|NCT01971632|Oxycodone|oxycodone|mesh-list
153614957|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
153614958|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153614970|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153614971|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153614972|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
153614973|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153614974|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615017|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615019|NCT01972230|Narcotics|narcotics|mesh-ancestor
153615020|NCT01972230|Analgesics|analgesics|mesh-ancestor
153615021|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
153615022|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615023|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153815077|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615024|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153615026|NCT01972269|Fentanyl|fentanyl|mesh-list
153615027|NCT01972269|Bupivacaine|bupivacaine|mesh-list
153615028|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
153615029|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
153615030|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615031|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615032|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
153615033|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615034|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153615035|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153615036|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153615037|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615038|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615039|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153615040|NCT01972269|Narcotics|narcotics|mesh-ancestor
153615041|NCT01972269|Analgesics|analgesics|mesh-ancestor
153615042|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153615043|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153615044|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
153615045|NCT01972373|Bevacizumab|bevacizumab|mesh-list
153615046|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153615047|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615048|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153615049|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153615051|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615052|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
153615053|NCT01972490|Bevacizumab|bevacizumab|mesh-list
153615054|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153615055|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615056|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153615112|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153615113|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153615114|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615115|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615116|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153615117|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
153615118|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615119|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615121|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153615122|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153615123|NCT01973010|Analgesics|analgesics|mesh-ancestor
153615124|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
153615125|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615126|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615127|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615168|NCT01973504|Chrysarobin|chrysarobin|mesh-list
153615169|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153615170|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153615171|NCT01973504|Analgesics|analgesics|mesh-ancestor
153615173|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615174|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615175|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615176|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153615177|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153615179|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153615180|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153615182|NCT01973660|Paclitaxel|paclitaxel|mesh-list
153615183|NCT01973660|Trastuzumab|trastuzumab|mesh-list
153615184|NCT01973660|Letrozole|letrozole|mesh-list
153615185|NCT01973660|Lapatinib|lapatinib|mesh-list
153615186|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153615187|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615188|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
153615189|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
153615190|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
153615191|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615192|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153615193|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153615216|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615218|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153615219|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615220|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615221|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
153615222|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615223|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615224|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153615225|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
153615226|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153462053|NCT00636636|Gabapentin|gabapentin|mesh-list
153615227|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153615228|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153615230|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153615231|NCT01973816|Cyproterone|cyproterone|mesh-list
153615232|NCT01973816|Estrogens|estrogens|mesh-ancestor
153615233|NCT01973816|Hormones|hormones|mesh-ancestor
153615234|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615235|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615236|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153615237|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
153615238|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153615239|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153615240|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
153615243|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153615264|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153615265|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615267|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
153615268|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153615269|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615270|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
153615271|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153615272|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153615273|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615274|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153615275|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615276|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615277|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
153615278|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153615279|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153615280|NCT01974024|Prednisolone|prednisolone|mesh-list
153615281|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
153615282|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153615283|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
153615284|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615285|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
153615320|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615321|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153615322|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153615323|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615324|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153615325|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153615326|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153615327|NCT01974375|Fluconazole|fluconazole|mesh-list
153615328|NCT01974375|Micafungin|micafungin|mesh-list
153615329|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
153615330|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615331|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153615332|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153615333|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615334|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615335|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153813978|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153615336|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
153615337|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615338|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615339|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153615341|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
153615368|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153615370|NCT01974648|Analgesics|analgesics|mesh-ancestor
153615371|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
153615372|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615373|NCT01974843|Bupivacaine|bupivacaine|mesh-list
153615374|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
153615375|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
153615376|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
153462139|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343155|NCT01258855|Aldesleukin|aldesleukin|mesh-list
153615390|NCT01975012|Rilpivirine|rilpivirine|mesh-list
153615434|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
153615435|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153615436|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615437|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615438|NCT01975363|Curcumin|curcumin|mesh-list
153615439|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153615440|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153615441|NCT01975363|Analgesics|analgesics|mesh-ancestor
153615442|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
153615443|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615498|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
153615499|NCT01975727|BB 1101|bb 1101|mesh-list
153615500|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615501|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
153615502|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
153615503|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615506|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
153615568|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
153615569|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
153615570|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
153615571|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615572|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615585|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615586|NCT01976195|Thalidomide|thalidomide|mesh-list
153615587|NCT01976195|Dexamethasone|dexamethasone|mesh-list
153615624|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153615627|NCT01976676|Hematinics|hematinics|mesh-ancestor
153615628|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
153615629|NCT01976676|Vitamins|vitamins|mesh-ancestor
153615630|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
153615631|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615632|NCT01976780|Artesunate|artesunate|mesh-list
153615633|NCT01976780|Lumefantrine|lumefantrine|mesh-list
153615634|NCT01976780|Artemether|artemether|mesh-list
153615635|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153615636|NCT01976780|Mefloquine|mefloquine|mesh-list
153615637|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
153615638|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153615639|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153615640|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615641|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615642|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
153615643|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
153615644|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153615645|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
153615646|NCT01976923|Bevacizumab|bevacizumab|mesh-list
153615647|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153615648|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615649|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153615650|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153615651|NCT01976923|Growth Substances|growth substances|mesh-ancestor
153615652|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615653|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
153615654|NCT01976936|Lovastatin|lovastatin|mesh-list
153615655|NCT01976936|L 647318|l 647318|mesh-list
153615656|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
153615657|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153615658|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153615659|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
153615660|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615661|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153615662|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153615663|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615664|NCT01977118|Streptokinase|streptokinase|mesh-list
153615665|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153615666|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153615667|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615668|NCT01977209|Gossypol|gossypol|mesh-list
153615669|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153615671|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153615672|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343455|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153615674|NCT01977300|Olanzapine|olanzapine|mesh-list
153615675|NCT01977300|Risperidone|risperidone|mesh-list
153615677|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153615678|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
153615679|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615680|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615681|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615682|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153615683|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153615684|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615685|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615686|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153615687|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
153615689|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
153615690|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615691|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153615702|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
153615703|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615704|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615705|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
153615706|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615707|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153615708|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153615709|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153615710|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153615711|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153615712|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615762|NCT01978041|Fluorides|fluorides|mesh-list
153615763|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
153615764|NCT01978041|Protective Agents|protective agents|mesh-ancestor
153615765|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615766|NCT01978301|Triamcinolone|triamcinolone|mesh-list
153615767|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153615768|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153615769|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153615770|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615771|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
153615772|NCT01978301|Hormones|hormones|mesh-ancestor
153615773|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615824|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153615825|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615826|NCT01978496|Eletriptan|eletriptan|mesh-list
153615827|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153615828|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
153615829|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153615830|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615831|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615833|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615834|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
153615835|NCT01978665|Hormones|hormones|mesh-ancestor
153615836|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615837|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615838|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615839|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615840|NCT01978678|Budesonide|budesonide|mesh-list
153615841|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153615842|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153615843|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
153615844|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153615845|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615846|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153615873|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615874|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153615875|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
153615876|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153615878|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
153615879|NCT01978873|Androgens|androgens|mesh-list
153615880|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153615881|NCT01978873|Hormones|hormones|mesh-ancestor
153615882|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153615883|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615884|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
153615885|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615886|NCT01978873|Protective Agents|protective agents|mesh-ancestor
153615887|NCT01978873|Vitamins|vitamins|mesh-ancestor
153615888|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
153615889|NCT01978873|Estrogens|estrogens|mesh-ancestor
153615890|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153615891|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615892|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
153387522|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153615893|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153615894|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153615895|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615896|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
153343687|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
153615924|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615925|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615926|NCT01979653|Midazolam|midazolam|mesh-list
153615927|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
153615928|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153615929|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153615932|NCT01979653|Analgesics|analgesics|mesh-ancestor
153615988|NCT01980082|Cefazolin|cefazolin|mesh-list
153615989|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153615990|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153615991|NCT01980277|Paclitaxel|paclitaxel|mesh-list
153615992|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153615993|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615994|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
153615995|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
153615996|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
153615997|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153615998|NCT01980303|Esketamine|esketamine|mesh-list
153615999|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
153616000|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153616001|NCT01980316|Heparin|heparin|mesh-list
153616002|NCT01980316|Calcium heparin|calcium heparin|mesh-list
153616003|NCT01980316|Argatroban|argatroban|mesh-list
153616004|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
153616005|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153616006|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153616007|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616045|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616046|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
153616047|NCT01980498|Fentanyl|fentanyl|mesh-list
153616048|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153616049|NCT01980498|Narcotics|narcotics|mesh-ancestor
153616050|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616051|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616052|NCT01980498|Analgesics|analgesics|mesh-ancestor
153616053|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
153616054|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616055|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153616056|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153616057|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
153616058|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
153616069|NCT06329258|Betamethasone|betamethasone|mesh-list
153616070|NCT06329258|Calcipotriene|calcipotriene|mesh-list
153616071|NCT06329258|Deucravacitinib|deucravacitinib|mesh-list
153616105|NCT06329037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616106|NCT06329037|Hemostatics|hemostatics|mesh-ancestor
153616107|NCT06329037|Coagulants|coagulants|mesh-ancestor
153616108|NCT06329037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153616109|NCT06329037|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153616110|NCT06329037|Natriuretic Agents|natriuretic agents|mesh-ancestor
153616111|NCT06328998|Lidocaine|lidocaine|mesh-list
153616112|NCT06328998|Anesthetics, Local|anesthetics, local|mesh-ancestor
153616113|NCT06328998|Anesthetics|anesthetics|mesh-ancestor
153616114|NCT06328998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616115|NCT06328998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616162|NCT06328543|Histamine|histamine|mesh-list
153616191|NCT06328387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153616192|NCT06328387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153616193|NCT06328387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153616194|NCT06328387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616195|NCT06328387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616196|NCT06328387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153616197|NCT06328387|Immunoconjugates|immunoconjugates|mesh-ancestor
153616198|NCT06328387|Immunologic Factors|immunologic factors|mesh-ancestor
153343980|NCT00003748|Irinotecan|irinotecan|mesh-list
153616199|NCT06328387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616200|NCT06328205|Lidocaine|lidocaine|mesh-list
153616201|NCT06328205|Anesthetics, Local|anesthetics, local|mesh-ancestor
153616202|NCT06328205|Anesthetics|anesthetics|mesh-ancestor
153616203|NCT06328205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616249|NCT06328140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153616250|NCT06328140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153616251|NCT06328140|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616252|NCT06328140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616253|NCT06328140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616254|NCT06328140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153616255|NCT06328140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153616256|NCT06328140|Serotonin Agents|serotonin agents|mesh-ancestor
153616257|NCT06328140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153616258|NCT06328140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153616259|NCT06328140|Dopamine Agents|dopamine agents|mesh-ancestor
153616260|NCT06328062|Pregabalin|pregabalin|mesh-list
153616261|NCT06328062|Analgesics|analgesics|mesh-ancestor
153616262|NCT06328062|Sensory System Agents|sensory system agents|mesh-ancestor
153616263|NCT06328062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616264|NCT06328062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616265|NCT06328062|Anticonvulsants|anticonvulsants|mesh-ancestor
153616266|NCT06328062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153616311|NCT06327581|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153382186|NCT02334059|Ketamine|ketamine|mesh-list
153387524|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
153616312|NCT06327581|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153616313|NCT06327581|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153616314|NCT06327581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153462213|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
153616316|NCT06327581|Hormones|hormones|mesh-ancestor
153616317|NCT06327581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153616318|NCT06327581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616319|NCT06327581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153616320|NCT06327581|Immunologic Factors|immunologic factors|mesh-ancestor
153616321|NCT06327581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616322|NCT06327581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616323|NCT06327451|Atorvastatin|atorvastatin|mesh-list
153616324|NCT06327451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153616374|NCT06327269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616375|NCT06327269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153616376|NCT06327269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616377|NCT06327269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616459|NCT06321289|Cyclophosphamide|cyclophosphamide|mesh-list
153616460|NCT06321289|Fludarabine|fludarabine|mesh-list
153616461|NCT06321289|Fludarabine phosphate|fludarabine phosphate|mesh-list
153616462|NCT06321289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153616463|NCT06321289|Immunologic Factors|immunologic factors|mesh-ancestor
153616464|NCT06321289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616465|NCT06321289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153616466|NCT06321289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153616467|NCT06321289|Alkylating Agents|alkylating agents|mesh-ancestor
153616468|NCT06321289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616469|NCT06321289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616470|NCT06321289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153616471|NCT06321289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153616472|NCT06321289|Antimetabolites|antimetabolites|mesh-ancestor
153616484|NCT06309368|Polihexanide|polihexanide|mesh-list
153616487|NCT06309368|Lipotropic Agents|lipotropic agents|mesh-ancestor
153616488|NCT06309368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153616490|NCT06309368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616516|NCT06291363|Esmolol|esmolol|mesh-list
153616517|NCT06291363|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153616518|NCT06291363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153616519|NCT06291363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153616520|NCT06291363|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616521|NCT06291363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616522|NCT06291363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616523|NCT06291363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616524|NCT06280196|Carboplatin|carboplatin|mesh-list
153616525|NCT06280196|Pembrolizumab|pembrolizumab|mesh-list
153616526|NCT06280196|Pemetrexed|pemetrexed|mesh-list
153616527|NCT06280196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616528|NCT06280196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616577|NCT06264440|Rabeprazole|rabeprazole|mesh-list
153616578|NCT06264440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153616579|NCT06264440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153616580|NCT06264440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153616581|NCT06264440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781756|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
153616582|NCT06264440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616607|NCT06251986|Ofatumumab|ofatumumab|mesh-list
153616608|NCT06251986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616609|NCT06250283|Resveratrol|resveratrol|mesh-list
153616610|NCT06250283|Antioxidants|antioxidants|mesh-ancestor
153616612|NCT06250283|Protective Agents|protective agents|mesh-ancestor
153616682|NCT06186141|Sensory System Agents|sensory system agents|mesh-ancestor
153616683|NCT06186141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153616685|NCT06185985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153616686|NCT06185985|Antidepressive Agents|antidepressive agents|mesh-ancestor
153616687|NCT06185985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153616688|NCT06185985|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153616689|NCT06185985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153616690|NCT06185985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153616691|NCT06185985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616692|NCT06185985|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616693|NCT06185985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616694|NCT06185985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616695|NCT06182410|Defibrotide|defibrotide|mesh-list
153616696|NCT06182410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153616697|NCT06182410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153616698|NCT06182410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616699|NCT06182410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153616740|NCT06158126|Emtricitabine|emtricitabine|mesh-list
153616741|NCT06158126|Antiviral Agents|antiviral agents|mesh-ancestor
153616764|NCT06144177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153616765|NCT06144177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153616766|NCT06144177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153616767|NCT06144177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616768|NCT06144177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153616769|NCT06144177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153616770|NCT06144177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153616771|NCT06144177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153616772|NCT06144177|Anesthetics, General|anesthetics, general|mesh-ancestor
153616773|NCT06144177|Anesthetics|anesthetics|mesh-ancestor
153616774|NCT06144177|GABA Modulators|gaba modulators|mesh-ancestor
153616775|NCT06144177|GABA Agents|gaba agents|mesh-ancestor
153616776|NCT06144177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153616797|NCT06107205|Edaravone|edaravone|mesh-list
153616849|NCT06088290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153616850|NCT06088290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616851|NCT06088290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153616852|NCT06088290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153616853|NCT06088290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153616854|NCT06088290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153616860|NCT06063421|Nicotine|nicotine|mesh-list
153616861|NCT06063421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153616906|NCT06044935|Niacinamide|niacinamide|mesh-list
153616939|NCT06039826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153616940|NCT06039826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616941|NCT06039826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153616942|NCT06039826|Contraceptive Agents|contraceptive agents|mesh-ancestor
153616943|NCT06039826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153616944|NCT06039826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153616945|NCT06039826|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153616946|NCT06039826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153616947|NCT06039826|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153616948|NCT06039826|Hormone Antagonists|hormone antagonists|mesh-ancestor
153616950|NCT06039826|Diuretics|diuretics|mesh-ancestor
153616951|NCT06039826|Natriuretic Agents|natriuretic agents|mesh-ancestor
153616952|NCT06029270|Cisplatin|cisplatin|mesh-list
153616953|NCT06029270|Carboplatin|carboplatin|mesh-list
153616954|NCT06029270|Gemcitabine|gemcitabine|mesh-list
153616955|NCT06029270|Nivolumab|nivolumab|mesh-list
153616956|NCT06029270|Relatlimab|relatlimab|mesh-list
153616958|NCT06029270|Immunoglobulin G|immunoglobulin g|mesh-list
153616959|NCT06029270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153616960|NCT06029270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153616961|NCT06029270|Antimetabolites|antimetabolites|mesh-ancestor
153616962|NCT06029270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813631|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153813633|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
153616963|NCT06029270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153616964|NCT06029270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153616965|NCT06029270|Immunologic Factors|immunologic factors|mesh-ancestor
153616966|NCT06029270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153616971|NCT06013241|Mometasone Furoate|mometasone furoate|mesh-list
153617008|NCT05960773|Antimetabolites|antimetabolites|mesh-ancestor
153617009|NCT05960773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617010|NCT05960773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617011|NCT05960773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617012|NCT05957367|Cetuximab|cetuximab|mesh-list
153617013|NCT05957367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617014|NCT05957367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617015|NCT05954910|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153617016|NCT05954910|Immunoconjugates|immunoconjugates|mesh-ancestor
153617017|NCT05954910|Immunologic Factors|immunologic factors|mesh-ancestor
153617018|NCT05954910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617019|NCT05908786|Bevacizumab|bevacizumab|mesh-list
153617020|NCT05908786|Atezolizumab|atezolizumab|mesh-list
153617021|NCT05908786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617022|NCT05908786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617023|NCT05908786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153617024|NCT05908786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153617025|NCT05908786|Growth Substances|growth substances|mesh-ancestor
153617026|NCT05908786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617027|NCT05908786|Growth Inhibitors|growth inhibitors|mesh-ancestor
153617028|NCT05908786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153617029|NCT05908786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813985|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617045|NCT05890027|Oxymetazoline|oxymetazoline|mesh-list
153617046|NCT05890027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153617047|NCT05890027|Mydriatics|mydriatics|mesh-ancestor
153617048|NCT05890027|Autonomic Agents|autonomic agents|mesh-ancestor
153617049|NCT05890027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617050|NCT05890027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617051|NCT05890027|Sympathomimetics|sympathomimetics|mesh-ancestor
153617052|NCT05890027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153617053|NCT05890027|Nasal Decongestants|nasal decongestants|mesh-ancestor
153617069|NCT05856331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153617070|NCT05856331|Protease Inhibitors|protease inhibitors|mesh-ancestor
153617071|NCT05856331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617072|NCT05856331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617082|NCT05829460|Semaglutide|semaglutide|mesh-list
153617083|NCT05829460|Progestins|progestins|mesh-list
153617084|NCT05829460|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153617085|NCT05829460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153617086|NCT05829460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617087|NCT05829460|Hormones|hormones|mesh-ancestor
153617088|NCT05829460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344900|NCT05148884|Befiradol|befiradol|mesh-list
153617098|NCT05797246|Bevacizumab|bevacizumab|mesh-list
153617099|NCT05797246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617235|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617236|NCT05702905|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153617237|NCT05673200|Paclitaxel|paclitaxel|mesh-list
153617238|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
153617239|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153617240|NCT05673200|Decitabine|decitabine|mesh-list
153617241|NCT05673200|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153617242|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345040|NCT03377491|Paclitaxel|paclitaxel|mesh-list
153462439|NCT00982020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153617243|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617314|NCT05570825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617315|NCT05564598|Valganciclovir|valganciclovir|mesh-list
153617316|NCT05564598|Ganciclovir|ganciclovir|mesh-list
153617317|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
153617318|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617368|NCT05544929|Pembrolizumab|pembrolizumab|mesh-list
153617495|NCT05183035|Cytarabine|cytarabine|mesh-list
153617496|NCT05183035|Fludarabine|fludarabine|mesh-list
153617497|NCT05183035|Azacitidine|azacitidine|mesh-list
153617498|NCT05183035|Venetoclax|venetoclax|mesh-list
153617499|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
153617500|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617501|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153617502|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
153617503|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617504|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153617505|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
153617506|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617507|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
153617508|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617509|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617510|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617511|NCT05183035|Immunotoxins|immunotoxins|mesh-ancestor
153617512|NCT05183035|Immunoconjugates|immunoconjugates|mesh-ancestor
153617513|NCT05180942|Atorvastatin|atorvastatin|mesh-list
153617514|NCT05180942|Calcium|calcium|mesh-list
153617515|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153617516|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617517|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153617518|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153617519|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
153617520|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617521|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153617522|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153617523|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617524|NCT05176951|Treprostinil|treprostinil|mesh-list
153617525|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153617526|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
153617527|NCT05172258|Ipatasertib|ipatasertib|mesh-list
153617528|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617529|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617536|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153617537|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617538|NCT05157360|Vitamins|vitamins|mesh-list
153617539|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
153617540|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
153382295|NCT02299349|Analgesics|analgesics|mesh-ancestor
153617541|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462479|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
153462480|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153617542|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153617543|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
153617544|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153617545|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153617546|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153617547|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153617550|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617623|NCT05031780|Enzyme Activators|enzyme activators|mesh-ancestor
153617624|NCT05031780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617626|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153617627|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
153617628|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153617629|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781991|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153617630|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153617631|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153617632|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
153617633|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617634|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617635|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153617636|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153617637|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
153617638|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153617639|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617640|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617641|NCT04992624|Dronabinol|dronabinol|mesh-list
153617642|NCT04992624|Cannabidiol|cannabidiol|mesh-list
153617643|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
153617685|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617686|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153617689|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
153617690|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617702|NCT04883749|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153617703|NCT04883749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153617704|NCT04883749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153617705|NCT04883749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617706|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617707|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
153617708|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153617757|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153617758|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153617759|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153617760|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617761|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
153617762|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153617763|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
153617764|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153617838|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153617839|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
153617840|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
153617841|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
153617842|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153617843|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
153618003|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153618004|NCT04199468|Hormones|hormones|mesh-ancestor
153618005|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618006|NCT04195750|Everolimus|everolimus|mesh-list
153618007|NCT04195750|Belzutifan|belzutifan|mesh-list
153618008|NCT04195750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153618009|NCT04195750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153618010|NCT04195750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781992|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
153618011|NCT04195750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618012|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618013|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
153618014|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618015|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618017|NCT04183790|Elexacaftor|elexacaftor|mesh-list
153618018|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153618019|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153618040|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153618078|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153618079|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618080|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
153618081|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153618082|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618083|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153781993|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618084|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153618085|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153462680|NCT04123392|Busulfan|busulfan|mesh-list
153618086|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153618087|NCT04065399|Cobicistat|cobicistat|mesh-list
153618088|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153618089|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153618090|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
153618091|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618092|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153618093|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153618136|NCT03816332|Hormones|hormones|mesh-ancestor
153618137|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618138|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462791|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153462792|NCT04129710|Growth Substances|growth substances|mesh-ancestor
153618139|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618140|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618141|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618142|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618143|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618144|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618145|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
153618205|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153618206|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153618207|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153813992|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
153813993|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618208|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
153618209|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618210|NCT03763162|Dexamethasone|dexamethasone|mesh-list
153618211|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
153618212|NCT03763162|Bortezomib|bortezomib|mesh-list
153618213|NCT03763162|Daratumumab|daratumumab|mesh-list
153618214|NCT03763162|Ixazomib|ixazomib|mesh-list
153618215|NCT03763162|Ichthammol|ichthammol|mesh-list
153618216|NCT03763162|BB 1101|bb 1101|mesh-list
153618217|NCT03763162|Glycine|glycine|mesh-list
153618218|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153618219|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
153618221|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618222|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618223|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153618224|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
153618225|NCT03763162|Hormones|hormones|mesh-ancestor
153618226|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618227|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618228|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618229|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
153618230|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618231|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814002|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462796|NCT03200808|Methylene Blue|methylene blue|mesh-list
153618232|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
153618233|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
153618234|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153618251|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618252|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
153618253|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618254|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618255|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
153618256|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618257|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153618258|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153618259|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153618260|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618261|NCT03606967|Poly I-C|poly i-c|mesh-list
153618262|NCT03606967|Paclitaxel|paclitaxel|mesh-list
153618263|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153618264|NCT03606967|Carboplatin|carboplatin|mesh-list
153618265|NCT03606967|Gemcitabine|gemcitabine|mesh-list
153618266|NCT03606967|Durvalumab|durvalumab|mesh-list
153618313|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
153781996|NCT00259701|Acetylcholine|acetylcholine|mesh-list
153618314|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618315|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153618316|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153618317|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153618318|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153618319|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618320|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153618321|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153618322|NCT03571737|Analgesics|analgesics|mesh-ancestor
153618323|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153462869|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153618324|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618325|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153618326|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618327|NCT03564691|Paclitaxel|paclitaxel|mesh-list
153618328|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153618329|NCT03564691|Cisplatin|cisplatin|mesh-list
153618330|NCT03564691|Carboplatin|carboplatin|mesh-list
153618331|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
153618332|NCT03564691|Pemetrexed|pemetrexed|mesh-list
153618333|NCT03564691|Lenvatinib|lenvatinib|mesh-list
153618334|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153618335|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618336|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618337|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
153618338|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
153618339|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618340|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618357|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153618358|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618359|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618360|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153618361|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
153618365|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618366|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153618367|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618368|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618369|NCT03346668|Gabapentin|gabapentin|mesh-list
153618370|NCT03346668|Analgesics|analgesics|mesh-ancestor
153618371|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
153618372|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618373|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618374|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
153618375|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153618376|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153618378|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153618442|NCT03257215|Vitamin D|vitamin d|mesh-list
153618443|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
153618444|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
153618445|NCT03257215|Vitamins|vitamins|mesh-list
153618446|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
153618447|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618448|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153618449|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153618450|NCT03220035|Vemurafenib|vemurafenib|mesh-list
153618451|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618452|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153618453|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618454|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618455|NCT03217747|Avelumab|avelumab|mesh-list
153618471|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618472|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618473|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618502|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
153618503|NCT02936752|Entinostat|entinostat|mesh-list
153618504|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153618505|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618506|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618510|NCT02921997|Vaccines|vaccines|mesh-list
153618540|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153618541|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153618542|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153618543|NCT02828358|Cortisone|cortisone|mesh-list
153618544|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
153618545|NCT02828358|Methotrexate|methotrexate|mesh-list
153618546|NCT02828358|Vincristine|vincristine|mesh-list
153618547|NCT02828358|Azacitidine|azacitidine|mesh-list
153618548|NCT02828358|Daunorubicin|daunorubicin|mesh-list
153618549|NCT02828358|Asparaginase|asparaginase|mesh-list
153618550|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
153618608|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618609|NCT02779751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618610|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618611|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153618613|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153618614|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618615|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153618616|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
153618618|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781997|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
153618620|NCT02649790|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153618621|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153618622|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
153618623|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
153618624|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618625|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618685|NCT02057133|Tamoxifen|tamoxifen|mesh-list
153618686|NCT02057133|Trastuzumab|trastuzumab|mesh-list
153618687|NCT02057133|Pertuzumab|pertuzumab|mesh-list
153618688|NCT02057133|Everolimus|everolimus|mesh-list
153618689|NCT02057133|Letrozole|letrozole|mesh-list
153618690|NCT02057133|Fulvestrant|fulvestrant|mesh-list
153618691|NCT02057133|Anastrozole|anastrozole|mesh-list
153618692|NCT02057133|Exemestane|exemestane|mesh-list
153618693|NCT02057133|Loperamide|loperamide|mesh-list
153618694|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618695|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618696|NCT02057133|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153618697|NCT02057133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153618698|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618699|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618700|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618701|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
153618702|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463066|NCT04392648|Bortezomib|bortezomib|mesh-list
153618703|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153618704|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153618705|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153618714|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153618732|NCT01737502|Auranofin|auranofin|mesh-list
153618733|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153618734|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618735|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153618736|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618737|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
153618738|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153618739|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
153618740|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618741|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153618742|NCT01572480|Dexamethasone|dexamethasone|mesh-list
153618743|NCT01572480|Lenalidomide|lenalidomide|mesh-list
153618744|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153618745|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
153618746|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
153618747|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618748|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618749|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153618750|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
153618751|NCT01572480|Hormones|hormones|mesh-ancestor
153618779|NCT01046825|Leucovorin|leucovorin|mesh-list
153618780|NCT01046825|Folic Acid|folic acid|mesh-list
153618781|NCT01046825|Cytarabine|cytarabine|mesh-list
153463116|NCT02952222|Analgesics|analgesics|mesh-ancestor
153618782|NCT01046825|Prednisone|prednisone|mesh-list
153618783|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
153618792|NCT01046825|Hormones|hormones|mesh-ancestor
153347301|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
153347795|NCT01439815|Xhance|xhance|mesh-list
153347981|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
153348065|NCT01445821|Hormones|hormones|mesh-ancestor
153348130|NCT00183794|Gemcitabine|gemcitabine|mesh-list
153348641|NCT04352153|Febuxostat|febuxostat|mesh-list
153349081|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
153349547|NCT01791608|Zinc|zinc|mesh-list
153781998|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153349678|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
153349751|NCT01225289|Vitamin A|vitamin a|mesh-list
153350015|NCT05344404|Niacin|niacin|mesh-list
153350053|NCT01793948|Metformin|metformin|mesh-list
153350276|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153350369|NCT05902078|Calcitriol|calcitriol|mesh-list
153350420|NCT05901571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153351317|NCT02271230|Vitamin D|vitamin d|mesh-list
153352322|NCT00533546|Protein C|protein c|mesh-list
153354163|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
153354239|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153354461|NCT00576680|Temozolomide|temozolomide|mesh-list
153354701|NCT04224194|Adalimumab|adalimumab|mesh-list
153354837|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
153355062|NCT01582477|Bupivacaine|bupivacaine|mesh-list
153355207|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
153355284|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
153355433|NCT03006445|Dotinurad|dotinurad|mesh-list
153355507|NCT00684242|Lenalidomide|lenalidomide|mesh-list
153355952|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153356031|NCT00646646|Midazolam|midazolam|mesh-list
153356407|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
153356551|NCT01511042|Giapreza|giapreza|mesh-list
153356627|NCT02990858|Leronlimab|leronlimab|mesh-list
153356698|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153356927|NCT00729482|Everolimus|everolimus|mesh-list
153819677|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153395943|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396092|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463694|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396316|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153396719|NCT01943461|Avelumab|avelumab|mesh-list
153397521|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
153398041|NCT04748887|Protective Agents|protective agents|mesh-ancestor
153398118|NCT05349071|Prednisolone|prednisolone|mesh-list
153398734|NCT01996657|Warfarin|warfarin|mesh-list
153819734|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819735|NCT00429962|Ranibizumab|ranibizumab|mesh-list
153819736|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153463850|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
153819737|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153819738|NCT00429962|Growth Substances|growth substances|mesh-ancestor
153819739|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461142|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461143|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461144|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153461145|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153461146|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
153461147|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461148|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153461149|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153461150|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
153819744|NCT00430001|Vinorelbine|vinorelbine|mesh-list
153819745|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819746|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
153819747|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
153819748|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
153819749|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819750|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461152|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153461153|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461154|NCT03086538|Pemetrexed|pemetrexed|mesh-list
153461155|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153461156|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461157|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461158|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461159|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153461160|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153461161|NCT03086538|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153461162|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153461163|NCT03473730|Daratumumab|daratumumab|mesh-list
153461220|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153461221|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461222|NCT03417492|Urological Agents|urological agents|mesh-ancestor
153461224|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153461225|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
153461226|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461227|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464062|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
153461228|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461229|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
153819862|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
153819863|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819864|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153819865|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819866|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461269|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461270|NCT03086382|Lacosamide|lacosamide|mesh-list
153461271|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
153814183|NCT00444834|Carvedilol|carvedilol|mesh-list
153781770|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
153461272|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153461273|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153461274|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153461275|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461276|NCT03086226|Itraconazole|itraconazole|mesh-list
153461277|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
153461278|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461279|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153461280|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153461286|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461287|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153461288|NCT03085992|Bevacizumab|bevacizumab|mesh-list
153461289|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153819877|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153819888|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461290|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461291|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153461292|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153461293|NCT03085992|Growth Substances|growth substances|mesh-ancestor
153461294|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461295|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
153461296|NCT03086070|Omeprazole|omeprazole|mesh-list
153461314|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153461315|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153461316|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464377|NCT01711632|Vemurafenib|vemurafenib|mesh-list
153461317|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461318|NCT03359538|Sirolimus|sirolimus|mesh-list
153461319|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153461320|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461321|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153461322|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461323|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
153461324|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819906|NCT00470379|Immunologic Factors|immunologic factors|mesh-ancestor
153819907|NCT00470379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819908|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
153819909|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153461334|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461335|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461336|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153461337|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
153461338|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461339|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461340|NCT02336958|Ropivacaine|ropivacaine|mesh-list
153461341|NCT02336958|Prilocaine|prilocaine|mesh-list
153461342|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
153461343|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
153461344|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461345|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819932|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
153819933|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153819934|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
153819935|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153819936|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819937|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153819938|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153819939|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819940|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153819942|NCT02957409|Valsartan|valsartan|mesh-list
153819943|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153819944|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153461350|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461351|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461352|NCT03085368|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153461353|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153461365|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153461366|NCT03084588|Narcotics|narcotics|mesh-ancestor
153461367|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461368|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461369|NCT03084588|Analgesics|analgesics|mesh-ancestor
153461370|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
153461371|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461372|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
153461373|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
153461374|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
153461375|NCT05345574|Remifentanil|remifentanil|mesh-list
153461376|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153828189|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153828190|NCT01307020|Ketoprofen|ketoprofen|mesh-list
153828191|NCT01307020|Tramadol|tramadol|mesh-list
153828251|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828252|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828253|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828254|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828255|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153828256|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153828257|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828258|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828259|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
153828260|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153828261|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153828262|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153828263|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
153828264|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
153828265|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828266|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828267|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
153368268|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153828281|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828283|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153828284|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153828285|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
153828286|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828287|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368313|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828289|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
153828290|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
153368329|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
153368330|NCT03013010|Tegafur|tegafur|mesh-list
153368331|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368332|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153368349|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153368350|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153464448|NCT05580042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153368351|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368352|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368353|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153368354|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
153368355|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368356|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368387|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
153828385|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153828386|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
153828387|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153828388|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153828390|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153828391|NCT00484055|Gentamicins|gentamicins|mesh-list
153828392|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368421|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
153368422|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368423|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368425|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
153368426|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368427|NCT02469597|Furosemide|furosemide|mesh-list
153368428|NCT02469597|Diuretics|diuretics|mesh-ancestor
153368429|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
153368430|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368431|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153368432|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153368433|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368434|NCT02183792|Furosemide|furosemide|mesh-list
153368435|NCT02183792|Tolvaptan|tolvaptan|mesh-list
153368436|NCT02183792|Diuretics|diuretics|mesh-ancestor
153368437|NCT0218